id|nct_id|result_group_id|ctgov_group_code|period|reason|count
7800987|NCT01098461|12258569|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
7883779|NCT01785069|12383753|FG000|Overall Study|Implanted with nonstudy device|1
7883780|NCT01785069|12383754|FG001|Overall Study|Implanted with nonstudy device|2
7883781|NCT01785069|12383755|FG002|Overall Study|Implanted with nonstudy device|1
7883782|NCT01785069|12383756|FG003|Overall Study|Implanted with nonstudy device|0
7883783|NCT01785069|12383753|FG000|Overall Study|Death|0
7883784|NCT01785069|12383754|FG001|Overall Study|Death|0
7883785|NCT01785069|12383755|FG002|Overall Study|Death|2
7883786|NCT01785069|12383756|FG003|Overall Study|Death|0
7883787|NCT01785069|12383753|FG000|Overall Study|Subject choice|2
7883788|NCT01785069|12383754|FG001|Overall Study|Subject choice|2
7883789|NCT01785069|12383755|FG002|Overall Study|Subject choice|0
7883790|NCT01785069|12383756|FG003|Overall Study|Subject choice|1
7883791|NCT01785069|12383753|FG000|Overall Study|Lost to Follow-up|1
7883792|NCT01785069|12383754|FG001|Overall Study|Lost to Follow-up|2
7883793|NCT01785069|12383755|FG002|Overall Study|Lost to Follow-up|4
7883794|NCT01785069|12383756|FG003|Overall Study|Lost to Follow-up|1
7883795|NCT01785069|12383753|FG000|Overall Study|Reason not Specified|1
7883796|NCT01785069|12383754|FG001|Overall Study|Reason not Specified|2
7883797|NCT01785069|12383755|FG002|Overall Study|Reason not Specified|1
7883798|NCT01785069|12383756|FG003|Overall Study|Reason not Specified|4
7883799|NCT01785069|12383753|FG000|Overall Study|Not evaluable|7
7883800|NCT01785069|12383754|FG001|Overall Study|Not evaluable|4
7883801|NCT01785069|12383755|FG002|Overall Study|Not evaluable|5
7883802|NCT01785069|12383756|FG003|Overall Study|Not evaluable|8
7883803|NCT01785160|12383782|FG000|Treatment Period 1: Raltegravir|Not treated|1
7883804|NCT01785160|12383782|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1
7962743|NCT02714569|12517082|FG002|Part A Third Intervention|Adverse Event|1
7962744|NCT02714569|12517083|FG003|Part A Third Intervention|Adverse Event|0
7962745|NCT02714569|12517084|FG004|Part A Third Intervention|Adverse Event|0
7962746|NCT02714569|12517085|FG005|Part A Third Intervention|Adverse Event|0
7962747|NCT02714569|12517086|FG006|Part A Third Intervention|Adverse Event|0
7962748|NCT02714569|12517087|FG007|Part A Third Intervention|Adverse Event|0
7962749|NCT02714569|12517088|FG008|Part A Third Intervention|Adverse Event|0
7962750|NCT02714569|12517089|FG009|Part A Third Intervention|Adverse Event|0
7962751|NCT02714569|12517090|FG010|Part A Third Intervention|Adverse Event|0
7962752|NCT02714569|12517080|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1
7962753|NCT02714569|12517081|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7962754|NCT02714569|12517082|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7962755|NCT02714569|12517083|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7962756|NCT02714569|12517084|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7962757|NCT02714569|12517085|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1
7962758|NCT02714569|12517086|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7962759|NCT02714569|12517087|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7962760|NCT02714569|12517088|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7962761|NCT02714569|12517089|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7962762|NCT02714569|12517090|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7962763|NCT02714569|12517080|FG000|Part B (Overall)|Lost to Follow-up|0
7962764|NCT02714569|12517081|FG001|Part B (Overall)|Lost to Follow-up|0
7962765|NCT02714569|12517082|FG002|Part B (Overall)|Lost to Follow-up|0
7962766|NCT02714569|12517083|FG003|Part B (Overall)|Lost to Follow-up|0
7962767|NCT02714569|12517084|FG004|Part B (Overall)|Lost to Follow-up|0
7962768|NCT02714569|12517085|FG005|Part B (Overall)|Lost to Follow-up|0
7962769|NCT02714569|12517086|FG006|Part B (Overall)|Lost to Follow-up|1
7962770|NCT02714569|12517087|FG007|Part B (Overall)|Lost to Follow-up|0
7962771|NCT02714569|12517088|FG008|Part B (Overall)|Lost to Follow-up|0
7962772|NCT02714569|12517089|FG009|Part B (Overall)|Lost to Follow-up|0
7962773|NCT02714569|12517090|FG010|Part B (Overall)|Lost to Follow-up|0
7962774|NCT02714569|12517080|FG000|Part B (Overall)|Withdrawal by Subject|0
7962775|NCT02714569|12517081|FG001|Part B (Overall)|Withdrawal by Subject|0
7962776|NCT02714569|12517082|FG002|Part B (Overall)|Withdrawal by Subject|0
7962777|NCT02714569|12517083|FG003|Part B (Overall)|Withdrawal by Subject|0
7962778|NCT02714569|12517084|FG004|Part B (Overall)|Withdrawal by Subject|0
7962779|NCT02714569|12517085|FG005|Part B (Overall)|Withdrawal by Subject|0
7962780|NCT02714569|12517086|FG006|Part B (Overall)|Withdrawal by Subject|0
7962781|NCT02714569|12517087|FG007|Part B (Overall)|Withdrawal by Subject|1
7962782|NCT02714569|12517088|FG008|Part B (Overall)|Withdrawal by Subject|0
7962783|NCT02714569|12517089|FG009|Part B (Overall)|Withdrawal by Subject|1
7962784|NCT02714569|12517090|FG010|Part B (Overall)|Withdrawal by Subject|0
7962785|NCT02714569|12517080|FG000|Part B (Overall)|Adverse Event|0
7962786|NCT02714569|12517081|FG001|Part B (Overall)|Adverse Event|0
7962787|NCT02714569|12517082|FG002|Part B (Overall)|Adverse Event|0
7962788|NCT02714569|12517083|FG003|Part B (Overall)|Adverse Event|0
7962789|NCT02714569|12517084|FG004|Part B (Overall)|Adverse Event|0
7962790|NCT02714569|12517085|FG005|Part B (Overall)|Adverse Event|0
7962791|NCT02714569|12517086|FG006|Part B (Overall)|Adverse Event|0
7962792|NCT02714569|12517087|FG007|Part B (Overall)|Adverse Event|0
7962793|NCT02714569|12517088|FG008|Part B (Overall)|Adverse Event|0
7800988|NCT01098461|12258570|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
7800989|NCT01098461|12258571|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
7800990|NCT01098461|12258572|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
7800991|NCT01098461|12258569|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1
7800992|NCT01098461|12258570|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2
7800993|NCT01098461|12258571|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1
7800994|NCT01098461|12258572|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3
7883805|NCT01785472|12383814|FG000|Overall Study|Adverse Event|5
7883806|NCT01785472|12383815|FG001|Overall Study|Adverse Event|4
7883807|NCT01785472|12383816|FG002|Overall Study|Adverse Event|6
7883808|NCT01785472|12383814|FG000|Overall Study|Lack of Efficacy|2
7883809|NCT01785472|12383815|FG001|Overall Study|Lack of Efficacy|0
7883810|NCT01785472|12383816|FG002|Overall Study|Lack of Efficacy|1
7883811|NCT01785472|12383814|FG000|Overall Study|Lost to Follow-up|1
7883812|NCT01785472|12383815|FG001|Overall Study|Lost to Follow-up|2
7883813|NCT01785472|12383816|FG002|Overall Study|Lost to Follow-up|0
7883814|NCT01785472|12383814|FG000|Overall Study|Physician Decision|1
7883815|NCT01785472|12383815|FG001|Overall Study|Physician Decision|1
7883816|NCT01785472|12383816|FG002|Overall Study|Physician Decision|1
7883817|NCT01785472|12383814|FG000|Overall Study|Protocol deviation|0
7883818|NCT01785472|12383815|FG001|Overall Study|Protocol deviation|2
7883819|NCT01785472|12383816|FG002|Overall Study|Protocol deviation|2
7883820|NCT01785472|12383814|FG000|Overall Study|Subject/guardian decision|15
7883821|NCT01785472|12383815|FG001|Overall Study|Subject/guardian decision|10
7883822|NCT01785472|12383816|FG002|Overall Study|Subject/guardian decision|11
7883823|NCT01785472|12383814|FG000|Overall Study|Technical problems|0
7883824|NCT01785472|12383815|FG001|Overall Study|Technical problems|0
7883825|NCT01785472|12383816|FG002|Overall Study|Technical problems|1
7883826|NCT01785524|12383828|FG000|Overall Study|Withdrawal by Subject|2
7883827|NCT01785524|12383829|FG001|Overall Study|Withdrawal by Subject|2
7883828|NCT01785602|12383837|FG000|Overall Study|Withdrawal by Subject|2
7883829|NCT01785602|12383838|FG001|Overall Study|Withdrawal by Subject|0
7883830|NCT01785602|12383837|FG000|Overall Study|Lost to Follow-up|1
7883831|NCT01785602|12383838|FG001|Overall Study|Lost to Follow-up|1
7883832|NCT01785602|12383837|FG000|Overall Study|Adverse Event|3
7883833|NCT01785602|12383838|FG001|Overall Study|Adverse Event|5
7883834|NCT01785602|12383837|FG000|Overall Study|Administrative problems|7
7883835|NCT01785602|12383838|FG001|Overall Study|Administrative problems|3
7883836|NCT01785615|12383847|FG000|Dietary Phase|Lost to Follow-up|0
7883837|NCT01785615|12383848|FG001|Dietary Phase|Lost to Follow-up|0
7883838|NCT01785615|12383849|FG002|Dietary Phase|Lost to Follow-up|0
7883839|NCT01785615|12383850|FG003|Dietary Phase|Lost to Follow-up|24
7883840|NCT01785628|12383864|FG000|Overall Study|Lost to Follow-up|2
7883841|NCT01785628|12383865|FG001|Overall Study|Lost to Follow-up|3
7883842|NCT01785849|12383886|FG000|Overall Study|Death|7
7883843|NCT01785849|12383887|FG001|Overall Study|Death|9
7883844|NCT01785849|12383886|FG000|Overall Study|Protocol Specified Criteria|29
7883845|NCT01785849|12383887|FG001|Overall Study|Protocol Specified Criteria|1
7883846|NCT01785849|12383886|FG000|Overall Study|Withdrawal by Subject|15
7967297|NCT02764190|12524039|FG000|Overall Study|Lost to Follow-up|17
7967298|NCT02764190|12524040|FG001|Overall Study|Lost to Follow-up|13
7967299|NCT02764229|12524046|FG000|Overall Study|Withdrawal by Subject|15
7883847|NCT01785849|12383887|FG001|Overall Study|Withdrawal by Subject|12
7883848|NCT01785849|12383886|FG000|Overall Study|Sponsor Decision|0
7883849|NCT01785849|12383887|FG001|Overall Study|Sponsor Decision|1
7883850|NCT01785849|12383886|FG000|Overall Study|Lost to Follow-up|10
7883851|NCT01785849|12383887|FG001|Overall Study|Lost to Follow-up|11
7883852|NCT01785875|12383893|FG000|Overall Study|Withdrawal by Subject|41
7883853|NCT01785875|12383894|FG001|Overall Study|Withdrawal by Subject|34
7883854|NCT01785875|12383895|FG002|Overall Study|Withdrawal by Subject|36
7883855|NCT01785875|12383893|FG000|Overall Study|Lost to Follow-up|19
7883856|NCT01785875|12383894|FG001|Overall Study|Lost to Follow-up|22
7883857|NCT01785875|12383895|FG002|Overall Study|Lost to Follow-up|6
7883858|NCT01785875|12383893|FG000|Overall Study|Death|27
7883859|NCT01785875|12383894|FG001|Overall Study|Death|16
7883860|NCT01785875|12383895|FG002|Overall Study|Death|7
7883861|NCT01785875|12383893|FG000|Overall Study|Sponsor Decision|0
7883862|NCT01785875|12383894|FG001|Overall Study|Sponsor Decision|2
7883863|NCT01785875|12383895|FG002|Overall Study|Sponsor Decision|0
7883864|NCT01785875|12383893|FG000|Overall Study|Protocol Specified Criteria|207
7883865|NCT01785875|12383894|FG001|Overall Study|Protocol Specified Criteria|214
7883866|NCT01785875|12383895|FG002|Overall Study|Protocol Specified Criteria|55
7883867|NCT01785875|12383893|FG000|Overall Study|Missing|0
7883868|NCT01785875|12383894|FG001|Overall Study|Missing|1
7883869|NCT01785875|12383895|FG002|Overall Study|Missing|3
7883870|NCT01786109|12383909|FG000|Overall Study|fail manometry barostat tube placement|1
7883871|NCT01786109|12383910|FG001|Overall Study|fail manometry barostat tube placement|0
7883872|NCT01786109|12383911|FG002|Overall Study|fail manometry barostat tube placement|0
7883873|NCT01786109|12383909|FG000|Overall Study|unrelated illness|0
7883874|NCT01786109|12383910|FG001|Overall Study|unrelated illness|0
7883875|NCT01786109|12383911|FG002|Overall Study|unrelated illness|1
7883876|NCT01786109|12383909|FG000|Overall Study|adverse effects colon preparation|0
7883877|NCT01786109|12383910|FG001|Overall Study|adverse effects colon preparation|0
7883878|NCT01786109|12383911|FG002|Overall Study|adverse effects colon preparation|1
7883879|NCT01786148|12383921|FG000|Overall Study|Lost to Follow-up|21
7883880|NCT01786148|12383922|FG001|Overall Study|Lost to Follow-up|13
7883881|NCT01786148|12383921|FG000|Overall Study|Death|0
7883882|NCT01786148|12383922|FG001|Overall Study|Death|1
7883883|NCT01786148|12383921|FG000|Overall Study|Withdrawal by Subject|0
7883884|NCT01786148|12383922|FG001|Overall Study|Withdrawal by Subject|7
7883885|NCT01786148|12383921|FG000|Overall Study|Incarceration|1
7883886|NCT01786148|12383922|FG001|Overall Study|Incarceration|1
7883887|NCT01786174|12383941|FG000|Overall Study|Discontinued Study Drug|2
7883888|NCT01786174|12383942|FG001|Overall Study|Discontinued Study Drug|0
7883889|NCT01786330|12383980|FG000|Overall Study|Withdrawal by Subject|0
7883890|NCT01786330|12383981|FG001|Overall Study|Withdrawal by Subject|1
7883891|NCT01786330|12383980|FG000|Overall Study|Lost to Follow-up|0
7883892|NCT01786330|12383981|FG001|Overall Study|Lost to Follow-up|1
7883893|NCT01786330|12383980|FG000|Overall Study|Excluded intraoperatively|0
7883894|NCT01786330|12383981|FG001|Overall Study|Excluded intraoperatively|1
7883895|NCT01786330|12383980|FG000|Overall Study|Protocol Violation|1
7883896|NCT01786330|12383981|FG001|Overall Study|Protocol Violation|0
7883897|NCT01786512|12384007|FG000|Overall Study|Lost to Follow-up|0
7883898|NCT01786512|12384008|FG001|Overall Study|Lost to Follow-up|0
7883899|NCT01786512|12384009|FG002|Overall Study|Lost to Follow-up|0
7883900|NCT01786512|12384010|FG003|Overall Study|Lost to Follow-up|0
7883901|NCT01786512|12384011|FG004|Overall Study|Lost to Follow-up|0
7883902|NCT01786512|12384012|FG005|Overall Study|Lost to Follow-up|0
7883903|NCT01786512|12384013|FG006|Overall Study|Lost to Follow-up|0
7883904|NCT01786512|12384014|FG007|Overall Study|Lost to Follow-up|0
7883905|NCT01786512|12384015|FG008|Overall Study|Lost to Follow-up|0
7883906|NCT01786512|12384016|FG009|Overall Study|Lost to Follow-up|1
7883907|NCT01786512|12384017|FG010|Overall Study|Lost to Follow-up|0
7883908|NCT01786512|12384007|FG000|Overall Study|Decision by sponsor|0
7883909|NCT01786512|12384008|FG001|Overall Study|Decision by sponsor|0
7883910|NCT01786512|12384009|FG002|Overall Study|Decision by sponsor|0
7883911|NCT01786512|12384010|FG003|Overall Study|Decision by sponsor|0
7883912|NCT01786512|12384011|FG004|Overall Study|Decision by sponsor|0
7883913|NCT01786512|12384012|FG005|Overall Study|Decision by sponsor|0
7883914|NCT01786512|12384013|FG006|Overall Study|Decision by sponsor|0
7883915|NCT01786512|12384014|FG007|Overall Study|Decision by sponsor|0
7883916|NCT01786512|12384015|FG008|Overall Study|Decision by sponsor|0
7883917|NCT01786512|12384016|FG009|Overall Study|Decision by sponsor|0
7883918|NCT01786512|12384017|FG010|Overall Study|Decision by sponsor|2
7883919|NCT01786512|12384007|FG000|Overall Study|Withdrawal by Subject|0
7883920|NCT01786512|12384008|FG001|Overall Study|Withdrawal by Subject|1
7883921|NCT01786512|12384009|FG002|Overall Study|Withdrawal by Subject|0
7883922|NCT01786512|12384010|FG003|Overall Study|Withdrawal by Subject|0
7883923|NCT01786512|12384011|FG004|Overall Study|Withdrawal by Subject|0
7883924|NCT01786512|12384012|FG005|Overall Study|Withdrawal by Subject|0
7883925|NCT01786512|12384013|FG006|Overall Study|Withdrawal by Subject|1
7883926|NCT01786512|12384014|FG007|Overall Study|Withdrawal by Subject|0
7883927|NCT01786512|12384015|FG008|Overall Study|Withdrawal by Subject|0
7883928|NCT01786512|12384016|FG009|Overall Study|Withdrawal by Subject|3
7883929|NCT01786512|12384017|FG010|Overall Study|Withdrawal by Subject|7
7883930|NCT01786512|12384007|FG000|Overall Study|Death|0
7883931|NCT01786512|12384008|FG001|Overall Study|Death|0
7883932|NCT01786512|12384009|FG002|Overall Study|Death|0
7883933|NCT01786512|12384010|FG003|Overall Study|Death|0
7883934|NCT01786512|12384011|FG004|Overall Study|Death|0
7883935|NCT01786512|12384012|FG005|Overall Study|Death|0
7883936|NCT01786512|12384013|FG006|Overall Study|Death|0
7883937|NCT01786512|12384014|FG007|Overall Study|Death|0
7883938|NCT01786512|12384015|FG008|Overall Study|Death|4
7883939|NCT01786512|12384016|FG009|Overall Study|Death|1
7883940|NCT01786512|12384017|FG010|Overall Study|Death|3
7883941|NCT01786551|12384049|FG000|Overall Study|Participant withdrew consent|2
7883942|NCT01786564|12384053|FG000|Overall Study|Lost to Follow-up|47
7883943|NCT01786564|12384053|FG000|Overall Study|Ineligible|17
7967300|NCT02764229|12524046|FG000|Overall Study|Adverse Event|9
7967301|NCT02764229|12524046|FG000|Overall Study|Physician Decision|5
7967302|NCT02764229|12524046|FG000|Overall Study|Lost to Follow-up|3
7967303|NCT02764229|12524046|FG000|Overall Study|Lack of Efficacy|1
7967304|NCT02764229|12524046|FG000|Overall Study|Study Stopped by Sponsor|69
7967305|NCT02764320|12524052|FG000|Overall Study|Withdrawal by Subject|35
7967306|NCT02764320|12524053|FG001|Overall Study|Withdrawal by Subject|38
7967307|NCT02764320|12524052|FG000|Overall Study|Protocol Violation|11
7967308|NCT02764320|12524053|FG001|Overall Study|Protocol Violation|6
7967309|NCT02764320|12524052|FG000|Overall Study|Adverse Event|2
7967310|NCT02764320|12524053|FG001|Overall Study|Adverse Event|0
7967311|NCT02764320|12524052|FG000|Overall Study|Health Issues unable to continue|2
7967312|NCT02764320|12524053|FG001|Overall Study|Health Issues unable to continue|0
7967313|NCT02764320|12524052|FG000|Overall Study|Did not meet inclusion criteria|1
7967314|NCT02764320|12524053|FG001|Overall Study|Did not meet inclusion criteria|0
7967315|NCT02764320|12524052|FG000|Overall Study|Subject moved|0
7967316|NCT02764320|12524053|FG001|Overall Study|Subject moved|2
7967317|NCT02764320|12524052|FG000|Overall Study|Overused medication unavailable|0
7967318|NCT02764320|12524053|FG001|Overall Study|Overused medication unavailable|1
7967319|NCT02764320|12524052|FG000|Overall Study|Seeking care outside site|0
7967320|NCT02764320|12524053|FG001|Overall Study|Seeking care outside site|1
7967321|NCT02764320|12524052|FG000|Overall Study|Technology barriers|0
7967322|NCT02764320|12524053|FG001|Overall Study|Technology barriers|1
7967323|NCT02764333|12524059|FG000|Overall Study|Ineligible|1
7967324|NCT02764697|12524072|FG000|Overall Study|Lack of Efficacy|3
7967325|NCT02764775|12524076|FG000|Overall Study|Death|1
7967326|NCT02764775|12524076|FG000|Overall Study|Lost to Follow-up|2
7967327|NCT02764775|12524076|FG000|Overall Study|Withdrawal by Subject|3
7967328|NCT02765035|12524091|FG000|First Intervention (90 Days)|Adverse Event|1
7967329|NCT02765035|12524092|FG001|First Intervention (90 Days)|Adverse Event|1
7967330|NCT02765035|12524091|FG000|Second Intervention (30 Days)|Protocol Violation|2
7967331|NCT02765035|12524092|FG001|Second Intervention (30 Days)|Protocol Violation|2
7967332|NCT02765100|12524101|FG000|Overall Study|subject found ineligible after baseline|1
7967333|NCT02765100|12524102|FG001|Overall Study|subject found ineligible after baseline|1
7967334|NCT02765100|12524101|FG000|Overall Study|Lost to Follow-up|0
7967335|NCT02765100|12524102|FG001|Overall Study|Lost to Follow-up|1
7967336|NCT02765165|12524115|FG000|Treatment Period|Progressive disease|3
7967337|NCT02765165|12524116|FG001|Treatment Period|Progressive disease|2
7967338|NCT02765165|12524117|FG002|Treatment Period|Progressive disease|3
7967339|NCT02765165|12524118|FG003|Treatment Period|Progressive disease|3
7967340|NCT02765165|12524119|FG004|Treatment Period|Progressive disease|4
7967341|NCT02765165|12524120|FG005|Treatment Period|Progressive disease|2
7967342|NCT02765165|12524121|FG006|Treatment Period|Progressive disease|2
7967343|NCT02765165|12524115|FG000|Treatment Period|Physician Decision|0
7967344|NCT02765165|12524116|FG001|Treatment Period|Physician Decision|1
7967345|NCT02765165|12524117|FG002|Treatment Period|Physician Decision|0
7967346|NCT02765165|12524118|FG003|Treatment Period|Physician Decision|0
7967347|NCT02765165|12524119|FG004|Treatment Period|Physician Decision|0
7967348|NCT02765165|12524120|FG005|Treatment Period|Physician Decision|0
7967349|NCT02765165|12524121|FG006|Treatment Period|Physician Decision|0
7967350|NCT02765165|12524115|FG000|Treatment Period|Adverse Event|0
7967351|NCT02765165|12524116|FG001|Treatment Period|Adverse Event|1
7967352|NCT02765165|12524117|FG002|Treatment Period|Adverse Event|0
7967353|NCT02765165|12524118|FG003|Treatment Period|Adverse Event|0
7967354|NCT02765165|12524119|FG004|Treatment Period|Adverse Event|0
7967355|NCT02765165|12524120|FG005|Treatment Period|Adverse Event|0
7967356|NCT02765165|12524121|FG006|Treatment Period|Adverse Event|0
7967357|NCT02765165|12524115|FG000|Treatment Period|Withdrawal by Subject|0
7967358|NCT02765165|12524116|FG001|Treatment Period|Withdrawal by Subject|0
7967359|NCT02765165|12524117|FG002|Treatment Period|Withdrawal by Subject|0
7967360|NCT02765165|12524118|FG003|Treatment Period|Withdrawal by Subject|0
7967361|NCT02765165|12524119|FG004|Treatment Period|Withdrawal by Subject|2
7967362|NCT02765165|12524120|FG005|Treatment Period|Withdrawal by Subject|0
7967363|NCT02765165|12524121|FG006|Treatment Period|Withdrawal by Subject|0
7967364|NCT02765165|12524115|FG000|Treatment Period|Study terminated|0
7967365|NCT02765165|12524116|FG001|Treatment Period|Study terminated|0
7967366|NCT02765165|12524117|FG002|Treatment Period|Study terminated|0
7967367|NCT02765165|12524118|FG003|Treatment Period|Study terminated|0
7967368|NCT02765165|12524119|FG004|Treatment Period|Study terminated|0
7967369|NCT02765165|12524120|FG005|Treatment Period|Study terminated|1
7967370|NCT02765165|12524121|FG006|Treatment Period|Study terminated|2
7967371|NCT02765165|12524115|FG000|Post-treatment Follow-up|Death|1
7967372|NCT02765165|12524116|FG001|Post-treatment Follow-up|Death|2
7967373|NCT02765165|12524117|FG002|Post-treatment Follow-up|Death|1
7967374|NCT02765165|12524118|FG003|Post-treatment Follow-up|Death|1
7967375|NCT02765165|12524119|FG004|Post-treatment Follow-up|Death|1
7967376|NCT02765165|12524120|FG005|Post-treatment Follow-up|Death|1
7967377|NCT02765165|12524121|FG006|Post-treatment Follow-up|Death|0
7883944|NCT01786603|12384059|FG000|Overall Study|Death|5
7883945|NCT01786603|12384060|FG001|Overall Study|Death|1
7883946|NCT01786603|12384059|FG000|Overall Study|Adverse Event|6
7967378|NCT02765165|12524115|FG000|Post-treatment Follow-up|Lost to Follow-up|0
7967379|NCT02765165|12524116|FG001|Post-treatment Follow-up|Lost to Follow-up|0
7883947|NCT01786603|12384060|FG001|Overall Study|Adverse Event|2
7883948|NCT01786603|12384059|FG000|Overall Study|Physician decision to withdraw|6
7883949|NCT01786603|12384060|FG001|Overall Study|Physician decision to withdraw|7
7883950|NCT01786603|12384059|FG000|Overall Study|Lost to Follow-up|1
7883951|NCT01786603|12384060|FG001|Overall Study|Lost to Follow-up|2
7883952|NCT01786629|12384068|FG000|Overall Study|Lack of Efficacy|0
7883953|NCT01786629|12384069|FG001|Overall Study|Lack of Efficacy|4
7883954|NCT01786629|12384068|FG000|Overall Study|Adverse Event|0
7883955|NCT01786629|12384069|FG001|Overall Study|Adverse Event|1
7883956|NCT01786668|12384079|FG000|Overall Study|Adverse Event|0
7883957|NCT01786668|12384080|FG001|Overall Study|Adverse Event|1
7883958|NCT01786668|12384081|FG002|Overall Study|Adverse Event|1
7883959|NCT01786668|12384082|FG003|Overall Study|Adverse Event|2
7883960|NCT01786668|12384079|FG000|Overall Study|Withdrawal by Subject|0
7883961|NCT01786668|12384080|FG001|Overall Study|Withdrawal by Subject|0
7883962|NCT01786668|12384081|FG002|Overall Study|Withdrawal by Subject|3
7883963|NCT01786668|12384082|FG003|Overall Study|Withdrawal by Subject|1
7883964|NCT01786668|12384079|FG000|Overall Study|Pregnancy|0
7883965|NCT01786668|12384080|FG001|Overall Study|Pregnancy|0
7883966|NCT01786668|12384081|FG002|Overall Study|Pregnancy|0
7883967|NCT01786668|12384082|FG003|Overall Study|Pregnancy|1
7883968|NCT01786668|12384079|FG000|Overall Study|Lost to Follow-up|1
7883969|NCT01786668|12384080|FG001|Overall Study|Lost to Follow-up|0
7883970|NCT01786668|12384081|FG002|Overall Study|Lost to Follow-up|1
7883971|NCT01786668|12384082|FG003|Overall Study|Lost to Follow-up|0
7883972|NCT01786707|12384094|FG000|Overall Study|Lost to Follow-up|1
7883973|NCT01786707|12384095|FG001|Overall Study|Lost to Follow-up|1
7883974|NCT01786993|12384136|FG000|Overall Study|Death|6
7883975|NCT01786993|12384137|FG001|Overall Study|Death|7
7883976|NCT01786993|12384136|FG000|Overall Study|Withdrawal by Subject|3
7883977|NCT01786993|12384137|FG001|Overall Study|Withdrawal by Subject|2
7883978|NCT01786993|12384136|FG000|Overall Study|Lost to Follow-up|0
7883979|NCT01786993|12384137|FG001|Overall Study|Lost to Follow-up|1
7883980|NCT01786993|12384136|FG000|Overall Study|Subject Non-Compliance|1
7883981|NCT01786993|12384137|FG001|Overall Study|Subject Non-Compliance|0
7883982|NCT01786993|12384136|FG000|Overall Study|System Explant|1
7883983|NCT01786993|12384137|FG001|Overall Study|System Explant|0
7883984|NCT01786993|12384136|FG000|Overall Study|Hospice Admission|1
7883985|NCT01786993|12384137|FG001|Overall Study|Hospice Admission|0
7883986|NCT01787032|12384159|FG000|Overall Study|Protocol Violation|0
7883987|NCT01787032|12384160|FG001|Overall Study|Protocol Violation|0
7883988|NCT01787032|12384161|FG002|Overall Study|Protocol Violation|0
7883989|NCT01787032|12384162|FG003|Overall Study|Protocol Violation|0
7883990|NCT01787032|12384163|FG004|Overall Study|Protocol Violation|1
7883991|NCT01787032|12384164|FG005|Overall Study|Protocol Violation|1
7883992|NCT01787097|12384174|FG000|Overall Study|Withdrawal by Subject|1
7883993|NCT01787097|12384175|FG001|Overall Study|Withdrawal by Subject|0
7883994|NCT01787097|12384176|FG002|Overall Study|Withdrawal by Subject|0
7883995|NCT01787097|12384177|FG003|Overall Study|Withdrawal by Subject|0
7883996|NCT01787188|12384209|FG000|Overall Study|Adverse Event|2
7883997|NCT01787188|12384210|FG001|Overall Study|Adverse Event|4
7883998|NCT01787188|12384211|FG002|Overall Study|Adverse Event|6
7883999|NCT01787188|12384209|FG000|Overall Study|Lack of Efficacy|7
7884000|NCT01787188|12384210|FG001|Overall Study|Lack of Efficacy|3
7884001|NCT01787188|12384211|FG002|Overall Study|Lack of Efficacy|5
7884002|NCT01787188|12384209|FG000|Overall Study|Non-compliance with Study Drug|0
7884003|NCT01787188|12384210|FG001|Overall Study|Non-compliance with Study Drug|1
7884004|NCT01787188|12384211|FG002|Overall Study|Non-compliance with Study Drug|0
7884005|NCT01787188|12384209|FG000|Overall Study|Withdrawal by Subject|4
7884006|NCT01787188|12384210|FG001|Overall Study|Withdrawal by Subject|3
7884007|NCT01787188|12384211|FG002|Overall Study|Withdrawal by Subject|2
7884008|NCT01787188|12384209|FG000|Overall Study|Protocol Violation|3
7884009|NCT01787188|12384210|FG001|Overall Study|Protocol Violation|2
7884010|NCT01787188|12384211|FG002|Overall Study|Protocol Violation|3
7884011|NCT01787188|12384209|FG000|Overall Study|Lost to Follow-up|1
7884012|NCT01787188|12384210|FG001|Overall Study|Lost to Follow-up|2
7884013|NCT01787188|12384211|FG002|Overall Study|Lost to Follow-up|2
7884014|NCT01787188|12384209|FG000|Overall Study|Other, including patient moved|0
7884015|NCT01787188|12384210|FG001|Overall Study|Other, including patient moved|3
7884016|NCT01787188|12384211|FG002|Overall Study|Other, including patient moved|0
7884017|NCT01787279|12384231|FG000|Overall Study|Lost to Follow-up|2
7884018|NCT01787279|12384231|FG000|Overall Study|Lack of Efficacy|1
7884019|NCT01787292|12384235|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2
7884020|NCT01787292|12384236|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2
7884021|NCT01787292|12384235|FG000|Home Based Exercise Program|Withdrawal by Subject|3
7884022|NCT01787292|12384236|FG001|Home Based Exercise Program|Withdrawal by Subject|1
7884023|NCT01787331|12384247|FG000|Overall Study|Physician Decision|1
7884024|NCT01787331|12384247|FG000|Overall Study|Withdrawal by Subject|1
7884025|NCT01787461|12384270|FG000|Overall Study|Adverse Event|4
7884026|NCT01787461|12384271|FG001|Overall Study|Adverse Event|3
7884027|NCT01787461|12384270|FG000|Overall Study|Lost to Follow-up|3
7884028|NCT01787461|12384271|FG001|Overall Study|Lost to Follow-up|2
7884029|NCT01787461|12384270|FG000|Overall Study|No longer met eligibility criteria|1
7884030|NCT01787461|12384271|FG001|Overall Study|No longer met eligibility criteria|0
7884031|NCT01787461|12384270|FG000|Overall Study|Withdrawal by Subject|3
7884032|NCT01787461|12384271|FG001|Overall Study|Withdrawal by Subject|4
7884033|NCT01787461|12384270|FG000|Overall Study|Protocol Violation|3
7884034|NCT01787461|12384271|FG001|Overall Study|Protocol Violation|0
7884035|NCT01787591|12384279|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
7967380|NCT02765165|12524117|FG002|Post-treatment Follow-up|Lost to Follow-up|0
7967381|NCT02765165|12524118|FG003|Post-treatment Follow-up|Lost to Follow-up|1
7967382|NCT02765165|12524119|FG004|Post-treatment Follow-up|Lost to Follow-up|0
7967383|NCT02765165|12524120|FG005|Post-treatment Follow-up|Lost to Follow-up|0
7967384|NCT02765165|12524121|FG006|Post-treatment Follow-up|Lost to Follow-up|0
7967385|NCT02765165|12524115|FG000|Post-treatment Follow-up|Site terminated by sponsor|0
7967386|NCT02765165|12524116|FG001|Post-treatment Follow-up|Site terminated by sponsor|0
7967387|NCT02765165|12524117|FG002|Post-treatment Follow-up|Site terminated by sponsor|1
7967388|NCT02765165|12524118|FG003|Post-treatment Follow-up|Site terminated by sponsor|0
7967389|NCT02765165|12524119|FG004|Post-treatment Follow-up|Site terminated by sponsor|0
7967390|NCT02765165|12524120|FG005|Post-treatment Follow-up|Site terminated by sponsor|0
7967391|NCT02765165|12524121|FG006|Post-treatment Follow-up|Site terminated by sponsor|0
7967392|NCT02765165|12524115|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0
7967393|NCT02765165|12524116|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0
7967394|NCT02765165|12524117|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1
7967395|NCT02765165|12524118|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1
7967396|NCT02765165|12524119|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0
7967397|NCT02765165|12524120|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0
7967398|NCT02765165|12524121|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0
7967399|NCT02765165|12524115|FG000|Post-treatment Follow-up|Withdrawal by Subject|0
7967400|NCT02765165|12524116|FG001|Post-treatment Follow-up|Withdrawal by Subject|1
7967401|NCT02765165|12524117|FG002|Post-treatment Follow-up|Withdrawal by Subject|0
7967402|NCT02765165|12524118|FG003|Post-treatment Follow-up|Withdrawal by Subject|0
7967403|NCT02765165|12524119|FG004|Post-treatment Follow-up|Withdrawal by Subject|0
7967404|NCT02765165|12524120|FG005|Post-treatment Follow-up|Withdrawal by Subject|0
7967405|NCT02765165|12524121|FG006|Post-treatment Follow-up|Withdrawal by Subject|0
7967406|NCT02765165|12524115|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0
7967407|NCT02765165|12524116|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0
7967408|NCT02765165|12524117|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0
7967409|NCT02765165|12524118|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0
7967410|NCT02765165|12524119|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2
7967411|NCT02765165|12524120|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2
7967412|NCT02765165|12524121|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1
7967413|NCT02765490|12524161|FG000|Overall Study|Lost to Follow-up|1
7967414|NCT02765490|12524162|FG001|Overall Study|Lost to Follow-up|1
7967415|NCT02765490|12524161|FG000|Overall Study|Other|0
7967416|NCT02765490|12524162|FG001|Overall Study|Other|1
7967417|NCT02765490|12524161|FG000|Overall Study|Death|0
7967418|NCT02765490|12524162|FG001|Overall Study|Death|1
7967419|NCT02766023|12524170|FG000|Overall Study|Lost to Follow-up|23
7967420|NCT02766023|12524171|FG001|Overall Study|Lost to Follow-up|11
7967421|NCT02766023|12524170|FG000|Overall Study|Pregnancy|1
7967422|NCT02766023|12524171|FG001|Overall Study|Pregnancy|0
7967423|NCT02766023|12524170|FG000|Overall Study|Adverse Event|1
7967424|NCT02766023|12524171|FG001|Overall Study|Adverse Event|0
7967425|NCT02766023|12524170|FG000|Overall Study|Withdrawal by Subject|4
7967426|NCT02766023|12524171|FG001|Overall Study|Withdrawal by Subject|5
7967427|NCT02766023|12524170|FG000|Overall Study|Physician Decision|1
7967428|NCT02766023|12524171|FG001|Overall Study|Physician Decision|0
7967429|NCT02766023|12524170|FG000|Overall Study|Not Eligible at Enrollment|0
7967430|NCT02766023|12524171|FG001|Overall Study|Not Eligible at Enrollment|1
7967431|NCT02766088|12524177|FG000|Overall Study|Sponsor study termination|498
7967432|NCT02766088|12524177|FG000|Overall Study|Migrated/moved from the study area|1
7967433|NCT02766088|12524177|FG000|Overall Study|Lost to Follow-up|5
7967434|NCT02766088|12524177|FG000|Overall Study|Other|1
7967435|NCT02766088|12524177|FG000|Overall Study|Death|1
7967436|NCT02766283|12524190|FG000|Overall Study|Lost to Follow-up|27
7967437|NCT02766400|12524209|FG000|Overall Study|Death|1
7967438|NCT02766400|12524210|FG001|Overall Study|Death|2
7967439|NCT02766400|12524209|FG000|Overall Study|Withdrawal by Subject|1
7884036|NCT01787591|12384280|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
7884037|NCT01787591|12384281|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
7884038|NCT01787591|12384282|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
7962794|NCT02714569|12517089|FG009|Part B (Overall)|Adverse Event|1
7962795|NCT02714569|12517090|FG010|Part B (Overall)|Adverse Event|0
7962796|NCT02714595|12517152|FG000|Overall Study|Lost to Follow-up|1
7962797|NCT02714595|12517153|FG001|Overall Study|Lost to Follow-up|0
7962798|NCT02714595|12517152|FG000|Overall Study|Withdrawal by Subject|1
7962799|NCT02714595|12517153|FG001|Overall Study|Withdrawal by Subject|2
7962800|NCT02714595|12517152|FG000|Overall Study|Lack of Efficacy|0
7962801|NCT02714595|12517153|FG001|Overall Study|Lack of Efficacy|1
7962802|NCT02714595|12517152|FG000|Overall Study|Death|30
7962803|NCT02714595|12517153|FG001|Overall Study|Death|9
7962804|NCT02714595|12517152|FG000|Overall Study|Other-Miscellaneous|0
7962805|NCT02714595|12517153|FG001|Overall Study|Other-Miscellaneous|1
7884039|NCT01787760|12384305|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1
7884040|NCT01787760|12384306|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0
7884041|NCT01787760|12384307|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0
7884042|NCT01787760|12384305|FG000|Overall Study|Decompensated on left exotropia|0
7884043|NCT01787760|12384306|FG001|Overall Study|Decompensated on left exotropia|0
7884044|NCT01787760|12384307|FG002|Overall Study|Decompensated on left exotropia|1
7884045|NCT01787760|12384305|FG000|Overall Study|Dryness|0
7884046|NCT01787760|12384306|FG001|Overall Study|Dryness|1
7884047|NCT01787760|12384307|FG002|Overall Study|Dryness|0
7884048|NCT01787760|12384305|FG000|Overall Study|Relocation|1
7884049|NCT01787760|12384306|FG001|Overall Study|Relocation|1
7884050|NCT01787760|12384307|FG002|Overall Study|Relocation|0
7884051|NCT01787760|12384305|FG000|Overall Study|Lens discomfort|3
7884052|NCT01787760|12384306|FG001|Overall Study|Lens discomfort|0
7884053|NCT01787760|12384307|FG002|Overall Study|Lens discomfort|0
7884054|NCT01787760|12384305|FG000|Overall Study|Lens handling difficulty|1
7884055|NCT01787760|12384306|FG001|Overall Study|Lens handling difficulty|2
7884056|NCT01787760|12384307|FG002|Overall Study|Lens handling difficulty|0
7884057|NCT01787760|12384305|FG000|Overall Study|Protocol Violation|6
7884058|NCT01787760|12384306|FG001|Overall Study|Protocol Violation|0
7884059|NCT01787760|12384307|FG002|Overall Study|Protocol Violation|1
7884060|NCT01787760|12384305|FG000|Overall Study|Withdrawal by Subject|5
7884061|NCT01787760|12384306|FG001|Overall Study|Withdrawal by Subject|1
7884062|NCT01787760|12384307|FG002|Overall Study|Withdrawal by Subject|2
7884063|NCT01787760|12384305|FG000|Overall Study|Lost to Follow-up|1
7884064|NCT01787760|12384306|FG001|Overall Study|Lost to Follow-up|0
7884065|NCT01787760|12384307|FG002|Overall Study|Lost to Follow-up|1
7884066|NCT01787760|12384305|FG000|Overall Study|Stroke|1
7884067|NCT01787760|12384306|FG001|Overall Study|Stroke|0
7884068|NCT01787760|12384307|FG002|Overall Study|Stroke|0
7884069|NCT01787760|12384305|FG000|Overall Study|Unsatisfactory lens fitting performance|3
7884070|NCT01787760|12384306|FG001|Overall Study|Unsatisfactory lens fitting performance|6
7884071|NCT01787760|12384307|FG002|Overall Study|Unsatisfactory lens fitting performance|0
7884072|NCT01787760|12384305|FG000|Overall Study|Unsatisfactory physiological response|2
7884073|NCT01787760|12384306|FG001|Overall Study|Unsatisfactory physiological response|4
7884074|NCT01787760|12384307|FG002|Overall Study|Unsatisfactory physiological response|0
7884075|NCT01787760|12384305|FG000|Overall Study|Unsatisfactory visual response|1
7884076|NCT01787760|12384306|FG001|Overall Study|Unsatisfactory visual response|1
7884077|NCT01787760|12384307|FG002|Overall Study|Unsatisfactory visual response|0
7884078|NCT01787760|12384305|FG000|Overall Study|Near vision blur|1
7884079|NCT01787760|12384306|FG001|Overall Study|Near vision blur|0
7884080|NCT01787760|12384307|FG002|Overall Study|Near vision blur|0
7884081|NCT01787825|12384320|FG000|Overall Study|Subject Did Not Ingest Capsules|1
7884082|NCT01787825|12384321|FG001|Overall Study|Subject Did Not Ingest Capsules|0
7884083|NCT01787825|12384320|FG000|Overall Study|Data Not Analyzable|5
7884084|NCT01787825|12384321|FG001|Overall Study|Data Not Analyzable|1
7884085|NCT01787838|12384328|FG000|Overall Study|refused|1413
7884086|NCT01788046|12384341|FG000|Overall Study|Withdrawal by Subject|12
7967440|NCT02766400|12524210|FG001|Overall Study|Withdrawal by Subject|0
7967441|NCT02766608|12524234|FG000|Overall Study|Adverse Event|27
7967442|NCT02766608|12524235|FG001|Overall Study|Adverse Event|22
7967443|NCT02766608|12524236|FG002|Overall Study|Adverse Event|17
7967444|NCT02766608|12524237|FG003|Overall Study|Adverse Event|13
7967445|NCT02766608|12524238|FG004|Overall Study|Adverse Event|12
7967446|NCT02766608|12524234|FG000|Overall Study|Withdrawal by Subject|21
7967447|NCT02766608|12524235|FG001|Overall Study|Withdrawal by Subject|20
7967448|NCT02766608|12524236|FG002|Overall Study|Withdrawal by Subject|24
7967449|NCT02766608|12524237|FG003|Overall Study|Withdrawal by Subject|13
7967450|NCT02766608|12524238|FG004|Overall Study|Withdrawal by Subject|10
7967451|NCT02766608|12524234|FG000|Overall Study|Lack of Efficacy|16
7967452|NCT02766608|12524235|FG001|Overall Study|Lack of Efficacy|15
7967453|NCT02766608|12524236|FG002|Overall Study|Lack of Efficacy|32
7967454|NCT02766608|12524237|FG003|Overall Study|Lack of Efficacy|8
7967455|NCT02766608|12524238|FG004|Overall Study|Lack of Efficacy|2
7967456|NCT02766608|12524234|FG000|Overall Study|Lost to Follow-up|6
7967457|NCT02766608|12524235|FG001|Overall Study|Lost to Follow-up|3
7967458|NCT02766608|12524236|FG002|Overall Study|Lost to Follow-up|5
7967459|NCT02766608|12524237|FG003|Overall Study|Lost to Follow-up|2
7967460|NCT02766608|12524238|FG004|Overall Study|Lost to Follow-up|2
7967461|NCT02766608|12524234|FG000|Overall Study|Physician Decision|3
7967462|NCT02766608|12524235|FG001|Overall Study|Physician Decision|2
7967463|NCT02766608|12524236|FG002|Overall Study|Physician Decision|3
7884087|NCT01788046|12384342|FG001|Overall Study|Withdrawal by Subject|12
7884088|NCT01788046|12384341|FG000|Overall Study|Lost to Follow-up|12
7884089|NCT01788046|12384342|FG001|Overall Study|Lost to Follow-up|19
7884090|NCT01788046|12384341|FG000|Overall Study|Death|7
7884091|NCT01788046|12384342|FG001|Overall Study|Death|5
7884092|NCT01788046|12384341|FG000|Overall Study|Protocol Specified Criteria|25
7884093|NCT01788046|12384342|FG001|Overall Study|Protocol Specified Criteria|1
7967464|NCT02766608|12524237|FG003|Overall Study|Physician Decision|1
7967465|NCT02766608|12524238|FG004|Overall Study|Physician Decision|2
7967466|NCT02766608|12524234|FG000|Overall Study|Protocol disc criteria|3
7967467|NCT02766608|12524235|FG001|Overall Study|Protocol disc criteria|3
7967468|NCT02766608|12524236|FG002|Overall Study|Protocol disc criteria|4
7967469|NCT02766608|12524237|FG003|Overall Study|Protocol disc criteria|0
7967470|NCT02766608|12524238|FG004|Overall Study|Protocol disc criteria|0
7967471|NCT02766608|12524234|FG000|Overall Study|Protocol Violation|0
7967472|NCT02766608|12524235|FG001|Overall Study|Protocol Violation|4
7967473|NCT02766608|12524236|FG002|Overall Study|Protocol Violation|4
7967474|NCT02766608|12524237|FG003|Overall Study|Protocol Violation|0
7967475|NCT02766608|12524238|FG004|Overall Study|Protocol Violation|1
7967476|NCT02766608|12524234|FG000|Overall Study|Administrative Reasons|3
7967477|NCT02766608|12524235|FG001|Overall Study|Administrative Reasons|1
7967478|NCT02766608|12524236|FG002|Overall Study|Administrative Reasons|1
7967479|NCT02766608|12524237|FG003|Overall Study|Administrative Reasons|0
7967480|NCT02766608|12524238|FG004|Overall Study|Administrative Reasons|0
7967481|NCT02766777|12524266|FG000|Overall Study|Adverse Event|12
7967482|NCT02766777|12524266|FG000|Overall Study|Lost to Follow-up|16
7967483|NCT02766777|12524266|FG000|Overall Study|Non-Compliance With Study Drug|1
7967484|NCT02766777|12524266|FG000|Overall Study|Protocol Violation|1
7967485|NCT02766777|12524266|FG000|Overall Study|Withdrawal by Subject|4
7967486|NCT02767323|12524315|FG000|Overall Study|Withdrawal by Subject|17
7967487|NCT02767323|12524316|FG001|Overall Study|Withdrawal by Subject|5
7967488|NCT02767323|12524317|FG002|Overall Study|Withdrawal by Subject|13
7967489|NCT02767323|12524318|FG003|Overall Study|Withdrawal by Subject|0
7967490|NCT02767323|12524315|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17
7967491|NCT02767323|12524316|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20
7967492|NCT02767323|12524317|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17
7967493|NCT02767323|12524318|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0
7967494|NCT02767765|12524366|FG000|Overall Study|Adverse Event|4
7967495|NCT02767765|12524366|FG000|Overall Study|Death|1
7967496|NCT02767765|12524366|FG000|Overall Study|Insufficient response|1
7967497|NCT02767765|12524366|FG000|Overall Study|Lost to Follow-up|2
7967498|NCT02767765|12524366|FG000|Overall Study|Investigator decision|1
7967499|NCT02767765|12524366|FG000|Overall Study|Non-Compliance|1
7967500|NCT02767765|12524366|FG000|Overall Study|Withdrawal by Subject|1
7967501|NCT02768103|12524399|FG000|Overall Study|1 participant did not fit in the fMRI|1
7967502|NCT02768194|12524412|FG000|Period 1|Adverse Event|0
7967503|NCT02768194|12524413|FG001|Period 1|Adverse Event|0
7967504|NCT02768194|12524414|FG002|Period 1|Adverse Event|0
7967505|NCT02768194|12524415|FG003|Period 1|Adverse Event|1
7967506|NCT02768194|12524416|FG004|Period 1|Adverse Event|0
7967507|NCT02768194|12524417|FG005|Period 1|Adverse Event|0
7967508|NCT02768194|12524412|FG000|Period 2|Other (Reason not specified)|1
7967509|NCT02768194|12524413|FG001|Period 2|Other (Reason not specified)|0
7967510|NCT02768194|12524414|FG002|Period 2|Other (Reason not specified)|0
7967511|NCT02768194|12524415|FG003|Period 2|Other (Reason not specified)|0
7967512|NCT02768194|12524416|FG004|Period 2|Other (Reason not specified)|0
7967513|NCT02768194|12524417|FG005|Period 2|Other (Reason not specified)|0
7967514|NCT02768194|12524412|FG000|Period 3|Other (Reason not specified)|0
7967515|NCT02768194|12524413|FG001|Period 3|Other (Reason not specified)|1
7967516|NCT02768194|12524414|FG002|Period 3|Other (Reason not specified)|0
7967517|NCT02768194|12524415|FG003|Period 3|Other (Reason not specified)|0
7967518|NCT02768194|12524416|FG004|Period 3|Other (Reason not specified)|0
7967519|NCT02768194|12524417|FG005|Period 3|Other (Reason not specified)|0
7967520|NCT02768298|12524427|FG000|Overall Study|Adverse Event|1
7967521|NCT02768298|12524428|FG001|Overall Study|Adverse Event|4
7800995|NCT01098461|12258569|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
7861293|NCT01590758|12349952|FG000|Overall Study|Lost to Follow-up|4
7967522|NCT02768298|12524427|FG000|Overall Study|Death|2
7967523|NCT02768298|12524428|FG001|Overall Study|Death|1
7967524|NCT02768298|12524427|FG000|Overall Study|Non-compliance with study treatment|0
7967525|NCT02768298|12524428|FG001|Overall Study|Non-compliance with study treatment|1
7967526|NCT02768298|12524427|FG000|Overall Study|Subject/guardian decision|1
7967527|NCT02768298|12524428|FG001|Overall Study|Subject/guardian decision|0
7967528|NCT02768298|12524427|FG000|Overall Study|Withdrawal of informed consent|0
7967529|NCT02768298|12524428|FG001|Overall Study|Withdrawal of informed consent|1
7967530|NCT02769065|12524482|FG000|Overall Study|Voluntary Withdrawal|1
7967531|NCT02769065|12524483|FG001|Overall Study|Voluntary Withdrawal|0
7967532|NCT02769065|12524484|FG002|Overall Study|Voluntary Withdrawal|0
7967533|NCT02769065|12524485|FG003|Overall Study|Voluntary Withdrawal|0
7967534|NCT02769065|12524486|FG004|Overall Study|Voluntary Withdrawal|0
7967535|NCT02769065|12524487|FG005|Overall Study|Voluntary Withdrawal|0
7967536|NCT02769065|12524488|FG006|Overall Study|Voluntary Withdrawal|0
7967537|NCT02769065|12524489|FG007|Overall Study|Voluntary Withdrawal|0
7967538|NCT02769065|12524490|FG008|Overall Study|Voluntary Withdrawal|0
7967539|NCT02769065|12524491|FG009|Overall Study|Voluntary Withdrawal|0
7967540|NCT02769065|12524492|FG010|Overall Study|Voluntary Withdrawal|0
7967541|NCT02769065|12524493|FG011|Overall Study|Voluntary Withdrawal|0
7967542|NCT02769065|12524494|FG012|Overall Study|Voluntary Withdrawal|0
7967543|NCT02769065|12524495|FG013|Overall Study|Voluntary Withdrawal|0
7967544|NCT02769065|12524496|FG014|Overall Study|Voluntary Withdrawal|0
7967545|NCT02769065|12524497|FG015|Overall Study|Voluntary Withdrawal|0
7967546|NCT02769065|12524498|FG016|Overall Study|Voluntary Withdrawal|0
7967547|NCT02769065|12524499|FG017|Overall Study|Voluntary Withdrawal|0
7967548|NCT02769065|12524500|FG018|Overall Study|Voluntary Withdrawal|0
7967549|NCT02769065|12524501|FG019|Overall Study|Voluntary Withdrawal|0
7967550|NCT02769065|12524502|FG020|Overall Study|Voluntary Withdrawal|0
7967551|NCT02769065|12524503|FG021|Overall Study|Voluntary Withdrawal|0
7967552|NCT02769065|12524504|FG022|Overall Study|Voluntary Withdrawal|0
7967553|NCT02769065|12524505|FG023|Overall Study|Voluntary Withdrawal|0
7967554|NCT02769065|12524506|FG024|Overall Study|Voluntary Withdrawal|0
7967555|NCT02769065|12524507|FG025|Overall Study|Voluntary Withdrawal|0
7967556|NCT02769065|12524508|FG026|Overall Study|Voluntary Withdrawal|0
7967557|NCT02769065|12524509|FG027|Overall Study|Voluntary Withdrawal|0
7967558|NCT02769065|12524510|FG028|Overall Study|Voluntary Withdrawal|0
7967559|NCT02769065|12524511|FG029|Overall Study|Voluntary Withdrawal|0
7967560|NCT02769065|12524482|FG000|Overall Study|Reason Not Specified|0
7967561|NCT02769065|12524483|FG001|Overall Study|Reason Not Specified|0
7967562|NCT02769065|12524484|FG002|Overall Study|Reason Not Specified|0
7967563|NCT02769065|12524485|FG003|Overall Study|Reason Not Specified|0
7967564|NCT02769065|12524486|FG004|Overall Study|Reason Not Specified|0
7967565|NCT02769065|12524487|FG005|Overall Study|Reason Not Specified|0
7967566|NCT02769065|12524488|FG006|Overall Study|Reason Not Specified|1
7967567|NCT02769065|12524489|FG007|Overall Study|Reason Not Specified|0
7967568|NCT02769065|12524490|FG008|Overall Study|Reason Not Specified|0
7967569|NCT02769065|12524491|FG009|Overall Study|Reason Not Specified|0
7967570|NCT02769065|12524492|FG010|Overall Study|Reason Not Specified|0
7967571|NCT02769065|12524493|FG011|Overall Study|Reason Not Specified|0
7967572|NCT02769065|12524494|FG012|Overall Study|Reason Not Specified|0
7967573|NCT02769065|12524495|FG013|Overall Study|Reason Not Specified|0
7967574|NCT02769065|12524496|FG014|Overall Study|Reason Not Specified|0
7967575|NCT02769065|12524497|FG015|Overall Study|Reason Not Specified|0
7967576|NCT02769065|12524498|FG016|Overall Study|Reason Not Specified|0
7967577|NCT02769065|12524499|FG017|Overall Study|Reason Not Specified|0
7967578|NCT02769065|12524500|FG018|Overall Study|Reason Not Specified|0
7967579|NCT02769065|12524501|FG019|Overall Study|Reason Not Specified|0
7967580|NCT02769065|12524502|FG020|Overall Study|Reason Not Specified|0
7967581|NCT02769065|12524503|FG021|Overall Study|Reason Not Specified|0
7967582|NCT02769065|12524504|FG022|Overall Study|Reason Not Specified|0
7967583|NCT02769065|12524505|FG023|Overall Study|Reason Not Specified|0
7967584|NCT02769065|12524506|FG024|Overall Study|Reason Not Specified|0
7967585|NCT02769065|12524507|FG025|Overall Study|Reason Not Specified|0
7967586|NCT02769065|12524508|FG026|Overall Study|Reason Not Specified|0
7967587|NCT02769065|12524509|FG027|Overall Study|Reason Not Specified|0
7967588|NCT02769065|12524510|FG028|Overall Study|Reason Not Specified|0
7967589|NCT02769065|12524511|FG029|Overall Study|Reason Not Specified|0
7967590|NCT02769065|12524482|FG000|Overall Study|Pre-treatment Event/Adverse Event|0
7967591|NCT02769065|12524483|FG001|Overall Study|Pre-treatment Event/Adverse Event|0
7967592|NCT02769065|12524484|FG002|Overall Study|Pre-treatment Event/Adverse Event|0
7967593|NCT02769065|12524485|FG003|Overall Study|Pre-treatment Event/Adverse Event|0
7967594|NCT02769065|12524486|FG004|Overall Study|Pre-treatment Event/Adverse Event|0
7967595|NCT02769065|12524487|FG005|Overall Study|Pre-treatment Event/Adverse Event|0
7967596|NCT02769065|12524488|FG006|Overall Study|Pre-treatment Event/Adverse Event|0
7967597|NCT02769065|12524489|FG007|Overall Study|Pre-treatment Event/Adverse Event|0
7967598|NCT02769065|12524490|FG008|Overall Study|Pre-treatment Event/Adverse Event|0
7967599|NCT02769065|12524491|FG009|Overall Study|Pre-treatment Event/Adverse Event|0
7967600|NCT02769065|12524492|FG010|Overall Study|Pre-treatment Event/Adverse Event|1
7967601|NCT02769065|12524493|FG011|Overall Study|Pre-treatment Event/Adverse Event|0
7967602|NCT02769065|12524494|FG012|Overall Study|Pre-treatment Event/Adverse Event|0
7967603|NCT02769065|12524495|FG013|Overall Study|Pre-treatment Event/Adverse Event|0
7967604|NCT02769065|12524496|FG014|Overall Study|Pre-treatment Event/Adverse Event|0
7967605|NCT02769065|12524497|FG015|Overall Study|Pre-treatment Event/Adverse Event|0
7967606|NCT02769065|12524498|FG016|Overall Study|Pre-treatment Event/Adverse Event|0
7967607|NCT02769065|12524499|FG017|Overall Study|Pre-treatment Event/Adverse Event|0
7967608|NCT02769065|12524500|FG018|Overall Study|Pre-treatment Event/Adverse Event|0
7967609|NCT02769065|12524501|FG019|Overall Study|Pre-treatment Event/Adverse Event|0
7967610|NCT02769065|12524502|FG020|Overall Study|Pre-treatment Event/Adverse Event|0
7967611|NCT02769065|12524503|FG021|Overall Study|Pre-treatment Event/Adverse Event|0
7967612|NCT02769065|12524504|FG022|Overall Study|Pre-treatment Event/Adverse Event|0
7967613|NCT02769065|12524505|FG023|Overall Study|Pre-treatment Event/Adverse Event|0
7717469|NCT00519779|12141063|FG000|Overall Study|Withdrawal by Subject|0
7717470|NCT00519779|12141064|FG001|Overall Study|Withdrawal by Subject|1
7717471|NCT00519831|12141070|FG000|Overall Study|Adverse Event|3
7717472|NCT00519896|12141074|FG000|Overall Study|Protocol Violation|1
7717473|NCT00519896|12141074|FG000|Overall Study|Adverse Event|1
7717474|NCT00520013|12141081|FG000|Overall Study|Withdrawal by Subject|0
7717475|NCT00520013|12141082|FG001|Overall Study|Withdrawal by Subject|0
7717476|NCT00520013|12141083|FG002|Overall Study|Withdrawal by Subject|1
7717477|NCT00520013|12141081|FG000|Overall Study|Adverse Event|2
7717478|NCT00520013|12141082|FG001|Overall Study|Adverse Event|10
7717479|NCT00520013|12141083|FG002|Overall Study|Adverse Event|7
7717480|NCT00520013|12141081|FG000|Overall Study|Progressive Disease|7
7717481|NCT00520013|12141082|FG001|Overall Study|Progressive Disease|3
7717482|NCT00520013|12141083|FG002|Overall Study|Progressive Disease|0
7717483|NCT00520013|12141081|FG000|Overall Study|Clinical Progression|3
7717484|NCT00520013|12141082|FG001|Overall Study|Clinical Progression|1
7717485|NCT00520013|12141083|FG002|Overall Study|Clinical Progression|0
7717486|NCT00520013|12141081|FG000|Overall Study|Death|0
7717487|NCT00520013|12141082|FG001|Overall Study|Death|1
7717488|NCT00520013|12141083|FG002|Overall Study|Death|0
7717489|NCT00520013|12141081|FG000|Overall Study|Physician Decision|0
7717490|NCT00520013|12141082|FG001|Overall Study|Physician Decision|0
7717491|NCT00520013|12141083|FG002|Overall Study|Physician Decision|3
7767813|NCT00856206|12210596|FG001|Overall Study|Adverse Event|46
7767814|NCT00856206|12210595|FG000|Overall Study|Lack of Efficacy|1
7767815|NCT00856206|12210596|FG001|Overall Study|Lack of Efficacy|2
7767816|NCT00856206|12210595|FG000|Overall Study|Withdrawal by Subject|15
7767817|NCT00856206|12210596|FG001|Overall Study|Withdrawal by Subject|36
7767818|NCT00856206|12210595|FG000|Overall Study|Lost to Follow-up|13
7767819|NCT00856206|12210596|FG001|Overall Study|Lost to Follow-up|39
7967614|NCT02769065|12524506|FG024|Overall Study|Pre-treatment Event/Adverse Event|0
7967615|NCT02769065|12524507|FG025|Overall Study|Pre-treatment Event/Adverse Event|0
7967616|NCT02769065|12524508|FG026|Overall Study|Pre-treatment Event/Adverse Event|0
7967617|NCT02769065|12524509|FG027|Overall Study|Pre-treatment Event/Adverse Event|0
7967618|NCT02769065|12524510|FG028|Overall Study|Pre-treatment Event/Adverse Event|0
7967619|NCT02769065|12524511|FG029|Overall Study|Pre-treatment Event/Adverse Event|0
7967620|NCT02769247|12524608|FG000|Overall Study|Withdrawal by Subject|1
7967621|NCT02769247|12524609|FG001|Overall Study|Withdrawal by Subject|0
7967622|NCT02769247|12524610|FG002|Overall Study|Withdrawal by Subject|0
7967623|NCT02769247|12524611|FG003|Overall Study|Withdrawal by Subject|1
7967624|NCT02769247|12524608|FG000|Overall Study|Protocol Violation|0
7967625|NCT02769247|12524609|FG001|Overall Study|Protocol Violation|0
7967626|NCT02769247|12524610|FG002|Overall Study|Protocol Violation|1
7800996|NCT01098461|12258570|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
7800997|NCT01098461|12258571|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
7767820|NCT00856206|12210595|FG000|Overall Study|Death|2
7767821|NCT00856206|12210596|FG001|Overall Study|Death|2
7767822|NCT00856206|12210595|FG000|Overall Study|Decision by the Sponsor|4
7800998|NCT01098461|12258572|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
7800999|NCT01098461|12258569|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
7801000|NCT01098461|12258570|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
7801001|NCT01098461|12258571|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
7801002|NCT01098461|12258572|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
7801003|NCT01098461|12258569|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
7801004|NCT01098461|12258570|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
7801005|NCT01098461|12258571|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
7801006|NCT01098461|12258572|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
7801007|NCT01098461|12258569|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
7801008|NCT01098461|12258570|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
7801009|NCT01098461|12258571|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
7801010|NCT01098461|12258572|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
7801011|NCT01098461|12258569|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
7801012|NCT01098461|12258570|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
7801013|NCT01098461|12258571|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
7801014|NCT01098461|12258572|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
7801015|NCT01098474|12258589|FG000|Active Phase|Other|0
7801016|NCT01098474|12258590|FG001|Active Phase|Other|0
7801017|NCT01098474|12258591|FG002|Active Phase|Other|3
7801018|NCT01098474|12258592|FG003|Active Phase|Other|0
7801019|NCT01098474|12258593|FG004|Active Phase|Other|0
7801020|NCT01098474|12258594|FG005|Active Phase|Other|0
7801021|NCT01098474|12258589|FG000|Active Phase|Withdrawal by Subject|1
7801022|NCT01098474|12258590|FG001|Active Phase|Withdrawal by Subject|1
7801023|NCT01098474|12258591|FG002|Active Phase|Withdrawal by Subject|2
7801024|NCT01098474|12258592|FG003|Active Phase|Withdrawal by Subject|0
7801025|NCT01098474|12258593|FG004|Active Phase|Withdrawal by Subject|0
7801026|NCT01098474|12258594|FG005|Active Phase|Withdrawal by Subject|0
7801027|NCT01098474|12258589|FG000|Active Phase|Lost to Follow-up|1
7801028|NCT01098474|12258590|FG001|Active Phase|Lost to Follow-up|0
7801029|NCT01098474|12258591|FG002|Active Phase|Lost to Follow-up|0
7801030|NCT01098474|12258592|FG003|Active Phase|Lost to Follow-up|0
7801031|NCT01098474|12258593|FG004|Active Phase|Lost to Follow-up|0
7801032|NCT01098474|12258594|FG005|Active Phase|Lost to Follow-up|0
7801033|NCT01098474|12258589|FG000|Follow Up Phase|Travelled out of study area|0
7801034|NCT01098474|12258590|FG001|Follow Up Phase|Travelled out of study area|0
7801035|NCT01098474|12258591|FG002|Follow Up Phase|Travelled out of study area|0
7801036|NCT01098474|12258592|FG003|Follow Up Phase|Travelled out of study area|0
7801037|NCT01098474|12258593|FG004|Follow Up Phase|Travelled out of study area|1
7801038|NCT01098474|12258594|FG005|Follow Up Phase|Travelled out of study area|0
7801039|NCT01098474|12258589|FG000|Follow Up Phase|Other|0
7801040|NCT01098474|12258590|FG001|Follow Up Phase|Other|0
7801041|NCT01098474|12258591|FG002|Follow Up Phase|Other|0
7801042|NCT01098474|12258592|FG003|Follow Up Phase|Other|0
7801043|NCT01098474|12258593|FG004|Follow Up Phase|Other|0
7801044|NCT01098474|12258594|FG005|Follow Up Phase|Other|4
7801045|NCT01098474|12258589|FG000|Follow Up Phase|Withdrawal by Subject|0
7801046|NCT01098474|12258590|FG001|Follow Up Phase|Withdrawal by Subject|0
7801047|NCT01098474|12258591|FG002|Follow Up Phase|Withdrawal by Subject|0
7801048|NCT01098474|12258592|FG003|Follow Up Phase|Withdrawal by Subject|2
7801049|NCT01098474|12258593|FG004|Follow Up Phase|Withdrawal by Subject|0
7801050|NCT01098474|12258594|FG005|Follow Up Phase|Withdrawal by Subject|1
7801051|NCT01098474|12258589|FG000|Follow Up Phase|Lost to Follow-up|0
7801052|NCT01098474|12258590|FG001|Follow Up Phase|Lost to Follow-up|0
7801053|NCT01098474|12258591|FG002|Follow Up Phase|Lost to Follow-up|0
7801054|NCT01098474|12258592|FG003|Follow Up Phase|Lost to Follow-up|0
7967627|NCT02769247|12524611|FG003|Overall Study|Protocol Violation|0
7967628|NCT02769247|12524608|FG000|Overall Study|Physician Decision|1
7801055|NCT01098474|12258593|FG004|Follow Up Phase|Lost to Follow-up|1
7801056|NCT01098474|12258594|FG005|Follow Up Phase|Lost to Follow-up|0
7801057|NCT01098487|12258618|FG000|Overall Study|Adverse Event|22
7801058|NCT01098487|12258618|FG000|Overall Study|Lack of Efficacy|11
7884094|NCT01788163|12384366|FG000|Overall Study|Other|53
7884095|NCT01788163|12384367|FG001|Overall Study|Other|0
7884096|NCT01788163|12384368|FG002|Overall Study|Other|0
7884097|NCT01788163|12384369|FG003|Overall Study|Other|0
7884098|NCT01788163|12384370|FG004|Overall Study|Other|0
7884099|NCT01788163|12384371|FG005|Overall Study|Other|7
7884100|NCT01788163|12384372|FG006|Overall Study|Other|1
7884101|NCT01788163|12384373|FG007|Overall Study|Other|48
7884102|NCT01788163|12384374|FG008|Overall Study|Other|15
7884103|NCT01788163|12384366|FG000|Overall Study|Withdrawal by Subject|2
7884104|NCT01788163|12384367|FG001|Overall Study|Withdrawal by Subject|0
7884105|NCT01788163|12384368|FG002|Overall Study|Withdrawal by Subject|0
7884106|NCT01788163|12384369|FG003|Overall Study|Withdrawal by Subject|0
7884107|NCT01788163|12384370|FG004|Overall Study|Withdrawal by Subject|0
7884108|NCT01788163|12384371|FG005|Overall Study|Withdrawal by Subject|0
7884109|NCT01788163|12384372|FG006|Overall Study|Withdrawal by Subject|0
7884110|NCT01788163|12384373|FG007|Overall Study|Withdrawal by Subject|0
7884111|NCT01788163|12384374|FG008|Overall Study|Withdrawal by Subject|1
7884112|NCT01788215|12384455|FG000|Overall Study|Withdrawal by Subject|0
7884113|NCT01788215|12384456|FG001|Overall Study|Withdrawal by Subject|1
7884114|NCT01788215|12384455|FG000|Overall Study|Lost to Follow-up|2
7884115|NCT01788215|12384456|FG001|Overall Study|Lost to Follow-up|0
7884116|NCT01788228|12384464|FG000|Overall Study|Migrated/moved from study area|1
7884117|NCT01788228|12384465|FG001|Overall Study|Migrated/moved from study area|0
7884118|NCT01788358|12384474|FG000|Overall Study|Other|11
7801059|NCT01098487|12258618|FG000|Overall Study|Withdrawal by Subject|7
7801060|NCT01098487|12258618|FG000|Overall Study|Lost to Follow-up|3
7884119|NCT01788358|12384474|FG000|Overall Study|Logistical difficulties|1
7884120|NCT01788358|12384474|FG000|Overall Study|Lost to Follow-up|5
7884121|NCT01788358|12384474|FG000|Overall Study|Protocol Violation|3
7884122|NCT01788358|12384474|FG000|Overall Study|Withdrawal by Subject|26
7884123|NCT01788358|12384474|FG000|Overall Study|Lack of Efficacy|1
7967629|NCT02769247|12524609|FG001|Overall Study|Physician Decision|0
7717492|NCT00520039|12141091|FG000|Overall Study|Exclusion criteria met at first visit|7
7801061|NCT01098487|12258618|FG000|Overall Study|Physician Decision|1
7801062|NCT01098539|12258628|FG000|Overall Study|Adverse Event|26
7801063|NCT01098539|12258629|FG001|Overall Study|Adverse Event|26
7801064|NCT01098539|12258628|FG000|Overall Study|Protocol Violation|1
7801065|NCT01098539|12258629|FG001|Overall Study|Protocol Violation|4
7801066|NCT01098539|12258628|FG000|Overall Study|Noncompliance|3
7801067|NCT01098539|12258629|FG001|Overall Study|Noncompliance|5
7801068|NCT01098539|12258628|FG000|Overall Study|Lost to Follow-up|4
7801069|NCT01098539|12258629|FG001|Overall Study|Lost to Follow-up|4
7801070|NCT01098539|12258628|FG000|Overall Study|Withdrawal by Subject|12
7801071|NCT01098539|12258629|FG001|Overall Study|Withdrawal by Subject|26
7801072|NCT01098539|12258628|FG000|Overall Study|Physician Decision|5
7801073|NCT01098539|12258629|FG001|Overall Study|Physician Decision|3
7801074|NCT01098812|12258660|FG000|Overall Study|Death|2
7801075|NCT01098812|12258661|FG001|Overall Study|Death|0
7884124|NCT01788358|12384474|FG000|Overall Study|Adverse Event|51
7884125|NCT01788423|12384481|FG000|Overall Study|See Comments in Completed (above)|0
7884126|NCT01788423|12384482|FG001|Overall Study|See Comments in Completed (above)|4
7884127|NCT01788423|12384483|FG002|Overall Study|See Comments in Completed (above)|5
7884128|NCT01788566|12384491|FG000|Overall Study|Death|4
7884129|NCT01788566|12384491|FG000|Overall Study|Adverse Event|1
7884130|NCT01788566|12384491|FG000|Overall Study|Clinical Progressive Disease|3
7884131|NCT01788943|12384506|FG000|Overall Study|Withdrawal by Subject|1
7884132|NCT01788943|12384507|FG001|Overall Study|Withdrawal by Subject|0
7884133|NCT01789047|12384515|FG000|Overall Study|Adverse Event|3
7884134|NCT01789047|12384516|FG001|Overall Study|Adverse Event|2
7884135|NCT01789047|12384515|FG000|Overall Study|Withdrawal by Subject|1
7884136|NCT01789047|12384516|FG001|Overall Study|Withdrawal by Subject|2
7884137|NCT01789203|12384533|FG000|Overall Study|Adverse Event|2
7884138|NCT01789203|12384534|FG001|Overall Study|Adverse Event|2
7884139|NCT01789203|12384533|FG000|Overall Study|Withdrawal by Subject|1
7884140|NCT01789203|12384534|FG001|Overall Study|Withdrawal by Subject|0
7884141|NCT01789203|12384533|FG000|Overall Study|Death|1
7884142|NCT01789203|12384534|FG001|Overall Study|Death|0
7884143|NCT01789203|12384533|FG000|Overall Study|Protocol Violation|2
7884144|NCT01789203|12384534|FG001|Overall Study|Protocol Violation|1
7884145|NCT01789203|12384533|FG000|Overall Study|Other|1
7884146|NCT01789203|12384534|FG001|Overall Study|Other|1
7884147|NCT01789203|12384533|FG000|Overall Study|patient non-adherent|2
7884148|NCT01789203|12384534|FG001|Overall Study|patient non-adherent|0
7884149|NCT01789281|12384548|FG000|Overall Study|Disease progression|15
7884150|NCT01789281|12384549|FG001|Overall Study|Disease progression|4
7884151|NCT01789281|12384548|FG000|Overall Study|Adverse Event|5
7884152|NCT01789281|12384549|FG001|Overall Study|Adverse Event|5
7884153|NCT01789281|12384548|FG000|Overall Study|Withdrawal by Subject|1
7884154|NCT01789281|12384549|FG001|Overall Study|Withdrawal by Subject|0
7884155|NCT01789281|12384548|FG000|Overall Study|Lost to Follow-up|1
7884156|NCT01789281|12384549|FG001|Overall Study|Lost to Follow-up|0
7884157|NCT01789281|12384548|FG000|Overall Study|Administrative problems|0
7884158|NCT01789281|12384549|FG001|Overall Study|Administrative problems|1
7884159|NCT01789320|12384556|FG000|Overall Study|Re-enrolled into study|1
7884160|NCT01789320|12384556|FG000|Overall Study|Lost to Follow-up|1
7884161|NCT01789476|12384562|FG000|Overall Study|Lack of Efficacy|6
7884162|NCT01789476|12384563|FG001|Overall Study|Lack of Efficacy|2
7884163|NCT01789476|12384562|FG000|Overall Study|Adverse Event|1
7884164|NCT01789476|12384563|FG001|Overall Study|Adverse Event|0
7801076|NCT01098812|12258662|FG002|Overall Study|Death|1
7801077|NCT01098812|12258660|FG000|Overall Study|Lost to Follow-up|0
7801078|NCT01098812|12258661|FG001|Overall Study|Lost to Follow-up|1
7884165|NCT01789476|12384562|FG000|Overall Study|Unable to get IV access|1
7884166|NCT01789476|12384563|FG001|Overall Study|Unable to get IV access|0
7884167|NCT01789567|12384569|FG000|Overall Study|Death|6
7801079|NCT01098812|12258662|FG002|Overall Study|Lost to Follow-up|0
7801080|NCT01098851|12258671|FG000|Overall Study|Equipment failure|1
7801081|NCT01098851|12258672|FG001|Overall Study|Equipment failure|0
7801082|NCT01099215|12258711|FG000|Overall Study|Withdrawal by Subject|1
7801083|NCT01099215|12258712|FG001|Overall Study|Withdrawal by Subject|0
7801084|NCT01099215|12258711|FG000|Overall Study|Adverse Event|0
7801085|NCT01099215|12258712|FG001|Overall Study|Adverse Event|1
7801086|NCT01099267|12258718|FG000|MDS-003 Study|Adverse Event|37
7801087|NCT01099267|12258718|FG000|MDS-003 Study|Lack of Efficacy|52
7801088|NCT01099267|12258718|FG000|MDS-003 Study|Withdrawal by Subject|8
7801089|NCT01099267|12258718|FG000|MDS-003 Study|Lost to Follow-up|1
7801090|NCT01099267|12258718|FG000|MDS-003 Study|Death|11
7801091|NCT01099267|12258718|FG000|MDS-003 Study|Study Closed by Sponsor|2
7801092|NCT01099267|12258718|FG000|MDS-003 Study|Disease Progression|7
7801093|NCT01099267|12258718|FG000|MDS-003 Study|Investigator Decision|2
7801094|NCT01099267|12258718|FG000|MDS-003 Study|Non-Compliance|2
7801095|NCT01099267|12258718|FG000|MDS-003 Study|Loss of Response|1
7801096|NCT01099267|12258718|FG000|MDS-003 Study|Secondary Malign Disease|1
7801097|NCT01099397|12258736|FG000|Overall Study|Lost to Follow-up|4
7801098|NCT01099397|12258736|FG000|Overall Study|Protocol Violation|4
7801099|NCT01099397|12258736|FG000|Overall Study|Withdrawal by Subject|5
7801100|NCT01099579|12258779|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4
7801101|NCT01099579|12258780|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1
7801102|NCT01099579|12258781|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0
7801103|NCT01099579|12258779|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
7801104|NCT01099579|12258780|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
7801105|NCT01099579|12258781|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
7801106|NCT01099579|12258779|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
7801107|NCT01099579|12258780|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
7801108|NCT01099579|12258781|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
7801109|NCT01099579|12258779|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
7801110|NCT01099579|12258780|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
7801111|NCT01099579|12258781|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
7801112|NCT01099579|12258779|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2
7801113|NCT01099579|12258780|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2
7801114|NCT01099579|12258781|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1
7801115|NCT01099579|12258779|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1
7801116|NCT01099579|12258780|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1
7801117|NCT01099579|12258781|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1
7801118|NCT01099579|12258779|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0
7801119|NCT01099579|12258780|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0
7801120|NCT01099579|12258781|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2
7801121|NCT01099579|12258779|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
7801122|NCT01099579|12258780|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
7801123|NCT01099579|12258781|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
7801124|NCT01099579|12258779|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
7801125|NCT01099579|12258780|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
7801126|NCT01099579|12258781|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
7801127|NCT01099579|12258779|FG000|Stage 2 (ATV Capsule)|Adverse Event|0
7801128|NCT01099579|12258780|FG001|Stage 2 (ATV Capsule)|Adverse Event|1
7801129|NCT01099579|12258781|FG002|Stage 2 (ATV Capsule)|Adverse Event|0
7801130|NCT01099709|12258835|FG000|Period 1|Withdrawal by Subject|0
7801131|NCT01099709|12258836|FG001|Period 1|Withdrawal by Subject|1
7801132|NCT01099709|12258835|FG000|Period 1|Positive cotinine test|0
7801133|NCT01099709|12258836|FG001|Period 1|Positive cotinine test|1
7801134|NCT01099709|12258835|FG000|Period 1|Adverse Event|1
7801135|NCT01099709|12258836|FG001|Period 1|Adverse Event|0
7801136|NCT01099917|12258868|FG000|Overall Study|Adverse Event|3
7801137|NCT01099917|12258868|FG000|Overall Study|Not Treated|24
7801138|NCT01100034|12258889|FG000|Overall Study|Lost to Follow-up|11
7801139|NCT01100034|12258889|FG000|Overall Study|Withdrawal of parent/guardian consent|1
7801140|NCT01100034|12258889|FG000|Overall Study|Withdrawal by Subject|4
7801141|NCT01100034|12258889|FG000|Overall Study|Sponsor decision|21
7801142|NCT01100034|12258889|FG000|Overall Study|Participated in another clinical trial|1
7801143|NCT01100034|12258889|FG000|Overall Study|Participants moved to another hospital|4
7801144|NCT01100034|12258889|FG000|Overall Study|Site closed due to non-responsiveness|1
7801145|NCT01100073|12258893|FG000|Overall Study|Lack of Efficacy|4
7801146|NCT01100073|12258893|FG000|Overall Study|Insufficient Tolerability|21
7801147|NCT01100073|12258893|FG000|Overall Study|Withdrawal by Subject|13
7801148|NCT01100073|12258893|FG000|Overall Study|Lost to Follow-up|39
7801149|NCT01100073|12258893|FG000|Overall Study|Lack of effect + patient's wish|2
7801150|NCT01100073|12258893|FG000|Overall Study|Insufficient tolerability +patients wish|8
7801151|NCT01100073|12258893|FG000|Overall Study|Other|8
7801152|NCT01100073|12258893|FG000|Overall Study|Missing|5
7801153|NCT01100086|12258897|FG000|Period 1|Withdrawal by Subject|1
7801154|NCT01100086|12258898|FG001|Period 1|Withdrawal by Subject|0
7801155|NCT01100307|12258927|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
7801156|NCT01100307|12258928|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
7801157|NCT01100307|12258927|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
7801158|NCT01100307|12258928|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
7801159|NCT01100307|12258927|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5
7884168|NCT01789606|12384575|FG000|Overall Study|Participant not Purchased the Product|0
7884169|NCT01789606|12384576|FG001|Overall Study|Participant not Purchased the Product|20
7884170|NCT01789606|12384575|FG000|Overall Study|Withdrawal by Subject|0
7884171|NCT01789606|12384576|FG001|Overall Study|Withdrawal by Subject|1
7884172|NCT01789606|12384575|FG000|Overall Study|Ineligible|6
7884173|NCT01789606|12384576|FG001|Overall Study|Ineligible|2
7884174|NCT01789606|12384575|FG000|Overall Study|Administrative Reasons|17
7884175|NCT01789606|12384576|FG001|Overall Study|Administrative Reasons|6
7884176|NCT01789606|12384575|FG000|Overall Study|No Study Medication Taken|0
7884177|NCT01789606|12384576|FG001|Overall Study|No Study Medication Taken|1
7884178|NCT01789606|12384575|FG000|Overall Study|Protocol Violation|0
7884179|NCT01789606|12384576|FG001|Overall Study|Protocol Violation|55
7884180|NCT01789606|12384575|FG000|Overall Study|Adverse Event|0
7884181|NCT01789606|12384576|FG001|Overall Study|Adverse Event|3
7884182|NCT01789606|12384575|FG000|Overall Study|Lost to Follow-up|0
7884183|NCT01789606|12384576|FG001|Overall Study|Lost to Follow-up|14
7884184|NCT01789606|12384575|FG000|Overall Study|Ineligible or not Willing to Continue|0
7967630|NCT02769247|12524610|FG002|Overall Study|Physician Decision|0
7967631|NCT02769247|12524611|FG003|Overall Study|Physician Decision|0
7967632|NCT02769312|12524627|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
7967633|NCT02769312|12524628|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
7967634|NCT02769312|12524627|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1
7967635|NCT02769312|12524628|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0
7967636|NCT02769312|12524627|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1
7967637|NCT02769312|12524628|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0
7967638|NCT02769312|12524627|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0
7967639|NCT02769312|12524628|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1
7967640|NCT02769312|12524627|FG000|Follow-up|Lost to Follow-up|1
7967641|NCT02769312|12524628|FG001|Follow-up|Lost to Follow-up|1
7801160|NCT01100307|12258928|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2
7801161|NCT01100307|12258927|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
7801162|NCT01100307|12258928|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
7801163|NCT01100307|12258927|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
7801164|NCT01100307|12258928|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
7801165|NCT01100307|12258927|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3
7801166|NCT01100307|12258928|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8
7801167|NCT01100320|12258936|FG000|Period 1|Withdrawal by Subject|2
7801168|NCT01100320|12258937|FG001|Period 1|Withdrawal by Subject|4
7801169|NCT01100320|12258936|FG000|Period 1|Positive Drug Screen|1
7801170|NCT01100320|12258937|FG001|Period 1|Positive Drug Screen|1
7801171|NCT01100320|12258936|FG000|Period 1|Adverse Event|2
7801172|NCT01100320|12258937|FG001|Period 1|Adverse Event|2
7801173|NCT01100320|12258936|FG000|Period 2|Withdrawal by Subject|1
7801174|NCT01100320|12258937|FG001|Period 2|Withdrawal by Subject|1
7801175|NCT01100437|12258943|FG000|Titration/Stabilization|Adverse Event|0
7801176|NCT01100437|12258944|FG001|Titration/Stabilization|Adverse Event|0
7801177|NCT01100437|12258945|FG002|Titration/Stabilization|Adverse Event|4
7801178|NCT01100437|12258943|FG000|Titration/Stabilization|Non-compliance|0
7801179|NCT01100437|12258944|FG001|Titration/Stabilization|Non-compliance|0
7801180|NCT01100437|12258945|FG002|Titration/Stabilization|Non-compliance|1
7801181|NCT01100437|12258943|FG000|Titration/Stabilization|Sponsor canceled study|0
7801182|NCT01100437|12258944|FG001|Titration/Stabilization|Sponsor canceled study|0
7801183|NCT01100437|12258945|FG002|Titration/Stabilization|Sponsor canceled study|1
7801184|NCT01100437|12258943|FG000|Maintenance|Withdrawal by Subject|0
7801185|NCT01100437|12258944|FG001|Maintenance|Withdrawal by Subject|0
7801186|NCT01100437|12258945|FG002|Maintenance|Withdrawal by Subject|1
7801187|NCT01100437|12258943|FG000|Maintenance|Sponsor termination of study|0
7801188|NCT01100437|12258944|FG001|Maintenance|Sponsor termination of study|0
7801189|NCT01100437|12258945|FG002|Maintenance|Sponsor termination of study|1
7801190|NCT01100502|12258956|FG000|Overall Study|Withdrawal by Subject|18
7801191|NCT01100502|12258957|FG001|Overall Study|Withdrawal by Subject|25
7801192|NCT01100502|12258956|FG000|Overall Study|Lost to Follow-up|13
7801193|NCT01100502|12258957|FG001|Overall Study|Lost to Follow-up|28
7801194|NCT01100502|12258956|FG000|Overall Study|Site request to end participation in study|0
7801195|NCT01100502|12258957|FG001|Overall Study|Site request to end participation in study|1
7801196|NCT01100502|12258956|FG000|Overall Study|Death|45
7801197|NCT01100502|12258957|FG001|Overall Study|Death|40
7801198|NCT01100528|12258963|FG000|Overall Study|Death|1
7801199|NCT01100528|12258963|FG000|Overall Study|Withdrawal by Subject|2
7801200|NCT01100567|12258969|FG000|Overall Study|Withdrawal by Subject|5
7801201|NCT01100567|12258970|FG001|Overall Study|Withdrawal by Subject|8
7801202|NCT01100567|12258969|FG000|Overall Study|Early Hospital Discharge|6
7801203|NCT01100567|12258970|FG001|Overall Study|Early Hospital Discharge|4
7801204|NCT01100567|12258969|FG000|Overall Study|Lost to Follow-up|1
7801205|NCT01100567|12258970|FG001|Overall Study|Lost to Follow-up|2
7801206|NCT01100567|12258969|FG000|Overall Study|Physician Decision|0
7801207|NCT01100567|12258970|FG001|Overall Study|Physician Decision|1
7801208|NCT01100567|12258969|FG000|Overall Study|Deemed ineligible after consent|0
7801209|NCT01100567|12258970|FG001|Overall Study|Deemed ineligible after consent|1
7861294|NCT01590758|12349953|FG001|Overall Study|Lost to Follow-up|2
7861295|NCT01590771|12349961|FG000|Overall Study|Other Protocol Specified Criteria|5
7861296|NCT01590771|12349962|FG001|Overall Study|Other Protocol Specified Criteria|14
7861297|NCT01590771|12349961|FG000|Overall Study|Withdrawal by Subject|8
7861298|NCT01590771|12349962|FG001|Overall Study|Withdrawal by Subject|15
7861299|NCT01590771|12349961|FG000|Overall Study|Protocol Violation|1
7861300|NCT01590771|12349962|FG001|Overall Study|Protocol Violation|2
7861301|NCT01590771|12349961|FG000|Overall Study|Lost to Follow-up|1
7861302|NCT01590771|12349962|FG001|Overall Study|Lost to Follow-up|1
7861303|NCT01590771|12349961|FG000|Overall Study|Lack of Efficacy|1
7861304|NCT01590771|12349962|FG001|Overall Study|Lack of Efficacy|0
7861305|NCT01590771|12349961|FG000|Overall Study|Adverse Event|3
7861306|NCT01590771|12349962|FG001|Overall Study|Adverse Event|7
7861307|NCT01590797|12349970|FG000|Overall Study|Adverse Event|4
7861308|NCT01590797|12349971|FG001|Overall Study|Adverse Event|3
7861309|NCT01590797|12349970|FG000|Overall Study|Lack of Efficacy|0
7861310|NCT01590797|12349971|FG001|Overall Study|Lack of Efficacy|2
7861311|NCT01590797|12349970|FG000|Overall Study|Lost to Follow-up|0
7861312|NCT01590797|12349971|FG001|Overall Study|Lost to Follow-up|1
7861313|NCT01590797|12349970|FG000|Overall Study|Protocol Violation|4
7861314|NCT01590797|12349971|FG001|Overall Study|Protocol Violation|1
7861315|NCT01590797|12349970|FG000|Overall Study|Withdrawal by Subject|7
7861316|NCT01590797|12349971|FG001|Overall Study|Withdrawal by Subject|5
7861317|NCT01590797|12349970|FG000|Overall Study|Other Protocol Specified Criteria|2
7861318|NCT01590797|12349971|FG001|Overall Study|Other Protocol Specified Criteria|4
7861319|NCT01590810|12349982|FG000|Overall Study|Physician Decision|0
7861320|NCT01590810|12349983|FG001|Overall Study|Physician Decision|1
7861321|NCT01590810|12349984|FG002|Overall Study|Physician Decision|1
7861322|NCT01590810|12349985|FG003|Overall Study|Physician Decision|0
7861323|NCT01590810|12349986|FG004|Overall Study|Physician Decision|0
7861324|NCT01590888|12350033|FG000|Overall Study|Adverse Event|3
7861325|NCT01590888|12350034|FG001|Overall Study|Adverse Event|0
7861326|NCT01590888|12350035|FG002|Overall Study|Adverse Event|1
7861327|NCT01590888|12350033|FG000|Overall Study|Lost to Follow-up|1
7861328|NCT01590888|12350034|FG001|Overall Study|Lost to Follow-up|0
7861329|NCT01590888|12350035|FG002|Overall Study|Lost to Follow-up|0
7861330|NCT01591330|12350118|FG000|Period 1|Adverse Event|1
7861331|NCT01591330|12350119|FG001|Period 1|Adverse Event|0
7861332|NCT01591330|12350120|FG002|Period 1|Adverse Event|0
7861333|NCT01591330|12350121|FG003|Period 1|Adverse Event|0
7861334|NCT01591330|12350118|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1
7861335|NCT01591330|12350119|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0
7861336|NCT01591330|12350120|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0
7861337|NCT01591330|12350121|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0
7861338|NCT01591330|12350118|FG000|Period 2|Adverse Event|1
7861339|NCT01591330|12350119|FG001|Period 2|Adverse Event|0
7861340|NCT01591330|12350120|FG002|Period 2|Adverse Event|0
7861341|NCT01591330|12350121|FG003|Period 2|Adverse Event|0
7861342|NCT01591382|12350133|FG000|Overall Study|Discharged Prior to Study Completion|2
7861343|NCT01591382|12350134|FG001|Overall Study|Discharged Prior to Study Completion|1
7861344|NCT01591382|12350133|FG000|Overall Study|Participant Opted for Morphine PCA|1
7861345|NCT01591382|12350134|FG001|Overall Study|Participant Opted for Morphine PCA|1
7861346|NCT01591460|12350149|FG000|Overall Study|Adverse Event or Intercurrent Illness|5
7861347|NCT01591460|12350149|FG000|Overall Study|Futility Rule (Week 12)|7
7861348|NCT01591460|12350149|FG000|Overall Study|Futility Rule (Week 24)|3
7861349|NCT01591460|12350149|FG000|Overall Study|Rebound or Breakthrough|3
7801210|NCT01100853|12259000|FG000|Overall Study|Lost to Follow-up|11
7801211|NCT01100853|12259001|FG001|Overall Study|Lost to Follow-up|6
7801212|NCT01100853|12259000|FG000|Overall Study|Received <4 study injections|10
7801213|NCT01100853|12259001|FG001|Overall Study|Received <4 study injections|13
7884185|NCT01789606|12384576|FG001|Overall Study|Ineligible or not Willing to Continue|348
7884186|NCT01789970|12384616|FG000|Open-label Titration Period|Adverse Event|68
7884187|NCT01789970|12384617|FG001|Open-label Titration Period|Adverse Event|0
7884188|NCT01789970|12384618|FG002|Open-label Titration Period|Adverse Event|0
7884189|NCT01789970|12384616|FG000|Open-label Titration Period|Lack of Efficacy|31
7884190|NCT01789970|12384617|FG001|Open-label Titration Period|Lack of Efficacy|0
7884191|NCT01789970|12384618|FG002|Open-label Titration Period|Lack of Efficacy|0
7884192|NCT01789970|12384616|FG000|Open-label Titration Period|Withdrawal by Subject|31
7884193|NCT01789970|12384617|FG001|Open-label Titration Period|Withdrawal by Subject|0
7884194|NCT01789970|12384618|FG002|Open-label Titration Period|Withdrawal by Subject|0
7884195|NCT01789970|12384616|FG000|Open-label Titration Period|Protocol Violation|18
7884196|NCT01789970|12384617|FG001|Open-label Titration Period|Protocol Violation|0
7884197|NCT01789970|12384618|FG002|Open-label Titration Period|Protocol Violation|0
7884198|NCT01789970|12384616|FG000|Open-label Titration Period|Lost to Follow-up|5
7884199|NCT01789970|12384617|FG001|Open-label Titration Period|Lost to Follow-up|0
7884200|NCT01789970|12384618|FG002|Open-label Titration Period|Lost to Follow-up|0
7884201|NCT01789970|12384616|FG000|Open-label Titration Period|Noncompliance to study drug admin|11
7884202|NCT01789970|12384617|FG001|Open-label Titration Period|Noncompliance to study drug admin|0
7884203|NCT01789970|12384618|FG002|Open-label Titration Period|Noncompliance to study drug admin|0
7884204|NCT01789970|12384616|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2
7884205|NCT01789970|12384617|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0
7884206|NCT01789970|12384618|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0
7884207|NCT01789970|12384616|FG000|Open-label Titration Period|Noncompliance with study procedures|8
7884208|NCT01789970|12384617|FG001|Open-label Titration Period|Noncompliance with study procedures|0
7884209|NCT01789970|12384618|FG002|Open-label Titration Period|Noncompliance with study procedures|0
7884210|NCT01789970|12384616|FG000|Open-label Titration Period|Pregnancy|2
7884211|NCT01789970|12384617|FG001|Open-label Titration Period|Pregnancy|0
7884212|NCT01789970|12384618|FG002|Open-label Titration Period|Pregnancy|0
7884213|NCT01789970|12384616|FG000|Open-label Titration Period|Other|76
7884214|NCT01789970|12384617|FG001|Open-label Titration Period|Other|0
7884215|NCT01789970|12384618|FG002|Open-label Titration Period|Other|0
7884216|NCT01789970|12384616|FG000|Open-label Titration Period|Dropped out prior to dosing|2
7884217|NCT01789970|12384617|FG001|Open-label Titration Period|Dropped out prior to dosing|0
7884218|NCT01789970|12384618|FG002|Open-label Titration Period|Dropped out prior to dosing|0
7884219|NCT01789970|12384616|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
7884220|NCT01789970|12384617|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
7884221|NCT01789970|12384618|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
7884222|NCT01789970|12384616|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7884223|NCT01789970|12384617|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
7884224|NCT01789970|12384618|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
7884225|NCT01789970|12384616|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
7884226|NCT01789970|12384617|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
7884227|NCT01789970|12384618|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
7884228|NCT01789970|12384616|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
7884229|NCT01789970|12384617|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
7884230|NCT01789970|12384618|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
7884231|NCT01789970|12384616|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
7884232|NCT01789970|12384617|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
7801214|NCT01100853|12259000|FG000|Overall Study|Withdrawal by Subject|6
7801215|NCT01100853|12259001|FG001|Overall Study|Withdrawal by Subject|4
7801216|NCT01100944|12259017|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
7801217|NCT01100944|12259018|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
7801218|NCT01100944|12259019|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
7801219|NCT01100944|12259017|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
7801220|NCT01100944|12259018|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
7801221|NCT01100944|12259019|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
7801222|NCT01100944|12259017|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
7801223|NCT01100944|12259018|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
7801224|NCT01100944|12259019|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
7801225|NCT01100944|12259017|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
7801226|NCT01100944|12259018|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
7801227|NCT01100944|12259019|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
7801228|NCT01101022|12259042|FG000|Overall Study|Adverse Event|6
7801229|NCT01101022|12259043|FG001|Overall Study|Adverse Event|2
7801230|NCT01101022|12259042|FG000|Overall Study|Protocol Violation|4
7801231|NCT01101022|12259043|FG001|Overall Study|Protocol Violation|3
7801232|NCT01101022|12259042|FG000|Overall Study|Withdrawal by Subject|3
7801233|NCT01101022|12259043|FG001|Overall Study|Withdrawal by Subject|8
7801234|NCT01101022|12259042|FG000|Overall Study|Lost to Follow-up|1
7801235|NCT01101022|12259043|FG001|Overall Study|Lost to Follow-up|4
7801236|NCT01101022|12259042|FG000|Overall Study|Lack of Efficacy|0
7801237|NCT01101022|12259043|FG001|Overall Study|Lack of Efficacy|7
7801238|NCT01101022|12259042|FG000|Overall Study|Sponsor decision|1
7801239|NCT01101022|12259043|FG001|Overall Study|Sponsor decision|1
7801240|NCT01101022|12259042|FG000|Overall Study|Non-compliance|1
7801241|NCT01101022|12259043|FG001|Overall Study|Non-compliance|0
7801242|NCT01101022|12259042|FG000|Overall Study|Work schedule|1
7801243|NCT01101022|12259043|FG001|Overall Study|Work schedule|1
7801244|NCT01101022|12259042|FG000|Overall Study|Vacation|0
7801245|NCT01101022|12259043|FG001|Overall Study|Vacation|1
7801246|NCT01101035|12259051|FG000|Overall Study|Adverse Event|191
7801247|NCT01101035|12259052|FG001|Overall Study|Adverse Event|172
7801248|NCT01101035|12259051|FG000|Overall Study|Major Protocol Deviation|52
7801249|NCT01101035|12259052|FG001|Overall Study|Major Protocol Deviation|46
7801250|NCT01101035|12259051|FG000|Overall Study|Lost to Follow-up|226
7801251|NCT01101035|12259052|FG001|Overall Study|Lost to Follow-up|223
7801252|NCT01101035|12259051|FG000|Overall Study|Voluntary Withdrawal|595
7801253|NCT01101035|12259052|FG001|Overall Study|Voluntary Withdrawal|587
7801254|NCT01101035|12259051|FG000|Overall Study|Reason not Specified|333
7801255|NCT01101035|12259052|FG001|Overall Study|Reason not Specified|363
7801256|NCT01101061|12259064|FG000|Overall Study|Adverse Event|0
7801257|NCT01101061|12259065|FG001|Overall Study|Adverse Event|0
7801258|NCT01101061|12259066|FG002|Overall Study|Adverse Event|1
7801259|NCT01101061|12259067|FG003|Overall Study|Adverse Event|0
7801260|NCT01101061|12259068|FG004|Overall Study|Adverse Event|0
7801261|NCT01101061|12259069|FG005|Overall Study|Adverse Event|0
7801262|NCT01101165|12259092|FG000|Period 1|Adverse Event|1
7801263|NCT01101165|12259093|FG001|Period 1|Adverse Event|2
7801264|NCT01101165|12259092|FG000|Period 1|Withdrawal by Subject|0
7801265|NCT01101165|12259093|FG001|Period 1|Withdrawal by Subject|2
7801266|NCT01101165|12259092|FG000|Period 1|Positive Drug Screen|0
7801267|NCT01101165|12259093|FG001|Period 1|Positive Drug Screen|1
7801268|NCT01101165|12259092|FG000|Period 1|Lost to Follow-up|1
7801269|NCT01101165|12259093|FG001|Period 1|Lost to Follow-up|0
7801270|NCT01101165|12259092|FG000|Period 2|Withdrawal by Subject|3
7801271|NCT01101165|12259093|FG001|Period 2|Withdrawal by Subject|1
7801272|NCT01101165|12259092|FG000|Period 2|Adverse Event|1
7801273|NCT01101165|12259093|FG001|Period 2|Adverse Event|0
7801274|NCT01101178|12259099|FG000|Period 1|Withdrawal by Subject|1
7801275|NCT01101178|12259100|FG001|Period 1|Withdrawal by Subject|2
7801276|NCT01101178|12259099|FG000|Period 1|Positive drug screen|1
7801277|NCT01101178|12259100|FG001|Period 1|Positive drug screen|1
7801278|NCT01101178|12259099|FG000|Period 1|Adverse Event|2
7801279|NCT01101178|12259100|FG001|Period 1|Adverse Event|1
7801280|NCT01101178|12259099|FG000|Period 2|Withdrawal by Subject|0
7801281|NCT01101178|12259100|FG001|Period 2|Withdrawal by Subject|1
7801282|NCT01101191|12259107|FG000|Period 1|Withdrawal by Subject|1
7801283|NCT01101191|12259108|FG001|Period 1|Withdrawal by Subject|0
7801284|NCT01101191|12259107|FG000|Period 1|Adverse Event|1
7801285|NCT01101191|12259108|FG001|Period 1|Adverse Event|2
7801286|NCT01101308|12259115|FG000|Period 1|Adverse Event|2
7801287|NCT01101308|12259116|FG001|Period 1|Adverse Event|1
7801288|NCT01101308|12259115|FG000|Period 1|Positive for cotinine|1
7801289|NCT01101308|12259116|FG001|Period 1|Positive for cotinine|0
7801290|NCT01101321|12259123|FG000|Period 1|Withdrawal by Subject|1
7801291|NCT01101321|12259124|FG001|Period 1|Withdrawal by Subject|1
7801292|NCT01101321|12259123|FG000|Period 1|Adverse Event|3
7801293|NCT01101321|12259124|FG001|Period 1|Adverse Event|3
7801294|NCT01101334|12259132|FG000|Overall Study|Adverse Event|9
7801295|NCT01101334|12259133|FG001|Overall Study|Adverse Event|4
7801296|NCT01101334|12259132|FG000|Overall Study|Death|7
7801297|NCT01101334|12259133|FG001|Overall Study|Death|1
7801298|NCT01101334|12259132|FG000|Overall Study|Withdrawal by Subject|4
7801299|NCT01101334|12259133|FG001|Overall Study|Withdrawal by Subject|3
7801300|NCT01101334|12259132|FG000|Overall Study|Withdrawal by Sponsor|1
7801301|NCT01101334|12259133|FG001|Overall Study|Withdrawal by Sponsor|1
7801302|NCT01101334|12259132|FG000|Overall Study|Progressive Disease|22
7801303|NCT01101334|12259133|FG001|Overall Study|Progressive Disease|35
7801304|NCT01101334|12259132|FG000|Overall Study|Other|2
7801305|NCT01101334|12259133|FG001|Overall Study|Other|1
7801306|NCT01101477|12259142|FG000|Overall Study|Protocol Violation|5
7801307|NCT01101477|12259143|FG001|Overall Study|Protocol Violation|3
7801308|NCT01101477|12259144|FG002|Overall Study|Protocol Violation|1
7801309|NCT01101542|12259152|FG000|Year 3 Surveillance Period|Lost to Follow-up|7
7801310|NCT01101542|12259152|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4
7801311|NCT01101542|12259152|FG000|Year 4 Surveillance Period|Other|287
7801312|NCT01101542|12259152|FG000|Year 5 Surveillance Period|Lost to Follow-up|140
7801313|NCT01101542|12259152|FG000|Year 5 Surveillance Period|Pregnancy|1
7801314|NCT01101542|12259152|FG000|Year 6 Surveillance Period|Lost to Follow-up|986
7801315|NCT01101542|12259152|FG000|Year 6 Surveillance Period|Pregnancy|1
7801316|NCT01101542|12259152|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4
7801317|NCT01101841|12259162|FG000|Overall Study|Adverse Event|15
7801318|NCT01101841|12259163|FG001|Overall Study|Adverse Event|15
7801319|NCT01101841|12259162|FG000|Overall Study|Lost to Follow-up|9
7801320|NCT01101841|12259163|FG001|Overall Study|Lost to Follow-up|3
7801321|NCT01101841|12259162|FG000|Overall Study|Withdrawal by Subject|21
7801322|NCT01101841|12259163|FG001|Overall Study|Withdrawal by Subject|40
7801323|NCT01101841|12259162|FG000|Overall Study|Protocol Violation|1
7801324|NCT01101841|12259163|FG001|Overall Study|Protocol Violation|1
7801325|NCT01101841|12259162|FG000|Overall Study|Physician Decision|0
7801326|NCT01101841|12259163|FG001|Overall Study|Physician Decision|2
7801327|NCT01101841|12259162|FG000|Overall Study|Lack of Efficacy|0
7801328|NCT01101841|12259163|FG001|Overall Study|Lack of Efficacy|2
7801329|NCT01101841|12259162|FG000|Overall Study|Other|0
7801330|NCT01101841|12259163|FG001|Overall Study|Other|1
7801331|NCT01101841|12259162|FG000|Overall Study|Suicidality Tracking Scale|3
7801332|NCT01101841|12259163|FG001|Overall Study|Suicidality Tracking Scale|1
7801333|NCT01101841|12259162|FG000|Overall Study|Eligibility Criteria|1
7801334|NCT01101841|12259163|FG001|Overall Study|Eligibility Criteria|2
7801335|NCT01101997|12259200|FG000|Overall Study|Withdrawal by Subject|2
7801336|NCT01102231|12259215|FG000|Overall Study|Protocol Violation|3
7801337|NCT01102231|12259215|FG000|Overall Study|Lack of Efficacy|2
7801338|NCT01102231|12259215|FG000|Overall Study|Death|2
7801339|NCT01102231|12259215|FG000|Overall Study|Adverse Event|3
7801340|NCT01102231|12259215|FG000|Overall Study|Withdrawal by Subject|1
7801341|NCT01102231|12259215|FG000|Overall Study|Did not received the treatment|4
7801342|NCT01102257|12259222|FG000|Overall Study|Adverse Event|1
7801343|NCT01102257|12259223|FG001|Overall Study|Adverse Event|0
7801344|NCT01102257|12259222|FG000|Overall Study|Adverse Event|1
7801345|NCT01102257|12259223|FG001|Overall Study|Adverse Event|0
7801346|NCT01102374|12259238|FG000|Overall Study|Death|9
7801347|NCT01102374|12259239|FG001|Overall Study|Death|13
7801348|NCT01102374|12259238|FG000|Overall Study|Lost to Follow-up|7
7801349|NCT01102374|12259239|FG001|Overall Study|Lost to Follow-up|6
7801350|NCT01102426|12259256|FG000|Overall Study|Randomized but not treated|4
7801351|NCT01102426|12259257|FG001|Overall Study|Randomized but not treated|1
7801352|NCT01102426|12259256|FG000|Overall Study|Adverse Events (treatment-related)|15
7801353|NCT01102426|12259257|FG001|Overall Study|Adverse Events (treatment-related)|8
7801354|NCT01102426|12259256|FG000|Overall Study|Physician Decision|9
7801355|NCT01102426|12259257|FG001|Overall Study|Physician Decision|6
7801356|NCT01102426|12259256|FG000|Overall Study|Progressive Disease|85
7801357|NCT01102426|12259257|FG001|Overall Study|Progressive Disease|44
7801358|NCT01102426|12259256|FG000|Overall Study|Adverse Events (unrelated to|9
7801359|NCT01102426|12259257|FG001|Overall Study|Adverse Events (unrelated to|1
7801360|NCT01102426|12259256|FG000|Overall Study|Patient Refusal|24
7801361|NCT01102426|12259257|FG001|Overall Study|Patient Refusal|12
7801362|NCT01102426|12259256|FG000|Overall Study|Death (due to adverse events|0
7801363|NCT01102426|12259257|FG001|Overall Study|Death (due to adverse events|1
7801364|NCT01102426|12259256|FG000|Overall Study|Death (non-related to the study|19
7801365|NCT01102426|12259257|FG001|Overall Study|Death (non-related to the study|8
7801366|NCT01102491|12259265|FG000|Overall Study|Protocol Violation|11
7801367|NCT01102491|12259266|FG001|Overall Study|Protocol Violation|12
7801368|NCT01102777|12259287|FG000|Overall Study|Death|2
7801369|NCT01102777|12259288|FG001|Overall Study|Death|6
7801370|NCT01102777|12259287|FG000|Overall Study|Lost to Follow-up|7
7801371|NCT01102777|12259288|FG001|Overall Study|Lost to Follow-up|10
7801372|NCT01102803|12259297|FG000|Baseline to Post-Treatment|Lost to Follow-up|3
7801373|NCT01102803|12259298|FG001|Baseline to Post-Treatment|Lost to Follow-up|0
7801374|NCT01102803|12259297|FG000|Post to Follow-Up|Lost to Follow-up|1
7801375|NCT01102803|12259298|FG001|Post to Follow-Up|Lost to Follow-up|3
7801376|NCT01102972|12259314|FG000|Overall Study|Adverse Event|8
7801377|NCT01102972|12259315|FG001|Overall Study|Adverse Event|2
7801378|NCT01102972|12259314|FG000|Overall Study|Lack of Efficacy|2
7801379|NCT01102972|12259315|FG001|Overall Study|Lack of Efficacy|1
7801380|NCT01102972|12259314|FG000|Overall Study|Protocol Violation|1
7801381|NCT01102972|12259315|FG001|Overall Study|Protocol Violation|0
7801382|NCT01102972|12259314|FG000|Overall Study|Lost to Follow-up|10
7801383|NCT01102972|12259315|FG001|Overall Study|Lost to Follow-up|5
7801384|NCT01102972|12259314|FG000|Overall Study|Investigator Discretion|2
7801385|NCT01102972|12259315|FG001|Overall Study|Investigator Discretion|0
7801386|NCT01102972|12259314|FG000|Overall Study|Withdrawal by Subject|6
7801387|NCT01102972|12259315|FG001|Overall Study|Withdrawal by Subject|6
7801388|NCT01103063|12259323|FG000|Overall Study|Adverse Event|3
7801389|NCT01103063|12259324|FG001|Overall Study|Adverse Event|1
7801390|NCT01103063|12259323|FG000|Overall Study|Lost to Follow-up|68
7801391|NCT01103063|12259324|FG001|Overall Study|Lost to Follow-up|51
7801392|NCT01103063|12259323|FG000|Overall Study|Withdrawal by Subject|60
7801393|NCT01103063|12259324|FG001|Overall Study|Withdrawal by Subject|15
7801394|NCT01103063|12259323|FG000|Overall Study|Other|16
7884233|NCT01789970|12384618|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
7884234|NCT01789970|12384616|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
7884235|NCT01789970|12384617|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
7884236|NCT01789970|12384618|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
7884237|NCT01789970|12384616|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
7884238|NCT01789970|12384617|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
7962806|NCT02714868|12517179|FG000|Overall Study|Withdrawal by Subject|3
7801395|NCT01103063|12259324|FG001|Overall Study|Other|11
7801396|NCT01103063|12259323|FG000|Overall Study|Protocol Violation|1
7801397|NCT01103063|12259324|FG001|Overall Study|Protocol Violation|0
7884239|NCT01789970|12384618|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
7884240|NCT01789970|12384616|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
7884241|NCT01789970|12384617|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
7884242|NCT01789970|12384618|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
7884243|NCT01789970|12384616|FG000|Double-blind Treatment Period (12 Weeks)|Other|0
7884244|NCT01789970|12384617|FG001|Double-blind Treatment Period (12 Weeks)|Other|1
7884245|NCT01789970|12384618|FG002|Double-blind Treatment Period (12 Weeks)|Other|3
7884246|NCT01789970|12384616|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
7884247|NCT01789970|12384617|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
7884248|NCT01789970|12384618|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
7884249|NCT01790048|12384634|FG000|Overall Study|Incorrect Age|9
7884250|NCT01790048|12384635|FG001|Overall Study|Incorrect Age|14
7884251|NCT01790048|12384634|FG000|Overall Study|data entry error|0
7884252|NCT01790048|12384635|FG001|Overall Study|data entry error|1
7884253|NCT01790048|12384634|FG000|Overall Study|Other|0
7884254|NCT01790048|12384635|FG001|Overall Study|Other|2
7884255|NCT01790048|12384634|FG000|Overall Study|SAM at Enrollment|2
7884256|NCT01790048|12384635|FG001|Overall Study|SAM at Enrollment|0
7884257|NCT01790048|12384634|FG000|Overall Study|Measurement error|1
7884258|NCT01790048|12384635|FG001|Overall Study|Measurement error|0
7884259|NCT01790113|12384645|FG000|Overall Study|Adverse Event|2
7884260|NCT01790113|12384646|FG001|Overall Study|Adverse Event|7
7884261|NCT01790113|12384645|FG000|Overall Study|Study ended due to FDA clearance|1
7884262|NCT01790113|12384646|FG001|Overall Study|Study ended due to FDA clearance|68
7884263|NCT01790126|12384655|FG000|Overall Study|PSA Progression|12
7884264|NCT01790126|12384656|FG001|Overall Study|PSA Progression|16
7884265|NCT01790126|12384657|FG002|Overall Study|PSA Progression|16
7884266|NCT01790126|12384655|FG000|Overall Study|Other|5
7884267|NCT01790126|12384656|FG001|Overall Study|Other|4
7884268|NCT01790126|12384657|FG002|Overall Study|Other|8
7884269|NCT01790126|12384655|FG000|Overall Study|Initiation of Non-Protocol Therapy|3
7884270|NCT01790126|12384656|FG001|Overall Study|Initiation of Non-Protocol Therapy|4
7884271|NCT01790126|12384657|FG002|Overall Study|Initiation of Non-Protocol Therapy|2
7884272|NCT01790126|12384655|FG000|Overall Study|Withdrawal by Physician|1
7884273|NCT01790126|12384656|FG001|Overall Study|Withdrawal by Physician|1
7884274|NCT01790126|12384657|FG002|Overall Study|Withdrawal by Physician|2
7884275|NCT01790126|12384655|FG000|Overall Study|Withdrawal by Subject|3
7884276|NCT01790126|12384656|FG001|Overall Study|Withdrawal by Subject|1
7884277|NCT01790126|12384657|FG002|Overall Study|Withdrawal by Subject|2
7884278|NCT01790126|12384655|FG000|Overall Study|Lost to Follow-up|1
7884279|NCT01790126|12384656|FG001|Overall Study|Lost to Follow-up|0
7884280|NCT01790126|12384657|FG002|Overall Study|Lost to Follow-up|1
7884281|NCT01790126|12384655|FG000|Overall Study|Adverse Event|0
7884282|NCT01790126|12384656|FG001|Overall Study|Adverse Event|2
7884283|NCT01790126|12384657|FG002|Overall Study|Adverse Event|0
7884284|NCT01790126|12384655|FG000|Overall Study|Death|2
7884285|NCT01790126|12384656|FG001|Overall Study|Death|0
7884286|NCT01790126|12384657|FG002|Overall Study|Death|0
7884287|NCT01790126|12384655|FG000|Overall Study|Radiographic Progression|3
7884288|NCT01790126|12384656|FG001|Overall Study|Radiographic Progression|1
7884289|NCT01790126|12384657|FG002|Overall Study|Radiographic Progression|0
7801398|NCT01103063|12259323|FG000|Overall Study|Study terminated by Sponsor|326
7884290|NCT01790295|12384684|FG000|Overall Study|Adverse Event|1
7884291|NCT01790295|12384684|FG000|Overall Study|Death|4
7884292|NCT01790295|12384684|FG000|Overall Study|Lack of Efficacy|2
7884293|NCT01790295|12384684|FG000|Overall Study|Study closure|4
7884294|NCT01790438|12384691|FG000|Overall Study|Adverse Event|3
7884295|NCT01790438|12384692|FG001|Overall Study|Adverse Event|2
7884296|NCT01790438|12384691|FG000|Overall Study|Death|4
7801399|NCT01103063|12259324|FG001|Overall Study|Study terminated by Sponsor|342
7801400|NCT01103063|12259323|FG000|Overall Study|Death|3
7801401|NCT01103063|12259324|FG001|Overall Study|Death|1
7801402|NCT01103141|12259334|FG000|Overall Study|Death|0
7801403|NCT01103141|12259335|FG001|Overall Study|Death|1
7801404|NCT01103141|12259334|FG000|Overall Study|Lost to Follow-up|2
7801405|NCT01103141|12259335|FG001|Overall Study|Lost to Follow-up|1
7801406|NCT01103232|12259343|FG000|Overall Study|Withdrawal by Subject|1
7801407|NCT01103232|12259344|FG001|Overall Study|Withdrawal by Subject|1
7801408|NCT01103232|12259343|FG000|Overall Study|Protocol Violation|0
7801409|NCT01103232|12259344|FG001|Overall Study|Protocol Violation|1
7801410|NCT01103245|12259354|FG000|Overall Study|Withdrawal by Subject|1
7801411|NCT01103245|12259355|FG001|Overall Study|Withdrawal by Subject|0
7801412|NCT01103245|12259356|FG002|Overall Study|Withdrawal by Subject|3
7801413|NCT01103245|12259357|FG003|Overall Study|Withdrawal by Subject|0
7801414|NCT01103245|12259354|FG000|Overall Study|Inadequate IV access|1
7801415|NCT01103245|12259355|FG001|Overall Study|Inadequate IV access|0
7801416|NCT01103245|12259356|FG002|Overall Study|Inadequate IV access|0
7801417|NCT01103245|12259357|FG003|Overall Study|Inadequate IV access|0
7801418|NCT01103245|12259354|FG000|Overall Study|Adverse Event|0
7801419|NCT01103245|12259355|FG001|Overall Study|Adverse Event|2
7801420|NCT01103245|12259356|FG002|Overall Study|Adverse Event|1
7801421|NCT01103245|12259357|FG003|Overall Study|Adverse Event|0
7801422|NCT01103245|12259354|FG000|Overall Study|Physician Decision|1
7884297|NCT01790438|12384692|FG001|Overall Study|Death|0
7801423|NCT01103245|12259355|FG001|Overall Study|Physician Decision|0
7801424|NCT01103245|12259356|FG002|Overall Study|Physician Decision|0
7801425|NCT01103245|12259357|FG003|Overall Study|Physician Decision|0
7801426|NCT01103284|12259379|FG000|Overall Study|Death|2
7801427|NCT01103284|12259380|FG001|Overall Study|Death|0
7801428|NCT01103284|12259379|FG000|Overall Study|Lost to Follow-up|9
7801429|NCT01103284|12259380|FG001|Overall Study|Lost to Follow-up|10
7801430|NCT01103284|12259379|FG000|Overall Study|Pregnancy|3
7801431|NCT01103284|12259380|FG001|Overall Study|Pregnancy|1
7801432|NCT01103284|12259379|FG000|Overall Study|Protocol Violation|12
7801433|NCT01103284|12259380|FG001|Overall Study|Protocol Violation|5
7801434|NCT01103284|12259379|FG000|Overall Study|Adverse Event|0
7801435|NCT01103284|12259380|FG001|Overall Study|Adverse Event|5
7801436|NCT01103284|12259379|FG000|Overall Study|Withdrawal by Subject|14
7801437|NCT01103284|12259380|FG001|Overall Study|Withdrawal by Subject|18
7801438|NCT01103284|12259379|FG000|Overall Study|Dermal Hypersensitivity|0
7801439|NCT01103284|12259380|FG001|Overall Study|Dermal Hypersensitivity|1
7801440|NCT01103284|12259379|FG000|Overall Study|Termination by the Sponsor|0
7801441|NCT01103284|12259380|FG001|Overall Study|Termination by the Sponsor|1
7801442|NCT01103284|12259379|FG000|Overall Study|Not described|2
7801443|NCT01103284|12259380|FG001|Overall Study|Not described|1
7801444|NCT01103284|12259379|FG000|Overall Study|Missing CRF entries for study completion|0
7801445|NCT01103284|12259380|FG001|Overall Study|Missing CRF entries for study completion|2
7801446|NCT01103323|12259388|FG000|Without/Before Drug Switch|Adverse Event|50
7801447|NCT01103323|12259389|FG001|Without/Before Drug Switch|Adverse Event|7
7801448|NCT01103323|12259388|FG000|Without/Before Drug Switch|Withdrawal by Subject|17
7801449|NCT01103323|12259389|FG001|Without/Before Drug Switch|Withdrawal by Subject|5
7801450|NCT01103323|12259388|FG000|Without/Before Drug Switch|Protocol Violation|2
7801451|NCT01103323|12259389|FG001|Without/Before Drug Switch|Protocol Violation|0
7801452|NCT01103323|12259388|FG000|Without/Before Drug Switch|Physician Decision|2
7801453|NCT01103323|12259389|FG001|Without/Before Drug Switch|Physician Decision|0
7801454|NCT01103323|12259388|FG000|Without/Before Drug Switch|did not receive study treatment|5
7801455|NCT01103323|12259389|FG001|Without/Before Drug Switch|did not receive study treatment|2
7801456|NCT01103323|12259388|FG000|Without/Before Drug Switch|Switch to Regorafenib|0
7801457|NCT01103323|12259389|FG001|Without/Before Drug Switch|Switch to Regorafenib|4
7801458|NCT01103323|12259388|FG000|Switched From Placebo to Regorafenib|Adverse Event|0
7801459|NCT01103323|12259389|FG001|Switched From Placebo to Regorafenib|Adverse Event|1
7801460|NCT01103362|12259396|FG000|Overall Study|study terminated|596
7801461|NCT01103466|12259430|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2
7801462|NCT01103466|12259431|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0
7801463|NCT01103466|12259432|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0
7801464|NCT01103466|12259430|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2
7801465|NCT01103466|12259431|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1
7801466|NCT01103466|12259432|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0
7801467|NCT01103466|12259430|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
7801468|NCT01103466|12259431|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
7801469|NCT01103466|12259432|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
7801470|NCT01103466|12259430|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1
7801471|NCT01103466|12259431|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0
7801472|NCT01103466|12259432|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0
7801473|NCT01103466|12259430|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
7801474|NCT01103466|12259431|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
7801475|NCT01103466|12259432|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
7801476|NCT01103466|12259430|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0
7801477|NCT01103466|12259431|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0
7801478|NCT01103466|12259432|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1
7801479|NCT01103479|12259443|FG000|Overall Study|Up to date with CRC screening|1
7801480|NCT01103479|12259444|FG001|Overall Study|Up to date with CRC screening|9
7801481|NCT01103479|12259445|FG002|Overall Study|Up to date with CRC screening|12
7801482|NCT01103479|12259443|FG000|Overall Study|Family history of CRC|1
7801483|NCT01103479|12259444|FG001|Overall Study|Family history of CRC|0
7801484|NCT01103479|12259445|FG002|Overall Study|Family history of CRC|2
7801485|NCT01103479|12259443|FG000|Overall Study|Active cancer|1
7801486|NCT01103479|12259444|FG001|Overall Study|Active cancer|0
7801487|NCT01103479|12259445|FG002|Overall Study|Active cancer|0
7801488|NCT01103479|12259443|FG000|Overall Study|Saw non-study physician|2
7801489|NCT01103479|12259444|FG001|Overall Study|Saw non-study physician|0
7801490|NCT01103479|12259445|FG002|Overall Study|Saw non-study physician|0
7801491|NCT01103713|12259475|FG000|Overall Study|Lost to Follow-up|2
7801492|NCT01103713|12259475|FG000|Overall Study|Withdrawal by Subject|8
7801493|NCT01103713|12259475|FG000|Overall Study|Study terminated by sponsor|2
7801494|NCT01103713|12259475|FG000|Overall Study|Other|1
7801495|NCT01103778|12259482|FG000|Overall Study|Lost to Follow-up|1
7801496|NCT01103778|12259482|FG000|Overall Study|Proteinuria improved prior to enrollment|1
7801497|NCT01103778|12259482|FG000|Overall Study|Screen failure|1
7801498|NCT01103960|12259499|FG000|Overall Study|Adverse Event|2
7801499|NCT01103960|12259500|FG001|Overall Study|Adverse Event|1
7801500|NCT01103960|12259499|FG000|Overall Study|Withdrawal by Subject|2
7801501|NCT01103960|12259500|FG001|Overall Study|Withdrawal by Subject|1
7801502|NCT01103960|12259499|FG000|Overall Study|Other|1
7801503|NCT01103960|12259500|FG001|Overall Study|Other|0
7801504|NCT01104155|12259541|FG000|Overall Study|Adverse Event|15
7801505|NCT01104155|12259542|FG001|Overall Study|Adverse Event|8
7801506|NCT01104155|12259541|FG000|Overall Study|Participant choice|6
7801507|NCT01104155|12259542|FG001|Overall Study|Participant choice|5
7801508|NCT01104155|12259541|FG000|Overall Study|Withdrawal of consent|1
7801509|NCT01104155|12259542|FG001|Overall Study|Withdrawal of consent|1
7801510|NCT01104155|12259541|FG000|Overall Study|Other|3
7801511|NCT01104155|12259542|FG001|Overall Study|Other|4
7801512|NCT01104246|12259557|FG000|Overall Study|Withdrawal by Subject|1
7801513|NCT01104246|12259557|FG000|Overall Study|did not meet inclusion criteria|4
7801514|NCT01104311|12259572|FG000|Overall Study|Withdrawal by Subject|6
7801515|NCT01104311|12259573|FG001|Overall Study|Withdrawal by Subject|6
7801516|NCT01104311|12259572|FG000|Overall Study|Protocol Violation|0
7801517|NCT01104311|12259573|FG001|Overall Study|Protocol Violation|1
7801518|NCT01104311|12259572|FG000|Overall Study|Physician Decision|2
7801519|NCT01104311|12259573|FG001|Overall Study|Physician Decision|2
7801520|NCT01104311|12259572|FG000|Overall Study|low compliance|1
7801521|NCT01104311|12259573|FG001|Overall Study|low compliance|1
7801522|NCT01104311|12259572|FG000|Overall Study|Adverse Event|1
7801523|NCT01104311|12259573|FG001|Overall Study|Adverse Event|2
7801524|NCT01104376|12259583|FG000|Overall Study|Withdrawal by Subject|15
7801525|NCT01104376|12259583|FG000|Overall Study|Consented but excluded after labs|13
7801526|NCT01104415|12259596|FG000|Core Phase|Consent withdrawn by subjects|1
7801527|NCT01104415|12259597|FG001|Core Phase|Consent withdrawn by subjects|0
7801528|NCT01104415|12259596|FG000|Extension Period|Progressive disease|0
7801529|NCT01104415|12259597|FG001|Extension Period|Progressive disease|4
7801530|NCT01104415|12259596|FG000|Extension Period|Death|0
7801531|NCT01104415|12259597|FG001|Extension Period|Death|1
7801532|NCT01104415|12259596|FG000|Extension Period|Physician Decision|0
7801533|NCT01104415|12259597|FG001|Extension Period|Physician Decision|1
7801534|NCT01104415|12259596|FG000|Extension Period|Transition to Study LX1606.302|0
7801535|NCT01104415|12259597|FG001|Extension Period|Transition to Study LX1606.302|4
7801536|NCT01104415|12259596|FG000|Extension Period|Heart surgery/feeling miserable|0
7801537|NCT01104415|12259597|FG001|Extension Period|Heart surgery/feeling miserable|1
7801538|NCT01104493|12259606|FG000|Overall Study|Lost to Follow-up|0
7801539|NCT01104493|12259607|FG001|Overall Study|Lost to Follow-up|2
7801540|NCT01104545|12259616|FG000|Overall Study|Adverse Event|0
7801541|NCT01104545|12259617|FG001|Overall Study|Adverse Event|1
7801542|NCT01104545|12259618|FG002|Overall Study|Adverse Event|2
7801543|NCT01104558|12259663|FG000|Overall Study|Protocol Violation|6
7801544|NCT01104558|12259663|FG000|Overall Study|Missing of primary efficacy assessment|10
7801545|NCT01104558|12259663|FG000|Overall Study|Missing of genetic analysis results|1
7801546|NCT01104584|12259667|FG000|Overall Study|Study drug never administered|21
7801547|NCT01104584|12259667|FG000|Overall Study|Study prematurely discontinued|2
7801548|NCT01104636|12259689|FG000|Overall Study|Lack of Efficacy|43
7801549|NCT01104636|12259689|FG000|Overall Study|Lost to Follow-up|24
7801550|NCT01104636|12259689|FG000|Overall Study|Withdrawal by Subject|4
7801551|NCT01104636|12259689|FG000|Overall Study|Other|43
7801552|NCT01104636|12259689|FG000|Overall Study|Study terminated by sponsor|1
7801553|NCT01104636|12259689|FG000|Overall Study|Pregnancy|2
7801554|NCT01104636|12259689|FG000|Overall Study|Adverse Event|40
7801555|NCT01104636|12259689|FG000|Overall Study|Ongoing|21
7801556|NCT01104662|12259701|FG000|Overall Study|Adverse Event|2
7801557|NCT01104662|12259702|FG001|Overall Study|Adverse Event|2
7801558|NCT01104662|12259703|FG002|Overall Study|Adverse Event|0
7801559|NCT01104662|12259704|FG003|Overall Study|Adverse Event|1
7801560|NCT01104662|12259705|FG004|Overall Study|Adverse Event|1
7801561|NCT01104662|12259706|FG005|Overall Study|Adverse Event|1
7801562|NCT01104662|12259707|FG006|Overall Study|Adverse Event|0
7801563|NCT01104662|12259708|FG007|Overall Study|Adverse Event|0
7801564|NCT01104662|12259701|FG000|Overall Study|Clinical Failure|1
7801565|NCT01104662|12259702|FG001|Overall Study|Clinical Failure|0
7801566|NCT01104662|12259703|FG002|Overall Study|Clinical Failure|0
7801567|NCT01104662|12259704|FG003|Overall Study|Clinical Failure|0
7801568|NCT01104662|12259705|FG004|Overall Study|Clinical Failure|0
7801569|NCT01104662|12259706|FG005|Overall Study|Clinical Failure|1
7801570|NCT01104662|12259707|FG006|Overall Study|Clinical Failure|0
7801571|NCT01104662|12259708|FG007|Overall Study|Clinical Failure|0
7801572|NCT01104662|12259701|FG000|Overall Study|Participant left investigator's care|1
7801573|NCT01104662|12259702|FG001|Overall Study|Participant left investigator's care|1
7801574|NCT01104662|12259703|FG002|Overall Study|Participant left investigator's care|0
7801575|NCT01104662|12259704|FG003|Overall Study|Participant left investigator's care|0
7801576|NCT01104662|12259705|FG004|Overall Study|Participant left investigator's care|0
7801577|NCT01104662|12259706|FG005|Overall Study|Participant left investigator's care|0
7801578|NCT01104662|12259707|FG006|Overall Study|Participant left investigator's care|0
7801579|NCT01104662|12259708|FG007|Overall Study|Participant left investigator's care|0
7801580|NCT01104662|12259701|FG000|Overall Study|Reason not specified|3
7801581|NCT01104662|12259702|FG001|Overall Study|Reason not specified|3
7801582|NCT01104662|12259703|FG002|Overall Study|Reason not specified|0
7801583|NCT01104662|12259704|FG003|Overall Study|Reason not specified|0
7801584|NCT01104662|12259705|FG004|Overall Study|Reason not specified|0
7801585|NCT01104662|12259706|FG005|Overall Study|Reason not specified|1
7801586|NCT01104662|12259707|FG006|Overall Study|Reason not specified|0
7801587|NCT01104662|12259708|FG007|Overall Study|Reason not specified|0
7801588|NCT01104662|12259701|FG000|Overall Study|Randomized but not treated|3
7801589|NCT01104662|12259702|FG001|Overall Study|Randomized but not treated|4
7801590|NCT01104662|12259703|FG002|Overall Study|Randomized but not treated|1
7801591|NCT01104662|12259704|FG003|Overall Study|Randomized but not treated|0
7884298|NCT01790438|12384691|FG000|Overall Study|Lost to Follow-up|5
7884299|NCT01790438|12384692|FG001|Overall Study|Lost to Follow-up|2
7884300|NCT01790438|12384691|FG000|Overall Study|Withdrawal by Subject|13
7884301|NCT01790438|12384692|FG001|Overall Study|Withdrawal by Subject|2
7884302|NCT01790438|12384691|FG000|Overall Study|Physician Decision|3
7884303|NCT01790438|12384692|FG001|Overall Study|Physician Decision|1
7884304|NCT01790438|12384691|FG000|Overall Study|Sponsor Decision|0
7884305|NCT01790438|12384692|FG001|Overall Study|Sponsor Decision|3
7884306|NCT01790438|12384691|FG000|Overall Study|Protocol Required Discontinuation|7
7884307|NCT01790438|12384692|FG001|Overall Study|Protocol Required Discontinuation|1
7884308|NCT01790503|12384727|FG000|Overall Study|Adverse Event|1
7884309|NCT01790503|12384728|FG001|Overall Study|Adverse Event|0
7884310|NCT01790503|12384729|FG002|Overall Study|Adverse Event|0
7884311|NCT01790503|12384730|FG003|Overall Study|Adverse Event|0
7884312|NCT01790503|12384731|FG004|Overall Study|Adverse Event|0
7884313|NCT01790503|12384732|FG005|Overall Study|Adverse Event|2
7884314|NCT01790503|12384733|FG006|Overall Study|Adverse Event|0
7884315|NCT01790503|12384734|FG007|Overall Study|Adverse Event|0
7884316|NCT01790503|12384735|FG008|Overall Study|Adverse Event|2
7884317|NCT01790503|12384736|FG009|Overall Study|Adverse Event|4
7884318|NCT01790503|12384737|FG010|Overall Study|Adverse Event|7
7884319|NCT01790503|12384727|FG000|Overall Study|Withdrawal by Subject|0
7884320|NCT01790503|12384728|FG001|Overall Study|Withdrawal by Subject|0
7884321|NCT01790503|12384729|FG002|Overall Study|Withdrawal by Subject|1
7884322|NCT01790503|12384730|FG003|Overall Study|Withdrawal by Subject|1
7884323|NCT01790503|12384731|FG004|Overall Study|Withdrawal by Subject|1
7884324|NCT01790503|12384732|FG005|Overall Study|Withdrawal by Subject|2
7884325|NCT01790503|12384733|FG006|Overall Study|Withdrawal by Subject|1
7884326|NCT01790503|12384734|FG007|Overall Study|Withdrawal by Subject|0
7884327|NCT01790503|12384735|FG008|Overall Study|Withdrawal by Subject|0
7884328|NCT01790503|12384736|FG009|Overall Study|Withdrawal by Subject|0
7884329|NCT01790503|12384737|FG010|Overall Study|Withdrawal by Subject|1
7884330|NCT01790503|12384727|FG000|Overall Study|Disease progression|2
7884331|NCT01790503|12384728|FG001|Overall Study|Disease progression|1
7884332|NCT01790503|12384729|FG002|Overall Study|Disease progression|0
7884333|NCT01790503|12384730|FG003|Overall Study|Disease progression|1
7884334|NCT01790503|12384731|FG004|Overall Study|Disease progression|2
7884335|NCT01790503|12384732|FG005|Overall Study|Disease progression|1
7884336|NCT01790503|12384733|FG006|Overall Study|Disease progression|0
7884337|NCT01790503|12384734|FG007|Overall Study|Disease progression|1
7884338|NCT01790503|12384735|FG008|Overall Study|Disease progression|0
7884339|NCT01790503|12384736|FG009|Overall Study|Disease progression|17
7884340|NCT01790503|12384737|FG010|Overall Study|Disease progression|7
7884341|NCT01790503|12384727|FG000|Overall Study|Protocol Violation|0
7884342|NCT01790503|12384728|FG001|Overall Study|Protocol Violation|0
7884343|NCT01790503|12384729|FG002|Overall Study|Protocol Violation|0
7884344|NCT01790503|12384730|FG003|Overall Study|Protocol Violation|0
7884345|NCT01790503|12384731|FG004|Overall Study|Protocol Violation|0
7884346|NCT01790503|12384732|FG005|Overall Study|Protocol Violation|0
7884347|NCT01790503|12384733|FG006|Overall Study|Protocol Violation|0
7884348|NCT01790503|12384734|FG007|Overall Study|Protocol Violation|0
7884349|NCT01790503|12384735|FG008|Overall Study|Protocol Violation|0
7717493|NCT00520039|12141092|FG001|Overall Study|Exclusion criteria met at first visit|5
7717494|NCT00520130|12141102|FG000|Overall Study|Disease progression on study|4
7717495|NCT00520130|12141103|FG001|Overall Study|Disease progression on study|0
7717496|NCT00520130|12141102|FG000|Overall Study|Physician Decision|1
7717497|NCT00520130|12141103|FG001|Overall Study|Physician Decision|1
7717498|NCT00520299|12141135|FG000|Overall Study|Withdrawal by Subject|0
7717499|NCT00520299|12141136|FG001|Overall Study|Withdrawal by Subject|0
7717500|NCT00520299|12141137|FG002|Overall Study|Withdrawal by Subject|2
7717501|NCT00520299|12141135|FG000|Overall Study|Progressive disease|0
7717502|NCT00520299|12141136|FG001|Overall Study|Progressive disease|3
7801592|NCT01104662|12259705|FG004|Overall Study|Randomized but not treated|0
7801593|NCT01104662|12259706|FG005|Overall Study|Randomized but not treated|1
7801594|NCT01104662|12259707|FG006|Overall Study|Randomized but not treated|0
7801595|NCT01104662|12259708|FG007|Overall Study|Randomized but not treated|0
7801596|NCT01104701|12259731|FG000|Overall Study|Withdrawal by Subject|0
7801597|NCT01104701|12259732|FG001|Overall Study|Withdrawal by Subject|1
7801598|NCT01104701|12259733|FG002|Overall Study|Withdrawal by Subject|2
7801599|NCT01104701|12259734|FG003|Overall Study|Withdrawal by Subject|1
7801600|NCT01104701|12259731|FG000|Overall Study|Adverse Event|0
7801601|NCT01104701|12259732|FG001|Overall Study|Adverse Event|0
7801602|NCT01104701|12259733|FG002|Overall Study|Adverse Event|0
7801603|NCT01104701|12259734|FG003|Overall Study|Adverse Event|1
7801604|NCT01104701|12259731|FG000|Overall Study|Physician Decision|0
7801605|NCT01104701|12259732|FG001|Overall Study|Physician Decision|2
7801606|NCT01104701|12259733|FG002|Overall Study|Physician Decision|0
7801607|NCT01104701|12259734|FG003|Overall Study|Physician Decision|0
7884350|NCT01790503|12384736|FG009|Overall Study|Protocol Violation|1
7801608|NCT01104766|12259748|FG000|Overall Study|Did not meet inc/exc criteria|1
7801609|NCT01104766|12259749|FG001|Overall Study|Did not meet inc/exc criteria|0
7801610|NCT01104766|12259750|FG002|Overall Study|Did not meet inc/exc criteria|0
7801611|NCT01104766|12259751|FG003|Overall Study|Did not meet inc/exc criteria|0
7801612|NCT01104766|12259748|FG000|Overall Study|Adverse Event|17
7801613|NCT01104766|12259749|FG001|Overall Study|Adverse Event|15
7801614|NCT01104766|12259750|FG002|Overall Study|Adverse Event|20
7801615|NCT01104766|12259751|FG003|Overall Study|Adverse Event|14
7801616|NCT01104766|12259748|FG000|Overall Study|Lack of Efficacy|20
7801617|NCT01104766|12259749|FG001|Overall Study|Lack of Efficacy|15
7801618|NCT01104766|12259750|FG002|Overall Study|Lack of Efficacy|14
7801619|NCT01104766|12259751|FG003|Overall Study|Lack of Efficacy|8
7801620|NCT01104766|12259748|FG000|Overall Study|Protocol Violation|2
7801621|NCT01104766|12259749|FG001|Overall Study|Protocol Violation|0
7801622|NCT01104766|12259750|FG002|Overall Study|Protocol Violation|0
7801623|NCT01104766|12259751|FG003|Overall Study|Protocol Violation|0
7801624|NCT01104766|12259748|FG000|Overall Study|Withdrawal by Subject|17
7801625|NCT01104766|12259749|FG001|Overall Study|Withdrawal by Subject|19
7801626|NCT01104766|12259750|FG002|Overall Study|Withdrawal by Subject|25
7801627|NCT01104766|12259751|FG003|Overall Study|Withdrawal by Subject|15
7801628|NCT01104766|12259748|FG000|Overall Study|Lost to Follow-up|1
7801629|NCT01104766|12259749|FG001|Overall Study|Lost to Follow-up|2
7801630|NCT01104766|12259750|FG002|Overall Study|Lost to Follow-up|1
7801631|NCT01104766|12259751|FG003|Overall Study|Lost to Follow-up|1
7801632|NCT01104779|12259764|FG000|Overall Study|Protocol Violation|1
7801633|NCT01104779|12259765|FG001|Overall Study|Protocol Violation|2
7801634|NCT01104779|12259766|FG002|Overall Study|Protocol Violation|2
7801635|NCT01104779|12259764|FG000|Overall Study|Lack of Efficacy|26
7801636|NCT01104779|12259765|FG001|Overall Study|Lack of Efficacy|12
7801637|NCT01104779|12259766|FG002|Overall Study|Lack of Efficacy|13
7801638|NCT01104779|12259764|FG000|Overall Study|Adverse Event|13
7801639|NCT01104779|12259765|FG001|Overall Study|Adverse Event|14
7801640|NCT01104779|12259766|FG002|Overall Study|Adverse Event|13
7801641|NCT01104779|12259764|FG000|Overall Study|Did not meet inc/exc criteria|1
7801642|NCT01104779|12259765|FG001|Overall Study|Did not meet inc/exc criteria|1
7801643|NCT01104779|12259766|FG002|Overall Study|Did not meet inc/exc criteria|1
7801644|NCT01104779|12259764|FG000|Overall Study|Other reasons|0
7801645|NCT01104779|12259765|FG001|Overall Study|Other reasons|1
7801646|NCT01104779|12259766|FG002|Overall Study|Other reasons|0
7801647|NCT01104779|12259764|FG000|Overall Study|Lost to Follow-up|2
7801648|NCT01104779|12259765|FG001|Overall Study|Lost to Follow-up|0
7801649|NCT01104779|12259766|FG002|Overall Study|Lost to Follow-up|1
7801650|NCT01104779|12259764|FG000|Overall Study|Withdrawal by Subject|16
7801651|NCT01104779|12259765|FG001|Overall Study|Withdrawal by Subject|25
7801652|NCT01104779|12259766|FG002|Overall Study|Withdrawal by Subject|32
7801653|NCT01104792|12259774|FG000|Overall Study|Adverse Event|77
7801654|NCT01104792|12259774|FG000|Overall Study|Insufficient Therapeutic Response|22
7801655|NCT01104792|12259774|FG000|Overall Study|Protocol Violation|45
7801656|NCT01104792|12259774|FG000|Overall Study|Withdrawal of Consent|179
7801657|NCT01104792|12259774|FG000|Overall Study|Lost to Follow-up|43
7801658|NCT01104792|12259774|FG000|Overall Study|Reasons Not Specified|27
7801659|NCT01104792|12259774|FG000|Overall Study|Did Not Meet Eligibility Criteria|133
7801660|NCT01104870|12259781|FG000|Overall Study|Adverse Event|1
7801661|NCT01104870|12259782|FG001|Overall Study|Adverse Event|1
7801662|NCT01104870|12259783|FG002|Overall Study|Adverse Event|0
7801663|NCT01104870|12259781|FG000|Overall Study|Death|0
7801664|NCT01104870|12259782|FG001|Overall Study|Death|0
7801665|NCT01104870|12259783|FG002|Overall Study|Death|1
7801666|NCT01104870|12259781|FG000|Overall Study|Withdrawal by Subject|0
7801667|NCT01104870|12259782|FG001|Overall Study|Withdrawal by Subject|0
7801668|NCT01104870|12259783|FG002|Overall Study|Withdrawal by Subject|1
7801669|NCT01105065|12259791|FG000|Overall Study|Adverse Event|5
7801670|NCT01105065|12259791|FG000|Overall Study|Technical Problems|1
7801671|NCT01105091|12259799|FG000|Overall Study|Death|2
7801672|NCT01105091|12259800|FG001|Overall Study|Death|0
7801673|NCT01105130|12259820|FG000|Overall Study|Withdrawal by Subject|4
7801674|NCT01105130|12259821|FG001|Overall Study|Withdrawal by Subject|6
7801675|NCT01105130|12259822|FG002|Overall Study|Withdrawal by Subject|2
7801676|NCT01105130|12259820|FG000|Overall Study|Never Started|2
7801677|NCT01105130|12259821|FG001|Overall Study|Never Started|2
7801678|NCT01105130|12259822|FG002|Overall Study|Never Started|4
7801679|NCT01105130|12259820|FG000|Overall Study|Toxicity|1
7801680|NCT01105130|12259821|FG001|Overall Study|Toxicity|3
7801681|NCT01105130|12259822|FG002|Overall Study|Toxicity|2
7801682|NCT01105130|12259820|FG000|Overall Study|Multiple Reasons|3
7801683|NCT01105130|12259821|FG001|Overall Study|Multiple Reasons|0
7801684|NCT01105130|12259822|FG002|Overall Study|Multiple Reasons|2
7801685|NCT01105377|12259859|FG000|Overall Study|Withdrawal by Subject|0
7801686|NCT01105377|12259860|FG001|Overall Study|Withdrawal by Subject|1
7801687|NCT01105533|12259866|FG000|Overall Study|Death|0
7801688|NCT01105533|12259867|FG001|Overall Study|Death|0
7801689|NCT01105533|12259868|FG002|Overall Study|Death|0
7801690|NCT01105533|12259869|FG003|Overall Study|Death|0
7801691|NCT01105533|12259870|FG004|Overall Study|Death|1
7801692|NCT01105533|12259871|FG005|Overall Study|Death|0
7801693|NCT01105533|12259872|FG006|Overall Study|Death|0
7801694|NCT01105533|12259873|FG007|Overall Study|Death|0
7801695|NCT01105533|12259874|FG008|Overall Study|Death|0
7801696|NCT01105533|12259866|FG000|Overall Study|Lack of Efficacy|1
7801697|NCT01105533|12259867|FG001|Overall Study|Lack of Efficacy|1
7801698|NCT01105533|12259868|FG002|Overall Study|Lack of Efficacy|3
7801699|NCT01105533|12259869|FG003|Overall Study|Lack of Efficacy|3
7801700|NCT01105533|12259870|FG004|Overall Study|Lack of Efficacy|4
7801701|NCT01105533|12259871|FG005|Overall Study|Lack of Efficacy|5
7801702|NCT01105533|12259872|FG006|Overall Study|Lack of Efficacy|3
7801703|NCT01105533|12259873|FG007|Overall Study|Lack of Efficacy|2
7801704|NCT01105533|12259874|FG008|Overall Study|Lack of Efficacy|9
7801705|NCT01105533|12259866|FG000|Overall Study|Adverse Event|0
7801706|NCT01105533|12259867|FG001|Overall Study|Adverse Event|0
7801707|NCT01105533|12259868|FG002|Overall Study|Adverse Event|0
7801708|NCT01105533|12259869|FG003|Overall Study|Adverse Event|0
7801709|NCT01105533|12259870|FG004|Overall Study|Adverse Event|1
7801710|NCT01105533|12259871|FG005|Overall Study|Adverse Event|2
7801711|NCT01105533|12259872|FG006|Overall Study|Adverse Event|2
7801712|NCT01105533|12259873|FG007|Overall Study|Adverse Event|0
7801713|NCT01105533|12259874|FG008|Overall Study|Adverse Event|1
7801714|NCT01105533|12259866|FG000|Overall Study|Other|0
7801715|NCT01105533|12259867|FG001|Overall Study|Other|0
7801716|NCT01105533|12259868|FG002|Overall Study|Other|0
7801717|NCT01105533|12259869|FG003|Overall Study|Other|0
7801718|NCT01105533|12259870|FG004|Overall Study|Other|1
7801719|NCT01105533|12259871|FG005|Overall Study|Other|0
7801720|NCT01105533|12259872|FG006|Overall Study|Other|3
7801721|NCT01105533|12259873|FG007|Overall Study|Other|1
7801722|NCT01105533|12259874|FG008|Overall Study|Other|2
7801723|NCT01105533|12259866|FG000|Overall Study|Physician Decision|0
7801724|NCT01105533|12259867|FG001|Overall Study|Physician Decision|0
7801725|NCT01105533|12259868|FG002|Overall Study|Physician Decision|0
7801726|NCT01105533|12259869|FG003|Overall Study|Physician Decision|0
7801727|NCT01105533|12259870|FG004|Overall Study|Physician Decision|0
7801728|NCT01105533|12259871|FG005|Overall Study|Physician Decision|0
7801729|NCT01105533|12259872|FG006|Overall Study|Physician Decision|0
7801730|NCT01105533|12259873|FG007|Overall Study|Physician Decision|1
7801731|NCT01105533|12259874|FG008|Overall Study|Physician Decision|0
7801732|NCT01105767|12259919|FG000|Overall Study|Lost to Follow-up|1160
7801733|NCT01105767|12259920|FG001|Overall Study|Lost to Follow-up|1614
7801734|NCT01105767|12259921|FG002|Overall Study|Lost to Follow-up|1184
7801735|NCT01105936|12259929|FG000|Period 1|Adverse Event|0
7801736|NCT01105936|12259930|FG001|Period 1|Adverse Event|0
7801737|NCT01105936|12259931|FG002|Period 1|Adverse Event|0
7801738|NCT01105936|12259932|FG003|Period 1|Adverse Event|1
7801739|NCT01105936|12259929|FG000|Period 2|Adverse Event|1
7801740|NCT01105936|12259930|FG001|Period 2|Adverse Event|0
7801741|NCT01105936|12259931|FG002|Period 2|Adverse Event|0
7801742|NCT01105936|12259932|FG003|Period 2|Adverse Event|0
7801743|NCT01105936|12259929|FG000|Period 3|Protocol Violation|0
7801744|NCT01105936|12259930|FG001|Period 3|Protocol Violation|2
7801745|NCT01105936|12259931|FG002|Period 3|Protocol Violation|0
7801746|NCT01105936|12259932|FG003|Period 3|Protocol Violation|0
7801747|NCT01105975|12259951|FG000|Overall Study|Adverse Event|2
7801748|NCT01105975|12259952|FG001|Overall Study|Adverse Event|1
7801749|NCT01105975|12259953|FG002|Overall Study|Adverse Event|5
7801750|NCT01105975|12259954|FG003|Overall Study|Adverse Event|1
7801751|NCT01105975|12259955|FG004|Overall Study|Adverse Event|0
7801752|NCT01105975|12259956|FG005|Overall Study|Adverse Event|1
7801753|NCT01105975|12259957|FG006|Overall Study|Adverse Event|2
7801754|NCT01105975|12259958|FG007|Overall Study|Adverse Event|4
7801755|NCT01105975|12259959|FG008|Overall Study|Adverse Event|1
7801756|NCT01105975|12259960|FG009|Overall Study|Adverse Event|4
7801757|NCT01105975|12259951|FG000|Overall Study|Withdrawal by Subject|2
7801758|NCT01105975|12259952|FG001|Overall Study|Withdrawal by Subject|2
7801759|NCT01105975|12259953|FG002|Overall Study|Withdrawal by Subject|2
7801760|NCT01105975|12259954|FG003|Overall Study|Withdrawal by Subject|0
7801761|NCT01105975|12259955|FG004|Overall Study|Withdrawal by Subject|4
7801762|NCT01105975|12259956|FG005|Overall Study|Withdrawal by Subject|1
7801763|NCT01105975|12259957|FG006|Overall Study|Withdrawal by Subject|2
7801764|NCT01105975|12259958|FG007|Overall Study|Withdrawal by Subject|1
7801765|NCT01105975|12259959|FG008|Overall Study|Withdrawal by Subject|0
7801766|NCT01105975|12259960|FG009|Overall Study|Withdrawal by Subject|3
7801767|NCT01105975|12259951|FG000|Overall Study|Lost to Follow-up|1
7801768|NCT01105975|12259952|FG001|Overall Study|Lost to Follow-up|0
7801769|NCT01105975|12259953|FG002|Overall Study|Lost to Follow-up|0
7801770|NCT01105975|12259954|FG003|Overall Study|Lost to Follow-up|1
7801771|NCT01105975|12259955|FG004|Overall Study|Lost to Follow-up|1
7801772|NCT01105975|12259956|FG005|Overall Study|Lost to Follow-up|0
7801773|NCT01105975|12259957|FG006|Overall Study|Lost to Follow-up|0
7801774|NCT01105975|12259958|FG007|Overall Study|Lost to Follow-up|0
7801775|NCT01105975|12259959|FG008|Overall Study|Lost to Follow-up|1
7801776|NCT01105975|12259960|FG009|Overall Study|Lost to Follow-up|0
7801777|NCT01105975|12259951|FG000|Overall Study|Physician Decision|0
7801778|NCT01105975|12259952|FG001|Overall Study|Physician Decision|0
7801779|NCT01105975|12259953|FG002|Overall Study|Physician Decision|0
7801780|NCT01105975|12259954|FG003|Overall Study|Physician Decision|0
7801781|NCT01105975|12259955|FG004|Overall Study|Physician Decision|0
7801782|NCT01105975|12259956|FG005|Overall Study|Physician Decision|0
7801783|NCT01105975|12259957|FG006|Overall Study|Physician Decision|2
7801784|NCT01105975|12259958|FG007|Overall Study|Physician Decision|0
7801785|NCT01105975|12259959|FG008|Overall Study|Physician Decision|0
7801786|NCT01105975|12259960|FG009|Overall Study|Physician Decision|0
7801787|NCT01105975|12259951|FG000|Overall Study|Protocol Violation|0
7801788|NCT01105975|12259952|FG001|Overall Study|Protocol Violation|2
7801789|NCT01105975|12259953|FG002|Overall Study|Protocol Violation|2
7801790|NCT01105975|12259954|FG003|Overall Study|Protocol Violation|0
7801791|NCT01105975|12259955|FG004|Overall Study|Protocol Violation|1
7801792|NCT01105975|12259956|FG005|Overall Study|Protocol Violation|1
7801793|NCT01105975|12259957|FG006|Overall Study|Protocol Violation|1
7801794|NCT01105975|12259958|FG007|Overall Study|Protocol Violation|1
7801795|NCT01105975|12259959|FG008|Overall Study|Protocol Violation|2
7801796|NCT01105975|12259960|FG009|Overall Study|Protocol Violation|2
7801797|NCT01105975|12259951|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7801798|NCT01105975|12259952|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7801799|NCT01105975|12259953|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7801800|NCT01105975|12259954|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7801801|NCT01105975|12259955|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7801802|NCT01105975|12259956|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2
7801803|NCT01105975|12259957|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7801804|NCT01105975|12259958|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7801805|NCT01105975|12259959|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2
7801806|NCT01105975|12259960|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7801807|NCT01106014|12260003|FG000|Overall Study|Morbidity or Mortality primary endpoint|155
7801808|NCT01106014|12260004|FG001|Overall Study|Morbidity or Mortality primary endpoint|242
7801809|NCT01106014|12260003|FG000|Overall Study|Adverse Event|78
7801810|NCT01106014|12260004|FG001|Overall Study|Adverse Event|42
7801811|NCT01106014|12260003|FG000|Overall Study|Withdrawal by Subject|43
7801812|NCT01106014|12260004|FG001|Overall Study|Withdrawal by Subject|37
7801813|NCT01106014|12260003|FG000|Overall Study|Administrative reason|7
7801814|NCT01106014|12260004|FG001|Overall Study|Administrative reason|6
7801815|NCT01106014|12260003|FG000|Overall Study|Lost to Follow-up|2
7801816|NCT01106014|12260004|FG001|Overall Study|Lost to Follow-up|3
7801817|NCT01106027|12260010|FG000|Overall Study|Lost graft early, discontinued|1
7801818|NCT01106092|12260023|FG000|Overall Study|Withdrawal by Subject|0
7801819|NCT01106092|12260024|FG001|Overall Study|Withdrawal by Subject|0
7801820|NCT01106092|12260025|FG002|Overall Study|Withdrawal by Subject|0
7801821|NCT01106092|12260026|FG003|Overall Study|Withdrawal by Subject|1
7801822|NCT01106157|12260038|FG000|Overall Study|Withdrawal by Subject|1
7801823|NCT01106157|12260039|FG001|Overall Study|Withdrawal by Subject|0
7801824|NCT01106248|12260045|FG000|Overall Study|Adverse Event|1
7801825|NCT01106248|12260045|FG000|Overall Study|Administrative|2
7801826|NCT01106287|12260053|FG000|Overall Study|Adverse Event|1
7801827|NCT01106287|12260054|FG001|Overall Study|Adverse Event|0
7801828|NCT01106287|12260055|FG002|Overall Study|Adverse Event|0
7801829|NCT01106287|12260056|FG003|Overall Study|Adverse Event|0
7861350|NCT01591460|12350149|FG000|Overall Study|Treatment Discontinued by Error|1
7861351|NCT01591460|12350149|FG000|Overall Study|Lost to Follow-up|1
7884351|NCT01790503|12384737|FG010|Overall Study|Protocol Violation|0
7884352|NCT01790503|12384727|FG000|Overall Study|Physician Decision|0
7884353|NCT01790503|12384728|FG001|Overall Study|Physician Decision|0
7884354|NCT01790503|12384729|FG002|Overall Study|Physician Decision|0
7884355|NCT01790503|12384730|FG003|Overall Study|Physician Decision|0
7884356|NCT01790503|12384731|FG004|Overall Study|Physician Decision|0
7884357|NCT01790503|12384732|FG005|Overall Study|Physician Decision|0
7884358|NCT01790503|12384733|FG006|Overall Study|Physician Decision|0
7884359|NCT01790503|12384734|FG007|Overall Study|Physician Decision|0
7884360|NCT01790503|12384735|FG008|Overall Study|Physician Decision|0
7884361|NCT01790503|12384736|FG009|Overall Study|Physician Decision|1
7884362|NCT01790503|12384737|FG010|Overall Study|Physician Decision|1
7861352|NCT01591460|12350149|FG000|Overall Study|Noncompliance|1
7861353|NCT01591460|12350149|FG000|Overall Study|Participant Refusal|3
7861354|NCT01591460|12350149|FG000|Overall Study|Withdrawal by Subject|1
7861355|NCT01591460|12350149|FG000|Overall Study|Protocol Violation|1
7861356|NCT01591499|12350161|FG000|Baseline Visit|Withdrawal by Subject|0
7861357|NCT01591499|12350162|FG001|Baseline Visit|Withdrawal by Subject|2
7861358|NCT01591499|12350163|FG002|Baseline Visit|Withdrawal by Subject|0
7861359|NCT01591499|12350164|FG003|Baseline Visit|Withdrawal by Subject|2
7861360|NCT01591499|12350161|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
7861361|NCT01591499|12350162|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
7861362|NCT01591499|12350163|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
7861363|NCT01591499|12350164|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
7861364|NCT01591499|12350161|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4
7861365|NCT01591499|12350162|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3
7861366|NCT01591499|12350163|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1
7861367|NCT01591499|12350164|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3
7884363|NCT01790503|12384727|FG000|Overall Study|Death|0
7884364|NCT01790503|12384728|FG001|Overall Study|Death|0
7884365|NCT01790503|12384729|FG002|Overall Study|Death|0
7884366|NCT01790503|12384730|FG003|Overall Study|Death|0
7884367|NCT01790503|12384731|FG004|Overall Study|Death|0
7884368|NCT01790503|12384732|FG005|Overall Study|Death|0
7884369|NCT01790503|12384733|FG006|Overall Study|Death|0
7884370|NCT01790503|12384734|FG007|Overall Study|Death|0
7884371|NCT01790503|12384735|FG008|Overall Study|Death|0
7884372|NCT01790503|12384736|FG009|Overall Study|Death|1
7884373|NCT01790503|12384737|FG010|Overall Study|Death|0
7884374|NCT01790503|12384727|FG000|Overall Study|Non Compliance|0
7884375|NCT01790503|12384728|FG001|Overall Study|Non Compliance|0
7884376|NCT01790503|12384729|FG002|Overall Study|Non Compliance|0
7884377|NCT01790503|12384730|FG003|Overall Study|Non Compliance|0
7884378|NCT01790503|12384731|FG004|Overall Study|Non Compliance|1
7884379|NCT01790503|12384732|FG005|Overall Study|Non Compliance|0
7884380|NCT01790503|12384733|FG006|Overall Study|Non Compliance|0
7884381|NCT01790503|12384734|FG007|Overall Study|Non Compliance|0
7884382|NCT01790503|12384735|FG008|Overall Study|Non Compliance|0
7884383|NCT01790503|12384736|FG009|Overall Study|Non Compliance|0
7884384|NCT01790503|12384737|FG010|Overall Study|Non Compliance|0
7884385|NCT01790503|12384727|FG000|Overall Study|Other|0
7884386|NCT01790503|12384728|FG001|Overall Study|Other|0
7884387|NCT01790503|12384729|FG002|Overall Study|Other|0
7884388|NCT01790503|12384730|FG003|Overall Study|Other|0
7884389|NCT01790503|12384731|FG004|Overall Study|Other|1
7884390|NCT01790503|12384732|FG005|Overall Study|Other|0
7884391|NCT01790503|12384733|FG006|Overall Study|Other|0
7884392|NCT01790503|12384734|FG007|Overall Study|Other|0
7884393|NCT01790503|12384735|FG008|Overall Study|Other|1
7884394|NCT01790503|12384736|FG009|Overall Study|Other|2
7884395|NCT01790503|12384737|FG010|Overall Study|Other|0
7884396|NCT01790516|12384776|FG000|Overall Study|Physician Decision|1
7884397|NCT01790516|12384777|FG001|Overall Study|Physician Decision|0
7884398|NCT01790568|12384783|FG000|Overall Study|Progression prior to transplant|0
7884399|NCT01790568|12384784|FG001|Overall Study|Progression prior to transplant|1
7884400|NCT01790594|12384799|FG000|Overall Study|Death|1
7884401|NCT01790594|12384800|FG001|Overall Study|Death|0
7884402|NCT01790594|12384801|FG002|Overall Study|Death|0
7884403|NCT01790594|12384799|FG000|Overall Study|Physician Decision|2
7884404|NCT01790594|12384800|FG001|Overall Study|Physician Decision|1
7884405|NCT01790594|12384801|FG002|Overall Study|Physician Decision|0
7884406|NCT01790594|12384799|FG000|Overall Study|Withdrawal by Subject|2
7884407|NCT01790594|12384800|FG001|Overall Study|Withdrawal by Subject|0
7884408|NCT01790594|12384801|FG002|Overall Study|Withdrawal by Subject|0
7884409|NCT01790594|12384799|FG000|Overall Study|Transplant was not done|0
7884410|NCT01790594|12384800|FG001|Overall Study|Transplant was not done|0
7884411|NCT01790594|12384801|FG002|Overall Study|Transplant was not done|3
7884412|NCT01790594|12384799|FG000|Overall Study|Terminated prior to week 76|0
7884413|NCT01790594|12384800|FG001|Overall Study|Terminated prior to week 76|2
7884414|NCT01790594|12384801|FG002|Overall Study|Terminated prior to week 76|0
7884415|NCT01790633|12384810|FG000|Overall Study|Protocol Violation|1
7884416|NCT01790633|12384811|FG001|Overall Study|Protocol Violation|2
7884417|NCT01790633|12384810|FG000|Overall Study|Did not have serology performed|47
7884418|NCT01790633|12384811|FG001|Overall Study|Did not have serology performed|0
7884419|NCT01790633|12384810|FG000|Overall Study|RT failure and no follow-up ELISA|0
7884420|NCT01790633|12384811|FG001|Overall Study|RT failure and no follow-up ELISA|3
7884421|NCT01790828|12384841|FG000|Overall Study|Other|34
7884422|NCT01790932|12384845|FG000|Overall Study|Disease Progression|41
7884423|NCT01790932|12384845|FG000|Overall Study|Adverse Event|7
7884424|NCT01790932|12384845|FG000|Overall Study|Physician Decision|1
7884425|NCT01790932|12384845|FG000|Overall Study|Withdrawal by Subject|1
7884426|NCT01790984|12384851|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1
7884427|NCT01790984|12384852|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1
7884428|NCT01790984|12384853|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0
7884429|NCT01790984|12384854|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0
7884430|NCT01791127|12384877|FG000|Overall Study|Death|356
7884431|NCT01791127|12384877|FG000|Overall Study|Patient has withdrawn from study|293
7884432|NCT01791127|12384877|FG000|Overall Study|Lost to Follow-up|42
7884433|NCT01791127|12384877|FG000|Overall Study|All Siello leads are explanted|31
7884434|NCT01791127|12384877|FG000|Overall Study|Completion of 30 day safety registry|1
7884435|NCT01791127|12384877|FG000|Overall Study|Study terminated for EP Passion|749
7884436|NCT01791153|12384898|FG000|Part 1: Blinded Period|Adverse Event|7
7884437|NCT01791153|12384899|FG001|Part 1: Blinded Period|Adverse Event|3
7884438|NCT01791153|12384900|FG002|Part 1: Blinded Period|Adverse Event|2
7884439|NCT01791153|12384901|FG003|Part 1: Blinded Period|Adverse Event|0
7884440|NCT01791153|12384902|FG004|Part 1: Blinded Period|Adverse Event|0
7884441|NCT01791153|12384903|FG005|Part 1: Blinded Period|Adverse Event|0
7884442|NCT01791153|12384904|FG006|Part 1: Blinded Period|Adverse Event|0
7884443|NCT01791153|12384905|FG007|Part 1: Blinded Period|Adverse Event|0
7884444|NCT01791153|12384898|FG000|Part 1: Blinded Period|Lack of Efficacy|1
7884445|NCT01791153|12384899|FG001|Part 1: Blinded Period|Lack of Efficacy|3
7884446|NCT01791153|12384900|FG002|Part 1: Blinded Period|Lack of Efficacy|2
7884447|NCT01791153|12384901|FG003|Part 1: Blinded Period|Lack of Efficacy|2
7884448|NCT01791153|12384902|FG004|Part 1: Blinded Period|Lack of Efficacy|0
7884449|NCT01791153|12384903|FG005|Part 1: Blinded Period|Lack of Efficacy|0
7884450|NCT01791153|12384904|FG006|Part 1: Blinded Period|Lack of Efficacy|0
7884451|NCT01791153|12384905|FG007|Part 1: Blinded Period|Lack of Efficacy|0
7884452|NCT01791153|12384898|FG000|Part 1: Blinded Period|Non-Compliance|1
7884453|NCT01791153|12384899|FG001|Part 1: Blinded Period|Non-Compliance|0
7884454|NCT01791153|12384900|FG002|Part 1: Blinded Period|Non-Compliance|0
7884455|NCT01791153|12384901|FG003|Part 1: Blinded Period|Non-Compliance|0
7884456|NCT01791153|12384902|FG004|Part 1: Blinded Period|Non-Compliance|0
7884457|NCT01791153|12384903|FG005|Part 1: Blinded Period|Non-Compliance|0
7884458|NCT01791153|12384904|FG006|Part 1: Blinded Period|Non-Compliance|0
7884459|NCT01791153|12384905|FG007|Part 1: Blinded Period|Non-Compliance|0
7884460|NCT01791153|12384898|FG000|Part 1: Blinded Period|Physician Decision|0
7884461|NCT01791153|12384899|FG001|Part 1: Blinded Period|Physician Decision|0
7884462|NCT01791153|12384900|FG002|Part 1: Blinded Period|Physician Decision|0
7884463|NCT01791153|12384901|FG003|Part 1: Blinded Period|Physician Decision|1
7884464|NCT01791153|12384902|FG004|Part 1: Blinded Period|Physician Decision|0
7884465|NCT01791153|12384903|FG005|Part 1: Blinded Period|Physician Decision|0
7884466|NCT01791153|12384904|FG006|Part 1: Blinded Period|Physician Decision|0
7884467|NCT01791153|12384905|FG007|Part 1: Blinded Period|Physician Decision|0
7884468|NCT01791153|12384898|FG000|Part 1: Blinded Period|Protocol Violation|0
7884469|NCT01791153|12384899|FG001|Part 1: Blinded Period|Protocol Violation|0
7884470|NCT01791153|12384900|FG002|Part 1: Blinded Period|Protocol Violation|0
7884471|NCT01791153|12384901|FG003|Part 1: Blinded Period|Protocol Violation|1
7884472|NCT01791153|12384902|FG004|Part 1: Blinded Period|Protocol Violation|0
7884473|NCT01791153|12384903|FG005|Part 1: Blinded Period|Protocol Violation|0
7884474|NCT01791153|12384904|FG006|Part 1: Blinded Period|Protocol Violation|0
7884475|NCT01791153|12384905|FG007|Part 1: Blinded Period|Protocol Violation|0
7884476|NCT01791153|12384898|FG000|Part 1: Blinded Period|Withdrawal by Subject|6
7884477|NCT01791153|12384899|FG001|Part 1: Blinded Period|Withdrawal by Subject|2
7884478|NCT01791153|12384900|FG002|Part 1: Blinded Period|Withdrawal by Subject|2
7884479|NCT01791153|12384901|FG003|Part 1: Blinded Period|Withdrawal by Subject|1
7884480|NCT01791153|12384902|FG004|Part 1: Blinded Period|Withdrawal by Subject|0
7884481|NCT01791153|12384903|FG005|Part 1: Blinded Period|Withdrawal by Subject|0
7884482|NCT01791153|12384904|FG006|Part 1: Blinded Period|Withdrawal by Subject|0
7884483|NCT01791153|12384905|FG007|Part 1: Blinded Period|Withdrawal by Subject|0
7884484|NCT01791153|12384898|FG000|Part 2: Open-label Period|Adverse Event|0
7884485|NCT01791153|12384899|FG001|Part 2: Open-label Period|Adverse Event|0
7884486|NCT01791153|12384900|FG002|Part 2: Open-label Period|Adverse Event|0
7884487|NCT01791153|12384901|FG003|Part 2: Open-label Period|Adverse Event|0
7884488|NCT01791153|12384902|FG004|Part 2: Open-label Period|Adverse Event|0
7884489|NCT01791153|12384903|FG005|Part 2: Open-label Period|Adverse Event|1
7884490|NCT01791153|12384904|FG006|Part 2: Open-label Period|Adverse Event|1
7884491|NCT01791153|12384905|FG007|Part 2: Open-label Period|Adverse Event|2
7884492|NCT01791153|12384898|FG000|Part 2: Open-label Period|Death|0
7884493|NCT01791153|12384899|FG001|Part 2: Open-label Period|Death|0
7884494|NCT01791153|12384900|FG002|Part 2: Open-label Period|Death|0
7884495|NCT01791153|12384901|FG003|Part 2: Open-label Period|Death|0
7884496|NCT01791153|12384902|FG004|Part 2: Open-label Period|Death|0
7884497|NCT01791153|12384903|FG005|Part 2: Open-label Period|Death|1
7884498|NCT01791153|12384904|FG006|Part 2: Open-label Period|Death|1
7884499|NCT01791153|12384905|FG007|Part 2: Open-label Period|Death|1
7884500|NCT01791153|12384898|FG000|Part 2: Open-label Period|Lost to Follow-up|0
7884501|NCT01791153|12384899|FG001|Part 2: Open-label Period|Lost to Follow-up|0
7884502|NCT01791153|12384900|FG002|Part 2: Open-label Period|Lost to Follow-up|0
7884503|NCT01791153|12384901|FG003|Part 2: Open-label Period|Lost to Follow-up|0
7884504|NCT01791153|12384902|FG004|Part 2: Open-label Period|Lost to Follow-up|0
7884505|NCT01791153|12384903|FG005|Part 2: Open-label Period|Lost to Follow-up|0
7884506|NCT01791153|12384904|FG006|Part 2: Open-label Period|Lost to Follow-up|1
7884507|NCT01791153|12384905|FG007|Part 2: Open-label Period|Lost to Follow-up|0
7884508|NCT01791153|12384898|FG000|Part 2: Open-label Period|Lack of Efficacy|0
7884509|NCT01791153|12384899|FG001|Part 2: Open-label Period|Lack of Efficacy|0
7884510|NCT01791153|12384900|FG002|Part 2: Open-label Period|Lack of Efficacy|0
7884511|NCT01791153|12384901|FG003|Part 2: Open-label Period|Lack of Efficacy|0
7884512|NCT01791153|12384902|FG004|Part 2: Open-label Period|Lack of Efficacy|0
7884513|NCT01791153|12384903|FG005|Part 2: Open-label Period|Lack of Efficacy|0
7884514|NCT01791153|12384904|FG006|Part 2: Open-label Period|Lack of Efficacy|0
7884515|NCT01791153|12384905|FG007|Part 2: Open-label Period|Lack of Efficacy|1
7801830|NCT01106352|12260081|FG000|Overall Study|Subjects untreated|0
7801831|NCT01106352|12260082|FG001|Overall Study|Subjects untreated|0
7801832|NCT01106352|12260083|FG002|Overall Study|Subjects untreated|0
7801833|NCT01106352|12260084|FG003|Overall Study|Subjects untreated|3
7801834|NCT01106352|12260085|FG004|Overall Study|Subjects untreated|4
7801835|NCT01106352|12260081|FG000|Overall Study|Sponsor Decision|1
7801836|NCT01106352|12260082|FG001|Overall Study|Sponsor Decision|0
7801837|NCT01106352|12260083|FG002|Overall Study|Sponsor Decision|0
7801838|NCT01106352|12260084|FG003|Overall Study|Sponsor Decision|0
7801839|NCT01106352|12260085|FG004|Overall Study|Sponsor Decision|0
7801840|NCT01106352|12260081|FG000|Overall Study|Too ill to come in for the visit|0
7801841|NCT01106352|12260082|FG001|Overall Study|Too ill to come in for the visit|0
7801842|NCT01106352|12260083|FG002|Overall Study|Too ill to come in for the visit|1
7801843|NCT01106352|12260084|FG003|Overall Study|Too ill to come in for the visit|0
7801844|NCT01106352|12260085|FG004|Overall Study|Too ill to come in for the visit|0
7801845|NCT01106352|12260081|FG000|Overall Study|Lost to Follow-up|0
7801846|NCT01106352|12260082|FG001|Overall Study|Lost to Follow-up|0
7801847|NCT01106352|12260083|FG002|Overall Study|Lost to Follow-up|0
7801848|NCT01106352|12260084|FG003|Overall Study|Lost to Follow-up|0
7801849|NCT01106352|12260085|FG004|Overall Study|Lost to Follow-up|1
7801850|NCT01106352|12260081|FG000|Overall Study|Death|0
7801851|NCT01106352|12260082|FG001|Overall Study|Death|0
7801852|NCT01106352|12260083|FG002|Overall Study|Death|1
7801853|NCT01106352|12260084|FG003|Overall Study|Death|3
7801854|NCT01106352|12260085|FG004|Overall Study|Death|1
7801855|NCT01106352|12260081|FG000|Overall Study|Disease progression|0
7801856|NCT01106352|12260082|FG001|Overall Study|Disease progression|0
7801857|NCT01106352|12260083|FG002|Overall Study|Disease progression|0
7801858|NCT01106352|12260084|FG003|Overall Study|Disease progression|1
7801859|NCT01106352|12260085|FG004|Overall Study|Disease progression|0
7801860|NCT01106352|12260081|FG000|Overall Study|Withdrawal by Subject|0
7801861|NCT01106352|12260082|FG001|Overall Study|Withdrawal by Subject|0
7801862|NCT01106352|12260083|FG002|Overall Study|Withdrawal by Subject|0
7801863|NCT01106352|12260084|FG003|Overall Study|Withdrawal by Subject|3
7801864|NCT01106352|12260085|FG004|Overall Study|Withdrawal by Subject|2
7801865|NCT01106352|12260081|FG000|Overall Study|Went on hospice|0
7801866|NCT01106352|12260082|FG001|Overall Study|Went on hospice|0
7801867|NCT01106352|12260083|FG002|Overall Study|Went on hospice|0
7801868|NCT01106352|12260084|FG003|Overall Study|Went on hospice|1
7801869|NCT01106352|12260085|FG004|Overall Study|Went on hospice|0
7801870|NCT01106352|12260081|FG000|Overall Study|Subject entered hospice|0
7801871|NCT01106352|12260082|FG001|Overall Study|Subject entered hospice|0
7801872|NCT01106352|12260083|FG002|Overall Study|Subject entered hospice|0
7801873|NCT01106352|12260084|FG003|Overall Study|Subject entered hospice|1
7801874|NCT01106352|12260085|FG004|Overall Study|Subject entered hospice|0
7801875|NCT01106352|12260081|FG000|Overall Study|Home hospice since July 2013|0
7801876|NCT01106352|12260082|FG001|Overall Study|Home hospice since July 2013|0
7801877|NCT01106352|12260083|FG002|Overall Study|Home hospice since July 2013|0
7801878|NCT01106352|12260084|FG003|Overall Study|Home hospice since July 2013|1
7801879|NCT01106352|12260085|FG004|Overall Study|Home hospice since July 2013|0
7801880|NCT01106404|12260107|FG000|Period I (First 6 Weeks)|Adverse Event|2
7801881|NCT01106404|12260108|FG001|Period I (First 6 Weeks)|Adverse Event|0
7801882|NCT01106404|12260107|FG000|Period I (First 6 Weeks)|Physician Decision|1
7801883|NCT01106404|12260108|FG001|Period I (First 6 Weeks)|Physician Decision|0
7801884|NCT01106404|12260107|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0
7801885|NCT01106404|12260108|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1
7801886|NCT01106404|12260107|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0
7801887|NCT01106404|12260108|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1
7801888|NCT01106430|12260122|FG000|Overall Study|Adverse Event|8
7801889|NCT01106430|12260123|FG001|Overall Study|Adverse Event|10
7801890|NCT01106430|12260122|FG000|Overall Study|Lack of Efficacy|2
7801891|NCT01106430|12260123|FG001|Overall Study|Lack of Efficacy|13
7801892|NCT01106430|12260122|FG000|Overall Study|Lost to Follow-up|5
7801893|NCT01106430|12260123|FG001|Overall Study|Lost to Follow-up|1
7801894|NCT01106430|12260122|FG000|Overall Study|Early Termination Requested By Sponsor|1
7801895|NCT01106430|12260123|FG001|Overall Study|Early Termination Requested By Sponsor|0
7801896|NCT01106430|12260122|FG000|Overall Study|Moved Out Of State|0
7801897|NCT01106430|12260123|FG001|Overall Study|Moved Out Of State|1
7801898|NCT01106430|12260122|FG000|Overall Study|Refused To Take Medication|0
7801899|NCT01106430|12260123|FG001|Overall Study|Refused To Take Medication|1
7801900|NCT01106430|12260122|FG000|Overall Study|Noncompliance|0
7801901|NCT01106430|12260123|FG001|Overall Study|Noncompliance|1
7801902|NCT01106430|12260122|FG000|Overall Study|Hard Time Swallowing The Pills|1
7801903|NCT01106430|12260123|FG001|Overall Study|Hard Time Swallowing The Pills|0
7884516|NCT01791153|12384898|FG000|Part 2: Open-label Period|Withdrawal by Subject|0
7801904|NCT01106430|12260122|FG000|Overall Study|Previous Use Of Marijuana|1
7801905|NCT01106430|12260123|FG001|Overall Study|Previous Use Of Marijuana|0
7801906|NCT01106430|12260122|FG000|Overall Study|Protocol Violation|7
7801907|NCT01106430|12260123|FG001|Overall Study|Protocol Violation|2
7884517|NCT01791153|12384899|FG001|Part 2: Open-label Period|Withdrawal by Subject|0
7884518|NCT01791153|12384900|FG002|Part 2: Open-label Period|Withdrawal by Subject|0
7884519|NCT01791153|12384901|FG003|Part 2: Open-label Period|Withdrawal by Subject|0
7884520|NCT01791153|12384902|FG004|Part 2: Open-label Period|Withdrawal by Subject|1
7884521|NCT01791153|12384903|FG005|Part 2: Open-label Period|Withdrawal by Subject|1
7884522|NCT01791153|12384904|FG006|Part 2: Open-label Period|Withdrawal by Subject|3
7884523|NCT01791153|12384905|FG007|Part 2: Open-label Period|Withdrawal by Subject|2
7884524|NCT01791153|12384898|FG000|Part 2: Open-label Period|Physician Decision|0
7884525|NCT01791153|12384899|FG001|Part 2: Open-label Period|Physician Decision|0
7884526|NCT01791153|12384900|FG002|Part 2: Open-label Period|Physician Decision|0
7884527|NCT01791153|12384901|FG003|Part 2: Open-label Period|Physician Decision|0
7884528|NCT01791153|12384902|FG004|Part 2: Open-label Period|Physician Decision|1
7884529|NCT01791153|12384903|FG005|Part 2: Open-label Period|Physician Decision|1
7884530|NCT01791153|12384904|FG006|Part 2: Open-label Period|Physician Decision|0
7884531|NCT01791153|12384905|FG007|Part 2: Open-label Period|Physician Decision|0
7884532|NCT01791205|12384922|FG000|Phase II|Lack of Efficacy|6
7884533|NCT01791205|12384923|FG001|Phase II|Lack of Efficacy|0
7884534|NCT01791205|12384922|FG000|Phase II|Adverse Event|2
7801908|NCT01106430|12260122|FG000|Overall Study|Withdrawal by Subject|8
7801909|NCT01106430|12260123|FG001|Overall Study|Withdrawal by Subject|4
7884535|NCT01791205|12384923|FG001|Phase II|Adverse Event|0
7884536|NCT01791205|12384922|FG000|Phase II|Safety|1
7884537|NCT01791205|12384923|FG001|Phase II|Safety|0
7884538|NCT01791205|12384922|FG000|Phase II|Lost to Follow-up|1
7884539|NCT01791205|12384923|FG001|Phase II|Lost to Follow-up|0
7884540|NCT01791205|12384922|FG000|Phase II|Remission of disease|1
7884541|NCT01791205|12384923|FG001|Phase II|Remission of disease|0
7884542|NCT01791205|12384922|FG000|Phase II|Physician's decision|1
7884543|NCT01791205|12384923|FG001|Phase II|Physician's decision|0
7884544|NCT01791244|12384931|FG000|Overall Study|Adverse Event|5
7884545|NCT01791244|12384932|FG001|Overall Study|Adverse Event|7
7884546|NCT01791244|12384931|FG000|Overall Study|Insufficient clinical response|10
7884547|NCT01791244|12384932|FG001|Overall Study|Insufficient clinical response|10
7884548|NCT01791244|12384931|FG000|Overall Study|Laboratory Abnormality|0
7884549|NCT01791244|12384932|FG001|Overall Study|Laboratory Abnormality|1
7884550|NCT01791413|12384942|FG000|Overall Study|Lost to Follow-up|5
7884551|NCT01791413|12384943|FG001|Overall Study|Lost to Follow-up|1
7801910|NCT01106586|12260140|FG000|Overall Study|Adverse Event|9
7801911|NCT01106586|12260141|FG001|Overall Study|Adverse Event|15
7801912|NCT01106586|12260140|FG000|Overall Study|Death|1
7801913|NCT01106586|12260141|FG001|Overall Study|Death|3
7801914|NCT01106586|12260140|FG000|Overall Study|Pregnancy|2
7801915|NCT01106586|12260141|FG001|Overall Study|Pregnancy|2
7801916|NCT01106586|12260140|FG000|Overall Study|Lack of Efficacy|1
7801917|NCT01106586|12260141|FG001|Overall Study|Lack of Efficacy|0
7801918|NCT01106586|12260140|FG000|Overall Study|Investigator's Discretion|5
7801919|NCT01106586|12260141|FG001|Overall Study|Investigator's Discretion|8
7801920|NCT01106586|12260140|FG000|Overall Study|Withdrew Consent|18
7801921|NCT01106586|12260141|FG001|Overall Study|Withdrew Consent|30
7801922|NCT01106586|12260140|FG000|Overall Study|Lost to Follow-up|24
7801923|NCT01106586|12260141|FG001|Overall Study|Lost to Follow-up|20
7801924|NCT01106586|12260140|FG000|Overall Study|Participant Noncompliance|12
7801925|NCT01106586|12260141|FG001|Overall Study|Participant Noncompliance|10
7801926|NCT01106586|12260140|FG000|Overall Study|Protocol Violation|1
7801927|NCT01106586|12260141|FG001|Overall Study|Protocol Violation|0
7801928|NCT01106586|12260140|FG000|Overall Study|Participant Transferred to Another Study|212
7801929|NCT01106586|12260141|FG001|Overall Study|Participant Transferred to Another Study|197
7801930|NCT01106625|12260150|FG000|Core Period: Baseline to Week 26|Adverse Event|6
7801931|NCT01106625|12260151|FG001|Core Period: Baseline to Week 26|Adverse Event|8
7801932|NCT01106625|12260152|FG002|Core Period: Baseline to Week 26|Adverse Event|8
7801933|NCT01106625|12260150|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5
7801934|NCT01106625|12260151|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0
7801935|NCT01106625|12260152|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4
7801936|NCT01106625|12260150|FG000|Core Period: Baseline to Week 26|Physician Decision|1
7801937|NCT01106625|12260151|FG001|Core Period: Baseline to Week 26|Physician Decision|0
7801938|NCT01106625|12260152|FG002|Core Period: Baseline to Week 26|Physician Decision|0
7801939|NCT01106625|12260150|FG000|Core Period: Baseline to Week 26|Protocol Violation|2
7801940|NCT01106625|12260151|FG001|Core Period: Baseline to Week 26|Protocol Violation|1
7801941|NCT01106625|12260152|FG002|Core Period: Baseline to Week 26|Protocol Violation|3
7801942|NCT01106625|12260150|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6
7801943|NCT01106625|12260151|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9
7801944|NCT01106625|12260152|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7
7801945|NCT01106625|12260150|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
7801946|NCT01106625|12260151|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
7801947|NCT01106625|12260152|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7801948|NCT01106625|12260150|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
7801949|NCT01106625|12260151|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
7801950|NCT01106625|12260152|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
7801951|NCT01106625|12260150|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1
7801952|NCT01106625|12260151|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
7801953|NCT01106625|12260152|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7801954|NCT01106625|12260150|FG000|Core Period: Baseline to Week 26|Other|8
7801955|NCT01106625|12260151|FG001|Core Period: Baseline to Week 26|Other|7
7801956|NCT01106625|12260152|FG002|Core Period: Baseline to Week 26|Other|4
7801957|NCT01106625|12260150|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2
7801958|NCT01106625|12260151|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2
7801959|NCT01106625|12260152|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3
7801960|NCT01106625|12260150|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
7801961|NCT01106625|12260151|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
7861368|NCT01591616|12350188|FG000|Overall Study|Withdrawal by Subject|1
7861369|NCT01591681|12350336|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3
7861370|NCT01591681|12350336|FG000|Overall Study|Failed to use system during run-in|1
7861371|NCT01591785|12350359|FG000|Overall Study|worsening condition|1
7861372|NCT01591785|12350360|FG001|Overall Study|worsening condition|2
7861373|NCT01591785|12350359|FG000|Overall Study|Protocol Violation|2
7861374|NCT01591785|12350360|FG001|Overall Study|Protocol Violation|0
7861375|NCT01591785|12350359|FG000|Overall Study|Lost to Follow-up|1
7861376|NCT01591785|12350360|FG001|Overall Study|Lost to Follow-up|0
7801962|NCT01106625|12260152|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
7801963|NCT01106625|12260150|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2
7801964|NCT01106625|12260151|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0
7801965|NCT01106625|12260152|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1
7801966|NCT01106625|12260150|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0
7801967|NCT01106625|12260151|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
7801968|NCT01106625|12260152|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
7801969|NCT01106625|12260150|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
7801970|NCT01106625|12260151|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7801971|NCT01106625|12260152|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7801972|NCT01106625|12260150|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
7801973|NCT01106625|12260151|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
7801974|NCT01106625|12260152|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
7801975|NCT01106625|12260150|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
7801976|NCT01106625|12260151|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
7801977|NCT01106625|12260152|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
7801978|NCT01106625|12260150|FG000|Extension Period: Week 26 to Week 52|Other|5
7801979|NCT01106625|12260151|FG001|Extension Period: Week 26 to Week 52|Other|5
7801980|NCT01106625|12260152|FG002|Extension Period: Week 26 to Week 52|Other|4
7801981|NCT01106651|12260166|FG000|Overall Study|Adverse Event|17
7801982|NCT01106651|12260167|FG001|Overall Study|Adverse Event|9
7801983|NCT01106651|12260168|FG002|Overall Study|Adverse Event|23
7801984|NCT01106651|12260166|FG000|Overall Study|Lost to Follow-up|8
7801985|NCT01106651|12260167|FG001|Overall Study|Lost to Follow-up|2
7801986|NCT01106651|12260168|FG002|Overall Study|Lost to Follow-up|6
7801987|NCT01106651|12260166|FG000|Overall Study|Physician Decision|4
7801988|NCT01106651|12260167|FG001|Overall Study|Physician Decision|3
7801989|NCT01106651|12260168|FG002|Overall Study|Physician Decision|1
7801990|NCT01106651|12260166|FG000|Overall Study|Protocol Violation|1
7801991|NCT01106651|12260167|FG001|Overall Study|Protocol Violation|2
7801992|NCT01106651|12260168|FG002|Overall Study|Protocol Violation|1
7801993|NCT01106651|12260166|FG000|Overall Study|Withdrawal by Subject|14
7801994|NCT01106651|12260167|FG001|Overall Study|Withdrawal by Subject|7
7801995|NCT01106651|12260168|FG002|Overall Study|Withdrawal by Subject|4
7801996|NCT01106651|12260166|FG000|Overall Study|Noncompliance with study drug|1
7801997|NCT01106651|12260167|FG001|Overall Study|Noncompliance with study drug|0
7801998|NCT01106651|12260168|FG002|Overall Study|Noncompliance with study drug|2
7801999|NCT01106651|12260166|FG000|Overall Study|Other|34
7802000|NCT01106651|12260167|FG001|Overall Study|Other|31
7802001|NCT01106651|12260168|FG002|Overall Study|Other|21
7802002|NCT01106651|12260166|FG000|Overall Study|Death|0
7802003|NCT01106651|12260167|FG001|Overall Study|Death|3
7802004|NCT01106651|12260168|FG002|Overall Study|Death|0
7802005|NCT01106677|12260183|FG000|Core Period: Baseline to Week 26|Adverse Event|7
7802006|NCT01106677|12260184|FG001|Core Period: Baseline to Week 26|Adverse Event|18
7802007|NCT01106677|12260185|FG002|Core Period: Baseline to Week 26|Adverse Event|6
7802008|NCT01106677|12260186|FG003|Core Period: Baseline to Week 26|Adverse Event|8
7802009|NCT01106677|12260183|FG000|Core Period: Baseline to Week 26|Death|0
7802010|NCT01106677|12260184|FG001|Core Period: Baseline to Week 26|Death|0
7802011|NCT01106677|12260185|FG002|Core Period: Baseline to Week 26|Death|1
7802012|NCT01106677|12260186|FG003|Core Period: Baseline to Week 26|Death|0
7802013|NCT01106677|12260183|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1
7802014|NCT01106677|12260184|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0
7802015|NCT01106677|12260185|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0
7802016|NCT01106677|12260186|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0
7802017|NCT01106677|12260183|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3
7802018|NCT01106677|12260184|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1
7802019|NCT01106677|12260185|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6
7802020|NCT01106677|12260186|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3
7802021|NCT01106677|12260183|FG000|Core Period: Baseline to Week 26|Physician Decision|2
7802022|NCT01106677|12260184|FG001|Core Period: Baseline to Week 26|Physician Decision|1
7802023|NCT01106677|12260185|FG002|Core Period: Baseline to Week 26|Physician Decision|3
7802024|NCT01106677|12260186|FG003|Core Period: Baseline to Week 26|Physician Decision|1
7802025|NCT01106677|12260183|FG000|Core Period: Baseline to Week 26|Protocol Violation|0
7802026|NCT01106677|12260184|FG001|Core Period: Baseline to Week 26|Protocol Violation|1
7802027|NCT01106677|12260185|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
7802028|NCT01106677|12260186|FG003|Core Period: Baseline to Week 26|Protocol Violation|3
7802029|NCT01106677|12260183|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5
7802030|NCT01106677|12260184|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3
7802031|NCT01106677|12260185|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15
7802032|NCT01106677|12260186|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6
7802033|NCT01106677|12260183|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
7802034|NCT01106677|12260184|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
7802035|NCT01106677|12260185|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
7802036|NCT01106677|12260186|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
7802037|NCT01106677|12260183|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1
7802038|NCT01106677|12260184|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3
7802039|NCT01106677|12260185|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7802040|NCT01106677|12260186|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7802041|NCT01106677|12260183|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0
7802042|NCT01106677|12260184|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1
7802043|NCT01106677|12260185|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2
7802044|NCT01106677|12260186|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0
7802045|NCT01106677|12260183|FG000|Core Period: Baseline to Week 26|Product quality complaint|0
7802046|NCT01106677|12260184|FG001|Core Period: Baseline to Week 26|Product quality complaint|1
7802047|NCT01106677|12260185|FG002|Core Period: Baseline to Week 26|Product quality complaint|1
7802048|NCT01106677|12260186|FG003|Core Period: Baseline to Week 26|Product quality complaint|0
7802049|NCT01106677|12260183|FG000|Core Period: Baseline to Week 26|Other|8
7802050|NCT01106677|12260184|FG001|Core Period: Baseline to Week 26|Other|14
7802051|NCT01106677|12260185|FG002|Core Period: Baseline to Week 26|Other|8
7802052|NCT01106677|12260186|FG003|Core Period: Baseline to Week 26|Other|23
7802053|NCT01106677|12260183|FG000|Core Period: Baseline to Week 26|Pregnancy|0
7802054|NCT01106677|12260184|FG001|Core Period: Baseline to Week 26|Pregnancy|1
7802055|NCT01106677|12260185|FG002|Core Period: Baseline to Week 26|Pregnancy|0
7802056|NCT01106677|12260186|FG003|Core Period: Baseline to Week 26|Pregnancy|0
7802057|NCT01106677|12260183|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
7802058|NCT01106677|12260184|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
7802059|NCT01106677|12260185|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5
7802060|NCT01106677|12260186|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9
7802061|NCT01106677|12260183|FG000|Extension Period: Week 26 to Week 52|Death|0
7802062|NCT01106677|12260184|FG001|Extension Period: Week 26 to Week 52|Death|0
7802063|NCT01106677|12260185|FG002|Extension Period: Week 26 to Week 52|Death|0
7802064|NCT01106677|12260186|FG003|Extension Period: Week 26 to Week 52|Death|1
7802065|NCT01106677|12260183|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
7802066|NCT01106677|12260184|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
7802067|NCT01106677|12260185|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
7802068|NCT01106677|12260186|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
7884552|NCT01791517|12384962|FG000|Phase I: Period 1|Withdrawal by Subject|0
7884553|NCT01791517|12384963|FG001|Phase I: Period 1|Withdrawal by Subject|1
7884554|NCT01791517|12384964|FG002|Phase I: Period 1|Withdrawal by Subject|1
7884555|NCT01791517|12384965|FG003|Phase I: Period 1|Withdrawal by Subject|0
7884556|NCT01791517|12384966|FG004|Phase I: Period 1|Withdrawal by Subject|1
7884557|NCT01791517|12384967|FG005|Phase I: Period 1|Withdrawal by Subject|1
7884558|NCT01791517|12384968|FG006|Phase I: Period 1|Withdrawal by Subject|0
7802069|NCT01106677|12260183|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7802070|NCT01106677|12260184|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
7802071|NCT01106677|12260185|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
7802072|NCT01106677|12260186|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
7802073|NCT01106677|12260183|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2
7802074|NCT01106677|12260184|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3
7802075|NCT01106677|12260185|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2
7802076|NCT01106677|12260186|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3
7802077|NCT01106677|12260183|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1
7802078|NCT01106677|12260184|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0
7802079|NCT01106677|12260185|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
7802080|NCT01106677|12260186|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0
7802081|NCT01106677|12260183|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7802082|NCT01106677|12260184|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
7802083|NCT01106677|12260185|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
7802084|NCT01106677|12260186|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7802085|NCT01106677|12260183|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
7802086|NCT01106677|12260184|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
7802087|NCT01106677|12260185|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
7802088|NCT01106677|12260186|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
7802089|NCT01106677|12260183|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7802090|NCT01106677|12260184|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7802091|NCT01106677|12260185|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7802092|NCT01106677|12260186|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
7802093|NCT01106677|12260183|FG000|Extension Period: Week 26 to Week 52|Other|6
7802094|NCT01106677|12260184|FG001|Extension Period: Week 26 to Week 52|Other|5
7802095|NCT01106677|12260185|FG002|Extension Period: Week 26 to Week 52|Other|8
7802096|NCT01106677|12260186|FG003|Extension Period: Week 26 to Week 52|Other|5
7802097|NCT01106690|12260206|FG000|Core Period: Baseline to Week 26|Adverse Event|6
7802098|NCT01106690|12260207|FG001|Core Period: Baseline to Week 26|Adverse Event|1
7802099|NCT01106690|12260208|FG002|Core Period: Baseline to Week 26|Adverse Event|4
7802100|NCT01106690|12260206|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1
7802101|NCT01106690|12260207|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1
7802102|NCT01106690|12260208|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2
7802103|NCT01106690|12260206|FG000|Core Period: Baseline to Week 26|Protocol Violation|1
7802104|NCT01106690|12260207|FG001|Core Period: Baseline to Week 26|Protocol Violation|0
7802105|NCT01106690|12260208|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
7802106|NCT01106690|12260206|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4
7802107|NCT01106690|12260207|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1
7802108|NCT01106690|12260208|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0
7802109|NCT01106690|12260206|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
7802110|NCT01106690|12260207|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
7802111|NCT01106690|12260208|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
7802112|NCT01106690|12260206|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7802113|NCT01106690|12260207|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
7802114|NCT01106690|12260208|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7802115|NCT01106690|12260206|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
7802116|NCT01106690|12260207|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7802117|NCT01106690|12260208|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7802118|NCT01106690|12260206|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
7802119|NCT01106690|12260207|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
7802120|NCT01106690|12260208|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
7802121|NCT01106690|12260206|FG000|Core Period: Baseline to Week 26|Other|10
7802122|NCT01106690|12260207|FG001|Core Period: Baseline to Week 26|Other|2
7802123|NCT01106690|12260208|FG002|Core Period: Baseline to Week 26|Other|6
7802124|NCT01106690|12260206|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
7802125|NCT01106690|12260207|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
7802126|NCT01106690|12260208|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0
7802127|NCT01106690|12260206|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7802128|NCT01106690|12260207|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7802129|NCT01106690|12260208|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7802130|NCT01106690|12260206|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0
7802131|NCT01106690|12260207|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2
7802132|NCT01106690|12260208|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2
7802133|NCT01106690|12260206|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
7802134|NCT01106690|12260207|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
7802135|NCT01106690|12260208|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
7802136|NCT01106690|12260206|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
7802137|NCT01106690|12260207|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
7802138|NCT01106690|12260208|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7802139|NCT01106690|12260206|FG000|Extension Period: Week 26 to Week 52|Other|8
7802140|NCT01106690|12260207|FG001|Extension Period: Week 26 to Week 52|Other|3
7802141|NCT01106690|12260208|FG002|Extension Period: Week 26 to Week 52|Other|4
7802142|NCT01106690|12260206|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
7802143|NCT01106690|12260207|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7802144|NCT01106690|12260208|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7802145|NCT01106846|12260230|FG000|Overall Study|Change in surgical procedure|0
7802146|NCT01106846|12260231|FG001|Overall Study|Change in surgical procedure|1
7802147|NCT01106898|12260248|FG000|Overall Study|Adverse Event|6
7802148|NCT01106911|12260252|FG000|Overall Study|Physician Decision|2
7802149|NCT01106911|12260252|FG000|Overall Study|deemed ineligible after screening|3
7802150|NCT01106976|12260262|FG000|Overall Study|Lost to Follow-up|8
7802151|NCT01107197|12260285|FG000|Overall Study|Death|12
7802152|NCT01107197|12260286|FG001|Overall Study|Death|10
7802153|NCT01107197|12260285|FG000|Overall Study|Lost to Follow-up|5
7802154|NCT01107197|12260286|FG001|Overall Study|Lost to Follow-up|8
7802155|NCT01107197|12260285|FG000|Overall Study|Withdrawal by Subject|3
7802156|NCT01107197|12260286|FG001|Overall Study|Withdrawal by Subject|5
7802157|NCT01107353|12260294|FG000|Overall Study|Positive Drug Screen|1
7802158|NCT01107353|12260295|FG001|Overall Study|Positive Drug Screen|0
7802159|NCT01107379|12260301|FG000|Overall Study|Withdrawal by Subject|18
7802160|NCT01107379|12260301|FG000|Overall Study|Lost to Follow-up|3
7802161|NCT01107392|12260307|FG000|Overall Study|Adverse Event|2
7802162|NCT01107392|12260308|FG001|Overall Study|Adverse Event|0
7802163|NCT01107392|12260307|FG000|Overall Study|Personal Reasons|2
7802164|NCT01107392|12260308|FG001|Overall Study|Personal Reasons|3
7884559|NCT01791517|12384969|FG007|Phase I: Period 1|Withdrawal by Subject|0
7884560|NCT01791517|12384970|FG008|Phase I: Period 1|Withdrawal by Subject|0
7884561|NCT01791517|12384971|FG009|Phase I: Period 1|Withdrawal by Subject|0
7884562|NCT01791517|12384972|FG010|Phase I: Period 1|Withdrawal by Subject|0
7884563|NCT01791517|12384973|FG011|Phase I: Period 1|Withdrawal by Subject|0
7884564|NCT01791517|12384962|FG000|Phase I: Period 1|Adverse Event|0
7884565|NCT01791517|12384963|FG001|Phase I: Period 1|Adverse Event|0
7884566|NCT01791517|12384964|FG002|Phase I: Period 1|Adverse Event|1
7884567|NCT01791517|12384965|FG003|Phase I: Period 1|Adverse Event|1
7884568|NCT01791517|12384966|FG004|Phase I: Period 1|Adverse Event|0
7884569|NCT01791517|12384967|FG005|Phase I: Period 1|Adverse Event|0
7884570|NCT01791517|12384968|FG006|Phase I: Period 1|Adverse Event|0
7884571|NCT01791517|12384969|FG007|Phase I: Period 1|Adverse Event|0
7884572|NCT01791517|12384970|FG008|Phase I: Period 1|Adverse Event|0
7884573|NCT01791517|12384971|FG009|Phase I: Period 1|Adverse Event|0
7884574|NCT01791517|12384972|FG010|Phase I: Period 1|Adverse Event|0
7884575|NCT01791517|12384973|FG011|Phase I: Period 1|Adverse Event|0
7884576|NCT01791517|12384962|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1
7884577|NCT01791517|12384963|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7884578|NCT01791517|12384964|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7884579|NCT01791517|12384965|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7884580|NCT01791517|12384966|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7884581|NCT01791517|12384967|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7884582|NCT01791517|12384968|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7884583|NCT01791517|12384969|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7884584|NCT01791517|12384970|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7884585|NCT01791517|12384971|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7884586|NCT01791517|12384972|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7884587|NCT01791517|12384973|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7884588|NCT01791517|12384962|FG000|Phase I: Period 1|Protocol Violation|0
7884589|NCT01791517|12384963|FG001|Phase I: Period 1|Protocol Violation|1
7884590|NCT01791517|12384964|FG002|Phase I: Period 1|Protocol Violation|0
7884591|NCT01791517|12384965|FG003|Phase I: Period 1|Protocol Violation|0
7884592|NCT01791517|12384966|FG004|Phase I: Period 1|Protocol Violation|0
7884593|NCT01791517|12384967|FG005|Phase I: Period 1|Protocol Violation|0
7884594|NCT01791517|12384968|FG006|Phase I: Period 1|Protocol Violation|0
7884595|NCT01791517|12384969|FG007|Phase I: Period 1|Protocol Violation|0
7884596|NCT01791517|12384970|FG008|Phase I: Period 1|Protocol Violation|0
7884597|NCT01791517|12384971|FG009|Phase I: Period 1|Protocol Violation|0
7884598|NCT01791517|12384972|FG010|Phase I: Period 1|Protocol Violation|0
7884599|NCT01791517|12384973|FG011|Phase I: Period 1|Protocol Violation|0
7884600|NCT01791517|12384962|FG000|Phase I: Period 1|Lost to Follow-up|0
7884601|NCT01791517|12384963|FG001|Phase I: Period 1|Lost to Follow-up|0
7884602|NCT01791517|12384964|FG002|Phase I: Period 1|Lost to Follow-up|0
7884603|NCT01791517|12384965|FG003|Phase I: Period 1|Lost to Follow-up|1
7884604|NCT01791517|12384966|FG004|Phase I: Period 1|Lost to Follow-up|0
7884605|NCT01791517|12384967|FG005|Phase I: Period 1|Lost to Follow-up|0
7884606|NCT01791517|12384968|FG006|Phase I: Period 1|Lost to Follow-up|1
7884607|NCT01791517|12384969|FG007|Phase I: Period 1|Lost to Follow-up|0
7884608|NCT01791517|12384970|FG008|Phase I: Period 1|Lost to Follow-up|1
7884609|NCT01791517|12384971|FG009|Phase I: Period 1|Lost to Follow-up|1
7884610|NCT01791517|12384972|FG010|Phase I: Period 1|Lost to Follow-up|0
7884611|NCT01791517|12384973|FG011|Phase I: Period 1|Lost to Follow-up|0
7802165|NCT01107392|12260307|FG000|Overall Study|Administrative decision|1
7884612|NCT01791517|12384962|FG000|Phase I: Period 1|Lens Handling DIfficulties|0
7884613|NCT01791517|12384963|FG001|Phase I: Period 1|Lens Handling DIfficulties|0
7884614|NCT01791517|12384964|FG002|Phase I: Period 1|Lens Handling DIfficulties|0
7802166|NCT01107392|12260308|FG001|Overall Study|Administrative decision|0
7802167|NCT01107405|12260319|FG000|Overall Study|Adverse Event|1
7802168|NCT01107405|12260320|FG001|Overall Study|Adverse Event|1
7802169|NCT01107405|12260321|FG002|Overall Study|Adverse Event|0
7802170|NCT01107405|12260322|FG003|Overall Study|Adverse Event|0
7802171|NCT01107405|12260323|FG004|Overall Study|Adverse Event|2
7802172|NCT01107405|12260319|FG000|Overall Study|Withdrawal by Subject|1
7802173|NCT01107405|12260320|FG001|Overall Study|Withdrawal by Subject|0
7802174|NCT01107405|12260321|FG002|Overall Study|Withdrawal by Subject|1
7802175|NCT01107405|12260322|FG003|Overall Study|Withdrawal by Subject|2
7802176|NCT01107405|12260323|FG004|Overall Study|Withdrawal by Subject|1
7802177|NCT01107405|12260319|FG000|Overall Study|Protocol Violation|0
7802178|NCT01107405|12260320|FG001|Overall Study|Protocol Violation|0
7802179|NCT01107405|12260321|FG002|Overall Study|Protocol Violation|1
7802180|NCT01107405|12260322|FG003|Overall Study|Protocol Violation|1
7802181|NCT01107405|12260323|FG004|Overall Study|Protocol Violation|0
7802182|NCT01107418|12260339|FG000|Overall Study|Disease Progression|45
7802183|NCT01107418|12260339|FG000|Overall Study|Adverse Event|3
7802184|NCT01107418|12260339|FG000|Overall Study|Withdrawal by Subject|1
7802185|NCT01107418|12260339|FG000|Overall Study|Study Closing|1
7802186|NCT01107418|12260339|FG000|Overall Study|Started Other Therapy|1
7802187|NCT01107418|12260339|FG000|Overall Study|Entered Extension Study|1
7802188|NCT01107444|12260356|FG000|Overall Study|Withdrawal by Subject|8
7802189|NCT01107444|12260357|FG001|Overall Study|Withdrawal by Subject|12
7802190|NCT01107444|12260356|FG000|Overall Study|Protocol Entry Criteria Not Met|0
7802191|NCT01107444|12260357|FG001|Overall Study|Protocol Entry Criteria Not Met|1
7884615|NCT01791517|12384965|FG003|Phase I: Period 1|Lens Handling DIfficulties|0
7884616|NCT01791517|12384966|FG004|Phase I: Period 1|Lens Handling DIfficulties|0
7884617|NCT01791517|12384967|FG005|Phase I: Period 1|Lens Handling DIfficulties|0
7884618|NCT01791517|12384968|FG006|Phase I: Period 1|Lens Handling DIfficulties|0
7802192|NCT01107457|12260371|FG000|Part A|Adverse Event|1
7802193|NCT01107457|12260372|FG001|Part A|Adverse Event|2
7802194|NCT01107457|12260373|FG002|Part A|Adverse Event|1
7802195|NCT01107457|12260374|FG003|Part A|Adverse Event|0
7802196|NCT01107457|12260375|FG004|Part A|Adverse Event|0
7802197|NCT01107457|12260376|FG005|Part A|Adverse Event|0
7802198|NCT01107457|12260371|FG000|Part A|Withdrawal by Subject|3
7802199|NCT01107457|12260372|FG001|Part A|Withdrawal by Subject|3
7802200|NCT01107457|12260373|FG002|Part A|Withdrawal by Subject|0
7802201|NCT01107457|12260374|FG003|Part A|Withdrawal by Subject|3
7802202|NCT01107457|12260375|FG004|Part A|Withdrawal by Subject|1
7802203|NCT01107457|12260376|FG005|Part A|Withdrawal by Subject|0
7802204|NCT01107457|12260371|FG000|Part A|Lost to Follow-up|0
7802205|NCT01107457|12260372|FG001|Part A|Lost to Follow-up|1
7802206|NCT01107457|12260373|FG002|Part A|Lost to Follow-up|0
7802207|NCT01107457|12260374|FG003|Part A|Lost to Follow-up|0
7802208|NCT01107457|12260375|FG004|Part A|Lost to Follow-up|0
7802209|NCT01107457|12260376|FG005|Part A|Lost to Follow-up|0
7802210|NCT01107457|12260371|FG000|Part A|Lack of Efficacy|1
7802211|NCT01107457|12260372|FG001|Part A|Lack of Efficacy|0
7802212|NCT01107457|12260373|FG002|Part A|Lack of Efficacy|0
7802213|NCT01107457|12260374|FG003|Part A|Lack of Efficacy|0
7802214|NCT01107457|12260375|FG004|Part A|Lack of Efficacy|0
7802215|NCT01107457|12260376|FG005|Part A|Lack of Efficacy|0
7802216|NCT01107457|12260371|FG000|Part A|Protocol Violation|0
7802217|NCT01107457|12260372|FG001|Part A|Protocol Violation|1
7802218|NCT01107457|12260373|FG002|Part A|Protocol Violation|0
7802219|NCT01107457|12260374|FG003|Part A|Protocol Violation|0
7802220|NCT01107457|12260375|FG004|Part A|Protocol Violation|0
7802221|NCT01107457|12260376|FG005|Part A|Protocol Violation|0
7802222|NCT01107457|12260371|FG000|Part B and C|Adverse Event|0
7802223|NCT01107457|12260372|FG001|Part B and C|Adverse Event|0
7802224|NCT01107457|12260373|FG002|Part B and C|Adverse Event|0
7802225|NCT01107457|12260374|FG003|Part B and C|Adverse Event|0
7802226|NCT01107457|12260375|FG004|Part B and C|Adverse Event|0
7802227|NCT01107457|12260376|FG005|Part B and C|Adverse Event|12
7802228|NCT01107457|12260371|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0
7802229|NCT01107457|12260372|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0
7802230|NCT01107457|12260373|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0
7802231|NCT01107457|12260374|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0
7802232|NCT01107457|12260375|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0
7802233|NCT01107457|12260376|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1
7802234|NCT01107457|12260371|FG000|Part B and C|Physician Decision|0
7802235|NCT01107457|12260372|FG001|Part B and C|Physician Decision|0
7802236|NCT01107457|12260373|FG002|Part B and C|Physician Decision|0
7802237|NCT01107457|12260374|FG003|Part B and C|Physician Decision|0
7802238|NCT01107457|12260375|FG004|Part B and C|Physician Decision|0
7802239|NCT01107457|12260376|FG005|Part B and C|Physician Decision|3
7802240|NCT01107457|12260371|FG000|Part B and C|Lack of Efficacy|0
7802241|NCT01107457|12260372|FG001|Part B and C|Lack of Efficacy|0
7802242|NCT01107457|12260373|FG002|Part B and C|Lack of Efficacy|0
7802243|NCT01107457|12260374|FG003|Part B and C|Lack of Efficacy|0
7802244|NCT01107457|12260375|FG004|Part B and C|Lack of Efficacy|0
7802245|NCT01107457|12260376|FG005|Part B and C|Lack of Efficacy|7
7802246|NCT01107457|12260371|FG000|Part B and C|Lost to Follow-up|0
7802247|NCT01107457|12260372|FG001|Part B and C|Lost to Follow-up|0
7802248|NCT01107457|12260373|FG002|Part B and C|Lost to Follow-up|0
7802249|NCT01107457|12260374|FG003|Part B and C|Lost to Follow-up|0
7802250|NCT01107457|12260375|FG004|Part B and C|Lost to Follow-up|0
7802251|NCT01107457|12260376|FG005|Part B and C|Lost to Follow-up|10
7802252|NCT01107457|12260371|FG000|Part B and C|Protocol Violation|0
7802253|NCT01107457|12260372|FG001|Part B and C|Protocol Violation|0
7802254|NCT01107457|12260373|FG002|Part B and C|Protocol Violation|0
7802255|NCT01107457|12260374|FG003|Part B and C|Protocol Violation|0
7802256|NCT01107457|12260375|FG004|Part B and C|Protocol Violation|0
7802257|NCT01107457|12260376|FG005|Part B and C|Protocol Violation|1
7802258|NCT01107457|12260371|FG000|Part B and C|Sponsor Decision|0
7884619|NCT01791517|12384969|FG007|Phase I: Period 1|Lens Handling DIfficulties|0
7884620|NCT01791517|12384970|FG008|Phase I: Period 1|Lens Handling DIfficulties|0
7884621|NCT01791517|12384971|FG009|Phase I: Period 1|Lens Handling DIfficulties|0
7884622|NCT01791517|12384972|FG010|Phase I: Period 1|Lens Handling DIfficulties|0
7884623|NCT01791517|12384973|FG011|Phase I: Period 1|Lens Handling DIfficulties|1
7884624|NCT01791517|12384962|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1
7884625|NCT01791517|12384963|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0
7884626|NCT01791517|12384964|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0
7884627|NCT01791517|12384965|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0
7884628|NCT01791517|12384966|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0
7884629|NCT01791517|12384967|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0
7884630|NCT01791517|12384968|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0
7884631|NCT01791517|12384969|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0
7884632|NCT01791517|12384970|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0
7884633|NCT01791517|12384971|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0
7884634|NCT01791517|12384972|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0
7802259|NCT01107457|12260372|FG001|Part B and C|Sponsor Decision|0
7802260|NCT01107457|12260373|FG002|Part B and C|Sponsor Decision|0
7802261|NCT01107457|12260374|FG003|Part B and C|Sponsor Decision|0
7884635|NCT01791517|12384973|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0
7884636|NCT01791517|12384962|FG000|Phase I: Period 2|Protocol Violation|0
7884637|NCT01791517|12384963|FG001|Phase I: Period 2|Protocol Violation|0
7884638|NCT01791517|12384964|FG002|Phase I: Period 2|Protocol Violation|0
7884639|NCT01791517|12384965|FG003|Phase I: Period 2|Protocol Violation|1
7884640|NCT01791517|12384966|FG004|Phase I: Period 2|Protocol Violation|0
7884641|NCT01791517|12384967|FG005|Phase I: Period 2|Protocol Violation|0
7884642|NCT01791517|12384968|FG006|Phase I: Period 2|Protocol Violation|0
7884643|NCT01791517|12384969|FG007|Phase I: Period 2|Protocol Violation|0
7884644|NCT01791517|12384970|FG008|Phase I: Period 2|Protocol Violation|0
7884645|NCT01791517|12384971|FG009|Phase I: Period 2|Protocol Violation|0
7884646|NCT01791517|12384972|FG010|Phase I: Period 2|Protocol Violation|0
7884647|NCT01791517|12384973|FG011|Phase I: Period 2|Protocol Violation|0
7884648|NCT01791517|12384962|FG000|Phase I: Period 2|Withdrawal by Subject|0
7884649|NCT01791517|12384963|FG001|Phase I: Period 2|Withdrawal by Subject|0
7884650|NCT01791517|12384964|FG002|Phase I: Period 2|Withdrawal by Subject|0
7884651|NCT01791517|12384965|FG003|Phase I: Period 2|Withdrawal by Subject|0
7884652|NCT01791517|12384966|FG004|Phase I: Period 2|Withdrawal by Subject|0
7884653|NCT01791517|12384967|FG005|Phase I: Period 2|Withdrawal by Subject|0
7884654|NCT01791517|12384968|FG006|Phase I: Period 2|Withdrawal by Subject|0
7884655|NCT01791517|12384969|FG007|Phase I: Period 2|Withdrawal by Subject|0
7884656|NCT01791517|12384970|FG008|Phase I: Period 2|Withdrawal by Subject|0
7884657|NCT01791517|12384971|FG009|Phase I: Period 2|Withdrawal by Subject|1
7884658|NCT01791517|12384972|FG010|Phase I: Period 2|Withdrawal by Subject|1
7884659|NCT01791517|12384973|FG011|Phase I: Period 2|Withdrawal by Subject|0
7884660|NCT01791517|12384962|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0
7884661|NCT01791517|12384963|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0
7884662|NCT01791517|12384964|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0
7884663|NCT01791517|12384965|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0
7884664|NCT01791517|12384966|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0
7884665|NCT01791517|12384967|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0
7884666|NCT01791517|12384968|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0
7884667|NCT01791517|12384969|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0
7884668|NCT01791517|12384970|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0
7884669|NCT01791517|12384971|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0
7884670|NCT01791517|12384972|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1
7884671|NCT01791517|12384973|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0
7884672|NCT01791517|12384962|FG000|Phase I: Period 2|Lens Discomfort|0
7884673|NCT01791517|12384963|FG001|Phase I: Period 2|Lens Discomfort|0
7884674|NCT01791517|12384964|FG002|Phase I: Period 2|Lens Discomfort|0
7884675|NCT01791517|12384965|FG003|Phase I: Period 2|Lens Discomfort|0
7884676|NCT01791517|12384966|FG004|Phase I: Period 2|Lens Discomfort|0
7884677|NCT01791517|12384967|FG005|Phase I: Period 2|Lens Discomfort|1
7884678|NCT01791517|12384968|FG006|Phase I: Period 2|Lens Discomfort|0
7884679|NCT01791517|12384969|FG007|Phase I: Period 2|Lens Discomfort|0
7884680|NCT01791517|12384970|FG008|Phase I: Period 2|Lens Discomfort|0
7884681|NCT01791517|12384971|FG009|Phase I: Period 2|Lens Discomfort|0
7884682|NCT01791517|12384972|FG010|Phase I: Period 2|Lens Discomfort|0
7884683|NCT01791517|12384973|FG011|Phase I: Period 2|Lens Discomfort|0
7884684|NCT01791517|12384962|FG000|Phase I: Period 2|Lost to Follow-up|0
7884685|NCT01791517|12384963|FG001|Phase I: Period 2|Lost to Follow-up|3
7884686|NCT01791517|12384964|FG002|Phase I: Period 2|Lost to Follow-up|2
7884687|NCT01791517|12384965|FG003|Phase I: Period 2|Lost to Follow-up|0
7884688|NCT01791517|12384966|FG004|Phase I: Period 2|Lost to Follow-up|0
7884689|NCT01791517|12384967|FG005|Phase I: Period 2|Lost to Follow-up|0
7802262|NCT01107457|12260375|FG004|Part B and C|Sponsor Decision|0
7802263|NCT01107457|12260376|FG005|Part B and C|Sponsor Decision|66
7802264|NCT01107457|12260371|FG000|Part B and C|Withdrawal by Subject|0
7802265|NCT01107457|12260372|FG001|Part B and C|Withdrawal by Subject|0
7802266|NCT01107457|12260373|FG002|Part B and C|Withdrawal by Subject|0
7802267|NCT01107457|12260374|FG003|Part B and C|Withdrawal by Subject|0
7802268|NCT01107457|12260375|FG004|Part B and C|Withdrawal by Subject|0
7802269|NCT01107457|12260376|FG005|Part B and C|Withdrawal by Subject|16
7802270|NCT01107457|12260371|FG000|Part B and C|Clinical Relapse|0
7802271|NCT01107457|12260372|FG001|Part B and C|Clinical Relapse|0
7802272|NCT01107457|12260373|FG002|Part B and C|Clinical Relapse|0
7802273|NCT01107457|12260374|FG003|Part B and C|Clinical Relapse|0
7802274|NCT01107457|12260375|FG004|Part B and C|Clinical Relapse|0
7802275|NCT01107457|12260376|FG005|Part B and C|Clinical Relapse|4
7802276|NCT01107535|12260394|FG000|Overall Study|Death|5
7802277|NCT01107743|12260417|FG000|Overall Study|Protocol Violation|46
7802278|NCT01107886|12260477|FG000|Overall Study|Lost to Follow-up|15
7802279|NCT01107886|12260478|FG001|Overall Study|Lost to Follow-up|13
7802280|NCT01107886|12260477|FG000|Overall Study|Withdrawal by Subject|180
7802281|NCT01107886|12260478|FG001|Overall Study|Withdrawal by Subject|196
7802282|NCT01107886|12260477|FG000|Overall Study|Administrative withdrawal of consent|7
7802283|NCT01107886|12260478|FG001|Overall Study|Administrative withdrawal of consent|5
7802284|NCT01107899|12260487|FG000|Overall Study|Physician Decision|5
7802285|NCT01107899|12260488|FG001|Overall Study|Physician Decision|0
7802286|NCT01107899|12260489|FG002|Overall Study|Physician Decision|3
7802287|NCT01107899|12260487|FG000|Overall Study|Withdrawal by Subject|0
7802288|NCT01107899|12260488|FG001|Overall Study|Withdrawal by Subject|0
7884690|NCT01791517|12384968|FG006|Phase I: Period 2|Lost to Follow-up|0
7802289|NCT01107899|12260489|FG002|Overall Study|Withdrawal by Subject|1
7802290|NCT01107912|12260504|FG000|Period 1|Adverse Event|0
7802291|NCT01107912|12260505|FG001|Period 1|Adverse Event|0
7802292|NCT01107912|12260506|FG002|Period 1|Adverse Event|0
7802293|NCT01107912|12260507|FG003|Period 1|Adverse Event|0
7802294|NCT01107912|12260508|FG004|Period 1|Adverse Event|2
7802295|NCT01107912|12260509|FG005|Period 1|Adverse Event|0
7802296|NCT01107912|12260504|FG000|Period 1|Physician Decision|0
7802297|NCT01107912|12260505|FG001|Period 1|Physician Decision|0
7802298|NCT01107912|12260506|FG002|Period 1|Physician Decision|0
7802299|NCT01107912|12260507|FG003|Period 1|Physician Decision|0
7802300|NCT01107912|12260508|FG004|Period 1|Physician Decision|1
7802301|NCT01107912|12260509|FG005|Period 1|Physician Decision|0
7802302|NCT01107912|12260504|FG000|Period 1|Withdrawal by Subject|1
7802303|NCT01107912|12260505|FG001|Period 1|Withdrawal by Subject|0
7802304|NCT01107912|12260506|FG002|Period 1|Withdrawal by Subject|0
7802305|NCT01107912|12260507|FG003|Period 1|Withdrawal by Subject|0
7802306|NCT01107912|12260508|FG004|Period 1|Withdrawal by Subject|0
7802307|NCT01107912|12260509|FG005|Period 1|Withdrawal by Subject|0
7802308|NCT01107912|12260504|FG000|Period 2|Physician Decision|0
7802309|NCT01107912|12260505|FG001|Period 2|Physician Decision|0
7802310|NCT01107912|12260506|FG002|Period 2|Physician Decision|1
7802311|NCT01107912|12260507|FG003|Period 2|Physician Decision|0
7884691|NCT01791517|12384969|FG007|Phase I: Period 2|Lost to Follow-up|0
7802312|NCT01107912|12260508|FG004|Period 2|Physician Decision|0
7802313|NCT01107912|12260509|FG005|Period 2|Physician Decision|0
7802314|NCT01107912|12260504|FG000|Period 3|Adverse Event|0
7802315|NCT01107912|12260505|FG001|Period 3|Adverse Event|1
7802316|NCT01107912|12260506|FG002|Period 3|Adverse Event|1
7802317|NCT01107912|12260507|FG003|Period 3|Adverse Event|0
7802318|NCT01107912|12260508|FG004|Period 3|Adverse Event|0
7802319|NCT01107912|12260509|FG005|Period 3|Adverse Event|0
7802320|NCT01107912|12260504|FG000|Period 3|Withdrawal by Subject|0
7802321|NCT01107912|12260505|FG001|Period 3|Withdrawal by Subject|0
7884692|NCT01791517|12384970|FG008|Phase I: Period 2|Lost to Follow-up|0
7884693|NCT01791517|12384971|FG009|Phase I: Period 2|Lost to Follow-up|0
7884694|NCT01791517|12384972|FG010|Phase I: Period 2|Lost to Follow-up|0
7884695|NCT01791517|12384973|FG011|Phase I: Period 2|Lost to Follow-up|0
7884696|NCT01791517|12384962|FG000|Phase I: Period 3|Lens Discomfort|0
7884697|NCT01791517|12384963|FG001|Phase I: Period 3|Lens Discomfort|0
7884698|NCT01791517|12384964|FG002|Phase I: Period 3|Lens Discomfort|0
7884699|NCT01791517|12384965|FG003|Phase I: Period 3|Lens Discomfort|0
7884700|NCT01791517|12384966|FG004|Phase I: Period 3|Lens Discomfort|0
7884701|NCT01791517|12384967|FG005|Phase I: Period 3|Lens Discomfort|0
7802322|NCT01107912|12260506|FG002|Period 3|Withdrawal by Subject|0
7802323|NCT01107912|12260507|FG003|Period 3|Withdrawal by Subject|1
7802324|NCT01107912|12260508|FG004|Period 3|Withdrawal by Subject|0
7802325|NCT01107912|12260509|FG005|Period 3|Withdrawal by Subject|0
7802326|NCT01107925|12260528|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
7802327|NCT01107925|12260529|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
7802328|NCT01107925|12260530|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
7884702|NCT01791517|12384968|FG006|Phase I: Period 3|Lens Discomfort|0
7802329|NCT01107925|12260531|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
7802330|NCT01107925|12260532|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
7802331|NCT01107925|12260533|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
7802332|NCT01107925|12260528|FG000|Period 2|Withdrawal by Subject|0
7802333|NCT01107925|12260529|FG001|Period 2|Withdrawal by Subject|1
7802334|NCT01107925|12260530|FG002|Period 2|Withdrawal by Subject|0
7802335|NCT01107925|12260531|FG003|Period 2|Withdrawal by Subject|0
7802336|NCT01107925|12260532|FG004|Period 2|Withdrawal by Subject|0
7802337|NCT01107925|12260533|FG005|Period 2|Withdrawal by Subject|1
7802338|NCT01108068|12260581|FG000|Overall Study|5 not started, 1 stop due to side effect|6
7802339|NCT01108068|12260582|FG001|Overall Study|5 not started, 1 stop due to side effect|0
7802340|NCT01108094|12260610|FG000|Overall Study|Adverse Event|2
7802341|NCT01108094|12260611|FG001|Overall Study|Adverse Event|0
7802342|NCT01108094|12260612|FG002|Overall Study|Adverse Event|0
7802343|NCT01108094|12260613|FG003|Overall Study|Adverse Event|0
7802344|NCT01108094|12260610|FG000|Overall Study|Withdrawal by Subject|1
7802345|NCT01108094|12260611|FG001|Overall Study|Withdrawal by Subject|0
7802346|NCT01108094|12260612|FG002|Overall Study|Withdrawal by Subject|0
7802347|NCT01108094|12260613|FG003|Overall Study|Withdrawal by Subject|0
7802348|NCT01108185|12260626|FG000|Overall Study|Non-compliance|15
7802349|NCT01108185|12260626|FG000|Overall Study|Lost to Follow-up|12
7802350|NCT01108237|12260632|FG000|Overall Study|No alignment data|2
7802351|NCT01108237|12260633|FG001|Overall Study|No alignment data|17
7802352|NCT01108237|12260632|FG000|Overall Study|Did not meet criteria for analysis|7
7802353|NCT01108237|12260633|FG001|Overall Study|Did not meet criteria for analysis|0
7802354|NCT01108263|12260641|FG000|Overall Study|Adverse Event|0
7802355|NCT01108263|12260642|FG001|Overall Study|Adverse Event|1
7802356|NCT01108341|12260648|FG000|Overall Study|Death|2
7802357|NCT01108341|12260648|FG000|Overall Study|Withdrawal by Subject|1
7802358|NCT01108341|12260648|FG000|Overall Study|Lost to Follow-up|1
7802359|NCT01108341|12260648|FG000|Overall Study|Other|1
7802360|NCT01108458|12260667|FG000|Overall Study|Withdrawal by Subject|1
7884703|NCT01791517|12384969|FG007|Phase I: Period 3|Lens Discomfort|0
7884704|NCT01791517|12384970|FG008|Phase I: Period 3|Lens Discomfort|0
7802361|NCT01108510|12260673|FG000|Overall Study|Randomized but Not Treated|5
7802362|NCT01108510|12260674|FG001|Overall Study|Randomized but Not Treated|1
7802363|NCT01108510|12260673|FG000|Overall Study|Joined Another Gilead-sponsored Study|186
7802364|NCT01108510|12260674|FG001|Overall Study|Joined Another Gilead-sponsored Study|195
7802365|NCT01108510|12260673|FG000|Overall Study|Adverse Event|26
7802366|NCT01108510|12260674|FG001|Overall Study|Adverse Event|19
7802367|NCT01108510|12260673|FG000|Overall Study|Lost to Follow-up|20
7802368|NCT01108510|12260674|FG001|Overall Study|Lost to Follow-up|17
7802369|NCT01108510|12260673|FG000|Overall Study|Withdrew Consent|21
7802370|NCT01108510|12260674|FG001|Overall Study|Withdrew Consent|15
7802371|NCT01108510|12260673|FG000|Overall Study|Investigator's Discretion|12
7802372|NCT01108510|12260674|FG001|Overall Study|Investigator's Discretion|10
7802373|NCT01108510|12260673|FG000|Overall Study|Participant Noncompliance|5
7802374|NCT01108510|12260674|FG001|Overall Study|Participant Noncompliance|7
7802375|NCT01108510|12260673|FG000|Overall Study|Lack of Efficacy|3
7802376|NCT01108510|12260674|FG001|Overall Study|Lack of Efficacy|0
7802377|NCT01108510|12260673|FG000|Overall Study|Pregnancy|0
7802378|NCT01108510|12260674|FG001|Overall Study|Pregnancy|3
7802379|NCT01108510|12260673|FG000|Overall Study|Death|1
7802380|NCT01108510|12260674|FG001|Overall Study|Death|1
7802381|NCT01108718|12260682|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1
7802382|NCT01108718|12260683|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0
7802383|NCT01108731|12260690|FG000|Overall Study|Withdrawal by Subject|1
7802384|NCT01108731|12260691|FG001|Overall Study|Withdrawal by Subject|1
7802385|NCT01108731|12260690|FG000|Overall Study|Adverse Event|3
7802386|NCT01108731|12260691|FG001|Overall Study|Adverse Event|3
7802387|NCT01108796|12260710|FG000|Overall Study|Adverse Event|0
7802388|NCT01108796|12260711|FG001|Overall Study|Adverse Event|1
7802389|NCT01108796|12260710|FG000|Overall Study|Lost to Follow-up|7
7802390|NCT01108796|12260711|FG001|Overall Study|Lost to Follow-up|6
7802391|NCT01108809|12260719|FG000|Overall Study|Adverse Event|3
7802392|NCT01108809|12260719|FG000|Overall Study|Lost to Follow-up|1
7802393|NCT01109173|12260774|FG000|Overall Study|Adverse Event|15
7802394|NCT01109173|12260775|FG001|Overall Study|Adverse Event|17
7802395|NCT01109173|12260776|FG002|Overall Study|Adverse Event|9
7802396|NCT01109173|12260777|FG003|Overall Study|Adverse Event|6
7802397|NCT01109173|12260774|FG000|Overall Study|Lost to Follow-up|0
7802398|NCT01109173|12260775|FG001|Overall Study|Lost to Follow-up|1
7802399|NCT01109173|12260776|FG002|Overall Study|Lost to Follow-up|0
7802400|NCT01109173|12260777|FG003|Overall Study|Lost to Follow-up|0
7802401|NCT01109173|12260774|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
7802402|NCT01109173|12260775|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
7802403|NCT01109173|12260776|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
7802404|NCT01109173|12260777|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
7802405|NCT01109173|12260774|FG000|Overall Study|Noncompliance|0
7802406|NCT01109173|12260775|FG001|Overall Study|Noncompliance|1
7802407|NCT01109173|12260776|FG002|Overall Study|Noncompliance|0
7802408|NCT01109173|12260777|FG003|Overall Study|Noncompliance|0
7802409|NCT01109173|12260774|FG000|Overall Study|Treatment Failure|25
7802410|NCT01109173|12260775|FG001|Overall Study|Treatment Failure|32
7802411|NCT01109173|12260776|FG002|Overall Study|Treatment Failure|69
7802412|NCT01109173|12260777|FG003|Overall Study|Treatment Failure|64
7802413|NCT01109173|12260774|FG000|Overall Study|Protocol Violation|4
7802414|NCT01109173|12260775|FG001|Overall Study|Protocol Violation|5
7802415|NCT01109173|12260776|FG002|Overall Study|Protocol Violation|1
7802416|NCT01109173|12260777|FG003|Overall Study|Protocol Violation|2
7802417|NCT01109173|12260774|FG000|Overall Study|Patient Did Not Use Study Medication|34
7802418|NCT01109173|12260775|FG001|Overall Study|Patient Did Not Use Study Medication|26
7802419|NCT01109173|12260776|FG002|Overall Study|Patient Did Not Use Study Medication|11
7802420|NCT01109173|12260777|FG003|Overall Study|Patient Did Not Use Study Medication|7
7802421|NCT01109173|12260774|FG000|Overall Study|Not Specifiied|5
7802422|NCT01109173|12260775|FG001|Overall Study|Not Specifiied|4
7802423|NCT01109173|12260776|FG002|Overall Study|Not Specifiied|9
7802424|NCT01109173|12260777|FG003|Overall Study|Not Specifiied|14
7802425|NCT01109316|12260793|FG000|Study Period 1|Adverse Event|0
7802426|NCT01109316|12260794|FG001|Study Period 1|Adverse Event|0
7802427|NCT01109316|12260795|FG002|Study Period 1|Adverse Event|1
7884705|NCT01791517|12384971|FG009|Phase I: Period 3|Lens Discomfort|0
7884706|NCT01791517|12384972|FG010|Phase I: Period 3|Lens Discomfort|0
7884707|NCT01791517|12384973|FG011|Phase I: Period 3|Lens Discomfort|1
7884708|NCT01791517|12384962|FG000|Phase I: Period 3|Lost to Follow-up|0
7884709|NCT01791517|12384963|FG001|Phase I: Period 3|Lost to Follow-up|1
7884710|NCT01791517|12384964|FG002|Phase I: Period 3|Lost to Follow-up|0
7884711|NCT01791517|12384965|FG003|Phase I: Period 3|Lost to Follow-up|0
7884712|NCT01791517|12384966|FG004|Phase I: Period 3|Lost to Follow-up|1
7884713|NCT01791517|12384967|FG005|Phase I: Period 3|Lost to Follow-up|0
7884714|NCT01791517|12384968|FG006|Phase I: Period 3|Lost to Follow-up|0
7884715|NCT01791517|12384969|FG007|Phase I: Period 3|Lost to Follow-up|0
7884716|NCT01791517|12384970|FG008|Phase I: Period 3|Lost to Follow-up|0
7884717|NCT01791517|12384971|FG009|Phase I: Period 3|Lost to Follow-up|0
7884718|NCT01791517|12384972|FG010|Phase I: Period 3|Lost to Follow-up|0
7884719|NCT01791517|12384973|FG011|Phase I: Period 3|Lost to Follow-up|0
7884720|NCT01791517|12384962|FG000|Phase I: Period 3|Adverse Event|0
7884721|NCT01791517|12384963|FG001|Phase I: Period 3|Adverse Event|0
7884722|NCT01791517|12384964|FG002|Phase I: Period 3|Adverse Event|0
7884723|NCT01791517|12384965|FG003|Phase I: Period 3|Adverse Event|1
7884724|NCT01791517|12384966|FG004|Phase I: Period 3|Adverse Event|0
7884725|NCT01791517|12384967|FG005|Phase I: Period 3|Adverse Event|0
7884726|NCT01791517|12384968|FG006|Phase I: Period 3|Adverse Event|0
7884727|NCT01791517|12384969|FG007|Phase I: Period 3|Adverse Event|0
7884728|NCT01791517|12384970|FG008|Phase I: Period 3|Adverse Event|0
7884729|NCT01791517|12384971|FG009|Phase I: Period 3|Adverse Event|0
7884730|NCT01791517|12384972|FG010|Phase I: Period 3|Adverse Event|0
7884731|NCT01791517|12384973|FG011|Phase I: Period 3|Adverse Event|0
7884732|NCT01791517|12384962|FG000|Phase II|Lost to Follow-up|1
7884733|NCT01791517|12384963|FG001|Phase II|Lost to Follow-up|0
7884734|NCT01791517|12384964|FG002|Phase II|Lost to Follow-up|1
7884735|NCT01791517|12384965|FG003|Phase II|Lost to Follow-up|0
7884736|NCT01791517|12384966|FG004|Phase II|Lost to Follow-up|1
7884737|NCT01791517|12384967|FG005|Phase II|Lost to Follow-up|2
7884738|NCT01791517|12384968|FG006|Phase II|Lost to Follow-up|0
7884739|NCT01791517|12384969|FG007|Phase II|Lost to Follow-up|1
7884740|NCT01791517|12384970|FG008|Phase II|Lost to Follow-up|1
7884741|NCT01791517|12384971|FG009|Phase II|Lost to Follow-up|1
7884742|NCT01791517|12384972|FG010|Phase II|Lost to Follow-up|0
7884743|NCT01791517|12384973|FG011|Phase II|Lost to Follow-up|0
7884744|NCT01791517|12384962|FG000|Phase II|Withdrawal by Subject|1
7884745|NCT01791517|12384963|FG001|Phase II|Withdrawal by Subject|0
7884746|NCT01791517|12384964|FG002|Phase II|Withdrawal by Subject|0
7884747|NCT01791517|12384965|FG003|Phase II|Withdrawal by Subject|0
7884748|NCT01791517|12384966|FG004|Phase II|Withdrawal by Subject|0
7884749|NCT01791517|12384967|FG005|Phase II|Withdrawal by Subject|2
7884750|NCT01791517|12384968|FG006|Phase II|Withdrawal by Subject|0
7884751|NCT01791517|12384969|FG007|Phase II|Withdrawal by Subject|1
7884752|NCT01791517|12384970|FG008|Phase II|Withdrawal by Subject|0
7884753|NCT01791517|12384971|FG009|Phase II|Withdrawal by Subject|0
7884754|NCT01791517|12384972|FG010|Phase II|Withdrawal by Subject|1
7884755|NCT01791517|12384973|FG011|Phase II|Withdrawal by Subject|0
7884756|NCT01791517|12384962|FG000|Phase II|Lack of Efficacy|0
7884757|NCT01791517|12384963|FG001|Phase II|Lack of Efficacy|0
7884758|NCT01791517|12384964|FG002|Phase II|Lack of Efficacy|0
7884759|NCT01791517|12384965|FG003|Phase II|Lack of Efficacy|0
7884760|NCT01791517|12384966|FG004|Phase II|Lack of Efficacy|1
7884761|NCT01791517|12384967|FG005|Phase II|Lack of Efficacy|0
7884762|NCT01791517|12384968|FG006|Phase II|Lack of Efficacy|0
7884763|NCT01791517|12384969|FG007|Phase II|Lack of Efficacy|0
7884764|NCT01791517|12384970|FG008|Phase II|Lack of Efficacy|0
7884765|NCT01791517|12384971|FG009|Phase II|Lack of Efficacy|0
7884766|NCT01791517|12384972|FG010|Phase II|Lack of Efficacy|0
7884767|NCT01791517|12384973|FG011|Phase II|Lack of Efficacy|0
7884768|NCT01791517|12384962|FG000|Phase II|Adverse Event|0
7884769|NCT01791517|12384963|FG001|Phase II|Adverse Event|0
7884770|NCT01791517|12384964|FG002|Phase II|Adverse Event|0
7884771|NCT01791517|12384965|FG003|Phase II|Adverse Event|0
7884772|NCT01791517|12384966|FG004|Phase II|Adverse Event|0
7884773|NCT01791517|12384967|FG005|Phase II|Adverse Event|0
7884774|NCT01791517|12384968|FG006|Phase II|Adverse Event|2
7884775|NCT01791517|12384969|FG007|Phase II|Adverse Event|1
7884776|NCT01791517|12384970|FG008|Phase II|Adverse Event|0
7884777|NCT01791517|12384971|FG009|Phase II|Adverse Event|1
7802428|NCT01109316|12260796|FG003|Study Period 1|Adverse Event|0
7802429|NCT01109316|12260797|FG004|Study Period 1|Adverse Event|0
7802430|NCT01109316|12260798|FG005|Study Period 1|Adverse Event|0
7802431|NCT01109316|12260793|FG000|Study Period 1|Lost to Follow-up|0
7802432|NCT01109316|12260794|FG001|Study Period 1|Lost to Follow-up|0
7802433|NCT01109316|12260795|FG002|Study Period 1|Lost to Follow-up|1
7802434|NCT01109316|12260796|FG003|Study Period 1|Lost to Follow-up|1
7802435|NCT01109316|12260797|FG004|Study Period 1|Lost to Follow-up|0
7802436|NCT01109316|12260798|FG005|Study Period 1|Lost to Follow-up|0
7802437|NCT01109316|12260793|FG000|Study Period 1|Withdrawal by Subject|0
7802438|NCT01109316|12260794|FG001|Study Period 1|Withdrawal by Subject|0
7802439|NCT01109316|12260795|FG002|Study Period 1|Withdrawal by Subject|1
7802440|NCT01109316|12260796|FG003|Study Period 1|Withdrawal by Subject|0
7802441|NCT01109316|12260797|FG004|Study Period 1|Withdrawal by Subject|2
7802442|NCT01109316|12260798|FG005|Study Period 1|Withdrawal by Subject|0
7802443|NCT01109316|12260793|FG000|Study Period 1|Sponsor Decision|0
7802444|NCT01109316|12260794|FG001|Study Period 1|Sponsor Decision|0
7802445|NCT01109316|12260795|FG002|Study Period 1|Sponsor Decision|0
7802446|NCT01109316|12260796|FG003|Study Period 1|Sponsor Decision|0
7802447|NCT01109316|12260797|FG004|Study Period 1|Sponsor Decision|0
7802448|NCT01109316|12260798|FG005|Study Period 1|Sponsor Decision|2
7802449|NCT01109316|12260793|FG000|Study Period 2|Entry Criteria Not Met|0
7802450|NCT01109316|12260794|FG001|Study Period 2|Entry Criteria Not Met|1
7802451|NCT01109316|12260795|FG002|Study Period 2|Entry Criteria Not Met|0
7802452|NCT01109316|12260796|FG003|Study Period 2|Entry Criteria Not Met|0
7802453|NCT01109316|12260797|FG004|Study Period 2|Entry Criteria Not Met|0
7802454|NCT01109316|12260798|FG005|Study Period 2|Entry Criteria Not Met|0
7802455|NCT01109316|12260793|FG000|Study Period 2|Physician Decision|0
7884778|NCT01791517|12384972|FG010|Phase II|Adverse Event|0
7884779|NCT01791517|12384973|FG011|Phase II|Adverse Event|0
7884780|NCT01791517|12384962|FG000|Phase II|Lens Handling Difficulties|0
7884781|NCT01791517|12384963|FG001|Phase II|Lens Handling Difficulties|0
7802456|NCT01109316|12260794|FG001|Study Period 2|Physician Decision|0
7802457|NCT01109316|12260795|FG002|Study Period 2|Physician Decision|0
7802458|NCT01109316|12260796|FG003|Study Period 2|Physician Decision|1
7802459|NCT01109316|12260797|FG004|Study Period 2|Physician Decision|0
7802460|NCT01109316|12260798|FG005|Study Period 2|Physician Decision|0
7802461|NCT01109316|12260793|FG000|Study Period 2|Protocol Violation|1
7802462|NCT01109316|12260794|FG001|Study Period 2|Protocol Violation|0
7802463|NCT01109316|12260795|FG002|Study Period 2|Protocol Violation|0
7802464|NCT01109316|12260796|FG003|Study Period 2|Protocol Violation|0
7802465|NCT01109316|12260797|FG004|Study Period 2|Protocol Violation|0
7802466|NCT01109316|12260798|FG005|Study Period 2|Protocol Violation|0
7802467|NCT01109316|12260793|FG000|Study Period 2|Withdrawal by Subject|0
7802468|NCT01109316|12260794|FG001|Study Period 2|Withdrawal by Subject|0
7802469|NCT01109316|12260795|FG002|Study Period 2|Withdrawal by Subject|1
7802470|NCT01109316|12260796|FG003|Study Period 2|Withdrawal by Subject|0
7802471|NCT01109316|12260797|FG004|Study Period 2|Withdrawal by Subject|0
7802472|NCT01109316|12260798|FG005|Study Period 2|Withdrawal by Subject|1
7802473|NCT01109316|12260793|FG000|Study Period 3|Lost to Follow-up|0
7802474|NCT01109316|12260794|FG001|Study Period 3|Lost to Follow-up|0
7802475|NCT01109316|12260795|FG002|Study Period 3|Lost to Follow-up|0
7802476|NCT01109316|12260796|FG003|Study Period 3|Lost to Follow-up|0
7802477|NCT01109316|12260797|FG004|Study Period 3|Lost to Follow-up|1
7802478|NCT01109316|12260798|FG005|Study Period 3|Lost to Follow-up|0
7802479|NCT01109316|12260793|FG000|Study Period 3|Withdrawal by Subject|1
7802480|NCT01109316|12260794|FG001|Study Period 3|Withdrawal by Subject|0
7802481|NCT01109316|12260795|FG002|Study Period 3|Withdrawal by Subject|0
7802482|NCT01109316|12260796|FG003|Study Period 3|Withdrawal by Subject|0
7802483|NCT01109316|12260797|FG004|Study Period 3|Withdrawal by Subject|1
7802484|NCT01109316|12260798|FG005|Study Period 3|Withdrawal by Subject|0
7802485|NCT01109524|12260812|FG000|Overall Study|Disease Progression|29
7802486|NCT01109524|12260812|FG000|Overall Study|Study Drug toxicity|6
7802487|NCT01109524|12260812|FG000|Overall Study|Adverse Event|4
7802488|NCT01109524|12260812|FG000|Overall Study|Withdrawal by Subject|2
7802489|NCT01109524|12260812|FG000|Overall Study|Maximum clinical benefit|3
7802490|NCT01109524|12260812|FG000|Overall Study|Death|2
7802491|NCT01109524|12260812|FG000|Overall Study|No longer meets criteria|2
7802492|NCT01109524|12260812|FG000|Overall Study|Participant requested to end treatment|4
7802493|NCT01109524|12260812|FG000|Overall Study|Other|5
7802494|NCT01109849|12260834|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
7802495|NCT01109849|12260835|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
7802496|NCT01109849|12260836|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
7802497|NCT01109849|12260837|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
7802498|NCT01109849|12260838|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
7802499|NCT01109849|12260834|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1
7802500|NCT01109849|12260835|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0
7802501|NCT01109849|12260836|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0
7802502|NCT01109849|12260837|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0
7802503|NCT01109849|12260838|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0
7802504|NCT01109849|12260834|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
7802505|NCT01109849|12260835|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
7802506|NCT01109849|12260836|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
7802507|NCT01109849|12260837|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
7802508|NCT01109849|12260838|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
7802509|NCT01109849|12260834|FG000|Initial Randomization: ADHD Treatment|move away|2
7802510|NCT01109849|12260835|FG001|Initial Randomization: ADHD Treatment|move away|7
7802511|NCT01109849|12260836|FG002|Initial Randomization: ADHD Treatment|move away|0
7802512|NCT01109849|12260837|FG003|Initial Randomization: ADHD Treatment|move away|0
7802513|NCT01109849|12260838|FG004|Initial Randomization: ADHD Treatment|move away|0
7802514|NCT01109849|12260834|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
7802515|NCT01109849|12260835|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
7802516|NCT01109849|12260836|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
7802517|NCT01109849|12260837|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
7802518|NCT01109849|12260838|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
7802519|NCT01109849|12260834|FG000|Adaptive Randomization: Weight Recovery|moved away|0
7802520|NCT01109849|12260835|FG001|Adaptive Randomization: Weight Recovery|moved away|0
7802521|NCT01109849|12260836|FG002|Adaptive Randomization: Weight Recovery|moved away|0
7802522|NCT01109849|12260837|FG003|Adaptive Randomization: Weight Recovery|moved away|2
7802523|NCT01109849|12260838|FG004|Adaptive Randomization: Weight Recovery|moved away|0
7802524|NCT01109940|12260862|FG000|Overall Study|Administrative problems|2
7802525|NCT01109940|12260863|FG001|Overall Study|Administrative problems|0
7802526|NCT01109940|12260864|FG002|Overall Study|Administrative problems|0
7802527|NCT01109940|12260865|FG003|Overall Study|Administrative problems|0
7802528|NCT01109940|12260862|FG000|Overall Study|Serious Adverse Event|2
7802529|NCT01109940|12260863|FG001|Overall Study|Serious Adverse Event|1
7884782|NCT01791517|12384964|FG002|Phase II|Lens Handling Difficulties|0
7884783|NCT01791517|12384965|FG003|Phase II|Lens Handling Difficulties|0
7884784|NCT01791517|12384966|FG004|Phase II|Lens Handling Difficulties|0
7884785|NCT01791517|12384967|FG005|Phase II|Lens Handling Difficulties|0
7884786|NCT01791517|12384968|FG006|Phase II|Lens Handling Difficulties|0
7884787|NCT01791517|12384969|FG007|Phase II|Lens Handling Difficulties|0
7884788|NCT01791517|12384970|FG008|Phase II|Lens Handling Difficulties|1
7884789|NCT01791517|12384971|FG009|Phase II|Lens Handling Difficulties|0
7884790|NCT01791517|12384972|FG010|Phase II|Lens Handling Difficulties|0
7884791|NCT01791517|12384973|FG011|Phase II|Lens Handling Difficulties|0
7884792|NCT01791517|12384962|FG000|Phase II|Unsatisfactory Lens Fitting|0
7884793|NCT01791517|12384963|FG001|Phase II|Unsatisfactory Lens Fitting|0
7884794|NCT01791517|12384964|FG002|Phase II|Unsatisfactory Lens Fitting|0
7884795|NCT01791517|12384965|FG003|Phase II|Unsatisfactory Lens Fitting|0
7884796|NCT01791517|12384966|FG004|Phase II|Unsatisfactory Lens Fitting|0
7884797|NCT01791517|12384967|FG005|Phase II|Unsatisfactory Lens Fitting|0
7884798|NCT01791517|12384968|FG006|Phase II|Unsatisfactory Lens Fitting|0
7884799|NCT01791517|12384969|FG007|Phase II|Unsatisfactory Lens Fitting|0
7884800|NCT01791517|12384970|FG008|Phase II|Unsatisfactory Lens Fitting|0
7884801|NCT01791517|12384971|FG009|Phase II|Unsatisfactory Lens Fitting|1
7884802|NCT01791517|12384972|FG010|Phase II|Unsatisfactory Lens Fitting|0
7884803|NCT01791517|12384973|FG011|Phase II|Unsatisfactory Lens Fitting|0
7884804|NCT01791517|12384962|FG000|Phase II|Pre-Existing Ocular Issue|0
7884805|NCT01791517|12384963|FG001|Phase II|Pre-Existing Ocular Issue|0
7884806|NCT01791517|12384964|FG002|Phase II|Pre-Existing Ocular Issue|0
7884807|NCT01791517|12384965|FG003|Phase II|Pre-Existing Ocular Issue|0
7884808|NCT01791517|12384966|FG004|Phase II|Pre-Existing Ocular Issue|0
7884809|NCT01791517|12384967|FG005|Phase II|Pre-Existing Ocular Issue|0
7884810|NCT01791517|12384968|FG006|Phase II|Pre-Existing Ocular Issue|0
7884811|NCT01791517|12384969|FG007|Phase II|Pre-Existing Ocular Issue|0
7884812|NCT01791517|12384970|FG008|Phase II|Pre-Existing Ocular Issue|0
7884813|NCT01791517|12384971|FG009|Phase II|Pre-Existing Ocular Issue|0
7884814|NCT01791517|12384972|FG010|Phase II|Pre-Existing Ocular Issue|0
7884815|NCT01791517|12384973|FG011|Phase II|Pre-Existing Ocular Issue|1
7884816|NCT01791725|12384994|FG000|Overall Study|Withdrawal by Subject|0
7884817|NCT01791725|12384995|FG001|Overall Study|Withdrawal by Subject|1
7884818|NCT01791725|12384996|FG002|Overall Study|Withdrawal by Subject|0
7884819|NCT01791803|12385008|FG000|Overall Study|Withdrawal by Subject|0
7884820|NCT01791803|12385009|FG001|Overall Study|Withdrawal by Subject|0
7884821|NCT01791803|12385010|FG002|Overall Study|Withdrawal by Subject|0
7884822|NCT01791803|12385011|FG003|Overall Study|Withdrawal by Subject|2
7884823|NCT01791803|12385008|FG000|Overall Study|Physician Decision|0
7884824|NCT01791803|12385009|FG001|Overall Study|Physician Decision|2
7884825|NCT01791803|12385010|FG002|Overall Study|Physician Decision|0
7884826|NCT01791803|12385011|FG003|Overall Study|Physician Decision|1
7884827|NCT01791803|12385008|FG000|Overall Study|Death|0
7884828|NCT01791803|12385009|FG001|Overall Study|Death|0
7884829|NCT01791803|12385010|FG002|Overall Study|Death|2
7884830|NCT01791803|12385011|FG003|Overall Study|Death|2
7884831|NCT01791894|12385024|FG000|Overall Study|Adverse Event|1
7884832|NCT01792115|12385045|FG000|Overall Study|Lost to Follow-up|0
7884833|NCT01792115|12385046|FG001|Overall Study|Lost to Follow-up|1
7802530|NCT01109940|12260864|FG002|Overall Study|Serious Adverse Event|0
7802531|NCT01109940|12260865|FG003|Overall Study|Serious Adverse Event|0
7802532|NCT01109940|12260862|FG000|Overall Study|Lost to Follow-up|1
7884834|NCT01792115|12385047|FG002|Overall Study|Lost to Follow-up|0
7884835|NCT01792284|12385055|FG000|Lead-in Period|Adverse Event|15
7802533|NCT01109940|12260863|FG001|Overall Study|Lost to Follow-up|0
7802534|NCT01109940|12260864|FG002|Overall Study|Lost to Follow-up|0
7802535|NCT01109940|12260865|FG003|Overall Study|Lost to Follow-up|0
7802536|NCT01109940|12260862|FG000|Overall Study|Patient withdrew consent|1
7802537|NCT01109940|12260863|FG001|Overall Study|Patient withdrew consent|1
7802538|NCT01109940|12260864|FG002|Overall Study|Patient withdrew consent|0
7802539|NCT01109940|12260865|FG003|Overall Study|Patient withdrew consent|0
7802540|NCT01109940|12260862|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7802541|NCT01109940|12260863|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7802542|NCT01109940|12260864|FG002|Overall Study|Unsatisfactory therapeutic effect|1
7802543|NCT01109940|12260865|FG003|Overall Study|Unsatisfactory therapeutic effect|0
7802544|NCT01109979|12260877|FG000|Overall Study|Physician Decision|2
7802545|NCT01109979|12260878|FG001|Overall Study|Physician Decision|0
7802546|NCT01109979|12260877|FG000|Overall Study|Withdrawal by Subject|0
7802547|NCT01109979|12260878|FG001|Overall Study|Withdrawal by Subject|1
7802548|NCT01109992|12260886|FG000|Overall Study|Withdrawal by Subject|0
7802549|NCT01109992|12260887|FG001|Overall Study|Withdrawal by Subject|1
7802550|NCT01109992|12260886|FG000|Overall Study|Movement during rest scan.|0
7802551|NCT01109992|12260887|FG001|Overall Study|Movement during rest scan.|1
7802552|NCT01110005|12260898|FG000|Overall Study|ineligible|1
7802553|NCT01110005|12260899|FG001|Overall Study|ineligible|2
7802554|NCT01110005|12260898|FG000|Overall Study|missing consent|3
7802555|NCT01110005|12260899|FG001|Overall Study|missing consent|2
7802556|NCT01110005|12260898|FG000|Overall Study|Withdrawal by Subject|0
7802557|NCT01110005|12260899|FG001|Overall Study|Withdrawal by Subject|1
7802558|NCT01110200|12260922|FG000|Overall Study|Adverse Event|28
7802559|NCT01110200|12260923|FG001|Overall Study|Adverse Event|28
7802560|NCT01110200|12260922|FG000|Overall Study|Withdrawal by Subject|25
7802561|NCT01110200|12260923|FG001|Overall Study|Withdrawal by Subject|32
7802562|NCT01110200|12260922|FG000|Overall Study|Lack of Efficacy|16
7802563|NCT01110200|12260923|FG001|Overall Study|Lack of Efficacy|25
7802564|NCT01110200|12260922|FG000|Overall Study|Protocol Violation|14
7802565|NCT01110200|12260923|FG001|Overall Study|Protocol Violation|12
7802566|NCT01110200|12260922|FG000|Overall Study|Physician Decision|13
7802567|NCT01110200|12260923|FG001|Overall Study|Physician Decision|17
7802568|NCT01110200|12260922|FG000|Overall Study|Lost to Follow-up|10
7802569|NCT01110200|12260923|FG001|Overall Study|Lost to Follow-up|7
7802570|NCT01110239|12260933|FG000|Sham Preconditioning|Withdrawal by Subject|0
7802571|NCT01110239|12260934|FG001|Sham Preconditioning|Withdrawal by Subject|0
7802572|NCT01110239|12260935|FG002|Sham Preconditioning|Withdrawal by Subject|1
7802573|NCT01110239|12260936|FG003|Sham Preconditioning|Withdrawal by Subject|0
7802574|NCT01110239|12260933|FG000|7.5 Min Ischemia|Withdrawal by Subject|0
7802575|NCT01110239|12260934|FG001|7.5 Min Ischemia|Withdrawal by Subject|0
7802576|NCT01110239|12260935|FG002|7.5 Min Ischemia|Withdrawal by Subject|1
7802577|NCT01110239|12260936|FG003|7.5 Min Ischemia|Withdrawal by Subject|0
7802578|NCT01110330|12260955|FG000|Overall Study|Adverse Event|0
7802579|NCT01110330|12260956|FG001|Overall Study|Adverse Event|4
7802580|NCT01110330|12260957|FG002|Overall Study|Adverse Event|3
7802581|NCT01110330|12260955|FG000|Overall Study|Lack of Efficacy|3
7802582|NCT01110330|12260956|FG001|Overall Study|Lack of Efficacy|1
7802583|NCT01110330|12260957|FG002|Overall Study|Lack of Efficacy|1
7802584|NCT01110330|12260955|FG000|Overall Study|Lost to Follow-up|9
7802585|NCT01110330|12260956|FG001|Overall Study|Lost to Follow-up|10
7802586|NCT01110330|12260957|FG002|Overall Study|Lost to Follow-up|15
7802587|NCT01110330|12260955|FG000|Overall Study|Physician Decision|0
7802588|NCT01110330|12260956|FG001|Overall Study|Physician Decision|1
7802589|NCT01110330|12260957|FG002|Overall Study|Physician Decision|0
7802590|NCT01110330|12260955|FG000|Overall Study|Protocol Violation|2
7802591|NCT01110330|12260956|FG001|Overall Study|Protocol Violation|0
7802592|NCT01110330|12260957|FG002|Overall Study|Protocol Violation|4
7802593|NCT01110330|12260955|FG000|Overall Study|Withdrawal by Subject|0
7802594|NCT01110330|12260956|FG001|Overall Study|Withdrawal by Subject|6
7802595|NCT01110330|12260957|FG002|Overall Study|Withdrawal by Subject|2
7802596|NCT01110330|12260955|FG000|Overall Study|Other|1
7802597|NCT01110330|12260956|FG001|Overall Study|Other|1
7802598|NCT01110330|12260957|FG002|Overall Study|Other|1
7802599|NCT01110382|12260967|FG000|Overall Study|Withdrawal by Subject|0
7802600|NCT01110382|12260968|FG001|Overall Study|Withdrawal by Subject|1
7802601|NCT01110382|12260967|FG000|Overall Study|Protocol Violation|0
7802602|NCT01110382|12260968|FG001|Overall Study|Protocol Violation|1
7802603|NCT01110408|12260980|FG000|Overall Study|Protocol Violation|1
7802604|NCT01110408|12260981|FG001|Overall Study|Protocol Violation|0
7802605|NCT01110707|12261042|FG000|Overall Study|Protocol Violation|0
7802606|NCT01110707|12261043|FG001|Overall Study|Protocol Violation|3
7802607|NCT01110915|12261062|FG000|Overall Study|Death|2
7802608|NCT01110915|12261063|FG001|Overall Study|Death|1
7802609|NCT01110915|12261062|FG000|Overall Study|Lost to Follow-up|1
7802610|NCT01110915|12261063|FG001|Overall Study|Lost to Follow-up|0
7802611|NCT01110915|12261062|FG000|Overall Study|Withdrawal by Subject|7
7802612|NCT01110915|12261063|FG001|Overall Study|Withdrawal by Subject|1
7802613|NCT01111123|12261085|FG000|Open- Label Phase|Failed to be clear or almost cleared|14
7802614|NCT01111123|12261086|FG001|Open- Label Phase|Failed to be clear or almost cleared|0
7802615|NCT01111123|12261085|FG000|Maintenance Phase|Lost to Follow-up|0
7802616|NCT01111123|12261086|FG001|Maintenance Phase|Lost to Follow-up|2
7802617|NCT01111149|12261097|FG000|Overall Study|Protocol Violation|1
7802618|NCT01111149|12261098|FG001|Overall Study|Protocol Violation|1
7802619|NCT01111149|12261099|FG002|Overall Study|Protocol Violation|2
7802620|NCT01111149|12261097|FG000|Overall Study|Withdrawal by Subject|1
7802621|NCT01111149|12261098|FG001|Overall Study|Withdrawal by Subject|0
7802622|NCT01111149|12261099|FG002|Overall Study|Withdrawal by Subject|2
7802623|NCT01111240|12261112|FG000|Overall Study|Adverse Event|190
7802624|NCT01111240|12261112|FG000|Overall Study|Lack of Efficacy|545
7802625|NCT01111240|12261112|FG000|Overall Study|Lack of Efficacy and Adverse Event|19
7802626|NCT01111240|12261112|FG000|Overall Study|Other|312
7802627|NCT01111292|12261118|FG000|Treatment|Physician Decision|1
7802628|NCT01111292|12261119|FG001|Treatment|Physician Decision|1
7802629|NCT01111461|12261157|FG000|Overall Study|Adverse Event|32
7802630|NCT01111461|12261157|FG000|Overall Study|Participant choice|11
7802631|NCT01111461|12261157|FG000|Overall Study|Lost to Follow-up|1
7802632|NCT01111461|12261157|FG000|Overall Study|Withdrawal by Subject|1
7802633|NCT01111461|12261157|FG000|Overall Study|Other|6
7802634|NCT01111474|12261161|FG000|Overall Study|Lost to Follow-up|12
7802635|NCT01111526|12261167|FG000|Overall Study|GVHD Disease Progression|0
7802636|NCT01111526|12261168|FG001|Overall Study|GVHD Disease Progression|1
7802637|NCT01111526|12261169|FG002|Overall Study|GVHD Disease Progression|2
7802638|NCT01111539|12261173|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6
7802639|NCT01111539|12261174|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7802640|NCT01111539|12261175|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7802641|NCT01111539|12261176|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7717503|NCT00520299|12141137|FG002|Overall Study|Progressive disease|4
7717504|NCT00520351|12141147|FG000|First Intervention|Withdrawal by Subject|1
7717505|NCT00520351|12141148|FG001|First Intervention|Withdrawal by Subject|1
7802642|NCT01111539|12261177|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7802643|NCT01111539|12261173|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5
7802644|NCT01111539|12261174|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0
7802645|NCT01111539|12261175|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0
7802646|NCT01111539|12261176|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0
7802647|NCT01111539|12261177|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0
7802648|NCT01111539|12261173|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60
7802649|NCT01111539|12261174|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7802650|NCT01111539|12261175|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7802651|NCT01111539|12261176|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7802652|NCT01111539|12261177|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7802653|NCT01111539|12261173|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1
7802654|NCT01111539|12261174|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
7802655|NCT01111539|12261175|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
7802656|NCT01111539|12261176|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
7802657|NCT01111539|12261177|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
7802658|NCT01111539|12261173|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7
7802659|NCT01111539|12261174|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
7802660|NCT01111539|12261175|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
7802661|NCT01111539|12261176|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
7802662|NCT01111539|12261177|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
7802663|NCT01111539|12261173|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2
7802664|NCT01111539|12261174|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7802665|NCT01111539|12261175|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7802666|NCT01111539|12261176|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7802667|NCT01111539|12261177|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7802668|NCT01111539|12261173|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1
7802669|NCT01111539|12261174|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
7802670|NCT01111539|12261175|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
7802671|NCT01111539|12261176|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
7802672|NCT01111539|12261177|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
7802673|NCT01111539|12261173|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7802674|NCT01111539|12261174|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7802675|NCT01111539|12261175|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
7802676|NCT01111539|12261176|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7802677|NCT01111539|12261177|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
7802678|NCT01111539|12261173|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7802679|NCT01111539|12261174|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7802680|NCT01111539|12261175|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1
7802681|NCT01111539|12261176|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7802682|NCT01111539|12261177|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2
7802683|NCT01111539|12261173|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
7802684|NCT01111539|12261174|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7
7802685|NCT01111539|12261175|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4
7802686|NCT01111539|12261176|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
7802687|NCT01111539|12261177|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
7802688|NCT01111539|12261173|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
7802689|NCT01111539|12261174|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
7802690|NCT01111539|12261175|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
7802691|NCT01111539|12261176|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
7802692|NCT01111539|12261177|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1
7802693|NCT01111539|12261173|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
7802694|NCT01111539|12261174|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
7802695|NCT01111539|12261175|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
7802696|NCT01111539|12261176|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1
7802697|NCT01111539|12261177|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
7802698|NCT01111539|12261173|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
7802699|NCT01111539|12261174|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
7802700|NCT01111539|12261175|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
7802701|NCT01111539|12261176|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2
7802702|NCT01111539|12261177|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
7802703|NCT01111539|12261173|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7802704|NCT01111539|12261174|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7802705|NCT01111539|12261175|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7884836|NCT01792284|12385056|FG001|Lead-in Period|Adverse Event|0
7884837|NCT01792284|12385057|FG002|Lead-in Period|Adverse Event|0
7884838|NCT01792284|12385055|FG000|Lead-in Period|Lost to Follow-up|2
7884839|NCT01792284|12385056|FG001|Lead-in Period|Lost to Follow-up|0
7884840|NCT01792284|12385057|FG002|Lead-in Period|Lost to Follow-up|0
7884841|NCT01792284|12385055|FG000|Lead-in Period|Protocol Violation|1
7884842|NCT01792284|12385056|FG001|Lead-in Period|Protocol Violation|0
7884843|NCT01792284|12385057|FG002|Lead-in Period|Protocol Violation|0
7884844|NCT01792284|12385055|FG000|Lead-in Period|Withdrawal by Subject|10
7884845|NCT01792284|12385056|FG001|Lead-in Period|Withdrawal by Subject|0
7884846|NCT01792284|12385057|FG002|Lead-in Period|Withdrawal by Subject|0
7884847|NCT01792284|12385055|FG000|Lead-in Period|Physician Decision|1
7884848|NCT01792284|12385056|FG001|Lead-in Period|Physician Decision|0
7884849|NCT01792284|12385057|FG002|Lead-in Period|Physician Decision|0
7884850|NCT01792284|12385055|FG000|Lead-in Period|Protocol Required Discontinuation|1
7884851|NCT01792284|12385056|FG001|Lead-in Period|Protocol Required Discontinuation|0
7884852|NCT01792284|12385057|FG002|Lead-in Period|Protocol Required Discontinuation|0
7884853|NCT01792284|12385055|FG000|Randomization Period 1|Withdrawal by Subject|0
7884854|NCT01792284|12385056|FG001|Randomization Period 1|Withdrawal by Subject|1
7884855|NCT01792284|12385057|FG002|Randomization Period 1|Withdrawal by Subject|1
7884856|NCT01792284|12385055|FG000|Randomization Period 1|Physician Decision|0
7884857|NCT01792284|12385056|FG001|Randomization Period 1|Physician Decision|1
7884858|NCT01792284|12385057|FG002|Randomization Period 1|Physician Decision|1
7884859|NCT01792284|12385055|FG000|Randomization Period 1|Adverse Event|0
7884860|NCT01792284|12385056|FG001|Randomization Period 1|Adverse Event|0
7884861|NCT01792284|12385057|FG002|Randomization Period 1|Adverse Event|2
7884862|NCT01792284|12385055|FG000|Randomization Period 1|Lost to Follow-up|0
7884863|NCT01792284|12385056|FG001|Randomization Period 1|Lost to Follow-up|0
7884864|NCT01792284|12385057|FG002|Randomization Period 1|Lost to Follow-up|1
7884865|NCT01792284|12385055|FG000|Randomization Period 2|Protocol Violation|0
7884866|NCT01792284|12385056|FG001|Randomization Period 2|Protocol Violation|1
7884867|NCT01792284|12385057|FG002|Randomization Period 2|Protocol Violation|0
7884868|NCT01792284|12385055|FG000|Randomization Period 2|Withdrawal by Subject|0
7884869|NCT01792284|12385056|FG001|Randomization Period 2|Withdrawal by Subject|2
7884870|NCT01792284|12385057|FG002|Randomization Period 2|Withdrawal by Subject|0
7884871|NCT01792518|12385067|FG000|Overall Study|Adverse Event|3
7884872|NCT01792518|12385068|FG001|Overall Study|Adverse Event|4
7884873|NCT01792518|12385067|FG000|Overall Study|Protocol Violation|0
7884874|NCT01792518|12385068|FG001|Overall Study|Protocol Violation|1
7884875|NCT01792518|12385067|FG000|Overall Study|Lost to Follow-up|3
7884876|NCT01792518|12385068|FG001|Overall Study|Lost to Follow-up|1
7884877|NCT01792518|12385067|FG000|Overall Study|Withdrawal by Subject|2
7884878|NCT01792518|12385068|FG001|Overall Study|Withdrawal by Subject|0
7884879|NCT01792518|12385067|FG000|Overall Study|Other Reason|0
7884880|NCT01792518|12385068|FG001|Overall Study|Other Reason|1
7884881|NCT01792635|12385077|FG000|Part B|Adverse Event|0
7884882|NCT01792635|12385078|FG001|Part B|Adverse Event|0
7884883|NCT01792635|12385079|FG002|Part B|Adverse Event|1
7884884|NCT01792635|12385077|FG000|Part B|Study terminated|0
7884885|NCT01792635|12385078|FG001|Part B|Study terminated|4
7884886|NCT01792635|12385079|FG002|Part B|Study terminated|3
7884887|NCT01792830|12385110|FG000|Overall Study|Withdrawal by Subject|22
7884888|NCT01792830|12385111|FG001|Overall Study|Withdrawal by Subject|0
7884889|NCT01792830|12385112|FG002|Overall Study|Withdrawal by Subject|0
7802706|NCT01111539|12261176|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7802707|NCT01111539|12261177|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1
7884890|NCT01792830|12385113|FG003|Overall Study|Withdrawal by Subject|2
7884891|NCT01792830|12385114|FG004|Overall Study|Withdrawal by Subject|1
7802708|NCT01111552|12261187|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9
7802709|NCT01111552|12261188|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7802710|NCT01111552|12261189|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7802711|NCT01111552|12261190|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7802712|NCT01111552|12261191|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7802713|NCT01111552|12261187|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4
7802714|NCT01111552|12261188|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0
7802715|NCT01111552|12261189|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0
7802716|NCT01111552|12261190|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0
7802717|NCT01111552|12261191|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0
7802718|NCT01111552|12261187|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89
7802719|NCT01111552|12261188|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7802720|NCT01111552|12261189|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7802721|NCT01111552|12261190|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7802722|NCT01111552|12261191|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7802723|NCT01111552|12261187|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3
7802724|NCT01111552|12261188|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
7802725|NCT01111552|12261189|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
7802726|NCT01111552|12261190|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
7802727|NCT01111552|12261191|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
7802728|NCT01111552|12261187|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3
7802729|NCT01111552|12261188|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
7802730|NCT01111552|12261189|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
7802731|NCT01111552|12261190|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
7802732|NCT01111552|12261191|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
7802733|NCT01111552|12261187|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7
7802734|NCT01111552|12261188|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
7802735|NCT01111552|12261189|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
7802736|NCT01111552|12261190|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
7802737|NCT01111552|12261191|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
7802738|NCT01111552|12261187|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1
7802739|NCT01111552|12261188|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7802740|NCT01111552|12261189|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7802741|NCT01111552|12261190|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7802742|NCT01111552|12261191|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7802743|NCT01111552|12261187|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1
7802744|NCT01111552|12261188|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
7802745|NCT01111552|12261189|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
7802746|NCT01111552|12261190|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
7802747|NCT01111552|12261191|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
7802748|NCT01111552|12261187|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7802749|NCT01111552|12261188|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7802750|NCT01111552|12261189|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7802751|NCT01111552|12261190|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1
7802752|NCT01111552|12261191|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7802753|NCT01111552|12261187|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
7802754|NCT01111552|12261188|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
7802755|NCT01111552|12261189|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4
7802756|NCT01111552|12261190|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
7802757|NCT01111552|12261191|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
7884892|NCT01792830|12385115|FG005|Overall Study|Withdrawal by Subject|1
7884893|NCT01792830|12385116|FG006|Overall Study|Withdrawal by Subject|1
7884894|NCT01792830|12385117|FG007|Overall Study|Withdrawal by Subject|1
7884895|NCT01792830|12385118|FG008|Overall Study|Withdrawal by Subject|7
7884896|NCT01792830|12385119|FG009|Overall Study|Withdrawal by Subject|0
7884897|NCT01792830|12385120|FG010|Overall Study|Withdrawal by Subject|2
7884898|NCT01792830|12385110|FG000|Overall Study|Death|3
7884899|NCT01792830|12385111|FG001|Overall Study|Death|0
7884900|NCT01792830|12385112|FG002|Overall Study|Death|0
7802758|NCT01111552|12261187|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
7802759|NCT01111552|12261188|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2
7802760|NCT01111552|12261189|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
7802761|NCT01111552|12261190|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
7802762|NCT01111552|12261191|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
7802763|NCT01111552|12261187|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
7802764|NCT01111552|12261188|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1
7802765|NCT01111552|12261189|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
7802766|NCT01111552|12261190|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
7802767|NCT01111552|12261191|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
7802768|NCT01111552|12261187|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
7802769|NCT01111552|12261188|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1
7802770|NCT01111552|12261189|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
7802771|NCT01111552|12261190|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
7802772|NCT01111552|12261191|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
7802773|NCT01111552|12261187|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7802774|NCT01111552|12261188|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7802775|NCT01111552|12261189|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1
7802776|NCT01111552|12261190|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7802777|NCT01111552|12261191|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7861377|NCT01591863|12350375|FG000|Overall Study|Adverse Event|3
7861378|NCT01591863|12350375|FG000|Overall Study|Withdrawal by Subject|1
7861379|NCT01591863|12350375|FG000|Overall Study|recurrence|9
7861380|NCT01591863|12350375|FG000|Overall Study|Lack of Efficacy|1
7861381|NCT01592045|12350385|FG000|Overall Study|Disease Progression|1
7861382|NCT01592045|12350386|FG001|Overall Study|Disease Progression|1
7861383|NCT01592045|12350385|FG000|Overall Study|Adverse Event|1
7861384|NCT01592045|12350386|FG001|Overall Study|Adverse Event|1
7861385|NCT01592045|12350385|FG000|Overall Study|Withdrawal by Subject|1
7861386|NCT01592045|12350386|FG001|Overall Study|Withdrawal by Subject|0
7861387|NCT01592045|12350385|FG000|Overall Study|Moved out of country|2
7861388|NCT01592045|12350386|FG001|Overall Study|Moved out of country|0
7861389|NCT01592240|12350403|FG000|Overall Study|Adverse Event|1
7861390|NCT01592240|12350404|FG001|Overall Study|Adverse Event|0
7861391|NCT01592240|12350405|FG002|Overall Study|Adverse Event|0
7861392|NCT01592240|12350406|FG003|Overall Study|Adverse Event|1
7861393|NCT01592240|12350407|FG004|Overall Study|Adverse Event|1
7861394|NCT01592240|12350408|FG005|Overall Study|Adverse Event|0
7861395|NCT01592240|12350409|FG006|Overall Study|Adverse Event|0
7861396|NCT01592240|12350403|FG000|Overall Study|Death|0
7802778|NCT01111604|12261204|FG000|Overall Study|Lost to Follow-up|0
7802779|NCT01111604|12261205|FG001|Overall Study|Lost to Follow-up|0
7802780|NCT01111604|12261206|FG002|Overall Study|Lost to Follow-up|1
7802781|NCT01111604|12261204|FG000|Overall Study|Withdrew Consent|3
7802782|NCT01111604|12261205|FG001|Overall Study|Withdrew Consent|0
7802783|NCT01111604|12261206|FG002|Overall Study|Withdrew Consent|2
7802784|NCT01111604|12261204|FG000|Overall Study|Withdrawal by Subject|2
7802785|NCT01111604|12261205|FG001|Overall Study|Withdrawal by Subject|0
7802786|NCT01111604|12261206|FG002|Overall Study|Withdrawal by Subject|0
7802787|NCT01111604|12261204|FG000|Overall Study|Death|1
7802788|NCT01111604|12261205|FG001|Overall Study|Death|0
7802789|NCT01111604|12261206|FG002|Overall Study|Death|0
7802790|NCT01111604|12261204|FG000|Overall Study|Met Exclusion Criteria|2
7802791|NCT01111604|12261205|FG001|Overall Study|Met Exclusion Criteria|0
7802792|NCT01111604|12261206|FG002|Overall Study|Met Exclusion Criteria|0
7802793|NCT01111825|12261236|FG000|Overall Study|Withdrawal by Subject|0
7802794|NCT01111825|12261237|FG001|Overall Study|Withdrawal by Subject|0
7802795|NCT01111825|12261238|FG002|Overall Study|Withdrawal by Subject|1
7802796|NCT01111825|12261239|FG003|Overall Study|Withdrawal by Subject|0
7802797|NCT01111825|12261236|FG000|Overall Study|Lost to Follow-up|0
7802798|NCT01111825|12261237|FG001|Overall Study|Lost to Follow-up|0
7802799|NCT01111825|12261238|FG002|Overall Study|Lost to Follow-up|3
7802800|NCT01111825|12261239|FG003|Overall Study|Lost to Follow-up|1
7802801|NCT01111825|12261236|FG000|Overall Study|Adverse Event|2
7802802|NCT01111825|12261237|FG001|Overall Study|Adverse Event|1
7802803|NCT01111825|12261238|FG002|Overall Study|Adverse Event|4
7802804|NCT01111825|12261239|FG003|Overall Study|Adverse Event|0
7802805|NCT01111825|12261236|FG000|Overall Study|Disease Progression|1
7802806|NCT01111825|12261237|FG001|Overall Study|Disease Progression|0
7802807|NCT01111825|12261238|FG002|Overall Study|Disease Progression|0
7802808|NCT01111825|12261239|FG003|Overall Study|Disease Progression|0
7802809|NCT01111825|12261236|FG000|Overall Study|Discontinuation by Sponsor|0
7802810|NCT01111825|12261237|FG001|Overall Study|Discontinuation by Sponsor|0
7802811|NCT01111825|12261238|FG002|Overall Study|Discontinuation by Sponsor|0
7802812|NCT01111825|12261239|FG003|Overall Study|Discontinuation by Sponsor|20
7802813|NCT01111838|12261249|FG000|Overall Study|Patient Ineligible|2
7802814|NCT01111838|12261249|FG000|Overall Study|Not Treated|3
7802815|NCT01111838|12261249|FG000|Overall Study|Clinical deterioration|1
7802816|NCT01111838|12261249|FG000|Overall Study|Other Complicating Disease|1
7802817|NCT01111851|12261255|FG000|Overall Study|All planned PET scans were not obtained.|2
7802818|NCT01111851|12261256|FG001|Overall Study|All planned PET scans were not obtained.|0
7802819|NCT01112059|12261264|FG000|Overall Study|Withdrawal by Subject|1
7802820|NCT01112059|12261265|FG001|Overall Study|Withdrawal by Subject|0
7802821|NCT01112267|12261286|FG000|Overall Study|Adverse Event|24
7802822|NCT01112267|12261287|FG001|Overall Study|Adverse Event|6
7802823|NCT01112267|12261286|FG000|Overall Study|Withdrawal by Subject|3
7802824|NCT01112267|12261287|FG001|Overall Study|Withdrawal by Subject|5
7802825|NCT01112267|12261286|FG000|Overall Study|Protocol Violation|5
7802826|NCT01112267|12261287|FG001|Overall Study|Protocol Violation|3
7802827|NCT01112267|12261286|FG000|Overall Study|Participants not compliant|1
7802828|NCT01112267|12261287|FG001|Overall Study|Participants not compliant|2
7802829|NCT01112267|12261286|FG000|Overall Study|Participants not receive any study drug|1
7802830|NCT01112267|12261287|FG001|Overall Study|Participants not receive any study drug|2
7802831|NCT01112514|12261306|FG000|Overall Study|Lost to Follow-up|1
7802832|NCT01112579|12261312|FG000|Overall Study|Missed Visit|1
7802833|NCT01112579|12261313|FG001|Overall Study|Missed Visit|1
7802834|NCT01112579|12261312|FG000|Overall Study|Death|0
7802835|NCT01112579|12261313|FG001|Overall Study|Death|2
7802836|NCT01112917|12261361|FG000|Overall Study|Death|2
7802837|NCT01112917|12261362|FG001|Overall Study|Death|11
7802838|NCT01112917|12261361|FG000|Overall Study|Lost to Follow-up|1
7802839|NCT01112917|12261362|FG001|Overall Study|Lost to Follow-up|1
7802840|NCT01112917|12261361|FG000|Overall Study|Withdrawal by Subject|1
7802841|NCT01112917|12261362|FG001|Overall Study|Withdrawal by Subject|3
7802842|NCT01112917|12261361|FG000|Overall Study|Unable to Convert Filter|3
7802843|NCT01112917|12261362|FG001|Overall Study|Unable to Convert Filter|0
7802844|NCT01112982|12261366|FG000|Overall Study|Withdrawal by Subject|1
7802845|NCT01112982|12261366|FG000|Overall Study|exceeded weight limit to complete MRI|1
7802846|NCT01113463|12261390|FG000|Overall Study|Physician Decision|5
7802847|NCT01113502|12261399|FG000|Overall Study|Withdrawal by Subject|1
7802848|NCT01113502|12261400|FG001|Overall Study|Withdrawal by Subject|0
7802849|NCT01113502|12261401|FG002|Overall Study|Withdrawal by Subject|1
7802850|NCT01113502|12261402|FG003|Overall Study|Withdrawal by Subject|1
7802851|NCT01113502|12261403|FG004|Overall Study|Withdrawal by Subject|0
7802852|NCT01113502|12261399|FG000|Overall Study|Adverse Event|0
7802853|NCT01113502|12261400|FG001|Overall Study|Adverse Event|0
7802854|NCT01113502|12261401|FG002|Overall Study|Adverse Event|3
7802855|NCT01113502|12261402|FG003|Overall Study|Adverse Event|2
7802856|NCT01113502|12261403|FG004|Overall Study|Adverse Event|0
7802857|NCT01113541|12261416|FG000|Overall Study|Withdrawal by Subject|1
7802858|NCT01113541|12261416|FG000|Overall Study|Protocol Violation|1
7802859|NCT01113541|12261416|FG000|Overall Study|Study Terminated by Sponsor|7
7802860|NCT01113541|12261416|FG000|Overall Study|Adverse Event|4
7802861|NCT01113580|12261422|FG000|Overall Study|Protocol Violation|1
7802862|NCT01113580|12261423|FG001|Overall Study|Protocol Violation|0
7802863|NCT01113710|12261438|FG000|Overall Study|Adverse Event|64
7802864|NCT01113710|12261438|FG000|Overall Study|Lack of Efficacy|41
7802865|NCT01113710|12261438|FG000|Overall Study|No Information Available|40
7802866|NCT01113710|12261438|FG000|Overall Study|Withdrawal by Subject|28
7802867|NCT01113710|12261438|FG000|Overall Study|Lost to Follow-up|20
7802868|NCT01113710|12261438|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
7802869|NCT01113710|12261438|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11
7802870|NCT01113710|12261438|FG000|Overall Study|Lack of Patient's Compliance|8
7802871|NCT01113710|12261438|FG000|Overall Study|Other|7
7802872|NCT01113710|12261438|FG000|Overall Study|Adverse Event/Other|5
7802873|NCT01113710|12261438|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5
7802874|NCT01113710|12261438|FG000|Overall Study|Lack of Efficacy/Other|4
7802875|NCT01113710|12261438|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4
7802876|NCT01113710|12261438|FG000|Overall Study|Lack of Efficacy/Adverse Event|3
7802877|NCT01113710|12261438|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2
7802878|NCT01113710|12261438|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
7802879|NCT01113710|12261438|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2
7802880|NCT01113710|12261438|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1
7802881|NCT01113710|12261438|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1
7802882|NCT01113710|12261438|FG000|Overall Study|Compliance/Efficacy/AE/Other|1
7802883|NCT01113710|12261438|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
7802884|NCT01113710|12261438|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
7802885|NCT01113710|12261438|FG000|Overall Study|Lack of Patient's Compliance/Other|1
7802886|NCT01113710|12261438|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1
7802887|NCT01113710|12261438|FG000|Overall Study|Subject Did Not Receive Neupro|3
7802888|NCT01113749|12261455|FG000|Overall Study|Lost to Follow-up|1
7802889|NCT01113749|12261456|FG001|Overall Study|Lost to Follow-up|2
7802890|NCT01113801|12261466|FG000|Overall Study|Adverse Event|4
7802891|NCT01113801|12261467|FG001|Overall Study|Adverse Event|0
7802892|NCT01113801|12261468|FG002|Overall Study|Adverse Event|2
7802893|NCT01113801|12261469|FG003|Overall Study|Adverse Event|6
7802894|NCT01113801|12261466|FG000|Overall Study|Death|4
7802895|NCT01113801|12261467|FG001|Overall Study|Death|5
7802896|NCT01113801|12261468|FG002|Overall Study|Death|3
7802897|NCT01113801|12261469|FG003|Overall Study|Death|4
7802898|NCT01113801|12261466|FG000|Overall Study|Protocol Violation|0
7884901|NCT01792830|12385113|FG003|Overall Study|Death|1
7884902|NCT01792830|12385114|FG004|Overall Study|Death|0
7884903|NCT01792830|12385115|FG005|Overall Study|Death|0
7884904|NCT01792830|12385116|FG006|Overall Study|Death|1
7884905|NCT01792830|12385117|FG007|Overall Study|Death|0
7884906|NCT01792830|12385118|FG008|Overall Study|Death|1
7884907|NCT01792830|12385119|FG009|Overall Study|Death|0
7884908|NCT01792830|12385120|FG010|Overall Study|Death|1
7884909|NCT01792830|12385110|FG000|Overall Study|Adverse Event|0
7884910|NCT01792830|12385111|FG001|Overall Study|Adverse Event|0
7884911|NCT01792830|12385112|FG002|Overall Study|Adverse Event|0
7884912|NCT01792830|12385113|FG003|Overall Study|Adverse Event|0
7884913|NCT01792830|12385114|FG004|Overall Study|Adverse Event|0
7884914|NCT01792830|12385115|FG005|Overall Study|Adverse Event|0
7884915|NCT01792830|12385116|FG006|Overall Study|Adverse Event|0
7884916|NCT01792830|12385117|FG007|Overall Study|Adverse Event|0
7802899|NCT01113801|12261467|FG001|Overall Study|Protocol Violation|1
7802900|NCT01113801|12261468|FG002|Overall Study|Protocol Violation|0
7802901|NCT01113801|12261469|FG003|Overall Study|Protocol Violation|0
7802902|NCT01113801|12261466|FG000|Overall Study|Withdrawal by Subject|9
7802903|NCT01113801|12261467|FG001|Overall Study|Withdrawal by Subject|7
7802904|NCT01113801|12261468|FG002|Overall Study|Withdrawal by Subject|7
7802905|NCT01113801|12261469|FG003|Overall Study|Withdrawal by Subject|8
7802906|NCT01113801|12261466|FG000|Overall Study|Physician Decision|2
7802907|NCT01113801|12261467|FG001|Overall Study|Physician Decision|2
7802908|NCT01113801|12261468|FG002|Overall Study|Physician Decision|3
7802909|NCT01113801|12261469|FG003|Overall Study|Physician Decision|3
7802910|NCT01113801|12261466|FG000|Overall Study|Sponsor Decision|15
7802911|NCT01113801|12261467|FG001|Overall Study|Sponsor Decision|21
7802912|NCT01113801|12261468|FG002|Overall Study|Sponsor Decision|20
7802913|NCT01113801|12261469|FG003|Overall Study|Sponsor Decision|15
7802914|NCT01113801|12261466|FG000|Overall Study|Clinical Endpoint (ESRD)|7
7802915|NCT01113801|12261467|FG001|Overall Study|Clinical Endpoint (ESRD)|4
7802916|NCT01113801|12261468|FG002|Overall Study|Clinical Endpoint (ESRD)|2
7802917|NCT01113801|12261469|FG003|Overall Study|Clinical Endpoint (ESRD)|5
7802918|NCT01113879|12261481|FG000|Period 1: Block 1|Withdrawal by Subject|2
7802919|NCT01113879|12261482|FG001|Period 1: Block 1|Withdrawal by Subject|0
7802920|NCT01113892|12261492|FG000|Overall Study|Lost to Follow-up|2
7802921|NCT01113892|12261493|FG001|Overall Study|Lost to Follow-up|2
7802922|NCT01113892|12261492|FG000|Overall Study|Withdrawal by Subject|1
7802923|NCT01113892|12261493|FG001|Overall Study|Withdrawal by Subject|1
7802924|NCT01113892|12261492|FG000|Overall Study|Death|2
7802925|NCT01113892|12261493|FG001|Overall Study|Death|4
7802926|NCT01113892|12261492|FG000|Overall Study|Graft no longer evaluable|9
7802927|NCT01113892|12261493|FG001|Overall Study|Graft no longer evaluable|9
7802928|NCT01113931|12261501|FG000|Overall Study|Adverse Event|2
7884917|NCT01792830|12385118|FG008|Overall Study|Adverse Event|1
7884918|NCT01792830|12385119|FG009|Overall Study|Adverse Event|0
7802929|NCT01113931|12261502|FG001|Overall Study|Adverse Event|2
7802930|NCT01113931|12261501|FG000|Overall Study|Physician Decision|0
7802931|NCT01113931|12261502|FG001|Overall Study|Physician Decision|2
7802932|NCT01113931|12261501|FG000|Overall Study|Lost to Follow-up|12
7802933|NCT01113931|12261502|FG001|Overall Study|Lost to Follow-up|9
7802934|NCT01113931|12261501|FG000|Overall Study|Various|2
7802935|NCT01113931|12261502|FG001|Overall Study|Various|4
7802936|NCT01113931|12261501|FG000|Overall Study|Withdrawal by Subject|3
7802937|NCT01113931|12261502|FG001|Overall Study|Withdrawal by Subject|0
7802938|NCT01114360|12261527|FG000|Intervention 1 (4 Weeks)|Physician Decision|0
7802939|NCT01114360|12261528|FG001|Intervention 1 (4 Weeks)|Physician Decision|1
7802940|NCT01114373|12261548|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1
7802941|NCT01114373|12261549|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0
7802942|NCT01114373|12261548|FG000|Intervention 1 (4 Weeks)|Incarceration|1
7802943|NCT01114373|12261549|FG001|Intervention 1 (4 Weeks)|Incarceration|0
7802944|NCT01114373|12261548|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
7802945|NCT01114373|12261549|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
7802946|NCT01114373|12261548|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0
7802947|NCT01114373|12261549|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1
7802948|NCT01114438|12261559|FG000|Overall Study|Adverse Event|10
7802949|NCT01114438|12261559|FG000|Overall Study|concomitant medication|1
7802950|NCT01114438|12261559|FG000|Overall Study|Physician Decision|1
7802951|NCT01114438|12261559|FG000|Overall Study|Withdrawal by Subject|2
7802952|NCT01114516|12261574|FG000|Overall Study|Lost to Follow-up|2
7802953|NCT01114516|12261575|FG001|Overall Study|Lost to Follow-up|1
7802954|NCT01114529|12261584|FG000|Completed Study Medication at Month 24|Adverse Event|87
7802955|NCT01114529|12261585|FG001|Completed Study Medication at Month 24|Adverse Event|18
7802956|NCT01114529|12261586|FG002|Completed Study Medication at Month 24|Adverse Event|17
7802957|NCT01114529|12261584|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
7802958|NCT01114529|12261585|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
7802959|NCT01114529|12261586|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
7802960|NCT01114529|12261584|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
7802961|NCT01114529|12261585|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
7802962|NCT01114529|12261586|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
7802963|NCT01114529|12261584|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2
7802964|NCT01114529|12261585|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1
7802965|NCT01114529|12261586|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2
7802966|NCT01114529|12261584|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1
7802967|NCT01114529|12261585|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1
7802968|NCT01114529|12261586|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1
7802969|NCT01114529|12261584|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18
7802970|NCT01114529|12261585|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8
7802971|NCT01114529|12261586|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2
7802972|NCT01114529|12261584|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1
7802973|NCT01114529|12261585|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4
7802974|NCT01114529|12261586|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2
7802975|NCT01114529|12261584|FG000|Completed Study Medication at Month 24|Administrative problems|2
7802976|NCT01114529|12261585|FG001|Completed Study Medication at Month 24|Administrative problems|1
7802977|NCT01114529|12261586|FG002|Completed Study Medication at Month 24|Administrative problems|2
7802978|NCT01114529|12261584|FG000|Completed Study Medication at Month 24|Death|2
7802979|NCT01114529|12261585|FG001|Completed Study Medication at Month 24|Death|1
7802980|NCT01114529|12261586|FG002|Completed Study Medication at Month 24|Death|2
7802981|NCT01114529|12261584|FG000|Completed Study Medication at Month 24|Graft loss|0
7802982|NCT01114529|12261585|FG001|Completed Study Medication at Month 24|Graft loss|2
7802983|NCT01114529|12261586|FG002|Completed Study Medication at Month 24|Graft loss|0
7802984|NCT01114529|12261584|FG000|Completed Study Medication at Month 24|Protocol Violation|0
7802985|NCT01114529|12261585|FG001|Completed Study Medication at Month 24|Protocol Violation|5
7802986|NCT01114529|12261586|FG002|Completed Study Medication at Month 24|Protocol Violation|2
7802987|NCT01114529|12261584|FG000|Completed Study Medication at Month 24|Missing|2
7802988|NCT01114529|12261585|FG001|Completed Study Medication at Month 24|Missing|0
7802989|NCT01114529|12261586|FG002|Completed Study Medication at Month 24|Missing|0
7802990|NCT01114529|12261584|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18
7802991|NCT01114529|12261585|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6
7802992|NCT01114529|12261586|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3
7802993|NCT01114529|12261584|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10
7802994|NCT01114529|12261585|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5
7802995|NCT01114529|12261586|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7
7802996|NCT01114529|12261584|FG000|Completed Study Phase at Month 24|Death|8
7802997|NCT01114529|12261585|FG001|Completed Study Phase at Month 24|Death|5
7802998|NCT01114529|12261586|FG002|Completed Study Phase at Month 24|Death|4
7802999|NCT01114529|12261584|FG000|Completed Study Phase at Month 24|Other|2
7803000|NCT01114529|12261585|FG001|Completed Study Phase at Month 24|Other|0
7803001|NCT01114529|12261586|FG002|Completed Study Phase at Month 24|Other|0
7803002|NCT01114529|12261584|FG000|Completed Study Phase at Month 24|Missing|2
7803003|NCT01114529|12261585|FG001|Completed Study Phase at Month 24|Missing|0
7803004|NCT01114529|12261586|FG002|Completed Study Phase at Month 24|Missing|0
7803005|NCT01114646|12261615|FG000|Overall Study|Withdrawal by Subject|3
7803006|NCT01114646|12261616|FG001|Overall Study|Withdrawal by Subject|2
7803007|NCT01114672|12261624|FG000|Overall Study|Death|0
7803008|NCT01114672|12261625|FG001|Overall Study|Death|1
7803009|NCT01114672|12261624|FG000|Overall Study|Withdrawal by Subject|2
7803010|NCT01114672|12261625|FG001|Overall Study|Withdrawal by Subject|1
7803011|NCT01114672|12261624|FG000|Overall Study|Lost to Follow-up|1
7803012|NCT01114672|12261625|FG001|Overall Study|Lost to Follow-up|0
7803013|NCT01114672|12261624|FG000|Overall Study|transplanted|1
7803014|NCT01114672|12261625|FG001|Overall Study|transplanted|0
7803015|NCT01114724|12261631|FG000|Overall Study|Death|8
7803016|NCT01114724|12261631|FG000|Overall Study|Lost to Follow-up|1
7803017|NCT01114724|12261631|FG000|Overall Study|Withdrawal by Subject|1
7803018|NCT01114737|12261638|FG000|Randomized Treatment Period|Withdrawal by Subject|1
7803019|NCT01114737|12261639|FG001|Randomized Treatment Period|Withdrawal by Subject|0
7803020|NCT01114737|12261638|FG000|Randomized Treatment Period|Lost to Follow-up|1
7803021|NCT01114737|12261639|FG001|Randomized Treatment Period|Lost to Follow-up|1
7803022|NCT01114737|12261638|FG000|Randomized Treatment Period|Pregnancy|1
7803023|NCT01114737|12261639|FG001|Randomized Treatment Period|Pregnancy|0
7803024|NCT01114737|12261638|FG000|Open-Label Treatment Period|Withdrawal by Subject|1
7803025|NCT01114737|12261639|FG001|Open-Label Treatment Period|Withdrawal by Subject|1
7803026|NCT01114737|12261638|FG000|Open-Label Treatment Period|Lost to Follow-up|3
7803027|NCT01114737|12261639|FG001|Open-Label Treatment Period|Lost to Follow-up|1
7803028|NCT01114737|12261638|FG000|Open-Label Treatment Period|Difficult Personal Events|1
7803029|NCT01114737|12261639|FG001|Open-Label Treatment Period|Difficult Personal Events|0
7803030|NCT01114828|12261658|FG000|Overall Study|Adverse Event|1
7803031|NCT01114828|12261659|FG001|Overall Study|Adverse Event|1
7803032|NCT01114828|12261658|FG000|Overall Study|Lack of Efficacy|0
7803033|NCT01114828|12261659|FG001|Overall Study|Lack of Efficacy|2
7803034|NCT01114828|12261658|FG000|Overall Study|Protocol Violation|2
7803035|NCT01114828|12261659|FG001|Overall Study|Protocol Violation|0
7803036|NCT01114828|12261658|FG000|Overall Study|Withdrawal by Subject|0
7803037|NCT01114828|12261659|FG001|Overall Study|Withdrawal by Subject|1
7803038|NCT01114880|12261667|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4
7803039|NCT01114880|12261668|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0
7803040|NCT01114880|12261667|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
7803041|NCT01114880|12261668|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
7803042|NCT01114880|12261667|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
7803043|NCT01114880|12261668|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
7803044|NCT01114880|12261667|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
7803045|NCT01114880|12261668|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
7803046|NCT01114880|12261667|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3
7803047|NCT01114880|12261668|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0
7803048|NCT01114880|12261667|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
7803049|NCT01114880|12261668|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
7803050|NCT01115309|12261765|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2
7803051|NCT01115309|12261765|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1
7803052|NCT01115309|12261765|FG000|Long-term Follow-up|Lost to Follow-up|6
7803053|NCT01115491|12261778|FG000|Overall Study|Death|22
7803054|NCT01115491|12261778|FG000|Overall Study|Adverse Event|3
7803055|NCT01115491|12261778|FG000|Overall Study|Lost to Follow-up|3
7803056|NCT01115491|12261778|FG000|Overall Study|Withdrawal by Subject|1
7803057|NCT01115491|12261778|FG000|Overall Study|Physician Decision|1
7803058|NCT01115569|12261802|FG000|Conversion/Titration Phase|Adverse Event|59
7803059|NCT01115569|12261803|FG001|Conversion/Titration Phase|Adverse Event|0
7803060|NCT01115569|12261802|FG000|Conversion/Titration Phase|Lost to Follow-up|3
7803061|NCT01115569|12261803|FG001|Conversion/Titration Phase|Lost to Follow-up|0
7803062|NCT01115569|12261802|FG000|Conversion/Titration Phase|Physician Decision|5
7803063|NCT01115569|12261803|FG001|Conversion/Titration Phase|Physician Decision|0
7803064|NCT01115569|12261802|FG000|Conversion/Titration Phase|Protocol Violation|68
7803065|NCT01115569|12261803|FG001|Conversion/Titration Phase|Protocol Violation|0
7803066|NCT01115569|12261802|FG000|Conversion/Titration Phase|Withdrawal by Subject|26
7803067|NCT01115569|12261803|FG001|Conversion/Titration Phase|Withdrawal by Subject|0
7803068|NCT01115569|12261802|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53
7861397|NCT01592240|12350404|FG001|Overall Study|Death|1
7884919|NCT01792830|12385120|FG010|Overall Study|Adverse Event|0
7884920|NCT01793051|12385156|FG000|Overall Study|Withdrawal by Subject|6
7884921|NCT01793051|12385157|FG001|Overall Study|Withdrawal by Subject|4
7861398|NCT01592240|12350405|FG002|Overall Study|Death|0
7861399|NCT01592240|12350406|FG003|Overall Study|Death|0
7861400|NCT01592240|12350407|FG004|Overall Study|Death|0
7861401|NCT01592240|12350408|FG005|Overall Study|Death|0
7861402|NCT01592240|12350409|FG006|Overall Study|Death|0
7861403|NCT01592240|12350403|FG000|Overall Study|Lost to Follow-up|1
7861404|NCT01592240|12350404|FG001|Overall Study|Lost to Follow-up|3
7861405|NCT01592240|12350405|FG002|Overall Study|Lost to Follow-up|1
7861406|NCT01592240|12350406|FG003|Overall Study|Lost to Follow-up|0
7861407|NCT01592240|12350407|FG004|Overall Study|Lost to Follow-up|3
7884922|NCT01793051|12385156|FG000|Overall Study|Adverse Event|0
7884923|NCT01793051|12385157|FG001|Overall Study|Adverse Event|2
7884924|NCT01793051|12385156|FG000|Overall Study|Too ill to continue|1
7884925|NCT01793051|12385157|FG001|Overall Study|Too ill to continue|0
7884926|NCT01793051|12385156|FG000|Overall Study|Switched chemo|1
7884927|NCT01793051|12385157|FG001|Overall Study|Switched chemo|1
7884928|NCT01793051|12385156|FG000|Overall Study|Lack of compliance|1
7884929|NCT01793051|12385157|FG001|Overall Study|Lack of compliance|0
7884930|NCT01793051|12385156|FG000|Overall Study|Requested to be removed from the study|1
7884931|NCT01793051|12385157|FG001|Overall Study|Requested to be removed from the study|1
7884932|NCT01793142|12385163|FG000|Overall Study|Randomized not treated|7
7884933|NCT01793688|12385171|FG000|Overall Study|Protocol Violation|2
7884934|NCT01793792|12385175|FG000|Overall Study|Death|5
7884935|NCT01793792|12385175|FG000|Overall Study|Lost to Follow-up|5
7884936|NCT01793792|12385175|FG000|Overall Study|Withdrawal by Subject|1
7884937|NCT01793792|12385175|FG000|Overall Study|Device Not Implanted|1
7884938|NCT01793883|12385182|FG000|Overall Study|Withdrawal by Subject|3
7884939|NCT01793883|12385183|FG001|Overall Study|Withdrawal by Subject|7
7884940|NCT01793883|12385184|FG002|Overall Study|Withdrawal by Subject|3
7884941|NCT01793883|12385182|FG000|Overall Study|Subject noncompliance|0
7884942|NCT01793883|12385183|FG001|Overall Study|Subject noncompliance|1
7884943|NCT01793883|12385184|FG002|Overall Study|Subject noncompliance|1
7884944|NCT01793883|12385182|FG000|Overall Study|Lost to Follow-up|5
7884945|NCT01793883|12385183|FG001|Overall Study|Lost to Follow-up|1
7884946|NCT01793883|12385184|FG002|Overall Study|Lost to Follow-up|3
7884947|NCT01793883|12385182|FG000|Overall Study|Randomized in error|1
7884948|NCT01793883|12385183|FG001|Overall Study|Randomized in error|0
7884949|NCT01793883|12385184|FG002|Overall Study|Randomized in error|0
7884950|NCT01793883|12385182|FG000|Overall Study|Unable to complete spriometry|1
7884951|NCT01793883|12385183|FG001|Overall Study|Unable to complete spriometry|0
7884952|NCT01793883|12385184|FG002|Overall Study|Unable to complete spriometry|0
7884953|NCT01793883|12385182|FG000|Overall Study|Unable to complete measurements|1
7884954|NCT01793883|12385183|FG001|Overall Study|Unable to complete measurements|0
7884955|NCT01793883|12385184|FG002|Overall Study|Unable to complete measurements|0
7884956|NCT01793883|12385182|FG000|Overall Study|Met exclusion criteria|1
7884957|NCT01793883|12385183|FG001|Overall Study|Met exclusion criteria|0
7884958|NCT01793883|12385184|FG002|Overall Study|Met exclusion criteria|0
7884959|NCT01793883|12385182|FG000|Overall Study|Dosing error|0
7884960|NCT01793883|12385183|FG001|Overall Study|Dosing error|1
7884961|NCT01793883|12385184|FG002|Overall Study|Dosing error|0
7884962|NCT01793883|12385182|FG000|Overall Study|Respiratory distress during spirometry|0
7884963|NCT01793883|12385183|FG001|Overall Study|Respiratory distress during spirometry|0
7884964|NCT01793883|12385184|FG002|Overall Study|Respiratory distress during spirometry|1
7884965|NCT01793935|12385203|FG000|Overall Study|Pregnancy|1
7803069|NCT01115569|12261803|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0
7803070|NCT01115569|12261802|FG000|Maintenance Phase|Adverse Event|0
7803071|NCT01115569|12261803|FG001|Maintenance Phase|Adverse Event|43
7803072|NCT01115569|12261802|FG000|Maintenance Phase|Lost to Follow-up|0
7803073|NCT01115569|12261803|FG001|Maintenance Phase|Lost to Follow-up|8
7803074|NCT01115569|12261802|FG000|Maintenance Phase|Physician Decision|0
7803075|NCT01115569|12261803|FG001|Maintenance Phase|Physician Decision|3
7803076|NCT01115569|12261802|FG000|Maintenance Phase|Protocol Violation|0
7803077|NCT01115569|12261803|FG001|Maintenance Phase|Protocol Violation|9
7803078|NCT01115569|12261802|FG000|Maintenance Phase|Withdrawal by Subject|0
7803079|NCT01115569|12261803|FG001|Maintenance Phase|Withdrawal by Subject|27
7803080|NCT01115569|12261802|FG000|Maintenance Phase|Non-Compliance with Study Drug|0
7803081|NCT01115569|12261803|FG001|Maintenance Phase|Non-Compliance with Study Drug|48
7803082|NCT01115569|12261802|FG000|Maintenance Phase|Administrative|0
7803083|NCT01115569|12261803|FG001|Maintenance Phase|Administrative|1
7803084|NCT01115738|12261837|FG000|Overall Study|Death|1
7803085|NCT01115738|12261838|FG001|Overall Study|Death|0
7803086|NCT01115738|12261839|FG002|Overall Study|Death|0
7803087|NCT01115738|12261837|FG000|Overall Study|Lost to Follow-up|0
7803088|NCT01115738|12261838|FG001|Overall Study|Lost to Follow-up|0
7803089|NCT01115738|12261839|FG002|Overall Study|Lost to Follow-up|1
7803090|NCT01115738|12261837|FG000|Overall Study|Physician Decision|18
7803091|NCT01115738|12261838|FG001|Overall Study|Physician Decision|15
7803092|NCT01115738|12261839|FG002|Overall Study|Physician Decision|17
7803093|NCT01115738|12261837|FG000|Overall Study|Withdrawal by Subject|6
7803094|NCT01115738|12261838|FG001|Overall Study|Withdrawal by Subject|6
7803095|NCT01115738|12261839|FG002|Overall Study|Withdrawal by Subject|9
7803096|NCT01115803|12261862|FG000|Overall Study|Withdrawal by Subject|0
7803097|NCT01115803|12261863|FG001|Overall Study|Withdrawal by Subject|0
7803098|NCT01115803|12261864|FG002|Overall Study|Withdrawal by Subject|0
7803099|NCT01115803|12261865|FG003|Overall Study|Withdrawal by Subject|0
7803100|NCT01115803|12261866|FG004|Overall Study|Withdrawal by Subject|0
7803101|NCT01115803|12261867|FG005|Overall Study|Withdrawal by Subject|0
7803102|NCT01115803|12261868|FG006|Overall Study|Withdrawal by Subject|1
7803103|NCT01115803|12261862|FG000|Overall Study|Lost to Follow-up|0
7803104|NCT01115803|12261863|FG001|Overall Study|Lost to Follow-up|0
7884966|NCT01793935|12385204|FG001|Overall Study|Pregnancy|0
7884967|NCT01793935|12385203|FG000|Overall Study|Protocol Violation|2
7884968|NCT01793935|12385204|FG001|Overall Study|Protocol Violation|1
7803105|NCT01115803|12261864|FG002|Overall Study|Lost to Follow-up|1
7803106|NCT01115803|12261865|FG003|Overall Study|Lost to Follow-up|0
7803107|NCT01115803|12261866|FG004|Overall Study|Lost to Follow-up|0
7803108|NCT01115803|12261867|FG005|Overall Study|Lost to Follow-up|0
7803109|NCT01115803|12261868|FG006|Overall Study|Lost to Follow-up|0
7803110|NCT01115803|12261862|FG000|Overall Study|Progressive Disease during Cycle1|0
7803111|NCT01115803|12261863|FG001|Overall Study|Progressive Disease during Cycle1|0
7803112|NCT01115803|12261864|FG002|Overall Study|Progressive Disease during Cycle1|0
7803113|NCT01115803|12261865|FG003|Overall Study|Progressive Disease during Cycle1|0
7803114|NCT01115803|12261866|FG004|Overall Study|Progressive Disease during Cycle1|0
7803115|NCT01115803|12261867|FG005|Overall Study|Progressive Disease during Cycle1|0
7803116|NCT01115803|12261868|FG006|Overall Study|Progressive Disease during Cycle1|1
7803117|NCT01115855|12261891|FG000|Overall Study|Adverse Event|16
7803118|NCT01115855|12261892|FG001|Overall Study|Adverse Event|18
7803119|NCT01115855|12261891|FG000|Overall Study|Death|6
7803120|NCT01115855|12261892|FG001|Overall Study|Death|5
7803121|NCT01115855|12261891|FG000|Overall Study|Lab Abnormality|1
7803122|NCT01115855|12261892|FG001|Overall Study|Lab Abnormality|1
7803123|NCT01115855|12261891|FG000|Overall Study|Protocol Violation|0
7803124|NCT01115855|12261892|FG001|Overall Study|Protocol Violation|1
7803125|NCT01115855|12261891|FG000|Overall Study|Withdrawal by Subject|5
7803126|NCT01115855|12261892|FG001|Overall Study|Withdrawal by Subject|5
7803127|NCT01115855|12261891|FG000|Overall Study|Other|8
7803128|NCT01115855|12261892|FG001|Overall Study|Other|6
7803129|NCT01115933|12261898|FG000|Overall Study|Did not receive XIENCE PRIME SV|1
7803130|NCT01115998|12261957|FG000|Overall Study|Lost to Follow-up|6
7803131|NCT01115998|12261958|FG001|Overall Study|Lost to Follow-up|6
7803132|NCT01116427|12262033|FG000|Core Phase|Adverse Event|0
7803133|NCT01116427|12262034|FG001|Core Phase|Adverse Event|1
7803134|NCT01116427|12262033|FG000|Core Phase|Lost to Follow-up|1
7803135|NCT01116427|12262034|FG001|Core Phase|Lost to Follow-up|0
7803136|NCT01116427|12262033|FG000|Core Phase|Withdrawal by Subject|3
7803137|NCT01116427|12262034|FG001|Core Phase|Withdrawal by Subject|0
7803138|NCT01116427|12262033|FG000|Core Phase|Worsening Multiple Sclerosis|1
7803139|NCT01116427|12262034|FG001|Core Phase|Worsening Multiple Sclerosis|0
7803140|NCT01116427|12262033|FG000|Extension Phase|Adverse Event|1
7803141|NCT01116427|12262034|FG001|Extension Phase|Adverse Event|1
7803142|NCT01116427|12262033|FG000|Extension Phase|Lost to Follow-up|2
7803143|NCT01116427|12262034|FG001|Extension Phase|Lost to Follow-up|0
7803144|NCT01116427|12262033|FG000|Extension Phase|Withdrawal by Subject|5
7803145|NCT01116427|12262034|FG001|Extension Phase|Withdrawal by Subject|1
7803146|NCT01116427|12262033|FG000|Extension Phase|Not using appropriate birth control|1
7803147|NCT01116427|12262034|FG001|Extension Phase|Not using appropriate birth control|0
7803148|NCT01116440|12262046|FG000|Treatment|Withdrawal by Subject|2
7803149|NCT01116440|12262047|FG001|Treatment|Withdrawal by Subject|2
7803150|NCT01116440|12262046|FG000|Treatment|Lost to Follow-up|1
7803151|NCT01116440|12262047|FG001|Treatment|Lost to Follow-up|1
7803152|NCT01116440|12262046|FG000|Treatment|Protocol Violation|0
7803153|NCT01116440|12262047|FG001|Treatment|Protocol Violation|2
7803154|NCT01116440|12262046|FG000|Treatment|Lack of Efficacy|0
7803155|NCT01116440|12262047|FG001|Treatment|Lack of Efficacy|1
7803156|NCT01116440|12262046|FG000|Treatment|Adverse Event|0
7803157|NCT01116440|12262047|FG001|Treatment|Adverse Event|1
7803158|NCT01116440|12262046|FG000|Withdrawal|Withdrawal by Subject|0
7803159|NCT01116440|12262047|FG001|Withdrawal|Withdrawal by Subject|1
7803160|NCT01116440|12262046|FG000|Withdrawal|Lost to Follow-up|0
7803161|NCT01116440|12262047|FG001|Withdrawal|Lost to Follow-up|1
7803162|NCT01116440|12262046|FG000|Follow-up|Lost to Follow-up|0
7803163|NCT01116440|12262047|FG001|Follow-up|Lost to Follow-up|1
7803164|NCT01116440|12262046|FG000|Follow-up|Withdrawal by Subject|0
7803165|NCT01116440|12262047|FG001|Follow-up|Withdrawal by Subject|1
7803166|NCT01116544|12262062|FG000|Overall Study|Protocol Violation|1
7803167|NCT01116544|12262063|FG001|Overall Study|Protocol Violation|0
7803168|NCT01116544|12262062|FG000|Overall Study|Withdrawal by Subject|1
7803169|NCT01116544|12262063|FG001|Overall Study|Withdrawal by Subject|1
7803170|NCT01116687|12262073|FG000|Overall Study|Withdrawal by Subject|4
7803171|NCT01116739|12262079|FG000|Overall Study|Child had 2 years of HS|110
7803172|NCT01116739|12262080|FG001|Overall Study|Child had 2 years of HS|128
7803173|NCT01116739|12262079|FG000|Overall Study|Withdrawal by Subject|6
7803174|NCT01116739|12262080|FG001|Overall Study|Withdrawal by Subject|0
7803175|NCT01116739|12262079|FG000|Overall Study|child too young|2
7803176|NCT01116739|12262080|FG001|Overall Study|child too young|6
7803177|NCT01116739|12262079|FG000|Overall Study|child not enrolled in head start|10
7803178|NCT01116739|12262080|FG001|Overall Study|child not enrolled in head start|2
7803179|NCT01116739|12262079|FG000|Overall Study|enrolled caregiver not legal guardian|2
7803180|NCT01116739|12262080|FG001|Overall Study|enrolled caregiver not legal guardian|0
7803181|NCT01116882|12262088|FG000|30-day|Lost to Follow-up|50
7803182|NCT01116882|12262089|FG001|30-day|Lost to Follow-up|21
7803183|NCT01116882|12262088|FG000|30-day|Withdrawal by Subject|2
7803184|NCT01116882|12262089|FG001|30-day|Withdrawal by Subject|4
7803185|NCT01116882|12262088|FG000|30-day|Other Reasons|16
7803186|NCT01116882|12262089|FG001|30-day|Other Reasons|6
7803187|NCT01116882|12262088|FG000|12-month|Lost to Follow-up|111
7803188|NCT01116882|12262089|FG001|12-month|Lost to Follow-up|42
7803189|NCT01116882|12262088|FG000|12-month|Other Reasons|151
7803190|NCT01116882|12262089|FG001|12-month|Other Reasons|49
7803191|NCT01116882|12262088|FG000|12-month|Withdrawal by Subject|5
7803192|NCT01116882|12262089|FG001|12-month|Withdrawal by Subject|8
7803193|NCT01117012|12262218|FG000|Overall Study|Adverse Event|0
7884969|NCT01793935|12385203|FG000|Overall Study|Adverse Event|2
7884970|NCT01793935|12385204|FG001|Overall Study|Adverse Event|0
7884971|NCT01793935|12385203|FG000|Overall Study|Patient did not take study medication|1
7884972|NCT01793935|12385204|FG001|Overall Study|Patient did not take study medication|1
7884973|NCT01793935|12385203|FG000|Overall Study|Lost to Follow-up|0
7884974|NCT01793935|12385204|FG001|Overall Study|Lost to Follow-up|1
7884975|NCT01794000|12385212|FG000|Double-Blind Phase (DBP)|Adverse Event|5
7884976|NCT01794000|12385213|FG001|Double-Blind Phase (DBP)|Adverse Event|2
7884977|NCT01794000|12385212|FG000|Double-Blind Phase (DBP)|Death|1
7884978|NCT01794000|12385213|FG001|Double-Blind Phase (DBP)|Death|2
7884979|NCT01794000|12385212|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
7884980|NCT01794000|12385213|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
7884981|NCT01794000|12385212|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
7884982|NCT01794000|12385213|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
7884983|NCT01794000|12385212|FG000|Double-Blind Phase (DBP)|Physician Decision|2
7884984|NCT01794000|12385213|FG001|Double-Blind Phase (DBP)|Physician Decision|0
7884985|NCT01794000|12385212|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148
7884986|NCT01794000|12385213|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149
7884987|NCT01794000|12385212|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6
7884988|NCT01794000|12385213|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11
7884989|NCT01794000|12385212|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3
7884990|NCT01794000|12385213|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7884991|NCT01794117|12385235|FG000|Overall Study|Adverse Event|1
7884992|NCT01794117|12385236|FG001|Overall Study|Adverse Event|0
7884993|NCT01794117|12385237|FG002|Overall Study|Adverse Event|0
7803194|NCT01117012|12262219|FG001|Overall Study|Adverse Event|1
7803195|NCT01117012|12262218|FG000|Overall Study|Death|1
7803196|NCT01117012|12262219|FG001|Overall Study|Death|1
7803197|NCT01117012|12262218|FG000|Overall Study|Withdrawal by Subject|3
7803198|NCT01117012|12262219|FG001|Overall Study|Withdrawal by Subject|0
7803199|NCT01117012|12262218|FG000|Overall Study|Undefined|4
7803200|NCT01117012|12262219|FG001|Overall Study|Undefined|3
7803201|NCT01117051|12262227|FG000|Overall Study|Withdrawal by Subject|5
7803202|NCT01117051|12262228|FG001|Overall Study|Withdrawal by Subject|3
7803203|NCT01117051|12262227|FG000|Overall Study|Adverse Event|4
7803204|NCT01117051|12262228|FG001|Overall Study|Adverse Event|3
7803205|NCT01117051|12262227|FG000|Overall Study|Lost to Follow-up|0
7803206|NCT01117051|12262228|FG001|Overall Study|Lost to Follow-up|1
7803207|NCT01117051|12262227|FG000|Overall Study|Did not meet in-/exclusion criteria|0
7803208|NCT01117051|12262228|FG001|Overall Study|Did not meet in-/exclusion criteria|1
7803209|NCT01117051|12262227|FG000|Overall Study|Sponsor's decision|3
7803210|NCT01117051|12262228|FG001|Overall Study|Sponsor's decision|1
7803211|NCT01117051|12262227|FG000|Overall Study|Surgical procedure|0
7803212|NCT01117051|12262228|FG001|Overall Study|Surgical procedure|1
7803213|NCT01117051|12262227|FG000|Overall Study|Randomized by mistake|0
7803214|NCT01117051|12262228|FG001|Overall Study|Randomized by mistake|1
7803215|NCT01117051|12262227|FG000|Overall Study|Convenience issue|1
7803216|NCT01117051|12262228|FG001|Overall Study|Convenience issue|0
7803217|NCT01117181|12262248|FG000|Overall Study|Lost to Follow-up|1
7803218|NCT01117181|12262249|FG001|Overall Study|Lost to Follow-up|0
7803219|NCT01117181|12262248|FG000|Overall Study|Withdrawal by Subject|0
7803220|NCT01117181|12262249|FG001|Overall Study|Withdrawal by Subject|2
7803221|NCT01117337|12262266|FG000|Overall Study|Lost to Follow-up|4
7803222|NCT01117337|12262267|FG001|Overall Study|Lost to Follow-up|0
7803223|NCT01117350|12262275|FG000|Comparative Period|Not Treated|5
7803224|NCT01117350|12262276|FG001|Comparative Period|Not Treated|8
7803225|NCT01117350|12262275|FG000|Comparative Period|Adverse Event|6
7803226|NCT01117350|12262276|FG001|Comparative Period|Adverse Event|33
7803227|NCT01117350|12262275|FG000|Comparative Period|Lost to Follow-up|11
7803228|NCT01117350|12262276|FG001|Comparative Period|Lost to Follow-up|7
7803229|NCT01117350|12262275|FG000|Comparative Period|Withdrawal by Subject|9
7803230|NCT01117350|12262276|FG001|Comparative Period|Withdrawal by Subject|13
7803231|NCT01117350|12262275|FG000|Comparative Period|Protocol Violation|8
7803232|NCT01117350|12262276|FG001|Comparative Period|Protocol Violation|12
7803233|NCT01117350|12262275|FG000|Comparative Period|Lack of Efficacy|1
7803234|NCT01117350|12262276|FG001|Comparative Period|Lack of Efficacy|0
7803235|NCT01117350|12262275|FG000|Comparative Period|Physician Decision|0
7803236|NCT01117350|12262276|FG001|Comparative Period|Physician Decision|1
7803237|NCT01117350|12262275|FG000|Comparative Period|Move to another city/country|2
7803238|NCT01117350|12262276|FG001|Comparative Period|Move to another city/country|1
7803239|NCT01117350|12262275|FG000|Extension Period|Not included in extension, not treated|0
7803240|NCT01117350|12262276|FG001|Extension Period|Not included in extension, not treated|50
7803241|NCT01117350|12262275|FG000|Extension Period|Adverse Event|0
7803242|NCT01117350|12262276|FG001|Extension Period|Adverse Event|2
7803243|NCT01117350|12262275|FG000|Extension Period|Protocol Violation|0
7884994|NCT01794117|12385238|FG003|Overall Study|Adverse Event|0
7884995|NCT01794117|12385235|FG000|Overall Study|Participant noncompliance|0
7884996|NCT01794117|12385236|FG001|Overall Study|Participant noncompliance|1
7884997|NCT01794117|12385237|FG002|Overall Study|Participant noncompliance|0
7884998|NCT01794117|12385238|FG003|Overall Study|Participant noncompliance|0
7803244|NCT01117350|12262276|FG001|Extension Period|Protocol Violation|2
7803245|NCT01117350|12262275|FG000|Extension Period|Lost to Follow-up|0
7803246|NCT01117350|12262276|FG001|Extension Period|Lost to Follow-up|2
7803247|NCT01117350|12262275|FG000|Extension Period|Withdrawal by Subject|0
7803248|NCT01117350|12262276|FG001|Extension Period|Withdrawal by Subject|3
7803249|NCT01117350|12262275|FG000|Extension Period|Lack of Efficacy|0
7803250|NCT01117350|12262276|FG001|Extension Period|Lack of Efficacy|2
7803251|NCT01117350|12262275|FG000|Extension Period|Inclusion criteria not respected|0
7803252|NCT01117350|12262276|FG001|Extension Period|Inclusion criteria not respected|1
7803253|NCT01117350|12262275|FG000|Extension Period|Prohibited medication|0
7803254|NCT01117350|12262276|FG001|Extension Period|Prohibited medication|1
7803255|NCT01117428|12262291|FG000|Overall Study|Lack of Efficacy|1
7803256|NCT01117428|12262292|FG001|Overall Study|Lack of Efficacy|0
7803257|NCT01117428|12262293|FG002|Overall Study|Lack of Efficacy|0
7803258|NCT01117428|12262294|FG003|Overall Study|Lack of Efficacy|0
7803259|NCT01117428|12262295|FG004|Overall Study|Lack of Efficacy|0
7803260|NCT01117428|12262296|FG005|Overall Study|Lack of Efficacy|0
7803261|NCT01117428|12262291|FG000|Overall Study|Adverse Event|4
7803262|NCT01117428|12262292|FG001|Overall Study|Adverse Event|0
7803263|NCT01117428|12262293|FG002|Overall Study|Adverse Event|0
7803264|NCT01117428|12262294|FG003|Overall Study|Adverse Event|0
7803265|NCT01117428|12262295|FG004|Overall Study|Adverse Event|1
7803266|NCT01117428|12262296|FG005|Overall Study|Adverse Event|2
7803267|NCT01117428|12262291|FG000|Overall Study|Death|0
7803268|NCT01117428|12262292|FG001|Overall Study|Death|1
7803269|NCT01117428|12262293|FG002|Overall Study|Death|2
7803270|NCT01117428|12262294|FG003|Overall Study|Death|0
7803271|NCT01117428|12262295|FG004|Overall Study|Death|0
7803272|NCT01117428|12262296|FG005|Overall Study|Death|1
7803273|NCT01117428|12262291|FG000|Overall Study|Physician Decision|0
7803274|NCT01117428|12262292|FG001|Overall Study|Physician Decision|1
7803275|NCT01117428|12262293|FG002|Overall Study|Physician Decision|0
7803276|NCT01117428|12262294|FG003|Overall Study|Physician Decision|0
7803277|NCT01117428|12262295|FG004|Overall Study|Physician Decision|0
7803278|NCT01117428|12262296|FG005|Overall Study|Physician Decision|0
7803279|NCT01117428|12262291|FG000|Overall Study|Withdrawal by Subject|0
7803280|NCT01117428|12262292|FG001|Overall Study|Withdrawal by Subject|0
7803281|NCT01117428|12262293|FG002|Overall Study|Withdrawal by Subject|1
7803282|NCT01117428|12262294|FG003|Overall Study|Withdrawal by Subject|0
7803283|NCT01117428|12262295|FG004|Overall Study|Withdrawal by Subject|0
7803284|NCT01117428|12262296|FG005|Overall Study|Withdrawal by Subject|0
7803285|NCT01117428|12262291|FG000|Overall Study|Progressive disease|15
7803286|NCT01117428|12262292|FG001|Overall Study|Progressive disease|27
7803287|NCT01117428|12262293|FG002|Overall Study|Progressive disease|10
7803288|NCT01117428|12262294|FG003|Overall Study|Progressive disease|12
7803289|NCT01117428|12262295|FG004|Overall Study|Progressive disease|16
7803290|NCT01117428|12262296|FG005|Overall Study|Progressive disease|17
7803291|NCT01117454|12262314|FG000|Overall Study|Pregnancy|0
7803292|NCT01117454|12262315|FG001|Overall Study|Pregnancy|1
7803293|NCT01117480|12262321|FG000|Overall Study|Protocol Violation|8
7803294|NCT01117480|12262321|FG000|Overall Study|Did Not Start Adalimumab Therapy|20
7803295|NCT01117623|12262333|FG000|Overall Study|Adverse Event|0
7803296|NCT01117623|12262334|FG001|Overall Study|Adverse Event|2
7803297|NCT01117623|12262335|FG002|Overall Study|Adverse Event|4
7803298|NCT01117623|12262336|FG003|Overall Study|Adverse Event|0
7803299|NCT01117623|12262337|FG004|Overall Study|Adverse Event|2
7803300|NCT01117623|12262338|FG005|Overall Study|Adverse Event|0
7803301|NCT01117623|12262339|FG006|Overall Study|Adverse Event|0
7884999|NCT01794117|12385235|FG000|Overall Study|Refused further treatment|0
7885000|NCT01794117|12385236|FG001|Overall Study|Refused further treatment|2
7885001|NCT01794117|12385237|FG002|Overall Study|Refused further treatment|0
7885002|NCT01794117|12385238|FG003|Overall Study|Refused further treatment|0
7885003|NCT01794299|12385249|FG000|Overall Study|ATIR manufacturing not possible|1
7885004|NCT01794299|12385249|FG000|Overall Study|Death|14
7885005|NCT01794299|12385249|FG000|Overall Study|Graft failure|1
7885006|NCT01794299|12385249|FG000|Overall Study|ATIR batch rejected|2
7885007|NCT01794299|12385249|FG000|Overall Study|Relapse|2
7885008|NCT01794299|12385249|FG000|Overall Study|Discontinued from active follow-up|1
7885009|NCT01794299|12385249|FG000|Overall Study|Relapse and rejection of ATIR batch|1
7885010|NCT01794689|12385275|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3
7885011|NCT01794689|12385276|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0
7885012|NCT01794689|12385277|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2
7885013|NCT01794689|12385278|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4
7885014|NCT01794689|12385275|FG000|Intervention 1 (2 Nights)|Protocol Violation|1
7885015|NCT01794689|12385276|FG001|Intervention 1 (2 Nights)|Protocol Violation|0
7885016|NCT01794689|12385277|FG002|Intervention 1 (2 Nights)|Protocol Violation|1
7885017|NCT01794689|12385278|FG003|Intervention 1 (2 Nights)|Protocol Violation|0
7885018|NCT01794689|12385275|FG000|Intervention 1 (2 Nights)|Physician Decision|1
7885019|NCT01794689|12385276|FG001|Intervention 1 (2 Nights)|Physician Decision|1
7885020|NCT01794689|12385277|FG002|Intervention 1 (2 Nights)|Physician Decision|0
7885021|NCT01794689|12385278|FG003|Intervention 1 (2 Nights)|Physician Decision|0
7885022|NCT01794689|12385275|FG000|Intervention 1 (2 Nights)|Adverse Event|0
7885023|NCT01794689|12385276|FG001|Intervention 1 (2 Nights)|Adverse Event|1
7885024|NCT01794689|12385277|FG002|Intervention 1 (2 Nights)|Adverse Event|0
7885025|NCT01794689|12385278|FG003|Intervention 1 (2 Nights)|Adverse Event|0
7885026|NCT01794780|12385324|FG000|Overall Study|Adverse Event|0
7885027|NCT01794780|12385325|FG001|Overall Study|Adverse Event|1
7885028|NCT01794780|12385326|FG002|Overall Study|Adverse Event|2
7885029|NCT01794780|12385327|FG003|Overall Study|Adverse Event|0
7885030|NCT01794780|12385328|FG004|Overall Study|Adverse Event|0
7885031|NCT01794780|12385329|FG005|Overall Study|Adverse Event|0
7885032|NCT01794780|12385330|FG006|Overall Study|Adverse Event|0
7885033|NCT01794780|12385331|FG007|Overall Study|Adverse Event|0
7885034|NCT01794780|12385324|FG000|Overall Study|Death|0
7885035|NCT01794780|12385325|FG001|Overall Study|Death|2
7885036|NCT01794780|12385326|FG002|Overall Study|Death|14
7885037|NCT01794780|12385327|FG003|Overall Study|Death|1
7885038|NCT01794780|12385328|FG004|Overall Study|Death|0
7885039|NCT01794780|12385329|FG005|Overall Study|Death|9
7885040|NCT01794780|12385330|FG006|Overall Study|Death|4
7885041|NCT01794780|12385331|FG007|Overall Study|Death|0
7885042|NCT01794780|12385324|FG000|Overall Study|Lost to Follow-up|10
7885043|NCT01794780|12385325|FG001|Overall Study|Lost to Follow-up|64
7885044|NCT01794780|12385326|FG002|Overall Study|Lost to Follow-up|165
7885045|NCT01794780|12385327|FG003|Overall Study|Lost to Follow-up|53
7885046|NCT01794780|12385328|FG004|Overall Study|Lost to Follow-up|2
7885047|NCT01794780|12385329|FG005|Overall Study|Lost to Follow-up|99
7885048|NCT01794780|12385330|FG006|Overall Study|Lost to Follow-up|30
7885049|NCT01794780|12385331|FG007|Overall Study|Lost to Follow-up|5
7885050|NCT01794780|12385324|FG000|Overall Study|Withdrew informed consent|7
7885051|NCT01794780|12385325|FG001|Overall Study|Withdrew informed consent|17
7885052|NCT01794780|12385326|FG002|Overall Study|Withdrew informed consent|36
7885053|NCT01794780|12385327|FG003|Overall Study|Withdrew informed consent|9
7885054|NCT01794780|12385328|FG004|Overall Study|Withdrew informed consent|0
7885055|NCT01794780|12385329|FG005|Overall Study|Withdrew informed consent|48
7885056|NCT01794780|12385330|FG006|Overall Study|Withdrew informed consent|4
7885057|NCT01794780|12385331|FG007|Overall Study|Withdrew informed consent|3
7885058|NCT01794780|12385324|FG000|Overall Study|Other|0
7885059|NCT01794780|12385325|FG001|Overall Study|Other|12
7885060|NCT01794780|12385326|FG002|Overall Study|Other|25
7885061|NCT01794780|12385327|FG003|Overall Study|Other|20
7885062|NCT01794780|12385328|FG004|Overall Study|Other|1
7885063|NCT01794780|12385329|FG005|Overall Study|Other|24
7885064|NCT01794780|12385330|FG006|Overall Study|Other|4
7885065|NCT01794780|12385331|FG007|Overall Study|Other|1
7885066|NCT01794845|12385365|FG000|Overall Study|Withdrawal by Subject|1
7885067|NCT01794923|12385372|FG000|Overall Study|Adverse Event|0
7885068|NCT01794923|12385373|FG001|Overall Study|Adverse Event|0
7803302|NCT01117623|12262340|FG007|Overall Study|Adverse Event|2
7803303|NCT01117623|12262333|FG000|Overall Study|Disease progression, recurrence, relapse|3
7803304|NCT01117623|12262334|FG001|Overall Study|Disease progression, recurrence, relapse|6
7803305|NCT01117623|12262335|FG002|Overall Study|Disease progression, recurrence, relapse|5
7803306|NCT01117623|12262336|FG003|Overall Study|Disease progression, recurrence, relapse|6
7803307|NCT01117623|12262337|FG004|Overall Study|Disease progression, recurrence, relapse|8
7803308|NCT01117623|12262338|FG005|Overall Study|Disease progression, recurrence, relapse|14
7803309|NCT01117623|12262339|FG006|Overall Study|Disease progression, recurrence, relapse|5
7803310|NCT01117623|12262340|FG007|Overall Study|Disease progression, recurrence, relapse|22
7803311|NCT01117623|12262333|FG000|Overall Study|Withdrawal by Subject|0
7803312|NCT01117623|12262334|FG001|Overall Study|Withdrawal by Subject|0
7803313|NCT01117623|12262335|FG002|Overall Study|Withdrawal by Subject|2
7803314|NCT01117623|12262336|FG003|Overall Study|Withdrawal by Subject|0
7803315|NCT01117623|12262337|FG004|Overall Study|Withdrawal by Subject|0
7803316|NCT01117623|12262338|FG005|Overall Study|Withdrawal by Subject|1
7803317|NCT01117623|12262339|FG006|Overall Study|Withdrawal by Subject|1
7803318|NCT01117623|12262340|FG007|Overall Study|Withdrawal by Subject|1
7885069|NCT01794923|12385374|FG002|Overall Study|Adverse Event|1
7885070|NCT01794949|12385384|FG000|Overall Study|Lost to Follow-up|1
7885071|NCT01794949|12385385|FG001|Overall Study|Lost to Follow-up|0
7885072|NCT01795495|12385408|FG000|Overall Study|Protocol Violation|1
7885073|NCT01795495|12385409|FG001|Overall Study|Protocol Violation|0
7885074|NCT01795495|12385410|FG002|Overall Study|Protocol Violation|1
7885075|NCT01795495|12385408|FG000|Overall Study|Physician Decision|0
7885076|NCT01795495|12385409|FG001|Overall Study|Physician Decision|0
7885077|NCT01795495|12385410|FG002|Overall Study|Physician Decision|1
7885078|NCT01795547|12385427|FG000|Overall Study|Adverse Event|16
7885079|NCT01795547|12385428|FG001|Overall Study|Adverse Event|27
7885080|NCT01795547|12385427|FG000|Overall Study|Lack of Efficacy|8
7885081|NCT01795547|12385428|FG001|Overall Study|Lack of Efficacy|3
7885082|NCT01795547|12385427|FG000|Overall Study|Protocol Violation|6
7885083|NCT01795547|12385428|FG001|Overall Study|Protocol Violation|4
7885084|NCT01795547|12385427|FG000|Overall Study|Lost to Follow-up|2
7885085|NCT01795547|12385428|FG001|Overall Study|Lost to Follow-up|5
7885086|NCT01795547|12385427|FG000|Overall Study|Withdrawal of consent|7
7885087|NCT01795547|12385428|FG001|Overall Study|Withdrawal of consent|12
7885088|NCT01795547|12385427|FG000|Overall Study|Not Treated|4
7885089|NCT01795547|12385428|FG001|Overall Study|Not Treated|10
7885090|NCT01795547|12385427|FG000|Overall Study|Non-compliance with IMP|1
7885091|NCT01795547|12385428|FG001|Overall Study|Non-compliance with IMP|1
7885092|NCT01795547|12385427|FG000|Overall Study|Others|4
7885093|NCT01795547|12385428|FG001|Overall Study|Others|1
7885094|NCT01795547|12385427|FG000|Overall Study|Not stated|0
7885095|NCT01795547|12385428|FG001|Overall Study|Not stated|1
7885096|NCT01795638|12385438|FG000|Overall Study|Death|0
7885097|NCT01795638|12385439|FG001|Overall Study|Death|3
7885098|NCT01795638|12385438|FG000|Overall Study|transferred to quaternary hospital|2
7885099|NCT01795638|12385439|FG001|Overall Study|transferred to quaternary hospital|3
7885100|NCT01795638|12385438|FG000|Overall Study|Protocol Violation|3
7885101|NCT01795638|12385439|FG001|Overall Study|Protocol Violation|0
7885102|NCT01795638|12385438|FG000|Overall Study|discharged from hospital|7
7885103|NCT01795638|12385439|FG001|Overall Study|discharged from hospital|5
7885104|NCT01795638|12385438|FG000|Overall Study|Withdrawal by Subject|1
7885105|NCT01795638|12385439|FG001|Overall Study|Withdrawal by Subject|0
7885106|NCT01795898|12385474|FG000|Overall Study|Adverse Event|27
7885107|NCT01795898|12385474|FG000|Overall Study|Lost to Follow-up|20
7885108|NCT01795898|12385474|FG000|Overall Study|Withdrawal of consent|6
7885109|NCT01795898|12385474|FG000|Overall Study|Diagnosed with metastasis|1
7885110|NCT01795898|12385474|FG000|Overall Study|No pain|1
7885111|NCT01795898|12385474|FG000|Overall Study|Death|1
7885112|NCT01795898|12385474|FG000|Overall Study|Withdrew consent & had adverse events|3
7885113|NCT01795898|12385474|FG000|Overall Study|Physician Decision|1
7885114|NCT01795937|12385481|FG000|Overall Study|Withdrawal by Subject|1
7885115|NCT01795937|12385482|FG001|Overall Study|Withdrawal by Subject|0
7885116|NCT01795937|12385483|FG002|Overall Study|Withdrawal by Subject|0
7885117|NCT01795937|12385481|FG000|Overall Study|Physician Decision|0
7885118|NCT01795937|12385482|FG001|Overall Study|Physician Decision|1
7885119|NCT01795937|12385483|FG002|Overall Study|Physician Decision|0
7885120|NCT01796301|12385511|FG000|Overall Study|Withdrawal by Subject|15
7885121|NCT01796301|12385512|FG001|Overall Study|Withdrawal by Subject|15
7885122|NCT01796301|12385511|FG000|Overall Study|Lost to Follow-up|3
7885123|NCT01796301|12385512|FG001|Overall Study|Lost to Follow-up|3
7885124|NCT01796301|12385511|FG000|Overall Study|Death|0
7885125|NCT01796301|12385512|FG001|Overall Study|Death|1
7885126|NCT01796301|12385511|FG000|Overall Study|Decision by Sponsor|0
7885127|NCT01796301|12385512|FG001|Overall Study|Decision by Sponsor|1
7885128|NCT01796392|12385520|FG000|Overall Study|Withdrawal by Subject|2
7885129|NCT01796392|12385521|FG001|Overall Study|Withdrawal by Subject|0
7885130|NCT01796392|12385520|FG000|Overall Study|Death|5
7885131|NCT01796392|12385521|FG001|Overall Study|Death|1
7885132|NCT01796392|12385520|FG000|Overall Study|Excluded for medical reasons|1
7885133|NCT01796392|12385521|FG001|Overall Study|Excluded for medical reasons|2
7885134|NCT01796392|12385520|FG000|Overall Study|Lost to Follow-up|1
7885135|NCT01796392|12385521|FG001|Overall Study|Lost to Follow-up|0
7885136|NCT01796470|12385532|FG000|Overall Study|Adverse Event|4
7885137|NCT01796470|12385533|FG001|Overall Study|Adverse Event|2
7885138|NCT01796470|12385534|FG002|Overall Study|Adverse Event|2
7885139|NCT01796470|12385535|FG003|Overall Study|Adverse Event|1
7803319|NCT01117623|12262333|FG000|Overall Study|Non-compliance with study medication|0
7803320|NCT01117623|12262334|FG001|Overall Study|Non-compliance with study medication|0
7803321|NCT01117623|12262335|FG002|Overall Study|Non-compliance with study medication|0
7803322|NCT01117623|12262336|FG003|Overall Study|Non-compliance with study medication|0
7803323|NCT01117623|12262337|FG004|Overall Study|Non-compliance with study medication|0
7803324|NCT01117623|12262338|FG005|Overall Study|Non-compliance with study medication|0
7803325|NCT01117623|12262339|FG006|Overall Study|Non-compliance with study medication|0
7803326|NCT01117623|12262340|FG007|Overall Study|Non-compliance with study medication|1
7803327|NCT01117623|12262333|FG000|Overall Study|Invest. text: completed all planned txs|0
7803328|NCT01117623|12262334|FG001|Overall Study|Invest. text: completed all planned txs|0
7803329|NCT01117623|12262335|FG002|Overall Study|Invest. text: completed all planned txs|0
7803330|NCT01117623|12262336|FG003|Overall Study|Invest. text: completed all planned txs|0
7803331|NCT01117623|12262337|FG004|Overall Study|Invest. text: completed all planned txs|0
7803332|NCT01117623|12262338|FG005|Overall Study|Invest. text: completed all planned txs|1
7803333|NCT01117623|12262339|FG006|Overall Study|Invest. text: completed all planned txs|0
7803334|NCT01117623|12262340|FG007|Overall Study|Invest. text: completed all planned txs|0
7861408|NCT01592240|12350408|FG005|Overall Study|Lost to Follow-up|2
7861409|NCT01592240|12350409|FG006|Overall Study|Lost to Follow-up|0
7861410|NCT01592240|12350403|FG000|Overall Study|Protocol Violation|0
7861411|NCT01592240|12350404|FG001|Overall Study|Protocol Violation|0
7861412|NCT01592240|12350405|FG002|Overall Study|Protocol Violation|0
7861413|NCT01592240|12350406|FG003|Overall Study|Protocol Violation|0
7861414|NCT01592240|12350407|FG004|Overall Study|Protocol Violation|0
7861415|NCT01592240|12350408|FG005|Overall Study|Protocol Violation|1
7861416|NCT01592240|12350409|FG006|Overall Study|Protocol Violation|0
7861417|NCT01592240|12350403|FG000|Overall Study|Withdrawal by Subject|0
7861418|NCT01592240|12350404|FG001|Overall Study|Withdrawal by Subject|4
7861419|NCT01592240|12350405|FG002|Overall Study|Withdrawal by Subject|4
7861420|NCT01592240|12350406|FG003|Overall Study|Withdrawal by Subject|1
7861421|NCT01592240|12350407|FG004|Overall Study|Withdrawal by Subject|3
7861422|NCT01592240|12350408|FG005|Overall Study|Withdrawal by Subject|0
7861423|NCT01592240|12350409|FG006|Overall Study|Withdrawal by Subject|2
7861424|NCT01592240|12350403|FG000|Overall Study|Other|0
7861425|NCT01592240|12350404|FG001|Overall Study|Other|3
7861426|NCT01592240|12350405|FG002|Overall Study|Other|1
7861427|NCT01592240|12350406|FG003|Overall Study|Other|1
7803335|NCT01117766|12262365|FG000|First Intervention|Adverse Event|0
7803336|NCT01117766|12262366|FG001|First Intervention|Adverse Event|1
7803337|NCT01117766|12262365|FG000|First Intervention|Protocol Violation|1
7803338|NCT01117766|12262366|FG001|First Intervention|Protocol Violation|0
7803339|NCT01117766|12262365|FG000|Washout Period|Protocol Violation|0
7803340|NCT01117766|12262366|FG001|Washout Period|Protocol Violation|2
7803341|NCT01117766|12262365|FG000|Second Intervention|Lost to Follow-up|1
7803342|NCT01117766|12262366|FG001|Second Intervention|Lost to Follow-up|0
7803343|NCT01117766|12262365|FG000|Second Intervention|Other|1
7803344|NCT01117766|12262366|FG001|Second Intervention|Other|2
7803345|NCT01117766|12262365|FG000|Second Intervention|Adverse Event|0
7803346|NCT01117766|12262366|FG001|Second Intervention|Adverse Event|2
7803347|NCT01117766|12262365|FG000|Second Intervention|Withdrawal by Subject|0
7803348|NCT01117766|12262366|FG001|Second Intervention|Withdrawal by Subject|1
7803349|NCT01117792|12262372|FG000|Overall Study|Death|1
7803350|NCT01117792|12262372|FG000|Overall Study|Adverse Event|3
7803351|NCT01117857|12262376|FG000|Overall Study|Lost to Follow-up|4
7803352|NCT01117857|12262376|FG000|Overall Study|Withdrawal by Subject|4
7803353|NCT01117857|12262376|FG000|Overall Study|Physician Decision|1
7803354|NCT01117870|12262382|FG000|Overall Study|Inability to place needle|1
7803355|NCT01117870|12262383|FG001|Overall Study|Inability to place needle|0
7803356|NCT01117987|12262404|FG000|Overall Study|Protocol deviation|0
7803357|NCT01117987|12262405|FG001|Overall Study|Protocol deviation|1
7803358|NCT01117987|12262404|FG000|Overall Study|Subject no longer requires study drug|1
7803359|NCT01117987|12262405|FG001|Overall Study|Subject no longer requires study drug|0
7803360|NCT01117987|12262404|FG000|Overall Study|Lost to Follow-up|1
7803361|NCT01117987|12262405|FG001|Overall Study|Lost to Follow-up|1
7803362|NCT01117987|12262404|FG000|Overall Study|Abnormal test procedure result|2
7803363|NCT01117987|12262405|FG001|Overall Study|Abnormal test procedure result|0
7803364|NCT01117987|12262404|FG000|Overall Study|Lack of Efficacy|3
7803365|NCT01117987|12262405|FG001|Overall Study|Lack of Efficacy|4
7803366|NCT01117987|12262404|FG000|Overall Study|Death|5
7803367|NCT01117987|12262405|FG001|Overall Study|Death|10
7803368|NCT01117987|12262404|FG000|Overall Study|Withdrawal by Subject|5
7803369|NCT01117987|12262405|FG001|Overall Study|Withdrawal by Subject|10
7803370|NCT01117987|12262404|FG000|Overall Study|Adverse Event|19
7803371|NCT01117987|12262405|FG001|Overall Study|Adverse Event|26
7803372|NCT01117987|12262404|FG000|Overall Study|Administrative problems|25
7803373|NCT01117987|12262405|FG001|Overall Study|Administrative problems|22
7803374|NCT01118052|12262411|FG000|Overall Study|Never treated|2
7803375|NCT01118117|12262432|FG000|Overall Study|Death|8
7803376|NCT01118117|12262433|FG001|Overall Study|Death|0
7803377|NCT01118117|12262432|FG000|Overall Study|Lost to Follow-up|6
7803378|NCT01118117|12262433|FG001|Overall Study|Lost to Follow-up|0
7803379|NCT01118117|12262432|FG000|Overall Study|Missed 12 Month Visit|7
7803380|NCT01118117|12262433|FG001|Overall Study|Missed 12 Month Visit|0
7803381|NCT01118143|12262441|FG000|Overall Study|Withdrawal by Subject|2
7803382|NCT01118143|12262442|FG001|Overall Study|Withdrawal by Subject|5
7803383|NCT01118299|12262490|FG000|Overall Study|Death|7
7803384|NCT01118299|12262491|FG001|Overall Study|Death|5
7803385|NCT01118299|12262490|FG000|Overall Study|Withdrawal by Subject|8
7803386|NCT01118299|12262491|FG001|Overall Study|Withdrawal by Subject|8
7803387|NCT01118299|12262490|FG000|Overall Study|Lost to Follow-up|2
7803388|NCT01118299|12262491|FG001|Overall Study|Lost to Follow-up|1
7803389|NCT01118299|12262490|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6
7803390|NCT01118299|12262491|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15
7803391|NCT01118312|12262498|FG000|Overall Study|Lost to Follow-up|33
7803392|NCT01118312|12262499|FG001|Overall Study|Lost to Follow-up|32
7803393|NCT01118312|12262498|FG000|Overall Study|Withdrawal by Subject|1
7885140|NCT01796470|12385536|FG004|Overall Study|Adverse Event|3
7885141|NCT01796470|12385532|FG000|Overall Study|Death|2
7885142|NCT01796470|12385533|FG001|Overall Study|Death|0
7885143|NCT01796470|12385534|FG002|Overall Study|Death|0
7885144|NCT01796470|12385535|FG003|Overall Study|Death|0
7885145|NCT01796470|12385536|FG004|Overall Study|Death|1
7803394|NCT01118312|12262499|FG001|Overall Study|Withdrawal by Subject|3
7803395|NCT01118325|12262508|FG000|Overall Study|Adverse Event|1
7803396|NCT01118325|12262509|FG001|Overall Study|Adverse Event|0
7803397|NCT01118325|12262510|FG002|Overall Study|Adverse Event|1
7803398|NCT01118351|12262540|FG000|Overall Study|Adverse Event|3
7803399|NCT01118351|12262540|FG000|Overall Study|Withdrawal by Subject|1
7803400|NCT01118377|12262544|FG000|Overall Study|Did Not Receive Study Medication|1
7803401|NCT01118377|12262544|FG000|Overall Study|Death|38
7803402|NCT01118377|12262544|FG000|Overall Study|Failure to Return|3
7803403|NCT01118455|12262550|FG000|Baseline [Visits 1 & 2]|Adverse Event|1
7803404|NCT01118455|12262551|FG001|Baseline [Visits 1 & 2]|Adverse Event|0
7803405|NCT01118520|12262568|FG000|Overall Study|AAA repair|9
7803406|NCT01118520|12262569|FG001|Overall Study|AAA repair|7
7803407|NCT01118520|12262570|FG002|Overall Study|AAA repair|9
7803408|NCT01118520|12262568|FG000|Overall Study|Adverse Event|3
7803409|NCT01118520|12262569|FG001|Overall Study|Adverse Event|3
7803410|NCT01118520|12262570|FG002|Overall Study|Adverse Event|3
7803411|NCT01118520|12262568|FG000|Overall Study|Withdrawal by Subject|8
7803412|NCT01118520|12262569|FG001|Overall Study|Withdrawal by Subject|13
7803413|NCT01118520|12262570|FG002|Overall Study|Withdrawal by Subject|8
7885146|NCT01796470|12385532|FG000|Overall Study|Initiated New Therapy|9
7803414|NCT01118663|12262584|FG000|Overall Study|Adverse Event|2
7803415|NCT01118663|12262585|FG001|Overall Study|Adverse Event|1
7803416|NCT01118663|12262584|FG000|Overall Study|Withdrawal by Subject|0
7803417|NCT01118663|12262585|FG001|Overall Study|Withdrawal by Subject|1
7803418|NCT01118728|12262621|FG000|Overall Study|Adverse Event|17
7803419|NCT01118728|12262621|FG000|Overall Study|Lack of Efficacy|27
7803420|NCT01118728|12262621|FG000|Overall Study|Sponsor's decision to discontinue study|172
7803421|NCT01118728|12262621|FG000|Overall Study|Withdrawal by Subject|3
7803422|NCT01118728|12262621|FG000|Overall Study|Lost to Follow-up|4
7803423|NCT01118780|12262638|FG000|Overall Study|Adverse Event|15
7803424|NCT01118780|12262639|FG001|Overall Study|Adverse Event|15
7803425|NCT01118780|12262638|FG000|Overall Study|Death|1
7803426|NCT01118780|12262639|FG001|Overall Study|Death|0
7803427|NCT01118780|12262638|FG000|Overall Study|Lack of Efficacy|2
7803428|NCT01118780|12262639|FG001|Overall Study|Lack of Efficacy|6
7803429|NCT01118780|12262638|FG000|Overall Study|Physician Decision|2
7803430|NCT01118780|12262639|FG001|Overall Study|Physician Decision|0
7803431|NCT01118780|12262638|FG000|Overall Study|Protocol Violation|3
7803432|NCT01118780|12262639|FG001|Overall Study|Protocol Violation|6
7803433|NCT01118780|12262638|FG000|Overall Study|Withdrawal by Subject|13
7803434|NCT01118780|12262639|FG001|Overall Study|Withdrawal by Subject|8
7803435|NCT01118949|12262652|FG000|Overall Study|Adverse Event|5
7803436|NCT01118949|12262652|FG000|Overall Study|Withdrawal by Subject|4
7803437|NCT01118962|12262656|FG000|Overall Study|Adverse Event|2
7803438|NCT01118962|12262656|FG000|Overall Study|Lack of Efficacy|1
7803439|NCT01118962|12262656|FG000|Overall Study|Protocol Violation|1
7803440|NCT01118962|12262656|FG000|Overall Study|Withdrawal by Subject|4
7803441|NCT01118962|12262656|FG000|Overall Study|Pregnancy|1
7803442|NCT01118962|12262656|FG000|Overall Study|Non-compliance with Medicinal Product|1
7803443|NCT01118975|12262662|FG000|Overall Study|Adverse Event|0
7803444|NCT01118975|12262663|FG001|Overall Study|Adverse Event|1
7803445|NCT01119001|12262681|FG000|Overall Study|Withdrawal by Subject|2
7803446|NCT01119105|12262694|FG000|Overall Study|Withdrawal by Subject|1
7803447|NCT01119105|12262695|FG001|Overall Study|Withdrawal by Subject|1
7803448|NCT01119105|12262696|FG002|Overall Study|Withdrawal by Subject|1
7803449|NCT01119105|12262694|FG000|Overall Study|Lost to Follow-up|0
7803450|NCT01119105|12262695|FG001|Overall Study|Lost to Follow-up|2
7803451|NCT01119105|12262696|FG002|Overall Study|Lost to Follow-up|5
7803452|NCT01119105|12262694|FG000|Overall Study|Adverse Event|1
7803453|NCT01119105|12262695|FG001|Overall Study|Adverse Event|0
7803454|NCT01119105|12262696|FG002|Overall Study|Adverse Event|1
7803455|NCT01119105|12262694|FG000|Overall Study|study drug missed on 2 consecutive days|1
7885147|NCT01796470|12385533|FG001|Overall Study|Initiated New Therapy|0
7803456|NCT01119105|12262695|FG001|Overall Study|study drug missed on 2 consecutive days|2
7803457|NCT01119105|12262696|FG002|Overall Study|study drug missed on 2 consecutive days|1
7803458|NCT01119105|12262694|FG000|Overall Study|Other|1
7803459|NCT01119105|12262695|FG001|Overall Study|Other|1
7803460|NCT01119105|12262696|FG002|Overall Study|Other|0
7803461|NCT01119118|12262704|FG000|Overall Study|Adverse Event|1
7803462|NCT01119131|12262711|FG000|Overall Study|Adverse Event|1
7803463|NCT01119131|12262712|FG001|Overall Study|Adverse Event|1
7803464|NCT01119131|12262713|FG002|Overall Study|Adverse Event|1
7803465|NCT01119131|12262711|FG000|Overall Study|Non-Compliance|1
7803466|NCT01119131|12262712|FG001|Overall Study|Non-Compliance|0
7803467|NCT01119131|12262713|FG002|Overall Study|Non-Compliance|4
7803468|NCT01119131|12262711|FG000|Overall Study|Physician Decision|0
7803469|NCT01119131|12262712|FG001|Overall Study|Physician Decision|0
7803470|NCT01119131|12262713|FG002|Overall Study|Physician Decision|1
7803471|NCT01119248|12262737|FG000|Overall Study|Physician Decision|5
7803472|NCT01119287|12262748|FG000|Overall Study|Patient Decision, not related to AE|0
7803473|NCT01119287|12262749|FG001|Overall Study|Patient Decision, not related to AE|0
7803474|NCT01119287|12262750|FG002|Overall Study|Patient Decision, not related to AE|2
7803475|NCT01119287|12262751|FG003|Overall Study|Patient Decision, not related to AE|2
7803476|NCT01119287|12262752|FG004|Overall Study|Patient Decision, not related to AE|1
7803477|NCT01119287|12262753|FG005|Overall Study|Patient Decision, not related to AE|0
7803478|NCT01119443|12262767|FG000|Crossover Period 1 (5 Days)|Adverse Event|0
7803479|NCT01119443|12262768|FG001|Crossover Period 1 (5 Days)|Adverse Event|1
7803480|NCT01119508|12262817|FG000|Overall Study|Adverse Event|56
7803481|NCT01119508|12262817|FG000|Overall Study|Withdrawal by Subject|2
7803482|NCT01119508|12262817|FG000|Overall Study|Died before tumor response evaluation|1
7803483|NCT01119625|12262823|FG000|Overall Study|Lost to Follow-up|1
7803484|NCT01119625|12262824|FG001|Overall Study|Lost to Follow-up|2
7803485|NCT01119625|12262823|FG000|Overall Study|Withdrawal by Subject|2
7803486|NCT01119625|12262824|FG001|Overall Study|Withdrawal by Subject|1
7803487|NCT01119625|12262823|FG000|Overall Study|Other|0
7803488|NCT01119625|12262824|FG001|Overall Study|Other|1
7803489|NCT01119703|12262832|FG000|Overall Study|Adverse Event|0
7803490|NCT01119703|12262833|FG001|Overall Study|Adverse Event|1
7803491|NCT01119768|12262852|FG000|Treatment Period|Lack of Efficacy|18
7803492|NCT01119768|12262853|FG001|Treatment Period|Lack of Efficacy|25
7803493|NCT01119846|12262866|FG000|Overall Study|Adverse Event|1
7803494|NCT01119846|12262867|FG001|Overall Study|Adverse Event|0
7803495|NCT01119846|12262868|FG002|Overall Study|Adverse Event|6
7803496|NCT01119846|12262866|FG000|Overall Study|Physician Decision|1
7803497|NCT01119846|12262867|FG001|Overall Study|Physician Decision|0
7803498|NCT01119846|12262868|FG002|Overall Study|Physician Decision|0
7803499|NCT01119846|12262866|FG000|Overall Study|Protocol Violation|0
7885148|NCT01796470|12385534|FG002|Overall Study|Initiated New Therapy|0
7885149|NCT01796470|12385535|FG003|Overall Study|Initiated New Therapy|0
7967642|NCT02769481|12524651|FG000|Overall Study|Protocol Violation|1
7967643|NCT02769481|12524652|FG001|Overall Study|Protocol Violation|0
7967644|NCT02769481|12524651|FG000|Overall Study|Adverse Event|3
7967645|NCT02769481|12524652|FG001|Overall Study|Adverse Event|6
7967646|NCT02769481|12524651|FG000|Overall Study|Entry Criteria Not Met|1
7967647|NCT02769481|12524652|FG001|Overall Study|Entry Criteria Not Met|2
7967648|NCT02769481|12524651|FG000|Overall Study|Withdrawal by Subject|14
7967649|NCT02769481|12524652|FG001|Overall Study|Withdrawal by Subject|16
7967650|NCT02769481|12524651|FG000|Overall Study|Lost to Follow-up|9
7967651|NCT02769481|12524652|FG001|Overall Study|Lost to Follow-up|9
7967652|NCT02769481|12524651|FG000|Overall Study|Physician Decision|0
7967653|NCT02769481|12524652|FG001|Overall Study|Physician Decision|1
7967654|NCT02769481|12524651|FG000|Overall Study|Terminated by Sponsor|1
7967655|NCT02769481|12524652|FG001|Overall Study|Terminated by Sponsor|0
7967656|NCT02769481|12524651|FG000|Overall Study|Death|0
7967657|NCT02769481|12524652|FG001|Overall Study|Death|1
7967658|NCT02769481|12524651|FG000|Overall Study|Undefined|4
7967659|NCT02769481|12524652|FG001|Overall Study|Undefined|1
7967660|NCT02769624|12524658|FG000|Overall Study|Lost to Follow-up|0
7967661|NCT02769624|12524659|FG001|Overall Study|Lost to Follow-up|1
7967662|NCT02769858|12524669|FG000|Overall Study|Withdrawal by Subject|2
7967663|NCT02770170|12524682|FG000|Overall Study|Withdrawal by Subject|0
7967664|NCT02770170|12524683|FG001|Overall Study|Withdrawal by Subject|0
7967665|NCT02770170|12524684|FG002|Overall Study|Withdrawal by Subject|0
7967666|NCT02770170|12524685|FG003|Overall Study|Withdrawal by Subject|2
7967667|NCT02770170|12524682|FG000|Overall Study|due to pregnancy|1
7967668|NCT02770170|12524683|FG001|Overall Study|due to pregnancy|0
7967669|NCT02770170|12524684|FG002|Overall Study|due to pregnancy|0
7967670|NCT02770170|12524685|FG003|Overall Study|due to pregnancy|0
7967671|NCT02770170|12524682|FG000|Overall Study|Lack of Efficacy|2
7967672|NCT02770170|12524683|FG001|Overall Study|Lack of Efficacy|0
7967673|NCT02770170|12524684|FG002|Overall Study|Lack of Efficacy|0
7967674|NCT02770170|12524685|FG003|Overall Study|Lack of Efficacy|1
7967675|NCT02770170|12524682|FG000|Overall Study|Adverse Event|4
7967676|NCT02770170|12524683|FG001|Overall Study|Adverse Event|3
7967677|NCT02770170|12524684|FG002|Overall Study|Adverse Event|5
7967678|NCT02770170|12524685|FG003|Overall Study|Adverse Event|3
7803500|NCT01119846|12262867|FG001|Overall Study|Protocol Violation|0
7803501|NCT01119846|12262868|FG002|Overall Study|Protocol Violation|1
7803502|NCT01119846|12262866|FG000|Overall Study|Withdrawal by Subject|0
7803503|NCT01119846|12262867|FG001|Overall Study|Withdrawal by Subject|0
7803504|NCT01119846|12262868|FG002|Overall Study|Withdrawal by Subject|4
7803505|NCT01119859|12262905|FG000|Overall Study|Adverse Event|9
7803506|NCT01119859|12262906|FG001|Overall Study|Adverse Event|10
7803507|NCT01119859|12262905|FG000|Overall Study|Death|2
7803508|NCT01119859|12262906|FG001|Overall Study|Death|0
7803509|NCT01119859|12262905|FG000|Overall Study|Insufficient therapeutic response|7
7803510|NCT01119859|12262906|FG001|Overall Study|Insufficient therapeutic response|14
7803511|NCT01119859|12262905|FG000|Overall Study|Refused treatment|3
7803512|NCT01119859|12262906|FG001|Overall Study|Refused treatment|6
7803513|NCT01119859|12262905|FG000|Overall Study|Failure to return|3
7803514|NCT01119859|12262906|FG001|Overall Study|Failure to return|0
7803515|NCT01119898|12262914|FG000|Overall Study|Adverse Event|4
7803516|NCT01119898|12262915|FG001|Overall Study|Adverse Event|5
7803517|NCT01119898|12262914|FG000|Overall Study|Withdrawal by Subject|1
7803518|NCT01119898|12262915|FG001|Overall Study|Withdrawal by Subject|4
7803519|NCT01119898|12262914|FG000|Overall Study|Lack of Efficacy|0
7803520|NCT01119898|12262915|FG001|Overall Study|Lack of Efficacy|2
7803521|NCT01119898|12262914|FG000|Overall Study|Protocol Violation|1
7803522|NCT01119898|12262915|FG001|Overall Study|Protocol Violation|1
7803523|NCT01119898|12262914|FG000|Overall Study|Medical procedure|1
7803524|NCT01119898|12262915|FG001|Overall Study|Medical procedure|0
7803525|NCT01119898|12262914|FG000|Overall Study|Randomized in error did not participate|1
7885150|NCT01796470|12385536|FG004|Overall Study|Initiated New Therapy|2
7885151|NCT01796470|12385532|FG000|Overall Study|Lost to Follow-up|0
7885152|NCT01796470|12385533|FG001|Overall Study|Lost to Follow-up|1
7885153|NCT01796470|12385534|FG002|Overall Study|Lost to Follow-up|0
7885154|NCT01796470|12385535|FG003|Overall Study|Lost to Follow-up|0
7885155|NCT01796470|12385536|FG004|Overall Study|Lost to Follow-up|0
7885156|NCT01796470|12385532|FG000|Overall Study|Physician Decision|5
7885157|NCT01796470|12385533|FG001|Overall Study|Physician Decision|4
7885158|NCT01796470|12385534|FG002|Overall Study|Physician Decision|1
7885159|NCT01796470|12385535|FG003|Overall Study|Physician Decision|0
7885160|NCT01796470|12385536|FG004|Overall Study|Physician Decision|1
7885161|NCT01796470|12385532|FG000|Overall Study|Progressive Disease|7
7885162|NCT01796470|12385533|FG001|Overall Study|Progressive Disease|7
7885163|NCT01796470|12385534|FG002|Overall Study|Progressive Disease|3
7967679|NCT02770170|12524682|FG000|Overall Study|due to disease worsening|0
7967680|NCT02770170|12524683|FG001|Overall Study|due to disease worsening|0
7861428|NCT01592240|12350407|FG004|Overall Study|Other|0
7861429|NCT01592240|12350408|FG005|Overall Study|Other|0
7861430|NCT01592240|12350409|FG006|Overall Study|Other|1
7967681|NCT02770170|12524684|FG002|Overall Study|due to disease worsening|0
7885164|NCT01796470|12385535|FG003|Overall Study|Progressive Disease|2
7885165|NCT01796470|12385536|FG004|Overall Study|Progressive Disease|0
7885166|NCT01796470|12385532|FG000|Overall Study|Protocol Criteria for Withdrawal|1
7885167|NCT01796470|12385533|FG001|Overall Study|Protocol Criteria for Withdrawal|0
7885168|NCT01796470|12385534|FG002|Overall Study|Protocol Criteria for Withdrawal|0
7885169|NCT01796470|12385535|FG003|Overall Study|Protocol Criteria for Withdrawal|0
7885170|NCT01796470|12385536|FG004|Overall Study|Protocol Criteria for Withdrawal|0
7885171|NCT01796470|12385532|FG000|Overall Study|Withdrawal by Subject|7
7885172|NCT01796470|12385533|FG001|Overall Study|Withdrawal by Subject|0
7885173|NCT01796470|12385534|FG002|Overall Study|Withdrawal by Subject|0
7885174|NCT01796470|12385535|FG003|Overall Study|Withdrawal by Subject|0
7885175|NCT01796470|12385536|FG004|Overall Study|Withdrawal by Subject|1
7885176|NCT01796548|12385552|FG000|Overall Study|Lost to Follow-up|1
7885177|NCT01796548|12385552|FG000|Overall Study|Other|2
7885178|NCT01796860|12385569|FG000|Overall Study|Withdrawal by Subject|3
7885179|NCT01796964|12385584|FG000|Overall Study|Adverse Event|1
7885180|NCT01796964|12385585|FG001|Overall Study|Adverse Event|1
7885181|NCT01796964|12385584|FG000|Overall Study|Death|1
7885182|NCT01796964|12385585|FG001|Overall Study|Death|0
7885183|NCT01796964|12385584|FG000|Overall Study|Protocol Violation|0
7885184|NCT01796964|12385585|FG001|Overall Study|Protocol Violation|1
7885185|NCT01796964|12385584|FG000|Overall Study|Withdrawal by Subject|1
7885186|NCT01796964|12385585|FG001|Overall Study|Withdrawal by Subject|1
7885187|NCT01797081|12385614|FG000|Overall Study|Adverse Event|1
7885188|NCT01797081|12385615|FG001|Overall Study|Adverse Event|0
7885189|NCT01797081|12385616|FG002|Overall Study|Adverse Event|1
7885190|NCT01797081|12385617|FG003|Overall Study|Adverse Event|0
7885191|NCT01797081|12385614|FG000|Overall Study|Pregnancy|1
7885192|NCT01797081|12385615|FG001|Overall Study|Pregnancy|0
7885193|NCT01797081|12385616|FG002|Overall Study|Pregnancy|0
7885194|NCT01797081|12385617|FG003|Overall Study|Pregnancy|0
7885195|NCT01797081|12385614|FG000|Overall Study|Personal Reasons|12
7885196|NCT01797081|12385615|FG001|Overall Study|Personal Reasons|4
7885197|NCT01797081|12385616|FG002|Overall Study|Personal Reasons|4
7885198|NCT01797081|12385617|FG003|Overall Study|Personal Reasons|8
7885199|NCT01797081|12385614|FG000|Overall Study|Protocol Violation|0
7885200|NCT01797081|12385615|FG001|Overall Study|Protocol Violation|0
7885201|NCT01797081|12385616|FG002|Overall Study|Protocol Violation|0
7885202|NCT01797081|12385617|FG003|Overall Study|Protocol Violation|1
7885203|NCT01797094|12385627|FG000|Overall Study|Adverse Event|1
7803526|NCT01119898|12262915|FG001|Overall Study|Randomized in error did not participate|0
7803527|NCT01119937|12262923|FG000|Overall Study|Adverse Event|11
7885204|NCT01797094|12385628|FG001|Overall Study|Adverse Event|1
7885205|NCT01797094|12385627|FG000|Overall Study|Personal Reasons|4
7803528|NCT01119937|12262924|FG001|Overall Study|Adverse Event|5
7803529|NCT01119937|12262923|FG000|Overall Study|Protocol deviation|3
7803530|NCT01119937|12262924|FG001|Overall Study|Protocol deviation|1
7803531|NCT01119937|12262923|FG000|Overall Study|Unsatisfactory therapeutic effect|3
7803532|NCT01119937|12262924|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7803533|NCT01119937|12262923|FG000|Overall Study|Withdrawal by Subject|2
7803534|NCT01119937|12262924|FG001|Overall Study|Withdrawal by Subject|1
7803535|NCT01119950|12262930|FG000|Overall Study|Adverse Event|25
7803536|NCT01119950|12262930|FG000|Overall Study|Withdrawal by Subject|9
7803537|NCT01119950|12262930|FG000|Overall Study|Protocol Violation|5
7803538|NCT01119950|12262930|FG000|Overall Study|Lost to Follow-up|4
7803539|NCT01119950|12262930|FG000|Overall Study|Administrative|2
7803540|NCT01119950|12262930|FG000|Overall Study|Abnormal lab value|1
7803541|NCT01119950|12262930|FG000|Overall Study|Death|1
7803542|NCT01119963|12262958|FG000|Overall Study|Lost to Follow-up|1
7803543|NCT01119963|12262959|FG001|Overall Study|Lost to Follow-up|1
7803544|NCT01120028|12262971|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
7803545|NCT01120028|12262972|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5
7803546|NCT01120028|12262973|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
7803547|NCT01120028|12262974|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
7803548|NCT01120028|12262971|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14
7803549|NCT01120028|12262972|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18
7803550|NCT01120028|12262973|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
7803551|NCT01120028|12262974|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
7803552|NCT01120067|12262987|FG000|Overall Study|Lost to Follow-up|3
7803553|NCT01120067|12262988|FG001|Overall Study|Lost to Follow-up|1
7803554|NCT01120067|12262987|FG000|Overall Study|fail to engage >3 sessions|2
7803555|NCT01120067|12262988|FG001|Overall Study|fail to engage >3 sessions|0
7803556|NCT01120093|12262994|FG000|Treatment Period 1|Adverse Event|0
7803557|NCT01120093|12262995|FG001|Treatment Period 1|Adverse Event|0
7803558|NCT01120093|12262996|FG002|Treatment Period 1|Adverse Event|1
7803559|NCT01120093|12262997|FG003|Treatment Period 1|Adverse Event|0
7803560|NCT01120093|12262998|FG004|Treatment Period 1|Adverse Event|1
7803561|NCT01120093|12262994|FG000|Treatment Period 1|Withdrawal by Subject|0
7803562|NCT01120093|12262995|FG001|Treatment Period 1|Withdrawal by Subject|1
7803563|NCT01120093|12262996|FG002|Treatment Period 1|Withdrawal by Subject|0
7803564|NCT01120093|12262997|FG003|Treatment Period 1|Withdrawal by Subject|0
7803565|NCT01120093|12262998|FG004|Treatment Period 1|Withdrawal by Subject|0
7803566|NCT01120093|12262994|FG000|Treatment Period 2|Adverse Event|0
7803567|NCT01120093|12262995|FG001|Treatment Period 2|Adverse Event|0
7803568|NCT01120093|12262996|FG002|Treatment Period 2|Adverse Event|0
7803569|NCT01120093|12262997|FG003|Treatment Period 2|Adverse Event|1
7803570|NCT01120093|12262998|FG004|Treatment Period 2|Adverse Event|0
7803571|NCT01120093|12262994|FG000|Treatment Period 2|Withdrawal by Subject|0
7803572|NCT01120093|12262995|FG001|Treatment Period 2|Withdrawal by Subject|0
7803573|NCT01120093|12262996|FG002|Treatment Period 2|Withdrawal by Subject|0
7803574|NCT01120093|12262997|FG003|Treatment Period 2|Withdrawal by Subject|0
7803575|NCT01120093|12262998|FG004|Treatment Period 2|Withdrawal by Subject|1
7803576|NCT01120093|12262994|FG000|Treatment Period 3|Lack of Efficacy|0
7803577|NCT01120093|12262995|FG001|Treatment Period 3|Lack of Efficacy|0
7803578|NCT01120093|12262996|FG002|Treatment Period 3|Lack of Efficacy|0
7803579|NCT01120093|12262997|FG003|Treatment Period 3|Lack of Efficacy|1
7803580|NCT01120093|12262998|FG004|Treatment Period 3|Lack of Efficacy|0
7803581|NCT01120093|12262994|FG000|Treatment Period 3|Adverse Event|0
7803582|NCT01120093|12262995|FG001|Treatment Period 3|Adverse Event|0
7803583|NCT01120093|12262996|FG002|Treatment Period 3|Adverse Event|0
7803584|NCT01120093|12262997|FG003|Treatment Period 3|Adverse Event|0
7803585|NCT01120093|12262998|FG004|Treatment Period 3|Adverse Event|1
7803586|NCT01120093|12262994|FG000|Treatment Period 3|Withdrawal by Subject|0
7803587|NCT01120093|12262995|FG001|Treatment Period 3|Withdrawal by Subject|0
7803588|NCT01120093|12262996|FG002|Treatment Period 3|Withdrawal by Subject|1
7803589|NCT01120093|12262997|FG003|Treatment Period 3|Withdrawal by Subject|0
7803590|NCT01120093|12262998|FG004|Treatment Period 3|Withdrawal by Subject|0
7803591|NCT01120093|12262994|FG000|Treatment Period 4|Adverse Event|1
7803592|NCT01120093|12262995|FG001|Treatment Period 4|Adverse Event|0
7803593|NCT01120093|12262996|FG002|Treatment Period 4|Adverse Event|0
7803594|NCT01120093|12262997|FG003|Treatment Period 4|Adverse Event|0
7803595|NCT01120093|12262998|FG004|Treatment Period 4|Adverse Event|0
7803596|NCT01120093|12262994|FG000|Treatment Period 5|Adverse Event|0
7803597|NCT01120093|12262995|FG001|Treatment Period 5|Adverse Event|1
7803598|NCT01120093|12262996|FG002|Treatment Period 5|Adverse Event|0
7803599|NCT01120093|12262997|FG003|Treatment Period 5|Adverse Event|1
7803600|NCT01120093|12262998|FG004|Treatment Period 5|Adverse Event|0
7803601|NCT01120184|12263013|FG000|Overall Study|Adverse Event|0
7885206|NCT01797094|12385628|FG001|Overall Study|Personal Reasons|0
7803602|NCT01120184|12263014|FG001|Overall Study|Adverse Event|1
7803603|NCT01120184|12263015|FG002|Overall Study|Adverse Event|0
7803604|NCT01120184|12263013|FG000|Overall Study|Lost to Follow-up|13
7803605|NCT01120184|12263014|FG001|Overall Study|Lost to Follow-up|13
7803606|NCT01120184|12263015|FG002|Overall Study|Lost to Follow-up|11
7803607|NCT01120184|12263013|FG000|Overall Study|Physician Decision|9
7803608|NCT01120184|12263014|FG001|Overall Study|Physician Decision|1
7803609|NCT01120184|12263015|FG002|Overall Study|Physician Decision|3
7803610|NCT01120184|12263013|FG000|Overall Study|Reason not Specified|8
7803611|NCT01120184|12263014|FG001|Overall Study|Reason not Specified|3
7803612|NCT01120184|12263015|FG002|Overall Study|Reason not Specified|12
7803613|NCT01120184|12263013|FG000|Overall Study|Sponsor Decision to Terminate Study|133
7803614|NCT01120184|12263014|FG001|Overall Study|Sponsor Decision to Terminate Study|144
7803615|NCT01120184|12263015|FG002|Overall Study|Sponsor Decision to Terminate Study|143
7803616|NCT01120184|12263013|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32
7803617|NCT01120184|12263014|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29
7803618|NCT01120184|12263015|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25
7803619|NCT01120184|12263013|FG000|Overall Study|Death|170
7803620|NCT01120184|12263014|FG001|Overall Study|Death|176
7803621|NCT01120184|12263015|FG002|Overall Study|Death|169
7803622|NCT01120210|12263035|FG000|MAIN INFUSION|Adverse Event|1
7803623|NCT01120210|12263036|FG001|MAIN INFUSION|Adverse Event|0
7803624|NCT01120210|12263035|FG000|MAIN INFUSION|Withdrawal by Subject|0
7803625|NCT01120210|12263036|FG001|MAIN INFUSION|Withdrawal by Subject|1
7803626|NCT01120275|12263063|FG000|Overall Study|Adverse Event|3
7803627|NCT01120275|12263063|FG000|Overall Study|Progression|27
7803628|NCT01120275|12263063|FG000|Overall Study|Ineligible|3
7803629|NCT01120275|12263063|FG000|Overall Study|Withdrawal by Subject|1
7803630|NCT01120275|12263063|FG000|Overall Study|Refusal|1
7803631|NCT01120275|12263063|FG000|Overall Study|Not specific|1
7803632|NCT01120379|12263068|FG000|One Year Timepoint|Withdrawal by Subject|41
7803633|NCT01120379|12263068|FG000|One Year Timepoint|Lost to Follow-up|115
7803634|NCT01120379|12263068|FG000|One Year Timepoint|Death|108
7803635|NCT01120379|12263068|FG000|One Year Timepoint|Physician Decision|9
7803636|NCT01120379|12263068|FG000|One Year Timepoint|Any other reason for early termination|5
7803637|NCT01120379|12263068|FG000|Two Year Timepoint|Withdrawal by Subject|11
7803638|NCT01120379|12263068|FG000|Two Year Timepoint|Lost to Follow-up|87
7803639|NCT01120379|12263068|FG000|Two Year Timepoint|Death|123
7803640|NCT01120379|12263068|FG000|Two Year Timepoint|Physician Decision|12
7803641|NCT01120379|12263068|FG000|Two Year Timepoint|Any other reason for early termination|4
7803642|NCT01120379|12263068|FG000|Three Year Timepoint|Withdrawal by Subject|25
7803643|NCT01120379|12263068|FG000|Three Year Timepoint|Lost to Follow-up|43
7803644|NCT01120379|12263068|FG000|Three Year Timepoint|Death|120
7803645|NCT01120379|12263068|FG000|Three Year Timepoint|Physician Decision|9
7803646|NCT01120379|12263068|FG000|Three Year Timepoint|Any other reason for early termination|17
7803647|NCT01120379|12263068|FG000|Four Year Timepoint|Withdrawal by Subject|5
7803648|NCT01120379|12263068|FG000|Four Year Timepoint|Lost to Follow-up|10
7803649|NCT01120379|12263068|FG000|Four Year Timepoint|Death|131
7803650|NCT01120379|12263068|FG000|Four Year Timepoint|Physician Decision|5
7803651|NCT01120379|12263068|FG000|Four Year Timepoint|Any other reason for early termination|217
7803652|NCT01120600|12263085|FG000|Overall Study|Adverse Event|7
7803653|NCT01120600|12263086|FG001|Overall Study|Adverse Event|7
7803654|NCT01120600|12263085|FG000|Overall Study|Excessive Bone Loss|0
7803655|NCT01120600|12263086|FG001|Overall Study|Excessive Bone Loss|4
7803656|NCT01120600|12263085|FG000|Overall Study|Lost to Follow-up|1
7803657|NCT01120600|12263086|FG001|Overall Study|Lost to Follow-up|3
7803658|NCT01120600|12263085|FG000|Overall Study|Physician Decision|1
7803659|NCT01120600|12263086|FG001|Overall Study|Physician Decision|3
7803660|NCT01120600|12263085|FG000|Overall Study|Protocol Violation|0
7803661|NCT01120600|12263086|FG001|Overall Study|Protocol Violation|4
7803662|NCT01120600|12263085|FG000|Overall Study|Withdrawal by Subject|10
7803663|NCT01120600|12263086|FG001|Overall Study|Withdrawal by Subject|11
7803664|NCT01120626|12263094|FG000|Overall Study|Withdrawal by Subject|1
7803665|NCT01120626|12263095|FG001|Overall Study|Withdrawal by Subject|0
7803666|NCT01120691|12263121|FG000|Overall Study|Adverse Event|59
7803667|NCT01120691|12263122|FG001|Overall Study|Adverse Event|67
7803668|NCT01120691|12263123|FG002|Overall Study|Adverse Event|47
7803669|NCT01120691|12263121|FG000|Overall Study|Subject withdrew consent|33
7803670|NCT01120691|12263122|FG001|Overall Study|Subject withdrew consent|50
7803671|NCT01120691|12263123|FG002|Overall Study|Subject withdrew consent|44
7803672|NCT01120691|12263121|FG000|Overall Study|Death|21
7803673|NCT01120691|12263122|FG001|Overall Study|Death|22
7803674|NCT01120691|12263123|FG002|Overall Study|Death|24
7803675|NCT01120691|12263121|FG000|Overall Study|Unsatisfactory therapeutic effect|18
7803676|NCT01120691|12263122|FG001|Overall Study|Unsatisfactory therapeutic effect|32
7803677|NCT01120691|12263123|FG002|Overall Study|Unsatisfactory therapeutic effect|38
7803678|NCT01120691|12263121|FG000|Overall Study|Administrative problems|15
7803679|NCT01120691|12263122|FG001|Overall Study|Administrative problems|8
7803680|NCT01120691|12263123|FG002|Overall Study|Administrative problems|9
7803681|NCT01120691|12263121|FG000|Overall Study|Protocol deviation|13
7803682|NCT01120691|12263122|FG001|Overall Study|Protocol deviation|12
7803683|NCT01120691|12263123|FG002|Overall Study|Protocol deviation|12
7803684|NCT01120691|12263121|FG000|Overall Study|Lost to Follow-up|5
7803685|NCT01120691|12263122|FG001|Overall Study|Lost to Follow-up|6
7803686|NCT01120691|12263123|FG002|Overall Study|Lost to Follow-up|4
7803687|NCT01120691|12263121|FG000|Overall Study|Abnormal test procedure result(s)|3
7803688|NCT01120691|12263122|FG001|Overall Study|Abnormal test procedure result(s)|2
7803689|NCT01120691|12263123|FG002|Overall Study|Abnormal test procedure result(s)|1
7803690|NCT01120691|12263121|FG000|Overall Study|Patient's inability to use the device|3
7803691|NCT01120691|12263122|FG001|Overall Study|Patient's inability to use the device|1
7803692|NCT01120691|12263123|FG002|Overall Study|Patient's inability to use the device|0
7803693|NCT01120691|12263121|FG000|Overall Study|Abnormal laboratory value(s)|1
7803694|NCT01120691|12263122|FG001|Overall Study|Abnormal laboratory value(s)|3
7803695|NCT01120691|12263123|FG002|Overall Study|Abnormal laboratory value(s)|4
7803696|NCT01120717|12263214|FG000|Overall Study|Withdrawal by Subject|11
7803697|NCT01120717|12263215|FG001|Overall Study|Withdrawal by Subject|6
7803698|NCT01120717|12263214|FG000|Overall Study|Adverse Event|10
7803699|NCT01120717|12263215|FG001|Overall Study|Adverse Event|6
7803700|NCT01120717|12263214|FG000|Overall Study|Protocol Deviation|2
7803701|NCT01120717|12263215|FG001|Overall Study|Protocol Deviation|5
7803702|NCT01120717|12263214|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
7803703|NCT01120717|12263215|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3
7803704|NCT01120717|12263214|FG000|Overall Study|Lost to Follow-up|2
7803705|NCT01120717|12263215|FG001|Overall Study|Lost to Follow-up|3
7803706|NCT01120717|12263214|FG000|Overall Study|Death|3
7803707|NCT01120717|12263215|FG001|Overall Study|Death|1
7803708|NCT01120717|12263214|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
7803709|NCT01120717|12263215|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
7803710|NCT01120756|12263223|FG000|Overall Study|Withdrawal by Subject|1
7803711|NCT01120756|12263224|FG001|Overall Study|Withdrawal by Subject|1
7803712|NCT01120782|12263230|FG000|Overall Study|Test article shipping error|11
7803713|NCT01120899|12263242|FG000|Overall Study|Withdrawal by Subject|3
7803714|NCT01121146|12263252|FG000|Overall Study|Death|17
7803715|NCT01121146|12263253|FG001|Overall Study|Death|15
7803716|NCT01121146|12263252|FG000|Overall Study|Adverse Event|2
7803717|NCT01121146|12263253|FG001|Overall Study|Adverse Event|11
7803718|NCT01121146|12263252|FG000|Overall Study|Lost to Follow-up|7
7803719|NCT01121146|12263253|FG001|Overall Study|Lost to Follow-up|16
7803720|NCT01121185|12263272|FG000|Overall Study|Not infused|0
7803721|NCT01121185|12263273|FG001|Overall Study|Not infused|1
7803722|NCT01121185|12263272|FG000|Overall Study|Not transplanted|1
7803723|NCT01121185|12263273|FG001|Overall Study|Not transplanted|0
7803724|NCT01121263|12263303|FG000|Overall Study|Death|3
7803725|NCT01121263|12263304|FG001|Overall Study|Death|2
7803726|NCT01121263|12263303|FG000|Overall Study|Lost to Follow-up|22
7803727|NCT01121263|12263304|FG001|Overall Study|Lost to Follow-up|12
7803728|NCT01121263|12263303|FG000|Overall Study|Withdrawal by Subject|0
7803729|NCT01121263|12263304|FG001|Overall Study|Withdrawal by Subject|1
7803730|NCT01121393|12263314|FG000|Overall Study|Progressive disease|201
7803731|NCT01121393|12263315|FG001|Overall Study|Progressive disease|20
7803732|NCT01121393|12263314|FG000|Overall Study|Other Adverse events|24
7885207|NCT01797094|12385627|FG000|Overall Study|Protocol Violation|0
7803733|NCT01121393|12263315|FG001|Overall Study|Other Adverse events|45
7803734|NCT01121393|12263314|FG000|Overall Study|Non-compliant with protocol|0
7803735|NCT01121393|12263315|FG001|Overall Study|Non-compliant with protocol|3
7803736|NCT01121393|12263314|FG000|Overall Study|Lost to Follow-up|1
7803737|NCT01121393|12263315|FG001|Overall Study|Lost to Follow-up|0
7803738|NCT01121393|12263314|FG000|Overall Study|Refused cont. medication|7
7803739|NCT01121393|12263315|FG001|Overall Study|Refused cont. medication|7
7803740|NCT01121393|12263314|FG000|Overall Study|Not treated|3
7803741|NCT01121393|12263315|FG001|Overall Study|Not treated|9
7803742|NCT01121393|12263314|FG000|Overall Study|Other than listed|6
7803743|NCT01121393|12263315|FG001|Overall Study|Other than listed|0
7803744|NCT01121406|12263329|FG000|Overall Study|Progressive disease RECIST|44
7803745|NCT01121406|12263330|FG001|Overall Study|Progressive disease RECIST|28
7803746|NCT01121406|12263329|FG000|Overall Study|Wors. or AE of underlying cancer disease|4
7803747|NCT01121406|12263330|FG001|Overall Study|Wors. or AE of underlying cancer disease|6
7803748|NCT01121406|12263329|FG000|Overall Study|Other AE|3
7803749|NCT01121406|12263330|FG001|Overall Study|Other AE|10
7803750|NCT01121406|12263329|FG000|Overall Study|Non-compliant with protocol|0
7803751|NCT01121406|12263330|FG001|Overall Study|Non-compliant with protocol|2
7803752|NCT01121406|12263329|FG000|Overall Study|Lost to Follow-up|0
7803753|NCT01121406|12263330|FG001|Overall Study|Lost to Follow-up|1
7803754|NCT01121406|12263329|FG000|Overall Study|Refused continuation of study med.|1
7803755|NCT01121406|12263330|FG001|Overall Study|Refused continuation of study med.|2
7803756|NCT01121406|12263329|FG000|Overall Study|Reason other than specified above|2
7803757|NCT01121406|12263330|FG001|Overall Study|Reason other than specified above|6
7803758|NCT01121406|12263329|FG000|Overall Study|Not treated|1
7803759|NCT01121406|12263330|FG001|Overall Study|Not treated|0
7803760|NCT01121484|12263341|FG000|Overall Study|Adverse Event|12
7803761|NCT01121484|12263342|FG001|Overall Study|Adverse Event|5
7803762|NCT01121484|12263341|FG000|Overall Study|Lack of Efficacy|3
7803763|NCT01121484|12263342|FG001|Overall Study|Lack of Efficacy|11
7803764|NCT01121484|12263341|FG000|Overall Study|Lost to Follow-up|5
7803765|NCT01121484|12263342|FG001|Overall Study|Lost to Follow-up|9
7803766|NCT01121484|12263341|FG000|Overall Study|Physician Decision|0
7803767|NCT01121484|12263342|FG001|Overall Study|Physician Decision|3
7803768|NCT01121484|12263341|FG000|Overall Study|Protocol Violation|1
7803769|NCT01121484|12263342|FG001|Overall Study|Protocol Violation|0
7803770|NCT01121484|12263341|FG000|Overall Study|Withdrawal by Subject|8
7803771|NCT01121484|12263342|FG001|Overall Study|Withdrawal by Subject|7
7803772|NCT01121484|12263341|FG000|Overall Study|Discontinuation of study by sponsor|0
7803773|NCT01121484|12263342|FG001|Overall Study|Discontinuation of study by sponsor|1
7803774|NCT01121484|12263341|FG000|Overall Study|Other|3
7803775|NCT01121484|12263342|FG001|Overall Study|Other|3
7803776|NCT01121484|12263341|FG000|Overall Study|Randomized, not treated|1
7885208|NCT01797094|12385628|FG001|Overall Study|Protocol Violation|1
7885209|NCT01797094|12385627|FG000|Overall Study|Other Miscellaneous Reasons|1
7885210|NCT01797094|12385628|FG001|Overall Study|Other Miscellaneous Reasons|0
7885211|NCT01797120|12385636|FG000|Overall Study|Disesae progression|37
7885212|NCT01797120|12385637|FG001|Overall Study|Disesae progression|49
7885213|NCT01797120|12385636|FG000|Overall Study|Adverse Event|13
7885214|NCT01797120|12385637|FG001|Overall Study|Adverse Event|5
7885215|NCT01797120|12385636|FG000|Overall Study|Withdrawal by Subject|6
7885216|NCT01797120|12385637|FG001|Overall Study|Withdrawal by Subject|6
7885217|NCT01797120|12385636|FG000|Overall Study|Symptomatic progression|2
7885218|NCT01797120|12385637|FG001|Overall Study|Symptomatic progression|1
7885219|NCT01797120|12385636|FG000|Overall Study|Non-compliance|1
7885220|NCT01797120|12385637|FG001|Overall Study|Non-compliance|0
7885221|NCT01797120|12385636|FG000|Overall Study|Physician Decision|3
7885222|NCT01797120|12385637|FG001|Overall Study|Physician Decision|0
7885223|NCT01797120|12385636|FG000|Overall Study|still on treatment|2
7885224|NCT01797120|12385637|FG001|Overall Study|still on treatment|4
7885225|NCT01797120|12385636|FG000|Overall Study|never start protocol therapy|2
7885226|NCT01797120|12385637|FG001|Overall Study|never start protocol therapy|0
7885227|NCT01797185|12385651|FG000|Overall Study|Adverse Event|5
7885228|NCT01797185|12385652|FG001|Overall Study|Adverse Event|15
7885229|NCT01797185|12385653|FG002|Overall Study|Adverse Event|6
7885230|NCT01797185|12385651|FG000|Overall Study|Withdrawal by Subject|6
7885231|NCT01797185|12385652|FG001|Overall Study|Withdrawal by Subject|9
7885232|NCT01797185|12385653|FG002|Overall Study|Withdrawal by Subject|5
7885233|NCT01797185|12385651|FG000|Overall Study|Site terminated|8
7885234|NCT01797185|12385652|FG001|Overall Study|Site terminated|4
7885235|NCT01797185|12385653|FG002|Overall Study|Site terminated|0
7885236|NCT01797185|12385651|FG000|Overall Study|Lost to Follow-up|2
7885237|NCT01797185|12385652|FG001|Overall Study|Lost to Follow-up|6
7885238|NCT01797185|12385653|FG002|Overall Study|Lost to Follow-up|1
7885239|NCT01797185|12385651|FG000|Overall Study|Withdrawn per sponsor|5
7885240|NCT01797185|12385652|FG001|Overall Study|Withdrawn per sponsor|0
7885241|NCT01797185|12385653|FG002|Overall Study|Withdrawn per sponsor|0
7885242|NCT01797185|12385651|FG000|Overall Study|Physician Decision|1
7885243|NCT01797185|12385652|FG001|Overall Study|Physician Decision|3
7885244|NCT01797185|12385653|FG002|Overall Study|Physician Decision|0
7885245|NCT01797185|12385651|FG000|Overall Study|Protocol Violation|1
7803777|NCT01121484|12263342|FG001|Overall Study|Randomized, not treated|4
7803778|NCT01121536|12263348|FG000|Overall Study|Adverse Event|63
7885246|NCT01797185|12385652|FG001|Overall Study|Protocol Violation|1
7885247|NCT01797185|12385653|FG002|Overall Study|Protocol Violation|0
7885248|NCT01797263|12385663|FG000|Overall Study|Withdrawal by Subject|21
7967682|NCT02770170|12524685|FG003|Overall Study|due to disease worsening|1
7967683|NCT02770248|12524697|FG000|Overall Study|Adverse Event|0
7885249|NCT01797263|12385664|FG001|Overall Study|Withdrawal by Subject|25
7885250|NCT01797263|12385663|FG000|Overall Study|Death|1
7885251|NCT01797263|12385664|FG001|Overall Study|Death|0
7885252|NCT01797263|12385663|FG000|Overall Study|Lost to Follow-up|15
7885253|NCT01797263|12385664|FG001|Overall Study|Lost to Follow-up|15
7885254|NCT01797302|12385673|FG000|Overall Study|Lost to Follow-up|16
7885255|NCT01797302|12385674|FG001|Overall Study|Lost to Follow-up|23
7885256|NCT01797302|12385675|FG002|Overall Study|Lost to Follow-up|22
7885257|NCT01797302|12385673|FG000|Overall Study|Withdrawal by Subject|1
7885258|NCT01797302|12385674|FG001|Overall Study|Withdrawal by Subject|3
7885259|NCT01797302|12385675|FG002|Overall Study|Withdrawal by Subject|4
7885260|NCT01797432|12385692|FG000|Overall Study|Lost to Follow-up|1
7885261|NCT01797432|12385692|FG000|Overall Study|Adverse Event|1
7885262|NCT01797432|12385692|FG000|Overall Study|Withdrawal by Subject|1
7885263|NCT01797432|12385692|FG000|Overall Study|lived too far from study site|1
7885264|NCT01797445|12385698|FG000|Double-Blind Phase|Randomized but Not Treated|4
7885265|NCT01797445|12385699|FG001|Double-Blind Phase|Randomized but Not Treated|2
7885266|NCT01797445|12385698|FG000|Double-Blind Phase|Adverse Event|3
7885267|NCT01797445|12385699|FG001|Double-Blind Phase|Adverse Event|0
7885268|NCT01797445|12385698|FG000|Double-Blind Phase|Death|5
7885269|NCT01797445|12385699|FG001|Double-Blind Phase|Death|4
7885270|NCT01797445|12385698|FG000|Double-Blind Phase|Pregnancy|0
7885271|NCT01797445|12385699|FG001|Double-Blind Phase|Pregnancy|1
7885272|NCT01797445|12385698|FG000|Double-Blind Phase|Lack of Efficacy|1
7885273|NCT01797445|12385699|FG001|Double-Blind Phase|Lack of Efficacy|2
7885274|NCT01797445|12385698|FG000|Double-Blind Phase|Investigator's Discretion|15
7885275|NCT01797445|12385699|FG001|Double-Blind Phase|Investigator's Discretion|17
7885276|NCT01797445|12385698|FG000|Double-Blind Phase|Noncompliance with Study Drug|5
7885277|NCT01797445|12385699|FG001|Double-Blind Phase|Noncompliance with Study Drug|1
7885278|NCT01797445|12385698|FG000|Double-Blind Phase|Protocol Violation|0
7885279|NCT01797445|12385699|FG001|Double-Blind Phase|Protocol Violation|1
7885280|NCT01797445|12385698|FG000|Double-Blind Phase|Withdrew Consent|20
7885281|NCT01797445|12385699|FG001|Double-Blind Phase|Withdrew Consent|35
7885282|NCT01797445|12385698|FG000|Double-Blind Phase|Lost to Follow-up|34
7885283|NCT01797445|12385699|FG001|Double-Blind Phase|Lost to Follow-up|26
7803779|NCT01121536|12263348|FG000|Overall Study|Lack of Efficacy|35
7803780|NCT01121536|12263348|FG000|Overall Study|Withdrawal by Subject|65
7803781|NCT01121536|12263348|FG000|Overall Study|Protocol Violation|20
7803782|NCT01121536|12263348|FG000|Overall Study|Noncompliance with study medication|12
7803783|NCT01121536|12263348|FG000|Overall Study|Noncompliance with study procedures|9
7803784|NCT01121536|12263348|FG000|Overall Study|Lost to Follow-up|39
7803785|NCT01121536|12263348|FG000|Overall Study|Other|118
7803786|NCT01121549|12263352|FG000|Overall Study|Adverse Event|10
7803787|NCT01121549|12263352|FG000|Overall Study|Lack of Efficacy|11
7803788|NCT01121549|12263352|FG000|Overall Study|Lost to Follow-up|12
7803789|NCT01121549|12263352|FG000|Overall Study|Did not meet entrance criteria|9
7803790|NCT01121549|12263352|FG000|Overall Study|Study terminated by sponsor|197
7803791|NCT01121549|12263352|FG000|Overall Study|Pregnancy|1
7803792|NCT01121549|12263352|FG000|Overall Study|Protocol Violation|33
7803793|NCT01121549|12263352|FG000|Overall Study|Withdrawal by Subject|16
7803794|NCT01121549|12263352|FG000|Overall Study|Other|58
7803795|NCT01121562|12263356|FG000|Overall Study|Objective progression or relapse|8
7803796|NCT01121562|12263356|FG000|Overall Study|Withdrawal by Subject|1
7803797|NCT01121562|12263356|FG000|Overall Study|Adverse Event|1
7803798|NCT01121562|12263356|FG000|Overall Study|Sponsor Decision|1
7803799|NCT01121562|12263356|FG000|Overall Study|Met study discontinuation criteria|1
7803800|NCT01121575|12263366|FG000|Overall Study|Participant Refused Further Follow-Up|0
7803801|NCT01121575|12263367|FG001|Overall Study|Participant Refused Further Follow-Up|0
7803802|NCT01121575|12263368|FG002|Overall Study|Participant Refused Further Follow-Up|0
7803803|NCT01121575|12263369|FG003|Overall Study|Participant Refused Further Follow-Up|0
7803804|NCT01121575|12263370|FG004|Overall Study|Participant Refused Further Follow-Up|5
7803805|NCT01121575|12263371|FG005|Overall Study|Participant Refused Further Follow-Up|1
7803806|NCT01121575|12263366|FG000|Overall Study|Unspecified Reasons|8
7803807|NCT01121575|12263367|FG001|Overall Study|Unspecified Reasons|6
7803808|NCT01121575|12263368|FG002|Overall Study|Unspecified Reasons|7
7803809|NCT01121575|12263369|FG003|Overall Study|Unspecified Reasons|5
7803810|NCT01121575|12263370|FG004|Overall Study|Unspecified Reasons|13
7803811|NCT01121575|12263371|FG005|Overall Study|Unspecified Reasons|10
7803812|NCT01121575|12263366|FG000|Overall Study|Death|6
7803813|NCT01121575|12263367|FG001|Overall Study|Death|0
7803814|NCT01121575|12263368|FG002|Overall Study|Death|0
7803815|NCT01121575|12263369|FG003|Overall Study|Death|1
7803816|NCT01121575|12263370|FG004|Overall Study|Death|7
7803817|NCT01121575|12263371|FG005|Overall Study|Death|1
7803818|NCT01121666|12263392|FG000|Overall Study|Protocol Violation|29
7803819|NCT01121666|12263393|FG001|Overall Study|Protocol Violation|10
7803820|NCT01121757|12263401|FG000|First Drug|Death|1
7803821|NCT01121757|12263402|FG001|First Drug|Death|0
7803822|NCT01121757|12263401|FG000|First Drug|Disease Progression|0
7803823|NCT01121757|12263402|FG001|First Drug|Disease Progression|2
7803824|NCT01121757|12263401|FG000|Combination|Physician Decision|0
7803825|NCT01121757|12263402|FG001|Combination|Physician Decision|1
7803826|NCT01121757|12263401|FG000|Combination|Disease Progression|2
7803827|NCT01121757|12263402|FG001|Combination|Disease Progression|0
7803828|NCT01121900|12263410|FG000|First Intervention Period|Adverse Event|1
7803829|NCT01121900|12263411|FG001|First Intervention Period|Adverse Event|1
7803830|NCT01121900|12263410|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
7803831|NCT01121900|12263411|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7803832|NCT01121913|12263417|FG000|First Intervention Period|Adverse Event|0
7803833|NCT01121913|12263418|FG001|First Intervention Period|Adverse Event|0
7803834|NCT01121913|12263419|FG002|First Intervention Period|Adverse Event|1
7803835|NCT01121913|12263420|FG003|First Intervention Period|Adverse Event|0
7803836|NCT01121913|12263417|FG000|First Washout Period|Withdrawal by Subject|1
7803837|NCT01121913|12263418|FG001|First Washout Period|Withdrawal by Subject|0
7803838|NCT01121913|12263419|FG002|First Washout Period|Withdrawal by Subject|0
7803839|NCT01121913|12263420|FG003|First Washout Period|Withdrawal by Subject|0
7803840|NCT01121913|12263417|FG000|Second Intervention Period|Adverse Event|0
7803841|NCT01121913|12263418|FG001|Second Intervention Period|Adverse Event|0
7803842|NCT01121913|12263419|FG002|Second Intervention Period|Adverse Event|1
7803843|NCT01121913|12263420|FG003|Second Intervention Period|Adverse Event|0
7803844|NCT01121913|12263417|FG000|Second Washout Period|Withdrawal by Subject|0
7803845|NCT01121913|12263418|FG001|Second Washout Period|Withdrawal by Subject|0
7803846|NCT01121913|12263419|FG002|Second Washout Period|Withdrawal by Subject|1
7803847|NCT01121913|12263420|FG003|Second Washout Period|Withdrawal by Subject|0
7803848|NCT01121913|12263417|FG000|Third Washout Period|Adverse Event|1
7803849|NCT01121913|12263418|FG001|Third Washout Period|Adverse Event|0
7803850|NCT01121913|12263419|FG002|Third Washout Period|Adverse Event|0
7803851|NCT01121913|12263420|FG003|Third Washout Period|Adverse Event|0
7803852|NCT01121926|12263430|FG000|First Intervention Period|Adverse Event|1
7803853|NCT01121926|12263431|FG001|First Intervention Period|Adverse Event|0
7803854|NCT01121926|12263430|FG000|Washout Period|Adverse Event|0
7803855|NCT01121926|12263431|FG001|Washout Period|Adverse Event|1
7803856|NCT01121926|12263430|FG000|Washout Period|Positive pregnancy test|0
7803857|NCT01121926|12263431|FG001|Washout Period|Positive pregnancy test|1
7803858|NCT01121991|12263444|FG000|Overall Study|Lack of Ovarian Response|2
7803859|NCT01121991|12263444|FG000|Overall Study|No Oocytes Retrieved|3
7803860|NCT01121991|12263444|FG000|Overall Study|No Fertilization|1
7861431|NCT01592240|12350403|FG000|Overall Study|Did Not Meet Entrance Criteria|1
7861432|NCT01592240|12350404|FG001|Overall Study|Did Not Meet Entrance Criteria|0
7861433|NCT01592240|12350405|FG002|Overall Study|Did Not Meet Entrance Criteria|1
7861434|NCT01592240|12350406|FG003|Overall Study|Did Not Meet Entrance Criteria|0
7861435|NCT01592240|12350407|FG004|Overall Study|Did Not Meet Entrance Criteria|0
7861436|NCT01592240|12350408|FG005|Overall Study|Did Not Meet Entrance Criteria|0
7861437|NCT01592240|12350409|FG006|Overall Study|Did Not Meet Entrance Criteria|0
7861438|NCT01592292|12350432|FG000|Overall Study|Follow-up loss|3
7861439|NCT01592292|12350433|FG001|Overall Study|Follow-up loss|3
7861440|NCT01592292|12350434|FG002|Overall Study|Follow-up loss|1
7861441|NCT01592292|12350435|FG003|Overall Study|Follow-up loss|0
7861442|NCT01592292|12350432|FG000|Overall Study|Withdrew consent|2
7861443|NCT01592292|12350433|FG001|Overall Study|Withdrew consent|1
7861444|NCT01592292|12350434|FG002|Overall Study|Withdrew consent|0
7861445|NCT01592292|12350435|FG003|Overall Study|Withdrew consent|0
7861446|NCT01592292|12350432|FG000|Overall Study|Other|1
7861447|NCT01592292|12350433|FG001|Overall Study|Other|1
7861448|NCT01592292|12350434|FG002|Overall Study|Other|2
7861449|NCT01592292|12350435|FG003|Overall Study|Other|1
7861450|NCT01592344|12350443|FG000|Overall Study|Adverse Event|1
7861451|NCT01592344|12350444|FG001|Overall Study|Adverse Event|1
7861452|NCT01592344|12350443|FG000|Overall Study|Lack of Efficacy|1
7861453|NCT01592344|12350444|FG001|Overall Study|Lack of Efficacy|0
7861454|NCT01592344|12350443|FG000|Overall Study|not available at primary outcome visit|2
7861455|NCT01592344|12350444|FG001|Overall Study|not available at primary outcome visit|4
7861456|NCT01592409|12350462|FG000|Overall Study|Withdrawal by Subject|0
7861457|NCT01592409|12350463|FG001|Overall Study|Withdrawal by Subject|1
7861458|NCT01592695|12350494|FG000|Overall Study|Lost to Follow-up|8
7861459|NCT01592695|12350495|FG001|Overall Study|Lost to Follow-up|4
7861460|NCT01592708|12350503|FG000|Overall Study|Protocol Violation|3
7861461|NCT01592708|12350504|FG001|Overall Study|Protocol Violation|0
7861462|NCT01592747|12350516|FG000|Overall Study|Loss of Therapeutic Response|107
7861463|NCT01592747|12350517|FG001|Overall Study|Loss of Therapeutic Response|108
7861464|NCT01592747|12350518|FG002|Overall Study|Loss of Therapeutic Response|100
7861465|NCT01592747|12350516|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
7861466|NCT01592747|12350517|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
7861467|NCT01592747|12350518|FG002|Overall Study|Inclusion/Exclusion criteria not met|1
7861468|NCT01592747|12350516|FG000|Overall Study|Adverse Event|1
7861469|NCT01592747|12350517|FG001|Overall Study|Adverse Event|0
7861470|NCT01592747|12350518|FG002|Overall Study|Adverse Event|0
7861471|NCT01592747|12350516|FG000|Overall Study|Protocol Violation|4
7861472|NCT01592747|12350517|FG001|Overall Study|Protocol Violation|0
7861473|NCT01592747|12350518|FG002|Overall Study|Protocol Violation|4
7861474|NCT01592747|12350516|FG000|Overall Study|Lack of Efficacy|0
7861475|NCT01592747|12350517|FG001|Overall Study|Lack of Efficacy|1
7803861|NCT01122173|12263499|FG000|Overall Study|Lost to Follow-up|3
7803862|NCT01122173|12263499|FG000|Overall Study|Withdrawal by Subject|3
7803863|NCT01122173|12263499|FG000|Overall Study|Left study for other reasons|3
7803864|NCT01122264|12263552|FG000|Overall Study|Adverse Event|6
7803865|NCT01122264|12263553|FG001|Overall Study|Adverse Event|5
7803866|NCT01122264|12263554|FG002|Overall Study|Adverse Event|7
7803867|NCT01122264|12263552|FG000|Overall Study|Death|1
7803868|NCT01122264|12263553|FG001|Overall Study|Death|0
7803869|NCT01122264|12263554|FG002|Overall Study|Death|0
7803870|NCT01122264|12263552|FG000|Overall Study|Lost to Follow-up|5
7803871|NCT01122264|12263553|FG001|Overall Study|Lost to Follow-up|9
7803872|NCT01122264|12263554|FG002|Overall Study|Lost to Follow-up|13
7803873|NCT01122264|12263552|FG000|Overall Study|Entry Criteria Not Met|1
7803874|NCT01122264|12263553|FG001|Overall Study|Entry Criteria Not Met|0
7803875|NCT01122264|12263554|FG002|Overall Study|Entry Criteria Not Met|0
7803876|NCT01122264|12263552|FG000|Overall Study|Protocol Violation|7
7803877|NCT01122264|12263553|FG001|Overall Study|Protocol Violation|7
7803878|NCT01122264|12263554|FG002|Overall Study|Protocol Violation|9
7803879|NCT01122264|12263552|FG000|Overall Study|Withdrawal by Subject|6
7803880|NCT01122264|12263553|FG001|Overall Study|Withdrawal by Subject|6
7803881|NCT01122264|12263554|FG002|Overall Study|Withdrawal by Subject|16
7803882|NCT01122264|12263552|FG000|Overall Study|Physician Decision|3
7803883|NCT01122264|12263553|FG001|Overall Study|Physician Decision|1
7803884|NCT01122264|12263554|FG002|Overall Study|Physician Decision|1
7803885|NCT01122264|12263552|FG000|Overall Study|Lack of Efficacy|3
7803886|NCT01122264|12263553|FG001|Overall Study|Lack of Efficacy|1
7803887|NCT01122264|12263554|FG002|Overall Study|Lack of Efficacy|1
7803888|NCT01122394|12263572|FG000|Overall Study|Withdrawal by Subject|1
7803889|NCT01122394|12263573|FG001|Overall Study|Withdrawal by Subject|1
7803890|NCT01122394|12263572|FG000|Overall Study|Lost to Follow-up|2
7803891|NCT01122394|12263573|FG001|Overall Study|Lost to Follow-up|2
7803892|NCT01122394|12263572|FG000|Overall Study|Adverse Event|0
7803893|NCT01122394|12263573|FG001|Overall Study|Adverse Event|1
7803894|NCT01122576|12263593|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0
7803895|NCT01122576|12263594|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1
7803896|NCT01122576|12263595|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2
7803897|NCT01122576|12263593|FG000|Post-Cataract Surgery|Central Macular Edema|0
7803898|NCT01122576|12263594|FG001|Post-Cataract Surgery|Central Macular Edema|0
7803899|NCT01122576|12263595|FG002|Post-Cataract Surgery|Central Macular Edema|1
7803900|NCT01122576|12263593|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0
7803901|NCT01122576|12263594|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0
7803902|NCT01122576|12263595|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1
7803903|NCT01122680|12263606|FG000|Period 1 (4 Weeks)|Adverse Event|1
7803904|NCT01122680|12263607|FG001|Period 1 (4 Weeks)|Adverse Event|0
7803905|NCT01122680|12263608|FG002|Period 1 (4 Weeks)|Adverse Event|0
7803906|NCT01122680|12263609|FG003|Period 1 (4 Weeks)|Adverse Event|0
7803907|NCT01122680|12263606|FG000|Period 1 (4 Weeks)|Protocol Violation|1
7803908|NCT01122680|12263607|FG001|Period 1 (4 Weeks)|Protocol Violation|0
7803909|NCT01122680|12263608|FG002|Period 1 (4 Weeks)|Protocol Violation|0
7803910|NCT01122680|12263609|FG003|Period 1 (4 Weeks)|Protocol Violation|0
7803911|NCT01122680|12263606|FG000|Period 1 (4 Weeks)|Other|1
7803912|NCT01122680|12263607|FG001|Period 1 (4 Weeks)|Other|1
7803913|NCT01122680|12263608|FG002|Period 1 (4 Weeks)|Other|0
7803914|NCT01122680|12263609|FG003|Period 1 (4 Weeks)|Other|0
7803915|NCT01122680|12263606|FG000|Period 2 (4 Weeks)|Protocol Violation|0
7803916|NCT01122680|12263607|FG001|Period 2 (4 Weeks)|Protocol Violation|0
7803917|NCT01122680|12263608|FG002|Period 2 (4 Weeks)|Protocol Violation|0
7803918|NCT01122680|12263609|FG003|Period 2 (4 Weeks)|Protocol Violation|1
7803919|NCT01122680|12263606|FG000|Period 2 (4 Weeks)|Other|1
7803920|NCT01122680|12263607|FG001|Period 2 (4 Weeks)|Other|0
7803921|NCT01122680|12263608|FG002|Period 2 (4 Weeks)|Other|0
7803922|NCT01122680|12263609|FG003|Period 2 (4 Weeks)|Other|0
7803923|NCT01122680|12263606|FG000|Period 3 (4 Weeks)|Adverse Event|1
7803924|NCT01122680|12263607|FG001|Period 3 (4 Weeks)|Adverse Event|0
7803925|NCT01122680|12263608|FG002|Period 3 (4 Weeks)|Adverse Event|0
7803926|NCT01122680|12263609|FG003|Period 3 (4 Weeks)|Adverse Event|0
7803927|NCT01122680|12263606|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0
7803928|NCT01122680|12263607|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1
7803929|NCT01122680|12263608|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0
7803930|NCT01122680|12263609|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0
7803931|NCT01122862|12263642|FG000|Period 1|Protocol Violation|0
7803932|NCT01122862|12263643|FG001|Period 1|Protocol Violation|1
7803933|NCT01122862|12263644|FG002|Period 1|Protocol Violation|0
7717506|NCT00520403|12141154|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
7803934|NCT01122862|12263642|FG000|Period 2|Adverse Event|0
7803935|NCT01122862|12263643|FG001|Period 2|Adverse Event|0
7803936|NCT01122862|12263644|FG002|Period 2|Adverse Event|1
7803937|NCT01122927|12263667|FG000|Period 1 - Conversion Phase|Adverse Event|3
7803938|NCT01122927|12263668|FG001|Period 1 - Conversion Phase|Adverse Event|0
7803939|NCT01122927|12263667|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
7803940|NCT01122927|12263668|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
7803941|NCT01122927|12263667|FG000|Period 1 - Conversion Phase|Physician Decision|2
7803942|NCT01122927|12263668|FG001|Period 1 - Conversion Phase|Physician Decision|0
7803943|NCT01122927|12263667|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7
7803944|NCT01122927|12263668|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0
7803945|NCT01122927|12263667|FG000|Period 1 - Conversion Phase|Protocol Deviation|1
7803946|NCT01122927|12263668|FG001|Period 1 - Conversion Phase|Protocol Deviation|0
7803947|NCT01122927|12263667|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
7803948|NCT01122927|12263668|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
7803949|NCT01122927|12263667|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0
7803950|NCT01122927|12263668|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33
7803951|NCT01122927|12263667|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
7803952|NCT01122927|12263668|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
7803953|NCT01122927|12263667|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
7803954|NCT01122927|12263668|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
7803955|NCT01122927|12263667|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0
7803956|NCT01122927|12263668|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12
7803957|NCT01122927|12263667|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
7803958|NCT01122927|12263668|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
7803959|NCT01122927|12263667|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
7803960|NCT01122927|12263668|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
7803961|NCT01123070|12263682|FG000|Part B Double Blind Period|Protocol Violation|0
7803962|NCT01123070|12263683|FG001|Part B Double Blind Period|Protocol Violation|0
7803963|NCT01123070|12263684|FG002|Part B Double Blind Period|Protocol Violation|0
7803964|NCT01123070|12263685|FG003|Part B Double Blind Period|Protocol Violation|1
7803965|NCT01123070|12263682|FG000|Part B Double Blind Period|Adverse Event|0
7803966|NCT01123070|12263683|FG001|Part B Double Blind Period|Adverse Event|0
7803967|NCT01123070|12263684|FG002|Part B Double Blind Period|Adverse Event|2
7803968|NCT01123070|12263685|FG003|Part B Double Blind Period|Adverse Event|0
7803969|NCT01123070|12263682|FG000|Part B Double Blind Period|Sponsor's Decision|0
7803970|NCT01123070|12263683|FG001|Part B Double Blind Period|Sponsor's Decision|0
7803971|NCT01123070|12263684|FG002|Part B Double Blind Period|Sponsor's Decision|2
7803972|NCT01123070|12263685|FG003|Part B Double Blind Period|Sponsor's Decision|2
7803973|NCT01123083|12263698|FG000|Overall Study|Investigator recommendation|1
7803974|NCT01123083|12263699|FG001|Overall Study|Investigator recommendation|1
7803975|NCT01123083|12263698|FG000|Overall Study|Administrative reasons|0
7803976|NCT01123083|12263699|FG001|Overall Study|Administrative reasons|4
7803977|NCT01123083|12263698|FG000|Overall Study|Lost to Follow-up|2
7803978|NCT01123083|12263699|FG001|Overall Study|Lost to Follow-up|6
7803979|NCT01123083|12263698|FG000|Overall Study|Adverse Event|1
7803980|NCT01123083|12263699|FG001|Overall Study|Adverse Event|0
7803981|NCT01123083|12263698|FG000|Overall Study|Withdrew for another reason not covered|0
7803982|NCT01123083|12263699|FG001|Overall Study|Withdrew for another reason not covered|1
7803983|NCT01123083|12263698|FG000|Overall Study|Participant/legal representative request|7
7803984|NCT01123083|12263699|FG001|Overall Study|Participant/legal representative request|3
7803985|NCT01123148|12263705|FG000|Overall Study|Coughing caused unacceptable EEG quality|1
7803986|NCT01123148|12263705|FG000|Overall Study|Didn't meet milestone criteria|1
7803987|NCT01123161|12263711|FG000|Overall Study|Lost to Follow-up|1
7803988|NCT01123161|12263712|FG001|Overall Study|Lost to Follow-up|0
7803989|NCT01123161|12263711|FG000|Overall Study|Withdrawal by Subject|1
7803990|NCT01123161|12263712|FG001|Overall Study|Withdrawal by Subject|0
7803991|NCT01123200|12263721|FG000|Overall Study|Withdrawal by Subject|1
7803992|NCT01123356|12263725|FG000|Overall Study|Adverse Event|2
7803993|NCT01123356|12263725|FG000|Overall Study|Lack of Efficacy|4
7803994|NCT01123356|12263725|FG000|Overall Study|Withdrawal by Subject|1
7803995|NCT01123382|12263732|FG000|Overall Study|Withdrawal by Subject|1
7803996|NCT01123382|12263733|FG001|Overall Study|Withdrawal by Subject|4
7803997|NCT01123382|12263732|FG000|Overall Study|Lost to Follow-up|1
7803998|NCT01123382|12263733|FG001|Overall Study|Lost to Follow-up|2
7803999|NCT01123395|12263739|FG000|Washout Period of 14 Days|Withdrawal by Subject|0
7804000|NCT01123395|12263740|FG001|Washout Period of 14 Days|Withdrawal by Subject|1
7804001|NCT01123642|12263755|FG000|Overall Study|Lost to Follow-up|23
7804002|NCT01123642|12263755|FG000|Overall Study|Withdrawal by Subject|9
7804003|NCT01123642|12263755|FG000|Overall Study|ineligible at baseline assessment|36
7804004|NCT01123655|12263762|FG000|Overall Study|Medication for RA had to be changed|1
7861476|NCT01592747|12350518|FG002|Overall Study|Lack of Efficacy|0
7861477|NCT01592747|12350516|FG000|Overall Study|Withdrawal by Subject|2
7861478|NCT01592747|12350517|FG001|Overall Study|Withdrawal by Subject|0
7861479|NCT01592747|12350518|FG002|Overall Study|Withdrawal by Subject|2
7861480|NCT01592747|12350516|FG000|Overall Study|Lost to Follow-up|1
7861481|NCT01592747|12350517|FG001|Overall Study|Lost to Follow-up|0
7885284|NCT01797445|12385698|FG000|Open-Label Extension Phase|Investigator's Discretion|1
7885285|NCT01797445|12385699|FG001|Open-Label Extension Phase|Investigator's Discretion|0
7962807|NCT02714868|12517180|FG001|Overall Study|Withdrawal by Subject|0
7962808|NCT02714868|12517179|FG000|Overall Study|PI withdrawal safety risk self/others|1
7962809|NCT02714868|12517180|FG001|Overall Study|PI withdrawal safety risk self/others|0
7962810|NCT02714868|12517179|FG000|Overall Study|PI withdraw did not meet inclusion|1
7861482|NCT01592747|12350518|FG002|Overall Study|Lost to Follow-up|1
7861483|NCT01592747|12350516|FG000|Overall Study|Other Reasons|1
7861484|NCT01592747|12350517|FG001|Overall Study|Other Reasons|1
7861485|NCT01592747|12350518|FG002|Overall Study|Other Reasons|0
7885286|NCT01797536|12385724|FG000|Overall Study|Adverse Event|0
7885287|NCT01797536|12385725|FG001|Overall Study|Adverse Event|1
7885288|NCT01797536|12385726|FG002|Overall Study|Adverse Event|0
7885289|NCT01797536|12385727|FG003|Overall Study|Adverse Event|0
7885290|NCT01797562|12385737|FG000|Overall Study|Protocol Violation|5
7885291|NCT01797705|12385763|FG000|Overall Study|Equipment anomalies during sleep studies|4
7885292|NCT01797705|12385763|FG000|Overall Study|Withdrawal by Subject|1
7885293|NCT01797731|12385769|FG000|Overall Study|Didn't have proper radiographs required|3
7885294|NCT01797731|12385770|FG001|Overall Study|Didn't have proper radiographs required|3
7885295|NCT01797783|12385778|FG000|Overall Study|Adverse Event|1
7885296|NCT01797783|12385779|FG001|Overall Study|Adverse Event|1
7885297|NCT01797783|12385778|FG000|Overall Study|Withdrawal by Subject|1
7885298|NCT01797783|12385779|FG001|Overall Study|Withdrawal by Subject|0
7885299|NCT01797835|12385801|FG000|Overall Study|Lost to Follow-up|31
7885300|NCT01797835|12385802|FG001|Overall Study|Lost to Follow-up|27
7885301|NCT01797965|12385812|FG000|Overall Study|Adverse Event|104
7885302|NCT01797965|12385813|FG001|Overall Study|Adverse Event|129
7885303|NCT01797965|12385814|FG002|Overall Study|Adverse Event|4
7885304|NCT01797965|12385815|FG003|Overall Study|Adverse Event|21
7885305|NCT01797965|12385812|FG000|Overall Study|Lost to Follow-up|9
7885306|NCT01797965|12385813|FG001|Overall Study|Lost to Follow-up|8
7885307|NCT01797965|12385814|FG002|Overall Study|Lost to Follow-up|1
7885308|NCT01797965|12385815|FG003|Overall Study|Lost to Follow-up|2
7885309|NCT01797965|12385812|FG000|Overall Study|Consent withdrawn|130
7885310|NCT01797965|12385813|FG001|Overall Study|Consent withdrawn|117
7885311|NCT01797965|12385814|FG002|Overall Study|Consent withdrawn|3
7885312|NCT01797965|12385815|FG003|Overall Study|Consent withdrawn|35
7885313|NCT01797965|12385812|FG000|Overall Study|Investigator decision|21
7885314|NCT01797965|12385813|FG001|Overall Study|Investigator decision|15
7885315|NCT01797965|12385814|FG002|Overall Study|Investigator decision|0
7804005|NCT01123655|12263763|FG001|Overall Study|Medication for RA had to be changed|0
7804006|NCT01123655|12263764|FG002|Overall Study|Medication for RA had to be changed|0
7804007|NCT01123655|12263762|FG000|Overall Study|new illness|0
7804008|NCT01123655|12263763|FG001|Overall Study|new illness|1
7804009|NCT01123655|12263764|FG002|Overall Study|new illness|0
7804010|NCT01123655|12263762|FG000|Overall Study|began prohibitive drug|0
7804011|NCT01123655|12263763|FG001|Overall Study|began prohibitive drug|0
7885316|NCT01797965|12385815|FG003|Overall Study|Investigator decision|0
7885317|NCT01797965|12385812|FG000|Overall Study|Death|2
7804012|NCT01123655|12263764|FG002|Overall Study|began prohibitive drug|1
7804013|NCT01123889|12263772|FG000|Overall Study|Lost to Follow-up|3
7804014|NCT01123889|12263773|FG001|Overall Study|Lost to Follow-up|1
7804015|NCT01123941|12263790|FG000|Overall Study|Lost to Follow-up|2
7804016|NCT01123941|12263791|FG001|Overall Study|Lost to Follow-up|1
7804017|NCT01123980|12263799|FG000|Overall Study|Adverse Event|1
7804018|NCT01123980|12263800|FG001|Overall Study|Adverse Event|1
7804019|NCT01123980|12263799|FG000|Overall Study|Lack of Efficacy|1
7804020|NCT01123980|12263800|FG001|Overall Study|Lack of Efficacy|0
7804021|NCT01123980|12263799|FG000|Overall Study|Physician Decision|0
7804022|NCT01123980|12263800|FG001|Overall Study|Physician Decision|1
7804023|NCT01123980|12263799|FG000|Overall Study|Lost to Follow-up|0
7804024|NCT01123980|12263800|FG001|Overall Study|Lost to Follow-up|6
7804025|NCT01123980|12263799|FG000|Overall Study|Protocol Violation|6
7804026|NCT01123980|12263800|FG001|Overall Study|Protocol Violation|6
7804027|NCT01123980|12263799|FG000|Overall Study|Withdrawal by Subject|5
7804028|NCT01123980|12263800|FG001|Overall Study|Withdrawal by Subject|3
7804029|NCT01123980|12263799|FG000|Overall Study|Unclassified|6
7804030|NCT01123980|12263800|FG001|Overall Study|Unclassified|7
7804031|NCT01124006|12263809|FG000|Overall Study|Withdrawal by Subject|2
7804032|NCT01124006|12263810|FG001|Overall Study|Withdrawal by Subject|2
7804033|NCT01124006|12263811|FG002|Overall Study|Withdrawal by Subject|0
7804034|NCT01124006|12263809|FG000|Overall Study|Lost to Follow-up|1
7804035|NCT01124006|12263810|FG001|Overall Study|Lost to Follow-up|0
7804036|NCT01124006|12263811|FG002|Overall Study|Lost to Follow-up|1
7804037|NCT01124006|12263809|FG000|Overall Study|Other|0
7804038|NCT01124006|12263810|FG001|Overall Study|Other|0
7804039|NCT01124006|12263811|FG002|Overall Study|Other|1
7804040|NCT01124045|12263821|FG000|Overall Study|Lost to Follow-up|0
7804041|NCT01124045|12263822|FG001|Overall Study|Lost to Follow-up|1
7804042|NCT01124045|12263821|FG000|Overall Study|Physician Decision|0
7804043|NCT01124045|12263822|FG001|Overall Study|Physician Decision|2
7804044|NCT01124097|12263832|FG000|Overall Study|Withdrawal by Subject|4
7804045|NCT01124097|12263833|FG001|Overall Study|Withdrawal by Subject|3
7885318|NCT01797965|12385813|FG001|Overall Study|Death|4
7885319|NCT01797965|12385814|FG002|Overall Study|Death|0
7885320|NCT01797965|12385815|FG003|Overall Study|Death|0
7885321|NCT01797965|12385812|FG000|Overall Study|Disease progression, defined by protocol|3
7885322|NCT01797965|12385813|FG001|Overall Study|Disease progression, defined by protocol|1
7885323|NCT01797965|12385814|FG002|Overall Study|Disease progression, defined by protocol|0
7885324|NCT01797965|12385815|FG003|Overall Study|Disease progression, defined by protocol|0
7885325|NCT01797965|12385812|FG000|Overall Study|Reason Not Specified|280
7885326|NCT01797965|12385813|FG001|Overall Study|Reason Not Specified|295
7885327|NCT01797965|12385814|FG002|Overall Study|Reason Not Specified|0
7885328|NCT01797965|12385815|FG003|Overall Study|Reason Not Specified|15
7885329|NCT01798056|12385828|FG000|Overall Study|Serious Adverse Event|13
7885330|NCT01798056|12385829|FG001|Overall Study|Serious Adverse Event|12
7885331|NCT01798056|12385828|FG000|Overall Study|Withdrawal by Subject|12
7885332|NCT01798056|12385829|FG001|Overall Study|Withdrawal by Subject|9
7885333|NCT01798056|12385828|FG000|Overall Study|Migrated/moved from study area|1
7885334|NCT01798056|12385829|FG001|Overall Study|Migrated/moved from study area|1
7885335|NCT01798056|12385828|FG000|Overall Study|Lost to Follow-up|1
7885336|NCT01798056|12385829|FG001|Overall Study|Lost to Follow-up|1
7885337|NCT01798056|12385828|FG000|Overall Study|Other|0
7885338|NCT01798056|12385829|FG001|Overall Study|Other|2
7885339|NCT01798134|12385837|FG000|Overall Study|Lost to Follow-up|1
7885340|NCT01798134|12385837|FG000|Overall Study|Withdrawal by Subject|3
7885341|NCT01798134|12385837|FG000|Overall Study|Death|2
7885342|NCT01798134|12385837|FG000|Overall Study|Adverse Event|3
7885343|NCT01798134|12385837|FG000|Overall Study|Physician Decision|3
7885344|NCT01798134|12385837|FG000|Overall Study|Liver transplant/surgery|4
7885345|NCT01798485|12385909|FG000|Overall Study|Adverse Event|32
7885346|NCT01798485|12385910|FG001|Overall Study|Adverse Event|40
7885347|NCT01798485|12385909|FG000|Overall Study|Withdrawal by Subject|27
7885348|NCT01798485|12385910|FG001|Overall Study|Withdrawal by Subject|31
7885349|NCT01798485|12385909|FG000|Overall Study|Lost to Follow-up|0
7885350|NCT01798485|12385910|FG001|Overall Study|Lost to Follow-up|3
7885351|NCT01798485|12385909|FG000|Overall Study|Physician Decision|14
7885352|NCT01798485|12385910|FG001|Overall Study|Physician Decision|10
7885353|NCT01798485|12385909|FG000|Overall Study|Objective Disease Progression|152
7885354|NCT01798485|12385910|FG001|Overall Study|Objective Disease Progression|106
7804046|NCT01124097|12263834|FG002|Overall Study|Withdrawal by Subject|2
7804047|NCT01124097|12263835|FG003|Overall Study|Withdrawal by Subject|3
7804048|NCT01124097|12263832|FG000|Overall Study|Lack of Efficacy|2
7804049|NCT01124097|12263833|FG001|Overall Study|Lack of Efficacy|3
7804050|NCT01124097|12263834|FG002|Overall Study|Lack of Efficacy|1
7804051|NCT01124097|12263835|FG003|Overall Study|Lack of Efficacy|3
7804052|NCT01124097|12263832|FG000|Overall Study|Adverse Event|24
7804053|NCT01124097|12263833|FG001|Overall Study|Adverse Event|15
7804054|NCT01124097|12263834|FG002|Overall Study|Adverse Event|15
7885355|NCT01798485|12385909|FG000|Overall Study|Death|25
7885356|NCT01798485|12385910|FG001|Overall Study|Death|22
7885357|NCT01798485|12385909|FG000|Overall Study|Sponsor Decision|61
7885358|NCT01798485|12385910|FG001|Overall Study|Sponsor Decision|54
7804055|NCT01124097|12263835|FG003|Overall Study|Adverse Event|7
7804056|NCT01124097|12263832|FG000|Overall Study|Protocol Violation|2
7804057|NCT01124097|12263833|FG001|Overall Study|Protocol Violation|0
7804058|NCT01124097|12263834|FG002|Overall Study|Protocol Violation|2
7804059|NCT01124097|12263835|FG003|Overall Study|Protocol Violation|1
7804060|NCT01124097|12263832|FG000|Overall Study|Physician Decision|2
7804061|NCT01124097|12263833|FG001|Overall Study|Physician Decision|1
7804062|NCT01124097|12263834|FG002|Overall Study|Physician Decision|0
7804063|NCT01124097|12263835|FG003|Overall Study|Physician Decision|0
7804064|NCT01124149|12263845|FG000|Acute Phase|Withdrawal by Subject|22
7804065|NCT01124149|12263845|FG000|Acute Phase|Adverse Event|21
7804066|NCT01124149|12263845|FG000|Acute Phase|Lack of Efficacy|17
7804067|NCT01124149|12263845|FG000|Acute Phase|Protocol Violation|14
7804068|NCT01124149|12263845|FG000|Acute Phase|Lost to Follow-up|2
7804069|NCT01124149|12263845|FG000|Acute Phase|Prolonged antibiotic therapy|1
7804070|NCT01124149|12263845|FG000|Acute Phase|Sponsor request|1
7804071|NCT01124149|12263845|FG000|Acute Phase|UC symptoms not ameliorated|1
7804072|NCT01124149|12263845|FG000|Acute Phase|Non-compliance|1
7804073|NCT01124149|12263845|FG000|Acute Phase|Low hemoglobin|1
7804074|NCT01124149|12263845|FG000|Acute Phase|Travelling to another country|1
7804075|NCT01124149|12263845|FG000|Acute Phase|Sponsor decision|1
7804076|NCT01124149|12263845|FG000|Maintenance Phase|Lack of Efficacy|40
7804077|NCT01124149|12263845|FG000|Maintenance Phase|Adverse Event|24
7804078|NCT01124149|12263845|FG000|Maintenance Phase|Lost to Follow-up|15
7804079|NCT01124149|12263845|FG000|Maintenance Phase|Withdrawal by Subject|10
7804080|NCT01124149|12263845|FG000|Maintenance Phase|Protocol Violation|5
7804081|NCT01124149|12263845|FG000|Maintenance Phase|Coordinator error|1
7804082|NCT01124149|12263845|FG000|Maintenance Phase|Non-compliance|1
7804083|NCT01124162|12263854|FG000|First Intervention|Adverse Event|2
7804084|NCT01124162|12263855|FG001|First Intervention|Adverse Event|0
7804085|NCT01124162|12263854|FG000|Washout of 7 Days|Withdrawal by Subject|1
7804086|NCT01124162|12263855|FG001|Washout of 7 Days|Withdrawal by Subject|0
7804087|NCT01124175|12263863|FG000|Washout of 7 Days|Withdrawal by Subject|0
7804088|NCT01124175|12263864|FG001|Washout of 7 Days|Withdrawal by Subject|2
7804089|NCT01124292|12263882|FG000|Overall Study|Lost to Follow-up|2
7804090|NCT01124292|12263883|FG001|Overall Study|Lost to Follow-up|4
7804091|NCT01124292|12263884|FG002|Overall Study|Lost to Follow-up|3
7804092|NCT01124292|12263882|FG000|Overall Study|Physician Decision|0
7804093|NCT01124292|12263883|FG001|Overall Study|Physician Decision|3
7804094|NCT01124292|12263884|FG002|Overall Study|Physician Decision|2
7804095|NCT01124292|12263882|FG000|Overall Study|Withdrawal by Subject|0
7804096|NCT01124292|12263883|FG001|Overall Study|Withdrawal by Subject|6
7804097|NCT01124292|12263884|FG002|Overall Study|Withdrawal by Subject|2
7804098|NCT01124292|12263882|FG000|Overall Study|medical issue unrelated to the study|0
7804099|NCT01124292|12263883|FG001|Overall Study|medical issue unrelated to the study|0
7804100|NCT01124292|12263884|FG002|Overall Study|medical issue unrelated to the study|2
7804101|NCT01124292|12263882|FG000|Overall Study|piercing track closed|0
7804102|NCT01124292|12263883|FG001|Overall Study|piercing track closed|2
7804103|NCT01124292|12263884|FG002|Overall Study|piercing track closed|1
7804104|NCT01124422|12263910|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
7804105|NCT01124422|12263911|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
7804106|NCT01124422|12263912|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
7804107|NCT01124422|12263910|FG000|4-Week Open-label Run-in Phase|Adverse Event|7
7804108|NCT01124422|12263911|FG001|4-Week Open-label Run-in Phase|Adverse Event|0
7804109|NCT01124422|12263912|FG002|4-Week Open-label Run-in Phase|Adverse Event|0
7804110|NCT01124422|12263910|FG000|4-Week Open-label Run-in Phase|Physician Decision|4
7804111|NCT01124422|12263911|FG001|4-Week Open-label Run-in Phase|Physician Decision|0
7804112|NCT01124422|12263912|FG002|4-Week Open-label Run-in Phase|Physician Decision|0
7804113|NCT01124422|12263910|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1
7804114|NCT01124422|12263911|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0
7804115|NCT01124422|12263912|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0
7804116|NCT01124422|12263910|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
7804117|NCT01124422|12263911|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
7804118|NCT01124422|12263912|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
7804119|NCT01124422|12263910|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5
7804120|NCT01124422|12263911|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0
7804121|NCT01124422|12263912|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0
7804122|NCT01124422|12263910|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
7804123|NCT01124422|12263911|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
7804124|NCT01124422|12263912|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
7804125|NCT01124422|12263910|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0
7804126|NCT01124422|12263911|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6
7804127|NCT01124422|12263912|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3
7804128|NCT01124422|12263910|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0
7804129|NCT01124422|12263911|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5
7804130|NCT01124422|12263912|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2
7804131|NCT01124422|12263910|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
7804132|NCT01124422|12263911|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
7804133|NCT01124422|12263912|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
7804134|NCT01124448|12263921|FG000|Overall Study|Lost to Follow-up|0
7804135|NCT01124448|12263922|FG001|Overall Study|Lost to Follow-up|3
7804136|NCT01124448|12263921|FG000|Overall Study|Protocol Violation|2
7804137|NCT01124448|12263922|FG001|Overall Study|Protocol Violation|0
7804138|NCT01124604|12263930|FG000|Overall Study|Adverse Event|10
7804139|NCT01124604|12263931|FG001|Overall Study|Adverse Event|1
7804140|NCT01124604|12263930|FG000|Overall Study|Lack of Efficacy|1
7804141|NCT01124604|12263931|FG001|Overall Study|Lack of Efficacy|0
7804142|NCT01124604|12263930|FG000|Overall Study|Withdrawal by Subject|4
7804143|NCT01124604|12263931|FG001|Overall Study|Withdrawal by Subject|0
7804144|NCT01124604|12263930|FG000|Overall Study|Disease Progression|0
7804145|NCT01124604|12263931|FG001|Overall Study|Disease Progression|1
7804146|NCT01124617|12263939|FG000|Overall Study|Adverse Event|5
7804147|NCT01124617|12263940|FG001|Overall Study|Adverse Event|2
7804148|NCT01124617|12263939|FG000|Overall Study|Lack of Efficacy|2
7804149|NCT01124617|12263940|FG001|Overall Study|Lack of Efficacy|1
7804150|NCT01124617|12263939|FG000|Overall Study|Protocol Violation|1
7804151|NCT01124617|12263940|FG001|Overall Study|Protocol Violation|1
7804152|NCT01124617|12263939|FG000|Overall Study|Withdrawal by Subject|9
7804153|NCT01124617|12263940|FG001|Overall Study|Withdrawal by Subject|1
7804154|NCT01124617|12263939|FG000|Overall Study|Other|2
7804155|NCT01124617|12263940|FG001|Overall Study|Other|1
7804156|NCT01124643|12263946|FG000|Overall Study|Death|1
7804157|NCT01124734|12263950|FG000|Overall Study|Disease progression|13
7804158|NCT01124734|12263950|FG000|Overall Study|Adverse Event|1
7804159|NCT01124734|12263950|FG000|Overall Study|Withdrawal by Subject|1
7804160|NCT01124734|12263950|FG000|Overall Study|Elected for alternative treatment|2
7804161|NCT01124838|12263970|FG000|Overall Study|Miscellaneous|4
7804162|NCT01124838|12263971|FG001|Overall Study|Miscellaneous|2
7804163|NCT01124838|12263970|FG000|Overall Study|Adverse Event|7
7804164|NCT01124838|12263971|FG001|Overall Study|Adverse Event|11
7804165|NCT01124838|12263970|FG000|Overall Study|Lack of Efficacy|2
7804166|NCT01124838|12263971|FG001|Overall Study|Lack of Efficacy|0
7804167|NCT01124838|12263970|FG000|Overall Study|Withdrawal by Subject|3
7804168|NCT01124838|12263971|FG001|Overall Study|Withdrawal by Subject|2
7804169|NCT01124838|12263970|FG000|Overall Study|Lost to Follow-up|2
7804170|NCT01124838|12263971|FG001|Overall Study|Lost to Follow-up|0
7804171|NCT01124864|12263985|FG000|Overall Study|Follow up phase competed as per protocol|18
7804172|NCT01124864|12263986|FG001|Overall Study|Follow up phase competed as per protocol|22
7804173|NCT01124864|12263987|FG002|Overall Study|Follow up phase competed as per protocol|24
7804174|NCT01124864|12263988|FG003|Overall Study|Follow up phase competed as per protocol|18
7804175|NCT01124864|12263989|FG004|Overall Study|Follow up phase competed as per protocol|26
7804176|NCT01124864|12263990|FG005|Overall Study|Follow up phase competed as per protocol|2
7804177|NCT01124864|12263985|FG000|Overall Study|Death|6
7804178|NCT01124864|12263986|FG001|Overall Study|Death|9
7804179|NCT01124864|12263987|FG002|Overall Study|Death|6
7804180|NCT01124864|12263988|FG003|Overall Study|Death|2
7804181|NCT01124864|12263989|FG004|Overall Study|Death|1
7804182|NCT01124864|12263990|FG005|Overall Study|Death|0
7804183|NCT01124864|12263985|FG000|Overall Study|Withdrawal by Subject|2
7804184|NCT01124864|12263986|FG001|Overall Study|Withdrawal by Subject|3
7804185|NCT01124864|12263987|FG002|Overall Study|Withdrawal by Subject|4
7804186|NCT01124864|12263988|FG003|Overall Study|Withdrawal by Subject|0
7804187|NCT01124864|12263989|FG004|Overall Study|Withdrawal by Subject|2
7804188|NCT01124864|12263990|FG005|Overall Study|Withdrawal by Subject|1
7804189|NCT01124864|12263985|FG000|Overall Study|Lost to Follow-up|1
7804190|NCT01124864|12263986|FG001|Overall Study|Lost to Follow-up|1
7804191|NCT01124864|12263987|FG002|Overall Study|Lost to Follow-up|0
7804192|NCT01124864|12263988|FG003|Overall Study|Lost to Follow-up|1
7804193|NCT01124864|12263989|FG004|Overall Study|Lost to Follow-up|0
7804194|NCT01124864|12263990|FG005|Overall Study|Lost to Follow-up|0
7804195|NCT01124864|12263985|FG000|Overall Study|Protocol Violation|1
7804196|NCT01124864|12263986|FG001|Overall Study|Protocol Violation|0
7804197|NCT01124864|12263987|FG002|Overall Study|Protocol Violation|0
7804198|NCT01124864|12263988|FG003|Overall Study|Protocol Violation|0
7804199|NCT01124864|12263989|FG004|Overall Study|Protocol Violation|1
7804200|NCT01124864|12263990|FG005|Overall Study|Protocol Violation|0
7804201|NCT01124916|12264008|FG000|Overall Study|Lost to Follow-up|3
7804202|NCT01124916|12264009|FG001|Overall Study|Lost to Follow-up|2
7804203|NCT01125046|12264024|FG000|First 6 Months of Treatment|Death|1
7804204|NCT01125046|12264024|FG000|First 6 Months of Treatment|Withdrawal by Subject|2
7804205|NCT01125046|12264024|FG000|First 6 Months of Treatment|Non-compliance|1
7804206|NCT01125046|12264024|FG000|First 6 Months of Treatment|Surgery|1
7804207|NCT01125046|12264024|FG000|First 6 Months of Treatment|Progressive Disease|7
7804208|NCT01125046|12264024|FG000|First 6 Months of Treatment|Adverse Event|2
7804209|NCT01125046|12264024|FG000|Continued Treatment After 6 Months|Progressive Disease|2
7804210|NCT01125046|12264024|FG000|Continued Treatment After 6 Months|Adverse Event|1
7804211|NCT01125046|12264024|FG000|Follow-up/Data Cut Off Point|Death|29
7804212|NCT01125046|12264024|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4
7804213|NCT01125189|12264050|FG000|Treatment Period|Lack of Efficacy|15
7804214|NCT01125189|12264051|FG001|Treatment Period|Lack of Efficacy|18
7804215|NCT01125189|12264052|FG002|Treatment Period|Lack of Efficacy|25
7804216|NCT01125189|12264050|FG000|Treatment Period|Adverse Event|7
7804217|NCT01125189|12264051|FG001|Treatment Period|Adverse Event|8
7804218|NCT01125189|12264052|FG002|Treatment Period|Adverse Event|8
7804219|NCT01125189|12264050|FG000|Treatment Period|Withdrawal by Subject|3
7804220|NCT01125189|12264051|FG001|Treatment Period|Withdrawal by Subject|1
7717507|NCT00520403|12141154|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4
7717508|NCT00520403|12141154|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
7717509|NCT00520403|12141154|FG000|Bevacizumab + IFN/Vinblastine|Death|2
7804221|NCT01125189|12264052|FG002|Treatment Period|Withdrawal by Subject|1
7804222|NCT01125189|12264050|FG000|Treatment Period|Death|1
7804223|NCT01125189|12264051|FG001|Treatment Period|Death|0
7804224|NCT01125189|12264052|FG002|Treatment Period|Death|0
7804225|NCT01125189|12264050|FG000|Treatment Period|Lost to Follow-up|1
7804226|NCT01125189|12264051|FG001|Treatment Period|Lost to Follow-up|2
7804227|NCT01125189|12264052|FG002|Treatment Period|Lost to Follow-up|1
7804228|NCT01125189|12264050|FG000|Treatment Period|Poor compliance/noncompliance|0
7804229|NCT01125189|12264051|FG001|Treatment Period|Poor compliance/noncompliance|1
7804230|NCT01125189|12264052|FG002|Treatment Period|Poor compliance/noncompliance|0
7804231|NCT01125189|12264050|FG000|Treatment Period|Participants requested to discontinue|1
7804232|NCT01125189|12264051|FG001|Treatment Period|Participants requested to discontinue|3
7804233|NCT01125189|12264052|FG002|Treatment Period|Participants requested to discontinue|4
7804234|NCT01125189|12264050|FG000|Treatment Period|Other reasons|1
7804235|NCT01125189|12264051|FG001|Treatment Period|Other reasons|1
7804236|NCT01125189|12264052|FG002|Treatment Period|Other reasons|0
7804237|NCT01125189|12264050|FG000|Treatment Period|Completed 24 week treatment period only|2
7804238|NCT01125189|12264051|FG001|Treatment Period|Completed 24 week treatment period only|1
7804239|NCT01125189|12264052|FG002|Treatment Period|Completed 24 week treatment period only|2
7804240|NCT01125189|12264050|FG000|Follow up Period|Withdrawal by Subject|3
7804241|NCT01125189|12264051|FG001|Follow up Period|Withdrawal by Subject|2
7804242|NCT01125189|12264052|FG002|Follow up Period|Withdrawal by Subject|5
7804243|NCT01125189|12264050|FG000|Follow up Period|Death|1
7804244|NCT01125189|12264051|FG001|Follow up Period|Death|0
7804245|NCT01125189|12264052|FG002|Follow up Period|Death|0
7804246|NCT01125189|12264050|FG000|Follow up Period|Lost to Follow-up|12
7804247|NCT01125189|12264051|FG001|Follow up Period|Lost to Follow-up|9
7804248|NCT01125189|12264052|FG002|Follow up Period|Lost to Follow-up|6
7804249|NCT01125189|12264050|FG000|Follow up Period|Other reasons|4
7804250|NCT01125189|12264051|FG001|Follow up Period|Other reasons|4
7804251|NCT01125189|12264052|FG002|Follow up Period|Other reasons|5
7804252|NCT01125293|12264078|FG000|Overall Study|Disease Progression|1
7804253|NCT01125293|12264079|FG001|Overall Study|Disease Progression|3
7804254|NCT01125293|12264080|FG002|Overall Study|Disease Progression|4
7804255|NCT01125293|12264081|FG003|Overall Study|Disease Progression|3
7804256|NCT01125293|12264082|FG004|Overall Study|Disease Progression|5
7804257|NCT01125293|12264083|FG005|Overall Study|Disease Progression|12
7804258|NCT01125293|12264078|FG000|Overall Study|Adverse Event|1
7804259|NCT01125293|12264079|FG001|Overall Study|Adverse Event|0
7804260|NCT01125293|12264080|FG002|Overall Study|Adverse Event|0
7804261|NCT01125293|12264081|FG003|Overall Study|Adverse Event|0
7804262|NCT01125293|12264082|FG004|Overall Study|Adverse Event|2
7804263|NCT01125293|12264083|FG005|Overall Study|Adverse Event|8
7804264|NCT01125293|12264078|FG000|Overall Study|Symptomatic Deterioration|1
7804265|NCT01125293|12264079|FG001|Overall Study|Symptomatic Deterioration|0
7804266|NCT01125293|12264080|FG002|Overall Study|Symptomatic Deterioration|0
7804267|NCT01125293|12264081|FG003|Overall Study|Symptomatic Deterioration|0
7804268|NCT01125293|12264082|FG004|Overall Study|Symptomatic Deterioration|0
7804269|NCT01125293|12264083|FG005|Overall Study|Symptomatic Deterioration|0
7804270|NCT01125293|12264078|FG000|Overall Study|Death|0
7804271|NCT01125293|12264079|FG001|Overall Study|Death|0
7804272|NCT01125293|12264080|FG002|Overall Study|Death|0
7804273|NCT01125293|12264081|FG003|Overall Study|Death|0
7804274|NCT01125293|12264082|FG004|Overall Study|Death|1
7804275|NCT01125293|12264083|FG005|Overall Study|Death|0
7804276|NCT01125293|12264078|FG000|Overall Study|Withdrawal by Subject|0
7804277|NCT01125293|12264079|FG001|Overall Study|Withdrawal by Subject|0
7804278|NCT01125293|12264080|FG002|Overall Study|Withdrawal by Subject|0
7804279|NCT01125293|12264081|FG003|Overall Study|Withdrawal by Subject|0
7804280|NCT01125293|12264082|FG004|Overall Study|Withdrawal by Subject|2
7804281|NCT01125293|12264083|FG005|Overall Study|Withdrawal by Subject|1
7804282|NCT01125293|12264078|FG000|Overall Study|Physician Decision|0
7804283|NCT01125293|12264079|FG001|Overall Study|Physician Decision|0
7804284|NCT01125293|12264080|FG002|Overall Study|Physician Decision|0
7804285|NCT01125293|12264081|FG003|Overall Study|Physician Decision|0
7804286|NCT01125293|12264082|FG004|Overall Study|Physician Decision|0
7804287|NCT01125293|12264083|FG005|Overall Study|Physician Decision|2
7804288|NCT01125358|12264104|FG000|Overall Study|Adverse Event|3
7804289|NCT01125358|12264105|FG001|Overall Study|Adverse Event|0
7804290|NCT01125358|12264106|FG002|Overall Study|Adverse Event|0
7885359|NCT01798485|12385909|FG000|Overall Study|Clinical Progression|35
7885360|NCT01798485|12385910|FG001|Overall Study|Clinical Progression|24
7885361|NCT01798706|12385945|FG000|Overall Study|Adverse Event|15
7885362|NCT01798706|12385946|FG001|Overall Study|Adverse Event|10
7885363|NCT01798706|12385945|FG000|Overall Study|Lack of Efficacy|0
7885364|NCT01798706|12385946|FG001|Overall Study|Lack of Efficacy|2
7885365|NCT01798706|12385945|FG000|Overall Study|Poor compliance to protocol|1
7804291|NCT01125358|12264107|FG003|Overall Study|Adverse Event|2
7804292|NCT01125358|12264104|FG000|Overall Study|Perceived Lack of Efficacy|6
7804293|NCT01125358|12264105|FG001|Overall Study|Perceived Lack of Efficacy|3
7804294|NCT01125358|12264106|FG002|Overall Study|Perceived Lack of Efficacy|7
7804295|NCT01125358|12264107|FG003|Overall Study|Perceived Lack of Efficacy|4
7804296|NCT01125358|12264104|FG000|Overall Study|Protocol Violation|1
7804297|NCT01125358|12264105|FG001|Overall Study|Protocol Violation|0
7804298|NCT01125358|12264106|FG002|Overall Study|Protocol Violation|0
7804299|NCT01125358|12264107|FG003|Overall Study|Protocol Violation|0
7804300|NCT01125358|12264104|FG000|Overall Study|Sponsor Decision|0
7804301|NCT01125358|12264105|FG001|Overall Study|Sponsor Decision|0
7804302|NCT01125358|12264106|FG002|Overall Study|Sponsor Decision|1
7804303|NCT01125358|12264107|FG003|Overall Study|Sponsor Decision|1
7804304|NCT01125358|12264104|FG000|Overall Study|Withdrawal by Subject|2
7804305|NCT01125358|12264105|FG001|Overall Study|Withdrawal by Subject|1
7804306|NCT01125358|12264106|FG002|Overall Study|Withdrawal by Subject|1
7804307|NCT01125358|12264107|FG003|Overall Study|Withdrawal by Subject|1
7861486|NCT01592760|12350530|FG000|24-hour Follow-Up|Lost to Follow-up|4
7861487|NCT01592760|12350531|FG001|24-hour Follow-Up|Lost to Follow-up|3
7861488|NCT01592760|12350532|FG002|24-hour Follow-Up|Lost to Follow-up|2
7861489|NCT01592773|12350543|FG000|Overall Study|Study Terminated by Sponsor|582
7861490|NCT01592773|12350543|FG000|Overall Study|Withdrawal by Subject|35
7861491|NCT01592773|12350543|FG000|Overall Study|Lost to Follow-up|19
7861492|NCT01592773|12350543|FG000|Overall Study|Adverse Event|17
7861493|NCT01592773|12350543|FG000|Overall Study|Lack of Efficacy|9
7861494|NCT01592773|12350543|FG000|Overall Study|Protocol Violation|2
7861495|NCT01592773|12350543|FG000|Overall Study|Inclusion/exclusion not meet|1
7861496|NCT01592773|12350543|FG000|Overall Study|Other Reason|1
7861497|NCT01592786|12350547|FG000|Overall Study|Adverse Event|60
7861498|NCT01592786|12350547|FG000|Overall Study|Lack of Efficacy|19
7861499|NCT01592786|12350547|FG000|Overall Study|Protocol Violation|14
7861500|NCT01592786|12350547|FG000|Overall Study|Withdrawal by Subject|23
7861501|NCT01592786|12350547|FG000|Overall Study|Lost to Follow-up|19
7861502|NCT01592786|12350547|FG000|Overall Study|Other|3
7863960|NCT01609556|12353455|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7863961|NCT01609556|12353456|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7863962|NCT01609556|12353457|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7863963|NCT01609556|12353458|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7863964|NCT01609556|12353459|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7863965|NCT01609556|12353444|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2
7863966|NCT01609556|12353445|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0
7863967|NCT01609556|12353446|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0
7863968|NCT01609556|12353447|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0
7863969|NCT01609556|12353448|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0
7863970|NCT01609556|12353449|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1
7863971|NCT01609556|12353450|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0
7804308|NCT04364737|12264144|FG000|Overall Study|Withdrawal by Subject|4
7804309|NCT04364737|12264145|FG001|Overall Study|Withdrawal by Subject|9
7804310|NCT04364737|12264144|FG000|Overall Study|Lost to Follow-up|1
7804311|NCT04364737|12264145|FG001|Overall Study|Lost to Follow-up|1
7804312|NCT04354155|12264151|FG000|Overall Study|Withdrawal by Subject|1
7804313|NCT04354155|12264151|FG000|Overall Study|Did not meet criteria for study intervention|1
7804314|NCT04085367|12264157|FG000|Overall Study|Adverse Event|1
7804315|NCT04085367|12264158|FG001|Overall Study|Adverse Event|1
7804316|NCT04085367|12264157|FG000|Overall Study|Withdrawal by Subject|13
7804317|NCT04085367|12264158|FG001|Overall Study|Withdrawal by Subject|4
7804318|NCT04085367|12264157|FG000|Overall Study|Lost to Follow-up|3
7804319|NCT04085367|12264158|FG001|Overall Study|Lost to Follow-up|1
7804320|NCT04085367|12264157|FG000|Overall Study|Other unspecified|2
7804321|NCT04085367|12264158|FG001|Overall Study|Other unspecified|1
7804322|NCT04085367|12264157|FG000|Overall Study|Status Unknown|1
7804323|NCT04085367|12264158|FG001|Overall Study|Status Unknown|1
7861503|NCT01592864|12350568|FG000|Overall Study|Withdrawal by Subject|0
7861504|NCT01592864|12350569|FG001|Overall Study|Withdrawal by Subject|1
7861505|NCT01593020|12350577|FG000|Overall Study|Adverse Event|1
7861506|NCT01593020|12350578|FG001|Overall Study|Adverse Event|1
7967684|NCT02770248|12524698|FG001|Overall Study|Adverse Event|1
7861507|NCT01593020|12350577|FG000|Overall Study|Death|0
7861508|NCT01593020|12350578|FG001|Overall Study|Death|1
7861509|NCT01593020|12350577|FG000|Overall Study|Ineligible|1
7861510|NCT01593020|12350578|FG001|Overall Study|Ineligible|0
7861511|NCT01593696|12350610|FG000|Dose Escalation|Progressive Disease|2
7861512|NCT01593696|12350611|FG001|Dose Escalation|Progressive Disease|0
7861513|NCT01593696|12350612|FG002|Dose Escalation|Progressive Disease|0
7861514|NCT01593696|12350613|FG003|Dose Escalation|Progressive Disease|0
7861515|NCT01593696|12350610|FG000|Dose Expansion|Fungal infection|0
7861516|NCT01593696|12350611|FG001|Dose Expansion|Fungal infection|0
7861517|NCT01593696|12350612|FG002|Dose Expansion|Fungal infection|1
7861518|NCT01593696|12350613|FG003|Dose Expansion|Fungal infection|0
7861519|NCT01593787|12350646|FG000|Overall Study|Adverse Event|1
7861520|NCT01593787|12350647|FG001|Overall Study|Adverse Event|0
7885366|NCT01798706|12385946|FG001|Overall Study|Poor compliance to protocol|0
7885367|NCT01798706|12385945|FG000|Overall Study|Other than specified above|5
7861521|NCT01593787|12350648|FG002|Overall Study|Adverse Event|0
7861522|NCT01593917|12350658|FG000|Overall Study|Death|67
7861523|NCT01593917|12350658|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60
7861524|NCT01593917|12350658|FG000|Overall Study|Withdrawal by Subject|23
7861525|NCT01593917|12350658|FG000|Overall Study|Lost to Follow-up|12
7861526|NCT01593917|12350658|FG000|Overall Study|Protocol Violation|5
7861527|NCT01593917|12350658|FG000|Overall Study|Physician Decision|3
7861528|NCT01594125|12350667|FG000|Overall Study|Withdrawal by Subject|1
7861529|NCT01594125|12350668|FG001|Overall Study|Withdrawal by Subject|0
7861530|NCT01594125|12350669|FG002|Overall Study|Withdrawal by Subject|0
7861531|NCT01594125|12350670|FG003|Overall Study|Withdrawal by Subject|1
7861532|NCT01594125|12350671|FG004|Overall Study|Withdrawal by Subject|0
7861533|NCT01594125|12350667|FG000|Overall Study|Progressive Disease|3
7861534|NCT01594125|12350668|FG001|Overall Study|Progressive Disease|12
7861535|NCT01594125|12350669|FG002|Overall Study|Progressive Disease|3
7861536|NCT01594125|12350670|FG003|Overall Study|Progressive Disease|3
7861537|NCT01594125|12350671|FG004|Overall Study|Progressive Disease|7
7861538|NCT01594281|12350686|FG000|Interventional Core Phase|Protocol Deviation|1
7861539|NCT01594281|12350687|FG001|Interventional Core Phase|Protocol Deviation|0
7861540|NCT01594281|12350688|FG002|Interventional Core Phase|Protocol Deviation|0
7861541|NCT01594281|12350686|FG000|Interventional Core Phase|Subject Withdrew Consent|0
7861542|NCT01594281|12350687|FG001|Interventional Core Phase|Subject Withdrew Consent|1
7861543|NCT01594281|12350688|FG002|Interventional Core Phase|Subject Withdrew Consent|1
7861544|NCT01594281|12350686|FG000|Interventional Core Phase|Death|1
7861545|NCT01594281|12350687|FG001|Interventional Core Phase|Death|1
7861546|NCT01594281|12350688|FG002|Interventional Core Phase|Death|2
7861547|NCT01594281|12350686|FG000|Interventional Core Phase|Lost to Follow-up|1
7861548|NCT01594281|12350687|FG001|Interventional Core Phase|Lost to Follow-up|4
7861549|NCT01594281|12350688|FG002|Interventional Core Phase|Lost to Follow-up|1
7861550|NCT01594281|12350686|FG000|Interventional Core Phase|Adverse Event|4
7861551|NCT01594281|12350687|FG001|Interventional Core Phase|Adverse Event|4
7861552|NCT01594281|12350688|FG002|Interventional Core Phase|Adverse Event|4
7861553|NCT01594281|12350686|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2
7861554|NCT01594281|12350687|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2
7861555|NCT01594281|12350688|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0
7861556|NCT01594281|12350686|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0
7861557|NCT01594281|12350687|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0
7861558|NCT01594281|12350688|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1
7861559|NCT01594281|12350686|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
7861560|NCT01594281|12350687|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0
7861561|NCT01594281|12350688|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
7861562|NCT01594333|12350710|FG000|Overall Study|Death|96
7861563|NCT01594333|12350711|FG001|Overall Study|Death|83
7861564|NCT01594333|12350710|FG000|Overall Study|Lost to Follow-up|5
7804324|NCT03621696|12264172|FG000|Overall Study|Not eligible|0
7804325|NCT03621696|12264173|FG001|Overall Study|Not eligible|0
7804326|NCT03621696|12264174|FG002|Overall Study|Not eligible|0
7804327|NCT03621696|12264175|FG003|Overall Study|Not eligible|5
7804328|NCT03621696|12264172|FG000|Overall Study|Withdrawal by Subject|1
7804329|NCT03621696|12264173|FG001|Overall Study|Withdrawal by Subject|1
7804330|NCT03621696|12264174|FG002|Overall Study|Withdrawal by Subject|1
7804331|NCT03621696|12264175|FG003|Overall Study|Withdrawal by Subject|0
7804332|NCT03621696|12264172|FG000|Overall Study|Physician Decision|0
7804333|NCT03621696|12264173|FG001|Overall Study|Physician Decision|0
7804334|NCT03621696|12264174|FG002|Overall Study|Physician Decision|1
7804335|NCT03621696|12264175|FG003|Overall Study|Physician Decision|0
7804336|NCT03544268|12264185|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2
7804337|NCT03544268|12264186|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0
7804338|NCT03038438|12264238|FG000|Overall Study|Death|2
7804339|NCT03038438|12264238|FG000|Overall Study|Lost to Follow-up|4
7804340|NCT03038438|12264238|FG000|Overall Study|Subject Incarceration|1
7804341|NCT03038438|12264238|FG000|Overall Study|Withdrawal by Subject|2
7804342|NCT03038438|12264238|FG000|Overall Study|No 24-Month Follow-Up|43
7861565|NCT01594333|12350711|FG001|Overall Study|Lost to Follow-up|5
7861566|NCT01594333|12350710|FG000|Overall Study|Withdrawal by Subject|60
7861567|NCT01594333|12350711|FG001|Overall Study|Withdrawal by Subject|63
7861568|NCT01594411|12350730|FG000|Overall Study|Lost to Follow-up|2
7861569|NCT01594476|12350743|FG000|Overall Study|Protocol Violation|1
7861570|NCT01594476|12350744|FG001|Overall Study|Protocol Violation|3
7861571|NCT01594749|12350808|FG000|Overall Study|Adverse Event|2
7861572|NCT01594749|12350809|FG001|Overall Study|Adverse Event|1
7861573|NCT01594749|12350808|FG000|Overall Study|Withdrawal by Subject|2
7861574|NCT01594749|12350809|FG001|Overall Study|Withdrawal by Subject|2
7861575|NCT01594749|12350808|FG000|Overall Study|Protocol Violation|2
7861576|NCT01594749|12350809|FG001|Overall Study|Protocol Violation|0
7861577|NCT01594749|12350808|FG000|Overall Study|Physician Decision|1
7861578|NCT01594749|12350809|FG001|Overall Study|Physician Decision|1
7861579|NCT01594749|12350808|FG000|Overall Study|Non-compliance with Protocol|0
7861580|NCT01594749|12350809|FG001|Overall Study|Non-compliance with Protocol|1
7861581|NCT01594749|12350808|FG000|Overall Study|Lost to Follow-up|1
7861582|NCT01594749|12350809|FG001|Overall Study|Lost to Follow-up|0
7861583|NCT01594749|12350808|FG000|Overall Study|Death|9
7861584|NCT01594749|12350809|FG001|Overall Study|Death|3
7861585|NCT01594749|12350808|FG000|Overall Study|Not Treated|4
7861586|NCT01594749|12350809|FG001|Overall Study|Not Treated|10
7861587|NCT01594749|12350808|FG000|Overall Study|Lost Source Documentation|1
7861588|NCT01594749|12350809|FG001|Overall Study|Lost Source Documentation|0
7861589|NCT01594762|12350817|FG000|Overall Study|Withdrawal by Subject|1
7861590|NCT01594762|12350818|FG001|Overall Study|Withdrawal by Subject|0
7861591|NCT01594762|12350817|FG000|Overall Study|Lost to Follow-up|10
7861592|NCT01594762|12350818|FG001|Overall Study|Lost to Follow-up|10
7861593|NCT01594827|12350826|FG000|Overall Study|Adverse Event|1
7861594|NCT01594827|12350827|FG001|Overall Study|Adverse Event|0
7861595|NCT01594827|12350826|FG000|Overall Study|Physician Decision|3
7861596|NCT01594827|12350827|FG001|Overall Study|Physician Decision|0
7861597|NCT01594853|12350837|FG000|Overall Study|Withdrawal by Subject|1
7861598|NCT01594853|12350838|FG001|Overall Study|Withdrawal by Subject|1
7861599|NCT01594853|12350837|FG000|Overall Study|Lost to Follow-up|1
7861600|NCT01594853|12350838|FG001|Overall Study|Lost to Follow-up|1
7861601|NCT01594853|12350837|FG000|Overall Study|noncompliance with exercise|0
7861602|NCT01594853|12350838|FG001|Overall Study|noncompliance with exercise|1
7861603|NCT01594931|12350847|FG000|Overall Study|Adverse Event|3
7861604|NCT01594931|12350848|FG001|Overall Study|Adverse Event|1
7861605|NCT01594931|12350849|FG002|Overall Study|Adverse Event|1
7861606|NCT01594931|12350847|FG000|Overall Study|Withdrawal by Subject|2
7861607|NCT01594931|12350848|FG001|Overall Study|Withdrawal by Subject|1
7861608|NCT01594931|12350849|FG002|Overall Study|Withdrawal by Subject|1
7861609|NCT01594931|12350847|FG000|Overall Study|Lack of Efficacy|7
7861610|NCT01594931|12350848|FG001|Overall Study|Lack of Efficacy|2
7861611|NCT01594931|12350849|FG002|Overall Study|Lack of Efficacy|2
7861612|NCT01594931|12350847|FG000|Overall Study|Lost to Follow-up|4
7861613|NCT01594931|12350848|FG001|Overall Study|Lost to Follow-up|3
7861614|NCT01594931|12350849|FG002|Overall Study|Lost to Follow-up|3
7861615|NCT01594931|12350847|FG000|Overall Study|Protocol Violation|2
7861616|NCT01594931|12350848|FG001|Overall Study|Protocol Violation|1
7861617|NCT01594931|12350849|FG002|Overall Study|Protocol Violation|0
7861618|NCT01594931|12350847|FG000|Overall Study|No defiined|11
7861619|NCT01594931|12350848|FG001|Overall Study|No defiined|4
7861620|NCT01594931|12350849|FG002|Overall Study|No defiined|7
7861621|NCT01594970|12350860|FG000|Overall Study|Non-Adverse Event Related|4
7861622|NCT01594970|12350861|FG001|Overall Study|Non-Adverse Event Related|5
7861623|NCT01594970|12350862|FG002|Overall Study|Non-Adverse Event Related|6
7861624|NCT01594970|12350860|FG000|Overall Study|Adverse Event|17
7861625|NCT01594970|12350861|FG001|Overall Study|Adverse Event|23
7861626|NCT01594970|12350862|FG002|Overall Study|Adverse Event|23
7861627|NCT01594970|12350860|FG000|Overall Study|Lost to Follow-up|54
7885368|NCT01798706|12385946|FG001|Overall Study|Other than specified above|9
7861628|NCT01594970|12350861|FG001|Overall Study|Lost to Follow-up|54
7861629|NCT01594970|12350862|FG002|Overall Study|Lost to Follow-up|37
7885369|NCT01798849|12385955|FG000|Overall Study|Physician Decision|0
7885370|NCT01798849|12385956|FG001|Overall Study|Physician Decision|0
7885371|NCT01798849|12385957|FG002|Overall Study|Physician Decision|1
7885372|NCT01798927|12385994|FG000|Overall Study|Withdrawal by Subject|1
7885373|NCT01798992|12386007|FG000|Overall Study|Administrative withdrawal|0
7885374|NCT01798992|12386008|FG001|Overall Study|Administrative withdrawal|1
7885375|NCT01798992|12386009|FG002|Overall Study|Administrative withdrawal|0
7885376|NCT01798992|12386010|FG003|Overall Study|Administrative withdrawal|1
7885377|NCT01798992|12386007|FG000|Overall Study|Lost to Follow-up|0
7885378|NCT01798992|12386008|FG001|Overall Study|Lost to Follow-up|1
7885379|NCT01798992|12386009|FG002|Overall Study|Lost to Follow-up|1
7885380|NCT01798992|12386010|FG003|Overall Study|Lost to Follow-up|0
7885381|NCT01798992|12386007|FG000|Overall Study|Insufficient biopsy tissue|0
7885382|NCT01798992|12386008|FG001|Overall Study|Insufficient biopsy tissue|0
7885383|NCT01798992|12386009|FG002|Overall Study|Insufficient biopsy tissue|1
7885384|NCT01798992|12386010|FG003|Overall Study|Insufficient biopsy tissue|0
7885385|NCT01799226|12386040|FG000|Overall Study|Withdrawal by Subject|1
7885386|NCT01799226|12386041|FG001|Overall Study|Withdrawal by Subject|0
7885387|NCT01799226|12386040|FG000|Overall Study|Disqualified at Day 14|1
7885388|NCT01799226|12386041|FG001|Overall Study|Disqualified at Day 14|0
7885389|NCT01799239|12386047|FG000|Period 1 (7 Days)|Lack of Efficacy|1
7885390|NCT01799239|12386048|FG001|Period 1 (7 Days)|Lack of Efficacy|0
7885391|NCT01799239|12386047|FG000|Period 1 (7 Days)|Withdrawal by Subject|2
7885392|NCT01799239|12386048|FG001|Period 1 (7 Days)|Withdrawal by Subject|0
7885393|NCT01799239|12386047|FG000|Period 1 (7 Days)|Protocol Violation|0
7804343|NCT02451943|12264253|FG000|Overall Study|On Treatment|4
7804344|NCT02451943|12264254|FG001|Overall Study|On Treatment|4
7804345|NCT02451943|12264253|FG000|Overall Study|Withdrawal by Subject|13
7804346|NCT02451943|12264254|FG001|Overall Study|Withdrawal by Subject|16
7804347|NCT02451943|12264253|FG000|Overall Study|Lost to Follow-up|3
7804348|NCT02451943|12264254|FG001|Overall Study|Lost to Follow-up|4
7804349|NCT02198794|12264260|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79
7804350|NCT02198794|12264261|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
7804351|NCT02198794|12264262|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
7804352|NCT02198794|12264263|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
7804353|NCT02198794|12264260|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33
7804354|NCT02198794|12264261|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0
7804355|NCT02198794|12264262|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0
7885394|NCT01799239|12386048|FG001|Period 1 (7 Days)|Protocol Violation|1
7885395|NCT01799239|12386047|FG000|Period 2 (7 Days)|Withdrawal by Subject|1
7885396|NCT01799239|12386048|FG001|Period 2 (7 Days)|Withdrawal by Subject|1
7885397|NCT01799239|12386047|FG000|Period 2 (7 Days)|Protocol Violation|1
7885398|NCT01799239|12386048|FG001|Period 2 (7 Days)|Protocol Violation|0
7885399|NCT01799590|12386065|FG000|Overall Study|Adverse Event|13
7885400|NCT01799590|12386066|FG001|Overall Study|Adverse Event|7
7885401|NCT01799590|12386067|FG002|Overall Study|Adverse Event|5
7885402|NCT01799590|12386065|FG000|Overall Study|Pregnancy|2
7885403|NCT01799590|12386066|FG001|Overall Study|Pregnancy|0
7885404|NCT01799590|12386067|FG002|Overall Study|Pregnancy|0
7885405|NCT01799590|12386065|FG000|Overall Study|Lack of Efficacy|3
7885406|NCT01799590|12386066|FG001|Overall Study|Lack of Efficacy|1
7885407|NCT01799590|12386067|FG002|Overall Study|Lack of Efficacy|3
7885408|NCT01799590|12386065|FG000|Overall Study|Participants convenience|4
7885409|NCT01799590|12386066|FG001|Overall Study|Participants convenience|4
7885410|NCT01799590|12386067|FG002|Overall Study|Participants convenience|2
7885411|NCT01799590|12386065|FG000|Overall Study|Aggravation of complications|0
7885412|NCT01799590|12386066|FG001|Overall Study|Aggravation of complications|1
7885413|NCT01799590|12386067|FG002|Overall Study|Aggravation of complications|1
7885414|NCT01799590|12386065|FG000|Overall Study|Using drugs with restricted days of use|0
7885415|NCT01799590|12386066|FG001|Overall Study|Using drugs with restricted days of use|3
7885416|NCT01799590|12386067|FG002|Overall Study|Using drugs with restricted days of use|2
7885417|NCT01799590|12386065|FG000|Overall Study|Use of prohibited concomitant drugs|1
7885418|NCT01799590|12386066|FG001|Overall Study|Use of prohibited concomitant drugs|0
7885419|NCT01799590|12386067|FG002|Overall Study|Use of prohibited concomitant drugs|0
7885420|NCT01799590|12386065|FG000|Overall Study|Other|3
7885421|NCT01799590|12386066|FG001|Overall Study|Other|0
7885422|NCT01799590|12386067|FG002|Overall Study|Other|1
7885423|NCT01799720|12386078|FG000|Overall Study|Withdrawal by Subject|3
7885424|NCT01799720|12386079|FG001|Overall Study|Withdrawal by Subject|0
7885425|NCT01799720|12386080|FG002|Overall Study|Withdrawal by Subject|0
7885426|NCT01799720|12386078|FG000|Overall Study|Protocol Violation|0
7885427|NCT01799720|12386079|FG001|Overall Study|Protocol Violation|1
7885428|NCT01799720|12386080|FG002|Overall Study|Protocol Violation|0
7885429|NCT01799720|12386078|FG000|Overall Study|Pregnancy|0
7885430|NCT01799720|12386079|FG001|Overall Study|Pregnancy|0
7885431|NCT01799720|12386080|FG002|Overall Study|Pregnancy|1
7885432|NCT01799889|12386100|FG000|Overall Study|Adverse Event|4
7885433|NCT01799889|12386101|FG001|Overall Study|Adverse Event|4
7885434|NCT01799889|12386102|FG002|Overall Study|Adverse Event|5
7885435|NCT01799889|12386103|FG003|Overall Study|Adverse Event|1
7885436|NCT01799889|12386104|FG004|Overall Study|Adverse Event|11
7885437|NCT01799889|12386105|FG005|Overall Study|Adverse Event|1
7885438|NCT01799889|12386106|FG006|Overall Study|Adverse Event|5
7804356|NCT02198794|12264263|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0
7885439|NCT01799889|12386107|FG007|Overall Study|Adverse Event|2
7885440|NCT01799889|12386108|FG008|Overall Study|Adverse Event|3
7885441|NCT01799889|12386109|FG009|Overall Study|Adverse Event|1
7885442|NCT01799889|12386110|FG010|Overall Study|Adverse Event|1
7885443|NCT01799889|12386111|FG011|Overall Study|Adverse Event|0
7885444|NCT01799889|12386100|FG000|Overall Study|Death|1
7885445|NCT01799889|12386101|FG001|Overall Study|Death|0
7885446|NCT01799889|12386102|FG002|Overall Study|Death|5
7885447|NCT01799889|12386103|FG003|Overall Study|Death|3
7885448|NCT01799889|12386104|FG004|Overall Study|Death|1
7885449|NCT01799889|12386105|FG005|Overall Study|Death|0
7885450|NCT01799889|12386106|FG006|Overall Study|Death|0
7885451|NCT01799889|12386107|FG007|Overall Study|Death|0
7885452|NCT01799889|12386108|FG008|Overall Study|Death|1
7885453|NCT01799889|12386109|FG009|Overall Study|Death|0
7885454|NCT01799889|12386110|FG010|Overall Study|Death|1
7885455|NCT01799889|12386111|FG011|Overall Study|Death|0
7885456|NCT01799889|12386100|FG000|Overall Study|Lack of Efficacy|1
7885457|NCT01799889|12386101|FG001|Overall Study|Lack of Efficacy|1
7885458|NCT01799889|12386102|FG002|Overall Study|Lack of Efficacy|0
7885459|NCT01799889|12386103|FG003|Overall Study|Lack of Efficacy|1
7885460|NCT01799889|12386104|FG004|Overall Study|Lack of Efficacy|2
7885461|NCT01799889|12386105|FG005|Overall Study|Lack of Efficacy|2
7885462|NCT01799889|12386106|FG006|Overall Study|Lack of Efficacy|0
7885463|NCT01799889|12386107|FG007|Overall Study|Lack of Efficacy|0
7804357|NCT02198794|12264260|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24
7804358|NCT02198794|12264261|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
7804359|NCT02198794|12264262|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
7804360|NCT02198794|12264263|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
7804361|NCT02198794|12264260|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9
7804362|NCT02198794|12264261|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
7804363|NCT02198794|12264262|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
7804364|NCT02198794|12264263|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
7804365|NCT02198794|12264260|FG000|Part A: Open-Label (158 Weeks)|Death|8
7804366|NCT02198794|12264261|FG001|Part A: Open-Label (158 Weeks)|Death|0
7804367|NCT02198794|12264262|FG002|Part A: Open-Label (158 Weeks)|Death|0
7804368|NCT02198794|12264263|FG003|Part A: Open-Label (158 Weeks)|Death|0
7804369|NCT02198794|12264260|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3
7804370|NCT02198794|12264261|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
7804371|NCT02198794|12264262|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
7804372|NCT02198794|12264263|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
7804373|NCT02198794|12264260|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5
7804374|NCT02198794|12264261|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0
7804375|NCT02198794|12264262|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0
7804376|NCT02198794|12264263|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0
7804377|NCT02198794|12264260|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1
7804378|NCT02198794|12264261|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0
7804379|NCT02198794|12264262|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0
7804380|NCT02198794|12264263|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0
7804381|NCT02198794|12264260|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1
7804382|NCT02198794|12264261|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0
7804383|NCT02198794|12264262|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0
7804384|NCT02198794|12264263|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0
7804385|NCT02198794|12264260|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142
7804386|NCT02198794|12264261|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
7804387|NCT02198794|12264262|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
7804388|NCT02198794|12264263|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
7804389|NCT02198794|12264260|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0
7804390|NCT02198794|12264261|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3
7804391|NCT02198794|12264262|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1
7861630|NCT01595438|12350890|FG000|Overall Study|Lost to Follow-up|20
7861631|NCT01595438|12350891|FG001|Overall Study|Lost to Follow-up|20
7885464|NCT01799889|12386108|FG008|Overall Study|Lack of Efficacy|2
7885465|NCT01799889|12386109|FG009|Overall Study|Lack of Efficacy|0
7885466|NCT01799889|12386110|FG010|Overall Study|Lack of Efficacy|1
7885467|NCT01799889|12386111|FG011|Overall Study|Lack of Efficacy|0
7885468|NCT01799889|12386100|FG000|Overall Study|Lost to Follow-up|0
7885469|NCT01799889|12386101|FG001|Overall Study|Lost to Follow-up|1
7861632|NCT01595438|12350890|FG000|Overall Study|Withdrawal by Subject|12
7861633|NCT01595438|12350891|FG001|Overall Study|Withdrawal by Subject|12
7861634|NCT01595438|12350890|FG000|Overall Study|Other Eligibility criteria|11
7861635|NCT01595438|12350891|FG001|Overall Study|Other Eligibility criteria|9
7861636|NCT01595529|12350926|FG000|Overall Study|Adverse Event|2
7861637|NCT01595529|12350927|FG001|Overall Study|Adverse Event|0
7861638|NCT01595529|12350926|FG000|Overall Study|Subject Non-Compliant|2
7861639|NCT01595529|12350927|FG001|Overall Study|Subject Non-Compliant|0
7861640|NCT01595529|12350926|FG000|Overall Study|Lost to Follow-up|8
7861641|NCT01595529|12350927|FG001|Overall Study|Lost to Follow-up|14
7861642|NCT01595529|12350926|FG000|Overall Study|Protocol Violation|1
7861643|NCT01595529|12350927|FG001|Overall Study|Protocol Violation|2
7861644|NCT01595529|12350926|FG000|Overall Study|Physician Decision|1
7885470|NCT01799889|12386102|FG002|Overall Study|Lost to Follow-up|0
7885471|NCT01799889|12386103|FG003|Overall Study|Lost to Follow-up|0
7885472|NCT01799889|12386104|FG004|Overall Study|Lost to Follow-up|0
7885473|NCT01799889|12386105|FG005|Overall Study|Lost to Follow-up|0
7885474|NCT01799889|12386106|FG006|Overall Study|Lost to Follow-up|0
7885475|NCT01799889|12386107|FG007|Overall Study|Lost to Follow-up|0
7885476|NCT01799889|12386108|FG008|Overall Study|Lost to Follow-up|0
7885477|NCT01799889|12386109|FG009|Overall Study|Lost to Follow-up|0
7885478|NCT01799889|12386110|FG010|Overall Study|Lost to Follow-up|0
7885479|NCT01799889|12386111|FG011|Overall Study|Lost to Follow-up|0
7885480|NCT01799889|12386100|FG000|Overall Study|Physician Decision|3
7885481|NCT01799889|12386101|FG001|Overall Study|Physician Decision|2
7885482|NCT01799889|12386102|FG002|Overall Study|Physician Decision|4
7885483|NCT01799889|12386103|FG003|Overall Study|Physician Decision|4
7885484|NCT01799889|12386104|FG004|Overall Study|Physician Decision|5
7885485|NCT01799889|12386105|FG005|Overall Study|Physician Decision|5
7885486|NCT01799889|12386106|FG006|Overall Study|Physician Decision|5
7885487|NCT01799889|12386107|FG007|Overall Study|Physician Decision|2
7885488|NCT01799889|12386108|FG008|Overall Study|Physician Decision|6
7885489|NCT01799889|12386109|FG009|Overall Study|Physician Decision|0
7885490|NCT01799889|12386110|FG010|Overall Study|Physician Decision|0
7885491|NCT01799889|12386111|FG011|Overall Study|Physician Decision|1
7885492|NCT01799889|12386100|FG000|Overall Study|Progressive Disease|30
7885493|NCT01799889|12386101|FG001|Overall Study|Progressive Disease|26
7885494|NCT01799889|12386102|FG002|Overall Study|Progressive Disease|25
7885495|NCT01799889|12386103|FG003|Overall Study|Progressive Disease|30
7885496|NCT01799889|12386104|FG004|Overall Study|Progressive Disease|23
7885497|NCT01799889|12386105|FG005|Overall Study|Progressive Disease|9
7885498|NCT01799889|12386106|FG006|Overall Study|Progressive Disease|8
7804392|NCT02198794|12264263|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0
7804393|NCT02198794|12264260|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0
7885499|NCT01799889|12386107|FG007|Overall Study|Progressive Disease|13
7804394|NCT02198794|12264261|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
7804395|NCT02198794|12264262|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
7804396|NCT02198794|12264263|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0
7804397|NCT02198794|12264260|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
7804398|NCT02198794|12264261|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
7804399|NCT02198794|12264262|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
7804400|NCT02198794|12264263|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3
7804401|NCT02198794|12264260|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
7804402|NCT02198794|12264261|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
7804403|NCT02198794|12264262|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
7804404|NCT02198794|12264263|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2
7804405|NCT02198794|12264260|FG000|Part C: Safety Assessment (52 Weeks)|Death|0
7804406|NCT02198794|12264261|FG001|Part C: Safety Assessment (52 Weeks)|Death|0
7804407|NCT02198794|12264262|FG002|Part C: Safety Assessment (52 Weeks)|Death|0
7804408|NCT02198794|12264263|FG003|Part C: Safety Assessment (52 Weeks)|Death|2
7804409|NCT01877655|12264274|FG000|Overall Study|Death|57
7804410|NCT01877655|12264275|FG001|Overall Study|Death|52
7804411|NCT01877655|12264274|FG000|Overall Study|Withdrawal by Subject|18
7804412|NCT01877655|12264275|FG001|Overall Study|Withdrawal by Subject|26
7804413|NCT01877655|12264274|FG000|Overall Study|Physician Decision|11
7804414|NCT01877655|12264275|FG001|Overall Study|Physician Decision|10
7804415|NCT01877655|12264274|FG000|Overall Study|Miscellaneous|4
7804416|NCT01877655|12264275|FG001|Overall Study|Miscellaneous|4
7804417|NCT01877655|12264274|FG000|Overall Study|Randomized but Never Received Drug|8
7885500|NCT01799889|12386108|FG008|Overall Study|Progressive Disease|18
7885501|NCT01799889|12386109|FG009|Overall Study|Progressive Disease|5
7885502|NCT01799889|12386110|FG010|Overall Study|Progressive Disease|3
7885503|NCT01799889|12386111|FG011|Overall Study|Progressive Disease|1
7885504|NCT01799889|12386100|FG000|Overall Study|Specified Criteria for Withdrawal|0
7885505|NCT01799889|12386101|FG001|Overall Study|Specified Criteria for Withdrawal|1
7885506|NCT01799889|12386102|FG002|Overall Study|Specified Criteria for Withdrawal|1
7885507|NCT01799889|12386103|FG003|Overall Study|Specified Criteria for Withdrawal|0
7885508|NCT01799889|12386104|FG004|Overall Study|Specified Criteria for Withdrawal|0
7885509|NCT01799889|12386105|FG005|Overall Study|Specified Criteria for Withdrawal|0
7885510|NCT01799889|12386106|FG006|Overall Study|Specified Criteria for Withdrawal|0
7885511|NCT01799889|12386107|FG007|Overall Study|Specified Criteria for Withdrawal|0
7885512|NCT01799889|12386108|FG008|Overall Study|Specified Criteria for Withdrawal|0
7885513|NCT01799889|12386109|FG009|Overall Study|Specified Criteria for Withdrawal|0
7885514|NCT01799889|12386110|FG010|Overall Study|Specified Criteria for Withdrawal|0
7885515|NCT01799889|12386111|FG011|Overall Study|Specified Criteria for Withdrawal|0
7885516|NCT01799889|12386100|FG000|Overall Study|Study Terminated By Sponsor|1
7885517|NCT01799889|12386101|FG001|Overall Study|Study Terminated By Sponsor|0
7885518|NCT01799889|12386102|FG002|Overall Study|Study Terminated By Sponsor|0
7885519|NCT01799889|12386103|FG003|Overall Study|Study Terminated By Sponsor|0
7885520|NCT01799889|12386104|FG004|Overall Study|Study Terminated By Sponsor|2
7885521|NCT01799889|12386105|FG005|Overall Study|Study Terminated By Sponsor|1
7885522|NCT01799889|12386106|FG006|Overall Study|Study Terminated By Sponsor|0
7885523|NCT01799889|12386107|FG007|Overall Study|Study Terminated By Sponsor|2
7885524|NCT01799889|12386108|FG008|Overall Study|Study Terminated By Sponsor|1
7885525|NCT01799889|12386109|FG009|Overall Study|Study Terminated By Sponsor|1
7885526|NCT01799889|12386110|FG010|Overall Study|Study Terminated By Sponsor|0
7885527|NCT01799889|12386111|FG011|Overall Study|Study Terminated By Sponsor|0
7885528|NCT01799889|12386100|FG000|Overall Study|Withdrawal by Subject|1
7885529|NCT01799889|12386101|FG001|Overall Study|Withdrawal by Subject|6
7885530|NCT01799889|12386102|FG002|Overall Study|Withdrawal by Subject|4
7885531|NCT01799889|12386103|FG003|Overall Study|Withdrawal by Subject|0
7885532|NCT01799889|12386104|FG004|Overall Study|Withdrawal by Subject|5
7885533|NCT01799889|12386105|FG005|Overall Study|Withdrawal by Subject|1
7885534|NCT01799889|12386106|FG006|Overall Study|Withdrawal by Subject|3
7885535|NCT01799889|12386107|FG007|Overall Study|Withdrawal by Subject|1
7885536|NCT01799889|12386108|FG008|Overall Study|Withdrawal by Subject|2
7885537|NCT01799889|12386109|FG009|Overall Study|Withdrawal by Subject|1
7885538|NCT01799889|12386110|FG010|Overall Study|Withdrawal by Subject|1
7885539|NCT01799889|12386111|FG011|Overall Study|Withdrawal by Subject|1
7885540|NCT01799889|12386100|FG000|Overall Study|Non-Compliance With Study Drug|0
7885541|NCT01799889|12386101|FG001|Overall Study|Non-Compliance With Study Drug|0
7885542|NCT01799889|12386102|FG002|Overall Study|Non-Compliance With Study Drug|0
7804418|NCT01877655|12264275|FG001|Overall Study|Randomized but Never Received Drug|5
7804419|NCT00308685|12264283|FG000|Overall Study|Lost to Follow-up|1
7804420|NCT00308685|12264284|FG001|Overall Study|Lost to Follow-up|0
7804421|NCT00308685|12264283|FG000|Overall Study|Need to administer prohibited medication|1
7804422|NCT00308685|12264284|FG001|Overall Study|Need to administer prohibited medication|2
7804423|NCT00308685|12264283|FG000|Overall Study|Other than specified|1
7804424|NCT00308685|12264284|FG001|Overall Study|Other than specified|3
7804425|NCT01125514|12264290|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
7804426|NCT01125514|12264290|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
7804427|NCT01125514|12264290|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
7804428|NCT01125514|12264290|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
7804429|NCT01125514|12264290|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
7804430|NCT01125514|12264290|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
7804431|NCT01125566|12264306|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182
7804432|NCT01125566|12264307|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119
7804433|NCT01125566|12264308|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
7804434|NCT01125566|12264306|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
7804435|NCT01125566|12264307|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
7804436|NCT01125566|12264308|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
7804437|NCT01125566|12264306|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25
7804438|NCT01125566|12264307|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5
7804439|NCT01125566|12264308|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0
7804440|NCT01125566|12264306|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0
7804441|NCT01125566|12264307|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2
7804442|NCT01125566|12264308|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0
7804443|NCT01125566|12264306|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24
7804444|NCT01125566|12264307|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23
7804445|NCT01125566|12264308|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
7804446|NCT01125566|12264306|FG000|Patients Before the Switch (26Apr2013)|Not treated|2
7804447|NCT01125566|12264307|FG001|Patients Before the Switch (26Apr2013)|Not treated|0
7804448|NCT01125566|12264308|FG002|Patients Before the Switch (26Apr2013)|Not treated|0
7804449|NCT01125566|12264306|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25
7804450|NCT01125566|12264307|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13
7804451|NCT01125566|12264308|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0
7804452|NCT01125566|12264306|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
7804453|NCT01125566|12264307|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
7804454|NCT01125566|12264308|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0
7804455|NCT01125566|12264306|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
7804456|NCT01125566|12264307|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
7861645|NCT01595529|12350927|FG001|Overall Study|Physician Decision|0
7861646|NCT01595529|12350926|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
7861647|NCT01595529|12350927|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
7861648|NCT01595529|12350926|FG000|Overall Study|Administrative Decision|1
7861649|NCT01595529|12350927|FG001|Overall Study|Administrative Decision|0
7861650|NCT01595529|12350926|FG000|Overall Study|Entry Failure/Screening Failure|6
7861651|NCT01595529|12350927|FG001|Overall Study|Entry Failure/Screening Failure|1
7861652|NCT01595646|12350936|FG000|Overall Study|Withdrawal by Subject|1
7861653|NCT01595646|12350937|FG001|Overall Study|Withdrawal by Subject|0
7861654|NCT01595646|12350938|FG002|Overall Study|Withdrawal by Subject|0
7861655|NCT01596062|12350979|FG000|Overall Study|Adverse Event|1
7861656|NCT01596062|12350980|FG001|Overall Study|Adverse Event|0
7861657|NCT01596062|12350981|FG002|Overall Study|Adverse Event|2
7861658|NCT01596062|12350979|FG000|Overall Study|Lack of Efficacy|0
7861659|NCT01596062|12350980|FG001|Overall Study|Lack of Efficacy|0
7804457|NCT01125566|12264308|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59
7804458|NCT01125566|12264306|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0
7804459|NCT01125566|12264307|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0
7804460|NCT01125566|12264308|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7
7804461|NCT01125566|12264306|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
7804462|NCT01125566|12264307|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
7804463|NCT01125566|12264308|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3
7804464|NCT01125566|12264306|FG000|Patients Who Switched From AV to TV|Other than listed above|0
7804465|NCT01125566|12264307|FG001|Patients Who Switched From AV to TV|Other than listed above|0
7804466|NCT01125566|12264308|FG002|Patients Who Switched From AV to TV|Other than listed above|4
7804467|NCT01125722|12264334|FG000|Overall Study|Withdrawal by Subject|2
7885543|NCT01799889|12386103|FG003|Overall Study|Non-Compliance With Study Drug|0
7885544|NCT01799889|12386104|FG004|Overall Study|Non-Compliance With Study Drug|0
7885545|NCT01799889|12386105|FG005|Overall Study|Non-Compliance With Study Drug|1
7885546|NCT01799889|12386106|FG006|Overall Study|Non-Compliance With Study Drug|0
7885547|NCT01799889|12386107|FG007|Overall Study|Non-Compliance With Study Drug|0
7885548|NCT01799889|12386108|FG008|Overall Study|Non-Compliance With Study Drug|0
7885549|NCT01799889|12386109|FG009|Overall Study|Non-Compliance With Study Drug|0
7885550|NCT01799889|12386110|FG010|Overall Study|Non-Compliance With Study Drug|0
7885551|NCT01799889|12386111|FG011|Overall Study|Non-Compliance With Study Drug|0
7885552|NCT01799941|12386148|FG000|Overall Study|Adverse Event|34
7885553|NCT01799941|12386148|FG000|Overall Study|Withdrawal by Subject|21
7885554|NCT01799941|12386148|FG000|Overall Study|Death|2
7885555|NCT01799941|12386148|FG000|Overall Study|Investigator Decision|4
7885556|NCT01799941|12386148|FG000|Overall Study|Lack of Efficacy|3
7885557|NCT01799941|12386148|FG000|Overall Study|Lost to Follow-up|17
7885558|NCT01799941|12386148|FG000|Overall Study|Other|15
7885559|NCT01799993|12386160|FG000|Overall Study|"Didn't complete CRF page End of FU"|30
7885560|NCT01799993|12386161|FG001|Overall Study|"Didn't complete CRF page End of FU"|40
7885561|NCT01799993|12386160|FG000|Overall Study|Death|61
7885562|NCT01799993|12386161|FG001|Overall Study|Death|45
7885563|NCT01799993|12386160|FG000|Overall Study|Withdrawal by Subject|23
7885564|NCT01799993|12386161|FG001|Overall Study|Withdrawal by Subject|24
7885565|NCT01799993|12386160|FG000|Overall Study|Lost to Follow-up|5
7804468|NCT01125722|12264335|FG001|Overall Study|Withdrawal by Subject|1
7804469|NCT01125722|12264334|FG000|Overall Study|Lost to Follow-up|1
7804470|NCT01125722|12264335|FG001|Overall Study|Lost to Follow-up|0
7804471|NCT01125748|12264343|FG000|Overall Study|Adverse Event|0
7804472|NCT01125748|12264344|FG001|Overall Study|Adverse Event|2
7804473|NCT01125748|12264343|FG000|Overall Study|Lost to Follow-up|0
7804474|NCT01125748|12264344|FG001|Overall Study|Lost to Follow-up|1
7804475|NCT01125748|12264343|FG000|Overall Study|Physician Decision|8
7804476|NCT01125748|12264344|FG001|Overall Study|Physician Decision|7
7804477|NCT01125748|12264343|FG000|Overall Study|Patient Decision to Withdraw|2
7804478|NCT01125748|12264344|FG001|Overall Study|Patient Decision to Withdraw|4
7804479|NCT01125800|12264366|FG000|Phase I|Protocol Violation|0
7804480|NCT01125800|12264367|FG001|Phase I|Protocol Violation|3
7804481|NCT01125800|12264368|FG002|Phase I|Protocol Violation|1
7804482|NCT01125800|12264369|FG003|Phase I|Protocol Violation|1
7804483|NCT01125800|12264370|FG004|Phase I|Protocol Violation|0
7804484|NCT01125800|12264366|FG000|Phase I|Adverse Event|2
7804485|NCT01125800|12264367|FG001|Phase I|Adverse Event|2
7804486|NCT01125800|12264368|FG002|Phase I|Adverse Event|1
7804487|NCT01125800|12264369|FG003|Phase I|Adverse Event|7
7804488|NCT01125800|12264370|FG004|Phase I|Adverse Event|0
7804489|NCT01125800|12264366|FG000|Phase I|Administrative problems|1
7804490|NCT01125800|12264367|FG001|Phase I|Administrative problems|0
7804491|NCT01125800|12264368|FG002|Phase I|Administrative problems|0
7804492|NCT01125800|12264369|FG003|Phase I|Administrative problems|0
7804493|NCT01125800|12264370|FG004|Phase I|Administrative problems|0
7804494|NCT01125800|12264366|FG000|Phase I|Withdrawal by Subject|0
7804495|NCT01125800|12264367|FG001|Phase I|Withdrawal by Subject|0
7804496|NCT01125800|12264368|FG002|Phase I|Withdrawal by Subject|1
7804497|NCT01125800|12264369|FG003|Phase I|Withdrawal by Subject|0
7885566|NCT01799993|12386161|FG001|Overall Study|Lost to Follow-up|8
7885567|NCT01799993|12386160|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5
7885568|NCT01799993|12386161|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3
7885569|NCT01799993|12386160|FG000|Overall Study|Protocol driven decision point|0
7885570|NCT01799993|12386161|FG001|Overall Study|Protocol driven decision point|3
7885571|NCT01799993|12386160|FG000|Overall Study|Protocol Violation|1
7885572|NCT01799993|12386161|FG001|Overall Study|Protocol Violation|1
7885573|NCT01799993|12386160|FG000|Overall Study|Deterioration of general conditions|2
7885574|NCT01799993|12386161|FG001|Overall Study|Deterioration of general conditions|0
7885575|NCT01799993|12386160|FG000|Overall Study|Screen failure|0
7885576|NCT01799993|12386161|FG001|Overall Study|Screen failure|1
7885577|NCT01799993|12386160|FG000|Overall Study|Adverse Event|1
7885578|NCT01799993|12386161|FG001|Overall Study|Adverse Event|0
7885579|NCT01799993|12386160|FG000|Overall Study|Lack of Efficacy|1
7804498|NCT01125800|12264370|FG004|Phase I|Withdrawal by Subject|0
7804499|NCT01125800|12264366|FG000|Phase I|Disease progression|5
7804500|NCT01125800|12264367|FG001|Phase I|Disease progression|4
7885580|NCT01799993|12386161|FG001|Overall Study|Lack of Efficacy|0
7885581|NCT01799993|12386160|FG000|Overall Study|Recovery|0
7885582|NCT01799993|12386161|FG001|Overall Study|Recovery|1
7885583|NCT01799993|12386160|FG000|Overall Study|Logistical difficulties|1
7885584|NCT01799993|12386161|FG001|Overall Study|Logistical difficulties|0
7885585|NCT01799993|12386160|FG000|Overall Study|Protocol deviation|1
7885586|NCT01799993|12386161|FG001|Overall Study|Protocol deviation|0
7885587|NCT01799993|12386160|FG000|Overall Study|Non-compliance with medical device|1
7885588|NCT01799993|12386161|FG001|Overall Study|Non-compliance with medical device|0
7885589|NCT01799993|12386160|FG000|Overall Study|Withdrawal by parent/guardian|0
7885590|NCT01799993|12386161|FG001|Overall Study|Withdrawal by parent/guardian|1
7885591|NCT01799993|12386160|FG000|Overall Study|Other|1
7885592|NCT01799993|12386161|FG001|Overall Study|Other|0
7885593|NCT01799993|12386160|FG000|Overall Study|Subject didn't return for follow-up|0
7885594|NCT01799993|12386161|FG001|Overall Study|Subject didn't return for follow-up|1
7885595|NCT01800058|12386167|FG000|Overall Study|Lost to Follow-up|1
7885596|NCT01800201|12386174|FG000|Overall Study|Withdrawal by Subject|2
7885597|NCT01800201|12386175|FG001|Overall Study|Withdrawal by Subject|0
7885598|NCT01800201|12386174|FG000|Overall Study|patient privacy concerns|1
7885599|NCT01800201|12386175|FG001|Overall Study|patient privacy concerns|1
7885600|NCT01800201|12386174|FG000|Overall Study|did not want to use device|0
7885601|NCT01800201|12386175|FG001|Overall Study|did not want to use device|1
7885602|NCT01800201|12386174|FG000|Overall Study|PI withdrawal, cognitive concerns|0
7885603|NCT01800201|12386175|FG001|Overall Study|PI withdrawal, cognitive concerns|1
7885604|NCT01800903|12386250|FG000|Second Test Period|unable to catheterise|1
7885605|NCT01800903|12386251|FG001|Second Test Period|unable to catheterise|0
7885606|NCT01800903|12386252|FG002|Second Test Period|unable to catheterise|0
7885607|NCT01800903|12386253|FG003|Second Test Period|unable to catheterise|0
7804501|NCT01125800|12264368|FG002|Phase I|Disease progression|1
7804502|NCT01125800|12264369|FG003|Phase I|Disease progression|3
7885608|NCT01800903|12386254|FG004|Second Test Period|unable to catheterise|0
7885609|NCT01800903|12386255|FG005|Second Test Period|unable to catheterise|0
7804503|NCT01125800|12264370|FG004|Phase I|Disease progression|0
7804504|NCT01125800|12264366|FG000|Phase II|Protocol Violation|0
7804505|NCT01125800|12264367|FG001|Phase II|Protocol Violation|0
7804506|NCT01125800|12264368|FG002|Phase II|Protocol Violation|0
7804507|NCT01125800|12264369|FG003|Phase II|Protocol Violation|0
7804508|NCT01125800|12264370|FG004|Phase II|Protocol Violation|1
7804509|NCT01125800|12264366|FG000|Phase II|Adverse Event|0
7804510|NCT01125800|12264367|FG001|Phase II|Adverse Event|0
7804511|NCT01125800|12264368|FG002|Phase II|Adverse Event|0
7804512|NCT01125800|12264369|FG003|Phase II|Adverse Event|0
7804513|NCT01125800|12264370|FG004|Phase II|Adverse Event|2
7804514|NCT01125800|12264366|FG000|Phase II|Disease progression|0
7804515|NCT01125800|12264367|FG001|Phase II|Disease progression|0
7804516|NCT01125800|12264368|FG002|Phase II|Disease progression|0
7804517|NCT01125800|12264369|FG003|Phase II|Disease progression|1
7804518|NCT01125800|12264370|FG004|Phase II|Disease progression|8
7804519|NCT01125813|12264385|FG000|Overall Study|Death|1
7804520|NCT01125813|12264385|FG000|Overall Study|Withdrawal by Subject|1
7804521|NCT01125813|12264385|FG000|Overall Study|Screen Failures|4
7804522|NCT01125917|12264389|FG000|Overall Study|Adverse Event|43
7804523|NCT01125917|12264389|FG000|Overall Study|Lost to Follow-up|23
7804524|NCT01125917|12264389|FG000|Overall Study|Withdrawal by Subject|31
7804525|NCT01125917|12264389|FG000|Overall Study|Administrative|223
7804526|NCT01125917|12264389|FG000|Overall Study|Lack of Efficacy|19
7804527|NCT01125930|12264395|FG000|Overall Study|Adverse Event|0
7804528|NCT01125930|12264396|FG001|Overall Study|Adverse Event|1
7804529|NCT01125930|12264395|FG000|Overall Study|Withdrawal by Subject|1
7804530|NCT01125930|12264396|FG001|Overall Study|Withdrawal by Subject|6
7804531|NCT01125930|12264395|FG000|Overall Study|Protocol Violation|0
7804532|NCT01125930|12264396|FG001|Overall Study|Protocol Violation|1
7885610|NCT01800916|12386261|FG000|Test Period 1 (1 Week)|Convex product user|0
7885611|NCT01800916|12386262|FG001|Test Period 1 (1 Week)|Convex product user|0
7885612|NCT01800916|12386263|FG002|Test Period 1 (1 Week)|Convex product user|0
7885613|NCT01800916|12386264|FG003|Test Period 1 (1 Week)|Convex product user|1
7885614|NCT01800916|12386265|FG004|Test Period 1 (1 Week)|Convex product user|0
7885615|NCT01800916|12386266|FG005|Test Period 1 (1 Week)|Convex product user|0
7885616|NCT01800916|12386267|FG006|Test Period 1 (1 Week)|Convex product user|0
7885617|NCT01800916|12386268|FG007|Test Period 1 (1 Week)|Convex product user|0
7885618|NCT01800916|12386269|FG008|Test Period 1 (1 Week)|Convex product user|0
7885619|NCT01800916|12386261|FG000|Test Period 1 (1 Week)|Adverse Event|0
7885620|NCT01800916|12386262|FG001|Test Period 1 (1 Week)|Adverse Event|0
7885621|NCT01800916|12386263|FG002|Test Period 1 (1 Week)|Adverse Event|0
7885622|NCT01800916|12386264|FG003|Test Period 1 (1 Week)|Adverse Event|0
7885623|NCT01800916|12386265|FG004|Test Period 1 (1 Week)|Adverse Event|1
7885624|NCT01800916|12386266|FG005|Test Period 1 (1 Week)|Adverse Event|0
7885625|NCT01800916|12386267|FG006|Test Period 1 (1 Week)|Adverse Event|0
7885626|NCT01800916|12386268|FG007|Test Period 1 (1 Week)|Adverse Event|0
7885627|NCT01800916|12386269|FG008|Test Period 1 (1 Week)|Adverse Event|0
7885628|NCT01800968|12386281|FG000|Overall Study|Death|23
7804533|NCT01125930|12264395|FG000|Overall Study|Lost to Follow-up|0
7885629|NCT01800968|12386282|FG001|Overall Study|Death|16
7885630|NCT01800968|12386281|FG000|Overall Study|Lost to Follow-up|5
7885631|NCT01800968|12386282|FG001|Overall Study|Lost to Follow-up|7
7885632|NCT01800968|12386281|FG000|Overall Study|Withdrawal by Subject|7
7885633|NCT01800968|12386282|FG001|Overall Study|Withdrawal by Subject|9
7885634|NCT01800968|12386281|FG000|Overall Study|Physician Decision|1
7885635|NCT01800968|12386282|FG001|Overall Study|Physician Decision|0
7885636|NCT01801007|12386288|FG000|Overall Study|Adverse Event|2
7885637|NCT01801007|12386288|FG000|Overall Study|Lost to Follow-up|4
7885638|NCT01801007|12386288|FG000|Overall Study|Withdrawal by Subject|5
7885639|NCT01801111|12386292|FG000|Overall Study|Adverse Event|12
7885640|NCT01801111|12386292|FG000|Overall Study|Death|8
7885641|NCT01801111|12386292|FG000|Overall Study|Physician Decision|5
7885642|NCT01801111|12386292|FG000|Overall Study|Other|1
7885643|NCT01801111|12386292|FG000|Overall Study|Withdrawal by Subject|4
7885644|NCT01801111|12386292|FG000|Overall Study|Study Terminated by Sponsor|27
7885645|NCT01801111|12386292|FG000|Overall Study|Progressive Disease|81
7885646|NCT01801280|12386313|FG000|Period 1|Withdrawal by Subject|0
7885647|NCT01801280|12386314|FG001|Period 1|Withdrawal by Subject|1
7885648|NCT01801280|12386315|FG002|Period 1|Withdrawal by Subject|0
7885649|NCT01801280|12386316|FG003|Period 1|Withdrawal by Subject|0
7885650|NCT01801280|12386313|FG000|Period 2|Withdrawal by Subject|1
7885651|NCT01801280|12386314|FG001|Period 2|Withdrawal by Subject|0
7885652|NCT01801280|12386315|FG002|Period 2|Withdrawal by Subject|0
7885653|NCT01801280|12386316|FG003|Period 2|Withdrawal by Subject|0
7885654|NCT01801280|12386313|FG000|Period 4|Protocol Violation|0
7885655|NCT01801280|12386314|FG001|Period 4|Protocol Violation|0
7885656|NCT01801280|12386315|FG002|Period 4|Protocol Violation|1
7885657|NCT01801280|12386316|FG003|Period 4|Protocol Violation|0
7885658|NCT01801358|12386332|FG000|Overall Study|Adverse Event|0
7885659|NCT01801358|12386333|FG001|Overall Study|Adverse Event|2
7967685|NCT02770248|12524697|FG000|Overall Study|Randomized in error, prior to treatment|0
7885660|NCT01801358|12386334|FG002|Overall Study|Adverse Event|1
7885661|NCT01801358|12386335|FG003|Overall Study|Adverse Event|0
7885662|NCT01801358|12386336|FG004|Overall Study|Adverse Event|0
7885663|NCT01801358|12386337|FG005|Overall Study|Adverse Event|1
7804534|NCT01125930|12264396|FG001|Overall Study|Lost to Follow-up|2
7804535|NCT01126060|12264420|FG000|Overall Study|Protocol Violation|0
7804536|NCT01126060|12264421|FG001|Overall Study|Protocol Violation|2
7804537|NCT01126268|12264436|FG000|Overall Study|Adverse Event|1
7804538|NCT01126359|12264440|FG000|First Intervention (20-minutes)|Physician Decision|0
7804539|NCT01126359|12264441|FG001|First Intervention (20-minutes)|Physician Decision|1
7804540|NCT01126424|12264457|FG000|Overall Study|Adverse Event|0
7804541|NCT01126424|12264458|FG001|Overall Study|Adverse Event|0
7804542|NCT01126424|12264459|FG002|Overall Study|Adverse Event|0
7804543|NCT01126424|12264460|FG003|Overall Study|Adverse Event|0
7804544|NCT01126424|12264461|FG004|Overall Study|Adverse Event|1
7804545|NCT01126424|12264462|FG005|Overall Study|Adverse Event|0
7804546|NCT01126424|12264457|FG000|Overall Study|Withdrawal by Subject|0
7804547|NCT01126424|12264458|FG001|Overall Study|Withdrawal by Subject|0
7804548|NCT01126424|12264459|FG002|Overall Study|Withdrawal by Subject|1
7804549|NCT01126424|12264460|FG003|Overall Study|Withdrawal by Subject|3
7804550|NCT01126424|12264461|FG004|Overall Study|Withdrawal by Subject|1
7804551|NCT01126424|12264462|FG005|Overall Study|Withdrawal by Subject|0
7804552|NCT01126437|12264473|FG000|Overall Study|Not treated|11
7804553|NCT01126437|12264474|FG001|Overall Study|Not treated|18
7804554|NCT01126437|12264475|FG002|Overall Study|Not treated|19
7804555|NCT01126437|12264473|FG000|Overall Study|Sites with data irregularities/fraud|6
7804556|NCT01126437|12264474|FG001|Overall Study|Sites with data irregularities/fraud|6
7804557|NCT01126437|12264475|FG002|Overall Study|Sites with data irregularities/fraud|7
7804558|NCT01126437|12264473|FG000|Overall Study|Adverse Event|602
7804559|NCT01126437|12264474|FG001|Overall Study|Adverse Event|606
7804560|NCT01126437|12264475|FG002|Overall Study|Adverse Event|635
7804561|NCT01126437|12264473|FG000|Overall Study|Lack of Efficacy|65
7804562|NCT01126437|12264474|FG001|Overall Study|Lack of Efficacy|60
7804563|NCT01126437|12264475|FG002|Overall Study|Lack of Efficacy|59
7804564|NCT01126437|12264473|FG000|Overall Study|Protocol Violation|64
7804565|NCT01126437|12264474|FG001|Overall Study|Protocol Violation|66
7804566|NCT01126437|12264475|FG002|Overall Study|Protocol Violation|41
7804567|NCT01126437|12264473|FG000|Overall Study|Lost to Follow-up|52
7804568|NCT01126437|12264474|FG001|Overall Study|Lost to Follow-up|63
7804569|NCT01126437|12264475|FG002|Overall Study|Lost to Follow-up|55
7804570|NCT01126437|12264473|FG000|Overall Study|Withdrawal by Subject|331
7804571|NCT01126437|12264474|FG001|Overall Study|Withdrawal by Subject|335
7804572|NCT01126437|12264475|FG002|Overall Study|Withdrawal by Subject|319
7804573|NCT01126437|12264473|FG000|Overall Study|Other reason not specified|210
7804574|NCT01126437|12264474|FG001|Overall Study|Other reason not specified|176
7804575|NCT01126437|12264475|FG002|Overall Study|Other reason not specified|178
7804576|NCT01126541|12264486|FG000|Overall Study|Adverse Event|0
7804577|NCT01126541|12264487|FG001|Overall Study|Adverse Event|2
7804578|NCT01126541|12264488|FG002|Overall Study|Adverse Event|4
7804579|NCT01126541|12264486|FG000|Overall Study|Death|0
7804580|NCT01126541|12264487|FG001|Overall Study|Death|1
7804581|NCT01126541|12264488|FG002|Overall Study|Death|0
7804582|NCT01126541|12264486|FG000|Overall Study|Lack of Efficacy|6
7804583|NCT01126541|12264487|FG001|Overall Study|Lack of Efficacy|1
7804584|NCT01126541|12264488|FG002|Overall Study|Lack of Efficacy|11
7885664|NCT01801358|12386332|FG000|Overall Study|Physician Decision|0
7804585|NCT01126541|12264486|FG000|Overall Study|Lost to Follow-up|1
7804586|NCT01126541|12264487|FG001|Overall Study|Lost to Follow-up|2
7804587|NCT01126541|12264488|FG002|Overall Study|Lost to Follow-up|2
7804588|NCT01126541|12264486|FG000|Overall Study|Withdrawal by Subject|2
7804589|NCT01126541|12264487|FG001|Overall Study|Withdrawal by Subject|5
7804590|NCT01126541|12264488|FG002|Overall Study|Withdrawal by Subject|6
7804591|NCT01126541|12264486|FG000|Overall Study|Protocol Violation|0
7804592|NCT01126541|12264487|FG001|Overall Study|Protocol Violation|0
7804593|NCT01126541|12264488|FG002|Overall Study|Protocol Violation|1
7804594|NCT01126541|12264486|FG000|Overall Study|Administrative reason or other|1
7804595|NCT01126541|12264487|FG001|Overall Study|Administrative reason or other|1
7804596|NCT01126541|12264488|FG002|Overall Study|Administrative reason or other|2
7804597|NCT01126580|12264501|FG000|Overall Study|Adverse Event|14
7804598|NCT01126580|12264502|FG001|Overall Study|Adverse Event|8
7804599|NCT01126580|12264503|FG002|Overall Study|Adverse Event|12
7804600|NCT01126580|12264501|FG000|Overall Study|Withdrawal by Subject|11
7804601|NCT01126580|12264502|FG001|Overall Study|Withdrawal by Subject|19
7804602|NCT01126580|12264503|FG002|Overall Study|Withdrawal by Subject|14
7804603|NCT01126580|12264501|FG000|Overall Study|Sponsor Decision|5
7804604|NCT01126580|12264502|FG001|Overall Study|Sponsor Decision|4
7804605|NCT01126580|12264503|FG002|Overall Study|Sponsor Decision|7
7804606|NCT01126580|12264501|FG000|Overall Study|Physician Decision|1
7804607|NCT01126580|12264502|FG001|Overall Study|Physician Decision|1
7804608|NCT01126580|12264503|FG002|Overall Study|Physician Decision|2
7804609|NCT01126580|12264501|FG000|Overall Study|Entry Criteria Not Met|1
7804610|NCT01126580|12264502|FG001|Overall Study|Entry Criteria Not Met|1
7804611|NCT01126580|12264503|FG002|Overall Study|Entry Criteria Not Met|2
7804612|NCT01126580|12264501|FG000|Overall Study|Lack of Efficacy|2
7804613|NCT01126580|12264502|FG001|Overall Study|Lack of Efficacy|3
7804614|NCT01126580|12264503|FG002|Overall Study|Lack of Efficacy|4
7804615|NCT01126580|12264501|FG000|Overall Study|Protocol Violation|0
7804616|NCT01126580|12264502|FG001|Overall Study|Protocol Violation|1
7804617|NCT01126580|12264503|FG002|Overall Study|Protocol Violation|2
7804618|NCT01126580|12264501|FG000|Overall Study|Lost to Follow-up|15
7804619|NCT01126580|12264502|FG001|Overall Study|Lost to Follow-up|13
7804620|NCT01126580|12264503|FG002|Overall Study|Lost to Follow-up|9
7885665|NCT01801358|12386333|FG001|Overall Study|Physician Decision|0
7885666|NCT01801358|12386334|FG002|Overall Study|Physician Decision|1
7885667|NCT01801358|12386335|FG003|Overall Study|Physician Decision|0
7885668|NCT01801358|12386336|FG004|Overall Study|Physician Decision|0
7885669|NCT01801358|12386337|FG005|Overall Study|Physician Decision|0
7885670|NCT01801358|12386332|FG000|Overall Study|Progressive Disease|6
7885671|NCT01801358|12386333|FG001|Overall Study|Progressive Disease|4
7885672|NCT01801358|12386334|FG002|Overall Study|Progressive Disease|4
7885673|NCT01801358|12386335|FG003|Overall Study|Progressive Disease|5
7885674|NCT01801358|12386336|FG004|Overall Study|Progressive Disease|6
7885675|NCT01801358|12386337|FG005|Overall Study|Progressive Disease|5
7885676|NCT01801358|12386332|FG000|Overall Study|Withdrawal by Subject|0
7885677|NCT01801358|12386333|FG001|Overall Study|Withdrawal by Subject|0
7885678|NCT01801358|12386334|FG002|Overall Study|Withdrawal by Subject|0
7885679|NCT01801358|12386335|FG003|Overall Study|Withdrawal by Subject|1
7885680|NCT01801358|12386336|FG004|Overall Study|Withdrawal by Subject|0
7885681|NCT01801358|12386337|FG005|Overall Study|Withdrawal by Subject|2
7885682|NCT01801436|12386372|FG000|Overall Study|Withdrawal by Subject|3
7885683|NCT01801436|12386372|FG000|Overall Study|Adverse Event|2
7885684|NCT01801436|12386372|FG000|Overall Study|Progressive disease|4
7885685|NCT01801475|12386384|FG000|Overall Study|Withdrawal by Subject|0
7885686|NCT01801475|12386385|FG001|Overall Study|Withdrawal by Subject|0
7885687|NCT01801475|12386386|FG002|Overall Study|Withdrawal by Subject|0
7885688|NCT01801475|12386387|FG003|Overall Study|Withdrawal by Subject|0
7885689|NCT01801475|12386388|FG004|Overall Study|Withdrawal by Subject|1
7885690|NCT01801735|12386397|FG000|Overall Study|Adverse Event|79
7885691|NCT01801735|12386397|FG000|Overall Study|Lack of Efficacy|28
7885692|NCT01801735|12386397|FG000|Overall Study|Withdrawal by Subject|27
7885693|NCT01801735|12386397|FG000|Overall Study|Protocol Violation|25
7885694|NCT01801735|12386397|FG000|Overall Study|Lost to Follow-up|15
7885695|NCT01801735|12386397|FG000|Overall Study|Non-compliance with Trial Drug|13
7885696|NCT01801735|12386397|FG000|Overall Study|Physician Decision|3
7885697|NCT01801735|12386397|FG000|Overall Study|Death|1
7885698|NCT01801735|12386397|FG000|Overall Study|Other, including site closure|19
7885699|NCT01801865|12386401|FG000|Overall Study|Patients scanned on another MRI scanner|35
7885700|NCT01801865|12386401|FG000|Overall Study|Physician Decision|7
7885701|NCT01801917|12386409|FG000|Period 1 - Randomized|Adverse Event|1
7885702|NCT01801917|12386410|FG001|Period 1 - Randomized|Adverse Event|0
7885703|NCT01801917|12386411|FG002|Period 1 - Randomized|Adverse Event|1
7885704|NCT01801917|12386412|FG003|Period 1 - Randomized|Adverse Event|0
7885705|NCT01801930|12386427|FG000|Overall Study|Clear progression of the primary disease is observed|6
7885706|NCT01801930|12386428|FG001|Overall Study|Clear progression of the primary disease is observed|5
7885707|NCT01801930|12386429|FG002|Overall Study|Clear progression of the primary disease is observed|6
7885708|NCT01801930|12386430|FG003|Overall Study|Clear progression of the primary disease is observed|6
7885709|NCT01801930|12386427|FG000|Overall Study|DLT occurs|0
7885710|NCT01801930|12386428|FG001|Overall Study|DLT occurs|1
7885711|NCT01801930|12386429|FG002|Overall Study|DLT occurs|0
7885712|NCT01801930|12386430|FG003|Overall Study|DLT occurs|0
7885713|NCT01801982|12386440|FG000|Overall Study|Lost to Follow-up|1
7885714|NCT01802073|12386446|FG000|Overall Study|Lost to Follow-up|0
7885715|NCT01802073|12386447|FG001|Overall Study|Lost to Follow-up|1
7885716|NCT01802073|12386446|FG000|Overall Study|Non-compliant|4
7885717|NCT01802073|12386447|FG001|Overall Study|Non-compliant|2
7885718|NCT01802073|12386446|FG000|Overall Study|Withdrawal by Subject|1
7885719|NCT01802073|12386447|FG001|Overall Study|Withdrawal by Subject|1
7885720|NCT01802073|12386446|FG000|Overall Study|Physician Decision|0
7885721|NCT01802073|12386447|FG001|Overall Study|Physician Decision|7
7885722|NCT01802216|12386472|FG000|4 Month Visit|Participant did not show to visit|3
7885723|NCT01802216|12386473|FG001|4 Month Visit|Participant did not show to visit|4
7885724|NCT01802216|12386472|FG000|8 Month Visit|Participant did not show to visit|3
7885725|NCT01802216|12386473|FG001|8 Month Visit|Participant did not show to visit|5
7885726|NCT01802216|12386472|FG000|12 Month Visit|Participant did not show to visit|3
7885727|NCT01802216|12386473|FG001|12 Month Visit|Participant did not show to visit|4
7885728|NCT01802320|12386479|FG000|Overall Study|Death|1
7885729|NCT01802320|12386479|FG000|Overall Study|Withdrawal by Subject|1
7885730|NCT01802333|12386486|FG000|Overall Study|Ineligible|2
7885731|NCT01802333|12386487|FG001|Overall Study|Ineligible|6
7885732|NCT01802333|12386488|FG002|Overall Study|Ineligible|8
7885733|NCT01802333|12386486|FG000|Overall Study|Adverse Event|1
7885734|NCT01802333|12386487|FG001|Overall Study|Adverse Event|8
7885735|NCT01802333|12386488|FG002|Overall Study|Adverse Event|8
7885736|NCT01802333|12386486|FG000|Overall Study|Withdrawal by Subject|6
7885737|NCT01802333|12386487|FG001|Overall Study|Withdrawal by Subject|6
7885738|NCT01802333|12386488|FG002|Overall Study|Withdrawal by Subject|5
7804621|NCT01126580|12264501|FG000|Overall Study|Treatment Non-compliance|0
7804622|NCT01126580|12264502|FG001|Overall Study|Treatment Non-compliance|2
7804623|NCT01126580|12264503|FG002|Overall Study|Treatment Non-compliance|3
7804624|NCT01126619|12264525|FG000|Overall Study|Not eligible for the study|2
7804625|NCT01126619|12264525|FG000|Overall Study|Investigator decision|4
7804626|NCT01126619|12264525|FG000|Overall Study|Serious adverse event|1
7804627|NCT01126619|12264525|FG000|Overall Study|Withdrawal by Subject|9
7804628|NCT01126619|12264525|FG000|Overall Study|Non-compliance|1
7804629|NCT01127061|12264553|FG000|Overall Study|Lost to Follow-up|7
7804630|NCT01127061|12264554|FG001|Overall Study|Lost to Follow-up|10
7804631|NCT01127061|12264553|FG000|Overall Study|Physician Decision|3
7804632|NCT01127061|12264554|FG001|Overall Study|Physician Decision|3
7804633|NCT01127139|12264571|FG000|Overall Study|Adverse Event|40
7804634|NCT01127139|12264571|FG000|Overall Study|Incompliance|12
7804635|NCT01127139|12264571|FG000|Overall Study|Lack of Efficacy|4
7804636|NCT01127139|12264571|FG000|Overall Study|Reason not specified|1
7804637|NCT01127165|12264580|FG000|Overall Study|Adverse Event|2
7804638|NCT01127165|12264581|FG001|Overall Study|Adverse Event|2
7804639|NCT01127165|12264580|FG000|Overall Study|Lack of Efficacy|10
7804640|NCT01127165|12264581|FG001|Overall Study|Lack of Efficacy|8
7804641|NCT01127165|12264580|FG000|Overall Study|Lost to Follow-up|3
7804642|NCT01127165|12264581|FG001|Overall Study|Lost to Follow-up|5
7804643|NCT01127165|12264580|FG000|Overall Study|Withdrawal by Subject|1
7804644|NCT01127165|12264581|FG001|Overall Study|Withdrawal by Subject|3
7804645|NCT01127165|12264580|FG000|Overall Study|Protocol Violation|0
7885739|NCT01802333|12386486|FG000|Overall Study|Progression/relapse|1
7885740|NCT01802333|12386487|FG001|Overall Study|Progression/relapse|3
7885741|NCT01802333|12386488|FG002|Overall Study|Progression/relapse|0
7885742|NCT01802333|12386486|FG000|Overall Study|Death|7
7885743|NCT01802333|12386487|FG001|Overall Study|Death|14
7885744|NCT01802333|12386488|FG002|Overall Study|Death|13
7804646|NCT01127165|12264581|FG001|Overall Study|Protocol Violation|1
7804647|NCT01127373|12264608|FG000|Overall Study|Not Treated|3
7804648|NCT01127373|12264608|FG000|Overall Study|Lost to Follow-up|7
7804649|NCT01127373|12264608|FG000|Overall Study|Withdrawal by Subject|1
7804650|NCT01127373|12264608|FG000|Overall Study|Disease progression|1
7804651|NCT01127607|12264644|FG000|Phase II (Between Subjects)|Lost to Follow-up|0
7804652|NCT01127607|12264645|FG001|Phase II (Between Subjects)|Lost to Follow-up|2
7804653|NCT01127607|12264644|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1
7804654|NCT01127607|12264645|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0
7804655|NCT01127633|12264670|FG000|Overall Study|Adverse Event|74
7804656|NCT01127633|12264671|FG001|Overall Study|Adverse Event|73
7804657|NCT01127633|12264670|FG000|Overall Study|Death|40
7804658|NCT01127633|12264671|FG001|Overall Study|Death|43
7804659|NCT01127633|12264670|FG000|Overall Study|Lost to Follow-up|4
7804660|NCT01127633|12264671|FG001|Overall Study|Lost to Follow-up|0
7804661|NCT01127633|12264670|FG000|Overall Study|Parent/Caregiver Decision|246
7804662|NCT01127633|12264671|FG001|Overall Study|Parent/Caregiver Decision|228
7804663|NCT01127633|12264670|FG000|Overall Study|Physician Decision|60
7804664|NCT01127633|12264671|FG001|Overall Study|Physician Decision|45
7804665|NCT01127633|12264670|FG000|Overall Study|Withdrawal by Subject|57
7804666|NCT01127633|12264671|FG001|Overall Study|Withdrawal by Subject|72
7804667|NCT01127633|12264670|FG000|Overall Study|Sponsor Decision|163
7804668|NCT01127633|12264671|FG001|Overall Study|Sponsor Decision|195
7804669|NCT01127633|12264670|FG000|Overall Study|Protocol Violation|8
7804670|NCT01127633|12264671|FG001|Overall Study|Protocol Violation|16
7804671|NCT01127633|12264670|FG000|Overall Study|Abnormal Lab/ECG Result|0
7885745|NCT01802333|12386486|FG000|Overall Study|Other - not protocol specified|32
7885746|NCT01802333|12386487|FG001|Overall Study|Other - not protocol specified|22
7804672|NCT01127633|12264671|FG001|Overall Study|Abnormal Lab/ECG Result|1
7804673|NCT01127633|12264670|FG000|Overall Study|Not treated|1
7804674|NCT01127633|12264671|FG001|Overall Study|Not treated|0
7804675|NCT01127646|12264679|FG000|Overall Study|Entry Criteria Not Met|1
7804676|NCT01127646|12264680|FG001|Overall Study|Entry Criteria Not Met|0
7804677|NCT01127646|12264679|FG000|Overall Study|Protocol Violation|0
7804678|NCT01127646|12264680|FG001|Overall Study|Protocol Violation|1
7804679|NCT01127763|12264722|FG000|Overall Study|Adverse Event|2
7804680|NCT01127763|12264722|FG000|Overall Study|Withdrawal by Subject|1
7804681|NCT01127763|12264722|FG000|Overall Study|Physician Decision|2
7804682|NCT01127893|12264730|FG000|Overall Study|Study Termination by the Sponsor|1
7804683|NCT01128153|12264749|FG000|Overall Study|Adverse Event|1
7804684|NCT01128153|12264750|FG001|Overall Study|Adverse Event|3
7804685|NCT01128153|12264749|FG000|Overall Study|Condition under investigation worsened|8
7804686|NCT01128153|12264750|FG001|Overall Study|Condition under investigation worsened|7
7804687|NCT01128153|12264749|FG000|Overall Study|Withdrawal by Subject|2
7804688|NCT01128153|12264750|FG001|Overall Study|Withdrawal by Subject|3
7804689|NCT01128153|12264749|FG000|Overall Study|Incorrect enrolment to study|2
7804690|NCT01128153|12264750|FG001|Overall Study|Incorrect enrolment to study|1
7804691|NCT01128153|12264749|FG000|Overall Study|Protocol Violation|2
7804692|NCT01128153|12264750|FG001|Overall Study|Protocol Violation|0
7804693|NCT01128153|12264749|FG000|Overall Study|Developed discontinuation criteria|1
7804694|NCT01128153|12264750|FG001|Overall Study|Developed discontinuation criteria|1
7804695|NCT01128179|12264758|FG000|Overall Study|Death|1
7885747|NCT01802333|12386488|FG002|Overall Study|Other - not protocol specified|24
7804696|NCT01128179|12264759|FG001|Overall Study|Death|0
7804697|NCT01128179|12264758|FG000|Overall Study|Protocol Violation|1
7804698|NCT01128179|12264759|FG001|Overall Study|Protocol Violation|0
7804699|NCT01128244|12264780|FG000|Overall Study|Adverse Event|1
7804700|NCT01128244|12264780|FG000|Overall Study|Scheduling conflict|2
7804701|NCT01128296|12264800|FG000|Overall Study|Physician Decision|0
7804702|NCT01128296|12264801|FG001|Overall Study|Physician Decision|0
7804703|NCT01128296|12264802|FG002|Overall Study|Physician Decision|0
7804704|NCT01128296|12264803|FG003|Overall Study|Physician Decision|0
7804705|NCT01128296|12264804|FG004|Overall Study|Physician Decision|0
7804706|NCT01128296|12264805|FG005|Overall Study|Physician Decision|3
7804707|NCT01128296|12264800|FG000|Overall Study|Withdrawal by Subject|0
7804708|NCT01128296|12264801|FG001|Overall Study|Withdrawal by Subject|0
7804709|NCT01128296|12264802|FG002|Overall Study|Withdrawal by Subject|0
7804710|NCT01128296|12264803|FG003|Overall Study|Withdrawal by Subject|0
7804711|NCT01128296|12264804|FG004|Overall Study|Withdrawal by Subject|0
7804712|NCT01128296|12264805|FG005|Overall Study|Withdrawal by Subject|2
7804713|NCT01128361|12264818|FG000|Overall Study|Lost to Follow-up|0
7804714|NCT01128361|12264819|FG001|Overall Study|Lost to Follow-up|1
7804715|NCT01128361|12264818|FG000|Overall Study|Withdrawal by Subject|5
7804716|NCT01128361|12264819|FG001|Overall Study|Withdrawal by Subject|2
7804717|NCT01128387|12264827|FG000|Overall Study|Physician Decision|0
7804718|NCT01128387|12264828|FG001|Overall Study|Physician Decision|1
7804719|NCT01128400|12264837|FG000|Overall Study|Lost to Follow-up|1
7885748|NCT01802333|12386486|FG000|Overall Study|Did not start treatment|0
7885749|NCT01802333|12386487|FG001|Overall Study|Did not start treatment|2
7885750|NCT01802333|12386488|FG002|Overall Study|Did not start treatment|5
7885751|NCT01802385|12386504|FG000|Overall Study|Death|106
7885752|NCT01802385|12386505|FG001|Overall Study|Death|120
7885753|NCT01802411|12386513|FG000|Overall Study|Death|2
7885754|NCT01802411|12386514|FG001|Overall Study|Death|1
7885755|NCT01802411|12386513|FG000|Overall Study|Adverse Event|2
7885756|NCT01802411|12386514|FG001|Overall Study|Adverse Event|7
7885757|NCT01802411|12386513|FG000|Overall Study|Lack of Efficacy|8
7885758|NCT01802411|12386514|FG001|Overall Study|Lack of Efficacy|10
7885759|NCT01802411|12386513|FG000|Overall Study|Withdrawal by Subject|0
7885760|NCT01802411|12386514|FG001|Overall Study|Withdrawal by Subject|2
7885761|NCT01802411|12386513|FG000|Overall Study|Planned pleurodesis as part of the proc|1
7885762|NCT01802411|12386514|FG001|Overall Study|Planned pleurodesis as part of the proc|0
7885763|NCT01802411|12386513|FG000|Overall Study|Surgery aborted after bronchoscopy|1
7885764|NCT01802411|12386514|FG001|Overall Study|Surgery aborted after bronchoscopy|0
7885765|NCT01802411|12386513|FG000|Overall Study|Proc changed to video-asst thorascopic|0
7885766|NCT01802411|12386514|FG001|Overall Study|Proc changed to video-asst thorascopic|1
7885767|NCT01802437|12386522|FG000|Overall Study|Lost to Follow-up|1
7885768|NCT01802437|12386523|FG001|Overall Study|Lost to Follow-up|0
7885769|NCT01802437|12386522|FG000|Overall Study|Withdrawal by Subject|3
7885770|NCT01802437|12386523|FG001|Overall Study|Withdrawal by Subject|4
7885771|NCT01802515|12386532|FG000|Overall Study|Withdrawal by Subject|3
7885772|NCT01802515|12386533|FG001|Overall Study|Withdrawal by Subject|0
7885773|NCT01802515|12386534|FG002|Overall Study|Withdrawal by Subject|0
7885774|NCT01802580|12386553|FG000|Overall Study|Physician Decision|1
7885775|NCT01802580|12386554|FG001|Overall Study|Physician Decision|0
7885776|NCT01802580|12386553|FG000|Overall Study|Protocol Violation|2
7885777|NCT01802580|12386554|FG001|Overall Study|Protocol Violation|0
7885778|NCT01802580|12386553|FG000|Overall Study|Withdrawal by Subject|5
7885779|NCT01802580|12386554|FG001|Overall Study|Withdrawal by Subject|6
7885780|NCT01802580|12386553|FG000|Overall Study|Other|1
7885781|NCT01802580|12386554|FG001|Overall Study|Other|3
7885782|NCT01802580|12386553|FG000|Overall Study|Lack of Efficacy|0
7885783|NCT01802580|12386554|FG001|Overall Study|Lack of Efficacy|2
7885784|NCT01802775|12386573|FG000|Overall Study|Death|0
7885785|NCT01802775|12386574|FG001|Overall Study|Death|3
7885786|NCT01802775|12386573|FG000|Overall Study|Reason not provided|0
7885787|NCT01802775|12386574|FG001|Overall Study|Reason not provided|1
7885788|NCT01802775|12386573|FG000|Overall Study|Physician Decision|1
7885789|NCT01802775|12386574|FG001|Overall Study|Physician Decision|0
7885790|NCT01802775|12386573|FG000|Overall Study|Adverse Event|1
7885791|NCT01802775|12386574|FG001|Overall Study|Adverse Event|1
7885792|NCT01802775|12386573|FG000|Overall Study|Withdrawal by Subject|3
7885793|NCT01802775|12386574|FG001|Overall Study|Withdrawal by Subject|5
7885794|NCT01802775|12386573|FG000|Overall Study|Lost to Follow-up|1
7885795|NCT01802775|12386574|FG001|Overall Study|Lost to Follow-up|2
7885796|NCT01802879|12386580|FG000|Overall Study|Administrative problems|2
7885797|NCT01802879|12386580|FG000|Overall Study|Disease progression|6
7885798|NCT01803269|12386662|FG000|Overall Study|Withdrawal by Subject|3
7885799|NCT01803269|12386663|FG001|Overall Study|Withdrawal by Subject|0
7885800|NCT01803269|12386664|FG002|Overall Study|Withdrawal by Subject|0
7885801|NCT01803282|12386684|FG000|Overall Study|Progressive Disease|4
7885802|NCT01803282|12386685|FG001|Overall Study|Progressive Disease|3
7885803|NCT01803282|12386686|FG002|Overall Study|Progressive Disease|6
7885804|NCT01803282|12386687|FG003|Overall Study|Progressive Disease|22
7885805|NCT01803282|12386688|FG004|Overall Study|Progressive Disease|5
7885806|NCT01803282|12386689|FG005|Overall Study|Progressive Disease|8
7885807|NCT01803282|12386690|FG006|Overall Study|Progressive Disease|23
7885808|NCT01803282|12386691|FG007|Overall Study|Progressive Disease|24
7885809|NCT01803282|12386692|FG008|Overall Study|Progressive Disease|3
7885810|NCT01803282|12386693|FG009|Overall Study|Progressive Disease|29
7804720|NCT01128400|12264838|FG001|Overall Study|Lost to Follow-up|0
7804721|NCT01128400|12264839|FG002|Overall Study|Lost to Follow-up|1
7804722|NCT01128400|12264837|FG000|Overall Study|Screening failure|1
7804723|NCT01128400|12264838|FG001|Overall Study|Screening failure|0
7804724|NCT01128400|12264839|FG002|Overall Study|Screening failure|0
7804725|NCT01128400|12264837|FG000|Overall Study|were not invited to participate on taste|0
7804726|NCT01128400|12264838|FG001|Overall Study|were not invited to participate on taste|0
7804727|NCT01128400|12264839|FG002|Overall Study|were not invited to participate on taste|15
7804728|NCT01128400|12264837|FG000|Overall Study|Excluded due to sinus problems|0
7804729|NCT01128400|12264838|FG001|Overall Study|Excluded due to sinus problems|1
7804730|NCT01128400|12264839|FG002|Overall Study|Excluded due to sinus problems|0
7804731|NCT01128413|12264849|FG000|Overall Study|Withdrawal by Subject|1
7804732|NCT01128413|12264850|FG001|Overall Study|Withdrawal by Subject|0
7804733|NCT01128413|12264849|FG000|Overall Study|NICOM Monitor Problems|2
7804734|NCT01128413|12264850|FG001|Overall Study|NICOM Monitor Problems|1
7804735|NCT01128413|12264849|FG000|Overall Study|Pt made DNR|1
7804736|NCT01128413|12264850|FG001|Overall Study|Pt made DNR|0
7804737|NCT01128543|12264862|FG000|Overall Study|Withdrawal by Subject|3
7804738|NCT01128543|12264862|FG000|Overall Study|Protocol Violation|1
7804739|NCT01128569|12264866|FG000|Washout Period 1|Adverse Event|0
7804740|NCT01128569|12264867|FG001|Washout Period 1|Adverse Event|0
7804741|NCT01128569|12264868|FG002|Washout Period 1|Adverse Event|1
7804742|NCT01128569|12264869|FG003|Washout Period 1|Adverse Event|0
7804743|NCT01128569|12264870|FG004|Washout Period 1|Adverse Event|0
7804744|NCT01128569|12264871|FG005|Washout Period 1|Adverse Event|0
7804745|NCT01128569|12264866|FG000|Treatment Period 2|Withdrawal by Subject|0
7804746|NCT01128569|12264867|FG001|Treatment Period 2|Withdrawal by Subject|1
7804747|NCT01128569|12264868|FG002|Treatment Period 2|Withdrawal by Subject|0
7804748|NCT01128569|12264869|FG003|Treatment Period 2|Withdrawal by Subject|0
7804749|NCT01128569|12264870|FG004|Treatment Period 2|Withdrawal by Subject|0
7804750|NCT01128569|12264871|FG005|Treatment Period 2|Withdrawal by Subject|0
7804751|NCT01128595|12264879|FG000|Treatment Period 3|Withdrawal by Subject|0
7804752|NCT01128595|12264880|FG001|Treatment Period 3|Withdrawal by Subject|1
7804753|NCT01128595|12264881|FG002|Treatment Period 3|Withdrawal by Subject|0
7804754|NCT01128595|12264882|FG003|Treatment Period 3|Withdrawal by Subject|0
7804755|NCT01128621|12264895|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
7804756|NCT01128621|12264896|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
7885811|NCT01803282|12386694|FG010|Overall Study|Progressive Disease|6
7885812|NCT01803282|12386695|FG011|Overall Study|Progressive Disease|11
7885813|NCT01803282|12386684|FG000|Overall Study|Death|0
7885814|NCT01803282|12386685|FG001|Overall Study|Death|0
7885815|NCT01803282|12386686|FG002|Overall Study|Death|0
7885816|NCT01803282|12386687|FG003|Overall Study|Death|0
7885817|NCT01803282|12386688|FG004|Overall Study|Death|2
7885818|NCT01803282|12386689|FG005|Overall Study|Death|1
7804757|NCT01128738|12264920|FG000|First Treatment Phase (TP)|Lost to Follow-up|1
7804758|NCT01128738|12264921|FG001|First Treatment Phase (TP)|Lost to Follow-up|0
7804759|NCT01128738|12264920|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3
7804760|NCT01128738|12264921|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1
7804761|NCT01128738|12264920|FG000|Second TP|Lost to Follow-up|0
7804762|NCT01128738|12264921|FG001|Second TP|Lost to Follow-up|1
7804763|NCT01128738|12264920|FG000|Second TP|Withdrawal by Subject|0
7804764|NCT01128738|12264921|FG001|Second TP|Withdrawal by Subject|2
7885819|NCT01803282|12386690|FG006|Overall Study|Death|1
7885820|NCT01803282|12386691|FG007|Overall Study|Death|5
7885821|NCT01803282|12386692|FG008|Overall Study|Death|1
7885822|NCT01803282|12386693|FG009|Overall Study|Death|1
7804765|NCT01128842|12264933|FG000|Overall Study|Adverse Event|1
7804766|NCT01128842|12264933|FG000|Overall Study|Disease Progression|6
7804767|NCT01128894|12264940|FG000|Overall Study|Adverse Event|31
7804768|NCT01128894|12264941|FG001|Overall Study|Adverse Event|41
7804769|NCT01128894|12264940|FG000|Overall Study|Protocol Violation|2
7804770|NCT01128894|12264941|FG001|Overall Study|Protocol Violation|1
7804771|NCT01128894|12264940|FG000|Overall Study|Noncompliance|4
7885823|NCT01803282|12386694|FG010|Overall Study|Death|0
7885824|NCT01803282|12386695|FG011|Overall Study|Death|0
7885825|NCT01803282|12386684|FG000|Overall Study|Withdrew Consent|0
7885826|NCT01803282|12386685|FG001|Overall Study|Withdrew Consent|0
7885827|NCT01803282|12386686|FG002|Overall Study|Withdrew Consent|0
7885828|NCT01803282|12386687|FG003|Overall Study|Withdrew Consent|6
7885829|NCT01803282|12386688|FG004|Overall Study|Withdrew Consent|1
7885830|NCT01803282|12386689|FG005|Overall Study|Withdrew Consent|0
7885831|NCT01803282|12386690|FG006|Overall Study|Withdrew Consent|8
7885832|NCT01803282|12386691|FG007|Overall Study|Withdrew Consent|3
7885833|NCT01803282|12386692|FG008|Overall Study|Withdrew Consent|1
7885834|NCT01803282|12386693|FG009|Overall Study|Withdrew Consent|5
7885835|NCT01803282|12386694|FG010|Overall Study|Withdrew Consent|0
7885836|NCT01803282|12386695|FG011|Overall Study|Withdrew Consent|1
7804772|NCT01128894|12264941|FG001|Overall Study|Noncompliance|5
7804773|NCT01128894|12264940|FG000|Overall Study|Lost to Follow-up|8
7804774|NCT01128894|12264941|FG001|Overall Study|Lost to Follow-up|8
7804775|NCT01128894|12264940|FG000|Overall Study|Withdrawal by Subject|10
7804776|NCT01128894|12264941|FG001|Overall Study|Withdrawal by Subject|12
7804777|NCT01128894|12264940|FG000|Overall Study|Physician Decision|2
7804778|NCT01128894|12264941|FG001|Overall Study|Physician Decision|1
7804779|NCT01128894|12264940|FG000|Overall Study|Conflicting HbA1c Results at Screening|1
7804780|NCT01128894|12264941|FG001|Overall Study|Conflicting HbA1c Results at Screening|0
7804781|NCT01128946|12264947|FG000|Period I|Protocol Violation|0
7804782|NCT01128946|12264948|FG001|Period I|Protocol Violation|1
7804783|NCT01128946|12264949|FG002|Period I|Protocol Violation|0
7804784|NCT01128946|12264950|FG003|Period I|Protocol Violation|0
7804785|NCT01128946|12264947|FG000|Period I|Withdrawal by Subject|0
7804786|NCT01128946|12264948|FG001|Period I|Withdrawal by Subject|0
7804787|NCT01128946|12264949|FG002|Period I|Withdrawal by Subject|1
7804788|NCT01128946|12264950|FG003|Period I|Withdrawal by Subject|1
7804789|NCT01128946|12264947|FG000|Period II|Protocol Violation|0
7804790|NCT01128946|12264948|FG001|Period II|Protocol Violation|1
7804791|NCT01128946|12264949|FG002|Period II|Protocol Violation|0
7804792|NCT01128946|12264950|FG003|Period II|Protocol Violation|0
7804793|NCT01128946|12264947|FG000|Period II|Withdrawal by Subject|0
7804794|NCT01128946|12264948|FG001|Period II|Withdrawal by Subject|0
7804795|NCT01128946|12264949|FG002|Period II|Withdrawal by Subject|0
7804796|NCT01128946|12264950|FG003|Period II|Withdrawal by Subject|1
7804797|NCT01128946|12264947|FG000|Period III|Protocol Violation|1
7804798|NCT01128946|12264948|FG001|Period III|Protocol Violation|0
7804799|NCT01128946|12264949|FG002|Period III|Protocol Violation|0
7804800|NCT01128946|12264950|FG003|Period III|Protocol Violation|0
7804801|NCT01128959|12264961|FG000|Lead in Period|Adverse Event|3
7804802|NCT01128959|12264961|FG000|Treatment Period|Adverse Event|3
7804803|NCT01128959|12264961|FG000|Treatment Period|Withdrawal by Subject|1
7804804|NCT01129024|12264989|FG000|Overall Study|Physician Decision|5
7804805|NCT01129024|12264989|FG000|Overall Study|Study Terminated by Sponsor|8
7804806|NCT01129024|12264989|FG000|Overall Study|Withdrawal by Subject|2
7804807|NCT01129024|12264989|FG000|Overall Study|Lack of Efficacy|3
7804808|NCT01129024|12264989|FG000|Overall Study|Needed a Platelet Transfusion|1
7804809|NCT01129102|12264996|FG000|Overall Study|No study drug treatment|2
7804810|NCT01129102|12264997|FG001|Overall Study|No study drug treatment|3
7804811|NCT01129102|12264998|FG002|Overall Study|No study drug treatment|1
7804812|NCT01129102|12264996|FG000|Overall Study|Withdrawal by Subject|2
7804813|NCT01129102|12264997|FG001|Overall Study|Withdrawal by Subject|0
7804814|NCT01129102|12264998|FG002|Overall Study|Withdrawal by Subject|3
7804815|NCT01129102|12264996|FG000|Overall Study|Protocol Violation|0
7804816|NCT01129102|12264997|FG001|Overall Study|Protocol Violation|1
7804817|NCT01129102|12264998|FG002|Overall Study|Protocol Violation|1
7804818|NCT01129102|12264996|FG000|Overall Study|Pregnancy|0
7804819|NCT01129102|12264997|FG001|Overall Study|Pregnancy|0
7804820|NCT01129102|12264998|FG002|Overall Study|Pregnancy|1
7804821|NCT01129102|12264996|FG000|Overall Study|Adverse Event|2
7804822|NCT01129102|12264997|FG001|Overall Study|Adverse Event|2
7804823|NCT01129102|12264998|FG002|Overall Study|Adverse Event|1
7804824|NCT01129102|12264996|FG000|Overall Study|Lost to Follow-up|2
7804825|NCT01129102|12264997|FG001|Overall Study|Lost to Follow-up|0
7804826|NCT01129102|12264998|FG002|Overall Study|Lost to Follow-up|0
7861660|NCT01596062|12350981|FG002|Overall Study|Lack of Efficacy|1
7861661|NCT01596127|12350993|FG000|Overall Study|Patient Ineligible|1
7861662|NCT01596335|12351019|FG000|Overall Study|exacerbation of primary disease|5
7861663|NCT01596335|12351020|FG001|Overall Study|exacerbation of primary disease|9
7861664|NCT01596504|12351029|FG000|Overall Study|Participant's Private Reason|0
7861665|NCT01596504|12351030|FG001|Overall Study|Participant's Private Reason|1
7861666|NCT01596504|12351031|FG002|Overall Study|Participant's Private Reason|0
7861667|NCT01596504|12351029|FG000|Overall Study|Adverse Event|1
7861668|NCT01596504|12351030|FG001|Overall Study|Adverse Event|2
7861669|NCT01596504|12351031|FG002|Overall Study|Adverse Event|1
7804827|NCT01129115|12265009|FG000|Overall Study|Adverse Event|1
7804828|NCT01129115|12265010|FG001|Overall Study|Adverse Event|2
7804829|NCT01129115|12265011|FG002|Overall Study|Adverse Event|3
7804830|NCT01129115|12265012|FG003|Overall Study|Adverse Event|3
7804831|NCT01129115|12265009|FG000|Overall Study|Withdrawal by Subject|1
7804832|NCT01129115|12265010|FG001|Overall Study|Withdrawal by Subject|3
7804833|NCT01129115|12265011|FG002|Overall Study|Withdrawal by Subject|1
7804834|NCT01129115|12265012|FG003|Overall Study|Withdrawal by Subject|4
7804835|NCT01129115|12265009|FG000|Overall Study|Protocol Violation|0
7804836|NCT01129115|12265010|FG001|Overall Study|Protocol Violation|2
7804837|NCT01129115|12265011|FG002|Overall Study|Protocol Violation|2
7804838|NCT01129115|12265012|FG003|Overall Study|Protocol Violation|2
7804839|NCT01129128|12265025|FG000|Overall Study|Lost to Follow-up|2
7804840|NCT01129128|12265026|FG001|Overall Study|Lost to Follow-up|2
7804841|NCT01129128|12265027|FG002|Overall Study|Lost to Follow-up|1
7804842|NCT01129128|12265025|FG000|Overall Study|Protocol Violation|0
7804843|NCT01129128|12265026|FG001|Overall Study|Protocol Violation|1
7804844|NCT01129128|12265027|FG002|Overall Study|Protocol Violation|0
7804845|NCT01129128|12265025|FG000|Overall Study|Withdrawal by Subject|0
7804846|NCT01129128|12265026|FG001|Overall Study|Withdrawal by Subject|1
7804847|NCT01129128|12265027|FG002|Overall Study|Withdrawal by Subject|3
7804848|NCT01129128|12265025|FG000|Overall Study|Physician Decision|1
7804849|NCT01129128|12265026|FG001|Overall Study|Physician Decision|0
7804850|NCT01129128|12265027|FG002|Overall Study|Physician Decision|0
7804851|NCT01129284|12265066|FG000|Overall Study|Adverse Event|2
7804852|NCT01129284|12265067|FG001|Overall Study|Adverse Event|0
7804853|NCT01129284|12265068|FG002|Overall Study|Adverse Event|1
7804854|NCT01129336|12265078|FG000|Overall Study|Protocol Violation|1
7804855|NCT01129336|12265079|FG001|Overall Study|Protocol Violation|0
7804856|NCT01129336|12265078|FG000|Overall Study|Disease Progression|1
7885837|NCT01803282|12386684|FG000|Overall Study|Investigator's Discretion|0
7804857|NCT01129336|12265079|FG001|Overall Study|Disease Progression|4
7804858|NCT01129336|12265078|FG000|Overall Study|Lost to Follow-up|1
7804859|NCT01129336|12265079|FG001|Overall Study|Lost to Follow-up|0
7804860|NCT01129336|12265078|FG000|Overall Study|Withdrawal by Subject|7
7804861|NCT01129336|12265079|FG001|Overall Study|Withdrawal by Subject|4
7804862|NCT01129336|12265078|FG000|Overall Study|Adverse Event|0
7804863|NCT01129336|12265079|FG001|Overall Study|Adverse Event|1
7804864|NCT01129336|12265078|FG000|Overall Study|Missing Study Completion Status|2
7804865|NCT01129336|12265079|FG001|Overall Study|Missing Study Completion Status|3
7804866|NCT01129336|12265078|FG000|Overall Study|Death|0
7804867|NCT01129336|12265079|FG001|Overall Study|Death|4
7804868|NCT01129557|12265115|FG000|Overall Study|Adverse Event|1
7804869|NCT01129557|12265116|FG001|Overall Study|Adverse Event|2
7804870|NCT01129557|12265117|FG002|Overall Study|Adverse Event|2
7804871|NCT01129557|12265115|FG000|Overall Study|Novartis terminated study early|3
7804872|NCT01129557|12265116|FG001|Overall Study|Novartis terminated study early|3
7804873|NCT01129557|12265117|FG002|Overall Study|Novartis terminated study early|2
7804874|NCT01129583|12265138|FG000|Overall Study|Death|1
7804875|NCT01129583|12265139|FG001|Overall Study|Death|0
7804876|NCT01129583|12265138|FG000|Overall Study|Lost to Follow-up|1
7804877|NCT01129583|12265139|FG001|Overall Study|Lost to Follow-up|1
7804878|NCT01129583|12265138|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1
7804879|NCT01129583|12265139|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1
7804880|NCT01129622|12265149|FG000|Overall Study|Withdrawal by Subject|2
7804881|NCT01129882|12265171|FG000|Overall Study|Adverse Event|39
7804882|NCT01129882|12265171|FG000|Overall Study|Death|6
7804883|NCT01129882|12265171|FG000|Overall Study|Lack of Efficacy|5
7804884|NCT01129882|12265171|FG000|Overall Study|Lost to Follow-up|13
7804885|NCT01129882|12265171|FG000|Overall Study|Physician Decision|27
7804886|NCT01129882|12265171|FG000|Overall Study|Protocol Deviation|3
7804887|NCT01129882|12265171|FG000|Overall Study|Withdrawal Criteria Met|19
7804888|NCT01129882|12265171|FG000|Overall Study|Trial Termination by Sponsor|6
7804889|NCT01129882|12265171|FG000|Overall Study|Withdrawal by Subject|160
7804890|NCT01129921|12265177|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
7804891|NCT01129921|12265178|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
7804892|NCT01129921|12265177|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
7804893|NCT01129921|12265178|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
7804894|NCT01129921|12265177|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
7804895|NCT01129921|12265178|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
7804896|NCT01129921|12265177|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
7804897|NCT01129921|12265178|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
7804898|NCT01129960|12265192|FG000|Overall Study|Withdrawal by Subject|3
7804899|NCT01129960|12265193|FG001|Overall Study|Withdrawal by Subject|0
7804900|NCT01129960|12265194|FG002|Overall Study|Withdrawal by Subject|3
7804901|NCT01129960|12265195|FG003|Overall Study|Withdrawal by Subject|2
7804902|NCT01129960|12265192|FG000|Overall Study|Lack of Efficacy|1
7804903|NCT01129960|12265193|FG001|Overall Study|Lack of Efficacy|1
7804904|NCT01129960|12265194|FG002|Overall Study|Lack of Efficacy|1
7804905|NCT01129960|12265195|FG003|Overall Study|Lack of Efficacy|1
7804906|NCT01129960|12265192|FG000|Overall Study|Adverse Event|23
7804907|NCT01129960|12265193|FG001|Overall Study|Adverse Event|16
7804908|NCT01129960|12265194|FG002|Overall Study|Adverse Event|16
7804909|NCT01129960|12265195|FG003|Overall Study|Adverse Event|7
7804910|NCT01129960|12265192|FG000|Overall Study|Protocol Violation|1
7804911|NCT01129960|12265193|FG001|Overall Study|Protocol Violation|2
7804912|NCT01129960|12265194|FG002|Overall Study|Protocol Violation|3
7804913|NCT01129960|12265195|FG003|Overall Study|Protocol Violation|0
7804914|NCT01129960|12265192|FG000|Overall Study|Lost to Follow-up|0
7804915|NCT01129960|12265193|FG001|Overall Study|Lost to Follow-up|2
7804916|NCT01129960|12265194|FG002|Overall Study|Lost to Follow-up|3
7804917|NCT01129960|12265195|FG003|Overall Study|Lost to Follow-up|3
7804918|NCT01129960|12265192|FG000|Overall Study|Discontinuation of the study by Sponsor|0
7804919|NCT01129960|12265193|FG001|Overall Study|Discontinuation of the study by Sponsor|1
7804920|NCT01129960|12265194|FG002|Overall Study|Discontinuation of the study by Sponsor|0
7804921|NCT01129960|12265195|FG003|Overall Study|Discontinuation of the study by Sponsor|0
7804922|NCT01129960|12265192|FG000|Overall Study|Physician Decision|1
7804923|NCT01129960|12265193|FG001|Overall Study|Physician Decision|0
7804924|NCT01129960|12265194|FG002|Overall Study|Physician Decision|0
7804925|NCT01129960|12265195|FG003|Overall Study|Physician Decision|0
7804926|NCT01129960|12265192|FG000|Overall Study|Pregnancy|1
7804927|NCT01129960|12265193|FG001|Overall Study|Pregnancy|0
7804928|NCT01129960|12265194|FG002|Overall Study|Pregnancy|0
7804929|NCT01129960|12265195|FG003|Overall Study|Pregnancy|0
7804930|NCT01130051|12265205|FG000|Washout Period of 14 Days|Withdrawal by Subject|0
7804931|NCT01130051|12265206|FG001|Washout Period of 14 Days|Withdrawal by Subject|1
7804932|NCT01130051|12265205|FG000|Washout Period of 14 Days|Protocol Violation|1
7804933|NCT01130051|12265206|FG001|Washout Period of 14 Days|Protocol Violation|1
7804934|NCT01130103|12265214|FG000|Randomized Treatment|Adverse Event|1
7804935|NCT01130103|12265215|FG001|Randomized Treatment|Adverse Event|1
7804936|NCT01130103|12265214|FG000|Randomized Treatment|Lost to Follow-up|1
7804937|NCT01130103|12265215|FG001|Randomized Treatment|Lost to Follow-up|0
7804938|NCT01130103|12265214|FG000|Randomized Treatment|Protocol Violation|3
7804939|NCT01130103|12265215|FG001|Randomized Treatment|Protocol Violation|2
7804940|NCT01130103|12265214|FG000|Randomized Treatment|Withdrawal by Subject|1
7804941|NCT01130103|12265215|FG001|Randomized Treatment|Withdrawal by Subject|2
7804942|NCT01130103|12265214|FG000|Maintenance Treatment|Lack of Efficacy|0
7804943|NCT01130103|12265215|FG001|Maintenance Treatment|Lack of Efficacy|1
7804944|NCT01130103|12265214|FG000|Maintenance Treatment|Lost to Follow-up|1
7804945|NCT01130103|12265215|FG001|Maintenance Treatment|Lost to Follow-up|1
7804946|NCT01130103|12265214|FG000|Maintenance Treatment|Withdrawal by Subject|1
7804947|NCT01130103|12265215|FG001|Maintenance Treatment|Withdrawal by Subject|0
7804948|NCT01130168|12265221|FG000|Period 1|Withdrawal by Subject|0
7885838|NCT01803282|12386685|FG001|Overall Study|Investigator's Discretion|0
7885839|NCT01803282|12386686|FG002|Overall Study|Investigator's Discretion|0
7885840|NCT01803282|12386687|FG003|Overall Study|Investigator's Discretion|7
7885841|NCT01803282|12386688|FG004|Overall Study|Investigator's Discretion|2
7885842|NCT01803282|12386689|FG005|Overall Study|Investigator's Discretion|1
7885843|NCT01803282|12386690|FG006|Overall Study|Investigator's Discretion|7
7885844|NCT01803282|12386691|FG007|Overall Study|Investigator's Discretion|10
7885845|NCT01803282|12386692|FG008|Overall Study|Investigator's Discretion|6
7804949|NCT01130168|12265222|FG001|Period 1|Withdrawal by Subject|1
7804950|NCT01130168|12265223|FG002|Period 1|Withdrawal by Subject|0
7804951|NCT01130168|12265224|FG003|Period 1|Withdrawal by Subject|1
7804952|NCT01130168|12265225|FG004|Period 1|Withdrawal by Subject|0
7804953|NCT01130168|12265226|FG005|Period 1|Withdrawal by Subject|0
7804954|NCT01130168|12265221|FG000|Period 1|Discontinued For Other Reason|0
7804955|NCT01130168|12265222|FG001|Period 1|Discontinued For Other Reason|0
7804956|NCT01130168|12265223|FG002|Period 1|Discontinued For Other Reason|1
7804957|NCT01130168|12265224|FG003|Period 1|Discontinued For Other Reason|1
7804958|NCT01130168|12265225|FG004|Period 1|Discontinued For Other Reason|0
7804959|NCT01130168|12265226|FG005|Period 1|Discontinued For Other Reason|0
7804960|NCT01130168|12265221|FG000|Period 1|Adverse Event|0
7804961|NCT01130168|12265222|FG001|Period 1|Adverse Event|0
7804962|NCT01130168|12265223|FG002|Period 1|Adverse Event|0
7804963|NCT01130168|12265224|FG003|Period 1|Adverse Event|1
7804964|NCT01130168|12265225|FG004|Period 1|Adverse Event|0
7804965|NCT01130168|12265226|FG005|Period 1|Adverse Event|0
7804966|NCT01130272|12265240|FG000|Overall Study|Adverse Event|2
7804967|NCT01130272|12265241|FG001|Overall Study|Adverse Event|5
7804968|NCT01130272|12265242|FG002|Overall Study|Adverse Event|6
7804969|NCT01130272|12265243|FG003|Overall Study|Adverse Event|22
7804970|NCT01130272|12265244|FG004|Overall Study|Adverse Event|7
7804971|NCT01130272|12265240|FG000|Overall Study|IVRS-confirmed constipation|0
7804972|NCT01130272|12265241|FG001|Overall Study|IVRS-confirmed constipation|1
7804973|NCT01130272|12265242|FG002|Overall Study|IVRS-confirmed constipation|1
7804974|NCT01130272|12265243|FG003|Overall Study|IVRS-confirmed constipation|2
7804975|NCT01130272|12265244|FG004|Overall Study|IVRS-confirmed constipation|0
7804976|NCT01130272|12265240|FG000|Overall Study|Rescue medications due to diarrhea|3
7804977|NCT01130272|12265241|FG001|Overall Study|Rescue medications due to diarrhea|5
7804978|NCT01130272|12265242|FG002|Overall Study|Rescue medications due to diarrhea|8
7804979|NCT01130272|12265243|FG003|Overall Study|Rescue medications due to diarrhea|8
7804980|NCT01130272|12265244|FG004|Overall Study|Rescue medications due to diarrhea|6
7804981|NCT01130272|12265240|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
7885846|NCT01803282|12386693|FG009|Overall Study|Investigator's Discretion|7
7885847|NCT01803282|12386694|FG010|Overall Study|Investigator's Discretion|1
7885848|NCT01803282|12386695|FG011|Overall Study|Investigator's Discretion|0
7885849|NCT01803282|12386684|FG000|Overall Study|Adverse Event|0
7885850|NCT01803282|12386685|FG001|Overall Study|Adverse Event|0
7885851|NCT01803282|12386686|FG002|Overall Study|Adverse Event|0
7885852|NCT01803282|12386687|FG003|Overall Study|Adverse Event|0
7885853|NCT01803282|12386688|FG004|Overall Study|Adverse Event|0
7885854|NCT01803282|12386689|FG005|Overall Study|Adverse Event|0
7885855|NCT01803282|12386690|FG006|Overall Study|Adverse Event|1
7885856|NCT01803282|12386691|FG007|Overall Study|Adverse Event|2
7885857|NCT01803282|12386692|FG008|Overall Study|Adverse Event|0
7885858|NCT01803282|12386693|FG009|Overall Study|Adverse Event|1
7885859|NCT01803282|12386694|FG010|Overall Study|Adverse Event|0
7885860|NCT01803282|12386695|FG011|Overall Study|Adverse Event|3
7885861|NCT01803282|12386684|FG000|Overall Study|Non-Compliance with Study Drug|0
7885862|NCT01803282|12386685|FG001|Overall Study|Non-Compliance with Study Drug|0
7885863|NCT01803282|12386686|FG002|Overall Study|Non-Compliance with Study Drug|0
7885864|NCT01803282|12386687|FG003|Overall Study|Non-Compliance with Study Drug|1
7885865|NCT01803282|12386688|FG004|Overall Study|Non-Compliance with Study Drug|0
7885866|NCT01803282|12386689|FG005|Overall Study|Non-Compliance with Study Drug|0
7885867|NCT01803282|12386690|FG006|Overall Study|Non-Compliance with Study Drug|0
7885868|NCT01803282|12386691|FG007|Overall Study|Non-Compliance with Study Drug|0
7885869|NCT01803282|12386692|FG008|Overall Study|Non-Compliance with Study Drug|0
7885870|NCT01803282|12386693|FG009|Overall Study|Non-Compliance with Study Drug|0
7885871|NCT01803282|12386694|FG010|Overall Study|Non-Compliance with Study Drug|0
7885872|NCT01803282|12386695|FG011|Overall Study|Non-Compliance with Study Drug|0
7885873|NCT01803282|12386684|FG000|Overall Study|Unknown Reason|0
7885874|NCT01803282|12386685|FG001|Overall Study|Unknown Reason|0
7885875|NCT01803282|12386686|FG002|Overall Study|Unknown Reason|0
7885876|NCT01803282|12386687|FG003|Overall Study|Unknown Reason|0
7804982|NCT01130272|12265241|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
7885877|NCT01803282|12386688|FG004|Overall Study|Unknown Reason|0
7804983|NCT01130272|12265242|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
7804984|NCT01130272|12265243|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
7804985|NCT01130272|12265244|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2
7804986|NCT01130272|12265240|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
7804987|NCT01130272|12265241|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
7804988|NCT01130272|12265242|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
7804989|NCT01130272|12265243|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1
7804990|NCT01130272|12265244|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
7804991|NCT01130272|12265240|FG000|Overall Study|Protocol Violation|0
7804992|NCT01130272|12265241|FG001|Overall Study|Protocol Violation|0
7804993|NCT01130272|12265242|FG002|Overall Study|Protocol Violation|3
7804994|NCT01130272|12265243|FG003|Overall Study|Protocol Violation|5
7804995|NCT01130272|12265244|FG004|Overall Study|Protocol Violation|5
7804996|NCT01130272|12265240|FG000|Overall Study|Lost to Follow-up|4
7804997|NCT01130272|12265241|FG001|Overall Study|Lost to Follow-up|3
7804998|NCT01130272|12265242|FG002|Overall Study|Lost to Follow-up|4
7804999|NCT01130272|12265243|FG003|Overall Study|Lost to Follow-up|7
7805000|NCT01130272|12265244|FG004|Overall Study|Lost to Follow-up|6
7805001|NCT01130272|12265240|FG000|Overall Study|Withdrawal by Subject|4
7805002|NCT01130272|12265241|FG001|Overall Study|Withdrawal by Subject|11
7805003|NCT01130272|12265242|FG002|Overall Study|Withdrawal by Subject|10
7805004|NCT01130272|12265243|FG003|Overall Study|Withdrawal by Subject|9
7805005|NCT01130272|12265244|FG004|Overall Study|Withdrawal by Subject|8
7805006|NCT01130272|12265240|FG000|Overall Study|Physician Decision|1
7805007|NCT01130272|12265241|FG001|Overall Study|Physician Decision|1
7885878|NCT01803282|12386689|FG005|Overall Study|Unknown Reason|0
7885879|NCT01803282|12386690|FG006|Overall Study|Unknown Reason|0
7885880|NCT01803282|12386691|FG007|Overall Study|Unknown Reason|1
7885881|NCT01803282|12386692|FG008|Overall Study|Unknown Reason|0
7967686|NCT02770248|12524698|FG001|Overall Study|Randomized in error, prior to treatment|1
7967687|NCT02770547|12524751|FG000|Overall Study|Patient non-compliant|1
7967688|NCT02770547|12524752|FG001|Overall Study|Patient non-compliant|0
7967689|NCT02770547|12524751|FG000|Overall Study|Adverse Event|0
7967690|NCT02770547|12524752|FG001|Overall Study|Adverse Event|1
7967691|NCT02770612|12524758|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1
7967692|NCT02770820|12524766|FG000|Overall Study|Death|1
7967693|NCT02770820|12524766|FG000|Overall Study|Physician Decision|2
7967694|NCT02771145|12524790|FG000|Overall Study|Adverse Event|3
7967695|NCT02771145|12524790|FG000|Overall Study|Lost to Follow-up|1
7967696|NCT02771210|12524812|FG000|Period 1|Adverse Event|5
7967697|NCT02771210|12524813|FG001|Period 1|Adverse Event|3
7967698|NCT02771210|12524812|FG000|Period 1|Lack of Efficacy|3
7967699|NCT02771210|12524813|FG001|Period 1|Lack of Efficacy|6
7967700|NCT02771210|12524812|FG000|Period 1|Lost to Follow-up|2
7967701|NCT02771210|12524813|FG001|Period 1|Lost to Follow-up|0
7967702|NCT02771210|12524812|FG000|Period 1|Physician Decision|0
7967703|NCT02771210|12524813|FG001|Period 1|Physician Decision|1
7967704|NCT02771210|12524812|FG000|Period 1|Withdrawal by Subject|0
7967705|NCT02771210|12524813|FG001|Period 1|Withdrawal by Subject|3
7967706|NCT02771210|12524812|FG000|Period 1|Withdrawal of informed consent|1
7967707|NCT02771210|12524813|FG001|Period 1|Withdrawal of informed consent|5
7967708|NCT02771210|12524812|FG000|Period 2|Adverse Event|1
7967709|NCT02771210|12524813|FG001|Period 2|Adverse Event|0
7967710|NCT02771210|12524812|FG000|Period 2|Lack of Efficacy|0
7967711|NCT02771210|12524813|FG001|Period 2|Lack of Efficacy|1
7967712|NCT02771210|12524812|FG000|Period 2|Withdrawal by Subject|1
7967713|NCT02771210|12524813|FG001|Period 2|Withdrawal by Subject|0
7967714|NCT02771210|12524812|FG000|Period 2|Withdrawal of informed consent|0
7967715|NCT02771210|12524813|FG001|Period 2|Withdrawal of informed consent|2
7967716|NCT02771366|12524834|FG000|Period 1|Withdrawal by Subject|0
7967717|NCT02771366|12524835|FG001|Period 1|Withdrawal by Subject|2
7967718|NCT02771366|12524834|FG000|Period 2 (Crossover)|Withdrawal by Subject|2
7967719|NCT02771366|12524835|FG001|Period 2 (Crossover)|Withdrawal by Subject|0
7967720|NCT02771522|12524842|FG000|Overall Study|Lost to Follow-up|3
7967721|NCT02771522|12524842|FG000|Overall Study|Withdrawal by Subject|2
7967722|NCT02771522|12524842|FG000|Overall Study|No white spot lesions|3
7967723|NCT02772757|12524901|FG000|Overall Study|Withdrawal by Subject|1
7967724|NCT02772757|12524902|FG001|Overall Study|Withdrawal by Subject|0
7967725|NCT02772757|12524903|FG002|Overall Study|Withdrawal by Subject|1
7967726|NCT02772757|12524901|FG000|Overall Study|Protocol Violation|0
7967727|NCT02772757|12524902|FG001|Overall Study|Protocol Violation|0
7967728|NCT02772757|12524903|FG002|Overall Study|Protocol Violation|1
7967729|NCT02772757|12524901|FG000|Overall Study|Physician Decision|0
7967730|NCT02772757|12524902|FG001|Overall Study|Physician Decision|3
7967731|NCT02772757|12524903|FG002|Overall Study|Physician Decision|3
7967732|NCT02772809|12524921|FG000|Overall Study|not completed some tasks|6
7967733|NCT02772978|12524930|FG000|Overall Study|Withdrawal by Subject|1
7967734|NCT02772978|12524931|FG001|Overall Study|Withdrawal by Subject|1
7967735|NCT02773368|12524938|FG000|Overall Study|Lost to Follow-up|4
7805008|NCT01130272|12265242|FG002|Overall Study|Physician Decision|0
7805009|NCT01130272|12265243|FG003|Overall Study|Physician Decision|1
7805010|NCT01130272|12265244|FG004|Overall Study|Physician Decision|2
7805011|NCT01130272|12265240|FG000|Overall Study|Sponsor decision|6
7805012|NCT01130272|12265241|FG001|Overall Study|Sponsor decision|15
7805013|NCT01130272|12265242|FG002|Overall Study|Sponsor decision|16
7805014|NCT01130272|12265243|FG003|Overall Study|Sponsor decision|13
7805015|NCT01130272|12265244|FG004|Overall Study|Sponsor decision|16
7805016|NCT01130272|12265240|FG000|Overall Study|Study arm discontinued|38
7805017|NCT01130272|12265241|FG001|Overall Study|Study arm discontinued|0
7805018|NCT01130272|12265242|FG002|Overall Study|Study arm discontinued|0
7805019|NCT01130272|12265243|FG003|Overall Study|Study arm discontinued|0
7805020|NCT01130272|12265244|FG004|Overall Study|Study arm discontinued|0
7805021|NCT01130337|12265256|FG000|Overall Study|Withdrawal by Subject|3
7805022|NCT01130337|12265256|FG000|Overall Study|Principal investigator decision|1
7805023|NCT01130337|12265256|FG000|Overall Study|Death|1
7805024|NCT01130337|12265256|FG000|Overall Study|Disease progression|1
7805025|NCT01130337|12265256|FG000|Overall Study|Toxicity, AE/intercurrent disease|7
7805026|NCT01130337|12265256|FG000|Overall Study|Surgical resection (R2)|1
7805027|NCT01130493|12265260|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1
7805028|NCT01130493|12265261|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0
7805029|NCT01130493|12265262|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0
7805030|NCT01130493|12265260|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3
7805031|NCT01130493|12265261|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0
7805032|NCT01130493|12265262|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0
7805033|NCT01130493|12265260|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
7805034|NCT01130493|12265261|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
7805035|NCT01130493|12265262|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
7805036|NCT01130493|12265260|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
7805037|NCT01130493|12265261|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
7805038|NCT01130493|12265262|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
7805039|NCT01130493|12265260|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1
7805040|NCT01130493|12265261|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0
7885882|NCT01803282|12386693|FG009|Overall Study|Unknown Reason|0
7885883|NCT01803282|12386694|FG010|Overall Study|Unknown Reason|0
7885884|NCT01803282|12386695|FG011|Overall Study|Unknown Reason|0
7885885|NCT01803282|12386684|FG000|Overall Study|Specified Criteria for Withdrawal|0
7885886|NCT01803282|12386685|FG001|Overall Study|Specified Criteria for Withdrawal|0
7885887|NCT01803282|12386686|FG002|Overall Study|Specified Criteria for Withdrawal|0
7885888|NCT01803282|12386687|FG003|Overall Study|Specified Criteria for Withdrawal|0
7885889|NCT01803282|12386688|FG004|Overall Study|Specified Criteria for Withdrawal|0
7885890|NCT01803282|12386689|FG005|Overall Study|Specified Criteria for Withdrawal|0
7885891|NCT01803282|12386690|FG006|Overall Study|Specified Criteria for Withdrawal|0
7885892|NCT01803282|12386691|FG007|Overall Study|Specified Criteria for Withdrawal|0
7885893|NCT01803282|12386692|FG008|Overall Study|Specified Criteria for Withdrawal|0
7885894|NCT01803282|12386693|FG009|Overall Study|Specified Criteria for Withdrawal|1
7885895|NCT01803282|12386694|FG010|Overall Study|Specified Criteria for Withdrawal|1
7885896|NCT01803282|12386695|FG011|Overall Study|Specified Criteria for Withdrawal|0
7885897|NCT01803282|12386684|FG000|Overall Study|Enrolled but Never Treated|0
7885898|NCT01803282|12386685|FG001|Overall Study|Enrolled but Never Treated|0
7967736|NCT02773368|12524939|FG001|Overall Study|Lost to Follow-up|1
7967737|NCT02773368|12524938|FG000|Overall Study|Withdrawal by Subject|5
7967738|NCT02773368|12524939|FG001|Overall Study|Withdrawal by Subject|1
7885899|NCT01803282|12386686|FG002|Overall Study|Enrolled but Never Treated|0
7885900|NCT01803282|12386687|FG003|Overall Study|Enrolled but Never Treated|0
7885901|NCT01803282|12386688|FG004|Overall Study|Enrolled but Never Treated|1
7885902|NCT01803282|12386689|FG005|Overall Study|Enrolled but Never Treated|0
7885903|NCT01803282|12386690|FG006|Overall Study|Enrolled but Never Treated|1
7885904|NCT01803282|12386691|FG007|Overall Study|Enrolled but Never Treated|1
7885905|NCT01803282|12386692|FG008|Overall Study|Enrolled but Never Treated|0
7885906|NCT01803282|12386693|FG009|Overall Study|Enrolled but Never Treated|1
7885907|NCT01803282|12386694|FG010|Overall Study|Enrolled but Never Treated|0
7885908|NCT01803282|12386695|FG011|Overall Study|Enrolled but Never Treated|0
7885909|NCT01803464|12386725|FG000|Overall Study|Incomplete data|0
7885910|NCT01803464|12386726|FG001|Overall Study|Incomplete data|0
7885911|NCT01803464|12386727|FG002|Overall Study|Incomplete data|4
7885912|NCT01803464|12386728|FG003|Overall Study|Incomplete data|0
7885913|NCT01803464|12386725|FG000|Overall Study|Withdrawal by Subject|1
7885914|NCT01803464|12386726|FG001|Overall Study|Withdrawal by Subject|0
7885915|NCT01803464|12386727|FG002|Overall Study|Withdrawal by Subject|0
7885916|NCT01803464|12386728|FG003|Overall Study|Withdrawal by Subject|0
7885917|NCT01803607|12386744|FG000|Overall Study|Adverse Event|5
7885918|NCT01803607|12386745|FG001|Overall Study|Adverse Event|3
7885919|NCT01803607|12386744|FG000|Overall Study|Lack of Efficacy|0
7885920|NCT01803607|12386745|FG001|Overall Study|Lack of Efficacy|1
7885921|NCT01803607|12386744|FG000|Overall Study|Protocol Violation|3
7805041|NCT01130493|12265262|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0
7805042|NCT01130493|12265260|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
7805043|NCT01130493|12265261|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
7805044|NCT01130493|12265262|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
7805045|NCT01130493|12265260|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
7805046|NCT01130493|12265261|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
7805047|NCT01130493|12265262|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
7805048|NCT01130493|12265260|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
7805049|NCT01130493|12265261|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
7805050|NCT01130493|12265262|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
7805051|NCT01130493|12265260|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0
7805052|NCT01130493|12265261|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0
7805053|NCT01130493|12265262|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1
7805054|NCT01130493|12265260|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
7805055|NCT01130493|12265261|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
7805056|NCT01130493|12265262|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
7805057|NCT01130493|12265260|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
7805058|NCT01130493|12265261|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
7805059|NCT01130493|12265262|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
7805060|NCT01130493|12265260|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0
7717510|NCT00520403|12141154|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
7717511|NCT00520403|12141154|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
7717512|NCT00520403|12141154|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1
7717513|NCT00520403|12141154|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
7885922|NCT01803607|12386745|FG001|Overall Study|Protocol Violation|2
7885923|NCT01803607|12386744|FG000|Overall Study|Study terminated by sponsor|54
7885924|NCT01803607|12386745|FG001|Overall Study|Study terminated by sponsor|56
7805061|NCT01130493|12265261|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0
7805062|NCT01130493|12265262|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1
7805063|NCT01130493|12265260|FG000|Part 2: OLE|Adverse Event|0
7805064|NCT01130493|12265261|FG001|Part 2: OLE|Adverse Event|2
7805065|NCT01130493|12265262|FG002|Part 2: OLE|Adverse Event|1
7805066|NCT01130493|12265260|FG000|Part 2: OLE|Withdrawal by Subject|0
7805067|NCT01130493|12265261|FG001|Part 2: OLE|Withdrawal by Subject|1
7805068|NCT01130493|12265262|FG002|Part 2: OLE|Withdrawal by Subject|4
7805069|NCT01130532|12265276|FG000|Period III (Weeks 0-12)|Adverse Event|3
7805070|NCT01130532|12265277|FG001|Period III (Weeks 0-12)|Adverse Event|3
7805071|NCT01130532|12265278|FG002|Period III (Weeks 0-12)|Adverse Event|2
7805072|NCT01130532|12265279|FG003|Period III (Weeks 0-12)|Adverse Event|0
7805073|NCT01130532|12265276|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4
7885925|NCT01803607|12386744|FG000|Overall Study|Withdrawal by Subject|6
7885926|NCT01803607|12386745|FG001|Overall Study|Withdrawal by Subject|5
7885927|NCT01803646|12386753|FG000|Overall Study|Protocol Violation|1
7885928|NCT01803646|12386754|FG001|Overall Study|Protocol Violation|0
7885929|NCT01803646|12386753|FG000|Overall Study|Adverse Event|1
7885930|NCT01803646|12386754|FG001|Overall Study|Adverse Event|1
7885931|NCT01803646|12386753|FG000|Overall Study|Withdrawal by Subject|9
7885932|NCT01803646|12386754|FG001|Overall Study|Withdrawal by Subject|6
7885933|NCT01803646|12386753|FG000|Overall Study|Randomization error|1
7885934|NCT01803646|12386754|FG001|Overall Study|Randomization error|2
7885935|NCT01803646|12386753|FG000|Overall Study|Lost to Follow-up|5
7885936|NCT01803646|12386754|FG001|Overall Study|Lost to Follow-up|1
7885937|NCT01803737|12386762|FG000|Overall Study|Lack of Time|1
7885938|NCT01803737|12386763|FG001|Overall Study|Lack of Time|0
7885939|NCT01803737|12386762|FG000|Overall Study|Medical Reason|0
7885940|NCT01803737|12386763|FG001|Overall Study|Medical Reason|1
7885941|NCT01803737|12386762|FG000|Overall Study|Lost to Follow-up|0
7885942|NCT01803737|12386763|FG001|Overall Study|Lost to Follow-up|2
7885943|NCT01803880|12386772|FG000|Overall Study|Adverse Event|1
7885944|NCT01803880|12386773|FG001|Overall Study|Adverse Event|0
7885945|NCT01803880|12386774|FG002|Overall Study|Adverse Event|0
7885946|NCT01803880|12386772|FG000|Overall Study|Withdrawal by Subject|1
7885947|NCT01803880|12386773|FG001|Overall Study|Withdrawal by Subject|1
7885948|NCT01803880|12386774|FG002|Overall Study|Withdrawal by Subject|4
7885949|NCT01803880|12386772|FG000|Overall Study|Physician Decision|0
7885950|NCT01803880|12386773|FG001|Overall Study|Physician Decision|0
7885951|NCT01803880|12386774|FG002|Overall Study|Physician Decision|1
7885952|NCT01803880|12386772|FG000|Overall Study|Unable to return for follow-up visits|0
7885953|NCT01803880|12386773|FG001|Overall Study|Unable to return for follow-up visits|1
7885954|NCT01803880|12386774|FG002|Overall Study|Unable to return for follow-up visits|2
7885955|NCT01803880|12386772|FG000|Overall Study|Lost to Follow-up|1
7885956|NCT01803880|12386773|FG001|Overall Study|Lost to Follow-up|2
7885957|NCT01803880|12386774|FG002|Overall Study|Lost to Follow-up|3
7885958|NCT01803880|12386772|FG000|Overall Study|Protocol Violation|1
7885959|NCT01803880|12386773|FG001|Overall Study|Protocol Violation|0
7885960|NCT01803880|12386774|FG002|Overall Study|Protocol Violation|0
7885961|NCT01803880|12386772|FG000|Overall Study|Early study termination|0
7885962|NCT01803880|12386773|FG001|Overall Study|Early study termination|6
7885963|NCT01803880|12386774|FG002|Overall Study|Early study termination|5
7885964|NCT01803880|12386772|FG000|Overall Study|Incomplete data entry by sites|2
7885965|NCT01803880|12386773|FG001|Overall Study|Incomplete data entry by sites|0
7805074|NCT01130532|12265277|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2
7805075|NCT01130532|12265278|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4
7805076|NCT01130532|12265279|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0
7885966|NCT01803880|12386774|FG002|Overall Study|Incomplete data entry by sites|0
7885967|NCT01804049|12386796|FG000|Overall Study|Adverse Event|2
7885968|NCT01804049|12386797|FG001|Overall Study|Adverse Event|10
7885969|NCT01804049|12386796|FG000|Overall Study|Lost to Follow-up|2
7885970|NCT01804049|12386797|FG001|Overall Study|Lost to Follow-up|1
7885971|NCT01804049|12386796|FG000|Overall Study|Decreased interest/personal|4
7885972|NCT01804049|12386797|FG001|Overall Study|Decreased interest/personal|5
7885973|NCT01804049|12386796|FG000|Overall Study|Other health concerns|2
7885974|NCT01804049|12386797|FG001|Overall Study|Other health concerns|7
7805077|NCT01130532|12265276|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2
7805078|NCT01130532|12265277|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0
7805079|NCT01130532|12265278|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1
7805080|NCT01130532|12265279|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0
7805081|NCT01130532|12265276|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2
7805082|NCT01130532|12265277|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2
7805083|NCT01130532|12265278|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3
7805084|NCT01130532|12265279|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0
7805085|NCT01130532|12265276|FG000|Period III (Weeks 0-12)|Protocol Violation|0
7805086|NCT01130532|12265277|FG001|Period III (Weeks 0-12)|Protocol Violation|0
7805087|NCT01130532|12265278|FG002|Period III (Weeks 0-12)|Protocol Violation|1
7805088|NCT01130532|12265279|FG003|Period III (Weeks 0-12)|Protocol Violation|0
7805089|NCT01130532|12265276|FG000|Period III (Weeks 0-12)|Sponsor Decision|3
7805090|NCT01130532|12265277|FG001|Period III (Weeks 0-12)|Sponsor Decision|4
7805091|NCT01130532|12265278|FG002|Period III (Weeks 0-12)|Sponsor Decision|2
7805092|NCT01130532|12265279|FG003|Period III (Weeks 0-12)|Sponsor Decision|0
7805093|NCT01130532|12265276|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7
7805094|NCT01130532|12265277|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7
7805095|NCT01130532|12265278|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6
7805096|NCT01130532|12265279|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0
7805097|NCT01130532|12265276|FG000|Period IV (Weeks 13-16)|Adverse Event|0
7805098|NCT01130532|12265277|FG001|Period IV (Weeks 13-16)|Adverse Event|0
7805099|NCT01130532|12265278|FG002|Period IV (Weeks 13-16)|Adverse Event|0
7805100|NCT01130532|12265279|FG003|Period IV (Weeks 13-16)|Adverse Event|1
7805101|NCT01130532|12265276|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
7805102|NCT01130532|12265277|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
7805103|NCT01130532|12265278|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
7805104|NCT01130532|12265279|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
7805105|NCT01130532|12265276|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0
7805106|NCT01130532|12265277|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0
7805107|NCT01130532|12265278|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0
7805108|NCT01130532|12265279|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5
7805109|NCT01130532|12265276|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0
7885975|NCT01804049|12386796|FG000|Overall Study|Moved out of area|0
7885976|NCT01804049|12386797|FG001|Overall Study|Moved out of area|7
7885977|NCT01804049|12386796|FG000|Overall Study|other MD recommended|1
7885978|NCT01804049|12386797|FG001|Overall Study|other MD recommended|1
7885979|NCT01804049|12386796|FG000|Overall Study|Enrollment in dual studies|0
7885980|NCT01804049|12386797|FG001|Overall Study|Enrollment in dual studies|1
7885981|NCT01804140|12386840|FG000|Overall Study|No sampling or biopsy procedures done|114
7885982|NCT01804582|12386859|FG000|Overall Study|Lost to Follow-up|47
7885983|NCT01804582|12386860|FG001|Overall Study|Lost to Follow-up|56
7885984|NCT01804582|12386859|FG000|Overall Study|Physician Decision|2
7885985|NCT01804582|12386860|FG001|Overall Study|Physician Decision|0
7885986|NCT01804673|12386867|FG000|Overall Study|Adverse Event|4
7885987|NCT01804673|12386867|FG000|Overall Study|Withdrawal by Subject|1
7885988|NCT01804673|12386867|FG000|Overall Study|Lack of Efficacy|9
7885989|NCT01804673|12386867|FG000|Overall Study|Change to Oral Therapy|37
7885990|NCT01804673|12386867|FG000|Overall Study|No Further Therapy Required|84
7885991|NCT01804673|12386867|FG000|Overall Study|Use of Prohibited Medication|1
7885992|NCT01804673|12386867|FG000|Overall Study|Other|4
7885993|NCT01804842|12386874|FG000|Overall Study|Adverse Event|1
7885994|NCT01804842|12386875|FG001|Overall Study|Adverse Event|1
7885995|NCT01804842|12386876|FG002|Overall Study|Adverse Event|0
7885996|NCT01804842|12386874|FG000|Overall Study|Lost to Follow-up|1
7885997|NCT01804842|12386875|FG001|Overall Study|Lost to Follow-up|0
7885998|NCT01804842|12386876|FG002|Overall Study|Lost to Follow-up|0
7885999|NCT01804842|12386874|FG000|Overall Study|Non-Compliance|1
7886000|NCT01804842|12386875|FG001|Overall Study|Non-Compliance|1
7805110|NCT01130532|12265277|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0
7805111|NCT01130532|12265278|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0
7805112|NCT01130532|12265279|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3
7805113|NCT01130597|12265291|FG000|Overall Study|Protocol-specified (High K+)|1
7805114|NCT01130597|12265291|FG000|Overall Study|Adverse Event|4
7805115|NCT01130597|12265291|FG000|Overall Study|Death|1
7805116|NCT01130597|12265291|FG000|Overall Study|Protocol Violation|1
7805117|NCT01130831|12265304|FG000|Overall Study|Withdrawal by Subject|7
7805118|NCT01130831|12265304|FG000|Overall Study|Death|4
7805119|NCT01130831|12265304|FG000|Overall Study|Information was missing|3
7886001|NCT01804842|12386876|FG002|Overall Study|Non-Compliance|0
7886002|NCT01804842|12386874|FG000|Overall Study|Personal Reason|0
7886003|NCT01804842|12386875|FG001|Overall Study|Personal Reason|0
7886004|NCT01804842|12386876|FG002|Overall Study|Personal Reason|1
7886005|NCT01804946|12386897|FG000|Overall Study|Protocol Violation|1
7886006|NCT01804946|12386898|FG001|Overall Study|Protocol Violation|0
7886007|NCT01804946|12386897|FG000|Overall Study|Adverse Event|0
7886008|NCT01804946|12386898|FG001|Overall Study|Adverse Event|1
7886009|NCT01804946|12386897|FG000|Overall Study|Insufficient data available|0
7805120|NCT01130883|12265336|FG000|Overall Study|Patient Noncompliance|6
7805121|NCT01130883|12265336|FG000|Overall Study|Reason Unknown|1
7805122|NCT01130883|12265336|FG000|Overall Study|Adverse Event|3
7805123|NCT01130974|12265346|FG000|Overall Study|Protocol Violation|10
7805124|NCT01130974|12265347|FG001|Overall Study|Protocol Violation|10
7805125|NCT01130974|12265346|FG000|Overall Study|Withdrawal by Subject|0
7805126|NCT01130974|12265347|FG001|Overall Study|Withdrawal by Subject|1
7805127|NCT01130974|12265346|FG000|Overall Study|Ineligibility criteria|5
7805128|NCT01130974|12265347|FG001|Overall Study|Ineligibility criteria|2
7805129|NCT01131078|12265370|FG000|Overall Study|Adverse Event|22
7805130|NCT01131078|12265371|FG001|Overall Study|Adverse Event|12
7805131|NCT01131078|12265372|FG002|Overall Study|Adverse Event|17
7805132|NCT01131078|12265370|FG000|Overall Study|Progressive Disease|58
7805133|NCT01131078|12265371|FG001|Overall Study|Progressive Disease|77
7805134|NCT01131078|12265372|FG002|Overall Study|Progressive Disease|71
7805135|NCT01131078|12265370|FG000|Overall Study|Protocol Violation|1
7805136|NCT01131078|12265371|FG001|Overall Study|Protocol Violation|0
7805137|NCT01131078|12265372|FG002|Overall Study|Protocol Violation|0
7805138|NCT01131078|12265370|FG000|Overall Study|Lost to Follow-up|1
7805139|NCT01131078|12265371|FG001|Overall Study|Lost to Follow-up|1
7805140|NCT01131078|12265372|FG002|Overall Study|Lost to Follow-up|1
7805141|NCT01131078|12265370|FG000|Overall Study|Withdrawal by Subject|2
7805142|NCT01131078|12265371|FG001|Overall Study|Withdrawal by Subject|4
7805143|NCT01131078|12265372|FG002|Overall Study|Withdrawal by Subject|3
7805144|NCT01131078|12265370|FG000|Overall Study|Non-compliance|3
7805145|NCT01131078|12265371|FG001|Overall Study|Non-compliance|0
7805146|NCT01131078|12265372|FG002|Overall Study|Non-compliance|0
7805147|NCT01131078|12265370|FG000|Overall Study|Physician Decision|10
7805148|NCT01131078|12265371|FG001|Overall Study|Physician Decision|6
7805149|NCT01131078|12265372|FG002|Overall Study|Physician Decision|8
7805150|NCT01131078|12265370|FG000|Overall Study|Death|4
7805151|NCT01131078|12265371|FG001|Overall Study|Death|0
7805152|NCT01131078|12265372|FG002|Overall Study|Death|2
7805153|NCT01131078|12265370|FG000|Overall Study|Other|0
7805154|NCT01131078|12265371|FG001|Overall Study|Other|1
7805155|NCT01131078|12265372|FG002|Overall Study|Other|0
7805156|NCT01131104|12265382|FG000|Overall Study|Withdrawal by Subject|3
7805157|NCT01131104|12265382|FG000|Overall Study|Physician Decision|4
7805158|NCT01131104|12265382|FG000|Overall Study|Information Not Available|5
7805159|NCT01131104|12265382|FG000|Overall Study|No Information on Index Date of Onset|1
7805160|NCT01131130|12265386|FG000|Period 1 - Baseline|Pregnancy|1
7805161|NCT01131130|12265386|FG000|Period 3- Crossover|+ Slit lamp finding|1
7805162|NCT01131260|12265396|FG000|Overall Study|Randomization error|5
7805163|NCT01131260|12265397|FG001|Overall Study|Randomization error|1
7805164|NCT01131260|12265396|FG000|Overall Study|Declined to continue participation|8
7805165|NCT01131260|12265397|FG001|Overall Study|Declined to continue participation|13
7805166|NCT01131260|12265396|FG000|Overall Study|Physician Decision|22
7805167|NCT01131260|12265397|FG001|Overall Study|Physician Decision|24
7805168|NCT01131260|12265396|FG000|Overall Study|Technical problems|7
7805169|NCT01131260|12265397|FG001|Overall Study|Technical problems|6
7805170|NCT01131260|12265396|FG000|Overall Study|Staff error|2
7886010|NCT01804946|12386898|FG001|Overall Study|Insufficient data available|1
7805171|NCT01131260|12265397|FG001|Overall Study|Staff error|1
7805172|NCT01131260|12265396|FG000|Overall Study|Ineligible|0
7805173|NCT01131260|12265397|FG001|Overall Study|Ineligible|2
7805174|NCT01131299|12265405|FG000|Overall Study|Withdrawal by Subject|4
7805175|NCT01131299|12265406|FG001|Overall Study|Withdrawal by Subject|7
7805176|NCT01131312|12265414|FG000|Overall Study|Lost to Follow-up|425
7805177|NCT01131312|12265415|FG001|Overall Study|Lost to Follow-up|229
7805178|NCT01131312|12265416|FG002|Overall Study|Lost to Follow-up|351
7805179|NCT01131325|12265424|FG000|Overall Study|Adverse Event|1
7805180|NCT01131325|12265424|FG000|Overall Study|The participants discontinued the study as the study got terminated|2
7805181|NCT01131351|12265430|FG000|Overall Study|Adverse Event|0
7805182|NCT01131351|12265431|FG001|Overall Study|Adverse Event|2
7805183|NCT01131351|12265430|FG000|Overall Study|Protocol Deviation|0
7805184|NCT01131351|12265431|FG001|Overall Study|Protocol Deviation|1
7805185|NCT01131494|12265437|FG000|Overall Study|Withdrawal by Subject|2
7805186|NCT01131507|12265442|FG000|Overall Study|Adverse Event|1
7805187|NCT01131507|12265442|FG000|Overall Study|Lost to Follow-up|1
7805188|NCT01131507|12265442|FG000|Overall Study|Withdrawal by Subject|1
7805189|NCT01131520|12265448|FG000|Overall Study|Computer problem|1
7805190|NCT01131520|12265449|FG001|Overall Study|Computer problem|0
7805191|NCT01131520|12265448|FG000|Overall Study|Counselor not available|0
7805192|NCT01131520|12265449|FG001|Overall Study|Counselor not available|3
7805193|NCT01131520|12265448|FG000|Overall Study|Subject changed history after enrollment|0
7805194|NCT01131520|12265449|FG001|Overall Study|Subject changed history after enrollment|1
7805195|NCT01131585|12265457|FG000|Overall Study|Adverse Event|0
7805196|NCT01131585|12265458|FG001|Overall Study|Adverse Event|2
7805197|NCT01131585|12265457|FG000|Overall Study|Abnormal laboratory value|1
7805198|NCT01131585|12265458|FG001|Overall Study|Abnormal laboratory value|0
7805199|NCT01131585|12265457|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7805200|NCT01131585|12265458|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7805201|NCT01131585|12265457|FG000|Overall Study|Protocol Violation|2
7805202|NCT01131585|12265458|FG001|Overall Study|Protocol Violation|1
7805203|NCT01131585|12265457|FG000|Overall Study|Withdrawal by Subject|3
7805204|NCT01131585|12265458|FG001|Overall Study|Withdrawal by Subject|3
7805205|NCT01131585|12265457|FG000|Overall Study|Lost to Follow-up|0
7805206|NCT01131585|12265458|FG001|Overall Study|Lost to Follow-up|1
7805207|NCT01131585|12265457|FG000|Overall Study|Administrative problems|1
7805208|NCT01131585|12265458|FG001|Overall Study|Administrative problems|1
7805209|NCT01131585|12265457|FG000|Overall Study|Study termination|78
7805210|NCT01131585|12265458|FG001|Overall Study|Study termination|32
7805211|NCT01131676|12265467|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5
7805212|NCT01131676|12265468|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3
7805213|NCT01131676|12265469|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4
7805214|NCT01131676|12265467|FG000|Discontinuation From Treatment|Not treated|4
7805215|NCT01131676|12265468|FG001|Discontinuation From Treatment|Not treated|2
7805216|NCT01131676|12265469|FG002|Discontinuation From Treatment|Not treated|2
7805217|NCT01131676|12265467|FG000|Discontinuation From Treatment|Lack of Efficacy|11
7805218|NCT01131676|12265468|FG001|Discontinuation From Treatment|Lack of Efficacy|1
7805219|NCT01131676|12265469|FG002|Discontinuation From Treatment|Lack of Efficacy|0
7805220|NCT01131676|12265467|FG000|Discontinuation From Treatment|Non compliant with protocol|15
7805221|NCT01131676|12265468|FG001|Discontinuation From Treatment|Non compliant with protocol|15
7805222|NCT01131676|12265469|FG002|Discontinuation From Treatment|Non compliant with protocol|12
7805223|NCT01131676|12265467|FG000|Discontinuation From Treatment|Lost to Follow-up|15
7805224|NCT01131676|12265468|FG001|Discontinuation From Treatment|Lost to Follow-up|9
7805225|NCT01131676|12265469|FG002|Discontinuation From Treatment|Lost to Follow-up|6
7805226|NCT01131676|12265467|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172
7805227|NCT01131676|12265468|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118
7805228|NCT01131676|12265469|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122
7805229|NCT01131676|12265467|FG000|Discontinuation From Treatment|Other than those specified|162
7805230|NCT01131676|12265468|FG001|Discontinuation From Treatment|Other than those specified|142
7805231|NCT01131676|12265469|FG002|Discontinuation From Treatment|Other than those specified|125
7805232|NCT01131676|12265467|FG000|Discontinuation From Treatment|Adverse Event|303
7805233|NCT01131676|12265468|FG001|Discontinuation From Treatment|Adverse Event|267
7805234|NCT01131676|12265469|FG002|Discontinuation From Treatment|Adverse Event|273
7805235|NCT01131676|12265467|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
7805236|NCT01131676|12265468|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
7805237|NCT01131676|12265469|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
7805238|NCT01131676|12265467|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
7886011|NCT01804946|12386897|FG000|Overall Study|Do not meet inclusion criteria|1
7886012|NCT01804946|12386898|FG001|Overall Study|Do not meet inclusion criteria|2
7886013|NCT01805037|12386923|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0
7886014|NCT01805037|12386924|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2
7886015|NCT01805037|12386923|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0
7886016|NCT01805037|12386924|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2
7886017|NCT01805037|12386923|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0
7886018|NCT01805037|12386924|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1
7886019|NCT01805037|12386923|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0
7886020|NCT01805037|12386924|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1
7886021|NCT01805037|12386923|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0
7886022|NCT01805037|12386924|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10
7886023|NCT01805037|12386923|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0
7886024|NCT01805037|12386924|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1
7886025|NCT01805037|12386923|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0
7886026|NCT01805037|12386924|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1
7886027|NCT01805037|12386923|FG000|Follow Up (up to 3 Years)|Death|0
7886028|NCT01805037|12386924|FG001|Follow Up (up to 3 Years)|Death|2
7886029|NCT01805037|12386923|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0
7886030|NCT01805037|12386924|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3
7886031|NCT01805037|12386923|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0
7886032|NCT01805037|12386924|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1
7962811|NCT02714868|12517180|FG001|Overall Study|PI withdraw did not meet inclusion|0
7962812|NCT02715258|12517214|FG000|Overall Study|Withdrawal by Subject|6
7962813|NCT02715258|12517215|FG001|Overall Study|Withdrawal by Subject|1
7962814|NCT02715258|12517214|FG000|Overall Study|Lost to Follow-up|7
7962815|NCT02715258|12517215|FG001|Overall Study|Lost to Follow-up|1
7805239|NCT01131676|12265468|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
7805240|NCT01131676|12265469|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
7805241|NCT01131676|12265467|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
7805242|NCT01131676|12265468|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
7805243|NCT01131676|12265469|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
7805244|NCT01131676|12265467|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
7805245|NCT01131676|12265468|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
7805246|NCT01131676|12265469|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
7805247|NCT01131676|12265467|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
7805248|NCT01131676|12265468|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
7805249|NCT01131676|12265469|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
7805250|NCT01131676|12265467|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
7805251|NCT01131676|12265468|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
7805252|NCT01131676|12265469|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
7805253|NCT01132118|12265480|FG000|First Intervention (8 Weeks)|Adverse Event|1
7805254|NCT01132118|12265481|FG001|First Intervention (8 Weeks)|Adverse Event|0
7805255|NCT01132118|12265480|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
7805256|NCT01132118|12265481|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3
7805257|NCT01132118|12265480|FG000|Second Intervention (8 Weeks)|Adverse Event|0
7805258|NCT01132118|12265481|FG001|Second Intervention (8 Weeks)|Adverse Event|1
7805259|NCT01132313|12265510|FG000|Overall Study|Lack of Efficacy|1
7805260|NCT01132313|12265511|FG001|Overall Study|Lack of Efficacy|0
7805261|NCT01132313|12265512|FG002|Overall Study|Lack of Efficacy|0
7805262|NCT01132313|12265513|FG003|Overall Study|Lack of Efficacy|0
7805263|NCT01132313|12265514|FG004|Overall Study|Lack of Efficacy|0
7805264|NCT01132313|12265515|FG005|Overall Study|Lack of Efficacy|0
7805265|NCT01132313|12265516|FG006|Overall Study|Lack of Efficacy|0
7717514|NCT00520481|12141164|FG000|Overall Study|Adverse Event|4
7717515|NCT00520481|12141165|FG001|Overall Study|Adverse Event|1
7717516|NCT00520481|12141164|FG000|Overall Study|Withdrawal by Subject|3
7717517|NCT00520481|12141165|FG001|Overall Study|Withdrawal by Subject|0
7717518|NCT00520494|12141173|FG000|Overall Study|Withdrawal by Subject|1
7717519|NCT00520533|12141177|FG000|Overall Study|Death|1
7717520|NCT00520533|12141177|FG000|Overall Study|Suspension of the study for safety reasons|1
7717521|NCT00520533|12141177|FG000|Overall Study|Withdrawal by Subject|1
7717522|NCT00520533|12141177|FG000|Overall Study|Physician Decision|1
7717523|NCT00520546|12141182|FG000|Overall Study|Withdrawal by Subject|1
7717524|NCT00520546|12141182|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5
7717525|NCT00520572|12141197|FG000|Overall Study|Adverse Event|9
7717526|NCT00520572|12141198|FG001|Overall Study|Adverse Event|3
7717527|NCT00520572|12141199|FG002|Overall Study|Adverse Event|6
7717528|NCT00520572|12141200|FG003|Overall Study|Adverse Event|9
7717529|NCT00520572|12141201|FG004|Overall Study|Adverse Event|7
7717530|NCT00520572|12141202|FG005|Overall Study|Adverse Event|2
7717531|NCT00520572|12141197|FG000|Overall Study|Withdrawal by Subject|0
7717532|NCT00520572|12141198|FG001|Overall Study|Withdrawal by Subject|9
7717533|NCT00520572|12141199|FG002|Overall Study|Withdrawal by Subject|5
7717534|NCT00520572|12141200|FG003|Overall Study|Withdrawal by Subject|2
7717535|NCT00520572|12141201|FG004|Overall Study|Withdrawal by Subject|2
7717536|NCT00520572|12141202|FG005|Overall Study|Withdrawal by Subject|0
7717537|NCT00520572|12141197|FG000|Overall Study|Protocol Violation|0
7717538|NCT00520572|12141198|FG001|Overall Study|Protocol Violation|0
7717539|NCT00520572|12141199|FG002|Overall Study|Protocol Violation|1
7717540|NCT00520572|12141200|FG003|Overall Study|Protocol Violation|0
7717541|NCT00520572|12141201|FG004|Overall Study|Protocol Violation|0
7717542|NCT00520572|12141202|FG005|Overall Study|Protocol Violation|0
7717543|NCT00520572|12141197|FG000|Overall Study|Lack of Efficacy|1
7717544|NCT00520572|12141198|FG001|Overall Study|Lack of Efficacy|1
7717545|NCT00520572|12141199|FG002|Overall Study|Lack of Efficacy|1
7717546|NCT00520572|12141200|FG003|Overall Study|Lack of Efficacy|2
7717547|NCT00520572|12141201|FG004|Overall Study|Lack of Efficacy|1
7717548|NCT00520572|12141202|FG005|Overall Study|Lack of Efficacy|0
7717549|NCT00520572|12141197|FG000|Overall Study|Lost to Follow-up|0
7717550|NCT00520572|12141198|FG001|Overall Study|Lost to Follow-up|0
7717551|NCT00520572|12141199|FG002|Overall Study|Lost to Follow-up|0
7805266|NCT01132313|12265517|FG007|Overall Study|Lack of Efficacy|3
7805267|NCT01132313|12265518|FG008|Overall Study|Lack of Efficacy|14
7805268|NCT01132313|12265519|FG009|Overall Study|Lack of Efficacy|16
7805269|NCT01132313|12265520|FG010|Overall Study|Lack of Efficacy|0
7805270|NCT01132313|12265521|FG011|Overall Study|Lack of Efficacy|0
7805271|NCT01132313|12265510|FG000|Overall Study|Not treated|2
7805272|NCT01132313|12265511|FG001|Overall Study|Not treated|0
7805273|NCT01132313|12265512|FG002|Overall Study|Not treated|0
7805274|NCT01132313|12265513|FG003|Overall Study|Not treated|0
7805275|NCT01132313|12265514|FG004|Overall Study|Not treated|2
7805276|NCT01132313|12265515|FG005|Overall Study|Not treated|1
7805277|NCT01132313|12265516|FG006|Overall Study|Not treated|3
7805278|NCT01132313|12265517|FG007|Overall Study|Not treated|0
7805279|NCT01132313|12265518|FG008|Overall Study|Not treated|0
7805280|NCT01132313|12265519|FG009|Overall Study|Not treated|0
7805281|NCT01132313|12265520|FG010|Overall Study|Not treated|0
7805282|NCT01132313|12265521|FG011|Overall Study|Not treated|0
7805283|NCT01132313|12265510|FG000|Overall Study|Adverse Event|0
7805284|NCT01132313|12265511|FG001|Overall Study|Adverse Event|0
7805285|NCT01132313|12265512|FG002|Overall Study|Adverse Event|4
7805286|NCT01132313|12265513|FG003|Overall Study|Adverse Event|10
7805287|NCT01132313|12265514|FG004|Overall Study|Adverse Event|19
7805288|NCT01132313|12265515|FG005|Overall Study|Adverse Event|6
7805289|NCT01132313|12265516|FG006|Overall Study|Adverse Event|5
7805290|NCT01132313|12265517|FG007|Overall Study|Adverse Event|3
7805291|NCT01132313|12265518|FG008|Overall Study|Adverse Event|7
7805292|NCT01132313|12265519|FG009|Overall Study|Adverse Event|2
7805293|NCT01132313|12265520|FG010|Overall Study|Adverse Event|0
7805294|NCT01132313|12265521|FG011|Overall Study|Adverse Event|0
7805295|NCT01132313|12265510|FG000|Overall Study|Protocol Violation|0
7805296|NCT01132313|12265511|FG001|Overall Study|Protocol Violation|0
7805297|NCT01132313|12265512|FG002|Overall Study|Protocol Violation|0
7805298|NCT01132313|12265513|FG003|Overall Study|Protocol Violation|1
7805299|NCT01132313|12265514|FG004|Overall Study|Protocol Violation|0
7805300|NCT01132313|12265515|FG005|Overall Study|Protocol Violation|0
7805301|NCT01132313|12265516|FG006|Overall Study|Protocol Violation|0
7805302|NCT01132313|12265517|FG007|Overall Study|Protocol Violation|0
7805303|NCT01132313|12265518|FG008|Overall Study|Protocol Violation|0
7805304|NCT01132313|12265519|FG009|Overall Study|Protocol Violation|0
7805305|NCT01132313|12265520|FG010|Overall Study|Protocol Violation|0
7805306|NCT01132313|12265521|FG011|Overall Study|Protocol Violation|0
7805307|NCT01132313|12265510|FG000|Overall Study|Lost to Follow-up|0
7805308|NCT01132313|12265511|FG001|Overall Study|Lost to Follow-up|0
7805309|NCT01132313|12265512|FG002|Overall Study|Lost to Follow-up|1
7886033|NCT01805180|12386946|FG000|Lead-in Donor Phase|screen failure|1
7886034|NCT01805180|12386947|FG001|Lead-in Donor Phase|screen failure|0
7886035|NCT01805180|12386948|FG002|Lead-in Donor Phase|screen failure|0
7886036|NCT01806064|12387050|FG000|Overall Study|Randomized Not Enrolled|0
7886037|NCT01806064|12387051|FG001|Overall Study|Randomized Not Enrolled|0
7886038|NCT01806064|12387052|FG002|Overall Study|Randomized Not Enrolled|0
7886039|NCT01806064|12387053|FG003|Overall Study|Randomized Not Enrolled|1
7886040|NCT01806064|12387054|FG004|Overall Study|Randomized Not Enrolled|2
7886041|NCT01806168|12387073|FG000|Overall Study|Adverse Event|1
7886042|NCT01806168|12387074|FG001|Overall Study|Adverse Event|0
7886043|NCT01806168|12387075|FG002|Overall Study|Adverse Event|0
7886044|NCT01806168|12387073|FG000|Overall Study|Withdrawal by Subject|0
7886045|NCT01806168|12387074|FG001|Overall Study|Withdrawal by Subject|1
7886046|NCT01806168|12387075|FG002|Overall Study|Withdrawal by Subject|2
7886047|NCT01806168|12387073|FG000|Overall Study|Protocol Violation|0
7886048|NCT01806168|12387074|FG001|Overall Study|Protocol Violation|0
7886049|NCT01806168|12387075|FG002|Overall Study|Protocol Violation|1
7886050|NCT01806298|12387096|FG000|Overall Study|Adverse Event|3
7886051|NCT01806298|12387096|FG000|Overall Study|Protocol Non-compliance|1
7886052|NCT01806298|12387096|FG000|Overall Study|Withdrawal by Subject|1
7886053|NCT01806298|12387096|FG000|Overall Study|Other|5
7886054|NCT01806389|12387100|FG000|Overall Study|Withdrawal by Subject|4
7886055|NCT01806506|12387116|FG000|Overall Study|Lost to Follow-up|2
7886056|NCT01806506|12387117|FG001|Overall Study|Lost to Follow-up|1
7886057|NCT01806545|12387125|FG000|Overall Study|Adverse Event|2
7886058|NCT01806545|12387126|FG001|Overall Study|Adverse Event|3
7886059|NCT01806545|12387125|FG000|Overall Study|Lost to Follow-up|1
7886060|NCT01806545|12387126|FG001|Overall Study|Lost to Follow-up|0
7886061|NCT01806545|12387125|FG000|Overall Study|Withdrawal by Subject|3
7886062|NCT01806545|12387126|FG001|Overall Study|Withdrawal by Subject|2
7886063|NCT01806584|12387138|FG000|Overall Study|Adverse Event|2
7886064|NCT01806584|12387139|FG001|Overall Study|Adverse Event|1
7886065|NCT01806584|12387138|FG000|Overall Study|Death|1
7886066|NCT01806584|12387139|FG001|Overall Study|Death|0
7886067|NCT01806584|12387138|FG000|Overall Study|Lost to Follow-up|0
7805310|NCT01132313|12265513|FG003|Overall Study|Lost to Follow-up|0
7886068|NCT01806584|12387139|FG001|Overall Study|Lost to Follow-up|2
7886069|NCT01806584|12387138|FG000|Overall Study|Study terminated by sponsor|9
7886070|NCT01806584|12387139|FG001|Overall Study|Study terminated by sponsor|14
7886071|NCT01806584|12387138|FG000|Overall Study|Withdrawal by Subject|1
7886072|NCT01806584|12387139|FG001|Overall Study|Withdrawal by Subject|1
7886073|NCT01806584|12387138|FG000|Overall Study|Other unspecified|1
7886074|NCT01806584|12387139|FG001|Overall Study|Other unspecified|0
7886075|NCT01806597|12387148|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1
7886076|NCT01806597|12387149|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1
7886077|NCT01806597|12387150|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0
7886078|NCT01806597|12387151|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0
7886079|NCT01806597|12387152|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2
7886080|NCT01806597|12387153|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0
7886081|NCT01806597|12387148|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
7886082|NCT01806597|12387149|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7805311|NCT01132313|12265514|FG004|Overall Study|Lost to Follow-up|0
7805312|NCT01132313|12265515|FG005|Overall Study|Lost to Follow-up|0
7886083|NCT01806597|12387150|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7886084|NCT01806597|12387151|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7886085|NCT01806597|12387152|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
7886086|NCT01806597|12387153|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7886087|NCT01806597|12387148|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0
7886088|NCT01806597|12387149|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1
7805313|NCT01132313|12265516|FG006|Overall Study|Lost to Follow-up|0
7805314|NCT01132313|12265517|FG007|Overall Study|Lost to Follow-up|1
7805315|NCT01132313|12265518|FG008|Overall Study|Lost to Follow-up|0
7805316|NCT01132313|12265519|FG009|Overall Study|Lost to Follow-up|0
7805317|NCT01132313|12265520|FG010|Overall Study|Lost to Follow-up|0
7805318|NCT01132313|12265521|FG011|Overall Study|Lost to Follow-up|0
7805319|NCT01132313|12265510|FG000|Overall Study|Withdrawal by Subject|0
7805320|NCT01132313|12265511|FG001|Overall Study|Withdrawal by Subject|0
7805321|NCT01132313|12265512|FG002|Overall Study|Withdrawal by Subject|3
7805322|NCT01132313|12265513|FG003|Overall Study|Withdrawal by Subject|3
7805323|NCT01132313|12265514|FG004|Overall Study|Withdrawal by Subject|6
7805324|NCT01132313|12265515|FG005|Overall Study|Withdrawal by Subject|0
7805325|NCT01132313|12265516|FG006|Overall Study|Withdrawal by Subject|1
7805326|NCT01132313|12265517|FG007|Overall Study|Withdrawal by Subject|0
7805327|NCT01132313|12265518|FG008|Overall Study|Withdrawal by Subject|0
7805328|NCT01132313|12265519|FG009|Overall Study|Withdrawal by Subject|2
7805329|NCT01132313|12265520|FG010|Overall Study|Withdrawal by Subject|0
7805330|NCT01132313|12265521|FG011|Overall Study|Withdrawal by Subject|0
7886089|NCT01806597|12387150|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0
7886090|NCT01806597|12387151|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0
7886091|NCT01806597|12387152|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0
7886092|NCT01806597|12387153|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0
7886093|NCT01806597|12387148|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
7886094|NCT01806597|12387149|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
7886095|NCT01806597|12387150|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
7886096|NCT01806597|12387151|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
7886097|NCT01806597|12387152|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
7886098|NCT01806597|12387153|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
7886099|NCT01806597|12387148|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0
7886100|NCT01806597|12387149|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1
7886101|NCT01806597|12387150|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0
7886102|NCT01806597|12387151|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0
7886103|NCT01806597|12387152|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0
7886104|NCT01806597|12387153|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0
7886105|NCT01806597|12387148|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
7886106|NCT01806597|12387149|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
7886107|NCT01806597|12387150|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
7886108|NCT01806597|12387151|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
7886109|NCT01806597|12387152|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
7886110|NCT01806597|12387153|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
7886111|NCT01806597|12387148|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
7886112|NCT01806597|12387149|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
7886113|NCT01806597|12387150|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
7886114|NCT01806597|12387151|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
7886115|NCT01806597|12387152|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
7886116|NCT01806597|12387153|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
7886117|NCT01806597|12387148|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
7886118|NCT01806597|12387149|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7886119|NCT01806597|12387150|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7886120|NCT01806597|12387151|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7886121|NCT01806597|12387152|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7886122|NCT01806597|12387153|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7886123|NCT01806597|12387148|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
7886124|NCT01806597|12387149|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
7886125|NCT01806597|12387150|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7886126|NCT01806597|12387151|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7886127|NCT01806597|12387152|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7886128|NCT01806597|12387153|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7886129|NCT01806597|12387148|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
7805331|NCT01132313|12265510|FG000|Overall Study|Lack of antiviral response|0
7805332|NCT01132313|12265511|FG001|Overall Study|Lack of antiviral response|0
7805333|NCT01132313|12265512|FG002|Overall Study|Lack of antiviral response|12
7805334|NCT01132313|12265513|FG003|Overall Study|Lack of antiviral response|18
7886130|NCT01806597|12387149|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7886131|NCT01806597|12387150|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7886132|NCT01806597|12387151|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7886133|NCT01806597|12387152|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7886134|NCT01806597|12387153|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7886135|NCT01806597|12387148|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7886136|NCT01806597|12387149|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
7886137|NCT01806597|12387150|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7886138|NCT01806597|12387151|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
7886139|NCT01806597|12387152|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7886140|NCT01806597|12387153|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7886141|NCT01806597|12387148|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
7805335|NCT01132313|12265514|FG004|Overall Study|Lack of antiviral response|18
7805336|NCT01132313|12265515|FG005|Overall Study|Lack of antiviral response|18
7805337|NCT01132313|12265516|FG006|Overall Study|Lack of antiviral response|21
7805338|NCT01132313|12265517|FG007|Overall Study|Lack of antiviral response|0
7805339|NCT01132313|12265518|FG008|Overall Study|Lack of antiviral response|0
7805340|NCT01132313|12265519|FG009|Overall Study|Lack of antiviral response|0
7805341|NCT01132313|12265520|FG010|Overall Study|Lack of antiviral response|1
7805342|NCT01132313|12265521|FG011|Overall Study|Lack of antiviral response|0
7805343|NCT01132313|12265510|FG000|Overall Study|Other reason not defined above|0
7805344|NCT01132313|12265511|FG001|Overall Study|Other reason not defined above|0
7805345|NCT01132313|12265512|FG002|Overall Study|Other reason not defined above|0
7805346|NCT01132313|12265513|FG003|Overall Study|Other reason not defined above|0
7805347|NCT01132313|12265514|FG004|Overall Study|Other reason not defined above|0
7805348|NCT01132313|12265515|FG005|Overall Study|Other reason not defined above|0
7805349|NCT01132313|12265516|FG006|Overall Study|Other reason not defined above|0
7805350|NCT01132313|12265517|FG007|Overall Study|Other reason not defined above|1
7805351|NCT01132313|12265518|FG008|Overall Study|Other reason not defined above|0
7805352|NCT01132313|12265519|FG009|Overall Study|Other reason not defined above|0
7805353|NCT01132313|12265520|FG010|Overall Study|Other reason not defined above|0
7805354|NCT01132313|12265521|FG011|Overall Study|Other reason not defined above|0
7805355|NCT01132326|12265552|FG000|Overall Study|Lack of Efficacy|25
7805356|NCT01132326|12265552|FG000|Overall Study|Adverse Event|37
7805357|NCT01132326|12265552|FG000|Overall Study|Protocol Violation|1
7805358|NCT01132326|12265552|FG000|Overall Study|Lost to Follow-up|16
7805359|NCT01132326|12265552|FG000|Overall Study|Withdrawal by Subject|40
7805360|NCT01132326|12265552|FG000|Overall Study|Physician Decision|10
7805361|NCT01132326|12265552|FG000|Overall Study|Study Termination|80
7805362|NCT01132326|12265552|FG000|Overall Study|Declining Health|1
7805363|NCT01132326|12265552|FG000|Overall Study|Pregnancy|1
7805364|NCT01132326|12265552|FG000|Overall Study|Caregiver Withdrew Consent|1
7805365|NCT01132326|12265552|FG000|Overall Study|Death|5
7805366|NCT01132326|12265552|FG000|Overall Study|Subject Unable to Come To Visits|1
7886142|NCT01806597|12387149|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
7886143|NCT01806597|12387150|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
7886144|NCT01806597|12387151|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
7886145|NCT01806597|12387152|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
7886146|NCT01806597|12387153|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
7886147|NCT01806597|12387148|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
7886148|NCT01806597|12387149|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
7886149|NCT01806597|12387150|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
7886150|NCT01806597|12387151|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
7886151|NCT01806597|12387152|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
7886152|NCT01806597|12387153|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
7886153|NCT01806597|12387148|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1
7886154|NCT01806597|12387149|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0
7886155|NCT01806597|12387150|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0
7886156|NCT01806597|12387151|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0
7886157|NCT01806597|12387152|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0
7962816|NCT02715258|12517214|FG000|Overall Study|Terminated by Sponsor|0
7886158|NCT01806597|12387153|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0
7886159|NCT01806597|12387148|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7886160|NCT01806597|12387149|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7886161|NCT01806597|12387150|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7886162|NCT01806597|12387151|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7886163|NCT01806597|12387152|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7886164|NCT01806597|12387153|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
7886165|NCT01806597|12387148|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7886166|NCT01806597|12387149|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7886167|NCT01806597|12387150|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7886168|NCT01806597|12387151|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7886169|NCT01806597|12387152|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7886170|NCT01806597|12387153|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
7886171|NCT01806597|12387148|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7886172|NCT01806597|12387149|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7886173|NCT01806597|12387150|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7886174|NCT01806597|12387151|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7886175|NCT01806597|12387152|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7886176|NCT01806597|12387153|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
7886177|NCT01806597|12387148|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7886178|NCT01806597|12387149|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7886179|NCT01806597|12387150|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7886180|NCT01806597|12387151|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7805367|NCT01132482|12265563|FG000|Overall Study|Adverse Event|1
7805368|NCT01132482|12265564|FG001|Overall Study|Adverse Event|0
7805369|NCT01132495|12265574|FG000|Overall Study|Various reasons|40
7805370|NCT01132495|12265575|FG001|Overall Study|Various reasons|38
7886181|NCT01806597|12387152|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7886182|NCT01806597|12387153|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
7886183|NCT01806597|12387148|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7886184|NCT01806597|12387149|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7886185|NCT01806597|12387150|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7886186|NCT01806597|12387151|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7886187|NCT01806597|12387152|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7886188|NCT01806597|12387153|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
7886189|NCT01806623|12387167|FG000|Overall Study|Withdrawal by Subject|1
7886190|NCT01806623|12387167|FG000|Overall Study|Adverse Event|1
7886191|NCT01806623|12387167|FG000|Overall Study|Did not meet the inclusion criteria|56
7886192|NCT01806662|12387171|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
7886193|NCT01806662|12387172|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
7886194|NCT01806662|12387171|FG000|First Intervention (Weeks 0-16)|Adverse Event|0
7886195|NCT01806662|12387172|FG001|First Intervention (Weeks 0-16)|Adverse Event|1
7886196|NCT01806662|12387171|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
7886197|NCT01806662|12387172|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
7886198|NCT01806662|12387171|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
7886199|NCT01806662|12387172|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
7886200|NCT01806714|12387205|FG000|Overall Study|No functioning phone number|200
7886201|NCT01806714|12387206|FG001|Overall Study|No functioning phone number|170
7886202|NCT01806740|12387212|FG000|Overall Study|Withdrawal by Subject|4
7886203|NCT01806740|12387212|FG000|Overall Study|Physician Decision|1
7886204|NCT01806740|12387212|FG000|Overall Study|Patient's refusal of treatment|1
7886205|NCT01806779|12387221|FG000|Overall Study|Physician Decision|2
7886206|NCT01806779|12387222|FG001|Overall Study|Physician Decision|0
7886207|NCT01806779|12387223|FG002|Overall Study|Physician Decision|1
7886208|NCT01806779|12387221|FG000|Overall Study|Lack of Efficacy|1
7886209|NCT01806779|12387222|FG001|Overall Study|Lack of Efficacy|1
7886210|NCT01806779|12387223|FG002|Overall Study|Lack of Efficacy|0
7886211|NCT01806779|12387221|FG000|Overall Study|Lost to Follow-up|19
7886212|NCT01806779|12387222|FG001|Overall Study|Lost to Follow-up|20
7886213|NCT01806779|12387223|FG002|Overall Study|Lost to Follow-up|0
7886214|NCT01806779|12387221|FG000|Overall Study|Withdrawal by Subject|20
7886215|NCT01806779|12387222|FG001|Overall Study|Withdrawal by Subject|23
7886216|NCT01806779|12387223|FG002|Overall Study|Withdrawal by Subject|22
7886217|NCT01806896|12387240|FG000|Overall Study|Adverse Event|2
7886218|NCT01806896|12387241|FG001|Overall Study|Adverse Event|0
7886219|NCT01806896|12387240|FG000|Overall Study|Other|1
7886220|NCT01806896|12387241|FG001|Overall Study|Other|0
7886221|NCT01807065|12387283|FG000|Overall Study|Receive no sip-T due to IV access|1
7886222|NCT01807065|12387284|FG001|Overall Study|Receive no sip-T due to IV access|1
7886223|NCT01807156|12387303|FG000|Overall Study|Physician Decision|1
7886224|NCT01807221|12387313|FG000|Overall Study|Progressive disease|1
7886225|NCT01807221|12387314|FG001|Overall Study|Progressive disease|0
7886226|NCT01807221|12387315|FG002|Overall Study|Progressive disease|1
7886227|NCT01807221|12387316|FG003|Overall Study|Progressive disease|0
7886228|NCT01807221|12387317|FG004|Overall Study|Progressive disease|0
7805371|NCT01132495|12265576|FG002|Overall Study|Various reasons|20
7886229|NCT01807221|12387318|FG005|Overall Study|Progressive disease|0
7886230|NCT01807221|12387313|FG000|Overall Study|Death|7
7886231|NCT01807221|12387314|FG001|Overall Study|Death|9
7886232|NCT01807221|12387315|FG002|Overall Study|Death|4
7886233|NCT01807221|12387316|FG003|Overall Study|Death|2
7886234|NCT01807221|12387317|FG004|Overall Study|Death|1
7886235|NCT01807221|12387318|FG005|Overall Study|Death|6
7886236|NCT01807221|12387313|FG000|Overall Study|Physician Decision|2
7886237|NCT01807221|12387314|FG001|Overall Study|Physician Decision|1
7886238|NCT01807221|12387315|FG002|Overall Study|Physician Decision|0
7805372|NCT01132495|12265577|FG003|Overall Study|Various reasons|12
7805373|NCT01132547|12265594|FG000|Overall Study|Withdrawal by Subject|3
7805374|NCT01132547|12265595|FG001|Overall Study|Withdrawal by Subject|1
7805375|NCT01132547|12265594|FG000|Overall Study|Death|1
7805376|NCT01132547|12265595|FG001|Overall Study|Death|0
7805377|NCT01132612|12265604|FG000|Overall Study|Death|0
7805378|NCT01132612|12265605|FG001|Overall Study|Death|0
7805379|NCT01132612|12265606|FG002|Overall Study|Death|1
7805380|NCT01132612|12265604|FG000|Overall Study|Protocol deviation|0
7805381|NCT01132612|12265605|FG001|Overall Study|Protocol deviation|0
7805382|NCT01132612|12265606|FG002|Overall Study|Protocol deviation|3
7805383|NCT01132612|12265604|FG000|Overall Study|Lost to Follow-up|2
7805384|NCT01132612|12265605|FG001|Overall Study|Lost to Follow-up|2
7805385|NCT01132612|12265606|FG002|Overall Study|Lost to Follow-up|7
7805386|NCT01132612|12265604|FG000|Overall Study|Adverse Event|5
7805387|NCT01132612|12265605|FG001|Overall Study|Adverse Event|2
7805388|NCT01132612|12265606|FG002|Overall Study|Adverse Event|15
7805389|NCT01132612|12265604|FG000|Overall Study|Withdrawal by Subject|5
7805390|NCT01132612|12265605|FG001|Overall Study|Withdrawal by Subject|8
7805391|NCT01132612|12265606|FG002|Overall Study|Withdrawal by Subject|19
7805392|NCT01132612|12265604|FG000|Overall Study|Administrative problems|5
7805393|NCT01132612|12265605|FG001|Overall Study|Administrative problems|1
7805394|NCT01132612|12265606|FG002|Overall Study|Administrative problems|52
7805395|NCT01132612|12265604|FG000|Overall Study|Lack of Efficacy|23
7805396|NCT01132612|12265605|FG001|Overall Study|Lack of Efficacy|22
7805397|NCT01132612|12265606|FG002|Overall Study|Lack of Efficacy|73
7805398|NCT01132651|12265616|FG000|Overall Study|Lost to Follow-up|1
7805399|NCT01132651|12265617|FG001|Overall Study|Lost to Follow-up|1
7805400|NCT01132664|12265628|FG000|Phase lb|Adverse Event|0
7805401|NCT01132664|12265629|FG001|Phase lb|Adverse Event|1
7805402|NCT01132664|12265630|FG002|Phase lb|Adverse Event|0
7805403|NCT01132664|12265631|FG003|Phase lb|Adverse Event|0
7805404|NCT01132664|12265632|FG004|Phase lb|Adverse Event|0
7805405|NCT01132664|12265628|FG000|Phase lb|Withdrawal by Subject|1
7805406|NCT01132664|12265629|FG001|Phase lb|Withdrawal by Subject|2
7805407|NCT01132664|12265630|FG002|Phase lb|Withdrawal by Subject|0
7805408|NCT01132664|12265631|FG003|Phase lb|Withdrawal by Subject|0
7805409|NCT01132664|12265632|FG004|Phase lb|Withdrawal by Subject|0
7805410|NCT01132664|12265628|FG000|Phase lb|Disease Progression|4
7805411|NCT01132664|12265629|FG001|Phase lb|Disease Progression|9
7805412|NCT01132664|12265630|FG002|Phase lb|Disease Progression|0
7805413|NCT01132664|12265631|FG003|Phase lb|Disease Progression|0
7805414|NCT01132664|12265632|FG004|Phase lb|Disease Progression|0
7805415|NCT01132664|12265628|FG000|Phase ll|Death|0
7805416|NCT01132664|12265629|FG001|Phase ll|Death|0
7805417|NCT01132664|12265630|FG002|Phase ll|Death|2
7805418|NCT01132664|12265631|FG003|Phase ll|Death|0
7805419|NCT01132664|12265632|FG004|Phase ll|Death|0
7805420|NCT01132664|12265628|FG000|Phase ll|Adverse Event|0
7805421|NCT01132664|12265629|FG001|Phase ll|Adverse Event|0
7805422|NCT01132664|12265630|FG002|Phase ll|Adverse Event|10
7805423|NCT01132664|12265631|FG003|Phase ll|Adverse Event|0
7805424|NCT01132664|12265632|FG004|Phase ll|Adverse Event|0
7805425|NCT01132664|12265628|FG000|Phase ll|Withdrawal by Subject|0
7805426|NCT01132664|12265629|FG001|Phase ll|Withdrawal by Subject|0
7805427|NCT01132664|12265630|FG002|Phase ll|Withdrawal by Subject|3
7805428|NCT01132664|12265631|FG003|Phase ll|Withdrawal by Subject|0
7805429|NCT01132664|12265632|FG004|Phase ll|Withdrawal by Subject|0
7805430|NCT01132664|12265628|FG000|Phase ll|Disease progression|0
7805431|NCT01132664|12265629|FG001|Phase ll|Disease progression|0
7805432|NCT01132664|12265630|FG002|Phase ll|Disease progression|35
7805433|NCT01132664|12265631|FG003|Phase ll|Disease progression|0
7805434|NCT01132664|12265632|FG004|Phase ll|Disease progression|0
7805435|NCT01132664|12265628|FG000|BM Cohort|Disease progression|0
7805436|NCT01132664|12265629|FG001|BM Cohort|Disease progression|0
7805437|NCT01132664|12265630|FG002|BM Cohort|Disease progression|0
7805438|NCT01132664|12265631|FG003|BM Cohort|Disease progression|3
7805439|NCT01132664|12265632|FG004|BM Cohort|Disease progression|4
7805440|NCT01132664|12265628|FG000|BM Cohort|Adverse Event|0
7805441|NCT01132664|12265629|FG001|BM Cohort|Adverse Event|0
7805442|NCT01132664|12265630|FG002|BM Cohort|Adverse Event|0
7805443|NCT01132664|12265631|FG003|BM Cohort|Adverse Event|0
7805444|NCT01132664|12265632|FG004|BM Cohort|Adverse Event|1
7805445|NCT01132664|12265628|FG000|BM Cohort|Withdrawal by Subject|0
7805446|NCT01132664|12265629|FG001|BM Cohort|Withdrawal by Subject|0
7805447|NCT01132664|12265630|FG002|BM Cohort|Withdrawal by Subject|0
7805448|NCT01132664|12265631|FG003|BM Cohort|Withdrawal by Subject|0
7805449|NCT01132664|12265632|FG004|BM Cohort|Withdrawal by Subject|1
7886239|NCT01807221|12387316|FG003|Overall Study|Physician Decision|0
7886240|NCT01807221|12387317|FG004|Overall Study|Physician Decision|0
7886241|NCT01807221|12387318|FG005|Overall Study|Physician Decision|0
7805450|NCT01132755|12265653|FG000|Overall Study|Procedure not done due to medical reason|23
7805451|NCT01132755|12265653|FG000|Overall Study|Protocol Violation|15
7805452|NCT01132755|12265653|FG000|Overall Study|Withdrawal by Subject|4
7805453|NCT01132807|12265657|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9
7805454|NCT01132807|12265658|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0
7805455|NCT01132807|12265659|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0
7805456|NCT01132807|12265657|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6
7805457|NCT01132807|12265658|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0
7805458|NCT01132807|12265659|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0
7805459|NCT01132820|12265667|FG000|Overall Study|Ineligible: wrong cell type|1
7805460|NCT01132820|12265667|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1
7805461|NCT01132820|12265667|FG000|Overall Study|Ineligible:Inadequate pathology|1
7805462|NCT01132820|12265667|FG000|Overall Study|Never treated|1
7805463|NCT01132820|12265667|FG000|Overall Study|Inadequate data|1
7805464|NCT01133067|12265686|FG000|Overall Study|Death|136
7805465|NCT01133067|12265686|FG000|Overall Study|Lost to Follow-up|3
7805466|NCT01133171|12265699|FG000|Overall Study|Withdrawal by Subject|1
7805467|NCT01133171|12265700|FG001|Overall Study|Withdrawal by Subject|2
7805468|NCT01133171|12265701|FG002|Overall Study|Withdrawal by Subject|0
7805469|NCT01133275|12265709|FG000|Overall Study|Withdrawal by Subject|1
7805470|NCT01133275|12265709|FG000|Overall Study|Cerebrovascular accident (CVA)|1
7805471|NCT01133379|12265716|FG000|Overall Study|Withdrawal by Subject|0
7805472|NCT01133379|12265717|FG001|Overall Study|Withdrawal by Subject|1
7805473|NCT01133379|12265718|FG002|Overall Study|Withdrawal by Subject|1
7805474|NCT01133379|12265716|FG000|Overall Study|Lost to Follow-up|1
7805475|NCT01133379|12265717|FG001|Overall Study|Lost to Follow-up|1
7805476|NCT01133379|12265718|FG002|Overall Study|Lost to Follow-up|1
7805477|NCT01133392|12265728|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
7805478|NCT01133392|12265729|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
7805479|NCT01133392|12265728|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0
7805480|NCT01133392|12265729|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1
7805481|NCT01133405|12265745|FG000|Period 1|Withdrawal by Subject|0
7805482|NCT01133405|12265746|FG001|Period 1|Withdrawal by Subject|1
7805483|NCT01133405|12265747|FG002|Period 1|Withdrawal by Subject|0
7805484|NCT01133405|12265748|FG003|Period 1|Withdrawal by Subject|1
7805485|NCT01133405|12265749|FG004|Period 1|Withdrawal by Subject|0
7805486|NCT01133405|12265750|FG005|Period 1|Withdrawal by Subject|1
7805487|NCT01133405|12265751|FG006|Period 1|Withdrawal by Subject|0
7805488|NCT01133405|12265752|FG007|Period 1|Withdrawal by Subject|0
7805489|NCT01133405|12265753|FG008|Period 1|Withdrawal by Subject|0
7805490|NCT01133405|12265754|FG009|Period 1|Withdrawal by Subject|0
7805491|NCT01133405|12265745|FG000|Period 1|Physician Decision|0
7805492|NCT01133405|12265746|FG001|Period 1|Physician Decision|0
7805493|NCT01133405|12265747|FG002|Period 1|Physician Decision|0
7805494|NCT01133405|12265748|FG003|Period 1|Physician Decision|1
7805495|NCT01133405|12265749|FG004|Period 1|Physician Decision|0
7805496|NCT01133405|12265750|FG005|Period 1|Physician Decision|0
7805497|NCT01133405|12265751|FG006|Period 1|Physician Decision|0
7805498|NCT01133405|12265752|FG007|Period 1|Physician Decision|0
7805499|NCT01133405|12265753|FG008|Period 1|Physician Decision|0
7805500|NCT01133405|12265754|FG009|Period 1|Physician Decision|0
7805501|NCT01133405|12265745|FG000|Period 1|Discontinued after randomization|1
7805502|NCT01133405|12265746|FG001|Period 1|Discontinued after randomization|0
7805503|NCT01133405|12265747|FG002|Period 1|Discontinued after randomization|0
7805504|NCT01133405|12265748|FG003|Period 1|Discontinued after randomization|0
7805505|NCT01133405|12265749|FG004|Period 1|Discontinued after randomization|0
7805506|NCT01133405|12265750|FG005|Period 1|Discontinued after randomization|0
7805507|NCT01133405|12265751|FG006|Period 1|Discontinued after randomization|1
7805508|NCT01133405|12265752|FG007|Period 1|Discontinued after randomization|0
7805509|NCT01133405|12265753|FG008|Period 1|Discontinued after randomization|0
7805510|NCT01133405|12265754|FG009|Period 1|Discontinued after randomization|0
7805511|NCT01133405|12265745|FG000|Period 1|Received drug only in period 2|0
7805512|NCT01133405|12265746|FG001|Period 1|Received drug only in period 2|1
7805513|NCT01133405|12265747|FG002|Period 1|Received drug only in period 2|0
7805514|NCT01133405|12265748|FG003|Period 1|Received drug only in period 2|2
7805515|NCT01133405|12265749|FG004|Period 1|Received drug only in period 2|0
7805516|NCT01133405|12265750|FG005|Period 1|Received drug only in period 2|1
7805517|NCT01133405|12265751|FG006|Period 1|Received drug only in period 2|0
7805518|NCT01133405|12265752|FG007|Period 1|Received drug only in period 2|0
7805519|NCT01133405|12265753|FG008|Period 1|Received drug only in period 2|0
7805520|NCT01133405|12265754|FG009|Period 1|Received drug only in period 2|0
7805521|NCT01133405|12265745|FG000|Period 1|Received drug only in period 3|0
7805522|NCT01133405|12265746|FG001|Period 1|Received drug only in period 3|1
7805523|NCT01133405|12265747|FG002|Period 1|Received drug only in period 3|1
7805524|NCT01133405|12265748|FG003|Period 1|Received drug only in period 3|0
7805525|NCT01133405|12265749|FG004|Period 1|Received drug only in period 3|0
7805526|NCT01133405|12265750|FG005|Period 1|Received drug only in period 3|0
7805527|NCT01133405|12265751|FG006|Period 1|Received drug only in period 3|0
7805528|NCT01133405|12265752|FG007|Period 1|Received drug only in period 3|0
7805529|NCT01133405|12265753|FG008|Period 1|Received drug only in period 3|0
7805530|NCT01133405|12265754|FG009|Period 1|Received drug only in period 3|0
7805531|NCT01133405|12265745|FG000|Period 2|Adverse Event|0
7886242|NCT01807221|12387313|FG000|Overall Study|Adverse Event|33
7886243|NCT01807221|12387314|FG001|Overall Study|Adverse Event|22
7886244|NCT01807221|12387315|FG002|Overall Study|Adverse Event|26
7886245|NCT01807221|12387316|FG003|Overall Study|Adverse Event|25
7886246|NCT01807221|12387317|FG004|Overall Study|Adverse Event|18
7886247|NCT01807221|12387318|FG005|Overall Study|Adverse Event|21
7886248|NCT01807221|12387313|FG000|Overall Study|Protocol Violation|0
7886249|NCT01807221|12387314|FG001|Overall Study|Protocol Violation|2
7886250|NCT01807221|12387315|FG002|Overall Study|Protocol Violation|1
7886251|NCT01807221|12387316|FG003|Overall Study|Protocol Violation|2
7886252|NCT01807221|12387317|FG004|Overall Study|Protocol Violation|0
7886253|NCT01807221|12387318|FG005|Overall Study|Protocol Violation|1
7886254|NCT01807221|12387313|FG000|Overall Study|Non-compliance|1
7886255|NCT01807221|12387314|FG001|Overall Study|Non-compliance|2
7805532|NCT01133405|12265746|FG001|Period 2|Adverse Event|0
7805533|NCT01133405|12265747|FG002|Period 2|Adverse Event|1
7805534|NCT01133405|12265748|FG003|Period 2|Adverse Event|0
7886256|NCT01807221|12387315|FG002|Overall Study|Non-compliance|0
7805535|NCT01133405|12265749|FG004|Period 2|Adverse Event|0
7805536|NCT01133405|12265750|FG005|Period 2|Adverse Event|0
7805537|NCT01133405|12265751|FG006|Period 2|Adverse Event|0
7886257|NCT01807221|12387316|FG003|Overall Study|Non-compliance|1
7886258|NCT01807221|12387317|FG004|Overall Study|Non-compliance|0
7886259|NCT01807221|12387318|FG005|Overall Study|Non-compliance|0
7886260|NCT01807221|12387313|FG000|Overall Study|Logistical difficulties|0
7886261|NCT01807221|12387314|FG001|Overall Study|Logistical difficulties|1
7886262|NCT01807221|12387315|FG002|Overall Study|Logistical difficulties|0
7886263|NCT01807221|12387316|FG003|Overall Study|Logistical difficulties|0
7886264|NCT01807221|12387317|FG004|Overall Study|Logistical difficulties|1
7886265|NCT01807221|12387318|FG005|Overall Study|Logistical difficulties|0
7886266|NCT01807221|12387313|FG000|Overall Study|Withdrawal by Subject|33
7886267|NCT01807221|12387314|FG001|Overall Study|Withdrawal by Subject|15
7886268|NCT01807221|12387315|FG002|Overall Study|Withdrawal by Subject|8
7886269|NCT01807221|12387316|FG003|Overall Study|Withdrawal by Subject|14
7886270|NCT01807221|12387317|FG004|Overall Study|Withdrawal by Subject|16
7886271|NCT01807221|12387318|FG005|Overall Study|Withdrawal by Subject|13
7886272|NCT01807221|12387313|FG000|Overall Study|Sponsor decision|2
7886273|NCT01807221|12387314|FG001|Overall Study|Sponsor decision|0
7886274|NCT01807221|12387315|FG002|Overall Study|Sponsor decision|1
7886275|NCT01807221|12387316|FG003|Overall Study|Sponsor decision|1
7886276|NCT01807221|12387317|FG004|Overall Study|Sponsor decision|0
7886277|NCT01807221|12387318|FG005|Overall Study|Sponsor decision|0
7886278|NCT01807221|12387313|FG000|Overall Study|Lost to Follow-up|1
7886279|NCT01807221|12387314|FG001|Overall Study|Lost to Follow-up|0
7886280|NCT01807221|12387315|FG002|Overall Study|Lost to Follow-up|2
7886281|NCT01807221|12387316|FG003|Overall Study|Lost to Follow-up|1
7886282|NCT01807221|12387317|FG004|Overall Study|Lost to Follow-up|0
7886283|NCT01807221|12387318|FG005|Overall Study|Lost to Follow-up|0
7886284|NCT01807234|12387338|FG000|Overall Study|Lost to Follow-up|2
7886285|NCT01807234|12387339|FG001|Overall Study|Lost to Follow-up|5
7886286|NCT01807234|12387340|FG002|Overall Study|Lost to Follow-up|1
7886287|NCT01807234|12387341|FG003|Overall Study|Lost to Follow-up|1
7886288|NCT01807234|12387342|FG004|Overall Study|Lost to Follow-up|1
7886289|NCT01807234|12387343|FG005|Overall Study|Lost to Follow-up|2
7886290|NCT01807234|12387338|FG000|Overall Study|Withdrawal by Subject|3
7886291|NCT01807234|12387339|FG001|Overall Study|Withdrawal by Subject|1
7886292|NCT01807234|12387340|FG002|Overall Study|Withdrawal by Subject|1
7886293|NCT01807234|12387341|FG003|Overall Study|Withdrawal by Subject|1
7886294|NCT01807234|12387342|FG004|Overall Study|Withdrawal by Subject|2
7886295|NCT01807234|12387343|FG005|Overall Study|Withdrawal by Subject|1
7886296|NCT01807234|12387338|FG000|Overall Study|Lack of Efficacy|0
7886297|NCT01807234|12387339|FG001|Overall Study|Lack of Efficacy|0
7886298|NCT01807234|12387340|FG002|Overall Study|Lack of Efficacy|0
7886299|NCT01807234|12387341|FG003|Overall Study|Lack of Efficacy|0
7886300|NCT01807234|12387342|FG004|Overall Study|Lack of Efficacy|1
7886301|NCT01807234|12387343|FG005|Overall Study|Lack of Efficacy|1
7886302|NCT01807299|12387357|FG000|Overall Study|Protocol Violation|3
7805538|NCT01133405|12265752|FG007|Period 2|Adverse Event|0
7805539|NCT01133405|12265753|FG008|Period 2|Adverse Event|0
7805540|NCT01133405|12265754|FG009|Period 2|Adverse Event|0
7805541|NCT01133405|12265745|FG000|Period 2|Withdrawal by Subject|0
7805542|NCT01133405|12265746|FG001|Period 2|Withdrawal by Subject|0
7805543|NCT01133405|12265747|FG002|Period 2|Withdrawal by Subject|0
7805544|NCT01133405|12265748|FG003|Period 2|Withdrawal by Subject|1
7805545|NCT01133405|12265749|FG004|Period 2|Withdrawal by Subject|0
7805546|NCT01133405|12265750|FG005|Period 2|Withdrawal by Subject|1
7805547|NCT01133405|12265751|FG006|Period 2|Withdrawal by Subject|0
7805548|NCT01133405|12265752|FG007|Period 2|Withdrawal by Subject|0
7886303|NCT01807299|12387358|FG001|Overall Study|Protocol Violation|1
7886304|NCT01807299|12387359|FG002|Overall Study|Protocol Violation|0
7886305|NCT01807299|12387360|FG003|Overall Study|Protocol Violation|2
7886306|NCT01807520|12387373|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7886307|NCT01807520|12387374|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
7886308|NCT01807520|12387375|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
7886309|NCT01807520|12387376|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7886310|NCT01807520|12387377|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7805549|NCT01133405|12265753|FG008|Period 2|Withdrawal by Subject|0
7805550|NCT01133405|12265754|FG009|Period 2|Withdrawal by Subject|0
7805551|NCT01133405|12265745|FG000|Period 2|Entry Criteria Not Met|0
7805552|NCT01133405|12265746|FG001|Period 2|Entry Criteria Not Met|1
7805553|NCT01133405|12265747|FG002|Period 2|Entry Criteria Not Met|0
7805554|NCT01133405|12265748|FG003|Period 2|Entry Criteria Not Met|0
7805555|NCT01133405|12265749|FG004|Period 2|Entry Criteria Not Met|0
7805556|NCT01133405|12265750|FG005|Period 2|Entry Criteria Not Met|0
7805557|NCT01133405|12265751|FG006|Period 2|Entry Criteria Not Met|0
7805558|NCT01133405|12265752|FG007|Period 2|Entry Criteria Not Met|0
7805559|NCT01133405|12265753|FG008|Period 2|Entry Criteria Not Met|0
7805560|NCT01133405|12265754|FG009|Period 2|Entry Criteria Not Met|0
7805561|NCT01133405|12265745|FG000|Period 2|Physician Decision|0
7805562|NCT01133405|12265746|FG001|Period 2|Physician Decision|0
7805563|NCT01133405|12265747|FG002|Period 2|Physician Decision|0
7805564|NCT01133405|12265748|FG003|Period 2|Physician Decision|0
7805565|NCT01133405|12265749|FG004|Period 2|Physician Decision|0
7805566|NCT01133405|12265750|FG005|Period 2|Physician Decision|1
7805567|NCT01133405|12265751|FG006|Period 2|Physician Decision|0
7805568|NCT01133405|12265752|FG007|Period 2|Physician Decision|0
7805569|NCT01133405|12265753|FG008|Period 2|Physician Decision|0
7805570|NCT01133405|12265754|FG009|Period 2|Physician Decision|0
7805571|NCT01133418|12265786|FG000|Overall Study|Lost to Follow-up|5
7805572|NCT01133418|12265787|FG001|Overall Study|Lost to Follow-up|6
7805573|NCT01133522|12265803|FG000|Overall Study|Withdrawal by Subject|0
7805574|NCT01133522|12265804|FG001|Overall Study|Withdrawal by Subject|1
7805575|NCT01133522|12265805|FG002|Overall Study|Withdrawal by Subject|0
7805576|NCT01133522|12265806|FG003|Overall Study|Withdrawal by Subject|1
7805577|NCT01133522|12265807|FG004|Overall Study|Withdrawal by Subject|0
7805578|NCT01133522|12265808|FG005|Overall Study|Withdrawal by Subject|0
7805579|NCT01133522|12265809|FG006|Overall Study|Withdrawal by Subject|0
7805580|NCT01133522|12265810|FG007|Overall Study|Withdrawal by Subject|0
7805581|NCT01133522|12265811|FG008|Overall Study|Withdrawal by Subject|0
7805582|NCT01133522|12265812|FG009|Overall Study|Withdrawal by Subject|0
7805583|NCT01133522|12265803|FG000|Overall Study|Physician Decision|0
7805584|NCT01133522|12265804|FG001|Overall Study|Physician Decision|0
7805585|NCT01133522|12265805|FG002|Overall Study|Physician Decision|0
7805586|NCT01133522|12265806|FG003|Overall Study|Physician Decision|0
7805587|NCT01133522|12265807|FG004|Overall Study|Physician Decision|1
7805588|NCT01133522|12265808|FG005|Overall Study|Physician Decision|0
7805589|NCT01133522|12265809|FG006|Overall Study|Physician Decision|0
7805590|NCT01133522|12265810|FG007|Overall Study|Physician Decision|0
7805591|NCT01133522|12265811|FG008|Overall Study|Physician Decision|0
7805592|NCT01133522|12265812|FG009|Overall Study|Physician Decision|0
7805593|NCT01133626|12265844|FG000|Overall Study|Adverse Event|0
7805594|NCT01133626|12265845|FG001|Overall Study|Adverse Event|1
7805595|NCT01133626|12265846|FG002|Overall Study|Adverse Event|0
7805596|NCT01133626|12265844|FG000|Overall Study|Withdrawal by Subject|1
7805597|NCT01133626|12265845|FG001|Overall Study|Withdrawal by Subject|2
7805598|NCT01133626|12265846|FG002|Overall Study|Withdrawal by Subject|2
7805599|NCT01133626|12265844|FG000|Overall Study|Other|0
7805600|NCT01133626|12265845|FG001|Overall Study|Other|2
7805601|NCT01133626|12265846|FG002|Overall Study|Other|0
7805602|NCT01133665|12265854|FG000|Overall Study|Physician Decision|2
7805603|NCT01133678|12265860|FG000|Overall Study|Death|1
7805604|NCT01133678|12265861|FG001|Overall Study|Death|1
7805605|NCT01133704|12265869|FG000|Overall Study|Death|44
7805606|NCT01133704|12265870|FG001|Overall Study|Death|26
7805607|NCT01133704|12265869|FG000|Overall Study|Patient refused to continue|4
7805608|NCT01133704|12265870|FG001|Overall Study|Patient refused to continue|0
7805609|NCT01133704|12265869|FG000|Overall Study|Study Closure|1
7805610|NCT01133704|12265870|FG001|Overall Study|Study Closure|0
7805611|NCT01133756|12265879|FG000|Overall Study|Adverse Event|1
7805612|NCT01133756|12265880|FG001|Overall Study|Adverse Event|2
7805613|NCT01133756|12265881|FG002|Overall Study|Adverse Event|1
7805614|NCT01133756|12265879|FG000|Overall Study|Investigator Decision|1
7805615|NCT01133756|12265880|FG001|Overall Study|Investigator Decision|0
7805616|NCT01133756|12265881|FG002|Overall Study|Investigator Decision|0
7805617|NCT01133756|12265879|FG000|Overall Study|Withdrawal by Subject|0
7805618|NCT01133756|12265880|FG001|Overall Study|Withdrawal by Subject|1
7805619|NCT01133756|12265881|FG002|Overall Study|Withdrawal by Subject|0
7805620|NCT01133756|12265879|FG000|Overall Study|Progression of Disease|0
7805621|NCT01133756|12265880|FG001|Overall Study|Progression of Disease|0
7805622|NCT01133756|12265881|FG002|Overall Study|Progression of Disease|1
7805623|NCT01133821|12265891|FG000|Overall Study|Lost to Follow-up|8
7805624|NCT01133821|12265892|FG001|Overall Study|Lost to Follow-up|11
7805625|NCT01133821|12265891|FG000|Overall Study|Withdrawal by Subject|8
7805626|NCT01133821|12265892|FG001|Overall Study|Withdrawal by Subject|3
7805627|NCT01133821|12265891|FG000|Overall Study|preferred other treatment|1
7805628|NCT01133821|12265892|FG001|Overall Study|preferred other treatment|1
7805629|NCT01133821|12265891|FG000|Overall Study|Protocol Violation|0
7805630|NCT01133821|12265892|FG001|Overall Study|Protocol Violation|1
7805631|NCT01133821|12265891|FG000|Overall Study|Refused participation|1
7805632|NCT01133821|12265892|FG001|Overall Study|Refused participation|3
7805633|NCT01133847|12265901|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
7805634|NCT01133847|12265902|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
7805635|NCT01133847|12265903|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
7805636|NCT01133847|12265901|FG000|Follow-Up Phase|Lost to Follow-up|1
7805637|NCT01133847|12265902|FG001|Follow-Up Phase|Lost to Follow-up|3
7805638|NCT01133847|12265903|FG002|Follow-Up Phase|Lost to Follow-up|7
7805639|NCT01133977|12265922|FG000|Overall Study|Adverse Event|0
7805640|NCT01133977|12265923|FG001|Overall Study|Adverse Event|0
7805641|NCT01133977|12265924|FG002|Overall Study|Adverse Event|1
7805642|NCT01133977|12265925|FG003|Overall Study|Adverse Event|0
7805643|NCT01133977|12265926|FG004|Overall Study|Adverse Event|0
7805644|NCT01133977|12265922|FG000|Overall Study|Death|1
7805645|NCT01133977|12265923|FG001|Overall Study|Death|1
7805646|NCT01133977|12265924|FG002|Overall Study|Death|1
7805647|NCT01133977|12265925|FG003|Overall Study|Death|7
7805648|NCT01133977|12265926|FG004|Overall Study|Death|3
7805649|NCT01133977|12265922|FG000|Overall Study|Started a New Line of Therapy|2
7805650|NCT01133977|12265923|FG001|Overall Study|Started a New Line of Therapy|6
7805651|NCT01133977|12265924|FG002|Overall Study|Started a New Line of Therapy|4
7805652|NCT01133977|12265925|FG003|Overall Study|Started a New Line of Therapy|25
7805653|NCT01133977|12265926|FG004|Overall Study|Started a New Line of Therapy|33
7805654|NCT01133977|12265922|FG000|Overall Study|Lost to Follow-up|0
7805655|NCT01133977|12265923|FG001|Overall Study|Lost to Follow-up|0
7805656|NCT01133977|12265924|FG002|Overall Study|Lost to Follow-up|0
7805657|NCT01133977|12265925|FG003|Overall Study|Lost to Follow-up|2
7805658|NCT01133977|12265926|FG004|Overall Study|Lost to Follow-up|1
7805659|NCT01133977|12265922|FG000|Overall Study|Withdrawal by Subject|0
7886311|NCT01807520|12387378|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7886312|NCT01807520|12387379|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7886313|NCT01807520|12387373|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
7886314|NCT01807520|12387374|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7886315|NCT01807520|12387375|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
7886316|NCT01807520|12387376|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7886317|NCT01807520|12387377|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7886318|NCT01807520|12387378|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7886319|NCT01807520|12387379|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7886320|NCT01807520|12387373|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7886321|NCT01807520|12387374|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7886322|NCT01807520|12387375|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
7886323|NCT01807520|12387376|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7886324|NCT01807520|12387377|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7886325|NCT01807520|12387378|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7886326|NCT01807520|12387379|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7886327|NCT01807520|12387373|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
7886328|NCT01807520|12387374|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7886329|NCT01807520|12387375|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7886330|NCT01807520|12387376|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7886331|NCT01807520|12387377|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7886332|NCT01807520|12387378|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7886333|NCT01807520|12387379|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7886334|NCT01807520|12387373|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7886335|NCT01807520|12387374|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7886336|NCT01807520|12387375|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
7886337|NCT01807520|12387376|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7886338|NCT01807520|12387377|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7886339|NCT01807520|12387378|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7886340|NCT01807520|12387379|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7886341|NCT01807520|12387373|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
7886342|NCT01807520|12387374|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7886343|NCT01807520|12387375|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7886344|NCT01807520|12387376|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7886345|NCT01807520|12387377|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7886346|NCT01807520|12387378|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7886347|NCT01807520|12387379|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7886348|NCT01807520|12387373|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7
7886349|NCT01807520|12387374|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4
7886350|NCT01807520|12387375|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7886351|NCT01807520|12387376|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7886352|NCT01807520|12387377|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2
7886353|NCT01807520|12387378|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7886354|NCT01807520|12387379|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7886355|NCT01807520|12387373|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7805660|NCT01133977|12265923|FG001|Overall Study|Withdrawal by Subject|0
7805661|NCT01133977|12265924|FG002|Overall Study|Withdrawal by Subject|0
7805662|NCT01133977|12265925|FG003|Overall Study|Withdrawal by Subject|5
7886356|NCT01807520|12387374|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7886357|NCT01807520|12387375|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7886358|NCT01807520|12387376|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
7886359|NCT01807520|12387377|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7886360|NCT01807520|12387378|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7886361|NCT01807520|12387379|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7886362|NCT01807520|12387373|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
7886363|NCT01807520|12387374|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7886364|NCT01807520|12387375|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7886365|NCT01807520|12387376|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7886366|NCT01807520|12387377|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7886367|NCT01807520|12387378|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7886368|NCT01807520|12387379|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7886369|NCT01807520|12387373|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7886370|NCT01807520|12387374|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
7886371|NCT01807520|12387375|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7805663|NCT01133977|12265926|FG004|Overall Study|Withdrawal by Subject|1
7805664|NCT01134042|12265977|FG000|Overall Study|Adverse Event|3
7805665|NCT01134042|12265978|FG001|Overall Study|Adverse Event|7
7805666|NCT01134042|12265979|FG002|Overall Study|Adverse Event|2
7805667|NCT01134042|12265977|FG000|Overall Study|Lack of Efficacy|21
7805668|NCT01134042|12265978|FG001|Overall Study|Lack of Efficacy|6
7805669|NCT01134042|12265979|FG002|Overall Study|Lack of Efficacy|18
7805670|NCT01134042|12265977|FG000|Overall Study|Protocol Violation|5
7805671|NCT01134042|12265978|FG001|Overall Study|Protocol Violation|3
7805672|NCT01134042|12265979|FG002|Overall Study|Protocol Violation|5
7805673|NCT01134042|12265977|FG000|Overall Study|Lost to Follow-up|2
7805674|NCT01134042|12265978|FG001|Overall Study|Lost to Follow-up|0
7805675|NCT01134042|12265979|FG002|Overall Study|Lost to Follow-up|1
7805676|NCT01134042|12265977|FG000|Overall Study|Physician Decision|4
7805677|NCT01134042|12265978|FG001|Overall Study|Physician Decision|8
7805678|NCT01134042|12265979|FG002|Overall Study|Physician Decision|1
7805679|NCT01134042|12265977|FG000|Overall Study|Withdrawal by Subject|13
7805680|NCT01134042|12265978|FG001|Overall Study|Withdrawal by Subject|4
7805681|NCT01134042|12265979|FG002|Overall Study|Withdrawal by Subject|7
7805682|NCT01134055|12265995|FG000|Overall Study|Adverse Event|5
7805683|NCT01134055|12265996|FG001|Overall Study|Adverse Event|2
7805684|NCT01134055|12265997|FG002|Overall Study|Adverse Event|2
7805685|NCT01134055|12265998|FG003|Overall Study|Adverse Event|2
7805686|NCT01134055|12265999|FG004|Overall Study|Adverse Event|5
7805687|NCT01134055|12266000|FG005|Overall Study|Adverse Event|7
7805688|NCT01134055|12266001|FG006|Overall Study|Adverse Event|2
7805689|NCT01134055|12265995|FG000|Overall Study|Lost to Follow-up|0
7805690|NCT01134055|12265996|FG001|Overall Study|Lost to Follow-up|1
7805691|NCT01134055|12265997|FG002|Overall Study|Lost to Follow-up|0
7805692|NCT01134055|12265998|FG003|Overall Study|Lost to Follow-up|1
7805693|NCT01134055|12265999|FG004|Overall Study|Lost to Follow-up|0
7805694|NCT01134055|12266000|FG005|Overall Study|Lost to Follow-up|0
7805695|NCT01134055|12266001|FG006|Overall Study|Lost to Follow-up|0
7805696|NCT01134055|12265995|FG000|Overall Study|Withdrawal by Subject|3
7805697|NCT01134055|12265996|FG001|Overall Study|Withdrawal by Subject|3
7805698|NCT01134055|12265997|FG002|Overall Study|Withdrawal by Subject|1
7805699|NCT01134055|12265998|FG003|Overall Study|Withdrawal by Subject|2
7805700|NCT01134055|12265999|FG004|Overall Study|Withdrawal by Subject|0
7805701|NCT01134055|12266000|FG005|Overall Study|Withdrawal by Subject|0
7805702|NCT01134055|12266001|FG006|Overall Study|Withdrawal by Subject|8
7805703|NCT01134055|12265995|FG000|Overall Study|Protocol Violation|0
7805704|NCT01134055|12265996|FG001|Overall Study|Protocol Violation|0
7805705|NCT01134055|12265997|FG002|Overall Study|Protocol Violation|0
7805706|NCT01134055|12265998|FG003|Overall Study|Protocol Violation|1
7805707|NCT01134055|12265999|FG004|Overall Study|Protocol Violation|1
7805708|NCT01134055|12266000|FG005|Overall Study|Protocol Violation|0
7805709|NCT01134055|12266001|FG006|Overall Study|Protocol Violation|0
7805710|NCT01134055|12265995|FG000|Overall Study|Physician Decision|0
7805711|NCT01134055|12265996|FG001|Overall Study|Physician Decision|0
7805712|NCT01134055|12265997|FG002|Overall Study|Physician Decision|0
7805713|NCT01134055|12265998|FG003|Overall Study|Physician Decision|0
7805714|NCT01134055|12265999|FG004|Overall Study|Physician Decision|0
7805715|NCT01134055|12266000|FG005|Overall Study|Physician Decision|0
7805716|NCT01134055|12266001|FG006|Overall Study|Physician Decision|1
7805717|NCT01134107|12266033|FG000|Period 1-First Treatment Intervention|Adverse Event|1
7805718|NCT01134107|12266034|FG001|Period 1-First Treatment Intervention|Adverse Event|0
7805719|NCT01134107|12266033|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
7805720|NCT01134107|12266034|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
7805721|NCT01134107|12266033|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3
7805722|NCT01134107|12266034|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4
7805723|NCT01134107|12266033|FG000|Period 1-First Treatment Intervention|Physician Decision|1
7805724|NCT01134107|12266034|FG001|Period 1-First Treatment Intervention|Physician Decision|0
7805725|NCT01134107|12266033|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
7805726|NCT01134107|12266034|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
7805727|NCT01134107|12266033|FG000|Period 2-Second Treatment Intervention|Physician Decision|1
7886372|NCT01807520|12387376|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7886373|NCT01807520|12387377|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7805728|NCT01134107|12266034|FG001|Period 2-Second Treatment Intervention|Physician Decision|0
7805729|NCT01134107|12266033|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1
7805730|NCT01134107|12266034|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0
7805731|NCT01134263|12266054|FG000|Overall Study|Serious adverse event|2
7805732|NCT01134263|12266055|FG001|Overall Study|Serious adverse event|1
7805733|NCT01134263|12266056|FG002|Overall Study|Serious adverse event|1
7805734|NCT01134263|12266057|FG003|Overall Study|Serious adverse event|1
7805735|NCT01134263|12266058|FG004|Overall Study|Serious adverse event|1
7805736|NCT01134263|12266054|FG000|Overall Study|Other adverse event|1
7805737|NCT01134263|12266055|FG001|Overall Study|Other adverse event|2
7805738|NCT01134263|12266056|FG002|Overall Study|Other adverse event|5
7805739|NCT01134263|12266057|FG003|Overall Study|Other adverse event|3
7805740|NCT01134263|12266058|FG004|Overall Study|Other adverse event|0
7805741|NCT01134263|12266054|FG000|Overall Study|Protocol Violation|8
7805742|NCT01134263|12266055|FG001|Overall Study|Protocol Violation|7
7805743|NCT01134263|12266056|FG002|Overall Study|Protocol Violation|2
7805744|NCT01134263|12266057|FG003|Overall Study|Protocol Violation|4
7805745|NCT01134263|12266058|FG004|Overall Study|Protocol Violation|2
7805746|NCT01134263|12266054|FG000|Overall Study|Lost to Follow-up|4
7805747|NCT01134263|12266055|FG001|Overall Study|Lost to Follow-up|3
7805748|NCT01134263|12266056|FG002|Overall Study|Lost to Follow-up|5
7805749|NCT01134263|12266057|FG003|Overall Study|Lost to Follow-up|3
7805750|NCT01134263|12266058|FG004|Overall Study|Lost to Follow-up|1
7805751|NCT01134263|12266054|FG000|Overall Study|Withdrawal by Subject|8
7805752|NCT01134263|12266055|FG001|Overall Study|Withdrawal by Subject|6
7805753|NCT01134263|12266056|FG002|Overall Study|Withdrawal by Subject|16
7805754|NCT01134263|12266057|FG003|Overall Study|Withdrawal by Subject|7
7805755|NCT01134263|12266058|FG004|Overall Study|Withdrawal by Subject|5
7805756|NCT01134263|12266054|FG000|Overall Study|Enrolled, but not treated|1
7805757|NCT01134263|12266055|FG001|Overall Study|Enrolled, but not treated|1
7805758|NCT01134263|12266056|FG002|Overall Study|Enrolled, but not treated|0
7805759|NCT01134263|12266057|FG003|Overall Study|Enrolled, but not treated|1
7805760|NCT01134263|12266058|FG004|Overall Study|Enrolled, but not treated|0
7805761|NCT01134315|12266090|FG000|Overall Study|Adverse Event|1
7805762|NCT01134315|12266091|FG001|Overall Study|Adverse Event|2
7805763|NCT01134315|12266090|FG000|Overall Study|Other Reason|8
7805764|NCT01134315|12266091|FG001|Overall Study|Other Reason|17
7805765|NCT01134393|12266114|FG000|Overall Study|Adverse Event|18
7805766|NCT01134393|12266114|FG000|Overall Study|Lack of Efficacy|2
7805767|NCT01134393|12266114|FG000|Overall Study|Protocol Violation|12
7805768|NCT01134393|12266114|FG000|Overall Study|Lost to Follow-up|3
7805769|NCT01134393|12266114|FG000|Overall Study|Withdrawal by Subject|11
7805770|NCT01134393|12266114|FG000|Overall Study|Other|6
7805771|NCT01129011|12266133|FG000|Overall Study|Adverse Event|20
7805772|NCT01129011|12266134|FG001|Overall Study|Adverse Event|30
7805773|NCT01129011|12266133|FG000|Overall Study|Withdrawal by Subject|24
7805774|NCT01129011|12266134|FG001|Overall Study|Withdrawal by Subject|8
7805775|NCT01129011|12266133|FG000|Overall Study|Lost to Follow-up|6
7805776|NCT01129011|12266134|FG001|Overall Study|Lost to Follow-up|7
7805777|NCT01129011|12266133|FG000|Overall Study|Duodenal Ulcer|2
7805778|NCT01129011|12266134|FG001|Overall Study|Duodenal Ulcer|8
7805779|NCT01129011|12266133|FG000|Overall Study|misc|7
7805780|NCT01129011|12266134|FG001|Overall Study|misc|4
7805781|NCT01134562|12266171|FG000|Overall Study|Adverse Event|0
7805782|NCT01134562|12266172|FG001|Overall Study|Adverse Event|1
7805783|NCT01134562|12266173|FG002|Overall Study|Adverse Event|0
7805784|NCT01134562|12266174|FG003|Overall Study|Adverse Event|0
7805785|NCT01134562|12266175|FG004|Overall Study|Adverse Event|0
7805786|NCT01134627|12266210|FG000|Overall Study|Adverse Event|47
7805787|NCT01134627|12266211|FG001|Overall Study|Adverse Event|31
7805788|NCT01134627|12266210|FG000|Overall Study|Lost to Follow-up|1
7805789|NCT01134627|12266211|FG001|Overall Study|Lost to Follow-up|2
7805790|NCT01134627|12266210|FG000|Overall Study|Protocol Violation|3
7805791|NCT01134627|12266211|FG001|Overall Study|Protocol Violation|5
7805792|NCT01134627|12266210|FG000|Overall Study|Lack of Efficacy|2
7805793|NCT01134627|12266211|FG001|Overall Study|Lack of Efficacy|12
7805794|NCT01134627|12266210|FG000|Overall Study|Withdrawal by Subject|4
7805795|NCT01134627|12266211|FG001|Overall Study|Withdrawal by Subject|3
7805796|NCT01134627|12266210|FG000|Overall Study|Planning to become pregnant/pregnancy|1
7805797|NCT01134627|12266211|FG001|Overall Study|Planning to become pregnant/pregnancy|0
7805798|NCT01134627|12266210|FG000|Overall Study|Other|11
7805799|NCT01134627|12266211|FG001|Overall Study|Other|14
7861670|NCT01596504|12351029|FG000|Overall Study|Withdrawal by Subject|1
7861671|NCT01596504|12351030|FG001|Overall Study|Withdrawal by Subject|0
7861672|NCT01596504|12351031|FG002|Overall Study|Withdrawal by Subject|0
7861673|NCT01596582|12351042|FG000|Overall Study|Deemed ineligible after study visit|3
7861674|NCT01596582|12351043|FG001|Overall Study|Deemed ineligible after study visit|6
7861675|NCT01596582|12351042|FG000|Overall Study|Missing all outcome data|1
7861676|NCT01596582|12351043|FG001|Overall Study|Missing all outcome data|1
7861677|NCT01596972|12351114|FG000|Overall Study|Physician Decision|1
7861678|NCT01596972|12351115|FG001|Overall Study|Physician Decision|9
7861679|NCT01596972|12351114|FG000|Overall Study|Lost to Follow-up|0
7861680|NCT01596972|12351115|FG001|Overall Study|Lost to Follow-up|4
7861681|NCT01596972|12351114|FG000|Overall Study|Withdrawal by Subject|0
7861682|NCT01596972|12351115|FG001|Overall Study|Withdrawal by Subject|1
7805800|NCT01134705|12266219|FG000|Overall Study|Adverse Event|1
7805801|NCT01134705|12266220|FG001|Overall Study|Adverse Event|7
7805802|NCT01134705|12266219|FG000|Overall Study|Withdrawal by Subject|6
7805803|NCT01134705|12266220|FG001|Overall Study|Withdrawal by Subject|6
7805804|NCT01134705|12266219|FG000|Overall Study|Pregnancy|1
7805805|NCT01134705|12266220|FG001|Overall Study|Pregnancy|0
7805806|NCT01134705|12266219|FG000|Overall Study|Lost to Follow-up|5
7805807|NCT01134705|12266220|FG001|Overall Study|Lost to Follow-up|2
7805808|NCT01134705|12266219|FG000|Overall Study|Protocol Violation|1
7805809|NCT01134705|12266220|FG001|Overall Study|Protocol Violation|1
7805810|NCT01134705|12266219|FG000|Overall Study|Other|1
7805811|NCT01134705|12266220|FG001|Overall Study|Other|6
7805812|NCT01134731|12266229|FG000|Overall Study|Adverse Event|3
7805813|NCT01134731|12266230|FG001|Overall Study|Adverse Event|2
7805814|NCT01134731|12266231|FG002|Overall Study|Adverse Event|1
7805815|NCT01134731|12266229|FG000|Overall Study|Physician Decision|2
7805816|NCT01134731|12266230|FG001|Overall Study|Physician Decision|2
7805817|NCT01134731|12266231|FG002|Overall Study|Physician Decision|2
7805818|NCT01134731|12266229|FG000|Overall Study|Lack of Efficacy|0
7805819|NCT01134731|12266230|FG001|Overall Study|Lack of Efficacy|0
7805820|NCT01134731|12266231|FG002|Overall Study|Lack of Efficacy|1
7805821|NCT01134731|12266229|FG000|Overall Study|Withdrawal by Subject|3
7805822|NCT01134731|12266230|FG001|Overall Study|Withdrawal by Subject|3
7805823|NCT01134731|12266231|FG002|Overall Study|Withdrawal by Subject|1
7805824|NCT01134731|12266229|FG000|Overall Study|Lost to Follow-up|5
7805825|NCT01134731|12266230|FG001|Overall Study|Lost to Follow-up|4
7805826|NCT01134731|12266231|FG002|Overall Study|Lost to Follow-up|3
7805827|NCT01134783|12266242|FG000|Overall Study|Pregnancy|16
7805828|NCT01134783|12266243|FG001|Overall Study|Pregnancy|8
7805829|NCT01134783|12266242|FG000|Overall Study|Withdrawal by Subject|15
7805830|NCT01134783|12266243|FG001|Overall Study|Withdrawal by Subject|9
7805831|NCT01134783|12266242|FG000|Overall Study|Lost to Follow-up|5
7805832|NCT01134783|12266243|FG001|Overall Study|Lost to Follow-up|20
7805833|NCT01134939|12266285|FG000|Overall Study|Adverse Event|9
7805834|NCT01134939|12266286|FG001|Overall Study|Adverse Event|3
7805835|NCT01134939|12266287|FG002|Overall Study|Adverse Event|4
7805836|NCT01134939|12266288|FG003|Overall Study|Adverse Event|5
7805837|NCT01134939|12266289|FG004|Overall Study|Adverse Event|5
7805838|NCT01134939|12266290|FG005|Overall Study|Adverse Event|5
7805839|NCT01134939|12266291|FG006|Overall Study|Adverse Event|1
7805840|NCT01134939|12266292|FG007|Overall Study|Adverse Event|0
7805841|NCT01134939|12266285|FG000|Overall Study|Lack of Efficacy|2
7805842|NCT01134939|12266286|FG001|Overall Study|Lack of Efficacy|5
7805843|NCT01134939|12266287|FG002|Overall Study|Lack of Efficacy|1
7805844|NCT01134939|12266288|FG003|Overall Study|Lack of Efficacy|0
7886374|NCT01807520|12387378|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7886375|NCT01807520|12387379|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7886376|NCT01807520|12387373|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
7886377|NCT01807520|12387374|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7886378|NCT01807520|12387375|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7886379|NCT01807520|12387376|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
7886380|NCT01807520|12387377|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7886381|NCT01807520|12387378|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7886382|NCT01807520|12387379|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7886383|NCT01807520|12387373|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
7886384|NCT01807520|12387374|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
7886385|NCT01807520|12387375|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7886386|NCT01807520|12387376|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7886387|NCT01807520|12387377|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
7886388|NCT01807520|12387378|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7886389|NCT01807520|12387379|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7886390|NCT01807520|12387373|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
7886391|NCT01807520|12387374|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
7886392|NCT01807520|12387375|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7886393|NCT01807520|12387376|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
7886394|NCT01807520|12387377|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7886395|NCT01807520|12387378|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7886396|NCT01807520|12387379|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7886397|NCT01807520|12387373|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
7886398|NCT01807520|12387374|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
7886399|NCT01807520|12387375|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
7886400|NCT01807520|12387376|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
7886401|NCT01807520|12387377|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
7886402|NCT01807520|12387378|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
7886403|NCT01807520|12387379|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
7886404|NCT01807520|12387373|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7886405|NCT01807520|12387374|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7886406|NCT01807520|12387375|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7805845|NCT01134939|12266289|FG004|Overall Study|Lack of Efficacy|3
7805846|NCT01134939|12266290|FG005|Overall Study|Lack of Efficacy|0
7886407|NCT01807520|12387376|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7886408|NCT01807520|12387377|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7886409|NCT01807520|12387378|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
7886410|NCT01807520|12387379|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7886411|NCT01807520|12387373|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0
7886412|NCT01807520|12387374|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0
7886413|NCT01807520|12387375|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0
7886414|NCT01807520|12387376|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0
7886415|NCT01807520|12387377|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0
7805847|NCT01134939|12266291|FG006|Overall Study|Lack of Efficacy|1
7805848|NCT01134939|12266292|FG007|Overall Study|Lack of Efficacy|0
7805849|NCT01134939|12266285|FG000|Overall Study|Lost to Follow-up|2
7805850|NCT01134939|12266286|FG001|Overall Study|Lost to Follow-up|3
7805851|NCT01134939|12266287|FG002|Overall Study|Lost to Follow-up|0
7805852|NCT01134939|12266288|FG003|Overall Study|Lost to Follow-up|1
7805853|NCT01134939|12266289|FG004|Overall Study|Lost to Follow-up|2
7805854|NCT01134939|12266290|FG005|Overall Study|Lost to Follow-up|1
7805855|NCT01134939|12266291|FG006|Overall Study|Lost to Follow-up|0
7805856|NCT01134939|12266292|FG007|Overall Study|Lost to Follow-up|0
7805857|NCT01134939|12266285|FG000|Overall Study|Death|0
7805858|NCT01134939|12266286|FG001|Overall Study|Death|1
7805859|NCT01134939|12266287|FG002|Overall Study|Death|0
7805860|NCT01134939|12266288|FG003|Overall Study|Death|0
7805861|NCT01134939|12266289|FG004|Overall Study|Death|0
7805862|NCT01134939|12266290|FG005|Overall Study|Death|0
7805863|NCT01134939|12266291|FG006|Overall Study|Death|0
7805864|NCT01134939|12266292|FG007|Overall Study|Death|0
7805865|NCT01134939|12266285|FG000|Overall Study|Termination page not available|4
7805866|NCT01134939|12266286|FG001|Overall Study|Termination page not available|6
7805867|NCT01134939|12266287|FG002|Overall Study|Termination page not available|5
7805868|NCT01134939|12266288|FG003|Overall Study|Termination page not available|8
7805869|NCT01134939|12266289|FG004|Overall Study|Termination page not available|0
7805870|NCT01134939|12266290|FG005|Overall Study|Termination page not available|3
7805871|NCT01134939|12266291|FG006|Overall Study|Termination page not available|7
7886416|NCT01807520|12387378|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1
7886417|NCT01807520|12387379|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0
7886418|NCT01807520|12387373|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7886419|NCT01807520|12387374|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7886420|NCT01807520|12387375|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7886421|NCT01807520|12387376|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7886422|NCT01807520|12387377|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7886423|NCT01807520|12387378|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
7886424|NCT01807520|12387379|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
7886425|NCT01807598|12387406|FG000|Overall Study|Withdrawal by Subject|4
7886426|NCT01807598|12387406|FG000|Overall Study|Adverse Event|1
7886427|NCT01807598|12387406|FG000|Overall Study|Other Physician Decision|1
7886428|NCT01807650|12387425|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13
7886429|NCT01807650|12387425|FG000|Overall Study|Adverse Event|5
7886430|NCT01807650|12387425|FG000|Overall Study|Other|2
7886431|NCT01807923|12387478|FG000|Overall Study|Adverse Event|2
7886432|NCT01807923|12387479|FG001|Overall Study|Adverse Event|1
7886433|NCT01807923|12387480|FG002|Overall Study|Adverse Event|2
7886434|NCT01807923|12387478|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
7886435|NCT01807923|12387479|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3
7886436|NCT01807923|12387480|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2
7886437|NCT01807923|12387478|FG000|Overall Study|Physician Decision|0
7886438|NCT01807923|12387479|FG001|Overall Study|Physician Decision|0
7886439|NCT01807923|12387480|FG002|Overall Study|Physician Decision|1
7886440|NCT01807923|12387478|FG000|Overall Study|Not Eligible (Genotype)|0
7886441|NCT01807923|12387479|FG001|Overall Study|Not Eligible (Genotype)|0
7886442|NCT01807923|12387480|FG002|Overall Study|Not Eligible (Genotype)|1
7886443|NCT01807923|12387478|FG000|Overall Study|Randomized But Not Treated|3
7886444|NCT01807923|12387479|FG001|Overall Study|Randomized But Not Treated|2
7886445|NCT01807923|12387480|FG002|Overall Study|Randomized But Not Treated|5
7886446|NCT01807949|12387493|FG000|Overall Study|Adverse Event|1
7886447|NCT01807949|12387494|FG001|Overall Study|Adverse Event|2
7886448|NCT01807949|12387495|FG002|Overall Study|Adverse Event|2
7886449|NCT01807949|12387493|FG000|Overall Study|Withdrawal by Subject|1
7886450|NCT01807949|12387494|FG001|Overall Study|Withdrawal by Subject|2
7886451|NCT01807949|12387495|FG002|Overall Study|Withdrawal by Subject|2
7886452|NCT01807949|12387493|FG000|Overall Study|Non-Compliance|0
7886453|NCT01807949|12387494|FG001|Overall Study|Non-Compliance|0
7886454|NCT01807949|12387495|FG002|Overall Study|Non-Compliance|1
7886455|NCT01807949|12387493|FG000|Overall Study|Undefined|0
7886456|NCT01807949|12387494|FG001|Overall Study|Undefined|1
7886457|NCT01807949|12387495|FG002|Overall Study|Undefined|2
7886458|NCT01807949|12387493|FG000|Overall Study|Randomized But Not Treated|0
7886459|NCT01807949|12387494|FG001|Overall Study|Randomized But Not Treated|2
7805872|NCT01134939|12266292|FG007|Overall Study|Termination page not available|0
7886460|NCT01807949|12387495|FG002|Overall Study|Randomized But Not Treated|2
7886461|NCT01808066|12387505|FG000|Overall Study|Withdrawal by Subject|15
7886462|NCT01808092|12387512|FG000|Overall Study|Death|39
7886463|NCT01808092|12387513|FG001|Overall Study|Death|29
7886464|NCT01808092|12387512|FG000|Overall Study|Lost to Follow-up|3
7886465|NCT01808092|12387513|FG001|Overall Study|Lost to Follow-up|7
7886466|NCT01808092|12387512|FG000|Overall Study|Withdrawal by Subject|9
7886467|NCT01808092|12387513|FG001|Overall Study|Withdrawal by Subject|4
7886468|NCT01808092|12387512|FG000|Overall Study|Other Eligibility criteria|3
7886469|NCT01808092|12387513|FG001|Overall Study|Other Eligibility criteria|5
7886470|NCT01808118|12387519|FG000|Period 1|Adverse Event|15
7886471|NCT01808118|12387520|FG001|Period 1|Adverse Event|0
7886472|NCT01808118|12387521|FG002|Period 1|Adverse Event|0
7886473|NCT01808118|12387519|FG000|Period 1|Withdrew consent|24
7886474|NCT01808118|12387520|FG001|Period 1|Withdrew consent|0
7886475|NCT01808118|12387521|FG002|Period 1|Withdrew consent|0
7805873|NCT01135017|12266316|FG000|Overall Study|Adverse Event|3
7805874|NCT01135017|12266317|FG001|Overall Study|Adverse Event|8
7805875|NCT01135017|12266316|FG000|Overall Study|Other than above|3
7805876|NCT01135017|12266317|FG001|Overall Study|Other than above|4
7805877|NCT01135394|12266406|FG000|Screening|Lost to Follow-up|2
7805878|NCT01135394|12266406|FG000|Screening|Withdrawal by Subject|10
7805879|NCT01135394|12266406|FG000|Screening|Screening failure|16
7805880|NCT01135394|12266406|FG000|Screening|Physician Decision|5
7805881|NCT01135394|12266406|FG000|Baseline Assessment|Withdrawal by Subject|9
7805882|NCT01135394|12266406|FG000|Baseline Assessment|Physician Decision|3
7805883|NCT01135394|12266406|FG000|Baseline Assessment|Lost to Follow-up|2
7805884|NCT01135394|12266406|FG000|Baseline Assessment|Adverse Event|1
7805885|NCT01135394|12266406|FG000|Study Treatment|Withdrawal by Subject|1
7805886|NCT01135394|12266406|FG000|Study Treatment|Physician Decision|1
7805887|NCT01135394|12266406|FG000|Study Treatment|Adverse Event|2
7805888|NCT01135498|12266419|FG000|Overall Study|Adverse Event|20
7805889|NCT01135498|12266419|FG000|Overall Study|Progressive disease|38
7805890|NCT01135498|12266419|FG000|Overall Study|Investigator judgement|25
7805891|NCT01135498|12266419|FG000|Overall Study|Withdrawal by Subject|4
7805892|NCT01135498|12266419|FG000|Overall Study|Death|1
7805893|NCT01135498|12266419|FG000|Overall Study|Ongoing at time of analysis|2
7805894|NCT01135511|12266433|FG000|Overall Study|Adverse Event|0
7805895|NCT01135511|12266434|FG001|Overall Study|Adverse Event|1
7805896|NCT01135511|12266435|FG002|Overall Study|Adverse Event|2
7805897|NCT01135511|12266436|FG003|Overall Study|Adverse Event|0
7805898|NCT01135511|12266437|FG004|Overall Study|Adverse Event|0
7805899|NCT01135511|12266438|FG005|Overall Study|Adverse Event|1
7805900|NCT01135511|12266439|FG006|Overall Study|Adverse Event|0
7805901|NCT01135511|12266440|FG007|Overall Study|Adverse Event|1
7805902|NCT01135511|12266441|FG008|Overall Study|Adverse Event|0
7805903|NCT01135511|12266433|FG000|Overall Study|Lack of Efficacy|0
7805904|NCT01135511|12266434|FG001|Overall Study|Lack of Efficacy|1
7805905|NCT01135511|12266435|FG002|Overall Study|Lack of Efficacy|1
7805906|NCT01135511|12266436|FG003|Overall Study|Lack of Efficacy|2
7805907|NCT01135511|12266437|FG004|Overall Study|Lack of Efficacy|0
7805908|NCT01135511|12266438|FG005|Overall Study|Lack of Efficacy|0
7805909|NCT01135511|12266439|FG006|Overall Study|Lack of Efficacy|0
7805910|NCT01135511|12266440|FG007|Overall Study|Lack of Efficacy|0
7805911|NCT01135511|12266441|FG008|Overall Study|Lack of Efficacy|0
7805912|NCT01135511|12266433|FG000|Overall Study|Protocol Violation|0
7805913|NCT01135511|12266434|FG001|Overall Study|Protocol Violation|0
7805914|NCT01135511|12266435|FG002|Overall Study|Protocol Violation|3
7805915|NCT01135511|12266436|FG003|Overall Study|Protocol Violation|0
7805916|NCT01135511|12266437|FG004|Overall Study|Protocol Violation|0
7805917|NCT01135511|12266438|FG005|Overall Study|Protocol Violation|0
7805918|NCT01135511|12266439|FG006|Overall Study|Protocol Violation|0
7805919|NCT01135511|12266440|FG007|Overall Study|Protocol Violation|0
7805920|NCT01135511|12266441|FG008|Overall Study|Protocol Violation|0
7805921|NCT01135511|12266433|FG000|Overall Study|Pregnancy|0
7805922|NCT01135511|12266434|FG001|Overall Study|Pregnancy|0
7805923|NCT01135511|12266435|FG002|Overall Study|Pregnancy|0
7805924|NCT01135511|12266436|FG003|Overall Study|Pregnancy|1
7805925|NCT01135511|12266437|FG004|Overall Study|Pregnancy|0
7805926|NCT01135511|12266438|FG005|Overall Study|Pregnancy|0
7805927|NCT01135511|12266439|FG006|Overall Study|Pregnancy|0
7805928|NCT01135511|12266440|FG007|Overall Study|Pregnancy|0
7805929|NCT01135511|12266441|FG008|Overall Study|Pregnancy|0
7805930|NCT01135511|12266433|FG000|Overall Study|could not visit the clinic|0
7805931|NCT01135511|12266434|FG001|Overall Study|could not visit the clinic|1
7805932|NCT01135511|12266435|FG002|Overall Study|could not visit the clinic|2
7805933|NCT01135511|12266436|FG003|Overall Study|could not visit the clinic|0
7805934|NCT01135511|12266437|FG004|Overall Study|could not visit the clinic|0
7805935|NCT01135511|12266438|FG005|Overall Study|could not visit the clinic|0
7805936|NCT01135511|12266439|FG006|Overall Study|could not visit the clinic|0
7805937|NCT01135511|12266440|FG007|Overall Study|could not visit the clinic|0
7805938|NCT01135511|12266441|FG008|Overall Study|could not visit the clinic|0
7805939|NCT01135511|12266433|FG000|Overall Study|noncompliance with study drug taken|0
7805940|NCT01135511|12266434|FG001|Overall Study|noncompliance with study drug taken|0
7805941|NCT01135511|12266435|FG002|Overall Study|noncompliance with study drug taken|0
7805942|NCT01135511|12266436|FG003|Overall Study|noncompliance with study drug taken|0
7805943|NCT01135511|12266437|FG004|Overall Study|noncompliance with study drug taken|1
7805944|NCT01135511|12266438|FG005|Overall Study|noncompliance with study drug taken|0
7805945|NCT01135511|12266439|FG006|Overall Study|noncompliance with study drug taken|0
7886476|NCT01808118|12387519|FG000|Period 1|Lost to Follow-up|9
7805946|NCT01135511|12266440|FG007|Overall Study|noncompliance with study drug taken|0
7805947|NCT01135511|12266441|FG008|Overall Study|noncompliance with study drug taken|0
7805948|NCT01135511|12266433|FG000|Overall Study|Withdrawal by Subject|0
7805949|NCT01135511|12266434|FG001|Overall Study|Withdrawal by Subject|0
7805950|NCT01135511|12266435|FG002|Overall Study|Withdrawal by Subject|0
7805951|NCT01135511|12266436|FG003|Overall Study|Withdrawal by Subject|0
7805952|NCT01135511|12266437|FG004|Overall Study|Withdrawal by Subject|0
7805953|NCT01135511|12266438|FG005|Overall Study|Withdrawal by Subject|0
7805954|NCT01135511|12266439|FG006|Overall Study|Withdrawal by Subject|1
7805955|NCT01135511|12266440|FG007|Overall Study|Withdrawal by Subject|0
7805956|NCT01135511|12266441|FG008|Overall Study|Withdrawal by Subject|1
7805957|NCT01135524|12266461|FG000|Overall Study|Withdrawal by Subject|14
7805958|NCT01135524|12266461|FG000|Overall Study|Adverse Event|20
7805959|NCT01135524|12266461|FG000|Overall Study|Lost to Follow-up|3
7805960|NCT01135524|12266461|FG000|Overall Study|Administrative|151
7805961|NCT01135524|12266461|FG000|Overall Study|Lack of Efficacy|8
7805962|NCT01135914|12266472|FG000|Overall Study|Withdrawal by Subject|1
7805963|NCT01135914|12266473|FG001|Overall Study|Withdrawal by Subject|3
7805964|NCT01135914|12266474|FG002|Overall Study|Withdrawal by Subject|6
7805965|NCT01135914|12266472|FG000|Overall Study|Lost to Follow-up|1
7805966|NCT01135914|12266473|FG001|Overall Study|Lost to Follow-up|0
7805967|NCT01135914|12266474|FG002|Overall Study|Lost to Follow-up|1
7805968|NCT01135914|12266472|FG000|Overall Study|Protocol Violation|0
7805969|NCT01135914|12266473|FG001|Overall Study|Protocol Violation|0
7805970|NCT01135914|12266474|FG002|Overall Study|Protocol Violation|3
7805971|NCT01135914|12266472|FG000|Overall Study|Lack of Efficacy|2
7805972|NCT01135914|12266473|FG001|Overall Study|Lack of Efficacy|1
7805973|NCT01135914|12266474|FG002|Overall Study|Lack of Efficacy|10
7805974|NCT01135914|12266472|FG000|Overall Study|Adverse Event|0
7805975|NCT01135914|12266473|FG001|Overall Study|Adverse Event|1
7805976|NCT01135914|12266474|FG002|Overall Study|Adverse Event|2
7805977|NCT01135992|12266482|FG000|Overall Study|Adverse Event|1
7805978|NCT01135992|12266482|FG000|Overall Study|Lack of Efficacy|1
7805979|NCT01135992|12266482|FG000|Overall Study|Protocol Violation|2
7805980|NCT01135992|12266482|FG000|Overall Study|Withdrawal criteria|10
7805981|NCT01135992|12266482|FG000|Overall Study|Unclassified|7
7805982|NCT01136174|12266490|FG000|Overall Study|Adverse Event|0
7805983|NCT01136174|12266491|FG001|Overall Study|Adverse Event|0
7805984|NCT01136174|12266492|FG002|Overall Study|Adverse Event|0
7805985|NCT01136174|12266493|FG003|Overall Study|Adverse Event|4
7805986|NCT01136291|12266519|FG000|Overall Study|Lost to Follow-up|1
7805987|NCT01136291|12266520|FG001|Overall Study|Lost to Follow-up|1
7805988|NCT01136356|12266526|FG000|First 18-day Withdrawal|Withdrawal by Subject|3
7805989|NCT01136356|12266527|FG001|First 18-day Withdrawal|Withdrawal by Subject|0
7805990|NCT01136356|12266526|FG000|First 18-day Withdrawal|Physician Decision|1
7805991|NCT01136356|12266527|FG001|First 18-day Withdrawal|Physician Decision|0
7805992|NCT01136356|12266526|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0
7805993|NCT01136356|12266527|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1
7886477|NCT01808118|12387520|FG001|Period 1|Lost to Follow-up|0
7886478|NCT01808118|12387521|FG002|Period 1|Lost to Follow-up|0
7886479|NCT01808118|12387519|FG000|Period 1|Did not meet criteria for remission|303
7886480|NCT01808118|12387520|FG001|Period 1|Did not meet criteria for remission|0
7886481|NCT01808118|12387521|FG002|Period 1|Did not meet criteria for remission|0
7886482|NCT01808118|12387519|FG000|Period 1|Enrolled in error|7
7886483|NCT01808118|12387520|FG001|Period 1|Enrolled in error|0
7886484|NCT01808118|12387521|FG002|Period 1|Enrolled in error|0
7886485|NCT01808118|12387519|FG000|Period 1|Did not meet inclusion criteria|3
7886486|NCT01808118|12387520|FG001|Period 1|Did not meet inclusion criteria|0
7886487|NCT01808118|12387521|FG002|Period 1|Did not meet inclusion criteria|0
7886488|NCT01808118|12387519|FG000|Period 1|Non-conformance with inclusion criteria|3
7886489|NCT01808118|12387520|FG001|Period 1|Non-conformance with inclusion criteria|0
7886490|NCT01808118|12387521|FG002|Period 1|Non-conformance with inclusion criteria|0
7886491|NCT01808118|12387519|FG000|Period 1|Investigator decision: site closure|2
7886492|NCT01808118|12387520|FG001|Period 1|Investigator decision: site closure|0
7886493|NCT01808118|12387521|FG002|Period 1|Investigator decision: site closure|0
7886494|NCT01808118|12387519|FG000|Period 1|Non-compliance per sponsor|1
7886495|NCT01808118|12387520|FG001|Period 1|Non-compliance per sponsor|0
7886496|NCT01808118|12387521|FG002|Period 1|Non-compliance per sponsor|0
7886497|NCT01808118|12387519|FG000|Period 1|Lack of Efficacy|1
7886498|NCT01808118|12387520|FG001|Period 1|Lack of Efficacy|0
7886499|NCT01808118|12387521|FG002|Period 1|Lack of Efficacy|0
7886500|NCT01808118|12387519|FG000|Period 2|Adverse Event|0
7886501|NCT01808118|12387520|FG001|Period 2|Adverse Event|4
7886502|NCT01808118|12387521|FG002|Period 2|Adverse Event|0
7886503|NCT01808118|12387519|FG000|Period 2|Withdrew consent|0
7886504|NCT01808118|12387520|FG001|Period 2|Withdrew consent|7
7886505|NCT01808118|12387521|FG002|Period 2|Withdrew consent|6
7886506|NCT01808118|12387519|FG000|Period 2|Lost to Follow-up|0
7886507|NCT01808118|12387520|FG001|Period 2|Lost to Follow-up|0
7886508|NCT01808118|12387521|FG002|Period 2|Lost to Follow-up|2
7886509|NCT01808118|12387519|FG000|Period 2|Investigator no longer conducting trials|0
7886510|NCT01808118|12387520|FG001|Period 2|Investigator no longer conducting trials|1
7886511|NCT01808118|12387521|FG002|Period 2|Investigator no longer conducting trials|0
7886512|NCT01808118|12387519|FG000|Period 2|Switched to other therapy|0
7886513|NCT01808118|12387520|FG001|Period 2|Switched to other therapy|1
7886514|NCT01808118|12387521|FG002|Period 2|Switched to other therapy|0
7886515|NCT01808144|12387537|FG000|Overall Study|Death|1
7886516|NCT01808144|12387538|FG001|Overall Study|Death|0
7886517|NCT01808144|12387537|FG000|Overall Study|Withdrawal by Subject|16
7886518|NCT01808144|12387538|FG001|Overall Study|Withdrawal by Subject|23
7886519|NCT01808144|12387537|FG000|Overall Study|Lost to Follow-up|6
7886520|NCT01808144|12387538|FG001|Overall Study|Lost to Follow-up|3
7886521|NCT01808144|12387537|FG000|Overall Study|Protocol Violation|6
7886522|NCT01808144|12387538|FG001|Overall Study|Protocol Violation|6
7886523|NCT01808144|12387537|FG000|Overall Study|Gout flare|0
7805994|NCT01136382|12266534|FG000|Overall Study|Other|8
7805995|NCT01136382|12266535|FG001|Overall Study|Other|3
7805996|NCT01136382|12266534|FG000|Overall Study|Study-Specific Withdrawal Criteria|48
7805997|NCT01136382|12266535|FG001|Overall Study|Study-Specific Withdrawal Criteria|25
7805998|NCT01136382|12266534|FG000|Overall Study|Severe Non-Compliance to Protocol|0
7805999|NCT01136382|12266535|FG001|Overall Study|Severe Non-Compliance to Protocol|2
7806000|NCT01136382|12266534|FG000|Overall Study|Withdrawal by Subject|4
7806001|NCT01136382|12266535|FG001|Overall Study|Withdrawal by Subject|1
7806002|NCT01136408|12266544|FG000|Overall Study|Adverse Event|4
7806003|NCT01136408|12266545|FG001|Overall Study|Adverse Event|8
7806004|NCT01136408|12266546|FG002|Overall Study|Adverse Event|4
7806005|NCT01136408|12266544|FG000|Overall Study|Protocol Violation|1
7806006|NCT01136408|12266545|FG001|Overall Study|Protocol Violation|1
7806007|NCT01136408|12266546|FG002|Overall Study|Protocol Violation|1
7806008|NCT01136655|12266562|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
7806009|NCT01136655|12266562|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
7806010|NCT01136655|12266562|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
7806011|NCT01136655|12266562|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
7806012|NCT01136733|12266582|FG000|Phase 1b|Adverse Event|0
7806013|NCT01136733|12266583|FG001|Phase 1b|Adverse Event|3
7886524|NCT01808144|12387538|FG001|Overall Study|Gout flare|1
7886525|NCT01808144|12387537|FG000|Overall Study|Adverse Event|11
7886526|NCT01808144|12387538|FG001|Overall Study|Adverse Event|15
7886527|NCT01808196|12387544|FG000|Overall Study|Lost to Follow-up|1
7886528|NCT01808209|12387550|FG000|Overall Study|Lost to Follow-up|0
7886529|NCT01808209|12387551|FG001|Overall Study|Lost to Follow-up|1
7886530|NCT01808222|12387561|FG000|Overall Study|mpMR scan was not performed|1
7886531|NCT01808248|12387567|FG000|Overall Study|Lack of Efficacy|3
7886532|NCT01808248|12387567|FG000|Overall Study|Withdrawal by Subject|1
7886533|NCT01808248|12387567|FG000|Overall Study|Lost to Follow-up|1
7886534|NCT01808313|12387573|FG000|Overall Study|Adverse Event|5
7886535|NCT01808313|12387573|FG000|Overall Study|Protocol Violation|2
7886536|NCT01808313|12387573|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
7886537|NCT01808313|12387573|FG000|Overall Study|Lost to Follow-up|1
7886538|NCT01808313|12387573|FG000|Overall Study|Physician Decision|1
7886539|NCT01808339|12387581|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
7886540|NCT01808339|12387582|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
7886541|NCT01808339|12387583|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
7886542|NCT01808339|12387584|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
7886543|NCT01808339|12387585|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
7886544|NCT01808339|12387586|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
7886545|NCT01808339|12387581|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7886546|NCT01808339|12387582|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7886547|NCT01808339|12387583|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7886548|NCT01808339|12387584|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7886549|NCT01808339|12387585|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7886550|NCT01808339|12387586|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7886551|NCT01808339|12387581|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7886552|NCT01808339|12387582|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7886553|NCT01808339|12387583|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
7886554|NCT01808339|12387584|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7886555|NCT01808339|12387585|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7886556|NCT01808339|12387586|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7886557|NCT01808508|12387597|FG000|Overall Study|Lost to Follow-up|1
7886558|NCT01808508|12387598|FG001|Overall Study|Lost to Follow-up|0
7886559|NCT01808508|12387599|FG002|Overall Study|Lost to Follow-up|0
7886560|NCT01808534|12387607|FG000|Overall Study|Disease progression|3
7886561|NCT01808534|12387607|FG000|Overall Study|Physician Decision|1
7886562|NCT01808573|12387635|FG000|Overall Study|Death|212
7886563|NCT01808573|12387636|FG001|Overall Study|Death|240
7886564|NCT01808573|12387635|FG000|Overall Study|Withdrawal by Subject|12
7886565|NCT01808573|12387636|FG001|Overall Study|Withdrawal by Subject|10
7886566|NCT01808573|12387635|FG000|Overall Study|Lost to Follow-up|3
7886567|NCT01808573|12387636|FG001|Overall Study|Lost to Follow-up|0
7886568|NCT01808573|12387635|FG000|Overall Study|Discontinuation of study by sponsor|79
7886569|NCT01808573|12387636|FG001|Overall Study|Discontinuation of study by sponsor|64
7886570|NCT01808573|12387635|FG000|Overall Study|Randomized in Error|1
7886571|NCT01808573|12387636|FG001|Overall Study|Randomized in Error|0
7886572|NCT01808612|12387645|FG000|Treatment Period|Adverse Event|8
7886573|NCT01808612|12387646|FG001|Treatment Period|Adverse Event|4
7886574|NCT01808612|12387647|FG002|Treatment Period|Adverse Event|3
7886575|NCT01808612|12387645|FG000|Treatment Period|Lost to Follow-up|2
7886576|NCT01808612|12387646|FG001|Treatment Period|Lost to Follow-up|2
7886577|NCT01808612|12387647|FG002|Treatment Period|Lost to Follow-up|1
7886578|NCT01808612|12387645|FG000|Treatment Period|Protocol Violation|1
7886579|NCT01808612|12387646|FG001|Treatment Period|Protocol Violation|0
7886580|NCT01808612|12387647|FG002|Treatment Period|Protocol Violation|0
7886581|NCT01808612|12387645|FG000|Treatment Period|Withdrawal by Subject|1
7806014|NCT01136733|12266584|FG002|Phase 1b|Adverse Event|1
7806015|NCT01136733|12266585|FG003|Phase 1b|Adverse Event|0
7806016|NCT01136733|12266586|FG004|Phase 1b|Adverse Event|0
7806017|NCT01136733|12266587|FG005|Phase 1b|Adverse Event|0
7806018|NCT01136733|12266588|FG006|Phase 1b|Adverse Event|0
7886582|NCT01808612|12387646|FG001|Treatment Period|Withdrawal by Subject|0
7967739|NCT02773368|12524938|FG000|Overall Study|Unclassified|1
7806019|NCT01136733|12266582|FG000|Phase 1b|Participant Choice|0
7886583|NCT01808612|12387647|FG002|Treatment Period|Withdrawal by Subject|4
7886584|NCT01808612|12387645|FG000|Treatment Period|Physician Decision|1
7886585|NCT01808612|12387646|FG001|Treatment Period|Physician Decision|0
7886586|NCT01808612|12387647|FG002|Treatment Period|Physician Decision|4
7886587|NCT01808612|12387645|FG000|Treatment Period|Sponsor Decision|1
7886588|NCT01808612|12387646|FG001|Treatment Period|Sponsor Decision|0
7886589|NCT01808612|12387647|FG002|Treatment Period|Sponsor Decision|0
7886590|NCT01808612|12387645|FG000|Treatment Period|Lack of Efficacy|1
7886591|NCT01808612|12387646|FG001|Treatment Period|Lack of Efficacy|1
7886592|NCT01808612|12387647|FG002|Treatment Period|Lack of Efficacy|2
7886593|NCT01808612|12387645|FG000|Discontinuation Period|Adverse Event|1
7886594|NCT01808612|12387646|FG001|Discontinuation Period|Adverse Event|0
7886595|NCT01808612|12387647|FG002|Discontinuation Period|Adverse Event|0
7886596|NCT01808612|12387645|FG000|Discontinuation Period|Physician Decision|1
7886597|NCT01808612|12387646|FG001|Discontinuation Period|Physician Decision|0
7886598|NCT01808612|12387647|FG002|Discontinuation Period|Physician Decision|0
7886599|NCT01808612|12387645|FG000|Discontinuation Period|Lost to Follow-up|0
7886600|NCT01808612|12387646|FG001|Discontinuation Period|Lost to Follow-up|1
7886601|NCT01808612|12387647|FG002|Discontinuation Period|Lost to Follow-up|0
7886602|NCT01808651|12387661|FG000|Study Period 1|Lost to Follow-up|1
7886603|NCT01808651|12387662|FG001|Study Period 1|Lost to Follow-up|3
7886604|NCT01808651|12387663|FG002|Study Period 1|Lost to Follow-up|0
7886605|NCT01808651|12387661|FG000|Study Period 1|Protocol Violation|1
7886606|NCT01808651|12387662|FG001|Study Period 1|Protocol Violation|0
7886607|NCT01808651|12387663|FG002|Study Period 1|Protocol Violation|1
7886608|NCT01808651|12387661|FG000|Study Period 1|Physician Decision|3
7886609|NCT01808651|12387662|FG001|Study Period 1|Physician Decision|2
7886610|NCT01808651|12387663|FG002|Study Period 1|Physician Decision|0
7886611|NCT01808651|12387661|FG000|Study Period 1|Lack of Efficacy|2
7886612|NCT01808651|12387662|FG001|Study Period 1|Lack of Efficacy|1
7886613|NCT01808651|12387663|FG002|Study Period 1|Lack of Efficacy|0
7886614|NCT01808651|12387661|FG000|Study Period 1|Adverse Event|10
7886615|NCT01808651|12387662|FG001|Study Period 1|Adverse Event|4
7886616|NCT01808651|12387663|FG002|Study Period 1|Adverse Event|1
7886617|NCT01808651|12387661|FG000|Study Period 1|Participant Decision|9
7886618|NCT01808651|12387662|FG001|Study Period 1|Participant Decision|7
7886619|NCT01808651|12387663|FG002|Study Period 1|Participant Decision|3
7886620|NCT01808690|12387676|FG000|Overall Study|Withdrawal by Subject|1
7886621|NCT01808690|12387677|FG001|Overall Study|Withdrawal by Subject|2
7886622|NCT01809132|12387722|FG000|Overall Study|Withdrawal by Subject|0
7886623|NCT01809132|12387723|FG001|Overall Study|Withdrawal by Subject|0
7886624|NCT01809132|12387724|FG002|Overall Study|Withdrawal by Subject|1
7886625|NCT01809197|12387734|FG000|Overall Study|Lost to Follow-up|4
7886626|NCT01809197|12387735|FG001|Overall Study|Lost to Follow-up|2
7886627|NCT01809197|12387734|FG000|Overall Study|Adverse Event|2
7886628|NCT01809197|12387735|FG001|Overall Study|Adverse Event|3
7886629|NCT01809197|12387734|FG000|Overall Study|Failed slit lamp exam|1
7886630|NCT01809197|12387735|FG001|Overall Study|Failed slit lamp exam|0
7886631|NCT01809197|12387734|FG000|Overall Study|Non-Compliance|1
7886632|NCT01809197|12387735|FG001|Overall Study|Non-Compliance|1
7886633|NCT01809197|12387734|FG000|Overall Study|Decision Unrelated to an Adverse Event|1
7886634|NCT01809197|12387735|FG001|Overall Study|Decision Unrelated to an Adverse Event|0
7886635|NCT01809197|12387734|FG000|Overall Study|Withdrawal by Subject|1
7886636|NCT01809197|12387735|FG001|Overall Study|Withdrawal by Subject|1
7886637|NCT01809197|12387734|FG000|Overall Study|Product not available|0
7886638|NCT01809197|12387735|FG001|Overall Study|Product not available|1
7886639|NCT01809210|12387748|FG000|Overall Study|Withdrawal by Subject|0
7886640|NCT01809210|12387749|FG001|Overall Study|Withdrawal by Subject|0
7886641|NCT01809210|12387750|FG002|Overall Study|Withdrawal by Subject|1
7886642|NCT01809210|12387751|FG003|Overall Study|Withdrawal by Subject|1
7886643|NCT01809210|12387752|FG004|Overall Study|Withdrawal by Subject|1
7886644|NCT01809210|12387753|FG005|Overall Study|Withdrawal by Subject|0
7886645|NCT01809210|12387754|FG006|Overall Study|Withdrawal by Subject|4
7886646|NCT01809210|12387748|FG000|Overall Study|Death|1
7886647|NCT01809210|12387749|FG001|Overall Study|Death|1
7806020|NCT01136733|12266583|FG001|Phase 1b|Participant Choice|0
7806021|NCT01136733|12266584|FG002|Phase 1b|Participant Choice|1
7806022|NCT01136733|12266585|FG003|Phase 1b|Participant Choice|0
7806023|NCT01136733|12266586|FG004|Phase 1b|Participant Choice|0
7806024|NCT01136733|12266587|FG005|Phase 1b|Participant Choice|0
7806025|NCT01136733|12266588|FG006|Phase 1b|Participant Choice|0
7806026|NCT01136733|12266582|FG000|Phase 1b|Administrative-Withdrew Consent|0
7806027|NCT01136733|12266583|FG001|Phase 1b|Administrative-Withdrew Consent|1
7806028|NCT01136733|12266584|FG002|Phase 1b|Administrative-Withdrew Consent|0
7806029|NCT01136733|12266585|FG003|Phase 1b|Administrative-Withdrew Consent|0
7806030|NCT01136733|12266586|FG004|Phase 1b|Administrative-Withdrew Consent|0
7806031|NCT01136733|12266587|FG005|Phase 1b|Administrative-Withdrew Consent|0
7806032|NCT01136733|12266588|FG006|Phase 1b|Administrative-Withdrew Consent|0
7806033|NCT01136733|12266582|FG000|Phase 1b|Clinical Progression|1
7806034|NCT01136733|12266583|FG001|Phase 1b|Clinical Progression|1
7806035|NCT01136733|12266584|FG002|Phase 1b|Clinical Progression|0
7806036|NCT01136733|12266585|FG003|Phase 1b|Clinical Progression|0
7806037|NCT01136733|12266586|FG004|Phase 1b|Clinical Progression|0
7806038|NCT01136733|12266587|FG005|Phase 1b|Clinical Progression|0
7806039|NCT01136733|12266588|FG006|Phase 1b|Clinical Progression|0
7806040|NCT01136733|12266582|FG000|Phase 2|Disease Progression|0
7806041|NCT01136733|12266583|FG001|Phase 2|Disease Progression|0
7806042|NCT01136733|12266584|FG002|Phase 2|Disease Progression|0
7806043|NCT01136733|12266585|FG003|Phase 2|Disease Progression|0
7806044|NCT01136733|12266586|FG004|Phase 2|Disease Progression|30
7806045|NCT01136733|12266587|FG005|Phase 2|Disease Progression|32
7806046|NCT01136733|12266588|FG006|Phase 2|Disease Progression|38
7806047|NCT01136733|12266582|FG000|Phase 2|Adverse Event|0
7806048|NCT01136733|12266583|FG001|Phase 2|Adverse Event|0
7806049|NCT01136733|12266584|FG002|Phase 2|Adverse Event|0
7806050|NCT01136733|12266585|FG003|Phase 2|Adverse Event|0
7886648|NCT01809210|12387750|FG002|Overall Study|Death|2
7886649|NCT01809210|12387751|FG003|Overall Study|Death|0
7886650|NCT01809210|12387752|FG004|Overall Study|Death|1
7886651|NCT01809210|12387753|FG005|Overall Study|Death|3
7886652|NCT01809210|12387754|FG006|Overall Study|Death|1
7886653|NCT01809262|12387770|FG000|Period 1 (First Dose + Washout)|Adverse Event|0
7886654|NCT01809262|12387771|FG001|Period 1 (First Dose + Washout)|Adverse Event|0
7886655|NCT01809262|12387772|FG002|Period 1 (First Dose + Washout)|Adverse Event|0
7886656|NCT01809262|12387773|FG003|Period 1 (First Dose + Washout)|Adverse Event|0
7886657|NCT01809262|12387774|FG004|Period 1 (First Dose + Washout)|Adverse Event|1
7886658|NCT01809262|12387775|FG005|Period 1 (First Dose + Washout)|Adverse Event|0
7886659|NCT01809262|12387776|FG006|Period 1 (First Dose + Washout)|Adverse Event|0
7886660|NCT01809262|12387777|FG007|Period 1 (First Dose + Washout)|Adverse Event|0
7886661|NCT01809262|12387778|FG008|Period 1 (First Dose + Washout)|Adverse Event|0
7886662|NCT01809262|12387779|FG009|Period 1 (First Dose + Washout)|Adverse Event|0
7886663|NCT01809262|12387770|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0
7886664|NCT01809262|12387771|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1
7886665|NCT01809262|12387772|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0
7886666|NCT01809262|12387773|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0
7886667|NCT01809262|12387774|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0
7886668|NCT01809262|12387775|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0
7886669|NCT01809262|12387776|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0
7886670|NCT01809262|12387777|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0
7886671|NCT01809262|12387778|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0
7886672|NCT01809262|12387779|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0
7886673|NCT01809314|12387791|FG000|Overall Study|Withdrawal Prior to Treatment|1
7886674|NCT01809314|12387791|FG000|Overall Study|Adverse Event|6
7886675|NCT01809314|12387791|FG000|Overall Study|Insufficient Therapeutic Response|14
7886676|NCT01809314|12387791|FG000|Overall Study|Lost to Follow-up|724
7886677|NCT01809327|12387800|FG000|Overall Study|Lost to Follow-up|5
7886678|NCT01809327|12387801|FG001|Overall Study|Lost to Follow-up|2
7886679|NCT01809327|12387802|FG002|Overall Study|Lost to Follow-up|4
7886680|NCT01809327|12387803|FG003|Overall Study|Lost to Follow-up|2
7886681|NCT01809327|12387804|FG004|Overall Study|Lost to Follow-up|3
7886682|NCT01809327|12387800|FG000|Overall Study|Withdrawal by Subject|6
7886683|NCT01809327|12387801|FG001|Overall Study|Withdrawal by Subject|4
7886684|NCT01809327|12387802|FG002|Overall Study|Withdrawal by Subject|4
7886685|NCT01809327|12387803|FG003|Overall Study|Withdrawal by Subject|2
7886686|NCT01809327|12387804|FG004|Overall Study|Withdrawal by Subject|5
7886687|NCT01809327|12387800|FG000|Overall Study|Adverse Event|4
7886688|NCT01809327|12387801|FG001|Overall Study|Adverse Event|3
7886689|NCT01809327|12387802|FG002|Overall Study|Adverse Event|7
7886690|NCT01809327|12387803|FG003|Overall Study|Adverse Event|4
7886691|NCT01809327|12387804|FG004|Overall Study|Adverse Event|8
7886692|NCT01809327|12387800|FG000|Overall Study|Death|1
7886693|NCT01809327|12387801|FG001|Overall Study|Death|0
7886694|NCT01809327|12387802|FG002|Overall Study|Death|0
7886695|NCT01809327|12387803|FG003|Overall Study|Death|0
7886696|NCT01809327|12387804|FG004|Overall Study|Death|0
7886697|NCT01809327|12387800|FG000|Overall Study|Protocol Violation|0
7886698|NCT01809327|12387801|FG001|Overall Study|Protocol Violation|1
7886699|NCT01809327|12387802|FG002|Overall Study|Protocol Violation|0
7886700|NCT01809327|12387803|FG003|Overall Study|Protocol Violation|0
7886701|NCT01809327|12387804|FG004|Overall Study|Protocol Violation|0
7886702|NCT01809327|12387800|FG000|Overall Study|Physician Decision|1
7886703|NCT01809327|12387801|FG001|Overall Study|Physician Decision|1
7886704|NCT01809327|12387802|FG002|Overall Study|Physician Decision|0
7886705|NCT01809327|12387803|FG003|Overall Study|Physician Decision|0
7886706|NCT01809327|12387804|FG004|Overall Study|Physician Decision|0
7886707|NCT01809327|12387800|FG000|Overall Study|Pregnancy|1
7886708|NCT01809327|12387801|FG001|Overall Study|Pregnancy|0
7886709|NCT01809327|12387802|FG002|Overall Study|Pregnancy|0
7886710|NCT01809327|12387803|FG003|Overall Study|Pregnancy|0
7886711|NCT01809327|12387804|FG004|Overall Study|Pregnancy|0
7886712|NCT01809327|12387800|FG000|Overall Study|Other|14
7886713|NCT01809327|12387801|FG001|Overall Study|Other|15
7886714|NCT01809327|12387802|FG002|Overall Study|Other|7
7886715|NCT01809327|12387803|FG003|Overall Study|Other|4
7886716|NCT01809327|12387804|FG004|Overall Study|Other|9
7886717|NCT01810016|12387840|FG000|Overall Study|Progressive disease|1
7806051|NCT01136733|12266586|FG004|Phase 2|Adverse Event|11
7806052|NCT01136733|12266587|FG005|Phase 2|Adverse Event|13
7806053|NCT01136733|12266588|FG006|Phase 2|Adverse Event|5
7806054|NCT01136733|12266582|FG000|Phase 2|Participant Choice|0
7806055|NCT01136733|12266583|FG001|Phase 2|Participant Choice|0
7806056|NCT01136733|12266584|FG002|Phase 2|Participant Choice|0
7806057|NCT01136733|12266585|FG003|Phase 2|Participant Choice|0
7806058|NCT01136733|12266586|FG004|Phase 2|Participant Choice|3
7806059|NCT01136733|12266587|FG005|Phase 2|Participant Choice|0
7806060|NCT01136733|12266588|FG006|Phase 2|Participant Choice|1
7806061|NCT01136733|12266582|FG000|Phase 2|Administrative-Withdrew Consent|0
7806062|NCT01136733|12266583|FG001|Phase 2|Administrative-Withdrew Consent|0
7806063|NCT01136733|12266584|FG002|Phase 2|Administrative-Withdrew Consent|0
7806064|NCT01136733|12266585|FG003|Phase 2|Administrative-Withdrew Consent|0
7806065|NCT01136733|12266586|FG004|Phase 2|Administrative-Withdrew Consent|1
7806066|NCT01136733|12266587|FG005|Phase 2|Administrative-Withdrew Consent|0
7806067|NCT01136733|12266588|FG006|Phase 2|Administrative-Withdrew Consent|0
7806068|NCT01136733|12266582|FG000|Phase 2|Other|0
7806069|NCT01136733|12266583|FG001|Phase 2|Other|0
7806070|NCT01136733|12266584|FG002|Phase 2|Other|0
7806071|NCT01136733|12266585|FG003|Phase 2|Other|0
7806072|NCT01136733|12266586|FG004|Phase 2|Other|6
7806073|NCT01136733|12266587|FG005|Phase 2|Other|7
7886718|NCT01810016|12387841|FG001|Overall Study|Progressive disease|1
7886719|NCT01810016|12387842|FG002|Overall Study|Progressive disease|0
7886720|NCT01810016|12387840|FG000|Overall Study|Death|0
7886721|NCT01810016|12387841|FG001|Overall Study|Death|0
7886722|NCT01810016|12387842|FG002|Overall Study|Death|1
7886723|NCT01810042|12387850|FG000|Overall Study|Lost to Follow-up|10
7886724|NCT01810263|12387856|FG000|Overall Study|Lost to Follow-up|8
7886725|NCT01810263|12387857|FG001|Overall Study|Lost to Follow-up|7
7886726|NCT01810380|12387875|FG000|Overall Study|Randomised not treated|2
7886727|NCT01810380|12387876|FG001|Overall Study|Randomised not treated|1
7886728|NCT01810380|12387877|FG002|Overall Study|Randomised not treated|1
7886729|NCT01810380|12387875|FG000|Overall Study|Adverse Event|11
7886730|NCT01810380|12387876|FG001|Overall Study|Adverse Event|14
7886731|NCT01810380|12387877|FG002|Overall Study|Adverse Event|4
7886732|NCT01810380|12387875|FG000|Overall Study|Lack of Efficacy|24
7886733|NCT01810380|12387876|FG001|Overall Study|Lack of Efficacy|10
7886734|NCT01810380|12387877|FG002|Overall Study|Lack of Efficacy|11
7886735|NCT01810380|12387875|FG000|Overall Study|Protocol Violation|1
7886736|NCT01810380|12387876|FG001|Overall Study|Protocol Violation|0
7886737|NCT01810380|12387877|FG002|Overall Study|Protocol Violation|1
7886738|NCT01810380|12387875|FG000|Overall Study|Withdrawal by Subject|6
7886739|NCT01810380|12387876|FG001|Overall Study|Withdrawal by Subject|0
7886740|NCT01810380|12387877|FG002|Overall Study|Withdrawal by Subject|6
7886741|NCT01810380|12387875|FG000|Overall Study|Administrative or other reasons|11
7886742|NCT01810380|12387876|FG001|Overall Study|Administrative or other reasons|13
7886743|NCT01810380|12387877|FG002|Overall Study|Administrative or other reasons|9
7886744|NCT01810432|12387885|FG000|Washout|Protocol Violation|0
7886745|NCT01810432|12387886|FG001|Washout|Protocol Violation|1
7886746|NCT01810432|12387885|FG000|Washout|Adverse Event|1
7886747|NCT01810432|12387886|FG001|Washout|Adverse Event|0
7886748|NCT01810432|12387885|FG000|Period 2|Withdrawal by Subject|2
7886749|NCT01810432|12387886|FG001|Period 2|Withdrawal by Subject|1
7886750|NCT01810432|12387885|FG000|Period 2|Physician Decision|1
7886751|NCT01810432|12387886|FG001|Period 2|Physician Decision|0
7886752|NCT01810432|12387885|FG000|Period 2|Lost to Follow-up|1
7886753|NCT01810432|12387886|FG001|Period 2|Lost to Follow-up|1
7886754|NCT01810783|12387905|FG000|Overall Study|Adverse Event|32
7886755|NCT01810783|12387905|FG000|Overall Study|Withdrawal by Subject|22
7886756|NCT01810783|12387905|FG000|Overall Study|Lack of Efficacy|12
7886757|NCT01810783|12387905|FG000|Overall Study|Lost to Follow-up|10
7886758|NCT01810783|12387905|FG000|Overall Study|Protocol Violation|5
7886759|NCT01810783|12387905|FG000|Overall Study|Non-compliance with IMP|4
7886760|NCT01810783|12387905|FG000|Overall Study|Adminstrative or other reason(s)|23
7886761|NCT01810783|12387905|FG000|Overall Study|Enrolled, not treated|1
7886762|NCT01810939|12387909|FG000|Part A Treatment Period|Non-compliance with Study Drug|1
7886763|NCT01810939|12387910|FG001|Part A Treatment Period|Non-compliance with Study Drug|0
7886764|NCT01810939|12387911|FG002|Part A Treatment Period|Non-compliance with Study Drug|0
7886765|NCT01810939|12387909|FG000|Part A Treatment Period|Protocol Violation|2
7886766|NCT01810939|12387910|FG001|Part A Treatment Period|Protocol Violation|0
7886767|NCT01810939|12387911|FG002|Part A Treatment Period|Protocol Violation|0
7886768|NCT01810939|12387909|FG000|Part A Treatment Period|Adverse Event|10
7886769|NCT01810939|12387910|FG001|Part A Treatment Period|Adverse Event|0
7886770|NCT01810939|12387911|FG002|Part A Treatment Period|Adverse Event|0
7886771|NCT01810939|12387909|FG000|Part A Treatment Period|Withdrawal by Subject|5
7886772|NCT01810939|12387910|FG001|Part A Treatment Period|Withdrawal by Subject|0
7886773|NCT01810939|12387911|FG002|Part A Treatment Period|Withdrawal by Subject|0
7886774|NCT01810939|12387909|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2
7886775|NCT01810939|12387910|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0
7886776|NCT01810939|12387911|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0
7806074|NCT01136733|12266588|FG006|Phase 2|Other|6
7806075|NCT01136746|12266620|FG000|Overall Study|Lost to Follow-up|0
7806076|NCT01136746|12266621|FG001|Overall Study|Lost to Follow-up|2
7806077|NCT01136746|12266620|FG000|Overall Study|Protocol Violation|2
7806078|NCT01136746|12266621|FG001|Overall Study|Protocol Violation|1
7806079|NCT01136746|12266620|FG000|Overall Study|Death|1
7806080|NCT01136746|12266621|FG001|Overall Study|Death|0
7806081|NCT01136772|12266629|FG000|Overall Study|Adverse Event|15
7806082|NCT01136772|12266630|FG001|Overall Study|Adverse Event|14
7806083|NCT01136772|12266629|FG000|Overall Study|Lack of Efficacy|42
7806084|NCT01136772|12266630|FG001|Overall Study|Lack of Efficacy|39
7806085|NCT01136772|12266629|FG000|Overall Study|Administrative|14
7806086|NCT01136772|12266630|FG001|Overall Study|Administrative|12
7806087|NCT01136772|12266629|FG000|Overall Study|Withdrawal by Subject|33
7806088|NCT01136772|12266630|FG001|Overall Study|Withdrawal by Subject|36
7806089|NCT01136772|12266629|FG000|Overall Study|Did not receive injection|10
7806090|NCT01136772|12266630|FG001|Overall Study|Did not receive injection|7
7806091|NCT01136772|12266629|FG000|Overall Study|Did not follow up after first injection|2
7806092|NCT01136772|12266630|FG001|Overall Study|Did not follow up after first injection|2
7806093|NCT01136785|12266638|FG000|Overall Study|Protocol Violation|2
7806094|NCT01136785|12266639|FG001|Overall Study|Protocol Violation|1
7806095|NCT01136876|12266660|FG000|Overall Study|Lost to Follow-up|0
7806096|NCT01136876|12266661|FG001|Overall Study|Lost to Follow-up|1
7806097|NCT01136876|12266660|FG000|Overall Study|Physician Decision|3
7806098|NCT01136876|12266661|FG001|Overall Study|Physician Decision|5
7806099|NCT01136876|12266660|FG000|Overall Study|Missing NGAL measurement|2
7806100|NCT01136876|12266661|FG001|Overall Study|Missing NGAL measurement|5
7806101|NCT01136915|12266671|FG000|Overall Study|Lost to Follow-up|2
7806102|NCT01136915|12266672|FG001|Overall Study|Lost to Follow-up|0
7806103|NCT01136915|12266671|FG000|Overall Study|Exclusion criterion met|0
7806104|NCT01136915|12266672|FG001|Overall Study|Exclusion criterion met|1
7806105|NCT01136954|12266682|FG000|Overall Study|Adverse Event|3
7806106|NCT01136954|12266683|FG001|Overall Study|Adverse Event|2
7806107|NCT01136954|12266682|FG000|Overall Study|Withdrawal by Subject|6
7806108|NCT01136954|12266683|FG001|Overall Study|Withdrawal by Subject|2
7806109|NCT01136954|12266682|FG000|Overall Study|Lack of Efficacy|14
7806110|NCT01136954|12266683|FG001|Overall Study|Lack of Efficacy|13
7806111|NCT01136954|12266682|FG000|Overall Study|Physician Decision|0
7806112|NCT01136954|12266683|FG001|Overall Study|Physician Decision|1
7806113|NCT01136954|12266682|FG000|Overall Study|Other|1
7806114|NCT01136954|12266683|FG001|Overall Study|Other|3
7806115|NCT01137071|12266724|FG000|Overall Study|Disease Progression|11
7806116|NCT01137071|12266724|FG000|Overall Study|Withdrawal by Subject|2
7806117|NCT01137071|12266724|FG000|Overall Study|Wrongly Included|1
7806118|NCT01137110|12266735|FG000|Overall Study|Protocol Violation|1
7806119|NCT01137110|12266736|FG001|Overall Study|Protocol Violation|0
7806120|NCT01137292|12266742|FG000|Overall Study|Death|30
7806121|NCT01137292|12266742|FG000|Overall Study|Adverse Event|3
7806122|NCT01137292|12266742|FG000|Overall Study|Lack of Efficacy|13
7806123|NCT01137292|12266742|FG000|Overall Study|Lost to Follow-up|1
7806124|NCT01137292|12266742|FG000|Overall Study|Other|7
7806125|NCT01137474|12266768|FG000|Overall Study|Adverse Event|3
7806126|NCT01137474|12266769|FG001|Overall Study|Adverse Event|5
7806127|NCT01137474|12266770|FG002|Overall Study|Adverse Event|1
7806128|NCT01137474|12266771|FG003|Overall Study|Adverse Event|3
7806129|NCT01137474|12266768|FG000|Overall Study|Withdrawal by Subject|7
7806130|NCT01137474|12266769|FG001|Overall Study|Withdrawal by Subject|2
7806131|NCT01137474|12266770|FG002|Overall Study|Withdrawal by Subject|6
7806132|NCT01137474|12266771|FG003|Overall Study|Withdrawal by Subject|9
7806133|NCT01137474|12266768|FG000|Overall Study|No longer met study criteria|6
7806134|NCT01137474|12266769|FG001|Overall Study|No longer met study criteria|1
7806135|NCT01137474|12266770|FG002|Overall Study|No longer met study criteria|0
7806136|NCT01137474|12266771|FG003|Overall Study|No longer met study criteria|5
7806137|NCT01137474|12266768|FG000|Overall Study|Lost to Follow-up|5
7806138|NCT01137474|12266769|FG001|Overall Study|Lost to Follow-up|1
7806139|NCT01137474|12266770|FG002|Overall Study|Lost to Follow-up|0
7806140|NCT01137474|12266771|FG003|Overall Study|Lost to Follow-up|2
7806141|NCT01137474|12266768|FG000|Overall Study|Lack of Efficacy|0
7806142|NCT01137474|12266769|FG001|Overall Study|Lack of Efficacy|0
7806143|NCT01137474|12266770|FG002|Overall Study|Lack of Efficacy|0
7806144|NCT01137474|12266771|FG003|Overall Study|Lack of Efficacy|2
7806145|NCT01137474|12266768|FG000|Overall Study|Other|3
7806146|NCT01137474|12266769|FG001|Overall Study|Other|1
7806147|NCT01137474|12266770|FG002|Overall Study|Other|0
7806148|NCT01137474|12266771|FG003|Overall Study|Other|0
7806149|NCT01137474|12266768|FG000|Overall Study|Pregnancy|0
7806150|NCT01137474|12266769|FG001|Overall Study|Pregnancy|1
7806151|NCT01137474|12266770|FG002|Overall Study|Pregnancy|0
7806152|NCT01137474|12266771|FG003|Overall Study|Pregnancy|0
7806153|NCT01137474|12266768|FG000|Overall Study|Administrative reason by sponsor|0
7806154|NCT01137474|12266769|FG001|Overall Study|Administrative reason by sponsor|1
7806155|NCT01137474|12266770|FG002|Overall Study|Administrative reason by sponsor|0
7806156|NCT01137474|12266771|FG003|Overall Study|Administrative reason by sponsor|0
7806157|NCT01137578|12266785|FG000|Overall Study|Participant requested to Discontinue|3
7806158|NCT01137578|12266786|FG001|Overall Study|Participant requested to Discontinue|0
7806159|NCT01137578|12266787|FG002|Overall Study|Participant requested to Discontinue|0
7806160|NCT01137578|12266785|FG000|Overall Study|Withdrawal by Subject|1
7806161|NCT01137578|12266786|FG001|Overall Study|Withdrawal by Subject|0
7806162|NCT01137578|12266787|FG002|Overall Study|Withdrawal by Subject|0
7806163|NCT01137578|12266785|FG000|Overall Study|Other|12
7806164|NCT01137578|12266786|FG001|Overall Study|Other|2
7806165|NCT01137578|12266787|FG002|Overall Study|Other|6
7806166|NCT01137682|12266818|FG000|Overall Study|Adverse Event-CORE|2
7806167|NCT01137682|12266819|FG001|Overall Study|Adverse Event-CORE|4
7806168|NCT01137682|12266820|FG002|Overall Study|Adverse Event-CORE|0
7886777|NCT01810939|12387909|FG000|Part A Treatment Period|Protocol-specified (High K+)|3
7886778|NCT01810939|12387910|FG001|Part A Treatment Period|Protocol-specified (High K+)|0
7886779|NCT01810939|12387911|FG002|Part A Treatment Period|Protocol-specified (High K+)|0
7886780|NCT01810939|12387909|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1
7886781|NCT01810939|12387910|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0
7886782|NCT01810939|12387911|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0
7886783|NCT01810939|12387909|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0
7886784|NCT01810939|12387910|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1
7886785|NCT01810939|12387911|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1
7886786|NCT01810939|12387909|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
7886787|NCT01810939|12387910|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
7886788|NCT01810939|12387911|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
7886789|NCT01810939|12387909|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0
7886790|NCT01810939|12387910|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1
7886791|NCT01810939|12387911|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1
7886792|NCT01810939|12387909|FG000|Part B Placebo-Controlled Withdrawal|Death|0
7886793|NCT01810939|12387910|FG001|Part B Placebo-Controlled Withdrawal|Death|0
7886794|NCT01810939|12387911|FG002|Part B Placebo-Controlled Withdrawal|Death|1
7886795|NCT01810939|12387909|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
7886796|NCT01810939|12387910|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
7886797|NCT01810939|12387911|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
7886798|NCT01810939|12387909|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
7886799|NCT01810939|12387910|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
7886800|NCT01810939|12387911|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
7886801|NCT01810939|12387909|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
7886802|NCT01810939|12387910|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
7886803|NCT01810939|12387911|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
7886804|NCT01810939|12387909|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
7886805|NCT01810939|12387910|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
7886806|NCT01810939|12387911|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
7886807|NCT01810939|12387909|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
7886808|NCT01810939|12387910|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
7886809|NCT01810939|12387911|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
7886810|NCT01810939|12387909|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
7886811|NCT01810939|12387910|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
7886812|NCT01810939|12387911|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
7886813|NCT01811186|12387973|FG000|Overall Study|Adverse Event|54
7886814|NCT01811186|12387974|FG001|Overall Study|Adverse Event|38
7886815|NCT01811186|12387973|FG000|Overall Study|Protocol Violation|5
7886816|NCT01811186|12387974|FG001|Overall Study|Protocol Violation|6
7886817|NCT01811186|12387973|FG000|Overall Study|Withdrawal by Subject|5
7886818|NCT01811186|12387974|FG001|Overall Study|Withdrawal by Subject|10
7886819|NCT01811186|12387973|FG000|Overall Study|Lack of Efficacy|3
7886820|NCT01811186|12387974|FG001|Overall Study|Lack of Efficacy|6
7886821|NCT01811186|12387973|FG000|Overall Study|Lost to Follow-up|4
7886822|NCT01811186|12387974|FG001|Overall Study|Lost to Follow-up|2
7886823|NCT01811225|12387988|FG000|Treatment Period 1|Adverse Event|2
7886824|NCT01811225|12387989|FG001|Treatment Period 1|Adverse Event|3
7806169|NCT01137682|12266818|FG000|Overall Study|Withdrawal by Subject-CORE|2
7806170|NCT01137682|12266819|FG001|Overall Study|Withdrawal by Subject-CORE|2
7806171|NCT01137682|12266820|FG002|Overall Study|Withdrawal by Subject-CORE|2
7806172|NCT01137682|12266818|FG000|Overall Study|Administrative problems-CORE|2
7806173|NCT01137682|12266819|FG001|Overall Study|Administrative problems-CORE|1
7806174|NCT01137682|12266820|FG002|Overall Study|Administrative problems-CORE|0
7806175|NCT01137682|12266818|FG000|Overall Study|Protocol Violation-CORE|0
7806176|NCT01137682|12266819|FG001|Overall Study|Protocol Violation-CORE|1
7806177|NCT01137682|12266820|FG002|Overall Study|Protocol Violation-CORE|1
7806178|NCT01137682|12266818|FG000|Overall Study|Adverse Event-Extension|4
7806179|NCT01137682|12266819|FG001|Overall Study|Adverse Event-Extension|8
7806180|NCT01137682|12266820|FG002|Overall Study|Adverse Event-Extension|7
7806181|NCT01137682|12266818|FG000|Overall Study|Lack of Efficacy-Extension|15
7806182|NCT01137682|12266819|FG001|Overall Study|Lack of Efficacy-Extension|9
7806183|NCT01137682|12266820|FG002|Overall Study|Lack of Efficacy-Extension|13
7806184|NCT01137682|12266818|FG000|Overall Study|Withdrawal by Subject-Extension|6
7806185|NCT01137682|12266819|FG001|Overall Study|Withdrawal by Subject-Extension|8
7806186|NCT01137682|12266820|FG002|Overall Study|Withdrawal by Subject-Extension|8
7806187|NCT01137682|12266818|FG000|Overall Study|Lost to Follow Up-Extension|0
7806188|NCT01137682|12266819|FG001|Overall Study|Lost to Follow Up-Extension|1
7806189|NCT01137682|12266820|FG002|Overall Study|Lost to Follow Up-Extension|0
7806190|NCT01137682|12266818|FG000|Overall Study|Administrative problems-Extension|0
7806191|NCT01137682|12266819|FG001|Overall Study|Administrative problems-Extension|2
7806192|NCT01137682|12266820|FG002|Overall Study|Administrative problems-Extension|0
7806193|NCT01137682|12266818|FG000|Overall Study|Death-Extension|2
7806194|NCT01137682|12266819|FG001|Overall Study|Death-Extension|0
7806195|NCT01137682|12266820|FG002|Overall Study|Death-Extension|0
7806196|NCT01137682|12266818|FG000|Overall Study|Protocol Violation-Extension|2
7806197|NCT01137682|12266819|FG001|Overall Study|Protocol Violation-Extension|1
7806198|NCT01137682|12266820|FG002|Overall Study|Protocol Violation-Extension|0
7806199|NCT01137682|12266818|FG000|Overall Study|Did not enter extension|2
7806200|NCT01137682|12266819|FG001|Overall Study|Did not enter extension|3
7806201|NCT01137682|12266820|FG002|Overall Study|Did not enter extension|2
7806202|NCT01137682|12266818|FG000|Overall Study|Did not receive treatment in extension|0
7806203|NCT01137682|12266819|FG001|Overall Study|Did not receive treatment in extension|0
7806204|NCT01137682|12266820|FG002|Overall Study|Did not receive treatment in extension|1
7806205|NCT01137786|12266834|FG000|Overall Study|Lost to Follow-up|0
7806206|NCT01137786|12266835|FG001|Overall Study|Lost to Follow-up|2
7806207|NCT01137786|12266834|FG000|Overall Study|Withdrawal by Subject|1
7806208|NCT01137786|12266835|FG001|Overall Study|Withdrawal by Subject|1
7806209|NCT01137812|12266845|FG000|Overall Study|Adverse Event|21
7806210|NCT01137812|12266846|FG001|Overall Study|Adverse Event|14
7806211|NCT01137812|12266845|FG000|Overall Study|Lost to Follow-up|6
7806212|NCT01137812|12266846|FG001|Overall Study|Lost to Follow-up|8
7806213|NCT01137812|12266845|FG000|Overall Study|Physician Decision|25
7806214|NCT01137812|12266846|FG001|Overall Study|Physician Decision|17
7806215|NCT01137812|12266845|FG000|Overall Study|Protocol Violation|5
7806216|NCT01137812|12266846|FG001|Overall Study|Protocol Violation|4
7806217|NCT01137812|12266845|FG000|Overall Study|Withdrawal by Subject|5
7806218|NCT01137812|12266846|FG001|Overall Study|Withdrawal by Subject|13
7806219|NCT01137812|12266845|FG000|Overall Study|Death|2
7806220|NCT01137812|12266846|FG001|Overall Study|Death|0
7806221|NCT01137812|12266845|FG000|Overall Study|Patient met glycemic withdrawal criteria|40
7806222|NCT01137812|12266846|FG001|Overall Study|Patient met glycemic withdrawal criteria|85
7806223|NCT01137812|12266845|FG000|Overall Study|Other|19
7806224|NCT01137812|12266846|FG001|Overall Study|Other|27
7806225|NCT01138007|12266910|FG000|Overall Study|Adverse Event|4
7806226|NCT01138007|12266911|FG001|Overall Study|Adverse Event|12
7806227|NCT01138007|12266912|FG002|Overall Study|Adverse Event|9
7806228|NCT01138007|12266910|FG000|Overall Study|Lack of Efficacy|2
7806229|NCT01138007|12266911|FG001|Overall Study|Lack of Efficacy|0
7806230|NCT01138007|12266912|FG002|Overall Study|Lack of Efficacy|6
7806231|NCT01138007|12266910|FG000|Overall Study|Protocol Violation|2
7806232|NCT01138007|12266911|FG001|Overall Study|Protocol Violation|3
7806233|NCT01138007|12266912|FG002|Overall Study|Protocol Violation|2
7806234|NCT01138007|12266910|FG000|Overall Study|Protocol-Defined Stopping Criteria|6
7806235|NCT01138007|12266911|FG001|Overall Study|Protocol-Defined Stopping Criteria|1
7806236|NCT01138007|12266912|FG002|Overall Study|Protocol-Defined Stopping Criteria|8
7806237|NCT01138007|12266910|FG000|Overall Study|Lost to Follow-up|3
7806238|NCT01138007|12266911|FG001|Overall Study|Lost to Follow-up|3
7806239|NCT01138007|12266912|FG002|Overall Study|Lost to Follow-up|5
7806240|NCT01138007|12266910|FG000|Overall Study|Physician Decision|0
7806241|NCT01138007|12266911|FG001|Overall Study|Physician Decision|5
7806242|NCT01138007|12266912|FG002|Overall Study|Physician Decision|3
7806243|NCT01138007|12266910|FG000|Overall Study|Withdrawal by Subject|5
7806244|NCT01138007|12266911|FG001|Overall Study|Withdrawal by Subject|6
7806245|NCT01138007|12266912|FG002|Overall Study|Withdrawal by Subject|15
7806246|NCT01138046|12266922|FG000|Overall Study|Withdrawal due to death|6
7806247|NCT01138111|12266935|FG000|Overall Study|Withdrawal by Subject|5
7806248|NCT01138111|12266935|FG000|Overall Study|Adverse Event|1
7806249|NCT01138111|12266935|FG000|Overall Study|Death|1
7806250|NCT01138111|12266935|FG000|Overall Study|Lost to Follow-up|2
7806251|NCT01138150|12266981|FG000|Overall Study|blood unable to be processed|0
7806252|NCT01138150|12266982|FG001|Overall Study|blood unable to be processed|1
7806253|NCT01138150|12266981|FG000|Overall Study|Physician Decision|1
7806254|NCT01138150|12266982|FG001|Overall Study|Physician Decision|0
7806255|NCT01138501|12267017|FG000|Overall Study|Protocol Violation|2
7806256|NCT01138501|12267017|FG000|Overall Study|Withdrawal by Subject|3
7806257|NCT01138657|12267037|FG000|Overall Study|Adverse Event|3
7806258|NCT01138657|12267038|FG001|Overall Study|Adverse Event|10
7806259|NCT01138657|12267037|FG000|Overall Study|Lack of Efficacy|2
7806260|NCT01138657|12267038|FG001|Overall Study|Lack of Efficacy|1
7806261|NCT01138657|12267037|FG000|Overall Study|Lost to Follow-up|0
7806262|NCT01138657|12267038|FG001|Overall Study|Lost to Follow-up|3
7806263|NCT01138657|12267037|FG000|Overall Study|Miscellaneous Reasons|3
7806264|NCT01138657|12267038|FG001|Overall Study|Miscellaneous Reasons|4
7806265|NCT01138826|12267055|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1
7806266|NCT01138826|12267056|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1
7806267|NCT01138826|12267057|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0
7806268|NCT01138826|12267058|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0
7806269|NCT01138826|12267059|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1
7806270|NCT01138826|12267060|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0
7806271|NCT01139021|12267101|FG000|Overall Study|Adverse Event|0
7806272|NCT01139021|12267102|FG001|Overall Study|Adverse Event|0
7806273|NCT01139021|12267103|FG002|Overall Study|Adverse Event|0
7806274|NCT01139021|12267104|FG003|Overall Study|Adverse Event|0
7806275|NCT01139021|12267105|FG004|Overall Study|Adverse Event|1
7806276|NCT01139021|12267106|FG005|Overall Study|Adverse Event|0
7806277|NCT01139021|12267101|FG000|Overall Study|Lost to Follow-up|0
7806278|NCT01139021|12267102|FG001|Overall Study|Lost to Follow-up|0
7806279|NCT01139021|12267103|FG002|Overall Study|Lost to Follow-up|0
7806280|NCT01139021|12267104|FG003|Overall Study|Lost to Follow-up|0
7806281|NCT01139021|12267105|FG004|Overall Study|Lost to Follow-up|2
7806282|NCT01139021|12267106|FG005|Overall Study|Lost to Follow-up|0
7806283|NCT01139021|12267101|FG000|Overall Study|Protocol Violation|1
7806284|NCT01139021|12267102|FG001|Overall Study|Protocol Violation|0
7806285|NCT01139021|12267103|FG002|Overall Study|Protocol Violation|0
7806286|NCT01139021|12267104|FG003|Overall Study|Protocol Violation|0
7806287|NCT01139021|12267105|FG004|Overall Study|Protocol Violation|2
7806288|NCT01139021|12267106|FG005|Overall Study|Protocol Violation|0
7806289|NCT01139021|12267101|FG000|Overall Study|Withdrawal by Subject|0
7806290|NCT01139021|12267102|FG001|Overall Study|Withdrawal by Subject|0
7806291|NCT01139021|12267103|FG002|Overall Study|Withdrawal by Subject|0
7806292|NCT01139021|12267104|FG003|Overall Study|Withdrawal by Subject|1
7806293|NCT01139021|12267105|FG004|Overall Study|Withdrawal by Subject|4
7806294|NCT01139021|12267106|FG005|Overall Study|Withdrawal by Subject|0
7806295|NCT01139164|12267124|FG000|Overall Study|Withdrawn prior to study start|0
7806296|NCT01139164|12267125|FG001|Overall Study|Withdrawn prior to study start|2
7806297|NCT01139164|12267126|FG002|Overall Study|Withdrawn prior to study start|0
7806298|NCT01139450|12267157|FG000|Overall Study|Withdrawal by Subject|7
7806299|NCT01139450|12267158|FG001|Overall Study|Withdrawal by Subject|10
7806300|NCT01139450|12267159|FG002|Overall Study|Withdrawal by Subject|13
7806301|NCT01139450|12267157|FG000|Overall Study|Lack of Efficacy|3
7806302|NCT01139450|12267158|FG001|Overall Study|Lack of Efficacy|1
7806303|NCT01139450|12267159|FG002|Overall Study|Lack of Efficacy|8
7806304|NCT01139450|12267157|FG000|Overall Study|Protocol Violation|6
7806305|NCT01139450|12267158|FG001|Overall Study|Protocol Violation|5
7806306|NCT01139450|12267159|FG002|Overall Study|Protocol Violation|2
7806307|NCT01139450|12267157|FG000|Overall Study|Lost to Follow-up|9
7806308|NCT01139450|12267158|FG001|Overall Study|Lost to Follow-up|7
7806309|NCT01139450|12267159|FG002|Overall Study|Lost to Follow-up|11
7806310|NCT01139450|12267157|FG000|Overall Study|Administrative|0
7806311|NCT01139450|12267158|FG001|Overall Study|Administrative|0
7806312|NCT01139450|12267159|FG002|Overall Study|Administrative|1
7806313|NCT01139450|12267157|FG000|Overall Study|Adverse Event|2
7806314|NCT01139450|12267158|FG001|Overall Study|Adverse Event|2
7806315|NCT01139450|12267159|FG002|Overall Study|Adverse Event|3
7806316|NCT01139580|12267182|FG000|Overall Study|Adverse Event|5
7806317|NCT01139580|12267183|FG001|Overall Study|Adverse Event|4
7806318|NCT01139580|12267182|FG000|Overall Study|Lost to Follow-up|9
7806319|NCT01139580|12267183|FG001|Overall Study|Lost to Follow-up|1
7806320|NCT01139580|12267182|FG000|Overall Study|Lack of Efficacy|0
7806321|NCT01139580|12267183|FG001|Overall Study|Lack of Efficacy|2
7806322|NCT01139580|12267182|FG000|Overall Study|Withdrawal by Subject|6
7806323|NCT01139580|12267183|FG001|Overall Study|Withdrawal by Subject|9
7806324|NCT01139580|12267182|FG000|Overall Study|Used Excluded Medicine After Enrollment|1
7806325|NCT01139580|12267183|FG001|Overall Study|Used Excluded Medicine After Enrollment|0
7806326|NCT01139580|12267182|FG000|Overall Study|Did Not Meet Exclusion Criteria|1
7806327|NCT01139580|12267183|FG001|Overall Study|Did Not Meet Exclusion Criteria|0
7806328|NCT01139580|12267182|FG000|Overall Study|Misrandomized|1
7806329|NCT01139580|12267183|FG001|Overall Study|Misrandomized|0
7806330|NCT01139580|12267182|FG000|Overall Study|Beginning Study Exclusion Treatment|0
7806331|NCT01139580|12267183|FG001|Overall Study|Beginning Study Exclusion Treatment|1
7806332|NCT01139580|12267182|FG000|Overall Study|Participant Randomization in Error|0
7806333|NCT01139580|12267183|FG001|Overall Study|Participant Randomization in Error|1
7806334|NCT01139658|12267191|FG000|Overall Study|Adverse Event|10
7806335|NCT01139658|12267192|FG001|Overall Study|Adverse Event|27
7806336|NCT01139658|12267191|FG000|Overall Study|Lack of Efficacy|15
7806337|NCT01139658|12267192|FG001|Overall Study|Lack of Efficacy|7
7806338|NCT01139658|12267191|FG000|Overall Study|Withdrawal by Subject|2
7806339|NCT01139658|12267192|FG001|Overall Study|Withdrawal by Subject|4
7806340|NCT01139658|12267191|FG000|Overall Study|No documentation of treatment|1
7806341|NCT01139658|12267192|FG001|Overall Study|No documentation of treatment|0
7806342|NCT01139658|12267191|FG000|Overall Study|Other|28
7806343|NCT01139658|12267192|FG001|Overall Study|Other|75
7806344|NCT01139762|12267200|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
7806345|NCT01139762|12267201|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
7806346|NCT01139762|12267202|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
7806347|NCT01139762|12267200|FG000|Washout and Placebo Lead-In Period|Adverse Event|1
7806348|NCT01139762|12267201|FG001|Washout and Placebo Lead-In Period|Adverse Event|0
7806349|NCT01139762|12267202|FG002|Washout and Placebo Lead-In Period|Adverse Event|0
7806350|NCT01139762|12267200|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
7806351|NCT01139762|12267201|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
7806352|NCT01139762|12267202|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
7806353|NCT01139762|12267200|FG000|Washout and Placebo Lead-In Period|Physician Decision|12
7806354|NCT01139762|12267201|FG001|Washout and Placebo Lead-In Period|Physician Decision|0
7967740|NCT02773368|12524939|FG001|Overall Study|Unclassified|1
7806355|NCT01139762|12267202|FG002|Washout and Placebo Lead-In Period|Physician Decision|0
7806356|NCT01139762|12267200|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10
7806357|NCT01139762|12267201|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0
7806358|NCT01139762|12267202|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0
7806359|NCT01139762|12267200|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10
7806360|NCT01139762|12267201|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0
7806361|NCT01139762|12267202|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0
7806362|NCT01139762|12267200|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0
7806363|NCT01139762|12267201|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4
7806364|NCT01139762|12267202|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10
7806365|NCT01139762|12267200|FG000|Double-Blind Randomized Active Treatment|Death|0
7806366|NCT01139762|12267201|FG001|Double-Blind Randomized Active Treatment|Death|1
7806367|NCT01139762|12267202|FG002|Double-Blind Randomized Active Treatment|Death|1
7806368|NCT01139762|12267200|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
7806369|NCT01139762|12267201|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
7806370|NCT01139762|12267202|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
7806371|NCT01139762|12267200|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0
7806372|NCT01139762|12267201|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2
7806373|NCT01139762|12267202|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8
7806374|NCT01139762|12267200|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
7806375|NCT01139762|12267201|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
7806376|NCT01139762|12267202|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
7806377|NCT01139762|12267200|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0
7806378|NCT01139762|12267201|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2
7806379|NCT01139762|12267202|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0
7806380|NCT01139762|12267200|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0
7806381|NCT01139762|12267201|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5
7806382|NCT01139762|12267202|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6
7806383|NCT01139762|12267200|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
7806384|NCT01139762|12267201|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
7806385|NCT01139762|12267202|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
7806386|NCT01139762|12267200|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
7806387|NCT01139762|12267201|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
7806388|NCT01139762|12267202|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
7806389|NCT01139775|12267212|FG000|Overall Study|Adverse Event|0
7806390|NCT01139775|12267213|FG001|Overall Study|Adverse Event|6
7806391|NCT01139775|12267214|FG002|Overall Study|Adverse Event|2
7806392|NCT01139775|12267212|FG000|Overall Study|Protocol Violation|0
7806393|NCT01139775|12267213|FG001|Overall Study|Protocol Violation|5
7806394|NCT01139775|12267214|FG002|Overall Study|Protocol Violation|0
7806395|NCT01139775|12267212|FG000|Overall Study|Withdrawal by Subject|1
7806396|NCT01139775|12267213|FG001|Overall Study|Withdrawal by Subject|0
7806397|NCT01139775|12267214|FG002|Overall Study|Withdrawal by Subject|2
7806398|NCT01139775|12267212|FG000|Overall Study|Physician Decision|0
7806399|NCT01139775|12267213|FG001|Overall Study|Physician Decision|2
7806400|NCT01139775|12267214|FG002|Overall Study|Physician Decision|2
7806401|NCT01140061|12267254|FG000|Part I|Adverse Event|1
7806402|NCT01140061|12267255|FG001|Part I|Adverse Event|0
7806403|NCT01140061|12267256|FG002|Part I|Adverse Event|0
7806404|NCT01140061|12267257|FG003|Part I|Adverse Event|0
7806405|NCT01140061|12267258|FG004|Part I|Adverse Event|0
7806406|NCT01140061|12267259|FG005|Part I|Adverse Event|0
7806407|NCT01140061|12267260|FG006|Part I|Adverse Event|0
7806408|NCT01140061|12267261|FG007|Part I|Adverse Event|0
7806409|NCT01140061|12267262|FG008|Part I|Adverse Event|0
7806410|NCT01140061|12267263|FG009|Part I|Adverse Event|0
7806411|NCT01140061|12267254|FG000|Extension|Laboratory Adverse Event|0
7806412|NCT01140061|12267255|FG001|Extension|Laboratory Adverse Event|0
7806413|NCT01140061|12267256|FG002|Extension|Laboratory Adverse Event|0
7806414|NCT01140061|12267257|FG003|Extension|Laboratory Adverse Event|0
7806415|NCT01140061|12267258|FG004|Extension|Laboratory Adverse Event|0
7806416|NCT01140061|12267259|FG005|Extension|Laboratory Adverse Event|0
7806417|NCT01140061|12267260|FG006|Extension|Laboratory Adverse Event|0
7967741|NCT02773368|12524938|FG000|Overall Study|Missing|0
7806418|NCT01140061|12267261|FG007|Extension|Laboratory Adverse Event|0
7806419|NCT01140061|12267262|FG008|Extension|Laboratory Adverse Event|0
7806420|NCT01140061|12267263|FG009|Extension|Laboratory Adverse Event|1
7806421|NCT01140347|12267295|FG000|Overall Study|Lost to Follow-up|5
7806422|NCT01140347|12267296|FG001|Overall Study|Lost to Follow-up|6
7806423|NCT01140347|12267295|FG000|Overall Study|Withdrawal by Subject|13
7806424|NCT01140347|12267296|FG001|Overall Study|Withdrawal by Subject|8
7806425|NCT01140477|12267308|FG000|Overall Study|Lost to Follow-up|4
7806426|NCT01140477|12267309|FG001|Overall Study|Lost to Follow-up|0
7806427|NCT01140477|12267308|FG000|Overall Study|Withdrawal by Subject|1
7806428|NCT01140477|12267309|FG001|Overall Study|Withdrawal by Subject|4
7806429|NCT01140477|12267308|FG000|Overall Study|Surgical complication preventing implant|2
7806430|NCT01140477|12267309|FG001|Overall Study|Surgical complication preventing implant|0
7806431|NCT01140477|12267308|FG000|Overall Study|Death|1
7806432|NCT01140477|12267309|FG001|Overall Study|Death|1
7806433|NCT01140477|12267308|FG000|Overall Study|Subject explanted|0
7806434|NCT01140477|12267309|FG001|Overall Study|Subject explanted|1
7806435|NCT01140503|12267315|FG000|Overall Study|Withdrawal by Subject|1
7806436|NCT01140568|12267319|FG000|Overall Study|disease progression|31
7806437|NCT01140568|12267319|FG000|Overall Study|Withdrawal by Subject|1
7806438|NCT01140568|12267319|FG000|Overall Study|Screen Fail|4
7806439|NCT01140646|12267323|FG000|Overall Study|Adverse Event|4
7806440|NCT01140646|12267323|FG000|Overall Study|Refused Further Treatment|5
7806441|NCT01140880|12267340|FG000|Overall Study|Death|0
7806442|NCT01140880|12267341|FG001|Overall Study|Death|1
7806443|NCT01140880|12267340|FG000|Overall Study|Withdrawal by Subject|6
7806444|NCT01140880|12267341|FG001|Overall Study|Withdrawal by Subject|3
7806445|NCT01140880|12267340|FG000|Overall Study|Lost to Follow-up|8
7806446|NCT01140880|12267341|FG001|Overall Study|Lost to Follow-up|10
7806447|NCT01140880|12267340|FG000|Overall Study|Protocol Violation|0
7806448|NCT01140880|12267341|FG001|Overall Study|Protocol Violation|30
7806449|NCT01140906|12267351|FG000|Overall Study|Adverse Event|7
7806450|NCT01140906|12267352|FG001|Overall Study|Adverse Event|10
7806451|NCT01140906|12267353|FG002|Overall Study|Adverse Event|17
7806452|NCT01140906|12267354|FG003|Overall Study|Adverse Event|7
7806453|NCT01140906|12267351|FG000|Overall Study|Lack of Efficacy|6
7806454|NCT01140906|12267352|FG001|Overall Study|Lack of Efficacy|8
7806455|NCT01140906|12267353|FG002|Overall Study|Lack of Efficacy|2
7806456|NCT01140906|12267354|FG003|Overall Study|Lack of Efficacy|1
7806457|NCT01140906|12267351|FG000|Overall Study|Non-compliance|0
7806458|NCT01140906|12267352|FG001|Overall Study|Non-compliance|1
7806459|NCT01140906|12267353|FG002|Overall Study|Non-compliance|0
7806460|NCT01140906|12267354|FG003|Overall Study|Non-compliance|1
7806461|NCT01140906|12267351|FG000|Overall Study|Protocol Violation|5
7806462|NCT01140906|12267352|FG001|Overall Study|Protocol Violation|3
7806463|NCT01140906|12267353|FG002|Overall Study|Protocol Violation|2
7806464|NCT01140906|12267354|FG003|Overall Study|Protocol Violation|1
7806465|NCT01140906|12267351|FG000|Overall Study|Withdrawal of consent|6
7806466|NCT01140906|12267352|FG001|Overall Study|Withdrawal of consent|6
7806467|NCT01140906|12267353|FG002|Overall Study|Withdrawal of consent|2
7806468|NCT01140906|12267354|FG003|Overall Study|Withdrawal of consent|2
7806469|NCT01140906|12267351|FG000|Overall Study|Lost to Follow-up|1
7806470|NCT01140906|12267352|FG001|Overall Study|Lost to Follow-up|1
7806471|NCT01140906|12267353|FG002|Overall Study|Lost to Follow-up|0
7806472|NCT01140906|12267354|FG003|Overall Study|Lost to Follow-up|2
7806473|NCT01140906|12267351|FG000|Overall Study|Administrative or other reason|0
7806474|NCT01140906|12267352|FG001|Overall Study|Administrative or other reason|5
7806475|NCT01140906|12267353|FG002|Overall Study|Administrative or other reason|3
7806476|NCT01140906|12267354|FG003|Overall Study|Administrative or other reason|2
7806477|NCT01141205|12267379|FG000|Overall Study|Physician Decision|1
7806478|NCT01141205|12267380|FG001|Overall Study|Physician Decision|1
7806479|NCT01141205|12267379|FG000|Overall Study|Lost to Follow-up|1
7806480|NCT01141205|12267380|FG001|Overall Study|Lost to Follow-up|0
7806481|NCT01141205|12267379|FG000|Overall Study|Withdrawal by Subject|1
7806482|NCT01141205|12267380|FG001|Overall Study|Withdrawal by Subject|1
7806483|NCT01141283|12267390|FG000|Overall Study|Adverse Event|56
7806484|NCT01141283|12267390|FG000|Overall Study|Lost to Follow-up|4
7806485|NCT01141283|12267390|FG000|Overall Study|Withdrawal by Subject|14
7806486|NCT01141283|12267390|FG000|Overall Study|Administrative|4
7806487|NCT01141283|12267390|FG000|Overall Study|Lack of Efficacy|10
7806488|NCT01141478|12267411|FG000|Overall Study|Withdrawal by Subject|1
7806489|NCT01141478|12267412|FG001|Overall Study|Withdrawal by Subject|1
7861683|NCT01597050|12351123|FG000|Overall Study|Withdrawal by Subject|1
7861684|NCT01597050|12351124|FG001|Overall Study|Withdrawal by Subject|0
7861685|NCT01597193|12351157|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7
7861686|NCT01597193|12351158|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8
7861687|NCT01597193|12351159|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7861688|NCT01597193|12351160|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7861689|NCT01597193|12351161|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7861690|NCT01597193|12351162|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7861691|NCT01597193|12351163|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7861692|NCT01597193|12351157|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7861693|NCT01597193|12351158|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7806490|NCT01141660|12267455|FG000|Overall Study|Physician Decision|0
7806491|NCT01141660|12267456|FG001|Overall Study|Physician Decision|12
7806492|NCT01142089|12267482|FG000|Overall Study|Physician Decision|1
7806493|NCT01142089|12267483|FG001|Overall Study|Physician Decision|0
7806494|NCT01142089|12267482|FG000|Overall Study|Withdrawal by Subject|1
7806495|NCT01142089|12267483|FG001|Overall Study|Withdrawal by Subject|2
7806496|NCT01142089|12267482|FG000|Overall Study|Use of prohibited medications|0
7806497|NCT01142089|12267483|FG001|Overall Study|Use of prohibited medications|1
7806498|NCT01142089|12267482|FG000|Overall Study|Noncompliance with study procedures|2
7806499|NCT01142089|12267483|FG001|Overall Study|Noncompliance with study procedures|1
7806500|NCT01142089|12267482|FG000|Overall Study|Patient required rescue medication|8
7806501|NCT01142089|12267483|FG001|Overall Study|Patient required rescue medication|17
7806502|NCT01142115|12267489|FG000|First Intervention|Lack of Efficacy|1
7806503|NCT01142115|12267490|FG001|First Intervention|Lack of Efficacy|1
7806504|NCT01142115|12267489|FG000|First Intervention|Adverse Event|1
7806505|NCT01142115|12267490|FG001|First Intervention|Adverse Event|0
7806506|NCT01142193|12267497|FG000|Overall Study|Adverse Event|12
7806507|NCT01142193|12267498|FG001|Overall Study|Adverse Event|4
7806508|NCT01142193|12267497|FG000|Overall Study|Lack of Efficacy|2
7806509|NCT01142193|12267498|FG001|Overall Study|Lack of Efficacy|1
7806510|NCT01142193|12267497|FG000|Overall Study|Physician Decision|1
7806511|NCT01142193|12267498|FG001|Overall Study|Physician Decision|1
7806512|NCT01142193|12267497|FG000|Overall Study|Withdrawal by Subject|4
7806513|NCT01142193|12267498|FG001|Overall Study|Withdrawal by Subject|3
7806514|NCT01142193|12267497|FG000|Overall Study|Protocol Discontinuation Criterion Met|1
7806515|NCT01142193|12267498|FG001|Overall Study|Protocol Discontinuation Criterion Met|0
7806516|NCT01142193|12267497|FG000|Overall Study|Other|1
7806517|NCT01142193|12267498|FG001|Overall Study|Other|2
7806518|NCT01142232|12267509|FG000|Overall Study|Adverse Event|1
7806519|NCT01142232|12267510|FG001|Overall Study|Adverse Event|2
7806520|NCT01142232|12267511|FG002|Overall Study|Adverse Event|1
7806521|NCT01142232|12267512|FG003|Overall Study|Adverse Event|0
7806522|NCT01142232|12267513|FG004|Overall Study|Adverse Event|4
7806523|NCT01142232|12267509|FG000|Overall Study|Death|0
7806524|NCT01142232|12267510|FG001|Overall Study|Death|0
7806525|NCT01142232|12267511|FG002|Overall Study|Death|0
7806526|NCT01142232|12267512|FG003|Overall Study|Death|0
7806527|NCT01142232|12267513|FG004|Overall Study|Death|1
7806528|NCT01142232|12267509|FG000|Overall Study|Disease Progression|2
7806529|NCT01142232|12267510|FG001|Overall Study|Disease Progression|0
7806530|NCT01142232|12267511|FG002|Overall Study|Disease Progression|1
7806531|NCT01142232|12267512|FG003|Overall Study|Disease Progression|2
7806532|NCT01142232|12267513|FG004|Overall Study|Disease Progression|12
7806533|NCT01142232|12267509|FG000|Overall Study|Withdrawal by Subject|0
7806534|NCT01142232|12267510|FG001|Overall Study|Withdrawal by Subject|0
7806535|NCT01142232|12267511|FG002|Overall Study|Withdrawal by Subject|0
7806536|NCT01142232|12267512|FG003|Overall Study|Withdrawal by Subject|1
7806537|NCT01142232|12267513|FG004|Overall Study|Withdrawal by Subject|3
7806538|NCT01142232|12267509|FG000|Overall Study|Physician Decision|0
7806539|NCT01142232|12267510|FG001|Overall Study|Physician Decision|1
7806540|NCT01142232|12267511|FG002|Overall Study|Physician Decision|0
7806541|NCT01142232|12267512|FG003|Overall Study|Physician Decision|2
7806542|NCT01142232|12267513|FG004|Overall Study|Physician Decision|10
7806543|NCT01142232|12267509|FG000|Overall Study|Alternative Therapy|0
7806544|NCT01142232|12267510|FG001|Overall Study|Alternative Therapy|1
7806545|NCT01142232|12267511|FG002|Overall Study|Alternative Therapy|1
7806546|NCT01142232|12267512|FG003|Overall Study|Alternative Therapy|0
7806547|NCT01142232|12267513|FG004|Overall Study|Alternative Therapy|1
7806548|NCT01142232|12267509|FG000|Overall Study|Off Trt for other complicating disease|0
7806549|NCT01142232|12267510|FG001|Overall Study|Off Trt for other complicating disease|0
7806550|NCT01142232|12267511|FG002|Overall Study|Off Trt for other complicating disease|0
7806551|NCT01142232|12267512|FG003|Overall Study|Off Trt for other complicating disease|0
7806552|NCT01142232|12267513|FG004|Overall Study|Off Trt for other complicating disease|1
7806553|NCT01142232|12267509|FG000|Overall Study|Noncompliance|0
7806554|NCT01142232|12267510|FG001|Overall Study|Noncompliance|0
7806555|NCT01142232|12267511|FG002|Overall Study|Noncompliance|0
7806556|NCT01142232|12267512|FG003|Overall Study|Noncompliance|0
7806557|NCT01142232|12267513|FG004|Overall Study|Noncompliance|2
7806558|NCT01142336|12267549|FG000|Overall Study|Adverse Event|1
7806559|NCT01142336|12267550|FG001|Overall Study|Adverse Event|1
7806560|NCT01142336|12267549|FG000|Overall Study|Lost to Follow-up|0
7806561|NCT01142336|12267550|FG001|Overall Study|Lost to Follow-up|1
7806562|NCT01142466|12267561|FG000|Overall Study|Adverse Event|2
7806563|NCT01142466|12267562|FG001|Overall Study|Adverse Event|1
7806564|NCT01142466|12267561|FG000|Overall Study|Withdrawal by Subject|1
7806565|NCT01142466|12267562|FG001|Overall Study|Withdrawal by Subject|1
7806566|NCT01142661|12267568|FG000|Overall Study|Adverse Event|2
7806567|NCT01142661|12267568|FG000|Overall Study|Withdrawal by Subject|1
7806568|NCT01142661|12267568|FG000|Overall Study|Physician Decision|1
7806569|NCT01142726|12267575|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
7806570|NCT01142726|12267576|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
7806571|NCT01142726|12267577|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
7806572|NCT01142726|12267575|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
7883580|NCT01782872|12383299|FG001|Overall Study|Protocol Violation|0
7806573|NCT01142726|12267576|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
7806574|NCT01142726|12267577|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
7806575|NCT01142726|12267575|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
7806576|NCT01142726|12267576|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
7806577|NCT01142726|12267577|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
7806578|NCT01142726|12267575|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
7806579|NCT01142726|12267576|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
7806580|NCT01142726|12267577|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
7806581|NCT01142726|12267575|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
7806582|NCT01142726|12267576|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
7806583|NCT01142726|12267577|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
7806584|NCT01142726|12267575|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
7806585|NCT01142726|12267576|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
7806586|NCT01142726|12267577|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
7806587|NCT01142726|12267575|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
7806588|NCT01142726|12267576|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
7806589|NCT01142726|12267577|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
7806590|NCT01142726|12267575|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
7806591|NCT01142726|12267576|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
7806592|NCT01142726|12267577|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
7806593|NCT01142726|12267575|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
7806594|NCT01142726|12267576|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
7806595|NCT01142726|12267577|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
7806596|NCT01142726|12267575|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
7806597|NCT01142726|12267576|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
7806598|NCT01142726|12267577|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
7806599|NCT01142726|12267575|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
7806600|NCT01142726|12267576|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
7806601|NCT01142726|12267577|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
7806602|NCT01142726|12267575|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0
7806603|NCT01142726|12267576|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1
7806604|NCT01142726|12267577|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1
7806605|NCT01142726|12267575|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
7806606|NCT01142726|12267576|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
7806607|NCT01142726|12267577|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
7806608|NCT01142726|12267575|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
7806609|NCT01142726|12267576|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
7806610|NCT01142726|12267577|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
7806611|NCT01142726|12267575|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
7886825|NCT01811225|12387988|FG000|Treatment Period 1|Lost to Follow-up|12
7886826|NCT01811225|12387989|FG001|Treatment Period 1|Lost to Follow-up|8
7886827|NCT01811225|12387988|FG000|Treatment Period 1|transporation|1
7886828|NCT01811225|12387989|FG001|Treatment Period 1|transporation|0
7886829|NCT01811225|12387988|FG000|Treatment Period 1|unable to remain smoke free overnight|10
7886830|NCT01811225|12387989|FG001|Treatment Period 1|unable to remain smoke free overnight|6
7886831|NCT01811225|12387988|FG000|Treatment Period 2|Lost to Follow-up|1
7886832|NCT01811225|12387989|FG001|Treatment Period 2|Lost to Follow-up|2
7886833|NCT01811225|12387988|FG000|Treatment Period 2|unable to remain smoke free overnight|3
7886834|NCT01811225|12387989|FG001|Treatment Period 2|unable to remain smoke free overnight|4
7886835|NCT01811238|12387995|FG000|Overall Study|Withdrawal by Subject|42
7886836|NCT01811238|12387995|FG000|Overall Study|Adverse Event|25
7886837|NCT01811238|12387995|FG000|Overall Study|Protocol Violation|4
7886838|NCT01811238|12387995|FG000|Overall Study|Lack of Efficacy|4
7886839|NCT01811238|12387995|FG000|Overall Study|subject refused study medication|6
7962817|NCT02715258|12517215|FG001|Overall Study|Terminated by Sponsor|1
7962818|NCT02715258|12517214|FG000|Overall Study|Death|0
7962819|NCT02715258|12517215|FG001|Overall Study|Death|1
7962820|NCT02715258|12517214|FG000|Overall Study|Subject non-compliant|1
7962821|NCT02715258|12517215|FG001|Overall Study|Subject non-compliant|1
7962822|NCT02715258|12517214|FG000|Overall Study|GCP violation|2
7962823|NCT02715258|12517215|FG001|Overall Study|GCP violation|1
7962824|NCT02715726|12517231|FG000|Overall Study|Adverse Event|2
7962825|NCT02715726|12517232|FG001|Overall Study|Adverse Event|6
7962826|NCT02715726|12517231|FG000|Overall Study|Protocol Violation|1
7962827|NCT02715726|12517232|FG001|Overall Study|Protocol Violation|0
7962828|NCT02715726|12517231|FG000|Overall Study|Death|2
7962829|NCT02715726|12517232|FG001|Overall Study|Death|1
7962830|NCT02715726|12517231|FG000|Overall Study|Participant moved|1
7962831|NCT02715726|12517232|FG001|Overall Study|Participant moved|3
7962832|NCT02715726|12517231|FG000|Overall Study|Other than specified above|11
7962833|NCT02715726|12517232|FG001|Overall Study|Other than specified above|15
7962834|NCT02715726|12517231|FG000|Overall Study|Randomized but not treated|1
7962835|NCT02715726|12517232|FG001|Overall Study|Randomized but not treated|2
7962836|NCT02715804|12517240|FG000|Overall Study|Death|222
7962837|NCT02715804|12517241|FG001|Overall Study|Death|106
7886840|NCT01811472|12388036|FG000|Overall Study|Adverse Event|1
7886841|NCT01811472|12388037|FG001|Overall Study|Adverse Event|0
7886842|NCT01811472|12388038|FG002|Overall Study|Adverse Event|4
7886843|NCT01811472|12388036|FG000|Overall Study|Lost to Follow-up|0
7806612|NCT01142726|12267576|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
7806613|NCT01142726|12267577|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
7806614|NCT01142726|12267575|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
7806615|NCT01142726|12267576|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
7806616|NCT01142726|12267577|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
7806617|NCT01142791|12267593|FG000|Overall Study|Alternative Treatment|1
7806618|NCT01142791|12267594|FG001|Overall Study|Alternative Treatment|0
7806619|NCT01142791|12267593|FG000|Overall Study|Lost to Follow-up|1
7806620|NCT01142791|12267594|FG001|Overall Study|Lost to Follow-up|0
7806621|NCT01142791|12267593|FG000|Overall Study|Withdrawal by Subject|5
7806622|NCT01142791|12267594|FG001|Overall Study|Withdrawal by Subject|0
7806623|NCT01142791|12267593|FG000|Overall Study|Received only 1 sonication|0
7806624|NCT01142791|12267594|FG001|Overall Study|Received only 1 sonication|6
7806625|NCT01142908|12267600|FG000|Overall Study|Lost to Follow-up|19
7806626|NCT01142908|12267601|FG001|Overall Study|Lost to Follow-up|13
7806627|NCT01142908|12267600|FG000|Overall Study|Death|1
7806628|NCT01142908|12267601|FG001|Overall Study|Death|4
7806629|NCT01142908|12267600|FG000|Overall Study|Excluded - did not meet criteria|9
7806630|NCT01142908|12267601|FG001|Overall Study|Excluded - did not meet criteria|5
7806631|NCT01142908|12267600|FG000|Overall Study|Withdrawal by Subject|3
7806632|NCT01142908|12267601|FG001|Overall Study|Withdrawal by Subject|0
7806633|NCT01143051|12267617|FG000|3-14 Day Washout|Withdrawal by Subject|0
7806634|NCT01143051|12267618|FG001|3-14 Day Washout|Withdrawal by Subject|0
7806635|NCT01143051|12267619|FG002|3-14 Day Washout|Withdrawal by Subject|1
7806636|NCT01143051|12267620|FG003|3-14 Day Washout|Withdrawal by Subject|0
7806637|NCT01143051|12267621|FG004|3-14 Day Washout|Withdrawal by Subject|0
7806638|NCT01143051|12267622|FG005|3-14 Day Washout|Withdrawal by Subject|0
7806639|NCT01143051|12267617|FG000|3-14 Day Washout|Withdrawal by Subject|0
7806640|NCT01143051|12267618|FG001|3-14 Day Washout|Withdrawal by Subject|0
7806641|NCT01143051|12267619|FG002|3-14 Day Washout|Withdrawal by Subject|0
7806642|NCT01143051|12267620|FG003|3-14 Day Washout|Withdrawal by Subject|0
7806643|NCT01143051|12267621|FG004|3-14 Day Washout|Withdrawal by Subject|0
7886844|NCT01811472|12388037|FG001|Overall Study|Lost to Follow-up|0
7886845|NCT01811472|12388038|FG002|Overall Study|Lost to Follow-up|1
7886846|NCT01811472|12388036|FG000|Overall Study|Subject/guardian decision|1
7886847|NCT01811472|12388037|FG001|Overall Study|Subject/guardian decision|0
7886848|NCT01811472|12388038|FG002|Overall Study|Subject/guardian decision|0
7886849|NCT01811485|12388050|FG000|Overall Study|Adverse Event|1
7886850|NCT01811485|12388051|FG001|Overall Study|Adverse Event|3
7886851|NCT01811485|12388052|FG002|Overall Study|Adverse Event|2
7886852|NCT01811485|12388050|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7886853|NCT01811485|12388051|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7886854|NCT01811485|12388052|FG002|Overall Study|Unsatisfactory therapeutic effect|3
7886855|NCT01811485|12388050|FG000|Overall Study|Administrative problems|1
7886856|NCT01811485|12388051|FG001|Overall Study|Administrative problems|0
7886857|NCT01811485|12388052|FG002|Overall Study|Administrative problems|0
7886858|NCT01811485|12388050|FG000|Overall Study|Protocol Deviation|0
7886859|NCT01811485|12388051|FG001|Overall Study|Protocol Deviation|1
7886860|NCT01811485|12388052|FG002|Overall Study|Protocol Deviation|0
7886861|NCT01811563|12388065|FG000|Overall Study|Lost to Follow-up|5
7886862|NCT01811563|12388066|FG001|Overall Study|Lost to Follow-up|2
7886863|NCT01811563|12388065|FG000|Overall Study|Incorrect Randomization procedure|0
7886864|NCT01811563|12388066|FG001|Overall Study|Incorrect Randomization procedure|1
7886865|NCT01811706|12388095|FG000|First Intervention ( 4 Weeks)|Adverse Event|1
7886866|NCT01811706|12388096|FG001|First Intervention ( 4 Weeks)|Adverse Event|0
7886867|NCT01811732|12388106|FG000|Overall Study|Lost to Follow-up|24
7886868|NCT01811732|12388107|FG001|Overall Study|Lost to Follow-up|30
7886869|NCT01811732|12388106|FG000|Overall Study|Withdrawal by Subject|16
7886870|NCT01811732|12388107|FG001|Overall Study|Withdrawal by Subject|10
7886871|NCT01811732|12388106|FG000|Overall Study|Adverse Event|3
7886872|NCT01811732|12388107|FG001|Overall Study|Adverse Event|9
7886873|NCT01811732|12388106|FG000|Overall Study|Lack of Efficacy|3
7886874|NCT01811732|12388107|FG001|Overall Study|Lack of Efficacy|1
7886875|NCT01811732|12388106|FG000|Overall Study|Non-compliance with study drug/procedure|3
7886876|NCT01811732|12388107|FG001|Overall Study|Non-compliance with study drug/procedure|3
7886877|NCT01811732|12388106|FG000|Overall Study|Physician Decision|2
7886878|NCT01811732|12388107|FG001|Overall Study|Physician Decision|0
7886879|NCT01811732|12388106|FG000|Overall Study|Death|1
7886880|NCT01811732|12388107|FG001|Overall Study|Death|1
7886881|NCT01811732|12388106|FG000|Overall Study|Insufficient venous access|0
7886882|NCT01811732|12388107|FG001|Overall Study|Insufficient venous access|1
7886883|NCT01811732|12388106|FG000|Overall Study|Protocol Violation|0
7886884|NCT01811732|12388107|FG001|Overall Study|Protocol Violation|1
7886885|NCT01811732|12388106|FG000|Overall Study|Subject incarcerated|1
7886886|NCT01811732|12388107|FG001|Overall Study|Subject incarcerated|2
7886887|NCT01811732|12388106|FG000|Overall Study|Admitted to another facility|1
7886888|NCT01811732|12388107|FG001|Overall Study|Admitted to another facility|0
7886889|NCT01811732|12388106|FG000|Overall Study|Correct study drug not available on site|1
7886890|NCT01811732|12388107|FG001|Overall Study|Correct study drug not available on site|0
7886891|NCT01811953|12388133|FG000|Overall Study|Adverse Event|0
7967742|NCT02773368|12524939|FG001|Overall Study|Missing|1
7967743|NCT02773446|12524951|FG000|First Admission|Withdrawal by Subject|0
7967744|NCT02773446|12524952|FG001|First Admission|Withdrawal by Subject|0
7967745|NCT02773446|12524953|FG002|First Admission|Withdrawal by Subject|0
7806644|NCT01143051|12267622|FG005|3-14 Day Washout|Withdrawal by Subject|1
7886892|NCT01811953|12388134|FG001|Overall Study|Adverse Event|0
7886893|NCT01811953|12388135|FG002|Overall Study|Adverse Event|0
7967746|NCT02773446|12524954|FG003|First Admission|Withdrawal by Subject|1
7967747|NCT02773446|12524955|FG004|First Admission|Withdrawal by Subject|0
7967748|NCT02773446|12524956|FG005|First Admission|Withdrawal by Subject|0
7967749|NCT02773446|12524951|FG000|First Admission|Lost to Follow-up|1
7967750|NCT02773446|12524952|FG001|First Admission|Lost to Follow-up|0
7967751|NCT02773446|12524953|FG002|First Admission|Lost to Follow-up|0
7967752|NCT02773446|12524954|FG003|First Admission|Lost to Follow-up|0
7967753|NCT02773446|12524955|FG004|First Admission|Lost to Follow-up|0
7967754|NCT02773446|12524956|FG005|First Admission|Lost to Follow-up|0
7967755|NCT02773537|12524976|FG000|Overall Study|Lost to Follow-up|0
7967756|NCT02773537|12524977|FG001|Overall Study|Lost to Follow-up|1
7967757|NCT02773537|12524978|FG002|Overall Study|Lost to Follow-up|4
7967758|NCT02774278|12525039|FG000|Overall Study|Lack of Efficacy|199
7967759|NCT02774278|12525039|FG000|Overall Study|Death|29
7806645|NCT01143077|12267635|FG000|Overall Study|Lack of Efficacy|0
7806646|NCT01143077|12267636|FG001|Overall Study|Lack of Efficacy|2
7806647|NCT01143077|12267637|FG002|Overall Study|Lack of Efficacy|1
7806648|NCT01143077|12267635|FG000|Overall Study|Adverse Event|5
7806649|NCT01143077|12267636|FG001|Overall Study|Adverse Event|6
7806650|NCT01143077|12267637|FG002|Overall Study|Adverse Event|5
7806651|NCT01143077|12267635|FG000|Overall Study|Lost to Follow-up|2
7806652|NCT01143077|12267636|FG001|Overall Study|Lost to Follow-up|3
7806653|NCT01143077|12267637|FG002|Overall Study|Lost to Follow-up|4
7806654|NCT01143077|12267635|FG000|Overall Study|Protocol Violation|2
7806655|NCT01143077|12267636|FG001|Overall Study|Protocol Violation|0
7806656|NCT01143077|12267637|FG002|Overall Study|Protocol Violation|0
7806657|NCT01143077|12267635|FG000|Overall Study|Withdrawal by Subject|4
7806658|NCT01143077|12267636|FG001|Overall Study|Withdrawal by Subject|3
7806659|NCT01143077|12267637|FG002|Overall Study|Withdrawal by Subject|3
7806660|NCT01143077|12267635|FG000|Overall Study|Non-compliance with study drug|0
7806661|NCT01143077|12267636|FG001|Overall Study|Non-compliance with study drug|1
7806662|NCT01143077|12267637|FG002|Overall Study|Non-compliance with study drug|1
7806663|NCT01143077|12267635|FG000|Overall Study|Administrative|1
7806664|NCT01143077|12267636|FG001|Overall Study|Administrative|0
7806665|NCT01143077|12267637|FG002|Overall Study|Administrative|0
7806666|NCT01143077|12267635|FG000|Overall Study|Principal Investigator Decision|2
7806667|NCT01143077|12267636|FG001|Overall Study|Principal Investigator Decision|0
7806668|NCT01143077|12267637|FG002|Overall Study|Principal Investigator Decision|1
7806669|NCT01143090|12267645|FG000|Overall Study|Lack of Efficacy|2
7806670|NCT01143090|12267645|FG000|Overall Study|Adverse Event|17
7806671|NCT01143090|12267645|FG000|Overall Study|Lost to Follow-up|9
7806672|NCT01143090|12267645|FG000|Overall Study|Protocol Violation|2
7806673|NCT01143090|12267645|FG000|Overall Study|Withdrawal by Subject|18
7806674|NCT01143090|12267645|FG000|Overall Study|Non-compliance with study drug|1
7806675|NCT01143090|12267645|FG000|Overall Study|Failure to meet eligibility criteria|1
7806676|NCT01143090|12267645|FG000|Overall Study|Administrative|1
7806677|NCT01143207|12267675|FG000|Overall Study|Lost to Follow-up|2
7806678|NCT01143259|12267681|FG000|Overall Study|Withdrawal by Subject|3
7806679|NCT01143259|12267682|FG001|Overall Study|Withdrawal by Subject|2
7886894|NCT01811953|12388136|FG003|Overall Study|Adverse Event|1
7886895|NCT01811953|12388137|FG004|Overall Study|Adverse Event|0
7886896|NCT01811953|12388138|FG005|Overall Study|Adverse Event|1
7886897|NCT01811953|12388133|FG000|Overall Study|Protocol Violation|0
7886898|NCT01811953|12388134|FG001|Overall Study|Protocol Violation|0
7886899|NCT01811953|12388135|FG002|Overall Study|Protocol Violation|0
7886900|NCT01811953|12388136|FG003|Overall Study|Protocol Violation|0
7886901|NCT01811953|12388137|FG004|Overall Study|Protocol Violation|1
7886902|NCT01811953|12388138|FG005|Overall Study|Protocol Violation|0
7886903|NCT01812057|12388176|FG000|Overall Study|Protocol Violation|1
7886904|NCT01812057|12388177|FG001|Overall Study|Protocol Violation|0
7886905|NCT01812057|12388176|FG000|Overall Study|Physician Decision|1
7886906|NCT01812057|12388177|FG001|Overall Study|Physician Decision|0
7886907|NCT01812109|12388187|FG000|Overall Study|research personnel delay|16
7886908|NCT01812109|12388187|FG000|Overall Study|NIRS Unattainable|17
7886909|NCT01812655|12388203|FG000|Overall Study|Protocol Violation|1
7886910|NCT01812655|12388204|FG001|Overall Study|Protocol Violation|1
7886911|NCT01812655|12388205|FG002|Overall Study|Protocol Violation|0
7886912|NCT01812707|12388233|FG000|Overall Study|Adverse Event|0
7886913|NCT01812707|12388234|FG001|Overall Study|Adverse Event|0
7886914|NCT01812707|12388235|FG002|Overall Study|Adverse Event|0
7886915|NCT01812707|12388236|FG003|Overall Study|Adverse Event|2
7886916|NCT01812707|12388233|FG000|Overall Study|Poor compliance to protocol|1
7886917|NCT01812707|12388234|FG001|Overall Study|Poor compliance to protocol|0
7886918|NCT01812707|12388235|FG002|Overall Study|Poor compliance to protocol|0
7967760|NCT02774278|12525039|FG000|Overall Study|Adverse event/intercurrent illness|16
7967761|NCT02774278|12525039|FG000|Overall Study|Refused treatment/did not cooperate|9
7886919|NCT01812707|12388236|FG003|Overall Study|Poor compliance to protocol|0
7886920|NCT01812707|12388233|FG000|Overall Study|Consent withdrawn by participant|1
7886921|NCT01812707|12388234|FG001|Overall Study|Consent withdrawn by participant|0
7886922|NCT01812707|12388235|FG002|Overall Study|Consent withdrawn by participant|0
7886923|NCT01812707|12388236|FG003|Overall Study|Consent withdrawn by participant|0
7886924|NCT01812759|12388250|FG000|Overall Study|Physician Decision|0
7886925|NCT01812759|12388251|FG001|Overall Study|Physician Decision|0
7967762|NCT02774278|12525039|FG000|Overall Study|Administrative reasons|6
7806680|NCT01143259|12267681|FG000|Overall Study|Protocol Violation|13
7806681|NCT01143259|12267682|FG001|Overall Study|Protocol Violation|9
7806682|NCT01143259|12267681|FG000|Overall Study|Screen Failure|7
7806683|NCT01143259|12267682|FG001|Overall Study|Screen Failure|9
7806684|NCT01143324|12267697|FG000|Overall Study|Lost to Follow-up|11
7806685|NCT01143324|12267697|FG000|Overall Study|Withdrawal by Subject|4
7806686|NCT01143324|12267697|FG000|Overall Study|Explant of the device|4
7806687|NCT01143337|12267703|FG000|Overall Study|Adverse Event|3
7806688|NCT01143337|12267704|FG001|Overall Study|Adverse Event|9
7806689|NCT01143337|12267705|FG002|Overall Study|Adverse Event|5
7806690|NCT01143337|12267703|FG000|Overall Study|Lack of Efficacy|6
7806691|NCT01143337|12267704|FG001|Overall Study|Lack of Efficacy|2
7806692|NCT01143337|12267705|FG002|Overall Study|Lack of Efficacy|1
7806693|NCT01143337|12267703|FG000|Overall Study|Protocol Violation|1
7806694|NCT01143337|12267704|FG001|Overall Study|Protocol Violation|0
7806695|NCT01143337|12267705|FG002|Overall Study|Protocol Violation|0
7806696|NCT01143337|12267703|FG000|Overall Study|Withdrawal by Subject|0
7806697|NCT01143337|12267704|FG001|Overall Study|Withdrawal by Subject|0
7806698|NCT01143337|12267705|FG002|Overall Study|Withdrawal by Subject|1
7806699|NCT01143337|12267703|FG000|Overall Study|Other reason|0
7806700|NCT01143337|12267704|FG001|Overall Study|Other reason|0
7806701|NCT01143337|12267705|FG002|Overall Study|Other reason|5
7806702|NCT01143389|12267713|FG000|Overall Study|Lost to Follow-up|26
7806703|NCT01143389|12267714|FG001|Overall Study|Lost to Follow-up|25
7806704|NCT01143402|12267723|FG000|Overall Study|Rapid clinical decline|1
7806705|NCT01143402|12267724|FG001|Overall Study|Rapid clinical decline|1
7806706|NCT01143402|12267725|FG002|Overall Study|Rapid clinical decline|0
7806707|NCT01143402|12267723|FG000|Overall Study|Not Treated|0
7806708|NCT01143402|12267724|FG001|Overall Study|Not Treated|0
7806709|NCT01143402|12267725|FG002|Overall Study|Not Treated|1
7806710|NCT01143714|12267802|FG000|Overall Study|Adverse Event|4
7806711|NCT01143714|12267803|FG001|Overall Study|Adverse Event|2
7806712|NCT01143714|12267802|FG000|Overall Study|Withdrawal by Subject|1
7806713|NCT01143714|12267803|FG001|Overall Study|Withdrawal by Subject|0
7806714|NCT01143714|12267802|FG000|Overall Study|Subject non-compliance|0
7806715|NCT01143714|12267803|FG001|Overall Study|Subject non-compliance|1
7806716|NCT01143714|12267802|FG000|Overall Study|wound closed = deemed healed|1
7806717|NCT01143714|12267803|FG001|Overall Study|wound closed = deemed healed|0
7806718|NCT01143714|12267802|FG000|Overall Study|wound size increased|1
7806719|NCT01143714|12267803|FG001|Overall Study|wound size increased|0
7806720|NCT01143896|12267881|FG000|Overall Study|Did not complete Baseline Interview|5
7806721|NCT01143896|12267882|FG001|Overall Study|Did not complete Baseline Interview|4
7806722|NCT01143896|12267881|FG000|Overall Study|Lost to Follow-up|18
7806723|NCT01143896|12267882|FG001|Overall Study|Lost to Follow-up|13
7806724|NCT01143896|12267881|FG000|Overall Study|Withdrawal by Subject|13
7806725|NCT01143896|12267882|FG001|Overall Study|Withdrawal by Subject|5
7806726|NCT01143896|12267881|FG000|Overall Study|Death|6
7806727|NCT01143896|12267882|FG001|Overall Study|Death|3
7806728|NCT01144052|12267900|FG000|Overall Study|Withdrawal by Subject|1
7806729|NCT01144052|12267901|FG001|Overall Study|Withdrawal by Subject|1
7806730|NCT01144182|12267928|FG000|Overall Study|Death|5
7806731|NCT01144182|12267929|FG001|Overall Study|Death|6
7806732|NCT01144182|12267928|FG000|Overall Study|Withdrawal by Subject|3
7806733|NCT01144182|12267929|FG001|Overall Study|Withdrawal by Subject|6
7806734|NCT01144182|12267928|FG000|Overall Study|Lost to Follow-up|9
7806735|NCT01144182|12267929|FG001|Overall Study|Lost to Follow-up|9
7806736|NCT01144299|12267955|FG000|Overall Study|Lost to Follow-up|1
7806737|NCT01144299|12267956|FG001|Overall Study|Lost to Follow-up|0
7806738|NCT01144299|12267955|FG000|Overall Study|Withdrawal by Subject|1
7806739|NCT01144299|12267956|FG001|Overall Study|Withdrawal by Subject|0
7806740|NCT01144364|12267973|FG000|Induction Phase|Disease progression|14
7806741|NCT01144364|12267974|FG001|Induction Phase|Disease progression|0
7806742|NCT01144364|12267975|FG002|Induction Phase|Disease progression|0
7806743|NCT01144364|12267973|FG000|Induction Phase|Adverse Event|9
7806744|NCT01144364|12267974|FG001|Induction Phase|Adverse Event|0
7806745|NCT01144364|12267975|FG002|Induction Phase|Adverse Event|0
7806746|NCT01144364|12267973|FG000|Induction Phase|Death|1
7806747|NCT01144364|12267974|FG001|Induction Phase|Death|0
7806748|NCT01144364|12267975|FG002|Induction Phase|Death|0
7806749|NCT01144364|12267973|FG000|Induction Phase|Withdrawal by Subject|1
7806750|NCT01144364|12267974|FG001|Induction Phase|Withdrawal by Subject|0
7806751|NCT01144364|12267975|FG002|Induction Phase|Withdrawal by Subject|0
7806752|NCT01144364|12267973|FG000|Induction Phase|Lost to Follow-up|2
7806753|NCT01144364|12267974|FG001|Induction Phase|Lost to Follow-up|0
7806754|NCT01144364|12267975|FG002|Induction Phase|Lost to Follow-up|0
7806755|NCT01144364|12267973|FG000|Induction Phase|Physician Decision|1
7806756|NCT01144364|12267974|FG001|Induction Phase|Physician Decision|0
7806757|NCT01144364|12267975|FG002|Induction Phase|Physician Decision|0
7806758|NCT01144364|12267973|FG000|Induction Phase|Stable disease|2
7806759|NCT01144364|12267974|FG001|Induction Phase|Stable disease|0
7806760|NCT01144364|12267975|FG002|Induction Phase|Stable disease|0
7806761|NCT01144364|12267973|FG000|Induction Phase|Secondary neoplasia|1
7806762|NCT01144364|12267974|FG001|Induction Phase|Secondary neoplasia|0
7806763|NCT01144364|12267975|FG002|Induction Phase|Secondary neoplasia|0
7806764|NCT01144364|12267973|FG000|Induction Phase|Protocol Violation|1
7806765|NCT01144364|12267974|FG001|Induction Phase|Protocol Violation|0
7806766|NCT01144364|12267975|FG002|Induction Phase|Protocol Violation|0
7806767|NCT01144364|12267973|FG000|Follow-Up/Maintenance Phase|Disease progression|0
7806768|NCT01144364|12267974|FG001|Follow-Up/Maintenance Phase|Disease progression|23
7806769|NCT01144364|12267975|FG002|Follow-Up/Maintenance Phase|Disease progression|29
7806770|NCT01144364|12267973|FG000|Follow-Up/Maintenance Phase|Adverse Event|0
7806771|NCT01144364|12267974|FG001|Follow-Up/Maintenance Phase|Adverse Event|3
7886926|NCT01812759|12388252|FG002|Overall Study|Physician Decision|1
7886927|NCT01812837|12388263|FG000|Overall Study|Lost to Follow-up|1
7886928|NCT01812837|12388264|FG001|Overall Study|Lost to Follow-up|1
7886929|NCT01812837|12388265|FG002|Overall Study|Lost to Follow-up|0
7886930|NCT01812837|12388263|FG000|Overall Study|Protocol Violation|1
7886931|NCT01812837|12388264|FG001|Overall Study|Protocol Violation|0
7886932|NCT01812837|12388265|FG002|Overall Study|Protocol Violation|0
7886933|NCT01813019|12388275|FG000|Overall Study|Adverse Event|0
7886934|NCT01813019|12388276|FG001|Overall Study|Adverse Event|3
7886935|NCT01813019|12388275|FG000|Overall Study|Withdrawal by Subject|3
7886936|NCT01813019|12388276|FG001|Overall Study|Withdrawal by Subject|2
7886937|NCT01813019|12388275|FG000|Overall Study|administrative problems|2
7886938|NCT01813019|12388276|FG001|Overall Study|administrative problems|0
7886939|NCT01813019|12388275|FG000|Overall Study|Protocol Deviation|2
7886940|NCT01813019|12388276|FG001|Overall Study|Protocol Deviation|1
7886941|NCT01813058|12388284|FG000|Overall Study|Withdrawal by Subject|5
7886942|NCT01813058|12388285|FG001|Overall Study|Withdrawal by Subject|4
7886943|NCT01813071|12388300|FG000|Overall Study|Protocol Violation|0
7886944|NCT01813071|12388301|FG001|Overall Study|Protocol Violation|0
7886945|NCT01813071|12388302|FG002|Overall Study|Protocol Violation|0
7886946|NCT01813071|12388303|FG003|Overall Study|Protocol Violation|0
7886947|NCT01813071|12388304|FG004|Overall Study|Protocol Violation|1
7886948|NCT01813071|12388305|FG005|Overall Study|Protocol Violation|4
7886949|NCT01813071|12388306|FG006|Overall Study|Protocol Violation|2
7886950|NCT01813071|12388307|FG007|Overall Study|Protocol Violation|4
7886951|NCT01813071|12388308|FG008|Overall Study|Protocol Violation|2
7886952|NCT01813071|12388300|FG000|Overall Study|Withdrawal by Subject|0
7886953|NCT01813071|12388301|FG001|Overall Study|Withdrawal by Subject|0
7886954|NCT01813071|12388302|FG002|Overall Study|Withdrawal by Subject|0
7886955|NCT01813071|12388303|FG003|Overall Study|Withdrawal by Subject|0
7886956|NCT01813071|12388304|FG004|Overall Study|Withdrawal by Subject|0
7886957|NCT01813071|12388305|FG005|Overall Study|Withdrawal by Subject|1
7886958|NCT01813071|12388306|FG006|Overall Study|Withdrawal by Subject|0
7886959|NCT01813071|12388307|FG007|Overall Study|Withdrawal by Subject|0
7886960|NCT01813071|12388308|FG008|Overall Study|Withdrawal by Subject|0
7886961|NCT01813071|12388300|FG000|Overall Study|Adverse Event|0
7886962|NCT01813071|12388301|FG001|Overall Study|Adverse Event|0
7886963|NCT01813071|12388302|FG002|Overall Study|Adverse Event|0
7886964|NCT01813071|12388303|FG003|Overall Study|Adverse Event|0
7886965|NCT01813071|12388304|FG004|Overall Study|Adverse Event|0
7886966|NCT01813071|12388305|FG005|Overall Study|Adverse Event|1
7886967|NCT01813071|12388306|FG006|Overall Study|Adverse Event|0
7886968|NCT01813071|12388307|FG007|Overall Study|Adverse Event|0
7886969|NCT01813071|12388308|FG008|Overall Study|Adverse Event|0
7886970|NCT01813071|12388300|FG000|Overall Study|Physician Decision|0
7886971|NCT01813071|12388301|FG001|Overall Study|Physician Decision|0
7886972|NCT01813071|12388302|FG002|Overall Study|Physician Decision|0
7886973|NCT01813071|12388303|FG003|Overall Study|Physician Decision|0
7886974|NCT01813071|12388304|FG004|Overall Study|Physician Decision|0
7886975|NCT01813071|12388305|FG005|Overall Study|Physician Decision|0
7886976|NCT01813071|12388306|FG006|Overall Study|Physician Decision|1
7886977|NCT01813071|12388307|FG007|Overall Study|Physician Decision|0
7886978|NCT01813071|12388308|FG008|Overall Study|Physician Decision|0
7886979|NCT01813071|12388300|FG000|Overall Study|Met inc/exc criteria|0
7886980|NCT01813071|12388301|FG001|Overall Study|Met inc/exc criteria|0
7886981|NCT01813071|12388302|FG002|Overall Study|Met inc/exc criteria|0
7886982|NCT01813071|12388303|FG003|Overall Study|Met inc/exc criteria|0
7886983|NCT01813071|12388304|FG004|Overall Study|Met inc/exc criteria|0
7886984|NCT01813071|12388305|FG005|Overall Study|Met inc/exc criteria|1
7886985|NCT01813071|12388306|FG006|Overall Study|Met inc/exc criteria|0
7806772|NCT01144364|12267975|FG002|Follow-Up/Maintenance Phase|Adverse Event|1
7886986|NCT01813071|12388307|FG007|Overall Study|Met inc/exc criteria|1
7886987|NCT01813071|12388308|FG008|Overall Study|Met inc/exc criteria|1
7886988|NCT01813357|12388375|FG000|Overall Study|Lost to Follow-up|5
7886989|NCT01813357|12388376|FG001|Overall Study|Lost to Follow-up|6
7886990|NCT01813422|12388384|FG000|Overall Study|Withdrawal by Subject|14
7886991|NCT01813422|12388385|FG001|Overall Study|Withdrawal by Subject|8
7886992|NCT01813422|12388384|FG000|Overall Study|Death|2
7886993|NCT01813422|12388385|FG001|Overall Study|Death|3
7886994|NCT01813422|12388384|FG000|Overall Study|Sponsor Decision|2
7886995|NCT01813422|12388385|FG001|Overall Study|Sponsor Decision|1
7886996|NCT01813422|12388384|FG000|Overall Study|Lost to Follow-up|2
7886997|NCT01813422|12388385|FG001|Overall Study|Lost to Follow-up|4
7886998|NCT01813474|12388394|FG000|Overall Study|Withdrawal by Subject|0
7886999|NCT01813474|12388395|FG001|Overall Study|Withdrawal by Subject|0
7887000|NCT01813474|12388396|FG002|Overall Study|Withdrawal by Subject|1
7806773|NCT01144364|12267973|FG000|Follow-Up/Maintenance Phase|Death|0
7806774|NCT01144364|12267974|FG001|Follow-Up/Maintenance Phase|Death|2
7806775|NCT01144364|12267975|FG002|Follow-Up/Maintenance Phase|Death|0
7806776|NCT01144364|12267973|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
7806777|NCT01144364|12267974|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
7806778|NCT01144364|12267975|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
7806779|NCT01144364|12267973|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0
7806780|NCT01144364|12267974|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1
7806781|NCT01144364|12267975|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4
7806782|NCT01144364|12267973|FG000|Follow-Up/Maintenance Phase|Relapse|0
7806783|NCT01144364|12267974|FG001|Follow-Up/Maintenance Phase|Relapse|5
7806784|NCT01144364|12267975|FG002|Follow-Up/Maintenance Phase|Relapse|5
7806785|NCT01144364|12267973|FG000|Follow-Up/Maintenance Phase|Physician Decision|0
7806786|NCT01144364|12267974|FG001|Follow-Up/Maintenance Phase|Physician Decision|0
7806787|NCT01144364|12267975|FG002|Follow-Up/Maintenance Phase|Physician Decision|1
7806788|NCT01144377|12267990|FG000|52 Week Treatment Period|Adverse Event|0
7806789|NCT01144377|12267991|FG001|52 Week Treatment Period|Adverse Event|0
7806790|NCT01144377|12267992|FG002|52 Week Treatment Period|Adverse Event|3
7806791|NCT01144377|12267993|FG003|52 Week Treatment Period|Adverse Event|2
7806792|NCT01144377|12267994|FG004|52 Week Treatment Period|Adverse Event|1
7806793|NCT01144377|12267990|FG000|52 Week Treatment Period|Entry Criteria Not Met|0
7806794|NCT01144377|12267991|FG001|52 Week Treatment Period|Entry Criteria Not Met|0
7806795|NCT01144377|12267992|FG002|52 Week Treatment Period|Entry Criteria Not Met|1
7806796|NCT01144377|12267993|FG003|52 Week Treatment Period|Entry Criteria Not Met|1
7806797|NCT01144377|12267994|FG004|52 Week Treatment Period|Entry Criteria Not Met|0
7806798|NCT01144377|12267990|FG000|52 Week Treatment Period|Protocol Violation|0
7806799|NCT01144377|12267991|FG001|52 Week Treatment Period|Protocol Violation|0
7806800|NCT01144377|12267992|FG002|52 Week Treatment Period|Protocol Violation|0
7806801|NCT01144377|12267993|FG003|52 Week Treatment Period|Protocol Violation|0
7806802|NCT01144377|12267994|FG004|52 Week Treatment Period|Protocol Violation|1
7806803|NCT01144377|12267990|FG000|52 Week Treatment Period|Lost to Follow-up|1
7806804|NCT01144377|12267991|FG001|52 Week Treatment Period|Lost to Follow-up|0
7806805|NCT01144377|12267992|FG002|52 Week Treatment Period|Lost to Follow-up|0
7806806|NCT01144377|12267993|FG003|52 Week Treatment Period|Lost to Follow-up|0
7806807|NCT01144377|12267994|FG004|52 Week Treatment Period|Lost to Follow-up|0
7806808|NCT01144377|12267990|FG000|52 Week Treatment Period|Withdrawal by Subject|4
7806809|NCT01144377|12267991|FG001|52 Week Treatment Period|Withdrawal by Subject|1
7806810|NCT01144377|12267992|FG002|52 Week Treatment Period|Withdrawal by Subject|1
7806811|NCT01144377|12267993|FG003|52 Week Treatment Period|Withdrawal by Subject|1
7806812|NCT01144377|12267994|FG004|52 Week Treatment Period|Withdrawal by Subject|0
7806813|NCT01144377|12267990|FG000|52 Week Treatment Period|Sponsor Decision|0
7806814|NCT01144377|12267991|FG001|52 Week Treatment Period|Sponsor Decision|0
7806815|NCT01144377|12267992|FG002|52 Week Treatment Period|Sponsor Decision|0
7806816|NCT01144377|12267993|FG003|52 Week Treatment Period|Sponsor Decision|0
7806817|NCT01144377|12267994|FG004|52 Week Treatment Period|Sponsor Decision|1
7806818|NCT01144377|12267990|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0
7806819|NCT01144377|12267991|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1
7806820|NCT01144377|12267992|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0
7806821|NCT01144377|12267993|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0
7806822|NCT01144377|12267994|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1
7806823|NCT01144377|12267990|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
7806824|NCT01144377|12267991|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
7806825|NCT01144377|12267992|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
7806826|NCT01144377|12267993|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
7806827|NCT01144377|12267994|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
7806828|NCT01144377|12267990|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
7806829|NCT01144377|12267991|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
7806830|NCT01144377|12267992|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
7806831|NCT01144377|12267993|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
7806832|NCT01144377|12267994|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
7806833|NCT01144403|12268008|FG000|Overall Study|Lost to Follow-up|3
7806834|NCT01144403|12268008|FG000|Overall Study|Death|1
7806835|NCT01144403|12268008|FG000|Overall Study|Adverse Event|1
7806836|NCT01144663|12268080|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2
7806837|NCT01144663|12268081|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0
7806838|NCT01144663|12268082|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1
7806839|NCT01144663|12268083|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0
7806840|NCT01144663|12268080|FG000|Primary Vaccination Phase|Adverse Event|1
7806841|NCT01144663|12268081|FG001|Primary Vaccination Phase|Adverse Event|0
7806842|NCT01144663|12268082|FG002|Primary Vaccination Phase|Adverse Event|0
7806843|NCT01144663|12268083|FG003|Primary Vaccination Phase|Adverse Event|1
7806844|NCT01144663|12268080|FG000|Primary Vaccination Phase|Protocol Violation|2
7806845|NCT01144663|12268081|FG001|Primary Vaccination Phase|Protocol Violation|0
7806846|NCT01144663|12268082|FG002|Primary Vaccination Phase|Protocol Violation|1
7806847|NCT01144663|12268083|FG003|Primary Vaccination Phase|Protocol Violation|0
7806848|NCT01144663|12268080|FG000|Primary Vaccination Phase|Withdrawal by Subject|9
7806849|NCT01144663|12268081|FG001|Primary Vaccination Phase|Withdrawal by Subject|5
7806850|NCT01144663|12268082|FG002|Primary Vaccination Phase|Withdrawal by Subject|3
7806851|NCT01144663|12268083|FG003|Primary Vaccination Phase|Withdrawal by Subject|10
7806852|NCT01144663|12268080|FG000|Primary Vaccination Phase|Migrated/moved from study area|4
7806853|NCT01144663|12268081|FG001|Primary Vaccination Phase|Migrated/moved from study area|1
7806854|NCT01144663|12268082|FG002|Primary Vaccination Phase|Migrated/moved from study area|2
7806855|NCT01144663|12268083|FG003|Primary Vaccination Phase|Migrated/moved from study area|3
7806856|NCT01144663|12268080|FG000|Primary Vaccination Phase|Lost to Follow-up|2
7806857|NCT01144663|12268081|FG001|Primary Vaccination Phase|Lost to Follow-up|0
7806858|NCT01144663|12268082|FG002|Primary Vaccination Phase|Lost to Follow-up|1
7806859|NCT01144663|12268083|FG003|Primary Vaccination Phase|Lost to Follow-up|2
7806860|NCT01144663|12268080|FG000|Primary Vaccination Phase|Other|0
7806861|NCT01144663|12268081|FG001|Primary Vaccination Phase|Other|1
7806862|NCT01144663|12268082|FG002|Primary Vaccination Phase|Other|0
7806863|NCT01144663|12268083|FG003|Primary Vaccination Phase|Other|2
7806864|NCT01144663|12268080|FG000|Booster Vaccination Phase|Withdrawal by Subject|0
7806865|NCT01144663|12268081|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
7806866|NCT01144663|12268082|FG002|Booster Vaccination Phase|Withdrawal by Subject|1
7806867|NCT01144663|12268083|FG003|Booster Vaccination Phase|Withdrawal by Subject|1
7806868|NCT01144663|12268080|FG000|Booster Vaccination Phase|Migrated/moved from study area|1
7806869|NCT01144663|12268081|FG001|Booster Vaccination Phase|Migrated/moved from study area|1
7806870|NCT01144663|12268082|FG002|Booster Vaccination Phase|Migrated/moved from study area|1
7806871|NCT01144663|12268083|FG003|Booster Vaccination Phase|Migrated/moved from study area|0
7806872|NCT01144663|12268080|FG000|Booster Vaccination Phase|Lost to Follow-up|2
7806873|NCT01144663|12268081|FG001|Booster Vaccination Phase|Lost to Follow-up|1
7806874|NCT01144663|12268082|FG002|Booster Vaccination Phase|Lost to Follow-up|3
7806875|NCT01144663|12268083|FG003|Booster Vaccination Phase|Lost to Follow-up|0
7806876|NCT01144663|12268080|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
7806877|NCT01144663|12268081|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
7806878|NCT01144663|12268082|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
7806879|NCT01144663|12268083|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
7806880|NCT01144663|12268080|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
7806881|NCT01144663|12268081|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3
7806882|NCT01144663|12268082|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
7806883|NCT01144663|12268083|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0
7806884|NCT01144663|12268080|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4
7806885|NCT01144663|12268081|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6
7806886|NCT01144663|12268082|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5
7806887|NCT01144663|12268083|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0
7806888|NCT01144715|12268095|FG000|Overall Study|Lost to Follow-up|2
7806889|NCT01144715|12268096|FG001|Overall Study|Lost to Follow-up|1
7806890|NCT01144715|12268095|FG000|Overall Study|Withdrawal by Subject|2
7806891|NCT01144715|12268096|FG001|Overall Study|Withdrawal by Subject|1
7806892|NCT01144715|12268095|FG000|Overall Study|Adverse Event|0
7806893|NCT01144715|12268096|FG001|Overall Study|Adverse Event|1
7806894|NCT01145053|12268128|FG000|Overall Study|Adverse Event|22
7806895|NCT01145053|12268128|FG000|Overall Study|Lost to Follow-up|28
7806896|NCT01145053|12268128|FG000|Overall Study|Withdrawal by Subject|25
7806897|NCT01145053|12268128|FG000|Overall Study|Other|18
7806898|NCT01145066|12268135|FG000|Overall Study|To resume NSAIDs|2
7806899|NCT01145066|12268136|FG001|Overall Study|To resume NSAIDs|2
7806900|NCT01145066|12268137|FG002|Overall Study|To resume NSAIDs|1
7806901|NCT01145066|12268135|FG000|Overall Study|Non-related surgery|0
7806902|NCT01145066|12268136|FG001|Overall Study|Non-related surgery|0
7806903|NCT01145066|12268137|FG002|Overall Study|Non-related surgery|1
7806904|NCT01145066|12268135|FG000|Overall Study|Withdrawal by Subject|0
7806905|NCT01145066|12268136|FG001|Overall Study|Withdrawal by Subject|0
7806906|NCT01145066|12268137|FG002|Overall Study|Withdrawal by Subject|2
7806907|NCT01145066|12268135|FG000|Overall Study|To start new med|1
7806908|NCT01145066|12268136|FG001|Overall Study|To start new med|0
7806909|NCT01145066|12268137|FG002|Overall Study|To start new med|0
7806910|NCT01145066|12268135|FG000|Overall Study|problems swallowing capsule|1
7806911|NCT01145066|12268136|FG001|Overall Study|problems swallowing capsule|0
7806912|NCT01145066|12268137|FG002|Overall Study|problems swallowing capsule|0
7806913|NCT01145066|12268135|FG000|Overall Study|Abdominal discomfort|0
7806914|NCT01145066|12268136|FG001|Overall Study|Abdominal discomfort|1
7806915|NCT01145066|12268137|FG002|Overall Study|Abdominal discomfort|0
7806916|NCT01145066|12268135|FG000|Overall Study|Low platelet count|0
7806917|NCT01145066|12268136|FG001|Overall Study|Low platelet count|1
7806918|NCT01145066|12268137|FG002|Overall Study|Low platelet count|0
7806919|NCT01145222|12268166|FG000|Overall Study|Procedure not done (no anesthesiologist)|0
7806920|NCT01145222|12268167|FG001|Overall Study|Procedure not done (no anesthesiologist)|0
7806921|NCT01145222|12268168|FG002|Overall Study|Procedure not done (no anesthesiologist)|1
7806922|NCT01145222|12268169|FG003|Overall Study|Procedure not done (no anesthesiologist)|0
7806923|NCT01145222|12268166|FG000|Overall Study|Poor bowel preparation|0
7806924|NCT01145222|12268167|FG001|Overall Study|Poor bowel preparation|0
7806925|NCT01145222|12268168|FG002|Overall Study|Poor bowel preparation|0
7806926|NCT01145222|12268169|FG003|Overall Study|Poor bowel preparation|1
7806927|NCT01145352|12268179|FG000|Overall Study|Found to have been registered twice|6
7806928|NCT01145352|12268179|FG000|Overall Study|Treated before marketing approval|4
7806929|NCT01145352|12268179|FG000|Overall Study|Syringe formulation was used|1
7806930|NCT01145417|12268196|FG000|Overall Study|Death|1
7806931|NCT01145417|12268197|FG001|Overall Study|Death|0
7806932|NCT01145417|12268196|FG000|Overall Study|Lost to Follow-up|2
7806933|NCT01145417|12268197|FG001|Overall Study|Lost to Follow-up|1
7806934|NCT01145417|12268196|FG000|Overall Study|Withdrawal by Subject|1
7806935|NCT01145417|12268197|FG001|Overall Study|Withdrawal by Subject|2
7806936|NCT01145417|12268196|FG000|Overall Study|Pregnancy|1
7806937|NCT01145417|12268197|FG001|Overall Study|Pregnancy|0
7806938|NCT01145417|12268196|FG000|Overall Study|Adverse Event|0
7806939|NCT01145417|12268197|FG001|Overall Study|Adverse Event|1
7806940|NCT01145417|12268196|FG000|Overall Study|Study terminated by sponsor|35
7806941|NCT01145417|12268197|FG001|Overall Study|Study terminated by sponsor|43
7806942|NCT01145417|12268196|FG000|Overall Study|Other|1
7806943|NCT01145417|12268197|FG001|Overall Study|Other|0
7806944|NCT01145482|12268205|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
7806945|NCT01145482|12268206|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
7806946|NCT01145508|12268214|FG000|Overall Study|Adverse Event|1
7806947|NCT01145508|12268215|FG001|Overall Study|Adverse Event|0
7806948|NCT01145508|12268214|FG000|Overall Study|Death|1
7806949|NCT01145508|12268215|FG001|Overall Study|Death|0
7806950|NCT01145508|12268214|FG000|Overall Study|Physician Decision|2
7806951|NCT01145508|12268215|FG001|Overall Study|Physician Decision|1
7806952|NCT01145508|12268214|FG000|Overall Study|Never started treatment|1
7806953|NCT01145508|12268215|FG001|Overall Study|Never started treatment|1
7806954|NCT01145560|12268231|FG000|Overall Study|Withdrawal by Subject|2
7887001|NCT01813474|12388394|FG000|Overall Study|Adverse Event|1
7887002|NCT01813474|12388395|FG001|Overall Study|Adverse Event|1
7887003|NCT01813474|12388396|FG002|Overall Study|Adverse Event|0
7887004|NCT01813474|12388394|FG000|Overall Study|Lack of Efficacy|2
7887005|NCT01813474|12388395|FG001|Overall Study|Lack of Efficacy|6
7887006|NCT01813474|12388396|FG002|Overall Study|Lack of Efficacy|9
7887007|NCT01813474|12388394|FG000|Overall Study|Death|0
7887008|NCT01813474|12388395|FG001|Overall Study|Death|0
7887009|NCT01813474|12388396|FG002|Overall Study|Death|1
7887010|NCT01813721|12388405|FG000|Overall Study|Ineligibility determined|63
7887011|NCT01813721|12388405|FG000|Overall Study|Withdrawal by Subject|1
7887012|NCT01813890|12388434|FG000|Overall Study|Adverse Event|0
7887013|NCT01813890|12388435|FG001|Overall Study|Adverse Event|3
7887014|NCT01813890|12388436|FG002|Overall Study|Adverse Event|4
7887015|NCT01813890|12388434|FG000|Overall Study|Lack of Efficacy|9
7887016|NCT01813890|12388435|FG001|Overall Study|Lack of Efficacy|1
7887017|NCT01813890|12388436|FG002|Overall Study|Lack of Efficacy|2
7887018|NCT01814007|12388444|FG000|Overall Study|Withdrawal by Subject|1
7887019|NCT01814046|12388451|FG000|Drug Administration|Death due to complications of RSV|1
7887020|NCT01814046|12388452|FG001|Drug Administration|Death due to complications of RSV|0
7887021|NCT01814046|12388453|FG002|Drug Administration|Death due to complications of RSV|0
7887022|NCT01814072|12388492|FG000|Overall Study|Lost to Follow-up|2
7887023|NCT01814072|12388493|FG001|Overall Study|Lost to Follow-up|2
7887024|NCT01814072|12388494|FG002|Overall Study|Lost to Follow-up|2
7887025|NCT01814072|12388495|FG003|Overall Study|Lost to Follow-up|0
7887026|NCT01814072|12388496|FG004|Overall Study|Lost to Follow-up|2
7887027|NCT01814072|12388497|FG005|Overall Study|Lost to Follow-up|3
7887028|NCT01814072|12388498|FG006|Overall Study|Lost to Follow-up|3
7887029|NCT01814072|12388499|FG007|Overall Study|Lost to Follow-up|1
7887030|NCT01814072|12388500|FG008|Overall Study|Lost to Follow-up|2
7887031|NCT01814072|12388501|FG009|Overall Study|Lost to Follow-up|3
7887032|NCT01814072|12388502|FG010|Overall Study|Lost to Follow-up|1
7887033|NCT01814072|12388503|FG011|Overall Study|Lost to Follow-up|2
7887034|NCT01814072|12388504|FG012|Overall Study|Lost to Follow-up|2
7887035|NCT01814072|12388505|FG013|Overall Study|Lost to Follow-up|1
7887036|NCT01814072|12388506|FG014|Overall Study|Lost to Follow-up|2
7887037|NCT01814072|12388507|FG015|Overall Study|Lost to Follow-up|1
7887038|NCT01814072|12388508|FG016|Overall Study|Lost to Follow-up|3
7887039|NCT01814072|12388509|FG017|Overall Study|Lost to Follow-up|1
7887040|NCT01814072|12388510|FG018|Overall Study|Lost to Follow-up|3
7887041|NCT01814072|12388511|FG019|Overall Study|Lost to Follow-up|3
7887042|NCT01814072|12388512|FG020|Overall Study|Lost to Follow-up|2
7887043|NCT01814072|12388513|FG021|Overall Study|Lost to Follow-up|1
7887044|NCT01814072|12388514|FG022|Overall Study|Lost to Follow-up|3
7887045|NCT01814072|12388515|FG023|Overall Study|Lost to Follow-up|1
7887046|NCT01814072|12388516|FG024|Overall Study|Lost to Follow-up|4
7887047|NCT01814072|12388517|FG025|Overall Study|Lost to Follow-up|1
7887048|NCT01814072|12388518|FG026|Overall Study|Lost to Follow-up|1
7887049|NCT01814072|12388519|FG027|Overall Study|Lost to Follow-up|2
7887050|NCT01814072|12388520|FG028|Overall Study|Lost to Follow-up|3
7887051|NCT01814072|12388521|FG029|Overall Study|Lost to Follow-up|3
7887052|NCT01814072|12388522|FG030|Overall Study|Lost to Follow-up|2
7887053|NCT01814072|12388523|FG031|Overall Study|Lost to Follow-up|0
7887054|NCT01814072|12388492|FG000|Overall Study|Withdrawal by Subject|2
7806955|NCT01145560|12268232|FG001|Overall Study|Withdrawal by Subject|1
7806956|NCT01145560|12268233|FG002|Overall Study|Withdrawal by Subject|0
7806957|NCT01145560|12268231|FG000|Overall Study|Lost to Follow-up|1
7806958|NCT01145560|12268232|FG001|Overall Study|Lost to Follow-up|1
7806959|NCT01145560|12268233|FG002|Overall Study|Lost to Follow-up|1
7806960|NCT01145560|12268231|FG000|Overall Study|No study drug by 24h after organ failure|1
7806961|NCT01145560|12268232|FG001|Overall Study|No study drug by 24h after organ failure|0
7806962|NCT01145560|12268233|FG002|Overall Study|No study drug by 24h after organ failure|0
7806963|NCT01145560|12268231|FG000|Overall Study|Accidental unblinding of study treatment|0
7806964|NCT01145560|12268232|FG001|Overall Study|Accidental unblinding of study treatment|1
7806965|NCT01145560|12268233|FG002|Overall Study|Accidental unblinding of study treatment|0
7806966|NCT01145560|12268231|FG000|Overall Study|False insurance information|0
7806967|NCT01145560|12268232|FG001|Overall Study|False insurance information|1
7806968|NCT01145560|12268233|FG002|Overall Study|False insurance information|0
7806969|NCT01145560|12268231|FG000|Overall Study|Withdrawal of therapy|0
7806970|NCT01145560|12268232|FG001|Overall Study|Withdrawal of therapy|0
7806971|NCT01145560|12268233|FG002|Overall Study|Withdrawal of therapy|1
7806972|NCT01145625|12268243|FG000|Overall Study|Lost to Follow-up|8
7806973|NCT01145625|12268244|FG001|Overall Study|Lost to Follow-up|9
7806974|NCT01145625|12268243|FG000|Overall Study|Adverse Event|6
7806975|NCT01145625|12268244|FG001|Overall Study|Adverse Event|4
7806976|NCT01145625|12268243|FG000|Overall Study|Protocol Violation|3
7806977|NCT01145625|12268244|FG001|Overall Study|Protocol Violation|1
7806978|NCT01145625|12268243|FG000|Overall Study|Withdrawal by Subject|7
7806979|NCT01145625|12268244|FG001|Overall Study|Withdrawal by Subject|16
7806980|NCT01145625|12268243|FG000|Overall Study|Pregnancy|0
7806981|NCT01145625|12268244|FG001|Overall Study|Pregnancy|1
7806982|NCT01145755|12268262|FG000|Overall Study|Adverse Event|2
7806983|NCT01145755|12268263|FG001|Overall Study|Adverse Event|4
7806984|NCT01145755|12268264|FG002|Overall Study|Adverse Event|2
7806985|NCT01145755|12268262|FG000|Overall Study|Withdrawal by Subject|2
7806986|NCT01145755|12268263|FG001|Overall Study|Withdrawal by Subject|2
7806987|NCT01145755|12268264|FG002|Overall Study|Withdrawal by Subject|2
7806988|NCT01145755|12268262|FG000|Overall Study|Lost to Follow-up|2
7806989|NCT01145755|12268263|FG001|Overall Study|Lost to Follow-up|3
7806990|NCT01145755|12268264|FG002|Overall Study|Lost to Follow-up|1
7806991|NCT01145755|12268262|FG000|Overall Study|Protocol Violation|0
7806992|NCT01145755|12268263|FG001|Overall Study|Protocol Violation|3
7806993|NCT01145755|12268264|FG002|Overall Study|Protocol Violation|1
7806994|NCT01145755|12268262|FG000|Overall Study|Study Closure|14
7806995|NCT01145755|12268263|FG001|Overall Study|Study Closure|14
7806996|NCT01145755|12268264|FG002|Overall Study|Study Closure|17
7806997|NCT01145755|12268262|FG000|Overall Study|Lack of Efficacy|0
7806998|NCT01145755|12268263|FG001|Overall Study|Lack of Efficacy|1
7806999|NCT01145755|12268264|FG002|Overall Study|Lack of Efficacy|0
7807000|NCT01145755|12268262|FG000|Overall Study|Patient could not swollow medication|0
7807001|NCT01145755|12268263|FG001|Overall Study|Patient could not swollow medication|0
7807002|NCT01145755|12268264|FG002|Overall Study|Patient could not swollow medication|1
7807003|NCT01145755|12268262|FG000|Overall Study|Withdrawal by Subject|0
7807004|NCT01145755|12268263|FG001|Overall Study|Withdrawal by Subject|0
7807005|NCT01145755|12268264|FG002|Overall Study|Withdrawal by Subject|1
7807006|NCT01145755|12268262|FG000|Overall Study|Positive urine ethanol|0
7807007|NCT01145755|12268263|FG001|Overall Study|Positive urine ethanol|1
7807008|NCT01145755|12268264|FG002|Overall Study|Positive urine ethanol|0
7807009|NCT01145885|12268281|FG000|Overall Study|Progressive Disease|7
7807010|NCT01145898|12268293|FG000|3-year Treatment|medication change by treating physician|3
7807011|NCT01145898|12268294|FG001|3-year Treatment|medication change by treating physician|16
7807012|NCT01146054|12268299|FG000|Overall Study|Did not meet dose constraints for SBRT|5
7807013|NCT01146054|12268299|FG000|Overall Study|Rapid tumor progression|2
7807014|NCT01146054|12268299|FG000|Overall Study|Other illness precluded treatment|2
7807015|NCT01146054|12268299|FG000|Overall Study|Lost to Follow-up|1
7807016|NCT01146288|12268305|FG000|First Intervention(1 Day)|Adverse Event|0
7807017|NCT01146288|12268306|FG001|First Intervention(1 Day)|Adverse Event|1
7807018|NCT01146561|12268361|FG000|Overall Study|Withdrawal by Subject|1
7807019|NCT01146561|12268361|FG000|Overall Study|Lost to Follow-up|1
7807020|NCT01146613|12268377|FG000|Overall Study|Lost to Follow-up|3
7807021|NCT01146613|12268378|FG001|Overall Study|Lost to Follow-up|8
7807022|NCT01146613|12268377|FG000|Overall Study|Lack of Efficacy|0
7807023|NCT01146613|12268378|FG001|Overall Study|Lack of Efficacy|1
7807024|NCT01146613|12268377|FG000|Overall Study|Death|1
7807025|NCT01146613|12268378|FG001|Overall Study|Death|0
7807026|NCT01146613|12268377|FG000|Overall Study|Physician Decision|1
7807027|NCT01146613|12268378|FG001|Overall Study|Physician Decision|0
7807028|NCT01146613|12268377|FG000|Overall Study|Withdrawal by Subject|0
7807029|NCT01146613|12268378|FG001|Overall Study|Withdrawal by Subject|3
7807030|NCT01146613|12268377|FG000|Overall Study|schedule conflict|1
7807031|NCT01146613|12268378|FG001|Overall Study|schedule conflict|0
7807032|NCT01146613|12268377|FG000|Overall Study|Outpatient detox|1
7807033|NCT01146613|12268378|FG001|Overall Study|Outpatient detox|0
7807034|NCT01146665|12268386|FG000|Overall Study|Withdrawal by Subject|10
7807035|NCT01146665|12268387|FG001|Overall Study|Withdrawal by Subject|16
7807036|NCT01146782|12268411|FG000|Screening Cohort|Screen Failure|187
7807037|NCT01146782|12268411|FG000|Screening Cohort|Lost to Follow-up|4
7807038|NCT01146782|12268411|FG000|Screening Cohort|Physician Decision|1
7807039|NCT01146782|12268411|FG000|Screening Cohort|Withdrawal by Subject|29
7807040|NCT01146782|12268411|FG000|Safety Cohort|Screen Failure|61
7807041|NCT01146782|12268411|FG000|Safety Cohort|Withdrawal by Subject|4
7807042|NCT01146782|12268411|FG000|Safety Cohort|Control AHI <5|4
7807043|NCT01146782|12268411|FG000|Safety Cohort|TST <4 hrs|14
7807044|NCT01146782|12268411|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5
7807045|NCT01146782|12268411|FG000|Primary Endpoint Cohort|Physician Decision|1
7807046|NCT01146795|12268416|FG000|Overall Study|Withdrawal by Subject|4
7807047|NCT01146795|12268416|FG000|Overall Study|Adverse Event|6
7807048|NCT01146795|12268416|FG000|Overall Study|Still in treatment at study closure|10
7807049|NCT01146860|12268447|FG000|Overall Study|Withdrawal by Subject|0
7807050|NCT01146860|12268448|FG001|Overall Study|Withdrawal by Subject|1
7807051|NCT01146873|12268456|FG000|Overall Study|Transfer out|0
7807052|NCT01146873|12268457|FG001|Overall Study|Transfer out|6
7807053|NCT01146912|12268470|FG000|Overall Study|Already received influenza vaccination|817
7807054|NCT01146912|12268471|FG001|Overall Study|Already received influenza vaccination|822
7807055|NCT01146912|12268472|FG002|Overall Study|Already received influenza vaccination|13
7807056|NCT01146912|12268473|FG003|Overall Study|Already received influenza vaccination|15
7807057|NCT01146912|12268474|FG004|Overall Study|Already received influenza vaccination|41
7807058|NCT01146912|12268475|FG005|Overall Study|Already received influenza vaccination|61
7807059|NCT01146912|12268476|FG006|Overall Study|Already received influenza vaccination|56
7807060|NCT01146912|12268477|FG007|Overall Study|Already received influenza vaccination|0
7807061|NCT01146912|12268470|FG000|Overall Study|< 14 weeks gestational age|0
7807062|NCT01146912|12268471|FG001|Overall Study|< 14 weeks gestational age|0
7807063|NCT01146912|12268472|FG002|Overall Study|< 14 weeks gestational age|3
7807064|NCT01146912|12268473|FG003|Overall Study|< 14 weeks gestational age|2
7807065|NCT01146912|12268474|FG004|Overall Study|< 14 weeks gestational age|0
7807066|NCT01146912|12268475|FG005|Overall Study|< 14 weeks gestational age|0
7807067|NCT01146912|12268476|FG006|Overall Study|< 14 weeks gestational age|0
7807068|NCT01146912|12268477|FG007|Overall Study|< 14 weeks gestational age|0
7807069|NCT01146912|12268470|FG000|Overall Study|Duplicate patient|0
7807070|NCT01146912|12268471|FG001|Overall Study|Duplicate patient|0
7807071|NCT01146912|12268472|FG002|Overall Study|Duplicate patient|1
7807072|NCT01146912|12268473|FG003|Overall Study|Duplicate patient|0
7807073|NCT01146912|12268474|FG004|Overall Study|Duplicate patient|0
7807074|NCT01146912|12268475|FG005|Overall Study|Duplicate patient|0
7807075|NCT01146912|12268476|FG006|Overall Study|Duplicate patient|0
7807076|NCT01146912|12268477|FG007|Overall Study|Duplicate patient|0
7807077|NCT01146951|12268498|FG000|Overall Study|Adverse Event|4
7807078|NCT01146951|12268499|FG001|Overall Study|Adverse Event|1
7861694|NCT01597193|12351159|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7861695|NCT01597193|12351160|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1
7861696|NCT01597193|12351161|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2
7861697|NCT01597193|12351162|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3
7861698|NCT01597193|12351163|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7861699|NCT01597193|12351157|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
7861700|NCT01597193|12351158|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
7861701|NCT01597193|12351159|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
7861702|NCT01597193|12351160|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
7861703|NCT01597193|12351161|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
7861704|NCT01597193|12351162|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
7861705|NCT01597193|12351163|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11
7861706|NCT01597193|12351157|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0
7861707|NCT01597193|12351158|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0
7861708|NCT01597193|12351159|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0
7861709|NCT01597193|12351160|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0
7861710|NCT01597193|12351161|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0
7861711|NCT01597193|12351162|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1
7861712|NCT01597193|12351163|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0
7861713|NCT01597193|12351157|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7861714|NCT01597193|12351158|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7861715|NCT01597193|12351159|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7861716|NCT01597193|12351160|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
7861717|NCT01597193|12351161|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7861718|NCT01597193|12351162|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
7861719|NCT01597193|12351163|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7861720|NCT01597245|12351188|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1
7861721|NCT01597245|12351189|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5
7861722|NCT01597245|12351190|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5
7861723|NCT01597245|12351191|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4
7861724|NCT01597245|12351192|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861725|NCT01597245|12351193|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861726|NCT01597245|12351194|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0
7883581|NCT01782872|12383300|FG002|Overall Study|Protocol Violation|0
7807079|NCT01147055|12268505|FG000|First Intervention Period|Lost to Follow-up|1
7807080|NCT01147055|12268506|FG001|First Intervention Period|Lost to Follow-up|0
7807081|NCT01147068|12268519|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1
7807082|NCT01147068|12268520|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0
7807083|NCT01147068|12268521|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0
7807084|NCT01147068|12268522|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0
7807085|NCT01147068|12268523|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0
7807086|NCT01147068|12268524|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1
7807087|NCT01147068|12268525|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0
7807088|NCT01147068|12268519|FG000|Subjects That Received 2nd Dose|Ineligible|0
7807089|NCT01147068|12268520|FG001|Subjects That Received 2nd Dose|Ineligible|1
7807090|NCT01147068|12268521|FG002|Subjects That Received 2nd Dose|Ineligible|0
7807091|NCT01147068|12268522|FG003|Subjects That Received 2nd Dose|Ineligible|0
7807092|NCT01147068|12268523|FG004|Subjects That Received 2nd Dose|Ineligible|0
7807093|NCT01147068|12268524|FG005|Subjects That Received 2nd Dose|Ineligible|0
7807094|NCT01147068|12268525|FG006|Subjects That Received 2nd Dose|Ineligible|0
7807095|NCT01147068|12268519|FG000|Subjects That Received 2nd Dose|Did not complete the study|0
7807096|NCT01147068|12268520|FG001|Subjects That Received 2nd Dose|Did not complete the study|1
7807097|NCT01147068|12268521|FG002|Subjects That Received 2nd Dose|Did not complete the study|0
7807098|NCT01147068|12268522|FG003|Subjects That Received 2nd Dose|Did not complete the study|0
7807099|NCT01147068|12268523|FG004|Subjects That Received 2nd Dose|Did not complete the study|0
7807100|NCT01147068|12268524|FG005|Subjects That Received 2nd Dose|Did not complete the study|1
7807101|NCT01147068|12268525|FG006|Subjects That Received 2nd Dose|Did not complete the study|0
7807102|NCT01147068|12268519|FG000|Subjects That Received 2nd Dose|Other|0
7807103|NCT01147068|12268520|FG001|Subjects That Received 2nd Dose|Other|3
7807104|NCT01147068|12268521|FG002|Subjects That Received 2nd Dose|Other|3
7807105|NCT01147068|12268522|FG003|Subjects That Received 2nd Dose|Other|0
7807106|NCT01147068|12268523|FG004|Subjects That Received 2nd Dose|Other|1
7807107|NCT01147068|12268524|FG005|Subjects That Received 2nd Dose|Other|0
7807108|NCT01147068|12268525|FG006|Subjects That Received 2nd Dose|Other|0
7807109|NCT01147068|12268519|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
7807110|NCT01147068|12268520|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
7807111|NCT01147068|12268521|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
7807112|NCT01147068|12268522|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
7807113|NCT01147068|12268523|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
7807114|NCT01147068|12268524|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
7807115|NCT01147068|12268525|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
7807116|NCT01147068|12268519|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7807117|NCT01147068|12268520|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7807118|NCT01147068|12268521|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7807119|NCT01147068|12268522|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
7807120|NCT01147068|12268523|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7807121|NCT01147068|12268524|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7807122|NCT01147068|12268525|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7807123|NCT01147068|12268519|FG000|Subjects That Completed Safety Follow-up|Ineligible|0
7807124|NCT01147068|12268520|FG001|Subjects That Completed Safety Follow-up|Ineligible|1
7807125|NCT01147068|12268521|FG002|Subjects That Completed Safety Follow-up|Ineligible|0
7807126|NCT01147068|12268522|FG003|Subjects That Completed Safety Follow-up|Ineligible|0
7807127|NCT01147068|12268523|FG004|Subjects That Completed Safety Follow-up|Ineligible|0
7807128|NCT01147068|12268524|FG005|Subjects That Completed Safety Follow-up|Ineligible|0
7807129|NCT01147068|12268525|FG006|Subjects That Completed Safety Follow-up|Ineligible|0
7807130|NCT01147107|12268543|FG000|Overall Study|Lack of Efficacy|5
7807131|NCT01147107|12268544|FG001|Overall Study|Lack of Efficacy|0
7887055|NCT01814072|12388493|FG001|Overall Study|Withdrawal by Subject|0
7887056|NCT01814072|12388494|FG002|Overall Study|Withdrawal by Subject|1
7887057|NCT01814072|12388495|FG003|Overall Study|Withdrawal by Subject|0
7887058|NCT01814072|12388496|FG004|Overall Study|Withdrawal by Subject|2
7887059|NCT01814072|12388497|FG005|Overall Study|Withdrawal by Subject|3
7887060|NCT01814072|12388498|FG006|Overall Study|Withdrawal by Subject|1
7887061|NCT01814072|12388499|FG007|Overall Study|Withdrawal by Subject|0
7887062|NCT01814072|12388500|FG008|Overall Study|Withdrawal by Subject|1
7887063|NCT01814072|12388501|FG009|Overall Study|Withdrawal by Subject|2
7887064|NCT01814072|12388502|FG010|Overall Study|Withdrawal by Subject|0
7887065|NCT01814072|12388503|FG011|Overall Study|Withdrawal by Subject|0
7887066|NCT01814072|12388504|FG012|Overall Study|Withdrawal by Subject|1
7887067|NCT01814072|12388505|FG013|Overall Study|Withdrawal by Subject|1
7887068|NCT01814072|12388506|FG014|Overall Study|Withdrawal by Subject|1
7887069|NCT01814072|12388507|FG015|Overall Study|Withdrawal by Subject|1
7887070|NCT01814072|12388508|FG016|Overall Study|Withdrawal by Subject|0
7887071|NCT01814072|12388509|FG017|Overall Study|Withdrawal by Subject|0
7887072|NCT01814072|12388510|FG018|Overall Study|Withdrawal by Subject|0
7887073|NCT01814072|12388511|FG019|Overall Study|Withdrawal by Subject|2
7887074|NCT01814072|12388512|FG020|Overall Study|Withdrawal by Subject|0
7887075|NCT01814072|12388513|FG021|Overall Study|Withdrawal by Subject|0
7887076|NCT01814072|12388514|FG022|Overall Study|Withdrawal by Subject|1
7887077|NCT01814072|12388515|FG023|Overall Study|Withdrawal by Subject|0
7887078|NCT01814072|12388516|FG024|Overall Study|Withdrawal by Subject|2
7807132|NCT01147107|12268543|FG000|Overall Study|Withdrawal by Subject|1
7887079|NCT01814072|12388517|FG025|Overall Study|Withdrawal by Subject|1
7887080|NCT01814072|12388518|FG026|Overall Study|Withdrawal by Subject|1
7807133|NCT01147107|12268544|FG001|Overall Study|Withdrawal by Subject|1
7807134|NCT01147172|12268550|FG000|Overall Study|Withdrawal by Subject|2
7807135|NCT01147172|12268550|FG000|Overall Study|Lost to Follow-up|2
7807136|NCT01147250|12268558|FG000|Overall Study|Lost to Follow-up|14
7807137|NCT01147250|12268559|FG001|Overall Study|Lost to Follow-up|11
7807138|NCT01147250|12268558|FG000|Overall Study|Withdrawal by Subject|83
7807139|NCT01147250|12268559|FG001|Overall Study|Withdrawal by Subject|88
7807140|NCT01147250|12268558|FG000|Overall Study|Site termination by sponsor|13
7807141|NCT01147250|12268559|FG001|Overall Study|Site termination by sponsor|5
7807142|NCT01147250|12268558|FG000|Overall Study|Other than specified|0
7807143|NCT01147250|12268559|FG001|Overall Study|Other than specified|1
7807144|NCT01147341|12268576|FG000|Double Blind Period|Lack of Efficacy|1
7807145|NCT01147341|12268577|FG001|Double Blind Period|Lack of Efficacy|1
7807146|NCT01147341|12268576|FG000|Double Blind Period|Withdrawal by Subject|0
7807147|NCT01147341|12268577|FG001|Double Blind Period|Withdrawal by Subject|1
7807148|NCT01147341|12268576|FG000|Open Label Period|Lack of Efficacy|3
7807149|NCT01147341|12268577|FG001|Open Label Period|Lack of Efficacy|0
7807150|NCT01147341|12268576|FG000|Open Label Period|Subject moved|1
7807151|NCT01147341|12268577|FG001|Open Label Period|Subject moved|0
7807152|NCT01147458|12268620|FG000|First Intervention|Study terminated by sponsor|8
7807153|NCT01147458|12268621|FG001|First Intervention|Study terminated by sponsor|8
7807154|NCT01147458|12268622|FG002|First Intervention|Study terminated by sponsor|7
7807155|NCT01147458|12268623|FG003|First Intervention|Study terminated by sponsor|8
7807156|NCT01147458|12268620|FG000|First Intervention|Protocol Violation|2
7807157|NCT01147458|12268621|FG001|First Intervention|Protocol Violation|3
7807158|NCT01147458|12268622|FG002|First Intervention|Protocol Violation|2
7807159|NCT01147458|12268623|FG003|First Intervention|Protocol Violation|3
7807160|NCT01147458|12268620|FG000|First Intervention|Withdrawal by Subject|3
7807161|NCT01147458|12268621|FG001|First Intervention|Withdrawal by Subject|0
7807162|NCT01147458|12268622|FG002|First Intervention|Withdrawal by Subject|1
7807163|NCT01147458|12268623|FG003|First Intervention|Withdrawal by Subject|0
7807164|NCT01147458|12268620|FG000|First Intervention|Adverse Event|0
7807165|NCT01147458|12268621|FG001|First Intervention|Adverse Event|3
7807166|NCT01147458|12268622|FG002|First Intervention|Adverse Event|2
7807167|NCT01147458|12268623|FG003|First Intervention|Adverse Event|3
7807168|NCT01147458|12268620|FG000|First Intervention|Other|1
7807169|NCT01147458|12268621|FG001|First Intervention|Other|2
7807170|NCT01147458|12268622|FG002|First Intervention|Other|0
7807171|NCT01147458|12268623|FG003|First Intervention|Other|0
7807172|NCT01147458|12268620|FG000|Second Intervention|Study terminated by sponsor|7
7807173|NCT01147458|12268621|FG001|Second Intervention|Study terminated by sponsor|5
7807174|NCT01147458|12268622|FG002|Second Intervention|Study terminated by sponsor|5
7807175|NCT01147458|12268623|FG003|Second Intervention|Study terminated by sponsor|3
7807176|NCT01147458|12268620|FG000|Second Intervention|Protocol Violation|0
7807177|NCT01147458|12268621|FG001|Second Intervention|Protocol Violation|1
7807178|NCT01147458|12268622|FG002|Second Intervention|Protocol Violation|1
7807179|NCT01147458|12268623|FG003|Second Intervention|Protocol Violation|0
7807180|NCT01147458|12268620|FG000|Second Intervention|Withdrawal by Subject|0
7807181|NCT01147458|12268621|FG001|Second Intervention|Withdrawal by Subject|1
7807182|NCT01147458|12268622|FG002|Second Intervention|Withdrawal by Subject|0
7807183|NCT01147458|12268623|FG003|Second Intervention|Withdrawal by Subject|0
7807184|NCT01147458|12268620|FG000|Second Intervention|Adverse Event|2
7807185|NCT01147458|12268621|FG001|Second Intervention|Adverse Event|0
7807186|NCT01147458|12268622|FG002|Second Intervention|Adverse Event|1
7807187|NCT01147458|12268623|FG003|Second Intervention|Adverse Event|1
7807188|NCT01147458|12268620|FG000|Second Intervention|Other|0
7807189|NCT01147458|12268621|FG001|Second Intervention|Other|0
7807190|NCT01147458|12268622|FG002|Second Intervention|Other|1
7807191|NCT01147458|12268623|FG003|Second Intervention|Other|0
7807192|NCT01147471|12268637|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
7807193|NCT01147471|12268638|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
7807194|NCT01147471|12268637|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
7807195|NCT01147471|12268638|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
7807196|NCT01147471|12268637|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
7807197|NCT01147471|12268638|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
7807198|NCT01147471|12268637|FG000|3 Month Follow Up|Lost to Follow-up|1
7807199|NCT01147471|12268638|FG001|3 Month Follow Up|Lost to Follow-up|1
7807200|NCT01147471|12268637|FG000|3 Month Follow Up|Physician Decision|0
7807201|NCT01147471|12268638|FG001|3 Month Follow Up|Physician Decision|1
7807202|NCT01147471|12268637|FG000|6 Month Follow Up|Lost to Follow-up|4
7807203|NCT01147471|12268638|FG001|6 Month Follow Up|Lost to Follow-up|2
7807204|NCT01147497|12268646|FG000|Overall Study|failed insertion|2
7807205|NCT01147497|12268647|FG001|Overall Study|failed insertion|0
7807206|NCT01147640|12268677|FG000|Overall Study|Adverse Event|2
7807207|NCT01147640|12268678|FG001|Overall Study|Adverse Event|0
7807208|NCT01147640|12268677|FG000|Overall Study|Physician Decision|1
7807209|NCT01147640|12268678|FG001|Overall Study|Physician Decision|0
7807210|NCT01147640|12268677|FG000|Overall Study|Withdrawal by Subject|1
7807211|NCT01147640|12268678|FG001|Overall Study|Withdrawal by Subject|0
7807212|NCT01147640|12268677|FG000|Overall Study|Lost to Follow-up|0
7807213|NCT01147640|12268678|FG001|Overall Study|Lost to Follow-up|1
7807214|NCT01147640|12268677|FG000|Overall Study|Didn't meet eligibility criteria|1
7807215|NCT01147640|12268678|FG001|Overall Study|Didn't meet eligibility criteria|0
7807216|NCT01147744|12268691|FG000|Overall Study|Protocol Violation|1
7807217|NCT01147744|12268692|FG001|Overall Study|Protocol Violation|0
7807218|NCT01147744|12268693|FG002|Overall Study|Protocol Violation|1
7807219|NCT01147744|12268694|FG003|Overall Study|Protocol Violation|0
7807220|NCT01147744|12268695|FG004|Overall Study|Protocol Violation|1
7807221|NCT01147744|12268696|FG005|Overall Study|Protocol Violation|3
7807222|NCT01147744|12268697|FG006|Overall Study|Protocol Violation|1
7807223|NCT01147744|12268691|FG000|Overall Study|Physician Decision|0
7807224|NCT01147744|12268692|FG001|Overall Study|Physician Decision|1
7807225|NCT01147744|12268693|FG002|Overall Study|Physician Decision|1
7807226|NCT01147744|12268694|FG003|Overall Study|Physician Decision|0
7807227|NCT01147744|12268695|FG004|Overall Study|Physician Decision|0
7807228|NCT01147744|12268696|FG005|Overall Study|Physician Decision|0
7807229|NCT01147744|12268697|FG006|Overall Study|Physician Decision|1
7807230|NCT01147744|12268691|FG000|Overall Study|Lack of Efficacy|11
7807231|NCT01147744|12268692|FG001|Overall Study|Lack of Efficacy|11
7807232|NCT01147744|12268693|FG002|Overall Study|Lack of Efficacy|9
7807233|NCT01147744|12268694|FG003|Overall Study|Lack of Efficacy|11
7807234|NCT01147744|12268695|FG004|Overall Study|Lack of Efficacy|13
7807235|NCT01147744|12268696|FG005|Overall Study|Lack of Efficacy|8
7807236|NCT01147744|12268697|FG006|Overall Study|Lack of Efficacy|7
7807237|NCT01147744|12268691|FG000|Overall Study|Adverse Event|1
7807238|NCT01147744|12268692|FG001|Overall Study|Adverse Event|2
7807239|NCT01147744|12268693|FG002|Overall Study|Adverse Event|3
7807240|NCT01147744|12268694|FG003|Overall Study|Adverse Event|0
7807241|NCT01147744|12268695|FG004|Overall Study|Adverse Event|2
7807242|NCT01147744|12268696|FG005|Overall Study|Adverse Event|1
7807243|NCT01147744|12268697|FG006|Overall Study|Adverse Event|2
7807244|NCT01147744|12268691|FG000|Overall Study|Withdrawal by Subject|8
7807245|NCT01147744|12268692|FG001|Overall Study|Withdrawal by Subject|4
7807246|NCT01147744|12268693|FG002|Overall Study|Withdrawal by Subject|2
7807247|NCT01147744|12268694|FG003|Overall Study|Withdrawal by Subject|2
7807248|NCT01147744|12268695|FG004|Overall Study|Withdrawal by Subject|2
7807249|NCT01147744|12268696|FG005|Overall Study|Withdrawal by Subject|5
7807250|NCT01147744|12268697|FG006|Overall Study|Withdrawal by Subject|2
7807251|NCT01147744|12268691|FG000|Overall Study|Lost to Follow-up|0
7807252|NCT01147744|12268692|FG001|Overall Study|Lost to Follow-up|1
7807253|NCT01147744|12268693|FG002|Overall Study|Lost to Follow-up|0
7807254|NCT01147744|12268694|FG003|Overall Study|Lost to Follow-up|0
7807255|NCT01147744|12268695|FG004|Overall Study|Lost to Follow-up|0
7807256|NCT01147744|12268696|FG005|Overall Study|Lost to Follow-up|0
7807257|NCT01147744|12268697|FG006|Overall Study|Lost to Follow-up|0
7807258|NCT01147744|12268691|FG000|Overall Study|Sponsor decision to amend protocol|7
7807259|NCT01147744|12268692|FG001|Overall Study|Sponsor decision to amend protocol|4
7807260|NCT01147744|12268693|FG002|Overall Study|Sponsor decision to amend protocol|2
7807261|NCT01147744|12268694|FG003|Overall Study|Sponsor decision to amend protocol|5
7807262|NCT01147744|12268695|FG004|Overall Study|Sponsor decision to amend protocol|7
7807263|NCT01147744|12268696|FG005|Overall Study|Sponsor decision to amend protocol|2
7807264|NCT01147744|12268697|FG006|Overall Study|Sponsor decision to amend protocol|6
7807265|NCT01147744|12268691|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
7807266|NCT01147744|12268692|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0
7807267|NCT01147744|12268693|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0
7807268|NCT01147744|12268694|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0
7807269|NCT01147744|12268695|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0
7807270|NCT01147744|12268696|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1
7807271|NCT01147744|12268697|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0
7807272|NCT01147809|12268725|FG000|Phase I (168 Days)|Adverse Event|0
7807273|NCT01147809|12268726|FG001|Phase I (168 Days)|Adverse Event|0
7807274|NCT01147809|12268727|FG002|Phase I (168 Days)|Adverse Event|0
7807275|NCT01147809|12268728|FG003|Phase I (168 Days)|Adverse Event|1
7807276|NCT01147809|12268729|FG004|Phase I (168 Days)|Adverse Event|0
7807277|NCT01147809|12268730|FG005|Phase I (168 Days)|Adverse Event|0
7807278|NCT01147809|12268725|FG000|Phase I (168 Days)|Lost to Follow-up|1
7807279|NCT01147809|12268726|FG001|Phase I (168 Days)|Lost to Follow-up|0
7807280|NCT01147809|12268727|FG002|Phase I (168 Days)|Lost to Follow-up|0
7807281|NCT01147809|12268728|FG003|Phase I (168 Days)|Lost to Follow-up|1
7807282|NCT01147809|12268729|FG004|Phase I (168 Days)|Lost to Follow-up|0
7807283|NCT01147809|12268730|FG005|Phase I (168 Days)|Lost to Follow-up|0
7807284|NCT01147809|12268725|FG000|Phase I (168 Days)|Physician Decision|0
7807285|NCT01147809|12268726|FG001|Phase I (168 Days)|Physician Decision|1
7807286|NCT01147809|12268727|FG002|Phase I (168 Days)|Physician Decision|2
7807287|NCT01147809|12268728|FG003|Phase I (168 Days)|Physician Decision|0
7807288|NCT01147809|12268729|FG004|Phase I (168 Days)|Physician Decision|0
7807289|NCT01147809|12268730|FG005|Phase I (168 Days)|Physician Decision|0
7807290|NCT01147809|12268725|FG000|Phase I (168 Days)|Withdrawal by Subject|0
7807291|NCT01147809|12268726|FG001|Phase I (168 Days)|Withdrawal by Subject|0
7807292|NCT01147809|12268727|FG002|Phase I (168 Days)|Withdrawal by Subject|0
7807293|NCT01147809|12268728|FG003|Phase I (168 Days)|Withdrawal by Subject|3
7807294|NCT01147809|12268729|FG004|Phase I (168 Days)|Withdrawal by Subject|0
7807295|NCT01147809|12268730|FG005|Phase I (168 Days)|Withdrawal by Subject|0
7807296|NCT01147809|12268725|FG000|Phase II (168 Days)|Adverse Event|0
7807297|NCT01147809|12268726|FG001|Phase II (168 Days)|Adverse Event|0
7807298|NCT01147809|12268727|FG002|Phase II (168 Days)|Adverse Event|0
7807299|NCT01147809|12268728|FG003|Phase II (168 Days)|Adverse Event|0
7887081|NCT01814072|12388519|FG027|Overall Study|Withdrawal by Subject|2
7887082|NCT01814072|12388520|FG028|Overall Study|Withdrawal by Subject|1
7887083|NCT01814072|12388521|FG029|Overall Study|Withdrawal by Subject|0
7887084|NCT01814072|12388522|FG030|Overall Study|Withdrawal by Subject|0
7887085|NCT01814072|12388523|FG031|Overall Study|Withdrawal by Subject|0
7887086|NCT01814137|12388565|FG000|Overall Study|Adverse Event|0
7887087|NCT01814137|12388566|FG001|Overall Study|Adverse Event|1
7887088|NCT01814137|12388565|FG000|Overall Study|Withdrawal by Subject|2
7887089|NCT01814137|12388566|FG001|Overall Study|Withdrawal by Subject|2
7887090|NCT01814137|12388565|FG000|Overall Study|Physician Decision|1
7887091|NCT01814137|12388566|FG001|Overall Study|Physician Decision|1
7887092|NCT01814137|12388565|FG000|Overall Study|Unclassified|2
7887093|NCT01814137|12388566|FG001|Overall Study|Unclassified|1
7887094|NCT01814332|12388579|FG000|Overall Study|Adverse Event|8
7887095|NCT01814332|12388580|FG001|Overall Study|Adverse Event|3
7887096|NCT01814332|12388579|FG000|Overall Study|Withdrawal by Subject|3
7887097|NCT01814332|12388580|FG001|Overall Study|Withdrawal by Subject|8
7887098|NCT01814332|12388579|FG000|Overall Study|Protocol Violation|0
7887099|NCT01814332|12388580|FG001|Overall Study|Protocol Violation|4
7887100|NCT01814332|12388579|FG000|Overall Study|Lost to Follow-up|5
7887101|NCT01814332|12388580|FG001|Overall Study|Lost to Follow-up|1
7887102|NCT01814371|12388588|FG000|Overall Study|Lost to Follow-up|30
7887103|NCT01814371|12388589|FG001|Overall Study|Lost to Follow-up|27
7887104|NCT01814397|12388598|FG000|Overall Study|Adverse Event|7
7887105|NCT01814397|12388598|FG000|Overall Study|Withdrawal by Subject|7
7887106|NCT01814553|12388604|FG000|Overall Study|PD per clinical progression|6
7887107|NCT01814553|12388605|FG001|Overall Study|PD per clinical progression|8
7887108|NCT01814553|12388604|FG000|Overall Study|Other Adverse Event|4
7887109|NCT01814553|12388605|FG001|Overall Study|Other Adverse Event|5
7887110|NCT01814553|12388604|FG000|Overall Study|Withdrawal by Subject|1
7887111|NCT01814553|12388605|FG001|Overall Study|Withdrawal by Subject|1
7887112|NCT01814553|12388604|FG000|Overall Study|Other than stated|7
7887113|NCT01814553|12388605|FG001|Overall Study|Other than stated|8
7887114|NCT01814670|12388611|FG000|Overall Study|Protocol Violation|12
7887115|NCT01814696|12388617|FG000|Overall Study|Withdrawal by Subject|1
7887116|NCT01814696|12388618|FG001|Overall Study|Withdrawal by Subject|0
7887117|NCT01814696|12388617|FG000|Overall Study|Randomized to wrong group|1
7887118|NCT01814696|12388618|FG001|Overall Study|Randomized to wrong group|0
7887119|NCT01814748|12388626|FG000|Overall Study|Lost to Follow-up|1
7887120|NCT01814748|12388627|FG001|Overall Study|Lost to Follow-up|2
7807300|NCT01147809|12268729|FG004|Phase II (168 Days)|Adverse Event|3
7807301|NCT01147809|12268730|FG005|Phase II (168 Days)|Adverse Event|6
7807302|NCT01147809|12268725|FG000|Phase II (168 Days)|Protocol Violation|0
7807303|NCT01147809|12268726|FG001|Phase II (168 Days)|Protocol Violation|0
7807304|NCT01147809|12268727|FG002|Phase II (168 Days)|Protocol Violation|0
7807305|NCT01147809|12268728|FG003|Phase II (168 Days)|Protocol Violation|0
7807306|NCT01147809|12268729|FG004|Phase II (168 Days)|Protocol Violation|0
7807307|NCT01147809|12268730|FG005|Phase II (168 Days)|Protocol Violation|1
7807308|NCT01147809|12268725|FG000|Phase II (168 Days)|Physician Decision|0
7807309|NCT01147809|12268726|FG001|Phase II (168 Days)|Physician Decision|0
7807310|NCT01147809|12268727|FG002|Phase II (168 Days)|Physician Decision|0
7807311|NCT01147809|12268728|FG003|Phase II (168 Days)|Physician Decision|0
7807312|NCT01147809|12268729|FG004|Phase II (168 Days)|Physician Decision|5
7807313|NCT01147809|12268730|FG005|Phase II (168 Days)|Physician Decision|11
7807314|NCT01147809|12268725|FG000|Phase II (168 Days)|Withdrawal by Subject|0
7807315|NCT01147809|12268726|FG001|Phase II (168 Days)|Withdrawal by Subject|0
7807316|NCT01147809|12268727|FG002|Phase II (168 Days)|Withdrawal by Subject|0
7807317|NCT01147809|12268728|FG003|Phase II (168 Days)|Withdrawal by Subject|0
7807318|NCT01147809|12268729|FG004|Phase II (168 Days)|Withdrawal by Subject|7
7807319|NCT01147809|12268730|FG005|Phase II (168 Days)|Withdrawal by Subject|15
7807320|NCT01147809|12268725|FG000|Phase II (168 Days)|Ongoing|0
7807321|NCT01147809|12268726|FG001|Phase II (168 Days)|Ongoing|0
7807322|NCT01147809|12268727|FG002|Phase II (168 Days)|Ongoing|0
7807323|NCT01147809|12268728|FG003|Phase II (168 Days)|Ongoing|0
7807324|NCT01147809|12268729|FG004|Phase II (168 Days)|Ongoing|1
7807325|NCT01147809|12268730|FG005|Phase II (168 Days)|Ongoing|0
7807326|NCT01147848|12268747|FG000|Run-in Period|Screen Failure|623
7807327|NCT01147848|12268748|FG001|Run-in Period|Screen Failure|0
7807328|NCT01147848|12268749|FG002|Run-in Period|Screen Failure|0
7807329|NCT01147848|12268747|FG000|Run-in Period|Run-in Failure|135
7807330|NCT01147848|12268748|FG001|Run-in Period|Run-in Failure|0
7807331|NCT01147848|12268749|FG002|Run-in Period|Run-in Failure|0
7807332|NCT01147848|12268747|FG000|Randomized Phase|Adverse Event|0
7807333|NCT01147848|12268748|FG001|Randomized Phase|Adverse Event|6
7807334|NCT01147848|12268749|FG002|Randomized Phase|Adverse Event|8
7807335|NCT01147848|12268747|FG000|Randomized Phase|Lack of Efficacy|0
7807336|NCT01147848|12268748|FG001|Randomized Phase|Lack of Efficacy|20
7807337|NCT01147848|12268749|FG002|Randomized Phase|Lack of Efficacy|11
7807338|NCT01147848|12268747|FG000|Randomized Phase|Protocol Violation|0
7807339|NCT01147848|12268748|FG001|Randomized Phase|Protocol Violation|7
7807340|NCT01147848|12268749|FG002|Randomized Phase|Protocol Violation|10
7807341|NCT01147848|12268747|FG000|Randomized Phase|Lost to Follow-up|0
7807342|NCT01147848|12268748|FG001|Randomized Phase|Lost to Follow-up|5
7807343|NCT01147848|12268749|FG002|Randomized Phase|Lost to Follow-up|7
7807344|NCT01147848|12268747|FG000|Randomized Phase|Physician Decision|0
7807345|NCT01147848|12268748|FG001|Randomized Phase|Physician Decision|0
7807346|NCT01147848|12268749|FG002|Randomized Phase|Physician Decision|1
7807347|NCT01147848|12268747|FG000|Randomized Phase|Withdrawal by Subject|0
7807348|NCT01147848|12268748|FG001|Randomized Phase|Withdrawal by Subject|7
7807349|NCT01147848|12268749|FG002|Randomized Phase|Withdrawal by Subject|9
7807350|NCT01147874|12268756|FG000|Overall Study|Adverse Event|5
7807351|NCT01147874|12268756|FG000|Overall Study|Investigator's Request|1
7807352|NCT01147874|12268756|FG000|Overall Study|Lost to Follow-up|25
7807353|NCT01147874|12268756|FG000|Overall Study|Other|5
7807354|NCT01147874|12268756|FG000|Overall Study|Protocol Violation|5
7807355|NCT01147874|12268756|FG000|Overall Study|Sponsor's Decision|2
7807356|NCT01147874|12268756|FG000|Overall Study|Withdrawal by Subject|24
7807357|NCT01147900|12268763|FG000|At Year 10|Lost to Follow-up|0
7807358|NCT01147900|12268764|FG001|At Year 10|Lost to Follow-up|1
7807359|NCT01147900|12268765|FG002|At Year 10|Lost to Follow-up|0
7807360|NCT01147926|12268775|FG000|Overall Study|Subject Withdrew Consent|9
7807361|NCT01147926|12268776|FG001|Overall Study|Subject Withdrew Consent|10
7807362|NCT01147926|12268775|FG000|Overall Study|Adverse Event|7
7807363|NCT01147926|12268776|FG001|Overall Study|Adverse Event|6
7807364|NCT01147926|12268775|FG000|Overall Study|Subject Non-Compliant|5
7807365|NCT01147926|12268776|FG001|Overall Study|Subject Non-Compliant|4
7807366|NCT01147926|12268775|FG000|Overall Study|Principal investigator left hospital|1
7807367|NCT01147926|12268776|FG001|Overall Study|Principal investigator left hospital|3
7807368|NCT01147926|12268775|FG000|Overall Study|Selection criteria not met|3
7807369|NCT01147926|12268776|FG001|Overall Study|Selection criteria not met|1
7807370|NCT01147926|12268775|FG000|Overall Study|Lost to Follow-up|0
7807371|NCT01147926|12268776|FG001|Overall Study|Lost to Follow-up|2
7807372|NCT01147926|12268775|FG000|Overall Study|Sponsor's Decision|0
7807373|NCT01147926|12268776|FG001|Overall Study|Sponsor's Decision|1
7807374|NCT01147926|12268775|FG000|Overall Study|Lack of Efficacy|1
7807375|NCT01147926|12268776|FG001|Overall Study|Lack of Efficacy|0
7807376|NCT01147926|12268775|FG000|Overall Study|Too busy, no time for study|1
7807377|NCT01147926|12268776|FG001|Overall Study|Too busy, no time for study|0
7807378|NCT01147926|12268775|FG000|Overall Study|Went on holiday|0
7807379|NCT01147926|12268776|FG001|Overall Study|Went on holiday|1
7807380|NCT01147926|12268775|FG000|Overall Study|Colonoscopy result|0
7807381|NCT01147926|12268776|FG001|Overall Study|Colonoscopy result|1
7807382|NCT01148017|12268786|FG000|Overall Study|Withdrawal by Subject|31
7807383|NCT01148017|12268787|FG001|Overall Study|Withdrawal by Subject|14
7807384|NCT01148017|12268788|FG002|Overall Study|Withdrawal by Subject|0
7807385|NCT01148017|12268789|FG003|Overall Study|Withdrawal by Subject|0
7807386|NCT01148017|12268786|FG000|Overall Study|Lost to Follow-up|23
7807387|NCT01148017|12268787|FG001|Overall Study|Lost to Follow-up|10
7807388|NCT01148017|12268788|FG002|Overall Study|Lost to Follow-up|0
7807389|NCT01148017|12268789|FG003|Overall Study|Lost to Follow-up|0
7807390|NCT01148017|12268786|FG000|Overall Study|Inappropriate enrollment|1
7807391|NCT01148017|12268787|FG001|Overall Study|Inappropriate enrollment|0
7807392|NCT01148017|12268788|FG002|Overall Study|Inappropriate enrollment|0
7807393|NCT01148017|12268789|FG003|Overall Study|Inappropriate enrollment|0
7807394|NCT01148017|12268786|FG000|Overall Study|Administrative reason|22
7807395|NCT01148017|12268787|FG001|Overall Study|Administrative reason|9
7807396|NCT01148017|12268788|FG002|Overall Study|Administrative reason|0
7807397|NCT01148017|12268789|FG003|Overall Study|Administrative reason|0
7807398|NCT01148017|12268786|FG000|Overall Study|Unable to classify|3
7807399|NCT01148017|12268787|FG001|Overall Study|Unable to classify|1
7807400|NCT01148017|12268788|FG002|Overall Study|Unable to classify|0
7807401|NCT01148017|12268789|FG003|Overall Study|Unable to classify|0
7807402|NCT01148225|12268800|FG000|Overall Study|Other|185
7807403|NCT01148459|12268814|FG000|Overall Study|Serious Adverse Event|5
7807404|NCT01148459|12268815|FG001|Overall Study|Serious Adverse Event|4
7807405|NCT01148459|12268814|FG000|Overall Study|Withdrawal by Subject|1
7807406|NCT01148459|12268815|FG001|Overall Study|Withdrawal by Subject|0
7807407|NCT01148459|12268814|FG000|Overall Study|Migrated/moved from study area|3
7807408|NCT01148459|12268815|FG001|Overall Study|Migrated/moved from study area|6
7807409|NCT01148459|12268814|FG000|Overall Study|Lost to Follow-up|2
7807410|NCT01148459|12268815|FG001|Overall Study|Lost to Follow-up|0
7807411|NCT01148459|12268814|FG000|Overall Study|Refusal|1
7807412|NCT01148459|12268815|FG001|Overall Study|Refusal|0
7807413|NCT01148459|12268814|FG000|Overall Study|Failure to comply with study procedures|0
7807414|NCT01148459|12268815|FG001|Overall Study|Failure to comply with study procedures|1
7807415|NCT01148511|12268823|FG000|Exposed to Study Drug|Protocol Violation|2
7807416|NCT01148511|12268824|FG001|Exposed to Study Drug|Protocol Violation|0
7807417|NCT01148511|12268825|FG002|Exposed to Study Drug|Protocol Violation|0
7807418|NCT01148511|12268823|FG000|Exposed to Study Drug|Lost to Follow-up|4
7807419|NCT01148511|12268824|FG001|Exposed to Study Drug|Lost to Follow-up|0
7807420|NCT01148511|12268825|FG002|Exposed to Study Drug|Lost to Follow-up|0
7807421|NCT01148511|12268823|FG000|Randomized|Adverse Event|0
7807422|NCT01148511|12268824|FG001|Randomized|Adverse Event|1
7807423|NCT01148511|12268825|FG002|Randomized|Adverse Event|0
7807424|NCT01148511|12268823|FG000|Randomized|Protocol Violation|0
7807425|NCT01148511|12268824|FG001|Randomized|Protocol Violation|2
7807426|NCT01148511|12268825|FG002|Randomized|Protocol Violation|1
7807427|NCT01148511|12268823|FG000|Randomized|Lost to Follow-up|0
7807428|NCT01148511|12268824|FG001|Randomized|Lost to Follow-up|1
7807429|NCT01148511|12268825|FG002|Randomized|Lost to Follow-up|1
7807430|NCT01148511|12268823|FG000|Randomized|Consent withdrawal|0
7807431|NCT01148511|12268824|FG001|Randomized|Consent withdrawal|5
7807432|NCT01148511|12268825|FG002|Randomized|Consent withdrawal|3
7807433|NCT01148511|12268823|FG000|Randomized|Other|0
7807434|NCT01148511|12268824|FG001|Randomized|Other|1
7807435|NCT01148511|12268825|FG002|Randomized|Other|1
7887121|NCT01814748|12388626|FG000|Overall Study|Study site terminated by sponsor|1
7887122|NCT01814748|12388627|FG001|Overall Study|Study site terminated by sponsor|1
7887123|NCT01814748|12388626|FG000|Overall Study|Withdrawal by Subject|6
7887124|NCT01814748|12388627|FG001|Overall Study|Withdrawal by Subject|4
7887125|NCT01814761|12388635|FG000|Overall Study|Other Reasons|1
7887126|NCT01814761|12388636|FG001|Overall Study|Other Reasons|10
7887127|NCT01814761|12388635|FG000|Overall Study|Ocular Adverse Event|6
7887128|NCT01814761|12388636|FG001|Overall Study|Ocular Adverse Event|15
7887129|NCT01814761|12388635|FG000|Overall Study|Lost to Follow-up|1
7887130|NCT01814761|12388636|FG001|Overall Study|Lost to Follow-up|5
7887131|NCT01814800|12388657|FG000|Overall Study|Adverse Event|2
7887132|NCT01814800|12388657|FG000|Overall Study|Pregnancy|1
7887133|NCT01814800|12388657|FG000|Overall Study|Sponsor decision|1
7887134|NCT01814800|12388657|FG000|Overall Study|Subject relocation|1
7887135|NCT01814878|12388676|FG000|Overall Study|Adverse Event|16
7887136|NCT01814878|12388677|FG001|Overall Study|Adverse Event|5
7887137|NCT01814878|12388676|FG000|Overall Study|Withdrawal by Subject|20
7887138|NCT01814878|12388677|FG001|Overall Study|Withdrawal by Subject|16
7887139|NCT01814878|12388676|FG000|Overall Study|Protocol Violation|5
7967763|NCT02774278|12525039|FG000|Overall Study|Withdrawal by Subject|3
7967764|NCT02774278|12525039|FG000|Overall Study|Protocol Violation|2
7967765|NCT02774681|12525067|FG000|Treatment on Study|Progressive Disease|7
7967766|NCT02774681|12525067|FG000|Follow-Up for 3 Years|Death|11
7967767|NCT02774681|12525067|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1
7967768|NCT02775344|12525110|FG000|Overall Study|No ovarian cyst identified|3
7967769|NCT02775344|12525111|FG001|Overall Study|No ovarian cyst identified|2
7967770|NCT02775864|12525130|FG000|Overall Study|Data ended end of 2010|1764
7967771|NCT02775864|12525131|FG001|Overall Study|Data ended end of 2010|2880
7967772|NCT02775864|12525132|FG002|Overall Study|Data ended end of 2010|1140
7967773|NCT02775864|12525133|FG003|Overall Study|Data ended end of 2010|1194
7967774|NCT02775864|12525130|FG000|Overall Study|Medicaid eligibility discontinued|1478
7967775|NCT02775864|12525131|FG001|Overall Study|Medicaid eligibility discontinued|2019
7967776|NCT02775864|12525132|FG002|Overall Study|Medicaid eligibility discontinued|720
7967777|NCT02775864|12525133|FG003|Overall Study|Medicaid eligibility discontinued|890
7967778|NCT02775916|12525146|FG000|Overall Study|Adverse Event|1
7967779|NCT02775916|12525147|FG001|Overall Study|Adverse Event|0
7967780|NCT02775916|12525146|FG000|Overall Study|Subject/Guardian Decision|2
7967781|NCT02775916|12525147|FG001|Overall Study|Subject/Guardian Decision|0
7967782|NCT02776033|12525156|FG000|Overall Study|Withdrawal by Subject|0
7967783|NCT02776033|12525157|FG001|Overall Study|Withdrawal by Subject|0
7967784|NCT02776033|12525158|FG002|Overall Study|Withdrawal by Subject|2
7967785|NCT02776033|12525156|FG000|Overall Study|Physician Decision|2
7967786|NCT02776033|12525157|FG001|Overall Study|Physician Decision|0
7967787|NCT02776033|12525158|FG002|Overall Study|Physician Decision|0
7967788|NCT02776033|12525156|FG000|Overall Study|Lost to Follow-up|1
7967789|NCT02776033|12525157|FG001|Overall Study|Lost to Follow-up|0
7967790|NCT02776033|12525158|FG002|Overall Study|Lost to Follow-up|0
7967791|NCT02776033|12525156|FG000|Overall Study|Adverse Event|1
7967792|NCT02776033|12525157|FG001|Overall Study|Adverse Event|2
7967793|NCT02776033|12525158|FG002|Overall Study|Adverse Event|0
7967794|NCT02776553|12525174|FG000|Overall Study|Lost to Follow-up|1
7967795|NCT02776553|12525175|FG001|Overall Study|Lost to Follow-up|0
7967796|NCT02776553|12525174|FG000|Overall Study|got liver transplant|1
7967797|NCT02776553|12525175|FG001|Overall Study|got liver transplant|2
7967798|NCT02776553|12525174|FG000|Overall Study|had other surgery|1
7967799|NCT02776553|12525175|FG001|Overall Study|had other surgery|0
7967800|NCT02776553|12525174|FG000|Overall Study|Protocol Violation|0
7887140|NCT01814878|12388677|FG001|Overall Study|Protocol Violation|5
7887141|NCT01814878|12388676|FG000|Overall Study|Physician Decision|3
7887142|NCT01814878|12388677|FG001|Overall Study|Physician Decision|1
7887143|NCT01814878|12388676|FG000|Overall Study|Screening failure (drop-out)|0
7967801|NCT02776553|12525175|FG001|Overall Study|Protocol Violation|1
7967802|NCT02776670|12525192|FG000|Overall Study|Adverse Event|0
7807436|NCT01148537|12268872|FG000|Overall Study|Withdrawal by Subject|1
7807437|NCT01148537|12268873|FG001|Overall Study|Withdrawal by Subject|0
7887144|NCT01814878|12388677|FG001|Overall Study|Screening failure (drop-out)|3
7967803|NCT02776670|12525193|FG001|Overall Study|Adverse Event|2
7967804|NCT02776670|12525192|FG000|Overall Study|Protocol Violation|0
7967805|NCT02776670|12525193|FG001|Overall Study|Protocol Violation|2
7967806|NCT02776670|12525192|FG000|Overall Study|Withdrawal by Subject|0
7967807|NCT02776670|12525193|FG001|Overall Study|Withdrawal by Subject|1
7967808|NCT02776670|12525192|FG000|Overall Study|Other - Reason not given|0
7967809|NCT02776670|12525193|FG001|Overall Study|Other - Reason not given|1
7807438|NCT01148537|12268874|FG002|Overall Study|Withdrawal by Subject|2
7807439|NCT01148537|12268872|FG000|Overall Study|Adverse Event|2
7807440|NCT01148537|12268873|FG001|Overall Study|Adverse Event|0
7807441|NCT01148537|12268874|FG002|Overall Study|Adverse Event|1
7807442|NCT01148693|12268895|FG000|Overall Study|Attempts for cannulation were failed|13
7807443|NCT01148693|12268896|FG001|Overall Study|Attempts for cannulation were failed|10
7807444|NCT01148771|12268910|FG000|Washout Period|Withdrawal by Subject|0
7807445|NCT01148771|12268911|FG001|Washout Period|Withdrawal by Subject|1
7807446|NCT01148810|12268923|FG000|Overall Study|Adverse Event|0
7807447|NCT01148810|12268924|FG001|Overall Study|Adverse Event|2
7807448|NCT01148810|12268923|FG000|Overall Study|Lack of Efficacy|0
7807449|NCT01148810|12268924|FG001|Overall Study|Lack of Efficacy|1
7807450|NCT01148810|12268923|FG000|Overall Study|Withdrawal by Subject|0
7807451|NCT01148810|12268924|FG001|Overall Study|Withdrawal by Subject|2
7807452|NCT01148810|12268923|FG000|Overall Study|Protocol Violation|1
7807453|NCT01148810|12268924|FG001|Overall Study|Protocol Violation|0
7807454|NCT01148862|12268940|FG000|Second Intervention|Withdrawal by Subject|0
7807455|NCT01148862|12268941|FG001|Second Intervention|Withdrawal by Subject|2
7807456|NCT01148979|12268961|FG000|Overall Study|Lost to Follow-up|0
7807457|NCT01148979|12268962|FG001|Overall Study|Lost to Follow-up|1
7807458|NCT01149057|12268968|FG000|Overall Study|Lack of Efficacy|16
7807459|NCT01149057|12268968|FG000|Overall Study|Adverse Event|13
7807460|NCT01149057|12268968|FG000|Overall Study|Withdrawal by Subject|9
7807461|NCT01149057|12268968|FG000|Overall Study|Positive Hepatitis B Core Antibody|5
7807462|NCT01149057|12268968|FG000|Overall Study|B Cell Depletion|4
7807463|NCT01149057|12268968|FG000|Overall Study|Participant Non-Compliance|2
7807464|NCT01149057|12268968|FG000|Overall Study|Lost to Follow-up|1
7807465|NCT01149057|12268968|FG000|Overall Study|High Parathyroid Hormone Value|1
7807466|NCT01149057|12268968|FG000|Overall Study|Other|6
7807467|NCT01149096|12268974|FG000|Overall Study|Lost to Follow-up|0
7807468|NCT01149096|12268975|FG001|Overall Study|Lost to Follow-up|1
7807469|NCT01149148|12268984|FG000|Overall Study|Lost to Follow-up|1
7807470|NCT01149148|12268985|FG001|Overall Study|Lost to Follow-up|2
7887145|NCT01814878|12388676|FG000|Overall Study|Other|2
7887146|NCT01814878|12388677|FG001|Overall Study|Other|0
7887147|NCT01815099|12388689|FG000|Overall Study|Lack of Efficacy|1
7887148|NCT01815099|12388689|FG000|Overall Study|unable to attend study visits|1
7887149|NCT01815138|12388696|FG000|Overall Study|Withdrawal by Subject|0
7887150|NCT01815138|12388697|FG001|Overall Study|Withdrawal by Subject|1
7887151|NCT01815138|12388696|FG000|Overall Study|Physician Decision|8
7887152|NCT01815138|12388697|FG001|Overall Study|Physician Decision|5
7887153|NCT01815424|12388722|FG000|Week 0 to 16|Adverse Event|1
7887154|NCT01815424|12388723|FG001|Week 0 to 16|Adverse Event|3
7887155|NCT01815424|12388724|FG002|Week 0 to 16|Adverse Event|3
7887156|NCT01815424|12388725|FG003|Week 0 to 16|Adverse Event|0
7887157|NCT01815424|12388726|FG004|Week 0 to 16|Adverse Event|0
7887158|NCT01815424|12388722|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2
7887159|NCT01815424|12388723|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0
7887160|NCT01815424|12388724|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0
7887161|NCT01815424|12388725|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0
7887162|NCT01815424|12388726|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0
7887163|NCT01815424|12388722|FG000|Week 0 to 16|Lost to Follow-up|0
7887164|NCT01815424|12388723|FG001|Week 0 to 16|Lost to Follow-up|1
7887165|NCT01815424|12388724|FG002|Week 0 to 16|Lost to Follow-up|0
7887166|NCT01815424|12388725|FG003|Week 0 to 16|Lost to Follow-up|0
7887167|NCT01815424|12388726|FG004|Week 0 to 16|Lost to Follow-up|0
7887168|NCT01815424|12388722|FG000|Week 0 to 16|Withdrawal by Subject|0
7887169|NCT01815424|12388723|FG001|Week 0 to 16|Withdrawal by Subject|0
7887170|NCT01815424|12388724|FG002|Week 0 to 16|Withdrawal by Subject|1
7887171|NCT01815424|12388725|FG003|Week 0 to 16|Withdrawal by Subject|0
7887172|NCT01815424|12388726|FG004|Week 0 to 16|Withdrawal by Subject|0
7887173|NCT01815424|12388722|FG000|Week 0 to 16|Other|1
7887174|NCT01815424|12388723|FG001|Week 0 to 16|Other|0
7887175|NCT01815424|12388724|FG002|Week 0 to 16|Other|3
7887176|NCT01815424|12388725|FG003|Week 0 to 16|Other|0
7887177|NCT01815424|12388726|FG004|Week 0 to 16|Other|0
7887178|NCT01815424|12388722|FG000|Week 0 to 16|Protocol Violation|1
7887179|NCT01815424|12388723|FG001|Week 0 to 16|Protocol Violation|0
7887180|NCT01815424|12388724|FG002|Week 0 to 16|Protocol Violation|0
7887181|NCT01815424|12388725|FG003|Week 0 to 16|Protocol Violation|0
7887182|NCT01815424|12388726|FG004|Week 0 to 16|Protocol Violation|0
7887183|NCT01815424|12388722|FG000|Week 0 to 16|Insufficient Clinical Response|2
7887184|NCT01815424|12388723|FG001|Week 0 to 16|Insufficient Clinical Response|0
7887185|NCT01815424|12388724|FG002|Week 0 to 16|Insufficient Clinical Response|4
7887186|NCT01815424|12388725|FG003|Week 0 to 16|Insufficient Clinical Response|0
7887187|NCT01815424|12388726|FG004|Week 0 to 16|Insufficient Clinical Response|0
7807471|NCT01149148|12268984|FG000|Overall Study|Death|1
7887188|NCT01815424|12388722|FG000|Week 16 to 52|Other|0
7807472|NCT01149148|12268985|FG001|Overall Study|Death|0
7887189|NCT01815424|12388723|FG001|Week 16 to 52|Other|1
7887190|NCT01815424|12388724|FG002|Week 16 to 52|Other|0
7887191|NCT01815424|12388725|FG003|Week 16 to 52|Other|0
7887192|NCT01815424|12388726|FG004|Week 16 to 52|Other|0
7887193|NCT01815424|12388722|FG000|Week 16 to 52|Adverse Event|0
7887194|NCT01815424|12388723|FG001|Week 16 to 52|Adverse Event|0
7887195|NCT01815424|12388724|FG002|Week 16 to 52|Adverse Event|0
7807473|NCT01149343|12268996|FG000|Overall Study|Withdrawal by Subject|1
7807474|NCT01149343|12268997|FG001|Overall Study|Withdrawal by Subject|1
7807475|NCT01149343|12268998|FG002|Overall Study|Withdrawal by Subject|1
7807476|NCT01149343|12268999|FG003|Overall Study|Withdrawal by Subject|5
7807477|NCT01149343|12268996|FG000|Overall Study|Death|10
7807478|NCT01149343|12268997|FG001|Overall Study|Death|13
7807479|NCT01149343|12268998|FG002|Overall Study|Death|18
7807480|NCT01149343|12268999|FG003|Overall Study|Death|18
7807481|NCT01149343|12268996|FG000|Overall Study|Lost to Follow-up|1
7807482|NCT01149343|12268997|FG001|Overall Study|Lost to Follow-up|0
7807483|NCT01149343|12268998|FG002|Overall Study|Lost to Follow-up|0
7807484|NCT01149343|12268999|FG003|Overall Study|Lost to Follow-up|1
7807485|NCT01149343|12268996|FG000|Overall Study|Other|8
7807486|NCT01149343|12268997|FG001|Overall Study|Other|10
7807487|NCT01149343|12268998|FG002|Overall Study|Other|2
7807488|NCT01149343|12268999|FG003|Overall Study|Other|14
7807489|NCT01149343|12268996|FG000|Overall Study|Sponsor study termination|0
7807490|NCT01149343|12268997|FG001|Overall Study|Sponsor study termination|0
7807491|NCT01149343|12268998|FG002|Overall Study|Sponsor study termination|0
7807492|NCT01149343|12268999|FG003|Overall Study|Sponsor study termination|2
7807493|NCT01149343|12268996|FG000|Overall Study|Recurrence / Progressive disease|0
7807494|NCT01149343|12268997|FG001|Overall Study|Recurrence / Progressive disease|0
7807495|NCT01149343|12268998|FG002|Overall Study|Recurrence / Progressive disease|1
7807496|NCT01149343|12268999|FG003|Overall Study|Recurrence / Progressive disease|0
7807497|NCT01149369|12269015|FG000|Overall Study|Adverse Event|6
7807498|NCT01149369|12269016|FG001|Overall Study|Adverse Event|3
7807499|NCT01149421|12269025|FG000|Overall Study|Adverse Event|22
7807500|NCT01149421|12269026|FG001|Overall Study|Adverse Event|6
7807501|NCT01149421|12269027|FG002|Overall Study|Adverse Event|11
7807502|NCT01149421|12269025|FG000|Overall Study|Withdrawal by Subject|20
7807503|NCT01149421|12269026|FG001|Overall Study|Withdrawal by Subject|12
7807504|NCT01149421|12269027|FG002|Overall Study|Withdrawal by Subject|13
7807505|NCT01149421|12269025|FG000|Overall Study|Sponsor Decision|0
7807506|NCT01149421|12269026|FG001|Overall Study|Sponsor Decision|1
7807507|NCT01149421|12269027|FG002|Overall Study|Sponsor Decision|1
7807508|NCT01149421|12269025|FG000|Overall Study|Lost to Follow-up|2
7807509|NCT01149421|12269026|FG001|Overall Study|Lost to Follow-up|4
7807510|NCT01149421|12269027|FG002|Overall Study|Lost to Follow-up|5
7807511|NCT01149421|12269025|FG000|Overall Study|Physician Decision|5
7807512|NCT01149421|12269026|FG001|Overall Study|Physician Decision|3
7807513|NCT01149421|12269027|FG002|Overall Study|Physician Decision|6
7807514|NCT01149421|12269025|FG000|Overall Study|Entry Criteria Not Met|1
7807515|NCT01149421|12269026|FG001|Overall Study|Entry Criteria Not Met|1
7807516|NCT01149421|12269027|FG002|Overall Study|Entry Criteria Not Met|2
7807517|NCT01149421|12269025|FG000|Overall Study|Protocol Violation|2
7807518|NCT01149421|12269026|FG001|Overall Study|Protocol Violation|2
7807519|NCT01149421|12269027|FG002|Overall Study|Protocol Violation|6
7807520|NCT01149460|12269047|FG000|Overall Study|Withdrawal by Subject|0
7807521|NCT01149460|12269048|FG001|Overall Study|Withdrawal by Subject|2
7807522|NCT01149473|12269056|FG000|First Intervention|Adverse Event|1
7807523|NCT01149473|12269057|FG001|First Intervention|Adverse Event|1
7807524|NCT01149473|12269056|FG000|Washout of 7 Days|Withdrawal by Subject|1
7807525|NCT01149473|12269057|FG001|Washout of 7 Days|Withdrawal by Subject|1
7807526|NCT01149486|12269065|FG000|First Intervention|Adverse Event|0
7807527|NCT01149486|12269066|FG001|First Intervention|Adverse Event|1
7807528|NCT01149538|12269078|FG000|Overall Study|Lost to Follow-up|0
7807529|NCT01149538|12269079|FG001|Overall Study|Lost to Follow-up|1
7807530|NCT01149538|12269078|FG000|Overall Study|Withdrawal by Subject|5
7807531|NCT01149538|12269079|FG001|Overall Study|Withdrawal by Subject|3
7807532|NCT01149655|12269098|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1
7807533|NCT01149655|12269099|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0
7807534|NCT01149655|12269100|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0
7807535|NCT01149655|12269101|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0
7807536|NCT01149655|12269098|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
7807537|NCT01149655|12269099|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
7807538|NCT01149655|12269100|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
7807539|NCT01149655|12269101|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
7807540|NCT01149655|12269098|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
7807541|NCT01149655|12269099|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
7807542|NCT01149655|12269100|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
7807543|NCT01149655|12269101|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
7807544|NCT01149655|12269098|FG000|Period 1 - Conversion Phase|Physician Decision|2
7807545|NCT01149655|12269099|FG001|Period 1 - Conversion Phase|Physician Decision|0
7807546|NCT01149655|12269100|FG002|Period 1 - Conversion Phase|Physician Decision|0
7807547|NCT01149655|12269101|FG003|Period 1 - Conversion Phase|Physician Decision|0
7807548|NCT01149655|12269098|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7
7807549|NCT01149655|12269099|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0
7807550|NCT01149655|12269100|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0
7807551|NCT01149655|12269101|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0
7807552|NCT01149655|12269098|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
7807553|NCT01149655|12269099|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
7807554|NCT01149655|12269100|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
7807555|NCT01149655|12269101|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
7807556|NCT01149655|12269098|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
7807557|NCT01149655|12269099|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
7807558|NCT01149655|12269100|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
7807559|NCT01149655|12269101|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
7807560|NCT01149655|12269098|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
7807561|NCT01149655|12269099|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
7807562|NCT01149655|12269100|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
7807563|NCT01149655|12269101|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
7807564|NCT01149655|12269098|FG000|Period 2-Stabilization Phase|Physician Decision|0
7807565|NCT01149655|12269099|FG001|Period 2-Stabilization Phase|Physician Decision|3
7807566|NCT01149655|12269100|FG002|Period 2-Stabilization Phase|Physician Decision|0
7807567|NCT01149655|12269101|FG003|Period 2-Stabilization Phase|Physician Decision|0
7807568|NCT01149655|12269098|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0
7807569|NCT01149655|12269099|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5
7807570|NCT01149655|12269100|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0
7807571|NCT01149655|12269101|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0
7807572|NCT01149655|12269098|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
7807573|NCT01149655|12269099|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
7807574|NCT01149655|12269100|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
7807575|NCT01149655|12269101|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
7887196|NCT01815424|12388725|FG003|Week 16 to 52|Adverse Event|0
7887197|NCT01815424|12388726|FG004|Week 16 to 52|Adverse Event|1
7887198|NCT01815424|12388722|FG000|Week 16 to 52|Insufficient Clinical Response|1
7887199|NCT01815424|12388723|FG001|Week 16 to 52|Insufficient Clinical Response|0
7887200|NCT01815424|12388724|FG002|Week 16 to 52|Insufficient Clinical Response|0
7887201|NCT01815424|12388725|FG003|Week 16 to 52|Insufficient Clinical Response|1
7887202|NCT01815424|12388726|FG004|Week 16 to 52|Insufficient Clinical Response|1
7887203|NCT01815424|12388722|FG000|Week 16 to 52|Lost to Follow-up|0
7887204|NCT01815424|12388723|FG001|Week 16 to 52|Lost to Follow-up|2
7887205|NCT01815424|12388724|FG002|Week 16 to 52|Lost to Follow-up|0
7887206|NCT01815424|12388725|FG003|Week 16 to 52|Lost to Follow-up|2
7887207|NCT01815424|12388726|FG004|Week 16 to 52|Lost to Follow-up|1
7887208|NCT01815424|12388722|FG000|Week 16 to 52|Withdrawal by Subject|1
7887209|NCT01815424|12388723|FG001|Week 16 to 52|Withdrawal by Subject|2
7887210|NCT01815424|12388724|FG002|Week 16 to 52|Withdrawal by Subject|0
7887211|NCT01815424|12388725|FG003|Week 16 to 52|Withdrawal by Subject|0
7887212|NCT01815424|12388726|FG004|Week 16 to 52|Withdrawal by Subject|0
7887213|NCT01815736|12388777|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11
7887214|NCT01815736|12388778|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17
7887215|NCT01815736|12388777|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10
7887216|NCT01815736|12388778|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9
7887217|NCT01815736|12388777|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11
7887218|NCT01815736|12388778|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2
7887219|NCT01815736|12388777|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7
7887220|NCT01815736|12388778|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4
7887221|NCT01815736|12388777|FG000|Randomized Treatment Phase-Up to Week 96|Death|4
7887222|NCT01815736|12388778|FG001|Randomized Treatment Phase-Up to Week 96|Death|0
7887223|NCT01815736|12388777|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1
7887224|NCT01815736|12388778|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0
7887225|NCT01815736|12388777|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1
7887226|NCT01815736|12388778|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0
7887227|NCT01815736|12388777|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4
7887228|NCT01815736|12388778|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3
7887229|NCT01815736|12388777|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31
7887230|NCT01815736|12388778|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15
7887231|NCT01815736|12388777|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13
7887232|NCT01815736|12388778|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9
7887233|NCT01815736|12388777|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5
7887234|NCT01815736|12388778|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1
7887235|NCT01815736|12388777|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1
7887236|NCT01815736|12388778|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1
7887237|NCT01815736|12388777|FG000|Extension Treatment Phase- After Week 96|Death|1
7887238|NCT01815736|12388778|FG001|Extension Treatment Phase- After Week 96|Death|0
7887239|NCT01815840|12388788|FG000|Overall Study|Missing|1
7887240|NCT01815840|12388789|FG001|Overall Study|Missing|0
7887241|NCT01815840|12388788|FG000|Overall Study|Withdrew Consent|31
7887242|NCT01815840|12388789|FG001|Overall Study|Withdrew Consent|30
7807576|NCT01149655|12269098|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
7807577|NCT01149655|12269099|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
7807578|NCT01149655|12269100|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
7807579|NCT01149655|12269101|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
7807580|NCT01149655|12269098|FG000|Period 3-DB Maintenance Phase|Physician Decision|0
7807581|NCT01149655|12269099|FG001|Period 3-DB Maintenance Phase|Physician Decision|0
7807582|NCT01149655|12269100|FG002|Period 3-DB Maintenance Phase|Physician Decision|1
7807583|NCT01149655|12269101|FG003|Period 3-DB Maintenance Phase|Physician Decision|0
7807584|NCT01149655|12269098|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
7807585|NCT01149655|12269099|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
7807586|NCT01149655|12269100|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
7807587|NCT01149655|12269101|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
7807588|NCT01149655|12269098|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
7807589|NCT01149655|12269099|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
7807590|NCT01149655|12269100|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
7807591|NCT01149655|12269101|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
7807592|NCT01149655|12269098|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0
7807593|NCT01149655|12269099|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0
7807594|NCT01149655|12269100|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19
7807595|NCT01149655|12269101|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18
7807596|NCT01149681|12269109|FG000|Overall Study|Withdrawal by Subject|7
7807597|NCT01149681|12269109|FG000|Overall Study|Progressive disease|1
7807598|NCT01149681|12269109|FG000|Overall Study|Physician Decision|2
7807599|NCT01149681|12269109|FG000|Overall Study|adverse events nonrelated study drug|2
7807600|NCT01149863|12269145|FG000|Overall Study|Missing data or Not receiveing studydrug|3
7807601|NCT01150097|12269170|FG000|Months 24 to 36 Post-transplantation|Death|2
7807602|NCT01150097|12269171|FG001|Months 24 to 36 Post-transplantation|Death|0
7807603|NCT01150097|12269172|FG002|Months 24 to 36 Post-transplantation|Death|0
7807604|NCT01150097|12269170|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5
7807605|NCT01150097|12269171|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2
7807606|NCT01150097|12269172|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2
7807607|NCT01150097|12269170|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
7807608|NCT01150097|12269171|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
7807609|NCT01150097|12269172|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
7807610|NCT01150097|12269170|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
7807611|NCT01150097|12269171|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
7807612|NCT01150097|12269172|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
7807613|NCT01150097|12269170|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5
7807614|NCT01150097|12269171|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4
7807615|NCT01150097|12269172|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0
7807616|NCT01150097|12269170|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
7807617|NCT01150097|12269171|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
7807618|NCT01150097|12269172|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
7807619|NCT01150097|12269170|FG000|Months 24 to 48 Post-transplantation|Death|2
7807620|NCT01150097|12269171|FG001|Months 24 to 48 Post-transplantation|Death|0
7807621|NCT01150097|12269172|FG002|Months 24 to 48 Post-transplantation|Death|0
7807622|NCT01150123|12269200|FG000|Overall Study|Withdrawal by Subject|1
7807623|NCT01150123|12269201|FG001|Overall Study|Withdrawal by Subject|1
7807624|NCT01150123|12269202|FG002|Overall Study|Withdrawal by Subject|2
7807625|NCT01150123|12269203|FG003|Overall Study|Withdrawal by Subject|1
7807626|NCT01150123|12269204|FG004|Overall Study|Withdrawal by Subject|1
7807627|NCT01150123|12269205|FG005|Overall Study|Withdrawal by Subject|1
7807628|NCT01150123|12269206|FG006|Overall Study|Withdrawal by Subject|0
7807629|NCT01150123|12269207|FG007|Overall Study|Withdrawal by Subject|3
7807630|NCT01150123|12269208|FG008|Overall Study|Withdrawal by Subject|2
7807631|NCT01150123|12269209|FG009|Overall Study|Withdrawal by Subject|0
7807632|NCT01150123|12269210|FG010|Overall Study|Withdrawal by Subject|1
7807633|NCT01150123|12269211|FG011|Overall Study|Withdrawal by Subject|0
7807634|NCT01150123|12269212|FG012|Overall Study|Withdrawal by Subject|1
7807635|NCT01150123|12269213|FG013|Overall Study|Withdrawal by Subject|0
7807636|NCT01150123|12269214|FG014|Overall Study|Withdrawal by Subject|0
7807637|NCT01150123|12269215|FG015|Overall Study|Withdrawal by Subject|1
7807638|NCT01150123|12269216|FG016|Overall Study|Withdrawal by Subject|0
7807639|NCT01150123|12269217|FG017|Overall Study|Withdrawal by Subject|1
7807640|NCT01150123|12269200|FG000|Overall Study|Lost to Follow-up|2
7807641|NCT01150123|12269201|FG001|Overall Study|Lost to Follow-up|1
7807642|NCT01150123|12269202|FG002|Overall Study|Lost to Follow-up|2
7807643|NCT01150123|12269203|FG003|Overall Study|Lost to Follow-up|2
7807644|NCT01150123|12269204|FG004|Overall Study|Lost to Follow-up|2
7807645|NCT01150123|12269205|FG005|Overall Study|Lost to Follow-up|5
7807646|NCT01150123|12269206|FG006|Overall Study|Lost to Follow-up|0
7807647|NCT01150123|12269207|FG007|Overall Study|Lost to Follow-up|0
7807648|NCT01150123|12269208|FG008|Overall Study|Lost to Follow-up|3
7807649|NCT01150123|12269209|FG009|Overall Study|Lost to Follow-up|1
7807650|NCT01150123|12269210|FG010|Overall Study|Lost to Follow-up|1
7807651|NCT01150123|12269211|FG011|Overall Study|Lost to Follow-up|1
7887243|NCT01815840|12388788|FG000|Overall Study|Administrative/Other|1
7807652|NCT01150123|12269212|FG012|Overall Study|Lost to Follow-up|2
7807653|NCT01150123|12269213|FG013|Overall Study|Lost to Follow-up|0
7807654|NCT01150123|12269214|FG014|Overall Study|Lost to Follow-up|0
7807655|NCT01150123|12269215|FG015|Overall Study|Lost to Follow-up|0
7807656|NCT01150123|12269216|FG016|Overall Study|Lost to Follow-up|0
7807657|NCT01150123|12269217|FG017|Overall Study|Lost to Follow-up|0
7807658|NCT01150357|12269277|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0
7807659|NCT01150357|12269278|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1
7807660|NCT01150357|12269279|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1
7807661|NCT01150357|12269277|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
7807662|NCT01150357|12269278|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
7807663|NCT01150357|12269279|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
7807664|NCT01150357|12269277|FG000|Dose Response Phase (Phase 1)|Adverse Event|0
7807665|NCT01150357|12269278|FG001|Dose Response Phase (Phase 1)|Adverse Event|0
7807666|NCT01150357|12269279|FG002|Dose Response Phase (Phase 1)|Adverse Event|1
7807667|NCT01150357|12269277|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
7807668|NCT01150357|12269278|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
7807669|NCT01150357|12269279|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
7807670|NCT01150357|12269277|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
7807671|NCT01150357|12269278|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
7807672|NCT01150357|12269279|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
7807673|NCT01150357|12269277|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
7807674|NCT01150357|12269278|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
7807675|NCT01150357|12269279|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
7807676|NCT01150357|12269277|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
7807677|NCT01150357|12269278|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
7807678|NCT01150357|12269279|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
7807679|NCT01150474|12269310|FG000|Overall Study|Withdrawal by Subject|5
7807680|NCT01150474|12269311|FG001|Overall Study|Withdrawal by Subject|2
7807681|NCT01150474|12269310|FG000|Overall Study|Cancer found|1
7807682|NCT01150474|12269311|FG001|Overall Study|Cancer found|0
7807683|NCT01150474|12269310|FG000|Overall Study|Multiple Studies|0
7807684|NCT01150474|12269311|FG001|Overall Study|Multiple Studies|1
7807685|NCT01150474|12269310|FG000|Overall Study|Rectotomy|1
7807686|NCT01150474|12269311|FG001|Overall Study|Rectotomy|0
7807687|NCT01150474|12269310|FG000|Overall Study|Drug did not arrive in time|1
7807688|NCT01150474|12269311|FG001|Overall Study|Drug did not arrive in time|0
7807689|NCT01150474|12269310|FG000|Overall Study|Drug not administered|1
7807690|NCT01150474|12269311|FG001|Overall Study|Drug not administered|0
7807691|NCT01150474|12269310|FG000|Overall Study|Surgery Changed|1
7807692|NCT01150474|12269311|FG001|Overall Study|Surgery Changed|0
7807693|NCT01151020|12269366|FG000|Overall Study|Death|25
7807694|NCT01151020|12269366|FG000|Overall Study|Conversion to open repair|1
7807695|NCT01151020|12269366|FG000|Overall Study|Lost to Follow-up|4
7807696|NCT01151020|12269366|FG000|Overall Study|Withdrawal by Subject|22
7807697|NCT01151020|12269366|FG000|Overall Study|Patients did not receive the device|2
7807698|NCT01151085|12269383|FG000|Overall Study|Lost to Follow-up|31
7807699|NCT01151085|12269383|FG000|Overall Study|Protocol Violation|25
7807700|NCT01151098|12269394|FG000|Overall Study|Adverse Event|82
7807701|NCT01151098|12269394|FG000|Overall Study|Lost to Follow-up|6
7807702|NCT01151098|12269394|FG000|Overall Study|Lack of Efficacy|15
7807703|NCT01151098|12269394|FG000|Overall Study|Protocol Violation|1
7807704|NCT01151098|12269394|FG000|Overall Study|Miscellaneous|13
7807705|NCT01151137|12269400|FG000|Overall Study|Death|15
7807706|NCT01151137|12269401|FG001|Overall Study|Death|27
7807707|NCT01151137|12269400|FG000|Overall Study|Lost to Follow-up|1
7807708|NCT01151137|12269401|FG001|Overall Study|Lost to Follow-up|1
7807709|NCT01151215|12269419|FG000|Overall Study|Worsening of condition under study|1
7807710|NCT01151215|12269420|FG001|Overall Study|Worsening of condition under study|1
7807711|NCT01151215|12269421|FG002|Overall Study|Worsening of condition under study|1
7807712|NCT01151215|12269419|FG000|Overall Study|Death|16
7807713|NCT01151215|12269420|FG001|Overall Study|Death|20
7807714|NCT01151215|12269421|FG002|Overall Study|Death|11
7807715|NCT01151215|12269419|FG000|Overall Study|Lost to Follow-up|0
7807716|NCT01151215|12269420|FG001|Overall Study|Lost to Follow-up|0
7807717|NCT01151215|12269421|FG002|Overall Study|Lost to Follow-up|3
7807718|NCT01151215|12269419|FG000|Overall Study|Withdrawal by Subject|3
7807719|NCT01151215|12269420|FG001|Overall Study|Withdrawal by Subject|1
7807720|NCT01151215|12269421|FG002|Overall Study|Withdrawal by Subject|2
7807721|NCT01151215|12269419|FG000|Overall Study|Disease progression|0
7807722|NCT01151215|12269420|FG001|Overall Study|Disease progression|1
7807723|NCT01151215|12269421|FG002|Overall Study|Disease progression|1
7807724|NCT01151215|12269419|FG000|Overall Study|Safety as judged by the investigator|0
7807725|NCT01151215|12269420|FG001|Overall Study|Safety as judged by the investigator|0
7807726|NCT01151215|12269421|FG002|Overall Study|Safety as judged by the investigator|1
7807727|NCT01151280|12269429|FG000|Overall Study|Adverse Event|1
7807728|NCT01151280|12269429|FG000|Overall Study|Lack of Efficacy|3
7807729|NCT01151345|12269433|FG000|First Intervention Period|Protocol Violation|0
7807730|NCT01151345|12269434|FG001|First Intervention Period|Protocol Violation|1
7807731|NCT01151410|12269455|FG000|Overall Study|Withdrawal by Subject|3
7807732|NCT01151410|12269456|FG001|Overall Study|Withdrawal by Subject|5
7807733|NCT01151410|12269455|FG000|Overall Study|Lost to Follow-up|3
7807734|NCT01151410|12269456|FG001|Overall Study|Lost to Follow-up|4
7807735|NCT01151410|12269455|FG000|Overall Study|Adverse Event|1
7807736|NCT01151410|12269456|FG001|Overall Study|Adverse Event|2
7807737|NCT01151410|12269455|FG000|Overall Study|Protocol deviation|2
7807738|NCT01151410|12269456|FG001|Overall Study|Protocol deviation|1
7807739|NCT01151410|12269455|FG000|Overall Study|Administrative problems|1
7807740|NCT01151410|12269456|FG001|Overall Study|Administrative problems|1
7807741|NCT01151410|12269455|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7807742|NCT01151410|12269456|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7807743|NCT01151410|12269455|FG000|Overall Study|Abnormal laboratory value(s)|0
7807744|NCT01151410|12269456|FG001|Overall Study|Abnormal laboratory value(s)|1
7807745|NCT01151423|12269464|FG000|Overall Study|Study terminated by Sponsor|9
7807746|NCT01151423|12269465|FG001|Overall Study|Study terminated by Sponsor|10
7807747|NCT01151423|12269464|FG000|Overall Study|Protocol Violation|0
7807748|NCT01151423|12269465|FG001|Overall Study|Protocol Violation|1
7807749|NCT01151423|12269464|FG000|Overall Study|Physician Decision|1
7807750|NCT01151423|12269465|FG001|Overall Study|Physician Decision|1
7807751|NCT01151423|12269464|FG000|Overall Study|Pregnancy|0
7807752|NCT01151423|12269465|FG001|Overall Study|Pregnancy|1
7807753|NCT01151423|12269464|FG000|Overall Study|Death|0
7807754|NCT01151423|12269465|FG001|Overall Study|Death|1
7807755|NCT01151423|12269464|FG000|Overall Study|Adverse Event|3
7807756|NCT01151423|12269465|FG001|Overall Study|Adverse Event|0
7807757|NCT01151423|12269464|FG000|Overall Study|Withdrawal by Subject|1
7807758|NCT01151423|12269465|FG001|Overall Study|Withdrawal by Subject|3
7807759|NCT01151423|12269464|FG000|Overall Study|Lost to Follow-up|1
7807760|NCT01151423|12269465|FG001|Overall Study|Lost to Follow-up|0
7807761|NCT01151423|12269464|FG000|Overall Study|Diagnosed as non-TTP patient|0
7807762|NCT01151423|12269465|FG001|Overall Study|Diagnosed as non-TTP patient|1
7807763|NCT01151423|12269464|FG000|Overall Study|Participated in other clinical trial|1
7807764|NCT01151423|12269465|FG001|Overall Study|Participated in other clinical trial|0
7807765|NCT01151540|12269479|FG000|Overall Study|Other|2
7807766|NCT01151540|12269479|FG000|Overall Study|Adverse event, non-fatal|4
7807767|NCT01151540|12269479|FG000|Overall Study|Withdrawal by Subject|7
7807768|NCT01151579|12269485|FG000|Overall Study|Physician Decision|3
7807769|NCT01151579|12269486|FG001|Overall Study|Physician Decision|1
7807770|NCT01151579|12269485|FG000|Overall Study|Withdrawal by Subject|3
7807771|NCT01151579|12269486|FG001|Overall Study|Withdrawal by Subject|2
7807772|NCT01151579|12269485|FG000|Overall Study|Not meet inclusion criteria|6
7807773|NCT01151579|12269486|FG001|Overall Study|Not meet inclusion criteria|4
7807774|NCT01151618|12269492|FG000|Overall Study|Adverse Event|2
7807775|NCT01151618|12269492|FG000|Overall Study|Withdrawal by Subject|7
7807776|NCT01152021|12269519|FG000|Overall Study|Adverse Event|4
7807777|NCT01152021|12269520|FG001|Overall Study|Adverse Event|4
7807778|NCT01152021|12269519|FG000|Overall Study|Study drug had expired|1
7807779|NCT01152021|12269520|FG001|Overall Study|Study drug had expired|0
7807780|NCT01152021|12269519|FG000|Overall Study|Physician Decision|1
7807781|NCT01152021|12269520|FG001|Overall Study|Physician Decision|1
7807782|NCT01152021|12269519|FG000|Overall Study|No access to study drug in Pharmacy|0
7807783|NCT01152021|12269520|FG001|Overall Study|No access to study drug in Pharmacy|1
7807784|NCT01152190|12269539|FG000|Overall Study|Adverse Event|2
7807785|NCT01152190|12269540|FG001|Overall Study|Adverse Event|4
7807786|NCT01152190|12269539|FG000|Overall Study|Death|1
7807787|NCT01152190|12269540|FG001|Overall Study|Death|0
7807788|NCT01152190|12269539|FG000|Overall Study|Protocol Violation|1
7807789|NCT01152190|12269540|FG001|Overall Study|Protocol Violation|1
7807790|NCT01152190|12269539|FG000|Overall Study|Withdrawal by Subject|1
7807791|NCT01152190|12269540|FG001|Overall Study|Withdrawal by Subject|3
7807792|NCT01152385|12269577|FG000|Overall Study|Withdrawal by Subject|3
7807793|NCT01152385|12269578|FG001|Overall Study|Withdrawal by Subject|1
7807794|NCT01152385|12269579|FG002|Overall Study|Withdrawal by Subject|1
7807795|NCT01152385|12269580|FG003|Overall Study|Withdrawal by Subject|1
7807796|NCT01152385|12269577|FG000|Overall Study|Protocol Violation|0
7807797|NCT01152385|12269578|FG001|Overall Study|Protocol Violation|0
7807798|NCT01152385|12269579|FG002|Overall Study|Protocol Violation|0
7807799|NCT01152385|12269580|FG003|Overall Study|Protocol Violation|1
7807800|NCT01152385|12269577|FG000|Overall Study|Adverse Event|1
7807801|NCT01152385|12269578|FG001|Overall Study|Adverse Event|1
7807802|NCT01152385|12269579|FG002|Overall Study|Adverse Event|0
7807803|NCT01152385|12269580|FG003|Overall Study|Adverse Event|0
7807804|NCT01152385|12269577|FG000|Overall Study|Study-specific withdrawal criteria|1
7807805|NCT01152385|12269578|FG001|Overall Study|Study-specific withdrawal criteria|1
7807806|NCT01152385|12269579|FG002|Overall Study|Study-specific withdrawal criteria|2
7807807|NCT01152385|12269580|FG003|Overall Study|Study-specific withdrawal criteria|0
7807808|NCT01152385|12269577|FG000|Overall Study|Other|4
7807809|NCT01152385|12269578|FG001|Overall Study|Other|3
7807810|NCT01152385|12269579|FG002|Overall Study|Other|2
7807811|NCT01152385|12269580|FG003|Overall Study|Other|3
7807812|NCT01152437|12269597|FG000|Overall Study|Other Adverse Event|8
7807813|NCT01152437|12269598|FG001|Overall Study|Other Adverse Event|1
7807814|NCT01152437|12269599|FG002|Overall Study|Other Adverse Event|7
7807815|NCT01152437|12269597|FG000|Overall Study|Not treated|0
7807816|NCT01152437|12269598|FG001|Overall Study|Not treated|1
7807817|NCT01152437|12269599|FG002|Overall Study|Not treated|2
7807818|NCT01152437|12269597|FG000|Overall Study|Progressive disease|27
7807819|NCT01152437|12269598|FG001|Overall Study|Progressive disease|13
7807820|NCT01152437|12269599|FG002|Overall Study|Progressive disease|32
7807821|NCT01152437|12269597|FG000|Overall Study|Refusal to continue taking trial medicat|1
7807822|NCT01152437|12269598|FG001|Overall Study|Refusal to continue taking trial medicat|0
7807823|NCT01152437|12269599|FG002|Overall Study|Refusal to continue taking trial medicat|2
7807824|NCT01152450|12269609|FG000|Period 1 (4 Weeks)|Adverse Event|0
7807825|NCT01152450|12269610|FG001|Period 1 (4 Weeks)|Adverse Event|0
7807826|NCT01152450|12269611|FG002|Period 1 (4 Weeks)|Adverse Event|0
7807827|NCT01152450|12269612|FG003|Period 1 (4 Weeks)|Adverse Event|0
7807828|NCT01152450|12269613|FG004|Period 1 (4 Weeks)|Adverse Event|1
7807829|NCT01152450|12269614|FG005|Period 1 (4 Weeks)|Adverse Event|1
7807830|NCT01152450|12269609|FG000|Period 1 (4 Weeks)|Protocol Violation|0
7807831|NCT01152450|12269610|FG001|Period 1 (4 Weeks)|Protocol Violation|0
7807832|NCT01152450|12269611|FG002|Period 1 (4 Weeks)|Protocol Violation|0
7807833|NCT01152450|12269612|FG003|Period 1 (4 Weeks)|Protocol Violation|0
7807834|NCT01152450|12269613|FG004|Period 1 (4 Weeks)|Protocol Violation|1
7807835|NCT01152450|12269614|FG005|Period 1 (4 Weeks)|Protocol Violation|0
7807836|NCT01152450|12269609|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0
7807837|NCT01152450|12269610|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1
7807838|NCT01152450|12269611|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1
7807839|NCT01152450|12269612|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0
7807840|NCT01152450|12269613|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0
7807841|NCT01152450|12269614|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0
7807842|NCT01152554|12269633|FG000|Overall Study|Withdrawal by Subject|73
7807843|NCT01152554|12269634|FG001|Overall Study|Withdrawal by Subject|28
7807844|NCT01152554|12269633|FG000|Overall Study|Eligiblity criteria not fulfilled|0
7807845|NCT01152554|12269634|FG001|Overall Study|Eligiblity criteria not fulfilled|1
7807846|NCT01152554|12269633|FG000|Overall Study|Adverse Event|67
7807847|NCT01152554|12269634|FG001|Overall Study|Adverse Event|14
7807848|NCT01152554|12269633|FG000|Overall Study|Severe non-compliance to protocol|36
7807849|NCT01152554|12269634|FG001|Overall Study|Severe non-compliance to protocol|14
7807850|NCT01152554|12269633|FG000|Overall Study|Condition under investigation worsened|5
7807851|NCT01152554|12269634|FG001|Overall Study|Condition under investigation worsened|2
7807852|NCT01152554|12269633|FG000|Overall Study|Lack of Efficacy|20
7807853|NCT01152554|12269634|FG001|Overall Study|Lack of Efficacy|3
7807854|NCT01152554|12269633|FG000|Overall Study|Study-specific withdrawal criteria|17
7807855|NCT01152554|12269634|FG001|Overall Study|Study-specific withdrawal criteria|8
7807856|NCT01152554|12269633|FG000|Overall Study|Lost to Follow-up|87
7807857|NCT01152554|12269634|FG001|Overall Study|Lost to Follow-up|32
7807858|NCT01152554|12269633|FG000|Overall Study|Other|28
7807859|NCT01152554|12269634|FG001|Overall Study|Other|8
7807860|NCT01152554|12269633|FG000|Overall Study|Death|1
7807861|NCT01152554|12269634|FG001|Overall Study|Death|1
7807862|NCT01152580|12269642|FG000|Overall Study|Withdrawal by Subject|0
7807863|NCT01152580|12269643|FG001|Overall Study|Withdrawal by Subject|1
7861727|NCT01597245|12351195|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861728|NCT01597245|12351196|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861729|NCT01597245|12351197|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861730|NCT01597245|12351198|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861731|NCT01597245|12351199|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861732|NCT01597245|12351200|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861733|NCT01597245|12351201|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861734|NCT01597245|12351202|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861735|NCT01597245|12351203|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861736|NCT01597245|12351204|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861737|NCT01597245|12351205|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861738|NCT01597245|12351206|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861739|NCT01597245|12351207|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861740|NCT01597245|12351208|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0
7861741|NCT01597245|12351188|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
7861742|NCT01597245|12351189|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
7861743|NCT01597245|12351190|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
7861744|NCT01597245|12351191|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
7861745|NCT01597245|12351192|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861746|NCT01597245|12351193|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861747|NCT01597245|12351194|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861748|NCT01597245|12351195|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861749|NCT01597245|12351196|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861750|NCT01597245|12351197|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861751|NCT01597245|12351198|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861752|NCT01597245|12351199|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861753|NCT01597245|12351200|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861754|NCT01597245|12351201|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861755|NCT01597245|12351202|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7887244|NCT01815840|12388789|FG001|Overall Study|Administrative/Other|3
7807864|NCT01152788|12269655|FG000|Overall Study|Withdrawal by Subject|0
7807865|NCT01152788|12269656|FG001|Overall Study|Withdrawal by Subject|3
7807866|NCT01152788|12269655|FG000|Overall Study|No treatment|0
7807867|NCT01152788|12269656|FG001|Overall Study|No treatment|1
7807868|NCT01152814|12269662|FG000|Overall Study|Lost to Follow-up|2
7807869|NCT01152996|12269666|FG000|Overall Study|Withdrawal by Subject|142
7807870|NCT01152996|12269666|FG000|Overall Study|Adverse Event|115
7807871|NCT01152996|12269666|FG000|Overall Study|Lost to Follow-up|112
7807872|NCT01152996|12269666|FG000|Overall Study|Lack of Efficacy|68
7807873|NCT01152996|12269666|FG000|Overall Study|Noncompliance|41
7807874|NCT01152996|12269666|FG000|Overall Study|Other|36
7807875|NCT01152996|12269666|FG000|Overall Study|Protocol Violation|22
7807876|NCT01152996|12269666|FG000|Overall Study|Elevated liver enzymes|1
7807877|NCT01153009|12269674|FG000|Overall Study|Adverse Event|4
7807878|NCT01153009|12269675|FG001|Overall Study|Adverse Event|14
7807879|NCT01153009|12269676|FG002|Overall Study|Adverse Event|14
7807880|NCT01153009|12269677|FG003|Overall Study|Adverse Event|10
7807881|NCT01153009|12269674|FG000|Overall Study|Lack of Efficacy|9
7807882|NCT01153009|12269675|FG001|Overall Study|Lack of Efficacy|0
7807883|NCT01153009|12269676|FG002|Overall Study|Lack of Efficacy|2
7807884|NCT01153009|12269677|FG003|Overall Study|Lack of Efficacy|1
7807885|NCT01153009|12269674|FG000|Overall Study|Noncompliance with Study Medication|1
7807886|NCT01153009|12269675|FG001|Overall Study|Noncompliance with Study Medication|3
7807887|NCT01153009|12269676|FG002|Overall Study|Noncompliance with Study Medication|4
7807888|NCT01153009|12269677|FG003|Overall Study|Noncompliance with Study Medication|1
7807889|NCT01153009|12269674|FG000|Overall Study|Protocol Deviations|4
7807890|NCT01153009|12269675|FG001|Overall Study|Protocol Deviations|3
7807891|NCT01153009|12269676|FG002|Overall Study|Protocol Deviations|3
7807892|NCT01153009|12269677|FG003|Overall Study|Protocol Deviations|2
7807893|NCT01153009|12269674|FG000|Overall Study|Withdrawal of Consent|5
7807894|NCT01153009|12269675|FG001|Overall Study|Withdrawal of Consent|5
7807895|NCT01153009|12269676|FG002|Overall Study|Withdrawal of Consent|4
7807896|NCT01153009|12269677|FG003|Overall Study|Withdrawal of Consent|6
7807897|NCT01153009|12269674|FG000|Overall Study|Lost to Follow-up|8
7807898|NCT01153009|12269675|FG001|Overall Study|Lost to Follow-up|8
7807899|NCT01153009|12269676|FG002|Overall Study|Lost to Follow-up|11
7807900|NCT01153009|12269677|FG003|Overall Study|Lost to Follow-up|15
7807901|NCT01153009|12269674|FG000|Overall Study|Other|1
7807902|NCT01153009|12269675|FG001|Overall Study|Other|1
7807903|NCT01153009|12269676|FG002|Overall Study|Other|3
7807904|NCT01153009|12269677|FG003|Overall Study|Other|2
7807905|NCT01153269|12269687|FG000|Overall Study|Withdrawal by Subject|1
7807906|NCT01153269|12269687|FG000|Overall Study|Antiretroviral therapy break|1
7807907|NCT01153321|12269696|FG000|Overall Study|Development of study withdrawal criteria|0
7807908|NCT01153321|12269697|FG001|Overall Study|Development of study withdrawal criteria|1
7807909|NCT01153321|12269696|FG000|Overall Study|Withdrawal by Subject|0
7807910|NCT01153321|12269697|FG001|Overall Study|Withdrawal by Subject|1
7807911|NCT01153321|12269696|FG000|Overall Study|Adverse Event|1
7807912|NCT01153321|12269697|FG001|Overall Study|Adverse Event|1
7807913|NCT01153347|12269707|FG000|Overall Study|Withdrawal by Subject|7
7807914|NCT01153347|12269708|FG001|Overall Study|Withdrawal by Subject|7
7807915|NCT01153347|12269709|FG002|Overall Study|Withdrawal by Subject|7
7807916|NCT01153347|12269710|FG003|Overall Study|Withdrawal by Subject|7
7807917|NCT01153347|12269707|FG000|Overall Study|Eligibility criteria not fulfilled|0
7807918|NCT01153347|12269708|FG001|Overall Study|Eligibility criteria not fulfilled|1
7807919|NCT01153347|12269709|FG002|Overall Study|Eligibility criteria not fulfilled|2
7807920|NCT01153347|12269710|FG003|Overall Study|Eligibility criteria not fulfilled|1
7807921|NCT01153347|12269707|FG000|Overall Study|Adverse Event|3
7807922|NCT01153347|12269708|FG001|Overall Study|Adverse Event|9
7807923|NCT01153347|12269709|FG002|Overall Study|Adverse Event|21
7807924|NCT01153347|12269710|FG003|Overall Study|Adverse Event|7
7807925|NCT01153347|12269707|FG000|Overall Study|Severe non-compliance to protocol|6
7807926|NCT01153347|12269708|FG001|Overall Study|Severe non-compliance to protocol|7
7807927|NCT01153347|12269709|FG002|Overall Study|Severe non-compliance to protocol|4
7807928|NCT01153347|12269710|FG003|Overall Study|Severe non-compliance to protocol|3
7807929|NCT01153347|12269707|FG000|Overall Study|Condition under investigation worsened|1
7807930|NCT01153347|12269708|FG001|Overall Study|Condition under investigation worsened|1
7807931|NCT01153347|12269709|FG002|Overall Study|Condition under investigation worsened|0
7807932|NCT01153347|12269710|FG003|Overall Study|Condition under investigation worsened|0
7807933|NCT01153347|12269707|FG000|Overall Study|Lack of Efficacy|2
7967810|NCT02776683|12525199|FG000|Pre-switch Period|Protocol Violation|1
7807934|NCT01153347|12269708|FG001|Overall Study|Lack of Efficacy|2
7807935|NCT01153347|12269709|FG002|Overall Study|Lack of Efficacy|0
7807936|NCT01153347|12269710|FG003|Overall Study|Lack of Efficacy|4
7807937|NCT01153347|12269707|FG000|Overall Study|Study-specific withdrawal criteria|4
7807938|NCT01153347|12269708|FG001|Overall Study|Study-specific withdrawal criteria|3
7807939|NCT01153347|12269709|FG002|Overall Study|Study-specific withdrawal criteria|1
7807940|NCT01153347|12269710|FG003|Overall Study|Study-specific withdrawal criteria|2
7807941|NCT01153347|12269707|FG000|Overall Study|Lost to Follow-up|4
7807942|NCT01153347|12269708|FG001|Overall Study|Lost to Follow-up|9
7807943|NCT01153347|12269709|FG002|Overall Study|Lost to Follow-up|11
7807944|NCT01153347|12269710|FG003|Overall Study|Lost to Follow-up|8
7967811|NCT02776683|12525200|FG001|Pre-switch Period|Protocol Violation|0
7807945|NCT01153347|12269707|FG000|Overall Study|Other|5
7807946|NCT01153347|12269708|FG001|Overall Study|Other|5
7807947|NCT01153347|12269709|FG002|Overall Study|Other|4
7807948|NCT01153347|12269710|FG003|Overall Study|Other|0
7807949|NCT01153347|12269707|FG000|Overall Study|Death|1
7807950|NCT01153347|12269708|FG001|Overall Study|Death|0
7807951|NCT01153347|12269709|FG002|Overall Study|Death|0
7807952|NCT01153347|12269710|FG003|Overall Study|Death|0
7807953|NCT01153425|12269722|FG000|Overall Study|Withdrawal by Subject|3
7807954|NCT01153425|12269723|FG001|Overall Study|Withdrawal by Subject|3
7887245|NCT01815840|12388788|FG000|Overall Study|Adverse Event|10
7887246|NCT01815840|12388789|FG001|Overall Study|Adverse Event|16
7887247|NCT01815840|12388788|FG000|Overall Study|Death|2
7887248|NCT01815840|12388789|FG001|Overall Study|Death|2
7887249|NCT01815840|12388788|FG000|Overall Study|Disease progression|3
7887250|NCT01815840|12388789|FG001|Overall Study|Disease progression|2
7887251|NCT01815840|12388788|FG000|Overall Study|Investigators Decision|2
7887252|NCT01815840|12388789|FG001|Overall Study|Investigators Decision|3
7887253|NCT01815840|12388788|FG000|Overall Study|Lost to Follow-up|3
7887254|NCT01815840|12388789|FG001|Overall Study|Lost to Follow-up|6
7887255|NCT01815840|12388788|FG000|Overall Study|Refused Treatment|5
7887256|NCT01815840|12388789|FG001|Overall Study|Refused Treatment|1
7887257|NCT01815840|12388788|FG000|Overall Study|Sponsor Termination Treatment|1
7887258|NCT01815840|12388789|FG001|Overall Study|Sponsor Termination Treatment|0
7887259|NCT01815918|12388797|FG000|Overall Study|Patient samples not analyzable|3
7887260|NCT01815918|12388798|FG001|Overall Study|Patient samples not analyzable|4
7887261|NCT01815918|12388797|FG000|Overall Study|Lack of Efficacy|15
7887262|NCT01815918|12388798|FG001|Overall Study|Lack of Efficacy|15
7887263|NCT01816048|12388808|FG000|Overall Study|Adverse Event|1
7887264|NCT01816048|12388808|FG000|Overall Study|Death|1
7887265|NCT01816048|12388808|FG000|Overall Study|Withdrawal by Subject|1
7887266|NCT01816048|12388808|FG000|Overall Study|Disease Progression|3
7887267|NCT01816061|12388815|FG000|Overall Study|Lost to Follow-up|13
7887268|NCT01816061|12388816|FG001|Overall Study|Lost to Follow-up|24
7887269|NCT01816074|12388826|FG000|Phase 1|Time commitment issues|0
7887270|NCT01816074|12388827|FG001|Phase 1|Time commitment issues|0
7887271|NCT01816074|12388828|FG002|Phase 1|Time commitment issues|1
7887272|NCT01816074|12388829|FG003|Phase 1|Time commitment issues|0
7887273|NCT01816074|12388826|FG000|Phase 2|Time commitment Issues|0
7887274|NCT01816074|12388827|FG001|Phase 2|Time commitment Issues|2
7887275|NCT01816074|12388828|FG002|Phase 2|Time commitment Issues|0
7887276|NCT01816074|12388829|FG003|Phase 2|Time commitment Issues|0
7887277|NCT01816074|12388826|FG000|Phase 2|Unsatisfied with Randomization assignmen|1
7887278|NCT01816074|12388827|FG001|Phase 2|Unsatisfied with Randomization assignmen|0
7887279|NCT01816074|12388828|FG002|Phase 2|Unsatisfied with Randomization assignmen|0
7887280|NCT01816074|12388829|FG003|Phase 2|Unsatisfied with Randomization assignmen|0
7887281|NCT01816074|12388826|FG000|Phase 2|Physician Decision|0
7887282|NCT01816074|12388827|FG001|Phase 2|Physician Decision|0
7887283|NCT01816074|12388828|FG002|Phase 2|Physician Decision|0
7887284|NCT01816074|12388829|FG003|Phase 2|Physician Decision|1
7887285|NCT01816074|12388826|FG000|Phase 2|Withdrawal by Subject|1
7887286|NCT01816074|12388827|FG001|Phase 2|Withdrawal by Subject|0
7887287|NCT01816074|12388828|FG002|Phase 2|Withdrawal by Subject|0
7967812|NCT02776683|12525199|FG000|Pre-switch Period|Adverse Event|21
7967813|NCT02776683|12525200|FG001|Pre-switch Period|Adverse Event|0
7967814|NCT02776683|12525199|FG000|Pre-switch Period|Withdrawal by Subject|9
7967815|NCT02776683|12525200|FG001|Pre-switch Period|Withdrawal by Subject|0
7967816|NCT02776683|12525199|FG000|Pre-switch Period|Physician Decision|7
7967817|NCT02776683|12525200|FG001|Pre-switch Period|Physician Decision|0
7967818|NCT02776683|12525199|FG000|Pre-switch Period|Progressive disease|39
7967819|NCT02776683|12525200|FG001|Pre-switch Period|Progressive disease|0
7967820|NCT02776683|12525199|FG000|Pre-switch Period|Other than listed|3
7967821|NCT02776683|12525200|FG001|Pre-switch Period|Other than listed|0
7967822|NCT02776683|12525199|FG000|Post-switch Period|Adverse Event|0
7967823|NCT02776683|12525200|FG001|Post-switch Period|Adverse Event|3
7967824|NCT02776683|12525199|FG000|Post-switch Period|Withdrawal by Subject|0
7967825|NCT02776683|12525200|FG001|Post-switch Period|Withdrawal by Subject|2
7967826|NCT02776683|12525199|FG000|Post-switch Period|Physician Decision|0
7967827|NCT02776683|12525200|FG001|Post-switch Period|Physician Decision|3
7967828|NCT02776683|12525199|FG000|Post-switch Period|Progressive disease|0
7967829|NCT02776683|12525200|FG001|Post-switch Period|Progressive disease|20
7967830|NCT02776683|12525199|FG000|Post-switch Period|Other than listed|0
7967831|NCT02776683|12525200|FG001|Post-switch Period|Other than listed|15
7967832|NCT02777086|12525235|FG000|Overall Study|Lost to Follow-up|96
7967833|NCT02777086|12525236|FG001|Overall Study|Lost to Follow-up|99
7807955|NCT01153516|12269745|FG000|Overall Study|Both subjects refused surgery|2
7807956|NCT01153516|12269746|FG001|Overall Study|Both subjects refused surgery|0
7887288|NCT01816074|12388829|FG003|Phase 2|Withdrawal by Subject|0
7887289|NCT01816243|12388857|FG000|Overall Study|Adverse Event|6
7887290|NCT01816243|12388857|FG000|Overall Study|Lost to Follow-up|1
7887291|NCT01816243|12388857|FG000|Overall Study|Lack of Efficacy|1
7887292|NCT01816243|12388857|FG000|Overall Study|Not eligible for the study|1
7887293|NCT01816243|12388857|FG000|Overall Study|Amputation|3
7887294|NCT01816295|12388863|FG000|Double Blind Phase|Adverse Event|11
7887295|NCT01816295|12388864|FG001|Double Blind Phase|Adverse Event|8
7807957|NCT01153633|12269773|FG000|Overall Study|Protocol Violation|1
7807958|NCT01153633|12269774|FG001|Overall Study|Protocol Violation|1
7807959|NCT01153633|12269773|FG000|Overall Study|Therapeutic failure|3
7807960|NCT01153633|12269774|FG001|Overall Study|Therapeutic failure|3
7807961|NCT01153698|12269795|FG000|Overall Study|Adverse Event|12
7807962|NCT01153698|12269795|FG000|Overall Study|Lost to Follow-up|4
7807963|NCT01153698|12269795|FG000|Overall Study|Withdrawal by Subject|2
7807964|NCT01153698|12269795|FG000|Overall Study|Switch to other anticoagulants|4
7807965|NCT01153698|12269795|FG000|Overall Study|Other|2
7807966|NCT01153698|12269795|FG000|Overall Study|Not treated with Pradaxa|5
7807967|NCT01153724|12269806|FG000|Treatment Period 1|Withdrawal by Subject|1
7807968|NCT01153724|12269806|FG000|Treatment Period 2|Adverse Event|1
7807969|NCT01153724|12269806|FG000|Treatment Period 2|Other reason not defined above|1
7807970|NCT01153763|12269812|FG000|Overall Study|Study Closed|16
7807971|NCT01153763|12269812|FG000|Overall Study|Lost to Follow-up|1
7807972|NCT01153763|12269812|FG000|Overall Study|Physician Decision|2
7807973|NCT01153763|12269812|FG000|Overall Study|Withdrawal by Subject|2
7807974|NCT01153815|12269818|FG000|Overall Study|Adverse Event|3
7807975|NCT01153815|12269819|FG001|Overall Study|Adverse Event|1
7807976|NCT01153815|12269818|FG000|Overall Study|Withdrawal by Subject|6
7807977|NCT01153815|12269819|FG001|Overall Study|Withdrawal by Subject|4
7807978|NCT01153841|12269827|FG000|Overall Study|Adverse Event|1
7807979|NCT01153841|12269828|FG001|Overall Study|Adverse Event|0
7807980|NCT01153841|12269827|FG000|Overall Study|Withdrawal by Subject|1
7807981|NCT01153841|12269828|FG001|Overall Study|Withdrawal by Subject|0
7887296|NCT01816295|12388863|FG000|Double Blind Phase|Entry Criteria Not Met|0
7887297|NCT01816295|12388864|FG001|Double Blind Phase|Entry Criteria Not Met|2
7887298|NCT01816295|12388863|FG000|Double Blind Phase|Lost to Follow-up|3
7887299|NCT01816295|12388864|FG001|Double Blind Phase|Lost to Follow-up|5
7887300|NCT01816295|12388863|FG000|Double Blind Phase|Physician Decision|2
7887301|NCT01816295|12388864|FG001|Double Blind Phase|Physician Decision|2
7887302|NCT01816295|12388863|FG000|Double Blind Phase|Protocol Violation|17
7887303|NCT01816295|12388864|FG001|Double Blind Phase|Protocol Violation|11
7887304|NCT01816295|12388863|FG000|Double Blind Phase|Sponsor Decision|8
7887305|NCT01816295|12388864|FG001|Double Blind Phase|Sponsor Decision|8
7887306|NCT01816295|12388863|FG000|Double Blind Phase|Withdrawal by Subject|22
7887307|NCT01816295|12388864|FG001|Double Blind Phase|Withdrawal by Subject|20
7887308|NCT01816295|12388863|FG000|OLE Phase|Adverse Event|17
7887309|NCT01816295|12388864|FG001|OLE Phase|Adverse Event|15
7887310|NCT01816295|12388863|FG000|OLE Phase|Death|1
7887311|NCT01816295|12388864|FG001|OLE Phase|Death|0
7887312|NCT01816295|12388863|FG000|OLE Phase|Entry Criteria Not Met|3
7887313|NCT01816295|12388864|FG001|OLE Phase|Entry Criteria Not Met|5
7887314|NCT01816295|12388863|FG000|OLE Phase|Lost to Follow-up|5
7887315|NCT01816295|12388864|FG001|OLE Phase|Lost to Follow-up|5
7887316|NCT01816295|12388863|FG000|OLE Phase|Physician Decision|3
7887317|NCT01816295|12388864|FG001|OLE Phase|Physician Decision|1
7887318|NCT01816295|12388863|FG000|OLE Phase|Protocol Violation|4
7887319|NCT01816295|12388864|FG001|OLE Phase|Protocol Violation|4
7887320|NCT01816295|12388863|FG000|OLE Phase|Sponsor Decision|7
7887321|NCT01816295|12388864|FG001|OLE Phase|Sponsor Decision|9
7887322|NCT01816295|12388863|FG000|OLE Phase|Withdrawal by Subject|10
7887323|NCT01816295|12388864|FG001|OLE Phase|Withdrawal by Subject|10
7887324|NCT01816295|12388863|FG000|OLE Phase|Lack of Efficacy|3
7887325|NCT01816295|12388864|FG001|OLE Phase|Lack of Efficacy|7
7887326|NCT01816477|12388888|FG000|Overall Study|Withdrawal by Subject|13
7887327|NCT01816477|12388889|FG001|Overall Study|Withdrawal by Subject|1
7967834|NCT02777125|12525244|FG000|Overall Study|Consent form violation|14
7967835|NCT02777125|12525245|FG001|Overall Study|Consent form violation|12
7967836|NCT02777125|12525244|FG000|Overall Study|Assent form violation|21
7967837|NCT02777125|12525245|FG001|Overall Study|Assent form violation|23
7967838|NCT02777125|12525244|FG000|Overall Study|Protocol Violation|8
7967839|NCT02777125|12525245|FG001|Overall Study|Protocol Violation|12
7967840|NCT02777242|12525252|FG000|Overall Study|Other|2
7967841|NCT02777242|12525252|FG000|Overall Study|Lost to Follow-up|1
7967842|NCT02777242|12525252|FG000|Overall Study|Multiple|1
7967843|NCT02777242|12525252|FG000|Overall Study|Sponsor's request|1
7967844|NCT02777242|12525252|FG000|Overall Study|Withdrawal by Subject|1
7967845|NCT02777333|12525280|FG000|Overall Study|Withdrawal by Subject|0
7807982|NCT01153841|12269827|FG000|Overall Study|Protocol Violation|2
7807983|NCT01153841|12269828|FG001|Overall Study|Protocol Violation|0
7807984|NCT01153841|12269827|FG000|Overall Study|Lost to Follow-up|2
7807985|NCT01153841|12269828|FG001|Overall Study|Lost to Follow-up|0
7807986|NCT01153893|12269836|FG000|Overall Study|Adverse Event|1
7807987|NCT01153893|12269837|FG001|Overall Study|Adverse Event|0
7807988|NCT01153958|12269845|FG000|Overall Study|Study Terminated|36
7807989|NCT01153958|12269846|FG001|Overall Study|Study Terminated|32
7807990|NCT01153971|12269852|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
7887328|NCT01816477|12388888|FG000|Overall Study|Unable to tolerate catheter placement|3
7887329|NCT01816477|12388889|FG001|Overall Study|Unable to tolerate catheter placement|0
7887330|NCT01816594|12388897|FG000|Overall Study|Local Progress|0
7887331|NCT01816594|12388898|FG001|Overall Study|Local Progress|2
7887332|NCT01816594|12388897|FG000|Overall Study|Adverse Event|9
7887333|NCT01816594|12388898|FG001|Overall Study|Adverse Event|0
7887334|NCT01816594|12388897|FG000|Overall Study|Withdrawal by Subject|1
7807991|NCT01153971|12269852|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
7807992|NCT01153971|12269852|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
7807993|NCT01153971|12269852|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
7807994|NCT01153971|12269852|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1
7807995|NCT01153971|12269852|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1
7807996|NCT01153971|12269852|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2
7807997|NCT01153984|12269856|FG000|Overall Study|Withdrawal by Subject|1
7807998|NCT01153984|12269856|FG000|Overall Study|Adverse Event|1
7807999|NCT01154010|12269862|FG000|Overall Study|Lost to Follow-up|0
7808000|NCT01154010|12269863|FG001|Overall Study|Lost to Follow-up|1
7808001|NCT01154088|12269872|FG000|Overall Study|Lost to Follow-up|4
7808002|NCT01154088|12269873|FG001|Overall Study|Lost to Follow-up|6
7808003|NCT01154088|12269874|FG002|Overall Study|Lost to Follow-up|7
7808004|NCT01154101|12269888|FG000|Overall Study|Adverse Event|0
7808005|NCT01154101|12269889|FG001|Overall Study|Adverse Event|2
7808006|NCT01154101|12269890|FG002|Overall Study|Adverse Event|1
7808007|NCT01154101|12269891|FG003|Overall Study|Adverse Event|1
7967846|NCT02777333|12525281|FG001|Overall Study|Withdrawal by Subject|1
7967847|NCT02777333|12525280|FG000|Overall Study|Lost to Follow-up|0
7967848|NCT02777333|12525281|FG001|Overall Study|Lost to Follow-up|1
7808008|NCT01154101|12269892|FG004|Overall Study|Adverse Event|0
7808009|NCT01154101|12269888|FG000|Overall Study|Lost to Follow-up|0
7808010|NCT01154101|12269889|FG001|Overall Study|Lost to Follow-up|1
7808011|NCT01154101|12269890|FG002|Overall Study|Lost to Follow-up|0
7808012|NCT01154101|12269891|FG003|Overall Study|Lost to Follow-up|1
7808013|NCT01154101|12269892|FG004|Overall Study|Lost to Follow-up|0
7808014|NCT01154101|12269888|FG000|Overall Study|Withdrawal by Subject|0
7808015|NCT01154101|12269889|FG001|Overall Study|Withdrawal by Subject|1
7808016|NCT01154101|12269890|FG002|Overall Study|Withdrawal by Subject|2
7808017|NCT01154101|12269891|FG003|Overall Study|Withdrawal by Subject|0
7808018|NCT01154101|12269892|FG004|Overall Study|Withdrawal by Subject|1
7808019|NCT01154127|12269911|FG000|Period 1 (21 Days)|Adverse Event|3
7808020|NCT01154127|12269912|FG001|Period 1 (21 Days)|Adverse Event|4
7808021|NCT01154127|12269911|FG000|Period 1 (21 Days)|Withdrawal by Subject|0
7808022|NCT01154127|12269912|FG001|Period 1 (21 Days)|Withdrawal by Subject|2
7808023|NCT01154127|12269911|FG000|Washout (14 - 28 Days)|Adverse Event|2
7808024|NCT01154127|12269912|FG001|Washout (14 - 28 Days)|Adverse Event|0
7808025|NCT01154127|12269911|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1
7887335|NCT01816594|12388898|FG001|Overall Study|Withdrawal by Subject|0
7887336|NCT01816594|12388897|FG000|Overall Study|Physician Decision|1
7887337|NCT01816594|12388898|FG001|Overall Study|Physician Decision|0
7887338|NCT01816685|12388912|FG000|Overall Study|Lost to Follow-up|7
7887339|NCT01816685|12388913|FG001|Overall Study|Lost to Follow-up|9
7887340|NCT01816685|12388912|FG000|Overall Study|Surgery Cancelled|3
7887341|NCT01816685|12388913|FG001|Overall Study|Surgery Cancelled|2
7887342|NCT01816763|12388931|FG000|Overall Study|The main reason for an incomplete survey|4
7887343|NCT01816763|12388932|FG001|Overall Study|The main reason for an incomplete survey|15
7887344|NCT01816763|12388933|FG002|Overall Study|The main reason for an incomplete survey|11
7887345|NCT01816893|12388955|FG000|Washout Period|Withdrawal by Subject|2
7887346|NCT01816893|12388956|FG001|Washout Period|Withdrawal by Subject|0
7887347|NCT01816906|12388964|FG000|Six Months|Did Not Show Up for Baseline Measurement|7
7887348|NCT01816906|12388965|FG001|Six Months|Did Not Show Up for Baseline Measurement|6
7887349|NCT01816906|12388964|FG000|Six Months|Lost to Follow-up|14
7887350|NCT01816906|12388965|FG001|Six Months|Lost to Follow-up|16
7887351|NCT01816906|12388964|FG000|12 Months|Adverse Event|2
7887352|NCT01816906|12388965|FG001|12 Months|Adverse Event|2
7887353|NCT01816906|12388964|FG000|12 Months|Death|0
7887354|NCT01816906|12388965|FG001|12 Months|Death|2
7887355|NCT01816906|12388964|FG000|12 Months|Lost to Follow-up|2
7887356|NCT01816906|12388965|FG001|12 Months|Lost to Follow-up|1
7887357|NCT01816984|12388981|FG000|Overall Study|declining health status|1
7887358|NCT01817075|12388987|FG000|Overall Study|Adverse Event|7
7887359|NCT01817075|12388988|FG001|Overall Study|Adverse Event|5
7887360|NCT01817075|12388987|FG000|Overall Study|Physician Decision|9
7887361|NCT01817075|12388988|FG001|Overall Study|Physician Decision|12
7967849|NCT05283499|12525289|FG000|Overall Study|Did not receive intervention|1
7967850|NCT05283499|12525290|FG001|Overall Study|Did not receive intervention|2
7967851|NCT04919317|12525298|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0
7967852|NCT04919317|12525299|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5
7967853|NCT04919317|12525298|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12
7967854|NCT04919317|12525299|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6
7887362|NCT01817075|12388987|FG000|Overall Study|Withdrawal by Subject|31
7887363|NCT01817075|12388988|FG001|Overall Study|Withdrawal by Subject|15
7887364|NCT01817075|12388987|FG000|Overall Study|Received Sorafenib after enrollment|0
7887365|NCT01817075|12388988|FG001|Overall Study|Received Sorafenib after enrollment|1
7887366|NCT01817075|12388987|FG000|Overall Study|Ineligible|0
7887367|NCT01817075|12388988|FG001|Overall Study|Ineligible|2
7887368|NCT01817530|12389018|FG000|Overall Study|Exclusionary Medication Received|0
7887369|NCT01817530|12389019|FG001|Overall Study|Exclusionary Medication Received|0
7887370|NCT01817530|12389020|FG002|Overall Study|Exclusionary Medication Received|0
7887371|NCT01817530|12389021|FG003|Overall Study|Exclusionary Medication Received|0
7887372|NCT01817530|12389022|FG004|Overall Study|Exclusionary Medication Received|1
7887373|NCT01817530|12389023|FG005|Overall Study|Exclusionary Medication Received|0
7887374|NCT01817530|12389024|FG006|Overall Study|Exclusionary Medication Received|0
7887375|NCT01817530|12389025|FG007|Overall Study|Exclusionary Medication Received|0
7808026|NCT01154127|12269912|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0
7808027|NCT01154127|12269911|FG000|Period 2 (21 Days)|Protocol Deviation|0
7808028|NCT01154127|12269912|FG001|Period 2 (21 Days)|Protocol Deviation|1
7808029|NCT01154140|12269920|FG000|Overall Study|Death|71
7808030|NCT01154140|12269921|FG001|Overall Study|Death|81
7808031|NCT01154140|12269920|FG000|Overall Study|Lost to Follow-up|4
7808032|NCT01154140|12269921|FG001|Overall Study|Lost to Follow-up|5
7808033|NCT01154140|12269920|FG000|Overall Study|Withdrawal by Subject|12
7808034|NCT01154140|12269921|FG001|Overall Study|Withdrawal by Subject|13
7808035|NCT01154140|12269920|FG000|Overall Study|Other|3
7808036|NCT01154140|12269921|FG001|Overall Study|Other|1
7808037|NCT01154140|12269920|FG000|Overall Study|Randomized but not treated|1
7808038|NCT01154140|12269921|FG001|Overall Study|Randomized but not treated|2
7808039|NCT01154153|12269929|FG000|Overall Study|Poor compliance to protocol|2
7808040|NCT01154153|12269930|FG001|Overall Study|Poor compliance to protocol|0
7808041|NCT01154153|12269929|FG000|Overall Study|Unable to use labs|2
7808042|NCT01154153|12269930|FG001|Overall Study|Unable to use labs|3
7808043|NCT01154153|12269929|FG000|Overall Study|Withdrew consent|1
7808044|NCT01154153|12269930|FG001|Overall Study|Withdrew consent|0
7808045|NCT01154166|12269938|FG000|Overall Study|Adverse Event|14
7808046|NCT01154166|12269939|FG001|Overall Study|Adverse Event|9
7808047|NCT01154166|12269938|FG000|Overall Study|Lost to Follow-up|1
7808048|NCT01154166|12269939|FG001|Overall Study|Lost to Follow-up|1
7808049|NCT01154166|12269938|FG000|Overall Study|Protocol Violation|4
7808050|NCT01154166|12269939|FG001|Overall Study|Protocol Violation|1
7808051|NCT01154166|12269938|FG000|Overall Study|Withdrawal by Subject|10
7808052|NCT01154166|12269939|FG001|Overall Study|Withdrawal by Subject|1
7808053|NCT01154166|12269938|FG000|Overall Study|Lack of Efficacy|3
7808054|NCT01154166|12269939|FG001|Overall Study|Lack of Efficacy|0
7808055|NCT01154166|12269938|FG000|Overall Study|Disease Progression|1
7808056|NCT01154166|12269939|FG001|Overall Study|Disease Progression|0
7808057|NCT01154166|12269938|FG000|Overall Study|Poor Compliance|1
7808058|NCT01154166|12269939|FG001|Overall Study|Poor Compliance|0
7808059|NCT01154218|12269959|FG000|Third Intervention Period|Adverse Event|0
7808060|NCT01154218|12269960|FG001|Third Intervention Period|Adverse Event|1
7808061|NCT01154218|12269961|FG002|Third Intervention Period|Adverse Event|0
7808062|NCT01154218|12269962|FG003|Third Intervention Period|Adverse Event|0
7808063|NCT01154218|12269959|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7808064|NCT01154218|12269960|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7808065|NCT01154218|12269961|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7808066|NCT01154218|12269962|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
7808067|NCT01154218|12269959|FG000|Fourth Intervention Period|Withdrawal by Subject|1
7808068|NCT01154218|12269960|FG001|Fourth Intervention Period|Withdrawal by Subject|0
7808069|NCT01154218|12269961|FG002|Fourth Intervention Period|Withdrawal by Subject|0
7808070|NCT01154218|12269962|FG003|Fourth Intervention Period|Withdrawal by Subject|0
7808071|NCT01154231|12269972|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1
7808072|NCT01154231|12269972|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1
7808073|NCT01154283|12269978|FG000|0-6 Weeks|Withdrawal by Subject|7
7808074|NCT01154283|12269979|FG001|0-6 Weeks|Withdrawal by Subject|2
7808075|NCT01154283|12269978|FG000|0-6 Weeks|Death|0
7808076|NCT01154283|12269979|FG001|0-6 Weeks|Death|1
7808077|NCT01154283|12269978|FG000|7-12 Weeks|Death|1
7808078|NCT01154283|12269979|FG001|7-12 Weeks|Death|0
7808079|NCT01154283|12269978|FG000|7-12 Weeks|Withdrawal by Subject|0
7808080|NCT01154283|12269979|FG001|7-12 Weeks|Withdrawal by Subject|1
7808081|NCT01154296|12269987|FG000|Randomization and Intervention|Decided to decline|1
7808082|NCT01154296|12269988|FG001|Randomization and Intervention|Decided to decline|1
7808083|NCT01154296|12269987|FG000|Randomization and Intervention|Declined by staff|1
7808084|NCT01154296|12269988|FG001|Randomization and Intervention|Declined by staff|0
7967855|NCT04537949|12525387|FG000|Overall Study|personal reasons not related to the IMP|1
7808085|NCT01154296|12269987|FG000|Randomization and Intervention|Did not return|1
7808086|NCT01154296|12269988|FG001|Randomization and Intervention|Did not return|0
7808087|NCT01154296|12269987|FG000|Randomization and Intervention|Left before test|0
7808088|NCT01154296|12269988|FG001|Randomization and Intervention|Left before test|1
7808089|NCT01154296|12269987|FG000|Randomization and Intervention|Left clinic early|2
7808090|NCT01154296|12269988|FG001|Randomization and Intervention|Left clinic early|0
7808091|NCT01154296|12269987|FG000|6-month Follow-up|Lost contact|269
7808092|NCT01154296|12269988|FG001|6-month Follow-up|Lost contact|275
7808093|NCT01154296|12269987|FG000|6-month Follow-up|Incarcerated|37
7808094|NCT01154296|12269988|FG001|6-month Follow-up|Incarcerated|32
7887376|NCT01817530|12389018|FG000|Overall Study|Adverse Event|6
7887377|NCT01817530|12389019|FG001|Overall Study|Adverse Event|3
7887378|NCT01817530|12389020|FG002|Overall Study|Adverse Event|2
7887379|NCT01817530|12389021|FG003|Overall Study|Adverse Event|5
7887380|NCT01817530|12389022|FG004|Overall Study|Adverse Event|0
7887381|NCT01817530|12389023|FG005|Overall Study|Adverse Event|10
7887382|NCT01817530|12389024|FG006|Overall Study|Adverse Event|5
7887383|NCT01817530|12389025|FG007|Overall Study|Adverse Event|8
7887384|NCT01817530|12389018|FG000|Overall Study|Subject Noncompliant|3
7808095|NCT01154296|12269987|FG000|6-month Follow-up|Withdrew consent|14
7808096|NCT01154296|12269988|FG001|6-month Follow-up|Withdrew consent|15
7808097|NCT01154296|12269987|FG000|6-month Follow-up|Death|3
7808098|NCT01154296|12269988|FG001|6-month Follow-up|Death|2
7887385|NCT01817530|12389019|FG001|Overall Study|Subject Noncompliant|1
7808099|NCT01154296|12269987|FG000|6-month Follow-up|Declined by Study Coordinator|5
7808100|NCT01154296|12269988|FG001|6-month Follow-up|Declined by Study Coordinator|4
7808101|NCT01154452|12270003|FG000|Phase Ib|Not Treated|1
7808102|NCT01154452|12270004|FG001|Phase Ib|Not Treated|0
7808103|NCT01154452|12270005|FG002|Phase Ib|Not Treated|0
7808104|NCT01154452|12270006|FG003|Phase Ib|Not Treated|0
7808105|NCT01154452|12270003|FG000|Phase Ib|Adverse Event|2
7808106|NCT01154452|12270004|FG001|Phase Ib|Adverse Event|1
7808107|NCT01154452|12270005|FG002|Phase Ib|Adverse Event|0
7808108|NCT01154452|12270006|FG003|Phase Ib|Adverse Event|0
7808109|NCT01154452|12270003|FG000|Phase II|Withdrawal by Subject|0
7808110|NCT01154452|12270004|FG001|Phase II|Withdrawal by Subject|0
7808111|NCT01154452|12270005|FG002|Phase II|Withdrawal by Subject|1
7808112|NCT01154452|12270006|FG003|Phase II|Withdrawal by Subject|2
7808113|NCT01154452|12270003|FG000|Phase II|Adverse Event|0
7808114|NCT01154452|12270004|FG001|Phase II|Adverse Event|0
7808115|NCT01154452|12270005|FG002|Phase II|Adverse Event|4
7808116|NCT01154452|12270006|FG003|Phase II|Adverse Event|4
7808117|NCT01154673|12270038|FG000|Overall Study|Lost to Follow-up|1
7808118|NCT01154673|12270039|FG001|Overall Study|Lost to Follow-up|0
7808119|NCT01154673|12270038|FG000|Overall Study|moved out of province|1
7808120|NCT01154673|12270039|FG001|Overall Study|moved out of province|0
7808121|NCT01154816|12270072|FG000|Overall Study|Withdrawal by Subject|1
7808122|NCT01154816|12270073|FG001|Overall Study|Withdrawal by Subject|0
7808123|NCT01154816|12270074|FG002|Overall Study|Withdrawal by Subject|0
7808124|NCT01154816|12270075|FG003|Overall Study|Withdrawal by Subject|1
7808125|NCT01154816|12270076|FG004|Overall Study|Withdrawal by Subject|0
7808126|NCT01154816|12270077|FG005|Overall Study|Withdrawal by Subject|0
7808127|NCT01154816|12270078|FG006|Overall Study|Withdrawal by Subject|0
7808128|NCT01154816|12270079|FG007|Overall Study|Withdrawal by Subject|0
7808129|NCT01154816|12270080|FG008|Overall Study|Withdrawal by Subject|1
7808130|NCT01154816|12270081|FG009|Overall Study|Withdrawal by Subject|3
7808131|NCT01154816|12270082|FG010|Overall Study|Withdrawal by Subject|0
7808132|NCT01154816|12270083|FG011|Overall Study|Withdrawal by Subject|0
7808133|NCT01154816|12270072|FG000|Overall Study|Progressive Disease|13
7808134|NCT01154816|12270073|FG001|Overall Study|Progressive Disease|8
7808135|NCT01154816|12270074|FG002|Overall Study|Progressive Disease|9
7808136|NCT01154816|12270075|FG003|Overall Study|Progressive Disease|9
7808137|NCT01154816|12270076|FG004|Overall Study|Progressive Disease|8
7808138|NCT01154816|12270077|FG005|Overall Study|Progressive Disease|8
7808139|NCT01154816|12270078|FG006|Overall Study|Progressive Disease|5
7808140|NCT01154816|12270079|FG007|Overall Study|Progressive Disease|6
7808141|NCT01154816|12270080|FG008|Overall Study|Progressive Disease|8
7808142|NCT01154816|12270081|FG009|Overall Study|Progressive Disease|6
7808143|NCT01154816|12270082|FG010|Overall Study|Progressive Disease|10
7808144|NCT01154816|12270083|FG011|Overall Study|Progressive Disease|3
7808145|NCT01154816|12270072|FG000|Overall Study|Physician Decision|1
7808146|NCT01154816|12270073|FG001|Overall Study|Physician Decision|0
7808147|NCT01154816|12270074|FG002|Overall Study|Physician Decision|1
7808148|NCT01154816|12270075|FG003|Overall Study|Physician Decision|0
7808149|NCT01154816|12270076|FG004|Overall Study|Physician Decision|2
7808150|NCT01154816|12270077|FG005|Overall Study|Physician Decision|0
7808151|NCT01154816|12270078|FG006|Overall Study|Physician Decision|0
7808152|NCT01154816|12270079|FG007|Overall Study|Physician Decision|0
7808153|NCT01154816|12270080|FG008|Overall Study|Physician Decision|0
7808154|NCT01154816|12270081|FG009|Overall Study|Physician Decision|1
7808155|NCT01154816|12270082|FG010|Overall Study|Physician Decision|1
7808156|NCT01154816|12270083|FG011|Overall Study|Physician Decision|1
7808157|NCT01154816|12270072|FG000|Overall Study|Adverse Event|5
7808158|NCT01154816|12270073|FG001|Overall Study|Adverse Event|2
7967856|NCT04537949|12525388|FG001|Overall Study|personal reasons not related to the IMP|0
7967857|NCT04537949|12525389|FG002|Overall Study|personal reasons not related to the IMP|0
7967858|NCT04537949|12525390|FG003|Overall Study|personal reasons not related to the IMP|0
7967859|NCT04537949|12525391|FG004|Overall Study|personal reasons not related to the IMP|0
7967860|NCT04537949|12525392|FG005|Overall Study|personal reasons not related to the IMP|0
7967861|NCT04537949|12525393|FG006|Overall Study|personal reasons not related to the IMP|0
7967862|NCT04537949|12525394|FG007|Overall Study|personal reasons not related to the IMP|0
7967863|NCT04346628|12525414|FG000|Overall Study|Lost to Follow-up|4
7967864|NCT04346628|12525415|FG001|Overall Study|Lost to Follow-up|4
7967865|NCT04346628|12525414|FG000|Overall Study|Withdrew (had personal reasons)|2
7808159|NCT01154816|12270074|FG002|Overall Study|Adverse Event|0
7808160|NCT01154816|12270075|FG003|Overall Study|Adverse Event|0
7808161|NCT01154816|12270076|FG004|Overall Study|Adverse Event|0
7808162|NCT01154816|12270077|FG005|Overall Study|Adverse Event|0
7808163|NCT01154816|12270078|FG006|Overall Study|Adverse Event|1
7967866|NCT04346628|12525415|FG001|Overall Study|Withdrew (had personal reasons)|5
7808164|NCT01154816|12270079|FG007|Overall Study|Adverse Event|1
7808165|NCT01154816|12270080|FG008|Overall Study|Adverse Event|0
7808166|NCT01154816|12270081|FG009|Overall Study|Adverse Event|0
7808167|NCT01154816|12270082|FG010|Overall Study|Adverse Event|0
7808168|NCT01154816|12270083|FG011|Overall Study|Adverse Event|0
7808169|NCT01155011|12270126|FG000|Baseline to 6 Months|Withdrawal by Subject|18
7808170|NCT01155011|12270127|FG001|Baseline to 6 Months|Withdrawal by Subject|19
7808171|NCT01155011|12270126|FG000|Baseline to 6 Months|investigator decision, moved|4
7808172|NCT01155011|12270127|FG001|Baseline to 6 Months|investigator decision, moved|5
7967867|NCT04346628|12525414|FG000|Overall Study|Withdrew (medication intolerant)|0
7967868|NCT04346628|12525415|FG001|Overall Study|Withdrew (medication intolerant)|3
7808173|NCT01155011|12270126|FG000|Baseline to 6 Months|Death|0
7808174|NCT01155011|12270127|FG001|Baseline to 6 Months|Death|1
7808175|NCT01155011|12270126|FG000|6 to 12 Months|Withdrawal by Subject|8
7808176|NCT01155011|12270127|FG001|6 to 12 Months|Withdrawal by Subject|5
7808177|NCT01155011|12270126|FG000|6 to 12 Months|Death|1
7808178|NCT01155011|12270127|FG001|6 to 12 Months|Death|5
7808179|NCT01155024|12270137|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
7808180|NCT01155024|12270138|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
7808181|NCT01155024|12270137|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
7808182|NCT01155024|12270138|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
7808183|NCT01155024|12270137|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
7808184|NCT01155024|12270138|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
7808185|NCT01155050|12270149|FG000|Overall Study|Lost to Follow-up|15
7808186|NCT01155050|12270150|FG001|Overall Study|Lost to Follow-up|20
7808187|NCT01155050|12270151|FG002|Overall Study|Lost to Follow-up|19
7808188|NCT01155050|12270152|FG003|Overall Study|Lost to Follow-up|22
7808189|NCT01155063|12270162|FG000|Overall Study|Adverse Event|1
7808190|NCT01155063|12270162|FG000|Overall Study|Withdrawal by Subject|1
7808191|NCT01155063|12270162|FG000|Overall Study|Study terminated by sponsor|87
7808192|NCT01155141|12270166|FG000|Overall Study|Withdrawal by Subject|1
7808193|NCT01155141|12270166|FG000|Overall Study|Screen Failure|1
7808194|NCT01155167|12270185|FG000|Overall Study|Insufficient ultrasound data|2
7808195|NCT01155167|12270186|FG001|Overall Study|Insufficient ultrasound data|0
7808196|NCT01155167|12270185|FG000|Overall Study|Access site changed to femoral artery|1
7808197|NCT01155167|12270186|FG001|Overall Study|Access site changed to femoral artery|0
7808198|NCT01155219|12270225|FG000|Overall Study|Adverse Event|3
7808199|NCT01155219|12270226|FG001|Overall Study|Adverse Event|1
7808200|NCT01155219|12270225|FG000|Overall Study|non-medical reason|1
7808201|NCT01155219|12270226|FG001|Overall Study|non-medical reason|2
7808202|NCT01155284|12270234|FG000|Overall Study|Withdrawal by Subject|4
7808203|NCT01155284|12270235|FG001|Overall Study|Withdrawal by Subject|3
7808204|NCT01155284|12270234|FG000|Overall Study|Lost to Follow-up|1
7808205|NCT01155284|12270235|FG001|Overall Study|Lost to Follow-up|2
7808206|NCT01155284|12270234|FG000|Overall Study|Physician Decision|1
7808207|NCT01155284|12270235|FG001|Overall Study|Physician Decision|0
7808208|NCT01155284|12270234|FG000|Overall Study|Adverse Event|1
7808209|NCT01155284|12270235|FG001|Overall Study|Adverse Event|0
7808210|NCT01155323|12270243|FG000|First Intervention|exclusion criteria|1
7808211|NCT01155323|12270244|FG001|First Intervention|exclusion criteria|1
7808212|NCT01155323|12270243|FG000|Second Intervention|Lost to Follow-up|1
7808213|NCT01155323|12270244|FG001|Second Intervention|Lost to Follow-up|1
7808214|NCT01155466|12270264|FG000|Overall Study|Adverse Event|13
7808215|NCT01155466|12270265|FG001|Overall Study|Adverse Event|15
7808216|NCT01155466|12270266|FG002|Overall Study|Adverse Event|6
7808217|NCT01155466|12270267|FG003|Overall Study|Adverse Event|17
7808218|NCT01155466|12270268|FG004|Overall Study|Adverse Event|18
7808219|NCT01155466|12270264|FG000|Overall Study|Lost to Follow-up|0
7808220|NCT01155466|12270265|FG001|Overall Study|Lost to Follow-up|0
7808221|NCT01155466|12270266|FG002|Overall Study|Lost to Follow-up|0
7808222|NCT01155466|12270267|FG003|Overall Study|Lost to Follow-up|0
7808223|NCT01155466|12270268|FG004|Overall Study|Lost to Follow-up|2
7808224|NCT01155466|12270264|FG000|Overall Study|Withdrawal by Subject|7
7808225|NCT01155466|12270265|FG001|Overall Study|Withdrawal by Subject|5
7808226|NCT01155466|12270266|FG002|Overall Study|Withdrawal by Subject|9
7808227|NCT01155466|12270267|FG003|Overall Study|Withdrawal by Subject|4
7808228|NCT01155466|12270268|FG004|Overall Study|Withdrawal by Subject|4
7808229|NCT01155466|12270264|FG000|Overall Study|Protocol Violation|0
7808230|NCT01155466|12270265|FG001|Overall Study|Protocol Violation|0
7808231|NCT01155466|12270266|FG002|Overall Study|Protocol Violation|2
7808232|NCT01155466|12270267|FG003|Overall Study|Protocol Violation|0
7808233|NCT01155466|12270268|FG004|Overall Study|Protocol Violation|1
7808234|NCT01155466|12270264|FG000|Overall Study|Administrative|0
7808235|NCT01155466|12270265|FG001|Overall Study|Administrative|3
7808236|NCT01155466|12270266|FG002|Overall Study|Administrative|0
7808237|NCT01155466|12270267|FG003|Overall Study|Administrative|0
7808238|NCT01155466|12270268|FG004|Overall Study|Administrative|0
7808239|NCT01155466|12270264|FG000|Overall Study|Randomized not treated|2
7808240|NCT01155466|12270265|FG001|Overall Study|Randomized not treated|2
7808241|NCT01155466|12270266|FG002|Overall Study|Randomized not treated|3
7808242|NCT01155466|12270267|FG003|Overall Study|Randomized not treated|0
7808243|NCT01155466|12270268|FG004|Overall Study|Randomized not treated|2
7808244|NCT01155479|12270285|FG000|Part I|Adverse Event|13
7808245|NCT01155479|12270286|FG001|Part I|Adverse Event|8
7808246|NCT01155479|12270287|FG002|Part I|Adverse Event|18
7808247|NCT01155479|12270288|FG003|Part I|Adverse Event|7
7808248|NCT01155479|12270289|FG004|Part I|Adverse Event|6
7808249|NCT01155479|12270285|FG000|Part I|Administrative|2
7808250|NCT01155479|12270286|FG001|Part I|Administrative|2
7808251|NCT01155479|12270287|FG002|Part I|Administrative|2
7808252|NCT01155479|12270288|FG003|Part I|Administrative|0
7808253|NCT01155479|12270289|FG004|Part I|Administrative|0
7967869|NCT04346628|12525414|FG000|Overall Study|Withdrew (declined intervention)|0
7808254|NCT01155479|12270285|FG000|Part I|Did Not Meet Protocol Eligibility|3
7808255|NCT01155479|12270286|FG001|Part I|Did Not Meet Protocol Eligibility|1
7808256|NCT01155479|12270287|FG002|Part I|Did Not Meet Protocol Eligibility|2
7808257|NCT01155479|12270288|FG003|Part I|Did Not Meet Protocol Eligibility|1
7808258|NCT01155479|12270289|FG004|Part I|Did Not Meet Protocol Eligibility|3
7808259|NCT01155479|12270285|FG000|Part I|Withdrawal by Subject|11
7967870|NCT04346628|12525415|FG001|Overall Study|Withdrew (declined intervention)|1
7808260|NCT01155479|12270286|FG001|Part I|Withdrawal by Subject|13
7808261|NCT01155479|12270287|FG002|Part I|Withdrawal by Subject|8
7808262|NCT01155479|12270288|FG003|Part I|Withdrawal by Subject|8
7887386|NCT01817530|12389020|FG002|Overall Study|Subject Noncompliant|0
7887387|NCT01817530|12389021|FG003|Overall Study|Subject Noncompliant|4
7887388|NCT01817530|12389022|FG004|Overall Study|Subject Noncompliant|0
7887389|NCT01817530|12389023|FG005|Overall Study|Subject Noncompliant|1
7887390|NCT01817530|12389024|FG006|Overall Study|Subject Noncompliant|1
7887391|NCT01817530|12389025|FG007|Overall Study|Subject Noncompliant|1
7808263|NCT01155479|12270289|FG004|Part I|Withdrawal by Subject|9
7808264|NCT01155479|12270285|FG000|Part I|Lost to Follow-up|0
7808265|NCT01155479|12270286|FG001|Part I|Lost to Follow-up|0
7808266|NCT01155479|12270287|FG002|Part I|Lost to Follow-up|1
7808267|NCT01155479|12270288|FG003|Part I|Lost to Follow-up|1
7808268|NCT01155479|12270289|FG004|Part I|Lost to Follow-up|0
7808269|NCT01155479|12270285|FG000|Part I|Treatment Failure|3
7808270|NCT01155479|12270286|FG001|Part I|Treatment Failure|0
7808271|NCT01155479|12270287|FG002|Part I|Treatment Failure|3
7808272|NCT01155479|12270288|FG003|Part I|Treatment Failure|1
7808273|NCT01155479|12270289|FG004|Part I|Treatment Failure|2
7808274|NCT01155479|12270285|FG000|Part I|Did Not Receive Treatment|4
7808275|NCT01155479|12270286|FG001|Part I|Did Not Receive Treatment|2
7808276|NCT01155479|12270287|FG002|Part I|Did Not Receive Treatment|2
7808277|NCT01155479|12270288|FG003|Part I|Did Not Receive Treatment|6
7808278|NCT01155479|12270289|FG004|Part I|Did Not Receive Treatment|1
7808279|NCT01155479|12270285|FG000|Part I|Non-Compliance with Protocol|2
7808280|NCT01155479|12270286|FG001|Part I|Non-Compliance with Protocol|1
7808281|NCT01155479|12270287|FG002|Part I|Non-Compliance with Protocol|3
7808282|NCT01155479|12270288|FG003|Part I|Non-Compliance with Protocol|3
7808283|NCT01155479|12270289|FG004|Part I|Non-Compliance with Protocol|2
7808284|NCT01155479|12270285|FG000|Part II|Adverse Event|7
7808285|NCT01155479|12270286|FG001|Part II|Adverse Event|6
7808286|NCT01155479|12270287|FG002|Part II|Adverse Event|8
7808287|NCT01155479|12270288|FG003|Part II|Adverse Event|3
7808288|NCT01155479|12270289|FG004|Part II|Adverse Event|4
7808289|NCT01155479|12270285|FG000|Part II|Administrative|43
7808290|NCT01155479|12270286|FG001|Part II|Administrative|49
7808291|NCT01155479|12270287|FG002|Part II|Administrative|36
7808292|NCT01155479|12270288|FG003|Part II|Administrative|38
7808293|NCT01155479|12270289|FG004|Part II|Administrative|46
7808294|NCT01155479|12270285|FG000|Part II|Withdrawal by Subject|8
7808295|NCT01155479|12270286|FG001|Part II|Withdrawal by Subject|4
7808296|NCT01155479|12270287|FG002|Part II|Withdrawal by Subject|12
7967871|NCT04040933|12525449|FG000|Overall Study|Protocol Violation|1
7967872|NCT04040933|12525449|FG000|Overall Study|Withdrawal by Subject|2
7967873|NCT03428997|12525512|FG000|Overall Study|Sponsor decision.|1
7967874|NCT03428997|12525512|FG000|Overall Study|Withdrawal by Subject|3
7808297|NCT01155479|12270288|FG003|Part II|Withdrawal by Subject|7
7808298|NCT01155479|12270289|FG004|Part II|Withdrawal by Subject|3
7808299|NCT01155479|12270285|FG000|Part II|Lost to Follow-up|1
7808300|NCT01155479|12270286|FG001|Part II|Lost to Follow-up|0
7808301|NCT01155479|12270287|FG002|Part II|Lost to Follow-up|0
7808302|NCT01155479|12270288|FG003|Part II|Lost to Follow-up|0
7808303|NCT01155479|12270289|FG004|Part II|Lost to Follow-up|1
7808304|NCT01155479|12270285|FG000|Part II|Treatment Failure|0
7808305|NCT01155479|12270286|FG001|Part II|Treatment Failure|1
7808306|NCT01155479|12270287|FG002|Part II|Treatment Failure|2
7808307|NCT01155479|12270288|FG003|Part II|Treatment Failure|0
7808308|NCT01155479|12270289|FG004|Part II|Treatment Failure|1
7808309|NCT01155479|12270285|FG000|Part II|Non-Compliance with Protocol|0
7808310|NCT01155479|12270286|FG001|Part II|Non-Compliance with Protocol|1
7808311|NCT01155479|12270287|FG002|Part II|Non-Compliance with Protocol|0
7808312|NCT01155479|12270288|FG003|Part II|Non-Compliance with Protocol|2
7808313|NCT01155479|12270289|FG004|Part II|Non-Compliance with Protocol|0
7808314|NCT01155531|12270321|FG000|Overall Study|Adverse Event|0
7808315|NCT01155531|12270322|FG001|Overall Study|Adverse Event|0
7808316|NCT01155531|12270323|FG002|Overall Study|Adverse Event|1
7808317|NCT01155531|12270324|FG003|Overall Study|Adverse Event|0
7808318|NCT01155531|12270321|FG000|Overall Study|Lost to Follow-up|0
7808319|NCT01155531|12270322|FG001|Overall Study|Lost to Follow-up|0
7808320|NCT01155531|12270323|FG002|Overall Study|Lost to Follow-up|0
7808321|NCT01155531|12270324|FG003|Overall Study|Lost to Follow-up|1
7808322|NCT01155531|12270321|FG000|Overall Study|Withdrawal by Subject|1
7808323|NCT01155531|12270322|FG001|Overall Study|Withdrawal by Subject|0
7808324|NCT01155531|12270323|FG002|Overall Study|Withdrawal by Subject|1
7808325|NCT01155531|12270324|FG003|Overall Study|Withdrawal by Subject|0
7808326|NCT01155570|12270334|FG000|Overall Study|Adverse Event|39
7808327|NCT01155570|12270334|FG000|Overall Study|Lack of Efficacy|46
7808328|NCT01155570|12270334|FG000|Overall Study|Participant's Economic Reasons|17
7808329|NCT01155570|12270334|FG000|Overall Study|No Hospital Visits|7
7808330|NCT01155570|12270334|FG000|Overall Study|Adverse Event + Lack of Efficacy|2
7808331|NCT01155570|12270334|FG000|Overall Study|Adverse Event + Other Reasons|7
7808332|NCT01155570|12270334|FG000|Overall Study|Participant's Economic Reasons + Other|1
7808333|NCT01155570|12270334|FG000|Overall Study|Other Reasons|23
7808334|NCT01155583|12270349|FG000|Phase I|Screen failure - did not start treatment|0
7808335|NCT01155583|12270350|FG001|Phase I|Screen failure - did not start treatment|0
7808336|NCT01155583|12270351|FG002|Phase I|Screen failure - did not start treatment|0
7808337|NCT01155583|12270352|FG003|Phase I|Screen failure - did not start treatment|0
7808338|NCT01155583|12270353|FG004|Phase I|Screen failure - did not start treatment|1
7808339|NCT01155583|12270354|FG005|Phase I|Screen failure - did not start treatment|0
7808340|NCT01155583|12270355|FG006|Phase I|Screen failure - did not start treatment|0
7808341|NCT01155583|12270356|FG007|Phase I|Screen failure - did not start treatment|2
7808342|NCT01155583|12270357|FG008|Phase I|Screen failure - did not start treatment|0
7808343|NCT01155583|12270349|FG000|Phase I|Withdrawal by Subject|0
7808344|NCT01155583|12270350|FG001|Phase I|Withdrawal by Subject|0
7808345|NCT01155583|12270351|FG002|Phase I|Withdrawal by Subject|0
7808346|NCT01155583|12270352|FG003|Phase I|Withdrawal by Subject|0
7808347|NCT01155583|12270353|FG004|Phase I|Withdrawal by Subject|0
7808348|NCT01155583|12270354|FG005|Phase I|Withdrawal by Subject|0
7808349|NCT01155583|12270355|FG006|Phase I|Withdrawal by Subject|0
7808350|NCT01155583|12270356|FG007|Phase I|Withdrawal by Subject|1
7808351|NCT01155583|12270357|FG008|Phase I|Withdrawal by Subject|0
7808352|NCT01155661|12270373|FG000|Overall Study|Adverse Event|101
7808353|NCT01155661|12270373|FG000|Overall Study|Death|1
7808354|NCT01155661|12270373|FG000|Overall Study|Lack of Efficacy|32
7808355|NCT01155661|12270373|FG000|Overall Study|Lost to Follow-up|22
7808356|NCT01155661|12270373|FG000|Overall Study|Physician Decision|3
7808357|NCT01155661|12270373|FG000|Overall Study|Protocol Violation|35
7808358|NCT01155661|12270373|FG000|Overall Study|Withdrawal by Subject|73
7808359|NCT01155661|12270373|FG000|Overall Study|Sponsor Decision|13
7808360|NCT01155726|12270379|FG000|Period 1, 3 Days (Masked)|Inconvenience|1
7808361|NCT01155726|12270380|FG001|Period 1, 3 Days (Masked)|Inconvenience|0
7808362|NCT01155726|12270381|FG002|Period 1, 3 Days (Masked)|Inconvenience|2
7808363|NCT01155726|12270382|FG003|Period 1, 3 Days (Masked)|Inconvenience|0
7808364|NCT01155869|12270432|FG000|Overall Study|Lost to Follow-up|3
7967875|NCT03428997|12525512|FG000|Overall Study|Lost to Follow-up|4
7967876|NCT03385564|12525522|FG000|Overall Study|Adverse Event|0
7967877|NCT03385564|12525523|FG001|Overall Study|Adverse Event|0
7967878|NCT03385564|12525524|FG002|Overall Study|Adverse Event|3
7967879|NCT03385564|12525525|FG003|Overall Study|Adverse Event|3
7967880|NCT03385564|12525522|FG000|Overall Study|Other than listed|0
7967881|NCT03385564|12525523|FG001|Overall Study|Other than listed|0
7967882|NCT03385564|12525524|FG002|Overall Study|Other than listed|0
7967883|NCT03385564|12525525|FG003|Overall Study|Other than listed|5
7967884|NCT03385564|12525522|FG000|Overall Study|Withdrawal by Subject|0
7967885|NCT03385564|12525523|FG001|Overall Study|Withdrawal by Subject|1
7967886|NCT03385564|12525524|FG002|Overall Study|Withdrawal by Subject|1
7967887|NCT03385564|12525525|FG003|Overall Study|Withdrawal by Subject|0
7967888|NCT03385564|12525522|FG000|Overall Study|Lack of Efficacy|0
7967889|NCT03385564|12525523|FG001|Overall Study|Lack of Efficacy|0
7967890|NCT03385564|12525524|FG002|Overall Study|Lack of Efficacy|0
7967891|NCT03385564|12525525|FG003|Overall Study|Lack of Efficacy|1
7967892|NCT03385564|12525522|FG000|Overall Study|Death|0
7967893|NCT03385564|12525523|FG001|Overall Study|Death|0
7967894|NCT03385564|12525524|FG002|Overall Study|Death|1
7967895|NCT03385564|12525525|FG003|Overall Study|Death|0
7967896|NCT03335163|12525535|FG000|Overall Study|Not eligible due to laboratory criteria|3
7967897|NCT03335163|12525535|FG000|Overall Study|Withdrawal by Subject|18
7808365|NCT01155869|12270433|FG001|Overall Study|Lost to Follow-up|1
7808366|NCT01156012|12270450|FG000|Overall Study|Adverse Event|3
7808367|NCT01156012|12270451|FG001|Overall Study|Adverse Event|1
7808368|NCT01156012|12270450|FG000|Overall Study|Lost to Follow-up|1
7808369|NCT01156012|12270451|FG001|Overall Study|Lost to Follow-up|0
7808370|NCT01156012|12270450|FG000|Overall Study|Withdrawal by Subject|1
7808371|NCT01156012|12270451|FG001|Overall Study|Withdrawal by Subject|0
7887392|NCT01817530|12389018|FG000|Overall Study|Lack of Efficacy|1
7887393|NCT01817530|12389019|FG001|Overall Study|Lack of Efficacy|0
7887394|NCT01817530|12389020|FG002|Overall Study|Lack of Efficacy|0
7887395|NCT01817530|12389021|FG003|Overall Study|Lack of Efficacy|0
7887396|NCT01817530|12389022|FG004|Overall Study|Lack of Efficacy|0
7887397|NCT01817530|12389023|FG005|Overall Study|Lack of Efficacy|1
7887398|NCT01817530|12389024|FG006|Overall Study|Lack of Efficacy|0
7887399|NCT01817530|12389025|FG007|Overall Study|Lack of Efficacy|1
7887400|NCT01817530|12389018|FG000|Overall Study|Pregnancy|0
7887401|NCT01817530|12389019|FG001|Overall Study|Pregnancy|0
7887402|NCT01817530|12389020|FG002|Overall Study|Pregnancy|0
7887403|NCT01817530|12389021|FG003|Overall Study|Pregnancy|0
7887404|NCT01817530|12389022|FG004|Overall Study|Pregnancy|0
7887405|NCT01817530|12389023|FG005|Overall Study|Pregnancy|1
7887406|NCT01817530|12389024|FG006|Overall Study|Pregnancy|0
7887407|NCT01817530|12389025|FG007|Overall Study|Pregnancy|0
7887408|NCT01817530|12389018|FG000|Overall Study|Other|0
7808372|NCT01156012|12270450|FG000|Overall Study|use of commercial drug instead of study|0
7808373|NCT01156012|12270451|FG001|Overall Study|use of commercial drug instead of study|1
7808374|NCT01156012|12270450|FG000|Overall Study|Non respect of one of inclusion criteria|2
7887409|NCT01817530|12389019|FG001|Overall Study|Other|1
7887410|NCT01817530|12389020|FG002|Overall Study|Other|0
7808375|NCT01156012|12270451|FG001|Overall Study|Non respect of one of inclusion criteria|1
7808376|NCT01156051|12270459|FG000|Overall Study|Lost to Follow-up|1
7808377|NCT01156051|12270460|FG001|Overall Study|Lost to Follow-up|0
7808378|NCT01156051|12270459|FG000|Overall Study|patient not compliant with protocol|0
7808379|NCT01156051|12270460|FG001|Overall Study|patient not compliant with protocol|1
7808380|NCT01156116|12270468|FG000|Overall Study|Withdrawal by Subject|3
7808381|NCT01156116|12270469|FG001|Overall Study|Withdrawal by Subject|1
7887411|NCT01817530|12389021|FG003|Overall Study|Other|0
7887412|NCT01817530|12389022|FG004|Overall Study|Other|1
7887413|NCT01817530|12389023|FG005|Overall Study|Other|0
7887414|NCT01817530|12389024|FG006|Overall Study|Other|5
7887415|NCT01817530|12389025|FG007|Overall Study|Other|0
7887416|NCT01817530|12389018|FG000|Overall Study|Surgery or Invasive Intervention|1
7887417|NCT01817530|12389019|FG001|Overall Study|Surgery or Invasive Intervention|0
7887418|NCT01817530|12389020|FG002|Overall Study|Surgery or Invasive Intervention|0
7887419|NCT01817530|12389021|FG003|Overall Study|Surgery or Invasive Intervention|0
7887420|NCT01817530|12389022|FG004|Overall Study|Surgery or Invasive Intervention|1
7887421|NCT01817530|12389023|FG005|Overall Study|Surgery or Invasive Intervention|1
7887422|NCT01817530|12389024|FG006|Overall Study|Surgery or Invasive Intervention|1
7887423|NCT01817530|12389025|FG007|Overall Study|Surgery or Invasive Intervention|0
7887424|NCT01817530|12389018|FG000|Overall Study|Consent Withdrawn by Subject|3
7887425|NCT01817530|12389019|FG001|Overall Study|Consent Withdrawn by Subject|4
7887426|NCT01817530|12389020|FG002|Overall Study|Consent Withdrawn by Subject|7
7887427|NCT01817530|12389021|FG003|Overall Study|Consent Withdrawn by Subject|3
7887428|NCT01817530|12389022|FG004|Overall Study|Consent Withdrawn by Subject|5
7887429|NCT01817530|12389023|FG005|Overall Study|Consent Withdrawn by Subject|3
7887430|NCT01817530|12389024|FG006|Overall Study|Consent Withdrawn by Subject|3
7887431|NCT01817530|12389025|FG007|Overall Study|Consent Withdrawn by Subject|10
7887432|NCT01817530|12389018|FG000|Overall Study|Lost to Follow-up|1
7967898|NCT03235544|12525543|FG000|Overall Study|Participants Still Ongoing in the Study|1
7967899|NCT03235544|12525544|FG001|Overall Study|Participants Still Ongoing in the Study|13
7967900|NCT03235544|12525545|FG002|Overall Study|Participants Still Ongoing in the Study|19
7967901|NCT03235544|12525546|FG003|Overall Study|Participants Still Ongoing in the Study|55
7967902|NCT03235544|12525543|FG000|Overall Study|Death|11
7887433|NCT01817530|12389019|FG001|Overall Study|Lost to Follow-up|4
7887434|NCT01817530|12389020|FG002|Overall Study|Lost to Follow-up|2
7887435|NCT01817530|12389021|FG003|Overall Study|Lost to Follow-up|1
7887436|NCT01817530|12389022|FG004|Overall Study|Lost to Follow-up|3
7887437|NCT01817530|12389023|FG005|Overall Study|Lost to Follow-up|2
7887438|NCT01817530|12389024|FG006|Overall Study|Lost to Follow-up|8
7887439|NCT01817530|12389025|FG007|Overall Study|Lost to Follow-up|4
7887440|NCT01817582|12389046|FG000|Overall Study|Withdrawal by Subject|0
7887441|NCT01817582|12389047|FG001|Overall Study|Withdrawal by Subject|1
7887442|NCT01817582|12389048|FG002|Overall Study|Withdrawal by Subject|0
7887443|NCT01817582|12389046|FG000|Overall Study|Participant revealed masked treatment|1
7887444|NCT01817582|12389047|FG001|Overall Study|Participant revealed masked treatment|0
7887445|NCT01817582|12389048|FG002|Overall Study|Participant revealed masked treatment|0
7887446|NCT01817582|12389046|FG000|Overall Study|Randomized but exclusion criteria met|1
7887447|NCT01817582|12389047|FG001|Overall Study|Randomized but exclusion criteria met|0
7887448|NCT01817582|12389048|FG002|Overall Study|Randomized but exclusion criteria met|0
7887449|NCT01817725|12389065|FG000|Overall Study|Withdrawal by Subject|1
7887450|NCT01817764|12389071|FG000|Overall Study|Adverse Event|7
7887451|NCT01817764|12389072|FG001|Overall Study|Adverse Event|10
7887452|NCT01817764|12389071|FG000|Overall Study|Lack of Efficacy|9
7887453|NCT01817764|12389072|FG001|Overall Study|Lack of Efficacy|7
7887454|NCT01817764|12389071|FG000|Overall Study|Protocol Violation|7
7887455|NCT01817764|12389072|FG001|Overall Study|Protocol Violation|5
7887456|NCT01817764|12389071|FG000|Overall Study|Lost to Follow-up|1
7887457|NCT01817764|12389072|FG001|Overall Study|Lost to Follow-up|4
7887458|NCT01817764|12389071|FG000|Overall Study|Withdrawal by Subject|10
7887459|NCT01817764|12389072|FG001|Overall Study|Withdrawal by Subject|12
7887460|NCT01817777|12389080|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3
7887461|NCT01817777|12389081|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0
7887462|NCT01817777|12389082|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0
7887463|NCT01817777|12389080|FG000|Observational Phase (8 Weeks)|Early Study Termination|2
7887464|NCT01817777|12389081|FG001|Observational Phase (8 Weeks)|Early Study Termination|0
7887465|NCT01817777|12389082|FG002|Observational Phase (8 Weeks)|Early Study Termination|0
7887466|NCT01817777|12389080|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
7887467|NCT01817777|12389081|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
7887468|NCT01817777|12389082|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
7887469|NCT01817777|12389080|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0
7887470|NCT01817777|12389081|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1
7887471|NCT01817777|12389082|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2
7887472|NCT01817777|12389080|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0
7808382|NCT01156116|12270468|FG000|Overall Study|CPAP intolerance|2
7967903|NCT03235544|12525544|FG001|Overall Study|Death|23
7808383|NCT01156116|12270469|FG001|Overall Study|CPAP intolerance|0
7808384|NCT01156142|12270477|FG000|Overall Study|Withdrawal by Subject|8
7808385|NCT01156142|12270478|FG001|Overall Study|Withdrawal by Subject|6
7808386|NCT01156142|12270477|FG000|Overall Study|Ineligible|0
7808387|NCT01156142|12270478|FG001|Overall Study|Ineligible|1
7808388|NCT01156311|12270486|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1
7808389|NCT01156311|12270487|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1
7808390|NCT01156311|12270488|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0
7808391|NCT01156311|12270489|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0
7808392|NCT01156311|12270486|FG000|2-Month Monotherapy Period|Physician Decision|0
7808393|NCT01156311|12270487|FG001|2-Month Monotherapy Period|Physician Decision|1
7808394|NCT01156311|12270488|FG002|2-Month Monotherapy Period|Physician Decision|0
7808395|NCT01156311|12270489|FG003|2-Month Monotherapy Period|Physician Decision|0
7967904|NCT03235544|12525545|FG002|Overall Study|Death|11
7967905|NCT03235544|12525546|FG003|Overall Study|Death|20
7967906|NCT03235544|12525543|FG000|Overall Study|Lost to Follow-up|0
7967907|NCT03235544|12525544|FG001|Overall Study|Lost to Follow-up|1
7967908|NCT03235544|12525545|FG002|Overall Study|Lost to Follow-up|0
7967909|NCT03235544|12525546|FG003|Overall Study|Lost to Follow-up|1
7967910|NCT03235544|12525543|FG000|Overall Study|Withdrawal by Participant|0
7967911|NCT03235544|12525544|FG001|Overall Study|Withdrawal by Participant|0
7967912|NCT03235544|12525545|FG002|Overall Study|Withdrawal by Participant|1
7808396|NCT01156311|12270486|FG000|2-Month Monotherapy Period|Other|1
7808397|NCT01156311|12270487|FG001|2-Month Monotherapy Period|Other|0
7808398|NCT01156311|12270488|FG002|2-Month Monotherapy Period|Other|0
7808399|NCT01156311|12270489|FG003|2-Month Monotherapy Period|Other|0
7808400|NCT01156311|12270486|FG000|6-month Add-on Therapy Period|Adverse Event|0
7808401|NCT01156311|12270487|FG001|6-month Add-on Therapy Period|Adverse Event|0
7808402|NCT01156311|12270488|FG002|6-month Add-on Therapy Period|Adverse Event|7
7808403|NCT01156311|12270489|FG003|6-month Add-on Therapy Period|Adverse Event|6
7808404|NCT01156311|12270486|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0
7808405|NCT01156311|12270487|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0
7808406|NCT01156311|12270488|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2
7808407|NCT01156311|12270489|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0
7808408|NCT01156311|12270486|FG000|6-month Add-on Therapy Period|Disease Activity|0
7808409|NCT01156311|12270487|FG001|6-month Add-on Therapy Period|Disease Activity|0
7967913|NCT03235544|12525546|FG003|Overall Study|Withdrawal by Participant|0
7967914|NCT03235544|12525543|FG000|Overall Study|Reason not Specified|0
7967915|NCT03235544|12525544|FG001|Overall Study|Reason not Specified|4
7967916|NCT03235544|12525545|FG002|Overall Study|Reason not Specified|0
7967917|NCT03235544|12525546|FG003|Overall Study|Reason not Specified|1
7967918|NCT03023046|12525557|FG000|Overall Study|Withdrawal by Subject|1
7967919|NCT02421172|12525596|FG000|Period 1|Adverse Event|1
7967920|NCT02421172|12525597|FG001|Period 1|Adverse Event|0
7967921|NCT02421172|12525598|FG002|Period 1|Adverse Event|0
7967922|NCT02421172|12525599|FG003|Period 1|Adverse Event|0
7967923|NCT02421172|12525600|FG004|Period 1|Adverse Event|0
7967924|NCT02421172|12525596|FG000|Period 1|Lost to Follow-up|3
7967925|NCT02421172|12525597|FG001|Period 1|Lost to Follow-up|1
7967926|NCT02421172|12525598|FG002|Period 1|Lost to Follow-up|0
7967927|NCT02421172|12525599|FG003|Period 1|Lost to Follow-up|0
7967928|NCT02421172|12525600|FG004|Period 1|Lost to Follow-up|0
7967929|NCT02421172|12525596|FG000|Period 1|Patient/guardian decision|0
7967930|NCT02421172|12525597|FG001|Period 1|Patient/guardian decision|1
7967931|NCT02421172|12525598|FG002|Period 1|Patient/guardian decision|0
7967932|NCT02421172|12525599|FG003|Period 1|Patient/guardian decision|0
7967933|NCT02421172|12525600|FG004|Period 1|Patient/guardian decision|0
7808410|NCT01156311|12270488|FG002|6-month Add-on Therapy Period|Disease Activity|1
7808411|NCT01156311|12270489|FG003|6-month Add-on Therapy Period|Disease Activity|2
7808412|NCT01156311|12270486|FG000|6-month Add-on Therapy Period|Physician Decision|0
7808413|NCT01156311|12270487|FG001|6-month Add-on Therapy Period|Physician Decision|0
7808414|NCT01156311|12270488|FG002|6-month Add-on Therapy Period|Physician Decision|1
7808415|NCT01156311|12270489|FG003|6-month Add-on Therapy Period|Physician Decision|0
7808416|NCT01156311|12270486|FG000|6-month Add-on Therapy Period|Other|0
7808417|NCT01156311|12270487|FG001|6-month Add-on Therapy Period|Other|0
7808418|NCT01156311|12270488|FG002|6-month Add-on Therapy Period|Other|1
7808419|NCT01156311|12270489|FG003|6-month Add-on Therapy Period|Other|2
7808420|NCT01156363|12270500|FG000|Overall Study|Adverse Event|6
7808421|NCT01156363|12270500|FG000|Overall Study|Insufficient Therapeutic Response|5
7808422|NCT01156363|12270500|FG000|Overall Study|Failure to Return|1
7808423|NCT01156363|12270500|FG000|Overall Study|Refused Treatment|4
7808424|NCT01156363|12270500|FG000|Overall Study|Other|6
7967934|NCT02421172|12525596|FG000|Period 2|Adverse Event|0
7808425|NCT01156376|12270514|FG000|Overall Study|Adverse Event|1
7808426|NCT01156376|12270515|FG001|Overall Study|Adverse Event|0
7808427|NCT01156376|12270516|FG002|Overall Study|Adverse Event|1
7808428|NCT01156376|12270514|FG000|Overall Study|Withdrawal by Subject|0
7808429|NCT01156376|12270515|FG001|Overall Study|Withdrawal by Subject|0
7808430|NCT01156376|12270516|FG002|Overall Study|Withdrawal by Subject|3
7808431|NCT01156480|12270526|FG000|Overall Study|change in diagnosis|0
7808432|NCT01156480|12270527|FG001|Overall Study|change in diagnosis|1
7808433|NCT01156532|12270535|FG000|Overall Study|Family Reasons|1
7808434|NCT01156532|12270535|FG000|Overall Study|Lost to Follow-up|1
7967935|NCT02421172|12525597|FG001|Period 2|Adverse Event|0
7967936|NCT02421172|12525598|FG002|Period 2|Adverse Event|4
7967937|NCT02421172|12525599|FG003|Period 2|Adverse Event|0
7808435|NCT01156675|12270561|FG000|Overall Study|Death|5
7808436|NCT01156675|12270562|FG001|Overall Study|Death|3
7808437|NCT01156675|12270563|FG002|Overall Study|Death|0
7808438|NCT01156675|12270561|FG000|Overall Study|No data|29
7808439|NCT01156675|12270562|FG001|Overall Study|No data|22
7808440|NCT01156675|12270563|FG002|Overall Study|No data|2
7808441|NCT01156714|12270588|FG000|Overall Study|Withdrawal by Subject|9
7967938|NCT02421172|12525600|FG004|Period 2|Adverse Event|0
7967939|NCT02421172|12525596|FG000|Period 2|Lost to Follow-up|0
7967940|NCT02421172|12525597|FG001|Period 2|Lost to Follow-up|0
7967941|NCT02421172|12525598|FG002|Period 2|Lost to Follow-up|0
7967942|NCT02421172|12525599|FG003|Period 2|Lost to Follow-up|1
7967943|NCT02421172|12525600|FG004|Period 2|Lost to Follow-up|0
7967944|NCT02421172|12525596|FG000|Period 2|Patient/guardian decision|0
7967945|NCT02421172|12525597|FG001|Period 2|Patient/guardian decision|0
7967946|NCT02421172|12525598|FG002|Period 2|Patient/guardian decision|3
7967947|NCT02421172|12525599|FG003|Period 2|Patient/guardian decision|2
7808442|NCT01156714|12270589|FG001|Overall Study|Withdrawal by Subject|4
7808443|NCT01156714|12270590|FG002|Overall Study|Withdrawal by Subject|3
7808444|NCT01156792|12270601|FG000|Overall Study|Adverse Event|1
7808445|NCT01156792|12270601|FG000|Overall Study|Lack of Efficacy|36
7808446|NCT01156792|12270601|FG000|Overall Study|Protocol Violation|6
7808447|NCT01156792|12270601|FG000|Overall Study|Lost to Follow-up|3
7808448|NCT01156792|12270601|FG000|Overall Study|Physician Decision|3
7808449|NCT01156792|12270601|FG000|Overall Study|Withdrawal by Subject|9
7808450|NCT01156792|12270601|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11
7808451|NCT01156844|12270629|FG000|Overall Study|Adverse Event|0
7808452|NCT01156844|12270630|FG001|Overall Study|Adverse Event|0
7808453|NCT01156844|12270631|FG002|Overall Study|Adverse Event|1
7808454|NCT01156844|12270632|FG003|Overall Study|Adverse Event|1
7808455|NCT01156844|12270629|FG000|Overall Study|Abnormal test procedure result(s)|0
7808456|NCT01156844|12270630|FG001|Overall Study|Abnormal test procedure result(s)|1
7808457|NCT01156844|12270631|FG002|Overall Study|Abnormal test procedure result(s)|2
7808458|NCT01156844|12270632|FG003|Overall Study|Abnormal test procedure result(s)|2
7808459|NCT01156844|12270629|FG000|Overall Study|Withdrawal by Subject|0
7808460|NCT01156844|12270630|FG001|Overall Study|Withdrawal by Subject|0
7808461|NCT01156844|12270631|FG002|Overall Study|Withdrawal by Subject|2
7967948|NCT02421172|12525600|FG004|Period 2|Patient/guardian decision|1
7808462|NCT01156844|12270632|FG003|Overall Study|Withdrawal by Subject|2
7967949|NCT02012296|12525635|FG000|Overall Study|Lack of Efficacy|0
7808463|NCT01156844|12270629|FG000|Overall Study|Lost to Follow-up|0
7808464|NCT01156844|12270630|FG001|Overall Study|Lost to Follow-up|0
7808465|NCT01156844|12270631|FG002|Overall Study|Lost to Follow-up|1
7808466|NCT01156844|12270632|FG003|Overall Study|Lost to Follow-up|0
7808467|NCT01156844|12270629|FG000|Overall Study|Administrative problems|0
7967950|NCT02012296|12525636|FG001|Overall Study|Lack of Efficacy|0
7808468|NCT01156844|12270630|FG001|Overall Study|Administrative problems|1
7808469|NCT01156844|12270631|FG002|Overall Study|Administrative problems|0
7808470|NCT01156844|12270632|FG003|Overall Study|Administrative problems|1
7808471|NCT01156844|12270629|FG000|Overall Study|Protocol deviation|2
7808472|NCT01156844|12270630|FG001|Overall Study|Protocol deviation|0
7808473|NCT01156844|12270631|FG002|Overall Study|Protocol deviation|0
7808474|NCT01156844|12270632|FG003|Overall Study|Protocol deviation|0
7967951|NCT02012296|12525637|FG002|Overall Study|Lack of Efficacy|15
7967952|NCT02012296|12525635|FG000|Overall Study|Adverse Event|0
7967953|NCT02012296|12525636|FG001|Overall Study|Adverse Event|0
7967954|NCT02012296|12525637|FG002|Overall Study|Adverse Event|2
7967955|NCT02012296|12525635|FG000|Overall Study|Early study closure|0
7967956|NCT02012296|12525636|FG001|Overall Study|Early study closure|0
7967957|NCT02012296|12525637|FG002|Overall Study|Early study closure|5
7967958|NCT02012296|12525635|FG000|Overall Study|Protocol Violation|0
7967959|NCT02012296|12525636|FG001|Overall Study|Protocol Violation|1
7967960|NCT02012296|12525637|FG002|Overall Study|Protocol Violation|0
7967961|NCT01915498|12525667|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7967962|NCT01915498|12525668|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7967963|NCT01915498|12525669|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7967964|NCT01915498|12525670|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7967965|NCT01915498|12525671|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7967966|NCT01915498|12525672|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7967967|NCT01915498|12525673|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7967968|NCT01915498|12525674|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7967969|NCT01915498|12525675|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7967970|NCT01915498|12525676|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7808475|NCT01157065|12270656|FG000|Overall Study|Death|0
7808476|NCT01157065|12270657|FG001|Overall Study|Death|1
7808477|NCT01157078|12270665|FG000|Overall Study|Withdrawal by Subject|12
7808478|NCT01157078|12270666|FG001|Overall Study|Withdrawal by Subject|14
7808479|NCT01157078|12270665|FG000|Overall Study|Eligibility criteria not fulfilled|2
7808480|NCT01157078|12270666|FG001|Overall Study|Eligibility criteria not fulfilled|0
7808481|NCT01157078|12270665|FG000|Overall Study|Adverse Event|6
7808482|NCT01157078|12270666|FG001|Overall Study|Adverse Event|6
7808483|NCT01157078|12270665|FG000|Overall Study|Severe non-compliance to protocol|2
7808484|NCT01157078|12270666|FG001|Overall Study|Severe non-compliance to protocol|4
7967971|NCT01915498|12525677|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7967972|NCT01915498|12525678|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7967973|NCT01915498|12525679|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7967974|NCT01915498|12525680|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
7967975|NCT01915498|12525681|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7967976|NCT01915498|12525682|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
7967977|NCT01915498|12525683|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
7967978|NCT01915498|12525684|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
7967979|NCT01915498|12525685|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7967980|NCT01915498|12525667|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7967981|NCT01915498|12525668|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7967982|NCT01915498|12525669|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7967983|NCT01915498|12525670|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7967984|NCT01915498|12525671|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7808485|NCT01157078|12270665|FG000|Overall Study|Condition under investigation worsened|0
7808486|NCT01157078|12270666|FG001|Overall Study|Condition under investigation worsened|1
7808487|NCT01157078|12270665|FG000|Overall Study|Lack of Efficacy|2
7808488|NCT01157078|12270666|FG001|Overall Study|Lack of Efficacy|0
7808489|NCT01157078|12270665|FG000|Overall Study|Study-specific withdrawal criteria|2
7808490|NCT01157078|12270666|FG001|Overall Study|Study-specific withdrawal criteria|2
7808491|NCT01157078|12270665|FG000|Overall Study|Lost to Follow-up|7
7808492|NCT01157078|12270666|FG001|Overall Study|Lost to Follow-up|5
7808493|NCT01157078|12270665|FG000|Overall Study|Other|2
7808494|NCT01157078|12270666|FG001|Overall Study|Other|4
7808495|NCT01157117|12270675|FG000|Overall Study|Dosing Symptoms|0
7808496|NCT01157117|12270676|FG001|Overall Study|Dosing Symptoms|4
7808497|NCT01157117|12270677|FG002|Overall Study|Dosing Symptoms|0
7967985|NCT01915498|12525672|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7967986|NCT01915498|12525673|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7967987|NCT01915498|12525674|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
7967988|NCT01915498|12525675|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7967989|NCT01915498|12525676|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7967990|NCT01915498|12525677|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7967991|NCT01915498|12525678|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7967992|NCT01915498|12525679|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7967993|NCT01915498|12525680|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
7967994|NCT01915498|12525681|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7967995|NCT01915498|12525682|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
7967996|NCT01915498|12525683|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7967997|NCT01915498|12525684|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16
7967998|NCT01915498|12525685|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7967999|NCT01915498|12525667|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1
7968000|NCT01915498|12525668|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7968001|NCT01915498|12525669|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7968002|NCT01915498|12525670|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
7968003|NCT01915498|12525671|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
7968004|NCT01915498|12525672|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
7968005|NCT01915498|12525673|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
7968006|NCT01915498|12525674|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15
7968007|NCT01915498|12525675|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
7968008|NCT01915498|12525676|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7
7968009|NCT01915498|12525677|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7968010|NCT01915498|12525678|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
7968011|NCT01915498|12525679|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7968012|NCT01915498|12525680|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24
7968013|NCT01915498|12525681|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14
7968014|NCT01915498|12525682|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9
7968015|NCT01915498|12525683|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8
7968016|NCT01915498|12525684|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41
7808498|NCT01157117|12270675|FG000|Overall Study|Withdrawal by Subject|4
7808499|NCT01157117|12270676|FG001|Overall Study|Withdrawal by Subject|1
7808500|NCT01157117|12270677|FG002|Overall Study|Withdrawal by Subject|1
7808501|NCT01157117|12270675|FG000|Overall Study|Lack of Efficacy|1
7808502|NCT01157117|12270676|FG001|Overall Study|Lack of Efficacy|1
7808503|NCT01157117|12270677|FG002|Overall Study|Lack of Efficacy|0
7808504|NCT01157117|12270675|FG000|Overall Study|Lost to Follow-up|0
7808505|NCT01157117|12270676|FG001|Overall Study|Lost to Follow-up|0
7808506|NCT01157117|12270677|FG002|Overall Study|Lost to Follow-up|1
7808507|NCT01157117|12270675|FG000|Overall Study|Unknown (Pending Final Form Submission)|4
7808508|NCT01157117|12270676|FG001|Overall Study|Unknown (Pending Final Form Submission)|5
7808509|NCT01157117|12270677|FG002|Overall Study|Unknown (Pending Final Form Submission)|13
7808510|NCT01157169|12270687|FG000|First Intervention|Emesis Within 4 hrs of Administration|4
7808511|NCT01157169|12270688|FG001|First Intervention|Emesis Within 4 hrs of Administration|2
7808512|NCT01157169|12270687|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0
7808513|NCT01157169|12270688|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1
7808514|NCT01157182|12270696|FG000|Washout of 28 Days|Adverse Event|2
7808515|NCT01157182|12270697|FG001|Washout of 28 Days|Adverse Event|0
7808516|NCT01157234|12270705|FG000|Overall Study|Withdrawal by Subject|1
7808517|NCT01157234|12270706|FG001|Overall Study|Withdrawal by Subject|0
7808518|NCT01157351|12270721|FG000|Overall Study|Adverse Event|5
7808519|NCT01157351|12270722|FG001|Overall Study|Adverse Event|4
7808520|NCT01157351|12270721|FG000|Overall Study|Death|1
7808521|NCT01157351|12270722|FG001|Overall Study|Death|0
7968017|NCT01915498|12525685|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0
7968018|NCT01915498|12525667|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968019|NCT01915498|12525668|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968020|NCT01915498|12525669|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968021|NCT01915498|12525670|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968022|NCT01915498|12525671|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968023|NCT01915498|12525672|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968024|NCT01915498|12525673|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968025|NCT01915498|12525674|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968026|NCT01915498|12525675|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968027|NCT01915498|12525676|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968028|NCT01915498|12525677|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1
7968029|NCT01915498|12525678|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968030|NCT01915498|12525679|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968031|NCT01915498|12525680|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968032|NCT01915498|12525681|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968033|NCT01915498|12525682|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968034|NCT01915498|12525683|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968035|NCT01915498|12525684|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968036|NCT01915498|12525685|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7968037|NCT01915498|12525667|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2
7968038|NCT01915498|12525668|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7968039|NCT01915498|12525669|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7968040|NCT01915498|12525670|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7968041|NCT01915498|12525671|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7968042|NCT01915498|12525672|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2
7968043|NCT01915498|12525673|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7968044|NCT01915498|12525674|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7968045|NCT01915498|12525675|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7808522|NCT01157351|12270721|FG000|Overall Study|Lost to Follow-up|53
7808523|NCT01157351|12270722|FG001|Overall Study|Lost to Follow-up|55
7808524|NCT01157351|12270721|FG000|Overall Study|Withdrawal by Subject|37
7808525|NCT01157351|12270722|FG001|Overall Study|Withdrawal by Subject|27
7808526|NCT01157351|12270721|FG000|Overall Study|Physician Decision|5
7808527|NCT01157351|12270722|FG001|Overall Study|Physician Decision|4
7808528|NCT01157351|12270721|FG000|Overall Study|Protocol Violation|0
7808529|NCT01157351|12270722|FG001|Overall Study|Protocol Violation|1
7808530|NCT01157351|12270721|FG000|Overall Study|Other|32
7808531|NCT01157351|12270722|FG001|Overall Study|Other|36
7808532|NCT01157351|12270721|FG000|Overall Study|Noncompliance with Study Drug|0
7808533|NCT01157351|12270722|FG001|Overall Study|Noncompliance with Study Drug|3
7808534|NCT01157351|12270721|FG000|Overall Study|Randomized but not Treated|4
7808535|NCT01157351|12270722|FG001|Overall Study|Randomized but not Treated|2
7808536|NCT01157364|12270734|FG000|Overall Study|Other Reasons|1
7808537|NCT01157364|12270735|FG001|Overall Study|Other Reasons|1
7808538|NCT01157364|12270736|FG002|Overall Study|Other Reasons|2
7808539|NCT01157364|12270737|FG003|Overall Study|Other Reasons|1
7808540|NCT01157364|12270738|FG004|Overall Study|Other Reasons|0
7808541|NCT01157364|12270739|FG005|Overall Study|Other Reasons|0
7808542|NCT01157364|12270734|FG000|Overall Study|Personal Reasons|0
7808543|NCT01157364|12270735|FG001|Overall Study|Personal Reasons|2
7808544|NCT01157364|12270736|FG002|Overall Study|Personal Reasons|0
7808545|NCT01157364|12270737|FG003|Overall Study|Personal Reasons|0
7808546|NCT01157364|12270738|FG004|Overall Study|Personal Reasons|1
7808547|NCT01157364|12270739|FG005|Overall Study|Personal Reasons|1
7808548|NCT01157364|12270734|FG000|Overall Study|Lost to Follow-up|1
7808549|NCT01157364|12270735|FG001|Overall Study|Lost to Follow-up|0
7808550|NCT01157364|12270736|FG002|Overall Study|Lost to Follow-up|1
7808551|NCT01157364|12270737|FG003|Overall Study|Lost to Follow-up|0
7808552|NCT01157364|12270738|FG004|Overall Study|Lost to Follow-up|0
7808553|NCT01157364|12270739|FG005|Overall Study|Lost to Follow-up|0
7808554|NCT01157364|12270734|FG000|Overall Study|Lack of Efficacy|0
7808555|NCT01157364|12270735|FG001|Overall Study|Lack of Efficacy|0
7808556|NCT01157364|12270736|FG002|Overall Study|Lack of Efficacy|0
7808557|NCT01157364|12270737|FG003|Overall Study|Lack of Efficacy|1
7808558|NCT01157364|12270738|FG004|Overall Study|Lack of Efficacy|0
7808559|NCT01157364|12270739|FG005|Overall Study|Lack of Efficacy|0
7808560|NCT01157364|12270734|FG000|Overall Study|Adverse Event|0
7808561|NCT01157364|12270735|FG001|Overall Study|Adverse Event|1
7808562|NCT01157364|12270736|FG002|Overall Study|Adverse Event|1
7808563|NCT01157364|12270737|FG003|Overall Study|Adverse Event|0
7808564|NCT01157364|12270738|FG004|Overall Study|Adverse Event|1
7808565|NCT01157364|12270739|FG005|Overall Study|Adverse Event|0
7808566|NCT01157377|12270760|FG000|Overall Study|Lost to Follow-up|0
7808567|NCT01157377|12270761|FG001|Overall Study|Lost to Follow-up|0
7808568|NCT01157377|12270762|FG002|Overall Study|Lost to Follow-up|1
7808569|NCT01157377|12270763|FG003|Overall Study|Lost to Follow-up|0
7808570|NCT01157377|12270764|FG004|Overall Study|Lost to Follow-up|1
7808571|NCT01157377|12270765|FG005|Overall Study|Lost to Follow-up|1
7968046|NCT01915498|12525676|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7968047|NCT01915498|12525677|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2
7968048|NCT01915498|12525678|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7968049|NCT01915498|12525679|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7968050|NCT01915498|12525680|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4
7968051|NCT01915498|12525681|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7968052|NCT01915498|12525682|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4
7968053|NCT01915498|12525683|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3
7968054|NCT01915498|12525684|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16
7968055|NCT01915498|12525685|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7968056|NCT01915498|12525667|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968057|NCT01915498|12525668|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968058|NCT01915498|12525669|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968059|NCT01915498|12525670|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968060|NCT01915498|12525671|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
7968061|NCT01915498|12525672|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968062|NCT01915498|12525673|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968063|NCT01915498|12525674|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968064|NCT01915498|12525675|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968065|NCT01915498|12525676|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
7968066|NCT01915498|12525677|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968067|NCT01915498|12525678|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968068|NCT01915498|12525679|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968069|NCT01915498|12525680|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968070|NCT01915498|12525681|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968071|NCT01915498|12525682|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968072|NCT01915498|12525683|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968073|NCT01915498|12525684|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7968074|NCT01915498|12525685|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7808572|NCT01157377|12270766|FG006|Overall Study|Lost to Follow-up|0
7808573|NCT01157377|12270760|FG000|Overall Study|Personal Reasons|2
7808574|NCT01157377|12270761|FG001|Overall Study|Personal Reasons|1
7808575|NCT01157377|12270762|FG002|Overall Study|Personal Reasons|0
7808576|NCT01157377|12270763|FG003|Overall Study|Personal Reasons|1
7808577|NCT01157377|12270764|FG004|Overall Study|Personal Reasons|0
7808578|NCT01157377|12270765|FG005|Overall Study|Personal Reasons|0
7808579|NCT01157377|12270766|FG006|Overall Study|Personal Reasons|0
7808580|NCT01157377|12270760|FG000|Overall Study|Protocol Violation|0
7808581|NCT01157377|12270761|FG001|Overall Study|Protocol Violation|0
7808582|NCT01157377|12270762|FG002|Overall Study|Protocol Violation|0
7808583|NCT01157377|12270763|FG003|Overall Study|Protocol Violation|0
7808584|NCT01157377|12270764|FG004|Overall Study|Protocol Violation|0
7808585|NCT01157377|12270765|FG005|Overall Study|Protocol Violation|1
7808586|NCT01157377|12270766|FG006|Overall Study|Protocol Violation|0
7887473|NCT01817777|12389081|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1
7887474|NCT01817777|12389082|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3
7887475|NCT01817790|12389090|FG000|Overall Study|Adverse Event|0
7887476|NCT01817790|12389091|FG001|Overall Study|Adverse Event|2
7887477|NCT01817790|12389090|FG000|Overall Study|Lost to Follow-up|0
7887478|NCT01817790|12389091|FG001|Overall Study|Lost to Follow-up|1
7887479|NCT01817790|12389090|FG000|Overall Study|Protocol Violation|2
7887480|NCT01817790|12389091|FG001|Overall Study|Protocol Violation|1
7887481|NCT01817790|12389090|FG000|Overall Study|Withdrawal by Subject|1
7887482|NCT01817790|12389091|FG001|Overall Study|Withdrawal by Subject|3
7968075|NCT01915498|12525667|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7968076|NCT01915498|12525668|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7808587|NCT01157377|12270760|FG000|Overall Study|Lack of Efficacy|0
7808588|NCT01157377|12270761|FG001|Overall Study|Lack of Efficacy|0
7808589|NCT01157377|12270762|FG002|Overall Study|Lack of Efficacy|0
7808590|NCT01157377|12270763|FG003|Overall Study|Lack of Efficacy|0
7808591|NCT01157377|12270764|FG004|Overall Study|Lack of Efficacy|0
7808592|NCT01157377|12270765|FG005|Overall Study|Lack of Efficacy|0
7808593|NCT01157377|12270766|FG006|Overall Study|Lack of Efficacy|1
7808594|NCT01157377|12270760|FG000|Overall Study|Other Miscellaneous Reasons|0
7808595|NCT01157377|12270761|FG001|Overall Study|Other Miscellaneous Reasons|2
7808596|NCT01157377|12270762|FG002|Overall Study|Other Miscellaneous Reasons|0
7808597|NCT01157377|12270763|FG003|Overall Study|Other Miscellaneous Reasons|0
7808598|NCT01157377|12270764|FG004|Overall Study|Other Miscellaneous Reasons|1
7887483|NCT01817790|12389090|FG000|Overall Study|Other: Could not attend appointment|1
7808599|NCT01157377|12270765|FG005|Overall Study|Other Miscellaneous Reasons|1
7808600|NCT01157377|12270766|FG006|Overall Study|Other Miscellaneous Reasons|1
7808601|NCT01157676|12270802|FG000|Randomization|Death|1
7808602|NCT01157676|12270803|FG001|Randomization|Death|1
7808603|NCT01157676|12270802|FG000|Randomization|unresectable|2
7968077|NCT01915498|12525669|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2
7968078|NCT01915498|12525670|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7968079|NCT01915498|12525671|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7968080|NCT01915498|12525672|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7808604|NCT01157676|12270803|FG001|Randomization|unresectable|3
7968081|NCT01915498|12525673|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7968082|NCT01915498|12525674|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7968083|NCT01915498|12525675|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7968084|NCT01915498|12525676|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7968085|NCT01915498|12525677|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7968086|NCT01915498|12525678|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7968087|NCT01915498|12525679|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7968088|NCT01915498|12525680|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7968089|NCT01915498|12525681|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7968090|NCT01915498|12525682|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7968091|NCT01915498|12525683|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4
7968092|NCT01915498|12525684|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8
7968093|NCT01915498|12525685|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7968094|NCT01915498|12525667|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7968095|NCT01915498|12525668|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
7968096|NCT01915498|12525669|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7968097|NCT01915498|12525670|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7968098|NCT01915498|12525671|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7968099|NCT01915498|12525672|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7808605|NCT01157676|12270802|FG000|Randomization|Withdrawal by Subject|17
7808606|NCT01157676|12270803|FG001|Randomization|Withdrawal by Subject|13
7808607|NCT01157676|12270802|FG000|Randomization|Physician Decision|1
7808608|NCT01157676|12270803|FG001|Randomization|Physician Decision|0
7808609|NCT01157676|12270802|FG000|Surgery|underwent open cystectomy|0
7808610|NCT01157676|12270803|FG001|Surgery|underwent open cystectomy|4
7808611|NCT01157676|12270802|FG000|Surgery|converted to open procedure|0
7808612|NCT01157676|12270803|FG001|Surgery|converted to open procedure|5
7808613|NCT01157676|12270802|FG000|Surgery|underwent robotic cystectomy|1
7808614|NCT01157676|12270803|FG001|Surgery|underwent robotic cystectomy|0
7861756|NCT01597245|12351203|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861757|NCT01597245|12351204|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861758|NCT01597245|12351205|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861759|NCT01597245|12351206|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861760|NCT01597245|12351207|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861761|NCT01597245|12351208|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7861762|NCT01597245|12351188|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2
7861763|NCT01597245|12351189|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4
7861764|NCT01597245|12351190|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5
7861765|NCT01597245|12351191|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2
7861766|NCT01597245|12351192|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861767|NCT01597245|12351193|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861768|NCT01597245|12351194|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861769|NCT01597245|12351195|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861770|NCT01597245|12351196|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861771|NCT01597245|12351197|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861772|NCT01597245|12351198|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861773|NCT01597245|12351199|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861774|NCT01597245|12351200|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861775|NCT01597245|12351201|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861776|NCT01597245|12351202|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7887484|NCT01817790|12389091|FG001|Overall Study|Other: Could not attend appointment|1
7887485|NCT01817959|12389133|FG000|Overall Study|Graft loss|1
7887486|NCT01817959|12389134|FG001|Overall Study|Graft loss|1
7887487|NCT01817959|12389133|FG000|Overall Study|forbidden medication|1
7861777|NCT01597245|12351203|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861778|NCT01597245|12351204|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861779|NCT01597245|12351205|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861780|NCT01597245|12351206|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861781|NCT01597245|12351207|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861782|NCT01597245|12351208|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7861783|NCT01597245|12351188|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
7861784|NCT01597245|12351189|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
7808615|NCT01157845|12270815|FG000|Overall Study|Lost to Follow-up|5
7968100|NCT01915498|12525673|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7968101|NCT01915498|12525674|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7968102|NCT01915498|12525675|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7968103|NCT01915498|12525676|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7968104|NCT01915498|12525677|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7968105|NCT01915498|12525678|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7968106|NCT01915498|12525679|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7968107|NCT01915498|12525680|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6
7968108|NCT01915498|12525681|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5
7968109|NCT01915498|12525682|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
7968110|NCT01915498|12525683|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
7968111|NCT01915498|12525684|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9
7968112|NCT01915498|12525685|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7968113|NCT01915498|12525667|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7968114|NCT01915498|12525668|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7968115|NCT01915498|12525669|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7968116|NCT01915498|12525670|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7968117|NCT01915498|12525671|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7968118|NCT01915498|12525672|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7968119|NCT01915498|12525673|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7968120|NCT01915498|12525674|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7968121|NCT01915498|12525675|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7968122|NCT01915498|12525676|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7968123|NCT01915498|12525677|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7968124|NCT01915498|12525678|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7968125|NCT01915498|12525679|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7968126|NCT01915498|12525680|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7968127|NCT01915498|12525681|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7968128|NCT01915498|12525682|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7968129|NCT01915498|12525683|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7968130|NCT01915498|12525684|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7968131|NCT01915498|12525685|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7968132|NCT01915498|12525667|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
7968133|NCT01915498|12525668|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7968134|NCT01915498|12525669|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7968135|NCT01915498|12525670|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7968136|NCT01915498|12525671|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7968137|NCT01915498|12525672|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
7968138|NCT01915498|12525673|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7968139|NCT01915498|12525674|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7968140|NCT01915498|12525675|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7968141|NCT01915498|12525676|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7968142|NCT01915498|12525677|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7968143|NCT01915498|12525678|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7968144|NCT01915498|12525679|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7968145|NCT01915498|12525680|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7968146|NCT01915498|12525681|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
7968147|NCT01915498|12525682|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7968148|NCT01915498|12525683|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7968149|NCT01915498|12525684|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2
7968150|NCT01915498|12525685|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7808616|NCT01157845|12270815|FG000|Overall Study|Withdrawal by Subject|12
7808617|NCT01157845|12270815|FG000|Overall Study|Physician Decision|3
7808618|NCT01157845|12270815|FG000|Overall Study|Protocol Violation|13
7808619|NCT01157845|12270815|FG000|Overall Study|Study was ended|1
7808620|NCT01157845|12270815|FG000|Overall Study|Device malfunction|1
7808621|NCT01157897|12270823|FG000|Overall Study|Lost to Follow-up|2
7887488|NCT01817959|12389134|FG001|Overall Study|forbidden medication|1
7887489|NCT01817959|12389133|FG000|Overall Study|Adverse Event|1
7887490|NCT01817959|12389134|FG001|Overall Study|Adverse Event|0
7887491|NCT01817959|12389133|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1
7887492|NCT01817959|12389134|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1
7808622|NCT01157897|12270824|FG001|Overall Study|Lost to Follow-up|0
7887493|NCT01818141|12389151|FG000|Overall Study|Withdrawal by Subject|2
7887494|NCT01818141|12389152|FG001|Overall Study|Withdrawal by Subject|0
7887495|NCT01818141|12389151|FG000|Overall Study|No baseline C.diff colonies|1
7887496|NCT01818141|12389152|FG001|Overall Study|No baseline C.diff colonies|1
7968151|NCT01915498|12525667|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7968152|NCT01915498|12525668|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7968153|NCT01915498|12525669|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7968154|NCT01915498|12525670|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7968155|NCT01915498|12525671|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7968156|NCT01915498|12525672|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
7968157|NCT01915498|12525673|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7968158|NCT01915498|12525674|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7968159|NCT01915498|12525675|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7968160|NCT01915498|12525676|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7968161|NCT01915498|12525677|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7968162|NCT01915498|12525678|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7968163|NCT01915498|12525679|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7968164|NCT01915498|12525680|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
7968165|NCT01915498|12525681|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7968166|NCT01915498|12525682|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
7968167|NCT01915498|12525683|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7968168|NCT01915498|12525684|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7968169|NCT01915498|12525685|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7968170|NCT01915498|12525667|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968171|NCT01915498|12525668|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7887497|NCT01818141|12389151|FG000|Overall Study|Lost to Follow-up|0
7887498|NCT01818141|12389152|FG001|Overall Study|Lost to Follow-up|2
7887499|NCT01818258|12389174|FG000|Overall Study|Death|3
7887500|NCT01818258|12389175|FG001|Overall Study|Death|0
7887501|NCT01818258|12389174|FG000|Overall Study|Withdrawal by Subject|0
7887502|NCT01818258|12389175|FG001|Overall Study|Withdrawal by Subject|1
7887503|NCT01818258|12389174|FG000|Overall Study|Lost to Follow-up|0
7887504|NCT01818258|12389175|FG001|Overall Study|Lost to Follow-up|1
7887505|NCT01818258|12389174|FG000|Overall Study|Unable to Travel to Clinic|0
7887506|NCT01818258|12389175|FG001|Overall Study|Unable to Travel to Clinic|1
7962838|NCT02715804|12517240|FG000|Overall Study|Withdrawal by Subject|5
7962839|NCT02715804|12517241|FG001|Overall Study|Withdrawal by Subject|4
7962840|NCT02715804|12517240|FG000|Overall Study|Other than specified|2
7962841|NCT02715804|12517241|FG001|Overall Study|Other than specified|3
7962842|NCT02716194|12517250|FG000|Period 1 - ADVATE|Withdrawal by Subject|1
7962843|NCT02716194|12517251|FG001|Period 1 - ADVATE|Withdrawal by Subject|1
7962844|NCT02716194|12517252|FG002|Period 1 - ADVATE|Withdrawal by Subject|0
7962845|NCT02716298|12517273|FG000|First Intervention (1 Month)|Lens discomfort|1
7962846|NCT02716298|12517274|FG001|First Intervention (1 Month)|Lens discomfort|1
7962847|NCT02716584|12517300|FG000|Overall Study|Lost to Follow-up|8
7962848|NCT02716584|12517301|FG001|Overall Study|Lost to Follow-up|5
7962849|NCT02716779|12517332|FG000|Monotherapy|Adverse Event|0
7962850|NCT02716779|12517333|FG001|Monotherapy|Adverse Event|1
7962851|NCT02716779|12517334|FG002|Monotherapy|Adverse Event|1
7962852|NCT02716779|12517332|FG000|Combination Therapy|Adverse Event|0
7962853|NCT02716779|12517333|FG001|Combination Therapy|Adverse Event|2
7962854|NCT02716779|12517334|FG002|Combination Therapy|Adverse Event|1
7962855|NCT02716805|12517348|FG000|Overall Study|Progressive disease|2
7808623|NCT01157897|12270825|FG002|Overall Study|Lost to Follow-up|0
7808624|NCT01157897|12270826|FG003|Overall Study|Lost to Follow-up|1
7808625|NCT01157897|12270823|FG000|Overall Study|Relocated|0
7808626|NCT01157897|12270824|FG001|Overall Study|Relocated|2
7808627|NCT01157897|12270825|FG002|Overall Study|Relocated|0
7808628|NCT01157897|12270826|FG003|Overall Study|Relocated|0
7808629|NCT01158118|12270838|FG000|Overall Study|Screen failure|1
7808630|NCT01158118|12270839|FG001|Overall Study|Screen failure|0
7808631|NCT01158118|12270838|FG000|Overall Study|Donor match was a screen failure|0
7808632|NCT01158118|12270839|FG001|Overall Study|Donor match was a screen failure|1
7808633|NCT01158118|12270838|FG000|Overall Study|Suffered stroke prior to transplant|0
7808634|NCT01158118|12270839|FG001|Overall Study|Suffered stroke prior to transplant|1
7808635|NCT01158118|12270838|FG000|Overall Study|Death|0
7808636|NCT01158118|12270839|FG001|Overall Study|Death|1
7808637|NCT01158222|12270849|FG000|Overall Study|Not eligible for intermediate phase|17
7808638|NCT01158261|12270853|FG000|Overall Study|Lost to Follow-up|9
7808639|NCT01158261|12270853|FG000|Overall Study|Death|7
7808640|NCT01158261|12270853|FG000|Overall Study|Withdrawal by Subject|1
7808641|NCT01158378|12270859|FG000|Overall Study|Death|4
7808642|NCT01158378|12270860|FG001|Overall Study|Death|5
7808643|NCT01158378|12270859|FG000|Overall Study|Lost to Follow-up|2
7808644|NCT01158378|12270860|FG001|Overall Study|Lost to Follow-up|4
7808645|NCT01158378|12270859|FG000|Overall Study|Withdrawal by Subject|4
7962856|NCT02716805|12517349|FG001|Overall Study|Progressive disease|0
7962857|NCT02716805|12517350|FG002|Overall Study|Progressive disease|0
7962858|NCT02716805|12517351|FG003|Overall Study|Progressive disease|0
7962859|NCT02716896|12517388|FG000|Overall Study|Physician Decision|0
7808646|NCT01158378|12270860|FG001|Overall Study|Withdrawal by Subject|0
7808647|NCT01158404|12270875|FG000|Overall Study|Withdrawal by Subject|0
7808648|NCT01158404|12270876|FG001|Overall Study|Withdrawal by Subject|1
7808649|NCT01158404|12270877|FG002|Overall Study|Withdrawal by Subject|0
7808650|NCT01158404|12270878|FG003|Overall Study|Withdrawal by Subject|0
7808651|NCT01158404|12270879|FG004|Overall Study|Withdrawal by Subject|3
7808652|NCT01158404|12270880|FG005|Overall Study|Withdrawal by Subject|1
7808653|NCT01158404|12270881|FG006|Overall Study|Withdrawal by Subject|0
7808654|NCT01158404|12270882|FG007|Overall Study|Withdrawal by Subject|1
7808655|NCT01158404|12270875|FG000|Overall Study|Physician Decision|0
7808656|NCT01158404|12270876|FG001|Overall Study|Physician Decision|0
7808657|NCT01158404|12270877|FG002|Overall Study|Physician Decision|0
7808658|NCT01158404|12270878|FG003|Overall Study|Physician Decision|0
7808659|NCT01158404|12270879|FG004|Overall Study|Physician Decision|0
7808660|NCT01158404|12270880|FG005|Overall Study|Physician Decision|0
7808661|NCT01158404|12270881|FG006|Overall Study|Physician Decision|0
7808662|NCT01158404|12270882|FG007|Overall Study|Physician Decision|1
7808663|NCT01158404|12270875|FG000|Overall Study|Progressive Disease|0
7808664|NCT01158404|12270876|FG001|Overall Study|Progressive Disease|0
7808665|NCT01158404|12270877|FG002|Overall Study|Progressive Disease|0
7808666|NCT01158404|12270878|FG003|Overall Study|Progressive Disease|0
7808667|NCT01158404|12270879|FG004|Overall Study|Progressive Disease|0
7808668|NCT01158404|12270880|FG005|Overall Study|Progressive Disease|0
7808669|NCT01158404|12270881|FG006|Overall Study|Progressive Disease|1
7808670|NCT01158404|12270882|FG007|Overall Study|Progressive Disease|0
7808671|NCT01158534|12270908|FG000|Overall Study|Withdrawal by Subject|1
7808672|NCT01158534|12270908|FG000|Overall Study|Death|1
7808673|NCT01158534|12270908|FG000|Overall Study|Other|1
7808674|NCT01158924|12270967|FG000|Overall Study|Withdrawal by Subject|1
7808675|NCT01158924|12270968|FG001|Overall Study|Withdrawal by Subject|2
7808676|NCT01158924|12270967|FG000|Overall Study|Lost to Follow-up|0
7808677|NCT01158924|12270968|FG001|Overall Study|Lost to Follow-up|1
7808678|NCT01158950|12270974|FG000|1st Intervention (1 Day)|Physician Decision|1
7808679|NCT01158950|12270975|FG001|1st Intervention (1 Day)|Physician Decision|2
7808680|NCT01159171|12271006|FG000|Overall Study|Adverse Event|11
7808681|NCT01159171|12271006|FG000|Overall Study|Progression of Disease|28
7808682|NCT01159171|12271006|FG000|Overall Study|Protocol Violation|1
7808683|NCT01159171|12271006|FG000|Overall Study|Need for Surgery|5
7808684|NCT01159171|12271006|FG000|Overall Study|Medical Decision|4
7808685|NCT01159171|12271006|FG000|Overall Study|Death|1
7808686|NCT01159431|12271026|FG000|Overall Study|Adverse Event|1
7808687|NCT01159431|12271027|FG001|Overall Study|Adverse Event|2
7808688|NCT01159431|12271026|FG000|Overall Study|non-compliance|1
7808689|NCT01159431|12271027|FG001|Overall Study|non-compliance|1
7808690|NCT01159431|12271026|FG000|Overall Study|Lack of Efficacy|0
7808691|NCT01159431|12271027|FG001|Overall Study|Lack of Efficacy|3
7808692|NCT01159574|12271053|FG000|Treatment Phase|non-evaluable/not included in analysis|1
7808693|NCT01159574|12271053|FG000|Treatment Phase|Adverse Event|3
7808694|NCT01159574|12271053|FG000|Treatment Phase|Death|6
7808695|NCT01159574|12271053|FG000|Treatment Phase|Physician Decision|2
7808696|NCT01159574|12271053|FG000|Treatment Phase|Withdrawal by Subject|7
7808697|NCT01159574|12271053|FG000|Treatment Phase|still on treatment|2
7808698|NCT01159574|12271053|FG000|Follow Up Phase|Lost to Follow-up|2
7808699|NCT01159574|12271053|FG000|Follow Up Phase|still being followed for overall surviva|18
7808700|NCT01159600|12271065|FG000|Overall Study|Not treated|0
7808701|NCT01159600|12271066|FG001|Overall Study|Not treated|0
7808702|NCT01159600|12271067|FG002|Overall Study|Not treated|1
7808703|NCT01159600|12271068|FG003|Overall Study|Not treated|0
7808704|NCT01159600|12271069|FG004|Overall Study|Not treated|0
7808705|NCT01159600|12271070|FG005|Overall Study|Not treated|1
7808706|NCT01159600|12271071|FG006|Overall Study|Not treated|2
7808707|NCT01159600|12271072|FG007|Overall Study|Not treated|2
7808708|NCT01159600|12271065|FG000|Overall Study|Adverse Event|7
7808709|NCT01159600|12271066|FG001|Overall Study|Adverse Event|2
7808710|NCT01159600|12271067|FG002|Overall Study|Adverse Event|5
7808711|NCT01159600|12271068|FG003|Overall Study|Adverse Event|1
7808712|NCT01159600|12271069|FG004|Overall Study|Adverse Event|8
7808713|NCT01159600|12271070|FG005|Overall Study|Adverse Event|6
7808714|NCT01159600|12271071|FG006|Overall Study|Adverse Event|7
7808715|NCT01159600|12271072|FG007|Overall Study|Adverse Event|5
7808716|NCT01159600|12271065|FG000|Overall Study|Lack of Efficacy|0
7808717|NCT01159600|12271066|FG001|Overall Study|Lack of Efficacy|0
7808718|NCT01159600|12271067|FG002|Overall Study|Lack of Efficacy|0
7808719|NCT01159600|12271068|FG003|Overall Study|Lack of Efficacy|0
7808720|NCT01159600|12271069|FG004|Overall Study|Lack of Efficacy|2
7808721|NCT01159600|12271070|FG005|Overall Study|Lack of Efficacy|0
7808722|NCT01159600|12271071|FG006|Overall Study|Lack of Efficacy|0
7808723|NCT01159600|12271072|FG007|Overall Study|Lack of Efficacy|1
7808724|NCT01159600|12271065|FG000|Overall Study|Non compliant with protocol|2
7808725|NCT01159600|12271066|FG001|Overall Study|Non compliant with protocol|1
7808726|NCT01159600|12271067|FG002|Overall Study|Non compliant with protocol|0
7808727|NCT01159600|12271068|FG003|Overall Study|Non compliant with protocol|0
7808728|NCT01159600|12271069|FG004|Overall Study|Non compliant with protocol|2
7808729|NCT01159600|12271070|FG005|Overall Study|Non compliant with protocol|0
7808730|NCT01159600|12271071|FG006|Overall Study|Non compliant with protocol|2
7808731|NCT01159600|12271072|FG007|Overall Study|Non compliant with protocol|0
7808732|NCT01159600|12271065|FG000|Overall Study|Lost to Follow-up|2
7808733|NCT01159600|12271066|FG001|Overall Study|Lost to Follow-up|3
7808734|NCT01159600|12271067|FG002|Overall Study|Lost to Follow-up|4
7808735|NCT01159600|12271068|FG003|Overall Study|Lost to Follow-up|3
7808736|NCT01159600|12271069|FG004|Overall Study|Lost to Follow-up|3
7808737|NCT01159600|12271070|FG005|Overall Study|Lost to Follow-up|0
7887507|NCT01818284|12389184|FG000|Overall Study|Not eligible due to White Blood Counts|4
7887508|NCT01818284|12389185|FG001|Overall Study|Not eligible due to White Blood Counts|4
7887509|NCT01818284|12389184|FG000|Overall Study|Death|0
7887510|NCT01818284|12389185|FG001|Overall Study|Death|2
7968172|NCT01915498|12525669|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968173|NCT01915498|12525670|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968174|NCT01915498|12525671|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968175|NCT01915498|12525672|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968176|NCT01915498|12525673|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968177|NCT01915498|12525674|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968178|NCT01915498|12525675|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968179|NCT01915498|12525676|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968180|NCT01915498|12525677|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968181|NCT01915498|12525678|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968182|NCT01915498|12525679|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968183|NCT01915498|12525680|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968184|NCT01915498|12525681|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968185|NCT01915498|12525682|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968186|NCT01915498|12525683|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7968187|NCT01915498|12525684|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7887511|NCT01818297|12389192|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
7887512|NCT01818297|12389193|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
7887513|NCT01818297|12389192|FG000|Open Label Phase (3-12 Months)|Physician Decision|1
7887514|NCT01818297|12389193|FG001|Open Label Phase (3-12 Months)|Physician Decision|0
7887515|NCT01818297|12389192|FG000|Open Label Phase (3-12 Months)|Early study closure|17
7887516|NCT01818297|12389193|FG001|Open Label Phase (3-12 Months)|Early study closure|10
7887517|NCT01818336|12389199|FG000|Overall Study|Declined retest visit|0
7887518|NCT01818336|12389200|FG001|Overall Study|Declined retest visit|11
7887519|NCT01818336|12389199|FG000|Overall Study|Lost to Follow-up|0
7887520|NCT01818336|12389200|FG001|Overall Study|Lost to Follow-up|1
7968188|NCT01915498|12525685|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2
7968189|NCT00033631|12525775|FG000|Overall Study|Protocol Violation|14
7968190|NCT00033631|12525776|FG001|Overall Study|Protocol Violation|11
7968191|NCT00033631|12525775|FG000|Overall Study|Withdrawal by Subject|4
7968192|NCT00033631|12525776|FG001|Overall Study|Withdrawal by Subject|4
7808738|NCT01159600|12271071|FG006|Overall Study|Lost to Follow-up|3
7808739|NCT01159600|12271072|FG007|Overall Study|Lost to Follow-up|2
7808740|NCT01159600|12271065|FG000|Overall Study|Patient refusal to continue,not due toAE|7
7808741|NCT01159600|12271066|FG001|Overall Study|Patient refusal to continue,not due toAE|2
7808742|NCT01159600|12271067|FG002|Overall Study|Patient refusal to continue,not due toAE|4
7808743|NCT01159600|12271068|FG003|Overall Study|Patient refusal to continue,not due toAE|5
7808744|NCT01159600|12271069|FG004|Overall Study|Patient refusal to continue,not due toAE|4
7808745|NCT01159600|12271070|FG005|Overall Study|Patient refusal to continue,not due toAE|4
7808746|NCT01159600|12271071|FG006|Overall Study|Patient refusal to continue,not due toAE|2
7808747|NCT01159600|12271072|FG007|Overall Study|Patient refusal to continue,not due toAE|5
7808748|NCT01159600|12271065|FG000|Overall Study|Other reason not defined above|3
7808749|NCT01159600|12271066|FG001|Overall Study|Other reason not defined above|0
7808750|NCT01159600|12271067|FG002|Overall Study|Other reason not defined above|4
7808751|NCT01159600|12271068|FG003|Overall Study|Other reason not defined above|2
7808752|NCT01159600|12271069|FG004|Overall Study|Other reason not defined above|5
7808753|NCT01159600|12271070|FG005|Overall Study|Other reason not defined above|7
7968193|NCT04952701|12525783|FG000|Control Lens|Physician Decision|4
7968194|NCT04952701|12525783|FG000|Test Lens|Physician Decision|1
7808754|NCT01159600|12271071|FG006|Overall Study|Other reason not defined above|3
7808755|NCT01159600|12271072|FG007|Overall Study|Other reason not defined above|3
7717552|NCT00520572|12141200|FG003|Overall Study|Lost to Follow-up|0
7808756|NCT01159665|12271097|FG000|Overall Study|Withdrawal by Subject|0
7808757|NCT01159665|12271098|FG001|Overall Study|Withdrawal by Subject|1
7808758|NCT01159665|12271099|FG002|Overall Study|Withdrawal by Subject|0
7808759|NCT01159665|12271100|FG003|Overall Study|Withdrawal by Subject|0
7808760|NCT01159665|12271101|FG004|Overall Study|Withdrawal by Subject|0
7808761|NCT01159665|12271102|FG005|Overall Study|Withdrawal by Subject|0
7808762|NCT01159691|12271116|FG000|Overall Study|Lost to Follow-up|2
7808763|NCT01159691|12271116|FG000|Overall Study|Unknown reasons|1
7808764|NCT01159691|12271116|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6
7808765|NCT01159691|12271116|FG000|Overall Study|Discontinued Neupro due to other reasons|1
7808766|NCT01159691|12271116|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2
7808767|NCT01159691|12271116|FG000|Overall Study|Disc. Neupro other & unknown reasons|7
7808768|NCT01159691|12271116|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2
7808769|NCT01159691|12271116|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1
7808770|NCT01159769|12271129|FG000|Overall Study|Adverse Event|1
7808771|NCT01159912|12271136|FG000|Overall Study|Adverse Event|2
7808772|NCT01159912|12271137|FG001|Overall Study|Adverse Event|2
7808773|NCT01159912|12271138|FG002|Overall Study|Adverse Event|3
7808774|NCT01159912|12271136|FG000|Overall Study|Lack of Efficacy|23
7808775|NCT01159912|12271137|FG001|Overall Study|Lack of Efficacy|15
7808776|NCT01159912|12271138|FG002|Overall Study|Lack of Efficacy|14
7808777|NCT01159912|12271136|FG000|Overall Study|Protocol Violation|1
7808778|NCT01159912|12271137|FG001|Overall Study|Protocol Violation|2
7808779|NCT01159912|12271138|FG002|Overall Study|Protocol Violation|3
7808780|NCT01159912|12271136|FG000|Overall Study|Lost to Follow-up|4
7808781|NCT01159912|12271137|FG001|Overall Study|Lost to Follow-up|0
7808782|NCT01159912|12271138|FG002|Overall Study|Lost to Follow-up|0
7887521|NCT01818492|12389226|FG000|Overall Study|Adverse Event|2
7887522|NCT01818492|12389226|FG000|Overall Study|Death|3
7887523|NCT01818492|12389226|FG000|Overall Study|Withdrawal by Subject|1
7887524|NCT01818492|12389226|FG000|Overall Study|Additional therapy when not allowed PP|4
7887525|NCT01818531|12389258|FG000|Overall Study|Withdrawn for case delay after block|1
7808783|NCT01159912|12271136|FG000|Overall Study|Physician Decision|0
7808784|NCT01159912|12271137|FG001|Overall Study|Physician Decision|0
7808785|NCT01159912|12271138|FG002|Overall Study|Physician Decision|3
7808786|NCT01159912|12271136|FG000|Overall Study|Withdrawal by Subject|10
7808787|NCT01159912|12271137|FG001|Overall Study|Withdrawal by Subject|3
7887526|NCT01818531|12389259|FG001|Overall Study|Withdrawn for case delay after block|0
7808788|NCT01159912|12271138|FG002|Overall Study|Withdrawal by Subject|3
7808789|NCT01159938|12271149|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0
7808790|NCT01159938|12271150|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0
7808791|NCT01159938|12271151|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1
7808792|NCT01159938|12271152|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0
7808793|NCT01159938|12271153|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0
7808794|NCT01160198|12271177|FG000|Overall Study|Withdrawal by Subject|2
7808795|NCT01160198|12271178|FG001|Overall Study|Withdrawal by Subject|1
7808796|NCT01160198|12271179|FG002|Overall Study|Withdrawal by Subject|0
7808797|NCT01160198|12271177|FG000|Overall Study|Adverse Event|0
7808798|NCT01160198|12271178|FG001|Overall Study|Adverse Event|1
7808799|NCT01160198|12271179|FG002|Overall Study|Adverse Event|0
7808800|NCT01160198|12271177|FG000|Overall Study|Lost to Follow-up|0
7808801|NCT01160198|12271178|FG001|Overall Study|Lost to Follow-up|1
7808802|NCT01160198|12271179|FG002|Overall Study|Lost to Follow-up|0
7808803|NCT01160198|12271177|FG000|Overall Study|Participant lost drug; withdrew consent|0
7808804|NCT01160198|12271178|FG001|Overall Study|Participant lost drug; withdrew consent|0
7808805|NCT01160198|12271179|FG002|Overall Study|Participant lost drug; withdrew consent|1
7808806|NCT01160289|12271205|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8
7808807|NCT01160289|12271206|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0
7808808|NCT01160289|12271207|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0
7808809|NCT01160289|12271208|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0
7808810|NCT01160289|12271209|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0
7808811|NCT01160289|12271210|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0
7808812|NCT01160289|12271205|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308
7808813|NCT01160289|12271206|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
7808814|NCT01160289|12271207|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
7808815|NCT01160289|12271208|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
7808816|NCT01160289|12271209|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
7808817|NCT01160289|12271210|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
7808818|NCT01160289|12271205|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1
7808819|NCT01160289|12271206|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
7808820|NCT01160289|12271207|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
7808821|NCT01160289|12271208|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
7808822|NCT01160289|12271209|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
7808823|NCT01160289|12271210|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
7808824|NCT01160289|12271205|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9
7808825|NCT01160289|12271206|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
7808826|NCT01160289|12271207|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
7808827|NCT01160289|12271208|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
7808828|NCT01160289|12271209|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
7808829|NCT01160289|12271210|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
7887527|NCT01818531|12389258|FG000|Overall Study|Withdrawn for long-acting opioid patch|0
7887528|NCT01818531|12389259|FG001|Overall Study|Withdrawn for long-acting opioid patch|1
7887529|NCT01818531|12389258|FG000|Overall Study|Withdrawn for failure to place block|0
7887530|NCT01818531|12389259|FG001|Overall Study|Withdrawn for failure to place block|1
7887531|NCT01818596|12389267|FG000|Overall Study|Enrolled but Not Treated|4
7887532|NCT01818596|12389268|FG001|Overall Study|Enrolled but Not Treated|0
7887533|NCT01818596|12389267|FG000|Overall Study|Adverse Event|7
7887534|NCT01818596|12389268|FG001|Overall Study|Adverse Event|0
7887535|NCT01818596|12389267|FG000|Overall Study|Death|3
7808830|NCT01160289|12271205|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26
7808831|NCT01160289|12271206|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0
7808832|NCT01160289|12271207|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0
7808833|NCT01160289|12271208|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0
7808834|NCT01160289|12271209|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0
7808835|NCT01160289|12271210|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0
7808836|NCT01160289|12271205|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1
7808837|NCT01160289|12271206|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0
7808838|NCT01160289|12271207|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0
7808839|NCT01160289|12271208|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0
7808840|NCT01160289|12271209|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0
7808841|NCT01160289|12271210|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0
7808842|NCT01160289|12271205|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67
7808843|NCT01160289|12271206|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
7808844|NCT01160289|12271207|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
7808845|NCT01160289|12271208|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
7887536|NCT01818596|12389268|FG001|Overall Study|Death|0
7808846|NCT01160289|12271209|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
7808847|NCT01160289|12271210|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
7808848|NCT01160289|12271205|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64
7808849|NCT01160289|12271206|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
7808850|NCT01160289|12271207|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
7808851|NCT01160289|12271208|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
7808852|NCT01160289|12271209|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
7808853|NCT01160289|12271210|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
7808854|NCT01160289|12271205|FG000|Post-Randomization Period|Adverse Event|0
7808855|NCT01160289|12271206|FG001|Post-Randomization Period|Adverse Event|4
7808856|NCT01160289|12271207|FG002|Post-Randomization Period|Adverse Event|4
7808857|NCT01160289|12271208|FG003|Post-Randomization Period|Adverse Event|2
7808858|NCT01160289|12271209|FG004|Post-Randomization Period|Adverse Event|0
7808859|NCT01160289|12271210|FG005|Post-Randomization Period|Adverse Event|0
7808860|NCT01160289|12271205|FG000|Post-Randomization Period|Death|0
7808861|NCT01160289|12271206|FG001|Post-Randomization Period|Death|0
7887537|NCT01818596|12389267|FG000|Overall Study|Investigator's Discretion|4
7808862|NCT01160289|12271207|FG002|Post-Randomization Period|Death|0
7808863|NCT01160289|12271208|FG003|Post-Randomization Period|Death|1
7808864|NCT01160289|12271209|FG004|Post-Randomization Period|Death|0
7808865|NCT01160289|12271210|FG005|Post-Randomization Period|Death|0
7808866|NCT01160289|12271205|FG000|Post-Randomization Period|Lack of Efficacy|0
7808867|NCT01160289|12271206|FG001|Post-Randomization Period|Lack of Efficacy|1
7808868|NCT01160289|12271207|FG002|Post-Randomization Period|Lack of Efficacy|0
7808869|NCT01160289|12271208|FG003|Post-Randomization Period|Lack of Efficacy|3
7808870|NCT01160289|12271209|FG004|Post-Randomization Period|Lack of Efficacy|0
7808871|NCT01160289|12271210|FG005|Post-Randomization Period|Lack of Efficacy|0
7808872|NCT01160289|12271205|FG000|Post-Randomization Period|Lost to Follow-up|0
7808873|NCT01160289|12271206|FG001|Post-Randomization Period|Lost to Follow-up|3
7808874|NCT01160289|12271207|FG002|Post-Randomization Period|Lost to Follow-up|2
7808875|NCT01160289|12271208|FG003|Post-Randomization Period|Lost to Follow-up|5
7808876|NCT01160289|12271209|FG004|Post-Randomization Period|Lost to Follow-up|3
7808877|NCT01160289|12271210|FG005|Post-Randomization Period|Lost to Follow-up|4
7808878|NCT01160289|12271205|FG000|Post-Randomization Period|Physician Decision|0
7808879|NCT01160289|12271206|FG001|Post-Randomization Period|Physician Decision|0
7808880|NCT01160289|12271207|FG002|Post-Randomization Period|Physician Decision|1
7808881|NCT01160289|12271208|FG003|Post-Randomization Period|Physician Decision|0
7808882|NCT01160289|12271209|FG004|Post-Randomization Period|Physician Decision|0
7808883|NCT01160289|12271210|FG005|Post-Randomization Period|Physician Decision|0
7808884|NCT01160289|12271205|FG000|Post-Randomization Period|Protocol Violation|0
7808885|NCT01160289|12271206|FG001|Post-Randomization Period|Protocol Violation|4
7808886|NCT01160289|12271207|FG002|Post-Randomization Period|Protocol Violation|2
7808887|NCT01160289|12271208|FG003|Post-Randomization Period|Protocol Violation|0
7808888|NCT01160289|12271209|FG004|Post-Randomization Period|Protocol Violation|1
7808889|NCT01160289|12271210|FG005|Post-Randomization Period|Protocol Violation|3
7808890|NCT01160289|12271205|FG000|Post-Randomization Period|Withdrawal by Subject|0
7808891|NCT01160289|12271206|FG001|Post-Randomization Period|Withdrawal by Subject|5
7808892|NCT01160289|12271207|FG002|Post-Randomization Period|Withdrawal by Subject|13
7808893|NCT01160289|12271208|FG003|Post-Randomization Period|Withdrawal by Subject|8
7808894|NCT01160289|12271209|FG004|Post-Randomization Period|Withdrawal by Subject|5
7808895|NCT01160289|12271210|FG005|Post-Randomization Period|Withdrawal by Subject|7
7808896|NCT01160289|12271205|FG000|Post-Randomization Period|Entry Criteria Not Met|0
7808897|NCT01160289|12271206|FG001|Post-Randomization Period|Entry Criteria Not Met|2
7808898|NCT01160289|12271207|FG002|Post-Randomization Period|Entry Criteria Not Met|2
7808899|NCT01160289|12271208|FG003|Post-Randomization Period|Entry Criteria Not Met|2
7808900|NCT01160289|12271209|FG004|Post-Randomization Period|Entry Criteria Not Met|0
7808901|NCT01160289|12271210|FG005|Post-Randomization Period|Entry Criteria Not Met|0
7808902|NCT01160289|12271205|FG000|Post-Randomization Period|Sponsor Decision|0
7808903|NCT01160289|12271206|FG001|Post-Randomization Period|Sponsor Decision|1
7808904|NCT01160289|12271207|FG002|Post-Randomization Period|Sponsor Decision|0
7808905|NCT01160289|12271208|FG003|Post-Randomization Period|Sponsor Decision|0
7808906|NCT01160289|12271209|FG004|Post-Randomization Period|Sponsor Decision|0
7808907|NCT01160289|12271210|FG005|Post-Randomization Period|Sponsor Decision|0
7808908|NCT01160354|12271226|FG000|Overall Study|Death|0
7808909|NCT01160354|12271227|FG001|Overall Study|Death|1
7808910|NCT01160354|12271228|FG002|Overall Study|Death|1
7808911|NCT01160484|12271258|FG000|Overall Study|Lack of Efficacy|9
7808912|NCT01160484|12271258|FG000|Overall Study|Adverse Event|6
7808913|NCT01160484|12271258|FG000|Overall Study|Withdrawal by Subject|2
7808914|NCT01160484|12271258|FG000|Overall Study|inclusion/exclusion criteria failure|1
7808915|NCT01160614|12271264|FG000|Overall Study|Withdrawal by Subject|0
7808916|NCT01160614|12271265|FG001|Overall Study|Withdrawal by Subject|2
7808917|NCT01160640|12271291|FG000|Overall Study|Physician Decision|3
7808918|NCT01160640|12271292|FG001|Overall Study|Physician Decision|3
7808919|NCT01160640|12271291|FG000|Overall Study|Incarceration|1
7808920|NCT01160640|12271292|FG001|Overall Study|Incarceration|0
7808921|NCT01160640|12271291|FG000|Overall Study|Withdrawal by Subject|0
7808922|NCT01160640|12271292|FG001|Overall Study|Withdrawal by Subject|3
7808923|NCT01160744|12271304|FG000|Overall Study|Withdrawal by Subject|11
7808924|NCT01160744|12271305|FG001|Overall Study|Withdrawal by Subject|5
7808925|NCT01160744|12271306|FG002|Overall Study|Withdrawal by Subject|6
7808926|NCT01160744|12271307|FG003|Overall Study|Withdrawal by Subject|4
7808927|NCT01160744|12271304|FG000|Overall Study|Not meet inclusion/exclusion criteria|0
7808928|NCT01160744|12271305|FG001|Overall Study|Not meet inclusion/exclusion criteria|0
7808929|NCT01160744|12271306|FG002|Overall Study|Not meet inclusion/exclusion criteria|1
7808930|NCT01160744|12271307|FG003|Overall Study|Not meet inclusion/exclusion criteria|0
7808931|NCT01160770|12271319|FG000|Overall Study|Adverse Event|10
7808932|NCT01160770|12271319|FG000|Overall Study|Protocol Violation|2
7808933|NCT01160770|12271319|FG000|Overall Study|Subject/parent/caregiver request|33
7808934|NCT01160770|12271319|FG000|Overall Study|Physician Decision|1
7808935|NCT01160770|12271319|FG000|Overall Study|Lost to Follow-up|7
7808936|NCT01160770|12271319|FG000|Overall Study|Study termination or sponsor request|1
7808937|NCT01160770|12271319|FG000|Overall Study|Death|9
7808938|NCT01160770|12271319|FG000|Overall Study|Lack of Efficacy|15
7808939|NCT01160770|12271319|FG000|Overall Study|Other Reasons|1
7808940|NCT01160822|12271330|FG000|Overall Study|Adverse Event|0
7808941|NCT01160822|12271331|FG001|Overall Study|Adverse Event|0
7808942|NCT01160822|12271332|FG002|Overall Study|Adverse Event|0
7808943|NCT01160822|12271333|FG003|Overall Study|Adverse Event|0
7808944|NCT01160822|12271334|FG004|Overall Study|Adverse Event|1
7808945|NCT01160822|12271335|FG005|Overall Study|Adverse Event|2
7808946|NCT01160822|12271336|FG006|Overall Study|Adverse Event|5
7808947|NCT01160822|12271330|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7808948|NCT01160822|12271331|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7808949|NCT01160822|12271332|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7808950|NCT01160822|12271333|FG003|Overall Study|Unsatisfactory therapeutic effect|0
7887538|NCT01818596|12389268|FG001|Overall Study|Investigator's Discretion|0
7887539|NCT01818596|12389267|FG000|Overall Study|Protocol Violation|1
7887540|NCT01818596|12389268|FG001|Overall Study|Protocol Violation|0
7887541|NCT01818596|12389267|FG000|Overall Study|Withdrew Consent|5
7887542|NCT01818596|12389268|FG001|Overall Study|Withdrew Consent|0
7887543|NCT01818596|12389267|FG000|Overall Study|Lost to Follow-up|7
7887544|NCT01818596|12389268|FG001|Overall Study|Lost to Follow-up|0
7887545|NCT01818700|12389275|FG000|Overall Study|Adverse Event|67
7887546|NCT01818700|12389275|FG000|Overall Study|Lack of Efficacy|2
7887547|NCT01818700|12389275|FG000|Overall Study|Lost to Follow-up|5
7887548|NCT01818700|12389275|FG000|Overall Study|Withdrawal by Subject|27
7887549|NCT01818700|12389275|FG000|Overall Study|Protocol Violation|2
7887550|NCT01818700|12389275|FG000|Overall Study|Other|1
7887551|NCT01818726|12389283|FG000|Overall Study|Administrative reasons|5
7887552|NCT01818726|12389284|FG001|Overall Study|Administrative reasons|1
7887553|NCT01818726|12389283|FG000|Overall Study|Withdrawal by Subject|0
7887554|NCT01818726|12389284|FG001|Overall Study|Withdrawal by Subject|1
7887555|NCT01818726|12389283|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1
7887556|NCT01818726|12389284|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0
7887557|NCT01818752|12389292|FG000|Overall Study|Adverse Event|64
7887558|NCT01818752|12389293|FG001|Overall Study|Adverse Event|74
7887559|NCT01818752|12389292|FG000|Overall Study|Death|14
7887560|NCT01818752|12389293|FG001|Overall Study|Death|18
7887561|NCT01818752|12389292|FG000|Overall Study|Non-compliance|16
7887562|NCT01818752|12389293|FG001|Overall Study|Non-compliance|20
7887563|NCT01818752|12389292|FG000|Overall Study|Withdrawal by Subject|15
7887564|NCT01818752|12389293|FG001|Overall Study|Withdrawal by Subject|14
7887565|NCT01818752|12389292|FG000|Overall Study|Physician Decision|9
7887566|NCT01818752|12389293|FG001|Overall Study|Physician Decision|8
7887567|NCT01818752|12389292|FG000|Overall Study|Disease Progression|54
7887568|NCT01818752|12389293|FG001|Overall Study|Disease Progression|48
7887569|NCT01818752|12389292|FG000|Overall Study|Other|7
7887570|NCT01818752|12389293|FG001|Overall Study|Other|8
7887571|NCT01818752|12389292|FG000|Overall Study|Continuing Treatment|1
7887572|NCT01818752|12389293|FG001|Overall Study|Continuing Treatment|4
7887573|NCT01818752|12389292|FG000|Overall Study|Randomized but not Dosed|7
7808951|NCT01160822|12271334|FG004|Overall Study|Unsatisfactory therapeutic effect|4
7808952|NCT01160822|12271335|FG005|Overall Study|Unsatisfactory therapeutic effect|5
7808953|NCT01160822|12271336|FG006|Overall Study|Unsatisfactory therapeutic effect|3
7808954|NCT01160822|12271330|FG000|Overall Study|Withdrawal by Subject|0
7808955|NCT01160822|12271331|FG001|Overall Study|Withdrawal by Subject|0
7808956|NCT01160822|12271332|FG002|Overall Study|Withdrawal by Subject|0
7808957|NCT01160822|12271333|FG003|Overall Study|Withdrawal by Subject|0
7808958|NCT01160822|12271334|FG004|Overall Study|Withdrawal by Subject|0
7808959|NCT01160822|12271335|FG005|Overall Study|Withdrawal by Subject|0
7808960|NCT01160822|12271336|FG006|Overall Study|Withdrawal by Subject|1
7808961|NCT01160822|12271330|FG000|Overall Study|Lost to Follow-up|0
7808962|NCT01160822|12271331|FG001|Overall Study|Lost to Follow-up|0
7808963|NCT01160822|12271332|FG002|Overall Study|Lost to Follow-up|0
7808964|NCT01160822|12271333|FG003|Overall Study|Lost to Follow-up|0
7808965|NCT01160822|12271334|FG004|Overall Study|Lost to Follow-up|1
7808966|NCT01160822|12271335|FG005|Overall Study|Lost to Follow-up|0
7808967|NCT01160822|12271336|FG006|Overall Study|Lost to Follow-up|0
7808968|NCT01160822|12271330|FG000|Overall Study|Administrative problems|0
7808969|NCT01160822|12271331|FG001|Overall Study|Administrative problems|0
7808970|NCT01160822|12271332|FG002|Overall Study|Administrative problems|0
7808971|NCT01160822|12271333|FG003|Overall Study|Administrative problems|0
7808972|NCT01160822|12271334|FG004|Overall Study|Administrative problems|1
7808973|NCT01160822|12271335|FG005|Overall Study|Administrative problems|0
7808974|NCT01160822|12271336|FG006|Overall Study|Administrative problems|0
7808975|NCT01160822|12271330|FG000|Overall Study|Protocol deviation|0
7808976|NCT01160822|12271331|FG001|Overall Study|Protocol deviation|0
7808977|NCT01160822|12271332|FG002|Overall Study|Protocol deviation|0
7808978|NCT01160822|12271333|FG003|Overall Study|Protocol deviation|0
7808979|NCT01160822|12271334|FG004|Overall Study|Protocol deviation|2
7808980|NCT01160822|12271335|FG005|Overall Study|Protocol deviation|0
7808981|NCT01160822|12271336|FG006|Overall Study|Protocol deviation|0
7808982|NCT01161043|12271366|FG000|Overall Study|Withdrawal by Subject|3
7808983|NCT01161173|12271391|FG000|Overall Study|Protocol Violation|13
7808984|NCT01161173|12271391|FG000|Overall Study|Lost to Follow-up|7
7808985|NCT01161173|12271391|FG000|Overall Study|Progressive Disease|82
7808986|NCT01161173|12271391|FG000|Overall Study|Withdrawal of Consent|5
7808987|NCT01161173|12271391|FG000|Overall Study|Unacceptable Toxicity|21
7808988|NCT01161173|12271391|FG000|Overall Study|Death|194
7808989|NCT01161173|12271391|FG000|Overall Study|End of Study|2
7808990|NCT01161173|12271391|FG000|Overall Study|Reasons Not Specified|23
7808991|NCT01161407|12271424|FG000|Overall Study|Protocol Violation|3
7808992|NCT01161407|12271425|FG001|Overall Study|Protocol Violation|1
7808993|NCT01161446|12271443|FG000|Overall Study|Lost to Follow-up|18
7808994|NCT01161446|12271444|FG001|Overall Study|Lost to Follow-up|14
7808995|NCT01161446|12271443|FG000|Overall Study|Withdrawal by Subject|0
7808996|NCT01161446|12271444|FG001|Overall Study|Withdrawal by Subject|1
7808997|NCT01161472|12271450|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
7717553|NCT00520572|12141201|FG004|Overall Study|Lost to Follow-up|1
7808998|NCT01161472|12271451|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
7808999|NCT01161472|12271452|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
7809000|NCT01161472|12271453|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
7809001|NCT01161498|12271465|FG000|Overall Study|Disease Progression|0
7809002|NCT01161498|12271466|FG001|Overall Study|Disease Progression|1
7809003|NCT01161524|12271474|FG000|Core Study (23 Weeks)|Adverse Event|3
7809004|NCT01161524|12271475|FG001|Core Study (23 Weeks)|Adverse Event|0
7717554|NCT00520572|12141202|FG005|Overall Study|Lost to Follow-up|0
7717555|NCT00520572|12141197|FG000|Overall Study|Incorrect enrollment|1
7717556|NCT00520572|12141198|FG001|Overall Study|Incorrect enrollment|0
7717557|NCT00520572|12141199|FG002|Overall Study|Incorrect enrollment|1
7717558|NCT00520572|12141200|FG003|Overall Study|Incorrect enrollment|0
7717559|NCT00520572|12141201|FG004|Overall Study|Incorrect enrollment|1
7717560|NCT00520572|12141202|FG005|Overall Study|Incorrect enrollment|0
7717561|NCT00520572|12141197|FG000|Overall Study|Oral corticotherapy for acute urticaria|0
7717562|NCT00520572|12141198|FG001|Overall Study|Oral corticotherapy for acute urticaria|1
7717563|NCT00520572|12141199|FG002|Overall Study|Oral corticotherapy for acute urticaria|0
7717564|NCT00520572|12141200|FG003|Overall Study|Oral corticotherapy for acute urticaria|0
7717565|NCT00520572|12141201|FG004|Overall Study|Oral corticotherapy for acute urticaria|0
7717566|NCT00520572|12141202|FG005|Overall Study|Oral corticotherapy for acute urticaria|0
7717567|NCT00520572|12141197|FG000|Overall Study|Long break in taking Medication|0
7717568|NCT00520572|12141198|FG001|Overall Study|Long break in taking Medication|0
7717569|NCT00520572|12141199|FG002|Overall Study|Long break in taking Medication|0
7717570|NCT00520572|12141200|FG003|Overall Study|Long break in taking Medication|1
7717571|NCT00520572|12141201|FG004|Overall Study|Long break in taking Medication|0
7717572|NCT00520572|12141202|FG005|Overall Study|Long break in taking Medication|0
7717573|NCT00520572|12141197|FG000|Overall Study|Did not receive Treatment|1
7717574|NCT00520572|12141198|FG001|Overall Study|Did not receive Treatment|0
7717575|NCT00520572|12141199|FG002|Overall Study|Did not receive Treatment|1
7717576|NCT00520572|12141200|FG003|Overall Study|Did not receive Treatment|0
7717577|NCT00520572|12141201|FG004|Overall Study|Did not receive Treatment|0
7717578|NCT00520572|12141202|FG005|Overall Study|Did not receive Treatment|0
7717579|NCT00520676|12141218|FG000|Overall Study|Death|84
7717580|NCT00520676|12141219|FG001|Overall Study|Death|81
7717581|NCT00520676|12141218|FG000|Overall Study|Lost to Follow-up|6
7809005|NCT01161524|12271476|FG002|Core Study (23 Weeks)|Adverse Event|0
7809006|NCT01161524|12271474|FG000|Core Study (23 Weeks)|Other|1
7809007|NCT01161524|12271475|FG001|Core Study (23 Weeks)|Other|0
7809008|NCT01161524|12271476|FG002|Core Study (23 Weeks)|Other|0
7809009|NCT01161524|12271474|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1
7887574|NCT01818752|12389293|FG001|Overall Study|Randomized but not Dosed|4
7887575|NCT01818765|12389299|FG000|Overall Study|Death|2
7887576|NCT01819129|12389315|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
7887577|NCT01819129|12389316|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
7887578|NCT01819129|12389315|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1
7887579|NCT01819129|12389316|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0
7887580|NCT01819129|12389315|FG000|Overall Study|Other, Subject moved out of the country|0
7887581|NCT01819129|12389316|FG001|Overall Study|Other, Subject moved out of the country|1
7887582|NCT01819129|12389315|FG000|Overall Study|Withdrawal by Subject|15
7887583|NCT01819129|12389316|FG001|Overall Study|Withdrawal by Subject|15
7887584|NCT01819129|12389315|FG000|Overall Study|Lost to Follow-up|5
7809010|NCT01161524|12271475|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1
7809011|NCT01161524|12271476|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0
7809012|NCT01161524|12271474|FG000|Core Study (23 Weeks)|Lost to Follow-up|1
7809013|NCT01161524|12271475|FG001|Core Study (23 Weeks)|Lost to Follow-up|2
7809014|NCT01161524|12271476|FG002|Core Study (23 Weeks)|Lost to Follow-up|0
7809015|NCT01161524|12271474|FG000|Core Study (23 Weeks)|Subject Choice|3
7809016|NCT01161524|12271475|FG001|Core Study (23 Weeks)|Subject Choice|2
7809017|NCT01161524|12271476|FG002|Core Study (23 Weeks)|Subject Choice|0
7809018|NCT01161524|12271474|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
7809019|NCT01161524|12271475|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
7809020|NCT01161524|12271476|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8
7809021|NCT01161524|12271474|FG000|Extension Phase (Approximately 83 Weeks)|Other|0
7809022|NCT01161524|12271475|FG001|Extension Phase (Approximately 83 Weeks)|Other|0
7809023|NCT01161524|12271476|FG002|Extension Phase (Approximately 83 Weeks)|Other|6
7809024|NCT01161524|12271474|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
7809025|NCT01161524|12271475|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
7809026|NCT01161524|12271476|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1
7809027|NCT01161524|12271474|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
7809028|NCT01161524|12271475|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
7809029|NCT01161524|12271476|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5
7809030|NCT01161524|12271474|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
7809031|NCT01161524|12271475|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
7809032|NCT01161524|12271476|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4
7809033|NCT01161537|12271485|FG000|Part B|Withdrawal by Subject|2
7809034|NCT01161628|12271503|FG000|Overall Study|Death|6
7809035|NCT01161628|12271503|FG000|Overall Study|Lack of Efficacy|2
7809036|NCT01162122|12271541|FG000|Overall Study|Withdrawal by Subject|52
7809037|NCT01162122|12271542|FG001|Overall Study|Withdrawal by Subject|43
7809038|NCT01162122|12271541|FG000|Overall Study|Lost to Follow-up|73
7809039|NCT01162122|12271542|FG001|Overall Study|Lost to Follow-up|91
7809040|NCT01162122|12271541|FG000|Overall Study|Adverse Event|3
7809041|NCT01162122|12271542|FG001|Overall Study|Adverse Event|2
7809042|NCT01162122|12271541|FG000|Overall Study|Death|51
7809043|NCT01162122|12271542|FG001|Overall Study|Death|46
7809044|NCT01162122|12271541|FG000|Overall Study|Protocol Violation|2
7809045|NCT01162122|12271542|FG001|Overall Study|Protocol Violation|2
7809046|NCT01162122|12271541|FG000|Overall Study|Inappropriate enrollment|5
7809047|NCT01162122|12271542|FG001|Overall Study|Inappropriate enrollment|4
7809048|NCT01162122|12271541|FG000|Overall Study|Administrative reason|1
7809049|NCT01162122|12271542|FG001|Overall Study|Administrative reason|1
7809050|NCT01162122|12271541|FG000|Overall Study|Unable to classify|3
7809051|NCT01162122|12271542|FG001|Overall Study|Unable to classify|7
7809052|NCT01162122|12271541|FG000|Overall Study|Missing primary reason|1
7809053|NCT01162122|12271542|FG001|Overall Study|Missing primary reason|0
7809054|NCT01162135|12271551|FG000|Overall Study|Withdrawal by Subject|1
7809055|NCT01162135|12271551|FG000|Overall Study|Severe back pain|1
7809056|NCT01162135|12271551|FG000|Overall Study|Ineligible|1
7809057|NCT01162239|12271559|FG000|Treatment Phase|Withdrawal by Subject|1
7809058|NCT01162239|12271560|FG001|Treatment Phase|Withdrawal by Subject|3
7809059|NCT01162239|12271561|FG002|Treatment Phase|Withdrawal by Subject|2
7809060|NCT01162239|12271562|FG003|Treatment Phase|Withdrawal by Subject|3
7809061|NCT01162239|12271559|FG000|Treatment Phase|Death|0
7809062|NCT01162239|12271560|FG001|Treatment Phase|Death|0
7809063|NCT01162239|12271561|FG002|Treatment Phase|Death|0
7809064|NCT01162239|12271562|FG003|Treatment Phase|Death|1
7809065|NCT01162239|12271559|FG000|Treatment Phase|Lost to Follow-up|5
7809066|NCT01162239|12271560|FG001|Treatment Phase|Lost to Follow-up|4
7809067|NCT01162239|12271561|FG002|Treatment Phase|Lost to Follow-up|2
7809068|NCT01162239|12271562|FG003|Treatment Phase|Lost to Follow-up|1
7809069|NCT01162239|12271559|FG000|Extended Follow-up|Lost to Follow-up|8
7809070|NCT01162239|12271560|FG001|Extended Follow-up|Lost to Follow-up|13
7809071|NCT01162239|12271561|FG002|Extended Follow-up|Lost to Follow-up|8
7809072|NCT01162239|12271562|FG003|Extended Follow-up|Lost to Follow-up|6
7809073|NCT01162343|12271582|FG000|Overall Study|Left ED prior to psychiatrist assessment|80
7809074|NCT01162343|12271582|FG000|Overall Study|Refused psychiatrist assessment|12
7809075|NCT01162421|12271588|FG000|Overall Study|Did not receive study drug|2
7809076|NCT01162421|12271589|FG001|Overall Study|Did not receive study drug|1
7809077|NCT01162421|12271588|FG000|Overall Study|Adverse Event|2
7809078|NCT01162421|12271589|FG001|Overall Study|Adverse Event|5
7809079|NCT01162421|12271588|FG000|Overall Study|Lost to Follow-up|0
7809080|NCT01162421|12271589|FG001|Overall Study|Lost to Follow-up|2
7809081|NCT01162421|12271588|FG000|Overall Study|Lack of Efficacy|2
7809082|NCT01162421|12271589|FG001|Overall Study|Lack of Efficacy|2
7809083|NCT01162421|12271588|FG000|Overall Study|Other|2
7809084|NCT01162421|12271589|FG001|Overall Study|Other|3
7809085|NCT01162473|12271597|FG000|Overall Study|Adverse Event|2
7809086|NCT01162473|12271598|FG001|Overall Study|Adverse Event|1
7809087|NCT01162473|12271597|FG000|Overall Study|Withdrawal by Subject|0
7809088|NCT01162473|12271598|FG001|Overall Study|Withdrawal by Subject|4
7809089|NCT01162486|12271609|FG000|Overall Study|low ANC|1
7809090|NCT01162486|12271610|FG001|Overall Study|low ANC|0
7809091|NCT01162486|12271611|FG002|Overall Study|low ANC|0
7809092|NCT01162486|12271612|FG003|Overall Study|low ANC|0
7809093|NCT01162486|12271613|FG004|Overall Study|low ANC|0
7809094|NCT01162486|12271609|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1
7809095|NCT01162486|12271610|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0
7809096|NCT01162486|12271611|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0
7809097|NCT01162486|12271612|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0
7809098|NCT01162486|12271613|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0
7809099|NCT01162486|12271609|FG000|Overall Study|elevated LFTs|0
7809100|NCT01162486|12271610|FG001|Overall Study|elevated LFTs|0
7809101|NCT01162486|12271611|FG002|Overall Study|elevated LFTs|1
7809102|NCT01162486|12271612|FG003|Overall Study|elevated LFTs|0
7809103|NCT01162486|12271613|FG004|Overall Study|elevated LFTs|0
7809104|NCT01162486|12271609|FG000|Overall Study|Pregnancy|0
7809105|NCT01162486|12271610|FG001|Overall Study|Pregnancy|0
7809106|NCT01162486|12271611|FG002|Overall Study|Pregnancy|0
7809107|NCT01162486|12271612|FG003|Overall Study|Pregnancy|1
7809108|NCT01162486|12271613|FG004|Overall Study|Pregnancy|0
7809109|NCT01162499|12271629|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0
7809110|NCT01162499|12271630|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1
7809111|NCT01162863|12271654|FG000|Overall Study|Lack of Efficacy|1
7809112|NCT01162863|12271655|FG001|Overall Study|Lack of Efficacy|0
7809113|NCT01162863|12271656|FG002|Overall Study|Lack of Efficacy|0
7809114|NCT01162863|12271654|FG000|Overall Study|Adverse Event|0
7809115|NCT01162863|12271655|FG001|Overall Study|Adverse Event|1
7809116|NCT01162863|12271656|FG002|Overall Study|Adverse Event|0
7809117|NCT01163032|12271667|FG000|Randomization Phase|Withdrawal by Subject|2
7809118|NCT01163032|12271668|FG001|Randomization Phase|Withdrawal by Subject|3
7809119|NCT01163032|12271669|FG002|Randomization Phase|Withdrawal by Subject|0
7809120|NCT01163032|12271667|FG000|Randomization Phase|Adverse Event|3
7809121|NCT01163032|12271668|FG001|Randomization Phase|Adverse Event|3
7809122|NCT01163032|12271669|FG002|Randomization Phase|Adverse Event|0
7809123|NCT01163032|12271667|FG000|Randomization Phase|Protocol Violation|0
7809124|NCT01163032|12271668|FG001|Randomization Phase|Protocol Violation|1
7809125|NCT01163032|12271669|FG002|Randomization Phase|Protocol Violation|0
7809126|NCT01163032|12271667|FG000|Randomization Phase|Various*|5
7809127|NCT01163032|12271668|FG001|Randomization Phase|Various*|4
7809128|NCT01163032|12271669|FG002|Randomization Phase|Various*|0
7809129|NCT01163032|12271667|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0
7809130|NCT01163032|12271668|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1
7809131|NCT01163032|12271669|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0
7809132|NCT01163032|12271667|FG000|Open Label Extension Phase|Adverse Event|0
7809133|NCT01163032|12271668|FG001|Open Label Extension Phase|Adverse Event|0
7809134|NCT01163032|12271669|FG002|Open Label Extension Phase|Adverse Event|3
7809135|NCT01163032|12271667|FG000|Open Label Extension Phase|Withdrawal by Subject|0
7809136|NCT01163032|12271668|FG001|Open Label Extension Phase|Withdrawal by Subject|0
7809137|NCT01163032|12271669|FG002|Open Label Extension Phase|Withdrawal by Subject|3
7809138|NCT01163032|12271667|FG000|Open Label Extension Phase|Protocol Violation|0
7809139|NCT01163032|12271668|FG001|Open Label Extension Phase|Protocol Violation|0
7809140|NCT01163032|12271669|FG002|Open Label Extension Phase|Protocol Violation|1
7809141|NCT01163032|12271667|FG000|Open Label Extension Phase|Study Termination|0
7809142|NCT01163032|12271668|FG001|Open Label Extension Phase|Study Termination|0
7809143|NCT01163032|12271669|FG002|Open Label Extension Phase|Study Termination|7
7809144|NCT01163032|12271667|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
7809145|NCT01163032|12271668|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
7809146|NCT01163032|12271669|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
7809147|NCT01163149|12271695|FG000|Extension Treatment Period|Withdrawal by Subject|2
7809148|NCT01163149|12271696|FG001|Extension Treatment Period|Withdrawal by Subject|0
7809149|NCT01163149|12271697|FG002|Extension Treatment Period|Withdrawal by Subject|1
7809150|NCT01163149|12271695|FG000|Extension Treatment Period|Adverse Event|0
7809151|NCT01163149|12271696|FG001|Extension Treatment Period|Adverse Event|1
7887585|NCT01819129|12389316|FG001|Overall Study|Lost to Follow-up|2
7887586|NCT01819129|12389315|FG000|Overall Study|Lack of Efficacy|0
7887587|NCT01819129|12389316|FG001|Overall Study|Lack of Efficacy|1
7887588|NCT01819129|12389315|FG000|Overall Study|Adverse Event|1
7887589|NCT01819129|12389316|FG001|Overall Study|Adverse Event|4
7887590|NCT01819129|12389315|FG000|Overall Study|Death|1
7887591|NCT01819129|12389316|FG001|Overall Study|Death|1
7887592|NCT01819129|12389315|FG000|Overall Study|Withdrawal Criteria|20
7887593|NCT01819129|12389316|FG001|Overall Study|Withdrawal Criteria|15
7887594|NCT01819194|12389322|FG000|Overall Study|Loss of study articles|2
7887595|NCT01819272|12389336|FG000|Overall Study|Adverse Event|1
7887596|NCT01819272|12389337|FG001|Overall Study|Adverse Event|0
7887597|NCT01819272|12389338|FG002|Overall Study|Adverse Event|0
7887598|NCT01819272|12389339|FG003|Overall Study|Adverse Event|2
7887599|NCT01819272|12389340|FG004|Overall Study|Adverse Event|0
7887600|NCT01819272|12389341|FG005|Overall Study|Adverse Event|0
7887601|NCT01819272|12389336|FG000|Overall Study|Lost to Follow-up|3
7887602|NCT01819272|12389337|FG001|Overall Study|Lost to Follow-up|0
7887603|NCT01819272|12389338|FG002|Overall Study|Lost to Follow-up|1
7887604|NCT01819272|12389339|FG003|Overall Study|Lost to Follow-up|0
7887605|NCT01819272|12389340|FG004|Overall Study|Lost to Follow-up|0
7887606|NCT01819272|12389341|FG005|Overall Study|Lost to Follow-up|3
7887607|NCT01819272|12389336|FG000|Overall Study|Protocol Violation|0
7887608|NCT01819272|12389337|FG001|Overall Study|Protocol Violation|0
7887609|NCT01819272|12389338|FG002|Overall Study|Protocol Violation|0
7887610|NCT01819272|12389339|FG003|Overall Study|Protocol Violation|1
7887611|NCT01819272|12389340|FG004|Overall Study|Protocol Violation|2
7887612|NCT01819272|12389341|FG005|Overall Study|Protocol Violation|3
7887613|NCT01819272|12389336|FG000|Overall Study|Physician Decision|0
7887614|NCT01819272|12389337|FG001|Overall Study|Physician Decision|1
7887615|NCT01819272|12389338|FG002|Overall Study|Physician Decision|0
7887616|NCT01819272|12389339|FG003|Overall Study|Physician Decision|0
7887617|NCT01819272|12389340|FG004|Overall Study|Physician Decision|0
7887618|NCT01819272|12389341|FG005|Overall Study|Physician Decision|0
7887619|NCT01819272|12389336|FG000|Overall Study|Withdrawal of Consent|0
7809152|NCT01163149|12271697|FG002|Extension Treatment Period|Adverse Event|0
7809153|NCT01163149|12271695|FG000|Extension Treatment Period|Noncompliance|0
7809154|NCT01163149|12271696|FG001|Extension Treatment Period|Noncompliance|0
7809155|NCT01163149|12271697|FG002|Extension Treatment Period|Noncompliance|1
7809156|NCT01163253|12271734|FG000|Overall Study|Withdrawn Due to Pregnancy|12
7809157|NCT01163253|12271735|FG001|Overall Study|Withdrawn Due to Pregnancy|2
7809158|NCT01163253|12271734|FG000|Overall Study|Study Terminated by Sponsor|978
7809159|NCT01163253|12271735|FG001|Overall Study|Study Terminated by Sponsor|349
7809160|NCT01163253|12271734|FG000|Overall Study|Protocol Violation|43
7809161|NCT01163253|12271735|FG001|Overall Study|Protocol Violation|12
7809162|NCT01163253|12271734|FG000|Overall Study|Withdrawal by Subject|199
7809163|NCT01163253|12271735|FG001|Overall Study|Withdrawal by Subject|50
7809164|NCT01163253|12271734|FG000|Overall Study|Medication Error|1
7809165|NCT01163253|12271735|FG001|Overall Study|Medication Error|0
7809166|NCT01163253|12271734|FG000|Overall Study|Lost to Follow-up|125
7809167|NCT01163253|12271735|FG001|Overall Study|Lost to Follow-up|23
7809168|NCT01163253|12271734|FG000|Overall Study|Insufficient Clinical Response|423
7809169|NCT01163253|12271735|FG001|Overall Study|Insufficient Clinical Response|29
7809170|NCT01163253|12271734|FG000|Overall Study|Adverse Event|300
7809171|NCT01163253|12271735|FG001|Overall Study|Adverse Event|78
7809172|NCT01163253|12271734|FG000|Overall Study|Death|17
7809173|NCT01163253|12271735|FG001|Overall Study|Death|5
7809174|NCT01163253|12271734|FG000|Overall Study|Ongoing|13
7809175|NCT01163253|12271735|FG001|Overall Study|Ongoing|4
7809176|NCT01163253|12271734|FG000|Overall Study|Other Unspecified|170
7809177|NCT01163253|12271735|FG001|Overall Study|Other Unspecified|34
7809178|NCT01163266|12271744|FG000|Overall Study|Pretreatment Event or Adverse Event|2
7809179|NCT01163266|12271745|FG001|Overall Study|Pretreatment Event or Adverse Event|9
7809180|NCT01163266|12271746|FG002|Overall Study|Pretreatment Event or Adverse Event|7
7809181|NCT01163266|12271744|FG000|Overall Study|Lack of Efficacy|1
7809182|NCT01163266|12271745|FG001|Overall Study|Lack of Efficacy|3
7809183|NCT01163266|12271746|FG002|Overall Study|Lack of Efficacy|1
7809184|NCT01163266|12271744|FG000|Overall Study|Noncompliance with Study Drug|0
7809185|NCT01163266|12271745|FG001|Overall Study|Noncompliance with Study Drug|2
7809186|NCT01163266|12271746|FG002|Overall Study|Noncompliance with Study Drug|0
7809187|NCT01163266|12271744|FG000|Overall Study|Protocol Deviations|2
7809188|NCT01163266|12271745|FG001|Overall Study|Protocol Deviations|2
7809189|NCT01163266|12271746|FG002|Overall Study|Protocol Deviations|5
7809190|NCT01163266|12271744|FG000|Overall Study|Withdrawal of Consent|5
7809191|NCT01163266|12271745|FG001|Overall Study|Withdrawal of Consent|7
7809192|NCT01163266|12271746|FG002|Overall Study|Withdrawal of Consent|3
7809193|NCT01163266|12271744|FG000|Overall Study|Lost to Follow-up|7
7809194|NCT01163266|12271745|FG001|Overall Study|Lost to Follow-up|7
7809195|NCT01163266|12271746|FG002|Overall Study|Lost to Follow-up|10
7809196|NCT01163266|12271744|FG000|Overall Study|Other|1
7809197|NCT01163266|12271745|FG001|Overall Study|Other|1
7809198|NCT01163266|12271746|FG002|Overall Study|Other|2
7809199|NCT01163279|12271756|FG000|Overall Study|Withdrawal by Subject|2
7809200|NCT01163279|12271757|FG001|Overall Study|Withdrawal by Subject|0
7809201|NCT01163292|12271766|FG000|Overall Study|Lack of Efficacy|9
7809202|NCT01163292|12271767|FG001|Overall Study|Lack of Efficacy|0
7809203|NCT01163292|12271766|FG000|Overall Study|Adverse Event|6
7809204|NCT01163292|12271767|FG001|Overall Study|Adverse Event|0
7809205|NCT01163292|12271766|FG000|Overall Study|Initiation of biological therapy|0
7809206|NCT01163292|12271767|FG001|Overall Study|Initiation of biological therapy|15
7809207|NCT01163292|12271766|FG000|Overall Study|Sufficient response to adalimumab|8
7809208|NCT01163292|12271767|FG001|Overall Study|Sufficient response to adalimumab|0
7809209|NCT01163292|12271766|FG000|Overall Study|Refusal to receive adalimumab|7
7809210|NCT01163292|12271767|FG001|Overall Study|Refusal to receive adalimumab|0
7887620|NCT01819272|12389337|FG001|Overall Study|Withdrawal of Consent|1
7809211|NCT01163292|12271766|FG000|Overall Study|Economic reasons|6
7809212|NCT01163292|12271767|FG001|Overall Study|Economic reasons|0
7809213|NCT01163292|12271766|FG000|Overall Study|No further visits|5
7809214|NCT01163292|12271767|FG001|Overall Study|No further visits|7
7809215|NCT01163318|12271773|FG000|Overall Study|Off-Label Use of Adalimumab|8
7809216|NCT01163318|12271773|FG000|Overall Study|Did Not Continue Use of Adalimumab|26
7809217|NCT01163318|12271773|FG000|Overall Study|History/comorbidity of malignant tumor|3
7809218|NCT01163318|12271773|FG000|Overall Study|Participants Without Case Report Form|7
7809219|NCT01163318|12271773|FG000|Overall Study|Multiple Reasons Per Participant|224
7809220|NCT01163474|12271782|FG000|Overall Study|Withdrawal by Subject|1
7809221|NCT01163474|12271782|FG000|Overall Study|Tech barriers to videoteleconference vis|12
7809222|NCT01163474|12271782|FG000|Overall Study|Lost to Follow-up|3
7809223|NCT01163617|12271798|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7809224|NCT01163617|12271799|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
7887621|NCT01819272|12389338|FG002|Overall Study|Withdrawal of Consent|2
7809225|NCT01163617|12271800|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7809226|NCT01163617|12271801|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7809227|NCT01163617|12271802|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7809228|NCT01163617|12271803|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7809229|NCT01163617|12271804|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7809230|NCT01163617|12271805|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7809231|NCT01163617|12271798|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7809232|NCT01163617|12271799|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
7809233|NCT01163617|12271800|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7809234|NCT01163617|12271801|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7809235|NCT01163617|12271802|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7809236|NCT01163617|12271803|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7809237|NCT01163617|12271804|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7809238|NCT01163617|12271805|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7809239|NCT01163617|12271798|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7809240|NCT01163617|12271799|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7809241|NCT01163617|12271800|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
7717582|NCT00520676|12141219|FG001|Overall Study|Lost to Follow-up|10
7809242|NCT01163617|12271801|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7809243|NCT01163617|12271802|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7717583|NCT00520676|12141218|FG000|Overall Study|Physician Decision|4
7717584|NCT00520676|12141219|FG001|Overall Study|Physician Decision|1
7717585|NCT00520676|12141218|FG000|Overall Study|Withdrawal by Subject|7
7717586|NCT00520676|12141219|FG001|Overall Study|Withdrawal by Subject|11
7717587|NCT00520741|12141227|FG000|Overall Study|Adverse Event|16
7717588|NCT00520741|12141228|FG001|Overall Study|Adverse Event|56
7717589|NCT00520741|12141227|FG000|Overall Study|Lack of Efficacy|11
7717590|NCT00520741|12141228|FG001|Overall Study|Lack of Efficacy|30
7717591|NCT00520741|12141227|FG000|Overall Study|Withdrawal by Subject|0
7717592|NCT00520741|12141228|FG001|Overall Study|Withdrawal by Subject|11
7717593|NCT00520741|12141227|FG000|Overall Study|Protocol Violation|2
7717594|NCT00520741|12141228|FG001|Overall Study|Protocol Violation|15
7717595|NCT00520741|12141227|FG000|Overall Study|Unsatisfactory compliance of subject|4
7717596|NCT00520741|12141228|FG001|Overall Study|Unsatisfactory compliance of subject|3
7717597|NCT00520741|12141227|FG000|Overall Study|Lost to Follow-up|4
7717598|NCT00520741|12141228|FG001|Overall Study|Lost to Follow-up|4
7717599|NCT00520741|12141227|FG000|Overall Study|Other reasons for premature termination|0
7717600|NCT00520741|12141228|FG001|Overall Study|Other reasons for premature termination|6
7717601|NCT00520845|12141236|FG000|Overall Study|Death|3
7717602|NCT00520845|12141236|FG000|Overall Study|Adverse Event|4
7717603|NCT00520845|12141236|FG000|Overall Study|Disease Progression, relapse|13
7717604|NCT00520845|12141236|FG000|Overall Study|Withdrawal by Subject|1
7717605|NCT00520845|12141236|FG000|Overall Study|Alternative Therapy|1
7717606|NCT00520936|12141269|FG000|Overall Study|Physician Decision|0
7809244|NCT01163617|12271803|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7809245|NCT01163617|12271804|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7809246|NCT01163617|12271805|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7809247|NCT01163721|12271861|FG000|Overall Study|Adverse Event|5
7809248|NCT01163721|12271862|FG001|Overall Study|Adverse Event|6
7809249|NCT01163721|12271861|FG000|Overall Study|Withdrawal by Subject|3
7809250|NCT01163721|12271862|FG001|Overall Study|Withdrawal by Subject|4
7809251|NCT01163721|12271861|FG000|Overall Study|Lost to Follow-up|0
7809252|NCT01163721|12271862|FG001|Overall Study|Lost to Follow-up|1
7809253|NCT01163721|12271861|FG000|Overall Study|Physician Decision|0
7809254|NCT01163721|12271862|FG001|Overall Study|Physician Decision|1
7809255|NCT01163747|12271870|FG000|Overall Study|Adverse Event|0
7809256|NCT01163747|12271871|FG001|Overall Study|Adverse Event|5
7809257|NCT01163747|12271870|FG000|Overall Study|Insufficient Therapeutic Response|0
7809258|NCT01163747|12271871|FG001|Overall Study|Insufficient Therapeutic Response|1
7809259|NCT01163747|12271870|FG000|Overall Study|Protocol Violation|0
7809260|NCT01163747|12271871|FG001|Overall Study|Protocol Violation|1
7809261|NCT01163747|12271870|FG000|Overall Study|Refused Treatment|6
7809262|NCT01163747|12271871|FG001|Overall Study|Refused Treatment|4
7809263|NCT01163786|12271888|FG000|Treatment With Bortezomib|Withdrawal by Subject|1
7809264|NCT01163786|12271888|FG000|Treatment With Bortezomib|Adverse Event|2
7809265|NCT01163786|12271888|FG000|Completed Follow up (Visit 9 and 10)|Other|1
7809266|NCT01163851|12271894|FG000|Overall Study|Site Closure|0
7809267|NCT01163851|12271895|FG001|Overall Study|Site Closure|1
7809268|NCT01163851|12271894|FG000|Overall Study|Enrolled but not treated|1
7809269|NCT01163851|12271895|FG001|Overall Study|Enrolled but not treated|0
7861785|NCT01597245|12351190|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
7861786|NCT01597245|12351191|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861787|NCT01597245|12351192|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861788|NCT01597245|12351193|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7809270|NCT01163916|12271904|FG000|Overall Study|Withdrawal by Subject|2
7809271|NCT01163916|12271905|FG001|Overall Study|Withdrawal by Subject|0
7809272|NCT01163916|12271906|FG002|Overall Study|Withdrawal by Subject|2
7809273|NCT01163916|12271904|FG000|Overall Study|Adverse Event|2
7809274|NCT01163916|12271905|FG001|Overall Study|Adverse Event|0
7809275|NCT01163916|12271906|FG002|Overall Study|Adverse Event|1
7809276|NCT01163916|12271904|FG000|Overall Study|Lack of Efficacy|2
7809277|NCT01163916|12271905|FG001|Overall Study|Lack of Efficacy|0
7809278|NCT01163916|12271906|FG002|Overall Study|Lack of Efficacy|1
7809279|NCT01163916|12271904|FG000|Overall Study|Other|24
7809280|NCT01163916|12271905|FG001|Overall Study|Other|4
7809281|NCT01163916|12271906|FG002|Overall Study|Other|16
7809282|NCT01164007|12271928|FG000|Overall Study|Adverse Event|5
7809283|NCT01164007|12271928|FG000|Overall Study|Progression of Disease|30
7809284|NCT01164007|12271928|FG000|Overall Study|Protocol Violation|1
7809285|NCT01164007|12271928|FG000|Overall Study|Withdrawal by Subject|1
7809286|NCT01164007|12271928|FG000|Overall Study|Medical Decision|3
7809287|NCT01164475|12271952|FG000|Overall Study|Lack of Efficacy|1
7809288|NCT01164475|12271953|FG001|Overall Study|Lack of Efficacy|0
7809289|NCT01164475|12271952|FG000|Overall Study|Other|0
7809290|NCT01164475|12271953|FG001|Overall Study|Other|1
7809291|NCT01164475|12271952|FG000|Overall Study|Progressive disease|0
7809292|NCT01164475|12271953|FG001|Overall Study|Progressive disease|1
7809293|NCT01164475|12271952|FG000|Overall Study|Protocol Violation|1
7809294|NCT01164475|12271953|FG001|Overall Study|Protocol Violation|0
7809295|NCT01164501|12271962|FG000|Overall Study|Not treated|2
7809296|NCT01164501|12271963|FG001|Overall Study|Not treated|0
7809297|NCT01164501|12271964|FG002|Overall Study|Not treated|1
7809298|NCT01164501|12271962|FG000|Overall Study|Adverse Event|18
7887622|NCT01819272|12389339|FG003|Overall Study|Withdrawal of Consent|1
7809299|NCT01164501|12271963|FG001|Overall Study|Adverse Event|4
7809300|NCT01164501|12271964|FG002|Overall Study|Adverse Event|21
7887623|NCT01819272|12389340|FG004|Overall Study|Withdrawal of Consent|0
7809301|NCT01164501|12271962|FG000|Overall Study|Lack of Efficacy|0
7809302|NCT01164501|12271963|FG001|Overall Study|Lack of Efficacy|0
7809303|NCT01164501|12271964|FG002|Overall Study|Lack of Efficacy|1
7809304|NCT01164501|12271962|FG000|Overall Study|Non compliant with protocol|1
7809305|NCT01164501|12271963|FG001|Overall Study|Non compliant with protocol|1
7809306|NCT01164501|12271964|FG002|Overall Study|Non compliant with protocol|4
7809307|NCT01164501|12271962|FG000|Overall Study|Lost to Follow-up|3
7809308|NCT01164501|12271963|FG001|Overall Study|Lost to Follow-up|0
7809309|NCT01164501|12271964|FG002|Overall Study|Lost to Follow-up|3
7809310|NCT01164501|12271962|FG000|Overall Study|Patient refusal to continue,not due toAE|10
7809311|NCT01164501|12271963|FG001|Overall Study|Patient refusal to continue,not due toAE|4
7809312|NCT01164501|12271964|FG002|Overall Study|Patient refusal to continue,not due toAE|8
7809313|NCT01164501|12271962|FG000|Overall Study|Other reason not defined above|9
7809314|NCT01164501|12271963|FG001|Overall Study|Other reason not defined above|1
7887624|NCT01819272|12389341|FG005|Overall Study|Withdrawal of Consent|1
7887625|NCT01819272|12389336|FG000|Overall Study|Loss of Glucose Control|2
7887626|NCT01819272|12389337|FG001|Overall Study|Loss of Glucose Control|1
7809315|NCT01164501|12271964|FG002|Overall Study|Other reason not defined above|4
7809316|NCT01164579|12271977|FG000|Overall Study|Lack of Efficacy|0
7809317|NCT01164579|12271978|FG001|Overall Study|Lack of Efficacy|0
7809318|NCT01164579|12271979|FG002|Overall Study|Lack of Efficacy|6
7809319|NCT01164579|12271977|FG000|Overall Study|Lost to Follow-up|1
7809320|NCT01164579|12271978|FG001|Overall Study|Lost to Follow-up|1
7809321|NCT01164579|12271979|FG002|Overall Study|Lost to Follow-up|0
7809322|NCT01164579|12271977|FG000|Overall Study|Withdrawal by Subject|2
7809323|NCT01164579|12271978|FG001|Overall Study|Withdrawal by Subject|5
7809324|NCT01164579|12271979|FG002|Overall Study|Withdrawal by Subject|3
7809325|NCT01164579|12271977|FG000|Overall Study|Protocol Violation|0
7809326|NCT01164579|12271978|FG001|Overall Study|Protocol Violation|1
7809327|NCT01164579|12271979|FG002|Overall Study|Protocol Violation|2
7809328|NCT01164579|12271977|FG000|Overall Study|Adverse Event|4
7809329|NCT01164579|12271978|FG001|Overall Study|Adverse Event|2
7809330|NCT01164579|12271979|FG002|Overall Study|Adverse Event|5
7809331|NCT01164579|12271977|FG000|Overall Study|Reason not specified|1
7809332|NCT01164579|12271978|FG001|Overall Study|Reason not specified|0
7809333|NCT01164579|12271979|FG002|Overall Study|Reason not specified|0
7809334|NCT01164722|12271999|FG000|Overall Study|Adverse Event|0
7809335|NCT01164722|12272000|FG001|Overall Study|Adverse Event|1
7809336|NCT01164722|12271999|FG000|Overall Study|Withdrawal by Subject|3
7809337|NCT01164722|12272000|FG001|Overall Study|Withdrawal by Subject|4
7809338|NCT01164722|12271999|FG000|Overall Study|Lost to Follow-up|3
7809339|NCT01164722|12272000|FG001|Overall Study|Lost to Follow-up|6
7809340|NCT01164722|12271999|FG000|Overall Study|met protocol criteria for non-treatment|11
7809341|NCT01164722|12272000|FG001|Overall Study|met protocol criteria for non-treatment|1
7809342|NCT01164722|12271999|FG000|Overall Study|enrolled on other study, concomitant med|1
7809343|NCT01164722|12272000|FG001|Overall Study|enrolled on other study, concomitant med|3
7809344|NCT01164865|12272008|FG000|Overall Study|Lost to Follow-up|2
7809345|NCT01164865|12272009|FG001|Overall Study|Lost to Follow-up|1
7809346|NCT01164891|12272015|FG000|Overall Study|Disease Progression|5
7809347|NCT01164891|12272015|FG000|Overall Study|Adverse Event|1
7809348|NCT01164956|12272020|FG000|Overall Study|Side Effects|1
7809349|NCT01164956|12272021|FG001|Overall Study|Side Effects|0
7809350|NCT01164956|12272022|FG002|Overall Study|Side Effects|1
7809351|NCT01165021|12272030|FG000|Overall Study|Death|1
7809352|NCT01165138|12272045|FG000|Overall Study|Adverse Event|0
7809353|NCT01165138|12272046|FG001|Overall Study|Adverse Event|1
7809354|NCT01165138|12272047|FG002|Overall Study|Adverse Event|0
7809355|NCT01165138|12272048|FG003|Overall Study|Adverse Event|2
7809356|NCT01165138|12272045|FG000|Overall Study|Lack of Efficacy|0
7809357|NCT01165138|12272046|FG001|Overall Study|Lack of Efficacy|32
7809358|NCT01165138|12272047|FG002|Overall Study|Lack of Efficacy|6
7809359|NCT01165138|12272048|FG003|Overall Study|Lack of Efficacy|7
7809360|NCT01165138|12272045|FG000|Overall Study|Protocol Violation|0
7809361|NCT01165138|12272046|FG001|Overall Study|Protocol Violation|7
7809362|NCT01165138|12272047|FG002|Overall Study|Protocol Violation|0
7809363|NCT01165138|12272048|FG003|Overall Study|Protocol Violation|2
7809364|NCT01165138|12272045|FG000|Overall Study|Lost to Follow-up|0
7809365|NCT01165138|12272046|FG001|Overall Study|Lost to Follow-up|0
7809366|NCT01165138|12272047|FG002|Overall Study|Lost to Follow-up|1
7809367|NCT01165138|12272048|FG003|Overall Study|Lost to Follow-up|2
7809368|NCT01165138|12272045|FG000|Overall Study|Physician Decision|0
7809369|NCT01165138|12272046|FG001|Overall Study|Physician Decision|6
7809370|NCT01165138|12272047|FG002|Overall Study|Physician Decision|7
7809371|NCT01165138|12272048|FG003|Overall Study|Physician Decision|6
7809372|NCT01165138|12272045|FG000|Overall Study|Withdrawal by Subject|0
7809373|NCT01165138|12272046|FG001|Overall Study|Withdrawal by Subject|6
7809374|NCT01165138|12272047|FG002|Overall Study|Withdrawal by Subject|6
7809375|NCT01165138|12272048|FG003|Overall Study|Withdrawal by Subject|3
7809376|NCT01165177|12272058|FG000|Overall Study|Serious Adverse Event|227
7809377|NCT01165177|12272059|FG001|Overall Study|Serious Adverse Event|235
7809378|NCT01165177|12272058|FG000|Overall Study|Withdrawal by Subject|368
7809379|NCT01165177|12272059|FG001|Overall Study|Withdrawal by Subject|354
7809380|NCT01165177|12272058|FG000|Overall Study|Protocol Violation|19
7809381|NCT01165177|12272059|FG001|Overall Study|Protocol Violation|21
7809382|NCT01165177|12272058|FG000|Overall Study|Non-serious adverse event|30
7809383|NCT01165177|12272059|FG001|Overall Study|Non-serious adverse event|18
7809384|NCT01165177|12272058|FG000|Overall Study|Other unspecified reasons|47
7809385|NCT01165177|12272059|FG001|Overall Study|Other unspecified reasons|35
7809386|NCT01165177|12272058|FG000|Overall Study|Suspected HZ episode|0
7809387|NCT01165177|12272059|FG001|Overall Study|Suspected HZ episode|2
7809388|NCT01165177|12272058|FG000|Overall Study|Lost to Follow-up|183
7809389|NCT01165177|12272059|FG001|Overall Study|Lost to Follow-up|194
7809390|NCT01165177|12272058|FG000|Overall Study|Migrated/ moved from study area|48
7887627|NCT01819272|12389338|FG002|Overall Study|Loss of Glucose Control|0
7809391|NCT01165177|12272059|FG001|Overall Study|Migrated/ moved from study area|43
7809392|NCT01165203|12272075|FG000|Active Phase|Serious Adverse Event|1
7809393|NCT01165203|12272076|FG001|Active Phase|Serious Adverse Event|0
7809394|NCT01165203|12272075|FG000|Active Phase|Withdrawal by Subject|2
7809395|NCT01165203|12272076|FG001|Active Phase|Withdrawal by Subject|1
7809396|NCT01165203|12272075|FG000|Active Phase|Migrated/moved from study area|0
7809397|NCT01165203|12272076|FG001|Active Phase|Migrated/moved from study area|1
7809398|NCT01165203|12272075|FG000|Active Phase|Lost to Follow-up|2
7809399|NCT01165203|12272076|FG001|Active Phase|Lost to Follow-up|0
7809400|NCT01165203|12272075|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1
7809401|NCT01165203|12272076|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0
7809402|NCT01165203|12272075|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2
7809403|NCT01165203|12272076|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2
7809404|NCT01165203|12272075|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2
7809405|NCT01165203|12272076|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1
7809406|NCT01165203|12272075|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2
7809407|NCT01165203|12272076|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0
7809408|NCT01165203|12272075|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0
7809409|NCT01165203|12272076|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1
7809410|NCT01165216|12272091|FG000|Overall Study|Adverse Event|6
7809411|NCT01165216|12272092|FG001|Overall Study|Adverse Event|3
7809412|NCT01165216|12272091|FG000|Overall Study|Withdrawal by Subject|1
7809413|NCT01165216|12272092|FG001|Overall Study|Withdrawal by Subject|1
7809414|NCT01165216|12272091|FG000|Overall Study|Disease progression|1
7809415|NCT01165216|12272092|FG001|Overall Study|Disease progression|3
7809416|NCT01165229|12272102|FG000|Overall Study|Serious Adverse Event|456
7717607|NCT00520936|12141270|FG001|Overall Study|Physician Decision|2
7809417|NCT01165229|12272103|FG001|Overall Study|Serious Adverse Event|487
7809418|NCT01165229|12272102|FG000|Overall Study|Non-Serious Adverse Event|47
7717608|NCT00520936|12141271|FG002|Overall Study|Physician Decision|1
7717609|NCT00520936|12141272|FG003|Overall Study|Physician Decision|0
7717610|NCT00520936|12141273|FG004|Overall Study|Physician Decision|0
7717611|NCT00520936|12141274|FG005|Overall Study|Physician Decision|0
7717612|NCT00520936|12141275|FG006|Overall Study|Physician Decision|0
7717613|NCT00520936|12141276|FG007|Overall Study|Physician Decision|0
7717614|NCT00520936|12141269|FG000|Overall Study|Withdrawal by Subject|0
7717615|NCT00520936|12141270|FG001|Overall Study|Withdrawal by Subject|0
7717616|NCT00520936|12141271|FG002|Overall Study|Withdrawal by Subject|0
7717617|NCT00520936|12141272|FG003|Overall Study|Withdrawal by Subject|0
7717618|NCT00520936|12141273|FG004|Overall Study|Withdrawal by Subject|0
7717619|NCT00520936|12141274|FG005|Overall Study|Withdrawal by Subject|0
7717620|NCT00520936|12141275|FG006|Overall Study|Withdrawal by Subject|0
7717621|NCT00520936|12141276|FG007|Overall Study|Withdrawal by Subject|1
7717622|NCT00520936|12141269|FG000|Overall Study|Toxicity Requiring Removal from Study|0
7717623|NCT00520936|12141270|FG001|Overall Study|Toxicity Requiring Removal from Study|1
7717624|NCT00520936|12141271|FG002|Overall Study|Toxicity Requiring Removal from Study|0
7717625|NCT00520936|12141272|FG003|Overall Study|Toxicity Requiring Removal from Study|0
7717626|NCT00520936|12141273|FG004|Overall Study|Toxicity Requiring Removal from Study|0
7717627|NCT00520936|12141274|FG005|Overall Study|Toxicity Requiring Removal from Study|0
7717628|NCT00520936|12141275|FG006|Overall Study|Toxicity Requiring Removal from Study|2
7717629|NCT00520936|12141276|FG007|Overall Study|Toxicity Requiring Removal from Study|0
7717630|NCT00520936|12141269|FG000|Overall Study|Death|0
7717631|NCT00520936|12141270|FG001|Overall Study|Death|0
7717632|NCT00520936|12141271|FG002|Overall Study|Death|0
7717633|NCT00520936|12141272|FG003|Overall Study|Death|0
7717634|NCT00520936|12141273|FG004|Overall Study|Death|0
7717635|NCT00520936|12141274|FG005|Overall Study|Death|0
7717636|NCT00520936|12141275|FG006|Overall Study|Death|1
7717637|NCT00520936|12141276|FG007|Overall Study|Death|0
7717638|NCT00520936|12141269|FG000|Overall Study|Protocol Violation|0
7717639|NCT00520936|12141270|FG001|Overall Study|Protocol Violation|1
7717640|NCT00520936|12141271|FG002|Overall Study|Protocol Violation|1
7717641|NCT00520936|12141272|FG003|Overall Study|Protocol Violation|0
7717642|NCT00520936|12141273|FG004|Overall Study|Protocol Violation|1
7809419|NCT01165229|12272103|FG001|Overall Study|Non-Serious Adverse Event|15
7809420|NCT01165229|12272102|FG000|Overall Study|Protocol Violation|6
7809421|NCT01165229|12272103|FG001|Overall Study|Protocol Violation|8
7887628|NCT01819272|12389339|FG003|Overall Study|Loss of Glucose Control|1
7809422|NCT01165229|12272102|FG000|Overall Study|Withdrawal by Subject|387
7809423|NCT01165229|12272103|FG001|Overall Study|Withdrawal by Subject|396
7809424|NCT01165229|12272102|FG000|Overall Study|Migrated/moved from study area|51
7809425|NCT01165229|12272103|FG001|Overall Study|Migrated/moved from study area|46
7809426|NCT01165229|12272102|FG000|Overall Study|Lost to Follow-up|123
7809427|NCT01165229|12272103|FG001|Overall Study|Lost to Follow-up|133
7809428|NCT01165229|12272102|FG000|Overall Study|Suspected HZ Episode|2
7809429|NCT01165229|12272103|FG001|Overall Study|Suspected HZ Episode|2
7809430|NCT01165229|12272102|FG000|Overall Study|No reason from the subject|108
7809431|NCT01165229|12272103|FG001|Overall Study|No reason from the subject|102
7809432|NCT01165229|12272102|FG000|Overall Study|Unknown completion status|0
7809433|NCT01165229|12272103|FG001|Overall Study|Unknown completion status|1
7809434|NCT01165242|12272142|FG000|Overall Study|Unreachable Subjects|1
7809435|NCT01165242|12272143|FG001|Overall Study|Unreachable Subjects|0
7809436|NCT01165242|12272144|FG002|Overall Study|Unreachable Subjects|0
7809437|NCT01165242|12272142|FG000|Overall Study|Incarcerated Subjects|0
7809438|NCT01165242|12272143|FG001|Overall Study|Incarcerated Subjects|1
7809439|NCT01165242|12272144|FG002|Overall Study|Incarcerated Subjects|0
7809440|NCT01165242|12272142|FG000|Overall Study|Visit 2 Declined by Subject|0
7809441|NCT01165242|12272143|FG001|Overall Study|Visit 2 Declined by Subject|0
7809442|NCT01165242|12272144|FG002|Overall Study|Visit 2 Declined by Subject|1
7809443|NCT01165242|12272142|FG000|Overall Study|Withdrawal by Subject|0
7809444|NCT01165242|12272143|FG001|Overall Study|Withdrawal by Subject|2
7809445|NCT01165242|12272144|FG002|Overall Study|Withdrawal by Subject|2
7809446|NCT01165242|12272142|FG000|Overall Study|Extended Holiday|0
7809447|NCT01165242|12272143|FG001|Overall Study|Extended Holiday|0
7809448|NCT01165242|12272144|FG002|Overall Study|Extended Holiday|1
7809449|NCT01165242|12272142|FG000|Overall Study|Lost to Follow-up|9
7809450|NCT01165242|12272143|FG001|Overall Study|Lost to Follow-up|7
7809451|NCT01165242|12272144|FG002|Overall Study|Lost to Follow-up|10
7809452|NCT01165281|12272156|FG000|Overall Study|Adverse Event|12
7809453|NCT01165281|12272157|FG001|Overall Study|Adverse Event|14
7809454|NCT01165281|12272156|FG000|Overall Study|Death|3
7809455|NCT01165281|12272157|FG001|Overall Study|Death|4
7809456|NCT01165281|12272156|FG000|Overall Study|Lack of Efficacy|4
7809457|NCT01165281|12272157|FG001|Overall Study|Lack of Efficacy|1
7809458|NCT01165281|12272156|FG000|Overall Study|Lost to Follow-up|0
7809459|NCT01165281|12272157|FG001|Overall Study|Lost to Follow-up|1
7809460|NCT01165281|12272156|FG000|Overall Study|Physician Decision|8
7809461|NCT01165281|12272157|FG001|Overall Study|Physician Decision|1
7809462|NCT01165281|12272156|FG000|Overall Study|Protocol Violation|6
7809463|NCT01165281|12272157|FG001|Overall Study|Protocol Violation|5
7809464|NCT01165281|12272156|FG000|Overall Study|Withdrawal by Subject|8
7809465|NCT01165281|12272157|FG001|Overall Study|Withdrawal by Subject|7
7809466|NCT01165281|12272156|FG000|Overall Study|Noncompliance with Study Drug|1
7809467|NCT01165281|12272157|FG001|Overall Study|Noncompliance with Study Drug|4
7809468|NCT01165281|12272156|FG000|Overall Study|Progressive Disease|10
7809469|NCT01165281|12272157|FG001|Overall Study|Progressive Disease|14
7809470|NCT01165281|12272156|FG000|Overall Study|Other|6
7717643|NCT00520936|12141274|FG005|Overall Study|Protocol Violation|0
7717644|NCT00520936|12141275|FG006|Overall Study|Protocol Violation|1
7717645|NCT00520936|12141276|FG007|Overall Study|Protocol Violation|0
7809471|NCT01165281|12272157|FG001|Overall Study|Other|0
7809472|NCT01165307|12272165|FG000|Overall Study|Lost to Follow-up|11
7809473|NCT01165307|12272166|FG001|Overall Study|Lost to Follow-up|3
7809474|NCT01165307|12272165|FG000|Overall Study|Withdrawal by Subject|2
7809475|NCT01165307|12272166|FG001|Overall Study|Withdrawal by Subject|0
7809476|NCT01165307|12272165|FG000|Overall Study|Subject not available for contact|1
7809477|NCT01165307|12272166|FG001|Overall Study|Subject not available for contact|0
7809478|NCT01165320|12272174|FG000|Overall Study|Clinical adverse experience|2
7809479|NCT01165320|12272175|FG001|Overall Study|Clinical adverse experience|1
7809480|NCT01165320|12272176|FG002|Overall Study|Clinical adverse experience|0
7809481|NCT01165320|12272174|FG000|Overall Study|Laboratory adverse experience|1
7809482|NCT01165320|12272175|FG001|Overall Study|Laboratory adverse experience|0
7809483|NCT01165320|12272176|FG002|Overall Study|Laboratory adverse experience|0
7809484|NCT01165320|12272174|FG000|Overall Study|Lack of Efficacy|0
7809485|NCT01165320|12272175|FG001|Overall Study|Lack of Efficacy|2
7809486|NCT01165320|12272176|FG002|Overall Study|Lack of Efficacy|0
7809487|NCT01165320|12272174|FG000|Overall Study|Reason unknown|0
7809488|NCT01165320|12272175|FG001|Overall Study|Reason unknown|1
7809489|NCT01165320|12272176|FG002|Overall Study|Reason unknown|0
7809490|NCT01165554|12272188|FG000|Overall Study|Withdrawal by Subject|23
7809491|NCT01165684|12272197|FG000|Overall Study|Adverse Event|1
7809492|NCT01165684|12272198|FG001|Overall Study|Adverse Event|1
7809493|NCT01165684|12272197|FG000|Overall Study|Lack of Efficacy|2
7809494|NCT01165684|12272198|FG001|Overall Study|Lack of Efficacy|1
7809495|NCT01165684|12272197|FG000|Overall Study|Protocol Violation|7
7809496|NCT01165684|12272198|FG001|Overall Study|Protocol Violation|15
7809497|NCT01165684|12272197|FG000|Overall Study|Withdrawal Criteria|2
7809498|NCT01165684|12272198|FG001|Overall Study|Withdrawal Criteria|13
7809499|NCT01165684|12272197|FG000|Overall Study|Unclassified|16
7809500|NCT01165684|12272198|FG001|Overall Study|Unclassified|22
7809501|NCT01165996|12272227|FG000|Overall Study|Death|1
7809502|NCT01165996|12272227|FG000|Overall Study|Physician Decision|1
7809503|NCT01166282|12272251|FG000|Open-label Period|Adverse Event|0
7809504|NCT01166282|12272252|FG001|Open-label Period|Adverse Event|0
7809505|NCT01166282|12272253|FG002|Open-label Period|Adverse Event|6
7809506|NCT01166282|12272251|FG000|Open-label Period|Withdrawal by Subject|0
7809507|NCT01166282|12272252|FG001|Open-label Period|Withdrawal by Subject|0
7809508|NCT01166282|12272253|FG002|Open-label Period|Withdrawal by Subject|4
7809509|NCT01166282|12272251|FG000|Open-label Period|Lack of Efficacy|0
7809510|NCT01166282|12272252|FG001|Open-label Period|Lack of Efficacy|0
7809511|NCT01166282|12272253|FG002|Open-label Period|Lack of Efficacy|2
7809512|NCT01166282|12272251|FG000|Open-label Period|Remission|0
7809513|NCT01166282|12272252|FG001|Open-label Period|Remission|0
7809514|NCT01166282|12272253|FG002|Open-label Period|Remission|4
7809515|NCT01166282|12272251|FG000|Open-label Period|Irregular Compliance|0
7809516|NCT01166282|12272252|FG001|Open-label Period|Irregular Compliance|0
7809517|NCT01166282|12272253|FG002|Open-label Period|Irregular Compliance|1
7809518|NCT01166373|12272274|FG000|Overall Study|Lost to Follow-up|3
7809519|NCT01166373|12272275|FG001|Overall Study|Lost to Follow-up|2
7809520|NCT01166373|12272276|FG002|Overall Study|Lost to Follow-up|2
7809521|NCT01166373|12272277|FG003|Overall Study|Lost to Follow-up|2
7809522|NCT01166373|12272274|FG000|Overall Study|Withdrawal by Subject|1
7809523|NCT01166373|12272275|FG001|Overall Study|Withdrawal by Subject|2
7809524|NCT01166373|12272276|FG002|Overall Study|Withdrawal by Subject|2
7809525|NCT01166373|12272277|FG003|Overall Study|Withdrawal by Subject|3
7809526|NCT01166373|12272274|FG000|Overall Study|Physician Decision|1
7809527|NCT01166373|12272275|FG001|Overall Study|Physician Decision|0
7809528|NCT01166373|12272276|FG002|Overall Study|Physician Decision|0
7809529|NCT01166373|12272277|FG003|Overall Study|Physician Decision|0
7809530|NCT01166438|12272291|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
7809531|NCT01166438|12272292|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
7809532|NCT01166438|12272291|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
7809533|NCT01166438|12272292|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
7809534|NCT01166438|12272291|FG000|Double-blind Phase: 1st 6 Months|Not treated|1
7809535|NCT01166438|12272292|FG001|Double-blind Phase: 1st 6 Months|Not treated|1
7809536|NCT01166438|12272291|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1
7809537|NCT01166438|12272292|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2
7809538|NCT01166438|12272291|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4
7809539|NCT01166438|12272292|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2
7809540|NCT01166438|12272291|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29
7809541|NCT01166438|12272292|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52
7809542|NCT01166568|12272302|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0
7809543|NCT01166568|12272303|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0
7809544|NCT01166568|12272304|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1
7809545|NCT01166568|12272302|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
7809546|NCT01166568|12272303|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
7809547|NCT01166568|12272304|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
7809548|NCT01166568|12272302|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
7809549|NCT01166568|12272303|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
7809550|NCT01166568|12272304|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
7809551|NCT01166646|12272312|FG000|Overall Study|Protocol Violation|0
7809552|NCT01166646|12272313|FG001|Overall Study|Protocol Violation|1
7809553|NCT01166646|12272312|FG000|Overall Study|Adverse Event|1
7809554|NCT01166646|12272313|FG001|Overall Study|Adverse Event|0
7809555|NCT01166659|12272319|FG000|Overall Study|Subject Decision|8
7809556|NCT01166659|12272319|FG000|Overall Study|Investigator Decision|2
7809557|NCT01166659|12272319|FG000|Overall Study|Death|1
7809558|NCT01166659|12272319|FG000|Overall Study|Lost to Follow-up|1
7809559|NCT01166659|12272319|FG000|Overall Study|Study Closed at Site|1
7809560|NCT01166750|12272326|FG000|Overall Study|Lost to Follow-up|1
7809561|NCT01166750|12272327|FG001|Overall Study|Lost to Follow-up|0
7809562|NCT01166763|12272333|FG000|Overall Study|Withdrawal by Subject|3
7809563|NCT01166945|12272339|FG000|Randomized|diagnosed with Group A strep|4
7809564|NCT01166945|12272340|FG001|Randomized|diagnosed with Group A strep|4
7809565|NCT01166945|12272339|FG000|Day 10|NonCompliance/Lost to Follow Up|3
7809566|NCT01166945|12272340|FG001|Day 10|NonCompliance/Lost to Follow Up|2
7809567|NCT01166945|12272339|FG000|Day 15|NonCompliance/Lost to Follow Up|2
7809568|NCT01166945|12272340|FG001|Day 15|NonCompliance/Lost to Follow Up|1
7809569|NCT01166945|12272339|FG000|Day 30|Lost to Follow-up|4
7809570|NCT01166945|12272340|FG001|Day 30|Lost to Follow-up|3
7809571|NCT01166958|12272350|FG000|Overall Study|Withdrawal by Subject|1
7809572|NCT01166958|12272351|FG001|Overall Study|Withdrawal by Subject|0
7809573|NCT01167023|12272410|FG000|Overall Study|Lost to Follow-up|0
7809574|NCT01167023|12272411|FG001|Overall Study|Lost to Follow-up|1
7809575|NCT01167023|12272412|FG002|Overall Study|Lost to Follow-up|1
7809576|NCT01167023|12272410|FG000|Overall Study|Screen Failure|0
7809577|NCT01167023|12272411|FG001|Overall Study|Screen Failure|1
7809578|NCT01167023|12272412|FG002|Overall Study|Screen Failure|0
7809579|NCT01167023|12272410|FG000|Overall Study|Sponsor Decision|0
7809580|NCT01167023|12272411|FG001|Overall Study|Sponsor Decision|1
7809581|NCT01167023|12272412|FG002|Overall Study|Sponsor Decision|0
7809582|NCT01167023|12272410|FG000|Overall Study|Withdrawal by Subject|0
7809583|NCT01167023|12272411|FG001|Overall Study|Withdrawal by Subject|0
7809584|NCT01167023|12272412|FG002|Overall Study|Withdrawal by Subject|1
7809585|NCT01167140|12272418|FG000|Overall Study|Withdrawal by Subject|1
7809586|NCT01167153|12272424|FG000|Overall Study|Non-effective therapy|1
7809587|NCT01167153|12272425|FG001|Overall Study|Non-effective therapy|4
7809588|NCT01167153|12272424|FG000|Overall Study|AE including clinical laboratory AE|2
7809589|NCT01167153|12272425|FG001|Overall Study|AE including clinical laboratory AE|8
7809590|NCT01167153|12272424|FG000|Overall Study|Hypotension|1
7809591|NCT01167153|12272425|FG001|Overall Study|Hypotension|0
7809592|NCT01167153|12272424|FG000|Overall Study|Lost to Follow-up|7
7809593|NCT01167153|12272425|FG001|Overall Study|Lost to Follow-up|9
7809594|NCT01167153|12272424|FG000|Overall Study|Non-compliance to concomitant medication|0
7809595|NCT01167153|12272425|FG001|Overall Study|Non-compliance to concomitant medication|2
7809596|NCT01167153|12272424|FG000|Overall Study|Investigator initiation withdrawal,Other|1
7809597|NCT01167153|12272425|FG001|Overall Study|Investigator initiation withdrawal,Other|1
7809598|NCT01167153|12272424|FG000|Overall Study|Withdrawal consent|1
7809599|NCT01167153|12272425|FG001|Overall Study|Withdrawal consent|1
7809600|NCT01167153|12272424|FG000|Overall Study|Subject initiation withdrawal, Other|5
7809601|NCT01167153|12272425|FG001|Overall Study|Subject initiation withdrawal, Other|8
7809602|NCT01167179|12272433|FG000|Overall Study|disease recurrence|4
7809603|NCT01167179|12272434|FG001|Overall Study|disease recurrence|4
7809604|NCT01167179|12272433|FG000|Overall Study|Death|4
7809605|NCT01167179|12272434|FG001|Overall Study|Death|10
7809606|NCT01167179|12272433|FG000|Overall Study|Withdrawal by Subject|1
7809607|NCT01167179|12272434|FG001|Overall Study|Withdrawal by Subject|2
7809608|NCT01167179|12272433|FG000|Overall Study|diverse|6
7809609|NCT01167179|12272434|FG001|Overall Study|diverse|5
7809610|NCT01167192|12272440|FG000|Overall Study|Adverse Event|1
7809611|NCT01167192|12272440|FG000|Overall Study|Death|1
7809612|NCT01167192|12272440|FG000|Overall Study|Withdrawal by Subject|1
7809613|NCT01167192|12272440|FG000|Overall Study|Insurance denial|1
7809614|NCT01167257|12272446|FG000|Overall Study|Lost to Follow-up|2
7809615|NCT01167257|12272447|FG001|Overall Study|Lost to Follow-up|2
7809616|NCT01167257|12272446|FG000|Overall Study|Withdrew consent|1
7809617|NCT01167257|12272447|FG001|Overall Study|Withdrew consent|1
7809618|NCT01167426|12272457|FG000|Overall Study|Lost to Follow-up|6
7809619|NCT01167426|12272457|FG000|Overall Study|Protocol Violation|1
7809620|NCT01167426|12272457|FG000|Overall Study|Withdrawal by Subject|2
7809621|NCT01167426|12272457|FG000|Overall Study|Sponsor Decision|1
7809622|NCT01167582|12272484|FG000|Overall Study|Lost to Follow-up|0
7809623|NCT01167582|12272485|FG001|Overall Study|Lost to Follow-up|1
7809624|NCT01167634|12272509|FG000|Overall Study|Lost to Follow-up|1
7809625|NCT01167634|12272510|FG001|Overall Study|Lost to Follow-up|3
7809626|NCT01167634|12272511|FG002|Overall Study|Lost to Follow-up|3
7809627|NCT01167634|12272512|FG003|Overall Study|Lost to Follow-up|4
7809628|NCT01167634|12272509|FG000|Overall Study|Withdrawal by Subject|1
7809629|NCT01167634|12272510|FG001|Overall Study|Withdrawal by Subject|1
7809630|NCT01167634|12272511|FG002|Overall Study|Withdrawal by Subject|0
7809631|NCT01167634|12272512|FG003|Overall Study|Withdrawal by Subject|0
7809632|NCT01167881|12272530|FG000|Overall Study|Adverse Event|47
7809633|NCT01167881|12272531|FG001|Overall Study|Adverse Event|51
7809634|NCT01167881|12272530|FG000|Overall Study|Lack of Efficacy|4
7809635|NCT01167881|12272531|FG001|Overall Study|Lack of Efficacy|7
7809636|NCT01167881|12272530|FG000|Overall Study|Non compliant with protocol|9
7809637|NCT01167881|12272531|FG001|Overall Study|Non compliant with protocol|18
7809638|NCT01167881|12272530|FG000|Overall Study|Lost to Follow-up|19
7809639|NCT01167881|12272531|FG001|Overall Study|Lost to Follow-up|20
7809640|NCT01167881|12272530|FG000|Overall Study|Patient refusal to cont., not due to AE|45
7809641|NCT01167881|12272531|FG001|Overall Study|Patient refusal to cont., not due to AE|40
7809642|NCT01167881|12272530|FG000|Overall Study|Not treated|4
7809643|NCT01167881|12272531|FG001|Overall Study|Not treated|0
7809644|NCT01167881|12272530|FG000|Overall Study|Other not defined above|31
7809645|NCT01167881|12272531|FG001|Overall Study|Other not defined above|55
7809646|NCT01167907|12272539|FG000|Overall Study|Protocol Violation|1
7809647|NCT01167907|12272540|FG001|Overall Study|Protocol Violation|0
7809648|NCT01167907|12272539|FG000|Overall Study|saphenous catheter dislodged before comp|1
7809649|NCT01167907|12272540|FG001|Overall Study|saphenous catheter dislodged before comp|1
7809650|NCT01168232|12272555|FG000|Overall Study|Ineligible-Second primary cancer site|1
7809651|NCT01168232|12272555|FG000|Overall Study|Ineligible- Wrong cell type|6
7809652|NCT01168232|12272555|FG000|Overall Study|Ineligible-Inadequate pathology|1
7809653|NCT01168349|12272559|FG000|Overall Study|Death|157
7809654|NCT01168349|12272559|FG000|Overall Study|Lost to Follow-up|34
7809655|NCT01168349|12272559|FG000|Overall Study|Withdrawal by Subject|9
7809656|NCT01168349|12272559|FG000|Overall Study|Kidney transplantation|3
7809657|NCT01168349|12272559|FG000|Overall Study|Other|22
7809658|NCT01168349|12272559|FG000|Overall Study|Protocol Violation|76
7809659|NCT01168401|12272590|FG000|Overall Study|Lost to Follow-up|1
7809660|NCT01168401|12272591|FG001|Overall Study|Lost to Follow-up|1
7809661|NCT01168401|12272592|FG002|Overall Study|Lost to Follow-up|2
7809662|NCT01168401|12272593|FG003|Overall Study|Lost to Follow-up|1
7809663|NCT01168401|12272594|FG004|Overall Study|Lost to Follow-up|0
7809664|NCT01168401|12272595|FG005|Overall Study|Lost to Follow-up|0
7809665|NCT01168401|12272596|FG006|Overall Study|Lost to Follow-up|0
7809666|NCT01168401|12272597|FG007|Overall Study|Lost to Follow-up|0
7809667|NCT01168401|12272598|FG008|Overall Study|Lost to Follow-up|0
7809668|NCT01168401|12272599|FG009|Overall Study|Lost to Follow-up|0
7809669|NCT01168401|12272600|FG010|Overall Study|Lost to Follow-up|0
7809670|NCT01168401|12272590|FG000|Overall Study|Withdrawal by Subject|0
7809671|NCT01168401|12272591|FG001|Overall Study|Withdrawal by Subject|0
7809672|NCT01168401|12272592|FG002|Overall Study|Withdrawal by Subject|0
7809673|NCT01168401|12272593|FG003|Overall Study|Withdrawal by Subject|1
7809674|NCT01168401|12272594|FG004|Overall Study|Withdrawal by Subject|0
7809675|NCT01168401|12272595|FG005|Overall Study|Withdrawal by Subject|0
7809676|NCT01168401|12272596|FG006|Overall Study|Withdrawal by Subject|0
7809677|NCT01168401|12272597|FG007|Overall Study|Withdrawal by Subject|0
7809678|NCT01168401|12272598|FG008|Overall Study|Withdrawal by Subject|0
7809679|NCT01168401|12272599|FG009|Overall Study|Withdrawal by Subject|0
7809680|NCT01168401|12272600|FG010|Overall Study|Withdrawal by Subject|0
7809681|NCT01168427|12272624|FG000|Overall Study|Patient exited prior to implant|1
7809682|NCT01168596|12272630|FG000|Overall Study|Withdrawal by Subject|3
7809683|NCT01168596|12272631|FG001|Overall Study|Withdrawal by Subject|1
7809684|NCT01168856|12272669|FG000|Overall Study|Lost to Follow-up|4
7809685|NCT01168856|12272670|FG001|Overall Study|Lost to Follow-up|34
7809686|NCT01168856|12272669|FG000|Overall Study|Withdrawal by Subject|6
7809687|NCT01168856|12272670|FG001|Overall Study|Withdrawal by Subject|8
7809688|NCT01168856|12272669|FG000|Overall Study|Physician Decision|2
7809689|NCT01168856|12272670|FG001|Overall Study|Physician Decision|1
7809690|NCT01168856|12272669|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0
7809691|NCT01168856|12272670|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1
7809692|NCT01168856|12272669|FG000|Overall Study|Participant received anti-HCV treatment|1
7809693|NCT01168856|12272670|FG001|Overall Study|Participant received anti-HCV treatment|0
7809694|NCT01168856|12272669|FG000|Overall Study|Death|0
7809695|NCT01168856|12272670|FG001|Overall Study|Death|2
7809696|NCT01168856|12272669|FG000|Overall Study|Other|1
7809697|NCT01168856|12272670|FG001|Overall Study|Other|291
7809698|NCT01168856|12272669|FG000|Overall Study|Protocol Violation|4
7809699|NCT01168856|12272670|FG001|Overall Study|Protocol Violation|6
7809700|NCT01168973|12272700|FG000|Overall Study|Progressive Disease|341
7809701|NCT01168973|12272701|FG001|Overall Study|Progressive Disease|429
7809702|NCT01168973|12272700|FG000|Overall Study|Adverse Event|94
7809703|NCT01168973|12272701|FG001|Overall Study|Adverse Event|55
7809704|NCT01168973|12272700|FG000|Overall Study|Withdrawal by Subject|90
7809705|NCT01168973|12272701|FG001|Overall Study|Withdrawal by Subject|53
7809706|NCT01168973|12272700|FG000|Overall Study|Death|42
7809707|NCT01168973|12272701|FG001|Overall Study|Death|45
7809708|NCT01168973|12272700|FG000|Overall Study|Physician Decision|37
7809709|NCT01168973|12272701|FG001|Overall Study|Physician Decision|19
7809710|NCT01168973|12272700|FG000|Overall Study|Sponsor Decision|2
7809711|NCT01168973|12272701|FG001|Overall Study|Sponsor Decision|1
7809712|NCT01168973|12272700|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7
7809713|NCT01168973|12272701|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9
7809714|NCT01168999|12272724|FG000|Overall Study|Lost to Follow-up|2
7809715|NCT01168999|12272725|FG001|Overall Study|Lost to Follow-up|1
7809716|NCT01168999|12272726|FG002|Overall Study|Lost to Follow-up|0
7809717|NCT01168999|12272727|FG003|Overall Study|Lost to Follow-up|0
7809718|NCT01169038|12272737|FG000|Overall Study|Death|1
7809719|NCT01169038|12272737|FG000|Overall Study|Adverse Event|5
7809720|NCT01169038|12272737|FG000|Overall Study|Required antibiotic administration|1
7809721|NCT01169103|12272754|FG000|Overall Study|Lost to Follow-up|3
7809722|NCT01169103|12272755|FG001|Overall Study|Lost to Follow-up|3
7809723|NCT01169103|12272754|FG000|Overall Study|Withdrawal by Subject|3
7809724|NCT01169103|12272755|FG001|Overall Study|Withdrawal by Subject|1
7809725|NCT01169337|12272769|FG000|Overall Study|Lack of Efficacy|5
7809726|NCT01169337|12272770|FG001|Overall Study|Lack of Efficacy|7
7809727|NCT01169337|12272771|FG002|Overall Study|Lack of Efficacy|0
7809728|NCT01169337|12272769|FG000|Overall Study|Adverse Event|12
7809729|NCT01169337|12272770|FG001|Overall Study|Adverse Event|18
7809730|NCT01169337|12272771|FG002|Overall Study|Adverse Event|0
7809731|NCT01169337|12272769|FG000|Overall Study|Death|2
7809732|NCT01169337|12272770|FG001|Overall Study|Death|0
7809733|NCT01169337|12272771|FG002|Overall Study|Death|0
7809734|NCT01169337|12272769|FG000|Overall Study|Withdrawal by Subject|11
7809735|NCT01169337|12272770|FG001|Overall Study|Withdrawal by Subject|11
7809736|NCT01169337|12272771|FG002|Overall Study|Withdrawal by Subject|6
7809737|NCT01169337|12272769|FG000|Overall Study|Noncompliance|2
7809738|NCT01169337|12272770|FG001|Overall Study|Noncompliance|0
7809739|NCT01169337|12272771|FG002|Overall Study|Noncompliance|0
7809740|NCT01169337|12272769|FG000|Overall Study|Other complicating disease|1
7809741|NCT01169337|12272770|FG001|Overall Study|Other complicating disease|1
7809742|NCT01169337|12272771|FG002|Overall Study|Other complicating disease|0
7809743|NCT01169337|12272769|FG000|Overall Study|Physician Decision|1
7809744|NCT01169337|12272770|FG001|Overall Study|Physician Decision|5
7809745|NCT01169337|12272771|FG002|Overall Study|Physician Decision|0
7809746|NCT01169337|12272769|FG000|Overall Study|Alternative therapy|0
7809747|NCT01169337|12272770|FG001|Overall Study|Alternative therapy|2
7809748|NCT01169337|12272771|FG002|Overall Study|Alternative therapy|0
7809749|NCT01169337|12272769|FG000|Overall Study|Changed hospital|0
7809750|NCT01169337|12272770|FG001|Overall Study|Changed hospital|1
7809751|NCT01169337|12272771|FG002|Overall Study|Changed hospital|0
7809752|NCT01169337|12272769|FG000|Overall Study|Never started treatment|0
7809753|NCT01169337|12272770|FG001|Overall Study|Never started treatment|2
7809754|NCT01169337|12272771|FG002|Overall Study|Never started treatment|0
7809755|NCT01169337|12272769|FG000|Overall Study|Reason not reported|1
7887629|NCT01819272|12389340|FG004|Overall Study|Loss of Glucose Control|2
7887630|NCT01819272|12389341|FG005|Overall Study|Loss of Glucose Control|0
7887631|NCT01819506|12389383|FG000|Overall Study|Physician Decision|5
7887632|NCT01819506|12389384|FG001|Overall Study|Physician Decision|2
7887633|NCT01819506|12389383|FG000|Overall Study|Withdrawal by Subject|3
7887634|NCT01819506|12389384|FG001|Overall Study|Withdrawal by Subject|3
7887635|NCT01819727|12389396|FG000|Overall Study|Adverse Event|8
7887636|NCT01819727|12389397|FG001|Overall Study|Adverse Event|9
7887637|NCT01819727|12389396|FG000|Overall Study|Death|1
7887638|NCT01819727|12389397|FG001|Overall Study|Death|0
7887639|NCT01819727|12389396|FG000|Overall Study|Lost to Follow-up|1
7887640|NCT01819727|12389397|FG001|Overall Study|Lost to Follow-up|1
7887641|NCT01819727|12389396|FG000|Overall Study|Physician Decision|3
7887642|NCT01819727|12389397|FG001|Overall Study|Physician Decision|2
7887643|NCT01819727|12389396|FG000|Overall Study|Pregnancy|1
7887644|NCT01819727|12389397|FG001|Overall Study|Pregnancy|0
7887645|NCT01819727|12389396|FG000|Overall Study|Protocol Violation|0
7887646|NCT01819727|12389397|FG001|Overall Study|Protocol Violation|2
7887647|NCT01819727|12389396|FG000|Overall Study|Study Terminated by Sponsor|0
7887648|NCT01819727|12389397|FG001|Overall Study|Study Terminated by Sponsor|1
7887649|NCT01819727|12389396|FG000|Overall Study|Withdrawal by Subject|6
7887650|NCT01819727|12389397|FG001|Overall Study|Withdrawal by Subject|11
7887651|NCT01819727|12389396|FG000|Overall Study|Unable to demostrate ability self-inject|0
7887652|NCT01819727|12389397|FG001|Overall Study|Unable to demostrate ability self-inject|1
7887653|NCT01819727|12389396|FG000|Overall Study|Quit due to lack of health benifits|0
7887654|NCT01819727|12389397|FG001|Overall Study|Quit due to lack of health benifits|1
7887655|NCT01820260|12389446|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7887656|NCT01820260|12389447|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7887657|NCT01820260|12389448|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7887658|NCT01820260|12389449|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7887659|NCT01820260|12389450|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7887660|NCT01820260|12389451|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7887661|NCT01820260|12389452|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1
7887662|NCT01820260|12389453|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7887663|NCT01820260|12389454|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7887664|NCT01820260|12389455|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7887665|NCT01820260|12389456|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7887666|NCT01820260|12389457|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7887667|NCT01820260|12389458|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7887668|NCT01820260|12389459|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7887669|NCT01820260|12389446|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0
7809756|NCT01169337|12272770|FG001|Overall Study|Reason not reported|0
7809757|NCT01169337|12272771|FG002|Overall Study|Reason not reported|0
7809758|NCT01169337|12272769|FG000|Overall Study|Continuing lenalidomide|9
7809759|NCT01169337|12272770|FG001|Overall Study|Continuing lenalidomide|43
7809760|NCT01169337|12272771|FG002|Overall Study|Continuing lenalidomide|0
7887670|NCT01820260|12389447|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0
7887671|NCT01820260|12389448|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0
7887672|NCT01820260|12389449|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0
7887673|NCT01820260|12389450|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0
7809761|NCT01169350|12272779|FG000|Overall Study|Physician Decision|3
7809762|NCT01169350|12272779|FG000|Overall Study|Lost to Follow-up|2
7809763|NCT01169493|12272798|FG000|Period 1 (6 Months)|Withdrawal by Subject|0
7809764|NCT01169493|12272799|FG001|Period 1 (6 Months)|Withdrawal by Subject|1
7809765|NCT01169493|12272800|FG002|Period 1 (6 Months)|Withdrawal by Subject|2
7809766|NCT01169493|12272801|FG003|Period 1 (6 Months)|Withdrawal by Subject|0
7809767|NCT01169493|12272802|FG004|Period 1 (6 Months)|Withdrawal by Subject|0
7809768|NCT01169493|12272803|FG005|Period 1 (6 Months)|Withdrawal by Subject|3
7809769|NCT01169493|12272798|FG000|Period 3 (6 Months)|Adverse Event|0
7809770|NCT01169493|12272799|FG001|Period 3 (6 Months)|Adverse Event|1
7809771|NCT01169493|12272800|FG002|Period 3 (6 Months)|Adverse Event|0
7809772|NCT01169493|12272801|FG003|Period 3 (6 Months)|Adverse Event|0
7809773|NCT01169493|12272802|FG004|Period 3 (6 Months)|Adverse Event|0
7809774|NCT01169493|12272803|FG005|Period 3 (6 Months)|Adverse Event|0
7809775|NCT01169493|12272798|FG000|Period 3 (6 Months)|Physician Decision|0
7809776|NCT01169493|12272799|FG001|Period 3 (6 Months)|Physician Decision|1
7809777|NCT01169493|12272800|FG002|Period 3 (6 Months)|Physician Decision|1
7809778|NCT01169493|12272801|FG003|Period 3 (6 Months)|Physician Decision|0
7809779|NCT01169493|12272802|FG004|Period 3 (6 Months)|Physician Decision|0
7809780|NCT01169493|12272803|FG005|Period 3 (6 Months)|Physician Decision|0
7809781|NCT01169532|12272823|FG000|Overall Study|Withdrawal by Subject|1
7809782|NCT01169558|12272827|FG000|Overall Study|Disease progression|98
7809783|NCT01169558|12272827|FG000|Overall Study|Adverse Event|25
7809784|NCT01169558|12272827|FG000|Overall Study|Withdrawal of Consent|8
7809785|NCT01169558|12272827|FG000|Overall Study|Medical Decision|7
7809786|NCT01169558|12272827|FG000|Overall Study|Stable Disease|4
7809787|NCT01169558|12272827|FG000|Overall Study|Lost to Follow-up|4
7809788|NCT01169558|12272827|FG000|Overall Study|Need for Surgery|4
7809789|NCT01169558|12272827|FG000|Overall Study|Non-compliance|2
7809790|NCT01169558|12272827|FG000|Overall Study|Protocol Violation|2
7809791|NCT01169558|12272827|FG000|Overall Study|Partial response|2
7809792|NCT01169636|12272836|FG000|Overall Study|Adverse Event|0
7809793|NCT01169636|12272837|FG001|Overall Study|Adverse Event|0
7809794|NCT01169636|12272838|FG002|Overall Study|Adverse Event|1
7809795|NCT01169636|12272839|FG003|Overall Study|Adverse Event|1
7809796|NCT01169636|12272840|FG004|Overall Study|Adverse Event|0
7809797|NCT01169636|12272836|FG000|Overall Study|Screen failure|0
7809798|NCT01169636|12272837|FG001|Overall Study|Screen failure|0
7809799|NCT01169636|12272838|FG002|Overall Study|Screen failure|2
7809800|NCT01169636|12272839|FG003|Overall Study|Screen failure|0
7809801|NCT01169636|12272840|FG004|Overall Study|Screen failure|0
7809802|NCT01169636|12272836|FG000|Overall Study|Withdrawal by Subject|0
7809803|NCT01169636|12272837|FG001|Overall Study|Withdrawal by Subject|0
7809804|NCT01169636|12272838|FG002|Overall Study|Withdrawal by Subject|0
7809805|NCT01169636|12272839|FG003|Overall Study|Withdrawal by Subject|0
7809806|NCT01169636|12272840|FG004|Overall Study|Withdrawal by Subject|3
7809807|NCT01169649|12272850|FG000|Overall Study|Patient Not Treated|3
7809808|NCT01169675|12272859|FG000|Overall Study|Progressive disease|13
7809809|NCT01169675|12272860|FG001|Overall Study|Progressive disease|2
7809810|NCT01169675|12272861|FG002|Overall Study|Progressive disease|5
7809811|NCT01169675|12272862|FG003|Overall Study|Progressive disease|15
7809812|NCT01169675|12272863|FG004|Overall Study|Progressive disease|1
7809813|NCT01169675|12272859|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1
7809814|NCT01169675|12272860|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
7809815|NCT01169675|12272861|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0
7809816|NCT01169675|12272862|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
7809817|NCT01169675|12272863|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2
7809818|NCT01169675|12272859|FG000|Overall Study|Adverse Event|5
7809819|NCT01169675|12272860|FG001|Overall Study|Adverse Event|1
7809820|NCT01169675|12272861|FG002|Overall Study|Adverse Event|2
7809821|NCT01169675|12272862|FG003|Overall Study|Adverse Event|0
7809822|NCT01169675|12272863|FG004|Overall Study|Adverse Event|0
7809823|NCT01169675|12272859|FG000|Overall Study|Withdrawal by Subject|1
7809824|NCT01169675|12272860|FG001|Overall Study|Withdrawal by Subject|0
7809825|NCT01169675|12272861|FG002|Overall Study|Withdrawal by Subject|0
7809826|NCT01169675|12272862|FG003|Overall Study|Withdrawal by Subject|1
7809827|NCT01169675|12272863|FG004|Overall Study|Withdrawal by Subject|2
7809828|NCT01169675|12272859|FG000|Overall Study|Other Reason Not Defined Above|0
7809829|NCT01169675|12272860|FG001|Overall Study|Other Reason Not Defined Above|0
7809830|NCT01169675|12272861|FG002|Overall Study|Other Reason Not Defined Above|0
7809831|NCT01169675|12272862|FG003|Overall Study|Other Reason Not Defined Above|1
7809832|NCT01169675|12272863|FG004|Overall Study|Other Reason Not Defined Above|1
7809833|NCT01169701|12272877|FG000|Overall Study|Lost to Follow-up|1
7809834|NCT01169701|12272878|FG001|Overall Study|Lost to Follow-up|1
7809835|NCT01169701|12272877|FG000|Overall Study|Withdrawal by Subject|1
7809836|NCT01169701|12272878|FG001|Overall Study|Withdrawal by Subject|3
7809837|NCT01169701|12272877|FG000|Overall Study|Adverse Event|1
7809838|NCT01169701|12272878|FG001|Overall Study|Adverse Event|2
7809839|NCT01169701|12272877|FG000|Overall Study|Exclusion criteria|2
7809840|NCT01169701|12272878|FG001|Overall Study|Exclusion criteria|0
7809841|NCT01169701|12272877|FG000|Overall Study|Death|0
7809842|NCT01169701|12272878|FG001|Overall Study|Death|1
7809843|NCT01169701|12272877|FG000|Overall Study|Administrative problems|0
7809844|NCT01169701|12272878|FG001|Overall Study|Administrative problems|1
7809845|NCT01169701|12272877|FG000|Overall Study|Serious adverse event|0
7809846|NCT01169701|12272878|FG001|Overall Study|Serious adverse event|1
7809847|NCT01169701|12272877|FG000|Overall Study|Sponsor decision|0
7809848|NCT01169701|12272878|FG001|Overall Study|Sponsor decision|1
7809849|NCT01169779|12272886|FG000|Overall Study|Adverse Event|3
7809850|NCT01169779|12272887|FG001|Overall Study|Adverse Event|11
7809851|NCT01169779|12272886|FG000|Overall Study|Lack of Efficacy|1
7809852|NCT01169779|12272887|FG001|Overall Study|Lack of Efficacy|0
7809853|NCT01169779|12272886|FG000|Overall Study|Protocol Violation|1
7809854|NCT01169779|12272887|FG001|Overall Study|Protocol Violation|1
7809855|NCT01169779|12272886|FG000|Overall Study|Withdrawal by Subject|3
7809856|NCT01169779|12272887|FG001|Overall Study|Withdrawal by Subject|2
7809857|NCT01169779|12272886|FG000|Overall Study|Familial and personal reasons|3
7809858|NCT01169779|12272887|FG001|Overall Study|Familial and personal reasons|3
7809859|NCT01169844|12272895|FG000|Overall Study|Adverse Event|0
7809860|NCT01169844|12272896|FG001|Overall Study|Adverse Event|1
7809861|NCT01169844|12272895|FG000|Overall Study|Patient withdrew consent|4
7809862|NCT01169844|12272896|FG001|Overall Study|Patient withdrew consent|0
7809863|NCT01169844|12272895|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7809864|NCT01169844|12272896|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7809865|NCT01169987|12272902|FG000|Overall Study|Withdrawal by Subject|3
7809866|NCT01169987|12272902|FG000|Overall Study|Lost to Follow-up|24
7809867|NCT01169987|12272902|FG000|Overall Study|Other|4
7809868|NCT01170039|12272914|FG000|Overall Study|Withdrawal by Subject|5
7809869|NCT01170039|12272915|FG001|Overall Study|Withdrawal by Subject|3
7809870|NCT01170039|12272914|FG000|Overall Study|Lack of funding, drug not available|3
7809871|NCT01170039|12272915|FG001|Overall Study|Lack of funding, drug not available|3
7861789|NCT01597245|12351194|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861790|NCT01597245|12351195|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861791|NCT01597245|12351196|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861792|NCT01597245|12351197|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861793|NCT01597245|12351198|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861794|NCT01597245|12351199|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861795|NCT01597245|12351200|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861796|NCT01597245|12351201|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861797|NCT01597245|12351202|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861798|NCT01597245|12351203|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861799|NCT01597245|12351204|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861800|NCT01597245|12351205|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861801|NCT01597245|12351206|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861802|NCT01597245|12351207|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861803|NCT01597245|12351208|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7861804|NCT01597245|12351188|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1
7861805|NCT01597245|12351189|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861806|NCT01597245|12351190|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861807|NCT01597245|12351191|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1
7861808|NCT01597245|12351192|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861809|NCT01597245|12351193|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861810|NCT01597245|12351194|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861811|NCT01597245|12351195|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861812|NCT01597245|12351196|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861813|NCT01597245|12351197|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861814|NCT01597245|12351198|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861815|NCT01597245|12351199|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861816|NCT01597245|12351200|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861817|NCT01597245|12351201|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861818|NCT01597245|12351202|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861819|NCT01597245|12351203|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861820|NCT01597245|12351204|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861821|NCT01597245|12351205|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861822|NCT01597245|12351206|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861823|NCT01597245|12351207|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861824|NCT01597245|12351208|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0
7861825|NCT01597245|12351188|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
7861826|NCT01597245|12351189|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
7861827|NCT01597245|12351190|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
7861828|NCT01597245|12351191|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861829|NCT01597245|12351192|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861830|NCT01597245|12351193|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861831|NCT01597245|12351194|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861832|NCT01597245|12351195|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7809872|NCT01170065|12272924|FG000|Overall Study|Adverse Event|17
7809873|NCT01170065|12272925|FG001|Overall Study|Adverse Event|50
7809874|NCT01170065|12272926|FG002|Overall Study|Adverse Event|10
7887674|NCT01820260|12389451|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0
7887675|NCT01820260|12389452|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0
7887676|NCT01820260|12389453|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0
7887677|NCT01820260|12389454|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0
7887678|NCT01820260|12389455|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1
7887679|NCT01820260|12389456|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0
7887680|NCT01820260|12389457|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0
7887681|NCT01820260|12389458|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0
7887682|NCT01820260|12389459|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0
7887683|NCT01820364|12389495|FG000|Part I: LGX818|Death|1
7887684|NCT01820364|12389496|FG001|Part I: LGX818|Death|0
7887685|NCT01820364|12389495|FG000|Part I: LGX818|Administrative Problems|3
7887686|NCT01820364|12389496|FG001|Part I: LGX818|Administrative Problems|0
7887687|NCT01820364|12389495|FG000|Part I: LGX818|Adverse Event|6
7887688|NCT01820364|12389496|FG001|Part I: LGX818|Adverse Event|0
7887689|NCT01820364|12389495|FG000|Part I: LGX818|Disease Progression|4
7887690|NCT01820364|12389496|FG001|Part I: LGX818|Disease Progression|0
7887691|NCT01820364|12389495|FG000|Part II: LGX818 + MEK162|Study Termination|0
7887692|NCT01820364|12389496|FG001|Part II: LGX818 + MEK162|Study Termination|1
7887693|NCT01820559|12389518|FG000|Overall Study|Adverse Event|4
7887694|NCT01820559|12389519|FG001|Overall Study|Adverse Event|6
7887695|NCT01820559|12389520|FG002|Overall Study|Adverse Event|13
7887696|NCT01820559|12389518|FG000|Overall Study|Withdrawal by Subject|1
7887697|NCT01820559|12389519|FG001|Overall Study|Withdrawal by Subject|2
7887698|NCT01820559|12389520|FG002|Overall Study|Withdrawal by Subject|5
7887699|NCT01820559|12389518|FG000|Overall Study|Protocol Violation|2
7887700|NCT01820559|12389519|FG001|Overall Study|Protocol Violation|1
7887701|NCT01820559|12389520|FG002|Overall Study|Protocol Violation|3
7887702|NCT01820559|12389518|FG000|Overall Study|Subject's non-compliance|1
7887703|NCT01820559|12389519|FG001|Overall Study|Subject's non-compliance|0
7887704|NCT01820559|12389520|FG002|Overall Study|Subject's non-compliance|2
7887705|NCT01820559|12389518|FG000|Overall Study|Lost to Follow-up|3
7887706|NCT01820559|12389519|FG001|Overall Study|Lost to Follow-up|2
7887707|NCT01820559|12389520|FG002|Overall Study|Lost to Follow-up|2
7887708|NCT01820559|12389518|FG000|Overall Study|At sponsor request|0
7887709|NCT01820559|12389519|FG001|Overall Study|At sponsor request|0
7887710|NCT01820559|12389520|FG002|Overall Study|At sponsor request|1
7887711|NCT01820559|12389518|FG000|Overall Study|Lack of Efficacy|3
7887712|NCT01820559|12389519|FG001|Overall Study|Lack of Efficacy|2
7887713|NCT01820559|12389520|FG002|Overall Study|Lack of Efficacy|3
7887714|NCT01820572|12389530|FG000|Randomization|Not Treated|2
7887715|NCT01820572|12389531|FG001|Randomization|Not Treated|1
7887716|NCT01820572|12389530|FG000|Treatment Period|Adverse Event|12
7887717|NCT01820572|12389531|FG001|Treatment Period|Adverse Event|7
7887718|NCT01820572|12389530|FG000|Treatment Period|Death|3
7887719|NCT01820572|12389531|FG001|Treatment Period|Death|3
7887720|NCT01820572|12389530|FG000|Treatment Period|Lack of Efficacy|1
7887721|NCT01820572|12389531|FG001|Treatment Period|Lack of Efficacy|0
7887722|NCT01820572|12389530|FG000|Treatment Period|poor/non compliance|0
7887723|NCT01820572|12389531|FG001|Treatment Period|poor/non compliance|3
7887724|NCT01820572|12389530|FG000|Treatment Period|request to discontinue|6
7887725|NCT01820572|12389531|FG001|Treatment Period|request to discontinue|11
7887726|NCT01820572|12389530|FG000|Treatment Period|No longer meets study criteria|3
7887727|NCT01820572|12389531|FG001|Treatment Period|No longer meets study criteria|10
7887728|NCT01820572|12389530|FG000|Treatment Period|withdrew consent|1
7887729|NCT01820572|12389531|FG001|Treatment Period|withdrew consent|2
7887730|NCT01820585|12389541|FG000|Overall Study|Adverse Event|9
7887731|NCT01820585|12389542|FG001|Overall Study|Adverse Event|13
7887732|NCT01820585|12389543|FG002|Overall Study|Adverse Event|23
7887733|NCT01820585|12389544|FG003|Overall Study|Adverse Event|34
7887734|NCT01820585|12389541|FG000|Overall Study|Lack of Efficacy|9
7887735|NCT01820585|12389542|FG001|Overall Study|Lack of Efficacy|7
7887736|NCT01820585|12389543|FG002|Overall Study|Lack of Efficacy|5
7887737|NCT01820585|12389544|FG003|Overall Study|Lack of Efficacy|1
7887738|NCT01820585|12389541|FG000|Overall Study|Withdrawal by Subject|3
7887739|NCT01820585|12389542|FG001|Overall Study|Withdrawal by Subject|7
7887740|NCT01820585|12389543|FG002|Overall Study|Withdrawal by Subject|3
7887741|NCT01820585|12389544|FG003|Overall Study|Withdrawal by Subject|8
7887742|NCT01820585|12389541|FG000|Overall Study|Lost to Follow-up|3
7887743|NCT01820585|12389542|FG001|Overall Study|Lost to Follow-up|3
7809875|NCT01170065|12272924|FG000|Overall Study|Lost to Follow-up|1
7887744|NCT01820585|12389543|FG002|Overall Study|Lost to Follow-up|0
7887745|NCT01820585|12389544|FG003|Overall Study|Lost to Follow-up|3
7887746|NCT01820585|12389541|FG000|Overall Study|Protocol Violation|3
7887747|NCT01820585|12389542|FG001|Overall Study|Protocol Violation|1
7887748|NCT01820585|12389543|FG002|Overall Study|Protocol Violation|1
7887749|NCT01820585|12389544|FG003|Overall Study|Protocol Violation|1
7887750|NCT01820585|12389541|FG000|Overall Study|Subject non-compliance|0
7887751|NCT01820585|12389542|FG001|Overall Study|Subject non-compliance|0
7887752|NCT01820585|12389543|FG002|Overall Study|Subject non-compliance|1
7887753|NCT01820585|12389544|FG003|Overall Study|Subject non-compliance|2
7887754|NCT01820585|12389541|FG000|Overall Study|at sponsor request|0
7887755|NCT01820585|12389542|FG001|Overall Study|at sponsor request|0
7809876|NCT01170065|12272925|FG001|Overall Study|Lost to Follow-up|4
7809877|NCT01170065|12272926|FG002|Overall Study|Lost to Follow-up|1
7809878|NCT01170065|12272924|FG000|Overall Study|Consent withdrawn, not due to AE|2
7809879|NCT01170065|12272925|FG001|Overall Study|Consent withdrawn, not due to AE|4
7809880|NCT01170065|12272926|FG002|Overall Study|Consent withdrawn, not due to AE|2
7809881|NCT01170065|12272924|FG000|Overall Study|Reason other than specified|3
7809882|NCT01170065|12272925|FG001|Overall Study|Reason other than specified|8
7809883|NCT01170065|12272926|FG002|Overall Study|Reason other than specified|3
7809884|NCT01170065|12272924|FG000|Overall Study|Ongoing after planned observation time|5
7809885|NCT01170065|12272925|FG001|Overall Study|Ongoing after planned observation time|26
7809886|NCT01170065|12272926|FG002|Overall Study|Ongoing after planned observation time|10
7809887|NCT01170091|12272934|FG000|Overall Study|Missing efficacy evaluation|3
7809888|NCT01170091|12272934|FG000|Overall Study|Treatment duration is less than 4 weeks|21
7809889|NCT01170208|12272950|FG000|Overall Study|Withdrawal by Subject|5
7809890|NCT01170208|12272951|FG001|Overall Study|Withdrawal by Subject|0
7809891|NCT01170208|12272952|FG002|Overall Study|Withdrawal by Subject|1
7809892|NCT01170208|12272950|FG000|Overall Study|Protocol Violation|1
7809893|NCT01170208|12272951|FG001|Overall Study|Protocol Violation|0
7809894|NCT01170208|12272952|FG002|Overall Study|Protocol Violation|1
7809895|NCT01170221|12272965|FG000|Overall Study|Lost to Follow-up|22
7809896|NCT01170221|12272966|FG001|Overall Study|Lost to Follow-up|21
7809897|NCT01170221|12272965|FG000|Overall Study|Withdrawal by Subject|9
7809898|NCT01170221|12272966|FG001|Overall Study|Withdrawal by Subject|7
7809899|NCT01170221|12272965|FG000|Overall Study|Subject completed only screening and LFU|1
7809900|NCT01170221|12272966|FG001|Overall Study|Subject completed only screening and LFU|0
7809901|NCT01170221|12272965|FG000|Overall Study|Randomized but not treated|1
7809902|NCT01170221|12272966|FG001|Overall Study|Randomized but not treated|0
7809903|NCT01170273|12272983|FG000|Overall Study|Lost to Follow-up|6
7809904|NCT01170273|12272984|FG001|Overall Study|Lost to Follow-up|8
7809905|NCT01170273|12272983|FG000|Overall Study|Protocol Violation|1
7809906|NCT01170273|12272984|FG001|Overall Study|Protocol Violation|0
7809907|NCT01170273|12272983|FG000|Overall Study|Death|1
7809908|NCT01170273|12272984|FG001|Overall Study|Death|0
7809909|NCT01170273|12272983|FG000|Overall Study|Adverse Event|0
7809910|NCT01170273|12272984|FG001|Overall Study|Adverse Event|1
7809911|NCT01170364|12272992|FG000|Overall Study|Protocol Violation|4
7809912|NCT01170364|12272993|FG001|Overall Study|Protocol Violation|1
7809913|NCT01170598|12273039|FG000|Overall Study|Withdrawal by Subject|1
7809914|NCT01170598|12273039|FG000|Overall Study|Death|3
7809915|NCT01170598|12273039|FG000|Overall Study|Lost to Follow-up|1
7809916|NCT01170598|12273039|FG000|Overall Study|Refused|1
7809917|NCT01170663|12273045|FG000|Overall Study|Lost to Follow-up|3
7809918|NCT01170663|12273046|FG001|Overall Study|Lost to Follow-up|9
7809919|NCT01170663|12273045|FG000|Overall Study|Withdrawal of consent without follow-up|11
7809920|NCT01170663|12273046|FG001|Overall Study|Withdrawal of consent without follow-up|11
7809921|NCT01170962|12273088|FG000|Treatment Period|Lack of Efficacy|96
7809922|NCT01170962|12273089|FG001|Treatment Period|Lack of Efficacy|91
7809923|NCT01170962|12273090|FG002|Treatment Period|Lack of Efficacy|7
7809924|NCT01170962|12273088|FG000|Treatment Period|Adverse Event|11
7809925|NCT01170962|12273089|FG001|Treatment Period|Adverse Event|12
7809926|NCT01170962|12273090|FG002|Treatment Period|Adverse Event|3
7809927|NCT01170962|12273088|FG000|Treatment Period|Withdrawal by Subject|2
7809928|NCT01170962|12273089|FG001|Treatment Period|Withdrawal by Subject|1
7809929|NCT01170962|12273090|FG002|Treatment Period|Withdrawal by Subject|0
7809930|NCT01170962|12273088|FG000|Treatment Period|Lost to Follow-up|1
7809931|NCT01170962|12273089|FG001|Treatment Period|Lost to Follow-up|1
7809932|NCT01170962|12273090|FG002|Treatment Period|Lost to Follow-up|1
7809933|NCT01170962|12273088|FG000|Treatment Period|Participant no longer meets criteria|0
7809934|NCT01170962|12273089|FG001|Treatment Period|Participant no longer meets criteria|1
7809935|NCT01170962|12273090|FG002|Treatment Period|Participant no longer meets criteria|0
7809936|NCT01170962|12273088|FG000|Treatment Period|Request to discontinue treatment|7
7809937|NCT01170962|12273089|FG001|Treatment Period|Request to discontinue treatment|3
7809938|NCT01170962|12273090|FG002|Treatment Period|Request to discontinue treatment|1
7809939|NCT01170962|12273088|FG000|Treatment Period|Completed 24 Week treatment period only|10
7809940|NCT01170962|12273089|FG001|Treatment Period|Completed 24 Week treatment period only|2
7809941|NCT01170962|12273090|FG002|Treatment Period|Completed 24 Week treatment period only|0
7809942|NCT01170962|12273088|FG000|Follow up Period|Withdrawal by Subject|14
7809943|NCT01170962|12273089|FG001|Follow up Period|Withdrawal by Subject|10
7809944|NCT01170962|12273090|FG002|Follow up Period|Withdrawal by Subject|2
7809945|NCT01170962|12273088|FG000|Follow up Period|Lost to Follow-up|13
7809946|NCT01170962|12273089|FG001|Follow up Period|Lost to Follow-up|8
7809947|NCT01170962|12273090|FG002|Follow up Period|Lost to Follow-up|1
7809948|NCT01170962|12273088|FG000|Follow up Period|Death|2
7809949|NCT01170962|12273089|FG001|Follow up Period|Death|2
7809950|NCT01170962|12273090|FG002|Follow up Period|Death|0
7809951|NCT01170962|12273088|FG000|Follow up Period|Others|10
7809952|NCT01170962|12273089|FG001|Follow up Period|Others|7
7809953|NCT01170962|12273090|FG002|Follow up Period|Others|3
7809954|NCT01171183|12273119|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
7809955|NCT01171183|12273120|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
7883582|NCT01782872|12383301|FG003|Overall Study|Protocol Violation|1
7809956|NCT01171183|12273119|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0
7809957|NCT01171183|12273120|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1
7809958|NCT01171183|12273119|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
7809959|NCT01171183|12273120|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
7809960|NCT01171183|12273119|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
7809961|NCT01171183|12273120|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
7809962|NCT01171183|12273119|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
7809963|NCT01171183|12273120|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
7809964|NCT01171183|12273119|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
7809965|NCT01171183|12273120|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
7809966|NCT01171521|12273126|FG000|Overall Study|Lost to Follow-up|5
7809967|NCT01171521|12273126|FG000|Overall Study|screen failure|1
7809968|NCT01171612|12273130|FG000|Overall Study|Lost to Follow-up|51
7809969|NCT01171625|12273137|FG000|Overall Study|On-Protocol|67
7809970|NCT01171625|12273137|FG000|Overall Study|Death|38
7809971|NCT01171625|12273137|FG000|Overall Study|Withdrawal by Subject|31
7809972|NCT01171625|12273137|FG000|Overall Study|Explanted|10
7809973|NCT01171625|12273137|FG000|Overall Study|Lost to Follow-up|5
7809974|NCT01171625|12273137|FG000|Overall Study|Patient received valve-in-valve|3
7809975|NCT01171625|12273137|FG000|Overall Study|Other|1
7809976|NCT01171625|12273137|FG000|Overall Study|Consented but did not receive device|25
7809977|NCT01171677|12273151|FG000|Overall Study|Withdrawal by Subject|0
7809978|NCT01171677|12273152|FG001|Overall Study|Withdrawal by Subject|3
7809979|NCT01171677|12273151|FG000|Overall Study|Adverse Event|1
7809980|NCT01171677|12273152|FG001|Overall Study|Adverse Event|0
7809981|NCT01171677|12273151|FG000|Overall Study|completed <70% IntenSati classes|5
7809982|NCT01171677|12273152|FG001|Overall Study|completed <70% IntenSati classes|0
7809983|NCT01171820|12273178|FG000|Overall Study|Death|3
7809984|NCT01171820|12273179|FG001|Overall Study|Death|3
7809985|NCT01171820|12273178|FG000|Overall Study|Lost to Follow-up|0
7809986|NCT01171820|12273179|FG001|Overall Study|Lost to Follow-up|1
7809987|NCT01171820|12273178|FG000|Overall Study|Withdrawal by Subject|2
7809988|NCT01171820|12273179|FG001|Overall Study|Withdrawal by Subject|0
7809989|NCT01171820|12273178|FG000|Overall Study|Physician Decision|0
7809990|NCT01171820|12273179|FG001|Overall Study|Physician Decision|1
7809991|NCT01171820|12273178|FG000|Overall Study|1-Year Missed Visit|1
7809992|NCT01171820|12273179|FG001|Overall Study|1-Year Missed Visit|1
7809993|NCT01171963|12273196|FG000|Overall Study|Adverse Event|10
7809994|NCT01171963|12273197|FG001|Overall Study|Adverse Event|15
7809995|NCT01171963|12273196|FG000|Overall Study|Lost to Follow-up|23
7809996|NCT01171963|12273197|FG001|Overall Study|Lost to Follow-up|24
7809997|NCT01171963|12273196|FG000|Overall Study|Other - diarrhoea|1
7809998|NCT01171963|12273197|FG001|Overall Study|Other - diarrhoea|0
7809999|NCT01171963|12273196|FG000|Overall Study|Withdrawal by Subject|114
7810000|NCT01171963|12273197|FG001|Overall Study|Withdrawal by Subject|129
7810001|NCT01171976|12273209|FG000|Overall Study|Protocol Violation|0
7810002|NCT01171976|12273210|FG001|Overall Study|Protocol Violation|0
7810003|NCT01171976|12273211|FG002|Overall Study|Protocol Violation|1
7810004|NCT01171976|12273209|FG000|Overall Study|Death|2
7810005|NCT01171976|12273210|FG001|Overall Study|Death|4
7810006|NCT01171976|12273211|FG002|Overall Study|Death|1
7810007|NCT01171976|12273209|FG000|Overall Study|Lost to Follow-up|4
7810008|NCT01171976|12273210|FG001|Overall Study|Lost to Follow-up|0
7810009|NCT01171976|12273211|FG002|Overall Study|Lost to Follow-up|2
7810010|NCT01171976|12273209|FG000|Overall Study|Withdrawal by Subject|1
7810011|NCT01171976|12273210|FG001|Overall Study|Withdrawal by Subject|5
7810012|NCT01171976|12273211|FG002|Overall Study|Withdrawal by Subject|6
7810013|NCT01171976|12273209|FG000|Overall Study|Abnormal test result|1
7810014|NCT01171976|12273210|FG001|Overall Study|Abnormal test result|0
7810015|NCT01171976|12273211|FG002|Overall Study|Abnormal test result|0
7810016|NCT01171976|12273209|FG000|Overall Study|Adverse Event|6
7810017|NCT01171976|12273210|FG001|Overall Study|Adverse Event|2
7810018|NCT01171976|12273211|FG002|Overall Study|Adverse Event|5
7810019|NCT01171989|12273222|FG000|Overall Study|Lost to Follow-up|0
7810020|NCT01171989|12273223|FG001|Overall Study|Lost to Follow-up|0
7810021|NCT01171989|12273224|FG002|Overall Study|Lost to Follow-up|1
7810022|NCT01172275|12273265|FG000|Overall Study|Lost to Follow-up|1
7810023|NCT01172275|12273266|FG001|Overall Study|Lost to Follow-up|0
7810024|NCT01172275|12273265|FG000|Overall Study|Protocol Violation|1
7810025|NCT01172275|12273266|FG001|Overall Study|Protocol Violation|0
7810026|NCT01172288|12273274|FG000|Overall Study|Adverse Event|1
7810027|NCT01172288|12273275|FG001|Overall Study|Adverse Event|0
7887756|NCT01820585|12389543|FG002|Overall Study|at sponsor request|1
7810028|NCT01172288|12273274|FG000|Overall Study|Protocol Violation|0
7810029|NCT01172288|12273275|FG001|Overall Study|Protocol Violation|1
7810030|NCT01172535|12273309|FG000|Overall Study|Death|3
7810031|NCT01172535|12273309|FG000|Overall Study|Withdrawal by Subject|2
7810032|NCT01172535|12273309|FG000|Overall Study|Lost to Follow-up|1
7810033|NCT01172535|12273309|FG000|Overall Study|Ineligible at study entry|1
7810034|NCT01172535|12273309|FG000|Overall Study|Unwilling to adhere to study requirement|1
7810035|NCT01172639|12273330|FG000|Overall Study|Death|1
7810036|NCT01172639|12273331|FG001|Overall Study|Death|1
7810037|NCT01172639|12273332|FG002|Overall Study|Death|0
7810038|NCT01172639|12273333|FG003|Overall Study|Death|0
7810039|NCT01172639|12273334|FG004|Overall Study|Death|0
7810040|NCT01172639|12273330|FG000|Overall Study|Lost to Follow-up|9
7810041|NCT01172639|12273331|FG001|Overall Study|Lost to Follow-up|7
7810042|NCT01172639|12273332|FG002|Overall Study|Lost to Follow-up|11
7810043|NCT01172639|12273333|FG003|Overall Study|Lost to Follow-up|6
7810044|NCT01172639|12273334|FG004|Overall Study|Lost to Follow-up|6
7810045|NCT01172639|12273330|FG000|Overall Study|Withdrawal by Subject|3
7810046|NCT01172639|12273331|FG001|Overall Study|Withdrawal by Subject|3
7810047|NCT01172639|12273332|FG002|Overall Study|Withdrawal by Subject|5
7810048|NCT01172639|12273333|FG003|Overall Study|Withdrawal by Subject|5
7810049|NCT01172639|12273334|FG004|Overall Study|Withdrawal by Subject|0
7810050|NCT01172808|12273350|FG000|Overall Study|Adverse Event|8
7810051|NCT01172808|12273351|FG001|Overall Study|Adverse Event|4
7810052|NCT01172808|12273352|FG002|Overall Study|Adverse Event|8
7810053|NCT01172808|12273353|FG003|Overall Study|Adverse Event|3
7810054|NCT01172808|12273350|FG000|Overall Study|Lack of Efficacy|1
7810055|NCT01172808|12273351|FG001|Overall Study|Lack of Efficacy|0
7810056|NCT01172808|12273352|FG002|Overall Study|Lack of Efficacy|0
7810057|NCT01172808|12273353|FG003|Overall Study|Lack of Efficacy|0
7810058|NCT01172808|12273350|FG000|Overall Study|Protocol Violation|2
7810059|NCT01172808|12273351|FG001|Overall Study|Protocol Violation|2
7810060|NCT01172808|12273352|FG002|Overall Study|Protocol Violation|2
7810061|NCT01172808|12273353|FG003|Overall Study|Protocol Violation|0
7810062|NCT01172808|12273350|FG000|Overall Study|Lost to Follow-up|0
7810063|NCT01172808|12273351|FG001|Overall Study|Lost to Follow-up|1
7810064|NCT01172808|12273352|FG002|Overall Study|Lost to Follow-up|1
7810065|NCT01172808|12273353|FG003|Overall Study|Lost to Follow-up|3
7810066|NCT01172808|12273350|FG000|Overall Study|Withdrawal by Subject|4
7810067|NCT01172808|12273351|FG001|Overall Study|Withdrawal by Subject|1
7810068|NCT01172808|12273352|FG002|Overall Study|Withdrawal by Subject|3
7810069|NCT01172808|12273353|FG003|Overall Study|Withdrawal by Subject|2
7810070|NCT01172808|12273350|FG000|Overall Study|Other|6
7810071|NCT01172808|12273351|FG001|Overall Study|Other|5
7810072|NCT01172808|12273352|FG002|Overall Study|Other|9
7810073|NCT01172808|12273353|FG003|Overall Study|Other|7
7810074|NCT01172821|12273367|FG000|Overall Study|Adverse Event|5
7810075|NCT01172821|12273368|FG001|Overall Study|Adverse Event|2
7810076|NCT01172821|12273369|FG002|Overall Study|Adverse Event|2
7810077|NCT01172821|12273370|FG003|Overall Study|Adverse Event|7
7810078|NCT01172821|12273367|FG000|Overall Study|Protocol Violation|0
7810079|NCT01172821|12273368|FG001|Overall Study|Protocol Violation|2
7810080|NCT01172821|12273369|FG002|Overall Study|Protocol Violation|1
7810081|NCT01172821|12273370|FG003|Overall Study|Protocol Violation|2
7810082|NCT01172821|12273367|FG000|Overall Study|Lost to Follow-up|4
7810083|NCT01172821|12273368|FG001|Overall Study|Lost to Follow-up|1
7810084|NCT01172821|12273369|FG002|Overall Study|Lost to Follow-up|2
7810085|NCT01172821|12273370|FG003|Overall Study|Lost to Follow-up|2
7810086|NCT01172821|12273367|FG000|Overall Study|Withdrawal by Subject|2
7810087|NCT01172821|12273368|FG001|Overall Study|Withdrawal by Subject|3
7810088|NCT01172821|12273369|FG002|Overall Study|Withdrawal by Subject|3
7810089|NCT01172821|12273370|FG003|Overall Study|Withdrawal by Subject|3
7810090|NCT01172821|12273367|FG000|Overall Study|Other|3
7810091|NCT01172821|12273368|FG001|Overall Study|Other|4
7810092|NCT01172821|12273369|FG002|Overall Study|Other|5
7810093|NCT01172821|12273370|FG003|Overall Study|Other|3
7810094|NCT01172847|12273380|FG000|Overall Study|Withdrawal by Subject|3
7810095|NCT01172873|12273392|FG000|Overall Study|Withdrawal by Subject|3
7810096|NCT01172873|12273393|FG001|Overall Study|Withdrawal by Subject|2
7810097|NCT01172938|12273402|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
7810098|NCT01172938|12273403|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
7810099|NCT01172938|12273404|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
7810100|NCT01172938|12273405|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7810101|NCT01172938|12273406|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7810102|NCT01172938|12273407|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7810103|NCT01172938|12273408|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7810104|NCT01172938|12273409|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7810105|NCT01172938|12273410|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7810106|NCT01172938|12273402|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
7810107|NCT01172938|12273403|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
7810108|NCT01172938|12273404|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
7810109|NCT01172938|12273405|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7810110|NCT01172938|12273406|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7810111|NCT01172938|12273407|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7810112|NCT01172938|12273408|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7810113|NCT01172938|12273409|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7810114|NCT01172938|12273410|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7810115|NCT01172938|12273402|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7810116|NCT01172938|12273403|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
7810117|NCT01172938|12273404|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
7810118|NCT01172938|12273405|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7810119|NCT01172938|12273406|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7810120|NCT01172938|12273407|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7810121|NCT01172938|12273408|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7810122|NCT01172938|12273409|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7810123|NCT01172938|12273410|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7810124|NCT01172938|12273402|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
7810125|NCT01172938|12273403|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
7810126|NCT01172938|12273404|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
7810127|NCT01172938|12273405|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7810128|NCT01172938|12273406|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7810129|NCT01172938|12273407|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7810130|NCT01172938|12273408|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7810131|NCT01172938|12273409|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7810132|NCT01172938|12273410|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7810133|NCT01172938|12273402|FG000|Placebo-controlled Phase (Week 0-24)|Death|0
7810134|NCT01172938|12273403|FG001|Placebo-controlled Phase (Week 0-24)|Death|1
7810135|NCT01172938|12273404|FG002|Placebo-controlled Phase (Week 0-24)|Death|0
7810136|NCT01172938|12273405|FG003|Placebo-controlled Phase (Week 0-24)|Death|0
7810137|NCT01172938|12273406|FG004|Placebo-controlled Phase (Week 0-24)|Death|0
7810138|NCT01172938|12273407|FG005|Placebo-controlled Phase (Week 0-24)|Death|0
7810139|NCT01172938|12273408|FG006|Placebo-controlled Phase (Week 0-24)|Death|0
7810140|NCT01172938|12273409|FG007|Placebo-controlled Phase (Week 0-24)|Death|0
7810141|NCT01172938|12273410|FG008|Placebo-controlled Phase (Week 0-24)|Death|0
7810142|NCT01172938|12273402|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
7810143|NCT01172938|12273403|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7810144|NCT01172938|12273404|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7810145|NCT01172938|12273405|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7810146|NCT01172938|12273406|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7810147|NCT01172938|12273407|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7810148|NCT01172938|12273408|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7810149|NCT01172938|12273409|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7810150|NCT01172938|12273410|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7810151|NCT01172938|12273402|FG000|Placebo-controlled Phase (Week 0-24)|Other|0
7810152|NCT01172938|12273403|FG001|Placebo-controlled Phase (Week 0-24)|Other|2
7810153|NCT01172938|12273404|FG002|Placebo-controlled Phase (Week 0-24)|Other|1
7810154|NCT01172938|12273405|FG003|Placebo-controlled Phase (Week 0-24)|Other|0
7810155|NCT01172938|12273406|FG004|Placebo-controlled Phase (Week 0-24)|Other|0
7810156|NCT01172938|12273407|FG005|Placebo-controlled Phase (Week 0-24)|Other|0
7810157|NCT01172938|12273408|FG006|Placebo-controlled Phase (Week 0-24)|Other|0
7810158|NCT01172938|12273409|FG007|Placebo-controlled Phase (Week 0-24)|Other|0
7810159|NCT01172938|12273410|FG008|Placebo-controlled Phase (Week 0-24)|Other|0
7810160|NCT01172938|12273402|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
7810161|NCT01172938|12273403|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
7810162|NCT01172938|12273404|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
7810163|NCT01172938|12273405|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
7810164|NCT01172938|12273406|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
7810165|NCT01172938|12273407|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
7810166|NCT01172938|12273408|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
7810167|NCT01172938|12273409|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
7810168|NCT01172938|12273410|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
7810169|NCT01172938|12273402|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
7810170|NCT01172938|12273403|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
7810171|NCT01172938|12273404|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
7810172|NCT01172938|12273405|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
7810173|NCT01172938|12273406|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
7810174|NCT01172938|12273407|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
7810175|NCT01172938|12273408|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
7810176|NCT01172938|12273409|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
7810177|NCT01172938|12273410|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
7810178|NCT01172938|12273402|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7810179|NCT01172938|12273403|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7810180|NCT01172938|12273404|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
7810181|NCT01172938|12273405|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7810182|NCT01172938|12273406|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7810183|NCT01172938|12273407|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7810184|NCT01172938|12273408|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7810185|NCT01172938|12273409|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7810186|NCT01172938|12273410|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7883583|NCT01782872|12383298|FG000|Overall Study|Withdrawal by Subject|0
7887757|NCT01820585|12389544|FG003|Overall Study|at sponsor request|0
7810187|NCT01172938|12273402|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
7810188|NCT01172938|12273403|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
7810189|NCT01172938|12273404|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
7810190|NCT01172938|12273405|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
7810191|NCT01172938|12273406|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
7810192|NCT01172938|12273407|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
7810193|NCT01172938|12273408|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
7810194|NCT01172938|12273409|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
7810195|NCT01172938|12273410|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
7810196|NCT01172938|12273402|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7810197|NCT01172938|12273403|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
7810198|NCT01172938|12273404|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
7810199|NCT01172938|12273405|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
7810200|NCT01172938|12273406|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7810201|NCT01172938|12273407|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7810202|NCT01172938|12273408|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7810203|NCT01172938|12273409|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7810204|NCT01172938|12273410|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7810205|NCT01172938|12273402|FG000|Active Treatment Phase (Weeks 25-52)|Other|0
7810206|NCT01172938|12273403|FG001|Active Treatment Phase (Weeks 25-52)|Other|0
7810207|NCT01172938|12273404|FG002|Active Treatment Phase (Weeks 25-52)|Other|0
7810208|NCT01172938|12273405|FG003|Active Treatment Phase (Weeks 25-52)|Other|0
7810209|NCT01172938|12273406|FG004|Active Treatment Phase (Weeks 25-52)|Other|0
7810210|NCT01172938|12273407|FG005|Active Treatment Phase (Weeks 25-52)|Other|1
7810211|NCT01172938|12273408|FG006|Active Treatment Phase (Weeks 25-52)|Other|1
7810212|NCT01172938|12273409|FG007|Active Treatment Phase (Weeks 25-52)|Other|0
7810213|NCT01172938|12273410|FG008|Active Treatment Phase (Weeks 25-52)|Other|0
7810214|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
7810215|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
7810216|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
7810217|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
7810218|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
7810219|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
7810220|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
7810221|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
7810222|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
7810223|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7810224|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
7810225|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
7810226|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7810227|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7810228|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7810229|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7810230|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
7810231|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7810232|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7810233|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7810234|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
7810235|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7810236|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7810237|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7810238|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7810239|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7810240|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7810241|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
7810242|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
7810243|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
7810244|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
7810245|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
7810246|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
7810247|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
7810248|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
7810249|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
7810250|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0
7810251|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0
7810252|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1
7810253|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0
7810254|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0
7810255|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0
7810256|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0
7810257|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0
7810258|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0
7810259|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7810260|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
7810261|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
7810262|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7810263|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7810264|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7810265|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7810266|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
7810267|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7810268|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7810269|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
7810270|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7810271|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7810272|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7810273|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7810274|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7810275|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7810276|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
7810277|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0
7810278|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1
7810279|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0
7810280|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0
7810281|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0
7810282|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0
7810283|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0
7810284|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0
7810285|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0
7810286|NCT01172938|12273402|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7810287|NCT01172938|12273403|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7810288|NCT01172938|12273404|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7810289|NCT01172938|12273405|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7810290|NCT01172938|12273406|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7810291|NCT01172938|12273407|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7810292|NCT01172938|12273408|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7810293|NCT01172938|12273409|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7810294|NCT01172938|12273410|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
7810295|NCT01172938|12273402|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
7810296|NCT01172938|12273403|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
7810297|NCT01172938|12273404|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
7810298|NCT01172938|12273405|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
7810299|NCT01172938|12273406|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
7810300|NCT01172938|12273407|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
7810301|NCT01172938|12273408|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
7810302|NCT01172938|12273409|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
7810303|NCT01172938|12273410|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
7810304|NCT01172938|12273402|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7810305|NCT01172938|12273403|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
7810306|NCT01172938|12273404|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
7810307|NCT01172938|12273405|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7810308|NCT01172938|12273406|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7810309|NCT01172938|12273407|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7810310|NCT01172938|12273408|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7810311|NCT01172938|12273409|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
7810312|NCT01172938|12273410|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
7810313|NCT01172938|12273402|FG000|Active-Treatment Phase Weeks (104-156)|Death|0
7810314|NCT01172938|12273403|FG001|Active-Treatment Phase Weeks (104-156)|Death|0
7810315|NCT01172938|12273404|FG002|Active-Treatment Phase Weeks (104-156)|Death|0
7810316|NCT01172938|12273405|FG003|Active-Treatment Phase Weeks (104-156)|Death|0
7810317|NCT01172938|12273406|FG004|Active-Treatment Phase Weeks (104-156)|Death|0
7810318|NCT01172938|12273407|FG005|Active-Treatment Phase Weeks (104-156)|Death|0
7810319|NCT01172938|12273408|FG006|Active-Treatment Phase Weeks (104-156)|Death|0
7810320|NCT01172938|12273409|FG007|Active-Treatment Phase Weeks (104-156)|Death|1
7810321|NCT01172938|12273410|FG008|Active-Treatment Phase Weeks (104-156)|Death|0
7810322|NCT01172938|12273402|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7810323|NCT01172938|12273403|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
7810324|NCT01172938|12273404|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7883584|NCT01782872|12383299|FG001|Overall Study|Withdrawal by Subject|1
7810325|NCT01172938|12273405|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7810326|NCT01172938|12273406|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7810327|NCT01172938|12273407|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7810328|NCT01172938|12273408|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7810329|NCT01172938|12273409|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7810330|NCT01172938|12273410|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7810331|NCT01172938|12273402|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7810332|NCT01172938|12273403|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7810333|NCT01172938|12273404|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
7810334|NCT01172938|12273405|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7810335|NCT01172938|12273406|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7810336|NCT01172938|12273407|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7810337|NCT01172938|12273408|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7810338|NCT01172938|12273409|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7810339|NCT01172938|12273410|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7810340|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7810341|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
7810342|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
7810343|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7810344|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7810345|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7810346|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7810347|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
7810348|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7810349|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
7810350|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
7810351|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
7810352|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
7810353|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
7810354|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
7810355|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
7810356|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
7810357|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
7810358|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7810359|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
7810360|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
7810361|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7810362|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7810363|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7810364|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7810365|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
7810366|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
7810367|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7810368|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7810369|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
7810370|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7810371|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7810372|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7810373|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7810374|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7810375|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
7810376|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7810377|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7810378|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7810379|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7810380|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7810381|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7810382|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7810383|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
7810384|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7810385|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7810386|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7810387|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
7810388|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7810389|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7810390|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7810391|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7810392|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
7810393|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
7810394|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7810395|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7810396|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
7810397|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7810398|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7810399|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7810400|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7810401|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7810402|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7810403|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7810404|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
7810405|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7810406|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7810407|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7810408|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7810409|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7810410|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
7810411|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7810412|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7810413|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
7810414|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
7810415|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7810416|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7810417|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7810418|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7810419|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
7810420|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7810421|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0
7810422|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0
7810423|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1
7810424|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0
7810425|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0
7810426|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0
7810427|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0
7810428|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0
7810429|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0
7810430|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7810431|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7810432|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
7810433|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7810434|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7810435|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7810436|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7810437|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7810438|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7810439|NCT01172938|12273402|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7810440|NCT01172938|12273403|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7810441|NCT01172938|12273404|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7810442|NCT01172938|12273405|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7810443|NCT01172938|12273406|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7810444|NCT01172938|12273407|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7810445|NCT01172938|12273408|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7810446|NCT01172938|12273409|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7810447|NCT01172938|12273410|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
7810448|NCT01173055|12273452|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2
7810449|NCT01173055|12273453|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2
7810450|NCT01173055|12273452|FG000|Period 2 - Day 64 to 112|Adverse Event|0
7810451|NCT01173055|12273453|FG001|Period 2 - Day 64 to 112|Adverse Event|1
7810452|NCT01173120|12273459|FG000|Overall Study|Lack of Efficacy|2
7810453|NCT01173120|12273459|FG000|Overall Study|Lost to Follow-up|1
7810454|NCT01173120|12273459|FG000|Overall Study|Participant Decision|2
7810455|NCT01173120|12273459|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33
7810456|NCT01173120|12273459|FG000|Overall Study|Switch-Participant Decision|12
7810457|NCT01173120|12273459|FG000|Overall Study|Switch-Difficulty With Device|12
7810458|NCT01173471|12273498|FG000|Overall Study|Eligibility criteria not fulfilled|0
7810459|NCT01173471|12273499|FG001|Overall Study|Eligibility criteria not fulfilled|0
7810460|NCT01173471|12273500|FG002|Overall Study|Eligibility criteria not fulfilled|1
7810461|NCT01173471|12273501|FG003|Overall Study|Eligibility criteria not fulfilled|1
7810462|NCT01173471|12273498|FG000|Overall Study|Condition under investigation worsened|2
7887758|NCT01820585|12389541|FG000|Overall Study|Pregnancy|0
7810463|NCT01173471|12273499|FG001|Overall Study|Condition under investigation worsened|0
7810464|NCT01173471|12273500|FG002|Overall Study|Condition under investigation worsened|0
7810465|NCT01173471|12273501|FG003|Overall Study|Condition under investigation worsened|0
7810466|NCT01173471|12273498|FG000|Overall Study|Lost to Follow-up|0
7810467|NCT01173471|12273499|FG001|Overall Study|Lost to Follow-up|0
7810468|NCT01173471|12273500|FG002|Overall Study|Lost to Follow-up|1
7810469|NCT01173471|12273501|FG003|Overall Study|Lost to Follow-up|0
7810470|NCT01173471|12273498|FG000|Overall Study|Reason given as Other|0
7810471|NCT01173471|12273499|FG001|Overall Study|Reason given as Other|0
7810472|NCT01173471|12273500|FG002|Overall Study|Reason given as Other|1
7810473|NCT01173471|12273501|FG003|Overall Study|Reason given as Other|0
7810474|NCT01173523|12273513|FG000|Overall Study|Clinical Progression|1
7810475|NCT01173523|12273514|FG001|Overall Study|Clinical Progression|1
7810476|NCT01173523|12273513|FG000|Overall Study|Progressive Disease|10
7810477|NCT01173523|12273514|FG001|Overall Study|Progressive Disease|8
7810478|NCT01173523|12273513|FG000|Overall Study|Other|2
7810479|NCT01173523|12273514|FG001|Overall Study|Other|3
7810480|NCT01173601|12273524|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
7810481|NCT01173601|12273525|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7810482|NCT01173601|12273526|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7810483|NCT01173601|12273527|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7810484|NCT01173601|12273528|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7810485|NCT01173601|12273524|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
7810486|NCT01173601|12273525|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7810487|NCT01173601|12273526|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7810488|NCT01173601|12273527|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7810489|NCT01173601|12273528|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7810490|NCT01173601|12273524|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
7810491|NCT01173601|12273525|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7810492|NCT01173601|12273526|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7810493|NCT01173601|12273527|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7810494|NCT01173601|12273528|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7810495|NCT01173601|12273524|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
7810496|NCT01173601|12273525|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7810497|NCT01173601|12273526|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7810498|NCT01173601|12273527|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7810499|NCT01173601|12273528|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7810500|NCT01173601|12273524|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
7810501|NCT01173601|12273525|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7810502|NCT01173601|12273526|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7810503|NCT01173601|12273527|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7810504|NCT01173601|12273528|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7810505|NCT01173601|12273524|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
7810506|NCT01173601|12273525|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7810507|NCT01173601|12273526|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7810508|NCT01173601|12273527|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7810509|NCT01173601|12273528|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7810510|NCT01173601|12273524|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
7810511|NCT01173601|12273525|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7810512|NCT01173601|12273526|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7810513|NCT01173601|12273527|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7810514|NCT01173601|12273528|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7810515|NCT01173601|12273524|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
7810516|NCT01173601|12273525|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
7810517|NCT01173601|12273526|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
7810518|NCT01173601|12273527|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
7810519|NCT01173601|12273528|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
7810520|NCT01173601|12273524|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
7810521|NCT01173601|12273525|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
7810522|NCT01173601|12273526|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
7810523|NCT01173601|12273527|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
7810524|NCT01173601|12273528|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
7810525|NCT01173601|12273524|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
7810526|NCT01173601|12273525|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
7810527|NCT01173601|12273526|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
7810528|NCT01173601|12273527|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
7810529|NCT01173601|12273528|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
7810530|NCT01173601|12273524|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7810531|NCT01173601|12273525|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
7810532|NCT01173601|12273526|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7810533|NCT01173601|12273527|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
7810534|NCT01173601|12273528|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
7810535|NCT01173601|12273524|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
7810536|NCT01173601|12273525|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
7810537|NCT01173601|12273526|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7810538|NCT01173601|12273527|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
7810539|NCT01173601|12273528|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7810540|NCT01173601|12273524|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
7810541|NCT01173601|12273525|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
7810542|NCT01173601|12273526|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
7810543|NCT01173601|12273527|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
7810544|NCT01173601|12273528|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
7810545|NCT01173601|12273524|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7810546|NCT01173601|12273525|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7810547|NCT01173601|12273526|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7810548|NCT01173601|12273527|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
7810549|NCT01173601|12273528|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
7810550|NCT01173653|12273548|FG000|Overall Study|Pts unwilling to provide follow-up|53
7810551|NCT01173653|12273549|FG001|Overall Study|Pts unwilling to provide follow-up|41
7810552|NCT01173679|12273555|FG000|Overall Study|Death|1
7810553|NCT01173692|12273562|FG000|Overall Study|Adverse Event|1
7810554|NCT01173692|12273563|FG001|Overall Study|Adverse Event|2
7810555|NCT01173692|12273562|FG000|Overall Study|Withdrawal by Subject|1
7810556|NCT01173692|12273563|FG001|Overall Study|Withdrawal by Subject|3
7810557|NCT01173718|12273569|FG000|Overall Study|Death|17
7810558|NCT01173718|12273569|FG000|Overall Study|Abandonment of study graft|27
7810559|NCT01174004|12273592|FG000|Overall Study|Adverse Event|2
7810560|NCT01174004|12273593|FG001|Overall Study|Adverse Event|10
7810561|NCT01174004|12273592|FG000|Overall Study|Withdrawal by Subject|2
7810562|NCT01174004|12273593|FG001|Overall Study|Withdrawal by Subject|3
7810563|NCT01174004|12273592|FG000|Overall Study|At Discretion of Sponsor|2
7810564|NCT01174004|12273593|FG001|Overall Study|At Discretion of Sponsor|2
7810565|NCT01174004|12273592|FG000|Overall Study|Protocol Violation|0
7810566|NCT01174004|12273593|FG001|Overall Study|Protocol Violation|1
7810567|NCT01174004|12273592|FG000|Overall Study|Physician Decision|1
7810568|NCT01174004|12273593|FG001|Overall Study|Physician Decision|0
7810569|NCT01174043|12273620|FG000|Overall Study|Disease progression|5
7810570|NCT01174043|12273620|FG000|Overall Study|Adverse Event|3
7810571|NCT01174043|12273620|FG000|Overall Study|Death|1
7810572|NCT01174043|12273620|FG000|Overall Study|Withdrawal by Subject|2
7810573|NCT01174160|12273635|FG000|Overall Study|Adverse Event|1
7810574|NCT01174160|12273636|FG001|Overall Study|Adverse Event|0
7810575|NCT01174160|12273635|FG000|Overall Study|Lost to Follow-up|1
7810576|NCT01174160|12273636|FG001|Overall Study|Lost to Follow-up|0
7810577|NCT01174160|12273635|FG000|Overall Study|Physician Decision|1
7810578|NCT01174160|12273636|FG001|Overall Study|Physician Decision|0
7810579|NCT01174160|12273635|FG000|Overall Study|Protocol Violation|4
7810580|NCT01174160|12273636|FG001|Overall Study|Protocol Violation|6
7810581|NCT01174160|12273635|FG000|Overall Study|Withdrawal by Subject|1
7810582|NCT01174160|12273636|FG001|Overall Study|Withdrawal by Subject|0
7810583|NCT01174173|12273642|FG000|Overall Study|drug-drug interaction|1
7810584|NCT01174186|12273649|FG000|Overall Study|Lost to Follow-up|0
7810585|NCT01174186|12273650|FG001|Overall Study|Lost to Follow-up|1
7810586|NCT01174186|12273649|FG000|Overall Study|Withdrawal by Subject|0
7810587|NCT01174186|12273650|FG001|Overall Study|Withdrawal by Subject|2
7810588|NCT01174238|12273656|FG000|Overall Study|Lost to Follow-up|2
7810589|NCT01174264|12273666|FG000|Single Dose Pharmacokinetics|Early progressive disease|1
7810590|NCT01174264|12273667|FG001|Single Dose Pharmacokinetics|Early progressive disease|0
7810591|NCT01174264|12273668|FG002|Single Dose Pharmacokinetics|Early progressive disease|1
7810592|NCT01174264|12273666|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0
7810593|NCT01174264|12273667|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0
7810594|NCT01174264|12273668|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1
7810595|NCT01174264|12273666|FG000|Steady-state Pharmacokinetics|Not evaluable|6
7810596|NCT01174264|12273667|FG001|Steady-state Pharmacokinetics|Not evaluable|0
7810597|NCT01174264|12273668|FG002|Steady-state Pharmacokinetics|Not evaluable|2
7810598|NCT01174342|12273676|FG000|Overall Study|Conversion to cesarean section|4
7810599|NCT01174446|12273680|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
7810600|NCT01174446|12273681|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
7810601|NCT01174446|12273682|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
7810602|NCT01174446|12273683|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
7810603|NCT01174446|12273680|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
7810604|NCT01174446|12273681|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
7810605|NCT01174446|12273682|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
7810606|NCT01174446|12273683|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
7810607|NCT01174446|12273680|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
7810608|NCT01174446|12273681|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
7810609|NCT01174446|12273682|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
7810610|NCT01174446|12273683|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
7810611|NCT01174446|12273680|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
7810612|NCT01174446|12273681|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
7810613|NCT01174446|12273682|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
7810614|NCT01174446|12273683|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
7810615|NCT01174459|12273730|FG000|Overall Study|case report form (CRF) not collected|5
7810616|NCT01174550|12273736|FG000|Overall Study|Death|75
7810617|NCT01174550|12273737|FG001|Overall Study|Death|74
7810618|NCT01174550|12273736|FG000|Overall Study|Lost to Follow-up|652
7810619|NCT01174550|12273737|FG001|Overall Study|Lost to Follow-up|510
7810620|NCT01174550|12273736|FG000|Overall Study|Withdrawal by Subject|543
7810621|NCT01174550|12273737|FG001|Overall Study|Withdrawal by Subject|289
7810622|NCT01174784|12273756|FG000|Overall Study|Screen fails|4
7810623|NCT01175018|12273777|FG000|Overall Study|Adverse Event|3
7810624|NCT01175018|12273778|FG001|Overall Study|Adverse Event|1
7810625|NCT01175083|12273800|FG000|Primary Epoch|Withdrawal by Subject|0
7810626|NCT01175083|12273801|FG001|Primary Epoch|Withdrawal by Subject|0
7810627|NCT01175083|12273802|FG002|Primary Epoch|Withdrawal by Subject|0
7810628|NCT01175083|12273803|FG003|Primary Epoch|Withdrawal by Subject|0
7810629|NCT01175083|12273804|FG004|Primary Epoch|Withdrawal by Subject|0
7810630|NCT01175083|12273805|FG005|Primary Epoch|Withdrawal by Subject|2
7810631|NCT01175083|12273800|FG000|Primary Epoch|Lost to Follow-up|0
7810632|NCT01175083|12273801|FG001|Primary Epoch|Lost to Follow-up|0
7810633|NCT01175083|12273802|FG002|Primary Epoch|Lost to Follow-up|0
7810634|NCT01175083|12273803|FG003|Primary Epoch|Lost to Follow-up|0
7810635|NCT01175083|12273804|FG004|Primary Epoch|Lost to Follow-up|0
7810636|NCT01175083|12273805|FG005|Primary Epoch|Lost to Follow-up|1
7810637|NCT01175083|12273800|FG000|Booster Epoch|Death|0
7810638|NCT01175083|12273801|FG001|Booster Epoch|Death|0
7810639|NCT01175083|12273802|FG002|Booster Epoch|Death|1
7810640|NCT01175083|12273803|FG003|Booster Epoch|Death|0
7810641|NCT01175083|12273804|FG004|Booster Epoch|Death|0
7810642|NCT01175083|12273805|FG005|Booster Epoch|Death|0
7810643|NCT01175083|12273800|FG000|Booster Epoch|Withdrawal by Subject|0
7810644|NCT01175083|12273801|FG001|Booster Epoch|Withdrawal by Subject|0
7810645|NCT01175083|12273802|FG002|Booster Epoch|Withdrawal by Subject|0
7810646|NCT01175083|12273803|FG003|Booster Epoch|Withdrawal by Subject|1
7810647|NCT01175083|12273804|FG004|Booster Epoch|Withdrawal by Subject|0
7810648|NCT01175083|12273805|FG005|Booster Epoch|Withdrawal by Subject|0
7810649|NCT01175135|12273827|FG000|Overall Study|Adverse Event|2
7810650|NCT01175135|12273828|FG001|Overall Study|Adverse Event|5
7810651|NCT01175135|12273829|FG002|Overall Study|Adverse Event|3
7810652|NCT01175135|12273830|FG003|Overall Study|Adverse Event|4
7810653|NCT01175135|12273827|FG000|Overall Study|Death|1
7810654|NCT01175135|12273828|FG001|Overall Study|Death|0
7810655|NCT01175135|12273829|FG002|Overall Study|Death|0
7810656|NCT01175135|12273830|FG003|Overall Study|Death|0
7810657|NCT01175135|12273827|FG000|Overall Study|Lack of Efficacy|4
7810658|NCT01175135|12273828|FG001|Overall Study|Lack of Efficacy|5
7810659|NCT01175135|12273829|FG002|Overall Study|Lack of Efficacy|0
7810660|NCT01175135|12273830|FG003|Overall Study|Lack of Efficacy|5
7810661|NCT01175135|12273827|FG000|Overall Study|Lost to Follow-up|1
7810662|NCT01175135|12273828|FG001|Overall Study|Lost to Follow-up|2
7810663|NCT01175135|12273829|FG002|Overall Study|Lost to Follow-up|0
7810664|NCT01175135|12273830|FG003|Overall Study|Lost to Follow-up|0
7810665|NCT01175135|12273827|FG000|Overall Study|Protocol Violation|1
7810666|NCT01175135|12273828|FG001|Overall Study|Protocol Violation|1
7810667|NCT01175135|12273829|FG002|Overall Study|Protocol Violation|0
7810668|NCT01175135|12273830|FG003|Overall Study|Protocol Violation|0
7810669|NCT01175135|12273827|FG000|Overall Study|Withdrawal by Subject|4
7810670|NCT01175135|12273828|FG001|Overall Study|Withdrawal by Subject|8
7810671|NCT01175135|12273829|FG002|Overall Study|Withdrawal by Subject|5
7810672|NCT01175135|12273830|FG003|Overall Study|Withdrawal by Subject|5
7810673|NCT01175135|12273827|FG000|Overall Study|Other|3
7810674|NCT01175135|12273828|FG001|Overall Study|Other|1
7810675|NCT01175135|12273829|FG002|Overall Study|Other|3
7810676|NCT01175135|12273830|FG003|Overall Study|Other|0
7810677|NCT01175135|12273827|FG000|Overall Study|Randomized But Not Treated|0
7810678|NCT01175135|12273828|FG001|Overall Study|Randomized But Not Treated|0
7810679|NCT01175135|12273829|FG002|Overall Study|Randomized But Not Treated|1
7810680|NCT01175135|12273830|FG003|Overall Study|Randomized But Not Treated|0
7810681|NCT01175213|12273852|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
7810682|NCT01175213|12273853|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
7810683|NCT01175213|12273852|FG000|IGSC, 10%/rHuPH20|Death|1
7810684|NCT01175213|12273853|FG001|IGSC, 10%/rHuPH20|Death|0
7810685|NCT01175213|12273852|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1
7810686|NCT01175213|12273853|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0
7810687|NCT01175213|12273852|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
7810688|NCT01175213|12273853|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
7810689|NCT01175213|12273852|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3
7810690|NCT01175213|12273853|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0
7810691|NCT01175213|12273852|FG000|Safety Follow-up|Adverse Event|1
7810692|NCT01175213|12273853|FG001|Safety Follow-up|Adverse Event|0
7810693|NCT01175382|12273896|FG000|Overall Study|Lost to Follow-up|4
7810694|NCT01175382|12273897|FG001|Overall Study|Lost to Follow-up|3
7810695|NCT01175382|12273898|FG002|Overall Study|Lost to Follow-up|1
7810696|NCT01175382|12273896|FG000|Overall Study|Physician Decision|0
7810697|NCT01175382|12273897|FG001|Overall Study|Physician Decision|1
7810698|NCT01175382|12273898|FG002|Overall Study|Physician Decision|0
7810699|NCT01175382|12273896|FG000|Overall Study|Withdrawal by Subject|0
7810700|NCT01175382|12273897|FG001|Overall Study|Withdrawal by Subject|0
7810701|NCT01175382|12273898|FG002|Overall Study|Withdrawal by Subject|1
7810702|NCT01175382|12273896|FG000|Overall Study|No longer having problem|1
7810703|NCT01175382|12273897|FG001|Overall Study|No longer having problem|0
7810704|NCT01175382|12273898|FG002|Overall Study|No longer having problem|1
7810705|NCT01175382|12273896|FG000|Overall Study|Unable/unwilling to attend visits|3
7810706|NCT01175382|12273897|FG001|Overall Study|Unable/unwilling to attend visits|1
7810707|NCT01175382|12273898|FG002|Overall Study|Unable/unwilling to attend visits|2
7810708|NCT01175382|12273896|FG000|Overall Study|Unwilling to follow protocol|0
7810709|NCT01175382|12273897|FG001|Overall Study|Unwilling to follow protocol|1
7810710|NCT01175382|12273898|FG002|Overall Study|Unwilling to follow protocol|0
7810711|NCT01175382|12273896|FG000|Overall Study|Unable to tolerate study meds|0
7810712|NCT01175382|12273897|FG001|Overall Study|Unable to tolerate study meds|1
7810713|NCT01175382|12273898|FG002|Overall Study|Unable to tolerate study meds|1
7810714|NCT01175473|12273921|FG000|Overall Study|Adverse Event|2
7810715|NCT01175473|12273922|FG001|Overall Study|Adverse Event|2
7810716|NCT01175590|12273930|FG000|Overall Study|Lost to Follow-up|1
7810717|NCT01175590|12273931|FG001|Overall Study|Lost to Follow-up|0
7810718|NCT01175590|12273930|FG000|Overall Study|Withdrawal by Subject|0
7810719|NCT01175590|12273931|FG001|Overall Study|Withdrawal by Subject|2
7810720|NCT01175590|12273930|FG000|Overall Study|Adverse Event|4
7810721|NCT01175590|12273931|FG001|Overall Study|Adverse Event|0
7810722|NCT01175590|12273930|FG000|Overall Study|Physician Decision|1
7887759|NCT01820585|12389542|FG001|Overall Study|Pregnancy|1
7887760|NCT01820585|12389543|FG002|Overall Study|Pregnancy|0
7887761|NCT01820585|12389544|FG003|Overall Study|Pregnancy|0
7887762|NCT01820637|12389554|FG000|Overall Study|Death|2
7887763|NCT01820637|12389554|FG000|Overall Study|Withdrawal by Subject|1
7887764|NCT01821118|12389568|FG000|Overall Study|Death|0
7887765|NCT01821118|12389569|FG001|Overall Study|Death|1
7887766|NCT01821391|12389623|FG000|Overall Study|Adverse Event|1
7887767|NCT01821391|12389624|FG001|Overall Study|Adverse Event|0
7887768|NCT01821560|12389647|FG000|Overall Study|Lost to Follow-up|5
7887769|NCT01821560|12389648|FG001|Overall Study|Lost to Follow-up|5
7887770|NCT01821560|12389647|FG000|Overall Study|Withdrawal by Subject|1
7887771|NCT01821560|12389648|FG001|Overall Study|Withdrawal by Subject|1
7887772|NCT01821560|12389647|FG000|Overall Study|Protocol Violation|0
7887773|NCT01821560|12389648|FG001|Overall Study|Protocol Violation|1
7887774|NCT01821625|12389654|FG000|Overall Study|Withdrawal by Subject|2
7887775|NCT01821625|12389654|FG000|Overall Study|Lack of Efficacy|2
7887776|NCT01821625|12389654|FG000|Overall Study|Adverse Event|1
7887777|NCT01821625|12389654|FG000|Overall Study|Medical contraindication|1
7887778|NCT01821729|12389658|FG000|Overall Study|Withdrawal by Subject|1
7887779|NCT01821807|12389664|FG000|Overall Study|Lost to Follow-up|3
7887780|NCT01821807|12389665|FG001|Overall Study|Lost to Follow-up|1
7887781|NCT01821937|12389673|FG000|Overall Study|Adverse Event|0
7887782|NCT01821937|12389674|FG001|Overall Study|Adverse Event|3
7887783|NCT01822132|12389688|FG000|Overall Study|Lost to Follow-up|4
7887784|NCT01822132|12389689|FG001|Overall Study|Lost to Follow-up|2
7887785|NCT01822223|12389707|FG000|Overall Study|Death|0
7887786|NCT01822223|12389708|FG001|Overall Study|Death|1
7887787|NCT01822353|12389729|FG000|Overall Study|Adverse Event|1
7887788|NCT01822353|12389730|FG001|Overall Study|Adverse Event|3
7887789|NCT01822353|12389731|FG002|Overall Study|Adverse Event|1
7887790|NCT01822353|12389729|FG000|Overall Study|Pregnancy|0
7887791|NCT01822353|12389730|FG001|Overall Study|Pregnancy|1
7887792|NCT01822353|12389731|FG002|Overall Study|Pregnancy|0
7887793|NCT01822353|12389729|FG000|Overall Study|Withdrawal by Subject|3
7887794|NCT01822353|12389730|FG001|Overall Study|Withdrawal by Subject|1
7887795|NCT01822353|12389731|FG002|Overall Study|Withdrawal by Subject|0
7887796|NCT01822366|12389746|FG000|Overall Study|Lost to Follow-up|5
7887797|NCT01822366|12389747|FG001|Overall Study|Lost to Follow-up|1
7968195|NCT04074161|12525796|FG000|Overall Study|Withdrawal by Subject|2
7887798|NCT01822366|12389748|FG002|Overall Study|Lost to Follow-up|5
7887799|NCT01822366|12389749|FG003|Overall Study|Lost to Follow-up|1
7887800|NCT01822366|12389746|FG000|Overall Study|Withdrawal by Subject|0
7968196|NCT04074161|12525797|FG001|Overall Study|Withdrawal by Subject|4
7887801|NCT01822366|12389747|FG001|Overall Study|Withdrawal by Subject|6
7887802|NCT01822366|12389748|FG002|Overall Study|Withdrawal by Subject|0
7968197|NCT04074161|12525798|FG002|Overall Study|Withdrawal by Subject|1
7887803|NCT01822366|12389749|FG003|Overall Study|Withdrawal by Subject|6
7887804|NCT01822366|12389746|FG000|Overall Study|Partial Intervention Completion|0
7887805|NCT01822366|12389747|FG001|Overall Study|Partial Intervention Completion|15
7887806|NCT01822366|12389748|FG002|Overall Study|Partial Intervention Completion|0
7887807|NCT01822366|12389749|FG003|Overall Study|Partial Intervention Completion|15
7887808|NCT01822496|12389790|FG000|Overall Study|Protocol Violation|2
7887809|NCT01822496|12389791|FG001|Overall Study|Protocol Violation|2
7887810|NCT01822496|12389792|FG002|Overall Study|Protocol Violation|0
7887811|NCT01822496|12389793|FG003|Overall Study|Protocol Violation|1
7810723|NCT01175590|12273931|FG001|Overall Study|Physician Decision|4
7810724|NCT01175590|12273930|FG000|Overall Study|Lack of Efficacy|1
7810725|NCT01175590|12273931|FG001|Overall Study|Lack of Efficacy|1
7887812|NCT01822496|12389790|FG000|Overall Study|Withdrawal by Subject|0
7810726|NCT01175590|12273930|FG000|Overall Study|Residual Bacterial Conjunctivitis|1
7810727|NCT01175590|12273931|FG001|Overall Study|Residual Bacterial Conjunctivitis|0
7810728|NCT01175590|12273930|FG000|Overall Study|Treated not as randomized|3
7810729|NCT01175590|12273931|FG001|Overall Study|Treated not as randomized|2
7810730|NCT01175590|12273930|FG000|Overall Study|Herpes Simplex Dermatitis|1
7810731|NCT01175590|12273931|FG001|Overall Study|Herpes Simplex Dermatitis|0
7810732|NCT01175590|12273930|FG000|Overall Study|Protocol Violation|0
7810733|NCT01175590|12273931|FG001|Overall Study|Protocol Violation|1
7810734|NCT01175668|12273940|FG000|Overall Study|Withdrawal by Subject|2
7810735|NCT01175668|12273941|FG001|Overall Study|Withdrawal by Subject|0
7810736|NCT01175707|12273949|FG000|Overall Study|Adverse Event|4
7810737|NCT01175707|12273950|FG001|Overall Study|Adverse Event|6
7810738|NCT01175811|12273968|FG000|Overall Study|Adverse Event|1
7810739|NCT01175811|12273969|FG001|Overall Study|Adverse Event|1
7810740|NCT01175811|12273968|FG000|Overall Study|Entry criteria not met|3
7810741|NCT01175811|12273969|FG001|Overall Study|Entry criteria not met|1
7810742|NCT01175811|12273968|FG000|Overall Study|Lack of Efficacy|1
7810743|NCT01175811|12273969|FG001|Overall Study|Lack of Efficacy|0
7810744|NCT01175811|12273968|FG000|Overall Study|Lost to Follow-up|3
7810745|NCT01175811|12273969|FG001|Overall Study|Lost to Follow-up|2
7810746|NCT01175811|12273968|FG000|Overall Study|Physician Decision|1
7810747|NCT01175811|12273969|FG001|Overall Study|Physician Decision|1
7810748|NCT01175811|12273968|FG000|Overall Study|Protocol Violation|1
7810749|NCT01175811|12273969|FG001|Overall Study|Protocol Violation|2
7810750|NCT01175811|12273968|FG000|Overall Study|Withdrawal by Subject|6
7810751|NCT01175811|12273969|FG001|Overall Study|Withdrawal by Subject|7
7810752|NCT01175824|12273977|FG000|Overall Study|Adverse Event|2
7810753|NCT01175824|12273978|FG001|Overall Study|Adverse Event|1
7810754|NCT01175824|12273977|FG000|Overall Study|Lack of Efficacy|2
7810755|NCT01175824|12273978|FG001|Overall Study|Lack of Efficacy|0
7810756|NCT01175824|12273977|FG000|Overall Study|Lost to Follow-up|0
7810757|NCT01175824|12273978|FG001|Overall Study|Lost to Follow-up|1
7810758|NCT01175824|12273977|FG000|Overall Study|Physician Decision|0
7810759|NCT01175824|12273978|FG001|Overall Study|Physician Decision|4
7810760|NCT01175824|12273977|FG000|Overall Study|Protocol Violation|2
7810761|NCT01175824|12273978|FG001|Overall Study|Protocol Violation|5
7810762|NCT01175824|12273977|FG000|Overall Study|Withdrawal by Subject|3
7810763|NCT01175824|12273978|FG001|Overall Study|Withdrawal by Subject|7
7810764|NCT01175824|12273977|FG000|Overall Study|Sponsor Decision|1
7810765|NCT01175824|12273978|FG001|Overall Study|Sponsor Decision|0
7810766|NCT01175824|12273977|FG000|Overall Study|Entry Criteria Not Met|6
7810767|NCT01175824|12273978|FG001|Overall Study|Entry Criteria Not Met|4
7861833|NCT01597245|12351196|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861834|NCT01597245|12351197|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861835|NCT01597245|12351198|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861836|NCT01597245|12351199|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861837|NCT01597245|12351200|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861838|NCT01597245|12351201|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861839|NCT01597245|12351202|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861840|NCT01597245|12351203|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861841|NCT01597245|12351204|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861842|NCT01597245|12351205|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861843|NCT01597245|12351206|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861844|NCT01597245|12351207|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861845|NCT01597245|12351208|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7861846|NCT01597245|12351188|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861847|NCT01597245|12351189|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861848|NCT01597245|12351190|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861849|NCT01597245|12351191|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861850|NCT01597245|12351192|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861851|NCT01597245|12351193|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1
7861852|NCT01597245|12351194|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1
7861853|NCT01597245|12351195|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861854|NCT01597245|12351196|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861855|NCT01597245|12351197|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861856|NCT01597245|12351198|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861857|NCT01597245|12351199|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861858|NCT01597245|12351200|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861859|NCT01597245|12351201|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861860|NCT01597245|12351202|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861861|NCT01597245|12351203|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861862|NCT01597245|12351204|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861863|NCT01597245|12351205|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861864|NCT01597245|12351206|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861865|NCT01597245|12351207|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7883585|NCT01782872|12383300|FG002|Overall Study|Withdrawal by Subject|0
7810768|NCT01176032|12274011|FG000|Overall Study|Adverse Event|1
7810769|NCT01176032|12274012|FG001|Overall Study|Adverse Event|0
7810770|NCT01176032|12274011|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7810771|NCT01176032|12274012|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7810772|NCT01176032|12274011|FG000|Overall Study|Protocol Violation|1
7810773|NCT01176032|12274012|FG001|Overall Study|Protocol Violation|0
7810774|NCT01176032|12274011|FG000|Overall Study|Informed consent withdrawn|3
7810775|NCT01176032|12274012|FG001|Overall Study|Informed consent withdrawn|0
7810776|NCT01176032|12274011|FG000|Overall Study|Other|1
7810777|NCT01176032|12274012|FG001|Overall Study|Other|0
7810778|NCT01176058|12274025|FG000|Overall Study|Adverse Event|1
7810779|NCT01176058|12274026|FG001|Overall Study|Adverse Event|0
7810780|NCT01176058|12274025|FG000|Overall Study|Insufficient clinical response|2
7810781|NCT01176058|12274026|FG001|Overall Study|Insufficient clinical response|2
7810782|NCT01176058|12274025|FG000|Overall Study|Insufficient mycological response|0
7810783|NCT01176058|12274026|FG001|Overall Study|Insufficient mycological response|1
7810784|NCT01176058|12274025|FG000|Overall Study|Withdrawal by Subject|1
7810785|NCT01176058|12274026|FG001|Overall Study|Withdrawal by Subject|0
7810786|NCT01176240|12274036|FG000|Study 306A|Lack of Efficacy|2
7810787|NCT01176240|12274037|FG001|Study 306A|Lack of Efficacy|1
7810788|NCT01176240|12274036|FG000|Study 306A|Protocol Violation|0
7810789|NCT01176240|12274037|FG001|Study 306A|Protocol Violation|1
7810790|NCT01176240|12274036|FG000|Study 306A|Withdrawal by Subject|0
7810791|NCT01176240|12274037|FG001|Study 306A|Withdrawal by Subject|1
7810792|NCT01176240|12274036|FG000|Study 306A|Stop due to diverse problems|1
7810793|NCT01176240|12274037|FG001|Study 306A|Stop due to diverse problems|0
7810794|NCT01176240|12274036|FG000|Study 306B|Lack of Efficacy|5
7810795|NCT01176240|12274037|FG001|Study 306B|Lack of Efficacy|3
7810796|NCT01176240|12274036|FG000|Study 306B|Adverse Event|10
7810797|NCT01176240|12274037|FG001|Study 306B|Adverse Event|5
7810798|NCT01176240|12274036|FG000|Study 306B|Protocol Violation|2
7810799|NCT01176240|12274037|FG001|Study 306B|Protocol Violation|3
7810800|NCT01176240|12274036|FG000|Study 306B|Withdrawal by Subject|4
7810801|NCT01176240|12274037|FG001|Study 306B|Withdrawal by Subject|1
7810802|NCT01176240|12274036|FG000|Study 306B|Physician Decision|2
7810803|NCT01176240|12274037|FG001|Study 306B|Physician Decision|1
7810804|NCT01176240|12274036|FG000|Study 306B|Supine Hypertension|1
7810805|NCT01176240|12274037|FG001|Study 306B|Supine Hypertension|2
7810806|NCT01176240|12274036|FG000|Study 306B|Lost to Follow-up|0
7810807|NCT01176240|12274037|FG001|Study 306B|Lost to Follow-up|1
7810808|NCT01176240|12274036|FG000|Study 306B|withdrew prior to dosing|2
7810809|NCT01176240|12274037|FG001|Study 306B|withdrew prior to dosing|1
7810810|NCT01176266|12274043|FG000|Overall Study|Death|6
7810811|NCT01176266|12274043|FG000|Overall Study|Withdrawal by Subject|3
7810812|NCT01176292|12274053|FG000|Overall Study|Lost to Follow-up|2
7810813|NCT01176292|12274054|FG001|Overall Study|Lost to Follow-up|4
7810814|NCT01176292|12274053|FG000|Overall Study|Adverse Event|1
7810815|NCT01176292|12274054|FG001|Overall Study|Adverse Event|1
7810816|NCT01176292|12274053|FG000|Overall Study|Physician Decision|0
7810817|NCT01176292|12274054|FG001|Overall Study|Physician Decision|2
7810818|NCT01176292|12274053|FG000|Overall Study|Has not scheduled one-year visit yet|2
7810819|NCT01176292|12274054|FG001|Overall Study|Has not scheduled one-year visit yet|2
7810820|NCT01176565|12274083|FG000|Overall Study|Lost to Follow-up|12
7810821|NCT01176565|12274084|FG001|Overall Study|Lost to Follow-up|16
7810822|NCT01176565|12274083|FG000|Overall Study|Withdrawal by Subject|7
7810823|NCT01176565|12274084|FG001|Overall Study|Withdrawal by Subject|1
7810824|NCT01176565|12274083|FG000|Overall Study|Not Analyzed (any other reason)|1
7810825|NCT01176565|12274084|FG001|Overall Study|Not Analyzed (any other reason)|2
7810826|NCT01176773|12274113|FG000|Overall Study|Screen Failure|2
7887813|NCT01822496|12389791|FG001|Overall Study|Withdrawal by Subject|0
7887814|NCT01822496|12389792|FG002|Overall Study|Withdrawal by Subject|0
7887815|NCT01822496|12389793|FG003|Overall Study|Withdrawal by Subject|3
7887816|NCT01822535|12389805|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
7887817|NCT01822535|12389806|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
7887818|NCT01822535|12389805|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
7887819|NCT01822535|12389806|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
7887820|NCT01822535|12389805|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
7887821|NCT01822535|12389806|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
7887822|NCT01822561|12389824|FG000|Overall Study|Withdrawal by Subject|2
7887823|NCT01822587|12389848|FG000|Overall Study|Lost to Follow-up|7
7887824|NCT01822587|12389849|FG001|Overall Study|Lost to Follow-up|9
7887825|NCT01822587|12389850|FG002|Overall Study|Lost to Follow-up|12
7887826|NCT01822587|12389848|FG000|Overall Study|Physician Decision|9
7887827|NCT01822587|12389849|FG001|Overall Study|Physician Decision|6
7887828|NCT01822587|12389850|FG002|Overall Study|Physician Decision|6
7887829|NCT01822665|12389858|FG000|Overall Study|Adverse Event|3
7887830|NCT01822665|12389858|FG000|Overall Study|Other Reason|5
7887831|NCT01822678|12389879|FG000|Overall Study|Withdrawal by Subject|5
7810827|NCT01176773|12274113|FG000|Overall Study|Withdrew consent|1
7810828|NCT01176916|12274123|FG000|Overall Study|Adverse Event|61
7810829|NCT01176916|12274123|FG000|Overall Study|Death|1
7810830|NCT01176916|12274123|FG000|Overall Study|Lost to Follow-up|15
7810831|NCT01176916|12274123|FG000|Overall Study|Objective progression or relapse|17
7810832|NCT01176916|12274123|FG000|Overall Study|Protocol Violation|24
7810833|NCT01176916|12274123|FG000|Overall Study|Withdrawal by Subject|37
7810834|NCT01176916|12274123|FG000|Overall Study|Other|6
7810835|NCT01176916|12274123|FG000|Overall Study|Withdrawal prior to Treatment|6
7810836|NCT01176968|12274141|FG000|Overall Study|Adverse Event|10
7810837|NCT01176968|12274142|FG001|Overall Study|Adverse Event|11
7810838|NCT01176968|12274141|FG000|Overall Study|Death|2
7810839|NCT01176968|12274142|FG001|Overall Study|Death|3
7810840|NCT01176968|12274141|FG000|Overall Study|Lack of Efficacy|0
7810841|NCT01176968|12274142|FG001|Overall Study|Lack of Efficacy|1
7810842|NCT01176968|12274141|FG000|Overall Study|Lost to Follow-up|16
7810843|NCT01176968|12274142|FG001|Overall Study|Lost to Follow-up|14
7810844|NCT01176968|12274141|FG000|Overall Study|Withdrawal by Subject|48
7810845|NCT01176968|12274142|FG001|Overall Study|Withdrawal by Subject|48
7810846|NCT01176968|12274141|FG000|Overall Study|Protocol Violation|2
7810847|NCT01176968|12274142|FG001|Overall Study|Protocol Violation|1
7810848|NCT01176968|12274141|FG000|Overall Study|Did Not Meet Entrance Criteria|1
7810849|NCT01176968|12274142|FG001|Overall Study|Did Not Meet Entrance Criteria|0
7810850|NCT01176968|12274141|FG000|Overall Study|Study terminated by sponsor|0
7810851|NCT01176968|12274142|FG001|Overall Study|Study terminated by sponsor|1
7810852|NCT01176968|12274141|FG000|Overall Study|Reason not defined|5
7810853|NCT01176968|12274142|FG001|Overall Study|Reason not defined|3
7810854|NCT01177007|12274152|FG000|Overall Study|Lost to Follow-up|2
7810855|NCT01177007|12274152|FG000|Overall Study|Death|4
7810856|NCT01177007|12274152|FG000|Overall Study|Entered hospice care|5
7810857|NCT01177007|12274152|FG000|Overall Study|Required additional Y90 treatment|6
7810858|NCT01177007|12274152|FG000|Overall Study|Change in treatment modality|21
7810859|NCT01177059|12274158|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
7810860|NCT01177059|12274158|FG000|Overall Study|Withdrew consent|2
7810861|NCT01177059|12274158|FG000|Overall Study|Lost to Follow-up|18
7810862|NCT01177137|12274174|FG000|Overall Study|Withdrawal by Subject|10
7810863|NCT01177137|12274175|FG001|Overall Study|Withdrawal by Subject|10
7810864|NCT01177137|12274176|FG002|Overall Study|Withdrawal by Subject|2
7810865|NCT01177228|12274200|FG000|Overall Study|Positive tuberculosis test|0
7810866|NCT01177228|12274201|FG001|Overall Study|Positive tuberculosis test|1
7810867|NCT01177228|12274202|FG002|Overall Study|Positive tuberculosis test|0
7810868|NCT01177228|12274203|FG003|Overall Study|Positive tuberculosis test|0
7810869|NCT01177228|12274200|FG000|Overall Study|Worsening disease activity|1
7810870|NCT01177228|12274201|FG001|Overall Study|Worsening disease activity|0
7810871|NCT01177228|12274202|FG002|Overall Study|Worsening disease activity|0
7810872|NCT01177228|12274203|FG003|Overall Study|Worsening disease activity|0
7810873|NCT01177228|12274200|FG000|Overall Study|Withdrawal by Subject|0
7810874|NCT01177228|12274201|FG001|Overall Study|Withdrawal by Subject|1
7810875|NCT01177228|12274202|FG002|Overall Study|Withdrawal by Subject|0
7810876|NCT01177228|12274203|FG003|Overall Study|Withdrawal by Subject|0
7810877|NCT01177293|12274218|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0
7810878|NCT01177293|12274219|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1
7810879|NCT01177384|12274227|FG000|Overall Study|Adverse Event|6
7810880|NCT01177384|12274228|FG001|Overall Study|Adverse Event|4
7810881|NCT01177384|12274227|FG000|Overall Study|Lack of Efficacy|0
7810882|NCT01177384|12274228|FG001|Overall Study|Lack of Efficacy|1
7810883|NCT01177384|12274227|FG000|Overall Study|Lost to Follow-up|3
7810884|NCT01177384|12274228|FG001|Overall Study|Lost to Follow-up|4
7810885|NCT01177384|12274227|FG000|Overall Study|Physician Decision|0
7810886|NCT01177384|12274228|FG001|Overall Study|Physician Decision|3
7810887|NCT01177384|12274227|FG000|Overall Study|Protocol Violation|0
7810888|NCT01177384|12274228|FG001|Overall Study|Protocol Violation|2
7810889|NCT01177384|12274227|FG000|Overall Study|Withdrawal by Subject|5
7810890|NCT01177384|12274228|FG001|Overall Study|Withdrawal by Subject|12
7810891|NCT01177410|12274237|FG000|Overall Study|Adverse Event|0
7810892|NCT01177410|12274238|FG001|Overall Study|Adverse Event|2
7810893|NCT01177410|12274239|FG002|Overall Study|Adverse Event|2
7810894|NCT01177410|12274237|FG000|Overall Study|Withdrawal by Subject|1
7810895|NCT01177410|12274238|FG001|Overall Study|Withdrawal by Subject|4
7810896|NCT01177410|12274239|FG002|Overall Study|Withdrawal by Subject|3
7810897|NCT01177410|12274237|FG000|Overall Study|Lost to Follow-up|0
7810898|NCT01177410|12274238|FG001|Overall Study|Lost to Follow-up|1
7810899|NCT01177410|12274239|FG002|Overall Study|Lost to Follow-up|0
7810900|NCT01177553|12274249|FG000|Overall Study|babies not yet 6 months of age|1
7810901|NCT01177553|12274250|FG001|Overall Study|babies not yet 6 months of age|0
7810902|NCT01177670|12274256|FG000|Overall Study|Study Terminated|115
7810903|NCT01177670|12274256|FG000|Overall Study|Physician Decision|50
7810904|NCT01177670|12274256|FG000|Overall Study|Withdrawal by Subject|4
7810905|NCT01177722|12274268|FG000|Overall Study|Serious Adverse Event|0
7810906|NCT01177722|12274269|FG001|Overall Study|Serious Adverse Event|0
7810907|NCT01177722|12274270|FG002|Overall Study|Serious Adverse Event|1
7810908|NCT01177722|12274271|FG003|Overall Study|Serious Adverse Event|0
7810909|NCT01177722|12274268|FG000|Overall Study|Protocol Violation|0
7810910|NCT01177722|12274269|FG001|Overall Study|Protocol Violation|0
7810911|NCT01177722|12274270|FG002|Overall Study|Protocol Violation|1
7810912|NCT01177722|12274271|FG003|Overall Study|Protocol Violation|0
7810913|NCT01177722|12274268|FG000|Overall Study|Lost to Follow-up|3
7810914|NCT01177722|12274269|FG001|Overall Study|Lost to Follow-up|4
7810915|NCT01177722|12274270|FG002|Overall Study|Lost to Follow-up|3
7810916|NCT01177722|12274271|FG003|Overall Study|Lost to Follow-up|1
7810917|NCT01177722|12274268|FG000|Overall Study|Withdrawal by Subject|10
7810918|NCT01177722|12274269|FG001|Overall Study|Withdrawal by Subject|6
7810919|NCT01177722|12274270|FG002|Overall Study|Withdrawal by Subject|4
7810920|NCT01177722|12274271|FG003|Overall Study|Withdrawal by Subject|6
7810921|NCT01177787|12274286|FG000|Cryolipolysis on Thigh|Protocol Violation|4
7810922|NCT01177787|12274286|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9
7810923|NCT01177787|12274286|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1
7810924|NCT01177800|12274300|FG000|Overall Study|Adverse Event|9
7810925|NCT01177800|12274301|FG001|Overall Study|Adverse Event|3
7810926|NCT01177800|12274300|FG000|Overall Study|Protocol Violation|0
7810927|NCT01177800|12274301|FG001|Overall Study|Protocol Violation|1
7810928|NCT01177800|12274300|FG000|Overall Study|Physician Decision|1
7810929|NCT01177800|12274301|FG001|Overall Study|Physician Decision|0
7810930|NCT01177800|12274300|FG000|Overall Study|Withdrawal of informed consent|0
7810931|NCT01177800|12274301|FG001|Overall Study|Withdrawal of informed consent|1
7810932|NCT01177813|12274312|FG000|Overall Study|Adverse Event|8
7810933|NCT01177813|12274313|FG001|Overall Study|Adverse Event|2
7810934|NCT01177813|12274314|FG002|Overall Study|Adverse Event|4
7810935|NCT01177813|12274315|FG003|Overall Study|Adverse Event|6
7810936|NCT01177813|12274316|FG004|Overall Study|Adverse Event|3
7810937|NCT01177813|12274312|FG000|Overall Study|Lack of Efficacy|1
7810938|NCT01177813|12274313|FG001|Overall Study|Lack of Efficacy|0
7810939|NCT01177813|12274314|FG002|Overall Study|Lack of Efficacy|0
7810940|NCT01177813|12274315|FG003|Overall Study|Lack of Efficacy|0
7810941|NCT01177813|12274316|FG004|Overall Study|Lack of Efficacy|0
7810942|NCT01177813|12274312|FG000|Overall Study|Protocol Violation|3
7810943|NCT01177813|12274313|FG001|Overall Study|Protocol Violation|2
7810944|NCT01177813|12274314|FG002|Overall Study|Protocol Violation|2
7810945|NCT01177813|12274315|FG003|Overall Study|Protocol Violation|0
7810946|NCT01177813|12274316|FG004|Overall Study|Protocol Violation|1
7810947|NCT01177813|12274312|FG000|Overall Study|Lost to Follow-up|12
7810948|NCT01177813|12274313|FG001|Overall Study|Lost to Follow-up|5
7810949|NCT01177813|12274314|FG002|Overall Study|Lost to Follow-up|6
7810950|NCT01177813|12274315|FG003|Overall Study|Lost to Follow-up|3
7810951|NCT01177813|12274316|FG004|Overall Study|Lost to Follow-up|0
7810952|NCT01177813|12274312|FG000|Overall Study|Withdrawal by Subject|12
7810953|NCT01177813|12274313|FG001|Overall Study|Withdrawal by Subject|7
7810954|NCT01177813|12274314|FG002|Overall Study|Withdrawal by Subject|6
7810955|NCT01177813|12274315|FG003|Overall Study|Withdrawal by Subject|5
7810956|NCT01177813|12274316|FG004|Overall Study|Withdrawal by Subject|3
7810957|NCT01177813|12274312|FG000|Overall Study|Other reason not defined above|5
7810958|NCT01177813|12274313|FG001|Overall Study|Other reason not defined above|2
7810959|NCT01177813|12274314|FG002|Overall Study|Other reason not defined above|2
7810960|NCT01177813|12274315|FG003|Overall Study|Other reason not defined above|3
7810961|NCT01177813|12274316|FG004|Overall Study|Other reason not defined above|2
7810962|NCT01177943|12274330|FG000|First Intervention|Withdrawal by Subject|2
7810963|NCT01177943|12274331|FG001|First Intervention|Withdrawal by Subject|0
7810964|NCT01177969|12274344|FG000|Overall Study|Protocol Violation|2
7810965|NCT01177969|12274345|FG001|Overall Study|Protocol Violation|1
7810966|NCT01177969|12274344|FG000|Overall Study|Withdrawal by Subject|1
7810967|NCT01177969|12274345|FG001|Overall Study|Withdrawal by Subject|2
7810968|NCT01178073|12274354|FG000|Overall Study|Adverse Event|34
7810969|NCT01178073|12274355|FG001|Overall Study|Adverse Event|27
7810970|NCT01178073|12274356|FG002|Overall Study|Adverse Event|24
7810971|NCT01178073|12274354|FG000|Overall Study|Protocol Violation|1
7810972|NCT01178073|12274355|FG001|Overall Study|Protocol Violation|1
7810973|NCT01178073|12274356|FG002|Overall Study|Protocol Violation|1
7810974|NCT01178073|12274354|FG000|Overall Study|Lost to Follow-up|2
7810975|NCT01178073|12274355|FG001|Overall Study|Lost to Follow-up|0
7810976|NCT01178073|12274356|FG002|Overall Study|Lost to Follow-up|3
7810977|NCT01178073|12274354|FG000|Overall Study|Physician Decision|14
7810978|NCT01178073|12274355|FG001|Overall Study|Physician Decision|10
7810979|NCT01178073|12274356|FG002|Overall Study|Physician Decision|10
7810980|NCT01178073|12274354|FG000|Overall Study|Withdrawal by Subject|10
7810981|NCT01178073|12274355|FG001|Overall Study|Withdrawal by Subject|6
7810982|NCT01178073|12274356|FG002|Overall Study|Withdrawal by Subject|8
7810983|NCT01178073|12274354|FG000|Overall Study|Missing Completion Status|1
7810984|NCT01178073|12274355|FG001|Overall Study|Missing Completion Status|0
7810985|NCT01178073|12274356|FG002|Overall Study|Missing Completion Status|0
7810986|NCT01178086|12274367|FG000|Overall Study|Participant refusal|7
7810987|NCT01178086|12274367|FG000|Overall Study|Physician Decision|44
7810988|NCT01178086|12274367|FG000|Overall Study|Switch to other CLL therapy|113
7810989|NCT01178086|12274367|FG000|Overall Study|Death|59
7810990|NCT01178086|12274367|FG000|Overall Study|Other unspecified|89
7810991|NCT01178086|12274367|FG000|Overall Study|Excluded from EAS|20
7810992|NCT01178099|12274377|FG000|Overall Study|Physician Decision|0
7810993|NCT01178099|12274378|FG001|Overall Study|Physician Decision|1
7810994|NCT01178125|12274388|FG000|Overall Study|Lost to Follow-up|397
7810995|NCT01178125|12274388|FG000|Overall Study|Adverse Event|244
7810996|NCT01178125|12274388|FG000|Overall Study|Withdrawal by Subject|209
7810997|NCT01178125|12274388|FG000|Overall Study|Noncompliance|184
7810998|NCT01178125|12274388|FG000|Overall Study|Pregnancy|55
7810999|NCT01178125|12274388|FG000|Overall Study|Other Reason|39
7811000|NCT01178125|12274388|FG000|Overall Study|Sponsor Decision|28
7811001|NCT01178125|12274388|FG000|Overall Study|Protocol Violation|17
7811002|NCT01178125|12274388|FG000|Overall Study|Investigator Decision|5
7811003|NCT01178138|12274397|FG000|Overall Study|Lost to Follow-up|8
7811004|NCT01178138|12274397|FG000|Overall Study|Withdrawal by Subject|7
7811005|NCT01178138|12274397|FG000|Overall Study|Physician Decision|8
7811006|NCT01178294|12274434|FG000|Overall Study|Adverse Event|4
7811007|NCT01178294|12274434|FG000|Overall Study|Lost to Follow-up|2
7811008|NCT01178294|12274434|FG000|Overall Study|Lack of Efficacy|1
7811009|NCT01178294|12274434|FG000|Overall Study|Death|1
7811010|NCT01178294|12274434|FG000|Overall Study|Development of inhibitors to OBI-1|1
7811011|NCT01178294|12274434|FG000|Overall Study|Subject status is terminal|1
7811012|NCT01178294|12274434|FG000|Overall Study|Completion status could not be verified|1
7811013|NCT01178385|12274455|FG000|Overall Study|Withdrawal by Subject|2
7811014|NCT01178385|12274456|FG001|Overall Study|Withdrawal by Subject|0
7811015|NCT01178411|12274462|FG000|Overall Study|Adverse Event|5
7811016|NCT01178411|12274462|FG000|Overall Study|Withdrawal by Subject|4
7811017|NCT01178411|12274462|FG000|Overall Study|Protocol Violation|1
7811018|NCT01178411|12274462|FG000|Overall Study|Progressive disease per RECIST|32
7811019|NCT01178411|12274462|FG000|Overall Study|Progressive disease per clinician|9
7811020|NCT01178411|12274462|FG000|Overall Study|Physician Decision|6
7811021|NCT01178411|12274462|FG000|Overall Study|Death|1
7811022|NCT01178411|12274462|FG000|Overall Study|No reason provided|1
7811023|NCT01178411|12274462|FG000|Overall Study|Drug manufacturing ended|1
7811024|NCT01178671|12274482|FG000|Overall Study|Adverse Event|4
7811025|NCT01178671|12274483|FG001|Overall Study|Adverse Event|6
7811026|NCT01178671|12274482|FG000|Overall Study|Protocol Violation|1
7811027|NCT01178671|12274483|FG001|Overall Study|Protocol Violation|1
7811028|NCT01178671|12274482|FG000|Overall Study|Lack of Efficacy|0
7811029|NCT01178671|12274483|FG001|Overall Study|Lack of Efficacy|1
7811030|NCT01178671|12274482|FG000|Overall Study|Lost to Follow-up|3
7811031|NCT01178671|12274483|FG001|Overall Study|Lost to Follow-up|1
7811032|NCT01178671|12274482|FG000|Overall Study|Physician Decision|4
7811033|NCT01178671|12274483|FG001|Overall Study|Physician Decision|6
7811034|NCT01178762|12274489|FG000|Overall Study|Lost to Follow-up|15
7811035|NCT01178853|12274508|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1
7811036|NCT01178853|12274509|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2
7811037|NCT01178853|12274508|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
7811038|NCT01178853|12274509|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
7811039|NCT01178853|12274508|FG000|Period 3 (Warfarin Titration)|Adverse Event|1
7811040|NCT01178853|12274509|FG001|Period 3 (Warfarin Titration)|Adverse Event|0
7811041|NCT01178853|12274508|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0
7811042|NCT01178853|12274509|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2
7811043|NCT01178853|12274508|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
7811044|NCT01178853|12274509|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
7811045|NCT01179048|12274521|FG000|Overall Study|Withdrawn - does not allow contact|4
7811046|NCT01179048|12274522|FG001|Overall Study|Withdrawn - does not allow contact|8
7811047|NCT01179048|12274521|FG000|Overall Study|Lost to Follow-up|8
7811048|NCT01179048|12274522|FG001|Overall Study|Lost to Follow-up|9
7811049|NCT01179048|12274521|FG000|Overall Study|Alive|127
7811050|NCT01179048|12274522|FG001|Overall Study|Alive|142
7811051|NCT01179191|12274537|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47
7811052|NCT01179191|12274537|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
7811053|NCT01179191|12274537|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30
7811054|NCT01179191|12274537|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
7811055|NCT01179191|12274537|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
7811056|NCT01179191|12274537|FG000|Titration Phase (up to 6 Weeks)|Other|62
7811057|NCT01179191|12274537|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10
7811058|NCT01179191|12274537|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
7811059|NCT01179191|12274537|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3
7811060|NCT01179191|12274537|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
7811061|NCT01179191|12274537|FG000|Maintenance Phase (8 Weeks)|Other|66
7811062|NCT01179334|12274554|FG000|Treatment Period|Adverse Event|1
7811063|NCT01179334|12274555|FG001|Treatment Period|Adverse Event|0
7811064|NCT01179334|12274554|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6
7811065|NCT01179334|12274555|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2
7811066|NCT01179334|12274554|FG000|Long-term Extension (LTE) Period|Death|3
7811067|NCT01179334|12274555|FG001|Long-term Extension (LTE) Period|Death|0
7811068|NCT01179334|12274554|FG000|Long-term Extension (LTE) Period|Adverse Event|2
7811069|NCT01179334|12274555|FG001|Long-term Extension (LTE) Period|Adverse Event|4
7811070|NCT01179347|12274563|FG000|Double-blind Period (12 Weeks)|Adverse Event|2
7811071|NCT01179347|12274564|FG001|Double-blind Period (12 Weeks)|Adverse Event|6
7811072|NCT01179347|12274563|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2
7811073|NCT01179347|12274564|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0
7811074|NCT01179347|12274563|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1
7811075|NCT01179347|12274564|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2
7811076|NCT01179347|12274563|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
7811077|NCT01179347|12274564|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
7811078|NCT01179347|12274563|FG000|Double-blind Period (12 Weeks)|Other|2
7811079|NCT01179347|12274564|FG001|Double-blind Period (12 Weeks)|Other|4
7811080|NCT01179347|12274563|FG000|Open-label Period (12 Weeks)|Adverse Event|5
7811081|NCT01179347|12274564|FG001|Open-label Period (12 Weeks)|Adverse Event|9
7811082|NCT01179347|12274563|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0
7811083|NCT01179347|12274564|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2
7811084|NCT01179347|12274563|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1
7811085|NCT01179347|12274564|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0
7811086|NCT01179347|12274563|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1
7811087|NCT01179347|12274564|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1
7717646|NCT00520975|12141289|FG000|Overall Study|Disease progression|31
7717647|NCT00520975|12141290|FG001|Overall Study|Disease progression|23
7717648|NCT00520975|12141289|FG000|Overall Study|Adverse Event|7
7717649|NCT00520975|12141290|FG001|Overall Study|Adverse Event|10
7811088|NCT01179347|12274563|FG000|Open-label Period (12 Weeks)|Protocol Violation|1
7811089|NCT01179347|12274564|FG001|Open-label Period (12 Weeks)|Protocol Violation|0
7811090|NCT01179347|12274563|FG000|Open-label Period (12 Weeks)|Other|7
7811091|NCT01179347|12274564|FG001|Open-label Period (12 Weeks)|Other|4
7811092|NCT01179477|12274572|FG000|Overall Study|Death|542
7811093|NCT01179477|12274572|FG000|Overall Study|Unsuccessful implant|80
7811094|NCT01179477|12274572|FG000|Overall Study|Non-death withdrawal|438
7811095|NCT01179477|12274572|FG000|Overall Study|Did not complete final visit|27
7811096|NCT01179516|12274583|FG000|Overall Study|Pretreatment Event or Adverse Event|6
7811097|NCT01179516|12274584|FG001|Overall Study|Pretreatment Event or Adverse Event|8
7811098|NCT01179516|12274585|FG002|Overall Study|Pretreatment Event or Adverse Event|12
7811099|NCT01179516|12274583|FG000|Overall Study|Lack of Efficacy|4
7811100|NCT01179516|12274584|FG001|Overall Study|Lack of Efficacy|2
7811101|NCT01179516|12274585|FG002|Overall Study|Lack of Efficacy|0
7811102|NCT01179516|12274583|FG000|Overall Study|Noncompliance with Study Drug|2
7811103|NCT01179516|12274584|FG001|Overall Study|Noncompliance with Study Drug|0
7811104|NCT01179516|12274585|FG002|Overall Study|Noncompliance with Study Drug|1
7811105|NCT01179516|12274583|FG000|Overall Study|Protocol Deviations|4
7811106|NCT01179516|12274584|FG001|Overall Study|Protocol Deviations|3
7811107|NCT01179516|12274585|FG002|Overall Study|Protocol Deviations|3
7811108|NCT01179516|12274583|FG000|Overall Study|Withdrawal of Consent|2
7811109|NCT01179516|12274584|FG001|Overall Study|Withdrawal of Consent|6
7811110|NCT01179516|12274585|FG002|Overall Study|Withdrawal of Consent|10
7811111|NCT01179516|12274583|FG000|Overall Study|Lost to Follow-up|7
7811112|NCT01179516|12274584|FG001|Overall Study|Lost to Follow-up|7
7811113|NCT01179516|12274585|FG002|Overall Study|Lost to Follow-up|3
7811114|NCT01179516|12274583|FG000|Overall Study|Other|2
7811115|NCT01179516|12274584|FG001|Overall Study|Other|0
7811116|NCT01179516|12274585|FG002|Overall Study|Other|2
7811117|NCT01179672|12274615|FG000|Overall Study|Adverse Event|17
7811118|NCT01179672|12274616|FG001|Overall Study|Adverse Event|8
7811119|NCT01179672|12274615|FG000|Overall Study|Withdrawal by Subject|10
7811120|NCT01179672|12274616|FG001|Overall Study|Withdrawal by Subject|12
7811121|NCT01179672|12274615|FG000|Overall Study|Entry Criteria Not Met|0
7811122|NCT01179672|12274616|FG001|Overall Study|Entry Criteria Not Met|2
7811123|NCT01179672|12274615|FG000|Overall Study|Lost to Follow-up|0
7811124|NCT01179672|12274616|FG001|Overall Study|Lost to Follow-up|1
7811125|NCT01179672|12274615|FG000|Overall Study|Protocol Violation|2
7811126|NCT01179672|12274616|FG001|Overall Study|Protocol Violation|2
7811127|NCT01179672|12274615|FG000|Overall Study|Physician Decision|1
7811128|NCT01179672|12274616|FG001|Overall Study|Physician Decision|1
7811129|NCT01179919|12274626|FG000|Overall Study|Protocol Violation|1
7811130|NCT01179919|12274626|FG000|Overall Study|Adverse Event|1
7811131|NCT01180049|12274648|FG000|Overall Study|Other|9
7811132|NCT01180049|12274649|FG001|Overall Study|Other|7
7811133|NCT01180049|12274648|FG000|Overall Study|Lost to Follow-up|8
7811134|NCT01180049|12274649|FG001|Overall Study|Lost to Follow-up|6
7811135|NCT01180049|12274648|FG000|Overall Study|Death|36
7811136|NCT01180049|12274649|FG001|Overall Study|Death|35
7811137|NCT01180244|12274678|FG000|Overall Study|Lack of Efficacy|0
7811138|NCT01180244|12274679|FG001|Overall Study|Lack of Efficacy|7
7811139|NCT01180244|12274678|FG000|Overall Study|Physician Decision|3
7811140|NCT01180244|12274679|FG001|Overall Study|Physician Decision|0
7811141|NCT01180244|12274678|FG000|Overall Study|Adverse Event|1
7811142|NCT01180244|12274679|FG001|Overall Study|Adverse Event|0
7811143|NCT01180244|12274678|FG000|Overall Study|Withdrawal by Subject|0
7811144|NCT01180244|12274679|FG001|Overall Study|Withdrawal by Subject|1
7811145|NCT01180244|12274678|FG000|Overall Study|Protocol Violation|1
7811146|NCT01180244|12274679|FG001|Overall Study|Protocol Violation|0
7811147|NCT01180244|12274678|FG000|Overall Study|Lost to Follow-up|1
7811148|NCT01180244|12274679|FG001|Overall Study|Lost to Follow-up|0
7811149|NCT01180296|12274687|FG000|Overall Study|Protocol Violation|1
7811150|NCT01180296|12274688|FG001|Overall Study|Protocol Violation|2
7811151|NCT01180400|12274698|FG000|Overall Study|Withdrawal by Subject|5
7811152|NCT01180400|12274699|FG001|Overall Study|Withdrawal by Subject|6
7811153|NCT01180400|12274698|FG000|Overall Study|Eligibility criteria not fulfilled|0
7811154|NCT01180400|12274699|FG001|Overall Study|Eligibility criteria not fulfilled|2
7811155|NCT01180400|12274698|FG000|Overall Study|Adverse Event|12
7811156|NCT01180400|12274699|FG001|Overall Study|Adverse Event|10
7811157|NCT01180400|12274698|FG000|Overall Study|Severe non-compliance to protocol|1
7811158|NCT01180400|12274699|FG001|Overall Study|Severe non-compliance to protocol|2
7811159|NCT01180400|12274698|FG000|Overall Study|Condition under investigation worsened|2
7883586|NCT01782872|12383301|FG003|Overall Study|Withdrawal by Subject|0
7811160|NCT01180400|12274699|FG001|Overall Study|Condition under investigation worsened|1
7811161|NCT01180400|12274698|FG000|Overall Study|Lack of Efficacy|2
7811162|NCT01180400|12274699|FG001|Overall Study|Lack of Efficacy|0
7811163|NCT01180400|12274698|FG000|Overall Study|Study-specific withdrawal criteria|1
7811164|NCT01180400|12274699|FG001|Overall Study|Study-specific withdrawal criteria|2
7811165|NCT01180400|12274698|FG000|Overall Study|Lost to Follow-up|2
7811166|NCT01180400|12274699|FG001|Overall Study|Lost to Follow-up|3
7811167|NCT01180400|12274698|FG000|Overall Study|Other|0
7811168|NCT01180400|12274699|FG001|Overall Study|Other|1
7811169|NCT01180647|12274718|FG000|Overall Study|Lost to Follow-up|5
7811170|NCT01180647|12274719|FG001|Overall Study|Lost to Follow-up|6
7811171|NCT01180660|12274727|FG000|Overall Study|Changed to open surgery|1
7811172|NCT01180660|12274728|FG001|Overall Study|Changed to open surgery|0
7811173|NCT01180777|12274734|FG000|Overall Study|Protocol Violation|6
7811174|NCT01180777|12274734|FG000|Overall Study|Poor lens fit|4
7811175|NCT01180777|12274734|FG000|Overall Study|Lost to Follow-up|1
7811176|NCT01180777|12274734|FG000|Overall Study|Adverse Event|1
7811177|NCT01180790|12274747|FG000|Overall Study|Adverse Event|1
7811178|NCT01180790|12274748|FG001|Overall Study|Adverse Event|1
7811179|NCT01180790|12274749|FG002|Overall Study|Adverse Event|2
7811180|NCT01180790|12274750|FG003|Overall Study|Adverse Event|0
7811181|NCT01180790|12274751|FG004|Overall Study|Adverse Event|1
7811182|NCT01180790|12274752|FG005|Overall Study|Adverse Event|3
7811183|NCT01180790|12274753|FG006|Overall Study|Adverse Event|0
7811184|NCT01180790|12274747|FG000|Overall Study|Withdrawal by Subject|3
7811185|NCT01180790|12274748|FG001|Overall Study|Withdrawal by Subject|0
7811186|NCT01180790|12274749|FG002|Overall Study|Withdrawal by Subject|5
7811187|NCT01180790|12274750|FG003|Overall Study|Withdrawal by Subject|0
7811188|NCT01180790|12274751|FG004|Overall Study|Withdrawal by Subject|2
7811189|NCT01180790|12274752|FG005|Overall Study|Withdrawal by Subject|1
7811190|NCT01180790|12274753|FG006|Overall Study|Withdrawal by Subject|0
7811191|NCT01180790|12274747|FG000|Overall Study|Lost to Follow-up|3
7811192|NCT01180790|12274748|FG001|Overall Study|Lost to Follow-up|1
7811193|NCT01180790|12274749|FG002|Overall Study|Lost to Follow-up|0
7811194|NCT01180790|12274750|FG003|Overall Study|Lost to Follow-up|2
7811195|NCT01180790|12274751|FG004|Overall Study|Lost to Follow-up|1
7811196|NCT01180790|12274752|FG005|Overall Study|Lost to Follow-up|0
7811197|NCT01180790|12274753|FG006|Overall Study|Lost to Follow-up|1
7811198|NCT01180790|12274747|FG000|Overall Study|Physician Decision|1
7811199|NCT01180790|12274748|FG001|Overall Study|Physician Decision|0
7811200|NCT01180790|12274749|FG002|Overall Study|Physician Decision|0
7811201|NCT01180790|12274750|FG003|Overall Study|Physician Decision|1
7811202|NCT01180790|12274751|FG004|Overall Study|Physician Decision|0
7811203|NCT01180790|12274752|FG005|Overall Study|Physician Decision|0
7811204|NCT01180790|12274753|FG006|Overall Study|Physician Decision|0
7811205|NCT01180790|12274747|FG000|Overall Study|Lack of Efficacy|1
7811206|NCT01180790|12274748|FG001|Overall Study|Lack of Efficacy|2
7811207|NCT01180790|12274749|FG002|Overall Study|Lack of Efficacy|5
7811208|NCT01180790|12274750|FG003|Overall Study|Lack of Efficacy|6
7811209|NCT01180790|12274751|FG004|Overall Study|Lack of Efficacy|1
7811210|NCT01180790|12274752|FG005|Overall Study|Lack of Efficacy|3
7811211|NCT01180790|12274753|FG006|Overall Study|Lack of Efficacy|0
7811212|NCT01180790|12274747|FG000|Overall Study|compliance|0
7811213|NCT01180790|12274748|FG001|Overall Study|compliance|1
7811214|NCT01180790|12274749|FG002|Overall Study|compliance|0
7811215|NCT01180790|12274750|FG003|Overall Study|compliance|0
7811216|NCT01180790|12274751|FG004|Overall Study|compliance|0
7811217|NCT01180790|12274752|FG005|Overall Study|compliance|0
7811218|NCT01180790|12274753|FG006|Overall Study|compliance|0
7811219|NCT01180790|12274747|FG000|Overall Study|Severe coronary atherosclerosis (death)|0
7811220|NCT01180790|12274748|FG001|Overall Study|Severe coronary atherosclerosis (death)|0
7811221|NCT01180790|12274749|FG002|Overall Study|Severe coronary atherosclerosis (death)|1
7811222|NCT01180790|12274750|FG003|Overall Study|Severe coronary atherosclerosis (death)|0
7811223|NCT01180790|12274751|FG004|Overall Study|Severe coronary atherosclerosis (death)|0
7811224|NCT01180790|12274752|FG005|Overall Study|Severe coronary atherosclerosis (death)|0
7811225|NCT01180790|12274753|FG006|Overall Study|Severe coronary atherosclerosis (death)|0
7811226|NCT01180985|12274808|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
7811227|NCT01180985|12274809|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
7811228|NCT01180998|12274819|FG000|Overall Study|Poor Vision|0
7811229|NCT01180998|12274820|FG001|Overall Study|Poor Vision|2
7811230|NCT01180998|12274821|FG002|Overall Study|Poor Vision|2
7811231|NCT01180998|12274819|FG000|Overall Study|Lost to Follow-up|0
7811232|NCT01180998|12274820|FG001|Overall Study|Lost to Follow-up|0
7811233|NCT01180998|12274821|FG002|Overall Study|Lost to Follow-up|1
7887832|NCT01822678|12389880|FG001|Overall Study|Withdrawal by Subject|4
7887833|NCT01822678|12389881|FG002|Overall Study|Withdrawal by Subject|4
7887834|NCT01822678|12389879|FG000|Overall Study|Adverse Event|4
7887835|NCT01822678|12389880|FG001|Overall Study|Adverse Event|3
7887836|NCT01822678|12389881|FG002|Overall Study|Adverse Event|1
7887837|NCT01822678|12389879|FG000|Overall Study|Lack of Efficacy|3
7887838|NCT01822678|12389880|FG001|Overall Study|Lack of Efficacy|6
7887839|NCT01822678|12389881|FG002|Overall Study|Lack of Efficacy|5
7887840|NCT01822678|12389879|FG000|Overall Study|Lost to Follow-up|0
7811234|NCT01180998|12274819|FG000|Overall Study|Protocol Violation|1
7811235|NCT01180998|12274820|FG001|Overall Study|Protocol Violation|2
7811236|NCT01180998|12274821|FG002|Overall Study|Protocol Violation|0
7887841|NCT01822678|12389880|FG001|Overall Study|Lost to Follow-up|2
7887842|NCT01822678|12389881|FG002|Overall Study|Lost to Follow-up|1
7887843|NCT01822691|12389889|FG000|Overall Study|Withdrawal by Subject|2
7887844|NCT01822756|12389898|FG000|Overall Study|Adverse Event|0
7887845|NCT01822756|12389899|FG001|Overall Study|Adverse Event|0
7887846|NCT01822756|12389900|FG002|Overall Study|Adverse Event|0
7887847|NCT01822756|12389901|FG003|Overall Study|Adverse Event|2
7887848|NCT01822756|12389902|FG004|Overall Study|Adverse Event|0
7887849|NCT01822756|12389898|FG000|Overall Study|Disease progression|11
7887850|NCT01822756|12389899|FG001|Overall Study|Disease progression|1
7887851|NCT01822756|12389900|FG002|Overall Study|Disease progression|7
7887852|NCT01822756|12389901|FG003|Overall Study|Disease progression|2
7887853|NCT01822756|12389902|FG004|Overall Study|Disease progression|6
7887854|NCT01822756|12389898|FG000|Overall Study|Death|2
7887855|NCT01822756|12389899|FG001|Overall Study|Death|2
7887856|NCT01822756|12389900|FG002|Overall Study|Death|1
7887857|NCT01822756|12389901|FG003|Overall Study|Death|0
7887858|NCT01822756|12389902|FG004|Overall Study|Death|0
7887859|NCT01822756|12389898|FG000|Overall Study|Lost to Follow-up|1
7887860|NCT01822756|12389899|FG001|Overall Study|Lost to Follow-up|0
7887861|NCT01822756|12389900|FG002|Overall Study|Lost to Follow-up|1
7887862|NCT01822756|12389901|FG003|Overall Study|Lost to Follow-up|0
7887863|NCT01822756|12389902|FG004|Overall Study|Lost to Follow-up|1
7887864|NCT01822756|12389898|FG000|Overall Study|Physician Decision|0
7887865|NCT01822756|12389899|FG001|Overall Study|Physician Decision|1
7887866|NCT01822756|12389900|FG002|Overall Study|Physician Decision|0
7887867|NCT01822756|12389901|FG003|Overall Study|Physician Decision|0
7887868|NCT01822756|12389902|FG004|Overall Study|Physician Decision|0
7887869|NCT01822756|12389898|FG000|Overall Study|disease progression & patient preference|2
7887870|NCT01822756|12389899|FG001|Overall Study|disease progression & patient preference|0
7887871|NCT01822756|12389900|FG002|Overall Study|disease progression & patient preference|1
7887872|NCT01822756|12389901|FG003|Overall Study|disease progression & patient preference|0
7887873|NCT01822756|12389902|FG004|Overall Study|disease progression & patient preference|0
7887874|NCT01822821|12389916|FG000|Overall Study|Eligible surgery cancelled|1
7887875|NCT01822821|12389917|FG001|Overall Study|Eligible surgery cancelled|1
7887876|NCT01822821|12389916|FG000|Overall Study|Other reasons|1
7887877|NCT01822821|12389917|FG001|Overall Study|Other reasons|0
7887878|NCT01822899|12389929|FG000|Overall Study|Adverse Event|6
7887879|NCT01822899|12389930|FG001|Overall Study|Adverse Event|5
7887880|NCT01822899|12389929|FG000|Overall Study|Lack of Efficacy|6
7887881|NCT01822899|12389930|FG001|Overall Study|Lack of Efficacy|3
7887882|NCT01822899|12389929|FG000|Overall Study|Protocol Violation|6
7887883|NCT01822899|12389930|FG001|Overall Study|Protocol Violation|3
7887884|NCT01822899|12389929|FG000|Overall Study|Lost to Follow-up|1
7887885|NCT01822899|12389930|FG001|Overall Study|Lost to Follow-up|0
7887886|NCT01822899|12389929|FG000|Overall Study|Withdrawal by Subject|5
7887887|NCT01822899|12389930|FG001|Overall Study|Withdrawal by Subject|7
7887888|NCT01822925|12389940|FG000|Overall Study|Adverse Event|1
7887889|NCT01822925|12389941|FG001|Overall Study|Adverse Event|1
7887890|NCT01822925|12389942|FG002|Overall Study|Adverse Event|1
7887891|NCT01822925|12389943|FG003|Overall Study|Adverse Event|1
7887892|NCT01822925|12389940|FG000|Overall Study|Lost to Follow-up|0
7887893|NCT01822925|12389941|FG001|Overall Study|Lost to Follow-up|1
7887894|NCT01822925|12389942|FG002|Overall Study|Lost to Follow-up|0
7887895|NCT01822925|12389943|FG003|Overall Study|Lost to Follow-up|0
7887896|NCT01822925|12389940|FG000|Overall Study|Protocol Violation|1
7887897|NCT01822925|12389941|FG001|Overall Study|Protocol Violation|0
7887898|NCT01822925|12389942|FG002|Overall Study|Protocol Violation|0
7887899|NCT01822925|12389943|FG003|Overall Study|Protocol Violation|1
7887900|NCT01822925|12389940|FG000|Overall Study|Withdrawal by Subject|2
7887901|NCT01822925|12389941|FG001|Overall Study|Withdrawal by Subject|0
7887902|NCT01822925|12389942|FG002|Overall Study|Withdrawal by Subject|2
7887903|NCT01822925|12389943|FG003|Overall Study|Withdrawal by Subject|2
7887904|NCT01822925|12389940|FG000|Overall Study|Taking prohibited medication|2
7887905|NCT01822925|12389941|FG001|Overall Study|Taking prohibited medication|0
7887906|NCT01822925|12389942|FG002|Overall Study|Taking prohibited medication|0
7887907|NCT01822925|12389943|FG003|Overall Study|Taking prohibited medication|1
7887908|NCT01823107|12389953|FG000|Overall Study|Withdrawal by Subject|1
7887909|NCT01823146|12389959|FG000|Overall Study|Withdrawal by Subject|0
7887910|NCT01823146|12389960|FG001|Overall Study|Withdrawal by Subject|1
7887911|NCT01823146|12389959|FG000|Overall Study|Lost to Follow-up|2
7887912|NCT01823146|12389960|FG001|Overall Study|Lost to Follow-up|1
7887913|NCT01823224|12389968|FG000|Overall Study|Lost to Follow-up|5
7887914|NCT01823224|12389969|FG001|Overall Study|Lost to Follow-up|6
7887915|NCT01823224|12389968|FG000|Overall Study|didn't qualify|1
7887916|NCT01823224|12389969|FG001|Overall Study|didn't qualify|2
7887917|NCT01823224|12389968|FG000|Overall Study|pharmacy error|0
7887918|NCT01823224|12389969|FG001|Overall Study|pharmacy error|1
7887919|NCT01823224|12389968|FG000|Overall Study|missed med dose|0
7887920|NCT01823224|12389969|FG001|Overall Study|missed med dose|1
7887921|NCT01823224|12389968|FG000|Overall Study|Withdrawal by Subject|0
7887922|NCT01823224|12389969|FG001|Overall Study|Withdrawal by Subject|1
7887923|NCT01823289|12389977|FG000|Overall Study|Lost to Follow-up|5
7887924|NCT01823289|12389977|FG000|Overall Study|Adverse Event|5
7887925|NCT01823289|12389977|FG000|Overall Study|Lack of Efficacy|1
7887926|NCT01823289|12389977|FG000|Overall Study|Physician Decision|9
7887927|NCT01823289|12389977|FG000|Overall Study|Administered contraindicated medicine|1
7887928|NCT01823289|12389977|FG000|Overall Study|Transaminase increased more than 3 times|1
7887929|NCT01823289|12389977|FG000|Overall Study|Drug affected efficacy and safety|1
7887930|NCT01823289|12389977|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1
7887931|NCT01823328|12389983|FG000|Overall Study|Withdrawal by Subject|8
7887932|NCT01823328|12389984|FG001|Overall Study|Withdrawal by Subject|6
7887933|NCT01823341|12389990|FG000|Overall Study|Failed run-in|7
7887934|NCT01823341|12389990|FG000|Overall Study|Withdrawal by Subject|7
7887935|NCT01823341|12389990|FG000|Overall Study|Adverse Event|1
7887936|NCT01823536|12390019|FG000|Overall Study|Lost to Follow-up|1
7887937|NCT01823536|12390020|FG001|Overall Study|Lost to Follow-up|0
7887938|NCT01823536|12390021|FG002|Overall Study|Lost to Follow-up|0
7887939|NCT01823536|12390022|FG003|Overall Study|Lost to Follow-up|1
7887940|NCT01823536|12390023|FG004|Overall Study|Lost to Follow-up|1
7887941|NCT01823536|12390024|FG005|Overall Study|Lost to Follow-up|0
7887942|NCT01823536|12390019|FG000|Overall Study|Protocol Violation|0
7887943|NCT01823536|12390020|FG001|Overall Study|Protocol Violation|1
7887944|NCT01823536|12390021|FG002|Overall Study|Protocol Violation|0
7887945|NCT01823536|12390022|FG003|Overall Study|Protocol Violation|0
7887946|NCT01823536|12390023|FG004|Overall Study|Protocol Violation|0
7887947|NCT01823536|12390024|FG005|Overall Study|Protocol Violation|0
7887948|NCT01823536|12390019|FG000|Overall Study|Withdrawal by Subject|1
7887949|NCT01823536|12390020|FG001|Overall Study|Withdrawal by Subject|1
7887950|NCT01823536|12390021|FG002|Overall Study|Withdrawal by Subject|0
7887951|NCT01823536|12390022|FG003|Overall Study|Withdrawal by Subject|0
7887952|NCT01823536|12390023|FG004|Overall Study|Withdrawal by Subject|0
7887953|NCT01823536|12390024|FG005|Overall Study|Withdrawal by Subject|0
7887954|NCT01823536|12390019|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0
7887955|NCT01823536|12390020|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0
7887956|NCT01823536|12390021|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1
7887957|NCT01823536|12390022|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0
7887958|NCT01823536|12390023|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0
7887959|NCT01823536|12390024|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0
7887960|NCT01823536|12390019|FG000|Overall Study|Met exclusion criterion No 6|0
7887961|NCT01823536|12390020|FG001|Overall Study|Met exclusion criterion No 6|0
7717650|NCT00520975|12141289|FG000|Overall Study|Death|0
7717651|NCT00520975|12141290|FG001|Overall Study|Death|2
7717652|NCT00520975|12141289|FG000|Overall Study|Withdrawal by Subject|3
7717653|NCT00520975|12141290|FG001|Overall Study|Withdrawal by Subject|5
7717654|NCT00520975|12141289|FG000|Overall Study|Other therapy|2
7717655|NCT00520975|12141290|FG001|Overall Study|Other therapy|4
7717656|NCT00520975|12141289|FG000|Overall Study|Other reasons|4
7717657|NCT00520975|12141290|FG001|Overall Study|Other reasons|2
7717658|NCT00520975|12141289|FG000|Overall Study|Not start protocol therapy|1
7717659|NCT00520975|12141290|FG001|Overall Study|Not start protocol therapy|2
7717660|NCT00521001|12141296|FG000|Overall Study|Ineligible|1
7717661|NCT00521014|12141300|FG000|Overall Study|Inevaluable, not treated|1
7717662|NCT00521053|12141304|FG000|Observation Phase|Disease Progression|55
7717663|NCT00521053|12141304|FG000|Observation Phase|Additional PV-10 via alternate protocol|8
7717664|NCT00521053|12141304|FG000|Observation Phase|Death|2
7717665|NCT00521053|12141304|FG000|Observation Phase|Adverse Event|1
7717666|NCT00521053|12141304|FG000|Observation Phase|Other non-study melanoma treatment|1
7717667|NCT00521053|12141304|FG000|Observation Phase|Physician Decision|1
7717668|NCT00521079|12141313|FG000|Overall Study|Adverse Event|7
7717669|NCT00521079|12141314|FG001|Overall Study|Adverse Event|1
7717670|NCT00521079|12141313|FG000|Overall Study|Lost to Follow-up|2
7717671|NCT00521079|12141314|FG001|Overall Study|Lost to Follow-up|1
7717672|NCT00521079|12141313|FG000|Overall Study|Withdrawal by Subject|5
7717673|NCT00521079|12141314|FG001|Overall Study|Withdrawal by Subject|3
7717674|NCT00521144|12141325|FG000|Overall Study|Not Treated|0
7717675|NCT00521144|12141326|FG001|Overall Study|Not Treated|0
7717676|NCT00521144|12141327|FG002|Overall Study|Not Treated|0
7717677|NCT00521144|12141328|FG003|Overall Study|Not Treated|1
7717678|NCT00521144|12141329|FG004|Overall Study|Not Treated|0
7717679|NCT00521144|12141325|FG000|Overall Study|Adverse Event|0
7717680|NCT00521144|12141326|FG001|Overall Study|Adverse Event|1
7717681|NCT00521144|12141327|FG002|Overall Study|Adverse Event|0
7717682|NCT00521144|12141328|FG003|Overall Study|Adverse Event|0
7717683|NCT00521144|12141329|FG004|Overall Study|Adverse Event|1
7717684|NCT00521144|12141325|FG000|Overall Study|Progressive Disease|4
7717685|NCT00521144|12141326|FG001|Overall Study|Progressive Disease|2
7887962|NCT01823536|12390021|FG002|Overall Study|Met exclusion criterion No 6|0
7887963|NCT01823536|12390022|FG003|Overall Study|Met exclusion criterion No 6|1
7887964|NCT01823536|12390023|FG004|Overall Study|Met exclusion criterion No 6|0
7887965|NCT01823536|12390024|FG005|Overall Study|Met exclusion criterion No 6|0
7887966|NCT01823536|12390019|FG000|Overall Study|Subject moved out of the state|0
7717686|NCT00521144|12141327|FG002|Overall Study|Progressive Disease|2
7717687|NCT00521144|12141328|FG003|Overall Study|Progressive Disease|0
7717688|NCT00521144|12141329|FG004|Overall Study|Progressive Disease|6
7717689|NCT00521339|12141341|FG000|Treatment Phase|Adverse Event|2
7717690|NCT00521339|12141342|FG001|Treatment Phase|Adverse Event|0
7717691|NCT00521339|12141343|FG002|Treatment Phase|Adverse Event|0
7887967|NCT01823536|12390020|FG001|Overall Study|Subject moved out of the state|0
7887968|NCT01823536|12390021|FG002|Overall Study|Subject moved out of the state|0
7887969|NCT01823536|12390022|FG003|Overall Study|Subject moved out of the state|0
7887970|NCT01823536|12390023|FG004|Overall Study|Subject moved out of the state|1
7887971|NCT01823536|12390024|FG005|Overall Study|Subject moved out of the state|0
7887972|NCT01823679|12390075|FG000|Overall Study|Death|1
7887973|NCT01823835|12390095|FG000|Overall Study|Adverse Event|0
7887974|NCT01823835|12390096|FG001|Overall Study|Adverse Event|0
7887975|NCT01823835|12390097|FG002|Overall Study|Adverse Event|0
7887976|NCT01823835|12390098|FG003|Overall Study|Adverse Event|0
7887977|NCT01823835|12390099|FG004|Overall Study|Adverse Event|1
7887978|NCT01823835|12390100|FG005|Overall Study|Adverse Event|0
7887979|NCT01823835|12390101|FG006|Overall Study|Adverse Event|1
7887980|NCT01823835|12390102|FG007|Overall Study|Adverse Event|0
7887981|NCT01823835|12390103|FG008|Overall Study|Adverse Event|0
7887982|NCT01823835|12390104|FG009|Overall Study|Adverse Event|0
7887983|NCT01823835|12390105|FG010|Overall Study|Adverse Event|1
7887984|NCT01823835|12390106|FG011|Overall Study|Adverse Event|2
7887985|NCT01823835|12390107|FG012|Overall Study|Adverse Event|0
7887986|NCT01823835|12390108|FG013|Overall Study|Adverse Event|0
7887987|NCT01823835|12390109|FG014|Overall Study|Adverse Event|0
7887988|NCT01823835|12390095|FG000|Overall Study|Physician Decision|0
7887989|NCT01823835|12390096|FG001|Overall Study|Physician Decision|0
7887990|NCT01823835|12390097|FG002|Overall Study|Physician Decision|0
7887991|NCT01823835|12390098|FG003|Overall Study|Physician Decision|0
7887992|NCT01823835|12390099|FG004|Overall Study|Physician Decision|0
7887993|NCT01823835|12390100|FG005|Overall Study|Physician Decision|0
7887994|NCT01823835|12390101|FG006|Overall Study|Physician Decision|0
7887995|NCT01823835|12390102|FG007|Overall Study|Physician Decision|0
7887996|NCT01823835|12390103|FG008|Overall Study|Physician Decision|0
7887997|NCT01823835|12390104|FG009|Overall Study|Physician Decision|0
7887998|NCT01823835|12390105|FG010|Overall Study|Physician Decision|0
7887999|NCT01823835|12390106|FG011|Overall Study|Physician Decision|2
7888000|NCT01823835|12390107|FG012|Overall Study|Physician Decision|0
7888001|NCT01823835|12390108|FG013|Overall Study|Physician Decision|0
7888002|NCT01823835|12390109|FG014|Overall Study|Physician Decision|0
7888003|NCT01823835|12390095|FG000|Overall Study|Progressive Disease|3
7888004|NCT01823835|12390096|FG001|Overall Study|Progressive Disease|4
7888005|NCT01823835|12390097|FG002|Overall Study|Progressive Disease|3
7888006|NCT01823835|12390098|FG003|Overall Study|Progressive Disease|6
7888007|NCT01823835|12390099|FG004|Overall Study|Progressive Disease|4
7888008|NCT01823835|12390100|FG005|Overall Study|Progressive Disease|6
7888009|NCT01823835|12390101|FG006|Overall Study|Progressive Disease|5
7888010|NCT01823835|12390102|FG007|Overall Study|Progressive Disease|3
7888011|NCT01823835|12390103|FG008|Overall Study|Progressive Disease|3
7888012|NCT01823835|12390104|FG009|Overall Study|Progressive Disease|18
7888013|NCT01823835|12390105|FG010|Overall Study|Progressive Disease|8
7888014|NCT01823835|12390106|FG011|Overall Study|Progressive Disease|46
7888015|NCT01823835|12390107|FG012|Overall Study|Progressive Disease|18
7888016|NCT01823835|12390108|FG013|Overall Study|Progressive Disease|4
7888017|NCT01823835|12390109|FG014|Overall Study|Progressive Disease|6
7888018|NCT01823835|12390095|FG000|Overall Study|Study Termination|0
7888019|NCT01823835|12390096|FG001|Overall Study|Study Termination|0
7888020|NCT01823835|12390097|FG002|Overall Study|Study Termination|0
7888021|NCT01823835|12390098|FG003|Overall Study|Study Termination|0
7888022|NCT01823835|12390099|FG004|Overall Study|Study Termination|1
7888023|NCT01823835|12390100|FG005|Overall Study|Study Termination|0
7888024|NCT01823835|12390101|FG006|Overall Study|Study Termination|0
7888025|NCT01823835|12390102|FG007|Overall Study|Study Termination|0
7888026|NCT01823835|12390103|FG008|Overall Study|Study Termination|0
7888027|NCT01823835|12390104|FG009|Overall Study|Study Termination|0
7888028|NCT01823835|12390105|FG010|Overall Study|Study Termination|0
7888029|NCT01823835|12390106|FG011|Overall Study|Study Termination|1
7888030|NCT01823835|12390107|FG012|Overall Study|Study Termination|0
7888031|NCT01823835|12390108|FG013|Overall Study|Study Termination|0
7888032|NCT01823835|12390109|FG014|Overall Study|Study Termination|0
7888033|NCT01823835|12390095|FG000|Overall Study|Withdrawal by Subject|0
7888034|NCT01823835|12390096|FG001|Overall Study|Withdrawal by Subject|0
7888035|NCT01823835|12390097|FG002|Overall Study|Withdrawal by Subject|1
7888036|NCT01823835|12390098|FG003|Overall Study|Withdrawal by Subject|0
7888037|NCT01823835|12390099|FG004|Overall Study|Withdrawal by Subject|0
7888038|NCT01823835|12390100|FG005|Overall Study|Withdrawal by Subject|0
7888039|NCT01823835|12390101|FG006|Overall Study|Withdrawal by Subject|0
7888040|NCT01823835|12390102|FG007|Overall Study|Withdrawal by Subject|0
7888041|NCT01823835|12390103|FG008|Overall Study|Withdrawal by Subject|0
7888042|NCT01823835|12390104|FG009|Overall Study|Withdrawal by Subject|1
7968198|NCT04074161|12525796|FG000|Overall Study|Lost to Follow-up|4
7888043|NCT01823835|12390105|FG010|Overall Study|Withdrawal by Subject|1
7888044|NCT01823835|12390106|FG011|Overall Study|Withdrawal by Subject|2
7888045|NCT01823835|12390107|FG012|Overall Study|Withdrawal by Subject|1
7888046|NCT01823835|12390108|FG013|Overall Study|Withdrawal by Subject|0
7888047|NCT01823835|12390109|FG014|Overall Study|Withdrawal by Subject|0
7888048|NCT01823991|12390160|FG000|Overall Study|Withdrawal by Subject|8
7888049|NCT01823991|12390161|FG001|Overall Study|Withdrawal by Subject|5
7888050|NCT01824290|12390190|FG000|Period 1: Double Blind|Entry Criteria Not Met|1
7888051|NCT01824290|12390191|FG001|Period 1: Double Blind|Entry Criteria Not Met|0
7888052|NCT01824290|12390192|FG002|Period 1: Double Blind|Entry Criteria Not Met|0
7888053|NCT01824290|12390193|FG003|Period 1: Double Blind|Entry Criteria Not Met|0
7888054|NCT01824290|12390190|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1
7888055|NCT01824290|12390191|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1
7888056|NCT01824290|12390192|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0
7888057|NCT01824290|12390193|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0
7888058|NCT01824290|12390190|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1
7888059|NCT01824290|12390191|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1
7888060|NCT01824290|12390192|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0
7888061|NCT01824290|12390193|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0
7717692|NCT00521339|12141341|FG000|Treatment Phase|Intolerability to study drug|2
7717693|NCT00521339|12141342|FG001|Treatment Phase|Intolerability to study drug|0
7717694|NCT00521339|12141343|FG002|Treatment Phase|Intolerability to study drug|0
7717695|NCT00521339|12141341|FG000|Treatment Phase|Lack of Efficacy|3
7888062|NCT01824290|12390190|FG000|Period 2: Open-Label Treatment|Adverse Event|0
7888063|NCT01824290|12390191|FG001|Period 2: Open-Label Treatment|Adverse Event|0
7888064|NCT01824290|12390192|FG002|Period 2: Open-Label Treatment|Adverse Event|0
7717696|NCT00521339|12141342|FG001|Treatment Phase|Lack of Efficacy|0
7717697|NCT00521339|12141343|FG002|Treatment Phase|Lack of Efficacy|0
7717698|NCT00521339|12141341|FG000|Treatment Phase|Withdrawal by Subject|3
7717699|NCT00521339|12141342|FG001|Treatment Phase|Withdrawal by Subject|0
7717700|NCT00521339|12141343|FG002|Treatment Phase|Withdrawal by Subject|0
7717701|NCT00521339|12141341|FG000|Treatment Phase|Lost to Follow-up|1
7717702|NCT00521339|12141342|FG001|Treatment Phase|Lost to Follow-up|0
7717703|NCT00521339|12141343|FG002|Treatment Phase|Lost to Follow-up|0
7717704|NCT00521339|12141341|FG000|Treatment Phase|Protocol Violation|1
7717705|NCT00521339|12141342|FG001|Treatment Phase|Protocol Violation|0
7717706|NCT00521339|12141343|FG002|Treatment Phase|Protocol Violation|0
7717707|NCT00521339|12141341|FG000|Treatment Extension Phase|Withdrawal by Subject|0
7717708|NCT00521339|12141342|FG001|Treatment Extension Phase|Withdrawal by Subject|0
7767823|NCT00856206|12210596|FG001|Overall Study|Decision by the Sponsor|8
7888065|NCT01824290|12390193|FG003|Period 2: Open-Label Treatment|Adverse Event|1
7888066|NCT01824290|12390190|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0
7888067|NCT01824290|12390191|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0
7888068|NCT01824290|12390192|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1
7888069|NCT01824290|12390193|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1
7888070|NCT01824290|12390190|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0
7888071|NCT01824290|12390191|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0
7888072|NCT01824290|12390192|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2
7888073|NCT01824290|12390193|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1
7888074|NCT01824303|12390207|FG000|Randomized Study|Withdrawal by Subject|1
7888075|NCT01824303|12390208|FG001|Randomized Study|Withdrawal by Subject|1
7888076|NCT01824303|12390207|FG000|Randomized Study|Other Miscellaneous Reasons|1
7888077|NCT01824303|12390208|FG001|Randomized Study|Other Miscellaneous Reasons|0
7888078|NCT01824342|12390218|FG000|Overall Study|Withdrawal by Subject|0
7888079|NCT01824342|12390219|FG001|Overall Study|Withdrawal by Subject|3
7888080|NCT01824342|12390218|FG000|Overall Study|Adverse Event|1
7888081|NCT01824342|12390219|FG001|Overall Study|Adverse Event|1
7888082|NCT01824342|12390218|FG000|Overall Study|Disease Progression|1
7888083|NCT01824342|12390219|FG001|Overall Study|Disease Progression|1
7888084|NCT01824342|12390218|FG000|Overall Study|Physician Decision|5
7888085|NCT01824342|12390219|FG001|Overall Study|Physician Decision|0
7888086|NCT01824342|12390218|FG000|Overall Study|Death|2
7888087|NCT01824342|12390219|FG001|Overall Study|Death|0
7888088|NCT01824355|12390225|FG000|Overall Study|Adverse Event|2
7888089|NCT01824355|12390225|FG000|Overall Study|unevaluable reference method results per|1
7888090|NCT01824394|12390232|FG000|Overall Study|Early Termination|1
7888091|NCT01824394|12390233|FG001|Overall Study|Early Termination|1
7888092|NCT01824394|12390234|FG002|Overall Study|Early Termination|3
7888093|NCT01824394|12390232|FG000|Overall Study|Withdrawn due to Study Termination|91
7888094|NCT01824394|12390233|FG001|Overall Study|Withdrawn due to Study Termination|83
7888095|NCT01824394|12390234|FG002|Overall Study|Withdrawn due to Study Termination|41
7888096|NCT01824394|12390232|FG000|Overall Study|Lost to Follow-up|0
7888097|NCT01824394|12390233|FG001|Overall Study|Lost to Follow-up|9
7888098|NCT01824394|12390234|FG002|Overall Study|Lost to Follow-up|3
7888099|NCT01824394|12390232|FG000|Overall Study|Death|3
7888100|NCT01824394|12390233|FG001|Overall Study|Death|2
7888101|NCT01824394|12390234|FG002|Overall Study|Death|4
7888102|NCT01824394|12390232|FG000|Overall Study|Discontinued Subjects|1
7888103|NCT01824394|12390233|FG001|Overall Study|Discontinued Subjects|1
7888104|NCT01824394|12390234|FG002|Overall Study|Discontinued Subjects|2
7888105|NCT01824394|12390232|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23
7888106|NCT01824394|12390233|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20
7888107|NCT01824394|12390234|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21
7888108|NCT01824472|12390249|FG000|Overall Study|Lost to Follow-up|0
7888109|NCT01824472|12390250|FG001|Overall Study|Lost to Follow-up|0
7888110|NCT01824472|12390251|FG002|Overall Study|Lost to Follow-up|1
7888111|NCT01824472|12390249|FG000|Overall Study|Withdrawal by Subject|1
7888112|NCT01824472|12390250|FG001|Overall Study|Withdrawal by Subject|5
7888113|NCT01824472|12390251|FG002|Overall Study|Withdrawal by Subject|3
7888114|NCT01824472|12390249|FG000|Overall Study|Ineligible post randomization&screening|0
7888115|NCT01824472|12390250|FG001|Overall Study|Ineligible post randomization&screening|2
7888116|NCT01824472|12390251|FG002|Overall Study|Ineligible post randomization&screening|0
7888117|NCT01824498|12390265|FG000|Washout (8 Weeks)|Withdrawal by Subject|2
7888118|NCT01824498|12390266|FG001|Washout (8 Weeks)|Withdrawal by Subject|0
7888119|NCT01824498|12390267|FG002|Washout (8 Weeks)|Withdrawal by Subject|2
7888120|NCT01824498|12390268|FG003|Washout (8 Weeks)|Withdrawal by Subject|1
7888121|NCT01824498|12390269|FG004|Washout (8 Weeks)|Withdrawal by Subject|1
7888122|NCT01824498|12390270|FG005|Washout (8 Weeks)|Withdrawal by Subject|0
7888123|NCT01824576|12390278|FG000|Overall Study|Device deficiency|2
7888124|NCT01824602|12390303|FG000|Overall Study|Withdrawal by Subject|0
7888125|NCT01824602|12390304|FG001|Overall Study|Withdrawal by Subject|0
7888126|NCT01824602|12390305|FG002|Overall Study|Withdrawal by Subject|1
7888127|NCT01824602|12390306|FG003|Overall Study|Withdrawal by Subject|2
7888128|NCT01824602|12390303|FG000|Overall Study|Patient non-compliance|0
7888129|NCT01824602|12390304|FG001|Overall Study|Patient non-compliance|0
7888130|NCT01824602|12390305|FG002|Overall Study|Patient non-compliance|1
7888131|NCT01824602|12390306|FG003|Overall Study|Patient non-compliance|0
7888132|NCT01824602|12390303|FG000|Overall Study|Adverse Event|1
7888133|NCT01824602|12390304|FG001|Overall Study|Adverse Event|0
7888134|NCT01824602|12390305|FG002|Overall Study|Adverse Event|2
7888135|NCT01824602|12390306|FG003|Overall Study|Adverse Event|2
7888136|NCT01824602|12390303|FG000|Overall Study|Treatment failure|0
7888137|NCT01824602|12390304|FG001|Overall Study|Treatment failure|0
7888138|NCT01824602|12390305|FG002|Overall Study|Treatment failure|0
7888139|NCT01824602|12390306|FG003|Overall Study|Treatment failure|1
7888140|NCT01824693|12390319|FG000|Overall Study|Death|0
7888141|NCT01824693|12390320|FG001|Overall Study|Death|1
7888142|NCT01824693|12390321|FG002|Overall Study|Death|0
7888143|NCT01824693|12390319|FG000|Overall Study|Physician Decision|1
7888144|NCT01824693|12390320|FG001|Overall Study|Physician Decision|1
7888145|NCT01824693|12390321|FG002|Overall Study|Physician Decision|1
7888146|NCT01824693|12390319|FG000|Overall Study|Withdrawal by Subject|0
7888147|NCT01824693|12390320|FG001|Overall Study|Withdrawal by Subject|0
7888148|NCT01824693|12390321|FG002|Overall Study|Withdrawal by Subject|1
7888149|NCT01824693|12390319|FG000|Overall Study|Progressive Disease|0
7888150|NCT01824693|12390320|FG001|Overall Study|Progressive Disease|5
7888151|NCT01824693|12390321|FG002|Overall Study|Progressive Disease|0
7888152|NCT01824693|12390319|FG000|Overall Study|Ineligible|0
7888153|NCT01824693|12390320|FG001|Overall Study|Ineligible|0
7888154|NCT01824693|12390321|FG002|Overall Study|Ineligible|3
7888155|NCT01824693|12390319|FG000|Overall Study|No Transplant Planned|0
7888156|NCT01824693|12390320|FG001|Overall Study|No Transplant Planned|0
7888157|NCT01824693|12390321|FG002|Overall Study|No Transplant Planned|10
7962860|NCT02716896|12517389|FG001|Overall Study|Physician Decision|1
7962861|NCT02716987|12517401|FG000|Overall Study|Ligand synthesis failure|0
7962862|NCT02716987|12517402|FG001|Overall Study|Ligand synthesis failure|0
7962863|NCT02716987|12517403|FG002|Overall Study|Ligand synthesis failure|1
7962864|NCT02716987|12517404|FG003|Overall Study|Ligand synthesis failure|0
7962865|NCT02716987|12517405|FG004|Overall Study|Ligand synthesis failure|0
7962866|NCT02716987|12517406|FG005|Overall Study|Ligand synthesis failure|0
7962867|NCT02716987|12517401|FG000|Overall Study|Withdrawal by Subject|0
7962868|NCT02716987|12517402|FG001|Overall Study|Withdrawal by Subject|0
7962869|NCT02716987|12517403|FG002|Overall Study|Withdrawal by Subject|0
7962870|NCT02716987|12517404|FG003|Overall Study|Withdrawal by Subject|0
7962871|NCT02716987|12517405|FG004|Overall Study|Withdrawal by Subject|1
7962872|NCT02716987|12517406|FG005|Overall Study|Withdrawal by Subject|1
7962873|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Adverse Event|19
7962874|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Adverse Event|7
7962875|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Adverse Event|0
7962876|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Adverse Event|0
7962877|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Adverse Event|0
7962878|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2
7962879|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1
7962880|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7962881|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7962882|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7962883|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7
7962884|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1
7962885|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
7962886|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
7962887|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
7962888|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3
7962889|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1
7962890|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0
7962891|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0
7962892|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0
7962893|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43
7962894|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12
7888158|NCT01824823|12390330|FG000|Overall Study|Lack of Efficacy|1
7888159|NCT01824823|12390331|FG001|Overall Study|Lack of Efficacy|1
7888160|NCT01824823|12390330|FG000|Overall Study|Off-treatment reason not submitted|1
7888161|NCT01824823|12390331|FG001|Overall Study|Off-treatment reason not submitted|0
7888162|NCT01824979|12390346|FG000|Overall Study|Withdrawal by Subject|5
7888163|NCT01824979|12390347|FG001|Overall Study|Withdrawal by Subject|0
7888164|NCT01824979|12390346|FG000|Overall Study|Physician Decision|2
7888165|NCT01824979|12390347|FG001|Overall Study|Physician Decision|0
7888166|NCT01824979|12390346|FG000|Overall Study|Protocol Violation|6
7888167|NCT01824979|12390347|FG001|Overall Study|Protocol Violation|13
7888168|NCT01825200|12390380|FG000|Overall Study|Lost to Follow-up|5
7888169|NCT01825200|12390381|FG001|Overall Study|Lost to Follow-up|6
7888170|NCT01825200|12390380|FG000|Overall Study|Withdrawal by Subject|0
7888171|NCT01825200|12390381|FG001|Overall Study|Withdrawal by Subject|1
7888172|NCT01825577|12390413|FG000|Overall Study|Physician Decision|2
7888173|NCT01825577|12390413|FG000|Overall Study|Withdrawal by Subject|1
7888174|NCT01825577|12390413|FG000|Overall Study|Withdrawn by family members|2
7888175|NCT01825577|12390413|FG000|Overall Study|Lack of Efficacy|3
7888176|NCT01825785|12390433|FG000|Overall Study|Adverse Event|0
7888177|NCT01825785|12390434|FG001|Overall Study|Adverse Event|0
7888178|NCT01825785|12390435|FG002|Overall Study|Adverse Event|0
7888179|NCT01825785|12390436|FG003|Overall Study|Adverse Event|0
7888180|NCT01825785|12390437|FG004|Overall Study|Adverse Event|1
7888181|NCT01825785|12390438|FG005|Overall Study|Adverse Event|0
7888182|NCT01825785|12390439|FG006|Overall Study|Adverse Event|0
7888183|NCT01825785|12390433|FG000|Overall Study|Withdrawal by Subject|0
7888184|NCT01825785|12390434|FG001|Overall Study|Withdrawal by Subject|0
7888185|NCT01825785|12390435|FG002|Overall Study|Withdrawal by Subject|0
7888186|NCT01825785|12390436|FG003|Overall Study|Withdrawal by Subject|0
7888187|NCT01825785|12390437|FG004|Overall Study|Withdrawal by Subject|1
7888188|NCT01825785|12390438|FG005|Overall Study|Withdrawal by Subject|1
7888189|NCT01825785|12390439|FG006|Overall Study|Withdrawal by Subject|0
7888190|NCT01825798|12390463|FG000|Overall Study|Adverse Event|1
7888191|NCT01825798|12390464|FG001|Overall Study|Adverse Event|5
7888192|NCT01825798|12390463|FG000|Overall Study|Lost to Follow-up|1
7888193|NCT01825798|12390464|FG001|Overall Study|Lost to Follow-up|0
7888194|NCT01825837|12390474|FG000|PART I|Withdrawal by Subject|0
7888195|NCT01825837|12390475|FG001|PART I|Withdrawal by Subject|0
7888196|NCT01825837|12390476|FG002|PART I|Withdrawal by Subject|0
7888197|NCT01825837|12390477|FG003|PART I|Withdrawal by Subject|6
7888198|NCT01825837|12390474|FG000|PART I|Patient non-compliance|0
7888199|NCT01825837|12390475|FG001|PART I|Patient non-compliance|0
7888200|NCT01825837|12390476|FG002|PART I|Patient non-compliance|0
7888201|NCT01825837|12390477|FG003|PART I|Patient non-compliance|1
7888202|NCT01825837|12390474|FG000|PART I|Treatment failure|0
7888203|NCT01825837|12390475|FG001|PART I|Treatment failure|0
7888204|NCT01825837|12390476|FG002|PART I|Treatment failure|0
7888205|NCT01825837|12390477|FG003|PART I|Treatment failure|7
7888206|NCT01825837|12390474|FG000|PART I|reason unspecified|0
7888207|NCT01825837|12390475|FG001|PART I|reason unspecified|0
7888208|NCT01825837|12390476|FG002|PART I|reason unspecified|0
7888209|NCT01825837|12390477|FG003|PART I|reason unspecified|3
7888210|NCT01825837|12390474|FG000|PART II|Withdrawal by Subject|3
7888211|NCT01825837|12390475|FG001|PART II|Withdrawal by Subject|3
7888212|NCT01825837|12390476|FG002|PART II|Withdrawal by Subject|7
7888213|NCT01825837|12390477|FG003|PART II|Withdrawal by Subject|0
7888214|NCT01825837|12390474|FG000|PART II|Patient non-compliance|5
7888215|NCT01825837|12390475|FG001|PART II|Patient non-compliance|2
7888216|NCT01825837|12390476|FG002|PART II|Patient non-compliance|4
7888217|NCT01825837|12390477|FG003|PART II|Patient non-compliance|0
7888218|NCT01825837|12390474|FG000|PART II|Adverse Event|3
7888219|NCT01825837|12390475|FG001|PART II|Adverse Event|3
7888220|NCT01825837|12390476|FG002|PART II|Adverse Event|1
7888221|NCT01825837|12390477|FG003|PART II|Adverse Event|0
7888222|NCT01825837|12390474|FG000|PART II|Treatment failure|6
7888223|NCT01825837|12390475|FG001|PART II|Treatment failure|4
7888224|NCT01825837|12390476|FG002|PART II|Treatment failure|5
7888225|NCT01825837|12390477|FG003|PART II|Treatment failure|0
7888226|NCT01825837|12390474|FG000|PART II|reason unspecified|2
7888227|NCT01825837|12390475|FG001|PART II|reason unspecified|2
7888228|NCT01825837|12390476|FG002|PART II|reason unspecified|2
7888229|NCT01825837|12390477|FG003|PART II|reason unspecified|0
7888230|NCT01825876|12390485|FG000|Period 2|Withdrawal by Subject|0
7888231|NCT01825876|12390486|FG001|Period 2|Withdrawal by Subject|1
7888232|NCT01825941|12390506|FG000|Overall Study|Lost to Follow-up|4
7888233|NCT01825941|12390507|FG001|Overall Study|Lost to Follow-up|1
7888234|NCT01826201|12390513|FG000|Overall Study|Non compliance with protocol|4
7888235|NCT01826214|12390521|FG000|Overall Study|Adverse Event|7
7888236|NCT01826214|12390522|FG001|Overall Study|Adverse Event|6
7888237|NCT01826214|12390521|FG000|Overall Study|Death|3
7888238|NCT01826214|12390522|FG001|Overall Study|Death|1
7888239|NCT01826214|12390521|FG000|Overall Study|Lost to Follow-up|1
7888240|NCT01826214|12390522|FG001|Overall Study|Lost to Follow-up|0
7888241|NCT01826214|12390521|FG000|Overall Study|Physician Decision|0
7888242|NCT01826214|12390522|FG001|Overall Study|Physician Decision|2
7888243|NCT01826214|12390521|FG000|Overall Study|Progressive disease|22
7888244|NCT01826214|12390522|FG001|Overall Study|Progressive disease|21
7888245|NCT01826214|12390521|FG000|Overall Study|Study terminated by Sponsor|0
7888246|NCT01826214|12390522|FG001|Overall Study|Study terminated by Sponsor|1
7888247|NCT01826214|12390521|FG000|Overall Study|Subject/guardian decision|2
7888248|NCT01826214|12390522|FG001|Overall Study|Subject/guardian decision|3
7888249|NCT01826370|12390532|FG000|Overall Study|Protocol Violation|6
7888250|NCT01826370|12390532|FG000|Overall Study|Lost to Follow-up|12
7888251|NCT01826370|12390532|FG000|Overall Study|Other reason not defined above|2
7888252|NCT01826422|12390538|FG000|Overall Study|Withdrawal by Subject|1
7888253|NCT01826422|12390539|FG001|Overall Study|Withdrawal by Subject|3
7888254|NCT01826448|12390547|FG000|Overall Study|Adverse Event|1
7888255|NCT01826448|12390548|FG001|Overall Study|Adverse Event|3
7888256|NCT01826448|12390547|FG000|Overall Study|Disease progression|2
7888257|NCT01826448|12390548|FG001|Overall Study|Disease progression|4
7888258|NCT01826448|12390547|FG000|Overall Study|Withdrawal by Subject|1
7888259|NCT01826448|12390548|FG001|Overall Study|Withdrawal by Subject|0
7888260|NCT01826448|12390547|FG000|Overall Study|Physician Decision|0
7888261|NCT01826448|12390548|FG001|Overall Study|Physician Decision|1
7888262|NCT01826448|12390547|FG000|Overall Study|2 active cancers|0
7888263|NCT01826448|12390548|FG001|Overall Study|2 active cancers|1
7888264|NCT01826487|12390556|FG000|Overall Study|Adverse Event|1
7888265|NCT01826487|12390557|FG001|Overall Study|Adverse Event|1
7888266|NCT01826487|12390556|FG000|Overall Study|Lost to Follow-up|1
7888267|NCT01826487|12390557|FG001|Overall Study|Lost to Follow-up|0
7888268|NCT01826487|12390556|FG000|Overall Study|Withdrawal by Subject|1
7888269|NCT01826487|12390557|FG001|Overall Study|Withdrawal by Subject|3
7888270|NCT01826487|12390556|FG000|Overall Study|Protocol Violation|1
7888271|NCT01826487|12390557|FG001|Overall Study|Protocol Violation|1
7888272|NCT01826604|12390578|FG000|Overall Study|Lost to Follow-up|8
7888273|NCT01826604|12390579|FG001|Overall Study|Lost to Follow-up|9
7888274|NCT01826825|12390598|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0
7888275|NCT01826825|12390599|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2
7888276|NCT01826981|12390631|FG000|Overall Study|Lack of Efficacy|0
7888277|NCT01826981|12390632|FG001|Overall Study|Lack of Efficacy|1
7888278|NCT01826981|12390633|FG002|Overall Study|Lack of Efficacy|0
7888279|NCT01826981|12390634|FG003|Overall Study|Lack of Efficacy|0
7888280|NCT01826981|12390635|FG004|Overall Study|Lack of Efficacy|5
7888281|NCT01826981|12390636|FG005|Overall Study|Lack of Efficacy|0
7888282|NCT01826981|12390637|FG006|Overall Study|Lack of Efficacy|0
7888283|NCT01826981|12390638|FG007|Overall Study|Lack of Efficacy|8
7888284|NCT01826981|12390639|FG008|Overall Study|Lack of Efficacy|7
7888285|NCT01826981|12390640|FG009|Overall Study|Lack of Efficacy|0
7888286|NCT01826981|12390641|FG010|Overall Study|Lack of Efficacy|1
7888287|NCT01826981|12390642|FG011|Overall Study|Lack of Efficacy|0
7888288|NCT01826981|12390643|FG012|Overall Study|Lack of Efficacy|0
7888289|NCT01826981|12390644|FG013|Overall Study|Lack of Efficacy|3
7888290|NCT01826981|12390645|FG014|Overall Study|Lack of Efficacy|0
7888291|NCT01826981|12390631|FG000|Overall Study|Lost to Follow-up|0
7888292|NCT01826981|12390632|FG001|Overall Study|Lost to Follow-up|0
7888293|NCT01826981|12390633|FG002|Overall Study|Lost to Follow-up|0
7888294|NCT01826981|12390634|FG003|Overall Study|Lost to Follow-up|0
7888295|NCT01826981|12390635|FG004|Overall Study|Lost to Follow-up|1
7888296|NCT01826981|12390636|FG005|Overall Study|Lost to Follow-up|1
7888297|NCT01826981|12390637|FG006|Overall Study|Lost to Follow-up|0
7888298|NCT01826981|12390638|FG007|Overall Study|Lost to Follow-up|1
7888299|NCT01826981|12390639|FG008|Overall Study|Lost to Follow-up|0
7888300|NCT01826981|12390640|FG009|Overall Study|Lost to Follow-up|1
7888301|NCT01826981|12390641|FG010|Overall Study|Lost to Follow-up|1
7888302|NCT01826981|12390642|FG011|Overall Study|Lost to Follow-up|1
7888303|NCT01826981|12390643|FG012|Overall Study|Lost to Follow-up|1
7888304|NCT01826981|12390644|FG013|Overall Study|Lost to Follow-up|0
7888305|NCT01826981|12390645|FG014|Overall Study|Lost to Follow-up|0
7888306|NCT01826981|12390631|FG000|Overall Study|Withdrew Consent|0
7888307|NCT01826981|12390632|FG001|Overall Study|Withdrew Consent|0
7888308|NCT01826981|12390633|FG002|Overall Study|Withdrew Consent|0
7888309|NCT01826981|12390634|FG003|Overall Study|Withdrew Consent|0
7888310|NCT01826981|12390635|FG004|Overall Study|Withdrew Consent|0
7888311|NCT01826981|12390636|FG005|Overall Study|Withdrew Consent|0
7888312|NCT01826981|12390637|FG006|Overall Study|Withdrew Consent|1
7888313|NCT01826981|12390638|FG007|Overall Study|Withdrew Consent|1
7888314|NCT01826981|12390639|FG008|Overall Study|Withdrew Consent|0
7888315|NCT01826981|12390640|FG009|Overall Study|Withdrew Consent|0
7888316|NCT01826981|12390641|FG010|Overall Study|Withdrew Consent|0
7888317|NCT01826981|12390642|FG011|Overall Study|Withdrew Consent|1
7888318|NCT01826981|12390643|FG012|Overall Study|Withdrew Consent|0
7888319|NCT01826981|12390644|FG013|Overall Study|Withdrew Consent|1
7888320|NCT01826981|12390645|FG014|Overall Study|Withdrew Consent|0
7888321|NCT01826981|12390631|FG000|Overall Study|Adverse Event|0
7888322|NCT01826981|12390632|FG001|Overall Study|Adverse Event|0
7888323|NCT01826981|12390633|FG002|Overall Study|Adverse Event|0
7888324|NCT01826981|12390634|FG003|Overall Study|Adverse Event|0
7888325|NCT01826981|12390635|FG004|Overall Study|Adverse Event|1
7888326|NCT01826981|12390636|FG005|Overall Study|Adverse Event|0
7888327|NCT01826981|12390637|FG006|Overall Study|Adverse Event|0
7888328|NCT01826981|12390638|FG007|Overall Study|Adverse Event|0
7888329|NCT01826981|12390639|FG008|Overall Study|Adverse Event|0
7888330|NCT01826981|12390640|FG009|Overall Study|Adverse Event|0
7888331|NCT01826981|12390641|FG010|Overall Study|Adverse Event|0
7888332|NCT01826981|12390642|FG011|Overall Study|Adverse Event|0
7888333|NCT01826981|12390643|FG012|Overall Study|Adverse Event|0
7888334|NCT01826981|12390644|FG013|Overall Study|Adverse Event|0
7888335|NCT01826981|12390645|FG014|Overall Study|Adverse Event|0
7888336|NCT01826981|12390631|FG000|Overall Study|Upper G-I Haemorrhage|0
7888337|NCT01826981|12390632|FG001|Overall Study|Upper G-I Haemorrhage|0
7888338|NCT01826981|12390633|FG002|Overall Study|Upper G-I Haemorrhage|0
7888339|NCT01826981|12390634|FG003|Overall Study|Upper G-I Haemorrhage|0
7888340|NCT01826981|12390635|FG004|Overall Study|Upper G-I Haemorrhage|0
7888341|NCT01826981|12390636|FG005|Overall Study|Upper G-I Haemorrhage|0
7888342|NCT01826981|12390637|FG006|Overall Study|Upper G-I Haemorrhage|0
7888343|NCT01826981|12390638|FG007|Overall Study|Upper G-I Haemorrhage|0
7888344|NCT01826981|12390639|FG008|Overall Study|Upper G-I Haemorrhage|0
7888345|NCT01826981|12390640|FG009|Overall Study|Upper G-I Haemorrhage|0
7888346|NCT01826981|12390641|FG010|Overall Study|Upper G-I Haemorrhage|0
7888347|NCT01826981|12390642|FG011|Overall Study|Upper G-I Haemorrhage|0
7888348|NCT01826981|12390643|FG012|Overall Study|Upper G-I Haemorrhage|0
7888349|NCT01826981|12390644|FG013|Overall Study|Upper G-I Haemorrhage|1
7888350|NCT01826981|12390645|FG014|Overall Study|Upper G-I Haemorrhage|0
7888351|NCT01826981|12390631|FG000|Overall Study|Enrolled/Randomized but Not Treated|0
7888352|NCT01826981|12390632|FG001|Overall Study|Enrolled/Randomized but Not Treated|0
7888353|NCT01826981|12390633|FG002|Overall Study|Enrolled/Randomized but Not Treated|0
7888354|NCT01826981|12390634|FG003|Overall Study|Enrolled/Randomized but Not Treated|0
7888355|NCT01826981|12390635|FG004|Overall Study|Enrolled/Randomized but Not Treated|0
7888356|NCT01826981|12390636|FG005|Overall Study|Enrolled/Randomized but Not Treated|0
7888357|NCT01826981|12390637|FG006|Overall Study|Enrolled/Randomized but Not Treated|0
7888358|NCT01826981|12390638|FG007|Overall Study|Enrolled/Randomized but Not Treated|1
7888359|NCT01826981|12390639|FG008|Overall Study|Enrolled/Randomized but Not Treated|0
7888360|NCT01826981|12390640|FG009|Overall Study|Enrolled/Randomized but Not Treated|0
7888361|NCT01826981|12390641|FG010|Overall Study|Enrolled/Randomized but Not Treated|0
7888362|NCT01826981|12390642|FG011|Overall Study|Enrolled/Randomized but Not Treated|0
7888363|NCT01826981|12390643|FG012|Overall Study|Enrolled/Randomized but Not Treated|0
7888364|NCT01826981|12390644|FG013|Overall Study|Enrolled/Randomized but Not Treated|0
7888365|NCT01826981|12390645|FG014|Overall Study|Enrolled/Randomized but Not Treated|0
7888366|NCT01827046|12390683|FG000|Overall Study|Lost to Follow-up|1
7888367|NCT01827046|12390684|FG001|Overall Study|Lost to Follow-up|5
7888368|NCT01827046|12390683|FG000|Overall Study|Withdrawal by Subject|0
7888369|NCT01827046|12390684|FG001|Overall Study|Withdrawal by Subject|4
7888370|NCT01827163|12390690|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2
7888371|NCT01827163|12390690|FG000|Overall Study|Adverse Event|9
7888372|NCT01827254|12390694|FG000|Overall Study|Death|10
7888373|NCT01827254|12390694|FG000|Overall Study|Case report form not completed|4
7888374|NCT01827254|12390694|FG000|Overall Study|Invalidated centre|3
7888375|NCT01827254|12390694|FG000|Overall Study|Discontinued prior initiation: sunitinib|1
7888376|NCT01827254|12390694|FG000|Overall Study|Did not complete re-challenge|1
7888377|NCT01827254|12390694|FG000|Overall Study|Disease progression|36
7888378|NCT01827254|12390694|FG000|Overall Study|Intolerance to treatment|4
7888379|NCT01827267|12390704|FG000|Overall Study|Did not receive study drug|1
7888380|NCT01827267|12390705|FG001|Overall Study|Did not receive study drug|1
7888381|NCT01827267|12390704|FG000|Overall Study|Physician Decision|1
7888382|NCT01827267|12390705|FG001|Overall Study|Physician Decision|0
7888383|NCT01827267|12390704|FG000|Overall Study|Disease Progression|1
7888384|NCT01827267|12390705|FG001|Overall Study|Disease Progression|1
7888385|NCT01827267|12390704|FG000|Overall Study|Sponsor Discontinued Study|2
7888386|NCT01827267|12390705|FG001|Overall Study|Sponsor Discontinued Study|8
7888387|NCT01827267|12390704|FG000|Overall Study|Still on study|0
7888388|NCT01827267|12390705|FG001|Overall Study|Still on study|2
7888389|NCT01827319|12390721|FG000|Overall Study|Lost to Follow-up|3
7888390|NCT01827332|12390727|FG000|Overall Study|Lost to Follow-up|2
7888391|NCT01827332|12390728|FG001|Overall Study|Lost to Follow-up|1
7888392|NCT01827371|12390747|FG000|Overall Study|Adverse Event|0
7888393|NCT01827371|12390748|FG001|Overall Study|Adverse Event|0
7888394|NCT01827371|12390749|FG002|Overall Study|Adverse Event|4
7968199|NCT04074161|12525797|FG001|Overall Study|Lost to Follow-up|5
7968200|NCT04074161|12525798|FG002|Overall Study|Lost to Follow-up|3
7968201|NCT04033432|12525806|FG000|Overall Study|Progressive Disease|8
7968202|NCT04033432|12525806|FG000|Overall Study|Adverse Event|4
7968203|NCT04033432|12525806|FG000|Overall Study|Death|1
7968204|NCT04030247|12525811|FG000|Overall Study|Withdrawal by Subject|4
7968205|NCT04030247|12525811|FG000|Overall Study|Lost to Follow-up|13
7968206|NCT03893565|12525820|FG000|Double-blind Induction Phase (10 Weeks)|Other|1
7888395|NCT01827371|12390750|FG003|Overall Study|Adverse Event|2
7888396|NCT01827371|12390747|FG000|Overall Study|Lost to Follow-up|0
7888397|NCT01827371|12390748|FG001|Overall Study|Lost to Follow-up|2
7888398|NCT01827371|12390749|FG002|Overall Study|Lost to Follow-up|0
7888399|NCT01827371|12390750|FG003|Overall Study|Lost to Follow-up|4
7888400|NCT01827371|12390747|FG000|Overall Study|Protocol Violation|1
7888401|NCT01827371|12390748|FG001|Overall Study|Protocol Violation|0
7888402|NCT01827371|12390749|FG002|Overall Study|Protocol Violation|0
7888403|NCT01827371|12390750|FG003|Overall Study|Protocol Violation|0
7888404|NCT01827371|12390747|FG000|Overall Study|Withdrawal by Subject|1
7968207|NCT03893565|12525821|FG001|Double-blind Induction Phase (10 Weeks)|Other|3
7888405|NCT01827371|12390748|FG001|Overall Study|Withdrawal by Subject|2
7888406|NCT01827371|12390749|FG002|Overall Study|Withdrawal by Subject|2
7888407|NCT01827371|12390750|FG003|Overall Study|Withdrawal by Subject|3
7888408|NCT01827371|12390747|FG000|Overall Study|Physician Decision|0
7888409|NCT01827371|12390748|FG001|Overall Study|Physician Decision|1
7888410|NCT01827371|12390749|FG002|Overall Study|Physician Decision|0
7888411|NCT01827371|12390750|FG003|Overall Study|Physician Decision|1
7888412|NCT01827371|12390747|FG000|Overall Study|Temporary study halt to vaccinations|11
7888413|NCT01827371|12390748|FG001|Overall Study|Temporary study halt to vaccinations|2
7888414|NCT01827371|12390749|FG002|Overall Study|Temporary study halt to vaccinations|5
7888415|NCT01827371|12390750|FG003|Overall Study|Temporary study halt to vaccinations|13
7888416|NCT01827592|12390792|FG000|Overall Study|Adverse Event|11
7888417|NCT01827592|12390793|FG001|Overall Study|Adverse Event|9
7888418|NCT01827592|12390794|FG002|Overall Study|Adverse Event|2
7888419|NCT01827592|12390792|FG000|Overall Study|Physician Decision|0
7888420|NCT01827592|12390793|FG001|Overall Study|Physician Decision|2
7888421|NCT01827592|12390794|FG002|Overall Study|Physician Decision|1
7888422|NCT01827592|12390792|FG000|Overall Study|Protocol Violation|2
7888423|NCT01827592|12390793|FG001|Overall Study|Protocol Violation|1
7888424|NCT01827592|12390794|FG002|Overall Study|Protocol Violation|0
7888425|NCT01827592|12390792|FG000|Overall Study|Lost to Follow-up|1
7888426|NCT01827592|12390793|FG001|Overall Study|Lost to Follow-up|2
7888427|NCT01827592|12390794|FG002|Overall Study|Lost to Follow-up|2
7888428|NCT01827592|12390792|FG000|Overall Study|Withdrawal by Subject|12
7888429|NCT01827592|12390793|FG001|Overall Study|Withdrawal by Subject|11
7888430|NCT01827592|12390794|FG002|Overall Study|Withdrawal by Subject|11
7888431|NCT01827592|12390792|FG000|Overall Study|Patient's substantial non-compliance|1
7888432|NCT01827592|12390793|FG001|Overall Study|Patient's substantial non-compliance|1
7888433|NCT01827592|12390794|FG002|Overall Study|Patient's substantial non-compliance|6
7888434|NCT01827592|12390792|FG000|Overall Study|Trial terminated by Sponsor|47
7888435|NCT01827592|12390793|FG001|Overall Study|Trial terminated by Sponsor|53
7888436|NCT01827592|12390794|FG002|Overall Study|Trial terminated by Sponsor|51
7888437|NCT01827592|12390792|FG000|Overall Study|Others|0
7888438|NCT01827592|12390793|FG001|Overall Study|Others|1
7888439|NCT01827592|12390794|FG002|Overall Study|Others|3
7888440|NCT01827670|12390804|FG000|Overall Study|Withdrawal of Consent|3
7888441|NCT01827670|12390805|FG001|Overall Study|Withdrawal of Consent|2
7888442|NCT01827670|12390804|FG000|Overall Study|Lost to Follow-up|0
7888443|NCT01827670|12390805|FG001|Overall Study|Lost to Follow-up|1
7888444|NCT01827839|12390828|FG000|Overall Study|Adverse Event|1
7888445|NCT01827839|12390828|FG000|Overall Study|Consent Withdrawal|2
7888446|NCT01827943|12390852|FG000|Overall Study|Protocol Violation|8
7888447|NCT01827943|12390852|FG000|Overall Study|Never treated because of an rapid progression|1
7888448|NCT01828034|12390860|FG000|Overall Study|Withdrawal by Subject|0
7888449|NCT01828034|12390861|FG001|Overall Study|Withdrawal by Subject|0
7888450|NCT01828034|12390862|FG002|Overall Study|Withdrawal by Subject|0
7888451|NCT01828034|12390863|FG003|Overall Study|Withdrawal by Subject|1
7888452|NCT01828073|12390872|FG000|Overall Study|Lost to Follow-up|1
7888453|NCT01828073|12390873|FG001|Overall Study|Lost to Follow-up|2
7888454|NCT01828281|12390917|FG000|Overall Study|Withdrawal by Subject|1
7888455|NCT01828281|12390918|FG001|Overall Study|Withdrawal by Subject|0
7888456|NCT01828567|12390949|FG000|Overall Study|Lost to Follow-up|27
7888457|NCT01828567|12390950|FG001|Overall Study|Lost to Follow-up|9
7888458|NCT01828567|12390949|FG000|Overall Study|Excluded - did not meet criteria|4
7888459|NCT01828567|12390950|FG001|Overall Study|Excluded - did not meet criteria|1
7888460|NCT01829048|12390986|FG000|Overall Study|Withdrawal by Subject|0
7888461|NCT01829048|12390987|FG001|Overall Study|Withdrawal by Subject|0
7888462|NCT01829048|12390988|FG002|Overall Study|Withdrawal by Subject|0
7888463|NCT01829048|12390989|FG003|Overall Study|Withdrawal by Subject|2
7888464|NCT01829048|12390990|FG004|Overall Study|Withdrawal by Subject|0
7888465|NCT01829113|12391005|FG000|Overall Study|Disease Progression|37
7888466|NCT01829113|12391006|FG001|Overall Study|Disease Progression|48
7888467|NCT01829113|12391005|FG000|Overall Study|Adverse Event|14
7888468|NCT01829113|12391006|FG001|Overall Study|Adverse Event|10
7888469|NCT01829113|12391005|FG000|Overall Study|Withdrawal by Subject|17
7888470|NCT01829113|12391006|FG001|Overall Study|Withdrawal by Subject|10
7888471|NCT01829113|12391005|FG000|Overall Study|Death|4
7888472|NCT01829113|12391006|FG001|Overall Study|Death|6
7888473|NCT01829113|12391005|FG000|Overall Study|Sponsor Decision|1
7888474|NCT01829113|12391006|FG001|Overall Study|Sponsor Decision|1
7888475|NCT01829113|12391005|FG000|Overall Study|No Study Treatment Received|3
7888476|NCT01829113|12391006|FG001|Overall Study|No Study Treatment Received|2
7888477|NCT01829113|12391005|FG000|Overall Study|Physician Decision|1
7888478|NCT01829113|12391006|FG001|Overall Study|Physician Decision|1
7888479|NCT01829165|12391016|FG000|Overall Study|Did not complete intervention|2
7888480|NCT01829165|12391017|FG001|Overall Study|Did not complete intervention|0
7888481|NCT01829191|12391025|FG000|Overall Study|Relocation|0
7888482|NCT01829191|12391026|FG001|Overall Study|Relocation|1
7888483|NCT01829191|12391025|FG000|Overall Study|Lens discomfort|0
7888484|NCT01829191|12391026|FG001|Overall Study|Lens discomfort|3
7888485|NCT01829191|12391025|FG000|Overall Study|Lens handling difficulty|1
7888486|NCT01829191|12391026|FG001|Overall Study|Lens handling difficulty|4
7888487|NCT01829191|12391025|FG000|Overall Study|Protocol Violation|4
7888488|NCT01829191|12391026|FG001|Overall Study|Protocol Violation|1
7888489|NCT01829191|12391025|FG000|Overall Study|Withdrawal by Subject|2
7888490|NCT01829191|12391026|FG001|Overall Study|Withdrawal by Subject|3
7888491|NCT01829191|12391025|FG000|Overall Study|Lost to Follow-up|0
7888492|NCT01829191|12391026|FG001|Overall Study|Lost to Follow-up|1
7888493|NCT01829191|12391025|FG000|Overall Study|Subject was fit for ortho - k|0
7888494|NCT01829191|12391026|FG001|Overall Study|Subject was fit for ortho - k|1
7888495|NCT01829230|12391037|FG000|Overall Study|Protocol Violation|0
7888496|NCT01829230|12391038|FG001|Overall Study|Protocol Violation|2
7888497|NCT01829230|12391037|FG000|Overall Study|Withdrawal by Subject|0
7888498|NCT01829230|12391038|FG001|Overall Study|Withdrawal by Subject|1
7888499|NCT01829230|12391037|FG000|Overall Study|Lost to Follow-up|1
7888500|NCT01829230|12391038|FG001|Overall Study|Lost to Follow-up|1
7888501|NCT01829243|12391044|FG000|First Intervention|Screen Failure|4
7888502|NCT01829243|12391045|FG001|First Intervention|Screen Failure|2
7888503|NCT01829295|12391055|FG000|6-12 Months|Did not want to switch antimetabolites|0
7888504|NCT01829295|12391056|FG001|6-12 Months|Did not want to switch antimetabolites|0
7888505|NCT01829295|12391057|FG002|6-12 Months|Did not want to switch antimetabolites|9
7888506|NCT01829295|12391058|FG003|6-12 Months|Did not want to switch antimetabolites|11
7888507|NCT01829295|12391055|FG000|6-12 Months|Adverse Event|0
7888508|NCT01829295|12391056|FG001|6-12 Months|Adverse Event|0
7888509|NCT01829295|12391057|FG002|6-12 Months|Adverse Event|3
7888510|NCT01829295|12391058|FG003|6-12 Months|Adverse Event|2
7888511|NCT01829295|12391055|FG000|6-12 Months|Lost to Follow-up|2
7888512|NCT01829295|12391056|FG001|6-12 Months|Lost to Follow-up|0
7888513|NCT01829295|12391057|FG002|6-12 Months|Lost to Follow-up|0
7888514|NCT01829295|12391058|FG003|6-12 Months|Lost to Follow-up|0
7888515|NCT01829295|12391055|FG000|6-12 Months|Withdrawal by Subject|2
7888516|NCT01829295|12391056|FG001|6-12 Months|Withdrawal by Subject|2
7888517|NCT01829295|12391057|FG002|6-12 Months|Withdrawal by Subject|0
7888518|NCT01829295|12391058|FG003|6-12 Months|Withdrawal by Subject|0
7888519|NCT01829347|12391070|FG000|VTI-210|Death|5
7888520|NCT01829347|12391071|FG001|VTI-210|Death|3
7888521|NCT01829347|12391070|FG000|VTI-210|Withdrawal by Subject|1
7888522|NCT01829347|12391071|FG001|VTI-210|Withdrawal by Subject|0
7888523|NCT01829347|12391070|FG000|VTI-210E|Death|2
7888524|NCT01829347|12391071|FG001|VTI-210E|Death|1
7888525|NCT01829347|12391070|FG000|VTI-210E|Study terminated prematurely|1
7888526|NCT01829347|12391071|FG001|VTI-210E|Study terminated prematurely|5
7888527|NCT01829360|12391081|FG000|Overall Study|Protocol Violation|0
7888528|NCT01829360|12391082|FG001|Overall Study|Protocol Violation|0
7888529|NCT01829360|12391083|FG002|Overall Study|Protocol Violation|1
7888530|NCT01829360|12391084|FG003|Overall Study|Protocol Violation|0
7888531|NCT01829425|12391111|FG000|Overall Study|Withdrawal by Subject|4
7888532|NCT01829425|12391112|FG001|Overall Study|Withdrawal by Subject|3
7888533|NCT01829425|12391111|FG000|Overall Study|Lost to Follow-up|2
7888534|NCT01829425|12391112|FG001|Overall Study|Lost to Follow-up|1
7888535|NCT01829464|12391121|FG000|Overall Study|Adverse Event|1
7888536|NCT01829464|12391122|FG001|Overall Study|Adverse Event|0
7888537|NCT01829464|12391123|FG002|Overall Study|Adverse Event|0
7888538|NCT01829464|12391121|FG000|Overall Study|Lost to Follow-up|0
7888539|NCT01829464|12391122|FG001|Overall Study|Lost to Follow-up|0
7888540|NCT01829464|12391123|FG002|Overall Study|Lost to Follow-up|1
7888541|NCT01829464|12391121|FG000|Overall Study|Withdrawal by Subject|2
7888542|NCT01829464|12391122|FG001|Overall Study|Withdrawal by Subject|0
7888543|NCT01829464|12391123|FG002|Overall Study|Withdrawal by Subject|0
7888544|NCT01829464|12391121|FG000|Overall Study|Study terminated by sponsor|25
7888545|NCT01829464|12391122|FG001|Overall Study|Study terminated by sponsor|28
7888546|NCT01829464|12391123|FG002|Overall Study|Study terminated by sponsor|25
7888547|NCT01829464|12391121|FG000|Overall Study|Lack of Efficacy|0
7888548|NCT01829464|12391122|FG001|Overall Study|Lack of Efficacy|1
7888549|NCT01829464|12391123|FG002|Overall Study|Lack of Efficacy|0
7888550|NCT01830127|12391156|FG000|Overall Study|Adverse Event|1
7888551|NCT01830127|12391157|FG001|Overall Study|Adverse Event|6
7888552|NCT01830127|12391156|FG000|Overall Study|Lack of Efficacy|3
7888553|NCT01830127|12391157|FG001|Overall Study|Lack of Efficacy|0
7888554|NCT01830127|12391156|FG000|Overall Study|Withdrawal by Subject|1
7888555|NCT01830127|12391157|FG001|Overall Study|Withdrawal by Subject|1
7888556|NCT01830127|12391156|FG000|Overall Study|Other reason not defined above|0
7888557|NCT01830127|12391157|FG001|Overall Study|Other reason not defined above|2
7888558|NCT01830543|12391203|FG000|Overall Study|Subject Decision|19
7888559|NCT01830543|12391204|FG001|Overall Study|Subject Decision|21
7888560|NCT01830543|12391205|FG002|Overall Study|Subject Decision|57
7888561|NCT01830543|12391203|FG000|Overall Study|Adverse Event|91
7888562|NCT01830543|12391204|FG001|Overall Study|Adverse Event|77
7888563|NCT01830543|12391205|FG002|Overall Study|Adverse Event|76
7888564|NCT01830543|12391203|FG000|Overall Study|Death|20
7968208|NCT03893565|12525822|FG002|Double-blind Induction Phase (10 Weeks)|Other|0
7888565|NCT01830543|12391204|FG001|Overall Study|Death|22
7888566|NCT01830543|12391205|FG002|Overall Study|Death|22
7888567|NCT01830543|12391203|FG000|Overall Study|Protocol Violation|3
7888568|NCT01830543|12391204|FG001|Overall Study|Protocol Violation|7
7888569|NCT01830543|12391205|FG002|Overall Study|Protocol Violation|7
7888570|NCT01830543|12391203|FG000|Overall Study|Physician Decision|11
7888571|NCT01830543|12391204|FG001|Overall Study|Physician Decision|5
7888572|NCT01830543|12391205|FG002|Overall Study|Physician Decision|12
7888573|NCT01830543|12391203|FG000|Overall Study|Withdrawal by consent|3
7888574|NCT01830543|12391204|FG001|Overall Study|Withdrawal by consent|3
7888575|NCT01830543|12391205|FG002|Overall Study|Withdrawal by consent|3
7888576|NCT01830543|12391203|FG000|Overall Study|Other|12
7888577|NCT01830543|12391204|FG001|Overall Study|Other|17
7888578|NCT01830543|12391205|FG002|Overall Study|Other|37
7888579|NCT01830595|12391213|FG000|First Period|Withdrawal by Subject|1
7888580|NCT01830595|12391214|FG001|First Period|Withdrawal by Subject|3
7888581|NCT01830595|12391213|FG000|Washout|Withdrawal by Subject|2
7888582|NCT01830595|12391214|FG001|Washout|Withdrawal by Subject|2
7888583|NCT01830816|12391241|FG000|Overall Study|Progressive Disease|12
7888584|NCT01830816|12391242|FG001|Overall Study|Progressive Disease|7
7888585|NCT01830816|12391243|FG002|Overall Study|Progressive Disease|7
7888586|NCT01830816|12391241|FG000|Overall Study|Adverse Event|3
7888587|NCT01830816|12391242|FG001|Overall Study|Adverse Event|4
7888588|NCT01830816|12391243|FG002|Overall Study|Adverse Event|0
7888589|NCT01830816|12391241|FG000|Overall Study|Study Terminated by Sponsor|1
7888590|NCT01830816|12391242|FG001|Overall Study|Study Terminated by Sponsor|1
7888591|NCT01830816|12391243|FG002|Overall Study|Study Terminated by Sponsor|0
7888592|NCT01830816|12391241|FG000|Overall Study|Withdrawal by Subject|1
7888593|NCT01830816|12391242|FG001|Overall Study|Withdrawal by Subject|1
7888594|NCT01830816|12391243|FG002|Overall Study|Withdrawal by Subject|0
7888595|NCT01830816|12391241|FG000|Overall Study|Lost to Follow-up|0
7888596|NCT01830816|12391242|FG001|Overall Study|Lost to Follow-up|1
7888597|NCT01830816|12391243|FG002|Overall Study|Lost to Follow-up|0
7888598|NCT01830816|12391241|FG000|Overall Study|Symptomatic Deterioration|1
7888599|NCT01830816|12391242|FG001|Overall Study|Symptomatic Deterioration|0
7888600|NCT01830816|12391243|FG002|Overall Study|Symptomatic Deterioration|0
7888601|NCT01830816|12391241|FG000|Overall Study|Reason not Specified|2
7888602|NCT01830816|12391242|FG001|Overall Study|Reason not Specified|0
7888603|NCT01830816|12391243|FG002|Overall Study|Reason not Specified|0
7888604|NCT01830855|12391267|FG000|Overall Study|Other|7
7888605|NCT01830855|12391268|FG001|Overall Study|Other|1
7888606|NCT01830855|12391269|FG002|Overall Study|Other|4
7888607|NCT01830855|12391270|FG003|Overall Study|Other|4
7888608|NCT01830855|12391267|FG000|Overall Study|Medication error without associated AE|1
7888609|NCT01830855|12391268|FG001|Overall Study|Medication error without associated AE|0
7888610|NCT01830855|12391269|FG002|Overall Study|Medication error without associated AE|0
7888611|NCT01830855|12391270|FG003|Overall Study|Medication error without associated AE|1
7888612|NCT01830855|12391267|FG000|Overall Study|Pregnancy|3
7888613|NCT01830855|12391268|FG001|Overall Study|Pregnancy|1
7888614|NCT01830855|12391269|FG002|Overall Study|Pregnancy|2
7888615|NCT01830855|12391270|FG003|Overall Study|Pregnancy|1
7888616|NCT01830855|12391267|FG000|Overall Study|No longer meets eligibility criteria|11
7888617|NCT01830855|12391268|FG001|Overall Study|No longer meets eligibility criteria|2
7888618|NCT01830855|12391269|FG002|Overall Study|No longer meets eligibility criteria|3
7888619|NCT01830855|12391270|FG003|Overall Study|No longer meets eligibility criteria|5
7888620|NCT01830855|12391267|FG000|Overall Study|Adverse Event|11
7888621|NCT01830855|12391268|FG001|Overall Study|Adverse Event|5
7888622|NCT01830855|12391269|FG002|Overall Study|Adverse Event|6
7888623|NCT01830855|12391270|FG003|Overall Study|Adverse Event|3
7888624|NCT01830855|12391267|FG000|Overall Study|Protocol deviation|10
7888625|NCT01830855|12391268|FG001|Overall Study|Protocol deviation|5
7888626|NCT01830855|12391269|FG002|Overall Study|Protocol deviation|6
7888627|NCT01830855|12391270|FG003|Overall Study|Protocol deviation|6
7888628|NCT01830855|12391267|FG000|Overall Study|Withdrawal by Subject|33
7888629|NCT01830855|12391268|FG001|Overall Study|Withdrawal by Subject|14
7888630|NCT01830855|12391269|FG002|Overall Study|Withdrawal by Subject|10
7888631|NCT01830855|12391270|FG003|Overall Study|Withdrawal by Subject|12
7888632|NCT01830855|12391267|FG000|Overall Study|No longer willing to participate|32
7888633|NCT01830855|12391268|FG001|Overall Study|No longer willing to participate|13
7888634|NCT01830855|12391269|FG002|Overall Study|No longer willing to participate|12
7888635|NCT01830855|12391270|FG003|Overall Study|No longer willing to participate|17
7888636|NCT01830855|12391267|FG000|Overall Study|Lost to Follow-up|47
7888637|NCT01830855|12391268|FG001|Overall Study|Lost to Follow-up|20
7888638|NCT01830855|12391269|FG002|Overall Study|Lost to Follow-up|23
7888639|NCT01830855|12391270|FG003|Overall Study|Lost to Follow-up|33
7888640|NCT01830881|12391287|FG000|Overall Study|Changed decision to have an abortion|0
7888641|NCT01830881|12391288|FG001|Overall Study|Changed decision to have an abortion|1
7888642|NCT01830920|12391301|FG000|Overall Study|Adverse Event|1
7888643|NCT01830920|12391302|FG001|Overall Study|Adverse Event|0
7888644|NCT01830920|12391303|FG002|Overall Study|Adverse Event|1
7888645|NCT01830920|12391304|FG003|Overall Study|Adverse Event|0
7888646|NCT01830920|12391305|FG004|Overall Study|Adverse Event|0
7888647|NCT01830920|12391301|FG000|Overall Study|Withdrawal by Subject|2
7888648|NCT01830920|12391302|FG001|Overall Study|Withdrawal by Subject|2
7888649|NCT01830920|12391303|FG002|Overall Study|Withdrawal by Subject|1
7888650|NCT01830920|12391304|FG003|Overall Study|Withdrawal by Subject|7
7888651|NCT01830920|12391305|FG004|Overall Study|Withdrawal by Subject|1
7888652|NCT01830920|12391301|FG000|Overall Study|Death|3
7888653|NCT01830920|12391302|FG001|Overall Study|Death|3
7888654|NCT01830920|12391303|FG002|Overall Study|Death|5
7888655|NCT01830920|12391304|FG003|Overall Study|Death|4
7888656|NCT01830920|12391305|FG004|Overall Study|Death|4
7888657|NCT01830920|12391301|FG000|Overall Study|Other|15
7888658|NCT01830920|12391302|FG001|Overall Study|Other|1
7888659|NCT01830920|12391303|FG002|Overall Study|Other|1
7888660|NCT01830920|12391304|FG003|Overall Study|Other|5
7888661|NCT01830920|12391305|FG004|Overall Study|Other|3
7888662|NCT01830972|12391328|FG000|Part II|Withdrawal by Subject|2
7888663|NCT01830972|12391329|FG001|Part II|Withdrawal by Subject|2
7888664|NCT01830972|12391328|FG000|Part III|Withdrawal by Subject|1
7888665|NCT01830972|12391329|FG001|Part III|Withdrawal by Subject|0
7888666|NCT01830972|12391328|FG000|Part III|Noncompliance|1
7888667|NCT01830972|12391329|FG001|Part III|Noncompliance|0
7888668|NCT01830972|12391328|FG000|Part IV|Withdrawal by Subject|2
7888669|NCT01830972|12391329|FG001|Part IV|Withdrawal by Subject|1
7888670|NCT01830972|12391328|FG000|Part IV|Non-Compliance|1
7888671|NCT01830972|12391329|FG001|Part IV|Non-Compliance|0
7888672|NCT01831089|12391351|FG000|Cohort I: Dose Level 1|Progressive disease|3
7888673|NCT01831089|12391352|FG001|Cohort I: Dose Level 1|Progressive disease|0
7888674|NCT01831089|12391353|FG002|Cohort I: Dose Level 1|Progressive disease|0
7888675|NCT01831089|12391354|FG003|Cohort I: Dose Level 1|Progressive disease|0
7888676|NCT01831089|12391355|FG004|Cohort I: Dose Level 1|Progressive disease|0
7888677|NCT01831089|12391356|FG005|Cohort I: Dose Level 1|Progressive disease|0
7888678|NCT01831089|12391351|FG000|Cohort II: Dose Level 2|Progressive disease|0
7888679|NCT01831089|12391352|FG001|Cohort II: Dose Level 2|Progressive disease|2
7888680|NCT01831089|12391353|FG002|Cohort II: Dose Level 2|Progressive disease|0
7888681|NCT01831089|12391354|FG003|Cohort II: Dose Level 2|Progressive disease|0
7888682|NCT01831089|12391355|FG004|Cohort II: Dose Level 2|Progressive disease|0
7888683|NCT01831089|12391356|FG005|Cohort II: Dose Level 2|Progressive disease|0
7888684|NCT01831089|12391351|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0
7888685|NCT01831089|12391352|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1
7888686|NCT01831089|12391353|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0
7888687|NCT01831089|12391354|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0
7888688|NCT01831089|12391355|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0
7888689|NCT01831089|12391356|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0
7888690|NCT01831089|12391351|FG000|Cohort III: Dose Level 3|Progressive disease|0
7888691|NCT01831089|12391352|FG001|Cohort III: Dose Level 3|Progressive disease|0
7888692|NCT01831089|12391353|FG002|Cohort III: Dose Level 3|Progressive disease|3
7888693|NCT01831089|12391354|FG003|Cohort III: Dose Level 3|Progressive disease|0
7888694|NCT01831089|12391355|FG004|Cohort III: Dose Level 3|Progressive disease|0
7888695|NCT01831089|12391356|FG005|Cohort III: Dose Level 3|Progressive disease|0
7888696|NCT01831089|12391351|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0
7888697|NCT01831089|12391352|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0
7888698|NCT01831089|12391353|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1
7888699|NCT01831089|12391354|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0
7888700|NCT01831089|12391355|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0
7888701|NCT01831089|12391356|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0
7888702|NCT01831089|12391351|FG000|Cohort III: Dose Level 3|Adverse Event|0
7888703|NCT01831089|12391352|FG001|Cohort III: Dose Level 3|Adverse Event|0
7888704|NCT01831089|12391353|FG002|Cohort III: Dose Level 3|Adverse Event|1
7888705|NCT01831089|12391354|FG003|Cohort III: Dose Level 3|Adverse Event|0
7888706|NCT01831089|12391355|FG004|Cohort III: Dose Level 3|Adverse Event|0
7888707|NCT01831089|12391356|FG005|Cohort III: Dose Level 3|Adverse Event|0
7888708|NCT01831089|12391351|FG000|Cohort III: Dose Level 3|Global end of study|0
7888709|NCT01831089|12391352|FG001|Cohort III: Dose Level 3|Global end of study|0
7888710|NCT01831089|12391353|FG002|Cohort III: Dose Level 3|Global end of study|1
7888711|NCT01831089|12391354|FG003|Cohort III: Dose Level 3|Global end of study|0
7888712|NCT01831089|12391355|FG004|Cohort III: Dose Level 3|Global end of study|0
7888713|NCT01831089|12391356|FG005|Cohort III: Dose Level 3|Global end of study|0
7888714|NCT01831089|12391351|FG000|Cohort IV: Dose Level 4|Progressive disease|0
7888715|NCT01831089|12391352|FG001|Cohort IV: Dose Level 4|Progressive disease|0
7888716|NCT01831089|12391353|FG002|Cohort IV: Dose Level 4|Progressive disease|0
7888717|NCT01831089|12391354|FG003|Cohort IV: Dose Level 4|Progressive disease|6
7888718|NCT01831089|12391355|FG004|Cohort IV: Dose Level 4|Progressive disease|0
7888719|NCT01831089|12391356|FG005|Cohort IV: Dose Level 4|Progressive disease|0
7888720|NCT01831089|12391351|FG000|Cohort V: Dose Level 5|Progressive disease|0
7888721|NCT01831089|12391352|FG001|Cohort V: Dose Level 5|Progressive disease|0
7888722|NCT01831089|12391353|FG002|Cohort V: Dose Level 5|Progressive disease|0
7888723|NCT01831089|12391354|FG003|Cohort V: Dose Level 5|Progressive disease|0
7888724|NCT01831089|12391355|FG004|Cohort V: Dose Level 5|Progressive disease|30
7888725|NCT01831089|12391356|FG005|Cohort V: Dose Level 5|Progressive disease|0
7888726|NCT01831089|12391351|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0
7888727|NCT01831089|12391352|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0
7888728|NCT01831089|12391353|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0
7888729|NCT01831089|12391354|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0
7968209|NCT03893565|12525823|FG003|Double-blind Induction Phase (10 Weeks)|Other|0
7888730|NCT01831089|12391355|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3
7888731|NCT01831089|12391356|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0
7888732|NCT01831089|12391351|FG000|Cohort V: Dose Level 5|Death|0
7888733|NCT01831089|12391352|FG001|Cohort V: Dose Level 5|Death|0
7888734|NCT01831089|12391353|FG002|Cohort V: Dose Level 5|Death|0
7888735|NCT01831089|12391354|FG003|Cohort V: Dose Level 5|Death|0
7888736|NCT01831089|12391355|FG004|Cohort V: Dose Level 5|Death|1
7888737|NCT01831089|12391356|FG005|Cohort V: Dose Level 5|Death|0
7888738|NCT01831089|12391351|FG000|Cohort V: Dose Level 5|Global end of study|0
7888739|NCT01831089|12391352|FG001|Cohort V: Dose Level 5|Global end of study|0
7888740|NCT01831089|12391353|FG002|Cohort V: Dose Level 5|Global end of study|0
7888741|NCT01831089|12391354|FG003|Cohort V: Dose Level 5|Global end of study|0
7888742|NCT01831089|12391355|FG004|Cohort V: Dose Level 5|Global end of study|2
7888743|NCT01831089|12391356|FG005|Cohort V: Dose Level 5|Global end of study|0
7888744|NCT01831089|12391351|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0
7888745|NCT01831089|12391352|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0
7888746|NCT01831089|12391353|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0
7888747|NCT01831089|12391354|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0
7888748|NCT01831089|12391355|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1
7888749|NCT01831089|12391356|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0
7888750|NCT01831089|12391351|FG000|Cohort B: Arm B|Progressive disease|0
7888751|NCT01831089|12391352|FG001|Cohort B: Arm B|Progressive disease|0
7888752|NCT01831089|12391353|FG002|Cohort B: Arm B|Progressive disease|0
7888753|NCT01831089|12391354|FG003|Cohort B: Arm B|Progressive disease|0
7888754|NCT01831089|12391355|FG004|Cohort B: Arm B|Progressive disease|0
7888755|NCT01831089|12391356|FG005|Cohort B: Arm B|Progressive disease|8
7888756|NCT01831089|12391351|FG000|Cohort B: Arm B|Physician Decision|0
7888757|NCT01831089|12391352|FG001|Cohort B: Arm B|Physician Decision|0
7888758|NCT01831089|12391353|FG002|Cohort B: Arm B|Physician Decision|0
7888759|NCT01831089|12391354|FG003|Cohort B: Arm B|Physician Decision|0
7888760|NCT01831089|12391355|FG004|Cohort B: Arm B|Physician Decision|0
7888761|NCT01831089|12391356|FG005|Cohort B: Arm B|Physician Decision|2
7888762|NCT01831089|12391351|FG000|Cohort B: Arm B|Never treated|0
7888763|NCT01831089|12391352|FG001|Cohort B: Arm B|Never treated|0
7888764|NCT01831089|12391353|FG002|Cohort B: Arm B|Never treated|0
7888765|NCT01831089|12391354|FG003|Cohort B: Arm B|Never treated|0
7888766|NCT01831089|12391355|FG004|Cohort B: Arm B|Never treated|0
7888767|NCT01831089|12391356|FG005|Cohort B: Arm B|Never treated|2
7888768|NCT01831089|12391351|FG000|Cohort B: Arm B|Adverse Event|0
7888769|NCT01831089|12391352|FG001|Cohort B: Arm B|Adverse Event|0
7888770|NCT01831089|12391353|FG002|Cohort B: Arm B|Adverse Event|0
7888771|NCT01831089|12391354|FG003|Cohort B: Arm B|Adverse Event|0
7888772|NCT01831089|12391355|FG004|Cohort B: Arm B|Adverse Event|0
7888773|NCT01831089|12391356|FG005|Cohort B: Arm B|Adverse Event|1
7888774|NCT01831089|12391351|FG000|Cohort B: Arm B|Global end of study|0
7888775|NCT01831089|12391352|FG001|Cohort B: Arm B|Global end of study|0
7888776|NCT01831089|12391353|FG002|Cohort B: Arm B|Global end of study|0
7888777|NCT01831089|12391354|FG003|Cohort B: Arm B|Global end of study|0
7888778|NCT01831089|12391355|FG004|Cohort B: Arm B|Global end of study|0
7888779|NCT01831089|12391356|FG005|Cohort B: Arm B|Global end of study|1
7888780|NCT01831258|12391397|FG000|Overall Study|Withdrawal by Subject|2
7888781|NCT01831258|12391398|FG001|Overall Study|Withdrawal by Subject|1
7888782|NCT01831258|12391397|FG000|Overall Study|Lost to Follow-up|3
7888783|NCT01831258|12391398|FG001|Overall Study|Lost to Follow-up|2
7888784|NCT01831427|12391417|FG000|Overall Study|Adverse Event|0
7888785|NCT01831427|12391418|FG001|Overall Study|Adverse Event|1
7888786|NCT01831427|12391419|FG002|Overall Study|Adverse Event|0
7888787|NCT01831427|12391420|FG003|Overall Study|Adverse Event|0
7888788|NCT01831427|12391421|FG004|Overall Study|Adverse Event|0
7888789|NCT01831427|12391422|FG005|Overall Study|Adverse Event|1
7888790|NCT01831427|12391423|FG006|Overall Study|Adverse Event|0
7888791|NCT01831427|12391424|FG007|Overall Study|Adverse Event|1
7888792|NCT01831427|12391425|FG008|Overall Study|Adverse Event|0
7888793|NCT01831427|12391426|FG009|Overall Study|Adverse Event|0
7888794|NCT01831427|12391427|FG010|Overall Study|Adverse Event|2
7888795|NCT01831427|12391417|FG000|Overall Study|Investigator's Discretion|0
7888796|NCT01831427|12391418|FG001|Overall Study|Investigator's Discretion|0
7888797|NCT01831427|12391419|FG002|Overall Study|Investigator's Discretion|0
7888798|NCT01831427|12391420|FG003|Overall Study|Investigator's Discretion|1
7888799|NCT01831427|12391421|FG004|Overall Study|Investigator's Discretion|0
7888800|NCT01831427|12391422|FG005|Overall Study|Investigator's Discretion|0
7888801|NCT01831427|12391423|FG006|Overall Study|Investigator's Discretion|0
7888802|NCT01831427|12391424|FG007|Overall Study|Investigator's Discretion|0
7888803|NCT01831427|12391425|FG008|Overall Study|Investigator's Discretion|0
7888804|NCT01831427|12391426|FG009|Overall Study|Investigator's Discretion|0
7888805|NCT01831427|12391427|FG010|Overall Study|Investigator's Discretion|0
7888806|NCT01831427|12391417|FG000|Overall Study|Withdrew Consent|0
7888807|NCT01831427|12391418|FG001|Overall Study|Withdrew Consent|0
7888808|NCT01831427|12391419|FG002|Overall Study|Withdrew Consent|0
7888809|NCT01831427|12391420|FG003|Overall Study|Withdrew Consent|0
7888810|NCT01831427|12391421|FG004|Overall Study|Withdrew Consent|0
7888811|NCT01831427|12391422|FG005|Overall Study|Withdrew Consent|0
7888812|NCT01831427|12391423|FG006|Overall Study|Withdrew Consent|2
7888813|NCT01831427|12391424|FG007|Overall Study|Withdrew Consent|0
7888814|NCT01831427|12391425|FG008|Overall Study|Withdrew Consent|0
7888815|NCT01831427|12391426|FG009|Overall Study|Withdrew Consent|1
7888816|NCT01831427|12391427|FG010|Overall Study|Withdrew Consent|1
7888817|NCT01831466|12391474|FG000|Overall Study|Protocol Violation|1
7888818|NCT01831466|12391475|FG001|Overall Study|Protocol Violation|1
7888819|NCT01831466|12391476|FG002|Overall Study|Protocol Violation|2
7888820|NCT01831466|12391477|FG003|Overall Study|Protocol Violation|0
7888821|NCT01831466|12391478|FG004|Overall Study|Protocol Violation|0
7888822|NCT01831466|12391479|FG005|Overall Study|Protocol Violation|1
7888823|NCT01831466|12391480|FG006|Overall Study|Protocol Violation|0
7888824|NCT01831466|12391481|FG007|Overall Study|Protocol Violation|0
7888825|NCT01831466|12391482|FG008|Overall Study|Protocol Violation|0
7888826|NCT01831466|12391483|FG009|Overall Study|Protocol Violation|0
7888827|NCT01831466|12391484|FG010|Overall Study|Protocol Violation|0
7888828|NCT01831466|12391485|FG011|Overall Study|Protocol Violation|0
7888829|NCT01831466|12391474|FG000|Overall Study|Other|2
7888830|NCT01831466|12391475|FG001|Overall Study|Other|3
7888831|NCT01831466|12391476|FG002|Overall Study|Other|2
7888832|NCT01831466|12391477|FG003|Overall Study|Other|2
7888833|NCT01831466|12391478|FG004|Overall Study|Other|2
7888834|NCT01831466|12391479|FG005|Overall Study|Other|1
7888835|NCT01831466|12391480|FG006|Overall Study|Other|0
7888836|NCT01831466|12391481|FG007|Overall Study|Other|0
7888837|NCT01831466|12391482|FG008|Overall Study|Other|0
7888838|NCT01831466|12391483|FG009|Overall Study|Other|0
7888839|NCT01831466|12391484|FG010|Overall Study|Other|0
7888840|NCT01831466|12391485|FG011|Overall Study|Other|0
7888841|NCT01831466|12391474|FG000|Overall Study|Non-compliance with study treatment|2
7888842|NCT01831466|12391475|FG001|Overall Study|Non-compliance with study treatment|1
7888843|NCT01831466|12391476|FG002|Overall Study|Non-compliance with study treatment|1
7888844|NCT01831466|12391477|FG003|Overall Study|Non-compliance with study treatment|0
7888845|NCT01831466|12391478|FG004|Overall Study|Non-compliance with study treatment|0
7888846|NCT01831466|12391479|FG005|Overall Study|Non-compliance with study treatment|1
7888847|NCT01831466|12391480|FG006|Overall Study|Non-compliance with study treatment|0
7888848|NCT01831466|12391481|FG007|Overall Study|Non-compliance with study treatment|0
7888849|NCT01831466|12391482|FG008|Overall Study|Non-compliance with study treatment|0
7888850|NCT01831466|12391483|FG009|Overall Study|Non-compliance with study treatment|0
7888851|NCT01831466|12391484|FG010|Overall Study|Non-compliance with study treatment|0
7888852|NCT01831466|12391485|FG011|Overall Study|Non-compliance with study treatment|0
7888853|NCT01831466|12391474|FG000|Overall Study|Death|0
7888854|NCT01831466|12391475|FG001|Overall Study|Death|1
7888855|NCT01831466|12391476|FG002|Overall Study|Death|0
7888856|NCT01831466|12391477|FG003|Overall Study|Death|0
7888857|NCT01831466|12391478|FG004|Overall Study|Death|0
7888858|NCT01831466|12391479|FG005|Overall Study|Death|0
7888859|NCT01831466|12391480|FG006|Overall Study|Death|0
7888860|NCT01831466|12391481|FG007|Overall Study|Death|0
7888861|NCT01831466|12391482|FG008|Overall Study|Death|0
7888862|NCT01831466|12391483|FG009|Overall Study|Death|0
7888863|NCT01831466|12391484|FG010|Overall Study|Death|0
7888864|NCT01831466|12391485|FG011|Overall Study|Death|0
7888865|NCT01831466|12391474|FG000|Overall Study|Withdrawal by Subject|6
7888866|NCT01831466|12391475|FG001|Overall Study|Withdrawal by Subject|3
7888867|NCT01831466|12391476|FG002|Overall Study|Withdrawal by Subject|3
7888868|NCT01831466|12391477|FG003|Overall Study|Withdrawal by Subject|3
7888869|NCT01831466|12391478|FG004|Overall Study|Withdrawal by Subject|3
7888870|NCT01831466|12391479|FG005|Overall Study|Withdrawal by Subject|5
7888871|NCT01831466|12391480|FG006|Overall Study|Withdrawal by Subject|0
7888872|NCT01831466|12391481|FG007|Overall Study|Withdrawal by Subject|0
7888873|NCT01831466|12391482|FG008|Overall Study|Withdrawal by Subject|0
7888874|NCT01831466|12391483|FG009|Overall Study|Withdrawal by Subject|1
7888875|NCT01831466|12391484|FG010|Overall Study|Withdrawal by Subject|0
7888876|NCT01831466|12391485|FG011|Overall Study|Withdrawal by Subject|1
7888877|NCT01831466|12391474|FG000|Overall Study|Lost to Follow-up|0
7888878|NCT01831466|12391475|FG001|Overall Study|Lost to Follow-up|1
7888879|NCT01831466|12391476|FG002|Overall Study|Lost to Follow-up|4
7888880|NCT01831466|12391477|FG003|Overall Study|Lost to Follow-up|2
7888881|NCT01831466|12391478|FG004|Overall Study|Lost to Follow-up|0
7888882|NCT01831466|12391479|FG005|Overall Study|Lost to Follow-up|3
7888883|NCT01831466|12391480|FG006|Overall Study|Lost to Follow-up|0
7888884|NCT01831466|12391481|FG007|Overall Study|Lost to Follow-up|0
7888885|NCT01831466|12391482|FG008|Overall Study|Lost to Follow-up|0
7888886|NCT01831466|12391483|FG009|Overall Study|Lost to Follow-up|1
7888887|NCT01831466|12391484|FG010|Overall Study|Lost to Follow-up|0
7888888|NCT01831466|12391485|FG011|Overall Study|Lost to Follow-up|1
7888889|NCT01831466|12391474|FG000|Overall Study|Lack of Efficacy|5
7888890|NCT01831466|12391475|FG001|Overall Study|Lack of Efficacy|8
7888891|NCT01831466|12391476|FG002|Overall Study|Lack of Efficacy|7
7888892|NCT01831466|12391477|FG003|Overall Study|Lack of Efficacy|6
7888893|NCT01831466|12391478|FG004|Overall Study|Lack of Efficacy|9
7888894|NCT01831466|12391479|FG005|Overall Study|Lack of Efficacy|8
7888895|NCT01831466|12391480|FG006|Overall Study|Lack of Efficacy|1
7888896|NCT01831466|12391481|FG007|Overall Study|Lack of Efficacy|1
7888897|NCT01831466|12391482|FG008|Overall Study|Lack of Efficacy|2
7888898|NCT01831466|12391483|FG009|Overall Study|Lack of Efficacy|2
7888899|NCT01831466|12391484|FG010|Overall Study|Lack of Efficacy|2
7888900|NCT01831466|12391485|FG011|Overall Study|Lack of Efficacy|0
7888901|NCT01831466|12391474|FG000|Overall Study|Adverse Event|0
7888902|NCT01831466|12391475|FG001|Overall Study|Adverse Event|0
7888903|NCT01831466|12391476|FG002|Overall Study|Adverse Event|4
7888904|NCT01831466|12391477|FG003|Overall Study|Adverse Event|6
7888905|NCT01831466|12391478|FG004|Overall Study|Adverse Event|3
7888906|NCT01831466|12391479|FG005|Overall Study|Adverse Event|7
7888907|NCT01831466|12391480|FG006|Overall Study|Adverse Event|0
7888908|NCT01831466|12391481|FG007|Overall Study|Adverse Event|1
7888909|NCT01831466|12391482|FG008|Overall Study|Adverse Event|1
7888910|NCT01831466|12391483|FG009|Overall Study|Adverse Event|1
7888911|NCT01831466|12391484|FG010|Overall Study|Adverse Event|0
7888912|NCT01831466|12391485|FG011|Overall Study|Adverse Event|2
7888913|NCT01831544|12391505|FG000|Overall Study|Death|1
7888914|NCT01831544|12391505|FG000|Overall Study|Still on original MVAD device|2
7888915|NCT01831726|12391509|FG000|Overall Study|Adverse Event|16
7888916|NCT01831726|12391509|FG000|Overall Study|Death|7
7888917|NCT01831726|12391509|FG000|Overall Study|Disease Progression|49
7888918|NCT01831726|12391509|FG000|Overall Study|Physician Decision|1
7888919|NCT01831726|12391509|FG000|Overall Study|Subject/guardian decision|7
7888920|NCT01831765|12391516|FG000|Overall Study|Lack of Efficacy|1
7888921|NCT01831765|12391517|FG001|Overall Study|Lack of Efficacy|0
7888922|NCT01831765|12391518|FG002|Overall Study|Lack of Efficacy|0
7888923|NCT01831765|12391516|FG000|Overall Study|Other, sponsor withdrew subject|0
7888924|NCT01831765|12391517|FG001|Overall Study|Other, sponsor withdrew subject|1
7888925|NCT01831765|12391518|FG002|Overall Study|Other, sponsor withdrew subject|0
7888926|NCT01831765|12391516|FG000|Overall Study|Pregnancy|1
7888927|NCT01831765|12391517|FG001|Overall Study|Pregnancy|1
7888928|NCT01831765|12391518|FG002|Overall Study|Pregnancy|2
7888929|NCT01831765|12391516|FG000|Overall Study|Death|0
7888930|NCT01831765|12391517|FG001|Overall Study|Death|1
7888931|NCT01831765|12391518|FG002|Overall Study|Death|1
7888932|NCT01831765|12391516|FG000|Overall Study|Other, site closed|1
7888933|NCT01831765|12391517|FG001|Overall Study|Other, site closed|1
7888934|NCT01831765|12391518|FG002|Overall Study|Other, site closed|0
7888935|NCT01831765|12391516|FG000|Overall Study|Adverse Event|5
7888936|NCT01831765|12391517|FG001|Overall Study|Adverse Event|3
7888937|NCT01831765|12391518|FG002|Overall Study|Adverse Event|3
7888938|NCT01831765|12391516|FG000|Overall Study|Withdrawal by Subject|22
7888939|NCT01831765|12391517|FG001|Overall Study|Withdrawal by Subject|7
7888940|NCT01831765|12391518|FG002|Overall Study|Withdrawal by Subject|17
7888941|NCT01831765|12391516|FG000|Overall Study|Withdrawal criteria|12
7888942|NCT01831765|12391517|FG001|Overall Study|Withdrawal criteria|10
7888943|NCT01831765|12391518|FG002|Overall Study|Withdrawal criteria|16
7888944|NCT01831765|12391516|FG000|Overall Study|Lost to Follow-up|2
7888945|NCT01831765|12391517|FG001|Overall Study|Lost to Follow-up|3
7888946|NCT01831765|12391518|FG002|Overall Study|Lost to Follow-up|3
7888947|NCT01831791|12391528|FG000|Overall Study|Withdrawal by Subject|10
7962895|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7962896|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7962897|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7962898|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9
7962899|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4
7962900|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0
7962901|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0
7962902|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0
7962903|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189
7962904|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75
7962905|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
7962906|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
7962907|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
7962908|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3
7962909|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3
7962910|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0
7962911|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0
7962912|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0
7962913|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1
7962914|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7962915|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7962916|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7962917|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7962918|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Technical error|1
7962919|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Technical error|0
7962920|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Technical error|0
7962921|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Technical error|0
7962922|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Technical error|0
7962923|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Patient decision|5
7962924|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Patient decision|2
7962925|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Patient decision|0
7962926|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Patient decision|0
7962927|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Patient decision|0
7962928|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1
7888948|NCT01831804|12391541|FG000|Overall Study|Adverse Event|0
7888949|NCT01831804|12391542|FG001|Overall Study|Adverse Event|0
7888950|NCT01831804|12391543|FG002|Overall Study|Adverse Event|0
7888951|NCT01831804|12391544|FG003|Overall Study|Adverse Event|0
7888952|NCT01831804|12391545|FG004|Overall Study|Adverse Event|0
7888953|NCT01831804|12391546|FG005|Overall Study|Adverse Event|0
7888954|NCT01831804|12391547|FG006|Overall Study|Adverse Event|1
7888955|NCT01831804|12391548|FG007|Overall Study|Adverse Event|0
7888956|NCT01831804|12391549|FG008|Overall Study|Adverse Event|1
7888957|NCT01831804|12391541|FG000|Overall Study|Protocol Violation|0
7888958|NCT01831804|12391542|FG001|Overall Study|Protocol Violation|0
7888959|NCT01831804|12391543|FG002|Overall Study|Protocol Violation|2
7888960|NCT01831804|12391544|FG003|Overall Study|Protocol Violation|0
7888961|NCT01831804|12391545|FG004|Overall Study|Protocol Violation|0
7888962|NCT01831804|12391546|FG005|Overall Study|Protocol Violation|0
7888963|NCT01831804|12391547|FG006|Overall Study|Protocol Violation|0
7888964|NCT01831804|12391548|FG007|Overall Study|Protocol Violation|0
7888965|NCT01831804|12391549|FG008|Overall Study|Protocol Violation|0
7888966|NCT01831804|12391541|FG000|Overall Study|Protocol defined stopping criteria|1
7888967|NCT01831804|12391542|FG001|Overall Study|Protocol defined stopping criteria|1
7888968|NCT01831804|12391543|FG002|Overall Study|Protocol defined stopping criteria|3
7888969|NCT01831804|12391544|FG003|Overall Study|Protocol defined stopping criteria|0
7888970|NCT01831804|12391545|FG004|Overall Study|Protocol defined stopping criteria|1
7888971|NCT01831804|12391546|FG005|Overall Study|Protocol defined stopping criteria|0
7888972|NCT01831804|12391547|FG006|Overall Study|Protocol defined stopping criteria|0
7888973|NCT01831804|12391548|FG007|Overall Study|Protocol defined stopping criteria|0
7888974|NCT01831804|12391549|FG008|Overall Study|Protocol defined stopping criteria|0
7888975|NCT01831804|12391541|FG000|Overall Study|Lost to Follow-up|0
7888976|NCT01831804|12391542|FG001|Overall Study|Lost to Follow-up|0
7888977|NCT01831804|12391543|FG002|Overall Study|Lost to Follow-up|1
7888978|NCT01831804|12391544|FG003|Overall Study|Lost to Follow-up|0
7888979|NCT01831804|12391545|FG004|Overall Study|Lost to Follow-up|0
7888980|NCT01831804|12391546|FG005|Overall Study|Lost to Follow-up|0
7888981|NCT01831804|12391547|FG006|Overall Study|Lost to Follow-up|0
7888982|NCT01831804|12391548|FG007|Overall Study|Lost to Follow-up|0
7888983|NCT01831804|12391549|FG008|Overall Study|Lost to Follow-up|1
7888984|NCT01831804|12391541|FG000|Overall Study|Investigator discretion|0
7888985|NCT01831804|12391542|FG001|Overall Study|Investigator discretion|0
7888986|NCT01831804|12391543|FG002|Overall Study|Investigator discretion|0
7888987|NCT01831804|12391544|FG003|Overall Study|Investigator discretion|0
7888988|NCT01831804|12391545|FG004|Overall Study|Investigator discretion|1
7888989|NCT01831804|12391546|FG005|Overall Study|Investigator discretion|0
7888990|NCT01831804|12391547|FG006|Overall Study|Investigator discretion|0
7888991|NCT01831804|12391548|FG007|Overall Study|Investigator discretion|1
7888992|NCT01831804|12391549|FG008|Overall Study|Investigator discretion|0
7888993|NCT01831804|12391541|FG000|Overall Study|Withdrew Consent|0
7888994|NCT01831804|12391542|FG001|Overall Study|Withdrew Consent|1
7888995|NCT01831804|12391543|FG002|Overall Study|Withdrew Consent|0
7888996|NCT01831804|12391544|FG003|Overall Study|Withdrew Consent|0
7888997|NCT01831804|12391545|FG004|Overall Study|Withdrew Consent|0
7888998|NCT01831804|12391546|FG005|Overall Study|Withdrew Consent|0
7888999|NCT01831804|12391547|FG006|Overall Study|Withdrew Consent|0
7889000|NCT01831804|12391548|FG007|Overall Study|Withdrew Consent|2
7889001|NCT01831804|12391549|FG008|Overall Study|Withdrew Consent|0
7889002|NCT01831817|12391582|FG000|Overall Study|Lost to Follow-up|1
7889003|NCT01831817|12391583|FG001|Overall Study|Lost to Follow-up|0
7889004|NCT01831817|12391584|FG002|Overall Study|Lost to Follow-up|0
7889005|NCT01831817|12391585|FG003|Overall Study|Lost to Follow-up|0
7889006|NCT01831817|12391582|FG000|Overall Study|Withdrawl of Consent|3
7889007|NCT01831817|12391583|FG001|Overall Study|Withdrawl of Consent|0
7889008|NCT01831817|12391584|FG002|Overall Study|Withdrawl of Consent|0
7889009|NCT01831817|12391585|FG003|Overall Study|Withdrawl of Consent|0
7889010|NCT01831856|12391597|FG000|Overall Study|Adverse Event|5
7889011|NCT01831856|12391598|FG001|Overall Study|Adverse Event|8
7889012|NCT01831856|12391597|FG000|Overall Study|Lack of Efficacy|13
7889013|NCT01831856|12391598|FG001|Overall Study|Lack of Efficacy|11
7889014|NCT01831856|12391597|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16
7889015|NCT01831856|12391598|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18
7889016|NCT01832038|12391635|FG000|Overall Study|Death|5
7889017|NCT01832038|12391635|FG000|Overall Study|Adverse Event|50
7889018|NCT01832038|12391635|FG000|Overall Study|Lack of Efficacy|81
7889019|NCT01832038|12391635|FG000|Overall Study|Protocol Violation|7
7889020|NCT01832038|12391635|FG000|Overall Study|Lost to Follow-up|10
7889021|NCT01832038|12391635|FG000|Overall Study|Withdrawal by Subject|49
7889022|NCT01832038|12391635|FG000|Overall Study|Visit non-compliance|2
7889023|NCT01832038|12391635|FG000|Overall Study|Subject refused to return visit|2
7889024|NCT01832038|12391635|FG000|Overall Study|Not convenient to come back to site|2
7889025|NCT01832038|12391635|FG000|Overall Study|Participant was asked to quit|5
7889026|NCT01832038|12391635|FG000|Overall Study|Back home|1
7889027|NCT01832038|12391635|FG000|Overall Study|Pregnancy|1
7889028|NCT01832038|12391635|FG000|Overall Study|Low compliance|3
7889029|NCT01832038|12391635|FG000|Overall Study|Prohibit procedure|2
7889030|NCT01832038|12391635|FG000|Overall Study|Not possible to visit the hospital|1
7889031|NCT01832038|12391635|FG000|Overall Study|Changes of implementation system|3
7889032|NCT01832038|12391635|FG000|Overall Study|Plan to pregnancy|7
7889033|NCT01832038|12391635|FG000|Overall Study|Bad mood and has suicidal thought|1
7889034|NCT01832038|12391635|FG000|Overall Study|Prohibited concomitant medication|1
7889035|NCT01832038|12391635|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1
7889036|NCT01832038|12391635|FG000|Overall Study|Subject considered the efficacy was poor|1
7889037|NCT01832155|12391671|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
7889038|NCT01832155|12391672|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
7889039|NCT01832155|12391671|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
7889040|NCT01832155|12391672|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
7811237|NCT01180998|12274819|FG000|Overall Study|Withdrawal by Subject|0
7811238|NCT01180998|12274820|FG001|Overall Study|Withdrawal by Subject|0
7811239|NCT01180998|12274821|FG002|Overall Study|Withdrawal by Subject|1
7811240|NCT01180998|12274819|FG000|Overall Study|Poor comfort|3
7811241|NCT01180998|12274820|FG001|Overall Study|Poor comfort|0
7811242|NCT01180998|12274821|FG002|Overall Study|Poor comfort|4
7811243|NCT01180998|12274819|FG000|Overall Study|Poor lens handling|0
7811244|NCT01180998|12274820|FG001|Overall Study|Poor lens handling|0
7811245|NCT01180998|12274821|FG002|Overall Study|Poor lens handling|2
7811246|NCT01181011|12274830|FG000|Overall Study|Adverse Event|2
7811247|NCT01181011|12274830|FG000|Overall Study|Lost to Follow-up|1
7811248|NCT01181102|12274859|FG000|Overall Study|Adverse Event|28
7811249|NCT01181102|12274860|FG001|Overall Study|Adverse Event|26
7811250|NCT01181102|12274859|FG000|Overall Study|Lack of Efficacy|3
7811251|NCT01181102|12274860|FG001|Overall Study|Lack of Efficacy|1
7811252|NCT01181102|12274859|FG000|Overall Study|Lost to Follow-up|2
7811253|NCT01181102|12274860|FG001|Overall Study|Lost to Follow-up|0
7811254|NCT01181102|12274859|FG000|Overall Study|Physician Decision|3
7811255|NCT01181102|12274860|FG001|Overall Study|Physician Decision|1
7811256|NCT01181102|12274859|FG000|Overall Study|Protocol Violation|5
7811257|NCT01181102|12274860|FG001|Overall Study|Protocol Violation|6
7811258|NCT01181102|12274859|FG000|Overall Study|Withdrawal by Subject|10
7811259|NCT01181102|12274860|FG001|Overall Study|Withdrawal by Subject|12
7811260|NCT01181128|12274869|FG000|Overall Study|Withdrawal by Subject|2
7811261|NCT01181128|12274870|FG001|Overall Study|Withdrawal by Subject|2
7811262|NCT01181128|12274871|FG002|Overall Study|Withdrawal by Subject|0
7811263|NCT01181128|12274869|FG000|Overall Study|Death|1
7889041|NCT01832480|12391695|FG000|Overall Study|Lost to Follow-up|33
7889042|NCT01832480|12391696|FG001|Overall Study|Lost to Follow-up|30
7889043|NCT01832480|12391695|FG000|Overall Study|Withdrawal by Subject|0
7889044|NCT01832480|12391696|FG001|Overall Study|Withdrawal by Subject|2
7889045|NCT01832480|12391695|FG000|Overall Study|post randomization ineligible|8
7811264|NCT01181128|12274870|FG001|Overall Study|Death|0
7811265|NCT01181128|12274871|FG002|Overall Study|Death|0
7811266|NCT01181128|12274869|FG000|Overall Study|Physician Decision|2
7811267|NCT01181128|12274870|FG001|Overall Study|Physician Decision|0
7811268|NCT01181128|12274871|FG002|Overall Study|Physician Decision|0
7811269|NCT01181128|12274869|FG000|Overall Study|Adverse Event|0
7811270|NCT01181128|12274870|FG001|Overall Study|Adverse Event|2
7889046|NCT01832480|12391696|FG001|Overall Study|post randomization ineligible|10
7889047|NCT01832493|12391702|FG000|Overall Study|Physician Decision|2
7889048|NCT01832493|12391702|FG000|Overall Study|Protocol Violation|4
7889049|NCT01832493|12391702|FG000|Overall Study|Unable to place LV lead|2
7968210|NCT03893565|12525824|FG004|Double-blind Induction Phase (10 Weeks)|Other|1
7968211|NCT03893565|12525825|FG005|Double-blind Induction Phase (10 Weeks)|Other|0
7968212|NCT03893565|12525826|FG006|Double-blind Induction Phase (10 Weeks)|Other|0
7968213|NCT03893565|12525827|FG007|Double-blind Induction Phase (10 Weeks)|Other|0
7968214|NCT03893565|12525828|FG008|Double-blind Induction Phase (10 Weeks)|Other|0
7968215|NCT03893565|12525820|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7968216|NCT03893565|12525821|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1
7968217|NCT03893565|12525822|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7968218|NCT03893565|12525823|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7968219|NCT03893565|12525824|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7968220|NCT03893565|12525825|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7968221|NCT03893565|12525826|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7968222|NCT03893565|12525827|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7968223|NCT03893565|12525828|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7968224|NCT03893565|12525820|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7968225|NCT03893565|12525821|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2
7968226|NCT03893565|12525822|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7968227|NCT03893565|12525823|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1
7968228|NCT03893565|12525824|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7968229|NCT03893565|12525825|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7968230|NCT03893565|12525826|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7968231|NCT03893565|12525827|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7968232|NCT03893565|12525828|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7968233|NCT03893565|12525820|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7811271|NCT01181128|12274871|FG002|Overall Study|Adverse Event|0
7968234|NCT03893565|12525821|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1
7968235|NCT03893565|12525822|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7968236|NCT03893565|12525823|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6
7968237|NCT03893565|12525824|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7968238|NCT03893565|12525825|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7968239|NCT03893565|12525826|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7968240|NCT03893565|12525827|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7968241|NCT03893565|12525828|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7968242|NCT03893565|12525820|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5
7968243|NCT03893565|12525821|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5
7968244|NCT03893565|12525822|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9
7968245|NCT03893565|12525823|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
7968246|NCT03893565|12525824|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6
7968247|NCT03893565|12525825|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
7968248|NCT03893565|12525826|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
7968249|NCT03893565|12525827|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
7968250|NCT03893565|12525828|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
7968251|NCT03893565|12525820|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7968252|NCT03893565|12525821|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2
7968253|NCT03893565|12525822|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7968254|NCT03893565|12525823|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7889050|NCT01832532|12391726|FG000|Overall Study|Withdrawal by Subject|5
7889051|NCT01832532|12391727|FG001|Overall Study|Withdrawal by Subject|2
7889052|NCT01832727|12391746|FG000|Overall Study|Adverse Event|4
7889053|NCT01832727|12391747|FG001|Overall Study|Adverse Event|6
7889054|NCT01832727|12391748|FG002|Overall Study|Adverse Event|1
7889055|NCT01832727|12391749|FG003|Overall Study|Adverse Event|0
7889056|NCT01832727|12391750|FG004|Overall Study|Adverse Event|1
7889057|NCT01832727|12391751|FG005|Overall Study|Adverse Event|1
7889058|NCT01832727|12391752|FG006|Overall Study|Adverse Event|2
7889059|NCT01832727|12391753|FG007|Overall Study|Adverse Event|1
7889060|NCT01832727|12391754|FG008|Overall Study|Adverse Event|9
7889061|NCT01832727|12391746|FG000|Overall Study|Disease progression|3
7889062|NCT01832727|12391747|FG001|Overall Study|Disease progression|0
7889063|NCT01832727|12391748|FG002|Overall Study|Disease progression|2
7889064|NCT01832727|12391749|FG003|Overall Study|Disease progression|1
7889065|NCT01832727|12391750|FG004|Overall Study|Disease progression|3
7889066|NCT01832727|12391751|FG005|Overall Study|Disease progression|3
7889067|NCT01832727|12391752|FG006|Overall Study|Disease progression|6
7889068|NCT01832727|12391753|FG007|Overall Study|Disease progression|2
7889069|NCT01832727|12391754|FG008|Overall Study|Disease progression|7
7889070|NCT01832727|12391746|FG000|Overall Study|Lost to Follow-up|0
7889071|NCT01832727|12391747|FG001|Overall Study|Lost to Follow-up|0
7889072|NCT01832727|12391748|FG002|Overall Study|Lost to Follow-up|0
7889073|NCT01832727|12391749|FG003|Overall Study|Lost to Follow-up|1
7889074|NCT01832727|12391750|FG004|Overall Study|Lost to Follow-up|0
7889075|NCT01832727|12391751|FG005|Overall Study|Lost to Follow-up|0
7889076|NCT01832727|12391752|FG006|Overall Study|Lost to Follow-up|0
7889077|NCT01832727|12391753|FG007|Overall Study|Lost to Follow-up|0
7889078|NCT01832727|12391754|FG008|Overall Study|Lost to Follow-up|0
7889079|NCT01832727|12391746|FG000|Overall Study|Physician Decision|1
7889080|NCT01832727|12391747|FG001|Overall Study|Physician Decision|0
7889081|NCT01832727|12391748|FG002|Overall Study|Physician Decision|0
7889082|NCT01832727|12391749|FG003|Overall Study|Physician Decision|1
7889083|NCT01832727|12391750|FG004|Overall Study|Physician Decision|0
7889084|NCT01832727|12391751|FG005|Overall Study|Physician Decision|1
7889085|NCT01832727|12391752|FG006|Overall Study|Physician Decision|0
7889086|NCT01832727|12391753|FG007|Overall Study|Physician Decision|0
7889087|NCT01832727|12391754|FG008|Overall Study|Physician Decision|0
7889088|NCT01832727|12391746|FG000|Overall Study|Withdrawal by Subject|1
7889089|NCT01832727|12391747|FG001|Overall Study|Withdrawal by Subject|1
7889090|NCT01832727|12391748|FG002|Overall Study|Withdrawal by Subject|0
7889091|NCT01832727|12391749|FG003|Overall Study|Withdrawal by Subject|1
7889092|NCT01832727|12391750|FG004|Overall Study|Withdrawal by Subject|0
7889093|NCT01832727|12391751|FG005|Overall Study|Withdrawal by Subject|1
7889094|NCT01832727|12391752|FG006|Overall Study|Withdrawal by Subject|0
7889095|NCT01832727|12391753|FG007|Overall Study|Withdrawal by Subject|2
7889096|NCT01832727|12391754|FG008|Overall Study|Withdrawal by Subject|1
7889097|NCT01832727|12391746|FG000|Overall Study|Study terminated by sponsor|0
7889098|NCT01832727|12391747|FG001|Overall Study|Study terminated by sponsor|0
7889099|NCT01832727|12391748|FG002|Overall Study|Study terminated by sponsor|0
7889100|NCT01832727|12391749|FG003|Overall Study|Study terminated by sponsor|0
7889101|NCT01832727|12391750|FG004|Overall Study|Study terminated by sponsor|0
7889102|NCT01832727|12391751|FG005|Overall Study|Study terminated by sponsor|0
7889103|NCT01832727|12391752|FG006|Overall Study|Study terminated by sponsor|0
7889104|NCT01832727|12391753|FG007|Overall Study|Study terminated by sponsor|1
7889105|NCT01832727|12391754|FG008|Overall Study|Study terminated by sponsor|1
7889106|NCT01832766|12391797|FG000|Washout|Lost to Follow-up|0
7889107|NCT01832766|12391798|FG001|Washout|Lost to Follow-up|1
7889108|NCT01832818|12391804|FG000|Overall Study|Lost to Follow-up|6
7889109|NCT01833065|12391836|FG000|Overall Study|Adverse Event|6
7889110|NCT01833065|12391837|FG001|Overall Study|Adverse Event|1
7889111|NCT01833065|12391838|FG002|Overall Study|Adverse Event|0
7889112|NCT01833065|12391839|FG003|Overall Study|Adverse Event|2
7889113|NCT01833065|12391840|FG004|Overall Study|Adverse Event|3
7889114|NCT01833065|12391836|FG000|Overall Study|Protocol Violation|1
7889115|NCT01833065|12391837|FG001|Overall Study|Protocol Violation|0
7889116|NCT01833065|12391838|FG002|Overall Study|Protocol Violation|0
7889117|NCT01833065|12391839|FG003|Overall Study|Protocol Violation|0
7889118|NCT01833065|12391840|FG004|Overall Study|Protocol Violation|2
7889119|NCT01833065|12391836|FG000|Overall Study|Lost to Follow-up|1
7889120|NCT01833065|12391837|FG001|Overall Study|Lost to Follow-up|0
7889121|NCT01833065|12391838|FG002|Overall Study|Lost to Follow-up|0
7889122|NCT01833065|12391839|FG003|Overall Study|Lost to Follow-up|0
7889123|NCT01833065|12391840|FG004|Overall Study|Lost to Follow-up|3
7889124|NCT01833065|12391836|FG000|Overall Study|Withdrawal by Subject|6
7889125|NCT01833065|12391837|FG001|Overall Study|Withdrawal by Subject|2
7889126|NCT01833065|12391838|FG002|Overall Study|Withdrawal by Subject|4
7889127|NCT01833065|12391839|FG003|Overall Study|Withdrawal by Subject|3
7889128|NCT01833065|12391840|FG004|Overall Study|Withdrawal by Subject|11
7889129|NCT01833065|12391836|FG000|Overall Study|Subject's substantial non-compliance|0
7889130|NCT01833065|12391837|FG001|Overall Study|Subject's substantial non-compliance|1
7889131|NCT01833065|12391838|FG002|Overall Study|Subject's substantial non-compliance|0
7889132|NCT01833065|12391839|FG003|Overall Study|Subject's substantial non-compliance|0
7889133|NCT01833065|12391840|FG004|Overall Study|Subject's substantial non-compliance|0
7889134|NCT01833065|12391836|FG000|Overall Study|Trial terminated by sponsor|8
7889135|NCT01833065|12391837|FG001|Overall Study|Trial terminated by sponsor|8
7889136|NCT01833065|12391838|FG002|Overall Study|Trial terminated by sponsor|7
7889137|NCT01833065|12391839|FG003|Overall Study|Trial terminated by sponsor|3
7889138|NCT01833065|12391840|FG004|Overall Study|Trial terminated by sponsor|13
7889139|NCT01833065|12391836|FG000|Overall Study|Others|2
7889140|NCT01833065|12391837|FG001|Overall Study|Others|1
7889141|NCT01833065|12391838|FG002|Overall Study|Others|1
7889142|NCT01833065|12391839|FG003|Overall Study|Others|1
7889143|NCT01833065|12391840|FG004|Overall Study|Others|4
7889144|NCT01833143|12391872|FG000|Overall Study|Not Treated|1
7889145|NCT01833169|12391876|FG000|Overall Study|Disease Progression|99
7889146|NCT01833169|12391876|FG000|Overall Study|Adverse Event|33
7889147|NCT01833169|12391876|FG000|Overall Study|Withdrawal by Subject|9
7889148|NCT01833169|12391876|FG000|Overall Study|Death|3
7889149|NCT01833169|12391876|FG000|Overall Study|Physician Decision|2
7889150|NCT01833455|12391891|FG000|Overall Study|Withdrawal by Subject|1
7889151|NCT01833455|12391892|FG001|Overall Study|Withdrawal by Subject|0
7889152|NCT01833494|12391923|FG000|Overall Study|Adverse Event|24
7889153|NCT01833494|12391923|FG000|Overall Study|Physician Decision|6
7889154|NCT01833494|12391923|FG000|Overall Study|Withdrawal by Subject|6
7889155|NCT01833494|12391923|FG000|Overall Study|Decrease in serum phosphorus|4
7889156|NCT01833494|12391923|FG000|Overall Study|Decrease in serum calcium|4
7889157|NCT01833494|12391923|FG000|Overall Study|Increase in serum ferritin|1
7889158|NCT01833520|12391929|FG000|Overall Study|Lack of Efficacy|3
7889159|NCT01833520|12391930|FG001|Overall Study|Lack of Efficacy|3
7889160|NCT01833520|12391931|FG002|Overall Study|Lack of Efficacy|8
7889161|NCT01833520|12391932|FG003|Overall Study|Lack of Efficacy|3
7889162|NCT01833533|12391946|FG000|Overall Study|Adverse Event|0
7889163|NCT01833533|12391947|FG001|Overall Study|Adverse Event|1
7889164|NCT01833533|12391946|FG000|Overall Study|Lost to Follow-up|4
7889165|NCT01833533|12391947|FG001|Overall Study|Lost to Follow-up|9
7889166|NCT01833533|12391946|FG000|Overall Study|To Enter an Extension Study|0
7889167|NCT01833533|12391947|FG001|Overall Study|To Enter an Extension Study|4
7889168|NCT01833533|12391946|FG000|Overall Study|Other|2
7889169|NCT01833533|12391947|FG001|Overall Study|Other|7
7889170|NCT01833832|12391975|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1
7889171|NCT01833897|12391983|FG000|Overall Study|Lack of Efficacy|1
7889172|NCT01834222|12392017|FG000|Overall Study|Not meet inclusion/exclusion criteria|1
7889173|NCT01834274|12392032|FG000|Overall Study|Study Termination|41
7889174|NCT01834274|12392033|FG001|Overall Study|Study Termination|38
7889175|NCT01834274|12392032|FG000|Overall Study|Withdrawal by Subject|1
7889176|NCT01834274|12392033|FG001|Overall Study|Withdrawal by Subject|1
7889177|NCT01834274|12392032|FG000|Overall Study|Lost to Follow-up|3
7889178|NCT01834274|12392033|FG001|Overall Study|Lost to Follow-up|1
7889179|NCT01834274|12392032|FG000|Overall Study|Other|2
7889180|NCT01834274|12392033|FG001|Overall Study|Other|1
7889181|NCT01834586|12392057|FG000|Overall Study|Adverse Event|1
7889182|NCT01834729|12392080|FG000|Overall Study|Did not return bowel diaries|0
7889183|NCT01834729|12392081|FG001|Overall Study|Did not return bowel diaries|0
7889184|NCT01834729|12392082|FG002|Overall Study|Did not return bowel diaries|3
7889185|NCT01834729|12392083|FG003|Overall Study|Did not return bowel diaries|0
7889186|NCT01834729|12392080|FG000|Overall Study|Withdrawal by Subject|1
7889187|NCT01834729|12392081|FG001|Overall Study|Withdrawal by Subject|1
7889188|NCT01834729|12392082|FG002|Overall Study|Withdrawal by Subject|0
7889189|NCT01834729|12392083|FG003|Overall Study|Withdrawal by Subject|0
7889190|NCT01834729|12392080|FG000|Overall Study|Adverse Event|0
7889191|NCT01834729|12392081|FG001|Overall Study|Adverse Event|0
7889192|NCT01834729|12392082|FG002|Overall Study|Adverse Event|0
7889193|NCT01834729|12392083|FG003|Overall Study|Adverse Event|2
7889194|NCT01835015|12392099|FG000|Overall Study|Adverse Event|0
7889195|NCT01835015|12392100|FG001|Overall Study|Adverse Event|0
7889196|NCT01835015|12392101|FG002|Overall Study|Adverse Event|1
7889197|NCT01835015|12392102|FG003|Overall Study|Adverse Event|0
7889198|NCT01835015|12392103|FG004|Overall Study|Adverse Event|0
7889199|NCT01835132|12392116|FG000|Initial Phase|Insufficient Therapeutic Response|2
7889200|NCT01835158|12392122|FG000|Overall Study|Withdrawal by Subject|1
7889201|NCT01835158|12392123|FG001|Overall Study|Withdrawal by Subject|6
7889202|NCT01835223|12392131|FG000|Overall Study|Adverse Event|1
7889203|NCT01835223|12392132|FG001|Overall Study|Adverse Event|0
7889204|NCT01835223|12392131|FG000|Overall Study|Withdrawal by Subject|2
7889205|NCT01835223|12392132|FG001|Overall Study|Withdrawal by Subject|0
7889206|NCT01835223|12392131|FG000|Overall Study|Disease progression|2
7889207|NCT01835223|12392132|FG001|Overall Study|Disease progression|1
7889208|NCT01835223|12392131|FG000|Overall Study|Became Inelligible|4
7889209|NCT01835223|12392132|FG001|Overall Study|Became Inelligible|0
7889210|NCT01835431|12392160|FG000|Overall Study|Adverse Event|1
7889211|NCT01835431|12392161|FG001|Overall Study|Adverse Event|0
7889212|NCT01835431|12392160|FG000|Overall Study|other|0
7889213|NCT01835431|12392161|FG001|Overall Study|other|2
7889214|NCT01835431|12392160|FG000|Overall Study|Withdrawal by Subject|6
7889215|NCT01835431|12392161|FG001|Overall Study|Withdrawal by Subject|10
7889216|NCT01835431|12392160|FG000|Overall Study|Protocol Violation|1
7889217|NCT01835431|12392161|FG001|Overall Study|Protocol Violation|0
7889218|NCT01835470|12392167|FG000|Long Term Treatment Period|Subject Request to Discontinue|1
7889219|NCT01835470|12392167|FG000|Long Term Treatment Period|Lack of Efficacy|3
7889220|NCT01835548|12392178|FG000|Dose Optimization Period|Adverse Event|0
7889221|NCT01835548|12392179|FG001|Dose Optimization Period|Adverse Event|0
7889222|NCT01835548|12392180|FG002|Dose Optimization Period|Adverse Event|1
7889223|NCT01835548|12392178|FG000|Dose Optimization Period|Withdrawal by Subject|0
7889224|NCT01835548|12392179|FG001|Dose Optimization Period|Withdrawal by Subject|0
7889225|NCT01835548|12392180|FG002|Dose Optimization Period|Withdrawal by Subject|1
7889226|NCT01835548|12392178|FG000|Double-Blind Treatment Period|Adverse Event|0
7889227|NCT01835548|12392179|FG001|Double-Blind Treatment Period|Adverse Event|1
7889228|NCT01835548|12392180|FG002|Double-Blind Treatment Period|Adverse Event|0
7889229|NCT01835548|12392178|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7889230|NCT01835548|12392179|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
7889231|NCT01835548|12392180|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0
7889232|NCT01835587|12392196|FG000|Overall Study|Disease Recurrence or Relapse|0
7889233|NCT01835587|12392197|FG001|Overall Study|Disease Recurrence or Relapse|3
7889234|NCT01835587|12392198|FG002|Overall Study|Disease Recurrence or Relapse|0
7889235|NCT01835587|12392199|FG003|Overall Study|Disease Recurrence or Relapse|3
7889236|NCT01835587|12392196|FG000|Overall Study|Withdrawal by Subject|2
7889237|NCT01835587|12392197|FG001|Overall Study|Withdrawal by Subject|0
7889238|NCT01835587|12392198|FG002|Overall Study|Withdrawal by Subject|0
7889239|NCT01835587|12392199|FG003|Overall Study|Withdrawal by Subject|3
7889240|NCT01835587|12392196|FG000|Overall Study|Adverse Event|0
7889241|NCT01835587|12392197|FG001|Overall Study|Adverse Event|0
7889242|NCT01835587|12392198|FG002|Overall Study|Adverse Event|2
7889243|NCT01835587|12392199|FG003|Overall Study|Adverse Event|2
7889244|NCT01835587|12392196|FG000|Overall Study|Death|0
7889245|NCT01835587|12392197|FG001|Overall Study|Death|0
7889246|NCT01835587|12392198|FG002|Overall Study|Death|0
7889247|NCT01835587|12392199|FG003|Overall Study|Death|1
7889248|NCT01835587|12392196|FG000|Overall Study|Miscellaneous|0
7889249|NCT01835587|12392197|FG001|Overall Study|Miscellaneous|1
7889250|NCT01835587|12392198|FG002|Overall Study|Miscellaneous|0
7889251|NCT01835587|12392199|FG003|Overall Study|Miscellaneous|0
7889252|NCT01835899|12392243|FG000|Overall Study|Adverse Event|0
7889253|NCT01835899|12392244|FG001|Overall Study|Adverse Event|0
7889254|NCT01835899|12392245|FG002|Overall Study|Adverse Event|1
7889255|NCT01835899|12392243|FG000|Overall Study|Other than stated above|0
7889256|NCT01835899|12392244|FG001|Overall Study|Other than stated above|1
7889257|NCT01835899|12392245|FG002|Overall Study|Other than stated above|0
7889258|NCT01836198|12392310|FG000|Part A, Period 2|Protocol Violation|0
7889259|NCT01836198|12392311|FG001|Part A, Period 2|Protocol Violation|1
7889260|NCT01836198|12392312|FG002|Part A, Period 2|Protocol Violation|0
7889261|NCT01836276|12392330|FG000|Overall Study|Lost to Follow-up|28
7889262|NCT01836276|12392331|FG001|Overall Study|Lost to Follow-up|51
7889263|NCT01836458|12392341|FG000|Overall Study|Unsatisfactory therapeutic effect|3
7889264|NCT01836458|12392342|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7889265|NCT01836458|12392343|FG002|Overall Study|Unsatisfactory therapeutic effect|5
7889266|NCT01836458|12392344|FG003|Overall Study|Unsatisfactory therapeutic effect|6
7889267|NCT01836471|12392359|FG000|Overall Study|Pregnancy|1
7889268|NCT01836471|12392360|FG001|Overall Study|Pregnancy|0
7889269|NCT01836471|12392361|FG002|Overall Study|Pregnancy|0
7889270|NCT01836471|12392362|FG003|Overall Study|Pregnancy|0
7889271|NCT01836471|12392363|FG004|Overall Study|Pregnancy|0
7889272|NCT01836471|12392359|FG000|Overall Study|Withdrawal by Subject|3
7889273|NCT01836471|12392360|FG001|Overall Study|Withdrawal by Subject|4
7889274|NCT01836471|12392361|FG002|Overall Study|Withdrawal by Subject|1
7889275|NCT01836471|12392362|FG003|Overall Study|Withdrawal by Subject|0
7889276|NCT01836471|12392363|FG004|Overall Study|Withdrawal by Subject|2
7889277|NCT01836471|12392359|FG000|Overall Study|Physician Decision|0
7889278|NCT01836471|12392360|FG001|Overall Study|Physician Decision|1
7889279|NCT01836471|12392361|FG002|Overall Study|Physician Decision|0
7889280|NCT01836471|12392362|FG003|Overall Study|Physician Decision|0
7889281|NCT01836471|12392363|FG004|Overall Study|Physician Decision|0
7889282|NCT01836471|12392359|FG000|Overall Study|Lost to Follow-up|0
7889283|NCT01836471|12392360|FG001|Overall Study|Lost to Follow-up|0
7889284|NCT01836471|12392361|FG002|Overall Study|Lost to Follow-up|0
7889285|NCT01836471|12392362|FG003|Overall Study|Lost to Follow-up|1
7889286|NCT01836471|12392363|FG004|Overall Study|Lost to Follow-up|1
7889287|NCT01836471|12392359|FG000|Overall Study|Adverse Event|6
7889288|NCT01836471|12392360|FG001|Overall Study|Adverse Event|3
7889289|NCT01836471|12392361|FG002|Overall Study|Adverse Event|1
7889290|NCT01836471|12392362|FG003|Overall Study|Adverse Event|1
7889291|NCT01836471|12392363|FG004|Overall Study|Adverse Event|2
7889292|NCT01836471|12392359|FG000|Overall Study|Non compliance with tx|1
7889293|NCT01836471|12392360|FG001|Overall Study|Non compliance with tx|1
7889294|NCT01836471|12392361|FG002|Overall Study|Non compliance with tx|0
7889295|NCT01836471|12392362|FG003|Overall Study|Non compliance with tx|0
7889296|NCT01836471|12392363|FG004|Overall Study|Non compliance with tx|0
7889297|NCT01836523|12392380|FG000|Overall Study|Adverse Event|15
7889298|NCT01836523|12392381|FG001|Overall Study|Adverse Event|41
7889299|NCT01836523|12392382|FG002|Overall Study|Adverse Event|49
7889300|NCT01836523|12392383|FG003|Overall Study|Adverse Event|14
7889301|NCT01836523|12392380|FG000|Overall Study|Protocol Violation|6
7889302|NCT01836523|12392381|FG001|Overall Study|Protocol Violation|3
7889303|NCT01836523|12392382|FG002|Overall Study|Protocol Violation|2
7889304|NCT01836523|12392383|FG003|Overall Study|Protocol Violation|4
7889305|NCT01836523|12392380|FG000|Overall Study|Met Withdrawal Criteria|13
7889306|NCT01836523|12392381|FG001|Overall Study|Met Withdrawal Criteria|13
7889307|NCT01836523|12392382|FG002|Overall Study|Met Withdrawal Criteria|21
7889308|NCT01836523|12392383|FG003|Overall Study|Met Withdrawal Criteria|27
7889309|NCT01836523|12392380|FG000|Overall Study|Unclassified|17
7889310|NCT01836523|12392381|FG001|Overall Study|Unclassified|28
7889311|NCT01836523|12392382|FG002|Overall Study|Unclassified|19
7889312|NCT01836523|12392383|FG003|Overall Study|Unclassified|29
7889313|NCT01836549|12392399|FG000|Overall Study|Did not receive study drug|0
7889314|NCT01836549|12392400|FG001|Overall Study|Did not receive study drug|0
7889315|NCT01836549|12392401|FG002|Overall Study|Did not receive study drug|1
7889316|NCT01836549|12392402|FG003|Overall Study|Did not receive study drug|0
7889317|NCT01836549|12392403|FG004|Overall Study|Did not receive study drug|0
7889318|NCT01836549|12392404|FG005|Overall Study|Did not receive study drug|0
7889319|NCT01836549|12392405|FG006|Overall Study|Did not receive study drug|0
7889320|NCT01836549|12392399|FG000|Overall Study|Patient declared ineligible|0
7889321|NCT01836549|12392400|FG001|Overall Study|Patient declared ineligible|0
7889322|NCT01836549|12392401|FG002|Overall Study|Patient declared ineligible|0
7889323|NCT01836549|12392402|FG003|Overall Study|Patient declared ineligible|1
7889324|NCT01836549|12392403|FG004|Overall Study|Patient declared ineligible|0
7889325|NCT01836549|12392404|FG005|Overall Study|Patient declared ineligible|0
7889326|NCT01836549|12392405|FG006|Overall Study|Patient declared ineligible|0
7889327|NCT01836549|12392399|FG000|Overall Study|Patient inevaluable to start therapy|0
7889328|NCT01836549|12392400|FG001|Overall Study|Patient inevaluable to start therapy|0
7889329|NCT01836549|12392401|FG002|Overall Study|Patient inevaluable to start therapy|0
7889330|NCT01836549|12392402|FG003|Overall Study|Patient inevaluable to start therapy|0
7889331|NCT01836549|12392403|FG004|Overall Study|Patient inevaluable to start therapy|0
7889332|NCT01836549|12392404|FG005|Overall Study|Patient inevaluable to start therapy|0
7889333|NCT01836549|12392405|FG006|Overall Study|Patient inevaluable to start therapy|1
7889334|NCT01837680|12392463|FG000|Overall Study|Lost to Follow-up|2
7889335|NCT01837680|12392464|FG001|Overall Study|Lost to Follow-up|2
7889336|NCT01837680|12392463|FG000|Overall Study|lack of insurance|0
7889337|NCT01837680|12392464|FG001|Overall Study|lack of insurance|2
7889338|NCT01837680|12392463|FG000|Overall Study|allergic reaction|6
7889339|NCT01837680|12392464|FG001|Overall Study|allergic reaction|0
7889340|NCT01837680|12392463|FG000|Overall Study|switched to oral hypoglycemic or diet|2
7889341|NCT01837680|12392464|FG001|Overall Study|switched to oral hypoglycemic or diet|4
7889342|NCT01837719|12392470|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
7889343|NCT01837719|12392470|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
7889344|NCT01837797|12392488|FG000|Period 1|Adverse Event|9
7889345|NCT01837797|12392489|FG001|Period 1|Adverse Event|0
7889346|NCT01837797|12392490|FG002|Period 1|Adverse Event|0
7889347|NCT01837797|12392491|FG003|Period 1|Adverse Event|0
7889348|NCT01837797|12392492|FG004|Period 1|Adverse Event|0
7889349|NCT01837797|12392488|FG000|Period 1|Withdrawal by Subject|6
7889350|NCT01837797|12392489|FG001|Period 1|Withdrawal by Subject|0
7889351|NCT01837797|12392490|FG002|Period 1|Withdrawal by Subject|0
7889352|NCT01837797|12392491|FG003|Period 1|Withdrawal by Subject|0
7889353|NCT01837797|12392492|FG004|Period 1|Withdrawal by Subject|0
7889354|NCT01837797|12392488|FG000|Period 1|Administrative reasons|76
7889355|NCT01837797|12392489|FG001|Period 1|Administrative reasons|0
7889356|NCT01837797|12392490|FG002|Period 1|Administrative reasons|0
7889357|NCT01837797|12392491|FG003|Period 1|Administrative reasons|0
7889358|NCT01837797|12392492|FG004|Period 1|Administrative reasons|0
7889359|NCT01837797|12392488|FG000|Period 1|Withdrawal of consent before treatment|1
7889360|NCT01837797|12392489|FG001|Period 1|Withdrawal of consent before treatment|0
7889361|NCT01837797|12392490|FG002|Period 1|Withdrawal of consent before treatment|0
7889362|NCT01837797|12392491|FG003|Period 1|Withdrawal of consent before treatment|0
7889363|NCT01837797|12392492|FG004|Period 1|Withdrawal of consent before treatment|0
7889364|NCT01837797|12392488|FG000|Period 1|Other|10
7889365|NCT01837797|12392489|FG001|Period 1|Other|0
7889366|NCT01837797|12392490|FG002|Period 1|Other|0
7889367|NCT01837797|12392491|FG003|Period 1|Other|0
7889368|NCT01837797|12392492|FG004|Period 1|Other|0
7889369|NCT01837797|12392488|FG000|Period 2|Administrative or other reasons|0
7889370|NCT01837797|12392489|FG001|Period 2|Administrative or other reasons|5
7889371|NCT01837797|12392490|FG002|Period 2|Administrative or other reasons|2
7889372|NCT01837797|12392491|FG003|Period 2|Administrative or other reasons|4
7889373|NCT01837797|12392492|FG004|Period 2|Administrative or other reasons|0
7889374|NCT01837797|12392488|FG000|Period 2|Adverse Event|0
7889375|NCT01837797|12392489|FG001|Period 2|Adverse Event|0
7889376|NCT01837797|12392490|FG002|Period 2|Adverse Event|0
7889377|NCT01837797|12392491|FG003|Period 2|Adverse Event|1
7889378|NCT01837797|12392492|FG004|Period 2|Adverse Event|0
7889379|NCT01837797|12392488|FG000|Period 3|Adverse Event|0
7889380|NCT01837797|12392489|FG001|Period 3|Adverse Event|0
7889381|NCT01837797|12392490|FG002|Period 3|Adverse Event|0
7889382|NCT01837797|12392491|FG003|Period 3|Adverse Event|0
7889383|NCT01837797|12392492|FG004|Period 3|Adverse Event|1
7889384|NCT01837797|12392488|FG000|Period 3|Administrative reasons|0
7889385|NCT01837797|12392489|FG001|Period 3|Administrative reasons|0
7889386|NCT01837797|12392490|FG002|Period 3|Administrative reasons|0
7889387|NCT01837797|12392491|FG003|Period 3|Administrative reasons|0
7889388|NCT01837797|12392492|FG004|Period 3|Administrative reasons|20
7889389|NCT01837797|12392488|FG000|Period 3|Other|0
7889390|NCT01837797|12392489|FG001|Period 3|Other|0
7889391|NCT01837797|12392490|FG002|Period 3|Other|0
7889392|NCT01837797|12392491|FG003|Period 3|Other|0
7889393|NCT01837797|12392492|FG004|Period 3|Other|2
7889394|NCT01837823|12392500|FG000|Overall Study|Lost to Follow-up|6
7889395|NCT01837966|12392523|FG000|Overall Study|Withdrawal by Subject|2
7889396|NCT01837966|12392524|FG001|Overall Study|Withdrawal by Subject|1
7889397|NCT01838044|12392532|FG000|Overall Study|Adverse Event|4
7889398|NCT01838044|12392533|FG001|Overall Study|Adverse Event|6
7889399|NCT01838044|12392532|FG000|Overall Study|Protocol Violation|3
7889400|NCT01838044|12392533|FG001|Overall Study|Protocol Violation|3
7889401|NCT01838044|12392532|FG000|Overall Study|Withdrawal by Subject|0
7889402|NCT01838044|12392533|FG001|Overall Study|Withdrawal by Subject|2
7889403|NCT01838044|12392532|FG000|Overall Study|Insufficient clinical response|1
7889404|NCT01838044|12392533|FG001|Overall Study|Insufficient clinical response|2
7889405|NCT01838044|12392532|FG000|Overall Study|Medication error without associated AE|0
7889406|NCT01838044|12392533|FG001|Overall Study|Medication error without associated AE|1
7889407|NCT01838044|12392532|FG000|Overall Study|Lost to Follow-up|0
7889408|NCT01838044|12392533|FG001|Overall Study|Lost to Follow-up|2
7889409|NCT01838200|12392542|FG000|Overall Study|Adverse Event|0
7889410|NCT01838200|12392543|FG001|Overall Study|Adverse Event|2
7889411|NCT01838200|12392542|FG000|Overall Study|Progressive disease|3
7889412|NCT01838200|12392543|FG001|Overall Study|Progressive disease|0
7889413|NCT01838213|12392551|FG000|Overall Study|Ineligible|166
7889414|NCT01838213|12392552|FG001|Overall Study|Ineligible|191
7889415|NCT01838447|12392587|FG000|Overall Study|Change in surgical plan|1
7889416|NCT01838447|12392588|FG001|Overall Study|Change in surgical plan|2
7889417|NCT01838447|12392587|FG000|Overall Study|Withdrawal by Subject|1
7889418|NCT01838447|12392588|FG001|Overall Study|Withdrawal by Subject|1
7889419|NCT01838499|12392596|FG000|Overall Study|Protocol Violation|0
7889420|NCT01838499|12392597|FG001|Overall Study|Protocol Violation|1
7889421|NCT01838499|12392596|FG000|Overall Study|Lost to Follow-up|2
7889422|NCT01838499|12392597|FG001|Overall Study|Lost to Follow-up|4
7889423|NCT01838499|12392596|FG000|Overall Study|Lack of Efficacy|1
7889424|NCT01838499|12392597|FG001|Overall Study|Lack of Efficacy|2
7889425|NCT01838499|12392596|FG000|Overall Study|Adverse Event|2
7889426|NCT01838499|12392597|FG001|Overall Study|Adverse Event|1
7889427|NCT01838499|12392596|FG000|Overall Study|Withdrawal by Subject|19
7889428|NCT01838499|12392597|FG001|Overall Study|Withdrawal by Subject|9
7889429|NCT01838551|12392603|FG000|Overall Study|Adverse Event|16
7889430|NCT01838551|12392603|FG000|Overall Study|Death|1
7889431|NCT01838551|12392603|FG000|Overall Study|Lack of Efficacy|10
7889432|NCT01838551|12392603|FG000|Overall Study|Physician Decision|4
7889433|NCT01838551|12392603|FG000|Overall Study|Withdrawal by Subject|10
7889434|NCT01838551|12392603|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7
7889435|NCT01838590|12392611|FG000|Overall Study|Lack of Efficacy|12
7889436|NCT01838590|12392612|FG001|Overall Study|Lack of Efficacy|4
7889437|NCT01838590|12392611|FG000|Overall Study|Lost to Follow-up|0
7889438|NCT01838590|12392612|FG001|Overall Study|Lost to Follow-up|1
7889439|NCT01838616|12392624|FG000|Titration Period|Adverse Event|18
7889440|NCT01838616|12392625|FG001|Titration Period|Adverse Event|48
7889441|NCT01838616|12392624|FG000|Titration Period|Lack of Efficacy|5
7889442|NCT01838616|12392625|FG001|Titration Period|Lack of Efficacy|12
7889443|NCT01838616|12392624|FG000|Titration Period|Withdrawal by Subject|5
7889444|NCT01838616|12392625|FG001|Titration Period|Withdrawal by Subject|5
7889445|NCT01838616|12392624|FG000|Titration Period|Technical problems|1
7889446|NCT01838616|12392625|FG001|Titration Period|Technical problems|0
7889447|NCT01838616|12392624|FG000|Titration Period|Other|1
7889448|NCT01838616|12392625|FG001|Titration Period|Other|0
7889449|NCT01838616|12392624|FG000|Titration Period|Protocol Violation|0
7889450|NCT01838616|12392625|FG001|Titration Period|Protocol Violation|1
7889451|NCT01838616|12392624|FG000|Continuation Period|Lack of Efficacy|3
7889452|NCT01838616|12392625|FG001|Continuation Period|Lack of Efficacy|5
7889453|NCT01838616|12392624|FG000|Continuation Period|Adverse Event|8
7889454|NCT01838616|12392625|FG001|Continuation Period|Adverse Event|4
7889455|NCT01838616|12392624|FG000|Continuation Period|Protocol Violation|2
7889456|NCT01838616|12392625|FG001|Continuation Period|Protocol Violation|0
7889457|NCT01838616|12392624|FG000|Continuation Period|Lost to Follow-up|1
7889458|NCT01838616|12392625|FG001|Continuation Period|Lost to Follow-up|0
7889459|NCT01838616|12392624|FG000|Continuation Period|Withdrawal by Subject|0
7889460|NCT01838616|12392625|FG001|Continuation Period|Withdrawal by Subject|4
7889461|NCT01838616|12392624|FG000|Continuation Period|Technical problems|0
7889462|NCT01838616|12392625|FG001|Continuation Period|Technical problems|1
7889463|NCT01838616|12392624|FG000|Pick-up Arm|Lack of Efficacy|4
7889464|NCT01838616|12392625|FG001|Pick-up Arm|Lack of Efficacy|0
7889465|NCT01838616|12392624|FG000|Pick-up Arm|Adverse Event|9
7889466|NCT01838616|12392625|FG001|Pick-up Arm|Adverse Event|0
7889467|NCT01838616|12392624|FG000|Pick-up Arm|Withdrawal by Subject|1
7889468|NCT01838616|12392625|FG001|Pick-up Arm|Withdrawal by Subject|0
7889469|NCT01838616|12392624|FG000|Pick-up Arm|Technical problems|1
7889470|NCT01838616|12392625|FG001|Pick-up Arm|Technical problems|0
7889471|NCT01838642|12392636|FG000|Overall Study|Died on study|1
7962929|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7962930|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7717709|NCT00521339|12141343|FG002|Treatment Extension Phase|Withdrawal by Subject|2
7717710|NCT00521339|12141341|FG000|Treatment Extension Phase|Death|0
7717711|NCT00521339|12141342|FG001|Treatment Extension Phase|Death|0
7717712|NCT00521339|12141343|FG002|Treatment Extension Phase|Death|1
7717713|NCT00521365|12141373|FG000|Overall Study|Adverse Event|3
7717714|NCT00521365|12141373|FG000|Overall Study|Lost to Follow-up|6
7717715|NCT00521365|12141373|FG000|Overall Study|Protocol deviation|2
7717716|NCT00521365|12141373|FG000|Overall Study|Drug compliance|3
7717717|NCT00521365|12141373|FG000|Overall Study|Usage of not allowed drugs|6
7717718|NCT00521404|12141377|FG000|Overall Study|Adverse Event|13
7717719|NCT00521404|12141377|FG000|Overall Study|Disease Progression|33
7717720|NCT00521404|12141377|FG000|Overall Study|Investigator decision|5
7717721|NCT00521404|12141377|FG000|Overall Study|Withdrawal of consent|3
7717722|NCT00521404|12141377|FG000|Overall Study|Noncompliance or lack of cooperation|1
7717723|NCT00521404|12141377|FG000|Overall Study|Other|7
7717724|NCT00521586|12141392|FG000|Initial Vaccination (Year 0)|Subject request|8
7717725|NCT00521586|12141393|FG001|Initial Vaccination (Year 0)|Subject request|11
7717726|NCT00521586|12141392|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5
7717727|NCT00521586|12141393|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10
7717728|NCT00521586|12141392|FG000|Initial Vaccination (Year 0)|Protocol Violation|2
7717729|NCT00521586|12141393|FG001|Initial Vaccination (Year 0)|Protocol Violation|5
7717730|NCT00521586|12141392|FG000|Initial Vaccination (Year 0)|Other, unspecified|3
7717731|NCT00521586|12141393|FG001|Initial Vaccination (Year 0)|Other, unspecified|1
7717732|NCT00521586|12141392|FG000|Initial Vaccination (Year 0)|Investigator request|2
7717733|NCT00521586|12141393|FG001|Initial Vaccination (Year 0)|Investigator request|0
7717734|NCT00521586|12141392|FG000|Initial Vaccination (Year 0)|Adverse Event|0
7717735|NCT00521586|12141393|FG001|Initial Vaccination (Year 0)|Adverse Event|1
7717736|NCT00521586|12141392|FG000|Initial Vaccination (Year 0)|Death|1
7717737|NCT00521586|12141393|FG001|Initial Vaccination (Year 0)|Death|0
7717738|NCT00521586|12141392|FG000|Initial Vaccination (Year 0)|Failed to return|0
7717739|NCT00521586|12141393|FG001|Initial Vaccination (Year 0)|Failed to return|1
7717740|NCT00521586|12141392|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
7717741|NCT00521586|12141393|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
7717742|NCT00521586|12141392|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
7717743|NCT00521586|12141393|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
7717744|NCT00521586|12141392|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
7717745|NCT00521586|12141393|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
7717746|NCT00521586|12141392|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
7717747|NCT00521586|12141393|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
7717748|NCT00521586|12141392|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
7717749|NCT00521586|12141393|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
7717750|NCT00521586|12141392|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
7717751|NCT00521586|12141393|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
7717752|NCT00521586|12141392|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
7717753|NCT00521586|12141393|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
7717754|NCT00521586|12141392|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
7717755|NCT00521586|12141393|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
7717756|NCT00521586|12141392|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0
7717757|NCT00521586|12141393|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1
7717758|NCT00521586|12141392|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1
7717759|NCT00521586|12141393|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4
7717760|NCT00521586|12141392|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
7717761|NCT00521586|12141393|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
7717762|NCT00522041|12141438|FG000|Overall Study|Adverse Event|9
7717763|NCT00522041|12141439|FG001|Overall Study|Adverse Event|3
7717764|NCT00522041|12141438|FG000|Overall Study|Protocol Violation|2
7717765|NCT00522041|12141439|FG001|Overall Study|Protocol Violation|0
7717766|NCT00522041|12141438|FG000|Overall Study|Lost to Follow-up|1
7889472|NCT01838681|12392645|FG000|Period A|Adverse Event|39
7889473|NCT01838681|12392646|FG001|Period A|Adverse Event|0
7889474|NCT01838681|12392647|FG002|Period A|Adverse Event|0
7889475|NCT01838681|12392648|FG003|Period A|Adverse Event|0
7889476|NCT01838681|12392645|FG000|Period A|Lack of Efficacy|21
7889477|NCT01838681|12392646|FG001|Period A|Lack of Efficacy|0
7889478|NCT01838681|12392647|FG002|Period A|Lack of Efficacy|0
7889479|NCT01838681|12392648|FG003|Period A|Lack of Efficacy|0
7889480|NCT01838681|12392645|FG000|Period A|Early response|148
7889481|NCT01838681|12392646|FG001|Period A|Early response|0
7889482|NCT01838681|12392647|FG002|Period A|Early response|0
7889483|NCT01838681|12392648|FG003|Period A|Early response|0
7889484|NCT01838681|12392645|FG000|Period A|Withdrawal by Subject|70
7889485|NCT01838681|12392646|FG001|Period A|Withdrawal by Subject|0
7889486|NCT01838681|12392647|FG002|Period A|Withdrawal by Subject|0
7889487|NCT01838681|12392648|FG003|Period A|Withdrawal by Subject|0
7889488|NCT01838681|12392645|FG000|Period A|Protocol Violation|16
7889489|NCT01838681|12392646|FG001|Period A|Protocol Violation|0
7889490|NCT01838681|12392647|FG002|Period A|Protocol Violation|0
7889491|NCT01838681|12392648|FG003|Period A|Protocol Violation|0
7889492|NCT01838681|12392645|FG000|Period A|Non-compliance with IMP|6
7889493|NCT01838681|12392646|FG001|Period A|Non-compliance with IMP|0
7889494|NCT01838681|12392647|FG002|Period A|Non-compliance with IMP|0
7889495|NCT01838681|12392648|FG003|Period A|Non-compliance with IMP|0
7889496|NCT01838681|12392645|FG000|Period A|Lost to Follow-up|4
7889497|NCT01838681|12392646|FG001|Period A|Lost to Follow-up|0
7889498|NCT01838681|12392647|FG002|Period A|Lost to Follow-up|0
7889499|NCT01838681|12392648|FG003|Period A|Lost to Follow-up|0
7889500|NCT01838681|12392645|FG000|Period A|Withdrawal before treatment|4
7889501|NCT01838681|12392646|FG001|Period A|Withdrawal before treatment|0
7889502|NCT01838681|12392647|FG002|Period A|Withdrawal before treatment|0
7889503|NCT01838681|12392648|FG003|Period A|Withdrawal before treatment|0
7889504|NCT01838681|12392645|FG000|Period A|Administrative or other reasons|17
7889505|NCT01838681|12392646|FG001|Period A|Administrative or other reasons|0
7889506|NCT01838681|12392647|FG002|Period A|Administrative or other reasons|0
7889507|NCT01838681|12392648|FG003|Period A|Administrative or other reasons|0
7889508|NCT01838681|12392645|FG000|Period B/A+|Adverse Event|0
7889509|NCT01838681|12392646|FG001|Period B/A+|Adverse Event|13
7889510|NCT01838681|12392647|FG002|Period B/A+|Adverse Event|27
7889511|NCT01838681|12392648|FG003|Period B/A+|Adverse Event|16
7889512|NCT01838681|12392645|FG000|Period B/A+|Lack of Efficacy|0
7889513|NCT01838681|12392646|FG001|Period B/A+|Lack of Efficacy|9
7889514|NCT01838681|12392647|FG002|Period B/A+|Lack of Efficacy|11
7889515|NCT01838681|12392648|FG003|Period B/A+|Lack of Efficacy|6
7889516|NCT01838681|12392645|FG000|Period B/A+|Withdrawal by Subject|0
7889517|NCT01838681|12392646|FG001|Period B/A+|Withdrawal by Subject|28
7889518|NCT01838681|12392647|FG002|Period B/A+|Withdrawal by Subject|35
7889519|NCT01838681|12392648|FG003|Period B/A+|Withdrawal by Subject|47
7889520|NCT01838681|12392645|FG000|Period B/A+|Protocol Violation|0
7889521|NCT01838681|12392646|FG001|Period B/A+|Protocol Violation|1
7889522|NCT01838681|12392647|FG002|Period B/A+|Protocol Violation|4
7889523|NCT01838681|12392648|FG003|Period B/A+|Protocol Violation|6
7889524|NCT01838681|12392645|FG000|Period B/A+|Non-compliance with IMP|0
7889525|NCT01838681|12392646|FG001|Period B/A+|Non-compliance with IMP|2
7889526|NCT01838681|12392647|FG002|Period B/A+|Non-compliance with IMP|3
7889527|NCT01838681|12392648|FG003|Period B/A+|Non-compliance with IMP|3
7889528|NCT01838681|12392645|FG000|Period B/A+|Lost to Follow-up|0
7889529|NCT01838681|12392646|FG001|Period B/A+|Lost to Follow-up|2
7889530|NCT01838681|12392647|FG002|Period B/A+|Lost to Follow-up|5
7889531|NCT01838681|12392648|FG003|Period B/A+|Lost to Follow-up|11
7889532|NCT01838681|12392645|FG000|Period B/A+|Withdrawal before treatment|0
7889533|NCT01838681|12392646|FG001|Period B/A+|Withdrawal before treatment|1
7889534|NCT01838681|12392647|FG002|Period B/A+|Withdrawal before treatment|0
7889535|NCT01838681|12392648|FG003|Period B/A+|Withdrawal before treatment|0
7889536|NCT01838681|12392645|FG000|Period B/A+|Administrative or other reasons|0
7889537|NCT01838681|12392646|FG001|Period B/A+|Administrative or other reasons|6
7889538|NCT01838681|12392647|FG002|Period B/A+|Administrative or other reasons|10
7889539|NCT01838681|12392648|FG003|Period B/A+|Administrative or other reasons|28
7889540|NCT01838694|12392656|FG000|Overall Study|Adverse Event|0
7889541|NCT01838694|12392657|FG001|Overall Study|Adverse Event|1
7889542|NCT01838876|12392679|FG000|Overall Study|Adverse Event|49
7889543|NCT01838876|12392679|FG000|Overall Study|Insufficient Therapeutic Response|10
7889544|NCT01838876|12392679|FG000|Overall Study|Protocol Violation|34
7889545|NCT01838876|12392679|FG000|Overall Study|Withdrawal of Consent|33
7889546|NCT01838876|12392679|FG000|Overall Study|Lost to Follow-up|21
7889547|NCT01838876|12392679|FG000|Overall Study|Study or Site Terminated by Sponsor|1
7889548|NCT01838876|12392679|FG000|Overall Study|Reason not Specified|7
7889549|NCT01838876|12392679|FG000|Overall Study|Did not meet eligibility criteria|78
7889550|NCT01838941|12392685|FG000|Overall Study|Adverse Event|1
7889551|NCT01838941|12392685|FG000|Overall Study|Withdrawal by Subject|1
7889552|NCT01839188|12392716|FG000|Overall Study|Withdrawal by Subject|1
7889553|NCT01839279|12392728|FG000|Overall Study|Adverse Event|4
7889554|NCT01839279|12392729|FG001|Overall Study|Adverse Event|1
7889555|NCT01839279|12392730|FG002|Overall Study|Adverse Event|1
7889556|NCT01839279|12392728|FG000|Overall Study|Withdrawal by Subject|4
7889557|NCT01839279|12392729|FG001|Overall Study|Withdrawal by Subject|1
7889558|NCT01839279|12392730|FG002|Overall Study|Withdrawal by Subject|1
7889559|NCT01839279|12392728|FG000|Overall Study|Classified as 'Other'|5
7889560|NCT01839279|12392729|FG001|Overall Study|Classified as 'Other'|0
7889561|NCT01839279|12392730|FG002|Overall Study|Classified as 'Other'|0
7889562|NCT01839487|12392760|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1
7889563|NCT01839487|12392761|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7889564|NCT01839487|12392762|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7889565|NCT01839487|12392763|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7889566|NCT01839487|12392764|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7889567|NCT01839487|12392765|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7889568|NCT01839487|12392760|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14
7889569|NCT01839487|12392761|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6
7889570|NCT01839487|12392762|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7889571|NCT01839487|12392763|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7889572|NCT01839487|12392764|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7889573|NCT01839487|12392765|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7889574|NCT01839487|12392760|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7889575|NCT01839487|12392761|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1
7889576|NCT01839487|12392762|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7889577|NCT01839487|12392763|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7889578|NCT01839487|12392764|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7889579|NCT01839487|12392765|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7889580|NCT01839487|12392760|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1
7889581|NCT01839487|12392761|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7889582|NCT01839487|12392762|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7889583|NCT01839487|12392763|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7889584|NCT01839487|12392764|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7889585|NCT01839487|12392765|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7889586|NCT01839487|12392760|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
7889587|NCT01839487|12392761|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
7889588|NCT01839487|12392762|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12
7889589|NCT01839487|12392763|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9
7889590|NCT01839487|12392764|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4
7889591|NCT01839487|12392765|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8
7889592|NCT01839487|12392760|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0
7889593|NCT01839487|12392761|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0
7889594|NCT01839487|12392762|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46
7889595|NCT01839487|12392763|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49
7889596|NCT01839487|12392764|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71
7889597|NCT01839487|12392765|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32
7889598|NCT01839487|12392760|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
7889599|NCT01839487|12392761|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
7889600|NCT01839487|12392762|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2
7889601|NCT01839487|12392763|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
7889602|NCT01839487|12392764|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1
7889603|NCT01839487|12392765|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
7889604|NCT01839487|12392760|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
7889605|NCT01839487|12392761|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
7889606|NCT01839487|12392762|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
7889607|NCT01839487|12392763|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1
7889608|NCT01839487|12392764|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10
7889609|NCT01839487|12392765|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3
7889610|NCT01839487|12392760|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
7889611|NCT01839487|12392761|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
7889612|NCT01839487|12392762|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
7889613|NCT01839487|12392763|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3
7889614|NCT01839487|12392764|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2
7889615|NCT01839487|12392765|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
7968255|NCT03893565|12525824|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7889616|NCT01839656|12392796|FG000|Overall Study|Withdrawal by Subject|1
7889617|NCT01839656|12392797|FG001|Overall Study|Withdrawal by Subject|1
7889618|NCT01839656|12392796|FG000|Overall Study|Adverse event, serious fatal|1
7889619|NCT01839656|12392797|FG001|Overall Study|Adverse event, serious fatal|4
7889620|NCT01839656|12392796|FG000|Overall Study|Early study closure|0
7889621|NCT01839656|12392797|FG001|Overall Study|Early study closure|11
7889622|NCT01839656|12392796|FG000|Overall Study|Adverse Event|1
7889623|NCT01839656|12392797|FG001|Overall Study|Adverse Event|0
7889624|NCT01839916|12392825|FG000|Overall Study|Death|9
7889625|NCT01839916|12392825|FG000|Overall Study|Physician Decision|17
7889626|NCT01839916|12392825|FG000|Overall Study|Relapse|12
7889627|NCT01839916|12392825|FG000|Overall Study|GVHD|2
7889628|NCT01839916|12392825|FG000|Overall Study|Graft Failure|1
7889629|NCT01840163|12392842|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19
7889630|NCT01840163|12392843|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16
7889631|NCT01840163|12392842|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
7889632|NCT01840163|12392843|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
7889633|NCT01840163|12392842|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
7889634|NCT01840163|12392843|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
7889635|NCT01840228|12392851|FG000|Overall Study|Lost to Follow-up|1
7889636|NCT01840228|12392852|FG001|Overall Study|Lost to Follow-up|1
7889637|NCT01840410|12392872|FG000|Overall Study|Physician Decision|1
7889638|NCT01840410|12392873|FG001|Overall Study|Physician Decision|2
7889639|NCT01840410|12392872|FG000|Overall Study|Pregnancy|1
7889640|NCT01840410|12392873|FG001|Overall Study|Pregnancy|0
7889641|NCT01840410|12392872|FG000|Overall Study|Protocol deviation|1
7889642|NCT01840410|12392873|FG001|Overall Study|Protocol deviation|0
7889643|NCT01840410|12392872|FG000|Overall Study|Lost to Follow-up|1
7889644|NCT01840410|12392873|FG001|Overall Study|Lost to Follow-up|0
7889645|NCT01840410|12392872|FG000|Overall Study|Withdrawal by Subject|2
7889646|NCT01840410|12392873|FG001|Overall Study|Withdrawal by Subject|1
7889647|NCT01840410|12392872|FG000|Overall Study|Adverse Event|1
7889648|NCT01840410|12392873|FG001|Overall Study|Adverse Event|1
7889649|NCT01840579|12392891|FG000|Overall Study|Status not recorded|0
7889650|NCT01840579|12392892|FG001|Overall Study|Status not recorded|0
7889651|NCT01840579|12392893|FG002|Overall Study|Status not recorded|2
7889652|NCT01840579|12392894|FG003|Overall Study|Status not recorded|3
7889653|NCT01840579|12392895|FG004|Overall Study|Status not recorded|4
7889654|NCT01840579|12392896|FG005|Overall Study|Status not recorded|3
7889655|NCT01840579|12392897|FG006|Overall Study|Status not recorded|0
7889656|NCT01840579|12392898|FG007|Overall Study|Status not recorded|3
7889657|NCT01840579|12392899|FG008|Overall Study|Status not recorded|3
7889658|NCT01840579|12392900|FG009|Overall Study|Status not recorded|3
7889659|NCT01840579|12392891|FG000|Overall Study|Progressive disease|3
7889660|NCT01840579|12392892|FG001|Overall Study|Progressive disease|5
7889661|NCT01840579|12392893|FG002|Overall Study|Progressive disease|0
7889662|NCT01840579|12392894|FG003|Overall Study|Progressive disease|0
7889663|NCT01840579|12392895|FG004|Overall Study|Progressive disease|0
7889664|NCT01840579|12392896|FG005|Overall Study|Progressive disease|0
7889665|NCT01840579|12392897|FG006|Overall Study|Progressive disease|0
7889666|NCT01840579|12392898|FG007|Overall Study|Progressive disease|0
7889667|NCT01840579|12392899|FG008|Overall Study|Progressive disease|0
7889668|NCT01840579|12392900|FG009|Overall Study|Progressive disease|0
7889669|NCT01840579|12392891|FG000|Overall Study|Ongoing in study|0
7889670|NCT01840579|12392892|FG001|Overall Study|Ongoing in study|1
7889671|NCT01840579|12392893|FG002|Overall Study|Ongoing in study|0
7889672|NCT01840579|12392894|FG003|Overall Study|Ongoing in study|0
7889673|NCT01840579|12392895|FG004|Overall Study|Ongoing in study|0
7889674|NCT01840579|12392896|FG005|Overall Study|Ongoing in study|0
7889675|NCT01840579|12392897|FG006|Overall Study|Ongoing in study|0
7889676|NCT01840579|12392898|FG007|Overall Study|Ongoing in study|0
7889677|NCT01840579|12392899|FG008|Overall Study|Ongoing in study|0
7889678|NCT01840579|12392900|FG009|Overall Study|Ongoing in study|0
7889679|NCT01840579|12392891|FG000|Overall Study|Death|0
7889680|NCT01840579|12392892|FG001|Overall Study|Death|0
7889681|NCT01840579|12392893|FG002|Overall Study|Death|0
7889682|NCT01840579|12392894|FG003|Overall Study|Death|0
7889683|NCT01840579|12392895|FG004|Overall Study|Death|0
7889684|NCT01840579|12392896|FG005|Overall Study|Death|1
7889685|NCT01840579|12392897|FG006|Overall Study|Death|0
7889686|NCT01840579|12392898|FG007|Overall Study|Death|0
7889687|NCT01840579|12392899|FG008|Overall Study|Death|0
7889688|NCT01840579|12392900|FG009|Overall Study|Death|0
7811272|NCT01181128|12274869|FG000|Overall Study|Other|1
7811273|NCT01181128|12274870|FG001|Overall Study|Other|1
7811274|NCT01181128|12274871|FG002|Overall Study|Other|1
7811275|NCT01181141|12274893|FG000|Overall Study|Adverse Event|2
7811276|NCT01181141|12274894|FG001|Overall Study|Adverse Event|1
7811277|NCT01181141|12274893|FG000|Overall Study|Lack of Efficacy|1
7811278|NCT01181141|12274894|FG001|Overall Study|Lack of Efficacy|0
7811279|NCT01181141|12274893|FG000|Overall Study|Lost to Follow-up|1
7811280|NCT01181141|12274894|FG001|Overall Study|Lost to Follow-up|1
7811281|NCT01181141|12274893|FG000|Overall Study|Physician Decision|2
7811282|NCT01181141|12274894|FG001|Overall Study|Physician Decision|0
7811283|NCT01181141|12274893|FG000|Overall Study|Protocol Violation|3
7811284|NCT01181141|12274894|FG001|Overall Study|Protocol Violation|1
7811285|NCT01181141|12274893|FG000|Overall Study|Withdrawal by Subject|3
7811286|NCT01181141|12274894|FG001|Overall Study|Withdrawal by Subject|1
7889689|NCT01840579|12392891|FG000|Overall Study|Adverse Event|0
7889690|NCT01840579|12392892|FG001|Overall Study|Adverse Event|1
7889691|NCT01840579|12392893|FG002|Overall Study|Adverse Event|0
7811287|NCT01181167|12274902|FG000|Overall Study|Adverse Event|11
7811288|NCT01181167|12274903|FG001|Overall Study|Adverse Event|21
7811289|NCT01181167|12274902|FG000|Overall Study|Lost to Follow-up|1
7811290|NCT01181167|12274903|FG001|Overall Study|Lost to Follow-up|0
7811291|NCT01181167|12274902|FG000|Overall Study|Physician Decision|2
7811292|NCT01181167|12274903|FG001|Overall Study|Physician Decision|3
7811293|NCT01181167|12274902|FG000|Overall Study|Protocol Violation|3
7811294|NCT01181167|12274903|FG001|Overall Study|Protocol Violation|0
7811295|NCT01181167|12274902|FG000|Overall Study|Withdrawal by Subject|6
7811296|NCT01181167|12274903|FG001|Overall Study|Withdrawal by Subject|8
7811297|NCT01181271|12274913|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
7811298|NCT01181271|12274913|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
7811299|NCT01181271|12274913|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2
7811300|NCT01181271|12274913|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
7811301|NCT01181531|12274983|FG000|Overall Study|Other|17
7811302|NCT01181531|12274984|FG001|Overall Study|Other|12
7811303|NCT01181531|12274983|FG000|Overall Study|Partial consent by subject withdrawn|0
7811304|NCT01181531|12274984|FG001|Overall Study|Partial consent by subject withdrawn|1
7811305|NCT01181531|12274983|FG000|Overall Study|Physician Decision|3
7811306|NCT01181531|12274984|FG001|Overall Study|Physician Decision|1
7811307|NCT01181531|12274983|FG000|Overall Study|Noncompliance|2
7811308|NCT01181531|12274984|FG001|Overall Study|Noncompliance|2
7811309|NCT01181531|12274983|FG000|Overall Study|Ineligibility determined|1
7811310|NCT01181531|12274984|FG001|Overall Study|Ineligibility determined|2
7811311|NCT01181531|12274983|FG000|Overall Study|Protocol Specified Criteria|15
7811312|NCT01181531|12274984|FG001|Overall Study|Protocol Specified Criteria|8
7811313|NCT01181531|12274983|FG000|Overall Study|Pregnancy|0
7811314|NCT01181531|12274984|FG001|Overall Study|Pregnancy|1
7811315|NCT01181531|12274983|FG000|Overall Study|Withdrawal by Subject|8
7811316|NCT01181531|12274984|FG001|Overall Study|Withdrawal by Subject|7
7811317|NCT01181531|12274983|FG000|Overall Study|Protocol Violation|6
7811318|NCT01181531|12274984|FG001|Overall Study|Protocol Violation|6
7811319|NCT01181531|12274983|FG000|Overall Study|Death|9
7811320|NCT01181531|12274984|FG001|Overall Study|Death|12
7811321|NCT01181531|12274983|FG000|Overall Study|Adverse Event|0
7811322|NCT01181531|12274984|FG001|Overall Study|Adverse Event|1
7811323|NCT01181609|12274995|FG000|Overall Study|Adverse Event|1
7811324|NCT01181609|12274995|FG000|Overall Study|Withdrawal by Subject|1
7811325|NCT01181609|12274995|FG000|Overall Study|Lost to Follow-up|1
7811326|NCT01181609|12274995|FG000|Overall Study|Death|50
7861866|NCT01597245|12351208|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7861867|NCT01597245|12351188|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7861868|NCT01597245|12351189|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7861869|NCT01597245|12351190|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7861870|NCT01597245|12351191|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7861871|NCT01597245|12351192|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150
7861872|NCT01597245|12351193|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22
7861873|NCT01597245|12351194|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80
7861874|NCT01597245|12351195|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2
7861875|NCT01597245|12351196|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7861876|NCT01597245|12351197|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114
7861877|NCT01597245|12351198|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7861878|NCT01597245|12351199|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7861879|NCT01597245|12351200|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7861880|NCT01597245|12351201|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7861881|NCT01597245|12351202|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7861882|NCT01597245|12351203|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7861883|NCT01597245|12351204|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7861884|NCT01597245|12351205|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7861885|NCT01597245|12351206|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7861886|NCT01597245|12351207|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7889692|NCT01840579|12392894|FG003|Overall Study|Adverse Event|0
7889693|NCT01840579|12392895|FG004|Overall Study|Adverse Event|0
7889694|NCT01840579|12392896|FG005|Overall Study|Adverse Event|0
7889695|NCT01840579|12392897|FG006|Overall Study|Adverse Event|0
7889696|NCT01840579|12392898|FG007|Overall Study|Adverse Event|0
7889697|NCT01840579|12392899|FG008|Overall Study|Adverse Event|0
7889698|NCT01840579|12392900|FG009|Overall Study|Adverse Event|0
7889699|NCT01840579|12392891|FG000|Overall Study|Follow-up ended by Sponsor|0
7889700|NCT01840579|12392892|FG001|Overall Study|Follow-up ended by Sponsor|0
7889701|NCT01840579|12392893|FG002|Overall Study|Follow-up ended by Sponsor|0
7889702|NCT01840579|12392894|FG003|Overall Study|Follow-up ended by Sponsor|0
7889703|NCT01840579|12392895|FG004|Overall Study|Follow-up ended by Sponsor|0
7889704|NCT01840579|12392896|FG005|Overall Study|Follow-up ended by Sponsor|0
7889705|NCT01840579|12392897|FG006|Overall Study|Follow-up ended by Sponsor|2
7889706|NCT01840579|12392898|FG007|Overall Study|Follow-up ended by Sponsor|0
7861887|NCT01597245|12351208|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7861888|NCT01597245|12351188|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7861889|NCT01597245|12351189|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7861890|NCT01597245|12351190|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7861891|NCT01597245|12351191|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7889707|NCT01840579|12392899|FG008|Overall Study|Follow-up ended by Sponsor|0
7889708|NCT01840579|12392900|FG009|Overall Study|Follow-up ended by Sponsor|0
7889709|NCT01840605|12392936|FG000|Overall Study|Adverse Event|0
7889710|NCT01840605|12392937|FG001|Overall Study|Adverse Event|1
7889711|NCT01840605|12392936|FG000|Overall Study|Physician Decision|2
7889712|NCT01840605|12392937|FG001|Overall Study|Physician Decision|1
7889713|NCT01840943|12392954|FG000|Overall Study|Withdrawal by Subject|5
7889714|NCT01840943|12392955|FG001|Overall Study|Withdrawal by Subject|6
7889715|NCT01840943|12392954|FG000|Overall Study|Physician Decision|4
7889716|NCT01840943|12392955|FG001|Overall Study|Physician Decision|2
7889717|NCT01840943|12392954|FG000|Overall Study|Lost to Follow-up|4
7889718|NCT01840943|12392955|FG001|Overall Study|Lost to Follow-up|4
7889719|NCT01841060|12392969|FG000|Overall Study|Protocol Violation|10
7889720|NCT01841073|12392975|FG000|Overall Study|Adverse Event|1
7889721|NCT01841073|12392976|FG001|Overall Study|Adverse Event|1
7889722|NCT01841073|12392975|FG000|Overall Study|Physician Decision|1
7889723|NCT01841073|12392976|FG001|Overall Study|Physician Decision|0
7889724|NCT01841073|12392975|FG000|Overall Study|Lost to Follow-up|0
7889725|NCT01841073|12392976|FG001|Overall Study|Lost to Follow-up|2
7889726|NCT01841554|12393014|FG000|Overall Study|Death|7
7889727|NCT01841554|12393014|FG000|Overall Study|No Implantation|1
7889728|NCT01841554|12393014|FG000|Overall Study|Discontinued Follow Up|5
7889729|NCT01841554|12393014|FG000|Overall Study|Study exit due to secondary intervention|6
7889730|NCT01841567|12393018|FG000|Overall Study|Adverse Event|3
7889731|NCT01841593|12393024|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0
7889732|NCT01841593|12393025|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1
7889733|NCT01841593|12393024|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1
7889734|NCT01841593|12393025|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0
7889735|NCT01841697|12393054|FG000|Overall Study|Death|0
7889736|NCT01841697|12393055|FG001|Overall Study|Death|1
7889737|NCT01841697|12393054|FG000|Overall Study|Lost to Follow-up|4
7889738|NCT01841697|12393055|FG001|Overall Study|Lost to Follow-up|1
7889739|NCT01841697|12393054|FG000|Overall Study|Withdrawal by Subject|16
7889740|NCT01841697|12393055|FG001|Overall Study|Withdrawal by Subject|16
7889741|NCT01841762|12393061|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
7889742|NCT01841762|12393061|FG000|Treatment Period|Adverse Event|16
7889743|NCT01841762|12393061|FG000|Treatment Period|Death|1
7889744|NCT01841762|12393061|FG000|Treatment Period|Withdrawal by Subject|7
7889745|NCT01841762|12393061|FG000|Treatment Period|Lost to Follow-up|1
7889746|NCT01841762|12393061|FG000|Treatment Period|Physician Decision|2
7889747|NCT01841762|12393061|FG000|Treatment Period|Other, including non-compliance|5
7889748|NCT01841762|12393061|FG000|Post-Treatment Safety Follow-Up Period|Death|1
7889749|NCT01841762|12393061|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
7889750|NCT01841762|12393061|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
7889751|NCT01841762|12393061|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
7889752|NCT01841970|12393065|FG000|Overall Study|Withdrawal by Subject|1
7889753|NCT01841970|12393065|FG000|Overall Study|Physician Decision|2
7889754|NCT01841970|12393065|FG000|Overall Study|Lost to Follow-up|8
7889755|NCT01842308|12393086|FG000|Overall Study|Withdrawal by Subject|0
7889756|NCT01842308|12393087|FG001|Overall Study|Withdrawal by Subject|0
7889757|NCT01842308|12393088|FG002|Overall Study|Withdrawal by Subject|0
7889758|NCT01842308|12393089|FG003|Overall Study|Withdrawal by Subject|0
7889759|NCT01842308|12393090|FG004|Overall Study|Withdrawal by Subject|1
7889760|NCT01842334|12393105|FG000|Overall Study|Withdrawal by Subject|3
7889761|NCT01842334|12393106|FG001|Overall Study|Withdrawal by Subject|3
7889762|NCT01842334|12393105|FG000|Overall Study|Moved away mid-study|0
7889763|NCT01842334|12393106|FG001|Overall Study|Moved away mid-study|1
7889764|NCT01842438|12393114|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6
7889765|NCT01842438|12393115|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8
7889766|NCT01842438|12393114|FG000|T2: 6month Follow-up|Withdrawal by Subject|4
7889767|NCT01842438|12393115|FG001|T2: 6month Follow-up|Withdrawal by Subject|3
7889768|NCT01842438|12393114|FG000|T2: 6month Follow-up|Death|0
7889769|NCT01842438|12393115|FG001|T2: 6month Follow-up|Death|1
7889770|NCT01842581|12393132|FG000|Overall Study|Adverse Event|6
7889771|NCT01842581|12393133|FG001|Overall Study|Adverse Event|4
7889772|NCT01842581|12393132|FG000|Overall Study|HE breakthrough|26
7889773|NCT01842581|12393133|FG001|Overall Study|HE breakthrough|13
7889774|NCT01842581|12393132|FG000|Overall Study|Liver transplant|2
7889775|NCT01842581|12393133|FG001|Overall Study|Liver transplant|0
7889776|NCT01842581|12393132|FG000|Overall Study|Lost to Follow-up|2
7889777|NCT01842581|12393133|FG001|Overall Study|Lost to Follow-up|5
7889778|NCT01842581|12393132|FG000|Overall Study|Withdrawal by Subject|5
7889779|NCT01842581|12393133|FG001|Overall Study|Withdrawal by Subject|7
7889780|NCT01842581|12393132|FG000|Overall Study|Other than specified|3
7889781|NCT01842581|12393133|FG001|Overall Study|Other than specified|1
7889782|NCT01842607|12393143|FG000|Overall Study|Adverse Event|11
7889783|NCT01842607|12393143|FG000|Overall Study|Lack of Efficacy|19
7889784|NCT01842607|12393143|FG000|Overall Study|Protocol Violation|8
7889785|NCT01842607|12393143|FG000|Overall Study|Protocol defined stopping criteria|2
7889786|NCT01842607|12393143|FG000|Overall Study|Lost to Follow-up|3
7889787|NCT01842607|12393143|FG000|Overall Study|Physician Decision|9
7889788|NCT01842607|12393143|FG000|Overall Study|Withdrawal by Subject|14
7889789|NCT01842620|12393147|FG000|Period 1|Withdrawal by Subject|1
7889790|NCT01842620|12393148|FG001|Period 1|Withdrawal by Subject|0
7889791|NCT01842633|12393157|FG000|Overall Study|Screen Failure|1
7889792|NCT01842633|12393158|FG001|Overall Study|Screen Failure|0
7889793|NCT01842633|12393159|FG002|Overall Study|Screen Failure|0
7889794|NCT01842633|12393157|FG000|Overall Study|Adverse Event|1
7889795|NCT01842633|12393158|FG001|Overall Study|Adverse Event|1
7889796|NCT01842633|12393159|FG002|Overall Study|Adverse Event|0
7889797|NCT01842633|12393157|FG000|Overall Study|Withdrawal by Subject|0
7889798|NCT01842633|12393158|FG001|Overall Study|Withdrawal by Subject|1
7889799|NCT01842633|12393159|FG002|Overall Study|Withdrawal by Subject|0
7889800|NCT01842633|12393157|FG000|Overall Study|Technical issues|1
7889801|NCT01842633|12393158|FG001|Overall Study|Technical issues|0
7889802|NCT01842633|12393159|FG002|Overall Study|Technical issues|0
7889803|NCT01842958|12393203|FG000|Overall Study|Lost to Follow-up|1
7889804|NCT01842958|12393204|FG001|Overall Study|Lost to Follow-up|1
7889805|NCT01843023|12393212|FG000|Overall Study|Death|1
7889806|NCT01843023|12393213|FG001|Overall Study|Death|0
7889807|NCT01843023|12393212|FG000|Overall Study|Lost to Follow-up|24
7889808|NCT01843023|12393213|FG001|Overall Study|Lost to Follow-up|29
7889809|NCT01843023|12393212|FG000|Overall Study|Withdrawal by Subject|8
7889810|NCT01843023|12393213|FG001|Overall Study|Withdrawal by Subject|6
7889811|NCT01843062|12393221|FG000|Overall Study|Protocol Violation|1
7889812|NCT01843062|12393222|FG001|Overall Study|Protocol Violation|0
7889813|NCT01843062|12393221|FG000|Overall Study|New treatment following progression|2
7889814|NCT01843062|12393222|FG001|Overall Study|New treatment following progression|0
7889815|NCT01843062|12393221|FG000|Overall Study|Pregnancy|1
7889816|NCT01843062|12393222|FG001|Overall Study|Pregnancy|0
7889817|NCT01843062|12393221|FG000|Overall Study|Adverse Event|2
7889818|NCT01843062|12393222|FG001|Overall Study|Adverse Event|0
7889819|NCT01843062|12393221|FG000|Overall Study|Incorrect randomisation|1
7889820|NCT01843062|12393222|FG001|Overall Study|Incorrect randomisation|0
7889821|NCT01843062|12393221|FG000|Overall Study|Withdrawal by Subject|12
7889822|NCT01843062|12393222|FG001|Overall Study|Withdrawal by Subject|3
7889823|NCT01843062|12393221|FG000|Overall Study|Death|1
7889824|NCT01843062|12393222|FG001|Overall Study|Death|2
7889825|NCT01843062|12393221|FG000|Overall Study|Lost to Follow-up|2
7889826|NCT01843062|12393222|FG001|Overall Study|Lost to Follow-up|4
7889827|NCT01843192|12393231|FG000|Overall Study|Intra-operative exclusions per protocol|2
7889828|NCT01843192|12393232|FG001|Overall Study|Intra-operative exclusions per protocol|6
7889829|NCT01843192|12393233|FG002|Overall Study|Intra-operative exclusions per protocol|2
7889830|NCT01843205|12393241|FG000|First Treatment (11 Days)|Withdrawal by Subject|1
7889831|NCT01843205|12393242|FG001|First Treatment (11 Days)|Withdrawal by Subject|0
7889832|NCT01843348|12393251|FG000|Overall Study|Withdrawal by Subject|4
7889833|NCT01843348|12393252|FG001|Overall Study|Withdrawal by Subject|16
7889834|NCT01843348|12393253|FG002|Overall Study|Withdrawal by Subject|18
7889835|NCT01843348|12393251|FG000|Overall Study|Lost to Follow-up|5
7889836|NCT01843348|12393252|FG001|Overall Study|Lost to Follow-up|4
7889837|NCT01843348|12393253|FG002|Overall Study|Lost to Follow-up|2
7889838|NCT01843348|12393251|FG000|Overall Study|Death|5
7889839|NCT01843348|12393252|FG001|Overall Study|Death|3
7889840|NCT01843348|12393253|FG002|Overall Study|Death|4
7889841|NCT01843348|12393251|FG000|Overall Study|Graft loss/retransplantation|5
7889842|NCT01843348|12393252|FG001|Overall Study|Graft loss/retransplantation|8
7889843|NCT01843348|12393253|FG002|Overall Study|Graft loss/retransplantation|11
7889844|NCT01843348|12393251|FG000|Overall Study|Various reasons|4
7889845|NCT01843348|12393252|FG001|Overall Study|Various reasons|9
7889846|NCT01843348|12393253|FG002|Overall Study|Various reasons|6
7889847|NCT01843660|12393279|FG000|Overall Study|Other|30
7889848|NCT01843673|12393283|FG000|Overall Study|Lack of Efficacy|2
7889849|NCT01843673|12393283|FG000|Overall Study|Withdrawal by Subject|4
7889850|NCT01843777|12393300|FG000|Overall Study|Withdrawal by Subject|1
7889851|NCT01843777|12393301|FG001|Overall Study|Withdrawal by Subject|0
7889852|NCT01843803|12393309|FG000|Overall Study|not a Veteran, did not see provider|1
7889853|NCT01843803|12393310|FG001|Overall Study|not a Veteran, did not see provider|3
7889854|NCT01843842|12393318|FG000|Overall Study|Do not meet inclusion criteria|1
7889855|NCT01843842|12393319|FG001|Overall Study|Do not meet inclusion criteria|1
7889856|NCT01843933|12393336|FG000|Overall Study|Data lost|6
7889857|NCT01843933|12393337|FG001|Overall Study|Data lost|4
7889858|NCT01843972|12393353|FG000|Overall Study|Withdrawal by Subject|0
7889859|NCT01843972|12393354|FG001|Overall Study|Withdrawal by Subject|0
7889860|NCT01843972|12393355|FG002|Overall Study|Withdrawal by Subject|0
7889861|NCT01843972|12393356|FG003|Overall Study|Withdrawal by Subject|0
7889862|NCT01843972|12393357|FG004|Overall Study|Withdrawal by Subject|1
7889863|NCT01843972|12393358|FG005|Overall Study|Withdrawal by Subject|0
7889864|NCT01843972|12393359|FG006|Overall Study|Withdrawal by Subject|0
7889865|NCT01843972|12393360|FG007|Overall Study|Withdrawal by Subject|0
7889866|NCT01843972|12393361|FG008|Overall Study|Withdrawal by Subject|0
7889867|NCT01843972|12393362|FG009|Overall Study|Withdrawal by Subject|0
7889868|NCT01844076|12393402|FG000|Overall Study|Adverse Event|1
7889869|NCT01844076|12393403|FG001|Overall Study|Adverse Event|0
7889870|NCT01844076|12393404|FG002|Overall Study|Adverse Event|0
7889871|NCT01844076|12393405|FG003|Overall Study|Adverse Event|0
7889872|NCT01844076|12393402|FG000|Overall Study|Withdrawal by Subject|1
7889873|NCT01844076|12393403|FG001|Overall Study|Withdrawal by Subject|0
7889874|NCT01844076|12393404|FG002|Overall Study|Withdrawal by Subject|0
7889875|NCT01844076|12393405|FG003|Overall Study|Withdrawal by Subject|0
7889876|NCT01844115|12393417|FG000|Overall Study|Adverse Event|4
7889877|NCT01844115|12393418|FG001|Overall Study|Adverse Event|22
7889878|NCT01844115|12393417|FG000|Overall Study|Lack of Efficacy|1
7889879|NCT01844115|12393418|FG001|Overall Study|Lack of Efficacy|4
7889880|NCT01844115|12393417|FG000|Overall Study|Protocol Violation|12
7889881|NCT01844115|12393418|FG001|Overall Study|Protocol Violation|10
7889882|NCT01844115|12393417|FG000|Overall Study|Withdrawal by Subject|11
7889883|NCT01844115|12393418|FG001|Overall Study|Withdrawal by Subject|11
7889884|NCT01844115|12393417|FG000|Overall Study|Lost to Follow-up|11
7889885|NCT01844115|12393418|FG001|Overall Study|Lost to Follow-up|10
7889886|NCT01844115|12393417|FG000|Overall Study|Pregnancy|0
7889887|NCT01844115|12393418|FG001|Overall Study|Pregnancy|1
7889888|NCT01844284|12393435|FG000|Overall Study|Lost to Follow-up|12
7889889|NCT01844284|12393436|FG001|Overall Study|Lost to Follow-up|7
7889890|NCT01844375|12393444|FG000|Overall Study|Protocol Violation|1
7889891|NCT01844375|12393445|FG001|Overall Study|Protocol Violation|1
7889892|NCT01844531|12393472|FG000|Overall Study|Withdrawal by Subject|0
7889893|NCT01844531|12393473|FG001|Overall Study|Withdrawal by Subject|1
7889894|NCT01844531|12393474|FG002|Overall Study|Withdrawal by Subject|0
7889895|NCT01844531|12393475|FG003|Overall Study|Withdrawal by Subject|0
7889896|NCT01844583|12393487|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8
7889897|NCT01844583|12393488|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10
7889898|NCT01844687|12393499|FG000|Visit 1|Protocol Violation|3
7889899|NCT01844687|12393499|FG000|Visit 1|Lost to Follow-up|5
7889900|NCT01844687|12393499|FG000|Visit 2|Withdrawal by Subject|1
7889901|NCT01844687|12393499|FG000|Visit 2|Protocol Violation|1
7889902|NCT01844687|12393499|FG000|Visit 3|Lost to Follow-up|1
7889903|NCT01844687|12393499|FG000|Visit 3|Withdrawal by Subject|3
7889904|NCT01844687|12393499|FG000|Visit 3|child care problems|1
7889905|NCT01844687|12393499|FG000|Visit 4|Pregnancy|1
7889906|NCT01844687|12393499|FG000|Visit 4|Lost to Follow-up|1
7889907|NCT01844687|12393499|FG000|Visit 4|Withdrawal by Subject|2
7889908|NCT01844700|12393523|FG000|Overall Study|Lack of Efficacy|1
7889909|NCT01844700|12393524|FG001|Overall Study|Lack of Efficacy|0
7889910|NCT01844700|12393523|FG000|Overall Study|refused medication switch|1
7889911|NCT01844700|12393524|FG001|Overall Study|refused medication switch|0
7889912|NCT01844700|12393523|FG000|Overall Study|Withdrawal by Subject|1
7889913|NCT01844700|12393524|FG001|Overall Study|Withdrawal by Subject|0
7889914|NCT01844700|12393523|FG000|Overall Study|stopped taking meds|0
7889915|NCT01844700|12393524|FG001|Overall Study|stopped taking meds|1
7889916|NCT01844765|12393532|FG000|Overall Study|Adverse Event|6
7889917|NCT01844765|12393533|FG001|Overall Study|Adverse Event|8
7889918|NCT01844765|12393532|FG000|Overall Study|Withdrawal by Subject|2
7889919|NCT01844765|12393533|FG001|Overall Study|Withdrawal by Subject|3
7889920|NCT01844765|12393532|FG000|Overall Study|Disease progression|1
7889921|NCT01844765|12393533|FG001|Overall Study|Disease progression|0
7889922|NCT01844765|12393532|FG000|Overall Study|Administrative problems|3
7889923|NCT01844765|12393533|FG001|Overall Study|Administrative problems|4
7889924|NCT01844765|12393532|FG000|Overall Study|Protocol deviation|2
7889925|NCT01844765|12393533|FG001|Overall Study|Protocol deviation|0
7889926|NCT01844765|12393532|FG000|Overall Study|Untreated|1
7889927|NCT01844765|12393533|FG001|Overall Study|Untreated|0
7889928|NCT01844778|12393547|FG000|Overall Study|Protocol deviation|0
7889929|NCT01844778|12393548|FG001|Overall Study|Protocol deviation|1
7889930|NCT01844778|12393549|FG002|Overall Study|Protocol deviation|2
7889931|NCT01844778|12393547|FG000|Overall Study|Withdrawal by Subject|2
7889932|NCT01844778|12393548|FG001|Overall Study|Withdrawal by Subject|0
7889933|NCT01844778|12393549|FG002|Overall Study|Withdrawal by Subject|0
7889934|NCT01844778|12393547|FG000|Overall Study|Adverse Event|0
7889935|NCT01844778|12393548|FG001|Overall Study|Adverse Event|2
7889936|NCT01844778|12393549|FG002|Overall Study|Adverse Event|2
7889937|NCT01844817|12393563|FG000|Enrolled and Randomized|Withdrawal by Subject|2
7889938|NCT01844817|12393564|FG001|Enrolled and Randomized|Withdrawal by Subject|3
7889939|NCT01844817|12393563|FG000|Treatment|Progressive Disease|27
7889940|NCT01844817|12393564|FG001|Treatment|Progressive Disease|36
7889941|NCT01844817|12393563|FG000|Treatment|Adverse Event|17
7889942|NCT01844817|12393564|FG001|Treatment|Adverse Event|9
7889943|NCT01844817|12393563|FG000|Treatment|Withdrawal by Subject|10
7889944|NCT01844817|12393564|FG001|Treatment|Withdrawal by Subject|6
7889945|NCT01844817|12393563|FG000|Treatment|Death|10
7889946|NCT01844817|12393564|FG001|Treatment|Death|8
7889947|NCT01844817|12393563|FG000|Treatment|Lost to Follow-up|0
7889948|NCT01844817|12393564|FG001|Treatment|Lost to Follow-up|1
7889949|NCT01844817|12393563|FG000|Treatment|Other|0
7889950|NCT01844817|12393564|FG001|Treatment|Other|3
7889951|NCT01844830|12393573|FG000|Overall Study|Withdrawal by Subject|1
7889952|NCT01844830|12393574|FG001|Overall Study|Withdrawal by Subject|0
7889953|NCT01844895|12393580|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
7889954|NCT01844895|12393580|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
7889955|NCT01844895|12393580|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
7889956|NCT01844895|12393580|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1
7889957|NCT01844895|12393580|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
7889958|NCT01844895|12393580|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3
7889959|NCT01844895|12393580|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1
7889960|NCT01845025|12393595|FG000|Overall Study|Adverse Event|6
7889961|NCT01845025|12393596|FG001|Overall Study|Adverse Event|3
7889962|NCT01845025|12393595|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7889963|NCT01845025|12393596|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7889964|NCT01845025|12393595|FG000|Overall Study|Withdrawal by Subject|48
7889965|NCT01845025|12393596|FG001|Overall Study|Withdrawal by Subject|44
7889966|NCT01845025|12393595|FG000|Overall Study|Lost to Follow-up|13
7889967|NCT01845025|12393596|FG001|Overall Study|Lost to Follow-up|13
7889968|NCT01845025|12393595|FG000|Overall Study|Administrative problems|8
7889969|NCT01845025|12393596|FG001|Overall Study|Administrative problems|8
7889970|NCT01845025|12393595|FG000|Overall Study|Death|2
7889971|NCT01845025|12393596|FG001|Overall Study|Death|0
7889972|NCT01845025|12393595|FG000|Overall Study|Protocol deviation|3
7889973|NCT01845025|12393596|FG001|Overall Study|Protocol deviation|6
7889974|NCT01845025|12393595|FG000|Overall Study|Missing|1
7889975|NCT01845025|12393596|FG001|Overall Study|Missing|1
7889976|NCT01845077|12393605|FG000|Washout Period|Lost to Follow-up|0
7889977|NCT01845077|12393606|FG001|Washout Period|Lost to Follow-up|1
7889978|NCT01845077|12393607|FG002|Washout Period|Lost to Follow-up|0
7889979|NCT01845077|12393608|FG003|Washout Period|Lost to Follow-up|1
7889980|NCT01845077|12393609|FG004|Washout Period|Lost to Follow-up|0
7889981|NCT01845077|12393610|FG005|Washout Period|Lost to Follow-up|1
7889982|NCT01845077|12393605|FG000|Washout Period|Adverse Event|1
7889983|NCT01845077|12393606|FG001|Washout Period|Adverse Event|0
7889984|NCT01845077|12393607|FG002|Washout Period|Adverse Event|0
7889985|NCT01845077|12393608|FG003|Washout Period|Adverse Event|0
7889986|NCT01845077|12393609|FG004|Washout Period|Adverse Event|0
7889987|NCT01845077|12393610|FG005|Washout Period|Adverse Event|0
7889988|NCT01845077|12393605|FG000|Washout Period|elevated lab values (not clinic. sign.)|0
7889989|NCT01845077|12393606|FG001|Washout Period|elevated lab values (not clinic. sign.)|0
7889990|NCT01845077|12393607|FG002|Washout Period|elevated lab values (not clinic. sign.)|1
7889991|NCT01845077|12393608|FG003|Washout Period|elevated lab values (not clinic. sign.)|0
7889992|NCT01845077|12393609|FG004|Washout Period|elevated lab values (not clinic. sign.)|0
7889993|NCT01845077|12393610|FG005|Washout Period|elevated lab values (not clinic. sign.)|0
7889994|NCT01845077|12393605|FG000|Washout Period|Protocol Violation|0
7889995|NCT01845077|12393606|FG001|Washout Period|Protocol Violation|0
7889996|NCT01845077|12393607|FG002|Washout Period|Protocol Violation|0
7889997|NCT01845077|12393608|FG003|Washout Period|Protocol Violation|1
7889998|NCT01845077|12393609|FG004|Washout Period|Protocol Violation|1
7889999|NCT01845077|12393610|FG005|Washout Period|Protocol Violation|0
7962931|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7962932|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7962933|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1
7962934|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0
7962935|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0
7962936|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0
7962937|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0
7962938|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7962939|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1
7962940|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7962941|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7962942|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7962943|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Investigator decision|2
7962944|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Investigator decision|1
7962945|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Investigator decision|0
7962946|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Investigator decision|0
7962947|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Investigator decision|0
7962948|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7962949|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1
7962950|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7962951|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7962952|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7962953|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1
7962954|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7962955|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7962956|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7962957|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7962958|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7962959|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1
7962960|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7962961|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7962962|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7890000|NCT01845818|12393660|FG000|Overall Study|Withdrawal by Subject|0
7890001|NCT01845818|12393661|FG001|Overall Study|Withdrawal by Subject|1
7890002|NCT01845818|12393660|FG000|Overall Study|Lost to Follow-up|7
7890003|NCT01845818|12393661|FG001|Overall Study|Lost to Follow-up|5
7890004|NCT01845818|12393660|FG000|Overall Study|Administrative Reasons|3
7890005|NCT01845818|12393661|FG001|Overall Study|Administrative Reasons|1
7890006|NCT01845818|12393660|FG000|Overall Study|Serious Adverse Event|1
7890007|NCT01845818|12393661|FG001|Overall Study|Serious Adverse Event|1
7890008|NCT01845818|12393660|FG000|Overall Study|Other|25
7890009|NCT01845818|12393661|FG001|Overall Study|Other|8
7890010|NCT01845818|12393660|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5
7890011|NCT01845818|12393661|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0
7890012|NCT01845818|12393660|FG000|Overall Study|No Follow-Up Data Available|4
7890013|NCT01845818|12393661|FG001|Overall Study|No Follow-Up Data Available|1
7890014|NCT01845831|12393671|FG000|Inpatient Phase|Withdrawal by Subject|1
7890015|NCT01845831|12393672|FG001|Inpatient Phase|Withdrawal by Subject|1
7890016|NCT01845831|12393673|FG002|Inpatient Phase|Withdrawal by Subject|0
7890017|NCT01845831|12393674|FG003|Inpatient Phase|Withdrawal by Subject|0
7890018|NCT01845831|12393675|FG004|Inpatient Phase|Withdrawal by Subject|0
7890019|NCT01845974|12393688|FG000|Overall Study|screen failure|1
7890020|NCT01845974|12393689|FG001|Overall Study|screen failure|0
7890021|NCT01846039|12393695|FG000|Overall Study|Protocol Violation|1
7890022|NCT01846039|12393695|FG000|Overall Study|Subject Withdrew Consent|1
7890023|NCT01846104|12393699|FG000|Overall Study|Withdrawal by Subject|1
7890024|NCT01846208|12393706|FG000|Overall Study|Withdrew prior to treatment|1
7890025|NCT01846208|12393707|FG001|Overall Study|Withdrew prior to treatment|1
7890026|NCT01846208|12393708|FG002|Overall Study|Withdrew prior to treatment|1
7890027|NCT01846208|12393706|FG000|Overall Study|Dosing Symptoms|1
7890028|NCT01846208|12393707|FG001|Overall Study|Dosing Symptoms|2
7890029|NCT01846208|12393708|FG002|Overall Study|Dosing Symptoms|6
7890030|NCT01846208|12393706|FG000|Overall Study|Withdrawal by Subject|5
7890031|NCT01846208|12393707|FG001|Overall Study|Withdrawal by Subject|0
7890032|NCT01846208|12393708|FG002|Overall Study|Withdrawal by Subject|0
7890033|NCT01846208|12393706|FG000|Overall Study|Non-compliance|1
7890034|NCT01846208|12393707|FG001|Overall Study|Non-compliance|1
7890035|NCT01846208|12393708|FG002|Overall Study|Non-compliance|0
7890036|NCT01846208|12393706|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
7890037|NCT01846208|12393707|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
7890038|NCT01846208|12393708|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
7890039|NCT01846208|12393706|FG000|Overall Study|Refused SU OFC|0
7890040|NCT01846208|12393707|FG001|Overall Study|Refused SU OFC|0
7890041|NCT01846208|12393708|FG002|Overall Study|Refused SU OFC|1
7890042|NCT01846221|12393718|FG000|Overall Study|Catheter Failure|2
7890043|NCT01846221|12393719|FG001|Overall Study|Catheter Failure|0
7890044|NCT01846221|12393718|FG000|Overall Study|Age Exclusion|1
7890045|NCT01846221|12393719|FG001|Overall Study|Age Exclusion|0
7890046|NCT01846299|12393727|FG000|Overall Study|Physician Decision|4
7890047|NCT01846299|12393728|FG001|Overall Study|Physician Decision|2
7890048|NCT01846299|12393727|FG000|Overall Study|Protocol deviation|1
7890049|NCT01846299|12393728|FG001|Overall Study|Protocol deviation|0
7890050|NCT01846299|12393727|FG000|Overall Study|Death|1
7890051|NCT01846299|12393728|FG001|Overall Study|Death|2
7890052|NCT01846299|12393727|FG000|Overall Study|Lost to Follow-up|3
7890053|NCT01846299|12393728|FG001|Overall Study|Lost to Follow-up|0
7890054|NCT01846299|12393727|FG000|Overall Study|Withdrawal by Subject|1
7890055|NCT01846299|12393728|FG001|Overall Study|Withdrawal by Subject|6
7890056|NCT01846299|12393727|FG000|Overall Study|Adverse Event|2
7890057|NCT01846299|12393728|FG001|Overall Study|Adverse Event|0
7890058|NCT01846416|12393739|FG000|Treatment Phase|Death|2
7890059|NCT01846416|12393740|FG001|Treatment Phase|Death|9
7890060|NCT01846416|12393741|FG002|Treatment Phase|Death|1
7890061|NCT01846416|12393739|FG000|Treatment Phase|Withdrawal by Subject|2
7890062|NCT01846416|12393740|FG001|Treatment Phase|Withdrawal by Subject|4
7890063|NCT01846416|12393741|FG002|Treatment Phase|Withdrawal by Subject|2
7890064|NCT01846416|12393739|FG000|Treatment Phase|Other|1
7890065|NCT01846416|12393740|FG001|Treatment Phase|Other|5
7890066|NCT01846416|12393741|FG002|Treatment Phase|Other|1
7890067|NCT01846416|12393739|FG000|Treatment Phase|Physician Decision|1
7890068|NCT01846416|12393740|FG001|Treatment Phase|Physician Decision|2
7890069|NCT01846416|12393741|FG002|Treatment Phase|Physician Decision|0
7890070|NCT01846416|12393739|FG000|Treatment Phase|Adverse Event|3
7890071|NCT01846416|12393740|FG001|Treatment Phase|Adverse Event|4
7890072|NCT01846416|12393741|FG002|Treatment Phase|Adverse Event|0
7890073|NCT01846416|12393739|FG000|Treatment Phase|Non-compliance|0
7890074|NCT01846416|12393740|FG001|Treatment Phase|Non-compliance|2
7890075|NCT01846416|12393741|FG002|Treatment Phase|Non-compliance|0
7890076|NCT01846416|12393739|FG000|Treatment Phase|Study Terminated by Sponsor|1
7890077|NCT01846416|12393740|FG001|Treatment Phase|Study Terminated by Sponsor|4
7890078|NCT01846416|12393741|FG002|Treatment Phase|Study Terminated by Sponsor|0
7890079|NCT01846416|12393739|FG000|Treatment Phase|Progressive Disease|21
7890080|NCT01846416|12393740|FG001|Treatment Phase|Progressive Disease|63
7890081|NCT01846416|12393741|FG002|Treatment Phase|Progressive Disease|9
7890082|NCT01846416|12393739|FG000|Survival Follow-up|Death|21
7890083|NCT01846416|12393740|FG001|Survival Follow-up|Death|62
7890084|NCT01846416|12393741|FG002|Survival Follow-up|Death|9
7890085|NCT01846416|12393739|FG000|Survival Follow-up|Lost to Follow-up|0
7890086|NCT01846416|12393740|FG001|Survival Follow-up|Lost to Follow-up|2
7890087|NCT01846416|12393741|FG002|Survival Follow-up|Lost to Follow-up|2
7890088|NCT01846416|12393739|FG000|Survival Follow-up|Withdrawal by Subject|2
7890089|NCT01846416|12393740|FG001|Survival Follow-up|Withdrawal by Subject|7
7890090|NCT01846416|12393741|FG002|Survival Follow-up|Withdrawal by Subject|0
7890091|NCT01846416|12393739|FG000|Survival Follow-up|Study Terminated by Sponsor|2
7890092|NCT01846416|12393740|FG001|Survival Follow-up|Study Terminated by Sponsor|8
7890093|NCT01846416|12393741|FG002|Survival Follow-up|Study Terminated by Sponsor|0
7890094|NCT01846416|12393739|FG000|Survival Follow-up|Other|3
7890095|NCT01846416|12393740|FG001|Survival Follow-up|Other|1
7890096|NCT01846416|12393741|FG002|Survival Follow-up|Other|1
7890097|NCT01846442|12393754|FG000|Overall Study|Adverse Event|2
7890098|NCT01846442|12393755|FG001|Overall Study|Adverse Event|4
7890099|NCT01846442|12393756|FG002|Overall Study|Adverse Event|2
7890100|NCT01846442|12393757|FG003|Overall Study|Adverse Event|1
7890101|NCT01846442|12393754|FG000|Overall Study|Lost to Follow-up|0
7890102|NCT01846442|12393755|FG001|Overall Study|Lost to Follow-up|0
7890103|NCT01846442|12393756|FG002|Overall Study|Lost to Follow-up|1
7890104|NCT01846442|12393757|FG003|Overall Study|Lost to Follow-up|0
7890105|NCT01846442|12393754|FG000|Overall Study|Withdrawal by Subject|3
7890106|NCT01846442|12393755|FG001|Overall Study|Withdrawal by Subject|2
7890107|NCT01846442|12393756|FG002|Overall Study|Withdrawal by Subject|0
7890108|NCT01846442|12393757|FG003|Overall Study|Withdrawal by Subject|1
7890109|NCT01846442|12393754|FG000|Overall Study|Left the city/Lost medication|1
7890110|NCT01846442|12393755|FG001|Overall Study|Left the city/Lost medication|0
7890111|NCT01846442|12393756|FG002|Overall Study|Left the city/Lost medication|1
7890112|NCT01846442|12393757|FG003|Overall Study|Left the city/Lost medication|1
7890113|NCT01846507|12393797|FG000|Overall Study|Lost to Follow-up|4
7890114|NCT01846507|12393797|FG000|Overall Study|Protocol Violation|1
7890115|NCT01846507|12393797|FG000|Overall Study|Missing data|2
7890116|NCT01846611|12393805|FG000|Overall Study|Lost to Follow-up|4
7890117|NCT01846611|12393806|FG001|Overall Study|Lost to Follow-up|6
7890118|NCT01846611|12393805|FG000|Overall Study|Withdrawal by Subject|15
7890119|NCT01846611|12393806|FG001|Overall Study|Withdrawal by Subject|19
7890120|NCT01846611|12393805|FG000|Overall Study|Other|19
7890121|NCT01846611|12393806|FG001|Overall Study|Other|18
7890122|NCT01846624|12393812|FG000|Overall Study|Died during induction, no midostaurin|1
7890123|NCT01846741|12393857|FG000|Baseline Visit|Subject did not meet entry criteria|2
7890124|NCT01847092|12393946|FG000|Overall Study|Adverse Event|12
7890125|NCT01847092|12393947|FG001|Overall Study|Adverse Event|3
7890126|NCT01847092|12393946|FG000|Overall Study|Withdrawal by Subject|5
7890127|NCT01847092|12393947|FG001|Overall Study|Withdrawal by Subject|5
7890128|NCT01847092|12393946|FG000|Overall Study|Protocol Specified|8
7890129|NCT01847092|12393947|FG001|Overall Study|Protocol Specified|0
7890130|NCT01847092|12393946|FG000|Overall Study|Physician Decision|1
7890131|NCT01847092|12393947|FG001|Overall Study|Physician Decision|1
7890132|NCT01847092|12393946|FG000|Overall Study|Protocol Violation|0
7890133|NCT01847092|12393947|FG001|Overall Study|Protocol Violation|2
7890134|NCT01847209|12393966|FG000|Overall Study|Withdrawal by Subject|1
7890135|NCT01847209|12393966|FG000|Overall Study|No lung nodule found on intraop CT scan|1
7890136|NCT01847313|12393972|FG000|Overall Study|Death|0
7890137|NCT01847313|12393973|FG001|Overall Study|Death|1
7890138|NCT01847313|12393972|FG000|Overall Study|Withdrawal by Subject|0
7890139|NCT01847313|12393973|FG001|Overall Study|Withdrawal by Subject|1
7890140|NCT01847443|12393983|FG000|Study Period 1|Withdrawal by Subject|0
7890141|NCT01847443|12393984|FG001|Study Period 1|Withdrawal by Subject|1
7890142|NCT01847443|12393985|FG002|Study Period 1|Withdrawal by Subject|0
7890143|NCT01847443|12393986|FG003|Study Period 1|Withdrawal by Subject|0
7890144|NCT01847443|12393983|FG000|Washout Period Before Study Period 2|Adverse Event|1
7890145|NCT01847443|12393984|FG001|Washout Period Before Study Period 2|Adverse Event|1
7890146|NCT01847443|12393985|FG002|Washout Period Before Study Period 2|Adverse Event|0
7890147|NCT01847443|12393986|FG003|Washout Period Before Study Period 2|Adverse Event|0
7890148|NCT01847443|12393983|FG000|Washout Period Before Study Period 2|Other reason|1
7890149|NCT01847443|12393984|FG001|Washout Period Before Study Period 2|Other reason|0
7890150|NCT01847443|12393985|FG002|Washout Period Before Study Period 2|Other reason|0
7890151|NCT01847443|12393986|FG003|Washout Period Before Study Period 2|Other reason|0
7890152|NCT01847443|12393983|FG000|Washout Period Before Study Period 3|Other reason|1
7890153|NCT01847443|12393984|FG001|Washout Period Before Study Period 3|Other reason|0
7890154|NCT01847443|12393985|FG002|Washout Period Before Study Period 3|Other reason|0
7890155|NCT01847443|12393986|FG003|Washout Period Before Study Period 3|Other reason|0
7890156|NCT01847443|12393983|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1
7890157|NCT01847443|12393984|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0
7890158|NCT01847443|12393985|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0
7890159|NCT01847443|12393986|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0
7890160|NCT01847443|12393983|FG000|Washout Period Before Study Period 4|Positive alcohol test|1
7890161|NCT01847443|12393984|FG001|Washout Period Before Study Period 4|Positive alcohol test|0
7890162|NCT01847443|12393985|FG002|Washout Period Before Study Period 4|Positive alcohol test|0
7890163|NCT01847443|12393986|FG003|Washout Period Before Study Period 4|Positive alcohol test|0
7890164|NCT01847755|12394087|FG000|Overall Study|Adverse Event|2
7890165|NCT01847755|12394087|FG000|Overall Study|Withdrawal by Subject|2
7890166|NCT01847755|12394087|FG000|Overall Study|Physician Decision|1
7890167|NCT01847885|12394093|FG000|Initial Enrollment (Consented)|Protocol Violation|1
7890168|NCT01847885|12394094|FG001|Initial Enrollment (Consented)|Protocol Violation|0
7968256|NCT03893565|12525825|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7968257|NCT03893565|12525826|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7968258|NCT03893565|12525827|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7968259|NCT03893565|12525828|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7968260|NCT03893565|12525820|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7968261|NCT03893565|12525821|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7968262|NCT03893565|12525822|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7968263|NCT03893565|12525823|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1
7968264|NCT03893565|12525824|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7968265|NCT03893565|12525825|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7968266|NCT03893565|12525826|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7968267|NCT03893565|12525827|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7968268|NCT03893565|12525828|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7968269|NCT03893565|12525820|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7968270|NCT03893565|12525821|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2
7968271|NCT03893565|12525822|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1
7968272|NCT03893565|12525823|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1
7968273|NCT03893565|12525824|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7968274|NCT03893565|12525825|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7968275|NCT03893565|12525826|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7968276|NCT03893565|12525827|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7968277|NCT03893565|12525828|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7968278|NCT03893565|12525820|FG000|Double-blind Extended Treatment(20weeks)|Other|0
7968279|NCT03893565|12525821|FG001|Double-blind Extended Treatment(20weeks)|Other|0
7968280|NCT03893565|12525822|FG002|Double-blind Extended Treatment(20weeks)|Other|0
7968281|NCT03893565|12525823|FG003|Double-blind Extended Treatment(20weeks)|Other|0
7968282|NCT03893565|12525824|FG004|Double-blind Extended Treatment(20weeks)|Other|0
7968283|NCT03893565|12525825|FG005|Double-blind Extended Treatment(20weeks)|Other|1
7968284|NCT03893565|12525826|FG006|Double-blind Extended Treatment(20weeks)|Other|1
7968285|NCT03893565|12525827|FG007|Double-blind Extended Treatment(20weeks)|Other|0
7968286|NCT03893565|12525828|FG008|Double-blind Extended Treatment(20weeks)|Other|0
7890169|NCT01847885|12394095|FG002|Initial Enrollment (Consented)|Protocol Violation|0
7890170|NCT01847885|12394093|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2
7890171|NCT01847885|12394094|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0
7890172|NCT01847885|12394095|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0
7890173|NCT01847885|12394093|FG000|Initial Enrollment (Consented)|Screen failure|39
7890174|NCT01847885|12394094|FG001|Initial Enrollment (Consented)|Screen failure|0
7890175|NCT01847885|12394095|FG002|Initial Enrollment (Consented)|Screen failure|0
7890176|NCT01847885|12394093|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
7890177|NCT01847885|12394094|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
7890178|NCT01847885|12394095|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
7890179|NCT01847885|12394093|FG000|Randomization|Protocol Violation|0
7890180|NCT01847885|12394094|FG001|Randomization|Protocol Violation|1
7890181|NCT01847885|12394095|FG002|Randomization|Protocol Violation|0
7890182|NCT01847885|12394093|FG000|Randomization|Withdrawal by Subject|0
7890183|NCT01847885|12394094|FG001|Randomization|Withdrawal by Subject|0
7890184|NCT01847885|12394095|FG002|Randomization|Withdrawal by Subject|2
7890185|NCT01847885|12394093|FG000|Randomization|Screen Failure|0
7890186|NCT01847885|12394094|FG001|Randomization|Screen Failure|3
7890187|NCT01847885|12394095|FG002|Randomization|Screen Failure|0
7890188|NCT01848145|12394140|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
7890189|NCT01848145|12394140|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
7890190|NCT01848145|12394140|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
7890191|NCT01848145|12394140|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
7890192|NCT01848145|12394140|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6
7890193|NCT01848145|12394140|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
7890194|NCT01848145|12394140|FG000|Subsequent Infusions: Weeks 3-8|Death|1
7890195|NCT01848210|12394165|FG000|Overall Study|Informed Consent Form Withdrawal|28
7890196|NCT01848210|12394166|FG001|Overall Study|Informed Consent Form Withdrawal|24
7890197|NCT01848210|12394165|FG000|Overall Study|Lost to Follow-up|24
7890198|NCT01848210|12394166|FG001|Overall Study|Lost to Follow-up|12
7890199|NCT01848210|12394165|FG000|Overall Study|Protocol Violation|3
7890200|NCT01848210|12394166|FG001|Overall Study|Protocol Violation|5
7890201|NCT01848210|12394165|FG000|Overall Study|Use of Forbidden Drugs|9
7890202|NCT01848210|12394166|FG001|Overall Study|Use of Forbidden Drugs|10
7890203|NCT01848210|12394165|FG000|Overall Study|Impedition Condition|5
7890204|NCT01848210|12394166|FG001|Overall Study|Impedition Condition|9
7890205|NCT01848210|12394165|FG000|Overall Study|Adverse Event|7
7890206|NCT01848210|12394166|FG001|Overall Study|Adverse Event|9
7890207|NCT01848210|12394165|FG000|Overall Study|Discontinuation Criterion|5
7890208|NCT01848210|12394166|FG001|Overall Study|Discontinuation Criterion|7
7890209|NCT01848210|12394165|FG000|Overall Study|Hypesensitivity|1
7890210|NCT01848210|12394166|FG001|Overall Study|Hypesensitivity|0
7890211|NCT01848210|12394165|FG000|Overall Study|Hepatic Function Alteration|4
7890212|NCT01848210|12394166|FG001|Overall Study|Hepatic Function Alteration|0
7890213|NCT01848210|12394165|FG000|Overall Study|Chronic Venous Insufficiency Course|1
7890214|NCT01848210|12394166|FG001|Overall Study|Chronic Venous Insufficiency Course|2
7890215|NCT01848210|12394165|FG000|Overall Study|Administrative|1
7890216|NCT01848210|12394166|FG001|Overall Study|Administrative|0
7890217|NCT01848288|12394172|FG000|Overall Study|Death|1
7890218|NCT01848288|12394172|FG000|Overall Study|Protocol Violation|1
7890219|NCT01848288|12394172|FG000|Overall Study|Withdrawal by Subject|1
7890220|NCT01848353|12394181|FG000|Phase 1|Withdrawal by Subject|3
7890221|NCT01848353|12394182|FG001|Phase 1|Withdrawal by Subject|1
7890222|NCT01848353|12394183|FG002|Phase 1|Withdrawal by Subject|0
7890223|NCT01848353|12394184|FG003|Phase 1|Withdrawal by Subject|0
7890224|NCT01848353|12394181|FG000|Phase 2|Withdrawal by Subject|3
7890225|NCT01848353|12394182|FG001|Phase 2|Withdrawal by Subject|2
7890226|NCT01848353|12394183|FG002|Phase 2|Withdrawal by Subject|0
7890227|NCT01848353|12394184|FG003|Phase 2|Withdrawal by Subject|0
7890228|NCT01848353|12394181|FG000|Phase 3|Withdrawal by Subject|1
7890229|NCT01848353|12394182|FG001|Phase 3|Withdrawal by Subject|1
7890230|NCT01848353|12394183|FG002|Phase 3|Withdrawal by Subject|0
7890231|NCT01848353|12394184|FG003|Phase 3|Withdrawal by Subject|0
7890232|NCT01848457|12394210|FG000|Overall Study|Death|1
7890233|NCT01848457|12394211|FG001|Overall Study|Death|0
7890234|NCT01848457|12394212|FG002|Overall Study|Death|0
7890235|NCT01848457|12394213|FG003|Overall Study|Death|0
7890236|NCT01848483|12394233|FG000|Overall Study|Death|2
7890237|NCT01848483|12394234|FG001|Overall Study|Death|1
7890238|NCT01848483|12394233|FG000|Overall Study|Lost to Follow-up|6
7890239|NCT01848483|12394234|FG001|Overall Study|Lost to Follow-up|8
7890240|NCT01848483|12394233|FG000|Overall Study|Withdrawal by Subject|1
7890241|NCT01848483|12394234|FG001|Overall Study|Withdrawal by Subject|0
7890242|NCT01848483|12394233|FG000|Overall Study|Incarceration|2
7890243|NCT01848483|12394234|FG001|Overall Study|Incarceration|2
7890244|NCT01848756|12394241|FG000|Overall Study|Adverse Event|1
7890245|NCT01848756|12394241|FG000|Overall Study|Withdrawal by Subject|1
7890246|NCT01848756|12394241|FG000|Overall Study|Enrolled in Error|1
7890247|NCT01848834|12394260|FG000|Overall Study|Adverse Event|3
7890248|NCT01848834|12394261|FG001|Overall Study|Adverse Event|11
7890249|NCT01848834|12394262|FG002|Overall Study|Adverse Event|3
7890250|NCT01848834|12394263|FG003|Overall Study|Adverse Event|5
7890251|NCT01848834|12394264|FG004|Overall Study|Adverse Event|9
7890252|NCT01848834|12394260|FG000|Overall Study|Death|2
7890253|NCT01848834|12394261|FG001|Overall Study|Death|11
7890254|NCT01848834|12394262|FG002|Overall Study|Death|1
7890255|NCT01848834|12394263|FG003|Overall Study|Death|8
7890256|NCT01848834|12394264|FG004|Overall Study|Death|27
7890257|NCT01848834|12394260|FG000|Overall Study|Excluded Medication|5
7890258|NCT01848834|12394261|FG001|Overall Study|Excluded Medication|4
7890259|NCT01848834|12394262|FG002|Overall Study|Excluded Medication|3
7890260|NCT01848834|12394263|FG003|Overall Study|Excluded Medication|6
7890261|NCT01848834|12394264|FG004|Overall Study|Excluded Medication|6
7890262|NCT01848834|12394260|FG000|Overall Study|Lost to Follow-up|5
7890263|NCT01848834|12394261|FG001|Overall Study|Lost to Follow-up|5
7890264|NCT01848834|12394262|FG002|Overall Study|Lost to Follow-up|3
7890265|NCT01848834|12394263|FG003|Overall Study|Lost to Follow-up|0
7890266|NCT01848834|12394264|FG004|Overall Study|Lost to Follow-up|3
7890267|NCT01848834|12394260|FG000|Overall Study|Physician Decision|1
7890268|NCT01848834|12394261|FG001|Overall Study|Physician Decision|3
7890269|NCT01848834|12394262|FG002|Overall Study|Physician Decision|4
7890270|NCT01848834|12394263|FG003|Overall Study|Physician Decision|0
7890271|NCT01848834|12394264|FG004|Overall Study|Physician Decision|11
7890272|NCT01848834|12394260|FG000|Overall Study|Protocol Violation|0
7890273|NCT01848834|12394261|FG001|Overall Study|Protocol Violation|0
7890274|NCT01848834|12394262|FG002|Overall Study|Protocol Violation|0
7890275|NCT01848834|12394263|FG003|Overall Study|Protocol Violation|0
7890276|NCT01848834|12394264|FG004|Overall Study|Protocol Violation|1
7890277|NCT01848834|12394260|FG000|Overall Study|Sponsor Decision|1
7890278|NCT01848834|12394261|FG001|Overall Study|Sponsor Decision|1
7890279|NCT01848834|12394262|FG002|Overall Study|Sponsor Decision|0
7890280|NCT01848834|12394263|FG003|Overall Study|Sponsor Decision|1
7890281|NCT01848834|12394264|FG004|Overall Study|Sponsor Decision|1
7890282|NCT01848834|12394260|FG000|Overall Study|Withdrawal by Subject|2
7890283|NCT01848834|12394261|FG001|Overall Study|Withdrawal by Subject|13
7890284|NCT01848834|12394262|FG002|Overall Study|Withdrawal by Subject|10
7890285|NCT01848834|12394263|FG003|Overall Study|Withdrawal by Subject|6
7890286|NCT01848834|12394264|FG004|Overall Study|Withdrawal by Subject|36
7890287|NCT01848938|12394300|FG000|Overall Study|Lost to Follow-up|1
7890288|NCT01848938|12394301|FG001|Overall Study|Lost to Follow-up|1
7890289|NCT01848990|12394319|FG000|Overall Study|Adverse Event|6
7890290|NCT01848990|12394320|FG001|Overall Study|Adverse Event|2
7890291|NCT01848990|12394321|FG002|Overall Study|Adverse Event|0
7890292|NCT01848990|12394319|FG000|Overall Study|Lost to Follow-up|6
7890293|NCT01848990|12394320|FG001|Overall Study|Lost to Follow-up|2
7890294|NCT01848990|12394321|FG002|Overall Study|Lost to Follow-up|2
7890295|NCT01848990|12394319|FG000|Overall Study|Protocol Violation|1
7890296|NCT01848990|12394320|FG001|Overall Study|Protocol Violation|1
7890297|NCT01848990|12394321|FG002|Overall Study|Protocol Violation|0
7890298|NCT01848990|12394319|FG000|Overall Study|Withdrawal by Subject|29
7890299|NCT01848990|12394320|FG001|Overall Study|Withdrawal by Subject|10
7890300|NCT01848990|12394321|FG002|Overall Study|Withdrawal by Subject|11
7890301|NCT01848990|12394319|FG000|Overall Study|Physician Decision|1
7890302|NCT01848990|12394320|FG001|Overall Study|Physician Decision|1
7890303|NCT01848990|12394321|FG002|Overall Study|Physician Decision|0
7890304|NCT01848990|12394319|FG000|Overall Study|Non Compliance|1
7890305|NCT01848990|12394320|FG001|Overall Study|Non Compliance|0
7890306|NCT01848990|12394321|FG002|Overall Study|Non Compliance|0
7890307|NCT01848990|12394319|FG000|Overall Study|Death|1
7890308|NCT01848990|12394320|FG001|Overall Study|Death|0
7890309|NCT01848990|12394321|FG002|Overall Study|Death|1
7968287|NCT03893565|12525820|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7890310|NCT01848990|12394319|FG000|Overall Study|Other|1
7890311|NCT01848990|12394320|FG001|Overall Study|Other|4
7890312|NCT01848990|12394321|FG002|Overall Study|Other|2
7890313|NCT01849055|12394339|FG000|Overall Study|Withdrawal by Subject|0
7890314|NCT01849055|12394340|FG001|Overall Study|Withdrawal by Subject|0
7890315|NCT01849055|12394341|FG002|Overall Study|Withdrawal by Subject|1
7890316|NCT01849055|12394342|FG003|Overall Study|Withdrawal by Subject|0
7890317|NCT01849055|12394343|FG004|Overall Study|Withdrawal by Subject|0
7890318|NCT01849055|12394344|FG005|Overall Study|Withdrawal by Subject|0
7890319|NCT01849276|12394380|FG000|Followed for Survival for 5 Years|Death|1
7890320|NCT01849276|12394380|FG000|Followed for Survival for 5 Years|Early termination of the study|1
7890321|NCT01849289|12394386|FG000|Overall Study|Adverse Event|3
7890322|NCT01849289|12394387|FG001|Overall Study|Adverse Event|3
7890323|NCT01849289|12394386|FG000|Overall Study|Protocol Violation|3
7890324|NCT01849289|12394387|FG001|Overall Study|Protocol Violation|3
7890325|NCT01849289|12394386|FG000|Overall Study|Withdrawal criteria|1
7890326|NCT01849289|12394387|FG001|Overall Study|Withdrawal criteria|0
7890327|NCT01849289|12394386|FG000|Overall Study|Unclassified|25
7890328|NCT01849289|12394387|FG001|Overall Study|Unclassified|18
7890329|NCT01849458|12394398|FG000|Overall Study|Lost to Follow-up|4
7890330|NCT01849497|12394404|FG000|Overall Study|Withdrawal by Subject|1
7890331|NCT01849497|12394405|FG001|Overall Study|Withdrawal by Subject|2
7968288|NCT03893565|12525821|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7890332|NCT01849497|12394404|FG000|Overall Study|Sponsor Decision|0
7890333|NCT01849497|12394405|FG001|Overall Study|Sponsor Decision|1
7890334|NCT01849497|12394404|FG000|Overall Study|Lost to Follow-up|0
7890335|NCT01849497|12394405|FG001|Overall Study|Lost to Follow-up|1
7890336|NCT01849562|12394414|FG000|Overall Study|Lost to Follow-up|1
7890337|NCT01849562|12394415|FG001|Overall Study|Lost to Follow-up|0
7890338|NCT01849562|12394416|FG002|Overall Study|Lost to Follow-up|0
7890339|NCT01849562|12394414|FG000|Overall Study|Non-compliance with Study Drug|1
7890340|NCT01849562|12394415|FG001|Overall Study|Non-compliance with Study Drug|0
7890341|NCT01849562|12394416|FG002|Overall Study|Non-compliance with Study Drug|0
7890342|NCT01849588|12394425|FG000|Overall Study|Lack of Efficacy|3
7890343|NCT01849848|12394478|FG000|Overall Study|Physician Decision|1
7890344|NCT01849848|12394478|FG000|Overall Study|Progression of the primary disease|3
7890345|NCT01850030|12394484|FG000|Overall Study|Adverse Event|64
7890346|NCT01850030|12394485|FG001|Overall Study|Adverse Event|82
7890347|NCT01850030|12394484|FG000|Overall Study|Lack of Efficacy|3
7890348|NCT01850030|12394485|FG001|Overall Study|Lack of Efficacy|1
7890349|NCT01850030|12394484|FG000|Overall Study|Lost to Follow-up|5
7890350|NCT01850030|12394485|FG001|Overall Study|Lost to Follow-up|5
7890351|NCT01850030|12394484|FG000|Overall Study|Withdrawal by Subject|3
7890352|NCT01850030|12394485|FG001|Overall Study|Withdrawal by Subject|4
7890353|NCT01850030|12394484|FG000|Overall Study|Protocol Violation|24
7890354|NCT01850030|12394485|FG001|Overall Study|Protocol Violation|28
7890355|NCT01850030|12394484|FG000|Overall Study|pregnancy not confirmed at visit 4|248
7890356|NCT01850030|12394485|FG001|Overall Study|pregnancy not confirmed at visit 4|249
7890357|NCT01850446|12394506|FG000|Overall Study|Lack of Efficacy|1
7890358|NCT01850446|12394507|FG001|Overall Study|Lack of Efficacy|0
7890359|NCT01850446|12394506|FG000|Overall Study|Withdrawal by Subject|4
7890360|NCT01850446|12394507|FG001|Overall Study|Withdrawal by Subject|0
7890361|NCT01850446|12394506|FG000|Overall Study|Protocol Violation|0
7890362|NCT01850446|12394507|FG001|Overall Study|Protocol Violation|2
7890363|NCT01850589|12394533|FG000|Overall Study|Withdrawal by Subject|8
7890364|NCT01850589|12394534|FG001|Overall Study|Withdrawal by Subject|0
7890365|NCT01850602|12394542|FG000|Overall Study|Adverse Event|7
7890366|NCT01850602|12394543|FG001|Overall Study|Adverse Event|10
7890367|NCT01850602|12394542|FG000|Overall Study|Physician Decision|2
7890368|NCT01850602|12394543|FG001|Overall Study|Physician Decision|1
7890369|NCT01850602|12394542|FG000|Overall Study|Withdrawal by Subject|2
7890370|NCT01850602|12394543|FG001|Overall Study|Withdrawal by Subject|4
7890371|NCT01850602|12394542|FG000|Overall Study|Decrease in serum calcium|2
7890372|NCT01850602|12394543|FG001|Overall Study|Decrease in serum calcium|3
7890373|NCT01850602|12394542|FG000|Overall Study|Increase in serum ferritin|1
7890374|NCT01850602|12394543|FG001|Overall Study|Increase in serum ferritin|0
7890375|NCT01850615|12394551|FG000|Overall Study|Protocol Violation|4
7890376|NCT01850615|12394552|FG001|Overall Study|Protocol Violation|1
7890377|NCT01850615|12394551|FG000|Overall Study|Adverse Event|2
7890378|NCT01850615|12394552|FG001|Overall Study|Adverse Event|1
7890379|NCT01850615|12394551|FG000|Overall Study|Withdrawal by Subject|3
7890380|NCT01850615|12394552|FG001|Overall Study|Withdrawal by Subject|1
7890381|NCT01850615|12394551|FG000|Overall Study|Lost to Follow-up|0
7890382|NCT01850615|12394552|FG001|Overall Study|Lost to Follow-up|1
7890383|NCT01850615|12394551|FG000|Overall Study|Unclassified|0
7890384|NCT01850615|12394552|FG001|Overall Study|Unclassified|1
7890385|NCT01850641|12394558|FG000|Overall Study|Physician Decision|1
7890386|NCT01850641|12394558|FG000|Overall Study|Decrease in serum phosphorus|1
7890387|NCT01850641|12394558|FG000|Overall Study|Decrease in serum calcium|2
7890388|NCT01850641|12394558|FG000|Overall Study|Increase in serum ferritin|1
7890389|NCT01850823|12394578|FG000|Overall Study|Early Visit Window|0
7890390|NCT01850823|12394579|FG001|Overall Study|Early Visit Window|1
7890391|NCT01850823|12394580|FG002|Overall Study|Early Visit Window|4
7890392|NCT01850823|12394578|FG000|Overall Study|Enrolled in Error|0
7890393|NCT01850823|12394579|FG001|Overall Study|Enrolled in Error|1
7890394|NCT01850823|12394580|FG002|Overall Study|Enrolled in Error|2
7890395|NCT01850823|12394578|FG000|Overall Study|Lack of Efficacy|1
7890396|NCT01850823|12394579|FG001|Overall Study|Lack of Efficacy|0
7890397|NCT01850823|12394580|FG002|Overall Study|Lack of Efficacy|0
7890398|NCT01850823|12394578|FG000|Overall Study|Lost to Follow-up|0
7890399|NCT01850823|12394579|FG001|Overall Study|Lost to Follow-up|0
7890400|NCT01850823|12394580|FG002|Overall Study|Lost to Follow-up|1
7890401|NCT01850823|12394578|FG000|Overall Study|Restricted Medication|0
7890402|NCT01850823|12394579|FG001|Overall Study|Restricted Medication|0
7890403|NCT01850823|12394580|FG002|Overall Study|Restricted Medication|2
7890404|NCT01850823|12394578|FG000|Overall Study|Significant worstening of SAR|0
7890405|NCT01850823|12394579|FG001|Overall Study|Significant worstening of SAR|1
7890406|NCT01850823|12394580|FG002|Overall Study|Significant worstening of SAR|0
7890407|NCT01850823|12394578|FG000|Overall Study|Withdrawal by Subject|2
7890408|NCT01850823|12394579|FG001|Overall Study|Withdrawal by Subject|0
7890409|NCT01850823|12394580|FG002|Overall Study|Withdrawal by Subject|1
7890410|NCT01851330|12394593|FG000|Overall Study|Lack of Efficacy|10
7890411|NCT01851330|12394594|FG001|Overall Study|Lack of Efficacy|9
7890412|NCT01851330|12394595|FG002|Overall Study|Lack of Efficacy|2
7890413|NCT01851330|12394593|FG000|Overall Study|Lost to Follow-up|1
7890414|NCT01851330|12394594|FG001|Overall Study|Lost to Follow-up|6
7890415|NCT01851330|12394595|FG002|Overall Study|Lost to Follow-up|9
7890416|NCT01851330|12394593|FG000|Overall Study|Withdrew Consent|2
7890417|NCT01851330|12394594|FG001|Overall Study|Withdrew Consent|1
7890418|NCT01851330|12394595|FG002|Overall Study|Withdrew Consent|0
7890419|NCT01851330|12394593|FG000|Overall Study|Investigator's Discretion|0
7890420|NCT01851330|12394594|FG001|Overall Study|Investigator's Discretion|0
7890421|NCT01851330|12394595|FG002|Overall Study|Investigator's Discretion|1
7890422|NCT01851590|12394606|FG000|Overall Study|Withdrawal by Subject|0
7890423|NCT01851590|12394607|FG001|Overall Study|Withdrawal by Subject|0
7890424|NCT01851590|12394608|FG002|Overall Study|Withdrawal by Subject|1
7890425|NCT01851590|12394606|FG000|Overall Study|Adverse Event|0
7890426|NCT01851590|12394607|FG001|Overall Study|Adverse Event|0
7890427|NCT01851590|12394608|FG002|Overall Study|Adverse Event|2
7890428|NCT01851590|12394606|FG000|Overall Study|Lack of Efficacy|0
7890429|NCT01851590|12394607|FG001|Overall Study|Lack of Efficacy|1
7890430|NCT01851590|12394608|FG002|Overall Study|Lack of Efficacy|0
7890431|NCT01851720|12394631|FG000|Overall Study|Lost to Follow-up|0
7890432|NCT01851720|12394632|FG001|Overall Study|Lost to Follow-up|1
7890433|NCT01851863|12394646|FG000|Overall Study|Did not receive study medication|2
7890434|NCT01851863|12394647|FG001|Overall Study|Did not receive study medication|5
7890435|NCT01851863|12394648|FG002|Overall Study|Did not receive study medication|3
7890436|NCT01851863|12394649|FG003|Overall Study|Did not receive study medication|0
7890437|NCT01851863|12394646|FG000|Overall Study|Lost to Follow-up|3
7890438|NCT01851863|12394647|FG001|Overall Study|Lost to Follow-up|4
7890439|NCT01851863|12394648|FG002|Overall Study|Lost to Follow-up|2
7890440|NCT01851863|12394649|FG003|Overall Study|Lost to Follow-up|3
7890441|NCT01852045|12394697|FG000|Overall Study|Adverse Event|1
7890442|NCT01852045|12394698|FG001|Overall Study|Adverse Event|0
7890443|NCT01852045|12394699|FG002|Overall Study|Adverse Event|0
7890444|NCT01852045|12394697|FG000|Overall Study|Lack of Efficacy|3
7890445|NCT01852045|12394698|FG001|Overall Study|Lack of Efficacy|0
7890446|NCT01852045|12394699|FG002|Overall Study|Lack of Efficacy|0
7890447|NCT01852045|12394697|FG000|Overall Study|Lost to Follow-up|0
7890448|NCT01852045|12394698|FG001|Overall Study|Lost to Follow-up|1
7890449|NCT01852045|12394699|FG002|Overall Study|Lost to Follow-up|1
7890450|NCT01852045|12394697|FG000|Overall Study|Withdrawal by Subject|1
7890451|NCT01852045|12394698|FG001|Overall Study|Withdrawal by Subject|0
7890452|NCT01852045|12394699|FG002|Overall Study|Withdrawal by Subject|1
7890453|NCT01852045|12394697|FG000|Overall Study|Other Miscellaneous Reasons|1
7890454|NCT01852045|12394698|FG001|Overall Study|Other Miscellaneous Reasons|3
7890455|NCT01852045|12394699|FG002|Overall Study|Other Miscellaneous Reasons|2
7890456|NCT01852058|12394710|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1
7890457|NCT01852058|12394711|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7890458|NCT01852058|12394712|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7890459|NCT01852058|12394713|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7890460|NCT01852058|12394714|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7890461|NCT01852058|12394715|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7890462|NCT01852058|12394716|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7890463|NCT01852058|12394717|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7890464|NCT01852058|12394718|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7890465|NCT01852058|12394719|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7890466|NCT01852058|12394720|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7890467|NCT01852058|12394721|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7890468|NCT01852058|12394710|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7890469|NCT01852058|12394711|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7890470|NCT01852058|12394712|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7890471|NCT01852058|12394713|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7890472|NCT01852058|12394714|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1
7890473|NCT01852058|12394715|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7890474|NCT01852058|12394716|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7890475|NCT01852058|12394717|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7890476|NCT01852058|12394718|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7890477|NCT01852058|12394719|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7890478|NCT01852058|12394720|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7890479|NCT01852058|12394721|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7890480|NCT01852058|12394710|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7890481|NCT01852058|12394711|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7890482|NCT01852058|12394712|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7890483|NCT01852058|12394713|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7890484|NCT01852058|12394714|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
7890485|NCT01852058|12394715|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
7890486|NCT01852058|12394716|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7890487|NCT01852058|12394717|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7890488|NCT01852058|12394718|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7890489|NCT01852058|12394719|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7890490|NCT01852058|12394720|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7890491|NCT01852058|12394721|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7890492|NCT01852058|12394710|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7890493|NCT01852058|12394711|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7890494|NCT01852058|12394712|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7890495|NCT01852058|12394713|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7890496|NCT01852058|12394714|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1
7890497|NCT01852058|12394715|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7890498|NCT01852058|12394716|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7890499|NCT01852058|12394717|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7890500|NCT01852058|12394718|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7890501|NCT01852058|12394719|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7890502|NCT01852058|12394720|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7890503|NCT01852058|12394721|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7890504|NCT01852058|12394710|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7890505|NCT01852058|12394711|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7890506|NCT01852058|12394712|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7890507|NCT01852058|12394713|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7890508|NCT01852058|12394714|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3
7890509|NCT01852058|12394715|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1
7890510|NCT01852058|12394716|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7890511|NCT01852058|12394717|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7890512|NCT01852058|12394718|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7890513|NCT01852058|12394719|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7890514|NCT01852058|12394720|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7890515|NCT01852058|12394721|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7890516|NCT01852058|12394710|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7890517|NCT01852058|12394711|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7890518|NCT01852058|12394712|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7890519|NCT01852058|12394713|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1
7890520|NCT01852058|12394714|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7890521|NCT01852058|12394715|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7890522|NCT01852058|12394716|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7890523|NCT01852058|12394717|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7890524|NCT01852058|12394718|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7890525|NCT01852058|12394719|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7890526|NCT01852058|12394720|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7890527|NCT01852058|12394721|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7890528|NCT01852058|12394710|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7890529|NCT01852058|12394711|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7890530|NCT01852058|12394712|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7890531|NCT01852058|12394713|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7890532|NCT01852058|12394714|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1
7890533|NCT01852058|12394715|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7
7890534|NCT01852058|12394716|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7890535|NCT01852058|12394717|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7890536|NCT01852058|12394718|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7890537|NCT01852058|12394719|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7890538|NCT01852058|12394720|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7890539|NCT01852058|12394721|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7890540|NCT01852058|12394710|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7890541|NCT01852058|12394711|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7890542|NCT01852058|12394712|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7890543|NCT01852058|12394713|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7890544|NCT01852058|12394714|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7890545|NCT01852058|12394715|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7890546|NCT01852058|12394716|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7890547|NCT01852058|12394717|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1
7890548|NCT01852058|12394718|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7890549|NCT01852058|12394719|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7890550|NCT01852058|12394720|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7890551|NCT01852058|12394721|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7890552|NCT01852058|12394710|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7890553|NCT01852058|12394711|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7890554|NCT01852058|12394712|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7890555|NCT01852058|12394713|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7890556|NCT01852058|12394714|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7890557|NCT01852058|12394715|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7890558|NCT01852058|12394716|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7890559|NCT01852058|12394717|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7890560|NCT01852058|12394718|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1
7890561|NCT01852058|12394719|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7890562|NCT01852058|12394720|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7890563|NCT01852058|12394721|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7890564|NCT01852110|12394775|FG000|Overall Study|Adverse Event|12
7890565|NCT01852110|12394776|FG001|Overall Study|Adverse Event|5
7890566|NCT01852110|12394777|FG002|Overall Study|Adverse Event|0
7890567|NCT01852110|12394778|FG003|Overall Study|Adverse Event|0
7890568|NCT01852110|12394779|FG004|Overall Study|Adverse Event|0
7890569|NCT01852110|12394780|FG005|Overall Study|Adverse Event|0
7890570|NCT01852110|12394775|FG000|Overall Study|Lost to Follow-up|1
7890571|NCT01852110|12394776|FG001|Overall Study|Lost to Follow-up|3
7890572|NCT01852110|12394777|FG002|Overall Study|Lost to Follow-up|0
7890573|NCT01852110|12394778|FG003|Overall Study|Lost to Follow-up|0
7890574|NCT01852110|12394779|FG004|Overall Study|Lost to Follow-up|0
7890575|NCT01852110|12394780|FG005|Overall Study|Lost to Follow-up|0
7890576|NCT01852110|12394775|FG000|Overall Study|Non-compliance with Study Drug|2
7890577|NCT01852110|12394776|FG001|Overall Study|Non-compliance with Study Drug|1
7890578|NCT01852110|12394777|FG002|Overall Study|Non-compliance with Study Drug|0
7890579|NCT01852110|12394778|FG003|Overall Study|Non-compliance with Study Drug|0
7890580|NCT01852110|12394779|FG004|Overall Study|Non-compliance with Study Drug|0
7890581|NCT01852110|12394780|FG005|Overall Study|Non-compliance with Study Drug|0
7890582|NCT01852110|12394775|FG000|Overall Study|Physician Decision|1
7890583|NCT01852110|12394776|FG001|Overall Study|Physician Decision|0
7890584|NCT01852110|12394777|FG002|Overall Study|Physician Decision|0
7890585|NCT01852110|12394778|FG003|Overall Study|Physician Decision|0
7890586|NCT01852110|12394779|FG004|Overall Study|Physician Decision|0
7890587|NCT01852110|12394780|FG005|Overall Study|Physician Decision|0
7890588|NCT01852110|12394775|FG000|Overall Study|Protocol Violation|0
7890589|NCT01852110|12394776|FG001|Overall Study|Protocol Violation|1
7890590|NCT01852110|12394777|FG002|Overall Study|Protocol Violation|0
7890591|NCT01852110|12394778|FG003|Overall Study|Protocol Violation|0
7890592|NCT01852110|12394779|FG004|Overall Study|Protocol Violation|0
7890593|NCT01852110|12394780|FG005|Overall Study|Protocol Violation|0
7890594|NCT01852110|12394775|FG000|Overall Study|Study Terminated by Sponsor|30
7890595|NCT01852110|12394776|FG001|Overall Study|Study Terminated by Sponsor|32
7890596|NCT01852110|12394777|FG002|Overall Study|Study Terminated by Sponsor|0
7890597|NCT01852110|12394778|FG003|Overall Study|Study Terminated by Sponsor|0
7890598|NCT01852110|12394779|FG004|Overall Study|Study Terminated by Sponsor|0
7968289|NCT03893565|12525822|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7968290|NCT03893565|12525823|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7968291|NCT03893565|12525824|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7968292|NCT03893565|12525825|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7968293|NCT03893565|12525826|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1
7968294|NCT03893565|12525827|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7968295|NCT03893565|12525828|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7968296|NCT03893565|12525820|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7968297|NCT03893565|12525821|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7968298|NCT03893565|12525822|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7968299|NCT03893565|12525823|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7968300|NCT03893565|12525824|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7890599|NCT01852110|12394780|FG005|Overall Study|Study Terminated by Sponsor|0
7890600|NCT01852110|12394775|FG000|Overall Study|Withdrawal by Subject|4
7890601|NCT01852110|12394776|FG001|Overall Study|Withdrawal by Subject|4
7890602|NCT01852110|12394777|FG002|Overall Study|Withdrawal by Subject|0
7890603|NCT01852110|12394778|FG003|Overall Study|Withdrawal by Subject|0
7890604|NCT01852110|12394779|FG004|Overall Study|Withdrawal by Subject|0
7890605|NCT01852110|12394780|FG005|Overall Study|Withdrawal by Subject|0
7890606|NCT01852162|12394796|FG000|Overall Study|Adverse Event|1
7890607|NCT01852162|12394797|FG001|Overall Study|Adverse Event|0
7890608|NCT01852162|12394796|FG000|Overall Study|Withdrawal by Subject|3
7890609|NCT01852162|12394797|FG001|Overall Study|Withdrawal by Subject|1
7890610|NCT01852214|12394822|FG000|Period 1|Adverse Event|1
7890611|NCT01852214|12394823|FG001|Period 1|Adverse Event|2
7890612|NCT01852214|12394822|FG000|Period 1|Withdrawal by Subject|0
7890613|NCT01852214|12394823|FG001|Period 1|Withdrawal by Subject|1
7890614|NCT01852214|12394822|FG000|Washout Period|Withdrawal by Subject|0
7890615|NCT01852214|12394823|FG001|Washout Period|Withdrawal by Subject|1
7890616|NCT01852292|12394832|FG000|Overall Study|Untreated - did not receive study drug|3
7890617|NCT01852292|12394833|FG001|Overall Study|Untreated - did not receive study drug|1
7890618|NCT01852292|12394832|FG000|Overall Study|Death|9
7890619|NCT01852292|12394833|FG001|Overall Study|Death|8
7890620|NCT01852292|12394832|FG000|Overall Study|Patient/guardian decision|8
7890621|NCT01852292|12394833|FG001|Overall Study|Patient/guardian decision|4
7890622|NCT01852292|12394832|FG000|Overall Study|Adverse Event|8
7890623|NCT01852292|12394833|FG001|Overall Study|Adverse Event|11
7890624|NCT01852292|12394832|FG000|Overall Study|Physician Decision|6
7890625|NCT01852292|12394833|FG001|Overall Study|Physician Decision|2
7890626|NCT01852292|12394832|FG000|Overall Study|Protocol Violation|2
7890627|NCT01852292|12394833|FG001|Overall Study|Protocol Violation|0
7890628|NCT01852292|12394832|FG000|Overall Study|Non-compliance with study treatment|1
7890629|NCT01852292|12394833|FG001|Overall Study|Non-compliance with study treatment|0
7890630|NCT01852292|12394832|FG000|Overall Study|Study terminated by Sponsor|0
7890631|NCT01852292|12394833|FG001|Overall Study|Study terminated by Sponsor|1
7890632|NCT01852292|12394832|FG000|Overall Study|Progressive disease|42
7890633|NCT01852292|12394833|FG001|Overall Study|Progressive disease|52
7962963|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1
7962964|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0
7962965|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0
7962966|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0
7962967|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0
7962968|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0
7962969|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1
7962970|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0
7962971|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0
7962972|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0
7962973|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1
7962974|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7962975|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7962976|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7962977|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7962978|NCT02717195|12517435|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1
7962979|NCT02717195|12517436|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7962980|NCT02717195|12517437|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7962981|NCT02717195|12517438|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7962982|NCT02717195|12517439|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7962983|NCT02717195|12517435|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0
7962984|NCT02717195|12517436|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0
7962985|NCT02717195|12517437|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10
7962986|NCT02717195|12517438|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11
7962987|NCT02717195|12517439|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8
7962988|NCT02717195|12517435|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
7890634|NCT01852591|12394871|FG000|Overall Study|Withdrawal by Subject|2
7890635|NCT01852591|12394871|FG000|Overall Study|Not Evaluable at Time of Analysis|1
7890636|NCT01852825|12394891|FG000|Overall Study|Withdrawal by Subject|2
7890637|NCT01852825|12394892|FG001|Overall Study|Withdrawal by Subject|0
7890638|NCT01852825|12394893|FG002|Overall Study|Withdrawal by Subject|0
7890639|NCT01852942|12394903|FG000|Overall Study|Physician Decision|1
7890640|NCT01852942|12394904|FG001|Overall Study|Physician Decision|0
7890641|NCT01852942|12394903|FG000|Overall Study|Death|1
7890642|NCT01852942|12394904|FG001|Overall Study|Death|1
7890643|NCT01852942|12394903|FG000|Overall Study|Withdrawal by Subject|2
7890644|NCT01852942|12394904|FG001|Overall Study|Withdrawal by Subject|3
7890645|NCT01852942|12394903|FG000|Overall Study|Lost to Follow-up|1
7890646|NCT01852942|12394904|FG001|Overall Study|Lost to Follow-up|2
7890647|NCT01853046|12394922|FG000|Overall Study|Withdrawal by Subject|1
7890648|NCT01853046|12394923|FG001|Overall Study|Withdrawal by Subject|1
7890649|NCT01853046|12394922|FG000|Overall Study|Adverse Event|4
7890650|NCT01853046|12394923|FG001|Overall Study|Adverse Event|2
7890651|NCT01853046|12394922|FG000|Overall Study|Disease progression|13
7890652|NCT01853046|12394923|FG001|Overall Study|Disease progression|3
7890653|NCT01853072|12394932|FG000|Overall Study|Adverse event prior to treatment|0
7890654|NCT01853072|12394933|FG001|Overall Study|Adverse event prior to treatment|1
7890655|NCT01853072|12394932|FG000|Overall Study|Adverse Event|0
7890656|NCT01853072|12394933|FG001|Overall Study|Adverse Event|3
7890657|NCT01853072|12394932|FG000|Overall Study|Death|1
7890658|NCT01853072|12394933|FG001|Overall Study|Death|4
7890659|NCT01853072|12394932|FG000|Overall Study|Lost to Follow-up|0
7890660|NCT01853072|12394933|FG001|Overall Study|Lost to Follow-up|3
7890661|NCT01853072|12394932|FG000|Overall Study|Non-compliance with study drug|0
7890662|NCT01853072|12394933|FG001|Overall Study|Non-compliance with study drug|1
7890663|NCT01853072|12394932|FG000|Overall Study|Physician Decision|1
7890664|NCT01853072|12394933|FG001|Overall Study|Physician Decision|1
7890665|NCT01853072|12394932|FG000|Overall Study|Withdrawal by Subject|1
7890666|NCT01853072|12394933|FG001|Overall Study|Withdrawal by Subject|2
7890667|NCT01853072|12394932|FG000|Overall Study|Reason not specified|9
7890668|NCT01853072|12394933|FG001|Overall Study|Reason not specified|6
7890669|NCT01853137|12394947|FG000|Overall Study|Lost to Follow-up|4
7890670|NCT01853137|12394948|FG001|Overall Study|Lost to Follow-up|1
7890671|NCT01853228|12394960|FG000|Phase 1|Lack of Efficacy|8
7890672|NCT01853228|12394961|FG001|Phase 1|Lack of Efficacy|0
7890673|NCT01853228|12394960|FG000|Phase 1|Other|1
7890674|NCT01853228|12394961|FG001|Phase 1|Other|0
7890675|NCT01853228|12394960|FG000|Phase 2|Physician Decision|0
7890676|NCT01853228|12394961|FG001|Phase 2|Physician Decision|1
7890677|NCT01853228|12394960|FG000|Phase 2|Proceed To Transplant|0
7890678|NCT01853228|12394961|FG001|Phase 2|Proceed To Transplant|3
7890679|NCT01853228|12394960|FG000|Phase 2|Lack of Efficacy|0
7890680|NCT01853228|12394961|FG001|Phase 2|Lack of Efficacy|4
7890681|NCT01853254|12394966|FG000|Overall Study|Abnormal Laboratory Test|1
7890682|NCT01853254|12394966|FG000|Overall Study|Adverse Event/Intercurrent Illness|3
7890683|NCT01853254|12394966|FG000|Overall Study|Death|1
7890684|NCT01853254|12394966|FG000|Overall Study|Failure to Return|43
7890685|NCT01853254|12394966|FG000|Overall Study|Insufficient Therapeutic Response|22
7890686|NCT01853254|12394966|FG000|Overall Study|Refusal of Treatment|1
7890687|NCT01853254|12394966|FG000|Overall Study|Other Protocol Violation|1
7890688|NCT01853254|12394966|FG000|Overall Study|Withdrawal of Consent|16
7890689|NCT01853254|12394966|FG000|Overall Study|Administrative/Other|16
7890690|NCT01853280|12394972|FG000|Overall Study|Lack of Efficacy|2
7890691|NCT01853280|12394973|FG001|Overall Study|Lack of Efficacy|2
7890692|NCT01853280|12394972|FG000|Overall Study|Lost to Follow-up|0
7890693|NCT01853280|12394973|FG001|Overall Study|Lost to Follow-up|1
7890694|NCT01853280|12394972|FG000|Overall Study|Physician Decision|0
7890695|NCT01853280|12394973|FG001|Overall Study|Physician Decision|1
7890696|NCT01853280|12394972|FG000|Overall Study|Withdrawal by Subject|0
7890697|NCT01853280|12394973|FG001|Overall Study|Withdrawal by Subject|1
7890698|NCT01853280|12394972|FG000|Overall Study|Ineligible|0
7890699|NCT01853280|12394973|FG001|Overall Study|Ineligible|1
7890700|NCT01853384|12394995|FG000|Randomized|Adverse Event|5
7890701|NCT01853384|12394996|FG001|Randomized|Adverse Event|3
7890702|NCT01853384|12394995|FG000|Randomized|Death|1
7890703|NCT01853384|12394996|FG001|Randomized|Death|2
7890704|NCT01853384|12394995|FG000|Randomized|Lost to Follow-up|1
7890705|NCT01853384|12394996|FG001|Randomized|Lost to Follow-up|1
7890706|NCT01853384|12394995|FG000|Randomized|Withdrawal by Subject|5
7890707|NCT01853384|12394996|FG001|Randomized|Withdrawal by Subject|3
7890708|NCT01853384|12394995|FG000|Randomized|Sponsor Decision|47
7890709|NCT01853384|12394996|FG001|Randomized|Sponsor Decision|34
7890710|NCT01853384|12394995|FG000|Randomized|Other|3
7890711|NCT01853384|12394996|FG001|Randomized|Other|3
7890712|NCT01853384|12394995|FG000|Completed Follow up Visit 1|Early Termination|13
7890713|NCT01853384|12394996|FG001|Completed Follow up Visit 1|Early Termination|9
7890714|NCT01853384|12394995|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1
7890715|NCT01853384|12394996|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0
7890716|NCT01853384|12394995|FG000|Completed Follow up Visit 2|Adverse Event|1
7890717|NCT01853384|12394996|FG001|Completed Follow up Visit 2|Adverse Event|0
7890718|NCT01853384|12394995|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1
7890719|NCT01853384|12394996|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2
7890720|NCT01853384|12394995|FG000|Completed Follow up Visit 2|Death|1
7890721|NCT01853384|12394996|FG001|Completed Follow up Visit 2|Death|0
7890722|NCT01853384|12394995|FG000|Completed Follow up Visit 2|Lost to Follow-up|0
7890723|NCT01853384|12394996|FG001|Completed Follow up Visit 2|Lost to Follow-up|1
7890724|NCT01853397|12395006|FG000|Overall Study|Withdrawal by Subject|0
7890725|NCT01853397|12395007|FG001|Overall Study|Withdrawal by Subject|0
7890726|NCT01853397|12395008|FG002|Overall Study|Withdrawal by Subject|0
7890727|NCT01853397|12395009|FG003|Overall Study|Withdrawal by Subject|1
7890728|NCT01853397|12395006|FG000|Overall Study|Subject Noncompliance|0
7890729|NCT01853397|12395007|FG001|Overall Study|Subject Noncompliance|0
7890730|NCT01853397|12395008|FG002|Overall Study|Subject Noncompliance|0
7890731|NCT01853397|12395009|FG003|Overall Study|Subject Noncompliance|1
7890732|NCT01853462|12395021|FG000|Overall Study|Withdrawal by Subject|1
7890733|NCT01853462|12395022|FG001|Overall Study|Withdrawal by Subject|1
7890734|NCT01853475|12395033|FG000|Overall Study|Withdrawal by Subject|0
7890735|NCT01853475|12395034|FG001|Overall Study|Withdrawal by Subject|1
7890736|NCT01853475|12395035|FG002|Overall Study|Withdrawal by Subject|0
7890737|NCT01853618|12395074|FG000|Overall Study|Bile duct stent blockage/progressive dis|1
7890738|NCT01853618|12395075|FG001|Overall Study|Bile duct stent blockage/progressive dis|0
7890739|NCT01853618|12395076|FG002|Overall Study|Bile duct stent blockage/progressive dis|0
7890740|NCT01853618|12395077|FG003|Overall Study|Bile duct stent blockage/progressive dis|0
7890741|NCT01853618|12395078|FG004|Overall Study|Bile duct stent blockage/progressive dis|0
7890742|NCT01853618|12395074|FG000|Overall Study|Progressive disease|1
7890743|NCT01853618|12395075|FG001|Overall Study|Progressive disease|1
7890744|NCT01853618|12395076|FG002|Overall Study|Progressive disease|1
7890745|NCT01853618|12395077|FG003|Overall Study|Progressive disease|1
7890746|NCT01853618|12395078|FG004|Overall Study|Progressive disease|2
7890747|NCT01853618|12395074|FG000|Overall Study|Physician Decision|0
7890748|NCT01853618|12395075|FG001|Overall Study|Physician Decision|1
7890749|NCT01853618|12395076|FG002|Overall Study|Physician Decision|1
7890750|NCT01853618|12395077|FG003|Overall Study|Physician Decision|0
7890751|NCT01853618|12395078|FG004|Overall Study|Physician Decision|0
7890752|NCT01853618|12395074|FG000|Overall Study|Refused further treatment|0
7890753|NCT01853618|12395075|FG001|Overall Study|Refused further treatment|0
7890754|NCT01853618|12395076|FG002|Overall Study|Refused further treatment|0
7890755|NCT01853618|12395077|FG003|Overall Study|Refused further treatment|0
7890756|NCT01853618|12395078|FG004|Overall Study|Refused further treatment|1
7890757|NCT01853644|12395091|FG000|Registration and Treatment Start|Did not start treatment|1
7890758|NCT01853644|12395091|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2
7890759|NCT01853644|12395091|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1
7890760|NCT01853644|12395091|FG000|Reached First Response/Complete 2 Cycles|Other|1
7890761|NCT01853644|12395091|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2
7890762|NCT01853644|12395091|FG000|Continued Treatment After First Response|Adverse Event|2
7890763|NCT01853644|12395091|FG000|Continued Treatment After First Response|Progressive Diseaes|10
7890764|NCT01853696|12395097|FG000|Overall Study|Withdrawal by Subject|1
7890765|NCT01853696|12395098|FG001|Overall Study|Withdrawal by Subject|1
7890766|NCT01853696|12395097|FG000|Overall Study|Lost to Follow-up|5
7890767|NCT01853696|12395098|FG001|Overall Study|Lost to Follow-up|4
7890768|NCT01853839|12395115|FG000|Overall Study|Violated inclusion criteria|2
7890769|NCT01853839|12395115|FG000|Overall Study|Not meet ITT population definition|58
7890770|NCT01853839|12395115|FG000|Overall Study|End of treatment visit too early|33
7890771|NCT01853839|12395115|FG000|Overall Study|Lost to follow-up or no valid BP measure|336
7890772|NCT01853878|12395125|FG000|Overall Study|Recurrence|2
7890773|NCT01853878|12395126|FG001|Overall Study|Recurrence|0
7890774|NCT01853878|12395125|FG000|Overall Study|Adverse Event|2
7890775|NCT01853878|12395126|FG001|Overall Study|Adverse Event|0
7890776|NCT01853878|12395125|FG000|Overall Study|Withdrawal by Subject|3
7890777|NCT01853878|12395126|FG001|Overall Study|Withdrawal by Subject|1
7890778|NCT01853878|12395125|FG000|Overall Study|Migrated/moved from the study area|1
7890779|NCT01853878|12395126|FG001|Overall Study|Migrated/moved from the study area|0
7890780|NCT01853878|12395125|FG000|Overall Study|Other|55
7890781|NCT01853878|12395126|FG001|Overall Study|Other|43
7890782|NCT01854047|12395150|FG000|Overall Study|Lack of Efficacy|1
7890783|NCT01854047|12395151|FG001|Overall Study|Lack of Efficacy|0
7890784|NCT01854047|12395152|FG002|Overall Study|Lack of Efficacy|0
7890785|NCT01854047|12395153|FG003|Overall Study|Lack of Efficacy|0
7890786|NCT01854047|12395154|FG004|Overall Study|Lack of Efficacy|0
7890787|NCT01854047|12395150|FG000|Overall Study|Poor compliance to protocol|3
7890788|NCT01854047|12395151|FG001|Overall Study|Poor compliance to protocol|0
7890789|NCT01854047|12395152|FG002|Overall Study|Poor compliance to protocol|2
7890790|NCT01854047|12395153|FG003|Overall Study|Poor compliance to protocol|0
7890791|NCT01854047|12395154|FG004|Overall Study|Poor compliance to protocol|0
7890792|NCT01854047|12395150|FG000|Overall Study|Adverse Event|5
7890793|NCT01854047|12395151|FG001|Overall Study|Adverse Event|4
7890794|NCT01854047|12395152|FG002|Overall Study|Adverse Event|6
7890795|NCT01854047|12395153|FG003|Overall Study|Adverse Event|10
7890796|NCT01854047|12395154|FG004|Overall Study|Adverse Event|7
7890797|NCT01854047|12395150|FG000|Overall Study|Randomized but not treated|0
7890798|NCT01854047|12395151|FG001|Overall Study|Randomized but not treated|1
7890799|NCT01854047|12395152|FG002|Overall Study|Randomized but not treated|2
7890800|NCT01854047|12395153|FG003|Overall Study|Randomized but not treated|0
7890801|NCT01854047|12395154|FG004|Overall Study|Randomized but not treated|4
7890802|NCT01854047|12395150|FG000|Overall Study|Other than specified above|3
7890803|NCT01854047|12395151|FG001|Overall Study|Other than specified above|3
7890804|NCT01854047|12395152|FG002|Overall Study|Other than specified above|3
7890805|NCT01854047|12395153|FG003|Overall Study|Other than specified above|5
7890806|NCT01854047|12395154|FG004|Overall Study|Other than specified above|8
7890807|NCT01854528|12395222|FG000|Overall Study|Adverse Event|0
7890808|NCT01854528|12395223|FG001|Overall Study|Adverse Event|4
7890809|NCT01854528|12395222|FG000|Overall Study|Withdrawal by Subject|0
7890810|NCT01854528|12395223|FG001|Overall Study|Withdrawal by Subject|2
7890811|NCT01854528|12395222|FG000|Overall Study|Virologic Failure|0
7890812|NCT01854528|12395223|FG001|Overall Study|Virologic Failure|9
7890813|NCT01854645|12395253|FG000|Overall Study|Protocol-Specified Criteria|13
7890814|NCT01854645|12395254|FG001|Overall Study|Protocol-Specified Criteria|10
7890815|NCT01854645|12395255|FG002|Overall Study|Protocol-Specified Criteria|8
7890816|NCT01854645|12395256|FG003|Overall Study|Protocol-Specified Criteria|5
7890817|NCT01854645|12395257|FG004|Overall Study|Protocol-Specified Criteria|7
7890818|NCT01854645|12395253|FG000|Overall Study|Administrative Reasons / Missing|0
7890819|NCT01854645|12395254|FG001|Overall Study|Administrative Reasons / Missing|0
7890820|NCT01854645|12395255|FG002|Overall Study|Administrative Reasons / Missing|0
7890821|NCT01854645|12395256|FG003|Overall Study|Administrative Reasons / Missing|1
7890822|NCT01854645|12395257|FG004|Overall Study|Administrative Reasons / Missing|1
7890823|NCT01854645|12395253|FG000|Overall Study|Protocol Violation|3
7890824|NCT01854645|12395254|FG001|Overall Study|Protocol Violation|0
7890825|NCT01854645|12395255|FG002|Overall Study|Protocol Violation|5
7890826|NCT01854645|12395256|FG003|Overall Study|Protocol Violation|4
7890827|NCT01854645|12395257|FG004|Overall Study|Protocol Violation|1
7890828|NCT01854645|12395253|FG000|Overall Study|Lost to Follow-up|10
7890829|NCT01854645|12395254|FG001|Overall Study|Lost to Follow-up|7
7890830|NCT01854645|12395255|FG002|Overall Study|Lost to Follow-up|8
7890831|NCT01854645|12395256|FG003|Overall Study|Lost to Follow-up|5
7890832|NCT01854645|12395257|FG004|Overall Study|Lost to Follow-up|0
7890833|NCT01854645|12395253|FG000|Overall Study|Physician Decision|1
7890834|NCT01854645|12395254|FG001|Overall Study|Physician Decision|5
7890835|NCT01854645|12395255|FG002|Overall Study|Physician Decision|3
7890836|NCT01854645|12395256|FG003|Overall Study|Physician Decision|3
7890837|NCT01854645|12395257|FG004|Overall Study|Physician Decision|7
7890838|NCT01854645|12395253|FG000|Overall Study|Withdrawal by Subject|31
7890839|NCT01854645|12395254|FG001|Overall Study|Withdrawal by Subject|41
7890840|NCT01854645|12395255|FG002|Overall Study|Withdrawal by Subject|30
7890841|NCT01854645|12395256|FG003|Overall Study|Withdrawal by Subject|21
7890842|NCT01854645|12395257|FG004|Overall Study|Withdrawal by Subject|24
7890843|NCT01854645|12395253|FG000|Overall Study|Lack of Efficacy|7
7890844|NCT01854645|12395254|FG001|Overall Study|Lack of Efficacy|12
7890845|NCT01854645|12395255|FG002|Overall Study|Lack of Efficacy|9
7890846|NCT01854645|12395256|FG003|Overall Study|Lack of Efficacy|3
7890847|NCT01854645|12395257|FG004|Overall Study|Lack of Efficacy|9
7890848|NCT01854645|12395253|FG000|Overall Study|Adverse Event|33
7890849|NCT01854645|12395254|FG001|Overall Study|Adverse Event|31
7890850|NCT01854645|12395255|FG002|Overall Study|Adverse Event|19
7890851|NCT01854645|12395256|FG003|Overall Study|Adverse Event|20
7890852|NCT01854645|12395257|FG004|Overall Study|Adverse Event|11
7890853|NCT01854658|12395273|FG000|Overall Study|Protocol Violation|6
7890854|NCT01854658|12395274|FG001|Overall Study|Protocol Violation|2
7890855|NCT01854658|12395275|FG002|Overall Study|Protocol Violation|2
7890856|NCT01854658|12395276|FG003|Overall Study|Protocol Violation|1
7890857|NCT01854658|12395273|FG000|Overall Study|Physician Decision|7
7890858|NCT01854658|12395274|FG001|Overall Study|Physician Decision|5
7890859|NCT01854658|12395275|FG002|Overall Study|Physician Decision|2
7890860|NCT01854658|12395276|FG003|Overall Study|Physician Decision|4
7890861|NCT01854658|12395273|FG000|Overall Study|Lost to Follow-up|8
7890862|NCT01854658|12395274|FG001|Overall Study|Lost to Follow-up|9
7890863|NCT01854658|12395275|FG002|Overall Study|Lost to Follow-up|8
7890864|NCT01854658|12395276|FG003|Overall Study|Lost to Follow-up|4
7890865|NCT01854658|12395273|FG000|Overall Study|Withdrawal by Subject|28
7890866|NCT01854658|12395274|FG001|Overall Study|Withdrawal by Subject|21
7890867|NCT01854658|12395275|FG002|Overall Study|Withdrawal by Subject|29
7890868|NCT01854658|12395276|FG003|Overall Study|Withdrawal by Subject|15
7890869|NCT01854658|12395273|FG000|Overall Study|Protocol-specified criteria|15
7890870|NCT01854658|12395274|FG001|Overall Study|Protocol-specified criteria|15
7890871|NCT01854658|12395275|FG002|Overall Study|Protocol-specified criteria|10
7890872|NCT01854658|12395276|FG003|Overall Study|Protocol-specified criteria|7
7890873|NCT01854658|12395273|FG000|Overall Study|Lack of Efficacy|3
7890874|NCT01854658|12395274|FG001|Overall Study|Lack of Efficacy|8
7890875|NCT01854658|12395275|FG002|Overall Study|Lack of Efficacy|4
7890876|NCT01854658|12395276|FG003|Overall Study|Lack of Efficacy|7
7890877|NCT01854658|12395273|FG000|Overall Study|Adverse Event|21
7890878|NCT01854658|12395274|FG001|Overall Study|Adverse Event|14
7890879|NCT01854658|12395275|FG002|Overall Study|Adverse Event|23
7890880|NCT01854658|12395276|FG003|Overall Study|Adverse Event|19
7890881|NCT01854658|12395273|FG000|Overall Study|Administrative reasons|5
7890882|NCT01854658|12395274|FG001|Overall Study|Administrative reasons|1
7890883|NCT01854658|12395275|FG002|Overall Study|Administrative reasons|2
7890884|NCT01854658|12395276|FG003|Overall Study|Administrative reasons|2
7890885|NCT01854697|12395291|FG000|Overall Study|Adverse Event|1
7890886|NCT01854697|12395292|FG001|Overall Study|Adverse Event|0
7890887|NCT01854697|12395293|FG002|Overall Study|Adverse Event|0
7890888|NCT01854697|12395294|FG003|Overall Study|Adverse Event|0
7890889|NCT01854697|12395295|FG004|Overall Study|Adverse Event|1
7890890|NCT01854697|12395291|FG000|Overall Study|Lost to Follow-up|4
7890891|NCT01854697|12395292|FG001|Overall Study|Lost to Follow-up|1
7890892|NCT01854697|12395293|FG002|Overall Study|Lost to Follow-up|1
7890893|NCT01854697|12395294|FG003|Overall Study|Lost to Follow-up|2
7890894|NCT01854697|12395295|FG004|Overall Study|Lost to Follow-up|0
7890895|NCT01854697|12395291|FG000|Overall Study|To enter another AbbVie study|1
7890896|NCT01854697|12395292|FG001|Overall Study|To enter another AbbVie study|0
7890897|NCT01854697|12395293|FG002|Overall Study|To enter another AbbVie study|0
7890898|NCT01854697|12395294|FG003|Overall Study|To enter another AbbVie study|0
7890899|NCT01854697|12395295|FG004|Overall Study|To enter another AbbVie study|1
7890900|NCT01854697|12395291|FG000|Overall Study|Withdrew Consent|0
7890901|NCT01854697|12395292|FG001|Overall Study|Withdrew Consent|1
7890902|NCT01854697|12395293|FG002|Overall Study|Withdrew Consent|0
7890903|NCT01854697|12395294|FG003|Overall Study|Withdrew Consent|1
7890904|NCT01854697|12395295|FG004|Overall Study|Withdrew Consent|0
7890905|NCT01854697|12395291|FG000|Overall Study|Other|0
7890906|NCT01854697|12395292|FG001|Overall Study|Other|1
7890907|NCT01854697|12395293|FG002|Overall Study|Other|1
7890908|NCT01854697|12395294|FG003|Overall Study|Other|0
7890909|NCT01854697|12395295|FG004|Overall Study|Other|0
7890910|NCT01854710|12395305|FG000|Overall Study|Withdrawal by Subject|2
7890911|NCT01854710|12395306|FG001|Overall Study|Withdrawal by Subject|1
7890912|NCT01854710|12395307|FG002|Overall Study|Withdrawal by Subject|0
7890913|NCT01854710|12395308|FG003|Overall Study|Withdrawal by Subject|0
7890914|NCT01854710|12395309|FG004|Overall Study|Withdrawal by Subject|0
7890915|NCT01854710|12395310|FG005|Overall Study|Withdrawal by Subject|0
7890916|NCT01854710|12395305|FG000|Overall Study|CRI procedural error|2
7890917|NCT01854710|12395306|FG001|Overall Study|CRI procedural error|2
7890918|NCT01854710|12395307|FG002|Overall Study|CRI procedural error|2
7890919|NCT01854710|12395308|FG003|Overall Study|CRI procedural error|2
7890920|NCT01854710|12395309|FG004|Overall Study|CRI procedural error|2
7890921|NCT01854710|12395310|FG005|Overall Study|CRI procedural error|2
7890922|NCT01854827|12395320|FG000|Overall Study|Death|1
7890923|NCT01854879|12395324|FG000|Overall Study|Could not complete testing within the scheduled time.|1
7890924|NCT01854879|12395324|FG000|Overall Study|screen fail|3
7890925|NCT01854879|12395324|FG000|Overall Study|incomplete data set|1
7890926|NCT01854918|12395334|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20
7890927|NCT01854918|12395335|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49
7890928|NCT01854918|12395334|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2
7890929|NCT01854918|12395335|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1
7890930|NCT01854918|12395334|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3
7890931|NCT01854918|12395335|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8
7890932|NCT01854918|12395334|FG000|SOC-controlled Period (Year 1)|Death|5
7890933|NCT01854918|12395335|FG001|SOC-controlled Period (Year 1)|Death|5
7890934|NCT01854918|12395334|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78
7890935|NCT01854918|12395335|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117
7890936|NCT01854918|12395334|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8
7890937|NCT01854918|12395335|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11
7890938|NCT01854918|12395334|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27
7890939|NCT01854918|12395335|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51
7890940|NCT01854918|12395334|FG000|All-IP Period (Years 2 and 3)|Death|5
7890941|NCT01854918|12395335|FG001|All-IP Period (Years 2 and 3)|Death|16
7890942|NCT01854944|12395351|FG000|Overall Study|Withdrawal by Subject|0
7890943|NCT01854944|12395352|FG001|Overall Study|Withdrawal by Subject|0
7890944|NCT01854944|12395353|FG002|Overall Study|Withdrawal by Subject|1
7890945|NCT01855048|12395381|FG000|Overall Study|Withdrawal by Subject|0
7890946|NCT01855048|12395382|FG001|Overall Study|Withdrawal by Subject|1
7890947|NCT01855048|12395383|FG002|Overall Study|Withdrawal by Subject|0
7890948|NCT01855048|12395384|FG003|Overall Study|Withdrawal by Subject|0
7890949|NCT01855048|12395385|FG004|Overall Study|Withdrawal by Subject|1
7890950|NCT01855048|12395386|FG005|Overall Study|Withdrawal by Subject|0
7890951|NCT01855074|12395410|FG000|Overall Study|Adverse Event|1
7890952|NCT01855074|12395410|FG000|Overall Study|Lost to Follow-up|4
7890953|NCT01855074|12395410|FG000|Overall Study|Withdrawal by Subject|8
7890954|NCT01855074|12395410|FG000|Overall Study|Started but not treated|1
7890955|NCT01855126|12395416|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4
7890956|NCT01855126|12395417|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6
7890957|NCT01855126|12395416|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2
7890958|NCT01855126|12395417|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2
7890959|NCT01855243|12395430|FG000|Overall Study|develpoed diabetic ketoacidosis|1
7890960|NCT01855243|12395431|FG001|Overall Study|develpoed diabetic ketoacidosis|0
7890961|NCT01855243|12395432|FG002|Overall Study|develpoed diabetic ketoacidosis|0
7890962|NCT01855399|12395446|FG000|6 Month|Lost to Follow-up|12
7890963|NCT01855399|12395447|FG001|6 Month|Lost to Follow-up|9
7890964|NCT01855399|12395446|FG000|6 Month|Withdrawal by Subject|8
7890965|NCT01855399|12395447|FG001|6 Month|Withdrawal by Subject|6
7890966|NCT01855399|12395446|FG000|12 Month|Lost to Follow-up|7
7890967|NCT01855399|12395447|FG001|12 Month|Lost to Follow-up|11
7890968|NCT01855425|12395453|FG000|Overall Study|Physician Decision|20
7890969|NCT01855750|12395459|FG000|Overall Study|Death|78
7890970|NCT01855750|12395460|FG001|Overall Study|Death|78
7890971|NCT01855750|12395459|FG000|Overall Study|Lost to Follow-up|9
7890972|NCT01855750|12395460|FG001|Overall Study|Lost to Follow-up|23
7890973|NCT01855750|12395459|FG000|Overall Study|Withdrawal by Subject|35
7890974|NCT01855750|12395460|FG001|Overall Study|Withdrawal by Subject|28
7890975|NCT01855750|12395459|FG000|Overall Study|Sponsor ends the study|297
7890976|NCT01855750|12395460|FG001|Overall Study|Sponsor ends the study|290
7890977|NCT01855789|12395466|FG000|1) Baseline up to Week 24|Adverse Event|37
7890978|NCT01855789|12395467|FG001|1) Baseline up to Week 24|Adverse Event|0
7890979|NCT01855789|12395468|FG002|1) Baseline up to Week 24|Adverse Event|0
7890980|NCT01855789|12395469|FG003|1) Baseline up to Week 24|Adverse Event|0
7890981|NCT01855789|12395466|FG000|1) Baseline up to Week 24|Death|2
7890982|NCT01855789|12395467|FG001|1) Baseline up to Week 24|Death|0
7890983|NCT01855789|12395468|FG002|1) Baseline up to Week 24|Death|0
7890984|NCT01855789|12395469|FG003|1) Baseline up to Week 24|Death|0
7890985|NCT01855789|12395466|FG000|1) Baseline up to Week 24|Lack of Efficacy|16
7890986|NCT01855789|12395467|FG001|1) Baseline up to Week 24|Lack of Efficacy|0
7890987|NCT01855789|12395468|FG002|1) Baseline up to Week 24|Lack of Efficacy|0
7890988|NCT01855789|12395469|FG003|1) Baseline up to Week 24|Lack of Efficacy|0
7890989|NCT01855789|12395466|FG000|1) Baseline up to Week 24|Lost to Follow-up|11
7890990|NCT01855789|12395467|FG001|1) Baseline up to Week 24|Lost to Follow-up|0
7890991|NCT01855789|12395468|FG002|1) Baseline up to Week 24|Lost to Follow-up|0
7890992|NCT01855789|12395469|FG003|1) Baseline up to Week 24|Lost to Follow-up|0
7890993|NCT01855789|12395466|FG000|1) Baseline up to Week 24|Protocol Violation|4
7890994|NCT01855789|12395467|FG001|1) Baseline up to Week 24|Protocol Violation|0
7890995|NCT01855789|12395468|FG002|1) Baseline up to Week 24|Protocol Violation|0
7890996|NCT01855789|12395469|FG003|1) Baseline up to Week 24|Protocol Violation|0
7890997|NCT01855789|12395466|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31
7890998|NCT01855789|12395467|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0
7890999|NCT01855789|12395468|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0
7891000|NCT01855789|12395469|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0
7891001|NCT01855789|12395466|FG000|1) Baseline up to Week 24|Physician Decision|4
7891002|NCT01855789|12395467|FG001|1) Baseline up to Week 24|Physician Decision|0
7891003|NCT01855789|12395468|FG002|1) Baseline up to Week 24|Physician Decision|0
7891004|NCT01855789|12395469|FG003|1) Baseline up to Week 24|Physician Decision|0
7891005|NCT01855789|12395466|FG000|1) Baseline up to Week 24|Pregnancy|1
7891006|NCT01855789|12395467|FG001|1) Baseline up to Week 24|Pregnancy|0
7891007|NCT01855789|12395468|FG002|1) Baseline up to Week 24|Pregnancy|0
7891008|NCT01855789|12395469|FG003|1) Baseline up to Week 24|Pregnancy|0
7891009|NCT01855789|12395466|FG000|1) Baseline up to Week 24|Participant Non-compliance|3
7891010|NCT01855789|12395467|FG001|1) Baseline up to Week 24|Participant Non-compliance|0
7891011|NCT01855789|12395468|FG002|1) Baseline up to Week 24|Participant Non-compliance|0
7891012|NCT01855789|12395469|FG003|1) Baseline up to Week 24|Participant Non-compliance|0
7891013|NCT01855789|12395466|FG000|1) Baseline up to Week 24|Sponsor Decision|3
7891014|NCT01855789|12395467|FG001|1) Baseline up to Week 24|Sponsor Decision|0
7891015|NCT01855789|12395468|FG002|1) Baseline up to Week 24|Sponsor Decision|0
7891016|NCT01855789|12395469|FG003|1) Baseline up to Week 24|Sponsor Decision|0
7891017|NCT01855789|12395466|FG000|1) Baseline up to Week 24|Other|4
7891018|NCT01855789|12395467|FG001|1) Baseline up to Week 24|Other|0
7891019|NCT01855789|12395468|FG002|1) Baseline up to Week 24|Other|0
7891020|NCT01855789|12395469|FG003|1) Baseline up to Week 24|Other|0
7891021|NCT01855789|12395466|FG000|2) Week 24 up to End of Study|Adverse Event|0
7891022|NCT01855789|12395467|FG001|2) Week 24 up to End of Study|Adverse Event|4
7891023|NCT01855789|12395468|FG002|2) Week 24 up to End of Study|Adverse Event|5
7891024|NCT01855789|12395469|FG003|2) Week 24 up to End of Study|Adverse Event|21
7891025|NCT01855789|12395466|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
7891026|NCT01855789|12395467|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
7891027|NCT01855789|12395468|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
7891028|NCT01855789|12395469|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
7891029|NCT01855789|12395466|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0
7891030|NCT01855789|12395467|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2
7891031|NCT01855789|12395468|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5
7891032|NCT01855789|12395469|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16
7891033|NCT01855789|12395466|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0
7891034|NCT01855789|12395467|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1
7891035|NCT01855789|12395468|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1
7891036|NCT01855789|12395469|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4
7891037|NCT01855789|12395466|FG000|2) Week 24 up to End of Study|Protocol Violation|0
7891038|NCT01855789|12395467|FG001|2) Week 24 up to End of Study|Protocol Violation|0
7891039|NCT01855789|12395468|FG002|2) Week 24 up to End of Study|Protocol Violation|0
7891040|NCT01855789|12395469|FG003|2) Week 24 up to End of Study|Protocol Violation|1
7891041|NCT01855789|12395466|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0
7891042|NCT01855789|12395467|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7
7891043|NCT01855789|12395468|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5
7891044|NCT01855789|12395469|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8
7891045|NCT01855789|12395466|FG000|2) Week 24 up to End of Study|Physician Decision|0
7891046|NCT01855789|12395467|FG001|2) Week 24 up to End of Study|Physician Decision|0
7891047|NCT01855789|12395468|FG002|2) Week 24 up to End of Study|Physician Decision|2
7891048|NCT01855789|12395469|FG003|2) Week 24 up to End of Study|Physician Decision|4
7891049|NCT01855789|12395466|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0
7891050|NCT01855789|12395467|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1
7891051|NCT01855789|12395468|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0
7891052|NCT01855789|12395469|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1
7891053|NCT01855789|12395466|FG000|2) Week 24 up to End of Study|Sponsor Decision|0
7891054|NCT01855789|12395467|FG001|2) Week 24 up to End of Study|Sponsor Decision|0
7891055|NCT01855789|12395468|FG002|2) Week 24 up to End of Study|Sponsor Decision|0
7891056|NCT01855789|12395469|FG003|2) Week 24 up to End of Study|Sponsor Decision|1
7891057|NCT01855789|12395466|FG000|2) Week 24 up to End of Study|Other|0
7891058|NCT01855789|12395467|FG001|2) Week 24 up to End of Study|Other|0
7891059|NCT01855789|12395468|FG002|2) Week 24 up to End of Study|Other|0
7891060|NCT01855789|12395469|FG003|2) Week 24 up to End of Study|Other|1
7891061|NCT01855828|12395475|FG000|Overall Study|Adverse Event|1
7891062|NCT01855828|12395475|FG000|Overall Study|Withdrawal by Subject|1
7891063|NCT01855919|12395486|FG000|Overall Study|Adverse Event|16
7891064|NCT01855919|12395487|FG001|Overall Study|Adverse Event|8
7891065|NCT01855919|12395486|FG000|Overall Study|Lack of Efficacy|1
7891066|NCT01855919|12395487|FG001|Overall Study|Lack of Efficacy|3
7891067|NCT01855919|12395486|FG000|Overall Study|Withdrawal by Subject|4
7891068|NCT01855919|12395487|FG001|Overall Study|Withdrawal by Subject|10
7891069|NCT01855919|12395486|FG000|Overall Study|Entry Criteria Not Met|1
7891070|NCT01855919|12395487|FG001|Overall Study|Entry Criteria Not Met|1
7891071|NCT01855919|12395486|FG000|Overall Study|Protocol Violation|1
7891072|NCT01855919|12395487|FG001|Overall Study|Protocol Violation|4
7891073|NCT01855945|12395506|FG000|Overall Study|Adverse Event|0
7891074|NCT01855945|12395507|FG001|Overall Study|Adverse Event|0
7891075|NCT01855945|12395508|FG002|Overall Study|Adverse Event|0
7891076|NCT01855945|12395509|FG003|Overall Study|Adverse Event|0
7891077|NCT01855945|12395510|FG004|Overall Study|Adverse Event|0
7891078|NCT01855945|12395511|FG005|Overall Study|Adverse Event|0
7891079|NCT01855945|12395512|FG006|Overall Study|Adverse Event|1
7891080|NCT01855945|12395513|FG007|Overall Study|Adverse Event|0
7891081|NCT01855945|12395514|FG008|Overall Study|Adverse Event|0
7891082|NCT01855945|12395515|FG009|Overall Study|Adverse Event|0
7891083|NCT01855945|12395516|FG010|Overall Study|Adverse Event|0
7891084|NCT01855945|12395517|FG011|Overall Study|Adverse Event|0
7891085|NCT01855945|12395506|FG000|Overall Study|Death|0
7891086|NCT01855945|12395507|FG001|Overall Study|Death|0
7891087|NCT01855945|12395508|FG002|Overall Study|Death|0
7891088|NCT01855945|12395509|FG003|Overall Study|Death|0
7891089|NCT01855945|12395510|FG004|Overall Study|Death|0
7891090|NCT01855945|12395511|FG005|Overall Study|Death|0
7891091|NCT01855945|12395512|FG006|Overall Study|Death|2
7891092|NCT01855945|12395513|FG007|Overall Study|Death|0
7891093|NCT01855945|12395514|FG008|Overall Study|Death|0
7891094|NCT01855945|12395515|FG009|Overall Study|Death|0
7891095|NCT01855945|12395516|FG010|Overall Study|Death|0
7891096|NCT01855945|12395517|FG011|Overall Study|Death|0
7891097|NCT01855945|12395506|FG000|Overall Study|Lost to Follow-up|11
7891098|NCT01855945|12395507|FG001|Overall Study|Lost to Follow-up|10
7891099|NCT01855945|12395508|FG002|Overall Study|Lost to Follow-up|7
7891100|NCT01855945|12395509|FG003|Overall Study|Lost to Follow-up|3
7891101|NCT01855945|12395510|FG004|Overall Study|Lost to Follow-up|0
7891102|NCT01855945|12395511|FG005|Overall Study|Lost to Follow-up|3
7891103|NCT01855945|12395512|FG006|Overall Study|Lost to Follow-up|4
7891104|NCT01855945|12395513|FG007|Overall Study|Lost to Follow-up|7
7891105|NCT01855945|12395514|FG008|Overall Study|Lost to Follow-up|2
7891106|NCT01855945|12395515|FG009|Overall Study|Lost to Follow-up|0
7891107|NCT01855945|12395516|FG010|Overall Study|Lost to Follow-up|0
7891108|NCT01855945|12395517|FG011|Overall Study|Lost to Follow-up|2
7891109|NCT01855945|12395506|FG000|Overall Study|Other - Unclassified|1
7891110|NCT01855945|12395507|FG001|Overall Study|Other - Unclassified|1
7891111|NCT01855945|12395508|FG002|Overall Study|Other - Unclassified|1
7891112|NCT01855945|12395509|FG003|Overall Study|Other - Unclassified|0
7891113|NCT01855945|12395510|FG004|Overall Study|Other - Unclassified|0
7891114|NCT01855945|12395511|FG005|Overall Study|Other - Unclassified|0
7891115|NCT01855945|12395512|FG006|Overall Study|Other - Unclassified|2
7891116|NCT01855945|12395513|FG007|Overall Study|Other - Unclassified|1
7891117|NCT01855945|12395514|FG008|Overall Study|Other - Unclassified|0
7891118|NCT01855945|12395515|FG009|Overall Study|Other - Unclassified|0
7891119|NCT01855945|12395516|FG010|Overall Study|Other - Unclassified|1
7891120|NCT01855945|12395517|FG011|Overall Study|Other - Unclassified|0
7891121|NCT01855945|12395506|FG000|Overall Study|Withdrawal by Subject|4
7891122|NCT01855945|12395507|FG001|Overall Study|Withdrawal by Subject|0
7891123|NCT01855945|12395508|FG002|Overall Study|Withdrawal by Subject|4
7891124|NCT01855945|12395509|FG003|Overall Study|Withdrawal by Subject|1
7891125|NCT01855945|12395510|FG004|Overall Study|Withdrawal by Subject|1
7891126|NCT01855945|12395511|FG005|Overall Study|Withdrawal by Subject|0
7891127|NCT01855945|12395512|FG006|Overall Study|Withdrawal by Subject|1
7891128|NCT01855945|12395513|FG007|Overall Study|Withdrawal by Subject|0
7891129|NCT01855945|12395514|FG008|Overall Study|Withdrawal by Subject|0
7891130|NCT01855945|12395515|FG009|Overall Study|Withdrawal by Subject|2
7891131|NCT01855945|12395516|FG010|Overall Study|Withdrawal by Subject|4
7891132|NCT01855945|12395517|FG011|Overall Study|Withdrawal by Subject|1
7891133|NCT01855958|12395582|FG000|Overall Study|Withdrawal by Subject|1
7891134|NCT01855958|12395583|FG001|Overall Study|Withdrawal by Subject|0
7891135|NCT01856114|12395605|FG000|Overall Study|Withdrawal by Subject|1
7891136|NCT01856114|12395606|FG001|Overall Study|Withdrawal by Subject|0
7891137|NCT01856114|12395605|FG000|Overall Study|Adverse Event|1
7891138|NCT01856114|12395606|FG001|Overall Study|Adverse Event|0
7891139|NCT01856257|12395619|FG000|Overall Study|Death|2
7891140|NCT01856257|12395620|FG001|Overall Study|Death|0
7891141|NCT01856257|12395621|FG002|Overall Study|Death|0
7891142|NCT01856257|12395622|FG003|Overall Study|Death|0
7891143|NCT01856257|12395619|FG000|Overall Study|Physician Decision|0
7891144|NCT01856257|12395620|FG001|Overall Study|Physician Decision|0
7891145|NCT01856257|12395621|FG002|Overall Study|Physician Decision|0
7891146|NCT01856257|12395622|FG003|Overall Study|Physician Decision|1
7891147|NCT01856257|12395619|FG000|Overall Study|Withdrawal by Subject|1
7891148|NCT01856257|12395620|FG001|Overall Study|Withdrawal by Subject|1
7891149|NCT01856257|12395621|FG002|Overall Study|Withdrawal by Subject|0
7891150|NCT01856257|12395622|FG003|Overall Study|Withdrawal by Subject|0
7891151|NCT01856257|12395619|FG000|Overall Study|Donor complication|0
7891152|NCT01856257|12395620|FG001|Overall Study|Donor complication|0
7891153|NCT01856257|12395621|FG002|Overall Study|Donor complication|0
7891154|NCT01856257|12395622|FG003|Overall Study|Donor complication|1
7891155|NCT01856309|12395635|FG000|Overall Study|Death|4
7891156|NCT01856309|12395636|FG001|Overall Study|Death|6
7891157|NCT01856309|12395637|FG002|Overall Study|Death|11
7891158|NCT01856309|12395638|FG003|Overall Study|Death|6
7891159|NCT01856309|12395635|FG000|Overall Study|Lost to Follow-up|6
7891160|NCT01856309|12395636|FG001|Overall Study|Lost to Follow-up|2
7891161|NCT01856309|12395637|FG002|Overall Study|Lost to Follow-up|4
7891162|NCT01856309|12395638|FG003|Overall Study|Lost to Follow-up|8
7891163|NCT01856309|12395635|FG000|Overall Study|Withdrawal by Subject|11
7891164|NCT01856309|12395636|FG001|Overall Study|Withdrawal by Subject|13
7891165|NCT01856309|12395637|FG002|Overall Study|Withdrawal by Subject|28
7891166|NCT01856309|12395638|FG003|Overall Study|Withdrawal by Subject|26
7891167|NCT01856309|12395635|FG000|Overall Study|Other|227
7891168|NCT01856309|12395636|FG001|Overall Study|Other|225
7891169|NCT01856309|12395637|FG002|Overall Study|Other|447
7891170|NCT01856309|12395638|FG003|Overall Study|Other|469
7891171|NCT01856309|12395635|FG000|Overall Study|Lack of Efficacy|14
7891172|NCT01856309|12395636|FG001|Overall Study|Lack of Efficacy|9
7891173|NCT01856309|12395637|FG002|Overall Study|Lack of Efficacy|40
7891174|NCT01856309|12395638|FG003|Overall Study|Lack of Efficacy|25
7891175|NCT01856309|12395635|FG000|Overall Study|Adverse Event|31
7891176|NCT01856309|12395636|FG001|Overall Study|Adverse Event|31
7891177|NCT01856309|12395637|FG002|Overall Study|Adverse Event|55
7891178|NCT01856309|12395638|FG003|Overall Study|Adverse Event|65
7891179|NCT01856309|12395635|FG000|Overall Study|Pregnancy|0
7891180|NCT01856309|12395636|FG001|Overall Study|Pregnancy|0
7891181|NCT01856309|12395637|FG002|Overall Study|Pregnancy|0
7891182|NCT01856309|12395638|FG003|Overall Study|Pregnancy|1
7891183|NCT01856309|12395635|FG000|Overall Study|Physician Decision|6
7891184|NCT01856309|12395636|FG001|Overall Study|Physician Decision|1
7891185|NCT01856309|12395637|FG002|Overall Study|Physician Decision|6
7891186|NCT01856309|12395638|FG003|Overall Study|Physician Decision|8
7891187|NCT01856309|12395635|FG000|Overall Study|Noncompliance With Study Drug|0
7891188|NCT01856309|12395636|FG001|Overall Study|Noncompliance With Study Drug|1
7891189|NCT01856309|12395637|FG002|Overall Study|Noncompliance With Study Drug|4
7891190|NCT01856309|12395638|FG003|Overall Study|Noncompliance With Study Drug|1
7891191|NCT01856543|12395663|FG000|Overall Study|Treatment discontinued|6
7891192|NCT01856543|12395664|FG001|Overall Study|Treatment discontinued|3
7891193|NCT01856543|12395663|FG000|Overall Study|Withdrawn before start|7
7891194|NCT01856543|12395664|FG001|Overall Study|Withdrawn before start|3
7891195|NCT01856569|12395671|FG000|Overall Study|Other|1
7891196|NCT01856569|12395671|FG000|Overall Study|Changed Site/Structure|1
7891197|NCT01856569|12395671|FG000|Overall Study|Lost to Follow-up|3
7891198|NCT01856569|12395671|FG000|Overall Study|Did not met inclusion criteria|8
7891199|NCT01856582|12395675|FG000|Overall Study|Died prior to Boost infusion|1
7891200|NCT01856595|12395688|FG000|Overall Study|Withdrawal by Subject|0
7891201|NCT01856595|12395689|FG001|Overall Study|Withdrawal by Subject|1
7891202|NCT01856595|12395690|FG002|Overall Study|Withdrawal by Subject|0
7891203|NCT01856595|12395691|FG003|Overall Study|Withdrawal by Subject|0
7891204|NCT01856595|12395692|FG004|Overall Study|Withdrawal by Subject|0
7891205|NCT01856595|12395693|FG005|Overall Study|Withdrawal by Subject|0
7891206|NCT01856595|12395694|FG006|Overall Study|Withdrawal by Subject|1
7891207|NCT01856595|12395695|FG007|Overall Study|Withdrawal by Subject|0
7891208|NCT01856595|12395696|FG008|Overall Study|Withdrawal by Subject|0
7891209|NCT01856673|12395734|FG000|Overall Study|Withdrawal by Subject|44
7891210|NCT01856673|12395735|FG001|Overall Study|Withdrawal by Subject|50
7891211|NCT01856673|12395736|FG002|Overall Study|Withdrawal by Subject|33
7891212|NCT01856673|12395734|FG000|Overall Study|Lost to Follow-up|31
7891213|NCT01856673|12395735|FG001|Overall Study|Lost to Follow-up|34
7891214|NCT01856673|12395736|FG002|Overall Study|Lost to Follow-up|0
7891215|NCT01856673|12395734|FG000|Overall Study|Unknown reasons|9
7891216|NCT01856673|12395735|FG001|Overall Study|Unknown reasons|0
7891217|NCT01856673|12395736|FG002|Overall Study|Unknown reasons|0
7891218|NCT01856673|12395734|FG000|Overall Study|Psychologist decision|1
7891219|NCT01856673|12395735|FG001|Overall Study|Psychologist decision|0
7891220|NCT01856673|12395736|FG002|Overall Study|Psychologist decision|0
7891221|NCT01856673|12395734|FG000|Overall Study|Paperwork errors|8
7891222|NCT01856673|12395735|FG001|Overall Study|Paperwork errors|0
7891223|NCT01856673|12395736|FG002|Overall Study|Paperwork errors|0
7891224|NCT01856673|12395734|FG000|Overall Study|Death|1
7891225|NCT01856673|12395735|FG001|Overall Study|Death|1
7891226|NCT01856673|12395736|FG002|Overall Study|Death|0
7891227|NCT01856673|12395734|FG000|Overall Study|Protocol Violation|1
7891228|NCT01856673|12395735|FG001|Overall Study|Protocol Violation|0
7891229|NCT01856673|12395736|FG002|Overall Study|Protocol Violation|1
7891230|NCT01856686|12395746|FG000|Overall Study|Lost to Follow-up|5
7891231|NCT01856686|12395747|FG001|Overall Study|Lost to Follow-up|11
7891232|NCT01856790|12395775|FG000|Closed Loop Control|Withdrawal by Subject|2
7891233|NCT01856790|12395775|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2
7891234|NCT01856907|12395789|FG000|Overall Study|Pregnancy|0
7891235|NCT01856907|12395790|FG001|Overall Study|Pregnancy|1
7891236|NCT01856907|12395791|FG002|Overall Study|Pregnancy|0
7891237|NCT01856907|12395789|FG000|Overall Study|Pregnancy|0
7891238|NCT01856907|12395790|FG001|Overall Study|Pregnancy|1
7891239|NCT01856907|12395791|FG002|Overall Study|Pregnancy|0
7891240|NCT01856907|12395789|FG000|Overall Study|Withdrawal by Subject|0
7891241|NCT01856907|12395790|FG001|Overall Study|Withdrawal by Subject|1
7891242|NCT01856907|12395791|FG002|Overall Study|Withdrawal by Subject|0
7891243|NCT01857102|12395806|FG000|Period 1|No longer meets Eligibility Criteria|0
7891244|NCT01857102|12395807|FG001|Period 1|No longer meets Eligibility Criteria|2
7891245|NCT01857102|12395806|FG000|Period 1|Lost to Follow-up|0
7891246|NCT01857102|12395807|FG001|Period 1|Lost to Follow-up|3
7891247|NCT01857102|12395806|FG000|Period 1|Unsatisfactory Lens Fit|1
7891248|NCT01857102|12395807|FG001|Period 1|Unsatisfactory Lens Fit|0
7891249|NCT01857102|12395806|FG000|Period 1|Unsatisfactory Visual Response|1
7891250|NCT01857102|12395807|FG001|Period 1|Unsatisfactory Visual Response|0
7891251|NCT01857102|12395806|FG000|Period 1|Physician Decision|1
7891252|NCT01857102|12395807|FG001|Period 1|Physician Decision|0
7891253|NCT01857102|12395806|FG000|Period 2|Lens Discomfort|1
7891254|NCT01857102|12395807|FG001|Period 2|Lens Discomfort|0
7891255|NCT01857102|12395806|FG000|Period 2|Unsatisfactory Lens Fit|1
7891256|NCT01857102|12395807|FG001|Period 2|Unsatisfactory Lens Fit|0
7891257|NCT01857206|12395817|FG000|Overall Study|ADMINISTRATIVE REASON|0
7891258|NCT01857206|12395818|FG001|Overall Study|ADMINISTRATIVE REASON|1
7891259|NCT01857206|12395817|FG000|Overall Study|Lost to Follow-up|9
7891260|NCT01857206|12395818|FG001|Overall Study|Lost to Follow-up|6
7891261|NCT01857206|12395817|FG000|Overall Study|Unclassified|3
7891262|NCT01857206|12395818|FG001|Overall Study|Unclassified|3
7891263|NCT01857206|12395817|FG000|Overall Study|Withdrawal by Subject|1
7891264|NCT01857206|12395818|FG001|Overall Study|Withdrawal by Subject|0
7891265|NCT01857310|12395872|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315
7891266|NCT01857310|12395873|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282
7891267|NCT01857323|12395879|FG000|Overall Study|Adverse Event|1
7891268|NCT01857323|12395879|FG000|Overall Study|Withdrawal by Subject|3
7891269|NCT01857323|12395879|FG000|Overall Study|Non-compliance|1
7891270|NCT01857323|12395879|FG000|Overall Study|Protocol Violation|6
7891271|NCT01857323|12395879|FG000|Overall Study|Lost to Follow-up|1
7891272|NCT01857323|12395879|FG000|Overall Study|Other|4
7891273|NCT01857323|12395879|FG000|Overall Study|Did not complete 180 doses|48
7891274|NCT01857531|12395890|FG000|Overall Study|Withdrawal by Subject|4
7891275|NCT01857583|12395898|FG000|Overall Study|Adverse Event|0
7891276|NCT01857583|12395899|FG001|Overall Study|Adverse Event|0
7891277|NCT01857583|12395900|FG002|Overall Study|Adverse Event|1
7891278|NCT01857583|12395901|FG003|Overall Study|Adverse Event|1
7891279|NCT01857583|12395898|FG000|Overall Study|Death|0
7891280|NCT01857583|12395899|FG001|Overall Study|Death|1
7891281|NCT01857583|12395900|FG002|Overall Study|Death|1
7891282|NCT01857583|12395901|FG003|Overall Study|Death|0
7891283|NCT01857583|12395898|FG000|Overall Study|Physician Decision|0
7891284|NCT01857583|12395899|FG001|Overall Study|Physician Decision|0
7891285|NCT01857583|12395900|FG002|Overall Study|Physician Decision|0
7891286|NCT01857583|12395901|FG003|Overall Study|Physician Decision|1
7891287|NCT01857583|12395898|FG000|Overall Study|Withdrawal by Subject|1
7891288|NCT01857583|12395899|FG001|Overall Study|Withdrawal by Subject|0
7891289|NCT01857583|12395900|FG002|Overall Study|Withdrawal by Subject|1
7891290|NCT01857583|12395901|FG003|Overall Study|Withdrawal by Subject|2
7891291|NCT01857622|12395914|FG000|Overall Study|Adverse Event|5
7891292|NCT01857622|12395915|FG001|Overall Study|Adverse Event|0
7891293|NCT01857622|12395916|FG002|Overall Study|Adverse Event|2
7891294|NCT01857622|12395914|FG000|Overall Study|Physician Decision|1
7891295|NCT01857622|12395915|FG001|Overall Study|Physician Decision|0
7891296|NCT01857622|12395916|FG002|Overall Study|Physician Decision|0
7891297|NCT01857622|12395914|FG000|Overall Study|Protocol Violation|4
7891298|NCT01857622|12395915|FG001|Overall Study|Protocol Violation|1
7891299|NCT01857622|12395916|FG002|Overall Study|Protocol Violation|0
7891300|NCT01857622|12395914|FG000|Overall Study|Withdrawal by Subject|1
7891301|NCT01857622|12395915|FG001|Overall Study|Withdrawal by Subject|0
7891302|NCT01857622|12395916|FG002|Overall Study|Withdrawal by Subject|0
7891303|NCT01857869|12395940|FG000|Primary/Challenge Phase|Lost to Follow-up|2
7891304|NCT01857869|12395941|FG001|Primary/Challenge Phase|Lost to Follow-up|0
7891305|NCT01857869|12395942|FG002|Primary/Challenge Phase|Lost to Follow-up|0
7891306|NCT01857869|12395943|FG003|Primary/Challenge Phase|Lost to Follow-up|0
7891307|NCT01857869|12395944|FG004|Primary/Challenge Phase|Lost to Follow-up|0
7891308|NCT01857869|12395945|FG005|Primary/Challenge Phase|Lost to Follow-up|0
7891309|NCT01857869|12395946|FG006|Primary/Challenge Phase|Lost to Follow-up|0
7891310|NCT01857869|12395947|FG007|Primary/Challenge Phase|Lost to Follow-up|0
7891311|NCT01857869|12395948|FG008|Primary/Challenge Phase|Lost to Follow-up|0
7891312|NCT01857869|12395949|FG009|Primary/Challenge Phase|Lost to Follow-up|0
7891313|NCT01857869|12395940|FG000|Primary/Challenge Phase|Pregnancy|1
7891314|NCT01857869|12395941|FG001|Primary/Challenge Phase|Pregnancy|0
7891315|NCT01857869|12395942|FG002|Primary/Challenge Phase|Pregnancy|0
7891316|NCT01857869|12395943|FG003|Primary/Challenge Phase|Pregnancy|0
7891317|NCT01857869|12395944|FG004|Primary/Challenge Phase|Pregnancy|0
7891318|NCT01857869|12395945|FG005|Primary/Challenge Phase|Pregnancy|0
7891319|NCT01857869|12395946|FG006|Primary/Challenge Phase|Pregnancy|0
7891320|NCT01857869|12395947|FG007|Primary/Challenge Phase|Pregnancy|0
7891321|NCT01857869|12395948|FG008|Primary/Challenge Phase|Pregnancy|0
7891322|NCT01857869|12395949|FG009|Primary/Challenge Phase|Pregnancy|0
7891323|NCT01857869|12395940|FG000|Primary/Challenge Phase|Protocol Violation|1
7891324|NCT01857869|12395941|FG001|Primary/Challenge Phase|Protocol Violation|0
7891325|NCT01857869|12395942|FG002|Primary/Challenge Phase|Protocol Violation|0
7891326|NCT01857869|12395943|FG003|Primary/Challenge Phase|Protocol Violation|0
7891327|NCT01857869|12395944|FG004|Primary/Challenge Phase|Protocol Violation|0
7891328|NCT01857869|12395945|FG005|Primary/Challenge Phase|Protocol Violation|0
7891329|NCT01857869|12395946|FG006|Primary/Challenge Phase|Protocol Violation|0
7891330|NCT01857869|12395947|FG007|Primary/Challenge Phase|Protocol Violation|0
7891331|NCT01857869|12395948|FG008|Primary/Challenge Phase|Protocol Violation|0
7891332|NCT01857869|12395949|FG009|Primary/Challenge Phase|Protocol Violation|0
7891333|NCT01857869|12395940|FG000|Primary/Challenge Phase|Other|1
7891334|NCT01857869|12395941|FG001|Primary/Challenge Phase|Other|1
7891335|NCT01857869|12395942|FG002|Primary/Challenge Phase|Other|0
7891336|NCT01857869|12395943|FG003|Primary/Challenge Phase|Other|0
7891337|NCT01857869|12395944|FG004|Primary/Challenge Phase|Other|0
7891338|NCT01857869|12395945|FG005|Primary/Challenge Phase|Other|0
7891339|NCT01857869|12395946|FG006|Primary/Challenge Phase|Other|0
7891340|NCT01857869|12395947|FG007|Primary/Challenge Phase|Other|0
7891341|NCT01857869|12395948|FG008|Primary/Challenge Phase|Other|0
7891342|NCT01857869|12395949|FG009|Primary/Challenge Phase|Other|0
7891343|NCT01857869|12395940|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0
7891344|NCT01857869|12395941|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0
7891345|NCT01857869|12395942|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0
7891346|NCT01857869|12395943|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1
7891347|NCT01857869|12395944|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0
7891348|NCT01857869|12395945|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0
7891349|NCT01857869|12395946|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0
7891350|NCT01857869|12395947|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0
7891351|NCT01857869|12395948|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0
7891352|NCT01857869|12395949|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0
7891353|NCT01857869|12395940|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7891354|NCT01857869|12395941|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7891355|NCT01857869|12395942|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7891356|NCT01857869|12395943|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
7891357|NCT01857869|12395944|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7891358|NCT01857869|12395945|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7891359|NCT01857869|12395946|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7891360|NCT01857869|12395947|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7891361|NCT01857869|12395948|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7891362|NCT01857869|12395949|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7891363|NCT01857973|12395981|FG000|Overall Study|Subject did not meet required BG range|3
7891364|NCT01857973|12395981|FG000|Overall Study|drop out after 3 failed attempts|1
7891365|NCT01857973|12395981|FG000|Overall Study|Physician Decision|1
7891366|NCT01858194|12395996|FG000|Overall Study|Total Artificial Heart Implant|0
7891367|NCT01858194|12395997|FG001|Overall Study|Total Artificial Heart Implant|1
7891368|NCT01858194|12395996|FG000|Overall Study|Lost to Follow-up|0
7891369|NCT01858194|12395997|FG001|Overall Study|Lost to Follow-up|1
7891370|NCT01858363|12396007|FG000|Overall Study|Death|35
7891371|NCT01858363|12396008|FG001|Overall Study|Death|9
7891372|NCT01858363|12396007|FG000|Overall Study|Withdrawal by Subject|28
7891373|NCT01858363|12396008|FG001|Overall Study|Withdrawal by Subject|14
7891374|NCT01858363|12396007|FG000|Overall Study|Lost to Follow-up|13
7891375|NCT01858363|12396008|FG001|Overall Study|Lost to Follow-up|3
7891376|NCT01858376|12396014|FG000|Overall Study|Dropped d/t lab work not fitting criter|4
7962989|NCT02717195|12517436|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
7962990|NCT02717195|12517437|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6
7891377|NCT01858389|12396020|FG000|Overall Study|Death|1
7891378|NCT01858389|12396021|FG001|Overall Study|Death|3
7891379|NCT01858389|12396020|FG000|Overall Study|Study terminated by sponsor|0
7891380|NCT01858389|12396021|FG001|Overall Study|Study terminated by sponsor|2
7891381|NCT01858389|12396020|FG000|Overall Study|Withdrawal by Subject|0
7891382|NCT01858389|12396021|FG001|Overall Study|Withdrawal by Subject|1
7891383|NCT01858389|12396020|FG000|Overall Study|Progressive disease|10
7891384|NCT01858389|12396021|FG001|Overall Study|Progressive disease|11
7891385|NCT01858389|12396020|FG000|Overall Study|Other|2
7891386|NCT01858389|12396021|FG001|Overall Study|Other|4
7891387|NCT01858389|12396020|FG000|Overall Study|Adverse Event|3
7891388|NCT01858389|12396021|FG001|Overall Study|Adverse Event|1
7891389|NCT01858389|12396020|FG000|Overall Study|Did not receive treatment|0
7891390|NCT01858389|12396021|FG001|Overall Study|Did not receive treatment|3
7891391|NCT01858532|12396042|FG000|Overall Study|Adverse Event|58
7891392|NCT01858532|12396043|FG001|Overall Study|Adverse Event|50
7891393|NCT01858532|12396044|FG002|Overall Study|Adverse Event|23
7891394|NCT01858532|12396045|FG003|Overall Study|Adverse Event|28
7891395|NCT01858532|12396042|FG000|Overall Study|Withdrew consent|71
7891396|NCT01858532|12396043|FG001|Overall Study|Withdrew consent|93
7891397|NCT01858532|12396044|FG002|Overall Study|Withdrew consent|46
7891398|NCT01858532|12396045|FG003|Overall Study|Withdrew consent|27
7891399|NCT01858532|12396042|FG000|Overall Study|Lost to Follow-up|17
7891400|NCT01858532|12396043|FG001|Overall Study|Lost to Follow-up|26
7891401|NCT01858532|12396044|FG002|Overall Study|Lost to Follow-up|11
7891402|NCT01858532|12396045|FG003|Overall Study|Lost to Follow-up|14
7891403|NCT01858532|12396042|FG000|Overall Study|Deterioration of medical status|3
7891404|NCT01858532|12396043|FG001|Overall Study|Deterioration of medical status|4
7891405|NCT01858532|12396044|FG002|Overall Study|Deterioration of medical status|3
7891406|NCT01858532|12396045|FG003|Overall Study|Deterioration of medical status|7
7891407|NCT01858532|12396042|FG000|Overall Study|Investigator request|3
7891408|NCT01858532|12396043|FG001|Overall Study|Investigator request|4
7891409|NCT01858532|12396044|FG002|Overall Study|Investigator request|2
7891410|NCT01858532|12396045|FG003|Overall Study|Investigator request|6
7891411|NCT01858532|12396042|FG000|Overall Study|Other, not specified|29
7891412|NCT01858532|12396043|FG001|Overall Study|Other, not specified|15
7891413|NCT01858532|12396044|FG002|Overall Study|Other, not specified|13
7891414|NCT01858532|12396045|FG003|Overall Study|Other, not specified|11
7891415|NCT01858558|12396066|FG000|Overall Study|Death|1
7891416|NCT01858558|12396067|FG001|Overall Study|Death|1
7891417|NCT01858558|12396066|FG000|Overall Study|Lost to Follow-up|1
7891418|NCT01858558|12396067|FG001|Overall Study|Lost to Follow-up|0
7891419|NCT01858558|12396066|FG000|Overall Study|Disease progression|3
7891420|NCT01858558|12396067|FG001|Overall Study|Disease progression|1
7891421|NCT01858558|12396066|FG000|Overall Study|Product contamination|2
7891422|NCT01858558|12396067|FG001|Overall Study|Product contamination|0
7891423|NCT01858558|12396066|FG000|Overall Study|Failed expansion of cell product|2
7891424|NCT01858558|12396067|FG001|Overall Study|Failed expansion of cell product|0
7891425|NCT01858636|12396073|FG000|Overall Study|No Device Deployment Attempted|24
7891426|NCT01858636|12396073|FG000|Overall Study|Physician Decision|1
7968301|NCT03893565|12525825|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2
7968302|NCT03893565|12525826|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2
7968303|NCT03893565|12525827|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7968304|NCT03893565|12525828|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7968305|NCT03893565|12525820|FG000|Open-label Induction Phase (10 Weeks)|Other|0
7968306|NCT03893565|12525821|FG001|Open-label Induction Phase (10 Weeks)|Other|0
7968307|NCT03893565|12525822|FG002|Open-label Induction Phase (10 Weeks)|Other|0
7968308|NCT03893565|12525823|FG003|Open-label Induction Phase (10 Weeks)|Other|0
7968309|NCT03893565|12525824|FG004|Open-label Induction Phase (10 Weeks)|Other|0
7968310|NCT03893565|12525825|FG005|Open-label Induction Phase (10 Weeks)|Other|0
7968311|NCT03893565|12525826|FG006|Open-label Induction Phase (10 Weeks)|Other|0
7968312|NCT03893565|12525827|FG007|Open-label Induction Phase (10 Weeks)|Other|3
7968313|NCT03893565|12525828|FG008|Open-label Induction Phase (10 Weeks)|Other|0
7968314|NCT03893565|12525820|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7968315|NCT03893565|12525821|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7968316|NCT03893565|12525822|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7968317|NCT03893565|12525823|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7968318|NCT03893565|12525824|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7968319|NCT03893565|12525825|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7968320|NCT03893565|12525826|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7968321|NCT03893565|12525827|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5
7968322|NCT03893565|12525828|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7968323|NCT03893565|12525820|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7968324|NCT03893565|12525821|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7968325|NCT03893565|12525822|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7968326|NCT03893565|12525823|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7968327|NCT03893565|12525824|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7968328|NCT03893565|12525825|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7968329|NCT03893565|12525826|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7968330|NCT03893565|12525827|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15
7968331|NCT03893565|12525828|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7968332|NCT03893565|12525820|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7968333|NCT03893565|12525821|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7968334|NCT03893565|12525822|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7968335|NCT03893565|12525823|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7968336|NCT03893565|12525824|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7968337|NCT03893565|12525825|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7968338|NCT03893565|12525826|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7968339|NCT03893565|12525827|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7
7968340|NCT03893565|12525828|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7968341|NCT03893565|12525820|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7968342|NCT03893565|12525821|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7968343|NCT03893565|12525822|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7968344|NCT03893565|12525823|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7968345|NCT03893565|12525824|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7968346|NCT03893565|12525825|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7968347|NCT03893565|12525826|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7968348|NCT03893565|12525827|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7968349|NCT03893565|12525828|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4
7891427|NCT01858636|12396073|FG000|Overall Study|Death|1
7891428|NCT01858636|12396073|FG000|Overall Study|Lost to Follow-up|1
7891429|NCT01858636|12396073|FG000|Overall Study|Withdrawal by Subject|1
7891430|NCT01858701|12396078|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
7891431|NCT01858701|12396079|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
7891432|NCT01858701|12396078|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
7891433|NCT01858701|12396079|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
7891434|NCT01858701|12396078|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1
7891435|NCT01858701|12396079|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2
7891436|NCT01858701|12396078|FG000|Period 2, Second 30 Days of Wear|Comfort|0
7891437|NCT01858701|12396079|FG001|Period 2, Second 30 Days of Wear|Comfort|1
7891438|NCT01858766|12396113|FG000|Overall Study|Randomized but Never Treated|0
7891439|NCT01858766|12396114|FG001|Overall Study|Randomized but Never Treated|0
7891440|NCT01858766|12396115|FG002|Overall Study|Randomized but Never Treated|0
7891441|NCT01858766|12396116|FG003|Overall Study|Randomized but Never Treated|0
7891442|NCT01858766|12396117|FG004|Overall Study|Randomized but Never Treated|0
7891443|NCT01858766|12396118|FG005|Overall Study|Randomized but Never Treated|1
7891444|NCT01858766|12396119|FG006|Overall Study|Randomized but Never Treated|0
7891445|NCT01858766|12396120|FG007|Overall Study|Randomized but Never Treated|0
7891446|NCT01858766|12396121|FG008|Overall Study|Randomized but Never Treated|0
7891447|NCT01858766|12396122|FG009|Overall Study|Randomized but Never Treated|0
7891448|NCT01858766|12396123|FG010|Overall Study|Randomized but Never Treated|0
7891449|NCT01858766|12396124|FG011|Overall Study|Randomized but Never Treated|0
7891450|NCT01858766|12396125|FG012|Overall Study|Randomized but Never Treated|0
7891451|NCT01858766|12396126|FG013|Overall Study|Randomized but Never Treated|0
7891452|NCT01858766|12396127|FG014|Overall Study|Randomized but Never Treated|0
7891453|NCT01858766|12396128|FG015|Overall Study|Randomized but Never Treated|0
7891454|NCT01858766|12396129|FG016|Overall Study|Randomized but Never Treated|0
7891455|NCT01858766|12396130|FG017|Overall Study|Randomized but Never Treated|1
7717767|NCT00522041|12141439|FG001|Overall Study|Lost to Follow-up|4
7717768|NCT00522041|12141438|FG000|Overall Study|Voluntary withdrawal|5
7717769|NCT00522041|12141439|FG001|Overall Study|Voluntary withdrawal|4
7891456|NCT01858766|12396131|FG018|Overall Study|Randomized but Never Treated|0
7891457|NCT01858766|12396113|FG000|Overall Study|Death|0
7891458|NCT01858766|12396114|FG001|Overall Study|Death|0
7891459|NCT01858766|12396115|FG002|Overall Study|Death|1
7891460|NCT01858766|12396116|FG003|Overall Study|Death|0
7891461|NCT01858766|12396117|FG004|Overall Study|Death|0
7891462|NCT01858766|12396118|FG005|Overall Study|Death|0
7891463|NCT01858766|12396119|FG006|Overall Study|Death|0
7891464|NCT01858766|12396120|FG007|Overall Study|Death|0
7891465|NCT01858766|12396121|FG008|Overall Study|Death|0
7891466|NCT01858766|12396122|FG009|Overall Study|Death|0
7891467|NCT01858766|12396123|FG010|Overall Study|Death|0
7891468|NCT01858766|12396124|FG011|Overall Study|Death|0
7891469|NCT01858766|12396125|FG012|Overall Study|Death|0
7891470|NCT01858766|12396126|FG013|Overall Study|Death|0
7891471|NCT01858766|12396127|FG014|Overall Study|Death|0
7891472|NCT01858766|12396128|FG015|Overall Study|Death|0
7891473|NCT01858766|12396129|FG016|Overall Study|Death|0
7891474|NCT01858766|12396130|FG017|Overall Study|Death|0
7891475|NCT01858766|12396131|FG018|Overall Study|Death|0
7891476|NCT01858766|12396113|FG000|Overall Study|Lack of Efficacy|1
7891477|NCT01858766|12396114|FG001|Overall Study|Lack of Efficacy|0
7891478|NCT01858766|12396115|FG002|Overall Study|Lack of Efficacy|0
7891479|NCT01858766|12396116|FG003|Overall Study|Lack of Efficacy|0
7891480|NCT01858766|12396117|FG004|Overall Study|Lack of Efficacy|1
7891481|NCT01858766|12396118|FG005|Overall Study|Lack of Efficacy|2
7891482|NCT01858766|12396119|FG006|Overall Study|Lack of Efficacy|0
7891483|NCT01858766|12396120|FG007|Overall Study|Lack of Efficacy|0
7891484|NCT01858766|12396121|FG008|Overall Study|Lack of Efficacy|0
7891485|NCT01858766|12396122|FG009|Overall Study|Lack of Efficacy|0
7891486|NCT01858766|12396123|FG010|Overall Study|Lack of Efficacy|0
7891487|NCT01858766|12396124|FG011|Overall Study|Lack of Efficacy|3
7891488|NCT01858766|12396125|FG012|Overall Study|Lack of Efficacy|5
7891489|NCT01858766|12396126|FG013|Overall Study|Lack of Efficacy|3
7891490|NCT01858766|12396127|FG014|Overall Study|Lack of Efficacy|5
7891491|NCT01858766|12396128|FG015|Overall Study|Lack of Efficacy|5
7891492|NCT01858766|12396129|FG016|Overall Study|Lack of Efficacy|2
7891493|NCT01858766|12396130|FG017|Overall Study|Lack of Efficacy|3
7891494|NCT01858766|12396131|FG018|Overall Study|Lack of Efficacy|3
7891495|NCT01858766|12396113|FG000|Overall Study|Lost to Follow-up|0
7891496|NCT01858766|12396114|FG001|Overall Study|Lost to Follow-up|0
7891497|NCT01858766|12396115|FG002|Overall Study|Lost to Follow-up|0
7891498|NCT01858766|12396116|FG003|Overall Study|Lost to Follow-up|0
7891499|NCT01858766|12396117|FG004|Overall Study|Lost to Follow-up|0
7891500|NCT01858766|12396118|FG005|Overall Study|Lost to Follow-up|1
7891501|NCT01858766|12396119|FG006|Overall Study|Lost to Follow-up|0
7891502|NCT01858766|12396120|FG007|Overall Study|Lost to Follow-up|2
7891503|NCT01858766|12396121|FG008|Overall Study|Lost to Follow-up|0
7891504|NCT01858766|12396122|FG009|Overall Study|Lost to Follow-up|0
7891505|NCT01858766|12396123|FG010|Overall Study|Lost to Follow-up|0
7891506|NCT01858766|12396124|FG011|Overall Study|Lost to Follow-up|1
7891507|NCT01858766|12396125|FG012|Overall Study|Lost to Follow-up|0
7891508|NCT01858766|12396126|FG013|Overall Study|Lost to Follow-up|0
7891509|NCT01858766|12396127|FG014|Overall Study|Lost to Follow-up|3
7891510|NCT01858766|12396128|FG015|Overall Study|Lost to Follow-up|1
7891511|NCT01858766|12396129|FG016|Overall Study|Lost to Follow-up|1
7891512|NCT01858766|12396130|FG017|Overall Study|Lost to Follow-up|0
7891513|NCT01858766|12396131|FG018|Overall Study|Lost to Follow-up|1
7891514|NCT01858766|12396113|FG000|Overall Study|Withdrew Consent|0
7891515|NCT01858766|12396114|FG001|Overall Study|Withdrew Consent|0
7891516|NCT01858766|12396115|FG002|Overall Study|Withdrew Consent|0
7891517|NCT01858766|12396116|FG003|Overall Study|Withdrew Consent|0
7891518|NCT01858766|12396117|FG004|Overall Study|Withdrew Consent|0
7891519|NCT01858766|12396118|FG005|Overall Study|Withdrew Consent|0
7891520|NCT01858766|12396119|FG006|Overall Study|Withdrew Consent|0
7891521|NCT01858766|12396120|FG007|Overall Study|Withdrew Consent|0
7891522|NCT01858766|12396121|FG008|Overall Study|Withdrew Consent|0
7891523|NCT01858766|12396122|FG009|Overall Study|Withdrew Consent|0
7891524|NCT01858766|12396123|FG010|Overall Study|Withdrew Consent|0
7891525|NCT01858766|12396124|FG011|Overall Study|Withdrew Consent|1
7891526|NCT01858766|12396125|FG012|Overall Study|Withdrew Consent|0
7891527|NCT01858766|12396126|FG013|Overall Study|Withdrew Consent|0
7891528|NCT01858766|12396127|FG014|Overall Study|Withdrew Consent|0
7891529|NCT01858766|12396128|FG015|Overall Study|Withdrew Consent|0
7891530|NCT01858766|12396129|FG016|Overall Study|Withdrew Consent|0
7891531|NCT01858766|12396130|FG017|Overall Study|Withdrew Consent|0
7891532|NCT01858766|12396131|FG018|Overall Study|Withdrew Consent|0
7891533|NCT01859143|12396181|FG000|Overall Study|Lost to Follow-up|2
7891534|NCT01859143|12396182|FG001|Overall Study|Lost to Follow-up|0
7891535|NCT01859390|12396251|FG000|Overall Study|Insufficient Sputum Collected|1
7891536|NCT01859390|12396252|FG001|Overall Study|Insufficient Sputum Collected|3
7891537|NCT01859390|12396251|FG000|Overall Study|Sample Missing Collection Date|0
7891538|NCT01859390|12396252|FG001|Overall Study|Sample Missing Collection Date|1
7891539|NCT01859390|12396251|FG000|Overall Study|Tube Cracked|0
7891540|NCT01859390|12396252|FG001|Overall Study|Tube Cracked|2
7891541|NCT01859390|12396251|FG000|Overall Study|Shipment Error|0
7891542|NCT01859390|12396252|FG001|Overall Study|Shipment Error|1
7891543|NCT01859403|12396260|FG000|Primary Endpoint Measure|Lost to Follow-up|0
7891544|NCT01859403|12396261|FG001|Primary Endpoint Measure|Lost to Follow-up|2
7891545|NCT01859403|12396260|FG000|Primary Endpoint Measure|Withdrawal by Subject|1
7891546|NCT01859403|12396261|FG001|Primary Endpoint Measure|Withdrawal by Subject|1
7891547|NCT01859403|12396260|FG000|Primary Endpoint Measure|Physician Decision|0
7891548|NCT01859403|12396261|FG001|Primary Endpoint Measure|Physician Decision|1
7891549|NCT01859403|12396260|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6
7891550|NCT01859403|12396261|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8
7891551|NCT01859494|12396267|FG000|Overall Study|Adverse Event|1
7891552|NCT01859507|12396271|FG000|Overall Study|left the country|4
7891553|NCT01859598|12396276|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742
7891554|NCT01859702|12396290|FG000|Overall Study|Protocol deviation|3
7891555|NCT01859702|12396290|FG000|Overall Study|Adverse Event|2
7891556|NCT01859715|12396297|FG000|Overall Study|No 2nd VAS|16
7891557|NCT01859715|12396298|FG001|Overall Study|No 2nd VAS|8
7891558|NCT01859715|12396299|FG002|Overall Study|No 2nd VAS|23
7891559|NCT01859741|12396317|FG000|Overall Study|Death|3
7891560|NCT01859741|12396318|FG001|Overall Study|Death|2
7891561|NCT01859741|12396319|FG002|Overall Study|Death|4
7891562|NCT01859741|12396320|FG003|Overall Study|Death|3
7891563|NCT01859741|12396321|FG004|Overall Study|Death|5
7891564|NCT01859741|12396322|FG005|Overall Study|Death|4
7891565|NCT01859741|12396323|FG006|Overall Study|Death|51
7891566|NCT01859741|12396324|FG007|Overall Study|Death|51
7891567|NCT01859741|12396317|FG000|Overall Study|Lost to Follow-up|0
7891568|NCT01859741|12396318|FG001|Overall Study|Lost to Follow-up|0
7891569|NCT01859741|12396319|FG002|Overall Study|Lost to Follow-up|0
7891570|NCT01859741|12396320|FG003|Overall Study|Lost to Follow-up|0
7891571|NCT01859741|12396321|FG004|Overall Study|Lost to Follow-up|0
7891572|NCT01859741|12396322|FG005|Overall Study|Lost to Follow-up|1
7891573|NCT01859741|12396323|FG006|Overall Study|Lost to Follow-up|0
7891574|NCT01859741|12396324|FG007|Overall Study|Lost to Follow-up|4
7891575|NCT01859741|12396317|FG000|Overall Study|Withdrawal by Subject|0
7891576|NCT01859741|12396318|FG001|Overall Study|Withdrawal by Subject|1
7891577|NCT01859741|12396319|FG002|Overall Study|Withdrawal by Subject|2
7891578|NCT01859741|12396320|FG003|Overall Study|Withdrawal by Subject|0
7891579|NCT01859741|12396321|FG004|Overall Study|Withdrawal by Subject|0
7891580|NCT01859741|12396322|FG005|Overall Study|Withdrawal by Subject|1
7891581|NCT01859741|12396323|FG006|Overall Study|Withdrawal by Subject|1
7891582|NCT01859741|12396324|FG007|Overall Study|Withdrawal by Subject|1
7891583|NCT01859741|12396317|FG000|Overall Study|Study Terminated by Sponsor|0
7891584|NCT01859741|12396318|FG001|Overall Study|Study Terminated by Sponsor|0
7891585|NCT01859741|12396319|FG002|Overall Study|Study Terminated by Sponsor|0
7891586|NCT01859741|12396320|FG003|Overall Study|Study Terminated by Sponsor|0
7891587|NCT01859741|12396321|FG004|Overall Study|Study Terminated by Sponsor|1
7891588|NCT01859741|12396322|FG005|Overall Study|Study Terminated by Sponsor|0
7891589|NCT01859741|12396323|FG006|Overall Study|Study Terminated by Sponsor|16
7891590|NCT01859741|12396324|FG007|Overall Study|Study Terminated by Sponsor|14
7891591|NCT01859741|12396317|FG000|Overall Study|Other|0
7891592|NCT01859741|12396318|FG001|Overall Study|Other|0
7891593|NCT01859741|12396319|FG002|Overall Study|Other|0
7891594|NCT01859741|12396320|FG003|Overall Study|Other|0
7891595|NCT01859741|12396321|FG004|Overall Study|Other|0
7891596|NCT01859741|12396322|FG005|Overall Study|Other|0
7891597|NCT01859741|12396323|FG006|Overall Study|Other|2
7891598|NCT01859741|12396324|FG007|Overall Study|Other|0
7891599|NCT01859793|12396344|FG000|First Intervention (8 Weeks)|Protocol Violation|2
7891600|NCT01859793|12396345|FG001|First Intervention (8 Weeks)|Protocol Violation|0
7891601|NCT01859793|12396344|FG000|First Intervention (8 Weeks)|Adverse Event|1
7891602|NCT01859793|12396345|FG001|First Intervention (8 Weeks)|Adverse Event|0
7891603|NCT01859793|12396344|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
7891604|NCT01859793|12396345|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1
7891605|NCT01859793|12396344|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1
7891606|NCT01859793|12396345|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1
7891607|NCT01859923|12396355|FG000|Overall Study|Adverse Event|0
7891608|NCT01859923|12396356|FG001|Overall Study|Adverse Event|0
7891609|NCT01859923|12396357|FG002|Overall Study|Adverse Event|1
7891610|NCT01859923|12396358|FG003|Overall Study|Adverse Event|1
7891611|NCT01859949|12396373|FG000|Overall Study|Family Matters|0
7891612|NCT01859949|12396374|FG001|Overall Study|Family Matters|1
7891613|NCT01859949|12396373|FG000|Overall Study|Physician Decision|2
7891614|NCT01859949|12396374|FG001|Overall Study|Physician Decision|4
7891615|NCT01859949|12396373|FG000|Overall Study|Withdrawal by Subject|11
7891616|NCT01859949|12396374|FG001|Overall Study|Withdrawal by Subject|10
7891617|NCT01859949|12396373|FG000|Overall Study|Protocol Violation|1
7891618|NCT01859949|12396374|FG001|Overall Study|Protocol Violation|1
7891619|NCT01859949|12396373|FG000|Overall Study|Adverse Event|0
7891620|NCT01859949|12396374|FG001|Overall Study|Adverse Event|1
7891621|NCT01859988|12396386|FG000|Overall Study|Withdrawal by Subject|6
7891622|NCT01859988|12396387|FG001|Overall Study|Withdrawal by Subject|3
7891623|NCT01859988|12396388|FG002|Overall Study|Withdrawal by Subject|4
7891624|NCT01859988|12396389|FG003|Overall Study|Withdrawal by Subject|3
7891625|NCT01859988|12396390|FG004|Overall Study|Withdrawal by Subject|2
7891626|NCT01859988|12396391|FG005|Overall Study|Withdrawal by Subject|2
7891627|NCT01859988|12396386|FG000|Overall Study|Lack of Efficacy|1
7891628|NCT01859988|12396387|FG001|Overall Study|Lack of Efficacy|1
7891629|NCT01859988|12396388|FG002|Overall Study|Lack of Efficacy|5
7891630|NCT01859988|12396389|FG003|Overall Study|Lack of Efficacy|0
7891631|NCT01859988|12396390|FG004|Overall Study|Lack of Efficacy|7
7891632|NCT01859988|12396391|FG005|Overall Study|Lack of Efficacy|9
7891633|NCT01859988|12396386|FG000|Overall Study|Physician Decision|1
7891634|NCT01859988|12396387|FG001|Overall Study|Physician Decision|3
7891635|NCT01859988|12396388|FG002|Overall Study|Physician Decision|1
7891636|NCT01859988|12396389|FG003|Overall Study|Physician Decision|3
7891637|NCT01859988|12396390|FG004|Overall Study|Physician Decision|4
7891638|NCT01859988|12396391|FG005|Overall Study|Physician Decision|1
7891639|NCT01859988|12396386|FG000|Overall Study|Adverse Event|2
7891640|NCT01859988|12396387|FG001|Overall Study|Adverse Event|1
7891641|NCT01859988|12396388|FG002|Overall Study|Adverse Event|3
7891642|NCT01859988|12396389|FG003|Overall Study|Adverse Event|1
7891643|NCT01859988|12396390|FG004|Overall Study|Adverse Event|2
7891644|NCT01859988|12396391|FG005|Overall Study|Adverse Event|2
7891645|NCT01859988|12396386|FG000|Overall Study|Lost to Follow-up|1
7891646|NCT01859988|12396387|FG001|Overall Study|Lost to Follow-up|2
7891647|NCT01859988|12396388|FG002|Overall Study|Lost to Follow-up|3
7891648|NCT01859988|12396389|FG003|Overall Study|Lost to Follow-up|0
7891649|NCT01859988|12396390|FG004|Overall Study|Lost to Follow-up|3
7891650|NCT01859988|12396391|FG005|Overall Study|Lost to Follow-up|2
7891651|NCT01859988|12396386|FG000|Overall Study|Protocol Violation|0
7891652|NCT01859988|12396387|FG001|Overall Study|Protocol Violation|0
7891653|NCT01859988|12396388|FG002|Overall Study|Protocol Violation|1
7891654|NCT01859988|12396389|FG003|Overall Study|Protocol Violation|0
7891655|NCT01859988|12396390|FG004|Overall Study|Protocol Violation|0
7891656|NCT01859988|12396391|FG005|Overall Study|Protocol Violation|0
7891657|NCT01859988|12396386|FG000|Overall Study|Other than specified above|0
7891658|NCT01859988|12396387|FG001|Overall Study|Other than specified above|2
7891659|NCT01859988|12396388|FG002|Overall Study|Other than specified above|11
7891660|NCT01859988|12396389|FG003|Overall Study|Other than specified above|3
7891661|NCT01859988|12396390|FG004|Overall Study|Other than specified above|5
7891662|NCT01859988|12396391|FG005|Overall Study|Other than specified above|3
7891663|NCT01860079|12396407|FG000|Overall Study|Physician Decision|14
7891664|NCT01860079|12396408|FG001|Overall Study|Physician Decision|22
7891665|NCT01860534|12396451|FG000|ROP #1|Needed treatment for ROP|0
7891666|NCT01860534|12396452|FG001|ROP #1|Needed treatment for ROP|1
7891667|NCT01860534|12396451|FG000|ROP #2|discharged prior to ROP #2|1
7891668|NCT01860534|12396452|FG001|ROP #2|discharged prior to ROP #2|0
7891669|NCT01860677|12396489|FG000|Second Intervention (1 Day)|Lost to Follow-up|7
7891670|NCT01860677|12396490|FG001|Second Intervention (1 Day)|Lost to Follow-up|0
7891671|NCT01860703|12396497|FG000|Overall Study|Adverse Event|1
7891672|NCT01860703|12396498|FG001|Overall Study|Adverse Event|4
7891673|NCT01860703|12396499|FG002|Overall Study|Adverse Event|0
7891674|NCT01860703|12396500|FG003|Overall Study|Adverse Event|2
7891675|NCT01860703|12396497|FG000|Overall Study|Withdrawal by Subject|0
7891676|NCT01860703|12396498|FG001|Overall Study|Withdrawal by Subject|1
7891677|NCT01860703|12396499|FG002|Overall Study|Withdrawal by Subject|0
7891678|NCT01860703|12396500|FG003|Overall Study|Withdrawal by Subject|0
7891679|NCT01860703|12396497|FG000|Overall Study|Personal reason|1
7891680|NCT01860703|12396498|FG001|Overall Study|Personal reason|0
7891681|NCT01860703|12396499|FG002|Overall Study|Personal reason|1
7891682|NCT01860703|12396500|FG003|Overall Study|Personal reason|0
7891683|NCT01860846|12396525|FG000|Overall Study|Lost to Follow-up|33
7891684|NCT01860989|12396555|FG000|Overall Study|Unsatisfactory therapeutic|5
7891685|NCT01861522|12396600|FG000|Overall Study|Adverse Event|1
7891686|NCT01861522|12396601|FG001|Overall Study|Adverse Event|0
7891687|NCT01861522|12396600|FG000|Overall Study|Withdrawal by Subject|2
7891688|NCT01861522|12396601|FG001|Overall Study|Withdrawal by Subject|0
7891689|NCT01862029|12396681|FG000|Overall Study|Physician Decision|1
7891690|NCT01862250|12396697|FG000|Overall Study|Adverse Event|4
7891691|NCT01862328|12396708|FG000|Overall Study|Progressive Disease|3
7891692|NCT01862328|12396709|FG001|Overall Study|Progressive Disease|11
7891693|NCT01862328|12396710|FG002|Overall Study|Progressive Disease|5
7891694|NCT01862328|12396711|FG003|Overall Study|Progressive Disease|6
7891695|NCT01862328|12396712|FG004|Overall Study|Progressive Disease|7
7891696|NCT01862328|12396713|FG005|Overall Study|Progressive Disease|4
7891697|NCT01862328|12396714|FG006|Overall Study|Progressive Disease|3
7891698|NCT01862328|12396708|FG000|Overall Study|Adverse Event|0
7891699|NCT01862328|12396709|FG001|Overall Study|Adverse Event|4
7891700|NCT01862328|12396710|FG002|Overall Study|Adverse Event|0
7891701|NCT01862328|12396711|FG003|Overall Study|Adverse Event|1
7891702|NCT01862328|12396712|FG004|Overall Study|Adverse Event|0
7891703|NCT01862328|12396713|FG005|Overall Study|Adverse Event|2
7891704|NCT01862328|12396714|FG006|Overall Study|Adverse Event|4
7891705|NCT01862328|12396708|FG000|Overall Study|Other|0
7891706|NCT01862328|12396709|FG001|Overall Study|Other|2
7891707|NCT01862328|12396710|FG002|Overall Study|Other|1
7891708|NCT01862328|12396711|FG003|Overall Study|Other|0
7891709|NCT01862328|12396712|FG004|Overall Study|Other|4
7891710|NCT01862328|12396713|FG005|Overall Study|Other|0
7891711|NCT01862328|12396714|FG006|Overall Study|Other|1
7891712|NCT01862328|12396708|FG000|Overall Study|Withdrawal by Subject|1
7891713|NCT01862328|12396709|FG001|Overall Study|Withdrawal by Subject|1
7891714|NCT01862328|12396710|FG002|Overall Study|Withdrawal by Subject|0
7891715|NCT01862328|12396711|FG003|Overall Study|Withdrawal by Subject|0
7891716|NCT01862328|12396712|FG004|Overall Study|Withdrawal by Subject|1
7891717|NCT01862328|12396713|FG005|Overall Study|Withdrawal by Subject|1
7891718|NCT01862328|12396714|FG006|Overall Study|Withdrawal by Subject|1
7891719|NCT01862328|12396708|FG000|Overall Study|Symptomatic Deterioration|0
7891720|NCT01862328|12396709|FG001|Overall Study|Symptomatic Deterioration|0
7891721|NCT01862328|12396710|FG002|Overall Study|Symptomatic Deterioration|0
7891722|NCT01862328|12396711|FG003|Overall Study|Symptomatic Deterioration|0
7891723|NCT01862328|12396712|FG004|Overall Study|Symptomatic Deterioration|0
7891724|NCT01862328|12396713|FG005|Overall Study|Symptomatic Deterioration|0
7891725|NCT01862328|12396714|FG006|Overall Study|Symptomatic Deterioration|1
7891726|NCT01862484|12396747|FG000|Overall Study|Lack of Efficacy|1
7891727|NCT01862484|12396748|FG001|Overall Study|Lack of Efficacy|1
7891728|NCT01862484|12396747|FG000|Overall Study|Lost to Follow-up|1
7891729|NCT01862484|12396748|FG001|Overall Study|Lost to Follow-up|2
7891730|NCT01862484|12396747|FG000|Overall Study|Protocol Violation|0
7891731|NCT01862484|12396748|FG001|Overall Study|Protocol Violation|2
7891732|NCT01862484|12396747|FG000|Overall Study|Withdrawal by Subject|0
7891733|NCT01862484|12396748|FG001|Overall Study|Withdrawal by Subject|3
7891734|NCT01862640|12396776|FG000|Overall Study|Adverse Event|4
7891735|NCT01862640|12396777|FG001|Overall Study|Adverse Event|10
7891736|NCT01862640|12396778|FG002|Overall Study|Adverse Event|6
7891737|NCT01862640|12396779|FG003|Overall Study|Adverse Event|8
7891738|NCT01862640|12396776|FG000|Overall Study|Participant Met Withdrawal Criteria|1
7891739|NCT01862640|12396777|FG001|Overall Study|Participant Met Withdrawal Criteria|1
7891740|NCT01862640|12396778|FG002|Overall Study|Participant Met Withdrawal Criteria|2
7891741|NCT01862640|12396779|FG003|Overall Study|Participant Met Withdrawal Criteria|1
7891742|NCT01862640|12396776|FG000|Overall Study|Participant Withdrawn by Investigator|0
7891743|NCT01862640|12396777|FG001|Overall Study|Participant Withdrawn by Investigator|1
7891744|NCT01862640|12396778|FG002|Overall Study|Participant Withdrawn by Investigator|1
7891745|NCT01862640|12396779|FG003|Overall Study|Participant Withdrawn by Investigator|1
7891746|NCT01862640|12396776|FG000|Overall Study|Withdrawal by Subject|2
7891747|NCT01862640|12396777|FG001|Overall Study|Withdrawal by Subject|4
7891748|NCT01862640|12396778|FG002|Overall Study|Withdrawal by Subject|8
7891749|NCT01862640|12396779|FG003|Overall Study|Withdrawal by Subject|5
7891750|NCT01862640|12396776|FG000|Overall Study|Protocol Deviation|0
7891751|NCT01862640|12396777|FG001|Overall Study|Protocol Deviation|0
7891752|NCT01862640|12396778|FG002|Overall Study|Protocol Deviation|1
7891753|NCT01862640|12396779|FG003|Overall Study|Protocol Deviation|0
7891754|NCT01862796|12396791|FG000|Overall Study|Prohibited medications|0
7891755|NCT01862796|12396792|FG001|Overall Study|Prohibited medications|0
7891756|NCT01862796|12396793|FG002|Overall Study|Prohibited medications|1
7891757|NCT01862874|12396803|FG000|Overall Study|Randomized not treated|1
7891758|NCT01862874|12396804|FG001|Overall Study|Randomized not treated|0
7891759|NCT01862874|12396803|FG000|Overall Study|Adverse Event|0
7891760|NCT01862874|12396804|FG001|Overall Study|Adverse Event|3
7891761|NCT01862874|12396803|FG000|Overall Study|Lost to Follow-up|26
7891762|NCT01862874|12396804|FG001|Overall Study|Lost to Follow-up|29
7891763|NCT01862874|12396803|FG000|Overall Study|Physician Decision|5
7891764|NCT01862874|12396804|FG001|Overall Study|Physician Decision|3
7891765|NCT01862874|12396803|FG000|Overall Study|Withdrawn by parent/guardian|1
7891766|NCT01862874|12396804|FG001|Overall Study|Withdrawn by parent/guardian|1
7891767|NCT01862874|12396803|FG000|Overall Study|Withdrawal by Subject|46
7891768|NCT01862874|12396804|FG001|Overall Study|Withdrawal by Subject|40
7891769|NCT01862874|12396803|FG000|Overall Study|Death|0
7891770|NCT01862874|12396804|FG001|Overall Study|Death|1
7891771|NCT01862991|12396813|FG000|Overall Study|Lost to Follow-up|2
7891772|NCT01862991|12396814|FG001|Overall Study|Lost to Follow-up|1
7891773|NCT01862991|12396815|FG002|Overall Study|Lost to Follow-up|1
7891774|NCT01862991|12396813|FG000|Overall Study|Protocol Violation|1
7891775|NCT01862991|12396814|FG001|Overall Study|Protocol Violation|0
7891776|NCT01862991|12396815|FG002|Overall Study|Protocol Violation|0
7891777|NCT01863368|12396848|FG000|Phase I, Day 0 to Day 35|Adverse Event|2
7891778|NCT01863368|12396849|FG001|Phase I, Day 0 to Day 35|Adverse Event|4
7891779|NCT01863368|12396848|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1
7891780|NCT01863368|12396849|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0
7891781|NCT01863368|12396848|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
7891782|NCT01863368|12396849|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
7891783|NCT01863368|12396848|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
7891784|NCT01863368|12396849|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
7891785|NCT01863368|12396848|FG000|Phase II, Day 35 to Day 90|Adverse Event|1
7891786|NCT01863368|12396849|FG001|Phase II, Day 35 to Day 90|Adverse Event|0
7891787|NCT01863368|12396848|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1
7891788|NCT01863368|12396849|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0
7891789|NCT01863433|12396856|FG000|Overall Study|Protocol Violation|1
7891790|NCT01863667|12396875|FG000|Overall Study|Adverse Event|1
7891791|NCT01863667|12396876|FG001|Overall Study|Adverse Event|0
7891792|NCT01863667|12396875|FG000|Overall Study|Study terminated by Sponsor|30
7891793|NCT01863667|12396876|FG001|Overall Study|Study terminated by Sponsor|30
7891794|NCT01863667|12396875|FG000|Overall Study|Withdrawal by Subject|2
7891795|NCT01863667|12396876|FG001|Overall Study|Withdrawal by Subject|2
7891796|NCT01863680|12396882|FG000|Overall Study|Adverse Event|17
7891797|NCT01863680|12396882|FG000|Overall Study|Risk of OHSS|17
7891798|NCT01863680|12396882|FG000|Overall Study|Spontaneous pregnancy|2
7891799|NCT01863680|12396882|FG000|Overall Study|Withdrawal by Subject|1
7891800|NCT01863680|12396882|FG000|Overall Study|Did not undergo IVF/ET|14
7891801|NCT01863680|12396882|FG000|Overall Study|Other|6
7891802|NCT01863732|12396890|FG000|Overall Study|Adverse Event|2
7891803|NCT01863732|12396891|FG001|Overall Study|Adverse Event|0
7891804|NCT01863732|12396892|FG002|Overall Study|Adverse Event|3
7891805|NCT01863732|12396893|FG003|Overall Study|Adverse Event|3
7891806|NCT01863732|12396890|FG000|Overall Study|Lack of Efficacy|1
7891807|NCT01863732|12396891|FG001|Overall Study|Lack of Efficacy|0
7891808|NCT01863732|12396892|FG002|Overall Study|Lack of Efficacy|2
7891809|NCT01863732|12396893|FG003|Overall Study|Lack of Efficacy|1
7891810|NCT01863732|12396890|FG000|Overall Study|Lost to Follow-up|2
7891811|NCT01863732|12396891|FG001|Overall Study|Lost to Follow-up|2
7891812|NCT01863732|12396892|FG002|Overall Study|Lost to Follow-up|1
7891813|NCT01863732|12396893|FG003|Overall Study|Lost to Follow-up|1
7891814|NCT01863732|12396890|FG000|Overall Study|Physician Decision|1
7891815|NCT01863732|12396891|FG001|Overall Study|Physician Decision|0
7891816|NCT01863732|12396892|FG002|Overall Study|Physician Decision|1
7891817|NCT01863732|12396893|FG003|Overall Study|Physician Decision|0
7891818|NCT01863732|12396890|FG000|Overall Study|Pregnancy|0
7891819|NCT01863732|12396891|FG001|Overall Study|Pregnancy|0
7891820|NCT01863732|12396892|FG002|Overall Study|Pregnancy|0
7891821|NCT01863732|12396893|FG003|Overall Study|Pregnancy|1
7891822|NCT01863732|12396890|FG000|Overall Study|Technical problems|0
7891823|NCT01863732|12396891|FG001|Overall Study|Technical problems|1
7891824|NCT01863732|12396892|FG002|Overall Study|Technical problems|1
7891825|NCT01863732|12396893|FG003|Overall Study|Technical problems|0
7891826|NCT01863732|12396890|FG000|Overall Study|Subject/guardian decision|6
7891827|NCT01863732|12396891|FG001|Overall Study|Subject/guardian decision|9
7891828|NCT01863732|12396892|FG002|Overall Study|Subject/guardian decision|3
7891829|NCT01863732|12396893|FG003|Overall Study|Subject/guardian decision|1
7891830|NCT01863732|12396890|FG000|Overall Study|Death|1
7891831|NCT01863732|12396891|FG001|Overall Study|Death|0
7891832|NCT01863732|12396892|FG002|Overall Study|Death|0
7891833|NCT01863732|12396893|FG003|Overall Study|Death|1
7891834|NCT01863758|12396902|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
7891835|NCT01863758|12396902|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1
7891836|NCT01863771|12396906|FG000|Induction Phase|Adverse Event|9
7891837|NCT01863771|12396907|FG001|Induction Phase|Adverse Event|0
7891838|NCT01863771|12396908|FG002|Induction Phase|Adverse Event|0
7891839|NCT01863771|12396909|FG003|Induction Phase|Adverse Event|0
7891840|NCT01863771|12396906|FG000|Induction Phase|Lack of Efficacy|10
7891841|NCT01863771|12396907|FG001|Induction Phase|Lack of Efficacy|0
7891842|NCT01863771|12396908|FG002|Induction Phase|Lack of Efficacy|0
7891843|NCT01863771|12396909|FG003|Induction Phase|Lack of Efficacy|0
7891844|NCT01863771|12396906|FG000|Induction Phase|Withdrawal by Subject|2
7891845|NCT01863771|12396907|FG001|Induction Phase|Withdrawal by Subject|0
7891846|NCT01863771|12396908|FG002|Induction Phase|Withdrawal by Subject|0
7891847|NCT01863771|12396909|FG003|Induction Phase|Withdrawal by Subject|0
7891848|NCT01863771|12396906|FG000|Maintenance Phase|Adverse Event|0
7891849|NCT01863771|12396907|FG001|Maintenance Phase|Adverse Event|0
7891850|NCT01863771|12396908|FG002|Maintenance Phase|Adverse Event|1
7891851|NCT01863771|12396909|FG003|Maintenance Phase|Adverse Event|1
7891852|NCT01863771|12396906|FG000|Maintenance Phase|Lack of Efficacy|0
7891853|NCT01863771|12396907|FG001|Maintenance Phase|Lack of Efficacy|3
7891854|NCT01863771|12396908|FG002|Maintenance Phase|Lack of Efficacy|7
7891855|NCT01863771|12396909|FG003|Maintenance Phase|Lack of Efficacy|38
7891856|NCT01863771|12396906|FG000|Maintenance Phase|Physician Decision|0
7891857|NCT01863771|12396907|FG001|Maintenance Phase|Physician Decision|0
7891858|NCT01863771|12396908|FG002|Maintenance Phase|Physician Decision|2
7891859|NCT01863771|12396909|FG003|Maintenance Phase|Physician Decision|1
7891860|NCT01863771|12396906|FG000|Maintenance Phase|Pregnancy|0
7891861|NCT01863771|12396907|FG001|Maintenance Phase|Pregnancy|1
7891862|NCT01863771|12396908|FG002|Maintenance Phase|Pregnancy|0
7891863|NCT01863771|12396909|FG003|Maintenance Phase|Pregnancy|0
7891864|NCT01863771|12396906|FG000|Maintenance Phase|Withdrawal by Subject|0
7891865|NCT01863771|12396907|FG001|Maintenance Phase|Withdrawal by Subject|1
7891866|NCT01863771|12396908|FG002|Maintenance Phase|Withdrawal by Subject|2
7891867|NCT01863771|12396909|FG003|Maintenance Phase|Withdrawal by Subject|3
7891868|NCT01863849|12396919|FG000|Overall Study|Lost to Follow-up|1
7891869|NCT01863849|12396920|FG001|Overall Study|Lost to Follow-up|0
7891870|NCT01863953|12396930|FG000|Overall Study|Adverse Event|0
7891871|NCT01863953|12396931|FG001|Overall Study|Adverse Event|0
7891872|NCT01863953|12396932|FG002|Overall Study|Adverse Event|1
7891873|NCT01864005|12396942|FG000|Overall Study|Protocol Violation|0
7891874|NCT01864005|12396943|FG001|Overall Study|Protocol Violation|1
7891875|NCT01864005|12396942|FG000|Overall Study|Withdrawal by Subject|0
7891876|NCT01864005|12396943|FG001|Overall Study|Withdrawal by Subject|1
7891877|NCT01864005|12396942|FG000|Overall Study|Incorrect enrolment|1
7891878|NCT01864005|12396943|FG001|Overall Study|Incorrect enrolment|0
7891879|NCT01864005|12396942|FG000|Overall Study|Disease need|1
7891880|NCT01864005|12396943|FG001|Overall Study|Disease need|1
7891881|NCT01864005|12396942|FG000|Overall Study|Need GP IIb/IIIa|1
7891882|NCT01864005|12396943|FG001|Overall Study|Need GP IIb/IIIa|3
7891883|NCT01864148|12396954|FG000|Overall Study|Other|2
7891884|NCT01864148|12396955|FG001|Overall Study|Other|1
7891885|NCT01864148|12396956|FG002|Overall Study|Other|1
7891886|NCT01864148|12396957|FG003|Overall Study|Other|3
7891887|NCT01864148|12396958|FG004|Overall Study|Other|1
7891888|NCT01864148|12396954|FG000|Overall Study|Death|0
7891889|NCT01864148|12396955|FG001|Overall Study|Death|0
7891890|NCT01864148|12396956|FG002|Overall Study|Death|0
7891891|NCT01864148|12396957|FG003|Overall Study|Death|1
7891892|NCT01864148|12396958|FG004|Overall Study|Death|0
7891893|NCT01864148|12396954|FG000|Overall Study|Investigator Decision|5
7891894|NCT01864148|12396955|FG001|Overall Study|Investigator Decision|0
7891895|NCT01864148|12396956|FG002|Overall Study|Investigator Decision|0
7891896|NCT01864148|12396957|FG003|Overall Study|Investigator Decision|4
7891897|NCT01864148|12396958|FG004|Overall Study|Investigator Decision|6
7891898|NCT01864148|12396954|FG000|Overall Study|Withdrawal by Subject|9
7891899|NCT01864148|12396955|FG001|Overall Study|Withdrawal by Subject|2
7891900|NCT01864148|12396956|FG002|Overall Study|Withdrawal by Subject|6
7891901|NCT01864148|12396957|FG003|Overall Study|Withdrawal by Subject|8
7891902|NCT01864148|12396958|FG004|Overall Study|Withdrawal by Subject|8
7891903|NCT01864148|12396954|FG000|Overall Study|Lost to Follow-up|0
7891904|NCT01864148|12396955|FG001|Overall Study|Lost to Follow-up|0
7891905|NCT01864148|12396956|FG002|Overall Study|Lost to Follow-up|0
7891906|NCT01864148|12396957|FG003|Overall Study|Lost to Follow-up|2
7891907|NCT01864148|12396958|FG004|Overall Study|Lost to Follow-up|1
7891908|NCT01864148|12396954|FG000|Overall Study|Adverse Event|4
7891909|NCT01864148|12396955|FG001|Overall Study|Adverse Event|2
7891910|NCT01864148|12396956|FG002|Overall Study|Adverse Event|4
7891911|NCT01864148|12396957|FG003|Overall Study|Adverse Event|7
7891912|NCT01864148|12396958|FG004|Overall Study|Adverse Event|7
7891913|NCT01864148|12396954|FG000|Overall Study|Not Dosed|0
7891914|NCT01864148|12396955|FG001|Overall Study|Not Dosed|0
7891915|NCT01864148|12396956|FG002|Overall Study|Not Dosed|0
7891916|NCT01864148|12396957|FG003|Overall Study|Not Dosed|1
7891917|NCT01864148|12396958|FG004|Overall Study|Not Dosed|0
7891918|NCT01864174|12396977|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
7891919|NCT01864174|12396978|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
7891920|NCT01864174|12396977|FG000|Double Blind - Compliant Randomized|Adverse Event|6
7891921|NCT01864174|12396978|FG001|Double Blind - Compliant Randomized|Adverse Event|1
7891922|NCT01864174|12396977|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
7891923|NCT01864174|12396978|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
7891924|NCT01864174|12396977|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
7891925|NCT01864174|12396978|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
7891926|NCT01864174|12396977|FG000|Double Blind - Compliant Randomized|Death|1
7891927|NCT01864174|12396978|FG001|Double Blind - Compliant Randomized|Death|0
7891928|NCT01864174|12396977|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3
7891929|NCT01864174|12396978|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10
7891930|NCT01864174|12396977|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1
7891931|NCT01864174|12396978|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0
7891932|NCT01864174|12396977|FG000|Double Blind - Compliant Randomized|Other|6
7891933|NCT01864174|12396978|FG001|Double Blind - Compliant Randomized|Other|10
7891934|NCT01864174|12396977|FG000|Off Treatment Follow-Up|Other|2
7891935|NCT01864174|12396978|FG001|Off Treatment Follow-Up|Other|0
7891936|NCT01864174|12396977|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1
7891937|NCT01864174|12396978|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0
7891938|NCT01864200|12396986|FG000|Overall Study|Lost to Follow-up|1
7891939|NCT01864200|12396987|FG001|Overall Study|Lost to Follow-up|3
7891940|NCT01864200|12396986|FG000|Overall Study|Protocol Violation|1
7891941|NCT01864200|12396987|FG001|Overall Study|Protocol Violation|0
7891942|NCT01864291|12396993|FG000|Overall Study|need for revision surgery|2
7891943|NCT01864525|12397008|FG000|Overall Study|Adverse Event|1
7891944|NCT01864525|12397009|FG001|Overall Study|Adverse Event|0
7891945|NCT01864564|12397021|FG000|Overall Study|Lost to Follow-up|17
7891946|NCT01864564|12397022|FG001|Overall Study|Lost to Follow-up|23
7891947|NCT01864564|12397021|FG000|Overall Study|Withdrawal by Subject|20
7891948|NCT01864564|12397022|FG001|Overall Study|Withdrawal by Subject|11
7891949|NCT01864564|12397021|FG000|Overall Study|Protocol Violation|0
7891950|NCT01864564|12397022|FG001|Overall Study|Protocol Violation|27
7891951|NCT01864564|12397021|FG000|Overall Study|not reported|0
7891952|NCT01864564|12397022|FG001|Overall Study|not reported|34
7891953|NCT01865084|12397031|FG000|Double Blind Period (DB)|Adverse Event|2
7891954|NCT01865084|12397032|FG001|Double Blind Period (DB)|Adverse Event|2
7891955|NCT01865084|12397033|FG002|Double Blind Period (DB)|Adverse Event|1
7891956|NCT01865084|12397031|FG000|Double Blind Period (DB)|Protocol Violation|0
7891957|NCT01865084|12397032|FG001|Double Blind Period (DB)|Protocol Violation|0
7891958|NCT01865084|12397033|FG002|Double Blind Period (DB)|Protocol Violation|1
7891959|NCT01865084|12397031|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
7891960|NCT01865084|12397032|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
7891961|NCT01865084|12397033|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
7891962|NCT01865084|12397031|FG000|Double Blind Period (DB)|Withdrawal by Subject|1
7891963|NCT01865084|12397032|FG001|Double Blind Period (DB)|Withdrawal by Subject|0
7891964|NCT01865084|12397033|FG002|Double Blind Period (DB)|Withdrawal by Subject|0
7891965|NCT01865084|12397031|FG000|Open Label Extension (OLE) Period|Adverse Event|0
7891966|NCT01865084|12397032|FG001|Open Label Extension (OLE) Period|Adverse Event|0
7891967|NCT01865084|12397033|FG002|Open Label Extension (OLE) Period|Adverse Event|1
7891968|NCT01865084|12397031|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0
7891969|NCT01865084|12397032|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0
7891970|NCT01865084|12397033|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2
7891971|NCT01865084|12397031|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0
7891972|NCT01865084|12397032|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1
7891973|NCT01865084|12397033|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0
7891974|NCT01865084|12397031|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
7968350|NCT03701516|12525847|FG000|Period 1|Lost to Follow-up|0
7891975|NCT01865084|12397032|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
7891976|NCT01865084|12397033|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
7891977|NCT01865084|12397031|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0
7891978|NCT01865084|12397032|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2
7891979|NCT01865084|12397033|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2
7891980|NCT01865448|12397047|FG000|Overall Study|Adverse Event|1
7891981|NCT01865448|12397048|FG001|Overall Study|Adverse Event|1
7891982|NCT01865448|12397047|FG000|Overall Study|Pregnancy|0
7891983|NCT01865448|12397048|FG001|Overall Study|Pregnancy|1
7891984|NCT01865448|12397047|FG000|Overall Study|dropout unrelated to study|1
7891985|NCT01865448|12397048|FG001|Overall Study|dropout unrelated to study|1
7891986|NCT01865487|12397061|FG000|Overall Study|Lost to Follow-up|0
7891987|NCT01865487|12397062|FG001|Overall Study|Lost to Follow-up|0
7891988|NCT01865487|12397063|FG002|Overall Study|Lost to Follow-up|0
7891989|NCT01865487|12397064|FG003|Overall Study|Lost to Follow-up|1
7891990|NCT01865487|12397065|FG004|Overall Study|Lost to Follow-up|0
7891991|NCT01865487|12397066|FG005|Overall Study|Lost to Follow-up|0
7891992|NCT01865487|12397067|FG006|Overall Study|Lost to Follow-up|1
7891993|NCT01865487|12397068|FG007|Overall Study|Lost to Follow-up|0
7891994|NCT01865487|12397069|FG008|Overall Study|Lost to Follow-up|0
7891995|NCT01865487|12397070|FG009|Overall Study|Lost to Follow-up|0
7891996|NCT01865487|12397061|FG000|Overall Study|Withdrawal by Subject|0
7891997|NCT01865487|12397062|FG001|Overall Study|Withdrawal by Subject|0
7891998|NCT01865487|12397063|FG002|Overall Study|Withdrawal by Subject|0
7891999|NCT01865487|12397064|FG003|Overall Study|Withdrawal by Subject|0
7892000|NCT01865487|12397065|FG004|Overall Study|Withdrawal by Subject|1
7892001|NCT01865487|12397066|FG005|Overall Study|Withdrawal by Subject|0
7892002|NCT01865487|12397067|FG006|Overall Study|Withdrawal by Subject|0
7892003|NCT01865487|12397068|FG007|Overall Study|Withdrawal by Subject|0
7892004|NCT01865487|12397069|FG008|Overall Study|Withdrawal by Subject|0
7892005|NCT01865487|12397070|FG009|Overall Study|Withdrawal by Subject|0
7892006|NCT01865552|12397104|FG000|Period 1|Adverse Event|1
7892007|NCT01865552|12397105|FG001|Period 1|Adverse Event|0
7892008|NCT01865552|12397106|FG002|Period 1|Adverse Event|0
7892009|NCT01865552|12397107|FG003|Period 1|Adverse Event|1
7892010|NCT01865552|12397108|FG004|Period 1|Adverse Event|1
7892011|NCT01865552|12397109|FG005|Period 1|Adverse Event|1
7892012|NCT01865552|12397104|FG000|Period 1|Pathological lab|0
7892013|NCT01865552|12397105|FG001|Period 1|Pathological lab|0
7892014|NCT01865552|12397106|FG002|Period 1|Pathological lab|0
7892015|NCT01865552|12397107|FG003|Period 1|Pathological lab|0
7892016|NCT01865552|12397108|FG004|Period 1|Pathological lab|1
7892017|NCT01865552|12397109|FG005|Period 1|Pathological lab|0
7892018|NCT01865552|12397104|FG000|Period 1|Other|0
7892019|NCT01865552|12397105|FG001|Period 1|Other|0
7892020|NCT01865552|12397106|FG002|Period 1|Other|0
7892021|NCT01865552|12397107|FG003|Period 1|Other|0
7892022|NCT01865552|12397108|FG004|Period 1|Other|1
7892023|NCT01865552|12397109|FG005|Period 1|Other|0
7892024|NCT01865747|12397129|FG000|Overall Study (ITT)|Adverse Event|32
7892025|NCT01865747|12397130|FG001|Overall Study (ITT)|Adverse Event|31
7892026|NCT01865747|12397129|FG000|Overall Study (ITT)|Clinical Deterioration|29
7892027|NCT01865747|12397130|FG001|Overall Study (ITT)|Clinical Deterioration|50
7892028|NCT01865747|12397129|FG000|Overall Study (ITT)|Lack of Efficacy|3
7892029|NCT01865747|12397130|FG001|Overall Study (ITT)|Lack of Efficacy|0
7892030|NCT01865747|12397129|FG000|Overall Study (ITT)|Protocol Violation|1
7892031|NCT01865747|12397130|FG001|Overall Study (ITT)|Protocol Violation|1
7892032|NCT01865747|12397129|FG000|Overall Study (ITT)|Physician Decision|5
7892033|NCT01865747|12397130|FG001|Overall Study (ITT)|Physician Decision|2
7892034|NCT01865747|12397129|FG000|Overall Study (ITT)|Withdrawal by Subject|6
7892035|NCT01865747|12397130|FG001|Overall Study (ITT)|Withdrawal by Subject|11
7892036|NCT01865747|12397129|FG000|Overall Study (ITT)|Sponsor Decision|0
7892037|NCT01865747|12397130|FG001|Overall Study (ITT)|Sponsor Decision|1
7892038|NCT01865747|12397129|FG000|Overall Study (ITT)|Progressive Disease|122
7892039|NCT01865747|12397130|FG001|Overall Study (ITT)|Progressive Disease|158
7892040|NCT01865747|12397129|FG000|Overall Study (ITT)|Reason Not Provided|0
7892041|NCT01865747|12397130|FG001|Overall Study (ITT)|Reason Not Provided|1
7892042|NCT01865747|12397129|FG000|Primary Intent to Treat (PITT)|Adverse Event|21
7892043|NCT01865747|12397130|FG001|Primary Intent to Treat (PITT)|Adverse Event|20
7892044|NCT01865747|12397129|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18
7892045|NCT01865747|12397130|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29
7892046|NCT01865747|12397129|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2
7892047|NCT01865747|12397130|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0
7892048|NCT01865747|12397129|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1
7892049|NCT01865747|12397130|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1
7892050|NCT01865747|12397129|FG000|Primary Intent to Treat (PITT)|Physician Decision|4
7892051|NCT01865747|12397130|FG001|Primary Intent to Treat (PITT)|Physician Decision|2
7892052|NCT01865747|12397129|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
7892053|NCT01865747|12397130|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
7892054|NCT01865747|12397129|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82
7892055|NCT01865747|12397130|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92
7892056|NCT01865747|12397129|FG000|Primary Intent to Treat (PITT)|Other|0
7892057|NCT01865747|12397130|FG001|Primary Intent to Treat (PITT)|Other|1
7892058|NCT01866098|12397139|FG000|Overall Study|Lost to Follow-up|11
7892059|NCT01866098|12397140|FG001|Overall Study|Lost to Follow-up|18
7892060|NCT01866098|12397141|FG002|Overall Study|Lost to Follow-up|13
7892061|NCT01866098|12397139|FG000|Overall Study|Physician Decision|0
7892062|NCT01866098|12397140|FG001|Overall Study|Physician Decision|1
7892063|NCT01866098|12397141|FG002|Overall Study|Physician Decision|2
7892064|NCT01866098|12397139|FG000|Overall Study|Adverse Event|1
7892065|NCT01866098|12397140|FG001|Overall Study|Adverse Event|5
7892066|NCT01866098|12397141|FG002|Overall Study|Adverse Event|4
7892067|NCT01866098|12397139|FG000|Overall Study|Protocol Violation|1
7892068|NCT01866098|12397140|FG001|Overall Study|Protocol Violation|0
7892069|NCT01866098|12397141|FG002|Overall Study|Protocol Violation|0
7892070|NCT01866098|12397139|FG000|Overall Study|Withdrawal by Subject|1
7892071|NCT01866098|12397140|FG001|Overall Study|Withdrawal by Subject|2
7892072|NCT01866098|12397141|FG002|Overall Study|Withdrawal by Subject|0
7968351|NCT03701516|12525848|FG001|Period 1|Lost to Follow-up|1
7968352|NCT03701516|12525847|FG000|Period 1|Adverse Event|0
7968353|NCT03701516|12525848|FG001|Period 1|Adverse Event|2
7968354|NCT03701516|12525847|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2
7968355|NCT03701516|12525848|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0
7968356|NCT03701516|12525847|FG000|Period 1|Non Compliance to Protocol|2
7968357|NCT03701516|12525848|FG001|Period 1|Non Compliance to Protocol|1
7968358|NCT03701516|12525847|FG000|Period 1|Withdrawal by Subject|0
7968359|NCT03701516|12525848|FG001|Period 1|Withdrawal by Subject|1
7968360|NCT03701516|12525847|FG000|Period 2|failed to meet all eligibility creiteria|1
7968361|NCT03701516|12525848|FG001|Period 2|failed to meet all eligibility creiteria|0
7968362|NCT03701516|12525847|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0
7968363|NCT03701516|12525848|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1
7968364|NCT03650556|12525854|FG000|Overall Study|Death|2
7968365|NCT03650556|12525854|FG000|Overall Study|Withdrawal by Subject|20
7968366|NCT03650556|12525854|FG000|Overall Study|Physician Decision|2
7968367|NCT03650556|12525854|FG000|Overall Study|Lost to Follow-up|8
7968368|NCT03650556|12525854|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4
7892073|NCT01866098|12397139|FG000|Overall Study|Unrelated Hospitalization|2
7892074|NCT01866098|12397140|FG001|Overall Study|Unrelated Hospitalization|0
7892075|NCT01866098|12397141|FG002|Overall Study|Unrelated Hospitalization|1
7892076|NCT01866098|12397139|FG000|Overall Study|Non-compliance|1
7892077|NCT01866098|12397140|FG001|Overall Study|Non-compliance|0
7892078|NCT01866098|12397141|FG002|Overall Study|Non-compliance|1
7892079|NCT01866098|12397139|FG000|Overall Study|Pregnancy|2
7892080|NCT01866098|12397140|FG001|Overall Study|Pregnancy|0
7892081|NCT01866098|12397141|FG002|Overall Study|Pregnancy|0
7892082|NCT01866098|12397139|FG000|Overall Study|Death|0
7892083|NCT01866098|12397140|FG001|Overall Study|Death|1
7892084|NCT01866098|12397141|FG002|Overall Study|Death|0
7962991|NCT02717195|12517438|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9
7962992|NCT02717195|12517439|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2
7962993|NCT02717195|12517435|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
7962994|NCT02717195|12517436|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
7962995|NCT02717195|12517437|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4
7962996|NCT02717195|12517438|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3
7962997|NCT02717195|12517439|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2
7962998|NCT02717195|12517435|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0
7962999|NCT02717195|12517436|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0
7963000|NCT02717195|12517437|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1
7963001|NCT02717195|12517438|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0
7963002|NCT02717195|12517439|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1
7963003|NCT02717195|12517435|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
7963004|NCT02717195|12517436|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
7963005|NCT02717195|12517437|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14
7963006|NCT02717195|12517438|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13
7963007|NCT02717195|12517439|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8
7963008|NCT02717195|12517435|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
7963009|NCT02717195|12517436|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
7963010|NCT02717195|12517437|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
7963011|NCT02717195|12517438|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3
7963012|NCT02717195|12517439|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2
7963013|NCT02717195|12517435|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7963014|NCT02717195|12517436|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7963015|NCT02717195|12517437|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1
7963016|NCT02717195|12517438|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7963017|NCT02717195|12517439|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7963018|NCT02717195|12517435|FG000|Double-blind Treatment (DBT) Period|Patient decision|0
7963019|NCT02717195|12517436|FG001|Double-blind Treatment (DBT) Period|Patient decision|0
7963020|NCT02717195|12517437|FG002|Double-blind Treatment (DBT) Period|Patient decision|0
7963021|NCT02717195|12517438|FG003|Double-blind Treatment (DBT) Period|Patient decision|2
7963022|NCT02717195|12517439|FG004|Double-blind Treatment (DBT) Period|Patient decision|2
7892085|NCT01866293|12397165|FG000|Overall Study|Adverse Event|2
7892086|NCT01866319|12397201|FG000|Overall Study|Adverse Event|12
7892087|NCT01866319|12397202|FG001|Overall Study|Adverse Event|5
7892088|NCT01866319|12397203|FG002|Overall Study|Adverse Event|9
7892089|NCT01866319|12397201|FG000|Overall Study|Clinical progression|3
7892090|NCT01866319|12397202|FG001|Overall Study|Clinical progression|2
7892091|NCT01866319|12397203|FG002|Overall Study|Clinical progression|2
7892092|NCT01866319|12397201|FG000|Overall Study|Death|153
7892093|NCT01866319|12397202|FG001|Overall Study|Death|154
7892094|NCT01866319|12397203|FG002|Overall Study|Death|147
7892095|NCT01866319|12397201|FG000|Overall Study|Lost to Follow-up|6
7892096|NCT01866319|12397202|FG001|Overall Study|Lost to Follow-up|3
7892097|NCT01866319|12397203|FG002|Overall Study|Lost to Follow-up|8
7892098|NCT01866319|12397201|FG000|Overall Study|Physician Decision|1
7892099|NCT01866319|12397202|FG001|Overall Study|Physician Decision|0
7892100|NCT01866319|12397203|FG002|Overall Study|Physician Decision|1
7892101|NCT01866319|12397201|FG000|Overall Study|Protocol Violation|0
7892102|NCT01866319|12397202|FG001|Overall Study|Protocol Violation|0
7892103|NCT01866319|12397203|FG002|Overall Study|Protocol Violation|1
7892104|NCT01866319|12397201|FG000|Overall Study|Withdrawal by Subject|32
7892105|NCT01866319|12397202|FG001|Overall Study|Withdrawal by Subject|14
7892106|NCT01866319|12397203|FG002|Overall Study|Withdrawal by Subject|12
7892107|NCT01866423|12397218|FG000|Overall Study|Lack of Efficacy|3
7892108|NCT01866423|12397218|FG000|Overall Study|Sponsor Decision|1
7892109|NCT01866826|12397226|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1
7892110|NCT01866826|12397227|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0
7892111|NCT01866826|12397226|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0
7892112|NCT01866826|12397227|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2
7892113|NCT01866826|12397226|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0
7892114|NCT01866826|12397227|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1
7892115|NCT01866917|12397239|FG000|Overall Study|Pharmacist stopped dispensing treatment|4
7892116|NCT01866917|12397240|FG001|Overall Study|Pharmacist stopped dispensing treatment|6
7892117|NCT01867008|12397258|FG000|Overall Study|Withdrawal by Subject|1
7892118|NCT01867021|12397264|FG000|Overall Study|Adverse Event|0
7892119|NCT01867021|12397265|FG001|Overall Study|Adverse Event|1
7892120|NCT01867021|12397264|FG000|Overall Study|Not Eligible|0
7892121|NCT01867021|12397265|FG001|Overall Study|Not Eligible|1
7892122|NCT01867021|12397264|FG000|Overall Study|Death|1
7892123|NCT01867021|12397265|FG001|Overall Study|Death|0
7892124|NCT01867021|12397264|FG000|Overall Study|Lost to Follow-up|0
7892125|NCT01867021|12397265|FG001|Overall Study|Lost to Follow-up|2
7892126|NCT01867021|12397264|FG000|Overall Study|Withdrawal by Subject|1
7892127|NCT01867021|12397265|FG001|Overall Study|Withdrawal by Subject|6
7892128|NCT01867047|12397278|FG000|Overall Study|Lost to Follow-up|3
7892129|NCT01867047|12397279|FG001|Overall Study|Lost to Follow-up|3
7892130|NCT01867047|12397278|FG000|Overall Study|Withdrawal by Subject|2
7892131|NCT01867047|12397279|FG001|Overall Study|Withdrawal by Subject|0
7892132|NCT01867047|12397278|FG000|Overall Study|Physician Decision|2
7892133|NCT01867047|12397279|FG001|Overall Study|Physician Decision|0
7892134|NCT01867047|12397278|FG000|Overall Study|surgery not indicated in protocol|1
7892135|NCT01867047|12397279|FG001|Overall Study|surgery not indicated in protocol|2
7892136|NCT01867086|12397289|FG000|Overall Study|Disease Progression|1
7892137|NCT01867216|12397309|FG000|Overall Study|Withdrawal by Subject|2
7892138|NCT01867216|12397310|FG001|Overall Study|Withdrawal by Subject|0
7892139|NCT01867216|12397311|FG002|Overall Study|Withdrawal by Subject|0
7892140|NCT01867216|12397312|FG003|Overall Study|Withdrawal by Subject|0
7892141|NCT01867216|12397313|FG004|Overall Study|Withdrawal by Subject|1
7892142|NCT01867216|12397314|FG005|Overall Study|Withdrawal by Subject|0
7892143|NCT01867216|12397315|FG006|Overall Study|Withdrawal by Subject|1
7892144|NCT01867216|12397309|FG000|Overall Study|Physician Decision|1
7892145|NCT01867216|12397310|FG001|Overall Study|Physician Decision|0
7892146|NCT01867216|12397311|FG002|Overall Study|Physician Decision|0
7892147|NCT01867216|12397312|FG003|Overall Study|Physician Decision|0
7892148|NCT01867216|12397313|FG004|Overall Study|Physician Decision|0
7892149|NCT01867216|12397314|FG005|Overall Study|Physician Decision|0
7892150|NCT01867216|12397315|FG006|Overall Study|Physician Decision|0
7892151|NCT01867216|12397309|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1
7892152|NCT01867216|12397310|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0
7892153|NCT01867216|12397311|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0
7892154|NCT01867216|12397312|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0
7892155|NCT01867216|12397313|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0
7892156|NCT01867216|12397314|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0
7892157|NCT01867216|12397315|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0
7892158|NCT01867294|12397341|FG000|Overall Study|Withdrawal by Subject|1
7892159|NCT01867294|12397342|FG001|Overall Study|Withdrawal by Subject|1
7892160|NCT01867294|12397343|FG002|Overall Study|Withdrawal by Subject|0
7892161|NCT01867294|12397344|FG003|Overall Study|Withdrawal by Subject|0
7892162|NCT01867307|12397354|FG000|Overall Study|Protocol Violation|2
7892163|NCT01867307|12397355|FG001|Overall Study|Protocol Violation|0
7892164|NCT01867307|12397354|FG000|Overall Study|Other Adverse Event|1
7892165|NCT01867307|12397355|FG001|Overall Study|Other Adverse Event|3
7892166|NCT01867424|12397363|FG000|Overall Study|Patient noncompliance|2
7892167|NCT01867424|12397364|FG001|Overall Study|Patient noncompliance|1
7892168|NCT01867658|12397392|FG000|Overall Study|Withdrawal by Subject|6
7892169|NCT01867658|12397392|FG000|Overall Study|Death|2
7892170|NCT01867658|12397392|FG000|Overall Study|Subject could not be contacted|1
7892171|NCT01867671|12397398|FG000|Overall Study|Adverse Event|5
7892172|NCT01867671|12397399|FG001|Overall Study|Adverse Event|3
7892173|NCT01867671|12397398|FG000|Overall Study|Anaphylaxis|0
7892174|NCT01867671|12397399|FG001|Overall Study|Anaphylaxis|1
7892175|NCT01867671|12397398|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2
7892176|NCT01867671|12397399|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0
7892177|NCT01867671|12397398|FG000|Overall Study|Lost to Follow-up|0
7892178|NCT01867671|12397399|FG001|Overall Study|Lost to Follow-up|1
7892179|NCT01867671|12397398|FG000|Overall Study|Non-compliance with Study Drug|1
7892180|NCT01867671|12397399|FG001|Overall Study|Non-compliance with Study Drug|2
7892181|NCT01867671|12397398|FG000|Overall Study|Withdrawal by Subject|21
7892182|NCT01867671|12397399|FG001|Overall Study|Withdrawal by Subject|21
7892183|NCT01867710|12397409|FG000|Overall Study|Death|25
7892184|NCT01867710|12397410|FG001|Overall Study|Death|15
7892185|NCT01867710|12397411|FG002|Overall Study|Death|27
7892186|NCT01867710|12397412|FG003|Overall Study|Death|20
7892187|NCT01867710|12397409|FG000|Overall Study|Lost to Follow-up|3
7892188|NCT01867710|12397410|FG001|Overall Study|Lost to Follow-up|4
7892189|NCT01867710|12397411|FG002|Overall Study|Lost to Follow-up|3
7892190|NCT01867710|12397412|FG003|Overall Study|Lost to Follow-up|2
7892191|NCT01867710|12397409|FG000|Overall Study|Withdrawal of consent|2
7892192|NCT01867710|12397410|FG001|Overall Study|Withdrawal of consent|5
7892193|NCT01867710|12397411|FG002|Overall Study|Withdrawal of consent|1
7892194|NCT01867710|12397412|FG003|Overall Study|Withdrawal of consent|2
7892195|NCT01867710|12397409|FG000|Overall Study|Study Terminated by Sponsor|9
7892196|NCT01867710|12397410|FG001|Overall Study|Study Terminated by Sponsor|13
7892197|NCT01867710|12397411|FG002|Overall Study|Study Terminated by Sponsor|8
7892198|NCT01867710|12397412|FG003|Overall Study|Study Terminated by Sponsor|16
7892199|NCT01867710|12397409|FG000|Overall Study|Biochemical progression|0
7892200|NCT01867710|12397410|FG001|Overall Study|Biochemical progression|1
7892201|NCT01867710|12397411|FG002|Overall Study|Biochemical progression|0
7892202|NCT01867710|12397412|FG003|Overall Study|Biochemical progression|0
7892203|NCT01867710|12397409|FG000|Overall Study|Clinical progression|0
7892204|NCT01867710|12397410|FG001|Overall Study|Clinical progression|0
7892205|NCT01867710|12397411|FG002|Overall Study|Clinical progression|1
7892206|NCT01867710|12397412|FG003|Overall Study|Clinical progression|0
7892207|NCT01867710|12397409|FG000|Overall Study|Disease progression|1
7892208|NCT01867710|12397410|FG001|Overall Study|Disease progression|0
7892209|NCT01867710|12397411|FG002|Overall Study|Disease progression|0
7892210|NCT01867710|12397412|FG003|Overall Study|Disease progression|0
7892211|NCT01867710|12397409|FG000|Overall Study|Patient decision|0
7892212|NCT01867710|12397410|FG001|Overall Study|Patient decision|0
7892213|NCT01867710|12397411|FG002|Overall Study|Patient decision|0
7892214|NCT01867710|12397412|FG003|Overall Study|Patient decision|1
7892215|NCT01867710|12397409|FG000|Overall Study|Patient to follow subsequent treatment|0
7892216|NCT01867710|12397410|FG001|Overall Study|Patient to follow subsequent treatment|1
7892217|NCT01867710|12397411|FG002|Overall Study|Patient to follow subsequent treatment|0
7892218|NCT01867710|12397412|FG003|Overall Study|Patient to follow subsequent treatment|0
7892219|NCT01867710|12397409|FG000|Overall Study|Progressive disease|1
7892220|NCT01867710|12397410|FG001|Overall Study|Progressive disease|0
7892221|NCT01867710|12397411|FG002|Overall Study|Progressive disease|0
7892222|NCT01867710|12397412|FG003|Overall Study|Progressive disease|0
7892223|NCT01867710|12397409|FG000|Overall Study|Protocol Violation|0
7892224|NCT01867710|12397410|FG001|Overall Study|Protocol Violation|0
7892225|NCT01867710|12397411|FG002|Overall Study|Protocol Violation|0
7892226|NCT01867710|12397412|FG003|Overall Study|Protocol Violation|1
7892227|NCT01867710|12397409|FG000|Overall Study|PSA-progression|0
7892228|NCT01867710|12397410|FG001|Overall Study|PSA-progression|1
7892229|NCT01867710|12397411|FG002|Overall Study|PSA-progression|0
7892230|NCT01867710|12397412|FG003|Overall Study|PSA-progression|0
7892231|NCT01867710|12397409|FG000|Overall Study|Study medication no longer effective|0
7892232|NCT01867710|12397410|FG001|Overall Study|Study medication no longer effective|1
7892233|NCT01867710|12397411|FG002|Overall Study|Study medication no longer effective|0
7892234|NCT01867710|12397412|FG003|Overall Study|Study medication no longer effective|0
7892235|NCT01868009|12397422|FG000|Period 1 (5-9 Days)|Adverse Event|0
7892236|NCT01868009|12397423|FG001|Period 1 (5-9 Days)|Adverse Event|2
7892237|NCT01868009|12397422|FG000|Period 2 (5-9 Days)|Adverse Event|1
7892238|NCT01868009|12397423|FG001|Period 2 (5-9 Days)|Adverse Event|0
7892239|NCT01868009|12397422|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
7892240|NCT01868009|12397423|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
7892241|NCT01868022|12397438|FG000|Overall Study|Withdrawal by Subject|0
7892242|NCT01868022|12397439|FG001|Overall Study|Withdrawal by Subject|0
7892243|NCT01868022|12397440|FG002|Overall Study|Withdrawal by Subject|1
7892244|NCT01868022|12397441|FG003|Overall Study|Withdrawal by Subject|1
7892245|NCT01868022|12397442|FG004|Overall Study|Withdrawal by Subject|0
7892246|NCT01868022|12397443|FG005|Overall Study|Withdrawal by Subject|0
7892247|NCT01868022|12397444|FG006|Overall Study|Withdrawal by Subject|0
7892248|NCT01868022|12397445|FG007|Overall Study|Withdrawal by Subject|1
7892249|NCT01868022|12397446|FG008|Overall Study|Withdrawal by Subject|0
7892250|NCT01868022|12397438|FG000|Overall Study|Adverse Event|0
7892251|NCT01868022|12397439|FG001|Overall Study|Adverse Event|0
7892252|NCT01868022|12397440|FG002|Overall Study|Adverse Event|0
7892253|NCT01868022|12397441|FG003|Overall Study|Adverse Event|0
7892254|NCT01868022|12397442|FG004|Overall Study|Adverse Event|2
7892255|NCT01868022|12397443|FG005|Overall Study|Adverse Event|0
7892256|NCT01868022|12397444|FG006|Overall Study|Adverse Event|0
7892257|NCT01868022|12397445|FG007|Overall Study|Adverse Event|2
7892258|NCT01868022|12397446|FG008|Overall Study|Adverse Event|2
7892259|NCT01868022|12397438|FG000|Overall Study|Physician Decision|0
7892260|NCT01868022|12397439|FG001|Overall Study|Physician Decision|0
7892261|NCT01868022|12397440|FG002|Overall Study|Physician Decision|0
7892262|NCT01868022|12397441|FG003|Overall Study|Physician Decision|0
7892263|NCT01868022|12397442|FG004|Overall Study|Physician Decision|0
7892264|NCT01868022|12397443|FG005|Overall Study|Physician Decision|1
7892265|NCT01868022|12397444|FG006|Overall Study|Physician Decision|0
7892266|NCT01868022|12397445|FG007|Overall Study|Physician Decision|2
7892267|NCT01868022|12397446|FG008|Overall Study|Physician Decision|0
7892268|NCT01868022|12397438|FG000|Overall Study|Study closed/terminated|0
7892269|NCT01868022|12397439|FG001|Overall Study|Study closed/terminated|0
7892270|NCT01868022|12397440|FG002|Overall Study|Study closed/terminated|0
7892271|NCT01868022|12397441|FG003|Overall Study|Study closed/terminated|0
7892272|NCT01868022|12397442|FG004|Overall Study|Study closed/terminated|0
7892273|NCT01868022|12397443|FG005|Overall Study|Study closed/terminated|0
7892274|NCT01868022|12397444|FG006|Overall Study|Study closed/terminated|0
7892275|NCT01868022|12397445|FG007|Overall Study|Study closed/terminated|1
7892276|NCT01868022|12397446|FG008|Overall Study|Study closed/terminated|0
7892277|NCT01868022|12397438|FG000|Overall Study|Ongoing|0
7892278|NCT01868022|12397439|FG001|Overall Study|Ongoing|0
7892279|NCT01868022|12397440|FG002|Overall Study|Ongoing|0
7892280|NCT01868022|12397441|FG003|Overall Study|Ongoing|0
7892281|NCT01868022|12397442|FG004|Overall Study|Ongoing|0
7892282|NCT01868022|12397443|FG005|Overall Study|Ongoing|0
7892283|NCT01868022|12397444|FG006|Overall Study|Ongoing|0
7892284|NCT01868022|12397445|FG007|Overall Study|Ongoing|3
7892285|NCT01868022|12397446|FG008|Overall Study|Ongoing|0
7892286|NCT01868035|12397472|FG000|Overall Study|Lost to Follow-up|3
7892287|NCT01868035|12397472|FG000|Overall Study|Withdrawal by Subject|1
7892288|NCT01868035|12397472|FG000|Overall Study|Progressive Disease|2
7892289|NCT01868035|12397472|FG000|Overall Study|Non-compliance|1
7892290|NCT01868074|12397478|FG000|Overall Study|Lost to Follow-up|3
7892291|NCT01868074|12397479|FG001|Overall Study|Lost to Follow-up|2
7892292|NCT01868074|12397478|FG000|Overall Study|Withdrawal by Subject|4
7892293|NCT01868074|12397479|FG001|Overall Study|Withdrawal by Subject|2
7892294|NCT01868165|12397485|FG000|Overall Study|Withdrawal by Subject|36
7892295|NCT01868165|12397485|FG000|Overall Study|Physician Decision|2
7892296|NCT01868165|12397485|FG000|Overall Study|Lost to Follow-up|3
7892297|NCT01868165|12397485|FG000|Overall Study|Death|4
7892298|NCT01868243|12397491|FG000|Overall Study|Death|0
7892299|NCT01868243|12397492|FG001|Overall Study|Death|1
7892300|NCT01868477|12397554|FG000|Overall Study|Adverse Event|2
7892301|NCT01868477|12397555|FG001|Overall Study|Adverse Event|4
7892302|NCT01868477|12397554|FG000|Overall Study|Disease progression|1
7892303|NCT01868477|12397555|FG001|Overall Study|Disease progression|1
7892304|NCT01868477|12397554|FG000|Overall Study|Withdrawal by Subject|1
7892305|NCT01868477|12397555|FG001|Overall Study|Withdrawal by Subject|0
7892306|NCT01868503|12397568|FG000|Overall Study|Withdrawal by Subject|1
7892307|NCT01868503|12397568|FG000|Overall Study|Protocol Violation|1
7892308|NCT01868542|12397576|FG000|Overall Study|Protocol Violation|0
7892309|NCT01868542|12397577|FG001|Overall Study|Protocol Violation|1
7892310|NCT01868542|12397576|FG000|Overall Study|Unclassified|0
7892311|NCT01868542|12397577|FG001|Overall Study|Unclassified|1
7892312|NCT01868594|12397585|FG000|Overall Study|Do not meet inclusion criteria|4
7892313|NCT01868594|12397586|FG001|Overall Study|Do not meet inclusion criteria|3
7892314|NCT01868646|12397605|FG000|Overall Study|Do not meet inclusion criteria|3
7892315|NCT01868646|12397606|FG001|Overall Study|Do not meet inclusion criteria|5
7892316|NCT01868893|12397630|FG000|Overall Study|Adverse Event|2
7892317|NCT01868893|12397630|FG000|Overall Study|Commercial availability of study drug|17
7892318|NCT01868893|12397630|FG000|Overall Study|Neutropenia|1
7892319|NCT01868997|12397638|FG000|Overall Study|Adverse Event|2
7892320|NCT01868997|12397639|FG001|Overall Study|Adverse Event|5
7892321|NCT01868997|12397638|FG000|Overall Study|Lack of Efficacy|2
7892322|NCT01868997|12397639|FG001|Overall Study|Lack of Efficacy|0
7892323|NCT01868997|12397638|FG000|Overall Study|Other|3
7892324|NCT01868997|12397639|FG001|Overall Study|Other|1
7892325|NCT01869192|12397672|FG000|Preoperative Chemotherapy to Surgery|patient choice|2
7892326|NCT01869192|12397673|FG001|Preoperative Chemotherapy to Surgery|patient choice|1
7892327|NCT01869192|12397672|FG000|Postoperative Chemotherapy|Physician Decision|0
7892328|NCT01869192|12397673|FG001|Postoperative Chemotherapy|Physician Decision|2
7892329|NCT01869348|12397681|FG000|Overall Study|Withdrawal by Subject|1
7892330|NCT01869348|12397682|FG001|Overall Study|Withdrawal by Subject|1
7892331|NCT01869699|12397729|FG000|Overall Study|Withdrawal by Subject|1
7892332|NCT01869699|12397730|FG001|Overall Study|Withdrawal by Subject|0
7892333|NCT01869725|12397736|FG000|Overall Study|ineligible after registration|1
7892334|NCT01869725|12397736|FG000|Overall Study|Death|1
7892335|NCT01869725|12397736|FG000|Overall Study|Lost to Follow-up|2
7892336|NCT01869764|12397742|FG000|Overall Study|Withdrawal by Subject|0
7892337|NCT01869764|12397743|FG001|Overall Study|Withdrawal by Subject|2
7892338|NCT01869777|12397749|FG000|Overall Study|Excluded from the analysis, ineligible|1
7892339|NCT01869959|12397757|FG000|Randomization Period|Physician Decision|0
7892340|NCT01869959|12397758|FG001|Randomization Period|Physician Decision|0
7892341|NCT01869959|12397759|FG002|Randomization Period|Physician Decision|0
7892342|NCT01869959|12397760|FG003|Randomization Period|Physician Decision|0
7892343|NCT01869959|12397761|FG004|Randomization Period|Physician Decision|1
7892344|NCT01869959|12397757|FG000|Treatment Period|Adverse Event|1
7892345|NCT01869959|12397758|FG001|Treatment Period|Adverse Event|0
7892346|NCT01869959|12397759|FG002|Treatment Period|Adverse Event|3
7892347|NCT01869959|12397760|FG003|Treatment Period|Adverse Event|1
7892348|NCT01869959|12397761|FG004|Treatment Period|Adverse Event|0
7892349|NCT01869959|12397757|FG000|Treatment Period|Sponsor decision|0
7892350|NCT01869959|12397758|FG001|Treatment Period|Sponsor decision|1
7892351|NCT01869959|12397759|FG002|Treatment Period|Sponsor decision|0
7892352|NCT01869959|12397760|FG003|Treatment Period|Sponsor decision|1
7892353|NCT01869959|12397761|FG004|Treatment Period|Sponsor decision|0
7892354|NCT01869959|12397757|FG000|Treatment Period|Withdrawal by Subject|0
7892355|NCT01869959|12397758|FG001|Treatment Period|Withdrawal by Subject|1
7892356|NCT01869959|12397759|FG002|Treatment Period|Withdrawal by Subject|0
7892357|NCT01869959|12397760|FG003|Treatment Period|Withdrawal by Subject|0
7892358|NCT01869959|12397761|FG004|Treatment Period|Withdrawal by Subject|0
7892359|NCT01870076|12397775|FG000|Overall Study|Withdrawal by Subject|1
7892360|NCT01870076|12397776|FG001|Overall Study|Withdrawal by Subject|0
7892361|NCT01870076|12397777|FG002|Overall Study|Withdrawal by Subject|1
7892362|NCT01870076|12397778|FG003|Overall Study|Withdrawal by Subject|0
7892363|NCT01870297|12397795|FG000|Overall Study|Adverse Event|0
7892364|NCT01870297|12397796|FG001|Overall Study|Adverse Event|0
7892365|NCT01870297|12397797|FG002|Overall Study|Adverse Event|0
7892366|NCT01870297|12397798|FG003|Overall Study|Adverse Event|0
7892367|NCT01870297|12397799|FG004|Overall Study|Adverse Event|2
7892368|NCT01870297|12397800|FG005|Overall Study|Adverse Event|0
7892369|NCT01870297|12397801|FG006|Overall Study|Adverse Event|0
7892370|NCT01870297|12397795|FG000|Overall Study|Lost to Follow-up|0
7892371|NCT01870297|12397796|FG001|Overall Study|Lost to Follow-up|1
7892372|NCT01870297|12397797|FG002|Overall Study|Lost to Follow-up|1
7892373|NCT01870297|12397798|FG003|Overall Study|Lost to Follow-up|0
7892374|NCT01870297|12397799|FG004|Overall Study|Lost to Follow-up|0
7892375|NCT01870297|12397800|FG005|Overall Study|Lost to Follow-up|0
7892376|NCT01870297|12397801|FG006|Overall Study|Lost to Follow-up|0
7892377|NCT01870297|12397795|FG000|Overall Study|Withdrawal by Subject|0
7892378|NCT01870297|12397796|FG001|Overall Study|Withdrawal by Subject|0
7892379|NCT01870297|12397797|FG002|Overall Study|Withdrawal by Subject|0
7892380|NCT01870297|12397798|FG003|Overall Study|Withdrawal by Subject|0
7892381|NCT01870297|12397799|FG004|Overall Study|Withdrawal by Subject|1
7892382|NCT01870297|12397800|FG005|Overall Study|Withdrawal by Subject|1
7892383|NCT01870297|12397801|FG006|Overall Study|Withdrawal by Subject|1
7892384|NCT01870297|12397795|FG000|Overall Study|Sponsor Decision|0
7892385|NCT01870297|12397796|FG001|Overall Study|Sponsor Decision|6
7892386|NCT01870297|12397797|FG002|Overall Study|Sponsor Decision|0
7892387|NCT01870297|12397798|FG003|Overall Study|Sponsor Decision|0
7892388|NCT01870297|12397799|FG004|Overall Study|Sponsor Decision|0
7892389|NCT01870297|12397800|FG005|Overall Study|Sponsor Decision|0
7892390|NCT01870297|12397801|FG006|Overall Study|Sponsor Decision|1
7892391|NCT01870583|12397840|FG000|Overall Study|Protocol Violation|0
7892392|NCT01870583|12397841|FG001|Overall Study|Protocol Violation|5
7892393|NCT01870583|12397842|FG002|Overall Study|Protocol Violation|3
7892394|NCT01870583|12397840|FG000|Overall Study|Lost to Follow-up|11
7892395|NCT01870583|12397841|FG001|Overall Study|Lost to Follow-up|13
7892396|NCT01870583|12397842|FG002|Overall Study|Lost to Follow-up|5
7892397|NCT01870726|12397866|FG000|Overall Study|Withdrawal of informed consent|0
7892398|NCT01870726|12397867|FG001|Overall Study|Withdrawal of informed consent|0
7892399|NCT01870726|12397868|FG002|Overall Study|Withdrawal of informed consent|0
7892400|NCT01870726|12397869|FG003|Overall Study|Withdrawal of informed consent|1
7892401|NCT01870726|12397870|FG004|Overall Study|Withdrawal of informed consent|0
7892402|NCT01870726|12397871|FG005|Overall Study|Withdrawal of informed consent|0
7892403|NCT01870726|12397872|FG006|Overall Study|Withdrawal of informed consent|0
7892404|NCT01870726|12397866|FG000|Overall Study|Withdrawal by Subject|0
7892405|NCT01870726|12397867|FG001|Overall Study|Withdrawal by Subject|1
7892406|NCT01870726|12397868|FG002|Overall Study|Withdrawal by Subject|0
7892407|NCT01870726|12397869|FG003|Overall Study|Withdrawal by Subject|0
7892408|NCT01870726|12397870|FG004|Overall Study|Withdrawal by Subject|0
7892409|NCT01870726|12397871|FG005|Overall Study|Withdrawal by Subject|0
7892410|NCT01870726|12397872|FG006|Overall Study|Withdrawal by Subject|0
7892411|NCT01870726|12397866|FG000|Overall Study|Adverse Event|0
7892412|NCT01870726|12397867|FG001|Overall Study|Adverse Event|0
7892413|NCT01870726|12397868|FG002|Overall Study|Adverse Event|0
7892414|NCT01870726|12397869|FG003|Overall Study|Adverse Event|0
7892415|NCT01870726|12397870|FG004|Overall Study|Adverse Event|1
7892416|NCT01870726|12397871|FG005|Overall Study|Adverse Event|1
7892417|NCT01870726|12397872|FG006|Overall Study|Adverse Event|0
7892418|NCT01870726|12397866|FG000|Overall Study|Progressive disease|5
7892419|NCT01870726|12397867|FG001|Overall Study|Progressive disease|5
7892420|NCT01870726|12397868|FG002|Overall Study|Progressive disease|4
7892421|NCT01870726|12397869|FG003|Overall Study|Progressive disease|5
7892422|NCT01870726|12397870|FG004|Overall Study|Progressive disease|6
7892423|NCT01870726|12397871|FG005|Overall Study|Progressive disease|4
7892424|NCT01870726|12397872|FG006|Overall Study|Progressive disease|10
7892425|NCT01870739|12397899|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0
7892426|NCT01870739|12397900|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1
7892427|NCT01870739|12397899|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0
7892428|NCT01870739|12397900|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1
7892429|NCT01870739|12397899|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3
7892430|NCT01870739|12397900|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2
7892431|NCT01870739|12397899|FG000|Add-on Period (40 Weeks)|Adverse Event|0
7892432|NCT01870739|12397900|FG001|Add-on Period (40 Weeks)|Adverse Event|1
7892433|NCT01870739|12397899|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
7892434|NCT01870739|12397900|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
7892435|NCT01870739|12397899|FG000|Add-on Period (40 Weeks)|Protocol deviation|1
7892436|NCT01870739|12397900|FG001|Add-on Period (40 Weeks)|Protocol deviation|1
7892437|NCT01870739|12397899|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1
7892438|NCT01870739|12397900|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0
7892439|NCT01870778|12397918|FG000|Overall Study|Withdrawal by Subject|8
7892440|NCT01870778|12397919|FG001|Overall Study|Withdrawal by Subject|7
7892441|NCT01870778|12397918|FG000|Overall Study|Lost to Follow-up|0
7892442|NCT01870778|12397919|FG001|Overall Study|Lost to Follow-up|2
7892443|NCT01870843|12397925|FG000|Overall Study|Adverse Event|10
7892444|NCT01870843|12397925|FG000|Overall Study|Lost to Follow-up|24
7892445|NCT01870843|12397925|FG000|Overall Study|Death|1
7892446|NCT01870843|12397925|FG000|Overall Study|Withdrawal by Subject|18
7892447|NCT01870869|12397944|FG000|Overall Study|Implanted with nonstudy device|1
7892448|NCT01870869|12397945|FG001|Overall Study|Implanted with nonstudy device|3
7892449|NCT01870869|12397946|FG002|Overall Study|Implanted with nonstudy device|14
7892450|NCT01870869|12397947|FG003|Overall Study|Implanted with nonstudy device|4
7892451|NCT01870869|12397944|FG000|Overall Study|Death|0
7892452|NCT01870869|12397945|FG001|Overall Study|Death|0
7892453|NCT01870869|12397946|FG002|Overall Study|Death|7
7892454|NCT01870869|12397947|FG003|Overall Study|Death|1
7892455|NCT01870869|12397944|FG000|Overall Study|Subject choice|6
7892456|NCT01870869|12397945|FG001|Overall Study|Subject choice|2
7892457|NCT01870869|12397946|FG002|Overall Study|Subject choice|22
7892458|NCT01870869|12397947|FG003|Overall Study|Subject choice|8
7892459|NCT01870869|12397944|FG000|Overall Study|Lost to Follow-up|10
7892460|NCT01870869|12397945|FG001|Overall Study|Lost to Follow-up|2
7892461|NCT01870869|12397946|FG002|Overall Study|Lost to Follow-up|25
7892462|NCT01870869|12397947|FG003|Overall Study|Lost to Follow-up|3
7892463|NCT01870869|12397944|FG000|Overall Study|Reason not Specified|1
7892464|NCT01870869|12397945|FG001|Overall Study|Reason not Specified|2
7892465|NCT01870869|12397946|FG002|Overall Study|Reason not Specified|20
7892466|NCT01870869|12397947|FG003|Overall Study|Reason not Specified|4
7892467|NCT01870869|12397944|FG000|Overall Study|Not evaluable|10
7892468|NCT01870869|12397945|FG001|Overall Study|Not evaluable|5
7892469|NCT01870869|12397946|FG002|Overall Study|Not evaluable|42
7892470|NCT01870869|12397947|FG003|Overall Study|Not evaluable|10
7892471|NCT01870921|12397957|FG000|Overall Study|Subject decision|80
7892472|NCT01870921|12397957|FG000|Overall Study|Severe non-compliance to protocol|7
7892473|NCT01870921|12397957|FG000|Overall Study|Subject Lost to Follow up|2
7892474|NCT01870921|12397957|FG000|Overall Study|Other|1
7892475|NCT01870973|12397963|FG000|Overall Study|Lost to Follow-up|10
7892476|NCT01870973|12397964|FG001|Overall Study|Lost to Follow-up|3
7892477|NCT01870999|12397973|FG000|Overall Study|Adverse Event|0
7892478|NCT01870999|12397974|FG001|Overall Study|Adverse Event|4
7892479|NCT01870999|12397975|FG002|Overall Study|Adverse Event|1
7892480|NCT01870999|12397973|FG000|Overall Study|Subject met withdrawal criteria|3
7892481|NCT01870999|12397974|FG001|Overall Study|Subject met withdrawal criteria|2
7892482|NCT01870999|12397975|FG002|Overall Study|Subject met withdrawal criteria|0
7892483|NCT01870999|12397973|FG000|Overall Study|Subject withdrawn by Investigator|1
7892484|NCT01870999|12397974|FG001|Overall Study|Subject withdrawn by Investigator|0
7892485|NCT01870999|12397975|FG002|Overall Study|Subject withdrawn by Investigator|0
7892486|NCT01870999|12397973|FG000|Overall Study|Withdrawal by Subject|0
7892487|NCT01870999|12397974|FG001|Overall Study|Withdrawal by Subject|2
7892488|NCT01870999|12397975|FG002|Overall Study|Withdrawal by Subject|5
7892489|NCT01870999|12397973|FG000|Overall Study|Protocol Violation|0
7892490|NCT01870999|12397974|FG001|Overall Study|Protocol Violation|0
7892491|NCT01870999|12397975|FG002|Overall Study|Protocol Violation|1
7892492|NCT01871090|12397989|FG000|Overall Study|Interrogation not done in Emergency Room|1
7892493|NCT01871090|12397990|FG001|Overall Study|Interrogation not done in Emergency Room|22
7892494|NCT01871090|12397989|FG000|Overall Study|Interrogation not completed correctly|1
7892495|NCT01871090|12397990|FG001|Overall Study|Interrogation not completed correctly|0
7892496|NCT01871090|12397989|FG000|Overall Study|Subject Non-Compliance|0
7892497|NCT01871090|12397990|FG001|Overall Study|Subject Non-Compliance|1
7892498|NCT01871142|12397996|FG000|Overall Study|Adverse Event|1
7892499|NCT01871285|12398012|FG000|First Intervention (1 Day)|Adverse Event|1
7892500|NCT01871285|12398013|FG001|First Intervention (1 Day)|Adverse Event|0
7892501|NCT01871285|12398014|FG002|First Intervention (1 Day)|Adverse Event|0
7892502|NCT01871285|12398015|FG003|First Intervention (1 Day)|Adverse Event|0
7892503|NCT01871285|12398012|FG000|First Intervention (1 Day)|Lost to Follow-up|0
7892504|NCT01871285|12398013|FG001|First Intervention (1 Day)|Lost to Follow-up|1
7892505|NCT01871285|12398014|FG002|First Intervention (1 Day)|Lost to Follow-up|1
7892506|NCT01871285|12398015|FG003|First Intervention (1 Day)|Lost to Follow-up|0
7892507|NCT01871402|12398027|FG000|Overall Study|Lost to Follow-up|1
7892508|NCT01871402|12398028|FG001|Overall Study|Lost to Follow-up|0
7892509|NCT01871402|12398027|FG000|Overall Study|Withdrawal by Subject|0
7892510|NCT01871402|12398028|FG001|Overall Study|Withdrawal by Subject|2
7892511|NCT01871402|12398027|FG000|Overall Study|Non-compliance|0
7892512|NCT01871402|12398028|FG001|Overall Study|Non-compliance|1
7892513|NCT01871519|12398061|FG000|Overall Study|Death|26
7892514|NCT01871519|12398061|FG000|Overall Study|Lost to Follow-up|15
7892515|NCT01871519|12398061|FG000|Overall Study|Withdrawal by Subject|49
7892516|NCT01871532|12398068|FG000|Overall Study|Withdrawal by Subject|1
7892517|NCT01871532|12398069|FG001|Overall Study|Withdrawal by Subject|2
7892518|NCT01871545|12398077|FG000|Overall Study|Death|2
7892519|NCT01871545|12398078|FG001|Overall Study|Death|0
7892520|NCT01871545|12398077|FG000|Overall Study|Lack of Efficacy|11
7892521|NCT01871545|12398078|FG001|Overall Study|Lack of Efficacy|2
7892522|NCT01871545|12398077|FG000|Overall Study|Physician Decision|4
7892523|NCT01871545|12398078|FG001|Overall Study|Physician Decision|0
7892524|NCT01871545|12398077|FG000|Overall Study|Withdrawal by Subject|0
7892525|NCT01871545|12398078|FG001|Overall Study|Withdrawal by Subject|1
7892526|NCT01871558|12398089|FG000|Overall Study|Other reason|0
7892527|NCT01871558|12398090|FG001|Overall Study|Other reason|1
7892528|NCT01871558|12398089|FG000|Overall Study|antidiabetic drug prematurely stopped|1
7892529|NCT01871558|12398090|FG001|Overall Study|antidiabetic drug prematurely stopped|1
7892530|NCT01871558|12398089|FG000|Overall Study|Withdrawal by Subject|2
7892531|NCT01871558|12398090|FG001|Overall Study|Withdrawal by Subject|0
7892532|NCT01871805|12398102|FG000|Phase I|Death|7
7892533|NCT01871805|12398103|FG001|Phase I|Death|4
7892534|NCT01871805|12398104|FG002|Phase I|Death|6
7892535|NCT01871805|12398105|FG003|Phase I|Death|2
7892536|NCT01871805|12398106|FG004|Phase I|Death|9
7892537|NCT01871805|12398107|FG005|Phase I|Death|0
7892538|NCT01871805|12398102|FG000|Phase I|Alive in Survival Follow-up|0
7892539|NCT01871805|12398103|FG001|Phase I|Alive in Survival Follow-up|2
7892540|NCT01871805|12398104|FG002|Phase I|Alive in Survival Follow-up|4
7892541|NCT01871805|12398105|FG003|Phase I|Alive in Survival Follow-up|5
7892542|NCT01871805|12398106|FG004|Phase I|Alive in Survival Follow-up|4
7892543|NCT01871805|12398107|FG005|Phase I|Alive in Survival Follow-up|0
7892544|NCT01871805|12398102|FG000|Phase I|Lost to Follow-up|0
7892545|NCT01871805|12398103|FG001|Phase I|Lost to Follow-up|1
7892546|NCT01871805|12398104|FG002|Phase I|Lost to Follow-up|3
7892547|NCT01871805|12398105|FG003|Phase I|Lost to Follow-up|0
7892548|NCT01871805|12398106|FG004|Phase I|Lost to Follow-up|0
7892549|NCT01871805|12398107|FG005|Phase I|Lost to Follow-up|0
7892550|NCT01871805|12398102|FG000|Phase II|Death|0
7892551|NCT01871805|12398103|FG001|Phase II|Death|0
7892552|NCT01871805|12398104|FG002|Phase II|Death|0
7892553|NCT01871805|12398105|FG003|Phase II|Death|0
7892554|NCT01871805|12398106|FG004|Phase II|Death|0
7892555|NCT01871805|12398107|FG005|Phase II|Death|45
7892556|NCT01871805|12398102|FG000|Phase II|Alive in Survival Follow-up|0
7892557|NCT01871805|12398103|FG001|Phase II|Alive in Survival Follow-up|0
7892558|NCT01871805|12398104|FG002|Phase II|Alive in Survival Follow-up|0
7892559|NCT01871805|12398105|FG003|Phase II|Alive in Survival Follow-up|0
7892560|NCT01871805|12398106|FG004|Phase II|Alive in Survival Follow-up|0
7892561|NCT01871805|12398107|FG005|Phase II|Alive in Survival Follow-up|29
7892562|NCT01871805|12398102|FG000|Phase II|Lost to Follow-up|0
7892563|NCT01871805|12398103|FG001|Phase II|Lost to Follow-up|0
7892564|NCT01871805|12398104|FG002|Phase II|Lost to Follow-up|0
7892565|NCT01871805|12398105|FG003|Phase II|Lost to Follow-up|0
7892566|NCT01871805|12398106|FG004|Phase II|Lost to Follow-up|0
7892567|NCT01871805|12398107|FG005|Phase II|Lost to Follow-up|13
7892568|NCT01871870|12398138|FG000|Overall Study|Hardware issues|7
7892569|NCT01871870|12398138|FG000|Overall Study|hyperglycemia|2
7892570|NCT01872078|12398146|FG000|Overall Study|Adverse Event|0
7892571|NCT01872078|12398147|FG001|Overall Study|Adverse Event|0
7892572|NCT01872078|12398148|FG002|Overall Study|Adverse Event|1
7892573|NCT01872078|12398149|FG003|Overall Study|Adverse Event|0
7892574|NCT01872078|12398146|FG000|Overall Study|Dose administration non-compliance|0
7892575|NCT01872078|12398147|FG001|Overall Study|Dose administration non-compliance|0
7892576|NCT01872078|12398148|FG002|Overall Study|Dose administration non-compliance|0
7892577|NCT01872078|12398149|FG003|Overall Study|Dose administration non-compliance|1
7892578|NCT01872078|12398146|FG000|Overall Study|Protocol Violation|0
7892579|NCT01872078|12398147|FG001|Overall Study|Protocol Violation|0
7892580|NCT01872078|12398148|FG002|Overall Study|Protocol Violation|1
7892581|NCT01872078|12398149|FG003|Overall Study|Protocol Violation|0
7892582|NCT01872078|12398146|FG000|Overall Study|Withdrawal by Subject|0
7892583|NCT01872078|12398147|FG001|Overall Study|Withdrawal by Subject|0
7892584|NCT01872078|12398148|FG002|Overall Study|Withdrawal by Subject|1
7892585|NCT01872078|12398149|FG003|Overall Study|Withdrawal by Subject|0
7892586|NCT01872078|12398146|FG000|Overall Study|Patient met exclusion criterion 16.|0
7892587|NCT01872078|12398147|FG001|Overall Study|Patient met exclusion criterion 16.|0
7892588|NCT01872078|12398148|FG002|Overall Study|Patient met exclusion criterion 16.|0
7892589|NCT01872078|12398149|FG003|Overall Study|Patient met exclusion criterion 16.|1
7892590|NCT01872611|12398179|FG000|Overall Study|Adverse Event|3
7892591|NCT01872611|12398180|FG001|Overall Study|Adverse Event|1
7892592|NCT01872611|12398179|FG000|Overall Study|Adverse Event, prior to treatment|0
7892593|NCT01872611|12398180|FG001|Overall Study|Adverse Event, prior to treatment|1
7892594|NCT01872611|12398179|FG000|Overall Study|Death|0
7892595|NCT01872611|12398180|FG001|Overall Study|Death|1
7892596|NCT01872611|12398179|FG000|Overall Study|Death, prior to treatment|0
7892597|NCT01872611|12398180|FG001|Overall Study|Death, prior to treatment|1
7892598|NCT01872611|12398179|FG000|Overall Study|Lost to Follow-up|8
7892599|NCT01872611|12398180|FG001|Overall Study|Lost to Follow-up|1
7892600|NCT01872611|12398179|FG000|Overall Study|Physician Decision|1
7892601|NCT01872611|12398180|FG001|Overall Study|Physician Decision|0
7892602|NCT01872611|12398179|FG000|Overall Study|Withdrawal by Subject|6
7892603|NCT01872611|12398180|FG001|Overall Study|Withdrawal by Subject|1
7892604|NCT01872611|12398179|FG000|Overall Study|Reason not provided|6
7892605|NCT01872611|12398180|FG001|Overall Study|Reason not provided|6
7892606|NCT01872689|12398192|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
7892607|NCT01872689|12398193|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
7892608|NCT01872689|12398194|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
7892609|NCT01872689|12398195|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
7892610|NCT01872689|12398192|FG000|Double-Blind/Placebo-Controlled Period|Other|1
7892611|NCT01872689|12398193|FG001|Double-Blind/Placebo-Controlled Period|Other|1
7892612|NCT01872689|12398194|FG002|Double-Blind/Placebo-Controlled Period|Other|6
7892613|NCT01872689|12398195|FG003|Double-Blind/Placebo-Controlled Period|Other|3
7892614|NCT01872689|12398192|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
7892615|NCT01872689|12398193|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
7892616|NCT01872689|12398194|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
7892617|NCT01872689|12398195|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
7892618|NCT01872689|12398192|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
7892619|NCT01872689|12398193|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
7892620|NCT01872689|12398194|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
7892621|NCT01872689|12398195|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
7892622|NCT01872689|12398192|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0
7892623|NCT01872689|12398193|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3
7892624|NCT01872689|12398194|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3
7892625|NCT01872689|12398195|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1
7892626|NCT01872689|12398192|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
7892627|NCT01872689|12398193|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
7892628|NCT01872689|12398194|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
7892629|NCT01872689|12398195|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
7892630|NCT01872689|12398192|FG000|Double-Blind/Placebo-Controlled Period|Death|3
7892631|NCT01872689|12398193|FG001|Double-Blind/Placebo-Controlled Period|Death|4
7892632|NCT01872689|12398194|FG002|Double-Blind/Placebo-Controlled Period|Death|14
7892633|NCT01872689|12398195|FG003|Double-Blind/Placebo-Controlled Period|Death|9
7892634|NCT01872689|12398192|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6
7892635|NCT01872689|12398193|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3
7892636|NCT01872689|12398194|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10
7892637|NCT01872689|12398195|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7
7892638|NCT01872689|12398192|FG000|Open-Label Period (Only For Monotherapy)|Other|2
7892639|NCT01872689|12398193|FG001|Open-Label Period (Only For Monotherapy)|Other|3
7892640|NCT01872689|12398194|FG002|Open-Label Period (Only For Monotherapy)|Other|0
7892641|NCT01872689|12398195|FG003|Open-Label Period (Only For Monotherapy)|Other|0
7892642|NCT01872689|12398192|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
7892643|NCT01872689|12398193|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
7892644|NCT01872689|12398194|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
7892645|NCT01872689|12398195|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
7892646|NCT01872689|12398192|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0
7892647|NCT01872689|12398193|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1
7892648|NCT01872689|12398194|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0
7892649|NCT01872689|12398195|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0
7892650|NCT01872689|12398192|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
7892651|NCT01872689|12398193|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
7892652|NCT01872689|12398194|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
7892653|NCT01872689|12398195|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
7892654|NCT01872689|12398192|FG000|Open-Label Period (Only For Monotherapy)|Death|5
7892655|NCT01872689|12398193|FG001|Open-Label Period (Only For Monotherapy)|Death|3
7892656|NCT01872689|12398194|FG002|Open-Label Period (Only For Monotherapy)|Death|0
7892657|NCT01872689|12398195|FG003|Open-Label Period (Only For Monotherapy)|Death|0
7892658|NCT01872689|12398192|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2
7892659|NCT01872689|12398193|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1
7892660|NCT01872689|12398194|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0
7892661|NCT01872689|12398195|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0
7892662|NCT01872910|12398219|FG000|Overall Study|Lost to Follow-up|2
7892663|NCT01872910|12398220|FG001|Overall Study|Lost to Follow-up|0
7892664|NCT01872910|12398221|FG002|Overall Study|Lost to Follow-up|2
7892665|NCT01872910|12398222|FG003|Overall Study|Lost to Follow-up|0
7892666|NCT01872910|12398223|FG004|Overall Study|Lost to Follow-up|0
7892667|NCT01872910|12398224|FG005|Overall Study|Lost to Follow-up|0
7892668|NCT01873417|12398248|FG000|Overall Study|Did Not Receive Any Study Drug|4
7892669|NCT01873417|12398248|FG000|Overall Study|Adverse Event|24
7892670|NCT01873417|12398248|FG000|Overall Study|Lost to Follow-up|2
7892671|NCT01873417|12398248|FG000|Overall Study|Withdrawal by Subject|2
7892672|NCT01873417|12398248|FG000|Overall Study|Physician Decision|3
7892673|NCT01873495|12398252|FG000|Overall Study|Withdrawal by Subject|1
7892674|NCT01873495|12398252|FG000|Overall Study|Physician Decision|3
7892675|NCT01873495|12398252|FG000|Overall Study|Adverse Event|1
7892676|NCT01873495|12398252|FG000|Overall Study|Removed for Transplantation|1
7892677|NCT01873495|12398252|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1
7892678|NCT01873586|12398256|FG000|Overall Study|Lost to Follow-up|3
7892679|NCT01873729|12398263|FG000|Overall Study|Withdrawal by Subject|1
7892680|NCT01873742|12398269|FG000|Overall Study|Lost to Follow-up|68
7892681|NCT01873742|12398270|FG001|Overall Study|Lost to Follow-up|76
7892682|NCT01873859|12398282|FG000|Overall Study|Withdrawal by Subject|0
7892683|NCT01873859|12398283|FG001|Overall Study|Withdrawal by Subject|4
7892684|NCT01873950|12398290|FG000|Period 5|Withdrawal by Subject|0
7892685|NCT01873950|12398291|FG001|Period 5|Withdrawal by Subject|0
7892686|NCT01873950|12398292|FG002|Period 5|Withdrawal by Subject|0
7892687|NCT01873950|12398293|FG003|Period 5|Withdrawal by Subject|1
7892688|NCT01873950|12398294|FG004|Period 5|Withdrawal by Subject|0
7963023|NCT02717195|12517435|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0
7963024|NCT02717195|12517436|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0
7963025|NCT02717195|12517437|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0
7963026|NCT02717195|12517438|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1
7963027|NCT02717195|12517439|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1
7963028|NCT02717195|12517435|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0
7963029|NCT02717195|12517436|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0
7963030|NCT02717195|12517437|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0
7963031|NCT02717195|12517438|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0
7963032|NCT02717195|12517439|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1
7963033|NCT02717195|12517435|FG000|Double-blind Treatment (DBT) Period|Change of residence|0
7963034|NCT02717195|12517436|FG001|Double-blind Treatment (DBT) Period|Change of residence|0
7963035|NCT02717195|12517437|FG002|Double-blind Treatment (DBT) Period|Change of residence|0
7963036|NCT02717195|12517438|FG003|Double-blind Treatment (DBT) Period|Change of residence|1
7963037|NCT02717195|12517439|FG004|Double-blind Treatment (DBT) Period|Change of residence|1
7963038|NCT02717195|12517435|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7963039|NCT02717195|12517436|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7963040|NCT02717195|12517437|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7963041|NCT02717195|12517438|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7963042|NCT02717195|12517439|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1
7963043|NCT02717195|12517435|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7963044|NCT02717195|12517436|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7963045|NCT02717195|12517437|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1
7963046|NCT02717195|12517438|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7963047|NCT02717195|12517439|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7963048|NCT02717195|12517435|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0
7963049|NCT02717195|12517436|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0
7963050|NCT02717195|12517437|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0
7963051|NCT02717195|12517438|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1
7963052|NCT02717195|12517439|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1
7963053|NCT02717494|12517464|FG000|First Intervention (Step 1)|Lost to Follow-up|4
7963054|NCT02717494|12517465|FG001|First Intervention (Step 1)|Lost to Follow-up|7
7963055|NCT02717494|12517466|FG002|First Intervention (Step 1)|Lost to Follow-up|3
7963056|NCT02717494|12517464|FG000|First Intervention (Step 1)|Withdrawal by Subject|2
7963057|NCT02717494|12517465|FG001|First Intervention (Step 1)|Withdrawal by Subject|0
7963058|NCT02717494|12517466|FG002|First Intervention (Step 1)|Withdrawal by Subject|1
7963059|NCT02717494|12517464|FG000|First Intervention (Step 1)|Death|0
7963060|NCT02717494|12517465|FG001|First Intervention (Step 1)|Death|0
7963061|NCT02717494|12517466|FG002|First Intervention (Step 1)|Death|1
7963062|NCT02717494|12517464|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
7963063|NCT02717494|12517465|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
7963064|NCT02717494|12517466|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4
7963065|NCT02717546|12517492|FG000|Overall Study|Lost to Follow-up|12
7963066|NCT02717754|12517502|FG000|Overall Study|Incorrect Infusion Duration|0
7963067|NCT02717754|12517503|FG001|Overall Study|Incorrect Infusion Duration|0
7963068|NCT02717754|12517504|FG002|Overall Study|Incorrect Infusion Duration|0
7963069|NCT02717754|12517505|FG003|Overall Study|Incorrect Infusion Duration|10
7892689|NCT01874054|12398317|FG000|Overall Study|Withdrawal by Subject|3
7892690|NCT01874054|12398317|FG000|Overall Study|Study Termination by Sponsor|42
7892691|NCT01874054|12398317|FG000|Overall Study|Lost to Follow-up|5
7892692|NCT01874054|12398317|FG000|Overall Study|Death|5
7892693|NCT01874145|12398343|FG000|Core Period|Non-compliance|1
7968369|NCT03650556|12525854|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1
7968370|NCT03628716|12525861|FG000|Overall Study|Adverse Event|1
7968371|NCT03628716|12525862|FG001|Overall Study|Adverse Event|1
7892694|NCT01874145|12398344|FG001|Core Period|Non-compliance|0
7892695|NCT01874145|12398343|FG000|Core Period|Protocol Violation|1
7892696|NCT01874145|12398344|FG001|Core Period|Protocol Violation|1
7892697|NCT01874145|12398343|FG000|Core Period|Physician Decision|1
7892698|NCT01874145|12398344|FG001|Core Period|Physician Decision|1
7892699|NCT01874145|12398343|FG000|Core Period|Adverse Event|0
7892700|NCT01874145|12398344|FG001|Core Period|Adverse Event|1
7892701|NCT01874145|12398343|FG000|Core Period|Withdrawal by Subject|0
7892702|NCT01874145|12398344|FG001|Core Period|Withdrawal by Subject|4
7892703|NCT01874145|12398343|FG000|Extension Period|Adverse Event|3
7892704|NCT01874145|12398344|FG001|Extension Period|Adverse Event|2
7892705|NCT01874145|12398343|FG000|Extension Period|Withdrawal by Subject|2
7892706|NCT01874145|12398344|FG001|Extension Period|Withdrawal by Subject|1
7892707|NCT01874145|12398343|FG000|Extension Period|Lost to Follow-up|1
7892708|NCT01874145|12398344|FG001|Extension Period|Lost to Follow-up|1
7892709|NCT01874275|12398365|FG000|Overall Study|Lost to Follow-up|1
7892710|NCT01874275|12398366|FG001|Overall Study|Lost to Follow-up|0
7892711|NCT01874288|12398383|FG000|Overall Study|Withdrawal by Subject|1
7892712|NCT01874288|12398384|FG001|Overall Study|Withdrawal by Subject|0
7892713|NCT01874288|12398385|FG002|Overall Study|Withdrawal by Subject|2
7892714|NCT01874288|12398386|FG003|Overall Study|Withdrawal by Subject|1
7892715|NCT01874288|12398387|FG004|Overall Study|Withdrawal by Subject|1
7968372|NCT03628716|12525861|FG000|Overall Study|Death|1
7892716|NCT01874288|12398383|FG000|Overall Study|Physician Decision|0
7892717|NCT01874288|12398384|FG001|Overall Study|Physician Decision|0
7892718|NCT01874288|12398385|FG002|Overall Study|Physician Decision|0
7892719|NCT01874288|12398386|FG003|Overall Study|Physician Decision|1
7892720|NCT01874288|12398387|FG004|Overall Study|Physician Decision|0
7892721|NCT01874288|12398383|FG000|Overall Study|Progressive disease|2
7892722|NCT01874288|12398384|FG001|Overall Study|Progressive disease|0
7892723|NCT01874288|12398385|FG002|Overall Study|Progressive disease|3
7892724|NCT01874288|12398386|FG003|Overall Study|Progressive disease|5
7892725|NCT01874288|12398387|FG004|Overall Study|Progressive disease|1
7892726|NCT01874340|12398404|FG000|Overall Study|Study terminated by Sponsor|6
7892727|NCT01874340|12398405|FG001|Overall Study|Study terminated by Sponsor|8
7892728|NCT01874340|12398406|FG002|Overall Study|Study terminated by Sponsor|8
7892729|NCT01874340|12398407|FG003|Overall Study|Study terminated by Sponsor|4
7892730|NCT01874340|12398404|FG000|Overall Study|Withdrawal by Subject|0
7892731|NCT01874340|12398405|FG001|Overall Study|Withdrawal by Subject|0
7892732|NCT01874340|12398406|FG002|Overall Study|Withdrawal by Subject|0
7892733|NCT01874340|12398407|FG003|Overall Study|Withdrawal by Subject|1
7892734|NCT01874431|12398429|FG000|Overall Study|Physician Decision|0
7892735|NCT01874431|12398430|FG001|Overall Study|Physician Decision|0
7892736|NCT01874431|12398431|FG002|Overall Study|Physician Decision|1
7892737|NCT01874431|12398432|FG003|Overall Study|Physician Decision|0
7892738|NCT01874431|12398433|FG004|Overall Study|Physician Decision|0
7892739|NCT01874431|12398434|FG005|Overall Study|Physician Decision|0
7892740|NCT01874431|12398435|FG006|Overall Study|Physician Decision|0
7892741|NCT01874431|12398436|FG007|Overall Study|Physician Decision|0
7892742|NCT01874431|12398429|FG000|Overall Study|Adverse Event|5
7892743|NCT01874431|12398430|FG001|Overall Study|Adverse Event|4
7892744|NCT01874431|12398431|FG002|Overall Study|Adverse Event|6
7892745|NCT01874431|12398432|FG003|Overall Study|Adverse Event|5
7892746|NCT01874431|12398433|FG004|Overall Study|Adverse Event|2
7892747|NCT01874431|12398434|FG005|Overall Study|Adverse Event|8
7892748|NCT01874431|12398435|FG006|Overall Study|Adverse Event|2
7892749|NCT01874431|12398436|FG007|Overall Study|Adverse Event|3
7892750|NCT01874431|12398429|FG000|Overall Study|Protocol Violation|1
7892751|NCT01874431|12398430|FG001|Overall Study|Protocol Violation|1
7892752|NCT01874431|12398431|FG002|Overall Study|Protocol Violation|1
7892753|NCT01874431|12398432|FG003|Overall Study|Protocol Violation|0
7892754|NCT01874431|12398433|FG004|Overall Study|Protocol Violation|3
7892755|NCT01874431|12398434|FG005|Overall Study|Protocol Violation|2
7892756|NCT01874431|12398435|FG006|Overall Study|Protocol Violation|1
7892757|NCT01874431|12398436|FG007|Overall Study|Protocol Violation|1
7892758|NCT01874431|12398429|FG000|Overall Study|Non-compliance|0
7892759|NCT01874431|12398430|FG001|Overall Study|Non-compliance|0
7892760|NCT01874431|12398431|FG002|Overall Study|Non-compliance|0
7892761|NCT01874431|12398432|FG003|Overall Study|Non-compliance|0
7892762|NCT01874431|12398433|FG004|Overall Study|Non-compliance|1
7892763|NCT01874431|12398434|FG005|Overall Study|Non-compliance|0
7892764|NCT01874431|12398435|FG006|Overall Study|Non-compliance|1
7892765|NCT01874431|12398436|FG007|Overall Study|Non-compliance|0
7892766|NCT01874431|12398429|FG000|Overall Study|Logistical difficulties|0
7892767|NCT01874431|12398430|FG001|Overall Study|Logistical difficulties|0
7892768|NCT01874431|12398431|FG002|Overall Study|Logistical difficulties|0
7892769|NCT01874431|12398432|FG003|Overall Study|Logistical difficulties|0
7892770|NCT01874431|12398433|FG004|Overall Study|Logistical difficulties|0
7892771|NCT01874431|12398434|FG005|Overall Study|Logistical difficulties|0
7892772|NCT01874431|12398435|FG006|Overall Study|Logistical difficulties|1
7892773|NCT01874431|12398436|FG007|Overall Study|Logistical difficulties|0
7892774|NCT01874431|12398429|FG000|Overall Study|Withdrawal by Subject|0
7892775|NCT01874431|12398430|FG001|Overall Study|Withdrawal by Subject|0
7892776|NCT01874431|12398431|FG002|Overall Study|Withdrawal by Subject|1
7892777|NCT01874431|12398432|FG003|Overall Study|Withdrawal by Subject|2
7892778|NCT01874431|12398433|FG004|Overall Study|Withdrawal by Subject|1
7892779|NCT01874431|12398434|FG005|Overall Study|Withdrawal by Subject|1
7892780|NCT01874431|12398435|FG006|Overall Study|Withdrawal by Subject|3
7892781|NCT01874431|12398436|FG007|Overall Study|Withdrawal by Subject|0
7892782|NCT01874431|12398429|FG000|Overall Study|Sponsor decision|0
7892783|NCT01874431|12398430|FG001|Overall Study|Sponsor decision|0
7892784|NCT01874431|12398431|FG002|Overall Study|Sponsor decision|0
7892785|NCT01874431|12398432|FG003|Overall Study|Sponsor decision|0
7892786|NCT01874431|12398433|FG004|Overall Study|Sponsor decision|1
7892787|NCT01874431|12398434|FG005|Overall Study|Sponsor decision|0
7892788|NCT01874431|12398435|FG006|Overall Study|Sponsor decision|0
7892789|NCT01874431|12398436|FG007|Overall Study|Sponsor decision|0
7892790|NCT01874431|12398429|FG000|Overall Study|Lost to Follow-up|0
7892791|NCT01874431|12398430|FG001|Overall Study|Lost to Follow-up|0
7892792|NCT01874431|12398431|FG002|Overall Study|Lost to Follow-up|1
7892793|NCT01874431|12398432|FG003|Overall Study|Lost to Follow-up|0
7892794|NCT01874431|12398433|FG004|Overall Study|Lost to Follow-up|0
7892795|NCT01874431|12398434|FG005|Overall Study|Lost to Follow-up|0
7892796|NCT01874431|12398435|FG006|Overall Study|Lost to Follow-up|0
7892797|NCT01874431|12398436|FG007|Overall Study|Lost to Follow-up|0
7892798|NCT01874535|12398456|FG000|Overall Study|Lost to Follow-up|10
7892799|NCT01874535|12398457|FG001|Overall Study|Lost to Follow-up|9
7892800|NCT01874535|12398456|FG000|Overall Study|incomplete symptom resolution|45
7892801|NCT01874535|12398457|FG001|Overall Study|incomplete symptom resolution|35
7892802|NCT01874665|12398465|FG000|Overall Study|Adverse Event|6
7892803|NCT01874665|12398466|FG001|Overall Study|Adverse Event|2
7892804|NCT01874665|12398465|FG000|Overall Study|Withdrawal by Subject|4
7892805|NCT01874665|12398466|FG001|Overall Study|Withdrawal by Subject|1
7892806|NCT01874665|12398465|FG000|Overall Study|Physician Decision|3
7892807|NCT01874665|12398466|FG001|Overall Study|Physician Decision|0
7892808|NCT01874665|12398465|FG000|Overall Study|Clinical Progressive Disease|4
7892809|NCT01874665|12398466|FG001|Overall Study|Clinical Progressive Disease|3
7892810|NCT01874665|12398465|FG000|Overall Study|Study Terminated by Sponsor|0
7892811|NCT01874665|12398466|FG001|Overall Study|Study Terminated by Sponsor|2
7892812|NCT01874665|12398465|FG000|Overall Study|Documented Progressive Disease|11
7892813|NCT01874665|12398466|FG001|Overall Study|Documented Progressive Disease|7
7892814|NCT01874665|12398465|FG000|Overall Study|Other|2
7892815|NCT01874665|12398466|FG001|Overall Study|Other|0
7892816|NCT01875237|12398513|FG000|Overall Study|GVDH before DLI|1
7892817|NCT01875237|12398514|FG001|Overall Study|GVDH before DLI|0
7892818|NCT01875237|12398513|FG000|Overall Study|DLI cells could not be produced|1
7892819|NCT01875237|12398514|FG001|Overall Study|DLI cells could not be produced|0
7892820|NCT01875250|12398524|FG000|Overall Study|Adverse Event|2
7892821|NCT01875250|12398525|FG001|Overall Study|Adverse Event|0
7892822|NCT01875367|12398535|FG000|Overall Study|Not complete at least 2 questionaries|4
7892823|NCT01875367|12398536|FG001|Overall Study|Not complete at least 2 questionaries|2
7892824|NCT01875367|12398535|FG000|Overall Study|Not receive study treatment|1
7892825|NCT01875367|12398536|FG001|Overall Study|Not receive study treatment|0
7892826|NCT01875445|12398548|FG000|Overall Study|Lost to Follow-up|5
7892827|NCT01875445|12398549|FG001|Overall Study|Lost to Follow-up|0
7892828|NCT01875445|12398548|FG000|Overall Study|Withdrawal by Subject|2
7892829|NCT01875445|12398549|FG001|Overall Study|Withdrawal by Subject|0
7892830|NCT01875471|12398557|FG000|Overall Study|Adverse Event|0
7892831|NCT01875471|12398558|FG001|Overall Study|Adverse Event|1
7892832|NCT01875471|12398557|FG000|Overall Study|Unsatisfactory Lens Fitting|1
7892833|NCT01875471|12398558|FG001|Overall Study|Unsatisfactory Lens Fitting|0
7892834|NCT01875731|12398575|FG000|Overall Study|Fail to obtain lab sample|1
7892835|NCT01875731|12398576|FG001|Overall Study|Fail to obtain lab sample|0
7892836|NCT01875848|12398590|FG000|Overall Study|Withdrawal by Subject|2
7892837|NCT01875848|12398591|FG001|Overall Study|Withdrawal by Subject|0
7892838|NCT01875874|12398607|FG000|Overall Study|Death|3
7892839|NCT01875991|12398625|FG000|Overall Study|Withdrawal by Subject|6
7892840|NCT01875991|12398626|FG001|Overall Study|Withdrawal by Subject|6
7892841|NCT01875991|12398625|FG000|Overall Study|Sponsor Decision|1
7892842|NCT01875991|12398626|FG001|Overall Study|Sponsor Decision|0
7892843|NCT01876043|12398635|FG000|Overall Study|Death|1
7892844|NCT01876043|12398635|FG000|Overall Study|Withdrawal by Subject|1
7892845|NCT01876082|12398641|FG000|Overall Study|Withdrawal by Subject|0
7892846|NCT01876082|12398642|FG001|Overall Study|Withdrawal by Subject|2
7892847|NCT01876082|12398641|FG000|Overall Study|Protocol Violation|1
7892848|NCT01876082|12398642|FG001|Overall Study|Protocol Violation|0
7892849|NCT01876082|12398641|FG000|Overall Study|Adverse Event|1
7892850|NCT01876082|12398642|FG001|Overall Study|Adverse Event|1
7892851|NCT01876082|12398641|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0
7892852|NCT01876082|12398642|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1
7892853|NCT01876251|12398660|FG000|Overall Study|Clinical progression|1
7892854|NCT01876251|12398661|FG001|Overall Study|Clinical progression|0
7892855|NCT01876251|12398662|FG002|Overall Study|Clinical progression|0
7892856|NCT01876251|12398660|FG000|Overall Study|Death|2
7892857|NCT01876251|12398661|FG001|Overall Study|Death|0
7892858|NCT01876251|12398662|FG002|Overall Study|Death|1
7892859|NCT01876251|12398660|FG000|Overall Study|Participant started new treatment|1
7892860|NCT01876251|12398661|FG001|Overall Study|Participant started new treatment|0
7892861|NCT01876251|12398662|FG002|Overall Study|Participant started new treatment|1
7892862|NCT01876251|12398660|FG000|Overall Study|Participant refused further follow-up|0
7892863|NCT01876251|12398661|FG001|Overall Study|Participant refused further follow-up|0
7892864|NCT01876251|12398662|FG002|Overall Study|Participant refused further follow-up|1
7892865|NCT01876251|12398660|FG000|Overall Study|Study terminated|1
7892866|NCT01876251|12398661|FG001|Overall Study|Study terminated|0
7892867|NCT01876251|12398662|FG002|Overall Study|Study terminated|0
7892868|NCT01876251|12398660|FG000|Overall Study|Objective progression or relapse|10
7892869|NCT01876251|12398661|FG001|Overall Study|Objective progression or relapse|3
7892870|NCT01876251|12398662|FG002|Overall Study|Objective progression or relapse|8
7892871|NCT01876368|12398686|FG000|Overall Study|Adverse Event|2
7892872|NCT01876368|12398687|FG001|Overall Study|Adverse Event|5
7892873|NCT01876368|12398686|FG000|Overall Study|Lack of Efficacy|1
7892874|NCT01876368|12398687|FG001|Overall Study|Lack of Efficacy|0
7892875|NCT01876368|12398686|FG000|Overall Study|Lost to Follow-up|0
7892876|NCT01876368|12398687|FG001|Overall Study|Lost to Follow-up|1
7892877|NCT01876368|12398686|FG000|Overall Study|Non-compliance with study treatment|0
7892878|NCT01876368|12398687|FG001|Overall Study|Non-compliance with study treatment|1
7892879|NCT01876368|12398686|FG000|Overall Study|Physician Decision|0
7892880|NCT01876368|12398687|FG001|Overall Study|Physician Decision|2
7892881|NCT01876368|12398686|FG000|Overall Study|Protocol deviation|3
7892882|NCT01876368|12398687|FG001|Overall Study|Protocol deviation|3
7892883|NCT01876368|12398686|FG000|Overall Study|Subject/guardian decision|3
7892884|NCT01876368|12398687|FG001|Overall Study|Subject/guardian decision|1
7892885|NCT01876381|12398693|FG000|Overall Study|Lack of Efficacy|5
7892886|NCT01876381|12398693|FG000|Overall Study|Physician Decision|1
7892887|NCT01876381|12398693|FG000|Overall Study|Withdrawal by Subject|1
7892888|NCT01876420|12398697|FG000|Overall Study|Missed 30 day visit|1
7892889|NCT01876446|12398703|FG000|Overall Study|Death|0
7892890|NCT01876446|12398704|FG001|Overall Study|Death|1
7892891|NCT01876446|12398703|FG000|Overall Study|Withdrawal by Subject|1
7892892|NCT01876446|12398704|FG001|Overall Study|Withdrawal by Subject|2
7892893|NCT01876446|12398703|FG000|Overall Study|Physician Decision|1
7892894|NCT01876446|12398704|FG001|Overall Study|Physician Decision|3
7892895|NCT01876511|12398722|FG000|Overall Study|Disease Progression-clinical/radiologic|11
7892896|NCT01876511|12398723|FG001|Overall Study|Disease Progression-clinical/radiologic|24
7892897|NCT01876511|12398724|FG002|Overall Study|Disease Progression-clinical/radiologic|16
7892898|NCT01876511|12398722|FG000|Overall Study|Death (unrelated)|3
7892899|NCT01876511|12398723|FG001|Overall Study|Death (unrelated)|0
7892900|NCT01876511|12398724|FG002|Overall Study|Death (unrelated)|2
7892901|NCT01876511|12398722|FG000|Overall Study|Drug-related Toxicity|5
7892902|NCT01876511|12398723|FG001|Overall Study|Drug-related Toxicity|1
7892903|NCT01876511|12398724|FG002|Overall Study|Drug-related Toxicity|6
7892904|NCT01876511|12398722|FG000|Overall Study|Patient Decision|3
7892905|NCT01876511|12398723|FG001|Overall Study|Patient Decision|0
7892906|NCT01876511|12398724|FG002|Overall Study|Patient Decision|6
7892907|NCT01876511|12398722|FG000|Overall Study|Physician Decision|1
7892908|NCT01876511|12398723|FG001|Overall Study|Physician Decision|0
7892909|NCT01876511|12398724|FG002|Overall Study|Physician Decision|1
7892910|NCT01876706|12398734|FG000|Overall Study|BPH Intervention|9
7892911|NCT01876706|12398734|FG000|Overall Study|Lost to Follow-up|7
7892912|NCT01876706|12398734|FG000|Overall Study|Withdrawals|6
7892913|NCT01876706|12398734|FG000|Overall Study|Death|3
7892914|NCT01876732|12398738|FG000|Overall Study|MMA was not over 800mg/dL|75
7892915|NCT01876784|12398745|FG000|Overall Study|Withdrawal by Subject|17
7892916|NCT01876784|12398746|FG001|Overall Study|Withdrawal by Subject|2
7892917|NCT01876784|12398745|FG000|Overall Study|Adverse Event|15
7892918|NCT01876784|12398746|FG001|Overall Study|Adverse Event|2
7892919|NCT01876784|12398745|FG000|Overall Study|Protocol Violation|1
7892920|NCT01876784|12398746|FG001|Overall Study|Protocol Violation|0
7892921|NCT01876784|12398745|FG000|Overall Study|Disease progression|37
7892922|NCT01876784|12398746|FG001|Overall Study|Disease progression|67
7892923|NCT01876784|12398745|FG000|Overall Study|Lost to Follow-up|0
7892924|NCT01876784|12398746|FG001|Overall Study|Lost to Follow-up|1
7892925|NCT01876784|12398745|FG000|Overall Study|Death|1
7892926|NCT01876784|12398746|FG001|Overall Study|Death|0
7892927|NCT01876784|12398745|FG000|Overall Study|Randomized but not treated|2
7892928|NCT01876784|12398746|FG001|Overall Study|Randomized but not treated|1
7892929|NCT01876784|12398745|FG000|Overall Study|Other than specified above|5
7892930|NCT01876784|12398746|FG001|Overall Study|Other than specified above|6
7892931|NCT01876784|12398745|FG000|Overall Study|Ongoing|41
7892932|NCT01876784|12398746|FG001|Overall Study|Ongoing|40
7892933|NCT01876810|12398752|FG000|Overall Study|Physician Decision|0
7892934|NCT01876810|12398753|FG001|Overall Study|Physician Decision|1
7892935|NCT01876823|12398762|FG000|Overall Study|Withdrawal by Subject|5
7892936|NCT01876823|12398762|FG000|Overall Study|Physician Decision|2
7892937|NCT01876823|12398762|FG000|Overall Study|Patients moved|2
7892938|NCT01876901|12398768|FG000|Overall Study|Protocol Violation|10
7892939|NCT01876901|12398769|FG001|Overall Study|Protocol Violation|2
7892940|NCT01876901|12398768|FG000|Overall Study|No or other surgical intervention|7
7892941|NCT01876901|12398769|FG001|Overall Study|No or other surgical intervention|5
7892942|NCT01876979|12398778|FG000|Overall Study|Physician Decision|2
7892943|NCT01876979|12398779|FG001|Overall Study|Physician Decision|3
7892944|NCT01877083|12398795|FG000|Treatment Phase|Disease Progression|10
7892945|NCT01877083|12398795|FG000|Treatment Phase|Clinical Progression|1
7892946|NCT01877083|12398795|FG000|Treatment Phase|Adverse Event|6
7892947|NCT01877083|12398795|FG000|Treatment Phase|Withdrawal by Subject|2
7892948|NCT01877083|12398795|FG000|Treatment Phase|Lost to Follow-up|1
7892949|NCT01877083|12398795|FG000|Extension Phase|Disease Progression|3
7892950|NCT01877083|12398795|FG000|Extension Phase|Adverse Event|2
7892951|NCT01877187|12398816|FG000|Overall Study|Death|2
7892952|NCT01877187|12398816|FG000|Overall Study|Withdrawal by Subject|4
7892953|NCT01877187|12398816|FG000|Overall Study|Lost to Follow-up|3
7892954|NCT01877187|12398816|FG000|Overall Study|Declining clinical status|11
7892955|NCT01877187|12398816|FG000|Overall Study|Liver transplant|2
7892956|NCT01877239|12398823|FG000|Overall Study|Adverse Event|4
7892957|NCT01877239|12398823|FG000|Overall Study|Disease Remission|1
7892958|NCT01877239|12398823|FG000|Overall Study|Withdrawal by Subject|4
7892959|NCT01877239|12398823|FG000|Overall Study|Other|2
7892960|NCT01877239|12398823|FG000|Overall Study|Lack of Efficacy|4
7892961|NCT01877239|12398823|FG000|Overall Study|Data not available|35
7892962|NCT01877265|12398827|FG000|Treatment Period 1|Sponsor Decision|0
7892963|NCT01877265|12398828|FG001|Treatment Period 1|Sponsor Decision|0
7892964|NCT01877265|12398829|FG002|Treatment Period 1|Sponsor Decision|1
7892965|NCT01877265|12398830|FG003|Treatment Period 1|Sponsor Decision|0
7892966|NCT01877265|12398831|FG004|Treatment Period 1|Sponsor Decision|0
7892967|NCT01877265|12398832|FG005|Treatment Period 1|Sponsor Decision|0
7892968|NCT01877265|12398827|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7892969|NCT01877265|12398828|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7892970|NCT01877265|12398829|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7892971|NCT01877265|12398830|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7892972|NCT01877265|12398831|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7892973|NCT01877265|12398832|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
7892974|NCT01877265|12398827|FG000|Treatment Period 3|Lost to Follow-up|1
7892975|NCT01877265|12398828|FG001|Treatment Period 3|Lost to Follow-up|0
7892976|NCT01877265|12398829|FG002|Treatment Period 3|Lost to Follow-up|0
7892977|NCT01877265|12398830|FG003|Treatment Period 3|Lost to Follow-up|0
7892978|NCT01877265|12398831|FG004|Treatment Period 3|Lost to Follow-up|0
7892979|NCT01877265|12398832|FG005|Treatment Period 3|Lost to Follow-up|0
7892980|NCT01877278|12398845|FG000|Overall Study|Lost to Follow-up|3
7892981|NCT01877278|12398846|FG001|Overall Study|Lost to Follow-up|3
7892982|NCT01877408|12398854|FG000|Overall Study|Lost to Follow-up|0
7892983|NCT01877408|12398855|FG001|Overall Study|Lost to Follow-up|2
7892984|NCT01877421|12398894|FG000|Phase 2|Lost to Follow-up|0
7892985|NCT01877421|12398895|FG001|Phase 2|Lost to Follow-up|0
7892986|NCT01877421|12398896|FG002|Phase 2|Lost to Follow-up|0
7892987|NCT01877421|12398897|FG003|Phase 2|Lost to Follow-up|0
7892988|NCT01877421|12398898|FG004|Phase 2|Lost to Follow-up|0
7892989|NCT01877421|12398899|FG005|Phase 2|Lost to Follow-up|0
7892990|NCT01877421|12398900|FG006|Phase 2|Lost to Follow-up|1
7892991|NCT01877421|12398901|FG007|Phase 2|Lost to Follow-up|0
7892992|NCT01877421|12398902|FG008|Phase 2|Lost to Follow-up|0
7892993|NCT01877421|12398903|FG009|Phase 2|Lost to Follow-up|0
7892994|NCT01877421|12398904|FG010|Phase 2|Lost to Follow-up|0
7892995|NCT01877421|12398905|FG011|Phase 2|Lost to Follow-up|0
7892996|NCT01877421|12398906|FG012|Phase 2|Lost to Follow-up|0
7892997|NCT01877421|12398907|FG013|Phase 2|Lost to Follow-up|0
7892998|NCT01877421|12398908|FG014|Phase 2|Lost to Follow-up|0
7892999|NCT01877421|12398909|FG015|Phase 2|Lost to Follow-up|0
7893000|NCT01877421|12398910|FG016|Phase 2|Lost to Follow-up|0
7968373|NCT03628716|12525862|FG001|Overall Study|Death|0
7968374|NCT03628716|12525861|FG000|Overall Study|Lack of Efficacy|15
7968375|NCT03628716|12525862|FG001|Overall Study|Lack of Efficacy|20
7968376|NCT03628716|12525861|FG000|Overall Study|Withdrawal by Subject|1
7968377|NCT03628716|12525862|FG001|Overall Study|Withdrawal by Subject|2
7968378|NCT03628716|12525861|FG000|Overall Study|Study Terminated by Sponsor|1
7968379|NCT03628716|12525862|FG001|Overall Study|Study Terminated by Sponsor|0
7893001|NCT01877421|12398911|FG017|Phase 2|Lost to Follow-up|0
7893002|NCT01877421|12398894|FG000|Phase 2|Withdrawal by Subject|0
7968380|NCT03377699|12525872|FG000|Overall Study|Withdrawal by Subject|2
7968381|NCT03377699|12525873|FG001|Overall Study|Withdrawal by Subject|9
7968382|NCT03377699|12525872|FG000|Overall Study|Lost to Follow-up|1
7968383|NCT03377699|12525873|FG001|Overall Study|Lost to Follow-up|1
7968384|NCT03377699|12525872|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1
7968385|NCT03377699|12525873|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0
7968386|NCT03377699|12525872|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1
7968387|NCT03377699|12525873|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1
7968388|NCT03377699|12525872|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11
7968389|NCT03377699|12525873|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8
7968390|NCT03377699|12525872|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6
7968391|NCT03377699|12525873|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6
7968392|NCT03275350|12525883|FG000|Overall Study|Lost to Follow-up|4
7968393|NCT03275350|12525884|FG001|Overall Study|Lost to Follow-up|6
7968394|NCT03275350|12525883|FG000|Overall Study|Death|2
7968395|NCT03275350|12525884|FG001|Overall Study|Death|1
7968396|NCT03275350|12525883|FG000|Overall Study|Physician Decision|1
7968397|NCT03275350|12525884|FG001|Overall Study|Physician Decision|0
7968398|NCT03275350|12525883|FG000|Overall Study|Incarcerated|1
7968399|NCT03275350|12525884|FG001|Overall Study|Incarcerated|1
7968400|NCT03272347|12525895|FG000|Overall Study|Death|0
7968401|NCT03272347|12525896|FG001|Overall Study|Death|0
7968402|NCT03272347|12525897|FG002|Overall Study|Death|0
7968403|NCT03272347|12525898|FG003|Overall Study|Death|1
7968404|NCT03272347|12525895|FG000|Overall Study|Lost to Follow-up|1
7968405|NCT03272347|12525896|FG001|Overall Study|Lost to Follow-up|0
7968406|NCT03272347|12525897|FG002|Overall Study|Lost to Follow-up|5
7968407|NCT03272347|12525898|FG003|Overall Study|Lost to Follow-up|1
7893003|NCT01877421|12398895|FG001|Phase 2|Withdrawal by Subject|0
7893004|NCT01877421|12398896|FG002|Phase 2|Withdrawal by Subject|0
7717770|NCT00522041|12141438|FG000|Overall Study|Did not receive treatment|0
7717771|NCT00522041|12141439|FG001|Overall Study|Did not receive treatment|1
7717772|NCT00522275|12141455|FG000|Overall Study|Adverse Event|35
7717773|NCT00522275|12141455|FG000|Overall Study|Lack of Efficacy|80
7717774|NCT00522275|12141455|FG000|Overall Study|Subject withdrew consent|16
7717775|NCT00522275|12141455|FG000|Overall Study|Protocol deviation|1
7717776|NCT00522275|12141455|FG000|Overall Study|Unsatisfactory compliance|11
7717777|NCT00522275|12141455|FG000|Overall Study|Lost to Follow-up|8
7717778|NCT00522275|12141455|FG000|Overall Study|Other: Subject wants to become pregnant|2
7717779|NCT00522275|12141455|FG000|Overall Study|Other: Subject is pregnant|2
7717780|NCT00522275|12141455|FG000|Overall Study|Other: Subject relocated|2
7717781|NCT00522275|12141455|FG000|Overall Study|Other: Subject arrested|1
7717782|NCT00522275|12141455|FG000|Overall Study|Other: Site / clinic closed|4
7717783|NCT00522275|12141455|FG000|Overall Study|Other: Travel to / from site difficulty|3
7717784|NCT00522275|12141455|FG000|Overall Study|Other: Sponsor request|2
7717785|NCT00522275|12141455|FG000|Overall Study|Other: Subject ran out of medication|1
7717786|NCT00522275|12141455|FG000|Overall Study|Other: Subject had surgery for epilepsy|2
7717787|NCT00522379|12141464|FG000|Overall Study|Adverse Event|12
7717788|NCT00522379|12141465|FG001|Overall Study|Adverse Event|15
7717789|NCT00522379|12141466|FG002|Overall Study|Adverse Event|12
7717790|NCT00522379|12141467|FG003|Overall Study|Adverse Event|5
7717791|NCT00522379|12141468|FG004|Overall Study|Adverse Event|17
7717792|NCT00522379|12141464|FG000|Overall Study|Lack of Efficacy|3
7717793|NCT00522379|12141465|FG001|Overall Study|Lack of Efficacy|0
7717794|NCT00522379|12141466|FG002|Overall Study|Lack of Efficacy|2
7717795|NCT00522379|12141467|FG003|Overall Study|Lack of Efficacy|2
7893005|NCT01877421|12398897|FG003|Phase 2|Withdrawal by Subject|0
7893006|NCT01877421|12398898|FG004|Phase 2|Withdrawal by Subject|0
7893007|NCT01877421|12398899|FG005|Phase 2|Withdrawal by Subject|0
7893008|NCT01877421|12398900|FG006|Phase 2|Withdrawal by Subject|0
7893009|NCT01877421|12398901|FG007|Phase 2|Withdrawal by Subject|0
7893010|NCT01877421|12398902|FG008|Phase 2|Withdrawal by Subject|1
7893011|NCT01877421|12398903|FG009|Phase 2|Withdrawal by Subject|0
7893012|NCT01877421|12398904|FG010|Phase 2|Withdrawal by Subject|1
7893013|NCT01877421|12398905|FG011|Phase 2|Withdrawal by Subject|0
7893014|NCT01877421|12398906|FG012|Phase 2|Withdrawal by Subject|1
7893015|NCT01877421|12398907|FG013|Phase 2|Withdrawal by Subject|0
7893016|NCT01877421|12398908|FG014|Phase 2|Withdrawal by Subject|0
7893017|NCT01877421|12398909|FG015|Phase 2|Withdrawal by Subject|1
7893018|NCT01877421|12398910|FG016|Phase 2|Withdrawal by Subject|0
7893019|NCT01877421|12398911|FG017|Phase 2|Withdrawal by Subject|0
7893020|NCT01877421|12398894|FG000|Phase 2|Protocol Violation|0
7893021|NCT01877421|12398895|FG001|Phase 2|Protocol Violation|0
7893022|NCT01877421|12398896|FG002|Phase 2|Protocol Violation|0
7893023|NCT01877421|12398897|FG003|Phase 2|Protocol Violation|0
7893024|NCT01877421|12398898|FG004|Phase 2|Protocol Violation|0
7893025|NCT01877421|12398899|FG005|Phase 2|Protocol Violation|0
7717796|NCT00522379|12141468|FG004|Overall Study|Lack of Efficacy|7
7717797|NCT00522379|12141464|FG000|Overall Study|Withdrawal by Subject|2
7717798|NCT00522379|12141465|FG001|Overall Study|Withdrawal by Subject|3
7893026|NCT01877421|12398900|FG006|Phase 2|Protocol Violation|0
7893027|NCT01877421|12398901|FG007|Phase 2|Protocol Violation|0
7893028|NCT01877421|12398902|FG008|Phase 2|Protocol Violation|0
7893029|NCT01877421|12398903|FG009|Phase 2|Protocol Violation|0
7893030|NCT01877421|12398904|FG010|Phase 2|Protocol Violation|1
7893031|NCT01877421|12398905|FG011|Phase 2|Protocol Violation|0
7893032|NCT01877421|12398906|FG012|Phase 2|Protocol Violation|0
7893033|NCT01877421|12398907|FG013|Phase 2|Protocol Violation|0
7893034|NCT01877421|12398908|FG014|Phase 2|Protocol Violation|0
7893035|NCT01877421|12398909|FG015|Phase 2|Protocol Violation|0
7893036|NCT01877421|12398910|FG016|Phase 2|Protocol Violation|0
7893037|NCT01877421|12398911|FG017|Phase 2|Protocol Violation|0
7893038|NCT01877551|12398997|FG000|Overall Study|Physician Decision|0
7893039|NCT01877551|12398998|FG001|Overall Study|Physician Decision|1
7893040|NCT01877668|12399026|FG000|Overall Study|Death|0
7893041|NCT01877668|12399027|FG001|Overall Study|Death|0
7893042|NCT01877668|12399028|FG002|Overall Study|Death|0
7893043|NCT01877668|12399029|FG003|Overall Study|Death|1
7893044|NCT01877668|12399030|FG004|Overall Study|Death|0
7893045|NCT01877668|12399026|FG000|Overall Study|No longer met study criteria|1
7893046|NCT01877668|12399027|FG001|Overall Study|No longer met study criteria|0
7893047|NCT01877668|12399028|FG002|Overall Study|No longer met study criteria|1
7893048|NCT01877668|12399029|FG003|Overall Study|No longer met study criteria|0
7893049|NCT01877668|12399030|FG004|Overall Study|No longer met study criteria|0
7893050|NCT01877668|12399026|FG000|Overall Study|Insufficient clinical response|0
7893051|NCT01877668|12399027|FG001|Overall Study|Insufficient clinical response|1
7893052|NCT01877668|12399028|FG002|Overall Study|Insufficient clinical response|2
7893053|NCT01877668|12399029|FG003|Overall Study|Insufficient clinical response|2
7893054|NCT01877668|12399030|FG004|Overall Study|Insufficient clinical response|0
7893055|NCT01877668|12399026|FG000|Overall Study|Lost to Follow-up|0
7893056|NCT01877668|12399027|FG001|Overall Study|Lost to Follow-up|2
7893057|NCT01877668|12399028|FG002|Overall Study|Lost to Follow-up|1
7893058|NCT01877668|12399029|FG003|Overall Study|Lost to Follow-up|0
7893059|NCT01877668|12399030|FG004|Overall Study|Lost to Follow-up|0
7893060|NCT01877668|12399026|FG000|Overall Study|Withdrawal by Subject|2
7893061|NCT01877668|12399027|FG001|Overall Study|Withdrawal by Subject|0
7893062|NCT01877668|12399028|FG002|Overall Study|Withdrawal by Subject|3
7893063|NCT01877668|12399029|FG003|Overall Study|Withdrawal by Subject|2
7893064|NCT01877668|12399030|FG004|Overall Study|Withdrawal by Subject|2
7893065|NCT01877668|12399026|FG000|Overall Study|Other|1
7893066|NCT01877668|12399027|FG001|Overall Study|Other|1
7893067|NCT01877668|12399028|FG002|Overall Study|Other|1
7893068|NCT01877668|12399029|FG003|Overall Study|Other|1
7893069|NCT01877668|12399030|FG004|Overall Study|Other|3
7893070|NCT01877668|12399026|FG000|Overall Study|Protocol Violation|1
7893071|NCT01877668|12399027|FG001|Overall Study|Protocol Violation|1
7893072|NCT01877668|12399028|FG002|Overall Study|Protocol Violation|0
7893073|NCT01877668|12399029|FG003|Overall Study|Protocol Violation|0
7893074|NCT01877668|12399030|FG004|Overall Study|Protocol Violation|3
7893075|NCT01877668|12399026|FG000|Overall Study|Adverse event related to study drug|2
7893076|NCT01877668|12399027|FG001|Overall Study|Adverse event related to study drug|2
7893077|NCT01877668|12399028|FG002|Overall Study|Adverse event related to study drug|2
7893078|NCT01877668|12399029|FG003|Overall Study|Adverse event related to study drug|2
7893079|NCT01877668|12399030|FG004|Overall Study|Adverse event related to study drug|1
7893080|NCT01877668|12399026|FG000|Overall Study|Adverse event unrelated to study drug|4
7893081|NCT01877668|12399027|FG001|Overall Study|Adverse event unrelated to study drug|1
7893082|NCT01877668|12399028|FG002|Overall Study|Adverse event unrelated to study drug|2
7893083|NCT01877668|12399029|FG003|Overall Study|Adverse event unrelated to study drug|0
7893084|NCT01877668|12399030|FG004|Overall Study|Adverse event unrelated to study drug|1
7893085|NCT01877720|12399046|FG000|Overall Study|Adverse Event|1
7893086|NCT01877720|12399047|FG001|Overall Study|Adverse Event|0
7893087|NCT01877915|12399055|FG000|Overall Study|Lost to Follow-up|10
7893088|NCT01877915|12399056|FG001|Overall Study|Lost to Follow-up|9
7893089|NCT01877915|12399055|FG000|Overall Study|Withdrawal by Subject|42
7893090|NCT01877915|12399056|FG001|Overall Study|Withdrawal by Subject|55
7893091|NCT01877915|12399055|FG000|Overall Study|Other|2
7893092|NCT01877915|12399056|FG001|Overall Study|Other|4
7893093|NCT01878084|12399074|FG000|Overall Study|Physician Decision|2
7893094|NCT01878097|12399081|FG000|Baseline|Surveys not fully completed|2497
7893095|NCT01878097|12399082|FG001|Baseline|Surveys not fully completed|1800
7893096|NCT01878097|12399081|FG000|Implementation Year 1|Surveys not fully completed|3202
7893097|NCT01878097|12399082|FG001|Implementation Year 1|Surveys not fully completed|2549
7893098|NCT01878097|12399081|FG000|Implementation Year 2|Surveys not fully completed|3281
7893099|NCT01878097|12399082|FG001|Implementation Year 2|Surveys not fully completed|2841
7893100|NCT01878097|12399081|FG000|Implementation Year 3|Surveys not fully completed|3494
7893101|NCT01878097|12399082|FG001|Implementation Year 3|Surveys not fully completed|2980
7893102|NCT01878097|12399081|FG000|Implementation Year 4|Surveys not fully completed|3604
7893103|NCT01878097|12399082|FG001|Implementation Year 4|Surveys not fully completed|3007
7893104|NCT01878149|12399090|FG000|Overall Study|Did Not Meet Eligibility Criteria|2
7893105|NCT01878149|12399091|FG001|Overall Study|Did Not Meet Eligibility Criteria|2
7893106|NCT01878175|12399097|FG000|Overall Study|Developed contraindicated health problem|2
7893107|NCT01878214|12399104|FG000|Overall Study|Withdrawal by Subject|18
7893108|NCT01878214|12399105|FG001|Overall Study|Withdrawal by Subject|7
7893109|NCT01878214|12399104|FG000|Overall Study|Death|0
7893110|NCT01878214|12399105|FG001|Overall Study|Death|1
7893111|NCT01878214|12399104|FG000|Overall Study|Lost to Follow-up|35
7893112|NCT01878214|12399105|FG001|Overall Study|Lost to Follow-up|36
7893113|NCT01878253|12399111|FG000|Overall Study|Death|1
7893114|NCT01878253|12399111|FG000|Overall Study|SIdus System Removal|3
7893115|NCT01878253|12399111|FG000|Overall Study|Withdrawal by Subject|1
7893116|NCT01878253|12399111|FG000|Overall Study|Lost to Follow-up|2
7893117|NCT01878253|12399111|FG000|Overall Study|Completed Study w/o Follow-up Data|2
7893118|NCT01878292|12399123|FG000|Randomized|Protocol Violation|1
7893119|NCT01878292|12399124|FG001|Randomized|Protocol Violation|0
7893120|NCT01878292|12399125|FG002|Randomized|Protocol Violation|0
7893121|NCT01878292|12399123|FG000|Randomized|Lost to Follow-up|1
7893122|NCT01878292|12399124|FG001|Randomized|Lost to Follow-up|0
7893123|NCT01878292|12399125|FG002|Randomized|Lost to Follow-up|0
7893124|NCT01878292|12399123|FG000|Randomized|Adverse Event|1
7893125|NCT01878292|12399124|FG001|Randomized|Adverse Event|0
7893126|NCT01878292|12399125|FG002|Randomized|Adverse Event|0
7893127|NCT01878292|12399123|FG000|Double-blind Treatment Period|Other Reasons|2
7893128|NCT01878292|12399124|FG001|Double-blind Treatment Period|Other Reasons|0
7893129|NCT01878292|12399125|FG002|Double-blind Treatment Period|Other Reasons|0
7893130|NCT01878292|12399123|FG000|Double-blind Treatment Period|Lost to Follow-up|6
7893131|NCT01878292|12399124|FG001|Double-blind Treatment Period|Lost to Follow-up|3
7893132|NCT01878292|12399125|FG002|Double-blind Treatment Period|Lost to Follow-up|1
7893133|NCT01878292|12399123|FG000|Double-blind Treatment Period|Withdrawal by Subject|9
7893134|NCT01878292|12399124|FG001|Double-blind Treatment Period|Withdrawal by Subject|7
7893135|NCT01878292|12399125|FG002|Double-blind Treatment Period|Withdrawal by Subject|8
7893136|NCT01878292|12399123|FG000|Double-blind Treatment Period|Protocol Violation|3
7893137|NCT01878292|12399124|FG001|Double-blind Treatment Period|Protocol Violation|4
7893138|NCT01878292|12399125|FG002|Double-blind Treatment Period|Protocol Violation|2
7893139|NCT01878292|12399123|FG000|Double-blind Treatment Period|Lack of Efficacy|5
7893140|NCT01878292|12399124|FG001|Double-blind Treatment Period|Lack of Efficacy|3
7893141|NCT01878292|12399125|FG002|Double-blind Treatment Period|Lack of Efficacy|0
7893142|NCT01878292|12399123|FG000|Double-blind Treatment Period|Adverse Event|4
7893143|NCT01878292|12399124|FG001|Double-blind Treatment Period|Adverse Event|9
7893144|NCT01878292|12399125|FG002|Double-blind Treatment Period|Adverse Event|8
7893145|NCT01878292|12399123|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5
7893146|NCT01878292|12399124|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8
7893147|NCT01878292|12399125|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4
7893148|NCT01878383|12399135|FG000|Overall Study|Lost to Follow-up|0
7893149|NCT01878383|12399136|FG001|Overall Study|Lost to Follow-up|1499
7893150|NCT01878890|12399206|FG000|Overall Study|Protocol Violation|0
7893151|NCT01878890|12399207|FG001|Overall Study|Protocol Violation|1
7893152|NCT01878890|12399208|FG002|Overall Study|Protocol Violation|0
7893153|NCT01878890|12399209|FG003|Overall Study|Protocol Violation|0
7893154|NCT01879072|12399224|FG000|Overall Study|Withdrawal by Subject|121
7893155|NCT01879072|12399224|FG000|Overall Study|Not Transplanted|30
7893156|NCT01879319|12399239|FG000|Overall Study|Withdrawal by Subject|1
7893157|NCT01879319|12399240|FG001|Overall Study|Withdrawal by Subject|0
7893158|NCT01879319|12399239|FG000|Overall Study|Lost to Follow-up|1
7893159|NCT01879319|12399240|FG001|Overall Study|Lost to Follow-up|5
7893160|NCT01879410|12399295|FG000|Overall Study|Adverse Event|9
7893161|NCT01879410|12399296|FG001|Overall Study|Adverse Event|14
7893162|NCT01879410|12399295|FG000|Overall Study|Lack of Efficacy|4
7893163|NCT01879410|12399296|FG001|Overall Study|Lack of Efficacy|6
7893164|NCT01879410|12399295|FG000|Overall Study|Protocol Violation|1
7893165|NCT01879410|12399296|FG001|Overall Study|Protocol Violation|7
7893166|NCT01879410|12399295|FG000|Overall Study|Lost to Follow-up|2
7893167|NCT01879410|12399296|FG001|Overall Study|Lost to Follow-up|1
7893168|NCT01879410|12399295|FG000|Overall Study|Withdrawal by Subject|7
7893169|NCT01879410|12399296|FG001|Overall Study|Withdrawal by Subject|8
7893170|NCT01879410|12399295|FG000|Overall Study|Randomised in Error|1
7893171|NCT01879410|12399296|FG001|Overall Study|Randomised in Error|2
7893172|NCT01879553|12399308|FG000|Overall Study|Withdrawal by Subject|1
7893173|NCT01879553|12399309|FG001|Overall Study|Withdrawal by Subject|0
7893174|NCT01879579|12399318|FG000|Overall Study|Phone incompatible with texting platform|3
7893175|NCT01879579|12399319|FG001|Overall Study|Phone incompatible with texting platform|0
7893176|NCT01879579|12399318|FG000|Overall Study|Did not enroll in texting platform|1
7893177|NCT01879579|12399319|FG001|Overall Study|Did not enroll in texting platform|0
7893178|NCT01879579|12399318|FG000|Overall Study|Did not initiate insulin treatment|1
7893179|NCT01879579|12399319|FG001|Overall Study|Did not initiate insulin treatment|0
7893180|NCT01879579|12399318|FG000|Overall Study|Phenotypic type 1 diabetes|0
7893181|NCT01879579|12399319|FG001|Overall Study|Phenotypic type 1 diabetes|1
7893182|NCT01879579|12399318|FG000|Overall Study|Discontinued insulin - possible allergy|0
7893183|NCT01879579|12399319|FG001|Overall Study|Discontinued insulin - possible allergy|1
7893184|NCT01879618|12399328|FG000|Overall Study|Does not meet entrance criteria|1
7893185|NCT01879618|12399328|FG000|Overall Study|Withdrawal by Subject|1
7893186|NCT01879618|12399328|FG000|Overall Study|Surgery;changed schedule; not available|8
7893187|NCT01879618|12399328|FG000|Overall Study|Protocol Violation|6
7893188|NCT01879618|12399328|FG000|Overall Study|Adverse Event|5
7893189|NCT01879683|12399332|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1
7893190|NCT01879722|12399346|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7893191|NCT01879722|12399347|FG001|Overall Study|Pretreatment Event/Adverse Event|1
7893192|NCT01879722|12399348|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7893193|NCT01879722|12399349|FG003|Overall Study|Pretreatment Event/Adverse Event|1
7893194|NCT01879722|12399350|FG004|Overall Study|Pretreatment Event/Adverse Event|1
7893195|NCT01879722|12399351|FG005|Overall Study|Pretreatment Event/Adverse Event|0
7893196|NCT01879722|12399352|FG006|Overall Study|Pretreatment Event/Adverse Event|0
7893197|NCT01879722|12399353|FG007|Overall Study|Pretreatment Event/Adverse Event|1
7893198|NCT01879722|12399354|FG008|Overall Study|Pretreatment Event/Adverse Event|1
7893199|NCT01879722|12399355|FG009|Overall Study|Pretreatment Event/Adverse Event|0
7893200|NCT01879722|12399346|FG000|Overall Study|Voluntary Withdrawal|0
7893201|NCT01879722|12399347|FG001|Overall Study|Voluntary Withdrawal|0
7893202|NCT01879722|12399348|FG002|Overall Study|Voluntary Withdrawal|0
7893203|NCT01879722|12399349|FG003|Overall Study|Voluntary Withdrawal|0
7893204|NCT01879722|12399350|FG004|Overall Study|Voluntary Withdrawal|0
7893205|NCT01879722|12399351|FG005|Overall Study|Voluntary Withdrawal|0
7893206|NCT01879722|12399352|FG006|Overall Study|Voluntary Withdrawal|0
7893207|NCT01879722|12399353|FG007|Overall Study|Voluntary Withdrawal|0
7893208|NCT01879722|12399354|FG008|Overall Study|Voluntary Withdrawal|1
7893209|NCT01879722|12399355|FG009|Overall Study|Voluntary Withdrawal|0
7963070|NCT02717754|12517506|FG004|Overall Study|Incorrect Infusion Duration|20
7963071|NCT02717754|12517507|FG005|Overall Study|Incorrect Infusion Duration|20
7963072|NCT02718131|12517519|FG000|Overall Study|Withdrawal by Subject|1
7963073|NCT02718131|12517520|FG001|Overall Study|Withdrawal by Subject|0
7963074|NCT02718131|12517519|FG000|Overall Study|Adverse Event|1
7963075|NCT02718131|12517520|FG001|Overall Study|Adverse Event|0
7963076|NCT02718131|12517519|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1
7963077|NCT02718131|12517520|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0
7963078|NCT02718326|12517539|FG000|Overall Study|Adverse Event|4
7963079|NCT02718326|12517540|FG001|Overall Study|Adverse Event|9
7963080|NCT02718326|12517541|FG002|Overall Study|Adverse Event|0
7963081|NCT02718326|12517539|FG000|Overall Study|Death|8
7963082|NCT02718326|12517540|FG001|Overall Study|Death|1
7963083|NCT02718326|12517541|FG002|Overall Study|Death|2
7963084|NCT02718326|12517539|FG000|Overall Study|Withdrawal by Subject|4
7963085|NCT02718326|12517540|FG001|Overall Study|Withdrawal by Subject|9
7963086|NCT02718326|12517541|FG002|Overall Study|Withdrawal by Subject|6
7963087|NCT02718326|12517539|FG000|Overall Study|Lost to Follow-up|18
7963088|NCT02718326|12517540|FG001|Overall Study|Lost to Follow-up|5
7963089|NCT02718326|12517541|FG002|Overall Study|Lost to Follow-up|14
7963090|NCT02718326|12517539|FG000|Overall Study|Protocol Deviation|1
7963091|NCT02718326|12517540|FG001|Overall Study|Protocol Deviation|0
7963092|NCT02718326|12517541|FG002|Overall Study|Protocol Deviation|0
7963093|NCT02718326|12517539|FG000|Overall Study|Pregnancy|1
7963094|NCT02718326|12517540|FG001|Overall Study|Pregnancy|0
7963095|NCT02718326|12517541|FG002|Overall Study|Pregnancy|0
7963096|NCT02718417|12517554|FG000|Chemotherapy Phase (CP)|Adverse Event|9
7963097|NCT02718417|12517555|FG001|Chemotherapy Phase (CP)|Adverse Event|14
7963098|NCT02718417|12517556|FG002|Chemotherapy Phase (CP)|Adverse Event|13
7963099|NCT02718417|12517554|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5
7963100|NCT02718417|12517555|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4
7963101|NCT02718417|12517556|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1
7963102|NCT02718417|12517554|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3
7963103|NCT02718417|12517555|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2
7963104|NCT02718417|12517556|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1
7963105|NCT02718417|12517554|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4
7963106|NCT02718417|12517555|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2
7963107|NCT02718417|12517556|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1
7963108|NCT02718417|12517554|FG000|Chemotherapy Phase (CP)|Physician's decision|5
7963109|NCT02718417|12517555|FG001|Chemotherapy Phase (CP)|Physician's decision|0
7963110|NCT02718417|12517556|FG002|Chemotherapy Phase (CP)|Physician's decision|4
7963111|NCT02718417|12517554|FG000|Chemotherapy Phase (CP)|Progressive disease|11
7963112|NCT02718417|12517555|FG001|Chemotherapy Phase (CP)|Progressive disease|7
7963113|NCT02718417|12517556|FG002|Chemotherapy Phase (CP)|Progressive disease|10
7963114|NCT02718417|12517554|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13
7963115|NCT02718417|12517555|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8
7963116|NCT02718417|12517556|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15
7963117|NCT02718417|12517554|FG000|Chemotherapy Phase (CP)|Other|2
7963118|NCT02718417|12517555|FG001|Chemotherapy Phase (CP)|Other|0
7963119|NCT02718417|12517556|FG002|Chemotherapy Phase (CP)|Other|1
7963120|NCT02718417|12517554|FG000|Maintenance Phase (MP)|Adverse Event|21
7963121|NCT02718417|12517555|FG001|Maintenance Phase (MP)|Adverse Event|26
7963122|NCT02718417|12517556|FG002|Maintenance Phase (MP)|Adverse Event|0
7963123|NCT02718417|12517554|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1
7963124|NCT02718417|12517555|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1
7963125|NCT02718417|12517556|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0
7963126|NCT02718417|12517554|FG000|Maintenance Phase (MP)|Global deterioration of health status|5
7963127|NCT02718417|12517555|FG001|Maintenance Phase (MP)|Global deterioration of health status|3
7893210|NCT04495829|12399389|FG000|Overall Study|Lost to Follow-up|2
7893211|NCT04495829|12399389|FG000|Overall Study|Inclusion criterion not met|3
7963128|NCT02718417|12517556|FG002|Maintenance Phase (MP)|Global deterioration of health status|0
7963129|NCT02718417|12517554|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0
7963130|NCT02718417|12517555|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1
7963131|NCT02718417|12517556|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0
7963132|NCT02718417|12517554|FG000|Maintenance Phase (MP)|Physician's decision|6
7963133|NCT02718417|12517555|FG001|Maintenance Phase (MP)|Physician's decision|7
7963134|NCT02718417|12517556|FG002|Maintenance Phase (MP)|Physician's decision|0
7963135|NCT02718417|12517554|FG000|Maintenance Phase (MP)|Progressive disease|100
7963136|NCT02718417|12517555|FG001|Maintenance Phase (MP)|Progressive disease|88
7963137|NCT02718417|12517556|FG002|Maintenance Phase (MP)|Progressive disease|0
7963138|NCT02718417|12517554|FG000|Maintenance Phase (MP)|Other|2
7963139|NCT02718417|12517555|FG001|Maintenance Phase (MP)|Other|1
7963140|NCT02718417|12517556|FG002|Maintenance Phase (MP)|Other|0
7963141|NCT02718417|12517554|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17
7963142|NCT02718417|12517555|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20
7963143|NCT02718417|12517556|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0
7963144|NCT02718417|12517554|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114
7963145|NCT02718417|12517555|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140
7963146|NCT02718417|12517556|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0
7963147|NCT02718417|12517554|FG000|Observation Phase (OP)|Adverse Event|0
7963148|NCT02718417|12517555|FG001|Observation Phase (OP)|Adverse Event|0
7963149|NCT02718417|12517556|FG002|Observation Phase (OP)|Adverse Event|1
7963150|NCT02718417|12517554|FG000|Observation Phase (OP)|Death leading to discontinuation|0
7963151|NCT02718417|12517555|FG001|Observation Phase (OP)|Death leading to discontinuation|0
7963152|NCT02718417|12517556|FG002|Observation Phase (OP)|Death leading to discontinuation|2
7963153|NCT02718417|12517554|FG000|Observation Phase (OP)|Lost to Follow-up|0
7963154|NCT02718417|12517555|FG001|Observation Phase (OP)|Lost to Follow-up|0
7963155|NCT02718417|12517556|FG002|Observation Phase (OP)|Lost to Follow-up|1
7963156|NCT02718417|12517554|FG000|Observation Phase (OP)|Physician Decision|0
7963157|NCT02718417|12517555|FG001|Observation Phase (OP)|Physician Decision|0
7963158|NCT02718417|12517556|FG002|Observation Phase (OP)|Physician Decision|9
7963159|NCT02718417|12517554|FG000|Observation Phase (OP)|Progressive disease|0
7963160|NCT02718417|12517555|FG001|Observation Phase (OP)|Progressive disease|0
7963161|NCT02718417|12517556|FG002|Observation Phase (OP)|Progressive disease|92
7963162|NCT02718417|12517554|FG000|Observation Phase (OP)|Study terminated by sponsor|0
7963163|NCT02718417|12517555|FG001|Observation Phase (OP)|Study terminated by sponsor|0
7963164|NCT02718417|12517556|FG002|Observation Phase (OP)|Study terminated by sponsor|135
7963165|NCT02718417|12517554|FG000|Observation Phase (OP)|Withdrawal by Subject|0
7963166|NCT02718417|12517555|FG001|Observation Phase (OP)|Withdrawal by Subject|0
7963167|NCT02718417|12517556|FG002|Observation Phase (OP)|Withdrawal by Subject|34
7963168|NCT02718417|12517554|FG000|Observation Phase (OP)|Global deterioration of health status|0
7963169|NCT02718417|12517555|FG001|Observation Phase (OP)|Global deterioration of health status|0
7963170|NCT02718417|12517556|FG002|Observation Phase (OP)|Global deterioration of health status|1
7963171|NCT02718417|12517554|FG000|Observation Phase (OP)|Other|0
7963172|NCT02718417|12517555|FG001|Observation Phase (OP)|Other|0
7963173|NCT02718417|12517556|FG002|Observation Phase (OP)|Other|7
7963174|NCT02718417|12517554|FG000|Follow-up Phase|Adverse Event|3
7963175|NCT02718417|12517555|FG001|Follow-up Phase|Adverse Event|1
7963176|NCT02718417|12517556|FG002|Follow-up Phase|Adverse Event|1
7963177|NCT02718417|12517554|FG000|Follow-up Phase|Other|4
7963178|NCT02718417|12517555|FG001|Follow-up Phase|Other|6
7963179|NCT02718417|12517556|FG002|Follow-up Phase|Other|4
7963180|NCT02718417|12517554|FG000|Follow-up Phase|Withdrawal by Subject|19
7963181|NCT02718417|12517555|FG001|Follow-up Phase|Withdrawal by Subject|17
7963182|NCT02718417|12517556|FG002|Follow-up Phase|Withdrawal by Subject|5
7963183|NCT02718417|12517554|FG000|Follow-up Phase|Study terminated by sponsor|100
7963184|NCT02718417|12517555|FG001|Follow-up Phase|Study terminated by sponsor|138
7963185|NCT02718417|12517556|FG002|Follow-up Phase|Study terminated by sponsor|6
7963186|NCT02718417|12517554|FG000|Follow-up Phase|Lost to Follow-up|2
7963187|NCT02718417|12517555|FG001|Follow-up Phase|Lost to Follow-up|3
7963188|NCT02718417|12517556|FG002|Follow-up Phase|Lost to Follow-up|0
7963189|NCT02718417|12517554|FG000|Follow-up Phase|Death leading to discontinuation|7
7963190|NCT02718417|12517555|FG001|Follow-up Phase|Death leading to discontinuation|7
7963191|NCT02718417|12517556|FG002|Follow-up Phase|Death leading to discontinuation|3
7963192|NCT02718417|12517554|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20
7963193|NCT02718417|12517555|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17
7963194|NCT02718417|12517556|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11
7963195|NCT02718417|12517554|FG000|Long-term Follow-up Phase|Lost to Follow-up|8
7963196|NCT02718417|12517555|FG001|Long-term Follow-up Phase|Lost to Follow-up|4
7963197|NCT02718417|12517556|FG002|Long-term Follow-up Phase|Lost to Follow-up|3
7963198|NCT02718417|12517554|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105
7963199|NCT02718417|12517555|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80
7963200|NCT02718417|12517556|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112
7963201|NCT02718417|12517554|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6
7893212|NCT03861052|12399397|FG000|Overall Study|Adverse Event|1
7893213|NCT03861052|12399398|FG001|Overall Study|Adverse Event|1
7893214|NCT03861052|12399399|FG002|Overall Study|Adverse Event|2
7893215|NCT03861052|12399400|FG003|Overall Study|Adverse Event|4
7893216|NCT03861052|12399397|FG000|Overall Study|Lost to Follow-up|0
7893217|NCT03861052|12399398|FG001|Overall Study|Lost to Follow-up|0
7893218|NCT03861052|12399399|FG002|Overall Study|Lost to Follow-up|0
7893219|NCT03861052|12399400|FG003|Overall Study|Lost to Follow-up|1
7893220|NCT03861052|12399397|FG000|Overall Study|Physician Decision|0
7893221|NCT03861052|12399398|FG001|Overall Study|Physician Decision|1
7893222|NCT03861052|12399399|FG002|Overall Study|Physician Decision|0
7893223|NCT03861052|12399400|FG003|Overall Study|Physician Decision|0
7893224|NCT03861052|12399397|FG000|Overall Study|Withdrawal by Subject|2
7893225|NCT03861052|12399398|FG001|Overall Study|Withdrawal by Subject|5
7893226|NCT03861052|12399399|FG002|Overall Study|Withdrawal by Subject|3
7893227|NCT03861052|12399400|FG003|Overall Study|Withdrawal by Subject|0
7893228|NCT03861052|12399397|FG000|Overall Study|Relocation to other city|1
7893229|NCT03861052|12399398|FG001|Overall Study|Relocation to other city|0
7893230|NCT03861052|12399399|FG002|Overall Study|Relocation to other city|0
7893231|NCT03861052|12399400|FG003|Overall Study|Relocation to other city|0
7893232|NCT03846453|12399417|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465
7893233|NCT03846453|12399418|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0
7893234|NCT03846453|12399419|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0
7893235|NCT03846453|12399417|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3
7893236|NCT03846453|12399418|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0
7893237|NCT03846453|12399419|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0
7893238|NCT03846453|12399417|FG000|Placebo Run-in (14 Days)|Physician Decision|1
7893239|NCT03846453|12399418|FG001|Placebo Run-in (14 Days)|Physician Decision|0
7893240|NCT03846453|12399419|FG002|Placebo Run-in (14 Days)|Physician Decision|0
7893241|NCT03846453|12399417|FG000|Placebo Run-in (14 Days)|Other|2
7893242|NCT03846453|12399418|FG001|Placebo Run-in (14 Days)|Other|0
7893243|NCT03846453|12399419|FG002|Placebo Run-in (14 Days)|Other|0
7893244|NCT03846453|12399417|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0
7893245|NCT03846453|12399418|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16
7893246|NCT03846453|12399419|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8
7893247|NCT03846453|12399417|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0
7893248|NCT03846453|12399418|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6
7893249|NCT03846453|12399419|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5
7893250|NCT03846453|12399417|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0
7893251|NCT03846453|12399418|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2
7893252|NCT03846453|12399419|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4
7893253|NCT03846453|12399417|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0
7893254|NCT03846453|12399418|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2
7893255|NCT03846453|12399419|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4
7893256|NCT03846453|12399417|FG000|Randomized Treatment Period (Days 57±3)|Other|0
7893257|NCT03846453|12399418|FG001|Randomized Treatment Period (Days 57±3)|Other|1
7893258|NCT03846453|12399419|FG002|Randomized Treatment Period (Days 57±3)|Other|4
7893259|NCT03605862|12399429|FG000|Overall Study|Withdrawal by Subject|12
7893260|NCT03605862|12399430|FG001|Overall Study|Withdrawal by Subject|9
7893261|NCT03605862|12399429|FG000|Overall Study|Adverse Event|2
7893262|NCT03605862|12399430|FG001|Overall Study|Adverse Event|1
7893263|NCT03605862|12399429|FG000|Overall Study|Physician Decision|3
7893264|NCT03605862|12399430|FG001|Overall Study|Physician Decision|1
7893265|NCT03605862|12399429|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11
7893266|NCT03605862|12399430|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15
7893267|NCT03541252|12399437|FG000|Overall Study|Withdrawal by Subject|1
7893268|NCT03401112|12399446|FG000|Overall Study|Adverse Event|1
7893269|NCT03401112|12399447|FG001|Overall Study|Adverse Event|2
7893270|NCT03401112|12399448|FG002|Overall Study|Adverse Event|3
7893271|NCT03401112|12399449|FG003|Overall Study|Adverse Event|2
7893272|NCT03401112|12399450|FG004|Overall Study|Adverse Event|0
7893273|NCT03401112|12399446|FG000|Overall Study|Lost to Follow-up|1
7893274|NCT03401112|12399447|FG001|Overall Study|Lost to Follow-up|0
7893275|NCT03401112|12399448|FG002|Overall Study|Lost to Follow-up|0
7893276|NCT03401112|12399449|FG003|Overall Study|Lost to Follow-up|0
7893277|NCT03401112|12399450|FG004|Overall Study|Lost to Follow-up|0
7893278|NCT03401112|12399446|FG000|Overall Study|Noncompliance|1
7893279|NCT03401112|12399447|FG001|Overall Study|Noncompliance|2
7893280|NCT03401112|12399448|FG002|Overall Study|Noncompliance|3
7893281|NCT03401112|12399449|FG003|Overall Study|Noncompliance|0
7893282|NCT03401112|12399450|FG004|Overall Study|Noncompliance|0
7893283|NCT03401112|12399446|FG000|Overall Study|Did not Meet Inclusion Criteria|1
7893284|NCT03401112|12399447|FG001|Overall Study|Did not Meet Inclusion Criteria|0
7893285|NCT03401112|12399448|FG002|Overall Study|Did not Meet Inclusion Criteria|0
7893286|NCT03401112|12399449|FG003|Overall Study|Did not Meet Inclusion Criteria|0
7893287|NCT03401112|12399450|FG004|Overall Study|Did not Meet Inclusion Criteria|0
7893288|NCT03401112|12399446|FG000|Overall Study|Withdrawal by Subject|0
7893289|NCT03401112|12399447|FG001|Overall Study|Withdrawal by Subject|3
7893290|NCT03401112|12399448|FG002|Overall Study|Withdrawal by Subject|2
7893291|NCT03401112|12399449|FG003|Overall Study|Withdrawal by Subject|1
7893292|NCT03401112|12399450|FG004|Overall Study|Withdrawal by Subject|0
7893293|NCT03401112|12399446|FG000|Overall Study|Physician Decision|0
7893294|NCT03401112|12399447|FG001|Overall Study|Physician Decision|0
7893295|NCT03401112|12399448|FG002|Overall Study|Physician Decision|0
7893296|NCT03401112|12399449|FG003|Overall Study|Physician Decision|2
7893297|NCT03401112|12399450|FG004|Overall Study|Physician Decision|0
7893298|NCT03401112|12399446|FG000|Overall Study|Study was Terminated by Sponsor|0
7893299|NCT03401112|12399447|FG001|Overall Study|Study was Terminated by Sponsor|0
7893300|NCT03401112|12399448|FG002|Overall Study|Study was Terminated by Sponsor|0
7893301|NCT03401112|12399449|FG003|Overall Study|Study was Terminated by Sponsor|1
7893302|NCT03401112|12399450|FG004|Overall Study|Study was Terminated by Sponsor|0
7893303|NCT03401112|12399446|FG000|Overall Study|Day 1 Assessment not Done|1
7893304|NCT03401112|12399447|FG001|Overall Study|Day 1 Assessment not Done|0
7893305|NCT03401112|12399448|FG002|Overall Study|Day 1 Assessment not Done|0
7893306|NCT03401112|12399449|FG003|Overall Study|Day 1 Assessment not Done|0
7893307|NCT03401112|12399450|FG004|Overall Study|Day 1 Assessment not Done|0
7893308|NCT03401112|12399446|FG000|Overall Study|Not Dosed|0
7893309|NCT03401112|12399447|FG001|Overall Study|Not Dosed|0
7893310|NCT03401112|12399448|FG002|Overall Study|Not Dosed|1
7893311|NCT03401112|12399449|FG003|Overall Study|Not Dosed|0
7893312|NCT03401112|12399450|FG004|Overall Study|Not Dosed|0
7893313|NCT03401112|12399446|FG000|Overall Study|Missed Clinical Visit|0
7893314|NCT03401112|12399447|FG001|Overall Study|Missed Clinical Visit|0
7893315|NCT03401112|12399448|FG002|Overall Study|Missed Clinical Visit|1
7893316|NCT03401112|12399449|FG003|Overall Study|Missed Clinical Visit|0
7893317|NCT03401112|12399450|FG004|Overall Study|Missed Clinical Visit|0
7893318|NCT03401112|12399446|FG000|Overall Study|Missed Doses|0
7893319|NCT03401112|12399447|FG001|Overall Study|Missed Doses|0
7893320|NCT03401112|12399448|FG002|Overall Study|Missed Doses|1
7893321|NCT03401112|12399449|FG003|Overall Study|Missed Doses|0
7893322|NCT03401112|12399450|FG004|Overall Study|Missed Doses|0
7963202|NCT02718417|12517555|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9
7963203|NCT02718417|12517556|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9
7963204|NCT02718417|12517554|FG000|Long-term Follow-up Phase|Other|0
7963205|NCT02718417|12517555|FG001|Long-term Follow-up Phase|Other|2
7963206|NCT02718417|12517556|FG002|Long-term Follow-up Phase|Other|0
7963207|NCT02718625|12517573|FG000|Overall Study|Adverse Event|0
7963208|NCT02718625|12517574|FG001|Overall Study|Adverse Event|1
7963209|NCT02718625|12517573|FG000|Overall Study|Termination of Study by Sponsor|0
7963210|NCT02718625|12517574|FG001|Overall Study|Termination of Study by Sponsor|1
7963211|NCT02718898|12517582|FG000|Blinded Treatment Period|Adverse Event|5
7963212|NCT02718898|12517583|FG001|Blinded Treatment Period|Adverse Event|1
7963213|NCT02718898|12517584|FG002|Blinded Treatment Period|Adverse Event|0
7963214|NCT02718898|12517585|FG003|Blinded Treatment Period|Adverse Event|0
7963215|NCT02718898|12517586|FG004|Blinded Treatment Period|Adverse Event|0
7963216|NCT02718898|12517587|FG005|Blinded Treatment Period|Adverse Event|0
7963217|NCT02718898|12517588|FG006|Blinded Treatment Period|Adverse Event|0
7963218|NCT02718898|12517582|FG000|Blinded Treatment Period|Physician Decision|1
7963219|NCT02718898|12517583|FG001|Blinded Treatment Period|Physician Decision|0
7963220|NCT02718898|12517584|FG002|Blinded Treatment Period|Physician Decision|0
7963221|NCT02718898|12517585|FG003|Blinded Treatment Period|Physician Decision|0
7963222|NCT02718898|12517586|FG004|Blinded Treatment Period|Physician Decision|0
7963223|NCT02718898|12517587|FG005|Blinded Treatment Period|Physician Decision|0
7963224|NCT02718898|12517588|FG006|Blinded Treatment Period|Physician Decision|0
7963225|NCT02718898|12517582|FG000|Blinded Treatment Period|Lack of Efficacy|1
7963226|NCT02718898|12517583|FG001|Blinded Treatment Period|Lack of Efficacy|0
7963227|NCT02718898|12517584|FG002|Blinded Treatment Period|Lack of Efficacy|0
7963228|NCT02718898|12517585|FG003|Blinded Treatment Period|Lack of Efficacy|0
7963229|NCT02718898|12517586|FG004|Blinded Treatment Period|Lack of Efficacy|0
7963230|NCT02718898|12517587|FG005|Blinded Treatment Period|Lack of Efficacy|0
7963231|NCT02718898|12517588|FG006|Blinded Treatment Period|Lack of Efficacy|0
7963232|NCT02718898|12517582|FG000|Blinded Treatment Period|Lost to Follow-up|2
7963233|NCT02718898|12517583|FG001|Blinded Treatment Period|Lost to Follow-up|0
7963234|NCT02718898|12517584|FG002|Blinded Treatment Period|Lost to Follow-up|0
7963235|NCT02718898|12517585|FG003|Blinded Treatment Period|Lost to Follow-up|0
7963236|NCT02718898|12517586|FG004|Blinded Treatment Period|Lost to Follow-up|0
7963237|NCT02718898|12517587|FG005|Blinded Treatment Period|Lost to Follow-up|0
7963238|NCT02718898|12517588|FG006|Blinded Treatment Period|Lost to Follow-up|0
7963239|NCT02718898|12517582|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0
7963240|NCT02718898|12517583|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0
7963241|NCT02718898|12517584|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1
7963242|NCT02718898|12517585|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1
7963243|NCT02718898|12517586|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0
7963244|NCT02718898|12517587|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0
7963245|NCT02718898|12517588|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0
7963246|NCT02718898|12517582|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7963247|NCT02718898|12517583|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7963248|NCT02718898|12517584|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7893323|NCT03041701|12399488|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1
7893324|NCT03041701|12399489|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1
7893325|NCT03041701|12399490|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0
7893326|NCT03041701|12399488|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0
7893327|NCT03041701|12399489|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0
7893328|NCT03041701|12399490|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1
7893329|NCT03000179|12399501|FG000|Overall Study|Lost to Follow-up|2
7893330|NCT02876835|12399507|FG000|Treatment Period (51.1 Month)|Other|1
7893331|NCT02876835|12399508|FG001|Treatment Period (51.1 Month)|Other|0
7893332|NCT02876835|12399507|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6
7893333|NCT02876835|12399508|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13
7893334|NCT02876835|12399507|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32
7893335|NCT02876835|12399508|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23
7893336|NCT02876835|12399507|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25
7893337|NCT02876835|12399508|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29
7893338|NCT01492361|12399534|FG000|Overall Study|Withdrawal by Subject|281
7893339|NCT01492361|12399535|FG001|Overall Study|Withdrawal by Subject|297
7893340|NCT01492361|12399534|FG000|Overall Study|Physician Decision|12
7893341|NCT01492361|12399535|FG001|Overall Study|Physician Decision|12
7893342|NCT01492361|12399534|FG000|Overall Study|Lost to Follow-up|6
7893343|NCT01492361|12399535|FG001|Overall Study|Lost to Follow-up|13
7893344|NCT01492361|12399534|FG000|Overall Study|Other than specified above|106
7893345|NCT01492361|12399535|FG001|Overall Study|Other than specified above|138
7893346|NCT01296711|12399549|FG000|Overall Study|Adverse Event|3
7893347|NCT01296711|12399550|FG001|Overall Study|Adverse Event|1
7893348|NCT01296711|12399551|FG002|Overall Study|Adverse Event|4
7893349|NCT01296711|12399552|FG003|Overall Study|Adverse Event|3
7893350|NCT01296711|12399553|FG004|Overall Study|Adverse Event|1
7893351|NCT01296711|12399554|FG005|Overall Study|Adverse Event|6
7893352|NCT01296711|12399555|FG006|Overall Study|Adverse Event|11
7893353|NCT01296711|12399556|FG007|Overall Study|Adverse Event|3
7893354|NCT01296711|12399549|FG000|Overall Study|Lack of Efficacy|1
7893355|NCT01296711|12399550|FG001|Overall Study|Lack of Efficacy|4
7893356|NCT01296711|12399551|FG002|Overall Study|Lack of Efficacy|1
7893357|NCT01296711|12399552|FG003|Overall Study|Lack of Efficacy|1
7893358|NCT01296711|12399553|FG004|Overall Study|Lack of Efficacy|1
7893359|NCT01296711|12399554|FG005|Overall Study|Lack of Efficacy|0
7893360|NCT01296711|12399555|FG006|Overall Study|Lack of Efficacy|2
7893361|NCT01296711|12399556|FG007|Overall Study|Lack of Efficacy|3
7893362|NCT01296711|12399549|FG000|Overall Study|Lost to Follow-up|0
7893363|NCT01296711|12399550|FG001|Overall Study|Lost to Follow-up|0
7893364|NCT01296711|12399551|FG002|Overall Study|Lost to Follow-up|1
7893365|NCT01296711|12399552|FG003|Overall Study|Lost to Follow-up|1
7893366|NCT01296711|12399553|FG004|Overall Study|Lost to Follow-up|2
7893367|NCT01296711|12399554|FG005|Overall Study|Lost to Follow-up|0
7893368|NCT01296711|12399555|FG006|Overall Study|Lost to Follow-up|4
7893369|NCT01296711|12399556|FG007|Overall Study|Lost to Follow-up|2
7893370|NCT01296711|12399549|FG000|Overall Study|Protocol Violation|0
7893371|NCT01296711|12399550|FG001|Overall Study|Protocol Violation|0
7893372|NCT01296711|12399551|FG002|Overall Study|Protocol Violation|0
7893373|NCT01296711|12399552|FG003|Overall Study|Protocol Violation|1
7893374|NCT01296711|12399553|FG004|Overall Study|Protocol Violation|1
7893375|NCT01296711|12399554|FG005|Overall Study|Protocol Violation|0
7893376|NCT01296711|12399555|FG006|Overall Study|Protocol Violation|0
7893377|NCT01296711|12399556|FG007|Overall Study|Protocol Violation|0
7893378|NCT01296711|12399549|FG000|Overall Study|Withdrawal by Subject|4
7893379|NCT01296711|12399550|FG001|Overall Study|Withdrawal by Subject|2
7893380|NCT01296711|12399551|FG002|Overall Study|Withdrawal by Subject|2
7893381|NCT01296711|12399552|FG003|Overall Study|Withdrawal by Subject|1
7893382|NCT01296711|12399553|FG004|Overall Study|Withdrawal by Subject|1
7893383|NCT01296711|12399554|FG005|Overall Study|Withdrawal by Subject|1
7893384|NCT01296711|12399555|FG006|Overall Study|Withdrawal by Subject|2
7893385|NCT01296711|12399556|FG007|Overall Study|Withdrawal by Subject|1
7893386|NCT01296711|12399549|FG000|Overall Study|Study termination|8
7893387|NCT01296711|12399550|FG001|Overall Study|Study termination|1
7893388|NCT01296711|12399551|FG002|Overall Study|Study termination|5
7893389|NCT01296711|12399552|FG003|Overall Study|Study termination|4
7893390|NCT01296711|12399553|FG004|Overall Study|Study termination|4
7893391|NCT01296711|12399554|FG005|Overall Study|Study termination|4
7893392|NCT01296711|12399555|FG006|Overall Study|Study termination|8
7893393|NCT01296711|12399556|FG007|Overall Study|Study termination|10
7893394|NCT01296711|12399549|FG000|Overall Study|Continued elevated liver enzymes|0
7893395|NCT01296711|12399550|FG001|Overall Study|Continued elevated liver enzymes|0
7893396|NCT01296711|12399551|FG002|Overall Study|Continued elevated liver enzymes|0
7893397|NCT01296711|12399552|FG003|Overall Study|Continued elevated liver enzymes|1
7893398|NCT01296711|12399553|FG004|Overall Study|Continued elevated liver enzymes|0
7893399|NCT01296711|12399554|FG005|Overall Study|Continued elevated liver enzymes|0
7893400|NCT01296711|12399555|FG006|Overall Study|Continued elevated liver enzymes|0
7893401|NCT01296711|12399556|FG007|Overall Study|Continued elevated liver enzymes|0
7893402|NCT01296711|12399549|FG000|Overall Study|Methotrexate discontinued|0
7968408|NCT03272347|12525895|FG000|Overall Study|Physician Decision|4
7968409|NCT03272347|12525896|FG001|Overall Study|Physician Decision|2
7968410|NCT03272347|12525897|FG002|Overall Study|Physician Decision|5
7968411|NCT03272347|12525898|FG003|Overall Study|Physician Decision|4
7968412|NCT03272347|12525895|FG000|Overall Study|Screen Failure|1
7968413|NCT03272347|12525896|FG001|Overall Study|Screen Failure|0
7968414|NCT03272347|12525897|FG002|Overall Study|Screen Failure|0
7968415|NCT03272347|12525898|FG003|Overall Study|Screen Failure|0
7968416|NCT03272347|12525895|FG000|Overall Study|Withdrawal by Subject|3
7968417|NCT03272347|12525896|FG001|Overall Study|Withdrawal by Subject|1
7968418|NCT03272347|12525897|FG002|Overall Study|Withdrawal by Subject|2
7968419|NCT03272347|12525898|FG003|Overall Study|Withdrawal by Subject|1
7968420|NCT03272347|12525895|FG000|Overall Study|Status Not Recorded|22
7968421|NCT03272347|12525896|FG001|Overall Study|Status Not Recorded|26
7968422|NCT03272347|12525897|FG002|Overall Study|Status Not Recorded|19
7968423|NCT03272347|12525898|FG003|Overall Study|Status Not Recorded|22
7968424|NCT02674750|12525939|FG000|Overall Study|Death|4
7968425|NCT02674750|12525940|FG001|Overall Study|Death|5
7968426|NCT02674750|12525941|FG002|Overall Study|Death|8
7968427|NCT02674750|12525939|FG000|Overall Study|Lost to Follow-up|0
7968428|NCT02674750|12525940|FG001|Overall Study|Lost to Follow-up|8
7968429|NCT02674750|12525941|FG002|Overall Study|Lost to Follow-up|0
7968430|NCT02674750|12525939|FG000|Overall Study|Lack of Efficacy|1
7968431|NCT02674750|12525940|FG001|Overall Study|Lack of Efficacy|17
7968432|NCT02674750|12525941|FG002|Overall Study|Lack of Efficacy|3
7968433|NCT02674750|12525939|FG000|Overall Study|Withdrawal by Subject|0
7968434|NCT02674750|12525940|FG001|Overall Study|Withdrawal by Subject|7
7968435|NCT02674750|12525941|FG002|Overall Study|Withdrawal by Subject|1
7968436|NCT02674750|12525939|FG000|Overall Study|Other|0
7893403|NCT01296711|12399550|FG001|Overall Study|Methotrexate discontinued|0
7893404|NCT01296711|12399551|FG002|Overall Study|Methotrexate discontinued|0
7893405|NCT01296711|12399552|FG003|Overall Study|Methotrexate discontinued|1
7893406|NCT01296711|12399553|FG004|Overall Study|Methotrexate discontinued|0
7893407|NCT01296711|12399554|FG005|Overall Study|Methotrexate discontinued|0
7893408|NCT01296711|12399555|FG006|Overall Study|Methotrexate discontinued|0
7893409|NCT01296711|12399556|FG007|Overall Study|Methotrexate discontinued|0
7893410|NCT01296711|12399549|FG000|Overall Study|Investigator discretion|0
7893411|NCT01296711|12399550|FG001|Overall Study|Investigator discretion|0
7893412|NCT01296711|12399551|FG002|Overall Study|Investigator discretion|0
7893413|NCT01296711|12399552|FG003|Overall Study|Investigator discretion|0
7893414|NCT01296711|12399553|FG004|Overall Study|Investigator discretion|0
7893415|NCT01296711|12399554|FG005|Overall Study|Investigator discretion|0
7893416|NCT01296711|12399555|FG006|Overall Study|Investigator discretion|1
7893417|NCT01296711|12399556|FG007|Overall Study|Investigator discretion|0
7893418|NCT01296711|12399549|FG000|Overall Study|Other|0
7893419|NCT01296711|12399550|FG001|Overall Study|Other|0
7893420|NCT01296711|12399551|FG002|Overall Study|Other|0
7893421|NCT01296711|12399552|FG003|Overall Study|Other|0
7893422|NCT01296711|12399553|FG004|Overall Study|Other|0
7893423|NCT01296711|12399554|FG005|Overall Study|Other|0
7893424|NCT01296711|12399555|FG006|Overall Study|Other|1
7893425|NCT01296711|12399556|FG007|Overall Study|Other|0
7893426|NCT01296711|12399549|FG000|Overall Study|Required restricted steroid injections|0
7893427|NCT01296711|12399550|FG001|Overall Study|Required restricted steroid injections|0
7893428|NCT01296711|12399551|FG002|Overall Study|Required restricted steroid injections|0
7893429|NCT01296711|12399552|FG003|Overall Study|Required restricted steroid injections|0
7893430|NCT01296711|12399553|FG004|Overall Study|Required restricted steroid injections|0
7893431|NCT01296711|12399554|FG005|Overall Study|Required restricted steroid injections|0
7893432|NCT01296711|12399555|FG006|Overall Study|Required restricted steroid injections|1
7893433|NCT01296711|12399556|FG007|Overall Study|Required restricted steroid injections|0
7893434|NCT01296711|12399549|FG000|Overall Study|Ongoing missed appointments|0
7893435|NCT01296711|12399550|FG001|Overall Study|Ongoing missed appointments|0
7893436|NCT01296711|12399551|FG002|Overall Study|Ongoing missed appointments|0
7893437|NCT01296711|12399552|FG003|Overall Study|Ongoing missed appointments|0
7893438|NCT01296711|12399553|FG004|Overall Study|Ongoing missed appointments|0
7893439|NCT01296711|12399554|FG005|Overall Study|Ongoing missed appointments|0
7893440|NCT01296711|12399555|FG006|Overall Study|Ongoing missed appointments|1
7893441|NCT01296711|12399556|FG007|Overall Study|Ongoing missed appointments|0
7893442|NCT01296711|12399549|FG000|Overall Study|Failure to comply with visits|0
7893443|NCT01296711|12399550|FG001|Overall Study|Failure to comply with visits|0
7893444|NCT01296711|12399551|FG002|Overall Study|Failure to comply with visits|0
7893445|NCT01296711|12399552|FG003|Overall Study|Failure to comply with visits|0
7893446|NCT01296711|12399553|FG004|Overall Study|Failure to comply with visits|0
7893447|NCT01296711|12399554|FG005|Overall Study|Failure to comply with visits|0
7893448|NCT01296711|12399555|FG006|Overall Study|Failure to comply with visits|0
7893449|NCT01296711|12399556|FG007|Overall Study|Failure to comply with visits|1
7893450|NCT01296711|12399549|FG000|Overall Study|Patient decision due to transport|0
7893451|NCT01296711|12399550|FG001|Overall Study|Patient decision due to transport|0
7893452|NCT01296711|12399551|FG002|Overall Study|Patient decision due to transport|0
7893453|NCT01296711|12399552|FG003|Overall Study|Patient decision due to transport|0
7893454|NCT01296711|12399553|FG004|Overall Study|Patient decision due to transport|0
7893455|NCT01296711|12399554|FG005|Overall Study|Patient decision due to transport|0
7968437|NCT02674750|12525940|FG001|Overall Study|Other|8
7968438|NCT02674750|12525941|FG002|Overall Study|Other|0
7893456|NCT01296711|12399555|FG006|Overall Study|Patient decision due to transport|0
7893457|NCT01296711|12399556|FG007|Overall Study|Patient decision due to transport|1
7963249|NCT02718898|12517585|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2
7963250|NCT02718898|12517586|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7963251|NCT02718898|12517587|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7963252|NCT02718898|12517588|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7963253|NCT02718898|12517582|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7963254|NCT02718898|12517583|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7963255|NCT02718898|12517584|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1
7963256|NCT02718898|12517585|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3
7963257|NCT02718898|12517586|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7963258|NCT02718898|12517587|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7963259|NCT02718898|12517588|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7963260|NCT02718898|12517582|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7963261|NCT02718898|12517583|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7963262|NCT02718898|12517584|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1
7963263|NCT02718898|12517585|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2
7963264|NCT02718898|12517586|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7963265|NCT02718898|12517587|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7963266|NCT02718898|12517588|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7963267|NCT02718898|12517582|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7963268|NCT02718898|12517583|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7963269|NCT02718898|12517584|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7963270|NCT02718898|12517585|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1
7963271|NCT02718898|12517586|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7963272|NCT02718898|12517587|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7963273|NCT02718898|12517588|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7963274|NCT02718898|12517582|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7963275|NCT02718898|12517583|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7963276|NCT02718898|12517584|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7963277|NCT02718898|12517585|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1
7963278|NCT02718898|12517586|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7963279|NCT02718898|12517587|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7963280|NCT02718898|12517588|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7963281|NCT02718898|12517582|FG000|Post Treatment Follow-up Period|Adverse Event|0
7963282|NCT02718898|12517583|FG001|Post Treatment Follow-up Period|Adverse Event|0
7963283|NCT02718898|12517584|FG002|Post Treatment Follow-up Period|Adverse Event|0
7963284|NCT02718898|12517585|FG003|Post Treatment Follow-up Period|Adverse Event|0
7963285|NCT02718898|12517586|FG004|Post Treatment Follow-up Period|Adverse Event|0
7963286|NCT02718898|12517587|FG005|Post Treatment Follow-up Period|Adverse Event|1
7963287|NCT02718898|12517588|FG006|Post Treatment Follow-up Period|Adverse Event|1
7963288|NCT02718898|12517582|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0
7963289|NCT02718898|12517583|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0
7963290|NCT02718898|12517584|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0
7963291|NCT02718898|12517585|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0
7963292|NCT02718898|12517586|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1
7963293|NCT02718898|12517587|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5
7963294|NCT02718898|12517588|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1
7963295|NCT02718898|12517582|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0
7963296|NCT02718898|12517583|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0
7963297|NCT02718898|12517584|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0
7963298|NCT02718898|12517585|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0
7963299|NCT02718898|12517586|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0
7963300|NCT02718898|12517587|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5
7963301|NCT02718898|12517588|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3
7963302|NCT02719028|12517614|FG000|Overall Study|Adverse Event|2
7963303|NCT02719028|12517615|FG001|Overall Study|Adverse Event|1
7963304|NCT02719028|12517616|FG002|Overall Study|Adverse Event|4
7963305|NCT02719028|12517617|FG003|Overall Study|Adverse Event|8
7963306|NCT02719028|12517614|FG000|Overall Study|Physician Decision|0
7963307|NCT02719028|12517615|FG001|Overall Study|Physician Decision|1
7963308|NCT02719028|12517616|FG002|Overall Study|Physician Decision|1
7963309|NCT02719028|12517617|FG003|Overall Study|Physician Decision|1
7963310|NCT02719028|12517614|FG000|Overall Study|Use of prohibited medication|0
7963311|NCT02719028|12517615|FG001|Overall Study|Use of prohibited medication|0
7963312|NCT02719028|12517616|FG002|Overall Study|Use of prohibited medication|1
7963313|NCT02719028|12517617|FG003|Overall Study|Use of prohibited medication|0
7963314|NCT02719028|12517614|FG000|Overall Study|Protocol Violation|0
7963315|NCT02719028|12517615|FG001|Overall Study|Protocol Violation|0
7963316|NCT02719028|12517616|FG002|Overall Study|Protocol Violation|0
7963317|NCT02719028|12517617|FG003|Overall Study|Protocol Violation|1
7963318|NCT02719171|12517645|FG000|Overall Study|Adverse Event|1
7893458|NCT00084656|12399577|FG000|Overall Study|Other reasons|0
7893459|NCT00084656|12399578|FG001|Overall Study|Other reasons|12
7893460|NCT00084656|12399579|FG002|Overall Study|Other reasons|11
7893461|NCT00084656|12399577|FG000|Overall Study|Withdrawal by Subject|15
7893462|NCT00084656|12399578|FG001|Overall Study|Withdrawal by Subject|4
7893463|NCT00084656|12399579|FG002|Overall Study|Withdrawal by Subject|4
7893464|NCT00084656|12399577|FG000|Overall Study|Disease relapse|0
7893465|NCT00084656|12399578|FG001|Overall Study|Disease relapse|9
7893466|NCT00084656|12399579|FG002|Overall Study|Disease relapse|10
7893467|NCT00084656|12399577|FG000|Overall Study|Disease progression|9
7893468|NCT00084656|12399578|FG001|Overall Study|Disease progression|0
7893469|NCT00084656|12399579|FG002|Overall Study|Disease progression|0
7893470|NCT00084656|12399577|FG000|Overall Study|Lost to Follow-up|1
7893471|NCT00084656|12399578|FG001|Overall Study|Lost to Follow-up|0
7893472|NCT00084656|12399579|FG002|Overall Study|Lost to Follow-up|1
7893473|NCT01879852|12399618|FG000|Overall Study|Withdrawal by Subject|2
7893474|NCT01879852|12399619|FG001|Overall Study|Withdrawal by Subject|0
7893475|NCT01880086|12399655|FG000|Overall Study|Lost to Follow-up|1
7893476|NCT01880086|12399656|FG001|Overall Study|Lost to Follow-up|1
7893477|NCT01880424|12399690|FG000|Overall Study|Adverse Event|7
7893478|NCT01880424|12399691|FG001|Overall Study|Adverse Event|6
7893479|NCT01880424|12399690|FG000|Overall Study|Lack of Efficacy|1
7893480|NCT01880424|12399691|FG001|Overall Study|Lack of Efficacy|4
7893481|NCT01880424|12399690|FG000|Overall Study|Lost to Follow-up|3
7893482|NCT01880424|12399691|FG001|Overall Study|Lost to Follow-up|2
7893483|NCT01880424|12399690|FG000|Overall Study|Protocol Violation|11
7893484|NCT01880424|12399691|FG001|Overall Study|Protocol Violation|13
7893485|NCT01880424|12399690|FG000|Overall Study|Withdrawal by Subject|10
7893486|NCT01880424|12399691|FG001|Overall Study|Withdrawal by Subject|30
7893487|NCT01880424|12399690|FG000|Overall Study|Other|1
7893488|NCT01880424|12399691|FG001|Overall Study|Other|0
7893489|NCT01880437|12399700|FG000|Overall Study|Death|12
7893490|NCT01880437|12399701|FG001|Overall Study|Death|4
7893491|NCT01880437|12399702|FG002|Overall Study|Death|17
7893492|NCT01880437|12399700|FG000|Overall Study|Study terminated by Sponsor|3
7893493|NCT01880437|12399701|FG001|Overall Study|Study terminated by Sponsor|0
7893494|NCT01880437|12399702|FG002|Overall Study|Study terminated by Sponsor|2
7893495|NCT01880515|12399714|FG000|Overall Study|Lost to Follow-up|3
7893496|NCT01880515|12399715|FG001|Overall Study|Lost to Follow-up|2
7893497|NCT01880515|12399714|FG000|Overall Study|Disease Progression|5
7893498|NCT01880515|12399715|FG001|Overall Study|Disease Progression|7
7893499|NCT01880528|12399724|FG000|Overall Study|Other|1
7893500|NCT01880528|12399725|FG001|Overall Study|Other|1
7893501|NCT01880554|12399731|FG000|Overall Study|Protocol Violation|14
7893502|NCT01880554|12399731|FG000|Overall Study|Simon's design requirements|2
7893503|NCT01880593|12399738|FG000|Overall Study|Adverse Event|1
7893504|NCT01880593|12399739|FG001|Overall Study|Adverse Event|0
7893505|NCT01880593|12399738|FG000|Overall Study|Lack of Efficacy|1
7893506|NCT01880593|12399739|FG001|Overall Study|Lack of Efficacy|5
7893507|NCT01880593|12399738|FG000|Overall Study|Withdrawal by Subject|6
7893508|NCT01880593|12399739|FG001|Overall Study|Withdrawal by Subject|1
7893509|NCT01880736|12399767|FG000|Overall Study|Adverse Event|0
7893510|NCT01880736|12399768|FG001|Overall Study|Adverse Event|0
7893511|NCT01880736|12399769|FG002|Overall Study|Adverse Event|0
7893512|NCT01880736|12399770|FG003|Overall Study|Adverse Event|1
7893513|NCT01880736|12399767|FG000|Overall Study|Withdrawal Criteria|1
7893514|NCT01880736|12399768|FG001|Overall Study|Withdrawal Criteria|2
7893515|NCT01880736|12399769|FG002|Overall Study|Withdrawal Criteria|1
7893516|NCT01880736|12399770|FG003|Overall Study|Withdrawal Criteria|5
7893517|NCT01881009|12399791|FG000|Summer Camp Session (6 Days)|Unable to wear device|0
7893518|NCT01881009|12399792|FG001|Summer Camp Session (6 Days)|Unable to wear device|1
7893519|NCT01881126|12399823|FG000|Overall Study|Non-compliance|1
7893520|NCT01881126|12399824|FG001|Overall Study|Non-compliance|1
7893521|NCT01881126|12399823|FG000|Overall Study|Adverse Event|0
7893522|NCT01881126|12399824|FG001|Overall Study|Adverse Event|1
7893523|NCT01881230|12399833|FG000|Overall Study|Death|2
7893524|NCT01881230|12399834|FG001|Overall Study|Death|0
7893525|NCT01881230|12399835|FG002|Overall Study|Death|1
7893526|NCT01881230|12399833|FG000|Overall Study|Adverse Event|9
7893527|NCT01881230|12399834|FG001|Overall Study|Adverse Event|13
7893528|NCT01881230|12399835|FG002|Overall Study|Adverse Event|12
7893529|NCT01881230|12399833|FG000|Overall Study|Progressive Disease|31
7893530|NCT01881230|12399834|FG001|Overall Study|Progressive Disease|35
7893531|NCT01881230|12399835|FG002|Overall Study|Progressive Disease|36
7893532|NCT01881230|12399833|FG000|Overall Study|Symptomatic Deterioration|3
7893533|NCT01881230|12399834|FG001|Overall Study|Symptomatic Deterioration|3
7893534|NCT01881230|12399835|FG002|Overall Study|Symptomatic Deterioration|1
7893535|NCT01881230|12399833|FG000|Overall Study|Withdrawal by Subject|6
7893536|NCT01881230|12399834|FG001|Overall Study|Withdrawal by Subject|4
7893537|NCT01881230|12399835|FG002|Overall Study|Withdrawal by Subject|6
7893538|NCT01881230|12399833|FG000|Overall Study|Physician Decision|4
7893539|NCT01881230|12399834|FG001|Overall Study|Physician Decision|3
7893540|NCT01881230|12399835|FG002|Overall Study|Physician Decision|6
7893541|NCT01881230|12399833|FG000|Overall Study|Non-Compliance with Study Drug|1
7893542|NCT01881230|12399834|FG001|Overall Study|Non-Compliance with Study Drug|2
7893543|NCT01881230|12399835|FG002|Overall Study|Non-Compliance with Study Drug|0
7893544|NCT01881230|12399833|FG000|Overall Study|Given Commercially Available Drug|0
7893545|NCT01881230|12399834|FG001|Overall Study|Given Commercially Available Drug|0
7893546|NCT01881230|12399835|FG002|Overall Study|Given Commercially Available Drug|2
7893547|NCT01881230|12399833|FG000|Overall Study|Protocol Violation|1
7893548|NCT01881230|12399834|FG001|Overall Study|Protocol Violation|1
7893549|NCT01881230|12399835|FG002|Overall Study|Protocol Violation|0
7893550|NCT01881230|12399833|FG000|Overall Study|Miscellaneous|3
7893551|NCT01881230|12399834|FG001|Overall Study|Miscellaneous|3
7893552|NCT01881230|12399835|FG002|Overall Study|Miscellaneous|0
7893553|NCT01881230|12399833|FG000|Overall Study|Untreated: Other|0
7893554|NCT01881230|12399834|FG001|Overall Study|Untreated: Other|0
7893555|NCT01881230|12399835|FG002|Overall Study|Untreated: Other|1
7893556|NCT01881230|12399833|FG000|Overall Study|Untreated: Death|0
7893557|NCT01881230|12399834|FG001|Overall Study|Untreated: Death|0
7893558|NCT01881230|12399835|FG002|Overall Study|Untreated: Death|1
7893559|NCT01881230|12399833|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1
7893560|NCT01881230|12399834|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0
7893561|NCT01881230|12399835|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0
7893562|NCT01881620|12399869|FG000|Overall Study|Protocol Violation|4
7893563|NCT01881737|12399873|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3
7893564|NCT01881737|12399873|FG000|Overall Study|Withdrawal by Subject|1
7893565|NCT01881737|12399873|FG000|Overall Study|Worsening of baseline behavior|1
7893566|NCT01881750|12399881|FG000|Overall Study|Changes in concomitant therapies|2
7893567|NCT01881750|12399882|FG001|Overall Study|Changes in concomitant therapies|3
7893568|NCT01881750|12399881|FG000|Overall Study|Lost to Follow-up|0
7893569|NCT01881750|12399882|FG001|Overall Study|Lost to Follow-up|1
7893570|NCT01881776|12399893|FG000|Overall Study|Lost to Follow-up|1
7893571|NCT01881776|12399894|FG001|Overall Study|Lost to Follow-up|2
7893572|NCT01881776|12399895|FG002|Overall Study|Lost to Follow-up|1
7893573|NCT01881776|12399893|FG000|Overall Study|Protocol Violation|0
7893574|NCT01881776|12399894|FG001|Overall Study|Protocol Violation|2
7893575|NCT01881776|12399895|FG002|Overall Study|Protocol Violation|1
7893576|NCT01881789|12399909|FG000|Overall Study|Withdrawal by Subject|0
7893577|NCT01881789|12399910|FG001|Overall Study|Withdrawal by Subject|2
7893578|NCT01881789|12399911|FG002|Overall Study|Withdrawal by Subject|1
7893579|NCT01881789|12399912|FG003|Overall Study|Withdrawal by Subject|0
7893580|NCT01881789|12399913|FG004|Overall Study|Withdrawal by Subject|1
7893581|NCT01881789|12399914|FG005|Overall Study|Withdrawal by Subject|1
7893582|NCT01881789|12399909|FG000|Overall Study|Study Terminated by Sponsor|0
7893583|NCT01881789|12399910|FG001|Overall Study|Study Terminated by Sponsor|0
7893584|NCT01881789|12399911|FG002|Overall Study|Study Terminated by Sponsor|0
7893585|NCT01881789|12399912|FG003|Overall Study|Study Terminated by Sponsor|0
7893586|NCT01881789|12399913|FG004|Overall Study|Study Terminated by Sponsor|0
7893587|NCT01881789|12399914|FG005|Overall Study|Study Terminated by Sponsor|1
7893588|NCT01881789|12399909|FG000|Overall Study|Other|3
7893589|NCT01881789|12399910|FG001|Overall Study|Other|5
7893590|NCT01881789|12399911|FG002|Overall Study|Other|2
7893591|NCT01881789|12399912|FG003|Overall Study|Other|3
7893592|NCT01881789|12399913|FG004|Overall Study|Other|1
7893593|NCT01881789|12399914|FG005|Overall Study|Other|1
7893594|NCT01882088|12399953|FG000|Overall Study|Intolerance of esophageal manometry|1
7893595|NCT01882088|12399953|FG000|Overall Study|no possibility to place the catheter|1
7893596|NCT01882088|12399953|FG000|Overall Study|Protocol Violation|1
7893597|NCT01882088|12399953|FG000|Overall Study|inadequate pH-impedance tracings|2
7893598|NCT01882257|12399960|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0
7893599|NCT01882257|12399961|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2
7893600|NCT01882257|12399962|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1
7893601|NCT01882257|12399960|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
7893602|NCT01882257|12399961|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
7893603|NCT01882257|12399962|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
7893604|NCT01882439|12399977|FG000|Overall Study|Adverse event related to study drug|3
7893605|NCT01882439|12399978|FG001|Overall Study|Adverse event related to study drug|8
7893606|NCT01882439|12399979|FG002|Overall Study|Adverse event related to study drug|1
7893607|NCT01882439|12399980|FG003|Overall Study|Adverse event related to study drug|2
7893608|NCT01882439|12399977|FG000|Overall Study|Pregnancy|0
7893609|NCT01882439|12399978|FG001|Overall Study|Pregnancy|1
7893610|NCT01882439|12399979|FG002|Overall Study|Pregnancy|0
7893611|NCT01882439|12399980|FG003|Overall Study|Pregnancy|0
7893612|NCT01882439|12399977|FG000|Overall Study|Protocol Violation|2
7893613|NCT01882439|12399978|FG001|Overall Study|Protocol Violation|2
7893614|NCT01882439|12399979|FG002|Overall Study|Protocol Violation|0
7893615|NCT01882439|12399980|FG003|Overall Study|Protocol Violation|1
7893616|NCT01882439|12399977|FG000|Overall Study|No longer willing to participate|1
7893617|NCT01882439|12399978|FG001|Overall Study|No longer willing to participate|4
7893618|NCT01882439|12399979|FG002|Overall Study|No longer willing to participate|2
7893619|NCT01882439|12399980|FG003|Overall Study|No longer willing to participate|3
7893620|NCT01882439|12399977|FG000|Overall Study|Medication error with no associated AE|0
7893621|NCT01882439|12399978|FG001|Overall Study|Medication error with no associated AE|0
7893622|NCT01882439|12399979|FG002|Overall Study|Medication error with no associated AE|2
7893623|NCT01882439|12399980|FG003|Overall Study|Medication error with no associated AE|0
7893624|NCT01882439|12399977|FG000|Overall Study|Insufficient clinical response|1
7893625|NCT01882439|12399978|FG001|Overall Study|Insufficient clinical response|4
7893626|NCT01882439|12399979|FG002|Overall Study|Insufficient clinical response|4
7893627|NCT01882439|12399980|FG003|Overall Study|Insufficient clinical response|2
7893628|NCT01882439|12399977|FG000|Overall Study|Adverse event unrelated to study drug|2
7893629|NCT01882439|12399978|FG001|Overall Study|Adverse event unrelated to study drug|2
7893630|NCT01882439|12399979|FG002|Overall Study|Adverse event unrelated to study drug|1
7893631|NCT01882439|12399980|FG003|Overall Study|Adverse event unrelated to study drug|1
7893632|NCT01882465|12399995|FG000|Period 1|Lens Discomfort|0
7893633|NCT01882465|12399996|FG001|Period 1|Lens Discomfort|0
7893634|NCT01882465|12399997|FG002|Period 1|Lens Discomfort|0
7893635|NCT01882465|12399998|FG003|Period 1|Lens Discomfort|1
7893636|NCT01882465|12399999|FG004|Period 1|Lens Discomfort|0
7893637|NCT01882465|12400000|FG005|Period 1|Lens Discomfort|0
7893638|NCT01882465|12400001|FG006|Period 1|Lens Discomfort|0
7893639|NCT01882465|12399995|FG000|Period 1|Withdrawal by Subject|0
7893640|NCT01882465|12399996|FG001|Period 1|Withdrawal by Subject|0
7893641|NCT01882465|12399997|FG002|Period 1|Withdrawal by Subject|0
7893642|NCT01882465|12399998|FG003|Period 1|Withdrawal by Subject|0
7893643|NCT01882465|12399999|FG004|Period 1|Withdrawal by Subject|0
7893644|NCT01882465|12400000|FG005|Period 1|Withdrawal by Subject|0
7893645|NCT01882465|12400001|FG006|Period 1|Withdrawal by Subject|1
7893646|NCT01882465|12399995|FG000|Period 2|Protocol Violation|0
7893647|NCT01882465|12399996|FG001|Period 2|Protocol Violation|0
7893648|NCT01882465|12399997|FG002|Period 2|Protocol Violation|0
7893649|NCT01882465|12399998|FG003|Period 2|Protocol Violation|0
7893650|NCT01882465|12399999|FG004|Period 2|Protocol Violation|1
7893651|NCT01882465|12400000|FG005|Period 2|Protocol Violation|0
7893652|NCT01882465|12400001|FG006|Period 2|Protocol Violation|0
7893653|NCT01882647|12400021|FG000|Overall Study|Lost to Follow-up|2
7893654|NCT01882647|12400022|FG001|Overall Study|Lost to Follow-up|2
7893655|NCT01882647|12400021|FG000|Overall Study|Withdrawal by Subject|0
7893656|NCT01882647|12400022|FG001|Overall Study|Withdrawal by Subject|4
7893657|NCT01882803|12400041|FG000|Overall Study|Disease Progression|53
7893658|NCT01882803|12400041|FG000|Overall Study|Adverse Event|22
7893659|NCT01882803|12400041|FG000|Overall Study|Death|7
7893660|NCT01882803|12400041|FG000|Overall Study|Physician Decision|7
7893661|NCT01882803|12400041|FG000|Overall Study|Protocol Violation|1
7893662|NCT01882803|12400041|FG000|Overall Study|Withdrawal by Subject|4
7893663|NCT01882829|12400046|FG000|Overall Study|Adverse Event|4
7968439|NCT02440854|12525948|FG000|Overall Study|Relocation of patient|1
7968440|NCT02440854|12525948|FG000|Overall Study|Death|6
7968441|NCT02440854|12525948|FG000|Overall Study|Lost to Follow-up|10
7968442|NCT02440854|12525948|FG000|Overall Study|Afatinib discontinuation|46
7968443|NCT02440854|12525948|FG000|Overall Study|stopped study at earlier timepoint|14
7968444|NCT02440854|12525948|FG000|Overall Study|Study medication not received|1
7968445|NCT02440854|12525948|FG000|Overall Study|Violation of inclusion criteria|2
7893664|NCT01882829|12400046|FG000|Overall Study|Protocol Violation|1
7893665|NCT01882829|12400046|FG000|Overall Study|Withdrawal by Subject|1
7893666|NCT01882907|12400056|FG000|Overall Study|Adverse Event|3
7893667|NCT01882907|12400057|FG001|Overall Study|Adverse Event|1
7893668|NCT01882907|12400056|FG000|Overall Study|Lack of Efficacy|0
7893669|NCT01882907|12400057|FG001|Overall Study|Lack of Efficacy|3
7893670|NCT01882907|12400056|FG000|Overall Study|Lost to Follow-up|1
7893671|NCT01882907|12400057|FG001|Overall Study|Lost to Follow-up|4
7893672|NCT01882907|12400056|FG000|Overall Study|Protocol Violation|10
7893673|NCT01882907|12400057|FG001|Overall Study|Protocol Violation|14
7893674|NCT01882907|12400056|FG000|Overall Study|Withdrawal by Subject|0
7893675|NCT01882907|12400057|FG001|Overall Study|Withdrawal by Subject|6
7893676|NCT01882985|12400065|FG000|Overall Study|Lost to Follow-up|1
7893677|NCT01882985|12400065|FG000|Overall Study|Withdrawal by Subject|1
7893678|NCT01883362|12400075|FG000|Treatment|Adverse Event|1
7893679|NCT01883362|12400076|FG001|Treatment|Adverse Event|8
7893680|NCT01883362|12400075|FG000|Treatment|Withdrawal by Subject|6
7893681|NCT01883362|12400076|FG001|Treatment|Withdrawal by Subject|2
7893682|NCT01883362|12400075|FG000|Treatment|Administrative problems|4
7893683|NCT01883362|12400076|FG001|Treatment|Administrative problems|1
7893684|NCT01883362|12400075|FG000|Treatment|Relapse|4
7893685|NCT01883362|12400076|FG001|Treatment|Relapse|2
7893686|NCT01883362|12400075|FG000|Treatment|Randomized, not treated|1
7893687|NCT01883362|12400076|FG001|Treatment|Randomized, not treated|1
7893688|NCT01883362|12400075|FG000|Post Treatment Follow-up|Protocol Violation|0
7893689|NCT01883362|12400076|FG001|Post Treatment Follow-up|Protocol Violation|1
7893690|NCT01883362|12400075|FG000|Post Treatment Follow-up|Withdrawal by Subject|4
7893691|NCT01883362|12400076|FG001|Post Treatment Follow-up|Withdrawal by Subject|3
7893692|NCT01883362|12400075|FG000|Post Treatment Follow-up|Lost to Follow-up|1
7893693|NCT01883362|12400076|FG001|Post Treatment Follow-up|Lost to Follow-up|4
7893694|NCT01883362|12400075|FG000|Post Treatment Follow-up|Administrative problems|2
7893695|NCT01883362|12400076|FG001|Post Treatment Follow-up|Administrative problems|0
7893696|NCT01883362|12400075|FG000|Post Treatment Follow-up|Death|8
7893697|NCT01883362|12400076|FG001|Post Treatment Follow-up|Death|4
7893698|NCT01883362|12400075|FG000|Post Treatment Follow-up|Relapse|1
7893699|NCT01883362|12400076|FG001|Post Treatment Follow-up|Relapse|2
7893700|NCT01883453|12400107|FG000|Overall Study|No episode of common cold|25
7893701|NCT01883453|12400108|FG001|Overall Study|No episode of common cold|23
7893702|NCT01883492|12400116|FG000|Overall Study|Lost to Follow-up|3
7893703|NCT01883492|12400117|FG001|Overall Study|Lost to Follow-up|4
7893704|NCT01883492|12400116|FG000|Overall Study|Surgery on contra-lateral hip|0
7893705|NCT01883492|12400117|FG001|Overall Study|Surgery on contra-lateral hip|1
7893706|NCT01883492|12400116|FG000|Overall Study|Poor X-ray quality|7
7893707|NCT01883492|12400117|FG001|Overall Study|Poor X-ray quality|4
7893708|NCT01883492|12400116|FG000|Overall Study|Withdrawal by Subject|1
7893709|NCT01883492|12400117|FG001|Overall Study|Withdrawal by Subject|0
7893710|NCT01883492|12400116|FG000|Overall Study|inappropriate implant used|1
7893711|NCT01883492|12400117|FG001|Overall Study|inappropriate implant used|1
7893712|NCT01883492|12400116|FG000|Overall Study|bone anatomy did not meet study criteria|1
7893713|NCT01883492|12400117|FG001|Overall Study|bone anatomy did not meet study criteria|1
7893714|NCT01883635|12400125|FG000|Overall Study|Withdrawal by Subject|4
7893715|NCT01883635|12400126|FG001|Overall Study|Withdrawal by Subject|0
7893716|NCT01883895|12400143|FG000|Overall Study|Lost to Follow-up|2
7893717|NCT01884025|12400162|FG000|Overall Study|Lost to Follow-up|3
7893718|NCT01884025|12400163|FG001|Overall Study|Lost to Follow-up|4
7893719|NCT01884311|12400178|FG000|Overall Study|Withdrawal by Subject|3
7893720|NCT01884311|12400178|FG000|Overall Study|withdrew consent due to AEs|1
7893721|NCT01884311|12400178|FG000|Overall Study|Precautionary measure|1
7893722|NCT01884337|12400187|FG000|Treatment|Adverse Event|2
7893723|NCT01884337|12400188|FG001|Treatment|Adverse Event|2
7893724|NCT01884337|12400187|FG000|Treatment|Subj. request to discont. treatment|2
7893725|NCT01884337|12400188|FG001|Treatment|Subj. request to discont. treatment|0
7893726|NCT01884337|12400187|FG000|Follow-up Period|Lost to Follow-up|1
7893727|NCT01884337|12400188|FG001|Follow-up Period|Lost to Follow-up|1
7893728|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17
7893729|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20
7893730|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0
7893731|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6
7893732|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4
7893733|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0
7893734|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
7893735|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1
7893736|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
7893737|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7
7893738|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6
7893739|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0
7893740|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15
7893741|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11
7893742|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0
7893743|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
7893744|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2
7893745|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
7893746|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2
7893747|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5
7893748|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0
7893749|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2
7893750|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
7893751|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
7893752|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
7893753|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
7893754|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0
7893755|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
7893756|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
7893757|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0
7893758|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
7893759|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
7893760|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0
7893761|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21
7893762|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0
7893763|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2
7893764|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7
7893765|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3
7893766|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3
7893767|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
7893768|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0
7893769|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
7893770|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17
7893771|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6
7893772|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3
7893773|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17
7893774|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3
7893775|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0
7893776|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3
7893777|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0
7893778|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2
7893779|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4
7893780|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
7893781|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
7893782|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3
7893783|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
7893784|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
7893785|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4
7893786|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1
7893787|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0
7893788|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1
7893789|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
7893790|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
7893791|NCT01884350|12400196|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2
7893792|NCT01884350|12400197|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
7893793|NCT01884350|12400198|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
7893794|NCT01884545|12400229|FG000|Overall Study|Lost to Follow-up|6
7893795|NCT01884545|12400230|FG001|Overall Study|Lost to Follow-up|4
7893796|NCT01884545|12400231|FG002|Overall Study|Lost to Follow-up|9
7893797|NCT01884545|12400232|FG003|Overall Study|Lost to Follow-up|4
7893798|NCT01884545|12400229|FG000|Overall Study|Patient withdrawn|7
7893799|NCT01884545|12400230|FG001|Overall Study|Patient withdrawn|12
7893800|NCT01884545|12400231|FG002|Overall Study|Patient withdrawn|5
7893801|NCT01884545|12400232|FG003|Overall Study|Patient withdrawn|5
7893802|NCT01884545|12400229|FG000|Overall Study|Non-adherence|0
7893803|NCT01884545|12400230|FG001|Overall Study|Non-adherence|2
7893804|NCT01884545|12400231|FG002|Overall Study|Non-adherence|0
7893805|NCT01884545|12400232|FG003|Overall Study|Non-adherence|0
7893806|NCT01884571|12400242|FG000|Overall Study|Adverse Event|1
7893807|NCT01884571|12400242|FG000|Overall Study|Death|2
7893808|NCT01884571|12400242|FG000|Overall Study|Withdrawal by Subject|2
7893809|NCT01884571|12400242|FG000|Overall Study|Disease progression|3
7893810|NCT01884597|12400249|FG000|Overall Study|Adverse Event|0
7893811|NCT01884597|12400250|FG001|Overall Study|Adverse Event|0
7893812|NCT01884597|12400251|FG002|Overall Study|Adverse Event|1
7893813|NCT01884597|12400249|FG000|Overall Study|Lack of Efficacy|1
7893814|NCT01884597|12400250|FG001|Overall Study|Lack of Efficacy|0
7893815|NCT01884597|12400251|FG002|Overall Study|Lack of Efficacy|0
7893816|NCT01884597|12400249|FG000|Overall Study|Death|0
7893817|NCT01884597|12400250|FG001|Overall Study|Death|1
7893818|NCT01884597|12400251|FG002|Overall Study|Death|0
7893819|NCT01884675|12400267|FG000|Overall Study|Study closed/terminated|3
7893820|NCT01884675|12400268|FG001|Overall Study|Study closed/terminated|2
7893821|NCT01884688|12400276|FG000|Overall Study|Screen Failure|2
7893822|NCT01885000|12400291|FG000|Overall Study|Adverse Event|1
7893823|NCT01885000|12400292|FG001|Overall Study|Adverse Event|0
7893824|NCT01885000|12400291|FG000|Overall Study|Withdrawal by Subject|1
7893825|NCT01885000|12400292|FG001|Overall Study|Withdrawal by Subject|1
7893826|NCT01885000|12400291|FG000|Overall Study|Protocol Violation|0
7893827|NCT01885000|12400292|FG001|Overall Study|Protocol Violation|1
7893828|NCT01885104|12400300|FG000|Overall Study|Withdrawal of Consent|1
7893829|NCT01885104|12400301|FG001|Overall Study|Withdrawal of Consent|0
7893830|NCT01885104|12400300|FG000|Overall Study|Lost to Follow-up|0
7893831|NCT01885104|12400301|FG001|Overall Study|Lost to Follow-up|1
7893832|NCT01885104|12400300|FG000|Overall Study|Physician Decision|1
7893833|NCT01885104|12400301|FG001|Overall Study|Physician Decision|0
7893834|NCT01885182|12400318|FG000|Overall Study|Adverse Event|11
7893835|NCT01885182|12400319|FG001|Overall Study|Adverse Event|13
7893836|NCT01885182|12400318|FG000|Overall Study|Withdrawal by Subject|13
7893837|NCT01885182|12400319|FG001|Overall Study|Withdrawal by Subject|6
7893838|NCT01885182|12400318|FG000|Overall Study|Lost to Follow-up|2
7893839|NCT01885182|12400319|FG001|Overall Study|Lost to Follow-up|2
7893840|NCT01885182|12400318|FG000|Overall Study|Lack of Efficacy|8
7893841|NCT01885182|12400319|FG001|Overall Study|Lack of Efficacy|1
7893842|NCT01885195|12400327|FG000|Overall Study|Adverse Event|29
7893843|NCT01885195|12400327|FG000|Overall Study|Death|1
7893844|NCT01885195|12400327|FG000|Overall Study|Disease Progression|67
7893845|NCT01885195|12400327|FG000|Overall Study|Protocol Deviation|2
7893846|NCT01885195|12400327|FG000|Overall Study|Physician Decision|3
7893847|NCT01885195|12400327|FG000|Overall Study|Patient/guardian decision|8
7893848|NCT01885208|12400333|FG000|Overall Study|Unclassified|32
7893849|NCT01885208|12400334|FG001|Overall Study|Unclassified|38
7893850|NCT01885559|12400342|FG000|Overall Study|Lost to Follow-up|15
7893851|NCT01885559|12400343|FG001|Overall Study|Lost to Follow-up|16
7893852|NCT01885559|12400342|FG000|Overall Study|Less than full participation|9
7893853|NCT01885559|12400343|FG001|Overall Study|Less than full participation|19
7893854|NCT01885559|12400342|FG000|Overall Study|Protocol Violation|0
7893855|NCT01885559|12400343|FG001|Overall Study|Protocol Violation|1
7893856|NCT01885936|12400386|FG000|Overall Study|Withdrawal by Subject|1
7893857|NCT01885936|12400387|FG001|Overall Study|Withdrawal by Subject|0
7893858|NCT01886105|12400393|FG000|Overall Study|Lack of Efficacy|3
7893859|NCT01886287|12400402|FG000|Overall Study|Radiographic disease progression|1
7893860|NCT01886287|12400402|FG000|Overall Study|Clinical progression due to disease|1
7893861|NCT01886300|12400406|FG000|Overall Study|Trial terminated by sponsor|16
7893862|NCT01886313|12400412|FG000|Overall Study|Adverse Event|1
7893863|NCT01886313|12400413|FG001|Overall Study|Adverse Event|1
7893864|NCT01886378|12400419|FG000|Overall Study|Adverse Event|1
7893865|NCT01886378|12400419|FG000|Overall Study|Withdrawal by Subject|4
7893866|NCT01886690|12400425|FG000|Overall Study|Protocol Violation|0
7893867|NCT01886690|12400426|FG001|Overall Study|Protocol Violation|1
7893868|NCT01886690|12400425|FG000|Overall Study|Personal Reasons|0
7893869|NCT01886690|12400426|FG001|Overall Study|Personal Reasons|1
7893870|NCT01886716|12400436|FG000|Week 1|Lost to Follow-up|0
7893871|NCT01886716|12400437|FG001|Week 1|Lost to Follow-up|0
7893872|NCT01886716|12400438|FG002|Week 1|Lost to Follow-up|2
7893873|NCT01886716|12400439|FG003|Week 1|Lost to Follow-up|2
7893874|NCT01886716|12400436|FG000|Week 2|Lost to Follow-up|3
7893875|NCT01886716|12400437|FG001|Week 2|Lost to Follow-up|2
7893876|NCT01886716|12400438|FG002|Week 2|Lost to Follow-up|1
7893877|NCT01886716|12400439|FG003|Week 2|Lost to Follow-up|3
7893878|NCT01886716|12400436|FG000|Week 3|Lost to Follow-up|1
7893879|NCT01886716|12400437|FG001|Week 3|Lost to Follow-up|1
7893880|NCT01886716|12400438|FG002|Week 3|Lost to Follow-up|0
7893881|NCT01886716|12400439|FG003|Week 3|Lost to Follow-up|1
7893882|NCT01886781|12400451|FG000|Overall Study|Protocol Violation|5
7893883|NCT01886781|12400452|FG001|Overall Study|Protocol Violation|0
7893884|NCT01886781|12400451|FG000|Overall Study|Adverse Event|1
7893885|NCT01886781|12400452|FG001|Overall Study|Adverse Event|0
7893886|NCT01886781|12400451|FG000|Overall Study|Lost to Follow-up|5
7893887|NCT01886781|12400452|FG001|Overall Study|Lost to Follow-up|0
7893888|NCT01886781|12400451|FG000|Overall Study|Withdrawal by Subject|2
7893889|NCT01886781|12400452|FG001|Overall Study|Withdrawal by Subject|1
7893890|NCT01886781|12400451|FG000|Overall Study|Worsening of symptoms|1
7893891|NCT01886781|12400452|FG001|Overall Study|Worsening of symptoms|1
7893892|NCT01886833|12400474|FG000|Overall Study|IgA not available from both periods|204
7893893|NCT01887210|12400505|FG000|Overall Study|Withdrawal by Subject|1
7893894|NCT01887210|12400506|FG001|Overall Study|Withdrawal by Subject|3
7893895|NCT01887210|12400505|FG000|Overall Study|Lost to Follow-up|0
7893896|NCT01887210|12400506|FG001|Overall Study|Lost to Follow-up|1
7963319|NCT02719171|12517646|FG001|Overall Study|Adverse Event|2
7963320|NCT02719171|12517647|FG002|Overall Study|Adverse Event|0
7963321|NCT02719171|12517648|FG003|Overall Study|Adverse Event|0
7963322|NCT02719171|12517649|FG004|Overall Study|Adverse Event|2
7963323|NCT02719171|12517645|FG000|Overall Study|Lost to Follow-up|0
7963324|NCT02719171|12517646|FG001|Overall Study|Lost to Follow-up|0
7963325|NCT02719171|12517647|FG002|Overall Study|Lost to Follow-up|1
7963326|NCT02719171|12517648|FG003|Overall Study|Lost to Follow-up|0
7963327|NCT02719171|12517649|FG004|Overall Study|Lost to Follow-up|0
7963328|NCT02719171|12517645|FG000|Overall Study|Subject Withdrawal|0
7963329|NCT02719171|12517646|FG001|Overall Study|Subject Withdrawal|2
7963330|NCT02719171|12517647|FG002|Overall Study|Subject Withdrawal|2
7963331|NCT02719171|12517648|FG003|Overall Study|Subject Withdrawal|1
7963332|NCT02719171|12517649|FG004|Overall Study|Subject Withdrawal|0
7963333|NCT02719171|12517645|FG000|Overall Study|Other|0
7963334|NCT02719171|12517646|FG001|Overall Study|Other|0
7963335|NCT02719171|12517647|FG002|Overall Study|Other|0
7963336|NCT02719171|12517648|FG003|Overall Study|Other|1
7963337|NCT02719171|12517649|FG004|Overall Study|Other|0
7963338|NCT02719353|12517664|FG000|First Intervention|Physician Decision|0
7963339|NCT02719353|12517665|FG001|First Intervention|Physician Decision|1
7963340|NCT02719743|12517693|FG000|Overall Study|Consent withdrawal|0
7963341|NCT02719743|12517694|FG001|Overall Study|Consent withdrawal|2
7963342|NCT02719743|12517695|FG002|Overall Study|Consent withdrawal|0
7963343|NCT02719743|12517696|FG003|Overall Study|Consent withdrawal|1
7963344|NCT02719743|12517697|FG004|Overall Study|Consent withdrawal|0
7963345|NCT02719743|12517693|FG000|Overall Study|Migrated/moved from study area|0
7963346|NCT02719743|12517694|FG001|Overall Study|Migrated/moved from study area|0
7963347|NCT02719743|12517695|FG002|Overall Study|Migrated/moved from study area|0
7963348|NCT02719743|12517696|FG003|Overall Study|Migrated/moved from study area|0
7963349|NCT02719743|12517697|FG004|Overall Study|Migrated/moved from study area|2
7963350|NCT02719743|12517693|FG000|Overall Study|Lost to Follow-up|1
7893897|NCT01887353|12400528|FG000|Overall Study|Study stopped early|4
7893898|NCT01887353|12400529|FG001|Overall Study|Study stopped early|3
7893899|NCT01887418|12400538|FG000|Overall Study|Travelling difficulties|0
7893900|NCT01887418|12400539|FG001|Overall Study|Travelling difficulties|0
7893901|NCT01887418|12400540|FG002|Overall Study|Travelling difficulties|1
7893902|NCT01887600|12400572|FG000|Overall Study|Death|39
7893903|NCT01887600|12400573|FG001|Overall Study|Death|16
7893904|NCT01887600|12400572|FG000|Overall Study|Lack of Efficacy|3
7893905|NCT01887600|12400573|FG001|Overall Study|Lack of Efficacy|26
7893906|NCT01887600|12400572|FG000|Overall Study|Lost to Follow-up|5
7893907|NCT01887600|12400573|FG001|Overall Study|Lost to Follow-up|1
7893908|NCT01887600|12400572|FG000|Overall Study|Physician Decision|7
7893909|NCT01887600|12400573|FG001|Overall Study|Physician Decision|8
7893910|NCT01887600|12400572|FG000|Overall Study|Protocol Deviation|3
7893911|NCT01887600|12400573|FG001|Overall Study|Protocol Deviation|0
7893912|NCT01887600|12400572|FG000|Overall Study|Withdrawal by Subject|58
7893913|NCT01887600|12400573|FG001|Overall Study|Withdrawal by Subject|52
7893914|NCT01887600|12400572|FG000|Overall Study|Adverse Event|21
7893915|NCT01887600|12400573|FG001|Overall Study|Adverse Event|9
7893916|NCT01887600|12400572|FG000|Overall Study|Non-compliance with study drug|3
7893917|NCT01887600|12400573|FG001|Overall Study|Non-compliance with study drug|0
7893918|NCT01887600|12400572|FG000|Overall Study|Miscellaneous|6
7893919|NCT01887600|12400573|FG001|Overall Study|Miscellaneous|2
7893920|NCT01887600|12400572|FG000|Overall Study|Progressive Disease|1
7893921|NCT01887600|12400573|FG001|Overall Study|Progressive Disease|0
7893922|NCT01887678|12400582|FG000|Overall Study|Adverse Event|4
7893923|NCT01887678|12400583|FG001|Overall Study|Adverse Event|6
7893924|NCT01887678|12400582|FG000|Overall Study|Exceeded rescue medication dosage|4
7893925|NCT01887678|12400583|FG001|Overall Study|Exceeded rescue medication dosage|5
7893926|NCT01887678|12400582|FG000|Overall Study|Withdrawal of consent|3
7893927|NCT01887678|12400583|FG001|Overall Study|Withdrawal of consent|4
7893928|NCT01887678|12400582|FG000|Overall Study|Lost to Follow-up|4
7893929|NCT01887678|12400583|FG001|Overall Study|Lost to Follow-up|2
7893930|NCT01887678|12400582|FG000|Overall Study|Deterioration of clinical condition|0
7893931|NCT01887678|12400583|FG001|Overall Study|Deterioration of clinical condition|4
7893932|NCT01887678|12400582|FG000|Overall Study|Lack of Efficacy|1
7893933|NCT01887678|12400583|FG001|Overall Study|Lack of Efficacy|2
7893934|NCT01887678|12400582|FG000|Overall Study|Non-compliance|0
7893935|NCT01887678|12400583|FG001|Overall Study|Non-compliance|3
7893936|NCT01887678|12400582|FG000|Overall Study|Specified|1
7893937|NCT01887678|12400583|FG001|Overall Study|Specified|2
7893938|NCT01887717|12400591|FG000|Overall Study|Withdrawal by Subject|1
7893939|NCT01887717|12400592|FG001|Overall Study|Withdrawal by Subject|7
7893940|NCT01887717|12400591|FG000|Overall Study|Physician Decision|0
7893941|NCT01887717|12400592|FG001|Overall Study|Physician Decision|2
7893942|NCT01887717|12400591|FG000|Overall Study|Administrative reasons|5
7893943|NCT01887717|12400592|FG001|Overall Study|Administrative reasons|2
7893944|NCT01888003|12400620|FG000|Overall Study|Study Terminated|5
7893945|NCT01888003|12400621|FG001|Overall Study|Study Terminated|6
7893946|NCT01888003|12400622|FG002|Overall Study|Study Terminated|40
7893947|NCT01888367|12400633|FG000|Overall Study|Physician Decision|3
7893948|NCT01888367|12400634|FG001|Overall Study|Physician Decision|4
7893949|NCT01888367|12400635|FG002|Overall Study|Physician Decision|2
7893950|NCT01888367|12400633|FG000|Overall Study|Death|2
7893951|NCT01888367|12400634|FG001|Overall Study|Death|0
7893952|NCT01888367|12400635|FG002|Overall Study|Death|1
7893953|NCT01888367|12400633|FG000|Overall Study|Withdrawal by Subject|1
7893954|NCT01888367|12400634|FG001|Overall Study|Withdrawal by Subject|0
7893955|NCT01888367|12400635|FG002|Overall Study|Withdrawal by Subject|1
7893956|NCT01888367|12400633|FG000|Overall Study|Lost to Follow-up|1
7893957|NCT01888367|12400634|FG001|Overall Study|Lost to Follow-up|1
7893958|NCT01888367|12400635|FG002|Overall Study|Lost to Follow-up|0
7893959|NCT01888367|12400633|FG000|Overall Study|Protocol Violation|0
7893960|NCT01888367|12400634|FG001|Overall Study|Protocol Violation|0
7893961|NCT01888367|12400635|FG002|Overall Study|Protocol Violation|1
7893962|NCT01888367|12400633|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1
7893963|NCT01888367|12400634|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0
7893964|NCT01888367|12400635|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0
7893965|NCT01888432|12400645|FG000|12-month Analysis (FAS)|Lost to Follow-up|0
7893966|NCT01888432|12400646|FG001|12-month Analysis (FAS)|Lost to Follow-up|2
7893967|NCT01888432|12400645|FG000|12-month Analysis (FAS)|Physician Decision|1
7893968|NCT01888432|12400646|FG001|12-month Analysis (FAS)|Physician Decision|1
7893969|NCT01888432|12400645|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6
7893970|NCT01888432|12400646|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3
7893971|NCT01888432|12400645|FG000|12-month Analysis (FAS)|Death|4
7893972|NCT01888432|12400646|FG001|12-month Analysis (FAS)|Death|3
7893973|NCT01888432|12400645|FG000|24-month Analysis (FAS)|Graft loss|0
7893974|NCT01888432|12400646|FG001|24-month Analysis (FAS)|Graft loss|1
7893975|NCT01888432|12400645|FG000|24-month Analysis (FAS)|Lost to Follow-up|0
7893976|NCT01888432|12400646|FG001|24-month Analysis (FAS)|Lost to Follow-up|2
7893977|NCT01888432|12400645|FG000|24-month Analysis (FAS)|Physician Decision|2
7893978|NCT01888432|12400646|FG001|24-month Analysis (FAS)|Physician Decision|4
7893979|NCT01888432|12400645|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7
7893980|NCT01888432|12400646|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6
7893981|NCT01888432|12400645|FG000|24-month Analysis (FAS)|Death|8
7893982|NCT01888432|12400646|FG001|24-month Analysis (FAS)|Death|4
7893983|NCT01888432|12400645|FG000|36-month Analysis (Extension)|Death|1
7893984|NCT01888432|12400646|FG001|36-month Analysis (Extension)|Death|0
7893985|NCT01888497|12400662|FG000|Washout Period 1|Withdrawal by Subject|0
7893986|NCT01888497|12400663|FG001|Washout Period 1|Withdrawal by Subject|0
7893987|NCT01888497|12400664|FG002|Washout Period 1|Withdrawal by Subject|1
7893988|NCT01888497|12400665|FG003|Washout Period 1|Withdrawal by Subject|1
7893989|NCT01888497|12400662|FG000|Washout Period 2|Adverse Event|0
7893990|NCT01888497|12400663|FG001|Washout Period 2|Adverse Event|0
7893991|NCT01888497|12400664|FG002|Washout Period 2|Adverse Event|0
7893992|NCT01888497|12400665|FG003|Washout Period 2|Adverse Event|1
7893993|NCT01888497|12400662|FG000|Washout Period 2|Withdrawal by Subject|0
7893994|NCT01888497|12400663|FG001|Washout Period 2|Withdrawal by Subject|0
7893995|NCT01888497|12400664|FG002|Washout Period 2|Withdrawal by Subject|0
7893996|NCT01888497|12400665|FG003|Washout Period 2|Withdrawal by Subject|1
7893997|NCT01888640|12400678|FG000|Overall Study|Lost to Follow-up|1
7893998|NCT01888640|12400679|FG001|Overall Study|Lost to Follow-up|2
7893999|NCT01888640|12400680|FG002|Overall Study|Lost to Follow-up|0
7894000|NCT01888640|12400678|FG000|Overall Study|Withdrawal by Subject|15
7894001|NCT01888640|12400679|FG001|Overall Study|Withdrawal by Subject|11
7894002|NCT01888640|12400680|FG002|Overall Study|Withdrawal by Subject|4
7894003|NCT01888640|12400678|FG000|Overall Study|Minimum dose not met|10
7894004|NCT01888640|12400679|FG001|Overall Study|Minimum dose not met|16
7894005|NCT01888640|12400680|FG002|Overall Study|Minimum dose not met|0
7894006|NCT01888640|12400678|FG000|Overall Study|Given wrong unit (placebo)|1
7894007|NCT01888640|12400679|FG001|Overall Study|Given wrong unit (placebo)|0
7894008|NCT01888640|12400680|FG002|Overall Study|Given wrong unit (placebo)|0
7894009|NCT01888640|12400678|FG000|Overall Study|Excluded for prior TENS|0
7894010|NCT01888640|12400679|FG001|Overall Study|Excluded for prior TENS|1
7894011|NCT01888640|12400680|FG002|Overall Study|Excluded for prior TENS|0
7894012|NCT01888640|12400678|FG000|Overall Study|Researcher Termination of Participant|0
7894013|NCT01888640|12400679|FG001|Overall Study|Researcher Termination of Participant|1
7894014|NCT01888640|12400680|FG002|Overall Study|Researcher Termination of Participant|1
7894015|NCT01888874|12400698|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7894016|NCT01888874|12400699|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7894017|NCT01888874|12400700|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
7894018|NCT01888874|12400701|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4
7894019|NCT01888874|12400702|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
7894020|NCT01888874|12400703|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
7894021|NCT01888874|12400704|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
7894022|NCT01888874|12400698|FG000|Period 1 (Baseline up to Week 12)|Other|1
7894023|NCT01888874|12400699|FG001|Period 1 (Baseline up to Week 12)|Other|0
7894024|NCT01888874|12400700|FG002|Period 1 (Baseline up to Week 12)|Other|1
7894025|NCT01888874|12400701|FG003|Period 1 (Baseline up to Week 12)|Other|1
7894026|NCT01888874|12400702|FG004|Period 1 (Baseline up to Week 12)|Other|3
7894027|NCT01888874|12400703|FG005|Period 1 (Baseline up to Week 12)|Other|3
7894028|NCT01888874|12400704|FG006|Period 1 (Baseline up to Week 12)|Other|0
7894029|NCT01888874|12400698|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0
7894030|NCT01888874|12400699|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0
7894031|NCT01888874|12400700|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0
7894032|NCT01888874|12400701|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0
7894033|NCT01888874|12400702|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0
7894034|NCT01888874|12400703|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0
7894035|NCT01888874|12400704|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1
7894036|NCT01888874|12400698|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0
7894037|NCT01888874|12400699|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2
7894038|NCT01888874|12400700|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3
7894039|NCT01888874|12400701|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1
7894040|NCT01888874|12400702|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2
7894041|NCT01888874|12400703|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1
7894042|NCT01888874|12400704|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0
7894043|NCT01888874|12400698|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7894044|NCT01888874|12400699|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7894045|NCT01888874|12400700|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7894046|NCT01888874|12400701|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7894047|NCT01888874|12400702|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1
7894048|NCT01888874|12400703|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7894049|NCT01888874|12400704|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7894050|NCT01888874|12400698|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7894051|NCT01888874|12400699|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1
7894052|NCT01888874|12400700|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7894053|NCT01888874|12400701|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7894054|NCT01888874|12400702|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7894055|NCT01888874|12400703|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7894056|NCT01888874|12400704|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7894057|NCT01888874|12400698|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7894058|NCT01888874|12400699|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
7894059|NCT01888874|12400700|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7894060|NCT01888874|12400701|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7894061|NCT01888874|12400702|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7894062|NCT01888874|12400703|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
7894063|NCT01888874|12400704|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7894064|NCT01888874|12400698|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
7894065|NCT01888874|12400699|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
7894066|NCT01888874|12400700|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
7894067|NCT01888874|12400701|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7894068|NCT01888874|12400702|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
7894069|NCT01888874|12400703|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7894070|NCT01888874|12400704|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7894071|NCT01888874|12400698|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7894072|NCT01888874|12400699|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7894073|NCT01888874|12400700|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7894074|NCT01888874|12400701|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7894075|NCT01888874|12400702|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1
7894076|NCT01888874|12400703|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7894077|NCT01888874|12400704|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7894078|NCT01888874|12400698|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7894079|NCT01888874|12400699|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7894080|NCT01888874|12400700|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2
7894081|NCT01888874|12400701|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7894082|NCT01888874|12400702|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7894083|NCT01888874|12400703|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1
7894084|NCT01888874|12400704|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7894085|NCT01888874|12400698|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0
7894086|NCT01888874|12400699|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0
7894087|NCT01888874|12400700|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1
7894088|NCT01888874|12400701|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0
7894089|NCT01888874|12400702|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0
7894090|NCT01888874|12400703|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0
7894091|NCT01888874|12400704|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0
7894092|NCT01888874|12400698|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2
7894093|NCT01888874|12400699|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0
7894094|NCT01888874|12400700|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3
7894095|NCT01888874|12400701|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2
7894096|NCT01888874|12400702|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1
7894097|NCT01888874|12400703|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1
7894098|NCT01888874|12400704|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3
7894099|NCT01888874|12400698|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7894100|NCT01888874|12400699|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
7894101|NCT01888874|12400700|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7894102|NCT01888874|12400701|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7894103|NCT01888874|12400702|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7894104|NCT01888874|12400703|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
7894105|NCT01888874|12400704|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7894106|NCT01888900|12400723|FG000|Overall Study|failed treatment|0
7894107|NCT01888900|12400724|FG001|Overall Study|failed treatment|2
7894108|NCT01888965|12400736|FG000|Overall Study|Adverse Event|5
7894109|NCT01888965|12400736|FG000|Overall Study|Lack of Efficacy|4
7894110|NCT01889069|12400742|FG000|Overall Study|Death|18
7894111|NCT01889069|12400742|FG000|Overall Study|Progression of Disease|14
7894112|NCT01889069|12400742|FG000|Overall Study|Lost to Follow-up|6
7894113|NCT01889069|12400742|FG000|Overall Study|Other|4
7894114|NCT01889069|12400742|FG000|Overall Study|Consent Withdrawal|3
7894115|NCT01889251|12400754|FG000|Overall Study|Adverse Event|1
7894116|NCT01889251|12400755|FG001|Overall Study|Adverse Event|0
7894117|NCT01889602|12400777|FG000|First Intervention|Adverse Event|1
7894118|NCT01889602|12400778|FG001|First Intervention|Adverse Event|1
7894119|NCT01889602|12400779|FG002|First Intervention|Adverse Event|1
7894120|NCT01889602|12400777|FG000|First Intervention|Protocol Violation|0
7894121|NCT01889602|12400778|FG001|First Intervention|Protocol Violation|1
7894122|NCT01889602|12400779|FG002|First Intervention|Protocol Violation|1
7894123|NCT01889602|12400777|FG000|First Intervention|Study ending|0
7894124|NCT01889602|12400778|FG001|First Intervention|Study ending|1
7894125|NCT01889602|12400779|FG002|First Intervention|Study ending|0
7894126|NCT01889602|12400777|FG000|Second Intervention|Adverse Event|0
7894127|NCT01889602|12400778|FG001|Second Intervention|Adverse Event|0
7894128|NCT01889602|12400779|FG002|Second Intervention|Adverse Event|1
7894129|NCT01889602|12400777|FG000|Second Intervention|Study ending|1
7894130|NCT01889602|12400778|FG001|Second Intervention|Study ending|0
7894131|NCT01889602|12400779|FG002|Second Intervention|Study ending|0
7894132|NCT01889602|12400777|FG000|Second Intervention|Withdrawal by Subject|0
7894133|NCT01889602|12400778|FG001|Second Intervention|Withdrawal by Subject|0
7894134|NCT01889602|12400779|FG002|Second Intervention|Withdrawal by Subject|1
7894135|NCT01889602|12400777|FG000|Third Intervention|Protocol Violation|1
7894136|NCT01889602|12400778|FG001|Third Intervention|Protocol Violation|0
7894137|NCT01889602|12400779|FG002|Third Intervention|Protocol Violation|0
7894138|NCT01889602|12400777|FG000|Third Intervention|Withdrawal by Subject|2
7968446|NCT02154529|12525967|FG000|Overall Study|Death|1
7968447|NCT02154529|12525968|FG001|Overall Study|Death|1
7968448|NCT02154529|12525969|FG002|Overall Study|Death|5
7968449|NCT02154529|12525970|FG003|Overall Study|Death|1
7968450|NCT02154529|12525967|FG000|Overall Study|Termination of study by sponsor|2
7968451|NCT02154529|12525968|FG001|Overall Study|Termination of study by sponsor|2
7968452|NCT02154529|12525969|FG002|Overall Study|Termination of study by sponsor|3
7968453|NCT02154529|12525970|FG003|Overall Study|Termination of study by sponsor|1
7968454|NCT02154529|12525967|FG000|Overall Study|Lost to Follow-up|1
7894139|NCT01889602|12400778|FG001|Third Intervention|Withdrawal by Subject|2
7894140|NCT01889602|12400779|FG002|Third Intervention|Withdrawal by Subject|0
7894141|NCT01889862|12400819|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4
7894142|NCT01889862|12400820|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0
7894143|NCT01889862|12400821|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0
7894144|NCT01889862|12400822|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0
7894145|NCT01889862|12400823|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0
7894146|NCT01889862|12400819|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2
7894147|NCT01889862|12400820|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7894148|NCT01889862|12400821|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7894149|NCT01889862|12400822|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7894150|NCT01889862|12400823|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7894151|NCT01889862|12400819|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4
7894152|NCT01889862|12400820|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7894153|NCT01889862|12400821|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7894154|NCT01889862|12400822|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7894155|NCT01889862|12400823|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7894156|NCT01889862|12400819|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2
7894157|NCT01889862|12400820|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0
7894158|NCT01889862|12400821|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0
7894159|NCT01889862|12400822|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0
7894160|NCT01889862|12400823|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0
7894161|NCT01889862|12400819|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0
7894162|NCT01889862|12400820|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0
7894163|NCT01889862|12400821|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1
7894164|NCT01889862|12400822|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0
7894165|NCT01889862|12400823|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0
7894166|NCT01889862|12400819|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0
7894167|NCT01889862|12400820|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0
7894168|NCT01889862|12400821|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0
7894169|NCT01889862|12400822|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0
7894170|NCT01889862|12400823|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5
7894171|NCT01889862|12400819|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7894172|NCT01889862|12400820|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7894173|NCT01889862|12400821|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7894174|NCT01889862|12400822|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7894175|NCT01889862|12400823|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14
7894176|NCT01889862|12400819|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7894177|NCT01889862|12400820|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7894178|NCT01889862|12400821|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7894179|NCT01889862|12400822|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7894180|NCT01889862|12400823|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4
7894181|NCT01889862|12400819|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0
7894182|NCT01889862|12400820|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0
7894183|NCT01889862|12400821|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0
7894184|NCT01889862|12400822|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0
7894185|NCT01889862|12400823|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5
7894186|NCT01889862|12400819|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7894187|NCT01889862|12400820|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7894188|NCT01889862|12400821|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7894189|NCT01889862|12400822|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7894190|NCT01889862|12400823|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2
7894191|NCT01890109|12400871|FG000|Overall Study|Withdrawal by Subject|0
7894192|NCT01890109|12400872|FG001|Overall Study|Withdrawal by Subject|3
7894193|NCT01890109|12400871|FG000|Overall Study|Lost to Follow-up|1
7894194|NCT01890109|12400872|FG001|Overall Study|Lost to Follow-up|2
7894195|NCT01890122|12400883|FG000|Overall Study|Adverse Event|1
7894196|NCT01890122|12400884|FG001|Overall Study|Adverse Event|1
7894197|NCT01890122|12400885|FG002|Overall Study|Adverse Event|1
7894198|NCT01890122|12400886|FG003|Overall Study|Adverse Event|2
7968455|NCT02154529|12525968|FG001|Overall Study|Lost to Follow-up|0
7894199|NCT01890122|12400883|FG000|Overall Study|Major Protocol Deviation|3
7894200|NCT01890122|12400884|FG001|Overall Study|Major Protocol Deviation|1
7894201|NCT01890122|12400885|FG002|Overall Study|Major Protocol Deviation|0
7894202|NCT01890122|12400886|FG003|Overall Study|Major Protocol Deviation|1
7894203|NCT01890122|12400883|FG000|Overall Study|Lost to Follow-up|0
7894204|NCT01890122|12400884|FG001|Overall Study|Lost to Follow-up|1
7894205|NCT01890122|12400885|FG002|Overall Study|Lost to Follow-up|2
7894206|NCT01890122|12400886|FG003|Overall Study|Lost to Follow-up|2
7894207|NCT01890122|12400883|FG000|Overall Study|Voluntary Withdrawal|8
7894208|NCT01890122|12400884|FG001|Overall Study|Voluntary Withdrawal|8
7894209|NCT01890122|12400885|FG002|Overall Study|Voluntary Withdrawal|2
7894210|NCT01890122|12400886|FG003|Overall Study|Voluntary Withdrawal|11
7894211|NCT01890122|12400883|FG000|Overall Study|Lack of Efficacy|14
7894212|NCT01890122|12400884|FG001|Overall Study|Lack of Efficacy|24
7894213|NCT01890122|12400885|FG002|Overall Study|Lack of Efficacy|7
7894214|NCT01890122|12400886|FG003|Overall Study|Lack of Efficacy|41
7894215|NCT01890122|12400883|FG000|Overall Study|Reason not Specified|0
7894216|NCT01890122|12400884|FG001|Overall Study|Reason not Specified|1
7894217|NCT01890122|12400885|FG002|Overall Study|Reason not Specified|1
7894218|NCT01890122|12400886|FG003|Overall Study|Reason not Specified|2
7894219|NCT01890122|12400883|FG000|Overall Study|Randomized but not Treated|1
7894220|NCT01890122|12400884|FG001|Overall Study|Randomized but not Treated|1
7894221|NCT01890122|12400885|FG002|Overall Study|Randomized but not Treated|0
7894222|NCT01890122|12400886|FG003|Overall Study|Randomized but not Treated|0
7894223|NCT01890148|12400896|FG000|Overall Study|Adverse Event|1
7894224|NCT01890265|12400915|FG000|Overall Study|Other (Unspecified reason)|0
7894225|NCT01890265|12400916|FG001|Overall Study|Other (Unspecified reason)|1
7894226|NCT01890265|12400917|FG002|Overall Study|Other (Unspecified reason)|0
7894227|NCT01890265|12400918|FG003|Overall Study|Other (Unspecified reason)|0
7894228|NCT01890265|12400919|FG004|Overall Study|Other (Unspecified reason)|0
7894229|NCT01890265|12400920|FG005|Overall Study|Other (Unspecified reason)|0
7894230|NCT01890265|12400915|FG000|Overall Study|Progressive disease|6
7894231|NCT01890265|12400916|FG001|Overall Study|Progressive disease|6
7894232|NCT01890265|12400917|FG002|Overall Study|Progressive disease|0
7894233|NCT01890265|12400918|FG003|Overall Study|Progressive disease|0
7894234|NCT01890265|12400919|FG004|Overall Study|Progressive disease|0
7894235|NCT01890265|12400920|FG005|Overall Study|Progressive disease|0
7894236|NCT01890265|12400915|FG000|Overall Study|Adverse Event|2
7894237|NCT01890265|12400916|FG001|Overall Study|Adverse Event|1
7894238|NCT01890265|12400917|FG002|Overall Study|Adverse Event|0
7894239|NCT01890265|12400918|FG003|Overall Study|Adverse Event|0
7894240|NCT01890265|12400919|FG004|Overall Study|Adverse Event|0
7894241|NCT01890265|12400920|FG005|Overall Study|Adverse Event|0
7894242|NCT01890265|12400915|FG000|Overall Study|Death|2
7894243|NCT01890265|12400916|FG001|Overall Study|Death|3
7894244|NCT01890265|12400917|FG002|Overall Study|Death|1
7894245|NCT01890265|12400918|FG003|Overall Study|Death|0
7894246|NCT01890265|12400919|FG004|Overall Study|Death|0
7894247|NCT01890265|12400920|FG005|Overall Study|Death|0
7894248|NCT01890265|12400915|FG000|Overall Study|Withdrawal by Subject|0
7894249|NCT01890265|12400916|FG001|Overall Study|Withdrawal by Subject|2
7894250|NCT01890265|12400917|FG002|Overall Study|Withdrawal by Subject|3
7894251|NCT01890265|12400918|FG003|Overall Study|Withdrawal by Subject|0
7894252|NCT01890265|12400919|FG004|Overall Study|Withdrawal by Subject|2
7894253|NCT01890265|12400920|FG005|Overall Study|Withdrawal by Subject|0
7894254|NCT01890421|12400943|FG000|Overall Study|Adverse Event|1
7894255|NCT01890421|12400943|FG000|Overall Study|Other reason|10
7894256|NCT01890434|12400947|FG000|Overall Study|Adverse Event|8
7894257|NCT01890434|12400947|FG000|Overall Study|PCI at external hospital|1
7894258|NCT01890434|12400947|FG000|Overall Study|Assessment discrepancy|1
7894259|NCT01890434|12400947|FG000|Overall Study|CRC didn't contact participant for FU|1
7894260|NCT01890434|12400947|FG000|Overall Study|Could not get whole set of images|1
7894261|NCT01890434|12400947|FG000|Overall Study|Decline to return for GSPECT|1
7894262|NCT01890434|12400947|FG000|Overall Study|GSPECT at rest was not done|1
7894263|NCT01890434|12400947|FG000|Overall Study|Participant didn't complete MRI|1
7894264|NCT01890434|12400947|FG000|Overall Study|Uncontactable by phone|1
7894265|NCT01890434|12400947|FG000|Overall Study|Moved out of position|1
7894266|NCT01890434|12400947|FG000|Overall Study|Unable to contact|1
7894267|NCT01890434|12400947|FG000|Overall Study|Withdrawal by PI for ICA not performed|2
7894268|NCT01890473|12400953|FG000|Overall Study|Lost to Follow-up|1
7894269|NCT01890473|12400954|FG001|Overall Study|Lost to Follow-up|0
7894270|NCT01890473|12400953|FG000|Overall Study|Poor/non-compliance|1
7894271|NCT01890473|12400954|FG001|Overall Study|Poor/non-compliance|0
7894272|NCT01890512|12400962|FG000|Overall Study|Physician Decision|1
7894273|NCT01890512|12400962|FG000|Overall Study|Withdrawal by Subject|1
7894274|NCT01890512|12400962|FG000|Overall Study|Protocol Violation|1
7894275|NCT01890707|12400981|FG000|Overall Study|Lost to Follow-up|1
7894276|NCT01890707|12400982|FG001|Overall Study|Lost to Follow-up|1
7894277|NCT01890746|12400990|FG000|Overall Study|Death|39
7894278|NCT01890746|12400991|FG001|Overall Study|Death|30
7894279|NCT01890746|12400990|FG000|Overall Study|Adverse Event|1
7894280|NCT01890746|12400991|FG001|Overall Study|Adverse Event|0
7894281|NCT01890746|12400990|FG000|Overall Study|Lost to Follow-up|4
7894282|NCT01890746|12400991|FG001|Overall Study|Lost to Follow-up|1
7894283|NCT01890746|12400990|FG000|Overall Study|Physician Decision|3
7894284|NCT01890746|12400991|FG001|Overall Study|Physician Decision|2
7894285|NCT01890746|12400990|FG000|Overall Study|Withdrawal by Subject|5
7894286|NCT01890746|12400991|FG001|Overall Study|Withdrawal by Subject|8
7894287|NCT01890785|12401003|FG000|Third Intervention|Withdrawal by Subject|0
7894288|NCT01890785|12401004|FG001|Third Intervention|Withdrawal by Subject|1
7894289|NCT01890785|12401005|FG002|Third Intervention|Withdrawal by Subject|0
7894290|NCT01890785|12401006|FG003|Third Intervention|Withdrawal by Subject|0
7894291|NCT01890785|12401007|FG004|Third Intervention|Withdrawal by Subject|0
7894292|NCT01890785|12401008|FG005|Third Intervention|Withdrawal by Subject|0
7894293|NCT01890915|12401019|FG000|Overall Study|Adverse Event|1
7894294|NCT01890915|12401020|FG001|Overall Study|Adverse Event|0
7894295|NCT01890915|12401019|FG000|Overall Study|Protocol Violation|2
7894296|NCT01890915|12401020|FG001|Overall Study|Protocol Violation|0
7894297|NCT01890915|12401019|FG000|Overall Study|Equipment Malfunction|0
7894298|NCT01890915|12401020|FG001|Overall Study|Equipment Malfunction|1
7894299|NCT01890967|12401032|FG000|Overall Study|Adverse Event|3
7894300|NCT01890967|12401033|FG001|Overall Study|Adverse Event|3
7894301|NCT01890967|12401034|FG002|Overall Study|Adverse Event|3
7894302|NCT01890967|12401035|FG003|Overall Study|Adverse Event|2
7894303|NCT01890967|12401036|FG004|Overall Study|Adverse Event|1
7894304|NCT01890967|12401037|FG005|Overall Study|Adverse Event|7
7894305|NCT01890967|12401032|FG000|Overall Study|Death|1
7894306|NCT01890967|12401033|FG001|Overall Study|Death|0
7894307|NCT01890967|12401034|FG002|Overall Study|Death|0
7894308|NCT01890967|12401035|FG003|Overall Study|Death|0
7894309|NCT01890967|12401036|FG004|Overall Study|Death|0
7894310|NCT01890967|12401037|FG005|Overall Study|Death|0
7894311|NCT01890967|12401032|FG000|Overall Study|Lost to Follow-up|1
7894312|NCT01890967|12401033|FG001|Overall Study|Lost to Follow-up|1
7894313|NCT01890967|12401034|FG002|Overall Study|Lost to Follow-up|1
7894314|NCT01890967|12401035|FG003|Overall Study|Lost to Follow-up|1
7894315|NCT01890967|12401036|FG004|Overall Study|Lost to Follow-up|0
7894316|NCT01890967|12401037|FG005|Overall Study|Lost to Follow-up|1
7894317|NCT01890967|12401032|FG000|Overall Study|Protocol Violation|0
7894318|NCT01890967|12401033|FG001|Overall Study|Protocol Violation|3
7894319|NCT01890967|12401034|FG002|Overall Study|Protocol Violation|3
7894320|NCT01890967|12401035|FG003|Overall Study|Protocol Violation|2
7894321|NCT01890967|12401036|FG004|Overall Study|Protocol Violation|4
7894322|NCT01890967|12401037|FG005|Overall Study|Protocol Violation|1
7894323|NCT01890967|12401032|FG000|Overall Study|Sponsor Decision|2
7894324|NCT01890967|12401033|FG001|Overall Study|Sponsor Decision|0
7894325|NCT01890967|12401034|FG002|Overall Study|Sponsor Decision|1
7894326|NCT01890967|12401035|FG003|Overall Study|Sponsor Decision|3
7894327|NCT01890967|12401036|FG004|Overall Study|Sponsor Decision|2
7894328|NCT01890967|12401037|FG005|Overall Study|Sponsor Decision|3
7894329|NCT01890967|12401032|FG000|Overall Study|Withdrawal by Subject|3
7894330|NCT01890967|12401033|FG001|Overall Study|Withdrawal by Subject|4
7894331|NCT01890967|12401034|FG002|Overall Study|Withdrawal by Subject|2
7894332|NCT01890967|12401035|FG003|Overall Study|Withdrawal by Subject|3
7894333|NCT01890967|12401036|FG004|Overall Study|Withdrawal by Subject|3
7894334|NCT01890967|12401037|FG005|Overall Study|Withdrawal by Subject|1
7894335|NCT01891357|12401090|FG000|Overall Study|Protocol Violation|3
7894336|NCT01891669|12401104|FG000|Overall Study|Death|0
7894337|NCT01891669|12401105|FG001|Overall Study|Death|0
7894338|NCT01891669|12401106|FG002|Overall Study|Death|0
7894339|NCT01891669|12401107|FG003|Overall Study|Death|0
7894340|NCT01891669|12401108|FG004|Overall Study|Death|0
7894341|NCT01891669|12401109|FG005|Overall Study|Death|0
7894342|NCT01891669|12401110|FG006|Overall Study|Death|0
7894343|NCT01891669|12401111|FG007|Overall Study|Death|1
7894344|NCT01891669|12401112|FG008|Overall Study|Death|0
7894345|NCT01891669|12401113|FG009|Overall Study|Death|1
7894346|NCT01891669|12401104|FG000|Overall Study|Withdrawal by Subject|1
7894347|NCT01891669|12401105|FG001|Overall Study|Withdrawal by Subject|1
7894348|NCT01891669|12401106|FG002|Overall Study|Withdrawal by Subject|0
7894349|NCT01891669|12401107|FG003|Overall Study|Withdrawal by Subject|0
7894350|NCT01891669|12401108|FG004|Overall Study|Withdrawal by Subject|0
7894351|NCT01891669|12401109|FG005|Overall Study|Withdrawal by Subject|0
7894352|NCT01891669|12401110|FG006|Overall Study|Withdrawal by Subject|1
7894353|NCT01891669|12401111|FG007|Overall Study|Withdrawal by Subject|2
7894354|NCT01891669|12401112|FG008|Overall Study|Withdrawal by Subject|1
7894355|NCT01891669|12401113|FG009|Overall Study|Withdrawal by Subject|1
7894356|NCT01891669|12401104|FG000|Overall Study|Other|1
7894357|NCT01891669|12401105|FG001|Overall Study|Other|0
7894358|NCT01891669|12401106|FG002|Overall Study|Other|0
7894359|NCT01891669|12401107|FG003|Overall Study|Other|0
7894360|NCT01891669|12401108|FG004|Overall Study|Other|0
7894361|NCT01891669|12401109|FG005|Overall Study|Other|0
7894362|NCT01891669|12401110|FG006|Overall Study|Other|0
7894363|NCT01891669|12401111|FG007|Overall Study|Other|1
7894364|NCT01891669|12401112|FG008|Overall Study|Other|0
7894365|NCT01891669|12401113|FG009|Overall Study|Other|0
7894366|NCT01891721|12401147|FG000|Overall Study|Lost to Follow-up|10
7894367|NCT01891721|12401148|FG001|Overall Study|Lost to Follow-up|5
7894368|NCT01891721|12401149|FG002|Overall Study|Lost to Follow-up|1
7894369|NCT01891864|12401170|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1
7894370|NCT01891864|12401171|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1
7963351|NCT02719743|12517694|FG001|Overall Study|Lost to Follow-up|1
7894371|NCT01891864|12401172|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7894372|NCT01891864|12401173|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7894373|NCT01891864|12401174|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7894374|NCT01891864|12401175|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7894375|NCT01891864|12401170|FG000|Treatment Period 1|Physician Decision|0
7894376|NCT01891864|12401171|FG001|Treatment Period 1|Physician Decision|1
7894377|NCT01891864|12401172|FG002|Treatment Period 1|Physician Decision|0
7894378|NCT01891864|12401173|FG003|Treatment Period 1|Physician Decision|0
7894379|NCT01891864|12401174|FG004|Treatment Period 1|Physician Decision|0
7894380|NCT01891864|12401175|FG005|Treatment Period 1|Physician Decision|0
7894381|NCT01891864|12401170|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0
7894382|NCT01891864|12401171|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1
7894383|NCT01891864|12401172|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0
7894384|NCT01891864|12401173|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0
7894385|NCT01891864|12401174|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0
7894386|NCT01891864|12401175|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0
7894387|NCT01891864|12401170|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4
7894388|NCT01891864|12401171|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4
7894389|NCT01891864|12401172|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7894390|NCT01891864|12401173|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7894391|NCT01891864|12401174|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7894392|NCT01891864|12401175|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7894393|NCT01891864|12401170|FG000|Treatment Period 1|Withdrawal by Subject|2
7894394|NCT01891864|12401171|FG001|Treatment Period 1|Withdrawal by Subject|5
7894395|NCT01891864|12401172|FG002|Treatment Period 1|Withdrawal by Subject|0
7894396|NCT01891864|12401173|FG003|Treatment Period 1|Withdrawal by Subject|0
7894397|NCT01891864|12401174|FG004|Treatment Period 1|Withdrawal by Subject|0
7894398|NCT01891864|12401175|FG005|Treatment Period 1|Withdrawal by Subject|0
7894399|NCT01891864|12401170|FG000|Treatment Period 1|Lost to Follow-up|1
7894400|NCT01891864|12401171|FG001|Treatment Period 1|Lost to Follow-up|0
7894401|NCT01891864|12401172|FG002|Treatment Period 1|Lost to Follow-up|0
7894402|NCT01891864|12401173|FG003|Treatment Period 1|Lost to Follow-up|0
7894403|NCT01891864|12401174|FG004|Treatment Period 1|Lost to Follow-up|0
7894404|NCT01891864|12401175|FG005|Treatment Period 1|Lost to Follow-up|0
7894405|NCT01891864|12401170|FG000|Treatment Period 2|Protocol Violation|0
7894406|NCT01891864|12401171|FG001|Treatment Period 2|Protocol Violation|0
7894407|NCT01891864|12401172|FG002|Treatment Period 2|Protocol Violation|0
7894408|NCT01891864|12401173|FG003|Treatment Period 2|Protocol Violation|1
7894409|NCT01891864|12401174|FG004|Treatment Period 2|Protocol Violation|0
7894410|NCT01891864|12401175|FG005|Treatment Period 2|Protocol Violation|0
7894411|NCT01891864|12401170|FG000|Treatment Period 2|Physician Decision|0
7894412|NCT01891864|12401171|FG001|Treatment Period 2|Physician Decision|0
7894413|NCT01891864|12401172|FG002|Treatment Period 2|Physician Decision|1
7894414|NCT01891864|12401173|FG003|Treatment Period 2|Physician Decision|0
7894415|NCT01891864|12401174|FG004|Treatment Period 2|Physician Decision|0
7894416|NCT01891864|12401175|FG005|Treatment Period 2|Physician Decision|0
7894417|NCT01891864|12401170|FG000|Treatment Period 2|Site Termination|0
7894418|NCT01891864|12401171|FG001|Treatment Period 2|Site Termination|0
7894419|NCT01891864|12401172|FG002|Treatment Period 2|Site Termination|1
7894420|NCT01891864|12401173|FG003|Treatment Period 2|Site Termination|2
7894421|NCT01891864|12401174|FG004|Treatment Period 2|Site Termination|0
7894422|NCT01891864|12401175|FG005|Treatment Period 2|Site Termination|0
7894423|NCT01891864|12401170|FG000|Treatment Period 2|Lack of Efficacy|0
7894424|NCT01891864|12401171|FG001|Treatment Period 2|Lack of Efficacy|0
7894425|NCT01891864|12401172|FG002|Treatment Period 2|Lack of Efficacy|1
7894426|NCT01891864|12401173|FG003|Treatment Period 2|Lack of Efficacy|0
7894427|NCT01891864|12401174|FG004|Treatment Period 2|Lack of Efficacy|1
7894428|NCT01891864|12401175|FG005|Treatment Period 2|Lack of Efficacy|0
7894429|NCT01891864|12401170|FG000|Treatment Period 2|Adverse Event|0
7894430|NCT01891864|12401171|FG001|Treatment Period 2|Adverse Event|0
7894431|NCT01891864|12401172|FG002|Treatment Period 2|Adverse Event|1
7894432|NCT01891864|12401173|FG003|Treatment Period 2|Adverse Event|2
7894433|NCT01891864|12401174|FG004|Treatment Period 2|Adverse Event|0
7894434|NCT01891864|12401175|FG005|Treatment Period 2|Adverse Event|4
7894435|NCT01891864|12401170|FG000|Treatment Period 2|Termination of Site|0
7894436|NCT01891864|12401171|FG001|Treatment Period 2|Termination of Site|0
7894437|NCT01891864|12401172|FG002|Treatment Period 2|Termination of Site|0
7894438|NCT01891864|12401173|FG003|Treatment Period 2|Termination of Site|0
7894439|NCT01891864|12401174|FG004|Treatment Period 2|Termination of Site|2
7894440|NCT01891864|12401175|FG005|Treatment Period 2|Termination of Site|0
7894441|NCT01891864|12401170|FG000|Treatment Period 2|Withdrawal by Subject|0
7894442|NCT01891864|12401171|FG001|Treatment Period 2|Withdrawal by Subject|0
7894443|NCT01891864|12401172|FG002|Treatment Period 2|Withdrawal by Subject|3
7894444|NCT01891864|12401173|FG003|Treatment Period 2|Withdrawal by Subject|4
7894445|NCT01891864|12401174|FG004|Treatment Period 2|Withdrawal by Subject|1
7894446|NCT01891864|12401175|FG005|Treatment Period 2|Withdrawal by Subject|1
7894447|NCT01891864|12401170|FG000|Extension Period|Lack of Efficacy|0
7894448|NCT01891864|12401171|FG001|Extension Period|Lack of Efficacy|0
7894449|NCT01891864|12401172|FG002|Extension Period|Lack of Efficacy|0
7894450|NCT01891864|12401173|FG003|Extension Period|Lack of Efficacy|1
7894451|NCT01891864|12401174|FG004|Extension Period|Lack of Efficacy|1
7894452|NCT01891864|12401175|FG005|Extension Period|Lack of Efficacy|0
7894453|NCT01891864|12401170|FG000|Extension Period|Pregnancy|0
7894454|NCT01891864|12401171|FG001|Extension Period|Pregnancy|0
7894455|NCT01891864|12401172|FG002|Extension Period|Pregnancy|1
7894456|NCT01891864|12401173|FG003|Extension Period|Pregnancy|0
7894457|NCT01891864|12401174|FG004|Extension Period|Pregnancy|0
7894458|NCT01891864|12401175|FG005|Extension Period|Pregnancy|0
7894459|NCT01891864|12401170|FG000|Extension Period|Adverse Event|0
7894460|NCT01891864|12401171|FG001|Extension Period|Adverse Event|0
7894461|NCT01891864|12401172|FG002|Extension Period|Adverse Event|4
7894462|NCT01891864|12401173|FG003|Extension Period|Adverse Event|2
7894463|NCT01891864|12401174|FG004|Extension Period|Adverse Event|2
7894464|NCT01891864|12401175|FG005|Extension Period|Adverse Event|0
7894465|NCT01891864|12401170|FG000|Extension Period|Withdrawal by Subject|0
7894466|NCT01891864|12401171|FG001|Extension Period|Withdrawal by Subject|0
7894467|NCT01891864|12401172|FG002|Extension Period|Withdrawal by Subject|1
7894468|NCT01891864|12401173|FG003|Extension Period|Withdrawal by Subject|2
7894469|NCT01891864|12401174|FG004|Extension Period|Withdrawal by Subject|4
7894470|NCT01891864|12401175|FG005|Extension Period|Withdrawal by Subject|0
7894471|NCT01891864|12401170|FG000|Extension Period|Lost to Follow-up|0
7894472|NCT01891864|12401171|FG001|Extension Period|Lost to Follow-up|0
7894473|NCT01891864|12401172|FG002|Extension Period|Lost to Follow-up|2
7894474|NCT01891864|12401173|FG003|Extension Period|Lost to Follow-up|0
7894475|NCT01891864|12401174|FG004|Extension Period|Lost to Follow-up|0
7894476|NCT01891864|12401175|FG005|Extension Period|Lost to Follow-up|0
7894477|NCT01891890|12401190|FG000|Overall Study|Lost to Follow-up|0
7894478|NCT01891890|12401191|FG001|Overall Study|Lost to Follow-up|0
7894479|NCT01891890|12401192|FG002|Overall Study|Lost to Follow-up|1
7894480|NCT01891890|12401190|FG000|Overall Study|Study ended before endpoint reached|7
7894481|NCT01891890|12401191|FG001|Overall Study|Study ended before endpoint reached|3
7894482|NCT01891890|12401192|FG002|Overall Study|Study ended before endpoint reached|6
7894483|NCT01892020|12401213|FG000|Period 1|Adverse Event|1
7894484|NCT01892020|12401214|FG001|Period 1|Adverse Event|1
7894485|NCT01892020|12401213|FG000|Period 1|Protocol Violation|2
7894486|NCT01892020|12401214|FG001|Period 1|Protocol Violation|4
7894487|NCT01892020|12401213|FG000|Period 1|Unclassified|0
7894488|NCT01892020|12401214|FG001|Period 1|Unclassified|1
7894489|NCT01892020|12401213|FG000|Period 2|Protocol Violation|1
7894490|NCT01892020|12401214|FG001|Period 2|Protocol Violation|0
7894491|NCT01892163|12401222|FG000|Overall Study|Death|1
7894492|NCT01892163|12401223|FG001|Overall Study|Death|1
7894493|NCT01892163|12401222|FG000|Overall Study|Lost to Follow-up|1
7894494|NCT01892163|12401223|FG001|Overall Study|Lost to Follow-up|0
7894495|NCT01892189|12401238|FG000|Washout Period 1 (7 Days)|Adverse Event|0
7894496|NCT01892189|12401239|FG001|Washout Period 1 (7 Days)|Adverse Event|0
7894497|NCT01892189|12401240|FG002|Washout Period 1 (7 Days)|Adverse Event|0
7894498|NCT01892189|12401241|FG003|Washout Period 1 (7 Days)|Adverse Event|0
7894499|NCT01892189|12401242|FG004|Washout Period 1 (7 Days)|Adverse Event|0
7894500|NCT01892189|12401243|FG005|Washout Period 1 (7 Days)|Adverse Event|0
7894501|NCT01892189|12401244|FG006|Washout Period 1 (7 Days)|Adverse Event|0
7894502|NCT01892189|12401245|FG007|Washout Period 1 (7 Days)|Adverse Event|0
7894503|NCT01892189|12401246|FG008|Washout Period 1 (7 Days)|Adverse Event|1
7894504|NCT01892189|12401238|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7894505|NCT01892189|12401239|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7894506|NCT01892189|12401240|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2
7894507|NCT01892189|12401241|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7894508|NCT01892189|12401242|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7894509|NCT01892189|12401243|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7894510|NCT01892189|12401244|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7894511|NCT01892189|12401245|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7894512|NCT01892189|12401246|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7894513|NCT01892189|12401238|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7894514|NCT01892189|12401239|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7894515|NCT01892189|12401240|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7894516|NCT01892189|12401241|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7894517|NCT01892189|12401242|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7894518|NCT01892189|12401243|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
7894519|NCT01892189|12401244|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7894520|NCT01892189|12401245|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7894521|NCT01892189|12401246|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7894522|NCT01892293|12401270|FG000|Overall Study|Apheresed but not treated|4
7894523|NCT01892345|12401285|FG000|Overall Study|Adverse Event|0
7894524|NCT01892345|12401286|FG001|Overall Study|Adverse Event|2
7894525|NCT01892345|12401285|FG000|Overall Study|Death|1
7894526|NCT01892345|12401286|FG001|Overall Study|Death|0
7894527|NCT01892345|12401285|FG000|Overall Study|Lost to Follow-up|3
7894528|NCT01892345|12401286|FG001|Overall Study|Lost to Follow-up|0
7894529|NCT01892345|12401285|FG000|Overall Study|Withdrawal by Subject|12
7894530|NCT01892345|12401286|FG001|Overall Study|Withdrawal by Subject|1
7894531|NCT01892436|12401296|FG000|Overall Study|Withdrawal by Subject|8
7894532|NCT01892436|12401297|FG001|Overall Study|Withdrawal by Subject|15
7894533|NCT01892436|12401298|FG002|Overall Study|Withdrawal by Subject|4
7894534|NCT01892436|12401299|FG003|Overall Study|Withdrawal by Subject|4
7894535|NCT01892436|12401296|FG000|Overall Study|Death|1
7894536|NCT01892436|12401297|FG001|Overall Study|Death|1
7894537|NCT01892436|12401298|FG002|Overall Study|Death|0
7894538|NCT01892436|12401299|FG003|Overall Study|Death|0
7894539|NCT01892436|12401296|FG000|Overall Study|Physician Decision|2
7894540|NCT01892436|12401297|FG001|Overall Study|Physician Decision|1
7894541|NCT01892436|12401298|FG002|Overall Study|Physician Decision|0
7894542|NCT01892436|12401299|FG003|Overall Study|Physician Decision|1
7894543|NCT01892436|12401296|FG000|Overall Study|Pregnancy|0
7894544|NCT01892436|12401297|FG001|Overall Study|Pregnancy|2
7894545|NCT01892436|12401298|FG002|Overall Study|Pregnancy|1
7894546|NCT01892436|12401299|FG003|Overall Study|Pregnancy|0
7894547|NCT01892436|12401296|FG000|Overall Study|Technical problems|2
7894548|NCT01892436|12401297|FG001|Overall Study|Technical problems|1
7894549|NCT01892436|12401298|FG002|Overall Study|Technical problems|1
7894550|NCT01892436|12401299|FG003|Overall Study|Technical problems|1
7894551|NCT01892436|12401296|FG000|Overall Study|Lack of Efficacy|1
7894552|NCT01892436|12401297|FG001|Overall Study|Lack of Efficacy|2
7894553|NCT01892436|12401298|FG002|Overall Study|Lack of Efficacy|2
7894554|NCT01892436|12401299|FG003|Overall Study|Lack of Efficacy|2
7894555|NCT01892436|12401296|FG000|Overall Study|Lost to Follow-up|1
7894556|NCT01892436|12401297|FG001|Overall Study|Lost to Follow-up|1
7894557|NCT01892436|12401298|FG002|Overall Study|Lost to Follow-up|1
7894558|NCT01892436|12401299|FG003|Overall Study|Lost to Follow-up|3
7894559|NCT01892436|12401296|FG000|Overall Study|non-compliance with treatment|1
7894560|NCT01892436|12401297|FG001|Overall Study|non-compliance with treatment|0
7894561|NCT01892436|12401298|FG002|Overall Study|non-compliance with treatment|0
7894562|NCT01892436|12401299|FG003|Overall Study|non-compliance with treatment|0
7894563|NCT01892436|12401296|FG000|Overall Study|Adverse Event|7
7894564|NCT01892436|12401297|FG001|Overall Study|Adverse Event|6
7894565|NCT01892436|12401298|FG002|Overall Study|Adverse Event|2
7894566|NCT01892436|12401299|FG003|Overall Study|Adverse Event|3
7894567|NCT01892501|12401309|FG000|Overall Study|Protocol Violation|2
7894568|NCT01892501|12401309|FG000|Overall Study|Puncture not carried out|9
7894569|NCT01892501|12401309|FG000|Overall Study|Radiological monitoring not carried out|5
7894570|NCT01892501|12401309|FG000|Overall Study|Non-contributory histological result|12
7894571|NCT01892540|12401316|FG000|Overall Study|Did not complete PET/MRI|0
7894572|NCT01892540|12401317|FG001|Overall Study|Did not complete PET/MRI|0
7894573|NCT01892540|12401318|FG002|Overall Study|Did not complete PET/MRI|2
7894574|NCT01892540|12401316|FG000|Overall Study|Did not fit in scanner|0
7894575|NCT01892540|12401317|FG001|Overall Study|Did not fit in scanner|0
7894576|NCT01892540|12401318|FG002|Overall Study|Did not fit in scanner|1
7894577|NCT01893203|12401343|FG000|Overall Study|Withdrawal by Subject|1
7894578|NCT01893281|12401347|FG000|Overall Study|Adverse Event|1
7894579|NCT01893281|12401347|FG000|Overall Study|Protocol Violation|1
7894580|NCT01893281|12401347|FG000|Overall Study|Withdrawal by Subject|1
7894581|NCT01893346|12401355|FG000|Overall Study|Lost to Follow-up|0
7894582|NCT01893346|12401356|FG001|Overall Study|Lost to Follow-up|1
7894583|NCT01893346|12401357|FG002|Overall Study|Lost to Follow-up|0
7894584|NCT01893346|12401358|FG003|Overall Study|Lost to Follow-up|0
7894585|NCT01893346|12401355|FG000|Overall Study|Protocol Violation|1
7894586|NCT01893346|12401356|FG001|Overall Study|Protocol Violation|0
7894587|NCT01893346|12401357|FG002|Overall Study|Protocol Violation|0
7894588|NCT01893346|12401358|FG003|Overall Study|Protocol Violation|0
7894589|NCT01893346|12401355|FG000|Overall Study|Withdrawal by Subject|2
7894590|NCT01893346|12401356|FG001|Overall Study|Withdrawal by Subject|0
7894591|NCT01893346|12401357|FG002|Overall Study|Withdrawal by Subject|0
7894592|NCT01893346|12401358|FG003|Overall Study|Withdrawal by Subject|0
7894593|NCT01893411|12401380|FG000|Overall Study|Protocol Violation|1
7894594|NCT01893411|12401381|FG001|Overall Study|Protocol Violation|0
7894595|NCT01893411|12401382|FG002|Overall Study|Protocol Violation|0
7894596|NCT01893411|12401380|FG000|Overall Study|Physician Decision|1
7894597|NCT01893411|12401381|FG001|Overall Study|Physician Decision|1
7894598|NCT01893411|12401382|FG002|Overall Study|Physician Decision|2
7894599|NCT01893411|12401380|FG000|Overall Study|Lack of Efficacy|2
7894600|NCT01893411|12401381|FG001|Overall Study|Lack of Efficacy|1
7894601|NCT01893411|12401382|FG002|Overall Study|Lack of Efficacy|0
7894602|NCT01893411|12401380|FG000|Overall Study|Other|3
7894603|NCT01893411|12401381|FG001|Overall Study|Other|1
7894604|NCT01893411|12401382|FG002|Overall Study|Other|3
7894605|NCT01893411|12401380|FG000|Overall Study|Adverse Event|1
7894606|NCT01893411|12401381|FG001|Overall Study|Adverse Event|0
7894607|NCT01893411|12401382|FG002|Overall Study|Adverse Event|0
7894608|NCT01893411|12401380|FG000|Overall Study|Withdrawal by Subject|7
7894609|NCT01893411|12401381|FG001|Overall Study|Withdrawal by Subject|4
7894610|NCT01893411|12401382|FG002|Overall Study|Withdrawal by Subject|3
7968456|NCT02154529|12525969|FG002|Overall Study|Lost to Follow-up|0
7968457|NCT02154529|12525970|FG003|Overall Study|Lost to Follow-up|0
7968458|NCT00788125|12525982|FG000|Overall Study|Death|6
7968459|NCT02777554|12525988|FG000|Overall Study|Adverse Event|4
7968460|NCT02777554|12525989|FG001|Overall Study|Adverse Event|4
7968461|NCT02777554|12525990|FG002|Overall Study|Adverse Event|0
7968462|NCT02777554|12525991|FG003|Overall Study|Adverse Event|1
7968463|NCT02777554|12525992|FG004|Overall Study|Adverse Event|0
7968464|NCT02777554|12525993|FG005|Overall Study|Adverse Event|0
7968465|NCT02777554|12525988|FG000|Overall Study|Withdrawal by Subject|3
7968466|NCT02777554|12525989|FG001|Overall Study|Withdrawal by Subject|1
7968467|NCT02777554|12525990|FG002|Overall Study|Withdrawal by Subject|1
7968468|NCT02777554|12525991|FG003|Overall Study|Withdrawal by Subject|0
7968469|NCT02777554|12525992|FG004|Overall Study|Withdrawal by Subject|0
7968470|NCT02777554|12525993|FG005|Overall Study|Withdrawal by Subject|0
7968471|NCT02777554|12525988|FG000|Overall Study|Discharged early due to hurricane|22
7894611|NCT01893411|12401380|FG000|Overall Study|Lost to Follow-up|2
7894612|NCT01893411|12401381|FG001|Overall Study|Lost to Follow-up|0
7894613|NCT01893411|12401382|FG002|Overall Study|Lost to Follow-up|1
7894614|NCT01893827|12401407|FG000|Overall Study|Lost to Follow-up|19
7894615|NCT01893827|12401408|FG001|Overall Study|Lost to Follow-up|26
7894616|NCT01893905|12401425|FG000|Overall Study|Withdrawal by Subject|1
7968472|NCT02777554|12525989|FG001|Overall Study|Discharged early due to hurricane|20
7968473|NCT02777554|12525990|FG002|Overall Study|Discharged early due to hurricane|0
7968474|NCT02777554|12525991|FG003|Overall Study|Discharged early due to hurricane|0
7894617|NCT01893905|12401426|FG001|Overall Study|Withdrawal by Subject|0
7894618|NCT01893905|12401425|FG000|Overall Study|Adverse Event|9
7894619|NCT01893905|12401426|FG001|Overall Study|Adverse Event|3
7894620|NCT01893905|12401425|FG000|Overall Study|Lack of Efficacy|5
7894621|NCT01893905|12401426|FG001|Overall Study|Lack of Efficacy|7
7894622|NCT01893905|12401425|FG000|Overall Study|Lost to Follow-up|1
7894623|NCT01893905|12401426|FG001|Overall Study|Lost to Follow-up|0
7894624|NCT01893905|12401425|FG000|Overall Study|Protocol Violation|6
7894625|NCT01893905|12401426|FG001|Overall Study|Protocol Violation|1
7894626|NCT01893905|12401425|FG000|Overall Study|Lack of adherence to treatment|2
7894627|NCT01893905|12401426|FG001|Overall Study|Lack of adherence to treatment|0
7894628|NCT01893905|12401425|FG000|Overall Study|Other reason|1
7894629|NCT01893905|12401426|FG001|Overall Study|Other reason|3
7894630|NCT01894022|12401443|FG000|Overall Study|Death|1
7894631|NCT01894022|12401444|FG001|Overall Study|Death|0
7894632|NCT01894022|12401443|FG000|Overall Study|Adverse Event, non-fatal|1
7894633|NCT01894022|12401444|FG001|Overall Study|Adverse Event, non-fatal|0
7894634|NCT01894022|12401443|FG000|Overall Study|Study Closed/terminated|7
7894635|NCT01894022|12401444|FG001|Overall Study|Study Closed/terminated|10
7894636|NCT01894100|12401462|FG000|Overall Study|Lost to Follow-up|0
7894637|NCT01894100|12401463|FG001|Overall Study|Lost to Follow-up|1
7894638|NCT01894100|12401462|FG000|Overall Study|Withdrawal by Subject|3
7894639|NCT01894100|12401463|FG001|Overall Study|Withdrawal by Subject|0
7894640|NCT01894152|12401469|FG000|Overall Study|No DMR and no Stent thrombosis|151
7894641|NCT01894230|12401484|FG000|Overall Study|Lost to Follow-up|2
7894642|NCT01894230|12401485|FG001|Overall Study|Lost to Follow-up|2
7894643|NCT01894230|12401484|FG000|Overall Study|Withdrawal by Subject|4
7894644|NCT01894230|12401485|FG001|Overall Study|Withdrawal by Subject|4
7894645|NCT01894230|12401484|FG000|Overall Study|Non-adherent|0
7894646|NCT01894230|12401485|FG001|Overall Study|Non-adherent|1
7894647|NCT01894230|12401484|FG000|Overall Study|Death|1
7894648|NCT01894230|12401485|FG001|Overall Study|Death|0
7894649|NCT01894243|12401494|FG000|Overall Study|Adverse Event|0
7894650|NCT01894243|12401495|FG001|Overall Study|Adverse Event|1
7894651|NCT01894243|12401496|FG002|Overall Study|Adverse Event|2
7894652|NCT01894243|12401494|FG000|Overall Study|Death|0
7894653|NCT01894243|12401495|FG001|Overall Study|Death|0
7894654|NCT01894243|12401496|FG002|Overall Study|Death|3
7894655|NCT01894243|12401494|FG000|Overall Study|Lack of Efficacy|3
7894656|NCT01894243|12401495|FG001|Overall Study|Lack of Efficacy|3
7894657|NCT01894243|12401496|FG002|Overall Study|Lack of Efficacy|1
7894658|NCT01894243|12401494|FG000|Overall Study|Condition under investigation worsened|8
7894659|NCT01894243|12401495|FG001|Overall Study|Condition under investigation worsened|6
7894660|NCT01894243|12401496|FG002|Overall Study|Condition under investigation worsened|2
7894661|NCT01894243|12401494|FG000|Overall Study|Subject decision|1
7894662|NCT01894243|12401495|FG001|Overall Study|Subject decision|0
7894663|NCT01894243|12401496|FG002|Overall Study|Subject decision|0
7894664|NCT01894243|12401494|FG000|Overall Study|Other|1
7894665|NCT01894243|12401495|FG001|Overall Study|Other|0
7894666|NCT01894243|12401496|FG002|Overall Study|Other|0
7894667|NCT01894256|12401514|FG000|Part A|Adverse Event|0
7894668|NCT01894256|12401515|FG001|Part A|Adverse Event|1
7894669|NCT01894256|12401516|FG002|Part A|Adverse Event|0
7894670|NCT01894256|12401514|FG000|Part B|Death|0
7894671|NCT01894256|12401515|FG001|Part B|Death|1
7894672|NCT01894256|12401516|FG002|Part B|Death|1
7894673|NCT01894256|12401514|FG000|Part B|Withdrawal by Subject|0
7894674|NCT01894256|12401515|FG001|Part B|Withdrawal by Subject|1
7894675|NCT01894256|12401516|FG002|Part B|Withdrawal by Subject|0
7894676|NCT01894256|12401514|FG000|Part B|Lack of Efficacy|15
7894677|NCT01894256|12401515|FG001|Part B|Lack of Efficacy|12
7894678|NCT01894256|12401516|FG002|Part B|Lack of Efficacy|13
7894679|NCT01894477|12401529|FG000|Overall Study|Protocol Violation|0
7894680|NCT01894477|12401530|FG001|Overall Study|Protocol Violation|1
7894681|NCT01894477|12401529|FG000|Overall Study|protocol changed due SC changed to cord|0
7894682|NCT01894477|12401530|FG001|Overall Study|protocol changed due SC changed to cord|1
7894683|NCT01894516|12401545|FG000|Period 1 (Baseline up to Week 12)|Other|0
7894684|NCT01894516|12401546|FG001|Period 1 (Baseline up to Week 12)|Other|1
7894685|NCT01894516|12401547|FG002|Period 1 (Baseline up to Week 12)|Other|1
7894686|NCT01894516|12401548|FG003|Period 1 (Baseline up to Week 12)|Other|0
7894687|NCT01894516|12401545|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2
7894688|NCT01894516|12401546|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7894689|NCT01894516|12401547|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7894690|NCT01894516|12401548|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7894691|NCT01894516|12401545|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
7894692|NCT01894516|12401546|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
7894693|NCT01894516|12401547|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
7894694|NCT01894516|12401548|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
7894695|NCT01894516|12401545|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0
7894696|NCT01894516|12401546|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0
7894697|NCT01894516|12401547|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1
7894698|NCT01894516|12401548|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0
7894699|NCT01894516|12401545|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2
7894700|NCT01894516|12401546|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0
7894701|NCT01894516|12401547|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0
7894702|NCT01894516|12401548|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1
7894703|NCT01894516|12401545|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7894704|NCT01894516|12401546|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
7894705|NCT01894516|12401547|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1
7894706|NCT01894516|12401548|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7968475|NCT02777554|12525992|FG004|Overall Study|Discharged early due to hurricane|0
7968476|NCT02777554|12525993|FG005|Overall Study|Discharged early due to hurricane|0
7968477|NCT02777554|12525988|FG000|Overall Study|Other - Miscellaneous|1
7968478|NCT02777554|12525989|FG001|Overall Study|Other - Miscellaneous|0
7968479|NCT02777554|12525990|FG002|Overall Study|Other - Miscellaneous|0
7968480|NCT02777554|12525991|FG003|Overall Study|Other - Miscellaneous|0
7968481|NCT02777554|12525992|FG004|Overall Study|Other - Miscellaneous|0
7968482|NCT02777554|12525993|FG005|Overall Study|Other - Miscellaneous|0
7968483|NCT02777827|12526030|FG000|Washout Between Periods 3 and 4|Protocol Violation|0
7968484|NCT02777827|12526031|FG001|Washout Between Periods 3 and 4|Protocol Violation|0
7968485|NCT02777827|12526032|FG002|Washout Between Periods 3 and 4|Protocol Violation|1
7968486|NCT02777827|12526033|FG003|Washout Between Periods 3 and 4|Protocol Violation|0
7968487|NCT02777827|12526034|FG004|Washout Between Periods 3 and 4|Protocol Violation|0
7968488|NCT02777827|12526035|FG005|Washout Between Periods 3 and 4|Protocol Violation|0
7968489|NCT02777918|12526051|FG000|Overall Study|Medical reasons|1
7968490|NCT02777918|12526052|FG001|Overall Study|Medical reasons|2
7968491|NCT02777918|12526051|FG000|Overall Study|Too busy / stressed|1
7968492|NCT02777918|12526052|FG001|Overall Study|Too busy / stressed|1
7968493|NCT02777918|12526051|FG000|Overall Study|Withdrawal by Subject|1
7968494|NCT02777918|12526052|FG001|Overall Study|Withdrawal by Subject|1
7968495|NCT02777970|12526079|FG000|Overall Study|Lost to Follow-up|0
7968496|NCT02777970|12526080|FG001|Overall Study|Lost to Follow-up|1
7968497|NCT02777970|12526081|FG002|Overall Study|Lost to Follow-up|0
7968498|NCT02777970|12526079|FG000|Overall Study|Protocol Violation|1
7968499|NCT02777970|12526080|FG001|Overall Study|Protocol Violation|0
7968500|NCT02777970|12526081|FG002|Overall Study|Protocol Violation|0
7968501|NCT02778074|12526093|FG000|Overall Study|Lost to Follow-up|7
7968502|NCT02778074|12526094|FG001|Overall Study|Lost to Follow-up|10
7968503|NCT02778100|12526102|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1
7968504|NCT02778100|12526103|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0
7968505|NCT02778555|12526133|FG000|Overall Study|Withdrawal by Subject|55
7968506|NCT02778555|12526134|FG001|Overall Study|Withdrawal by Subject|32
7968507|NCT02778555|12526135|FG002|Overall Study|Withdrawal by Subject|107
7968508|NCT02778867|12526145|FG000|Phase 1|Withdrawal by Subject|2
7968509|NCT02778867|12526146|FG001|Phase 1|Withdrawal by Subject|3
7968510|NCT02778867|12526147|FG002|Phase 1|Withdrawal by Subject|0
7968511|NCT02778867|12526148|FG003|Phase 1|Withdrawal by Subject|0
7968512|NCT02778867|12526145|FG000|Phase 2|Withdrawal by Subject|0
7968513|NCT02778867|12526146|FG001|Phase 2|Withdrawal by Subject|0
7968514|NCT02778867|12526147|FG002|Phase 2|Withdrawal by Subject|1
7968515|NCT02778867|12526148|FG003|Phase 2|Withdrawal by Subject|0
7968516|NCT02778867|12526145|FG000|Phase 2|Physician Decision|0
7968517|NCT02778867|12526146|FG001|Phase 2|Physician Decision|0
7968518|NCT02778867|12526147|FG002|Phase 2|Physician Decision|0
7968519|NCT02778867|12526148|FG003|Phase 2|Physician Decision|1
7968520|NCT02778867|12526145|FG000|Phase 2|Adverse Event|0
7968521|NCT02778867|12526146|FG001|Phase 2|Adverse Event|0
7968522|NCT02778867|12526147|FG002|Phase 2|Adverse Event|0
7968523|NCT02778867|12526148|FG003|Phase 2|Adverse Event|1
7968524|NCT02779075|12526178|FG000|Overall Study|Withdrawal by Subject|1
7968525|NCT02779075|12526179|FG001|Overall Study|Withdrawal by Subject|3
7968526|NCT02779075|12526178|FG000|Overall Study|IV lost during 2nd study|1
7968527|NCT02779075|12526179|FG001|Overall Study|IV lost during 2nd study|0
7968528|NCT02780115|12526226|FG000|Overall Study|Withdrawal by Subject|0
7968529|NCT02780115|12526227|FG001|Overall Study|Withdrawal by Subject|1
7968530|NCT02780115|12526228|FG002|Overall Study|Withdrawal by Subject|1
7968531|NCT02780115|12526229|FG003|Overall Study|Withdrawal by Subject|0
7968532|NCT02780115|12526230|FG004|Overall Study|Withdrawal by Subject|0
7968533|NCT02780115|12526226|FG000|Overall Study|Adverse Event|0
7968534|NCT02780115|12526227|FG001|Overall Study|Adverse Event|0
7968535|NCT02780115|12526228|FG002|Overall Study|Adverse Event|0
7968536|NCT02780115|12526229|FG003|Overall Study|Adverse Event|1
7968537|NCT02780115|12526230|FG004|Overall Study|Adverse Event|1
7968538|NCT02780167|12526247|FG000|Overall Study|Adverse Event|9
7968539|NCT02780167|12526248|FG001|Overall Study|Adverse Event|8
7968540|NCT02780167|12526249|FG002|Overall Study|Adverse Event|8
7968541|NCT02780167|12526250|FG003|Overall Study|Adverse Event|12
7968542|NCT02780167|12526251|FG004|Overall Study|Adverse Event|8
7968543|NCT02780167|12526247|FG000|Overall Study|Lack of Efficacy|6
7968544|NCT02780167|12526248|FG001|Overall Study|Lack of Efficacy|5
7968545|NCT02780167|12526249|FG002|Overall Study|Lack of Efficacy|6
7968546|NCT02780167|12526250|FG003|Overall Study|Lack of Efficacy|1
7968547|NCT02780167|12526251|FG004|Overall Study|Lack of Efficacy|0
7968548|NCT02780167|12526247|FG000|Overall Study|Lost to Follow-up|2
7968549|NCT02780167|12526248|FG001|Overall Study|Lost to Follow-up|0
7894707|NCT01894516|12401545|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0
7894708|NCT01894516|12401546|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2
7894709|NCT01894516|12401547|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3
7894710|NCT01894516|12401548|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1
7894711|NCT01894516|12401545|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7894712|NCT01894516|12401546|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7894713|NCT01894516|12401547|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
7894714|NCT01894516|12401548|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7894715|NCT01894568|12401568|FG000|Overall Study|Adverse Event|2
7894716|NCT01894568|12401569|FG001|Overall Study|Adverse Event|3
7894717|NCT01894568|12401568|FG000|Overall Study|Protocol required discontinuation|2
7894718|NCT01894568|12401569|FG001|Overall Study|Protocol required discontinuation|1
7894719|NCT01894568|12401568|FG000|Overall Study|Withdrawal by Subject|5
7894720|NCT01894568|12401569|FG001|Overall Study|Withdrawal by Subject|5
7894721|NCT01894568|12401568|FG000|Overall Study|Physician Decision|1
7894722|NCT01894568|12401569|FG001|Overall Study|Physician Decision|0
7894723|NCT01894568|12401568|FG000|Overall Study|Lost to Follow-up|0
7894724|NCT01894568|12401569|FG001|Overall Study|Lost to Follow-up|1
7894725|NCT01894581|12401578|FG000|Overall Study|Withdrawal by Subject|2
7894726|NCT01894581|12401579|FG001|Overall Study|Withdrawal by Subject|3
7894727|NCT01894581|12401578|FG000|Overall Study|Screen Failure|3
7894728|NCT01894581|12401579|FG001|Overall Study|Screen Failure|4
7894729|NCT01894607|12401585|FG000|Overall Study|Ineligible|1
7894730|NCT01894620|12401591|FG000|Overall Study|Withdrawal by Subject|0
7894731|NCT01894620|12401592|FG001|Overall Study|Withdrawal by Subject|1
7894732|NCT01894776|12401605|FG000|Overall Study|Withdrawal by Subject|1
7894733|NCT01894841|12401611|FG000|Overall Study|Withdrawal by Subject|9
7894734|NCT01894841|12401612|FG001|Overall Study|Withdrawal by Subject|4
7894735|NCT01894841|12401611|FG000|Overall Study|Withdrawn by investigator|2
7894736|NCT01894841|12401612|FG001|Overall Study|Withdrawn by investigator|2
7894737|NCT01894841|12401611|FG000|Overall Study|Lost to Follow-up|7
7894738|NCT01894841|12401612|FG001|Overall Study|Lost to Follow-up|3
7894739|NCT01894919|12401656|FG000|Overall Study|Withdrawal by Subject|1
7894740|NCT01894919|12401657|FG001|Overall Study|Withdrawal by Subject|0
7894741|NCT01894919|12401658|FG002|Overall Study|Withdrawal by Subject|0
7894742|NCT01894919|12401659|FG003|Overall Study|Withdrawal by Subject|0
7894743|NCT01894919|12401660|FG004|Overall Study|Withdrawal by Subject|1
7894744|NCT01894919|12401661|FG005|Overall Study|Withdrawal by Subject|0
7894745|NCT01894919|12401662|FG006|Overall Study|Withdrawal by Subject|0
7894746|NCT01894919|12401663|FG007|Overall Study|Withdrawal by Subject|0
7894747|NCT01894919|12401664|FG008|Overall Study|Withdrawal by Subject|0
7894748|NCT01894919|12401665|FG009|Overall Study|Withdrawal by Subject|1
7894749|NCT01894919|12401666|FG010|Overall Study|Withdrawal by Subject|1
7894750|NCT01894919|12401667|FG011|Overall Study|Withdrawal by Subject|0
7894751|NCT01894919|12401668|FG012|Overall Study|Withdrawal by Subject|0
7894752|NCT01894919|12401656|FG000|Overall Study|Adverse Event|0
7894753|NCT01894919|12401657|FG001|Overall Study|Adverse Event|0
7894754|NCT01894919|12401658|FG002|Overall Study|Adverse Event|0
7894755|NCT01894919|12401659|FG003|Overall Study|Adverse Event|0
7894756|NCT01894919|12401660|FG004|Overall Study|Adverse Event|0
7894757|NCT01894919|12401661|FG005|Overall Study|Adverse Event|0
7894758|NCT01894919|12401662|FG006|Overall Study|Adverse Event|0
7894759|NCT01894919|12401663|FG007|Overall Study|Adverse Event|0
7894760|NCT01894919|12401664|FG008|Overall Study|Adverse Event|0
7894761|NCT01894919|12401665|FG009|Overall Study|Adverse Event|0
7894762|NCT01894919|12401666|FG010|Overall Study|Adverse Event|1
7894763|NCT01894919|12401667|FG011|Overall Study|Adverse Event|0
7894764|NCT01894919|12401668|FG012|Overall Study|Adverse Event|0
7894765|NCT01894919|12401656|FG000|Overall Study|Other-Unspecified|1
7894766|NCT01894919|12401657|FG001|Overall Study|Other-Unspecified|0
7894767|NCT01894919|12401658|FG002|Overall Study|Other-Unspecified|0
7894768|NCT01894919|12401659|FG003|Overall Study|Other-Unspecified|0
7894769|NCT01894919|12401660|FG004|Overall Study|Other-Unspecified|0
7894770|NCT01894919|12401661|FG005|Overall Study|Other-Unspecified|0
7968550|NCT02780167|12526249|FG002|Overall Study|Lost to Follow-up|1
7894771|NCT01894919|12401662|FG006|Overall Study|Other-Unspecified|0
7894772|NCT01894919|12401663|FG007|Overall Study|Other-Unspecified|0
7894773|NCT01894919|12401664|FG008|Overall Study|Other-Unspecified|0
7894774|NCT01894919|12401665|FG009|Overall Study|Other-Unspecified|0
7894775|NCT01894919|12401666|FG010|Overall Study|Other-Unspecified|0
7894776|NCT01894919|12401667|FG011|Overall Study|Other-Unspecified|0
7894777|NCT01894919|12401668|FG012|Overall Study|Other-Unspecified|0
7894778|NCT01894919|12401656|FG000|Overall Study|Lost to Follow-up|0
7894779|NCT01894919|12401657|FG001|Overall Study|Lost to Follow-up|0
7894780|NCT01894919|12401658|FG002|Overall Study|Lost to Follow-up|0
7894781|NCT01894919|12401659|FG003|Overall Study|Lost to Follow-up|0
7894782|NCT01894919|12401660|FG004|Overall Study|Lost to Follow-up|2
7894783|NCT01894919|12401661|FG005|Overall Study|Lost to Follow-up|0
7894784|NCT01894919|12401662|FG006|Overall Study|Lost to Follow-up|0
7894785|NCT01894919|12401663|FG007|Overall Study|Lost to Follow-up|0
7894786|NCT01894919|12401664|FG008|Overall Study|Lost to Follow-up|0
7894787|NCT01894919|12401665|FG009|Overall Study|Lost to Follow-up|0
7894788|NCT01894919|12401666|FG010|Overall Study|Lost to Follow-up|0
7894789|NCT01894919|12401667|FG011|Overall Study|Lost to Follow-up|0
7894790|NCT01894919|12401668|FG012|Overall Study|Lost to Follow-up|0
7894791|NCT01894984|12401712|FG000|Overall Study|Other|314
7894792|NCT01894984|12401713|FG001|Overall Study|Other|175
7963352|NCT02719743|12517695|FG002|Overall Study|Lost to Follow-up|0
7963353|NCT02719743|12517696|FG003|Overall Study|Lost to Follow-up|0
7963354|NCT02719743|12517697|FG004|Overall Study|Lost to Follow-up|0
7963355|NCT02720042|12517718|FG000|Overall Study|Death|3
7963356|NCT02720042|12517718|FG000|Overall Study|Lost to Follow-up|4
7963357|NCT02720042|12517718|FG000|Overall Study|Withdrawal by Subject|1
7963358|NCT02720042|12517718|FG000|Overall Study|Physician Decision|3
7963359|NCT02720042|12517718|FG000|Overall Study|Phasix Mesh explanted|1
7963360|NCT02720042|12517718|FG000|Overall Study|unable due to non-study-related illness|3
7963361|NCT02720081|12517724|FG000|Overall Study|Adverse Event|0
7963362|NCT02720081|12517725|FG001|Overall Study|Adverse Event|3
7963363|NCT02720081|12517724|FG000|Overall Study|Protocol Violation|4
7963364|NCT02720081|12517725|FG001|Overall Study|Protocol Violation|1
7963365|NCT02720198|12517737|FG000|Overall Study|Withdrawal by Subject|0
7963366|NCT02720198|12517738|FG001|Overall Study|Withdrawal by Subject|1
7966809|NCT02757352|12523226|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1
7966810|NCT02757352|12523227|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7966811|NCT02757352|12523228|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7966812|NCT02757352|12523229|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7966813|NCT02757352|12523230|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7966814|NCT02757352|12523231|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7966815|NCT02757352|12523222|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7966816|NCT02757352|12523223|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7966817|NCT02757352|12523224|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7966818|NCT02757352|12523225|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7966819|NCT02757352|12523226|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7966820|NCT02757352|12523227|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1
7966821|NCT02757352|12523228|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7966822|NCT02757352|12523229|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7966823|NCT02757352|12523230|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7966824|NCT02757352|12523231|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7966825|NCT02757352|12523222|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7966826|NCT02757352|12523223|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7966827|NCT02757352|12523224|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7966828|NCT02757352|12523225|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2
7966829|NCT02757352|12523226|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
7966830|NCT02757352|12523227|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
7966831|NCT02757352|12523228|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7966832|NCT02757352|12523229|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7894793|NCT01895101|12401739|FG000|Overall Study|OPCAB procedure|1
7894794|NCT01895101|12401740|FG001|Overall Study|OPCAB procedure|1
7894795|NCT01895101|12401741|FG002|Overall Study|OPCAB procedure|3
7894796|NCT01895101|12401739|FG000|Overall Study|Withdrawal by Subject|0
7894797|NCT01895101|12401740|FG001|Overall Study|Withdrawal by Subject|1
7894798|NCT01895101|12401741|FG002|Overall Study|Withdrawal by Subject|2
7894799|NCT01895101|12401739|FG000|Overall Study|another study, enrolled in other study|0
7894800|NCT01895101|12401740|FG001|Overall Study|another study, enrolled in other study|1
7894801|NCT01895101|12401741|FG002|Overall Study|another study, enrolled in other study|0
7894802|NCT01895101|12401739|FG000|Overall Study|Death|0
7894803|NCT01895101|12401740|FG001|Overall Study|Death|1
7894804|NCT01895101|12401741|FG002|Overall Study|Death|0
7894805|NCT01895101|12401739|FG000|Overall Study|coagulation disorder|0
7894806|NCT01895101|12401740|FG001|Overall Study|coagulation disorder|1
7894807|NCT01895101|12401741|FG002|Overall Study|coagulation disorder|0
7894808|NCT01895270|12401761|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0
7894809|NCT01895270|12401762|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2
7894810|NCT01895270|12401761|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
7894811|NCT01895270|12401762|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
7894812|NCT01895270|12401761|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3
7894813|NCT01895270|12401762|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1
7894814|NCT01895270|12401761|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0
7894815|NCT01895270|12401762|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1
7894816|NCT01895270|12401761|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
7894817|NCT01895270|12401762|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
7894818|NCT01895270|12401761|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0
7894819|NCT01895270|12401762|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1
7894820|NCT01895270|12401761|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0
7894821|NCT01895270|12401762|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1
7894822|NCT01895309|12401770|FG000|Overall Study|Adverse Event|13
7894823|NCT01895309|12401771|FG001|Overall Study|Adverse Event|17
7894824|NCT01895309|12401770|FG000|Overall Study|Protocol Violation|1
7894825|NCT01895309|12401771|FG001|Overall Study|Protocol Violation|0
7894826|NCT01895309|12401770|FG000|Overall Study|Lack of Efficacy|1
7894827|NCT01895309|12401771|FG001|Overall Study|Lack of Efficacy|3
7894828|NCT01895309|12401770|FG000|Overall Study|Lost to Follow-up|1
7894829|NCT01895309|12401771|FG001|Overall Study|Lost to Follow-up|3
7894830|NCT01895309|12401770|FG000|Overall Study|Physician Decision|15
7894831|NCT01895309|12401771|FG001|Overall Study|Physician Decision|10
7894832|NCT01895309|12401770|FG000|Overall Study|Withdrawal by Subject|9
7894833|NCT01895309|12401771|FG001|Overall Study|Withdrawal by Subject|18
7894834|NCT01895322|12401781|FG000|Overall Study|Adverse Event|1
7894835|NCT01895322|12401781|FG000|Overall Study|Withdrawal by Subject|2
7894836|NCT01895322|12401781|FG000|Overall Study|Protocol Violation|10
7894837|NCT01895335|12401786|FG000|Overall Study|Adverse Event|106
7894838|NCT01895335|12401786|FG000|Overall Study|Lack of Efficacy|53
7894839|NCT01895335|12401786|FG000|Overall Study|Poor Compliance to Protocol|11
7894840|NCT01895335|12401786|FG000|Overall Study|Included But Not treated|1
7894841|NCT01895335|12401786|FG000|Overall Study|Other than Specified Above|44
7894842|NCT01895361|12401793|FG000|Overall Study|Adverse Event|1
7894843|NCT01895361|12401794|FG001|Overall Study|Adverse Event|1
7894844|NCT01895361|12401795|FG002|Overall Study|Adverse Event|3
7894845|NCT01895361|12401793|FG000|Overall Study|Death|2
7894846|NCT01895361|12401794|FG001|Overall Study|Death|1
7894847|NCT01895361|12401795|FG002|Overall Study|Death|2
7894848|NCT01895361|12401793|FG000|Overall Study|Lost to Follow-up|4
7894849|NCT01895361|12401794|FG001|Overall Study|Lost to Follow-up|4
7894850|NCT01895361|12401795|FG002|Overall Study|Lost to Follow-up|6
7894851|NCT01895361|12401793|FG000|Overall Study|Non-compliance with study|1
7894852|NCT01895361|12401794|FG001|Overall Study|Non-compliance with study|3
7894853|NCT01895361|12401795|FG002|Overall Study|Non-compliance with study|1
7894854|NCT01895361|12401793|FG000|Overall Study|Physician Decision|2
7894855|NCT01895361|12401794|FG001|Overall Study|Physician Decision|2
7894856|NCT01895361|12401795|FG002|Overall Study|Physician Decision|2
7894857|NCT01895361|12401793|FG000|Overall Study|Withdrawal by Subject|7
7894858|NCT01895361|12401794|FG001|Overall Study|Withdrawal by Subject|6
7894859|NCT01895361|12401795|FG002|Overall Study|Withdrawal by Subject|6
7894860|NCT01895361|12401793|FG000|Overall Study|Lack of Efficacy|0
7894861|NCT01895361|12401794|FG001|Overall Study|Lack of Efficacy|1
7894862|NCT01895361|12401795|FG002|Overall Study|Lack of Efficacy|0
7894863|NCT01895361|12401793|FG000|Overall Study|Reasons different from categories above|7
7894864|NCT01895361|12401794|FG001|Overall Study|Reasons different from categories above|3
7894865|NCT01895361|12401795|FG002|Overall Study|Reasons different from categories above|4
7894866|NCT01895452|12401805|FG000|Overall Study|Adverse Event|1
7894867|NCT01895452|12401806|FG001|Overall Study|Adverse Event|4
7894868|NCT01895452|12401805|FG000|Overall Study|Lost to Follow-up|1
7894869|NCT01895452|12401806|FG001|Overall Study|Lost to Follow-up|5
7894870|NCT01895452|12401805|FG000|Overall Study|Pregnancy|0
7894871|NCT01895452|12401806|FG001|Overall Study|Pregnancy|1
7894872|NCT01895452|12401805|FG000|Overall Study|Withdrawal by Subject|2
7894873|NCT01895452|12401806|FG001|Overall Study|Withdrawal by Subject|14
7894874|NCT01895452|12401805|FG000|Overall Study|Underlying disease|0
7894875|NCT01895452|12401806|FG001|Overall Study|Underlying disease|3
7894876|NCT01895452|12401805|FG000|Overall Study|Noncompliance with study drug|0
7894877|NCT01895452|12401806|FG001|Overall Study|Noncompliance with study drug|1
7894878|NCT01895543|12401812|FG000|Overall Study|Withdrawal by Subject|43
7894879|NCT01895543|12401812|FG000|Overall Study|Lost to Follow-up|25
7894880|NCT01895543|12401812|FG000|Overall Study|Adverse Event|28
7894881|NCT01895543|12401812|FG000|Overall Study|Subject's substantial non-compliance|6
7894882|NCT01895543|12401812|FG000|Overall Study|Protocol Violation|1
7894883|NCT01895543|12401812|FG000|Overall Study|Physician Decision|2
7894884|NCT01895543|12401812|FG000|Overall Study|Other (Not fulfilling above criteria)|24
7894885|NCT01895608|12401820|FG000|Overall Study|change in health status|0
7894886|NCT01895608|12401821|FG001|Overall Study|change in health status|1
7894887|NCT01895608|12401822|FG002|Overall Study|change in health status|1
7894888|NCT01895608|12401823|FG003|Overall Study|change in health status|0
7894889|NCT01895608|12401820|FG000|Overall Study|Withdrawal by Subject|0
7894890|NCT01895608|12401821|FG001|Overall Study|Withdrawal by Subject|0
7894891|NCT01895608|12401822|FG002|Overall Study|Withdrawal by Subject|2
7894892|NCT01895608|12401823|FG003|Overall Study|Withdrawal by Subject|0
7894893|NCT01895777|12401852|FG000|Overall Study|Adverse Event|1
7894894|NCT01895777|12401853|FG001|Overall Study|Adverse Event|2
7894895|NCT01895777|12401852|FG000|Overall Study|Lost to Follow-up|2
7894896|NCT01895777|12401853|FG001|Overall Study|Lost to Follow-up|0
7894897|NCT01895777|12401852|FG000|Overall Study|Not treated|1
7894898|NCT01895777|12401853|FG001|Overall Study|Not treated|0
7894899|NCT01895777|12401852|FG000|Overall Study|Other reasons|3
7894900|NCT01895777|12401853|FG001|Overall Study|Other reasons|2
7894901|NCT01895777|12401852|FG000|Overall Study|Non-compliance with the CTP|2
7894902|NCT01895777|12401853|FG001|Overall Study|Non-compliance with the CTP|1
7894903|NCT01896050|12401890|FG000|Overall Study|Adverse Event|37
7894904|NCT01896050|12401891|FG001|Overall Study|Adverse Event|2
7894905|NCT01896050|12401890|FG000|Overall Study|Death|1
7894906|NCT01896050|12401891|FG001|Overall Study|Death|0
7894907|NCT01896128|12401915|FG000|Overall Study|Withdrawal by Subject|3
7894908|NCT01896128|12401916|FG001|Overall Study|Withdrawal by Subject|3
7894909|NCT01896193|12401926|FG000|Overall Study|Lack of Efficacy|20
7894910|NCT01896193|12401927|FG001|Overall Study|Lack of Efficacy|11
7894911|NCT01896193|12401926|FG000|Overall Study|Protocol Violation|0
7894912|NCT01896193|12401927|FG001|Overall Study|Protocol Violation|1
7894913|NCT01896193|12401926|FG000|Overall Study|Withdrew Consent|1
7894914|NCT01896193|12401927|FG001|Overall Study|Withdrew Consent|0
7894915|NCT01896232|12401941|FG000|Overall Study|Death|6
7894916|NCT01896232|12401942|FG001|Overall Study|Death|10
7894917|NCT01896232|12401941|FG000|Overall Study|Withdrawal by Subject|32
7894918|NCT01896232|12401942|FG001|Overall Study|Withdrawal by Subject|31
7894919|NCT01896232|12401941|FG000|Overall Study|Sponsor Decision|2
7894920|NCT01896232|12401942|FG001|Overall Study|Sponsor Decision|0
7894921|NCT01896232|12401941|FG000|Overall Study|Lost to Follow-up|9
7894922|NCT01896232|12401942|FG001|Overall Study|Lost to Follow-up|12
7894923|NCT01896271|12401948|FG000|Overall Study|Physician Decision|10
7894924|NCT01896297|12401952|FG000|Overall Study|Died in post treatment phase|1
7894925|NCT01896557|12401974|FG000|Clopidogrel Alone|Adverse Event|1
7894926|NCT01896557|12401975|FG001|Clopidogrel Alone|Adverse Event|0
7894927|NCT01896557|12401974|FG000|Clopidogrel + GI Protector|low adherence|1
7894928|NCT01896557|12401975|FG001|Clopidogrel + GI Protector|low adherence|1
7894929|NCT01896557|12401974|FG000|Clopidogrel + GI Protector|Reading error|1
7894930|NCT01896557|12401975|FG001|Clopidogrel + GI Protector|Reading error|3
7894931|NCT01896700|12401992|FG000|Overall Study|Adverse Event|4
7894932|NCT01896700|12401993|FG001|Overall Study|Adverse Event|5
7894933|NCT01896700|12401992|FG000|Overall Study|Withdrawal by Subject|0
7894934|NCT01896700|12401993|FG001|Overall Study|Withdrawal by Subject|1
7894935|NCT01896726|12401999|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1
7894936|NCT01896726|12401999|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
7894937|NCT01896856|12402012|FG000|Overall Study|Transportation issues / Non-compliance|0
7894938|NCT01896856|12402013|FG001|Overall Study|Transportation issues / Non-compliance|0
7894939|NCT01896856|12402014|FG002|Overall Study|Transportation issues / Non-compliance|1
7894940|NCT01896856|12402015|FG003|Overall Study|Transportation issues / Non-compliance|0
7894941|NCT01896856|12402016|FG004|Overall Study|Transportation issues / Non-compliance|0
7894942|NCT01896856|12402017|FG005|Overall Study|Transportation issues / Non-compliance|0
7894943|NCT01896869|12402034|FG000|Overall Study|Withdrawal by Subject|0
7894944|NCT01896869|12402035|FG001|Overall Study|Withdrawal by Subject|6
7894945|NCT01896869|12402034|FG000|Overall Study|Lost to Follow-up|1
7894946|NCT01896869|12402035|FG001|Overall Study|Lost to Follow-up|0
7894947|NCT01896895|12402046|FG000|Double-blind MP|Physician Decision|0
7894948|NCT01896895|12402047|FG001|Double-blind MP|Physician Decision|0
7894949|NCT01896895|12402048|FG002|Double-blind MP|Physician Decision|1
7894950|NCT01896895|12402049|FG003|Double-blind MP|Physician Decision|0
7894951|NCT01896895|12402046|FG000|Double-blind MP|Withdrawal by Subject|0
7894952|NCT01896895|12402047|FG001|Double-blind MP|Withdrawal by Subject|2
7894953|NCT01896895|12402048|FG002|Double-blind MP|Withdrawal by Subject|1
7894954|NCT01896895|12402049|FG003|Double-blind MP|Withdrawal by Subject|0
7894955|NCT01896895|12402046|FG000|Double-blind MP|Lost to Follow-up|1
7894956|NCT01896895|12402047|FG001|Double-blind MP|Lost to Follow-up|0
7894957|NCT01896895|12402048|FG002|Double-blind MP|Lost to Follow-up|1
7894958|NCT01896895|12402049|FG003|Double-blind MP|Lost to Follow-up|0
7894959|NCT01896934|12402062|FG000|Overall Study|Adverse Event|1
7894960|NCT01896934|12402062|FG000|Overall Study|Withdrawal by Subject|1
7894961|NCT01896986|12402068|FG000|Overall Study|samples lost|14
7894962|NCT01896986|12402069|FG001|Overall Study|samples lost|23
7894963|NCT01897233|12402093|FG000|Part B (24 Weeks)|Adverse Event|1
7894964|NCT01897233|12402093|FG000|Part B (24 Weeks)|Withdrawal by Subject|2
7894965|NCT01897233|12402093|FG000|Part B (24 Weeks)|Physician Decision|1
7894966|NCT01897493|12402122|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
7894967|NCT01897532|12402131|FG000|Discontinuation From Treatment|Not Treated|7
7894968|NCT01897532|12402132|FG001|Discontinuation From Treatment|Not Treated|5
7894969|NCT01897532|12402131|FG000|Discontinuation From Treatment|Other reason than specified|196
7894970|NCT01897532|12402132|FG001|Discontinuation From Treatment|Other reason than specified|176
7894971|NCT01897532|12402131|FG000|Discontinuation From Treatment|Withdrawal by Subject|333
7894972|NCT01897532|12402132|FG001|Discontinuation From Treatment|Withdrawal by Subject|281
7894973|NCT01897532|12402131|FG000|Discontinuation From Treatment|Non compliance|24
7894974|NCT01897532|12402132|FG001|Discontinuation From Treatment|Non compliance|15
7894975|NCT01897532|12402131|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402
7894976|NCT01897532|12402132|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362
7894977|NCT01897532|12402131|FG000|Discontinuation From Trial|Not Treated|7
7894978|NCT01897532|12402132|FG001|Discontinuation From Trial|Not Treated|5
7894979|NCT01897532|12402131|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55
7894980|NCT01897532|12402132|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36
7894981|NCT01897714|12402144|FG000|Phase I (Dose Escalation)|Disease progression|3
7894982|NCT01897714|12402145|FG001|Phase I (Dose Escalation)|Disease progression|5
7894983|NCT01897714|12402146|FG002|Phase I (Dose Escalation)|Disease progression|1
7894984|NCT01897714|12402147|FG003|Phase I (Dose Escalation)|Disease progression|3
7894985|NCT01897714|12402148|FG004|Phase I (Dose Escalation)|Disease progression|0
7894986|NCT01897714|12402149|FG005|Phase I (Dose Escalation)|Disease progression|0
7894987|NCT01897714|12402144|FG000|Phase I (Dose Escalation)|Adverse Event|0
7894988|NCT01897714|12402145|FG001|Phase I (Dose Escalation)|Adverse Event|1
7894989|NCT01897714|12402146|FG002|Phase I (Dose Escalation)|Adverse Event|4
7894990|NCT01897714|12402147|FG003|Phase I (Dose Escalation)|Adverse Event|3
7894991|NCT01897714|12402148|FG004|Phase I (Dose Escalation)|Adverse Event|0
7894992|NCT01897714|12402149|FG005|Phase I (Dose Escalation)|Adverse Event|0
7894993|NCT01897714|12402144|FG000|Phase I (Dose Escalation)|Other|0
7894994|NCT01897714|12402145|FG001|Phase I (Dose Escalation)|Other|1
7894995|NCT01897714|12402146|FG002|Phase I (Dose Escalation)|Other|0
7894996|NCT01897714|12402147|FG003|Phase I (Dose Escalation)|Other|0
7894997|NCT01897714|12402148|FG004|Phase I (Dose Escalation)|Other|0
7894998|NCT01897714|12402149|FG005|Phase I (Dose Escalation)|Other|0
7894999|NCT01897714|12402144|FG000|Phase II (MTD)|Withdrawal by Subject|0
7895000|NCT01897714|12402145|FG001|Phase II (MTD)|Withdrawal by Subject|0
7895001|NCT01897714|12402146|FG002|Phase II (MTD)|Withdrawal by Subject|0
7895002|NCT01897714|12402147|FG003|Phase II (MTD)|Withdrawal by Subject|0
7895003|NCT01897714|12402148|FG004|Phase II (MTD)|Withdrawal by Subject|0
7895004|NCT01897714|12402149|FG005|Phase II (MTD)|Withdrawal by Subject|1
7895005|NCT01897714|12402144|FG000|Phase II (MTD)|Lost to Follow-up|0
7895006|NCT01897714|12402145|FG001|Phase II (MTD)|Lost to Follow-up|0
7895007|NCT01897714|12402146|FG002|Phase II (MTD)|Lost to Follow-up|0
7895008|NCT01897714|12402147|FG003|Phase II (MTD)|Lost to Follow-up|0
7895009|NCT01897714|12402148|FG004|Phase II (MTD)|Lost to Follow-up|1
7895010|NCT01897714|12402149|FG005|Phase II (MTD)|Lost to Follow-up|0
7895011|NCT01897714|12402144|FG000|Phase II (MTD)|Death|0
7895012|NCT01897714|12402145|FG001|Phase II (MTD)|Death|0
7895013|NCT01897714|12402146|FG002|Phase II (MTD)|Death|0
7895014|NCT01897714|12402147|FG003|Phase II (MTD)|Death|0
7895015|NCT01897714|12402148|FG004|Phase II (MTD)|Death|25
7895016|NCT01897714|12402149|FG005|Phase II (MTD)|Death|10
7895017|NCT01897714|12402144|FG000|Phase II (MTD)|Study terminated with patient alive|0
7895018|NCT01897714|12402145|FG001|Phase II (MTD)|Study terminated with patient alive|0
7895019|NCT01897714|12402146|FG002|Phase II (MTD)|Study terminated with patient alive|0
7895020|NCT01897714|12402147|FG003|Phase II (MTD)|Study terminated with patient alive|0
7895021|NCT01897714|12402148|FG004|Phase II (MTD)|Study terminated with patient alive|1
7895022|NCT01897714|12402149|FG005|Phase II (MTD)|Study terminated with patient alive|0
7895023|NCT01897714|12402144|FG000|Phase II (MTD)|Other|0
7895024|NCT01897714|12402145|FG001|Phase II (MTD)|Other|0
7895025|NCT01897714|12402146|FG002|Phase II (MTD)|Other|0
7895026|NCT01897714|12402147|FG003|Phase II (MTD)|Other|0
7895027|NCT01897714|12402148|FG004|Phase II (MTD)|Other|3
7717799|NCT00522379|12141466|FG002|Overall Study|Withdrawal by Subject|1
7717800|NCT00522379|12141467|FG003|Overall Study|Withdrawal by Subject|2
7717801|NCT00522379|12141468|FG004|Overall Study|Withdrawal by Subject|0
7895028|NCT01897714|12402149|FG005|Phase II (MTD)|Other|0
7895029|NCT01897727|12402167|FG000|Overall Study|Exclusion: central sleep apnea|0
7895030|NCT01897727|12402168|FG001|Overall Study|Exclusion: central sleep apnea|1
7895031|NCT01897896|12402193|FG000|Overall Study|Death|1
7895032|NCT01897896|12402194|FG001|Overall Study|Death|0
7895033|NCT01897896|12402193|FG000|Overall Study|Adverse Event|11
7895034|NCT01897896|12402194|FG001|Overall Study|Adverse Event|1
7895035|NCT01897896|12402193|FG000|Overall Study|Lost to Follow-up|1
7895036|NCT01897896|12402194|FG001|Overall Study|Lost to Follow-up|0
7895037|NCT01897896|12402193|FG000|Overall Study|Non-compliance with study drug dosing|1
7895038|NCT01897896|12402194|FG001|Overall Study|Non-compliance with study drug dosing|1
7895039|NCT01897896|12402193|FG000|Overall Study|Withdrawal by Subject|7
7895040|NCT01897896|12402194|FG001|Overall Study|Withdrawal by Subject|1
7895041|NCT01897896|12402193|FG000|Overall Study|Require drug that interfere with study|1
7895042|NCT01897896|12402194|FG001|Overall Study|Require drug that interfere with study|4
7895043|NCT01897896|12402193|FG000|Overall Study|Protocol Violation|1
7895044|NCT01897896|12402194|FG001|Overall Study|Protocol Violation|1
7895045|NCT01897896|12402193|FG000|Overall Study|Withdrawal per Investigator's judgement|1
7895046|NCT01897896|12402194|FG001|Overall Study|Withdrawal per Investigator's judgement|1
7895047|NCT01897896|12402193|FG000|Overall Study|Caregiver can no longer participate|0
7895048|NCT01897896|12402194|FG001|Overall Study|Caregiver can no longer participate|2
7895049|NCT01897896|12402193|FG000|Overall Study|Other than specified|2
7895050|NCT01897896|12402194|FG001|Overall Study|Other than specified|1
7895051|NCT01898078|12402213|FG000|Overall Study|Progressive Disease|1
7895052|NCT01898078|12402214|FG001|Overall Study|Progressive Disease|5
7895053|NCT01898078|12402213|FG000|Overall Study|Adverse Event|2
7895054|NCT01898078|12402214|FG001|Overall Study|Adverse Event|1
7895055|NCT01898078|12402213|FG000|Overall Study|Withdrawal by Subject|1
7895056|NCT01898078|12402214|FG001|Overall Study|Withdrawal by Subject|1
7895057|NCT01898078|12402213|FG000|Overall Study|Symptomatic Deterioration|2
7895058|NCT01898078|12402214|FG001|Overall Study|Symptomatic Deterioration|0
7895059|NCT01898078|12402213|FG000|Overall Study|Reason not Specified|0
7895060|NCT01898078|12402214|FG001|Overall Study|Reason not Specified|1
7895061|NCT01898091|12402224|FG000|Overall Study|Lost to Follow-up|1
7895062|NCT01898091|12402225|FG001|Overall Study|Lost to Follow-up|1
7895063|NCT01898091|12402224|FG000|Overall Study|Withdrawal by Subject|1
7895064|NCT01898091|12402225|FG001|Overall Study|Withdrawal by Subject|5
7895065|NCT01898130|12402231|FG000|Treatment|Withdrawal by Subject|2
7895066|NCT01898130|12402231|FG000|Treatment|Progressive Disease|4
7895067|NCT01898130|12402231|FG000|Follow up Until PD or Death|Lost to Follow-up|1
7895068|NCT01898195|12402238|FG000|Smoking Abstinence|Did not have good measurements|35
7895069|NCT01898195|12402239|FG001|Smoking Abstinence|Did not have good measurements|38
7895070|NCT01898195|12402240|FG002|Smoking Abstinence|Did not have good measurements|36
7895071|NCT01898208|12402251|FG000|Overall Study|Positive blood culture|17
7895072|NCT01898208|12402252|FG001|Overall Study|Positive blood culture|23
7895073|NCT01898208|12402253|FG002|Overall Study|Positive blood culture|15
7895074|NCT01898208|12402251|FG000|Overall Study|Death/comfort care within 24 hours|10
7895075|NCT01898208|12402252|FG001|Overall Study|Death/comfort care within 24 hours|9
7895076|NCT01898208|12402253|FG002|Overall Study|Death/comfort care within 24 hours|8
7895077|NCT01898208|12402251|FG000|Overall Study|Negative Gram Stain|6
7895078|NCT01898208|12402252|FG001|Overall Study|Negative Gram Stain|9
7895079|NCT01898208|12402253|FG002|Overall Study|Negative Gram Stain|6
7895080|NCT01898208|12402251|FG000|Overall Study|Non-Blood Specimens in Bottles|3
7895081|NCT01898208|12402252|FG001|Overall Study|Non-Blood Specimens in Bottles|5
7895082|NCT01898208|12402253|FG002|Overall Study|Non-Blood Specimens in Bottles|4
7895083|NCT01898208|12402251|FG000|Overall Study|System/Technical Error|1
7895084|NCT01898208|12402252|FG001|Overall Study|System/Technical Error|2
7895085|NCT01898208|12402253|FG002|Overall Study|System/Technical Error|3
7895086|NCT01898208|12402251|FG000|Overall Study|Lost to Follow-up|3
7895087|NCT01898208|12402252|FG001|Overall Study|Lost to Follow-up|1
7895088|NCT01898208|12402253|FG002|Overall Study|Lost to Follow-up|1
7895089|NCT01898286|12402261|FG000|Overall Study|Withdrawal by Subject|1
7895090|NCT01898286|12402261|FG000|Overall Study|Protocol Violation|1
7895091|NCT01898286|12402261|FG000|Overall Study|Lost to Follow-up|1
7895092|NCT01898299|12402267|FG000|Post Treatment (One Month)|Lost to Follow-up|3
7895093|NCT01898299|12402268|FG001|Post Treatment (One Month)|Lost to Follow-up|4
7895094|NCT01898442|12402289|FG000|Overall Study|Hemolysis/technical problems|1
7895095|NCT01898442|12402290|FG001|Overall Study|Hemolysis/technical problems|2
7895096|NCT01898442|12402291|FG002|Overall Study|Hemolysis/technical problems|2
7895097|NCT01898442|12402289|FG000|Overall Study|Patient vomited pills|0
7895098|NCT01898442|12402290|FG001|Overall Study|Patient vomited pills|0
7895099|NCT01898442|12402291|FG002|Overall Study|Patient vomited pills|1
7895100|NCT01898598|12402301|FG000|Overall Study|Adverse Event|1
7895101|NCT01898598|12402302|FG001|Overall Study|Adverse Event|0
7895102|NCT01898598|12402301|FG000|Overall Study|Withdrawal by Subject|3
7895103|NCT01898598|12402302|FG001|Overall Study|Withdrawal by Subject|0
7895104|NCT01898598|12402301|FG000|Overall Study|Lost to Follow-up|0
7895105|NCT01898598|12402302|FG001|Overall Study|Lost to Follow-up|1
7895106|NCT01898598|12402301|FG000|Overall Study|Other|0
7895107|NCT01898598|12402302|FG001|Overall Study|Other|1
7895108|NCT01898806|12402337|FG000|Overall Study|Withdrawal by Subject|2
7895109|NCT01898806|12402337|FG000|Overall Study|Physician Decision|1
7895110|NCT01898884|12402346|FG000|Multiple Dose Period|Adverse Event|0
7895111|NCT01898884|12402347|FG001|Multiple Dose Period|Adverse Event|0
7895112|NCT01898884|12402348|FG002|Multiple Dose Period|Adverse Event|0
7895113|NCT01898884|12402349|FG003|Multiple Dose Period|Adverse Event|0
7895114|NCT01898884|12402350|FG004|Multiple Dose Period|Adverse Event|0
7895115|NCT01898884|12402351|FG005|Multiple Dose Period|Adverse Event|0
7895116|NCT01898884|12402352|FG006|Multiple Dose Period|Adverse Event|1
7895117|NCT01898884|12402353|FG007|Multiple Dose Period|Adverse Event|0
7895118|NCT01898884|12402354|FG008|Multiple Dose Period|Adverse Event|0
7895119|NCT01898884|12402346|FG000|Multiple Dose Period|Randomized Not Treated|0
7895120|NCT01898884|12402347|FG001|Multiple Dose Period|Randomized Not Treated|0
7895121|NCT01898884|12402348|FG002|Multiple Dose Period|Randomized Not Treated|0
7895122|NCT01898884|12402349|FG003|Multiple Dose Period|Randomized Not Treated|0
7895123|NCT01898884|12402350|FG004|Multiple Dose Period|Randomized Not Treated|0
7895124|NCT01898884|12402351|FG005|Multiple Dose Period|Randomized Not Treated|0
7895125|NCT01898884|12402352|FG006|Multiple Dose Period|Randomized Not Treated|0
7895126|NCT01898884|12402353|FG007|Multiple Dose Period|Randomized Not Treated|0
7895127|NCT01898884|12402354|FG008|Multiple Dose Period|Randomized Not Treated|1
7895128|NCT01898923|12402392|FG000|Overall Study|Lack of Efficacy|5
7895129|NCT01898923|12402393|FG001|Overall Study|Lack of Efficacy|6
7895130|NCT01898923|12402392|FG000|Overall Study|Adverse Event|3
7895131|NCT01898923|12402393|FG001|Overall Study|Adverse Event|1
7895132|NCT01898923|12402392|FG000|Overall Study|Lost to Follow-up|0
7895133|NCT01898923|12402393|FG001|Overall Study|Lost to Follow-up|1
7895134|NCT01898923|12402392|FG000|Overall Study|Withdrawal by Subject|4
7895135|NCT01898923|12402393|FG001|Overall Study|Withdrawal by Subject|7
7895136|NCT01898923|12402392|FG000|Overall Study|Physician Decision|3
7895137|NCT01898923|12402393|FG001|Overall Study|Physician Decision|4
7895138|NCT01898923|12402392|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1
7895139|NCT01898923|12402393|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2
7895140|NCT01899053|12402413|FG000|Overall Study|Progressive Disease|4
7895141|NCT01899053|12402414|FG001|Overall Study|Progressive Disease|0
7895142|NCT01899053|12402415|FG002|Overall Study|Progressive Disease|3
7895143|NCT01899053|12402416|FG003|Overall Study|Progressive Disease|0
7895144|NCT01899053|12402417|FG004|Overall Study|Progressive Disease|3
7895145|NCT01899053|12402418|FG005|Overall Study|Progressive Disease|1
7895146|NCT01899053|12402419|FG006|Overall Study|Progressive Disease|1
7895147|NCT01899053|12402420|FG007|Overall Study|Progressive Disease|1
7895148|NCT01899053|12402421|FG008|Overall Study|Progressive Disease|4
7895149|NCT01899053|12402422|FG009|Overall Study|Progressive Disease|3
7895150|NCT01899053|12402423|FG010|Overall Study|Progressive Disease|12
7895151|NCT01899053|12402424|FG011|Overall Study|Progressive Disease|5
7895152|NCT01899053|12402425|FG012|Overall Study|Progressive Disease|8
7895153|NCT01899053|12402426|FG013|Overall Study|Progressive Disease|17
7895154|NCT01899053|12402413|FG000|Overall Study|Adverse Event|1
7895155|NCT01899053|12402414|FG001|Overall Study|Adverse Event|1
7895156|NCT01899053|12402415|FG002|Overall Study|Adverse Event|1
7895157|NCT01899053|12402416|FG003|Overall Study|Adverse Event|3
7895158|NCT01899053|12402417|FG004|Overall Study|Adverse Event|1
7895159|NCT01899053|12402418|FG005|Overall Study|Adverse Event|1
7895160|NCT01899053|12402419|FG006|Overall Study|Adverse Event|1
7895161|NCT01899053|12402420|FG007|Overall Study|Adverse Event|0
7895162|NCT01899053|12402421|FG008|Overall Study|Adverse Event|2
7895163|NCT01899053|12402422|FG009|Overall Study|Adverse Event|0
7895164|NCT01899053|12402423|FG010|Overall Study|Adverse Event|3
7895165|NCT01899053|12402424|FG011|Overall Study|Adverse Event|1
7895166|NCT01899053|12402425|FG012|Overall Study|Adverse Event|2
7895167|NCT01899053|12402426|FG013|Overall Study|Adverse Event|2
7895168|NCT01899053|12402413|FG000|Overall Study|Reason Not Specified|0
7895169|NCT01899053|12402414|FG001|Overall Study|Reason Not Specified|0
7895170|NCT01899053|12402415|FG002|Overall Study|Reason Not Specified|0
7895171|NCT01899053|12402416|FG003|Overall Study|Reason Not Specified|0
7895172|NCT01899053|12402417|FG004|Overall Study|Reason Not Specified|0
7895173|NCT01899053|12402418|FG005|Overall Study|Reason Not Specified|0
7895174|NCT01899053|12402419|FG006|Overall Study|Reason Not Specified|1
7895175|NCT01899053|12402420|FG007|Overall Study|Reason Not Specified|0
7895176|NCT01899053|12402421|FG008|Overall Study|Reason Not Specified|0
7895177|NCT01899053|12402422|FG009|Overall Study|Reason Not Specified|0
7895178|NCT01899053|12402423|FG010|Overall Study|Reason Not Specified|0
7895179|NCT01899053|12402424|FG011|Overall Study|Reason Not Specified|0
7895180|NCT01899053|12402425|FG012|Overall Study|Reason Not Specified|1
7895181|NCT01899053|12402426|FG013|Overall Study|Reason Not Specified|0
7895182|NCT01899053|12402413|FG000|Overall Study|Withdrawal by Subject|1
7895183|NCT01899053|12402414|FG001|Overall Study|Withdrawal by Subject|1
7895184|NCT01899053|12402415|FG002|Overall Study|Withdrawal by Subject|2
7895185|NCT01899053|12402416|FG003|Overall Study|Withdrawal by Subject|0
7895186|NCT01899053|12402417|FG004|Overall Study|Withdrawal by Subject|2
7895187|NCT01899053|12402418|FG005|Overall Study|Withdrawal by Subject|0
7895188|NCT01899053|12402419|FG006|Overall Study|Withdrawal by Subject|0
7895189|NCT01899053|12402420|FG007|Overall Study|Withdrawal by Subject|1
7895190|NCT01899053|12402421|FG008|Overall Study|Withdrawal by Subject|0
7895191|NCT01899053|12402422|FG009|Overall Study|Withdrawal by Subject|0
7895192|NCT01899053|12402423|FG010|Overall Study|Withdrawal by Subject|0
7895193|NCT01899053|12402424|FG011|Overall Study|Withdrawal by Subject|0
7895194|NCT01899053|12402425|FG012|Overall Study|Withdrawal by Subject|1
7895195|NCT01899053|12402426|FG013|Overall Study|Withdrawal by Subject|1
7895196|NCT01899053|12402413|FG000|Overall Study|Protocol Violation|0
7895197|NCT01899053|12402414|FG001|Overall Study|Protocol Violation|0
7895198|NCT01899053|12402415|FG002|Overall Study|Protocol Violation|1
7895199|NCT01899053|12402416|FG003|Overall Study|Protocol Violation|0
7895200|NCT01899053|12402417|FG004|Overall Study|Protocol Violation|0
7895201|NCT01899053|12402418|FG005|Overall Study|Protocol Violation|0
7895202|NCT01899053|12402419|FG006|Overall Study|Protocol Violation|0
7895203|NCT01899053|12402420|FG007|Overall Study|Protocol Violation|0
7895204|NCT01899053|12402421|FG008|Overall Study|Protocol Violation|0
7895205|NCT01899053|12402422|FG009|Overall Study|Protocol Violation|0
7895206|NCT01899053|12402423|FG010|Overall Study|Protocol Violation|0
7895207|NCT01899053|12402424|FG011|Overall Study|Protocol Violation|0
7895208|NCT01899053|12402425|FG012|Overall Study|Protocol Violation|0
7895209|NCT01899053|12402426|FG013|Overall Study|Protocol Violation|0
7895210|NCT01899053|12402413|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
7895211|NCT01899053|12402414|FG001|Overall Study|Unsatisfactory Therapeutic Response|1
7895212|NCT01899053|12402415|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
7895213|NCT01899053|12402416|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
7895214|NCT01899053|12402417|FG004|Overall Study|Unsatisfactory Therapeutic Response|0
7895215|NCT01899053|12402418|FG005|Overall Study|Unsatisfactory Therapeutic Response|0
7895216|NCT01899053|12402419|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
7895217|NCT01899053|12402420|FG007|Overall Study|Unsatisfactory Therapeutic Response|0
7895218|NCT01899053|12402421|FG008|Overall Study|Unsatisfactory Therapeutic Response|0
7895219|NCT01899053|12402422|FG009|Overall Study|Unsatisfactory Therapeutic Response|0
7895220|NCT01899053|12402423|FG010|Overall Study|Unsatisfactory Therapeutic Response|1
7895221|NCT01899053|12402424|FG011|Overall Study|Unsatisfactory Therapeutic Response|0
7895222|NCT01899053|12402425|FG012|Overall Study|Unsatisfactory Therapeutic Response|0
7895223|NCT01899053|12402426|FG013|Overall Study|Unsatisfactory Therapeutic Response|0
7895224|NCT01899053|12402413|FG000|Overall Study|Symptomatic Deterioration|0
7895225|NCT01899053|12402414|FG001|Overall Study|Symptomatic Deterioration|0
7895226|NCT01899053|12402415|FG002|Overall Study|Symptomatic Deterioration|0
7895227|NCT01899053|12402416|FG003|Overall Study|Symptomatic Deterioration|0
7895228|NCT01899053|12402417|FG004|Overall Study|Symptomatic Deterioration|0
7895229|NCT01899053|12402418|FG005|Overall Study|Symptomatic Deterioration|1
7895230|NCT01899053|12402419|FG006|Overall Study|Symptomatic Deterioration|0
7895231|NCT01899053|12402420|FG007|Overall Study|Symptomatic Deterioration|1
7895232|NCT01899053|12402421|FG008|Overall Study|Symptomatic Deterioration|0
7895233|NCT01899053|12402422|FG009|Overall Study|Symptomatic Deterioration|0
7895234|NCT01899053|12402423|FG010|Overall Study|Symptomatic Deterioration|0
7895235|NCT01899053|12402424|FG011|Overall Study|Symptomatic Deterioration|1
7895236|NCT01899053|12402425|FG012|Overall Study|Symptomatic Deterioration|2
7895237|NCT01899053|12402426|FG013|Overall Study|Symptomatic Deterioration|0
7895238|NCT01899742|12402476|FG000|Overall Study|Adverse Event|5
7895239|NCT01899742|12402477|FG001|Overall Study|Adverse Event|4
7895240|NCT01899742|12402476|FG000|Overall Study|Lack of Efficacy|1
7895241|NCT01899742|12402477|FG001|Overall Study|Lack of Efficacy|5
7895242|NCT01899742|12402476|FG000|Overall Study|Protocol Violation|2
7895243|NCT01899742|12402477|FG001|Overall Study|Protocol Violation|2
7895244|NCT01899742|12402476|FG000|Overall Study|Withdrawal by Subject|9
7895245|NCT01899742|12402477|FG001|Overall Study|Withdrawal by Subject|5
7895246|NCT01899768|12402483|FG000|Part A|Adverse Event|2
7895247|NCT01899768|12402483|FG000|Part A|Withdrawal by Subject|1
7895248|NCT01899768|12402483|FG000|Part B|Adverse Event|1
7895249|NCT01899768|12402483|FG000|Part B|Withdrawal by Subject|1
7895250|NCT01900054|12402495|FG000|Overall Study|Physician Decision|1
7895251|NCT01900054|12402495|FG000|Overall Study|Withdrawal by Subject|1
7895252|NCT01900314|12402523|FG000|Overall Study|Lost to Follow-up|1
7895253|NCT01900314|12402524|FG001|Overall Study|Lost to Follow-up|0
7895254|NCT01900314|12402523|FG000|Overall Study|Protocol Violation|0
7895255|NCT01900314|12402524|FG001|Overall Study|Protocol Violation|1
7895256|NCT01900314|12402523|FG000|Overall Study|Withdrawal by Subject|3
7895257|NCT01900314|12402524|FG001|Overall Study|Withdrawal by Subject|3
7895258|NCT01900431|12402546|FG000|Principal Treatment Period (Part A)|Adverse Event|1
7895259|NCT01900431|12402547|FG001|Principal Treatment Period (Part A)|Adverse Event|3
7895260|NCT01900431|12402548|FG002|Principal Treatment Period (Part A)|Adverse Event|0
7895261|NCT01900431|12402546|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6
7895262|NCT01900431|12402547|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6
7895263|NCT01900431|12402548|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0
7895264|NCT01900431|12402546|FG000|Principal Treatment Period (Part A)|Other than specified above|0
7895265|NCT01900431|12402547|FG001|Principal Treatment Period (Part A)|Other than specified above|1
7895266|NCT01900431|12402548|FG002|Principal Treatment Period (Part A)|Other than specified above|0
7895267|NCT01900431|12402546|FG000|Extended Treatment Period (Part B)|Adverse Event|0
7895268|NCT01900431|12402547|FG001|Extended Treatment Period (Part B)|Adverse Event|2
7895269|NCT01900431|12402548|FG002|Extended Treatment Period (Part B)|Adverse Event|0
7895270|NCT01900431|12402546|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1
7895271|NCT01900431|12402547|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7
7895272|NCT01900431|12402548|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0
7895273|NCT01900431|12402546|FG000|Extended Treatment Period (Part B)|Other than specified above|0
7895274|NCT01900431|12402547|FG001|Extended Treatment Period (Part B)|Other than specified above|1
7895275|NCT01900431|12402548|FG002|Extended Treatment Period (Part B)|Other than specified above|0
7895276|NCT01900431|12402546|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0
7895277|NCT01900431|12402547|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0
7895278|NCT01900431|12402548|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2
7895279|NCT01900431|12402546|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
7895280|NCT01900431|12402547|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
7895281|NCT01900431|12402548|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
7895282|NCT01900431|12402546|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
7895283|NCT01900431|12402547|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
7895284|NCT01900431|12402548|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
7895285|NCT01900652|12402567|FG000|Overall Study|Progressive Disease|1
7895286|NCT01900652|12402568|FG001|Overall Study|Progressive Disease|0
7895287|NCT01900652|12402567|FG000|Overall Study|Consent withdrawn by subject|1
7895288|NCT01900652|12402568|FG001|Overall Study|Consent withdrawn by subject|1
7895289|NCT01900652|12402567|FG000|Overall Study|Death|3
7895290|NCT01900652|12402568|FG001|Overall Study|Death|0
7895291|NCT01900652|12402567|FG000|Overall Study|Adverse Event|2
7968551|NCT02780167|12526250|FG003|Overall Study|Lost to Follow-up|0
7895292|NCT01900652|12402568|FG001|Overall Study|Adverse Event|1
7895293|NCT01900652|12402567|FG000|Overall Study|Physician Decision|1
7895294|NCT01900652|12402568|FG001|Overall Study|Physician Decision|1
7895295|NCT01900665|12402581|FG000|Placebo Controlled Period|Death|9
7895296|NCT01900665|12402582|FG001|Placebo Controlled Period|Death|16
7895297|NCT01900665|12402581|FG000|Placebo Controlled Period|Adverse Event|48
7895298|NCT01900665|12402582|FG001|Placebo Controlled Period|Adverse Event|39
7895299|NCT01900665|12402581|FG000|Placebo Controlled Period|Protocol Violation|1
7895300|NCT01900665|12402582|FG001|Placebo Controlled Period|Protocol Violation|7
7895301|NCT01900665|12402581|FG000|Placebo Controlled Period|Withdrawal by Subject|33
7895302|NCT01900665|12402582|FG001|Placebo Controlled Period|Withdrawal by Subject|45
7895303|NCT01900665|12402581|FG000|Placebo Controlled Period|Physician Decision|11
7895304|NCT01900665|12402582|FG001|Placebo Controlled Period|Physician Decision|7
7895305|NCT01900665|12402581|FG000|Placebo Controlled Period|Lost to Follow-up|3
7895306|NCT01900665|12402582|FG001|Placebo Controlled Period|Lost to Follow-up|0
7895307|NCT01900665|12402581|FG000|Placebo Controlled Period|Caregiver Decision|33
7895308|NCT01900665|12402582|FG001|Placebo Controlled Period|Caregiver Decision|41
7895309|NCT01900665|12402581|FG000|Placebo Controlled Period|Entry Criteria Not Met|5
7895310|NCT01900665|12402582|FG001|Placebo Controlled Period|Entry Criteria Not Met|9
7895311|NCT01900665|12402581|FG000|Open Label Period|Adverse Event|16
7895312|NCT01900665|12402582|FG001|Open Label Period|Adverse Event|20
7895313|NCT01900665|12402581|FG000|Open Label Period|Death|5
7895314|NCT01900665|12402582|FG001|Open Label Period|Death|6
7895315|NCT01900665|12402581|FG000|Open Label Period|Lost to Follow-up|1
7895316|NCT01900665|12402582|FG001|Open Label Period|Lost to Follow-up|1
7895317|NCT01900665|12402581|FG000|Open Label Period|Parent/Caregiver Decision|33
7895318|NCT01900665|12402582|FG001|Open Label Period|Parent/Caregiver Decision|34
7895319|NCT01900665|12402581|FG000|Open Label Period|Physician Decision|4
7895320|NCT01900665|12402582|FG001|Open Label Period|Physician Decision|4
7895321|NCT01900665|12402581|FG000|Open Label Period|Protocol Violation|0
7895322|NCT01900665|12402582|FG001|Open Label Period|Protocol Violation|1
7895323|NCT01900665|12402581|FG000|Open Label Period|Sponsor Decision|802
7895324|NCT01900665|12402582|FG001|Open Label Period|Sponsor Decision|765
7895325|NCT01900665|12402581|FG000|Open Label Period|Withdrawal by Subject|20
7895326|NCT01900665|12402582|FG001|Open Label Period|Withdrawal by Subject|28
7895327|NCT01900899|12402607|FG000|Overall Study|Withdrawal by Subject|7
7895328|NCT01900899|12402608|FG001|Overall Study|Withdrawal by Subject|1
7895329|NCT01900899|12402607|FG000|Overall Study|Migrated from study area|2
7895330|NCT01900899|12402608|FG001|Overall Study|Migrated from study area|0
7895331|NCT01901055|12402616|FG000|Randomization But Not Titrated|Did not come to titration study|1
7895332|NCT01901055|12402617|FG001|Randomization But Not Titrated|Did not come to titration study|1
7895333|NCT01901055|12402616|FG000|Randomization But Not Titrated|Physician Decision|0
7895334|NCT01901055|12402617|FG001|Randomization But Not Titrated|Physician Decision|1
7895335|NCT01901055|12402616|FG000|Started Protocol to Week 6|Physician Decision|2
7895336|NCT01901055|12402617|FG001|Started Protocol to Week 6|Physician Decision|1
7895337|NCT01901055|12402616|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0
7895338|NCT01901055|12402617|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2
7895339|NCT01901055|12402616|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1
7895340|NCT01901055|12402617|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0
7895341|NCT01901055|12402616|FG000|Started Protocol to Week 6|Withdrawal by Subject|0
7895342|NCT01901055|12402617|FG001|Started Protocol to Week 6|Withdrawal by Subject|1
7895343|NCT01901055|12402616|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1
7895344|NCT01901055|12402617|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0
7895345|NCT01901055|12402616|FG000|Week 12 Assessment|Withdrawal by Subject|0
7895346|NCT01901055|12402617|FG001|Week 12 Assessment|Withdrawal by Subject|4
7895347|NCT01901055|12402616|FG000|Week 24|Withdrawal by Subject|13
7895348|NCT01901055|12402617|FG001|Week 24|Withdrawal by Subject|19
7895349|NCT01901055|12402616|FG000|Week 24|Physician Decision|1
7895350|NCT01901055|12402617|FG001|Week 24|Physician Decision|0
7895351|NCT01901055|12402616|FG000|Week 36|Withdrawal by Subject|0
7895352|NCT01901055|12402617|FG001|Week 36|Withdrawal by Subject|5
7895353|NCT01901146|12402628|FG000|Neoadjuvant Phase|Death|1
7895354|NCT01901146|12402629|FG001|Neoadjuvant Phase|Death|2
7895355|NCT01901146|12402630|FG002|Neoadjuvant Phase|Death|0
7895356|NCT01901146|12402631|FG003|Neoadjuvant Phase|Death|0
7895357|NCT01901146|12402632|FG004|Neoadjuvant Phase|Death|0
7895358|NCT01901146|12402628|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2
7895359|NCT01901146|12402629|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3
7895360|NCT01901146|12402630|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0
7895361|NCT01901146|12402631|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0
7895362|NCT01901146|12402632|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0
7895363|NCT01901146|12402628|FG000|Neoadjuvant Phase|Lost to Follow-up|0
7895364|NCT01901146|12402629|FG001|Neoadjuvant Phase|Lost to Follow-up|1
7895365|NCT01901146|12402630|FG002|Neoadjuvant Phase|Lost to Follow-up|0
7895366|NCT01901146|12402631|FG003|Neoadjuvant Phase|Lost to Follow-up|0
7895367|NCT01901146|12402632|FG004|Neoadjuvant Phase|Lost to Follow-up|0
7895368|NCT01901146|12402628|FG000|Neoadjuvant Phase|Physician Decision|1
7895369|NCT01901146|12402629|FG001|Neoadjuvant Phase|Physician Decision|2
7895370|NCT01901146|12402630|FG002|Neoadjuvant Phase|Physician Decision|0
7895371|NCT01901146|12402631|FG003|Neoadjuvant Phase|Physician Decision|0
7895372|NCT01901146|12402632|FG004|Neoadjuvant Phase|Physician Decision|0
7895373|NCT01901146|12402628|FG000|Neoadjuvant Phase|Withdrawal by Subject|2
7895374|NCT01901146|12402629|FG001|Neoadjuvant Phase|Withdrawal by Subject|5
7895375|NCT01901146|12402630|FG002|Neoadjuvant Phase|Withdrawal by Subject|0
7895376|NCT01901146|12402631|FG003|Neoadjuvant Phase|Withdrawal by Subject|0
7895377|NCT01901146|12402632|FG004|Neoadjuvant Phase|Withdrawal by Subject|0
7895378|NCT01901146|12402628|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7895379|NCT01901146|12402629|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1
7895380|NCT01901146|12402630|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7895381|NCT01901146|12402631|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7895382|NCT01901146|12402632|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7895383|NCT01901146|12402628|FG000|Adjuvant Phase|Other|0
7895384|NCT01901146|12402629|FG001|Adjuvant Phase|Other|0
7895385|NCT01901146|12402630|FG002|Adjuvant Phase|Other|1
7895386|NCT01901146|12402631|FG003|Adjuvant Phase|Other|0
7895387|NCT01901146|12402632|FG004|Adjuvant Phase|Other|0
7895388|NCT01901146|12402628|FG000|Adjuvant Phase|Death|0
7895389|NCT01901146|12402629|FG001|Adjuvant Phase|Death|0
7895390|NCT01901146|12402630|FG002|Adjuvant Phase|Death|0
7895391|NCT01901146|12402631|FG003|Adjuvant Phase|Death|0
7895392|NCT01901146|12402632|FG004|Adjuvant Phase|Death|3
7895393|NCT01901146|12402628|FG000|Adjuvant Phase|Disease Progression or Recurrence|0
7895394|NCT01901146|12402629|FG001|Adjuvant Phase|Disease Progression or Recurrence|0
7895395|NCT01901146|12402630|FG002|Adjuvant Phase|Disease Progression or Recurrence|12
7895396|NCT01901146|12402631|FG003|Adjuvant Phase|Disease Progression or Recurrence|4
7895397|NCT01901146|12402632|FG004|Adjuvant Phase|Disease Progression or Recurrence|3
7895398|NCT01901146|12402628|FG000|Adjuvant Phase|Physician Decision|0
7895399|NCT01901146|12402629|FG001|Adjuvant Phase|Physician Decision|0
7895400|NCT01901146|12402630|FG002|Adjuvant Phase|Physician Decision|9
7895401|NCT01901146|12402631|FG003|Adjuvant Phase|Physician Decision|2
7895402|NCT01901146|12402632|FG004|Adjuvant Phase|Physician Decision|4
7895403|NCT01901146|12402628|FG000|Adjuvant Phase|Withdrawal by Subject|0
7895404|NCT01901146|12402629|FG001|Adjuvant Phase|Withdrawal by Subject|0
7895405|NCT01901146|12402630|FG002|Adjuvant Phase|Withdrawal by Subject|4
7895406|NCT01901146|12402631|FG003|Adjuvant Phase|Withdrawal by Subject|1
7895407|NCT01901146|12402632|FG004|Adjuvant Phase|Withdrawal by Subject|4
7895408|NCT01901185|12402641|FG000|Overall Study|Withdrawal by Subject|2
7895409|NCT01901302|12402665|FG000|Overall Study|Adverse Event|2
7895410|NCT01901302|12402666|FG001|Overall Study|Adverse Event|1
7895411|NCT01901302|12402665|FG000|Overall Study|Lack of Efficacy|0
7895412|NCT01901302|12402666|FG001|Overall Study|Lack of Efficacy|2
7895413|NCT01901302|12402665|FG000|Overall Study|Study Terminated by Sponsor|23
7895414|NCT01901302|12402666|FG001|Overall Study|Study Terminated by Sponsor|20
7717802|NCT00522379|12141464|FG000|Overall Study|Protocol Violation|1
7717803|NCT00522379|12141465|FG001|Overall Study|Protocol Violation|1
7717804|NCT00522379|12141466|FG002|Overall Study|Protocol Violation|2
7717805|NCT00522379|12141467|FG003|Overall Study|Protocol Violation|0
7717806|NCT00522379|12141468|FG004|Overall Study|Protocol Violation|0
7717807|NCT00522379|12141464|FG000|Overall Study|Unsatisfactory Subject Compliance|1
7717808|NCT00522379|12141465|FG001|Overall Study|Unsatisfactory Subject Compliance|2
7717809|NCT00522379|12141466|FG002|Overall Study|Unsatisfactory Subject Compliance|0
7717810|NCT00522379|12141467|FG003|Overall Study|Unsatisfactory Subject Compliance|0
7717811|NCT00522379|12141468|FG004|Overall Study|Unsatisfactory Subject Compliance|0
7717812|NCT00522379|12141464|FG000|Overall Study|Lost to Follow-up|1
7717813|NCT00522379|12141465|FG001|Overall Study|Lost to Follow-up|0
7717814|NCT00522379|12141466|FG002|Overall Study|Lost to Follow-up|4
7717815|NCT00522379|12141467|FG003|Overall Study|Lost to Follow-up|2
7717816|NCT00522379|12141468|FG004|Overall Study|Lost to Follow-up|2
7717817|NCT00522379|12141464|FG000|Overall Study|Randomization error|0
7717818|NCT00522379|12141465|FG001|Overall Study|Randomization error|0
7717819|NCT00522379|12141466|FG002|Overall Study|Randomization error|0
7717820|NCT00522379|12141467|FG003|Overall Study|Randomization error|0
7895415|NCT01901302|12402665|FG000|Overall Study|Withdrawal by Subject|2
7717821|NCT00522379|12141468|FG004|Overall Study|Randomization error|1
7717822|NCT00522379|12141464|FG000|Overall Study|Dispensing error|1
7717823|NCT00522379|12141465|FG001|Overall Study|Dispensing error|0
7717824|NCT00522379|12141466|FG002|Overall Study|Dispensing error|0
7717825|NCT00522379|12141467|FG003|Overall Study|Dispensing error|1
7717826|NCT00522379|12141468|FG004|Overall Study|Dispensing error|0
7895416|NCT01901302|12402666|FG001|Overall Study|Withdrawal by Subject|0
7895417|NCT01901328|12402674|FG000|Overall Study|Lost to Follow-up|1
7895418|NCT01901328|12402675|FG001|Overall Study|Lost to Follow-up|0
7895419|NCT01901328|12402674|FG000|Overall Study|Physician Decision|0
7895420|NCT01901328|12402675|FG001|Overall Study|Physician Decision|1
7895421|NCT01901328|12402674|FG000|Overall Study|Protocol Violation|1
7895422|NCT01901328|12402675|FG001|Overall Study|Protocol Violation|1
7895423|NCT01901328|12402674|FG000|Overall Study|Study Terminated by Sponsor|19
7895424|NCT01901328|12402675|FG001|Overall Study|Study Terminated by Sponsor|16
7895425|NCT01901328|12402674|FG000|Overall Study|Withdrawal by Subject|1
7895426|NCT01901328|12402675|FG001|Overall Study|Withdrawal by Subject|2
7895427|NCT01901328|12402674|FG000|Overall Study|Lack of Efficacy|0
7895428|NCT01901328|12402675|FG001|Overall Study|Lack of Efficacy|1
7895429|NCT01901341|12402684|FG000|Overall Study|Adverse Event|4
7895430|NCT01901341|12402685|FG001|Overall Study|Adverse Event|2
7895431|NCT01901341|12402684|FG000|Overall Study|Lack of Efficacy|0
7895432|NCT01901341|12402685|FG001|Overall Study|Lack of Efficacy|2
7895433|NCT01901341|12402684|FG000|Overall Study|Lost to Follow-up|0
7895434|NCT01901341|12402685|FG001|Overall Study|Lost to Follow-up|1
7895435|NCT01901341|12402684|FG000|Overall Study|Protocol Violation|2
7895436|NCT01901341|12402685|FG001|Overall Study|Protocol Violation|0
7895437|NCT01901341|12402684|FG000|Overall Study|Study Terminated by Sponsor|13
7895438|NCT01901341|12402685|FG001|Overall Study|Study Terminated by Sponsor|15
7895439|NCT01901341|12402684|FG000|Overall Study|Withdrawal by Subject|1
7895440|NCT01901341|12402685|FG001|Overall Study|Withdrawal by Subject|1
7895441|NCT01901393|12402694|FG000|Overall Study|Adverse Event|1
7895442|NCT01901393|12402695|FG001|Overall Study|Adverse Event|0
7895443|NCT01901419|12402703|FG000|Overall Study|Protocol Violation|2
7895444|NCT01901419|12402704|FG001|Overall Study|Protocol Violation|6
7895445|NCT01901419|12402703|FG000|Overall Study|unavailable researchers|6
7895446|NCT01901419|12402704|FG001|Overall Study|unavailable researchers|3
7895447|NCT01901614|12402726|FG000|Overall Study|Adverse Event|0
7895448|NCT01901614|12402727|FG001|Overall Study|Adverse Event|1
7895449|NCT01901614|12402726|FG000|Overall Study|Lost to Follow-up|1
7895450|NCT01901614|12402727|FG001|Overall Study|Lost to Follow-up|0
7895451|NCT01901614|12402726|FG000|Overall Study|Screen Fail|1
7895452|NCT01901614|12402727|FG001|Overall Study|Screen Fail|0
7895453|NCT01901653|12402746|FG000|Overall Study|Death|2
7895454|NCT01901653|12402747|FG001|Overall Study|Death|1
7895455|NCT01901653|12402748|FG002|Overall Study|Death|8
7895456|NCT01901653|12402749|FG003|Overall Study|Death|3
7895457|NCT01901653|12402750|FG004|Overall Study|Death|2
7895458|NCT01901653|12402751|FG005|Overall Study|Death|2
7895459|NCT01901653|12402752|FG006|Overall Study|Death|6
7895460|NCT01901653|12402753|FG007|Overall Study|Death|9
7895461|NCT01901653|12402754|FG008|Overall Study|Death|1
7895462|NCT01901653|12402755|FG009|Overall Study|Death|16
7895463|NCT01901653|12402756|FG010|Overall Study|Death|2
7895464|NCT01901653|12402757|FG011|Overall Study|Death|15
7895465|NCT01901653|12402758|FG012|Overall Study|Death|4
7895466|NCT01901653|12402746|FG000|Overall Study|Lost to Follow-up|1
7895467|NCT01901653|12402747|FG001|Overall Study|Lost to Follow-up|0
7895468|NCT01901653|12402748|FG002|Overall Study|Lost to Follow-up|2
7895469|NCT01901653|12402749|FG003|Overall Study|Lost to Follow-up|0
7895470|NCT01901653|12402750|FG004|Overall Study|Lost to Follow-up|0
7895471|NCT01901653|12402751|FG005|Overall Study|Lost to Follow-up|1
7895472|NCT01901653|12402752|FG006|Overall Study|Lost to Follow-up|0
7895473|NCT01901653|12402753|FG007|Overall Study|Lost to Follow-up|1
7895474|NCT01901653|12402754|FG008|Overall Study|Lost to Follow-up|0
7895475|NCT01901653|12402755|FG009|Overall Study|Lost to Follow-up|0
7895476|NCT01901653|12402756|FG010|Overall Study|Lost to Follow-up|0
7895477|NCT01901653|12402757|FG011|Overall Study|Lost to Follow-up|0
7895478|NCT01901653|12402758|FG012|Overall Study|Lost to Follow-up|0
7895479|NCT01901653|12402746|FG000|Overall Study|Withdrawal by Subject|0
7895480|NCT01901653|12402747|FG001|Overall Study|Withdrawal by Subject|0
7895481|NCT01901653|12402748|FG002|Overall Study|Withdrawal by Subject|0
7895482|NCT01901653|12402749|FG003|Overall Study|Withdrawal by Subject|0
7895483|NCT01901653|12402750|FG004|Overall Study|Withdrawal by Subject|0
7895484|NCT01901653|12402751|FG005|Overall Study|Withdrawal by Subject|0
7895485|NCT01901653|12402752|FG006|Overall Study|Withdrawal by Subject|1
7895486|NCT01901653|12402753|FG007|Overall Study|Withdrawal by Subject|0
7895487|NCT01901653|12402754|FG008|Overall Study|Withdrawal by Subject|0
7895488|NCT01901653|12402755|FG009|Overall Study|Withdrawal by Subject|0
7895489|NCT01901653|12402756|FG010|Overall Study|Withdrawal by Subject|0
7895490|NCT01901653|12402757|FG011|Overall Study|Withdrawal by Subject|0
7895491|NCT01901653|12402758|FG012|Overall Study|Withdrawal by Subject|0
7895492|NCT01901653|12402746|FG000|Overall Study|Alive at Study Termination by Sponsor|0
7895493|NCT01901653|12402747|FG001|Overall Study|Alive at Study Termination by Sponsor|0
7895494|NCT01901653|12402748|FG002|Overall Study|Alive at Study Termination by Sponsor|1
7895495|NCT01901653|12402749|FG003|Overall Study|Alive at Study Termination by Sponsor|0
7895496|NCT01901653|12402750|FG004|Overall Study|Alive at Study Termination by Sponsor|0
7895497|NCT01901653|12402751|FG005|Overall Study|Alive at Study Termination by Sponsor|0
7895498|NCT01901653|12402752|FG006|Overall Study|Alive at Study Termination by Sponsor|0
7895499|NCT01901653|12402753|FG007|Overall Study|Alive at Study Termination by Sponsor|0
7895500|NCT01901653|12402754|FG008|Overall Study|Alive at Study Termination by Sponsor|0
7895501|NCT01901653|12402755|FG009|Overall Study|Alive at Study Termination by Sponsor|2
7895502|NCT01901653|12402756|FG010|Overall Study|Alive at Study Termination by Sponsor|0
7895503|NCT01901653|12402757|FG011|Overall Study|Alive at Study Termination by Sponsor|1
7895504|NCT01901653|12402758|FG012|Overall Study|Alive at Study Termination by Sponsor|1
7895505|NCT01901848|12402807|FG000|Randomized and Treated|Lost to Follow-up|3
7895506|NCT01901848|12402808|FG001|Randomized and Treated|Lost to Follow-up|6
7895507|NCT01901848|12402807|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10
7895508|NCT01901848|12402808|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0
7968552|NCT02780167|12526251|FG004|Overall Study|Lost to Follow-up|0
7968553|NCT02780167|12526247|FG000|Overall Study|Does not meet entrance criteria|0
7895509|NCT01901874|12402814|FG000|Screening Committee Retrospective Review|Protocol Violation|47
7895510|NCT01901874|12402814|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1
7895511|NCT01901874|12402814|FG000|1-Year (365-Day) MAE Evaluation|Death|7
7895512|NCT01901874|12402814|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5
7895513|NCT01901874|12402814|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2
7895514|NCT01901874|12402814|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6
7963367|NCT02720484|12517748|FG000|Treatment on Study|Adverse Event|1
7963368|NCT02720484|12517748|FG000|Treatment on Study|Withdrawal by Subject|1
7963369|NCT02720484|12517748|FG000|Treatment on Study|Progressive Disease|4
7963370|NCT02720484|12517748|FG000|Follow Up for 2 Years|Withdrawal by Subject|1
7963371|NCT02720484|12517748|FG000|Follow Up for 2 Years|Death|3
7963372|NCT02720484|12517748|FG000|Follow Up for 2 Years|Lost to Follow-up|2
7963373|NCT02720536|12517752|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11
7963374|NCT02720536|12517752|FG000|Overall Study|PR - pregnancy|2
7963375|NCT02720536|12517752|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2
7963376|NCT02720536|12517752|FG000|Overall Study|PR - death|1
7963377|NCT02720536|12517752|FG000|Overall Study|PR - adverse event|1
7963378|NCT02720536|12517752|FG000|Overall Study|PR - abnormal lab value(s)|1
7963379|NCT02720536|12517752|FG000|Overall Study|PR- unwilling to comply with procedures|1
7963380|NCT02720757|12517766|FG000|Overall Study|Other reason|5
7963381|NCT02720757|12517766|FG000|Overall Study|Loss of contact|4
7963382|NCT02720757|12517766|FG000|Overall Study|Informed consent withdrawal|1
7963383|NCT02720757|12517766|FG000|Overall Study|Patients wish to withdraw|2
7963384|NCT02720757|12517766|FG000|Overall Study|Missing|3
7963385|NCT02720757|12517766|FG000|Overall Study|General exclusion|3
7963386|NCT02721147|12517784|FG000|Overall Study|Lost to Follow-up|2
7963387|NCT02721147|12517785|FG001|Overall Study|Lost to Follow-up|0
7963388|NCT02721147|12517786|FG002|Overall Study|Lost to Follow-up|0
7963389|NCT02721251|12517797|FG000|Overall Study|Withdrawal by Subject|8
7963390|NCT02721251|12517798|FG001|Overall Study|Withdrawal by Subject|7
7963391|NCT02721251|12517799|FG002|Overall Study|Withdrawal by Subject|9
7963392|NCT02721251|12517797|FG000|Overall Study|poor adherence|2
7963393|NCT02721251|12517798|FG001|Overall Study|poor adherence|2
7963394|NCT02721251|12517799|FG002|Overall Study|poor adherence|2
7963395|NCT02721355|12517810|FG000|Overall Study|Lost to Follow-up|6
7963396|NCT02721355|12517811|FG001|Overall Study|Lost to Follow-up|1
7963397|NCT02721875|12517823|FG000|Overall Study|Progressive disease/relapse|1
7963398|NCT02721875|12517824|FG001|Overall Study|Progressive disease/relapse|0
7963399|NCT02721966|12517833|FG000|Overall Study|Protocol Violation|1
7963400|NCT02721966|12517834|FG001|Overall Study|Protocol Violation|0
7963401|NCT02721966|12517835|FG002|Overall Study|Protocol Violation|0
7963402|NCT02721966|12517836|FG003|Overall Study|Protocol Violation|0
7963403|NCT02721966|12517837|FG004|Overall Study|Protocol Violation|0
7963404|NCT02721966|12517833|FG000|Overall Study|Withdrawal by Subject|9
7963405|NCT02721966|12517834|FG001|Overall Study|Withdrawal by Subject|2
7963406|NCT02721966|12517835|FG002|Overall Study|Withdrawal by Subject|3
7963407|NCT02721966|12517836|FG003|Overall Study|Withdrawal by Subject|7
7963408|NCT02721966|12517837|FG004|Overall Study|Withdrawal by Subject|0
7963409|NCT02721966|12517833|FG000|Overall Study|Adverse Event|4
7963410|NCT02721966|12517834|FG001|Overall Study|Adverse Event|4
7963411|NCT02721966|12517835|FG002|Overall Study|Adverse Event|3
7963412|NCT02721966|12517836|FG003|Overall Study|Adverse Event|0
7963413|NCT02721966|12517837|FG004|Overall Study|Adverse Event|0
7963414|NCT02721966|12517833|FG000|Overall Study|Death|1
7963415|NCT02721966|12517834|FG001|Overall Study|Death|0
7963416|NCT02721966|12517835|FG002|Overall Study|Death|0
7963417|NCT02721966|12517836|FG003|Overall Study|Death|0
7963418|NCT02721966|12517837|FG004|Overall Study|Death|0
7963419|NCT02721966|12517833|FG000|Overall Study|Lack of Efficacy|7
7963420|NCT02721966|12517834|FG001|Overall Study|Lack of Efficacy|4
7963421|NCT02721966|12517835|FG002|Overall Study|Lack of Efficacy|0
7963422|NCT02721966|12517836|FG003|Overall Study|Lack of Efficacy|0
7963423|NCT02721966|12517837|FG004|Overall Study|Lack of Efficacy|0
7963424|NCT02721966|12517833|FG000|Overall Study|Lost to Follow-up|0
7963425|NCT02721966|12517834|FG001|Overall Study|Lost to Follow-up|0
7963426|NCT02721966|12517835|FG002|Overall Study|Lost to Follow-up|3
7963427|NCT02721966|12517836|FG003|Overall Study|Lost to Follow-up|0
7895515|NCT01902134|12402833|FG000|Overall Study|Adverse Event|3
7895516|NCT01902134|12402834|FG001|Overall Study|Adverse Event|1
7895517|NCT01902134|12402835|FG002|Overall Study|Adverse Event|2
7895518|NCT01902134|12402836|FG003|Overall Study|Adverse Event|1
7895519|NCT01902134|12402837|FG004|Overall Study|Adverse Event|1
7895520|NCT01902134|12402838|FG005|Overall Study|Adverse Event|3
7895521|NCT01902134|12402833|FG000|Overall Study|Lack of Efficacy|0
7895522|NCT01902134|12402834|FG001|Overall Study|Lack of Efficacy|0
7895523|NCT01902134|12402835|FG002|Overall Study|Lack of Efficacy|2
7895524|NCT01902134|12402836|FG003|Overall Study|Lack of Efficacy|0
7895525|NCT01902134|12402837|FG004|Overall Study|Lack of Efficacy|0
7895526|NCT01902134|12402838|FG005|Overall Study|Lack of Efficacy|1
7895527|NCT01902134|12402833|FG000|Overall Study|Physician Decision|0
7895528|NCT01902134|12402834|FG001|Overall Study|Physician Decision|1
7895529|NCT01902134|12402835|FG002|Overall Study|Physician Decision|0
7895530|NCT01902134|12402836|FG003|Overall Study|Physician Decision|0
7895531|NCT01902134|12402837|FG004|Overall Study|Physician Decision|0
7895532|NCT01902134|12402838|FG005|Overall Study|Physician Decision|0
7895533|NCT01902134|12402833|FG000|Overall Study|Protocol Violation|0
7895534|NCT01902134|12402834|FG001|Overall Study|Protocol Violation|0
7895535|NCT01902134|12402835|FG002|Overall Study|Protocol Violation|0
7895536|NCT01902134|12402836|FG003|Overall Study|Protocol Violation|0
7895537|NCT01902134|12402837|FG004|Overall Study|Protocol Violation|0
7895538|NCT01902134|12402838|FG005|Overall Study|Protocol Violation|1
7895539|NCT01902134|12402833|FG000|Overall Study|Withdrawal by Subject|4
7895540|NCT01902134|12402834|FG001|Overall Study|Withdrawal by Subject|8
7895541|NCT01902134|12402835|FG002|Overall Study|Withdrawal by Subject|9
7895542|NCT01902134|12402836|FG003|Overall Study|Withdrawal by Subject|1
7895543|NCT01902134|12402837|FG004|Overall Study|Withdrawal by Subject|5
7895544|NCT01902134|12402838|FG005|Overall Study|Withdrawal by Subject|4
7895545|NCT01902134|12402833|FG000|Overall Study|no compliance|1
7895546|NCT01902134|12402834|FG001|Overall Study|no compliance|0
7895547|NCT01902134|12402835|FG002|Overall Study|no compliance|0
7895548|NCT01902134|12402836|FG003|Overall Study|no compliance|0
7895549|NCT01902134|12402837|FG004|Overall Study|no compliance|0
7895550|NCT01902134|12402838|FG005|Overall Study|no compliance|0
7895551|NCT01902134|12402833|FG000|Overall Study|Other|0
7895552|NCT01902134|12402834|FG001|Overall Study|Other|1
7895553|NCT01902134|12402835|FG002|Overall Study|Other|2
7895554|NCT01902134|12402836|FG003|Overall Study|Other|0
7895555|NCT01902134|12402837|FG004|Overall Study|Other|1
7895556|NCT01902134|12402838|FG005|Overall Study|Other|0
7895557|NCT01902303|12402856|FG000|Overall Study|Adverse Event|0
7895558|NCT01902303|12402857|FG001|Overall Study|Adverse Event|1
7895559|NCT01902303|12402856|FG000|Overall Study|Lost to Follow-up|0
7895560|NCT01902303|12402857|FG001|Overall Study|Lost to Follow-up|1
7895561|NCT01902303|12402856|FG000|Overall Study|Protocol Violation|2
7895562|NCT01902303|12402857|FG001|Overall Study|Protocol Violation|2
7895563|NCT01902303|12402856|FG000|Overall Study|subject lost investigational product|0
7895564|NCT01902303|12402857|FG001|Overall Study|subject lost investigational product|1
7895565|NCT01902303|12402856|FG000|Overall Study|Did not develop a cold sore|21
7895566|NCT01902303|12402857|FG001|Overall Study|Did not develop a cold sore|19
7895567|NCT01902628|12402874|FG000|Overall Study|Withdrawal of participant's consent|7
7895568|NCT01902628|12402874|FG000|Overall Study|Adverse Event|41
7895569|NCT01902628|12402874|FG000|Overall Study|Lost to Follow-up|35
7895570|NCT01903031|12402910|FG000|Overall Study|Not Able to Attend Clinic|1
7895571|NCT01903031|12402911|FG001|Overall Study|Not Able to Attend Clinic|1
7895572|NCT01903031|12402912|FG002|Overall Study|Not Able to Attend Clinic|0
7895573|NCT01903031|12402910|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1
7895574|NCT01903031|12402911|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0
7895575|NCT01903031|12402912|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0
7895576|NCT01903031|12402910|FG000|Overall Study|Adverse Event|0
7895577|NCT01903031|12402911|FG001|Overall Study|Adverse Event|1
7895578|NCT01903031|12402912|FG002|Overall Study|Adverse Event|0
7895579|NCT01903031|12402910|FG000|Overall Study|Withdrawal by Subject|0
7895580|NCT01903031|12402911|FG001|Overall Study|Withdrawal by Subject|1
7895581|NCT01903031|12402912|FG002|Overall Study|Withdrawal by Subject|1
7895582|NCT01903031|12402910|FG000|Overall Study|Protocol Violation|0
7895583|NCT01903031|12402911|FG001|Overall Study|Protocol Violation|0
7895584|NCT01903031|12402912|FG002|Overall Study|Protocol Violation|2
7895585|NCT01903031|12402910|FG000|Overall Study|Lost to Follow-up|0
7895586|NCT01903031|12402911|FG001|Overall Study|Lost to Follow-up|0
7895587|NCT01903031|12402912|FG002|Overall Study|Lost to Follow-up|1
7895588|NCT01903031|12402910|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0
7895589|NCT01903031|12402911|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0
7895590|NCT01903031|12402912|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1
7895591|NCT01903252|12402943|FG000|Double-Blind Induction|Adverse Event|20
7895592|NCT01903252|12402944|FG001|Double-Blind Induction|Adverse Event|18
7895593|NCT01903252|12402945|FG002|Double-Blind Induction|Adverse Event|0
7895594|NCT01903252|12402946|FG003|Double-Blind Induction|Adverse Event|0
7895595|NCT01903252|12402947|FG004|Double-Blind Induction|Adverse Event|0
7895596|NCT01903252|12402948|FG005|Double-Blind Induction|Adverse Event|0
7895597|NCT01903252|12402943|FG000|Double-Blind Induction|Withdrawal by Subject|10
7895598|NCT01903252|12402944|FG001|Double-Blind Induction|Withdrawal by Subject|13
7895599|NCT01903252|12402945|FG002|Double-Blind Induction|Withdrawal by Subject|0
7895600|NCT01903252|12402946|FG003|Double-Blind Induction|Withdrawal by Subject|0
7895601|NCT01903252|12402947|FG004|Double-Blind Induction|Withdrawal by Subject|0
7895602|NCT01903252|12402948|FG005|Double-Blind Induction|Withdrawal by Subject|0
7895603|NCT01903252|12402943|FG000|Double-Blind Induction|Physician Decision|2
7895604|NCT01903252|12402944|FG001|Double-Blind Induction|Physician Decision|3
7895605|NCT01903252|12402945|FG002|Double-Blind Induction|Physician Decision|0
7895606|NCT01903252|12402946|FG003|Double-Blind Induction|Physician Decision|0
7895607|NCT01903252|12402947|FG004|Double-Blind Induction|Physician Decision|0
7895608|NCT01903252|12402948|FG005|Double-Blind Induction|Physician Decision|0
7895609|NCT01903252|12402943|FG000|Double-Blind Induction|non-compliance,|7
7895610|NCT01903252|12402944|FG001|Double-Blind Induction|non-compliance,|7
7895611|NCT01903252|12402945|FG002|Double-Blind Induction|non-compliance,|0
7895612|NCT01903252|12402946|FG003|Double-Blind Induction|non-compliance,|0
7895613|NCT01903252|12402947|FG004|Double-Blind Induction|non-compliance,|0
7895614|NCT01903252|12402948|FG005|Double-Blind Induction|non-compliance,|0
7895615|NCT01903252|12402943|FG000|Extended Induction, Open-Label|Adverse Event|0
7895616|NCT01903252|12402944|FG001|Extended Induction, Open-Label|Adverse Event|0
7895617|NCT01903252|12402945|FG002|Extended Induction, Open-Label|Adverse Event|17
7895618|NCT01903252|12402946|FG003|Extended Induction, Open-Label|Adverse Event|0
7895619|NCT01903252|12402947|FG004|Extended Induction, Open-Label|Adverse Event|0
7895620|NCT01903252|12402948|FG005|Extended Induction, Open-Label|Adverse Event|0
7895621|NCT01903252|12402943|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0
7895622|NCT01903252|12402944|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0
7895623|NCT01903252|12402945|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5
7895624|NCT01903252|12402946|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0
7895625|NCT01903252|12402947|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0
7895626|NCT01903252|12402948|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0
7895627|NCT01903252|12402943|FG000|Extended Induction, Open-Label|Physician Decision|0
7895628|NCT01903252|12402944|FG001|Extended Induction, Open-Label|Physician Decision|0
7895629|NCT01903252|12402945|FG002|Extended Induction, Open-Label|Physician Decision|1
7895630|NCT01903252|12402946|FG003|Extended Induction, Open-Label|Physician Decision|0
7895631|NCT01903252|12402947|FG004|Extended Induction, Open-Label|Physician Decision|0
7895632|NCT01903252|12402948|FG005|Extended Induction, Open-Label|Physician Decision|0
7895633|NCT01903252|12402943|FG000|Maintenance, Open-Label|Adverse Event|0
7895634|NCT01903252|12402944|FG001|Maintenance, Open-Label|Adverse Event|0
7895635|NCT01903252|12402945|FG002|Maintenance, Open-Label|Adverse Event|0
7895636|NCT01903252|12402946|FG003|Maintenance, Open-Label|Adverse Event|3
7895637|NCT01903252|12402947|FG004|Maintenance, Open-Label|Adverse Event|9
7895638|NCT01903252|12402948|FG005|Maintenance, Open-Label|Adverse Event|14
7895639|NCT01903252|12402943|FG000|Maintenance, Open-Label|Withdrawal by Subject|0
7895640|NCT01903252|12402944|FG001|Maintenance, Open-Label|Withdrawal by Subject|0
7895641|NCT01903252|12402945|FG002|Maintenance, Open-Label|Withdrawal by Subject|0
7895642|NCT01903252|12402946|FG003|Maintenance, Open-Label|Withdrawal by Subject|1
7895643|NCT01903252|12402947|FG004|Maintenance, Open-Label|Withdrawal by Subject|6
7895644|NCT01903252|12402948|FG005|Maintenance, Open-Label|Withdrawal by Subject|2
7895645|NCT01903252|12402943|FG000|Maintenance, Open-Label|Other|0
7895646|NCT01903252|12402944|FG001|Maintenance, Open-Label|Other|0
7895647|NCT01903252|12402945|FG002|Maintenance, Open-Label|Other|0
7895648|NCT01903252|12402946|FG003|Maintenance, Open-Label|Other|2
7895649|NCT01903252|12402947|FG004|Maintenance, Open-Label|Other|6
7895650|NCT01903252|12402948|FG005|Maintenance, Open-Label|Other|2
7895651|NCT01903356|12402975|FG000|Overall Study|Lost to Follow-up|7
7895652|NCT01903356|12402975|FG000|Overall Study|Violated inclusion/exclusion criteria|5
7895653|NCT01903356|12402975|FG000|Overall Study|Violated the dosage and administration|3
7895654|NCT01903434|12402979|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1
7895655|NCT01903434|12402980|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0
7895656|NCT01903434|12402979|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
7895657|NCT01903434|12402980|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
7895658|NCT01903460|12402990|FG000|Overall Study|Adverse Event|0
7895659|NCT01903460|12402991|FG001|Overall Study|Adverse Event|0
7895660|NCT01903460|12402992|FG002|Overall Study|Adverse Event|0
7895661|NCT01903460|12402993|FG003|Overall Study|Adverse Event|1
7895662|NCT01903525|12403004|FG000|Overall Study|Lost to Follow-up|5
7895663|NCT01903525|12403005|FG001|Overall Study|Lost to Follow-up|9
7895664|NCT01903525|12403004|FG000|Overall Study|Adverse Event|0
7895665|NCT01903525|12403005|FG001|Overall Study|Adverse Event|1
7895666|NCT01903720|12403020|FG000|Overall Study|Inclusion / exclusion criteria not met|6
7895667|NCT01903720|12403020|FG000|Overall Study|Adverse Event|1
7895668|NCT01903720|12403020|FG000|Overall Study|Rescinding of informed consent|2
7895669|NCT01903720|12403020|FG000|Overall Study|Lost to Follow-up|2
7895670|NCT01903720|12403020|FG000|Overall Study|Treatment with alternative drug|1
7895671|NCT01903811|12403043|FG000|Overall Study|No measurable disease|1
7895672|NCT01903811|12403044|FG001|Overall Study|No measurable disease|1
7895673|NCT01903811|12403043|FG000|Overall Study|Incomplete/discontinued prior therapy|1
7895674|NCT01903811|12403044|FG001|Overall Study|Incomplete/discontinued prior therapy|1
7895675|NCT01903811|12403043|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6
7895676|NCT01903811|12403044|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11
7895677|NCT01903811|12403043|FG000|Overall Study|Withdrawal by Subject|0
7895678|NCT01903811|12403044|FG001|Overall Study|Withdrawal by Subject|1
7895679|NCT01903837|12403057|FG000|Part A|Withdrawal by Subject|4
7895680|NCT01903837|12403058|FG001|Part A|Withdrawal by Subject|9
7895681|NCT01903837|12403059|FG002|Part A|Withdrawal by Subject|8
7895682|NCT01903837|12403060|FG003|Part A|Withdrawal by Subject|5
7895683|NCT01903837|12403057|FG000|Part A|Adverse Event|3
7895684|NCT01903837|12403058|FG001|Part A|Adverse Event|6
7895685|NCT01903837|12403059|FG002|Part A|Adverse Event|9
7895686|NCT01903837|12403060|FG003|Part A|Adverse Event|6
7895687|NCT01903837|12403057|FG000|Part A|Lost to Follow-up|9
7895688|NCT01903837|12403058|FG001|Part A|Lost to Follow-up|7
7895689|NCT01903837|12403059|FG002|Part A|Lost to Follow-up|7
7895690|NCT01903837|12403060|FG003|Part A|Lost to Follow-up|2
7895691|NCT01903837|12403057|FG000|Part A|Non-compliance with study drug|1
7895692|NCT01903837|12403058|FG001|Part A|Non-compliance with study drug|4
7895693|NCT01903837|12403059|FG002|Part A|Non-compliance with study drug|4
7895694|NCT01903837|12403060|FG003|Part A|Non-compliance with study drug|0
7895695|NCT01903837|12403057|FG000|Part A|Physician Decision|1
7895696|NCT01903837|12403058|FG001|Part A|Physician Decision|1
7895697|NCT01903837|12403059|FG002|Part A|Physician Decision|0
7895698|NCT01903837|12403060|FG003|Part A|Physician Decision|0
7895699|NCT01903837|12403057|FG000|Part A|Protocol Violation|1
7895700|NCT01903837|12403058|FG001|Part A|Protocol Violation|1
7895701|NCT01903837|12403059|FG002|Part A|Protocol Violation|0
7895702|NCT01903837|12403060|FG003|Part A|Protocol Violation|0
7895703|NCT01903837|12403057|FG000|Part B|Lost to Follow-up|0
7895704|NCT01903837|12403058|FG001|Part B|Lost to Follow-up|3
7895705|NCT01903837|12403059|FG002|Part B|Lost to Follow-up|3
7895706|NCT01903837|12403060|FG003|Part B|Lost to Follow-up|4
7895707|NCT01903837|12403057|FG000|Part B|Withdrawal by Subject|1
7895708|NCT01903837|12403058|FG001|Part B|Withdrawal by Subject|2
7895709|NCT01903837|12403059|FG002|Part B|Withdrawal by Subject|0
7895710|NCT01903837|12403060|FG003|Part B|Withdrawal by Subject|3
7895711|NCT01903837|12403057|FG000|Part B|Adverse Event|3
7895712|NCT01903837|12403058|FG001|Part B|Adverse Event|0
7895713|NCT01903837|12403059|FG002|Part B|Adverse Event|2
7895714|NCT01903837|12403060|FG003|Part B|Adverse Event|0
7895715|NCT01903837|12403057|FG000|Part B|Non-compliance with study drug|2
7895716|NCT01903837|12403058|FG001|Part B|Non-compliance with study drug|0
7895717|NCT01903837|12403059|FG002|Part B|Non-compliance with study drug|0
7895718|NCT01903837|12403060|FG003|Part B|Non-compliance with study drug|1
7895719|NCT01903837|12403057|FG000|Part B|Incarceration|2
7895720|NCT01903837|12403058|FG001|Part B|Incarceration|0
7895721|NCT01903837|12403059|FG002|Part B|Incarceration|0
7895722|NCT01903837|12403060|FG003|Part B|Incarceration|1
7895723|NCT01903837|12403057|FG000|Part B|Physician Decision|1
7895724|NCT01903837|12403058|FG001|Part B|Physician Decision|0
7895725|NCT01903837|12403059|FG002|Part B|Physician Decision|0
7895726|NCT01903837|12403060|FG003|Part B|Physician Decision|2
7895727|NCT01903837|12403057|FG000|Part B|Lack of Efficacy|0
7895728|NCT01903837|12403058|FG001|Part B|Lack of Efficacy|1
7895729|NCT01903837|12403059|FG002|Part B|Lack of Efficacy|0
7895730|NCT01903837|12403060|FG003|Part B|Lack of Efficacy|0
7895731|NCT01903863|12403093|FG000|Overall Study|Physician Decision|2
7895732|NCT01903863|12403094|FG001|Overall Study|Physician Decision|0
7895733|NCT01903876|12403102|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184
7895734|NCT01903876|12403103|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108
7895735|NCT01903876|12403102|FG000|Six-Month Follow-up Period|Lost to Follow-up|91
7895736|NCT01903876|12403103|FG001|Six-Month Follow-up Period|Lost to Follow-up|145
7895737|NCT01903993|12403111|FG000|Overall Study|Death|118
7895738|NCT01903993|12403112|FG001|Overall Study|Death|121
7895739|NCT01903993|12403111|FG000|Overall Study|Withdrawal by Subject|15
7895740|NCT01903993|12403112|FG001|Overall Study|Withdrawal by Subject|4
7895741|NCT01903993|12403111|FG000|Overall Study|Lost to Follow-up|2
7895742|NCT01903993|12403112|FG001|Overall Study|Lost to Follow-up|3
7895743|NCT01903993|12403111|FG000|Overall Study|Study Terminated by Sponsor|8
7895744|NCT01903993|12403112|FG001|Overall Study|Study Terminated by Sponsor|14
7895745|NCT01903993|12403111|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0
7895746|NCT01903993|12403112|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2
7895747|NCT01904019|12403119|FG000|1 Year Follow-up|Withdrawal by Subject|4
7895748|NCT01904019|12403119|FG000|1 Year Follow-up|Impossibility to contact patient|5
7895749|NCT01904019|12403119|FG000|3 Year Follow-up|Withdrawal by Subject|1
7895750|NCT01904019|12403119|FG000|3 Year Follow-up|Impossibility to contact patient|14
7895751|NCT01904019|12403119|FG000|5 Year Follow-up|Withdrawal by Subject|2
7895752|NCT01904019|12403119|FG000|5 Year Follow-up|Impossibility to contact patient|4
7895753|NCT01904058|12403127|FG000|Overall Study|Adverse Event|2
7895754|NCT01904058|12403128|FG001|Overall Study|Adverse Event|0
7895755|NCT01904058|12403129|FG002|Overall Study|Adverse Event|0
7895756|NCT01904058|12403130|FG003|Overall Study|Adverse Event|0
7895757|NCT01904058|12403127|FG000|Overall Study|Withdrawal by Subject|1
7895758|NCT01904058|12403128|FG001|Overall Study|Withdrawal by Subject|0
7895759|NCT01904058|12403129|FG002|Overall Study|Withdrawal by Subject|1
7895760|NCT01904058|12403130|FG003|Overall Study|Withdrawal by Subject|0
7895761|NCT01904058|12403127|FG000|Overall Study|Pregnancy|0
7895762|NCT01904058|12403128|FG001|Overall Study|Pregnancy|0
7895763|NCT01904058|12403129|FG002|Overall Study|Pregnancy|0
7895764|NCT01904058|12403130|FG003|Overall Study|Pregnancy|1
7895765|NCT01904149|12403165|FG000|Overall Study|Adverse Event|3
7895766|NCT01904149|12403166|FG001|Overall Study|Adverse Event|4
7895767|NCT01904149|12403167|FG002|Overall Study|Adverse Event|0
7895768|NCT01904149|12403168|FG003|Overall Study|Adverse Event|1
7895769|NCT01904149|12403169|FG004|Overall Study|Adverse Event|1
7895770|NCT01904149|12403170|FG005|Overall Study|Adverse Event|2
7895771|NCT01904149|12403165|FG000|Overall Study|Lack of Efficacy|0
7895772|NCT01904149|12403166|FG001|Overall Study|Lack of Efficacy|3
7895773|NCT01904149|12403167|FG002|Overall Study|Lack of Efficacy|1
7895774|NCT01904149|12403168|FG003|Overall Study|Lack of Efficacy|3
7895775|NCT01904149|12403169|FG004|Overall Study|Lack of Efficacy|3
7895776|NCT01904149|12403170|FG005|Overall Study|Lack of Efficacy|1
7895777|NCT01904149|12403165|FG000|Overall Study|Withdrawal by Subject|1
7895778|NCT01904149|12403166|FG001|Overall Study|Withdrawal by Subject|3
7895779|NCT01904149|12403167|FG002|Overall Study|Withdrawal by Subject|1
7895780|NCT01904149|12403168|FG003|Overall Study|Withdrawal by Subject|0
7895781|NCT01904149|12403169|FG004|Overall Study|Withdrawal by Subject|1
7895782|NCT01904149|12403170|FG005|Overall Study|Withdrawal by Subject|0
7895783|NCT01904149|12403165|FG000|Overall Study|Protocol Violation|0
7895784|NCT01904149|12403166|FG001|Overall Study|Protocol Violation|1
7895785|NCT01904149|12403167|FG002|Overall Study|Protocol Violation|0
7895786|NCT01904149|12403168|FG003|Overall Study|Protocol Violation|0
7895787|NCT01904149|12403169|FG004|Overall Study|Protocol Violation|0
7895788|NCT01904149|12403170|FG005|Overall Study|Protocol Violation|0
7895789|NCT01904149|12403165|FG000|Overall Study|non compliance with study drug|1
7895790|NCT01904149|12403166|FG001|Overall Study|non compliance with study drug|0
7895791|NCT01904149|12403167|FG002|Overall Study|non compliance with study drug|0
7895792|NCT01904149|12403168|FG003|Overall Study|non compliance with study drug|0
7895793|NCT01904149|12403169|FG004|Overall Study|non compliance with study drug|0
7895794|NCT01904149|12403170|FG005|Overall Study|non compliance with study drug|0
7895795|NCT01904383|12403186|FG000|Overall Study|CRF not collected|117
7895796|NCT01904383|12403186|FG000|Overall Study|Reason not listed|147
7895797|NCT01904383|12403186|FG000|Overall Study|Lost to Follow-up|674
7895798|NCT01904383|12403186|FG000|Overall Study|Lack of Efficacy|370
7895799|NCT01904383|12403186|FG000|Overall Study|Improvement|141
7895800|NCT01904383|12403186|FG000|Overall Study|Adverse Event|271
7895801|NCT01904383|12403186|FG000|Overall Study|No patient visit after entry|54
7895802|NCT01904604|12403206|FG000|Overall Study|Withdrew before receiving dosing|0
7895803|NCT01904604|12403207|FG001|Overall Study|Withdrew before receiving dosing|1
7895804|NCT01904604|12403208|FG002|Overall Study|Withdrew before receiving dosing|0
7895805|NCT01904604|12403206|FG000|Overall Study|Non-compliance|1
7895806|NCT01904604|12403207|FG001|Overall Study|Non-compliance|0
7895807|NCT01904604|12403208|FG002|Overall Study|Non-compliance|0
7895808|NCT01904604|12403206|FG000|Overall Study|Anxiety about OFC/Refused OFC|2
7895809|NCT01904604|12403207|FG001|Overall Study|Anxiety about OFC/Refused OFC|0
7895810|NCT01904604|12403208|FG002|Overall Study|Anxiety about OFC/Refused OFC|0
7968554|NCT02780167|12526248|FG001|Overall Study|Does not meet entrance criteria|0
7968555|NCT02780167|12526249|FG002|Overall Study|Does not meet entrance criteria|1
7968556|NCT02780167|12526250|FG003|Overall Study|Does not meet entrance criteria|0
7968557|NCT02780167|12526251|FG004|Overall Study|Does not meet entrance criteria|0
7968558|NCT02780167|12526247|FG000|Overall Study|No longer meets eligibility criteria|0
7968559|NCT02780167|12526248|FG001|Overall Study|No longer meets eligibility criteria|0
7968560|NCT02780167|12526249|FG002|Overall Study|No longer meets eligibility criteria|0
7968561|NCT02780167|12526250|FG003|Overall Study|No longer meets eligibility criteria|1
7968562|NCT02780167|12526251|FG004|Overall Study|No longer meets eligibility criteria|1
7968563|NCT02780167|12526247|FG000|Overall Study|Protocol Violation|5
7968564|NCT02780167|12526248|FG001|Overall Study|Protocol Violation|5
7968565|NCT02780167|12526249|FG002|Overall Study|Protocol Violation|1
7968566|NCT02780167|12526250|FG003|Overall Study|Protocol Violation|1
7968567|NCT02780167|12526251|FG004|Overall Study|Protocol Violation|2
7968568|NCT02780167|12526247|FG000|Overall Study|Withdrawal by Subject|6
7968569|NCT02780167|12526248|FG001|Overall Study|Withdrawal by Subject|4
7968570|NCT02780167|12526249|FG002|Overall Study|Withdrawal by Subject|4
7968571|NCT02780167|12526250|FG003|Overall Study|Withdrawal by Subject|3
7968572|NCT02780167|12526251|FG004|Overall Study|Withdrawal by Subject|4
7968573|NCT02780167|12526247|FG000|Overall Study|Other|0
7968574|NCT02780167|12526248|FG001|Overall Study|Other|0
7968575|NCT02780167|12526249|FG002|Overall Study|Other|3
7968576|NCT02780167|12526250|FG003|Overall Study|Other|1
7968577|NCT02780167|12526251|FG004|Overall Study|Other|2
7968578|NCT02780388|12526272|FG000|Overall Study|Lost to Follow-up|0
7968579|NCT02780388|12526273|FG001|Overall Study|Lost to Follow-up|1
7968580|NCT02780388|12526274|FG002|Overall Study|Lost to Follow-up|0
7968581|NCT02780388|12526275|FG003|Overall Study|Lost to Follow-up|0
7968582|NCT02780388|12526276|FG004|Overall Study|Lost to Follow-up|0
7968583|NCT02780388|12526272|FG000|Overall Study|Withdrawal by Subject|1
7968584|NCT02780388|12526273|FG001|Overall Study|Withdrawal by Subject|1
7968585|NCT02780388|12526274|FG002|Overall Study|Withdrawal by Subject|0
7968586|NCT02780388|12526275|FG003|Overall Study|Withdrawal by Subject|0
7968587|NCT02780388|12526276|FG004|Overall Study|Withdrawal by Subject|0
7968588|NCT02780687|12526310|FG000|Overall Study|Adverse Event|1
7968589|NCT02780687|12526311|FG001|Overall Study|Adverse Event|1
7968590|NCT02780687|12526310|FG000|Overall Study|Withdrawal by Subject|2
7968591|NCT02780687|12526311|FG001|Overall Study|Withdrawal by Subject|1
7968592|NCT02780687|12526310|FG000|Overall Study|Switched to commercial program (in CTP)|2
7968593|NCT02780687|12526311|FG001|Overall Study|Switched to commercial program (in CTP)|0
7968594|NCT02780687|12526310|FG000|Overall Study|progressive disease|29
7895811|NCT01904604|12403206|FG000|Overall Study|Patch site reactions|1
7895812|NCT01904604|12403207|FG001|Overall Study|Patch site reactions|1
7895813|NCT01904604|12403208|FG002|Overall Study|Patch site reactions|0
7895814|NCT01904604|12403206|FG000|Overall Study|Increased syncope|0
7895815|NCT01904604|12403207|FG001|Overall Study|Increased syncope|1
7895816|NCT01904604|12403208|FG002|Overall Study|Increased syncope|0
7895817|NCT01904604|12403206|FG000|Overall Study|Unrelated illness|0
7968595|NCT02780687|12526311|FG001|Overall Study|progressive disease|6
7968596|NCT02780700|12526316|FG000|Overall Study|Progressive disease|1
7895818|NCT01904604|12403207|FG001|Overall Study|Unrelated illness|1
7895819|NCT01904604|12403208|FG002|Overall Study|Unrelated illness|0
7895820|NCT01904604|12403206|FG000|Overall Study|Passed Week 52 OFC|1
7895821|NCT01904604|12403207|FG001|Overall Study|Passed Week 52 OFC|0
7895822|NCT01904604|12403208|FG002|Overall Study|Passed Week 52 OFC|0
7895823|NCT01904604|12403206|FG000|Overall Study|Withdrawal by Subject|1
7895824|NCT01904604|12403207|FG001|Overall Study|Withdrawal by Subject|2
7895825|NCT01904604|12403208|FG002|Overall Study|Withdrawal by Subject|0
7895826|NCT01904604|12403206|FG000|Overall Study|Participant Relocated|1
7895827|NCT01904604|12403207|FG001|Overall Study|Participant Relocated|1
7895828|NCT01904604|12403208|FG002|Overall Study|Participant Relocated|1
7895829|NCT01904604|12403206|FG000|Overall Study|Lost to Follow-up|0
7895830|NCT01904604|12403207|FG001|Overall Study|Lost to Follow-up|0
7895831|NCT01904604|12403208|FG002|Overall Study|Lost to Follow-up|1
7895832|NCT01904721|12403226|FG000|Overall Study|Other Reasons|0
7895833|NCT01904721|12403227|FG001|Overall Study|Other Reasons|0
7895834|NCT01904721|12403228|FG002|Overall Study|Other Reasons|1
7895835|NCT01904721|12403229|FG003|Overall Study|Other Reasons|1
7895836|NCT01904721|12403230|FG004|Overall Study|Other Reasons|2
7895837|NCT01904721|12403231|FG005|Overall Study|Other Reasons|2
7895838|NCT01904721|12403232|FG006|Overall Study|Other Reasons|2
7895839|NCT01904721|12403226|FG000|Overall Study|Personal Reasons|0
7895840|NCT01904721|12403227|FG001|Overall Study|Personal Reasons|0
7895841|NCT01904721|12403228|FG002|Overall Study|Personal Reasons|0
7895842|NCT01904721|12403229|FG003|Overall Study|Personal Reasons|0
7895843|NCT01904721|12403230|FG004|Overall Study|Personal Reasons|2
7895844|NCT01904721|12403231|FG005|Overall Study|Personal Reasons|3
7895845|NCT01904721|12403232|FG006|Overall Study|Personal Reasons|3
7895846|NCT01904721|12403226|FG000|Overall Study|Lost to Follow-up|0
7895847|NCT01904721|12403227|FG001|Overall Study|Lost to Follow-up|0
7895848|NCT01904721|12403228|FG002|Overall Study|Lost to Follow-up|0
7895849|NCT01904721|12403229|FG003|Overall Study|Lost to Follow-up|0
7895850|NCT01904721|12403230|FG004|Overall Study|Lost to Follow-up|1
7895851|NCT01904721|12403231|FG005|Overall Study|Lost to Follow-up|3
7895852|NCT01904721|12403232|FG006|Overall Study|Lost to Follow-up|1
7895853|NCT01904721|12403226|FG000|Overall Study|Lack of Efficacy|0
7895854|NCT01904721|12403227|FG001|Overall Study|Lack of Efficacy|0
7895855|NCT01904721|12403228|FG002|Overall Study|Lack of Efficacy|0
7895856|NCT01904721|12403229|FG003|Overall Study|Lack of Efficacy|0
7895857|NCT01904721|12403230|FG004|Overall Study|Lack of Efficacy|0
7895858|NCT01904721|12403231|FG005|Overall Study|Lack of Efficacy|0
7895859|NCT01904721|12403232|FG006|Overall Study|Lack of Efficacy|1
7895860|NCT01904721|12403226|FG000|Overall Study|Adverse Event|0
7895861|NCT01904721|12403227|FG001|Overall Study|Adverse Event|0
7895862|NCT01904721|12403228|FG002|Overall Study|Adverse Event|0
7895863|NCT01904721|12403229|FG003|Overall Study|Adverse Event|0
7895864|NCT01904721|12403230|FG004|Overall Study|Adverse Event|3
7895865|NCT01904721|12403231|FG005|Overall Study|Adverse Event|1
7895866|NCT01904721|12403232|FG006|Overall Study|Adverse Event|0
7895867|NCT01904760|12403246|FG000|Overall Study|Protocol Violation|1
7895868|NCT01904760|12403247|FG001|Overall Study|Protocol Violation|0
7895869|NCT01904773|12403253|FG000|Screen|Screen failure|3
7895870|NCT01904773|12403254|FG001|Screen|Screen failure|0
7895871|NCT01904773|12403255|FG002|Screen|Screen failure|0
7895872|NCT01904773|12403256|FG003|Screen|Screen failure|0
7895873|NCT01904773|12403257|FG004|Screen|Screen failure|0
7895874|NCT01904773|12403258|FG005|Screen|Screen failure|0
7895875|NCT01904773|12403259|FG006|Screen|Screen failure|0
7895876|NCT01904773|12403260|FG007|Screen|Screen failure|0
7895877|NCT01904773|12403261|FG008|Screen|Screen failure|0
7895878|NCT01904773|12403253|FG000|Screen|Withdrawal by Subject|1
7895879|NCT01904773|12403254|FG001|Screen|Withdrawal by Subject|0
7895880|NCT01904773|12403255|FG002|Screen|Withdrawal by Subject|0
7895881|NCT01904773|12403256|FG003|Screen|Withdrawal by Subject|0
7895882|NCT01904773|12403257|FG004|Screen|Withdrawal by Subject|0
7895883|NCT01904773|12403258|FG005|Screen|Withdrawal by Subject|0
7895884|NCT01904773|12403259|FG006|Screen|Withdrawal by Subject|0
7895885|NCT01904773|12403260|FG007|Screen|Withdrawal by Subject|0
7895886|NCT01904773|12403261|FG008|Screen|Withdrawal by Subject|0
7895887|NCT01904773|12403253|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
7895888|NCT01904773|12403254|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7895889|NCT01904773|12403255|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7895890|NCT01904773|12403256|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7895891|NCT01904773|12403257|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7895892|NCT01904773|12403258|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7895893|NCT01904773|12403259|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7895894|NCT01904773|12403260|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7895895|NCT01904773|12403261|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7895896|NCT01904773|12403253|FG000|First Intervention|Adverse Event|0
7895897|NCT01904773|12403254|FG001|First Intervention|Adverse Event|0
7895898|NCT01904773|12403255|FG002|First Intervention|Adverse Event|0
7895899|NCT01904773|12403256|FG003|First Intervention|Adverse Event|0
7895900|NCT01904773|12403257|FG004|First Intervention|Adverse Event|0
7895901|NCT01904773|12403258|FG005|First Intervention|Adverse Event|0
7895902|NCT01904773|12403259|FG006|First Intervention|Adverse Event|1
7895903|NCT01904773|12403260|FG007|First Intervention|Adverse Event|0
7895904|NCT01904773|12403261|FG008|First Intervention|Adverse Event|0
7895905|NCT01904773|12403253|FG000|Placebo Washout First Intervention|Condition worsened|0
7895906|NCT01904773|12403254|FG001|Placebo Washout First Intervention|Condition worsened|1
7895907|NCT01904773|12403255|FG002|Placebo Washout First Intervention|Condition worsened|0
7895908|NCT01904773|12403256|FG003|Placebo Washout First Intervention|Condition worsened|0
7895909|NCT01904773|12403257|FG004|Placebo Washout First Intervention|Condition worsened|0
7895910|NCT01904773|12403258|FG005|Placebo Washout First Intervention|Condition worsened|0
7895911|NCT01904773|12403259|FG006|Placebo Washout First Intervention|Condition worsened|0
7895912|NCT01904773|12403260|FG007|Placebo Washout First Intervention|Condition worsened|0
7895913|NCT01904773|12403261|FG008|Placebo Washout First Intervention|Condition worsened|0
7895914|NCT01904773|12403253|FG000|Fifth Intervention|Adverse Event|0
7895915|NCT01904773|12403254|FG001|Fifth Intervention|Adverse Event|0
7895916|NCT01904773|12403255|FG002|Fifth Intervention|Adverse Event|0
7895917|NCT01904773|12403256|FG003|Fifth Intervention|Adverse Event|0
7895918|NCT01904773|12403257|FG004|Fifth Intervention|Adverse Event|0
7895919|NCT01904773|12403258|FG005|Fifth Intervention|Adverse Event|0
7895920|NCT01904773|12403259|FG006|Fifth Intervention|Adverse Event|0
7895921|NCT01904773|12403260|FG007|Fifth Intervention|Adverse Event|1
7895922|NCT01904773|12403261|FG008|Fifth Intervention|Adverse Event|0
7895923|NCT01904773|12403253|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7895924|NCT01904773|12403254|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
7895925|NCT01904773|12403255|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7895926|NCT01904773|12403256|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7895927|NCT01904773|12403257|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7895928|NCT01904773|12403258|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7895929|NCT01904773|12403259|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7895930|NCT01904773|12403260|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7895931|NCT01904773|12403261|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7895932|NCT01905267|12403292|FG000|Overall Study|Physician Decision|2
7895933|NCT01905267|12403293|FG001|Overall Study|Physician Decision|2
7895934|NCT01905540|12403324|FG000|Period 3|Other|1
7895935|NCT01905540|12403325|FG001|Period 3|Other|0
7895936|NCT01905540|12403326|FG002|Period 3|Other|1
7895937|NCT01905540|12403327|FG003|Period 3|Other|1
7895938|NCT01905553|12403339|FG000|Period 2|Adverse Event|1
7895939|NCT01905553|12403340|FG001|Period 2|Adverse Event|0
7895940|NCT01905592|12403348|FG000|Overall Study|Disease Progression|51
7895941|NCT01905592|12403349|FG001|Overall Study|Disease Progression|104
7895942|NCT01905592|12403348|FG000|Overall Study|Toxicity|1
7895943|NCT01905592|12403349|FG001|Overall Study|Toxicity|16
7895944|NCT01905592|12403348|FG000|Overall Study|Physician Decision|0
7895945|NCT01905592|12403349|FG001|Overall Study|Physician Decision|2
7895946|NCT01905592|12403348|FG000|Overall Study|New anti-cancer|1
7895947|NCT01905592|12403349|FG001|Overall Study|New anti-cancer|0
7895948|NCT01905592|12403348|FG000|Overall Study|Protocol Violation|0
7895949|NCT01905592|12403349|FG001|Overall Study|Protocol Violation|1
7895950|NCT01905592|12403348|FG000|Overall Study|Sponsor's decision|1
7895951|NCT01905592|12403349|FG001|Overall Study|Sponsor's decision|0
7895952|NCT01905592|12403348|FG000|Overall Study|Not treated|7
7895953|NCT01905592|12403349|FG001|Overall Study|Not treated|3
7895954|NCT01905592|12403348|FG000|Overall Study|Ongoing in Study|0
7895955|NCT01905592|12403349|FG001|Overall Study|Ongoing in Study|7
7895956|NCT01905592|12403348|FG000|Overall Study|Withdrawal by Subject|10
7895957|NCT01905592|12403349|FG001|Overall Study|Withdrawal by Subject|2
7895958|NCT01905657|12403358|FG000|Overall Study|Adverse Event|23
7895959|NCT01905657|12403359|FG001|Overall Study|Adverse Event|17
7895960|NCT01905657|12403360|FG002|Overall Study|Adverse Event|18
7895961|NCT01905657|12403358|FG000|Overall Study|Clinical Progression|103
7895962|NCT01905657|12403359|FG001|Overall Study|Clinical Progression|78
7895963|NCT01905657|12403360|FG002|Overall Study|Clinical Progression|59
7895964|NCT01905657|12403358|FG000|Overall Study|Death|40
7895965|NCT01905657|12403359|FG001|Overall Study|Death|43
7895966|NCT01905657|12403360|FG002|Overall Study|Death|47
7895967|NCT01905657|12403358|FG000|Overall Study|Excluded Medication|13
7895968|NCT01905657|12403359|FG001|Overall Study|Excluded Medication|16
7895969|NCT01905657|12403360|FG002|Overall Study|Excluded Medication|9
7895970|NCT01905657|12403358|FG000|Overall Study|Lost to Follow-up|1
7895971|NCT01905657|12403359|FG001|Overall Study|Lost to Follow-up|2
7895972|NCT01905657|12403360|FG002|Overall Study|Lost to Follow-up|1
7895973|NCT01905657|12403358|FG000|Overall Study|Physician Decision|5
7895974|NCT01905657|12403359|FG001|Overall Study|Physician Decision|8
7895975|NCT01905657|12403360|FG002|Overall Study|Physician Decision|12
7895976|NCT01905657|12403358|FG000|Overall Study|Protocol Violation|2
7895977|NCT01905657|12403359|FG001|Overall Study|Protocol Violation|1
7895978|NCT01905657|12403360|FG002|Overall Study|Protocol Violation|1
7895979|NCT01905657|12403358|FG000|Overall Study|Screen Failure|0
7895980|NCT01905657|12403359|FG001|Overall Study|Screen Failure|1
7895981|NCT01905657|12403360|FG002|Overall Study|Screen Failure|0
7895982|NCT01905657|12403358|FG000|Overall Study|Withdrawal by Subject|15
7895983|NCT01905657|12403359|FG001|Overall Study|Withdrawal by Subject|21
7895984|NCT01905657|12403360|FG002|Overall Study|Withdrawal by Subject|53
7895985|NCT01905657|12403358|FG000|Overall Study|Sponsor Decision|1
7895986|NCT01905657|12403359|FG001|Overall Study|Sponsor Decision|0
7895987|NCT01905657|12403360|FG002|Overall Study|Sponsor Decision|0
7895988|NCT01905683|12403371|FG000|Overall Study|Protocol Violation|1
7895989|NCT01905683|12403371|FG000|Overall Study|Re-injection criteria not met; others|13
7895990|NCT01905683|12403371|FG000|Overall Study|Physician Decision|1
7895991|NCT01905683|12403371|FG000|Overall Study|Lack of Efficacy|8
7895992|NCT01905683|12403371|FG000|Overall Study|Withdrawal by Subject|20
7895993|NCT01905683|12403371|FG000|Overall Study|Adverse Event|4
7895994|NCT01905683|12403371|FG000|Overall Study|Lost to Follow-up|4
7895995|NCT01905943|12403375|FG000|Overall Study|Withdrawal of consent|90
7895996|NCT01905943|12403375|FG000|Overall Study|Lost to Follow-up|16
7895997|NCT01905943|12403375|FG000|Overall Study|Investigator discretion|7
7895998|NCT01905943|12403375|FG000|Overall Study|Death|186
7895999|NCT01905943|12403375|FG000|Overall Study|Adverse Event|3
7896000|NCT01905943|12403375|FG000|Overall Study|Other|12
7896001|NCT01906008|12403405|FG000|Overall Study|Lost to Follow-up|2
7896002|NCT01906008|12403406|FG001|Overall Study|Lost to Follow-up|0
7896003|NCT01906008|12403405|FG000|Overall Study|Oxaliplatin toxicity|2
7896004|NCT01906008|12403406|FG001|Overall Study|Oxaliplatin toxicity|0
7896005|NCT01906008|12403405|FG000|Overall Study|Protocol Violation|0
7896006|NCT01906008|12403406|FG001|Overall Study|Protocol Violation|1
7896007|NCT01906008|12403405|FG000|Overall Study|Withdrawal by Subject|1
7896008|NCT01906008|12403406|FG001|Overall Study|Withdrawal by Subject|5
7896009|NCT01906008|12403405|FG000|Overall Study|Did not start study med|3
7896010|NCT01906008|12403406|FG001|Overall Study|Did not start study med|4
7896011|NCT01906008|12403405|FG000|Overall Study|Oxaliplatin stops|10
7896012|NCT01906008|12403406|FG001|Overall Study|Oxaliplatin stops|8
7896013|NCT01906008|12403405|FG000|Overall Study|Hospice|1
7896014|NCT01906008|12403406|FG001|Overall Study|Hospice|0
7896015|NCT01906008|12403405|FG000|Overall Study|Physician Decision|3
7811327|NCT01181726|12275014|FG000|First Intervention|Adverse Event|1
7811328|NCT01181726|12275015|FG001|First Intervention|Adverse Event|0
7811329|NCT01181895|12275041|FG000|Overall Study|Adverse Event|3
7811330|NCT01181895|12275042|FG001|Overall Study|Adverse Event|1
7811331|NCT01181895|12275043|FG002|Overall Study|Adverse Event|1
7811332|NCT01181895|12275041|FG000|Overall Study|Lack of Efficacy|8
7811333|NCT01181895|12275042|FG001|Overall Study|Lack of Efficacy|9
7811334|NCT01181895|12275043|FG002|Overall Study|Lack of Efficacy|9
7811335|NCT01181895|12275041|FG000|Overall Study|Protocol Violation|2
7811336|NCT01181895|12275042|FG001|Overall Study|Protocol Violation|1
7811337|NCT01181895|12275043|FG002|Overall Study|Protocol Violation|0
7811338|NCT01181895|12275041|FG000|Overall Study|Lost to Follow-up|0
7896016|NCT01906008|12403406|FG001|Overall Study|Physician Decision|3
7896017|NCT01906008|12403405|FG000|Overall Study|Lack of compliance of study med|5
7896018|NCT01906008|12403406|FG001|Overall Study|Lack of compliance of study med|3
7896019|NCT01906008|12403405|FG000|Overall Study|Adverse Event|0
7896020|NCT01906008|12403406|FG001|Overall Study|Adverse Event|3
7896021|NCT01906346|12403412|FG000|Overall Study|AEs|1
7896022|NCT01906372|12403418|FG000|Overall Study|Withdrawal by Subject|2
7896023|NCT01906476|12403425|FG000|Overall Study|Lost to Follow-up|17
7896024|NCT01906476|12403426|FG001|Overall Study|Lost to Follow-up|16
7896025|NCT01907087|12403471|FG000|Overall Study|Withdrawal by Subject|1
7896026|NCT01907100|12403479|FG000|Overall Study|PD based on modified RECIST criteria|31
7896027|NCT01907100|12403480|FG001|Overall Study|PD based on modified RECIST criteria|32
7896028|NCT01907100|12403481|FG002|Overall Study|PD based on modified RECIST criteria|95
7896029|NCT01907100|12403482|FG003|Overall Study|PD based on modified RECIST criteria|92
7896030|NCT01907100|12403479|FG000|Overall Study|Withdrawal by Subject|2
7896031|NCT01907100|12403480|FG001|Overall Study|Withdrawal by Subject|5
7896032|NCT01907100|12403481|FG002|Overall Study|Withdrawal by Subject|10
7896033|NCT01907100|12403482|FG003|Overall Study|Withdrawal by Subject|13
7896034|NCT01907100|12403479|FG000|Overall Study|Protocol Violation|0
7896035|NCT01907100|12403480|FG001|Overall Study|Protocol Violation|0
7896036|NCT01907100|12403481|FG002|Overall Study|Protocol Violation|1
7896037|NCT01907100|12403482|FG003|Overall Study|Protocol Violation|1
7896038|NCT01907100|12403479|FG000|Overall Study|Lost to Follow-up|0
7811339|NCT01181895|12275042|FG001|Overall Study|Lost to Follow-up|1
7811340|NCT01181895|12275043|FG002|Overall Study|Lost to Follow-up|2
7811341|NCT01181895|12275041|FG000|Overall Study|Investigator Discretion|1
7811342|NCT01181895|12275042|FG001|Overall Study|Investigator Discretion|2
7896039|NCT01907100|12403480|FG001|Overall Study|Lost to Follow-up|0
7896040|NCT01907100|12403481|FG002|Overall Study|Lost to Follow-up|0
7896041|NCT01907100|12403482|FG003|Overall Study|Lost to Follow-up|1
7896042|NCT01907100|12403479|FG000|Overall Study|Not treated|2
7896043|NCT01907100|12403480|FG001|Overall Study|Not treated|0
7896044|NCT01907100|12403481|FG002|Overall Study|Not treated|1
7896045|NCT01907100|12403482|FG003|Overall Study|Not treated|2
7896046|NCT01907100|12403479|FG000|Overall Study|Other than reasons specified|1
7968597|NCT02780713|12526320|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7968598|NCT02780713|12526321|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7968599|NCT02780713|12526322|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2
7968600|NCT02780713|12526323|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7968601|NCT02780713|12526324|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7968602|NCT02780856|12526352|FG000|Overall Study|Lost to Follow-up|1
7968603|NCT02781311|12526376|FG000|Overall Study|Adverse Event|2
7968604|NCT02781311|12526377|FG001|Overall Study|Adverse Event|6
7968605|NCT02781311|12526378|FG002|Overall Study|Adverse Event|1
7968606|NCT02781311|12526376|FG000|Overall Study|Withdrawal of Consent|11
7968607|NCT02781311|12526377|FG001|Overall Study|Withdrawal of Consent|12
7968608|NCT02781311|12526378|FG002|Overall Study|Withdrawal of Consent|2
7968609|NCT02781311|12526376|FG000|Overall Study|Lost to Follow-up|11
7968610|NCT02781311|12526377|FG001|Overall Study|Lost to Follow-up|8
7968611|NCT02781311|12526378|FG002|Overall Study|Lost to Follow-up|1
7968612|NCT02781311|12526376|FG000|Overall Study|Non-Compliance with Study Drug|2
7968613|NCT02781311|12526377|FG001|Overall Study|Non-Compliance with Study Drug|0
7968614|NCT02781311|12526378|FG002|Overall Study|Non-Compliance with Study Drug|0
7896047|NCT01907100|12403480|FG001|Overall Study|Other than reasons specified|0
7896048|NCT01907100|12403481|FG002|Overall Study|Other than reasons specified|10
7896049|NCT01907100|12403482|FG003|Overall Study|Other than reasons specified|6
7896050|NCT01907100|12403479|FG000|Overall Study|Adverse event (AE)|6
7896051|NCT01907100|12403480|FG001|Overall Study|Adverse event (AE)|3
7896052|NCT01907100|12403481|FG002|Overall Study|Adverse event (AE)|22
7896053|NCT01907100|12403482|FG003|Overall Study|Adverse event (AE)|23
7896054|NCT01907100|12403479|FG000|Overall Study|Worsening/AE underlying cancer disease|0
7896055|NCT01907100|12403480|FG001|Overall Study|Worsening/AE underlying cancer disease|0
7963428|NCT02721966|12517837|FG004|Overall Study|Lost to Follow-up|0
7896056|NCT01907100|12403481|FG002|Overall Study|Worsening/AE underlying cancer disease|8
7896057|NCT01907100|12403482|FG003|Overall Study|Worsening/AE underlying cancer disease|8
7896058|NCT01907217|12403513|FG000|Overall Study|Withdrawal by Subject|0
7896059|NCT01907217|12403514|FG001|Overall Study|Withdrawal by Subject|2
7896060|NCT01907516|12403548|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5
7896061|NCT01907516|12403549|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9
7896062|NCT01907516|12403548|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1
7896063|NCT01907516|12403549|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3
7896064|NCT01907516|12403548|FG000|First Intervention (3 Weeks)|Delivered before second arm|3
7896065|NCT01907516|12403549|FG001|First Intervention (3 Weeks)|Delivered before second arm|4
7896066|NCT01907516|12403548|FG000|First Intervention (3 Weeks)|Developed DKA during study|1
7896067|NCT01907516|12403549|FG001|First Intervention (3 Weeks)|Developed DKA during study|0
7896068|NCT01907737|12403560|FG000|Overall Study|Withdrawal by Subject|1
7896069|NCT01907815|12403572|FG000|Overall Study|Withdrawal by Subject|1
7896070|NCT01907815|12403573|FG001|Overall Study|Withdrawal by Subject|0
7896071|NCT01907828|12403583|FG000|Overall Study|Exclusion criteria not met|0
7896072|NCT01907828|12403584|FG001|Overall Study|Exclusion criteria not met|1
7896073|NCT01907828|12403583|FG000|Overall Study|Withdrawal by Subject|3
7896074|NCT01907828|12403584|FG001|Overall Study|Withdrawal by Subject|4
7896075|NCT01907828|12403583|FG000|Overall Study|Lost to Follow-up|3
7896076|NCT01907828|12403584|FG001|Overall Study|Lost to Follow-up|0
7896077|NCT01907828|12403583|FG000|Overall Study|Participant refused 24-month follow-up|1
7896078|NCT01907828|12403584|FG001|Overall Study|Participant refused 24-month follow-up|0
7896079|NCT01907828|12403583|FG000|Overall Study|Participant met exclusion criteria|0
7896080|NCT01907828|12403584|FG001|Overall Study|Participant met exclusion criteria|1
7896081|NCT01907854|12403592|FG000|Overall Study|Protocol Violation|1
7896082|NCT01907854|12403593|FG001|Overall Study|Protocol Violation|1
7896083|NCT01907854|12403592|FG000|Overall Study|Withdrawal by Subject|9
7896084|NCT01907854|12403593|FG001|Overall Study|Withdrawal by Subject|7
7896085|NCT01907854|12403592|FG000|Overall Study|Lost to Follow-up|2
7896086|NCT01907854|12403593|FG001|Overall Study|Lost to Follow-up|2
7896087|NCT01907854|12403592|FG000|Overall Study|Unclassified|4
7896088|NCT01907854|12403593|FG001|Overall Study|Unclassified|3
7896089|NCT01907906|12403601|FG000|Overall Study|Withdrawal by Subject|1
7896090|NCT01907906|12403602|FG001|Overall Study|Withdrawal by Subject|0
7896091|NCT01907906|12403601|FG000|Overall Study|Physician Decision|3
7896092|NCT01907906|12403602|FG001|Overall Study|Physician Decision|1
7896093|NCT01908101|12403622|FG000|Overall Study|Physician Decision|1
7896094|NCT01908101|12403622|FG000|Overall Study|Withdrawal by Subject|1
7896095|NCT01908101|12403622|FG000|Overall Study|Incorrect Diagnosis|2
7896096|NCT01908101|12403622|FG000|Overall Study|Incorrect Starting Dose|1
7896097|NCT01908101|12403622|FG000|Overall Study|Did not complete the first cycle|4
7896098|NCT01908140|12403637|FG000|Overall Study|Other or Progressive Disease|5
7896099|NCT01908140|12403638|FG001|Overall Study|Other or Progressive Disease|12
7896100|NCT01908140|12403637|FG000|Overall Study|Lack of Efficacy|7
7896101|NCT01908140|12403638|FG001|Overall Study|Lack of Efficacy|5
7896102|NCT01908140|12403637|FG000|Overall Study|Withdrawal by Subject|23
7896103|NCT01908140|12403638|FG001|Overall Study|Withdrawal by Subject|24
7896104|NCT01908140|12403637|FG000|Overall Study|Lost to Follow-up|1
7896105|NCT01908140|12403638|FG001|Overall Study|Lost to Follow-up|6
7896106|NCT01908140|12403637|FG000|Overall Study|Protocol Violation|8
7896107|NCT01908140|12403638|FG001|Overall Study|Protocol Violation|9
7896108|NCT01908140|12403637|FG000|Overall Study|Adverse Event|22
7896109|NCT01908140|12403638|FG001|Overall Study|Adverse Event|23
7896110|NCT01908205|12403646|FG000|Overall Study|Lost to Follow-up|2
7896111|NCT01908205|12403647|FG001|Overall Study|Lost to Follow-up|0
7896112|NCT01908205|12403646|FG000|Overall Study|Withdrawal by Subject|3
7896113|NCT01908205|12403647|FG001|Overall Study|Withdrawal by Subject|1
7896114|NCT01908426|12403668|FG000|Overall Study|Adverse Event|98
7896115|NCT01908426|12403669|FG001|Overall Study|Adverse Event|11
7896116|NCT01908426|12403668|FG000|Overall Study|Clinical Deterioration|72
7896117|NCT01908426|12403669|FG001|Overall Study|Clinical Deterioration|38
7896118|NCT01908426|12403668|FG000|Overall Study|Lack of Efficacy|3
7896119|NCT01908426|12403669|FG001|Overall Study|Lack of Efficacy|0
7896120|NCT01908426|12403668|FG000|Overall Study|Lost to Follow-up|0
7896121|NCT01908426|12403669|FG001|Overall Study|Lost to Follow-up|1
7896122|NCT01908426|12403668|FG000|Overall Study|Physician Decision|3
7896123|NCT01908426|12403669|FG001|Overall Study|Physician Decision|3
7896124|NCT01908426|12403668|FG000|Overall Study|Withdrawal by Subject|11
7896125|NCT01908426|12403669|FG001|Overall Study|Withdrawal by Subject|6
7896126|NCT01908426|12403668|FG000|Overall Study|Progressive Disease|206
7896127|NCT01908426|12403669|FG001|Overall Study|Progressive Disease|152
7896128|NCT01908426|12403668|FG000|Overall Study|Protocol Violation|1
7896129|NCT01908426|12403669|FG001|Overall Study|Protocol Violation|0
7896130|NCT01908426|12403668|FG000|Overall Study|No Study Treatment Given|3
7896131|NCT01908426|12403669|FG001|Overall Study|No Study Treatment Given|0
7896132|NCT01908582|12403691|FG000|Period 2|Physician Decision|1
7896133|NCT01908582|12403691|FG000|Period 2|Withdrawal by Subject|1
7896134|NCT01908634|12403698|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1
7896135|NCT01908634|12403698|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5
7896136|NCT01908699|12403708|FG000|Overall Study|Adverse Event|8
7896137|NCT01908699|12403709|FG001|Overall Study|Adverse Event|12
7896138|NCT01908699|12403708|FG000|Overall Study|Lack of Efficacy|2
7896139|NCT01908699|12403709|FG001|Overall Study|Lack of Efficacy|2
7896140|NCT01908699|12403708|FG000|Overall Study|Lost to Follow-up|2
7896141|NCT01908699|12403709|FG001|Overall Study|Lost to Follow-up|4
7896142|NCT01908699|12403708|FG000|Overall Study|Physician Decision|8
7896143|NCT01908699|12403709|FG001|Overall Study|Physician Decision|8
7896144|NCT01908699|12403708|FG000|Overall Study|Withdrawal by Subject|15
7896145|NCT01908699|12403709|FG001|Overall Study|Withdrawal by Subject|10
7896146|NCT01908699|12403708|FG000|Overall Study|Pregnancy|0
7896147|NCT01908699|12403709|FG001|Overall Study|Pregnancy|1
7896148|NCT01908699|12403708|FG000|Overall Study|Randomized in Error|1
7896149|NCT01908699|12403709|FG001|Overall Study|Randomized in Error|0
7896150|NCT01908699|12403708|FG000|Overall Study|Death|9
7896151|NCT01908699|12403709|FG001|Overall Study|Death|12
7896152|NCT01908699|12403708|FG000|Overall Study|Progressive Disease|30
7896153|NCT01908699|12403709|FG001|Overall Study|Progressive Disease|29
7896154|NCT01908803|12403734|FG000|Overall Study|Adverse Event|1
7896155|NCT01908803|12403735|FG001|Overall Study|Adverse Event|0
7896156|NCT01908803|12403734|FG000|Overall Study|Physician Decision|0
7896157|NCT01908803|12403735|FG001|Overall Study|Physician Decision|1
7896158|NCT01908803|12403734|FG000|Overall Study|Withdrawal by Subject|1
7896159|NCT01908803|12403735|FG001|Overall Study|Withdrawal by Subject|0
7896160|NCT01908803|12403734|FG000|Overall Study|Randomization Error|1
7896161|NCT01908803|12403735|FG001|Overall Study|Randomization Error|0
7896162|NCT01908803|12403734|FG000|Overall Study|Adverse Event (pre-treatment)|1
7896163|NCT01908803|12403735|FG001|Overall Study|Adverse Event (pre-treatment)|0
7896164|NCT01908816|12403746|FG000|Overall Study|Subject's no longer requires study drug|0
7896165|NCT01908816|12403747|FG001|Overall Study|Subject's no longer requires study drug|0
7896166|NCT01908816|12403748|FG002|Overall Study|Subject's no longer requires study drug|0
7896167|NCT01908816|12403749|FG003|Overall Study|Subject's no longer requires study drug|1
7896168|NCT01908816|12403746|FG000|Overall Study|Protocol deviation|1
7896169|NCT01908816|12403747|FG001|Overall Study|Protocol deviation|2
7896170|NCT01908816|12403748|FG002|Overall Study|Protocol deviation|1
7896171|NCT01908816|12403749|FG003|Overall Study|Protocol deviation|1
7896172|NCT01908816|12403746|FG000|Overall Study|Withdrawal by Subject|0
7896173|NCT01908816|12403747|FG001|Overall Study|Withdrawal by Subject|4
7896174|NCT01908816|12403748|FG002|Overall Study|Withdrawal by Subject|2
7896175|NCT01908816|12403749|FG003|Overall Study|Withdrawal by Subject|2
7896176|NCT01908816|12403746|FG000|Overall Study|Lost to Follow-up|3
7896177|NCT01908816|12403747|FG001|Overall Study|Lost to Follow-up|5
7896178|NCT01908816|12403748|FG002|Overall Study|Lost to Follow-up|4
7896179|NCT01908816|12403749|FG003|Overall Study|Lost to Follow-up|2
7896180|NCT01908816|12403746|FG000|Overall Study|Death|1
7896181|NCT01908816|12403747|FG001|Overall Study|Death|0
7896182|NCT01908816|12403748|FG002|Overall Study|Death|7
7896183|NCT01908816|12403749|FG003|Overall Study|Death|1
7896184|NCT01908816|12403746|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7896185|NCT01908816|12403747|FG001|Overall Study|Unsatisfactory therapeutic effect|13
7896186|NCT01908816|12403748|FG002|Overall Study|Unsatisfactory therapeutic effect|1
7896187|NCT01908816|12403749|FG003|Overall Study|Unsatisfactory therapeutic effect|0
7896188|NCT01908816|12403746|FG000|Overall Study|Early termination|87
7896189|NCT01908816|12403747|FG001|Overall Study|Early termination|60
7896190|NCT01908816|12403748|FG002|Overall Study|Early termination|43
7896191|NCT01908816|12403749|FG003|Overall Study|Early termination|28
7896192|NCT01908829|12403765|FG000|Overall Study|Adverse Event|13
7896193|NCT01908829|12403766|FG001|Overall Study|Adverse Event|11
7896194|NCT01908829|12403767|FG002|Overall Study|Adverse Event|13
7896195|NCT01908829|12403765|FG000|Overall Study|Lost to Follow-up|4
7896196|NCT01908829|12403766|FG001|Overall Study|Lost to Follow-up|2
7896197|NCT01908829|12403767|FG002|Overall Study|Lost to Follow-up|1
7896198|NCT01908829|12403765|FG000|Overall Study|Randomized no double-blind drug received|1
7896199|NCT01908829|12403766|FG001|Overall Study|Randomized no double-blind drug received|0
7896200|NCT01908829|12403767|FG002|Overall Study|Randomized no double-blind drug received|1
7896201|NCT01908829|12403765|FG000|Overall Study|Discontinued (no EoT page)|2
7896202|NCT01908829|12403766|FG001|Overall Study|Discontinued (no EoT page)|0
7896203|NCT01908829|12403767|FG002|Overall Study|Discontinued (no EoT page)|0
7896204|NCT01908829|12403765|FG000|Overall Study|Miscellaneous|0
7896205|NCT01908829|12403766|FG001|Overall Study|Miscellaneous|2
7896206|NCT01908829|12403767|FG002|Overall Study|Miscellaneous|0
7896207|NCT01908829|12403765|FG000|Overall Study|Protocol Violation|2
7896208|NCT01908829|12403766|FG001|Overall Study|Protocol Violation|2
7896209|NCT01908829|12403767|FG002|Overall Study|Protocol Violation|0
7896210|NCT01908829|12403765|FG000|Overall Study|Lack of Efficacy|1
7896211|NCT01908829|12403766|FG001|Overall Study|Lack of Efficacy|3
7896212|NCT01908829|12403767|FG002|Overall Study|Lack of Efficacy|2
7896213|NCT01908829|12403765|FG000|Overall Study|Withdrawal by Subject|26
7896214|NCT01908829|12403766|FG001|Overall Study|Withdrawal by Subject|29
7896215|NCT01908829|12403767|FG002|Overall Study|Withdrawal by Subject|22
7896216|NCT01908907|12403786|FG000|Overall Study|Physician Decision|1
7896217|NCT01908907|12403787|FG001|Overall Study|Physician Decision|0
7896218|NCT01908907|12403786|FG000|Overall Study|Protocol Violation|1
7896219|NCT01908907|12403787|FG001|Overall Study|Protocol Violation|0
7896220|NCT01909336|12403839|FG000|Overall Study|Lost to Follow-up|4
7896221|NCT01909336|12403840|FG001|Overall Study|Lost to Follow-up|2
7896222|NCT01909336|12403841|FG002|Overall Study|Lost to Follow-up|2
7896223|NCT01909336|12403839|FG000|Overall Study|Physician Decision|0
7896224|NCT01909336|12403840|FG001|Overall Study|Physician Decision|1
7896225|NCT01909336|12403841|FG002|Overall Study|Physician Decision|1
7896226|NCT01909466|12403849|FG000|Overall Study|Lost to Follow-up|5
7896227|NCT01909466|12403850|FG001|Overall Study|Lost to Follow-up|7
7896228|NCT01909466|12403849|FG000|Overall Study|Adverse Event|3
7896229|NCT01909466|12403850|FG001|Overall Study|Adverse Event|4
7896230|NCT01909466|12403849|FG000|Overall Study|Met Withdrawal Criteria|0
7896231|NCT01909466|12403850|FG001|Overall Study|Met Withdrawal Criteria|3
7896232|NCT01909466|12403849|FG000|Overall Study|Physician Decision|2
7896233|NCT01909466|12403850|FG001|Overall Study|Physician Decision|0
7896234|NCT01909466|12403849|FG000|Overall Study|Withdrawal by Subject|11
7896235|NCT01909466|12403850|FG001|Overall Study|Withdrawal by Subject|9
7896236|NCT01909466|12403849|FG000|Overall Study|Lack of Efficacy|1
7896237|NCT01909466|12403850|FG001|Overall Study|Lack of Efficacy|0
7896238|NCT01909674|12403856|FG000|Overall Study|Withdrawal by Subject|5
7896239|NCT01909674|12403857|FG001|Overall Study|Withdrawal by Subject|2
7896240|NCT01909778|12403863|FG000|Overall Study|failed screening|1
7896241|NCT01909791|12403872|FG000|Overall Study|Death|9
7896242|NCT01909791|12403873|FG001|Overall Study|Death|8
7896243|NCT01909791|12403874|FG002|Overall Study|Death|4
7896244|NCT01909791|12403872|FG000|Overall Study|Withdrawal by Subject|5
7896245|NCT01909791|12403873|FG001|Overall Study|Withdrawal by Subject|9
7896246|NCT01909791|12403874|FG002|Overall Study|Withdrawal by Subject|13
7896247|NCT01909791|12403872|FG000|Overall Study|Lost to Follow-up|5
7896248|NCT01909791|12403873|FG001|Overall Study|Lost to Follow-up|11
7896249|NCT01909791|12403874|FG002|Overall Study|Lost to Follow-up|10
7896250|NCT01909791|12403872|FG000|Overall Study|Missed Visit|2
7896251|NCT01909791|12403873|FG001|Overall Study|Missed Visit|0
7896252|NCT01909791|12403874|FG002|Overall Study|Missed Visit|1
7896253|NCT01909804|12403899|FG000|Overall Study|Randomized but Never Treated|0
7896254|NCT01909804|12403900|FG001|Overall Study|Randomized but Never Treated|0
7896255|NCT01909804|12403901|FG002|Overall Study|Randomized but Never Treated|0
7896256|NCT01909804|12403902|FG003|Overall Study|Randomized but Never Treated|0
7896257|NCT01909804|12403903|FG004|Overall Study|Randomized but Never Treated|0
7896258|NCT01909804|12403904|FG005|Overall Study|Randomized but Never Treated|0
7896259|NCT01909804|12403905|FG006|Overall Study|Randomized but Never Treated|1
7896260|NCT01909804|12403906|FG007|Overall Study|Randomized but Never Treated|0
7896261|NCT01909804|12403907|FG008|Overall Study|Randomized but Never Treated|0
7896262|NCT01909804|12403908|FG009|Overall Study|Randomized but Never Treated|0
7896263|NCT01909804|12403909|FG010|Overall Study|Randomized but Never Treated|0
7896264|NCT01909804|12403910|FG011|Overall Study|Randomized but Never Treated|1
7896265|NCT01909804|12403899|FG000|Overall Study|Death|0
7896266|NCT01909804|12403900|FG001|Overall Study|Death|0
7896267|NCT01909804|12403901|FG002|Overall Study|Death|0
7896268|NCT01909804|12403902|FG003|Overall Study|Death|0
7896269|NCT01909804|12403903|FG004|Overall Study|Death|0
7896270|NCT01909804|12403904|FG005|Overall Study|Death|0
7896271|NCT01909804|12403905|FG006|Overall Study|Death|0
7896272|NCT01909804|12403906|FG007|Overall Study|Death|0
7896273|NCT01909804|12403907|FG008|Overall Study|Death|0
7896274|NCT01909804|12403908|FG009|Overall Study|Death|0
7896275|NCT01909804|12403909|FG010|Overall Study|Death|1
7896276|NCT01909804|12403910|FG011|Overall Study|Death|0
7896277|NCT01909804|12403899|FG000|Overall Study|Lack of Efficacy|4
7896278|NCT01909804|12403900|FG001|Overall Study|Lack of Efficacy|1
7896279|NCT01909804|12403901|FG002|Overall Study|Lack of Efficacy|0
7896280|NCT01909804|12403902|FG003|Overall Study|Lack of Efficacy|0
7896281|NCT01909804|12403903|FG004|Overall Study|Lack of Efficacy|7
7896282|NCT01909804|12403904|FG005|Overall Study|Lack of Efficacy|3
7896283|NCT01909804|12403905|FG006|Overall Study|Lack of Efficacy|1
7896284|NCT01909804|12403906|FG007|Overall Study|Lack of Efficacy|1
7896285|NCT01909804|12403907|FG008|Overall Study|Lack of Efficacy|0
7896286|NCT01909804|12403908|FG009|Overall Study|Lack of Efficacy|1
7896287|NCT01909804|12403909|FG010|Overall Study|Lack of Efficacy|0
7896288|NCT01909804|12403910|FG011|Overall Study|Lack of Efficacy|1
7896289|NCT01909804|12403899|FG000|Overall Study|Withdrew Consent|0
7896290|NCT01909804|12403900|FG001|Overall Study|Withdrew Consent|0
7896291|NCT01909804|12403901|FG002|Overall Study|Withdrew Consent|0
7896292|NCT01909804|12403902|FG003|Overall Study|Withdrew Consent|0
7896293|NCT01909804|12403903|FG004|Overall Study|Withdrew Consent|1
7896294|NCT01909804|12403904|FG005|Overall Study|Withdrew Consent|1
7896295|NCT01909804|12403905|FG006|Overall Study|Withdrew Consent|0
7896296|NCT01909804|12403906|FG007|Overall Study|Withdrew Consent|0
7896297|NCT01909804|12403907|FG008|Overall Study|Withdrew Consent|0
7896298|NCT01909804|12403908|FG009|Overall Study|Withdrew Consent|0
7896299|NCT01909804|12403909|FG010|Overall Study|Withdrew Consent|0
7896300|NCT01909804|12403910|FG011|Overall Study|Withdrew Consent|0
7896301|NCT01909804|12403899|FG000|Overall Study|Protocol Violation|0
7896302|NCT01909804|12403900|FG001|Overall Study|Protocol Violation|0
7896303|NCT01909804|12403901|FG002|Overall Study|Protocol Violation|0
7896304|NCT01909804|12403902|FG003|Overall Study|Protocol Violation|0
7896305|NCT01909804|12403903|FG004|Overall Study|Protocol Violation|0
7896306|NCT01909804|12403904|FG005|Overall Study|Protocol Violation|0
7896307|NCT01909804|12403905|FG006|Overall Study|Protocol Violation|0
7896308|NCT01909804|12403906|FG007|Overall Study|Protocol Violation|0
7896309|NCT01909804|12403907|FG008|Overall Study|Protocol Violation|0
7896310|NCT01909804|12403908|FG009|Overall Study|Protocol Violation|0
7896311|NCT01909804|12403909|FG010|Overall Study|Protocol Violation|0
7896312|NCT01909804|12403910|FG011|Overall Study|Protocol Violation|1
7896313|NCT01909973|12403934|FG000|Overall Study|Lost to Follow-up|1
7896314|NCT01909973|12403935|FG001|Overall Study|Lost to Follow-up|0
7963429|NCT02721966|12517833|FG000|Overall Study|Physician Decision|1
7963430|NCT02721966|12517834|FG001|Overall Study|Physician Decision|1
7963431|NCT02721966|12517835|FG002|Overall Study|Physician Decision|0
7963432|NCT02721966|12517836|FG003|Overall Study|Physician Decision|0
7963433|NCT02721966|12517837|FG004|Overall Study|Physician Decision|0
7963434|NCT02721966|12517833|FG000|Overall Study|Pregnancy|1
7963435|NCT02721966|12517834|FG001|Overall Study|Pregnancy|0
7963436|NCT02721966|12517835|FG002|Overall Study|Pregnancy|0
7963437|NCT02721966|12517836|FG003|Overall Study|Pregnancy|0
7963438|NCT02721966|12517837|FG004|Overall Study|Pregnancy|0
7963439|NCT02721966|12517833|FG000|Overall Study|Did not continue to period 2|5
7963440|NCT02721966|12517834|FG001|Overall Study|Did not continue to period 2|12
7963441|NCT02721966|12517835|FG002|Overall Study|Did not continue to period 2|0
7963442|NCT02721966|12517836|FG003|Overall Study|Did not continue to period 2|0
7963443|NCT02721966|12517837|FG004|Overall Study|Did not continue to period 2|5
7963444|NCT02722044|12517845|FG000|Overall Study|Adverse Event|2
7963445|NCT02722044|12517845|FG000|Overall Study|Physician Decision|1
7963446|NCT02722044|12517845|FG000|Overall Study|Withdrawal by Subject|1
7963447|NCT02722044|12517845|FG000|Overall Study|Did Not Meet Criteria at Week 14|1
7963448|NCT02722148|12517850|FG000|Overall Study|Lost to Follow-up|2
7963449|NCT02722148|12517850|FG000|Overall Study|Non compliant with treatment regimen|3
7963450|NCT02722278|12517866|FG000|Overall Study|Withdrawal by Subject|5
7963451|NCT02722278|12517867|FG001|Overall Study|Withdrawal by Subject|3
7963452|NCT02722278|12517866|FG000|Overall Study|Adverse Event|4
7963453|NCT02722278|12517867|FG001|Overall Study|Adverse Event|1
7963454|NCT02722278|12517866|FG000|Overall Study|Lost to Follow-up|2
7963455|NCT02722278|12517867|FG001|Overall Study|Lost to Follow-up|0
7963456|NCT02722278|12517866|FG000|Overall Study|Protocol Violation|1
7963457|NCT02722278|12517867|FG001|Overall Study|Protocol Violation|0
7963458|NCT02722278|12517866|FG000|Overall Study|High PSA pre-study/ not eligible|0
7963459|NCT02722278|12517867|FG001|Overall Study|High PSA pre-study/ not eligible|1
7963460|NCT02722278|12517866|FG000|Overall Study|Subject declined after tx assignment|0
7963461|NCT02722278|12517867|FG001|Overall Study|Subject declined after tx assignment|1
7963462|NCT02722278|12517866|FG000|Overall Study|Site closure not study related|0
7963463|NCT02722278|12517867|FG001|Overall Study|Site closure not study related|1
7963464|NCT02722304|12517880|FG000|Overall Study|Study Terminated by Sponsor|1
7963465|NCT02722304|12517881|FG001|Overall Study|Study Terminated by Sponsor|0
7963466|NCT02722304|12517882|FG002|Overall Study|Study Terminated by Sponsor|2
7963467|NCT02722304|12517883|FG003|Overall Study|Study Terminated by Sponsor|1
7963468|NCT02722304|12517884|FG004|Overall Study|Study Terminated by Sponsor|1
7963469|NCT02722304|12517880|FG000|Overall Study|Other|0
7963470|NCT02722304|12517881|FG001|Overall Study|Other|0
7963471|NCT02722304|12517882|FG002|Overall Study|Other|0
7963472|NCT02722304|12517883|FG003|Overall Study|Other|1
7963473|NCT02722304|12517884|FG004|Overall Study|Other|1
7963474|NCT02722499|12517911|FG000|Overall Study|Lost to Follow-up|2
7963475|NCT02722499|12517912|FG001|Overall Study|Lost to Follow-up|0
7963476|NCT02722499|12517913|FG002|Overall Study|Lost to Follow-up|1
7963477|NCT02722928|12517940|FG000|Overall Study|Standard CT was not as required per prot|5
7963478|NCT02722928|12517941|FG001|Overall Study|Standard CT was not as required per prot|13
7963479|NCT02722928|12517940|FG000|Overall Study|Required Intraoperative MRI|5
7963480|NCT02722928|12517941|FG001|Overall Study|Required Intraoperative MRI|7
7963481|NCT02722967|12517954|FG000|Overall Study|Adverse Event|1
7963482|NCT02722967|12517955|FG001|Overall Study|Adverse Event|0
7963483|NCT02722967|12517956|FG002|Overall Study|Adverse Event|0
7963484|NCT02722967|12517954|FG000|Overall Study|Lost to Follow-up|0
7963485|NCT02722967|12517955|FG001|Overall Study|Lost to Follow-up|1
7963486|NCT02722967|12517956|FG002|Overall Study|Lost to Follow-up|0
7963487|NCT02722967|12517954|FG000|Overall Study|Non-compliance with patch wearing|2
7963488|NCT02722967|12517955|FG001|Overall Study|Non-compliance with patch wearing|1
7963489|NCT02722967|12517956|FG002|Overall Study|Non-compliance with patch wearing|1
7963490|NCT02722967|12517954|FG000|Overall Study|Withdrawal by Subject|1
7963491|NCT02722967|12517955|FG001|Overall Study|Withdrawal by Subject|0
7963492|NCT02722967|12517956|FG002|Overall Study|Withdrawal by Subject|1
7963493|NCT02722967|12517954|FG000|Overall Study|Physician Decision|1
7963494|NCT02722967|12517955|FG001|Overall Study|Physician Decision|0
7963495|NCT02722967|12517956|FG002|Overall Study|Physician Decision|0
7963496|NCT02722967|12517954|FG000|Overall Study|Non-adherence of the patch to the skin|0
7963497|NCT02722967|12517955|FG001|Overall Study|Non-adherence of the patch to the skin|0
7963498|NCT02722967|12517956|FG002|Overall Study|Non-adherence of the patch to the skin|2
7963499|NCT02723006|12517967|FG000|Overall Study|Withdrawal by Subject|0
7963500|NCT02723006|12517968|FG001|Overall Study|Withdrawal by Subject|1
7963501|NCT02723006|12517969|FG002|Overall Study|Withdrawal by Subject|1
7963502|NCT02723006|12517967|FG000|Overall Study|Study Terminated by Sponsor|1
7963503|NCT02723006|12517968|FG001|Overall Study|Study Terminated by Sponsor|6
7963504|NCT02723006|12517969|FG002|Overall Study|Study Terminated by Sponsor|6
7963505|NCT02723084|12517979|FG000|Overall Study|Withdrawal by Subject|1
7896315|NCT01910116|12403947|FG000|Overall Study|Adverse Event|0
7896316|NCT01910116|12403948|FG001|Overall Study|Adverse Event|3
7896317|NCT01910116|12403947|FG000|Overall Study|Lack of Efficacy|3
7896318|NCT01910116|12403948|FG001|Overall Study|Lack of Efficacy|4
7896319|NCT01910116|12403947|FG000|Overall Study|Lost to Follow-up|1
7896320|NCT01910116|12403948|FG001|Overall Study|Lost to Follow-up|0
7896321|NCT01910116|12403947|FG000|Overall Study|Protocol Violation|1
7896322|NCT01910116|12403948|FG001|Overall Study|Protocol Violation|2
7896323|NCT01910116|12403947|FG000|Overall Study|Withdrawal by Subject|8
7896324|NCT01910116|12403948|FG001|Overall Study|Withdrawal by Subject|3
7896325|NCT01910116|12403947|FG000|Overall Study|uncertain allocation|1
7896326|NCT01910116|12403948|FG001|Overall Study|uncertain allocation|3
7896327|NCT01910116|12403947|FG000|Overall Study|incomplete data|0
7896328|NCT01910116|12403948|FG001|Overall Study|incomplete data|1
7896329|NCT01910129|12403956|FG000|Randomized Phase 2|Withdrawal by Subject|2
7896330|NCT01910129|12403957|FG001|Randomized Phase 2|Withdrawal by Subject|1
7896331|NCT01910129|12403958|FG002|Randomized Phase 2|Withdrawal by Subject|0
7896332|NCT01910129|12403956|FG000|Randomized Phase 3|Withdrawal by Subject|0
7896333|NCT01910129|12403957|FG001|Randomized Phase 3|Withdrawal by Subject|1
7896334|NCT01910129|12403958|FG002|Randomized Phase 3|Withdrawal by Subject|0
7896335|NCT01910181|12403976|FG000|Overall Study|Death|37
7896336|NCT01910181|12403976|FG000|Overall Study|Lost to Follow-up|3
7896337|NCT01910181|12403976|FG000|Overall Study|Study Terminated by Sponsor|6
7896338|NCT01910298|12403983|FG000|Overall Study|Adverse Event|1
7896339|NCT01910298|12403984|FG001|Overall Study|Adverse Event|0
7896340|NCT01910298|12403983|FG000|Overall Study|Withdrawal by Subject|2
7896341|NCT01910298|12403984|FG001|Overall Study|Withdrawal by Subject|7
7896342|NCT01910298|12403983|FG000|Overall Study|Protocol Deviation|0
7896343|NCT01910298|12403984|FG001|Overall Study|Protocol Deviation|5
7896344|NCT01910298|12403983|FG000|Overall Study|Lost to Follow-up|1
7896345|NCT01910298|12403984|FG001|Overall Study|Lost to Follow-up|1
7896346|NCT01910298|12403983|FG000|Overall Study|Study Terminated by Sponsor|1
7896347|NCT01910298|12403984|FG001|Overall Study|Study Terminated by Sponsor|17
7896348|NCT01910298|12403983|FG000|Overall Study|Other Miscellaneous Reasons|0
7896349|NCT01910298|12403984|FG001|Overall Study|Other Miscellaneous Reasons|2
7896350|NCT01910519|12404000|FG000|Overall Study|Withdrawal by Subject|2
7896351|NCT01910519|12404001|FG001|Overall Study|Withdrawal by Subject|0
7896352|NCT01910519|12404000|FG000|Overall Study|Adverse Event|2
7896353|NCT01910519|12404001|FG001|Overall Study|Adverse Event|0
7896354|NCT01911260|12404060|FG000|Supplementation Period|transference or evasion of school|7
7896355|NCT01911260|12404061|FG001|Supplementation Period|transference or evasion of school|9
7896356|NCT01911260|12404062|FG002|Supplementation Period|transference or evasion of school|7
7896357|NCT01911260|12404063|FG003|Supplementation Period|transference or evasion of school|6
7896358|NCT01911260|12404060|FG000|Supplementation Period|Adverse Event|2
7896359|NCT01911260|12404061|FG001|Supplementation Period|Adverse Event|0
7896360|NCT01911260|12404062|FG002|Supplementation Period|Adverse Event|1
7896361|NCT01911260|12404063|FG003|Supplementation Period|Adverse Event|0
7896362|NCT01911260|12404060|FG000|Supplementation Period|refused to receive supplement|1
7896363|NCT01911260|12404061|FG001|Supplementation Period|refused to receive supplement|0
7896364|NCT01911260|12404062|FG002|Supplementation Period|refused to receive supplement|1
7896365|NCT01911260|12404063|FG003|Supplementation Period|refused to receive supplement|0
7896366|NCT01911260|12404060|FG000|Supplementation Period|less than 12 weeks supplementation|0
7896367|NCT01911260|12404061|FG001|Supplementation Period|less than 12 weeks supplementation|3
7896368|NCT01911260|12404062|FG002|Supplementation Period|less than 12 weeks supplementation|1
7896369|NCT01911260|12404063|FG003|Supplementation Period|less than 12 weeks supplementation|2
7896370|NCT01911260|12404060|FG000|Follow-up Period|transference or evasion of school|13
7896371|NCT01911260|12404061|FG001|Follow-up Period|transference or evasion of school|20
7896372|NCT01911260|12404062|FG002|Follow-up Period|transference or evasion of school|15
7896373|NCT01911260|12404063|FG003|Follow-up Period|transference or evasion of school|12
7896374|NCT01911273|12404075|FG000|Overall Study|Progression of Disease|1
7896375|NCT01911273|12404076|FG001|Overall Study|Progression of Disease|0
7896376|NCT01911273|12404075|FG000|Overall Study|Withdrawal by Subject|0
7896377|NCT01911273|12404076|FG001|Overall Study|Withdrawal by Subject|2
7896378|NCT01911429|12404120|FG000|Overall Study|Adverse Event|5
7896379|NCT01911429|12404121|FG001|Overall Study|Adverse Event|3
7896380|NCT01911429|12404122|FG002|Overall Study|Adverse Event|9
7896381|NCT01911429|12404120|FG000|Overall Study|Lack of Efficacy|1
7896382|NCT01911429|12404121|FG001|Overall Study|Lack of Efficacy|2
7896383|NCT01911429|12404122|FG002|Overall Study|Lack of Efficacy|4
7896384|NCT01911429|12404120|FG000|Overall Study|Lost to Follow-up|0
7896385|NCT01911429|12404121|FG001|Overall Study|Lost to Follow-up|0
7896386|NCT01911429|12404122|FG002|Overall Study|Lost to Follow-up|1
7896387|NCT01911429|12404120|FG000|Overall Study|Protocol Violation|0
7896388|NCT01911429|12404121|FG001|Overall Study|Protocol Violation|0
7896389|NCT01911429|12404122|FG002|Overall Study|Protocol Violation|1
7896390|NCT01911429|12404120|FG000|Overall Study|Withdrawal by Subject|5
7896391|NCT01911429|12404121|FG001|Overall Study|Withdrawal by Subject|5
7896392|NCT01911429|12404122|FG002|Overall Study|Withdrawal by Subject|4
7896393|NCT01911429|12404120|FG000|Overall Study|Accidental randomization|0
7896394|NCT01911429|12404121|FG001|Overall Study|Accidental randomization|0
7896395|NCT01911429|12404122|FG002|Overall Study|Accidental randomization|1
7896396|NCT01911429|12404120|FG000|Overall Study|subject left study|1
7896397|NCT01911429|12404121|FG001|Overall Study|subject left study|0
7896398|NCT01911429|12404122|FG002|Overall Study|subject left study|0
7896399|NCT01911442|12404133|FG000|Overall Study|Adverse Event|2
7896400|NCT01911442|12404134|FG001|Overall Study|Adverse Event|2
7896401|NCT01911442|12404135|FG002|Overall Study|Adverse Event|4
7896402|NCT01911442|12404133|FG000|Overall Study|Lack of Efficacy|1
7896403|NCT01911442|12404134|FG001|Overall Study|Lack of Efficacy|1
7896404|NCT01911442|12404135|FG002|Overall Study|Lack of Efficacy|1
7896405|NCT01911442|12404133|FG000|Overall Study|Lost to Follow-up|2
7896406|NCT01911442|12404134|FG001|Overall Study|Lost to Follow-up|0
7896407|NCT01911442|12404135|FG002|Overall Study|Lost to Follow-up|1
7896408|NCT01911442|12404133|FG000|Overall Study|Withdrawal by Subject|1
7896409|NCT01911442|12404134|FG001|Overall Study|Withdrawal by Subject|0
7896410|NCT01911442|12404135|FG002|Overall Study|Withdrawal by Subject|6
7896411|NCT01911442|12404133|FG000|Overall Study|Mother's Work Schedule|0
7896412|NCT01911442|12404134|FG001|Overall Study|Mother's Work Schedule|1
7896413|NCT01911442|12404135|FG002|Overall Study|Mother's Work Schedule|0
7896414|NCT01911546|12404147|FG000|Overall Study|Lost to Follow-up|1
7896415|NCT01911546|12404147|FG000|Overall Study|Everolimus was discontinued|5
7896416|NCT01911780|12404169|FG000|Double-blind Period (8 Weeks)|Adverse Event|1
7896417|NCT01911780|12404170|FG001|Double-blind Period (8 Weeks)|Adverse Event|2
7896418|NCT01911780|12404169|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
7896419|NCT01911780|12404170|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
7896420|NCT01911780|12404169|FG000|Double-blind Period (8 Weeks)|Personal reason|1
7896421|NCT01911780|12404170|FG001|Double-blind Period (8 Weeks)|Personal reason|0
7896422|NCT01911780|12404169|FG000|Extension Period (52 Weeks)|Adverse Event|3
7896423|NCT01911780|12404170|FG001|Extension Period (52 Weeks)|Adverse Event|0
7896424|NCT01911780|12404169|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
7896425|NCT01911780|12404170|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
7896426|NCT01911780|12404169|FG000|Extension Period (52 Weeks)|Personal reason|1
7896427|NCT01911780|12404170|FG001|Extension Period (52 Weeks)|Personal reason|1
7896428|NCT01911819|12404183|FG000|Overall Study|Adverse Event|0
7896429|NCT01911819|12404184|FG001|Overall Study|Adverse Event|1
7896430|NCT01911819|12404185|FG002|Overall Study|Adverse Event|0
7896431|NCT01911819|12404183|FG000|Overall Study|Withdrawal by Subject|1
7896432|NCT01911819|12404184|FG001|Overall Study|Withdrawal by Subject|1
7896433|NCT01911819|12404185|FG002|Overall Study|Withdrawal by Subject|0
7896434|NCT01911845|12404193|FG000|Overall Study|Adverse Event|2
7896435|NCT01911845|12404193|FG000|Overall Study|Lost to Follow-up|1
7896436|NCT01911845|12404193|FG000|Overall Study|Other (not specified)|3
7896437|NCT01912222|12404211|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
7896438|NCT01912222|12404212|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
7896439|NCT01912222|12404213|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
7896440|NCT01912222|12404211|FG000|Part B: Treatment Period|Progressive disease|10
7896441|NCT01912222|12404212|FG001|Part B: Treatment Period|Progressive disease|12
7896442|NCT01912222|12404213|FG002|Part B: Treatment Period|Progressive disease|15
7896443|NCT01912222|12404211|FG000|Part B: Treatment Period|Adverse Event|1
7896444|NCT01912222|12404212|FG001|Part B: Treatment Period|Adverse Event|2
7896445|NCT01912222|12404213|FG002|Part B: Treatment Period|Adverse Event|3
7896446|NCT01912222|12404211|FG000|Part B: Treatment Period|Withdrawal by Subject|2
7896447|NCT01912222|12404212|FG001|Part B: Treatment Period|Withdrawal by Subject|1
7896448|NCT01912222|12404213|FG002|Part B: Treatment Period|Withdrawal by Subject|2
7896449|NCT01912287|12404229|FG000|Overall Study|Ineligible|1
7896450|NCT01912287|12404230|FG001|Overall Study|Ineligible|0
7896451|NCT01912287|12404231|FG002|Overall Study|Ineligible|1
7896452|NCT01912287|12404229|FG000|Overall Study|No-show|0
7896453|NCT01912287|12404230|FG001|Overall Study|No-show|0
7896454|NCT01912287|12404231|FG002|Overall Study|No-show|1
7896455|NCT01912287|12404229|FG000|Overall Study|Dissatisfaction with assigned treatment|4
7896456|NCT01912287|12404230|FG001|Overall Study|Dissatisfaction with assigned treatment|2
7896457|NCT01912287|12404231|FG002|Overall Study|Dissatisfaction with assigned treatment|1
7896458|NCT01912287|12404229|FG000|Overall Study|Felt treatment no longer needed|0
7896459|NCT01912287|12404230|FG001|Overall Study|Felt treatment no longer needed|1
7896460|NCT01912287|12404231|FG002|Overall Study|Felt treatment no longer needed|0
7896461|NCT01912287|12404229|FG000|Overall Study|Life circumstances|4
7896462|NCT01912287|12404230|FG001|Overall Study|Life circumstances|2
7896463|NCT01912287|12404231|FG002|Overall Study|Life circumstances|0
7896464|NCT01912287|12404229|FG000|Overall Study|Lost Interest|1
7896465|NCT01912287|12404230|FG001|Overall Study|Lost Interest|0
7896466|NCT01912287|12404231|FG002|Overall Study|Lost Interest|0
7896467|NCT01912287|12404229|FG000|Overall Study|Uknown reason - subject drop out|5
7896468|NCT01912287|12404230|FG001|Overall Study|Uknown reason - subject drop out|7
7896469|NCT01912287|12404231|FG002|Overall Study|Uknown reason - subject drop out|3
7896470|NCT01912287|12404229|FG000|Overall Study|Missed Assesment|1
7896471|NCT01912287|12404230|FG001|Overall Study|Missed Assesment|1
7896472|NCT01912287|12404231|FG002|Overall Study|Missed Assesment|1
7896473|NCT01912287|12404229|FG000|Overall Study|Scheduling/change in availability|17
7896474|NCT01912287|12404230|FG001|Overall Study|Scheduling/change in availability|10
7896475|NCT01912287|12404231|FG002|Overall Study|Scheduling/change in availability|8
7896476|NCT01912339|12404241|FG000|Blinded (0 to 3 Months)|Declined to participate|1
7896477|NCT01912339|12404242|FG001|Blinded (0 to 3 Months)|Declined to participate|0
7896478|NCT01912339|12404243|FG002|Blinded (0 to 3 Months)|Declined to participate|0
7896479|NCT01912339|12404241|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1
7896480|NCT01912339|12404242|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0
7896481|NCT01912339|12404243|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0
7896482|NCT01912339|12404241|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
7896483|NCT01912339|12404242|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
7896484|NCT01912339|12404243|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
7896485|NCT01912339|12404241|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
7896486|NCT01912339|12404242|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
7896487|NCT01912339|12404243|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
7896488|NCT01912339|12404241|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
7896489|NCT01912339|12404242|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
7896490|NCT01912339|12404243|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
7896491|NCT01912339|12404241|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
7896492|NCT01912339|12404242|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
7896493|NCT01912339|12404243|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
7896494|NCT01912339|12404241|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
7896495|NCT01912339|12404242|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
7896496|NCT01912339|12404243|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
7896497|NCT01912339|12404241|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
7896498|NCT01912339|12404242|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
7896499|NCT01912339|12404243|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
7896500|NCT01912339|12404241|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
7896501|NCT01912339|12404242|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
7896502|NCT01912339|12404243|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
7896503|NCT01912339|12404241|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
7896504|NCT01912339|12404242|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
7896505|NCT01912339|12404243|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
7896506|NCT01912339|12404241|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
7896507|NCT01912339|12404242|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
7896508|NCT01912339|12404243|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
7896509|NCT01912339|12404241|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
7896510|NCT01912339|12404242|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
7896511|NCT01912339|12404243|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
7896512|NCT01912339|12404241|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
7896513|NCT01912339|12404242|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
7896514|NCT01912339|12404243|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
7896515|NCT01912456|12404255|FG000|Period 1|Physician Decision|0
7896516|NCT01912456|12404256|FG001|Period 1|Physician Decision|0
7896517|NCT01912456|12404257|FG002|Period 1|Physician Decision|1
7896518|NCT01912456|12404258|FG003|Period 1|Physician Decision|0
7896519|NCT01912456|12404255|FG000|Period 1|non-compliance|1
7896520|NCT01912456|12404256|FG001|Period 1|non-compliance|0
7896521|NCT01912456|12404257|FG002|Period 1|non-compliance|0
7896522|NCT01912456|12404258|FG003|Period 1|non-compliance|1
7896523|NCT01912456|12404255|FG000|Period 1|Adverse Event|1
7896524|NCT01912456|12404256|FG001|Period 1|Adverse Event|0
7896525|NCT01912456|12404257|FG002|Period 1|Adverse Event|0
7896526|NCT01912456|12404258|FG003|Period 1|Adverse Event|1
7896527|NCT01912456|12404255|FG000|Period 1|Withdrawal by Subject|0
7896528|NCT01912456|12404256|FG001|Period 1|Withdrawal by Subject|1
7896529|NCT01912456|12404257|FG002|Period 1|Withdrawal by Subject|1
7896530|NCT01912456|12404258|FG003|Period 1|Withdrawal by Subject|1
7896531|NCT01912456|12404255|FG000|Period 2|Lack of Efficacy|0
7896532|NCT01912456|12404256|FG001|Period 2|Lack of Efficacy|2
7896533|NCT01912456|12404257|FG002|Period 2|Lack of Efficacy|0
7896534|NCT01912456|12404258|FG003|Period 2|Lack of Efficacy|0
7896535|NCT01912456|12404255|FG000|Period 2|Adverse Event|0
7896536|NCT01912456|12404256|FG001|Period 2|Adverse Event|0
7896537|NCT01912456|12404257|FG002|Period 2|Adverse Event|0
7896538|NCT01912456|12404258|FG003|Period 2|Adverse Event|1
7896539|NCT01912599|12404277|FG000|Overall Study|Withdrawal by Subject|0
7896540|NCT01912599|12404278|FG001|Overall Study|Withdrawal by Subject|1
7896541|NCT01912612|12404286|FG000|Overall Study|Adverse Event|4
7896542|NCT01912612|12404287|FG001|Overall Study|Adverse Event|0
7896543|NCT01912612|12404288|FG002|Overall Study|Adverse Event|0
7896544|NCT01912612|12404286|FG000|Overall Study|Withdrew consent|1
7896545|NCT01912612|12404287|FG001|Overall Study|Withdrew consent|0
7896546|NCT01912612|12404288|FG002|Overall Study|Withdrew consent|0
7896547|NCT01912612|12404286|FG000|Overall Study|Study design change|0
7896548|NCT01912612|12404287|FG001|Overall Study|Study design change|0
7896549|NCT01912612|12404288|FG002|Overall Study|Study design change|3
7896550|NCT01912729|12404307|FG000|Overall Study|Withdrawal by Subject|0
7896551|NCT01912729|12404308|FG001|Overall Study|Withdrawal by Subject|1
7896552|NCT01912768|12404316|FG000|Overall Study|Adverse Event|2
7896553|NCT01912768|12404317|FG001|Overall Study|Adverse Event|0
7896554|NCT01912768|12404316|FG000|Overall Study|Lost to Follow-up|2
7896555|NCT01912768|12404317|FG001|Overall Study|Lost to Follow-up|1
7896556|NCT01912768|12404316|FG000|Overall Study|Withdrawal by Subject|5
7896557|NCT01912768|12404317|FG001|Overall Study|Withdrawal by Subject|3
7896558|NCT01912768|12404316|FG000|Overall Study|Randomized in error|1
7896559|NCT01912768|12404317|FG001|Overall Study|Randomized in error|0
7896560|NCT01912781|12404326|FG000|Overall Study|Withdrawal by Subject|2
7896561|NCT01912781|12404327|FG001|Overall Study|Withdrawal by Subject|0
7896562|NCT01912807|12404336|FG000|Overall Study|Did not meet elegibility criteria|6
7896563|NCT01912807|12404337|FG001|Overall Study|Did not meet elegibility criteria|4
7896564|NCT01912807|12404336|FG000|Overall Study|Lost to Follow-up|36
7896565|NCT01912807|12404337|FG001|Overall Study|Lost to Follow-up|37
7896566|NCT01912872|12404347|FG000|Overall Study|Lost to Follow-up|2
7896567|NCT01912872|12404348|FG001|Overall Study|Lost to Follow-up|3
7896568|NCT01912872|12404349|FG002|Overall Study|Lost to Follow-up|5
7896569|NCT01912872|12404350|FG003|Overall Study|Lost to Follow-up|5
7896570|NCT01912872|12404347|FG000|Overall Study|Other unspecified|3
7896571|NCT01912872|12404348|FG001|Overall Study|Other unspecified|1
7896572|NCT01912872|12404349|FG002|Overall Study|Other unspecified|3
7896573|NCT01912872|12404350|FG003|Overall Study|Other unspecified|0
7896574|NCT01912872|12404347|FG000|Overall Study|Informed consent withdrawn|0
7896575|NCT01912872|12404348|FG001|Overall Study|Informed consent withdrawn|0
7896576|NCT01912872|12404349|FG002|Overall Study|Informed consent withdrawn|1
7896577|NCT01912872|12404350|FG003|Overall Study|Informed consent withdrawn|1
7896578|NCT01912872|12404347|FG000|Overall Study|Non-compliance with lab inc/exclusion|0
7896579|NCT01912872|12404348|FG001|Overall Study|Non-compliance with lab inc/exclusion|0
7896580|NCT01912872|12404349|FG002|Overall Study|Non-compliance with lab inc/exclusion|0
7896581|NCT01912872|12404350|FG003|Overall Study|Non-compliance with lab inc/exclusion|1
7896582|NCT01912872|12404347|FG000|Overall Study|Protocol Violation|0
7896583|NCT01912872|12404348|FG001|Overall Study|Protocol Violation|0
7896584|NCT01912872|12404349|FG002|Overall Study|Protocol Violation|1
7896585|NCT01912872|12404350|FG003|Overall Study|Protocol Violation|0
7896586|NCT01912872|12404347|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7896587|NCT01912872|12404348|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7896588|NCT01912872|12404349|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7896589|NCT01912872|12404350|FG003|Overall Study|Unsatisfactory therapeutic effect|2
7896590|NCT01912872|12404347|FG000|Overall Study|Withdrawal of study medication|0
7896591|NCT01912872|12404348|FG001|Overall Study|Withdrawal of study medication|0
7896592|NCT01912872|12404349|FG002|Overall Study|Withdrawal of study medication|0
7896593|NCT01912872|12404350|FG003|Overall Study|Withdrawal of study medication|2
7896594|NCT01912872|12404347|FG000|Overall Study|Missing|0
7896595|NCT01912872|12404348|FG001|Overall Study|Missing|0
7896596|NCT01912872|12404349|FG002|Overall Study|Missing|0
7896597|NCT01912872|12404350|FG003|Overall Study|Missing|1
7896598|NCT01912963|12404364|FG000|Overall Study|Disease Progression (RECIST1.1)|6
7896599|NCT01912963|12404365|FG001|Overall Study|Disease Progression (RECIST1.1)|9
7896600|NCT01912963|12404366|FG002|Overall Study|Disease Progression (RECIST1.1)|5
7896601|NCT01912963|12404364|FG000|Overall Study|Disease Progression (not RECIST1.1)|0
7896602|NCT01912963|12404365|FG001|Overall Study|Disease Progression (not RECIST1.1)|7
7896603|NCT01912963|12404366|FG002|Overall Study|Disease Progression (not RECIST1.1)|1
7896604|NCT01912963|12404364|FG000|Overall Study|Adverse Event|0
7896605|NCT01912963|12404365|FG001|Overall Study|Adverse Event|1
7896606|NCT01912963|12404366|FG002|Overall Study|Adverse Event|1
7896607|NCT01912963|12404364|FG000|Overall Study|Withdrawal by Subject|0
7896608|NCT01912963|12404365|FG001|Overall Study|Withdrawal by Subject|1
7896609|NCT01912963|12404366|FG002|Overall Study|Withdrawal by Subject|0
7896610|NCT01912963|12404364|FG000|Overall Study|Sought treatment locally|0
7896611|NCT01912963|12404365|FG001|Overall Study|Sought treatment locally|1
7896612|NCT01912963|12404366|FG002|Overall Study|Sought treatment locally|0
7896613|NCT01913041|12404374|FG000|Overall Study|Protocol Violation|35
7896614|NCT01913041|12404374|FG000|Overall Study|Withdrawal by Subject|3
7896615|NCT01913041|12404374|FG000|Overall Study|Physician Decision|1
7896616|NCT01913340|12404384|FG000|Overall Study|Death|2
7896617|NCT01913340|12404385|FG001|Overall Study|Death|5
7896618|NCT01913340|12404384|FG000|Overall Study|Lost to Follow-up|1
7896619|NCT01913340|12404385|FG001|Overall Study|Lost to Follow-up|1
7896620|NCT01913353|12404393|FG000|Overall Study|Adverse Event|2
7896621|NCT01913353|12404394|FG001|Overall Study|Adverse Event|0
7896622|NCT01913353|12404393|FG000|Overall Study|Physician Decision|0
7896623|NCT01913353|12404394|FG001|Overall Study|Physician Decision|2
7896624|NCT01913353|12404393|FG000|Overall Study|Withdrawal by Subject|20
7896625|NCT01913353|12404394|FG001|Overall Study|Withdrawal by Subject|6
7896626|NCT01913353|12404393|FG000|Overall Study|multiple reasons|10
7896627|NCT01913353|12404394|FG001|Overall Study|multiple reasons|7
7896628|NCT01913405|12404407|FG000|Overall Study|Withdrawal by Subject|1
7896629|NCT01913405|12404407|FG000|Overall Study|Adverse Event|1
7896630|NCT01913470|12404426|FG000|Overall Study|Lost to Follow-up|0
7896631|NCT01913470|12404427|FG001|Overall Study|Lost to Follow-up|1
7896632|NCT01913470|12404426|FG000|Overall Study|Physician Decision|0
7896633|NCT01913470|12404427|FG001|Overall Study|Physician Decision|1
7896634|NCT01913470|12404426|FG000|Overall Study|Withdrawal by Subject|0
7896635|NCT01913470|12404427|FG001|Overall Study|Withdrawal by Subject|1
7896636|NCT01913483|12404436|FG000|Overall Study|Withdrawal by Subject|1
7896637|NCT01913483|12404437|FG001|Overall Study|Withdrawal by Subject|2
7896638|NCT01913483|12404436|FG000|Overall Study|Lost to Follow-up|6
7896639|NCT01913483|12404437|FG001|Overall Study|Lost to Follow-up|3
7896640|NCT01913483|12404436|FG000|Overall Study|Death|14
7896641|NCT01913483|12404437|FG001|Overall Study|Death|17
7896642|NCT01913639|12404469|FG000|Overall Study|Not Eligible|3
7896643|NCT01914393|12404489|FG000|Overall Study|Protocol Violation|11
7896644|NCT01914393|12404490|FG001|Overall Study|Protocol Violation|3
7896645|NCT01914393|12404491|FG002|Overall Study|Protocol Violation|19
7896646|NCT01914393|12404489|FG000|Overall Study|Lack of Efficacy|11
7896647|NCT01914393|12404490|FG001|Overall Study|Lack of Efficacy|16
7896648|NCT01914393|12404491|FG002|Overall Study|Lack of Efficacy|5
7896649|NCT01914393|12404489|FG000|Overall Study|no reason given|14
7896650|NCT01914393|12404490|FG001|Overall Study|no reason given|8
7896651|NCT01914393|12404491|FG002|Overall Study|no reason given|16
7896652|NCT01914393|12404489|FG000|Overall Study|Adverse Event|29
7896653|NCT01914393|12404490|FG001|Overall Study|Adverse Event|18
7896654|NCT01914393|12404491|FG002|Overall Study|Adverse Event|31
7896655|NCT01914393|12404489|FG000|Overall Study|Withdrawal by Subject|38
7896656|NCT01914393|12404490|FG001|Overall Study|Withdrawal by Subject|20
7896657|NCT01914393|12404491|FG002|Overall Study|Withdrawal by Subject|47
7896658|NCT01914393|12404489|FG000|Overall Study|Lost to Follow-up|12
7896659|NCT01914393|12404490|FG001|Overall Study|Lost to Follow-up|6
7896660|NCT01914393|12404491|FG002|Overall Study|Lost to Follow-up|19
7896661|NCT01914393|12404489|FG000|Overall Study|subject never dosed|0
7896662|NCT01914393|12404490|FG001|Overall Study|subject never dosed|0
7896663|NCT01914393|12404491|FG002|Overall Study|subject never dosed|1
7896664|NCT01914666|12404511|FG000|Treatment Period|Lack of Efficacy|0
7896665|NCT01914666|12404512|FG001|Treatment Period|Lack of Efficacy|0
7896666|NCT01914666|12404513|FG002|Treatment Period|Lack of Efficacy|2
7896667|NCT01914666|12404511|FG000|Treatment Period|Adverse Event|10
7896668|NCT01914666|12404512|FG001|Treatment Period|Adverse Event|4
7896669|NCT01914666|12404513|FG002|Treatment Period|Adverse Event|2
7896670|NCT01914666|12404511|FG000|Treatment Period|Withdrawal by Subject|3
7896671|NCT01914666|12404512|FG001|Treatment Period|Withdrawal by Subject|2
7896672|NCT01914666|12404513|FG002|Treatment Period|Withdrawal by Subject|2
7896673|NCT01914666|12404511|FG000|Treatment Period|Physician Decision|0
7896674|NCT01914666|12404512|FG001|Treatment Period|Physician Decision|0
7896675|NCT01914666|12404513|FG002|Treatment Period|Physician Decision|2
7896676|NCT01914679|12404519|FG000|Overall Study|Lack of Efficacy|1
7896677|NCT01914679|12404519|FG000|Overall Study|Sponsor terminated study|4
7896678|NCT01914757|12404526|FG000|Overall Study|Severe non-compliance to protocol|3
7896679|NCT01914757|12404527|FG001|Overall Study|Severe non-compliance to protocol|1
7896680|NCT01914757|12404528|FG002|Overall Study|Severe non-compliance to protocol|2
7896681|NCT01914757|12404526|FG000|Overall Study|Lost to Follow-up|5
7896682|NCT01914757|12404527|FG001|Overall Study|Lost to Follow-up|8
7896683|NCT01914757|12404528|FG002|Overall Study|Lost to Follow-up|6
7896684|NCT01914757|12404526|FG000|Overall Study|Withdrawal by Subject|15
7896685|NCT01914757|12404527|FG001|Overall Study|Withdrawal by Subject|27
7896686|NCT01914757|12404528|FG002|Overall Study|Withdrawal by Subject|19
7896687|NCT01914757|12404526|FG000|Overall Study|Death|2
7896688|NCT01914757|12404527|FG001|Overall Study|Death|2
7896689|NCT01914757|12404528|FG002|Overall Study|Death|1
7896690|NCT01914757|12404526|FG000|Overall Study|Adverse Event|4
7896691|NCT01914757|12404527|FG001|Overall Study|Adverse Event|3
7896692|NCT01914757|12404528|FG002|Overall Study|Adverse Event|4
7896693|NCT01914757|12404526|FG000|Overall Study|Study specific withdrawal criteria|0
7896694|NCT01914757|12404527|FG001|Overall Study|Study specific withdrawal criteria|1
7896695|NCT01914757|12404528|FG002|Overall Study|Study specific withdrawal criteria|0
7896696|NCT01914757|12404526|FG000|Overall Study|Eligibility criteria not fulfilled|2
7896697|NCT01914757|12404527|FG001|Overall Study|Eligibility criteria not fulfilled|0
7896698|NCT01914757|12404528|FG002|Overall Study|Eligibility criteria not fulfilled|2
7896699|NCT01914757|12404526|FG000|Overall Study|Other reasons|5
7896700|NCT01914757|12404527|FG001|Overall Study|Other reasons|9
7896701|NCT01914757|12404528|FG002|Overall Study|Other reasons|4
7896702|NCT01914926|12404538|FG000|Overall Study|Adverse Event|1
7896703|NCT01914926|12404539|FG001|Overall Study|Adverse Event|0
7896704|NCT01914926|12404538|FG000|Overall Study|uncooperative, agitated and removed|0
7896705|NCT01914926|12404539|FG001|Overall Study|uncooperative, agitated and removed|1
7896706|NCT01915095|12404552|FG000|Overall Study|Some subjects were unable to commit to the training study.|0
7896707|NCT01915095|12404553|FG001|Overall Study|Some subjects were unable to commit to the training study.|0
7896708|NCT01915095|12404554|FG002|Overall Study|Some subjects were unable to commit to the training study.|0
7896709|NCT01915095|12404555|FG003|Overall Study|Some subjects were unable to commit to the training study.|4
7896710|NCT01915095|12404556|FG004|Overall Study|Some subjects were unable to commit to the training study.|6
7896711|NCT01915303|12404611|FG000|Core Phase|Adverse Event|7
7896712|NCT01915303|12404611|FG000|Core Phase|Unsatisfactory therapeutic effect|3
7896713|NCT01915303|12404611|FG000|Core Phase|Death|2
7896714|NCT01915303|12404611|FG000|Core Phase|Protocol Violation|2
7896715|NCT01915303|12404611|FG000|Core Phase|Abnormal lab value|1
7896716|NCT01915303|12404611|FG000|Core Phase|Withdrawal by Subject|1
7896717|NCT01915303|12404611|FG000|Extension Phase|Unsatisfactory therapeutic effect|8
7896718|NCT01915303|12404611|FG000|Extension Phase|Withdrawal by Subject|4
7896719|NCT01915303|12404611|FG000|Extension Phase|Adverse Event|3
7896720|NCT01915303|12404611|FG000|Extension Phase|Death|1
7896721|NCT01915303|12404611|FG000|Extension Phase|Protocol Violation|1
7896722|NCT01915732|12404626|FG000|Overall Study|Withdrawal by Subject|18
7896723|NCT01915732|12404627|FG001|Overall Study|Withdrawal by Subject|18
7896724|NCT01915732|12404626|FG000|Overall Study|Failure to Meet Randomization Criteria|1
7896725|NCT01915732|12404627|FG001|Overall Study|Failure to Meet Randomization Criteria|0
7896726|NCT01915732|12404626|FG000|Overall Study|Adverse Event|12
7896727|NCT01915732|12404627|FG001|Overall Study|Adverse Event|4
7896728|NCT01915732|12404626|FG000|Overall Study|Protocol Violation|5
7896729|NCT01915732|12404627|FG001|Overall Study|Protocol Violation|5
7896730|NCT01915732|12404626|FG000|Overall Study|Lack of Efficacy|6
7896731|NCT01915732|12404627|FG001|Overall Study|Lack of Efficacy|11
7896732|NCT01915732|12404626|FG000|Overall Study|Lost to Follow-up|22
7896733|NCT01915732|12404627|FG001|Overall Study|Lost to Follow-up|26
7896734|NCT01915732|12404626|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1
7896735|NCT01915732|12404627|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0
7896736|NCT01915732|12404626|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1
7896737|NCT01915732|12404627|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0
7896738|NCT01915732|12404626|FG000|Overall Study|Drug Release Error|1
7896739|NCT01915732|12404627|FG001|Overall Study|Drug Release Error|0
7896740|NCT01915732|12404626|FG000|Overall Study|Recovered|1
7896741|NCT01915732|12404627|FG001|Overall Study|Recovered|0
7896742|NCT01915732|12404626|FG000|Overall Study|Pregnancy|1
7896743|NCT01915732|12404627|FG001|Overall Study|Pregnancy|0
7896744|NCT01915732|12404626|FG000|Overall Study|Poor Perceived Efficacy|1
7896745|NCT01915732|12404627|FG001|Overall Study|Poor Perceived Efficacy|0
7896746|NCT01915732|12404626|FG000|Overall Study|Par. Unable to Come to the Hospital|0
7896747|NCT01915732|12404627|FG001|Overall Study|Par. Unable to Come to the Hospital|1
7896748|NCT01915732|12404626|FG000|Overall Study|Got Well|0
7896749|NCT01915732|12404627|FG001|Overall Study|Got Well|1
7896750|NCT01915732|12404626|FG000|Overall Study|Par. not Willing to Continue Treatment|0
7896751|NCT01915732|12404627|FG001|Overall Study|Par. not Willing to Continue Treatment|1
7896752|NCT01915732|12404626|FG000|Overall Study|Par. Refused to Hospital Visits|0
7896753|NCT01915732|12404627|FG001|Overall Study|Par. Refused to Hospital Visits|1
7896754|NCT01915732|12404626|FG000|Overall Study|Job Transfer|0
7896755|NCT01915732|12404627|FG001|Overall Study|Job Transfer|1
7896756|NCT01915732|12404626|FG000|Overall Study|Improper Facial Procedure|0
7896757|NCT01915732|12404627|FG001|Overall Study|Improper Facial Procedure|1
7896758|NCT01915732|12404626|FG000|Overall Study|Poor Conscious Effect|0
7896759|NCT01915732|12404627|FG001|Overall Study|Poor Conscious Effect|1
7896760|NCT01915771|12404633|FG000|Day 1|Withdrawal by Subject|1
7896761|NCT01915771|12404633|FG000|Day 15|Withdrawal by Subject|1
7896762|NCT01915849|12404654|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1
7896763|NCT01915849|12404655|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0
7896764|NCT01915849|12404656|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0
7896765|NCT01915849|12404657|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0
7896766|NCT01915849|12404654|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
7896767|NCT01915849|12404655|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7896768|NCT01915849|12404656|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7896769|NCT01915849|12404657|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7896770|NCT01915914|12404667|FG000|Acute Phase|Withdrawal by Subject|4
7896771|NCT01915914|12404668|FG001|Acute Phase|Withdrawal by Subject|0
7896772|NCT01915914|12404669|FG002|Acute Phase|Withdrawal by Subject|0
7896773|NCT01915914|12404670|FG003|Acute Phase|Withdrawal by Subject|0
7896774|NCT01915914|12404667|FG000|Acute Phase|Lost to Follow-up|4
7896775|NCT01915914|12404668|FG001|Acute Phase|Lost to Follow-up|0
7896776|NCT01915914|12404669|FG002|Acute Phase|Lost to Follow-up|0
7896777|NCT01915914|12404670|FG003|Acute Phase|Lost to Follow-up|0
7896778|NCT01915914|12404667|FG000|Acute Phase|Physician Decision|1
7896779|NCT01915914|12404668|FG001|Acute Phase|Physician Decision|0
7896780|NCT01915914|12404669|FG002|Acute Phase|Physician Decision|0
7896781|NCT01915914|12404670|FG003|Acute Phase|Physician Decision|0
7896782|NCT01915914|12404667|FG000|Acute Phase|Accepted Other Topic Therapies|1
7896783|NCT01915914|12404668|FG001|Acute Phase|Accepted Other Topic Therapies|0
7896784|NCT01915914|12404669|FG002|Acute Phase|Accepted Other Topic Therapies|0
7896785|NCT01915914|12404670|FG003|Acute Phase|Accepted Other Topic Therapies|0
7896786|NCT01915914|12404667|FG000|Acute Phase|"Not Achieved treatment success"|1
7896787|NCT01915914|12404668|FG001|Acute Phase|"Not Achieved treatment success"|0
7896788|NCT01915914|12404669|FG002|Acute Phase|"Not Achieved treatment success"|0
7896789|NCT01915914|12404670|FG003|Acute Phase|"Not Achieved treatment success"|0
7896790|NCT01915914|12404667|FG000|Acute Phase|Missing|1
7896791|NCT01915914|12404668|FG001|Acute Phase|Missing|0
7896792|NCT01915914|12404669|FG002|Acute Phase|Missing|0
7896793|NCT01915914|12404670|FG003|Acute Phase|Missing|0
7896794|NCT01915914|12404667|FG000|Maintenance Phase|Withdrawal by Subject|0
7896795|NCT01915914|12404668|FG001|Maintenance Phase|Withdrawal by Subject|1
7896796|NCT01915914|12404669|FG002|Maintenance Phase|Withdrawal by Subject|1
7896797|NCT01915914|12404670|FG003|Maintenance Phase|Withdrawal by Subject|0
7896798|NCT01915914|12404667|FG000|Maintenance Phase|Lost to Follow-up|0
7896799|NCT01915914|12404668|FG001|Maintenance Phase|Lost to Follow-up|4
7896800|NCT01915914|12404669|FG002|Maintenance Phase|Lost to Follow-up|1
7896801|NCT01915914|12404670|FG003|Maintenance Phase|Lost to Follow-up|0
7896802|NCT01915914|12404667|FG000|Maintenance Phase|Missing|0
7896803|NCT01915914|12404668|FG001|Maintenance Phase|Missing|1
7896804|NCT01915914|12404669|FG002|Maintenance Phase|Missing|0
7896805|NCT01915914|12404670|FG003|Maintenance Phase|Missing|0
7896806|NCT01915914|12404667|FG000|Follow-up Phase|Withdrawal by Subject|0
7896807|NCT01915914|12404668|FG001|Follow-up Phase|Withdrawal by Subject|0
7896808|NCT01915914|12404669|FG002|Follow-up Phase|Withdrawal by Subject|0
7896809|NCT01915914|12404670|FG003|Follow-up Phase|Withdrawal by Subject|1
7896810|NCT01915914|12404667|FG000|Follow-up Phase|Physician Decision|0
7896811|NCT01915914|12404668|FG001|Follow-up Phase|Physician Decision|0
7896812|NCT01915914|12404669|FG002|Follow-up Phase|Physician Decision|0
7896813|NCT01915914|12404670|FG003|Follow-up Phase|Physician Decision|1
7896814|NCT01915940|12404690|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39
7896815|NCT01915940|12404691|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0
7896816|NCT01915940|12404692|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0
7896817|NCT01915940|12404690|FG000|Treatment Period|Decision of Participant|0
7968615|NCT02781324|12526387|FG000|Overall Study|Withdrawal by Subject|1
7968616|NCT02781324|12526388|FG001|Overall Study|Withdrawal by Subject|0
7968617|NCT02781324|12526387|FG000|Overall Study|Physician Decision|1
7968618|NCT02781324|12526388|FG001|Overall Study|Physician Decision|2
7968619|NCT02781558|12526424|FG000|Overall Study|Lost to Follow-up|2
7968620|NCT02781558|12526425|FG001|Overall Study|Lost to Follow-up|2
7968621|NCT02781558|12526424|FG000|Overall Study|Adverse Event|1
7968622|NCT02781558|12526425|FG001|Overall Study|Adverse Event|0
7968623|NCT02781818|12526469|FG000|Overall Study|Lost to Follow-up|4
7968624|NCT02781818|12526470|FG001|Overall Study|Lost to Follow-up|2
7968625|NCT02781818|12526471|FG002|Overall Study|Lost to Follow-up|1
7968626|NCT02781844|12526483|FG000|Treatment Period 1|Adverse Event|0
7968627|NCT02781844|12526484|FG001|Treatment Period 1|Adverse Event|0
7968628|NCT02781844|12526485|FG002|Treatment Period 1|Adverse Event|0
7968629|NCT02781844|12526486|FG003|Treatment Period 1|Adverse Event|0
7968630|NCT02781844|12526487|FG004|Treatment Period 1|Adverse Event|0
7968631|NCT02781844|12526488|FG005|Treatment Period 1|Adverse Event|1
7968632|NCT02781844|12526489|FG006|Treatment Period 1|Adverse Event|0
7968633|NCT02781844|12526490|FG007|Treatment Period 1|Adverse Event|0
7968634|NCT02782169|12526513|FG000|Overall Study|Lost to Follow-up|1
7968635|NCT02782169|12526514|FG001|Overall Study|Lost to Follow-up|2
7968636|NCT02782325|12526522|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4
7968637|NCT02782325|12526523|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2
7968638|NCT02782325|12526524|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0
7968639|NCT02782325|12526522|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
7968640|NCT02782325|12526523|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
7968641|NCT02782325|12526524|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4
7968642|NCT02782377|12526540|FG000|Overall Study|Physician Decision|5
7968643|NCT02782676|12526545|FG000|Overall Study|Lost to Follow-up|0
7968644|NCT02782676|12526546|FG001|Overall Study|Lost to Follow-up|1
7968645|NCT02782780|12526554|FG000|Overall Study|dropped out after randomization.|7
7968646|NCT02782780|12526555|FG001|Overall Study|dropped out after randomization.|5
7968647|NCT02782780|12526554|FG000|Overall Study|Protocol Violation|0
7968648|NCT02782780|12526555|FG001|Overall Study|Protocol Violation|2
7968649|NCT02782923|12526561|FG000|Overall Study|Lost to Follow-up|15
7968650|NCT02783066|12526574|FG000|Overall Study|Withdrawal by Subject|13
7968651|NCT02783170|12526581|FG000|Overall Study|Randomized but not Vaccinated|1
7968652|NCT02783170|12526582|FG001|Overall Study|Randomized but not Vaccinated|0
7968653|NCT02783573|12526605|FG000|Placebo-Controlled Treatment Period|Adverse Event|13
7968654|NCT02783573|12526606|FG001|Placebo-Controlled Treatment Period|Adverse Event|17
7968655|NCT02783573|12526607|FG002|Placebo-Controlled Treatment Period|Adverse Event|13
7968656|NCT02783573|12526605|FG000|Placebo-Controlled Treatment Period|Death|4
7968657|NCT02783573|12526606|FG001|Placebo-Controlled Treatment Period|Death|2
7968658|NCT02783573|12526607|FG002|Placebo-Controlled Treatment Period|Death|3
7968659|NCT02783573|12526605|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0
7968660|NCT02783573|12526606|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0
7968661|NCT02783573|12526607|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2
7968662|NCT02783573|12526605|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3
7968663|NCT02783573|12526606|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3
7968664|NCT02783573|12526607|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1
7896818|NCT01915940|12404691|FG001|Treatment Period|Decision of Participant|1
7896819|NCT01915940|12404692|FG002|Treatment Period|Decision of Participant|3
7896820|NCT01915940|12404690|FG000|Treatment Period|Adverse Event|0
7896821|NCT01915940|12404691|FG001|Treatment Period|Adverse Event|9
7896822|NCT01915940|12404692|FG002|Treatment Period|Adverse Event|1
7896823|NCT01915940|12404690|FG000|Treatment Period|Other Miscellaneous Reasons|0
7896824|NCT01915940|12404691|FG001|Treatment Period|Other Miscellaneous Reasons|1
7896825|NCT01915940|12404692|FG002|Treatment Period|Other Miscellaneous Reasons|0
7896826|NCT01916109|12404698|FG000|Overall Study|Withdrawal by Subject|1
7896827|NCT01916226|12404706|FG000|Overall Study|Adverse Event|1
7896828|NCT01916226|12404707|FG001|Overall Study|Adverse Event|0
7896829|NCT01916226|12404708|FG002|Overall Study|Adverse Event|1
7896830|NCT01916226|12404709|FG003|Overall Study|Adverse Event|1
7896831|NCT01916226|12404706|FG000|Overall Study|Lack of Efficacy|0
7896832|NCT01916226|12404707|FG001|Overall Study|Lack of Efficacy|0
7896833|NCT01916226|12404708|FG002|Overall Study|Lack of Efficacy|2
7968665|NCT02783573|12526605|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0
7896834|NCT01916226|12404709|FG003|Overall Study|Lack of Efficacy|1
7896835|NCT01916226|12404706|FG000|Overall Study|Protocol Violation|0
7896836|NCT01916226|12404707|FG001|Overall Study|Protocol Violation|1
7896837|NCT01916226|12404708|FG002|Overall Study|Protocol Violation|0
7896838|NCT01916226|12404709|FG003|Overall Study|Protocol Violation|1
7896839|NCT01916226|12404706|FG000|Overall Study|Physician Decision|0
7896840|NCT01916226|12404707|FG001|Overall Study|Physician Decision|0
7896841|NCT01916226|12404708|FG002|Overall Study|Physician Decision|0
7896842|NCT01916226|12404709|FG003|Overall Study|Physician Decision|1
7896843|NCT01916304|12404720|FG000|Overall Study|Screening failure|17
7896844|NCT01916824|12404766|FG000|Overall Study|Lost to Follow-up|3
7896845|NCT01916824|12404767|FG001|Overall Study|Lost to Follow-up|6
7896846|NCT01916824|12404766|FG000|Overall Study|Physician Decision|2
7896847|NCT01916824|12404767|FG001|Overall Study|Physician Decision|0
7896848|NCT01916824|12404766|FG000|Overall Study|Withdrawal by Subject|2
7896849|NCT01916824|12404767|FG001|Overall Study|Withdrawal by Subject|3
7896850|NCT01917006|12404793|FG000|Randomized-treatment Period|Lost to Follow-up|1
7896851|NCT01917006|12404794|FG001|Randomized-treatment Period|Lost to Follow-up|0
7896852|NCT01917006|12404795|FG002|Randomized-treatment Period|Lost to Follow-up|0
7896853|NCT01917006|12404796|FG003|Randomized-treatment Period|Lost to Follow-up|1
7896854|NCT01917006|12404797|FG004|Randomized-treatment Period|Lost to Follow-up|0
7896855|NCT01917006|12404798|FG005|Randomized-treatment Period|Lost to Follow-up|0
7896856|NCT01917006|12404799|FG006|Randomized-treatment Period|Lost to Follow-up|0
7896857|NCT01917006|12404800|FG007|Randomized-treatment Period|Lost to Follow-up|0
7896858|NCT01917006|12404793|FG000|Randomized-treatment Period|Personal Reasons|0
7896859|NCT01917006|12404794|FG001|Randomized-treatment Period|Personal Reasons|0
7896860|NCT01917006|12404795|FG002|Randomized-treatment Period|Personal Reasons|0
7896861|NCT01917006|12404796|FG003|Randomized-treatment Period|Personal Reasons|0
7896862|NCT01917006|12404797|FG004|Randomized-treatment Period|Personal Reasons|0
7896863|NCT01917006|12404798|FG005|Randomized-treatment Period|Personal Reasons|1
7896864|NCT01917006|12404799|FG006|Randomized-treatment Period|Personal Reasons|0
7896865|NCT01917006|12404800|FG007|Randomized-treatment Period|Personal Reasons|0
7896866|NCT01917006|12404793|FG000|Randomized-treatment Period|Protocol Violation|1
7896867|NCT01917006|12404794|FG001|Randomized-treatment Period|Protocol Violation|0
7896868|NCT01917006|12404795|FG002|Randomized-treatment Period|Protocol Violation|0
7896869|NCT01917006|12404796|FG003|Randomized-treatment Period|Protocol Violation|0
7896870|NCT01917006|12404797|FG004|Randomized-treatment Period|Protocol Violation|0
7896871|NCT01917006|12404798|FG005|Randomized-treatment Period|Protocol Violation|0
7896872|NCT01917006|12404799|FG006|Randomized-treatment Period|Protocol Violation|0
7896873|NCT01917006|12404800|FG007|Randomized-treatment Period|Protocol Violation|0
7896874|NCT01917006|12404793|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0
7896875|NCT01917006|12404794|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0
7896876|NCT01917006|12404795|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0
7896877|NCT01917006|12404796|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0
7896878|NCT01917006|12404797|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0
7896879|NCT01917006|12404798|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0
7896880|NCT01917006|12404799|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1
7896881|NCT01917006|12404800|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0
7896882|NCT01917006|12404793|FG000|Open-label Period|Adverse Event|0
7896883|NCT01917006|12404794|FG001|Open-label Period|Adverse Event|0
7896884|NCT01917006|12404795|FG002|Open-label Period|Adverse Event|0
7896885|NCT01917006|12404796|FG003|Open-label Period|Adverse Event|0
7896886|NCT01917006|12404797|FG004|Open-label Period|Adverse Event|0
7896887|NCT01917006|12404798|FG005|Open-label Period|Adverse Event|0
7896888|NCT01917006|12404799|FG006|Open-label Period|Adverse Event|0
7896889|NCT01917006|12404800|FG007|Open-label Period|Adverse Event|1
7896890|NCT01917006|12404793|FG000|Open-label Period|Lost to Follow-up|0
7896891|NCT01917006|12404794|FG001|Open-label Period|Lost to Follow-up|0
7896892|NCT01917006|12404795|FG002|Open-label Period|Lost to Follow-up|0
7896893|NCT01917006|12404796|FG003|Open-label Period|Lost to Follow-up|0
7896894|NCT01917006|12404797|FG004|Open-label Period|Lost to Follow-up|0
7896895|NCT01917006|12404798|FG005|Open-label Period|Lost to Follow-up|0
7896896|NCT01917006|12404799|FG006|Open-label Period|Lost to Follow-up|0
7896897|NCT01917006|12404800|FG007|Open-label Period|Lost to Follow-up|1
7896898|NCT01917084|12404817|FG000|Overall Study|Withdrawal by Subject|1
7896899|NCT01917344|12404843|FG000|Overall Study|Withdrawal by Subject|1
7896900|NCT01917526|12404858|FG000|Overall Study|Protocol Violation|1
7896901|NCT01917526|12404859|FG001|Overall Study|Protocol Violation|1
7896902|NCT01917656|12404867|FG000|Overall Study|Adverse Event|11
7896903|NCT01917656|12404868|FG001|Overall Study|Adverse Event|0
7896904|NCT01917656|12404867|FG000|Overall Study|Withdrawal criteria|8
7896905|NCT01917656|12404868|FG001|Overall Study|Withdrawal criteria|14
7896906|NCT01917656|12404867|FG000|Overall Study|Unclassified|0
7896907|NCT01917656|12404868|FG001|Overall Study|Unclassified|3
7896908|NCT01917656|12404867|FG000|Overall Study|Withdrawal by Subject|4
7896909|NCT01917656|12404868|FG001|Overall Study|Withdrawal by Subject|3
7896910|NCT01917656|12404867|FG000|Overall Study|Lost to Follow-up|3
7896911|NCT01917656|12404868|FG001|Overall Study|Lost to Follow-up|4
7896912|NCT01917747|12404881|FG000|Overall Study|Withdrawal by Subject|1
7896913|NCT01917747|12404882|FG001|Overall Study|Withdrawal by Subject|2
7896914|NCT01917747|12404881|FG000|Overall Study|Lost to Follow-up|18
7896915|NCT01917747|12404882|FG001|Overall Study|Lost to Follow-up|9
7896916|NCT01917968|12404913|FG000|Overall Study|Death|3
7896917|NCT01917968|12404914|FG001|Overall Study|Death|2
7896918|NCT01917968|12404913|FG000|Overall Study|Lost to Follow-up|21
7896919|NCT01917968|12404914|FG001|Overall Study|Lost to Follow-up|39
7896920|NCT01917968|12404913|FG000|Overall Study|Physician Decision|1
7896921|NCT01917968|12404914|FG001|Overall Study|Physician Decision|2
7896922|NCT01917968|12404913|FG000|Overall Study|Withdrawal by Subject|20
7896923|NCT01917968|12404914|FG001|Overall Study|Withdrawal by Subject|35
7896924|NCT01917968|12404913|FG000|Overall Study|Subject Relocation|5
7896925|NCT01917968|12404914|FG001|Overall Study|Subject Relocation|1
7896926|NCT01917968|12404913|FG000|Overall Study|36M Missed Visit|3
7896927|NCT01917968|12404914|FG001|Overall Study|36M Missed Visit|2
7896928|NCT01917968|12404913|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1
7896929|NCT01917968|12404914|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0
7896930|NCT01917968|12404913|FG000|Overall Study|Change in Family Circumstances|0
7896931|NCT01917968|12404914|FG001|Overall Study|Change in Family Circumstances|1
7896932|NCT01917968|12404913|FG000|Overall Study|No Data Available|0
7896933|NCT01917968|12404914|FG001|Overall Study|No Data Available|2
7896934|NCT01918085|12404941|FG000|Test Period 1: Strata Strip|Adverse Event|0
7896935|NCT01918085|12404942|FG001|Test Period 1: Strata Strip|Adverse Event|1
7896936|NCT01918306|12404957|FG000|Overall Study|progresive disease|4
7896937|NCT01918306|12404958|FG001|Overall Study|progresive disease|0
7896938|NCT01918306|12404959|FG002|Overall Study|progresive disease|1
7896939|NCT01918306|12404960|FG003|Overall Study|progresive disease|1
7896940|NCT01918306|12404957|FG000|Overall Study|Withdrawal by Subject|0
7896941|NCT01918306|12404958|FG001|Overall Study|Withdrawal by Subject|0
7896942|NCT01918306|12404959|FG002|Overall Study|Withdrawal by Subject|0
7896943|NCT01918306|12404960|FG003|Overall Study|Withdrawal by Subject|2
7896944|NCT01918306|12404957|FG000|Overall Study|neutropenia|1
7896945|NCT01918306|12404958|FG001|Overall Study|neutropenia|0
7896946|NCT01918306|12404959|FG002|Overall Study|neutropenia|0
7896947|NCT01918306|12404960|FG003|Overall Study|neutropenia|0
7896948|NCT01918306|12404957|FG000|Overall Study|Lack of Efficacy|1
7896949|NCT01918306|12404958|FG001|Overall Study|Lack of Efficacy|0
7896950|NCT01918306|12404959|FG002|Overall Study|Lack of Efficacy|0
7896951|NCT01918306|12404960|FG003|Overall Study|Lack of Efficacy|0
7896952|NCT01918306|12404957|FG000|Overall Study|progress disease, crossover|0
7896953|NCT01918306|12404958|FG001|Overall Study|progress disease, crossover|0
7896954|NCT01918306|12404959|FG002|Overall Study|progress disease, crossover|1
7896955|NCT01918306|12404960|FG003|Overall Study|progress disease, crossover|0
7896956|NCT01918332|12404984|FG000|Overall Study|Adverse Event|0
7896957|NCT01918332|12404985|FG001|Overall Study|Adverse Event|0
7896958|NCT01918332|12404986|FG002|Overall Study|Adverse Event|0
7896959|NCT01918332|12404987|FG003|Overall Study|Adverse Event|1
7896960|NCT01918332|12404984|FG000|Overall Study|Withdrawal by Subject|2
7896961|NCT01918332|12404985|FG001|Overall Study|Withdrawal by Subject|3
7896962|NCT01918332|12404986|FG002|Overall Study|Withdrawal by Subject|2
7896963|NCT01918332|12404987|FG003|Overall Study|Withdrawal by Subject|3
7896964|NCT01918332|12404984|FG000|Overall Study|Protocol Violation|6
7896965|NCT01918332|12404985|FG001|Overall Study|Protocol Violation|2
7896966|NCT01918332|12404986|FG002|Overall Study|Protocol Violation|6
7896967|NCT01918332|12404987|FG003|Overall Study|Protocol Violation|3
7896968|NCT01918332|12404984|FG000|Overall Study|lipid result by central lab did not meet|0
7896969|NCT01918332|12404985|FG001|Overall Study|lipid result by central lab did not meet|0
7896970|NCT01918332|12404986|FG002|Overall Study|lipid result by central lab did not meet|1
7896971|NCT01918332|12404987|FG003|Overall Study|lipid result by central lab did not meet|0
7896972|NCT01918371|12404999|FG000|Overall Study|Missing Data|1
7896973|NCT01918371|12405000|FG001|Overall Study|Missing Data|1
7963506|NCT02723084|12517980|FG001|Overall Study|Withdrawal by Subject|1
7963507|NCT02723084|12517979|FG000|Overall Study|Lost to Follow-up|3
7963508|NCT02723084|12517980|FG001|Overall Study|Lost to Follow-up|0
7963509|NCT02723175|12517988|FG000|Overall Study|Lost to 1 Month Follow Up|3
7963510|NCT02723175|12517989|FG001|Overall Study|Lost to 1 Month Follow Up|2
7963511|NCT02723175|12517988|FG000|Overall Study|Lost to 3 Month Follow Up|1
7963512|NCT02723175|12517989|FG001|Overall Study|Lost to 3 Month Follow Up|1
7963513|NCT02723188|12517998|FG000|Overall Study|Withdrawal by Subject|1
7963514|NCT02723188|12517999|FG001|Overall Study|Withdrawal by Subject|0
7963515|NCT02723188|12518000|FG002|Overall Study|Withdrawal by Subject|0
7963516|NCT02723201|12518011|FG000|Second Intervention Period|Protocol Violation|1
7963517|NCT02723201|12518012|FG001|Second Intervention Period|Protocol Violation|0
7963518|NCT02723201|12518013|FG002|Second Intervention Period|Protocol Violation|0
7963519|NCT02723201|12518011|FG000|Second Intervention Period|Adverse Event|1
7963520|NCT02723201|12518012|FG001|Second Intervention Period|Adverse Event|0
7963521|NCT02723201|12518013|FG002|Second Intervention Period|Adverse Event|0
7963522|NCT02723344|12518029|FG000|Overall Study|Lost to Follow-up|0
7963523|NCT02723344|12518030|FG001|Overall Study|Lost to Follow-up|4
7963524|NCT02723591|12518038|FG000|Overall Study|Adverse Event|48
7963525|NCT02723591|12518039|FG001|Overall Study|Adverse Event|40
7963526|NCT02723591|12518038|FG000|Overall Study|Death|2
7963527|NCT02723591|12518039|FG001|Overall Study|Death|2
7963528|NCT02723591|12518038|FG000|Overall Study|Lack of Efficacy|4
7963529|NCT02723591|12518039|FG001|Overall Study|Lack of Efficacy|3
7963530|NCT02723591|12518038|FG000|Overall Study|Lost to Follow-up|1
7896974|NCT01918774|12405010|FG000|Overall Study|Lost prior to first CBTw session|4
7896975|NCT01918774|12405010|FG000|Overall Study|Lost to Follow-up|1
7896976|NCT01919112|12405026|FG000|Secondary Analysis-day 30|Death|1
7896977|NCT01919112|12405027|FG001|Secondary Analysis-day 30|Death|1
7896978|NCT01919112|12405028|FG002|Secondary Analysis-day 30|Death|1
7896979|NCT01919112|12405026|FG000|Secondary Analysis-day 30|Lost to Follow-up|1
7896980|NCT01919112|12405027|FG001|Secondary Analysis-day 30|Lost to Follow-up|0
7896981|NCT01919112|12405028|FG002|Secondary Analysis-day 30|Lost to Follow-up|0
7896982|NCT01919164|12405041|FG000|Overall Study|Adverse Event|6
7896983|NCT01919164|12405042|FG001|Overall Study|Adverse Event|4
7896984|NCT01919164|12405043|FG002|Overall Study|Adverse Event|9
7896985|NCT01919164|12405044|FG003|Overall Study|Adverse Event|3
7896986|NCT01919164|12405045|FG004|Overall Study|Adverse Event|2
7896987|NCT01919164|12405041|FG000|Overall Study|Lost to Follow-up|2
7896988|NCT01919164|12405042|FG001|Overall Study|Lost to Follow-up|2
7896989|NCT01919164|12405043|FG002|Overall Study|Lost to Follow-up|2
7896990|NCT01919164|12405044|FG003|Overall Study|Lost to Follow-up|0
7896991|NCT01919164|12405045|FG004|Overall Study|Lost to Follow-up|4
7896992|NCT01919164|12405041|FG000|Overall Study|Death|1
7896993|NCT01919164|12405042|FG001|Overall Study|Death|0
7896994|NCT01919164|12405043|FG002|Overall Study|Death|0
7896995|NCT01919164|12405044|FG003|Overall Study|Death|0
7896996|NCT01919164|12405045|FG004|Overall Study|Death|0
7896997|NCT01919164|12405041|FG000|Overall Study|Protocol Violation|6
7896998|NCT01919164|12405042|FG001|Overall Study|Protocol Violation|0
7896999|NCT01919164|12405043|FG002|Overall Study|Protocol Violation|3
7897000|NCT01919164|12405044|FG003|Overall Study|Protocol Violation|2
7897001|NCT01919164|12405045|FG004|Overall Study|Protocol Violation|2
7897002|NCT01919164|12405041|FG000|Overall Study|Disease progression|2
7897003|NCT01919164|12405042|FG001|Overall Study|Disease progression|2
7897004|NCT01919164|12405043|FG002|Overall Study|Disease progression|1
7897005|NCT01919164|12405044|FG003|Overall Study|Disease progression|2
7897006|NCT01919164|12405045|FG004|Overall Study|Disease progression|1
7897007|NCT01919164|12405041|FG000|Overall Study|Withdrew consent|13
7897008|NCT01919164|12405042|FG001|Overall Study|Withdrew consent|13
7897009|NCT01919164|12405043|FG002|Overall Study|Withdrew consent|14
7897010|NCT01919164|12405044|FG003|Overall Study|Withdrew consent|14
7897011|NCT01919164|12405045|FG004|Overall Study|Withdrew consent|9
7897012|NCT01919164|12405041|FG000|Overall Study|Other Un-specified|13
7897013|NCT01919164|12405042|FG001|Overall Study|Other Un-specified|9
7897014|NCT01919164|12405043|FG002|Overall Study|Other Un-specified|8
7897015|NCT01919164|12405044|FG003|Overall Study|Other Un-specified|7
7897016|NCT01919164|12405045|FG004|Overall Study|Other Un-specified|15
7897017|NCT01919190|12405059|FG000|Overall Study|Intra-op findings, etc.|3
7897018|NCT01919190|12405060|FG001|Overall Study|Intra-op findings, etc.|0
7897019|NCT01919229|12405083|FG000|Overall Study|Subject/guardian decision|0
7897020|NCT01919229|12405084|FG001|Overall Study|Subject/guardian decision|0
7897021|NCT01919229|12405085|FG002|Overall Study|Subject/guardian decision|1
7897022|NCT01919307|12405093|FG000|Overall Study|Withdrawal by Subject|9
7897023|NCT01919398|12405100|FG000|Overall Study|Progressive Disease|0
7897024|NCT01919398|12405101|FG001|Overall Study|Progressive Disease|0
7897025|NCT01919398|12405102|FG002|Overall Study|Progressive Disease|4
7897026|NCT01919411|12405112|FG000|Overall Study|Lost to Follow-up|2
7897027|NCT01919411|12405113|FG001|Overall Study|Lost to Follow-up|4
7897028|NCT01919411|12405112|FG000|Overall Study|Physician Decision|1
7897029|NCT01919411|12405113|FG001|Overall Study|Physician Decision|0
7897030|NCT01919411|12405112|FG000|Overall Study|Protocol Violation|2
7897031|NCT01919411|12405113|FG001|Overall Study|Protocol Violation|1
7897032|NCT01919489|12405138|FG000|Overall Study|Rejected the need of injections|4
7897033|NCT01919489|12405139|FG001|Overall Study|Rejected the need of injections|7
7897034|NCT01919489|12405138|FG000|Overall Study|Adverse Event|10
7897035|NCT01919489|12405139|FG001|Overall Study|Adverse Event|0
7897036|NCT01919489|12405138|FG000|Overall Study|Hospital readmission|2
7897037|NCT01919489|12405139|FG001|Overall Study|Hospital readmission|9
7897038|NCT01919489|12405138|FG000|Overall Study|Death|2
7897039|NCT01919489|12405139|FG001|Overall Study|Death|1
7897040|NCT01919489|12405138|FG000|Overall Study|Lost to Follow-up|38
7897041|NCT01919489|12405139|FG001|Overall Study|Lost to Follow-up|27
7897042|NCT01919723|12405166|FG000|Overall Study|Blood Samples Hemolyzed|2
7897043|NCT01919723|12405167|FG001|Overall Study|Blood Samples Hemolyzed|2
7897044|NCT01919801|12405175|FG000|Overall Study|Withdrawal by Subject|1
7897045|NCT01919801|12405176|FG001|Overall Study|Withdrawal by Subject|0
7897046|NCT01919801|12405175|FG000|Overall Study|Physician Decision|0
7897047|NCT01919801|12405176|FG001|Overall Study|Physician Decision|1
7897048|NCT01919801|12405175|FG000|Overall Study|Lost to Follow-up|0
7897049|NCT01919801|12405176|FG001|Overall Study|Lost to Follow-up|1
7897050|NCT01919801|12405175|FG000|Overall Study|Other|0
7897051|NCT01919801|12405176|FG001|Overall Study|Other|1
7897052|NCT01919814|12405182|FG000|Overall Study|Adverse Event|1
7897053|NCT01919814|12405183|FG001|Overall Study|Adverse Event|0
7897054|NCT01919814|12405182|FG000|Overall Study|Protocol Violation|1
7897055|NCT01919814|12405183|FG001|Overall Study|Protocol Violation|0
7897056|NCT01919814|12405182|FG000|Overall Study|Withdrawal by Subject|1
7897057|NCT01919814|12405183|FG001|Overall Study|Withdrawal by Subject|0
7897058|NCT01919970|12405191|FG000|Overall Study|Withdrawal by Subject|3
7897059|NCT01919970|12405192|FG001|Overall Study|Withdrawal by Subject|0
7897060|NCT01920152|12405204|FG000|Overall Study|Withdrawal by Subject|1
7897061|NCT01920152|12405205|FG001|Overall Study|Withdrawal by Subject|2
7897062|NCT01920178|12405213|FG000|Overall Study|Lost to Follow-up|2
7897063|NCT01920178|12405214|FG001|Overall Study|Lost to Follow-up|1
7897064|NCT01920477|12405235|FG000|Overall Study|Adverse Event|0
7897065|NCT01920477|12405236|FG001|Overall Study|Adverse Event|1
7897066|NCT01920477|12405235|FG000|Overall Study|Lack of Efficacy|1
7897067|NCT01920477|12405236|FG001|Overall Study|Lack of Efficacy|0
7897068|NCT01920477|12405235|FG000|Overall Study|Study closed/terminated|14
7897069|NCT01920477|12405236|FG001|Overall Study|Study closed/terminated|15
7897070|NCT01920477|12405235|FG000|Overall Study|Withdrawal by Subject|0
7897071|NCT01920477|12405236|FG001|Overall Study|Withdrawal by Subject|1
7897072|NCT01920555|12405247|FG000|Overall Study|Physician Decision|1
7897073|NCT01920555|12405248|FG001|Overall Study|Physician Decision|2
7897074|NCT01920555|12405249|FG002|Overall Study|Physician Decision|1
7897075|NCT01920555|12405250|FG003|Overall Study|Physician Decision|2
7897076|NCT01920555|12405251|FG004|Overall Study|Physician Decision|0
7897077|NCT01920555|12405247|FG000|Overall Study|Lack of Efficacy|2
7897078|NCT01920555|12405248|FG001|Overall Study|Lack of Efficacy|0
7897079|NCT01920555|12405249|FG002|Overall Study|Lack of Efficacy|0
7897080|NCT01920555|12405250|FG003|Overall Study|Lack of Efficacy|0
7897081|NCT01920555|12405251|FG004|Overall Study|Lack of Efficacy|0
7897082|NCT01920555|12405247|FG000|Overall Study|Travel Difficulties|1
7897083|NCT01920555|12405248|FG001|Overall Study|Travel Difficulties|1
7897084|NCT01920555|12405249|FG002|Overall Study|Travel Difficulties|0
7897085|NCT01920555|12405250|FG003|Overall Study|Travel Difficulties|0
7897086|NCT01920555|12405251|FG004|Overall Study|Travel Difficulties|1
7897087|NCT01920555|12405247|FG000|Overall Study|Lost to Follow-up|0
7897088|NCT01920555|12405248|FG001|Overall Study|Lost to Follow-up|1
7897089|NCT01920555|12405249|FG002|Overall Study|Lost to Follow-up|0
7897090|NCT01920555|12405250|FG003|Overall Study|Lost to Follow-up|1
7897091|NCT01920555|12405251|FG004|Overall Study|Lost to Follow-up|0
7897092|NCT01920568|12405265|FG000|Overall Study|Adverse Event|27
7897093|NCT01920568|12405266|FG001|Overall Study|Adverse Event|8
7897094|NCT01920568|12405265|FG000|Overall Study|Protocol Violation|5
7897095|NCT01920568|12405266|FG001|Overall Study|Protocol Violation|3
7897096|NCT01920568|12405265|FG000|Overall Study|Lost to Follow-up|2
7897097|NCT01920568|12405266|FG001|Overall Study|Lost to Follow-up|2
7897098|NCT01920568|12405265|FG000|Overall Study|Physician Decision|13
7897099|NCT01920568|12405266|FG001|Overall Study|Physician Decision|4
7897100|NCT01920568|12405265|FG000|Overall Study|Withdrawal by Subject|79
7897101|NCT01920568|12405266|FG001|Overall Study|Withdrawal by Subject|55
7897102|NCT01920568|12405265|FG000|Overall Study|Death due to disease progression|25
7897103|NCT01920568|12405266|FG001|Overall Study|Death due to disease progression|12
7897104|NCT01920594|12405275|FG000|Overall Study|Adverse Event|4
7897105|NCT01920594|12405276|FG001|Overall Study|Adverse Event|2
7897106|NCT01920594|12405275|FG000|Overall Study|Lost to Follow-up|1
7897107|NCT01920594|12405276|FG001|Overall Study|Lost to Follow-up|0
7897108|NCT01920594|12405275|FG000|Overall Study|Recovery|2
7897109|NCT01920594|12405276|FG001|Overall Study|Recovery|0
7897110|NCT01920594|12405275|FG000|Overall Study|Investigator discretion|0
7897111|NCT01920594|12405276|FG001|Overall Study|Investigator discretion|1
7897112|NCT01920711|12405284|FG000|Overall Study|Death|347
7897113|NCT01920711|12405285|FG001|Overall Study|Death|356
7897114|NCT01920711|12405284|FG000|Overall Study|Lost to Follow-up|13
7897115|NCT01920711|12405285|FG001|Overall Study|Lost to Follow-up|14
7897116|NCT01920711|12405284|FG000|Overall Study|Withdrawal by Subject|4
7897117|NCT01920711|12405285|FG001|Overall Study|Withdrawal by Subject|3
7897118|NCT01920854|12405312|FG000|Overall Study|Withdrawal by Subject|1
7897119|NCT01920854|12405313|FG001|Overall Study|Withdrawal by Subject|0
7897120|NCT01920854|12405314|FG002|Overall Study|Withdrawal by Subject|0
7897121|NCT01920854|12405315|FG003|Overall Study|Withdrawal by Subject|0
7897122|NCT01920854|12405316|FG004|Overall Study|Withdrawal by Subject|1
7897123|NCT01920854|12405317|FG005|Overall Study|Withdrawal by Subject|0
7897124|NCT01920854|12405318|FG006|Overall Study|Withdrawal by Subject|1
7897125|NCT01920893|12405355|FG000|Overall Study|Adverse Event|5
7897126|NCT01920893|12405356|FG001|Overall Study|Adverse Event|2
7897127|NCT01920893|12405355|FG000|Overall Study|Lack of Efficacy|2
7897128|NCT01920893|12405356|FG001|Overall Study|Lack of Efficacy|0
7897129|NCT01920958|12405363|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5
7897130|NCT01921101|12405369|FG000|Overall Study|Death|16
7897131|NCT01921101|12405370|FG001|Overall Study|Death|6
7897132|NCT01921179|12405378|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
7897133|NCT01921179|12405379|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
7897134|NCT01921179|12405378|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2
7897135|NCT01921179|12405379|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0
7897136|NCT01921205|12405388|FG000|Overall Study|Adverse Event|12
7897137|NCT01921205|12405389|FG001|Overall Study|Adverse Event|7
7897138|NCT01921205|12405388|FG000|Overall Study|Lack of Efficacy|1
7897139|NCT01921205|12405389|FG001|Overall Study|Lack of Efficacy|0
7897140|NCT01921205|12405388|FG000|Overall Study|Protocol Violation|1
7897141|NCT01921205|12405389|FG001|Overall Study|Protocol Violation|3
7897142|NCT01921205|12405388|FG000|Overall Study|Lost to Follow-up|1
7897143|NCT01921205|12405389|FG001|Overall Study|Lost to Follow-up|1
7897144|NCT01921205|12405388|FG000|Overall Study|Withdrawal by Subject|6
7897145|NCT01921205|12405389|FG001|Overall Study|Withdrawal by Subject|5
7897146|NCT01921205|12405388|FG000|Overall Study|Use Of Prohibited Medication|0
7897147|NCT01921205|12405389|FG001|Overall Study|Use Of Prohibited Medication|1
7897148|NCT01921205|12405388|FG000|Overall Study|The Excessive Use Of Rescue Medication|0
7897149|NCT01921205|12405389|FG001|Overall Study|The Excessive Use Of Rescue Medication|1
7897150|NCT01921205|12405388|FG000|Overall Study|Non Compliance Of The Parent|0
7897151|NCT01921205|12405389|FG001|Overall Study|Non Compliance Of The Parent|1
7897152|NCT01921205|12405388|FG000|Overall Study|Non Compliance Of Child|0
7897153|NCT01921205|12405389|FG001|Overall Study|Non Compliance Of Child|1
7897154|NCT01921257|12405395|FG000|Overall Study|Adverse Event|1
7897155|NCT01921257|12405395|FG000|Overall Study|Protocol Violation|1
7897156|NCT01921257|12405395|FG000|Overall Study|Withdrawal by Subject|1
7897157|NCT01921270|12405400|FG000|Overall Study|Withdrawal by Subject|1
7897158|NCT01921348|12405419|FG000|Overall Study|Withdrawal by Subject|1
7897159|NCT01921348|12405420|FG001|Overall Study|Withdrawal by Subject|0
7897160|NCT01921348|12405419|FG000|Overall Study|Lost to Follow-up|0
7897161|NCT01921348|12405420|FG001|Overall Study|Lost to Follow-up|2
7897162|NCT01921387|12405426|FG000|Overall Study|Adverse Event|1
7897163|NCT01921517|12405437|FG000|Overall Study|Lost to Follow-up|5
7897164|NCT01921517|12405438|FG001|Overall Study|Lost to Follow-up|0
7897165|NCT01921517|12405437|FG000|Overall Study|Newly diagnosed health concern|2
7897166|NCT01921517|12405438|FG001|Overall Study|Newly diagnosed health concern|0
7897167|NCT01921517|12405437|FG000|Overall Study|Physician Decision|0
7897168|NCT01921517|12405438|FG001|Overall Study|Physician Decision|2
7897169|NCT01921517|12405437|FG000|Overall Study|Withdrawal by Subject|7
7897170|NCT01921517|12405438|FG001|Overall Study|Withdrawal by Subject|3
7897171|NCT01921517|12405437|FG000|Overall Study|Subject missed final imaging|1
7897172|NCT01921517|12405438|FG001|Overall Study|Subject missed final imaging|4
7897173|NCT01921829|12405465|FG000|Overall Study|Withdrawal by Subject|0
7897174|NCT01921829|12405466|FG001|Overall Study|Withdrawal by Subject|1
7897175|NCT01922011|12405499|FG000|Overall Study|Protocol Violation|0
7897176|NCT01922011|12405500|FG001|Overall Study|Protocol Violation|1
7897177|NCT01922011|12405499|FG000|Overall Study|Physician Decision|0
7897178|NCT01922011|12405500|FG001|Overall Study|Physician Decision|1
7897179|NCT01922011|12405499|FG000|Overall Study|Parent/Guardian Decision|3
7897180|NCT01922011|12405500|FG001|Overall Study|Parent/Guardian Decision|0
7897181|NCT01922011|12405499|FG000|Overall Study|Lost to Follow-up|0
7897182|NCT01922011|12405500|FG001|Overall Study|Lost to Follow-up|1
7897183|NCT01922011|12405499|FG000|Overall Study|Missed Test-of-Cure Visit|0
7897184|NCT01922011|12405500|FG001|Overall Study|Missed Test-of-Cure Visit|2
7897185|NCT01922011|12405499|FG000|Overall Study|Not Treated|1
7897186|NCT01922011|12405500|FG001|Overall Study|Not Treated|0
7897187|NCT01922011|12405499|FG000|Overall Study|Lack of willing home health agency|1
7897188|NCT01922011|12405500|FG001|Overall Study|Lack of willing home health agency|0
7897189|NCT01922011|12405499|FG000|Overall Study|Randomized in error|1
7897190|NCT01922011|12405500|FG001|Overall Study|Randomized in error|0
7897191|NCT01922037|12405523|FG000|Overall Study|Withdrawal by Subject|2
7897192|NCT01922037|12405524|FG001|Overall Study|Withdrawal by Subject|44
7897193|NCT01922037|12405523|FG000|Overall Study|Adverse Event|1
7897194|NCT01922037|12405524|FG001|Overall Study|Adverse Event|7
7897195|NCT01922037|12405523|FG000|Overall Study|Death|0
7897196|NCT01922037|12405524|FG001|Overall Study|Death|5
7897197|NCT01922037|12405523|FG000|Overall Study|Pregnancy|0
7897198|NCT01922037|12405524|FG001|Overall Study|Pregnancy|2
7897199|NCT01922037|12405523|FG000|Overall Study|Participant non-compliance|4
7897200|NCT01922037|12405524|FG001|Overall Study|Participant non-compliance|46
7897201|NCT01922037|12405523|FG000|Overall Study|Investigator/Sponsor decision|1
7897202|NCT01922037|12405524|FG001|Overall Study|Investigator/Sponsor decision|4
7897203|NCT01922037|12405523|FG000|Overall Study|Other unspecified|2
7897204|NCT01922037|12405524|FG001|Overall Study|Other unspecified|66
7897205|NCT01922089|12405591|FG000|Overall Study|Adverse Event|18
7897206|NCT01922089|12405592|FG001|Overall Study|Adverse Event|13
7897207|NCT01922089|12405591|FG000|Overall Study|Protocol Deviation|10
7897208|NCT01922089|12405592|FG001|Overall Study|Protocol Deviation|7
7897209|NCT01922089|12405591|FG000|Overall Study|Withdrawal by Subject|3
7897210|NCT01922089|12405592|FG001|Overall Study|Withdrawal by Subject|4
7897211|NCT01922089|12405591|FG000|Overall Study|administrative problems|4
7897212|NCT01922089|12405592|FG001|Overall Study|administrative problems|1
7897213|NCT01922089|12405591|FG000|Overall Study|Physician Decision|2
7897214|NCT01922089|12405592|FG001|Overall Study|Physician Decision|3
7897215|NCT01922089|12405591|FG000|Overall Study|Death|2
7897216|NCT01922089|12405592|FG001|Overall Study|Death|1
7897217|NCT01922089|12405591|FG000|Overall Study|Lost to Follow-up|0
7897218|NCT01922089|12405592|FG001|Overall Study|Lost to Follow-up|1
7897219|NCT01922102|12405601|FG000|Overall Study|Withdrawal by Subject|7
7897220|NCT01922102|12405602|FG001|Overall Study|Withdrawal by Subject|3
7897221|NCT01922102|12405603|FG002|Overall Study|Withdrawal by Subject|7
7897222|NCT01922102|12405601|FG000|Overall Study|Physician Decision|0
7897223|NCT01922102|12405602|FG001|Overall Study|Physician Decision|2
7897224|NCT01922102|12405603|FG002|Overall Study|Physician Decision|1
7897225|NCT01922102|12405601|FG000|Overall Study|Adverse Event|1
7897226|NCT01922102|12405602|FG001|Overall Study|Adverse Event|2
7897227|NCT01922102|12405603|FG002|Overall Study|Adverse Event|0
7897228|NCT01922102|12405601|FG000|Overall Study|Lost to Follow-up|1
7897229|NCT01922102|12405602|FG001|Overall Study|Lost to Follow-up|0
7897230|NCT01922102|12405603|FG002|Overall Study|Lost to Follow-up|0
7897231|NCT01922102|12405601|FG000|Overall Study|Administrative problems|0
7897232|NCT01922102|12405602|FG001|Overall Study|Administrative problems|2
7897233|NCT01922102|12405603|FG002|Overall Study|Administrative problems|0
7897234|NCT01922258|12405630|FG000|Overall Study|Lost to Follow-up|1
7897235|NCT01922258|12405631|FG001|Overall Study|Lost to Follow-up|1
7897236|NCT01922258|12405630|FG000|Overall Study|Adverse Event|9
7897237|NCT01922258|12405631|FG001|Overall Study|Adverse Event|2
7897238|NCT01922258|12405630|FG000|Overall Study|Met Withdrawal Criteria|0
7897239|NCT01922258|12405631|FG001|Overall Study|Met Withdrawal Criteria|4
7897240|NCT01922258|12405630|FG000|Overall Study|Withdrawn by the Investigator|1
7897241|NCT01922258|12405631|FG001|Overall Study|Withdrawn by the Investigator|4
7897242|NCT01922258|12405630|FG000|Overall Study|Withdrawal by participant|5
7897243|NCT01922258|12405631|FG001|Overall Study|Withdrawal by participant|5
7897244|NCT01922271|12405639|FG000|WASHOUT Period|Withdrawal by Subject|1
7897245|NCT01922271|12405640|FG001|WASHOUT Period|Withdrawal by Subject|0
7897246|NCT01922349|12405663|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0
7897247|NCT01922349|12405664|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0
7897248|NCT01922349|12405665|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0
7897249|NCT01922349|12405666|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1
7897250|NCT01922739|12405702|FG000|Titration/Adjustment Period|Adverse Event|3
7897251|NCT01922739|12405702|FG000|Titration/Adjustment Period|Withdrawal by Subject|5
7897252|NCT01922739|12405702|FG000|Titration/Adjustment Period|Lost to Follow-up|1
7897253|NCT01922739|12405702|FG000|Titration/Adjustment Period|Lack of Efficacy|3
7897254|NCT01922739|12405702|FG000|Open-label Treatment Period|Adverse Event|6
7897255|NCT01922739|12405702|FG000|Open-label Treatment Period|Withdrawal by Subject|14
7897256|NCT01922739|12405702|FG000|Open-label Treatment Period|Noncompliance to study medication|3
7897257|NCT01922739|12405702|FG000|Open-label Treatment Period|Protocol Violation|5
7897258|NCT01922739|12405702|FG000|Open-label Treatment Period|Pregnancy|1
7897259|NCT01922739|12405702|FG000|Open-label Treatment Period|Noncompliance to study procedures|1
7897260|NCT01922739|12405702|FG000|Open-label Treatment Period|Lost to Follow-up|2
7897261|NCT01922739|12405702|FG000|Open-label Treatment Period|Physician Decision|1
7897262|NCT01922739|12405702|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1
7897263|NCT01922934|12405720|FG000|Eligible Patients|Death|0
7897264|NCT01922934|12405721|FG001|Eligible Patients|Death|7
7897265|NCT01922934|12405720|FG000|Eligible Patients|Physician Decision|17
7897266|NCT01922934|12405721|FG001|Eligible Patients|Physician Decision|0
7897267|NCT01922934|12405720|FG000|Eligible Patients|Did not meet inclusion criteria|36
7897268|NCT01922934|12405721|FG001|Eligible Patients|Did not meet inclusion criteria|81
7897269|NCT01922934|12405720|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
7897270|NCT01922934|12405721|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
7897271|NCT01922934|12405720|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
7897272|NCT01922934|12405721|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
7897273|NCT01922934|12405720|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
7897274|NCT01922934|12405721|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
7897275|NCT01923181|12405756|FG000|Overall Study|Protocol Violation|2
7897276|NCT01923181|12405757|FG001|Overall Study|Protocol Violation|2
7897277|NCT01923181|12405758|FG002|Overall Study|Protocol Violation|0
7897278|NCT01923181|12405759|FG003|Overall Study|Protocol Violation|2
7897279|NCT01923181|12405760|FG004|Overall Study|Protocol Violation|2
7897280|NCT01923181|12405761|FG005|Overall Study|Protocol Violation|1
7897281|NCT01923181|12405762|FG006|Overall Study|Protocol Violation|1
7897282|NCT01923181|12405763|FG007|Overall Study|Protocol Violation|2
7897283|NCT01923181|12405764|FG008|Overall Study|Protocol Violation|1
7897284|NCT01923181|12405756|FG000|Overall Study|Withdrawal by Subject|0
7897285|NCT01923181|12405757|FG001|Overall Study|Withdrawal by Subject|1
7897286|NCT01923181|12405758|FG002|Overall Study|Withdrawal by Subject|0
7897287|NCT01923181|12405759|FG003|Overall Study|Withdrawal by Subject|1
7897288|NCT01923181|12405760|FG004|Overall Study|Withdrawal by Subject|4
7897289|NCT01923181|12405761|FG005|Overall Study|Withdrawal by Subject|2
7897290|NCT01923181|12405762|FG006|Overall Study|Withdrawal by Subject|4
7897291|NCT01923181|12405763|FG007|Overall Study|Withdrawal by Subject|3
7897292|NCT01923181|12405764|FG008|Overall Study|Withdrawal by Subject|1
7897293|NCT01923181|12405756|FG000|Overall Study|Other|1
7897294|NCT01923181|12405757|FG001|Overall Study|Other|0
7897295|NCT01923181|12405758|FG002|Overall Study|Other|0
7897296|NCT01923181|12405759|FG003|Overall Study|Other|1
7897297|NCT01923181|12405760|FG004|Overall Study|Other|0
7897298|NCT01923181|12405761|FG005|Overall Study|Other|0
7897299|NCT01923181|12405762|FG006|Overall Study|Other|0
7897300|NCT01923181|12405763|FG007|Overall Study|Other|0
7897301|NCT01923181|12405764|FG008|Overall Study|Other|0
7897302|NCT01923181|12405756|FG000|Overall Study|Lost to Follow-up|0
7897303|NCT01923181|12405757|FG001|Overall Study|Lost to Follow-up|3
7897304|NCT01923181|12405758|FG002|Overall Study|Lost to Follow-up|2
7897305|NCT01923181|12405759|FG003|Overall Study|Lost to Follow-up|1
7897306|NCT01923181|12405760|FG004|Overall Study|Lost to Follow-up|2
7897307|NCT01923181|12405761|FG005|Overall Study|Lost to Follow-up|1
7897308|NCT01923181|12405762|FG006|Overall Study|Lost to Follow-up|3
7897309|NCT01923181|12405763|FG007|Overall Study|Lost to Follow-up|3
7897310|NCT01923181|12405764|FG008|Overall Study|Lost to Follow-up|1
7897311|NCT01923285|12405789|FG000|Overall Study|Withdrawal by Subject|7
7897312|NCT01923285|12405790|FG001|Overall Study|Withdrawal by Subject|6
7897313|NCT01923311|12405798|FG000|Overall Study|Pregnancy|1
7897314|NCT01923311|12405799|FG001|Overall Study|Pregnancy|0
7897315|NCT01923311|12405798|FG000|Overall Study|Investigator's Discretion|1
7897316|NCT01923311|12405799|FG001|Overall Study|Investigator's Discretion|0
7897317|NCT01923311|12405798|FG000|Overall Study|Non-Compliance with Study Drug|2
7897318|NCT01923311|12405799|FG001|Overall Study|Non-Compliance with Study Drug|1
7897319|NCT01923311|12405798|FG000|Overall Study|Withdrew Consent|1
7897320|NCT01923311|12405799|FG001|Overall Study|Withdrew Consent|0
7897321|NCT01923311|12405798|FG000|Overall Study|Study Terminated by Sponsor|12
7897322|NCT01923311|12405799|FG001|Overall Study|Study Terminated by Sponsor|0
7897323|NCT01923363|12405806|FG000|Overall Study|Protocol Violation|1
7897324|NCT01923389|12405812|FG000|Overall Study|Protocol Violation|1
7897325|NCT01923389|12405813|FG001|Overall Study|Protocol Violation|0
7897326|NCT01923428|12405824|FG000|Overall Study|Adverse Event|8
7897327|NCT01923428|12405825|FG001|Overall Study|Adverse Event|6
7897328|NCT01923428|12405826|FG002|Overall Study|Adverse Event|3
7897329|NCT01923428|12405827|FG003|Overall Study|Adverse Event|3
7897330|NCT01923428|12405824|FG000|Overall Study|Withdrawal by Subject|5
7897331|NCT01923428|12405825|FG001|Overall Study|Withdrawal by Subject|3
7897332|NCT01923428|12405826|FG002|Overall Study|Withdrawal by Subject|0
7897333|NCT01923428|12405827|FG003|Overall Study|Withdrawal by Subject|4
7897334|NCT01923428|12405824|FG000|Overall Study|Lost to Follow-up|2
7897335|NCT01923428|12405825|FG001|Overall Study|Lost to Follow-up|1
7897336|NCT01923428|12405826|FG002|Overall Study|Lost to Follow-up|5
7897337|NCT01923428|12405827|FG003|Overall Study|Lost to Follow-up|0
7897338|NCT01923428|12405824|FG000|Overall Study|Protocol Violation|3
7717827|NCT00522379|12141464|FG000|Overall Study|Subject Moved|1
7717828|NCT00522379|12141465|FG001|Overall Study|Subject Moved|1
7717829|NCT00522379|12141466|FG002|Overall Study|Subject Moved|0
7717830|NCT00522379|12141467|FG003|Overall Study|Subject Moved|0
7717831|NCT00522379|12141468|FG004|Overall Study|Subject Moved|0
7717832|NCT00522379|12141464|FG000|Overall Study|Sponsor Request|0
7717833|NCT00522379|12141465|FG001|Overall Study|Sponsor Request|1
7717834|NCT00522379|12141466|FG002|Overall Study|Sponsor Request|0
7717835|NCT00522379|12141467|FG003|Overall Study|Sponsor Request|0
7717836|NCT00522379|12141468|FG004|Overall Study|Sponsor Request|0
7717837|NCT00522379|12141464|FG000|Overall Study|Family Problem|0
7717838|NCT00522379|12141465|FG001|Overall Study|Family Problem|0
7717839|NCT00522379|12141466|FG002|Overall Study|Family Problem|1
7717840|NCT00522379|12141467|FG003|Overall Study|Family Problem|0
7717841|NCT00522379|12141468|FG004|Overall Study|Family Problem|0
7717842|NCT00522379|12141464|FG000|Overall Study|Site Closed|0
7717843|NCT00522379|12141465|FG001|Overall Study|Site Closed|0
7717844|NCT00522379|12141466|FG002|Overall Study|Site Closed|0
7717845|NCT00522379|12141467|FG003|Overall Study|Site Closed|1
7717846|NCT00522379|12141468|FG004|Overall Study|Site Closed|0
7717847|NCT00522379|12141464|FG000|Overall Study|Subject Withdrawal|0
7717848|NCT00522379|12141465|FG001|Overall Study|Subject Withdrawal|0
7717849|NCT00522379|12141466|FG002|Overall Study|Subject Withdrawal|0
7717850|NCT00522379|12141467|FG003|Overall Study|Subject Withdrawal|1
7717851|NCT00522379|12141468|FG004|Overall Study|Subject Withdrawal|0
7717852|NCT00522392|12141482|FG000|Overall Study|Disease progression|0
7717853|NCT00522392|12141483|FG001|Overall Study|Disease progression|3
7717854|NCT00522392|12141482|FG000|Overall Study|Adverse Event|7
7717855|NCT00522392|12141483|FG001|Overall Study|Adverse Event|7
7717856|NCT00522392|12141482|FG000|Overall Study|Withdrawal by Subject|1
7717857|NCT00522392|12141483|FG001|Overall Study|Withdrawal by Subject|1
7717858|NCT00522392|12141482|FG000|Overall Study|Physician Decision|0
7717859|NCT00522392|12141483|FG001|Overall Study|Physician Decision|1
7717860|NCT00522392|12141482|FG000|Overall Study|Non-compliance|0
7717861|NCT00522392|12141483|FG001|Overall Study|Non-compliance|1
7717862|NCT00522418|12141491|FG000|Overall Study|Local IRB Consent Violation|5
7897339|NCT01923428|12405825|FG001|Overall Study|Protocol Violation|0
7897340|NCT01923428|12405826|FG002|Overall Study|Protocol Violation|2
7897341|NCT01923428|12405827|FG003|Overall Study|Protocol Violation|1
7897342|NCT01923428|12405824|FG000|Overall Study|Non Compliance to treatment|1
7897343|NCT01923428|12405825|FG001|Overall Study|Non Compliance to treatment|2
7897344|NCT01923428|12405826|FG002|Overall Study|Non Compliance to treatment|0
7897345|NCT01923428|12405827|FG003|Overall Study|Non Compliance to treatment|1
7897346|NCT01923428|12405824|FG000|Overall Study|Lack of Efficacy|0
7897347|NCT01923428|12405825|FG001|Overall Study|Lack of Efficacy|0
7897348|NCT01923428|12405826|FG002|Overall Study|Lack of Efficacy|1
7897349|NCT01923428|12405827|FG003|Overall Study|Lack of Efficacy|1
7897350|NCT01923467|12405837|FG000|Overall Study|Lost to Follow-up|62
7897351|NCT01923467|12405837|FG000|Overall Study|Subject non-interest|479
7897352|NCT01923740|12405843|FG000|Overall Study|Lost to Follow-up|4
7897353|NCT01923740|12405844|FG001|Overall Study|Lost to Follow-up|9
7717863|NCT00522418|12141492|FG001|Overall Study|Local IRB Consent Violation|5
7717864|NCT00522418|12141491|FG000|Overall Study|Early Study Termination|46
7717865|NCT00522418|12141492|FG001|Overall Study|Early Study Termination|47
7717866|NCT00522418|12141491|FG000|Overall Study|Noncompliance|2
7717867|NCT00522418|12141492|FG001|Overall Study|Noncompliance|2
7717868|NCT00522418|12141491|FG000|Overall Study|Reason Not Specified|3
7717869|NCT00522418|12141492|FG001|Overall Study|Reason Not Specified|1
7897354|NCT01923740|12405843|FG000|Overall Study|Withdrawal by Subject|2
7897355|NCT01923740|12405844|FG001|Overall Study|Withdrawal by Subject|0
7897356|NCT01923896|12405861|FG000|Overall Study|Adverse Event|1
7897357|NCT01923896|12405862|FG001|Overall Study|Adverse Event|0
7897358|NCT01924182|12405887|FG000|Overall Study|Withdrawal by Subject|1
7897359|NCT01924182|12405888|FG001|Overall Study|Withdrawal by Subject|0
7897360|NCT01924299|12405896|FG000|Period 2|Withdrawal by Subject|1
7897361|NCT01924299|12405897|FG001|Period 2|Withdrawal by Subject|0
7897362|NCT01924299|12405896|FG000|Period 2|Adverse Event|0
7897363|NCT01924299|12405897|FG001|Period 2|Adverse Event|1
7897364|NCT01924364|12405909|FG000|Overall Study|Physician Decision|3
7897365|NCT01924429|12405935|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3
7897366|NCT01924429|12405936|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2
7897367|NCT01924689|12405973|FG000|Overall Study|Death|0
7897368|NCT01924689|12405974|FG001|Overall Study|Death|1
7897369|NCT01924689|12405975|FG002|Overall Study|Death|0
7897370|NCT01924689|12405976|FG003|Overall Study|Death|1
7897371|NCT01924689|12405977|FG004|Overall Study|Death|0
7897372|NCT01924689|12405978|FG005|Overall Study|Death|0
7897373|NCT01924689|12405973|FG000|Overall Study|Disease progression|0
7897374|NCT01924689|12405974|FG001|Overall Study|Disease progression|0
7897375|NCT01924689|12405975|FG002|Overall Study|Disease progression|2
7897376|NCT01924689|12405976|FG003|Overall Study|Disease progression|0
7897377|NCT01924689|12405977|FG004|Overall Study|Disease progression|3
7897378|NCT01924689|12405978|FG005|Overall Study|Disease progression|2
7897379|NCT01924689|12405973|FG000|Overall Study|New therapy or study|3
7897380|NCT01924689|12405974|FG001|Overall Study|New therapy or study|2
7897381|NCT01924689|12405975|FG002|Overall Study|New therapy or study|1
7897382|NCT01924689|12405976|FG003|Overall Study|New therapy or study|4
7897383|NCT01924689|12405977|FG004|Overall Study|New therapy or study|2
7897384|NCT01924689|12405978|FG005|Overall Study|New therapy or study|0
7897385|NCT01924689|12405973|FG000|Overall Study|Withdrawal of consent|0
7897386|NCT01924689|12405974|FG001|Overall Study|Withdrawal of consent|0
7897387|NCT01924689|12405975|FG002|Overall Study|Withdrawal of consent|1
7897388|NCT01924689|12405976|FG003|Overall Study|Withdrawal of consent|1
7897389|NCT01924689|12405977|FG004|Overall Study|Withdrawal of consent|0
7897390|NCT01924689|12405978|FG005|Overall Study|Withdrawal of consent|0
7897391|NCT01924689|12405973|FG000|Overall Study|Other|0
7897392|NCT01924689|12405974|FG001|Overall Study|Other|0
7897393|NCT01924689|12405975|FG002|Overall Study|Other|0
7897394|NCT01924689|12405976|FG003|Overall Study|Other|0
7897395|NCT01924689|12405977|FG004|Overall Study|Other|1
7897396|NCT01924689|12405978|FG005|Overall Study|Other|0
7897397|NCT01924754|12405999|FG000|Overall Study|Lost to Follow-up|1
7897398|NCT01924754|12406000|FG001|Overall Study|Lost to Follow-up|2
7897399|NCT01924754|12406001|FG002|Overall Study|Lost to Follow-up|1
7897400|NCT01924754|12405999|FG000|Overall Study|Pregnancy|0
7897401|NCT01924754|12406000|FG001|Overall Study|Pregnancy|1
7897402|NCT01924754|12406001|FG002|Overall Study|Pregnancy|2
7897403|NCT01924767|12406017|FG000|Overall Study|Adverse Event|1
7897404|NCT01924767|12406018|FG001|Overall Study|Adverse Event|0
7897405|NCT01924767|12406019|FG002|Overall Study|Adverse Event|1
7897406|NCT01924767|12406020|FG003|Overall Study|Adverse Event|0
7897407|NCT01924767|12406021|FG004|Overall Study|Adverse Event|0
7897408|NCT01924806|12406040|FG000|Overall Study|Physician Decision|2
7897409|NCT01924806|12406041|FG001|Overall Study|Physician Decision|1
7897410|NCT01924845|12406047|FG000|Overall Study|Adverse Event|3
7897411|NCT01924845|12406047|FG000|Overall Study|Withdrawal by Subject|2
7897412|NCT01924845|12406047|FG000|Overall Study|Protocol Violation|1
7897413|NCT01925014|12406082|FG000|Overall Study|Inappropriate enrollment|4
7897414|NCT01925014|12406083|FG001|Overall Study|Inappropriate enrollment|6
7897415|NCT01925014|12406082|FG000|Overall Study|Withdrawal by Subject|5
7897416|NCT01925014|12406083|FG001|Overall Study|Withdrawal by Subject|13
7897417|NCT01925170|12406096|FG000|Overall Study|Unverified cancer status|53
7897418|NCT01925183|12406104|FG000|Overall Study|Adverse Event|1
7897419|NCT01925183|12406105|FG001|Overall Study|Adverse Event|0
7897420|NCT01925209|12406115|FG000|Treatment Epoch|Physician Decision|1
7897421|NCT01925209|12406116|FG001|Treatment Epoch|Physician Decision|0
7897422|NCT01925209|12406117|FG002|Treatment Epoch|Physician Decision|0
7897423|NCT01925209|12406118|FG003|Treatment Epoch|Physician Decision|0
7897424|NCT01925209|12406115|FG000|Treatment Epoch|Non-compliance with study treatment|0
7897425|NCT01925209|12406116|FG001|Treatment Epoch|Non-compliance with study treatment|0
7897426|NCT01925209|12406117|FG002|Treatment Epoch|Non-compliance with study treatment|0
7897427|NCT01925209|12406118|FG003|Treatment Epoch|Non-compliance with study treatment|1
7897428|NCT01925209|12406115|FG000|Treatment Epoch|Death|1
7897429|NCT01925209|12406116|FG001|Treatment Epoch|Death|0
7897430|NCT01925209|12406117|FG002|Treatment Epoch|Death|0
7897431|NCT01925209|12406118|FG003|Treatment Epoch|Death|0
7897432|NCT01925209|12406115|FG000|Treatment Epoch|Protocol deviation|0
7897433|NCT01925209|12406116|FG001|Treatment Epoch|Protocol deviation|0
7897434|NCT01925209|12406117|FG002|Treatment Epoch|Protocol deviation|1
7897435|NCT01925209|12406118|FG003|Treatment Epoch|Protocol deviation|1
7897436|NCT01925209|12406115|FG000|Treatment Epoch|Withdrawal by Subject|4
7897437|NCT01925209|12406116|FG001|Treatment Epoch|Withdrawal by Subject|3
7897438|NCT01925209|12406117|FG002|Treatment Epoch|Withdrawal by Subject|3
7897439|NCT01925209|12406118|FG003|Treatment Epoch|Withdrawal by Subject|2
7897440|NCT01925209|12406115|FG000|Treatment Epoch|Adverse Event|3
7897441|NCT01925209|12406116|FG001|Treatment Epoch|Adverse Event|5
7897442|NCT01925209|12406117|FG002|Treatment Epoch|Adverse Event|3
7897443|NCT01925209|12406118|FG003|Treatment Epoch|Adverse Event|1
7897444|NCT01925209|12406115|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0
7897445|NCT01925209|12406116|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1
7897446|NCT01925209|12406117|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1
7897447|NCT01925209|12406118|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2
7897448|NCT01925209|12406115|FG000|Maintenance Treatment Epoch|Adverse Event|0
7897449|NCT01925209|12406116|FG001|Maintenance Treatment Epoch|Adverse Event|0
7897450|NCT01925209|12406117|FG002|Maintenance Treatment Epoch|Adverse Event|1
7897451|NCT01925209|12406118|FG003|Maintenance Treatment Epoch|Adverse Event|0
7897452|NCT01925209|12406115|FG000|Follow-up|Adverse Event|1
7897453|NCT01925209|12406116|FG001|Follow-up|Adverse Event|4
7897454|NCT01925209|12406117|FG002|Follow-up|Adverse Event|0
7897455|NCT01925209|12406118|FG003|Follow-up|Adverse Event|1
7897456|NCT01925209|12406115|FG000|Follow-up|Physician Decision|0
7897457|NCT01925209|12406116|FG001|Follow-up|Physician Decision|0
7897458|NCT01925209|12406117|FG002|Follow-up|Physician Decision|1
7897459|NCT01925209|12406118|FG003|Follow-up|Physician Decision|0
7897460|NCT01925209|12406115|FG000|Follow-up|Non-compliance with study treatment|0
7897461|NCT01925209|12406116|FG001|Follow-up|Non-compliance with study treatment|0
7897462|NCT01925209|12406117|FG002|Follow-up|Non-compliance with study treatment|0
7897463|NCT01925209|12406118|FG003|Follow-up|Non-compliance with study treatment|1
7897464|NCT01925209|12406115|FG000|Follow-up|Withdrawal by Subject|0
7897465|NCT01925209|12406116|FG001|Follow-up|Withdrawal by Subject|2
7897466|NCT01925209|12406117|FG002|Follow-up|Withdrawal by Subject|0
7897467|NCT01925209|12406118|FG003|Follow-up|Withdrawal by Subject|2
7897468|NCT01925274|12406131|FG000|Overall Study|Death|1
7897469|NCT01925274|12406132|FG001|Overall Study|Death|0
7897470|NCT01925274|12406133|FG002|Overall Study|Death|0
7897471|NCT01925274|12406131|FG000|Overall Study|Lost to Follow-up|0
7897472|NCT01925274|12406132|FG001|Overall Study|Lost to Follow-up|1
7897473|NCT01925274|12406133|FG002|Overall Study|Lost to Follow-up|0
7897474|NCT01925274|12406131|FG000|Overall Study|Withdrawal by Subject|1
7897475|NCT01925274|12406132|FG001|Overall Study|Withdrawal by Subject|2
7897476|NCT01925274|12406133|FG002|Overall Study|Withdrawal by Subject|0
7897477|NCT01925274|12406131|FG000|Overall Study|Study terminated by sponsor|4
7897478|NCT01925274|12406132|FG001|Overall Study|Study terminated by sponsor|0
7897479|NCT01925274|12406133|FG002|Overall Study|Study terminated by sponsor|0
7897480|NCT01925274|12406131|FG000|Overall Study|Protocol amendment|1
7897481|NCT01925274|12406132|FG001|Overall Study|Protocol amendment|3
7897482|NCT01925274|12406133|FG002|Overall Study|Protocol amendment|6
7897483|NCT01925339|12406145|FG000|Overall Study|Adverse Event|2
7897484|NCT01925339|12406146|FG001|Overall Study|Adverse Event|0
7897485|NCT01925417|12406169|FG000|Overall Study|Withdrawal by Subject|2
7897486|NCT01925417|12406169|FG000|Overall Study|Death|1
7963531|NCT02723591|12518039|FG001|Overall Study|Lost to Follow-up|7
7963532|NCT02723591|12518038|FG000|Overall Study|Protocol Violation|20
7963533|NCT02723591|12518039|FG001|Overall Study|Protocol Violation|23
7963534|NCT02723591|12518038|FG000|Overall Study|Withdrawal by Subject|4
7963535|NCT02723591|12518039|FG001|Overall Study|Withdrawal by Subject|8
7963536|NCT02723591|12518038|FG000|Overall Study|Randomized but Never Received StudyDrug|12
7963537|NCT02723591|12518039|FG001|Overall Study|Randomized but Never Received StudyDrug|12
7963538|NCT02723591|12518038|FG000|Overall Study|Miscellaneous|5
7963539|NCT02723591|12518039|FG001|Overall Study|Miscellaneous|6
7963540|NCT02723630|12518051|FG000|Intervention Period 1|Adverse Event|1
7963541|NCT02723630|12518052|FG001|Intervention Period 1|Adverse Event|0
7963542|NCT02723630|12518053|FG002|Intervention Period 1|Adverse Event|0
7963543|NCT02723630|12518054|FG003|Intervention Period 1|Adverse Event|0
7963544|NCT02723630|12518055|FG004|Intervention Period 1|Adverse Event|0
7963545|NCT02723630|12518056|FG005|Intervention Period 1|Adverse Event|0
7963546|NCT02723630|12518051|FG000|Intervention Period 3|consumption of restricted item|0
7963547|NCT02723630|12518052|FG001|Intervention Period 3|consumption of restricted item|1
7963548|NCT02723630|12518053|FG002|Intervention Period 3|consumption of restricted item|0
7963549|NCT02723630|12518054|FG003|Intervention Period 3|consumption of restricted item|0
7963550|NCT02723630|12518055|FG004|Intervention Period 3|consumption of restricted item|0
7963551|NCT02723630|12518056|FG005|Intervention Period 3|consumption of restricted item|0
7963552|NCT02723786|12518069|FG000|Overall Study|Lost to Follow-up|1
7963553|NCT02724020|12518085|FG000|Overall Study|Death|16
7963554|NCT02724020|12518086|FG001|Overall Study|Death|18
7963555|NCT02724020|12518087|FG002|Overall Study|Death|19
7963556|NCT02724020|12518085|FG000|Overall Study|Lost to Follow-up|0
7963557|NCT02724020|12518086|FG001|Overall Study|Lost to Follow-up|3
7963558|NCT02724020|12518087|FG002|Overall Study|Lost to Follow-up|0
7963559|NCT02724020|12518085|FG000|Overall Study|Site Terminated by Sponsor|15
7963560|NCT02724020|12518086|FG001|Overall Study|Site Terminated by Sponsor|8
7963561|NCT02724020|12518087|FG002|Overall Study|Site Terminated by Sponsor|8
7963562|NCT02724020|12518085|FG000|Overall Study|Withdrawal by Subject|1
7963563|NCT02724020|12518086|FG001|Overall Study|Withdrawal by Subject|3
7963564|NCT02724020|12518087|FG002|Overall Study|Withdrawal by Subject|5
7963565|NCT02724111|12518110|FG000|Overall Study|Protocol Violation|2
7963566|NCT02724111|12518111|FG001|Overall Study|Protocol Violation|5
7897487|NCT01925612|12406188|FG000|Overall Study|Progressive Disease|1
7897488|NCT01925612|12406189|FG001|Overall Study|Progressive Disease|1
7897489|NCT01925612|12406190|FG002|Overall Study|Progressive Disease|1
7897490|NCT01925612|12406191|FG003|Overall Study|Progressive Disease|0
7897491|NCT01925612|12406192|FG004|Overall Study|Progressive Disease|0
7897492|NCT01925612|12406188|FG000|Overall Study|Adverse Event|3
7897493|NCT01925612|12406189|FG001|Overall Study|Adverse Event|3
7897494|NCT01925612|12406190|FG002|Overall Study|Adverse Event|0
7897495|NCT01925612|12406191|FG003|Overall Study|Adverse Event|1
7897496|NCT01925612|12406192|FG004|Overall Study|Adverse Event|2
7897497|NCT01925703|12406208|FG000|Overall Study|Physician Decision|1
7897498|NCT01925703|12406208|FG000|Overall Study|Lost to Follow-up|2
7897499|NCT01925703|12406208|FG000|Overall Study|Discharge prior to full iron repletion|1
7897500|NCT01925768|12406214|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7897501|NCT01925768|12406215|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7897502|NCT01925768|12406214|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7897503|NCT01925768|12406215|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2
7897504|NCT01925768|12406214|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
7897505|NCT01925768|12406215|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
7897506|NCT01925768|12406214|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
7897507|NCT01925768|12406215|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
7897508|NCT01925768|12406214|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
7897509|NCT01925768|12406215|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
7897510|NCT01925768|12406214|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0
7897511|NCT01925768|12406215|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1
7897512|NCT01925768|12406214|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
7897513|NCT01925768|12406215|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
7897514|NCT01925768|12406214|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7
7897515|NCT01925768|12406215|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9
7897516|NCT01925768|12406214|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2
7897517|NCT01925768|12406215|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1
7897518|NCT01925768|12406214|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0
7897519|NCT01925768|12406215|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1
7897520|NCT01925768|12406214|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5
7897521|NCT01925768|12406215|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1
7897522|NCT01925950|12406236|FG000|Part 2|Withdrawal by Subject|1
7897523|NCT01925950|12406237|FG001|Part 2|Withdrawal by Subject|0
7897524|NCT01925989|12406245|FG000|Period 1|Sponsor Decision|1
7897525|NCT01925989|12406246|FG001|Period 1|Sponsor Decision|1
7897526|NCT01925989|12406247|FG002|Period 1|Sponsor Decision|0
7897527|NCT01925989|12406245|FG000|Period 1|Withdrawal by Subject|0
7897528|NCT01925989|12406246|FG001|Period 1|Withdrawal by Subject|1
7897529|NCT01925989|12406247|FG002|Period 1|Withdrawal by Subject|0
7897530|NCT01926015|12406261|FG000|Overall Study|Withdrawal by parent/guardian|0
7897531|NCT01926015|12406262|FG001|Overall Study|Withdrawal by parent/guardian|1
7897532|NCT01926015|12406261|FG000|Overall Study|Randomized not treated|2
7897533|NCT01926015|12406262|FG001|Overall Study|Randomized not treated|0
7897534|NCT01926028|12406271|FG000|Overall Study|Lost to Follow-up|7
7897535|NCT01926028|12406272|FG001|Overall Study|Lost to Follow-up|6
7897536|NCT01926028|12406273|FG002|Overall Study|Lost to Follow-up|0
7897537|NCT01926028|12406271|FG000|Overall Study|Physician Decision|1
7897538|NCT01926028|12406272|FG001|Overall Study|Physician Decision|5
7897539|NCT01926028|12406273|FG002|Overall Study|Physician Decision|0
7897540|NCT01926028|12406271|FG000|Overall Study|Withdrawal by Subject|9
7897541|NCT01926028|12406272|FG001|Overall Study|Withdrawal by Subject|9
7897542|NCT01926028|12406273|FG002|Overall Study|Withdrawal by Subject|2
7897543|NCT01926028|12406271|FG000|Overall Study|Non compliance or other reasons|4
7897544|NCT01926028|12406272|FG001|Overall Study|Non compliance or other reasons|2
7897545|NCT01926028|12406273|FG002|Overall Study|Non compliance or other reasons|0
7897546|NCT01926119|12406282|FG000|Overall Study|Withdrawal by Subject|1
7897547|NCT01926444|12406290|FG000|Overall Study|Colonoscopy not performed|0
7897548|NCT01926444|12406291|FG001|Overall Study|Colonoscopy not performed|0
7897549|NCT01926444|12406292|FG002|Overall Study|Colonoscopy not performed|4
7897550|NCT01926444|12406293|FG003|Overall Study|Colonoscopy not performed|2
7897551|NCT01926509|12406320|FG000|Overall Study|vital sign met discontinuation criteria|1
7897552|NCT01926509|12406321|FG001|Overall Study|vital sign met discontinuation criteria|0
7897553|NCT01926509|12406322|FG002|Overall Study|vital sign met discontinuation criteria|0
7897554|NCT01926509|12406323|FG003|Overall Study|vital sign met discontinuation criteria|0
7897555|NCT01926626|12406333|FG000|Overall Study|Withdrawal by Subject|15
7897556|NCT01926626|12406333|FG000|Overall Study|Lost to Follow-up|7
7897557|NCT01926782|12406343|FG000|Overall Study|Participant moved|2
7897558|NCT01926782|12406344|FG001|Overall Study|Participant moved|0
7897559|NCT01926782|12406345|FG002|Overall Study|Participant moved|1
7897560|NCT01926782|12406346|FG003|Overall Study|Participant moved|1
7897561|NCT01926782|12406347|FG004|Overall Study|Participant moved|0
7897562|NCT01926782|12406348|FG005|Overall Study|Participant moved|3
7897563|NCT01926782|12406343|FG000|Overall Study|Physician Decision|0
7897564|NCT01926782|12406344|FG001|Overall Study|Physician Decision|2
7897565|NCT01926782|12406345|FG002|Overall Study|Physician Decision|1
7897566|NCT01926782|12406346|FG003|Overall Study|Physician Decision|1
7897567|NCT01926782|12406347|FG004|Overall Study|Physician Decision|0
7897568|NCT01926782|12406348|FG005|Overall Study|Physician Decision|0
7897569|NCT01926782|12406343|FG000|Overall Study|Other than specified|2
7897570|NCT01926782|12406344|FG001|Overall Study|Other than specified|3
7897571|NCT01926782|12406345|FG002|Overall Study|Other than specified|5
7897572|NCT01926782|12406346|FG003|Overall Study|Other than specified|12
7897573|NCT01926782|12406347|FG004|Overall Study|Other than specified|4
7897574|NCT01926782|12406348|FG005|Overall Study|Other than specified|11
7897575|NCT01926782|12406343|FG000|Overall Study|Adverse Event|13
7897576|NCT01926782|12406344|FG001|Overall Study|Adverse Event|4
7897577|NCT01926782|12406345|FG002|Overall Study|Adverse Event|17
7897578|NCT01926782|12406346|FG003|Overall Study|Adverse Event|4
7897579|NCT01926782|12406347|FG004|Overall Study|Adverse Event|3
7897580|NCT01926782|12406348|FG005|Overall Study|Adverse Event|14
7897581|NCT01926782|12406343|FG000|Overall Study|Poor compliance to protocol|5
7897582|NCT01926782|12406344|FG001|Overall Study|Poor compliance to protocol|3
7897583|NCT01926782|12406345|FG002|Overall Study|Poor compliance to protocol|8
7897584|NCT01926782|12406346|FG003|Overall Study|Poor compliance to protocol|0
7897585|NCT01926782|12406347|FG004|Overall Study|Poor compliance to protocol|1
7897586|NCT01926782|12406348|FG005|Overall Study|Poor compliance to protocol|6
7897587|NCT01926782|12406343|FG000|Overall Study|Randomized and not treated|0
7897588|NCT01926782|12406344|FG001|Overall Study|Randomized and not treated|0
7897589|NCT01926782|12406345|FG002|Overall Study|Randomized and not treated|0
7897590|NCT01926782|12406346|FG003|Overall Study|Randomized and not treated|1
7897591|NCT01926782|12406347|FG004|Overall Study|Randomized and not treated|0
7897592|NCT01926782|12406348|FG005|Overall Study|Randomized and not treated|0
7897593|NCT01926782|12406343|FG000|Overall Study|Withdrawal by Subject|6
7897594|NCT01926782|12406344|FG001|Overall Study|Withdrawal by Subject|1
7897595|NCT01926782|12406345|FG002|Overall Study|Withdrawal by Subject|8
7897596|NCT01926782|12406346|FG003|Overall Study|Withdrawal by Subject|1
7897597|NCT01926782|12406347|FG004|Overall Study|Withdrawal by Subject|0
7897598|NCT01926782|12406348|FG005|Overall Study|Withdrawal by Subject|5
7897599|NCT01926782|12406343|FG000|Overall Study|Related to study drug administration|0
7897600|NCT01926782|12406344|FG001|Overall Study|Related to study drug administration|0
7897601|NCT01926782|12406345|FG002|Overall Study|Related to study drug administration|0
7897602|NCT01926782|12406346|FG003|Overall Study|Related to study drug administration|0
7897603|NCT01926782|12406347|FG004|Overall Study|Related to study drug administration|0
7897604|NCT01926782|12406348|FG005|Overall Study|Related to study drug administration|2
7897605|NCT01926886|12406363|FG000|Overall Study|Administrative/other|1
7897606|NCT01926886|12406364|FG001|Overall Study|Administrative/other|0
7897607|NCT01926886|12406363|FG000|Overall Study|Adverse event/intercurrent illness|4
7897608|NCT01926886|12406364|FG001|Overall Study|Adverse event/intercurrent illness|0
7897609|NCT01926886|12406363|FG000|Overall Study|Disease progression/recurrence|4
7897610|NCT01926886|12406364|FG001|Overall Study|Disease progression/recurrence|0
7897611|NCT01926886|12406363|FG000|Overall Study|Withdrawal by Subject|15
7897612|NCT01926886|12406364|FG001|Overall Study|Withdrawal by Subject|0
7897613|NCT01926886|12406363|FG000|Overall Study|Failure to return|3
7897614|NCT01926886|12406364|FG001|Overall Study|Failure to return|0
7897615|NCT01926886|12406363|FG000|Overall Study|Recurrence of disease|1
7897616|NCT01926886|12406364|FG001|Overall Study|Recurrence of disease|0
7897617|NCT01926886|12406363|FG000|Overall Study|Progression of disease|2
7897618|NCT01926886|12406364|FG001|Overall Study|Progression of disease|0
7897619|NCT01926886|12406363|FG000|Overall Study|Death|1
7897620|NCT01926886|12406364|FG001|Overall Study|Death|0
7897621|NCT01926886|12406363|FG000|Overall Study|Did not cooperate|1
7897622|NCT01926886|12406364|FG001|Overall Study|Did not cooperate|0
7897623|NCT01927055|12406382|FG000|Open-label|Adverse Event|6
7897624|NCT01927055|12406383|FG001|Open-label|Adverse Event|0
7897625|NCT01927055|12406384|FG002|Open-label|Adverse Event|0
7897626|NCT01927055|12406382|FG000|Open-label|Withdrawal by Subject|1
7897627|NCT01927055|12406383|FG001|Open-label|Withdrawal by Subject|0
7897628|NCT01927055|12406384|FG002|Open-label|Withdrawal by Subject|0
7897629|NCT01927055|12406382|FG000|Open-label|Study Stopped|4
7897630|NCT01927055|12406383|FG001|Open-label|Study Stopped|0
7897631|NCT01927055|12406384|FG002|Open-label|Study Stopped|0
7897632|NCT01927055|12406382|FG000|Open-label|Supine Hypertension|4
7897633|NCT01927055|12406383|FG001|Open-label|Supine Hypertension|0
7897634|NCT01927055|12406384|FG002|Open-label|Supine Hypertension|0
7897635|NCT01927055|12406382|FG000|Open-label|Difficulty attending study visits|1
7897636|NCT01927055|12406383|FG001|Open-label|Difficulty attending study visits|0
7897637|NCT01927055|12406384|FG002|Open-label|Difficulty attending study visits|0
7897638|NCT01927055|12406382|FG000|Double-Blind|Adverse Event|0
7897639|NCT01927055|12406383|FG001|Double-Blind|Adverse Event|1
7897640|NCT01927055|12406384|FG002|Double-Blind|Adverse Event|1
7897641|NCT01927055|12406382|FG000|Double-Blind|Protocol Violation|0
7897642|NCT01927055|12406383|FG001|Double-Blind|Protocol Violation|0
7897643|NCT01927055|12406384|FG002|Double-Blind|Protocol Violation|1
7897644|NCT01927055|12406382|FG000|Double-Blind|Withdrawal by Subject|0
7897645|NCT01927055|12406383|FG001|Double-Blind|Withdrawal by Subject|2
7897646|NCT01927055|12406384|FG002|Double-Blind|Withdrawal by Subject|3
7897647|NCT01927055|12406382|FG000|Double-Blind|Study Stopped|0
7897648|NCT01927055|12406383|FG001|Double-Blind|Study Stopped|7
7897649|NCT01927055|12406384|FG002|Double-Blind|Study Stopped|7
7897650|NCT01927055|12406382|FG000|Double-Blind|Supine Hypertension|0
7897651|NCT01927055|12406383|FG001|Double-Blind|Supine Hypertension|0
7897652|NCT01927055|12406384|FG002|Double-Blind|Supine Hypertension|1
7897653|NCT01927055|12406382|FG000|Double-Blind|Extended Vacation|0
7897654|NCT01927055|12406383|FG001|Double-Blind|Extended Vacation|1
7897655|NCT01927055|12406384|FG002|Double-Blind|Extended Vacation|0
7897656|NCT01927341|12406400|FG000|Phase 1b|Lost to Follow-up|1
7897657|NCT01927341|12406401|FG001|Phase 1b|Lost to Follow-up|0
7897658|NCT01927341|12406402|FG002|Phase 1b|Lost to Follow-up|0
7897659|NCT01927341|12406403|FG003|Phase 1b|Lost to Follow-up|0
7897660|NCT01927341|12406404|FG004|Phase 1b|Lost to Follow-up|0
7897661|NCT01927341|12406400|FG000|Phase 1b|Death|2
7897662|NCT01927341|12406401|FG001|Phase 1b|Death|0
7897663|NCT01927341|12406402|FG002|Phase 1b|Death|0
7897664|NCT01927341|12406403|FG003|Phase 1b|Death|0
7897665|NCT01927341|12406404|FG004|Phase 1b|Death|0
7897666|NCT01927341|12406400|FG000|Phase 1b|Follow-up completed|7
7897667|NCT01927341|12406401|FG001|Phase 1b|Follow-up completed|0
7897668|NCT01927341|12406402|FG002|Phase 1b|Follow-up completed|0
7897669|NCT01927341|12406403|FG003|Phase 1b|Follow-up completed|0
7897670|NCT01927341|12406404|FG004|Phase 1b|Follow-up completed|0
7897671|NCT01927341|12406400|FG000|Phase 2|Lost to Follow-up|0
7897672|NCT01927341|12406401|FG001|Phase 2|Lost to Follow-up|1
7897673|NCT01927341|12406402|FG002|Phase 2|Lost to Follow-up|0
7897674|NCT01927341|12406403|FG003|Phase 2|Lost to Follow-up|0
7897675|NCT01927341|12406404|FG004|Phase 2|Lost to Follow-up|0
7897676|NCT01927341|12406400|FG000|Phase 2|Participant withdrew consent|0
7897677|NCT01927341|12406401|FG001|Phase 2|Participant withdrew consent|2
7897678|NCT01927341|12406402|FG002|Phase 2|Participant withdrew consent|1
7897679|NCT01927341|12406403|FG003|Phase 2|Participant withdrew consent|2
7897680|NCT01927341|12406404|FG004|Phase 2|Participant withdrew consent|3
7897681|NCT01927341|12406400|FG000|Phase 2|Death|0
7897682|NCT01927341|12406401|FG001|Phase 2|Death|4
7897683|NCT01927341|12406402|FG002|Phase 2|Death|0
7897684|NCT01927341|12406403|FG003|Phase 2|Death|3
7897685|NCT01927341|12406404|FG004|Phase 2|Death|2
7897686|NCT01927341|12406400|FG000|Phase 2|New cancer therapy|0
7897687|NCT01927341|12406401|FG001|Phase 2|New cancer therapy|1
7897688|NCT01927341|12406402|FG002|Phase 2|New cancer therapy|0
7897689|NCT01927341|12406403|FG003|Phase 2|New cancer therapy|4
7897690|NCT01927341|12406404|FG004|Phase 2|New cancer therapy|1
7897691|NCT01927341|12406400|FG000|Phase 2|Disease progression|0
7897692|NCT01927341|12406401|FG001|Phase 2|Disease progression|1
7897693|NCT01927341|12406402|FG002|Phase 2|Disease progression|1
7897694|NCT01927341|12406403|FG003|Phase 2|Disease progression|1
7897695|NCT01927341|12406404|FG004|Phase 2|Disease progression|0
7897696|NCT01927341|12406400|FG000|Phase 2|Follow-up completed|0
7897697|NCT01927341|12406401|FG001|Phase 2|Follow-up completed|6
7897698|NCT01927341|12406402|FG002|Phase 2|Follow-up completed|3
7897699|NCT01927341|12406403|FG003|Phase 2|Follow-up completed|5
7897700|NCT01927341|12406404|FG004|Phase 2|Follow-up completed|2
7897701|NCT01927367|12406422|FG000|Overall Study|Withdrawal by Subject|7
7897702|NCT01927367|12406423|FG001|Overall Study|Withdrawal by Subject|4
7897703|NCT01927367|12406422|FG000|Overall Study|No baseline data|0
7897704|NCT01927367|12406423|FG001|Overall Study|No baseline data|1
7897705|NCT01927497|12406431|FG000|Overall Study|Death|0
7897706|NCT01927497|12406432|FG001|Overall Study|Death|1
7897707|NCT01927497|12406431|FG000|Overall Study|Protocol Violation|2
7897708|NCT01927497|12406432|FG001|Overall Study|Protocol Violation|0
7897709|NCT01927562|12406438|FG000|Overall Study|Lost to Follow-up|30
7897710|NCT01927562|12406438|FG000|Overall Study|Withdrawal by Subject|3
7897711|NCT01927562|12406438|FG000|Overall Study|Physician Decision|5
7897712|NCT01927627|12406450|FG000|Overall Study|Adverse Event|3
7897713|NCT01927627|12406450|FG000|Overall Study|Lack of Efficacy|1
7897714|NCT01927627|12406450|FG000|Overall Study|Financial Concerns|1
7897715|NCT01927757|12406458|FG000|Overall Study|Withdrawal by Subject|14
7897716|NCT01927757|12406458|FG000|Overall Study|Lost to Follow-up|2
7897717|NCT01927757|12406458|FG000|Overall Study|Decision by Sponsor|2
7897718|NCT01927757|12406458|FG000|Overall Study|Other|1
7897719|NCT01927757|12406458|FG000|Overall Study|Ethical Reasons|4
7897720|NCT01927861|12406468|FG000|Extension Phase (104 Weeks)|Adverse Event|0
7897721|NCT01927861|12406469|FG001|Extension Phase (104 Weeks)|Adverse Event|2
7897722|NCT01927861|12406468|FG000|Extension Phase (104 Weeks)|Unclassified|0
7897723|NCT01927861|12406469|FG001|Extension Phase (104 Weeks)|Unclassified|1
7897724|NCT01928225|12406504|FG000|Overall Study|Pregnancy|1
7897725|NCT01928225|12406505|FG001|Overall Study|Pregnancy|0
7897726|NCT01928225|12406504|FG000|Overall Study|basaloid cervical cancer|1
7897727|NCT01928225|12406505|FG001|Overall Study|basaloid cervical cancer|0
7897728|NCT01928225|12406504|FG000|Overall Study|Lost to Follow-up|1
7897729|NCT01928225|12406505|FG001|Overall Study|Lost to Follow-up|3
7897730|NCT01928329|12406523|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1
7897731|NCT01928329|12406524|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3
7897732|NCT01928329|12406523|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0
7897733|NCT01928329|12406524|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1
7897734|NCT01928329|12406523|FG000|Overall Study|Adverse Event|5
7897735|NCT01928329|12406524|FG001|Overall Study|Adverse Event|3
7897736|NCT01928329|12406523|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4
7897737|NCT01928329|12406524|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1
7897738|NCT01928329|12406523|FG000|Overall Study|Withdrawal by Subject|1
7897739|NCT01928329|12406524|FG001|Overall Study|Withdrawal by Subject|5
7897740|NCT01928329|12406523|FG000|Overall Study|Physician Decision|1
7897741|NCT01928329|12406524|FG001|Overall Study|Physician Decision|1
7897742|NCT01928381|12406530|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
7897743|NCT01928381|12406531|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7897744|NCT01928381|12406532|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7897745|NCT01928381|12406533|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7897746|NCT01928381|12406534|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7897747|NCT01928381|12406535|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7897748|NCT01928381|12406536|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7897749|NCT01928381|12406530|FG000|Part 1 - Pain Training|Pain training criteria not met|29
7897750|NCT01928381|12406531|FG001|Part 1 - Pain Training|Pain training criteria not met|0
7897751|NCT01928381|12406532|FG002|Part 1 - Pain Training|Pain training criteria not met|0
7897752|NCT01928381|12406533|FG003|Part 1 - Pain Training|Pain training criteria not met|0
7897753|NCT01928381|12406534|FG004|Part 1 - Pain Training|Pain training criteria not met|0
7897754|NCT01928381|12406535|FG005|Part 1 - Pain Training|Pain training criteria not met|0
7897755|NCT01928381|12406536|FG006|Part 1 - Pain Training|Pain training criteria not met|0
7897756|NCT01928381|12406530|FG000|Part 1 - Pain Training|Withdrawal by Subject|1
7897757|NCT01928381|12406531|FG001|Part 1 - Pain Training|Withdrawal by Subject|0
7897758|NCT01928381|12406532|FG002|Part 1 - Pain Training|Withdrawal by Subject|0
7897759|NCT01928381|12406533|FG003|Part 1 - Pain Training|Withdrawal by Subject|0
7897760|NCT01928381|12406534|FG004|Part 1 - Pain Training|Withdrawal by Subject|0
7897761|NCT01928381|12406535|FG005|Part 1 - Pain Training|Withdrawal by Subject|0
7897762|NCT01928381|12406536|FG006|Part 1 - Pain Training|Withdrawal by Subject|0
7897763|NCT01928381|12406530|FG000|Part 1 - Pain Training|Lost to Follow-up|4
7897764|NCT01928381|12406531|FG001|Part 1 - Pain Training|Lost to Follow-up|0
7897765|NCT01928381|12406532|FG002|Part 1 - Pain Training|Lost to Follow-up|0
7897766|NCT01928381|12406533|FG003|Part 1 - Pain Training|Lost to Follow-up|0
7897767|NCT01928381|12406534|FG004|Part 1 - Pain Training|Lost to Follow-up|0
7897768|NCT01928381|12406535|FG005|Part 1 - Pain Training|Lost to Follow-up|0
7897769|NCT01928381|12406536|FG006|Part 1 - Pain Training|Lost to Follow-up|0
7897770|NCT01928381|12406530|FG000|Part 1 - Pain Training|Protocol Violation|1
7897771|NCT01928381|12406531|FG001|Part 1 - Pain Training|Protocol Violation|0
7897772|NCT01928381|12406532|FG002|Part 1 - Pain Training|Protocol Violation|0
7897773|NCT01928381|12406533|FG003|Part 1 - Pain Training|Protocol Violation|0
7897774|NCT01928381|12406534|FG004|Part 1 - Pain Training|Protocol Violation|0
7897775|NCT01928381|12406535|FG005|Part 1 - Pain Training|Protocol Violation|0
7897776|NCT01928381|12406536|FG006|Part 1 - Pain Training|Protocol Violation|0
7897777|NCT01928381|12406530|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1
7897778|NCT01928381|12406531|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7897779|NCT01928381|12406532|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7897780|NCT01928381|12406533|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7897781|NCT01928381|12406534|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7897782|NCT01928381|12406535|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7897783|NCT01928381|12406536|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7897784|NCT01928381|12406530|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
7897785|NCT01928381|12406531|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7897786|NCT01928381|12406532|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7897787|NCT01928381|12406533|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7897788|NCT01928381|12406534|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7897789|NCT01928381|12406535|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7897790|NCT01928381|12406536|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7897791|NCT01928381|12406530|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
7897792|NCT01928381|12406531|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7897793|NCT01928381|12406532|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7897794|NCT01928381|12406533|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7897795|NCT01928381|12406534|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7897796|NCT01928381|12406535|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7897797|NCT01928381|12406536|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7897798|NCT01928381|12406530|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
7897799|NCT01928381|12406531|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7897800|NCT01928381|12406532|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7897801|NCT01928381|12406533|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7897802|NCT01928381|12406534|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7897803|NCT01928381|12406535|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7897804|NCT01928381|12406536|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7897805|NCT01928381|12406530|FG000|Part 2 - First Intervention|Withdrawal by Subject|0
7897806|NCT01928381|12406531|FG001|Part 2 - First Intervention|Withdrawal by Subject|0
7897807|NCT01928381|12406532|FG002|Part 2 - First Intervention|Withdrawal by Subject|1
7897808|NCT01928381|12406533|FG003|Part 2 - First Intervention|Withdrawal by Subject|0
7897809|NCT01928381|12406534|FG004|Part 2 - First Intervention|Withdrawal by Subject|0
7897810|NCT01928381|12406535|FG005|Part 2 - First Intervention|Withdrawal by Subject|0
7897811|NCT01928381|12406536|FG006|Part 2 - First Intervention|Withdrawal by Subject|0
7897812|NCT01928381|12406530|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0
7897813|NCT01928381|12406531|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0
7897814|NCT01928381|12406532|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1
7897815|NCT01928381|12406533|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0
7897816|NCT01928381|12406534|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0
7897817|NCT01928381|12406535|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0
7897818|NCT01928381|12406536|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0
7897819|NCT01928381|12406530|FG000|Part 2 - First Intervention|Eligibility criterion not met|0
7897820|NCT01928381|12406531|FG001|Part 2 - First Intervention|Eligibility criterion not met|0
7897821|NCT01928381|12406532|FG002|Part 2 - First Intervention|Eligibility criterion not met|0
7897822|NCT01928381|12406533|FG003|Part 2 - First Intervention|Eligibility criterion not met|0
7897823|NCT01928381|12406534|FG004|Part 2 - First Intervention|Eligibility criterion not met|0
7897824|NCT01928381|12406535|FG005|Part 2 - First Intervention|Eligibility criterion not met|1
7897825|NCT01928381|12406536|FG006|Part 2 - First Intervention|Eligibility criterion not met|1
7897826|NCT01928381|12406530|FG000|Part 2 - First Intervention|Lost to Follow-up|0
7897827|NCT01928381|12406531|FG001|Part 2 - First Intervention|Lost to Follow-up|0
7897828|NCT01928381|12406532|FG002|Part 2 - First Intervention|Lost to Follow-up|0
7897829|NCT01928381|12406533|FG003|Part 2 - First Intervention|Lost to Follow-up|1
7897830|NCT01928381|12406534|FG004|Part 2 - First Intervention|Lost to Follow-up|0
7897831|NCT01928381|12406535|FG005|Part 2 - First Intervention|Lost to Follow-up|0
7897832|NCT01928381|12406536|FG006|Part 2 - First Intervention|Lost to Follow-up|0
7897833|NCT01928381|12406530|FG000|Washout First Intervention|Protocol Violation|0
7897834|NCT01928381|12406531|FG001|Washout First Intervention|Protocol Violation|0
7897835|NCT01928381|12406532|FG002|Washout First Intervention|Protocol Violation|0
7897836|NCT01928381|12406533|FG003|Washout First Intervention|Protocol Violation|0
7897837|NCT01928381|12406534|FG004|Washout First Intervention|Protocol Violation|1
7897838|NCT01928381|12406535|FG005|Washout First Intervention|Protocol Violation|0
7897839|NCT01928381|12406536|FG006|Washout First Intervention|Protocol Violation|0
7897840|NCT01928381|12406530|FG000|Part 2 - Second Intervention|Lost to Follow-up|0
7897841|NCT01928381|12406531|FG001|Part 2 - Second Intervention|Lost to Follow-up|1
7897842|NCT01928381|12406532|FG002|Part 2 - Second Intervention|Lost to Follow-up|0
7897843|NCT01928381|12406533|FG003|Part 2 - Second Intervention|Lost to Follow-up|1
7897844|NCT01928381|12406534|FG004|Part 2 - Second Intervention|Lost to Follow-up|0
7897845|NCT01928381|12406535|FG005|Part 2 - Second Intervention|Lost to Follow-up|0
7897846|NCT01928381|12406536|FG006|Part 2 - Second Intervention|Lost to Follow-up|0
7897847|NCT01928381|12406530|FG000|Part 2 - Post Third Intervention|Protocol Violation|0
7897848|NCT01928381|12406531|FG001|Part 2 - Post Third Intervention|Protocol Violation|0
7897849|NCT01928381|12406532|FG002|Part 2 - Post Third Intervention|Protocol Violation|1
7897850|NCT01928381|12406533|FG003|Part 2 - Post Third Intervention|Protocol Violation|0
7897851|NCT01928381|12406534|FG004|Part 2 - Post Third Intervention|Protocol Violation|0
7897852|NCT01928381|12406535|FG005|Part 2 - Post Third Intervention|Protocol Violation|0
7897853|NCT01928381|12406536|FG006|Part 2 - Post Third Intervention|Protocol Violation|0
7897854|NCT01928433|12406549|FG000|Overall Study|Adverse Event|5
7897855|NCT01928433|12406550|FG001|Overall Study|Adverse Event|2
7897856|NCT01928433|12406551|FG002|Overall Study|Adverse Event|5
7897857|NCT01928433|12406549|FG000|Overall Study|Protocol Violation|0
7897858|NCT01928433|12406550|FG001|Overall Study|Protocol Violation|0
7897859|NCT01928433|12406551|FG002|Overall Study|Protocol Violation|2
7897860|NCT01928433|12406549|FG000|Overall Study|Lack of Efficacy|5
7897861|NCT01928433|12406550|FG001|Overall Study|Lack of Efficacy|4
7897862|NCT01928433|12406551|FG002|Overall Study|Lack of Efficacy|4
7897863|NCT01928433|12406549|FG000|Overall Study|Withdrawal by Subject|0
7897864|NCT01928433|12406550|FG001|Overall Study|Withdrawal by Subject|4
7897865|NCT01928433|12406551|FG002|Overall Study|Withdrawal by Subject|0
7897866|NCT01928433|12406549|FG000|Overall Study|Negative screening urine culture|7
7897867|NCT01928433|12406550|FG001|Overall Study|Negative screening urine culture|6
7897868|NCT01928433|12406551|FG002|Overall Study|Negative screening urine culture|10
7897869|NCT01928433|12406549|FG000|Overall Study|Lost to Follow-up|0
7897870|NCT01928433|12406550|FG001|Overall Study|Lost to Follow-up|2
7897871|NCT01928433|12406551|FG002|Overall Study|Lost to Follow-up|3
7897872|NCT01928433|12406549|FG000|Overall Study|Other reasons|3
7897873|NCT01928433|12406550|FG001|Overall Study|Other reasons|3
7897874|NCT01928433|12406551|FG002|Overall Study|Other reasons|4
7897875|NCT01928472|12406577|FG000|Overall Study|Death|0
7897876|NCT01928472|12406578|FG001|Overall Study|Death|0
7897877|NCT01928472|12406579|FG002|Overall Study|Death|1
7897878|NCT01928472|12406580|FG003|Overall Study|Death|0
7897879|NCT01928472|12406577|FG000|Overall Study|Withdrawal by Subject|4
7897880|NCT01928472|12406578|FG001|Overall Study|Withdrawal by Subject|4
7897881|NCT01928472|12406579|FG002|Overall Study|Withdrawal by Subject|1
7897882|NCT01928472|12406580|FG003|Overall Study|Withdrawal by Subject|2
7897883|NCT01928472|12406577|FG000|Overall Study|Lost to Follow-up|2
7897884|NCT01928472|12406578|FG001|Overall Study|Lost to Follow-up|3
7897885|NCT01928472|12406579|FG002|Overall Study|Lost to Follow-up|4
7897886|NCT01928472|12406580|FG003|Overall Study|Lost to Follow-up|0
7897887|NCT01928472|12406577|FG000|Overall Study|Administrative Reason|2
7897888|NCT01928472|12406578|FG001|Overall Study|Administrative Reason|1
7897889|NCT01928472|12406579|FG002|Overall Study|Administrative Reason|0
7897890|NCT01928472|12406580|FG003|Overall Study|Administrative Reason|0
7897891|NCT01928472|12406577|FG000|Overall Study|Unclassified|0
7897892|NCT01928472|12406578|FG001|Overall Study|Unclassified|0
7897893|NCT01928472|12406579|FG002|Overall Study|Unclassified|1
7897894|NCT01928472|12406580|FG003|Overall Study|Unclassified|0
7897895|NCT01928485|12406593|FG000|Overall Study|Physician Decision|0
7897896|NCT01928485|12406594|FG001|Overall Study|Physician Decision|1
7897897|NCT01928719|12406648|FG000|Overall Study|Lost to Follow-up|26
7897898|NCT01928719|12406649|FG001|Overall Study|Lost to Follow-up|11
7897899|NCT01928719|12406648|FG000|Overall Study|Withdrawal by Subject|22
7897900|NCT01928719|12406649|FG001|Overall Study|Withdrawal by Subject|7
7897901|NCT01928719|12406648|FG000|Overall Study|Protocol Violation|3
7897902|NCT01928719|12406649|FG001|Overall Study|Protocol Violation|1
7897903|NCT01928719|12406648|FG000|Overall Study|Adverse Event|1
7897904|NCT01928719|12406649|FG001|Overall Study|Adverse Event|0
7897905|NCT01928758|12406659|FG000|Overall Study|Lost to Follow-up|14
7897906|NCT01928758|12406660|FG001|Overall Study|Lost to Follow-up|9
7897907|NCT01928758|12406659|FG000|Overall Study|Withdrawal by Subject|5
7897908|NCT01928758|12406660|FG001|Overall Study|Withdrawal by Subject|2
7897909|NCT01928758|12406659|FG000|Overall Study|Adverse Event|3
7897910|NCT01928758|12406660|FG001|Overall Study|Adverse Event|5
7897911|NCT01928758|12406659|FG000|Overall Study|Protocol Violation|3
7897912|NCT01928758|12406660|FG001|Overall Study|Protocol Violation|4
7897913|NCT01928771|12406670|FG000|Overall Study|Adverse Event|6
7897914|NCT01928771|12406671|FG001|Overall Study|Adverse Event|5
7897915|NCT01928771|12406672|FG002|Overall Study|Adverse Event|1
7897916|NCT01928771|12406670|FG000|Overall Study|Death|2
7897917|NCT01928771|12406671|FG001|Overall Study|Death|2
7897918|NCT01928771|12406672|FG002|Overall Study|Death|2
7897919|NCT01928771|12406670|FG000|Overall Study|Lost to Follow-up|5
7897920|NCT01928771|12406671|FG001|Overall Study|Lost to Follow-up|6
7897921|NCT01928771|12406672|FG002|Overall Study|Lost to Follow-up|3
7897922|NCT01928771|12406670|FG000|Overall Study|Withdrawal by Subject|20
7897923|NCT01928771|12406671|FG001|Overall Study|Withdrawal by Subject|15
7897924|NCT01928771|12406672|FG002|Overall Study|Withdrawal by Subject|17
7897925|NCT01928771|12406670|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
7897926|NCT01928771|12406671|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
7897927|NCT01928771|12406672|FG002|Overall Study|Study-Specific Withdrawal Criteria|1
7897928|NCT01928771|12406670|FG000|Overall Study|Other Reasons|9
7897929|NCT01928771|12406671|FG001|Overall Study|Other Reasons|9
7897930|NCT01928771|12406672|FG002|Overall Study|Other Reasons|14
7897931|NCT01928771|12406670|FG000|Overall Study|Severe Non-Compliance to Protocol|4
7897932|NCT01928771|12406671|FG001|Overall Study|Severe Non-Compliance to Protocol|2
7897933|NCT01928771|12406672|FG002|Overall Study|Severe Non-Compliance to Protocol|2
7897934|NCT01928862|12406705|FG000|Overall Study|Lost to Follow-up|1
7897935|NCT01928862|12406706|FG001|Overall Study|Lost to Follow-up|0
7897936|NCT01928862|12406707|FG002|Overall Study|Lost to Follow-up|0
7897937|NCT01928862|12406708|FG003|Overall Study|Lost to Follow-up|0
7897938|NCT01928862|12406709|FG004|Overall Study|Lost to Follow-up|1
7968666|NCT02783573|12526606|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1
7968667|NCT02783573|12526607|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0
7717870|NCT00522418|12141491|FG000|Overall Study|Consent Withdraw|1
7717871|NCT00522418|12141492|FG001|Overall Study|Consent Withdraw|2
7717872|NCT00522418|12141491|FG000|Overall Study|Lack of Efficacy|0
7717873|NCT00522418|12141492|FG001|Overall Study|Lack of Efficacy|1
7717874|NCT00522431|12141500|FG000|Overall Study|Adverse Event|5
7897939|NCT01928927|12406724|FG000|Overall Study|Lost to Follow-up|1
7897940|NCT01928927|12406725|FG001|Overall Study|Lost to Follow-up|0
7897941|NCT01928927|12406724|FG000|Overall Study|Withdrawal by Subject|1
7897942|NCT01928927|12406725|FG001|Overall Study|Withdrawal by Subject|1
7897943|NCT01928940|12406737|FG000|Overall Study|Adverse Event|0
7897944|NCT01928940|12406738|FG001|Overall Study|Adverse Event|1
7897945|NCT01929018|12406747|FG000|Overall Study|Lost to Follow-up|1
7897946|NCT01929018|12406748|FG001|Overall Study|Lost to Follow-up|0
7897947|NCT01929018|12406747|FG000|Overall Study|Hospitalization|0
7897948|NCT01929018|12406748|FG001|Overall Study|Hospitalization|1
7897949|NCT01929031|12406758|FG000|Overall Study|Adverse Event|3
7897950|NCT01929031|12406759|FG001|Overall Study|Adverse Event|1
7897951|NCT01929031|12406760|FG002|Overall Study|Adverse Event|1
7897952|NCT01929031|12406761|FG003|Overall Study|Adverse Event|0
7897953|NCT01929031|12406762|FG004|Overall Study|Adverse Event|0
7897954|NCT01929031|12406763|FG005|Overall Study|Adverse Event|0
7897955|NCT01929031|12406758|FG000|Overall Study|Protocol Violation|1
7897956|NCT01929031|12406759|FG001|Overall Study|Protocol Violation|0
7897957|NCT01929031|12406760|FG002|Overall Study|Protocol Violation|0
7897958|NCT01929031|12406761|FG003|Overall Study|Protocol Violation|0
7897959|NCT01929031|12406762|FG004|Overall Study|Protocol Violation|0
7897960|NCT01929031|12406763|FG005|Overall Study|Protocol Violation|1
7897961|NCT01929031|12406758|FG000|Overall Study|Reason other than specified above|0
7897962|NCT01929031|12406759|FG001|Overall Study|Reason other than specified above|1
7897963|NCT01929031|12406760|FG002|Overall Study|Reason other than specified above|0
7897964|NCT01929031|12406761|FG003|Overall Study|Reason other than specified above|0
7897965|NCT01929031|12406762|FG004|Overall Study|Reason other than specified above|1
7897966|NCT01929031|12406763|FG005|Overall Study|Reason other than specified above|0
7897967|NCT01929044|12406775|FG000|Overall Study|Adverse Event|1
7897968|NCT01929044|12406776|FG001|Overall Study|Adverse Event|0
7897969|NCT01929044|12406775|FG000|Overall Study|Protocol Violation|9
7897970|NCT01929044|12406776|FG001|Overall Study|Protocol Violation|14
7897971|NCT01929044|12406775|FG000|Overall Study|Not Treated|1
7897972|NCT01929044|12406776|FG001|Overall Study|Not Treated|3
7897973|NCT01929083|12406793|FG000|Intervention 1|Lost to Follow-up|2
7897974|NCT01929083|12406794|FG001|Intervention 1|Lost to Follow-up|0
7897975|NCT01929083|12406793|FG000|Intervention 1|Nonadherent to study medications|1
7897976|NCT01929083|12406794|FG001|Intervention 1|Nonadherent to study medications|0
7897977|NCT01929083|12406793|FG000|Intervention 2|Adverse Event|0
7897978|NCT01929083|12406794|FG001|Intervention 2|Adverse Event|1
7897979|NCT01929109|12406805|FG000|Period 1 (All Groups)|Deviation from protocol|0
7897980|NCT01929109|12406806|FG001|Period 1 (All Groups)|Deviation from protocol|0
7897981|NCT01929109|12406807|FG002|Period 1 (All Groups)|Deviation from protocol|1
7897982|NCT01929109|12406808|FG003|Period 1 (All Groups)|Deviation from protocol|0
7897983|NCT01929109|12406809|FG004|Period 1 (All Groups)|Deviation from protocol|0
7897984|NCT01929135|12406826|FG000|Overall Study|Lost to Follow-up|1
7897985|NCT01929135|12406827|FG001|Overall Study|Lost to Follow-up|1
7897986|NCT01929226|12406837|FG000|Overall Study|Lost to Follow-up|4
7897987|NCT01929226|12406838|FG001|Overall Study|Lost to Follow-up|0
7897988|NCT01929226|12406837|FG000|Overall Study|Withdrawal by Subject|1
7897989|NCT01929226|12406838|FG001|Overall Study|Withdrawal by Subject|1
7897990|NCT01929317|12406851|FG000|Dose Increase Effect Verification Phase|Adverse Event|5
7897991|NCT01929317|12406852|FG001|Dose Increase Effect Verification Phase|Adverse Event|1
7897992|NCT01929317|12406851|FG000|Dose Increase Effect Verification Phase|Physician Decision|1
7897993|NCT01929317|12406852|FG001|Dose Increase Effect Verification Phase|Physician Decision|0
7897994|NCT01929317|12406851|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
7897995|NCT01929317|12406852|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
7897996|NCT01929317|12406851|FG000|Long-term Phase|Adverse Event|5
7897997|NCT01929317|12406852|FG001|Long-term Phase|Adverse Event|1
7897998|NCT01929317|12406851|FG000|Long-term Phase|Physician Decision|3
7897999|NCT01929317|12406852|FG001|Long-term Phase|Physician Decision|0
7898000|NCT01929317|12406851|FG000|Long-term Phase|Withdrawal by Subject|4
7898001|NCT01929317|12406852|FG001|Long-term Phase|Withdrawal by Subject|0
7898002|NCT01929317|12406851|FG000|Long-term Phase|Protocol Violation|1
7898003|NCT01929317|12406852|FG001|Long-term Phase|Protocol Violation|0
7898004|NCT01929317|12406851|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1
7898005|NCT01929317|12406852|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0
7898006|NCT01929317|12406851|FG000|Long-term Phase|Study Closed/Terminated|5
7898007|NCT01929317|12406852|FG001|Long-term Phase|Study Closed/Terminated|3
7898008|NCT01929343|12406867|FG000|Overall Study|Physician Decision|0
7898009|NCT01929343|12406868|FG001|Overall Study|Physician Decision|2
7898010|NCT01929343|12406869|FG002|Overall Study|Physician Decision|0
7898011|NCT01929343|12406867|FG000|Overall Study|Withdrawal by Subject|1
7898012|NCT01929343|12406868|FG001|Overall Study|Withdrawal by Subject|0
7898013|NCT01929343|12406869|FG002|Overall Study|Withdrawal by Subject|0
7898014|NCT01929395|12406880|FG000|Overall Study|Did not complete - non-related toxicity|1
7898015|NCT01929395|12406881|FG001|Overall Study|Did not complete - non-related toxicity|0
7898016|NCT01929395|12406882|FG002|Overall Study|Did not complete - non-related toxicity|0
7898017|NCT01929395|12406880|FG000|Overall Study|Withdrawal by Subject|0
7898018|NCT01929395|12406881|FG001|Overall Study|Withdrawal by Subject|1
7898019|NCT01929395|12406882|FG002|Overall Study|Withdrawal by Subject|0
7898020|NCT01929395|12406880|FG000|Overall Study|Screen Fail|0
7898021|NCT01929395|12406881|FG001|Overall Study|Screen Fail|0
7898022|NCT01929395|12406882|FG002|Overall Study|Screen Fail|1
7898023|NCT01929408|12406890|FG000|Overall Study|received HCT as initial treatment|8
7898024|NCT01929681|12406915|FG000|Overall Study|Withdrawal by Subject|1
7898025|NCT01929681|12406916|FG001|Overall Study|Withdrawal by Subject|0
7898026|NCT01929681|12406915|FG000|Overall Study|Physician Decision|1
7898027|NCT01929681|12406916|FG001|Overall Study|Physician Decision|1
7898028|NCT01929707|12406922|FG000|Intervention Period 1|Lost to Follow-up|0
7898029|NCT01929707|12406923|FG001|Intervention Period 1|Lost to Follow-up|0
7898030|NCT01929707|12406924|FG002|Intervention Period 1|Lost to Follow-up|0
7898031|NCT01929707|12406925|FG003|Intervention Period 1|Lost to Follow-up|1
7898032|NCT01929707|12406926|FG004|Intervention Period 1|Lost to Follow-up|0
7898033|NCT01929707|12406927|FG005|Intervention Period 1|Lost to Follow-up|0
7898034|NCT01929707|12406928|FG006|Intervention Period 1|Lost to Follow-up|0
7898035|NCT01929707|12406929|FG007|Intervention Period 1|Lost to Follow-up|0
7898036|NCT01929707|12406922|FG000|Intervention Period 1|Withdrawal by Subject|0
7898037|NCT01929707|12406923|FG001|Intervention Period 1|Withdrawal by Subject|0
7898038|NCT01929707|12406924|FG002|Intervention Period 1|Withdrawal by Subject|0
7898039|NCT01929707|12406925|FG003|Intervention Period 1|Withdrawal by Subject|2
7898040|NCT01929707|12406926|FG004|Intervention Period 1|Withdrawal by Subject|0
7898041|NCT01929707|12406927|FG005|Intervention Period 1|Withdrawal by Subject|0
7898042|NCT01929707|12406928|FG006|Intervention Period 1|Withdrawal by Subject|0
7898043|NCT01929707|12406929|FG007|Intervention Period 1|Withdrawal by Subject|0
7898044|NCT01929707|12406922|FG000|Intervention Period 2|Withdrawal by Subject|0
7898045|NCT01929707|12406923|FG001|Intervention Period 2|Withdrawal by Subject|0
7898046|NCT01929707|12406924|FG002|Intervention Period 2|Withdrawal by Subject|0
7898047|NCT01929707|12406925|FG003|Intervention Period 2|Withdrawal by Subject|0
7898048|NCT01929707|12406926|FG004|Intervention Period 2|Withdrawal by Subject|0
7898049|NCT01929707|12406927|FG005|Intervention Period 2|Withdrawal by Subject|2
7898050|NCT01929707|12406928|FG006|Intervention Period 2|Withdrawal by Subject|0
7898051|NCT01929707|12406929|FG007|Intervention Period 2|Withdrawal by Subject|0
7898052|NCT01929863|12406954|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
7898053|NCT01929863|12406955|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
7898054|NCT01929863|12406954|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
7898055|NCT01929863|12406955|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
7898056|NCT01929863|12406954|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
7898057|NCT01929863|12406955|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
7898058|NCT01929876|12406966|FG000|Period 2|Non-Compliance|1
7898059|NCT01929980|12406974|FG000|Overall Study|Physician Decision|1
7898060|NCT01929993|12406980|FG000|Overall Study|Protocol Violation|4
7898061|NCT01929993|12406981|FG001|Overall Study|Protocol Violation|6
7898062|NCT01929993|12406980|FG000|Overall Study|Absent CIN, invasion present or artifact|26
7898063|NCT01929993|12406981|FG001|Overall Study|Absent CIN, invasion present or artifact|22
7898064|NCT01930045|12406987|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0
7898065|NCT01930045|12406988|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0
7898066|NCT01930045|12406989|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0
7898067|NCT01930045|12406990|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0
7898068|NCT01930045|12406991|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0
7898069|NCT01930045|12406992|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1
7898070|NCT01930045|12406987|FG000|Pause (up to 37 Days)|Protocol Violation|0
7898071|NCT01930045|12406988|FG001|Pause (up to 37 Days)|Protocol Violation|0
7898072|NCT01930045|12406989|FG002|Pause (up to 37 Days)|Protocol Violation|0
7898073|NCT01930045|12406990|FG003|Pause (up to 37 Days)|Protocol Violation|0
7898074|NCT01930045|12406991|FG004|Pause (up to 37 Days)|Protocol Violation|0
7898075|NCT01930045|12406992|FG005|Pause (up to 37 Days)|Protocol Violation|1
7898076|NCT01930162|12407016|FG000|Overall Study|Abnormal test procedure result(s)|4
7898077|NCT01930162|12407016|FG000|Overall Study|Death|1
7898078|NCT01930175|12407024|FG000|Core Study|Lost to Follow-up|0
7898079|NCT01930175|12407025|FG001|Core Study|Lost to Follow-up|1
7898080|NCT01930175|12407026|FG002|Core Study|Lost to Follow-up|0
7898081|NCT01930175|12407024|FG000|Core Study|Adverse Event|0
7898082|NCT01930175|12407025|FG001|Core Study|Adverse Event|0
7898083|NCT01930175|12407026|FG002|Core Study|Adverse Event|1
7898084|NCT01930188|12407038|FG000|Overall Study|unclassified|4
7898085|NCT01930188|12407039|FG001|Overall Study|unclassified|5
7898086|NCT01930188|12407040|FG002|Overall Study|unclassified|3
7898087|NCT01930188|12407038|FG000|Overall Study|Missing follow-up information|2
7898088|NCT01930188|12407039|FG001|Overall Study|Missing follow-up information|2
7898089|NCT01930188|12407040|FG002|Overall Study|Missing follow-up information|3
7898090|NCT01930188|12407038|FG000|Overall Study|Lost to Follow-up|5
7898091|NCT01930188|12407039|FG001|Overall Study|Lost to Follow-up|2
7898092|NCT01930188|12407040|FG002|Overall Study|Lost to Follow-up|2
7898093|NCT01930188|12407038|FG000|Overall Study|Death|2
7898094|NCT01930188|12407039|FG001|Overall Study|Death|1
7898095|NCT01930188|12407040|FG002|Overall Study|Death|3
7898096|NCT01930188|12407038|FG000|Overall Study|Withdrawal by Subject|9
7898097|NCT01930188|12407039|FG001|Overall Study|Withdrawal by Subject|11
7898098|NCT01930188|12407040|FG002|Overall Study|Withdrawal by Subject|8
7898099|NCT01930214|12407052|FG000|Overall Study|Death|4
7898100|NCT01930214|12407053|FG001|Overall Study|Death|4
7898101|NCT01930214|12407054|FG002|Overall Study|Death|11
7898102|NCT01930214|12407052|FG000|Overall Study|Lost to Follow-up|12
7898103|NCT01930214|12407053|FG001|Overall Study|Lost to Follow-up|13
7898104|NCT01930214|12407054|FG002|Overall Study|Lost to Follow-up|12
7898105|NCT01930214|12407052|FG000|Overall Study|Voluntary withdrawal of infomed consent|2
7898106|NCT01930214|12407053|FG001|Overall Study|Voluntary withdrawal of infomed consent|4
7898107|NCT01930214|12407054|FG002|Overall Study|Voluntary withdrawal of infomed consent|2
7898108|NCT01930214|12407052|FG000|Overall Study|Physician Decision|2
7898109|NCT01930214|12407053|FG001|Overall Study|Physician Decision|0
7898110|NCT01930214|12407054|FG002|Overall Study|Physician Decision|0
7898111|NCT01930799|12407096|FG000|Overall Study|Withdrawal by Subject|3
7898112|NCT01930799|12407096|FG000|Overall Study|Lost to Follow-up|5
7898113|NCT01930890|12407104|FG000|Overall Study|Study Termination|14
7898114|NCT01930890|12407105|FG001|Overall Study|Study Termination|28
7898115|NCT01930890|12407106|FG002|Overall Study|Study Termination|13
7898116|NCT01930890|12407107|FG003|Overall Study|Study Termination|25
7898117|NCT01930890|12407104|FG000|Overall Study|Death|0
7898118|NCT01930890|12407105|FG001|Overall Study|Death|0
7898119|NCT01930890|12407106|FG002|Overall Study|Death|0
7898120|NCT01930890|12407107|FG003|Overall Study|Death|1
7898121|NCT01930890|12407104|FG000|Overall Study|Investigator Decision|0
7898122|NCT01930890|12407105|FG001|Overall Study|Investigator Decision|1
7898123|NCT01930890|12407106|FG002|Overall Study|Investigator Decision|0
7898124|NCT01930890|12407107|FG003|Overall Study|Investigator Decision|0
7898125|NCT01930890|12407104|FG000|Overall Study|Consent Withdrawn|0
7898126|NCT01930890|12407105|FG001|Overall Study|Consent Withdrawn|3
7898127|NCT01930890|12407106|FG002|Overall Study|Consent Withdrawn|0
7898128|NCT01930890|12407107|FG003|Overall Study|Consent Withdrawn|1
7898129|NCT01930890|12407104|FG000|Overall Study|Adverse Event|0
7898130|NCT01930890|12407105|FG001|Overall Study|Adverse Event|1
7898131|NCT01930890|12407106|FG002|Overall Study|Adverse Event|0
7898132|NCT01930890|12407107|FG003|Overall Study|Adverse Event|0
7898133|NCT01931059|12407119|FG000|Day 1|Pregnancy|0
7898134|NCT01931059|12407120|FG001|Day 1|Pregnancy|1
7898135|NCT01931059|12407119|FG000|Day3|Lost to Follow-up|1
7898136|NCT01931059|12407120|FG001|Day3|Lost to Follow-up|0
7898137|NCT01931150|12407134|FG000|Overall Study|Withdrawal by Subject|1
7898138|NCT01931150|12407135|FG001|Overall Study|Withdrawal by Subject|2
7898139|NCT01931202|12407148|FG000|Overall Study|Withdrawal by Subject|0
7898140|NCT01931202|12407149|FG001|Overall Study|Withdrawal by Subject|0
7898141|NCT01931202|12407150|FG002|Overall Study|Withdrawal by Subject|2
7898142|NCT01931202|12407148|FG000|Overall Study|Lost to Follow-up|0
7898143|NCT01931202|12407149|FG001|Overall Study|Lost to Follow-up|5
7898144|NCT01931202|12407150|FG002|Overall Study|Lost to Follow-up|2
7898145|NCT01931397|12407161|FG000|Overall Study|Physician Decision|2
7898146|NCT01931397|12407161|FG000|Overall Study|Withdrawal by Subject|8
7898147|NCT01931397|12407161|FG000|Overall Study|moved out of state|1
7898148|NCT01931462|12407169|FG000|Overall Study|Withdrawal by Subject|1
7898149|NCT01931475|12407175|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20
7898150|NCT01931475|12407176|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10
7898151|NCT01931475|12407175|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
7898152|NCT01931475|12407176|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
7898153|NCT01931475|12407175|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
7898154|NCT01931475|12407176|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
7898155|NCT01931475|12407175|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
7898156|NCT01931475|12407176|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
7898157|NCT01931475|12407175|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0
7898158|NCT01931475|12407176|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1
7898159|NCT01931475|12407175|FG000|Period 2: Extension Treatment Phase|Adverse Event|0
7898160|NCT01931475|12407176|FG001|Period 2: Extension Treatment Phase|Adverse Event|8
7898161|NCT01931475|12407175|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1
7898162|NCT01931475|12407176|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0
7898163|NCT01931475|12407175|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
7898164|NCT01931475|12407176|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
7898165|NCT01931475|12407175|FG000|Period 2: Extension Treatment Phase|Physician Decision|1
7898166|NCT01931475|12407176|FG001|Period 2: Extension Treatment Phase|Physician Decision|1
7898167|NCT01931475|12407175|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
7898168|NCT01931475|12407176|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
7898169|NCT01931475|12407175|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1
7898170|NCT01931475|12407176|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1
7898171|NCT01931566|12407203|FG000|Overall Study|Randomized But Not Treated|6
7898172|NCT01931566|12407204|FG001|Overall Study|Randomized But Not Treated|9
7898173|NCT01931566|12407205|FG002|Overall Study|Randomized But Not Treated|14
7898174|NCT01931566|12407203|FG000|Overall Study|Adverse Event|37
7898175|NCT01931566|12407204|FG001|Overall Study|Adverse Event|167
7898176|NCT01931566|12407205|FG002|Overall Study|Adverse Event|132
7898177|NCT01931566|12407203|FG000|Overall Study|Major Protocol Deviation|5
7898178|NCT01931566|12407204|FG001|Overall Study|Major Protocol Deviation|14
7898179|NCT01931566|12407205|FG002|Overall Study|Major Protocol Deviation|21
7898180|NCT01931566|12407203|FG000|Overall Study|Lost to Follow-up|3
7898181|NCT01931566|12407204|FG001|Overall Study|Lost to Follow-up|26
7898182|NCT01931566|12407205|FG002|Overall Study|Lost to Follow-up|23
7898183|NCT01931566|12407203|FG000|Overall Study|Voluntary Withdrawal|78
7898184|NCT01931566|12407204|FG001|Overall Study|Voluntary Withdrawal|245
7898185|NCT01931566|12407205|FG002|Overall Study|Voluntary Withdrawal|225
7898186|NCT01931566|12407203|FG000|Overall Study|Study Termination|289
7898187|NCT01931566|12407204|FG001|Overall Study|Study Termination|968
7898188|NCT01931566|12407205|FG002|Overall Study|Study Termination|1037
7898189|NCT01931566|12407203|FG000|Overall Study|Reason Not Specified|11
7898190|NCT01931566|12407204|FG001|Overall Study|Reason Not Specified|47
7898191|NCT01931566|12407205|FG002|Overall Study|Reason Not Specified|53
7898192|NCT01931566|12407203|FG000|Overall Study|Missing|0
7898193|NCT01931566|12407204|FG001|Overall Study|Missing|0
7898194|NCT01931566|12407205|FG002|Overall Study|Missing|1
7898195|NCT01931670|12407217|FG000|Treatment Period|Exclusionary Medication Received|1
7898196|NCT01931670|12407218|FG001|Treatment Period|Exclusionary Medication Received|1
7898197|NCT01931670|12407219|FG002|Treatment Period|Exclusionary Medication Received|1
7898198|NCT01931670|12407217|FG000|Treatment Period|Surgery/Invasive Intervention|4
7898199|NCT01931670|12407218|FG001|Treatment Period|Surgery/Invasive Intervention|2
7898200|NCT01931670|12407219|FG002|Treatment Period|Surgery/Invasive Intervention|0
7898201|NCT01931670|12407217|FG000|Treatment Period|Subject Noncompliant|4
7898202|NCT01931670|12407218|FG001|Treatment Period|Subject Noncompliant|9
7898203|NCT01931670|12407219|FG002|Treatment Period|Subject Noncompliant|5
7898204|NCT01931670|12407217|FG000|Treatment Period|Adverse Event|19
7898205|NCT01931670|12407218|FG001|Treatment Period|Adverse Event|8
7898206|NCT01931670|12407219|FG002|Treatment Period|Adverse Event|21
7898207|NCT01931670|12407217|FG000|Treatment Period|Lack of Efficacy|11
7898208|NCT01931670|12407218|FG001|Treatment Period|Lack of Efficacy|2
7898209|NCT01931670|12407219|FG002|Treatment Period|Lack of Efficacy|2
7898210|NCT01931670|12407217|FG000|Treatment Period|Pregnancy|7
7898211|NCT01931670|12407218|FG001|Treatment Period|Pregnancy|2
7898212|NCT01931670|12407219|FG002|Treatment Period|Pregnancy|0
7898213|NCT01931670|12407217|FG000|Treatment Period|Other|8
7898214|NCT01931670|12407218|FG001|Treatment Period|Other|7
7898215|NCT01931670|12407219|FG002|Treatment Period|Other|2
7898216|NCT01931670|12407217|FG000|Treatment Period|Consent Withdrawn by Subject|17
7898217|NCT01931670|12407218|FG001|Treatment Period|Consent Withdrawn by Subject|12
7898218|NCT01931670|12407219|FG002|Treatment Period|Consent Withdrawn by Subject|7
7898219|NCT01931670|12407217|FG000|Treatment Period|Lost to Follow-up|19
7898220|NCT01931670|12407218|FG001|Treatment Period|Lost to Follow-up|5
7898221|NCT01931670|12407219|FG002|Treatment Period|Lost to Follow-up|7
7898222|NCT01931670|12407217|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
7898223|NCT01931670|12407218|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
7898224|NCT01931670|12407219|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
7898225|NCT01931670|12407217|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
7898226|NCT01931670|12407218|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
7898227|NCT01931670|12407219|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
7898228|NCT01931670|12407217|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
7898229|NCT01931670|12407218|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
7898230|NCT01931670|12407219|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
7898231|NCT01931670|12407217|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6
7898232|NCT01931670|12407218|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3
7898233|NCT01931670|12407219|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3
7898234|NCT01931670|12407217|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
7898235|NCT01931670|12407218|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
7898236|NCT01931670|12407219|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
7898237|NCT01931670|12407217|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
7898238|NCT01931670|12407218|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
7898239|NCT01931670|12407219|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
7898240|NCT01931735|12407231|FG000|Randomized Phase|Lost to Follow-up|2
7898241|NCT01931735|12407232|FG001|Randomized Phase|Lost to Follow-up|2
7898242|NCT01931735|12407233|FG002|Randomized Phase|Lost to Follow-up|5
7898243|NCT01931735|12407234|FG003|Randomized Phase|Lost to Follow-up|0
7898244|NCT01931735|12407231|FG000|Observational Non-Randomized Phase|Adverse Event|0
7898245|NCT01931735|12407232|FG001|Observational Non-Randomized Phase|Adverse Event|0
7898246|NCT01931735|12407233|FG002|Observational Non-Randomized Phase|Adverse Event|0
7898247|NCT01931735|12407234|FG003|Observational Non-Randomized Phase|Adverse Event|1
7898248|NCT01931735|12407231|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0
7898249|NCT01931735|12407232|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0
7898250|NCT01931735|12407233|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0
7898251|NCT01931735|12407234|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1
7898252|NCT01931839|12407251|FG000|Overall Study|Death|0
7898253|NCT01931839|12407252|FG001|Overall Study|Death|1
7898254|NCT01931839|12407253|FG002|Overall Study|Death|2
7898255|NCT01931839|12407254|FG003|Overall Study|Death|0
7898256|NCT01931839|12407255|FG004|Overall Study|Death|0
7898257|NCT01931839|12407256|FG005|Overall Study|Death|0
7898258|NCT01931839|12407257|FG006|Overall Study|Death|0
7898259|NCT01931839|12407251|FG000|Overall Study|Physician Decision|1
7898260|NCT01931839|12407252|FG001|Overall Study|Physician Decision|0
7898261|NCT01931839|12407253|FG002|Overall Study|Physician Decision|1
7898262|NCT01931839|12407254|FG003|Overall Study|Physician Decision|0
7898263|NCT01931839|12407255|FG004|Overall Study|Physician Decision|0
7898264|NCT01931839|12407256|FG005|Overall Study|Physician Decision|0
7898265|NCT01931839|12407257|FG006|Overall Study|Physician Decision|1
7898266|NCT01931839|12407251|FG000|Overall Study|Withdrawal of consent|0
7898267|NCT01931839|12407252|FG001|Overall Study|Withdrawal of consent|0
7898268|NCT01931839|12407253|FG002|Overall Study|Withdrawal of consent|0
7898269|NCT01931839|12407254|FG003|Overall Study|Withdrawal of consent|0
7898270|NCT01931839|12407255|FG004|Overall Study|Withdrawal of consent|1
7898271|NCT01931839|12407256|FG005|Overall Study|Withdrawal of consent|0
7898272|NCT01931839|12407257|FG006|Overall Study|Withdrawal of consent|0
7898273|NCT01931839|12407251|FG000|Overall Study|Adverse Event|9
7898274|NCT01931839|12407252|FG001|Overall Study|Adverse Event|4
7898275|NCT01931839|12407253|FG002|Overall Study|Adverse Event|1
7898276|NCT01931839|12407254|FG003|Overall Study|Adverse Event|3
7898277|NCT01931839|12407255|FG004|Overall Study|Adverse Event|0
7898278|NCT01931839|12407256|FG005|Overall Study|Adverse Event|0
7898279|NCT01931839|12407257|FG006|Overall Study|Adverse Event|1
7898280|NCT01931839|12407251|FG000|Overall Study|Withdrawal of consent (not due to AE)|11
7898281|NCT01931839|12407252|FG001|Overall Study|Withdrawal of consent (not due to AE)|8
7898282|NCT01931839|12407253|FG002|Overall Study|Withdrawal of consent (not due to AE)|13
7898283|NCT01931839|12407254|FG003|Overall Study|Withdrawal of consent (not due to AE)|3
7898284|NCT01931839|12407255|FG004|Overall Study|Withdrawal of consent (not due to AE)|0
7898285|NCT01931839|12407256|FG005|Overall Study|Withdrawal of consent (not due to AE)|2
7898286|NCT01931839|12407257|FG006|Overall Study|Withdrawal of consent (not due to AE)|2
7898287|NCT01931839|12407251|FG000|Overall Study|Other non-compliance|15
7898288|NCT01931839|12407252|FG001|Overall Study|Other non-compliance|9
7898289|NCT01931839|12407253|FG002|Overall Study|Other non-compliance|12
7898290|NCT01931839|12407254|FG003|Overall Study|Other non-compliance|3
7898291|NCT01931839|12407255|FG004|Overall Study|Other non-compliance|0
7898292|NCT01931839|12407256|FG005|Overall Study|Other non-compliance|3
7898293|NCT01931839|12407257|FG006|Overall Study|Other non-compliance|0
7898294|NCT01931839|12407251|FG000|Overall Study|Lost to Follow-up|1
7898295|NCT01931839|12407252|FG001|Overall Study|Lost to Follow-up|2
7898296|NCT01931839|12407253|FG002|Overall Study|Lost to Follow-up|4
7898297|NCT01931839|12407254|FG003|Overall Study|Lost to Follow-up|5
7898298|NCT01931839|12407255|FG004|Overall Study|Lost to Follow-up|0
7898299|NCT01931839|12407256|FG005|Overall Study|Lost to Follow-up|0
7898300|NCT01931839|12407257|FG006|Overall Study|Lost to Follow-up|0
7898301|NCT01931839|12407251|FG000|Overall Study|Other|4
7898302|NCT01931839|12407252|FG001|Overall Study|Other|2
7898303|NCT01931839|12407253|FG002|Overall Study|Other|6
7898304|NCT01931839|12407254|FG003|Overall Study|Other|0
7898305|NCT01931839|12407255|FG004|Overall Study|Other|0
7898306|NCT01931839|12407256|FG005|Overall Study|Other|0
7898307|NCT01931839|12407257|FG006|Overall Study|Other|0
7963567|NCT02724462|12518128|FG000|3 Month Follow-up Survey|Lost to Follow-up|171
7963568|NCT02724462|12518129|FG001|3 Month Follow-up Survey|Lost to Follow-up|151
7963569|NCT02724462|12518128|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40
7963570|NCT02724462|12518129|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48
7963571|NCT02724462|12518128|FG000|6 Month Follow-up Survey|Lost to Follow-up|156
7963572|NCT02724462|12518129|FG001|6 Month Follow-up Survey|Lost to Follow-up|123
7963573|NCT02724462|12518128|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40
7963574|NCT02724462|12518129|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48
7963575|NCT02724462|12518128|FG000|12 Month Follow-up Survey|Lost to Follow-up|174
7963576|NCT02724462|12518129|FG001|12 Month Follow-up Survey|Lost to Follow-up|134
7963577|NCT02724462|12518128|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40
7963578|NCT02724462|12518129|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48
7963579|NCT02724592|12518137|FG000|Overall Study|Lost to Follow-up|4
7963580|NCT02724592|12518138|FG001|Overall Study|Lost to Follow-up|1
7963581|NCT02724644|12518146|FG000|Overall Study|Adverse Event|7
7963582|NCT02724644|12518147|FG001|Overall Study|Adverse Event|1
7963583|NCT02724644|12518146|FG000|Overall Study|Lost to Follow-up|6
7963584|NCT02724644|12518147|FG001|Overall Study|Lost to Follow-up|2
7963585|NCT02724644|12518146|FG000|Overall Study|Withdrawal by Subject|7
7963586|NCT02724644|12518147|FG001|Overall Study|Withdrawal by Subject|1
7963587|NCT02724644|12518146|FG000|Overall Study|Administrative|1
7963588|NCT02724644|12518147|FG001|Overall Study|Administrative|0
7963589|NCT02724839|12518169|FG000|Overall Study|Withdrawal by Subject|1
7963590|NCT02724839|12518170|FG001|Overall Study|Withdrawal by Subject|1
7963591|NCT02724839|12518171|FG002|Overall Study|Withdrawal by Subject|0
7963592|NCT02724839|12518169|FG000|Overall Study|Lost to Follow-up|0
7963593|NCT02724839|12518170|FG001|Overall Study|Lost to Follow-up|3
7963594|NCT02724839|12518171|FG002|Overall Study|Lost to Follow-up|2
7963595|NCT02724839|12518169|FG000|Overall Study|Physician Decision|0
7963596|NCT02724839|12518170|FG001|Overall Study|Physician Decision|0
7963597|NCT02724839|12518171|FG002|Overall Study|Physician Decision|3
7963598|NCT02724956|12518188|FG000|Overall Study|Physician Decision|1
7963599|NCT02724956|12518189|FG001|Overall Study|Physician Decision|0
7963600|NCT02724956|12518188|FG000|Overall Study|Lack of Efficacy|0
7963601|NCT02724956|12518189|FG001|Overall Study|Lack of Efficacy|1
7963602|NCT02724956|12518188|FG000|Overall Study|Withdrawal by Subject|0
7963603|NCT02724956|12518189|FG001|Overall Study|Withdrawal by Subject|1
7963604|NCT02725008|12518197|FG000|Overall Study|Lost to Follow-up|7
7963605|NCT02725008|12518198|FG001|Overall Study|Lost to Follow-up|9
7963606|NCT02725008|12518197|FG000|Overall Study|Withdrawal by Subject|2
7963607|NCT02725008|12518198|FG001|Overall Study|Withdrawal by Subject|2
7963608|NCT02725008|12518197|FG000|Overall Study|Admitted to hospital|0
7963609|NCT02725008|12518198|FG001|Overall Study|Admitted to hospital|1
7963610|NCT02725268|12518208|FG000|Overall Study|Death|58
7963611|NCT02725268|12518209|FG001|Overall Study|Death|59
7963612|NCT02725268|12518210|FG002|Overall Study|Death|30
7963613|NCT02725268|12518211|FG003|Overall Study|Death|16
7963614|NCT02725268|12518208|FG000|Overall Study|Lost to Follow-up|4
7963615|NCT02725268|12518209|FG001|Overall Study|Lost to Follow-up|3
7963616|NCT02725268|12518210|FG002|Overall Study|Lost to Follow-up|0
7963617|NCT02725268|12518211|FG003|Overall Study|Lost to Follow-up|1
7963618|NCT02725268|12518208|FG000|Overall Study|Site Terminated by Sponsor|0
7963619|NCT02725268|12518209|FG001|Overall Study|Site Terminated by Sponsor|1
7963620|NCT02725268|12518210|FG002|Overall Study|Site Terminated by Sponsor|0
7963621|NCT02725268|12518211|FG003|Overall Study|Site Terminated by Sponsor|0
7963622|NCT02725268|12518208|FG000|Overall Study|Withdrawal by Subject|8
7963623|NCT02725268|12518209|FG001|Overall Study|Withdrawal by Subject|6
7898308|NCT01931865|12407277|FG000|Overall Study|Lost to Follow-up|2
7898309|NCT01931865|12407277|FG000|Overall Study|Withdrawal by Subject|2
7898310|NCT01931956|12407297|FG000|Overall Study|Death|42
7898311|NCT01931956|12407298|FG001|Overall Study|Death|7
7898312|NCT01931956|12407299|FG002|Overall Study|Death|379
7898313|NCT01931956|12407300|FG003|Overall Study|Death|96
7898314|NCT01931956|12407297|FG000|Overall Study|Withdrawal by Subject|5
7898315|NCT01931956|12407298|FG001|Overall Study|Withdrawal by Subject|0
7898316|NCT01931956|12407299|FG002|Overall Study|Withdrawal by Subject|70
7898317|NCT01931956|12407300|FG003|Overall Study|Withdrawal by Subject|30
7898318|NCT01931956|12407297|FG000|Overall Study|Lost to Follow-up|2
7898319|NCT01931956|12407298|FG001|Overall Study|Lost to Follow-up|0
7898320|NCT01931956|12407299|FG002|Overall Study|Lost to Follow-up|11
7898321|NCT01931956|12407300|FG003|Overall Study|Lost to Follow-up|7
7898322|NCT01931956|12407297|FG000|Overall Study|Expected|2
7898323|NCT01931956|12407298|FG001|Overall Study|Expected|0
7898324|NCT01931956|12407299|FG002|Overall Study|Expected|6
7898325|NCT01931956|12407300|FG003|Overall Study|Expected|0
7898326|NCT01931956|12407297|FG000|Overall Study|Not due|0
7898327|NCT01931956|12407298|FG001|Overall Study|Not due|0
7898328|NCT01931956|12407299|FG002|Overall Study|Not due|21
7898329|NCT01931956|12407300|FG003|Overall Study|Not due|0
7898330|NCT01931995|12407325|FG000|First Intervention (1 Day)|Withdrawal by Subject|2
7898331|NCT01931995|12407326|FG001|First Intervention (1 Day)|Withdrawal by Subject|2
7898332|NCT01931995|12407325|FG000|First Intervention (1 Day)|Physician Decision|1
7898333|NCT01931995|12407326|FG001|First Intervention (1 Day)|Physician Decision|1
7898334|NCT01931995|12407325|FG000|First Intervention (1 Day)|Lost to Follow-up|1
7898335|NCT01931995|12407326|FG001|First Intervention (1 Day)|Lost to Follow-up|1
7898336|NCT01932294|12407358|FG000|Overall Study|Death|43
7898337|NCT01932294|12407358|FG000|Overall Study|Lost to Follow-up|8
7898338|NCT01932294|12407358|FG000|Overall Study|VAD Implantation|20
7898339|NCT01932294|12407358|FG000|Overall Study|Heart Transplantation|16
7898340|NCT01932294|12407358|FG000|Overall Study|Transferred to other hospitals|12
7898341|NCT01932437|12407365|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7898342|NCT01932437|12407366|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7898343|NCT01932437|12407367|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7898344|NCT01932437|12407368|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7898345|NCT01932437|12407369|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7898346|NCT01932437|12407370|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1
7898347|NCT01932697|12407402|FG000|Overall Study|Received a different amount of tx|1
7898348|NCT01932697|12407403|FG001|Overall Study|Received a different amount of tx|0
7898349|NCT01932697|12407402|FG000|Overall Study|Ineligible|1
7898350|NCT01932697|12407403|FG001|Overall Study|Ineligible|0
7898351|NCT01932762|12407415|FG000|Overall Study|Withdrawal by Subject|1
7898352|NCT01932762|12407416|FG001|Overall Study|Withdrawal by Subject|2
7898353|NCT01932762|12407417|FG002|Overall Study|Withdrawal by Subject|0
7898354|NCT01932762|12407418|FG003|Overall Study|Withdrawal by Subject|0
7898355|NCT01932762|12407415|FG000|Overall Study|Lost to Follow-up|4
7898356|NCT01932762|12407416|FG001|Overall Study|Lost to Follow-up|0
7898357|NCT01932762|12407417|FG002|Overall Study|Lost to Follow-up|0
7898358|NCT01932762|12407418|FG003|Overall Study|Lost to Follow-up|1
7898359|NCT01932762|12407415|FG000|Overall Study|Physician Decision|1
7898360|NCT01932762|12407416|FG001|Overall Study|Physician Decision|0
7898361|NCT01932762|12407417|FG002|Overall Study|Physician Decision|0
7898362|NCT01932762|12407418|FG003|Overall Study|Physician Decision|0
7898363|NCT01932788|12407430|FG000|Overall Study|Protocol Violation|18
7898364|NCT01932788|12407431|FG001|Overall Study|Protocol Violation|0
7898365|NCT01932788|12407430|FG000|Overall Study|Lost to Follow-up|18
7898366|NCT01932788|12407431|FG001|Overall Study|Lost to Follow-up|46
7898367|NCT01932788|12407430|FG000|Overall Study|Lack of Efficacy|2
7898368|NCT01932788|12407431|FG001|Overall Study|Lack of Efficacy|0
7898369|NCT01932788|12407430|FG000|Overall Study|Withdrawal by Subject|0
7898370|NCT01932788|12407431|FG001|Overall Study|Withdrawal by Subject|5
7898371|NCT01932970|12407437|FG000|Overall Study|Withdrawal by Subject|5
7898372|NCT01932970|12407437|FG000|Overall Study|Death|1
7898373|NCT01932970|12407437|FG000|Overall Study|Lost to Follow-up|2
7898374|NCT01932970|12407437|FG000|Overall Study|Protocol Specified Criteria|10
7898375|NCT01932996|12407443|FG000|Overall Study|Protocol Violation|2
7898376|NCT01932996|12407444|FG001|Overall Study|Protocol Violation|0
7898377|NCT01933048|12407452|FG000|Overall Study|Lost to Follow-up|15
7898378|NCT01933048|12407453|FG001|Overall Study|Lost to Follow-up|18
7898379|NCT01933048|12407452|FG000|Overall Study|personal reasons|1
7898380|NCT01933048|12407453|FG001|Overall Study|personal reasons|1
7898381|NCT01933048|12407452|FG000|Overall Study|Protocol Violation|7
7898382|NCT01933048|12407453|FG001|Overall Study|Protocol Violation|8
7898383|NCT01933048|12407452|FG000|Overall Study|Physician Decision|1
7898384|NCT01933048|12407453|FG001|Overall Study|Physician Decision|0
7898385|NCT01933048|12407452|FG000|Overall Study|unknown reasons|1
7898386|NCT01933048|12407453|FG001|Overall Study|unknown reasons|1
7898387|NCT01933113|12407462|FG000|Overall Study|Fractured nonfunctioning lead.|1
7898388|NCT01933217|12407468|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1
7898389|NCT01933217|12407469|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3
7898390|NCT01933217|12407468|FG000|Randomization (4 Weeks)|Lost to Follow-up|1
7898391|NCT01933217|12407469|FG001|Randomization (4 Weeks)|Lost to Follow-up|1
7898392|NCT01933334|12407492|FG000|Overall Study|Adverse Event|5
7898393|NCT01933334|12407493|FG001|Overall Study|Adverse Event|1
7898394|NCT01933334|12407492|FG000|Overall Study|Withdrawal by Subject|0
7898395|NCT01933334|12407493|FG001|Overall Study|Withdrawal by Subject|1
7898396|NCT01933594|12407536|FG000|Overall Study|Lost to Follow-up|1
7968668|NCT02783573|12526605|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0
7898397|NCT01933594|12407537|FG001|Overall Study|Lost to Follow-up|0
7898398|NCT01933594|12407538|FG002|Overall Study|Lost to Follow-up|0
7898399|NCT01933594|12407539|FG003|Overall Study|Lost to Follow-up|0
7898400|NCT01933594|12407540|FG004|Overall Study|Lost to Follow-up|1
7898401|NCT01933594|12407541|FG005|Overall Study|Lost to Follow-up|0
7898402|NCT01933594|12407536|FG000|Overall Study|Ineligible for subsequent study step|0
7898403|NCT01933594|12407537|FG001|Overall Study|Ineligible for subsequent study step|0
7898404|NCT01933594|12407538|FG002|Overall Study|Ineligible for subsequent study step|0
7898405|NCT01933594|12407539|FG003|Overall Study|Ineligible for subsequent study step|0
7898406|NCT01933594|12407540|FG004|Overall Study|Ineligible for subsequent study step|1
7898407|NCT01933594|12407541|FG005|Overall Study|Ineligible for subsequent study step|0
7898408|NCT01933672|12407559|FG000|Metformin Run-in Period|Adverse Event|1
7898409|NCT01933672|12407560|FG001|Metformin Run-in Period|Adverse Event|0
7898410|NCT01933672|12407561|FG002|Metformin Run-in Period|Adverse Event|0
7898411|NCT01933672|12407562|FG003|Metformin Run-in Period|Adverse Event|0
7898412|NCT01933672|12407563|FG004|Metformin Run-in Period|Adverse Event|0
7898413|NCT01933672|12407564|FG005|Metformin Run-in Period|Adverse Event|0
7898414|NCT01933672|12407565|FG006|Metformin Run-in Period|Adverse Event|0
7898415|NCT01933672|12407559|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4
7898416|NCT01933672|12407560|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0
7898417|NCT01933672|12407561|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0
7898418|NCT01933672|12407562|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0
7898419|NCT01933672|12407563|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0
7898420|NCT01933672|12407564|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0
7898421|NCT01933672|12407565|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0
7898422|NCT01933672|12407559|FG000|Metformin Run-in Period|Other|5
7898423|NCT01933672|12407560|FG001|Metformin Run-in Period|Other|0
7898424|NCT01933672|12407561|FG002|Metformin Run-in Period|Other|0
7898425|NCT01933672|12407562|FG003|Metformin Run-in Period|Other|0
7898426|NCT01933672|12407563|FG004|Metformin Run-in Period|Other|0
7898427|NCT01933672|12407564|FG005|Metformin Run-in Period|Other|0
7898428|NCT01933672|12407565|FG006|Metformin Run-in Period|Other|0
7898429|NCT01933672|12407559|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7898430|NCT01933672|12407560|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7898431|NCT01933672|12407561|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7898432|NCT01933672|12407562|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7898433|NCT01933672|12407563|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1
7898434|NCT01933672|12407564|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7898435|NCT01933672|12407565|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7898436|NCT01933672|12407559|FG000|First Intervention Period (12-16 Days)|Other|0
7898437|NCT01933672|12407560|FG001|First Intervention Period (12-16 Days)|Other|0
7968669|NCT02783573|12526606|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1
7968670|NCT02783573|12526607|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2
7968671|NCT02783573|12526605|FG000|Placebo-Controlled Treatment Period|Physician Decision|3
7898438|NCT01933672|12407561|FG002|First Intervention Period (12-16 Days)|Other|1
7898439|NCT01933672|12407562|FG003|First Intervention Period (12-16 Days)|Other|0
7898440|NCT01933672|12407563|FG004|First Intervention Period (12-16 Days)|Other|0
7898441|NCT01933672|12407564|FG005|First Intervention Period (12-16 Days)|Other|1
7898442|NCT01933672|12407565|FG006|First Intervention Period (12-16 Days)|Other|0
7898443|NCT01933672|12407559|FG000|Second Intervention Period (12-16 Days)|Other|0
7898444|NCT01933672|12407560|FG001|Second Intervention Period (12-16 Days)|Other|1
7898445|NCT01933672|12407561|FG002|Second Intervention Period (12-16 Days)|Other|1
7898446|NCT01933672|12407562|FG003|Second Intervention Period (12-16 Days)|Other|0
7898447|NCT01933672|12407563|FG004|Second Intervention Period (12-16 Days)|Other|0
7898448|NCT01933672|12407564|FG005|Second Intervention Period (12-16 Days)|Other|0
7898449|NCT01933672|12407565|FG006|Second Intervention Period (12-16 Days)|Other|0
7898450|NCT01933672|12407559|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7898451|NCT01933672|12407560|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7898452|NCT01933672|12407561|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7898453|NCT01933672|12407562|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
7898454|NCT01933672|12407563|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7898455|NCT01933672|12407564|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7898456|NCT01933672|12407565|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7898457|NCT01933672|12407559|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7898458|NCT01933672|12407560|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
7898459|NCT01933672|12407561|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7898460|NCT01933672|12407562|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7898461|NCT01933672|12407563|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7898462|NCT01933672|12407564|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7898463|NCT01933672|12407565|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7898464|NCT01933789|12407596|FG000|Overall Study|Death|0
7898465|NCT01933789|12407597|FG001|Overall Study|Death|0
7898466|NCT01933789|12407598|FG002|Overall Study|Death|0
7898467|NCT01933789|12407599|FG003|Overall Study|Death|0
7898468|NCT01933789|12407600|FG004|Overall Study|Death|21
7898469|NCT01933789|12407601|FG005|Overall Study|Death|32
7898470|NCT01933789|12407602|FG006|Overall Study|Death|0
7898471|NCT01933789|12407603|FG007|Overall Study|Death|0
7898472|NCT01933789|12407604|FG008|Overall Study|Death|0
7898473|NCT01933789|12407596|FG000|Overall Study|Lost to Follow-up|0
7898474|NCT01933789|12407597|FG001|Overall Study|Lost to Follow-up|0
7898475|NCT01933789|12407598|FG002|Overall Study|Lost to Follow-up|0
7898476|NCT01933789|12407599|FG003|Overall Study|Lost to Follow-up|1
7898477|NCT01933789|12407600|FG004|Overall Study|Lost to Follow-up|8
7898478|NCT01933789|12407601|FG005|Overall Study|Lost to Follow-up|9
7898479|NCT01933789|12407602|FG006|Overall Study|Lost to Follow-up|1
7898480|NCT01933789|12407603|FG007|Overall Study|Lost to Follow-up|4
7898481|NCT01933789|12407604|FG008|Overall Study|Lost to Follow-up|0
7898482|NCT01933789|12407596|FG000|Overall Study|Withdrawal by Subject|2
7898483|NCT01933789|12407597|FG001|Overall Study|Withdrawal by Subject|1
7898484|NCT01933789|12407598|FG002|Overall Study|Withdrawal by Subject|0
7898485|NCT01933789|12407599|FG003|Overall Study|Withdrawal by Subject|0
7898486|NCT01933789|12407600|FG004|Overall Study|Withdrawal by Subject|17
7898487|NCT01933789|12407601|FG005|Overall Study|Withdrawal by Subject|16
7898488|NCT01933789|12407602|FG006|Overall Study|Withdrawal by Subject|1
7898489|NCT01933789|12407603|FG007|Overall Study|Withdrawal by Subject|4
7898490|NCT01933789|12407604|FG008|Overall Study|Withdrawal by Subject|0
7898491|NCT01933789|12407596|FG000|Overall Study|Became Ineligible|4
7898492|NCT01933789|12407597|FG001|Overall Study|Became Ineligible|0
7898493|NCT01933789|12407598|FG002|Overall Study|Became Ineligible|0
7898494|NCT01933789|12407599|FG003|Overall Study|Became Ineligible|0
7898495|NCT01933789|12407600|FG004|Overall Study|Became Ineligible|13
7898496|NCT01933789|12407601|FG005|Overall Study|Became Ineligible|10
7898497|NCT01933789|12407602|FG006|Overall Study|Became Ineligible|13
7898498|NCT01933789|12407603|FG007|Overall Study|Became Ineligible|6
7898499|NCT01933789|12407604|FG008|Overall Study|Became Ineligible|0
7898500|NCT01933880|12407626|FG000|Overall Study|Withdrawal by Subject|5
7898501|NCT01933880|12407627|FG001|Overall Study|Withdrawal by Subject|0
7898502|NCT01933880|12407626|FG000|Overall Study|Lack of Efficacy|1
7898503|NCT01933880|12407627|FG001|Overall Study|Lack of Efficacy|0
7898504|NCT01933880|12407626|FG000|Overall Study|Concomitant medication Interference|0
7898505|NCT01933880|12407627|FG001|Overall Study|Concomitant medication Interference|1
7898506|NCT01933880|12407626|FG000|Overall Study|Followup exceeded 4 days to visit window|19
7898507|NCT01933880|12407627|FG001|Overall Study|Followup exceeded 4 days to visit window|0
7898508|NCT01933880|12407626|FG000|Overall Study|Other|4
7898509|NCT01933880|12407627|FG001|Overall Study|Other|0
7898510|NCT01933880|12407626|FG000|Overall Study|Protocol Violation|1
7898511|NCT01933880|12407627|FG001|Overall Study|Protocol Violation|0
7898512|NCT01933919|12407640|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0
7898513|NCT01933919|12407641|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1
7898514|NCT01933919|12407640|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
7898515|NCT01933919|12407641|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
7898516|NCT01933919|12407640|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
7898517|NCT01933919|12407641|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
7898518|NCT01933919|12407640|FG000|Open-label Long-term Phase|Adverse Event|2
7898519|NCT01933919|12407641|FG001|Open-label Long-term Phase|Adverse Event|0
7898520|NCT01933919|12407640|FG000|Open-label Long-term Phase|Withdrawal by Subject|3
7898521|NCT01933919|12407641|FG001|Open-label Long-term Phase|Withdrawal by Subject|4
7898522|NCT01933919|12407640|FG000|Open-label Long-term Phase|Lost to Follow-up|1
7898523|NCT01933919|12407641|FG001|Open-label Long-term Phase|Lost to Follow-up|0
7898524|NCT01933919|12407640|FG000|Open-label Long-term Phase|Other|1
7898525|NCT01933919|12407641|FG001|Open-label Long-term Phase|Other|2
7898526|NCT01934010|12407675|FG000|Overall Study|Adverse Event|1
7898527|NCT01934010|12407676|FG001|Overall Study|Adverse Event|1
7898528|NCT01934010|12407677|FG002|Overall Study|Adverse Event|0
7898529|NCT01934010|12407675|FG000|Overall Study|Withdrawal by Subject|15
7898530|NCT01934010|12407676|FG001|Overall Study|Withdrawal by Subject|6
7898531|NCT01934010|12407677|FG002|Overall Study|Withdrawal by Subject|2
7898532|NCT01934010|12407675|FG000|Overall Study|Lost to Follow-up|7
7898533|NCT01934010|12407676|FG001|Overall Study|Lost to Follow-up|4
7898534|NCT01934010|12407677|FG002|Overall Study|Lost to Follow-up|0
7898535|NCT01934140|12407696|FG000|Persistence Phase (Year 6-10)|Other|24
7898536|NCT01934140|12407697|FG001|Persistence Phase (Year 6-10)|Other|6
7898537|NCT01934140|12407696|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5
7898538|NCT01934140|12407697|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2
7898539|NCT01934140|12407696|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31
7898540|NCT01934140|12407697|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10
7898541|NCT01934140|12407696|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2
7898542|NCT01934140|12407697|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0
7963624|NCT02725268|12518210|FG002|Overall Study|Withdrawal by Subject|8
7898543|NCT01934140|12407696|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21
7898544|NCT01934140|12407697|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7
7898545|NCT01934140|12407696|FG000|Booster Phase (6 Months)|Lost to Follow-up|1
7898546|NCT01934140|12407697|FG001|Booster Phase (6 Months)|Lost to Follow-up|0
7898547|NCT01934140|12407696|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2
7898548|NCT01934140|12407697|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1
7898549|NCT01934140|12407696|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2
7898550|NCT01934140|12407697|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2
7898551|NCT01934192|12407709|FG000|Overall Study|Protocol Violation|0
7898552|NCT01934192|12407710|FG001|Overall Study|Protocol Violation|0
7898553|NCT01934192|12407711|FG002|Overall Study|Protocol Violation|0
7898554|NCT01934192|12407712|FG003|Overall Study|Protocol Violation|1
7898555|NCT01934192|12407709|FG000|Overall Study|Other: reached stopping criteria|6
7898556|NCT01934192|12407710|FG001|Overall Study|Other: reached stopping criteria|5
7898557|NCT01934192|12407711|FG002|Overall Study|Other: reached stopping criteria|1
7898558|NCT01934192|12407712|FG003|Overall Study|Other: reached stopping criteria|0
7898559|NCT01934192|12407709|FG000|Overall Study|Physician Decision|3
7898560|NCT01934192|12407710|FG001|Overall Study|Physician Decision|2
7898561|NCT01934192|12407711|FG002|Overall Study|Physician Decision|0
7898562|NCT01934192|12407712|FG003|Overall Study|Physician Decision|0
7898563|NCT01934218|12407735|FG000|Double-blind Phase|Adverse Event|8
7898564|NCT01934218|12407736|FG001|Double-blind Phase|Adverse Event|8
7898565|NCT01934218|12407735|FG000|Double-blind Phase|Lack of Efficacy|6
7898566|NCT01934218|12407736|FG001|Double-blind Phase|Lack of Efficacy|7
7898567|NCT01934218|12407735|FG000|Double-blind Phase|Lost to Follow-up|7
7898568|NCT01934218|12407736|FG001|Double-blind Phase|Lost to Follow-up|14
7898569|NCT01934218|12407735|FG000|Double-blind Phase|Physician Decision|1
7898570|NCT01934218|12407736|FG001|Double-blind Phase|Physician Decision|2
7898571|NCT01934218|12407735|FG000|Double-blind Phase|Protocol Violation|4
7898572|NCT01934218|12407736|FG001|Double-blind Phase|Protocol Violation|0
7898573|NCT01934218|12407735|FG000|Double-blind Phase|Withdrawal by Subject|16
7898574|NCT01934218|12407736|FG001|Double-blind Phase|Withdrawal by Subject|13
7898575|NCT01934218|12407735|FG000|Double-blind Phase|Noncompliance with Study Protocol|5
7898576|NCT01934218|12407736|FG001|Double-blind Phase|Noncompliance with Study Protocol|8
7898577|NCT01934218|12407735|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1
7898578|NCT01934218|12407736|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2
7898579|NCT01934218|12407735|FG000|Open-Label Phase|Adverse Event|2
7898580|NCT01934218|12407736|FG001|Open-Label Phase|Adverse Event|4
7898581|NCT01934218|12407735|FG000|Open-Label Phase|Lack of Efficacy|1
7898582|NCT01934218|12407736|FG001|Open-Label Phase|Lack of Efficacy|4
7898583|NCT01934218|12407735|FG000|Open-Label Phase|Lost to Follow-up|4
7898584|NCT01934218|12407736|FG001|Open-Label Phase|Lost to Follow-up|2
7898585|NCT01934218|12407735|FG000|Open-Label Phase|Physician Decision|1
7898586|NCT01934218|12407736|FG001|Open-Label Phase|Physician Decision|0
7898587|NCT01934218|12407735|FG000|Open-Label Phase|Protocol Violation|1
7898588|NCT01934218|12407736|FG001|Open-Label Phase|Protocol Violation|0
7898589|NCT01934218|12407735|FG000|Open-Label Phase|Withdrawal by Subject|13
7898590|NCT01934218|12407736|FG001|Open-Label Phase|Withdrawal by Subject|11
7898591|NCT01934218|12407735|FG000|Open-Label Phase|Noncompliance with Study Protocol|4
7898592|NCT01934218|12407736|FG001|Open-Label Phase|Noncompliance with Study Protocol|2
7898593|NCT01934218|12407735|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0
7898594|NCT01934218|12407736|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1
7898595|NCT01934335|12407748|FG000|Overall Study|Withdrawal by Subject|1
7898596|NCT01934335|12407749|FG001|Overall Study|Withdrawal by Subject|1
7898597|NCT01934556|12407766|FG000|Overall Study|Withdrawal by Subject|0
7898598|NCT01934556|12407767|FG001|Overall Study|Withdrawal by Subject|1
7898599|NCT01934556|12407768|FG002|Overall Study|Withdrawal by Subject|1
7898600|NCT01934556|12407766|FG000|Overall Study|Lost to Follow-up|4
7898601|NCT01934556|12407767|FG001|Overall Study|Lost to Follow-up|10
7898602|NCT01934556|12407768|FG002|Overall Study|Lost to Follow-up|7
7898603|NCT01934556|12407766|FG000|Overall Study|Death|1
7898604|NCT01934556|12407767|FG001|Overall Study|Death|5
7898605|NCT01934556|12407768|FG002|Overall Study|Death|2
7898606|NCT01934790|12407782|FG000|Treatment|Adverse Event|3
7898607|NCT01934790|12407782|FG000|Treatment|Clinical progression|6
7898608|NCT01934790|12407782|FG000|Treatment|Radiological progression|4
7898609|NCT01934790|12407782|FG000|Treatment|Withdrawal by Subject|2
7898610|NCT01934790|12407782|FG000|Treatment|Study drug never administered|1
7898611|NCT01934790|12407782|FG000|Active Follow up|Death|20
7898612|NCT01934790|12407782|FG000|Active Follow up|Physician Decision|2
7898613|NCT01934790|12407782|FG000|Active Follow up|Progressive disease|1
7898614|NCT01934790|12407782|FG000|Active Follow up|Other reason|1
7898615|NCT01934894|12407788|FG000|Overall Study|Adverse Event|1
7898616|NCT01934894|12407789|FG001|Overall Study|Adverse Event|2
7898617|NCT01934894|12407788|FG000|Overall Study|Death|2
7898618|NCT01934894|12407789|FG001|Overall Study|Death|0
7898619|NCT01934894|12407788|FG000|Overall Study|Withdrawal by Subject|0
7898620|NCT01934894|12407789|FG001|Overall Study|Withdrawal by Subject|1
7898621|NCT01934894|12407788|FG000|Overall Study|Progressive Disease|3
7898622|NCT01934894|12407789|FG001|Overall Study|Progressive Disease|2
7898623|NCT01934972|12407800|FG000|Overall Study|Withdrawal by Subject|9
7898624|NCT01934972|12407801|FG001|Overall Study|Withdrawal by Subject|6
7898625|NCT01935700|12407831|FG000|Overall Study|Withdrawal by Subject|1
7898626|NCT01935700|12407832|FG001|Overall Study|Withdrawal by Subject|0
7898627|NCT01935700|12407831|FG000|Overall Study|Physician Decision|4
7898628|NCT01935700|12407832|FG001|Overall Study|Physician Decision|0
7898629|NCT01936181|12407864|FG000|Randomised, Double-blind|Adverse Event|27
7898630|NCT01936181|12407865|FG001|Randomised, Double-blind|Adverse Event|21
7898631|NCT01936181|12407866|FG002|Randomised, Double-blind|Adverse Event|0
7898632|NCT01936181|12407867|FG003|Randomised, Double-blind|Adverse Event|0
7898633|NCT01936181|12407864|FG000|Randomised, Double-blind|Protocol Violation|1
7898634|NCT01936181|12407865|FG001|Randomised, Double-blind|Protocol Violation|5
7898635|NCT01936181|12407866|FG002|Randomised, Double-blind|Protocol Violation|0
7898636|NCT01936181|12407867|FG003|Randomised, Double-blind|Protocol Violation|0
7898637|NCT01936181|12407864|FG000|Randomised, Double-blind|Lack of Efficacy|5
7898638|NCT01936181|12407865|FG001|Randomised, Double-blind|Lack of Efficacy|6
7898639|NCT01936181|12407866|FG002|Randomised, Double-blind|Lack of Efficacy|0
7898640|NCT01936181|12407867|FG003|Randomised, Double-blind|Lack of Efficacy|0
7898641|NCT01936181|12407864|FG000|Randomised, Double-blind|Lost to Follow-up|0
7898642|NCT01936181|12407865|FG001|Randomised, Double-blind|Lost to Follow-up|1
7898643|NCT01936181|12407866|FG002|Randomised, Double-blind|Lost to Follow-up|0
7898644|NCT01936181|12407867|FG003|Randomised, Double-blind|Lost to Follow-up|0
7898645|NCT01936181|12407864|FG000|Randomised, Double-blind|Pregnancy|0
7898646|NCT01936181|12407865|FG001|Randomised, Double-blind|Pregnancy|1
7898647|NCT01936181|12407866|FG002|Randomised, Double-blind|Pregnancy|0
7898648|NCT01936181|12407867|FG003|Randomised, Double-blind|Pregnancy|0
7898649|NCT01936181|12407864|FG000|Randomised, Double-blind|Physician Decision|4
7898650|NCT01936181|12407865|FG001|Randomised, Double-blind|Physician Decision|4
7898651|NCT01936181|12407866|FG002|Randomised, Double-blind|Physician Decision|0
7898652|NCT01936181|12407867|FG003|Randomised, Double-blind|Physician Decision|0
7898653|NCT01936181|12407864|FG000|Randomised, Double-blind|Withdrawal by Subject|23
7898654|NCT01936181|12407865|FG001|Randomised, Double-blind|Withdrawal by Subject|26
7898655|NCT01936181|12407866|FG002|Randomised, Double-blind|Withdrawal by Subject|0
7898656|NCT01936181|12407867|FG003|Randomised, Double-blind|Withdrawal by Subject|0
7898657|NCT01936181|12407864|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
7898658|NCT01936181|12407865|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
7898659|NCT01936181|12407866|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
7898660|NCT01936181|12407867|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
7898661|NCT01936181|12407864|FG000|Transition-extension|Adverse Event|3
7898662|NCT01936181|12407865|FG001|Transition-extension|Adverse Event|0
7898663|NCT01936181|12407866|FG002|Transition-extension|Adverse Event|3
7898664|NCT01936181|12407867|FG003|Transition-extension|Adverse Event|1
7898665|NCT01936181|12407864|FG000|Transition-extension|Lost to Follow-up|3
7898666|NCT01936181|12407865|FG001|Transition-extension|Lost to Follow-up|0
7898667|NCT01936181|12407866|FG002|Transition-extension|Lost to Follow-up|1
7898668|NCT01936181|12407867|FG003|Transition-extension|Lost to Follow-up|2
7898669|NCT01936181|12407864|FG000|Transition-extension|Physician Decision|2
7898670|NCT01936181|12407865|FG001|Transition-extension|Physician Decision|0
7898671|NCT01936181|12407866|FG002|Transition-extension|Physician Decision|0
7898672|NCT01936181|12407867|FG003|Transition-extension|Physician Decision|1
7898673|NCT01936181|12407864|FG000|Transition-extension|Withdrawal by Subject|7
7898674|NCT01936181|12407865|FG001|Transition-extension|Withdrawal by Subject|0
7898675|NCT01936181|12407866|FG002|Transition-extension|Withdrawal by Subject|2
7898676|NCT01936181|12407867|FG003|Transition-extension|Withdrawal by Subject|1
7898677|NCT01936623|12407944|FG000|Overall Study|Lost to Follow-up|0
7898678|NCT01936623|12407945|FG001|Overall Study|Lost to Follow-up|5
7898679|NCT01936649|12407951|FG000|Overall Study|Withdrawal by Subject|4
7898680|NCT01936649|12407951|FG000|Overall Study|Physician Decision|2
7898681|NCT01936649|12407951|FG000|Overall Study|Protocol Violation|2
7898682|NCT01936649|12407951|FG000|Overall Study|Other than specified above|5
7898683|NCT01936870|12407975|FG000|Overall Study|No Visit After Treatment|176
7898684|NCT01936870|12407975|FG000|Overall Study|Protocol Violation|12
7898685|NCT01936870|12407975|FG000|Overall Study|No Drug Administration|1
7898686|NCT01936948|12408000|FG000|Overall Study|no 30-day follow-up data|0
7898687|NCT01936948|12408001|FG001|Overall Study|no 30-day follow-up data|3
7898688|NCT01936948|12408002|FG002|Overall Study|no 30-day follow-up data|3
7898689|NCT01936948|12408003|FG003|Overall Study|no 30-day follow-up data|3
7898690|NCT01937117|12408018|FG000|Overall Study|Disease Progression|7
7898691|NCT01937117|12408018|FG000|Overall Study|Physician Decision|4
7898692|NCT01937117|12408018|FG000|Overall Study|Adverse Event|2
7898693|NCT01937130|12408026|FG000|Overall Study|Withdrawal by Subject|0
7898694|NCT01937130|12408027|FG001|Overall Study|Withdrawal by Subject|0
7898695|NCT01937130|12408028|FG002|Overall Study|Withdrawal by Subject|0
7898696|NCT01937130|12408029|FG003|Overall Study|Withdrawal by Subject|1
7898697|NCT01937130|12408026|FG000|Overall Study|Adverse Event|0
7898698|NCT01937130|12408027|FG001|Overall Study|Adverse Event|1
7898699|NCT01937130|12408028|FG002|Overall Study|Adverse Event|0
7898700|NCT01937130|12408029|FG003|Overall Study|Adverse Event|1
7898701|NCT01937130|12408026|FG000|Overall Study|Death|1
7898702|NCT01937130|12408027|FG001|Overall Study|Death|1
7898703|NCT01937130|12408028|FG002|Overall Study|Death|1
7898704|NCT01937130|12408029|FG003|Overall Study|Death|0
7898705|NCT01937130|12408026|FG000|Overall Study|Lost to Follow-up|2
7898706|NCT01937130|12408027|FG001|Overall Study|Lost to Follow-up|0
7898707|NCT01937130|12408028|FG002|Overall Study|Lost to Follow-up|2
7898708|NCT01937130|12408029|FG003|Overall Study|Lost to Follow-up|0
7898709|NCT01937130|12408026|FG000|Overall Study|Physician Decision|0
7898710|NCT01937130|12408027|FG001|Overall Study|Physician Decision|1
7898711|NCT01937130|12408028|FG002|Overall Study|Physician Decision|0
7898712|NCT01937130|12408029|FG003|Overall Study|Physician Decision|0
7898713|NCT01937130|12408026|FG000|Overall Study|Patients unable to swallow|0
7898714|NCT01937130|12408027|FG001|Overall Study|Patients unable to swallow|1
7898715|NCT01937130|12408028|FG002|Overall Study|Patients unable to swallow|0
7898716|NCT01937130|12408029|FG003|Overall Study|Patients unable to swallow|0
7898717|NCT01937130|12408026|FG000|Overall Study|Patient lost to FU due to death|2
7898718|NCT01937130|12408027|FG001|Overall Study|Patient lost to FU due to death|0
7898719|NCT01937130|12408028|FG002|Overall Study|Patient lost to FU due to death|0
7898720|NCT01937130|12408029|FG003|Overall Study|Patient lost to FU due to death|0
7898721|NCT01937299|12408054|FG000|Overall Study|Adverse Event|13
7898722|NCT01937299|12408055|FG001|Overall Study|Adverse Event|0
7898723|NCT01937299|12408054|FG000|Overall Study|Lack of Efficacy|0
7898724|NCT01937299|12408055|FG001|Overall Study|Lack of Efficacy|4
7898725|NCT01937299|12408054|FG000|Overall Study|Withdrawal by Subject|1
7898726|NCT01937299|12408055|FG001|Overall Study|Withdrawal by Subject|0
7898727|NCT01937312|12408064|FG000|Overall Study|Adverse Event|10
7898728|NCT01937312|12408065|FG001|Overall Study|Adverse Event|1
7898729|NCT01937312|12408064|FG000|Overall Study|Lack of Efficacy|0
7898730|NCT01937312|12408065|FG001|Overall Study|Lack of Efficacy|1
7898731|NCT01937312|12408064|FG000|Overall Study|Withdrawal of subject prior to treatment|1
7898732|NCT01937312|12408065|FG001|Overall Study|Withdrawal of subject prior to treatment|1
7898733|NCT01937351|12408074|FG000|Overall Study|Withdrawal by Subject|4
7898734|NCT01937351|12408075|FG001|Overall Study|Withdrawal by Subject|2
7898735|NCT01937351|12408074|FG000|Overall Study|Death|1
7898736|NCT01937351|12408075|FG001|Overall Study|Death|0
7898737|NCT01937351|12408074|FG000|Overall Study|Not treated w device, per protocol fail|4
7898738|NCT01937351|12408075|FG001|Overall Study|Not treated w device, per protocol fail|0
7898739|NCT01937364|12408082|FG000|Overall Study|Adverse Event|2
7898740|NCT01937364|12408083|FG001|Overall Study|Adverse Event|1
7898741|NCT01937390|12408089|FG000|Overall Study|Death|2
7898742|NCT01937390|12408089|FG000|Overall Study|Lost to Follow-up|7
7898743|NCT01937390|12408089|FG000|Overall Study|Withdrawal by Subject|5
7898744|NCT01937390|12408089|FG000|Overall Study|Fail to return|21
7898745|NCT01937559|12408106|FG000|Overall Study|Physician Decision|3
7898746|NCT01937559|12408107|FG001|Overall Study|Physician Decision|3
7898747|NCT01937559|12408108|FG002|Overall Study|Physician Decision|0
7898748|NCT01937559|12408106|FG000|Overall Study|Withdrawal by Subject|6
7898749|NCT01937559|12408107|FG001|Overall Study|Withdrawal by Subject|4
7898750|NCT01937559|12408108|FG002|Overall Study|Withdrawal by Subject|0
7898751|NCT01937559|12408106|FG000|Overall Study|screen fail|2
7898752|NCT01937559|12408107|FG001|Overall Study|screen fail|4
7898753|NCT01937559|12408108|FG002|Overall Study|screen fail|0
7898754|NCT01937715|12408136|FG000|Overall Study|Death|0
7898755|NCT01937715|12408137|FG001|Overall Study|Death|0
7898756|NCT01937715|12408138|FG002|Overall Study|Death|0
7898757|NCT01937715|12408139|FG003|Overall Study|Death|1
7898758|NCT01937715|12408140|FG004|Overall Study|Death|0
7898759|NCT01937715|12408136|FG000|Overall Study|Withdrawal by Subject|0
7898760|NCT01937715|12408137|FG001|Overall Study|Withdrawal by Subject|1
7898761|NCT01937715|12408138|FG002|Overall Study|Withdrawal by Subject|0
7898762|NCT01937715|12408139|FG003|Overall Study|Withdrawal by Subject|0
7898763|NCT01937715|12408140|FG004|Overall Study|Withdrawal by Subject|2
7898764|NCT01937715|12408136|FG000|Overall Study|Other|0
7898765|NCT01937715|12408137|FG001|Overall Study|Other|0
7898766|NCT01937715|12408138|FG002|Overall Study|Other|0
7898767|NCT01937715|12408139|FG003|Overall Study|Other|3
7898768|NCT01937715|12408140|FG004|Overall Study|Other|0
7898769|NCT01937871|12408155|FG000|Overall Study|Adverse Event|6
7898770|NCT01937871|12408156|FG001|Overall Study|Adverse Event|6
7898771|NCT01937871|12408157|FG002|Overall Study|Adverse Event|2
7898772|NCT01937871|12408155|FG000|Overall Study|Lost to Follow-up|8
7898773|NCT01937871|12408156|FG001|Overall Study|Lost to Follow-up|2
7898774|NCT01937871|12408157|FG002|Overall Study|Lost to Follow-up|4
7898775|NCT01937871|12408155|FG000|Overall Study|Withdrawal by Subject|9
7898776|NCT01937871|12408156|FG001|Overall Study|Withdrawal by Subject|6
7898777|NCT01937871|12408157|FG002|Overall Study|Withdrawal by Subject|4
7898778|NCT01937871|12408155|FG000|Overall Study|Physician Decision|0
7898779|NCT01937871|12408156|FG001|Overall Study|Physician Decision|1
7898780|NCT01937871|12408157|FG002|Overall Study|Physician Decision|0
7898781|NCT01937871|12408155|FG000|Overall Study|Entry Criteria Not Met|1
7898782|NCT01937871|12408156|FG001|Overall Study|Entry Criteria Not Met|2
7898783|NCT01937871|12408157|FG002|Overall Study|Entry Criteria Not Met|1
7898784|NCT01937884|12408170|FG000|Overall Study|Withdrawal by Subject|1
7898785|NCT01937884|12408171|FG001|Overall Study|Withdrawal by Subject|0
7898786|NCT01938391|12408254|FG000|6 Month Follow up|Withdrawal by Subject|1
7898787|NCT01938391|12408254|FG000|12 Month Follow up|Physician Decision|1
7898788|NCT01938391|12408254|FG000|12 Month Follow up|Withdrawal by Subject|1
7898789|NCT01938430|12408272|FG000|Overall Study|Randomized but Not Treated|0
7898790|NCT01938430|12408273|FG001|Overall Study|Randomized but Not Treated|0
7898791|NCT01938430|12408274|FG002|Overall Study|Randomized but Not Treated|0
7898792|NCT01938430|12408275|FG003|Overall Study|Randomized but Not Treated|0
7898793|NCT01938430|12408276|FG004|Overall Study|Randomized but Not Treated|0
7898794|NCT01938430|12408277|FG005|Overall Study|Randomized but Not Treated|0
7898795|NCT01938430|12408278|FG006|Overall Study|Randomized but Not Treated|0
7898796|NCT01938430|12408279|FG007|Overall Study|Randomized but Not Treated|0
7898797|NCT01938430|12408280|FG008|Overall Study|Randomized but Not Treated|0
7898798|NCT01938430|12408281|FG009|Overall Study|Randomized but Not Treated|0
7898799|NCT01938430|12408282|FG010|Overall Study|Randomized but Not Treated|1
7898800|NCT01938430|12408283|FG011|Overall Study|Randomized but Not Treated|0
7898801|NCT01938430|12408284|FG012|Overall Study|Randomized but Not Treated|0
7898802|NCT01938430|12408285|FG013|Overall Study|Randomized but Not Treated|1
7898803|NCT01938430|12408272|FG000|Overall Study|Adverse Event|0
7898804|NCT01938430|12408273|FG001|Overall Study|Adverse Event|0
7898805|NCT01938430|12408274|FG002|Overall Study|Adverse Event|0
7898806|NCT01938430|12408275|FG003|Overall Study|Adverse Event|0
7898807|NCT01938430|12408276|FG004|Overall Study|Adverse Event|0
7898808|NCT01938430|12408277|FG005|Overall Study|Adverse Event|0
7898809|NCT01938430|12408278|FG006|Overall Study|Adverse Event|1
7898810|NCT01938430|12408279|FG007|Overall Study|Adverse Event|0
7898811|NCT01938430|12408280|FG008|Overall Study|Adverse Event|0
7898812|NCT01938430|12408281|FG009|Overall Study|Adverse Event|0
7898813|NCT01938430|12408282|FG010|Overall Study|Adverse Event|0
7898814|NCT01938430|12408283|FG011|Overall Study|Adverse Event|0
7898815|NCT01938430|12408284|FG012|Overall Study|Adverse Event|0
7898816|NCT01938430|12408285|FG013|Overall Study|Adverse Event|0
7898817|NCT01938430|12408272|FG000|Overall Study|Death|1
7898818|NCT01938430|12408273|FG001|Overall Study|Death|2
7898819|NCT01938430|12408274|FG002|Overall Study|Death|2
7898820|NCT01938430|12408275|FG003|Overall Study|Death|1
7898821|NCT01938430|12408276|FG004|Overall Study|Death|0
7898822|NCT01938430|12408277|FG005|Overall Study|Death|0
7898823|NCT01938430|12408278|FG006|Overall Study|Death|1
7898824|NCT01938430|12408279|FG007|Overall Study|Death|1
7898825|NCT01938430|12408280|FG008|Overall Study|Death|2
7898826|NCT01938430|12408281|FG009|Overall Study|Death|3
7898827|NCT01938430|12408282|FG010|Overall Study|Death|0
7898828|NCT01938430|12408283|FG011|Overall Study|Death|0
7898829|NCT01938430|12408284|FG012|Overall Study|Death|0
7898830|NCT01938430|12408285|FG013|Overall Study|Death|0
7898831|NCT01938430|12408272|FG000|Overall Study|Investigator's Discretion|0
7898832|NCT01938430|12408273|FG001|Overall Study|Investigator's Discretion|0
7898833|NCT01938430|12408274|FG002|Overall Study|Investigator's Discretion|1
7898834|NCT01938430|12408275|FG003|Overall Study|Investigator's Discretion|0
7898835|NCT01938430|12408276|FG004|Overall Study|Investigator's Discretion|0
7898836|NCT01938430|12408277|FG005|Overall Study|Investigator's Discretion|0
7898837|NCT01938430|12408278|FG006|Overall Study|Investigator's Discretion|0
7898838|NCT01938430|12408279|FG007|Overall Study|Investigator's Discretion|0
7898839|NCT01938430|12408280|FG008|Overall Study|Investigator's Discretion|0
7898840|NCT01938430|12408281|FG009|Overall Study|Investigator's Discretion|0
7898841|NCT01938430|12408282|FG010|Overall Study|Investigator's Discretion|0
7898842|NCT01938430|12408283|FG011|Overall Study|Investigator's Discretion|0
7898843|NCT01938430|12408284|FG012|Overall Study|Investigator's Discretion|0
7898844|NCT01938430|12408285|FG013|Overall Study|Investigator's Discretion|0
7898845|NCT01938430|12408272|FG000|Overall Study|Lack of Efficacy|3
7898846|NCT01938430|12408273|FG001|Overall Study|Lack of Efficacy|1
7898847|NCT01938430|12408274|FG002|Overall Study|Lack of Efficacy|1
7898848|NCT01938430|12408275|FG003|Overall Study|Lack of Efficacy|1
7898849|NCT01938430|12408276|FG004|Overall Study|Lack of Efficacy|0
7898850|NCT01938430|12408277|FG005|Overall Study|Lack of Efficacy|0
7898851|NCT01938430|12408278|FG006|Overall Study|Lack of Efficacy|0
7898852|NCT01938430|12408279|FG007|Overall Study|Lack of Efficacy|0
7898853|NCT01938430|12408280|FG008|Overall Study|Lack of Efficacy|1
7898854|NCT01938430|12408281|FG009|Overall Study|Lack of Efficacy|0
7898855|NCT01938430|12408282|FG010|Overall Study|Lack of Efficacy|2
7898856|NCT01938430|12408283|FG011|Overall Study|Lack of Efficacy|1
7898857|NCT01938430|12408284|FG012|Overall Study|Lack of Efficacy|0
7898858|NCT01938430|12408285|FG013|Overall Study|Lack of Efficacy|0
7898859|NCT01938430|12408272|FG000|Overall Study|Lost to Follow-up|0
7898860|NCT01938430|12408273|FG001|Overall Study|Lost to Follow-up|0
7898861|NCT01938430|12408274|FG002|Overall Study|Lost to Follow-up|1
7898862|NCT01938430|12408275|FG003|Overall Study|Lost to Follow-up|0
7898863|NCT01938430|12408276|FG004|Overall Study|Lost to Follow-up|0
7898864|NCT01938430|12408277|FG005|Overall Study|Lost to Follow-up|1
7898865|NCT01938430|12408278|FG006|Overall Study|Lost to Follow-up|0
7898866|NCT01938430|12408279|FG007|Overall Study|Lost to Follow-up|0
7898867|NCT01938430|12408280|FG008|Overall Study|Lost to Follow-up|0
7898868|NCT01938430|12408281|FG009|Overall Study|Lost to Follow-up|0
7898869|NCT01938430|12408282|FG010|Overall Study|Lost to Follow-up|0
7898870|NCT01938430|12408283|FG011|Overall Study|Lost to Follow-up|0
7898871|NCT01938430|12408284|FG012|Overall Study|Lost to Follow-up|0
7898872|NCT01938430|12408285|FG013|Overall Study|Lost to Follow-up|0
7898873|NCT01938430|12408272|FG000|Overall Study|Withdrew Consent|0
7898874|NCT01938430|12408273|FG001|Overall Study|Withdrew Consent|0
7898875|NCT01938430|12408274|FG002|Overall Study|Withdrew Consent|0
7898876|NCT01938430|12408275|FG003|Overall Study|Withdrew Consent|0
7898877|NCT01938430|12408276|FG004|Overall Study|Withdrew Consent|0
7898878|NCT01938430|12408277|FG005|Overall Study|Withdrew Consent|0
7898879|NCT01938430|12408278|FG006|Overall Study|Withdrew Consent|0
7898880|NCT01938430|12408279|FG007|Overall Study|Withdrew Consent|0
7898881|NCT01938430|12408280|FG008|Overall Study|Withdrew Consent|1
7898882|NCT01938430|12408281|FG009|Overall Study|Withdrew Consent|0
7898883|NCT01938430|12408282|FG010|Overall Study|Withdrew Consent|0
7898884|NCT01938430|12408283|FG011|Overall Study|Withdrew Consent|0
7898885|NCT01938430|12408284|FG012|Overall Study|Withdrew Consent|0
7898886|NCT01938430|12408285|FG013|Overall Study|Withdrew Consent|0
7898887|NCT01938573|12408340|FG000|Overall Study|Lack of Efficacy|1
7898888|NCT01938573|12408341|FG001|Overall Study|Lack of Efficacy|0
7898889|NCT01938573|12408340|FG000|Overall Study|Operation at other hospital|1
7898890|NCT01938573|12408341|FG001|Overall Study|Operation at other hospital|0
7898891|NCT01938625|12408348|FG000|Overall Study|Withdrawal by Subject|0
7898892|NCT01938625|12408349|FG001|Overall Study|Withdrawal by Subject|1
7898893|NCT01938625|12408348|FG000|Overall Study|Adverse Event|0
7898894|NCT01938625|12408349|FG001|Overall Study|Adverse Event|1
7898895|NCT01938846|12408367|FG000|Overall Study|Progressive disease|26
7898896|NCT01938846|12408368|FG001|Overall Study|Progressive disease|18
7898897|NCT01938846|12408369|FG002|Overall Study|Progressive disease|16
7898898|NCT01938846|12408367|FG000|Overall Study|Adverse Event|8
7898899|NCT01938846|12408368|FG001|Overall Study|Adverse Event|4
7898900|NCT01938846|12408369|FG002|Overall Study|Adverse Event|3
7898901|NCT01938846|12408367|FG000|Overall Study|Withdrawal by Subject|2
7898902|NCT01938846|12408368|FG001|Overall Study|Withdrawal by Subject|2
7898903|NCT01938846|12408369|FG002|Overall Study|Withdrawal by Subject|1
7898904|NCT01938846|12408367|FG000|Overall Study|Other than listed|5
7898905|NCT01938846|12408368|FG001|Overall Study|Other than listed|1
7898906|NCT01938846|12408369|FG002|Overall Study|Other than listed|4
7898907|NCT01939002|12408419|FG000|Overall Study|Adverse Event|13
7898908|NCT01939002|12408420|FG001|Overall Study|Adverse Event|13
7898909|NCT01939002|12408419|FG000|Overall Study|Withdrawal by Subject|5
7898910|NCT01939002|12408420|FG001|Overall Study|Withdrawal by Subject|3
7898911|NCT01939002|12408419|FG000|Overall Study|Other|1
7898912|NCT01939002|12408420|FG001|Overall Study|Other|2
7898913|NCT01939028|12408431|FG000|Overall Study|Withdrawal by Subject|5
7898914|NCT01939028|12408431|FG000|Overall Study|Physician Decision|7
7898915|NCT01939158|12408448|FG000|Overall Study|Adverse Event|1
7898916|NCT01939158|12408449|FG001|Overall Study|Adverse Event|0
7898917|NCT01939158|12408450|FG002|Overall Study|Adverse Event|0
7898918|NCT01939158|12408451|FG003|Overall Study|Adverse Event|0
7898919|NCT01939158|12408448|FG000|Overall Study|Withdrawal by Subject|22
7898920|NCT01939158|12408449|FG001|Overall Study|Withdrawal by Subject|25
7898921|NCT01939158|12408450|FG002|Overall Study|Withdrawal by Subject|15
7898922|NCT01939158|12408451|FG003|Overall Study|Withdrawal by Subject|17
7898923|NCT01939158|12408448|FG000|Overall Study|Migrated/moved from study area|5
7898924|NCT01939158|12408449|FG001|Overall Study|Migrated/moved from study area|7
7898925|NCT01939158|12408450|FG002|Overall Study|Migrated/moved from study area|3
7898926|NCT01939158|12408451|FG003|Overall Study|Migrated/moved from study area|6
7898927|NCT01939158|12408448|FG000|Overall Study|Lost to Follow-up|18
7898928|NCT01939158|12408449|FG001|Overall Study|Lost to Follow-up|17
7898929|NCT01939158|12408450|FG002|Overall Study|Lost to Follow-up|17
7898930|NCT01939158|12408451|FG003|Overall Study|Lost to Follow-up|17
7898931|NCT01939158|12408448|FG000|Overall Study|Death|0
7898932|NCT01939158|12408449|FG001|Overall Study|Death|0
7898933|NCT01939158|12408450|FG002|Overall Study|Death|1
7898934|NCT01939158|12408451|FG003|Overall Study|Death|1
7898935|NCT01939158|12408448|FG000|Overall Study|No longer meets eligibility criteria|0
7898936|NCT01939158|12408449|FG001|Overall Study|No longer meets eligibility criteria|0
7898937|NCT01939158|12408450|FG002|Overall Study|No longer meets eligibility criteria|1
7898938|NCT01939158|12408451|FG003|Overall Study|No longer meets eligibility criteria|0
7898939|NCT01939158|12408448|FG000|Overall Study|Other|1
7898940|NCT01939158|12408449|FG001|Overall Study|Other|3
7898941|NCT01939158|12408450|FG002|Overall Study|Other|4
7898942|NCT01939158|12408451|FG003|Overall Study|Other|3
7898943|NCT01939197|12408472|FG000|Overall Study|Withdrawal by Subject|1
7898944|NCT01939197|12408473|FG001|Overall Study|Withdrawal by Subject|0
7898945|NCT01939197|12408474|FG002|Overall Study|Withdrawal by Subject|0
7898946|NCT01939197|12408475|FG003|Overall Study|Withdrawal by Subject|0
7898947|NCT01939197|12408476|FG004|Overall Study|Withdrawal by Subject|1
7898948|NCT01939197|12408477|FG005|Overall Study|Withdrawal by Subject|0
7898949|NCT01939197|12408478|FG006|Overall Study|Withdrawal by Subject|0
7898950|NCT01939197|12408472|FG000|Overall Study|Lost to Follow-up|0
7898951|NCT01939197|12408473|FG001|Overall Study|Lost to Follow-up|1
7898952|NCT01939197|12408474|FG002|Overall Study|Lost to Follow-up|0
7898953|NCT01939197|12408475|FG003|Overall Study|Lost to Follow-up|1
7898954|NCT01939197|12408476|FG004|Overall Study|Lost to Follow-up|3
7898955|NCT01939197|12408477|FG005|Overall Study|Lost to Follow-up|1
7898956|NCT01939197|12408478|FG006|Overall Study|Lost to Follow-up|2
7963625|NCT02725268|12518211|FG003|Overall Study|Withdrawal by Subject|1
7963626|NCT02725268|12518208|FG000|Overall Study|Reason not Specified|2
7963627|NCT02725268|12518209|FG001|Overall Study|Reason not Specified|1
7963628|NCT02725268|12518210|FG002|Overall Study|Reason not Specified|0
7963629|NCT02725268|12518211|FG003|Overall Study|Reason not Specified|0
7898957|NCT01939314|12408527|FG000|Overall Study|Withdrawal by Subject|3
7898958|NCT01939314|12408528|FG001|Overall Study|Withdrawal by Subject|1
7898959|NCT01939314|12408527|FG000|Overall Study|Protocol Violation|1
7898960|NCT01939314|12408528|FG001|Overall Study|Protocol Violation|0
7898961|NCT01939314|12408527|FG000|Overall Study|Pregnancy|0
7898962|NCT01939314|12408528|FG001|Overall Study|Pregnancy|1
7898963|NCT01939314|12408527|FG000|Overall Study|Lost to Follow-up|5
7898964|NCT01939314|12408528|FG001|Overall Study|Lost to Follow-up|6
7898965|NCT01939353|12408536|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3
7898966|NCT01939353|12408536|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1
7898967|NCT01939353|12408536|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2
7898968|NCT01939353|12408536|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1
7898969|NCT01939353|12408536|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1
7898970|NCT01939366|12408545|FG000|Overall Study|Adverse Event|8
7898971|NCT01939366|12408546|FG001|Overall Study|Adverse Event|17
7898972|NCT01939366|12408547|FG002|Overall Study|Adverse Event|30
7898973|NCT01939366|12408548|FG003|Overall Study|Adverse Event|8
7898974|NCT01939366|12408549|FG004|Overall Study|Adverse Event|5
7898975|NCT01939366|12408545|FG000|Overall Study|Lack of Efficacy|2
7898976|NCT01939366|12408546|FG001|Overall Study|Lack of Efficacy|1
7898977|NCT01939366|12408547|FG002|Overall Study|Lack of Efficacy|1
7898978|NCT01939366|12408548|FG003|Overall Study|Lack of Efficacy|1
7898979|NCT01939366|12408549|FG004|Overall Study|Lack of Efficacy|3
7898980|NCT01939366|12408545|FG000|Overall Study|Lost to Follow-up|1
7898981|NCT01939366|12408546|FG001|Overall Study|Lost to Follow-up|1
7898982|NCT01939366|12408547|FG002|Overall Study|Lost to Follow-up|0
7898983|NCT01939366|12408548|FG003|Overall Study|Lost to Follow-up|0
7898984|NCT01939366|12408549|FG004|Overall Study|Lost to Follow-up|0
7898985|NCT01939366|12408545|FG000|Overall Study|Withdrawal by Subject|1
7898986|NCT01939366|12408546|FG001|Overall Study|Withdrawal by Subject|0
7898987|NCT01939366|12408547|FG002|Overall Study|Withdrawal by Subject|2
7898988|NCT01939366|12408548|FG003|Overall Study|Withdrawal by Subject|2
7898989|NCT01939366|12408549|FG004|Overall Study|Withdrawal by Subject|3
7898990|NCT01939366|12408545|FG000|Overall Study|Inclusion criteria not met|0
7898991|NCT01939366|12408546|FG001|Overall Study|Inclusion criteria not met|1
7898992|NCT01939366|12408547|FG002|Overall Study|Inclusion criteria not met|1
7898993|NCT01939366|12408548|FG003|Overall Study|Inclusion criteria not met|0
7898994|NCT01939366|12408549|FG004|Overall Study|Inclusion criteria not met|1
7898995|NCT01939366|12408545|FG000|Overall Study|Other|0
7898996|NCT01939366|12408546|FG001|Overall Study|Other|0
7898997|NCT01939366|12408547|FG002|Overall Study|Other|2
7898998|NCT01939366|12408548|FG003|Overall Study|Other|2
7898999|NCT01939366|12408549|FG004|Overall Study|Other|1
7899000|NCT01939366|12408545|FG000|Overall Study|Protocol Violation|0
7899001|NCT01939366|12408546|FG001|Overall Study|Protocol Violation|0
7899002|NCT01939366|12408547|FG002|Overall Study|Protocol Violation|0
7899003|NCT01939366|12408548|FG003|Overall Study|Protocol Violation|1
7899004|NCT01939366|12408549|FG004|Overall Study|Protocol Violation|0
7899005|NCT01939366|12408545|FG000|Overall Study|Sponsor decision|0
7899006|NCT01939366|12408546|FG001|Overall Study|Sponsor decision|0
7899007|NCT01939366|12408547|FG002|Overall Study|Sponsor decision|0
7899008|NCT01939366|12408548|FG003|Overall Study|Sponsor decision|0
7899009|NCT01939366|12408549|FG004|Overall Study|Sponsor decision|2
7899010|NCT01939366|12408545|FG000|Overall Study|GCP non-compliance at site|2
7899011|NCT01939366|12408546|FG001|Overall Study|GCP non-compliance at site|3
7899012|NCT01939366|12408547|FG002|Overall Study|GCP non-compliance at site|2
7899013|NCT01939366|12408548|FG003|Overall Study|GCP non-compliance at site|3
7899014|NCT01939366|12408549|FG004|Overall Study|GCP non-compliance at site|3
7899015|NCT01939496|12408573|FG000|Overall Study|Adverse Event|2
7899016|NCT01939496|12408574|FG001|Overall Study|Adverse Event|0
7899017|NCT01939496|12408575|FG002|Overall Study|Adverse Event|0
7899018|NCT01939496|12408573|FG000|Overall Study|Lost to Follow-up|1
7899019|NCT01939496|12408574|FG001|Overall Study|Lost to Follow-up|1
7899020|NCT01939496|12408575|FG002|Overall Study|Lost to Follow-up|0
7899021|NCT01939496|12408573|FG000|Overall Study|Physician Decision|1
7899022|NCT01939496|12408574|FG001|Overall Study|Physician Decision|0
7899023|NCT01939496|12408575|FG002|Overall Study|Physician Decision|0
7899024|NCT01939496|12408573|FG000|Overall Study|Protocol Violation|3
7899025|NCT01939496|12408574|FG001|Overall Study|Protocol Violation|0
7899026|NCT01939496|12408575|FG002|Overall Study|Protocol Violation|0
7899027|NCT01939496|12408573|FG000|Overall Study|Withdrawal by Subject|0
7899028|NCT01939496|12408574|FG001|Overall Study|Withdrawal by Subject|1
7899029|NCT01939496|12408575|FG002|Overall Study|Withdrawal by Subject|1
7899030|NCT01939496|12408573|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0
7899031|NCT01939496|12408574|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1
7899032|NCT01939496|12408575|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0
7899033|NCT01939496|12408573|FG000|Overall Study|Other|2
7899034|NCT01939496|12408574|FG001|Overall Study|Other|0
7899035|NCT01939496|12408575|FG002|Overall Study|Other|1
7899036|NCT01939548|12408586|FG000|Overall Study|Non compliance|0
7899037|NCT01939548|12408587|FG001|Overall Study|Non compliance|2
7899038|NCT01939548|12408588|FG002|Overall Study|Non compliance|0
7899039|NCT01939548|12408586|FG000|Overall Study|Study Terminated by Sponsor|17
7899040|NCT01939548|12408587|FG001|Overall Study|Study Terminated by Sponsor|19
7899041|NCT01939548|12408588|FG002|Overall Study|Study Terminated by Sponsor|12
7899042|NCT01939548|12408586|FG000|Overall Study|Insufficient Clinical Response|1
7899043|NCT01939548|12408587|FG001|Overall Study|Insufficient Clinical Response|0
7899044|NCT01939548|12408588|FG002|Overall Study|Insufficient Clinical Response|0
7899045|NCT01939548|12408586|FG000|Overall Study|Did Not Meet Entrance Criteria|1
7899046|NCT01939548|12408587|FG001|Overall Study|Did Not Meet Entrance Criteria|0
7899047|NCT01939548|12408588|FG002|Overall Study|Did Not Meet Entrance Criteria|0
7899048|NCT01939548|12408586|FG000|Overall Study|Withdrawal by Subject|4
7899049|NCT01939548|12408587|FG001|Overall Study|Withdrawal by Subject|4
7899050|NCT01939548|12408588|FG002|Overall Study|Withdrawal by Subject|1
7899051|NCT01939548|12408586|FG000|Overall Study|Protocol Violation|7
7899052|NCT01939548|12408587|FG001|Overall Study|Protocol Violation|6
7899053|NCT01939548|12408588|FG002|Overall Study|Protocol Violation|5
7899054|NCT01939548|12408586|FG000|Overall Study|Lost to Follow-up|5
7899055|NCT01939548|12408587|FG001|Overall Study|Lost to Follow-up|5
7899056|NCT01939548|12408588|FG002|Overall Study|Lost to Follow-up|3
7811343|NCT01181895|12275043|FG002|Overall Study|Investigator Discretion|1
7811344|NCT01181895|12275041|FG000|Overall Study|Withdrawal by Subject|3
7811345|NCT01181895|12275042|FG001|Overall Study|Withdrawal by Subject|0
7811346|NCT01181895|12275043|FG002|Overall Study|Withdrawal by Subject|5
7811347|NCT01181986|12275058|FG000|Phase 1|Lost to Follow-up|0
7811348|NCT01181986|12275059|FG001|Phase 1|Lost to Follow-up|1
7811349|NCT01181986|12275060|FG002|Phase 1|Lost to Follow-up|1
7811350|NCT01181986|12275058|FG000|Phase 1|Adverse Event|0
7811351|NCT01181986|12275059|FG001|Phase 1|Adverse Event|0
7811352|NCT01181986|12275060|FG002|Phase 1|Adverse Event|1
7811353|NCT01181986|12275058|FG000|Phase 1|Protocol Violation|1
7811354|NCT01181986|12275059|FG001|Phase 1|Protocol Violation|0
7811355|NCT01181986|12275060|FG002|Phase 1|Protocol Violation|0
7811356|NCT01181986|12275058|FG000|Phase 2|Adverse Event|0
7811357|NCT01181986|12275059|FG001|Phase 2|Adverse Event|3
7811358|NCT01181986|12275060|FG002|Phase 2|Adverse Event|0
7811359|NCT01181986|12275058|FG000|Phase 2|Medical condition|0
7811360|NCT01181986|12275059|FG001|Phase 2|Medical condition|1
7811361|NCT01181986|12275060|FG002|Phase 2|Medical condition|0
7811362|NCT01182181|12275088|FG000|First Intervention|Adverse Event|1
7811363|NCT01182181|12275089|FG001|First Intervention|Adverse Event|0
7811364|NCT01182181|12275088|FG000|Washout of 21 Days|Withdrawal by Subject|0
7899057|NCT01939548|12408586|FG000|Overall Study|Adverse Event|2
7899058|NCT01939548|12408587|FG001|Overall Study|Adverse Event|9
7899059|NCT01939548|12408588|FG002|Overall Study|Adverse Event|7
7899060|NCT01939548|12408586|FG000|Overall Study|Death|0
7899061|NCT01939548|12408587|FG001|Overall Study|Death|0
7899062|NCT01939548|12408588|FG002|Overall Study|Death|1
7899063|NCT01939548|12408586|FG000|Overall Study|Participant dropped|0
7899064|NCT01939548|12408587|FG001|Overall Study|Participant dropped|0
7899065|NCT01939548|12408588|FG002|Overall Study|Participant dropped|1
7899066|NCT01939548|12408586|FG000|Overall Study|Participant unwilling to continue|0
7899067|NCT01939548|12408587|FG001|Overall Study|Participant unwilling to continue|1
7899068|NCT01939548|12408588|FG002|Overall Study|Participant unwilling to continue|0
7899069|NCT01939548|12408586|FG000|Overall Study|Participant withdrew consent|0
7899070|NCT01939548|12408587|FG001|Overall Study|Participant withdrew consent|2
7899071|NCT01939548|12408588|FG002|Overall Study|Participant withdrew consent|0
7899072|NCT01939548|12408586|FG000|Overall Study|Did not complete follow-up|0
7899073|NCT01939548|12408587|FG001|Overall Study|Did not complete follow-up|1
7899074|NCT01939548|12408588|FG002|Overall Study|Did not complete follow-up|0
7899075|NCT01939899|12408601|FG000|Lead-in Dose Finding Phase|Death|0
7899076|NCT01939899|12408602|FG001|Lead-in Dose Finding Phase|Death|3
7899077|NCT01939899|12408603|FG002|Lead-in Dose Finding Phase|Death|1
7899078|NCT01939899|12408604|FG003|Lead-in Dose Finding Phase|Death|0
7899079|NCT01939899|12408605|FG004|Lead-in Dose Finding Phase|Death|0
7899080|NCT01939899|12408601|FG000|Lead-in Dose Finding Phase|Disease Progression|2
7899081|NCT01939899|12408602|FG001|Lead-in Dose Finding Phase|Disease Progression|4
7899082|NCT01939899|12408603|FG002|Lead-in Dose Finding Phase|Disease Progression|3
7899083|NCT01939899|12408604|FG003|Lead-in Dose Finding Phase|Disease Progression|0
7899084|NCT01939899|12408605|FG004|Lead-in Dose Finding Phase|Disease Progression|0
7899085|NCT01939899|12408601|FG000|Lead-in Dose Finding Phase|Other|0
7899086|NCT01939899|12408602|FG001|Lead-in Dose Finding Phase|Other|0
7899087|NCT01939899|12408603|FG002|Lead-in Dose Finding Phase|Other|1
7899088|NCT01939899|12408604|FG003|Lead-in Dose Finding Phase|Other|0
7899089|NCT01939899|12408605|FG004|Lead-in Dose Finding Phase|Other|0
7899090|NCT01939899|12408601|FG000|Phase 2|Withdrawal by Subject|0
7899091|NCT01939899|12408602|FG001|Phase 2|Withdrawal by Subject|0
7899092|NCT01939899|12408603|FG002|Phase 2|Withdrawal by Subject|0
7899093|NCT01939899|12408604|FG003|Phase 2|Withdrawal by Subject|2
7899094|NCT01939899|12408605|FG004|Phase 2|Withdrawal by Subject|0
7899095|NCT01939899|12408601|FG000|Phase 2|Disease Progression|0
7899096|NCT01939899|12408602|FG001|Phase 2|Disease Progression|0
7899097|NCT01939899|12408603|FG002|Phase 2|Disease Progression|0
7899098|NCT01939899|12408604|FG003|Phase 2|Disease Progression|9
7899099|NCT01939899|12408605|FG004|Phase 2|Disease Progression|1
7811365|NCT01182181|12275089|FG001|Washout of 21 Days|Withdrawal by Subject|1
7811366|NCT01182194|12275097|FG000|Washout of 28 Days|Withdrawal by Subject|1
7811367|NCT01182194|12275098|FG001|Washout of 28 Days|Withdrawal by Subject|0
7811368|NCT01182207|12275106|FG000|First Intervention|Positive Hepatitis Results|0
7811369|NCT01182207|12275107|FG001|First Intervention|Positive Hepatitis Results|1
7899100|NCT01939977|12408631|FG000|Overall Study|Adverse Event|4
7899101|NCT01939977|12408632|FG001|Overall Study|Adverse Event|3
7899102|NCT01939977|12408631|FG000|Overall Study|Lack of Efficacy|3
7899103|NCT01939977|12408632|FG001|Overall Study|Lack of Efficacy|0
7899104|NCT01939977|12408631|FG000|Overall Study|Physician Decision|1
7899105|NCT01939977|12408632|FG001|Overall Study|Physician Decision|1
7899106|NCT01939977|12408631|FG000|Overall Study|Withdrawal by Subject|0
7899107|NCT01939977|12408632|FG001|Overall Study|Withdrawal by Subject|2
7899108|NCT01939977|12408631|FG000|Overall Study|Did not meet inclusion criteria|1
7899109|NCT01939977|12408632|FG001|Overall Study|Did not meet inclusion criteria|0
7899110|NCT01939977|12408631|FG000|Overall Study|Did not receive study medication|0
7899111|NCT01939977|12408632|FG001|Overall Study|Did not receive study medication|1
7899112|NCT01940120|12408638|FG000|Overall Study|Death|40
7899113|NCT01940120|12408638|FG000|Overall Study|Withdrawal by Subject|8
7899114|NCT01940354|12408671|FG000|Overall Study|Withdrawal by Subject|4
7899115|NCT01940354|12408672|FG001|Overall Study|Withdrawal by Subject|2
7899116|NCT01940484|12408678|FG000|Overall Study|Withdrawal by Subject|3
7899117|NCT01940484|12408678|FG000|Overall Study|Underwent transplantation|4
7899118|NCT01940484|12408678|FG000|Overall Study|Death|2
7899119|NCT01940484|12408678|FG000|Overall Study|Adverse Event|1
7899120|NCT01940497|12408684|FG000|Overall Study|Adverse Event/Intercurrent Illness|11
7899121|NCT01940497|12408685|FG001|Overall Study|Adverse Event/Intercurrent Illness|8
7899122|NCT01940497|12408684|FG000|Overall Study|Recurrence of Disease Postsurgery|1
7899123|NCT01940497|12408685|FG001|Overall Study|Recurrence of Disease Postsurgery|3
7899124|NCT01940497|12408684|FG000|Overall Study|Violation of Entry Criteria|1
7899125|NCT01940497|12408685|FG001|Overall Study|Violation of Entry Criteria|1
7899126|NCT01940497|12408684|FG000|Overall Study|Refused Treatment|1
7899127|NCT01940497|12408685|FG001|Overall Study|Refused Treatment|3
7899128|NCT01940497|12408684|FG000|Overall Study|Withdrew Consent|6
7899129|NCT01940497|12408685|FG001|Overall Study|Withdrew Consent|2
7899130|NCT01940497|12408684|FG000|Overall Study|Administrative/Other|1
7899131|NCT01940497|12408685|FG001|Overall Study|Administrative/Other|1
7899132|NCT01940705|12408724|FG000|Overall Study|Lost to Follow-up|1
7899133|NCT01940705|12408725|FG001|Overall Study|Lost to Follow-up|3
7899134|NCT01940705|12408726|FG002|Overall Study|Lost to Follow-up|2
7899135|NCT01940705|12408727|FG003|Overall Study|Lost to Follow-up|2
7899136|NCT01940705|12408724|FG000|Overall Study|Withdrawal by Subject|2
7899137|NCT01940705|12408725|FG001|Overall Study|Withdrawal by Subject|2
7899138|NCT01940705|12408726|FG002|Overall Study|Withdrawal by Subject|3
7899139|NCT01940705|12408727|FG003|Overall Study|Withdrawal by Subject|2
7899140|NCT01940705|12408724|FG000|Overall Study|Intervention not given|0
7899141|NCT01940705|12408725|FG001|Overall Study|Intervention not given|3
7899142|NCT01940705|12408726|FG002|Overall Study|Intervention not given|3
7899143|NCT01940705|12408727|FG003|Overall Study|Intervention not given|0
7899144|NCT01940705|12408724|FG000|Overall Study|Withdrawal by team - hearing aid change|1
7899145|NCT01940705|12408725|FG001|Overall Study|Withdrawal by team - hearing aid change|0
7899146|NCT01940705|12408726|FG002|Overall Study|Withdrawal by team - hearing aid change|0
7899147|NCT01940705|12408727|FG003|Overall Study|Withdrawal by team - hearing aid change|0
7899148|NCT01940887|12408742|FG000|Year 1|Protocol Violation|0
7899149|NCT01940887|12408743|FG001|Year 1|Protocol Violation|1
7899150|NCT01940887|12408742|FG000|Year 1|Physician Decision|7
7899151|NCT01940887|12408743|FG001|Year 1|Physician Decision|3
7899152|NCT01940887|12408742|FG000|Year 1|Death|5
7899153|NCT01940887|12408743|FG001|Year 1|Death|3
7899154|NCT01940887|12408742|FG000|Year 1|Adverse Event|7
7899155|NCT01940887|12408743|FG001|Year 1|Adverse Event|6
7899156|NCT01940887|12408742|FG000|Year 1|Withdrawal by Subject|18
7899157|NCT01940887|12408743|FG001|Year 1|Withdrawal by Subject|9
7899158|NCT01940887|12408742|FG000|Year 1|Lost to Follow-up|2
7899159|NCT01940887|12408743|FG001|Year 1|Lost to Follow-up|1
7899160|NCT01940887|12408742|FG000|Year 2|Physician Decision|8
7899161|NCT01940887|12408743|FG001|Year 2|Physician Decision|1
7899162|NCT01940887|12408742|FG000|Year 2|Death|0
7899163|NCT01940887|12408743|FG001|Year 2|Death|2
7899164|NCT01940887|12408742|FG000|Year 2|Sponsor Decision, early termination|192
7899165|NCT01940887|12408743|FG001|Year 2|Sponsor Decision, early termination|203
7899166|NCT01940887|12408742|FG000|Year 2|Adverse Event|8
7899167|NCT01940887|12408743|FG001|Year 2|Adverse Event|2
7899168|NCT01940887|12408742|FG000|Year 2|Withdrawal by Subject|8
7899169|NCT01940887|12408743|FG001|Year 2|Withdrawal by Subject|8
7899170|NCT01940887|12408742|FG000|Year 2|Lost to Follow-up|1
7899171|NCT01940887|12408743|FG001|Year 2|Lost to Follow-up|6
7899172|NCT01940900|12408751|FG000|Overall Study|Physician Decision|4
7899173|NCT01940900|12408752|FG001|Overall Study|Physician Decision|0
7899174|NCT01940900|12408751|FG000|Overall Study|Adverse Event|10
7899175|NCT01940900|12408752|FG001|Overall Study|Adverse Event|15
7899176|NCT01940900|12408751|FG000|Overall Study|Withdrawal by Subject|11
7899177|NCT01940900|12408752|FG001|Overall Study|Withdrawal by Subject|15
7899178|NCT01940900|12408751|FG000|Overall Study|Lost to Follow-up|1
7899179|NCT01940900|12408752|FG001|Overall Study|Lost to Follow-up|0
7899180|NCT01940900|12408751|FG000|Overall Study|Sponsor Decision|1
7899181|NCT01940900|12408752|FG001|Overall Study|Sponsor Decision|0
7899182|NCT01940900|12408751|FG000|Overall Study|subject non-compliance|1
7899183|NCT01940900|12408752|FG001|Overall Study|subject non-compliance|1
7899184|NCT01940900|12408751|FG000|Overall Study|other|1
7899185|NCT01940900|12408752|FG001|Overall Study|other|0
7899186|NCT01940939|12408760|FG000|Overall Study|Withdrawal by Subject|2
7899187|NCT01940939|12408761|FG001|Overall Study|Withdrawal by Subject|8
7899188|NCT01941030|12408769|FG000|Overall Study|Death|3
7899189|NCT01941030|12408770|FG001|Overall Study|Death|2
7899190|NCT01941030|12408769|FG000|Overall Study|Lost to Follow-up|6
7899191|NCT01941030|12408770|FG001|Overall Study|Lost to Follow-up|5
7899192|NCT01941030|12408769|FG000|Overall Study|Withdrawal by Subject|4
7899193|NCT01941030|12408770|FG001|Overall Study|Withdrawal by Subject|6
7899194|NCT01941095|12408776|FG000|Overall Study|Insufficient therapeutic response|13
7899195|NCT01941095|12408776|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2
7899196|NCT01941095|12408776|FG000|Overall Study|Adverse Event|11
7899197|NCT01941095|12408776|FG000|Overall Study|Physician Decision|3
7899198|NCT01941095|12408776|FG000|Overall Study|Withdrawal by Subject|17
7899199|NCT01941095|12408776|FG000|Overall Study|Lost to Follow-up|10
7899200|NCT01941186|12408783|FG000|Follow-up|Lost to Follow-up|1
7899201|NCT01941186|12408784|FG001|Follow-up|Lost to Follow-up|0
7899202|NCT01941498|12408829|FG000|Overall Study|Relocated out of state|1
7899203|NCT01941537|12408850|FG000|Overall Study|Lack of Efficacy|1
7899204|NCT01941537|12408851|FG001|Overall Study|Lack of Efficacy|2
7899205|NCT01941537|12408850|FG000|Overall Study|Lost to Follow-up|1
7899206|NCT01941537|12408851|FG001|Overall Study|Lost to Follow-up|0
7899207|NCT01941537|12408850|FG000|Overall Study|Pregnancy|1
7899208|NCT01941537|12408851|FG001|Overall Study|Pregnancy|0
7899209|NCT01941537|12408850|FG000|Overall Study|Adverse Event|1
7899210|NCT01941537|12408851|FG001|Overall Study|Adverse Event|0
7899211|NCT01941537|12408850|FG000|Overall Study|Withdrawal by Subject|0
7899212|NCT01941537|12408851|FG001|Overall Study|Withdrawal by Subject|1
7899213|NCT01941940|12408896|FG000|Overall Study|Adverse Event|11
7899214|NCT01941940|12408896|FG000|Overall Study|Lost to Follow-up|2
7899215|NCT01941940|12408896|FG000|Overall Study|Physician Decision|2
7899216|NCT01941940|12408896|FG000|Overall Study|Withdrawal by Subject|15
7899217|NCT01941940|12408896|FG000|Overall Study|Death|1
7899218|NCT01941940|12408896|FG000|Overall Study|Other|1
7899219|NCT01941940|12408896|FG000|Overall Study|Other|1
7899220|NCT01942148|12408900|FG000|Overall Study|Adverse Event|4
7899221|NCT01942148|12408900|FG000|Overall Study|Lack of Efficacy|2
7899222|NCT01942148|12408900|FG000|Overall Study|Physician Decision|11
7899223|NCT01942148|12408900|FG000|Overall Study|Protocol Violation|1
7899224|NCT01942148|12408900|FG000|Overall Study|Withdrawal by Subject|8
7899225|NCT01942148|12408900|FG000|Overall Study|Use of the prohibition medicine|1
7899226|NCT01942161|12408907|FG000|Overall Study|Adverse Event|1
7899227|NCT01942161|12408908|FG001|Overall Study|Adverse Event|2
7899228|NCT01942161|12408909|FG002|Overall Study|Adverse Event|5
7899229|NCT01942161|12408907|FG000|Overall Study|Physician Decision|3
7899230|NCT01942161|12408908|FG001|Overall Study|Physician Decision|1
7899231|NCT01942161|12408909|FG002|Overall Study|Physician Decision|0
7899232|NCT01942161|12408907|FG000|Overall Study|Protocol Violation|1
7899233|NCT01942161|12408908|FG001|Overall Study|Protocol Violation|0
7899234|NCT01942161|12408909|FG002|Overall Study|Protocol Violation|0
7899235|NCT01942161|12408907|FG000|Overall Study|Withdrawal by Subject|3
7899236|NCT01942161|12408908|FG001|Overall Study|Withdrawal by Subject|3
7899237|NCT01942161|12408909|FG002|Overall Study|Withdrawal by Subject|1
7899238|NCT01942486|12408917|FG000|Overall Study|Lost to Follow-up|27
7899239|NCT01942590|12408923|FG000|Overall Study|Withdrawal by Subject|0
7899240|NCT01942590|12408924|FG001|Overall Study|Withdrawal by Subject|1
7899241|NCT01942590|12408923|FG000|Overall Study|Adverse Event|1
7899242|NCT01942590|12408924|FG001|Overall Study|Adverse Event|0
7899243|NCT01942733|12408970|FG000|Overall Study|Lost to Follow-up|1
7899244|NCT01942733|12408970|FG000|Overall Study|Non-compliance with IMP|1
7899245|NCT01942733|12408970|FG000|Overall Study|Administrative|1
7899246|NCT01942785|12408974|FG000|Overall Study|Adverse Event|2
7899247|NCT01942785|12408974|FG000|Overall Study|Withdrawal by Subject|1
7899248|NCT01942785|12408974|FG000|Overall Study|Protocol Violation|1
7899249|NCT01942993|12408980|FG000|Overall Study|Lost to Follow-up|1
7899250|NCT01942993|12408980|FG000|Overall Study|Physician Decision|1
7899251|NCT01943292|12409012|FG000|Overall Study|Withdrawal by Subject|1
7899252|NCT01943292|12409013|FG001|Overall Study|Withdrawal by Subject|0
7899253|NCT01943292|12409014|FG002|Overall Study|Withdrawal by Subject|0
7899254|NCT01943435|12409031|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4
7899255|NCT01943435|12409032|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12
7899256|NCT01943435|12409033|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3
7899257|NCT01943435|12409031|FG000|Intervention Period|Withdrawal by Subject|3
7899258|NCT01943435|12409032|FG001|Intervention Period|Withdrawal by Subject|3
7899259|NCT01943435|12409033|FG002|Intervention Period|Withdrawal by Subject|4
7899260|NCT01943435|12409031|FG000|2 Month Follow up|Lost to Follow-up|2
7899261|NCT01943435|12409032|FG001|2 Month Follow up|Lost to Follow-up|3
7899262|NCT01943435|12409033|FG002|2 Month Follow up|Lost to Follow-up|0
7899263|NCT01943435|12409031|FG000|6 Month Follow up|Lost to Follow-up|12
7899264|NCT01943435|12409032|FG001|6 Month Follow up|Lost to Follow-up|7
7899265|NCT01943435|12409033|FG002|6 Month Follow up|Lost to Follow-up|15
7899266|NCT01943539|12409067|FG000|Overall Study|Non-compliance with at-home intervention|4
7899267|NCT01943539|12409068|FG001|Overall Study|Non-compliance with at-home intervention|0
7899268|NCT01943552|12409077|FG000|Overall Study|Adverse Event|3
7899269|NCT01943552|12409078|FG001|Overall Study|Adverse Event|2
7899270|NCT01943552|12409077|FG000|Overall Study|Withdrawal by Subject|6
7899271|NCT01943552|12409078|FG001|Overall Study|Withdrawal by Subject|6
7899272|NCT01943552|12409077|FG000|Overall Study|Other Reasons|16
7899273|NCT01943552|12409078|FG001|Overall Study|Other Reasons|17
7899274|NCT01943591|12409099|FG000|Overall Study|Lost to Follow-up|3
7899275|NCT01943591|12409100|FG001|Overall Study|Lost to Follow-up|4
7899276|NCT01943591|12409099|FG000|Overall Study|Death|2
7899277|NCT01943591|12409100|FG001|Overall Study|Death|7
7899278|NCT01943799|12409110|FG000|Overall Study|Lost to Follow-up|0
7899279|NCT01943799|12409111|FG001|Overall Study|Lost to Follow-up|1
7899280|NCT01943799|12409112|FG002|Overall Study|Lost to Follow-up|1
7899281|NCT01943799|12409113|FG003|Overall Study|Lost to Follow-up|0
7899282|NCT01943799|12409110|FG000|Overall Study|Protocol Violation|1
7899283|NCT01943799|12409111|FG001|Overall Study|Protocol Violation|0
7899284|NCT01943799|12409112|FG002|Overall Study|Protocol Violation|0
7899285|NCT01943799|12409113|FG003|Overall Study|Protocol Violation|0
7899286|NCT01943799|12409110|FG000|Overall Study|Withdrawal by Subject|4
7899287|NCT01943799|12409111|FG001|Overall Study|Withdrawal by Subject|2
7899288|NCT01943799|12409112|FG002|Overall Study|Withdrawal by Subject|1
7899289|NCT01943799|12409113|FG003|Overall Study|Withdrawal by Subject|0
7899290|NCT01943851|12409141|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7899291|NCT01943851|12409142|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7899292|NCT01943851|12409143|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7899293|NCT01943851|12409144|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7899294|NCT01943851|12409145|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7899295|NCT01943851|12409146|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7899296|NCT01943851|12409147|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7968672|NCT02783573|12526606|FG001|Placebo-Controlled Treatment Period|Physician Decision|1
7968673|NCT02783573|12526607|FG002|Placebo-Controlled Treatment Period|Physician Decision|3
7968674|NCT02783573|12526605|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1
7968675|NCT02783573|12526606|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2
7968676|NCT02783573|12526607|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0
7899297|NCT01943851|12409148|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7899298|NCT01943851|12409149|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7899299|NCT01943851|12409150|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7899300|NCT01943851|12409151|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7899301|NCT01943851|12409152|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7899302|NCT01943851|12409153|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7899303|NCT01943851|12409154|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7899304|NCT01943851|12409155|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7899305|NCT01943851|12409156|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7899306|NCT01943851|12409157|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7899307|NCT01943851|12409158|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7899308|NCT01943851|12409141|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899309|NCT01943851|12409142|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899310|NCT01943851|12409143|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899311|NCT01943851|12409144|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899312|NCT01943851|12409145|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1
7899313|NCT01943851|12409146|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899314|NCT01943851|12409147|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899315|NCT01943851|12409148|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1
7899316|NCT01943851|12409149|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899317|NCT01943851|12409150|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899318|NCT01943851|12409151|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899319|NCT01943851|12409152|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899320|NCT01943851|12409153|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899321|NCT01943851|12409154|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899322|NCT01943851|12409155|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899323|NCT01943851|12409156|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899324|NCT01943851|12409157|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899325|NCT01943851|12409158|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7899326|NCT01943851|12409141|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899327|NCT01943851|12409142|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899328|NCT01943851|12409143|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899329|NCT01943851|12409144|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899330|NCT01943851|12409145|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899331|NCT01943851|12409146|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899332|NCT01943851|12409147|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899333|NCT01943851|12409148|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899334|NCT01943851|12409149|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899335|NCT01943851|12409150|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899336|NCT01943851|12409151|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899337|NCT01943851|12409152|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899338|NCT01943851|12409153|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899339|NCT01943851|12409154|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1
7899340|NCT01943851|12409155|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899341|NCT01943851|12409156|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899342|NCT01943851|12409157|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899343|NCT01943851|12409158|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7899344|NCT01943851|12409141|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899345|NCT01943851|12409142|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899346|NCT01943851|12409143|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899347|NCT01943851|12409144|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899348|NCT01943851|12409145|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899349|NCT01943851|12409146|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899350|NCT01943851|12409147|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899351|NCT01943851|12409148|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899352|NCT01943851|12409149|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899353|NCT01943851|12409150|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899354|NCT01943851|12409151|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899355|NCT01943851|12409152|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899356|NCT01943851|12409153|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899357|NCT01943851|12409154|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899358|NCT01943851|12409155|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899359|NCT01943851|12409156|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2
7899360|NCT01943851|12409157|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899361|NCT01943851|12409158|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7899362|NCT01943851|12409141|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7899363|NCT01943851|12409142|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7899364|NCT01943851|12409143|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7899365|NCT01943851|12409144|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7899366|NCT01943851|12409145|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7899367|NCT01943851|12409146|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7899368|NCT01943851|12409147|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7899369|NCT01943851|12409148|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7899370|NCT01943851|12409149|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7899371|NCT01943851|12409150|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7899372|NCT01943851|12409151|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7899373|NCT01943851|12409152|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7899374|NCT01943851|12409153|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7899375|NCT01943851|12409154|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7899376|NCT01943851|12409155|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7899377|NCT01943851|12409156|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4
7899378|NCT01943851|12409157|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3
7899379|NCT01943851|12409158|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1
7899380|NCT01943916|12409203|FG000|Overall Study|Technically invalid images|10
7899381|NCT01943916|12409203|FG000|Overall Study|Enrollment Failure|23
7899382|NCT01943916|12409203|FG000|Overall Study|Pilot Phase exclusion|100
7899383|NCT01943916|12409203|FG000|Overall Study|Quality Assurance Reader Fail|130
7899384|NCT01943916|12409203|FG000|Overall Study|Technical Failure|39
7899385|NCT01943916|12409203|FG000|Overall Study|Protocol Deviation No Biopsy|25
7899386|NCT01943916|12409203|FG000|Overall Study|No Truth Panel Review|38
7899387|NCT01943916|12409203|FG000|Overall Study|Protocol Deviation|1
7899388|NCT01944046|12409214|FG000|Randomized to DB|Adverse Event|5
7899389|NCT01944046|12409215|FG001|Randomized to DB|Adverse Event|2
7899390|NCT01944046|12409214|FG000|Randomized to DB|Clinical Worsening|3
7899391|NCT01944046|12409215|FG001|Randomized to DB|Clinical Worsening|2
7899392|NCT01944046|12409214|FG000|Randomized to DB|Lost to Follow-up|3
7899393|NCT01944046|12409215|FG001|Randomized to DB|Lost to Follow-up|3
7899394|NCT01944046|12409214|FG000|Randomized to DB|Withdrawal by Subject|2
7899395|NCT01944046|12409215|FG001|Randomized to DB|Withdrawal by Subject|4
7899396|NCT01944046|12409214|FG000|Randomized to DB|Physician Decision|1
7899397|NCT01944046|12409215|FG001|Randomized to DB|Physician Decision|2
7899398|NCT01944046|12409214|FG000|Randomized to DB|Did not have baseline ABC-SW|2
7899399|NCT01944046|12409215|FG001|Randomized to DB|Did not have baseline ABC-SW|0
7899400|NCT01944046|12409214|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5
7899401|NCT01944046|12409215|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6
7899402|NCT01944046|12409214|FG000|Open Label Eligible and Consented|Lost to Follow-up|3
7899403|NCT01944046|12409215|FG001|Open Label Eligible and Consented|Lost to Follow-up|5
7899404|NCT01944046|12409214|FG000|Open Label Eligible and Consented|Adverse Event|6
7899405|NCT01944046|12409215|FG001|Open Label Eligible and Consented|Adverse Event|1
7899406|NCT01944046|12409214|FG000|Open Label Eligible and Consented|Clinical Worsening|4
7899407|NCT01944046|12409215|FG001|Open Label Eligible and Consented|Clinical Worsening|2
7899408|NCT01944046|12409214|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1
7899409|NCT01944046|12409215|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0
7899410|NCT01944098|12409227|FG000|Overall Study|Physician Decision|1
7899411|NCT01944098|12409228|FG001|Overall Study|Physician Decision|0
7899412|NCT01944462|12409279|FG000|PPPP Educational Program|Lost to Follow-up|60
7899413|NCT01944631|12409286|FG000|Overall Study|Adverse Event|1
7899414|NCT01944631|12409287|FG001|Overall Study|Adverse Event|0
7899415|NCT01944631|12409286|FG000|Overall Study|Lost to Follow-up|3
7899416|NCT01944631|12409287|FG001|Overall Study|Lost to Follow-up|1
7899417|NCT01944631|12409286|FG000|Overall Study|Withdrawal by Subject|0
7899418|NCT01944631|12409287|FG001|Overall Study|Withdrawal by Subject|1
7899419|NCT01944670|12409302|FG000|Overall Study|Lost to Follow-up|2
7899420|NCT01944722|12409308|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
7899421|NCT01944722|12409308|FG000|Overall Study|Specimen Shipping Issues|34
7899422|NCT01944722|12409308|FG000|Overall Study|Improper Storage/Transport|5
7899423|NCT01944722|12409308|FG000|Overall Study|Insufficient Volume for Test|1
7899424|NCT01944722|12409308|FG000|Overall Study|Missing Specimens|3
7899425|NCT01944722|12409308|FG000|Overall Study|Specimens Mislabeled|2
7899426|NCT01944722|12409308|FG000|Overall Study|Withdrawal by Subject|8
7899427|NCT01944722|12409308|FG000|Overall Study|NILM Subjects <30 years old|8106
7899428|NCT01944722|12409308|FG000|Overall Study|Unsatisfactory Cytology Result|63
7899429|NCT01944722|12409308|FG000|Overall Study|>ASCUS Cytology|1122
7899430|NCT01944774|12409320|FG000|Overall Study|Withdrawal by Subject|2
7899431|NCT01944774|12409321|FG001|Overall Study|Withdrawal by Subject|3
7899432|NCT01944774|12409322|FG002|Overall Study|Withdrawal by Subject|3
7899433|NCT01944774|12409320|FG000|Overall Study|Adverse Event|3
7899434|NCT01944774|12409321|FG001|Overall Study|Adverse Event|2
7899435|NCT01944774|12409322|FG002|Overall Study|Adverse Event|3
7899436|NCT01944774|12409320|FG000|Overall Study|Lack of Efficacy|1
7899437|NCT01944774|12409321|FG001|Overall Study|Lack of Efficacy|2
7899438|NCT01944774|12409322|FG002|Overall Study|Lack of Efficacy|2
7899439|NCT01944774|12409320|FG000|Overall Study|Lost to Follow-up|0
7899440|NCT01944774|12409321|FG001|Overall Study|Lost to Follow-up|1
7899441|NCT01944774|12409322|FG002|Overall Study|Lost to Follow-up|0
7899442|NCT01944839|12409335|FG000|Overall Study|Physician Decision|2
7899443|NCT01944839|12409336|FG001|Overall Study|Physician Decision|2
7899444|NCT01944839|12409335|FG000|Overall Study|Protocol Violation|0
7899445|NCT01944839|12409336|FG001|Overall Study|Protocol Violation|1
7899446|NCT01944839|12409335|FG000|Overall Study|Adverse Event|10
7899447|NCT01944839|12409336|FG001|Overall Study|Adverse Event|5
7899448|NCT01944839|12409335|FG000|Overall Study|Withdrawal by Subject|9
7899449|NCT01944839|12409336|FG001|Overall Study|Withdrawal by Subject|17
7899450|NCT01944839|12409335|FG000|Overall Study|Lost to Follow-up|1
7899451|NCT01944839|12409336|FG001|Overall Study|Lost to Follow-up|0
7899452|NCT01944839|12409335|FG000|Overall Study|Subject non-compliance|0
7899453|NCT01944839|12409336|FG001|Overall Study|Subject non-compliance|3
7899454|NCT01944969|12409362|FG000|Overall Study|Adverse Event|1
7899455|NCT01944969|12409362|FG000|Overall Study|Lack of Efficacy|1
7899456|NCT01944969|12409362|FG000|Overall Study|Non-compliance with IMP|1
7899457|NCT01944969|12409362|FG000|Overall Study|Administrative or other reasons|23
7899458|NCT01945034|12409371|FG000|Overall Study|Medication Error|0
7899459|NCT01945034|12409372|FG001|Overall Study|Medication Error|1
7899460|NCT01945034|12409373|FG002|Overall Study|Medication Error|0
7899461|NCT01945034|12409371|FG000|Overall Study|Withdrawal by Subject|0
7899462|NCT01945034|12409372|FG001|Overall Study|Withdrawal by Subject|3
7899463|NCT01945034|12409373|FG002|Overall Study|Withdrawal by Subject|1
7899464|NCT01945034|12409371|FG000|Overall Study|Other|0
7899465|NCT01945034|12409372|FG001|Overall Study|Other|1
7899466|NCT01945034|12409373|FG002|Overall Study|Other|3
7899467|NCT01945034|12409371|FG000|Overall Study|Lost to Follow-up|0
7899468|NCT01945034|12409372|FG001|Overall Study|Lost to Follow-up|0
7899469|NCT01945034|12409373|FG002|Overall Study|Lost to Follow-up|2
7899470|NCT01945034|12409371|FG000|Overall Study|Protocol Violation|1
7899471|NCT01945034|12409372|FG001|Overall Study|Protocol Violation|0
7899472|NCT01945034|12409373|FG002|Overall Study|Protocol Violation|1
7899473|NCT01945086|12409384|FG000|Overall Study|Withdrawal by Subject|1
7899474|NCT01945086|12409385|FG001|Overall Study|Withdrawal by Subject|0
7899475|NCT01945086|12409386|FG002|Overall Study|Withdrawal by Subject|1
7899476|NCT01945086|12409384|FG000|Overall Study|Adverse Event|0
7899477|NCT01945086|12409385|FG001|Overall Study|Adverse Event|0
7899478|NCT01945086|12409386|FG002|Overall Study|Adverse Event|1
7899479|NCT01945216|12409412|FG000|Overall Study|Case report forms (CRF) uncollected|52
7899480|NCT01945216|12409412|FG000|Overall Study|Protocol Violation|42
7899481|NCT01945216|12409412|FG000|Overall Study|CRF not assured by investigators|5
7899482|NCT01945242|12409422|FG000|Overall Study|Physician Decision|3
7899483|NCT01945242|12409423|FG001|Overall Study|Physician Decision|3
7899484|NCT01945281|12409432|FG000|Overall Study|Adverse Event|1
7899485|NCT01945281|12409433|FG001|Overall Study|Adverse Event|0
7899486|NCT01945281|12409432|FG000|Overall Study|Death|3
7899487|NCT01945281|12409433|FG001|Overall Study|Death|3
7899488|NCT01945281|12409432|FG000|Overall Study|Physician Decision|1
7899489|NCT01945281|12409433|FG001|Overall Study|Physician Decision|1
7899490|NCT01945281|12409432|FG000|Overall Study|Technical Problems|1
7899491|NCT01945281|12409433|FG001|Overall Study|Technical Problems|0
7899492|NCT01945489|12409456|FG000|Cycle 1|Adverse Event|2
7899493|NCT01945489|12409457|FG001|Cycle 1|Adverse Event|0
7899494|NCT01945489|12409456|FG000|Cycle 1|Lost to Follow-up|4
7899495|NCT01945489|12409457|FG001|Cycle 1|Lost to Follow-up|0
7899496|NCT01945489|12409456|FG000|Cycle 1|Personal Reasons|4
7899497|NCT01945489|12409457|FG001|Cycle 1|Personal Reasons|2
7899498|NCT01945489|12409456|FG000|Cycle 1|Protocol Violation|0
7899499|NCT01945489|12409457|FG001|Cycle 1|Protocol Violation|1
7899500|NCT01945489|12409456|FG000|Cycle 1|Other Miscellaneous Reasons|3
7899501|NCT01945489|12409457|FG001|Cycle 1|Other Miscellaneous Reasons|1
7899502|NCT01945489|12409456|FG000|Cycle 2|Adverse Event|1
7899503|NCT01945489|12409457|FG001|Cycle 2|Adverse Event|0
7899504|NCT01945489|12409456|FG000|Cycle 2|Lost to Follow-up|0
7899505|NCT01945489|12409457|FG001|Cycle 2|Lost to Follow-up|1
7899506|NCT01945580|12409466|FG000|Overall Study|Withdrawal by Subject|13
7899507|NCT01945580|12409467|FG001|Overall Study|Withdrawal by Subject|35
7899508|NCT01945580|12409466|FG000|Overall Study|Physician Decision|3
7899509|NCT01945580|12409467|FG001|Overall Study|Physician Decision|2
7899510|NCT01945580|12409466|FG000|Overall Study|Lost to Follow-up|26
7899511|NCT01945580|12409467|FG001|Overall Study|Lost to Follow-up|39
7899512|NCT01945580|12409466|FG000|Overall Study|Death|7
7899513|NCT01945580|12409467|FG001|Overall Study|Death|2
7899514|NCT01945580|12409466|FG000|Overall Study|Patient moved out of state|0
7899515|NCT01945580|12409467|FG001|Overall Study|Patient moved out of state|1
7899516|NCT01945580|12409466|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1
7899517|NCT01945580|12409467|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0
7899518|NCT01945580|12409466|FG000|Overall Study|Family illness - unable to return|0
7899519|NCT01945580|12409467|FG001|Overall Study|Family illness - unable to return|1
7899520|NCT01945580|12409466|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0
7899521|NCT01945580|12409467|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1
7899522|NCT01945580|12409466|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0
7899523|NCT01945580|12409467|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1
7899524|NCT01945580|12409466|FG000|Overall Study|Noncompliance with 36 month visit|1
7899525|NCT01945580|12409467|FG001|Overall Study|Noncompliance with 36 month visit|0
7899526|NCT01945580|12409466|FG000|Overall Study|The patient moved.|1
7899527|NCT01945580|12409467|FG001|Overall Study|The patient moved.|0
7899528|NCT01945580|12409466|FG000|Overall Study|No data available|0
7899529|NCT01945580|12409467|FG001|Overall Study|No data available|2
7899530|NCT01945593|12409481|FG000|Overall Study|Adverse Event|0
7899531|NCT01945593|12409482|FG001|Overall Study|Adverse Event|0
7899532|NCT01945593|12409483|FG002|Overall Study|Adverse Event|0
7899533|NCT01945593|12409484|FG003|Overall Study|Adverse Event|5
7899534|NCT01945593|12409481|FG000|Overall Study|Physician Decision|0
7899535|NCT01945593|12409482|FG001|Overall Study|Physician Decision|0
7899536|NCT01945593|12409483|FG002|Overall Study|Physician Decision|1
7899537|NCT01945593|12409484|FG003|Overall Study|Physician Decision|1
7899538|NCT01945593|12409481|FG000|Overall Study|Withdrawal by Subject|0
7899539|NCT01945593|12409482|FG001|Overall Study|Withdrawal by Subject|2
7899540|NCT01945593|12409483|FG002|Overall Study|Withdrawal by Subject|0
7899541|NCT01945593|12409484|FG003|Overall Study|Withdrawal by Subject|4
7899542|NCT01945593|12409481|FG000|Overall Study|Protocol Violation|0
7899543|NCT01945593|12409482|FG001|Overall Study|Protocol Violation|2
7899544|NCT01945593|12409483|FG002|Overall Study|Protocol Violation|1
7899545|NCT01945593|12409484|FG003|Overall Study|Protocol Violation|3
7899546|NCT01945593|12409481|FG000|Overall Study|Death|0
7899547|NCT01945593|12409482|FG001|Overall Study|Death|0
7899548|NCT01945593|12409483|FG002|Overall Study|Death|1
7899549|NCT01945593|12409484|FG003|Overall Study|Death|0
7899550|NCT01945593|12409481|FG000|Overall Study|Other: Terminated|0
7899551|NCT01945593|12409482|FG001|Overall Study|Other: Terminated|0
7899552|NCT01945593|12409483|FG002|Overall Study|Other: Terminated|0
7899553|NCT01945593|12409484|FG003|Overall Study|Other: Terminated|1
7899554|NCT01945593|12409481|FG000|Overall Study|Other: Surgical Procedure|0
7899555|NCT01945593|12409482|FG001|Overall Study|Other: Surgical Procedure|2
7899556|NCT01945593|12409483|FG002|Overall Study|Other: Surgical Procedure|0
7899557|NCT01945593|12409484|FG003|Overall Study|Other: Surgical Procedure|6
7899558|NCT01945593|12409481|FG000|Overall Study|Other: Screen Failure|0
7899559|NCT01945593|12409482|FG001|Overall Study|Other: Screen Failure|2
7899560|NCT01945593|12409483|FG002|Overall Study|Other: Screen Failure|0
7899561|NCT01945593|12409484|FG003|Overall Study|Other: Screen Failure|0
7899562|NCT01945710|12409506|FG000|Overall Study|Progressive Disease|5
7899563|NCT01945710|12409507|FG001|Overall Study|Progressive Disease|4
7899564|NCT01945710|12409508|FG002|Overall Study|Progressive Disease|3
7899565|NCT01945710|12409509|FG003|Overall Study|Progressive Disease|2
7899566|NCT01945710|12409510|FG004|Overall Study|Progressive Disease|7
7899567|NCT01945710|12409511|FG005|Overall Study|Progressive Disease|3
7899568|NCT01945710|12409512|FG006|Overall Study|Progressive Disease|19
7899569|NCT01945710|12409506|FG000|Overall Study|Adverse Event|0
7899570|NCT01945710|12409507|FG001|Overall Study|Adverse Event|1
7899571|NCT01945710|12409508|FG002|Overall Study|Adverse Event|0
7899572|NCT01945710|12409509|FG003|Overall Study|Adverse Event|0
7899573|NCT01945710|12409510|FG004|Overall Study|Adverse Event|0
7899574|NCT01945710|12409511|FG005|Overall Study|Adverse Event|0
7899575|NCT01945710|12409512|FG006|Overall Study|Adverse Event|0
7899576|NCT01945710|12409506|FG000|Overall Study|Other|2
7899577|NCT01945710|12409507|FG001|Overall Study|Other|0
7899578|NCT01945710|12409508|FG002|Overall Study|Other|3
7899579|NCT01945710|12409509|FG003|Overall Study|Other|1
7899580|NCT01945710|12409510|FG004|Overall Study|Other|1
7899581|NCT01945710|12409511|FG005|Overall Study|Other|0
7899582|NCT01945710|12409512|FG006|Overall Study|Other|4
7899583|NCT01945710|12409506|FG000|Overall Study|Withdrawal by Subject|0
7899584|NCT01945710|12409507|FG001|Overall Study|Withdrawal by Subject|1
7899585|NCT01945710|12409508|FG002|Overall Study|Withdrawal by Subject|1
7899586|NCT01945710|12409509|FG003|Overall Study|Withdrawal by Subject|0
7899587|NCT01945710|12409510|FG004|Overall Study|Withdrawal by Subject|1
7899588|NCT01945710|12409511|FG005|Overall Study|Withdrawal by Subject|0
7899589|NCT01945710|12409512|FG006|Overall Study|Withdrawal by Subject|0
7899590|NCT01945866|12409532|FG000|Overall Study|Eyes did not complete or were dropped|2
7899591|NCT01945866|12409533|FG001|Overall Study|Eyes did not complete or were dropped|0
7899592|NCT01945944|12409542|FG000|Overall Study|Adverse Event|0
7899593|NCT01945944|12409543|FG001|Overall Study|Adverse Event|2
7899594|NCT01945944|12409542|FG000|Overall Study|Physician Decision|1
7899595|NCT01945944|12409543|FG001|Overall Study|Physician Decision|0
7899596|NCT01945944|12409542|FG000|Overall Study|Withdrawal by Subject|0
7899597|NCT01945944|12409543|FG001|Overall Study|Withdrawal by Subject|1
7899598|NCT01945996|12409568|FG000|Overall Study|Lost to Follow-up|3
7899599|NCT01945996|12409569|FG001|Overall Study|Lost to Follow-up|5
7899600|NCT01946152|12409590|FG000|Overall Study|Adverse Event|1
7899601|NCT01946152|12409591|FG001|Overall Study|Adverse Event|0
7899602|NCT01946152|12409592|FG002|Overall Study|Adverse Event|0
7899603|NCT01946152|12409593|FG003|Overall Study|Adverse Event|0
7899604|NCT01946152|12409590|FG000|Overall Study|Withdrawal by Subject|0
7899605|NCT01946152|12409591|FG001|Overall Study|Withdrawal by Subject|2
7899606|NCT01946152|12409592|FG002|Overall Study|Withdrawal by Subject|0
7899607|NCT01946152|12409593|FG003|Overall Study|Withdrawal by Subject|0
7899608|NCT01946152|12409590|FG000|Overall Study|Progression|0
7899609|NCT01946152|12409591|FG001|Overall Study|Progression|1
7899610|NCT01946152|12409592|FG002|Overall Study|Progression|4
7899611|NCT01946152|12409593|FG003|Overall Study|Progression|7
7899612|NCT01946152|12409590|FG000|Overall Study|Physician Decision|0
7899613|NCT01946152|12409591|FG001|Overall Study|Physician Decision|0
7899614|NCT01946152|12409592|FG002|Overall Study|Physician Decision|1
7899615|NCT01946152|12409593|FG003|Overall Study|Physician Decision|0
7899616|NCT01946152|12409590|FG000|Overall Study|Second malignancy|0
7899617|NCT01946152|12409591|FG001|Overall Study|Second malignancy|0
7899618|NCT01946152|12409592|FG002|Overall Study|Second malignancy|1
7899619|NCT01946152|12409593|FG003|Overall Study|Second malignancy|0
7899620|NCT01946152|12409590|FG000|Overall Study|Adverse Event|0
7899621|NCT01946152|12409591|FG001|Overall Study|Adverse Event|0
7899622|NCT01946152|12409592|FG002|Overall Study|Adverse Event|0
7899623|NCT01946152|12409593|FG003|Overall Study|Adverse Event|1
7899624|NCT01946165|12409607|FG000|Overall Study|Physician Decision|2
7899625|NCT01946165|12409608|FG001|Overall Study|Physician Decision|0
7899626|NCT01946165|12409607|FG000|Overall Study|Withdrawal by Subject|0
7899627|NCT01946165|12409608|FG001|Overall Study|Withdrawal by Subject|2
7899628|NCT01946178|12409615|FG000|Overall Study|Pregnancy|1
7899629|NCT01946178|12409615|FG000|Overall Study|Lost to Follow-up|1
7899630|NCT01946191|12409625|FG000|Allocation|Did not complete orientation|1
7899631|NCT01946191|12409626|FG001|Allocation|Did not complete orientation|1
7899632|NCT01946191|12409625|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4
7899633|NCT01946191|12409626|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2
7899634|NCT01946191|12409625|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0
7899635|NCT01946191|12409626|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1
7899636|NCT01946191|12409625|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13
7899637|NCT01946191|12409626|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15
7899638|NCT01946282|12409642|FG000|Year 1|Did not return FIT kit|4186
7899639|NCT01946282|12409643|FG001|Year 1|Did not return FIT kit|608
7899640|NCT01946282|12409644|FG002|Year 1|Did not return FIT kit|654
7899641|NCT01946282|12409642|FG000|Year 2|Did not return FIT kit|803
7899642|NCT01946282|12409643|FG001|Year 2|Did not return FIT kit|131
7899643|NCT01946282|12409644|FG002|Year 2|Did not return FIT kit|115
7899644|NCT01946282|12409642|FG000|Year 3|Did not return FIT kit|288
7899645|NCT01946282|12409643|FG001|Year 3|Did not return FIT kit|43
7899646|NCT01946282|12409644|FG002|Year 3|Did not return FIT kit|30
7899647|NCT01946412|12409654|FG000|Overall Study|Adverse Event|1
7899648|NCT01946412|12409654|FG000|Overall Study|Non-Compliance|1
7899649|NCT01946412|12409654|FG000|Overall Study|Continued with commercial Kalydeco|2
7899650|NCT01946412|12409654|FG000|Overall Study|Difficulty in swallowing|1
7899651|NCT01946425|12409662|FG000|Overall Study|Protocol Violation|1
7899652|NCT01946425|12409663|FG001|Overall Study|Protocol Violation|0
7899653|NCT01946425|12409662|FG000|Overall Study|Withdrawal by Subject|1
7899654|NCT01946425|12409663|FG001|Overall Study|Withdrawal by Subject|0
7899655|NCT01946438|12409674|FG000|Overall Study|Adverse Event|0
7899656|NCT01946438|12409675|FG001|Overall Study|Adverse Event|0
7899657|NCT01946438|12409676|FG002|Overall Study|Adverse Event|0
7899658|NCT01946438|12409677|FG003|Overall Study|Adverse Event|1
7899659|NCT01946438|12409674|FG000|Overall Study|Serious Adverse event|1
7899660|NCT01946438|12409675|FG001|Overall Study|Serious Adverse event|0
7899661|NCT01946438|12409676|FG002|Overall Study|Serious Adverse event|0
7899662|NCT01946438|12409677|FG003|Overall Study|Serious Adverse event|0
7899663|NCT01946438|12409674|FG000|Overall Study|Protocol Violation|0
7899664|NCT01946438|12409675|FG001|Overall Study|Protocol Violation|0
7899665|NCT01946438|12409676|FG002|Overall Study|Protocol Violation|1
7899666|NCT01946438|12409677|FG003|Overall Study|Protocol Violation|0
7899667|NCT01946438|12409674|FG000|Overall Study|Withdrawal by Subject|1
7899668|NCT01946438|12409675|FG001|Overall Study|Withdrawal by Subject|0
7899669|NCT01946438|12409676|FG002|Overall Study|Withdrawal by Subject|0
7899670|NCT01946438|12409677|FG003|Overall Study|Withdrawal by Subject|0
7963630|NCT02725411|12518224|FG000|Treatment Period (56 Weeks)|Adverse Event|3
7963631|NCT02725411|12518225|FG001|Treatment Period (56 Weeks)|Adverse Event|5
7899671|NCT01946802|12409693|FG000|Overall Study|Death|1
7899672|NCT01946802|12409693|FG000|Overall Study|Withdrawal by Subject|2
7899673|NCT01946802|12409693|FG000|Overall Study|Combined septic shock|1
7899674|NCT01946802|12409693|FG000|Overall Study|Protocol Violation|1
7899675|NCT01946880|12409699|FG000|Overall Study|Lost to Follow-up|1
7899676|NCT01946880|12409700|FG001|Overall Study|Lost to Follow-up|0
7899677|NCT01946880|12409699|FG000|Overall Study|Physician Decision|1
7899678|NCT01946880|12409700|FG001|Overall Study|Physician Decision|1
7899679|NCT01946880|12409699|FG000|Overall Study|Withdrawal by Subject|3
7899680|NCT01946880|12409700|FG001|Overall Study|Withdrawal by Subject|2
7899681|NCT01946880|12409699|FG000|Overall Study|Met Primary Endpoint|1
7899682|NCT01946880|12409700|FG001|Overall Study|Met Primary Endpoint|0
7899683|NCT01946880|12409699|FG000|Overall Study|Personal and Family Issues|1
7899684|NCT01946880|12409700|FG001|Overall Study|Personal and Family Issues|0
7899685|NCT01947127|12409708|FG000|Overall Study|Protocol Violation|18
7899686|NCT01947127|12409709|FG001|Overall Study|Protocol Violation|38
7899687|NCT01947127|12409708|FG000|Overall Study|Withdrawal by Subject|1
7899688|NCT01947127|12409709|FG001|Overall Study|Withdrawal by Subject|1
7899689|NCT01947127|12409708|FG000|Overall Study|Data loss|4
7899690|NCT01947127|12409709|FG001|Overall Study|Data loss|4
7899691|NCT01947283|12409729|FG000|Overall Study|Death|1
7899692|NCT01947283|12409730|FG001|Overall Study|Death|1
7899693|NCT01947283|12409731|FG002|Overall Study|Death|1
7899694|NCT01947283|12409732|FG003|Overall Study|Death|0
7899695|NCT01947283|12409733|FG004|Overall Study|Death|0
7899696|NCT01947283|12409734|FG005|Overall Study|Death|0
7899697|NCT01947283|12409735|FG006|Overall Study|Death|0
7899698|NCT01947283|12409729|FG000|Overall Study|Lost to Follow-up|4
7899699|NCT01947283|12409730|FG001|Overall Study|Lost to Follow-up|6
7899700|NCT01947283|12409731|FG002|Overall Study|Lost to Follow-up|5
7899701|NCT01947283|12409732|FG003|Overall Study|Lost to Follow-up|5
7899702|NCT01947283|12409733|FG004|Overall Study|Lost to Follow-up|0
7899703|NCT01947283|12409734|FG005|Overall Study|Lost to Follow-up|2
7899704|NCT01947283|12409735|FG006|Overall Study|Lost to Follow-up|5
7899705|NCT01947283|12409729|FG000|Overall Study|Withdrawal by Subject|10
7899706|NCT01947283|12409730|FG001|Overall Study|Withdrawal by Subject|8
7899707|NCT01947283|12409731|FG002|Overall Study|Withdrawal by Subject|4
7899708|NCT01947283|12409732|FG003|Overall Study|Withdrawal by Subject|1
7899709|NCT01947283|12409733|FG004|Overall Study|Withdrawal by Subject|0
7899710|NCT01947283|12409734|FG005|Overall Study|Withdrawal by Subject|0
7899711|NCT01947283|12409735|FG006|Overall Study|Withdrawal by Subject|2
7899712|NCT01947283|12409729|FG000|Overall Study|No Clinical Recording|12
7899713|NCT01947283|12409730|FG001|Overall Study|No Clinical Recording|6
7899714|NCT01947283|12409731|FG002|Overall Study|No Clinical Recording|8
7899715|NCT01947283|12409732|FG003|Overall Study|No Clinical Recording|10
7899716|NCT01947283|12409733|FG004|Overall Study|No Clinical Recording|0
7899717|NCT01947283|12409734|FG005|Overall Study|No Clinical Recording|0
7899718|NCT01947283|12409735|FG006|Overall Study|No Clinical Recording|0
7899719|NCT01947283|12409729|FG000|Overall Study|Non-coding Clinical Recording language|0
7899720|NCT01947283|12409730|FG001|Overall Study|Non-coding Clinical Recording language|0
7899721|NCT01947283|12409731|FG002|Overall Study|Non-coding Clinical Recording language|0
7899722|NCT01947283|12409732|FG003|Overall Study|Non-coding Clinical Recording language|1
7899723|NCT01947283|12409733|FG004|Overall Study|Non-coding Clinical Recording language|0
7899724|NCT01947283|12409734|FG005|Overall Study|Non-coding Clinical Recording language|0
7899725|NCT01947283|12409735|FG006|Overall Study|Non-coding Clinical Recording language|0
7899726|NCT01947283|12409729|FG000|Overall Study|Missing Follow-up Assessment|2
7899727|NCT01947283|12409730|FG001|Overall Study|Missing Follow-up Assessment|2
7899728|NCT01947283|12409731|FG002|Overall Study|Missing Follow-up Assessment|3
7899729|NCT01947283|12409732|FG003|Overall Study|Missing Follow-up Assessment|0
7899730|NCT01947283|12409733|FG004|Overall Study|Missing Follow-up Assessment|0
7899731|NCT01947283|12409734|FG005|Overall Study|Missing Follow-up Assessment|2
7899732|NCT01947283|12409735|FG006|Overall Study|Missing Follow-up Assessment|0
7899733|NCT01947283|12409729|FG000|Overall Study|No patients were enrolled in study|0
7899734|NCT01947283|12409730|FG001|Overall Study|No patients were enrolled in study|0
7899735|NCT01947283|12409731|FG002|Overall Study|No patients were enrolled in study|0
7899736|NCT01947283|12409732|FG003|Overall Study|No patients were enrolled in study|0
7899737|NCT01947283|12409733|FG004|Overall Study|No patients were enrolled in study|0
7899738|NCT01947283|12409734|FG005|Overall Study|No patients were enrolled in study|3
7899739|NCT01947283|12409735|FG006|Overall Study|No patients were enrolled in study|1
7899740|NCT01947491|12409765|FG000|Overall Study|Lost to Follow-up|5
7899741|NCT01947491|12409766|FG001|Overall Study|Lost to Follow-up|3
7899742|NCT01947491|12409767|FG002|Overall Study|Lost to Follow-up|1
7899743|NCT01947491|12409768|FG003|Overall Study|Lost to Follow-up|2
7899744|NCT01947491|12409765|FG000|Overall Study|Lack of Efficacy|1
7899745|NCT01947491|12409766|FG001|Overall Study|Lack of Efficacy|0
7899746|NCT01947491|12409767|FG002|Overall Study|Lack of Efficacy|0
7899747|NCT01947491|12409768|FG003|Overall Study|Lack of Efficacy|1
7899748|NCT01947491|12409765|FG000|Overall Study|Protocol Violation|1
7899749|NCT01947491|12409766|FG001|Overall Study|Protocol Violation|0
7899750|NCT01947491|12409767|FG002|Overall Study|Protocol Violation|0
7899751|NCT01947491|12409768|FG003|Overall Study|Protocol Violation|0
7899752|NCT01947491|12409765|FG000|Overall Study|Withdrawal by Subject|1
7899753|NCT01947491|12409766|FG001|Overall Study|Withdrawal by Subject|1
7899754|NCT01947491|12409767|FG002|Overall Study|Withdrawal by Subject|1
7899755|NCT01947491|12409768|FG003|Overall Study|Withdrawal by Subject|0
7899756|NCT01947491|12409765|FG000|Overall Study|Worsening of condition|0
7899757|NCT01947491|12409766|FG001|Overall Study|Worsening of condition|1
7899758|NCT01947491|12409767|FG002|Overall Study|Worsening of condition|0
7899759|NCT01947491|12409768|FG003|Overall Study|Worsening of condition|0
7899760|NCT01947491|12409765|FG000|Overall Study|Adverse Event|0
7899761|NCT01947491|12409766|FG001|Overall Study|Adverse Event|1
7899762|NCT01947491|12409767|FG002|Overall Study|Adverse Event|0
7899763|NCT01947491|12409768|FG003|Overall Study|Adverse Event|2
7899764|NCT01947517|12409780|FG000|Overall Study|Withdrawal by Subject|1
7899765|NCT01947517|12409781|FG001|Overall Study|Withdrawal by Subject|1
7899766|NCT01947582|12409787|FG000|Overall Study|Withdrawal by Subject|1
7899767|NCT01947855|12409807|FG000|Overall Study|Withdrawal by Subject|1
7899768|NCT01947855|12409808|FG001|Overall Study|Withdrawal by Subject|0
7899769|NCT01947855|12409809|FG002|Overall Study|Withdrawal by Subject|0
7899770|NCT01947894|12409820|FG000|Overall Study|Other|3
7899771|NCT01947894|12409821|FG001|Overall Study|Other|4
7899772|NCT01947894|12409822|FG002|Overall Study|Other|3
7899773|NCT01947894|12409820|FG000|Overall Study|Withdrawal by Subject|12
7899774|NCT01947894|12409821|FG001|Overall Study|Withdrawal by Subject|4
7899775|NCT01947894|12409822|FG002|Overall Study|Withdrawal by Subject|1
7899776|NCT01947894|12409820|FG000|Overall Study|Death|12
7899777|NCT01947894|12409821|FG001|Overall Study|Death|1
7899778|NCT01947894|12409822|FG002|Overall Study|Death|0
7899779|NCT01947894|12409820|FG000|Overall Study|Physician Decision|2
7899780|NCT01947894|12409821|FG001|Overall Study|Physician Decision|0
7899781|NCT01947894|12409822|FG002|Overall Study|Physician Decision|0
7899782|NCT01947894|12409820|FG000|Overall Study|Adverse Event|5
7899783|NCT01947894|12409821|FG001|Overall Study|Adverse Event|1
7899784|NCT01947894|12409822|FG002|Overall Study|Adverse Event|0
7899785|NCT01947894|12409820|FG000|Overall Study|Switched to other growth hormone brand|53
7899786|NCT01947894|12409821|FG001|Overall Study|Switched to other growth hormone brand|8
7899787|NCT01947894|12409822|FG002|Overall Study|Switched to other growth hormone brand|23
7899788|NCT01948050|12409862|FG000|Overall Study|Withdrawal by Subject|0
7899789|NCT01948050|12409863|FG001|Overall Study|Withdrawal by Subject|1
7899790|NCT01948063|12409871|FG000|Overall Study|Boston MCI halted research protocol|0
7899791|NCT01948063|12409872|FG001|Overall Study|Boston MCI halted research protocol|1
7899792|NCT01948063|12409871|FG000|Overall Study|Discovered an enrollment in other study|0
7899793|NCT01948063|12409872|FG001|Overall Study|Discovered an enrollment in other study|1
7899794|NCT01948063|12409871|FG000|Overall Study|Blood samples were accidentally thawed|1
7899795|NCT01948063|12409872|FG001|Overall Study|Blood samples were accidentally thawed|0
7899796|NCT01948076|12409880|FG000|Overall Study|Withdrawal by Subject|0
7899797|NCT01948076|12409881|FG001|Overall Study|Withdrawal by Subject|1
7899798|NCT01948193|12409893|FG000|Overall Study|Serious event|2
7899799|NCT01948193|12409893|FG000|Overall Study|Lost to Follow-up|7
7899800|NCT01948258|12409898|FG000|Overall Study|Pregnancy|41
7899801|NCT01948258|12409898|FG000|Overall Study|Did not complete by cut-off date|35
7899802|NCT01948258|12409898|FG000|Overall Study|Lost to Follow-up|27
7899803|NCT01948258|12409898|FG000|Overall Study|Withdrawal by SPD|8
7899804|NCT01948258|12409898|FG000|Overall Study|Withdrawal by Subject|6
7899805|NCT01948258|12409898|FG000|Overall Study|Health Care Professional|43
7899806|NCT01948258|12409898|FG000|Overall Study|Removed from statistical analysis|2
7899807|NCT01948427|12409938|FG000|Overall Study|Serious Adverse Event|3
7899808|NCT01948427|12409939|FG001|Overall Study|Serious Adverse Event|0
7899809|NCT01948427|12409940|FG002|Overall Study|Serious Adverse Event|0
7899810|NCT01948427|12409941|FG003|Overall Study|Serious Adverse Event|0
7899811|NCT01948427|12409942|FG004|Overall Study|Serious Adverse Event|1
7899812|NCT01948427|12409938|FG000|Overall Study|Investigator Request|0
7899813|NCT01948427|12409939|FG001|Overall Study|Investigator Request|8
7899814|NCT01948427|12409940|FG002|Overall Study|Investigator Request|0
7899815|NCT01948427|12409941|FG003|Overall Study|Investigator Request|0
7899816|NCT01948427|12409942|FG004|Overall Study|Investigator Request|6
7899817|NCT01948427|12409938|FG000|Overall Study|Lost to Follow-up|1
7899818|NCT01948427|12409939|FG001|Overall Study|Lost to Follow-up|0
7899819|NCT01948427|12409940|FG002|Overall Study|Lost to Follow-up|0
7899820|NCT01948427|12409941|FG003|Overall Study|Lost to Follow-up|0
7899821|NCT01948427|12409942|FG004|Overall Study|Lost to Follow-up|4
7899822|NCT01948427|12409938|FG000|Overall Study|Withdrawal by Subject|2
7899823|NCT01948427|12409939|FG001|Overall Study|Withdrawal by Subject|0
7899824|NCT01948427|12409940|FG002|Overall Study|Withdrawal by Subject|0
7899825|NCT01948427|12409941|FG003|Overall Study|Withdrawal by Subject|0
7899826|NCT01948427|12409942|FG004|Overall Study|Withdrawal by Subject|1
7899827|NCT01948427|12409938|FG000|Overall Study|Other, Not Specified|1
7899828|NCT01948427|12409939|FG001|Overall Study|Other, Not Specified|9
7899829|NCT01948427|12409940|FG002|Overall Study|Other, Not Specified|0
7899830|NCT01948427|12409941|FG003|Overall Study|Other, Not Specified|0
7899831|NCT01948427|12409942|FG004|Overall Study|Other, Not Specified|2
7899832|NCT01948791|12409967|FG000|Overall Study|Adverse Event|12
7899833|NCT01948791|12409967|FG000|Overall Study|Lack of Efficacy|3
7899834|NCT01948791|12409967|FG000|Overall Study|Protocol Violation|2
7899835|NCT01948791|12409967|FG000|Overall Study|Withdrawal by Subject|5
7899836|NCT01948791|12409967|FG000|Overall Study|Lost to Follow-up|6
7899837|NCT01948791|12409967|FG000|Overall Study|Management issues|1
7899838|NCT01948791|12409967|FG000|Overall Study|Others|7
7899839|NCT01948791|12409967|FG000|Overall Study|Screening failure|35
7899840|NCT01948830|12409973|FG000|Overall Study|Physician Decision|1
7899841|NCT01948830|12409974|FG001|Overall Study|Physician Decision|3
7899842|NCT01948830|12409973|FG000|Overall Study|Protocol deviation|1
7899843|NCT01948830|12409974|FG001|Overall Study|Protocol deviation|2
7899844|NCT01948830|12409973|FG000|Overall Study|Lost to Follow-up|5
7899845|NCT01948830|12409974|FG001|Overall Study|Lost to Follow-up|4
7899846|NCT01948830|12409973|FG000|Overall Study|Withdrawal by Subject|14
7899847|NCT01948830|12409974|FG001|Overall Study|Withdrawal by Subject|17
7899848|NCT01948830|12409973|FG000|Overall Study|Adverse Event|9
7899849|NCT01948830|12409974|FG001|Overall Study|Adverse Event|2
7899850|NCT01948830|12409973|FG000|Overall Study|Death|3
7899851|NCT01948830|12409974|FG001|Overall Study|Death|4
7899852|NCT01948908|12409983|FG000|Overall Study|Protocol Violation|1
7899853|NCT01948908|12409984|FG001|Overall Study|Protocol Violation|0
7899854|NCT01948908|12409985|FG002|Overall Study|Protocol Violation|2
7899855|NCT01949051|12410023|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1
7899856|NCT01949051|12410024|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0
7899857|NCT01949051|12410025|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0
7899858|NCT01949051|12410026|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1
7899859|NCT01949051|12410027|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0
7899860|NCT01949051|12410028|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0
7899861|NCT01949051|12410023|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1
7899862|NCT01949051|12410024|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7899863|NCT01949051|12410025|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7899864|NCT01949051|12410026|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7899865|NCT01949051|12410027|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7899866|NCT01949051|12410028|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7899867|NCT01949051|12410023|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0
7899868|NCT01949051|12410024|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0
7899869|NCT01949051|12410025|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0
7899870|NCT01949051|12410026|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0
7899871|NCT01949051|12410027|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0
7899872|NCT01949051|12410028|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1
7899873|NCT01949051|12410023|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7899874|NCT01949051|12410024|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1
7899875|NCT01949051|12410025|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7899876|NCT01949051|12410026|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7899877|NCT01949051|12410027|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7899878|NCT01949051|12410028|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7899879|NCT01949051|12410023|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7899880|NCT01949051|12410024|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7899881|NCT01949051|12410025|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
7899882|NCT01949051|12410026|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7899883|NCT01949051|12410027|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7899884|NCT01949051|12410028|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7899885|NCT01949090|12410041|FG000|Overall Study|Serious Adverse Event|0
7899886|NCT01949090|12410042|FG001|Overall Study|Serious Adverse Event|1
7899887|NCT01949090|12410043|FG002|Overall Study|Serious Adverse Event|2
7899888|NCT01949090|12410044|FG003|Overall Study|Serious Adverse Event|0
7899889|NCT01949090|12410045|FG004|Overall Study|Serious Adverse Event|1
7899890|NCT01949090|12410041|FG000|Overall Study|Withdrawal by Subject|2
7899891|NCT01949090|12410042|FG001|Overall Study|Withdrawal by Subject|0
7899892|NCT01949090|12410043|FG002|Overall Study|Withdrawal by Subject|0
7899893|NCT01949090|12410044|FG003|Overall Study|Withdrawal by Subject|0
7899894|NCT01949090|12410045|FG004|Overall Study|Withdrawal by Subject|1
7899895|NCT01949090|12410041|FG000|Overall Study|Protocol non-compliance|0
7899896|NCT01949090|12410042|FG001|Overall Study|Protocol non-compliance|0
7899897|NCT01949090|12410043|FG002|Overall Study|Protocol non-compliance|0
7899898|NCT01949090|12410044|FG003|Overall Study|Protocol non-compliance|0
7899899|NCT01949090|12410045|FG004|Overall Study|Protocol non-compliance|1
7899900|NCT01949090|12410041|FG000|Overall Study|Lost to Follow-up|2
7899901|NCT01949090|12410042|FG001|Overall Study|Lost to Follow-up|1
7899902|NCT01949090|12410043|FG002|Overall Study|Lost to Follow-up|0
7899903|NCT01949090|12410044|FG003|Overall Study|Lost to Follow-up|1
7899904|NCT01949090|12410045|FG004|Overall Study|Lost to Follow-up|1
7899905|NCT01949116|12410060|FG000|Overall Study|Death|2
7899906|NCT01949116|12410061|FG001|Overall Study|Death|0
7899907|NCT01949116|12410060|FG000|Overall Study|Lost to Follow-up|1
7899908|NCT01949116|12410061|FG001|Overall Study|Lost to Follow-up|3
7899909|NCT01949116|12410060|FG000|Overall Study|Withdrawal by Subject|5
7899910|NCT01949116|12410061|FG001|Overall Study|Withdrawal by Subject|3
7899911|NCT01949142|12410073|FG000|Overall Study|Withdrawal of consent|1
7899912|NCT01949142|12410074|FG001|Overall Study|Withdrawal of consent|0
7899913|NCT01949142|12410073|FG000|Overall Study|Lost to Follow-up|1
7899914|NCT01949142|12410074|FG001|Overall Study|Lost to Follow-up|1
7899915|NCT01949142|12410073|FG000|Overall Study|Parent changed their mind|1
7899916|NCT01949142|12410074|FG001|Overall Study|Parent changed their mind|0
7899917|NCT01949155|12410083|FG000|Overall Study|Lost to Follow-up|1
7899918|NCT01949155|12410084|FG001|Overall Study|Lost to Follow-up|0
7899919|NCT01949155|12410083|FG000|Overall Study|Protocol Violation|1
7899920|NCT01949155|12410084|FG001|Overall Study|Protocol Violation|0
7899921|NCT01949480|12410097|FG000|Overall Study|Physician Decision|5
7899922|NCT01949480|12410098|FG001|Overall Study|Physician Decision|8
7899923|NCT01949532|12410106|FG000|Overall Study|On-study at the Data Cut-off Date|3
7899924|NCT01949532|12410107|FG001|Overall Study|On-study at the Data Cut-off Date|3
7899925|NCT01949870|12410138|FG000|Overall Study|Lack of Efficacy|2
7899926|NCT01949870|12410138|FG000|Overall Study|Adverse Event|1
7899927|NCT01949870|12410138|FG000|Overall Study|Study termination|1
7899928|NCT01949870|12410138|FG000|Overall Study|Eligibility requirements not fulfilled|2
7899929|NCT01950013|12410145|FG000|Overall Study|Withdrawal by Subject|0
7899930|NCT01950013|12410146|FG001|Overall Study|Withdrawal by Subject|2
7899931|NCT01950013|12410147|FG002|Overall Study|Withdrawal by Subject|0
7899932|NCT01950169|12410176|FG000|Overall Study|Withdrawal by Subject|2
7899933|NCT01950169|12410177|FG001|Overall Study|Withdrawal by Subject|8
7899934|NCT01950169|12410178|FG002|Overall Study|Withdrawal by Subject|1
7899935|NCT01950169|12410176|FG000|Overall Study|Death|1
7899936|NCT01950169|12410177|FG001|Overall Study|Death|0
7899937|NCT01950169|12410178|FG002|Overall Study|Death|0
7899938|NCT01950273|12410198|FG000|Overall Study|Protocol Violation|1
7899939|NCT01950273|12410199|FG001|Overall Study|Protocol Violation|0
7899940|NCT01950273|12410198|FG000|Overall Study|Withdrawal by Subject|2
7899941|NCT01950273|12410199|FG001|Overall Study|Withdrawal by Subject|0
7899942|NCT01950273|12410198|FG000|Overall Study|Other not defined above|1
7899943|NCT01950273|12410199|FG001|Overall Study|Other not defined above|0
7899944|NCT01950364|12410220|FG000|Overall Study|Adverse Event|3
7899945|NCT01950364|12410221|FG001|Overall Study|Adverse Event|0
7899946|NCT01950364|12410220|FG000|Overall Study|Stem Cell Transplant|2
7899947|NCT01950364|12410221|FG001|Overall Study|Stem Cell Transplant|6
7899948|NCT01950364|12410220|FG000|Overall Study|Disease Progression|5
7899949|NCT01950364|12410221|FG001|Overall Study|Disease Progression|2
7899950|NCT01950364|12410220|FG000|Overall Study|Withdrawal by Subject|0
7899951|NCT01950364|12410221|FG001|Overall Study|Withdrawal by Subject|1
7899952|NCT01950364|12410220|FG000|Overall Study|Protocol Violation|0
7899953|NCT01950364|12410221|FG001|Overall Study|Protocol Violation|1
7968677|NCT02783573|12526605|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15
7968678|NCT02783573|12526606|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20
7968679|NCT02783573|12526607|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23
7968680|NCT02783573|12526605|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
7968681|NCT02783573|12526606|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
7968682|NCT02783573|12526607|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9
7968683|NCT02783573|12526605|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494
7968684|NCT02783573|12526606|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512
7968685|NCT02783573|12526607|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492
7968686|NCT02783573|12526605|FG000|Delayed-Start Period|Sponsor Decision|0
7968687|NCT02783573|12526606|FG001|Delayed-Start Period|Sponsor Decision|17
7968688|NCT02783573|12526607|FG002|Delayed-Start Period|Sponsor Decision|12
7968689|NCT02783599|12526618|FG000|Overall Study|Progressive disease|23
7968690|NCT02783599|12526618|FG000|Overall Study|Surgical Resection|10
7968691|NCT02783599|12526618|FG000|Overall Study|Adverse Event|4
7968692|NCT02783599|12526618|FG000|Overall Study|Physician Decision|2
7968693|NCT02783599|12526618|FG000|Overall Study|Death|1
7968694|NCT02783729|12526633|FG000|Overall Study|Lack of Efficacy|1
7968695|NCT02783729|12526634|FG001|Overall Study|Lack of Efficacy|0
7968696|NCT02783729|12526635|FG002|Overall Study|Lack of Efficacy|0
7968697|NCT02783729|12526636|FG003|Overall Study|Lack of Efficacy|0
7968698|NCT02783729|12526633|FG000|Overall Study|Adverse Event|2
7968699|NCT02783729|12526634|FG001|Overall Study|Adverse Event|6
7968700|NCT02783729|12526635|FG002|Overall Study|Adverse Event|2
7968701|NCT02783729|12526636|FG003|Overall Study|Adverse Event|3
7968702|NCT02783729|12526633|FG000|Overall Study|Other|1
7968703|NCT02783729|12526634|FG001|Overall Study|Other|6
7968704|NCT02783729|12526635|FG002|Overall Study|Other|2
7968705|NCT02783729|12526636|FG003|Overall Study|Other|3
7968706|NCT02783729|12526633|FG000|Overall Study|Withdrawal by Subject|2
7968707|NCT02783729|12526634|FG001|Overall Study|Withdrawal by Subject|3
7968708|NCT02783729|12526635|FG002|Overall Study|Withdrawal by Subject|1
7968709|NCT02783729|12526636|FG003|Overall Study|Withdrawal by Subject|2
7968710|NCT02783729|12526633|FG000|Overall Study|Participant's choice|2
7968711|NCT02783729|12526634|FG001|Overall Study|Participant's choice|1
7968712|NCT02783729|12526635|FG002|Overall Study|Participant's choice|2
7968713|NCT02783729|12526636|FG003|Overall Study|Participant's choice|1
7968714|NCT02783729|12526633|FG000|Overall Study|Lost to Follow-up|2
7968715|NCT02783729|12526634|FG001|Overall Study|Lost to Follow-up|1
7968716|NCT02783729|12526635|FG002|Overall Study|Lost to Follow-up|1
7968717|NCT02783729|12526636|FG003|Overall Study|Lost to Follow-up|0
7968718|NCT02783768|12526651|FG000|Overall Study|Lost to Follow-up|1
7968719|NCT02783768|12526652|FG001|Overall Study|Lost to Follow-up|0
7968720|NCT02783911|12526688|FG000|Overall Study|Lost to Follow-up|3
7968721|NCT02783911|12526689|FG001|Overall Study|Lost to Follow-up|32
7899954|NCT01950741|12410231|FG000|Overall Study|Lost to Follow-up|1
7968722|NCT02784106|12526697|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
7968723|NCT02784106|12526698|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
7968724|NCT02784106|12526699|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
7968725|NCT02784106|12526700|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
7968726|NCT02784106|12526697|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
7968727|NCT02784106|12526698|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
7968728|NCT02784106|12526699|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
7968729|NCT02784106|12526700|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
7968730|NCT02784106|12526697|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2
7968731|NCT02784106|12526698|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0
7968732|NCT02784106|12526699|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0
7968733|NCT02784106|12526700|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0
7968734|NCT02784106|12526697|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
7968735|NCT02784106|12526698|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7968736|NCT02784106|12526699|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7968737|NCT02784106|12526700|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7968738|NCT02784106|12526697|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0
7968739|NCT02784106|12526698|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0
7968740|NCT02784106|12526699|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2
7968741|NCT02784106|12526700|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1
7968742|NCT02784106|12526697|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
7968743|NCT02784106|12526698|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
7968744|NCT02784106|12526699|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
7968745|NCT02784106|12526700|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
7968746|NCT02784834|12526756|FG000|Overall Study|Lack of Efficacy|1
7899955|NCT01950741|12410231|FG000|Overall Study|Death|1
7899956|NCT01950741|12410231|FG000|Overall Study|Withdrawal by Subject|1
7899957|NCT01950819|12410242|FG000|Overall Study|Graft Loss|35
7899958|NCT01950819|12410243|FG001|Overall Study|Graft Loss|30
7899959|NCT01950819|12410242|FG000|Overall Study|Death|29
7899960|NCT01950819|12410243|FG001|Overall Study|Death|34
7899961|NCT01950819|12410242|FG000|Overall Study|Subject / Gardian decision|54
7899962|NCT01950819|12410243|FG001|Overall Study|Subject / Gardian decision|51
7899963|NCT01950819|12410242|FG000|Overall Study|technical problems|2
7899964|NCT01950819|12410243|FG001|Overall Study|technical problems|0
7899965|NCT01950819|12410242|FG000|Overall Study|Pregnancy|0
7899966|NCT01950819|12410243|FG001|Overall Study|Pregnancy|2
7899967|NCT01950819|12410242|FG000|Overall Study|Lost to Follow-up|9
7899968|NCT01950819|12410243|FG001|Overall Study|Lost to Follow-up|17
7899969|NCT01951092|12410255|FG000|Overall Study|Lost to Follow-up|10
7899970|NCT01951092|12410255|FG000|Overall Study|Incarceration|1
7899971|NCT01951092|12410255|FG000|Overall Study|Transfer of Care|1
7899972|NCT01951105|12410262|FG000|Overall Study|Adverse Event|0
7899973|NCT01951105|12410263|FG001|Overall Study|Adverse Event|5
7899974|NCT01951105|12410264|FG002|Overall Study|Adverse Event|0
7899975|NCT01951105|12410262|FG000|Overall Study|Lost to Follow-up|0
7899976|NCT01951105|12410263|FG001|Overall Study|Lost to Follow-up|1
7899977|NCT01951105|12410264|FG002|Overall Study|Lost to Follow-up|0
7899978|NCT01951105|12410262|FG000|Overall Study|Protocol Violation|1
7899979|NCT01951105|12410263|FG001|Overall Study|Protocol Violation|1
7899980|NCT01951105|12410264|FG002|Overall Study|Protocol Violation|1
7899981|NCT01951105|12410262|FG000|Overall Study|Withdrawal by Subject|0
7899982|NCT01951105|12410263|FG001|Overall Study|Withdrawal by Subject|3
7899983|NCT01951105|12410264|FG002|Overall Study|Withdrawal by Subject|1
7899984|NCT01951157|12410290|FG000|Overall Study|Progressive Disease|12
7899985|NCT01951157|12410291|FG001|Overall Study|Progressive Disease|13
7899986|NCT01951157|12410292|FG002|Overall Study|Progressive Disease|10
7899987|NCT01951157|12410290|FG000|Overall Study|Treatment-unrelated AE|1
7899988|NCT01951157|12410291|FG001|Overall Study|Treatment-unrelated AE|0
7899989|NCT01951157|12410292|FG002|Overall Study|Treatment-unrelated AE|3
7899990|NCT01951157|12410290|FG000|Overall Study|Study Termination|0
7899991|NCT01951157|12410291|FG001|Overall Study|Study Termination|0
7899992|NCT01951157|12410292|FG002|Overall Study|Study Termination|1
7899993|NCT01951157|12410290|FG000|Overall Study|Physician Decision|5
7899994|NCT01951157|12410291|FG001|Overall Study|Physician Decision|3
7899995|NCT01951157|12410292|FG002|Overall Study|Physician Decision|2
7899996|NCT01951157|12410290|FG000|Overall Study|Non-treatmentrelated death|2
7899997|NCT01951157|12410291|FG001|Overall Study|Non-treatmentrelated death|2
7899998|NCT01951157|12410292|FG002|Overall Study|Non-treatmentrelated death|2
7899999|NCT01951157|12410290|FG000|Overall Study|No treated|0
7900000|NCT01951157|12410291|FG001|Overall Study|No treated|1
7900001|NCT01951157|12410292|FG002|Overall Study|No treated|0
7900002|NCT01951157|12410290|FG000|Overall Study|Treatment-related AE|2
7900003|NCT01951157|12410291|FG001|Overall Study|Treatment-related AE|0
7900004|NCT01951157|12410292|FG002|Overall Study|Treatment-related AE|4
7900005|NCT01951157|12410290|FG000|Overall Study|Consent withdrawn by subject|0
7900006|NCT01951157|12410291|FG001|Overall Study|Consent withdrawn by subject|1
7900007|NCT01951157|12410292|FG002|Overall Study|Consent withdrawn by subject|3
7900008|NCT01951157|12410290|FG000|Overall Study|Treatment-related death|0
7900009|NCT01951157|12410291|FG001|Overall Study|Treatment-related death|2
7900010|NCT01951157|12410292|FG002|Overall Study|Treatment-related death|0
7900011|NCT01951170|12410301|FG000|Overall Study|Investigator decision|1
7900012|NCT01951261|12410307|FG000|Overall Study|Death|1
7900013|NCT01951261|12410308|FG001|Overall Study|Death|0
7900014|NCT01951261|12410307|FG000|Overall Study|Lost to Follow-up|4
7900015|NCT01951261|12410308|FG001|Overall Study|Lost to Follow-up|3
7900016|NCT01951261|12410307|FG000|Overall Study|Protocol Violation|4
7900017|NCT01951261|12410308|FG001|Overall Study|Protocol Violation|3
7900018|NCT01951573|12410348|FG000|Washout Period|Adverse Event|0
7900019|NCT01951573|12410349|FG001|Washout Period|Adverse Event|1
7900020|NCT01951586|12410357|FG000|Overall Study|Death|61
7900021|NCT01951586|12410358|FG001|Overall Study|Death|120
7900022|NCT01951586|12410357|FG000|Overall Study|Withdrawal by Subject|8
7900023|NCT01951586|12410358|FG001|Overall Study|Withdrawal by Subject|17
7900024|NCT01951586|12410357|FG000|Overall Study|Lost to Follow-up|0
7900025|NCT01951586|12410358|FG001|Overall Study|Lost to Follow-up|1
7900026|NCT01951586|12410357|FG000|Overall Study|Sponsor Decision|9
7900027|NCT01951586|12410358|FG001|Overall Study|Sponsor Decision|10
7900028|NCT01951625|12410370|FG000|Treatment Period|Protocol Violation|2
7900029|NCT01951625|12410371|FG001|Treatment Period|Protocol Violation|0
7900030|NCT01951625|12410372|FG002|Treatment Period|Protocol Violation|1
7900031|NCT01951625|12410373|FG003|Treatment Period|Protocol Violation|3
7900032|NCT01951625|12410374|FG004|Treatment Period|Protocol Violation|2
7900033|NCT01951625|12410370|FG000|Treatment Period|Physician Decision|0
7900034|NCT01951625|12410371|FG001|Treatment Period|Physician Decision|0
7900035|NCT01951625|12410372|FG002|Treatment Period|Physician Decision|0
7900036|NCT01951625|12410373|FG003|Treatment Period|Physician Decision|0
7900037|NCT01951625|12410374|FG004|Treatment Period|Physician Decision|1
7900038|NCT01951625|12410370|FG000|Treatment Period|Protocol driven decision point|0
7900039|NCT01951625|12410371|FG001|Treatment Period|Protocol driven decision point|5
7900040|NCT01951625|12410372|FG002|Treatment Period|Protocol driven decision point|0
7900041|NCT01951625|12410373|FG003|Treatment Period|Protocol driven decision point|2
7900042|NCT01951625|12410374|FG004|Treatment Period|Protocol driven decision point|1
7900043|NCT01951625|12410370|FG000|Treatment Period|Non compliance with study drug|1
7900044|NCT01951625|12410371|FG001|Treatment Period|Non compliance with study drug|2
7900045|NCT01951625|12410372|FG002|Treatment Period|Non compliance with study drug|2
7900046|NCT01951625|12410373|FG003|Treatment Period|Non compliance with study drug|0
7900047|NCT01951625|12410374|FG004|Treatment Period|Non compliance with study drug|0
7900048|NCT01951625|12410370|FG000|Treatment Period|Death|3
7900049|NCT01951625|12410371|FG001|Treatment Period|Death|2
7900050|NCT01951625|12410372|FG002|Treatment Period|Death|2
7900051|NCT01951625|12410373|FG003|Treatment Period|Death|1
7900052|NCT01951625|12410374|FG004|Treatment Period|Death|2
7900053|NCT01951625|12410370|FG000|Treatment Period|Adverse Event|7
7900054|NCT01951625|12410371|FG001|Treatment Period|Adverse Event|10
7900055|NCT01951625|12410372|FG002|Treatment Period|Adverse Event|9
7900056|NCT01951625|12410373|FG003|Treatment Period|Adverse Event|8
7900057|NCT01951625|12410374|FG004|Treatment Period|Adverse Event|8
7900058|NCT01951625|12410370|FG000|Treatment Period|Withdrawal by Subject|5
7900059|NCT01951625|12410371|FG001|Treatment Period|Withdrawal by Subject|2
7900060|NCT01951625|12410372|FG002|Treatment Period|Withdrawal by Subject|1
7900061|NCT01951625|12410373|FG003|Treatment Period|Withdrawal by Subject|7
7900062|NCT01951625|12410374|FG004|Treatment Period|Withdrawal by Subject|3
7900063|NCT01951625|12410370|FG000|Treatment Period|Lost to Follow-up|1
7900064|NCT01951625|12410371|FG001|Treatment Period|Lost to Follow-up|0
7900065|NCT01951625|12410372|FG002|Treatment Period|Lost to Follow-up|0
7900066|NCT01951625|12410373|FG003|Treatment Period|Lost to Follow-up|1
7900067|NCT01951625|12410374|FG004|Treatment Period|Lost to Follow-up|0
7900068|NCT01951625|12410370|FG000|Follow Up Period|Non-compliance with study drug|1
7900069|NCT01951625|12410371|FG001|Follow Up Period|Non-compliance with study drug|0
7900070|NCT01951625|12410372|FG002|Follow Up Period|Non-compliance with study drug|0
7900071|NCT01951625|12410373|FG003|Follow Up Period|Non-compliance with study drug|0
7900072|NCT01951625|12410374|FG004|Follow Up Period|Non-compliance with study drug|0
7900073|NCT01951625|12410370|FG000|Follow Up Period|Death|1
7900074|NCT01951625|12410371|FG001|Follow Up Period|Death|3
7900075|NCT01951625|12410372|FG002|Follow Up Period|Death|2
7900076|NCT01951625|12410373|FG003|Follow Up Period|Death|2
7900077|NCT01951625|12410374|FG004|Follow Up Period|Death|1
7900078|NCT01951625|12410370|FG000|Follow Up Period|Logistical difficulties|1
7900079|NCT01951625|12410371|FG001|Follow Up Period|Logistical difficulties|2
7900080|NCT01951625|12410372|FG002|Follow Up Period|Logistical difficulties|0
7900081|NCT01951625|12410373|FG003|Follow Up Period|Logistical difficulties|0
7900082|NCT01951625|12410374|FG004|Follow Up Period|Logistical difficulties|0
7900083|NCT01951625|12410370|FG000|Follow Up Period|Adverse Event|0
7900084|NCT01951625|12410371|FG001|Follow Up Period|Adverse Event|3
7900085|NCT01951625|12410372|FG002|Follow Up Period|Adverse Event|2
7900086|NCT01951625|12410373|FG003|Follow Up Period|Adverse Event|3
7900087|NCT01951625|12410374|FG004|Follow Up Period|Adverse Event|5
7900088|NCT01951625|12410370|FG000|Follow Up Period|Withdrawal by Subject|4
7900089|NCT01951625|12410371|FG001|Follow Up Period|Withdrawal by Subject|1
7900090|NCT01951625|12410372|FG002|Follow Up Period|Withdrawal by Subject|0
7900091|NCT01951625|12410373|FG003|Follow Up Period|Withdrawal by Subject|5
7900092|NCT01951625|12410374|FG004|Follow Up Period|Withdrawal by Subject|3
7900093|NCT01951625|12410370|FG000|Follow Up Period|Lost to Follow-up|1
7900094|NCT01951625|12410371|FG001|Follow Up Period|Lost to Follow-up|0
7900095|NCT01951625|12410372|FG002|Follow Up Period|Lost to Follow-up|0
7900096|NCT01951625|12410373|FG003|Follow Up Period|Lost to Follow-up|1
7900097|NCT01951625|12410374|FG004|Follow Up Period|Lost to Follow-up|1
7900098|NCT01951638|12410392|FG000|Treatment Period|Protocol Violation|0
7900099|NCT01951638|12410393|FG001|Treatment Period|Protocol Violation|0
7900100|NCT01951638|12410394|FG002|Treatment Period|Protocol Violation|0
7900101|NCT01951638|12410395|FG003|Treatment Period|Protocol Violation|2
7900102|NCT01951638|12410396|FG004|Treatment Period|Protocol Violation|0
7900103|NCT01951638|12410392|FG000|Treatment Period|Protocol-driven decision point|1
7900104|NCT01951638|12410393|FG001|Treatment Period|Protocol-driven decision point|3
7900105|NCT01951638|12410394|FG002|Treatment Period|Protocol-driven decision point|0
7900106|NCT01951638|12410395|FG003|Treatment Period|Protocol-driven decision point|0
7900107|NCT01951638|12410396|FG004|Treatment Period|Protocol-driven decision point|0
7900108|NCT01951638|12410392|FG000|Treatment Period|Logistical difficulties|0
7900109|NCT01951638|12410393|FG001|Treatment Period|Logistical difficulties|1
7900110|NCT01951638|12410394|FG002|Treatment Period|Logistical difficulties|1
7900111|NCT01951638|12410395|FG003|Treatment Period|Logistical difficulties|0
7900112|NCT01951638|12410396|FG004|Treatment Period|Logistical difficulties|0
7900113|NCT01951638|12410392|FG000|Treatment Period|Withdrawal by Subject|9
7900114|NCT01951638|12410393|FG001|Treatment Period|Withdrawal by Subject|6
7900115|NCT01951638|12410394|FG002|Treatment Period|Withdrawal by Subject|4
7900116|NCT01951638|12410395|FG003|Treatment Period|Withdrawal by Subject|5
7900117|NCT01951638|12410396|FG004|Treatment Period|Withdrawal by Subject|4
7900118|NCT01951638|12410392|FG000|Treatment Period|Death|0
7900119|NCT01951638|12410393|FG001|Treatment Period|Death|0
7900120|NCT01951638|12410394|FG002|Treatment Period|Death|0
7900121|NCT01951638|12410395|FG003|Treatment Period|Death|3
7900122|NCT01951638|12410396|FG004|Treatment Period|Death|1
7900123|NCT01951638|12410392|FG000|Treatment Period|Adverse Event|3
7900124|NCT01951638|12410393|FG001|Treatment Period|Adverse Event|4
7900125|NCT01951638|12410394|FG002|Treatment Period|Adverse Event|8
7900126|NCT01951638|12410395|FG003|Treatment Period|Adverse Event|6
7900127|NCT01951638|12410396|FG004|Treatment Period|Adverse Event|5
7900128|NCT01951638|12410392|FG000|Follow-up Period|Protocol Violation|0
7900129|NCT01951638|12410393|FG001|Follow-up Period|Protocol Violation|0
7900130|NCT01951638|12410394|FG002|Follow-up Period|Protocol Violation|0
7900131|NCT01951638|12410395|FG003|Follow-up Period|Protocol Violation|1
7900132|NCT01951638|12410396|FG004|Follow-up Period|Protocol Violation|0
7900133|NCT01951638|12410392|FG000|Follow-up Period|Logistical difficulties|0
7900134|NCT01951638|12410393|FG001|Follow-up Period|Logistical difficulties|2
7900135|NCT01951638|12410394|FG002|Follow-up Period|Logistical difficulties|0
7900136|NCT01951638|12410395|FG003|Follow-up Period|Logistical difficulties|0
7900137|NCT01951638|12410396|FG004|Follow-up Period|Logistical difficulties|1
7900138|NCT01951638|12410392|FG000|Follow-up Period|Withdrawal by Subject|1
7900139|NCT01951638|12410393|FG001|Follow-up Period|Withdrawal by Subject|5
7900140|NCT01951638|12410394|FG002|Follow-up Period|Withdrawal by Subject|2
7900141|NCT01951638|12410395|FG003|Follow-up Period|Withdrawal by Subject|1
7900142|NCT01951638|12410396|FG004|Follow-up Period|Withdrawal by Subject|2
7900143|NCT01951638|12410392|FG000|Follow-up Period|Lost to Follow-up|0
7900144|NCT01951638|12410393|FG001|Follow-up Period|Lost to Follow-up|1
7900145|NCT01951638|12410394|FG002|Follow-up Period|Lost to Follow-up|0
7900146|NCT01951638|12410395|FG003|Follow-up Period|Lost to Follow-up|1
7900147|NCT01951638|12410396|FG004|Follow-up Period|Lost to Follow-up|0
7900148|NCT01951638|12410392|FG000|Follow-up Period|Death|1
7900149|NCT01951638|12410393|FG001|Follow-up Period|Death|0
7900150|NCT01951638|12410394|FG002|Follow-up Period|Death|1
7900151|NCT01951638|12410395|FG003|Follow-up Period|Death|4
7900152|NCT01951638|12410396|FG004|Follow-up Period|Death|1
7900153|NCT01951638|12410392|FG000|Follow-up Period|Adverse Event|0
7900154|NCT01951638|12410393|FG001|Follow-up Period|Adverse Event|1
7900155|NCT01951638|12410394|FG002|Follow-up Period|Adverse Event|2
7900156|NCT01951638|12410395|FG003|Follow-up Period|Adverse Event|1
7900157|NCT01951638|12410396|FG004|Follow-up Period|Adverse Event|1
7900158|NCT01951703|12410419|FG000|First Intervention|Withdrawal by Subject|1
7900159|NCT01951703|12410420|FG001|First Intervention|Withdrawal by Subject|0
7900160|NCT01951703|12410419|FG000|First Intervention|Subject was not compliant|1
7900161|NCT01951703|12410420|FG001|First Intervention|Subject was not compliant|1
7900162|NCT01951703|12410419|FG000|First Intervention|Physician Decision|1
7900163|NCT01951703|12410420|FG001|First Intervention|Physician Decision|0
7900164|NCT01951703|12410419|FG000|Second Intervention|Protocol Violation|0
7900165|NCT01951703|12410420|FG001|Second Intervention|Protocol Violation|1
7900166|NCT01951703|12410419|FG000|Second Intervention|Unsatisfactory Lens fitting|0
7900167|NCT01951703|12410420|FG001|Second Intervention|Unsatisfactory Lens fitting|1
7900168|NCT01952015|12410467|FG000|Induction|Protocol Violation|1
7900169|NCT01952015|12410467|FG000|Maintenance|Adverse Event|2
7900170|NCT01952015|12410467|FG000|Treatment Period 3|Physician Decision|9
7900171|NCT01952041|12410485|FG000|Overall Study|Lost to Follow-up|9
7900172|NCT01952041|12410486|FG001|Overall Study|Lost to Follow-up|16
7900173|NCT01952041|12410485|FG000|Overall Study|Withdrawal by Subject|7
7900174|NCT01952041|12410486|FG001|Overall Study|Withdrawal by Subject|5
7900175|NCT01952041|12410485|FG000|Overall Study|Death|1
7900176|NCT01952041|12410486|FG001|Overall Study|Death|0
7900177|NCT01952054|12410492|FG000|Overall Study|Physician Decision|1
7900178|NCT01952080|12410500|FG000|Overall Study|Withdrawal by Subject|0
7900179|NCT01952080|12410501|FG001|Overall Study|Withdrawal by Subject|0
7900180|NCT01952080|12410502|FG002|Overall Study|Withdrawal by Subject|0
7900181|NCT01952080|12410503|FG003|Overall Study|Withdrawal by Subject|1
7900182|NCT01952080|12410500|FG000|Overall Study|Protocol Non-compliance|0
7900183|NCT01952080|12410501|FG001|Overall Study|Protocol Non-compliance|1
7900184|NCT01952080|12410502|FG002|Overall Study|Protocol Non-compliance|0
7900185|NCT01952080|12410503|FG003|Overall Study|Protocol Non-compliance|0
7900186|NCT01952145|12410515|FG000|Overall Study|Protocol Violation|2
7900187|NCT01952145|12410516|FG001|Overall Study|Protocol Violation|1
7900188|NCT01952145|12410515|FG000|Overall Study|Death|0
7900189|NCT01952145|12410516|FG001|Overall Study|Death|1
7900190|NCT01952145|12410515|FG000|Overall Study|Adverse Event|9
7900191|NCT01952145|12410516|FG001|Overall Study|Adverse Event|0
7900192|NCT01952145|12410515|FG000|Overall Study|Withdrawal Criteria|16
7900193|NCT01952145|12410516|FG001|Overall Study|Withdrawal Criteria|11
7900194|NCT01952145|12410515|FG000|Overall Study|Unclassified|1
7900195|NCT01952145|12410516|FG001|Overall Study|Unclassified|1
7900196|NCT01952366|12410528|FG000|Overall Study|Death|22
7900197|NCT01952366|12410528|FG000|Overall Study|Withdrawal by Subject|9
7900198|NCT01952665|12410582|FG000|Overall Study|Physician Decision|3
7900199|NCT01952665|12410583|FG001|Overall Study|Physician Decision|2
7900200|NCT01952665|12410582|FG000|Overall Study|Lost to Follow-up|1
7900201|NCT01952665|12410583|FG001|Overall Study|Lost to Follow-up|2
7900202|NCT01952665|12410582|FG000|Overall Study|Adverse Event|2
7900203|NCT01952665|12410583|FG001|Overall Study|Adverse Event|1
7900204|NCT01952665|12410582|FG000|Overall Study|Protocol Violation|0
7900205|NCT01952665|12410583|FG001|Overall Study|Protocol Violation|1
7900206|NCT01952691|12410611|FG000|Overall Study|Lost to Follow-up|2
7900207|NCT01952834|12410615|FG000|Overall Study|Adverse Event|1
7900208|NCT01953003|12410622|FG000|Overall Study|Not treated|0
7900209|NCT01953003|12410623|FG001|Overall Study|Not treated|1
7900210|NCT01953003|12410622|FG000|Overall Study|Progressive disease|35
7900211|NCT01953003|12410623|FG001|Overall Study|Progressive disease|45
7900212|NCT01953003|12410622|FG000|Overall Study|Related Adverse events|7
7900213|NCT01953003|12410623|FG001|Overall Study|Related Adverse events|2
7900214|NCT01953003|12410622|FG000|Overall Study|Non-related adverse events|0
7900215|NCT01953003|12410623|FG001|Overall Study|Non-related adverse events|2
7900216|NCT01953003|12410622|FG000|Overall Study|Protocol Violation|0
7900217|NCT01953003|12410623|FG001|Overall Study|Protocol Violation|1
7900218|NCT01953003|12410622|FG000|Overall Study|Withdrawal by Subject|14
7900219|NCT01953003|12410623|FG001|Overall Study|Withdrawal by Subject|4
7900220|NCT01953224|12410646|FG000|Overall Study|Lost to Follow-up|1
7900221|NCT01953224|12410647|FG001|Overall Study|Lost to Follow-up|1
7900222|NCT01953224|12410646|FG000|Overall Study|Withdrawal by Subject|1
7900223|NCT01953224|12410647|FG001|Overall Study|Withdrawal by Subject|2
7900224|NCT01953328|12410670|FG000|Overall Study|Withdrawal by Subject|0
7900225|NCT01953328|12410671|FG001|Overall Study|Withdrawal by Subject|0
7900226|NCT01953328|12410672|FG002|Overall Study|Withdrawal by Subject|0
7900227|NCT01953328|12410673|FG003|Overall Study|Withdrawal by Subject|0
7900228|NCT01953328|12410674|FG004|Overall Study|Withdrawal by Subject|1
7900229|NCT01953328|12410675|FG005|Overall Study|Withdrawal by Subject|0
7900230|NCT01953328|12410676|FG006|Overall Study|Withdrawal by Subject|0
7900231|NCT01953328|12410677|FG007|Overall Study|Withdrawal by Subject|0
7900232|NCT01953328|12410670|FG000|Overall Study|Lost to Follow-up|0
7900233|NCT01953328|12410671|FG001|Overall Study|Lost to Follow-up|0
7900234|NCT01953328|12410672|FG002|Overall Study|Lost to Follow-up|0
7900235|NCT01953328|12410673|FG003|Overall Study|Lost to Follow-up|0
7900236|NCT01953328|12410674|FG004|Overall Study|Lost to Follow-up|1
7900237|NCT01953328|12410675|FG005|Overall Study|Lost to Follow-up|0
7900238|NCT01953328|12410676|FG006|Overall Study|Lost to Follow-up|0
7900239|NCT01953328|12410677|FG007|Overall Study|Lost to Follow-up|0
7900240|NCT01953354|12410697|FG000|Overall Study|Withdrawal by Subject|0
7900241|NCT01953354|12410698|FG001|Overall Study|Withdrawal by Subject|1
7900242|NCT01953354|12410697|FG000|Overall Study|Decision of Sponsor|0
7900243|NCT01953354|12410698|FG001|Overall Study|Decision of Sponsor|1
7900244|NCT01953354|12410697|FG000|Overall Study|Disease Exacerbation|1
7900245|NCT01953354|12410698|FG001|Overall Study|Disease Exacerbation|0
7963632|NCT02725411|12518226|FG002|Treatment Period (56 Weeks)|Adverse Event|4
7963633|NCT02725411|12518224|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1
7963634|NCT02725411|12518225|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4
7963635|NCT02725411|12518226|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1
7963636|NCT02725411|12518224|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0
7963637|NCT02725411|12518225|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1
7963638|NCT02725411|12518226|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0
7963639|NCT02725411|12518224|FG000|Treatment Period (56 Weeks)|Other|1
7963640|NCT02725411|12518225|FG001|Treatment Period (56 Weeks)|Other|4
7963641|NCT02725411|12518226|FG002|Treatment Period (56 Weeks)|Other|5
7963642|NCT02725411|12518224|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0
7717875|NCT00522431|12141500|FG000|Overall Study|Protocol Violation|2
7717876|NCT00522431|12141500|FG000|Overall Study|Withdrawal by Subject|2
7717877|NCT00522431|12141500|FG000|Overall Study|Subject non-compliance|1
7717878|NCT00522431|12141500|FG000|Overall Study|Other/unknown|1
7717879|NCT00522548|12141506|FG000|Overall Study|Adverse Event|2
7717880|NCT00522548|12141507|FG001|Overall Study|Adverse Event|2
7963643|NCT02725411|12518225|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1
7717881|NCT00522548|12141506|FG000|Overall Study|Withdrawal by Subject|0
7717882|NCT00522548|12141507|FG001|Overall Study|Withdrawal by Subject|2
7717883|NCT00522626|12141513|FG000|Overall Study|Lost to Follow-up|7
7717884|NCT00522873|12141523|FG000|Overall Study|Adverse Event|41
7717885|NCT00522873|12141524|FG001|Overall Study|Adverse Event|26
7717886|NCT00522873|12141523|FG000|Overall Study|Withdrawal by Subject|20
7717887|NCT00522873|12141524|FG001|Overall Study|Withdrawal by Subject|9
7717888|NCT00522873|12141523|FG000|Overall Study|Protocol Violation|14
7717889|NCT00522873|12141524|FG001|Overall Study|Protocol Violation|4
7717890|NCT00522873|12141523|FG000|Overall Study|Lost to Follow-up|11
7717891|NCT00522873|12141524|FG001|Overall Study|Lost to Follow-up|3
7717892|NCT00522873|12141523|FG000|Overall Study|Personal Reasons|8
7717893|NCT00522873|12141524|FG001|Overall Study|Personal Reasons|1
7717894|NCT00522873|12141523|FG000|Overall Study|Medication Errors|1
7717895|NCT00522873|12141524|FG001|Overall Study|Medication Errors|1
7717896|NCT00522873|12141523|FG000|Overall Study|Never Received Medication|1
7717897|NCT00522873|12141524|FG001|Overall Study|Never Received Medication|0
7717898|NCT00522951|12141543|FG000|Period 1|body motion|0
7900246|NCT01953601|12410729|FG000|Part 1 (Base Study)|Adverse Event|24
7900247|NCT01953601|12410730|FG001|Part 1 (Base Study)|Adverse Event|37
7900248|NCT01953601|12410731|FG002|Part 1 (Base Study)|Adverse Event|15
7900249|NCT01953601|12410729|FG000|Part 1 (Base Study)|Death|2
7900250|NCT01953601|12410730|FG001|Part 1 (Base Study)|Death|0
7900251|NCT01953601|12410731|FG002|Part 1 (Base Study)|Death|3
7900252|NCT01953601|12410729|FG000|Part 1 (Base Study)|Lack of Efficacy|3
7900253|NCT01953601|12410730|FG001|Part 1 (Base Study)|Lack of Efficacy|1
7900254|NCT01953601|12410731|FG002|Part 1 (Base Study)|Lack of Efficacy|4
7900255|NCT01953601|12410729|FG000|Part 1 (Base Study)|Lost to Follow-up|1
7900256|NCT01953601|12410730|FG001|Part 1 (Base Study)|Lost to Follow-up|3
7900257|NCT01953601|12410731|FG002|Part 1 (Base Study)|Lost to Follow-up|6
7900258|NCT01953601|12410729|FG000|Part 1 (Base Study)|Non-compliance with study drug|0
7900259|NCT01953601|12410730|FG001|Part 1 (Base Study)|Non-compliance with study drug|3
7900260|NCT01953601|12410731|FG002|Part 1 (Base Study)|Non-compliance with study drug|1
7900261|NCT01953601|12410729|FG000|Part 1 (Base Study)|Physician Decision|3
7900262|NCT01953601|12410730|FG001|Part 1 (Base Study)|Physician Decision|7
7900263|NCT01953601|12410731|FG002|Part 1 (Base Study)|Physician Decision|4
7900264|NCT01953601|12410729|FG000|Part 1 (Base Study)|Screen failure|1
7900265|NCT01953601|12410730|FG001|Part 1 (Base Study)|Screen failure|0
7900266|NCT01953601|12410731|FG002|Part 1 (Base Study)|Screen failure|1
7900267|NCT01953601|12410729|FG000|Part 1 (Base Study)|Site discontinued study participation|2
7900268|NCT01953601|12410730|FG001|Part 1 (Base Study)|Site discontinued study participation|0
7900269|NCT01953601|12410731|FG002|Part 1 (Base Study)|Site discontinued study participation|0
7900270|NCT01953601|12410729|FG000|Part 1 (Base Study)|Study terminated by sponsor|174
7900271|NCT01953601|12410730|FG001|Part 1 (Base Study)|Study terminated by sponsor|169
7900272|NCT01953601|12410731|FG002|Part 1 (Base Study)|Study terminated by sponsor|179
7900273|NCT01953601|12410729|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7
7900274|NCT01953601|12410730|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8
7900275|NCT01953601|12410731|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10
7900276|NCT01953601|12410729|FG000|Part 1 (Base Study)|Subject moved|2
7900277|NCT01953601|12410730|FG001|Part 1 (Base Study)|Subject moved|2
7900278|NCT01953601|12410731|FG002|Part 1 (Base Study)|Subject moved|1
7900279|NCT01953601|12410729|FG000|Part 1 (Base Study)|Withdrawal by Subject|32
7900280|NCT01953601|12410730|FG001|Part 1 (Base Study)|Withdrawal by Subject|23
7900281|NCT01953601|12410731|FG002|Part 1 (Base Study)|Withdrawal by Subject|22
7900282|NCT01953601|12410729|FG000|Part 2 (Extension Study)|Adverse Event|1
7900283|NCT01953601|12410730|FG001|Part 2 (Extension Study)|Adverse Event|1
7900284|NCT01953601|12410731|FG002|Part 2 (Extension Study)|Adverse Event|10
7900285|NCT01953601|12410729|FG000|Part 2 (Extension Study)|Death|0
7900286|NCT01953601|12410730|FG001|Part 2 (Extension Study)|Death|3
7900287|NCT01953601|12410731|FG002|Part 2 (Extension Study)|Death|0
7900288|NCT01953601|12410729|FG000|Part 2 (Extension Study)|Lack of Efficacy|2
7900289|NCT01953601|12410730|FG001|Part 2 (Extension Study)|Lack of Efficacy|0
7900290|NCT01953601|12410731|FG002|Part 2 (Extension Study)|Lack of Efficacy|0
7900291|NCT01953601|12410729|FG000|Part 2 (Extension Study)|Lost to Follow-up|2
7900292|NCT01953601|12410730|FG001|Part 2 (Extension Study)|Lost to Follow-up|1
7900293|NCT01953601|12410731|FG002|Part 2 (Extension Study)|Lost to Follow-up|1
7900294|NCT01953601|12410729|FG000|Part 2 (Extension Study)|Physician Decision|2
7900295|NCT01953601|12410730|FG001|Part 2 (Extension Study)|Physician Decision|0
7900296|NCT01953601|12410731|FG002|Part 2 (Extension Study)|Physician Decision|2
7900297|NCT01953601|12410729|FG000|Part 2 (Extension Study)|Site discontinued study participation|0
7900298|NCT01953601|12410730|FG001|Part 2 (Extension Study)|Site discontinued study participation|1
7900299|NCT01953601|12410731|FG002|Part 2 (Extension Study)|Site discontinued study participation|1
7900300|NCT01953601|12410729|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185
7900301|NCT01953601|12410730|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178
7900302|NCT01953601|12410731|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187
7900303|NCT01953601|12410729|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1
7900304|NCT01953601|12410730|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3
7900305|NCT01953601|12410731|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0
7900306|NCT01953601|12410729|FG000|Part 2 (Extension Study)|Subject moved|0
7900307|NCT01953601|12410730|FG001|Part 2 (Extension Study)|Subject moved|0
7900308|NCT01953601|12410731|FG002|Part 2 (Extension Study)|Subject moved|1
7900309|NCT01953601|12410729|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5
7900310|NCT01953601|12410730|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4
7900311|NCT01953601|12410731|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2
7900312|NCT01953692|12410751|FG000|Overall Study|Adverse Event|5
7900313|NCT01953692|12410752|FG001|Overall Study|Adverse Event|2
7900314|NCT01953692|12410753|FG002|Overall Study|Adverse Event|4
7900315|NCT01953692|12410754|FG003|Overall Study|Adverse Event|2
7900316|NCT01953692|12410755|FG004|Overall Study|Adverse Event|1
7900317|NCT01953692|12410756|FG005|Overall Study|Adverse Event|2
7900318|NCT01953692|12410757|FG006|Overall Study|Adverse Event|0
7900319|NCT01953692|12410758|FG007|Overall Study|Adverse Event|0
7900320|NCT01953692|12410759|FG008|Overall Study|Adverse Event|0
7900321|NCT01953692|12410751|FG000|Overall Study|Clinical Progression|0
7900322|NCT01953692|12410752|FG001|Overall Study|Clinical Progression|15
7900323|NCT01953692|12410753|FG002|Overall Study|Clinical Progression|7
7900324|NCT01953692|12410754|FG003|Overall Study|Clinical Progression|5
7900325|NCT01953692|12410755|FG004|Overall Study|Clinical Progression|0
7900326|NCT01953692|12410756|FG005|Overall Study|Clinical Progression|7
7900327|NCT01953692|12410757|FG006|Overall Study|Clinical Progression|20
7900328|NCT01953692|12410758|FG007|Overall Study|Clinical Progression|3
7900329|NCT01953692|12410759|FG008|Overall Study|Clinical Progression|3
7900330|NCT01953692|12410751|FG000|Overall Study|Death|5
7900331|NCT01953692|12410752|FG001|Overall Study|Death|0
7900332|NCT01953692|12410753|FG002|Overall Study|Death|2
7900333|NCT01953692|12410754|FG003|Overall Study|Death|2
7900334|NCT01953692|12410755|FG004|Overall Study|Death|1
7900335|NCT01953692|12410756|FG005|Overall Study|Death|3
7900336|NCT01953692|12410757|FG006|Overall Study|Death|6
7900337|NCT01953692|12410758|FG007|Overall Study|Death|2
7900338|NCT01953692|12410759|FG008|Overall Study|Death|1
7900339|NCT01953692|12410751|FG000|Overall Study|Excluded Medication|1
7900340|NCT01953692|12410752|FG001|Overall Study|Excluded Medication|0
7900341|NCT01953692|12410753|FG002|Overall Study|Excluded Medication|0
7900342|NCT01953692|12410754|FG003|Overall Study|Excluded Medication|0
7900343|NCT01953692|12410755|FG004|Overall Study|Excluded Medication|0
7900344|NCT01953692|12410756|FG005|Overall Study|Excluded Medication|0
7900345|NCT01953692|12410757|FG006|Overall Study|Excluded Medication|0
7900346|NCT01953692|12410758|FG007|Overall Study|Excluded Medication|0
7900347|NCT01953692|12410759|FG008|Overall Study|Excluded Medication|0
7900348|NCT01953692|12410751|FG000|Overall Study|Lost to Follow-up|1
7900349|NCT01953692|12410752|FG001|Overall Study|Lost to Follow-up|0
7900350|NCT01953692|12410753|FG002|Overall Study|Lost to Follow-up|3
7900351|NCT01953692|12410754|FG003|Overall Study|Lost to Follow-up|1
7900352|NCT01953692|12410755|FG004|Overall Study|Lost to Follow-up|0
7900353|NCT01953692|12410756|FG005|Overall Study|Lost to Follow-up|1
7900354|NCT01953692|12410757|FG006|Overall Study|Lost to Follow-up|0
7900355|NCT01953692|12410758|FG007|Overall Study|Lost to Follow-up|0
7900356|NCT01953692|12410759|FG008|Overall Study|Lost to Follow-up|0
7900357|NCT01953692|12410751|FG000|Overall Study|Physician Decision|11
7900358|NCT01953692|12410752|FG001|Overall Study|Physician Decision|4
7900359|NCT01953692|12410753|FG002|Overall Study|Physician Decision|2
7900360|NCT01953692|12410754|FG003|Overall Study|Physician Decision|2
7900361|NCT01953692|12410755|FG004|Overall Study|Physician Decision|1
7900362|NCT01953692|12410756|FG005|Overall Study|Physician Decision|2
7900363|NCT01953692|12410757|FG006|Overall Study|Physician Decision|4
7900364|NCT01953692|12410758|FG007|Overall Study|Physician Decision|1
7900365|NCT01953692|12410759|FG008|Overall Study|Physician Decision|0
7900366|NCT01953692|12410751|FG000|Overall Study|Protocol Violation|0
7900367|NCT01953692|12410752|FG001|Overall Study|Protocol Violation|2
7900368|NCT01953692|12410753|FG002|Overall Study|Protocol Violation|1
7900369|NCT01953692|12410754|FG003|Overall Study|Protocol Violation|0
7900370|NCT01953692|12410755|FG004|Overall Study|Protocol Violation|0
7900371|NCT01953692|12410756|FG005|Overall Study|Protocol Violation|0
7900372|NCT01953692|12410757|FG006|Overall Study|Protocol Violation|0
7900373|NCT01953692|12410758|FG007|Overall Study|Protocol Violation|1
7900374|NCT01953692|12410759|FG008|Overall Study|Protocol Violation|0
7900375|NCT01953692|12410751|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7900376|NCT01953692|12410752|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7900377|NCT01953692|12410753|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7900378|NCT01953692|12410754|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7900379|NCT01953692|12410755|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7900380|NCT01953692|12410756|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7900381|NCT01953692|12410757|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7900382|NCT01953692|12410758|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2
7900383|NCT01953692|12410759|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7900384|NCT01953692|12410751|FG000|Overall Study|Withdrawal by Subject|4
7900385|NCT01953692|12410752|FG001|Overall Study|Withdrawal by Subject|2
7900386|NCT01953692|12410753|FG002|Overall Study|Withdrawal by Subject|1
7900387|NCT01953692|12410754|FG003|Overall Study|Withdrawal by Subject|2
7900388|NCT01953692|12410755|FG004|Overall Study|Withdrawal by Subject|0
7900389|NCT01953692|12410756|FG005|Overall Study|Withdrawal by Subject|3
7900390|NCT01953692|12410757|FG006|Overall Study|Withdrawal by Subject|2
7900391|NCT01953692|12410758|FG007|Overall Study|Withdrawal by Subject|1
7900392|NCT01953692|12410759|FG008|Overall Study|Withdrawal by Subject|1
7900393|NCT01953783|12410789|FG000|Overall Study|Progressive disease|2
7900394|NCT01953913|12410803|FG000|Overall Study|Disease Progression|349
7900395|NCT01953913|12410803|FG000|Overall Study|Worsening of underlying cancer|22
7900396|NCT01953913|12410803|FG000|Overall Study|Adverse Event|20
7900397|NCT01953913|12410803|FG000|Overall Study|Protocol Violation|6
7900398|NCT01953913|12410803|FG000|Overall Study|Lost to Follow-up|4
7900399|NCT01953913|12410803|FG000|Overall Study|Withdrawal by Subject|32
7900400|NCT01953913|12410803|FG000|Overall Study|Other than listed|108
7900401|NCT01953913|12410803|FG000|Overall Study|Not Treated|1
7900402|NCT01954017|12410810|FG000|Overall Study|Adverse Event|0
7900403|NCT01954017|12410811|FG001|Overall Study|Adverse Event|0
7900404|NCT01954017|12410812|FG002|Overall Study|Adverse Event|1
7900405|NCT01954017|12410810|FG000|Overall Study|Death|2
7900406|NCT01954017|12410811|FG001|Overall Study|Death|1
7900407|NCT01954017|12410812|FG002|Overall Study|Death|1
7900408|NCT01954017|12410810|FG000|Overall Study|Withdrawal by Subject|0
7900409|NCT01954017|12410811|FG001|Overall Study|Withdrawal by Subject|1
7900410|NCT01954017|12410812|FG002|Overall Study|Withdrawal by Subject|0
7900411|NCT01954017|12410810|FG000|Overall Study|Protocol Violation|0
7900412|NCT01954017|12410811|FG001|Overall Study|Protocol Violation|3
7900413|NCT01954017|12410812|FG002|Overall Study|Protocol Violation|2
7900414|NCT01954017|12410810|FG000|Overall Study|Necrotizing enterocolitis|1
7900415|NCT01954017|12410811|FG001|Overall Study|Necrotizing enterocolitis|0
7900416|NCT01954017|12410812|FG002|Overall Study|Necrotizing enterocolitis|1
7900417|NCT01954017|12410810|FG000|Overall Study|Enteral intake stopped >7 days|0
7900418|NCT01954017|12410811|FG001|Overall Study|Enteral intake stopped >7 days|1
7900419|NCT01954017|12410812|FG002|Overall Study|Enteral intake stopped >7 days|1
7900420|NCT01954017|12410810|FG000|Overall Study|All other reasons|2
7900421|NCT01954017|12410811|FG001|Overall Study|All other reasons|2
7900422|NCT01954017|12410812|FG002|Overall Study|All other reasons|7
7900423|NCT01954056|12410848|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1
7900424|NCT01954056|12410849|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0
7900425|NCT01954082|12410857|FG000|Overall Study|Study Suspension|42
7900426|NCT01954082|12410858|FG001|Overall Study|Study Suspension|36
7900427|NCT01954082|12410857|FG000|Overall Study|Adverse Event|10
7900428|NCT01954082|12410858|FG001|Overall Study|Adverse Event|4
7900429|NCT01954082|12410857|FG000|Overall Study|Intolerance|0
7900430|NCT01954082|12410858|FG001|Overall Study|Intolerance|1
7900431|NCT01954082|12410857|FG000|Overall Study|Non-compliance|6
7900432|NCT01954082|12410858|FG001|Overall Study|Non-compliance|4
7900433|NCT01954082|12410857|FG000|Overall Study|Physician Decision|2
7900434|NCT01954082|12410858|FG001|Overall Study|Physician Decision|0
7900435|NCT01954082|12410857|FG000|Overall Study|Parent Decision|1
7900436|NCT01954082|12410858|FG001|Overall Study|Parent Decision|0
7900437|NCT01954082|12410857|FG000|Overall Study|Withdrawal by Subject|0
7900438|NCT01954082|12410858|FG001|Overall Study|Withdrawal by Subject|1
7900439|NCT01954082|12410857|FG000|Overall Study|Discontinued Early Prior to Transfer|3
7900440|NCT01954082|12410858|FG001|Overall Study|Discontinued Early Prior to Transfer|2
7900441|NCT01954082|12410857|FG000|Overall Study|Redirection of Care|0
7900442|NCT01954082|12410858|FG001|Overall Study|Redirection of Care|2
7900443|NCT01954082|12410857|FG000|Overall Study|Miscalculation of Final Dose Day|0
7900444|NCT01954082|12410858|FG001|Overall Study|Miscalculation of Final Dose Day|3
7900445|NCT01954082|12410857|FG000|Overall Study|Comfort Care|0
7900446|NCT01954082|12410858|FG001|Overall Study|Comfort Care|1
7900447|NCT01954082|12410857|FG000|Overall Study|Infant Moved|0
7900448|NCT01954082|12410858|FG001|Overall Study|Infant Moved|1
7900449|NCT01954082|12410857|FG000|Overall Study|Randomized not Treated|4
7900450|NCT01954082|12410858|FG001|Overall Study|Randomized not Treated|2
7900451|NCT01954121|12410866|FG000|Overall Study|Lack of Efficacy|94
7900452|NCT01954121|12410867|FG001|Overall Study|Lack of Efficacy|41
7900453|NCT01954121|12410866|FG000|Overall Study|Protocol Violation|0
7900454|NCT01954121|12410867|FG001|Overall Study|Protocol Violation|2
7900455|NCT01954121|12410866|FG000|Overall Study|Lost to Follow-up|5
7900456|NCT01954121|12410867|FG001|Overall Study|Lost to Follow-up|6
7900457|NCT01954121|12410866|FG000|Overall Study|Withdrawal by Subject|18
7900458|NCT01954121|12410867|FG001|Overall Study|Withdrawal by Subject|12
7900459|NCT01954121|12410866|FG000|Overall Study|Pregnancy|1
7900460|NCT01954121|12410867|FG001|Overall Study|Pregnancy|1
7900461|NCT01954121|12410866|FG000|Overall Study|AE, serious fatal|1
7900462|NCT01954121|12410867|FG001|Overall Study|AE, serious fatal|0
7900463|NCT01954121|12410866|FG000|Overall Study|AE, non-serious non-fatal|5
7900464|NCT01954121|12410867|FG001|Overall Study|AE, non-serious non-fatal|22
7900465|NCT01954121|12410866|FG000|Overall Study|SAE, non-fatal|1
7900466|NCT01954121|12410867|FG001|Overall Study|SAE, non-fatal|4
7900467|NCT01954121|12410866|FG000|Overall Study|Non-compliant with study procedures|1
7900468|NCT01954121|12410867|FG001|Overall Study|Non-compliant with study procedures|0
7900469|NCT01954121|12410866|FG000|Overall Study|Non-compliant patient|1
7900470|NCT01954121|12410867|FG001|Overall Study|Non-compliant patient|1
7900471|NCT01954121|12410866|FG000|Overall Study|Subject did not follow instructions|0
7900472|NCT01954121|12410867|FG001|Overall Study|Subject did not follow instructions|2
7900473|NCT01954251|12410875|FG000|Overall Study|Adverse Event|5
7900474|NCT01954251|12410876|FG001|Overall Study|Adverse Event|7
7900475|NCT01954251|12410875|FG000|Overall Study|Lost to Follow-up|6
7900476|NCT01954251|12410876|FG001|Overall Study|Lost to Follow-up|6
7900477|NCT01954251|12410875|FG000|Overall Study|Withdrawal by Subject|2
7900478|NCT01954251|12410876|FG001|Overall Study|Withdrawal by Subject|6
7900479|NCT01954342|12410904|FG000|Overall Study|Missing data from 13-16week study visit|0
7900480|NCT01954342|12410905|FG001|Overall Study|Missing data from 13-16week study visit|0
7900481|NCT01954342|12410906|FG002|Overall Study|Missing data from 13-16week study visit|0
7900482|NCT01954342|12410907|FG003|Overall Study|Missing data from 13-16week study visit|1
7900483|NCT01954342|12410904|FG000|Overall Study|Miscarriage|0
7900484|NCT01954342|12410905|FG001|Overall Study|Miscarriage|0
7900485|NCT01954342|12410906|FG002|Overall Study|Miscarriage|0
7900486|NCT01954342|12410907|FG003|Overall Study|Miscarriage|3
7900487|NCT01954342|12410904|FG000|Overall Study|Lost to Follow-up|0
7900488|NCT01954342|12410905|FG001|Overall Study|Lost to Follow-up|0
7900489|NCT01954342|12410906|FG002|Overall Study|Lost to Follow-up|0
7900490|NCT01954342|12410907|FG003|Overall Study|Lost to Follow-up|5
7900491|NCT01954342|12410904|FG000|Overall Study|Preterm delivery|0
7900492|NCT01954342|12410905|FG001|Overall Study|Preterm delivery|0
7900493|NCT01954342|12410906|FG002|Overall Study|Preterm delivery|0
7900494|NCT01954342|12410907|FG003|Overall Study|Preterm delivery|3
7900495|NCT01954342|12410904|FG000|Overall Study|Pre-eclampsia|0
7900496|NCT01954342|12410905|FG001|Overall Study|Pre-eclampsia|0
7900497|NCT01954342|12410906|FG002|Overall Study|Pre-eclampsia|0
7900498|NCT01954342|12410907|FG003|Overall Study|Pre-eclampsia|4
7900499|NCT01954342|12410904|FG000|Overall Study|Unreliable Data|0
7900500|NCT01954342|12410905|FG001|Overall Study|Unreliable Data|0
7900501|NCT01954342|12410906|FG002|Overall Study|Unreliable Data|0
7900502|NCT01954342|12410907|FG003|Overall Study|Unreliable Data|2
7900503|NCT01954394|12410919|FG000|Overall Study|Enrolled but not treated|1
7900504|NCT01954394|12410920|FG001|Overall Study|Enrolled but not treated|0
7900505|NCT01954394|12410919|FG000|Overall Study|Adverse Event|10
7900506|NCT01954394|12410920|FG001|Overall Study|Adverse Event|23
7900507|NCT01954394|12410919|FG000|Overall Study|Poor compliance to protocol|7
7900508|NCT01954394|12410920|FG001|Overall Study|Poor compliance to protocol|7
7900509|NCT01954394|12410919|FG000|Overall Study|Participant Moved|0
7900510|NCT01954394|12410920|FG001|Overall Study|Participant Moved|4
7900511|NCT01954394|12410919|FG000|Overall Study|Related to Study Drug administration|2
7900512|NCT01954394|12410920|FG001|Overall Study|Related to Study Drug administration|2
7900513|NCT01954394|12410919|FG000|Overall Study|Other than specified above|10
7900514|NCT01954394|12410920|FG001|Overall Study|Other than specified above|21
7900515|NCT01954745|12410941|FG000|Overall Study|Radiological Progression|11
7900516|NCT01954745|12410941|FG000|Overall Study|Clinical Progression|5
7900517|NCT01954745|12410941|FG000|Overall Study|Adverse Event|2
7900518|NCT01954745|12410941|FG000|Overall Study|Death|1
7900519|NCT01954771|12410948|FG000|Overall Study|Missing HbA1c of end-point|1
7900520|NCT01954771|12410949|FG001|Overall Study|Missing HbA1c of end-point|1
7900521|NCT01954771|12410950|FG002|Overall Study|Missing HbA1c of end-point|0
7900522|NCT01954771|12410948|FG000|Overall Study|Missing CGMS of end-point|1
7900523|NCT01954771|12410949|FG001|Overall Study|Missing CGMS of end-point|1
7900524|NCT01954771|12410950|FG002|Overall Study|Missing CGMS of end-point|0
7900525|NCT01954771|12410948|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5
7900526|NCT01954771|12410949|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1
7900527|NCT01954771|12410950|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3
7900528|NCT01954927|12410963|FG000|Overall Study|Withdrawal by Subject|3
7900529|NCT01954927|12410964|FG001|Overall Study|Withdrawal by Subject|1
7900530|NCT01955005|12410972|FG000|Overall Study|Withdrawal by Subject|3
7900531|NCT01955005|12410973|FG001|Overall Study|Withdrawal by Subject|5
7900532|NCT01955044|12410982|FG000|Overall Study|Death|1
7900533|NCT01955044|12410983|FG001|Overall Study|Death|1
7900534|NCT01955044|12410984|FG002|Overall Study|Death|0
7900535|NCT01955083|12410994|FG000|Overall Study|Lost to Follow-up|1
7811370|NCT01182207|12275106|FG000|Second Intervention|Emeses within 1 hour of dosing|1
7900536|NCT01955083|12410995|FG001|Overall Study|Lost to Follow-up|1
7900537|NCT01955122|12411027|FG000|Overall Study|Physician Decision|5
7900538|NCT01955122|12411028|FG001|Overall Study|Physician Decision|5
7900539|NCT01955161|12411043|FG000|Overall Study|Withdrawal before treatment|2
7900540|NCT01955161|12411044|FG001|Overall Study|Withdrawal before treatment|0
7811371|NCT01182207|12275107|FG001|Second Intervention|Emeses within 1 hour of dosing|0
7811372|NCT01182285|12275113|FG000|First Intervention Week 1-10|Disease progression|1
7811373|NCT01182285|12275114|FG001|First Intervention Week 1-10|Disease progression|0
7811374|NCT01182285|12275115|FG002|First Intervention Week 1-10|Disease progression|0
7811375|NCT01182285|12275113|FG000|First Intervention Week 1-10|Adverse Event|1
7811376|NCT01182285|12275114|FG001|First Intervention Week 1-10|Adverse Event|0
7811377|NCT01182285|12275115|FG002|First Intervention Week 1-10|Adverse Event|0
7811378|NCT01182285|12275113|FG000|First Intervention Week 1-10|Non-compliance|1
7811379|NCT01182285|12275114|FG001|First Intervention Week 1-10|Non-compliance|0
7811380|NCT01182285|12275115|FG002|First Intervention Week 1-10|Non-compliance|0
7811381|NCT01182285|12275113|FG000|Third Intervention Week 11-52|Disease Progression|0
7811382|NCT01182285|12275114|FG001|Third Intervention Week 11-52|Disease Progression|0
7811383|NCT01182285|12275115|FG002|Third Intervention Week 11-52|Disease Progression|6
7900541|NCT01955161|12411045|FG002|Overall Study|Withdrawal before treatment|1
7900542|NCT01955161|12411043|FG000|Overall Study|Adverse Event|10
7900543|NCT01955161|12411044|FG001|Overall Study|Adverse Event|14
7900544|NCT01955161|12411045|FG002|Overall Study|Adverse Event|15
7811384|NCT01182285|12275113|FG000|Third Intervention Week 11-52|Other|0
7811385|NCT01182285|12275114|FG001|Third Intervention Week 11-52|Other|0
7811386|NCT01182285|12275115|FG002|Third Intervention Week 11-52|Other|2
7811387|NCT01182298|12275122|FG000|Overall Study|Lack of Efficacy|4
7811388|NCT01182298|12275122|FG000|Overall Study|Withdrawal by Subject|2
7811389|NCT01182337|12275128|FG000|Overall Study|Withdrawal by Subject|3
7811390|NCT01182337|12275129|FG001|Overall Study|Withdrawal by Subject|1
7811391|NCT01182337|12275128|FG000|Overall Study|Lost to Follow-up|0
7811392|NCT01182337|12275129|FG001|Overall Study|Lost to Follow-up|1
7900545|NCT01955161|12411043|FG000|Overall Study|Death|1
7900546|NCT01955161|12411044|FG001|Overall Study|Death|1
7900547|NCT01955161|12411045|FG002|Overall Study|Death|3
7900548|NCT01955161|12411043|FG000|Overall Study|Withdrawal by Subject|9
7900549|NCT01955161|12411044|FG001|Overall Study|Withdrawal by Subject|8
7900550|NCT01955161|12411045|FG002|Overall Study|Withdrawal by Subject|12
7900551|NCT01955161|12411043|FG000|Overall Study|Protocol Violation|2
7900552|NCT01955161|12411044|FG001|Overall Study|Protocol Violation|0
7900553|NCT01955161|12411045|FG002|Overall Study|Protocol Violation|0
7900554|NCT01955161|12411043|FG000|Overall Study|Other reason: physician decision|0
7900555|NCT01955161|12411044|FG001|Overall Study|Other reason: physician decision|1
7900556|NCT01955161|12411045|FG002|Overall Study|Other reason: physician decision|1
7900557|NCT01955161|12411043|FG000|Overall Study|Other reason: disallowed medication|1
7900558|NCT01955161|12411044|FG001|Overall Study|Other reason: disallowed medication|0
7900559|NCT01955161|12411045|FG002|Overall Study|Other reason: disallowed medication|1
7900560|NCT01955161|12411043|FG000|Overall Study|Other reason: caregiver unavailable|1
7900561|NCT01955161|12411044|FG001|Overall Study|Other reason: caregiver unavailable|0
7900562|NCT01955161|12411045|FG002|Overall Study|Other reason: caregiver unavailable|0
7900563|NCT01955161|12411043|FG000|Overall Study|Other reason: moved to nursing home|0
7968747|NCT02785458|12526849|FG000|1 Month|Withdrawal by Subject|2
7968748|NCT02785458|12526850|FG001|1 Month|Withdrawal by Subject|1
7968749|NCT02785458|12526849|FG000|1 Month|Lost to Follow-up|38
7968750|NCT02785458|12526850|FG001|1 Month|Lost to Follow-up|31
7968751|NCT02785458|12526849|FG000|1 Month|Deemed Ineligible|1
7968752|NCT02785458|12526850|FG001|1 Month|Deemed Ineligible|0
7968753|NCT02785458|12526849|FG000|1 Month|Completed Evaluation by Baseline|42
7968754|NCT02785458|12526850|FG001|1 Month|Completed Evaluation by Baseline|39
7968755|NCT02785458|12526849|FG000|1 Month|Partial Interview|0
7968756|NCT02785458|12526850|FG001|1 Month|Partial Interview|4
7968757|NCT02785458|12526849|FG000|3 Months|Withdrawal by Subject|3
7968758|NCT02785458|12526850|FG001|3 Months|Withdrawal by Subject|1
7968759|NCT02785458|12526849|FG000|3 Months|Lost to Follow-up|25
7968760|NCT02785458|12526850|FG001|3 Months|Lost to Follow-up|21
7968761|NCT02785458|12526849|FG000|3 Months|Completed Evaluation at 1 Month|100
7968762|NCT02785458|12526850|FG001|3 Months|Completed Evaluation at 1 Month|89
7968763|NCT02785588|12526856|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1
7968764|NCT02785588|12526856|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1
7968765|NCT02785770|12526860|FG000|Intervention Period 2 (1 Day)|Adverse Event|0
7968766|NCT02785770|12526861|FG001|Intervention Period 2 (1 Day)|Adverse Event|1
7968767|NCT02785770|12526862|FG002|Intervention Period 2 (1 Day)|Adverse Event|0
7968768|NCT02785770|12526863|FG003|Intervention Period 2 (1 Day)|Adverse Event|0
7968769|NCT02785770|12526860|FG000|Intervention Period 2 (1 Day)|Family related obligations|0
7968770|NCT02785770|12526861|FG001|Intervention Period 2 (1 Day)|Family related obligations|0
7968771|NCT02785770|12526862|FG002|Intervention Period 2 (1 Day)|Family related obligations|1
7968772|NCT02785770|12526863|FG003|Intervention Period 2 (1 Day)|Family related obligations|0
7968773|NCT02785770|12526860|FG000|Intervention Period 3 (1 Day)|Adverse Event|0
7968774|NCT02785770|12526861|FG001|Intervention Period 3 (1 Day)|Adverse Event|0
7968775|NCT02785770|12526862|FG002|Intervention Period 3 (1 Day)|Adverse Event|0
7968776|NCT02785770|12526863|FG003|Intervention Period 3 (1 Day)|Adverse Event|1
7968777|NCT02785900|12526878|FG000|Overall Study|Study Termination by Sponsor|64
7968778|NCT02785900|12526879|FG001|Overall Study|Study Termination by Sponsor|81
7968779|NCT02785900|12526878|FG000|Overall Study|Death|46
7968780|NCT02785900|12526879|FG001|Overall Study|Death|32
7968781|NCT02785900|12526878|FG000|Overall Study|Withdrawal by Subject|4
7968782|NCT02785900|12526879|FG001|Overall Study|Withdrawal by Subject|8
7968783|NCT02785900|12526878|FG000|Overall Study|Physician Decision|3
7968784|NCT02785900|12526879|FG001|Overall Study|Physician Decision|2
7968785|NCT02785913|12526885|FG000|Overall Study|Adverse Event|5
7968786|NCT02785913|12526885|FG000|Overall Study|Death|2
7968787|NCT02785913|12526885|FG000|Overall Study|Progression|18
7968788|NCT02785913|12526885|FG000|Overall Study|Not protocol specified|1
7968789|NCT02785939|12526892|FG000|Overall Study|Progression|25
7968790|NCT02785939|12526893|FG001|Overall Study|Progression|8
7968791|NCT02785939|12526892|FG000|Overall Study|Adverse Event|3
7968792|NCT02785939|12526893|FG001|Overall Study|Adverse Event|1
7968793|NCT02785939|12526892|FG000|Overall Study|Death|1
7968794|NCT02785939|12526893|FG001|Overall Study|Death|0
7968795|NCT02785939|12526892|FG000|Overall Study|Refusal|1
7968796|NCT02785939|12526893|FG001|Overall Study|Refusal|0
7968797|NCT02785939|12526892|FG000|Overall Study|Deteriorating health|1
7968798|NCT02785939|12526893|FG001|Overall Study|Deteriorating health|0
7968799|NCT02785939|12526892|FG000|Overall Study|Not protocol specified|0
7968800|NCT02785939|12526893|FG001|Overall Study|Not protocol specified|1
7968801|NCT02786004|12526901|FG000|Overall Study|Withdrawal by Subject|0
7968802|NCT02786004|12526902|FG001|Overall Study|Withdrawal by Subject|1
7968803|NCT02786836|12526943|FG000|Overall Study|Death|1
7968804|NCT02786836|12526943|FG000|Overall Study|Lack of Efficacy|2
7968805|NCT02786836|12526943|FG000|Overall Study|Protocol Violation|3
7968806|NCT02786836|12526943|FG000|Overall Study|Withdrawal by Subject|3
7968807|NCT02786836|12526943|FG000|Overall Study|Liver Transplantation|2
7968808|NCT02786836|12526943|FG000|Overall Study|Device or Pharmacy Issues|3
7968809|NCT02786901|12526951|FG000|Overall Study|Adverse Event|1
7968810|NCT02786901|12526952|FG001|Overall Study|Adverse Event|1
7968811|NCT02786901|12526953|FG002|Overall Study|Adverse Event|2
7968812|NCT02786901|12526951|FG000|Overall Study|Physician Decision|1
7968813|NCT02786901|12526952|FG001|Overall Study|Physician Decision|0
7968814|NCT02786901|12526953|FG002|Overall Study|Physician Decision|0
7968815|NCT02786901|12526951|FG000|Overall Study|Rescue Therapy Use|71
7968816|NCT02786901|12526952|FG001|Overall Study|Rescue Therapy Use|49
7968817|NCT02786901|12526953|FG002|Overall Study|Rescue Therapy Use|33
7968818|NCT02786901|12526951|FG000|Overall Study|Subject Request/Lost to Follow up|1
7717899|NCT00522951|12141544|FG001|Period 1|body motion|1
7717900|NCT00522951|12141543|FG000|Washout Period|Adverse Event|0
7717901|NCT00522951|12141544|FG001|Washout Period|Adverse Event|1
7717902|NCT00522951|12141543|FG000|Washout Period|Death|0
7717903|NCT00522951|12141544|FG001|Washout Period|Death|1
7717904|NCT00522951|12141543|FG000|Period 2|Withdrawal by Subject|1
7717905|NCT00522951|12141544|FG001|Period 2|Withdrawal by Subject|0
7717906|NCT00522951|12141543|FG000|Period 2|residual contrast medium|1
7900564|NCT01955161|12411044|FG001|Overall Study|Other reason: moved to nursing home|1
7900565|NCT01955161|12411045|FG002|Overall Study|Other reason: moved to nursing home|0
7900566|NCT01955161|12411043|FG000|Overall Study|Other reason: insufficient compliance|0
7900567|NCT01955161|12411044|FG001|Overall Study|Other reason: insufficient compliance|0
7900568|NCT01955161|12411045|FG002|Overall Study|Other reason: insufficient compliance|1
7900569|NCT01955161|12411043|FG000|Overall Study|Other reason: primary biliary cirrhosis|1
7900570|NCT01955161|12411044|FG001|Overall Study|Other reason: primary biliary cirrhosis|0
7900571|NCT01955161|12411045|FG002|Overall Study|Other reason: primary biliary cirrhosis|0
7900572|NCT01955161|12411043|FG000|Overall Study|Other reason: patient's will|0
7900573|NCT01955161|12411044|FG001|Overall Study|Other reason: patient's will|0
7900574|NCT01955161|12411045|FG002|Overall Study|Other reason: patient's will|1
7900575|NCT01955707|12411137|FG000|Overall Study|Adverse Event|1
7900576|NCT01955707|12411138|FG001|Overall Study|Adverse Event|2
7900577|NCT01955707|12411137|FG000|Overall Study|Lost to Follow-up|2
7900578|NCT01955707|12411138|FG001|Overall Study|Lost to Follow-up|1
7900579|NCT01955707|12411137|FG000|Overall Study|Withdrawal by Subject|0
7900580|NCT01955707|12411138|FG001|Overall Study|Withdrawal by Subject|3
7900581|NCT01955707|12411137|FG000|Overall Study|Death|13
7900582|NCT01955707|12411138|FG001|Overall Study|Death|14
7900583|NCT01955707|12411137|FG000|Overall Study|Other|4
7900584|NCT01955707|12411138|FG001|Overall Study|Other|2
7900585|NCT01955733|12411198|FG000|Period 1|Lost to Follow-up|1
7900586|NCT01955733|12411199|FG001|Period 1|Lost to Follow-up|0
7900587|NCT01955733|12411200|FG002|Period 1|Lost to Follow-up|0
7900588|NCT01955733|12411198|FG000|Period 2|Adverse Event|1
7900589|NCT01955733|12411199|FG001|Period 2|Adverse Event|0
7900590|NCT01955733|12411200|FG002|Period 2|Adverse Event|0
7900591|NCT01955733|12411198|FG000|Period 2|Physician Decision|0
7900592|NCT01955733|12411199|FG001|Period 2|Physician Decision|0
7900593|NCT01955733|12411200|FG002|Period 2|Physician Decision|1
7900594|NCT01955733|12411198|FG000|Period 2|Withdrawal by Subject|1
7900595|NCT01955733|12411199|FG001|Period 2|Withdrawal by Subject|3
7900596|NCT01955733|12411200|FG002|Period 2|Withdrawal by Subject|2
7900597|NCT01955733|12411198|FG000|Period 2|Study terminated by sponsor|8
7900598|NCT01955733|12411199|FG001|Period 2|Study terminated by sponsor|14
7900599|NCT01955733|12411200|FG002|Period 2|Study terminated by sponsor|16
7900600|NCT01955733|12411198|FG000|Period 2|Lost to Follow-up|2
7900601|NCT01955733|12411199|FG001|Period 2|Lost to Follow-up|0
7900602|NCT01955733|12411200|FG002|Period 2|Lost to Follow-up|0
7900603|NCT01955733|12411198|FG000|Period 2|Other not defined above|0
7900604|NCT01955733|12411199|FG001|Period 2|Other not defined above|2
7900605|NCT01955733|12411200|FG002|Period 2|Other not defined above|2
7900606|NCT01956123|12411244|FG000|COS Cycle 2|Protocol Violation|8
7900607|NCT01956123|12411245|FG001|COS Cycle 2|Protocol Violation|3
7900608|NCT01956123|12411246|FG002|COS Cycle 2|Protocol Violation|0
7900609|NCT01956123|12411247|FG003|COS Cycle 2|Protocol Violation|0
7900610|NCT01956123|12411244|FG000|COS Cycle 2|Adverse Event|3
7900611|NCT01956123|12411245|FG001|COS Cycle 2|Adverse Event|4
7900612|NCT01956123|12411246|FG002|COS Cycle 2|Adverse Event|0
7900613|NCT01956123|12411247|FG003|COS Cycle 2|Adverse Event|0
7900614|NCT01956123|12411244|FG000|COS Cycle 2|Personal Reasons|2
7900615|NCT01956123|12411245|FG001|COS Cycle 2|Personal Reasons|0
7900616|NCT01956123|12411246|FG002|COS Cycle 2|Personal Reasons|0
7900617|NCT01956123|12411247|FG003|COS Cycle 2|Personal Reasons|0
7900618|NCT01956123|12411244|FG000|COS Cycle 2|Withdrawal by Subject|1
7968819|NCT02786901|12526952|FG001|Overall Study|Subject Request/Lost to Follow up|5
7968820|NCT02786901|12526953|FG002|Overall Study|Subject Request/Lost to Follow up|5
7968821|NCT02786901|12526951|FG000|Overall Study|Disallowed medication|1
7968822|NCT02786901|12526952|FG001|Overall Study|Disallowed medication|1
7968823|NCT02786901|12526953|FG002|Overall Study|Disallowed medication|0
7968824|NCT02786901|12526951|FG000|Overall Study|Randomized in error|2
7900619|NCT01956123|12411245|FG001|COS Cycle 2|Withdrawal by Subject|0
7900620|NCT01956123|12411246|FG002|COS Cycle 2|Withdrawal by Subject|0
7900621|NCT01956123|12411247|FG003|COS Cycle 2|Withdrawal by Subject|0
7900622|NCT01956123|12411244|FG000|COS Cycle 3|Protocol Violation|0
7900623|NCT01956123|12411245|FG001|COS Cycle 3|Protocol Violation|0
7900624|NCT01956123|12411246|FG002|COS Cycle 3|Protocol Violation|2
7900625|NCT01956123|12411247|FG003|COS Cycle 3|Protocol Violation|1
7900626|NCT01956123|12411244|FG000|COS Cycle 3|Adverse Event|0
7900627|NCT01956123|12411245|FG001|COS Cycle 3|Adverse Event|0
7900628|NCT01956123|12411246|FG002|COS Cycle 3|Adverse Event|3
7900629|NCT01956123|12411247|FG003|COS Cycle 3|Adverse Event|0
7900630|NCT01956123|12411244|FG000|COS Cycle 3|Personal Reasons|0
7900631|NCT01956123|12411245|FG001|COS Cycle 3|Personal Reasons|0
7900632|NCT01956123|12411246|FG002|COS Cycle 3|Personal Reasons|1
7900633|NCT01956123|12411247|FG003|COS Cycle 3|Personal Reasons|0
7900634|NCT01956123|12411244|FG000|COS Cycle 3|Withdrawal by Subject|0
7900635|NCT01956123|12411245|FG001|COS Cycle 3|Withdrawal by Subject|0
7900636|NCT01956123|12411246|FG002|COS Cycle 3|Withdrawal by Subject|0
7900637|NCT01956123|12411247|FG003|COS Cycle 3|Withdrawal by Subject|1
7900638|NCT01956240|12411260|FG000|Overall Study|Lost to Follow-up|6
7900639|NCT01956240|12411261|FG001|Overall Study|Lost to Follow-up|20
7900640|NCT01956240|12411260|FG000|Overall Study|Adverse Event|17
7900641|NCT01956240|12411261|FG001|Overall Study|Adverse Event|4
7900642|NCT01956773|12411286|FG000|Overall Study|Lost to Follow-up|628
7900643|NCT01956773|12411287|FG001|Overall Study|Lost to Follow-up|1
7900644|NCT01957111|12411300|FG000|Overall Study|Withdrawal by Subject|1
7900645|NCT01957111|12411301|FG001|Overall Study|Withdrawal by Subject|1
7900646|NCT01957137|12411307|FG000|Randomized Portion|Adverse Event|1
7900647|NCT01957137|12411307|FG000|Randomized Portion|Withdrawal by Subject|1
7900648|NCT01957150|12411321|FG000|Overall Study|Adverse Event|23
7900649|NCT01957150|12411322|FG001|Overall Study|Adverse Event|20
7900650|NCT01957150|12411321|FG000|Overall Study|Withdrawal by Subject|13
7900651|NCT01957150|12411322|FG001|Overall Study|Withdrawal by Subject|17
7900652|NCT01957150|12411321|FG000|Overall Study|Physician Decision|3
7900653|NCT01957150|12411322|FG001|Overall Study|Physician Decision|6
7900654|NCT01957150|12411321|FG000|Overall Study|Lost to Follow-up|4
7900655|NCT01957150|12411322|FG001|Overall Study|Lost to Follow-up|4
7900656|NCT01957150|12411321|FG000|Overall Study|Protocol Violation|1
7900657|NCT01957150|12411322|FG001|Overall Study|Protocol Violation|0
7900658|NCT01957150|12411321|FG000|Overall Study|Lack of Efficacy|11
7900659|NCT01957150|12411322|FG001|Overall Study|Lack of Efficacy|11
7900660|NCT01957163|12411331|FG000|Overall Study|Adverse Event|5
7900661|NCT01957163|12411332|FG001|Overall Study|Adverse Event|2
7900662|NCT01957163|12411333|FG002|Overall Study|Adverse Event|4
7900663|NCT01957163|12411331|FG000|Overall Study|Lack of Efficacy|5
7900664|NCT01957163|12411332|FG001|Overall Study|Lack of Efficacy|4
7900665|NCT01957163|12411333|FG002|Overall Study|Lack of Efficacy|9
7900666|NCT01957163|12411331|FG000|Overall Study|Protocol Violation|1
7900667|NCT01957163|12411332|FG001|Overall Study|Protocol Violation|2
7900668|NCT01957163|12411333|FG002|Overall Study|Protocol Violation|0
7900669|NCT01957163|12411331|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0
7900670|NCT01957163|12411332|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0
7900671|NCT01957163|12411333|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1
7900672|NCT01957163|12411331|FG000|Overall Study|Lost to Follow-up|0
7900673|NCT01957163|12411332|FG001|Overall Study|Lost to Follow-up|1
7900674|NCT01957163|12411333|FG002|Overall Study|Lost to Follow-up|0
7900675|NCT01957163|12411331|FG000|Overall Study|Withdrawal by Subject|4
7900676|NCT01957163|12411332|FG001|Overall Study|Withdrawal by Subject|2
7900677|NCT01957163|12411333|FG002|Overall Study|Withdrawal by Subject|4
7900678|NCT01957202|12411341|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900679|NCT01957202|12411342|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
7900680|NCT01957202|12411343|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900681|NCT01957202|12411344|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900682|NCT01957202|12411345|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900683|NCT01957202|12411346|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900684|NCT01957202|12411347|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900685|NCT01957202|12411348|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900686|NCT01957202|12411349|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900687|NCT01957202|12411350|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900688|NCT01957202|12411351|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900689|NCT01957202|12411352|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900690|NCT01957202|12411353|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900691|NCT01957202|12411354|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900692|NCT01957202|12411355|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900693|NCT01957202|12411356|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900694|NCT01957202|12411357|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
7900695|NCT01957202|12411358|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7900696|NCT01957202|12411341|FG000|Treatment Period 3 (8 Days)|Adverse Event|0
7900697|NCT01957202|12411342|FG001|Treatment Period 3 (8 Days)|Adverse Event|0
7900698|NCT01957202|12411343|FG002|Treatment Period 3 (8 Days)|Adverse Event|0
7900699|NCT01957202|12411344|FG003|Treatment Period 3 (8 Days)|Adverse Event|0
7900700|NCT01957202|12411345|FG004|Treatment Period 3 (8 Days)|Adverse Event|0
7900701|NCT01957202|12411346|FG005|Treatment Period 3 (8 Days)|Adverse Event|0
7900702|NCT01957202|12411347|FG006|Treatment Period 3 (8 Days)|Adverse Event|0
7900703|NCT01957202|12411348|FG007|Treatment Period 3 (8 Days)|Adverse Event|0
7900704|NCT01957202|12411349|FG008|Treatment Period 3 (8 Days)|Adverse Event|0
7900705|NCT01957202|12411350|FG009|Treatment Period 3 (8 Days)|Adverse Event|0
7900706|NCT01957202|12411351|FG010|Treatment Period 3 (8 Days)|Adverse Event|0
7900707|NCT01957202|12411352|FG011|Treatment Period 3 (8 Days)|Adverse Event|0
7900708|NCT01957202|12411353|FG012|Treatment Period 3 (8 Days)|Adverse Event|0
7900709|NCT01957202|12411354|FG013|Treatment Period 3 (8 Days)|Adverse Event|0
7900710|NCT01957202|12411355|FG014|Treatment Period 3 (8 Days)|Adverse Event|0
7900711|NCT01957202|12411356|FG015|Treatment Period 3 (8 Days)|Adverse Event|0
7900712|NCT01957202|12411357|FG016|Treatment Period 3 (8 Days)|Adverse Event|1
7900713|NCT01957202|12411358|FG017|Treatment Period 3 (8 Days)|Adverse Event|0
7900714|NCT01957215|12411370|FG000|Overall Study|Adverse Event|2
7900715|NCT01957215|12411371|FG001|Overall Study|Adverse Event|2
7900716|NCT01957215|12411370|FG000|Overall Study|Lost to Follow-up|3
7900717|NCT01957215|12411371|FG001|Overall Study|Lost to Follow-up|3
7900718|NCT01957215|12411370|FG000|Overall Study|Protocol Violation|1
7900719|NCT01957215|12411371|FG001|Overall Study|Protocol Violation|2
7900720|NCT01957215|12411370|FG000|Overall Study|Withdrawal by Subject|7
7900721|NCT01957215|12411371|FG001|Overall Study|Withdrawal by Subject|5
7900722|NCT01957397|12411394|FG000|Test Period 1|sudden leakage/small bag|1
7900723|NCT01957397|12411395|FG001|Test Period 1|sudden leakage/small bag|1
7900724|NCT01957397|12411394|FG000|Test Period 1|Withdrawal by Subject|1
7900725|NCT01957397|12411395|FG001|Test Period 1|Withdrawal by Subject|0
7900726|NCT01957397|12411394|FG000|Test Period 2|Adverse Event|0
7900727|NCT01957397|12411395|FG001|Test Period 2|Adverse Event|1
7900728|NCT01957397|12411394|FG000|Test Period 3|Adverse Event|1
7900729|NCT01957397|12411395|FG001|Test Period 3|Adverse Event|2
7900730|NCT01957397|12411394|FG000|Test Period 3|the adhesive did not work|1
7900731|NCT01957397|12411395|FG001|Test Period 3|the adhesive did not work|0
7900732|NCT01957462|12411409|FG000|Test Period 1|Withdrawal by Subject|1
7900733|NCT01957462|12411410|FG001|Test Period 1|Withdrawal by Subject|0
7900734|NCT01957462|12411409|FG000|Test Period 1|Adverse Event|1
7900735|NCT01957462|12411410|FG001|Test Period 1|Adverse Event|0
7900736|NCT01957475|12411416|FG000|Test Period 1|Withdrawal by Subject|1
7900737|NCT01957475|12411417|FG001|Test Period 1|Withdrawal by Subject|0
7900738|NCT01957475|12411416|FG000|Test Period 1|Other|1
7900739|NCT01957475|12411417|FG001|Test Period 1|Other|0
7900740|NCT01957475|12411416|FG000|Test Period 1|Lack of Efficacy|0
7900741|NCT01957475|12411417|FG001|Test Period 1|Lack of Efficacy|1
7900742|NCT01957475|12411416|FG000|Test Period 2|Adverse Event|1
7900743|NCT01957475|12411417|FG001|Test Period 2|Adverse Event|0
7900744|NCT01957488|12411423|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2
7900745|NCT01957488|12411424|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0
7900746|NCT01957488|12411425|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1
7900747|NCT01957488|12411426|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1
7900748|NCT01957488|12411427|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0
7900749|NCT01957488|12411428|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0
7900750|NCT01957488|12411423|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1
7900751|NCT01957488|12411424|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2
7900752|NCT01957488|12411425|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2
7900753|NCT01957488|12411426|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1
7900754|NCT01957488|12411427|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0
7900755|NCT01957488|12411428|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3
7900756|NCT01957488|12411423|FG000|Test Period 1 (2 Weeks)|Adverse Event|0
7900757|NCT01957488|12411424|FG001|Test Period 1 (2 Weeks)|Adverse Event|1
7900758|NCT01957488|12411425|FG002|Test Period 1 (2 Weeks)|Adverse Event|1
7900759|NCT01957488|12411426|FG003|Test Period 1 (2 Weeks)|Adverse Event|0
7900760|NCT01957488|12411427|FG004|Test Period 1 (2 Weeks)|Adverse Event|1
7900761|NCT01957488|12411428|FG005|Test Period 1 (2 Weeks)|Adverse Event|0
7900762|NCT01957488|12411423|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
7900763|NCT01957488|12411424|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
7900764|NCT01957488|12411425|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
7900765|NCT01957488|12411426|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
7900766|NCT01957488|12411427|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
7900767|NCT01957488|12411428|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2
7900768|NCT01957488|12411423|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7900769|NCT01957488|12411424|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7900770|NCT01957488|12411425|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7900771|NCT01957488|12411426|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7900772|NCT01957488|12411427|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1
7900773|NCT01957488|12411428|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7900774|NCT01957488|12411423|FG000|Test Period 1 (2 Weeks)|screen failure|0
7900775|NCT01957488|12411424|FG001|Test Period 1 (2 Weeks)|screen failure|0
7900776|NCT01957488|12411425|FG002|Test Period 1 (2 Weeks)|screen failure|0
7900777|NCT01957488|12411426|FG003|Test Period 1 (2 Weeks)|screen failure|0
7900778|NCT01957488|12411427|FG004|Test Period 1 (2 Weeks)|screen failure|0
7900779|NCT01957488|12411428|FG005|Test Period 1 (2 Weeks)|screen failure|1
7900780|NCT01957488|12411423|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2
7900781|NCT01957488|12411424|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0
7900782|NCT01957488|12411425|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1
7900783|NCT01957488|12411426|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1
7900784|NCT01957488|12411427|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0
7900785|NCT01957488|12411428|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0
7900786|NCT01957488|12411423|FG000|Test Period 2 (2 Weeks)|Other|1
7900787|NCT01957488|12411424|FG001|Test Period 2 (2 Weeks)|Other|0
7900788|NCT01957488|12411425|FG002|Test Period 2 (2 Weeks)|Other|0
7900789|NCT01957488|12411426|FG003|Test Period 2 (2 Weeks)|Other|0
7900790|NCT01957488|12411427|FG004|Test Period 2 (2 Weeks)|Other|0
7900791|NCT01957488|12411428|FG005|Test Period 2 (2 Weeks)|Other|0
7900792|NCT01957488|12411423|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7900793|NCT01957488|12411424|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1
7900794|NCT01957488|12411425|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7900795|NCT01957488|12411426|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7900796|NCT01957488|12411427|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7900797|NCT01957488|12411428|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7900798|NCT01957488|12411423|FG000|Test Period 2 (2 Weeks)|Adverse Event|0
7900799|NCT01957488|12411424|FG001|Test Period 2 (2 Weeks)|Adverse Event|0
7900800|NCT01957488|12411425|FG002|Test Period 2 (2 Weeks)|Adverse Event|0
7900801|NCT01957488|12411426|FG003|Test Period 2 (2 Weeks)|Adverse Event|0
7900802|NCT01957488|12411427|FG004|Test Period 2 (2 Weeks)|Adverse Event|2
7900803|NCT01957488|12411428|FG005|Test Period 2 (2 Weeks)|Adverse Event|0
7900804|NCT01957488|12411423|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7900805|NCT01957488|12411424|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7900806|NCT01957488|12411425|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7900807|NCT01957488|12411426|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7900808|NCT01957488|12411427|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7900809|NCT01957488|12411428|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1
7900810|NCT01957488|12411423|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1
7900811|NCT01957488|12411424|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7900812|NCT01957488|12411425|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7900813|NCT01957488|12411426|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7900814|NCT01957488|12411427|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7900815|NCT01957488|12411428|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7900816|NCT01957488|12411423|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7900817|NCT01957488|12411424|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1
7900818|NCT01957488|12411425|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7900819|NCT01957488|12411426|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7900820|NCT01957488|12411427|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7900821|NCT01957488|12411428|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7900822|NCT01957553|12411436|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
7900823|NCT01957553|12411437|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
7900824|NCT01957553|12411436|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2
7900825|NCT01957553|12411437|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0
7900826|NCT01957553|12411436|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
7900827|NCT01957553|12411437|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
7900828|NCT01957553|12411436|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1
7900829|NCT01957553|12411437|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0
7900830|NCT01957553|12411436|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1
7900831|NCT01957553|12411437|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3
7900832|NCT01957553|12411436|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
7900833|NCT01957553|12411437|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
7900834|NCT01957553|12411436|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
7900835|NCT01957553|12411437|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
7900836|NCT01957553|12411436|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
7900837|NCT01957553|12411437|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
7900838|NCT01957553|12411436|FG000|Test Period 2 (21 +- 1 Days)|Other|1
7900839|NCT01957553|12411437|FG001|Test Period 2 (21 +- 1 Days)|Other|0
7900840|NCT01957579|12411447|FG000|Overall Study|Withdrawal of concent|0
7900841|NCT01957579|12411448|FG001|Overall Study|Withdrawal of concent|1
7900842|NCT01957579|12411449|FG002|Overall Study|Withdrawal of concent|0
7900843|NCT01957579|12411450|FG003|Overall Study|Withdrawal of concent|0
7900844|NCT01957579|12411447|FG000|Overall Study|Death|0
7900845|NCT01957579|12411448|FG001|Overall Study|Death|0
7900846|NCT01957579|12411449|FG002|Overall Study|Death|2
7900847|NCT01957579|12411450|FG003|Overall Study|Death|0
7900848|NCT01957644|12411482|FG000|Overall Study|Adverse Event|4
7900849|NCT01957644|12411483|FG001|Overall Study|Adverse Event|2
7900850|NCT01957644|12411484|FG002|Overall Study|Adverse Event|0
7900851|NCT01957644|12411485|FG003|Overall Study|Adverse Event|0
7900852|NCT01957644|12411486|FG004|Overall Study|Adverse Event|1
7900853|NCT01957644|12411482|FG000|Overall Study|Progressive disease / relapse|0
7900854|NCT01957644|12411483|FG001|Overall Study|Progressive disease / relapse|1
7900855|NCT01957644|12411484|FG002|Overall Study|Progressive disease / relapse|0
7900856|NCT01957644|12411485|FG003|Overall Study|Progressive disease / relapse|1
7900857|NCT01957644|12411486|FG004|Overall Study|Progressive disease / relapse|0
7900858|NCT01957644|12411482|FG000|Overall Study|Other reason|1
7900859|NCT01957644|12411483|FG001|Overall Study|Other reason|2
7900860|NCT01957644|12411484|FG002|Overall Study|Other reason|1
7900861|NCT01957644|12411485|FG003|Overall Study|Other reason|1
7900862|NCT01957644|12411486|FG004|Overall Study|Other reason|0
7900863|NCT01957644|12411482|FG000|Overall Study|Withdrawal by Subject|1
7900864|NCT01957644|12411483|FG001|Overall Study|Withdrawal by Subject|0
7900865|NCT01957644|12411484|FG002|Overall Study|Withdrawal by Subject|0
7900866|NCT01957644|12411485|FG003|Overall Study|Withdrawal by Subject|0
7900867|NCT01957644|12411486|FG004|Overall Study|Withdrawal by Subject|0
7900868|NCT01957644|12411482|FG000|Overall Study|Protocol Violation|0
7900869|NCT01957644|12411483|FG001|Overall Study|Protocol Violation|1
7900870|NCT01957644|12411484|FG002|Overall Study|Protocol Violation|0
7900871|NCT01957644|12411485|FG003|Overall Study|Protocol Violation|0
7900872|NCT01957644|12411486|FG004|Overall Study|Protocol Violation|0
7900873|NCT01957709|12411504|FG000|Overall Study|Patient refused to complete post-tx bx|1
7900874|NCT01957787|12411512|FG000|Overall Study|Death|18
7900875|NCT01957787|12411512|FG000|Overall Study|Lost to Follow-up|3
7900876|NCT01957787|12411512|FG000|Overall Study|Withdrawal by Subject|3
7900877|NCT01957787|12411512|FG000|Overall Study|Entered Hospice or Similar Program|2
7900878|NCT01957787|12411512|FG000|Overall Study|Index Tumor(s) Resected|2
7900879|NCT01957787|12411512|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2
7900880|NCT01957787|12411512|FG000|Overall Study|Local therapy, not cryoablation|6
7900881|NCT01957865|12411519|FG000|Overall Study|Found HIV negative|0
7900882|NCT01957865|12411520|FG001|Overall Study|Found HIV negative|0
7900883|NCT01957865|12411521|FG002|Overall Study|Found HIV negative|1
7900884|NCT01957865|12411519|FG000|Overall Study|Lost to Follow-up|0
7900885|NCT01957865|12411520|FG001|Overall Study|Lost to Follow-up|2
7900886|NCT01957865|12411521|FG002|Overall Study|Lost to Follow-up|2
7900887|NCT01958008|12411546|FG000|Overall Study|Worsening of disease under study|0
7900888|NCT01958008|12411547|FG001|Overall Study|Worsening of disease under study|0
7900889|NCT01958008|12411548|FG002|Overall Study|Worsening of disease under study|1
7900890|NCT01958008|12411549|FG003|Overall Study|Worsening of disease under study|0
7900891|NCT01958008|12411546|FG000|Overall Study|Other adverse event|1
7900892|NCT01958008|12411547|FG001|Overall Study|Other adverse event|0
7900893|NCT01958008|12411548|FG002|Overall Study|Other adverse event|0
7900894|NCT01958008|12411549|FG003|Overall Study|Other adverse event|0
7900895|NCT01958060|12411568|FG000|Overall Study|Not treated|2
7900896|NCT01958060|12411569|FG001|Overall Study|Not treated|0
7900897|NCT01958060|12411570|FG002|Overall Study|Not treated|0
7900898|NCT01958060|12411571|FG003|Overall Study|Not treated|0
7900899|NCT01958060|12411572|FG004|Overall Study|Not treated|1
7900900|NCT01958060|12411573|FG005|Overall Study|Not treated|0
7900901|NCT01958125|12411620|FG000|Overall Study|Missing diary data|2
7900902|NCT01958125|12411621|FG001|Overall Study|Missing diary data|6
7900903|NCT01958125|12411620|FG000|Overall Study|No headache attacks|0
7900904|NCT01958125|12411621|FG001|Overall Study|No headache attacks|2
7900905|NCT01958164|12411629|FG000|Overall Study|Adverse Event|0
7900906|NCT01958164|12411630|FG001|Overall Study|Adverse Event|2
7900907|NCT01958164|12411629|FG000|Overall Study|Lost to Follow-up|2
7900908|NCT01958164|12411630|FG001|Overall Study|Lost to Follow-up|3
7900909|NCT01958281|12411639|FG000|Overall Study|Lack of Efficacy|5
7900910|NCT01958281|12411640|FG001|Overall Study|Lack of Efficacy|2
7900911|NCT01958281|12411641|FG002|Overall Study|Lack of Efficacy|0
7900912|NCT01958281|12411639|FG000|Overall Study|Adverse Event|0
7900913|NCT01958281|12411640|FG001|Overall Study|Adverse Event|2
7900914|NCT01958281|12411641|FG002|Overall Study|Adverse Event|0
7900915|NCT01958281|12411639|FG000|Overall Study|Withdrew Consent|1
7900916|NCT01958281|12411640|FG001|Overall Study|Withdrew Consent|0
7900917|NCT01958281|12411641|FG002|Overall Study|Withdrew Consent|0
7900918|NCT01958294|12411650|FG000|Overall Study|Clinical Circumstances|2
7900919|NCT01958437|12411676|FG000|Overall Study|Incidental MRI findings|0
7900920|NCT01958437|12411677|FG001|Overall Study|Incidental MRI findings|0
7900921|NCT01958437|12411678|FG002|Overall Study|Incidental MRI findings|1
7900922|NCT01958437|12411679|FG003|Overall Study|Incidental MRI findings|1
7900923|NCT01958476|12411698|FG000|Overall Study|Parent requested exclusion from analysis|1
7900924|NCT01958476|12411699|FG001|Overall Study|Parent requested exclusion from analysis|0
7900925|NCT01958489|12411705|FG000|Period 2|Adverse Event|0
7900926|NCT01958489|12411706|FG001|Period 2|Adverse Event|1
7900927|NCT01958619|12411730|FG000|Overall Study|Protocol Violation|2
7900928|NCT01958619|12411731|FG001|Overall Study|Protocol Violation|0
7900929|NCT01958619|12411732|FG002|Overall Study|Protocol Violation|1
7900930|NCT01958619|12411733|FG003|Overall Study|Protocol Violation|0
7900931|NCT01958671|12411761|FG000|Overall Study|Adverse Event|1
7900932|NCT01958671|12411762|FG001|Overall Study|Adverse Event|1
7900933|NCT01958671|12411763|FG002|Overall Study|Adverse Event|5
7900934|NCT01958671|12411761|FG000|Overall Study|Death|1
7900935|NCT01958671|12411762|FG001|Overall Study|Death|0
7900936|NCT01958671|12411763|FG002|Overall Study|Death|0
7900937|NCT01958671|12411761|FG000|Overall Study|Excluded medication|0
7900938|NCT01958671|12411762|FG001|Overall Study|Excluded medication|0
7900939|NCT01958671|12411763|FG002|Overall Study|Excluded medication|1
7900940|NCT01958671|12411761|FG000|Overall Study|Hyperglycemia|0
7900941|NCT01958671|12411762|FG001|Overall Study|Hyperglycemia|0
7900942|NCT01958671|12411763|FG002|Overall Study|Hyperglycemia|2
7900943|NCT01958671|12411761|FG000|Overall Study|Lost to Follow-up|7
7900944|NCT01958671|12411762|FG001|Overall Study|Lost to Follow-up|11
7900945|NCT01958671|12411763|FG002|Overall Study|Lost to Follow-up|7
7900946|NCT01958671|12411761|FG000|Overall Study|Non-compliance with study drug|1
7900947|NCT01958671|12411762|FG001|Overall Study|Non-compliance with study drug|1
7900948|NCT01958671|12411763|FG002|Overall Study|Non-compliance with study drug|1
7900949|NCT01958671|12411761|FG000|Overall Study|Pregnancy|0
7900950|NCT01958671|12411762|FG001|Overall Study|Pregnancy|0
7900951|NCT01958671|12411763|FG002|Overall Study|Pregnancy|1
7900952|NCT01958671|12411761|FG000|Overall Study|Protocol Violation|0
7900953|NCT01958671|12411762|FG001|Overall Study|Protocol Violation|1
7900954|NCT01958671|12411763|FG002|Overall Study|Protocol Violation|0
7900955|NCT01958671|12411761|FG000|Overall Study|Study site terminated by sponsor|1
7900956|NCT01958671|12411762|FG001|Overall Study|Study site terminated by sponsor|0
7900957|NCT01958671|12411763|FG002|Overall Study|Study site terminated by sponsor|1
7900958|NCT01958671|12411761|FG000|Overall Study|Participant moved|0
7900959|NCT01958671|12411762|FG001|Overall Study|Participant moved|0
7900960|NCT01958671|12411763|FG002|Overall Study|Participant moved|1
7900961|NCT01958671|12411761|FG000|Overall Study|Withdrawal by Subject|8
7900962|NCT01958671|12411762|FG001|Overall Study|Withdrawal by Subject|10
7900963|NCT01958671|12411763|FG002|Overall Study|Withdrawal by Subject|13
7900964|NCT01958827|12411779|FG000|Overall Study|Adverse Event|3
7900965|NCT01958827|12411779|FG000|Overall Study|Lack of Efficacy|6
7900966|NCT01958827|12411779|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1
7900967|NCT01958918|12411785|FG000|Overall Study|Death|1
7900968|NCT01958918|12411786|FG001|Overall Study|Death|3
7900969|NCT01958918|12411785|FG000|Overall Study|Lost to Follow-up|4
7900970|NCT01958918|12411786|FG001|Overall Study|Lost to Follow-up|7
7900971|NCT01958918|12411785|FG000|Overall Study|Withdrawal by Subject|13
7900972|NCT01958918|12411786|FG001|Overall Study|Withdrawal by Subject|8
7900973|NCT01958918|12411785|FG000|Overall Study|Lack of Efficacy|13
7900974|NCT01958918|12411786|FG001|Overall Study|Lack of Efficacy|10
7900975|NCT01958918|12411785|FG000|Overall Study|Adverse Event|12
7900976|NCT01958918|12411786|FG001|Overall Study|Adverse Event|12
7900977|NCT01958918|12411785|FG000|Overall Study|administrative problems|0
7900978|NCT01958918|12411786|FG001|Overall Study|administrative problems|2
7900979|NCT01959035|12411792|FG000|Overall Study|Adverse Event|5
7900980|NCT01959035|12411792|FG000|Overall Study|Withdrawal by Subject|4
7900981|NCT01959035|12411792|FG000|Overall Study|Lost to Follow-up|1
7900982|NCT01959035|12411792|FG000|Overall Study|Other (no primary reason given)|1
7900983|NCT01959165|12411810|FG000|Overall Study|Adverse Event|0
7900984|NCT01959165|12411811|FG001|Overall Study|Adverse Event|0
7900985|NCT01959165|12411812|FG002|Overall Study|Adverse Event|0
7900986|NCT01959165|12411813|FG003|Overall Study|Adverse Event|1
7900987|NCT01959165|12411810|FG000|Overall Study|Lack of Efficacy|1
7900988|NCT01959165|12411811|FG001|Overall Study|Lack of Efficacy|0
7900989|NCT01959165|12411812|FG002|Overall Study|Lack of Efficacy|0
7900990|NCT01959165|12411813|FG003|Overall Study|Lack of Efficacy|0
7900991|NCT01959165|12411810|FG000|Overall Study|overdose|0
7900992|NCT01959165|12411811|FG001|Overall Study|overdose|0
7900993|NCT01959165|12411812|FG002|Overall Study|overdose|0
7900994|NCT01959165|12411813|FG003|Overall Study|overdose|1
7900995|NCT01959165|12411810|FG000|Overall Study|Welfare recipient|0
7900996|NCT01959165|12411811|FG001|Overall Study|Welfare recipient|1
7900997|NCT01959165|12411812|FG002|Overall Study|Welfare recipient|0
7900998|NCT01959165|12411813|FG003|Overall Study|Welfare recipient|0
7900999|NCT01959230|12411832|FG000|Overall Study|Failure to follow study procedures|0
7901000|NCT01959230|12411833|FG001|Overall Study|Failure to follow study procedures|1
7901001|NCT01959230|12411832|FG000|Overall Study|Administrative reasons|2
7901002|NCT01959230|12411833|FG001|Overall Study|Administrative reasons|0
7901003|NCT01959230|12411832|FG000|Overall Study|Withdrawal by Subject|2
7901004|NCT01959230|12411833|FG001|Overall Study|Withdrawal by Subject|0
7901005|NCT01959243|12411841|FG000|Overall Study|Investigator Decision|3
7901006|NCT01959243|12411842|FG001|Overall Study|Investigator Decision|0
7901007|NCT01959243|12411841|FG000|Overall Study|Adverse Event|5
7901008|NCT01959243|12411842|FG001|Overall Study|Adverse Event|2
7901009|NCT01959243|12411841|FG000|Overall Study|Administrative reasons|2
7901010|NCT01959243|12411842|FG001|Overall Study|Administrative reasons|1
7901011|NCT01959243|12411841|FG000|Overall Study|Lost to Follow-up|3
7901012|NCT01959243|12411842|FG001|Overall Study|Lost to Follow-up|1
7901013|NCT01959334|12411850|FG000|Second Dose|Adverse Event|1
7717907|NCT00522951|12141544|FG001|Period 2|residual contrast medium|1
7717908|NCT00523367|12141567|FG000|Overall Study|19 screen failures|19
7717909|NCT00523367|12141567|FG000|Overall Study|4 Withdrawn by PI|4
7717910|NCT00523419|12141571|FG000|Overall Study|Adverse Event|1
7717911|NCT00523419|12141571|FG000|Overall Study|Withdrawal by Subject|1
7717912|NCT00523419|12141571|FG000|Overall Study|Physician Decision|2
7717913|NCT00523419|12141571|FG000|Overall Study|Progressive Disease|22
7717914|NCT00523419|12141571|FG000|Overall Study|Death due to Study Disease|4
7717915|NCT00523419|12141571|FG000|Overall Study|Death due to Adverse Event|2
7717916|NCT00523549|12141577|FG000|Overall Study|Adverse Event|6
7717917|NCT00523549|12141578|FG001|Overall Study|Adverse Event|3
7717918|NCT00523549|12141577|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7717919|NCT00523549|12141578|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7717920|NCT00523549|12141577|FG000|Overall Study|Protocol Deviation|3
7717921|NCT00523549|12141578|FG001|Overall Study|Protocol Deviation|1
7717922|NCT00523549|12141577|FG000|Overall Study|Patient withdrew consent|7
7901014|NCT01959334|12411851|FG001|Second Dose|Adverse Event|0
7717923|NCT00523549|12141578|FG001|Overall Study|Patient withdrew consent|6
7717924|NCT00523549|12141577|FG000|Overall Study|Lost to Follow-up|3
7717925|NCT00523549|12141578|FG001|Overall Study|Lost to Follow-up|5
7717926|NCT00523640|12141593|FG000|Overall Study|Death|1
7717927|NCT00523705|12141599|FG000|Overall Study|No time for study.|0
7717928|NCT00523705|12141600|FG001|Overall Study|No time for study.|1
7717929|NCT00523718|12141608|FG000|Overall Study|Withdrawal by Subject|1
7717930|NCT00523718|12141609|FG001|Overall Study|Withdrawal by Subject|0
7717931|NCT00523718|12141608|FG000|Overall Study|Protocol Violation|2
7717932|NCT00523718|12141609|FG001|Overall Study|Protocol Violation|0
7717933|NCT00523744|12141615|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
7717934|NCT00523744|12141615|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
7901015|NCT01959334|12411850|FG000|Third Dose|Adverse Event|0
7901016|NCT01959334|12411851|FG001|Third Dose|Adverse Event|1
7901017|NCT01959347|12411859|FG000|Overall Study|Protocol Violation|9
7901018|NCT01959347|12411860|FG001|Overall Study|Protocol Violation|7
7901019|NCT01959412|12411866|FG000|Overall Study|Protocol deviation|1
7901020|NCT01959412|12411867|FG001|Overall Study|Protocol deviation|1
7901021|NCT01959412|12411868|FG002|Overall Study|Protocol deviation|0
7901022|NCT01959412|12411869|FG003|Overall Study|Protocol deviation|1
7901023|NCT01959412|12411870|FG004|Overall Study|Protocol deviation|3
7901024|NCT01959412|12411871|FG005|Overall Study|Protocol deviation|0
7901025|NCT01959412|12411866|FG000|Overall Study|Adverse Event|0
7901026|NCT01959412|12411867|FG001|Overall Study|Adverse Event|0
7901027|NCT01959412|12411868|FG002|Overall Study|Adverse Event|0
7901028|NCT01959412|12411869|FG003|Overall Study|Adverse Event|1
7901029|NCT01959412|12411870|FG004|Overall Study|Adverse Event|0
7901030|NCT01959412|12411871|FG005|Overall Study|Adverse Event|0
7901031|NCT01959425|12411887|FG000|Overall Study|Withdrawal by Subject|5
7901032|NCT01959425|12411888|FG001|Overall Study|Withdrawal by Subject|4
7901033|NCT01959425|12411887|FG000|Overall Study|Lost to Follow-up|1
7901034|NCT01959425|12411888|FG001|Overall Study|Lost to Follow-up|0
7901035|NCT01959425|12411887|FG000|Overall Study|Discontinued Subjects|6
7901036|NCT01959425|12411888|FG001|Overall Study|Discontinued Subjects|4
7901037|NCT01959503|12411909|FG000|Overall Study|Death|2
7901038|NCT01959503|12411910|FG001|Overall Study|Death|1
7901039|NCT01959503|12411909|FG000|Overall Study|Randomized but not treated|1
7901040|NCT01959503|12411910|FG001|Overall Study|Randomized but not treated|1
7901041|NCT01959516|12411916|FG000|Epoch 1|Adverse Event|4
7901042|NCT01959516|12411917|FG001|Epoch 1|Adverse Event|1
7901043|NCT01959516|12411916|FG000|Epoch 1|unsatisfactory therapeutic effect|1
7901044|NCT01959516|12411917|FG001|Epoch 1|unsatisfactory therapeutic effect|0
7901045|NCT01959516|12411916|FG000|Epoch 1|Subject withdrew consent|3
7901046|NCT01959516|12411917|FG001|Epoch 1|Subject withdrew consent|2
7901047|NCT01959516|12411916|FG000|Epoch 1|Administrative problems|1
7901048|NCT01959516|12411917|FG001|Epoch 1|Administrative problems|0
7901049|NCT01959516|12411916|FG000|Epoch 1|Use of prohibited treatment|1
7901050|NCT01959516|12411917|FG001|Epoch 1|Use of prohibited treatment|0
7901051|NCT01959516|12411916|FG000|Epoch 1|Moderate or severe COPD exacerbation|0
7901052|NCT01959516|12411917|FG001|Epoch 1|Moderate or severe COPD exacerbation|1
7901053|NCT01959516|12411916|FG000|Epoch 1|Protocol deviation|0
7901054|NCT01959516|12411917|FG001|Epoch 1|Protocol deviation|1
7901055|NCT01959516|12411916|FG000|Epoch 2|unsatisfactory therapeutic effect|1
7901056|NCT01959516|12411917|FG001|Epoch 2|unsatisfactory therapeutic effect|0
7901057|NCT01959516|12411916|FG000|Epoch 2|Subject withdrew consent|1
7901058|NCT01959516|12411917|FG001|Epoch 2|Subject withdrew consent|0
7901059|NCT01959516|12411916|FG000|Epoch 2|Moderate or severe COPD exacerbation|0
7901060|NCT01959516|12411917|FG001|Epoch 2|Moderate or severe COPD exacerbation|1
7901061|NCT01959529|12411925|FG000|Overall Study|Adverse event (not hypoglycaemia)|0
7901062|NCT01959529|12411926|FG001|Overall Study|Adverse event (not hypoglycaemia)|1
7901063|NCT01959529|12411925|FG000|Overall Study|Lost to Follow-up|4
7901064|NCT01959529|12411926|FG001|Overall Study|Lost to Follow-up|1
7901065|NCT01959529|12411925|FG000|Overall Study|Other|70
7901066|NCT01959529|12411926|FG001|Overall Study|Other|68
7901067|NCT01959529|12411925|FG000|Overall Study|Hypoglycaemia|1
7901068|NCT01959529|12411926|FG001|Overall Study|Hypoglycaemia|1
7901069|NCT01959529|12411925|FG000|Overall Study|Lack of glycaemic control|1
7901070|NCT01959529|12411926|FG001|Overall Study|Lack of glycaemic control|1
7963644|NCT02725411|12518226|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4
7963645|NCT02725411|12518224|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25
7963646|NCT02725411|12518225|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
7963647|NCT02725411|12518226|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
7963648|NCT02725411|12518224|FG000|Follow-up Period (24 Weeks)|Adverse Event|1
7963649|NCT02725411|12518225|FG001|Follow-up Period (24 Weeks)|Adverse Event|1
7963650|NCT02725411|12518226|FG002|Follow-up Period (24 Weeks)|Adverse Event|0
7963651|NCT02725411|12518224|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0
7963652|NCT02725411|12518225|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2
7963653|NCT02725411|12518226|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0
7963654|NCT02725411|12518224|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1
7963655|NCT02725411|12518225|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1
7717935|NCT00523744|12141615|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
7963656|NCT02725411|12518226|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0
7963657|NCT02725411|12518224|FG000|Follow-up Period (24 Weeks)|Other|1
7901071|NCT01959581|12411937|FG000|Overall Study|Lost to Follow-up|5
7901072|NCT01959607|12411943|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
7901073|NCT01959607|12411944|FG001|First Intervention (Day 1)|Withdrawal by Subject|1
7901074|NCT01959607|12411945|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
7901075|NCT01959607|12411946|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
7901076|NCT01959672|12411955|FG000|Overall Study|Death|1
7901077|NCT01959841|12411969|FG000|Overall Study|Adverse Event|1
7901078|NCT01959841|12411970|FG001|Overall Study|Adverse Event|3
7901079|NCT01959841|12411971|FG002|Overall Study|Adverse Event|2
7901080|NCT01959841|12411969|FG000|Overall Study|Lack of Efficacy|5
7901081|NCT01959841|12411970|FG001|Overall Study|Lack of Efficacy|0
7901082|NCT01959841|12411971|FG002|Overall Study|Lack of Efficacy|0
7901083|NCT01959841|12411969|FG000|Overall Study|Lost to Follow-up|1
7901084|NCT01959841|12411970|FG001|Overall Study|Lost to Follow-up|1
7901085|NCT01959841|12411971|FG002|Overall Study|Lost to Follow-up|0
7901086|NCT01959841|12411969|FG000|Overall Study|Physician Decision|0
7901087|NCT01959841|12411970|FG001|Overall Study|Physician Decision|2
7901088|NCT01959841|12411971|FG002|Overall Study|Physician Decision|3
7901089|NCT01959841|12411969|FG000|Overall Study|Protocol Violation|16
7901090|NCT01959841|12411970|FG001|Overall Study|Protocol Violation|23
7901091|NCT01959841|12411971|FG002|Overall Study|Protocol Violation|16
7901092|NCT01959841|12411969|FG000|Overall Study|Withdrawal by Subject|7
7901093|NCT01959841|12411970|FG001|Overall Study|Withdrawal by Subject|7
7901094|NCT01959841|12411971|FG002|Overall Study|Withdrawal by Subject|5
7901095|NCT01959841|12411969|FG000|Overall Study|Clinical laboratory value|2
7901096|NCT01959841|12411970|FG001|Overall Study|Clinical laboratory value|6
7901097|NCT01959841|12411971|FG002|Overall Study|Clinical laboratory value|6
7901098|NCT01959841|12411969|FG000|Overall Study|Platelet count below on day1 or 4|11
7901099|NCT01959841|12411970|FG001|Overall Study|Platelet count below on day1 or 4|15
7901100|NCT01959841|12411971|FG002|Overall Study|Platelet count below on day1 or 4|11
7901101|NCT01959880|12411983|FG000|Overall Study|Withdrawal by Subject|11
7901102|NCT01959880|12411984|FG001|Overall Study|Withdrawal by Subject|13
7901103|NCT01959880|12411985|FG002|Overall Study|Withdrawal by Subject|8
7901104|NCT01959880|12411986|FG003|Overall Study|Withdrawal by Subject|7
7901105|NCT01959880|12411983|FG000|Overall Study|Death|1
7901106|NCT01959880|12411984|FG001|Overall Study|Death|10
7901107|NCT01959880|12411985|FG002|Overall Study|Death|1
7901108|NCT01959880|12411986|FG003|Overall Study|Death|2
7901109|NCT01959880|12411983|FG000|Overall Study|Lost to Follow-up|95
7901110|NCT01959880|12411984|FG001|Overall Study|Lost to Follow-up|18
7901111|NCT01959880|12411985|FG002|Overall Study|Lost to Follow-up|15
7901112|NCT01959880|12411986|FG003|Overall Study|Lost to Follow-up|8
7901113|NCT01959880|12411983|FG000|Overall Study|Explantation w/o study device reimplant.|22
7901114|NCT01959880|12411984|FG001|Overall Study|Explantation w/o study device reimplant.|17
7901115|NCT01959880|12411985|FG002|Overall Study|Explantation w/o study device reimplant.|5
7901116|NCT01959880|12411986|FG003|Overall Study|Explantation w/o study device reimplant.|12
7901117|NCT01959880|12411983|FG000|Overall Study|Study completed early-FDA approved|1003
7901118|NCT01959880|12411984|FG001|Overall Study|Study completed early-FDA approved|311
7901119|NCT01959880|12411985|FG002|Overall Study|Study completed early-FDA approved|179
7901120|NCT01959880|12411986|FG003|Overall Study|Study completed early-FDA approved|152
7901121|NCT01959919|12411996|FG000|Overall Study|Did not meet the eligibility criteria|2
7901122|NCT01959932|12412003|FG000|Overall Study|Withdrawal by Subject|1
7901123|NCT01959932|12412004|FG001|Overall Study|Withdrawal by Subject|0
7901124|NCT01959932|12412005|FG002|Overall Study|Withdrawal by Subject|0
7901125|NCT01960114|12412048|FG000|Overall Study|Adverse Event|1
7901126|NCT01960114|12412049|FG001|Overall Study|Adverse Event|0
7901127|NCT01960114|12412048|FG000|Overall Study|Could not swallow study medication|0
7901128|NCT01960114|12412049|FG001|Overall Study|Could not swallow study medication|1
7901129|NCT01960140|12412055|FG000|Period 2 (Days 3-18)|Adverse Event|2
7901130|NCT01960257|12412063|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12
7901131|NCT01960257|12412064|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0
7901132|NCT01960257|12412065|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0
7901133|NCT01960257|12412063|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3
7901134|NCT01960257|12412064|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0
7901135|NCT01960257|12412065|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0
7901136|NCT01960257|12412063|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1
7901137|NCT01960257|12412064|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0
7901138|NCT01960257|12412065|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0
7901139|NCT01960296|12412077|FG000|Overall Study|Postponed surgery|1
7901140|NCT01960296|12412078|FG001|Overall Study|Postponed surgery|0
7901141|NCT01960296|12412077|FG000|Overall Study|Received different procedure|1
7901142|NCT01960296|12412078|FG001|Overall Study|Received different procedure|3
7901143|NCT01960348|12412086|FG000|Overall Study|Adverse event, not serious|2
7901144|NCT01960348|12412087|FG001|Overall Study|Adverse event, not serious|2
7901145|NCT01960348|12412086|FG000|Overall Study|Adverse event, serious fatal|6
7901146|NCT01960348|12412087|FG001|Overall Study|Adverse event, serious fatal|5
7901147|NCT01960348|12412086|FG000|Overall Study|Adverse event, serious non-fatal|0
7901148|NCT01960348|12412087|FG001|Overall Study|Adverse event, serious non-fatal|3
7901149|NCT01960348|12412086|FG000|Overall Study|Withdrawal by Subject|1
7901150|NCT01960348|12412087|FG001|Overall Study|Withdrawal by Subject|11
7901151|NCT01960348|12412086|FG000|Overall Study|Physician Decision|0
7901152|NCT01960348|12412087|FG001|Overall Study|Physician Decision|1
7901153|NCT01960348|12412086|FG000|Overall Study|Protocol Violation|1
7901154|NCT01960348|12412087|FG001|Overall Study|Protocol Violation|0
7901155|NCT01960413|12412108|FG000|Overall Study|Withdrawal by Subject|1
7901156|NCT01960413|12412109|FG001|Overall Study|Withdrawal by Subject|1
7901157|NCT01960413|12412108|FG000|Overall Study|Physician Decision|1
7901158|NCT01960413|12412109|FG001|Overall Study|Physician Decision|0
7901159|NCT01960413|12412108|FG000|Overall Study|Lost to Follow-up|2
7901160|NCT01960413|12412109|FG001|Overall Study|Lost to Follow-up|0
7901161|NCT01960725|12412126|FG000|Overall Study|Lost to Follow-up|4
7901162|NCT01960725|12412127|FG001|Overall Study|Lost to Follow-up|3
7901163|NCT01960725|12412126|FG000|Overall Study|Withdrawal by Subject|1
7901164|NCT01960725|12412127|FG001|Overall Study|Withdrawal by Subject|0
7901165|NCT01960725|12412126|FG000|Overall Study|unable to obtain blood sample|1
7901166|NCT01960725|12412127|FG001|Overall Study|unable to obtain blood sample|2
7901167|NCT01960790|12412133|FG000|Overall Study|Survey forms could not be recovered|3
7901168|NCT01960790|12412133|FG000|Overall Study|Treat with Humira outside survey period|3
7901169|NCT01960790|12412133|FG000|Overall Study|Transferred to another hospital|4
7901170|NCT01960790|12412133|FG000|Overall Study|Unevaluable for safety|1
7901171|NCT01960816|12412137|FG000|Overall Study|Lost to Follow-up|1
7901172|NCT01960842|12412141|FG000|Overall Study|Adverse Event|1
7901173|NCT01960842|12412141|FG000|Overall Study|Withdrawal by Subject|2
7901174|NCT01960855|12412150|FG000|Overall Study|Subject noncompliant|1
7901175|NCT01960855|12412151|FG001|Overall Study|Subject noncompliant|0
7901176|NCT01960855|12412152|FG002|Overall Study|Subject noncompliant|0
7901177|NCT01960855|12412153|FG003|Overall Study|Subject noncompliant|0
7901178|NCT01960855|12412154|FG004|Overall Study|Subject noncompliant|0
7901179|NCT01960855|12412150|FG000|Overall Study|Adverse Event|2
7901180|NCT01960855|12412151|FG001|Overall Study|Adverse Event|0
7901181|NCT01960855|12412152|FG002|Overall Study|Adverse Event|6
7901182|NCT01960855|12412153|FG003|Overall Study|Adverse Event|2
7901183|NCT01960855|12412154|FG004|Overall Study|Adverse Event|2
7901184|NCT01960855|12412150|FG000|Overall Study|Lack of Efficacy|1
7901185|NCT01960855|12412151|FG001|Overall Study|Lack of Efficacy|1
7901186|NCT01960855|12412152|FG002|Overall Study|Lack of Efficacy|0
7901187|NCT01960855|12412153|FG003|Overall Study|Lack of Efficacy|0
7901188|NCT01960855|12412154|FG004|Overall Study|Lack of Efficacy|0
7901189|NCT01960855|12412150|FG000|Overall Study|Other|2
7901190|NCT01960855|12412151|FG001|Overall Study|Other|1
7901191|NCT01960855|12412152|FG002|Overall Study|Other|1
7901192|NCT01960855|12412153|FG003|Overall Study|Other|1
7901193|NCT01960855|12412154|FG004|Overall Study|Other|0
7901194|NCT01960855|12412150|FG000|Overall Study|Consent withdrawn by subject|3
7901195|NCT01960855|12412151|FG001|Overall Study|Consent withdrawn by subject|1
7901196|NCT01960855|12412152|FG002|Overall Study|Consent withdrawn by subject|2
7901197|NCT01960855|12412153|FG003|Overall Study|Consent withdrawn by subject|1
7901198|NCT01960855|12412154|FG004|Overall Study|Consent withdrawn by subject|1
7901199|NCT01960855|12412150|FG000|Overall Study|Lost to Follow-up|2
7901200|NCT01960855|12412151|FG001|Overall Study|Lost to Follow-up|1
7901201|NCT01960855|12412152|FG002|Overall Study|Lost to Follow-up|0
7901202|NCT01960855|12412153|FG003|Overall Study|Lost to Follow-up|0
7901203|NCT01960855|12412154|FG004|Overall Study|Lost to Follow-up|2
7901204|NCT01960907|12412168|FG000|Overall Study|Death|4
7901205|NCT01960907|12412169|FG001|Overall Study|Death|3
7901206|NCT01960907|12412168|FG000|Overall Study|Withdrawal by Subject|32
7901207|NCT01960907|12412169|FG001|Overall Study|Withdrawal by Subject|42
7901208|NCT01960998|12412180|FG000|Overall Study|Lost to Follow-up|3
7901209|NCT01960998|12412181|FG001|Overall Study|Lost to Follow-up|7
7901210|NCT01960998|12412180|FG000|Overall Study|Death|0
7901211|NCT01960998|12412181|FG001|Overall Study|Death|1
7901212|NCT01960998|12412180|FG000|Overall Study|Withdrawal by Subject|8
7901213|NCT01960998|12412181|FG001|Overall Study|Withdrawal by Subject|2
7901214|NCT01960998|12412180|FG000|Overall Study|lost computer access|0
7901215|NCT01960998|12412181|FG001|Overall Study|lost computer access|1
7901216|NCT01961115|12412196|FG000|Overall Study|Disease Progression|1
7901217|NCT01961115|12412197|FG001|Overall Study|Disease Progression|0
7901218|NCT01961115|12412198|FG002|Overall Study|Disease Progression|3
7901219|NCT01961115|12412196|FG000|Overall Study|Adverse Event|1
7901220|NCT01961115|12412197|FG001|Overall Study|Adverse Event|0
7901221|NCT01961115|12412198|FG002|Overall Study|Adverse Event|1
7901222|NCT01961297|12412216|FG000|Overall Study|unconfirmed diagnosis of SD|2
7901223|NCT01961297|12412217|FG001|Overall Study|unconfirmed diagnosis of SD|1
7901224|NCT01961323|12412223|FG000|Overall Study|Withdrawal by Subject|7
7901225|NCT01961323|12412223|FG000|Overall Study|Lost to Follow-up|8
7901226|NCT01961323|12412223|FG000|Overall Study|screen failure|34
7901227|NCT01961349|12412230|FG000|Overall Study|Withdrawal by Subject|1
7901228|NCT01961349|12412231|FG001|Overall Study|Withdrawal by Subject|4
7901229|NCT01961349|12412232|FG002|Overall Study|Withdrawal by Subject|0
7901230|NCT01961349|12412230|FG000|Overall Study|Adverse Event|0
7901231|NCT01961349|12412231|FG001|Overall Study|Adverse Event|0
7901232|NCT01961349|12412232|FG002|Overall Study|Adverse Event|1
7901233|NCT01961349|12412230|FG000|Overall Study|registration error, personal reason etc|2
7901234|NCT01961349|12412231|FG001|Overall Study|registration error, personal reason etc|2
7901235|NCT01961349|12412232|FG002|Overall Study|registration error, personal reason etc|1
7901236|NCT01961544|12412244|FG000|Overall Study|Protocol Violation|1
7901237|NCT01961544|12412244|FG000|Overall Study|Withdrawal by Subject|7
7901238|NCT01961544|12412244|FG000|Overall Study|Adverse Event|1
7901239|NCT01961544|12412244|FG000|Overall Study|Physician Decision|2
7901240|NCT01961544|12412244|FG000|Overall Study|Poor Tolerance|1
7901241|NCT01961544|12412244|FG000|Overall Study|Aggravation of Steral Pain|1
7901242|NCT01961609|12412250|FG000|Initiation|Missing|3
7901243|NCT01961609|12412251|FG001|Initiation|Missing|2
7901244|NCT01961609|12412252|FG002|Initiation|Missing|0
7901245|NCT01961609|12412253|FG003|Initiation|Missing|0
7901246|NCT01961609|12412250|FG000|Initiation|Protocol deviation|1
7901247|NCT01961609|12412251|FG001|Initiation|Protocol deviation|0
7901248|NCT01961609|12412252|FG002|Initiation|Protocol deviation|0
7901249|NCT01961609|12412253|FG003|Initiation|Protocol deviation|0
7901250|NCT01961609|12412250|FG000|Initiation|Death|0
7901251|NCT01961609|12412251|FG001|Initiation|Death|1
7901252|NCT01961609|12412252|FG002|Initiation|Death|0
7901253|NCT01961609|12412253|FG003|Initiation|Death|0
7901254|NCT01961609|12412250|FG000|Initiation|Administrative problems|1
7901255|NCT01961609|12412251|FG001|Initiation|Administrative problems|0
7901256|NCT01961609|12412252|FG002|Initiation|Administrative problems|0
7901257|NCT01961609|12412253|FG003|Initiation|Administrative problems|0
7901258|NCT01961609|12412250|FG000|Initiation|Withdrawal by Subject|1
7901259|NCT01961609|12412251|FG001|Initiation|Withdrawal by Subject|2
7901260|NCT01961609|12412252|FG002|Initiation|Withdrawal by Subject|0
7901261|NCT01961609|12412253|FG003|Initiation|Withdrawal by Subject|0
7901262|NCT01961609|12412250|FG000|Initiation|Lack of Efficacy|2
7901263|NCT01961609|12412251|FG001|Initiation|Lack of Efficacy|1
7901264|NCT01961609|12412252|FG002|Initiation|Lack of Efficacy|0
7901265|NCT01961609|12412253|FG003|Initiation|Lack of Efficacy|0
7901266|NCT01961609|12412250|FG000|Initiation|Abnormal lab values|0
7901267|NCT01961609|12412251|FG001|Initiation|Abnormal lab values|1
7901268|NCT01961609|12412252|FG002|Initiation|Abnormal lab values|0
7901269|NCT01961609|12412253|FG003|Initiation|Abnormal lab values|0
7901270|NCT01961609|12412250|FG000|Initiation|Adverse Event|3
7901271|NCT01961609|12412251|FG001|Initiation|Adverse Event|5
7901272|NCT01961609|12412252|FG002|Initiation|Adverse Event|0
7901273|NCT01961609|12412253|FG003|Initiation|Adverse Event|0
7901274|NCT01961609|12412250|FG000|Initiation|Randomized but not treated|1
7901275|NCT01961609|12412251|FG001|Initiation|Randomized but not treated|1
7901276|NCT01961609|12412252|FG002|Initiation|Randomized but not treated|0
7901277|NCT01961609|12412253|FG003|Initiation|Randomized but not treated|0
7901278|NCT01961609|12412250|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1
7901279|NCT01961609|12412251|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
7901280|NCT01961609|12412252|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3
7901281|NCT01961609|12412253|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
7901282|NCT01961609|12412250|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3
7901283|NCT01961609|12412251|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
7901284|NCT01961609|12412252|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1
7901285|NCT01961609|12412253|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
7901286|NCT01961609|12412250|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
7901287|NCT01961609|12412251|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
7901288|NCT01961609|12412252|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
7901289|NCT01961609|12412253|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
7901290|NCT01961609|12412250|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13
7901291|NCT01961609|12412251|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4
7901292|NCT01961609|12412252|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10
7901293|NCT01961609|12412253|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0
7901294|NCT01961609|12412250|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
7901295|NCT01961609|12412251|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
7901296|NCT01961609|12412252|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3
7901297|NCT01961609|12412253|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0
7901298|NCT01961609|12412250|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
7901299|NCT01961609|12412251|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
7901300|NCT01961609|12412252|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1
7901301|NCT01961609|12412253|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
7901302|NCT01961609|12412250|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7
7901303|NCT01961609|12412251|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5
7901304|NCT01961609|12412252|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0
7901305|NCT01961609|12412253|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4
7901306|NCT01961609|12412250|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
7901307|NCT01961609|12412251|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
7901308|NCT01961609|12412252|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1
7901309|NCT01961609|12412253|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
7901310|NCT01961609|12412250|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1
7901311|NCT01961609|12412251|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
7901312|NCT01961609|12412252|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
7901313|NCT01961609|12412253|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
7901314|NCT01961609|12412250|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
7901315|NCT01961609|12412251|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1
7901316|NCT01961609|12412252|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
7901317|NCT01961609|12412253|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
7901318|NCT01961609|12412250|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
7901319|NCT01961609|12412251|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0
7901320|NCT01961609|12412252|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
7901321|NCT01961609|12412253|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1
7901322|NCT01961609|12412250|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1
7901323|NCT01961609|12412251|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
7901324|NCT01961609|12412252|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
7901325|NCT01961609|12412253|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2
7901326|NCT01961687|12412270|FG000|Overall Study|Lost to Follow-up|19
7901327|NCT01961687|12412270|FG000|Overall Study|Re-operation|17
7901328|NCT01961687|12412270|FG000|Overall Study|Death|7
7901329|NCT01961687|12412270|FG000|Overall Study|Withdrawal by Subject|6
7901330|NCT01961687|12412270|FG000|Overall Study|Adverse Event|6
7901331|NCT01961687|12412270|FG000|Overall Study|Moved to area without study site|2
7901332|NCT01961687|12412270|FG000|Overall Study|Sponsor decision|2
7901333|NCT01961687|12412270|FG000|Overall Study|Physician Decision|1
7901334|NCT01961687|12412270|FG000|Overall Study|Unable to meet follow-up requirements|1
7901335|NCT01961882|12412276|FG000|Overall Study|Adverse Event|3
7901336|NCT01961882|12412277|FG001|Overall Study|Adverse Event|2
7901337|NCT01961882|12412276|FG000|Overall Study|Physician Decision|1
7901338|NCT01961882|12412277|FG001|Overall Study|Physician Decision|0
7901339|NCT01961882|12412276|FG000|Overall Study|Withdrawal by Subject|4
7901340|NCT01961882|12412277|FG001|Overall Study|Withdrawal by Subject|1
7901341|NCT01961882|12412276|FG000|Overall Study|Relapse of AML|39
7901342|NCT01961882|12412277|FG001|Overall Study|Relapse of AML|37
7901343|NCT01961882|12412276|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2
7901344|NCT01961882|12412277|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2
7901345|NCT01961882|12412276|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1
7901346|NCT01961882|12412277|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0
7901347|NCT01962103|12412307|FG000|Phase 1|Adverse Event|4
7901348|NCT01962103|12412308|FG001|Phase 1|Adverse Event|0
7901349|NCT01962103|12412309|FG002|Phase 1|Adverse Event|2
7901350|NCT01962103|12412310|FG003|Phase 1|Adverse Event|1
7901351|NCT01962103|12412311|FG004|Phase 1|Adverse Event|2
7901352|NCT01962103|12412312|FG005|Phase 1|Adverse Event|2
7901353|NCT01962103|12412313|FG006|Phase 1|Adverse Event|0
7901354|NCT01962103|12412314|FG007|Phase 1|Adverse Event|0
7901355|NCT01962103|12412315|FG008|Phase 1|Adverse Event|0
7901356|NCT01962103|12412307|FG000|Phase 1|Progressive Disease|8
7901357|NCT01962103|12412308|FG001|Phase 1|Progressive Disease|6
7901358|NCT01962103|12412309|FG002|Phase 1|Progressive Disease|8
7901359|NCT01962103|12412310|FG003|Phase 1|Progressive Disease|4
7901360|NCT01962103|12412311|FG004|Phase 1|Progressive Disease|5
7901361|NCT01962103|12412312|FG005|Phase 1|Progressive Disease|4
7901362|NCT01962103|12412313|FG006|Phase 1|Progressive Disease|0
7901363|NCT01962103|12412314|FG007|Phase 1|Progressive Disease|0
7901364|NCT01962103|12412315|FG008|Phase 1|Progressive Disease|0
7901365|NCT01962103|12412307|FG000|Phase 1|Withdrawal by Subject|0
7901366|NCT01962103|12412308|FG001|Phase 1|Withdrawal by Subject|0
7901367|NCT01962103|12412309|FG002|Phase 1|Withdrawal by Subject|0
7901368|NCT01962103|12412310|FG003|Phase 1|Withdrawal by Subject|2
7901369|NCT01962103|12412311|FG004|Phase 1|Withdrawal by Subject|0
7901370|NCT01962103|12412312|FG005|Phase 1|Withdrawal by Subject|0
7901371|NCT01962103|12412313|FG006|Phase 1|Withdrawal by Subject|0
7901372|NCT01962103|12412314|FG007|Phase 1|Withdrawal by Subject|0
7901373|NCT01962103|12412315|FG008|Phase 1|Withdrawal by Subject|0
7901374|NCT01962103|12412307|FG000|Phase 1|Withdrawal by Parent/Guardian|0
7901375|NCT01962103|12412308|FG001|Phase 1|Withdrawal by Parent/Guardian|0
7901376|NCT01962103|12412309|FG002|Phase 1|Withdrawal by Parent/Guardian|2
7901377|NCT01962103|12412310|FG003|Phase 1|Withdrawal by Parent/Guardian|1
7901378|NCT01962103|12412311|FG004|Phase 1|Withdrawal by Parent/Guardian|0
7901379|NCT01962103|12412312|FG005|Phase 1|Withdrawal by Parent/Guardian|0
7901380|NCT01962103|12412313|FG006|Phase 1|Withdrawal by Parent/Guardian|0
7901381|NCT01962103|12412314|FG007|Phase 1|Withdrawal by Parent/Guardian|0
7901382|NCT01962103|12412315|FG008|Phase 1|Withdrawal by Parent/Guardian|0
7901383|NCT01962103|12412307|FG000|Phase 1|Physician Decision|0
7901384|NCT01962103|12412308|FG001|Phase 1|Physician Decision|0
7901385|NCT01962103|12412309|FG002|Phase 1|Physician Decision|0
7901386|NCT01962103|12412310|FG003|Phase 1|Physician Decision|1
7901387|NCT01962103|12412311|FG004|Phase 1|Physician Decision|0
7901388|NCT01962103|12412312|FG005|Phase 1|Physician Decision|0
7901389|NCT01962103|12412313|FG006|Phase 1|Physician Decision|0
7901390|NCT01962103|12412314|FG007|Phase 1|Physician Decision|0
7901391|NCT01962103|12412315|FG008|Phase 1|Physician Decision|0
7901392|NCT01962103|12412307|FG000|Phase 1|Symptomatic Deterioration|3
7901393|NCT01962103|12412308|FG001|Phase 1|Symptomatic Deterioration|2
7901394|NCT01962103|12412309|FG002|Phase 1|Symptomatic Deterioration|2
7901395|NCT01962103|12412310|FG003|Phase 1|Symptomatic Deterioration|2
7901396|NCT01962103|12412311|FG004|Phase 1|Symptomatic Deterioration|1
7901397|NCT01962103|12412312|FG005|Phase 1|Symptomatic Deterioration|1
7901398|NCT01962103|12412313|FG006|Phase 1|Symptomatic Deterioration|0
7901399|NCT01962103|12412314|FG007|Phase 1|Symptomatic Deterioration|0
7901400|NCT01962103|12412315|FG008|Phase 1|Symptomatic Deterioration|0
7901401|NCT01962103|12412307|FG000|Phase 1|Miscellaneous|1
7901402|NCT01962103|12412308|FG001|Phase 1|Miscellaneous|0
7901403|NCT01962103|12412309|FG002|Phase 1|Miscellaneous|0
7901404|NCT01962103|12412310|FG003|Phase 1|Miscellaneous|0
7901405|NCT01962103|12412311|FG004|Phase 1|Miscellaneous|0
7901406|NCT01962103|12412312|FG005|Phase 1|Miscellaneous|0
7901407|NCT01962103|12412313|FG006|Phase 1|Miscellaneous|0
7901408|NCT01962103|12412314|FG007|Phase 1|Miscellaneous|0
7901409|NCT01962103|12412315|FG008|Phase 1|Miscellaneous|0
7901410|NCT01962103|12412307|FG000|Phase 2|Adverse Event|0
7901411|NCT01962103|12412308|FG001|Phase 2|Adverse Event|0
7901412|NCT01962103|12412309|FG002|Phase 2|Adverse Event|0
7901413|NCT01962103|12412310|FG003|Phase 2|Adverse Event|0
7901414|NCT01962103|12412311|FG004|Phase 2|Adverse Event|0
7901415|NCT01962103|12412312|FG005|Phase 2|Adverse Event|0
7901416|NCT01962103|12412313|FG006|Phase 2|Adverse Event|1
7901417|NCT01962103|12412314|FG007|Phase 2|Adverse Event|0
7901418|NCT01962103|12412315|FG008|Phase 2|Adverse Event|3
7901419|NCT01962103|12412307|FG000|Phase 2|Progressive Disease|0
7901420|NCT01962103|12412308|FG001|Phase 2|Progressive Disease|0
7901421|NCT01962103|12412309|FG002|Phase 2|Progressive Disease|0
7901422|NCT01962103|12412310|FG003|Phase 2|Progressive Disease|0
7901423|NCT01962103|12412311|FG004|Phase 2|Progressive Disease|0
7901424|NCT01962103|12412312|FG005|Phase 2|Progressive Disease|0
7901425|NCT01962103|12412313|FG006|Phase 2|Progressive Disease|11
7901426|NCT01962103|12412314|FG007|Phase 2|Progressive Disease|12
7901427|NCT01962103|12412315|FG008|Phase 2|Progressive Disease|11
7901428|NCT01962103|12412307|FG000|Phase 2|Symptomatic Deterioration|0
7901429|NCT01962103|12412308|FG001|Phase 2|Symptomatic Deterioration|0
7901430|NCT01962103|12412309|FG002|Phase 2|Symptomatic Deterioration|0
7901431|NCT01962103|12412310|FG003|Phase 2|Symptomatic Deterioration|0
7901432|NCT01962103|12412311|FG004|Phase 2|Symptomatic Deterioration|0
7901433|NCT01962103|12412312|FG005|Phase 2|Symptomatic Deterioration|0
7901434|NCT01962103|12412313|FG006|Phase 2|Symptomatic Deterioration|2
7901435|NCT01962103|12412314|FG007|Phase 2|Symptomatic Deterioration|2
7901436|NCT01962103|12412315|FG008|Phase 2|Symptomatic Deterioration|0
7901437|NCT01962207|12412339|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2
7901438|NCT01962207|12412340|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1
7901439|NCT01962207|12412341|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5
7901440|NCT01962207|12412342|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2
7901441|NCT01962207|12412339|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2
7901442|NCT01962207|12412340|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0
7901443|NCT01962207|12412341|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4
7901444|NCT01962207|12412342|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0
7901445|NCT01962207|12412339|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4
7901446|NCT01962207|12412340|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5
7901447|NCT01962207|12412341|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18
7901448|NCT01962207|12412342|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4
7901449|NCT01962207|12412339|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
7901450|NCT01962207|12412340|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
7901451|NCT01962207|12412341|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3
7901452|NCT01962207|12412342|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1
7901453|NCT01962207|12412339|FG000|Persistence Phase (5 Years)|Adverse Event|0
7901454|NCT01962207|12412340|FG001|Persistence Phase (5 Years)|Adverse Event|0
7901455|NCT01962207|12412341|FG002|Persistence Phase (5 Years)|Adverse Event|1
7901456|NCT01962207|12412342|FG003|Persistence Phase (5 Years)|Adverse Event|0
7901457|NCT01962207|12412339|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21
7901458|NCT01962207|12412340|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7
7901459|NCT01962207|12412341|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13
7901460|NCT01962207|12412342|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5
7901461|NCT01962298|12412361|FG000|Overall Study|Protocol Violation|1
7901462|NCT01962298|12412362|FG001|Overall Study|Protocol Violation|0
7901463|NCT01962298|12412363|FG002|Overall Study|Protocol Violation|1
7901464|NCT01962298|12412364|FG003|Overall Study|Protocol Violation|1
7901465|NCT01962298|12412365|FG004|Overall Study|Protocol Violation|0
7901466|NCT01962298|12412361|FG000|Overall Study|Data quality insufficient|2
7901467|NCT01962298|12412362|FG001|Overall Study|Data quality insufficient|0
7901468|NCT01962298|12412363|FG002|Overall Study|Data quality insufficient|3
7901469|NCT01962298|12412364|FG003|Overall Study|Data quality insufficient|1
7901470|NCT01962298|12412365|FG004|Overall Study|Data quality insufficient|4
7901471|NCT01962298|12412361|FG000|Overall Study|Insufficient data|0
7901472|NCT01962298|12412362|FG001|Overall Study|Insufficient data|2
7901473|NCT01962298|12412363|FG002|Overall Study|Insufficient data|1
7901474|NCT01962298|12412364|FG003|Overall Study|Insufficient data|0
7901475|NCT01962298|12412365|FG004|Overall Study|Insufficient data|1
7901476|NCT01962298|12412361|FG000|Overall Study|Incorrect data recorded|0
7901477|NCT01962298|12412362|FG001|Overall Study|Incorrect data recorded|1
7901478|NCT01962298|12412363|FG002|Overall Study|Incorrect data recorded|0
7901479|NCT01962298|12412364|FG003|Overall Study|Incorrect data recorded|0
7901480|NCT01962298|12412365|FG004|Overall Study|Incorrect data recorded|0
7901481|NCT01962298|12412361|FG000|Overall Study|Physician Decision|0
7901482|NCT01962298|12412362|FG001|Overall Study|Physician Decision|1
7901483|NCT01962298|12412363|FG002|Overall Study|Physician Decision|0
7901484|NCT01962298|12412364|FG003|Overall Study|Physician Decision|0
7901485|NCT01962298|12412365|FG004|Overall Study|Physician Decision|1
7901486|NCT01962441|12412389|FG000|Randomized Period|Randomized but Never Treated|4
7901487|NCT01962441|12412390|FG001|Randomized Period|Randomized but Never Treated|2
7901488|NCT01962441|12412391|FG002|Randomized Period|Randomized but Never Treated|3
7901489|NCT01962441|12412389|FG000|Randomized Period|Lost to Follow-up|2
7901490|NCT01962441|12412390|FG001|Randomized Period|Lost to Follow-up|4
7901491|NCT01962441|12412391|FG002|Randomized Period|Lost to Follow-up|4
7901492|NCT01962441|12412389|FG000|Randomized Period|Withdrew Consent|3
7901493|NCT01962441|12412390|FG001|Randomized Period|Withdrew Consent|3
7901494|NCT01962441|12412391|FG002|Randomized Period|Withdrew Consent|2
7901495|NCT01962441|12412389|FG000|Randomized Period|Adverse Event|1
7901496|NCT01962441|12412390|FG001|Randomized Period|Adverse Event|1
7901497|NCT01962441|12412391|FG002|Randomized Period|Adverse Event|0
7901498|NCT01962441|12412389|FG000|Randomized Period|Death|0
7901499|NCT01962441|12412390|FG001|Randomized Period|Death|0
7901500|NCT01962441|12412391|FG002|Randomized Period|Death|2
7901501|NCT01962441|12412389|FG000|Randomized Period|Protocol Violation|0
7901502|NCT01962441|12412390|FG001|Randomized Period|Protocol Violation|1
7901503|NCT01962441|12412391|FG002|Randomized Period|Protocol Violation|0
7901504|NCT01962441|12412389|FG000|Retreatment Substudy|Lack of Efficacy|1
7901505|NCT01962441|12412390|FG001|Retreatment Substudy|Lack of Efficacy|0
7901506|NCT01962441|12412391|FG002|Retreatment Substudy|Lack of Efficacy|0
7901507|NCT01962441|12412389|FG000|Retreatment Substudy|Lost to Follow-up|1
7901508|NCT01962441|12412390|FG001|Retreatment Substudy|Lost to Follow-up|0
7901509|NCT01962441|12412391|FG002|Retreatment Substudy|Lost to Follow-up|0
7901510|NCT01962493|12412402|FG000|Overall Study|Adverse Event|1
7901511|NCT01962493|12412403|FG001|Overall Study|Adverse Event|2
7901512|NCT01962493|12412402|FG000|Overall Study|Protocol Violation|0
7901513|NCT01962493|12412403|FG001|Overall Study|Protocol Violation|1
7901514|NCT01962493|12412402|FG000|Overall Study|Withdrawal by Subject|4
7901515|NCT01962493|12412403|FG001|Overall Study|Withdrawal by Subject|2
7901516|NCT01962896|12412445|FG000|Overall Study|Lack of Efficacy|4
7901517|NCT01962922|12412452|FG000|PK Portion Day 7|Withdrawal by Subject|3
7901518|NCT01962922|12412453|FG001|PK Portion Day 7|Withdrawal by Subject|0
7901519|NCT01962922|12412452|FG000|PK Portion Day 7|non-compliance|1
7901520|NCT01962922|12412453|FG001|PK Portion Day 7|non-compliance|0
7901521|NCT01962922|12412452|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
7901522|NCT01962922|12412453|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
7901523|NCT01962922|12412452|FG000|Extendion Portion (up to Month 6)|Physician Decision|1
7901524|NCT01962922|12412453|FG001|Extendion Portion (up to Month 6)|Physician Decision|0
7901525|NCT01962987|12412475|FG000|Overall Study|Adverse Event|4
7901526|NCT01962987|12412476|FG001|Overall Study|Adverse Event|4
7901527|NCT01962987|12412477|FG002|Overall Study|Adverse Event|0
7901528|NCT01962987|12412475|FG000|Overall Study|Lost to Follow-up|0
7901529|NCT01962987|12412476|FG001|Overall Study|Lost to Follow-up|0
7901530|NCT01962987|12412477|FG002|Overall Study|Lost to Follow-up|1
7901531|NCT01962987|12412475|FG000|Overall Study|Non compliance with dosing requirements|4
7901532|NCT01962987|12412476|FG001|Overall Study|Non compliance with dosing requirements|2
7901533|NCT01962987|12412477|FG002|Overall Study|Non compliance with dosing requirements|0
7901534|NCT01962987|12412475|FG000|Overall Study|Miscellaneous|1
7901535|NCT01962987|12412476|FG001|Overall Study|Miscellaneous|9
7901536|NCT01962987|12412477|FG002|Overall Study|Miscellaneous|2
7901537|NCT01962987|12412475|FG000|Overall Study|Restricted medication|5
7901538|NCT01962987|12412476|FG001|Overall Study|Restricted medication|1
7901539|NCT01962987|12412477|FG002|Overall Study|Restricted medication|1
7901540|NCT01962987|12412475|FG000|Overall Study|Serious Adverse Event|1
7901541|NCT01962987|12412476|FG001|Overall Study|Serious Adverse Event|0
7901542|NCT01962987|12412477|FG002|Overall Study|Serious Adverse Event|0
7901543|NCT01962987|12412475|FG000|Overall Study|Withdrawal by Subject|11
7901544|NCT01962987|12412476|FG001|Overall Study|Withdrawal by Subject|10
7901545|NCT01962987|12412477|FG002|Overall Study|Withdrawal by Subject|6
7901546|NCT01962987|12412475|FG000|Overall Study|Randomized in Error|4
7901547|NCT01962987|12412476|FG001|Overall Study|Randomized in Error|2
7901548|NCT01962987|12412477|FG002|Overall Study|Randomized in Error|2
7901549|NCT01963117|12412511|FG000|Overall Study|Death|1
7901550|NCT01963260|12412565|FG000|Overall Study|Withdrawal by Subject|2
7901551|NCT01963260|12412566|FG001|Overall Study|Withdrawal by Subject|0
7901552|NCT01963260|12412567|FG002|Overall Study|Withdrawal by Subject|0
7901553|NCT01963260|12412568|FG003|Overall Study|Withdrawal by Subject|1
7901554|NCT01963260|12412569|FG004|Overall Study|Withdrawal by Subject|2
7901555|NCT01963260|12412570|FG005|Overall Study|Withdrawal by Subject|0
7901556|NCT01963260|12412571|FG006|Overall Study|Withdrawal by Subject|0
7901557|NCT01963260|12412572|FG007|Overall Study|Withdrawal by Subject|0
7901558|NCT01963260|12412573|FG008|Overall Study|Withdrawal by Subject|0
7901559|NCT01963260|12412574|FG009|Overall Study|Withdrawal by Subject|0
7901560|NCT01963403|12412605|FG000|Overall Study|Lost to Follow-up|2
7901561|NCT01963403|12412606|FG001|Overall Study|Lost to Follow-up|3
7901562|NCT01963403|12412605|FG000|Overall Study|Implant removal|0
7901563|NCT01963403|12412606|FG001|Overall Study|Implant removal|1
7901564|NCT01963611|12412623|FG000|Overall Study|Adverse Event|1
7901565|NCT01963611|12412624|FG001|Overall Study|Adverse Event|1
7901566|NCT01963611|12412625|FG002|Overall Study|Adverse Event|3
7901567|NCT01963611|12412626|FG003|Overall Study|Adverse Event|4
7901568|NCT01963611|12412627|FG004|Overall Study|Adverse Event|3
7901569|NCT01963611|12412623|FG000|Overall Study|Protocol Violation|0
7901570|NCT01963611|12412624|FG001|Overall Study|Protocol Violation|0
7901571|NCT01963611|12412625|FG002|Overall Study|Protocol Violation|0
7901572|NCT01963611|12412626|FG003|Overall Study|Protocol Violation|1
7901573|NCT01963611|12412627|FG004|Overall Study|Protocol Violation|0
7901574|NCT01963611|12412623|FG000|Overall Study|Lack of Efficacy|0
7901575|NCT01963611|12412624|FG001|Overall Study|Lack of Efficacy|0
7901576|NCT01963611|12412625|FG002|Overall Study|Lack of Efficacy|0
7901577|NCT01963611|12412626|FG003|Overall Study|Lack of Efficacy|1
7901578|NCT01963611|12412627|FG004|Overall Study|Lack of Efficacy|0
7901579|NCT01963611|12412623|FG000|Overall Study|Withdrawal by Subject|3
7901580|NCT01963611|12412624|FG001|Overall Study|Withdrawal by Subject|2
7901581|NCT01963611|12412625|FG002|Overall Study|Withdrawal by Subject|1
7901582|NCT01963611|12412626|FG003|Overall Study|Withdrawal by Subject|1
7901583|NCT01963611|12412627|FG004|Overall Study|Withdrawal by Subject|3
7901584|NCT01963611|12412623|FG000|Overall Study|Other|47
7901585|NCT01963611|12412624|FG001|Overall Study|Other|46
7901586|NCT01963611|12412625|FG002|Overall Study|Other|48
7901587|NCT01963611|12412626|FG003|Overall Study|Other|45
7901588|NCT01963611|12412627|FG004|Overall Study|Other|45
7901589|NCT01963676|12412642|FG000|Overall Study|Withdrawal by Subject|1
7901590|NCT01963676|12412643|FG001|Overall Study|Withdrawal by Subject|0
7901591|NCT01963767|12412651|FG000|Overall Study|Withdrawal by Subject|4
7901592|NCT01963767|12412652|FG001|Overall Study|Withdrawal by Subject|2
7901593|NCT01963767|12412651|FG000|Overall Study|Adverse Event|2
7901594|NCT01963767|12412652|FG001|Overall Study|Adverse Event|0
7901595|NCT01964105|12412710|FG000|Overall Study|Lost to Follow-up|2
7901596|NCT01964105|12412711|FG001|Overall Study|Lost to Follow-up|13
7901597|NCT01964105|12412712|FG002|Overall Study|Lost to Follow-up|0
7901598|NCT01964222|12412722|FG000|Overall Study|Lost to Follow-up|7
7901599|NCT01964222|12412723|FG001|Overall Study|Lost to Follow-up|5
7901600|NCT01964222|12412722|FG000|Overall Study|Withdrawal by Subject|6
7901601|NCT01964222|12412723|FG001|Overall Study|Withdrawal by Subject|6
7901602|NCT01964222|12412722|FG000|Overall Study|Screening Failure|2
7901603|NCT01964222|12412723|FG001|Overall Study|Screening Failure|0
7901604|NCT01964300|12412731|FG000|Overall Study|Ineligible after enrollment|0
7901605|NCT01964300|12412732|FG001|Overall Study|Ineligible after enrollment|1
7901606|NCT01964300|12412731|FG000|Overall Study|Adverse Event|1
7901607|NCT01964300|12412732|FG001|Overall Study|Adverse Event|1
7901608|NCT01964300|12412731|FG000|Overall Study|Lack of Efficacy|3
7901609|NCT01964300|12412732|FG001|Overall Study|Lack of Efficacy|5
7901610|NCT01964300|12412731|FG000|Overall Study|Withdrawal by Subject|0
7901611|NCT01964300|12412732|FG001|Overall Study|Withdrawal by Subject|1
7901612|NCT01964300|12412731|FG000|Overall Study|To receive alternative therapy|1
7901613|NCT01964300|12412732|FG001|Overall Study|To receive alternative therapy|2
7901614|NCT01964300|12412731|FG000|Overall Study|Enlargement of cyst requiring drainage|1
7901615|NCT01964300|12412732|FG001|Overall Study|Enlargement of cyst requiring drainage|0
7901616|NCT01964300|12412731|FG000|Overall Study|Weight criteria not met|0
7901617|NCT01964300|12412732|FG001|Overall Study|Weight criteria not met|1
7901618|NCT01964326|12412738|FG000|Overall Study|Adverse Event|48
7901619|NCT01964326|12412738|FG000|Overall Study|Death|2
7901620|NCT01964326|12412738|FG000|Overall Study|Protocol Violation|4
7901621|NCT01964326|12412738|FG000|Overall Study|Lost to Follow-up|88
7901622|NCT01964326|12412738|FG000|Overall Study|Withdrawal by Subject|87
7901623|NCT01964326|12412738|FG000|Overall Study|Pregnancy|1
7901624|NCT01964326|12412738|FG000|Overall Study|No Longer Meets Eligibility Criteria|1
7901625|NCT01964326|12412738|FG000|Overall Study|Physician Decision|55
7901626|NCT01964326|12412738|FG000|Overall Study|Investigator Discretion|1
7901627|NCT01964326|12412738|FG000|Overall Study|Other|9
7901628|NCT01964326|12412738|FG000|Overall Study|Did not meet eligibility criteria|1
7901629|NCT01964352|12412746|FG000|Overall Study|Adverse Event|13
7901630|NCT01964352|12412747|FG001|Overall Study|Adverse Event|3
7901631|NCT01964352|12412748|FG002|Overall Study|Adverse Event|4
7901632|NCT01964352|12412749|FG003|Overall Study|Adverse Event|3
7901633|NCT01964352|12412746|FG000|Overall Study|Lack of Efficacy|6
7901634|NCT01964352|12412747|FG001|Overall Study|Lack of Efficacy|0
7901635|NCT01964352|12412748|FG002|Overall Study|Lack of Efficacy|0
7901636|NCT01964352|12412749|FG003|Overall Study|Lack of Efficacy|0
7901637|NCT01964352|12412746|FG000|Overall Study|Protocol Violation|2
7901638|NCT01964352|12412747|FG001|Overall Study|Protocol Violation|4
7901639|NCT01964352|12412748|FG002|Overall Study|Protocol Violation|0
7901640|NCT01964352|12412749|FG003|Overall Study|Protocol Violation|2
7901641|NCT01964352|12412746|FG000|Overall Study|Lost to Follow-up|1
7901642|NCT01964352|12412747|FG001|Overall Study|Lost to Follow-up|0
7901643|NCT01964352|12412748|FG002|Overall Study|Lost to Follow-up|0
7901644|NCT01964352|12412749|FG003|Overall Study|Lost to Follow-up|1
7901645|NCT01964352|12412746|FG000|Overall Study|Withdrawal by Subject|4
7901646|NCT01964352|12412747|FG001|Overall Study|Withdrawal by Subject|2
7901647|NCT01964352|12412748|FG002|Overall Study|Withdrawal by Subject|1
7901648|NCT01964352|12412749|FG003|Overall Study|Withdrawal by Subject|0
7901649|NCT01964352|12412746|FG000|Overall Study|Other than stated above|0
7901650|NCT01964352|12412747|FG001|Overall Study|Other than stated above|2
7901651|NCT01964352|12412748|FG002|Overall Study|Other than stated above|1
7901652|NCT01964352|12412749|FG003|Overall Study|Other than stated above|2
7901653|NCT01964378|12412761|FG000|Overall Study|Disc. due to death before first dosing|0
7901654|NCT01964378|12412762|FG001|Overall Study|Disc. due to death before first dosing|1
7901655|NCT01964378|12412761|FG000|Overall Study|Disc. due to AE before first dosing|1
7901656|NCT01964378|12412762|FG001|Overall Study|Disc. due to AE before first dosing|0
7901657|NCT01964378|12412761|FG000|Overall Study|Death|3
7901658|NCT01964378|12412762|FG001|Overall Study|Death|2
7901659|NCT01964378|12412761|FG000|Overall Study|Adverse Event|12
7901660|NCT01964378|12412762|FG001|Overall Study|Adverse Event|5
7901661|NCT01964378|12412761|FG000|Overall Study|Lack of Efficacy|0
7901662|NCT01964378|12412762|FG001|Overall Study|Lack of Efficacy|1
7901663|NCT01964378|12412761|FG000|Overall Study|Protocol Violation|0
7901664|NCT01964378|12412762|FG001|Overall Study|Protocol Violation|1
7901665|NCT01964378|12412761|FG000|Overall Study|Lost to Follow-up|0
7901666|NCT01964378|12412762|FG001|Overall Study|Lost to Follow-up|1
7901667|NCT01964378|12412761|FG000|Overall Study|Withdrawal by Subject|7
7901668|NCT01964378|12412762|FG001|Overall Study|Withdrawal by Subject|5
7901669|NCT01964378|12412761|FG000|Overall Study|Inclusion/exclusion criteria not met|1
7901670|NCT01964378|12412762|FG001|Overall Study|Inclusion/exclusion criteria not met|3
7901671|NCT01964378|12412761|FG000|Overall Study|Other|1
7901672|NCT01964378|12412762|FG001|Overall Study|Other|2
7901673|NCT01964521|12412768|FG000|Overall Study|Lost to Follow-up|4
7901674|NCT01964547|12412775|FG000|Overall Study|Adverse Event|8
7901675|NCT01964547|12412776|FG001|Overall Study|Adverse Event|2
7901676|NCT01964547|12412775|FG000|Overall Study|Withdrawal by Subject|4
7901677|NCT01964547|12412776|FG001|Overall Study|Withdrawal by Subject|7
7901678|NCT01964547|12412775|FG000|Overall Study|Lost to Follow-up|0
7901679|NCT01964547|12412776|FG001|Overall Study|Lost to Follow-up|1
7901680|NCT01964547|12412775|FG000|Overall Study|Withdrawal by Investigator|0
7901681|NCT01964547|12412776|FG001|Overall Study|Withdrawal by Investigator|1
7901682|NCT01964716|12412784|FG000|Overall Study|Withdrawal by Subject|2
7901683|NCT01964716|12412785|FG001|Overall Study|Withdrawal by Subject|3
7901684|NCT01964716|12412784|FG000|Overall Study|Lost to Follow-up|1
7901685|NCT01964716|12412785|FG001|Overall Study|Lost to Follow-up|2
7901686|NCT01964716|12412784|FG000|Overall Study|No longer met eligibility criteria|1
7901687|NCT01964716|12412785|FG001|Overall Study|No longer met eligibility criteria|1
7901688|NCT01964716|12412784|FG000|Overall Study|Death|1
7901689|NCT01964716|12412785|FG001|Overall Study|Death|0
7901690|NCT01964755|12412799|FG000|Overall Study|Death|2
7901691|NCT01964898|12412805|FG000|Overall Study|ineligible post-randomization|1
7901692|NCT01964898|12412806|FG001|Overall Study|ineligible post-randomization|1
7901693|NCT01964898|12412805|FG000|Overall Study|did not receive the allocated interventi|2
7901694|NCT01964898|12412806|FG001|Overall Study|did not receive the allocated interventi|1
7901695|NCT01964898|12412805|FG000|Overall Study|Lost to Follow-up|3
7901696|NCT01964898|12412806|FG001|Overall Study|Lost to Follow-up|5
7901697|NCT01964898|12412805|FG000|Overall Study|Withdrawal by Subject|1
7901698|NCT01964898|12412806|FG001|Overall Study|Withdrawal by Subject|0
7901699|NCT01964924|12412812|FG000|Trametinib Monotherapy|Progression|19
7901700|NCT01964924|12412813|FG001|Trametinib Monotherapy|Progression|0
7901701|NCT01964950|12412824|FG000|Overall Study|Protocol Violation|25
7901702|NCT01964963|12412831|FG000|Overall Study|Case Report Forms Uncollected|888
7901703|NCT01964963|12412831|FG000|Overall Study|Protocol Deviation|50
7901704|NCT01964963|12412831|FG000|Overall Study|Data Reliability was not Assured|5
7901705|NCT01964976|12412837|FG000|Overall Study|Protocol Violation|31
7901706|NCT01965158|12412861|FG000|Overall Study|Adverse Event|14
7901707|NCT01965158|12412862|FG001|Overall Study|Adverse Event|5
7901708|NCT01965158|12412861|FG000|Overall Study|Withdrawal by Subject|16
7901709|NCT01965158|12412862|FG001|Overall Study|Withdrawal by Subject|24
7901710|NCT01965158|12412861|FG000|Overall Study|Lost to Follow-up|7
7901711|NCT01965158|12412862|FG001|Overall Study|Lost to Follow-up|5
7901712|NCT01965158|12412861|FG000|Overall Study|Protocol Violation|1
7901713|NCT01965158|12412862|FG001|Overall Study|Protocol Violation|1
7901714|NCT01965158|12412861|FG000|Overall Study|Other - Miscellaneous|3
7901715|NCT01965158|12412862|FG001|Overall Study|Other - Miscellaneous|0
7901716|NCT01965262|12412868|FG000|Second Intervention (7 Days)|Discontinued|0
7901717|NCT01965262|12412869|FG001|Second Intervention (7 Days)|Discontinued|1
7901718|NCT01965262|12412868|FG000|Second Intervention (7 Days)|Poor lens fit|0
7901719|NCT01965262|12412869|FG001|Second Intervention (7 Days)|Poor lens fit|9
7901720|NCT01965262|12412868|FG000|Second Intervention (7 Days)|Poor visual acuity|1
7901721|NCT01965262|12412869|FG001|Second Intervention (7 Days)|Poor visual acuity|0
7901722|NCT01965327|12412896|FG000|Overall Study|Physician Decision|2
7901723|NCT01965431|12412909|FG000|Overall Study|Adverse Event|0
7901724|NCT01965431|12412910|FG001|Overall Study|Adverse Event|1
7901725|NCT01965431|12412911|FG002|Overall Study|Adverse Event|0
7901726|NCT01965431|12412912|FG003|Overall Study|Adverse Event|0
7901727|NCT01965431|12412913|FG004|Overall Study|Adverse Event|0
7901728|NCT01965431|12412914|FG005|Overall Study|Adverse Event|0
7901729|NCT01965431|12412909|FG000|Overall Study|Other than stated above|6
7901730|NCT01965431|12412910|FG001|Overall Study|Other than stated above|5
7901731|NCT01965431|12412911|FG002|Overall Study|Other than stated above|6
7901732|NCT01965431|12412912|FG003|Overall Study|Other than stated above|6
7901733|NCT01965431|12412913|FG004|Overall Study|Other than stated above|6
7901734|NCT01965431|12412914|FG005|Overall Study|Other than stated above|6
7901735|NCT01965535|12412926|FG000|Overall Study|Lack of Efficacy|2
7901736|NCT01965535|12412927|FG001|Overall Study|Lack of Efficacy|1
7901737|NCT01965600|12412940|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
7901738|NCT01965600|12412941|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
7901739|NCT01965600|12412942|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
7901740|NCT01965600|12412943|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
7901741|NCT01965600|12412940|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
7901742|NCT01965600|12412941|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
7901743|NCT01965600|12412942|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
7901744|NCT01965600|12412943|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
7901745|NCT01965600|12412940|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
7901746|NCT01965600|12412941|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
7901747|NCT01965600|12412942|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
7901748|NCT01965600|12412943|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
7968825|NCT02786901|12526952|FG001|Overall Study|Randomized in error|0
7968826|NCT02786901|12526953|FG002|Overall Study|Randomized in error|1
7968827|NCT02786927|12526961|FG000|Overall Study|Adverse Event|1
7968828|NCT02786927|12526961|FG000|Overall Study|Protocol Violation|4
7968829|NCT02786953|12526968|FG000|Overall Study|Withdrawal by Subject|3
7968830|NCT02786953|12526969|FG001|Overall Study|Withdrawal by Subject|0
7968831|NCT02786953|12526968|FG000|Overall Study|Physician Decision|0
7968832|NCT02786953|12526969|FG001|Overall Study|Physician Decision|1
7968833|NCT02787083|12526986|FG000|Overall Study|Adverse Event|1
7968834|NCT02787083|12526987|FG001|Overall Study|Adverse Event|0
7968835|NCT02787083|12526986|FG000|Overall Study|Withdrawal by Subject|2
7968836|NCT02787083|12526987|FG001|Overall Study|Withdrawal by Subject|2
7968837|NCT02787304|12527001|FG000|Overall Study|Adverse Event|9
7968838|NCT02787304|12527002|FG001|Overall Study|Adverse Event|3
7968839|NCT02787304|12527003|FG002|Overall Study|Adverse Event|8
7968840|NCT02787304|12527004|FG003|Overall Study|Adverse Event|1
7968841|NCT02787304|12527001|FG000|Overall Study|Withdrawal by Subject|1
7968842|NCT02787304|12527002|FG001|Overall Study|Withdrawal by Subject|4
7968843|NCT02787304|12527003|FG002|Overall Study|Withdrawal by Subject|0
7968844|NCT02787304|12527004|FG003|Overall Study|Withdrawal by Subject|0
7968845|NCT02787304|12527001|FG000|Overall Study|Lost to Follow-up|1
7968846|NCT02787304|12527002|FG001|Overall Study|Lost to Follow-up|0
7968847|NCT02787304|12527003|FG002|Overall Study|Lost to Follow-up|0
7968848|NCT02787304|12527004|FG003|Overall Study|Lost to Follow-up|1
7968849|NCT02787304|12527001|FG000|Overall Study|Noncompliance with study drug|0
7968850|NCT02787304|12527002|FG001|Overall Study|Noncompliance with study drug|0
7968851|NCT02787304|12527003|FG002|Overall Study|Noncompliance with study drug|1
7968852|NCT02787304|12527004|FG003|Overall Study|Noncompliance with study drug|0
7968853|NCT02787304|12527001|FG000|Overall Study|Physician Decision|0
7968854|NCT02787304|12527002|FG001|Overall Study|Physician Decision|0
7968855|NCT02787304|12527003|FG002|Overall Study|Physician Decision|1
7968856|NCT02787304|12527004|FG003|Overall Study|Physician Decision|0
7968857|NCT02787304|12527001|FG000|Overall Study|Study terminated by sponsor|25
7968858|NCT02787304|12527002|FG001|Overall Study|Study terminated by sponsor|31
7968859|NCT02787304|12527003|FG002|Overall Study|Study terminated by sponsor|31
7968860|NCT02787304|12527004|FG003|Overall Study|Study terminated by sponsor|32
7968861|NCT02787863|12527048|FG000|Overall Study|Death|1
7968862|NCT02787863|12527049|FG001|Overall Study|Death|0
7968863|NCT02787863|12527050|FG002|Overall Study|Death|1
7968864|NCT02787863|12527051|FG003|Overall Study|Death|0
7968865|NCT02787863|12527052|FG004|Overall Study|Death|0
7968866|NCT02787863|12527053|FG005|Overall Study|Death|0
7968867|NCT02787863|12527054|FG006|Overall Study|Death|0
7968868|NCT02787863|12527055|FG007|Overall Study|Death|0
7968869|NCT02787863|12527048|FG000|Overall Study|Withdrawal by Subject|0
7968870|NCT02787863|12527049|FG001|Overall Study|Withdrawal by Subject|1
7968871|NCT02787863|12527050|FG002|Overall Study|Withdrawal by Subject|1
7968872|NCT02787863|12527051|FG003|Overall Study|Withdrawal by Subject|0
7968873|NCT02787863|12527052|FG004|Overall Study|Withdrawal by Subject|0
7968874|NCT02787863|12527053|FG005|Overall Study|Withdrawal by Subject|0
7968875|NCT02787863|12527054|FG006|Overall Study|Withdrawal by Subject|0
7968876|NCT02787863|12527055|FG007|Overall Study|Withdrawal by Subject|0
7968877|NCT02788175|12527114|FG000|Overall Study|Protocol Violation|3
7968878|NCT02788175|12527114|FG000|Overall Study|Withdrawal by Subject|4
7968879|NCT02788175|12527114|FG000|Overall Study|Ineligible prior to study agent|6
7968880|NCT02788201|12527153|FG000|Overall Study|Death|1
7968881|NCT02788201|12527154|FG001|Overall Study|Death|1
7968882|NCT02788201|12527155|FG002|Overall Study|Death|1
7968883|NCT02788201|12527156|FG003|Overall Study|Death|1
7968884|NCT02788201|12527157|FG004|Overall Study|Death|0
7968885|NCT02788201|12527158|FG005|Overall Study|Death|1
7968886|NCT02788201|12527153|FG000|Overall Study|Ineligible|0
7968887|NCT02788201|12527154|FG001|Overall Study|Ineligible|0
7968888|NCT02788201|12527155|FG002|Overall Study|Ineligible|0
7968889|NCT02788201|12527156|FG003|Overall Study|Ineligible|0
7968890|NCT02788201|12527157|FG004|Overall Study|Ineligible|0
7968891|NCT02788201|12527158|FG005|Overall Study|Ineligible|1
7968892|NCT02788201|12527153|FG000|Overall Study|Withdrawal by Subject|0
7968893|NCT02788201|12527154|FG001|Overall Study|Withdrawal by Subject|0
7968894|NCT02788201|12527155|FG002|Overall Study|Withdrawal by Subject|0
7968895|NCT02788201|12527156|FG003|Overall Study|Withdrawal by Subject|0
7968896|NCT02788201|12527157|FG004|Overall Study|Withdrawal by Subject|0
7968897|NCT02788201|12527158|FG005|Overall Study|Withdrawal by Subject|1
7968898|NCT02788279|12527177|FG000|Overall Study|Death|62
7968899|NCT02788279|12527178|FG001|Overall Study|Death|136
7968900|NCT02788279|12527179|FG002|Overall Study|Death|72
7968901|NCT02788279|12527177|FG000|Overall Study|Withdrawal by Subject|10
7901749|NCT01965600|12412940|FG000|Washout Period of Approximately 15 Days|Adverse Event|0
7901750|NCT01965600|12412941|FG001|Washout Period of Approximately 15 Days|Adverse Event|0
7901751|NCT01965600|12412942|FG002|Washout Period of Approximately 15 Days|Adverse Event|0
7901752|NCT01965600|12412943|FG003|Washout Period of Approximately 15 Days|Adverse Event|1
7901753|NCT01965600|12412940|FG000|Second Intervention|Study terminated by Sponsor|0
7901754|NCT01965600|12412941|FG001|Second Intervention|Study terminated by Sponsor|0
7901755|NCT01965600|12412942|FG002|Second Intervention|Study terminated by Sponsor|2
7901756|NCT01965600|12412943|FG003|Second Intervention|Study terminated by Sponsor|2
7901757|NCT01965652|12412953|FG000|Overall Study|Adverse Event|40
7901758|NCT01965652|12412954|FG001|Overall Study|Adverse Event|37
7901759|NCT01965652|12412953|FG000|Overall Study|Withdrawal by Subject|62
7901760|NCT01965652|12412954|FG001|Overall Study|Withdrawal by Subject|69
7901761|NCT01965652|12412953|FG000|Overall Study|Lost to Follow-up|53
7901762|NCT01965652|12412954|FG001|Overall Study|Lost to Follow-up|40
7901763|NCT01965652|12412953|FG000|Overall Study|Protocol Violation|34
7901764|NCT01965652|12412954|FG001|Overall Study|Protocol Violation|38
7901765|NCT01965652|12412953|FG000|Overall Study|Death|3
7901766|NCT01965652|12412954|FG001|Overall Study|Death|4
7901767|NCT01965652|12412953|FG000|Overall Study|Other - Miscellaneous|18
7901768|NCT01965652|12412954|FG001|Overall Study|Other - Miscellaneous|21
7901769|NCT01965652|12412953|FG000|Overall Study|Pregnancy|0
7901770|NCT01965652|12412954|FG001|Overall Study|Pregnancy|1
7901771|NCT01965834|12412977|FG000|Overall Study|Lack of Efficacy|4
7963658|NCT02725411|12518225|FG001|Follow-up Period (24 Weeks)|Other|4
7963659|NCT02725411|12518226|FG002|Follow-up Period (24 Weeks)|Other|2
7963660|NCT02725411|12518224|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
7963661|NCT02725411|12518225|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
7963662|NCT02725411|12518226|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
7963663|NCT02725476|12518236|FG000|Overall Study|Physician Decision|2
7963664|NCT02725476|12518237|FG001|Overall Study|Physician Decision|0
7963665|NCT02725476|12518236|FG000|Overall Study|Adverse Event|1
7963666|NCT02725476|12518237|FG001|Overall Study|Adverse Event|1
7963667|NCT02725515|12518245|FG000|Overall Study|Refused infusion (no study treatment)|1
7963668|NCT02725515|12518246|FG001|Overall Study|Refused infusion (no study treatment)|0
7963669|NCT02725515|12518245|FG000|Overall Study|Loss of Improvement per Protocol|14
7963670|NCT02725515|12518246|FG001|Overall Study|Loss of Improvement per Protocol|25
7963671|NCT02725515|12518245|FG000|Overall Study|Withdrawal by Subject|2
7963672|NCT02725515|12518246|FG001|Overall Study|Withdrawal by Subject|1
7963673|NCT02725515|12518245|FG000|Overall Study|Non-Compliance With Study Drug|0
7963674|NCT02725515|12518246|FG001|Overall Study|Non-Compliance With Study Drug|3
7963675|NCT02725515|12518245|FG000|Overall Study|Lost to Follow-up|1
7963676|NCT02725515|12518246|FG001|Overall Study|Lost to Follow-up|1
7963677|NCT02725515|12518245|FG000|Overall Study|Adverse Event|7
7963678|NCT02725515|12518246|FG001|Overall Study|Adverse Event|2
7963679|NCT02725515|12518245|FG000|Overall Study|No Documented Disease Improvement|0
7963680|NCT02725515|12518246|FG001|Overall Study|No Documented Disease Improvement|1
7963681|NCT02725515|12518245|FG000|Overall Study|Completed Study Under Original Protocol|0
7963682|NCT02725515|12518246|FG001|Overall Study|Completed Study Under Original Protocol|1
7963683|NCT02725515|12518245|FG000|Overall Study|Lack of Response|0
7963684|NCT02725515|12518246|FG001|Overall Study|Lack of Response|1
7963685|NCT02725710|12518258|FG000|Overall Study|Lost to Follow-up|1
7963686|NCT02725710|12518259|FG001|Overall Study|Lost to Follow-up|0
7963687|NCT02725788|12518267|FG000|Overall Study|Lost to Follow-up|1
7963688|NCT02725788|12518268|FG001|Overall Study|Lost to Follow-up|1
7963689|NCT02725788|12518267|FG000|Overall Study|Protocol Violation|0
7963690|NCT02725788|12518268|FG001|Overall Study|Protocol Violation|1
7963691|NCT02725866|12518283|FG000|Overall Study|Failure to return|6
7963692|NCT02725866|12518283|FG000|Overall Study|Withdrew consent|3
7963693|NCT02725866|12518283|FG000|Overall Study|Insufficient virological response|1
7963694|NCT02725866|12518283|FG000|Overall Study|Other, not specified|4
7963695|NCT02726022|12518287|FG000|Overall Study|Adverse Event|14
7963696|NCT02726022|12518287|FG000|Overall Study|Treatment Failure|8
7963697|NCT02726022|12518287|FG000|Overall Study|Poor Compliance|13
7963698|NCT02726022|12518287|FG000|Overall Study|Treatment Failure and Poor Compliance|1
7963699|NCT02726074|12518291|FG000|Overall Study|Withdrawal by Subject|4
7963700|NCT02726074|12518291|FG000|Overall Study|Adverse Event|14
7963701|NCT02726074|12518291|FG000|Overall Study|Protocol Violation|3
7963702|NCT02726074|12518291|FG000|Overall Study|Lost to Follow-up|2
7963703|NCT02726074|12518291|FG000|Overall Study|Others|3
7963704|NCT02726113|12518297|FG000|Total Enrollment|Physician Decision|0
7963705|NCT02726113|12518298|FG001|Total Enrollment|Physician Decision|1
7963706|NCT02726113|12518297|FG000|Total Enrollment|Protocol Violation|1
7968902|NCT02788279|12527178|FG001|Overall Study|Withdrawal by Subject|15
7901772|NCT01965860|12412984|FG000|Overall Study|Pregnancy|1
7901773|NCT01965860|12412985|FG001|Overall Study|Pregnancy|0
7901774|NCT01965860|12412986|FG002|Overall Study|Pregnancy|1
7901775|NCT01965860|12412984|FG000|Overall Study|Logistics|1
7901776|NCT01965860|12412985|FG001|Overall Study|Logistics|0
7901777|NCT01965860|12412986|FG002|Overall Study|Logistics|0
7901778|NCT01965938|12413001|FG000|Overall Study|Withdrawal by Subject|1
7901779|NCT01965938|12413002|FG001|Overall Study|Withdrawal by Subject|0
7901780|NCT01966003|12413012|FG000|Overall Study|Death|43
7901781|NCT01966003|12413013|FG001|Overall Study|Death|36
7901782|NCT01966003|12413012|FG000|Overall Study|Protocol Violation|6
7901783|NCT01966003|12413013|FG001|Overall Study|Protocol Violation|4
7901784|NCT01966003|12413012|FG000|Overall Study|Lost to Follow-up|4
7901785|NCT01966003|12413013|FG001|Overall Study|Lost to Follow-up|3
7901786|NCT01966003|12413012|FG000|Overall Study|Physician Decision|12
7901787|NCT01966003|12413013|FG001|Overall Study|Physician Decision|13
7901788|NCT01966003|12413012|FG000|Overall Study|Withdrawal by Subject|29
7901789|NCT01966003|12413013|FG001|Overall Study|Withdrawal by Subject|19
7901790|NCT01966003|12413012|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131
7901791|NCT01966003|12413013|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127
7901792|NCT01966003|12413012|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44
7901793|NCT01966003|12413013|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67
7901794|NCT01966003|12413012|FG000|Overall Study|Other|1
7901795|NCT01966003|12413013|FG001|Overall Study|Other|1
7901796|NCT01966042|12413019|FG000|Overall Study|Death|2
7901797|NCT01966068|12413025|FG000|Overall Study|Withdrawal by Subject|57
7901798|NCT01966068|12413025|FG000|Overall Study|Lost to Follow-up|81
7901799|NCT01966107|12413032|FG000|Overall Study|excluded from FAS|21
7901800|NCT01966107|12413033|FG001|Overall Study|excluded from FAS|20
7901801|NCT01966107|12413032|FG000|Overall Study|discontinued treatment|345
7901802|NCT01966107|12413033|FG001|Overall Study|discontinued treatment|372
7901803|NCT01966107|12413032|FG000|Overall Study|due to study closure|164
7901804|NCT01966107|12413033|FG001|Overall Study|due to study closure|186
7901805|NCT01966107|12413032|FG000|Overall Study|withdrew from the study|272
7901806|NCT01966107|12413033|FG001|Overall Study|withdrew from the study|303
7901807|NCT01966120|12413041|FG000|Overall Study|Withdrawal by Subject|0
7901808|NCT01966120|12413042|FG001|Overall Study|Withdrawal by Subject|5
7901809|NCT01966120|12413041|FG000|Overall Study|Lost to Follow-up|1
7901810|NCT01966120|12413042|FG001|Overall Study|Lost to Follow-up|1
7901811|NCT01966432|12413089|FG000|Overall Study|Lost to Follow-up|3
7901812|NCT01966432|12413090|FG001|Overall Study|Lost to Follow-up|2
7901813|NCT01966432|12413091|FG002|Overall Study|Lost to Follow-up|5
7901814|NCT01966432|12413089|FG000|Overall Study|Withdrawal by Subject|1
7901815|NCT01966432|12413090|FG001|Overall Study|Withdrawal by Subject|3
7901816|NCT01966432|12413091|FG002|Overall Study|Withdrawal by Subject|0
7901817|NCT01966432|12413089|FG000|Overall Study|Subject Incarcerated|0
7901818|NCT01966432|12413090|FG001|Overall Study|Subject Incarcerated|0
7901819|NCT01966432|12413091|FG002|Overall Study|Subject Incarcerated|1
7901820|NCT01966432|12413089|FG000|Overall Study|SBIRT program ended|1
7901821|NCT01966432|12413090|FG001|Overall Study|SBIRT program ended|8
7901822|NCT01966432|12413091|FG002|Overall Study|SBIRT program ended|20
7901823|NCT01966445|12413107|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7901824|NCT01966445|12413108|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7901825|NCT01966445|12413109|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7901826|NCT01966445|12413110|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2
7901827|NCT01966445|12413111|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7901828|NCT01966445|12413112|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1
7901829|NCT01966445|12413113|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7901830|NCT01966445|12413107|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7901831|NCT01966445|12413108|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
7901832|NCT01966445|12413109|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7901833|NCT01966445|12413110|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
7901834|NCT01966445|12413111|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
7901835|NCT01966445|12413112|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7901836|NCT01966445|12413113|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7901837|NCT01966445|12413107|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7901838|NCT01966445|12413108|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
7901839|NCT01966445|12413109|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
7901840|NCT01966445|12413110|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7901841|NCT01966445|12413111|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2
7901842|NCT01966445|12413112|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7901843|NCT01966445|12413113|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7901844|NCT01966445|12413107|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7901845|NCT01966445|12413108|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7901846|NCT01966445|12413109|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7901847|NCT01966445|12413110|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7901848|NCT01966445|12413111|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7901849|NCT01966445|12413112|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7963707|NCT02726113|12518298|FG001|Total Enrollment|Protocol Violation|0
7901850|NCT01966445|12413113|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3
7901851|NCT01966445|12413107|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7901852|NCT01966445|12413108|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7901853|NCT01966445|12413109|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7901854|NCT01966445|12413110|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7901855|NCT01966445|12413111|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7901856|NCT01966445|12413112|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7901857|NCT01966445|12413113|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2
7901858|NCT01967069|12413232|FG000|Overall Study|Adverse Event|2
7901859|NCT01967069|12413233|FG001|Overall Study|Adverse Event|2
7901860|NCT01967069|12413232|FG000|Overall Study|Lost to Follow-up|5
7901861|NCT01967069|12413233|FG001|Overall Study|Lost to Follow-up|2
7901862|NCT01967069|12413232|FG000|Overall Study|Withdrawal by Subject|1
7901863|NCT01967069|12413233|FG001|Overall Study|Withdrawal by Subject|3
7901864|NCT01967069|12413232|FG000|Overall Study|Lack of Efficacy|0
7901865|NCT01967069|12413233|FG001|Overall Study|Lack of Efficacy|1
7901866|NCT01967134|12413255|FG000|Overall Study|Lost to Follow-up|0
7901867|NCT01967134|12413256|FG001|Overall Study|Lost to Follow-up|1
7901868|NCT01967134|12413257|FG002|Overall Study|Lost to Follow-up|0
7901869|NCT01967147|12413267|FG000|Overall Study|Adverse Event|5
7901870|NCT01967147|12413268|FG001|Overall Study|Adverse Event|2
7901871|NCT01967147|12413267|FG000|Overall Study|Lack of Efficacy|1
7901872|NCT01967147|12413268|FG001|Overall Study|Lack of Efficacy|4
7901873|NCT01967147|12413267|FG000|Overall Study|Lost to Follow-up|1
7901874|NCT01967147|12413268|FG001|Overall Study|Lost to Follow-up|2
7901875|NCT01967147|12413267|FG000|Overall Study|Withdrawal by Subject|2
7901876|NCT01967147|12413268|FG001|Overall Study|Withdrawal by Subject|4
7901877|NCT01967147|12413267|FG000|Overall Study|Non-compliance with Study Drug|0
7901878|NCT01967147|12413268|FG001|Overall Study|Non-compliance with Study Drug|3
7901879|NCT01967147|12413267|FG000|Overall Study|Other|4
7901880|NCT01967147|12413268|FG001|Overall Study|Other|5
7901881|NCT01967173|12413283|FG000|Overall Study|Lost to Follow-up|5
7901882|NCT01967173|12413284|FG001|Overall Study|Lost to Follow-up|3
7901883|NCT01967173|12413285|FG002|Overall Study|Lost to Follow-up|2
7901884|NCT01967173|12413286|FG003|Overall Study|Lost to Follow-up|4
7901885|NCT01967173|12413287|FG004|Overall Study|Lost to Follow-up|8
7901886|NCT01967173|12413288|FG005|Overall Study|Lost to Follow-up|12
7901887|NCT01967173|12413289|FG006|Overall Study|Lost to Follow-up|6
7901888|NCT01967173|12413290|FG007|Overall Study|Lost to Follow-up|8
7901889|NCT01967173|12413283|FG000|Overall Study|Physician Decision|2
7901890|NCT01967173|12413284|FG001|Overall Study|Physician Decision|0
7901891|NCT01967173|12413285|FG002|Overall Study|Physician Decision|2
7901892|NCT01967173|12413286|FG003|Overall Study|Physician Decision|1
7901893|NCT01967173|12413287|FG004|Overall Study|Physician Decision|1
7901894|NCT01967173|12413288|FG005|Overall Study|Physician Decision|1
7901895|NCT01967173|12413289|FG006|Overall Study|Physician Decision|1
7901896|NCT01967173|12413290|FG007|Overall Study|Physician Decision|0
7901897|NCT01967173|12413283|FG000|Overall Study|Lack of Efficacy|2
7901898|NCT01967173|12413284|FG001|Overall Study|Lack of Efficacy|0
7901899|NCT01967173|12413285|FG002|Overall Study|Lack of Efficacy|2
7901900|NCT01967173|12413286|FG003|Overall Study|Lack of Efficacy|2
7901901|NCT01967173|12413287|FG004|Overall Study|Lack of Efficacy|0
7901902|NCT01967173|12413288|FG005|Overall Study|Lack of Efficacy|1
7901903|NCT01967173|12413289|FG006|Overall Study|Lack of Efficacy|0
7901904|NCT01967173|12413290|FG007|Overall Study|Lack of Efficacy|2
7901905|NCT01967173|12413283|FG000|Overall Study|Pregnancy|0
7901906|NCT01967173|12413284|FG001|Overall Study|Pregnancy|0
7901907|NCT01967173|12413285|FG002|Overall Study|Pregnancy|0
7901908|NCT01967173|12413286|FG003|Overall Study|Pregnancy|0
7901909|NCT01967173|12413287|FG004|Overall Study|Pregnancy|0
7901910|NCT01967173|12413288|FG005|Overall Study|Pregnancy|0
7901911|NCT01967173|12413289|FG006|Overall Study|Pregnancy|1
7901912|NCT01967173|12413290|FG007|Overall Study|Pregnancy|1
7901913|NCT01967173|12413283|FG000|Overall Study|Adverse Event|0
7901914|NCT01967173|12413284|FG001|Overall Study|Adverse Event|0
7901915|NCT01967173|12413285|FG002|Overall Study|Adverse Event|0
7901916|NCT01967173|12413286|FG003|Overall Study|Adverse Event|0
7901917|NCT01967173|12413287|FG004|Overall Study|Adverse Event|0
7901918|NCT01967173|12413288|FG005|Overall Study|Adverse Event|0
7901919|NCT01967173|12413289|FG006|Overall Study|Adverse Event|0
7901920|NCT01967173|12413290|FG007|Overall Study|Adverse Event|1
7901921|NCT01967173|12413283|FG000|Overall Study|Withdrawal by Subject|15
7901922|NCT01967173|12413284|FG001|Overall Study|Withdrawal by Subject|14
7901923|NCT01967173|12413285|FG002|Overall Study|Withdrawal by Subject|10
7901924|NCT01967173|12413286|FG003|Overall Study|Withdrawal by Subject|7
7901925|NCT01967173|12413287|FG004|Overall Study|Withdrawal by Subject|8
7901926|NCT01967173|12413288|FG005|Overall Study|Withdrawal by Subject|9
7901927|NCT01967173|12413289|FG006|Overall Study|Withdrawal by Subject|10
7901928|NCT01967173|12413290|FG007|Overall Study|Withdrawal by Subject|12
7901929|NCT01967225|12413306|FG000|Overall Study|Adverse Event|3
7901930|NCT01967225|12413307|FG001|Overall Study|Adverse Event|1
7901931|NCT01967225|12413306|FG000|Overall Study|Withdrawal by Subject|2
7901932|NCT01967225|12413307|FG001|Overall Study|Withdrawal by Subject|1
7901933|NCT01967225|12413306|FG000|Overall Study|Lack of Efficacy|1
7901934|NCT01967225|12413307|FG001|Overall Study|Lack of Efficacy|1
7901935|NCT01967225|12413306|FG000|Overall Study|Switching to other therapy|2
7901936|NCT01967225|12413307|FG001|Overall Study|Switching to other therapy|0
7901937|NCT01967225|12413306|FG000|Overall Study|Protocol driven decision point|1
7901938|NCT01967225|12413307|FG001|Overall Study|Protocol driven decision point|0
7901939|NCT01967225|12413306|FG000|Overall Study|Logistical difficulties|1
7901940|NCT01967225|12413307|FG001|Overall Study|Logistical difficulties|0
7901941|NCT01967225|12413306|FG000|Overall Study|Protocol Violation|2
7901942|NCT01967225|12413307|FG001|Overall Study|Protocol Violation|0
7901943|NCT01967277|12413317|FG000|Overall Study|Lost to Follow-up|1
7901944|NCT01967277|12413318|FG001|Overall Study|Lost to Follow-up|2
7901945|NCT01967277|12413317|FG000|Overall Study|Unrelated illness|0
7901946|NCT01967277|12413318|FG001|Overall Study|Unrelated illness|1
7901947|NCT01967537|12413352|FG000|Overall Study|Withdrawal by Subject|52
7901948|NCT01967537|12413352|FG000|Overall Study|Refuse treatment|2
7901949|NCT01967537|12413352|FG000|Overall Study|Lost to Follow-up|6
7901950|NCT01967550|12413358|FG000|Overall Study|Withdrawal by Subject|1
7901951|NCT01967550|12413359|FG001|Overall Study|Withdrawal by Subject|0
7901952|NCT01967550|12413358|FG000|Overall Study|Adverse Event|2
7901953|NCT01967550|12413359|FG001|Overall Study|Adverse Event|0
7901954|NCT01967550|12413358|FG000|Overall Study|Protocol Violation|2
7901955|NCT01967550|12413359|FG001|Overall Study|Protocol Violation|1
7901956|NCT01967550|12413358|FG000|Overall Study|Non Compliance|0
7901957|NCT01967550|12413359|FG001|Overall Study|Non Compliance|1
7901958|NCT01967576|12413365|FG000|Overall Study|Withdrawal by Subject|3
7901959|NCT01967576|12413365|FG000|Overall Study|Progressed/Removed from treatment|1
7901960|NCT01967576|12413365|FG000|Overall Study|Study closing at site|1
7901961|NCT01967576|12413365|FG000|Overall Study|Adverse Event|1
7901962|NCT01967576|12413365|FG000|Overall Study|Refused further treatment|1
7901963|NCT01967628|12413371|FG000|Overall Study|Withdrawal by Subject|2
7901964|NCT01967628|12413372|FG001|Overall Study|Withdrawal by Subject|0
7901965|NCT01967628|12413371|FG000|Overall Study|Unable to complete bronchoscopy|4
7901966|NCT01967628|12413372|FG001|Overall Study|Unable to complete bronchoscopy|6
7901967|NCT01967628|12413371|FG000|Overall Study|Lost to Follow-up|1
7901968|NCT01967628|12413372|FG001|Overall Study|Lost to Follow-up|0
7901969|NCT01967628|12413371|FG000|Overall Study|Low protein concentration in sample|20
7901970|NCT01967628|12413372|FG001|Overall Study|Low protein concentration in sample|25
7901971|NCT01967706|12413385|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
7901972|NCT01967706|12413386|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
7901973|NCT01967706|12413387|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
7901974|NCT01967706|12413388|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
7901975|NCT01967719|12413399|FG000|First Intervention (Day 1)|Withdrawal by Subject|0
7901976|NCT01967719|12413400|FG001|First Intervention (Day 1)|Withdrawal by Subject|1
7901977|NCT01967719|12413401|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
7901978|NCT01967719|12413402|FG003|First Intervention (Day 1)|Withdrawal by Subject|1
7901979|NCT01967719|12413399|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0
7901980|NCT01967719|12413400|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1
7901981|NCT01967719|12413401|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0
7901982|NCT01967719|12413402|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0
7901983|NCT01967732|12413414|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
7901984|NCT01967732|12413415|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
7901985|NCT01967732|12413416|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
7901986|NCT01967732|12413417|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
7901987|NCT01967732|12413414|FG000|First Intervention (Day 1)|Poor venous access|0
7901988|NCT01967732|12413415|FG001|First Intervention (Day 1)|Poor venous access|1
7901989|NCT01967732|12413416|FG002|First Intervention (Day 1)|Poor venous access|0
7901990|NCT01967732|12413417|FG003|First Intervention (Day 1)|Poor venous access|0
7901991|NCT01967888|12413440|FG000|Overall Study|Lost to Follow-up|6
7901992|NCT01967888|12413441|FG001|Overall Study|Lost to Follow-up|4
7901993|NCT01967888|12413440|FG000|Overall Study|Withdrawal by Subject|1
7901994|NCT01967888|12413441|FG001|Overall Study|Withdrawal by Subject|1
7901995|NCT01967888|12413440|FG000|Overall Study|Did Not Have Transplant|1
7901996|NCT01967888|12413441|FG001|Overall Study|Did Not Have Transplant|0
7901997|NCT01967888|12413440|FG000|Overall Study|Research visit not done, data recorded|1
7901998|NCT01967888|12413441|FG001|Overall Study|Research visit not done, data recorded|0
7901999|NCT01967888|12413440|FG000|Overall Study|Subject excluded after randomization|1
7902000|NCT01967888|12413441|FG001|Overall Study|Subject excluded after randomization|0
7902001|NCT01967888|12413440|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0
7902002|NCT01967888|12413441|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1
7902003|NCT01967888|12413440|FG000|Overall Study|Subject Unable To Comply With Final Day|0
7902004|NCT01967888|12413441|FG001|Overall Study|Subject Unable To Comply With Final Day|1
7902005|NCT01967940|12413450|FG000|Part 2|Enrolled in Part 2 and Never Treated|0
7902006|NCT01967940|12413451|FG001|Part 2|Enrolled in Part 2 and Never Treated|0
7902007|NCT01967940|12413452|FG002|Part 2|Enrolled in Part 2 and Never Treated|0
7902008|NCT01967940|12413453|FG003|Part 2|Enrolled in Part 2 and Never Treated|1
7902009|NCT01967940|12413450|FG000|Part 2|Adverse Event|0
7902010|NCT01967940|12413451|FG001|Part 2|Adverse Event|0
7902011|NCT01967940|12413452|FG002|Part 2|Adverse Event|0
7902012|NCT01967940|12413453|FG003|Part 2|Adverse Event|1
7902013|NCT01967940|12413450|FG000|Part 2|Unknown Reason|0
7902014|NCT01967940|12413451|FG001|Part 2|Unknown Reason|0
7902015|NCT01967940|12413452|FG002|Part 2|Unknown Reason|0
7902016|NCT01967940|12413453|FG003|Part 2|Unknown Reason|1
7902017|NCT01968031|12413466|FG000|Overall Study|Adverse Event|13
7902018|NCT01968031|12413467|FG001|Overall Study|Adverse Event|10
7902019|NCT01968031|12413468|FG002|Overall Study|Adverse Event|22
7902020|NCT01968031|12413466|FG000|Overall Study|Withdrawal by Subject|3
7902021|NCT01968031|12413467|FG001|Overall Study|Withdrawal by Subject|7
7902022|NCT01968031|12413468|FG002|Overall Study|Withdrawal by Subject|3
7902023|NCT01968031|12413466|FG000|Overall Study|Did not meet entry criteria|1
7902024|NCT01968031|12413467|FG001|Overall Study|Did not meet entry criteria|1
7902025|NCT01968031|12413468|FG002|Overall Study|Did not meet entry criteria|1
7902026|NCT01968031|12413466|FG000|Overall Study|Noncompliance|0
7902027|NCT01968031|12413467|FG001|Overall Study|Noncompliance|0
7902028|NCT01968031|12413468|FG002|Overall Study|Noncompliance|2
7902029|NCT01968031|12413466|FG000|Overall Study|Failed inclusion criteria|0
7902030|NCT01968031|12413467|FG001|Overall Study|Failed inclusion criteria|2
7902031|NCT01968031|12413468|FG002|Overall Study|Failed inclusion criteria|0
7902032|NCT01968031|12413466|FG000|Overall Study|Death|0
7902033|NCT01968031|12413467|FG001|Overall Study|Death|0
7902034|NCT01968031|12413468|FG002|Overall Study|Death|1
7902035|NCT01968031|12413466|FG000|Overall Study|Prohibited concomitant medication|1
7902036|NCT01968031|12413467|FG001|Overall Study|Prohibited concomitant medication|0
7902037|NCT01968031|12413468|FG002|Overall Study|Prohibited concomitant medication|0
7902038|NCT01968070|12413500|FG000|Period 1|Withdrawal by Subject|0
7902039|NCT01968070|12413501|FG001|Period 1|Withdrawal by Subject|1
7902040|NCT01968070|12413502|FG002|Period 1|Withdrawal by Subject|0
7902041|NCT01968070|12413503|FG003|Period 1|Withdrawal by Subject|0
7902042|NCT01968070|12413504|FG004|Period 1|Withdrawal by Subject|0
7902043|NCT01968070|12413505|FG005|Period 1|Withdrawal by Subject|0
7902044|NCT01968070|12413506|FG006|Period 1|Withdrawal by Subject|1
7902045|NCT01968070|12413507|FG007|Period 1|Withdrawal by Subject|0
7902046|NCT01968070|12413508|FG008|Period 1|Withdrawal by Subject|0
7902047|NCT01968070|12413509|FG009|Period 1|Withdrawal by Subject|0
7902048|NCT01968070|12413510|FG010|Period 1|Withdrawal by Subject|0
7902049|NCT01968070|12413511|FG011|Period 1|Withdrawal by Subject|0
7902050|NCT01968070|12413512|FG012|Period 1|Withdrawal by Subject|0
7902051|NCT01968070|12413513|FG013|Period 1|Withdrawal by Subject|0
7902052|NCT01968070|12413514|FG014|Period 1|Withdrawal by Subject|0
7902053|NCT01968070|12413515|FG015|Period 1|Withdrawal by Subject|1
7902054|NCT01968070|12413516|FG016|Period 1|Withdrawal by Subject|0
7902055|NCT01968070|12413517|FG017|Period 1|Withdrawal by Subject|0
7902056|NCT01968070|12413500|FG000|Period 1|Protocol Violation|0
7902057|NCT01968070|12413501|FG001|Period 1|Protocol Violation|0
7902058|NCT01968070|12413502|FG002|Period 1|Protocol Violation|0
7902059|NCT01968070|12413503|FG003|Period 1|Protocol Violation|1
7902060|NCT01968070|12413504|FG004|Period 1|Protocol Violation|1
7902061|NCT01968070|12413505|FG005|Period 1|Protocol Violation|0
7902062|NCT01968070|12413506|FG006|Period 1|Protocol Violation|0
7902063|NCT01968070|12413507|FG007|Period 1|Protocol Violation|0
7902064|NCT01968070|12413508|FG008|Period 1|Protocol Violation|0
7902065|NCT01968070|12413509|FG009|Period 1|Protocol Violation|0
7902066|NCT01968070|12413510|FG010|Period 1|Protocol Violation|0
7902067|NCT01968070|12413511|FG011|Period 1|Protocol Violation|0
7902068|NCT01968070|12413512|FG012|Period 1|Protocol Violation|0
7902069|NCT01968070|12413513|FG013|Period 1|Protocol Violation|0
7902070|NCT01968070|12413514|FG014|Period 1|Protocol Violation|0
7902071|NCT01968070|12413515|FG015|Period 1|Protocol Violation|0
7902072|NCT01968070|12413516|FG016|Period 1|Protocol Violation|0
7902073|NCT01968070|12413517|FG017|Period 1|Protocol Violation|0
7902074|NCT01968070|12413500|FG000|Period 1|Lost to Follow-up|0
7902075|NCT01968070|12413501|FG001|Period 1|Lost to Follow-up|0
7902076|NCT01968070|12413502|FG002|Period 1|Lost to Follow-up|0
7902077|NCT01968070|12413503|FG003|Period 1|Lost to Follow-up|1
7902078|NCT01968070|12413504|FG004|Period 1|Lost to Follow-up|0
7902079|NCT01968070|12413505|FG005|Period 1|Lost to Follow-up|0
7902080|NCT01968070|12413506|FG006|Period 1|Lost to Follow-up|0
7902081|NCT01968070|12413507|FG007|Period 1|Lost to Follow-up|0
7902082|NCT01968070|12413508|FG008|Period 1|Lost to Follow-up|0
7902083|NCT01968070|12413509|FG009|Period 1|Lost to Follow-up|0
7902084|NCT01968070|12413510|FG010|Period 1|Lost to Follow-up|0
7902085|NCT01968070|12413511|FG011|Period 1|Lost to Follow-up|0
7902086|NCT01968070|12413512|FG012|Period 1|Lost to Follow-up|0
7902087|NCT01968070|12413513|FG013|Period 1|Lost to Follow-up|0
7902088|NCT01968070|12413514|FG014|Period 1|Lost to Follow-up|0
7902089|NCT01968070|12413515|FG015|Period 1|Lost to Follow-up|0
7902090|NCT01968070|12413516|FG016|Period 1|Lost to Follow-up|0
7902091|NCT01968070|12413517|FG017|Period 1|Lost to Follow-up|0
7902092|NCT01968070|12413500|FG000|Period 1|Adverse Event|0
7902093|NCT01968070|12413501|FG001|Period 1|Adverse Event|0
7902094|NCT01968070|12413502|FG002|Period 1|Adverse Event|0
7902095|NCT01968070|12413503|FG003|Period 1|Adverse Event|0
7902096|NCT01968070|12413504|FG004|Period 1|Adverse Event|0
7902097|NCT01968070|12413505|FG005|Period 1|Adverse Event|0
7902098|NCT01968070|12413506|FG006|Period 1|Adverse Event|1
7902099|NCT01968070|12413507|FG007|Period 1|Adverse Event|0
7902100|NCT01968070|12413508|FG008|Period 1|Adverse Event|0
7902101|NCT01968070|12413509|FG009|Period 1|Adverse Event|0
7902102|NCT01968070|12413510|FG010|Period 1|Adverse Event|0
7902103|NCT01968070|12413511|FG011|Period 1|Adverse Event|0
7902104|NCT01968070|12413512|FG012|Period 1|Adverse Event|0
7902105|NCT01968070|12413513|FG013|Period 1|Adverse Event|0
7902106|NCT01968070|12413514|FG014|Period 1|Adverse Event|0
7902107|NCT01968070|12413515|FG015|Period 1|Adverse Event|0
7902108|NCT01968070|12413516|FG016|Period 1|Adverse Event|0
7902109|NCT01968070|12413517|FG017|Period 1|Adverse Event|0
7902110|NCT01968070|12413500|FG000|Period 1|Physician Decision|0
7902111|NCT01968070|12413501|FG001|Period 1|Physician Decision|0
7902112|NCT01968070|12413502|FG002|Period 1|Physician Decision|0
7902113|NCT01968070|12413503|FG003|Period 1|Physician Decision|0
7902114|NCT01968070|12413504|FG004|Period 1|Physician Decision|0
7902115|NCT01968070|12413505|FG005|Period 1|Physician Decision|0
7902116|NCT01968070|12413506|FG006|Period 1|Physician Decision|0
7902117|NCT01968070|12413507|FG007|Period 1|Physician Decision|0
7902118|NCT01968070|12413508|FG008|Period 1|Physician Decision|0
7902119|NCT01968070|12413509|FG009|Period 1|Physician Decision|0
7902120|NCT01968070|12413510|FG010|Period 1|Physician Decision|0
7902121|NCT01968070|12413511|FG011|Period 1|Physician Decision|1
7902122|NCT01968070|12413512|FG012|Period 1|Physician Decision|0
7902123|NCT01968070|12413513|FG013|Period 1|Physician Decision|0
7902124|NCT01968070|12413514|FG014|Period 1|Physician Decision|0
7902125|NCT01968070|12413515|FG015|Period 1|Physician Decision|0
7902126|NCT01968070|12413516|FG016|Period 1|Physician Decision|0
7902127|NCT01968070|12413517|FG017|Period 1|Physician Decision|0
7902128|NCT01968070|12413500|FG000|Period 2|Withdrawal by Subject|0
7902129|NCT01968070|12413501|FG001|Period 2|Withdrawal by Subject|0
7902130|NCT01968070|12413502|FG002|Period 2|Withdrawal by Subject|0
7902131|NCT01968070|12413503|FG003|Period 2|Withdrawal by Subject|0
7902132|NCT01968070|12413504|FG004|Period 2|Withdrawal by Subject|1
7902133|NCT01968070|12413505|FG005|Period 2|Withdrawal by Subject|0
7902134|NCT01968070|12413506|FG006|Period 2|Withdrawal by Subject|0
7902135|NCT01968070|12413507|FG007|Period 2|Withdrawal by Subject|0
7902136|NCT01968070|12413508|FG008|Period 2|Withdrawal by Subject|0
7902137|NCT01968070|12413509|FG009|Period 2|Withdrawal by Subject|0
7902138|NCT01968070|12413510|FG010|Period 2|Withdrawal by Subject|0
7902139|NCT01968070|12413511|FG011|Period 2|Withdrawal by Subject|0
7902140|NCT01968070|12413512|FG012|Period 2|Withdrawal by Subject|0
7902141|NCT01968070|12413513|FG013|Period 2|Withdrawal by Subject|0
7902142|NCT01968070|12413514|FG014|Period 2|Withdrawal by Subject|0
7902143|NCT01968070|12413515|FG015|Period 2|Withdrawal by Subject|0
7902144|NCT01968070|12413516|FG016|Period 2|Withdrawal by Subject|0
7902145|NCT01968070|12413517|FG017|Period 2|Withdrawal by Subject|0
7902146|NCT01968434|12413638|FG000|Overall Study|Lost to Follow-up|3
7902147|NCT01968434|12413639|FG001|Overall Study|Lost to Follow-up|6
7902148|NCT01968551|12413657|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
7902149|NCT01968551|12413658|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
7902150|NCT01968551|12413659|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
7902151|NCT01968551|12413657|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0
7902152|NCT01968551|12413658|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1
7902153|NCT01968551|12413659|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0
7902154|NCT01968551|12413657|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1
7902155|NCT01968551|12413658|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1
7902156|NCT01968551|12413659|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3
7902157|NCT01968551|12413657|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0
7902158|NCT01968551|12413658|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0
7902159|NCT01968551|12413659|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2
7902160|NCT01968551|12413657|FG000|Extension Phase|Adverse Event|0
7902161|NCT01968551|12413658|FG001|Extension Phase|Adverse Event|0
7902162|NCT01968551|12413659|FG002|Extension Phase|Adverse Event|2
7902163|NCT01968551|12413657|FG000|Extension Phase|Death|0
7902164|NCT01968551|12413658|FG001|Extension Phase|Death|1
7902165|NCT01968551|12413659|FG002|Extension Phase|Death|0
7902166|NCT01968551|12413657|FG000|Extension Phase|Withdrew Consent|0
7902167|NCT01968551|12413658|FG001|Extension Phase|Withdrew Consent|0
7902168|NCT01968551|12413659|FG002|Extension Phase|Withdrew Consent|1
7902169|NCT01968551|12413657|FG000|Extension Phase|Lost to Follow-up|1
7902170|NCT01968551|12413658|FG001|Extension Phase|Lost to Follow-up|0
7902171|NCT01968551|12413659|FG002|Extension Phase|Lost to Follow-up|1
7902172|NCT01968694|12413673|FG000|Washout (1 Month)|Lost to Follow-up|0
7902173|NCT01968694|12413674|FG001|Washout (1 Month)|Lost to Follow-up|1
7902174|NCT01968707|12413690|FG000|Overall Study|Did not meet treatment day baseline|49
7902175|NCT01968707|12413691|FG001|Overall Study|Did not meet treatment day baseline|12
7902176|NCT01968707|12413692|FG002|Overall Study|Did not meet treatment day baseline|41
7902177|NCT01968707|12413693|FG003|Overall Study|Did not meet treatment day baseline|44
7902178|NCT01968707|12413694|FG004|Overall Study|Did not meet treatment day baseline|36
7902179|NCT01968707|12413695|FG005|Overall Study|Did not meet treatment day baseline|11
7902180|NCT01968707|12413696|FG006|Overall Study|Did not meet treatment day baseline|34
7902181|NCT01968707|12413697|FG007|Overall Study|Did not meet treatment day baseline|35
7902182|NCT01968811|12413730|FG000|Overall Study|Protocol Violation|4
7902183|NCT01968811|12413730|FG000|Overall Study|post op.ref. of subject to other hospita|1
7902184|NCT01968954|12413736|FG000|Overall Study|Adverse Event|6
7902185|NCT01968954|12413737|FG001|Overall Study|Adverse Event|3
7902186|NCT01968954|12413736|FG000|Overall Study|Death|1
7902187|NCT01968954|12413737|FG001|Overall Study|Death|2
7902188|NCT01968954|12413736|FG000|Overall Study|Lost to Follow-up|6
7902189|NCT01968954|12413737|FG001|Overall Study|Lost to Follow-up|4
7902190|NCT01968954|12413736|FG000|Overall Study|Withdrawal by Subject|20
7902191|NCT01968954|12413737|FG001|Overall Study|Withdrawal by Subject|23
7902192|NCT01968954|12413736|FG000|Overall Study|Other|7
7902193|NCT01968954|12413737|FG001|Overall Study|Other|8
7902194|NCT01968954|12413736|FG000|Overall Study|Protocol Violation|0
7902195|NCT01968954|12413737|FG001|Overall Study|Protocol Violation|1
7902196|NCT01968954|12413736|FG000|Overall Study|Did not met inclusion criteria|0
7902197|NCT01968954|12413737|FG001|Overall Study|Did not met inclusion criteria|2
7902198|NCT01968967|12413746|FG000|Treatment Period|Other|22
7902199|NCT01968967|12413747|FG001|Treatment Period|Other|22
7902200|NCT01968967|12413748|FG002|Treatment Period|Other|0
7902201|NCT01968967|12413749|FG003|Treatment Period|Other|0
7902202|NCT01968967|12413750|FG004|Treatment Period|Other|0
7902203|NCT01968967|12413746|FG000|Treatment Period|Withdrawal by Subject|71
7902204|NCT01968967|12413747|FG001|Treatment Period|Withdrawal by Subject|61
7902205|NCT01968967|12413748|FG002|Treatment Period|Withdrawal by Subject|0
7902206|NCT01968967|12413749|FG003|Treatment Period|Withdrawal by Subject|0
7902207|NCT01968967|12413750|FG004|Treatment Period|Withdrawal by Subject|0
7902208|NCT01968967|12413746|FG000|Treatment Period|Did Not Meet Entrance Criteria|2
7902209|NCT01968967|12413747|FG001|Treatment Period|Did Not Meet Entrance Criteria|3
7902210|NCT01968967|12413748|FG002|Treatment Period|Did Not Meet Entrance Criteria|0
7902211|NCT01968967|12413749|FG003|Treatment Period|Did Not Meet Entrance Criteria|0
7902212|NCT01968967|12413750|FG004|Treatment Period|Did Not Meet Entrance Criteria|0
7902213|NCT01968967|12413746|FG000|Treatment Period|Lost to Follow-up|26
7902214|NCT01968967|12413747|FG001|Treatment Period|Lost to Follow-up|31
7902215|NCT01968967|12413748|FG002|Treatment Period|Lost to Follow-up|0
7902216|NCT01968967|12413749|FG003|Treatment Period|Lost to Follow-up|0
7902217|NCT01968967|12413750|FG004|Treatment Period|Lost to Follow-up|0
7902218|NCT01968967|12413746|FG000|Treatment Period|Protocol Violation|1
7902219|NCT01968967|12413747|FG001|Treatment Period|Protocol Violation|2
7902220|NCT01968967|12413748|FG002|Treatment Period|Protocol Violation|0
7902221|NCT01968967|12413749|FG003|Treatment Period|Protocol Violation|0
7902222|NCT01968967|12413750|FG004|Treatment Period|Protocol Violation|0
7902223|NCT01968967|12413746|FG000|Treatment Period|Adverse Event|9
7902224|NCT01968967|12413747|FG001|Treatment Period|Adverse Event|8
7902225|NCT01968967|12413748|FG002|Treatment Period|Adverse Event|0
7902226|NCT01968967|12413749|FG003|Treatment Period|Adverse Event|0
7902227|NCT01968967|12413750|FG004|Treatment Period|Adverse Event|0
7902228|NCT01968967|12413746|FG000|Treatment Period|Death|9
7902229|NCT01968967|12413747|FG001|Treatment Period|Death|2
7902230|NCT01968967|12413748|FG002|Treatment Period|Death|0
7902231|NCT01968967|12413749|FG003|Treatment Period|Death|0
7902232|NCT01968967|12413750|FG004|Treatment Period|Death|0
7902233|NCT01968967|12413746|FG000|Treatment Period|Randomized Not Treated|6
7902234|NCT01968967|12413747|FG001|Treatment Period|Randomized Not Treated|5
7902235|NCT01968967|12413748|FG002|Treatment Period|Randomized Not Treated|0
7902236|NCT01968967|12413749|FG003|Treatment Period|Randomized Not Treated|0
7902237|NCT01968967|12413750|FG004|Treatment Period|Randomized Not Treated|0
7902238|NCT01968967|12413746|FG000|Extension Period|Withdrew Consent|0
7902239|NCT01968967|12413747|FG001|Extension Period|Withdrew Consent|0
7902240|NCT01968967|12413748|FG002|Extension Period|Withdrew Consent|2
7902241|NCT01968967|12413749|FG003|Extension Period|Withdrew Consent|0
7902242|NCT01968967|12413750|FG004|Extension Period|Withdrew Consent|5
7902243|NCT01968980|12413766|FG000|Overall Study|Death|0
7902244|NCT01968980|12413767|FG001|Overall Study|Death|1
7902245|NCT01968980|12413766|FG000|Overall Study|Adverse Event|1
7902246|NCT01968980|12413767|FG001|Overall Study|Adverse Event|3
7902247|NCT01968980|12413766|FG000|Overall Study|Does not meet entry criteria|1
7902248|NCT01968980|12413767|FG001|Overall Study|Does not meet entry criteria|3
7902249|NCT01968980|12413766|FG000|Overall Study|Withdrawal by Subject|13
7902250|NCT01968980|12413767|FG001|Overall Study|Withdrawal by Subject|5
7902251|NCT01968980|12413766|FG000|Overall Study|Other unspecified|1
7902252|NCT01968980|12413767|FG001|Overall Study|Other unspecified|2
7902253|NCT01969058|12413776|FG000|Overall Study|Withdrawal by Subject|2
7902254|NCT01969058|12413777|FG001|Overall Study|Withdrawal by Subject|0
7902255|NCT01969058|12413776|FG000|Overall Study|Adverse Event|1
7902256|NCT01969058|12413777|FG001|Overall Study|Adverse Event|0
7902257|NCT01969084|12413785|FG000|Overall Study|Adverse Event|0
7902258|NCT01969084|12413786|FG001|Overall Study|Adverse Event|1
7902259|NCT01969500|12413843|FG000|Overall Study|Death|0
7902260|NCT01969500|12413844|FG001|Overall Study|Death|1
7902261|NCT01969500|12413843|FG000|Overall Study|extended hospitalization|1
7902262|NCT01969500|12413844|FG001|Overall Study|extended hospitalization|1
7902263|NCT01969721|12413863|FG000|Overall Study|Adverse Event|3
7902264|NCT01969721|12413864|FG001|Overall Study|Adverse Event|8
7902265|NCT01969721|12413865|FG002|Overall Study|Adverse Event|3
7902266|NCT01969721|12413866|FG003|Overall Study|Adverse Event|2
7902267|NCT01969721|12413863|FG000|Overall Study|Lack of Efficacy|0
7902268|NCT01969721|12413864|FG001|Overall Study|Lack of Efficacy|0
7902269|NCT01969721|12413865|FG002|Overall Study|Lack of Efficacy|1
7902270|NCT01969721|12413866|FG003|Overall Study|Lack of Efficacy|0
7902271|NCT01969721|12413863|FG000|Overall Study|Non compliant with protocol|1
7902272|NCT01969721|12413864|FG001|Overall Study|Non compliant with protocol|1
7902273|NCT01969721|12413865|FG002|Overall Study|Non compliant with protocol|0
7902274|NCT01969721|12413866|FG003|Overall Study|Non compliant with protocol|2
7902275|NCT01969721|12413863|FG000|Overall Study|Other not defined above|0
7902276|NCT01969721|12413864|FG001|Overall Study|Other not defined above|2
7902277|NCT01969721|12413865|FG002|Overall Study|Other not defined above|0
7902278|NCT01969721|12413866|FG003|Overall Study|Other not defined above|0
7902279|NCT01969721|12413863|FG000|Overall Study|Discontinued during washout periods.|0
7902280|NCT01969721|12413864|FG001|Overall Study|Discontinued during washout periods.|1
7902281|NCT01969721|12413865|FG002|Overall Study|Discontinued during washout periods.|1
7902282|NCT01969721|12413866|FG003|Overall Study|Discontinued during washout periods.|2
7902283|NCT01969799|12413895|FG000|Overall Study|Adverse Event|0
7902284|NCT01969799|12413896|FG001|Overall Study|Adverse Event|1
7902285|NCT01969799|12413895|FG000|Overall Study|Death|16
7902286|NCT01969799|12413896|FG001|Overall Study|Death|11
7902287|NCT01969799|12413895|FG000|Overall Study|Lost to Follow-up|0
7902288|NCT01969799|12413896|FG001|Overall Study|Lost to Follow-up|2
7902289|NCT01969799|12413895|FG000|Overall Study|Physician Decision|1
7902290|NCT01969799|12413896|FG001|Overall Study|Physician Decision|0
7902291|NCT01969851|12413905|FG000|Overall Study|Adverse Event|0
7902292|NCT01969851|12413906|FG001|Overall Study|Adverse Event|0
7902293|NCT01969851|12413907|FG002|Overall Study|Adverse Event|3
7902294|NCT01969851|12413905|FG000|Overall Study|Lack of Efficacy|0
7902295|NCT01969851|12413906|FG001|Overall Study|Lack of Efficacy|3
7902296|NCT01969851|12413907|FG002|Overall Study|Lack of Efficacy|1
7902297|NCT01969851|12413905|FG000|Overall Study|Withdrawal by Subject|1
7902298|NCT01969851|12413906|FG001|Overall Study|Withdrawal by Subject|0
7902299|NCT01969851|12413907|FG002|Overall Study|Withdrawal by Subject|1
7902300|NCT01969851|12413905|FG000|Overall Study|No effective dose in Titration period|0
7902301|NCT01969851|12413906|FG001|Overall Study|No effective dose in Titration period|0
7902302|NCT01969851|12413907|FG002|Overall Study|No effective dose in Titration period|1
7902303|NCT01969851|12413905|FG000|Overall Study|Sponsor decision|0
7902304|NCT01969851|12413906|FG001|Overall Study|Sponsor decision|0
7902305|NCT01969851|12413907|FG002|Overall Study|Sponsor decision|1
7902306|NCT01970007|12413919|FG000|Overall Study|Death|5
7902307|NCT01970007|12413919|FG000|Overall Study|Withdrawal by Subject|23
7902308|NCT01970007|12413919|FG000|Overall Study|Lost to Follow-up|24
7902309|NCT01970007|12413919|FG000|Overall Study|"Other endpoint"|3
7902310|NCT01970241|12413934|FG000|Overall Study|Withdrawal by Subject|2
7902311|NCT01970241|12413935|FG001|Overall Study|Withdrawal by Subject|0
7902312|NCT01970241|12413934|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15
7902313|NCT01970241|12413935|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8
7902314|NCT01970371|12413946|FG000|Overall Study|Death|8
7902315|NCT01970371|12413947|FG001|Overall Study|Death|13
7902316|NCT01970371|12413948|FG002|Overall Study|Death|12
7902317|NCT01970371|12413946|FG000|Overall Study|Lost to Follow-up|0
7902318|NCT01970371|12413947|FG001|Overall Study|Lost to Follow-up|0
7902319|NCT01970371|12413948|FG002|Overall Study|Lost to Follow-up|1
7902320|NCT01970397|12413960|FG000|Overall Study|Adverse Event|0
7902321|NCT01970397|12413961|FG001|Overall Study|Adverse Event|1
7902322|NCT01970397|12413960|FG000|Overall Study|Lost to Follow-up|0
7902323|NCT01970397|12413961|FG001|Overall Study|Lost to Follow-up|1
7902324|NCT01970397|12413960|FG000|Overall Study|Personal Reasons|1
7902325|NCT01970397|12413961|FG001|Overall Study|Personal Reasons|2
7902326|NCT01970397|12413960|FG000|Overall Study|Protocol Violation|1
7902327|NCT01970397|12413961|FG001|Overall Study|Protocol Violation|1
7902328|NCT01970475|12413969|FG000|Overall Study|Withdrawal by Subject|11
7902329|NCT01970475|12413970|FG001|Overall Study|Withdrawal by Subject|6
7902330|NCT01970475|12413969|FG000|Overall Study|Adverse Event|7
7902331|NCT01970475|12413970|FG001|Overall Study|Adverse Event|3
7902332|NCT01970475|12413969|FG000|Overall Study|Lost to Follow-up|2
7902333|NCT01970475|12413970|FG001|Overall Study|Lost to Follow-up|2
7902334|NCT01970475|12413969|FG000|Overall Study|Protocol Violation|1
7902335|NCT01970475|12413970|FG001|Overall Study|Protocol Violation|0
7902336|NCT01970488|12413978|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1
7902337|NCT01970488|12413979|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2
7902338|NCT01970488|12413980|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0
7902339|NCT01970488|12413981|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0
7902340|NCT01970488|12413982|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0
7902341|NCT01970488|12413978|FG000|Part 1: Through Week 16|Protocol Violation|1
7902342|NCT01970488|12413979|FG001|Part 1: Through Week 16|Protocol Violation|2
7902343|NCT01970488|12413980|FG002|Part 1: Through Week 16|Protocol Violation|0
7902344|NCT01970488|12413981|FG003|Part 1: Through Week 16|Protocol Violation|0
7902345|NCT01970488|12413982|FG004|Part 1: Through Week 16|Protocol Violation|0
7902346|NCT01970488|12413978|FG000|Part 1: Through Week 16|Adverse Event|6
7902347|NCT01970488|12413979|FG001|Part 1: Through Week 16|Adverse Event|5
7902348|NCT01970488|12413980|FG002|Part 1: Through Week 16|Adverse Event|0
7902349|NCT01970488|12413981|FG003|Part 1: Through Week 16|Adverse Event|0
7902350|NCT01970488|12413982|FG004|Part 1: Through Week 16|Adverse Event|0
7902351|NCT01970488|12413978|FG000|Part 1: Through Week 16|Withdrawal by Subject|3
7902352|NCT01970488|12413979|FG001|Part 1: Through Week 16|Withdrawal by Subject|2
7902353|NCT01970488|12413980|FG002|Part 1: Through Week 16|Withdrawal by Subject|0
7902354|NCT01970488|12413981|FG003|Part 1: Through Week 16|Withdrawal by Subject|0
7902355|NCT01970488|12413982|FG004|Part 1: Through Week 16|Withdrawal by Subject|0
7902356|NCT01970488|12413978|FG000|Part 1: Through Week 16|Lost to Follow-up|0
7902357|NCT01970488|12413979|FG001|Part 1: Through Week 16|Lost to Follow-up|2
7902358|NCT01970488|12413980|FG002|Part 1: Through Week 16|Lost to Follow-up|0
7902359|NCT01970488|12413981|FG003|Part 1: Through Week 16|Lost to Follow-up|0
7902360|NCT01970488|12413982|FG004|Part 1: Through Week 16|Lost to Follow-up|0
7902361|NCT01970488|12413978|FG000|Part 2: Post Week 16|Physician Decision|0
7902362|NCT01970488|12413979|FG001|Part 2: Post Week 16|Physician Decision|0
7902363|NCT01970488|12413980|FG002|Part 2: Post Week 16|Physician Decision|0
7902364|NCT01970488|12413981|FG003|Part 2: Post Week 16|Physician Decision|0
7902365|NCT01970488|12413982|FG004|Part 2: Post Week 16|Physician Decision|1
7902366|NCT01970488|12413978|FG000|Part 2: Post Week 16|Non-compliance|0
7902367|NCT01970488|12413979|FG001|Part 2: Post Week 16|Non-compliance|0
7902368|NCT01970488|12413980|FG002|Part 2: Post Week 16|Non-compliance|1
7902369|NCT01970488|12413981|FG003|Part 2: Post Week 16|Non-compliance|0
7902370|NCT01970488|12413982|FG004|Part 2: Post Week 16|Non-compliance|0
7902371|NCT01970488|12413978|FG000|Part 2: Post Week 16|Lack of Efficacy|0
7902372|NCT01970488|12413979|FG001|Part 2: Post Week 16|Lack of Efficacy|0
7902373|NCT01970488|12413980|FG002|Part 2: Post Week 16|Lack of Efficacy|2
7902374|NCT01970488|12413981|FG003|Part 2: Post Week 16|Lack of Efficacy|3
7902375|NCT01970488|12413982|FG004|Part 2: Post Week 16|Lack of Efficacy|1
7902376|NCT01970488|12413978|FG000|Part 2: Post Week 16|Adverse Event|0
7902377|NCT01970488|12413979|FG001|Part 2: Post Week 16|Adverse Event|0
7902378|NCT01970488|12413980|FG002|Part 2: Post Week 16|Adverse Event|5
7902379|NCT01970488|12413981|FG003|Part 2: Post Week 16|Adverse Event|1
7902380|NCT01970488|12413982|FG004|Part 2: Post Week 16|Adverse Event|1
7902381|NCT01970488|12413978|FG000|Part 2: Post Week 16|Withdrawal by Subject|0
7902382|NCT01970488|12413979|FG001|Part 2: Post Week 16|Withdrawal by Subject|0
7902383|NCT01970488|12413980|FG002|Part 2: Post Week 16|Withdrawal by Subject|8
7902384|NCT01970488|12413981|FG003|Part 2: Post Week 16|Withdrawal by Subject|3
7902385|NCT01970488|12413982|FG004|Part 2: Post Week 16|Withdrawal by Subject|3
7902386|NCT01970488|12413978|FG000|Part 2: Post Week 16|Lost to Follow-up|0
7902387|NCT01970488|12413979|FG001|Part 2: Post Week 16|Lost to Follow-up|0
7902388|NCT01970488|12413980|FG002|Part 2: Post Week 16|Lost to Follow-up|1
7902389|NCT01970488|12413981|FG003|Part 2: Post Week 16|Lost to Follow-up|1
7902390|NCT01970488|12413982|FG004|Part 2: Post Week 16|Lost to Follow-up|2
7902391|NCT01970527|12413999|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1
7902392|NCT01970527|12414000|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0
7902393|NCT01970527|12413999|FG000|Treatment|Disease progression|0
7902394|NCT01970527|12414000|FG001|Treatment|Disease progression|1
7902395|NCT01970527|12413999|FG000|Treatment|Participant did not tolerate Ipilimumab|0
7902396|NCT01970527|12414000|FG001|Treatment|Participant did not tolerate Ipilimumab|1
7902397|NCT01970527|12413999|FG000|Treatment|Death|0
7902398|NCT01970527|12414000|FG001|Treatment|Death|1
7902399|NCT01970527|12413999|FG000|Follow-up Clinic Visit|Disease progression|1
7902400|NCT01970527|12414000|FG001|Follow-up Clinic Visit|Disease progression|1
7902401|NCT01970527|12413999|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0
7902402|NCT01970527|12414000|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1
7902403|NCT01970527|12413999|FG000|Follow-up Clinic Visit|Lost to Follow-up|0
7902404|NCT01970527|12414000|FG001|Follow-up Clinic Visit|Lost to Follow-up|1
7902405|NCT01970540|12414012|FG000|Overall Study|Non-treatment-related AE|0
7902406|NCT01970540|12414013|FG001|Overall Study|Non-treatment-related AE|0
7902407|NCT01970540|12414014|FG002|Overall Study|Non-treatment-related AE|1
7902408|NCT01970540|12414012|FG000|Overall Study|Progressive disease|55
7902409|NCT01970540|12414013|FG001|Overall Study|Progressive disease|23
7902410|NCT01970540|12414014|FG002|Overall Study|Progressive disease|10
7902411|NCT01970540|12414012|FG000|Overall Study|Treatment delay over protocol|0
7902412|NCT01970540|12414013|FG001|Overall Study|Treatment delay over protocol|0
7902413|NCT01970540|12414014|FG002|Overall Study|Treatment delay over protocol|1
7902414|NCT01970540|12414012|FG000|Overall Study|Physician Decision|7
7902415|NCT01970540|12414013|FG001|Overall Study|Physician Decision|2
7902416|NCT01970540|12414014|FG002|Overall Study|Physician Decision|0
7902417|NCT01970540|12414012|FG000|Overall Study|Clinical progression|0
7902418|NCT01970540|12414013|FG001|Overall Study|Clinical progression|1
7902419|NCT01970540|12414014|FG002|Overall Study|Clinical progression|1
7902420|NCT01970540|12414012|FG000|Overall Study|End of study|2
7902421|NCT01970540|12414013|FG001|Overall Study|End of study|0
7902422|NCT01970540|12414014|FG002|Overall Study|End of study|2
7902423|NCT01970540|12414012|FG000|Overall Study|Adverse Event|0
7902424|NCT01970540|12414013|FG001|Overall Study|Adverse Event|2
7902425|NCT01970540|12414014|FG002|Overall Study|Adverse Event|1
7902426|NCT01970540|12414012|FG000|Overall Study|Treatment-related AE|4
7902427|NCT01970540|12414013|FG001|Overall Study|Treatment-related AE|0
7902428|NCT01970540|12414014|FG002|Overall Study|Treatment-related AE|2
7902429|NCT01970540|12414012|FG000|Overall Study|Withdrawal by Subject|4
7902430|NCT01970540|12414013|FG001|Overall Study|Withdrawal by Subject|0
7902431|NCT01970540|12414014|FG002|Overall Study|Withdrawal by Subject|1
7902432|NCT01970540|12414012|FG000|Overall Study|Clinical deterioration|1
7902433|NCT01970540|12414013|FG001|Overall Study|Clinical deterioration|0
7902434|NCT01970540|12414014|FG002|Overall Study|Clinical deterioration|0
7902435|NCT01970592|12414033|FG000|Overall Study|Withdrawal by Subject|4
7902436|NCT01970592|12414033|FG000|Overall Study|Physician Decision|1
7902437|NCT01970592|12414033|FG000|Overall Study|Adverse Event|1
7902438|NCT01970878|12414045|FG000|Overall Study|Withdrawal by Subject|11
7902439|NCT01970878|12414046|FG001|Overall Study|Withdrawal by Subject|10
7902440|NCT01970878|12414047|FG002|Overall Study|Withdrawal by Subject|14
7902441|NCT01970878|12414048|FG003|Overall Study|Withdrawal by Subject|7
7902442|NCT01970878|12414045|FG000|Overall Study|Lost to Follow-up|1
7902443|NCT01970878|12414046|FG001|Overall Study|Lost to Follow-up|3
7902444|NCT01970878|12414047|FG002|Overall Study|Lost to Follow-up|2
7902445|NCT01970878|12414048|FG003|Overall Study|Lost to Follow-up|4
7902446|NCT01970878|12414045|FG000|Overall Study|Administrative Reasons|1
7902447|NCT01970878|12414046|FG001|Overall Study|Administrative Reasons|0
7902448|NCT01970878|12414047|FG002|Overall Study|Administrative Reasons|0
7902449|NCT01970878|12414048|FG003|Overall Study|Administrative Reasons|4
7902450|NCT01970878|12414045|FG000|Overall Study|Lack of Efficacy|2
7902451|NCT01970878|12414046|FG001|Overall Study|Lack of Efficacy|1
7902452|NCT01970878|12414047|FG002|Overall Study|Lack of Efficacy|2
7902453|NCT01970878|12414048|FG003|Overall Study|Lack of Efficacy|0
7902454|NCT01970878|12414045|FG000|Overall Study|Adverse Event|12
7902455|NCT01970878|12414046|FG001|Overall Study|Adverse Event|7
7902456|NCT01970878|12414047|FG002|Overall Study|Adverse Event|4
7902457|NCT01970878|12414048|FG003|Overall Study|Adverse Event|3
7902458|NCT01970878|12414045|FG000|Overall Study|Protocol Specified Criteria|10
7902459|NCT01970878|12414046|FG001|Overall Study|Protocol Specified Criteria|4
7902460|NCT01970878|12414047|FG002|Overall Study|Protocol Specified Criteria|3
7902461|NCT01970878|12414048|FG003|Overall Study|Protocol Specified Criteria|6
7902462|NCT01970878|12414045|FG000|Overall Study|Physician Decision|0
7902463|NCT01970878|12414046|FG001|Overall Study|Physician Decision|1
7902464|NCT01970878|12414047|FG002|Overall Study|Physician Decision|1
7902465|NCT01970878|12414048|FG003|Overall Study|Physician Decision|0
7902466|NCT01970878|12414045|FG000|Overall Study|No Completion Status|0
7902467|NCT01970878|12414046|FG001|Overall Study|No Completion Status|1
7902468|NCT01970878|12414047|FG002|Overall Study|No Completion Status|0
7902469|NCT01970878|12414048|FG003|Overall Study|No Completion Status|0
7902470|NCT01970982|12414068|FG000|Overall Study|Withdrawal by Subject|0
7902471|NCT01970982|12414069|FG001|Overall Study|Withdrawal by Subject|0
7902472|NCT01970982|12414070|FG002|Overall Study|Withdrawal by Subject|2
7902473|NCT01970995|12414082|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7902474|NCT01970995|12414083|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7902475|NCT01970995|12414084|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7902476|NCT01970995|12414082|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1
7902477|NCT01970995|12414083|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0
7902478|NCT01970995|12414084|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1
7902479|NCT01971203|12414099|FG000|Overall Study|Protocol Violation|3
7902480|NCT01971203|12414100|FG001|Overall Study|Protocol Violation|2
7902481|NCT01971203|12414099|FG000|Overall Study|Withdrawal by Subject|5
7902482|NCT01971203|12414100|FG001|Overall Study|Withdrawal by Subject|6
7902483|NCT01971203|12414099|FG000|Overall Study|Adverse Event|1
7902484|NCT01971203|12414100|FG001|Overall Study|Adverse Event|0
7902485|NCT01971346|12414115|FG000|Overall Study|Protocol Violation|3
7902486|NCT01971346|12414115|FG000|Overall Study|Lost to Follow-up|2
7902487|NCT01971346|12414115|FG000|Overall Study|Withdrawal by Subject|2
7902488|NCT01971346|12414115|FG000|Overall Study|Physician Decision|1
7902489|NCT01971476|12414146|FG000|Cohort 1: 2 to <12 Years|Other not defined|3
7902490|NCT01971476|12414147|FG001|Cohort 1: 2 to <12 Years|Other not defined|3
7902491|NCT01971476|12414148|FG002|Cohort 1: 2 to <12 Years|Other not defined|6
7902492|NCT01971476|12414146|FG000|Cohort 2: 12 to <18 Years|Other not defined|6
7902493|NCT01971476|12414147|FG001|Cohort 2: 12 to <18 Years|Other not defined|3
7902494|NCT01971476|12414148|FG002|Cohort 2: 12 to <18 Years|Other not defined|0
7902495|NCT01971476|12414146|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0
7902496|NCT01971476|12414147|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1
7902497|NCT01971476|12414148|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0
7902498|NCT01971554|12414169|FG000|Overall Study|Lost to Follow-up|1
7902499|NCT01971554|12414170|FG001|Overall Study|Lost to Follow-up|0
7902500|NCT01971554|12414171|FG002|Overall Study|Lost to Follow-up|0
7902501|NCT01971554|12414172|FG003|Overall Study|Lost to Follow-up|0
7963708|NCT02726113|12518297|FG000|Total Enrollment|Withdrawal by Subject|2
7963709|NCT02726113|12518298|FG001|Total Enrollment|Withdrawal by Subject|1
7963710|NCT02726113|12518297|FG000|Total Enrollment|Insurance non-coverage for surgery|1
7963711|NCT02726113|12518298|FG001|Total Enrollment|Insurance non-coverage for surgery|1
7963712|NCT02726113|12518297|FG000|Genomic Analysis|Protocol Violation|1
7963713|NCT02726113|12518298|FG001|Genomic Analysis|Protocol Violation|0
7963714|NCT02726113|12518297|FG000|Genomic Analysis|Withdrawal by Subject|2
7963715|NCT02726113|12518298|FG001|Genomic Analysis|Withdrawal by Subject|1
7963716|NCT02726113|12518297|FG000|Genomic Analysis|Insurance non-coverage for surgery|1
7963717|NCT02726113|12518298|FG001|Genomic Analysis|Insurance non-coverage for surgery|1
7963718|NCT02726945|12518342|FG000|Overall Study|Withdrawal by Subject|0
7963719|NCT02726945|12518343|FG001|Overall Study|Withdrawal by Subject|0
7963720|NCT02726945|12518344|FG002|Overall Study|Withdrawal by Subject|1
7963721|NCT02726945|12518342|FG000|Overall Study|Elected to have total knee replacement|0
7963722|NCT02726945|12518343|FG001|Overall Study|Elected to have total knee replacement|1
7902502|NCT01971567|12414184|FG000|Overall Study|Withdrawal by Subject|3
7902503|NCT01971567|12414185|FG001|Overall Study|Withdrawal by Subject|2
7902504|NCT01971567|12414184|FG000|Overall Study|Lost to Follow-up|1
7902505|NCT01971567|12414185|FG001|Overall Study|Lost to Follow-up|0
7902506|NCT01971645|12414210|FG000|Overall Study|Adverse Event|1
7902507|NCT01971645|12414211|FG001|Overall Study|Adverse Event|0
7902508|NCT01971645|12414212|FG002|Overall Study|Adverse Event|0
7902509|NCT01971645|12414210|FG000|Overall Study|Lost to Follow-up|1
7902510|NCT01971645|12414211|FG001|Overall Study|Lost to Follow-up|0
7902511|NCT01971645|12414212|FG002|Overall Study|Lost to Follow-up|1
7902512|NCT01971645|12414210|FG000|Overall Study|Protocol Violation|0
7902513|NCT01971645|12414211|FG001|Overall Study|Protocol Violation|0
7902514|NCT01971645|12414212|FG002|Overall Study|Protocol Violation|1
7902515|NCT01971723|12414222|FG000|Overall Study|Withdrawal by Subject|1
7902516|NCT01971723|12414223|FG001|Overall Study|Withdrawal by Subject|1
7902517|NCT01971723|12414222|FG000|Overall Study|Protocol Violation|1
7902518|NCT01971723|12414223|FG001|Overall Study|Protocol Violation|2
7902519|NCT01972074|12414245|FG000|Overall Study|Adverse Event|4
7902520|NCT01972074|12414246|FG001|Overall Study|Adverse Event|1
7902521|NCT01972074|12414247|FG002|Overall Study|Adverse Event|0
7902522|NCT01972074|12414245|FG000|Overall Study|Lack of Efficacy|1
7902523|NCT01972074|12414246|FG001|Overall Study|Lack of Efficacy|1
7902524|NCT01972074|12414247|FG002|Overall Study|Lack of Efficacy|0
7902525|NCT01972074|12414245|FG000|Overall Study|Lost to Follow-up|0
7902526|NCT01972074|12414246|FG001|Overall Study|Lost to Follow-up|1
7902527|NCT01972074|12414247|FG002|Overall Study|Lost to Follow-up|1
7902528|NCT01972074|12414245|FG000|Overall Study|Withdrawal by Subject|1
7902529|NCT01972074|12414246|FG001|Overall Study|Withdrawal by Subject|1
7902530|NCT01972074|12414247|FG002|Overall Study|Withdrawal by Subject|1
7902531|NCT01972074|12414245|FG000|Overall Study|Scanner Unavailable|0
7902532|NCT01972074|12414246|FG001|Overall Study|Scanner Unavailable|0
7902533|NCT01972074|12414247|FG002|Overall Study|Scanner Unavailable|1
7902534|NCT01972152|12414254|FG000|First Treatment Visit|Lost to Follow-up|0
7902535|NCT01972152|12414255|FG001|First Treatment Visit|Lost to Follow-up|1
7902536|NCT01972152|12414256|FG002|First Treatment Visit|Lost to Follow-up|0
7902537|NCT01972152|12414257|FG003|First Treatment Visit|Lost to Follow-up|0
7902538|NCT01972152|12414258|FG004|First Treatment Visit|Lost to Follow-up|0
7902539|NCT01972152|12414259|FG005|First Treatment Visit|Lost to Follow-up|0
7902540|NCT01972152|12414254|FG000|Second Treatment Visit|Protocol Violation|0
7902541|NCT01972152|12414255|FG001|Second Treatment Visit|Protocol Violation|1
7902542|NCT01972152|12414256|FG002|Second Treatment Visit|Protocol Violation|0
7902543|NCT01972152|12414257|FG003|Second Treatment Visit|Protocol Violation|0
7902544|NCT01972152|12414258|FG004|Second Treatment Visit|Protocol Violation|0
7902545|NCT01972152|12414259|FG005|Second Treatment Visit|Protocol Violation|0
7902546|NCT01972438|12414285|FG000|Baseline-Month 3 Crossover Period|Death|1
7902547|NCT01972438|12414286|FG001|Baseline-Month 3 Crossover Period|Death|0
7902548|NCT01972438|12414285|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
7902549|NCT01972438|12414286|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
7902550|NCT01972438|12414285|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0
7902551|NCT01972438|12414286|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1
7902552|NCT01972438|12414285|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
7902553|NCT01972438|12414286|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
7902554|NCT01972438|12414285|FG000|Months 3-6 Crossover Period|Early Study Closure|0
7902555|NCT01972438|12414286|FG001|Months 3-6 Crossover Period|Early Study Closure|1
7902556|NCT01972438|12414285|FG000|Months 6-12 Study Period|Death|1
7902557|NCT01972438|12414286|FG001|Months 6-12 Study Period|Death|0
7902558|NCT01972438|12414285|FG000|Months 6-12 Study Period|Early Study Closure|2
7902559|NCT01972438|12414286|FG001|Months 6-12 Study Period|Early Study Closure|2
7902560|NCT01972438|12414285|FG000|Post Month 12 Study Period|Early Study Closure|3
7902561|NCT01972438|12414286|FG001|Post Month 12 Study Period|Early Study Closure|4
7902562|NCT01972464|12414296|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
7902563|NCT01972464|12414297|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
7902564|NCT01972464|12414296|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
7902565|NCT01972464|12414297|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
7902566|NCT01972464|12414296|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
7902567|NCT01972464|12414297|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
7902568|NCT01972464|12414296|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
7902569|NCT01972464|12414297|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
7902570|NCT01972529|12414317|FG000|Overall Study|Adverse Event|0
7902571|NCT01972529|12414318|FG001|Overall Study|Adverse Event|1
7902572|NCT01972529|12414319|FG002|Overall Study|Adverse Event|0
7902573|NCT01972529|12414320|FG003|Overall Study|Adverse Event|0
7902574|NCT01972529|12414317|FG000|Overall Study|Lost to Follow-up|1
7902575|NCT01972529|12414318|FG001|Overall Study|Lost to Follow-up|0
7902576|NCT01972529|12414319|FG002|Overall Study|Lost to Follow-up|0
7902577|NCT01972529|12414320|FG003|Overall Study|Lost to Follow-up|0
7902578|NCT01972529|12414317|FG000|Overall Study|Participant Choice|0
7902579|NCT01972529|12414318|FG001|Overall Study|Participant Choice|1
7902580|NCT01972529|12414319|FG002|Overall Study|Participant Choice|0
7902581|NCT01972529|12414320|FG003|Overall Study|Participant Choice|0
7902582|NCT01972529|12414317|FG000|Overall Study|Withdrawl of Consent|1
7902583|NCT01972529|12414318|FG001|Overall Study|Withdrawl of Consent|2
7902584|NCT01972529|12414319|FG002|Overall Study|Withdrawl of Consent|0
7902585|NCT01972529|12414320|FG003|Overall Study|Withdrawl of Consent|1
7902586|NCT01972529|12414317|FG000|Overall Study|Other|0
7902587|NCT01972529|12414318|FG001|Overall Study|Other|0
7902588|NCT01972529|12414319|FG002|Overall Study|Other|0
7902589|NCT01972529|12414320|FG003|Overall Study|Other|2
7902590|NCT01972529|12414317|FG000|Overall Study|Not treated|0
7902591|NCT01972529|12414318|FG001|Overall Study|Not treated|1
7902592|NCT01972529|12414319|FG002|Overall Study|Not treated|2
7902593|NCT01972529|12414320|FG003|Overall Study|Not treated|1
7968903|NCT02788279|12527179|FG002|Overall Study|Withdrawal by Subject|5
7968904|NCT02788279|12527177|FG000|Overall Study|Lost to Follow-up|0
7968905|NCT02788279|12527178|FG001|Overall Study|Lost to Follow-up|3
7968906|NCT02788279|12527179|FG002|Overall Study|Lost to Follow-up|2
7968907|NCT02788279|12527177|FG000|Overall Study|Sponsor decision|18
7968908|NCT02788279|12527178|FG001|Overall Study|Sponsor decision|29
7968909|NCT02788279|12527179|FG002|Overall Study|Sponsor decision|11
7968910|NCT02788357|12527192|FG000|Overall Study|Lost to Follow-up|3
7968911|NCT02788357|12527193|FG001|Overall Study|Lost to Follow-up|0
7968912|NCT02788474|12527201|FG000|Double Blind Treatment Period|Not treated|1
7968913|NCT02788474|12527202|FG001|Double Blind Treatment Period|Not treated|0
7968914|NCT02788474|12527201|FG000|Double Blind Treatment Period|Patient's refusal|3
7968915|NCT02788474|12527202|FG001|Double Blind Treatment Period|Patient's refusal|0
7968916|NCT02788474|12527201|FG000|Double Blind Treatment Period|Adverse Event|6
7968917|NCT02788474|12527202|FG001|Double Blind Treatment Period|Adverse Event|4
7968918|NCT02788474|12527201|FG000|Open Label Treatment Period|Adverse Event|29
7968919|NCT02788474|12527202|FG001|Open Label Treatment Period|Adverse Event|9
7968920|NCT02788474|12527201|FG000|Open Label Treatment Period|Other than reason specified|1
7968921|NCT02788474|12527202|FG001|Open Label Treatment Period|Other than reason specified|0
7968922|NCT02788474|12527201|FG000|Open Label Treatment Period|Patient's refusal|1
7968923|NCT02788474|12527202|FG001|Open Label Treatment Period|Patient's refusal|3
7968924|NCT02788474|12527201|FG000|Open Label Treatment Period|Non-compliance|1
7968925|NCT02788474|12527202|FG001|Open Label Treatment Period|Non-compliance|0
7968926|NCT02788513|12527214|FG000|Overall Study|Withdrawal by Subject|3
7968927|NCT02788513|12527215|FG001|Overall Study|Withdrawal by Subject|0
7968928|NCT02788513|12527216|FG002|Overall Study|Withdrawal by Subject|2
7968929|NCT02788513|12527217|FG003|Overall Study|Withdrawal by Subject|3
7968930|NCT02788513|12527218|FG004|Overall Study|Withdrawal by Subject|1
7968931|NCT02788513|12527214|FG000|Overall Study|Lost to Follow-up|1
7968932|NCT02788513|12527215|FG001|Overall Study|Lost to Follow-up|0
7968933|NCT02788513|12527216|FG002|Overall Study|Lost to Follow-up|0
7968934|NCT02788513|12527217|FG003|Overall Study|Lost to Follow-up|0
7968935|NCT02788513|12527218|FG004|Overall Study|Lost to Follow-up|1
7968936|NCT02788513|12527214|FG000|Overall Study|Adverse Event|5
7968937|NCT02788513|12527215|FG001|Overall Study|Adverse Event|8
7968938|NCT02788513|12527216|FG002|Overall Study|Adverse Event|4
7968939|NCT02788513|12527217|FG003|Overall Study|Adverse Event|2
7968940|NCT02788513|12527218|FG004|Overall Study|Adverse Event|2
7968941|NCT02788513|12527214|FG000|Overall Study|Protocol Violation|0
7968942|NCT02788513|12527215|FG001|Overall Study|Protocol Violation|0
7968943|NCT02788513|12527216|FG002|Overall Study|Protocol Violation|1
7968944|NCT02788513|12527217|FG003|Overall Study|Protocol Violation|1
7968945|NCT02788513|12527218|FG004|Overall Study|Protocol Violation|0
7968946|NCT02788513|12527214|FG000|Overall Study|Subject decided to stop taking treatment|0
7968947|NCT02788513|12527215|FG001|Overall Study|Subject decided to stop taking treatment|0
7968948|NCT02788513|12527216|FG002|Overall Study|Subject decided to stop taking treatment|1
7968949|NCT02788513|12527217|FG003|Overall Study|Subject decided to stop taking treatment|0
7968950|NCT02788513|12527218|FG004|Overall Study|Subject decided to stop taking treatment|0
7968951|NCT02788513|12527214|FG000|Overall Study|Decision by the study team|0
7968952|NCT02788513|12527215|FG001|Overall Study|Decision by the study team|0
7968953|NCT02788513|12527216|FG002|Overall Study|Decision by the study team|0
7968954|NCT02788513|12527217|FG003|Overall Study|Decision by the study team|0
7968955|NCT02788513|12527218|FG004|Overall Study|Decision by the study team|1
7968956|NCT02788656|12527232|FG000|Overall Study|Withdrawal by Subject|1
7968957|NCT02788656|12527233|FG001|Overall Study|Withdrawal by Subject|0
7968958|NCT02788747|12527242|FG000|Overall Study|Adverse Event|1
7968959|NCT02788747|12527243|FG001|Overall Study|Adverse Event|0
7968960|NCT02788747|12527244|FG002|Overall Study|Adverse Event|0
7968961|NCT02789111|12527285|FG000|Overall Study|Withdrawal by Subject|1
7968962|NCT02789111|12527286|FG001|Overall Study|Withdrawal by Subject|4
7968963|NCT02789137|12527294|FG000|Overall Study|Dropped out/Died|58
7968964|NCT02789176|12527303|FG000|Overall Study|Death|0
7968965|NCT02789176|12527304|FG001|Overall Study|Death|0
7968966|NCT02789176|12527305|FG002|Overall Study|Death|3
7968967|NCT02789176|12527306|FG003|Overall Study|Death|0
7968968|NCT02789176|12527303|FG000|Overall Study|Withdrawal by Subject|0
7968969|NCT02789176|12527304|FG001|Overall Study|Withdrawal by Subject|0
7968970|NCT02789176|12527305|FG002|Overall Study|Withdrawal by Subject|1
7968971|NCT02789176|12527306|FG003|Overall Study|Withdrawal by Subject|0
7968972|NCT02789176|12527303|FG000|Overall Study|Lost to Follow-up|8
7902594|NCT01972568|12414334|FG000|Overall Study|Other events|3
7902595|NCT01972568|12414335|FG001|Overall Study|Other events|0
7968973|NCT02789176|12527304|FG001|Overall Study|Lost to Follow-up|2
7968974|NCT02789176|12527305|FG002|Overall Study|Lost to Follow-up|6
7968975|NCT02789176|12527306|FG003|Overall Study|Lost to Follow-up|1
7968976|NCT02790073|12527325|FG000|Overall Study|Death|1
7968977|NCT02790073|12527325|FG000|Overall Study|Withdrawal from HD|1
7968978|NCT02790073|12527325|FG000|Overall Study|Withdrawal by Subject|1
7968979|NCT02790437|12527335|FG000|Overall Study|Patient graft failure - nephrectomy|1
7968980|NCT02790437|12527336|FG001|Overall Study|Patient graft failure - nephrectomy|0
7902596|NCT01972568|12414336|FG002|Overall Study|Other events|0
7902597|NCT01972568|12414334|FG000|Overall Study|Lack of Efficacy|0
7902598|NCT01972568|12414335|FG001|Overall Study|Lack of Efficacy|1
7902599|NCT01972568|12414336|FG002|Overall Study|Lack of Efficacy|2
7902600|NCT01972568|12414334|FG000|Overall Study|Protocol Violation|1
7902601|NCT01972568|12414335|FG001|Overall Study|Protocol Violation|2
7902602|NCT01972568|12414336|FG002|Overall Study|Protocol Violation|2
7902603|NCT01972568|12414334|FG000|Overall Study|Withdrawal by Subject|6
7902604|NCT01972568|12414335|FG001|Overall Study|Withdrawal by Subject|3
7902605|NCT01972568|12414336|FG002|Overall Study|Withdrawal by Subject|7
7902606|NCT01972568|12414334|FG000|Overall Study|Lost to Follow-up|1
7902607|NCT01972568|12414335|FG001|Overall Study|Lost to Follow-up|0
7902608|NCT01972568|12414336|FG002|Overall Study|Lost to Follow-up|0
7902609|NCT01972568|12414334|FG000|Overall Study|Adverse Event|5
7902610|NCT01972568|12414335|FG001|Overall Study|Adverse Event|6
7902611|NCT01972568|12414336|FG002|Overall Study|Adverse Event|5
7902612|NCT01972659|12414346|FG000|Overall Study|Protocol Violation|2
7902613|NCT01972659|12414347|FG001|Overall Study|Protocol Violation|2
7902614|NCT01972659|12414346|FG000|Overall Study|problems realted to acceleromyograph|2
7902615|NCT01972659|12414347|FG001|Overall Study|problems realted to acceleromyograph|1
7902616|NCT01972724|12414356|FG000|Double-Blind|Rescue Criteria Met|1
7902617|NCT01972724|12414357|FG001|Double-Blind|Rescue Criteria Met|0
7902618|NCT01972724|12414358|FG002|Double-Blind|Rescue Criteria Met|0
7902619|NCT01972724|12414356|FG000|Double-Blind|Adverse Event|1
7902620|NCT01972724|12414357|FG001|Double-Blind|Adverse Event|0
7902621|NCT01972724|12414358|FG002|Double-Blind|Adverse Event|0
7902622|NCT01972724|12414356|FG000|Double-Blind|Withdrawal of Consent|2
7902623|NCT01972724|12414357|FG001|Double-Blind|Withdrawal of Consent|1
7902624|NCT01972724|12414358|FG002|Double-Blind|Withdrawal of Consent|0
7902625|NCT01972724|12414356|FG000|Double-Blind|Significant Protocol Deviation|5
7902626|NCT01972724|12414357|FG001|Double-Blind|Significant Protocol Deviation|8
7902627|NCT01972724|12414358|FG002|Double-Blind|Significant Protocol Deviation|0
7902628|NCT01972724|12414356|FG000|Open-Label|Withdrew Consent|0
7902629|NCT01972724|12414357|FG001|Open-Label|Withdrew Consent|0
7902630|NCT01972724|12414358|FG002|Open-Label|Withdrew Consent|3
7902631|NCT01972724|12414356|FG000|Open-Label|Significant Protocol Deviation|0
7902632|NCT01972724|12414357|FG001|Open-Label|Significant Protocol Deviation|0
7902633|NCT01972724|12414358|FG002|Open-Label|Significant Protocol Deviation|2
7902634|NCT01972776|12414372|FG000|Part 1|Withdrawal by Subject|0
7902635|NCT01972776|12414373|FG001|Part 1|Withdrawal by Subject|0
7902636|NCT01972776|12414374|FG002|Part 1|Withdrawal by Subject|1
7902637|NCT01972776|12414375|FG003|Part 1|Withdrawal by Subject|0
7902638|NCT01972776|12414376|FG004|Part 1|Withdrawal by Subject|0
7902639|NCT01972776|12414377|FG005|Part 1|Withdrawal by Subject|0
7902640|NCT01972776|12414372|FG000|Part 1|Adverse Event|0
7902641|NCT01972776|12414373|FG001|Part 1|Adverse Event|0
7902642|NCT01972776|12414374|FG002|Part 1|Adverse Event|1
7902643|NCT01972776|12414375|FG003|Part 1|Adverse Event|1
7902644|NCT01972776|12414376|FG004|Part 1|Adverse Event|0
7902645|NCT01972776|12414377|FG005|Part 1|Adverse Event|0
7902646|NCT01972776|12414372|FG000|Part 2|Adverse Event|0
7902647|NCT01972776|12414373|FG001|Part 2|Adverse Event|0
7902648|NCT01972776|12414374|FG002|Part 2|Adverse Event|0
7902649|NCT01972776|12414375|FG003|Part 2|Adverse Event|0
7902650|NCT01972776|12414376|FG004|Part 2|Adverse Event|3
7902651|NCT01972776|12414377|FG005|Part 2|Adverse Event|0
7902652|NCT01972776|12414372|FG000|Part 2|Administrative problems|0
7902653|NCT01972776|12414373|FG001|Part 2|Administrative problems|0
7902654|NCT01972776|12414374|FG002|Part 2|Administrative problems|0
7902655|NCT01972776|12414375|FG003|Part 2|Administrative problems|0
7902656|NCT01972776|12414376|FG004|Part 2|Administrative problems|10
7902657|NCT01972776|12414377|FG005|Part 2|Administrative problems|7
7902658|NCT01972789|12414393|FG000|Overall Study|Adverse Event|11
7902659|NCT01972789|12414394|FG001|Overall Study|Adverse Event|4
7902660|NCT01972789|12414393|FG000|Overall Study|Subject withdrew consent|14
7902661|NCT01972789|12414394|FG001|Overall Study|Subject withdrew consent|12
7902662|NCT01972789|12414393|FG000|Overall Study|Lost to Follow-up|4
7902663|NCT01972789|12414394|FG001|Overall Study|Lost to Follow-up|7
7902664|NCT01972789|12414393|FG000|Overall Study|Death|7
7902665|NCT01972789|12414394|FG001|Overall Study|Death|5
7902666|NCT01972789|12414393|FG000|Overall Study|Protocol deviation|1
7902667|NCT01972789|12414394|FG001|Overall Study|Protocol deviation|0
7902668|NCT01972789|12414393|FG000|Overall Study|Physician Decision|3
7902669|NCT01972789|12414394|FG001|Overall Study|Physician Decision|2
7902670|NCT01972841|12414406|FG000|Overall Study|Randomized but Never Received Treatment|2
7902671|NCT01972841|12414407|FG001|Overall Study|Randomized but Never Received Treatment|5
7902672|NCT01972841|12414408|FG002|Overall Study|Randomized but Never Received Treatment|4
7902673|NCT01972841|12414409|FG003|Overall Study|Randomized but Never Received Treatment|2
7902674|NCT01972841|12414410|FG004|Overall Study|Randomized but Never Received Treatment|6
7902675|NCT01972841|12414411|FG005|Overall Study|Randomized but Never Received Treatment|13
7902676|NCT01972841|12414406|FG000|Overall Study|Adverse Event|13
7902677|NCT01972841|12414407|FG001|Overall Study|Adverse Event|8
7902678|NCT01972841|12414408|FG002|Overall Study|Adverse Event|12
7902679|NCT01972841|12414409|FG003|Overall Study|Adverse Event|9
7902680|NCT01972841|12414410|FG004|Overall Study|Adverse Event|21
7902681|NCT01972841|12414411|FG005|Overall Study|Adverse Event|26
7902682|NCT01972841|12414406|FG000|Overall Study|Lack of Efficacy|1
7902683|NCT01972841|12414407|FG001|Overall Study|Lack of Efficacy|0
7902684|NCT01972841|12414408|FG002|Overall Study|Lack of Efficacy|0
7902685|NCT01972841|12414409|FG003|Overall Study|Lack of Efficacy|2
7902686|NCT01972841|12414410|FG004|Overall Study|Lack of Efficacy|4
7902687|NCT01972841|12414411|FG005|Overall Study|Lack of Efficacy|1
7902688|NCT01972841|12414406|FG000|Overall Study|Lost to Follow-up|4
7902689|NCT01972841|12414407|FG001|Overall Study|Lost to Follow-up|2
7902690|NCT01972841|12414408|FG002|Overall Study|Lost to Follow-up|4
7902691|NCT01972841|12414409|FG003|Overall Study|Lost to Follow-up|2
7902692|NCT01972841|12414410|FG004|Overall Study|Lost to Follow-up|9
7902693|NCT01972841|12414411|FG005|Overall Study|Lost to Follow-up|3
7902694|NCT01972841|12414406|FG000|Overall Study|Protocol Violation|2
7902695|NCT01972841|12414407|FG001|Overall Study|Protocol Violation|2
7902696|NCT01972841|12414408|FG002|Overall Study|Protocol Violation|3
7902697|NCT01972841|12414409|FG003|Overall Study|Protocol Violation|5
7902698|NCT01972841|12414410|FG004|Overall Study|Protocol Violation|9
7902699|NCT01972841|12414411|FG005|Overall Study|Protocol Violation|4
7902700|NCT01972841|12414406|FG000|Overall Study|Withdrawal by participants|21
7902701|NCT01972841|12414407|FG001|Overall Study|Withdrawal by participants|27
7902702|NCT01972841|12414408|FG002|Overall Study|Withdrawal by participants|23
7902703|NCT01972841|12414409|FG003|Overall Study|Withdrawal by participants|16
7902704|NCT01972841|12414410|FG004|Overall Study|Withdrawal by participants|33
7902705|NCT01972841|12414411|FG005|Overall Study|Withdrawal by participants|34
7902706|NCT01972841|12414406|FG000|Overall Study|Miscellaneous|0
7902707|NCT01972841|12414407|FG001|Overall Study|Miscellaneous|0
7902708|NCT01972841|12414408|FG002|Overall Study|Miscellaneous|4
7902709|NCT01972841|12414409|FG003|Overall Study|Miscellaneous|1
7902710|NCT01972841|12414410|FG004|Overall Study|Miscellaneous|0
7902711|NCT01972841|12414411|FG005|Overall Study|Miscellaneous|4
7902712|NCT01972841|12414406|FG000|Overall Study|Did not have end of treatment page|0
7902713|NCT01972841|12414407|FG001|Overall Study|Did not have end of treatment page|0
7902714|NCT01972841|12414408|FG002|Overall Study|Did not have end of treatment page|0
7902715|NCT01972841|12414409|FG003|Overall Study|Did not have end of treatment page|0
7902716|NCT01972841|12414410|FG004|Overall Study|Did not have end of treatment page|1
7902717|NCT01972841|12414411|FG005|Overall Study|Did not have end of treatment page|0
7902718|NCT01973218|12414446|FG000|Overall Study|Adverse Event|1
7902719|NCT01973218|12414447|FG001|Overall Study|Adverse Event|0
7902720|NCT01973218|12414446|FG000|Overall Study|Withdrawal by Subject|1
7902721|NCT01973218|12414447|FG001|Overall Study|Withdrawal by Subject|0
7902722|NCT01973231|12414457|FG000|Overall Study|Protocol Violation|1
7902723|NCT01973231|12414458|FG001|Overall Study|Protocol Violation|1
7902724|NCT01973231|12414457|FG000|Overall Study|Lost to Follow-up|1
7902725|NCT01973231|12414458|FG001|Overall Study|Lost to Follow-up|1
7902726|NCT01973231|12414457|FG000|Overall Study|unclassified|2
7902727|NCT01973231|12414458|FG001|Overall Study|unclassified|1
7902728|NCT01973231|12414457|FG000|Overall Study|Withdrawal by Subject|7
7902729|NCT01973231|12414458|FG001|Overall Study|Withdrawal by Subject|9
7902730|NCT01973283|12414464|FG000|Overall Study|Lost to Follow-up|4
7902731|NCT01973387|12414506|FG000|Overall Study|Adverse Event|14
7902732|NCT01973387|12414507|FG001|Overall Study|Adverse Event|4
7902733|NCT01973387|12414506|FG000|Overall Study|Withdrawal by Subject|7
7902734|NCT01973387|12414507|FG001|Overall Study|Withdrawal by Subject|4
7902735|NCT01973387|12414506|FG000|Overall Study|Study terminated by sponsor|63
7902736|NCT01973387|12414507|FG001|Overall Study|Study terminated by sponsor|0
7902737|NCT01973387|12414506|FG000|Overall Study|Progressive disease or relapse|16
7902738|NCT01973387|12414507|FG001|Overall Study|Progressive disease or relapse|5
7902739|NCT01973387|12414506|FG000|Overall Study|Death|4
7902740|NCT01973387|12414507|FG001|Overall Study|Death|3
7902741|NCT01973387|12414506|FG000|Overall Study|Randomized, not treated|2
7902742|NCT01973387|12414507|FG001|Overall Study|Randomized, not treated|2
7902743|NCT01973439|12414523|FG000|Overall Study|Lost samples from one PK Day|2
7902744|NCT01973439|12414523|FG000|Overall Study|Vomiting after commencing once daily|1
7902745|NCT01973439|12414523|FG000|Overall Study|PK curve incomplete|2
7902746|NCT01973491|12414527|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
7902747|NCT01973491|12414527|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
7902748|NCT01973491|12414527|FG000|Treatment Period (16 Weeks)|Adverse Event|1
7902749|NCT01973569|12414534|FG000|Overall Study|Adverse Event|9
7902750|NCT01973569|12414535|FG001|Overall Study|Adverse Event|2
7902751|NCT01973569|12414536|FG002|Overall Study|Adverse Event|4
7902752|NCT01973569|12414534|FG000|Overall Study|Protocol Violation|2
7902753|NCT01973569|12414535|FG001|Overall Study|Protocol Violation|1
7902754|NCT01973569|12414536|FG002|Overall Study|Protocol Violation|3
7902755|NCT01973569|12414534|FG000|Overall Study|Withdrawal by Subject|7
7902756|NCT01973569|12414535|FG001|Overall Study|Withdrawal by Subject|5
7902757|NCT01973569|12414536|FG002|Overall Study|Withdrawal by Subject|2
7902758|NCT01973569|12414534|FG000|Overall Study|Invasive dental treatment|3
7902759|NCT01973569|12414535|FG001|Overall Study|Invasive dental treatment|5
7902760|NCT01973569|12414536|FG002|Overall Study|Invasive dental treatment|6
7902761|NCT01973569|12414534|FG000|Overall Study|Prohibited concomitant d|1
7902762|NCT01973569|12414535|FG001|Overall Study|Prohibited concomitant d|5
7902763|NCT01973569|12414536|FG002|Overall Study|Prohibited concomitant d|0
7902764|NCT01973569|12414534|FG000|Overall Study|Disease progression|0
7902765|NCT01973569|12414535|FG001|Overall Study|Disease progression|3
7902766|NCT01973569|12414536|FG002|Overall Study|Disease progression|0
7902767|NCT01973569|12414534|FG000|Overall Study|Other|1
7902768|NCT01973569|12414535|FG001|Overall Study|Other|1
7902769|NCT01973569|12414536|FG002|Overall Study|Other|0
7902770|NCT01973569|12414534|FG000|Overall Study|Did not receive study drug|6
7902771|NCT01973569|12414535|FG001|Overall Study|Did not receive study drug|3
7902772|NCT01973569|12414536|FG002|Overall Study|Did not receive study drug|3
7902773|NCT01973595|12414548|FG000|Washout|Withdrawal by Subject|1
7902774|NCT01973595|12414549|FG001|Washout|Withdrawal by Subject|0
7902775|NCT01973595|12414550|FG002|Washout|Withdrawal by Subject|1
7902776|NCT01973595|12414551|FG003|Washout|Withdrawal by Subject|0
7902777|NCT01973998|12414598|FG000|Overall Study|Death|2
7902778|NCT01973998|12414599|FG001|Overall Study|Death|2
7902779|NCT01974141|12414633|FG000|Overall Study|Other Reasons|28
7902780|NCT01974141|12414634|FG001|Overall Study|Other Reasons|18
7902781|NCT01974141|12414633|FG000|Overall Study|Protocol Violation|2
7902782|NCT01974141|12414634|FG001|Overall Study|Protocol Violation|6
7902783|NCT01974141|12414633|FG000|Overall Study|Personal Reasons|21
7902784|NCT01974141|12414634|FG001|Overall Study|Personal Reasons|20
7902785|NCT01974141|12414633|FG000|Overall Study|Lost to Follow-up|38
7902786|NCT01974141|12414634|FG001|Overall Study|Lost to Follow-up|29
7902787|NCT01974141|12414633|FG000|Overall Study|Pregnancy|3
7902788|NCT01974141|12414634|FG001|Overall Study|Pregnancy|3
7902789|NCT01974141|12414633|FG000|Overall Study|Lack of Efficacy|0
7902790|NCT01974141|12414634|FG001|Overall Study|Lack of Efficacy|1
7902791|NCT01974141|12414633|FG000|Overall Study|Adverse Event|4
7902792|NCT01974141|12414634|FG001|Overall Study|Adverse Event|5
7902793|NCT01974323|12414651|FG000|Overall Study|Other Reasons|25
7902794|NCT01974323|12414652|FG001|Overall Study|Other Reasons|28
7902795|NCT01974323|12414651|FG000|Overall Study|Protocol Violation|2
7902796|NCT01974323|12414652|FG001|Overall Study|Protocol Violation|2
7902797|NCT01974323|12414651|FG000|Overall Study|Personal Reasons|15
7902798|NCT01974323|12414652|FG001|Overall Study|Personal Reasons|19
7902799|NCT01974323|12414651|FG000|Overall Study|Lost to Follow-up|45
7902800|NCT01974323|12414652|FG001|Overall Study|Lost to Follow-up|40
7902801|NCT01974323|12414651|FG000|Overall Study|Pregnancy|2
7902802|NCT01974323|12414652|FG001|Overall Study|Pregnancy|1
7902803|NCT01974323|12414651|FG000|Overall Study|Lack of Efficacy|1
7902804|NCT01974323|12414652|FG001|Overall Study|Lack of Efficacy|1
7902805|NCT01974323|12414651|FG000|Overall Study|Adverse Event|2
7902806|NCT01974323|12414652|FG001|Overall Study|Adverse Event|2
7902807|NCT01974752|12414798|FG000|Overall Study|Death|33
7902808|NCT01974752|12414799|FG001|Overall Study|Death|11
7902809|NCT01974752|12414798|FG000|Overall Study|Lost to Follow-up|2
7902810|NCT01974752|12414799|FG001|Overall Study|Lost to Follow-up|0
7902811|NCT01974752|12414798|FG000|Overall Study|Withdrawal by Subject|2
7902812|NCT01974752|12414799|FG001|Overall Study|Withdrawal by Subject|3
7902813|NCT01974752|12414798|FG000|Overall Study|Other Eligibility Criteria|0
7902814|NCT01974752|12414799|FG001|Overall Study|Other Eligibility Criteria|1
7902815|NCT01974817|12414805|FG000|Overall Study|Death|4
7902816|NCT01974817|12414805|FG000|Overall Study|Lost to Follow-up|2
7902817|NCT01974817|12414805|FG000|Overall Study|Protocol Violation|2
7902818|NCT01974895|12414811|FG000|Overall Study|Protocol Violation|1
7902819|NCT01974895|12414812|FG001|Overall Study|Protocol Violation|0
7902820|NCT01974895|12414811|FG000|Overall Study|Lost to Follow-up|4
7902821|NCT01974895|12414812|FG001|Overall Study|Lost to Follow-up|6
7902822|NCT01974895|12414811|FG000|Overall Study|Withdrawal by Subject|0
7902823|NCT01974895|12414812|FG001|Overall Study|Withdrawal by Subject|1
7902824|NCT01974895|12414811|FG000|Overall Study|Other (Missed Visit)|1
7902825|NCT01974895|12414812|FG001|Overall Study|Other (Missed Visit)|0
7902826|NCT01974895|12414811|FG000|Overall Study|Other (Reason unknown)|9
7902827|NCT01974895|12414812|FG001|Overall Study|Other (Reason unknown)|8
7902828|NCT01975220|12414831|FG000|Test Period 1|Not treated|0
7902829|NCT01975220|12414832|FG001|Test Period 1|Not treated|1
7902830|NCT01975220|12414833|FG002|Test Period 1|Not treated|0
7902831|NCT01975220|12414834|FG003|Test Period 1|Not treated|0
7902832|NCT01975220|12414835|FG004|Test Period 1|Not treated|0
7902833|NCT01975220|12414836|FG005|Test Period 1|Not treated|0
7902834|NCT01975246|12414853|FG000|Overall Study|Adverse Event|2
7902835|NCT01975246|12414854|FG001|Overall Study|Adverse Event|1
7902836|NCT01975246|12414853|FG000|Overall Study|Lack of Efficacy|1
7902837|NCT01975246|12414854|FG001|Overall Study|Lack of Efficacy|0
7902838|NCT01975246|12414853|FG000|Overall Study|Protocol Violation|1
7902839|NCT01975246|12414854|FG001|Overall Study|Protocol Violation|0
7902840|NCT01975246|12414853|FG000|Overall Study|Other than stated|0
7902841|NCT01975246|12414854|FG001|Overall Study|Other than stated|1
7902842|NCT01975285|12414862|FG000|Overall Study|Failed Block and follow up|2
7902843|NCT01975285|12414863|FG001|Overall Study|Failed Block and follow up|2
7902844|NCT01975376|12414871|FG000|Overall Study|Adverse Event|5
7902845|NCT01975376|12414872|FG001|Overall Study|Adverse Event|5
7902846|NCT01975376|12414871|FG000|Overall Study|Death|65
7902847|NCT01975376|12414872|FG001|Overall Study|Death|72
7902848|NCT01975376|12414871|FG000|Overall Study|Lost to Follow-up|70
7902849|NCT01975376|12414872|FG001|Overall Study|Lost to Follow-up|66
7902850|NCT01975376|12414871|FG000|Overall Study|Withdrew consent|68
7902851|NCT01975376|12414872|FG001|Overall Study|Withdrew consent|62
7902852|NCT01975376|12414871|FG000|Overall Study|Other|2
7902853|NCT01975376|12414872|FG001|Overall Study|Other|4
7902854|NCT01975376|12414871|FG000|Overall Study|Randomized, Not Treated|16
7902855|NCT01975376|12414872|FG001|Overall Study|Randomized, Not Treated|8
7902856|NCT01975389|12414880|FG000|Overall Study|Adverse Event|10
7902857|NCT01975389|12414881|FG001|Overall Study|Adverse Event|6
7902858|NCT01975389|12414880|FG000|Overall Study|Death|61
7902859|NCT01975389|12414881|FG001|Overall Study|Death|54
7902860|NCT01975389|12414880|FG000|Overall Study|Lost to Follow-up|81
7902861|NCT01975389|12414881|FG001|Overall Study|Lost to Follow-up|86
7902862|NCT01975389|12414880|FG000|Overall Study|Withdrawal by Subject|90
7902863|NCT01975389|12414881|FG001|Overall Study|Withdrawal by Subject|76
7902864|NCT01975389|12414880|FG000|Overall Study|Other|6
7902865|NCT01975389|12414881|FG001|Overall Study|Other|9
7902866|NCT01975389|12414880|FG000|Overall Study|Randomized, not treated|4
7902867|NCT01975389|12414881|FG001|Overall Study|Randomized, not treated|5
7902868|NCT01975428|12414889|FG000|Overall Study|Lost to Follow-up|17
7902869|NCT01975428|12414890|FG001|Overall Study|Lost to Follow-up|4
7902870|NCT01975428|12414889|FG000|Overall Study|Withdrawal by Subject|3
7902871|NCT01975428|12414890|FG001|Overall Study|Withdrawal by Subject|10
7902872|NCT01975675|12414917|FG000|Overall Study|Death|0
7902873|NCT01975675|12414918|FG001|Overall Study|Death|1
7902874|NCT01975675|12414919|FG002|Overall Study|Death|0
7902875|NCT01975675|12414920|FG003|Overall Study|Death|0
7902876|NCT01975701|12414930|FG000|Overall Study|Lost to Follow-up|1
7902877|NCT01975701|12414930|FG000|Overall Study|Death|23
7902878|NCT01975701|12414930|FG000|Overall Study|Physician Decision|1
7902879|NCT01975831|12414943|FG000|Overall Study|Adverse Event|1
7902880|NCT01975831|12414944|FG001|Overall Study|Adverse Event|2
7902881|NCT01975831|12414945|FG002|Overall Study|Adverse Event|2
7902882|NCT01975831|12414946|FG003|Overall Study|Adverse Event|0
7902883|NCT01975831|12414947|FG004|Overall Study|Adverse Event|1
7902884|NCT01975831|12414948|FG005|Overall Study|Adverse Event|1
7902885|NCT01975831|12414949|FG006|Overall Study|Adverse Event|3
7902886|NCT01975831|12414950|FG007|Overall Study|Adverse Event|4
7902887|NCT01975831|12414951|FG008|Overall Study|Adverse Event|1
7902888|NCT01975831|12414943|FG000|Overall Study|Death|1
7902889|NCT01975831|12414944|FG001|Overall Study|Death|1
7902890|NCT01975831|12414945|FG002|Overall Study|Death|0
7902891|NCT01975831|12414946|FG003|Overall Study|Death|0
7902892|NCT01975831|12414947|FG004|Overall Study|Death|1
7902893|NCT01975831|12414948|FG005|Overall Study|Death|0
7902894|NCT01975831|12414949|FG006|Overall Study|Death|1
7902895|NCT01975831|12414950|FG007|Overall Study|Death|0
7902896|NCT01975831|12414951|FG008|Overall Study|Death|0
7902897|NCT01975831|12414943|FG000|Overall Study|Progressive Disease|1
7902898|NCT01975831|12414944|FG001|Overall Study|Progressive Disease|3
7902899|NCT01975831|12414945|FG002|Overall Study|Progressive Disease|2
7902900|NCT01975831|12414946|FG003|Overall Study|Progressive Disease|4
7902901|NCT01975831|12414947|FG004|Overall Study|Progressive Disease|13
7902902|NCT01975831|12414948|FG005|Overall Study|Progressive Disease|9
7902903|NCT01975831|12414949|FG006|Overall Study|Progressive Disease|10
7902904|NCT01975831|12414950|FG007|Overall Study|Progressive Disease|8
7902905|NCT01975831|12414951|FG008|Overall Study|Progressive Disease|10
7902906|NCT01975831|12414943|FG000|Overall Study|Withdrawal by Subject|0
7902907|NCT01975831|12414944|FG001|Overall Study|Withdrawal by Subject|3
7902908|NCT01975831|12414945|FG002|Overall Study|Withdrawal by Subject|0
7902909|NCT01975831|12414946|FG003|Overall Study|Withdrawal by Subject|0
7902910|NCT01975831|12414947|FG004|Overall Study|Withdrawal by Subject|3
7902911|NCT01975831|12414948|FG005|Overall Study|Withdrawal by Subject|1
7902912|NCT01975831|12414949|FG006|Overall Study|Withdrawal by Subject|1
7902913|NCT01975831|12414950|FG007|Overall Study|Withdrawal by Subject|0
7902914|NCT01975831|12414951|FG008|Overall Study|Withdrawal by Subject|0
7902915|NCT01975831|12414943|FG000|Overall Study|Physician Decision|0
7902916|NCT01975831|12414944|FG001|Overall Study|Physician Decision|0
7902917|NCT01975831|12414945|FG002|Overall Study|Physician Decision|0
7902918|NCT01975831|12414946|FG003|Overall Study|Physician Decision|0
7902919|NCT01975831|12414947|FG004|Overall Study|Physician Decision|0
7902920|NCT01975831|12414948|FG005|Overall Study|Physician Decision|1
7902921|NCT01975831|12414949|FG006|Overall Study|Physician Decision|0
7902922|NCT01975831|12414950|FG007|Overall Study|Physician Decision|1
7902923|NCT01975831|12414951|FG008|Overall Study|Physician Decision|0
7902924|NCT01975831|12414943|FG000|Overall Study|Initiation of Subsequent Therapy|0
7902925|NCT01975831|12414944|FG001|Overall Study|Initiation of Subsequent Therapy|0
7902926|NCT01975831|12414945|FG002|Overall Study|Initiation of Subsequent Therapy|0
7902927|NCT01975831|12414946|FG003|Overall Study|Initiation of Subsequent Therapy|0
7902928|NCT01975831|12414947|FG004|Overall Study|Initiation of Subsequent Therapy|0
7902929|NCT01975831|12414948|FG005|Overall Study|Initiation of Subsequent Therapy|1
7902930|NCT01975831|12414949|FG006|Overall Study|Initiation of Subsequent Therapy|0
7902931|NCT01975831|12414950|FG007|Overall Study|Initiation of Subsequent Therapy|2
7902932|NCT01975831|12414951|FG008|Overall Study|Initiation of Subsequent Therapy|0
7902933|NCT01975831|12414943|FG000|Overall Study|Entered Hospice|0
7902934|NCT01975831|12414944|FG001|Overall Study|Entered Hospice|0
7902935|NCT01975831|12414945|FG002|Overall Study|Entered Hospice|0
7902936|NCT01975831|12414946|FG003|Overall Study|Entered Hospice|0
7902937|NCT01975831|12414947|FG004|Overall Study|Entered Hospice|0
7902938|NCT01975831|12414948|FG005|Overall Study|Entered Hospice|1
7902939|NCT01975831|12414949|FG006|Overall Study|Entered Hospice|0
7902940|NCT01975831|12414950|FG007|Overall Study|Entered Hospice|0
7902941|NCT01975831|12414951|FG008|Overall Study|Entered Hospice|0
7902942|NCT01975831|12414943|FG000|Overall Study|Unable to Treat Within Protocol Windows|0
7902943|NCT01975831|12414944|FG001|Overall Study|Unable to Treat Within Protocol Windows|0
7902944|NCT01975831|12414945|FG002|Overall Study|Unable to Treat Within Protocol Windows|0
7902945|NCT01975831|12414946|FG003|Overall Study|Unable to Treat Within Protocol Windows|0
7902946|NCT01975831|12414947|FG004|Overall Study|Unable to Treat Within Protocol Windows|0
7902947|NCT01975831|12414948|FG005|Overall Study|Unable to Treat Within Protocol Windows|0
7902948|NCT01975831|12414949|FG006|Overall Study|Unable to Treat Within Protocol Windows|1
7902949|NCT01975831|12414950|FG007|Overall Study|Unable to Treat Within Protocol Windows|0
7902950|NCT01975831|12414951|FG008|Overall Study|Unable to Treat Within Protocol Windows|1
7902951|NCT01975948|12415002|FG000|Overall Study|Withdrawal by Subject|17
7902952|NCT01975948|12415003|FG001|Overall Study|Withdrawal by Subject|21
7902953|NCT01975948|12415004|FG002|Overall Study|Withdrawal by Subject|7
7902954|NCT01975948|12415005|FG003|Overall Study|Withdrawal by Subject|6
7902955|NCT01976104|12415023|FG000|Overall Study|Adverse Event|0
7902956|NCT01976104|12415024|FG001|Overall Study|Adverse Event|0
7902957|NCT01976104|12415025|FG002|Overall Study|Adverse Event|1
7902958|NCT01976104|12415026|FG003|Overall Study|Adverse Event|0
7902959|NCT01976104|12415023|FG000|Overall Study|Lost to Follow-up|3
7902960|NCT01976104|12415024|FG001|Overall Study|Lost to Follow-up|0
7902961|NCT01976104|12415025|FG002|Overall Study|Lost to Follow-up|1
7902962|NCT01976104|12415026|FG003|Overall Study|Lost to Follow-up|1
7902963|NCT01976104|12415023|FG000|Overall Study|Subject Choice|0
7902964|NCT01976104|12415024|FG001|Overall Study|Subject Choice|1
7902965|NCT01976104|12415025|FG002|Overall Study|Subject Choice|0
7902966|NCT01976104|12415026|FG003|Overall Study|Subject Choice|1
7902967|NCT01976104|12415023|FG000|Overall Study|Withdrawal by Subject|3
7902968|NCT01976104|12415024|FG001|Overall Study|Withdrawal by Subject|0
7902969|NCT01976104|12415025|FG002|Overall Study|Withdrawal by Subject|0
7902970|NCT01976104|12415026|FG003|Overall Study|Withdrawal by Subject|1
7902971|NCT01976104|12415023|FG000|Overall Study|Other|0
7902972|NCT01976104|12415024|FG001|Overall Study|Other|1
7902973|NCT01976104|12415025|FG002|Overall Study|Other|0
7902974|NCT01976104|12415026|FG003|Overall Study|Other|0
7902975|NCT01976299|12415039|FG000|Overall Study|Withdrawal by Subject|3
7902976|NCT01976299|12415040|FG001|Overall Study|Withdrawal by Subject|1
7902977|NCT01976299|12415039|FG000|Overall Study|Death|4
7902978|NCT01976299|12415040|FG001|Overall Study|Death|2
7902979|NCT01976299|12415039|FG000|Overall Study|Lost to Follow-up|7
7902980|NCT01976299|12415040|FG001|Overall Study|Lost to Follow-up|1
7902981|NCT01976299|12415039|FG000|Overall Study|See clarification above in comments|9
7902982|NCT01976299|12415040|FG001|Overall Study|See clarification above in comments|2
7902983|NCT01976312|12415048|FG000|Overall Study|Pregnancy|0
7902984|NCT01976312|12415049|FG001|Overall Study|Pregnancy|1
7902985|NCT01976312|12415048|FG000|Overall Study|Lost to Follow-up|2
7902986|NCT01976312|12415049|FG001|Overall Study|Lost to Follow-up|0
7902987|NCT01976312|12415048|FG000|Overall Study|Withdrawal by Subject|7
7902988|NCT01976312|12415049|FG001|Overall Study|Withdrawal by Subject|2
7902989|NCT01976312|12415048|FG000|Overall Study|Adverse Event|6
7902990|NCT01976312|12415049|FG001|Overall Study|Adverse Event|6
7902991|NCT01976312|12415048|FG000|Overall Study|Protocol Violation|2
7902992|NCT01976312|12415049|FG001|Overall Study|Protocol Violation|0
7902993|NCT01976338|12415058|FG000|Overall Study|Physician Decision|0
7902994|NCT01976338|12415059|FG001|Overall Study|Physician Decision|1
7902995|NCT01976338|12415058|FG000|Overall Study|Lost to Follow-up|3
7902996|NCT01976338|12415059|FG001|Overall Study|Lost to Follow-up|0
7902997|NCT01976338|12415058|FG000|Overall Study|Withdrawal by Subject|5
7902998|NCT01976338|12415059|FG001|Overall Study|Withdrawal by Subject|2
7902999|NCT01976338|12415058|FG000|Overall Study|Adverse Event|5
7903000|NCT01976338|12415059|FG001|Overall Study|Adverse Event|1
7903001|NCT01976364|12415066|FG000|Main Study (36 Months)|Adverse Event|63
7903002|NCT01976364|12415067|FG001|Main Study (36 Months)|Adverse Event|0
7903003|NCT01976364|12415068|FG002|Main Study (36 Months)|Adverse Event|0
7903004|NCT01976364|12415066|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5
7903005|NCT01976364|12415067|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0
7903006|NCT01976364|12415068|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0
7903007|NCT01976364|12415066|FG000|Main Study (36 Months)|Other|13
7903008|NCT01976364|12415067|FG001|Main Study (36 Months)|Other|0
7903009|NCT01976364|12415068|FG002|Main Study (36 Months)|Other|0
7903010|NCT01976364|12415066|FG000|Main Study (36 Months)|No longer met eligibility criteria|2
7903011|NCT01976364|12415067|FG001|Main Study (36 Months)|No longer met eligibility criteria|0
7903012|NCT01976364|12415068|FG002|Main Study (36 Months)|No longer met eligibility criteria|0
7903013|NCT01976364|12415066|FG000|Main Study (36 Months)|Medication error|1
7903014|NCT01976364|12415067|FG001|Main Study (36 Months)|Medication error|0
7903015|NCT01976364|12415068|FG002|Main Study (36 Months)|Medication error|0
7903016|NCT01976364|12415066|FG000|Main Study (36 Months)|Lost to Follow-up|10
7903017|NCT01976364|12415067|FG001|Main Study (36 Months)|Lost to Follow-up|0
7903018|NCT01976364|12415068|FG002|Main Study (36 Months)|Lost to Follow-up|0
7903019|NCT01976364|12415066|FG000|Main Study (36 Months)|Lack of Efficacy|40
7903020|NCT01976364|12415067|FG001|Main Study (36 Months)|Lack of Efficacy|0
7903021|NCT01976364|12415068|FG002|Main Study (36 Months)|Lack of Efficacy|0
7903022|NCT01976364|12415066|FG000|Main Study (36 Months)|Protocol Violation|13
7903023|NCT01976364|12415067|FG001|Main Study (36 Months)|Protocol Violation|0
7903024|NCT01976364|12415068|FG002|Main Study (36 Months)|Protocol Violation|0
7903025|NCT01976364|12415066|FG000|Main Study (36 Months)|Withdrawal by Subject|69
7903026|NCT01976364|12415067|FG001|Main Study (36 Months)|Withdrawal by Subject|0
7903027|NCT01976364|12415068|FG002|Main Study (36 Months)|Withdrawal by Subject|0
7903028|NCT01976364|12415066|FG000|Main Study (36 Months)|Death|5
7903029|NCT01976364|12415067|FG001|Main Study (36 Months)|Death|0
7903030|NCT01976364|12415068|FG002|Main Study (36 Months)|Death|0
7903031|NCT01976364|12415066|FG000|Sub-study (12 Months)|Lost to Follow-up|0
7903032|NCT01976364|12415067|FG001|Sub-study (12 Months)|Lost to Follow-up|1
7903033|NCT01976364|12415068|FG002|Sub-study (12 Months)|Lost to Follow-up|0
7903034|NCT01976364|12415066|FG000|Sub-study (12 Months)|Withdrawal by Subject|0
7903035|NCT01976364|12415067|FG001|Sub-study (12 Months)|Withdrawal by Subject|0
7903036|NCT01976364|12415068|FG002|Sub-study (12 Months)|Withdrawal by Subject|1
7903037|NCT01976364|12415066|FG000|Sub-study (12 Months)|Protocol Violation|0
7903038|NCT01976364|12415067|FG001|Sub-study (12 Months)|Protocol Violation|1
7903039|NCT01976364|12415068|FG002|Sub-study (12 Months)|Protocol Violation|1
7903040|NCT01976364|12415066|FG000|Sub-study (12 Months)|Adverse Event|0
7903041|NCT01976364|12415067|FG001|Sub-study (12 Months)|Adverse Event|4
7903042|NCT01976364|12415068|FG002|Sub-study (12 Months)|Adverse Event|3
7903043|NCT01976507|12415104|FG000|Overall Study|Adverse Event|6
7903044|NCT01976507|12415104|FG000|Overall Study|ablation not done, drug not given|1
7903045|NCT01976624|12415119|FG000|Overall Study|Participants contraindicated|2
7903046|NCT01976624|12415119|FG000|Overall Study|Participants age less than 19 years|12
7903047|NCT01976663|12415127|FG000|Overall Study|Completed 18 mos but no repeat treatment|24
7903048|NCT01976663|12415127|FG000|Overall Study|Personal Reasons|6
7903049|NCT01976663|12415127|FG000|Overall Study|Withdrawal by Subject|4
7903050|NCT01976663|12415127|FG000|Overall Study|Screen Failure|3
7903051|NCT01976663|12415127|FG000|Overall Study|Adverse Event|2
7903052|NCT01976663|12415127|FG000|Overall Study|Lost to Follow-up|3
7903053|NCT01976728|12415139|FG000|Overall Study|Subject missed multiple doses of IMP|1
7903054|NCT01976728|12415140|FG001|Overall Study|Subject missed multiple doses of IMP|0
7903055|NCT01976728|12415141|FG002|Overall Study|Subject missed multiple doses of IMP|0
7903056|NCT01976728|12415142|FG003|Overall Study|Subject missed multiple doses of IMP|0
7903057|NCT01976741|12415178|FG000|Overall Study|Withdrawal by Subject|1
7903058|NCT01976741|12415179|FG001|Overall Study|Withdrawal by Subject|0
7903059|NCT01976741|12415180|FG002|Overall Study|Withdrawal by Subject|1
7903060|NCT01976741|12415181|FG003|Overall Study|Withdrawal by Subject|1
7903061|NCT01976741|12415182|FG004|Overall Study|Withdrawal by Subject|0
7903062|NCT01976741|12415183|FG005|Overall Study|Withdrawal by Subject|0
7903063|NCT01976741|12415184|FG006|Overall Study|Withdrawal by Subject|1
7903064|NCT01976741|12415185|FG007|Overall Study|Withdrawal by Subject|4
7903065|NCT01976741|12415186|FG008|Overall Study|Withdrawal by Subject|0
7903066|NCT01976741|12415187|FG009|Overall Study|Withdrawal by Subject|0
7903067|NCT01976741|12415178|FG000|Overall Study|Adverse Event|0
7903068|NCT01976741|12415179|FG001|Overall Study|Adverse Event|0
7903069|NCT01976741|12415180|FG002|Overall Study|Adverse Event|2
7903070|NCT01976741|12415181|FG003|Overall Study|Adverse Event|0
7903071|NCT01976741|12415182|FG004|Overall Study|Adverse Event|0
7903072|NCT01976741|12415183|FG005|Overall Study|Adverse Event|0
7903073|NCT01976741|12415184|FG006|Overall Study|Adverse Event|3
7903074|NCT01976741|12415185|FG007|Overall Study|Adverse Event|8
7903075|NCT01976741|12415186|FG008|Overall Study|Adverse Event|1
7903076|NCT01976741|12415187|FG009|Overall Study|Adverse Event|4
7903077|NCT01976806|12415223|FG000|Overall Study|Lost to Follow-up|1
7903078|NCT01976806|12415224|FG001|Overall Study|Lost to Follow-up|4
7903079|NCT01976806|12415223|FG000|Overall Study|Adverse Event|1
7903080|NCT01976806|12415224|FG001|Overall Study|Adverse Event|1
7903081|NCT01976806|12415223|FG000|Overall Study|Withdrawal by Subject|1
7903082|NCT01976806|12415224|FG001|Overall Study|Withdrawal by Subject|1
7903083|NCT01976845|12415242|FG000|Overall Study|Physician Decision|8
7903084|NCT01976845|12415243|FG001|Overall Study|Physician Decision|8
7903085|NCT01976845|12415244|FG002|Overall Study|Physician Decision|3
7903086|NCT01977040|12415276|FG000|Overall Study|Vasa previa not confirmed|2
7903087|NCT01977092|12415286|FG000|Overall Study|Death|3
7903088|NCT01977092|12415287|FG001|Overall Study|Death|4
7903089|NCT01977092|12415286|FG000|Overall Study|Lost to Follow-up|23
7903090|NCT01977092|12415287|FG001|Overall Study|Lost to Follow-up|14
7903091|NCT01977092|12415286|FG000|Overall Study|Withdrawal by Subject|2
7903092|NCT01977092|12415287|FG001|Overall Study|Withdrawal by Subject|1
7903093|NCT01977092|12415286|FG000|Overall Study|In prison|3
7903094|NCT01977092|12415287|FG001|Overall Study|In prison|11
7903095|NCT01977222|12415293|FG000|Overall Study|Withdrawal by Subject|1
7903096|NCT01977352|12415299|FG000|Overall Study|Lost to Follow-up|1
7903097|NCT01977352|12415300|FG001|Overall Study|Lost to Follow-up|2
7903098|NCT01977456|12415306|FG000|Overall Study|Death|5
7903099|NCT01977482|12415316|FG000|Overall Study|Adverse Event|0
7903100|NCT01977482|12415317|FG001|Overall Study|Adverse Event|1
7903101|NCT01977482|12415318|FG002|Overall Study|Adverse Event|1
7903102|NCT01977482|12415319|FG003|Overall Study|Adverse Event|0
7903103|NCT01977482|12415320|FG004|Overall Study|Adverse Event|2
7903104|NCT01977482|12415321|FG005|Overall Study|Adverse Event|0
7903105|NCT01977482|12415316|FG000|Overall Study|Lost to Follow-up|1
7903106|NCT01977482|12415317|FG001|Overall Study|Lost to Follow-up|0
7903107|NCT01977482|12415318|FG002|Overall Study|Lost to Follow-up|0
7903108|NCT01977482|12415319|FG003|Overall Study|Lost to Follow-up|0
7903109|NCT01977482|12415320|FG004|Overall Study|Lost to Follow-up|0
7903110|NCT01977482|12415321|FG005|Overall Study|Lost to Follow-up|0
7717936|NCT00523744|12141615|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
7717937|NCT00523744|12141615|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
7903111|NCT01977482|12415316|FG000|Overall Study|Physician Decision|0
7903112|NCT01977482|12415317|FG001|Overall Study|Physician Decision|1
7903113|NCT01977482|12415318|FG002|Overall Study|Physician Decision|0
7903114|NCT01977482|12415319|FG003|Overall Study|Physician Decision|0
7903115|NCT01977482|12415320|FG004|Overall Study|Physician Decision|0
7903116|NCT01977482|12415321|FG005|Overall Study|Physician Decision|0
7903117|NCT01977482|12415316|FG000|Overall Study|Protocol Violation|0
7903118|NCT01977482|12415317|FG001|Overall Study|Protocol Violation|0
7903119|NCT01977482|12415318|FG002|Overall Study|Protocol Violation|1
7903120|NCT01977482|12415319|FG003|Overall Study|Protocol Violation|0
7903121|NCT01977482|12415320|FG004|Overall Study|Protocol Violation|0
7903122|NCT01977482|12415321|FG005|Overall Study|Protocol Violation|0
7903123|NCT01977482|12415316|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0
7903124|NCT01977482|12415317|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3
7903125|NCT01977482|12415318|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2
7903126|NCT01977482|12415319|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1
7903127|NCT01977482|12415320|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0
7903128|NCT01977482|12415321|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0
7903129|NCT01977482|12415316|FG000|Overall Study|Withdrawal by Subject|2
7903130|NCT01977482|12415317|FG001|Overall Study|Withdrawal by Subject|4
7903131|NCT01977482|12415318|FG002|Overall Study|Withdrawal by Subject|1
7903132|NCT01977482|12415319|FG003|Overall Study|Withdrawal by Subject|3
7903133|NCT01977482|12415320|FG004|Overall Study|Withdrawal by Subject|1
7903134|NCT01977482|12415321|FG005|Overall Study|Withdrawal by Subject|5
7903135|NCT01977573|12415353|FG000|Overall Study|Adverse Event|7
7903136|NCT01977573|12415354|FG001|Overall Study|Adverse Event|0
7903137|NCT01977573|12415355|FG002|Overall Study|Adverse Event|2
7903138|NCT01977573|12415356|FG003|Overall Study|Adverse Event|1
7903139|NCT01977573|12415353|FG000|Overall Study|Lost to Follow-up|1
7903140|NCT01977573|12415354|FG001|Overall Study|Lost to Follow-up|0
7903141|NCT01977573|12415355|FG002|Overall Study|Lost to Follow-up|0
7903142|NCT01977573|12415356|FG003|Overall Study|Lost to Follow-up|1
7903143|NCT01977573|12415353|FG000|Overall Study|Physician Decision|1
7903144|NCT01977573|12415354|FG001|Overall Study|Physician Decision|0
7903145|NCT01977573|12415355|FG002|Overall Study|Physician Decision|0
7903146|NCT01977573|12415356|FG003|Overall Study|Physician Decision|0
7903147|NCT01977573|12415353|FG000|Overall Study|Protocol Violation|3
7903148|NCT01977573|12415354|FG001|Overall Study|Protocol Violation|1
7903149|NCT01977573|12415355|FG002|Overall Study|Protocol Violation|0
7903150|NCT01977573|12415356|FG003|Overall Study|Protocol Violation|0
7903151|NCT01977573|12415353|FG000|Overall Study|Reached Defined Stopping Criteria|2
7903152|NCT01977573|12415354|FG001|Overall Study|Reached Defined Stopping Criteria|1
7903153|NCT01977573|12415355|FG002|Overall Study|Reached Defined Stopping Criteria|1
7903154|NCT01977573|12415356|FG003|Overall Study|Reached Defined Stopping Criteria|0
7903155|NCT01977573|12415353|FG000|Overall Study|Withdrawal by Subject|6
7903156|NCT01977573|12415354|FG001|Overall Study|Withdrawal by Subject|1
7903157|NCT01977573|12415355|FG002|Overall Study|Withdrawal by Subject|1
7903158|NCT01977573|12415356|FG003|Overall Study|Withdrawal by Subject|1
7903159|NCT01977612|12415378|FG000|Overall Study|Lost to Follow-up|1
7903160|NCT01977612|12415379|FG001|Overall Study|Lost to Follow-up|1
7903161|NCT01977625|12415385|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3
7903162|NCT01977625|12415386|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0
7903163|NCT01977625|12415385|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7903164|NCT01977625|12415386|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0
7903165|NCT01977651|12415394|FG000|4 Month Treatment Period|Adverse Event|34
7903166|NCT01977651|12415394|FG000|4 Month Treatment Period|Death|3
7903167|NCT01977651|12415394|FG000|4 Month Treatment Period|Progressive Disease|43
7903168|NCT01977651|12415394|FG000|4 Month Treatment Period|Withdrawal by Subject|17
7903169|NCT01977651|12415394|FG000|4 Month Treatment Period|Physician Decision|4
7903170|NCT01977651|12415394|FG000|1 Year Extension Period|Adverse Event|14
7903171|NCT01977651|12415394|FG000|1 Year Extension Period|Death|10
7903172|NCT01977651|12415394|FG000|1 Year Extension Period|Lost to Follow-up|2
7903173|NCT01977651|12415394|FG000|1 Year Extension Period|Progressive Disease|86
7903174|NCT01977651|12415394|FG000|1 Year Extension Period|Withdrawal by Subject|11
7903175|NCT01977651|12415394|FG000|1 Year Extension Period|Physician Decision|6
7903176|NCT01977651|12415394|FG000|1 Year Extension Period|Miscellaneous|1
7903177|NCT01977651|12415394|FG000|Post 1 Year Extension Period|Adverse Event|5
7903178|NCT01977651|12415394|FG000|Post 1 Year Extension Period|Death|13
7903179|NCT01977651|12415394|FG000|Post 1 Year Extension Period|Progressive Disease|60
7903180|NCT01977651|12415394|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13
7903181|NCT01977651|12415394|FG000|Post 1 Year Extension Period|Physician Decision|4
7903182|NCT01977651|12415394|FG000|Post 1 Year Extension Period|Miscellaneous|49
7903183|NCT01977677|12415401|FG000|Overall Study|Unrelated Adverse Event|0
7903184|NCT01977677|12415402|FG001|Overall Study|Unrelated Adverse Event|0
7903185|NCT01977677|12415403|FG002|Overall Study|Unrelated Adverse Event|1
7903186|NCT01977690|12415413|FG000|Overall Study|Withdrawal by Subject|0
7903187|NCT01977690|12415414|FG001|Overall Study|Withdrawal by Subject|4
7963723|NCT02726945|12518344|FG002|Overall Study|Elected to have total knee replacement|0
7963724|NCT02727192|12518363|FG000|Overall Study|Lost to Follow-up|1
7963725|NCT02727192|12518364|FG001|Overall Study|Lost to Follow-up|0
7963726|NCT02727192|12518365|FG002|Overall Study|Lost to Follow-up|0
7963727|NCT02727322|12518374|FG000|Overall Study|Withdrawal by Subject|1
7963728|NCT02727322|12518375|FG001|Overall Study|Withdrawal by Subject|1
7963729|NCT02727322|12518374|FG000|Overall Study|Protocol Violation|1
7963730|NCT02727322|12518375|FG001|Overall Study|Protocol Violation|0
7963731|NCT02727660|12518388|FG000|Overall Study|Lack of Efficacy|40
7963732|NCT02727660|12518389|FG001|Overall Study|Lack of Efficacy|40
7963733|NCT02727660|12518390|FG002|Overall Study|Lack of Efficacy|70
7963734|NCT02727660|12518388|FG000|Overall Study|Adverse Event|28
7963735|NCT02727660|12518389|FG001|Overall Study|Adverse Event|21
7963736|NCT02727660|12518390|FG002|Overall Study|Adverse Event|32
7963737|NCT02727660|12518388|FG000|Overall Study|Withdrawal by Subject|26
7963738|NCT02727660|12518389|FG001|Overall Study|Withdrawal by Subject|25
7963739|NCT02727660|12518390|FG002|Overall Study|Withdrawal by Subject|30
7963740|NCT02727660|12518388|FG000|Overall Study|Physician Decision|3
7963741|NCT02727660|12518389|FG001|Overall Study|Physician Decision|8
7963742|NCT02727660|12518390|FG002|Overall Study|Physician Decision|14
7963743|NCT02727660|12518388|FG000|Overall Study|Lost to Follow-up|5
7963744|NCT02727660|12518389|FG001|Overall Study|Lost to Follow-up|9
7963745|NCT02727660|12518390|FG002|Overall Study|Lost to Follow-up|8
7963746|NCT02727660|12518388|FG000|Overall Study|Protocol Violation|7
7963747|NCT02727660|12518389|FG001|Overall Study|Protocol Violation|5
7963748|NCT02727660|12518390|FG002|Overall Study|Protocol Violation|5
7963749|NCT02727660|12518388|FG000|Overall Study|Protocol Specified Disc. Criteria|5
7963750|NCT02727660|12518389|FG001|Overall Study|Protocol Specified Disc. Criteria|5
7963751|NCT02727660|12518390|FG002|Overall Study|Protocol Specified Disc. Criteria|2
7963752|NCT02727660|12518388|FG000|Overall Study|Administrative Reasons|2
7963753|NCT02727660|12518389|FG001|Overall Study|Administrative Reasons|3
7963754|NCT02727660|12518390|FG002|Overall Study|Administrative Reasons|4
7963755|NCT02727777|12518405|FG000|Overall Study|Screen Failure|2
7963756|NCT02727777|12518406|FG001|Overall Study|Screen Failure|0
7963757|NCT02727777|12518407|FG002|Overall Study|Screen Failure|0
7963758|NCT02727777|12518405|FG000|Overall Study|Progressive disease|2
7963759|NCT02727777|12518406|FG001|Overall Study|Progressive disease|0
7963760|NCT02727777|12518407|FG002|Overall Study|Progressive disease|0
7963761|NCT02728089|12518451|FG000|Overall Study|Physician Decision|2
7963762|NCT02728089|12518451|FG000|Overall Study|Withdrawal by Subject|1
7963763|NCT02728206|12518455|FG000|Overall Study|Death|1
7963764|NCT02728830|12518459|FG000|Overall Study|Exclusionary Surgery|9
7963765|NCT02728830|12518459|FG000|Overall Study|Exclusionary Pathology|6
7963766|NCT02728830|12518459|FG000|Overall Study|Physician Decision|3
7963767|NCT02728830|12518459|FG000|Overall Study|Withdrawal by Subject|2
7963768|NCT02728830|12518459|FG000|Overall Study|Lost to Follow-up|1
7963769|NCT02728830|12518459|FG000|Overall Study|Exclusionary Lab Values|1
7963770|NCT02728830|12518459|FG000|Overall Study|Contraindicated Illness|1
7963771|NCT02728830|12518459|FG000|Overall Study|Language Barrier|1
7963772|NCT02728895|12518465|FG000|Overall Study|Other|1
7963773|NCT02728895|12518466|FG001|Overall Study|Other|2
7963774|NCT02728895|12518465|FG000|Overall Study|Withdrawal by Subject|0
7963775|NCT02728895|12518466|FG001|Overall Study|Withdrawal by Subject|3
7963776|NCT02729051|12518498|FG000|Overall Study|Adverse Event|21
7963777|NCT02729051|12518499|FG001|Overall Study|Adverse Event|11
7963778|NCT02729051|12518498|FG000|Overall Study|Lack of Efficacy|1
7963779|NCT02729051|12518499|FG001|Overall Study|Lack of Efficacy|1
7963780|NCT02729051|12518498|FG000|Overall Study|Lost to Follow-up|1
7963781|NCT02729051|12518499|FG001|Overall Study|Lost to Follow-up|2
7963782|NCT02729051|12518498|FG000|Overall Study|Physician Decision|1
7963783|NCT02729051|12518499|FG001|Overall Study|Physician Decision|1
7963784|NCT02729051|12518498|FG000|Overall Study|Withdrawal by Subject|6
7963785|NCT02729051|12518499|FG001|Overall Study|Withdrawal by Subject|17
7963786|NCT02729194|12518505|FG000|Overall Study|Withdrawal by Subject|3
7963787|NCT02729545|12518511|FG000|Overall Study|Pregnancy|1
7963788|NCT02729545|12518512|FG001|Overall Study|Pregnancy|1
7963789|NCT02729545|12518511|FG000|Overall Study|Lost to Follow-up|0
7963790|NCT02729545|12518512|FG001|Overall Study|Lost to Follow-up|1
7963791|NCT02729545|12518511|FG000|Overall Study|Withdrawal by Subject|2
7963792|NCT02729545|12518512|FG001|Overall Study|Withdrawal by Subject|3
7963793|NCT02729740|12518518|FG000|Overall Study|Early Termination|130
7963794|NCT02729740|12518518|FG000|Overall Study|Other|1
7963795|NCT02729831|12518526|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38
7963796|NCT02729831|12518527|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23
7903188|NCT01977794|12415431|FG000|Overall Study|Adverse Event|2
7903189|NCT01977794|12415432|FG001|Overall Study|Adverse Event|2
7903190|NCT01977794|12415431|FG000|Overall Study|Lost to Follow-up|2
7903191|NCT01977794|12415432|FG001|Overall Study|Lost to Follow-up|1
7903192|NCT01977794|12415431|FG000|Overall Study|Protocol Violation|1
7903193|NCT01977794|12415432|FG001|Overall Study|Protocol Violation|0
7903194|NCT01977794|12415431|FG000|Overall Study|Death|1
7903195|NCT01977794|12415432|FG001|Overall Study|Death|1
7903196|NCT01977794|12415431|FG000|Overall Study|Withdrew consent|2
7903197|NCT01977794|12415432|FG001|Overall Study|Withdrew consent|1
7903198|NCT01977794|12415431|FG000|Overall Study|Other|0
7903199|NCT01977794|12415432|FG001|Overall Study|Other|1
7903200|NCT01977820|12415440|FG000|Overall Study|Sponsor terminated the study|1
7903201|NCT01977820|12415441|FG001|Overall Study|Sponsor terminated the study|1
7903202|NCT01977846|12415449|FG000|Total Study - Prospective|Death|0
7903203|NCT01977846|12415450|FG001|Total Study - Prospective|Death|1
7903204|NCT01977846|12415449|FG000|Total Study - Prospective|Lost to Follow-up|0
7903205|NCT01977846|12415450|FG001|Total Study - Prospective|Lost to Follow-up|8
7903206|NCT01977846|12415449|FG000|Total Study - Prospective|Withdrawal by Subject|0
7903207|NCT01977846|12415450|FG001|Total Study - Prospective|Withdrawal by Subject|13
7903208|NCT01977846|12415449|FG000|Total Study - Prospective|Not available at time of visit|0
7903209|NCT01977846|12415450|FG001|Total Study - Prospective|Not available at time of visit|5
7903210|NCT01977846|12415449|FG000|Total Study - Prospective|No show|0
7903211|NCT01977846|12415450|FG001|Total Study - Prospective|No show|1
7903212|NCT01977846|12415449|FG000|Total Study - Prospective|Protocol Violation|0
7903213|NCT01977846|12415450|FG001|Total Study - Prospective|Protocol Violation|1
7903214|NCT01977898|12415459|FG000|Overall Study|Non functioning catheter|1
7903215|NCT01977898|12415460|FG001|Overall Study|Non functioning catheter|1
7903216|NCT01977937|12415468|FG000|Overall Study|Withdrawal by Subject|2
7903217|NCT01977937|12415469|FG001|Overall Study|Withdrawal by Subject|1
7903218|NCT01977937|12415468|FG000|Overall Study|Adverse Event|1
7903219|NCT01977937|12415469|FG001|Overall Study|Adverse Event|0
7903220|NCT01977937|12415468|FG000|Overall Study|Physician Decision|0
7903221|NCT01977937|12415469|FG001|Overall Study|Physician Decision|1
7903222|NCT01978093|12415477|FG000|Overall Study|Death|1
7903223|NCT01978093|12415478|FG001|Overall Study|Death|0
7903224|NCT01978093|12415477|FG000|Overall Study|Adverse Event|0
7903225|NCT01978093|12415478|FG001|Overall Study|Adverse Event|5
7903226|NCT01978093|12415477|FG000|Overall Study|Protocol Violation|8
7903227|NCT01978093|12415478|FG001|Overall Study|Protocol Violation|2
7903228|NCT01978093|12415477|FG000|Overall Study|Withdrawal by Subject|29
7903229|NCT01978093|12415478|FG001|Overall Study|Withdrawal by Subject|25
7903230|NCT01978093|12415477|FG000|Overall Study|Lost to Follow-up|11
7903231|NCT01978093|12415478|FG001|Overall Study|Lost to Follow-up|15
7903232|NCT01978093|12415477|FG000|Overall Study|Migrated/moved from study area|11
7903233|NCT01978093|12415478|FG001|Overall Study|Migrated/moved from study area|13
7903234|NCT01978093|12415477|FG000|Overall Study|Loss of kaiser coverage|4
7903235|NCT01978093|12415478|FG001|Overall Study|Loss of kaiser coverage|10
7903236|NCT01978093|12415477|FG000|Overall Study|Lost kaiser health plan unable to contac|1
7903237|NCT01978093|12415478|FG001|Overall Study|Lost kaiser health plan unable to contac|0
7903238|NCT01978093|12415477|FG000|Overall Study|Mother lost custody of child|0
7903239|NCT01978093|12415478|FG001|Overall Study|Mother lost custody of child|1
7903240|NCT01978093|12415477|FG000|Overall Study|Child was in care of grandmother|0
7903241|NCT01978093|12415478|FG001|Overall Study|Child was in care of grandmother|1
7903242|NCT01978093|12415477|FG000|Overall Study|N/A for vaccine administration|0
7903243|NCT01978093|12415478|FG001|Overall Study|N/A for vaccine administration|1
7903244|NCT01978119|12415487|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
7903245|NCT01978119|12415488|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
7903246|NCT01978119|12415487|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7903247|NCT01978119|12415488|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7903248|NCT01978119|12415487|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7903249|NCT01978119|12415488|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
7903250|NCT01978145|12415494|FG000|Treatment Period 1|Adverse Event|1
7903251|NCT01978145|12415495|FG001|Treatment Period 1|Adverse Event|9
7903252|NCT01978145|12415494|FG000|Treatment Period 1|Physician Decision|1
7903253|NCT01978145|12415495|FG001|Treatment Period 1|Physician Decision|0
7903254|NCT01978145|12415494|FG000|Treatment Period 1|Withdrawal by Subject|5
7903255|NCT01978145|12415495|FG001|Treatment Period 1|Withdrawal by Subject|4
7903256|NCT01978145|12415494|FG000|Treatment Period 1|Par. reached defined stopping criteria|2
7903257|NCT01978145|12415495|FG001|Treatment Period 1|Par. reached defined stopping criteria|3
7903258|NCT01978145|12415494|FG000|Washout Period 1|Adverse Event|0
7903259|NCT01978145|12415495|FG001|Washout Period 1|Adverse Event|1
7903260|NCT01978145|12415494|FG000|Washout Period 1|Withdrawal by Subject|1
7903261|NCT01978145|12415495|FG001|Washout Period 1|Withdrawal by Subject|1
7903262|NCT01978145|12415494|FG000|Washout Period 1|Par. reached defined stopping criteria|0
7903263|NCT01978145|12415495|FG001|Washout Period 1|Par. reached defined stopping criteria|1
7903264|NCT01978145|12415494|FG000|Treatment Period 2|Adverse Event|3
7903265|NCT01978145|12415495|FG001|Treatment Period 2|Adverse Event|3
7903266|NCT01978145|12415494|FG000|Treatment Period 2|Protocol Violation|0
7903267|NCT01978145|12415495|FG001|Treatment Period 2|Protocol Violation|1
7903268|NCT01978145|12415494|FG000|Treatment Period 2|Lost to Follow-up|1
7903269|NCT01978145|12415495|FG001|Treatment Period 2|Lost to Follow-up|1
7903270|NCT01978145|12415494|FG000|Treatment Period 2|Withdrawal by Subject|7
7903271|NCT01978145|12415495|FG001|Treatment Period 2|Withdrawal by Subject|4
7903272|NCT01978145|12415494|FG000|Treatment Period 2|Par. reached defined stopping criteria|8
7903273|NCT01978145|12415495|FG001|Treatment Period 2|Par. reached defined stopping criteria|5
7903274|NCT01978184|12415503|FG000|Overall Study|Progressive disease|5
7903275|NCT01978184|12415504|FG001|Overall Study|Progressive disease|5
7903276|NCT01978184|12415503|FG000|Overall Study|Other than PDA|2
7903277|NCT01978184|12415504|FG001|Overall Study|Other than PDA|2
7903278|NCT01978184|12415503|FG000|Overall Study|Physician Decision|0
7903279|NCT01978184|12415504|FG001|Overall Study|Physician Decision|3
7903280|NCT01978184|12415503|FG000|Overall Study|Noncompliance|1
7903281|NCT01978184|12415504|FG001|Overall Study|Noncompliance|2
7903282|NCT01978184|12415503|FG000|Overall Study|Death|1
7903283|NCT01978184|12415504|FG001|Overall Study|Death|0
7903284|NCT01978184|12415503|FG000|Overall Study|Withdrew- toxicities or physical decline|4
7903285|NCT01978184|12415504|FG001|Overall Study|Withdrew- toxicities or physical decline|8
7903286|NCT01978236|12415510|FG000|Overall Study|Discontinued due to study close|2
7903287|NCT01978262|12415514|FG000|Overall Study|Withdrawal by Subject|9
7903288|NCT01978262|12415514|FG000|Overall Study|Lost to Follow-up|2
7903289|NCT01978912|12415582|FG000|Overall Study|Adverse Event|0
7903290|NCT01978912|12415583|FG001|Overall Study|Adverse Event|1
7903291|NCT01978912|12415584|FG002|Overall Study|Adverse Event|0
7903292|NCT01978912|12415585|FG003|Overall Study|Adverse Event|0
7903293|NCT01978912|12415582|FG000|Overall Study|Lost to Follow-up|1
7903294|NCT01978912|12415583|FG001|Overall Study|Lost to Follow-up|1
7903295|NCT01978912|12415584|FG002|Overall Study|Lost to Follow-up|0
7903296|NCT01978912|12415585|FG003|Overall Study|Lost to Follow-up|1
7903297|NCT01978912|12415582|FG000|Overall Study|Withdrawal by Subject|1
7903298|NCT01978912|12415583|FG001|Overall Study|Withdrawal by Subject|0
7903299|NCT01978912|12415584|FG002|Overall Study|Withdrawal by Subject|2
7903300|NCT01978912|12415585|FG003|Overall Study|Withdrawal by Subject|2
7903301|NCT01978912|12415582|FG000|Overall Study|Lumbar Surgery|1
7903302|NCT01978912|12415583|FG001|Overall Study|Lumbar Surgery|0
7903303|NCT01978912|12415584|FG002|Overall Study|Lumbar Surgery|1
7903304|NCT01978912|12415585|FG003|Overall Study|Lumbar Surgery|0
7968981|NCT02790437|12527335|FG000|Overall Study|Adverse Event|1
7968982|NCT02790437|12527336|FG001|Overall Study|Adverse Event|0
7968983|NCT02790437|12527335|FG000|Overall Study|Withdrawal by Subject|1
7968984|NCT02790437|12527336|FG001|Overall Study|Withdrawal by Subject|0
7968985|NCT02790606|12527358|FG000|Overall Study|Death|27
7968986|NCT02790606|12527358|FG000|Overall Study|Lost to Follow-up|4
7968987|NCT02790606|12527358|FG000|Overall Study|Physician Decision|3
7968988|NCT02790606|12527358|FG000|Overall Study|Withdrawal by Subject|1
7968989|NCT02791191|12527385|FG000|Overall Study|Adverse Event|2
7968990|NCT02791191|12527386|FG001|Overall Study|Adverse Event|4
7968991|NCT02791191|12527387|FG002|Overall Study|Adverse Event|5
7968992|NCT02791191|12527385|FG000|Overall Study|Lack of Efficacy|0
7968993|NCT02791191|12527386|FG001|Overall Study|Lack of Efficacy|1
7968994|NCT02791191|12527387|FG002|Overall Study|Lack of Efficacy|0
7968995|NCT02791191|12527385|FG000|Overall Study|Study Drug Non-Compliance|0
7968996|NCT02791191|12527386|FG001|Overall Study|Study Drug Non-Compliance|2
7968997|NCT02791191|12527387|FG002|Overall Study|Study Drug Non-Compliance|0
7968998|NCT02791191|12527385|FG000|Overall Study|Site Closed by Sponsor|1
7968999|NCT02791191|12527386|FG001|Overall Study|Site Closed by Sponsor|1
7969000|NCT02791191|12527387|FG002|Overall Study|Site Closed by Sponsor|3
7969001|NCT02791191|12527385|FG000|Overall Study|Progressive Disease|1
7969002|NCT02791191|12527386|FG001|Overall Study|Progressive Disease|0
7969003|NCT02791191|12527387|FG002|Overall Study|Progressive Disease|0
7969004|NCT02791191|12527385|FG000|Overall Study|Study Terminated by Sponsor|29
7969005|NCT02791191|12527386|FG001|Overall Study|Study Terminated by Sponsor|101
7969006|NCT02791191|12527387|FG002|Overall Study|Study Terminated by Sponsor|109
7969007|NCT02791191|12527385|FG000|Overall Study|Withdrawal by Subject|3
7969008|NCT02791191|12527386|FG001|Overall Study|Withdrawal by Subject|1
7969009|NCT02791191|12527387|FG002|Overall Study|Withdrawal by Subject|3
7969010|NCT02791191|12527385|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2
7969011|NCT02791191|12527386|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1
7969012|NCT02791191|12527387|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0
7969013|NCT02791269|12527397|FG000|Overall Study|Lost to Follow-up|0
7969014|NCT02791269|12527398|FG001|Overall Study|Lost to Follow-up|1
7969015|NCT02791438|12527430|FG000|Treatment Period|Adverse Event|1
7903305|NCT01978912|12415582|FG000|Overall Study|Intradiscal Steroid Injection|0
7903306|NCT01978912|12415583|FG001|Overall Study|Intradiscal Steroid Injection|1
7903307|NCT01978912|12415584|FG002|Overall Study|Intradiscal Steroid Injection|0
7903308|NCT01978912|12415585|FG003|Overall Study|Intradiscal Steroid Injection|0
7903309|NCT01979016|12415597|FG000|Overall Study|Withdrawal by Subject|2
7903310|NCT01979016|12415598|FG001|Overall Study|Withdrawal by Subject|0
7903311|NCT01979016|12415597|FG000|Overall Study|Adverse Event|0
7903312|NCT01979016|12415598|FG001|Overall Study|Adverse Event|1
7903313|NCT01979185|12415638|FG000|Period 2|Other|0
7903314|NCT01979185|12415639|FG001|Period 2|Other|1
7903315|NCT01979523|12415674|FG000|Overall Study|Withdrawal by Subject|1
7903316|NCT01979523|12415675|FG001|Overall Study|Withdrawal by Subject|0
7903317|NCT01979614|12415684|FG000|Overall Study|Adverse Event|1
7903318|NCT01979614|12415685|FG001|Overall Study|Adverse Event|1
7903319|NCT01979835|12415691|FG000|Primary Outcome SA Measurment|failed insertion|18
7903320|NCT01979835|12415691|FG000|Follow-up|Lost to Follow-up|32
7903321|NCT01979952|12415697|FG000|Overall Study|Adverse Event|4
7903322|NCT01979952|12415698|FG001|Overall Study|Adverse Event|5
7903323|NCT01979952|12415697|FG000|Overall Study|Protocol Violation|1
7903324|NCT01979952|12415698|FG001|Overall Study|Protocol Violation|0
7903325|NCT01979952|12415697|FG000|Overall Study|Withdrawal by Subject|2
7903326|NCT01979952|12415698|FG001|Overall Study|Withdrawal by Subject|1
7903327|NCT01979952|12415697|FG000|Overall Study|Other than specified above|1
7903328|NCT01979952|12415698|FG001|Overall Study|Other than specified above|0
7903329|NCT01980056|12415707|FG000|Overall Study|Death|1
7903330|NCT01980056|12415708|FG001|Overall Study|Death|1
7903331|NCT01980056|12415709|FG002|Overall Study|Death|0
7903332|NCT01980095|12415723|FG000|Overall Study|Lost to Follow-up|6
7903333|NCT01980095|12415724|FG001|Overall Study|Lost to Follow-up|7
7903334|NCT01980095|12415723|FG000|Overall Study|Withdrawal by Subject|2
7903335|NCT01980095|12415724|FG001|Overall Study|Withdrawal by Subject|3
7903336|NCT01980095|12415723|FG000|Overall Study|Poor compliance|5
7903337|NCT01980095|12415724|FG001|Overall Study|Poor compliance|0
7903338|NCT01980095|12415723|FG000|Overall Study|Safety issue|0
7903339|NCT01980095|12415724|FG001|Overall Study|Safety issue|1
7903340|NCT01980095|12415723|FG000|Overall Study|Study drug discontinued|1
7903341|NCT01980095|12415724|FG001|Overall Study|Study drug discontinued|0
7903342|NCT01980095|12415723|FG000|Overall Study|Randomized by mistake|1
7903343|NCT01980095|12415724|FG001|Overall Study|Randomized by mistake|0
7903344|NCT01980628|12415763|FG000|Overall Study|Adverse Event|12
7903345|NCT01980628|12415763|FG000|Overall Study|Physician Decision|5
7903346|NCT01980628|12415763|FG000|Overall Study|Withdrawal by Subject|4
7903347|NCT01980628|12415763|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42
7903348|NCT01980706|12415780|FG000|Overall Study|Withdrawal by Subject|9
7903349|NCT01980706|12415781|FG001|Overall Study|Withdrawal by Subject|6
7903350|NCT01980706|12415782|FG002|Overall Study|Withdrawal by Subject|2
7903351|NCT01980706|12415780|FG000|Overall Study|Adverse Event|1
7903352|NCT01980706|12415781|FG001|Overall Study|Adverse Event|2
7903353|NCT01980706|12415782|FG002|Overall Study|Adverse Event|5
7903354|NCT01980706|12415780|FG000|Overall Study|Lost to Follow-up|3
7903355|NCT01980706|12415781|FG001|Overall Study|Lost to Follow-up|4
7903356|NCT01980706|12415782|FG002|Overall Study|Lost to Follow-up|3
7903357|NCT01980706|12415780|FG000|Overall Study|miscellaneous|4
7903358|NCT01980706|12415781|FG001|Overall Study|miscellaneous|5
7903359|NCT01980706|12415782|FG002|Overall Study|miscellaneous|3
7903360|NCT01980888|12415801|FG000|Overall Study|Study Terminated by Sponsor|116
7903361|NCT01980888|12415802|FG001|Overall Study|Study Terminated by Sponsor|122
7903362|NCT01980888|12415801|FG000|Overall Study|Withdrew Consent|17
7903363|NCT01980888|12415802|FG001|Overall Study|Withdrew Consent|6
7903364|NCT01980888|12415801|FG000|Overall Study|Investigator's Discretion|8
7903365|NCT01980888|12415802|FG001|Overall Study|Investigator's Discretion|3
7903366|NCT01980888|12415801|FG000|Overall Study|Non-Compliance with Study Drug|3
7903367|NCT01980888|12415802|FG001|Overall Study|Non-Compliance with Study Drug|2
7903368|NCT01980992|12415815|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
7903369|NCT01980992|12415816|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
7903370|NCT01980992|12415815|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
7903371|NCT01980992|12415816|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
7903372|NCT01980992|12415815|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1
7903373|NCT01980992|12415816|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0
7903374|NCT01980992|12415815|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
7903375|NCT01980992|12415816|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
7903376|NCT01980992|12415815|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
7903377|NCT01980992|12415816|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
7903378|NCT01980992|12415815|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
7903379|NCT01980992|12415816|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
7903380|NCT01981109|12415838|FG000|Overall Study|Death|36
7903381|NCT01981109|12415838|FG000|Overall Study|Withdrawal by Subject|40
7903382|NCT01981109|12415838|FG000|Overall Study|Lost to Follow-up|9
7903383|NCT01981109|12415838|FG000|Overall Study|No Discontinuation Documentation|37
7903384|NCT01981109|12415838|FG000|Overall Study|Study Termination|100
7903385|NCT01981109|12415838|FG000|Overall Study|No data available|2
7903386|NCT01981122|12415845|FG000|Overall Study|Withdrawal by Subject|0
7903387|NCT01981122|12415846|FG001|Overall Study|Withdrawal by Subject|2
7903388|NCT01981122|12415845|FG000|Overall Study|Protocol Violation|0
7903389|NCT01981122|12415846|FG001|Overall Study|Protocol Violation|1
7903390|NCT01981122|12415845|FG000|Overall Study|Lost to Follow-up|0
7903391|NCT01981122|12415846|FG001|Overall Study|Lost to Follow-up|1
7903392|NCT01981122|12415845|FG000|Overall Study|Investigator Or Dendreon Discretion|0
7903393|NCT01981122|12415846|FG001|Overall Study|Investigator Or Dendreon Discretion|1
7903394|NCT01981122|12415845|FG000|Overall Study|Death|14
7903395|NCT01981122|12415846|FG001|Overall Study|Death|15
7903396|NCT01981187|12415852|FG000|Overall Study|Participant/guardian decision|2
7903397|NCT01981187|12415852|FG000|Overall Study|Physician Decision|1
7903398|NCT01981187|12415852|FG000|Overall Study|Disease progression|2
7903399|NCT01981187|12415852|FG000|Overall Study|Adverse Event|7
7903400|NCT01981356|12415858|FG000|Overall Study|Lost to Follow-up|4
7903401|NCT01981356|12415859|FG001|Overall Study|Lost to Follow-up|1
7903402|NCT01981356|12415858|FG000|Overall Study|Withdrawal by Subject|1
7903403|NCT01981356|12415859|FG001|Overall Study|Withdrawal by Subject|1
7903404|NCT01981356|12415858|FG000|Overall Study|Protocol Violation|2
7903405|NCT01981356|12415859|FG001|Overall Study|Protocol Violation|0
7903406|NCT01981473|12415869|FG000|Overall Study|Incorrect diagnosis of RA|0
7903407|NCT01981473|12415870|FG001|Overall Study|Incorrect diagnosis of RA|0
7903408|NCT01981473|12415871|FG002|Overall Study|Incorrect diagnosis of RA|1
7903409|NCT01981473|12415869|FG000|Overall Study|Received treatment for < 6 months|0
7903410|NCT01981473|12415870|FG001|Overall Study|Received treatment for < 6 months|0
7903411|NCT01981473|12415871|FG002|Overall Study|Received treatment for < 6 months|1
7903412|NCT01981473|12415869|FG000|Overall Study|Received treatment for >24 months|2
7903413|NCT01981473|12415870|FG001|Overall Study|Received treatment for >24 months|0
7903414|NCT01981473|12415871|FG002|Overall Study|Received treatment for >24 months|6
7903415|NCT01981616|12415899|FG000|Overall Study|Adverse Event|0
7903416|NCT01981616|12415900|FG001|Overall Study|Adverse Event|1
7903417|NCT01981616|12415899|FG000|Overall Study|Protocol Violation|1
7903418|NCT01981616|12415900|FG001|Overall Study|Protocol Violation|0
7903419|NCT01981954|12415933|FG000|Titration Period|Protocol Deviation|1
7903420|NCT01981954|12415933|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1
7903421|NCT01982292|12415969|FG000|Overall Study|Adverse Event|2
7903422|NCT01982292|12415970|FG001|Overall Study|Adverse Event|0
7903423|NCT01982292|12415969|FG000|Overall Study|Death|1
7903424|NCT01982292|12415970|FG001|Overall Study|Death|0
7903425|NCT01982292|12415969|FG000|Overall Study|Lost to Follow-up|2
7903426|NCT01982292|12415970|FG001|Overall Study|Lost to Follow-up|0
7903427|NCT01982292|12415969|FG000|Overall Study|Non-Compliance With Study Treatment|1
7903428|NCT01982292|12415970|FG001|Overall Study|Non-Compliance With Study Treatment|0
7903429|NCT01982292|12415969|FG000|Overall Study|Protocol Deviation|1
7903430|NCT01982292|12415970|FG001|Overall Study|Protocol Deviation|0
7903431|NCT01982292|12415969|FG000|Overall Study|Patient/Guardian Decision|3
7903432|NCT01982292|12415970|FG001|Overall Study|Patient/Guardian Decision|1
7903433|NCT01982292|12415969|FG000|Overall Study|Technical Problems|2
7903434|NCT01982292|12415970|FG001|Overall Study|Technical Problems|0
7903435|NCT01982331|12415978|FG000|Received Vaccination 2|Adverse Event|1
7903436|NCT01982331|12415979|FG001|Received Vaccination 2|Adverse Event|2
7903437|NCT01982331|12415978|FG000|Received Vaccination 2|Withdrawal by Subject|0
7903438|NCT01982331|12415979|FG001|Received Vaccination 2|Withdrawal by Subject|1
7903439|NCT01982331|12415978|FG000|Completed Study (Day 112)|Withdrawal by Subject|2
7903440|NCT01982331|12415979|FG001|Completed Study (Day 112)|Withdrawal by Subject|0
7903441|NCT01982435|12415987|FG000|Overall Study|Adverse Event|1
7903442|NCT01982435|12415988|FG001|Overall Study|Adverse Event|0
7903443|NCT01982682|12416002|FG000|Overall Study|Physician Decision|1
7903444|NCT01982773|12416018|FG000|Overall Study|Withdrawal by Subject|1
7903445|NCT01982773|12416019|FG001|Overall Study|Withdrawal by Subject|3
7903446|NCT01982773|12416018|FG000|Overall Study|Lost to Follow-up|7
7903447|NCT01982773|12416019|FG001|Overall Study|Lost to Follow-up|1
7903448|NCT01982812|12416036|FG000|Overall Study|Death|1
7903449|NCT01982812|12416037|FG001|Overall Study|Death|5
7903450|NCT01982812|12416036|FG000|Overall Study|Adverse Event|0
7903451|NCT01982812|12416037|FG001|Overall Study|Adverse Event|5
7903452|NCT01982942|12416045|FG000|Overall Study|Adverse Event|10
7903453|NCT01982942|12416046|FG001|Overall Study|Adverse Event|5
7903454|NCT01982942|12416045|FG000|Overall Study|Lost to Follow-up|4
7903455|NCT01982942|12416046|FG001|Overall Study|Lost to Follow-up|3
7903456|NCT01982942|12416045|FG000|Overall Study|Multiple sclerosis progression|3
7903457|NCT01982942|12416046|FG001|Overall Study|Multiple sclerosis progression|2
7903458|NCT01982942|12416045|FG000|Overall Study|Wanted to try therapy not permitted|1
7903459|NCT01982942|12416046|FG001|Overall Study|Wanted to try therapy not permitted|0
7903460|NCT01982942|12416045|FG000|Overall Study|Subject declined future visits|0
7903461|NCT01982942|12416046|FG001|Overall Study|Subject declined future visits|1
7903462|NCT01982942|12416045|FG000|Overall Study|Left geographical area|2
7903463|NCT01982942|12416046|FG001|Overall Study|Left geographical area|0
7903464|NCT01982942|12416045|FG000|Overall Study|Too many pills|1
7903465|NCT01982942|12416046|FG001|Overall Study|Too many pills|0
7903466|NCT01982942|12416045|FG000|Overall Study|MS Relapse|0
7903467|NCT01982942|12416046|FG001|Overall Study|MS Relapse|1
7903468|NCT01982942|12416045|FG000|Overall Study|Chose to join a stem cell trial|0
7903469|NCT01982942|12416046|FG001|Overall Study|Chose to join a stem cell trial|1
7903470|NCT01982942|12416045|FG000|Overall Study|Subject bedridden, rapidly declining|0
7903471|NCT01982942|12416046|FG001|Overall Study|Subject bedridden, rapidly declining|1
7903472|NCT01983111|12416080|FG000|Overall Study|Withdrawal by Subject|8
7903473|NCT01983111|12416081|FG001|Overall Study|Withdrawal by Subject|6
7903474|NCT01983111|12416080|FG000|Overall Study|Adverse Event|4
7903475|NCT01983111|12416081|FG001|Overall Study|Adverse Event|0
7903476|NCT01983111|12416080|FG000|Overall Study|Protocol Violation|0
7903477|NCT01983111|12416081|FG001|Overall Study|Protocol Violation|1
7903478|NCT01983254|12416100|FG000|Overall Study|Death|6
7903479|NCT01983254|12416101|FG001|Overall Study|Death|6
7903480|NCT01983254|12416100|FG000|Overall Study|Lost to Follow-up|17
7903481|NCT01983254|12416101|FG001|Overall Study|Lost to Follow-up|16
7903482|NCT01983254|12416100|FG000|Overall Study|too ill|11
7903483|NCT01983254|12416101|FG001|Overall Study|too ill|8
7903484|NCT01983293|12416109|FG000|Overall Study|Withdrawal by Subject|29
7903485|NCT01983293|12416110|FG001|Overall Study|Withdrawal by Subject|15
7903486|NCT01983293|12416109|FG000|Overall Study|Missing 12-month visit|3
7903487|NCT01983293|12416110|FG001|Overall Study|Missing 12-month visit|3
7903488|NCT01983293|12416109|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1
7903489|NCT01983293|12416110|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1
7903490|NCT01983683|12416136|FG000|Overall Study|Withdrawal by Subject|14
7903491|NCT01983683|12416137|FG001|Overall Study|Withdrawal by Subject|18
7903492|NCT01983683|12416136|FG000|Overall Study|Death|11
7903493|NCT01983683|12416137|FG001|Overall Study|Death|15
7903494|NCT01983683|12416136|FG000|Overall Study|Physician Decision|8
7903495|NCT01983683|12416137|FG001|Overall Study|Physician Decision|9
7903496|NCT01983683|12416136|FG000|Overall Study|Lost to Follow-up|4
7903497|NCT01983683|12416137|FG001|Overall Study|Lost to Follow-up|8
7903498|NCT01983683|12416136|FG000|Overall Study|Sponsor Decision|1
7903499|NCT01983683|12416137|FG001|Overall Study|Sponsor Decision|1
7903500|NCT01983930|12416190|FG000|Overall Study|Withdrawal by Subject|9
7903501|NCT01983930|12416191|FG001|Overall Study|Withdrawal by Subject|8
7903502|NCT01983930|12416190|FG000|Overall Study|Adverse Event|0
7903503|NCT01983930|12416191|FG001|Overall Study|Adverse Event|1
7903504|NCT01983969|12416201|FG000|Overall Study|Disease Progression|0
7903505|NCT01983969|12416202|FG001|Overall Study|Disease Progression|1
7903506|NCT01983969|12416203|FG002|Overall Study|Disease Progression|0
7903507|NCT01984164|12416217|FG000|Overall Study|Withdrawal by Subject|4
7903508|NCT01984164|12416218|FG001|Overall Study|Withdrawal by Subject|3
7903509|NCT01984164|12416217|FG000|Overall Study|Adverse Event|5
7903510|NCT01984164|12416218|FG001|Overall Study|Adverse Event|19
7903511|NCT01984164|12416217|FG000|Overall Study|Lost to Follow-up|1
7903512|NCT01984164|12416218|FG001|Overall Study|Lost to Follow-up|3
7903513|NCT01984229|12416226|FG000|Safety Follow-up Period|Adverse Event|1
7903514|NCT01984229|12416227|FG001|Safety Follow-up Period|Adverse Event|1
7903515|NCT01984229|12416226|FG000|Safety Follow-up Period|Lost to Follow-up|1
7903516|NCT01984229|12416227|FG001|Safety Follow-up Period|Lost to Follow-up|0
7903517|NCT01984242|12416242|FG000|Overall Study|Death|52
7903518|NCT01984242|12416243|FG001|Overall Study|Death|50
7903519|NCT01984242|12416244|FG002|Overall Study|Death|52
7903520|NCT01984242|12416242|FG000|Overall Study|Withdrawal by Subject|5
7903521|NCT01984242|12416243|FG001|Overall Study|Withdrawal by Subject|3
7903522|NCT01984242|12416244|FG002|Overall Study|Withdrawal by Subject|10
7903523|NCT01984242|12416242|FG000|Overall Study|Physician Decision|0
7903524|NCT01984242|12416243|FG001|Overall Study|Physician Decision|0
7903525|NCT01984242|12416244|FG002|Overall Study|Physician Decision|1
7903526|NCT01984242|12416242|FG000|Overall Study|Lost to Follow-up|4
7903527|NCT01984242|12416243|FG001|Overall Study|Lost to Follow-up|0
7903528|NCT01984242|12416244|FG002|Overall Study|Lost to Follow-up|3
7903529|NCT01984242|12416242|FG000|Overall Study|Sponsor Decision|1
7903530|NCT01984242|12416243|FG001|Overall Study|Sponsor Decision|0
7903531|NCT01984242|12416244|FG002|Overall Study|Sponsor Decision|0
7903532|NCT01984242|12416242|FG000|Overall Study|Non-Compliance|1
7903533|NCT01984242|12416243|FG001|Overall Study|Non-Compliance|0
7903534|NCT01984242|12416244|FG002|Overall Study|Non-Compliance|0
7903535|NCT01984242|12416242|FG000|Overall Study|Study terminated by Sponsor|38
7903536|NCT01984242|12416243|FG001|Overall Study|Study terminated by Sponsor|50
7903537|NCT01984242|12416244|FG002|Overall Study|Study terminated by Sponsor|34
7903538|NCT01984242|12416242|FG000|Overall Study|Disease Progression|0
7903539|NCT01984242|12416243|FG001|Overall Study|Disease Progression|0
7903540|NCT01984242|12416244|FG002|Overall Study|Disease Progression|1
7903541|NCT01984294|12416263|FG000|Overall Study|Randomized but Never Treated|0
7903542|NCT01984294|12416264|FG001|Overall Study|Randomized but Never Treated|0
7903543|NCT01984294|12416265|FG002|Overall Study|Randomized but Never Treated|1
7903544|NCT01984294|12416263|FG000|Overall Study|Lack of Efficacy|4
7903545|NCT01984294|12416264|FG001|Overall Study|Lack of Efficacy|2
7903546|NCT01984294|12416265|FG002|Overall Study|Lack of Efficacy|6
7903547|NCT01984294|12416263|FG000|Overall Study|Adverse Event|0
7903548|NCT01984294|12416264|FG001|Overall Study|Adverse Event|1
7903549|NCT01984294|12416265|FG002|Overall Study|Adverse Event|0
7903550|NCT01984424|12416290|FG000|Overall Study|Withdrawal by Subject|3
7903551|NCT01984424|12416291|FG001|Overall Study|Withdrawal by Subject|5
7903552|NCT01984424|12416290|FG000|Overall Study|Sponsor Decision|0
7903553|NCT01984424|12416291|FG001|Overall Study|Sponsor Decision|1
7903554|NCT01984424|12416290|FG000|Overall Study|Lost to Follow-up|0
7903555|NCT01984424|12416291|FG001|Overall Study|Lost to Follow-up|1
7903556|NCT01984684|12416303|FG000|Overall Study|Lost to Follow-up|25
7903557|NCT01984684|12416304|FG001|Overall Study|Lost to Follow-up|24
7903558|NCT01984684|12416303|FG000|Overall Study|Adverse Event|8
7903559|NCT01984684|12416304|FG001|Overall Study|Adverse Event|12
7903560|NCT01984684|12416303|FG000|Overall Study|Withdrawal by Subject|9
7903561|NCT01984684|12416304|FG001|Overall Study|Withdrawal by Subject|9
7903562|NCT01984684|12416303|FG000|Overall Study|Lack of Efficacy|3
7903563|NCT01984684|12416304|FG001|Overall Study|Lack of Efficacy|6
7903564|NCT01984684|12416303|FG000|Overall Study|Physician Decision|4
7903565|NCT01984684|12416304|FG001|Overall Study|Physician Decision|2
7903566|NCT01984684|12416303|FG000|Overall Study|Protocol Violation|4
7903567|NCT01984684|12416304|FG001|Overall Study|Protocol Violation|2
7903568|NCT01984684|12416303|FG000|Overall Study|Death|0
7903569|NCT01984684|12416304|FG001|Overall Study|Death|1
7903570|NCT01984684|12416303|FG000|Overall Study|Noncompliance with study drug|2
7903571|NCT01984684|12416304|FG001|Overall Study|Noncompliance with study drug|1
7903572|NCT01984684|12416303|FG000|Overall Study|Subject incarcerated|1
7903573|NCT01984684|12416304|FG001|Overall Study|Subject incarcerated|0
7903574|NCT01984684|12416303|FG000|Overall Study|Study drug not available at site|1
7903575|NCT01984684|12416304|FG001|Overall Study|Study drug not available at site|1
7903576|NCT01984684|12416303|FG000|Overall Study|Subject had inadequate IV access|0
7903577|NCT01984684|12416304|FG001|Overall Study|Subject had inadequate IV access|1
7903578|NCT01984697|12416315|FG000|Overall Study|Adverse Event|0
7903579|NCT01984697|12416316|FG001|Overall Study|Adverse Event|0
7903580|NCT01984697|12416317|FG002|Overall Study|Adverse Event|2
7903581|NCT01984697|12416318|FG003|Overall Study|Adverse Event|0
7903582|NCT01984697|12416319|FG004|Overall Study|Adverse Event|0
7903583|NCT01984697|12416315|FG000|Overall Study|Lost to Follow-up|14
7903584|NCT01984697|12416316|FG001|Overall Study|Lost to Follow-up|5
7903585|NCT01984697|12416317|FG002|Overall Study|Lost to Follow-up|10
7903586|NCT01984697|12416318|FG003|Overall Study|Lost to Follow-up|6
7903587|NCT01984697|12416319|FG004|Overall Study|Lost to Follow-up|21
7903588|NCT01984697|12416315|FG000|Overall Study|Physician Decision|3
7903589|NCT01984697|12416316|FG001|Overall Study|Physician Decision|0
7903590|NCT01984697|12416317|FG002|Overall Study|Physician Decision|0
7903591|NCT01984697|12416318|FG003|Overall Study|Physician Decision|1
7903592|NCT01984697|12416319|FG004|Overall Study|Physician Decision|0
7903593|NCT01984697|12416315|FG000|Overall Study|Protocol Violation|8
7903594|NCT01984697|12416316|FG001|Overall Study|Protocol Violation|5
7903595|NCT01984697|12416317|FG002|Overall Study|Protocol Violation|3
7903596|NCT01984697|12416318|FG003|Overall Study|Protocol Violation|2
7903597|NCT01984697|12416319|FG004|Overall Study|Protocol Violation|0
7903598|NCT01984697|12416315|FG000|Overall Study|Withdrawal by Subject|15
7903599|NCT01984697|12416316|FG001|Overall Study|Withdrawal by Subject|21
7903600|NCT01984697|12416317|FG002|Overall Study|Withdrawal by Subject|13
7903601|NCT01984697|12416318|FG003|Overall Study|Withdrawal by Subject|11
7903602|NCT01984697|12416319|FG004|Overall Study|Withdrawal by Subject|13
7903603|NCT01984697|12416315|FG000|Overall Study|Missed last follow-up visit|1
7903604|NCT01984697|12416316|FG001|Overall Study|Missed last follow-up visit|0
7903605|NCT01984697|12416317|FG002|Overall Study|Missed last follow-up visit|0
7903606|NCT01984697|12416318|FG003|Overall Study|Missed last follow-up visit|0
7903607|NCT01984697|12416319|FG004|Overall Study|Missed last follow-up visit|0
7903608|NCT01984697|12416315|FG000|Overall Study|Death|0
7903609|NCT01984697|12416316|FG001|Overall Study|Death|0
7903610|NCT01984697|12416317|FG002|Overall Study|Death|0
7903611|NCT01984697|12416318|FG003|Overall Study|Death|1
7903612|NCT01984697|12416319|FG004|Overall Study|Death|0
7903613|NCT01984697|12416315|FG000|Overall Study|Pregnancy|2
7903614|NCT01984697|12416316|FG001|Overall Study|Pregnancy|0
7903615|NCT01984697|12416317|FG002|Overall Study|Pregnancy|1
7903616|NCT01984697|12416318|FG003|Overall Study|Pregnancy|0
7903617|NCT01984697|12416319|FG004|Overall Study|Pregnancy|1
7903618|NCT01984892|12416331|FG000|Overall Study|Progressive disease|7
7903619|NCT01985126|12416337|FG000|Overall Study|Death|15
7903620|NCT01985126|12416338|FG001|Overall Study|Death|69
7903621|NCT01985126|12416337|FG000|Overall Study|Lost to Follow-up|0
7903622|NCT01985126|12416338|FG001|Overall Study|Lost to Follow-up|8
7903623|NCT01985126|12416337|FG000|Overall Study|Study Terminated By Sponsor|1
7903624|NCT01985126|12416338|FG001|Overall Study|Study Terminated By Sponsor|22
7903625|NCT01985126|12416337|FG000|Overall Study|Withdrawal by Subject|2
7903626|NCT01985126|12416338|FG001|Overall Study|Withdrawal by Subject|7
7903627|NCT01985321|12416346|FG000|Overall Study|Protocol Violation|4
7903628|NCT01985321|12416347|FG001|Overall Study|Protocol Violation|3
7903629|NCT01985321|12416346|FG000|Overall Study|Withdrawal by Subject|1
7903630|NCT01985321|12416347|FG001|Overall Study|Withdrawal by Subject|0
7903631|NCT01985321|12416346|FG000|Overall Study|Lost to Follow-up|5
7903632|NCT01985321|12416347|FG001|Overall Study|Lost to Follow-up|2
7903633|NCT01985321|12416346|FG000|Overall Study|Subject treated wrong type of sore|1
7903634|NCT01985321|12416347|FG001|Overall Study|Subject treated wrong type of sore|0
7903635|NCT01985334|12416361|FG000|Overall Study|Administrative problems|1
7903636|NCT01985334|12416362|FG001|Overall Study|Administrative problems|1
7903637|NCT01985334|12416363|FG002|Overall Study|Administrative problems|0
7903638|NCT01985334|12416364|FG003|Overall Study|Administrative problems|2
7903639|NCT01985334|12416365|FG004|Overall Study|Administrative problems|0
7903640|NCT01985334|12416366|FG005|Overall Study|Administrative problems|1
7903641|NCT01985334|12416367|FG006|Overall Study|Administrative problems|1
7903642|NCT01985334|12416368|FG007|Overall Study|Administrative problems|3
7903643|NCT01985334|12416361|FG000|Overall Study|Death|1
7903644|NCT01985334|12416362|FG001|Overall Study|Death|0
7903645|NCT01985334|12416363|FG002|Overall Study|Death|0
7903646|NCT01985334|12416364|FG003|Overall Study|Death|3
7903647|NCT01985334|12416365|FG004|Overall Study|Death|0
7903648|NCT01985334|12416366|FG005|Overall Study|Death|0
7903649|NCT01985334|12416367|FG006|Overall Study|Death|1
7903650|NCT01985334|12416368|FG007|Overall Study|Death|2
7903651|NCT01985334|12416361|FG000|Overall Study|Worsening of disease|0
7903652|NCT01985334|12416362|FG001|Overall Study|Worsening of disease|0
7903653|NCT01985334|12416363|FG002|Overall Study|Worsening of disease|0
7903654|NCT01985334|12416364|FG003|Overall Study|Worsening of disease|1
7903655|NCT01985334|12416365|FG004|Overall Study|Worsening of disease|0
7903656|NCT01985334|12416366|FG005|Overall Study|Worsening of disease|3
7903657|NCT01985334|12416367|FG006|Overall Study|Worsening of disease|0
7903658|NCT01985334|12416368|FG007|Overall Study|Worsening of disease|1
7903659|NCT01985334|12416361|FG000|Overall Study|Other|2
7903660|NCT01985334|12416362|FG001|Overall Study|Other|9
7903661|NCT01985334|12416363|FG002|Overall Study|Other|7
7903662|NCT01985334|12416364|FG003|Overall Study|Other|17
7903663|NCT01985334|12416365|FG004|Overall Study|Other|4
7903664|NCT01985334|12416366|FG005|Overall Study|Other|8
7903665|NCT01985334|12416367|FG006|Overall Study|Other|4
7903666|NCT01985334|12416368|FG007|Overall Study|Other|7
7903667|NCT01985334|12416361|FG000|Overall Study|Protocol deviation|6
7903668|NCT01985334|12416362|FG001|Overall Study|Protocol deviation|31
7903669|NCT01985334|12416363|FG002|Overall Study|Protocol deviation|25
7903670|NCT01985334|12416364|FG003|Overall Study|Protocol deviation|84
7903671|NCT01985334|12416365|FG004|Overall Study|Protocol deviation|17
7903672|NCT01985334|12416366|FG005|Overall Study|Protocol deviation|47
7903673|NCT01985334|12416367|FG006|Overall Study|Protocol deviation|15
7903674|NCT01985334|12416368|FG007|Overall Study|Protocol deviation|42
7903675|NCT01985334|12416361|FG000|Overall Study|Moderate / severe COPD exacerbation|5
7903676|NCT01985334|12416362|FG001|Overall Study|Moderate / severe COPD exacerbation|14
7903677|NCT01985334|12416363|FG002|Overall Study|Moderate / severe COPD exacerbation|12
7903678|NCT01985334|12416364|FG003|Overall Study|Moderate / severe COPD exacerbation|40
7903679|NCT01985334|12416365|FG004|Overall Study|Moderate / severe COPD exacerbation|6
7903680|NCT01985334|12416366|FG005|Overall Study|Moderate / severe COPD exacerbation|40
7903681|NCT01985334|12416367|FG006|Overall Study|Moderate / severe COPD exacerbation|8
7903682|NCT01985334|12416368|FG007|Overall Study|Moderate / severe COPD exacerbation|19
7903683|NCT01985334|12416361|FG000|Overall Study|Subject withdrawal of consent|3
7903684|NCT01985334|12416362|FG001|Overall Study|Subject withdrawal of consent|6
7903685|NCT01985334|12416363|FG002|Overall Study|Subject withdrawal of consent|2
7903686|NCT01985334|12416364|FG003|Overall Study|Subject withdrawal of consent|28
7903687|NCT01985334|12416365|FG004|Overall Study|Subject withdrawal of consent|4
7903688|NCT01985334|12416366|FG005|Overall Study|Subject withdrawal of consent|19
7903689|NCT01985334|12416367|FG006|Overall Study|Subject withdrawal of consent|0
7903690|NCT01985334|12416368|FG007|Overall Study|Subject withdrawal of consent|20
7903691|NCT01985334|12416361|FG000|Overall Study|Adverse Event|0
7903692|NCT01985334|12416362|FG001|Overall Study|Adverse Event|8
7903693|NCT01985334|12416363|FG002|Overall Study|Adverse Event|2
7903694|NCT01985334|12416364|FG003|Overall Study|Adverse Event|26
7903695|NCT01985334|12416365|FG004|Overall Study|Adverse Event|3
7903696|NCT01985334|12416366|FG005|Overall Study|Adverse Event|18
7903697|NCT01985334|12416367|FG006|Overall Study|Adverse Event|3
7903698|NCT01985334|12416368|FG007|Overall Study|Adverse Event|15
7903699|NCT01985334|12416361|FG000|Overall Study|Other|4
7903700|NCT01985334|12416362|FG001|Overall Study|Other|2
7903701|NCT01985334|12416363|FG002|Overall Study|Other|3
7903702|NCT01985334|12416364|FG003|Overall Study|Other|10
7903703|NCT01985334|12416365|FG004|Overall Study|Other|1
7903704|NCT01985334|12416366|FG005|Overall Study|Other|6
7903705|NCT01985334|12416367|FG006|Overall Study|Other|2
7903706|NCT01985334|12416368|FG007|Overall Study|Other|2
7903707|NCT01985334|12416361|FG000|Overall Study|Medication non-compliance|0
7903708|NCT01985334|12416362|FG001|Overall Study|Medication non-compliance|4
7903709|NCT01985334|12416363|FG002|Overall Study|Medication non-compliance|1
7903710|NCT01985334|12416364|FG003|Overall Study|Medication non-compliance|6
7903711|NCT01985334|12416365|FG004|Overall Study|Medication non-compliance|2
7903712|NCT01985334|12416366|FG005|Overall Study|Medication non-compliance|3
7903713|NCT01985334|12416367|FG006|Overall Study|Medication non-compliance|1
7903714|NCT01985334|12416368|FG007|Overall Study|Medication non-compliance|3
7903715|NCT01985334|12416361|FG000|Overall Study|Use of prohibited treatment|1
7903716|NCT01985334|12416362|FG001|Overall Study|Use of prohibited treatment|4
7903717|NCT01985334|12416363|FG002|Overall Study|Use of prohibited treatment|1
7903718|NCT01985334|12416364|FG003|Overall Study|Use of prohibited treatment|2
7903719|NCT01985334|12416365|FG004|Overall Study|Use of prohibited treatment|1
7903720|NCT01985334|12416366|FG005|Overall Study|Use of prohibited treatment|6
7903721|NCT01985334|12416367|FG006|Overall Study|Use of prohibited treatment|2
7903722|NCT01985334|12416368|FG007|Overall Study|Use of prohibited treatment|0
7903723|NCT01985334|12416361|FG000|Overall Study|Investigator decision|0
7903724|NCT01985334|12416362|FG001|Overall Study|Investigator decision|3
7903725|NCT01985334|12416363|FG002|Overall Study|Investigator decision|0
7903726|NCT01985334|12416364|FG003|Overall Study|Investigator decision|7
7903727|NCT01985334|12416365|FG004|Overall Study|Investigator decision|1
7903728|NCT01985334|12416366|FG005|Overall Study|Investigator decision|1
7903729|NCT01985334|12416367|FG006|Overall Study|Investigator decision|0
7903730|NCT01985334|12416368|FG007|Overall Study|Investigator decision|4
7903731|NCT01985334|12416361|FG000|Overall Study|Lost to Follow-up|0
7903732|NCT01985334|12416362|FG001|Overall Study|Lost to Follow-up|2
7903733|NCT01985334|12416363|FG002|Overall Study|Lost to Follow-up|0
7903734|NCT01985334|12416364|FG003|Overall Study|Lost to Follow-up|3
7903735|NCT01985334|12416365|FG004|Overall Study|Lost to Follow-up|1
7903736|NCT01985334|12416366|FG005|Overall Study|Lost to Follow-up|4
7903737|NCT01985334|12416367|FG006|Overall Study|Lost to Follow-up|0
7903738|NCT01985334|12416368|FG007|Overall Study|Lost to Follow-up|3
7903739|NCT01985360|12416402|FG000|Overall Study|Withdrawal by Subject|4
7903740|NCT01985360|12416403|FG001|Overall Study|Withdrawal by Subject|0
7903741|NCT01985360|12416402|FG000|Overall Study|Lost to Follow-up|5
7903742|NCT01985360|12416403|FG001|Overall Study|Lost to Follow-up|3
7963797|NCT02729831|12518528|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18
7963798|NCT02729831|12518529|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17
7963799|NCT02729831|12518526|FG000|1 Week Post-visit|Lost to Follow-up|43
7963800|NCT02729831|12518527|FG001|1 Week Post-visit|Lost to Follow-up|40
7963801|NCT02729831|12518528|FG002|1 Week Post-visit|Lost to Follow-up|38
7963802|NCT02729831|12518529|FG003|1 Week Post-visit|Lost to Follow-up|36
7963803|NCT02729831|12518526|FG000|6 Month Follow-up|Lost to Follow-up|54
7963804|NCT02729831|12518527|FG001|6 Month Follow-up|Lost to Follow-up|51
7963805|NCT02729831|12518528|FG002|6 Month Follow-up|Lost to Follow-up|48
7963806|NCT02729831|12518529|FG003|6 Month Follow-up|Lost to Follow-up|42
7963807|NCT02729831|12518526|FG000|6 Month Follow-up|Death|1
7963808|NCT02729831|12518527|FG001|6 Month Follow-up|Death|3
7963809|NCT02729831|12518528|FG002|6 Month Follow-up|Death|0
7963810|NCT02729831|12518529|FG003|6 Month Follow-up|Death|1
7963811|NCT02729896|12518542|FG000|Overall Study|Death|0
7963812|NCT02729896|12518543|FG001|Overall Study|Death|2
7963813|NCT02729896|12518544|FG002|Overall Study|Death|13
7963814|NCT02729896|12518542|FG000|Overall Study|Lost to Follow-up|0
7963815|NCT02729896|12518543|FG001|Overall Study|Lost to Follow-up|2
7963816|NCT02729896|12518544|FG002|Overall Study|Lost to Follow-up|3
7963817|NCT02729896|12518542|FG000|Overall Study|Other|0
7963818|NCT02729896|12518543|FG001|Overall Study|Other|2
7963819|NCT02729896|12518544|FG002|Overall Study|Other|0
7963820|NCT02729896|12518542|FG000|Overall Study|Physician Decision|1
7963821|NCT02729896|12518543|FG001|Overall Study|Physician Decision|2
7963822|NCT02729896|12518544|FG002|Overall Study|Physician Decision|3
7963823|NCT02729896|12518542|FG000|Overall Study|Progressive Disease|0
7963824|NCT02729896|12518543|FG001|Overall Study|Progressive Disease|1
7963825|NCT02729896|12518544|FG002|Overall Study|Progressive Disease|0
7963826|NCT02729896|12518542|FG000|Overall Study|Withdrawal by Subject|1
7963827|NCT02729896|12518543|FG001|Overall Study|Withdrawal by Subject|0
7963828|NCT02729896|12518544|FG002|Overall Study|Withdrawal by Subject|3
7963829|NCT02729909|12518555|FG000|Overall Study|Lost to Follow-up|0
7963830|NCT02729909|12518556|FG001|Overall Study|Lost to Follow-up|1
7963831|NCT02729909|12518555|FG000|Overall Study|Lack of Efficacy|0
7963832|NCT02729909|12518556|FG001|Overall Study|Lack of Efficacy|2
7963833|NCT02729909|12518555|FG000|Overall Study|Significant Protocol Deviation|0
7963834|NCT02729909|12518556|FG001|Overall Study|Significant Protocol Deviation|2
7963835|NCT02729909|12518555|FG000|Overall Study|Voluntary Withdrawal|1
7963836|NCT02729909|12518556|FG001|Overall Study|Voluntary Withdrawal|0
7963837|NCT02730195|12518562|FG000|Overall Study|Withdrawal by Subject|1
7963838|NCT02730208|12518568|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
7963839|NCT02730208|12518569|FG001|Overall Study|Withdrawal of consent (not due to AE)|1
7963840|NCT02730351|12518592|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1
7963841|NCT02730351|12518593|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0
7963842|NCT02730351|12518592|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0
7963843|NCT02730351|12518593|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1
7963844|NCT02730351|12518592|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
7963845|NCT02730351|12518593|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
7963846|NCT02730351|12518592|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1
7963847|NCT02730351|12518593|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0
7963848|NCT02730351|12518592|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
7963849|NCT02730351|12518593|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
7963850|NCT02730377|12518601|FG000|Overall Study|Other|5
7963851|NCT02730377|12518602|FG001|Overall Study|Other|4
7963852|NCT02730377|12518601|FG000|Overall Study|Death|1
7963853|NCT02730377|12518602|FG001|Overall Study|Death|8
7963854|NCT02730377|12518601|FG000|Overall Study|Inadequate glycaemic control|368
7963855|NCT02730377|12518602|FG001|Overall Study|Inadequate glycaemic control|473
7963856|NCT02730377|12518601|FG000|Overall Study|Adverse Event|79
7963857|NCT02730377|12518602|FG001|Overall Study|Adverse Event|41
7963858|NCT02730377|12518601|FG000|Overall Study|Protocol Violation|23
7963859|NCT02730377|12518602|FG001|Overall Study|Protocol Violation|30
7963860|NCT02730377|12518601|FG000|Overall Study|Lack of Efficacy|4
7963861|NCT02730377|12518602|FG001|Overall Study|Lack of Efficacy|13
7963862|NCT02730377|12518601|FG000|Overall Study|Pregnancy|0
7963863|NCT02730377|12518602|FG001|Overall Study|Pregnancy|1
7963864|NCT02730377|12518601|FG000|Overall Study|Withdrawal by Subject|45
7963865|NCT02730377|12518602|FG001|Overall Study|Withdrawal by Subject|42
7963866|NCT02730377|12518601|FG000|Overall Study|Lost to Follow-up|25
7963867|NCT02730377|12518602|FG001|Overall Study|Lost to Follow-up|21
7963868|NCT02730455|12518616|FG000|Overall Study|Death|5
7963869|NCT02730455|12518617|FG001|Overall Study|Death|6
7963870|NCT02730455|12518618|FG002|Overall Study|Death|4
7963871|NCT02730455|12518616|FG000|Overall Study|Consent withdrawn|2
7963872|NCT02730455|12518617|FG001|Overall Study|Consent withdrawn|4
7963873|NCT02730455|12518618|FG002|Overall Study|Consent withdrawn|1
7963874|NCT02730455|12518616|FG000|Overall Study|Lost to Follow-up|3
7963875|NCT02730455|12518617|FG001|Overall Study|Lost to Follow-up|1
7963876|NCT02730455|12518618|FG002|Overall Study|Lost to Follow-up|4
7963877|NCT02730455|12518616|FG000|Overall Study|Other|1
7963878|NCT02730455|12518617|FG001|Overall Study|Other|1
7903743|NCT01986010|12416491|FG000|Overall Study|Adverse Event|0
7903744|NCT01986010|12416492|FG001|Overall Study|Adverse Event|1
7903745|NCT01986010|12416493|FG002|Overall Study|Adverse Event|0
7903746|NCT01986010|12416494|FG003|Overall Study|Adverse Event|0
7903747|NCT01986010|12416495|FG004|Overall Study|Adverse Event|0
7903748|NCT01986010|12416496|FG005|Overall Study|Adverse Event|0
7903749|NCT01986010|12416497|FG006|Overall Study|Adverse Event|0
7903750|NCT01986010|12416498|FG007|Overall Study|Adverse Event|0
7903751|NCT01986010|12416499|FG008|Overall Study|Adverse Event|0
7903752|NCT01986010|12416500|FG009|Overall Study|Adverse Event|0
7903753|NCT01986010|12416501|FG010|Overall Study|Adverse Event|0
7903754|NCT01986010|12416502|FG011|Overall Study|Adverse Event|0
7903755|NCT01986010|12416503|FG012|Overall Study|Adverse Event|0
7903756|NCT01986010|12416504|FG013|Overall Study|Adverse Event|0
7903757|NCT01986010|12416505|FG014|Overall Study|Adverse Event|0
7903758|NCT01986010|12416506|FG015|Overall Study|Adverse Event|1
7903759|NCT01986010|12416507|FG016|Overall Study|Adverse Event|0
7903760|NCT01986010|12416491|FG000|Overall Study|Lost to Follow-up|2
7903761|NCT01986010|12416492|FG001|Overall Study|Lost to Follow-up|1
7903762|NCT01986010|12416493|FG002|Overall Study|Lost to Follow-up|2
7903763|NCT01986010|12416494|FG003|Overall Study|Lost to Follow-up|2
7903764|NCT01986010|12416495|FG004|Overall Study|Lost to Follow-up|2
7903765|NCT01986010|12416496|FG005|Overall Study|Lost to Follow-up|2
7903766|NCT01986010|12416497|FG006|Overall Study|Lost to Follow-up|0
7903767|NCT01986010|12416498|FG007|Overall Study|Lost to Follow-up|0
7903768|NCT01986010|12416499|FG008|Overall Study|Lost to Follow-up|4
7903769|NCT01986010|12416500|FG009|Overall Study|Lost to Follow-up|2
7903770|NCT01986010|12416501|FG010|Overall Study|Lost to Follow-up|0
7903771|NCT01986010|12416502|FG011|Overall Study|Lost to Follow-up|1
7903772|NCT01986010|12416503|FG012|Overall Study|Lost to Follow-up|1
7903773|NCT01986010|12416504|FG013|Overall Study|Lost to Follow-up|1
7903774|NCT01986010|12416505|FG014|Overall Study|Lost to Follow-up|2
7903775|NCT01986010|12416506|FG015|Overall Study|Lost to Follow-up|0
7903776|NCT01986010|12416507|FG016|Overall Study|Lost to Follow-up|0
7903777|NCT01986010|12416491|FG000|Overall Study|Physician Decision|0
7903778|NCT01986010|12416492|FG001|Overall Study|Physician Decision|0
7903779|NCT01986010|12416493|FG002|Overall Study|Physician Decision|0
7903780|NCT01986010|12416494|FG003|Overall Study|Physician Decision|0
7903781|NCT01986010|12416495|FG004|Overall Study|Physician Decision|0
7903782|NCT01986010|12416496|FG005|Overall Study|Physician Decision|0
7903783|NCT01986010|12416497|FG006|Overall Study|Physician Decision|0
7903784|NCT01986010|12416498|FG007|Overall Study|Physician Decision|0
7903785|NCT01986010|12416499|FG008|Overall Study|Physician Decision|0
7903786|NCT01986010|12416500|FG009|Overall Study|Physician Decision|0
7903787|NCT01986010|12416501|FG010|Overall Study|Physician Decision|0
7903788|NCT01986010|12416502|FG011|Overall Study|Physician Decision|0
7903789|NCT01986010|12416503|FG012|Overall Study|Physician Decision|0
7903790|NCT01986010|12416504|FG013|Overall Study|Physician Decision|0
7903791|NCT01986010|12416505|FG014|Overall Study|Physician Decision|1
7903792|NCT01986010|12416506|FG015|Overall Study|Physician Decision|0
7903793|NCT01986010|12416507|FG016|Overall Study|Physician Decision|0
7903794|NCT01986010|12416491|FG000|Overall Study|Withdrawal by Subject|2
7903795|NCT01986010|12416492|FG001|Overall Study|Withdrawal by Subject|2
7903796|NCT01986010|12416493|FG002|Overall Study|Withdrawal by Subject|3
7903797|NCT01986010|12416494|FG003|Overall Study|Withdrawal by Subject|0
7903798|NCT01986010|12416495|FG004|Overall Study|Withdrawal by Subject|2
7903799|NCT01986010|12416496|FG005|Overall Study|Withdrawal by Subject|4
7903800|NCT01986010|12416497|FG006|Overall Study|Withdrawal by Subject|0
7903801|NCT01986010|12416498|FG007|Overall Study|Withdrawal by Subject|0
7903802|NCT01986010|12416499|FG008|Overall Study|Withdrawal by Subject|0
7903803|NCT01986010|12416500|FG009|Overall Study|Withdrawal by Subject|0
7903804|NCT01986010|12416501|FG010|Overall Study|Withdrawal by Subject|0
7903805|NCT01986010|12416502|FG011|Overall Study|Withdrawal by Subject|2
7903806|NCT01986010|12416503|FG012|Overall Study|Withdrawal by Subject|0
7903807|NCT01986010|12416504|FG013|Overall Study|Withdrawal by Subject|1
7903808|NCT01986010|12416505|FG014|Overall Study|Withdrawal by Subject|2
7903809|NCT01986010|12416506|FG015|Overall Study|Withdrawal by Subject|0
7903810|NCT01986010|12416507|FG016|Overall Study|Withdrawal by Subject|0
7903811|NCT01986010|12416491|FG000|Overall Study|Status Not Recorded|2
7903812|NCT01986010|12416492|FG001|Overall Study|Status Not Recorded|4
7903813|NCT01986010|12416493|FG002|Overall Study|Status Not Recorded|2
7903814|NCT01986010|12416494|FG003|Overall Study|Status Not Recorded|0
7903815|NCT01986010|12416495|FG004|Overall Study|Status Not Recorded|1
7903816|NCT01986010|12416496|FG005|Overall Study|Status Not Recorded|2
7903817|NCT01986010|12416497|FG006|Overall Study|Status Not Recorded|0
7903818|NCT01986010|12416498|FG007|Overall Study|Status Not Recorded|0
7903819|NCT01986010|12416499|FG008|Overall Study|Status Not Recorded|2
7903820|NCT01986010|12416500|FG009|Overall Study|Status Not Recorded|1
7903821|NCT01986010|12416501|FG010|Overall Study|Status Not Recorded|7
7903822|NCT01986010|12416502|FG011|Overall Study|Status Not Recorded|7
7903823|NCT01986010|12416503|FG012|Overall Study|Status Not Recorded|9
7903824|NCT01986010|12416504|FG013|Overall Study|Status Not Recorded|9
7903825|NCT01986010|12416505|FG014|Overall Study|Status Not Recorded|5
7903826|NCT01986010|12416506|FG015|Overall Study|Status Not Recorded|10
7903827|NCT01986010|12416507|FG016|Overall Study|Status Not Recorded|4
7903828|NCT01986062|12416555|FG000|Overall Study|Lost to Follow-up|1
7903829|NCT01986062|12416556|FG001|Overall Study|Lost to Follow-up|0
7903830|NCT01986062|12416555|FG000|Overall Study|Withdrawal by Subject|0
7903831|NCT01986062|12416556|FG001|Overall Study|Withdrawal by Subject|1
7903832|NCT01986140|12416564|FG000|Overall Study|Withdrawal by Subject|31
7903833|NCT01986140|12416565|FG001|Overall Study|Withdrawal by Subject|25
7903834|NCT01986140|12416564|FG000|Overall Study|alternative treatment|1
7903835|NCT01986140|12416565|FG001|Overall Study|alternative treatment|1
7903836|NCT01986140|12416564|FG000|Overall Study|found not eligible|3
7903837|NCT01986140|12416565|FG001|Overall Study|found not eligible|0
7903838|NCT01986140|12416564|FG000|Overall Study|Adverse Event|0
7903839|NCT01986140|12416565|FG001|Overall Study|Adverse Event|1
7903840|NCT01986140|12416564|FG000|Overall Study|progression disease|0
7903841|NCT01986140|12416565|FG001|Overall Study|progression disease|1
7903842|NCT01986231|12416571|FG000|Overall Study|Adverse Event|1
7903843|NCT01986348|12416579|FG000|Overall Study|Death|8
7903844|NCT01986348|12416580|FG001|Overall Study|Death|22
7903845|NCT01986348|12416581|FG002|Overall Study|Death|10
7903846|NCT01986348|12416582|FG003|Overall Study|Death|21
7903847|NCT01986348|12416579|FG000|Overall Study|Lost to Follow-up|0
7903848|NCT01986348|12416580|FG001|Overall Study|Lost to Follow-up|0
7903849|NCT01986348|12416581|FG002|Overall Study|Lost to Follow-up|0
7903850|NCT01986348|12416582|FG003|Overall Study|Lost to Follow-up|2
7903851|NCT01986348|12416579|FG000|Overall Study|Physician Decision|0
7903852|NCT01986348|12416580|FG001|Overall Study|Physician Decision|0
7903853|NCT01986348|12416581|FG002|Overall Study|Physician Decision|0
7903854|NCT01986348|12416582|FG003|Overall Study|Physician Decision|1
7903855|NCT01986348|12416579|FG000|Overall Study|Progressive Disease|0
7903856|NCT01986348|12416580|FG001|Overall Study|Progressive Disease|0
7903857|NCT01986348|12416581|FG002|Overall Study|Progressive Disease|2
7903858|NCT01986348|12416582|FG003|Overall Study|Progressive Disease|0
7903859|NCT01986348|12416579|FG000|Overall Study|Withdrawal by Participant|0
7903860|NCT01986348|12416580|FG001|Overall Study|Withdrawal by Participant|1
7903861|NCT01986348|12416581|FG002|Overall Study|Withdrawal by Participant|2
7903862|NCT01986348|12416582|FG003|Overall Study|Withdrawal by Participant|1
7903863|NCT01986348|12416579|FG000|Overall Study|Study Terminated by Sponsor|0
7903864|NCT01986348|12416580|FG001|Overall Study|Study Terminated by Sponsor|0
7903865|NCT01986348|12416581|FG002|Overall Study|Study Terminated by Sponsor|0
7903866|NCT01986348|12416582|FG003|Overall Study|Study Terminated by Sponsor|3
7903867|NCT01986348|12416579|FG000|Overall Study|Other-unspecified|0
7903868|NCT01986348|12416580|FG001|Overall Study|Other-unspecified|1
7903869|NCT01986348|12416581|FG002|Overall Study|Other-unspecified|0
7903870|NCT01986348|12416582|FG003|Overall Study|Other-unspecified|2
7903871|NCT01986647|12416608|FG000|Overall Study|Lost to Follow-up|4
7903872|NCT01986647|12416609|FG001|Overall Study|Lost to Follow-up|1
7903873|NCT01986647|12416610|FG002|Overall Study|Lost to Follow-up|4
7903874|NCT01986647|12416611|FG003|Overall Study|Lost to Follow-up|4
7903875|NCT01986647|12416608|FG000|Overall Study|Withdrawal by Subject|1
7903876|NCT01986647|12416609|FG001|Overall Study|Withdrawal by Subject|3
7903877|NCT01986647|12416610|FG002|Overall Study|Withdrawal by Subject|2
7903878|NCT01986647|12416611|FG003|Overall Study|Withdrawal by Subject|3
7903879|NCT01986647|12416608|FG000|Overall Study|Health|5
7903880|NCT01986647|12416609|FG001|Overall Study|Health|3
7903881|NCT01986647|12416610|FG002|Overall Study|Health|6
7903882|NCT01986647|12416611|FG003|Overall Study|Health|4
7903883|NCT01986829|12416647|FG000|Overall Study|Death|1
7903884|NCT01986855|12416657|FG000|Overall Study|Adverse Event|1
7903885|NCT01986855|12416658|FG001|Overall Study|Adverse Event|0
7903886|NCT01986855|12416659|FG002|Overall Study|Adverse Event|0
7903887|NCT01986855|12416657|FG000|Overall Study|Death|3
7903888|NCT01986855|12416658|FG001|Overall Study|Death|4
7903889|NCT01986855|12416659|FG002|Overall Study|Death|4
7903890|NCT01986855|12416657|FG000|Overall Study|Lost to Follow-up|2
7903891|NCT01986855|12416658|FG001|Overall Study|Lost to Follow-up|1
7903892|NCT01986855|12416659|FG002|Overall Study|Lost to Follow-up|0
7903893|NCT01986855|12416657|FG000|Overall Study|Screen Failure|0
7903894|NCT01986855|12416658|FG001|Overall Study|Screen Failure|1
7903895|NCT01986855|12416659|FG002|Overall Study|Screen Failure|0
7903896|NCT01986855|12416657|FG000|Overall Study|Participant Moved|0
7903897|NCT01986855|12416658|FG001|Overall Study|Participant Moved|0
7903898|NCT01986855|12416659|FG002|Overall Study|Participant Moved|2
7903899|NCT01986855|12416657|FG000|Overall Study|Withdrawal by Subject|7
7903900|NCT01986855|12416658|FG001|Overall Study|Withdrawal by Subject|8
7903901|NCT01986855|12416659|FG002|Overall Study|Withdrawal by Subject|5
7903902|NCT01986907|12416667|FG000|Overall Study|Adverse Event|11
7903903|NCT01986907|12416667|FG000|Overall Study|Unsatisfactory therapeutic effect|24
7903904|NCT01986907|12416667|FG000|Overall Study|Protocol Violation|4
7903905|NCT01986907|12416667|FG000|Overall Study|Withdrawal by Subject|76
7903906|NCT01986907|12416667|FG000|Overall Study|Lost to Follow-up|38
7903907|NCT01986907|12416667|FG000|Overall Study|Death|9
7903908|NCT01986920|12416674|FG000|A- 101 25%|Withdrawal by Subject|1
7903909|NCT01986920|12416675|FG001|A- 101 25%|Withdrawal by Subject|0
7903910|NCT01986920|12416676|FG002|A- 101 25%|Withdrawal by Subject|0
7903911|NCT01986920|12416677|FG003|A- 101 25%|Withdrawal by Subject|0
7903912|NCT01986920|12416674|FG000|A-101 32.5%|Withdrawal by Subject|0
7903913|NCT01986920|12416675|FG001|A-101 32.5%|Withdrawal by Subject|1
7903914|NCT01986920|12416676|FG002|A-101 32.5%|Withdrawal by Subject|0
7903915|NCT01986920|12416677|FG003|A-101 32.5%|Withdrawal by Subject|0
7903916|NCT01986920|12416674|FG000|A-101 40%|Withdrawal by Subject|0
7903917|NCT01986920|12416675|FG001|A-101 40%|Withdrawal by Subject|0
7903918|NCT01986920|12416676|FG002|A-101 40%|Withdrawal by Subject|1
7903919|NCT01986920|12416677|FG003|A-101 40%|Withdrawal by Subject|0
7903920|NCT01986920|12416674|FG000|Placebo|Withdrawal by Subject|0
7903921|NCT01986920|12416675|FG001|Placebo|Withdrawal by Subject|0
7903922|NCT01986920|12416676|FG002|Placebo|Withdrawal by Subject|0
7903923|NCT01986920|12416677|FG003|Placebo|Withdrawal by Subject|1
7903924|NCT01986985|12416696|FG000|Overall Study|Withdrawal by Subject|4
7903925|NCT01986985|12416696|FG000|Overall Study|Scan not completed due to malfunction|3
7903926|NCT01987102|12416711|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
7903927|NCT01987102|12416712|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
7903928|NCT01987102|12416711|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1
7903929|NCT01987102|12416712|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2
7903930|NCT01987102|12416711|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1
7903931|NCT01987102|12416712|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0
7903932|NCT01987102|12416711|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0
7903933|NCT01987102|12416712|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1
7903934|NCT01987102|12416711|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0
7903935|NCT01987102|12416712|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1
7903936|NCT01987102|12416711|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0
7903937|NCT01987102|12416712|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1
7903938|NCT01987232|12416743|FG000|Overall Study|Ongoing in Study|0
7903939|NCT01987232|12416744|FG001|Overall Study|Ongoing in Study|0
7903940|NCT01987232|12416745|FG002|Overall Study|Ongoing in Study|0
7903941|NCT01987232|12416746|FG003|Overall Study|Ongoing in Study|1
7903942|NCT01987232|12416747|FG004|Overall Study|Ongoing in Study|0
7903943|NCT01987427|12416823|FG000|Overall Study|Adverse Event|4
7903944|NCT01987427|12416824|FG001|Overall Study|Adverse Event|2
7903945|NCT01987427|12416825|FG002|Overall Study|Adverse Event|8
7903946|NCT01987427|12416823|FG000|Overall Study|Lost to Follow-up|6
7903947|NCT01987427|12416824|FG001|Overall Study|Lost to Follow-up|6
7903948|NCT01987427|12416825|FG002|Overall Study|Lost to Follow-up|9
7903949|NCT01987427|12416823|FG000|Overall Study|Withdrawal by Subject|2
7903950|NCT01987427|12416824|FG001|Overall Study|Withdrawal by Subject|1
7903951|NCT01987427|12416825|FG002|Overall Study|Withdrawal by Subject|3
7903952|NCT01987427|12416823|FG000|Overall Study|Lack of Efficacy|1
7903953|NCT01987427|12416824|FG001|Overall Study|Lack of Efficacy|0
7903954|NCT01987427|12416825|FG002|Overall Study|Lack of Efficacy|0
7903955|NCT01987427|12416823|FG000|Overall Study|Other|1
7903956|NCT01987427|12416824|FG001|Overall Study|Other|1
7903957|NCT01987427|12416825|FG002|Overall Study|Other|0
7903958|NCT01987453|12416836|FG000|Overall Study|Death|0
7903959|NCT01987453|12416837|FG001|Overall Study|Death|0
7903960|NCT01987453|12416838|FG002|Overall Study|Death|1
7903961|NCT01987453|12416836|FG000|Overall Study|Lack of Efficacy|1
7969016|NCT02791438|12527431|FG001|Treatment Period|Adverse Event|0
7969017|NCT02791438|12527430|FG000|Treatment Period|Withdrawal by Subject|0
7903962|NCT01987453|12416837|FG001|Overall Study|Lack of Efficacy|12
7903963|NCT01987453|12416838|FG002|Overall Study|Lack of Efficacy|0
7903964|NCT01987479|12416850|FG000|Overall Study|Protocol Violation|1
7903965|NCT01987479|12416850|FG000|Overall Study|Physician Decision|2
7903966|NCT01987479|12416850|FG000|Overall Study|Participant/legal guardian decision|1
7903967|NCT01987479|12416850|FG000|Overall Study|Other|5
7903968|NCT01987479|12416850|FG000|Overall Study|Lost to Follow-up|1
7903969|NCT01987479|12416850|FG000|Overall Study|Adverse Event|7
7903970|NCT01987505|12416856|FG000|Overall Study|Other|9
7903971|NCT01987505|12416856|FG000|Overall Study|Withdrawal by Subject|2
7903972|NCT01987505|12416856|FG000|Overall Study|Other Reason|2
7903973|NCT01987505|12416856|FG000|Overall Study|Lost to Follow-up|15
7903974|NCT01987505|12416856|FG000|Overall Study|Investigator Decision|2
7903975|NCT01987505|12416856|FG000|Overall Study|Death|4
7903976|NCT01987557|12416865|FG000|Overall Study|Protocol Violation|1
7903977|NCT01987557|12416866|FG001|Overall Study|Protocol Violation|0
7903978|NCT01987557|12416867|FG002|Overall Study|Protocol Violation|1
7903979|NCT01987557|12416865|FG000|Overall Study|Withdrawal by Subject|2
7903980|NCT01987557|12416866|FG001|Overall Study|Withdrawal by Subject|1
7903981|NCT01987557|12416867|FG002|Overall Study|Withdrawal by Subject|2
7903982|NCT01987557|12416865|FG000|Overall Study|Adverse Event|0
7903983|NCT01987557|12416866|FG001|Overall Study|Adverse Event|2
7903984|NCT01987557|12416867|FG002|Overall Study|Adverse Event|0
7903985|NCT01987596|12416886|FG000|Overall Study|Physician Decision|1
7903986|NCT01987596|12416887|FG001|Overall Study|Physician Decision|0
7903987|NCT01987596|12416886|FG000|Overall Study|Progressive Disease; missing all period|0
7903988|NCT01987596|12416887|FG001|Overall Study|Progressive Disease; missing all period|1
7903989|NCT01987609|12416899|FG000|Overall Study|Adverse Event|1
7903990|NCT01987765|12416917|FG000|Overall Study|Protocol Violation|65
7903991|NCT01987765|12416917|FG000|Overall Study|Lost to Follow-up|37
7903992|NCT01987817|12416923|FG000|Overall Study|Adverse Event|4
7903993|NCT01987817|12416924|FG001|Overall Study|Adverse Event|0
7903994|NCT01987817|12416923|FG000|Overall Study|Withdrawal by Subject|1
7903995|NCT01987817|12416924|FG001|Overall Study|Withdrawal by Subject|1
7903996|NCT01987817|12416923|FG000|Overall Study|Physician Decision|1
7903997|NCT01987817|12416924|FG001|Overall Study|Physician Decision|0
7903998|NCT01987830|12416931|FG000|Overall Study|Never received baseline scan|1
7903999|NCT01987895|12416937|FG000|Overall Study|Withdrawal by Subject|12
7904000|NCT01987895|12416938|FG001|Overall Study|Withdrawal by Subject|7
7904001|NCT01987895|12416937|FG000|Overall Study|Physician Decision|8
7904002|NCT01987895|12416938|FG001|Overall Study|Physician Decision|10
7904003|NCT01987895|12416937|FG000|Overall Study|Death|7
7904004|NCT01987895|12416938|FG001|Overall Study|Death|7
7904005|NCT01987895|12416937|FG000|Overall Study|Lost to Follow-up|3
7904006|NCT01987895|12416938|FG001|Overall Study|Lost to Follow-up|5
7904007|NCT01987895|12416937|FG000|Overall Study|randomized before giving IC|0
7904008|NCT01987895|12416938|FG001|Overall Study|randomized before giving IC|1
7904009|NCT01987908|12416944|FG000|Placebo Lead-in Period|Adverse Event|2
7904010|NCT01987908|12416945|FG001|Placebo Lead-in Period|Adverse Event|0
7904011|NCT01987908|12416946|FG002|Placebo Lead-in Period|Adverse Event|0
7904012|NCT01987908|12416944|FG000|Placebo Lead-in Period|Physician Decision|2
7904013|NCT01987908|12416945|FG001|Placebo Lead-in Period|Physician Decision|0
7904014|NCT01987908|12416946|FG002|Placebo Lead-in Period|Physician Decision|0
7904015|NCT01987908|12416944|FG000|Placebo Lead-in Period|Withdrawal by Subject|1
7904016|NCT01987908|12416945|FG001|Placebo Lead-in Period|Withdrawal by Subject|0
7904017|NCT01987908|12416946|FG002|Placebo Lead-in Period|Withdrawal by Subject|0
7904018|NCT01987908|12416944|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
7904019|NCT01987908|12416945|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
7904020|NCT01987908|12416946|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
7904021|NCT01987908|12416944|FG000|Treatment Period|Adverse Event|0
7904022|NCT01987908|12416945|FG001|Treatment Period|Adverse Event|1
7904023|NCT01987908|12416946|FG002|Treatment Period|Adverse Event|1
7904024|NCT01987908|12416944|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
7904025|NCT01987908|12416945|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
7904026|NCT01987908|12416946|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
7904027|NCT01987908|12416944|FG000|Post-Treatment Observation Period|Other: Bad Veins|0
7904028|NCT01987908|12416945|FG001|Post-Treatment Observation Period|Other: Bad Veins|1
7904029|NCT01987908|12416946|FG002|Post-Treatment Observation Period|Other: Bad Veins|0
7904030|NCT01987960|12416972|FG000|Period 1|Adverse Event|24
7904031|NCT01987960|12416973|FG001|Period 1|Adverse Event|0
7904032|NCT01987960|12416974|FG002|Period 1|Adverse Event|0
7904033|NCT01987960|12416975|FG003|Period 1|Adverse Event|0
7904034|NCT01987960|12416972|FG000|Period 1|Lack of Efficacy|4
7904035|NCT01987960|12416973|FG001|Period 1|Lack of Efficacy|0
7904036|NCT01987960|12416974|FG002|Period 1|Lack of Efficacy|0
7904037|NCT01987960|12416975|FG003|Period 1|Lack of Efficacy|0
7904038|NCT01987960|12416972|FG000|Period 1|Non-compliance with IMP|6
7904039|NCT01987960|12416973|FG001|Period 1|Non-compliance with IMP|0
7904040|NCT01987960|12416974|FG002|Period 1|Non-compliance with IMP|0
7904041|NCT01987960|12416975|FG003|Period 1|Non-compliance with IMP|0
7904042|NCT01987960|12416972|FG000|Period 1|Protocol Violation|12
7904043|NCT01987960|12416973|FG001|Period 1|Protocol Violation|0
7904044|NCT01987960|12416974|FG002|Period 1|Protocol Violation|0
7904045|NCT01987960|12416975|FG003|Period 1|Protocol Violation|0
7904046|NCT01987960|12416972|FG000|Period 1|Withdrawal by Subject|21
7904047|NCT01987960|12416973|FG001|Period 1|Withdrawal by Subject|0
7904048|NCT01987960|12416974|FG002|Period 1|Withdrawal by Subject|0
7904049|NCT01987960|12416975|FG003|Period 1|Withdrawal by Subject|0
7904050|NCT01987960|12416972|FG000|Period 1|Lost to Follow-up|40
7904051|NCT01987960|12416973|FG001|Period 1|Lost to Follow-up|0
7904052|NCT01987960|12416974|FG002|Period 1|Lost to Follow-up|0
7904053|NCT01987960|12416975|FG003|Period 1|Lost to Follow-up|0
7904054|NCT01987960|12416972|FG000|Period 1|administrative or other reason|75
7904055|NCT01987960|12416973|FG001|Period 1|administrative or other reason|0
7904056|NCT01987960|12416974|FG002|Period 1|administrative or other reason|0
7904057|NCT01987960|12416975|FG003|Period 1|administrative or other reason|0
7904058|NCT01987960|12416972|FG000|Period 1|Withdrawal of consent before treatment|4
7904059|NCT01987960|12416973|FG001|Period 1|Withdrawal of consent before treatment|0
7904060|NCT01987960|12416974|FG002|Period 1|Withdrawal of consent before treatment|0
7904061|NCT01987960|12416975|FG003|Period 1|Withdrawal of consent before treatment|0
7904062|NCT01987960|12416972|FG000|Period 2|Adverse Event|0
7904063|NCT01987960|12416973|FG001|Period 2|Adverse Event|0
7904064|NCT01987960|12416974|FG002|Period 2|Adverse Event|1
7904065|NCT01987960|12416975|FG003|Period 2|Adverse Event|0
7904066|NCT01987960|12416972|FG000|Period 2|Withdrawal by Subject|0
7904067|NCT01987960|12416973|FG001|Period 2|Withdrawal by Subject|0
7904068|NCT01987960|12416974|FG002|Period 2|Withdrawal by Subject|1
7904069|NCT01987960|12416975|FG003|Period 2|Withdrawal by Subject|0
7904070|NCT01987960|12416972|FG000|Period 2|Administrative or other reason|0
7904071|NCT01987960|12416973|FG001|Period 2|Administrative or other reason|5
7811393|NCT01182350|12275136|FG000|Overall Study|Adverse Event|5
7811394|NCT01182350|12275137|FG001|Overall Study|Adverse Event|0
7811395|NCT01182350|12275138|FG002|Overall Study|Adverse Event|0
7811396|NCT01182350|12275139|FG003|Overall Study|Adverse Event|0
7904072|NCT01987960|12416974|FG002|Period 2|Administrative or other reason|7
7904073|NCT01987960|12416975|FG003|Period 2|Administrative or other reason|0
7904074|NCT01987960|12416972|FG000|Period 3|Adverse Event|0
7904075|NCT01987960|12416973|FG001|Period 3|Adverse Event|0
7904076|NCT01987960|12416974|FG002|Period 3|Adverse Event|0
7904077|NCT01987960|12416975|FG003|Period 3|Adverse Event|7
7811397|NCT01182350|12275140|FG004|Overall Study|Adverse Event|0
7904078|NCT01987960|12416972|FG000|Period 3|Non-compliance with IMP|0
7904079|NCT01987960|12416973|FG001|Period 3|Non-compliance with IMP|0
7904080|NCT01987960|12416974|FG002|Period 3|Non-compliance with IMP|0
7904081|NCT01987960|12416975|FG003|Period 3|Non-compliance with IMP|1
7904082|NCT01987960|12416972|FG000|Period 3|Protocol Violation|0
7904083|NCT01987960|12416973|FG001|Period 3|Protocol Violation|0
7904084|NCT01987960|12416974|FG002|Period 3|Protocol Violation|0
7904085|NCT01987960|12416975|FG003|Period 3|Protocol Violation|6
7904086|NCT01987960|12416972|FG000|Period 3|Withdrawal by Subject|0
7904087|NCT01987960|12416973|FG001|Period 3|Withdrawal by Subject|0
7904088|NCT01987960|12416974|FG002|Period 3|Withdrawal by Subject|0
7904089|NCT01987960|12416975|FG003|Period 3|Withdrawal by Subject|9
7904090|NCT01987960|12416972|FG000|Period 3|Lost to Follow-up|0
7904091|NCT01987960|12416973|FG001|Period 3|Lost to Follow-up|0
7904092|NCT01987960|12416974|FG002|Period 3|Lost to Follow-up|0
7904093|NCT01987960|12416975|FG003|Period 3|Lost to Follow-up|5
7904094|NCT01987960|12416972|FG000|Period 3|Administrative or other reason|0
7904095|NCT01987960|12416973|FG001|Period 3|Administrative or other reason|0
7904096|NCT01987960|12416974|FG002|Period 3|Administrative or other reason|0
7904097|NCT01987960|12416975|FG003|Period 3|Administrative or other reason|43
7904098|NCT01987986|12416989|FG000|Overall Study|Lost to Follow-up|1
7904099|NCT01987986|12416990|FG001|Overall Study|Lost to Follow-up|0
7904100|NCT01987986|12416991|FG002|Overall Study|Lost to Follow-up|0
7904101|NCT01987986|12416992|FG003|Overall Study|Lost to Follow-up|0
7904102|NCT01987986|12416989|FG000|Overall Study|Adverse Event|1
7904103|NCT01987986|12416990|FG001|Overall Study|Adverse Event|0
7904104|NCT01987986|12416991|FG002|Overall Study|Adverse Event|2
7904105|NCT01987986|12416992|FG003|Overall Study|Adverse Event|0
7904106|NCT01988012|12417002|FG000|Overall Study|Adverse Event|5
7904107|NCT01988012|12417002|FG000|Overall Study|Insufficient Therapeutic Response|3
7904108|NCT01988012|12417002|FG000|Overall Study|Patient Withdrawal of Consent|4
7904109|NCT01988012|12417002|FG000|Overall Study|Lost to Follow-up|1
7904110|NCT01988012|12417002|FG000|Overall Study|Physician Decision|1
7904111|NCT01988012|12417002|FG000|Overall Study|Protocol Violation|1
7904112|NCT01988090|12417008|FG000|Start Treament After Randomization|Withdrawal by Subject|2
7904113|NCT01988090|12417009|FG001|Start Treament After Randomization|Withdrawal by Subject|3
7904114|NCT01988090|12417008|FG000|Start Treament After Randomization|Protocol Violation|0
7904115|NCT01988090|12417009|FG001|Start Treament After Randomization|Protocol Violation|1
7904116|NCT01988090|12417008|FG000|Complete Study After Start|Withdrawal by Subject|2
7904117|NCT01988090|12417009|FG001|Complete Study After Start|Withdrawal by Subject|0
7904118|NCT01988090|12417008|FG000|Complete Study After Start|Protocol Violation|1
7904119|NCT01988090|12417009|FG001|Complete Study After Start|Protocol Violation|1
7904120|NCT01988103|12417018|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3
7811398|NCT01182350|12275136|FG000|Overall Study|Disease Progression|15
7811399|NCT01182350|12275137|FG001|Overall Study|Disease Progression|12
7811400|NCT01182350|12275138|FG002|Overall Study|Disease Progression|0
7811401|NCT01182350|12275139|FG003|Overall Study|Disease Progression|1
7811402|NCT01182350|12275140|FG004|Overall Study|Disease Progression|0
7811403|NCT01182350|12275136|FG000|Overall Study|Death|0
7811404|NCT01182350|12275137|FG001|Overall Study|Death|1
7811405|NCT01182350|12275138|FG002|Overall Study|Death|1
7811406|NCT01182350|12275139|FG003|Overall Study|Death|0
7904121|NCT01988103|12417019|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10
7904122|NCT01988103|12417020|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6
7904123|NCT01988103|12417021|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0
7904124|NCT01988103|12417022|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0
7904125|NCT01988103|12417018|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1
7904126|NCT01988103|12417019|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
7904127|NCT01988103|12417020|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
7904128|NCT01988103|12417021|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
7904129|NCT01988103|12417022|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
7904130|NCT01988103|12417018|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8
7904131|NCT01988103|12417019|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4
7904132|NCT01988103|12417020|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1
7904133|NCT01988103|12417021|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
7904134|NCT01988103|12417022|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
7904135|NCT01988103|12417018|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0
7904136|NCT01988103|12417019|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6
7904137|NCT01988103|12417020|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
7904138|NCT01988103|12417021|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
7904139|NCT01988103|12417022|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2
7904140|NCT01988103|12417018|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
7904141|NCT01988103|12417019|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1
7904142|NCT01988103|12417020|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2
7904143|NCT01988103|12417021|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
7904144|NCT01988103|12417022|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
7904145|NCT01988103|12417018|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
7904146|NCT01988103|12417019|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5
7811407|NCT01182350|12275140|FG004|Overall Study|Death|0
7904147|NCT01988103|12417020|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4
7904148|NCT01988103|12417021|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
7904149|NCT01988103|12417022|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1
7904150|NCT01988103|12417018|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
7904151|NCT01988103|12417019|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1
7904152|NCT01988103|12417020|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
7904153|NCT01988103|12417021|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
7904154|NCT01988103|12417022|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
7904155|NCT01988402|12417069|FG000|Overall Study|Adverse Event|1
7904156|NCT01988402|12417070|FG001|Overall Study|Adverse Event|2
7904157|NCT01988402|12417069|FG000|Overall Study|Withdrawal by Subject|1
7904158|NCT01988402|12417070|FG001|Overall Study|Withdrawal by Subject|0
7904159|NCT01988662|12417084|FG000|Overall Study|Subject/guardian decision|1
7904160|NCT01988662|12417085|FG001|Overall Study|Subject/guardian decision|1
7904161|NCT01988662|12417084|FG000|Overall Study|Adverse Event|3
7904162|NCT01988662|12417085|FG001|Overall Study|Adverse Event|1
7904163|NCT01988779|12417094|FG000|Overall Study|Withdrawal by Subject|2
7904164|NCT01988779|12417095|FG001|Overall Study|Withdrawal by Subject|2
7904165|NCT01988779|12417094|FG000|Overall Study|Protocol Violation|1
7904166|NCT01988779|12417095|FG001|Overall Study|Protocol Violation|0
7904167|NCT01989156|12417133|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
7904168|NCT01989156|12417134|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7904169|NCT01989156|12417135|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
7904170|NCT01989156|12417133|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0
7904171|NCT01989156|12417134|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0
7904172|NCT01989156|12417135|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1
7904173|NCT01989156|12417133|FG000|Confinement Period (Population at Day 5)|Adverse Event|0
7904174|NCT01989156|12417134|FG001|Confinement Period (Population at Day 5)|Adverse Event|0
7904175|NCT01989156|12417135|FG002|Confinement Period (Population at Day 5)|Adverse Event|1
7904176|NCT01989156|12417133|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2
7904177|NCT01989156|12417134|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2
7904178|NCT01989156|12417135|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2
7904179|NCT01989156|12417133|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3
7904180|NCT01989156|12417134|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2
7904181|NCT01989156|12417135|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0
7904182|NCT01989156|12417133|FG000|End of Study (Population at Day 90)|Physician Decision|1
7904183|NCT01989156|12417134|FG001|End of Study (Population at Day 90)|Physician Decision|0
7904184|NCT01989156|12417135|FG002|End of Study (Population at Day 90)|Physician Decision|1
7904185|NCT01989156|12417133|FG000|End of Study (Population at Day 90)|Moved out of state|1
7904186|NCT01989156|12417134|FG001|End of Study (Population at Day 90)|Moved out of state|0
7904187|NCT01989156|12417135|FG002|End of Study (Population at Day 90)|Moved out of state|0
7904188|NCT01989156|12417133|FG000|End of Study (Population at Day 90)|Employment Conflict|0
7904189|NCT01989156|12417134|FG001|End of Study (Population at Day 90)|Employment Conflict|1
7904190|NCT01989156|12417135|FG002|End of Study (Population at Day 90)|Employment Conflict|0
7904191|NCT01989169|12417145|FG000|Period 2|Adverse Event|0
7904192|NCT01989169|12417146|FG001|Period 2|Adverse Event|1
7904193|NCT01989208|12417161|FG000|200 mg (7 Days)|Protocol Violation|0
7904194|NCT01989208|12417162|FG001|200 mg (7 Days)|Protocol Violation|1
7904195|NCT01989455|12417189|FG000|Overall Study|Adverse Event|0
7904196|NCT01989455|12417190|FG001|Overall Study|Adverse Event|1
7904197|NCT01989455|12417191|FG002|Overall Study|Adverse Event|0
7904198|NCT01989455|12417192|FG003|Overall Study|Adverse Event|0
7904199|NCT01989455|12417193|FG004|Overall Study|Adverse Event|0
7904200|NCT01989455|12417189|FG000|Overall Study|Withdrawal by Subject|0
7904201|NCT01989455|12417190|FG001|Overall Study|Withdrawal by Subject|1
7904202|NCT01989455|12417191|FG002|Overall Study|Withdrawal by Subject|0
7904203|NCT01989455|12417192|FG003|Overall Study|Withdrawal by Subject|0
7904204|NCT01989455|12417193|FG004|Overall Study|Withdrawal by Subject|0
7904205|NCT01989455|12417189|FG000|Overall Study|Technical problems with infusion|0
7904206|NCT01989455|12417190|FG001|Overall Study|Technical problems with infusion|0
7904207|NCT01989455|12417191|FG002|Overall Study|Technical problems with infusion|1
7904208|NCT01989455|12417192|FG003|Overall Study|Technical problems with infusion|0
7904209|NCT01989455|12417193|FG004|Overall Study|Technical problems with infusion|1
7904210|NCT01989468|12417212|FG000|Overall Study|Adverse Event|10
7904211|NCT01989468|12417213|FG001|Overall Study|Adverse Event|15
7904212|NCT01989468|12417214|FG002|Overall Study|Adverse Event|4
7904213|NCT01989468|12417215|FG003|Overall Study|Adverse Event|5
7904214|NCT01989468|12417216|FG004|Overall Study|Adverse Event|4
7904215|NCT01989468|12417212|FG000|Overall Study|Lack of Efficacy|11
7904216|NCT01989468|12417213|FG001|Overall Study|Lack of Efficacy|11
7904217|NCT01989468|12417214|FG002|Overall Study|Lack of Efficacy|7
7904218|NCT01989468|12417215|FG003|Overall Study|Lack of Efficacy|4
7904219|NCT01989468|12417216|FG004|Overall Study|Lack of Efficacy|2
7904220|NCT01989468|12417212|FG000|Overall Study|Lost to Follow-up|5
7904221|NCT01989468|12417213|FG001|Overall Study|Lost to Follow-up|2
7904222|NCT01989468|12417214|FG002|Overall Study|Lost to Follow-up|0
7904223|NCT01989468|12417215|FG003|Overall Study|Lost to Follow-up|1
7904224|NCT01989468|12417216|FG004|Overall Study|Lost to Follow-up|1
7904225|NCT01989468|12417212|FG000|Overall Study|Physician Decision|4
7904226|NCT01989468|12417213|FG001|Overall Study|Physician Decision|1
7904227|NCT01989468|12417214|FG002|Overall Study|Physician Decision|0
7904228|NCT01989468|12417215|FG003|Overall Study|Physician Decision|1
7904229|NCT01989468|12417216|FG004|Overall Study|Physician Decision|0
7904230|NCT01989468|12417212|FG000|Overall Study|Pregnancy|0
7904231|NCT01989468|12417213|FG001|Overall Study|Pregnancy|1
7904232|NCT01989468|12417214|FG002|Overall Study|Pregnancy|0
7904233|NCT01989468|12417215|FG003|Overall Study|Pregnancy|0
7904234|NCT01989468|12417216|FG004|Overall Study|Pregnancy|0
7904235|NCT01989468|12417212|FG000|Overall Study|Technical Problems|3
7904236|NCT01989468|12417213|FG001|Overall Study|Technical Problems|1
7904237|NCT01989468|12417214|FG002|Overall Study|Technical Problems|3
7904238|NCT01989468|12417215|FG003|Overall Study|Technical Problems|1
7904239|NCT01989468|12417216|FG004|Overall Study|Technical Problems|0
7904240|NCT01989468|12417212|FG000|Overall Study|Subject Guardian Decision|11
7904241|NCT01989468|12417213|FG001|Overall Study|Subject Guardian Decision|6
7904242|NCT01989468|12417214|FG002|Overall Study|Subject Guardian Decision|4
7904243|NCT01989468|12417215|FG003|Overall Study|Subject Guardian Decision|4
7904244|NCT01989468|12417216|FG004|Overall Study|Subject Guardian Decision|1
7904245|NCT01989468|12417212|FG000|Overall Study|Death|3
7904246|NCT01989468|12417213|FG001|Overall Study|Death|0
7904247|NCT01989468|12417214|FG002|Overall Study|Death|1
7904248|NCT01989468|12417215|FG003|Overall Study|Death|0
7904249|NCT01989468|12417216|FG004|Overall Study|Death|0
7904250|NCT01989546|12417229|FG000|Overall Study|Clinical Progression|1
7904251|NCT01989546|12417229|FG000|Overall Study|Disease progression on study|8
7904252|NCT01989572|12417239|FG000|Overall Study|Lack of Efficacy|35
7904253|NCT01989572|12417240|FG001|Overall Study|Lack of Efficacy|48
7904254|NCT01989572|12417241|FG002|Overall Study|Lack of Efficacy|48
7904255|NCT01989572|12417242|FG003|Overall Study|Lack of Efficacy|43
7904256|NCT01989572|12417243|FG004|Overall Study|Lack of Efficacy|71
7904257|NCT01989572|12417244|FG005|Overall Study|Lack of Efficacy|79
7904258|NCT01989572|12417239|FG000|Overall Study|Adverse Event|2
7904259|NCT01989572|12417240|FG001|Overall Study|Adverse Event|1
7904260|NCT01989572|12417241|FG002|Overall Study|Adverse Event|3
7904261|NCT01989572|12417242|FG003|Overall Study|Adverse Event|0
7904262|NCT01989572|12417243|FG004|Overall Study|Adverse Event|3
7904263|NCT01989572|12417244|FG005|Overall Study|Adverse Event|0
7904264|NCT01989572|12417239|FG000|Overall Study|Death|0
7904265|NCT01989572|12417240|FG001|Overall Study|Death|0
7904266|NCT01989572|12417241|FG002|Overall Study|Death|0
7904267|NCT01989572|12417242|FG003|Overall Study|Death|0
7904268|NCT01989572|12417243|FG004|Overall Study|Death|1
7904269|NCT01989572|12417244|FG005|Overall Study|Death|0
7904270|NCT01989572|12417239|FG000|Overall Study|Withdrawal by Subject|4
7904271|NCT01989572|12417240|FG001|Overall Study|Withdrawal by Subject|1
7904272|NCT01989572|12417241|FG002|Overall Study|Withdrawal by Subject|5
7904273|NCT01989572|12417242|FG003|Overall Study|Withdrawal by Subject|1
7904274|NCT01989572|12417243|FG004|Overall Study|Withdrawal by Subject|12
7904275|NCT01989572|12417244|FG005|Overall Study|Withdrawal by Subject|4
7904276|NCT01989572|12417239|FG000|Overall Study|complicating disease|1
7904277|NCT01989572|12417240|FG001|Overall Study|complicating disease|1
7904278|NCT01989572|12417241|FG002|Overall Study|complicating disease|2
7904279|NCT01989572|12417242|FG003|Overall Study|complicating disease|0
7904280|NCT01989572|12417243|FG004|Overall Study|complicating disease|1
7904281|NCT01989572|12417244|FG005|Overall Study|complicating disease|0
7904282|NCT01989572|12417239|FG000|Overall Study|error|2
7904283|NCT01989572|12417240|FG001|Overall Study|error|1
7904284|NCT01989572|12417241|FG002|Overall Study|error|1
7904285|NCT01989572|12417242|FG003|Overall Study|error|1
7904286|NCT01989572|12417243|FG004|Overall Study|error|1
7904287|NCT01989572|12417244|FG005|Overall Study|error|1
7904288|NCT01989572|12417239|FG000|Overall Study|maximum dose reached|0
7904289|NCT01989572|12417240|FG001|Overall Study|maximum dose reached|1
7904290|NCT01989572|12417241|FG002|Overall Study|maximum dose reached|0
7904291|NCT01989572|12417242|FG003|Overall Study|maximum dose reached|0
7904292|NCT01989572|12417243|FG004|Overall Study|maximum dose reached|1
7904293|NCT01989572|12417244|FG005|Overall Study|maximum dose reached|0
7904294|NCT01989572|12417239|FG000|Overall Study|unknown/not specify|3
7904295|NCT01989572|12417240|FG001|Overall Study|unknown/not specify|4
7904296|NCT01989572|12417241|FG002|Overall Study|unknown/not specify|1
7904297|NCT01989572|12417242|FG003|Overall Study|unknown/not specify|3
7904298|NCT01989572|12417243|FG004|Overall Study|unknown/not specify|3
7904299|NCT01989572|12417244|FG005|Overall Study|unknown/not specify|5
7904300|NCT01989572|12417239|FG000|Overall Study|not start protocol therapy|5
7904301|NCT01989572|12417240|FG001|Overall Study|not start protocol therapy|1
7904302|NCT01989572|12417241|FG002|Overall Study|not start protocol therapy|2
7904303|NCT01989572|12417242|FG003|Overall Study|not start protocol therapy|3
7904304|NCT01989572|12417243|FG004|Overall Study|not start protocol therapy|4
7904305|NCT01989572|12417244|FG005|Overall Study|not start protocol therapy|18
7904306|NCT01989572|12417239|FG000|Overall Study|alternative therapy|3
7904307|NCT01989572|12417240|FG001|Overall Study|alternative therapy|0
7904308|NCT01989572|12417241|FG002|Overall Study|alternative therapy|0
7904309|NCT01989572|12417242|FG003|Overall Study|alternative therapy|0
7904310|NCT01989572|12417243|FG004|Overall Study|alternative therapy|1
7904311|NCT01989572|12417244|FG005|Overall Study|alternative therapy|3
7904312|NCT01989689|12417264|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
7904313|NCT01989689|12417265|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
7904314|NCT01989689|12417264|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
7904315|NCT01989689|12417265|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
7904316|NCT01989754|12417275|FG000|Overall Study|Withdrawal by Subject|10
7904317|NCT01989754|12417276|FG001|Overall Study|Withdrawal by Subject|14
7904318|NCT01989754|12417275|FG000|Overall Study|Lost to Follow-up|28
7904319|NCT01989754|12417276|FG001|Overall Study|Lost to Follow-up|20
7904320|NCT01989754|12417275|FG000|Overall Study|Closed Site|1
7904321|NCT01989754|12417276|FG001|Overall Study|Closed Site|1
7904322|NCT01990261|12417304|FG000|Overall Study|Death Before Treatment Start|2
7904323|NCT01990261|12417304|FG000|Overall Study|Death due to Disease Progression (PD)|10
7904324|NCT01990261|12417304|FG000|Overall Study|Death From other Causes|1
7904325|NCT01990261|12417304|FG000|Overall Study|Disease Progression (PD)|8
7904326|NCT01990261|12417304|FG000|Overall Study|PD Before Treatment Start|1
7904327|NCT01990261|12417304|FG000|Overall Study|Dossier not Approved|1
7904328|NCT01990261|12417304|FG000|Overall Study|Lost to Follow-up|2
7904329|NCT01990300|12417308|FG000|Overall Study|Case Report Forms Uncollected|89
7904330|NCT01990300|12417308|FG000|Overall Study|Protocol Deviation|53
7904331|NCT01990313|12417312|FG000|Overall Study|Lost to Follow-up|1
7904332|NCT01990339|12417316|FG000|Overall Study|Data Not Available|49
7904333|NCT01990339|12417316|FG000|Overall Study|Voluntary Withdrawal|1402
7904334|NCT01990339|12417316|FG000|Overall Study|Lost to Follow-up|861
7904335|NCT01990495|12417322|FG000|Overall Study|Physician Decision|5
7904336|NCT01990495|12417323|FG001|Overall Study|Physician Decision|4
7904337|NCT01990534|12417331|FG000|Overall Study|Death|22
7904338|NCT01990534|12417331|FG000|Overall Study|Progressive disease|3
7904339|NCT01990534|12417331|FG000|Overall Study|Protocol Violation|1
7904340|NCT01990534|12417331|FG000|Overall Study|Withdrawal of Informed Consent|2
7904341|NCT01990534|12417331|FG000|Overall Study|Symptomatic Deterioration|1
7904342|NCT01990534|12417331|FG000|Overall Study|Withdrawal by Subject|3
7904343|NCT01990534|12417331|FG000|Overall Study|Reason not Specified|2
7904344|NCT01990534|12417331|FG000|Overall Study|Lost to Follow-up|1
7904345|NCT01990560|12417335|FG000|Overall Study|Withdrawal by Subject|1
7904346|NCT01990573|12417342|FG000|Overall Study|Physician Decision|0
7904347|NCT01990573|12417343|FG001|Overall Study|Physician Decision|0
7904348|NCT01990573|12417344|FG002|Overall Study|Physician Decision|1
7904349|NCT01990612|12417354|FG000|Overall Study|Lost to Follow-up|2
7904350|NCT01990612|12417355|FG001|Overall Study|Lost to Follow-up|1
7904351|NCT01990612|12417354|FG000|Overall Study|Withdrawal by Subject|5
7904352|NCT01990612|12417355|FG001|Overall Study|Withdrawal by Subject|2
7904353|NCT01990664|12417363|FG000|Overall Study|Lost to Follow-up|2
7904354|NCT01990664|12417364|FG001|Overall Study|Lost to Follow-up|6
7904355|NCT01990664|12417363|FG000|Overall Study|Withdrawal by Subject|2
7904356|NCT01990664|12417364|FG001|Overall Study|Withdrawal by Subject|3
7904357|NCT01990664|12417363|FG000|Overall Study|Protocol Violation|1
7904358|NCT01990664|12417364|FG001|Overall Study|Protocol Violation|0
7904359|NCT01990664|12417363|FG000|Overall Study|Lens Discomfort|1
7904360|NCT01990664|12417364|FG001|Overall Study|Lens Discomfort|1
7904361|NCT01990664|12417363|FG000|Overall Study|Lens Handling Difficulties|1
7904362|NCT01990664|12417364|FG001|Overall Study|Lens Handling Difficulties|0
7904363|NCT01990664|12417363|FG000|Overall Study|Unsatisfactory Visual Response|0
7904364|NCT01990664|12417364|FG001|Overall Study|Unsatisfactory Visual Response|1
7904365|NCT01990742|12417390|FG000|Overall Study|Withdrawal by facility|407
7904366|NCT01990742|12417391|FG001|Overall Study|Withdrawal by facility|1083
7904367|NCT01990742|12417390|FG000|Overall Study|Facility closed|0
7904368|NCT01990742|12417391|FG001|Overall Study|Facility closed|270
7904369|NCT01990768|12417400|FG000|Intervention Started|Found to be ineligible|14
7904370|NCT01990768|12417401|FG001|Intervention Started|Found to be ineligible|13
7904371|NCT01990768|12417402|FG002|Intervention Started|Found to be ineligible|11
7904372|NCT01990768|12417400|FG000|Intervention Started|Study drug issue or kit malfunction|9
7904373|NCT01990768|12417401|FG001|Intervention Started|Study drug issue or kit malfunction|6
7904374|NCT01990768|12417402|FG002|Intervention Started|Study drug issue or kit malfunction|7
7904375|NCT01990768|12417400|FG000|Intervention Started|Patient became ineligible due to vitals|5
7904376|NCT01990768|12417401|FG001|Intervention Started|Patient became ineligible due to vitals|5
7904377|NCT01990768|12417402|FG002|Intervention Started|Patient became ineligible due to vitals|2
7904378|NCT01990768|12417400|FG000|Intervention Started|Not enough time for EMS to enroll|4
7904379|NCT01990768|12417401|FG001|Intervention Started|Not enough time for EMS to enroll|3
7904380|NCT01990768|12417402|FG002|Intervention Started|Not enough time for EMS to enroll|0
7904381|NCT01990768|12417400|FG000|Intervention Started|Patient care priority|1
7904382|NCT01990768|12417401|FG001|Intervention Started|Patient care priority|2
7904383|NCT01990768|12417402|FG002|Intervention Started|Patient care priority|3
7904384|NCT01990768|12417400|FG000|Intervention Started|IV lost|2
7904385|NCT01990768|12417401|FG001|Intervention Started|IV lost|2
7904386|NCT01990768|12417402|FG002|Intervention Started|IV lost|2
7904387|NCT01990768|12417400|FG000|Intervention Started|Required CPR|1
7904388|NCT01990768|12417401|FG001|Intervention Started|Required CPR|1
7904389|NCT01990768|12417402|FG002|Intervention Started|Required CPR|0
7904390|NCT01990768|12417400|FG000|Intervention Started|Seizure or hx of seizure|0
7904391|NCT01990768|12417401|FG001|Intervention Started|Seizure or hx of seizure|0
7904392|NCT01990768|12417402|FG002|Intervention Started|Seizure or hx of seizure|2
7904393|NCT01990768|12417400|FG000|Intervention Started|Discovered to be pregnant|0
7904394|NCT01990768|12417401|FG001|Intervention Started|Discovered to be pregnant|1
7904395|NCT01990768|12417402|FG002|Intervention Started|Discovered to be pregnant|0
7904396|NCT01990768|12417400|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4
7904397|NCT01990768|12417401|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11
7904398|NCT01990768|12417402|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10
7904399|NCT01990768|12417400|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
7904400|NCT01990768|12417401|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3
7904401|NCT01990768|12417402|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
7904402|NCT01990768|12417400|FG000|Prehospital Study Drug Infusion|Required CPR|2
7904403|NCT01990768|12417401|FG001|Prehospital Study Drug Infusion|Required CPR|6
7904404|NCT01990768|12417402|FG002|Prehospital Study Drug Infusion|Required CPR|0
7904405|NCT01990768|12417400|FG000|Prehospital Study Drug Infusion|Other safety concern|2
7904406|NCT01990768|12417401|FG001|Prehospital Study Drug Infusion|Other safety concern|1
7904407|NCT01990768|12417402|FG002|Prehospital Study Drug Infusion|Other safety concern|1
7904408|NCT01990768|12417400|FG000|Prehospital Study Drug Infusion|Death|3
7904409|NCT01990768|12417401|FG001|Prehospital Study Drug Infusion|Death|1
7904410|NCT01990768|12417402|FG002|Prehospital Study Drug Infusion|Death|1
7904411|NCT01990768|12417400|FG000|Prehospital Study Drug Infusion|Discharged|2
7904412|NCT01990768|12417401|FG001|Prehospital Study Drug Infusion|Discharged|1
7904413|NCT01990768|12417402|FG002|Prehospital Study Drug Infusion|Discharged|0
7904414|NCT01990768|12417400|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1
7904415|NCT01990768|12417401|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0
7904416|NCT01990768|12417402|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0
7904417|NCT01990768|12417400|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0
7904418|NCT01990768|12417401|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0
7904419|NCT01990768|12417402|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1
7904420|NCT01990768|12417400|FG000|Prehospital Study Drug Infusion|Unknown if completed|1
7904421|NCT01990768|12417401|FG001|Prehospital Study Drug Infusion|Unknown if completed|4
7904422|NCT01990768|12417402|FG002|Prehospital Study Drug Infusion|Unknown if completed|2
7904423|NCT01990768|12417400|FG000|In-Hospital Study Drug Infusion|Discharged|19
7904424|NCT01990768|12417401|FG001|In-Hospital Study Drug Infusion|Discharged|18
7904425|NCT01990768|12417402|FG002|In-Hospital Study Drug Infusion|Discharged|13
7904426|NCT01990768|12417400|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14
7904427|NCT01990768|12417401|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17
7904428|NCT01990768|12417402|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10
7904429|NCT01990768|12417400|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13
7904430|NCT01990768|12417401|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7
7904431|NCT01990768|12417402|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12
7904432|NCT01990768|12417400|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12
7904433|NCT01990768|12417401|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11
7904434|NCT01990768|12417402|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6
7904435|NCT01990768|12417400|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11
7904436|NCT01990768|12417401|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4
7904437|NCT01990768|12417402|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7
7904438|NCT01990768|12417400|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8
7904439|NCT01990768|12417401|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9
7904440|NCT01990768|12417402|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17
7904441|NCT01990768|12417400|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
7904442|NCT01990768|12417401|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
7904443|NCT01990768|12417402|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4
7904444|NCT01990768|12417400|FG000|In-Hospital Study Drug Infusion|Required CPR|3
7904445|NCT01990768|12417401|FG001|In-Hospital Study Drug Infusion|Required CPR|7
7904446|NCT01990768|12417402|FG002|In-Hospital Study Drug Infusion|Required CPR|1
7904447|NCT01990768|12417400|FG000|In-Hospital Study Drug Infusion|Other safety concern|4
7904448|NCT01990768|12417401|FG001|In-Hospital Study Drug Infusion|Other safety concern|2
7904449|NCT01990768|12417402|FG002|In-Hospital Study Drug Infusion|Other safety concern|3
7904450|NCT01990768|12417400|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4
7904451|NCT01990768|12417401|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0
7904452|NCT01990768|12417402|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3
7904453|NCT01990768|12417400|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1
7904454|NCT01990768|12417401|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1
7904455|NCT01990768|12417402|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1
7904456|NCT01990768|12417400|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
7904457|NCT01990768|12417401|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
7904458|NCT01990768|12417402|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0
7904459|NCT01990768|12417400|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0
7904460|NCT01990768|12417401|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1
7904461|NCT01990768|12417402|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2
7904462|NCT01990768|12417400|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0
7904463|NCT01990768|12417401|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0
7904464|NCT01990768|12417402|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1
7904465|NCT01990768|12417400|FG000|6-Month Follow-up|Withdrawal by Subject|25
7904466|NCT01990768|12417401|FG001|6-Month Follow-up|Withdrawal by Subject|25
7904467|NCT01990768|12417402|FG002|6-Month Follow-up|Withdrawal by Subject|26
7904468|NCT01990768|12417400|FG000|6-Month Follow-up|Calls unreturned or refused contact|4
7904469|NCT01990768|12417401|FG001|6-Month Follow-up|Calls unreturned or refused contact|15
7904470|NCT01990768|12417402|FG002|6-Month Follow-up|Calls unreturned or refused contact|20
7904471|NCT01990768|12417400|FG000|6-Month Follow-up|No contact information|5
7904472|NCT01990768|12417401|FG001|6-Month Follow-up|No contact information|6
7904473|NCT01990768|12417402|FG002|6-Month Follow-up|No contact information|5
7904474|NCT01990768|12417400|FG000|6-Month Follow-up|Homeless|4
7904475|NCT01990768|12417401|FG001|6-Month Follow-up|Homeless|3
7904476|NCT01990768|12417402|FG002|6-Month Follow-up|Homeless|6
7904477|NCT01990768|12417400|FG000|6-Month Follow-up|Prisoner at time of enrollment|0
7904478|NCT01990768|12417401|FG001|6-Month Follow-up|Prisoner at time of enrollment|0
7904479|NCT01990768|12417402|FG002|6-Month Follow-up|Prisoner at time of enrollment|1
7904480|NCT01990768|12417400|FG000|6-Month Follow-up|Prisoner at time of follow-up|0
7904481|NCT01990768|12417401|FG001|6-Month Follow-up|Prisoner at time of follow-up|2
7904482|NCT01990768|12417402|FG002|6-Month Follow-up|Prisoner at time of follow-up|0
7904483|NCT01990768|12417400|FG000|6-Month Follow-up|Patient at psychiatric hospital|1
7904484|NCT01990768|12417401|FG001|6-Month Follow-up|Patient at psychiatric hospital|0
7904485|NCT01990768|12417402|FG002|6-Month Follow-up|Patient at psychiatric hospital|0
7904486|NCT01990859|12417507|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
7904487|NCT01990859|12417507|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
7904488|NCT01990950|12417516|FG000|Overall Study|Death|3
7904489|NCT01990950|12417516|FG000|Overall Study|Lost to Follow-up|2
7904490|NCT01990950|12417516|FG000|Overall Study|Withdrawal by Subject|6
7904491|NCT01991197|12417522|FG000|Overall Study|Lost to Follow-up|1
7904492|NCT01991197|12417523|FG001|Overall Study|Lost to Follow-up|1
7904493|NCT01991197|12417522|FG000|Overall Study|Physician Decision|0
7904494|NCT01991197|12417523|FG001|Overall Study|Physician Decision|2
7904495|NCT01991197|12417522|FG000|Overall Study|Withdrawal by Subject|2
7904496|NCT01991197|12417523|FG001|Overall Study|Withdrawal by Subject|0
7904497|NCT01991314|12417536|FG000|Overall Study|Adverse Event|5
7904498|NCT01991314|12417537|FG001|Overall Study|Adverse Event|1
7904499|NCT01991314|12417536|FG000|Overall Study|Lost to Follow-up|6
7904500|NCT01991314|12417537|FG001|Overall Study|Lost to Follow-up|10
7904501|NCT01991470|12417543|FG000|Enlite 1 Period|Withdrawal by Subject|18
7904502|NCT01991470|12417543|FG000|Enlite 1 Period|Adverse Event|1
7904503|NCT01991470|12417543|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1
7904504|NCT01991470|12417543|FG000|Enlite 3 Period|Lost to Follow-up|1
7904505|NCT01991470|12417543|FG000|Enlite 3 Period|Physician Decision|2
7904506|NCT01991470|12417543|FG000|Enlite 3 Period|Physician Decision|8
7904507|NCT01991470|12417543|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
7904508|NCT01991483|12417559|FG000|Dose Level 600 mg|Withdrawal by Subject|0
7904509|NCT01991483|12417560|FG001|Dose Level 600 mg|Withdrawal by Subject|0
7904510|NCT01991483|12417561|FG002|Dose Level 600 mg|Withdrawal by Subject|1
7904511|NCT01991483|12417562|FG003|Dose Level 600 mg|Withdrawal by Subject|0
7904512|NCT01991483|12417559|FG000|Dose Level 600 mg|Physician Decision|0
7904513|NCT01991483|12417560|FG001|Dose Level 600 mg|Physician Decision|0
7904514|NCT01991483|12417561|FG002|Dose Level 600 mg|Physician Decision|1
7904515|NCT01991483|12417562|FG003|Dose Level 600 mg|Physician Decision|0
7904516|NCT01991483|12417559|FG000|Dose Level 1000 mg|Protocol Violation|0
7904517|NCT01991483|12417560|FG001|Dose Level 1000 mg|Protocol Violation|0
7904518|NCT01991483|12417561|FG002|Dose Level 1000 mg|Protocol Violation|0
7969018|NCT02791438|12527431|FG001|Treatment Period|Withdrawal by Subject|1
7969019|NCT02791438|12527430|FG000|Treatment Period|Withdrawal by Parent/Guardian|2
7969020|NCT02791438|12527431|FG001|Treatment Period|Withdrawal by Parent/Guardian|0
7969021|NCT02791490|12527439|FG000|Overall Study|Lost to Follow-up|1
7969022|NCT02791490|12527440|FG001|Overall Study|Lost to Follow-up|2
7969023|NCT02791490|12527439|FG000|Overall Study|Withdrawal by Subject|2
7969024|NCT02791490|12527440|FG001|Overall Study|Withdrawal by Subject|6
7969025|NCT02791516|12527448|FG000|Overall Study|Withdrawal by Subject|1
7969026|NCT02791516|12527449|FG001|Overall Study|Withdrawal by Subject|1
7969027|NCT02791659|12527457|FG000|Overall Study|Protocol Violation|0
7969028|NCT02791659|12527458|FG001|Overall Study|Protocol Violation|1
7969029|NCT02791763|12527467|FG000|Overall Study|Protocol Violation|0
7969030|NCT02791763|12527468|FG001|Overall Study|Protocol Violation|0
7969031|NCT02791763|12527469|FG002|Overall Study|Protocol Violation|1
7969032|NCT02791763|12527467|FG000|Overall Study|Withdrawal by Subject|5
7969033|NCT02791763|12527468|FG001|Overall Study|Withdrawal by Subject|1
7969034|NCT02791763|12527469|FG002|Overall Study|Withdrawal by Subject|0
7969035|NCT02791763|12527467|FG000|Overall Study|Physician Decision|0
7969036|NCT02791763|12527468|FG001|Overall Study|Physician Decision|1
7969037|NCT02791763|12527469|FG002|Overall Study|Physician Decision|0
7969038|NCT02791763|12527467|FG000|Overall Study|Needs maintenance/changes in dialysis|16
7969039|NCT02791763|12527468|FG001|Overall Study|Needs maintenance/changes in dialysis|19
7969040|NCT02791763|12527469|FG002|Overall Study|Needs maintenance/changes in dialysis|5
7969041|NCT02791763|12527467|FG000|Overall Study|Cancer event|1
7969042|NCT02791763|12527468|FG001|Overall Study|Cancer event|3
7969043|NCT02791763|12527469|FG002|Overall Study|Cancer event|0
7969044|NCT02791763|12527467|FG000|Overall Study|Participant had renal transplant|3
7969045|NCT02791763|12527468|FG001|Overall Study|Participant had renal transplant|0
7969046|NCT02791763|12527469|FG002|Overall Study|Participant had renal transplant|0
7969047|NCT02791763|12527467|FG000|Overall Study|Met hemoglobin stopping criteria|1
7969048|NCT02791763|12527468|FG001|Overall Study|Met hemoglobin stopping criteria|0
7969049|NCT02791763|12527469|FG002|Overall Study|Met hemoglobin stopping criteria|0
7969050|NCT02791763|12527467|FG000|Overall Study|Adverse Event|12
7969051|NCT02791763|12527468|FG001|Overall Study|Adverse Event|13
7969052|NCT02791763|12527469|FG002|Overall Study|Adverse Event|7
7969053|NCT02791893|12527488|FG000|Blinded Phase|Lost to Follow-up|2
7969054|NCT02791893|12527489|FG001|Blinded Phase|Lost to Follow-up|2
7969055|NCT02791893|12527488|FG000|Blinded Phase|Withdrawal by Subject|1
7969056|NCT02791893|12527489|FG001|Blinded Phase|Withdrawal by Subject|2
7969057|NCT02791893|12527488|FG000|Open Label Phase|Lost to Follow-up|3
7969058|NCT02791893|12527489|FG001|Open Label Phase|Lost to Follow-up|0
7969059|NCT02791893|12527488|FG000|Open Label Phase|Withdrawal by Subject|0
7969060|NCT02791893|12527489|FG001|Open Label Phase|Withdrawal by Subject|2
7969061|NCT02792062|12527532|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
7969062|NCT02792062|12527533|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7969063|NCT02792062|12527534|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7969064|NCT02792062|12527535|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7969065|NCT02792062|12527536|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7969066|NCT02792062|12527537|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7969067|NCT02792192|12527549|FG000|Overall Study|Death|1
7969068|NCT02792192|12527550|FG001|Overall Study|Death|0
7904519|NCT01991483|12417562|FG003|Dose Level 1000 mg|Protocol Violation|1
7904520|NCT01991743|12417592|FG000|Overall Study|external cephalic version not performed|0
7904521|NCT01991743|12417593|FG001|Overall Study|external cephalic version not performed|0
7904522|NCT01991743|12417594|FG002|Overall Study|external cephalic version not performed|1
7904523|NCT01991743|12417595|FG003|Overall Study|external cephalic version not performed|0
7904524|NCT01991795|12417607|FG000|Overall Study|Lost to Follow-up|6
7904525|NCT01991795|12417608|FG001|Overall Study|Lost to Follow-up|4
7904526|NCT01991795|12417607|FG000|Overall Study|Withdrawal by Subject|117
7904527|NCT01991795|12417608|FG001|Overall Study|Withdrawal by Subject|94
7904528|NCT01991795|12417607|FG000|Overall Study|Site prematurely closed by sponsor|26
7904529|NCT01991795|12417608|FG001|Overall Study|Site prematurely closed by sponsor|25
7904530|NCT01992094|12417663|FG000|Overall Study|ADMINISTRATIVE REASON|6
7904531|NCT01992094|12417664|FG001|Overall Study|ADMINISTRATIVE REASON|7
7904532|NCT01992094|12417665|FG002|Overall Study|ADMINISTRATIVE REASON|1
7904533|NCT01992094|12417663|FG000|Overall Study|Adverse Event|1
7904534|NCT01992094|12417664|FG001|Overall Study|Adverse Event|0
7904535|NCT01992094|12417665|FG002|Overall Study|Adverse Event|0
7904536|NCT01992094|12417663|FG000|Overall Study|Death|5
7904537|NCT01992094|12417664|FG001|Overall Study|Death|5
7904538|NCT01992094|12417665|FG002|Overall Study|Death|2
7904539|NCT01992094|12417663|FG000|Overall Study|Lost to Follow-up|26
7904540|NCT01992094|12417664|FG001|Overall Study|Lost to Follow-up|9
7904541|NCT01992094|12417665|FG002|Overall Study|Lost to Follow-up|13
7904542|NCT01992094|12417663|FG000|Overall Study|OTHER|4
7904543|NCT01992094|12417664|FG001|Overall Study|OTHER|0
7904544|NCT01992094|12417665|FG002|Overall Study|OTHER|0
7904545|NCT01992094|12417663|FG000|Overall Study|Protocol Violation|1
7904546|NCT01992094|12417664|FG001|Overall Study|Protocol Violation|0
7904547|NCT01992094|12417665|FG002|Overall Study|Protocol Violation|1
7904548|NCT01992094|12417663|FG000|Overall Study|Withdrawal by Subject|7
7904549|NCT01992094|12417664|FG001|Overall Study|Withdrawal by Subject|3
7904550|NCT01992094|12417665|FG002|Overall Study|Withdrawal by Subject|4
7963879|NCT02730455|12518618|FG002|Overall Study|Other|2
7963880|NCT02730455|12518616|FG000|Overall Study|Other|2
7963881|NCT02730455|12518617|FG001|Overall Study|Other|2
7963882|NCT02730455|12518618|FG002|Overall Study|Other|0
7963883|NCT02730598|12518628|FG000|Overall Study|Withdrawal by Subject|3
7963884|NCT02730598|12518629|FG001|Overall Study|Withdrawal by Subject|3
7963885|NCT02730598|12518628|FG000|Overall Study|Protocol Violation|0
7963886|NCT02730598|12518629|FG001|Overall Study|Protocol Violation|1
7969069|NCT02792192|12527551|FG002|Overall Study|Death|0
7969070|NCT02792192|12527552|FG003|Overall Study|Death|0
7969071|NCT02792192|12527549|FG000|Overall Study|Informed Consent Withdrawn|4
7904551|NCT01992107|12417692|FG000|Overall Study|Administrative reasons|2
7904552|NCT01992107|12417693|FG001|Overall Study|Administrative reasons|0
7904553|NCT01992107|12417694|FG002|Overall Study|Administrative reasons|0
7904554|NCT01992107|12417692|FG000|Overall Study|Adverse Event|0
7904555|NCT01992107|12417693|FG001|Overall Study|Adverse Event|1
7904556|NCT01992107|12417694|FG002|Overall Study|Adverse Event|0
7904557|NCT01992107|12417692|FG000|Overall Study|Lost to Follow-up|46
7904558|NCT01992107|12417693|FG001|Overall Study|Lost to Follow-up|22
7904559|NCT01992107|12417694|FG002|Overall Study|Lost to Follow-up|26
7904560|NCT01992107|12417692|FG000|Overall Study|noncompliance and were unavailable|7
7904561|NCT01992107|12417693|FG001|Overall Study|noncompliance and were unavailable|3
7904562|NCT01992107|12417694|FG002|Overall Study|noncompliance and were unavailable|2
7904563|NCT01992107|12417692|FG000|Overall Study|Withdrawal by Subject|13
7904564|NCT01992107|12417693|FG001|Overall Study|Withdrawal by Subject|7
7904565|NCT01992107|12417694|FG002|Overall Study|Withdrawal by Subject|8
7904566|NCT01992159|12417723|FG000|Overall Study|Withdrawal by Subject|4
7904567|NCT01992159|12417724|FG001|Overall Study|Withdrawal by Subject|7
7904568|NCT01992159|12417725|FG002|Overall Study|Withdrawal by Subject|0
7904569|NCT01992159|12417726|FG003|Overall Study|Withdrawal by Subject|3
7904570|NCT01992159|12417723|FG000|Overall Study|Adverse Event|0
7904571|NCT01992159|12417724|FG001|Overall Study|Adverse Event|1
7904572|NCT01992159|12417725|FG002|Overall Study|Adverse Event|0
7904573|NCT01992159|12417726|FG003|Overall Study|Adverse Event|1
7904574|NCT01992159|12417723|FG000|Overall Study|Death|0
7904575|NCT01992159|12417724|FG001|Overall Study|Death|0
7904576|NCT01992159|12417725|FG002|Overall Study|Death|1
7904577|NCT01992159|12417726|FG003|Overall Study|Death|0
7904578|NCT01992536|12417791|FG000|Overall Study|Administrative Reason|0
7904579|NCT01992536|12417792|FG001|Overall Study|Administrative Reason|0
7904580|NCT01992536|12417793|FG002|Overall Study|Administrative Reason|0
7904581|NCT01992536|12417794|FG003|Overall Study|Administrative Reason|0
7904582|NCT01992536|12417795|FG004|Overall Study|Administrative Reason|0
7904583|NCT01992536|12417796|FG005|Overall Study|Administrative Reason|0
7904584|NCT01992536|12417797|FG006|Overall Study|Administrative Reason|7
7904585|NCT01992536|12417798|FG007|Overall Study|Administrative Reason|0
7904586|NCT01992536|12417799|FG008|Overall Study|Administrative Reason|0
7904587|NCT01992536|12417800|FG009|Overall Study|Administrative Reason|0
7904588|NCT01992536|12417791|FG000|Overall Study|Lost to Follow-up|4
7904589|NCT01992536|12417792|FG001|Overall Study|Lost to Follow-up|2
7904590|NCT01992536|12417793|FG002|Overall Study|Lost to Follow-up|1
7904591|NCT01992536|12417794|FG003|Overall Study|Lost to Follow-up|0
7904592|NCT01992536|12417795|FG004|Overall Study|Lost to Follow-up|0
7904593|NCT01992536|12417796|FG005|Overall Study|Lost to Follow-up|1
7904594|NCT01992536|12417797|FG006|Overall Study|Lost to Follow-up|0
7904595|NCT01992536|12417798|FG007|Overall Study|Lost to Follow-up|0
7904596|NCT01992536|12417799|FG008|Overall Study|Lost to Follow-up|1
7904597|NCT01992536|12417800|FG009|Overall Study|Lost to Follow-up|1
7904598|NCT01992536|12417791|FG000|Overall Study|Withdrawal by Subject|0
7904599|NCT01992536|12417792|FG001|Overall Study|Withdrawal by Subject|1
7904600|NCT01992536|12417793|FG002|Overall Study|Withdrawal by Subject|0
7904601|NCT01992536|12417794|FG003|Overall Study|Withdrawal by Subject|2
7904602|NCT01992536|12417795|FG004|Overall Study|Withdrawal by Subject|0
7904603|NCT01992536|12417796|FG005|Overall Study|Withdrawal by Subject|0
7904604|NCT01992536|12417797|FG006|Overall Study|Withdrawal by Subject|0
7904605|NCT01992536|12417798|FG007|Overall Study|Withdrawal by Subject|0
7904606|NCT01992536|12417799|FG008|Overall Study|Withdrawal by Subject|0
7904607|NCT01992536|12417800|FG009|Overall Study|Withdrawal by Subject|0
7904608|NCT01992549|12417842|FG000|Overall Study|Lost to Follow-up|2
7904609|NCT01992549|12417842|FG000|Overall Study|Serious Adverse Event|1
7904610|NCT01992549|12417842|FG000|Overall Study|Product Switch to Extend Half Life|1
7904611|NCT01992757|12417852|FG000|Overall Study|2 patients excluded due to FFP given.|2
7904612|NCT01993017|12417872|FG000|Overall Study|Death|23
7904613|NCT01993017|12417873|FG001|Overall Study|Death|26
7904614|NCT01993017|12417874|FG002|Overall Study|Death|18
7904615|NCT01993017|12417872|FG000|Overall Study|Could not be contacted|43
7904616|NCT01993017|12417873|FG001|Overall Study|Could not be contacted|42
7904617|NCT01993017|12417874|FG002|Overall Study|Could not be contacted|38
7904618|NCT01993017|12417872|FG000|Overall Study|Dropped out|19
7904619|NCT01993017|12417873|FG001|Overall Study|Dropped out|6
7904620|NCT01993017|12417874|FG002|Overall Study|Dropped out|11
7904621|NCT01993017|12417872|FG000|Overall Study|Other reasons|17
7904622|NCT01993017|12417873|FG001|Overall Study|Other reasons|11
7904623|NCT01993017|12417874|FG002|Overall Study|Other reasons|7
7904624|NCT01993017|12417872|FG000|Overall Study|Ineligible after randomization|4
7904625|NCT01993017|12417873|FG001|Overall Study|Ineligible after randomization|5
7904626|NCT01993017|12417874|FG002|Overall Study|Ineligible after randomization|5
7904627|NCT01993030|12417885|FG000|Overall Study|Adverse Event|0
7904628|NCT01993030|12417886|FG001|Overall Study|Adverse Event|4
7904629|NCT01993186|12417915|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1
7904630|NCT01993186|12417916|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0
7904631|NCT01993186|12417915|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1
7904632|NCT01993186|12417916|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0
7904633|NCT01993186|12417915|FG000|Open-Label Extension Period|Other, Not Specified|0
7904634|NCT01993186|12417916|FG001|Open-Label Extension Period|Other, Not Specified|1
7904635|NCT01993186|12417915|FG000|Open-Label Extension Period|Adverse Event|1
7904636|NCT01993186|12417916|FG001|Open-Label Extension Period|Adverse Event|0
7904637|NCT01993186|12417915|FG000|Open-Label Extension Period|Principal Investigator Decision|1
7904638|NCT01993186|12417916|FG001|Open-Label Extension Period|Principal Investigator Decision|0
7904639|NCT01993186|12417915|FG000|Open-Label Extension Period|Withdrawal by Subject|4
7904640|NCT01993186|12417916|FG001|Open-Label Extension Period|Withdrawal by Subject|5
7904641|NCT01993186|12417915|FG000|Open-Label Extension Period|Subject Non-Compliance|1
7904642|NCT01993186|12417916|FG001|Open-Label Extension Period|Subject Non-Compliance|0
7904643|NCT01993329|12417933|FG000|Period 2|Adverse Event|0
7904644|NCT01993329|12417934|FG001|Period 2|Adverse Event|0
7904645|NCT01993329|12417935|FG002|Period 2|Adverse Event|0
7904646|NCT01993329|12417936|FG003|Period 2|Adverse Event|0
7904647|NCT01993329|12417937|FG004|Period 2|Adverse Event|0
7904648|NCT01993329|12417938|FG005|Period 2|Adverse Event|1
7904649|NCT01993329|12417933|FG000|Wash-out|Personal reasons|0
7904650|NCT01993329|12417934|FG001|Wash-out|Personal reasons|1
7904651|NCT01993329|12417935|FG002|Wash-out|Personal reasons|0
7904652|NCT01993329|12417936|FG003|Wash-out|Personal reasons|0
7904653|NCT01993329|12417937|FG004|Wash-out|Personal reasons|0
7904654|NCT01993329|12417938|FG005|Wash-out|Personal reasons|0
7904655|NCT01993615|12417952|FG000|Overall Study|Death|1
7904656|NCT01993615|12417953|FG001|Overall Study|Death|0
7904657|NCT01993667|12417961|FG000|Overall Study|Insufficient data to analyze|16
7904658|NCT01993667|12417962|FG001|Overall Study|Insufficient data to analyze|16
7904659|NCT01993667|12417961|FG000|Overall Study|Insufficient altitude reached|3
7904660|NCT01993667|12417962|FG001|Overall Study|Insufficient altitude reached|1
7904661|NCT01993667|12417961|FG000|Overall Study|Lost to Follow-up|2
7904662|NCT01993667|12417962|FG001|Overall Study|Lost to Follow-up|2
7904663|NCT01993823|12417970|FG000|Overall Study|Requested by the patient|6
7904664|NCT01993823|12417971|FG001|Overall Study|Requested by the patient|11
7904665|NCT01993823|12417970|FG000|Overall Study|Protocol Violation|0
7904666|NCT01993823|12417971|FG001|Overall Study|Protocol Violation|1
7904667|NCT01993823|12417970|FG000|Overall Study|Lost to Follow-up|1
7904668|NCT01993823|12417971|FG001|Overall Study|Lost to Follow-up|4
7963887|NCT02730598|12518628|FG000|Overall Study|Unrelated Injury affecting outcomes.|1
7963888|NCT02730598|12518629|FG001|Overall Study|Unrelated Injury affecting outcomes.|0
7963889|NCT02730728|12518642|FG000|Overall Study|Withdrawal by Subject|0
7963890|NCT02730728|12518643|FG001|Overall Study|Withdrawal by Subject|1
7963891|NCT02730728|12518644|FG002|Overall Study|Withdrawal by Subject|0
7963892|NCT02730728|12518642|FG000|Overall Study|Lack of Efficacy|0
7963893|NCT02730728|12518643|FG001|Overall Study|Lack of Efficacy|1
7963894|NCT02730728|12518644|FG002|Overall Study|Lack of Efficacy|1
7963895|NCT02730819|12518652|FG000|Overall Study|Lost to Follow-up|9
7966833|NCT02757352|12523230|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7966834|NCT02757352|12523231|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7966835|NCT02757352|12523222|FG000|Follow-Up Period|Adverse Event|0
7966836|NCT02757352|12523223|FG001|Follow-Up Period|Adverse Event|0
7966837|NCT02757352|12523224|FG002|Follow-Up Period|Adverse Event|0
7966838|NCT02757352|12523225|FG003|Follow-Up Period|Adverse Event|0
7966839|NCT02757352|12523226|FG004|Follow-Up Period|Adverse Event|0
7966840|NCT02757352|12523227|FG005|Follow-Up Period|Adverse Event|0
7966841|NCT02757352|12523228|FG006|Follow-Up Period|Adverse Event|1
7966842|NCT02757352|12523229|FG007|Follow-Up Period|Adverse Event|0
7966843|NCT02757352|12523230|FG008|Follow-Up Period|Adverse Event|2
7966844|NCT02757352|12523231|FG009|Follow-Up Period|Adverse Event|0
7966845|NCT02757352|12523222|FG000|Follow-Up Period|Lost to Follow-up|0
7966846|NCT02757352|12523223|FG001|Follow-Up Period|Lost to Follow-up|0
7966847|NCT02757352|12523224|FG002|Follow-Up Period|Lost to Follow-up|0
7966848|NCT02757352|12523225|FG003|Follow-Up Period|Lost to Follow-up|0
7966849|NCT02757352|12523226|FG004|Follow-Up Period|Lost to Follow-up|0
7966850|NCT02757352|12523227|FG005|Follow-Up Period|Lost to Follow-up|0
7966851|NCT02757352|12523228|FG006|Follow-Up Period|Lost to Follow-up|0
7966852|NCT02757352|12523229|FG007|Follow-Up Period|Lost to Follow-up|0
7966853|NCT02757352|12523230|FG008|Follow-Up Period|Lost to Follow-up|1
7966854|NCT02757352|12523231|FG009|Follow-Up Period|Lost to Follow-up|0
7966855|NCT02757352|12523222|FG000|Follow-Up Period|Lack of Efficacy|0
7966856|NCT02757352|12523223|FG001|Follow-Up Period|Lack of Efficacy|0
7966857|NCT02757352|12523224|FG002|Follow-Up Period|Lack of Efficacy|0
7966858|NCT02757352|12523225|FG003|Follow-Up Period|Lack of Efficacy|0
7966859|NCT02757352|12523226|FG004|Follow-Up Period|Lack of Efficacy|0
7966860|NCT02757352|12523227|FG005|Follow-Up Period|Lack of Efficacy|0
7966861|NCT02757352|12523228|FG006|Follow-Up Period|Lack of Efficacy|0
7966862|NCT02757352|12523229|FG007|Follow-Up Period|Lack of Efficacy|0
7966863|NCT02757352|12523230|FG008|Follow-Up Period|Lack of Efficacy|1
7966864|NCT02757352|12523231|FG009|Follow-Up Period|Lack of Efficacy|1
7966865|NCT02757352|12523222|FG000|Follow-Up Period|Withdrawal by Subject|0
7966866|NCT02757352|12523223|FG001|Follow-Up Period|Withdrawal by Subject|0
7966867|NCT02757352|12523224|FG002|Follow-Up Period|Withdrawal by Subject|0
7966868|NCT02757352|12523225|FG003|Follow-Up Period|Withdrawal by Subject|0
7966869|NCT02757352|12523226|FG004|Follow-Up Period|Withdrawal by Subject|0
7966870|NCT02757352|12523227|FG005|Follow-Up Period|Withdrawal by Subject|0
7966871|NCT02757352|12523228|FG006|Follow-Up Period|Withdrawal by Subject|0
7966872|NCT02757352|12523229|FG007|Follow-Up Period|Withdrawal by Subject|1
7904669|NCT01993836|12417980|FG000|Overall Study|Surgery Cancelled|3
7904670|NCT01993836|12417981|FG001|Overall Study|Surgery Cancelled|0
7904671|NCT01993836|12417982|FG002|Overall Study|Surgery Cancelled|0
7904672|NCT01993836|12417980|FG000|Overall Study|Physician Decision|2
7904673|NCT01993836|12417981|FG001|Overall Study|Physician Decision|1
7904674|NCT01993836|12417982|FG002|Overall Study|Physician Decision|0
7904675|NCT01993836|12417980|FG000|Overall Study|Death|0
7904676|NCT01993836|12417981|FG001|Overall Study|Death|2
7904677|NCT01993836|12417982|FG002|Overall Study|Death|0
7904678|NCT01993836|12417980|FG000|Overall Study|Withdrawal by Subject|12
7904679|NCT01993836|12417981|FG001|Overall Study|Withdrawal by Subject|10
7904680|NCT01993836|12417982|FG002|Overall Study|Withdrawal by Subject|5
7904681|NCT01993888|12418013|FG000|Overall Study|Death|1
7904682|NCT01993888|12418014|FG001|Overall Study|Death|1
7904683|NCT01993888|12418013|FG000|Overall Study|Lost to Follow-up|1
7904684|NCT01993888|12418014|FG001|Overall Study|Lost to Follow-up|1
7904685|NCT01993888|12418013|FG000|Overall Study|Withdrawal by Subject|0
7904686|NCT01993888|12418014|FG001|Overall Study|Withdrawal by Subject|1
7904687|NCT01993927|12418020|FG000|Overall Study|Case Report Forms Uncollected|18
7904688|NCT01993927|12418020|FG000|Overall Study|Protocol Violation|11
7904689|NCT01993940|12418026|FG000|Overall Study|Adverse Event|16
7904690|NCT01993940|12418027|FG001|Overall Study|Adverse Event|11
7904691|NCT01993940|12418026|FG000|Overall Study|Withdrawal by Subject|15
7904692|NCT01993940|12418027|FG001|Overall Study|Withdrawal by Subject|19
7904693|NCT01993940|12418026|FG000|Overall Study|Lost to Follow-up|2
7904694|NCT01993940|12418027|FG001|Overall Study|Lost to Follow-up|5
7904695|NCT01993940|12418026|FG000|Overall Study|Protocol Violation|5
7904696|NCT01993940|12418027|FG001|Overall Study|Protocol Violation|8
7904697|NCT01993940|12418026|FG000|Overall Study|Death|1
7904698|NCT01993940|12418027|FG001|Overall Study|Death|0
7904699|NCT01993940|12418026|FG000|Overall Study|Other - Miscellaneous|1
7904700|NCT01993940|12418027|FG001|Overall Study|Other - Miscellaneous|1
7904701|NCT01994226|12418051|FG000|Overall Study|Protocol Violation|13
7904702|NCT01994226|12418052|FG001|Overall Study|Protocol Violation|10
7904703|NCT01994226|12418051|FG000|Overall Study|Early Cessation of treatment|6
7904704|NCT01994226|12418052|FG001|Overall Study|Early Cessation of treatment|11
7904705|NCT01994291|12418061|FG000|Overall Study|Adverse Event|4
7904706|NCT01994291|12418062|FG001|Overall Study|Adverse Event|1
7904707|NCT01994291|12418063|FG002|Overall Study|Adverse Event|3
7904708|NCT01994291|12418061|FG000|Overall Study|Lost to Follow-up|1
7904709|NCT01994291|12418062|FG001|Overall Study|Lost to Follow-up|1
7904710|NCT01994291|12418063|FG002|Overall Study|Lost to Follow-up|0
7904711|NCT01994291|12418061|FG000|Overall Study|Does not meet entrance criteria|1
7904712|NCT01994291|12418062|FG001|Overall Study|Does not meet entrance criteria|0
7904713|NCT01994291|12418063|FG002|Overall Study|Does not meet entrance criteria|0
7904714|NCT01994291|12418061|FG000|Overall Study|Medication error without associated AE|1
7904715|NCT01994291|12418062|FG001|Overall Study|Medication error without associated AE|0
7904716|NCT01994291|12418063|FG002|Overall Study|Medication error without associated AE|1
7904717|NCT01994291|12418061|FG000|Overall Study|Protocol Violation|1
7904718|NCT01994291|12418062|FG001|Overall Study|Protocol Violation|0
7904719|NCT01994291|12418063|FG002|Overall Study|Protocol Violation|0
7904720|NCT01994291|12418061|FG000|Overall Study|Withdrawal by Subject|6
7904721|NCT01994291|12418062|FG001|Overall Study|Withdrawal by Subject|3
7904722|NCT01994291|12418063|FG002|Overall Study|Withdrawal by Subject|5
7904723|NCT01994291|12418061|FG000|Overall Study|Other|1
7904724|NCT01994291|12418062|FG001|Overall Study|Other|2
7904725|NCT01994291|12418063|FG002|Overall Study|Other|0
7904726|NCT01994395|12418074|FG000|Overall Study|Withdrawal by Subject|1
7904727|NCT01994395|12418075|FG001|Overall Study|Withdrawal by Subject|2
7904728|NCT01994590|12418096|FG000|Overall Study|Adverse Event|1
7904729|NCT01994590|12418096|FG000|Overall Study|Trial Terminated|1
7904730|NCT01994629|12418102|FG000|Overall Study|Withdrawal by Subject|1
7904731|NCT01994629|12418103|FG001|Overall Study|Withdrawal by Subject|0
7904732|NCT01994629|12418102|FG000|Overall Study|Lost to Follow-up|0
7904733|NCT01994629|12418103|FG001|Overall Study|Lost to Follow-up|3
7904734|NCT01994720|12418111|FG000|Overall Study|Withdrawal by Subject|46
7904735|NCT01994720|12418112|FG001|Overall Study|Withdrawal by Subject|56
7904736|NCT01994837|12418142|FG000|Overall Study|Progressive disease per protocol|23
7904737|NCT01994837|12418142|FG000|Overall Study|Adv event related to progressive disease|3
7904738|NCT01994837|12418142|FG000|Overall Study|Fatal progressive disease|2
7904739|NCT01994837|12418142|FG000|Overall Study|Adverse event not related to progression|1
7904740|NCT01994837|12418142|FG000|Overall Study|Chose palliative care|1
7904741|NCT01994837|12418142|FG000|Overall Study|Proceeded to transplant|1
7904742|NCT01994837|12418142|FG000|Overall Study|Removed from study due to no response|1
7904743|NCT01994850|12418146|FG000|Overall Study|Physician Decision|1
7904744|NCT01994850|12418146|FG000|Overall Study|Withdrawal by Subject|1
7904745|NCT01994863|12418150|FG000|Period 1|Adverse Event|4
7904746|NCT01994863|12418151|FG001|Period 1|Adverse Event|0
7904747|NCT01994863|12418150|FG000|Period 1|Withdrawal by Subject|1
7904748|NCT01994863|12418151|FG001|Period 1|Withdrawal by Subject|0
7904749|NCT01994863|12418150|FG000|Period 1|Trial stopped by sponsor|1
7904750|NCT01994863|12418151|FG001|Period 1|Trial stopped by sponsor|3
7904751|NCT01994863|12418150|FG000|Period 1|Lack of Efficacy|1
7904752|NCT01994863|12418151|FG001|Period 1|Lack of Efficacy|0
7904753|NCT01994863|12418150|FG000|Period 2|Adverse Event|0
7904754|NCT01994863|12418151|FG001|Period 2|Adverse Event|1
7904755|NCT01994863|12418150|FG000|Period 2|Lack of Efficacy|0
7904756|NCT01994863|12418151|FG001|Period 2|Lack of Efficacy|2
7904757|NCT01994863|12418150|FG000|Period 2|Withdrawal by Subject|1
7904758|NCT01994863|12418151|FG001|Period 2|Withdrawal by Subject|1
7904759|NCT01994876|12418157|FG000|Test Period 1|Withdrawal by Subject|0
7904760|NCT01994876|12418158|FG001|Test Period 1|Withdrawal by Subject|1
7904761|NCT01994876|12418157|FG000|Test Period 1|Adverse Event|0
7904762|NCT01994876|12418158|FG001|Test Period 1|Adverse Event|1
7904763|NCT01994876|12418157|FG000|Test Period 2|Adverse Event|1
7904764|NCT01994876|12418158|FG001|Test Period 2|Adverse Event|0
7904765|NCT01994876|12418157|FG000|Test Period 2|Protocol Violation|0
7904766|NCT01994876|12418158|FG001|Test Period 2|Protocol Violation|1
7904767|NCT01994889|12418169|FG000|Overall Study|Adverse Event|5
7904768|NCT01994889|12418170|FG001|Overall Study|Adverse Event|12
7904769|NCT01994889|12418171|FG002|Overall Study|Adverse Event|11
7904770|NCT01994889|12418169|FG000|Overall Study|Cardiac Device Implantation|0
7904771|NCT01994889|12418170|FG001|Overall Study|Cardiac Device Implantation|2
7904772|NCT01994889|12418171|FG002|Overall Study|Cardiac Device Implantation|0
7904773|NCT01994889|12418169|FG000|Overall Study|Organ Transplantation|1
7904774|NCT01994889|12418170|FG001|Overall Study|Organ Transplantation|5
7904775|NCT01994889|12418171|FG002|Overall Study|Organ Transplantation|5
7904776|NCT01994889|12418169|FG000|Overall Study|No longer willing to participate|8
7904777|NCT01994889|12418170|FG001|Overall Study|No longer willing to participate|17
7904778|NCT01994889|12418171|FG002|Overall Study|No longer willing to participate|37
7904779|NCT01994889|12418169|FG000|Overall Study|Lost to Follow-up|0
7904780|NCT01994889|12418170|FG001|Overall Study|Lost to Follow-up|1
7904781|NCT01994889|12418171|FG002|Overall Study|Lost to Follow-up|0
7904782|NCT01994889|12418169|FG000|Overall Study|Protocol Violation|0
7904783|NCT01994889|12418170|FG001|Overall Study|Protocol Violation|1
7904784|NCT01994889|12418171|FG002|Overall Study|Protocol Violation|1
7904785|NCT01994889|12418169|FG000|Overall Study|Death|14
7904786|NCT01994889|12418170|FG001|Overall Study|Death|25
7904787|NCT01994889|12418171|FG002|Overall Study|Death|38
7904788|NCT01994902|12418178|FG000|Test Period 1|Withdrawal by Subject|3
7904789|NCT01994902|12418179|FG001|Test Period 1|Withdrawal by Subject|0
7904790|NCT01994902|12418178|FG000|Test Period 1|device deficiency with adverse event|0
7904791|NCT01994902|12418179|FG001|Test Period 1|device deficiency with adverse event|1
7904792|NCT01994902|12418178|FG000|Test Period 1|Adverse Event|2
7904793|NCT01994902|12418179|FG001|Test Period 1|Adverse Event|1
7904794|NCT01994902|12418178|FG000|Test Period 1|Lack of Efficacy|0
7904795|NCT01994902|12418179|FG001|Test Period 1|Lack of Efficacy|1
7904796|NCT01994902|12418178|FG000|Test Period 1|bag too small|1
7904797|NCT01994902|12418179|FG001|Test Period 1|bag too small|0
7904798|NCT01994902|12418178|FG000|Test Period 2|Withdrawal by Subject|0
7904799|NCT01994902|12418179|FG001|Test Period 2|Withdrawal by Subject|2
7904800|NCT01994902|12418178|FG000|Test Period 2|Lack of Efficacy|0
7904801|NCT01994902|12418179|FG001|Test Period 2|Lack of Efficacy|1
7904802|NCT01994902|12418178|FG000|Test Period 2|Other|0
7904803|NCT01994902|12418179|FG001|Test Period 2|Other|3
7904804|NCT01994954|12418187|FG000|Overall Study|Death|1
7904805|NCT01994954|12418188|FG001|Overall Study|Death|0
7904806|NCT01994954|12418187|FG000|Overall Study|Withdrawal by Subject|9
7904807|NCT01994954|12418188|FG001|Overall Study|Withdrawal by Subject|14
7904808|NCT01994954|12418187|FG000|Overall Study|Physician Decision|2
7904809|NCT01994954|12418188|FG001|Overall Study|Physician Decision|2
7904810|NCT01994954|12418187|FG000|Overall Study|Lost to Follow-up|8
7904811|NCT01994954|12418188|FG001|Overall Study|Lost to Follow-up|10
7904812|NCT01994954|12418187|FG000|Overall Study|6 Month Follow-up Not Complete|5
7904813|NCT01994954|12418188|FG001|Overall Study|6 Month Follow-up Not Complete|4
7904814|NCT01995071|12418242|FG000|Overall Study|Adverse Event|0
7904815|NCT01995071|12418243|FG001|Overall Study|Adverse Event|0
7904816|NCT01995071|12418244|FG002|Overall Study|Adverse Event|0
7904817|NCT01995071|12418245|FG003|Overall Study|Adverse Event|0
7904818|NCT01995071|12418246|FG004|Overall Study|Adverse Event|0
7904819|NCT01995071|12418247|FG005|Overall Study|Adverse Event|0
7904820|NCT01995071|12418248|FG006|Overall Study|Adverse Event|1
7904821|NCT01995071|12418249|FG007|Overall Study|Adverse Event|0
7904822|NCT01995071|12418250|FG008|Overall Study|Adverse Event|0
7904823|NCT01995071|12418251|FG009|Overall Study|Adverse Event|0
7904824|NCT01995071|12418252|FG010|Overall Study|Adverse Event|0
7904825|NCT01995071|12418253|FG011|Overall Study|Adverse Event|0
7904826|NCT01995071|12418242|FG000|Overall Study|Moved|0
7904827|NCT01995071|12418243|FG001|Overall Study|Moved|0
7904828|NCT01995071|12418244|FG002|Overall Study|Moved|1
7904829|NCT01995071|12418245|FG003|Overall Study|Moved|0
7904830|NCT01995071|12418246|FG004|Overall Study|Moved|1
7904831|NCT01995071|12418247|FG005|Overall Study|Moved|0
7904832|NCT01995071|12418248|FG006|Overall Study|Moved|0
7904833|NCT01995071|12418249|FG007|Overall Study|Moved|0
7904834|NCT01995071|12418250|FG008|Overall Study|Moved|0
7904835|NCT01995071|12418251|FG009|Overall Study|Moved|0
7904836|NCT01995071|12418252|FG010|Overall Study|Moved|1
7904837|NCT01995071|12418253|FG011|Overall Study|Moved|0
7904838|NCT01995071|12418242|FG000|Overall Study|Lost to Follow-up|1
7904839|NCT01995071|12418243|FG001|Overall Study|Lost to Follow-up|0
7904840|NCT01995071|12418244|FG002|Overall Study|Lost to Follow-up|0
7904841|NCT01995071|12418245|FG003|Overall Study|Lost to Follow-up|0
7904842|NCT01995071|12418246|FG004|Overall Study|Lost to Follow-up|0
7904843|NCT01995071|12418247|FG005|Overall Study|Lost to Follow-up|0
7904844|NCT01995071|12418248|FG006|Overall Study|Lost to Follow-up|0
7904845|NCT01995071|12418249|FG007|Overall Study|Lost to Follow-up|1
7904846|NCT01995071|12418250|FG008|Overall Study|Lost to Follow-up|1
7904847|NCT01995071|12418251|FG009|Overall Study|Lost to Follow-up|0
7904848|NCT01995071|12418252|FG010|Overall Study|Lost to Follow-up|0
7904849|NCT01995071|12418253|FG011|Overall Study|Lost to Follow-up|0
7904850|NCT01995071|12418242|FG000|Overall Study|Incarcerated|0
7904851|NCT01995071|12418243|FG001|Overall Study|Incarcerated|0
7904852|NCT01995071|12418244|FG002|Overall Study|Incarcerated|0
7904853|NCT01995071|12418245|FG003|Overall Study|Incarcerated|0
7904854|NCT01995071|12418246|FG004|Overall Study|Incarcerated|0
7904855|NCT01995071|12418247|FG005|Overall Study|Incarcerated|0
7904856|NCT01995071|12418248|FG006|Overall Study|Incarcerated|0
7904857|NCT01995071|12418249|FG007|Overall Study|Incarcerated|1
7904858|NCT01995071|12418250|FG008|Overall Study|Incarcerated|0
7904859|NCT01995071|12418251|FG009|Overall Study|Incarcerated|0
7904860|NCT01995071|12418252|FG010|Overall Study|Incarcerated|0
7904861|NCT01995071|12418253|FG011|Overall Study|Incarcerated|0
7904862|NCT01995136|12418294|FG000|Overall Study|Change in residence|1
7904863|NCT01995201|12418300|FG000|From Baseline Until Week 24|Adverse Event|4
7904864|NCT01995201|12418301|FG001|From Baseline Until Week 24|Adverse Event|15
7904865|NCT01995201|12418302|FG002|From Baseline Until Week 24|Adverse Event|0
7904866|NCT01995201|12418303|FG003|From Baseline Until Week 24|Adverse Event|0
7904867|NCT01995201|12418304|FG004|From Baseline Until Week 24|Adverse Event|0
7904868|NCT01995201|12418305|FG005|From Baseline Until Week 24|Adverse Event|0
7904869|NCT01995201|12418306|FG006|From Baseline Until Week 24|Adverse Event|0
7904870|NCT01995201|12418300|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7904871|NCT01995201|12418301|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
7904872|NCT01995201|12418302|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7904873|NCT01995201|12418303|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7904874|NCT01995201|12418304|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7904875|NCT01995201|12418305|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7904876|NCT01995201|12418306|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7904877|NCT01995201|12418300|FG000|From Baseline Until Week 24|Death|0
7904878|NCT01995201|12418301|FG001|From Baseline Until Week 24|Death|1
7904879|NCT01995201|12418302|FG002|From Baseline Until Week 24|Death|0
7904880|NCT01995201|12418303|FG003|From Baseline Until Week 24|Death|0
7904881|NCT01995201|12418304|FG004|From Baseline Until Week 24|Death|0
7904882|NCT01995201|12418305|FG005|From Baseline Until Week 24|Death|0
7904883|NCT01995201|12418306|FG006|From Baseline Until Week 24|Death|0
7904884|NCT01995201|12418300|FG000|From Baseline Until Week 24|Lack of Efficacy|2
7904885|NCT01995201|12418301|FG001|From Baseline Until Week 24|Lack of Efficacy|5
7904886|NCT01995201|12418302|FG002|From Baseline Until Week 24|Lack of Efficacy|0
7904887|NCT01995201|12418303|FG003|From Baseline Until Week 24|Lack of Efficacy|0
7904888|NCT01995201|12418304|FG004|From Baseline Until Week 24|Lack of Efficacy|0
7904889|NCT01995201|12418305|FG005|From Baseline Until Week 24|Lack of Efficacy|0
7904890|NCT01995201|12418306|FG006|From Baseline Until Week 24|Lack of Efficacy|0
7904891|NCT01995201|12418300|FG000|From Baseline Until Week 24|Lost to Follow-up|2
7904892|NCT01995201|12418301|FG001|From Baseline Until Week 24|Lost to Follow-up|3
7904893|NCT01995201|12418302|FG002|From Baseline Until Week 24|Lost to Follow-up|0
7904894|NCT01995201|12418303|FG003|From Baseline Until Week 24|Lost to Follow-up|0
7904895|NCT01995201|12418304|FG004|From Baseline Until Week 24|Lost to Follow-up|0
7904896|NCT01995201|12418305|FG005|From Baseline Until Week 24|Lost to Follow-up|0
7904897|NCT01995201|12418306|FG006|From Baseline Until Week 24|Lost to Follow-up|0
7904898|NCT01995201|12418300|FG000|From Baseline Until Week 24|Withdrawal by Subject|2
7904899|NCT01995201|12418301|FG001|From Baseline Until Week 24|Withdrawal by Subject|8
7904900|NCT01995201|12418302|FG002|From Baseline Until Week 24|Withdrawal by Subject|0
7904901|NCT01995201|12418303|FG003|From Baseline Until Week 24|Withdrawal by Subject|0
7904902|NCT01995201|12418304|FG004|From Baseline Until Week 24|Withdrawal by Subject|0
7904903|NCT01995201|12418305|FG005|From Baseline Until Week 24|Withdrawal by Subject|0
7904904|NCT01995201|12418306|FG006|From Baseline Until Week 24|Withdrawal by Subject|0
7904905|NCT01995201|12418300|FG000|From Baseline Until Week 24|Physician Decision|0
7904906|NCT01995201|12418301|FG001|From Baseline Until Week 24|Physician Decision|2
7904907|NCT01995201|12418302|FG002|From Baseline Until Week 24|Physician Decision|0
7904908|NCT01995201|12418303|FG003|From Baseline Until Week 24|Physician Decision|0
7904909|NCT01995201|12418304|FG004|From Baseline Until Week 24|Physician Decision|0
7904910|NCT01995201|12418305|FG005|From Baseline Until Week 24|Physician Decision|0
7904911|NCT01995201|12418306|FG006|From Baseline Until Week 24|Physician Decision|0
7904912|NCT01995201|12418300|FG000|From Baseline Until Week 24|Protocol Violation|0
7904913|NCT01995201|12418301|FG001|From Baseline Until Week 24|Protocol Violation|9
7904914|NCT01995201|12418302|FG002|From Baseline Until Week 24|Protocol Violation|0
7904915|NCT01995201|12418303|FG003|From Baseline Until Week 24|Protocol Violation|0
7904916|NCT01995201|12418304|FG004|From Baseline Until Week 24|Protocol Violation|0
7904917|NCT01995201|12418305|FG005|From Baseline Until Week 24|Protocol Violation|0
7904918|NCT01995201|12418306|FG006|From Baseline Until Week 24|Protocol Violation|0
7904919|NCT01995201|12418300|FG000|From Week 24 Until Week 48|Adverse Event|0
7904920|NCT01995201|12418301|FG001|From Week 24 Until Week 48|Adverse Event|0
7904921|NCT01995201|12418302|FG002|From Week 24 Until Week 48|Adverse Event|2
7904922|NCT01995201|12418303|FG003|From Week 24 Until Week 48|Adverse Event|1
7904923|NCT01995201|12418304|FG004|From Week 24 Until Week 48|Adverse Event|1
7904924|NCT01995201|12418305|FG005|From Week 24 Until Week 48|Adverse Event|3
7904925|NCT01995201|12418306|FG006|From Week 24 Until Week 48|Adverse Event|1
7904926|NCT01995201|12418300|FG000|From Week 24 Until Week 48|Death|0
7904927|NCT01995201|12418301|FG001|From Week 24 Until Week 48|Death|0
7904928|NCT01995201|12418302|FG002|From Week 24 Until Week 48|Death|0
7904929|NCT01995201|12418303|FG003|From Week 24 Until Week 48|Death|0
7904930|NCT01995201|12418304|FG004|From Week 24 Until Week 48|Death|0
7904931|NCT01995201|12418305|FG005|From Week 24 Until Week 48|Death|2
7904932|NCT01995201|12418306|FG006|From Week 24 Until Week 48|Death|0
7904933|NCT01995201|12418300|FG000|From Week 24 Until Week 48|Lack of Efficacy|0
7904934|NCT01995201|12418301|FG001|From Week 24 Until Week 48|Lack of Efficacy|0
7904935|NCT01995201|12418302|FG002|From Week 24 Until Week 48|Lack of Efficacy|1
7904936|NCT01995201|12418303|FG003|From Week 24 Until Week 48|Lack of Efficacy|0
7904937|NCT01995201|12418304|FG004|From Week 24 Until Week 48|Lack of Efficacy|0
7904938|NCT01995201|12418305|FG005|From Week 24 Until Week 48|Lack of Efficacy|2
7904939|NCT01995201|12418306|FG006|From Week 24 Until Week 48|Lack of Efficacy|1
7904940|NCT01995201|12418300|FG000|From Week 24 Until Week 48|Lost to Follow-up|0
7904941|NCT01995201|12418301|FG001|From Week 24 Until Week 48|Lost to Follow-up|0
7904942|NCT01995201|12418302|FG002|From Week 24 Until Week 48|Lost to Follow-up|0
7904943|NCT01995201|12418303|FG003|From Week 24 Until Week 48|Lost to Follow-up|0
7904944|NCT01995201|12418304|FG004|From Week 24 Until Week 48|Lost to Follow-up|1
7904945|NCT01995201|12418305|FG005|From Week 24 Until Week 48|Lost to Follow-up|1
7904946|NCT01995201|12418306|FG006|From Week 24 Until Week 48|Lost to Follow-up|0
7904947|NCT01995201|12418300|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0
7904948|NCT01995201|12418301|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0
7904949|NCT01995201|12418302|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1
7904950|NCT01995201|12418303|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0
7904951|NCT01995201|12418304|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1
7904952|NCT01995201|12418305|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0
7904953|NCT01995201|12418306|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0
7904954|NCT01995201|12418300|FG000|From Week 24 Until Week 48|Physician Decision|0
7904955|NCT01995201|12418301|FG001|From Week 24 Until Week 48|Physician Decision|0
7904956|NCT01995201|12418302|FG002|From Week 24 Until Week 48|Physician Decision|0
7904957|NCT01995201|12418303|FG003|From Week 24 Until Week 48|Physician Decision|0
7904958|NCT01995201|12418304|FG004|From Week 24 Until Week 48|Physician Decision|1
7904959|NCT01995201|12418305|FG005|From Week 24 Until Week 48|Physician Decision|0
7904960|NCT01995201|12418306|FG006|From Week 24 Until Week 48|Physician Decision|0
7904961|NCT01995201|12418300|FG000|From Week 24 Until Week 48|Protocol Violation|0
7904962|NCT01995201|12418301|FG001|From Week 24 Until Week 48|Protocol Violation|0
7904963|NCT01995201|12418302|FG002|From Week 24 Until Week 48|Protocol Violation|1
7904964|NCT01995201|12418303|FG003|From Week 24 Until Week 48|Protocol Violation|0
7904965|NCT01995201|12418304|FG004|From Week 24 Until Week 48|Protocol Violation|2
7904966|NCT01995201|12418305|FG005|From Week 24 Until Week 48|Protocol Violation|0
7904967|NCT01995201|12418306|FG006|From Week 24 Until Week 48|Protocol Violation|0
7904968|NCT01995266|12418327|FG000|Overall Study|Death|1
7904969|NCT01995266|12418327|FG000|Overall Study|Lack of Efficacy|6
7904970|NCT01995266|12418327|FG000|Overall Study|Adverse Event|2
7904971|NCT01995357|12418331|FG000|Period 5|Lack of Efficacy|1
7904972|NCT01995357|12418332|FG001|Period 5|Lack of Efficacy|0
7904973|NCT01995357|12418333|FG002|Period 5|Lack of Efficacy|0
7904974|NCT01995357|12418334|FG003|Period 5|Lack of Efficacy|0
7904975|NCT01995357|12418335|FG004|Period 5|Lack of Efficacy|0
7904976|NCT01995357|12418336|FG005|Period 5|Lack of Efficacy|0
7904977|NCT01995357|12418331|FG000|Period 5|Adverse Event|1
7904978|NCT01995357|12418332|FG001|Period 5|Adverse Event|0
7904979|NCT01995357|12418333|FG002|Period 5|Adverse Event|1
7904980|NCT01995357|12418334|FG003|Period 5|Adverse Event|0
7904981|NCT01995357|12418335|FG004|Period 5|Adverse Event|0
7904982|NCT01995357|12418336|FG005|Period 5|Adverse Event|0
7904983|NCT01995461|12418352|FG000|Overall Study|Death|1
7904984|NCT01995461|12418352|FG000|Overall Study|Lost to Follow-up|2
7904985|NCT01995461|12418352|FG000|Overall Study|Withdrawal by Subject|2
7904986|NCT01995513|12418365|FG000|Open Label Treatment Period|Other|9
7904987|NCT01995513|12418366|FG001|Open Label Treatment Period|Other|0
7904988|NCT01995513|12418367|FG002|Open Label Treatment Period|Other|0
7904989|NCT01995513|12418365|FG000|Open Label Treatment Period|Withdrawal by Subject|14
7904990|NCT01995513|12418366|FG001|Open Label Treatment Period|Withdrawal by Subject|0
7904991|NCT01995513|12418367|FG002|Open Label Treatment Period|Withdrawal by Subject|0
7904992|NCT01995513|12418365|FG000|Open Label Treatment Period|Protocol Violation|1
7904993|NCT01995513|12418366|FG001|Open Label Treatment Period|Protocol Violation|0
7904994|NCT01995513|12418367|FG002|Open Label Treatment Period|Protocol Violation|0
7904995|NCT01995513|12418365|FG000|Open Label Treatment Period|Disease Progression|64
7904996|NCT01995513|12418366|FG001|Open Label Treatment Period|Disease Progression|0
7904997|NCT01995513|12418367|FG002|Open Label Treatment Period|Disease Progression|0
7904998|NCT01995513|12418365|FG000|Open Label Treatment Period|No PSA response at week 13|43
7904999|NCT01995513|12418366|FG001|Open Label Treatment Period|No PSA response at week 13|0
7905000|NCT01995513|12418367|FG002|Open Label Treatment Period|No PSA response at week 13|0
7905001|NCT01995513|12418365|FG000|Open Label Treatment Period|Adverse Event|35
7905002|NCT01995513|12418366|FG001|Open Label Treatment Period|Adverse Event|0
7905003|NCT01995513|12418367|FG002|Open Label Treatment Period|Adverse Event|0
7905004|NCT01995513|12418365|FG000|Open Label Treatment Period|Death|8
7905005|NCT01995513|12418366|FG001|Open Label Treatment Period|Death|0
7905006|NCT01995513|12418367|FG002|Open Label Treatment Period|Death|0
7905007|NCT01995513|12418365|FG000|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
7905008|NCT01995513|12418366|FG001|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
7905009|NCT01995513|12418367|FG002|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
7905010|NCT01995513|12418365|FG000|Double Blind Treatment Period|Adverse Event|0
7905011|NCT01995513|12418366|FG001|Double Blind Treatment Period|Adverse Event|12
7905012|NCT01995513|12418367|FG002|Double Blind Treatment Period|Adverse Event|5
7905013|NCT01995513|12418365|FG000|Double Blind Treatment Period|Other|0
7905014|NCT01995513|12418366|FG001|Double Blind Treatment Period|Other|1
7905015|NCT01995513|12418367|FG002|Double Blind Treatment Period|Other|2
7905016|NCT01995513|12418365|FG000|Double Blind Treatment Period|Withdrawal by Subject|0
7905017|NCT01995513|12418366|FG001|Double Blind Treatment Period|Withdrawal by Subject|4
7905018|NCT01995513|12418367|FG002|Double Blind Treatment Period|Withdrawal by Subject|6
7905019|NCT01995513|12418365|FG000|Double Blind Treatment Period|Death|0
7905020|NCT01995513|12418366|FG001|Double Blind Treatment Period|Death|0
7905021|NCT01995513|12418367|FG002|Double Blind Treatment Period|Death|1
7905022|NCT01995513|12418365|FG000|Double Blind Treatment Period|Disease Progression|0
7905023|NCT01995513|12418366|FG001|Double Blind Treatment Period|Disease Progression|82
7905024|NCT01995513|12418367|FG002|Double Blind Treatment Period|Disease Progression|93
7905025|NCT01995513|12418365|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
7905026|NCT01995513|12418366|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
7905027|NCT01995513|12418367|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
7905028|NCT01995526|12418377|FG000|Overall Study|Physician Decision|1
7905029|NCT01995539|12418381|FG000|Overall Study|Screening Failure|1
7905030|NCT01995539|12418381|FG000|Overall Study|Withdrawal by Investigator|15
7905031|NCT01995539|12418381|FG000|Overall Study|Withdrawal by Subject|11
7905032|NCT01995539|12418381|FG000|Overall Study|Lost to Follow-up|5
7905033|NCT01995539|12418381|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1
7905034|NCT01995552|12418385|FG000|Overall Study|Protocol Violation|1
7905035|NCT01995552|12418385|FG000|Overall Study|Lack of Efficacy|15
7905036|NCT01995552|12418385|FG000|Overall Study|Death|1
7905037|NCT01995825|12418393|FG000|Overall Study|Withdrawal by Subject|1
7905038|NCT01995825|12418394|FG001|Overall Study|Withdrawal by Subject|0
7905039|NCT01995838|12418407|FG000|Overall Study|Lost to Follow-up|0
7905040|NCT01995838|12418408|FG001|Overall Study|Lost to Follow-up|1
7905041|NCT01995838|12418409|FG002|Overall Study|Lost to Follow-up|0
7905042|NCT01995838|12418410|FG003|Overall Study|Lost to Follow-up|0
7905043|NCT01995838|12418411|FG004|Overall Study|Lost to Follow-up|0
7905044|NCT01995838|12418412|FG005|Overall Study|Lost to Follow-up|0
7905045|NCT01995838|12418413|FG006|Overall Study|Lost to Follow-up|1
7905046|NCT01995838|12418407|FG000|Overall Study|Participant choice|2
7905047|NCT01995838|12418408|FG001|Overall Study|Participant choice|0
7905048|NCT01995838|12418409|FG002|Overall Study|Participant choice|0
7905049|NCT01995838|12418410|FG003|Overall Study|Participant choice|0
7905050|NCT01995838|12418411|FG004|Overall Study|Participant choice|0
7905051|NCT01995838|12418412|FG005|Overall Study|Participant choice|1
7905052|NCT01995838|12418413|FG006|Overall Study|Participant choice|1
7905053|NCT01995838|12418407|FG000|Overall Study|Adverse Event|0
7905054|NCT01995838|12418408|FG001|Overall Study|Adverse Event|0
7905055|NCT01995838|12418409|FG002|Overall Study|Adverse Event|0
7905056|NCT01995838|12418410|FG003|Overall Study|Adverse Event|0
7905057|NCT01995838|12418411|FG004|Overall Study|Adverse Event|0
7905058|NCT01995838|12418412|FG005|Overall Study|Adverse Event|0
7905059|NCT01995838|12418413|FG006|Overall Study|Adverse Event|1
7905060|NCT01995838|12418407|FG000|Overall Study|Withdrawal by Subject|0
7905061|NCT01995838|12418408|FG001|Overall Study|Withdrawal by Subject|0
7905062|NCT01995838|12418409|FG002|Overall Study|Withdrawal by Subject|0
7905063|NCT01995838|12418410|FG003|Overall Study|Withdrawal by Subject|0
7905064|NCT01995838|12418411|FG004|Overall Study|Withdrawal by Subject|1
7905065|NCT01995838|12418412|FG005|Overall Study|Withdrawal by Subject|0
7905066|NCT01995838|12418413|FG006|Overall Study|Withdrawal by Subject|0
7905067|NCT01995838|12418407|FG000|Overall Study|Other|3
7905068|NCT01995838|12418408|FG001|Overall Study|Other|1
7905069|NCT01995838|12418409|FG002|Overall Study|Other|0
7905070|NCT01995838|12418410|FG003|Overall Study|Other|2
7905071|NCT01995838|12418411|FG004|Overall Study|Other|1
7905072|NCT01995838|12418412|FG005|Overall Study|Other|1
7905073|NCT01995838|12418413|FG006|Overall Study|Other|2
7905074|NCT01996033|12418430|FG000|Overall Study|Death|1
7905075|NCT01996033|12418430|FG000|Overall Study|Physician Decision|1
7905076|NCT01996033|12418430|FG000|Overall Study|Withdrawal by Subject|4
7905077|NCT01996033|12418430|FG000|Overall Study|Lost to Follow-up|3
7905078|NCT01996241|12418436|FG000|Overall Study|Lost to Follow-up|252
7905079|NCT01996241|12418437|FG001|Overall Study|Lost to Follow-up|235
7905080|NCT01996254|12418447|FG000|Overall Study|Change in Eligibility|0
7905081|NCT01996254|12418448|FG001|Overall Study|Change in Eligibility|2
7905082|NCT01996254|12418449|FG002|Overall Study|Change in Eligibility|0
7905083|NCT01996254|12418447|FG000|Overall Study|Withdrawal by Subject|0
7905084|NCT01996254|12418448|FG001|Overall Study|Withdrawal by Subject|3
7905085|NCT01996254|12418449|FG002|Overall Study|Withdrawal by Subject|4
7905086|NCT01996254|12418447|FG000|Overall Study|Lost to Follow-up|1
7905087|NCT01996254|12418448|FG001|Overall Study|Lost to Follow-up|0
7905088|NCT01996254|12418449|FG002|Overall Study|Lost to Follow-up|4
7905089|NCT01996319|12418461|FG000|Overall Study|Protocol Violation|1
7905090|NCT01996319|12418462|FG001|Overall Study|Protocol Violation|0
7905091|NCT01996319|12418461|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5
7905092|NCT01996319|12418462|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1
7905093|NCT01996319|12418461|FG000|Overall Study|Adverse Event|2
7905094|NCT01996319|12418462|FG001|Overall Study|Adverse Event|2
7905095|NCT01996332|12418468|FG000|Overall Study|Adverse Event|117
7905096|NCT01996332|12418468|FG000|Overall Study|Lack of Efficacy|1245
7905097|NCT01996332|12418468|FG000|Overall Study|Death|264
7905098|NCT01996332|12418468|FG000|Overall Study|Protocol Violation|9
7905099|NCT01996332|12418468|FG000|Overall Study|Withdrawal by Subject|71
7905100|NCT01996332|12418468|FG000|Overall Study|Other|20
7905101|NCT01996332|12418468|FG000|Overall Study|Clinical Deterioration|28
7905102|NCT01996332|12418468|FG000|Overall Study|Physician Decision|17
7905103|NCT01996332|12418468|FG000|Overall Study|Lost to Follow-up|34
7905104|NCT01996592|12418472|FG000|Overall Study|no response to text/no diary entry|32
7905105|NCT01996592|12418472|FG000|Overall Study|change in surgical date|4
7905106|NCT01996592|12418472|FG000|Overall Study|Withdrawal by Subject|5
7905107|NCT01996592|12418472|FG000|Overall Study|change in mode of delivery|4
7905108|NCT01996709|12418508|FG000|Overall Study|Withdrawal by Subject|1
7905109|NCT01996709|12418509|FG001|Overall Study|Withdrawal by Subject|0
7905110|NCT01996709|12418508|FG000|Overall Study|Lost to Follow-up|3
7905111|NCT01996709|12418509|FG001|Overall Study|Lost to Follow-up|0
7905112|NCT01996709|12418508|FG000|Overall Study|Subject Non-Compliant|1
7905113|NCT01996709|12418509|FG001|Overall Study|Subject Non-Compliant|0
7905114|NCT01996709|12418508|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
7905115|NCT01996709|12418509|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1
7905116|NCT01996748|12418521|FG000|Overall Study|Personal reason|1
7905117|NCT01996748|12418522|FG001|Overall Study|Personal reason|0
7905118|NCT01996748|12418521|FG000|Overall Study|Physician Decision|2
7905119|NCT01996748|12418522|FG001|Overall Study|Physician Decision|0
7905120|NCT01996748|12418521|FG000|Overall Study|Adverse Event|1
7905121|NCT01996748|12418522|FG001|Overall Study|Adverse Event|4
7905122|NCT01996748|12418521|FG000|Overall Study|Withdrawal by Subject|0
7905123|NCT01996748|12418522|FG001|Overall Study|Withdrawal by Subject|1
7905124|NCT01996748|12418521|FG000|Overall Study|Lost to Follow-up|4
7905125|NCT01996748|12418522|FG001|Overall Study|Lost to Follow-up|1
7905126|NCT01996826|12418541|FG000|Overall Study|Lost to Follow-up|6
7905127|NCT01996826|12418542|FG001|Overall Study|Lost to Follow-up|2
7905128|NCT01996826|12418541|FG000|Overall Study|Physician Decision|1
7905129|NCT01996826|12418542|FG001|Overall Study|Physician Decision|1
7905130|NCT01996904|12418563|FG000|Overall Study|Lost to Follow-up|38
7905131|NCT01996904|12418564|FG001|Overall Study|Lost to Follow-up|27
7905132|NCT01997281|12418606|FG000|Overall Study|Withdrawal by Subject|1
7905133|NCT01997281|12418607|FG001|Overall Study|Withdrawal by Subject|0
7905134|NCT01997333|12418615|FG000|Randomization and Treatment|Disease Progression|70
7905135|NCT01997333|12418616|FG001|Randomization and Treatment|Disease Progression|159
7905136|NCT01997333|12418615|FG000|Randomization and Treatment|Adverse Event|10
7905137|NCT01997333|12418616|FG001|Randomization and Treatment|Adverse Event|32
7905138|NCT01997333|12418615|FG000|Randomization and Treatment|Physician Decision|0
7905139|NCT01997333|12418616|FG001|Randomization and Treatment|Physician Decision|4
7905140|NCT01997333|12418615|FG000|Randomization and Treatment|Withdrawal by Subject|6
7905141|NCT01997333|12418616|FG001|Randomization and Treatment|Withdrawal by Subject|3
7905142|NCT01997333|12418615|FG000|Randomization and Treatment|Did not receive treatment|17
7905143|NCT01997333|12418616|FG001|Randomization and Treatment|Did not receive treatment|5
7905144|NCT01997333|12418615|FG000|Survival Follow up|Withdrawal by Subject|15
7905145|NCT01997333|12418616|FG001|Survival Follow up|Withdrawal by Subject|6
7905146|NCT01997333|12418615|FG000|Survival Follow up|Lost to Follow-up|0
7905147|NCT01997333|12418616|FG001|Survival Follow up|Lost to Follow-up|6
7905148|NCT01997333|12418615|FG000|Survival Follow up|Various|1
7905149|NCT01997333|12418616|FG001|Survival Follow up|Various|2
7905150|NCT01997892|12418680|FG000|Overall Study|Physician Decision|2
7905151|NCT01997892|12418680|FG000|Overall Study|Lost to Follow-up|6
7905152|NCT01997892|12418680|FG000|Overall Study|Death|14
7905153|NCT01997892|12418680|FG000|Overall Study|Renal transplant|8
7905154|NCT01997892|12418680|FG000|Overall Study|Other|3
7905155|NCT01997892|12418680|FG000|Overall Study|Study completion data not recorded|35
7905156|NCT01998243|12418695|FG000|Overall Study|Pregnancy|0
7905157|NCT01998243|12418696|FG001|Overall Study|Pregnancy|1
7905158|NCT01998243|12418695|FG000|Overall Study|Protocol Violation|5
7905159|NCT01998243|12418696|FG001|Overall Study|Protocol Violation|2
7905160|NCT01998243|12418695|FG000|Overall Study|Withdrawal by Subject|3
7905161|NCT01998243|12418696|FG001|Overall Study|Withdrawal by Subject|4
7905162|NCT01998399|12418719|FG000|Overall Study|Lost to Follow-up|1
7905163|NCT01998399|12418720|FG001|Overall Study|Lost to Follow-up|3
7905164|NCT01998399|12418719|FG000|Overall Study|Death|4
7905165|NCT01998399|12418720|FG001|Overall Study|Death|2
7905166|NCT01998399|12418719|FG000|Overall Study|Study stopped before dosing completed|3
7905167|NCT01998399|12418720|FG001|Overall Study|Study stopped before dosing completed|3
7905168|NCT01998399|12418719|FG000|Overall Study|Withdrawal by Subject|0
7905169|NCT01998399|12418720|FG001|Overall Study|Withdrawal by Subject|1
7905170|NCT01998477|12418741|FG000|Overall Study|Lost to Follow-up|4
7905171|NCT01998477|12418742|FG001|Overall Study|Lost to Follow-up|5
7905172|NCT01998477|12418741|FG000|Overall Study|Withdrawal by Subject|6
7905173|NCT01998477|12418742|FG001|Overall Study|Withdrawal by Subject|0
7905174|NCT01998581|12418775|FG000|Overall Study|Refused repeat treatment|20
7905175|NCT01998581|12418776|FG001|Overall Study|Refused repeat treatment|4
7905176|NCT01998581|12418775|FG000|Overall Study|Protocol Violation|1
7905177|NCT01998581|12418776|FG001|Overall Study|Protocol Violation|0
7905178|NCT01998581|12418775|FG000|Overall Study|Withdrawal by Subject|8
7905179|NCT01998581|12418776|FG001|Overall Study|Withdrawal by Subject|1
7905180|NCT01998581|12418775|FG000|Overall Study|Lost to Follow-up|12
7905181|NCT01998581|12418776|FG001|Overall Study|Lost to Follow-up|4
7905182|NCT01998581|12418775|FG000|Overall Study|Adverse Event|1
7905183|NCT01998581|12418776|FG001|Overall Study|Adverse Event|1
7905184|NCT01998581|12418775|FG000|Overall Study|Other reasons|3
7905185|NCT01998581|12418776|FG001|Overall Study|Other reasons|2
7905186|NCT01998581|12418775|FG000|Overall Study|Randomized but withdrew before treatment|1
7905187|NCT01998581|12418776|FG001|Overall Study|Randomized but withdrew before treatment|0
7905188|NCT01998633|12418785|FG000|Overall Study|Death|1
7905189|NCT01998737|12418795|FG000|Overall Study|Corrupted database|23
7905190|NCT01998737|12418796|FG001|Overall Study|Corrupted database|0
7905191|NCT01998880|12418804|FG000|Overall Study|Adverse Events or Intercurrent Illness|16
7905192|NCT01998880|12418805|FG001|Overall Study|Adverse Events or Intercurrent Illness|16
7905193|NCT01998880|12418804|FG000|Overall Study|Disease Progression|1
7905194|NCT01998880|12418805|FG001|Overall Study|Disease Progression|8
7905195|NCT01998880|12418804|FG000|Overall Study|Withdrew Consent|2
7905196|NCT01998880|12418805|FG001|Overall Study|Withdrew Consent|1
7905197|NCT01998880|12418804|FG000|Overall Study|Death|3
7905198|NCT01998880|12418805|FG001|Overall Study|Death|6
7905199|NCT01998880|12418804|FG000|Overall Study|Insufficient Therapeutic Response|1
7905200|NCT01998880|12418805|FG001|Overall Study|Insufficient Therapeutic Response|5
7905201|NCT01998880|12418804|FG000|Overall Study|Administrative/Other|1
7905202|NCT01998880|12418805|FG001|Overall Study|Administrative/Other|1
7905203|NCT01998880|12418804|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1
7905204|NCT01998880|12418805|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
7905205|NCT01998880|12418804|FG000|Overall Study|Violation of Selection Criteria at Entry|0
7905206|NCT01998880|12418805|FG001|Overall Study|Violation of Selection Criteria at Entry|1
7905207|NCT01998880|12418804|FG000|Overall Study|Did Not Receive Treatment|3
7905208|NCT01998880|12418805|FG001|Overall Study|Did Not Receive Treatment|2
7905209|NCT01998893|12418811|FG000|Overall Study|Adverse Event|2
7905210|NCT01998893|12418811|FG000|Overall Study|Death|1
7905211|NCT01998893|12418811|FG000|Overall Study|Lost to Follow-up|8
7905212|NCT01998893|12418811|FG000|Overall Study|Physician Decision|2
7905213|NCT01998893|12418811|FG000|Overall Study|Protocol Violation|2
7905214|NCT01998893|12418811|FG000|Overall Study|Withdrawal by Subject|1
7905215|NCT01998893|12418811|FG000|Overall Study|Transformation to high-grade lymphoma|1
7905216|NCT01998906|12418818|FG000|Overall Study|Participants ongoing in follow-up|77
7905217|NCT01998906|12418819|FG001|Overall Study|Participants ongoing in follow-up|60
7905218|NCT01998906|12418820|FG002|Overall Study|Participants ongoing in follow-up|58
7905219|NCT01998906|12418818|FG000|Overall Study|Death|21
7905220|NCT01998906|12418819|FG001|Overall Study|Death|30
7905221|NCT01998906|12418820|FG002|Overall Study|Death|17
7905222|NCT01998906|12418818|FG000|Overall Study|Lack of Efficacy|10
7905223|NCT01998906|12418819|FG001|Overall Study|Lack of Efficacy|9
7905224|NCT01998906|12418820|FG002|Overall Study|Lack of Efficacy|8
7905225|NCT01998906|12418818|FG000|Overall Study|Failure to return|0
7969072|NCT02792192|12527550|FG001|Overall Study|Informed Consent Withdrawn|0
7969073|NCT02792192|12527551|FG002|Overall Study|Informed Consent Withdrawn|0
7969074|NCT02792192|12527552|FG003|Overall Study|Informed Consent Withdrawn|0
7969075|NCT02792192|12527549|FG000|Overall Study|Physician Decision|1
7969076|NCT02792192|12527550|FG001|Overall Study|Physician Decision|0
7969077|NCT02792192|12527551|FG002|Overall Study|Physician Decision|0
7969078|NCT02792192|12527552|FG003|Overall Study|Physician Decision|0
7969079|NCT02792192|12527549|FG000|Overall Study|Progressive Disease|0
7969080|NCT02792192|12527550|FG001|Overall Study|Progressive Disease|1
7969081|NCT02792192|12527551|FG002|Overall Study|Progressive Disease|0
7969082|NCT02792192|12527552|FG003|Overall Study|Progressive Disease|0
7969083|NCT02792192|12527549|FG000|Overall Study|Study Terminated By Sponsor|6
7969084|NCT02792192|12527550|FG001|Overall Study|Study Terminated By Sponsor|10
7969085|NCT02792192|12527551|FG002|Overall Study|Study Terminated By Sponsor|0
7969086|NCT02792192|12527552|FG003|Overall Study|Study Terminated By Sponsor|0
7969087|NCT02792218|12527565|FG000|Overall Study|Patient/guardian decision|15
7969088|NCT02792218|12527566|FG001|Overall Study|Patient/guardian decision|42
7969089|NCT02792218|12527565|FG000|Overall Study|Adverse Event|15
7969090|NCT02792218|12527566|FG001|Overall Study|Adverse Event|14
7969091|NCT02792218|12527565|FG000|Overall Study|Lost to Follow-up|10
7969092|NCT02792218|12527566|FG001|Overall Study|Lost to Follow-up|5
7969093|NCT02792218|12527565|FG000|Overall Study|Lack of Efficacy|1
7969094|NCT02792218|12527566|FG001|Overall Study|Lack of Efficacy|12
7969095|NCT02792218|12527565|FG000|Overall Study|Physician Decision|4
7969096|NCT02792218|12527566|FG001|Overall Study|Physician Decision|4
7969097|NCT02792218|12527565|FG000|Overall Study|Protocol deviation|3
7969098|NCT02792218|12527566|FG001|Overall Study|Protocol deviation|2
7969099|NCT02792218|12527565|FG000|Overall Study|New therapy for study indication|0
7969100|NCT02792218|12527566|FG001|Overall Study|New therapy for study indication|1
7969101|NCT02792218|12527565|FG000|Overall Study|Non-compliance with study treatment|0
7969102|NCT02792218|12527566|FG001|Overall Study|Non-compliance with study treatment|1
7969103|NCT02792218|12527565|FG000|Overall Study|Pregnancy|1
7969104|NCT02792218|12527566|FG001|Overall Study|Pregnancy|0
7969105|NCT02792231|12527574|FG000|Overall Study|Patient/guardian decision|32
7969106|NCT02792231|12527575|FG001|Overall Study|Patient/guardian decision|42
7969107|NCT02792231|12527574|FG000|Overall Study|Adverse Event|15
7969108|NCT02792231|12527575|FG001|Overall Study|Adverse Event|11
7969109|NCT02792231|12527574|FG000|Overall Study|Physician Decision|14
7969110|NCT02792231|12527575|FG001|Overall Study|Physician Decision|12
7969111|NCT02792231|12527574|FG000|Overall Study|Lack of Efficacy|7
7969112|NCT02792231|12527575|FG001|Overall Study|Lack of Efficacy|9
7969113|NCT02792231|12527574|FG000|Overall Study|Lost to Follow-up|9
7969114|NCT02792231|12527575|FG001|Overall Study|Lost to Follow-up|5
7969115|NCT02792231|12527574|FG000|Overall Study|Pregnancy|1
7969116|NCT02792231|12527575|FG001|Overall Study|Pregnancy|3
7969117|NCT02792231|12527574|FG000|Overall Study|Non-compliance with study treatment|2
7969118|NCT02792231|12527575|FG001|Overall Study|Non-compliance with study treatment|1
7969119|NCT02792231|12527574|FG000|Overall Study|Protocol deviation|2
7969120|NCT02792231|12527575|FG001|Overall Study|Protocol deviation|0
7969121|NCT02792231|12527574|FG000|Overall Study|Technical problems|0
7969122|NCT02792231|12527575|FG001|Overall Study|Technical problems|1
7969123|NCT02792504|12527581|FG000|Overall Study|Lost to Follow-up|24
7969124|NCT02792504|12527581|FG000|Overall Study|Violated inclusion/exclusion criteria|6
7969125|NCT02792517|12527585|FG000|Overall Study|Withdrawal by Subject|10
7969126|NCT02792517|12527585|FG000|Overall Study|Decision by Sponsor|7
7969127|NCT02792517|12527585|FG000|Overall Study|Lost to Follow-up|3
7969128|NCT02792699|12527592|FG000|Overall Study|Adverse Event|1
7905226|NCT01998906|12418819|FG001|Overall Study|Failure to return|2
7905227|NCT01998906|12418820|FG002|Overall Study|Failure to return|4
7905228|NCT01998906|12418818|FG000|Overall Study|Violation of Selection Criteria|0
7905229|NCT01998906|12418819|FG001|Overall Study|Violation of Selection Criteria|0
7905230|NCT01998906|12418820|FG002|Overall Study|Violation of Selection Criteria|1
7905231|NCT01998906|12418818|FG000|Overall Study|Withdrawal by Subject|1
7905232|NCT01998906|12418819|FG001|Overall Study|Withdrawal by Subject|4
7905233|NCT01998906|12418820|FG002|Overall Study|Withdrawal by Subject|3
7905234|NCT01998906|12418818|FG000|Overall Study|Administrative/Other|2
7905235|NCT01998906|12418819|FG001|Overall Study|Administrative/Other|1
7905236|NCT01998906|12418820|FG002|Overall Study|Administrative/Other|3
7905237|NCT01998906|12418818|FG000|Overall Study|Other|3
7905238|NCT01998906|12418819|FG001|Overall Study|Other|8
7905239|NCT01998906|12418820|FG002|Overall Study|Other|4
7963896|NCT02730871|12518658|FG000|Overall Study|Adverse Event|6
7963897|NCT02730871|12518659|FG001|Overall Study|Adverse Event|0
7963898|NCT02731131|12518689|FG000|Overall Study|Psychiatric Disorder|0
7963899|NCT02731131|12518690|FG001|Overall Study|Psychiatric Disorder|1
7963900|NCT02731131|12518689|FG000|Overall Study|Refused Therapy|0
7963901|NCT02731131|12518690|FG001|Overall Study|Refused Therapy|1
7963902|NCT02731157|12518696|FG000|First Rejuvenated RCE|Withdrawal by Subject|1
7963903|NCT02731638|12518762|FG000|Overall Study|Lost to Follow-up|6
7963904|NCT02731638|12518763|FG001|Overall Study|Lost to Follow-up|9
7963905|NCT02731690|12518769|FG000|Overall Study|Adverse Event|1
7963906|NCT02731690|12518769|FG000|Overall Study|Withdrawal by Subject|3
7963907|NCT02731690|12518769|FG000|Overall Study|Discontinuation of Study by Sponsor|26
7963908|NCT02731729|12518775|FG000|Overall Study|Death|2
7963909|NCT02731729|12518776|FG001|Overall Study|Death|2
7963910|NCT02731729|12518775|FG000|Overall Study|Study terminated by Sponsor|6
7963911|NCT02731729|12518776|FG001|Overall Study|Study terminated by Sponsor|6
7963912|NCT02731729|12518775|FG000|Overall Study|Withdrawal by Subject|1
7963913|NCT02731729|12518776|FG001|Overall Study|Withdrawal by Subject|0
7963914|NCT02731742|12518786|FG000|Overall Study|Death|1
7963915|NCT02731742|12518787|FG001|Overall Study|Death|2
7963916|NCT02731742|12518788|FG002|Overall Study|Death|5
7963917|NCT02731742|12518789|FG003|Overall Study|Death|0
7963918|NCT02731742|12518786|FG000|Overall Study|Physician Decision|0
7963919|NCT02731742|12518787|FG001|Overall Study|Physician Decision|0
7963920|NCT02731742|12518788|FG002|Overall Study|Physician Decision|0
7963921|NCT02731742|12518789|FG003|Overall Study|Physician Decision|1
7963922|NCT02731742|12518786|FG000|Overall Study|Study Terminated by Sponsor|2
7963923|NCT02731742|12518787|FG001|Overall Study|Study Terminated by Sponsor|1
7963924|NCT02731742|12518788|FG002|Overall Study|Study Terminated by Sponsor|1
7969129|NCT02792699|12527593|FG001|Overall Study|Adverse Event|2
7969130|NCT02792699|12527594|FG002|Overall Study|Adverse Event|4
7969131|NCT02792699|12527592|FG000|Overall Study|Withdrawal by Subject|4
7969132|NCT02792699|12527593|FG001|Overall Study|Withdrawal by Subject|4
7969133|NCT02792699|12527594|FG002|Overall Study|Withdrawal by Subject|3
7969134|NCT02792699|12527592|FG000|Overall Study|Lost to Follow-up|0
7969135|NCT02792699|12527593|FG001|Overall Study|Lost to Follow-up|1
7969136|NCT02792699|12527594|FG002|Overall Study|Lost to Follow-up|2
7905240|NCT01998919|12418833|FG000|Overall Study|Death|2
7905241|NCT01998919|12418834|FG001|Overall Study|Death|2
7905242|NCT01998919|12418833|FG000|Overall Study|Adverse Event|0
7905243|NCT01998919|12418834|FG001|Overall Study|Adverse Event|5
7905244|NCT01998919|12418833|FG000|Overall Study|Disease progression|31
7905245|NCT01998919|12418834|FG001|Overall Study|Disease progression|22
7905246|NCT01998919|12418833|FG000|Overall Study|Withdrawal by Subject|2
7905247|NCT01998919|12418834|FG001|Overall Study|Withdrawal by Subject|4
7905248|NCT01998919|12418833|FG000|Overall Study|Lost to Follow-up|2
7905249|NCT01998919|12418834|FG001|Overall Study|Lost to Follow-up|0
7905250|NCT01998919|12418833|FG000|Overall Study|Other|5
7905251|NCT01998919|12418834|FG001|Overall Study|Other|2
7905252|NCT01998958|12418847|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905253|NCT01998958|12418848|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1
7905254|NCT01998958|12418849|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905255|NCT01998958|12418850|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905256|NCT01998958|12418851|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905257|NCT01998958|12418852|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905258|NCT01998958|12418853|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905259|NCT01998958|12418854|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905260|NCT01998958|12418855|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905261|NCT01998958|12418856|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905262|NCT01998958|12418857|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905263|NCT01998958|12418858|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905264|NCT01998958|12418859|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905265|NCT01998958|12418860|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905266|NCT01998958|12418861|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905267|NCT01998958|12418862|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905268|NCT01998958|12418863|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905269|NCT01998958|12418864|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905270|NCT01998958|12418865|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905271|NCT01998958|12418866|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905272|NCT01998958|12418867|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905273|NCT01998958|12418868|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905274|NCT01998958|12418869|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905275|NCT01998958|12418870|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905276|NCT01998958|12418871|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905277|NCT01998958|12418872|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905278|NCT01998958|12418873|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905279|NCT01998958|12418874|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905280|NCT01998958|12418875|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905281|NCT01998958|12418876|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905282|NCT01998958|12418877|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905283|NCT01998958|12418878|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0
7905284|NCT01998958|12418847|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0
7905285|NCT01998958|12418848|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1
7905286|NCT01998958|12418849|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0
7905287|NCT01998958|12418850|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0
7905288|NCT01998958|12418851|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0
7905289|NCT01998958|12418852|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0
7905290|NCT01998958|12418853|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0
7905291|NCT01998958|12418854|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0
7905292|NCT01998958|12418855|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0
7905293|NCT01998958|12418856|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0
7905294|NCT01998958|12418857|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0
7905295|NCT01998958|12418858|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0
7905296|NCT01998958|12418859|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0
7905297|NCT01998958|12418860|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0
7905298|NCT01998958|12418861|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0
7905299|NCT01998958|12418862|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0
7905300|NCT01998958|12418863|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0
7905301|NCT01998958|12418864|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0
7905302|NCT01998958|12418865|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0
7905303|NCT01998958|12418866|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0
7905304|NCT01998958|12418867|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0
7905305|NCT01998958|12418868|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0
7905306|NCT01998958|12418869|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0
7905307|NCT01998958|12418870|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0
7905308|NCT01998958|12418871|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0
7905309|NCT01998958|12418872|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0
7905310|NCT01998958|12418873|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0
7905311|NCT01998958|12418874|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0
7905312|NCT01998958|12418875|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0
7905313|NCT01998958|12418876|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0
7905314|NCT01998958|12418877|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0
7905315|NCT01998958|12418878|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0
7905316|NCT01998958|12418847|FG000|Period 1 (Panel A and B)|Adverse Event|0
7905317|NCT01998958|12418848|FG001|Period 1 (Panel A and B)|Adverse Event|1
7905318|NCT01998958|12418849|FG002|Period 1 (Panel A and B)|Adverse Event|0
7905319|NCT01998958|12418850|FG003|Period 1 (Panel A and B)|Adverse Event|0
7905320|NCT01998958|12418851|FG004|Period 1 (Panel A and B)|Adverse Event|0
7905321|NCT01998958|12418852|FG005|Period 1 (Panel A and B)|Adverse Event|0
7905322|NCT01998958|12418853|FG006|Period 1 (Panel A and B)|Adverse Event|0
7905323|NCT01998958|12418854|FG007|Period 1 (Panel A and B)|Adverse Event|0
7905324|NCT01998958|12418855|FG008|Period 1 (Panel A and B)|Adverse Event|0
7905325|NCT01998958|12418856|FG009|Period 1 (Panel A and B)|Adverse Event|0
7905326|NCT01998958|12418857|FG010|Period 1 (Panel A and B)|Adverse Event|0
7905327|NCT01998958|12418858|FG011|Period 1 (Panel A and B)|Adverse Event|0
7905328|NCT01998958|12418859|FG012|Period 1 (Panel A and B)|Adverse Event|0
7905329|NCT01998958|12418860|FG013|Period 1 (Panel A and B)|Adverse Event|0
7905330|NCT01998958|12418861|FG014|Period 1 (Panel A and B)|Adverse Event|0
7905331|NCT01998958|12418862|FG015|Period 1 (Panel A and B)|Adverse Event|0
7905332|NCT01998958|12418863|FG016|Period 1 (Panel A and B)|Adverse Event|0
7905333|NCT01998958|12418864|FG017|Period 1 (Panel A and B)|Adverse Event|0
7905334|NCT01998958|12418865|FG018|Period 1 (Panel A and B)|Adverse Event|0
7905335|NCT01998958|12418866|FG019|Period 1 (Panel A and B)|Adverse Event|0
7905336|NCT01998958|12418867|FG020|Period 1 (Panel A and B)|Adverse Event|0
7905337|NCT01998958|12418868|FG021|Period 1 (Panel A and B)|Adverse Event|0
7905338|NCT01998958|12418869|FG022|Period 1 (Panel A and B)|Adverse Event|0
7905339|NCT01998958|12418870|FG023|Period 1 (Panel A and B)|Adverse Event|0
7905340|NCT01998958|12418871|FG024|Period 1 (Panel A and B)|Adverse Event|0
7905341|NCT01998958|12418872|FG025|Period 1 (Panel A and B)|Adverse Event|0
7905342|NCT01998958|12418873|FG026|Period 1 (Panel A and B)|Adverse Event|0
7905343|NCT01998958|12418874|FG027|Period 1 (Panel A and B)|Adverse Event|0
7905344|NCT01998958|12418875|FG028|Period 1 (Panel A and B)|Adverse Event|0
7905345|NCT01998958|12418876|FG029|Period 1 (Panel A and B)|Adverse Event|0
7905346|NCT01998958|12418877|FG030|Period 1 (Panel A and B)|Adverse Event|0
7905347|NCT01998958|12418878|FG031|Period 1 (Panel A and B)|Adverse Event|0
7905348|NCT01998958|12418847|FG000|Period 1 (Panel A and B)|Other|1
7905349|NCT01998958|12418848|FG001|Period 1 (Panel A and B)|Other|0
7905350|NCT01998958|12418849|FG002|Period 1 (Panel A and B)|Other|0
7905351|NCT01998958|12418850|FG003|Period 1 (Panel A and B)|Other|0
7905352|NCT01998958|12418851|FG004|Period 1 (Panel A and B)|Other|0
7905353|NCT01998958|12418852|FG005|Period 1 (Panel A and B)|Other|0
7905354|NCT01998958|12418853|FG006|Period 1 (Panel A and B)|Other|0
7905355|NCT01998958|12418854|FG007|Period 1 (Panel A and B)|Other|0
7905356|NCT01998958|12418855|FG008|Period 1 (Panel A and B)|Other|0
7905357|NCT01998958|12418856|FG009|Period 1 (Panel A and B)|Other|0
7905358|NCT01998958|12418857|FG010|Period 1 (Panel A and B)|Other|0
7905359|NCT01998958|12418858|FG011|Period 1 (Panel A and B)|Other|0
7905360|NCT01998958|12418859|FG012|Period 1 (Panel A and B)|Other|0
7905361|NCT01998958|12418860|FG013|Period 1 (Panel A and B)|Other|0
7905362|NCT01998958|12418861|FG014|Period 1 (Panel A and B)|Other|0
7905363|NCT01998958|12418862|FG015|Period 1 (Panel A and B)|Other|0
7905364|NCT01998958|12418863|FG016|Period 1 (Panel A and B)|Other|0
7905365|NCT01998958|12418864|FG017|Period 1 (Panel A and B)|Other|0
7905366|NCT01998958|12418865|FG018|Period 1 (Panel A and B)|Other|0
7905367|NCT01998958|12418866|FG019|Period 1 (Panel A and B)|Other|0
7905368|NCT01998958|12418867|FG020|Period 1 (Panel A and B)|Other|0
7905369|NCT01998958|12418868|FG021|Period 1 (Panel A and B)|Other|0
7905370|NCT01998958|12418869|FG022|Period 1 (Panel A and B)|Other|0
7905371|NCT01998958|12418870|FG023|Period 1 (Panel A and B)|Other|0
7905372|NCT01998958|12418871|FG024|Period 1 (Panel A and B)|Other|0
7905373|NCT01998958|12418872|FG025|Period 1 (Panel A and B)|Other|0
7905374|NCT01998958|12418873|FG026|Period 1 (Panel A and B)|Other|0
7905375|NCT01998958|12418874|FG027|Period 1 (Panel A and B)|Other|0
7905376|NCT01998958|12418875|FG028|Period 1 (Panel A and B)|Other|0
7905377|NCT01998958|12418876|FG029|Period 1 (Panel A and B)|Other|0
7905378|NCT01998958|12418877|FG030|Period 1 (Panel A and B)|Other|0
7905379|NCT01998958|12418878|FG031|Period 1 (Panel A and B)|Other|0
7905380|NCT01998958|12418847|FG000|Period 2 (Panel A and B)|Adverse Event|0
7905381|NCT01998958|12418848|FG001|Period 2 (Panel A and B)|Adverse Event|0
7905382|NCT01998958|12418849|FG002|Period 2 (Panel A and B)|Adverse Event|0
7905383|NCT01998958|12418850|FG003|Period 2 (Panel A and B)|Adverse Event|0
7905384|NCT01998958|12418851|FG004|Period 2 (Panel A and B)|Adverse Event|0
7905385|NCT01998958|12418852|FG005|Period 2 (Panel A and B)|Adverse Event|0
7905386|NCT01998958|12418853|FG006|Period 2 (Panel A and B)|Adverse Event|0
7905387|NCT01998958|12418854|FG007|Period 2 (Panel A and B)|Adverse Event|0
7905388|NCT01998958|12418855|FG008|Period 2 (Panel A and B)|Adverse Event|0
7905389|NCT01998958|12418856|FG009|Period 2 (Panel A and B)|Adverse Event|0
7905390|NCT01998958|12418857|FG010|Period 2 (Panel A and B)|Adverse Event|1
7905391|NCT01998958|12418858|FG011|Period 2 (Panel A and B)|Adverse Event|0
7905392|NCT01998958|12418859|FG012|Period 2 (Panel A and B)|Adverse Event|0
7905393|NCT01998958|12418860|FG013|Period 2 (Panel A and B)|Adverse Event|0
7905394|NCT01998958|12418861|FG014|Period 2 (Panel A and B)|Adverse Event|1
7905395|NCT01998958|12418862|FG015|Period 2 (Panel A and B)|Adverse Event|0
7905396|NCT01998958|12418863|FG016|Period 2 (Panel A and B)|Adverse Event|0
7905397|NCT01998958|12418864|FG017|Period 2 (Panel A and B)|Adverse Event|0
7905398|NCT01998958|12418865|FG018|Period 2 (Panel A and B)|Adverse Event|0
7905399|NCT01998958|12418866|FG019|Period 2 (Panel A and B)|Adverse Event|0
7905400|NCT01998958|12418867|FG020|Period 2 (Panel A and B)|Adverse Event|0
7905401|NCT01998958|12418868|FG021|Period 2 (Panel A and B)|Adverse Event|0
7905402|NCT01998958|12418869|FG022|Period 2 (Panel A and B)|Adverse Event|0
7905403|NCT01998958|12418870|FG023|Period 2 (Panel A and B)|Adverse Event|0
7905404|NCT01998958|12418871|FG024|Period 2 (Panel A and B)|Adverse Event|0
7905405|NCT01998958|12418872|FG025|Period 2 (Panel A and B)|Adverse Event|0
7905406|NCT01998958|12418873|FG026|Period 2 (Panel A and B)|Adverse Event|0
7905407|NCT01998958|12418874|FG027|Period 2 (Panel A and B)|Adverse Event|0
7905408|NCT01998958|12418875|FG028|Period 2 (Panel A and B)|Adverse Event|0
7905409|NCT01998958|12418876|FG029|Period 2 (Panel A and B)|Adverse Event|0
7905410|NCT01998958|12418877|FG030|Period 2 (Panel A and B)|Adverse Event|0
7905411|NCT01998958|12418878|FG031|Period 2 (Panel A and B)|Adverse Event|0
7905412|NCT01998958|12418847|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905413|NCT01998958|12418848|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905414|NCT01998958|12418849|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905415|NCT01998958|12418850|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905416|NCT01998958|12418851|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905417|NCT01998958|12418852|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905418|NCT01998958|12418853|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905419|NCT01998958|12418854|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905420|NCT01998958|12418855|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905421|NCT01998958|12418856|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905422|NCT01998958|12418857|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905423|NCT01998958|12418858|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905424|NCT01998958|12418859|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905425|NCT01998958|12418860|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905426|NCT01998958|12418861|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1
7905427|NCT01998958|12418862|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905428|NCT01998958|12418863|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905429|NCT01998958|12418864|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905430|NCT01998958|12418865|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1
7905431|NCT01998958|12418866|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905432|NCT01998958|12418867|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905433|NCT01998958|12418868|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905434|NCT01998958|12418869|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905435|NCT01998958|12418870|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905436|NCT01998958|12418871|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905437|NCT01998958|12418872|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905438|NCT01998958|12418873|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905439|NCT01998958|12418874|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905440|NCT01998958|12418875|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905441|NCT01998958|12418876|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905442|NCT01998958|12418877|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905443|NCT01998958|12418878|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0
7905444|NCT01998958|12418847|FG000|Open Label Phase (Optional)|Adverse Event|0
7905445|NCT01998958|12418848|FG001|Open Label Phase (Optional)|Adverse Event|0
7905446|NCT01998958|12418849|FG002|Open Label Phase (Optional)|Adverse Event|0
7905447|NCT01998958|12418850|FG003|Open Label Phase (Optional)|Adverse Event|0
7905448|NCT01998958|12418851|FG004|Open Label Phase (Optional)|Adverse Event|0
7905449|NCT01998958|12418852|FG005|Open Label Phase (Optional)|Adverse Event|0
7905450|NCT01998958|12418853|FG006|Open Label Phase (Optional)|Adverse Event|0
7905451|NCT01998958|12418854|FG007|Open Label Phase (Optional)|Adverse Event|0
7905452|NCT01998958|12418855|FG008|Open Label Phase (Optional)|Adverse Event|0
7905453|NCT01998958|12418856|FG009|Open Label Phase (Optional)|Adverse Event|0
7905454|NCT01998958|12418857|FG010|Open Label Phase (Optional)|Adverse Event|0
7905455|NCT01998958|12418858|FG011|Open Label Phase (Optional)|Adverse Event|0
7905456|NCT01998958|12418859|FG012|Open Label Phase (Optional)|Adverse Event|0
7905457|NCT01998958|12418860|FG013|Open Label Phase (Optional)|Adverse Event|0
7905458|NCT01998958|12418861|FG014|Open Label Phase (Optional)|Adverse Event|0
7905459|NCT01998958|12418862|FG015|Open Label Phase (Optional)|Adverse Event|0
7905460|NCT01998958|12418863|FG016|Open Label Phase (Optional)|Adverse Event|0
7905461|NCT01998958|12418864|FG017|Open Label Phase (Optional)|Adverse Event|0
7905462|NCT01998958|12418865|FG018|Open Label Phase (Optional)|Adverse Event|0
7905463|NCT01998958|12418866|FG019|Open Label Phase (Optional)|Adverse Event|0
7905464|NCT01998958|12418867|FG020|Open Label Phase (Optional)|Adverse Event|0
7905465|NCT01998958|12418868|FG021|Open Label Phase (Optional)|Adverse Event|0
7905466|NCT01998958|12418869|FG022|Open Label Phase (Optional)|Adverse Event|0
7905467|NCT01998958|12418870|FG023|Open Label Phase (Optional)|Adverse Event|1
7905468|NCT01998958|12418871|FG024|Open Label Phase (Optional)|Adverse Event|0
7905469|NCT01998958|12418872|FG025|Open Label Phase (Optional)|Adverse Event|0
7905470|NCT01998958|12418873|FG026|Open Label Phase (Optional)|Adverse Event|0
7905471|NCT01998958|12418874|FG027|Open Label Phase (Optional)|Adverse Event|0
7905472|NCT01998958|12418875|FG028|Open Label Phase (Optional)|Adverse Event|0
7905473|NCT01998958|12418876|FG029|Open Label Phase (Optional)|Adverse Event|0
7905474|NCT01998958|12418877|FG030|Open Label Phase (Optional)|Adverse Event|0
7905475|NCT01998958|12418878|FG031|Open Label Phase (Optional)|Adverse Event|0
7905476|NCT01998958|12418847|FG000|Open Label Phase (Optional)|Other|0
7905477|NCT01998958|12418848|FG001|Open Label Phase (Optional)|Other|0
7905478|NCT01998958|12418849|FG002|Open Label Phase (Optional)|Other|0
7905479|NCT01998958|12418850|FG003|Open Label Phase (Optional)|Other|0
7905480|NCT01998958|12418851|FG004|Open Label Phase (Optional)|Other|0
7905481|NCT01998958|12418852|FG005|Open Label Phase (Optional)|Other|0
7905482|NCT01998958|12418853|FG006|Open Label Phase (Optional)|Other|0
7905483|NCT01998958|12418854|FG007|Open Label Phase (Optional)|Other|0
7905484|NCT01998958|12418855|FG008|Open Label Phase (Optional)|Other|0
7905485|NCT01998958|12418856|FG009|Open Label Phase (Optional)|Other|0
7905486|NCT01998958|12418857|FG010|Open Label Phase (Optional)|Other|0
7905487|NCT01998958|12418858|FG011|Open Label Phase (Optional)|Other|0
7905488|NCT01998958|12418859|FG012|Open Label Phase (Optional)|Other|0
7905489|NCT01998958|12418860|FG013|Open Label Phase (Optional)|Other|0
7905490|NCT01998958|12418861|FG014|Open Label Phase (Optional)|Other|0
7905491|NCT01998958|12418862|FG015|Open Label Phase (Optional)|Other|0
7905492|NCT01998958|12418863|FG016|Open Label Phase (Optional)|Other|0
7905493|NCT01998958|12418864|FG017|Open Label Phase (Optional)|Other|0
7905494|NCT01998958|12418865|FG018|Open Label Phase (Optional)|Other|0
7905495|NCT01998958|12418866|FG019|Open Label Phase (Optional)|Other|0
7905496|NCT01998958|12418867|FG020|Open Label Phase (Optional)|Other|0
7905497|NCT01998958|12418868|FG021|Open Label Phase (Optional)|Other|0
7905498|NCT01998958|12418869|FG022|Open Label Phase (Optional)|Other|5
7905499|NCT01998958|12418870|FG023|Open Label Phase (Optional)|Other|1
7905500|NCT01998958|12418871|FG024|Open Label Phase (Optional)|Other|0
7905501|NCT01998958|12418872|FG025|Open Label Phase (Optional)|Other|0
7905502|NCT01998958|12418873|FG026|Open Label Phase (Optional)|Other|0
7905503|NCT01998958|12418874|FG027|Open Label Phase (Optional)|Other|0
7905504|NCT01998958|12418875|FG028|Open Label Phase (Optional)|Other|0
7905505|NCT01998958|12418876|FG029|Open Label Phase (Optional)|Other|0
7905506|NCT01998958|12418877|FG030|Open Label Phase (Optional)|Other|0
7905507|NCT01998958|12418878|FG031|Open Label Phase (Optional)|Other|0
7905508|NCT01998958|12418847|FG000|Open Label Phase (Optional)|Lost to Follow-up|0
7905509|NCT01998958|12418848|FG001|Open Label Phase (Optional)|Lost to Follow-up|0
7905510|NCT01998958|12418849|FG002|Open Label Phase (Optional)|Lost to Follow-up|0
7905511|NCT01998958|12418850|FG003|Open Label Phase (Optional)|Lost to Follow-up|0
7905512|NCT01998958|12418851|FG004|Open Label Phase (Optional)|Lost to Follow-up|0
7905513|NCT01998958|12418852|FG005|Open Label Phase (Optional)|Lost to Follow-up|0
7905514|NCT01998958|12418853|FG006|Open Label Phase (Optional)|Lost to Follow-up|0
7905515|NCT01998958|12418854|FG007|Open Label Phase (Optional)|Lost to Follow-up|0
7905516|NCT01998958|12418855|FG008|Open Label Phase (Optional)|Lost to Follow-up|0
7905517|NCT01998958|12418856|FG009|Open Label Phase (Optional)|Lost to Follow-up|0
7905518|NCT01998958|12418857|FG010|Open Label Phase (Optional)|Lost to Follow-up|0
7905519|NCT01998958|12418858|FG011|Open Label Phase (Optional)|Lost to Follow-up|0
7905520|NCT01998958|12418859|FG012|Open Label Phase (Optional)|Lost to Follow-up|0
7905521|NCT01998958|12418860|FG013|Open Label Phase (Optional)|Lost to Follow-up|0
7905522|NCT01998958|12418861|FG014|Open Label Phase (Optional)|Lost to Follow-up|0
7905523|NCT01998958|12418862|FG015|Open Label Phase (Optional)|Lost to Follow-up|0
7905524|NCT01998958|12418863|FG016|Open Label Phase (Optional)|Lost to Follow-up|0
7905525|NCT01998958|12418864|FG017|Open Label Phase (Optional)|Lost to Follow-up|0
7905526|NCT01998958|12418865|FG018|Open Label Phase (Optional)|Lost to Follow-up|0
7905527|NCT01998958|12418866|FG019|Open Label Phase (Optional)|Lost to Follow-up|0
7905528|NCT01998958|12418867|FG020|Open Label Phase (Optional)|Lost to Follow-up|0
7905529|NCT01998958|12418868|FG021|Open Label Phase (Optional)|Lost to Follow-up|0
7905530|NCT01998958|12418869|FG022|Open Label Phase (Optional)|Lost to Follow-up|1
7905531|NCT01998958|12418870|FG023|Open Label Phase (Optional)|Lost to Follow-up|0
7905532|NCT01998958|12418871|FG024|Open Label Phase (Optional)|Lost to Follow-up|0
7905533|NCT01998958|12418872|FG025|Open Label Phase (Optional)|Lost to Follow-up|0
7905534|NCT01998958|12418873|FG026|Open Label Phase (Optional)|Lost to Follow-up|0
7905535|NCT01998958|12418874|FG027|Open Label Phase (Optional)|Lost to Follow-up|0
7905536|NCT01998958|12418875|FG028|Open Label Phase (Optional)|Lost to Follow-up|0
7905537|NCT01998958|12418876|FG029|Open Label Phase (Optional)|Lost to Follow-up|0
7905538|NCT01998958|12418877|FG030|Open Label Phase (Optional)|Lost to Follow-up|0
7905539|NCT01998958|12418878|FG031|Open Label Phase (Optional)|Lost to Follow-up|0
7905540|NCT01998958|12418847|FG000|Open Label Phase (Optional)|Lack of Efficacy|0
7905541|NCT01998958|12418848|FG001|Open Label Phase (Optional)|Lack of Efficacy|0
7905542|NCT01998958|12418849|FG002|Open Label Phase (Optional)|Lack of Efficacy|0
7905543|NCT01998958|12418850|FG003|Open Label Phase (Optional)|Lack of Efficacy|0
7905544|NCT01998958|12418851|FG004|Open Label Phase (Optional)|Lack of Efficacy|0
7905545|NCT01998958|12418852|FG005|Open Label Phase (Optional)|Lack of Efficacy|0
7905546|NCT01998958|12418853|FG006|Open Label Phase (Optional)|Lack of Efficacy|0
7905547|NCT01998958|12418854|FG007|Open Label Phase (Optional)|Lack of Efficacy|0
7905548|NCT01998958|12418855|FG008|Open Label Phase (Optional)|Lack of Efficacy|0
7905549|NCT01998958|12418856|FG009|Open Label Phase (Optional)|Lack of Efficacy|0
7905550|NCT01998958|12418857|FG010|Open Label Phase (Optional)|Lack of Efficacy|0
7905551|NCT01998958|12418858|FG011|Open Label Phase (Optional)|Lack of Efficacy|0
7905552|NCT01998958|12418859|FG012|Open Label Phase (Optional)|Lack of Efficacy|0
7905553|NCT01998958|12418860|FG013|Open Label Phase (Optional)|Lack of Efficacy|0
7905554|NCT01998958|12418861|FG014|Open Label Phase (Optional)|Lack of Efficacy|0
7905555|NCT01998958|12418862|FG015|Open Label Phase (Optional)|Lack of Efficacy|0
7905556|NCT01998958|12418863|FG016|Open Label Phase (Optional)|Lack of Efficacy|0
7905557|NCT01998958|12418864|FG017|Open Label Phase (Optional)|Lack of Efficacy|0
7905558|NCT01998958|12418865|FG018|Open Label Phase (Optional)|Lack of Efficacy|0
7905559|NCT01998958|12418866|FG019|Open Label Phase (Optional)|Lack of Efficacy|0
7905560|NCT01998958|12418867|FG020|Open Label Phase (Optional)|Lack of Efficacy|0
7905561|NCT01998958|12418868|FG021|Open Label Phase (Optional)|Lack of Efficacy|1
7905562|NCT01998958|12418869|FG022|Open Label Phase (Optional)|Lack of Efficacy|2
7905563|NCT01998958|12418870|FG023|Open Label Phase (Optional)|Lack of Efficacy|0
7905564|NCT01998958|12418871|FG024|Open Label Phase (Optional)|Lack of Efficacy|0
7905565|NCT01998958|12418872|FG025|Open Label Phase (Optional)|Lack of Efficacy|0
7905566|NCT01998958|12418873|FG026|Open Label Phase (Optional)|Lack of Efficacy|0
7905567|NCT01998958|12418874|FG027|Open Label Phase (Optional)|Lack of Efficacy|0
7905568|NCT01998958|12418875|FG028|Open Label Phase (Optional)|Lack of Efficacy|0
7905569|NCT01998958|12418876|FG029|Open Label Phase (Optional)|Lack of Efficacy|0
7905570|NCT01998958|12418877|FG030|Open Label Phase (Optional)|Lack of Efficacy|0
7905571|NCT01998958|12418878|FG031|Open Label Phase (Optional)|Lack of Efficacy|0
7905572|NCT01998958|12418847|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0
7905573|NCT01998958|12418848|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0
7905574|NCT01998958|12418849|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0
7905575|NCT01998958|12418850|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0
7905576|NCT01998958|12418851|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0
7905577|NCT01998958|12418852|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0
7905578|NCT01998958|12418853|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0
7905579|NCT01998958|12418854|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0
7905580|NCT01998958|12418855|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0
7905581|NCT01998958|12418856|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0
7905582|NCT01998958|12418857|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0
7905583|NCT01998958|12418858|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0
7905584|NCT01998958|12418859|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0
7905585|NCT01998958|12418860|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0
7905586|NCT01998958|12418861|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0
7905587|NCT01998958|12418862|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0
7905588|NCT01998958|12418863|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0
7905589|NCT01998958|12418864|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0
7905590|NCT01998958|12418865|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0
7905591|NCT01998958|12418866|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0
7905592|NCT01998958|12418867|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0
7905593|NCT01998958|12418868|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2
7905594|NCT01998958|12418869|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1
7905595|NCT01998958|12418870|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2
7905596|NCT01998958|12418871|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0
7905597|NCT01998958|12418872|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0
7905598|NCT01998958|12418873|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0
7905599|NCT01998958|12418874|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0
7905600|NCT01998958|12418875|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0
7905601|NCT01998958|12418876|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0
7905602|NCT01998958|12418877|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0
7905603|NCT01998958|12418878|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0
7905604|NCT01998984|12418932|FG000|Overall Study|Adverse Event|0
7905605|NCT01998984|12418933|FG001|Overall Study|Adverse Event|0
7905606|NCT01998984|12418934|FG002|Overall Study|Adverse Event|0
7905607|NCT01998984|12418935|FG003|Overall Study|Adverse Event|1
7905608|NCT01998984|12418932|FG000|Overall Study|Lost to Follow-up|0
7905609|NCT01998984|12418933|FG001|Overall Study|Lost to Follow-up|1
7905610|NCT01998984|12418934|FG002|Overall Study|Lost to Follow-up|0
7905611|NCT01998984|12418935|FG003|Overall Study|Lost to Follow-up|1
7905612|NCT01998984|12418932|FG000|Overall Study|Withdrawal by Subject|0
7905613|NCT01998984|12418933|FG001|Overall Study|Withdrawal by Subject|0
7905614|NCT01998984|12418934|FG002|Overall Study|Withdrawal by Subject|1
7905615|NCT01998984|12418935|FG003|Overall Study|Withdrawal by Subject|0
7905616|NCT01998984|12418932|FG000|Overall Study|Other|0
7905617|NCT01998984|12418933|FG001|Overall Study|Other|0
7905618|NCT01998984|12418934|FG002|Overall Study|Other|0
7905619|NCT01998984|12418935|FG003|Overall Study|Other|1
7905620|NCT01999114|12418950|FG000|Overall Study|Adverse Event|8
7905621|NCT01999114|12418951|FG001|Overall Study|Adverse Event|7
7905622|NCT01999114|12418952|FG002|Overall Study|Adverse Event|2
7905623|NCT01999114|12418953|FG003|Overall Study|Adverse Event|2
7905624|NCT01999114|12418954|FG004|Overall Study|Adverse Event|1
7905625|NCT01999114|12418950|FG000|Overall Study|Withdrawal by Subject|0
7905626|NCT01999114|12418951|FG001|Overall Study|Withdrawal by Subject|0
7905627|NCT01999114|12418952|FG002|Overall Study|Withdrawal by Subject|1
7905628|NCT01999114|12418953|FG003|Overall Study|Withdrawal by Subject|0
7905629|NCT01999114|12418954|FG004|Overall Study|Withdrawal by Subject|1
7905630|NCT01999114|12418950|FG000|Overall Study|Lost to Follow-up|0
7905631|NCT01999114|12418951|FG001|Overall Study|Lost to Follow-up|0
7905632|NCT01999114|12418952|FG002|Overall Study|Lost to Follow-up|1
7905633|NCT01999114|12418953|FG003|Overall Study|Lost to Follow-up|0
7905634|NCT01999114|12418954|FG004|Overall Study|Lost to Follow-up|0
7905635|NCT01999114|12418950|FG000|Overall Study|Administrative|0
7905636|NCT01999114|12418951|FG001|Overall Study|Administrative|0
7905637|NCT01999114|12418952|FG002|Overall Study|Administrative|1
7905638|NCT01999114|12418953|FG003|Overall Study|Administrative|1
7905639|NCT01999114|12418954|FG004|Overall Study|Administrative|2
7905640|NCT01999218|12419000|FG000|Overall Study|Hyperglycemia|18
7905641|NCT01999218|12419001|FG001|Overall Study|Hyperglycemia|17
7905642|NCT01999218|12419002|FG002|Overall Study|Hyperglycemia|17
7905643|NCT01999218|12419000|FG000|Overall Study|Lack of Efficacy|1
7905644|NCT01999218|12419001|FG001|Overall Study|Lack of Efficacy|0
7905645|NCT01999218|12419002|FG002|Overall Study|Lack of Efficacy|1
7905646|NCT01999218|12419000|FG000|Overall Study|Lost to Follow-up|22
7905647|NCT01999218|12419001|FG001|Overall Study|Lost to Follow-up|17
7905648|NCT01999218|12419002|FG002|Overall Study|Lost to Follow-up|18
7905649|NCT01999218|12419000|FG000|Overall Study|Non-Compliance With Study Drug|6
7905650|NCT01999218|12419001|FG001|Overall Study|Non-Compliance With Study Drug|4
7905651|NCT01999218|12419002|FG002|Overall Study|Non-Compliance With Study Drug|1
7905652|NCT01999218|12419000|FG000|Overall Study|Physician Decision|1
7905653|NCT01999218|12419001|FG001|Overall Study|Physician Decision|4
7905654|NCT01999218|12419002|FG002|Overall Study|Physician Decision|6
7905655|NCT01999218|12419000|FG000|Overall Study|Protocol Violation|4
7905656|NCT01999218|12419001|FG001|Overall Study|Protocol Violation|5
7905657|NCT01999218|12419002|FG002|Overall Study|Protocol Violation|4
7905658|NCT01999218|12419000|FG000|Overall Study|Screen failure|0
7905659|NCT01999218|12419001|FG001|Overall Study|Screen failure|1
7905660|NCT01999218|12419002|FG002|Overall Study|Screen failure|0
7905661|NCT01999218|12419000|FG000|Overall Study|Study Terminated By Sponsor|7
7905662|NCT01999218|12419001|FG001|Overall Study|Study Terminated By Sponsor|5
7905663|NCT01999218|12419002|FG002|Overall Study|Study Terminated By Sponsor|12
7905664|NCT01999218|12419000|FG000|Overall Study|Participant moves|2
7905665|NCT01999218|12419001|FG001|Overall Study|Participant moves|5
7905666|NCT01999218|12419002|FG002|Overall Study|Participant moves|3
7905667|NCT01999218|12419000|FG000|Overall Study|Withdrawal by Subject|28
7905668|NCT01999218|12419001|FG001|Overall Study|Withdrawal by Subject|29
7905669|NCT01999218|12419002|FG002|Overall Study|Withdrawal by Subject|34
7905670|NCT01999218|12419000|FG000|Overall Study|Creatinine/eGFR|0
7905671|NCT01999218|12419001|FG001|Overall Study|Creatinine/eGFR|0
7905672|NCT01999218|12419002|FG002|Overall Study|Creatinine/eGFR|1
7905673|NCT01999218|12419000|FG000|Overall Study|Death|7
7905674|NCT01999218|12419001|FG001|Overall Study|Death|1
7905675|NCT01999218|12419002|FG002|Overall Study|Death|2
7905676|NCT01999218|12419000|FG000|Overall Study|Excluded Medication|1
7905677|NCT01999218|12419001|FG001|Overall Study|Excluded Medication|1
7905678|NCT01999218|12419002|FG002|Overall Study|Excluded Medication|2
7905679|NCT01999218|12419000|FG000|Overall Study|Adverse Event|9
7905680|NCT01999218|12419001|FG001|Overall Study|Adverse Event|7
7905681|NCT01999218|12419002|FG002|Overall Study|Adverse Event|7
7905682|NCT01999218|12419000|FG000|Overall Study|Treated but excluded at 1 trial site|3
7905683|NCT01999218|12419001|FG001|Overall Study|Treated but excluded at 1 trial site|5
7905684|NCT01999218|12419002|FG002|Overall Study|Treated but excluded at 1 trial site|2
7905685|NCT01999322|12419031|FG000|Overall Study|Adverse Event|1
7905686|NCT01999322|12419032|FG001|Overall Study|Adverse Event|0
7905687|NCT01999335|12419043|FG000|Overall Study|Discontinued before receiving treatment|0
7905688|NCT01999335|12419044|FG001|Overall Study|Discontinued before receiving treatment|0
7905689|NCT01999335|12419045|FG002|Overall Study|Discontinued before receiving treatment|0
7905690|NCT01999335|12419046|FG003|Overall Study|Discontinued before receiving treatment|0
7905691|NCT01999335|12419047|FG004|Overall Study|Discontinued before receiving treatment|2
7905692|NCT01999465|12419083|FG000|Overall Study|Lost to Follow-up|0
7905693|NCT01999465|12419084|FG001|Overall Study|Lost to Follow-up|2
7905694|NCT01999465|12419083|FG000|Overall Study|Protocol Violation|0
7905695|NCT01999465|12419084|FG001|Overall Study|Protocol Violation|1
7905696|NCT01999868|12419115|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
7905697|NCT01999868|12419116|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
7905698|NCT01999868|12419117|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5
7905699|NCT01999868|12419115|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
7905700|NCT01999868|12419116|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
7905701|NCT01999868|12419117|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0
7905702|NCT01999868|12419115|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3
7905703|NCT01999868|12419116|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4
7905704|NCT01999868|12419117|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0
7905705|NCT01999868|12419115|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
7905706|NCT01999868|12419116|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1
7905707|NCT01999868|12419117|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
7905708|NCT01999868|12419115|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
7905709|NCT01999868|12419116|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2
7905710|NCT01999868|12419117|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
7905711|NCT01999868|12419115|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1
7905712|NCT01999868|12419116|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2
7905713|NCT01999868|12419117|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0
7905714|NCT01999868|12419115|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8
7905715|NCT01999868|12419116|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1
7905716|NCT01999868|12419117|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0
7905717|NCT01999868|12419115|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1
7905718|NCT01999868|12419116|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
7905719|NCT01999868|12419117|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
7905720|NCT01999868|12419115|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4
7905721|NCT01999868|12419116|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
7905722|NCT01999868|12419117|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
7905723|NCT01999868|12419115|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
7905724|NCT01999868|12419116|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1
7905725|NCT01999868|12419117|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
7905726|NCT01999868|12419115|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
7905727|NCT01999868|12419116|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1
7905728|NCT01999868|12419117|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
7905729|NCT01999868|12419115|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1
7905730|NCT01999868|12419116|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2
7905731|NCT01999868|12419117|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0
7905732|NCT01999868|12419115|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10
7905733|NCT01999868|12419116|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19
7905734|NCT01999868|12419117|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0
7905735|NCT01999868|12419115|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
7905736|NCT01999868|12419116|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2
7905737|NCT01999868|12419117|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
7905738|NCT01999868|12419115|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12
7905739|NCT01999868|12419116|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4
7905740|NCT01999868|12419117|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0
7905741|NCT01999894|12419125|FG000|Overall Study|Adverse Event|9
7905742|NCT01999894|12419125|FG000|Overall Study|Lack of Efficacy|5
7905743|NCT01999894|12419125|FG000|Overall Study|Protocol Violation|1
7905744|NCT01999894|12419125|FG000|Overall Study|Withdrawal by Subject|7
7905745|NCT01999894|12419125|FG000|Overall Study|Lost to Follow-up|10
7905746|NCT01999894|12419125|FG000|Overall Study|Other Reason|3
7905747|NCT01999894|12419125|FG000|Overall Study|Inclusion/exclusion criteria not met|1
7905748|NCT01999946|12419142|FG000|Overall Study|Participant not released from jail|2
7905749|NCT01999946|12419143|FG001|Overall Study|Participant not released from jail|2
7905750|NCT01999946|12419144|FG002|Overall Study|Participant not released from jail|0
7905751|NCT01999946|12419142|FG000|Overall Study|Not included in primary outcome analysis|0
7905752|NCT01999946|12419143|FG001|Overall Study|Not included in primary outcome analysis|0
7905753|NCT01999946|12419144|FG002|Overall Study|Not included in primary outcome analysis|79
7905754|NCT01999972|12419157|FG000|Dose Escalation Part|Participant refused further follow-up|1
7905755|NCT01999972|12419158|FG001|Dose Escalation Part|Participant refused further follow-up|0
7905756|NCT01999972|12419159|FG002|Dose Escalation Part|Participant refused further follow-up|1
7905757|NCT01999972|12419160|FG003|Dose Escalation Part|Participant refused further follow-up|1
7905758|NCT01999972|12419161|FG004|Dose Escalation Part|Participant refused further follow-up|0
7905759|NCT01999972|12419162|FG005|Dose Escalation Part|Participant refused further follow-up|0
7905760|NCT01999972|12419157|FG000|Dose Escalation Part|Death|0
7905761|NCT01999972|12419158|FG001|Dose Escalation Part|Death|1
7905762|NCT01999972|12419159|FG002|Dose Escalation Part|Death|0
7905763|NCT01999972|12419160|FG003|Dose Escalation Part|Death|0
7905764|NCT01999972|12419161|FG004|Dose Escalation Part|Death|0
7905765|NCT01999972|12419162|FG005|Dose Escalation Part|Death|0
7905766|NCT01999972|12419157|FG000|Dose Escalation Part|Enrolled but not treated|0
7905767|NCT01999972|12419158|FG001|Dose Escalation Part|Enrolled but not treated|0
7905768|NCT01999972|12419159|FG002|Dose Escalation Part|Enrolled but not treated|1
7905769|NCT01999972|12419160|FG003|Dose Escalation Part|Enrolled but not treated|1
7905770|NCT01999972|12419161|FG004|Dose Escalation Part|Enrolled but not treated|0
7905771|NCT01999972|12419162|FG005|Dose Escalation Part|Enrolled but not treated|0
7905772|NCT01999972|12419157|FG000|Dose Escalation Part|Disease progression|3
7905773|NCT01999972|12419158|FG001|Dose Escalation Part|Disease progression|2
7905774|NCT01999972|12419159|FG002|Dose Escalation Part|Disease progression|3
7905775|NCT01999972|12419160|FG003|Dose Escalation Part|Disease progression|6
7905776|NCT01999972|12419161|FG004|Dose Escalation Part|Disease progression|0
7905777|NCT01999972|12419162|FG005|Dose Escalation Part|Disease progression|0
7905778|NCT01999972|12419157|FG000|Dose Escalation Part|Adverse Event|0
7905779|NCT01999972|12419158|FG001|Dose Escalation Part|Adverse Event|0
7905780|NCT01999972|12419159|FG002|Dose Escalation Part|Adverse Event|0
7905781|NCT01999972|12419160|FG003|Dose Escalation Part|Adverse Event|2
7905782|NCT01999972|12419161|FG004|Dose Escalation Part|Adverse Event|0
7905783|NCT01999972|12419162|FG005|Dose Escalation Part|Adverse Event|0
7905784|NCT01999972|12419157|FG000|Dose Escalation Part|Global deterioration of health status|1
7905785|NCT01999972|12419158|FG001|Dose Escalation Part|Global deterioration of health status|0
7905786|NCT01999972|12419159|FG002|Dose Escalation Part|Global deterioration of health status|0
7905787|NCT01999972|12419160|FG003|Dose Escalation Part|Global deterioration of health status|1
7905788|NCT01999972|12419161|FG004|Dose Escalation Part|Global deterioration of health status|0
7905789|NCT01999972|12419162|FG005|Dose Escalation Part|Global deterioration of health status|0
7905790|NCT01999972|12419157|FG000|Dose Expansion Part|Death|0
7905791|NCT01999972|12419158|FG001|Dose Expansion Part|Death|0
7905792|NCT01999972|12419159|FG002|Dose Expansion Part|Death|0
7905793|NCT01999972|12419160|FG003|Dose Expansion Part|Death|0
7905794|NCT01999972|12419161|FG004|Dose Expansion Part|Death|2
7905795|NCT01999972|12419162|FG005|Dose Expansion Part|Death|1
7905796|NCT01999972|12419157|FG000|Dose Expansion Part|Disease progression|0
7905797|NCT01999972|12419158|FG001|Dose Expansion Part|Disease progression|0
7905798|NCT01999972|12419159|FG002|Dose Expansion Part|Disease progression|0
7905799|NCT01999972|12419160|FG003|Dose Expansion Part|Disease progression|0
7905800|NCT01999972|12419161|FG004|Dose Expansion Part|Disease progression|9
7905801|NCT01999972|12419162|FG005|Dose Expansion Part|Disease progression|3
7905802|NCT01999972|12419157|FG000|Dose Expansion Part|Sponsor decision|0
7905803|NCT01999972|12419158|FG001|Dose Expansion Part|Sponsor decision|0
7905804|NCT01999972|12419159|FG002|Dose Expansion Part|Sponsor decision|0
7905805|NCT01999972|12419160|FG003|Dose Expansion Part|Sponsor decision|0
7905806|NCT01999972|12419161|FG004|Dose Expansion Part|Sponsor decision|1
7905807|NCT01999972|12419162|FG005|Dose Expansion Part|Sponsor decision|0
7905808|NCT01999972|12419157|FG000|Dose Expansion Part|Adverse Event|0
7905809|NCT01999972|12419158|FG001|Dose Expansion Part|Adverse Event|0
7905810|NCT01999972|12419159|FG002|Dose Expansion Part|Adverse Event|0
7905811|NCT01999972|12419160|FG003|Dose Expansion Part|Adverse Event|0
7905812|NCT01999972|12419161|FG004|Dose Expansion Part|Adverse Event|4
7905813|NCT01999972|12419162|FG005|Dose Expansion Part|Adverse Event|2
7905814|NCT01999972|12419157|FG000|Dose Expansion Part|Participant's non-compliance|0
7905815|NCT01999972|12419158|FG001|Dose Expansion Part|Participant's non-compliance|0
7905816|NCT01999972|12419159|FG002|Dose Expansion Part|Participant's non-compliance|0
7905817|NCT01999972|12419160|FG003|Dose Expansion Part|Participant's non-compliance|0
7905818|NCT01999972|12419161|FG004|Dose Expansion Part|Participant's non-compliance|0
7905819|NCT01999972|12419162|FG005|Dose Expansion Part|Participant's non-compliance|1
7905820|NCT01999972|12419157|FG000|Dose Expansion Part|Participant refused further follow-up|0
7905821|NCT01999972|12419158|FG001|Dose Expansion Part|Participant refused further follow-up|0
7905822|NCT01999972|12419159|FG002|Dose Expansion Part|Participant refused further follow-up|0
7905823|NCT01999972|12419160|FG003|Dose Expansion Part|Participant refused further follow-up|0
7905824|NCT01999972|12419161|FG004|Dose Expansion Part|Participant refused further follow-up|4
7905825|NCT01999972|12419162|FG005|Dose Expansion Part|Participant refused further follow-up|0
7905826|NCT01999972|12419157|FG000|Dose Expansion Part|Changed to standard of care|0
7905827|NCT01999972|12419158|FG001|Dose Expansion Part|Changed to standard of care|0
7905828|NCT01999972|12419159|FG002|Dose Expansion Part|Changed to standard of care|0
7905829|NCT01999972|12419160|FG003|Dose Expansion Part|Changed to standard of care|0
7905830|NCT01999972|12419161|FG004|Dose Expansion Part|Changed to standard of care|1
7905831|NCT01999972|12419162|FG005|Dose Expansion Part|Changed to standard of care|0
7905832|NCT02000440|12419199|FG000|Overall Study|Adverse Event|3
7905833|NCT02000440|12419199|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1
7905834|NCT02000531|12419205|FG000|Overall Study|Lost to Follow-up|1
7905835|NCT02000531|12419206|FG001|Overall Study|Lost to Follow-up|0
7905836|NCT02000531|12419205|FG000|Overall Study|Discontinued due to data cut-off|3
7905837|NCT02000531|12419206|FG001|Overall Study|Discontinued due to data cut-off|8
7969137|NCT02792699|12527592|FG000|Overall Study|Physician Decision|2
7969138|NCT02792699|12527593|FG001|Overall Study|Physician Decision|0
7969139|NCT02792699|12527594|FG002|Overall Study|Physician Decision|0
7969140|NCT02792699|12527592|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1
7969141|NCT02792699|12527593|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3
7969142|NCT02792699|12527594|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1
7969143|NCT02792699|12527592|FG000|Overall Study|Other|1
7969144|NCT02792699|12527593|FG001|Overall Study|Other|0
7969145|NCT02792699|12527594|FG002|Overall Study|Other|0
7969146|NCT02792777|12527611|FG000|Overall Study|Withdrawal by Subject|2
7969147|NCT02792777|12527612|FG001|Overall Study|Withdrawal by Subject|0
7969148|NCT02792777|12527611|FG000|Overall Study|Recording malfunction|2
7969149|NCT02792777|12527612|FG001|Overall Study|Recording malfunction|0
7969150|NCT02792777|12527611|FG000|Overall Study|Later determined to be ineligible|2
7969151|NCT02792777|12527612|FG001|Overall Study|Later determined to be ineligible|0
7969152|NCT02792777|12527611|FG000|Overall Study|Participant interviewed twice|1
7969153|NCT02792777|12527612|FG001|Overall Study|Participant interviewed twice|0
7969154|NCT02792829|12527627|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0
7969155|NCT02792829|12527628|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1
7969156|NCT02792829|12527629|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0
7969157|NCT02792829|12527630|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0
7969158|NCT02792829|12527631|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0
7969159|NCT02792829|12527632|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0
7969160|NCT02792829|12527633|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0
7969161|NCT02792829|12527634|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0
7969162|NCT02792829|12527627|FG000|Treatment Period 2|Adverse Event|0
7969163|NCT02792829|12527628|FG001|Treatment Period 2|Adverse Event|0
7969164|NCT02792829|12527629|FG002|Treatment Period 2|Adverse Event|0
7969165|NCT02792829|12527630|FG003|Treatment Period 2|Adverse Event|0
7905838|NCT02000752|12419223|FG000|Overall Study|Dystocic delivery|19
7969166|NCT02792829|12527631|FG004|Treatment Period 2|Adverse Event|1
7969167|NCT02792829|12527632|FG005|Treatment Period 2|Adverse Event|0
7969168|NCT02792829|12527633|FG006|Treatment Period 2|Adverse Event|1
7969169|NCT02792829|12527634|FG007|Treatment Period 2|Adverse Event|1
7969170|NCT02792829|12527627|FG000|Treatment Period 2|Use of proscribed medications|0
7969171|NCT02792829|12527628|FG001|Treatment Period 2|Use of proscribed medications|0
7969172|NCT02792829|12527629|FG002|Treatment Period 2|Use of proscribed medications|0
7969173|NCT02792829|12527630|FG003|Treatment Period 2|Use of proscribed medications|0
7969174|NCT02792829|12527631|FG004|Treatment Period 2|Use of proscribed medications|0
7969175|NCT02792829|12527632|FG005|Treatment Period 2|Use of proscribed medications|0
7969176|NCT02792829|12527633|FG006|Treatment Period 2|Use of proscribed medications|0
7969177|NCT02792829|12527634|FG007|Treatment Period 2|Use of proscribed medications|1
7969178|NCT02792959|12527660|FG000|Overall Study|Protocol Violation|1
7969179|NCT02793128|12527664|FG000|Overall Study|Death|4
7969180|NCT02793128|12527664|FG000|Overall Study|Withdrawal by Subject|2
7969181|NCT02793128|12527664|FG000|Overall Study|Physician Decision|1
7969182|NCT02793128|12527664|FG000|Overall Study|Comorbid conditions and noncompliance|1
7969183|NCT02793128|12527664|FG000|Overall Study|Patient elected nephroureterectomy|1
7969184|NCT02793232|12527698|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7969185|NCT02793232|12527699|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7969186|NCT02793232|12527700|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7969187|NCT02793232|12527701|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7969188|NCT02793232|12527702|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
7969189|NCT02793232|12527703|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7969190|NCT02793232|12527704|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
7969191|NCT02793232|12527705|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7969192|NCT02793232|12527706|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7969193|NCT02793622|12527742|FG000|Overall Study|Lost to Follow-up|31
7969194|NCT02793622|12527743|FG001|Overall Study|Lost to Follow-up|19
7969195|NCT02793622|12527742|FG000|Overall Study|Withdrawal by Subject|21
7969196|NCT02793622|12527743|FG001|Overall Study|Withdrawal by Subject|17
7969197|NCT02793622|12527742|FG000|Overall Study|Adverse Event|0
7969198|NCT02793622|12527743|FG001|Overall Study|Adverse Event|1
7905839|NCT02000752|12419224|FG001|Overall Study|Dystocic delivery|8
7905840|NCT02000752|12419223|FG000|Overall Study|Shift Changes|12
7905841|NCT02000752|12419224|FG001|Overall Study|Shift Changes|5
7905842|NCT02000817|12419234|FG000|Overall Study|Withdrawal by Subject|2
7905843|NCT02000817|12419235|FG001|Overall Study|Withdrawal by Subject|0
7905844|NCT02000817|12419236|FG002|Overall Study|Withdrawal by Subject|0
7905845|NCT02000817|12419237|FG003|Overall Study|Withdrawal by Subject|0
7905846|NCT02000817|12419234|FG000|Overall Study|Adverse Event|0
7905847|NCT02000817|12419235|FG001|Overall Study|Adverse Event|1
7905848|NCT02000817|12419236|FG002|Overall Study|Adverse Event|0
7905849|NCT02000817|12419237|FG003|Overall Study|Adverse Event|0
7905850|NCT02000817|12419234|FG000|Overall Study|Lost to Follow-up|0
7905851|NCT02000817|12419235|FG001|Overall Study|Lost to Follow-up|0
7905852|NCT02000817|12419236|FG002|Overall Study|Lost to Follow-up|1
7905853|NCT02000817|12419237|FG003|Overall Study|Lost to Follow-up|0
7905854|NCT02000921|12419262|FG000|Overall Study|Withdrawal by Subject|3
7905855|NCT02000921|12419263|FG001|Overall Study|Withdrawal by Subject|10
7905856|NCT02000921|12419264|FG002|Overall Study|Withdrawal by Subject|5
7905857|NCT02000921|12419262|FG000|Overall Study|Lost to Follow-up|2
7905858|NCT02000921|12419263|FG001|Overall Study|Lost to Follow-up|4
7905859|NCT02000921|12419264|FG002|Overall Study|Lost to Follow-up|5
7905860|NCT02000921|12419262|FG000|Overall Study|Physician Decision|0
7905861|NCT02000921|12419263|FG001|Overall Study|Physician Decision|2
7905862|NCT02000921|12419264|FG002|Overall Study|Physician Decision|0
7905863|NCT02001051|12419291|FG000|Overall Study|Deemed not eligible following enrollment|0
7905864|NCT02001051|12419292|FG001|Overall Study|Deemed not eligible following enrollment|1
7905865|NCT02001064|12419300|FG000|Overall Study|Withdrawal by Subject|2
7905866|NCT02001064|12419301|FG001|Overall Study|Withdrawal by Subject|1
7905867|NCT02001181|12419309|FG000|Overall Study|Adverse Event|0
7905868|NCT02001181|12419310|FG001|Overall Study|Adverse Event|2
7905869|NCT02001181|12419309|FG000|Overall Study|Lost to Follow-up|1
7905870|NCT02001181|12419310|FG001|Overall Study|Lost to Follow-up|0
7905871|NCT02001181|12419309|FG000|Overall Study|Withdrawal by Subject|0
7905872|NCT02001181|12419310|FG001|Overall Study|Withdrawal by Subject|1
7905873|NCT02001194|12419320|FG000|Intervention Period (13 Weeks)|No longer interested|1
7905874|NCT02001194|12419321|FG001|Intervention Period (13 Weeks)|No longer interested|0
7905875|NCT02001194|12419322|FG002|Intervention Period (13 Weeks)|No longer interested|2
7905876|NCT02001194|12419323|FG003|Intervention Period (13 Weeks)|No longer interested|2
7905877|NCT02001194|12419320|FG000|Follow-Up Period (13 Weeks)|No longer interested|3
7905878|NCT02001194|12419321|FG001|Follow-Up Period (13 Weeks)|No longer interested|2
7905879|NCT02001194|12419322|FG002|Follow-Up Period (13 Weeks)|No longer interested|1
7905880|NCT02001194|12419323|FG003|Follow-Up Period (13 Weeks)|No longer interested|0
7905881|NCT02001558|12419335|FG000|Overall Study|Lost to Follow-up|8
7905882|NCT02001558|12419336|FG001|Overall Study|Lost to Follow-up|14
7905883|NCT02001688|12419345|FG000|Overall Study|Withdrawal by Subject|0
7905884|NCT02001688|12419346|FG001|Overall Study|Withdrawal by Subject|0
7905885|NCT02001688|12419347|FG002|Overall Study|Withdrawal by Subject|1
7905886|NCT02001688|12419345|FG000|Overall Study|Adverse Event|0
7905887|NCT02001688|12419346|FG001|Overall Study|Adverse Event|1
7905888|NCT02001688|12419347|FG002|Overall Study|Adverse Event|0
7905889|NCT02001987|12419365|FG000|Core Study Period (24 Weeks)|Adverse Event|9
7905890|NCT02001987|12419365|FG000|Core Study Period (24 Weeks)|Death|1
7905891|NCT02001987|12419365|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
7905892|NCT02001987|12419365|FG000|Core Study Period (24 Weeks)|Physician Decision|1
7905893|NCT02001987|12419365|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4
7905894|NCT02001987|12419365|FG000|Core Study Period (24 Weeks)|Protocol Violation|3
7905895|NCT02001987|12419365|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3
7905896|NCT02001987|12419365|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2
7905897|NCT02001987|12419365|FG000|LTE Period (52 Weeks)|Physician Decision|2
7905898|NCT02001987|12419365|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1
7905899|NCT02001987|12419365|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1
7905900|NCT02001987|12419365|FG000|LTE Period (52 Weeks)|Other|3
7905901|NCT02002091|12419376|FG000|Screening|Lost to Follow-up|10
7905902|NCT02002091|12419377|FG001|Screening|Lost to Follow-up|12
7905903|NCT02002091|12419376|FG000|Screening|Death|3
7905904|NCT02002091|12419377|FG001|Screening|Death|2
7905905|NCT02002221|12419423|FG000|Overall Study|Adverse Event|2
7905906|NCT02002221|12419424|FG001|Overall Study|Adverse Event|1
7905907|NCT02002221|12419423|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7905908|NCT02002221|12419424|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7905909|NCT02002221|12419423|FG000|Overall Study|Patient withdrew consent|0
7905910|NCT02002221|12419424|FG001|Overall Study|Patient withdrew consent|1
7905911|NCT02002533|12419447|FG000|Overall Study|Withdrawal by Subject|6
7905912|NCT02002533|12419448|FG001|Overall Study|Withdrawal by Subject|13
7905913|NCT02002533|12419447|FG000|Overall Study|Protocol Violation|0
7905914|NCT02002533|12419448|FG001|Overall Study|Protocol Violation|1
7905915|NCT02002533|12419447|FG000|Overall Study|Adverse Event|0
7905916|NCT02002533|12419448|FG001|Overall Study|Adverse Event|3
7905917|NCT02002533|12419447|FG000|Overall Study|Lost to Follow-up|0
7905918|NCT02002533|12419448|FG001|Overall Study|Lost to Follow-up|1
7905919|NCT02002689|12419465|FG000|Overall Study|Disease Progression|7
7905920|NCT02002689|12419465|FG000|Overall Study|Adverse Event|3
7905921|NCT02002884|12419509|FG000|Main Period (MP)|Other|0
7905922|NCT02002884|12419510|FG001|Main Period (MP)|Other|3
7905923|NCT02002884|12419511|FG002|Main Period (MP)|Other|3
7905924|NCT02002884|12419512|FG003|Main Period (MP)|Other|0
7905925|NCT02002884|12419509|FG000|Main Period (MP)|Adverse Event|0
7905926|NCT02002884|12419510|FG001|Main Period (MP)|Adverse Event|1
7905927|NCT02002884|12419511|FG002|Main Period (MP)|Adverse Event|1
7905928|NCT02002884|12419512|FG003|Main Period (MP)|Adverse Event|0
7905929|NCT02002884|12419509|FG000|Main Period (MP)|Withdrawal by Subject|6
7905930|NCT02002884|12419510|FG001|Main Period (MP)|Withdrawal by Subject|2
7905931|NCT02002884|12419511|FG002|Main Period (MP)|Withdrawal by Subject|2
7905932|NCT02002884|12419512|FG003|Main Period (MP)|Withdrawal by Subject|0
7905933|NCT02002884|12419509|FG000|Main Period (MP)|Lost to Follow-up|0
7905934|NCT02002884|12419510|FG001|Main Period (MP)|Lost to Follow-up|0
7905935|NCT02002884|12419511|FG002|Main Period (MP)|Lost to Follow-up|2
7905936|NCT02002884|12419512|FG003|Main Period (MP)|Lost to Follow-up|0
7905937|NCT02002884|12419509|FG000|Open-Label Extension Period (OLEX)|Other|0
7905938|NCT02002884|12419510|FG001|Open-Label Extension Period (OLEX)|Other|0
7905939|NCT02002884|12419511|FG002|Open-Label Extension Period (OLEX)|Other|0
7905940|NCT02002884|12419512|FG003|Open-Label Extension Period (OLEX)|Other|24
7905941|NCT02002884|12419509|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0
7905942|NCT02002884|12419510|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0
7905943|NCT02002884|12419511|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0
7905944|NCT02002884|12419512|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1
7905945|NCT02002884|12419509|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0
7905946|NCT02002884|12419510|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0
7905947|NCT02002884|12419511|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0
7905948|NCT02002884|12419512|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5
7905949|NCT02002884|12419509|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
7905950|NCT02002884|12419510|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
7905951|NCT02002884|12419511|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
7905952|NCT02002884|12419512|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10
7905953|NCT02002884|12419509|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
7905954|NCT02002884|12419510|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
7905955|NCT02002884|12419511|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
7905956|NCT02002884|12419512|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10
7905957|NCT02002975|12419526|FG000|Overall Study|Case Report Forms Uncollected|135
7905958|NCT02002975|12419526|FG000|Overall Study|Protocol Deviation|437
7905959|NCT02003014|12419530|FG000|Overall Study|Case report forms uncollected|9
7905960|NCT02003014|12419530|FG000|Overall Study|Treatment started after contract period|1
7905961|NCT02003014|12419530|FG000|Overall Study|Patient did not visit the study site|5
7905962|NCT02003014|12419530|FG000|Overall Study|Investigator's transfer|4
7905963|NCT02003183|12419545|FG000|Overall Study|Lost to Follow-up|0
7905964|NCT02003183|12419546|FG001|Overall Study|Lost to Follow-up|2
7905965|NCT02003365|12419559|FG000|Overall Study|Lost to Follow-up|0
7905966|NCT02003365|12419560|FG001|Overall Study|Lost to Follow-up|0
7905967|NCT02003365|12419561|FG002|Overall Study|Lost to Follow-up|1
7905968|NCT02003391|12419571|FG000|Overall Study|Withdrawal by Subject|2
7905969|NCT02003391|12419572|FG001|Overall Study|Withdrawal by Subject|1
7905970|NCT02003391|12419571|FG000|Overall Study|Protocol Violation|0
7905971|NCT02003391|12419572|FG001|Overall Study|Protocol Violation|1
7905972|NCT02003391|12419571|FG000|Overall Study|Adverse Event|1
7905973|NCT02003391|12419572|FG001|Overall Study|Adverse Event|0
7905974|NCT02003534|12419593|FG000|Overall Study|Lost to Follow-up|47
7905975|NCT02003573|12419600|FG000|Overall Study|Progressive disease|2
7905976|NCT02003573|12419601|FG001|Overall Study|Progressive disease|0
7905977|NCT02003573|12419602|FG002|Overall Study|Progressive disease|1
7905978|NCT02003573|12419600|FG000|Overall Study|Other Adverse event|0
7905979|NCT02003573|12419601|FG001|Overall Study|Other Adverse event|1
7905980|NCT02003573|12419602|FG002|Overall Study|Other Adverse event|1
7905981|NCT02003573|12419600|FG000|Overall Study|Refuse to take trial medication|0
7905982|NCT02003573|12419601|FG001|Overall Study|Refuse to take trial medication|1
7905983|NCT02003573|12419602|FG002|Overall Study|Refuse to take trial medication|1
7905984|NCT02003573|12419600|FG000|Overall Study|Other than specified|1
7905985|NCT02003573|12419601|FG001|Overall Study|Other than specified|2
7905986|NCT02003573|12419602|FG002|Overall Study|Other than specified|3
7905987|NCT02003638|12419623|FG000|Overall Study|Withdrawal by Subject|1
7905988|NCT02003638|12419624|FG001|Overall Study|Withdrawal by Subject|0
7905989|NCT02003898|12419630|FG000|Overall Study|Death|3
7905990|NCT02003898|12419630|FG000|Overall Study|Lost to Follow-up|12
7905991|NCT02003898|12419630|FG000|Overall Study|Withdrawal by Subject|52
7905992|NCT02003963|12419645|FG000|Overall Study|Lost to Follow-up|2
7905993|NCT02003963|12419646|FG001|Overall Study|Lost to Follow-up|1
7905994|NCT02004093|12419656|FG000|Overall Study|Death|2
7905995|NCT02004093|12419657|FG001|Overall Study|Death|1
7905996|NCT02004093|12419656|FG000|Overall Study|Lack of Efficacy|66
7905997|NCT02004093|12419657|FG001|Overall Study|Lack of Efficacy|62
7905998|NCT02004093|12419656|FG000|Overall Study|Protocol Violation|0
7905999|NCT02004093|12419657|FG001|Overall Study|Protocol Violation|1
7906000|NCT02004093|12419656|FG000|Overall Study|Lost to Follow-up|0
7906001|NCT02004093|12419657|FG001|Overall Study|Lost to Follow-up|1
7906002|NCT02004093|12419656|FG000|Overall Study|Withdrawal by Subject|3
7906003|NCT02004093|12419657|FG001|Overall Study|Withdrawal by Subject|7
7906004|NCT02004093|12419656|FG000|Overall Study|Other|3
7906005|NCT02004093|12419657|FG001|Overall Study|Other|1
7906006|NCT02004236|12419679|FG000|Overall Study|Lack of Efficacy|0
7906007|NCT02004236|12419680|FG001|Overall Study|Lack of Efficacy|0
7906008|NCT02004236|12419681|FG002|Overall Study|Lack of Efficacy|16
7906009|NCT02004262|12419696|FG000|Overall Study|Death|67
7906010|NCT02004262|12419697|FG001|Overall Study|Death|64
7906011|NCT02004262|12419698|FG002|Overall Study|Death|66
7906012|NCT02004262|12419699|FG003|Overall Study|Death|28
7906013|NCT02004262|12419700|FG004|Overall Study|Death|29
7906014|NCT02004262|12419701|FG005|Overall Study|Death|22
7906015|NCT02004262|12419696|FG000|Overall Study|Withdrawal by Subject|1
7906016|NCT02004262|12419697|FG001|Overall Study|Withdrawal by Subject|0
7906017|NCT02004262|12419698|FG002|Overall Study|Withdrawal by Subject|4
7906018|NCT02004262|12419699|FG003|Overall Study|Withdrawal by Subject|0
7906019|NCT02004262|12419700|FG004|Overall Study|Withdrawal by Subject|1
7906020|NCT02004262|12419701|FG005|Overall Study|Withdrawal by Subject|3
7906021|NCT02004262|12419696|FG000|Overall Study|Lost to Follow-up|1
7906022|NCT02004262|12419697|FG001|Overall Study|Lost to Follow-up|1
7906023|NCT02004262|12419698|FG002|Overall Study|Lost to Follow-up|0
7906024|NCT02004262|12419699|FG003|Overall Study|Lost to Follow-up|0
7906025|NCT02004262|12419700|FG004|Overall Study|Lost to Follow-up|0
7906026|NCT02004262|12419701|FG005|Overall Study|Lost to Follow-up|0
7906027|NCT02004262|12419696|FG000|Overall Study|Study Terminated by Sponsor|4
7906028|NCT02004262|12419697|FG001|Overall Study|Study Terminated by Sponsor|3
7906029|NCT02004262|12419698|FG002|Overall Study|Study Terminated by Sponsor|2
7906030|NCT02004262|12419699|FG003|Overall Study|Study Terminated by Sponsor|1
7906031|NCT02004262|12419700|FG004|Overall Study|Study Terminated by Sponsor|1
7906032|NCT02004262|12419701|FG005|Overall Study|Study Terminated by Sponsor|5
7906033|NCT02004353|12419724|FG000|Overall Study|Voluntary participation|1334
7906034|NCT02004847|12419761|FG000|Overall Study|Protocol Violation|1
7906035|NCT02004847|12419762|FG001|Overall Study|Protocol Violation|1
7906036|NCT02004873|12419777|FG000|Overall Study|Implant unsuccessful|6
7906037|NCT02004873|12419777|FG000|Overall Study|Awaiting 6-month visit|390
7906038|NCT02004873|12419777|FG000|Overall Study|Missed 6-month visit|4
7906039|NCT02004873|12419777|FG000|Overall Study|Death|23
7906040|NCT02004873|12419777|FG000|Overall Study|Withdrawal by Subject|1
7906041|NCT02004886|12419788|FG000|Overall Study|Adverse Event|0
7906042|NCT02004886|12419789|FG001|Overall Study|Adverse Event|1
7906043|NCT02004886|12419790|FG002|Overall Study|Adverse Event|0
7906044|NCT02004886|12419791|FG003|Overall Study|Adverse Event|0
7906045|NCT02004886|12419788|FG000|Overall Study|Unable to attend future visits|1
7906046|NCT02004886|12419789|FG001|Overall Study|Unable to attend future visits|0
7906047|NCT02004886|12419790|FG002|Overall Study|Unable to attend future visits|0
7906048|NCT02004886|12419791|FG003|Overall Study|Unable to attend future visits|0
7906049|NCT02005029|12419820|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1
7906050|NCT02005029|12419821|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0
7906051|NCT02005211|12419852|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7906052|NCT02005211|12419853|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7906053|NCT02005211|12419854|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7906054|NCT02005211|12419855|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7906055|NCT02005211|12419856|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
7906056|NCT02005211|12419857|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7906057|NCT02005211|12419858|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7906058|NCT02005250|12419883|FG000|Overall Study|Lost to Follow-up|15
7906059|NCT02005250|12419884|FG001|Overall Study|Lost to Follow-up|5
7906060|NCT02005276|12419894|FG000|Overall Study|No longer interested|5
7906061|NCT02005276|12419895|FG001|Overall Study|No longer interested|2
7906062|NCT02005276|12419896|FG002|Overall Study|No longer interested|3
7906063|NCT02005276|12419897|FG003|Overall Study|No longer interested|3
7906064|NCT02005484|12419922|FG000|Overall Study|Death|1
7906065|NCT02005484|12419922|FG000|Overall Study|Disease progression|1
7906066|NCT02005484|12419922|FG000|Overall Study|Changed to a Different Study|1
7906067|NCT02005484|12419922|FG000|Overall Study|Sponsor decision|1
7906068|NCT02005562|12419945|FG000|Overall Study|Death|2
7906069|NCT02005562|12419946|FG001|Overall Study|Death|2
7906070|NCT02005562|12419945|FG000|Overall Study|Graft loss|7
7906071|NCT02005562|12419946|FG001|Overall Study|Graft loss|6
7906072|NCT02005562|12419945|FG000|Overall Study|Withdrawal by Subject|2
7906073|NCT02005562|12419946|FG001|Overall Study|Withdrawal by Subject|2
7906074|NCT02005562|12419945|FG000|Overall Study|No transplant|1
7906075|NCT02005562|12419946|FG001|Overall Study|No transplant|4
7906076|NCT02005562|12419945|FG000|Overall Study|Physician Decision|0
7906077|NCT02005562|12419946|FG001|Overall Study|Physician Decision|1
7906078|NCT02005627|12419963|FG000|Overall Study|Lost to Follow-up|1
7906079|NCT02005627|12419964|FG001|Overall Study|Lost to Follow-up|2
7906080|NCT02005627|12419963|FG000|Overall Study|Withdrawal by Subject|1
7906081|NCT02005627|12419964|FG001|Overall Study|Withdrawal by Subject|2
7906082|NCT02005692|12419984|FG000|Overall Study|Protocol Violation|1
7906083|NCT02005692|12419984|FG000|Overall Study|Withdrawal by Subject|1
7906084|NCT02005692|12419984|FG000|Overall Study|Discharged earlier than anticipated|5
7906085|NCT02005887|12419991|FG000|Overall Study|Protocol Violation|0
7906086|NCT02005887|12419992|FG001|Overall Study|Protocol Violation|2
7963925|NCT02731742|12518789|FG003|Overall Study|Study Terminated by Sponsor|1
7963926|NCT02731755|12518799|FG000|First Intervention|Withdrawal by Subject|0
7963927|NCT02731755|12518800|FG001|First Intervention|Withdrawal by Subject|2
7963928|NCT02732015|12518826|FG000|Overall Study|Lost to Follow-up|0
7963929|NCT02732015|12518827|FG001|Overall Study|Lost to Follow-up|1
7963930|NCT02732119|12518838|FG000|Phase I|Adverse Event|1
7963931|NCT02732119|12518839|FG001|Phase I|Adverse Event|3
7963932|NCT02732119|12518840|FG002|Phase I|Adverse Event|1
7963933|NCT02732119|12518841|FG003|Phase I|Adverse Event|0
7963934|NCT02732119|12518842|FG004|Phase I|Adverse Event|0
7963935|NCT02732119|12518838|FG000|Phase I|Progressive disease|7
7963936|NCT02732119|12518839|FG001|Phase I|Progressive disease|3
7963937|NCT02732119|12518840|FG002|Phase I|Progressive disease|2
7963938|NCT02732119|12518841|FG003|Phase I|Progressive disease|0
7963939|NCT02732119|12518842|FG004|Phase I|Progressive disease|0
7963940|NCT02732119|12518838|FG000|Phase I|Protocol deviation|0
7963941|NCT02732119|12518839|FG001|Phase I|Protocol deviation|1
7963942|NCT02732119|12518840|FG002|Phase I|Protocol deviation|0
7963943|NCT02732119|12518841|FG003|Phase I|Protocol deviation|0
7963944|NCT02732119|12518842|FG004|Phase I|Protocol deviation|0
7963945|NCT02732119|12518838|FG000|Phase I|Physician Decision|0
7963946|NCT02732119|12518839|FG001|Phase I|Physician Decision|3
7963947|NCT02732119|12518840|FG002|Phase I|Physician Decision|4
7963948|NCT02732119|12518841|FG003|Phase I|Physician Decision|0
7963949|NCT02732119|12518842|FG004|Phase I|Physician Decision|0
7963950|NCT02732119|12518838|FG000|Phase II|Adverse Event|0
7963951|NCT02732119|12518839|FG001|Phase II|Adverse Event|0
7963952|NCT02732119|12518840|FG002|Phase II|Adverse Event|0
7963953|NCT02732119|12518841|FG003|Phase II|Adverse Event|3
7963954|NCT02732119|12518842|FG004|Phase II|Adverse Event|3
7963955|NCT02732119|12518838|FG000|Phase II|Death|0
7963956|NCT02732119|12518839|FG001|Phase II|Death|0
7963957|NCT02732119|12518840|FG002|Phase II|Death|0
7963958|NCT02732119|12518841|FG003|Phase II|Death|1
7963959|NCT02732119|12518842|FG004|Phase II|Death|0
7963960|NCT02732119|12518838|FG000|Phase II|Progressive dissease|0
7963961|NCT02732119|12518839|FG001|Phase II|Progressive dissease|0
7963962|NCT02732119|12518840|FG002|Phase II|Progressive dissease|0
7963963|NCT02732119|12518841|FG003|Phase II|Progressive dissease|30
7963964|NCT02732119|12518842|FG004|Phase II|Progressive dissease|23
7963965|NCT02732119|12518838|FG000|Phase II|Study terminated by sponsor|0
7963966|NCT02732119|12518839|FG001|Phase II|Study terminated by sponsor|0
7963967|NCT02732119|12518840|FG002|Phase II|Study terminated by sponsor|0
7963968|NCT02732119|12518841|FG003|Phase II|Study terminated by sponsor|2
7963969|NCT02732119|12518842|FG004|Phase II|Study terminated by sponsor|2
7963970|NCT02732119|12518838|FG000|Phase II|Other|0
7963971|NCT02732119|12518839|FG001|Phase II|Other|0
7963972|NCT02732119|12518840|FG002|Phase II|Other|0
7963973|NCT02732119|12518841|FG003|Phase II|Other|2
7963974|NCT02732119|12518842|FG004|Phase II|Other|0
7963975|NCT02732119|12518838|FG000|Phase II|Physician Decision|0
7906087|NCT02006121|12420013|FG000|Double Blind Phase|Adverse Event|6
7906088|NCT02006121|12420014|FG001|Double Blind Phase|Adverse Event|0
7906089|NCT02006121|12420013|FG000|Double Blind Phase|Lack of Efficacy|1
7906090|NCT02006121|12420014|FG001|Double Blind Phase|Lack of Efficacy|16
7906091|NCT02006121|12420013|FG000|Double Blind Phase|Withdrawal by Subject|3
7906092|NCT02006121|12420014|FG001|Double Blind Phase|Withdrawal by Subject|4
7906093|NCT02006121|12420013|FG000|Double Blind Phase|Non-compliance with study drug|1
7906094|NCT02006121|12420014|FG001|Double Blind Phase|Non-compliance with study drug|3
7906095|NCT02006121|12420013|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1
7906096|NCT02006121|12420014|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0
7906097|NCT02006121|12420013|FG000|Double Blind Phase|Inconvenience of infusion system|0
7906098|NCT02006121|12420014|FG001|Double Blind Phase|Inconvenience of infusion system|1
7906099|NCT02006121|12420013|FG000|Open Label Phase|Adverse Event|15
7906100|NCT02006121|12420014|FG001|Open Label Phase|Adverse Event|0
7906101|NCT02006121|12420013|FG000|Open Label Phase|Lack of Efficacy|2
7906102|NCT02006121|12420014|FG001|Open Label Phase|Lack of Efficacy|0
7906103|NCT02006121|12420013|FG000|Open Label Phase|Protocol Violation|2
7906104|NCT02006121|12420014|FG001|Open Label Phase|Protocol Violation|0
7906105|NCT02006121|12420013|FG000|Open Label Phase|Withdrawal by Subject|3
7906106|NCT02006121|12420014|FG001|Open Label Phase|Withdrawal by Subject|0
7906107|NCT02006121|12420013|FG000|Open Label Phase|Non-compliance with study drug|3
7906108|NCT02006121|12420014|FG001|Open Label Phase|Non-compliance with study drug|0
7906109|NCT02006472|12420071|FG000|Period 1 (Through Week 26)|Protocol Violation|1
7906110|NCT02006472|12420072|FG001|Period 1 (Through Week 26)|Protocol Violation|1
7906111|NCT02006472|12420073|FG002|Period 1 (Through Week 26)|Protocol Violation|1
7906112|NCT02006472|12420074|FG003|Period 1 (Through Week 26)|Protocol Violation|1
7906113|NCT02006472|12420075|FG004|Period 1 (Through Week 26)|Protocol Violation|0
7906114|NCT02006472|12420071|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0
7906115|NCT02006472|12420072|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0
7906116|NCT02006472|12420073|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1
7906117|NCT02006472|12420074|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0
7906118|NCT02006472|12420075|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0
7906119|NCT02006472|12420071|FG000|Period 1 (Through Week 26)|Noncompliance|2
7906120|NCT02006472|12420072|FG001|Period 1 (Through Week 26)|Noncompliance|1
7906121|NCT02006472|12420073|FG002|Period 1 (Through Week 26)|Noncompliance|1
7906122|NCT02006472|12420074|FG003|Period 1 (Through Week 26)|Noncompliance|0
7906123|NCT02006472|12420075|FG004|Period 1 (Through Week 26)|Noncompliance|0
7906124|NCT02006472|12420071|FG000|Period 1 (Through Week 26)|Other|1
7906125|NCT02006472|12420072|FG001|Period 1 (Through Week 26)|Other|5
7906126|NCT02006472|12420073|FG002|Period 1 (Through Week 26)|Other|0
7906127|NCT02006472|12420074|FG003|Period 1 (Through Week 26)|Other|2
7906128|NCT02006472|12420075|FG004|Period 1 (Through Week 26)|Other|3
7906129|NCT02006472|12420071|FG000|Period 1 (Through Week 26)|Adverse Event|5
7906130|NCT02006472|12420072|FG001|Period 1 (Through Week 26)|Adverse Event|6
7906131|NCT02006472|12420073|FG002|Period 1 (Through Week 26)|Adverse Event|11
7906132|NCT02006472|12420074|FG003|Period 1 (Through Week 26)|Adverse Event|11
7906133|NCT02006472|12420075|FG004|Period 1 (Through Week 26)|Adverse Event|14
7906134|NCT02006472|12420071|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3
7906135|NCT02006472|12420072|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9
7906136|NCT02006472|12420073|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3
7906137|NCT02006472|12420074|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0
7906138|NCT02006472|12420075|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3
7906139|NCT02006472|12420071|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1
7906140|NCT02006472|12420072|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0
7906141|NCT02006472|12420073|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0
7906142|NCT02006472|12420074|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1
7906143|NCT02006472|12420075|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1
7906144|NCT02006472|12420071|FG000|Period 2 (Through Week 52)|Noncompliance|1
7906145|NCT02006472|12420072|FG001|Period 2 (Through Week 52)|Noncompliance|0
7906146|NCT02006472|12420073|FG002|Period 2 (Through Week 52)|Noncompliance|0
7906147|NCT02006472|12420074|FG003|Period 2 (Through Week 52)|Noncompliance|0
7906148|NCT02006472|12420075|FG004|Period 2 (Through Week 52)|Noncompliance|0
7906149|NCT02006472|12420071|FG000|Period 2 (Through Week 52)|Adverse Event|1
7906150|NCT02006472|12420072|FG001|Period 2 (Through Week 52)|Adverse Event|4
7906151|NCT02006472|12420073|FG002|Period 2 (Through Week 52)|Adverse Event|5
7906152|NCT02006472|12420074|FG003|Period 2 (Through Week 52)|Adverse Event|1
7906153|NCT02006472|12420075|FG004|Period 2 (Through Week 52)|Adverse Event|1
7906154|NCT02006472|12420071|FG000|Period 2 (Through Week 52)|Other|0
7906155|NCT02006472|12420072|FG001|Period 2 (Through Week 52)|Other|1
7906156|NCT02006472|12420073|FG002|Period 2 (Through Week 52)|Other|0
7906157|NCT02006472|12420074|FG003|Period 2 (Through Week 52)|Other|1
7906158|NCT02006472|12420075|FG004|Period 2 (Through Week 52)|Other|0
7906159|NCT02006472|12420071|FG000|Period 2 (Through Week 52)|Not treated|0
7906160|NCT02006472|12420072|FG001|Period 2 (Through Week 52)|Not treated|0
7906161|NCT02006472|12420073|FG002|Period 2 (Through Week 52)|Not treated|2
7906162|NCT02006472|12420074|FG003|Period 2 (Through Week 52)|Not treated|0
7906163|NCT02006472|12420075|FG004|Period 2 (Through Week 52)|Not treated|0
7906164|NCT02006472|12420071|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2
7906165|NCT02006472|12420072|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1
7906166|NCT02006472|12420073|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2
7906167|NCT02006472|12420074|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0
7906168|NCT02006472|12420075|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0
7906169|NCT02006472|12420071|FG000|Period 2 (Through Week 52)|Sponsor decision|0
7906170|NCT02006472|12420072|FG001|Period 2 (Through Week 52)|Sponsor decision|0
7906171|NCT02006472|12420073|FG002|Period 2 (Through Week 52)|Sponsor decision|1
7906172|NCT02006472|12420074|FG003|Period 2 (Through Week 52)|Sponsor decision|0
7906173|NCT02006472|12420075|FG004|Period 2 (Through Week 52)|Sponsor decision|0
7906174|NCT02006576|12420095|FG000|Overall Study|Withdrawal by Subject|4
7906175|NCT02006576|12420096|FG001|Overall Study|Withdrawal by Subject|6
7906176|NCT02006576|12420097|FG002|Overall Study|Withdrawal by Subject|2
7906177|NCT02006576|12420095|FG000|Overall Study|Death|0
7906178|NCT02006576|12420096|FG001|Overall Study|Death|0
7906179|NCT02006576|12420097|FG002|Overall Study|Death|1
7906180|NCT02006576|12420095|FG000|Overall Study|Lost to Follow-up|1
7906181|NCT02006576|12420096|FG001|Overall Study|Lost to Follow-up|0
7906182|NCT02006576|12420097|FG002|Overall Study|Lost to Follow-up|1
7906183|NCT02006576|12420095|FG000|Overall Study|Screen Failure, too sick, other|13
7906184|NCT02006576|12420096|FG001|Overall Study|Screen Failure, too sick, other|1
7906185|NCT02006576|12420097|FG002|Overall Study|Screen Failure, too sick, other|13
7906186|NCT02006641|12420108|FG000|Overall Study|Withdrawal before treatment|2
7906187|NCT02006641|12420109|FG001|Overall Study|Withdrawal before treatment|5
7906188|NCT02006641|12420110|FG002|Overall Study|Withdrawal before treatment|3
7906189|NCT02006641|12420108|FG000|Overall Study|Adverse Event|15
7906190|NCT02006641|12420109|FG001|Overall Study|Adverse Event|11
7906191|NCT02006641|12420110|FG002|Overall Study|Adverse Event|15
7906192|NCT02006641|12420108|FG000|Overall Study|Protocol Violation|0
7906193|NCT02006641|12420109|FG001|Overall Study|Protocol Violation|2
7906194|NCT02006641|12420110|FG002|Overall Study|Protocol Violation|2
7906195|NCT02006641|12420108|FG000|Overall Study|Lost to Follow-up|0
7906196|NCT02006641|12420109|FG001|Overall Study|Lost to Follow-up|1
7906197|NCT02006641|12420110|FG002|Overall Study|Lost to Follow-up|0
7906198|NCT02006641|12420108|FG000|Overall Study|Withdrawal by Subject|7
7906199|NCT02006641|12420109|FG001|Overall Study|Withdrawal by Subject|12
7906200|NCT02006641|12420110|FG002|Overall Study|Withdrawal by Subject|11
7906201|NCT02006641|12420108|FG000|Overall Study|Other reason: patient didn't show up|1
7906202|NCT02006641|12420109|FG001|Overall Study|Other reason: patient didn't show up|0
7906203|NCT02006641|12420110|FG002|Overall Study|Other reason: patient didn't show up|0
7906204|NCT02006641|12420108|FG000|Overall Study|Other reason:patient didn't want to come|0
7906205|NCT02006641|12420109|FG001|Overall Study|Other reason:patient didn't want to come|0
7906206|NCT02006641|12420110|FG002|Overall Study|Other reason:patient didn't want to come|1
7906207|NCT02006641|12420108|FG000|Overall Study|Other reason: patient has moved|1
7906208|NCT02006641|12420109|FG001|Overall Study|Other reason: patient has moved|0
7906209|NCT02006641|12420110|FG002|Overall Study|Other reason: patient has moved|1
7906210|NCT02006641|12420108|FG000|Overall Study|Other reason: caregiver in hospital|0
7906211|NCT02006641|12420109|FG001|Overall Study|Other reason: caregiver in hospital|1
7906212|NCT02006641|12420110|FG002|Overall Study|Other reason: caregiver in hospital|0
7906213|NCT02006641|12420108|FG000|Overall Study|Other reason: patient's wife has died|0
7906214|NCT02006641|12420109|FG001|Overall Study|Other reason: patient's wife has died|0
7906215|NCT02006641|12420110|FG002|Overall Study|Other reason: patient's wife has died|1
7906216|NCT02006641|12420108|FG000|Overall Study|Other reason: hospitalisation|0
7906217|NCT02006641|12420109|FG001|Overall Study|Other reason: hospitalisation|1
7906218|NCT02006641|12420110|FG002|Overall Study|Other reason: hospitalisation|0
7906219|NCT02006641|12420108|FG000|Overall Study|Other reason: caregiver impossibility|0
7906220|NCT02006641|12420109|FG001|Overall Study|Other reason: caregiver impossibility|0
7906221|NCT02006641|12420110|FG002|Overall Study|Other reason: caregiver impossibility|1
7906222|NCT02006641|12420108|FG000|Overall Study|Other reason: protocol non-compliance|0
7906223|NCT02006641|12420109|FG001|Overall Study|Other reason: protocol non-compliance|0
7906224|NCT02006641|12420110|FG002|Overall Study|Other reason: protocol non-compliance|1
7906225|NCT02006654|12420120|FG000|Overall Study|Withdrawal before treatment|4
7906226|NCT02006654|12420121|FG001|Overall Study|Withdrawal before treatment|2
7906227|NCT02006654|12420120|FG000|Overall Study|Adverse Event|16
7906228|NCT02006654|12420121|FG001|Overall Study|Adverse Event|17
7906229|NCT02006654|12420120|FG000|Overall Study|Death|1
7906230|NCT02006654|12420121|FG001|Overall Study|Death|0
7906231|NCT02006654|12420120|FG000|Overall Study|Withdrawal by Subject|14
7906232|NCT02006654|12420121|FG001|Overall Study|Withdrawal by Subject|12
7906233|NCT02006654|12420120|FG000|Overall Study|Protocol Violation|5
7906234|NCT02006654|12420121|FG001|Overall Study|Protocol Violation|8
7906235|NCT02006654|12420120|FG000|Overall Study|Lost to Follow-up|1
7906236|NCT02006654|12420121|FG001|Overall Study|Lost to Follow-up|0
7906237|NCT02006654|12420120|FG000|Overall Study|patient's will|2
7906238|NCT02006654|12420121|FG001|Overall Study|patient's will|1
7906239|NCT02006654|12420120|FG000|Overall Study|insufficient compliance|1
7906240|NCT02006654|12420121|FG001|Overall Study|insufficient compliance|0
7906241|NCT02006654|12420120|FG000|Overall Study|worsening cognitive condition|0
7906242|NCT02006654|12420121|FG001|Overall Study|worsening cognitive condition|1
7906243|NCT02006654|12420120|FG000|Overall Study|faecal incontinence|0
7906244|NCT02006654|12420121|FG001|Overall Study|faecal incontinence|1
7906245|NCT02006654|12420120|FG000|Overall Study|mood disorder|0
7906246|NCT02006654|12420121|FG001|Overall Study|mood disorder|1
7906247|NCT02006654|12420120|FG000|Overall Study|disallowed medication|1
7906248|NCT02006654|12420121|FG001|Overall Study|disallowed medication|0
7906249|NCT02006654|12420120|FG000|Overall Study|moving out of state|0
7906250|NCT02006654|12420121|FG001|Overall Study|moving out of state|1
7906251|NCT02006667|12420128|FG000|Overall Study|Adverse Event|3
7906252|NCT02006667|12420128|FG000|Overall Study|Death|2
7906253|NCT02006667|12420128|FG000|Overall Study|Withdrawal by Subject|1
7906254|NCT02006693|12420134|FG000|Overall Study|No Reason Specified|6
7906255|NCT02006693|12420135|FG001|Overall Study|No Reason Specified|8
7906256|NCT02006693|12420134|FG000|Overall Study|Another Glaucoma-related Surgery|12
7906257|NCT02006693|12420135|FG001|Overall Study|Another Glaucoma-related Surgery|1
7906258|NCT02006693|12420134|FG000|Overall Study|XEN Implant Explantation|0
7906259|NCT02006693|12420135|FG001|Overall Study|XEN Implant Explantation|1
7906260|NCT02006693|12420134|FG000|Overall Study|Death|2
7906261|NCT02006693|12420135|FG001|Overall Study|Death|2
7906262|NCT02006693|12420134|FG000|Overall Study|Lost to Follow-up|4
7906263|NCT02006693|12420135|FG001|Overall Study|Lost to Follow-up|1
7906264|NCT02006693|12420134|FG000|Overall Study|Patient Decision|4
7906265|NCT02006693|12420135|FG001|Overall Study|Patient Decision|0
7906266|NCT02006706|12420141|FG000|Overall Study|Lost to Follow-up|1
7906267|NCT02006719|12420147|FG000|Overall Study|Withdrawal by Subject|10
7906268|NCT02006719|12420148|FG001|Overall Study|Withdrawal by Subject|2
7906269|NCT02006719|12420147|FG000|Overall Study|Lost to Follow-up|5
7906270|NCT02006719|12420148|FG001|Overall Study|Lost to Follow-up|1
7906271|NCT02006719|12420147|FG000|Overall Study|Protocol Violation|2
7906272|NCT02006719|12420148|FG001|Overall Study|Protocol Violation|0
7906273|NCT02006719|12420147|FG000|Overall Study|Adverse Event|1
7906274|NCT02006719|12420148|FG001|Overall Study|Adverse Event|1
7906275|NCT02006719|12420147|FG000|Overall Study|Other/Unknown|0
7906276|NCT02006719|12420148|FG001|Overall Study|Other/Unknown|1
7906277|NCT02006732|12420158|FG000|Overall Study|Adverse Event|10
7906278|NCT02006732|12420159|FG001|Overall Study|Adverse Event|7
7906279|NCT02006732|12420160|FG002|Overall Study|Adverse Event|4
7906280|NCT02006732|12420161|FG003|Overall Study|Adverse Event|2
7906281|NCT02006732|12420158|FG000|Overall Study|Lack of Efficacy|6
7906282|NCT02006732|12420159|FG001|Overall Study|Lack of Efficacy|3
7906283|NCT02006732|12420160|FG002|Overall Study|Lack of Efficacy|1
7906284|NCT02006732|12420161|FG003|Overall Study|Lack of Efficacy|1
7906285|NCT02006732|12420158|FG000|Overall Study|Protocol Violation|1
7906286|NCT02006732|12420159|FG001|Overall Study|Protocol Violation|1
7906287|NCT02006732|12420160|FG002|Overall Study|Protocol Violation|0
7906288|NCT02006732|12420161|FG003|Overall Study|Protocol Violation|0
7906289|NCT02006732|12420158|FG000|Overall Study|Lost to Follow-up|0
7906290|NCT02006732|12420159|FG001|Overall Study|Lost to Follow-up|1
7906291|NCT02006732|12420160|FG002|Overall Study|Lost to Follow-up|0
7906292|NCT02006732|12420161|FG003|Overall Study|Lost to Follow-up|0
7906293|NCT02006732|12420158|FG000|Overall Study|Withdrawal by Subject|3
7906294|NCT02006732|12420159|FG001|Overall Study|Withdrawal by Subject|0
7906295|NCT02006732|12420160|FG002|Overall Study|Withdrawal by Subject|4
7906296|NCT02006732|12420161|FG003|Overall Study|Withdrawal by Subject|1
7906297|NCT02006758|12420171|FG000|Overall Study|Protocol Violation|1
7906298|NCT02006758|12420171|FG000|Overall Study|Death|1
7906299|NCT02006758|12420171|FG000|Overall Study|Lost to Follow-up|4
7906300|NCT02006758|12420171|FG000|Overall Study|Withdrawal by Subject|4
7906301|NCT02006758|12420171|FG000|Overall Study|Procedurally excluded|1
7906302|NCT02006758|12420171|FG000|Overall Study|Other|2
7906303|NCT02006979|12420206|FG000|Overall Study|Withdrawal by Subject|1
7906304|NCT02006979|12420207|FG001|Overall Study|Withdrawal by Subject|1
7906305|NCT02006979|12420206|FG000|Overall Study|Protocol Violation|0
7906306|NCT02006979|12420207|FG001|Overall Study|Protocol Violation|1
7906307|NCT02007070|12420213|FG000|Overall Study|Adverse Event|4
7906308|NCT02007070|12420213|FG000|Overall Study|Clinical Progression|4
7906309|NCT02007070|12420213|FG000|Overall Study|Death|1
7906310|NCT02007070|12420213|FG000|Overall Study|Protocol Violation|2
7906311|NCT02007070|12420213|FG000|Overall Study|Physician Decision|1
7906312|NCT02007070|12420213|FG000|Overall Study|Progressive Disease|21
7906313|NCT02007096|12420219|FG000|Overall Study|medication not available|2
7906314|NCT02007096|12420220|FG001|Overall Study|medication not available|0
7906315|NCT02007096|12420219|FG000|Overall Study|did not inject saline|0
7906316|NCT02007096|12420220|FG001|Overall Study|did not inject saline|3
7906317|NCT02007096|12420219|FG000|Overall Study|did not follow postoperative protocol|8
7906318|NCT02007096|12420220|FG001|Overall Study|did not follow postoperative protocol|11
7906319|NCT02007096|12420219|FG000|Overall Study|converted to open surgery|1
7906320|NCT02007096|12420220|FG001|Overall Study|converted to open surgery|1
7906321|NCT02007096|12420219|FG000|Overall Study|no mesh placed|0
7906322|NCT02007096|12420220|FG001|Overall Study|no mesh placed|1
7906323|NCT02007109|12420226|FG000|Overall Study|Diary not returned or excluded|102
7906324|NCT02007109|12420226|FG000|Overall Study|Excluded - Age<7yo|9
7906325|NCT02007252|12420239|FG000|Overall Study|Administrative problems|3
7906326|NCT02007252|12420240|FG001|Overall Study|Administrative problems|7
7906327|NCT02007252|12420239|FG000|Overall Study|Abnormal laboratory value(s)|1
7906328|NCT02007252|12420240|FG001|Overall Study|Abnormal laboratory value(s)|0
7906329|NCT02007252|12420239|FG000|Overall Study|Adverse Event|7
7906330|NCT02007252|12420240|FG001|Overall Study|Adverse Event|4
7906331|NCT02007278|12420248|FG000|Overall Study|Failure to comply with an eligibility|0
7906332|NCT02007278|12420249|FG001|Overall Study|Failure to comply with an eligibility|1
7906333|NCT02007278|12420248|FG000|Overall Study|Ingestion of drugs not allowed in study|0
7906334|NCT02007278|12420249|FG001|Overall Study|Ingestion of drugs not allowed in study|1
7906335|NCT02007278|12420248|FG000|Overall Study|Incorrect medication administration|1
7906336|NCT02007278|12420249|FG001|Overall Study|Incorrect medication administration|0
7906337|NCT02007278|12420248|FG000|Overall Study|Mis-randomization|1
7906338|NCT02007278|12420249|FG001|Overall Study|Mis-randomization|1
7906339|NCT02007434|12420283|FG000|Overall Study|Lost to Follow-up|0
7906340|NCT02007434|12420284|FG001|Overall Study|Lost to Follow-up|1
7906341|NCT02007434|12420285|FG002|Overall Study|Lost to Follow-up|0
7906342|NCT02007434|12420286|FG003|Overall Study|Lost to Follow-up|0
7906343|NCT02007434|12420287|FG004|Overall Study|Lost to Follow-up|0
7906344|NCT02007434|12420288|FG005|Overall Study|Lost to Follow-up|0
7906345|NCT02007434|12420289|FG006|Overall Study|Lost to Follow-up|0
7906346|NCT02007434|12420290|FG007|Overall Study|Lost to Follow-up|0
7906347|NCT02007434|12420283|FG000|Overall Study|Non-compliance|1
7906348|NCT02007434|12420284|FG001|Overall Study|Non-compliance|0
7906349|NCT02007434|12420285|FG002|Overall Study|Non-compliance|1
7906350|NCT02007434|12420286|FG003|Overall Study|Non-compliance|0
7906351|NCT02007434|12420287|FG004|Overall Study|Non-compliance|0
7906352|NCT02007434|12420288|FG005|Overall Study|Non-compliance|0
7906353|NCT02007434|12420289|FG006|Overall Study|Non-compliance|0
7906354|NCT02007434|12420290|FG007|Overall Study|Non-compliance|0
7906355|NCT02007577|12420311|FG000|Overall Study|Adverse Event|1
7906356|NCT02007577|12420312|FG001|Overall Study|Adverse Event|0
7906357|NCT02007577|12420311|FG000|Overall Study|Withdrawal by Subject|0
7906358|NCT02007577|12420312|FG001|Overall Study|Withdrawal by Subject|1
7906359|NCT02007720|12420320|FG000|Overall Study|Withdrawal by Subject|9
7969199|NCT02793622|12527742|FG000|Overall Study|Protocol Violation|1
7969200|NCT02793622|12527743|FG001|Overall Study|Protocol Violation|5
7969201|NCT02793947|12527820|FG000|Overall Study|Death|1
7969202|NCT02793947|12527821|FG001|Overall Study|Death|0
7969203|NCT02793947|12527820|FG000|Overall Study|Physician Decision|1
7969204|NCT02793947|12527821|FG001|Overall Study|Physician Decision|5
7969205|NCT02794103|12527827|FG000|Overall Study|Loss to follow up due to high sedation|3
7969206|NCT02794246|12527839|FG000|Overall Study|Withdrawal by Subject|2
7969207|NCT02794246|12527839|FG000|Overall Study|Physician Decision|4
7969208|NCT02794480|12527854|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
7969209|NCT02794480|12527855|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
7969210|NCT02794480|12527856|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
7969211|NCT02794480|12527857|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
7969212|NCT02794480|12527854|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
7969213|NCT02794480|12527855|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
7969214|NCT02794480|12527856|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
7969215|NCT02794480|12527857|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
7969216|NCT02794480|12527854|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
7969217|NCT02794480|12527855|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
7969218|NCT02794480|12527856|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
7969219|NCT02794480|12527857|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
7969220|NCT02794480|12527854|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7969221|NCT02794480|12527855|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
7969222|NCT02794480|12527856|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7969223|NCT02794480|12527857|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7969224|NCT02794480|12527854|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
7969225|NCT02794480|12527855|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7969226|NCT02794480|12527856|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7969227|NCT02794480|12527857|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
7969228|NCT02794870|12527905|FG000|Overall Study|Withdrawal by Subject|2
7969229|NCT02794870|12527906|FG001|Overall Study|Withdrawal by Subject|0
7969230|NCT02794974|12527914|FG000|Overall Study|Physician Decision|0
7969231|NCT02794974|12527915|FG001|Overall Study|Physician Decision|1
7969232|NCT02795767|12527937|FG000|Overall Study|Received Commercial Emicizumab|1
7969233|NCT02795767|12527938|FG001|Overall Study|Received Commercial Emicizumab|0
7969234|NCT02795767|12527939|FG002|Overall Study|Received Commercial Emicizumab|0
7969235|NCT02795832|12527984|FG000|Overall Study|Adverse Event|0
7969236|NCT02795832|12527985|FG001|Overall Study|Adverse Event|0
7969237|NCT02795832|12527986|FG002|Overall Study|Adverse Event|0
7969238|NCT02795832|12527987|FG003|Overall Study|Adverse Event|0
7969239|NCT02795832|12527988|FG004|Overall Study|Adverse Event|0
7969240|NCT02795832|12527989|FG005|Overall Study|Adverse Event|3
7969241|NCT02796560|12528054|FG000|Overall Study|Adverse Event|2
7969242|NCT02796560|12528055|FG001|Overall Study|Adverse Event|0
7969243|NCT02796560|12528054|FG000|Overall Study|Withdrawal by Subject|2
7969244|NCT02796560|12528055|FG001|Overall Study|Withdrawal by Subject|2
7969245|NCT02796651|12528065|FG000|Overall Study|Adverse Event|6
7969246|NCT02796651|12528065|FG000|Overall Study|Lost to Follow-up|1
7969247|NCT02796651|12528065|FG000|Overall Study|Withdrawal by Subject|4
7969248|NCT02796651|12528065|FG000|Overall Study|Protocol Violation|4
7969249|NCT02796651|12528065|FG000|Overall Study|Lack of Efficacy|1
7969250|NCT02796651|12528065|FG000|Overall Study|Other|10
7969251|NCT02796664|12528082|FG000|Overall Study|Withdrawal by Subject|0
7969252|NCT02796664|12528083|FG001|Overall Study|Withdrawal by Subject|3
7969253|NCT02796664|12528082|FG000|Overall Study|Noncompliance|1
7969254|NCT02796664|12528083|FG001|Overall Study|Noncompliance|1
7969255|NCT02796664|12528082|FG000|Overall Study|Death|0
7969256|NCT02796664|12528083|FG001|Overall Study|Death|1
7969257|NCT02796677|12528095|FG000|Overall Study|Adverse Event|11
7969258|NCT02796677|12528096|FG001|Overall Study|Adverse Event|22
7969259|NCT02796677|12528097|FG002|Overall Study|Adverse Event|14
7969260|NCT02796677|12528098|FG003|Overall Study|Adverse Event|14
7969261|NCT02796677|12528095|FG000|Overall Study|Protocol Violation|7
7969262|NCT02796677|12528096|FG001|Overall Study|Protocol Violation|5
7969263|NCT02796677|12528097|FG002|Overall Study|Protocol Violation|4
7969264|NCT02796677|12528098|FG003|Overall Study|Protocol Violation|8
7969265|NCT02796677|12528095|FG000|Overall Study|Lost to Follow-up|1
7969266|NCT02796677|12528096|FG001|Overall Study|Lost to Follow-up|5
7969267|NCT02796677|12528097|FG002|Overall Study|Lost to Follow-up|2
7969268|NCT02796677|12528098|FG003|Overall Study|Lost to Follow-up|2
7969269|NCT02796677|12528095|FG000|Overall Study|Lack of Efficacy|7
7969270|NCT02796677|12528096|FG001|Overall Study|Lack of Efficacy|9
7969271|NCT02796677|12528097|FG002|Overall Study|Lack of Efficacy|14
7969272|NCT02796677|12528098|FG003|Overall Study|Lack of Efficacy|20
7969273|NCT02796677|12528095|FG000|Overall Study|Withdrawal by Subject|4
7906360|NCT02007720|12420321|FG001|Overall Study|Withdrawal by Subject|11
7906361|NCT02007720|12420320|FG000|Overall Study|study terminated by sponsor|58
7906362|NCT02007720|12420321|FG001|Overall Study|study terminated by sponsor|54
7906363|NCT02007720|12420320|FG000|Overall Study|technical problem|4
7906364|NCT02007720|12420321|FG001|Overall Study|technical problem|2
7906365|NCT02007720|12420320|FG000|Overall Study|patient followd less than 165 days|11
7906366|NCT02007720|12420321|FG001|Overall Study|patient followd less than 165 days|5
7906367|NCT02007954|12420332|FG000|Overall Study|Received liver transplant|3
7906368|NCT02007954|12420332|FG000|Overall Study|Switch in treatment modality|2
7906369|NCT02007954|12420332|FG000|Overall Study|Disease progression and unrelated AE|1
7906370|NCT02007954|12420332|FG000|Overall Study|Death|1
7906371|NCT02008227|12420351|FG000|Overall Study|Lost to Follow-up|7
7906372|NCT02008227|12420352|FG001|Overall Study|Lost to Follow-up|9
7906373|NCT02008227|12420351|FG000|Overall Study|Death|494
7906374|NCT02008227|12420352|FG001|Overall Study|Death|485
7906375|NCT02008227|12420351|FG000|Overall Study|Withdrawal by Subject|67
7906376|NCT02008227|12420352|FG001|Overall Study|Withdrawal by Subject|36
7906377|NCT02008227|12420351|FG000|Overall Study|Study Terminated By Sponsor|44
7906378|NCT02008227|12420352|FG001|Overall Study|Study Terminated By Sponsor|83
7906379|NCT02008318|12420361|FG000|Overall Study|Adverse Event|4
7906380|NCT02008318|12420362|FG001|Overall Study|Adverse Event|0
7906381|NCT02008318|12420361|FG000|Overall Study|Physician Decision|2
7906382|NCT02008318|12420362|FG001|Overall Study|Physician Decision|0
7906383|NCT02008318|12420361|FG000|Overall Study|Progressive Disease|2
7906384|NCT02008318|12420362|FG001|Overall Study|Progressive Disease|0
7906385|NCT02008318|12420361|FG000|Overall Study|Protocol Violation|1
7906386|NCT02008318|12420362|FG001|Overall Study|Protocol Violation|1
7906387|NCT02008318|12420361|FG000|Overall Study|Withdrawal by Subject|3
7906388|NCT02008318|12420362|FG001|Overall Study|Withdrawal by Subject|0
7906389|NCT02008526|12420374|FG000|Overall Study|Death|0
7906390|NCT02008526|12420375|FG001|Overall Study|Death|2
7906391|NCT02008526|12420376|FG002|Overall Study|Death|1
7906392|NCT02008526|12420374|FG000|Overall Study|Withdrawal by Subject|3
7906393|NCT02008526|12420375|FG001|Overall Study|Withdrawal by Subject|3
7906394|NCT02008526|12420376|FG002|Overall Study|Withdrawal by Subject|2
7906395|NCT02008526|12420374|FG000|Overall Study|Lost to Follow-up|5
7906396|NCT02008526|12420375|FG001|Overall Study|Lost to Follow-up|9
7906397|NCT02008526|12420376|FG002|Overall Study|Lost to Follow-up|6
7906398|NCT02008565|12420388|FG000|Overall Study|Protocol Violation|1
7906399|NCT02008565|12420389|FG001|Overall Study|Protocol Violation|1
7906400|NCT02008565|12420390|FG002|Overall Study|Protocol Violation|2
7906401|NCT02008565|12420391|FG003|Overall Study|Protocol Violation|0
7906402|NCT02008773|12420425|FG000|Overall Study|Adverse Event|3
7906403|NCT02008773|12420426|FG001|Overall Study|Adverse Event|3
7906404|NCT02008773|12420427|FG002|Overall Study|Adverse Event|1
7906405|NCT02008773|12420428|FG003|Overall Study|Adverse Event|2
7906406|NCT02008773|12420425|FG000|Overall Study|Medication Non-compliance|2
7906407|NCT02008773|12420426|FG001|Overall Study|Medication Non-compliance|1
7906408|NCT02008773|12420427|FG002|Overall Study|Medication Non-compliance|3
7906409|NCT02008773|12420428|FG003|Overall Study|Medication Non-compliance|2
7906410|NCT02008773|12420425|FG000|Overall Study|Withdrawal by Subject|8
7906411|NCT02008773|12420426|FG001|Overall Study|Withdrawal by Subject|4
7906412|NCT02008773|12420427|FG002|Overall Study|Withdrawal by Subject|7
7906413|NCT02008773|12420428|FG003|Overall Study|Withdrawal by Subject|6
7906414|NCT02008773|12420425|FG000|Overall Study|Lost to Follow-up|0
7906415|NCT02008773|12420426|FG001|Overall Study|Lost to Follow-up|1
7906416|NCT02008773|12420427|FG002|Overall Study|Lost to Follow-up|3
7906417|NCT02008773|12420428|FG003|Overall Study|Lost to Follow-up|2
7906418|NCT02008877|12420436|FG000|Overall Study|Inevaluable|0
7906419|NCT02008877|12420437|FG001|Overall Study|Inevaluable|1
7906420|NCT02008877|12420438|FG002|Overall Study|Inevaluable|0
7906421|NCT02008890|12420450|FG000|Period 1|Withdrawal by Subject|7
7969274|NCT02796677|12528096|FG001|Overall Study|Withdrawal by Subject|14
7906422|NCT02008890|12420451|FG001|Period 1|Withdrawal by Subject|7
7906423|NCT02008890|12420452|FG002|Period 1|Withdrawal by Subject|5
7906424|NCT02008890|12420453|FG003|Period 1|Withdrawal by Subject|0
7906425|NCT02008890|12420454|FG004|Period 1|Withdrawal by Subject|0
7906426|NCT02008890|12420450|FG000|Period 1|Pregnancy|1
7906427|NCT02008890|12420451|FG001|Period 1|Pregnancy|0
7906428|NCT02008890|12420452|FG002|Period 1|Pregnancy|0
7906429|NCT02008890|12420453|FG003|Period 1|Pregnancy|0
7906430|NCT02008890|12420454|FG004|Period 1|Pregnancy|0
7906431|NCT02008890|12420450|FG000|Period 1|Physician Decision|1
7906432|NCT02008890|12420451|FG001|Period 1|Physician Decision|0
7906433|NCT02008890|12420452|FG002|Period 1|Physician Decision|1
7906434|NCT02008890|12420453|FG003|Period 1|Physician Decision|0
7906435|NCT02008890|12420454|FG004|Period 1|Physician Decision|0
7906436|NCT02008890|12420450|FG000|Period 1|Adverse Event|6
7906437|NCT02008890|12420451|FG001|Period 1|Adverse Event|8
7906438|NCT02008890|12420452|FG002|Period 1|Adverse Event|6
7906439|NCT02008890|12420453|FG003|Period 1|Adverse Event|0
7906440|NCT02008890|12420454|FG004|Period 1|Adverse Event|0
7906441|NCT02008890|12420450|FG000|Period 2|Adverse Event|12
7906442|NCT02008890|12420451|FG001|Period 2|Adverse Event|7
7906443|NCT02008890|12420452|FG002|Period 2|Adverse Event|0
7906444|NCT02008890|12420453|FG003|Period 2|Adverse Event|5
7906445|NCT02008890|12420454|FG004|Period 2|Adverse Event|5
7906446|NCT02008890|12420450|FG000|Period 2|Withdrawal by Subject|11
7906447|NCT02008890|12420451|FG001|Period 2|Withdrawal by Subject|8
7906448|NCT02008890|12420452|FG002|Period 2|Withdrawal by Subject|0
7906449|NCT02008890|12420453|FG003|Period 2|Withdrawal by Subject|7
7906450|NCT02008890|12420454|FG004|Period 2|Withdrawal by Subject|2
7906451|NCT02008890|12420450|FG000|Period 2|Physician Decision|4
7906452|NCT02008890|12420451|FG001|Period 2|Physician Decision|0
7906453|NCT02008890|12420452|FG002|Period 2|Physician Decision|0
7906454|NCT02008890|12420453|FG003|Period 2|Physician Decision|2
7906455|NCT02008890|12420454|FG004|Period 2|Physician Decision|1
7906456|NCT02008890|12420450|FG000|Period 2|Lost to Follow-up|0
7906457|NCT02008890|12420451|FG001|Period 2|Lost to Follow-up|0
7906458|NCT02008890|12420452|FG002|Period 2|Lost to Follow-up|1
7906459|NCT02008890|12420453|FG003|Period 2|Lost to Follow-up|0
7906460|NCT02008890|12420454|FG004|Period 2|Lost to Follow-up|0
7906461|NCT02008890|12420450|FG000|Extension Period|Withdrawal by Subject|3
7906462|NCT02008890|12420451|FG001|Extension Period|Withdrawal by Subject|2
7906463|NCT02008890|12420452|FG002|Extension Period|Withdrawal by Subject|0
7906464|NCT02008890|12420453|FG003|Extension Period|Withdrawal by Subject|4
7906465|NCT02008890|12420454|FG004|Extension Period|Withdrawal by Subject|2
7906466|NCT02008890|12420450|FG000|Extension Period|Lost to Follow-up|1
7906467|NCT02008890|12420451|FG001|Extension Period|Lost to Follow-up|0
7906468|NCT02008890|12420452|FG002|Extension Period|Lost to Follow-up|0
7906469|NCT02008890|12420453|FG003|Extension Period|Lost to Follow-up|0
7906470|NCT02008890|12420454|FG004|Extension Period|Lost to Follow-up|0
7906471|NCT02008890|12420450|FG000|Extension Period|Adverse Event|1
7906472|NCT02008890|12420451|FG001|Extension Period|Adverse Event|3
7906473|NCT02008890|12420452|FG002|Extension Period|Adverse Event|0
7906474|NCT02008890|12420453|FG003|Extension Period|Adverse Event|0
7906475|NCT02008890|12420454|FG004|Extension Period|Adverse Event|2
7906476|NCT02008916|12420472|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
7906477|NCT02008916|12420473|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
7906478|NCT02008916|12420474|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
7906479|NCT02008916|12420472|FG000|Week 16 - 156|Adverse Event|4
7906480|NCT02008916|12420473|FG001|Week 16 - 156|Adverse Event|2
7906481|NCT02008916|12420474|FG002|Week 16 - 156|Adverse Event|3
7906482|NCT02008916|12420472|FG000|Week 16 - 156|Withdrawal by Subject|7
7906483|NCT02008916|12420473|FG001|Week 16 - 156|Withdrawal by Subject|3
7906484|NCT02008916|12420474|FG002|Week 16 - 156|Withdrawal by Subject|5
7906485|NCT02008916|12420472|FG000|Week 16 - 156|No longer requires treatment|0
7906486|NCT02008916|12420473|FG001|Week 16 - 156|No longer requires treatment|1
7906487|NCT02008916|12420474|FG002|Week 16 - 156|No longer requires treatment|0
7906488|NCT02008916|12420472|FG000|Week 16 - 156|Lost to Follow-up|5
7906489|NCT02008916|12420473|FG001|Week 16 - 156|Lost to Follow-up|0
7906490|NCT02008916|12420474|FG002|Week 16 - 156|Lost to Follow-up|0
7906491|NCT02008916|12420472|FG000|Week 16 - 156|Lack of Efficacy|3
7906492|NCT02008916|12420473|FG001|Week 16 - 156|Lack of Efficacy|5
7906493|NCT02008916|12420474|FG002|Week 16 - 156|Lack of Efficacy|2
7906494|NCT02008916|12420472|FG000|Week 16 - 156|Pregnancy|0
7906495|NCT02008916|12420473|FG001|Week 16 - 156|Pregnancy|1
7906496|NCT02008916|12420474|FG002|Week 16 - 156|Pregnancy|0
7906497|NCT02008916|12420472|FG000|Week 16 - 156|Physician Decision|0
7906498|NCT02008916|12420473|FG001|Week 16 - 156|Physician Decision|1
7906499|NCT02008916|12420474|FG002|Week 16 - 156|Physician Decision|0
7906500|NCT02009046|12420492|FG000|Overall Study|Lost to Follow-up|256
7906501|NCT02009046|12420493|FG001|Overall Study|Lost to Follow-up|206
7906502|NCT02009163|12420507|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
7906503|NCT02009163|12420508|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
7906504|NCT02009163|12420509|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
7906505|NCT02009163|12420507|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29
7906506|NCT02009163|12420508|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0
7963976|NCT02732119|12518839|FG001|Phase II|Physician Decision|0
7906507|NCT02009163|12420509|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0
7906508|NCT02009163|12420507|FG000|Open-label Period (Non-randomized)|Adverse Event|22
7906509|NCT02009163|12420508|FG001|Open-label Period (Non-randomized)|Adverse Event|0
7906510|NCT02009163|12420509|FG002|Open-label Period (Non-randomized)|Adverse Event|0
7906511|NCT02009163|12420507|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20
7906512|NCT02009163|12420508|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0
7906513|NCT02009163|12420509|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0
7906514|NCT02009163|12420507|FG000|Open-label Period (Non-randomized)|Protocol Violation|10
7906515|NCT02009163|12420508|FG001|Open-label Period (Non-randomized)|Protocol Violation|0
7906516|NCT02009163|12420509|FG002|Open-label Period (Non-randomized)|Protocol Violation|0
7906517|NCT02009163|12420507|FG000|Open-label Period (Non-randomized)|Pregnancy|1
7906518|NCT02009163|12420508|FG001|Open-label Period (Non-randomized)|Pregnancy|0
7906519|NCT02009163|12420509|FG002|Open-label Period (Non-randomized)|Pregnancy|0
7906520|NCT02009163|12420507|FG000|Open-label Period (Non-randomized)|Other|13
7906521|NCT02009163|12420508|FG001|Open-label Period (Non-randomized)|Other|0
7906522|NCT02009163|12420509|FG002|Open-label Period (Non-randomized)|Other|0
7906523|NCT02009163|12420507|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0
7906524|NCT02009163|12420508|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25
7906525|NCT02009163|12420509|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9
7906526|NCT02009163|12420507|FG000|Randomized-withdrawal Period|Lost to Follow-up|0
7906527|NCT02009163|12420508|FG001|Randomized-withdrawal Period|Lost to Follow-up|13
7906528|NCT02009163|12420509|FG002|Randomized-withdrawal Period|Lost to Follow-up|6
7906529|NCT02009163|12420507|FG000|Randomized-withdrawal Period|Adverse Event|0
7906530|NCT02009163|12420508|FG001|Randomized-withdrawal Period|Adverse Event|0
7906531|NCT02009163|12420509|FG002|Randomized-withdrawal Period|Adverse Event|6
7906532|NCT02009163|12420507|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0
7906533|NCT02009163|12420508|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40
7906534|NCT02009163|12420509|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5
7906535|NCT02009163|12420507|FG000|Randomized-withdrawal Period|Protocol Violation|0
7906536|NCT02009163|12420508|FG001|Randomized-withdrawal Period|Protocol Violation|1
7906537|NCT02009163|12420509|FG002|Randomized-withdrawal Period|Protocol Violation|2
7906538|NCT02009163|12420507|FG000|Randomized-withdrawal Period|Pregnancy|0
7906539|NCT02009163|12420508|FG001|Randomized-withdrawal Period|Pregnancy|0
7906540|NCT02009163|12420509|FG002|Randomized-withdrawal Period|Pregnancy|2
7906541|NCT02009163|12420507|FG000|Randomized-withdrawal Period|Other|0
7906542|NCT02009163|12420508|FG001|Randomized-withdrawal Period|Other|9
7906543|NCT02009163|12420509|FG002|Randomized-withdrawal Period|Other|5
7906544|NCT02009332|12420525|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7906545|NCT02009332|12420526|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1
7906546|NCT02009332|12420527|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7906547|NCT02009332|12420528|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7906548|NCT02009332|12420529|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7906549|NCT02009332|12420530|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7906550|NCT02009332|12420525|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7906551|NCT02009332|12420526|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7906552|NCT02009332|12420527|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7906553|NCT02009332|12420528|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7906554|NCT02009332|12420529|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1
7906555|NCT02009332|12420530|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7906556|NCT02009332|12420525|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7906557|NCT02009332|12420526|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7906558|NCT02009332|12420527|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7906559|NCT02009332|12420528|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7906560|NCT02009332|12420529|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7906561|NCT02009332|12420530|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1
7906562|NCT02009397|12420544|FG000|Overall Study|Protocol Violation|6
7906563|NCT02009397|12420544|FG000|Overall Study|Death|8
7906564|NCT02009397|12420544|FG000|Overall Study|Lost to Follow-up|6
7906565|NCT02009696|12420557|FG000|Overall Study|Withdrawal by Subject|2
7906566|NCT02009722|12420563|FG000|Overall Study|Protocol Violation|1
7906567|NCT02009722|12420564|FG001|Overall Study|Protocol Violation|2
7906568|NCT02009722|12420563|FG000|Overall Study|Did not receive intervention|0
7906569|NCT02009722|12420564|FG001|Overall Study|Did not receive intervention|1
7906570|NCT02009865|12420572|FG000|Overall Study|Adverse Event|0
7906571|NCT02009865|12420573|FG001|Overall Study|Adverse Event|2
7906572|NCT02009865|12420572|FG000|Overall Study|Protocol Violation|0
7906573|NCT02009865|12420573|FG001|Overall Study|Protocol Violation|2
7906574|NCT02009865|12420572|FG000|Overall Study|Withdrawal by Subject|1
7906575|NCT02009865|12420573|FG001|Overall Study|Withdrawal by Subject|1
7906576|NCT02009878|12420582|FG000|Overall Study|Participant Met Withdrawal Criteria|0
7906577|NCT02009878|12420583|FG001|Overall Study|Participant Met Withdrawal Criteria|1
7906578|NCT02009878|12420584|FG002|Overall Study|Participant Met Withdrawal Criteria|0
7906579|NCT02009930|12420592|FG000|Overall Study|withdrawn|5
7906580|NCT02010255|12420660|FG000|Overall Study|Death|0
7906581|NCT02010255|12420661|FG001|Overall Study|Death|1
7906582|NCT02010255|12420662|FG002|Overall Study|Death|4
7906583|NCT02010255|12420663|FG003|Overall Study|Death|4
7906584|NCT02010255|12420664|FG004|Overall Study|Death|2
7906585|NCT02010255|12420665|FG005|Overall Study|Death|0
7906586|NCT02010255|12420666|FG006|Overall Study|Death|1
7906587|NCT02010255|12420667|FG007|Overall Study|Death|1
7906588|NCT02010255|12420668|FG008|Overall Study|Death|1
7906589|NCT02010255|12420669|FG009|Overall Study|Death|0
7906590|NCT02010255|12420670|FG010|Overall Study|Death|1
7906591|NCT02010255|12420671|FG011|Overall Study|Death|1
7906592|NCT02010255|12420672|FG012|Overall Study|Death|0
7906593|NCT02010255|12420673|FG013|Overall Study|Death|0
7906594|NCT02010255|12420660|FG000|Overall Study|Lack of Efficacy|4
7906595|NCT02010255|12420661|FG001|Overall Study|Lack of Efficacy|1
7906596|NCT02010255|12420662|FG002|Overall Study|Lack of Efficacy|2
7906597|NCT02010255|12420663|FG003|Overall Study|Lack of Efficacy|1
7906598|NCT02010255|12420664|FG004|Overall Study|Lack of Efficacy|1
7906599|NCT02010255|12420665|FG005|Overall Study|Lack of Efficacy|0
7906600|NCT02010255|12420666|FG006|Overall Study|Lack of Efficacy|0
7906601|NCT02010255|12420667|FG007|Overall Study|Lack of Efficacy|0
7906602|NCT02010255|12420668|FG008|Overall Study|Lack of Efficacy|0
7906603|NCT02010255|12420669|FG009|Overall Study|Lack of Efficacy|0
7906604|NCT02010255|12420670|FG010|Overall Study|Lack of Efficacy|1
7906605|NCT02010255|12420671|FG011|Overall Study|Lack of Efficacy|0
7906606|NCT02010255|12420672|FG012|Overall Study|Lack of Efficacy|0
7906607|NCT02010255|12420673|FG013|Overall Study|Lack of Efficacy|0
7906608|NCT02010255|12420660|FG000|Overall Study|Withdrew Consent|1
7906609|NCT02010255|12420661|FG001|Overall Study|Withdrew Consent|0
7906610|NCT02010255|12420662|FG002|Overall Study|Withdrew Consent|0
7906611|NCT02010255|12420663|FG003|Overall Study|Withdrew Consent|1
7906612|NCT02010255|12420664|FG004|Overall Study|Withdrew Consent|0
7906613|NCT02010255|12420665|FG005|Overall Study|Withdrew Consent|0
7906614|NCT02010255|12420666|FG006|Overall Study|Withdrew Consent|0
7906615|NCT02010255|12420667|FG007|Overall Study|Withdrew Consent|0
7906616|NCT02010255|12420668|FG008|Overall Study|Withdrew Consent|0
7906617|NCT02010255|12420669|FG009|Overall Study|Withdrew Consent|0
7906618|NCT02010255|12420670|FG010|Overall Study|Withdrew Consent|0
7906619|NCT02010255|12420671|FG011|Overall Study|Withdrew Consent|0
7906620|NCT02010255|12420672|FG012|Overall Study|Withdrew Consent|0
7906621|NCT02010255|12420673|FG013|Overall Study|Withdrew Consent|0
7906622|NCT02010255|12420660|FG000|Overall Study|Adverse Event|1
7906623|NCT02010255|12420661|FG001|Overall Study|Adverse Event|0
7906624|NCT02010255|12420662|FG002|Overall Study|Adverse Event|0
7906625|NCT02010255|12420663|FG003|Overall Study|Adverse Event|0
7906626|NCT02010255|12420664|FG004|Overall Study|Adverse Event|0
7906627|NCT02010255|12420665|FG005|Overall Study|Adverse Event|0
7906628|NCT02010255|12420666|FG006|Overall Study|Adverse Event|0
7906629|NCT02010255|12420667|FG007|Overall Study|Adverse Event|0
7906630|NCT02010255|12420668|FG008|Overall Study|Adverse Event|0
7906631|NCT02010255|12420669|FG009|Overall Study|Adverse Event|0
7906632|NCT02010255|12420670|FG010|Overall Study|Adverse Event|0
7906633|NCT02010255|12420671|FG011|Overall Study|Adverse Event|0
7906634|NCT02010255|12420672|FG012|Overall Study|Adverse Event|0
7906635|NCT02010255|12420673|FG013|Overall Study|Adverse Event|0
7906636|NCT02010255|12420660|FG000|Overall Study|Lost to Follow-up|0
7906637|NCT02010255|12420661|FG001|Overall Study|Lost to Follow-up|0
7906638|NCT02010255|12420662|FG002|Overall Study|Lost to Follow-up|1
7906639|NCT02010255|12420663|FG003|Overall Study|Lost to Follow-up|0
7906640|NCT02010255|12420664|FG004|Overall Study|Lost to Follow-up|1
7906641|NCT02010255|12420665|FG005|Overall Study|Lost to Follow-up|0
7906642|NCT02010255|12420666|FG006|Overall Study|Lost to Follow-up|0
7906643|NCT02010255|12420667|FG007|Overall Study|Lost to Follow-up|0
7906644|NCT02010255|12420668|FG008|Overall Study|Lost to Follow-up|0
7906645|NCT02010255|12420669|FG009|Overall Study|Lost to Follow-up|0
7906646|NCT02010255|12420670|FG010|Overall Study|Lost to Follow-up|0
7906647|NCT02010255|12420671|FG011|Overall Study|Lost to Follow-up|0
7906648|NCT02010255|12420672|FG012|Overall Study|Lost to Follow-up|0
7906649|NCT02010255|12420673|FG013|Overall Study|Lost to Follow-up|0
7906650|NCT02010255|12420660|FG000|Overall Study|Randomized but Not Treated|0
7906651|NCT02010255|12420661|FG001|Overall Study|Randomized but Not Treated|0
7906652|NCT02010255|12420662|FG002|Overall Study|Randomized but Not Treated|0
7906653|NCT02010255|12420663|FG003|Overall Study|Randomized but Not Treated|0
7906654|NCT02010255|12420664|FG004|Overall Study|Randomized but Not Treated|0
7906655|NCT02010255|12420665|FG005|Overall Study|Randomized but Not Treated|0
7906656|NCT02010255|12420666|FG006|Overall Study|Randomized but Not Treated|0
7906657|NCT02010255|12420667|FG007|Overall Study|Randomized but Not Treated|0
7906658|NCT02010255|12420668|FG008|Overall Study|Randomized but Not Treated|0
7906659|NCT02010255|12420669|FG009|Overall Study|Randomized but Not Treated|0
7906660|NCT02010255|12420670|FG010|Overall Study|Randomized but Not Treated|0
7906661|NCT02010255|12420671|FG011|Overall Study|Randomized but Not Treated|0
7906662|NCT02010255|12420672|FG012|Overall Study|Randomized but Not Treated|0
7906663|NCT02010255|12420673|FG013|Overall Study|Randomized but Not Treated|1
7906664|NCT02010567|12420742|FG000|Overall Study|Adverse Event|0
7906665|NCT02010567|12420743|FG001|Overall Study|Adverse Event|0
7906666|NCT02010567|12420744|FG002|Overall Study|Adverse Event|1
7906667|NCT02010567|12420745|FG003|Overall Study|Adverse Event|0
7906668|NCT02010567|12420746|FG004|Overall Study|Adverse Event|1
7906669|NCT02010632|12420756|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1
7906670|NCT02010632|12420757|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0
7906671|NCT02010684|12420769|FG000|Overall Study|Lost to Follow-up|8
7906672|NCT02010684|12420770|FG001|Overall Study|Lost to Follow-up|18
7906673|NCT02010684|12420769|FG000|Overall Study|Withdrawal by Subject|4
7906674|NCT02010684|12420770|FG001|Overall Study|Withdrawal by Subject|5
7906675|NCT02010775|12420794|FG000|Overall Study|Adverse Event|0
7906676|NCT02010775|12420795|FG001|Overall Study|Adverse Event|0
7906677|NCT02010775|12420796|FG002|Overall Study|Adverse Event|0
7906678|NCT02010775|12420797|FG003|Overall Study|Adverse Event|0
7906679|NCT02010775|12420798|FG004|Overall Study|Adverse Event|1
7906680|NCT02010775|12420794|FG000|Overall Study|Pregnancy|0
7906681|NCT02010775|12420795|FG001|Overall Study|Pregnancy|0
7906682|NCT02010775|12420796|FG002|Overall Study|Pregnancy|2
7906683|NCT02010775|12420797|FG003|Overall Study|Pregnancy|0
7906684|NCT02010775|12420798|FG004|Overall Study|Pregnancy|0
7906685|NCT02010775|12420794|FG000|Overall Study|Lost to Follow-up|2
7906686|NCT02010775|12420795|FG001|Overall Study|Lost to Follow-up|0
7906687|NCT02010775|12420796|FG002|Overall Study|Lost to Follow-up|0
7906688|NCT02010775|12420797|FG003|Overall Study|Lost to Follow-up|1
7906689|NCT02010775|12420798|FG004|Overall Study|Lost to Follow-up|1
7906690|NCT02010775|12420794|FG000|Overall Study|Personal Reasons|3
7906691|NCT02010775|12420795|FG001|Overall Study|Personal Reasons|3
7906692|NCT02010775|12420796|FG002|Overall Study|Personal Reasons|1
7906693|NCT02010775|12420797|FG003|Overall Study|Personal Reasons|2
7906694|NCT02010775|12420798|FG004|Overall Study|Personal Reasons|4
7906695|NCT02011113|12420823|FG000|Overall Study|Adverse Event|4
7906696|NCT02011113|12420823|FG000|Overall Study|Disease Progression (DP)|16
7906697|NCT02011113|12420823|FG000|Overall Study|Death|1
7906698|NCT02011113|12420823|FG000|Overall Study|Insufficient effect of Pomalidomide|1
7906699|NCT02011113|12420823|FG000|Overall Study|Investigator's judgement- DP|3
7906700|NCT02011113|12420823|FG000|Overall Study|Study terminated by sponsor|11
7906701|NCT02011386|12420828|FG000|Overall Study|Non-compliance|2
7906702|NCT02011386|12420828|FG000|Overall Study|Lack of Efficacy|3
7906703|NCT02011893|12420884|FG000|Enrollment to Randomization|Adverse Event|2
7906704|NCT02011893|12420885|FG001|Enrollment to Randomization|Adverse Event|0
7906705|NCT02011893|12420886|FG002|Enrollment to Randomization|Adverse Event|0
7906706|NCT02011893|12420884|FG000|Enrollment to Randomization|Physician Decision|10
7906707|NCT02011893|12420885|FG001|Enrollment to Randomization|Physician Decision|0
7906708|NCT02011893|12420886|FG002|Enrollment to Randomization|Physician Decision|0
7906709|NCT02011893|12420884|FG000|Enrollment to Randomization|Withdrawal by Subject|21
7906710|NCT02011893|12420885|FG001|Enrollment to Randomization|Withdrawal by Subject|0
7906711|NCT02011893|12420886|FG002|Enrollment to Randomization|Withdrawal by Subject|0
7906712|NCT02011893|12420884|FG000|Enrollment to Randomization|Screening Failure|29
7906713|NCT02011893|12420885|FG001|Enrollment to Randomization|Screening Failure|0
7906714|NCT02011893|12420886|FG002|Enrollment to Randomization|Screening Failure|0
7906715|NCT02011893|12420884|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
7906716|NCT02011893|12420885|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
7906717|NCT02011893|12420886|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
7906718|NCT02011893|12420884|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2
7906719|NCT02011893|12420885|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0
7906720|NCT02011893|12420886|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0
7906721|NCT02011893|12420884|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
7906722|NCT02011893|12420885|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
7906723|NCT02011893|12420886|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
7906724|NCT02011893|12420884|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
7906725|NCT02011893|12420885|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
7906726|NCT02011893|12420886|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
7906727|NCT02011893|12420884|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
7906728|NCT02011893|12420885|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
7906729|NCT02011893|12420886|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
7906730|NCT02011945|12420894|FG000|Overall Study|Participant requested to Discontinue|0
7906731|NCT02011945|12420895|FG001|Overall Study|Participant requested to Discontinue|1
7906732|NCT02011945|12420896|FG002|Overall Study|Participant requested to Discontinue|1
7906733|NCT02011945|12420894|FG000|Overall Study|Adverse Event unrelated to Drug|0
7906734|NCT02011945|12420895|FG001|Overall Study|Adverse Event unrelated to Drug|2
7906735|NCT02011945|12420896|FG002|Overall Study|Adverse Event unrelated to Drug|1
7906736|NCT02011945|12420894|FG000|Overall Study|Study Drug Toxicity|0
7906737|NCT02011945|12420895|FG001|Overall Study|Study Drug Toxicity|0
7906738|NCT02011945|12420896|FG002|Overall Study|Study Drug Toxicity|1
7906739|NCT02011945|12420894|FG000|Overall Study|Treatment Failure|0
7906740|NCT02011945|12420895|FG001|Overall Study|Treatment Failure|7
7906741|NCT02011945|12420896|FG002|Overall Study|Treatment Failure|6
7906742|NCT02011945|12420894|FG000|Overall Study|No Longer Meets Study Criteria|1
7906743|NCT02011945|12420895|FG001|Overall Study|No Longer Meets Study Criteria|0
7906744|NCT02011945|12420896|FG002|Overall Study|No Longer Meets Study Criteria|0
7906745|NCT02011945|12420894|FG000|Overall Study|Proceeded to stem cell transplant|0
7906746|NCT02011945|12420895|FG001|Overall Study|Proceeded to stem cell transplant|0
7906747|NCT02011945|12420896|FG002|Overall Study|Proceeded to stem cell transplant|1
7906748|NCT02011945|12420894|FG000|Overall Study|Sub-Optimal Response to dasatinib|1
7906749|NCT02011945|12420895|FG001|Overall Study|Sub-Optimal Response to dasatinib|0
7906750|NCT02011945|12420896|FG002|Overall Study|Sub-Optimal Response to dasatinib|0
7906751|NCT02012218|12420918|FG000|Overall Study|Withdrawal by Subject|1
7906752|NCT02012218|12420919|FG001|Overall Study|Withdrawal by Subject|0
7906753|NCT02012218|12420920|FG002|Overall Study|Withdrawal by Subject|1
7906754|NCT02012218|12420921|FG003|Overall Study|Withdrawal by Subject|1
7906755|NCT02012218|12420922|FG004|Overall Study|Withdrawal by Subject|1
7906756|NCT02012218|12420918|FG000|Overall Study|Adverse Event|1
7906757|NCT02012218|12420919|FG001|Overall Study|Adverse Event|0
7906758|NCT02012218|12420920|FG002|Overall Study|Adverse Event|0
7906759|NCT02012218|12420921|FG003|Overall Study|Adverse Event|1
7906760|NCT02012218|12420922|FG004|Overall Study|Adverse Event|0
7906761|NCT02012218|12420918|FG000|Overall Study|Lost to Follow-up|0
7906762|NCT02012218|12420919|FG001|Overall Study|Lost to Follow-up|1
7906763|NCT02012218|12420920|FG002|Overall Study|Lost to Follow-up|1
7906764|NCT02012218|12420921|FG003|Overall Study|Lost to Follow-up|0
7906765|NCT02012218|12420922|FG004|Overall Study|Lost to Follow-up|0
7906766|NCT02012218|12420918|FG000|Overall Study|Protocol Specified|1
7906767|NCT02012218|12420919|FG001|Overall Study|Protocol Specified|0
7906768|NCT02012218|12420920|FG002|Overall Study|Protocol Specified|0
7906769|NCT02012218|12420921|FG003|Overall Study|Protocol Specified|0
7906770|NCT02012218|12420922|FG004|Overall Study|Protocol Specified|0
7906771|NCT02012218|12420918|FG000|Overall Study|Protocol Deviation|1
7906772|NCT02012218|12420919|FG001|Overall Study|Protocol Deviation|0
7906773|NCT02012218|12420920|FG002|Overall Study|Protocol Deviation|0
7906774|NCT02012218|12420921|FG003|Overall Study|Protocol Deviation|0
7906775|NCT02012218|12420922|FG004|Overall Study|Protocol Deviation|0
7906776|NCT02012452|12420963|FG000|Overall Study|Lost to Follow-up|2
7906777|NCT02012452|12420964|FG001|Overall Study|Lost to Follow-up|1
7906778|NCT02012452|12420963|FG000|Overall Study|Withdrawal by Subject|4
7906779|NCT02012452|12420964|FG001|Overall Study|Withdrawal by Subject|0
7906780|NCT02012491|12420972|FG000|Overall Study|Lost to Follow-up|1
7906781|NCT02012491|12420973|FG001|Overall Study|Lost to Follow-up|0
7906782|NCT02012491|12420972|FG000|Overall Study|Protocol Violation|0
7906783|NCT02012491|12420973|FG001|Overall Study|Protocol Violation|1
7906784|NCT02012491|12420972|FG000|Overall Study|Withdrawal by Subject|1
7906785|NCT02012491|12420973|FG001|Overall Study|Withdrawal by Subject|0
7906786|NCT02012686|12421002|FG000|Overall Study|muscle contraction|0
7906787|NCT02012686|12421003|FG001|Overall Study|muscle contraction|1
7906788|NCT02012686|12421002|FG000|Overall Study|electrocardiography monitoring noise|0
7906789|NCT02012686|12421003|FG001|Overall Study|electrocardiography monitoring noise|1
7906790|NCT02012959|12421009|FG000|Treatment Phase A|Adverse Event|2
7906791|NCT02012959|12421010|FG001|Treatment Phase A|Adverse Event|0
7906792|NCT02012959|12421011|FG002|Treatment Phase A|Adverse Event|0
7906793|NCT02012959|12421012|FG003|Treatment Phase A|Adverse Event|0
7906794|NCT02012959|12421013|FG004|Treatment Phase A|Adverse Event|0
7906795|NCT02013037|12421023|FG000|Overall Study|Death|6
7906796|NCT02013037|12421023|FG000|Overall Study|Withdrawal by Subject|1
7906797|NCT02013037|12421023|FG000|Overall Study|Awaiting Transplantation|7
7906798|NCT02013037|12421023|FG000|Overall Study|Transplanted without DSA|2
7906799|NCT02013206|12421056|FG000|Overall Study|Progressive disease (PD)|14
7906800|NCT02013206|12421057|FG001|Overall Study|Progressive disease (PD)|17
7906801|NCT02013206|12421056|FG000|Overall Study|Symptomatic deterioration|3
7906802|NCT02013206|12421057|FG001|Overall Study|Symptomatic deterioration|1
7906803|NCT02013206|12421056|FG000|Overall Study|Adverse Event|1
7906804|NCT02013206|12421057|FG001|Overall Study|Adverse Event|0
7906805|NCT02013206|12421056|FG000|Overall Study|Patient refusal|2
7906806|NCT02013206|12421057|FG001|Overall Study|Patient refusal|0
7906807|NCT02013206|12421056|FG000|Overall Study|Patient non-compliance|1
7906808|NCT02013206|12421057|FG001|Overall Study|Patient non-compliance|0
7906809|NCT02013206|12421056|FG000|Overall Study|Death|1
7906810|NCT02013206|12421057|FG001|Overall Study|Death|2
7906811|NCT02013206|12421056|FG000|Overall Study|Other reasons off treatment|5
7906812|NCT02013206|12421057|FG001|Overall Study|Other reasons off treatment|2
7906813|NCT02013375|12421080|FG000|Overall Study|Did not engraft|1
7906814|NCT02013375|12421080|FG000|Overall Study|Did not engraft|1
7906815|NCT02013388|12421093|FG000|Overall Study|work emergency|1
7906816|NCT02013388|12421094|FG001|Overall Study|work emergency|0
7906817|NCT02013388|12421095|FG002|Overall Study|work emergency|0
7906818|NCT02013388|12421096|FG003|Overall Study|work emergency|0
7906819|NCT02013388|12421097|FG004|Overall Study|work emergency|1
7906820|NCT02013388|12421098|FG005|Overall Study|work emergency|0
7906821|NCT02013388|12421099|FG006|Overall Study|work emergency|0
7906822|NCT02013388|12421100|FG007|Overall Study|work emergency|0
7906823|NCT02013531|12421122|FG000|Overall Study|Lost to Follow-up|3
7906824|NCT02013531|12421122|FG000|Overall Study|Met Withdrawal Criteria|1
7906825|NCT02013531|12421122|FG000|Overall Study|Withdrawal by Subject|1
7906826|NCT02013544|12421128|FG000|Overall Study|Adverse Event|5
7906827|NCT02013544|12421129|FG001|Overall Study|Adverse Event|5
7906828|NCT02013544|12421128|FG000|Overall Study|Lost to Follow-up|2
7906829|NCT02013544|12421129|FG001|Overall Study|Lost to Follow-up|3
7906830|NCT02013544|12421128|FG000|Overall Study|Withdrawal by Subject|2
7906831|NCT02013544|12421129|FG001|Overall Study|Withdrawal by Subject|8
7906832|NCT02013544|12421128|FG000|Overall Study|Physician Decision|0
7906833|NCT02013544|12421129|FG001|Overall Study|Physician Decision|1
7906834|NCT02013544|12421128|FG000|Overall Study|Entry criteria not met/non-compliance|2
7906835|NCT02013544|12421129|FG001|Overall Study|Entry criteria not met/non-compliance|3
7906836|NCT02013609|12421135|FG000|Overall Study|Withdrawal by Subject|9
7906837|NCT02013609|12421135|FG000|Overall Study|Lost to Follow-up|3
7906838|NCT02013609|12421135|FG000|Overall Study|Adverse Event|3
7906839|NCT02013609|12421135|FG000|Overall Study|Met Withdrawal Criteria|3
7906840|NCT02013622|12421139|FG000|Overall Study|Lost to Follow-up|10
7906841|NCT02013622|12421139|FG000|Overall Study|Adverse Event|3
7906842|NCT02013622|12421139|FG000|Overall Study|Met Withdrawal Criteria|3
7906843|NCT02013622|12421139|FG000|Overall Study|Withdrawal by Subject|6
7906844|NCT02013622|12421139|FG000|Overall Study|Protocol Deviation|1
7906845|NCT02013622|12421139|FG000|Overall Study|Lack of Efficacy|1
7906846|NCT02013674|12421145|FG000|Overall Study|Death|0
7906847|NCT02013674|12421146|FG001|Overall Study|Death|1
7906848|NCT02013674|12421145|FG000|Overall Study|Lost to Follow-up|1
7906849|NCT02013674|12421146|FG001|Overall Study|Lost to Follow-up|0
7906850|NCT02013687|12421156|FG000|Overall Study|Lost to Follow-up|0
7906851|NCT02013687|12421157|FG001|Overall Study|Lost to Follow-up|0
7906852|NCT02013687|12421158|FG002|Overall Study|Lost to Follow-up|1
7906853|NCT02013687|12421159|FG003|Overall Study|Lost to Follow-up|0
7906854|NCT02013687|12421156|FG000|Overall Study|Protocol Violation|0
7906855|NCT02013687|12421157|FG001|Overall Study|Protocol Violation|0
7906856|NCT02013687|12421158|FG002|Overall Study|Protocol Violation|0
7906857|NCT02013687|12421159|FG003|Overall Study|Protocol Violation|1
7906858|NCT02013687|12421156|FG000|Overall Study|Withdrawal by Subject|0
7906859|NCT02013687|12421157|FG001|Overall Study|Withdrawal by Subject|0
7906860|NCT02013687|12421158|FG002|Overall Study|Withdrawal by Subject|0
7906861|NCT02013687|12421159|FG003|Overall Study|Withdrawal by Subject|1
7906862|NCT02013687|12421156|FG000|Overall Study|Missed visits due to patient travel|0
7906863|NCT02013687|12421157|FG001|Overall Study|Missed visits due to patient travel|0
7906864|NCT02013687|12421158|FG002|Overall Study|Missed visits due to patient travel|1
7906865|NCT02013687|12421159|FG003|Overall Study|Missed visits due to patient travel|0
7906866|NCT02013765|12421173|FG000|Overall Study|Trial was terminated by sponsor|1
7906867|NCT02013778|12421177|FG000|Overall Study|Death|4
7906868|NCT02013778|12421177|FG000|Overall Study|Withdrawal by Subject|1
7906869|NCT02013778|12421177|FG000|Overall Study|Physician Decision|1
7906870|NCT02013778|12421177|FG000|Overall Study|Adverse Event|1
7906871|NCT02013791|12421190|FG000|Period 1|Lost to Follow-up|0
7906872|NCT02013791|12421191|FG001|Period 1|Lost to Follow-up|0
7906873|NCT02013791|12421192|FG002|Period 1|Lost to Follow-up|0
7906874|NCT02013791|12421193|FG003|Period 1|Lost to Follow-up|1
7906875|NCT02013791|12421194|FG004|Period 1|Lost to Follow-up|0
7906876|NCT02013791|12421195|FG005|Period 1|Lost to Follow-up|0
7906877|NCT02013791|12421196|FG006|Period 1|Lost to Follow-up|1
7906878|NCT02013791|12421197|FG007|Period 1|Lost to Follow-up|1
7906879|NCT02013791|12421198|FG008|Period 1|Lost to Follow-up|0
7906880|NCT02013791|12421190|FG000|Period 1|Other Miscellaneous Reasons|0
7906881|NCT02013791|12421191|FG001|Period 1|Other Miscellaneous Reasons|2
7906882|NCT02013791|12421192|FG002|Period 1|Other Miscellaneous Reasons|0
7906883|NCT02013791|12421193|FG003|Period 1|Other Miscellaneous Reasons|0
7906884|NCT02013791|12421194|FG004|Period 1|Other Miscellaneous Reasons|0
7906885|NCT02013791|12421195|FG005|Period 1|Other Miscellaneous Reasons|0
7906886|NCT02013791|12421196|FG006|Period 1|Other Miscellaneous Reasons|0
7906887|NCT02013791|12421197|FG007|Period 1|Other Miscellaneous Reasons|0
7906888|NCT02013791|12421198|FG008|Period 1|Other Miscellaneous Reasons|0
7963977|NCT02732119|12518840|FG002|Phase II|Physician Decision|0
7963978|NCT02732119|12518841|FG003|Phase II|Physician Decision|8
7963979|NCT02732119|12518842|FG004|Phase II|Physician Decision|5
7963980|NCT02732210|12518893|FG000|Overall Study|Site Closed|0
7963981|NCT02732210|12518894|FG001|Overall Study|Site Closed|11
7963982|NCT02732210|12518893|FG000|Overall Study|Study Ended|13
7963983|NCT02732210|12518894|FG001|Overall Study|Study Ended|13
7963984|NCT02732210|12518893|FG000|Overall Study|Withdrawal by Subject|28
7963985|NCT02732210|12518894|FG001|Overall Study|Withdrawal by Subject|87
7963986|NCT02732210|12518893|FG000|Overall Study|Lost to Follow-up|5
7963987|NCT02732210|12518894|FG001|Overall Study|Lost to Follow-up|57
7963988|NCT02732210|12518893|FG000|Overall Study|Death|4
7963989|NCT02732210|12518894|FG001|Overall Study|Death|15
7963990|NCT02732210|12518893|FG000|Overall Study|Other|35
7963991|NCT02732210|12518894|FG001|Overall Study|Other|103
7963992|NCT02732210|12518893|FG000|Overall Study|Missing|0
7963993|NCT02732210|12518894|FG001|Overall Study|Missing|8
7963994|NCT02732561|12518914|FG000|Overall Study|Lost to Follow-up|1
7963995|NCT02732561|12518915|FG001|Overall Study|Lost to Follow-up|1
7963996|NCT02732561|12518914|FG000|Overall Study|Withdrawal by Subject|1
7963997|NCT02732561|12518915|FG001|Overall Study|Withdrawal by Subject|0
7963998|NCT02732639|12518935|FG000|Overall Study|Lost to Follow-up|1
7963999|NCT02732847|12518941|FG000|Overall Study|some filled early|42
7964000|NCT02732847|12518942|FG001|Overall Study|some filled early|42
7964001|NCT02732912|12518959|FG000|Overall Study|Discharged before night|2
7964002|NCT02732912|12518960|FG001|Overall Study|Discharged before night|6
7964003|NCT02732912|12518959|FG000|Overall Study|Incomplete completion of questionnaire|2
7964004|NCT02732912|12518960|FG001|Overall Study|Incomplete completion of questionnaire|3
7964005|NCT02732912|12518959|FG000|Overall Study|No outcome; discharged or refused|6
7964006|NCT02732912|12518960|FG001|Overall Study|No outcome; discharged or refused|9
7964007|NCT02732938|12518968|FG000|Overall Study|Death|0
7964008|NCT02732938|12518969|FG001|Overall Study|Death|11
7906889|NCT02013817|12421219|FG000|Overall Study|Adverse Event|12
7906890|NCT02013817|12421219|FG000|Overall Study|Withdrawal by Subject|4
7906891|NCT02013817|12421219|FG000|Overall Study|Death|2
7906892|NCT02013817|12421219|FG000|Overall Study|Other|9
7906893|NCT02013830|12421223|FG000|Overall Study|Adverse Event|3
7906894|NCT02013830|12421223|FG000|Overall Study|Death|1
7906895|NCT02013830|12421223|FG000|Overall Study|Insufficient therapeutic response|25
7906896|NCT02013830|12421223|FG000|Overall Study|Refused treatment|1
7906897|NCT02014116|12421244|FG000|Overall Study|Progressive Disease|3
7906898|NCT02014116|12421245|FG001|Overall Study|Progressive Disease|4
7906899|NCT02014116|12421246|FG002|Overall Study|Progressive Disease|2
7906900|NCT02014116|12421247|FG003|Overall Study|Progressive Disease|6
7906901|NCT02014116|12421248|FG004|Overall Study|Progressive Disease|1
7906902|NCT02014116|12421249|FG005|Overall Study|Progressive Disease|13
7906903|NCT02014116|12421250|FG006|Overall Study|Progressive Disease|1
7906904|NCT02014116|12421251|FG007|Overall Study|Progressive Disease|3
7906905|NCT02014116|12421252|FG008|Overall Study|Progressive Disease|7
7906906|NCT02014116|12421244|FG000|Overall Study|Adverse Event|0
7906907|NCT02014116|12421245|FG001|Overall Study|Adverse Event|0
7906908|NCT02014116|12421246|FG002|Overall Study|Adverse Event|0
7906909|NCT02014116|12421247|FG003|Overall Study|Adverse Event|0
7906910|NCT02014116|12421248|FG004|Overall Study|Adverse Event|1
7906911|NCT02014116|12421249|FG005|Overall Study|Adverse Event|0
7906912|NCT02014116|12421250|FG006|Overall Study|Adverse Event|0
7906913|NCT02014116|12421251|FG007|Overall Study|Adverse Event|1
7906914|NCT02014116|12421252|FG008|Overall Study|Adverse Event|0
7906915|NCT02014116|12421244|FG000|Overall Study|Lost to Follow-up|0
7906916|NCT02014116|12421245|FG001|Overall Study|Lost to Follow-up|0
7906917|NCT02014116|12421246|FG002|Overall Study|Lost to Follow-up|0
7906918|NCT02014116|12421247|FG003|Overall Study|Lost to Follow-up|0
7906919|NCT02014116|12421248|FG004|Overall Study|Lost to Follow-up|0
7906920|NCT02014116|12421249|FG005|Overall Study|Lost to Follow-up|1
7906921|NCT02014116|12421250|FG006|Overall Study|Lost to Follow-up|0
7906922|NCT02014116|12421251|FG007|Overall Study|Lost to Follow-up|0
7906923|NCT02014116|12421252|FG008|Overall Study|Lost to Follow-up|1
7906924|NCT02014116|12421244|FG000|Overall Study|Death|0
7906925|NCT02014116|12421245|FG001|Overall Study|Death|0
7906926|NCT02014116|12421246|FG002|Overall Study|Death|0
7906927|NCT02014116|12421247|FG003|Overall Study|Death|0
7906928|NCT02014116|12421248|FG004|Overall Study|Death|0
7906929|NCT02014116|12421249|FG005|Overall Study|Death|0
7906930|NCT02014116|12421250|FG006|Overall Study|Death|0
7906931|NCT02014116|12421251|FG007|Overall Study|Death|1
7906932|NCT02014116|12421252|FG008|Overall Study|Death|1
7906933|NCT02014116|12421244|FG000|Overall Study|Withdrawal by Subject|0
7906934|NCT02014116|12421245|FG001|Overall Study|Withdrawal by Subject|0
7906935|NCT02014116|12421246|FG002|Overall Study|Withdrawal by Subject|1
7906936|NCT02014116|12421247|FG003|Overall Study|Withdrawal by Subject|1
7906937|NCT02014116|12421248|FG004|Overall Study|Withdrawal by Subject|0
7906938|NCT02014116|12421249|FG005|Overall Study|Withdrawal by Subject|1
7906939|NCT02014116|12421250|FG006|Overall Study|Withdrawal by Subject|0
7906940|NCT02014116|12421251|FG007|Overall Study|Withdrawal by Subject|0
7906941|NCT02014116|12421252|FG008|Overall Study|Withdrawal by Subject|0
7906942|NCT02014116|12421244|FG000|Overall Study|Withdrawal Caregiver Decision|0
7906943|NCT02014116|12421245|FG001|Overall Study|Withdrawal Caregiver Decision|0
7906944|NCT02014116|12421246|FG002|Overall Study|Withdrawal Caregiver Decision|0
7906945|NCT02014116|12421247|FG003|Overall Study|Withdrawal Caregiver Decision|0
7906946|NCT02014116|12421248|FG004|Overall Study|Withdrawal Caregiver Decision|0
7906947|NCT02014116|12421249|FG005|Overall Study|Withdrawal Caregiver Decision|1
7906948|NCT02014116|12421250|FG006|Overall Study|Withdrawal Caregiver Decision|0
7906949|NCT02014116|12421251|FG007|Overall Study|Withdrawal Caregiver Decision|0
7906950|NCT02014116|12421252|FG008|Overall Study|Withdrawal Caregiver Decision|0
7906951|NCT02014116|12421244|FG000|Overall Study|Physician Decision|0
7906952|NCT02014116|12421245|FG001|Overall Study|Physician Decision|0
7906953|NCT02014116|12421246|FG002|Overall Study|Physician Decision|0
7906954|NCT02014116|12421247|FG003|Overall Study|Physician Decision|0
7906955|NCT02014116|12421248|FG004|Overall Study|Physician Decision|0
7906956|NCT02014116|12421249|FG005|Overall Study|Physician Decision|0
7906957|NCT02014116|12421250|FG006|Overall Study|Physician Decision|0
7906958|NCT02014116|12421251|FG007|Overall Study|Physician Decision|0
7906959|NCT02014116|12421252|FG008|Overall Study|Physician Decision|1
7906960|NCT02014272|12421288|FG000|Intervention Period 1|Withdrawal by Subject|1
7906961|NCT02014272|12421289|FG001|Intervention Period 1|Withdrawal by Subject|0
7906962|NCT02014272|12421288|FG000|Intervention Period 1|Adverse Event|0
7969275|NCT02796677|12528097|FG002|Overall Study|Withdrawal by Subject|6
7969276|NCT02796677|12528098|FG003|Overall Study|Withdrawal by Subject|7
7969277|NCT02796677|12528095|FG000|Overall Study|Progressive disease|6
7969278|NCT02796677|12528096|FG001|Overall Study|Progressive disease|15
7969279|NCT02796677|12528097|FG002|Overall Study|Progressive disease|13
7969280|NCT02796677|12528098|FG003|Overall Study|Progressive disease|18
7969281|NCT02796677|12528095|FG000|Overall Study|Reason not mentioned|2
7969282|NCT02796677|12528096|FG001|Overall Study|Reason not mentioned|3
7969283|NCT02796677|12528097|FG002|Overall Study|Reason not mentioned|0
7969284|NCT02796677|12528098|FG003|Overall Study|Reason not mentioned|5
7969285|NCT02796755|12528112|FG000|Overall Study|Adverse Event|2
7969286|NCT02796755|12528113|FG001|Overall Study|Adverse Event|0
7969287|NCT02796963|12528127|FG000|Overall Study|Lost to Follow-up|89
7969288|NCT02796963|12528128|FG001|Overall Study|Lost to Follow-up|76
7969289|NCT02796963|12528129|FG002|Overall Study|Lost to Follow-up|69
7969290|NCT02796963|12528130|FG003|Overall Study|Lost to Follow-up|72
7969291|NCT02797080|12528153|FG000|Overall Study|Lost to Follow-up|1
7969292|NCT02797080|12528153|FG000|Overall Study|Withdrawal by Subject|1
7969293|NCT02797132|12528157|FG000|Part A (15 Days)|Adverse Event|1
7969294|NCT02797132|12528157|FG000|Part B (24 Weeks)|Adverse Event|3
7969295|NCT02797171|12528176|FG000|Overall Study|Lost to Follow-up|2
7969296|NCT02797171|12528177|FG001|Overall Study|Lost to Follow-up|0
7969297|NCT02797171|12528178|FG002|Overall Study|Lost to Follow-up|2
7969298|NCT02797171|12528179|FG003|Overall Study|Lost to Follow-up|1
7969299|NCT02797171|12528180|FG004|Overall Study|Lost to Follow-up|2
7969300|NCT02797171|12528181|FG005|Overall Study|Lost to Follow-up|0
7969301|NCT02797171|12528176|FG000|Overall Study|Withdrawal by Subject|1
7969302|NCT02797171|12528177|FG001|Overall Study|Withdrawal by Subject|1
7906963|NCT02014272|12421289|FG001|Intervention Period 1|Adverse Event|1
7906964|NCT02014376|12421311|FG000|Overall Study|Adverse Event|1
7906965|NCT02014376|12421312|FG001|Overall Study|Adverse Event|1
7906966|NCT02014376|12421313|FG002|Overall Study|Adverse Event|0
7906967|NCT02014376|12421311|FG000|Overall Study|Lost to Follow-up|2
7906968|NCT02014376|12421312|FG001|Overall Study|Lost to Follow-up|0
7906969|NCT02014376|12421313|FG002|Overall Study|Lost to Follow-up|0
7717938|NCT00523744|12141615|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
7717939|NCT00523848|12141622|FG000|Overall Study|Adverse Event|11
7717940|NCT00523848|12141622|FG000|Overall Study|Withdrawal by Subject|2
7717941|NCT00523848|12141622|FG000|Overall Study|NOT TREATED (Became ineligible)|2
7717942|NCT00523848|12141622|FG000|Overall Study|Disease Progression|5
7717943|NCT00523848|12141622|FG000|Overall Study|Other, unspecified|4
7717944|NCT00523978|12141628|FG000|Overall Study|Withdrawal by Subject|3
7717945|NCT00523978|12141629|FG001|Overall Study|Withdrawal by Subject|7
7717946|NCT00523978|12141628|FG000|Overall Study|Screen Failures|5
7906970|NCT02014402|12421325|FG000|Overall Study|Adverse Event|1
7906971|NCT02014402|12421326|FG001|Overall Study|Adverse Event|0
7906972|NCT02014402|12421327|FG002|Overall Study|Adverse Event|0
7906973|NCT02014402|12421328|FG003|Overall Study|Adverse Event|0
7906974|NCT02014402|12421325|FG000|Overall Study|Withdrawal by Subject|1
7906975|NCT02014402|12421326|FG001|Overall Study|Withdrawal by Subject|2
7906976|NCT02014402|12421327|FG002|Overall Study|Withdrawal by Subject|2
7906977|NCT02014402|12421328|FG003|Overall Study|Withdrawal by Subject|1
7906978|NCT02014402|12421325|FG000|Overall Study|Subject did not have transportation|0
7906979|NCT02014402|12421326|FG001|Overall Study|Subject did not have transportation|1
7906980|NCT02014402|12421327|FG002|Overall Study|Subject did not have transportation|0
7906981|NCT02014402|12421328|FG003|Overall Study|Subject did not have transportation|0
7906982|NCT02014402|12421325|FG000|Overall Study|Lost to Follow-up|0
7906983|NCT02014402|12421326|FG001|Overall Study|Lost to Follow-up|0
7906984|NCT02014402|12421327|FG002|Overall Study|Lost to Follow-up|1
7906985|NCT02014402|12421328|FG003|Overall Study|Lost to Follow-up|2
7906986|NCT02014441|12421345|FG000|Overall Study|Withdrawal by Subject|12
7906987|NCT02014467|12421353|FG000|Overall Study|Adverse Event|4
7906988|NCT02014467|12421354|FG001|Overall Study|Adverse Event|0
7906989|NCT02014467|12421353|FG000|Overall Study|Protocol Violation|3
7906990|NCT02014467|12421354|FG001|Overall Study|Protocol Violation|0
7906991|NCT02014467|12421353|FG000|Overall Study|Physician Decision|2
7906992|NCT02014467|12421354|FG001|Overall Study|Physician Decision|3
7906993|NCT02014467|12421353|FG000|Overall Study|Withdrawal by Subject|16
7906994|NCT02014467|12421354|FG001|Overall Study|Withdrawal by Subject|4
7906995|NCT02014480|12421360|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7906996|NCT02014480|12421361|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7906997|NCT02014480|12421362|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1
7906998|NCT02014480|12421363|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7906999|NCT02014480|12421364|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7907000|NCT02014480|12421365|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7907001|NCT02014480|12421360|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7907002|NCT02014480|12421361|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7907003|NCT02014480|12421362|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7907004|NCT02014480|12421363|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
7907005|NCT02014480|12421364|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7907006|NCT02014480|12421365|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7907007|NCT02014480|12421360|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7907008|NCT02014480|12421361|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7907009|NCT02014480|12421362|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
7907010|NCT02014480|12421363|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7907011|NCT02014480|12421364|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7907012|NCT02014480|12421365|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7907013|NCT02014480|12421360|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1
7907014|NCT02014480|12421361|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1
7907015|NCT02014480|12421362|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2
7907016|NCT02014480|12421363|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1
7907017|NCT02014480|12421364|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0
7969303|NCT02797171|12528178|FG002|Overall Study|Withdrawal by Subject|0
7907018|NCT02014480|12421365|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0
7907019|NCT02014480|12421360|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7907020|NCT02014480|12421361|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
7907021|NCT02014480|12421362|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7907022|NCT02014480|12421363|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7907023|NCT02014480|12421364|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7907024|NCT02014480|12421365|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7907025|NCT02014480|12421360|FG000|Treatment Period 3 (14 Days)|Adverse Event|0
7907026|NCT02014480|12421361|FG001|Treatment Period 3 (14 Days)|Adverse Event|0
7907027|NCT02014480|12421362|FG002|Treatment Period 3 (14 Days)|Adverse Event|1
7907028|NCT02014480|12421363|FG003|Treatment Period 3 (14 Days)|Adverse Event|0
7907029|NCT02014480|12421364|FG004|Treatment Period 3 (14 Days)|Adverse Event|0
7907030|NCT02014480|12421365|FG005|Treatment Period 3 (14 Days)|Adverse Event|1
7907031|NCT02014480|12421360|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7907032|NCT02014480|12421361|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7907033|NCT02014480|12421362|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7907034|NCT02014480|12421363|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7907035|NCT02014480|12421364|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7907036|NCT02014480|12421365|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1
7907037|NCT02014584|12421387|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0
7907038|NCT02014584|12421388|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1
7907039|NCT02014584|12421389|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0
7907040|NCT02014584|12421390|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0
7907041|NCT02014584|12421391|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0
7907042|NCT02014584|12421392|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0
7907043|NCT02014584|12421387|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
7907044|NCT02014584|12421388|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
7907045|NCT02014584|12421389|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7907046|NCT02014584|12421390|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7907047|NCT02014584|12421391|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7907048|NCT02014584|12421392|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7907049|NCT02014584|12421387|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7907050|NCT02014584|12421388|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7907051|NCT02014584|12421389|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2
7907052|NCT02014584|12421390|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7907053|NCT02014584|12421391|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7907054|NCT02014584|12421392|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7907055|NCT02014584|12421387|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7907056|NCT02014584|12421388|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7907057|NCT02014584|12421389|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
7907058|NCT02014584|12421390|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
7907059|NCT02014584|12421391|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7907060|NCT02014584|12421392|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7907061|NCT02014584|12421387|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7907062|NCT02014584|12421388|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7907063|NCT02014584|12421389|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7907064|NCT02014584|12421390|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7907065|NCT02014584|12421391|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
7907066|NCT02014584|12421392|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7907067|NCT02014597|12421406|FG000|Overall Study|Unable to record log contrast sensitivity|2
7907068|NCT02014597|12421407|FG001|Overall Study|Unable to record log contrast sensitivity|1
7907069|NCT02014740|12421415|FG000|Overall Study|Lost to Follow-up|4
7907070|NCT02014740|12421416|FG001|Overall Study|Lost to Follow-up|4
7907071|NCT02014740|12421415|FG000|Overall Study|Withdrawal by Subject|2
7907072|NCT02014740|12421416|FG001|Overall Study|Withdrawal by Subject|1
7907073|NCT02015039|12421424|FG000|Overall Study|Not eligible|0
7907074|NCT02015039|12421425|FG001|Overall Study|Not eligible|1
7907075|NCT02015065|12421434|FG000|Overall Study|Death on study|1
7907076|NCT02015065|12421435|FG001|Overall Study|Death on study|2
7907077|NCT02015065|12421436|FG002|Overall Study|Death on study|1
7907078|NCT02015104|12421446|FG000|Overall Study|Withdrew consent after first dose drug|1
7907079|NCT02015104|12421447|FG001|Overall Study|Withdrew consent after first dose drug|0
7907080|NCT02015104|12421446|FG000|Overall Study|Withdrew consent prior to treatment|0
7717947|NCT00523978|12141629|FG001|Overall Study|Screen Failures|1
7907081|NCT02015104|12421447|FG001|Overall Study|Withdrew consent prior to treatment|1
7907082|NCT02015195|12421463|FG000|Overall Study|Adverse Event|0
7907083|NCT02015195|12421464|FG001|Overall Study|Adverse Event|0
7907084|NCT02015195|12421465|FG002|Overall Study|Adverse Event|0
7907085|NCT02015195|12421466|FG003|Overall Study|Adverse Event|1
7907086|NCT02015195|12421467|FG004|Overall Study|Adverse Event|0
7907087|NCT02015195|12421468|FG005|Overall Study|Adverse Event|0
7907088|NCT02015195|12421469|FG006|Overall Study|Adverse Event|0
7907089|NCT02015221|12421486|FG000|Overall Study|Withdrawal by Subject|8
7907090|NCT02015221|12421487|FG001|Overall Study|Withdrawal by Subject|6
7907091|NCT02015221|12421486|FG000|Overall Study|Lost to Follow-up|1
7907092|NCT02015221|12421487|FG001|Overall Study|Lost to Follow-up|0
7907093|NCT02015390|12421506|FG000|Overall Study|Lost to Follow-up|1
7907094|NCT02015390|12421507|FG001|Overall Study|Lost to Follow-up|0
7907095|NCT02015390|12421506|FG000|Overall Study|Adverse Event|0
7907096|NCT02015390|12421507|FG001|Overall Study|Adverse Event|3
7907097|NCT02015390|12421506|FG000|Overall Study|Physician Decision|0
7907098|NCT02015390|12421507|FG001|Overall Study|Physician Decision|1
7907099|NCT02015481|12421521|FG000|Overall Study|Death|1
7907100|NCT02015520|12421530|FG000|Overall Study|Lack of Efficacy|1
7907101|NCT02015520|12421531|FG001|Overall Study|Lack of Efficacy|0
7907102|NCT02015520|12421532|FG002|Overall Study|Lack of Efficacy|3
7907103|NCT02015520|12421533|FG003|Overall Study|Lack of Efficacy|2
7907104|NCT02015520|12421530|FG000|Overall Study|Adverse Event|0
7907105|NCT02015520|12421531|FG001|Overall Study|Adverse Event|0
7907106|NCT02015520|12421532|FG002|Overall Study|Adverse Event|0
7907107|NCT02015520|12421533|FG003|Overall Study|Adverse Event|1
7907108|NCT02015520|12421530|FG000|Overall Study|Withdrawal by Subject|2
7907109|NCT02015520|12421531|FG001|Overall Study|Withdrawal by Subject|2
7907110|NCT02015520|12421532|FG002|Overall Study|Withdrawal by Subject|1
7907111|NCT02015520|12421533|FG003|Overall Study|Withdrawal by Subject|0
7907112|NCT02015520|12421530|FG000|Overall Study|Death|1
7907113|NCT02015520|12421531|FG001|Overall Study|Death|0
7907114|NCT02015520|12421532|FG002|Overall Study|Death|0
7907115|NCT02015520|12421533|FG003|Overall Study|Death|0
7907116|NCT02015520|12421530|FG000|Overall Study|Lost to Follow-up|0
7907117|NCT02015520|12421531|FG001|Overall Study|Lost to Follow-up|0
7907118|NCT02015520|12421532|FG002|Overall Study|Lost to Follow-up|1
7907119|NCT02015520|12421533|FG003|Overall Study|Lost to Follow-up|0
7907120|NCT02015520|12421530|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1
7907121|NCT02015520|12421531|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1
7907122|NCT02015520|12421532|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2
7907123|NCT02015520|12421533|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1
7907124|NCT02015520|12421530|FG000|Overall Study|Subject no Longer Meets Study Criteria|0
7907125|NCT02015520|12421531|FG001|Overall Study|Subject no Longer Meets Study Criteria|1
7907126|NCT02015520|12421532|FG002|Overall Study|Subject no Longer Meets Study Criteria|0
7907127|NCT02015520|12421533|FG003|Overall Study|Subject no Longer Meets Study Criteria|0
7907128|NCT02015546|12421546|FG000|Overall Study|Withdrawal by Subject|1
7907129|NCT02015546|12421547|FG001|Overall Study|Withdrawal by Subject|1
7907130|NCT02015546|12421548|FG002|Overall Study|Withdrawal by Subject|1
7907131|NCT02015546|12421546|FG000|Overall Study|Screem Failure|2
7907132|NCT02015546|12421547|FG001|Overall Study|Screem Failure|1
7907133|NCT02015546|12421548|FG002|Overall Study|Screem Failure|3
7907134|NCT02015637|12421558|FG000|Overall Study|Lost to Follow-up|3
7907135|NCT02015637|12421559|FG001|Overall Study|Lost to Follow-up|5
7907136|NCT02015637|12421558|FG000|Overall Study|Adverse Event|3
7907137|NCT02015637|12421559|FG001|Overall Study|Adverse Event|0
7907138|NCT02015637|12421558|FG000|Overall Study|Did not take study drug|2
7907139|NCT02015637|12421559|FG001|Overall Study|Did not take study drug|0
7907140|NCT02015676|12421568|FG000|Overall Study|Adverse Event|2
7907141|NCT02015676|12421569|FG001|Overall Study|Adverse Event|18
7907142|NCT02015676|12421570|FG002|Overall Study|Adverse Event|0
7907143|NCT02015676|12421568|FG000|Overall Study|Lack of Efficacy|2
7907144|NCT02015676|12421569|FG001|Overall Study|Lack of Efficacy|4
7907145|NCT02015676|12421570|FG002|Overall Study|Lack of Efficacy|0
7907146|NCT02015676|12421568|FG000|Overall Study|Protocol Violation|1
7907147|NCT02015676|12421569|FG001|Overall Study|Protocol Violation|0
7907148|NCT02015676|12421570|FG002|Overall Study|Protocol Violation|0
7907149|NCT02015676|12421568|FG000|Overall Study|Withdrawal by Subject|1
7907150|NCT02015676|12421569|FG001|Overall Study|Withdrawal by Subject|7
7907151|NCT02015676|12421570|FG002|Overall Study|Withdrawal by Subject|1
7907152|NCT02015676|12421568|FG000|Overall Study|Administrative reasons|0
7907153|NCT02015676|12421569|FG001|Overall Study|Administrative reasons|3
7907154|NCT02015676|12421570|FG002|Overall Study|Administrative reasons|1
7907155|NCT02015676|12421568|FG000|Overall Study|Death|0
7907156|NCT02015676|12421569|FG001|Overall Study|Death|1
7907157|NCT02015676|12421570|FG002|Overall Study|Death|0
7907158|NCT02015676|12421568|FG000|Overall Study|Disease progression|3
7907159|NCT02015676|12421569|FG001|Overall Study|Disease progression|1
7907160|NCT02015676|12421570|FG002|Overall Study|Disease progression|1
7907161|NCT02015754|12421574|FG000|Overall Study|Disease progression|5
7907162|NCT02015754|12421574|FG000|Overall Study|Change in treatment modality|5
7907163|NCT02015754|12421574|FG000|Overall Study|Lost to Follow-up|1
7907164|NCT02015793|12421580|FG000|Overall Study|Adverse Event|3
7907165|NCT02015793|12421581|FG001|Overall Study|Adverse Event|3
7907166|NCT02015793|12421580|FG000|Overall Study|Withdrawal by Subject|1
7907167|NCT02015793|12421581|FG001|Overall Study|Withdrawal by Subject|1
7907168|NCT02015819|12421597|FG000|Overall Study|Rickham catheter was misaligned|0
7907169|NCT02015819|12421598|FG001|Overall Study|Rickham catheter was misaligned|0
7907170|NCT02015819|12421599|FG002|Overall Study|Rickham catheter was misaligned|0
7907171|NCT02015819|12421600|FG003|Overall Study|Rickham catheter was misaligned|1
7907172|NCT02016105|12421616|FG000|TREATMENT PERIOD 1|Protocol Violation|2
7907173|NCT02016105|12421617|FG001|TREATMENT PERIOD 1|Protocol Violation|8
7907174|NCT02016105|12421618|FG002|TREATMENT PERIOD 1|Protocol Violation|0
7907175|NCT02016105|12421619|FG003|TREATMENT PERIOD 1|Protocol Violation|0
7907176|NCT02016105|12421620|FG004|TREATMENT PERIOD 1|Protocol Violation|0
7907177|NCT02016105|12421621|FG005|TREATMENT PERIOD 1|Protocol Violation|0
7907178|NCT02016105|12421616|FG000|TREATMENT PERIOD 1|Physician Decision|0
7907179|NCT02016105|12421617|FG001|TREATMENT PERIOD 1|Physician Decision|2
7907180|NCT02016105|12421618|FG002|TREATMENT PERIOD 1|Physician Decision|0
7907181|NCT02016105|12421619|FG003|TREATMENT PERIOD 1|Physician Decision|0
7907182|NCT02016105|12421620|FG004|TREATMENT PERIOD 1|Physician Decision|0
7907183|NCT02016105|12421621|FG005|TREATMENT PERIOD 1|Physician Decision|0
7907184|NCT02016105|12421616|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4
7907185|NCT02016105|12421617|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2
7907186|NCT02016105|12421618|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0
7907187|NCT02016105|12421619|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0
7907188|NCT02016105|12421620|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0
7907189|NCT02016105|12421621|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0
7907190|NCT02016105|12421616|FG000|TREATMENT PERIOD 1|Pregnancy|0
7907191|NCT02016105|12421617|FG001|TREATMENT PERIOD 1|Pregnancy|1
7907192|NCT02016105|12421618|FG002|TREATMENT PERIOD 1|Pregnancy|0
7907193|NCT02016105|12421619|FG003|TREATMENT PERIOD 1|Pregnancy|0
7907194|NCT02016105|12421620|FG004|TREATMENT PERIOD 1|Pregnancy|0
7907195|NCT02016105|12421621|FG005|TREATMENT PERIOD 1|Pregnancy|0
7907196|NCT02016105|12421616|FG000|TREATMENT PERIOD 1|Adverse Event|3
7907197|NCT02016105|12421617|FG001|TREATMENT PERIOD 1|Adverse Event|5
7907198|NCT02016105|12421618|FG002|TREATMENT PERIOD 1|Adverse Event|0
7907199|NCT02016105|12421619|FG003|TREATMENT PERIOD 1|Adverse Event|0
7907200|NCT02016105|12421620|FG004|TREATMENT PERIOD 1|Adverse Event|0
7907201|NCT02016105|12421621|FG005|TREATMENT PERIOD 1|Adverse Event|0
7907202|NCT02016105|12421616|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15
7907203|NCT02016105|12421617|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11
7907204|NCT02016105|12421618|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0
7907205|NCT02016105|12421619|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0
7907206|NCT02016105|12421620|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0
7907207|NCT02016105|12421621|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0
7907208|NCT02016105|12421616|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6
7907209|NCT02016105|12421617|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4
7907210|NCT02016105|12421618|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0
7907211|NCT02016105|12421619|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0
7907212|NCT02016105|12421620|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0
7907213|NCT02016105|12421621|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0
7907214|NCT02016105|12421616|FG000|TREATMENT PERIOD 2|Non compliance study medication|0
7907215|NCT02016105|12421617|FG001|TREATMENT PERIOD 2|Non compliance study medication|0
7907216|NCT02016105|12421618|FG002|TREATMENT PERIOD 2|Non compliance study medication|0
7907217|NCT02016105|12421619|FG003|TREATMENT PERIOD 2|Non compliance study medication|0
7907218|NCT02016105|12421620|FG004|TREATMENT PERIOD 2|Non compliance study medication|0
7907219|NCT02016105|12421621|FG005|TREATMENT PERIOD 2|Non compliance study medication|1
7907220|NCT02016105|12421616|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0
7907221|NCT02016105|12421617|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0
7907222|NCT02016105|12421618|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2
7907223|NCT02016105|12421619|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6
7907224|NCT02016105|12421620|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3
7907225|NCT02016105|12421621|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2
7907226|NCT02016105|12421616|FG000|TREATMENT PERIOD 2|Pregnancy|0
7907227|NCT02016105|12421617|FG001|TREATMENT PERIOD 2|Pregnancy|0
7907228|NCT02016105|12421618|FG002|TREATMENT PERIOD 2|Pregnancy|0
7907229|NCT02016105|12421619|FG003|TREATMENT PERIOD 2|Pregnancy|0
7907230|NCT02016105|12421620|FG004|TREATMENT PERIOD 2|Pregnancy|0
7907231|NCT02016105|12421621|FG005|TREATMENT PERIOD 2|Pregnancy|1
7907232|NCT02016105|12421616|FG000|TREATMENT PERIOD 2|Death|0
7907233|NCT02016105|12421617|FG001|TREATMENT PERIOD 2|Death|0
7907234|NCT02016105|12421618|FG002|TREATMENT PERIOD 2|Death|0
7907235|NCT02016105|12421619|FG003|TREATMENT PERIOD 2|Death|0
7907236|NCT02016105|12421620|FG004|TREATMENT PERIOD 2|Death|0
7907237|NCT02016105|12421621|FG005|TREATMENT PERIOD 2|Death|1
7907238|NCT02016105|12421616|FG000|TREATMENT PERIOD 2|Adverse Event|0
7907239|NCT02016105|12421617|FG001|TREATMENT PERIOD 2|Adverse Event|0
7907240|NCT02016105|12421618|FG002|TREATMENT PERIOD 2|Adverse Event|0
7907241|NCT02016105|12421619|FG003|TREATMENT PERIOD 2|Adverse Event|4
7907242|NCT02016105|12421620|FG004|TREATMENT PERIOD 2|Adverse Event|0
7907243|NCT02016105|12421621|FG005|TREATMENT PERIOD 2|Adverse Event|1
7907244|NCT02016105|12421616|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0
7907245|NCT02016105|12421617|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0
7907246|NCT02016105|12421618|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3
7907247|NCT02016105|12421619|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1
7907248|NCT02016105|12421620|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1
7907249|NCT02016105|12421621|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7
7907250|NCT02016105|12421616|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0
7907251|NCT02016105|12421617|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0
7907252|NCT02016105|12421618|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1
7907253|NCT02016105|12421619|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0
7907254|NCT02016105|12421620|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0
7907255|NCT02016105|12421621|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1
7907256|NCT02016105|12421616|FG000|EXTENSION PERIOD|New therapy for study indication|0
7907257|NCT02016105|12421617|FG001|EXTENSION PERIOD|New therapy for study indication|0
7907258|NCT02016105|12421618|FG002|EXTENSION PERIOD|New therapy for study indication|0
7907259|NCT02016105|12421619|FG003|EXTENSION PERIOD|New therapy for study indication|0
7907260|NCT02016105|12421620|FG004|EXTENSION PERIOD|New therapy for study indication|1
7907261|NCT02016105|12421621|FG005|EXTENSION PERIOD|New therapy for study indication|1
7907262|NCT02016105|12421616|FG000|EXTENSION PERIOD|Lack of Efficacy|0
7907263|NCT02016105|12421617|FG001|EXTENSION PERIOD|Lack of Efficacy|0
7907264|NCT02016105|12421618|FG002|EXTENSION PERIOD|Lack of Efficacy|1
7907265|NCT02016105|12421619|FG003|EXTENSION PERIOD|Lack of Efficacy|3
7907266|NCT02016105|12421620|FG004|EXTENSION PERIOD|Lack of Efficacy|1
7907267|NCT02016105|12421621|FG005|EXTENSION PERIOD|Lack of Efficacy|1
7907268|NCT02016105|12421616|FG000|EXTENSION PERIOD|Adverse Event|0
7907269|NCT02016105|12421617|FG001|EXTENSION PERIOD|Adverse Event|0
7907270|NCT02016105|12421618|FG002|EXTENSION PERIOD|Adverse Event|2
7907271|NCT02016105|12421619|FG003|EXTENSION PERIOD|Adverse Event|0
7907272|NCT02016105|12421620|FG004|EXTENSION PERIOD|Adverse Event|1
7907273|NCT02016105|12421621|FG005|EXTENSION PERIOD|Adverse Event|0
7907274|NCT02016105|12421616|FG000|EXTENSION PERIOD|Withdrawal by Subject|0
7907275|NCT02016105|12421617|FG001|EXTENSION PERIOD|Withdrawal by Subject|0
7907276|NCT02016105|12421618|FG002|EXTENSION PERIOD|Withdrawal by Subject|2
7907277|NCT02016105|12421619|FG003|EXTENSION PERIOD|Withdrawal by Subject|2
7907278|NCT02016105|12421620|FG004|EXTENSION PERIOD|Withdrawal by Subject|2
7907279|NCT02016105|12421621|FG005|EXTENSION PERIOD|Withdrawal by Subject|2
7907280|NCT02016105|12421616|FG000|EXTENSION PERIOD|Non-compliance with study indication|0
7907281|NCT02016105|12421617|FG001|EXTENSION PERIOD|Non-compliance with study indication|0
7907282|NCT02016105|12421618|FG002|EXTENSION PERIOD|Non-compliance with study indication|0
7907283|NCT02016105|12421619|FG003|EXTENSION PERIOD|Non-compliance with study indication|0
7907284|NCT02016105|12421620|FG004|EXTENSION PERIOD|Non-compliance with study indication|1
7907285|NCT02016105|12421621|FG005|EXTENSION PERIOD|Non-compliance with study indication|0
7907286|NCT02016105|12421616|FG000|EXTENSION PERIOD|Lost to Follow-up|0
7907287|NCT02016105|12421617|FG001|EXTENSION PERIOD|Lost to Follow-up|0
7907288|NCT02016105|12421618|FG002|EXTENSION PERIOD|Lost to Follow-up|0
7907289|NCT02016105|12421619|FG003|EXTENSION PERIOD|Lost to Follow-up|0
7907290|NCT02016105|12421620|FG004|EXTENSION PERIOD|Lost to Follow-up|0
7907291|NCT02016105|12421621|FG005|EXTENSION PERIOD|Lost to Follow-up|2
7907292|NCT02016170|12421638|FG000|Overall Study|Adverse Event|1
7907293|NCT02016170|12421639|FG001|Overall Study|Adverse Event|1
7907294|NCT02016170|12421640|FG002|Overall Study|Adverse Event|0
7907295|NCT02016170|12421638|FG000|Overall Study|Protocol Violation|1
7907296|NCT02016170|12421639|FG001|Overall Study|Protocol Violation|0
7907297|NCT02016170|12421640|FG002|Overall Study|Protocol Violation|0
7907298|NCT02016183|12421647|FG000|Overall Study|Case Report Forms Uncollected|13
7907299|NCT02016183|12421647|FG000|Overall Study|Protocol Violation|52
7907300|NCT02016300|12421666|FG000|Overall Study|Lost to Follow-up|0
7907301|NCT02016300|12421667|FG001|Overall Study|Lost to Follow-up|3
7907302|NCT02016482|12421675|FG000|Period A|Adverse Event|3
7907303|NCT02016482|12421676|FG001|Period A|Adverse Event|5
7907304|NCT02016482|12421675|FG000|Period A|Withdrawal by Subject|3
7907305|NCT02016482|12421676|FG001|Period A|Withdrawal by Subject|4
7907306|NCT02016482|12421675|FG000|Period A|Lost to Follow-up|3
7907307|NCT02016482|12421676|FG001|Period A|Lost to Follow-up|3
7907308|NCT02016482|12421675|FG000|Period A|Lack of Efficacy|2
7907309|NCT02016482|12421676|FG001|Period A|Lack of Efficacy|1
7907310|NCT02016482|12421675|FG000|Period A|Other|3
7907311|NCT02016482|12421676|FG001|Period A|Other|0
7907312|NCT02016482|12421675|FG000|Period A|Protocol Violation|0
7907313|NCT02016482|12421676|FG001|Period A|Protocol Violation|1
7907314|NCT02016482|12421675|FG000|Period A|Required Alternative/Prohibited Therapy|0
7907315|NCT02016482|12421676|FG001|Period A|Required Alternative/Prohibited Therapy|1
7907316|NCT02016482|12421675|FG000|Period B|Withdrawal by Subject|1
7907317|NCT02016482|12421676|FG001|Period B|Withdrawal by Subject|1
7907318|NCT02016482|12421675|FG000|Period B|Lost to Follow-up|2
7907319|NCT02016482|12421676|FG001|Period B|Lost to Follow-up|0
7907320|NCT02016482|12421675|FG000|Period B|Lack of Efficacy|6
7907321|NCT02016482|12421676|FG001|Period B|Lack of Efficacy|4
7907322|NCT02016482|12421675|FG000|Period B|Other|4
7907323|NCT02016482|12421676|FG001|Period B|Other|0
7907324|NCT02016482|12421675|FG000|Period B|Required Alternative/Prohibited Therapy|0
7907325|NCT02016482|12421676|FG001|Period B|Required Alternative/Prohibited Therapy|2
7907326|NCT02016625|12421736|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0
7907327|NCT02016625|12421737|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1
7907328|NCT02016625|12421736|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
7907329|NCT02016625|12421737|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
7907330|NCT02016625|12421736|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
7907331|NCT02016625|12421737|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
7907332|NCT02016690|12421753|FG000|Overall Study|Excluded from SAS: Enrollment violation|2
7907333|NCT02016690|12421753|FG000|Overall Study|Excluded from SAS: Duplication|2
7907334|NCT02016690|12421753|FG000|Overall Study|Excluded from SAS: Early treatment|2
7907335|NCT02016690|12421753|FG000|Overall Study|Excluded from SAS: Ineligible for study|2
7907336|NCT02016690|12421753|FG000|Overall Study|Did not meet inclusion criteria|13
7907337|NCT02016690|12421753|FG000|Overall Study|Hospitalized for RSV at study start|3
7907338|NCT02016716|12421760|FG000|Overall Study|Withdrawal by Subject|5
7907339|NCT02016716|12421761|FG001|Overall Study|Withdrawal by Subject|5
7907340|NCT02016716|12421762|FG002|Overall Study|Withdrawal by Subject|5
7907341|NCT02016716|12421760|FG000|Overall Study|Protocol-specified Criteria|0
7907342|NCT02016716|12421761|FG001|Overall Study|Protocol-specified Criteria|1
7907343|NCT02016716|12421762|FG002|Overall Study|Protocol-specified Criteria|0
7907344|NCT02016716|12421760|FG000|Overall Study|Lost to Follow-up|1
7907345|NCT02016716|12421761|FG001|Overall Study|Lost to Follow-up|2
7907346|NCT02016716|12421762|FG002|Overall Study|Lost to Follow-up|1
7907347|NCT02016755|12421771|FG000|Overall Study|Major amputation of index limb|2
7907348|NCT02016755|12421771|FG000|Overall Study|Adverse Event|2
7907349|NCT02016755|12421771|FG000|Overall Study|Physician Decision|1
7907350|NCT02016755|12421771|FG000|Overall Study|Death|2
7907351|NCT02016898|12421798|FG000|Overall Study|Death|1
7907352|NCT02016898|12421799|FG001|Overall Study|Death|1
7907353|NCT02016898|12421798|FG000|Overall Study|Lost to Follow-up|4
7907354|NCT02016898|12421799|FG001|Overall Study|Lost to Follow-up|4
7907355|NCT02017015|12421810|FG000|Overall Study|Adverse Event|9
7907356|NCT02017015|12421810|FG000|Overall Study|Withdrawal by Subject|21
7907357|NCT02017015|12421810|FG000|Overall Study|Death|4
7907358|NCT02017015|12421810|FG000|Overall Study|Progressive Disease|31
7907359|NCT02017015|12421810|FG000|Overall Study|Non-compliance with study drug|2
7907360|NCT02017015|12421810|FG000|Overall Study|Physician Decision|2
7907361|NCT02017171|12421828|FG000|Overall Study|Death|10
7907362|NCT02017171|12421829|FG001|Overall Study|Death|4
7907363|NCT02017171|12421828|FG000|Overall Study|Withdrawal by Subject|23
7907364|NCT02017171|12421829|FG001|Overall Study|Withdrawal by Subject|17
7907365|NCT02017171|12421828|FG000|Overall Study|Lost to Follow-up|21
7907366|NCT02017171|12421829|FG001|Overall Study|Lost to Follow-up|20
7907367|NCT02017171|12421828|FG000|Overall Study|ESKD|6
7907368|NCT02017171|12421829|FG001|Overall Study|ESKD|2
7907369|NCT02017171|12421828|FG000|Overall Study|Miscellaneous|2
7907370|NCT02017171|12421829|FG001|Overall Study|Miscellaneous|3
7907371|NCT02017223|12421852|FG000|Overall Study|Algorithm problems|2
7907372|NCT02017444|12421871|FG000|Overall Study|Physician Decision|1
7907373|NCT02017444|12421872|FG001|Overall Study|Physician Decision|0
7907374|NCT02017444|12421871|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1
7907375|NCT02017444|12421872|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0
7907376|NCT02017535|12421882|FG000|Overall Study|Withdrawal by Subject|1
7907377|NCT02017535|12421883|FG001|Overall Study|Withdrawal by Subject|0
7907378|NCT02017535|12421884|FG002|Overall Study|Withdrawal by Subject|0
7907379|NCT02017535|12421885|FG003|Overall Study|Withdrawal by Subject|0
7907380|NCT02017860|12421904|FG000|Overall Study|Adverse Event|1
7907381|NCT02017860|12421904|FG000|Overall Study|Withdrawal by Subject|1
7907382|NCT02017899|12421914|FG000|Overall Study|Withdrawal by Subject|0
7907383|NCT02017899|12421915|FG001|Overall Study|Withdrawal by Subject|0
7907384|NCT02017899|12421916|FG002|Overall Study|Withdrawal by Subject|0
7907385|NCT02017899|12421917|FG003|Overall Study|Withdrawal by Subject|1
7907386|NCT02017899|12421918|FG004|Overall Study|Withdrawal by Subject|1
7907387|NCT02017899|12421919|FG005|Overall Study|Withdrawal by Subject|0
7907388|NCT02018042|12421933|FG000|Overall Study|Withdrawal by Subject|1
7907389|NCT02018458|12421952|FG000|Overall Study|Death|4
7907390|NCT02018562|12421958|FG000|Overall Study|Withdrawal by Subject|2
7907391|NCT02018562|12421959|FG001|Overall Study|Withdrawal by Subject|0
7907392|NCT02018562|12421958|FG000|Overall Study|Discharged prior to study completion|1
7907393|NCT02018562|12421959|FG001|Overall Study|Discharged prior to study completion|0
7907394|NCT02018822|12422002|FG000|Overall Study|filling replaced by crown|0
7907395|NCT02018822|12422003|FG001|Overall Study|filling replaced by crown|1
7907396|NCT02018822|12422004|FG002|Overall Study|filling replaced by crown|0
7907397|NCT02018822|12422002|FG000|Overall Study|Physician Decision|0
7907398|NCT02018822|12422003|FG001|Overall Study|Physician Decision|1
7907399|NCT02018822|12422004|FG002|Overall Study|Physician Decision|1
7907400|NCT02018822|12422002|FG000|Overall Study|Lost to Follow-up|6
7907401|NCT02018822|12422003|FG001|Overall Study|Lost to Follow-up|6
7907402|NCT02018822|12422004|FG002|Overall Study|Lost to Follow-up|5
7907403|NCT02018887|12422023|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1
7907404|NCT02018887|12422024|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7907405|NCT02018887|12422025|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7907406|NCT02018887|12422026|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7907407|NCT02018887|12422027|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7907408|NCT02018887|12422028|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7907409|NCT02018887|12422029|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7907410|NCT02018887|12422030|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7907411|NCT02018887|12422031|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7907412|NCT02018887|12422032|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7907413|NCT02018887|12422033|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7907414|NCT02018887|12422023|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0
7907415|NCT02018887|12422024|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0
7907416|NCT02018887|12422025|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0
7907417|NCT02018887|12422026|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0
7907418|NCT02018887|12422027|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1
7907419|NCT02018887|12422028|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0
7907420|NCT02018887|12422029|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1
7907421|NCT02018887|12422030|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4
7907422|NCT02018887|12422031|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0
7907423|NCT02018887|12422032|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0
7907424|NCT02018887|12422033|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0
7907425|NCT02018887|12422023|FG000|Part C: Cohort 8 Overall|Adverse Event|0
7907426|NCT02018887|12422024|FG001|Part C: Cohort 8 Overall|Adverse Event|0
7907427|NCT02018887|12422025|FG002|Part C: Cohort 8 Overall|Adverse Event|0
7907428|NCT02018887|12422026|FG003|Part C: Cohort 8 Overall|Adverse Event|0
7907429|NCT02018887|12422027|FG004|Part C: Cohort 8 Overall|Adverse Event|0
7907430|NCT02018887|12422028|FG005|Part C: Cohort 8 Overall|Adverse Event|0
7907431|NCT02018887|12422029|FG006|Part C: Cohort 8 Overall|Adverse Event|0
7907432|NCT02018887|12422030|FG007|Part C: Cohort 8 Overall|Adverse Event|0
7907433|NCT02018887|12422031|FG008|Part C: Cohort 8 Overall|Adverse Event|1
7907434|NCT02018887|12422032|FG009|Part C: Cohort 8 Overall|Adverse Event|3
7907435|NCT02018887|12422033|FG010|Part C: Cohort 8 Overall|Adverse Event|0
7907436|NCT02018887|12422023|FG000|Part C: Cohort 8 Overall|Physician Decision|0
7907437|NCT02018887|12422024|FG001|Part C: Cohort 8 Overall|Physician Decision|0
7907438|NCT02018887|12422025|FG002|Part C: Cohort 8 Overall|Physician Decision|0
7907439|NCT02018887|12422026|FG003|Part C: Cohort 8 Overall|Physician Decision|0
7907440|NCT02018887|12422027|FG004|Part C: Cohort 8 Overall|Physician Decision|0
7907441|NCT02018887|12422028|FG005|Part C: Cohort 8 Overall|Physician Decision|0
7907442|NCT02018887|12422029|FG006|Part C: Cohort 8 Overall|Physician Decision|0
7907443|NCT02018887|12422030|FG007|Part C: Cohort 8 Overall|Physician Decision|0
7907444|NCT02018887|12422031|FG008|Part C: Cohort 8 Overall|Physician Decision|2
7907445|NCT02018887|12422032|FG009|Part C: Cohort 8 Overall|Physician Decision|0
7907446|NCT02018887|12422033|FG010|Part C: Cohort 8 Overall|Physician Decision|1
7907447|NCT02019108|12422105|FG000|Overall Study|Lost to Follow-up|5
7907448|NCT02019108|12422106|FG001|Overall Study|Lost to Follow-up|7
7907449|NCT02019264|12422114|FG000|Overall Study|Not treated|6
7907450|NCT02019264|12422115|FG001|Overall Study|Not treated|4
7907451|NCT02019264|12422114|FG000|Overall Study|Lost to Follow-up|50
7907452|NCT02019264|12422115|FG001|Overall Study|Lost to Follow-up|47
7907453|NCT02019264|12422114|FG000|Overall Study|Withdrawal by Subject|142
7907454|NCT02019264|12422115|FG001|Overall Study|Withdrawal by Subject|117
7907455|NCT02019264|12422114|FG000|Overall Study|Administrative reason|36
7907456|NCT02019264|12422115|FG001|Overall Study|Administrative reason|28
7907457|NCT02019264|12422114|FG000|Overall Study|Missing|14
7907458|NCT02019264|12422115|FG001|Overall Study|Missing|11
7907459|NCT02019277|12422121|FG000|Overall Study|Withdrawal by Subject|3
7907460|NCT02019277|12422121|FG000|Overall Study|Death|7
7907461|NCT02019277|12422121|FG000|Overall Study|Did no Cooperate|1
7907462|NCT02019277|12422121|FG000|Overall Study|Adverse Event|1
7907463|NCT02019420|12422127|FG000|Overall Study|Did not receive study drug|2
7907464|NCT02019420|12422128|FG001|Overall Study|Did not receive study drug|2
7907465|NCT02019420|12422127|FG000|Overall Study|Withdrawal by Subject|1
7907466|NCT02019420|12422128|FG001|Overall Study|Withdrawal by Subject|3
7907467|NCT02019420|12422127|FG000|Overall Study|At request of sponsor or investigator|0
7907468|NCT02019420|12422128|FG001|Overall Study|At request of sponsor or investigator|1
7907469|NCT02019420|12422127|FG000|Overall Study|Death|104
7907470|NCT02019420|12422128|FG001|Overall Study|Death|99
7907471|NCT02019420|12422127|FG000|Overall Study|Transferred to other care facility|1
7907472|NCT02019420|12422128|FG001|Overall Study|Transferred to other care facility|1
7907473|NCT02019472|12422137|FG000|Overall Study|Adverse Event|14
7907474|NCT02019472|12422138|FG001|Overall Study|Adverse Event|23
7907475|NCT02019472|12422139|FG002|Overall Study|Adverse Event|17
7907476|NCT02019472|12422137|FG000|Overall Study|Death|0
7907477|NCT02019472|12422138|FG001|Overall Study|Death|1
7907478|NCT02019472|12422139|FG002|Overall Study|Death|1
7907479|NCT02019472|12422137|FG000|Overall Study|Lack of Efficacy|7
7907480|NCT02019472|12422138|FG001|Overall Study|Lack of Efficacy|4
7907481|NCT02019472|12422139|FG002|Overall Study|Lack of Efficacy|4
7907482|NCT02019472|12422137|FG000|Overall Study|Lost to Follow-up|0
7907483|NCT02019472|12422138|FG001|Overall Study|Lost to Follow-up|2
7907484|NCT02019472|12422139|FG002|Overall Study|Lost to Follow-up|1
7907485|NCT02019472|12422137|FG000|Overall Study|Physician Decision|1
7907486|NCT02019472|12422138|FG001|Overall Study|Physician Decision|2
7907487|NCT02019472|12422139|FG002|Overall Study|Physician Decision|0
7907488|NCT02019472|12422137|FG000|Overall Study|Pregnancy|1
7907489|NCT02019472|12422138|FG001|Overall Study|Pregnancy|2
7907490|NCT02019472|12422139|FG002|Overall Study|Pregnancy|2
7907491|NCT02019472|12422137|FG000|Overall Study|Withdrawal by Subject|11
7907492|NCT02019472|12422138|FG001|Overall Study|Withdrawal by Subject|10
7907493|NCT02019472|12422139|FG002|Overall Study|Withdrawal by Subject|11
7907494|NCT02019472|12422137|FG000|Overall Study|Other|3
7907495|NCT02019472|12422138|FG001|Overall Study|Other|8
7907496|NCT02019472|12422139|FG002|Overall Study|Other|6
7907497|NCT02019550|12422153|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0
7907498|NCT02019550|12422154|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1
7907499|NCT02019602|12422175|FG000|Screening Period|Ineligibility|4
7907500|NCT02019602|12422176|FG001|Screening Period|Ineligibility|0
7907501|NCT02019602|12422175|FG000|Screening Period|Adverse Event|1
7907502|NCT02019602|12422176|FG001|Screening Period|Adverse Event|0
7907503|NCT02019667|12422183|FG000|First Intervention (6 Months)|Adverse Event|0
7907504|NCT02019667|12422184|FG001|First Intervention (6 Months)|Adverse Event|1
7907505|NCT02019667|12422183|FG000|2nd Intervention (6 Months)|Adverse Event|0
7907506|NCT02019667|12422184|FG001|2nd Intervention (6 Months)|Adverse Event|1
7907507|NCT02019667|12422183|FG000|2nd Intervention (6 Months)|Physician Decision|0
7907508|NCT02019667|12422184|FG001|2nd Intervention (6 Months)|Physician Decision|1
7907509|NCT02019719|12422197|FG000|Overall Study|Adverse Event|1
7907510|NCT02019719|12422198|FG001|Overall Study|Adverse Event|0
7907511|NCT02019719|12422199|FG002|Overall Study|Adverse Event|0
7969304|NCT02797171|12528179|FG003|Overall Study|Withdrawal by Subject|0
7969305|NCT02797171|12528180|FG004|Overall Study|Withdrawal by Subject|0
7907512|NCT02019719|12422200|FG003|Overall Study|Adverse Event|1
7907513|NCT02019719|12422201|FG004|Overall Study|Adverse Event|1
7907514|NCT02019719|12422197|FG000|Overall Study|Protocol Violation|1
7907515|NCT02019719|12422198|FG001|Overall Study|Protocol Violation|1
7907516|NCT02019719|12422199|FG002|Overall Study|Protocol Violation|0
7969306|NCT02797171|12528181|FG005|Overall Study|Withdrawal by Subject|0
7969307|NCT02797171|12528176|FG000|Overall Study|Protocol Violation|1
7969308|NCT02797171|12528177|FG001|Overall Study|Protocol Violation|0
7969309|NCT02797171|12528178|FG002|Overall Study|Protocol Violation|0
7969310|NCT02797171|12528179|FG003|Overall Study|Protocol Violation|0
7969311|NCT02797171|12528180|FG004|Overall Study|Protocol Violation|0
7969312|NCT02797171|12528181|FG005|Overall Study|Protocol Violation|0
7969313|NCT02797171|12528176|FG000|Overall Study|Participant unable to adhere|0
7969314|NCT02797171|12528177|FG001|Overall Study|Participant unable to adhere|1
7969315|NCT02797171|12528178|FG002|Overall Study|Participant unable to adhere|0
7969316|NCT02797171|12528179|FG003|Overall Study|Participant unable to adhere|0
7969317|NCT02797171|12528180|FG004|Overall Study|Participant unable to adhere|0
7969318|NCT02797171|12528181|FG005|Overall Study|Participant unable to adhere|0
7969319|NCT02797171|12528176|FG000|Overall Study|Not Randomized|0
7969320|NCT02797171|12528177|FG001|Overall Study|Not Randomized|0
7969321|NCT02797171|12528178|FG002|Overall Study|Not Randomized|0
7969322|NCT02797171|12528179|FG003|Overall Study|Not Randomized|0
7969323|NCT02797171|12528180|FG004|Overall Study|Not Randomized|0
7969324|NCT02797171|12528181|FG005|Overall Study|Not Randomized|1
7969325|NCT02797522|12528206|FG000|Overall Study|Study Terminated by Sponsor|0
7969326|NCT02797522|12528207|FG001|Overall Study|Study Terminated by Sponsor|0
7969327|NCT02797522|12528208|FG002|Overall Study|Study Terminated by Sponsor|0
7969328|NCT02797522|12528209|FG003|Overall Study|Study Terminated by Sponsor|0
7969329|NCT02797522|12528210|FG004|Overall Study|Study Terminated by Sponsor|0
7969330|NCT02797522|12528211|FG005|Overall Study|Study Terminated by Sponsor|0
7969331|NCT02797522|12528212|FG006|Overall Study|Study Terminated by Sponsor|0
7969332|NCT02797522|12528213|FG007|Overall Study|Study Terminated by Sponsor|4
7969333|NCT02797522|12528214|FG008|Overall Study|Study Terminated by Sponsor|2
7969334|NCT02797522|12528215|FG009|Overall Study|Study Terminated by Sponsor|4
7969335|NCT02797522|12528216|FG010|Overall Study|Study Terminated by Sponsor|1
7969336|NCT02797678|12528253|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25
7969337|NCT02797678|12528254|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0
7969338|NCT02797678|12528255|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0
7969339|NCT02797678|12528256|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0
7969340|NCT02797678|12528253|FG000|First Intervention (5 Nights)|study/device use non-compliance|0
7969341|NCT02797678|12528254|FG001|First Intervention (5 Nights)|study/device use non-compliance|1
7969342|NCT02797678|12528255|FG002|First Intervention (5 Nights)|study/device use non-compliance|0
7969343|NCT02797678|12528256|FG003|First Intervention (5 Nights)|study/device use non-compliance|0
7969344|NCT02797678|12528253|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0
7969345|NCT02797678|12528254|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0
7969346|NCT02797678|12528255|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1
7969347|NCT02797678|12528256|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0
7969348|NCT02797808|12528271|FG000|Overall Study|Withdrawal by Subject|1
7969349|NCT02797808|12528272|FG001|Overall Study|Withdrawal by Subject|1
7969350|NCT02797808|12528271|FG000|Overall Study|Physician Decision|6
7969351|NCT02797808|12528272|FG001|Overall Study|Physician Decision|2
7969352|NCT02798211|12528294|FG000|Period 1|Adverse Event|1
7969353|NCT02798211|12528295|FG001|Period 1|Adverse Event|1
7969354|NCT02798211|12528296|FG002|Period 1|Adverse Event|0
7969355|NCT02798211|12528297|FG003|Period 1|Adverse Event|0
7969356|NCT02798211|12528298|FG004|Period 1|Adverse Event|0
7969357|NCT02798211|12528299|FG005|Period 1|Adverse Event|0
7969358|NCT02798211|12528294|FG000|Period 1|Lost to Follow-up|2
7969359|NCT02798211|12528295|FG001|Period 1|Lost to Follow-up|1
7969360|NCT02798211|12528296|FG002|Period 1|Lost to Follow-up|0
7969361|NCT02798211|12528297|FG003|Period 1|Lost to Follow-up|0
7969362|NCT02798211|12528298|FG004|Period 1|Lost to Follow-up|0
7969363|NCT02798211|12528299|FG005|Period 1|Lost to Follow-up|0
7969364|NCT02798211|12528294|FG000|Period 1|Protocol Violation|0
7969365|NCT02798211|12528295|FG001|Period 1|Protocol Violation|0
7969366|NCT02798211|12528296|FG002|Period 1|Protocol Violation|2
7969367|NCT02798211|12528297|FG003|Period 1|Protocol Violation|0
7969368|NCT02798211|12528298|FG004|Period 1|Protocol Violation|0
7969369|NCT02798211|12528299|FG005|Period 1|Protocol Violation|0
7969370|NCT02798211|12528294|FG000|Period 1|Withdrawal by Subject|1
7969371|NCT02798211|12528295|FG001|Period 1|Withdrawal by Subject|1
7969372|NCT02798211|12528296|FG002|Period 1|Withdrawal by Subject|0
7969373|NCT02798211|12528297|FG003|Period 1|Withdrawal by Subject|0
7969374|NCT02798211|12528298|FG004|Period 1|Withdrawal by Subject|0
7907517|NCT02019719|12422200|FG003|Overall Study|Protocol Violation|0
7969375|NCT02798211|12528299|FG005|Period 1|Withdrawal by Subject|0
7969376|NCT02798211|12528294|FG000|Period 1|Death|0
7969377|NCT02798211|12528295|FG001|Period 1|Death|0
7969378|NCT02798211|12528296|FG002|Period 1|Death|1
7969379|NCT02798211|12528297|FG003|Period 1|Death|0
7969380|NCT02798211|12528298|FG004|Period 1|Death|0
7969381|NCT02798211|12528299|FG005|Period 1|Death|0
7969382|NCT02798211|12528294|FG000|Period 1|Withdrawal of Informed Consent|2
7969383|NCT02798211|12528295|FG001|Period 1|Withdrawal of Informed Consent|7
7969384|NCT02798211|12528296|FG002|Period 1|Withdrawal of Informed Consent|3
7969385|NCT02798211|12528297|FG003|Period 1|Withdrawal of Informed Consent|0
7969386|NCT02798211|12528298|FG004|Period 1|Withdrawal of Informed Consent|0
7969387|NCT02798211|12528299|FG005|Period 1|Withdrawal of Informed Consent|0
7969388|NCT02798211|12528294|FG000|Period 2|Withdrawal by Subject|2
7969389|NCT02798211|12528295|FG001|Period 2|Withdrawal by Subject|0
7969390|NCT02798211|12528296|FG002|Period 2|Withdrawal by Subject|0
7969391|NCT02798211|12528297|FG003|Period 2|Withdrawal by Subject|0
7969392|NCT02798211|12528298|FG004|Period 2|Withdrawal by Subject|2
7969393|NCT02798211|12528299|FG005|Period 2|Withdrawal by Subject|2
7969394|NCT02798211|12528294|FG000|Period 2|Adverse Event|5
7969395|NCT02798211|12528295|FG001|Period 2|Adverse Event|0
7969396|NCT02798211|12528296|FG002|Period 2|Adverse Event|0
7969397|NCT02798211|12528297|FG003|Period 2|Adverse Event|0
7969398|NCT02798211|12528298|FG004|Period 2|Adverse Event|1
7969399|NCT02798211|12528299|FG005|Period 2|Adverse Event|0
7969400|NCT02798211|12528294|FG000|Period 2|Lack of Efficacy|1
7969401|NCT02798211|12528295|FG001|Period 2|Lack of Efficacy|0
7969402|NCT02798211|12528296|FG002|Period 2|Lack of Efficacy|0
7969403|NCT02798211|12528297|FG003|Period 2|Lack of Efficacy|1
7969404|NCT02798211|12528298|FG004|Period 2|Lack of Efficacy|0
7969405|NCT02798211|12528299|FG005|Period 2|Lack of Efficacy|1
7969406|NCT02798211|12528294|FG000|Period 2|Lost to Follow-up|3
7969407|NCT02798211|12528295|FG001|Period 2|Lost to Follow-up|0
7969408|NCT02798211|12528296|FG002|Period 2|Lost to Follow-up|0
7969409|NCT02798211|12528297|FG003|Period 2|Lost to Follow-up|0
7969410|NCT02798211|12528298|FG004|Period 2|Lost to Follow-up|2
7969411|NCT02798211|12528299|FG005|Period 2|Lost to Follow-up|0
7969412|NCT02798211|12528294|FG000|Period 2|Physician Decision|1
7969413|NCT02798211|12528295|FG001|Period 2|Physician Decision|0
7969414|NCT02798211|12528296|FG002|Period 2|Physician Decision|0
7969415|NCT02798211|12528297|FG003|Period 2|Physician Decision|1
7969416|NCT02798211|12528298|FG004|Period 2|Physician Decision|1
7969417|NCT02798211|12528299|FG005|Period 2|Physician Decision|0
7969418|NCT02798211|12528294|FG000|Period 2|Pregnancy|0
7969419|NCT02798211|12528295|FG001|Period 2|Pregnancy|0
7969420|NCT02798211|12528296|FG002|Period 2|Pregnancy|0
7969421|NCT02798211|12528297|FG003|Period 2|Pregnancy|2
7969422|NCT02798211|12528298|FG004|Period 2|Pregnancy|0
7969423|NCT02798211|12528299|FG005|Period 2|Pregnancy|0
7969424|NCT02798211|12528294|FG000|Period 2|Technical problems|1
7969425|NCT02798211|12528295|FG001|Period 2|Technical problems|0
7969426|NCT02798211|12528296|FG002|Period 2|Technical problems|0
7969427|NCT02798211|12528297|FG003|Period 2|Technical problems|1
7969428|NCT02798211|12528298|FG004|Period 2|Technical problems|0
7969429|NCT02798211|12528299|FG005|Period 2|Technical problems|0
7969430|NCT02798211|12528294|FG000|Period 2|Withdrawal of Informed Consent|1
7969431|NCT02798211|12528295|FG001|Period 2|Withdrawal of Informed Consent|0
7969432|NCT02798211|12528296|FG002|Period 2|Withdrawal of Informed Consent|0
7969433|NCT02798211|12528297|FG003|Period 2|Withdrawal of Informed Consent|2
7969434|NCT02798211|12528298|FG004|Period 2|Withdrawal of Informed Consent|2
7969435|NCT02798211|12528299|FG005|Period 2|Withdrawal of Informed Consent|3
7969436|NCT02798315|12528315|FG000|Overall Study|Failure to return|1
7969437|NCT02798835|12528354|FG000|Overall Study|Protocol Violation|0
7969438|NCT02798835|12528355|FG001|Overall Study|Protocol Violation|0
7969439|NCT02798835|12528356|FG002|Overall Study|Protocol Violation|3
7969440|NCT02798861|12528364|FG000|Overall Study|Lost to Follow-up|22
7969441|NCT02798861|12528364|FG000|Overall Study|Withdrawal by Subject|1
7969442|NCT02799069|12528410|FG000|Overall Study|Adverse Event|0
7969443|NCT02799069|12528411|FG001|Overall Study|Adverse Event|2
7969444|NCT02799069|12528412|FG002|Overall Study|Adverse Event|2
7969445|NCT02799069|12528410|FG000|Overall Study|Lack of Efficacy|2
7969446|NCT02799069|12528411|FG001|Overall Study|Lack of Efficacy|0
7969447|NCT02799069|12528412|FG002|Overall Study|Lack of Efficacy|0
7969448|NCT02799069|12528410|FG000|Overall Study|Lost to Follow-up|1
7969449|NCT02799069|12528411|FG001|Overall Study|Lost to Follow-up|1
7969450|NCT02799069|12528412|FG002|Overall Study|Lost to Follow-up|0
7969451|NCT02799069|12528410|FG000|Overall Study|Withdrawal by Subject|4
7969452|NCT02799069|12528411|FG001|Overall Study|Withdrawal by Subject|4
7969453|NCT02799069|12528412|FG002|Overall Study|Withdrawal by Subject|3
7969454|NCT02799069|12528410|FG000|Overall Study|Protocol Violation|1
7969455|NCT02799069|12528411|FG001|Overall Study|Protocol Violation|0
7969456|NCT02799069|12528412|FG002|Overall Study|Protocol Violation|2
7969457|NCT02799082|12528422|FG000|Overall Study|Refused second PDT or withdraw consent|4
7969458|NCT02799082|12528423|FG001|Overall Study|Refused second PDT or withdraw consent|3
7969459|NCT02799082|12528422|FG000|Overall Study|Protocol Violation|0
7969460|NCT02799082|12528423|FG001|Overall Study|Protocol Violation|1
7969461|NCT02799381|12528448|FG000|Overall Study|Withdrew consent|3
7969462|NCT02799381|12528449|FG001|Overall Study|Withdrew consent|2
7969463|NCT02799381|12528448|FG000|Overall Study|Adverse Event|0
7969464|NCT02799381|12528449|FG001|Overall Study|Adverse Event|1
7969465|NCT02799381|12528448|FG000|Overall Study|Participant did not take any study drug|1
7969466|NCT02799381|12528449|FG001|Overall Study|Participant did not take any study drug|0
7969467|NCT02799472|12528457|FG000|Overall Study|Withdrawal by Subject|2
7969468|NCT02799472|12528458|FG001|Overall Study|Withdrawal by Subject|4
7969469|NCT02799472|12528457|FG000|Overall Study|Lack of Efficacy|2
7969470|NCT02799472|12528458|FG001|Overall Study|Lack of Efficacy|0
7969471|NCT02799472|12528457|FG000|Overall Study|Lost to Follow-up|0
7969472|NCT02799472|12528458|FG001|Overall Study|Lost to Follow-up|1
7969473|NCT02799745|12528475|FG000|Overall Study|Participant moved out of state|1
7969474|NCT02799745|12528476|FG001|Overall Study|Participant moved out of state|0
7969475|NCT02799745|12528475|FG000|Overall Study|Discontinued due to planned surgery|1
7969476|NCT02799745|12528476|FG001|Overall Study|Discontinued due to planned surgery|0
7969477|NCT02799745|12528475|FG000|Overall Study|Withdrawal by Subject|16
7969478|NCT02799745|12528476|FG001|Overall Study|Withdrawal by Subject|25
7969479|NCT02799745|12528475|FG000|Overall Study|Protocol Deviation|4
7969480|NCT02799745|12528476|FG001|Overall Study|Protocol Deviation|5
7969481|NCT02799745|12528475|FG000|Overall Study|Progressive Disease|28
7969482|NCT02799745|12528476|FG001|Overall Study|Progressive Disease|38
7969483|NCT02799745|12528475|FG000|Overall Study|Lost to Follow-up|3
7969484|NCT02799745|12528476|FG001|Overall Study|Lost to Follow-up|2
7969485|NCT02799745|12528475|FG000|Overall Study|Death|3
7969486|NCT02799745|12528476|FG001|Overall Study|Death|0
7969487|NCT02799745|12528475|FG000|Overall Study|Adverse Event|0
7969488|NCT02799745|12528476|FG001|Overall Study|Adverse Event|1
7969489|NCT02799784|12528482|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
7969490|NCT02799784|12528483|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
7969491|NCT02799784|12528482|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
7969492|NCT02799784|12528483|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
7969493|NCT02799784|12528482|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
7969494|NCT02799784|12528483|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
7969495|NCT02799784|12528482|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
7969496|NCT02799784|12528483|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
7969497|NCT02799784|12528482|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
7969498|NCT02799784|12528483|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
7969499|NCT02799784|12528482|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
7969500|NCT02799784|12528483|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
7969501|NCT02800642|12528515|FG000|Overall Study|Death|3
7969502|NCT02800642|12528515|FG000|Overall Study|Other|10
7969503|NCT02800642|12528515|FG000|Overall Study|Physician Decision|2
7969504|NCT02800642|12528515|FG000|Overall Study|Adverse Event|6
7969505|NCT02800642|12528515|FG000|Overall Study|Withdrawal by Subject|3
7969506|NCT02800642|12528515|FG000|Overall Study|Lost to Follow-up|1
7969507|NCT02800928|12528519|FG000|Overall Study|Withdrawal by Subject|1
7969508|NCT02800928|12528520|FG001|Overall Study|Withdrawal by Subject|1
7969509|NCT02800928|12528519|FG000|Overall Study|Protocol Violation|1
7969510|NCT02800928|12528520|FG001|Overall Study|Protocol Violation|1
7969511|NCT02801396|12528545|FG000|Period 1|Withdrawal by Subject|0
7969512|NCT02801396|12528546|FG001|Period 1|Withdrawal by Subject|0
7969513|NCT02801396|12528547|FG002|Period 1|Withdrawal by Subject|0
7969514|NCT02801396|12528548|FG003|Period 1|Withdrawal by Subject|0
7969515|NCT02801396|12528549|FG004|Period 1|Withdrawal by Subject|1
7969516|NCT02801396|12528550|FG005|Period 1|Withdrawal by Subject|0
7969517|NCT02801578|12528558|FG000|Overall Study|Adverse Event|2
7969518|NCT02801617|12528564|FG000|Overall Study|Protocol Violation|2
7969519|NCT02801617|12528565|FG001|Overall Study|Protocol Violation|6
7969520|NCT02801669|12528577|FG000|Overall Study|Death|66
7969521|NCT02801669|12528578|FG001|Overall Study|Death|69
7969522|NCT02801669|12528577|FG000|Overall Study|Withdrawal by Subject|81
7969523|NCT02801669|12528578|FG001|Overall Study|Withdrawal by Subject|77
7969524|NCT02801669|12528577|FG000|Overall Study|Other|4
7969525|NCT02801669|12528578|FG001|Overall Study|Other|6
7969526|NCT02801877|12528588|FG000|Overall Study|Lost to Follow-up|1
7969527|NCT02801877|12528589|FG001|Overall Study|Lost to Follow-up|1
7969528|NCT02801877|12528590|FG002|Overall Study|Lost to Follow-up|2
7969529|NCT02801877|12528591|FG003|Overall Study|Lost to Follow-up|0
7969530|NCT02801877|12528588|FG000|Overall Study|Never Started Treatment|2
7969531|NCT02801877|12528589|FG001|Overall Study|Never Started Treatment|0
7969532|NCT02801877|12528590|FG002|Overall Study|Never Started Treatment|4
7969533|NCT02801877|12528591|FG003|Overall Study|Never Started Treatment|0
7969534|NCT02802319|12528638|FG000|Overall Study|Physician Decision|2
7969535|NCT02802319|12528639|FG001|Overall Study|Physician Decision|1
7969536|NCT02802319|12528638|FG000|Overall Study|Lost to Follow-up|0
7969537|NCT02802319|12528639|FG001|Overall Study|Lost to Follow-up|4
7969538|NCT02802345|12528647|FG000|Overall Study|Not Treated|0
7969539|NCT02802345|12528648|FG001|Overall Study|Not Treated|1
7969540|NCT02802345|12528647|FG000|Overall Study|Adverse Event|28
7969541|NCT02802345|12528648|FG001|Overall Study|Adverse Event|20
7969542|NCT02802345|12528647|FG000|Overall Study|Withdrawal by Subject|3
7969543|NCT02802345|12528648|FG001|Overall Study|Withdrawal by Subject|3
7969544|NCT02802345|12528647|FG000|Overall Study|Protocol Violation|0
7969545|NCT02802345|12528648|FG001|Overall Study|Protocol Violation|1
7969546|NCT02802345|12528647|FG000|Overall Study|Other than listed|1
7969547|NCT02802345|12528648|FG001|Overall Study|Other than listed|5
7969548|NCT02802735|12528700|FG000|Overall Study|Withdrawal by Subject|0
7969549|NCT02802735|12528701|FG001|Overall Study|Withdrawal by Subject|1
7969550|NCT02802735|12528702|FG002|Overall Study|Withdrawal by Subject|0
7969551|NCT02802735|12528703|FG003|Overall Study|Withdrawal by Subject|0
7969552|NCT02802735|12528704|FG004|Overall Study|Withdrawal by Subject|0
7717948|NCT00523978|12141628|FG000|Overall Study|Death|1
7717949|NCT00523978|12141629|FG001|Overall Study|Death|0
7717950|NCT00523991|12141638|FG000|Overall Study|Adverse Event|6
7717951|NCT00523991|12141639|FG001|Overall Study|Adverse Event|5
7969553|NCT02802865|12528721|FG000|Overall Study|Pregnancy|1
7969554|NCT02802865|12528722|FG001|Overall Study|Pregnancy|1
7969555|NCT02802865|12528721|FG000|Overall Study|Ineliegible due to tuberculosis|0
7969556|NCT02802865|12528722|FG001|Overall Study|Ineliegible due to tuberculosis|1
7969557|NCT02802878|12528730|FG000|Overall Study|Withdrawal by Subject|3
7969558|NCT02802878|12528731|FG001|Overall Study|Withdrawal by Subject|3
7969559|NCT02802878|12528730|FG000|Overall Study|Protocol Violation|1
7969560|NCT02802878|12528731|FG001|Overall Study|Protocol Violation|0
7969561|NCT02803138|12528737|FG000|Overall Study|Failure to return|38
7969562|NCT02803138|12528737|FG000|Overall Study|Insufficient virological response|2
7969563|NCT02803138|12528737|FG000|Overall Study|Withdrawn consent|1
7969564|NCT02803138|12528737|FG000|Overall Study|Death|1
7969565|NCT02803138|12528737|FG000|Overall Study|Other, not specified|28
7969566|NCT02803580|12528763|FG000|Overall Study|Death|13
7969567|NCT02803580|12528763|FG000|Overall Study|Lost to Follow-up|19
7969568|NCT02803580|12528763|FG000|Overall Study|Withdrawal by Subject|3
7969569|NCT02803580|12528763|FG000|Overall Study|Inclusion in clinical trial|1
7969570|NCT02804178|12528776|FG000|Overall Study|Adverse Event|1
7969571|NCT02804399|12528780|FG000|Period 2|Adverse Event|0
7969572|NCT02804399|12528781|FG001|Period 2|Adverse Event|1
7969573|NCT02804750|12528801|FG000|Period 1|Adverse Event|0
7969574|NCT02804750|12528802|FG001|Period 1|Adverse Event|2
7969575|NCT02804750|12528801|FG000|Period 1|Withdrawal by Subject|0
7969576|NCT02804750|12528802|FG001|Period 1|Withdrawal by Subject|1
7969577|NCT02804750|12528801|FG000|Period 2|Adverse Event|1
7969578|NCT02804750|12528802|FG001|Period 2|Adverse Event|0
7969579|NCT02804750|12528801|FG000|Period 3|Adverse Event|0
7969580|NCT02804750|12528802|FG001|Period 3|Adverse Event|2
7969581|NCT02804750|12528801|FG000|Period 4|Adverse Event|0
7969582|NCT02804750|12528802|FG001|Period 4|Adverse Event|5
7969583|NCT02804763|12528814|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1
7969584|NCT02804763|12528815|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
7969585|NCT02804763|12528816|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
7969586|NCT02804763|12528817|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
7969587|NCT02804763|12528814|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0
7969588|NCT02804763|12528815|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0
7969589|NCT02804763|12528816|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1
7969590|NCT02804763|12528817|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2
7969591|NCT02804763|12528814|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
7969592|NCT02804763|12528815|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1
7969593|NCT02804763|12528816|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
7969594|NCT02804763|12528817|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
7969595|NCT02804763|12528814|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2
7969596|NCT02804763|12528815|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0
7969597|NCT02804763|12528816|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1
7969598|NCT02804763|12528817|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1
7969599|NCT02804763|12528814|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4
7969600|NCT02804763|12528815|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0
7969601|NCT02804763|12528816|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2
7969602|NCT02804763|12528817|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2
7969603|NCT02804763|12528814|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
7969604|NCT02804763|12528815|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1
7811408|NCT01182350|12275136|FG000|Overall Study|Withdrawal by Subject|3
7811409|NCT01182350|12275137|FG001|Overall Study|Withdrawal by Subject|1
7969605|NCT02804763|12528816|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
7969606|NCT02804763|12528817|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
7969607|NCT02805309|12528838|FG000|Overall Study|Lost to Follow-up|2
7969608|NCT02805309|12528839|FG001|Overall Study|Lost to Follow-up|2
7969609|NCT02805309|12528840|FG002|Overall Study|Lost to Follow-up|2
7969610|NCT02805309|12528838|FG000|Overall Study|Post-Randomization Exclusion|0
7969611|NCT02805309|12528839|FG001|Overall Study|Post-Randomization Exclusion|2
7969612|NCT02805309|12528840|FG002|Overall Study|Post-Randomization Exclusion|1
7969613|NCT02805660|12528864|FG000|Overall Study|Death|5
7969614|NCT02805660|12528865|FG001|Overall Study|Death|2
7969615|NCT02805660|12528866|FG002|Overall Study|Death|9
7969616|NCT02805660|12528867|FG003|Overall Study|Death|5
7969617|NCT02805660|12528868|FG004|Overall Study|Death|0
7969618|NCT02805660|12528869|FG005|Overall Study|Death|14
7969619|NCT02805660|12528870|FG006|Overall Study|Death|12
7969620|NCT02805660|12528864|FG000|Overall Study|Lost to Follow-up|0
7969621|NCT02805660|12528865|FG001|Overall Study|Lost to Follow-up|1
7969622|NCT02805660|12528866|FG002|Overall Study|Lost to Follow-up|1
7969623|NCT02805660|12528867|FG003|Overall Study|Lost to Follow-up|2
7969624|NCT02805660|12528868|FG004|Overall Study|Lost to Follow-up|0
7969625|NCT02805660|12528869|FG005|Overall Study|Lost to Follow-up|0
7969626|NCT02805660|12528870|FG006|Overall Study|Lost to Follow-up|0
7969627|NCT02805660|12528864|FG000|Overall Study|Withdrawal by Subject|0
7969628|NCT02805660|12528865|FG001|Overall Study|Withdrawal by Subject|0
7969629|NCT02805660|12528866|FG002|Overall Study|Withdrawal by Subject|0
7969630|NCT02805660|12528867|FG003|Overall Study|Withdrawal by Subject|3
7969631|NCT02805660|12528868|FG004|Overall Study|Withdrawal by Subject|1
7969632|NCT02805660|12528869|FG005|Overall Study|Withdrawal by Subject|0
7969633|NCT02805660|12528870|FG006|Overall Study|Withdrawal by Subject|2
7969634|NCT02805660|12528864|FG000|Overall Study|Study terminated by Sponsor|0
7969635|NCT02805660|12528865|FG001|Overall Study|Study terminated by Sponsor|0
7969636|NCT02805660|12528866|FG002|Overall Study|Study terminated by Sponsor|1
7969637|NCT02805660|12528867|FG003|Overall Study|Study terminated by Sponsor|4
7969638|NCT02805660|12528868|FG004|Overall Study|Study terminated by Sponsor|2
7969639|NCT02805660|12528869|FG005|Overall Study|Study terminated by Sponsor|3
7969640|NCT02805660|12528870|FG006|Overall Study|Study terminated by Sponsor|1
7969641|NCT02805660|12528864|FG000|Overall Study|Miscellaneous|0
7969642|NCT02805660|12528865|FG001|Overall Study|Miscellaneous|1
7969643|NCT02805660|12528866|FG002|Overall Study|Miscellaneous|0
7969644|NCT02805660|12528867|FG003|Overall Study|Miscellaneous|4
7969645|NCT02805660|12528868|FG004|Overall Study|Miscellaneous|0
7969646|NCT02805660|12528869|FG005|Overall Study|Miscellaneous|6
7969647|NCT02805660|12528870|FG006|Overall Study|Miscellaneous|4
7969648|NCT02805790|12528901|FG000|Second Intervention (4 Weeks)|Physician Decision|0
7969649|NCT02805790|12528902|FG001|Second Intervention (4 Weeks)|Physician Decision|1
7969650|NCT02805907|12528910|FG000|Overall Study|Lost to Follow-up|3
7969651|NCT02805907|12528911|FG001|Overall Study|Lost to Follow-up|3
7969652|NCT02805972|12528919|FG000|Washout Period|Lost to Follow-up|3
7969653|NCT02805972|12528920|FG001|Washout Period|Lost to Follow-up|0
7969654|NCT02806024|12528938|FG000|Overall Study|Night Delivery|1
7969655|NCT02806024|12528939|FG001|Overall Study|Night Delivery|1
7969656|NCT02806024|12528938|FG000|Overall Study|DVT during antepartum admission|0
7969657|NCT02806024|12528939|FG001|Overall Study|DVT during antepartum admission|1
7969658|NCT02806232|12528954|FG000|Overall Study|Lost to Follow-up|1
7969659|NCT02806232|12528955|FG001|Overall Study|Lost to Follow-up|2
7969660|NCT02806232|12528956|FG002|Overall Study|Lost to Follow-up|1
7969661|NCT02806232|12528957|FG003|Overall Study|Lost to Follow-up|0
7969662|NCT02806232|12528958|FG004|Overall Study|Lost to Follow-up|0
7969663|NCT02806232|12528959|FG005|Overall Study|Lost to Follow-up|1
7969664|NCT02806232|12528960|FG006|Overall Study|Lost to Follow-up|0
7969665|NCT02806232|12528961|FG007|Overall Study|Lost to Follow-up|0
7969666|NCT02806232|12528962|FG008|Overall Study|Lost to Follow-up|0
7969667|NCT02806232|12528954|FG000|Overall Study|Withdrawal by Subject|0
7969668|NCT02806232|12528955|FG001|Overall Study|Withdrawal by Subject|2
7969669|NCT02806232|12528956|FG002|Overall Study|Withdrawal by Subject|0
7969670|NCT02806232|12528957|FG003|Overall Study|Withdrawal by Subject|0
7969671|NCT02806232|12528958|FG004|Overall Study|Withdrawal by Subject|2
7969672|NCT02806232|12528959|FG005|Overall Study|Withdrawal by Subject|1
7969673|NCT02806232|12528960|FG006|Overall Study|Withdrawal by Subject|0
7969674|NCT02806232|12528961|FG007|Overall Study|Withdrawal by Subject|0
7969675|NCT02806232|12528962|FG008|Overall Study|Withdrawal by Subject|0
7969676|NCT02806414|12528982|FG000|Overall Study|Lost to Follow-up|2
7969677|NCT02806505|12528988|FG000|Overall Study|Adverse event/intercurrent illness|1
7969678|NCT02806505|12528989|FG001|Overall Study|Adverse event/intercurrent illness|3
7969679|NCT02806505|12528988|FG000|Overall Study|Death|4
7969680|NCT02806505|12528989|FG001|Overall Study|Death|0
7969681|NCT02806505|12528988|FG000|Overall Study|Did not cooperate/refused treatment|3
7969682|NCT02806505|12528989|FG001|Overall Study|Did not cooperate/refused treatment|3
7969683|NCT02806505|12528988|FG000|Overall Study|Failure to return|0
7969684|NCT02806505|12528989|FG001|Overall Study|Failure to return|1
7969685|NCT02806505|12528988|FG000|Overall Study|Insufficient therapeutic response|2
7969686|NCT02806505|12528989|FG001|Overall Study|Insufficient therapeutic response|4
7969687|NCT02806713|12529001|FG000|Overall Study|Urethral injury during procedure|1
7969688|NCT02806713|12529002|FG001|Overall Study|Urethral injury during procedure|0
7969689|NCT02806713|12529001|FG000|Overall Study|cancelled surgery|1
7969690|NCT02806713|12529002|FG001|Overall Study|cancelled surgery|2
7969691|NCT02806726|12529008|FG000|Overall Study|Lost to Follow-up|1
7969692|NCT02806947|12529044|FG000|Overall Study|Withdrawal by Subject|5
7969693|NCT02806947|12529045|FG001|Overall Study|Withdrawal by Subject|1
7969694|NCT02806973|12529051|FG000|Period 1|Withdrawal by Subject|0
7969695|NCT02806973|12529052|FG001|Period 1|Withdrawal by Subject|2
7969696|NCT02806973|12529053|FG002|Period 1|Withdrawal by Subject|1
7969697|NCT02806973|12529054|FG003|Period 1|Withdrawal by Subject|1
7969698|NCT02806973|12529051|FG000|Period 1|Adverse Event|0
7969699|NCT02806973|12529052|FG001|Period 1|Adverse Event|0
7969700|NCT02806973|12529053|FG002|Period 1|Adverse Event|0
7969701|NCT02806973|12529054|FG003|Period 1|Adverse Event|1
7969702|NCT02806973|12529051|FG000|Period 3|Withdrawal by Subject|0
7969703|NCT02806973|12529052|FG001|Period 3|Withdrawal by Subject|0
7969704|NCT02806973|12529053|FG002|Period 3|Withdrawal by Subject|0
7969705|NCT02806973|12529054|FG003|Period 3|Withdrawal by Subject|3
7969706|NCT02806973|12529051|FG000|Period 3|Adverse Event|0
7969707|NCT02806973|12529052|FG001|Period 3|Adverse Event|0
7969708|NCT02806973|12529053|FG002|Period 3|Adverse Event|1
7969709|NCT02806973|12529054|FG003|Period 3|Adverse Event|0
7969710|NCT02806986|12529064|FG000|Treatment Stage 1|Adverse Event|1
7969711|NCT02806986|12529064|FG000|Treatment Stage 2|Adverse Event|3
7969712|NCT02806986|12529064|FG000|Treatment Stage 2|Withdrawal by Subject|2
7969713|NCT02807259|12529074|FG000|Baseline (3 Months)|migration, refusal, not available|77
7969714|NCT02807259|12529075|FG001|Baseline (3 Months)|migration, refusal, not available|112
7969715|NCT02807259|12529074|FG000|Midline (3 Months)|migration, refusal, not available|30
7969716|NCT02807259|12529075|FG001|Midline (3 Months)|migration, refusal, not available|34
7969717|NCT02807259|12529074|FG000|Endline (3 Months)|migration, refusal, not available|35
7969718|NCT02807259|12529075|FG001|Endline (3 Months)|migration, refusal, not available|87
7969719|NCT02807376|12529085|FG000|Overall Study|Intra-operative exclusion criteria|3
7969720|NCT02807376|12529086|FG001|Overall Study|Intra-operative exclusion criteria|0
7969721|NCT02807376|12529085|FG000|Overall Study|Lost to Follow-up|0
7969722|NCT02807376|12529086|FG001|Overall Study|Lost to Follow-up|1
7969723|NCT02807402|12529092|FG000|Overall Study|Failure to Return|1
7969724|NCT02807402|12529092|FG000|Overall Study|Death|3
7969725|NCT02807402|12529092|FG000|Overall Study|Other|2
7969726|NCT02807623|12529107|FG000|Overall Study|Lost to Follow-up|23
7969727|NCT02807623|12529108|FG001|Overall Study|Lost to Follow-up|18
7969728|NCT02807623|12529109|FG002|Overall Study|Lost to Follow-up|22
7969729|NCT02807623|12529107|FG000|Overall Study|Drug intolerance|0
7969730|NCT02807623|12529108|FG001|Overall Study|Drug intolerance|1
7969731|NCT02807623|12529109|FG002|Overall Study|Drug intolerance|0
7969732|NCT02807623|12529107|FG000|Overall Study|incomplete blood draw|0
7969733|NCT02807623|12529108|FG001|Overall Study|incomplete blood draw|2
7969734|NCT02807623|12529109|FG002|Overall Study|incomplete blood draw|1
7969735|NCT02807844|12529136|FG000|Overall Study|Physician Decision|0
7969736|NCT02807844|12529137|FG001|Overall Study|Physician Decision|0
7969737|NCT02807844|12529138|FG002|Overall Study|Physician Decision|0
7969738|NCT02807844|12529139|FG003|Overall Study|Physician Decision|0
7969739|NCT02807844|12529140|FG004|Overall Study|Physician Decision|0
7969740|NCT02807844|12529141|FG005|Overall Study|Physician Decision|0
7969741|NCT02807844|12529142|FG006|Overall Study|Physician Decision|3
7969742|NCT02807844|12529143|FG007|Overall Study|Physician Decision|0
7969743|NCT02807844|12529144|FG008|Overall Study|Physician Decision|1
7969744|NCT02807844|12529145|FG009|Overall Study|Physician Decision|2
7969745|NCT02807844|12529136|FG000|Overall Study|Death|0
7969746|NCT02807844|12529137|FG001|Overall Study|Death|0
7969747|NCT02807844|12529138|FG002|Overall Study|Death|2
7969748|NCT02807844|12529139|FG003|Overall Study|Death|4
7969749|NCT02807844|12529140|FG004|Overall Study|Death|1
7969750|NCT02807844|12529141|FG005|Overall Study|Death|2
7969751|NCT02807844|12529142|FG006|Overall Study|Death|1
7969752|NCT02807844|12529143|FG007|Overall Study|Death|2
7969753|NCT02807844|12529144|FG008|Overall Study|Death|0
7969754|NCT02807844|12529145|FG009|Overall Study|Death|1
7969755|NCT02807844|12529136|FG000|Overall Study|Withdrawal by Subject|0
7969756|NCT02807844|12529137|FG001|Overall Study|Withdrawal by Subject|0
7969757|NCT02807844|12529138|FG002|Overall Study|Withdrawal by Subject|2
7969758|NCT02807844|12529139|FG003|Overall Study|Withdrawal by Subject|1
7969759|NCT02807844|12529140|FG004|Overall Study|Withdrawal by Subject|1
7969760|NCT02807844|12529141|FG005|Overall Study|Withdrawal by Subject|0
7969761|NCT02807844|12529142|FG006|Overall Study|Withdrawal by Subject|1
7969762|NCT02807844|12529143|FG007|Overall Study|Withdrawal by Subject|0
7969763|NCT02807844|12529144|FG008|Overall Study|Withdrawal by Subject|0
7969764|NCT02807844|12529145|FG009|Overall Study|Withdrawal by Subject|0
7969765|NCT02807844|12529136|FG000|Overall Study|Progressive disease|5
7969766|NCT02807844|12529137|FG001|Overall Study|Progressive disease|12
7969767|NCT02807844|12529138|FG002|Overall Study|Progressive disease|8
7969768|NCT02807844|12529139|FG003|Overall Study|Progressive disease|8
7969769|NCT02807844|12529140|FG004|Overall Study|Progressive disease|3
7969770|NCT02807844|12529141|FG005|Overall Study|Progressive disease|8
7969771|NCT02807844|12529142|FG006|Overall Study|Progressive disease|14
7969772|NCT02807844|12529143|FG007|Overall Study|Progressive disease|17
7969773|NCT02807844|12529144|FG008|Overall Study|Progressive disease|19
7969774|NCT02807844|12529145|FG009|Overall Study|Progressive disease|15
7969775|NCT02807844|12529136|FG000|Overall Study|Adverse Event|1
7969776|NCT02807844|12529137|FG001|Overall Study|Adverse Event|0
7969777|NCT02807844|12529138|FG002|Overall Study|Adverse Event|0
7969778|NCT02807844|12529139|FG003|Overall Study|Adverse Event|0
7969779|NCT02807844|12529140|FG004|Overall Study|Adverse Event|1
7969780|NCT02807844|12529141|FG005|Overall Study|Adverse Event|1
7969781|NCT02807844|12529142|FG006|Overall Study|Adverse Event|1
7969782|NCT02807844|12529143|FG007|Overall Study|Adverse Event|1
7969783|NCT02807844|12529144|FG008|Overall Study|Adverse Event|1
7969784|NCT02807844|12529145|FG009|Overall Study|Adverse Event|2
7969785|NCT02807857|12529171|FG000|Enrolled Set|Patients not suitable for follow-up.|551
7969786|NCT02807857|12529171|FG000|Follow-Up Set|Study Terminated By Sponsor|131
7969787|NCT02807857|12529171|FG000|Follow-Up Set|Withdrawal by Subject|8
7969788|NCT02807857|12529171|FG000|Follow-Up Set|Lost to Follow-up|7
7969789|NCT02807857|12529171|FG000|Follow-Up Set|Physician Decision|6
7969790|NCT02807857|12529171|FG000|Follow-Up Set|Adverse Event|3
7969791|NCT02807857|12529171|FG000|Follow-Up Set|Death|27
7969792|NCT02807857|12529171|FG000|Follow-Up Set|Relocation|2
7969793|NCT02807948|12529181|FG000|Overall Study|Physician Decision|1
7969794|NCT02807948|12529182|FG001|Overall Study|Physician Decision|0
7969795|NCT02808312|12529233|FG000|Overall Study|Enrolled but Never Treated|0
7969796|NCT02808312|12529234|FG001|Overall Study|Enrolled but Never Treated|0
7969797|NCT02808312|12529235|FG002|Overall Study|Enrolled but Never Treated|1
7969798|NCT02808312|12529236|FG003|Overall Study|Enrolled but Never Treated|0
7969799|NCT02808312|12529237|FG004|Overall Study|Enrolled but Never Treated|0
7969800|NCT02808338|12529254|FG000|Screening|Screen Failure|10
7969801|NCT02808338|12529254|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1
7969802|NCT02808338|12529254|FG000|Overnight In-lab Polysomonography|Reason not given|1
7969803|NCT02808429|12529268|FG000|Overall Study|Lost to Follow-up|1
7969804|NCT02808429|12529269|FG001|Overall Study|Lost to Follow-up|0
7969805|NCT02808429|12529270|FG002|Overall Study|Lost to Follow-up|0
7969806|NCT02808429|12529268|FG000|Overall Study|Protocol Violation|0
7969807|NCT02808429|12529269|FG001|Overall Study|Protocol Violation|1
7969808|NCT02808429|12529270|FG002|Overall Study|Protocol Violation|0
7969809|NCT02808429|12529268|FG000|Overall Study|Premature study termination by sponsor|2
7969810|NCT02808429|12529269|FG001|Overall Study|Premature study termination by sponsor|0
7969811|NCT02808429|12529270|FG002|Overall Study|Premature study termination by sponsor|1
7969812|NCT02808429|12529268|FG000|Overall Study|Relocation|0
7969813|NCT02808429|12529269|FG001|Overall Study|Relocation|0
7969814|NCT02808429|12529270|FG002|Overall Study|Relocation|1
7969815|NCT02808819|12529280|FG000|Overall Study|eg. no treatment efficacy on asthma|5
7969816|NCT02808819|12529281|FG001|Overall Study|eg. no treatment efficacy on asthma|4
7969817|NCT02808819|12529280|FG000|Overall Study|Withdrawal by Subject|10
7969818|NCT02808819|12529281|FG001|Overall Study|Withdrawal by Subject|13
7969819|NCT02808819|12529280|FG000|Overall Study|Site terminated by sponsor|2
7969820|NCT02808819|12529281|FG001|Overall Study|Site terminated by sponsor|0
7969821|NCT02808819|12529280|FG000|Overall Study|Pregnancy|1
7969822|NCT02808819|12529281|FG001|Overall Study|Pregnancy|0
7969823|NCT02808819|12529280|FG000|Overall Study|Lost to Follow-up|1
7969824|NCT02808819|12529281|FG001|Overall Study|Lost to Follow-up|6
7969825|NCT02808819|12529280|FG000|Overall Study|Protocol Violation|0
7969826|NCT02808819|12529281|FG001|Overall Study|Protocol Violation|1
7969827|NCT02808819|12529280|FG000|Overall Study|Development of study-specific withdrawal criteria|8
7969828|NCT02808819|12529281|FG001|Overall Study|Development of study-specific withdrawal criteria|3
7969829|NCT02808819|12529280|FG000|Overall Study|Death|1
7969830|NCT02808819|12529281|FG001|Overall Study|Death|0
7969831|NCT02808819|12529280|FG000|Overall Study|Adverse Event|3
7969832|NCT02808819|12529281|FG001|Overall Study|Adverse Event|4
7969833|NCT02808975|12529290|FG000|Overall Study|Adverse Event|3
7969834|NCT02808975|12529291|FG001|Overall Study|Adverse Event|4
7969835|NCT02808975|12529290|FG000|Overall Study|Withdrew consent|9
7969836|NCT02808975|12529291|FG001|Overall Study|Withdrew consent|8
7969837|NCT02808975|12529290|FG000|Overall Study|Lost to Follow-up|4
7969838|NCT02808975|12529291|FG001|Overall Study|Lost to Follow-up|6
7969839|NCT02808975|12529290|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1
7969840|NCT02808975|12529291|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0
7969841|NCT02808975|12529290|FG000|Overall Study|Other, not specified|5
7969842|NCT02808975|12529291|FG001|Overall Study|Other, not specified|1
7969843|NCT02809053|12529299|FG000|Overall Study|Death|0
7969844|NCT02809053|12529300|FG001|Overall Study|Death|1
7969845|NCT02809053|12529299|FG000|Overall Study|Lost to Follow-up|3
7969846|NCT02809053|12529300|FG001|Overall Study|Lost to Follow-up|1
7969847|NCT02809053|12529299|FG000|Overall Study|Withdrawal by Subject|2
7969848|NCT02809053|12529300|FG001|Overall Study|Withdrawal by Subject|3
7969849|NCT02809053|12529299|FG000|Overall Study|Disease Progression|2
7969850|NCT02809053|12529300|FG001|Overall Study|Disease Progression|1
7969851|NCT02809833|12529340|FG000|Overall Study|Death|3
7969852|NCT02809833|12529340|FG000|Overall Study|Intolerance|54
7969853|NCT02809833|12529340|FG000|Overall Study|Lack of Efficacy|89
7969854|NCT02809833|12529340|FG000|Overall Study|Remission/Treatment No Longer Needed|3
7969855|NCT02809833|12529340|FG000|Overall Study|Noncompliance|1
7969856|NCT02809833|12529340|FG000|Overall Study|Withdrawal by Subject|34
7969857|NCT02809833|12529340|FG000|Overall Study|Lost to Follow-up|35
7969858|NCT02809833|12529340|FG000|Overall Study|Adverse Event (AE)|24
7969859|NCT02809833|12529340|FG000|Overall Study|Other|5
7969860|NCT02809833|12529340|FG000|Overall Study|Missing Information|52
7969861|NCT02809976|12529366|FG000|Overall Study|Lost to Follow-up|1
7969862|NCT02809976|12529366|FG000|Overall Study|Withdrawal by Subject|1
7969863|NCT02810340|12529382|FG000|Overall Study|Withdrawal by Subject|1
7969864|NCT02810340|12529383|FG001|Overall Study|Withdrawal by Subject|0
7969865|NCT02810340|12529384|FG002|Overall Study|Withdrawal by Subject|0
7969866|NCT02810340|12529382|FG000|Overall Study|Incarceration|0
7969867|NCT02810340|12529383|FG001|Overall Study|Incarceration|1
7969868|NCT02810340|12529384|FG002|Overall Study|Incarceration|0
7969869|NCT02810340|12529382|FG000|Overall Study|Lost to Follow-up|0
7969870|NCT02810340|12529383|FG001|Overall Study|Lost to Follow-up|0
7969871|NCT02810340|12529384|FG002|Overall Study|Lost to Follow-up|1
7969872|NCT02810392|12529394|FG000|Overall Study|Subject too ill to continue|1
7969873|NCT02810392|12529395|FG001|Overall Study|Subject too ill to continue|0
7969874|NCT02810392|12529394|FG000|Overall Study|COVID 19 research restrictions|0
7969875|NCT02810392|12529395|FG001|Overall Study|COVID 19 research restrictions|1
7969876|NCT02810951|12529422|FG000|Overall Study|Adverse Event|1
7969877|NCT02810964|12529430|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1
7969878|NCT02810964|12529431|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2
7969879|NCT02810964|12529430|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1
7969880|NCT02810964|12529431|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0
7969881|NCT02810964|12529430|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0
7969882|NCT02810964|12529431|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1
7969883|NCT02810964|12529430|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1
7969884|NCT02810964|12529431|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0
7969885|NCT02811159|12529437|FG000|Treatment Course 1|Lost to Follow-up|1
7969886|NCT02811640|12529464|FG000|Overall Study|Technology malfunction|2
7969887|NCT02812186|12529495|FG000|Period 1|Post randomization screen failure|5
7969888|NCT02812186|12529496|FG001|Period 1|Post randomization screen failure|9
7969889|NCT02812186|12529495|FG000|Period 1|nonevaluable data sets|6
7969890|NCT02812186|12529496|FG001|Period 1|nonevaluable data sets|6
7969891|NCT02813421|12529543|FG000|Overall Study|Withdrawal by Subject|1
7969892|NCT02813421|12529544|FG001|Overall Study|Withdrawal by Subject|2
7969893|NCT02813421|12529543|FG000|Overall Study|Lost to Follow-up|1
7969894|NCT02813421|12529544|FG001|Overall Study|Lost to Follow-up|1
7969895|NCT02813577|12529563|FG000|Overall Study|Study terminated|4
7969896|NCT02813681|12529570|FG000|Overall Study|Physician Decision|5
7969897|NCT02813681|12529571|FG001|Overall Study|Physician Decision|5
7969898|NCT02813681|12529572|FG002|Overall Study|Physician Decision|0
7969899|NCT02813681|12529570|FG000|Overall Study|Lost to Follow-up|0
7969900|NCT02813681|12529571|FG001|Overall Study|Lost to Follow-up|1
7969901|NCT02813681|12529572|FG002|Overall Study|Lost to Follow-up|0
7969902|NCT02813694|12529584|FG000|Overall Study|Physician Decision|0
7969903|NCT02813694|12529585|FG001|Overall Study|Physician Decision|1
7969904|NCT02813694|12529584|FG000|Overall Study|Withdrawal by Subject|10
7969905|NCT02813694|12529585|FG001|Overall Study|Withdrawal by Subject|9
7969906|NCT02813694|12529584|FG000|Overall Study|Lost to Follow-up|1
7969907|NCT02813694|12529585|FG001|Overall Study|Lost to Follow-up|1
7969908|NCT02813694|12529584|FG000|Overall Study|Death|3
7969909|NCT02813694|12529585|FG001|Overall Study|Death|3
7969910|NCT02813694|12529584|FG000|Overall Study|Randomized- did not receive study drug|2
7969911|NCT02813694|12529585|FG001|Overall Study|Randomized- did not receive study drug|0
7969912|NCT02813694|12529584|FG000|Overall Study|Patient hospitalized|1
7969913|NCT02813694|12529585|FG001|Overall Study|Patient hospitalized|0
7969914|NCT02814175|12529593|FG000|Part 1|Adverse Event|2
7969915|NCT02814175|12529594|FG001|Part 1|Adverse Event|3
7969916|NCT02814175|12529595|FG002|Part 1|Adverse Event|0
7969917|NCT02814175|12529596|FG003|Part 1|Adverse Event|0
7969918|NCT02814175|12529597|FG004|Part 1|Adverse Event|0
7969919|NCT02814175|12529598|FG005|Part 1|Adverse Event|0
7969920|NCT02814175|12529593|FG000|Part 1|Withdrawal Consent|8
7969921|NCT02814175|12529594|FG001|Part 1|Withdrawal Consent|1
7969922|NCT02814175|12529595|FG002|Part 1|Withdrawal Consent|0
7969923|NCT02814175|12529596|FG003|Part 1|Withdrawal Consent|0
7969924|NCT02814175|12529597|FG004|Part 1|Withdrawal Consent|0
7969925|NCT02814175|12529598|FG005|Part 1|Withdrawal Consent|0
7969926|NCT02814175|12529593|FG000|Part 1|Lost to Follow-up|1
7969927|NCT02814175|12529594|FG001|Part 1|Lost to Follow-up|0
7969928|NCT02814175|12529595|FG002|Part 1|Lost to Follow-up|0
7969929|NCT02814175|12529596|FG003|Part 1|Lost to Follow-up|0
7969930|NCT02814175|12529597|FG004|Part 1|Lost to Follow-up|0
7969931|NCT02814175|12529598|FG005|Part 1|Lost to Follow-up|0
7969932|NCT02814175|12529593|FG000|Part 1|Lack of Efficacy|1
7969933|NCT02814175|12529594|FG001|Part 1|Lack of Efficacy|2
7969934|NCT02814175|12529595|FG002|Part 1|Lack of Efficacy|0
7969935|NCT02814175|12529596|FG003|Part 1|Lack of Efficacy|0
7969936|NCT02814175|12529597|FG004|Part 1|Lack of Efficacy|0
7969937|NCT02814175|12529598|FG005|Part 1|Lack of Efficacy|0
7969938|NCT02814175|12529593|FG000|Part 2|Adverse Event|0
7969939|NCT02814175|12529594|FG001|Part 2|Adverse Event|0
7969940|NCT02814175|12529595|FG002|Part 2|Adverse Event|0
7969941|NCT02814175|12529596|FG003|Part 2|Adverse Event|1
7969942|NCT02814175|12529597|FG004|Part 2|Adverse Event|1
7969943|NCT02814175|12529598|FG005|Part 2|Adverse Event|2
7969944|NCT02814175|12529593|FG000|Part 2|Withdrawal Consent|0
7969945|NCT02814175|12529594|FG001|Part 2|Withdrawal Consent|0
7969946|NCT02814175|12529595|FG002|Part 2|Withdrawal Consent|0
7969947|NCT02814175|12529596|FG003|Part 2|Withdrawal Consent|2
7969948|NCT02814175|12529597|FG004|Part 2|Withdrawal Consent|1
7969949|NCT02814175|12529598|FG005|Part 2|Withdrawal Consent|1
7969950|NCT02814175|12529593|FG000|Part 2|Lost to Follow-up|0
7969951|NCT02814175|12529594|FG001|Part 2|Lost to Follow-up|0
7969952|NCT02814175|12529595|FG002|Part 2|Lost to Follow-up|0
7969953|NCT02814175|12529596|FG003|Part 2|Lost to Follow-up|1
7969954|NCT02814175|12529597|FG004|Part 2|Lost to Follow-up|0
7969955|NCT02814175|12529598|FG005|Part 2|Lost to Follow-up|0
7969956|NCT02814175|12529593|FG000|Part 2|Lack of Efficacy|0
7969957|NCT02814175|12529594|FG001|Part 2|Lack of Efficacy|0
7969958|NCT02814175|12529595|FG002|Part 2|Lack of Efficacy|0
7969959|NCT02814175|12529596|FG003|Part 2|Lack of Efficacy|0
7969960|NCT02814175|12529597|FG004|Part 2|Lack of Efficacy|0
7969961|NCT02814175|12529598|FG005|Part 2|Lack of Efficacy|3
7969962|NCT02814565|12529648|FG000|Overall Study|Lack of Efficacy|0
7969963|NCT02814565|12529649|FG001|Overall Study|Lack of Efficacy|1
7969964|NCT02814565|12529648|FG000|Overall Study|Subject decision, caused by AE Influenza|1
7969965|NCT02814565|12529649|FG001|Overall Study|Subject decision, caused by AE Influenza|1
7969966|NCT02814643|12529657|FG000|Overall Study|Lost to Follow-up|0
7969967|NCT02814643|12529658|FG001|Overall Study|Lost to Follow-up|1
7969968|NCT02814643|12529657|FG000|Overall Study|Withdrawal by Subject|1
7969969|NCT02814643|12529658|FG001|Overall Study|Withdrawal by Subject|2
7969970|NCT02814838|12529683|FG000|Overall Study|3 agreed dates for the final visit missed|1
7969971|NCT02814838|12529684|FG001|Overall Study|3 agreed dates for the final visit missed|0
7969972|NCT02814838|12529683|FG000|Overall Study|Consent withdrawal|1
7969973|NCT02814838|12529684|FG001|Overall Study|Consent withdrawal|1
7969974|NCT02815293|12529708|FG000|Overall Study|Study termination by sponsor|10
7969975|NCT02815293|12529709|FG001|Overall Study|Study termination by sponsor|7
7969976|NCT02815293|12529710|FG002|Overall Study|Study termination by sponsor|0
7969977|NCT02815293|12529708|FG000|Overall Study|Participants not randomized|0
7969978|NCT02815293|12529709|FG001|Overall Study|Participants not randomized|0
7969979|NCT02815293|12529710|FG002|Overall Study|Participants not randomized|18
7969980|NCT02815293|12529708|FG000|Overall Study|Adverse Event|0
7969981|NCT02815293|12529709|FG001|Overall Study|Adverse Event|1
7969982|NCT02815293|12529710|FG002|Overall Study|Adverse Event|0
7969983|NCT02815670|12529725|FG000|Overall Study|Prematurely discontinued of the trial|1
7969984|NCT02815735|12529751|FG000|First Intervention (4 Weeks)|Discomfort|1
7969985|NCT02815735|12529752|FG001|First Intervention (4 Weeks)|Discomfort|0
7969986|NCT02815735|12529751|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1
7969987|NCT02815735|12529752|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0
7969988|NCT02815735|12529751|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0
7969989|NCT02815735|12529752|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1
7969990|NCT02815735|12529751|FG000|Second Intervention (4 Weeks)|Protocol Violation|1
7969991|NCT02815735|12529752|FG001|Second Intervention (4 Weeks)|Protocol Violation|0
7969992|NCT02816138|12529786|FG000|Overall Study|Adverse Event|1
7969993|NCT02816398|12529811|FG000|Overall Study|Death|5
7969994|NCT02816398|12529811|FG000|Overall Study|Lack of Efficacy|8
7969995|NCT02816398|12529811|FG000|Overall Study|Lost to Follow-up|1
7717952|NCT00523991|12141638|FG000|Overall Study|Protocol Violation|1
7717953|NCT00523991|12141639|FG001|Overall Study|Protocol Violation|4
7717954|NCT00523991|12141638|FG000|Overall Study|Lost to Follow-up|4
7717955|NCT00523991|12141639|FG001|Overall Study|Lost to Follow-up|1
7717956|NCT00523991|12141638|FG000|Overall Study|Withdrawal by Subject|7
7717957|NCT00523991|12141639|FG001|Overall Study|Withdrawal by Subject|17
7717958|NCT00523991|12141638|FG000|Overall Study|Other reason (not specified)|3
7767824|NCT00856206|12210595|FG000|Overall Study|Other than specified above|3
7969996|NCT02817087|12529842|FG000|Overall Study|Withdrawal by Subject|2
7969997|NCT02817087|12529843|FG001|Overall Study|Withdrawal by Subject|0
7969998|NCT02817516|12529853|FG000|Overall Study|Other|0
7969999|NCT02817516|12529854|FG001|Overall Study|Other|0
7970000|NCT02817516|12529855|FG002|Overall Study|Other|1
7970001|NCT02817516|12529856|FG003|Overall Study|Other|0
7970002|NCT02817555|12529871|FG000|Overall Study|Death|1
7970003|NCT02817555|12529872|FG001|Overall Study|Death|3
7970004|NCT02817555|12529871|FG000|Overall Study|moved away|1
7970005|NCT02817555|12529872|FG001|Overall Study|moved away|0
7970006|NCT02817555|12529871|FG000|Overall Study|transplant|1
7970007|NCT02817555|12529872|FG001|Overall Study|transplant|1
7970008|NCT02817555|12529871|FG000|Overall Study|changed to Peritoneal Dialysis|0
7970009|NCT02817555|12529872|FG001|Overall Study|changed to Peritoneal Dialysis|1
7970010|NCT02817594|12529878|FG000|Overall Study|Withdrawal by Subject|1
7970011|NCT02817594|12529878|FG000|Overall Study|Other|1
7970012|NCT02817594|12529878|FG000|Overall Study|Did Not Receive Treatment|1
7907518|NCT02019719|12422201|FG004|Overall Study|Protocol Violation|0
7907519|NCT02019719|12422197|FG000|Overall Study|Protocol defined stopping criteria|2
7907520|NCT02019719|12422198|FG001|Overall Study|Protocol defined stopping criteria|0
7907521|NCT02019719|12422199|FG002|Overall Study|Protocol defined stopping criteria|0
7907522|NCT02019719|12422200|FG003|Overall Study|Protocol defined stopping criteria|1
7907523|NCT02019719|12422201|FG004|Overall Study|Protocol defined stopping criteria|1
7907524|NCT02019719|12422197|FG000|Overall Study|Physician Decision|2
7907525|NCT02019719|12422198|FG001|Overall Study|Physician Decision|0
7907526|NCT02019719|12422199|FG002|Overall Study|Physician Decision|0
7907527|NCT02019719|12422200|FG003|Overall Study|Physician Decision|0
7970013|NCT02817776|12529895|FG000|Overall Study|Excluded|33
7970014|NCT02817776|12529895|FG000|Overall Study|Lost to Follow-up|20
7970015|NCT02817776|12529895|FG000|Overall Study|Withdrawal by Subject|33
7970016|NCT02817776|12529895|FG000|Overall Study|Death|2
7970017|NCT02817828|12529899|FG000|Overall Study|Lost to Follow-up|41
7970018|NCT02817828|12529899|FG000|Overall Study|Adverse event not related to bleeding|104
7970019|NCT02817828|12529899|FG000|Overall Study|Adverse event related to bleeding|53
7970020|NCT02817828|12529899|FG000|Overall Study|Protocol Violation|11
7970021|NCT02817828|12529899|FG000|Overall Study|Pregnancy|7
7970022|NCT02817828|12529899|FG000|Overall Study|Pregnancy wish|15
7970023|NCT02817828|12529899|FG000|Overall Study|Withdrawal by Subject|78
7970024|NCT02817828|12529899|FG000|Overall Study|Other|26
7970025|NCT02817841|12529908|FG000|Overall Study|Lost to Follow-up|287
7970026|NCT02817841|12529908|FG000|Overall Study|Withdrawal by Subject|183
7970027|NCT02817841|12529908|FG000|Overall Study|Adverse event not related to bleeding|131
7970028|NCT02817841|12529908|FG000|Overall Study|Adverse event related to bleeding|51
7970029|NCT02817841|12529908|FG000|Overall Study|Pregnancy|32
7970030|NCT02817841|12529908|FG000|Overall Study|Pregnancy wish|17
7970031|NCT02817841|12529908|FG000|Overall Study|Other reasons|53
7970032|NCT02817841|12529908|FG000|Overall Study|Protocol Violation|94
7970033|NCT02817906|12529918|FG000|Overall Study|Adverse Event|3
7970034|NCT02817906|12529919|FG001|Overall Study|Adverse Event|0
7970035|NCT02817906|12529918|FG000|Overall Study|Lack of Efficacy|1
7970036|NCT02817906|12529919|FG001|Overall Study|Lack of Efficacy|0
7970037|NCT02817906|12529918|FG000|Overall Study|Protocol Violation|1
7970038|NCT02817906|12529919|FG001|Overall Study|Protocol Violation|1
7970039|NCT02817906|12529918|FG000|Overall Study|Study Terminated by Sponsor|2
7970040|NCT02817906|12529919|FG001|Overall Study|Study Terminated by Sponsor|2
7970041|NCT02817906|12529918|FG000|Overall Study|Withdrawal by Subject|7
7970042|NCT02817906|12529919|FG001|Overall Study|Withdrawal by Subject|0
7970043|NCT02817906|12529918|FG000|Overall Study|Other|2
7970044|NCT02817906|12529919|FG001|Overall Study|Other|2
7970045|NCT02818036|12529927|FG000|Overall Study|head did not fit in fMRI scanner headres|1
7970046|NCT02818036|12529928|FG001|Overall Study|head did not fit in fMRI scanner headres|0
7970047|NCT02818036|12529927|FG000|Overall Study|Withdrawal by Subject|1
7970048|NCT02818036|12529928|FG001|Overall Study|Withdrawal by Subject|0
7970049|NCT02818777|12529966|FG000|Overall Study|Adverse Event|3
7970050|NCT02818998|12529979|FG000|Overall Study|Adverse Event|3
7970051|NCT02818998|12529980|FG001|Overall Study|Adverse Event|2
7970052|NCT02818998|12529981|FG002|Overall Study|Adverse Event|1
7970053|NCT02818998|12529979|FG000|Overall Study|Lost to Follow-up|4
7970054|NCT02818998|12529980|FG001|Overall Study|Lost to Follow-up|1
7970055|NCT02818998|12529981|FG002|Overall Study|Lost to Follow-up|2
7970056|NCT02818998|12529979|FG000|Overall Study|Withdrawal by sponsor|0
7970057|NCT02818998|12529980|FG001|Overall Study|Withdrawal by sponsor|1
7970058|NCT02818998|12529981|FG002|Overall Study|Withdrawal by sponsor|1
7970059|NCT02818998|12529979|FG000|Overall Study|Death|3
7970060|NCT02818998|12529980|FG001|Overall Study|Death|6
7970061|NCT02818998|12529981|FG002|Overall Study|Death|8
7970062|NCT02818998|12529979|FG000|Overall Study|Withdrawal by Subject|7
7970063|NCT02818998|12529980|FG001|Overall Study|Withdrawal by Subject|6
7970064|NCT02818998|12529981|FG002|Overall Study|Withdrawal by Subject|6
7970065|NCT02818998|12529979|FG000|Overall Study|Physician Decision|1
7970066|NCT02818998|12529980|FG001|Overall Study|Physician Decision|0
7970067|NCT02818998|12529981|FG002|Overall Study|Physician Decision|0
7970068|NCT02819297|12530010|FG000|Overall Study|Withdrawal by Subject|25
7970069|NCT02819297|12530011|FG001|Overall Study|Withdrawal by Subject|13
7970070|NCT02819297|12530010|FG000|Overall Study|Lost to Follow-up|12
7970071|NCT02819297|12530011|FG001|Overall Study|Lost to Follow-up|14
7970072|NCT02819297|12530010|FG000|Overall Study|Adverse Event|12
7970073|NCT02819297|12530011|FG001|Overall Study|Adverse Event|10
7970074|NCT02819297|12530010|FG000|Overall Study|Physician Decision|5
7970075|NCT02819297|12530011|FG001|Overall Study|Physician Decision|5
7970076|NCT02819297|12530010|FG000|Overall Study|Lack of Efficacy|5
7970077|NCT02819297|12530011|FG001|Overall Study|Lack of Efficacy|8
7970078|NCT02819297|12530010|FG000|Overall Study|Protocol Violation|1
7970079|NCT02819297|12530011|FG001|Overall Study|Protocol Violation|2
7970080|NCT02819310|12530017|FG000|Overall Study|Withdrawal by Subject|37
7970081|NCT02819310|12530017|FG000|Overall Study|Lost to Follow-up|16
7970082|NCT02819310|12530017|FG000|Overall Study|Adverse Event|13
7970083|NCT02819310|12530017|FG000|Overall Study|Lack of Efficacy|5
7970084|NCT02819310|12530017|FG000|Overall Study|Physician Decision|8
7970085|NCT02819310|12530017|FG000|Overall Study|Protocol Violation|30
7970086|NCT02819726|12530041|FG000|Part A (All Participants)|Lost to Follow-up|0
7970087|NCT02819726|12530042|FG001|Part A (All Participants)|Lost to Follow-up|1
7970088|NCT02819726|12530043|FG002|Part A (All Participants)|Lost to Follow-up|0
7970089|NCT02819726|12530044|FG003|Part A (All Participants)|Lost to Follow-up|0
7970090|NCT02819726|12530041|FG000|Part A (All Participants)|Withdrawal by Subject|3
7970091|NCT02819726|12530042|FG001|Part A (All Participants)|Withdrawal by Subject|5
7970092|NCT02819726|12530043|FG002|Part A (All Participants)|Withdrawal by Subject|6
7970093|NCT02819726|12530044|FG003|Part A (All Participants)|Withdrawal by Subject|0
7970094|NCT02819726|12530041|FG000|Part A (All Participants)|Protocol non-compliance|3
7970095|NCT02819726|12530042|FG001|Part A (All Participants)|Protocol non-compliance|4
7970096|NCT02819726|12530043|FG002|Part A (All Participants)|Protocol non-compliance|5
7970097|NCT02819726|12530044|FG003|Part A (All Participants)|Protocol non-compliance|0
7970098|NCT02819726|12530041|FG000|Part B (All Participants)|Lost to Follow-up|1
7970099|NCT02819726|12530042|FG001|Part B (All Participants)|Lost to Follow-up|1
7970100|NCT02819726|12530043|FG002|Part B (All Participants)|Lost to Follow-up|2
7970101|NCT02819726|12530044|FG003|Part B (All Participants)|Lost to Follow-up|2
7970102|NCT02819726|12530041|FG000|Part B (All Participants)|Withdrawal by Subject|2
7970103|NCT02819726|12530042|FG001|Part B (All Participants)|Withdrawal by Subject|1
7970104|NCT02819726|12530043|FG002|Part B (All Participants)|Withdrawal by Subject|1
7970105|NCT02819726|12530044|FG003|Part B (All Participants)|Withdrawal by Subject|0
7970106|NCT02819726|12530041|FG000|Part B (All Participants)|Protocol non-compliance|0
7970107|NCT02819726|12530042|FG001|Part B (All Participants)|Protocol non-compliance|0
7970108|NCT02819726|12530043|FG002|Part B (All Participants)|Protocol non-compliance|1
7970109|NCT02819726|12530044|FG003|Part B (All Participants)|Protocol non-compliance|0
7970110|NCT02820038|12530075|FG000|Overall Study|Lost to Follow-up|7
7970111|NCT02820038|12530076|FG001|Overall Study|Lost to Follow-up|11
7970112|NCT02820038|12530077|FG002|Overall Study|Lost to Follow-up|2
7970113|NCT02820038|12530078|FG003|Overall Study|Lost to Follow-up|9
7970114|NCT02820038|12530075|FG000|Overall Study|Withdrawal by Subject|3
7970115|NCT02820038|12530076|FG001|Overall Study|Withdrawal by Subject|14
7970116|NCT02820038|12530077|FG002|Overall Study|Withdrawal by Subject|3
7970117|NCT02820038|12530078|FG003|Overall Study|Withdrawal by Subject|13
7970118|NCT02820298|12530100|FG000|Overall Study|Withdrawal by Subject|0
7970119|NCT02820298|12530101|FG001|Overall Study|Withdrawal by Subject|1
7970120|NCT02820298|12530100|FG000|Overall Study|Physician Decision|1
7970121|NCT02820298|12530101|FG001|Overall Study|Physician Decision|0
7970122|NCT02820298|12530100|FG000|Overall Study|Protocol Violation|0
7970123|NCT02820298|12530101|FG001|Overall Study|Protocol Violation|1
7970124|NCT02820597|12530134|FG000|Overall Study|Lost to Follow-up|12
7970125|NCT02820844|12530140|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1
7970126|NCT02820844|12530141|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3
7970127|NCT02820844|12530142|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7970128|NCT02820844|12530143|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7970129|NCT02820844|12530144|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7970130|NCT02820844|12530145|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7970131|NCT02820844|12530140|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1
7970132|NCT02820844|12530141|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2
7970133|NCT02820844|12530142|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7970134|NCT02820844|12530143|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7970135|NCT02820844|12530144|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7970136|NCT02820844|12530145|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7970137|NCT02820844|12530140|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7970138|NCT02820844|12530141|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3
7970139|NCT02820844|12530142|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7970140|NCT02820844|12530143|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7970141|NCT02820844|12530144|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7970142|NCT02820844|12530145|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7970143|NCT02820844|12530140|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2
7970144|NCT02820844|12530141|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1
7970145|NCT02820844|12530142|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7970146|NCT02820844|12530143|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7970147|NCT02820844|12530144|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7970148|NCT02820844|12530145|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7970149|NCT02820844|12530140|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1
7970150|NCT02820844|12530141|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7970151|NCT02820844|12530142|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7970152|NCT02820844|12530143|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7970153|NCT02820844|12530144|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7970154|NCT02820844|12530145|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7970155|NCT02820844|12530140|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7970156|NCT02820844|12530141|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7970157|NCT02820844|12530142|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1
7970158|NCT02820844|12530143|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2
7970159|NCT02820844|12530144|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7970160|NCT02820844|12530145|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7970161|NCT02820844|12530140|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7970162|NCT02820844|12530141|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7970163|NCT02820844|12530142|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1
7970164|NCT02820844|12530143|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7970165|NCT02820844|12530144|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7970166|NCT02820844|12530145|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7970167|NCT02820844|12530140|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7970168|NCT02820844|12530141|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7970169|NCT02820844|12530142|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7
7970170|NCT02820844|12530143|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2
7970171|NCT02820844|12530144|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7970172|NCT02820844|12530145|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7970173|NCT02820844|12530140|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7970174|NCT02820844|12530141|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7970175|NCT02820844|12530142|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7970176|NCT02820844|12530143|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7970177|NCT02820844|12530144|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2
7970178|NCT02820844|12530145|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7970179|NCT02820844|12530140|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7970180|NCT02820844|12530141|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7970181|NCT02820844|12530142|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7970182|NCT02820844|12530143|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7970183|NCT02820844|12530144|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7970184|NCT02820844|12530145|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1
7970185|NCT02821416|12530204|FG000|Overall Study|Adverse Event|0
7970186|NCT02821416|12530205|FG001|Overall Study|Adverse Event|1
7970187|NCT02821416|12530204|FG000|Overall Study|Withdrawal by Subject|2
7970188|NCT02821416|12530205|FG001|Overall Study|Withdrawal by Subject|0
7970189|NCT02821416|12530204|FG000|Overall Study|Lost to Follow-up|1
7970190|NCT02821416|12530205|FG001|Overall Study|Lost to Follow-up|0
7970191|NCT02821715|12530216|FG000|Overall Study|Protocol Violation|1
7970192|NCT02821715|12530217|FG001|Overall Study|Protocol Violation|0
7970193|NCT02821715|12530218|FG002|Overall Study|Protocol Violation|0
7970194|NCT02821715|12530219|FG003|Overall Study|Protocol Violation|0
7970195|NCT02821715|12530220|FG004|Overall Study|Protocol Violation|0
7970196|NCT02821715|12530221|FG005|Overall Study|Protocol Violation|0
7970197|NCT02821819|12530229|FG000|Overall Study|Protocol Violation|1
7970198|NCT02821910|12530239|FG000|Overall Study|Withdrawal by Subject|0
7970199|NCT02821910|12530240|FG001|Overall Study|Withdrawal by Subject|0
7970200|NCT02821910|12530241|FG002|Overall Study|Withdrawal by Subject|1
7970201|NCT02821910|12530242|FG003|Overall Study|Withdrawal by Subject|0
7970202|NCT02821910|12530243|FG004|Overall Study|Withdrawal by Subject|0
7970203|NCT02821910|12530244|FG005|Overall Study|Withdrawal by Subject|1
7970204|NCT02821910|12530239|FG000|Overall Study|Other than specified|1
7970205|NCT02821910|12530240|FG001|Overall Study|Other than specified|0
7970206|NCT02821910|12530241|FG002|Overall Study|Other than specified|1
7970207|NCT02821910|12530242|FG003|Overall Study|Other than specified|0
7970208|NCT02821910|12530243|FG004|Overall Study|Other than specified|0
7970209|NCT02821910|12530244|FG005|Overall Study|Other than specified|0
7970210|NCT02821962|12530260|FG000|Overall Study|Lost to Follow-up|2
7970211|NCT02821962|12530261|FG001|Overall Study|Lost to Follow-up|0
7970212|NCT02822222|12530269|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1
7970213|NCT02822222|12530270|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0
7970214|NCT02822235|12530278|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144
7970215|NCT02822235|12530279|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107
7970216|NCT02822235|12530278|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2
7970217|NCT02822235|12530279|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0
7970218|NCT02822235|12530278|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0
7970219|NCT02822235|12530279|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1
7970220|NCT02822235|12530278|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4
7970221|NCT02822235|12530279|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0
7970222|NCT02822235|12530278|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1
7970223|NCT02822235|12530279|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0
7970224|NCT02822235|12530278|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6
7970225|NCT02822235|12530279|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1
7970226|NCT02822794|12530330|FG000|Overall Study|Withdrew Consent|1
7970227|NCT02822794|12530331|FG001|Overall Study|Withdrew Consent|0
7970228|NCT02823470|12530373|FG000|Overall Study|Adverse Event|1
7970229|NCT02823470|12530374|FG001|Overall Study|Adverse Event|0
7970230|NCT02823470|12530373|FG000|Overall Study|Study terminated by sponsor|8
7970231|NCT02823470|12530374|FG001|Overall Study|Study terminated by sponsor|15
7970232|NCT02823964|12530389|FG000|Overall Study|Adverse Event|2
7970233|NCT02823964|12530389|FG000|Overall Study|Physician Decision|1
7970234|NCT02823964|12530389|FG000|Overall Study|Lack of Efficacy|1
7970235|NCT02823964|12530389|FG000|Overall Study|Withdrawal by Subject|1
7970236|NCT02824224|12530395|FG000|Overall Study|Discontinued, IUS expulsion|0
7970237|NCT02824224|12530396|FG001|Overall Study|Discontinued, IUS expulsion|1
7970238|NCT02824224|12530395|FG000|Overall Study|Did not show up for allocation visit|2
7970239|NCT02824224|12530396|FG001|Overall Study|Did not show up for allocation visit|0
7970240|NCT02824432|12530404|FG000|Overall Study|Major Protocol Deviation|1
7970241|NCT02824432|12530405|FG001|Overall Study|Major Protocol Deviation|0
7970242|NCT02824562|12530413|FG000|Overall Study|Lost to Follow-up|3
7970243|NCT02824562|12530414|FG001|Overall Study|Lost to Follow-up|4
7970244|NCT02824562|12530413|FG000|Overall Study|Death|0
7970245|NCT02824562|12530414|FG001|Overall Study|Death|1
7970246|NCT02825251|12530437|FG000|Overall Study|Adverse Event|0
7970247|NCT02825251|12530438|FG001|Overall Study|Adverse Event|1
7970248|NCT02825251|12530437|FG000|Overall Study|Lost to Follow-up|0
7970249|NCT02825251|12530438|FG001|Overall Study|Lost to Follow-up|1
7970250|NCT02825251|12530437|FG000|Overall Study|Withdrawal by Subject|1
7970251|NCT02825251|12530438|FG001|Overall Study|Withdrawal by Subject|4
7970252|NCT02825251|12530437|FG000|Overall Study|Unclassified|2
7970253|NCT02825251|12530438|FG001|Overall Study|Unclassified|0
7970254|NCT02825420|12530446|FG000|Overall Study|Death|30
7970255|NCT02825420|12530447|FG001|Overall Study|Death|12
7970256|NCT02825420|12530446|FG000|Overall Study|Progressive disease|6
7970257|NCT02825420|12530447|FG001|Overall Study|Progressive disease|1
7970258|NCT02825420|12530446|FG000|Overall Study|Lost to Follow-up|2
7970259|NCT02825420|12530447|FG001|Overall Study|Lost to Follow-up|2
7970260|NCT02825420|12530446|FG000|Overall Study|Withdrawal by Subject|1
7970261|NCT02825420|12530447|FG001|Overall Study|Withdrawal by Subject|1
7717959|NCT00523991|12141639|FG001|Overall Study|Other reason (not specified)|0
7717960|NCT00524030|12141656|FG000|Overall Study|Lack of Efficacy|10
7717961|NCT00524030|12141657|FG001|Overall Study|Lack of Efficacy|24
7717962|NCT00524030|12141656|FG000|Overall Study|Lost to Follow-up|0
7717963|NCT00524030|12141657|FG001|Overall Study|Lost to Follow-up|2
7717964|NCT00524030|12141656|FG000|Overall Study|Withdrawal by Subject|3
7717965|NCT00524030|12141657|FG001|Overall Study|Withdrawal by Subject|8
7717966|NCT00524030|12141656|FG000|Overall Study|Noncompliance/Investigator discretion|0
7970262|NCT02825420|12530446|FG000|Overall Study|Protocol amendment not signed|1
7970263|NCT02825420|12530447|FG001|Overall Study|Protocol amendment not signed|1
7970264|NCT02825420|12530446|FG000|Overall Study|Physician Decision|1
7970265|NCT02825420|12530447|FG001|Overall Study|Physician Decision|0
7970266|NCT02825420|12530446|FG000|Overall Study|Did not receive PLD|2
7970267|NCT02825420|12530447|FG001|Overall Study|Did not receive PLD|0
7970268|NCT02825550|12530458|FG000|Overall Study|Physician Decision|1
7970269|NCT02825992|12530489|FG000|Overall Study|Withdrawal by Subject|4
7970270|NCT02825992|12530489|FG000|Overall Study|Lost to Follow-up|2
7970271|NCT02825992|12530489|FG000|Overall Study|Procedure terminated|2
7970272|NCT02826421|12530503|FG000|Overall Study|Adverse Event|1
7970273|NCT02826421|12530504|FG001|Overall Study|Adverse Event|0
7970274|NCT02826421|12530505|FG002|Overall Study|Adverse Event|0
7970275|NCT02826421|12530506|FG003|Overall Study|Adverse Event|1
7970276|NCT02826421|12530503|FG000|Overall Study|Withdrawal by Subject|1
7970277|NCT02826421|12530504|FG001|Overall Study|Withdrawal by Subject|3
7970278|NCT02826421|12530505|FG002|Overall Study|Withdrawal by Subject|1
7970279|NCT02826421|12530506|FG003|Overall Study|Withdrawal by Subject|1
7970280|NCT02826421|12530503|FG000|Overall Study|Reason not given|1
7970281|NCT02826421|12530504|FG001|Overall Study|Reason not given|0
7970282|NCT02826421|12530505|FG002|Overall Study|Reason not given|1
7970283|NCT02826421|12530506|FG003|Overall Study|Reason not given|0
7970284|NCT02826603|12530519|FG000|Overall Study|Adverse Event|17
7970285|NCT02826603|12530520|FG001|Overall Study|Adverse Event|9
7970286|NCT02826603|12530519|FG000|Overall Study|Lack of Efficacy|4
7970287|NCT02826603|12530520|FG001|Overall Study|Lack of Efficacy|9
7970288|NCT02826603|12530519|FG000|Overall Study|Lost to Follow-up|13
7970289|NCT02826603|12530520|FG001|Overall Study|Lost to Follow-up|12
7970290|NCT02826603|12530519|FG000|Overall Study|Noncompliance with treatment|0
7970291|NCT02826603|12530520|FG001|Overall Study|Noncompliance with treatment|2
7970292|NCT02826603|12530519|FG000|Overall Study|Physician Decision|1
7970293|NCT02826603|12530520|FG001|Overall Study|Physician Decision|7
7970294|NCT02826603|12530519|FG000|Overall Study|Pregnancy|1
7970295|NCT02826603|12530520|FG001|Overall Study|Pregnancy|2
7970296|NCT02826603|12530519|FG000|Overall Study|Protocol Violation|3
7970297|NCT02826603|12530520|FG001|Overall Study|Protocol Violation|3
7970298|NCT02826603|12530519|FG000|Overall Study|Withdrawal by Subject|20
7970299|NCT02826603|12530520|FG001|Overall Study|Withdrawal by Subject|19
7970300|NCT02826603|12530519|FG000|Overall Study|Death|2
7970301|NCT02826603|12530520|FG001|Overall Study|Death|0
7970302|NCT02826603|12530519|FG000|Overall Study|New therapy for study indication|0
7970303|NCT02826603|12530520|FG001|Overall Study|New therapy for study indication|1
7970304|NCT02826798|12530543|FG000|Overall Study|Withdrawal by Subject|0
7970305|NCT02826798|12530544|FG001|Overall Study|Withdrawal by Subject|1
7970306|NCT02826798|12530545|FG002|Overall Study|Withdrawal by Subject|0
7970307|NCT02826798|12530546|FG003|Overall Study|Withdrawal by Subject|1
7970308|NCT02826798|12530547|FG004|Overall Study|Withdrawal by Subject|0
7970309|NCT02827500|12530561|FG000|Overall Study|Death|7
7970310|NCT02827500|12530562|FG001|Overall Study|Death|3
7970311|NCT02827500|12530561|FG000|Overall Study|Lost to Follow-up|1
7970312|NCT02827500|12530562|FG001|Overall Study|Lost to Follow-up|1
7970313|NCT02827500|12530561|FG000|Overall Study|Withdrawal by Subject|3
7970314|NCT02827500|12530562|FG001|Overall Study|Withdrawal by Subject|1
7970315|NCT02827500|12530561|FG000|Overall Study|Missing primary endpoint data|3
7970316|NCT02827500|12530562|FG001|Overall Study|Missing primary endpoint data|1
7970317|NCT02827500|12530561|FG000|Overall Study|Other|5
7970318|NCT02827500|12530562|FG001|Overall Study|Other|1
7970319|NCT02827708|12530570|FG000|Overall Study|Lost to Follow-up|3
7970320|NCT02827708|12530571|FG001|Overall Study|Lost to Follow-up|1
7970321|NCT02827708|12530570|FG000|Overall Study|Withdrawal by Subject|1
7970322|NCT02827708|12530571|FG001|Overall Study|Withdrawal by Subject|2
7970323|NCT02827708|12530570|FG000|Overall Study|Death|1
7970324|NCT02827708|12530571|FG001|Overall Study|Death|2
7970325|NCT02828020|12530580|FG000|Treatment Period|Adverse Event|3
7970326|NCT02828020|12530581|FG001|Treatment Period|Adverse Event|1
7970327|NCT02828020|12530582|FG002|Treatment Period|Adverse Event|1
7970328|NCT02828020|12530580|FG000|Treatment Period|Withdrawal of Consent|10
7970329|NCT02828020|12530581|FG001|Treatment Period|Withdrawal of Consent|14
7970330|NCT02828020|12530582|FG002|Treatment Period|Withdrawal of Consent|9
7970331|NCT02828020|12530580|FG000|Treatment Period|Lost to Follow-up|21
7970332|NCT02828020|12530581|FG001|Treatment Period|Lost to Follow-up|24
7970333|NCT02828020|12530582|FG002|Treatment Period|Lost to Follow-up|18
7970334|NCT02828020|12530580|FG000|Treatment Period|Lack of Qualifying Event|44
7970335|NCT02828020|12530581|FG001|Treatment Period|Lack of Qualifying Event|53
7970336|NCT02828020|12530582|FG002|Treatment Period|Lack of Qualifying Event|43
7970337|NCT02828020|12530580|FG000|Treatment Period|Pregnancy|0
7970338|NCT02828020|12530581|FG001|Treatment Period|Pregnancy|2
7970339|NCT02828020|12530582|FG002|Treatment Period|Pregnancy|0
7970340|NCT02828020|12530580|FG000|Treatment Period|Protocol Violation|2
7970341|NCT02828020|12530581|FG001|Treatment Period|Protocol Violation|4
7970342|NCT02828020|12530582|FG002|Treatment Period|Protocol Violation|7
7970343|NCT02828020|12530580|FG000|Treatment Period|Other Miscellaneous Reasons|0
7970344|NCT02828020|12530581|FG001|Treatment Period|Other Miscellaneous Reasons|1
7970345|NCT02828020|12530582|FG002|Treatment Period|Other Miscellaneous Reasons|0
7970346|NCT02828020|12530580|FG000|Safety Follow-up Period|Withdrawal of Consent|10
7970347|NCT02828020|12530581|FG001|Safety Follow-up Period|Withdrawal of Consent|8
7970348|NCT02828020|12530582|FG002|Safety Follow-up Period|Withdrawal of Consent|7
7970349|NCT02828020|12530580|FG000|Safety Follow-up Period|Lost to Follow-up|9
7970350|NCT02828020|12530581|FG001|Safety Follow-up Period|Lost to Follow-up|8
7970351|NCT02828020|12530582|FG002|Safety Follow-up Period|Lost to Follow-up|11
7970352|NCT02828020|12530580|FG000|Safety Follow-up Period|Protocol Violation|0
7970353|NCT02828020|12530581|FG001|Safety Follow-up Period|Protocol Violation|2
7717967|NCT00524030|12141657|FG001|Overall Study|Noncompliance/Investigator discretion|2
7717968|NCT00524030|12141656|FG000|Overall Study|Protocol Violation|0
7717969|NCT00524030|12141657|FG001|Overall Study|Protocol Violation|1
7970354|NCT02828020|12530582|FG002|Safety Follow-up Period|Protocol Violation|1
7970355|NCT02828020|12530580|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1
7970356|NCT02828020|12530581|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0
7970357|NCT02828020|12530582|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0
7970358|NCT02828111|12530595|FG000|Overall Study|Withdrawal by Subject|0
7970359|NCT02828111|12530596|FG001|Overall Study|Withdrawal by Subject|0
7970360|NCT02828111|12530597|FG002|Overall Study|Withdrawal by Subject|2
7970361|NCT02828111|12530598|FG003|Overall Study|Withdrawal by Subject|0
7970362|NCT02828111|12530599|FG004|Overall Study|Withdrawal by Subject|0
7970363|NCT02828111|12530595|FG000|Overall Study|Lost to Follow-up|0
7970364|NCT02828111|12530596|FG001|Overall Study|Lost to Follow-up|0
7970365|NCT02828111|12530597|FG002|Overall Study|Lost to Follow-up|0
7970366|NCT02828111|12530598|FG003|Overall Study|Lost to Follow-up|1
7970367|NCT02828111|12530599|FG004|Overall Study|Lost to Follow-up|1
7970368|NCT02828241|12530635|FG000|Overall Study|Adverse Event|7
7970369|NCT02828241|12530636|FG001|Overall Study|Adverse Event|2
7970370|NCT02828241|12530635|FG000|Overall Study|Protocol Violation|1
7970371|NCT02828241|12530636|FG001|Overall Study|Protocol Violation|0
7970372|NCT02828358|12530664|FG000|Overall Study|Physician Decision|7
7970373|NCT02828358|12530665|FG001|Overall Study|Physician Decision|1
7970374|NCT02828358|12530664|FG000|Overall Study|Treatment Failure|6
7970375|NCT02828358|12530665|FG001|Overall Study|Treatment Failure|0
7970376|NCT02828358|12530664|FG000|Overall Study|Patients without KMT2A rearrangement|0
7970377|NCT02828358|12530665|FG001|Overall Study|Patients without KMT2A rearrangement|21
7970378|NCT02828358|12530664|FG000|Overall Study|Refusal of further protocol therapy|2
7970379|NCT02828358|12530665|FG001|Overall Study|Refusal of further protocol therapy|0
7970380|NCT02828358|12530664|FG000|Overall Study|Relapse|25
7970381|NCT02828358|12530665|FG001|Overall Study|Relapse|0
7970382|NCT02828358|12530664|FG000|Overall Study|Still on therapy|5
7970383|NCT02828358|12530665|FG001|Overall Study|Still on therapy|0
7970384|NCT02828436|12530670|FG000|Period 1|Did Not Meet Inclusion Criteria|0
7970385|NCT02828436|12530671|FG001|Period 1|Did Not Meet Inclusion Criteria|3
7970386|NCT02828436|12530670|FG000|Period 1|Lost to Follow-up|0
7970387|NCT02828436|12530671|FG001|Period 1|Lost to Follow-up|1
7970388|NCT02828436|12530670|FG000|Period 2|Withdrawal by Subject|4
7970389|NCT02828436|12530671|FG001|Period 2|Withdrawal by Subject|0
7970390|NCT02828436|12530670|FG000|Period 2|Did Not Meet Inclusion Criteria|3
7970391|NCT02828436|12530671|FG001|Period 2|Did Not Meet Inclusion Criteria|0
7970392|NCT02828436|12530670|FG000|Period 2|Lost to Follow-up|1
7970393|NCT02828436|12530671|FG001|Period 2|Lost to Follow-up|0
7970394|NCT02828644|12530679|FG000|Overall Study|Lost to Follow-up|23
7970395|NCT02828644|12530680|FG001|Overall Study|Lost to Follow-up|22
7970396|NCT02829138|12530698|FG000|Overall Study|Withdrawal by Subject|1
7970397|NCT02829138|12530699|FG001|Overall Study|Withdrawal by Subject|0
7970398|NCT02829775|12530735|FG000|Overall Study|Death|1
7970399|NCT02829775|12530735|FG000|Overall Study|Withdrawal by Subject|3
7970400|NCT02829775|12530735|FG000|Overall Study|Disease remission|1
7970401|NCT02829944|12530742|FG000|Overall Study|Physician Decision|0
7970402|NCT02829944|12530743|FG001|Overall Study|Physician Decision|1
7970403|NCT02829944|12530742|FG000|Overall Study|Screen Failure|2
7970404|NCT02829944|12530743|FG001|Overall Study|Screen Failure|2
7970405|NCT02829944|12530742|FG000|Overall Study|Inadequate Neuraxial Block|1
7970406|NCT02829944|12530743|FG001|Overall Study|Inadequate Neuraxial Block|1
7970407|NCT02829944|12530742|FG000|Overall Study|Withdrawal by Subject|2
7970408|NCT02829944|12530743|FG001|Overall Study|Withdrawal by Subject|1
7970409|NCT02829944|12530742|FG000|Overall Study|Catheter Displacement|1
7970410|NCT02829944|12530743|FG001|Overall Study|Catheter Displacement|0
7970411|NCT02829944|12530742|FG000|Overall Study|Catheter broke|0
7970412|NCT02829944|12530743|FG001|Overall Study|Catheter broke|1
7970413|NCT02829944|12530742|FG000|Overall Study|Staff unavailable|0
7970414|NCT02829944|12530743|FG001|Overall Study|Staff unavailable|1
7970415|NCT02829996|12530763|FG000|Overall Study|Withdrawal by Subject|1
7970416|NCT02829996|12530764|FG001|Overall Study|Withdrawal by Subject|0
7970417|NCT02829996|12530765|FG002|Overall Study|Withdrawal by Subject|0
7717970|NCT00524030|12141656|FG000|Overall Study|Pregnancy|1
7717971|NCT00524030|12141657|FG001|Overall Study|Pregnancy|0
7717972|NCT00524030|12141656|FG000|Overall Study|Adverse Event|3
7717973|NCT00524030|12141657|FG001|Overall Study|Adverse Event|21
7717974|NCT00524030|12141656|FG000|Overall Study|Death|0
7970418|NCT02829996|12530766|FG003|Overall Study|Withdrawal by Subject|0
7970419|NCT02829996|12530767|FG004|Overall Study|Withdrawal by Subject|0
7970420|NCT02830087|12530795|FG000|Overall Study|No study staff to follow-up patients|4
7970421|NCT02830087|12530796|FG001|Overall Study|No study staff to follow-up patients|4
7970422|NCT02830087|12530797|FG002|Overall Study|No study staff to follow-up patients|4
7970423|NCT02830087|12530798|FG003|Overall Study|No study staff to follow-up patients|3
7970424|NCT02830087|12530799|FG004|Overall Study|No study staff to follow-up patients|3
7970425|NCT02830087|12530800|FG005|Overall Study|No study staff to follow-up patients|3
7970426|NCT02830776|12530818|FG000|Overall Study|Lost to Follow-up|1
7970427|NCT02830880|12530823|FG000|Overall Study|Adverse reaction to chemotherapy|1
7970428|NCT02830880|12530823|FG000|Overall Study|Death|1
7970429|NCT02830880|12530823|FG000|Overall Study|Physician Decision|1
7970430|NCT02830893|12530829|FG000|Overall Study|Relocation to out of the country|1
7970431|NCT02830893|12530830|FG001|Overall Study|Relocation to out of the country|0
7970432|NCT02830893|12530829|FG000|Overall Study|Lost to Follow-up|0
7970433|NCT02830893|12530830|FG001|Overall Study|Lost to Follow-up|2
7970434|NCT02830893|12530829|FG000|Overall Study|Discharged to SNF, no transportation.|0
7970435|NCT02830893|12530830|FG001|Overall Study|Discharged to SNF, no transportation.|1
7717975|NCT00524030|12141657|FG001|Overall Study|Death|1
7970436|NCT02831387|12530838|FG000|Overall Study|Withdrawal by Subject|1
7970437|NCT02831387|12530839|FG001|Overall Study|Withdrawal by Subject|1
7970438|NCT02831387|12530838|FG000|Overall Study|Discontinued due to stock recovery|0
7970439|NCT02831387|12530839|FG001|Overall Study|Discontinued due to stock recovery|1
7970440|NCT02831855|12530864|FG000|Open Label Phase (24 Weeks)|Adverse Event|39
7970441|NCT02831855|12530865|FG001|Open Label Phase (24 Weeks)|Adverse Event|0
7970442|NCT02831855|12530866|FG002|Open Label Phase (24 Weeks)|Adverse Event|0
7970443|NCT02831855|12530864|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8
7970444|NCT02831855|12530865|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0
7970445|NCT02831855|12530866|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0
7970446|NCT02831855|12530864|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7
7970447|NCT02831855|12530865|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
7970448|NCT02831855|12530866|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
7970449|NCT02831855|12530864|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2
7970450|NCT02831855|12530865|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
7717976|NCT00524043|12141667|FG000|Overall Study|Lack of Efficacy|15
7970451|NCT02831855|12530866|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
7970452|NCT02831855|12530864|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5
7970453|NCT02831855|12530865|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0
7970454|NCT02831855|12530866|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0
7970455|NCT02831855|12530864|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6
7970456|NCT02831855|12530865|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
7970457|NCT02831855|12530866|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
7970458|NCT02831855|12530864|FG000|Open Label Phase (24 Weeks)|Other|4
7970459|NCT02831855|12530865|FG001|Open Label Phase (24 Weeks)|Other|0
7970460|NCT02831855|12530866|FG002|Open Label Phase (24 Weeks)|Other|0
7970461|NCT02831855|12530864|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0
7970462|NCT02831855|12530865|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6
7970463|NCT02831855|12530866|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6
7970464|NCT02831855|12530864|FG000|Double Blind Phase (24 Weeks)|Death|0
7970465|NCT02831855|12530865|FG001|Double Blind Phase (24 Weeks)|Death|0
7970466|NCT02831855|12530866|FG002|Double Blind Phase (24 Weeks)|Death|2
7970467|NCT02831855|12530864|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0
7970468|NCT02831855|12530865|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
7970469|NCT02831855|12530866|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
7970470|NCT02831855|12530864|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0
7970471|NCT02831855|12530865|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1
7970472|NCT02831855|12530866|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0
7970473|NCT02831855|12530864|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0
7970474|NCT02831855|12530865|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5
7970475|NCT02831855|12530866|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2
7970476|NCT02831855|12530864|FG000|Double Blind Phase (24 Weeks)|Other|0
7970477|NCT02831855|12530865|FG001|Double Blind Phase (24 Weeks)|Other|2
7970478|NCT02831855|12530866|FG002|Double Blind Phase (24 Weeks)|Other|5
7970479|NCT02831855|12530864|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0
7970480|NCT02831855|12530865|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6
7970481|NCT02831855|12530866|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1
7970482|NCT02831855|12530864|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0
7970483|NCT02831855|12530865|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5
7970484|NCT02831855|12530866|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2
7970485|NCT02831855|12530864|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
7970486|NCT02831855|12530865|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3
7970487|NCT02831855|12530866|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
7970488|NCT02832037|12530892|FG000|Overall Study|Administrative reasons|0
7970489|NCT02832037|12530893|FG001|Overall Study|Administrative reasons|0
7970490|NCT02832037|12530894|FG002|Overall Study|Administrative reasons|1
7970491|NCT02832037|12530895|FG003|Overall Study|Administrative reasons|0
7970492|NCT02832037|12530896|FG004|Overall Study|Administrative reasons|0
7970493|NCT02832037|12530892|FG000|Overall Study|Protocol Violation|3
7970494|NCT02832037|12530893|FG001|Overall Study|Protocol Violation|0
7970495|NCT02832037|12530894|FG002|Overall Study|Protocol Violation|4
7970496|NCT02832037|12530895|FG003|Overall Study|Protocol Violation|1
7970497|NCT02832037|12530896|FG004|Overall Study|Protocol Violation|2
7970498|NCT02832037|12530892|FG000|Overall Study|Lost to Follow-up|2
7970499|NCT02832037|12530893|FG001|Overall Study|Lost to Follow-up|0
7970500|NCT02832037|12530894|FG002|Overall Study|Lost to Follow-up|3
7970501|NCT02832037|12530895|FG003|Overall Study|Lost to Follow-up|0
7970502|NCT02832037|12530896|FG004|Overall Study|Lost to Follow-up|5
7970503|NCT02832037|12530892|FG000|Overall Study|Withdrawal by Subject|9
7970504|NCT02832037|12530893|FG001|Overall Study|Withdrawal by Subject|8
7970505|NCT02832037|12530894|FG002|Overall Study|Withdrawal by Subject|0
7970506|NCT02832037|12530895|FG003|Overall Study|Withdrawal by Subject|4
7970507|NCT02832037|12530896|FG004|Overall Study|Withdrawal by Subject|8
7970508|NCT02832037|12530892|FG000|Overall Study|Adverse Event|5
7970509|NCT02832037|12530893|FG001|Overall Study|Adverse Event|4
7970510|NCT02832037|12530894|FG002|Overall Study|Adverse Event|0
7970511|NCT02832037|12530895|FG003|Overall Study|Adverse Event|2
7970512|NCT02832037|12530896|FG004|Overall Study|Adverse Event|4
7970513|NCT02832375|12530927|FG000|Overall Study|Lost to Follow-up|1
7970514|NCT02832375|12530928|FG001|Overall Study|Lost to Follow-up|0
7970515|NCT02832375|12530927|FG000|Overall Study|Withdrawal of Consent|1
7970516|NCT02832375|12530928|FG001|Overall Study|Withdrawal of Consent|0
7970517|NCT02832622|12530935|FG000|Overall Study|MPP not programmed|1259
7970518|NCT02832622|12530935|FG000|Overall Study|Withdrawal by Subject|123
7970519|NCT02832622|12530935|FG000|Overall Study|Death|119
7970520|NCT02832622|12530935|FG000|Overall Study|Unsuccessful CRT implant|93
7970521|NCT02832622|12530935|FG000|Overall Study|Lost to Follow-up|45
7970522|NCT02832622|12530935|FG000|Overall Study|Patient non-compliance|42
7970523|NCT02832622|12530935|FG000|Overall Study|Withdrawal by other reasons|25
7970524|NCT02832622|12530935|FG000|Overall Study|System explant|24
7970525|NCT02832622|12530935|FG000|Overall Study|Physician Decision|6
7970526|NCT02833077|12530946|FG000|Overall Study|Adverse Event|1
7970527|NCT02833077|12530947|FG001|Overall Study|Adverse Event|2
7970528|NCT02833077|12530946|FG000|Overall Study|Lost to Follow-up|10
7970529|NCT02833077|12530947|FG001|Overall Study|Lost to Follow-up|1
7970530|NCT02833077|12530946|FG000|Overall Study|Personal Reasons|6
7970531|NCT02833077|12530947|FG001|Overall Study|Personal Reasons|4
7970532|NCT02833077|12530946|FG000|Overall Study|Protocol Deviation|0
7970533|NCT02833077|12530947|FG001|Overall Study|Protocol Deviation|1
7970534|NCT02833350|12530965|FG000|Overall Study|Adverse Event|0
7970535|NCT02833350|12530966|FG001|Overall Study|Adverse Event|3
7970536|NCT02833350|12530967|FG002|Overall Study|Adverse Event|4
7970537|NCT02833350|12530968|FG003|Overall Study|Adverse Event|4
7970538|NCT02833350|12530969|FG004|Overall Study|Adverse Event|1
7970539|NCT02833350|12530970|FG005|Overall Study|Adverse Event|0
7970540|NCT02833350|12530971|FG006|Overall Study|Adverse Event|1
7970541|NCT02833350|12530965|FG000|Overall Study|Death|0
7970542|NCT02833350|12530966|FG001|Overall Study|Death|0
7970543|NCT02833350|12530967|FG002|Overall Study|Death|1
7970544|NCT02833350|12530968|FG003|Overall Study|Death|0
7970545|NCT02833350|12530969|FG004|Overall Study|Death|0
7970546|NCT02833350|12530970|FG005|Overall Study|Death|0
7970547|NCT02833350|12530971|FG006|Overall Study|Death|0
7970548|NCT02833350|12530965|FG000|Overall Study|Lack of Efficacy|0
7970549|NCT02833350|12530966|FG001|Overall Study|Lack of Efficacy|2
7970550|NCT02833350|12530967|FG002|Overall Study|Lack of Efficacy|1
7970551|NCT02833350|12530968|FG003|Overall Study|Lack of Efficacy|4
7970552|NCT02833350|12530969|FG004|Overall Study|Lack of Efficacy|0
7970553|NCT02833350|12530970|FG005|Overall Study|Lack of Efficacy|1
7970554|NCT02833350|12530971|FG006|Overall Study|Lack of Efficacy|1
7970555|NCT02833350|12530965|FG000|Overall Study|Lost to Follow-up|0
7970556|NCT02833350|12530966|FG001|Overall Study|Lost to Follow-up|1
7970557|NCT02833350|12530967|FG002|Overall Study|Lost to Follow-up|0
7970558|NCT02833350|12530968|FG003|Overall Study|Lost to Follow-up|0
7970559|NCT02833350|12530969|FG004|Overall Study|Lost to Follow-up|0
7970560|NCT02833350|12530970|FG005|Overall Study|Lost to Follow-up|0
7970561|NCT02833350|12530971|FG006|Overall Study|Lost to Follow-up|1
7970562|NCT02833350|12530965|FG000|Overall Study|Withdrawal by Subject|3
7970563|NCT02833350|12530966|FG001|Overall Study|Withdrawal by Subject|3
7970564|NCT02833350|12530967|FG002|Overall Study|Withdrawal by Subject|2
7970565|NCT02833350|12530968|FG003|Overall Study|Withdrawal by Subject|0
7970566|NCT02833350|12530969|FG004|Overall Study|Withdrawal by Subject|2
7970567|NCT02833350|12530970|FG005|Overall Study|Withdrawal by Subject|0
7970568|NCT02833350|12530971|FG006|Overall Study|Withdrawal by Subject|2
7970569|NCT02833948|12531009|FG000|Overall Study|Death|2
7970570|NCT02833948|12531010|FG001|Overall Study|Death|3
7970571|NCT02833948|12531009|FG000|Overall Study|were not scanned|8
7970572|NCT02833948|12531010|FG001|Overall Study|were not scanned|13
7970573|NCT02833948|12531009|FG000|Overall Study|scans could not be evaluated|5
7970574|NCT02833948|12531010|FG001|Overall Study|scans could not be evaluated|2
7970575|NCT02833974|12531022|FG000|Overall Study|Lost to Follow-up|1
7970576|NCT02833974|12531023|FG001|Overall Study|Lost to Follow-up|0
7970577|NCT02833974|12531022|FG000|Overall Study|Adverse Event|0
7970578|NCT02833974|12531023|FG001|Overall Study|Adverse Event|3
7970579|NCT02834247|12531033|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1
7970580|NCT02834247|12531034|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2
7970581|NCT02834247|12531035|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0
7970582|NCT02834247|12531036|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0
7970583|NCT02834247|12531033|FG000|Dose Escalation Phase|Death|5
7970584|NCT02834247|12531034|FG001|Dose Escalation Phase|Death|6
7970585|NCT02834247|12531035|FG002|Dose Escalation Phase|Death|5
7970586|NCT02834247|12531036|FG003|Dose Escalation Phase|Death|0
7970587|NCT02834247|12531033|FG000|Dose Escalation Phase|Lost to Follow-up|0
7970588|NCT02834247|12531034|FG001|Dose Escalation Phase|Lost to Follow-up|1
7970589|NCT02834247|12531035|FG002|Dose Escalation Phase|Lost to Follow-up|0
7970590|NCT02834247|12531036|FG003|Dose Escalation Phase|Lost to Follow-up|0
7970591|NCT02834247|12531033|FG000|Dose Escalation Phase|Withdrawal by Subject|2
7970592|NCT02834247|12531034|FG001|Dose Escalation Phase|Withdrawal by Subject|2
7970593|NCT02834247|12531035|FG002|Dose Escalation Phase|Withdrawal by Subject|0
7970594|NCT02834247|12531036|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7970595|NCT02834247|12531033|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0
7970596|NCT02834247|12531034|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0
7970597|NCT02834247|12531035|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0
7970598|NCT02834247|12531036|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7
7970599|NCT02834247|12531033|FG000|Dose Expansion Phase|Death|0
7970600|NCT02834247|12531034|FG001|Dose Expansion Phase|Death|0
7970601|NCT02834247|12531035|FG002|Dose Expansion Phase|Death|0
7970602|NCT02834247|12531036|FG003|Dose Expansion Phase|Death|8
7970603|NCT02834247|12531033|FG000|Dose Expansion Phase|Lost to Follow-up|0
7970604|NCT02834247|12531034|FG001|Dose Expansion Phase|Lost to Follow-up|0
7970605|NCT02834247|12531035|FG002|Dose Expansion Phase|Lost to Follow-up|0
7970606|NCT02834247|12531036|FG003|Dose Expansion Phase|Lost to Follow-up|1
7970607|NCT02834247|12531033|FG000|Dose Expansion Phase|Withdrawal by Subject|0
7970608|NCT02834247|12531034|FG001|Dose Expansion Phase|Withdrawal by Subject|0
7970609|NCT02834247|12531035|FG002|Dose Expansion Phase|Withdrawal by Subject|0
7970610|NCT02834247|12531036|FG003|Dose Expansion Phase|Withdrawal by Subject|1
7970611|NCT02834390|12531050|FG000|Induction Phase|Progressive disease|0
7970612|NCT02834390|12531051|FG001|Induction Phase|Progressive disease|1
7970613|NCT02834390|12531050|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2
7970614|NCT02834390|12531051|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0
7970615|NCT02834390|12531050|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0
7970616|NCT02834390|12531051|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1
7970617|NCT02834390|12531050|FG000|Consolidation Phase|Physician Decision|1
7970618|NCT02834390|12531051|FG001|Consolidation Phase|Physician Decision|1
7970619|NCT02834819|12531091|FG000|Overall Study|Did not complete 7 day follow up call.|5
7970620|NCT02834819|12531092|FG001|Overall Study|Did not complete 7 day follow up call.|0
7970621|NCT02835092|12531101|FG000|Overall Study|Withdrawal by Subject|3
7970622|NCT02835092|12531102|FG001|Overall Study|Withdrawal by Subject|6
7970623|NCT02835092|12531103|FG002|Overall Study|Withdrawal by Subject|3
7970624|NCT02835092|12531101|FG000|Overall Study|Lost to Follow-up|0
7970625|NCT02835092|12531102|FG001|Overall Study|Lost to Follow-up|2
7970626|NCT02835092|12531103|FG002|Overall Study|Lost to Follow-up|0
7970627|NCT02835339|12531122|FG000|Overall Study|Did not receive allocated intervention|13
7970628|NCT02835339|12531123|FG001|Overall Study|Did not receive allocated intervention|16
7970629|NCT02835495|12531131|FG000|Overall Study|Cancer diagnosis prior intervention|1
7970630|NCT02835495|12531132|FG001|Overall Study|Cancer diagnosis prior intervention|0
7970631|NCT02835495|12531131|FG000|Overall Study|Declined in-person follow-up visit|4
7970632|NCT02835495|12531132|FG001|Overall Study|Declined in-person follow-up visit|2
7970633|NCT02835820|12531156|FG000|Overall Study|Baseline Screen Failure|0
7970634|NCT02835820|12531157|FG001|Overall Study|Baseline Screen Failure|3
7970635|NCT02836496|12531169|FG000|Overall Study|Adverse Event|2
7970636|NCT02836496|12531170|FG001|Overall Study|Adverse Event|1
7970637|NCT02836496|12531169|FG000|Overall Study|Withdrawal by Subject|0
7970638|NCT02836496|12531170|FG001|Overall Study|Withdrawal by Subject|1
7970639|NCT02836613|12531178|FG000|Overall Study|Accidental drowning|1
7970640|NCT02836613|12531179|FG001|Overall Study|Accidental drowning|0
7970641|NCT02836613|12531178|FG000|Overall Study|Lost to Follow-up|0
7970642|NCT02836613|12531179|FG001|Overall Study|Lost to Follow-up|1
7970643|NCT02836613|12531178|FG000|Overall Study|Withdrawal by Subject|0
7970644|NCT02836613|12531179|FG001|Overall Study|Withdrawal by Subject|2
7970645|NCT02836652|12531187|FG000|Overall Study|Death|3
7970646|NCT02836652|12531188|FG001|Overall Study|Death|3
7970647|NCT02836652|12531187|FG000|Overall Study|Transplant/Explant|3
7970648|NCT02836652|12531188|FG001|Overall Study|Transplant/Explant|4
7970649|NCT02836652|12531187|FG000|Overall Study|Withdrawn|9
7970650|NCT02836652|12531188|FG001|Overall Study|Withdrawn|9
7970651|NCT02836652|12531187|FG000|Overall Study|Not on treatment regimen post-op day 15|3
7970652|NCT02836652|12531188|FG001|Overall Study|Not on treatment regimen post-op day 15|3
7970653|NCT02836769|12531194|FG000|Overall Study|Lost to Follow-up|10
7970654|NCT02836769|12531194|FG000|Overall Study|Medical withdrawal|2
7970655|NCT02836769|12531194|FG000|Overall Study|Withdrawal by Subject|3
7970656|NCT02836873|12531200|FG000|Overall Study|Protocol Violation|0
7970657|NCT02836873|12531201|FG001|Overall Study|Protocol Violation|1
7970658|NCT02836873|12531200|FG000|Overall Study|Adverse Event|1
7970659|NCT02836873|12531201|FG001|Overall Study|Adverse Event|4
7970660|NCT02836873|12531200|FG000|Overall Study|Withdrawal by Subject|2
7970661|NCT02836873|12531201|FG001|Overall Study|Withdrawal by Subject|2
7970662|NCT02836873|12531200|FG000|Overall Study|Lost to Follow-up|1
7970663|NCT02836873|12531201|FG001|Overall Study|Lost to Follow-up|3
7970664|NCT02836873|12531200|FG000|Overall Study|Physician Decision|0
7970665|NCT02836873|12531201|FG001|Overall Study|Physician Decision|1
7970666|NCT02836873|12531200|FG000|Overall Study|Other|1
7970667|NCT02836873|12531201|FG001|Overall Study|Other|0
7970668|NCT02837731|12531233|FG000|Allocation|Admitted to General Floor|3
7970669|NCT02837731|12531234|FG001|Allocation|Admitted to General Floor|4
7970670|NCT02837731|12531233|FG000|Allocation|Immediate surgery/withdrew|2
7970671|NCT02837731|12531234|FG001|Allocation|Immediate surgery/withdrew|0
7970672|NCT02837731|12531233|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1
7970673|NCT02837731|12531234|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0
7970674|NCT02837731|12531233|FG000|Allocation|Withdrawal by Subject|2
7970675|NCT02837731|12531234|FG001|Allocation|Withdrawal by Subject|0
7970676|NCT02837731|12531233|FG000|Allocation|Device not available|1
7970677|NCT02837731|12531234|FG001|Allocation|Device not available|0
7970678|NCT02837731|12531233|FG000|Allocation|Protocol not implemented|7
7970679|NCT02837731|12531234|FG001|Allocation|Protocol not implemented|0
7970680|NCT02837731|12531233|FG000|Allocation|Moribund/Do not resuscitate|2
7970681|NCT02837731|12531234|FG001|Allocation|Moribund/Do not resuscitate|0
7970682|NCT02837731|12531233|FG000|Allocation|Did not meet sepsis criteria|1
7970683|NCT02837731|12531234|FG001|Allocation|Did not meet sepsis criteria|2
7970684|NCT02837731|12531233|FG000|Allocation|Known aortic abnormalities|0
7970685|NCT02837731|12531234|FG001|Allocation|Known aortic abnormalities|1
7970686|NCT02837952|12531255|FG000|Overall Study|Adverse Event|0
7970687|NCT02837952|12531256|FG001|Overall Study|Adverse Event|1
7970688|NCT02837952|12531255|FG000|Overall Study|Withdrawal by Subject|4
7970689|NCT02837952|12531256|FG001|Overall Study|Withdrawal by Subject|5
7970690|NCT02837952|12531255|FG000|Overall Study|Medication Error|1
7970691|NCT02837952|12531256|FG001|Overall Study|Medication Error|0
7970692|NCT02838017|12531264|FG000|Overall Study|Lost to Follow-up|14
7970693|NCT02838017|12531265|FG001|Overall Study|Lost to Follow-up|11
7970694|NCT02838134|12531273|FG000|Overall Study|Lost to Follow-up|1
7970695|NCT02838134|12531274|FG001|Overall Study|Lost to Follow-up|2
7970696|NCT02838134|12531273|FG000|Overall Study|logistic problems|1
7970697|NCT02838134|12531274|FG001|Overall Study|logistic problems|1
7970698|NCT02838420|12531286|FG000|Overall Study|Ongoing in Study|113
7970699|NCT02838420|12531287|FG001|Overall Study|Ongoing in Study|45
7970700|NCT02838420|12531286|FG000|Overall Study|Lost to Follow-up|1
7970701|NCT02838420|12531287|FG001|Overall Study|Lost to Follow-up|0
7970702|NCT02838420|12531286|FG000|Overall Study|Withdrawal by Subject|3
7970703|NCT02838420|12531287|FG001|Overall Study|Withdrawal by Subject|4
7970704|NCT02838420|12531286|FG000|Overall Study|Death|8
7970705|NCT02838420|12531287|FG001|Overall Study|Death|13
7970706|NCT02838628|12531295|FG000|Recurrence Follow-up Period|AK Recurrence|18
7970707|NCT02838628|12531296|FG001|Recurrence Follow-up Period|AK Recurrence|13
7970708|NCT02838628|12531295|FG000|Recurrence Follow-up Period|Adverse Event|1
7970709|NCT02838628|12531296|FG001|Recurrence Follow-up Period|Adverse Event|0
7970710|NCT02838628|12531295|FG000|Recurrence Follow-up Period|Non-compliance|0
7970711|NCT02838628|12531296|FG001|Recurrence Follow-up Period|Non-compliance|1
7970712|NCT02838628|12531295|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0
7970713|NCT02838628|12531296|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2
7970714|NCT02838628|12531295|FG000|Recurrence Follow-up Period|Other un-specified|1
7970715|NCT02838628|12531296|FG001|Recurrence Follow-up Period|Other un-specified|1
7970716|NCT02838901|12531305|FG000|Overall Study|Withdrawal by Subject|1
7970717|NCT02838901|12531306|FG001|Overall Study|Withdrawal by Subject|1
7970718|NCT02838901|12531305|FG000|Overall Study|Lost to Follow-up|1
7970719|NCT02838901|12531306|FG001|Overall Study|Lost to Follow-up|1
7970720|NCT02839200|12531320|FG000|Overall Study|Withdrawal by Subject|2
7970721|NCT02839200|12531321|FG001|Overall Study|Withdrawal by Subject|0
7970722|NCT02839200|12531322|FG002|Overall Study|Withdrawal by Subject|1
7970723|NCT02839200|12531323|FG003|Overall Study|Withdrawal by Subject|0
7970724|NCT02839200|12531324|FG004|Overall Study|Withdrawal by Subject|0
7970725|NCT02839200|12531325|FG005|Overall Study|Withdrawal by Subject|1
7970726|NCT02839200|12531320|FG000|Overall Study|Lost to Follow-up|2
7970727|NCT02839200|12531321|FG001|Overall Study|Lost to Follow-up|0
7970728|NCT02839200|12531322|FG002|Overall Study|Lost to Follow-up|0
7970729|NCT02839200|12531323|FG003|Overall Study|Lost to Follow-up|0
7970730|NCT02839200|12531324|FG004|Overall Study|Lost to Follow-up|1
7970731|NCT02839200|12531325|FG005|Overall Study|Lost to Follow-up|0
7970732|NCT02839200|12531320|FG000|Overall Study|Adverse Event|0
7970733|NCT02839200|12531321|FG001|Overall Study|Adverse Event|0
7970734|NCT02839200|12531322|FG002|Overall Study|Adverse Event|0
7970735|NCT02839200|12531323|FG003|Overall Study|Adverse Event|0
7970736|NCT02839200|12531324|FG004|Overall Study|Adverse Event|1
7970737|NCT02839200|12531325|FG005|Overall Study|Adverse Event|0
7970738|NCT02839200|12531320|FG000|Overall Study|Randomized in error|0
7970739|NCT02839200|12531321|FG001|Overall Study|Randomized in error|1
7970740|NCT02839200|12531322|FG002|Overall Study|Randomized in error|0
7970741|NCT02839200|12531323|FG003|Overall Study|Randomized in error|0
7970742|NCT02839200|12531324|FG004|Overall Study|Randomized in error|0
7970743|NCT02839200|12531325|FG005|Overall Study|Randomized in error|0
7970744|NCT02839330|12531343|FG000|Overall Study|Adverse Event|0
7970745|NCT02839330|12531344|FG001|Overall Study|Adverse Event|1
7970746|NCT02839330|12531345|FG002|Overall Study|Adverse Event|2
7970747|NCT02839330|12531346|FG003|Overall Study|Adverse Event|2
7970748|NCT02839330|12531343|FG000|Overall Study|Death|4
7970749|NCT02839330|12531344|FG001|Overall Study|Death|6
7970750|NCT02839330|12531345|FG002|Overall Study|Death|1
7970751|NCT02839330|12531346|FG003|Overall Study|Death|1
7970752|NCT02839330|12531343|FG000|Overall Study|Withdrawal by Subject|27
7970753|NCT02839330|12531344|FG001|Overall Study|Withdrawal by Subject|19
7970754|NCT02839330|12531345|FG002|Overall Study|Withdrawal by Subject|11
7970755|NCT02839330|12531346|FG003|Overall Study|Withdrawal by Subject|13
7970756|NCT02839330|12531343|FG000|Overall Study|Lost to Follow-up|22
7970757|NCT02839330|12531344|FG001|Overall Study|Lost to Follow-up|27
7970758|NCT02839330|12531345|FG002|Overall Study|Lost to Follow-up|29
7970759|NCT02839330|12531346|FG003|Overall Study|Lost to Follow-up|25
7970760|NCT02839330|12531343|FG000|Overall Study|Administrative Reason|0
7970761|NCT02839330|12531344|FG001|Overall Study|Administrative Reason|0
7970762|NCT02839330|12531345|FG002|Overall Study|Administrative Reason|0
7970763|NCT02839330|12531346|FG003|Overall Study|Administrative Reason|1
7970764|NCT02839330|12531343|FG000|Overall Study|Protocol Violation|1
7970765|NCT02839330|12531344|FG001|Overall Study|Protocol Violation|2
7970766|NCT02839330|12531345|FG002|Overall Study|Protocol Violation|2
7970767|NCT02839330|12531346|FG003|Overall Study|Protocol Violation|3
7970768|NCT02839330|12531343|FG000|Overall Study|Other reason, not specified|4
7970769|NCT02839330|12531344|FG001|Overall Study|Other reason, not specified|3
7970770|NCT02839330|12531345|FG002|Overall Study|Other reason, not specified|3
7970771|NCT02839330|12531346|FG003|Overall Study|Other reason, not specified|6
7970772|NCT02839681|12531357|FG000|Overall Study|Death|2
7970773|NCT02839746|12531361|FG000|Overall Study|Not met selection criteria|12
7970774|NCT02839798|12531388|FG000|Overall Study|Withdrawal by Subject|2
7970775|NCT02839876|12531394|FG000|Overall Study|Protocol Violation|10
7970776|NCT02839876|12531395|FG001|Overall Study|Protocol Violation|11
7970777|NCT02840253|12531435|FG000|Overall Study|Unsuccessful block|4
7970778|NCT02840461|12531442|FG000|Overall Study|Adverse Event|1
7970779|NCT02840461|12531443|FG001|Overall Study|Adverse Event|5
7970780|NCT02840461|12531444|FG002|Overall Study|Adverse Event|3
7970781|NCT02840461|12531442|FG000|Overall Study|Lost to Follow-up|10
7970782|NCT02840461|12531443|FG001|Overall Study|Lost to Follow-up|7
7970783|NCT02840461|12531444|FG002|Overall Study|Lost to Follow-up|6
7970784|NCT02840461|12531442|FG000|Overall Study|Non-Comliance with Dosing Requirements|0
7970785|NCT02840461|12531443|FG001|Overall Study|Non-Comliance with Dosing Requirements|1
7970786|NCT02840461|12531444|FG002|Overall Study|Non-Comliance with Dosing Requirements|0
7970787|NCT02840461|12531442|FG000|Overall Study|Protocol Violation|2
7970788|NCT02840461|12531443|FG001|Overall Study|Protocol Violation|3
7970789|NCT02840461|12531444|FG002|Overall Study|Protocol Violation|1
7970790|NCT02840461|12531442|FG000|Overall Study|Withdrawal by Subject|10
7970791|NCT02840461|12531443|FG001|Overall Study|Withdrawal by Subject|6
7970792|NCT02840461|12531444|FG002|Overall Study|Withdrawal by Subject|2
7970793|NCT02840461|12531442|FG000|Overall Study|Worsening of Symptom & Kit Error|0
7970794|NCT02840461|12531443|FG001|Overall Study|Worsening of Symptom & Kit Error|0
7970795|NCT02840461|12531444|FG002|Overall Study|Worsening of Symptom & Kit Error|2
7970796|NCT02840474|12531455|FG000|Overall Study|Lost to Follow-up|1
7970797|NCT02840474|12531456|FG001|Overall Study|Lost to Follow-up|0
7970798|NCT02840721|12531462|FG000|Treatment Period|Adverse Event|1
7970799|NCT02840721|12531462|FG000|Follow-Up|Lack of Efficacy|1
7970800|NCT02840721|12531462|FG000|Follow-Up|Withdrawal by Subject|4
7970801|NCT02840721|12531462|FG000|Follow-Up|Withdrawal of Consent|2
7970802|NCT02841709|12531530|FG000|5th Intervention|Adverse Event|2
7970803|NCT02841709|12531531|FG001|5th Intervention|Adverse Event|0
7970804|NCT02841709|12531532|FG002|5th Intervention|Adverse Event|0
7970805|NCT02841709|12531533|FG003|5th Intervention|Adverse Event|0
7970806|NCT02841709|12531534|FG004|5th Intervention|Adverse Event|2
7970807|NCT02841787|12531550|FG000|Overall Study|Lost to Follow-up|1
7970808|NCT02841787|12531551|FG001|Overall Study|Lost to Follow-up|0
7970809|NCT02841787|12531552|FG002|Overall Study|Lost to Follow-up|0
7970810|NCT02841787|12531550|FG000|Overall Study|Symptoms dropped below threshold|1
7970811|NCT02841787|12531551|FG001|Overall Study|Symptoms dropped below threshold|0
7970812|NCT02841787|12531552|FG002|Overall Study|Symptoms dropped below threshold|0
7970813|NCT02841787|12531550|FG000|Overall Study|Withdrawal by Subject|1
7970814|NCT02841787|12531551|FG001|Overall Study|Withdrawal by Subject|4
7970815|NCT02841787|12531552|FG002|Overall Study|Withdrawal by Subject|0
7970816|NCT02842073|12531569|FG000|Overall Study|Withdrawal by Subject|1
7970817|NCT02842151|12531573|FG000|Overall Study|Adverse Event|1
7970818|NCT02842151|12531573|FG000|Overall Study|Subject moved too far away|1
7970819|NCT02842736|12531588|FG000|Overall Study|Lost to Follow-up|13
7970820|NCT02842736|12531588|FG000|Overall Study|Intervention for menstrual bleeding|17
7970821|NCT02842736|12531588|FG000|Overall Study|Withdrawal by Subject|4
7970822|NCT02842736|12531588|FG000|Overall Study|Pregnancy|3
7970823|NCT02842736|12531588|FG000|Overall Study|Hysterectomy for fibroids|2
7970824|NCT02842736|12531588|FG000|Overall Study|Hysterectomy for uterine prolapse|1
7970825|NCT02842736|12531588|FG000|Overall Study|IUD: Mirena|1
7970826|NCT02843178|12531596|FG000|Overall Study|Lost to Follow-up|8
7970827|NCT02843178|12531597|FG001|Overall Study|Lost to Follow-up|8
7970828|NCT02843178|12531598|FG002|Overall Study|Lost to Follow-up|6
7970829|NCT02843178|12531599|FG003|Overall Study|Lost to Follow-up|3
7970830|NCT02843178|12531596|FG000|Overall Study|Withdrawal by Subject|0
7970831|NCT02843178|12531597|FG001|Overall Study|Withdrawal by Subject|0
7970832|NCT02843178|12531598|FG002|Overall Study|Withdrawal by Subject|1
7970833|NCT02843178|12531599|FG003|Overall Study|Withdrawal by Subject|1
7970834|NCT02843659|12531621|FG000|Overall Study|Subject Withdrew Consent|0
7970835|NCT02843659|12531622|FG001|Overall Study|Subject Withdrew Consent|0
7970836|NCT02843659|12531623|FG002|Overall Study|Subject Withdrew Consent|1
7970837|NCT02843659|12531621|FG000|Overall Study|Administrative Reason by Sponsor|4
7970838|NCT02843659|12531622|FG001|Overall Study|Administrative Reason by Sponsor|5
7970839|NCT02843659|12531623|FG002|Overall Study|Administrative Reason by Sponsor|4
7970840|NCT02843659|12531621|FG000|Overall Study|Adverse Event|0
7970841|NCT02843659|12531622|FG001|Overall Study|Adverse Event|1
7970842|NCT02843659|12531623|FG002|Overall Study|Adverse Event|0
7970843|NCT02844439|12531631|FG000|Overall Study|Withdrawal by Subject|1
7970844|NCT02844439|12531631|FG000|Overall Study|Lost to Follow-up|2
7970845|NCT02844439|12531631|FG000|Overall Study|Termination by Sponsor|4
7970846|NCT02844439|12531631|FG000|Overall Study|Death|28
7970847|NCT02844439|12531631|FG000|Overall Study|Other|5
7970848|NCT02844543|12531642|FG000|Overall Study|Withdrawal by Subject|4
7970849|NCT02844543|12531642|FG000|Overall Study|Did not meet eligibility criteria|1
7970850|NCT02844920|12531659|FG000|Overall Study|Lost to Follow-up|2
7970851|NCT02845336|12531678|FG000|Overall Study|Lost to Follow-up|3
7970852|NCT02845336|12531679|FG001|Overall Study|Lost to Follow-up|1
7970853|NCT02845336|12531678|FG000|Overall Study|Inability to get medication|2
7970854|NCT02845336|12531679|FG001|Overall Study|Inability to get medication|0
7970855|NCT02845375|12531688|FG000|Overall Study|upper airway obstruction|1
7970856|NCT02845375|12531689|FG001|Overall Study|upper airway obstruction|2
7970857|NCT02845375|12531690|FG002|Overall Study|upper airway obstruction|1
7970858|NCT02846324|12531738|FG000|Overall Study|Other|1
7970859|NCT02846324|12531739|FG001|Overall Study|Other|0
7970860|NCT02846324|12531740|FG002|Overall Study|Other|0
7970861|NCT02846324|12531741|FG003|Overall Study|Other|0
7970862|NCT02846324|12531738|FG000|Overall Study|Withdrawal by Subject|1
7970863|NCT02846324|12531739|FG001|Overall Study|Withdrawal by Subject|0
7970864|NCT02846324|12531740|FG002|Overall Study|Withdrawal by Subject|4
7970865|NCT02846324|12531741|FG003|Overall Study|Withdrawal by Subject|0
7970866|NCT02846415|12531762|FG000|Overall Study|Lost to Follow-up|2
7970867|NCT02846415|12531763|FG001|Overall Study|Lost to Follow-up|0
7970868|NCT02846415|12531762|FG000|Overall Study|Withdrawal by Subject|1
7970869|NCT02846415|12531763|FG001|Overall Study|Withdrawal by Subject|1
7970870|NCT02846558|12531773|FG000|Overall Study|Adverse Event|1
7970871|NCT02846558|12531774|FG001|Overall Study|Adverse Event|0
7970872|NCT02846558|12531775|FG002|Overall Study|Adverse Event|0
7970873|NCT02846558|12531776|FG003|Overall Study|Adverse Event|0
7970874|NCT02846558|12531773|FG000|Overall Study|Withdrawal by Subject|5
7970875|NCT02846558|12531774|FG001|Overall Study|Withdrawal by Subject|4
7970876|NCT02846558|12531775|FG002|Overall Study|Withdrawal by Subject|2
7970877|NCT02846558|12531776|FG003|Overall Study|Withdrawal by Subject|2
7970878|NCT02846558|12531773|FG000|Overall Study|Lost to Follow-up|2
7970879|NCT02846558|12531774|FG001|Overall Study|Lost to Follow-up|0
7970880|NCT02846558|12531775|FG002|Overall Study|Lost to Follow-up|0
7970881|NCT02846558|12531776|FG003|Overall Study|Lost to Follow-up|0
7970882|NCT02846779|12531809|FG000|Overall Study|Lost Enrollment|83
7970883|NCT02846779|12531810|FG001|Overall Study|Lost Enrollment|82
7970884|NCT02846779|12531811|FG002|Overall Study|Lost Enrollment|86
7970885|NCT02846779|12531809|FG000|Overall Study|Less than 31 days of follow-up|56
7970886|NCT02846779|12531810|FG001|Overall Study|Less than 31 days of follow-up|45
7970887|NCT02846779|12531811|FG002|Overall Study|Less than 31 days of follow-up|52
7970888|NCT02847182|12531847|FG000|Overall Study|Withdrawal by Subject|0
7970889|NCT02847182|12531848|FG001|Overall Study|Withdrawal by Subject|1
7970890|NCT02847260|12531860|FG000|Overall Study|Adverse Event|3
7970891|NCT02847260|12531860|FG000|Overall Study|Withdrawal by Subject|2
7970892|NCT02847260|12531860|FG000|Overall Study|Clinical Deterioration|1
7970893|NCT02847260|12531860|FG000|Overall Study|Physician Decision|1
7970894|NCT02847494|12531866|FG000|Overall Study|Lost to Follow-up|8
7970895|NCT02847494|12531867|FG001|Overall Study|Lost to Follow-up|5
7970896|NCT02847650|12531875|FG000|Overall Study|Adverse Event|2
7970897|NCT02847650|12531876|FG001|Overall Study|Adverse Event|4
7970898|NCT02847650|12531875|FG000|Overall Study|Lost to Follow-up|1
7970899|NCT02847650|12531876|FG001|Overall Study|Lost to Follow-up|0
7970900|NCT02847650|12531875|FG000|Overall Study|Protocol Violation|0
7970901|NCT02847650|12531876|FG001|Overall Study|Protocol Violation|1
7970902|NCT02847650|12531875|FG000|Overall Study|Withdrawal by Subject|1
7970903|NCT02847650|12531876|FG001|Overall Study|Withdrawal by Subject|1
7970904|NCT02847858|12531884|FG000|Overall Study|Lost to Follow-up|401
7970905|NCT02847858|12531885|FG001|Overall Study|Lost to Follow-up|269
7970906|NCT02848313|12531915|FG000|Overall Study|Adverse Event|1
7970907|NCT02848313|12531916|FG001|Overall Study|Adverse Event|2
7970908|NCT02848313|12531915|FG000|Overall Study|Lack of Efficacy|0
7970909|NCT02848313|12531916|FG001|Overall Study|Lack of Efficacy|1
7970910|NCT02848313|12531915|FG000|Overall Study|Withdrawal by Subject|1
7970911|NCT02848313|12531916|FG001|Overall Study|Withdrawal by Subject|1
7970912|NCT02848313|12531915|FG000|Overall Study|Lost to follow up|1
7970913|NCT02848313|12531916|FG001|Overall Study|Lost to follow up|0
7970914|NCT02848326|12531928|FG000|Treatment Period|Adverse Event|5
7970915|NCT02848326|12531929|FG001|Treatment Period|Adverse Event|4
7970916|NCT02848326|12531930|FG002|Treatment Period|Adverse Event|11
7970917|NCT02848326|12531931|FG003|Treatment Period|Adverse Event|6
7970918|NCT02848326|12531932|FG004|Treatment Period|Adverse Event|5
7970919|NCT02848326|12531933|FG005|Treatment Period|Adverse Event|7
7970920|NCT02848326|12531928|FG000|Treatment Period|Withdrawal of Consent|20
7970921|NCT02848326|12531929|FG001|Treatment Period|Withdrawal of Consent|6
7970922|NCT02848326|12531930|FG002|Treatment Period|Withdrawal of Consent|9
7970923|NCT02848326|12531931|FG003|Treatment Period|Withdrawal of Consent|6
7970924|NCT02848326|12531932|FG004|Treatment Period|Withdrawal of Consent|9
7970925|NCT02848326|12531933|FG005|Treatment Period|Withdrawal of Consent|6
7970926|NCT02848326|12531928|FG000|Treatment Period|Lost to Follow-up|5
7970927|NCT02848326|12531929|FG001|Treatment Period|Lost to Follow-up|1
7970928|NCT02848326|12531930|FG002|Treatment Period|Lost to Follow-up|11
7970929|NCT02848326|12531931|FG003|Treatment Period|Lost to Follow-up|7
7970930|NCT02848326|12531932|FG004|Treatment Period|Lost to Follow-up|2
7970931|NCT02848326|12531933|FG005|Treatment Period|Lost to Follow-up|3
7970932|NCT02848326|12531928|FG000|Treatment Period|Pregnancy|0
7970933|NCT02848326|12531929|FG001|Treatment Period|Pregnancy|0
7970934|NCT02848326|12531930|FG002|Treatment Period|Pregnancy|1
7970935|NCT02848326|12531931|FG003|Treatment Period|Pregnancy|1
7970936|NCT02848326|12531932|FG004|Treatment Period|Pregnancy|0
7970937|NCT02848326|12531933|FG005|Treatment Period|Pregnancy|1
7970938|NCT02848326|12531928|FG000|Treatment Period|Protocol Violation|4
7970939|NCT02848326|12531929|FG001|Treatment Period|Protocol Violation|3
7970940|NCT02848326|12531930|FG002|Treatment Period|Protocol Violation|4
7970941|NCT02848326|12531931|FG003|Treatment Period|Protocol Violation|2
7970942|NCT02848326|12531932|FG004|Treatment Period|Protocol Violation|3
7970943|NCT02848326|12531933|FG005|Treatment Period|Protocol Violation|3
7970944|NCT02848326|12531928|FG000|Treatment Period|Non-compliance with Study Drug|4
7970945|NCT02848326|12531929|FG001|Treatment Period|Non-compliance with Study Drug|0
7970946|NCT02848326|12531930|FG002|Treatment Period|Non-compliance with Study Drug|0
7970947|NCT02848326|12531931|FG003|Treatment Period|Non-compliance with Study Drug|1
7970948|NCT02848326|12531932|FG004|Treatment Period|Non-compliance with Study Drug|0
7970949|NCT02848326|12531933|FG005|Treatment Period|Non-compliance with Study Drug|0
7970950|NCT02848326|12531928|FG000|Safety Follow-up Period|Withdrawal of Consent|0
7970951|NCT02848326|12531929|FG001|Safety Follow-up Period|Withdrawal of Consent|1
7970952|NCT02848326|12531930|FG002|Safety Follow-up Period|Withdrawal of Consent|1
7970953|NCT02848326|12531931|FG003|Safety Follow-up Period|Withdrawal of Consent|0
7970954|NCT02848326|12531932|FG004|Safety Follow-up Period|Withdrawal of Consent|0
7970955|NCT02848326|12531933|FG005|Safety Follow-up Period|Withdrawal of Consent|2
7970956|NCT02848326|12531928|FG000|Safety Follow-up Period|Lost to Follow-up|4
7970957|NCT02848326|12531929|FG001|Safety Follow-up Period|Lost to Follow-up|0
7970958|NCT02848326|12531930|FG002|Safety Follow-up Period|Lost to Follow-up|2
7970959|NCT02848326|12531931|FG003|Safety Follow-up Period|Lost to Follow-up|0
7970960|NCT02848326|12531932|FG004|Safety Follow-up Period|Lost to Follow-up|1
7970961|NCT02848326|12531933|FG005|Safety Follow-up Period|Lost to Follow-up|3
7970962|NCT02848599|12531949|FG000|Overall Study|Protocol Violation|7
7970963|NCT02848599|12531950|FG001|Overall Study|Protocol Violation|9
7970964|NCT02848651|12531958|FG000|Overall Study|Death|85
7970965|NCT02848651|12531958|FG000|Overall Study|Lost to Follow-up|1
7970966|NCT02848651|12531958|FG000|Overall Study|Non-Compliance|1
7970967|NCT02848651|12531958|FG000|Overall Study|Symptomatic Deterioration|1
7970968|NCT02848651|12531958|FG000|Overall Study|Physician Decision|4
7970969|NCT02848651|12531958|FG000|Overall Study|Withdrawal by Subject|14
7970970|NCT02848664|12531978|FG000|Overall Study|Withdrawal by Subject|2
7970971|NCT02848664|12531978|FG000|Overall Study|Adverse Event|1
7970972|NCT02848664|12531978|FG000|Overall Study|no assistance for device training|1
7970973|NCT02848729|12531988|FG000|Overall Study|Withdrawal by Subject|1
7970974|NCT02848729|12531989|FG001|Overall Study|Withdrawal by Subject|0
7970975|NCT02848729|12531988|FG000|Overall Study|Emesis|15
7970976|NCT02848729|12531989|FG001|Overall Study|Emesis|11
7970977|NCT02848833|12532002|FG000|Overall Study|subject who are duplicated|1
7970978|NCT02848833|12532002|FG000|Overall Study|have not taken the study drug|11
7970979|NCT02848833|12532002|FG000|Overall Study|follow-up failure|6
7970980|NCT02848833|12532002|FG000|Overall Study|Protocol Violation|119
7970981|NCT02849509|12532041|FG000|Overall Study|Worsening of disease under study|1
7970982|NCT02849509|12532042|FG001|Overall Study|Worsening of disease under study|1
7970983|NCT02849509|12532043|FG002|Overall Study|Worsening of disease under study|1
7970984|NCT02849509|12532041|FG000|Overall Study|Worsening of other pre-existing disease|0
7970985|NCT02849509|12532042|FG001|Overall Study|Worsening of other pre-existing disease|1
7970986|NCT02849509|12532043|FG002|Overall Study|Worsening of other pre-existing disease|2
7970987|NCT02849509|12532041|FG000|Overall Study|Other adverse event|36
7970988|NCT02849509|12532042|FG001|Overall Study|Other adverse event|41
7970989|NCT02849509|12532043|FG002|Overall Study|Other adverse event|8
7970990|NCT02849509|12532041|FG000|Overall Study|Withdrawal by Subject|6
7970991|NCT02849509|12532042|FG001|Overall Study|Withdrawal by Subject|17
7970992|NCT02849509|12532043|FG002|Overall Study|Withdrawal by Subject|12
7970993|NCT02849509|12532041|FG000|Overall Study|Lost to Follow-up|27
7970994|NCT02849509|12532042|FG001|Overall Study|Lost to Follow-up|67
7970995|NCT02849509|12532043|FG002|Overall Study|Lost to Follow-up|36
7970996|NCT02849509|12532041|FG000|Overall Study|Other, reason not specified|14
7970997|NCT02849509|12532042|FG001|Overall Study|Other, reason not specified|29
7970998|NCT02849509|12532043|FG002|Overall Study|Other, reason not specified|25
7970999|NCT02849509|12532041|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6
7971000|NCT02849509|12532042|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10
7971001|NCT02849509|12532043|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1
7971002|NCT02849678|12532055|FG000|Overall Study|Protocol Violation|3
7971003|NCT02849678|12532056|FG001|Overall Study|Protocol Violation|6
7971004|NCT02849704|12532064|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1
7971005|NCT02849704|12532065|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0
7971006|NCT02849704|12532064|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1
7971007|NCT02849704|12532065|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0
7971008|NCT02849704|12532064|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1
7971009|NCT02849704|12532065|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0
7971010|NCT02850276|12532097|FG000|Overall Study|screen failure|43
7971011|NCT02850276|12532097|FG000|Overall Study|Withdrawal by Subject|14
7971012|NCT02850276|12532097|FG000|Overall Study|Physician Decision|2
7971013|NCT02850276|12532097|FG000|Overall Study|Lost to Follow-up|2
7971014|NCT02850965|12532113|FG000|Overall Study|Other than listed|3
7971015|NCT02850965|12532114|FG001|Overall Study|Other than listed|4
7971016|NCT02850965|12532113|FG000|Overall Study|Protocol Violation|0
7971017|NCT02850965|12532114|FG001|Overall Study|Protocol Violation|2
7971018|NCT02850965|12532113|FG000|Overall Study|Lost to Follow-up|5
7971019|NCT02850965|12532114|FG001|Overall Study|Lost to Follow-up|3
7971020|NCT02850965|12532113|FG000|Overall Study|Lack of Efficacy|4
7971021|NCT02850965|12532114|FG001|Overall Study|Lack of Efficacy|8
7971022|NCT02850965|12532113|FG000|Overall Study|Adverse Event|3
7971023|NCT02850965|12532114|FG001|Overall Study|Adverse Event|2
7971024|NCT02850965|12532113|FG000|Overall Study|Withdrawal by Subject|3
7971025|NCT02850965|12532114|FG001|Overall Study|Withdrawal by Subject|4
7971026|NCT02850965|12532113|FG000|Overall Study|Physician Decision|0
7971027|NCT02850965|12532114|FG001|Overall Study|Physician Decision|1
7971028|NCT02850965|12532113|FG000|Overall Study|Randomized but not treated|0
7971029|NCT02850965|12532114|FG001|Overall Study|Randomized but not treated|1
7971030|NCT02850978|12532120|FG000|Overall Study|Uncollectable CRF|27
7971031|NCT02850978|12532120|FG000|Overall Study|No visit since the first visit|35
7971032|NCT02850978|12532120|FG000|Overall Study|Adverse Event|81
7971033|NCT02850978|12532120|FG000|Overall Study|Lack of Efficacy|40
7971034|NCT02850978|12532120|FG000|Overall Study|Improvement in condition|34
7971035|NCT02850978|12532120|FG000|Overall Study|Lost to Follow-up|121
7971036|NCT02850978|12532120|FG000|Overall Study|Reason not listed|88
7971037|NCT02851069|12532124|FG000|Overall Study|Failure to Return|3
7971038|NCT02851069|12532124|FG000|Overall Study|Other|3
7971039|NCT02851615|12532140|FG000|Overall Study|Cognitive Issue|1
7971040|NCT02851615|12532141|FG001|Overall Study|Cognitive Issue|0
7971041|NCT02851615|12532140|FG000|Overall Study|Lost to Follow-up|0
7971042|NCT02851615|12532141|FG001|Overall Study|Lost to Follow-up|4
7971043|NCT02852265|12532156|FG000|3-month Follow-up|Lost to Follow-up|1
7971044|NCT02852265|12532157|FG001|3-month Follow-up|Lost to Follow-up|1
7971045|NCT02852434|12532173|FG000|Overall Study|Withdrawal by Subject|0
7971046|NCT02852434|12532174|FG001|Overall Study|Withdrawal by Subject|1
7971047|NCT02852434|12532173|FG000|Overall Study|Unsuccessful Dilator Procedure|2
7971048|NCT02852434|12532174|FG001|Overall Study|Unsuccessful Dilator Procedure|0
7971049|NCT02853032|12532182|FG000|Overall Study|Adverse Event|4
7971050|NCT02853032|12532183|FG001|Overall Study|Adverse Event|0
7971051|NCT02853032|12532182|FG000|Overall Study|Withdrawal by Subject|3
7971052|NCT02853032|12532183|FG001|Overall Study|Withdrawal by Subject|1
7971053|NCT02853032|12532182|FG000|Overall Study|Requested to withdraw from all treatment|2
7971054|NCT02853032|12532183|FG001|Overall Study|Requested to withdraw from all treatment|2
7971055|NCT02853123|12532191|FG000|Treatment Period 1|Adverse Event|0
7971056|NCT02853123|12532192|FG001|Treatment Period 1|Adverse Event|3
7971057|NCT02853123|12532191|FG000|Washout Period|Worsening of COPD|0
7971058|NCT02853123|12532192|FG001|Washout Period|Worsening of COPD|3
7971059|NCT02853123|12532191|FG000|Washout Period|Adverse Event|1
7971060|NCT02853123|12532192|FG001|Washout Period|Adverse Event|0
7971061|NCT02853318|12532199|FG000|Overall Study|Withdrawal by Subject|1
7971062|NCT02853435|12532206|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7971063|NCT02853435|12532207|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7971064|NCT02853435|12532208|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7971065|NCT02853435|12532209|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7971066|NCT02853435|12532210|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
7971067|NCT02853435|12532211|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7971068|NCT02853929|12532243|FG000|Overall Study|Lost to Follow-up|3
7971069|NCT02853929|12532244|FG001|Overall Study|Lost to Follow-up|0
7971070|NCT02853929|12532243|FG000|Overall Study|Withdrawal by Subject|1
7971071|NCT02853929|12532244|FG001|Overall Study|Withdrawal by Subject|0
7971072|NCT02853929|12532243|FG000|Overall Study|Subjects enrolled but not vaccinated|7
7971073|NCT02853929|12532244|FG001|Overall Study|Subjects enrolled but not vaccinated|4
7971074|NCT02854527|12532269|FG000|Overall Study|Adverse Event|0
7971075|NCT02854527|12532270|FG001|Overall Study|Adverse Event|0
7971076|NCT02854527|12532271|FG002|Overall Study|Adverse Event|0
7971077|NCT02854527|12532272|FG003|Overall Study|Adverse Event|0
7971078|NCT02854527|12532273|FG004|Overall Study|Adverse Event|1
7971079|NCT02854527|12532274|FG005|Overall Study|Adverse Event|0
7971080|NCT02854527|12532275|FG006|Overall Study|Adverse Event|0
7971081|NCT02854527|12532276|FG007|Overall Study|Adverse Event|0
7971082|NCT02854527|12532277|FG008|Overall Study|Adverse Event|0
7971083|NCT02854527|12532278|FG009|Overall Study|Adverse Event|0
7971084|NCT02854527|12532269|FG000|Overall Study|Lost to Follow-up|0
7971085|NCT02854527|12532270|FG001|Overall Study|Lost to Follow-up|0
7971086|NCT02854527|12532271|FG002|Overall Study|Lost to Follow-up|0
7971087|NCT02854527|12532272|FG003|Overall Study|Lost to Follow-up|1
7971088|NCT02854527|12532273|FG004|Overall Study|Lost to Follow-up|0
7971089|NCT02854527|12532274|FG005|Overall Study|Lost to Follow-up|0
7971090|NCT02854527|12532275|FG006|Overall Study|Lost to Follow-up|0
7971091|NCT02854527|12532276|FG007|Overall Study|Lost to Follow-up|0
7971092|NCT02854527|12532277|FG008|Overall Study|Lost to Follow-up|0
7971093|NCT02854527|12532278|FG009|Overall Study|Lost to Follow-up|0
7971094|NCT02854605|12532299|FG000|Overall Study|Adverse Event|1
7971095|NCT02854605|12532300|FG001|Overall Study|Adverse Event|5
7971096|NCT02854605|12532301|FG002|Overall Study|Adverse Event|2
7971097|NCT02854605|12532299|FG000|Overall Study|Lost to Follow-up|0
7971098|NCT02854605|12532300|FG001|Overall Study|Lost to Follow-up|2
7971099|NCT02854605|12532301|FG002|Overall Study|Lost to Follow-up|0
7971100|NCT02854605|12532299|FG000|Overall Study|Withdrew Consent|1
7971101|NCT02854605|12532300|FG001|Overall Study|Withdrew Consent|0
7971102|NCT02854605|12532301|FG002|Overall Study|Withdrew Consent|1
7971103|NCT02854605|12532299|FG000|Overall Study|Investigator's Discretion|1
7971104|NCT02854605|12532300|FG001|Overall Study|Investigator's Discretion|0
7971105|NCT02854605|12532301|FG002|Overall Study|Investigator's Discretion|0
7971106|NCT02854605|12532299|FG000|Overall Study|Protocol Violation|0
7971107|NCT02854605|12532300|FG001|Overall Study|Protocol Violation|0
7971108|NCT02854605|12532301|FG002|Overall Study|Protocol Violation|1
7971109|NCT02854631|12532311|FG000|Overall Study|Adverse Event|1
7971110|NCT02854631|12532312|FG001|Overall Study|Adverse Event|2
7971111|NCT02854631|12532311|FG000|Overall Study|Withdrew Consent|3
7971112|NCT02854631|12532312|FG001|Overall Study|Withdrew Consent|2
7971113|NCT02854631|12532311|FG000|Overall Study|Investigator's Discretion|2
7971114|NCT02854631|12532312|FG001|Overall Study|Investigator's Discretion|0
7971115|NCT02854631|12532311|FG000|Overall Study|Death|12
7971116|NCT02854631|12532312|FG001|Overall Study|Death|8
7971117|NCT02854631|12532311|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2
7971118|NCT02854631|12532312|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0
7971119|NCT02854631|12532311|FG000|Overall Study|Protocol Violation|0
7971120|NCT02854631|12532312|FG001|Overall Study|Protocol Violation|1
7971121|NCT02854631|12532311|FG000|Overall Study|Subjects Randomized but Never Treated|2
7971122|NCT02854631|12532312|FG001|Overall Study|Subjects Randomized but Never Treated|0
7971123|NCT02854631|12532311|FG000|Overall Study|Lost to Follow-up|4
7971124|NCT02854631|12532312|FG001|Overall Study|Lost to Follow-up|2
7971125|NCT02854800|12532321|FG000|Overall Study|Protocol Violation|16
7971126|NCT02854800|12532322|FG001|Overall Study|Protocol Violation|11
7971127|NCT02854800|12532323|FG002|Overall Study|Protocol Violation|3
7971128|NCT02854800|12532321|FG000|Overall Study|Withdrawal by Subject|4
7971129|NCT02854800|12532322|FG001|Overall Study|Withdrawal by Subject|2
7971130|NCT02854800|12532323|FG002|Overall Study|Withdrawal by Subject|3
7971131|NCT02855164|12532351|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7971132|NCT02855164|12532352|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7971133|NCT02855164|12532353|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1
7971134|NCT02855164|12532354|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2
7971135|NCT02855164|12532355|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1
7971136|NCT02855164|12532356|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7971137|NCT02855164|12532357|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7971138|NCT02855164|12532358|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7971139|NCT02855164|12532351|FG000|Parts A + B (Randomized Set)|Physician Decision|0
7971140|NCT02855164|12532352|FG001|Parts A + B (Randomized Set)|Physician Decision|0
7971141|NCT02855164|12532353|FG002|Parts A + B (Randomized Set)|Physician Decision|0
7971142|NCT02855164|12532354|FG003|Parts A + B (Randomized Set)|Physician Decision|2
7971143|NCT02855164|12532355|FG004|Parts A + B (Randomized Set)|Physician Decision|0
7971144|NCT02855164|12532356|FG005|Parts A + B (Randomized Set)|Physician Decision|0
7971145|NCT02855164|12532357|FG006|Parts A + B (Randomized Set)|Physician Decision|0
7971146|NCT02855164|12532358|FG007|Parts A + B (Randomized Set)|Physician Decision|0
7971147|NCT02855164|12532351|FG000|Parts A + B (Randomized Set)|Adverse Event|0
7971148|NCT02855164|12532352|FG001|Parts A + B (Randomized Set)|Adverse Event|0
7971149|NCT02855164|12532353|FG002|Parts A + B (Randomized Set)|Adverse Event|0
7971150|NCT02855164|12532354|FG003|Parts A + B (Randomized Set)|Adverse Event|4
7971151|NCT02855164|12532355|FG004|Parts A + B (Randomized Set)|Adverse Event|0
7971152|NCT02855164|12532356|FG005|Parts A + B (Randomized Set)|Adverse Event|0
7971153|NCT02855164|12532357|FG006|Parts A + B (Randomized Set)|Adverse Event|0
7971154|NCT02855164|12532358|FG007|Parts A + B (Randomized Set)|Adverse Event|0
7971155|NCT02855164|12532351|FG000|Part C (Randomized Set)|Adverse Event|0
7971156|NCT02855164|12532352|FG001|Part C (Randomized Set)|Adverse Event|0
7971157|NCT02855164|12532353|FG002|Part C (Randomized Set)|Adverse Event|0
7971158|NCT02855164|12532354|FG003|Part C (Randomized Set)|Adverse Event|0
7971159|NCT02855164|12532355|FG004|Part C (Randomized Set)|Adverse Event|0
7971160|NCT02855164|12532356|FG005|Part C (Randomized Set)|Adverse Event|5
7971161|NCT02855164|12532357|FG006|Part C (Randomized Set)|Adverse Event|9
7971162|NCT02855164|12532358|FG007|Part C (Randomized Set)|Adverse Event|2
7971163|NCT02855164|12532351|FG000|Part C (Randomized Set)|Lost to Follow-up|0
7971164|NCT02855164|12532352|FG001|Part C (Randomized Set)|Lost to Follow-up|0
7971165|NCT02855164|12532353|FG002|Part C (Randomized Set)|Lost to Follow-up|0
7971166|NCT02855164|12532354|FG003|Part C (Randomized Set)|Lost to Follow-up|0
7971167|NCT02855164|12532355|FG004|Part C (Randomized Set)|Lost to Follow-up|0
7971168|NCT02855164|12532356|FG005|Part C (Randomized Set)|Lost to Follow-up|1
7971169|NCT02855164|12532357|FG006|Part C (Randomized Set)|Lost to Follow-up|1
7971170|NCT02855164|12532358|FG007|Part C (Randomized Set)|Lost to Follow-up|1
7971171|NCT02855164|12532351|FG000|Part C (Randomized Set)|Physician Decision|0
7971172|NCT02855164|12532352|FG001|Part C (Randomized Set)|Physician Decision|0
7971173|NCT02855164|12532353|FG002|Part C (Randomized Set)|Physician Decision|0
7971174|NCT02855164|12532354|FG003|Part C (Randomized Set)|Physician Decision|0
7971175|NCT02855164|12532355|FG004|Part C (Randomized Set)|Physician Decision|0
7971176|NCT02855164|12532356|FG005|Part C (Randomized Set)|Physician Decision|1
7971177|NCT02855164|12532357|FG006|Part C (Randomized Set)|Physician Decision|0
7971178|NCT02855164|12532358|FG007|Part C (Randomized Set)|Physician Decision|1
7971179|NCT02855164|12532351|FG000|Part C (Randomized Set)|Withdrawal by Subject|0
7971180|NCT02855164|12532352|FG001|Part C (Randomized Set)|Withdrawal by Subject|0
7971181|NCT02855164|12532353|FG002|Part C (Randomized Set)|Withdrawal by Subject|0
7971182|NCT02855164|12532354|FG003|Part C (Randomized Set)|Withdrawal by Subject|0
7971183|NCT02855164|12532355|FG004|Part C (Randomized Set)|Withdrawal by Subject|0
7971184|NCT02855164|12532356|FG005|Part C (Randomized Set)|Withdrawal by Subject|5
7971185|NCT02855164|12532357|FG006|Part C (Randomized Set)|Withdrawal by Subject|4
7971186|NCT02855164|12532358|FG007|Part C (Randomized Set)|Withdrawal by Subject|3
7971187|NCT02855359|12532406|FG000|Overall Study|Death|2
7971188|NCT02855359|12532407|FG001|Overall Study|Death|2
7971189|NCT02855359|12532408|FG002|Overall Study|Death|0
7971190|NCT02855359|12532409|FG003|Overall Study|Death|0
7971191|NCT02855359|12532406|FG000|Overall Study|Study Termination by Sponsor|9
7971192|NCT02855359|12532407|FG001|Overall Study|Study Termination by Sponsor|11
7971193|NCT02855359|12532408|FG002|Overall Study|Study Termination by Sponsor|0
7971194|NCT02855359|12532409|FG003|Overall Study|Study Termination by Sponsor|0
7971195|NCT02855450|12532427|FG000|Overall Study|Adverse Event|1
7971196|NCT02855450|12532428|FG001|Overall Study|Adverse Event|0
7971197|NCT02855450|12532427|FG000|Overall Study|Lost to Follow-up|4
7971198|NCT02855450|12532428|FG001|Overall Study|Lost to Follow-up|0
7971199|NCT02855541|12532434|FG000|Overall Study|Change in health status|2
7971200|NCT02855541|12532434|FG000|Overall Study|Withdrawal by Subject|2
7971201|NCT02856282|12532451|FG000|Overall Study|Withdrawal by Subject|1
7971202|NCT02856555|12532471|FG000|Overall Study|Adverse Event|1
7971203|NCT02856555|12532472|FG001|Overall Study|Adverse Event|0
7971204|NCT02856555|12532473|FG002|Overall Study|Adverse Event|0
7971205|NCT02856555|12532471|FG000|Overall Study|Lost to Follow-up|1
7971206|NCT02856555|12532472|FG001|Overall Study|Lost to Follow-up|3
7971207|NCT02856555|12532473|FG002|Overall Study|Lost to Follow-up|0
7971208|NCT02856555|12532471|FG000|Overall Study|Withdrawal by Subject|3
7971209|NCT02856555|12532472|FG001|Overall Study|Withdrawal by Subject|0
7971210|NCT02856555|12532473|FG002|Overall Study|Withdrawal by Subject|0
7971211|NCT02856555|12532471|FG000|Overall Study|Randomized but Never Treated|0
7971212|NCT02856555|12532472|FG001|Overall Study|Randomized but Never Treated|1
7971213|NCT02856555|12532473|FG002|Overall Study|Randomized but Never Treated|0
7971214|NCT02856802|12532483|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0
7971215|NCT02856802|12532484|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2
7971216|NCT02856802|12532483|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1
7971217|NCT02856802|12532484|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0
7971218|NCT02856802|12532483|FG000|Double-Blind Treatment Period 1|Protocol Violation|0
7971219|NCT02856802|12532484|FG001|Double-Blind Treatment Period 1|Protocol Violation|1
7971220|NCT02856802|12532483|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1
7971221|NCT02856802|12532484|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0
7971222|NCT02856802|12532483|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0
7971223|NCT02856802|12532484|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2
7971224|NCT02856802|12532483|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1
7971225|NCT02856802|12532484|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0
7971226|NCT02856880|12532511|FG000|Overall Study|Withdrawal of consent|1
7971227|NCT02857283|12532532|FG000|First Exposure|Withdrawal by Subject|1
7971228|NCT02857283|12532533|FG001|First Exposure|Withdrawal by Subject|0
7971229|NCT02857816|12532540|FG000|Overall Study|Screen Failure|33
7971230|NCT02857816|12532540|FG000|Overall Study|Withdrawal by Subject|4
7971231|NCT02857816|12532540|FG000|Overall Study|Lost to Follow-up|1
7971232|NCT02858076|12532556|FG000|Overall Study|Death|6
7971233|NCT02858076|12532557|FG001|Overall Study|Death|3
7971234|NCT02858076|12532556|FG000|Overall Study|Withdrawal by Subject|1
7971235|NCT02858076|12532557|FG001|Overall Study|Withdrawal by Subject|5
7971236|NCT02858076|12532556|FG000|Overall Study|Lost to Follow-up|2
7971237|NCT02858076|12532557|FG001|Overall Study|Lost to Follow-up|7
7971238|NCT02858076|12532556|FG000|Overall Study|Completed Out of Window|1
7971239|NCT02858076|12532557|FG001|Overall Study|Completed Out of Window|3
7971240|NCT02858180|12532567|FG000|Overall Study|Lost to Follow-up|0
7971241|NCT02858180|12532568|FG001|Overall Study|Lost to Follow-up|2
7971242|NCT02858362|12532581|FG000|Overall Study|Protocol Violation|0
7971243|NCT02858362|12532582|FG001|Overall Study|Protocol Violation|1
7971244|NCT02858362|12532583|FG002|Overall Study|Protocol Violation|0
7971245|NCT02858362|12532581|FG000|Overall Study|Withdrawal by Subject|1
7971246|NCT02858362|12532582|FG001|Overall Study|Withdrawal by Subject|0
7971247|NCT02858362|12532583|FG002|Overall Study|Withdrawal by Subject|0
7971248|NCT02858362|12532581|FG000|Overall Study|Early Study Termination|0
7971249|NCT02858362|12532582|FG001|Overall Study|Early Study Termination|0
7971250|NCT02858362|12532583|FG002|Overall Study|Early Study Termination|3
7971251|NCT02858362|12532581|FG000|Overall Study|Lost to Follow-up|1
7971252|NCT02858362|12532582|FG001|Overall Study|Lost to Follow-up|0
7971253|NCT02858362|12532583|FG002|Overall Study|Lost to Follow-up|0
7971254|NCT02858401|12532603|FG000|Overall Study|Withdrew Consent|0
7971255|NCT02858401|12532604|FG001|Overall Study|Withdrew Consent|0
7971256|NCT02858401|12532605|FG002|Overall Study|Withdrew Consent|0
7971257|NCT02858401|12532606|FG003|Overall Study|Withdrew Consent|0
7971258|NCT02858401|12532607|FG004|Overall Study|Withdrew Consent|0
7971259|NCT02858401|12532608|FG005|Overall Study|Withdrew Consent|1
7971260|NCT02858401|12532609|FG006|Overall Study|Withdrew Consent|0
7971261|NCT02858401|12532603|FG000|Overall Study|Lost to Follow-up|0
7971262|NCT02858401|12532604|FG001|Overall Study|Lost to Follow-up|1
7971263|NCT02858401|12532605|FG002|Overall Study|Lost to Follow-up|0
7971264|NCT02858401|12532606|FG003|Overall Study|Lost to Follow-up|0
7971265|NCT02858401|12532607|FG004|Overall Study|Lost to Follow-up|0
7971266|NCT02858401|12532608|FG005|Overall Study|Lost to Follow-up|0
7971267|NCT02858401|12532609|FG006|Overall Study|Lost to Follow-up|0
7971268|NCT02858440|12532634|FG000|Overall Study|Lost to Follow-up|3
7971269|NCT02858440|12532634|FG000|Overall Study|Protocol Violation|2
7971270|NCT02858440|12532634|FG000|Overall Study|Consent withdrawal|3
7971271|NCT02858440|12532634|FG000|Overall Study|Migrated/moved from study area|4
7971272|NCT02858492|12532642|FG000|Overall Study|Withdrawal by Subject|0
7971273|NCT02858492|12532643|FG001|Overall Study|Withdrawal by Subject|1
7971274|NCT02858492|12532644|FG002|Overall Study|Withdrawal by Subject|0
7717977|NCT00524043|12141668|FG001|Overall Study|Lack of Efficacy|13
7717978|NCT00524043|12141669|FG002|Overall Study|Lack of Efficacy|14
7907528|NCT02019719|12422201|FG004|Overall Study|Physician Decision|0
7907529|NCT02019927|12422248|FG000|Overall Study|Lost to Follow-up|2
7907530|NCT02019927|12422249|FG001|Overall Study|Lost to Follow-up|4
7907531|NCT02019927|12422250|FG002|Overall Study|Lost to Follow-up|1
7907532|NCT02019927|12422251|FG003|Overall Study|Lost to Follow-up|2
7907533|NCT02019927|12422252|FG004|Overall Study|Lost to Follow-up|3
7907534|NCT02019927|12422253|FG005|Overall Study|Lost to Follow-up|1
7907535|NCT02019979|12422275|FG000|Overall Study|study terminated|14
7907536|NCT02020031|12422290|FG000|Overall Study|Physician Decision|1
7907537|NCT02020031|12422291|FG001|Overall Study|Physician Decision|1
7907538|NCT02020512|12422346|FG000|Overall Study|Adverse Event|1
7907539|NCT02020512|12422346|FG000|Overall Study|Lost to Follow-up|3
7907540|NCT02020512|12422346|FG000|Overall Study|Protocol Violation|4
7907541|NCT02020577|12422352|FG000|Overall Study|Progressive disease|3
7971275|NCT02858492|12532645|FG003|Overall Study|Withdrawal by Subject|1
7717979|NCT00524043|12141667|FG000|Overall Study|Withdrawal by Subject|5
7971276|NCT02858492|12532642|FG000|Overall Study|Adverse Event|0
7971277|NCT02858492|12532643|FG001|Overall Study|Adverse Event|0
7971278|NCT02858492|12532644|FG002|Overall Study|Adverse Event|0
7971279|NCT02858492|12532645|FG003|Overall Study|Adverse Event|3
7971280|NCT02858492|12532642|FG000|Overall Study|Lack of Efficacy|0
7971281|NCT02858492|12532643|FG001|Overall Study|Lack of Efficacy|0
7971282|NCT02858492|12532644|FG002|Overall Study|Lack of Efficacy|0
7971283|NCT02858492|12532645|FG003|Overall Study|Lack of Efficacy|1
7971284|NCT02858492|12532642|FG000|Overall Study|Protocol defined stopping criteria|0
7971285|NCT02858492|12532643|FG001|Overall Study|Protocol defined stopping criteria|0
7971286|NCT02858492|12532644|FG002|Overall Study|Protocol defined stopping criteria|0
7971287|NCT02858492|12532645|FG003|Overall Study|Protocol defined stopping criteria|1
7971288|NCT02858726|12532674|FG000|Overall Study|Adverse Event|4
7971289|NCT02858726|12532675|FG001|Overall Study|Adverse Event|4
7971290|NCT02858726|12532676|FG002|Overall Study|Adverse Event|9
7971291|NCT02858726|12532677|FG003|Overall Study|Adverse Event|1
7971292|NCT02858726|12532674|FG000|Overall Study|Physician Decision|0
7971293|NCT02858726|12532675|FG001|Overall Study|Physician Decision|0
7971294|NCT02858726|12532676|FG002|Overall Study|Physician Decision|1
7971295|NCT02858726|12532677|FG003|Overall Study|Physician Decision|0
7971296|NCT02858726|12532674|FG000|Overall Study|Protocol Violation|0
7971297|NCT02858726|12532675|FG001|Overall Study|Protocol Violation|0
7971298|NCT02858726|12532676|FG002|Overall Study|Protocol Violation|0
7971299|NCT02858726|12532677|FG003|Overall Study|Protocol Violation|1
7971300|NCT02858726|12532674|FG000|Overall Study|Study Terminated by Sponsor|0
7971301|NCT02858726|12532675|FG001|Overall Study|Study Terminated by Sponsor|0
7971302|NCT02858726|12532676|FG002|Overall Study|Study Terminated by Sponsor|0
7971303|NCT02858726|12532677|FG003|Overall Study|Study Terminated by Sponsor|1
7971304|NCT02858726|12532674|FG000|Overall Study|Withdrawal by Subject|1
7971305|NCT02858726|12532675|FG001|Overall Study|Withdrawal by Subject|2
7971306|NCT02858726|12532676|FG002|Overall Study|Withdrawal by Subject|1
7971307|NCT02858726|12532677|FG003|Overall Study|Withdrawal by Subject|0
7971308|NCT02858726|12532674|FG000|Overall Study|Noncompliance|0
7971309|NCT02858726|12532675|FG001|Overall Study|Noncompliance|1
7971310|NCT02858726|12532676|FG002|Overall Study|Noncompliance|0
7971311|NCT02858726|12532677|FG003|Overall Study|Noncompliance|0
7971312|NCT02859142|12532693|FG000|Overall Study|Adverse Event|1
7971313|NCT02859142|12532694|FG001|Overall Study|Adverse Event|2
7971314|NCT02859142|12532693|FG000|Overall Study|Lost to Follow-up|1
7971315|NCT02859142|12532694|FG001|Overall Study|Lost to Follow-up|4
7971316|NCT02859142|12532693|FG000|Overall Study|Withdrawal by Subject|2
7971317|NCT02859142|12532694|FG001|Overall Study|Withdrawal by Subject|0
7971318|NCT02859142|12532693|FG000|Overall Study|Scheduling difficulties|0
7971319|NCT02859142|12532694|FG001|Overall Study|Scheduling difficulties|3
7971320|NCT02859246|12532700|FG000|Overall Study|Screen fails|3
7971321|NCT02859246|12532700|FG000|Overall Study|Adverse Event|1
7971322|NCT02859246|12532700|FG000|Overall Study|Withdrawal by Subject|1
7971323|NCT02859324|12532708|FG000|Overall Study|Death|4
7971324|NCT02859324|12532709|FG001|Overall Study|Death|6
7971325|NCT02859324|12532710|FG002|Overall Study|Death|5
7971326|NCT02859324|12532708|FG000|Overall Study|Other reasons|3
7971327|NCT02859324|12532709|FG001|Overall Study|Other reasons|3
7971328|NCT02859324|12532710|FG002|Overall Study|Other reasons|0
7971329|NCT02859454|12532739|FG000|Overall Study|PI discretion/off study prior to trtmt|1
7971330|NCT02860130|12532759|FG000|Overall Study|Adverse Event|2
7971331|NCT02860130|12532760|FG001|Overall Study|Adverse Event|3
7971332|NCT02860130|12532759|FG000|Overall Study|Protocol Violation|1
7971333|NCT02860130|12532760|FG001|Overall Study|Protocol Violation|1
7971334|NCT02860130|12532759|FG000|Overall Study|Withdrawal by Subject|0
7971335|NCT02860130|12532760|FG001|Overall Study|Withdrawal by Subject|2
7971336|NCT02860130|12532759|FG000|Overall Study|Physician Decision|2
7971337|NCT02860130|12532760|FG001|Overall Study|Physician Decision|2
7971338|NCT02860130|12532759|FG000|Overall Study|Other|2
7971339|NCT02860130|12532760|FG001|Overall Study|Other|1
7971340|NCT02860546|12532793|FG000|Overall Study|Clinical Progression|6
7971341|NCT02860546|12532793|FG000|Overall Study|Radiological Progression|12
7971342|NCT02861534|12532841|FG000|Overall Study|Death|541
7971343|NCT02861534|12532842|FG001|Overall Study|Death|552
7971344|NCT02861534|12532841|FG000|Overall Study|Lost to Follow-up|14
7971345|NCT02861534|12532842|FG001|Overall Study|Lost to Follow-up|14
7971346|NCT02861534|12532841|FG000|Overall Study|Site Terminated by Sponsor|4
7971347|NCT02861534|12532842|FG001|Overall Study|Site Terminated by Sponsor|3
7971348|NCT02861534|12532841|FG000|Overall Study|Withdrawal by Subject|15
7971349|NCT02861534|12532842|FG001|Overall Study|Withdrawal by Subject|18
7971350|NCT02861586|12532856|FG000|Overall Study|Withdrawal by Subject|1
7971351|NCT02861586|12532857|FG001|Overall Study|Withdrawal by Subject|2
7971352|NCT02861586|12532858|FG002|Overall Study|Withdrawal by Subject|0
7971353|NCT02861586|12532859|FG003|Overall Study|Withdrawal by Subject|0
7971354|NCT02861586|12532860|FG004|Overall Study|Withdrawal by Subject|0
7971355|NCT02861586|12532861|FG005|Overall Study|Withdrawal by Subject|1
7971356|NCT02861586|12532862|FG006|Overall Study|Withdrawal by Subject|1
7971357|NCT02861586|12532863|FG007|Overall Study|Withdrawal by Subject|0
7971358|NCT02861586|12532856|FG000|Overall Study|Lost to Follow-up|3
7971359|NCT02861586|12532857|FG001|Overall Study|Lost to Follow-up|1
7971360|NCT02861586|12532858|FG002|Overall Study|Lost to Follow-up|1
7971361|NCT02861586|12532859|FG003|Overall Study|Lost to Follow-up|0
7971362|NCT02861586|12532860|FG004|Overall Study|Lost to Follow-up|0
7971363|NCT02861586|12532861|FG005|Overall Study|Lost to Follow-up|3
7971364|NCT02861586|12532862|FG006|Overall Study|Lost to Follow-up|0
7971365|NCT02861586|12532863|FG007|Overall Study|Lost to Follow-up|0
7971366|NCT02861586|12532856|FG000|Overall Study|Adverse Event|0
7971367|NCT02861586|12532857|FG001|Overall Study|Adverse Event|0
7971368|NCT02861586|12532858|FG002|Overall Study|Adverse Event|0
7971369|NCT02861586|12532859|FG003|Overall Study|Adverse Event|0
7971370|NCT02861586|12532860|FG004|Overall Study|Adverse Event|0
7971371|NCT02861586|12532861|FG005|Overall Study|Adverse Event|1
7971372|NCT02861586|12532862|FG006|Overall Study|Adverse Event|0
7971373|NCT02861586|12532863|FG007|Overall Study|Adverse Event|0
7971374|NCT02861664|12532888|FG000|Overall Study|Withdrawal of Consent|0
7971375|NCT02861664|12532889|FG001|Overall Study|Withdrawal of Consent|1
7971376|NCT02861807|12532897|FG000|Overall Study|Lost to Follow-up|7
7971377|NCT02861807|12532898|FG001|Overall Study|Lost to Follow-up|6
7971378|NCT02861807|12532897|FG000|Overall Study|Withdrawal by Subject|5
7971379|NCT02861807|12532898|FG001|Overall Study|Withdrawal by Subject|8
7971380|NCT02862106|12532939|FG000|Overall Study|Adverse Event|4
7971381|NCT02862106|12532940|FG001|Overall Study|Adverse Event|0
7971382|NCT02862106|12532939|FG000|Overall Study|Protocol Violation|16
7971383|NCT02862106|12532940|FG001|Overall Study|Protocol Violation|1
7971384|NCT02862106|12532939|FG000|Overall Study|Lost to Follow-up|15
7971385|NCT02862106|12532940|FG001|Overall Study|Lost to Follow-up|5
7971386|NCT02862106|12532939|FG000|Overall Study|Withdrawal by Subject|2
7971387|NCT02862106|12532940|FG001|Overall Study|Withdrawal by Subject|0
7971388|NCT02862106|12532939|FG000|Overall Study|Subjects moved to other city|1
7971389|NCT02862106|12532940|FG001|Overall Study|Subjects moved to other city|0
7971390|NCT02862535|12532956|FG000|Overall Study|Death|7
7971391|NCT02862535|12532957|FG001|Overall Study|Death|3
7971392|NCT02862535|12532958|FG002|Overall Study|Death|2
7971393|NCT02862535|12532959|FG003|Overall Study|Death|5
7971394|NCT02862535|12532956|FG000|Overall Study|Study Terminated by Sponsor|1
7971395|NCT02862535|12532957|FG001|Overall Study|Study Terminated by Sponsor|3
7971396|NCT02862535|12532958|FG002|Overall Study|Study Terminated by Sponsor|8
7971397|NCT02862535|12532959|FG003|Overall Study|Study Terminated by Sponsor|5
7971398|NCT02862535|12532956|FG000|Overall Study|Enrolled, not Treated|1
7971399|NCT02862535|12532957|FG001|Overall Study|Enrolled, not Treated|0
7971400|NCT02862535|12532958|FG002|Overall Study|Enrolled, not Treated|0
7971401|NCT02862535|12532959|FG003|Overall Study|Enrolled, not Treated|1
7971402|NCT02862574|12532972|FG000|Double-Blind Treatment Period|Adverse Event|0
7971403|NCT02862574|12532973|FG001|Double-Blind Treatment Period|Adverse Event|1
7971404|NCT02862574|12532974|FG002|Double-Blind Treatment Period|Adverse Event|0
7971405|NCT02862574|12532972|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3
7971406|NCT02862574|12532973|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1
7971407|NCT02862574|12532974|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4
7971408|NCT02862574|12532972|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2
7971409|NCT02862574|12532973|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3
7971410|NCT02862574|12532974|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1
7971411|NCT02862600|12532983|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
7971412|NCT02862600|12532983|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3
7971413|NCT02862600|12532983|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
7971414|NCT02862600|12532983|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
7971415|NCT02862730|12532989|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7971416|NCT02862730|12532990|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7971417|NCT02862730|12532991|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
7971418|NCT02862730|12532992|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7971419|NCT02862730|12532993|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7971420|NCT02862730|12532994|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7971421|NCT02862730|12532995|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7971422|NCT02862730|12532989|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1
7971423|NCT02862730|12532990|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0
7971424|NCT02862730|12532991|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0
7971425|NCT02862730|12532992|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0
7971426|NCT02862730|12532993|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0
7971427|NCT02862730|12532994|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0
7971428|NCT02862730|12532995|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0
7971429|NCT02862730|12532989|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7971430|NCT02862730|12532990|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7971431|NCT02862730|12532991|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
7971432|NCT02862730|12532992|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7971433|NCT02862730|12532993|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
7971434|NCT02862730|12532994|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7971435|NCT02862730|12532995|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7971436|NCT02862730|12532989|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7971437|NCT02862730|12532990|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7971438|NCT02862730|12532991|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7971439|NCT02862730|12532992|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
7971440|NCT02862730|12532993|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7971441|NCT02862730|12532994|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7971442|NCT02862730|12532995|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7971443|NCT02863354|12533046|FG000|Year 1|Lost to Follow-up|1
7971444|NCT02863354|12533047|FG001|Year 1|Lost to Follow-up|1
7971445|NCT02863354|12533046|FG000|Year 1|Withdrawal by Subject|3
7971446|NCT02863354|12533047|FG001|Year 1|Withdrawal by Subject|0
7971447|NCT02863354|12533046|FG000|Year 1|Death|0
7971448|NCT02863354|12533047|FG001|Year 1|Death|1
7971449|NCT02863354|12533046|FG000|Year 2|Lost to Follow-up|2
7971450|NCT02863354|12533047|FG001|Year 2|Lost to Follow-up|2
7971451|NCT02863575|12533056|FG000|Overall Study|Participants Unable To Swallow Capsule|1
7971452|NCT02863575|12533057|FG001|Overall Study|Participants Unable To Swallow Capsule|0
7971453|NCT02863575|12533058|FG002|Overall Study|Participants Unable To Swallow Capsule|0
7971454|NCT02863575|12533056|FG000|Overall Study|Withdrawal by Subject|0
7971455|NCT02863575|12533057|FG001|Overall Study|Withdrawal by Subject|1
7971456|NCT02863575|12533058|FG002|Overall Study|Withdrawal by Subject|1
7971457|NCT02863575|12533056|FG000|Overall Study|Adverse Event|0
7971458|NCT02863575|12533057|FG001|Overall Study|Adverse Event|1
7971459|NCT02863575|12533058|FG002|Overall Study|Adverse Event|0
7971460|NCT02864082|12533081|FG000|Overall Study|Adverse Event|1
7971461|NCT02864082|12533082|FG001|Overall Study|Adverse Event|1
7971462|NCT02864082|12533081|FG000|Overall Study|Lost to Follow-up|0
7971463|NCT02864082|12533082|FG001|Overall Study|Lost to Follow-up|1
7971464|NCT02864082|12533081|FG000|Overall Study|Withdrawal by Subject|2
7971465|NCT02864082|12533082|FG001|Overall Study|Withdrawal by Subject|2
7971466|NCT02864316|12533104|FG000|Overall Study|Progressive Disease|2
7971467|NCT02864316|12533105|FG001|Overall Study|Progressive Disease|1
7971468|NCT02864316|12533104|FG000|Overall Study|Adverse Event|0
7971469|NCT02864316|12533105|FG001|Overall Study|Adverse Event|1
7971470|NCT02864342|12533113|FG000|Overall Study|Eligibility Criteria Deviation|2
7971471|NCT02864342|12533114|FG001|Overall Study|Eligibility Criteria Deviation|3
7971472|NCT02864342|12533113|FG000|Overall Study|Withdrawal by Subject|4
7971473|NCT02864342|12533114|FG001|Overall Study|Withdrawal by Subject|2
7971474|NCT02864342|12533113|FG000|Overall Study|Device Technology Issue|6
7971475|NCT02864342|12533114|FG001|Overall Study|Device Technology Issue|7
7971476|NCT02864342|12533113|FG000|Overall Study|Death|0
7971477|NCT02864342|12533114|FG001|Overall Study|Death|1
7971478|NCT02864342|12533113|FG000|Overall Study|Did Not Start Treatment with Symbicort|0
7971479|NCT02864342|12533114|FG001|Overall Study|Did Not Start Treatment with Symbicort|1
7971480|NCT02864342|12533113|FG000|Overall Study|Lost to Follow-up|1
7971481|NCT02864342|12533114|FG001|Overall Study|Lost to Follow-up|5
7971482|NCT02864342|12533113|FG000|Overall Study|Lost Device|1
7971483|NCT02864342|12533114|FG001|Overall Study|Lost Device|0
7971484|NCT02864342|12533113|FG000|Overall Study|Adverse Event|1
7971485|NCT02864342|12533114|FG001|Overall Study|Adverse Event|0
7971486|NCT02864381|12533132|FG000|Overall Study|Death|58
7971487|NCT02864381|12533133|FG001|Overall Study|Death|61
7971488|NCT02864381|12533132|FG000|Overall Study|Withdrew Consent|5
7971489|NCT02864381|12533133|FG001|Overall Study|Withdrew Consent|6
7971490|NCT02864381|12533132|FG000|Overall Study|Reason Unknown|7
7971491|NCT02864381|12533133|FG001|Overall Study|Reason Unknown|3
7971492|NCT02864381|12533132|FG000|Overall Study|Lost to Follow-up|1
7971493|NCT02864381|12533133|FG001|Overall Study|Lost to Follow-up|1
7971494|NCT02864381|12533132|FG000|Overall Study|Investigator's Discretion|1
7971495|NCT02864381|12533133|FG001|Overall Study|Investigator's Discretion|0
7971496|NCT02864381|12533132|FG000|Overall Study|Protocol Violation|0
7971497|NCT02864381|12533133|FG001|Overall Study|Protocol Violation|1
7971498|NCT02865499|12533220|FG000|Baseline|Adverse Event|1
7971499|NCT02865499|12533220|FG000|Baseline|Withdrawal by Subject|1
7971500|NCT02865538|12533229|FG000|Overall Study|Withdrawal by Subject|0
7971501|NCT02865538|12533230|FG001|Overall Study|Withdrawal by Subject|0
7971502|NCT02865538|12533231|FG002|Overall Study|Withdrawal by Subject|1
7971503|NCT02865538|12533232|FG003|Overall Study|Withdrawal by Subject|0
7971504|NCT02865538|12533233|FG004|Overall Study|Withdrawal by Subject|0
7971505|NCT02865538|12533229|FG000|Overall Study|Lost to Follow-up|1
7971506|NCT02865538|12533230|FG001|Overall Study|Lost to Follow-up|0
7971507|NCT02865538|12533231|FG002|Overall Study|Lost to Follow-up|0
7971508|NCT02865538|12533232|FG003|Overall Study|Lost to Follow-up|0
7971509|NCT02865538|12533233|FG004|Overall Study|Lost to Follow-up|0
7971510|NCT02866175|12533264|FG000|Overall Study|Adverse Event|56
7971511|NCT02866175|12533265|FG001|Overall Study|Adverse Event|54
7971512|NCT02866175|12533264|FG000|Overall Study|Withdrawal by Subject|31
7971513|NCT02866175|12533265|FG001|Overall Study|Withdrawal by Subject|52
7971514|NCT02866175|12533264|FG000|Overall Study|Death|30
7971515|NCT02866175|12533265|FG001|Overall Study|Death|23
7971516|NCT02866175|12533264|FG000|Overall Study|Other|7
7971517|NCT02866175|12533265|FG001|Overall Study|Other|14
7971518|NCT02866175|12533264|FG000|Overall Study|Progressive disease|1
7971519|NCT02866175|12533265|FG001|Overall Study|Progressive disease|1
7971520|NCT02866175|12533264|FG000|Overall Study|Lost to Follow-up|2
7971521|NCT02866175|12533265|FG001|Overall Study|Lost to Follow-up|0
7971522|NCT02866175|12533264|FG000|Overall Study|Lack of Efficacy|0
7971523|NCT02866175|12533265|FG001|Overall Study|Lack of Efficacy|1
7971524|NCT02866175|12533264|FG000|Overall Study|Physician Decision|3
7971525|NCT02866175|12533265|FG001|Overall Study|Physician Decision|15
7971526|NCT02866175|12533264|FG000|Overall Study|Did not receive treatment|5
7971527|NCT02866175|12533265|FG001|Overall Study|Did not receive treatment|15
7971528|NCT02866942|12533272|FG000|Overall Study|Invalid consent|1
7971529|NCT02867709|12533326|FG000|Treatment Period|Adverse Event|1
7971530|NCT02867709|12533327|FG001|Treatment Period|Adverse Event|1
7971531|NCT02867709|12533328|FG002|Treatment Period|Adverse Event|2
7971532|NCT02867709|12533326|FG000|Treatment Period|Withdrawal of Consent|7
7971533|NCT02867709|12533327|FG001|Treatment Period|Withdrawal of Consent|9
7971534|NCT02867709|12533328|FG002|Treatment Period|Withdrawal of Consent|8
7971535|NCT02867709|12533326|FG000|Treatment Period|Lost to Follow-up|17
7971536|NCT02867709|12533327|FG001|Treatment Period|Lost to Follow-up|20
7971537|NCT02867709|12533328|FG002|Treatment Period|Lost to Follow-up|20
7971538|NCT02867709|12533326|FG000|Treatment Period|Lack of Qualifying Event|42
7971539|NCT02867709|12533327|FG001|Treatment Period|Lack of Qualifying Event|55
7971540|NCT02867709|12533328|FG002|Treatment Period|Lack of Qualifying Event|42
7971541|NCT02867709|12533326|FG000|Treatment Period|Protocol Violation|3
7971542|NCT02867709|12533327|FG001|Treatment Period|Protocol Violation|2
7971543|NCT02867709|12533328|FG002|Treatment Period|Protocol Violation|3
7971544|NCT02867709|12533326|FG000|Safety Follow-up Period|Withdrawal of Consent|1
7971545|NCT02867709|12533327|FG001|Safety Follow-up Period|Withdrawal of Consent|8
7971546|NCT02867709|12533328|FG002|Safety Follow-up Period|Withdrawal of Consent|6
7971547|NCT02867709|12533326|FG000|Safety Follow-up Period|Lost to Follow-up|10
7971548|NCT02867709|12533327|FG001|Safety Follow-up Period|Lost to Follow-up|5
7971549|NCT02867709|12533328|FG002|Safety Follow-up Period|Lost to Follow-up|7
7971550|NCT02867709|12533326|FG000|Safety Follow-up Period|Pregnancy|0
7971551|NCT02867709|12533327|FG001|Safety Follow-up Period|Pregnancy|1
7971552|NCT02867709|12533328|FG002|Safety Follow-up Period|Pregnancy|0
7971553|NCT02867709|12533326|FG000|Safety Follow-up Period|Protocol Violation|0
7971554|NCT02867709|12533327|FG001|Safety Follow-up Period|Protocol Violation|1
7971555|NCT02867709|12533328|FG002|Safety Follow-up Period|Protocol Violation|1
7971556|NCT02867995|12533338|FG000|Overall Study|Withdrawal by Subject|0
7971557|NCT02867995|12533339|FG001|Overall Study|Withdrawal by Subject|1
7971558|NCT02867995|12533338|FG000|Overall Study|Lost to Follow-up|0
7971559|NCT02867995|12533339|FG001|Overall Study|Lost to Follow-up|2
7971560|NCT02868216|12533351|FG000|Overall Study|Death|0
7971561|NCT02868216|12533352|FG001|Overall Study|Death|1
7971562|NCT02868216|12533351|FG000|Overall Study|coronary artery bypass|1
7971563|NCT02868216|12533352|FG001|Overall Study|coronary artery bypass|0
7971564|NCT02868216|12533351|FG000|Overall Study|Withdrawal by Subject|7
7971565|NCT02868216|12533352|FG001|Overall Study|Withdrawal by Subject|5
7971566|NCT02868229|12533362|FG000|Overall Study|Adverse Event|1
7971567|NCT02868229|12533363|FG001|Overall Study|Adverse Event|0
7971568|NCT02868229|12533364|FG002|Overall Study|Adverse Event|0
7971569|NCT02868229|12533365|FG003|Overall Study|Adverse Event|1
7971570|NCT02868229|12533362|FG000|Overall Study|Death|0
7971571|NCT02868229|12533363|FG001|Overall Study|Death|0
7971572|NCT02868229|12533364|FG002|Overall Study|Death|1
7971573|NCT02868229|12533365|FG003|Overall Study|Death|1
7971574|NCT02868229|12533362|FG000|Overall Study|Missed dose|0
7971575|NCT02868229|12533363|FG001|Overall Study|Missed dose|0
7971576|NCT02868229|12533364|FG002|Overall Study|Missed dose|0
7971577|NCT02868229|12533365|FG003|Overall Study|Missed dose|3
7971578|NCT02868281|12533388|FG000|Overall Study|Adverse Event|2
7971579|NCT02868281|12533389|FG001|Overall Study|Adverse Event|2
7971580|NCT02868281|12533388|FG000|Overall Study|Protocol Violation|13
7971581|NCT02868281|12533389|FG001|Overall Study|Protocol Violation|10
7971582|NCT02868281|12533388|FG000|Overall Study|Lost to Follow-up|3
7971583|NCT02868281|12533389|FG001|Overall Study|Lost to Follow-up|6
7971584|NCT02868281|12533388|FG000|Overall Study|Withdrawal by Subject|11
7971585|NCT02868281|12533389|FG001|Overall Study|Withdrawal by Subject|15
7971586|NCT02868281|12533388|FG000|Overall Study|Physician Decision|2
7971587|NCT02868281|12533389|FG001|Overall Study|Physician Decision|0
7971588|NCT02868281|12533388|FG000|Overall Study|Had protocol-defined asthma exacerbation|8
7971589|NCT02868281|12533389|FG001|Overall Study|Had protocol-defined asthma exacerbation|8
7971590|NCT02868281|12533388|FG000|Overall Study|Inclusion/exclusion criteria violation|3
7971591|NCT02868281|12533389|FG001|Overall Study|Inclusion/exclusion criteria violation|2
7971592|NCT02868281|12533388|FG000|Overall Study|Long journey/moving away|1
7971593|NCT02868281|12533389|FG001|Overall Study|Long journey/moving away|1
7971594|NCT02868554|12533398|FG000|Overall Study|Lost to Follow-up|3
7971595|NCT02868554|12533399|FG001|Overall Study|Lost to Follow-up|0
7971596|NCT02868554|12533400|FG002|Overall Study|Lost to Follow-up|1
7971597|NCT02869438|12533440|FG000|Overall Study|Lost to Follow-up|1
7971598|NCT02869438|12533441|FG001|Overall Study|Lost to Follow-up|0
7971599|NCT02869438|12533440|FG000|Overall Study|Adverse Event|1
7971600|NCT02869438|12533441|FG001|Overall Study|Adverse Event|0
7971601|NCT02869438|12533440|FG000|Overall Study|Withdrawal by Subject|1
7971602|NCT02869438|12533441|FG001|Overall Study|Withdrawal by Subject|2
7971603|NCT02869893|12533451|FG000|Overall Study|participant aversion to IV|5
7971604|NCT02869893|12533451|FG000|Overall Study|participant fear of MRI scanner|2
7971605|NCT02870933|12533507|FG000|Overall Study|Death|2
7971606|NCT02870933|12533508|FG001|Overall Study|Death|1
7971607|NCT02870933|12533507|FG000|Overall Study|Withdrawal by Subject|0
7971608|NCT02870933|12533508|FG001|Overall Study|Withdrawal by Subject|1
7971609|NCT02870972|12533520|FG000|Overall Study|Adverse Event|1
7971610|NCT02870972|12533521|FG001|Overall Study|Adverse Event|0
7971611|NCT02870972|12533522|FG002|Overall Study|Adverse Event|0
7971612|NCT02870972|12533523|FG003|Overall Study|Adverse Event|0
7971613|NCT02870972|12533524|FG004|Overall Study|Adverse Event|0
7971614|NCT02871375|12533560|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
7971615|NCT02871375|12533561|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
7971616|NCT02871492|12533601|FG000|Overall Study|Lost to Follow-up|6
7971617|NCT02871492|12533602|FG001|Overall Study|Lost to Follow-up|3
7971618|NCT02871492|12533603|FG002|Overall Study|Lost to Follow-up|5
7971619|NCT02871492|12533601|FG000|Overall Study|Withdrawal by Subject|0
7971620|NCT02871492|12533602|FG001|Overall Study|Withdrawal by Subject|0
7971621|NCT02871492|12533603|FG002|Overall Study|Withdrawal by Subject|1
7971622|NCT02871635|12533622|FG000|Overall Study|Primary lack of efficacy|4
7971623|NCT02871635|12533623|FG001|Overall Study|Primary lack of efficacy|4
7971624|NCT02871635|12533622|FG000|Overall Study|Protocol Violation|3
7971625|NCT02871635|12533623|FG001|Overall Study|Protocol Violation|1
7971626|NCT02871635|12533622|FG000|Overall Study|Lost to Follow-up|1
7971627|NCT02871635|12533623|FG001|Overall Study|Lost to Follow-up|2
7971628|NCT02871635|12533622|FG000|Overall Study|Pregnancy|0
7971629|NCT02871635|12533623|FG001|Overall Study|Pregnancy|2
7971630|NCT02871635|12533622|FG000|Overall Study|Physician Decision|1
7971631|NCT02871635|12533623|FG001|Overall Study|Physician Decision|1
7971632|NCT02871635|12533622|FG000|Overall Study|Withdrawal by Subject|3
7971633|NCT02871635|12533623|FG001|Overall Study|Withdrawal by Subject|4
7971634|NCT02871635|12533622|FG000|Overall Study|Adverse Event|4
7971635|NCT02871635|12533623|FG001|Overall Study|Adverse Event|4
7971636|NCT02871635|12533622|FG000|Overall Study|Secondary lack of efficacy|2
7971637|NCT02871635|12533623|FG001|Overall Study|Secondary lack of efficacy|1
7971638|NCT02871739|12533635|FG000|Overall Study|Lost to Follow-up|3
7971639|NCT02871739|12533636|FG001|Overall Study|Lost to Follow-up|2
7971640|NCT02871739|12533637|FG002|Overall Study|Lost to Follow-up|0
7971641|NCT02871739|12533638|FG003|Overall Study|Lost to Follow-up|2
7971642|NCT02872012|12533653|FG000|Overall Study|Withdrawal by Subject|1
7971643|NCT02872012|12533654|FG001|Overall Study|Withdrawal by Subject|0
7971644|NCT02872012|12533655|FG002|Overall Study|Withdrawal by Subject|0
7971645|NCT02872012|12533656|FG003|Overall Study|Withdrawal by Subject|0
7971646|NCT02872012|12533657|FG004|Overall Study|Withdrawal by Subject|0
7971647|NCT02872142|12533682|FG000|Overall Study|Adverse Event|2
7971648|NCT02872142|12533682|FG000|Overall Study|Death|1
7971649|NCT02872142|12533682|FG000|Overall Study|Participant Decision|3
7971650|NCT02872285|12533688|FG000|Overall Study|Withdrawal by Subject|2
7971651|NCT02872285|12533689|FG001|Overall Study|Withdrawal by Subject|0
7971652|NCT02872285|12533688|FG000|Overall Study|Lost to Follow-up|2
7971653|NCT02872285|12533689|FG001|Overall Study|Lost to Follow-up|2
7971654|NCT02872285|12533688|FG000|Overall Study|Discontinued due to back surgery|1
7971655|NCT02872285|12533689|FG001|Overall Study|Discontinued due to back surgery|0
7971656|NCT02872311|12533700|FG000|Overall Study|Death|2
7971657|NCT02872311|12533701|FG001|Overall Study|Death|0
7971658|NCT02872311|12533702|FG002|Overall Study|Death|0
7971659|NCT02872311|12533703|FG003|Overall Study|Death|0
7971660|NCT02872311|12533704|FG004|Overall Study|Death|0
7971661|NCT02872311|12533700|FG000|Overall Study|Lost to Follow-up|2
7971662|NCT02872311|12533701|FG001|Overall Study|Lost to Follow-up|0
7971663|NCT02872311|12533702|FG002|Overall Study|Lost to Follow-up|0
7971664|NCT02872311|12533703|FG003|Overall Study|Lost to Follow-up|0
7971665|NCT02872311|12533704|FG004|Overall Study|Lost to Follow-up|0
7971666|NCT02872311|12533700|FG000|Overall Study|Protocol Violation|0
7971667|NCT02872311|12533701|FG001|Overall Study|Protocol Violation|2
7971668|NCT02872311|12533702|FG002|Overall Study|Protocol Violation|1
7971669|NCT02872311|12533703|FG003|Overall Study|Protocol Violation|0
7971670|NCT02872311|12533704|FG004|Overall Study|Protocol Violation|0
7971671|NCT02872935|12533754|FG000|Overall Study|Other|0
7971672|NCT02872935|12533755|FG001|Overall Study|Other|1
7971673|NCT02873208|12533770|FG000|Overall Study|Withdrawal by Subject|36
7971674|NCT02873208|12533770|FG000|Overall Study|Lost to Follow-up|22
7971675|NCT02873208|12533770|FG000|Overall Study|Adverse Event|15
7971676|NCT02873208|12533770|FG000|Overall Study|Non-compliance with study drug|12
7971677|NCT02873208|12533770|FG000|Overall Study|Protocol Violation|8
7971678|NCT02873208|12533770|FG000|Overall Study|Pregnancy|2
7971679|NCT02873208|12533770|FG000|Overall Study|Incarceration|1
7971680|NCT02873208|12533770|FG000|Overall Study|Lack of Efficacy|1
7971681|NCT02873208|12533770|FG000|Overall Study|Physician Decision|1
7971682|NCT02873221|12533777|FG000|Treatment Period|Other Miscellaneous Reasons|0
7971683|NCT02873221|12533778|FG001|Treatment Period|Other Miscellaneous Reasons|2
7971684|NCT02873221|12533779|FG002|Treatment Period|Other Miscellaneous Reasons|1
7971685|NCT02873221|12533777|FG000|Treatment Period|Non-Compliance with Study Drug|0
7971686|NCT02873221|12533778|FG001|Treatment Period|Non-Compliance with Study Drug|3
7971687|NCT02873221|12533779|FG002|Treatment Period|Non-Compliance with Study Drug|2
7971688|NCT02873221|12533777|FG000|Treatment Period|Protocol Violation|2
7971689|NCT02873221|12533778|FG001|Treatment Period|Protocol Violation|5
7971690|NCT02873221|12533779|FG002|Treatment Period|Protocol Violation|8
7971691|NCT02873221|12533777|FG000|Treatment Period|Pregnancy|4
7971692|NCT02873221|12533778|FG001|Treatment Period|Pregnancy|6
7971693|NCT02873221|12533779|FG002|Treatment Period|Pregnancy|3
7971694|NCT02873221|12533777|FG000|Treatment Period|Lack of Qualifying Event|0
7971695|NCT02873221|12533778|FG001|Treatment Period|Lack of Qualifying Event|3
7971696|NCT02873221|12533779|FG002|Treatment Period|Lack of Qualifying Event|1
7971697|NCT02873221|12533777|FG000|Treatment Period|Withdrawal of Consent|52
7971698|NCT02873221|12533778|FG001|Treatment Period|Withdrawal of Consent|51
7971699|NCT02873221|12533779|FG002|Treatment Period|Withdrawal of Consent|41
7971700|NCT02873221|12533777|FG000|Treatment Period|Lack of Efficacy|0
7971701|NCT02873221|12533778|FG001|Treatment Period|Lack of Efficacy|17
7971702|NCT02873221|12533779|FG002|Treatment Period|Lack of Efficacy|12
7971703|NCT02873221|12533777|FG000|Treatment Period|Adverse Event|4
7971704|NCT02873221|12533778|FG001|Treatment Period|Adverse Event|9
7971705|NCT02873221|12533779|FG002|Treatment Period|Adverse Event|11
7971706|NCT02873221|12533777|FG000|Treatment Period|Lost to Follow-up|26
7971707|NCT02873221|12533778|FG001|Treatment Period|Lost to Follow-up|30
7971708|NCT02873221|12533779|FG002|Treatment Period|Lost to Follow-up|26
7971709|NCT02873221|12533777|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0
7971710|NCT02873221|12533778|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2
7971711|NCT02873221|12533779|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0
7971712|NCT02873221|12533777|FG000|Safety Follow-up Period|Protocol Violation|0
7971713|NCT02873221|12533778|FG001|Safety Follow-up Period|Protocol Violation|0
7971714|NCT02873221|12533779|FG002|Safety Follow-up Period|Protocol Violation|1
7971715|NCT02873221|12533777|FG000|Safety Follow-up Period|Lost to Follow-up|3
7971716|NCT02873221|12533778|FG001|Safety Follow-up Period|Lost to Follow-up|5
7971717|NCT02873221|12533779|FG002|Safety Follow-up Period|Lost to Follow-up|5
7971718|NCT02873221|12533777|FG000|Safety Follow-up Period|Withdrawal of Consent|4
7971719|NCT02873221|12533778|FG001|Safety Follow-up Period|Withdrawal of Consent|10
7971720|NCT02873221|12533779|FG002|Safety Follow-up Period|Withdrawal of Consent|8
7971721|NCT02873338|12533811|FG000|Overall Study|Adverse Event|0
7971722|NCT02873338|12533812|FG001|Overall Study|Adverse Event|2
7971723|NCT02873338|12533813|FG002|Overall Study|Adverse Event|1
7971724|NCT02873338|12533811|FG000|Overall Study|Death|2
7971725|NCT02873338|12533812|FG001|Overall Study|Death|1
7971726|NCT02873338|12533813|FG002|Overall Study|Death|1
7971727|NCT02873338|12533811|FG000|Overall Study|Withdrawal by Subject|2
7971728|NCT02873338|12533812|FG001|Overall Study|Withdrawal by Subject|1
7971729|NCT02873338|12533813|FG002|Overall Study|Withdrawal by Subject|3
7971730|NCT02873338|12533811|FG000|Overall Study|Lack of Efficacy|0
7971731|NCT02873338|12533812|FG001|Overall Study|Lack of Efficacy|2
7971732|NCT02873338|12533813|FG002|Overall Study|Lack of Efficacy|0
7971733|NCT02873338|12533811|FG000|Overall Study|Other or Missing|14
7971734|NCT02873338|12533812|FG001|Overall Study|Other or Missing|15
7971735|NCT02873338|12533813|FG002|Overall Study|Other or Missing|13
7971736|NCT02873377|12533823|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
7971737|NCT02873377|12533824|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
7971738|NCT02873377|12533823|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15
7971739|NCT02873377|12533824|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23
7971740|NCT02873429|12533833|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
7971741|NCT02873429|12533834|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
7971742|NCT02873429|12533833|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2
7971743|NCT02873429|12533834|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2
7971744|NCT02873429|12533833|FG000|16 Weeks|Lost to Follow-up|3
7971745|NCT02873429|12533834|FG001|16 Weeks|Lost to Follow-up|0
7971746|NCT02873689|12533859|FG000|Overall Study|Lack of Efficacy|1
7971747|NCT02873689|12533860|FG001|Overall Study|Lack of Efficacy|0
7971748|NCT02873689|12533859|FG000|Overall Study|Withdrawal by Subject|2
7971749|NCT02873689|12533860|FG001|Overall Study|Withdrawal by Subject|2
7971750|NCT02873689|12533859|FG000|Overall Study|Protocol Violation|1
7971751|NCT02873689|12533860|FG001|Overall Study|Protocol Violation|0
7971752|NCT02873689|12533859|FG000|Overall Study|Adverse Event|2
7971753|NCT02873689|12533860|FG001|Overall Study|Adverse Event|2
7971754|NCT02873689|12533859|FG000|Overall Study|Randomized but not Treated|1
7971755|NCT02873689|12533860|FG001|Overall Study|Randomized but not Treated|1
7971756|NCT02873702|12533868|FG000|Healing Period (up to Week 8)|Adverse Event|1
7971757|NCT02873702|12533869|FG001|Healing Period (up to Week 8)|Adverse Event|0
7971758|NCT02873702|12533870|FG002|Healing Period (up to Week 8)|Adverse Event|0
7971759|NCT02873702|12533871|FG003|Healing Period (up to Week 8)|Adverse Event|0
7971760|NCT02873702|12533868|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0
7971761|NCT02873702|12533869|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1
7971762|NCT02873702|12533870|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0
7971763|NCT02873702|12533871|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0
7971764|NCT02873702|12533868|FG000|Maintenance Period (up to Month 6)|Adverse Event|0
7971765|NCT02873702|12533869|FG001|Maintenance Period (up to Month 6)|Adverse Event|0
7971766|NCT02873702|12533870|FG002|Maintenance Period (up to Month 6)|Adverse Event|1
7971767|NCT02873702|12533871|FG003|Maintenance Period (up to Month 6)|Adverse Event|0
7971768|NCT02873702|12533868|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0
7971769|NCT02873702|12533869|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0
7971770|NCT02873702|12533870|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4
7971771|NCT02873702|12533871|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1
7971772|NCT02873702|12533868|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
7971773|NCT02873702|12533869|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
7971774|NCT02873702|12533870|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2
7971775|NCT02873702|12533871|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1
7971776|NCT02873754|12533881|FG000|Overall Study|Lost to Follow-up|5
7971777|NCT02873754|12533881|FG000|Overall Study|Couldn't complete study procedures|1
7971778|NCT02873936|12533892|FG000|Overall Study|Withdrew Consent|4
7971779|NCT02873936|12533893|FG001|Overall Study|Withdrew Consent|11
7971780|NCT02873936|12533894|FG002|Overall Study|Withdrew Consent|20
7971781|NCT02873936|12533892|FG000|Overall Study|Investigator's Discretion|3
7971782|NCT02873936|12533893|FG001|Overall Study|Investigator's Discretion|5
7971783|NCT02873936|12533894|FG002|Overall Study|Investigator's Discretion|4
7971784|NCT02873936|12533892|FG000|Overall Study|Adverse Event|3
7971785|NCT02873936|12533893|FG001|Overall Study|Adverse Event|5
7971786|NCT02873936|12533894|FG002|Overall Study|Adverse Event|3
7971787|NCT02873936|12533892|FG000|Overall Study|Protocol Violation|0
7971788|NCT02873936|12533893|FG001|Overall Study|Protocol Violation|1
7971789|NCT02873936|12533894|FG002|Overall Study|Protocol Violation|3
7971790|NCT02873936|12533892|FG000|Overall Study|Lost to Follow-up|1
7971791|NCT02873936|12533893|FG001|Overall Study|Lost to Follow-up|1
7971792|NCT02873936|12533894|FG002|Overall Study|Lost to Follow-up|1
7971793|NCT02873936|12533892|FG000|Overall Study|Non-compliance With Study Drug|1
7971794|NCT02873936|12533893|FG001|Overall Study|Non-compliance With Study Drug|0
7971795|NCT02873936|12533894|FG002|Overall Study|Non-compliance With Study Drug|1
7971796|NCT02873936|12533892|FG000|Overall Study|Randomized but not Dosed|1
7971797|NCT02873936|12533893|FG001|Overall Study|Randomized but not Dosed|0
7971798|NCT02873936|12533894|FG002|Overall Study|Randomized but not Dosed|0
7971799|NCT02874534|12533921|FG000|Overall Study|Withdrawal by Subject|5
7971800|NCT02874534|12533922|FG001|Overall Study|Withdrawal by Subject|8
7971801|NCT02874534|12533921|FG000|Overall Study|Lost to Follow-up|2
7971802|NCT02874534|12533922|FG001|Overall Study|Lost to Follow-up|2
7971803|NCT02874534|12533921|FG000|Overall Study|Ongoing in study|1
7971804|NCT02874534|12533922|FG001|Overall Study|Ongoing in study|1
7971805|NCT02874794|12533930|FG000|Overall Study|Physician Decision|3
7971806|NCT02874794|12533931|FG001|Overall Study|Physician Decision|2
7971807|NCT02874794|12533930|FG000|Overall Study|Withdrawal by Subject|2
7971808|NCT02874794|12533931|FG001|Overall Study|Withdrawal by Subject|8
7971809|NCT02874794|12533930|FG000|Overall Study|Death|2
7971810|NCT02874794|12533931|FG001|Overall Study|Death|1
7971811|NCT02874924|12533953|FG000|Overall Study|Adverse Event|2
7971812|NCT02874924|12533954|FG001|Overall Study|Adverse Event|0
7971813|NCT02874924|12533955|FG002|Overall Study|Adverse Event|0
7971814|NCT02874924|12533953|FG000|Overall Study|Withdrawal by Subject|1
7971815|NCT02874924|12533954|FG001|Overall Study|Withdrawal by Subject|0
7971816|NCT02874924|12533955|FG002|Overall Study|Withdrawal by Subject|0
7971817|NCT02875028|12533965|FG000|Washout Period|Withdrawal by Subject|0
7971818|NCT02875028|12533966|FG001|Washout Period|Withdrawal by Subject|1
7971819|NCT02875080|12533977|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2
7971820|NCT02875080|12533978|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
7971821|NCT02875080|12533979|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
7971822|NCT02875340|12533987|FG000|Overall Study|Death|2
7971823|NCT02875340|12533987|FG000|Overall Study|Withdrawal by Subject|2
7971824|NCT02875340|12533987|FG000|Overall Study|Physician Decision|3
7971825|NCT02875340|12533987|FG000|Overall Study|Adverse Event|1
7971826|NCT02875366|12533999|FG000|Overall Study|Adverse Event|0
7971827|NCT02875366|12534000|FG001|Overall Study|Adverse Event|2
7971828|NCT02875366|12533999|FG000|Overall Study|Noncompliance|0
7971829|NCT02875366|12534000|FG001|Overall Study|Noncompliance|1
7971830|NCT02875392|12534008|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7
7971831|NCT02875392|12534009|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8
7971832|NCT02875613|12534015|FG000|Overall Study|Withdrawal by Subject|1
7971833|NCT02875834|12534023|FG000|Open-label Phase|Withdrawal by Subject|3
7971834|NCT02875834|12534024|FG001|Open-label Phase|Withdrawal by Subject|0
7971835|NCT02875834|12534025|FG002|Open-label Phase|Withdrawal by Subject|0
7971836|NCT02875834|12534026|FG003|Open-label Phase|Withdrawal by Subject|0
7971837|NCT02875834|12534023|FG000|Open-label Phase|(Not collected)|4
7971838|NCT02875834|12534024|FG001|Open-label Phase|(Not collected)|0
7971839|NCT02875834|12534025|FG002|Open-label Phase|(Not collected)|0
7971840|NCT02875834|12534026|FG003|Open-label Phase|(Not collected)|0
7971841|NCT02875834|12534023|FG000|Randomized Treatment Phase|Withdrawal by Subject|0
7971842|NCT02875834|12534024|FG001|Randomized Treatment Phase|Withdrawal by Subject|3
7971843|NCT02875834|12534025|FG002|Randomized Treatment Phase|Withdrawal by Subject|1
7971844|NCT02875834|12534026|FG003|Randomized Treatment Phase|Withdrawal by Subject|0
7971845|NCT02875834|12534023|FG000|Randomized Treatment Phase|Protocol Violation|0
7971846|NCT02875834|12534024|FG001|Randomized Treatment Phase|Protocol Violation|2
7971847|NCT02875834|12534025|FG002|Randomized Treatment Phase|Protocol Violation|0
7971848|NCT02875834|12534026|FG003|Randomized Treatment Phase|Protocol Violation|0
7971849|NCT02875834|12534023|FG000|Randomized Treatment Phase|(Not collected)|0
7971850|NCT02875834|12534024|FG001|Randomized Treatment Phase|(Not collected)|9
7971851|NCT02875834|12534025|FG002|Randomized Treatment Phase|(Not collected)|10
7971852|NCT02875834|12534026|FG003|Randomized Treatment Phase|(Not collected)|9
7971853|NCT02875977|12534038|FG000|Overall Study|Lost to Follow-up|42
7971854|NCT02875977|12534039|FG001|Overall Study|Lost to Follow-up|29
7971855|NCT02876601|12534079|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
7971856|NCT02876601|12534080|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
7971857|NCT02876601|12534081|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1
7971858|NCT02876601|12534082|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
7971859|NCT02877004|12534174|FG000|Overall Study|Pregnancy|0
7971860|NCT02877004|12534175|FG001|Overall Study|Pregnancy|0
7971861|NCT02877004|12534176|FG002|Overall Study|Pregnancy|1
7971862|NCT02877082|12534184|FG000|Overall Study|Trial was closed early|5
7971863|NCT02877680|12534209|FG000|Overall Study|Lost to Follow-up|1
7971864|NCT02877680|12534210|FG001|Overall Study|Lost to Follow-up|1
7971865|NCT02877927|12534222|FG000|Overall Study|Adverse Event|1
7971866|NCT02877927|12534223|FG001|Overall Study|Adverse Event|0
7971867|NCT02877927|12534222|FG000|Overall Study|Lost to Follow-up|37
7971868|NCT02877927|12534223|FG001|Overall Study|Lost to Follow-up|38
7971869|NCT02877927|12534222|FG000|Overall Study|Withdrawal by Subject|11
7971870|NCT02877927|12534223|FG001|Overall Study|Withdrawal by Subject|12
7971871|NCT02877927|12534222|FG000|Overall Study|Physician Decision|0
7971872|NCT02877927|12534223|FG001|Overall Study|Physician Decision|1
7971873|NCT02877927|12534222|FG000|Overall Study|Missed EOT/PTE Visit|5
7971874|NCT02877927|12534223|FG001|Overall Study|Missed EOT/PTE Visit|6
7971875|NCT02878213|12534233|FG000|Overall Study|Withdrawal by Subject|2
7971876|NCT02878213|12534233|FG000|Overall Study|Adverse Event|1
7971877|NCT02878330|12534240|FG000|Overall Study|Death|3
7971878|NCT02878330|12534241|FG001|Overall Study|Death|2
7971879|NCT02878330|12534240|FG000|Overall Study|Lost to Follow-up|11
7971880|NCT02878330|12534241|FG001|Overall Study|Lost to Follow-up|26
7971881|NCT02878330|12534240|FG000|Overall Study|Withdrawal by Subject|11
7971882|NCT02878330|12534241|FG001|Overall Study|Withdrawal by Subject|21
7971883|NCT02878330|12534240|FG000|Overall Study|Other|4
7971884|NCT02878330|12534241|FG001|Overall Study|Other|7
7971885|NCT02878590|12534266|FG000|Overall Study|Withdrawal by Subject|2
7971886|NCT02879383|12534280|FG000|First 24 Weeks|Physician Decision|0
7971887|NCT02879383|12534281|FG001|First 24 Weeks|Physician Decision|1
7971888|NCT02879383|12534282|FG002|First 24 Weeks|Physician Decision|0
7971889|NCT02879383|12534283|FG003|First 24 Weeks|Physician Decision|0
7971890|NCT02879578|12534298|FG000|Overall Study|Adverse Event|1
7971891|NCT02879578|12534299|FG001|Overall Study|Adverse Event|2
7971892|NCT02879578|12534300|FG002|Overall Study|Adverse Event|14
7971893|NCT02879578|12534298|FG000|Overall Study|Protocol Violation|0
7971894|NCT02879578|12534299|FG001|Overall Study|Protocol Violation|1
7971895|NCT02879578|12534300|FG002|Overall Study|Protocol Violation|1
7971896|NCT02879578|12534298|FG000|Overall Study|Withdrawal by Subject|8
7971897|NCT02879578|12534299|FG001|Overall Study|Withdrawal by Subject|6
7971898|NCT02879578|12534300|FG002|Overall Study|Withdrawal by Subject|9
7971899|NCT02879578|12534298|FG000|Overall Study|Lost to Follow-up|1
7971900|NCT02879578|12534299|FG001|Overall Study|Lost to Follow-up|0
7971901|NCT02879578|12534300|FG002|Overall Study|Lost to Follow-up|4
7971902|NCT02879578|12534298|FG000|Overall Study|Physician Decision|0
7971903|NCT02879578|12534299|FG001|Overall Study|Physician Decision|0
7971904|NCT02879578|12534300|FG002|Overall Study|Physician Decision|4
7971905|NCT02879994|12534339|FG000|Overall Study|off treatment early|7
7971906|NCT02879994|12534339|FG000|Overall Study|Adverse Event|2
7971907|NCT02879994|12534339|FG000|Overall Study|Death|2
7971908|NCT02880761|12534390|FG000|Overall Study|Death|6
7971909|NCT02880761|12534391|FG001|Overall Study|Death|8
7971910|NCT02880761|12534390|FG000|Overall Study|Withdrawal by Subject|3
7971911|NCT02880761|12534391|FG001|Overall Study|Withdrawal by Subject|6
7971912|NCT02880761|12534390|FG000|Overall Study|Protocol Violation|4
7971913|NCT02880761|12534391|FG001|Overall Study|Protocol Violation|3
7971914|NCT02880761|12534390|FG000|Overall Study|Lost to Follow-up|3
7971915|NCT02880761|12534391|FG001|Overall Study|Lost to Follow-up|4
7971916|NCT02880865|12534403|FG000|Overall Study|Adverse Event|1
7971917|NCT02880865|12534404|FG001|Overall Study|Adverse Event|0
7971918|NCT02880865|12534403|FG000|Overall Study|Withdrawal by Subject|0
7971919|NCT02880865|12534404|FG001|Overall Study|Withdrawal by Subject|2
7971920|NCT02880865|12534403|FG000|Overall Study|Physician Decision|0
7971921|NCT02880865|12534404|FG001|Overall Study|Physician Decision|1
7971922|NCT02881047|12534459|FG000|Overall Study|Adverse Event|1
7971923|NCT02881047|12534459|FG000|Overall Study|Withdrawal by Subject|1
7971924|NCT02881567|12534467|FG000|Overall Study|Adverse Event|1
7971925|NCT02881567|12534467|FG000|Overall Study|Lost to Follow-up|3
7971926|NCT02881567|12534467|FG000|Overall Study|Consent withdrawn|1
7971927|NCT02881567|12534467|FG000|Overall Study|Investigator decision|1
7971928|NCT02881567|12534467|FG000|Overall Study|Study terminated by sponsor|9
7971929|NCT02881567|12534467|FG000|Overall Study|Reason not Specified|3
7971930|NCT02882152|12534504|FG000|Overall Study|Lost to Follow-up|1
7971931|NCT02882152|12534505|FG001|Overall Study|Lost to Follow-up|0
7971932|NCT02882854|12534530|FG000|Overall Study|Lost to Follow-up|1
7971933|NCT02882854|12534531|FG001|Overall Study|Lost to Follow-up|2
7971934|NCT02882854|12534530|FG000|Overall Study|Physician Decision|0
7971935|NCT02882854|12534531|FG001|Overall Study|Physician Decision|1
7971936|NCT02883244|12534539|FG000|Overall Study|Lost to Follow-up|0
7971937|NCT02883244|12534540|FG001|Overall Study|Lost to Follow-up|1
7971938|NCT02883452|12534552|FG000|Overall Study|Withdrawal by Subject|1
7971939|NCT02883452|12534553|FG001|Overall Study|Withdrawal by Subject|1
7971940|NCT02883452|12534554|FG002|Overall Study|Withdrawal by Subject|3
7971941|NCT02883452|12534555|FG003|Overall Study|Withdrawal by Subject|0
7971942|NCT02883452|12534556|FG004|Overall Study|Withdrawal by Subject|2
7971943|NCT02883452|12534557|FG005|Overall Study|Withdrawal by Subject|5
7971944|NCT02883452|12534552|FG000|Overall Study|Disease progression|1
7971945|NCT02883452|12534553|FG001|Overall Study|Disease progression|0
7971946|NCT02883452|12534554|FG002|Overall Study|Disease progression|0
7971947|NCT02883452|12534555|FG003|Overall Study|Disease progression|1
7971948|NCT02883452|12534556|FG004|Overall Study|Disease progression|4
7971949|NCT02883452|12534557|FG005|Overall Study|Disease progression|5
7971950|NCT02883452|12534552|FG000|Overall Study|Adverse Event|2
7971951|NCT02883452|12534553|FG001|Overall Study|Adverse Event|1
7971952|NCT02883452|12534554|FG002|Overall Study|Adverse Event|1
7971953|NCT02883452|12534555|FG003|Overall Study|Adverse Event|1
7971954|NCT02883452|12534556|FG004|Overall Study|Adverse Event|1
7971955|NCT02883452|12534557|FG005|Overall Study|Adverse Event|3
7971956|NCT02883452|12534552|FG000|Overall Study|Physician Decision|0
7971957|NCT02883452|12534553|FG001|Overall Study|Physician Decision|0
7971958|NCT02883452|12534554|FG002|Overall Study|Physician Decision|0
7971959|NCT02883452|12534555|FG003|Overall Study|Physician Decision|0
7971960|NCT02883452|12534556|FG004|Overall Study|Physician Decision|4
7971961|NCT02883452|12534557|FG005|Overall Study|Physician Decision|1
7971962|NCT02883452|12534552|FG000|Overall Study|Death|1
7971963|NCT02883452|12534553|FG001|Overall Study|Death|0
7811410|NCT01182350|12275138|FG002|Overall Study|Withdrawal by Subject|0
7811411|NCT01182350|12275139|FG003|Overall Study|Withdrawal by Subject|1
7971964|NCT02883452|12534554|FG002|Overall Study|Death|1
7971965|NCT02883452|12534555|FG003|Overall Study|Death|0
7971966|NCT02883452|12534556|FG004|Overall Study|Death|0
7971967|NCT02883452|12534557|FG005|Overall Study|Death|0
7971968|NCT02883452|12534552|FG000|Overall Study|Other|0
7971969|NCT02883452|12534553|FG001|Overall Study|Other|0
7971970|NCT02883452|12534554|FG002|Overall Study|Other|0
7971971|NCT02883452|12534555|FG003|Overall Study|Other|0
7971972|NCT02883452|12534556|FG004|Overall Study|Other|0
7971973|NCT02883452|12534557|FG005|Overall Study|Other|1
7971974|NCT02884089|12534572|FG000|Period 1|Dosing error|2
7971975|NCT02884089|12534573|FG001|Period 1|Dosing error|2
7971976|NCT02884089|12534574|FG002|Period 1|Dosing error|0
7971977|NCT02884089|12534575|FG003|Period 1|Dosing error|0
7971978|NCT02884089|12534572|FG000|Washout Period 1|Lost to Follow-up|0
7971979|NCT02884089|12534573|FG001|Washout Period 1|Lost to Follow-up|1
7971980|NCT02884089|12534574|FG002|Washout Period 1|Lost to Follow-up|0
7971981|NCT02884089|12534575|FG003|Washout Period 1|Lost to Follow-up|1
7971982|NCT02884089|12534572|FG000|Washout Period 1|Withdrawal by Subject|0
7971983|NCT02884089|12534573|FG001|Washout Period 1|Withdrawal by Subject|1
7971984|NCT02884089|12534574|FG002|Washout Period 1|Withdrawal by Subject|0
7971985|NCT02884089|12534575|FG003|Washout Period 1|Withdrawal by Subject|0
7971986|NCT02884089|12534572|FG000|Period 2|Adverse Event|1
7971987|NCT02884089|12534573|FG001|Period 2|Adverse Event|0
7971988|NCT02884089|12534574|FG002|Period 2|Adverse Event|0
7971989|NCT02884089|12534575|FG003|Period 2|Adverse Event|0
7971990|NCT02884089|12534572|FG000|Period 3|Withdrawal by Subject|0
7971991|NCT02884089|12534573|FG001|Period 3|Withdrawal by Subject|0
7971992|NCT02884089|12534574|FG002|Period 3|Withdrawal by Subject|1
7971993|NCT02884089|12534575|FG003|Period 3|Withdrawal by Subject|0
7971994|NCT02884089|12534572|FG000|Washout Period 3|Withdrawal by Subject|0
7971995|NCT02884089|12534573|FG001|Washout Period 3|Withdrawal by Subject|0
7971996|NCT02884089|12534574|FG002|Washout Period 3|Withdrawal by Subject|1
7971997|NCT02884089|12534575|FG003|Washout Period 3|Withdrawal by Subject|0
7971998|NCT02884089|12534572|FG000|Washout Period 3|Lost to Follow-up|0
7971999|NCT02884089|12534573|FG001|Washout Period 3|Lost to Follow-up|0
7972000|NCT02884089|12534574|FG002|Washout Period 3|Lost to Follow-up|0
7972001|NCT02884089|12534575|FG003|Washout Period 3|Lost to Follow-up|1
7972002|NCT02884089|12534572|FG000|Period 4|Withdrawal by Subject|0
7972003|NCT02884089|12534573|FG001|Period 4|Withdrawal by Subject|1
7972004|NCT02884089|12534574|FG002|Period 4|Withdrawal by Subject|0
7972005|NCT02884089|12534575|FG003|Period 4|Withdrawal by Subject|0
7972006|NCT02884089|12534572|FG000|Period 4|Lost to Follow-up|1
7972007|NCT02884089|12534573|FG001|Period 4|Lost to Follow-up|0
7972008|NCT02884089|12534574|FG002|Period 4|Lost to Follow-up|0
7972009|NCT02884089|12534575|FG003|Period 4|Lost to Follow-up|0
7972010|NCT02884089|12534572|FG000|Follow-up Visit|Withdrawal by Subject|1
7972011|NCT02884089|12534573|FG001|Follow-up Visit|Withdrawal by Subject|0
7972012|NCT02884089|12534574|FG002|Follow-up Visit|Withdrawal by Subject|0
7972013|NCT02884089|12534575|FG003|Follow-up Visit|Withdrawal by Subject|1
7972014|NCT02885181|12534645|FG000|Overall Study|Investigator's Discretion|0
7972015|NCT02885181|12534646|FG001|Overall Study|Investigator's Discretion|1
7972016|NCT02885181|12534647|FG002|Overall Study|Investigator's Discretion|0
7972017|NCT02885181|12534648|FG003|Overall Study|Investigator's Discretion|1
7972018|NCT02885181|12534645|FG000|Overall Study|Adverse Event|0
7972019|NCT02885181|12534646|FG001|Overall Study|Adverse Event|0
7972020|NCT02885181|12534647|FG002|Overall Study|Adverse Event|0
7972021|NCT02885181|12534648|FG003|Overall Study|Adverse Event|1
7972022|NCT02885181|12534645|FG000|Overall Study|Withdrawal by Subject|0
7972023|NCT02885181|12534646|FG001|Overall Study|Withdrawal by Subject|0
7972024|NCT02885181|12534647|FG002|Overall Study|Withdrawal by Subject|0
7972025|NCT02885181|12534648|FG003|Overall Study|Withdrawal by Subject|1
7972026|NCT02886338|12534744|FG000|Overall Study|Withdrawal by Subject|1
7972027|NCT02886494|12534750|FG000|Overall Study|Adverse Event|1
7972028|NCT02886494|12534751|FG001|Overall Study|Adverse Event|0
7972029|NCT02886494|12534750|FG000|Overall Study|Withdrawal by Subject|12
7972030|NCT02886494|12534751|FG001|Overall Study|Withdrawal by Subject|3
7972031|NCT02886494|12534750|FG000|Overall Study|Protocol Violation|4
7972032|NCT02886494|12534751|FG001|Overall Study|Protocol Violation|1
7972033|NCT02886624|12534760|FG000|12-week Post Treatment Follow-up|Death|1
7972034|NCT02886624|12534760|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1
7972035|NCT02886702|12534767|FG000|Overall Study|Other|4
7972036|NCT02886702|12534768|FG001|Overall Study|Other|3
7972037|NCT02886702|12534769|FG002|Overall Study|Other|9
7972038|NCT02886702|12534767|FG000|Overall Study|Withdrawal by Subject|24
7972039|NCT02886702|12534768|FG001|Overall Study|Withdrawal by Subject|18
7972040|NCT02886702|12534769|FG002|Overall Study|Withdrawal by Subject|22
7972041|NCT02886702|12534767|FG000|Overall Study|Significant Worsening of Condition|0
7972042|NCT02886702|12534768|FG001|Overall Study|Significant Worsening of Condition|1
7972043|NCT02886702|12534769|FG002|Overall Study|Significant Worsening of Condition|0
7972044|NCT02886702|12534767|FG000|Overall Study|Protocol Violation|2
7972045|NCT02886702|12534768|FG001|Overall Study|Protocol Violation|2
7972046|NCT02886702|12534769|FG002|Overall Study|Protocol Violation|1
7972047|NCT02886702|12534767|FG000|Overall Study|Non-Compliance With Study Drug|0
7972048|NCT02886702|12534768|FG001|Overall Study|Non-Compliance With Study Drug|1
7972049|NCT02886702|12534769|FG002|Overall Study|Non-Compliance With Study Drug|4
7972050|NCT02886702|12534767|FG000|Overall Study|Lost to Follow-up|11
7972051|NCT02886702|12534768|FG001|Overall Study|Lost to Follow-up|13
7972052|NCT02886702|12534769|FG002|Overall Study|Lost to Follow-up|8
7972053|NCT02886702|12534767|FG000|Overall Study|Lack of Efficacy|3
7972054|NCT02886702|12534768|FG001|Overall Study|Lack of Efficacy|4
7972055|NCT02886702|12534769|FG002|Overall Study|Lack of Efficacy|5
7972056|NCT02886702|12534767|FG000|Overall Study|Adverse Event|4
7972057|NCT02886702|12534768|FG001|Overall Study|Adverse Event|9
7972058|NCT02886702|12534769|FG002|Overall Study|Adverse Event|3
7972059|NCT02886702|12534767|FG000|Overall Study|Administrative Reasons|0
7972060|NCT02886702|12534768|FG001|Overall Study|Administrative Reasons|0
7972061|NCT02886702|12534769|FG002|Overall Study|Administrative Reasons|1
7972062|NCT02886715|12534780|FG000|Overall Study|Non-Compliance With Study Drug|0
7972063|NCT02886715|12534781|FG001|Overall Study|Non-Compliance With Study Drug|2
7972064|NCT02886715|12534782|FG002|Overall Study|Non-Compliance With Study Drug|0
7972065|NCT02886715|12534780|FG000|Overall Study|Adverse Event|4
7972066|NCT02886715|12534781|FG001|Overall Study|Adverse Event|2
7972067|NCT02886715|12534782|FG002|Overall Study|Adverse Event|0
7972068|NCT02886715|12534780|FG000|Overall Study|Lack of Efficacy|0
7972069|NCT02886715|12534781|FG001|Overall Study|Lack of Efficacy|2
7972070|NCT02886715|12534782|FG002|Overall Study|Lack of Efficacy|1
7972071|NCT02886715|12534780|FG000|Overall Study|Lost to Follow-up|29
7972072|NCT02886715|12534781|FG001|Overall Study|Lost to Follow-up|26
7972073|NCT02886715|12534782|FG002|Overall Study|Lost to Follow-up|10
7972074|NCT02886715|12534780|FG000|Overall Study|Pregnancy|1
7972075|NCT02886715|12534781|FG001|Overall Study|Pregnancy|1
7972076|NCT02886715|12534782|FG002|Overall Study|Pregnancy|1
7972077|NCT02886715|12534780|FG000|Overall Study|Protocol Violation|3
7972078|NCT02886715|12534781|FG001|Overall Study|Protocol Violation|2
7972079|NCT02886715|12534782|FG002|Overall Study|Protocol Violation|1
7972080|NCT02886715|12534780|FG000|Overall Study|Withdrawal by Subject|20
7972081|NCT02886715|12534781|FG001|Overall Study|Withdrawal by Subject|18
7972082|NCT02886715|12534782|FG002|Overall Study|Withdrawal by Subject|5
7972083|NCT02886715|12534780|FG000|Overall Study|missing|7
7972084|NCT02886715|12534781|FG001|Overall Study|missing|2
7972085|NCT02886715|12534782|FG002|Overall Study|missing|2
7972086|NCT02886728|12534794|FG000|Overall Study|Withdrew Consent|31
7972087|NCT02886728|12534795|FG001|Overall Study|Withdrew Consent|13
7972088|NCT02886728|12534796|FG002|Overall Study|Withdrew Consent|11
7972089|NCT02886728|12534797|FG003|Overall Study|Withdrew Consent|47
7972090|NCT02886728|12534794|FG000|Overall Study|Lost to Follow-up|12
7972091|NCT02886728|12534795|FG001|Overall Study|Lost to Follow-up|6
7972092|NCT02886728|12534796|FG002|Overall Study|Lost to Follow-up|13
7972093|NCT02886728|12534797|FG003|Overall Study|Lost to Follow-up|12
7972094|NCT02886728|12534794|FG000|Overall Study|Adverse Event|13
7972095|NCT02886728|12534795|FG001|Overall Study|Adverse Event|5
7972096|NCT02886728|12534796|FG002|Overall Study|Adverse Event|5
7972097|NCT02886728|12534797|FG003|Overall Study|Adverse Event|11
7972098|NCT02886728|12534794|FG000|Overall Study|Investigator's Discretion|11
7972099|NCT02886728|12534795|FG001|Overall Study|Investigator's Discretion|7
7972100|NCT02886728|12534796|FG002|Overall Study|Investigator's Discretion|5
7972101|NCT02886728|12534797|FG003|Overall Study|Investigator's Discretion|11
7972102|NCT02886728|12534794|FG000|Overall Study|Death|3
7972103|NCT02886728|12534795|FG001|Overall Study|Death|1
7972104|NCT02886728|12534796|FG002|Overall Study|Death|0
7972105|NCT02886728|12534797|FG003|Overall Study|Death|0
7972106|NCT02886728|12534794|FG000|Overall Study|Protocol Violation|0
7972107|NCT02886728|12534795|FG001|Overall Study|Protocol Violation|0
7972108|NCT02886728|12534796|FG002|Overall Study|Protocol Violation|0
7972109|NCT02886728|12534797|FG003|Overall Study|Protocol Violation|4
7972110|NCT02886728|12534794|FG000|Overall Study|Non-Compliance with Study Drug|1
7972111|NCT02886728|12534795|FG001|Overall Study|Non-Compliance with Study Drug|0
7972112|NCT02886728|12534796|FG002|Overall Study|Non-Compliance with Study Drug|1
7972113|NCT02886728|12534797|FG003|Overall Study|Non-Compliance with Study Drug|0
7972114|NCT02886728|12534794|FG000|Overall Study|Pregnancy|0
7972115|NCT02886728|12534795|FG001|Overall Study|Pregnancy|0
7972116|NCT02886728|12534796|FG002|Overall Study|Pregnancy|1
7972117|NCT02886728|12534797|FG003|Overall Study|Pregnancy|0
7972118|NCT02886728|12534794|FG000|Overall Study|Randomized but Not Dosed|1
7972119|NCT02886728|12534795|FG001|Overall Study|Randomized but Not Dosed|0
7972120|NCT02886728|12534796|FG002|Overall Study|Randomized but Not Dosed|0
7972121|NCT02886728|12534797|FG003|Overall Study|Randomized but Not Dosed|2
7972122|NCT02887183|12534814|FG000|Overall Study|Adverse Event|44
7972123|NCT02887183|12534814|FG000|Overall Study|Death|30
7972124|NCT02887183|12534814|FG000|Overall Study|Pregnancy|1
7972125|NCT02887183|12534814|FG000|Overall Study|Protocol Violation|6
7972126|NCT02887183|12534814|FG000|Overall Study|Technical Problems|2
7972127|NCT02887183|12534814|FG000|Overall Study|Lost to Follow-up|13
7972128|NCT02887183|12534814|FG000|Overall Study|Physician Decision|10
7972129|NCT02887183|12534814|FG000|Overall Study|Withdrawal by Subject|35
7972130|NCT02887521|12534830|FG000|Overall Study|Withdrawal by Subject|0
7972131|NCT02887521|12534831|FG001|Overall Study|Withdrawal by Subject|3
7972132|NCT02887989|12534839|FG000|Overall Study|Withdrawal by Subject|8
7972133|NCT02887989|12534840|FG001|Overall Study|Withdrawal by Subject|11
7972134|NCT02887989|12534839|FG000|Overall Study|Death|1
7972135|NCT02887989|12534840|FG001|Overall Study|Death|0
7972136|NCT02888080|12534848|FG000|Overall Study|Subject / Guardian decision|1
7972137|NCT02888080|12534849|FG001|Overall Study|Subject / Guardian decision|3
7972138|NCT02888080|12534848|FG000|Overall Study|New Therapy for study indication|1
7972139|NCT02888080|12534849|FG001|Overall Study|New Therapy for study indication|0
7972140|NCT02888080|12534848|FG000|Overall Study|Lack of Efficacy|0
7972141|NCT02888080|12534849|FG001|Overall Study|Lack of Efficacy|1
7972142|NCT02888080|12534848|FG000|Overall Study|Adverse Event|0
7972143|NCT02888080|12534849|FG001|Overall Study|Adverse Event|1
7972144|NCT02888106|12534872|FG000|Overall Study|Withdrawal by Subject|1
7972145|NCT02888106|12534873|FG001|Overall Study|Withdrawal by Subject|2
7972146|NCT02888106|12534874|FG002|Overall Study|Withdrawal by Subject|0
7972147|NCT02888106|12534875|FG003|Overall Study|Withdrawal by Subject|1
7972148|NCT02888106|12534876|FG004|Overall Study|Withdrawal by Subject|0
7972149|NCT02888106|12534877|FG005|Overall Study|Withdrawal by Subject|0
7972150|NCT02888106|12534872|FG000|Overall Study|Lost to Follow-up|1
7972151|NCT02888106|12534873|FG001|Overall Study|Lost to Follow-up|0
7972152|NCT02888106|12534874|FG002|Overall Study|Lost to Follow-up|0
7972153|NCT02888106|12534875|FG003|Overall Study|Lost to Follow-up|1
7972154|NCT02888106|12534876|FG004|Overall Study|Lost to Follow-up|0
7972155|NCT02888106|12534877|FG005|Overall Study|Lost to Follow-up|1
7972156|NCT02888106|12534872|FG000|Overall Study|Adverse Event|2
7972157|NCT02888106|12534873|FG001|Overall Study|Adverse Event|0
7972158|NCT02888106|12534874|FG002|Overall Study|Adverse Event|0
7972159|NCT02888106|12534875|FG003|Overall Study|Adverse Event|0
7972160|NCT02888106|12534876|FG004|Overall Study|Adverse Event|0
7972161|NCT02888106|12534877|FG005|Overall Study|Adverse Event|0
7972162|NCT02888106|12534872|FG000|Overall Study|Withdrawal of consent|0
7972163|NCT02888106|12534873|FG001|Overall Study|Withdrawal of consent|0
7972164|NCT02888106|12534874|FG002|Overall Study|Withdrawal of consent|0
7972165|NCT02888106|12534875|FG003|Overall Study|Withdrawal of consent|0
7972166|NCT02888106|12534876|FG004|Overall Study|Withdrawal of consent|1
7972167|NCT02888106|12534877|FG005|Overall Study|Withdrawal of consent|0
7972168|NCT02888106|12534872|FG000|Overall Study|Pregnancy|1
7972169|NCT02888106|12534873|FG001|Overall Study|Pregnancy|0
7972170|NCT02888106|12534874|FG002|Overall Study|Pregnancy|0
7972171|NCT02888106|12534875|FG003|Overall Study|Pregnancy|0
7972172|NCT02888106|12534876|FG004|Overall Study|Pregnancy|0
7972173|NCT02888106|12534877|FG005|Overall Study|Pregnancy|0
7972174|NCT02888171|12534899|FG000|Overall Study|Lost to Follow-up|2
7972175|NCT02888171|12534900|FG001|Overall Study|Lost to Follow-up|1
7972176|NCT02888171|12534899|FG000|Overall Study|Withdrawal by Subject|3
7972177|NCT02888171|12534900|FG001|Overall Study|Withdrawal by Subject|2
7972178|NCT02888171|12534899|FG000|Overall Study|Adverse Event|0
7972179|NCT02888171|12534900|FG001|Overall Study|Adverse Event|1
7972180|NCT02888756|12534930|FG000|Analytical Treatment Interruption|Physician Decision|10
7972181|NCT02888756|12534931|FG001|Analytical Treatment Interruption|Physician Decision|6
7972182|NCT02888756|12534932|FG002|Analytical Treatment Interruption|Physician Decision|5
7972183|NCT02889562|12534963|FG000|Overall Study|Physician Decision|0
7972184|NCT02889562|12534964|FG001|Overall Study|Physician Decision|1
7972185|NCT02889562|12534963|FG000|Overall Study|Withdrawal by Subject|0
7972186|NCT02889562|12534964|FG001|Overall Study|Withdrawal by Subject|1
7972187|NCT02889796|12534974|FG000|Overall Study|Withdrew Consent|18
7972188|NCT02889796|12534975|FG001|Overall Study|Withdrew Consent|29
7972189|NCT02889796|12534976|FG002|Overall Study|Withdrew Consent|20
7972190|NCT02889796|12534977|FG003|Overall Study|Withdrew Consent|1
7972191|NCT02889796|12534978|FG004|Overall Study|Withdrew Consent|2
7972192|NCT02889796|12534979|FG005|Overall Study|Withdrew Consent|35
7972193|NCT02889796|12534974|FG000|Overall Study|Investigator's Discretion|10
7972194|NCT02889796|12534975|FG001|Overall Study|Investigator's Discretion|9
7972195|NCT02889796|12534976|FG002|Overall Study|Investigator's Discretion|10
7972196|NCT02889796|12534977|FG003|Overall Study|Investigator's Discretion|3
7972197|NCT02889796|12534978|FG004|Overall Study|Investigator's Discretion|0
7972198|NCT02889796|12534979|FG005|Overall Study|Investigator's Discretion|15
7972199|NCT02889796|12534974|FG000|Overall Study|Adverse Event|17
7972200|NCT02889796|12534975|FG001|Overall Study|Adverse Event|8
7972201|NCT02889796|12534976|FG002|Overall Study|Adverse Event|8
7972202|NCT02889796|12534977|FG003|Overall Study|Adverse Event|4
7972203|NCT02889796|12534978|FG004|Overall Study|Adverse Event|1
7972204|NCT02889796|12534979|FG005|Overall Study|Adverse Event|7
7972205|NCT02889796|12534974|FG000|Overall Study|Lost to Follow-up|5
7972206|NCT02889796|12534975|FG001|Overall Study|Lost to Follow-up|7
7972207|NCT02889796|12534976|FG002|Overall Study|Lost to Follow-up|2
7972208|NCT02889796|12534977|FG003|Overall Study|Lost to Follow-up|0
7972209|NCT02889796|12534978|FG004|Overall Study|Lost to Follow-up|2
7972210|NCT02889796|12534979|FG005|Overall Study|Lost to Follow-up|6
7972211|NCT02889796|12534974|FG000|Overall Study|Protocol Violation|0
7972212|NCT02889796|12534975|FG001|Overall Study|Protocol Violation|1
7972213|NCT02889796|12534976|FG002|Overall Study|Protocol Violation|3
7972214|NCT02889796|12534977|FG003|Overall Study|Protocol Violation|0
7972215|NCT02889796|12534978|FG004|Overall Study|Protocol Violation|0
7972216|NCT02889796|12534979|FG005|Overall Study|Protocol Violation|4
7972217|NCT02889796|12534974|FG000|Overall Study|Non-compliance With Study Drug|0
7972218|NCT02889796|12534975|FG001|Overall Study|Non-compliance With Study Drug|2
7972219|NCT02889796|12534976|FG002|Overall Study|Non-compliance With Study Drug|0
7972220|NCT02889796|12534977|FG003|Overall Study|Non-compliance With Study Drug|0
7972221|NCT02889796|12534978|FG004|Overall Study|Non-compliance With Study Drug|1
7972222|NCT02889796|12534979|FG005|Overall Study|Non-compliance With Study Drug|2
7972223|NCT02889796|12534974|FG000|Overall Study|Death|1
7972224|NCT02889796|12534975|FG001|Overall Study|Death|1
7972225|NCT02889796|12534976|FG002|Overall Study|Death|0
7972226|NCT02889796|12534977|FG003|Overall Study|Death|1
7972227|NCT02889796|12534978|FG004|Overall Study|Death|0
7972228|NCT02889796|12534979|FG005|Overall Study|Death|1
7972229|NCT02889796|12534974|FG000|Overall Study|Pregnancy|0
7972230|NCT02889796|12534975|FG001|Overall Study|Pregnancy|1
7972231|NCT02889796|12534976|FG002|Overall Study|Pregnancy|1
7972232|NCT02889796|12534977|FG003|Overall Study|Pregnancy|0
7972233|NCT02889796|12534978|FG004|Overall Study|Pregnancy|0
7972234|NCT02889796|12534979|FG005|Overall Study|Pregnancy|0
7972235|NCT02889796|12534974|FG000|Overall Study|Randomized but not Dosed|2
7972236|NCT02889796|12534975|FG001|Overall Study|Randomized but not Dosed|0
7972237|NCT02889796|12534976|FG002|Overall Study|Randomized but not Dosed|0
7972238|NCT02889796|12534977|FG003|Overall Study|Randomized but not Dosed|0
7972239|NCT02889796|12534978|FG004|Overall Study|Randomized but not Dosed|0
7972240|NCT02889796|12534979|FG005|Overall Study|Randomized but not Dosed|2
7972241|NCT02889861|12535002|FG000|Overall Study|Ongoing in Survival Follow-up|2
7972242|NCT02890992|12535032|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0
7972243|NCT02890992|12535033|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1
7972244|NCT02890992|12535034|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0
7972245|NCT02890992|12535035|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0
7972246|NCT02890992|12535036|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0
7972247|NCT02890992|12535037|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0
7972248|NCT02890992|12535038|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0
7972249|NCT02890992|12535039|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0
7972250|NCT02890992|12535032|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0
7972251|NCT02890992|12535033|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0
7972252|NCT02890992|12535034|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0
7972253|NCT02890992|12535035|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0
7972254|NCT02890992|12535036|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0
7972255|NCT02890992|12535037|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0
7972256|NCT02890992|12535038|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1
7972257|NCT02890992|12535039|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1
7972258|NCT02890992|12535032|FG000|130 Weeks Open-Label Extension Period|Other than specified|0
7972259|NCT02890992|12535033|FG001|130 Weeks Open-Label Extension Period|Other than specified|2
7972260|NCT02890992|12535034|FG002|130 Weeks Open-Label Extension Period|Other than specified|0
7972261|NCT02890992|12535035|FG003|130 Weeks Open-Label Extension Period|Other than specified|0
7972262|NCT02890992|12535036|FG004|130 Weeks Open-Label Extension Period|Other than specified|0
7972263|NCT02890992|12535037|FG005|130 Weeks Open-Label Extension Period|Other than specified|0
7972264|NCT02890992|12535038|FG006|130 Weeks Open-Label Extension Period|Other than specified|0
7972265|NCT02890992|12535039|FG007|130 Weeks Open-Label Extension Period|Other than specified|0
7972266|NCT02891070|12535066|FG000|Overall Study|Adverse Event|1
7972267|NCT02891070|12535067|FG001|Overall Study|Adverse Event|0
7972268|NCT02891070|12535066|FG000|Overall Study|Physician Decision|0
7972269|NCT02891070|12535067|FG001|Overall Study|Physician Decision|1
7972270|NCT02891070|12535066|FG000|Overall Study|Lost to Follow-up|4
7972271|NCT02891070|12535067|FG001|Overall Study|Lost to Follow-up|4
7972272|NCT02891070|12535066|FG000|Overall Study|Other|1
7972273|NCT02891070|12535067|FG001|Overall Study|Other|0
7972274|NCT02891070|12535066|FG000|Overall Study|Protocol Violation|0
7972275|NCT02891070|12535067|FG001|Overall Study|Protocol Violation|1
7972276|NCT02891070|12535066|FG000|Overall Study|Withdrawal by Subject|1
7972277|NCT02891070|12535067|FG001|Overall Study|Withdrawal by Subject|2
7972278|NCT02891070|12535066|FG000|Overall Study|Death|3
7972279|NCT02891070|12535067|FG001|Overall Study|Death|0
7972280|NCT02891174|12535075|FG000|First Intervention (24 Hours)|Declined any study medication|1
7972281|NCT02891174|12535076|FG001|First Intervention (24 Hours)|Declined any study medication|5
7972282|NCT02891174|12535075|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0
7972283|NCT02891174|12535076|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2
7972284|NCT02891174|12535075|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2
7972285|NCT02891174|12535076|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6
7972286|NCT02891174|12535075|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1
7972287|NCT02891174|12535076|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0
7972288|NCT02891174|12535075|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3
7972289|NCT02891174|12535076|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5
7972290|NCT02891174|12535075|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2
7972291|NCT02891174|12535076|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1
7972292|NCT02891174|12535075|FG000|Second Intervention (24 Hours)|Protocol Violation|0
7972293|NCT02891174|12535076|FG001|Second Intervention (24 Hours)|Protocol Violation|1
7972294|NCT02891200|12535088|FG000|Overall Study|Lost to Follow-up|31
7972295|NCT02891200|12535089|FG001|Overall Study|Lost to Follow-up|36
7972296|NCT02891200|12535088|FG000|Overall Study|Death|10
7972297|NCT02891200|12535089|FG001|Overall Study|Death|9
7972298|NCT02891200|12535088|FG000|Overall Study|Withdrawal by Subject|1
7972299|NCT02891200|12535089|FG001|Overall Study|Withdrawal by Subject|4
7972300|NCT02891408|12535102|FG000|Overall Study|Lost to Follow-up|0
7972301|NCT02891408|12535103|FG001|Overall Study|Lost to Follow-up|0
7972302|NCT02891408|12535104|FG002|Overall Study|Lost to Follow-up|1
7972303|NCT02891408|12535105|FG003|Overall Study|Lost to Follow-up|0
7972304|NCT02891408|12535106|FG004|Overall Study|Lost to Follow-up|0
7972305|NCT02891408|12535107|FG005|Overall Study|Lost to Follow-up|0
7972306|NCT02891408|12535108|FG006|Overall Study|Lost to Follow-up|0
7972307|NCT02891681|12535146|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
7972308|NCT02891681|12535147|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
7972309|NCT02891681|12535148|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1
7972310|NCT02891681|12535146|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2
7972311|NCT02891681|12535147|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
7972312|NCT02891681|12535148|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
7972313|NCT02891681|12535146|FG000|Overall Study|Taken off study after first imaging appointment|1
7972314|NCT02891681|12535147|FG001|Overall Study|Taken off study after first imaging appointment|0
7972315|NCT02891681|12535148|FG002|Overall Study|Taken off study after first imaging appointment|0
7972316|NCT02891850|12535158|FG000|Overall Study|Adverse Event|3
7972317|NCT02891850|12535159|FG001|Overall Study|Adverse Event|0
7972318|NCT02891850|12535158|FG000|Overall Study|Death|0
7972319|NCT02891850|12535159|FG001|Overall Study|Death|4
7972320|NCT02891850|12535158|FG000|Overall Study|Physician Decision|1
7972321|NCT02891850|12535159|FG001|Overall Study|Physician Decision|0
7972322|NCT02891850|12535158|FG000|Overall Study|Pregnancy|1
7972323|NCT02891850|12535159|FG001|Overall Study|Pregnancy|0
7972324|NCT02891850|12535158|FG000|Overall Study|Withdrawal by Subject|2
7972325|NCT02891850|12535159|FG001|Overall Study|Withdrawal by Subject|3
7972326|NCT02891915|12535171|FG000|Overall Study|Enrolled but Treatment Not Administered|6
7972327|NCT02891915|12535172|FG001|Overall Study|Enrolled but Treatment Not Administered|4
7972328|NCT02891915|12535171|FG000|Overall Study|Withdrawal by Subject|3
7972329|NCT02891915|12535172|FG001|Overall Study|Withdrawal by Subject|3
7972330|NCT02891915|12535171|FG000|Overall Study|Became Ineligible After Enrollment|2
7972331|NCT02891915|12535172|FG001|Overall Study|Became Ineligible After Enrollment|1
7972332|NCT02891915|12535171|FG000|Overall Study|Lost to Follow-up|1
7972333|NCT02891915|12535172|FG001|Overall Study|Lost to Follow-up|4
7972334|NCT02891915|12535171|FG000|Overall Study|Physician Decision|1
7972335|NCT02891915|12535172|FG001|Overall Study|Physician Decision|0
7972336|NCT02892019|12535180|FG000|Overall Study|randomized but not treated|0
7972337|NCT02892019|12535181|FG001|Overall Study|randomized but not treated|1
7972338|NCT02892019|12535180|FG000|Overall Study|Withdrawal by Subject|0
7972339|NCT02892019|12535181|FG001|Overall Study|Withdrawal by Subject|1
7972340|NCT02892019|12535180|FG000|Overall Study|Adverse Event|1
7972341|NCT02892019|12535181|FG001|Overall Study|Adverse Event|1
7972342|NCT02892344|12535198|FG000|Overall Study|Protocol deviation|3
7972343|NCT02892344|12535199|FG001|Overall Study|Protocol deviation|4
7972344|NCT02892344|12535198|FG000|Overall Study|Adverse Event|1
7972345|NCT02892344|12535199|FG001|Overall Study|Adverse Event|8
7972346|NCT02892344|12535198|FG000|Overall Study|Lost to Follow-up|0
7972347|NCT02892344|12535199|FG001|Overall Study|Lost to Follow-up|1
7972348|NCT02892344|12535198|FG000|Overall Study|Non-compliance with study treatment|0
7972349|NCT02892344|12535199|FG001|Overall Study|Non-compliance with study treatment|1
7972350|NCT02892344|12535198|FG000|Overall Study|Physician Decision|0
7972351|NCT02892344|12535199|FG001|Overall Study|Physician Decision|2
7972352|NCT02892344|12535198|FG000|Overall Study|Subject/guardian decision|0
7972353|NCT02892344|12535199|FG001|Overall Study|Subject/guardian decision|4
7972354|NCT02892344|12535198|FG000|Overall Study|Technical problems|0
7972355|NCT02892344|12535199|FG001|Overall Study|Technical problems|1
7972356|NCT02892409|12535207|FG000|Overall Study|Adverse Event|1
7972357|NCT02892409|12535208|FG001|Overall Study|Adverse Event|0
7972358|NCT02892409|12535207|FG000|Overall Study|Withdrawal by Subject|2
7972359|NCT02892409|12535208|FG001|Overall Study|Withdrawal by Subject|1
7972360|NCT02892422|12535214|FG000|Overall Study|Enrolled not treated|4
7972361|NCT02892422|12535214|FG000|Overall Study|Adverse Event|38
7972362|NCT02892422|12535214|FG000|Overall Study|Lack of Efficacy|32
7972363|NCT02892422|12535214|FG000|Overall Study|Non-compliance with study drug|11
7972364|NCT02892422|12535214|FG000|Overall Study|Protocol Violation|4
7972365|NCT02892422|12535214|FG000|Overall Study|Withdrawal by Subject|56
7972366|NCT02892422|12535214|FG000|Overall Study|Lost to Follow-up|5
7972367|NCT02892422|12535214|FG000|Overall Study|sponsor information 16159A results|21
7972368|NCT02892422|12535214|FG000|Overall Study|withdrawal of consent|13
7972369|NCT02892422|12535214|FG000|Overall Study|exclusion criteria met|3
7972370|NCT02892422|12535214|FG000|Overall Study|moving elsewhere|4
7972371|NCT02892422|12535214|FG000|Overall Study|non-compliance|10
7972372|NCT02892422|12535214|FG000|Overall Study|patient legally incapable|1
7972373|NCT02892422|12535214|FG000|Overall Study|patient decision|7
7972374|NCT02892422|12535214|FG000|Overall Study|Investigator decision|1
7972375|NCT02892448|12535221|FG000|Overall Study|Screening failure|2
7972376|NCT02892448|12535222|FG001|Overall Study|Screening failure|2
7972377|NCT02892448|12535223|FG002|Overall Study|Screening failure|1
7972378|NCT02892513|12535233|FG000|Overall Study|Withdrawal by Subject|0
7972379|NCT02892513|12535234|FG001|Overall Study|Withdrawal by Subject|1
7972380|NCT02892734|12535240|FG000|Treatment on Study|Progressive Disease|2
7972381|NCT02892734|12535240|FG000|Follow up for 2 Years|Death|2
7972382|NCT02892734|12535240|FG000|Follow up for 2 Years|Study closed early|1
7972383|NCT02892760|12535244|FG000|Overall Study|Withdrawal by Subject|3
7972384|NCT02894502|12535267|FG000|Baseline|Withdrawal by Subject|24
7972385|NCT02894502|12535268|FG001|Baseline|Withdrawal by Subject|31
7972386|NCT02894502|12535269|FG002|Baseline|Withdrawal by Subject|36
7972387|NCT02894502|12535267|FG000|Baseline|Death|3
7972388|NCT02894502|12535268|FG001|Baseline|Death|1
7972389|NCT02894502|12535269|FG002|Baseline|Death|9
7972390|NCT02894502|12535267|FG000|First Follow up|Withdrawal by Subject|32
7972391|NCT02894502|12535268|FG001|First Follow up|Withdrawal by Subject|29
7972392|NCT02894502|12535269|FG002|First Follow up|Withdrawal by Subject|37
7972393|NCT02894502|12535267|FG000|First Follow up|Death|2
7972394|NCT02894502|12535268|FG001|First Follow up|Death|2
7972395|NCT02894502|12535269|FG002|First Follow up|Death|3
7972396|NCT02894502|12535267|FG000|Second Follow up|Withdrawal by Subject|13
7972397|NCT02894502|12535268|FG001|Second Follow up|Withdrawal by Subject|15
7972398|NCT02894502|12535269|FG002|Second Follow up|Withdrawal by Subject|13
7972399|NCT02894502|12535267|FG000|Second Follow up|Death|2
7972400|NCT02894502|12535268|FG001|Second Follow up|Death|3
7972401|NCT02894502|12535269|FG002|Second Follow up|Death|1
7972402|NCT02894502|12535267|FG000|Third Follow up|Withdrawal by Subject|5
7972403|NCT02894502|12535268|FG001|Third Follow up|Withdrawal by Subject|6
7972404|NCT02894502|12535269|FG002|Third Follow up|Withdrawal by Subject|3
7972405|NCT02894502|12535267|FG000|Third Follow up|Death|1
7972406|NCT02894502|12535268|FG001|Third Follow up|Death|1
7972407|NCT02894502|12535269|FG002|Third Follow up|Death|0
7972408|NCT02894840|12535284|FG000|Overall Study|Lost to Follow-up|1
7972409|NCT02894840|12535285|FG001|Overall Study|Lost to Follow-up|0
7972410|NCT02894840|12535286|FG002|Overall Study|Lost to Follow-up|3
7972411|NCT02894840|12535287|FG003|Overall Study|Lost to Follow-up|0
7972412|NCT02895295|12535329|FG000|Overall Study|Survey Non-response|71
7972413|NCT02895295|12535330|FG001|Overall Study|Survey Non-response|94
7972414|NCT02895295|12535331|FG002|Overall Study|Survey Non-response|92
7972415|NCT02895347|12535341|FG000|Overall Study|Withdrawal by Subject|3
7972416|NCT02895347|12535342|FG001|Overall Study|Withdrawal by Subject|1
7972417|NCT02895360|12535355|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4
7972418|NCT02895360|12535356|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7972419|NCT02895360|12535357|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7972420|NCT02895360|12535358|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7972421|NCT02895360|12535359|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7972422|NCT02895360|12535360|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7972423|NCT02895360|12535355|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7972424|NCT02895360|12535356|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3
7972425|NCT02895360|12535357|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7972426|NCT02895360|12535358|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7972427|NCT02895360|12535359|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7972428|NCT02895360|12535360|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7972429|NCT02895360|12535355|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7972430|NCT02895360|12535356|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7972431|NCT02895360|12535357|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2
7972432|NCT02895360|12535358|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7972433|NCT02895360|12535359|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7972434|NCT02895360|12535360|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7972435|NCT02895360|12535355|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7972436|NCT02895360|12535356|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7972437|NCT02895360|12535357|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7
7972438|NCT02895360|12535358|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7972439|NCT02895360|12535359|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7972440|NCT02895360|12535360|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7972441|NCT02895360|12535355|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7972442|NCT02895360|12535356|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7972443|NCT02895360|12535357|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7972444|NCT02895360|12535358|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4
7972445|NCT02895360|12535359|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7972446|NCT02895360|12535360|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7972447|NCT02895360|12535355|FG000|Phase 2a|Adverse Event|0
7972448|NCT02895360|12535356|FG001|Phase 2a|Adverse Event|0
7972449|NCT02895360|12535357|FG002|Phase 2a|Adverse Event|0
7972450|NCT02895360|12535358|FG003|Phase 2a|Adverse Event|0
7972451|NCT02895360|12535359|FG004|Phase 2a|Adverse Event|0
7972452|NCT02895360|12535360|FG005|Phase 2a|Adverse Event|1
7972453|NCT02895360|12535355|FG000|Phase 2a|Progressive disease|0
7972454|NCT02895360|12535356|FG001|Phase 2a|Progressive disease|0
7972455|NCT02895360|12535357|FG002|Phase 2a|Progressive disease|0
7972456|NCT02895360|12535358|FG003|Phase 2a|Progressive disease|0
7972457|NCT02895360|12535359|FG004|Phase 2a|Progressive disease|11
7972458|NCT02895360|12535360|FG005|Phase 2a|Progressive disease|11
7972459|NCT02895945|12535394|FG000|Overall Study|Physician Decision|2
7972460|NCT02895945|12535395|FG001|Overall Study|Physician Decision|1
7972461|NCT02896127|12535410|FG000|COMPLETED WEEK 52|Adverse Event|9
7972462|NCT02896127|12535411|FG001|COMPLETED WEEK 52|Adverse Event|2
7972463|NCT02896127|12535410|FG000|COMPLETED WEEK 52|Lack of Efficacy|2
7972464|NCT02896127|12535411|FG001|COMPLETED WEEK 52|Lack of Efficacy|3
7972465|NCT02896127|12535410|FG000|COMPLETED WEEK 52|Lost to Follow-up|0
7972466|NCT02896127|12535411|FG001|COMPLETED WEEK 52|Lost to Follow-up|1
7972467|NCT02896127|12535410|FG000|COMPLETED WEEK 52|Physician Decision|1
7972468|NCT02896127|12535411|FG001|COMPLETED WEEK 52|Physician Decision|1
7972469|NCT02896127|12535410|FG000|COMPLETED WEEK 52|Pregnancy|2
7972470|NCT02896127|12535411|FG001|COMPLETED WEEK 52|Pregnancy|0
7972471|NCT02896127|12535410|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12
7972472|NCT02896127|12535411|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4
7972473|NCT02896127|12535410|FG000|COMPLETED WEEK 52|Technical problems|1
7972474|NCT02896127|12535411|FG001|COMPLETED WEEK 52|Technical problems|0
7972475|NCT02896127|12535410|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2
7972476|NCT02896127|12535411|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3
7972477|NCT02896127|12535410|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0
7972478|NCT02896127|12535411|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1
7972479|NCT02896127|12535410|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1
7972480|NCT02896127|12535411|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0
7972481|NCT02896127|12535410|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1
7972482|NCT02896127|12535411|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0
7972483|NCT02896127|12535410|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0
7972484|NCT02896127|12535411|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1
7972485|NCT02896296|12535417|FG000|Overall Study|Adverse Event|1
7972486|NCT02896296|12535417|FG000|Overall Study|Lost to Follow-up|19
7972487|NCT02896296|12535417|FG000|Overall Study|Pregnancy|1
7972488|NCT02896296|12535417|FG000|Overall Study|Physician Decision|2
7972489|NCT02896296|12535417|FG000|Overall Study|Withdrawal by Subject|10
7972490|NCT02896296|12535417|FG000|Overall Study|Site closing|7
7972491|NCT02896296|12535417|FG000|Overall Study|Incarceration|1
7972492|NCT02896296|12535417|FG000|Overall Study|Relocation|1
7972493|NCT02896361|12535421|FG000|Third Intervention (2 Weeks)|Protocol Violation|1
7972494|NCT02896361|12535422|FG001|Third Intervention (2 Weeks)|Protocol Violation|0
7972495|NCT02896361|12535423|FG002|Third Intervention (2 Weeks)|Protocol Violation|0
7972496|NCT02896361|12535421|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
7972497|NCT02896361|12535422|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1
7972498|NCT02896361|12535423|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
7972499|NCT02896400|12535451|FG000|1 Month Follow-up|Lost to Follow-up|7
7972500|NCT02896400|12535452|FG001|1 Month Follow-up|Lost to Follow-up|7
7972501|NCT02896400|12535453|FG002|1 Month Follow-up|Lost to Follow-up|5
7972502|NCT02896400|12535454|FG003|1 Month Follow-up|Lost to Follow-up|8
7972503|NCT02896400|12535455|FG004|1 Month Follow-up|Lost to Follow-up|9
7972504|NCT02896400|12535456|FG005|1 Month Follow-up|Lost to Follow-up|6
7972505|NCT02896400|12535457|FG006|1 Month Follow-up|Lost to Follow-up|5
7972506|NCT02896400|12535458|FG007|1 Month Follow-up|Lost to Follow-up|6
7972507|NCT02896400|12535459|FG008|1 Month Follow-up|Lost to Follow-up|4
7972508|NCT02896400|12535460|FG009|1 Month Follow-up|Lost to Follow-up|7
7972509|NCT02896400|12535461|FG010|1 Month Follow-up|Lost to Follow-up|5
7972510|NCT02896400|12535462|FG011|1 Month Follow-up|Lost to Follow-up|5
7972511|NCT02896400|12535463|FG012|1 Month Follow-up|Lost to Follow-up|3
7972512|NCT02896400|12535464|FG013|1 Month Follow-up|Lost to Follow-up|4
7972513|NCT02896400|12535465|FG014|1 Month Follow-up|Lost to Follow-up|1
7972514|NCT02896400|12535466|FG015|1 Month Follow-up|Lost to Follow-up|2
7972515|NCT02896400|12535451|FG000|1 Month Follow-up|Death|0
7972516|NCT02896400|12535452|FG001|1 Month Follow-up|Death|0
7972517|NCT02896400|12535453|FG002|1 Month Follow-up|Death|0
7972518|NCT02896400|12535454|FG003|1 Month Follow-up|Death|0
7972519|NCT02896400|12535455|FG004|1 Month Follow-up|Death|0
7972520|NCT02896400|12535456|FG005|1 Month Follow-up|Death|0
7972521|NCT02896400|12535457|FG006|1 Month Follow-up|Death|0
7972522|NCT02896400|12535458|FG007|1 Month Follow-up|Death|0
7972523|NCT02896400|12535459|FG008|1 Month Follow-up|Death|0
7972524|NCT02896400|12535460|FG009|1 Month Follow-up|Death|0
7972525|NCT02896400|12535461|FG010|1 Month Follow-up|Death|0
7972526|NCT02896400|12535462|FG011|1 Month Follow-up|Death|0
7972527|NCT02896400|12535463|FG012|1 Month Follow-up|Death|0
7972528|NCT02896400|12535464|FG013|1 Month Follow-up|Death|0
7972529|NCT02896400|12535465|FG014|1 Month Follow-up|Death|0
7972530|NCT02896400|12535466|FG015|1 Month Follow-up|Death|1
7972531|NCT02896400|12535451|FG000|3 Month Follow-up|Lost to Follow-up|6
7972532|NCT02896400|12535452|FG001|3 Month Follow-up|Lost to Follow-up|3
7972533|NCT02896400|12535453|FG002|3 Month Follow-up|Lost to Follow-up|6
7972534|NCT02896400|12535454|FG003|3 Month Follow-up|Lost to Follow-up|11
7972535|NCT02896400|12535455|FG004|3 Month Follow-up|Lost to Follow-up|12
7972536|NCT02896400|12535456|FG005|3 Month Follow-up|Lost to Follow-up|6
7972537|NCT02896400|12535457|FG006|3 Month Follow-up|Lost to Follow-up|4
7972538|NCT02896400|12535458|FG007|3 Month Follow-up|Lost to Follow-up|3
7972539|NCT02896400|12535459|FG008|3 Month Follow-up|Lost to Follow-up|6
7972540|NCT02896400|12535460|FG009|3 Month Follow-up|Lost to Follow-up|5
7972541|NCT02896400|12535461|FG010|3 Month Follow-up|Lost to Follow-up|6
7972542|NCT02896400|12535462|FG011|3 Month Follow-up|Lost to Follow-up|6
7972543|NCT02896400|12535463|FG012|3 Month Follow-up|Lost to Follow-up|3
7972544|NCT02896400|12535464|FG013|3 Month Follow-up|Lost to Follow-up|5
7972545|NCT02896400|12535465|FG014|3 Month Follow-up|Lost to Follow-up|3
7972546|NCT02896400|12535466|FG015|3 Month Follow-up|Lost to Follow-up|2
7972547|NCT02896400|12535451|FG000|3 Month Follow-up|Death|0
7972548|NCT02896400|12535452|FG001|3 Month Follow-up|Death|0
7972549|NCT02896400|12535453|FG002|3 Month Follow-up|Death|0
7972550|NCT02896400|12535454|FG003|3 Month Follow-up|Death|0
7972551|NCT02896400|12535455|FG004|3 Month Follow-up|Death|0
7972552|NCT02896400|12535456|FG005|3 Month Follow-up|Death|0
7972553|NCT02896400|12535457|FG006|3 Month Follow-up|Death|0
7972554|NCT02896400|12535458|FG007|3 Month Follow-up|Death|0
7972555|NCT02896400|12535459|FG008|3 Month Follow-up|Death|0
7972556|NCT02896400|12535460|FG009|3 Month Follow-up|Death|0
7972557|NCT02896400|12535461|FG010|3 Month Follow-up|Death|0
7972558|NCT02896400|12535462|FG011|3 Month Follow-up|Death|0
7972559|NCT02896400|12535463|FG012|3 Month Follow-up|Death|0
7972560|NCT02896400|12535464|FG013|3 Month Follow-up|Death|1
7972561|NCT02896400|12535465|FG014|3 Month Follow-up|Death|1
7972562|NCT02896400|12535466|FG015|3 Month Follow-up|Death|0
7972563|NCT02896400|12535451|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1
7972564|NCT02896400|12535452|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0
7907542|NCT02020577|12422353|FG001|Overall Study|Progressive disease|38
7907543|NCT02020577|12422352|FG000|Overall Study|Other AE or clinical progression|0
7907544|NCT02020577|12422353|FG001|Overall Study|Other AE or clinical progression|15
7907545|NCT02020577|12422352|FG000|Overall Study|Withdrawal by Subject|0
7972565|NCT02896400|12535453|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1
7972566|NCT02896400|12535454|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1
7972567|NCT02896400|12535455|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0
7972568|NCT02896400|12535456|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1
7972569|NCT02896400|12535457|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3
7972570|NCT02896400|12535458|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2
7972571|NCT02896400|12535459|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1
7972572|NCT02896400|12535460|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1
7972573|NCT02896400|12535461|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0
7972574|NCT02896400|12535462|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0
7972575|NCT02896400|12535463|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1
7972576|NCT02896400|12535464|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0
7972577|NCT02896400|12535465|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3
7972578|NCT02896400|12535466|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1
7972579|NCT02896400|12535451|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
7972580|NCT02896400|12535452|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7907546|NCT02020577|12422353|FG001|Overall Study|Withdrawal by Subject|1
7907547|NCT02020577|12422352|FG000|Overall Study|Other than stated above|0
7972581|NCT02896400|12535453|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46
7972582|NCT02896400|12535454|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40
7972583|NCT02896400|12535455|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
7972584|NCT02896400|12535456|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7972585|NCT02896400|12535457|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7972586|NCT02896400|12535458|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47
7972587|NCT02896400|12535459|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44
7972588|NCT02896400|12535460|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
7972589|NCT02896400|12535461|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55
7972590|NCT02896400|12535462|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41
7972591|NCT02896400|12535463|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
7972592|NCT02896400|12535464|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7972593|NCT02896400|12535465|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
7972594|NCT02896400|12535466|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56
7972595|NCT02896569|12535494|FG000|Overall Study|Lost to Follow-up|2
7972596|NCT02896569|12535495|FG001|Overall Study|Lost to Follow-up|1
7972597|NCT02896569|12535494|FG000|Overall Study|Physician Decision|1
7972598|NCT02896569|12535495|FG001|Overall Study|Physician Decision|3
7972599|NCT02896569|12535494|FG000|Overall Study|Adverse Event|0
7972600|NCT02896569|12535495|FG001|Overall Study|Adverse Event|1
7972601|NCT02896569|12535494|FG000|Overall Study|Withdrawal by Subject|1
7972602|NCT02896569|12535495|FG001|Overall Study|Withdrawal by Subject|0
7972603|NCT02897115|12535516|FG000|Overall Study|Early termination of study by sponsor|11
7907548|NCT02020577|12422353|FG001|Overall Study|Other than stated above|1
7907549|NCT02020616|12422372|FG000|Overall Study|Adverse Event|0
7907550|NCT02020616|12422373|FG001|Overall Study|Adverse Event|0
7972604|NCT02897115|12535517|FG001|Overall Study|Early termination of study by sponsor|8
7972605|NCT02897349|12535545|FG000|Overall Study|Lost to Follow-up|2
7972606|NCT02897349|12535546|FG001|Overall Study|Lost to Follow-up|2
7972607|NCT02897349|12535545|FG000|Overall Study|Adverse Event|3
7972608|NCT02897349|12535546|FG001|Overall Study|Adverse Event|3
7972609|NCT02897349|12535545|FG000|Overall Study|Other than listed above|0
7972610|NCT02897349|12535546|FG001|Overall Study|Other than listed above|1
7972611|NCT02898116|12535565|FG000|Overall Study|Adverse Event|1
7972612|NCT02898116|12535565|FG000|Overall Study|Progressive disease|1
7972613|NCT02898454|12535572|FG000|Overall Study|Adverse Event|4
7972614|NCT02898454|12535573|FG001|Overall Study|Adverse Event|1
7972615|NCT02898454|12535574|FG002|Overall Study|Adverse Event|2
7972616|NCT02898454|12535572|FG000|Overall Study|Protocol Violation|1
7972617|NCT02898454|12535573|FG001|Overall Study|Protocol Violation|0
7972618|NCT02898454|12535574|FG002|Overall Study|Protocol Violation|1
7972619|NCT02898454|12535572|FG000|Overall Study|Lack of Efficacy|4
7972620|NCT02898454|12535573|FG001|Overall Study|Lack of Efficacy|1
7972621|NCT02898454|12535574|FG002|Overall Study|Lack of Efficacy|0
7972622|NCT02898454|12535572|FG000|Overall Study|Withdrawal by Subject|6
7972623|NCT02898454|12535573|FG001|Overall Study|Withdrawal by Subject|3
7972624|NCT02898454|12535574|FG002|Overall Study|Withdrawal by Subject|3
7972625|NCT02898454|12535572|FG000|Overall Study|Lost to Follow-up|1
7972626|NCT02898454|12535573|FG001|Overall Study|Lost to Follow-up|0
7972627|NCT02898454|12535574|FG002|Overall Study|Lost to Follow-up|0
7972628|NCT02898454|12535572|FG000|Overall Study|Did Not Met Eligibility Criteria|1
7972629|NCT02898454|12535573|FG001|Overall Study|Did Not Met Eligibility Criteria|0
7972630|NCT02898454|12535574|FG002|Overall Study|Did Not Met Eligibility Criteria|0
7972631|NCT02898597|12535589|FG000|Overall Study|Protocol Violation|4
7972632|NCT02898597|12535590|FG001|Overall Study|Protocol Violation|2
7972633|NCT02898597|12535589|FG000|Overall Study|Lost to Follow-up|0
7972634|NCT02898597|12535590|FG001|Overall Study|Lost to Follow-up|9
7972635|NCT02898597|12535589|FG000|Overall Study|Death|0
7972636|NCT02898597|12535590|FG001|Overall Study|Death|1
7972637|NCT02898662|12535598|FG000|Overall Study|Adverse Event|1
7972638|NCT02898662|12535599|FG001|Overall Study|Adverse Event|0
7972639|NCT02898662|12535598|FG000|Overall Study|Loss of asthma control|23
7972640|NCT02898662|12535599|FG001|Overall Study|Loss of asthma control|24
7972641|NCT02898662|12535598|FG000|Overall Study|Withdrawal by Subject|4
7972642|NCT02898662|12535599|FG001|Overall Study|Withdrawal by Subject|1
7972643|NCT02898662|12535598|FG000|Overall Study|Technical issue|0
7972644|NCT02898662|12535599|FG001|Overall Study|Technical issue|1
7972645|NCT02898662|12535598|FG000|Overall Study|Randomized in error|0
7972646|NCT02898662|12535599|FG001|Overall Study|Randomized in error|1
7972647|NCT02898662|12535598|FG000|Overall Study|Subject decision|1
7972648|NCT02898662|12535599|FG001|Overall Study|Subject decision|0
7972649|NCT02898662|12535598|FG000|Overall Study|Other|0
7972650|NCT02898662|12535599|FG001|Overall Study|Other|1
7972651|NCT02899156|12535625|FG000|Overall Study|Death|1
7972652|NCT02899156|12535626|FG001|Overall Study|Death|0
7972653|NCT02899156|12535625|FG000|Overall Study|Physician Decision|0
7972654|NCT02899156|12535626|FG001|Overall Study|Physician Decision|1
7972655|NCT02899195|12535632|FG000|Concurrent Durvalumab|Adverse Event|4
7972656|NCT02899195|12535632|FG000|Concurrent Durvalumab|Physician Decision|1
7972657|NCT02899195|12535632|FG000|Concurrent Durvalumab|Withdrawal by Subject|1
7972658|NCT02899195|12535632|FG000|Concurrent Durvalumab|Progressive Disease|5
7972659|NCT02899195|12535632|FG000|Maintenance Durvalumab|Adverse Event|1
7972660|NCT02899195|12535632|FG000|Maintenance Durvalumab|Physician Decision|1
7972661|NCT02899195|12535632|FG000|Maintenance Durvalumab|Withdrawal by Subject|1
7972662|NCT02899195|12535632|FG000|Maintenance Durvalumab|Progressive Disease|31
7972663|NCT02899338|12535638|FG000|Overall Study|Adverse Event|1
7972664|NCT02899338|12535639|FG001|Overall Study|Adverse Event|2
7972665|NCT02899338|12535638|FG000|Overall Study|Withdrawal by Subject|2
7972666|NCT02899338|12535639|FG001|Overall Study|Withdrawal by Subject|0
7972667|NCT02899377|12535647|FG000|Overall Study|Adverse Event|1
7972668|NCT02899377|12535648|FG001|Overall Study|Adverse Event|0
7972669|NCT02899962|12535684|FG000|Open-label Phase|Adverse Event|2
7972670|NCT02899962|12535685|FG001|Open-label Phase|Adverse Event|0
7972671|NCT02899962|12535686|FG002|Open-label Phase|Adverse Event|0
7972672|NCT02899962|12535684|FG000|Open-label Phase|Lost to Follow-up|9
7972673|NCT02899962|12535685|FG001|Open-label Phase|Lost to Follow-up|0
7972674|NCT02899962|12535686|FG002|Open-label Phase|Lost to Follow-up|0
7972675|NCT02899962|12535684|FG000|Open-label Phase|Other reasons|9
7972676|NCT02899962|12535685|FG001|Open-label Phase|Other reasons|0
7972677|NCT02899962|12535686|FG002|Open-label Phase|Other reasons|0
7972678|NCT02899962|12535684|FG000|Open-label Phase|Withdrawal by Subject|7
7972679|NCT02899962|12535685|FG001|Open-label Phase|Withdrawal by Subject|0
7972680|NCT02899962|12535686|FG002|Open-label Phase|Withdrawal by Subject|0
7972681|NCT02899962|12535684|FG000|Maintenance Phase|Adverse Event|0
7972682|NCT02899962|12535685|FG001|Maintenance Phase|Adverse Event|2
7972683|NCT02899962|12535686|FG002|Maintenance Phase|Adverse Event|1
7972684|NCT02899962|12535684|FG000|Maintenance Phase|Death|0
7972685|NCT02899962|12535685|FG001|Maintenance Phase|Death|0
7972686|NCT02899962|12535686|FG002|Maintenance Phase|Death|1
7972687|NCT02899962|12535684|FG000|Maintenance Phase|Lack of Efficacy|0
7972688|NCT02899962|12535685|FG001|Maintenance Phase|Lack of Efficacy|20
7972689|NCT02899962|12535686|FG002|Maintenance Phase|Lack of Efficacy|16
7972690|NCT02899962|12535684|FG000|Maintenance Phase|Lost to Follow-up|0
7972691|NCT02899962|12535685|FG001|Maintenance Phase|Lost to Follow-up|12
7972692|NCT02899962|12535686|FG002|Maintenance Phase|Lost to Follow-up|14
7972693|NCT02899962|12535684|FG000|Maintenance Phase|Other reasons|0
7972694|NCT02899962|12535685|FG001|Maintenance Phase|Other reasons|9
7972695|NCT02899962|12535686|FG002|Maintenance Phase|Other reasons|13
7972696|NCT02899962|12535684|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0
7972697|NCT02899962|12535685|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3
7972698|NCT02899962|12535686|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2
7972699|NCT02899962|12535684|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0
7972700|NCT02899962|12535685|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65
7972701|NCT02899962|12535686|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70
7972702|NCT02899962|12535684|FG000|Maintenance Phase|Withdrawal by Subject|0
7972703|NCT02899962|12535685|FG001|Maintenance Phase|Withdrawal by Subject|30
7972704|NCT02899962|12535686|FG002|Maintenance Phase|Withdrawal by Subject|36
7972705|NCT02899988|12535697|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2
7972706|NCT02899988|12535698|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1
7972707|NCT02899988|12535699|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
7972708|NCT02899988|12535700|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0
7972709|NCT02899988|12535701|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
7972710|NCT02899988|12535702|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
7972711|NCT02899988|12535703|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
7972712|NCT02899988|12535704|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
7972713|NCT02899988|12535705|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0
7972714|NCT02899988|12535706|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0
7972715|NCT02899988|12535707|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0
7972716|NCT02899988|12535697|FG000|Induction Period (16 Weeks)|Adverse Event|0
7972717|NCT02899988|12535698|FG001|Induction Period (16 Weeks)|Adverse Event|0
7972718|NCT02899988|12535699|FG002|Induction Period (16 Weeks)|Adverse Event|0
7972719|NCT02899988|12535700|FG003|Induction Period (16 Weeks)|Adverse Event|2
7972720|NCT02899988|12535701|FG004|Induction Period (16 Weeks)|Adverse Event|0
7972721|NCT02899988|12535702|FG005|Induction Period (16 Weeks)|Adverse Event|0
7972722|NCT02899988|12535703|FG006|Induction Period (16 Weeks)|Adverse Event|0
7972723|NCT02899988|12535704|FG007|Induction Period (16 Weeks)|Adverse Event|0
7972724|NCT02899988|12535705|FG008|Induction Period (16 Weeks)|Adverse Event|0
7972725|NCT02899988|12535706|FG009|Induction Period (16 Weeks)|Adverse Event|0
7972726|NCT02899988|12535707|FG010|Induction Period (16 Weeks)|Adverse Event|0
7972727|NCT02899988|12535697|FG000|Induction Period (16 Weeks)|Physician Decision|0
7972728|NCT02899988|12535698|FG001|Induction Period (16 Weeks)|Physician Decision|1
7972729|NCT02899988|12535699|FG002|Induction Period (16 Weeks)|Physician Decision|0
7972730|NCT02899988|12535700|FG003|Induction Period (16 Weeks)|Physician Decision|0
7972731|NCT02899988|12535701|FG004|Induction Period (16 Weeks)|Physician Decision|0
7972732|NCT02899988|12535702|FG005|Induction Period (16 Weeks)|Physician Decision|0
7972733|NCT02899988|12535703|FG006|Induction Period (16 Weeks)|Physician Decision|0
7972734|NCT02899988|12535704|FG007|Induction Period (16 Weeks)|Physician Decision|0
7972735|NCT02899988|12535705|FG008|Induction Period (16 Weeks)|Physician Decision|0
7972736|NCT02899988|12535706|FG009|Induction Period (16 Weeks)|Physician Decision|0
7972737|NCT02899988|12535707|FG010|Induction Period (16 Weeks)|Physician Decision|0
7972738|NCT02899988|12535697|FG000|Maintenance Period (88 Weeks)|Adverse Event|0
7972739|NCT02899988|12535698|FG001|Maintenance Period (88 Weeks)|Adverse Event|0
7972740|NCT02899988|12535699|FG002|Maintenance Period (88 Weeks)|Adverse Event|0
7972741|NCT02899988|12535700|FG003|Maintenance Period (88 Weeks)|Adverse Event|0
7972742|NCT02899988|12535701|FG004|Maintenance Period (88 Weeks)|Adverse Event|1
7972743|NCT02899988|12535702|FG005|Maintenance Period (88 Weeks)|Adverse Event|2
7972744|NCT02899988|12535703|FG006|Maintenance Period (88 Weeks)|Adverse Event|1
7972745|NCT02899988|12535704|FG007|Maintenance Period (88 Weeks)|Adverse Event|2
7972746|NCT02899988|12535705|FG008|Maintenance Period (88 Weeks)|Adverse Event|2
7972747|NCT02899988|12535706|FG009|Maintenance Period (88 Weeks)|Adverse Event|2
7972748|NCT02899988|12535707|FG010|Maintenance Period (88 Weeks)|Adverse Event|1
7972749|NCT02899988|12535697|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7972750|NCT02899988|12535698|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7972751|NCT02899988|12535699|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7972752|NCT02899988|12535700|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7972753|NCT02899988|12535701|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7972754|NCT02899988|12535702|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1
7972755|NCT02899988|12535703|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7972756|NCT02899988|12535704|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1
7972757|NCT02899988|12535705|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7972758|NCT02899988|12535706|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7972759|NCT02899988|12535707|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7972760|NCT02899988|12535697|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7972761|NCT02899988|12535698|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7972762|NCT02899988|12535699|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7972763|NCT02899988|12535700|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7972764|NCT02899988|12535701|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
7972765|NCT02899988|12535702|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7972766|NCT02899988|12535703|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3
7972767|NCT02899988|12535704|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
7972768|NCT02899988|12535705|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
7972769|NCT02899988|12535706|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7972770|NCT02899988|12535707|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
7972771|NCT02900092|12535739|FG000|Overall Study|Adverse Event|1
7972772|NCT02900170|12535743|FG000|Overall Study|Lost to Follow-up|8
7972773|NCT02900378|12535749|FG000|Randomization (Visit 2)|Adverse Event|14
7972774|NCT02900378|12535750|FG001|Randomization (Visit 2)|Adverse Event|11
7972775|NCT02900378|12535749|FG000|Randomization (Visit 2)|Death|1
7972776|NCT02900378|12535750|FG001|Randomization (Visit 2)|Death|4
7972777|NCT02900378|12535749|FG000|Randomization (Visit 2)|Lost to Follow-up|1
7972778|NCT02900378|12535750|FG001|Randomization (Visit 2)|Lost to Follow-up|0
7972779|NCT02900378|12535749|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1
7972780|NCT02900378|12535750|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1
7972781|NCT02900378|12535749|FG000|Randomization (Visit 2)|Protocol Deviation|1
7972782|NCT02900378|12535750|FG001|Randomization (Visit 2)|Protocol Deviation|7
7972783|NCT02900378|12535749|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5
7972784|NCT02900378|12535750|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3
7972785|NCT02900378|12535749|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0
7972786|NCT02900378|12535750|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2
7972787|NCT02901054|12535756|FG000|Overall Study|Physician Decision|1
7972788|NCT02901054|12535756|FG000|Overall Study|Withdrawal by Subject|3
7972789|NCT02901431|12535790|FG000|PK Part|Adverse Event|0
7972790|NCT02901431|12535791|FG001|PK Part|Adverse Event|1
7972791|NCT02901431|12535792|FG002|PK Part|Adverse Event|0
7972792|NCT02901431|12535793|FG003|PK Part|Adverse Event|0
7972793|NCT02901431|12535794|FG004|PK Part|Adverse Event|0
7972794|NCT02901431|12535795|FG005|PK Part|Adverse Event|0
7972795|NCT02901431|12535796|FG006|PK Part|Adverse Event|0
7972796|NCT02901431|12535797|FG007|PK Part|Adverse Event|0
7972797|NCT02901431|12535798|FG008|PK Part|Adverse Event|0
7972798|NCT02901431|12535799|FG009|PK Part|Adverse Event|0
7972799|NCT02901431|12535800|FG010|PK Part|Adverse Event|0
7717980|NCT00524043|12141668|FG001|Overall Study|Withdrawal by Subject|7
7717981|NCT00524043|12141669|FG002|Overall Study|Withdrawal by Subject|7
7717982|NCT00524043|12141667|FG000|Overall Study|Adverse Event|5
7717983|NCT00524043|12141668|FG001|Overall Study|Adverse Event|2
7717984|NCT00524043|12141669|FG002|Overall Study|Adverse Event|7
7972800|NCT02901431|12535801|FG011|PK Part|Adverse Event|0
7972801|NCT02901431|12535802|FG012|PK Part|Adverse Event|0
7972802|NCT02901431|12535790|FG000|PK Part|Lost to Follow-up|0
7972803|NCT02901431|12535791|FG001|PK Part|Lost to Follow-up|0
7972804|NCT02901431|12535792|FG002|PK Part|Lost to Follow-up|1
7972805|NCT02901431|12535793|FG003|PK Part|Lost to Follow-up|0
7972806|NCT02901431|12535794|FG004|PK Part|Lost to Follow-up|0
7972807|NCT02901431|12535795|FG005|PK Part|Lost to Follow-up|0
7972808|NCT02901431|12535796|FG006|PK Part|Lost to Follow-up|0
7972809|NCT02901431|12535797|FG007|PK Part|Lost to Follow-up|0
7972810|NCT02901431|12535798|FG008|PK Part|Lost to Follow-up|0
7972811|NCT02901431|12535799|FG009|PK Part|Lost to Follow-up|0
7972812|NCT02901431|12535800|FG010|PK Part|Lost to Follow-up|0
7972813|NCT02901431|12535801|FG011|PK Part|Lost to Follow-up|0
7972814|NCT02901431|12535802|FG012|PK Part|Lost to Follow-up|0
7972815|NCT02901431|12535790|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2
7972816|NCT02901431|12535791|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0
7972817|NCT02901431|12535792|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0
7972818|NCT02901431|12535793|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0
7972819|NCT02901431|12535794|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0
7972820|NCT02901431|12535795|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0
7972821|NCT02901431|12535796|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0
7972822|NCT02901431|12535797|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0
7972823|NCT02901431|12535798|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0
7972824|NCT02901431|12535799|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0
7972825|NCT02901431|12535800|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0
7972826|NCT02901431|12535801|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0
7972827|NCT02901431|12535802|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0
7972828|NCT02901431|12535790|FG000|PK Part|Pending dose confirmation|0
7972829|NCT02901431|12535791|FG001|PK Part|Pending dose confirmation|1
7972830|NCT02901431|12535792|FG002|PK Part|Pending dose confirmation|0
7972831|NCT02901431|12535793|FG003|PK Part|Pending dose confirmation|0
7972832|NCT02901431|12535794|FG004|PK Part|Pending dose confirmation|0
7972833|NCT02901431|12535795|FG005|PK Part|Pending dose confirmation|0
7972834|NCT02901431|12535796|FG006|PK Part|Pending dose confirmation|0
7972835|NCT02901431|12535797|FG007|PK Part|Pending dose confirmation|0
7972836|NCT02901431|12535798|FG008|PK Part|Pending dose confirmation|0
7972837|NCT02901431|12535799|FG009|PK Part|Pending dose confirmation|0
7972838|NCT02901431|12535800|FG010|PK Part|Pending dose confirmation|0
7972839|NCT02901431|12535801|FG011|PK Part|Pending dose confirmation|0
7972840|NCT02901431|12535802|FG012|PK Part|Pending dose confirmation|0
7972841|NCT02901431|12535790|FG000|PK Part|8 weeks of treatment ran out|2
7972842|NCT02901431|12535791|FG001|PK Part|8 weeks of treatment ran out|0
7972843|NCT02901431|12535792|FG002|PK Part|8 weeks of treatment ran out|0
7972844|NCT02901431|12535793|FG003|PK Part|8 weeks of treatment ran out|0
7972845|NCT02901431|12535794|FG004|PK Part|8 weeks of treatment ran out|0
7972846|NCT02901431|12535795|FG005|PK Part|8 weeks of treatment ran out|0
7972847|NCT02901431|12535796|FG006|PK Part|8 weeks of treatment ran out|0
7972848|NCT02901431|12535797|FG007|PK Part|8 weeks of treatment ran out|0
7972849|NCT02901431|12535798|FG008|PK Part|8 weeks of treatment ran out|0
7972850|NCT02901431|12535799|FG009|PK Part|8 weeks of treatment ran out|0
7972851|NCT02901431|12535800|FG010|PK Part|8 weeks of treatment ran out|0
7972852|NCT02901431|12535801|FG011|PK Part|8 weeks of treatment ran out|0
7972853|NCT02901431|12535802|FG012|PK Part|8 weeks of treatment ran out|0
7972854|NCT02901431|12535790|FG000|PK Part|Stopped treatment after 8 weeks|1
7972855|NCT02901431|12535791|FG001|PK Part|Stopped treatment after 8 weeks|0
7972856|NCT02901431|12535792|FG002|PK Part|Stopped treatment after 8 weeks|1
7972857|NCT02901431|12535793|FG003|PK Part|Stopped treatment after 8 weeks|0
7972858|NCT02901431|12535794|FG004|PK Part|Stopped treatment after 8 weeks|0
7972859|NCT02901431|12535795|FG005|PK Part|Stopped treatment after 8 weeks|0
7972860|NCT02901431|12535796|FG006|PK Part|Stopped treatment after 8 weeks|0
7972861|NCT02901431|12535797|FG007|PK Part|Stopped treatment after 8 weeks|0
7972862|NCT02901431|12535798|FG008|PK Part|Stopped treatment after 8 weeks|0
7972863|NCT02901431|12535799|FG009|PK Part|Stopped treatment after 8 weeks|0
7972864|NCT02901431|12535800|FG010|PK Part|Stopped treatment after 8 weeks|0
7972865|NCT02901431|12535801|FG011|PK Part|Stopped treatment after 8 weeks|0
7972866|NCT02901431|12535802|FG012|PK Part|Stopped treatment after 8 weeks|0
7972867|NCT02901431|12535790|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1
7972868|NCT02901431|12535791|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7972869|NCT02901431|12535792|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4
7972870|NCT02901431|12535793|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7972871|NCT02901431|12535794|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7972872|NCT02901431|12535795|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7972873|NCT02901431|12535796|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7972874|NCT02901431|12535797|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7972875|NCT02901431|12535798|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7972876|NCT02901431|12535799|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7972877|NCT02901431|12535800|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7972878|NCT02901431|12535801|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7972879|NCT02901431|12535802|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7972880|NCT02901431|12535790|FG000|PK Part|Discontinued per Sponsor|0
7972881|NCT02901431|12535791|FG001|PK Part|Discontinued per Sponsor|3
7972882|NCT02901431|12535792|FG002|PK Part|Discontinued per Sponsor|0
7972883|NCT02901431|12535793|FG003|PK Part|Discontinued per Sponsor|0
7972884|NCT02901431|12535794|FG004|PK Part|Discontinued per Sponsor|0
7972885|NCT02901431|12535795|FG005|PK Part|Discontinued per Sponsor|0
7972886|NCT02901431|12535796|FG006|PK Part|Discontinued per Sponsor|0
7972887|NCT02901431|12535797|FG007|PK Part|Discontinued per Sponsor|0
7972888|NCT02901431|12535798|FG008|PK Part|Discontinued per Sponsor|0
7972889|NCT02901431|12535799|FG009|PK Part|Discontinued per Sponsor|0
7972890|NCT02901431|12535800|FG010|PK Part|Discontinued per Sponsor|0
7972891|NCT02901431|12535801|FG011|PK Part|Discontinued per Sponsor|0
7972892|NCT02901431|12535802|FG012|PK Part|Discontinued per Sponsor|0
7972893|NCT02901431|12535790|FG000|PK Part|Withdrawal by Subject|1
7972894|NCT02901431|12535791|FG001|PK Part|Withdrawal by Subject|1
7972895|NCT02901431|12535792|FG002|PK Part|Withdrawal by Subject|3
7972896|NCT02901431|12535793|FG003|PK Part|Withdrawal by Subject|0
7972897|NCT02901431|12535794|FG004|PK Part|Withdrawal by Subject|0
7972898|NCT02901431|12535795|FG005|PK Part|Withdrawal by Subject|0
7972899|NCT02901431|12535796|FG006|PK Part|Withdrawal by Subject|0
7972900|NCT02901431|12535797|FG007|PK Part|Withdrawal by Subject|0
7972901|NCT02901431|12535798|FG008|PK Part|Withdrawal by Subject|0
7972902|NCT02901431|12535799|FG009|PK Part|Withdrawal by Subject|0
7972903|NCT02901431|12535800|FG010|PK Part|Withdrawal by Subject|0
7972904|NCT02901431|12535801|FG011|PK Part|Withdrawal by Subject|0
7972905|NCT02901431|12535802|FG012|PK Part|Withdrawal by Subject|0
7972906|NCT02901431|12535790|FG000|Main Treatment Part|Adverse Event|0
7972907|NCT02901431|12535791|FG001|Main Treatment Part|Adverse Event|0
7972908|NCT02901431|12535792|FG002|Main Treatment Part|Adverse Event|0
7972909|NCT02901431|12535793|FG003|Main Treatment Part|Adverse Event|3
7972910|NCT02901431|12535794|FG004|Main Treatment Part|Adverse Event|3
7972911|NCT02901431|12535795|FG005|Main Treatment Part|Adverse Event|4
7972912|NCT02901431|12535796|FG006|Main Treatment Part|Adverse Event|1
7972913|NCT02901431|12535797|FG007|Main Treatment Part|Adverse Event|0
7972914|NCT02901431|12535798|FG008|Main Treatment Part|Adverse Event|0
7972915|NCT02901431|12535799|FG009|Main Treatment Part|Adverse Event|0
7972916|NCT02901431|12535800|FG010|Main Treatment Part|Adverse Event|0
7972917|NCT02901431|12535801|FG011|Main Treatment Part|Adverse Event|0
7972918|NCT02901431|12535802|FG012|Main Treatment Part|Adverse Event|0
7972919|NCT02901431|12535790|FG000|Main Treatment Part|Lack of Efficacy|0
7972920|NCT02901431|12535791|FG001|Main Treatment Part|Lack of Efficacy|0
7972921|NCT02901431|12535792|FG002|Main Treatment Part|Lack of Efficacy|0
7972922|NCT02901431|12535793|FG003|Main Treatment Part|Lack of Efficacy|1
7972923|NCT02901431|12535794|FG004|Main Treatment Part|Lack of Efficacy|0
7972924|NCT02901431|12535795|FG005|Main Treatment Part|Lack of Efficacy|0
7972925|NCT02901431|12535796|FG006|Main Treatment Part|Lack of Efficacy|0
7972926|NCT02901431|12535797|FG007|Main Treatment Part|Lack of Efficacy|0
7972927|NCT02901431|12535798|FG008|Main Treatment Part|Lack of Efficacy|0
7972928|NCT02901431|12535799|FG009|Main Treatment Part|Lack of Efficacy|0
7972929|NCT02901431|12535800|FG010|Main Treatment Part|Lack of Efficacy|0
7972930|NCT02901431|12535801|FG011|Main Treatment Part|Lack of Efficacy|0
7972931|NCT02901431|12535802|FG012|Main Treatment Part|Lack of Efficacy|0
7972932|NCT02901431|12535790|FG000|Main Treatment Part|Lost to Follow-up|0
7972933|NCT02901431|12535791|FG001|Main Treatment Part|Lost to Follow-up|0
7972934|NCT02901431|12535792|FG002|Main Treatment Part|Lost to Follow-up|0
7972935|NCT02901431|12535793|FG003|Main Treatment Part|Lost to Follow-up|3
7972936|NCT02901431|12535794|FG004|Main Treatment Part|Lost to Follow-up|1
7972937|NCT02901431|12535795|FG005|Main Treatment Part|Lost to Follow-up|2
7972938|NCT02901431|12535796|FG006|Main Treatment Part|Lost to Follow-up|3
7972939|NCT02901431|12535797|FG007|Main Treatment Part|Lost to Follow-up|0
7972940|NCT02901431|12535798|FG008|Main Treatment Part|Lost to Follow-up|0
7972941|NCT02901431|12535799|FG009|Main Treatment Part|Lost to Follow-up|0
7972942|NCT02901431|12535800|FG010|Main Treatment Part|Lost to Follow-up|0
7972943|NCT02901431|12535801|FG011|Main Treatment Part|Lost to Follow-up|0
7972944|NCT02901431|12535802|FG012|Main Treatment Part|Lost to Follow-up|0
7972945|NCT02901431|12535790|FG000|Main Treatment Part|Withdrawal by Caregiver|0
7972946|NCT02901431|12535791|FG001|Main Treatment Part|Withdrawal by Caregiver|0
7972947|NCT02901431|12535792|FG002|Main Treatment Part|Withdrawal by Caregiver|0
7972948|NCT02901431|12535793|FG003|Main Treatment Part|Withdrawal by Caregiver|0
7972949|NCT02901431|12535794|FG004|Main Treatment Part|Withdrawal by Caregiver|0
7972950|NCT02901431|12535795|FG005|Main Treatment Part|Withdrawal by Caregiver|1
7972951|NCT02901431|12535796|FG006|Main Treatment Part|Withdrawal by Caregiver|0
7972952|NCT02901431|12535797|FG007|Main Treatment Part|Withdrawal by Caregiver|0
7972953|NCT02901431|12535798|FG008|Main Treatment Part|Withdrawal by Caregiver|0
7972954|NCT02901431|12535799|FG009|Main Treatment Part|Withdrawal by Caregiver|0
7972955|NCT02901431|12535800|FG010|Main Treatment Part|Withdrawal by Caregiver|0
7972956|NCT02901431|12535801|FG011|Main Treatment Part|Withdrawal by Caregiver|0
7972957|NCT02901431|12535802|FG012|Main Treatment Part|Withdrawal by Caregiver|0
7972958|NCT02901431|12535790|FG000|Main Treatment Part|Physician Decision|0
7972959|NCT02901431|12535791|FG001|Main Treatment Part|Physician Decision|0
7972960|NCT02901431|12535792|FG002|Main Treatment Part|Physician Decision|0
7972961|NCT02901431|12535793|FG003|Main Treatment Part|Physician Decision|1
7972962|NCT02901431|12535794|FG004|Main Treatment Part|Physician Decision|0
7972963|NCT02901431|12535795|FG005|Main Treatment Part|Physician Decision|0
7972964|NCT02901431|12535796|FG006|Main Treatment Part|Physician Decision|1
7972965|NCT02901431|12535797|FG007|Main Treatment Part|Physician Decision|0
7972966|NCT02901431|12535798|FG008|Main Treatment Part|Physician Decision|0
7972967|NCT02901431|12535799|FG009|Main Treatment Part|Physician Decision|0
7972968|NCT02901431|12535800|FG010|Main Treatment Part|Physician Decision|0
7972969|NCT02901431|12535801|FG011|Main Treatment Part|Physician Decision|0
7972970|NCT02901431|12535802|FG012|Main Treatment Part|Physician Decision|0
7972971|NCT02901431|12535790|FG000|Main Treatment Part|Withdrawal by Subject|0
7972972|NCT02901431|12535791|FG001|Main Treatment Part|Withdrawal by Subject|0
7972973|NCT02901431|12535792|FG002|Main Treatment Part|Withdrawal by Subject|0
7972974|NCT02901431|12535793|FG003|Main Treatment Part|Withdrawal by Subject|18
7972975|NCT02901431|12535794|FG004|Main Treatment Part|Withdrawal by Subject|3
7972976|NCT02901431|12535795|FG005|Main Treatment Part|Withdrawal by Subject|5
7972977|NCT02901431|12535796|FG006|Main Treatment Part|Withdrawal by Subject|6
7972978|NCT02901431|12535797|FG007|Main Treatment Part|Withdrawal by Subject|0
7972979|NCT02901431|12535798|FG008|Main Treatment Part|Withdrawal by Subject|0
7972980|NCT02901431|12535799|FG009|Main Treatment Part|Withdrawal by Subject|0
7972981|NCT02901431|12535800|FG010|Main Treatment Part|Withdrawal by Subject|0
7972982|NCT02901431|12535801|FG011|Main Treatment Part|Withdrawal by Subject|0
7972983|NCT02901431|12535802|FG012|Main Treatment Part|Withdrawal by Subject|0
7972984|NCT02901431|12535790|FG000|Open Label Part|Adverse Event|0
7972985|NCT02901431|12535791|FG001|Open Label Part|Adverse Event|0
7972986|NCT02901431|12535792|FG002|Open Label Part|Adverse Event|0
7972987|NCT02901431|12535793|FG003|Open Label Part|Adverse Event|0
7972988|NCT02901431|12535794|FG004|Open Label Part|Adverse Event|0
7972989|NCT02901431|12535795|FG005|Open Label Part|Adverse Event|0
7972990|NCT02901431|12535796|FG006|Open Label Part|Adverse Event|0
7972991|NCT02901431|12535797|FG007|Open Label Part|Adverse Event|0
7972992|NCT02901431|12535798|FG008|Open Label Part|Adverse Event|4
7972993|NCT02901431|12535799|FG009|Open Label Part|Adverse Event|4
7972994|NCT02901431|12535800|FG010|Open Label Part|Adverse Event|0
7972995|NCT02901431|12535801|FG011|Open Label Part|Adverse Event|4
7972996|NCT02901431|12535802|FG012|Open Label Part|Adverse Event|1
7972997|NCT02901431|12535790|FG000|Open Label Part|Lost to Follow-up|0
7972998|NCT02901431|12535791|FG001|Open Label Part|Lost to Follow-up|0
7972999|NCT02901431|12535792|FG002|Open Label Part|Lost to Follow-up|0
7973000|NCT02901431|12535793|FG003|Open Label Part|Lost to Follow-up|0
7973001|NCT02901431|12535794|FG004|Open Label Part|Lost to Follow-up|0
7973002|NCT02901431|12535795|FG005|Open Label Part|Lost to Follow-up|0
7973003|NCT02901431|12535796|FG006|Open Label Part|Lost to Follow-up|0
7973004|NCT02901431|12535797|FG007|Open Label Part|Lost to Follow-up|0
7973005|NCT02901431|12535798|FG008|Open Label Part|Lost to Follow-up|2
7973006|NCT02901431|12535799|FG009|Open Label Part|Lost to Follow-up|2
7973007|NCT02901431|12535800|FG010|Open Label Part|Lost to Follow-up|1
7973008|NCT02901431|12535801|FG011|Open Label Part|Lost to Follow-up|1
7973009|NCT02901431|12535802|FG012|Open Label Part|Lost to Follow-up|1
7973010|NCT02901431|12535790|FG000|Open Label Part|Physician Decision|0
7973011|NCT02901431|12535791|FG001|Open Label Part|Physician Decision|0
7973012|NCT02901431|12535792|FG002|Open Label Part|Physician Decision|0
7973013|NCT02901431|12535793|FG003|Open Label Part|Physician Decision|0
7973014|NCT02901431|12535794|FG004|Open Label Part|Physician Decision|0
7973015|NCT02901431|12535795|FG005|Open Label Part|Physician Decision|0
7973016|NCT02901431|12535796|FG006|Open Label Part|Physician Decision|0
7973017|NCT02901431|12535797|FG007|Open Label Part|Physician Decision|0
7973018|NCT02901431|12535798|FG008|Open Label Part|Physician Decision|1
7973019|NCT02901431|12535799|FG009|Open Label Part|Physician Decision|1
7973020|NCT02901431|12535800|FG010|Open Label Part|Physician Decision|0
7973021|NCT02901431|12535801|FG011|Open Label Part|Physician Decision|0
7973022|NCT02901431|12535802|FG012|Open Label Part|Physician Decision|0
7973023|NCT02901431|12535790|FG000|Open Label Part|Study Terminated By Sponsor|0
7973024|NCT02901431|12535791|FG001|Open Label Part|Study Terminated By Sponsor|0
7973025|NCT02901431|12535792|FG002|Open Label Part|Study Terminated By Sponsor|0
7973026|NCT02901431|12535793|FG003|Open Label Part|Study Terminated By Sponsor|0
7973027|NCT02901431|12535794|FG004|Open Label Part|Study Terminated By Sponsor|0
7973028|NCT02901431|12535795|FG005|Open Label Part|Study Terminated By Sponsor|0
7973029|NCT02901431|12535796|FG006|Open Label Part|Study Terminated By Sponsor|0
7973030|NCT02901431|12535797|FG007|Open Label Part|Study Terminated By Sponsor|0
7973031|NCT02901431|12535798|FG008|Open Label Part|Study Terminated By Sponsor|35
7973032|NCT02901431|12535799|FG009|Open Label Part|Study Terminated By Sponsor|12
7973033|NCT02901431|12535800|FG010|Open Label Part|Study Terminated By Sponsor|21
7973034|NCT02901431|12535801|FG011|Open Label Part|Study Terminated By Sponsor|31
7973035|NCT02901431|12535802|FG012|Open Label Part|Study Terminated By Sponsor|0
7973036|NCT02901431|12535790|FG000|Open Label Part|Withdrawal by Subject|0
7973037|NCT02901431|12535791|FG001|Open Label Part|Withdrawal by Subject|0
7973038|NCT02901431|12535792|FG002|Open Label Part|Withdrawal by Subject|0
7973039|NCT02901431|12535793|FG003|Open Label Part|Withdrawal by Subject|0
7973040|NCT02901431|12535794|FG004|Open Label Part|Withdrawal by Subject|0
7973041|NCT02901431|12535795|FG005|Open Label Part|Withdrawal by Subject|0
7973042|NCT02901431|12535796|FG006|Open Label Part|Withdrawal by Subject|0
7973043|NCT02901431|12535797|FG007|Open Label Part|Withdrawal by Subject|0
7973044|NCT02901431|12535798|FG008|Open Label Part|Withdrawal by Subject|6
7973045|NCT02901431|12535799|FG009|Open Label Part|Withdrawal by Subject|5
7973046|NCT02901431|12535800|FG010|Open Label Part|Withdrawal by Subject|7
7973047|NCT02901431|12535801|FG011|Open Label Part|Withdrawal by Subject|3
7973048|NCT02901431|12535802|FG012|Open Label Part|Withdrawal by Subject|1
7973049|NCT02902809|12535886|FG000|Overall Study|Discontinuation of asthma program|28
7973050|NCT02902965|12535898|FG000|Overall Study|Withdrawal by Subject|10
7973051|NCT02903030|12535905|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
7973052|NCT02903030|12535906|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1
7973053|NCT02903238|12535924|FG000|Overall Study|Lost to Follow-up|4
7973054|NCT02903368|12535931|FG000|Overall Study|Not sprcified|4
7973055|NCT02903368|12535932|FG001|Overall Study|Not sprcified|0
7973056|NCT02903420|12535960|FG000|Overall Study|Death|3
7973057|NCT02903511|12535975|FG000|Overall Study|Withdrawal by Subject|1
7973058|NCT02903511|12535976|FG001|Overall Study|Withdrawal by Subject|0
7973059|NCT02903511|12535975|FG000|Overall Study|Lost to Follow-up|3
7973060|NCT02903511|12535976|FG001|Overall Study|Lost to Follow-up|2
7973061|NCT02903966|12535997|FG000|Part A (Day 1 to 43)|Adverse Event|1
7973062|NCT02903966|12535998|FG001|Part A (Day 1 to 43)|Adverse Event|0
7973063|NCT02903966|12535997|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0
7973064|NCT02903966|12535998|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1
7973065|NCT02903966|12535997|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0
7973066|NCT02903966|12535998|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1
7973067|NCT02904096|12536021|FG000|Overall Study|Adverse Event|1
7973068|NCT02904096|12536022|FG001|Overall Study|Adverse Event|0
7973069|NCT02904096|12536021|FG000|Overall Study|Withdrawal by Subject|4
7973070|NCT02904096|12536022|FG001|Overall Study|Withdrawal by Subject|3
7973071|NCT02904096|12536021|FG000|Overall Study|Lost to Follow-up|10
7973072|NCT02904096|12536022|FG001|Overall Study|Lost to Follow-up|17
7973073|NCT02904096|12536021|FG000|Overall Study|Non-compliant|3
7973074|NCT02904096|12536022|FG001|Overall Study|Non-compliant|1
7973075|NCT02904096|12536021|FG000|Overall Study|Sponsor instructed|1
7973076|NCT02904096|12536022|FG001|Overall Study|Sponsor instructed|0
7973077|NCT02904200|12536028|FG000|Overall Study|Withdrawal by Subject|1
7973078|NCT02904200|12536029|FG001|Overall Study|Withdrawal by Subject|0
7973079|NCT02904265|12536066|FG000|Overall Study|Physician Decision|1
7973080|NCT02904265|12536067|FG001|Overall Study|Physician Decision|2
7973081|NCT02904512|12536075|FG000|Overall Study|Withdrawal by Subject|1
7973082|NCT02904512|12536076|FG001|Overall Study|Withdrawal by Subject|0
7973083|NCT02904512|12536075|FG000|Overall Study|Transferred to ICU|1
7973084|NCT02904512|12536076|FG001|Overall Study|Transferred to ICU|0
7973085|NCT02904512|12536075|FG000|Overall Study|Minor Bleeding at site of device insertion|1
7973086|NCT02904512|12536076|FG001|Overall Study|Minor Bleeding at site of device insertion|0
7973087|NCT02904902|12536082|FG000|Overall Study|Withdrawal by Subject|1
7973088|NCT02905149|12536097|FG000|Overall Study|Lost to Follow-up|2
7973089|NCT02905149|12536098|FG001|Overall Study|Lost to Follow-up|0
7973090|NCT02905266|12536106|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1
7973091|NCT02905266|12536107|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0
7973092|NCT02905266|12536106|FG000|Treatment Phase Part 1|Disease Progression|6
7973093|NCT02905266|12536107|FG001|Treatment Phase Part 1|Disease Progression|7
7973094|NCT02905266|12536106|FG000|Treatment Phase Part 1|Study Drug Toxicity|22
7973095|NCT02905266|12536107|FG001|Treatment Phase Part 1|Study Drug Toxicity|16
7973096|NCT02905266|12536106|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1
7973097|NCT02905266|12536107|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0
7973098|NCT02905266|12536106|FG000|Transition From Part 1 to Part 2|Disease progression|2
7973099|NCT02905266|12536107|FG001|Transition From Part 1 to Part 2|Disease progression|1
7973100|NCT02905266|12536106|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0
7973101|NCT02905266|12536107|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4
7973102|NCT02905266|12536106|FG000|Transition From Part 1 to Part 2|Death|0
7973103|NCT02905266|12536107|FG001|Transition From Part 1 to Part 2|Death|1
7973104|NCT02905266|12536106|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0
7973105|NCT02905266|12536107|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1
7973106|NCT02905266|12536106|FG000|Transition From Part 1 to Part 2|Adverse Event|1
7973107|NCT02905266|12536107|FG001|Transition From Part 1 to Part 2|Adverse Event|1
7973108|NCT02905266|12536106|FG000|Maintenance Phase Part 2|Disease Progression|9
7973109|NCT02905266|12536107|FG001|Maintenance Phase Part 2|Disease Progression|2
7973110|NCT02905266|12536106|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3
7973111|NCT02905266|12536107|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4
7973112|NCT02905266|12536106|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0
7973113|NCT02905266|12536107|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2
7973114|NCT02905331|12536115|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
7973115|NCT02905331|12536116|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
7973116|NCT02905331|12536117|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
7973117|NCT02905331|12536115|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
7973118|NCT02905331|12536116|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
7973119|NCT02905331|12536117|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
7973120|NCT02905331|12536115|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
7973121|NCT02905331|12536116|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
7973122|NCT02905331|12536117|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
7973123|NCT02905331|12536115|FG000|Active Treatment and Follow up (wk16-40)|Other|0
7973124|NCT02905331|12536116|FG001|Active Treatment and Follow up (wk16-40)|Other|6
7973125|NCT02905331|12536117|FG002|Active Treatment and Follow up (wk16-40)|Other|0
7973126|NCT02905331|12536115|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
7973127|NCT02905331|12536116|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
7973128|NCT02905331|12536117|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
7973129|NCT02905435|12536125|FG000|Overall Study|Death|2
7973130|NCT02905435|12536125|FG000|Overall Study|Physician Decision|1
7973131|NCT02905435|12536125|FG000|Overall Study|Lost to Follow-up|4
7973132|NCT02905825|12536130|FG000|Overall Study|Protocol Violation|11
7973133|NCT02905825|12536130|FG000|Overall Study|Device Malfunction|1
7973134|NCT02906358|12536140|FG000|Overall Study|Withdrawal by Subject|10
7973135|NCT02906358|12536141|FG001|Overall Study|Withdrawal by Subject|7
7973136|NCT02906358|12536140|FG000|Overall Study|Lost to Follow-up|12
7973137|NCT02906358|12536141|FG001|Overall Study|Lost to Follow-up|15
7973138|NCT02906579|12536158|FG000|Overall Study|Adverse Event|1
7973139|NCT02906579|12536158|FG000|Overall Study|Physician Decision|1
7973140|NCT02906644|12536180|FG000|First 2 Weeks|Withdrawal by Subject|0
7973141|NCT02906644|12536181|FG001|First 2 Weeks|Withdrawal by Subject|2
7973142|NCT02906644|12536180|FG000|First 2 Weeks|Physician Decision|1
7973143|NCT02906644|12536181|FG001|First 2 Weeks|Physician Decision|1
7973144|NCT02906644|12536180|FG000|Weeks 3 to 14|Withdrawal by Subject|13
7973145|NCT02906644|12536181|FG001|Weeks 3 to 14|Withdrawal by Subject|7
7973146|NCT02906644|12536180|FG000|Weeks 3 to 14|Lost to Follow-up|3
7973147|NCT02906644|12536181|FG001|Weeks 3 to 14|Lost to Follow-up|4
7973148|NCT02906670|12536198|FG000|Cohort 1, QW|Radiological Progression|1
7973149|NCT02906670|12536199|FG001|Cohort 1, QW|Radiological Progression|0
7973150|NCT02906670|12536200|FG002|Cohort 1, QW|Radiological Progression|0
7973151|NCT02906670|12536201|FG003|Cohort 1, QW|Radiological Progression|0
7973152|NCT02906670|12536202|FG004|Cohort 1, QW|Radiological Progression|0
7973153|NCT02906670|12536203|FG005|Cohort 1, QW|Radiological Progression|0
7973154|NCT02906670|12536204|FG006|Cohort 1, QW|Radiological Progression|0
7973155|NCT02906670|12536205|FG007|Cohort 1, QW|Radiological Progression|0
7973156|NCT02906670|12536206|FG008|Cohort 1, QW|Radiological Progression|0
7973157|NCT02906670|12536207|FG009|Cohort 1, QW|Radiological Progression|0
7973158|NCT02906670|12536198|FG000|Cohort 2, QW|Radiological Progression|0
7973159|NCT02906670|12536199|FG001|Cohort 2, QW|Radiological Progression|1
7973160|NCT02906670|12536200|FG002|Cohort 2, QW|Radiological Progression|0
7973161|NCT02906670|12536201|FG003|Cohort 2, QW|Radiological Progression|0
7973162|NCT02906670|12536202|FG004|Cohort 2, QW|Radiological Progression|0
7973163|NCT02906670|12536203|FG005|Cohort 2, QW|Radiological Progression|0
7973164|NCT02906670|12536204|FG006|Cohort 2, QW|Radiological Progression|0
7973165|NCT02906670|12536205|FG007|Cohort 2, QW|Radiological Progression|0
7973166|NCT02906670|12536206|FG008|Cohort 2, QW|Radiological Progression|0
7973167|NCT02906670|12536207|FG009|Cohort 2, QW|Radiological Progression|0
7973168|NCT02906670|12536198|FG000|Cohort 3, QW|Radiological Progression|0
7973169|NCT02906670|12536199|FG001|Cohort 3, QW|Radiological Progression|0
7973170|NCT02906670|12536200|FG002|Cohort 3, QW|Radiological Progression|2
7973171|NCT02906670|12536201|FG003|Cohort 3, QW|Radiological Progression|0
7973172|NCT02906670|12536202|FG004|Cohort 3, QW|Radiological Progression|0
7973173|NCT02906670|12536203|FG005|Cohort 3, QW|Radiological Progression|0
7973174|NCT02906670|12536204|FG006|Cohort 3, QW|Radiological Progression|0
7973175|NCT02906670|12536205|FG007|Cohort 3, QW|Radiological Progression|0
7973176|NCT02906670|12536206|FG008|Cohort 3, QW|Radiological Progression|0
7973177|NCT02906670|12536207|FG009|Cohort 3, QW|Radiological Progression|0
7973178|NCT02906670|12536198|FG000|Cohort 3, QW|Lack of Clinical Benefit|0
7973179|NCT02906670|12536199|FG001|Cohort 3, QW|Lack of Clinical Benefit|0
7973180|NCT02906670|12536200|FG002|Cohort 3, QW|Lack of Clinical Benefit|2
7973181|NCT02906670|12536201|FG003|Cohort 3, QW|Lack of Clinical Benefit|0
7973182|NCT02906670|12536202|FG004|Cohort 3, QW|Lack of Clinical Benefit|0
7973183|NCT02906670|12536203|FG005|Cohort 3, QW|Lack of Clinical Benefit|0
7973184|NCT02906670|12536204|FG006|Cohort 3, QW|Lack of Clinical Benefit|0
7973185|NCT02906670|12536205|FG007|Cohort 3, QW|Lack of Clinical Benefit|0
7973186|NCT02906670|12536206|FG008|Cohort 3, QW|Lack of Clinical Benefit|0
7973187|NCT02906670|12536207|FG009|Cohort 3, QW|Lack of Clinical Benefit|0
7973188|NCT02906670|12536198|FG000|Cohort 4, Q2W|Radiological Progression|0
7973189|NCT02906670|12536199|FG001|Cohort 4, Q2W|Radiological Progression|0
7973190|NCT02906670|12536200|FG002|Cohort 4, Q2W|Radiological Progression|0
7973191|NCT02906670|12536201|FG003|Cohort 4, Q2W|Radiological Progression|0
7973192|NCT02906670|12536202|FG004|Cohort 4, Q2W|Radiological Progression|0
7973193|NCT02906670|12536203|FG005|Cohort 4, Q2W|Radiological Progression|1
7973194|NCT02906670|12536204|FG006|Cohort 4, Q2W|Radiological Progression|0
7973195|NCT02906670|12536205|FG007|Cohort 4, Q2W|Radiological Progression|0
7973196|NCT02906670|12536206|FG008|Cohort 4, Q2W|Radiological Progression|0
7973197|NCT02906670|12536207|FG009|Cohort 4, Q2W|Radiological Progression|0
7973198|NCT02906670|12536198|FG000|Cohort 4, Q2W|Clinical Progression|0
7973199|NCT02906670|12536199|FG001|Cohort 4, Q2W|Clinical Progression|0
7973200|NCT02906670|12536200|FG002|Cohort 4, Q2W|Clinical Progression|0
7973201|NCT02906670|12536201|FG003|Cohort 4, Q2W|Clinical Progression|0
7973202|NCT02906670|12536202|FG004|Cohort 4, Q2W|Clinical Progression|0
7973203|NCT02906670|12536203|FG005|Cohort 4, Q2W|Clinical Progression|2
7973204|NCT02906670|12536204|FG006|Cohort 4, Q2W|Clinical Progression|0
7973205|NCT02906670|12536205|FG007|Cohort 4, Q2W|Clinical Progression|0
7973206|NCT02906670|12536206|FG008|Cohort 4, Q2W|Clinical Progression|0
7973207|NCT02906670|12536207|FG009|Cohort 4, Q2W|Clinical Progression|0
7973208|NCT02906670|12536198|FG000|Cohort 5, Q2W|Radiological Progression|0
7973209|NCT02906670|12536199|FG001|Cohort 5, Q2W|Radiological Progression|0
7973210|NCT02906670|12536200|FG002|Cohort 5, Q2W|Radiological Progression|0
7973211|NCT02906670|12536201|FG003|Cohort 5, Q2W|Radiological Progression|0
7973212|NCT02906670|12536202|FG004|Cohort 5, Q2W|Radiological Progression|0
7973213|NCT02906670|12536203|FG005|Cohort 5, Q2W|Radiological Progression|0
7973214|NCT02906670|12536204|FG006|Cohort 5, Q2W|Radiological Progression|4
7973215|NCT02906670|12536205|FG007|Cohort 5, Q2W|Radiological Progression|0
7973216|NCT02906670|12536206|FG008|Cohort 5, Q2W|Radiological Progression|0
7973217|NCT02906670|12536207|FG009|Cohort 5, Q2W|Radiological Progression|0
7973218|NCT02906670|12536198|FG000|Cohort 5, Q2W|Clinical Progression|0
7973219|NCT02906670|12536199|FG001|Cohort 5, Q2W|Clinical Progression|0
7973220|NCT02906670|12536200|FG002|Cohort 5, Q2W|Clinical Progression|0
7973221|NCT02906670|12536201|FG003|Cohort 5, Q2W|Clinical Progression|0
7973222|NCT02906670|12536202|FG004|Cohort 5, Q2W|Clinical Progression|0
7973223|NCT02906670|12536203|FG005|Cohort 5, Q2W|Clinical Progression|0
7973224|NCT02906670|12536204|FG006|Cohort 5, Q2W|Clinical Progression|1
7973225|NCT02906670|12536205|FG007|Cohort 5, Q2W|Clinical Progression|0
7973226|NCT02906670|12536206|FG008|Cohort 5, Q2W|Clinical Progression|0
7973227|NCT02906670|12536207|FG009|Cohort 5, Q2W|Clinical Progression|0
7973228|NCT02906670|12536198|FG000|Cohort 5, Q2W|Adverse Event|0
7973229|NCT02906670|12536199|FG001|Cohort 5, Q2W|Adverse Event|0
7973230|NCT02906670|12536200|FG002|Cohort 5, Q2W|Adverse Event|0
7973231|NCT02906670|12536201|FG003|Cohort 5, Q2W|Adverse Event|0
7973232|NCT02906670|12536202|FG004|Cohort 5, Q2W|Adverse Event|0
7973233|NCT02906670|12536203|FG005|Cohort 5, Q2W|Adverse Event|0
7973234|NCT02906670|12536204|FG006|Cohort 5, Q2W|Adverse Event|1
7973235|NCT02906670|12536205|FG007|Cohort 5, Q2W|Adverse Event|0
7973236|NCT02906670|12536206|FG008|Cohort 5, Q2W|Adverse Event|0
7973237|NCT02906670|12536207|FG009|Cohort 5, Q2W|Adverse Event|0
7973238|NCT02906670|12536198|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0
7973239|NCT02906670|12536199|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0
7973240|NCT02906670|12536200|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0
7973241|NCT02906670|12536201|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0
7973242|NCT02906670|12536202|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0
7973243|NCT02906670|12536203|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0
7973244|NCT02906670|12536204|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1
7973245|NCT02906670|12536205|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0
7973246|NCT02906670|12536206|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0
7973247|NCT02906670|12536207|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0
7973248|NCT02906670|12536198|FG000|Cohort 5P, Q2W|Radiological Progression|0
7973249|NCT02906670|12536199|FG001|Cohort 5P, Q2W|Radiological Progression|0
7973250|NCT02906670|12536200|FG002|Cohort 5P, Q2W|Radiological Progression|0
7973251|NCT02906670|12536201|FG003|Cohort 5P, Q2W|Radiological Progression|0
7973252|NCT02906670|12536202|FG004|Cohort 5P, Q2W|Radiological Progression|0
7973253|NCT02906670|12536203|FG005|Cohort 5P, Q2W|Radiological Progression|0
7973254|NCT02906670|12536204|FG006|Cohort 5P, Q2W|Radiological Progression|0
7973255|NCT02906670|12536205|FG007|Cohort 5P, Q2W|Radiological Progression|2
7973256|NCT02906670|12536206|FG008|Cohort 5P, Q2W|Radiological Progression|0
7973257|NCT02906670|12536207|FG009|Cohort 5P, Q2W|Radiological Progression|0
7973258|NCT02906670|12536198|FG000|Cohort 5P, Q2W|Adverse Event|0
7973259|NCT02906670|12536199|FG001|Cohort 5P, Q2W|Adverse Event|0
7973260|NCT02906670|12536200|FG002|Cohort 5P, Q2W|Adverse Event|0
7973261|NCT02906670|12536201|FG003|Cohort 5P, Q2W|Adverse Event|0
7973262|NCT02906670|12536202|FG004|Cohort 5P, Q2W|Adverse Event|0
7973263|NCT02906670|12536203|FG005|Cohort 5P, Q2W|Adverse Event|0
7973264|NCT02906670|12536204|FG006|Cohort 5P, Q2W|Adverse Event|0
7973265|NCT02906670|12536205|FG007|Cohort 5P, Q2W|Adverse Event|1
7973266|NCT02906670|12536206|FG008|Cohort 5P, Q2W|Adverse Event|0
7973267|NCT02906670|12536207|FG009|Cohort 5P, Q2W|Adverse Event|0
7973268|NCT02906670|12536198|FG000|Cohort 6P, Q2W|Radiological Progression|0
7973269|NCT02906670|12536199|FG001|Cohort 6P, Q2W|Radiological Progression|0
7973270|NCT02906670|12536200|FG002|Cohort 6P, Q2W|Radiological Progression|0
7973271|NCT02906670|12536201|FG003|Cohort 6P, Q2W|Radiological Progression|0
7973272|NCT02906670|12536202|FG004|Cohort 6P, Q2W|Radiological Progression|0
7973273|NCT02906670|12536203|FG005|Cohort 6P, Q2W|Radiological Progression|0
7973274|NCT02906670|12536204|FG006|Cohort 6P, Q2W|Radiological Progression|0
7973275|NCT02906670|12536205|FG007|Cohort 6P, Q2W|Radiological Progression|0
7973276|NCT02906670|12536206|FG008|Cohort 6P, Q2W|Radiological Progression|1
7973277|NCT02906670|12536207|FG009|Cohort 6P, Q2W|Radiological Progression|0
7973278|NCT02906670|12536198|FG000|Cohort 6P, Q2W|Clinical Progression|0
7973279|NCT02906670|12536199|FG001|Cohort 6P, Q2W|Clinical Progression|0
7973280|NCT02906670|12536200|FG002|Cohort 6P, Q2W|Clinical Progression|0
7973281|NCT02906670|12536201|FG003|Cohort 6P, Q2W|Clinical Progression|0
7973282|NCT02906670|12536202|FG004|Cohort 6P, Q2W|Clinical Progression|0
7973283|NCT02906670|12536203|FG005|Cohort 6P, Q2W|Clinical Progression|0
7973284|NCT02906670|12536204|FG006|Cohort 6P, Q2W|Clinical Progression|0
7973285|NCT02906670|12536205|FG007|Cohort 6P, Q2W|Clinical Progression|0
7973286|NCT02906670|12536206|FG008|Cohort 6P, Q2W|Clinical Progression|3
7973287|NCT02906670|12536207|FG009|Cohort 6P, Q2W|Clinical Progression|0
7973288|NCT02906670|12536198|FG000|Cohort 4P, QW|Radiological Progression|0
7973289|NCT02906670|12536199|FG001|Cohort 4P, QW|Radiological Progression|0
7973290|NCT02906670|12536200|FG002|Cohort 4P, QW|Radiological Progression|0
7973291|NCT02906670|12536201|FG003|Cohort 4P, QW|Radiological Progression|3
7973292|NCT02906670|12536202|FG004|Cohort 4P, QW|Radiological Progression|0
7973293|NCT02906670|12536203|FG005|Cohort 4P, QW|Radiological Progression|0
7973294|NCT02906670|12536204|FG006|Cohort 4P, QW|Radiological Progression|0
7973295|NCT02906670|12536205|FG007|Cohort 4P, QW|Radiological Progression|0
7973296|NCT02906670|12536206|FG008|Cohort 4P, QW|Radiological Progression|0
7973297|NCT02906670|12536207|FG009|Cohort 4P, QW|Radiological Progression|0
7973298|NCT02906670|12536198|FG000|Cohort 7P, Q2W|Adverse Event|0
7973299|NCT02906670|12536199|FG001|Cohort 7P, Q2W|Adverse Event|0
7973300|NCT02906670|12536200|FG002|Cohort 7P, Q2W|Adverse Event|0
7973301|NCT02906670|12536201|FG003|Cohort 7P, Q2W|Adverse Event|0
7973302|NCT02906670|12536202|FG004|Cohort 7P, Q2W|Adverse Event|0
7973303|NCT02906670|12536203|FG005|Cohort 7P, Q2W|Adverse Event|0
7973304|NCT02906670|12536204|FG006|Cohort 7P, Q2W|Adverse Event|0
7973305|NCT02906670|12536205|FG007|Cohort 7P, Q2W|Adverse Event|0
7973306|NCT02906670|12536206|FG008|Cohort 7P, Q2W|Adverse Event|0
7973307|NCT02906670|12536207|FG009|Cohort 7P, Q2W|Adverse Event|1
7973308|NCT02906670|12536198|FG000|Cohort 7P, Q2W|Physician Decision|0
7973309|NCT02906670|12536199|FG001|Cohort 7P, Q2W|Physician Decision|0
7973310|NCT02906670|12536200|FG002|Cohort 7P, Q2W|Physician Decision|0
7973311|NCT02906670|12536201|FG003|Cohort 7P, Q2W|Physician Decision|0
7973312|NCT02906670|12536202|FG004|Cohort 7P, Q2W|Physician Decision|0
7973313|NCT02906670|12536203|FG005|Cohort 7P, Q2W|Physician Decision|0
7973314|NCT02906670|12536204|FG006|Cohort 7P, Q2W|Physician Decision|0
7973315|NCT02906670|12536205|FG007|Cohort 7P, Q2W|Physician Decision|0
7973316|NCT02906670|12536206|FG008|Cohort 7P, Q2W|Physician Decision|0
7973317|NCT02906670|12536207|FG009|Cohort 7P, Q2W|Physician Decision|1
7973318|NCT02906670|12536198|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7973319|NCT02906670|12536199|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7973320|NCT02906670|12536200|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7973321|NCT02906670|12536201|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7973322|NCT02906670|12536202|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7973323|NCT02906670|12536203|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7973324|NCT02906670|12536204|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7973325|NCT02906670|12536205|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7973326|NCT02906670|12536206|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7973327|NCT02906670|12536207|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1
7973328|NCT02906670|12536198|FG000|Cohort 5P, QW|Radiological Progression|0
7973329|NCT02906670|12536199|FG001|Cohort 5P, QW|Radiological Progression|0
7973330|NCT02906670|12536200|FG002|Cohort 5P, QW|Radiological Progression|0
7973331|NCT02906670|12536201|FG003|Cohort 5P, QW|Radiological Progression|0
7973332|NCT02906670|12536202|FG004|Cohort 5P, QW|Radiological Progression|3
7973333|NCT02906670|12536203|FG005|Cohort 5P, QW|Radiological Progression|0
7973334|NCT02906670|12536204|FG006|Cohort 5P, QW|Radiological Progression|0
7973335|NCT02906670|12536205|FG007|Cohort 5P, QW|Radiological Progression|0
7973336|NCT02906670|12536206|FG008|Cohort 5P, QW|Radiological Progression|0
7973337|NCT02906670|12536207|FG009|Cohort 5P, QW|Radiological Progression|0
7973338|NCT02906709|12536263|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1
7973339|NCT02906709|12536264|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2
7973340|NCT02906709|12536263|FG000|Phase A (Week 0 to Week 16)|Death|0
7973341|NCT02906709|12536264|FG001|Phase A (Week 0 to Week 16)|Death|1
7973342|NCT02906709|12536263|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3
7973343|NCT02906709|12536264|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0
7973344|NCT02906709|12536263|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2
7973345|NCT02906709|12536264|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0
7973346|NCT02906917|12536291|FG000|Initiation Period (Week 0-26)|Unclassified|1
7973347|NCT02906917|12536292|FG001|Initiation Period (Week 0-26)|Unclassified|3
7973348|NCT02906917|12536291|FG000|Initiation Period (Week 0-26)|Adverse Event|1
7973349|NCT02906917|12536292|FG001|Initiation Period (Week 0-26)|Adverse Event|0
7973350|NCT02906917|12536291|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1
7973351|NCT02906917|12536292|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4
7973352|NCT02906917|12536291|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3
7973353|NCT02906917|12536292|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4
7973354|NCT02906917|12536291|FG000|Intensification Period (Week 26-38)|Unclassified|3
7973355|NCT02906917|12536292|FG001|Intensification Period (Week 26-38)|Unclassified|2
7973356|NCT02906917|12536291|FG000|Intensification Period (Week 26-38)|Adverse Event|0
7973357|NCT02906917|12536292|FG001|Intensification Period (Week 26-38)|Adverse Event|2
7973358|NCT02906917|12536291|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3
7973359|NCT02906917|12536292|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1
7973360|NCT02906917|12536291|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3
7973361|NCT02906917|12536292|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2
7973362|NCT02907177|12536313|FG000|Overall Study|Death|0
7973363|NCT02907177|12536314|FG001|Overall Study|Death|1
7973364|NCT02907177|12536313|FG000|Overall Study|Physician Decision|3
7973365|NCT02907177|12536314|FG001|Overall Study|Physician Decision|3
7973366|NCT02907177|12536313|FG000|Overall Study|Withdrawal by Subject|15
7973367|NCT02907177|12536314|FG001|Overall Study|Withdrawal by Subject|7
7973368|NCT02907177|12536313|FG000|Overall Study|Sponsor's Decision|50
7973369|NCT02907177|12536314|FG001|Overall Study|Sponsor's Decision|57
7973370|NCT02907216|12536322|FG000|Overall Study|No benefit to be obtained by continuing|0
7973371|NCT02907216|12536323|FG001|Overall Study|No benefit to be obtained by continuing|1
7973372|NCT02907216|12536322|FG000|Overall Study|Withdrawal by Subject|1
7973373|NCT02907216|12536323|FG001|Overall Study|Withdrawal by Subject|0
7973374|NCT02907463|12536337|FG000|Overall Study|Lost to Follow-up|17
7973375|NCT02907463|12536337|FG000|Overall Study|Death|10
7973376|NCT02907463|12536337|FG000|Overall Study|Withdrawal by Subject|4
7973377|NCT02907463|12536337|FG000|Overall Study|MIS Approach was not used|2
7973378|NCT02907463|12536337|FG000|Overall Study|Not Implanted with Study Device|2
7973379|NCT02907463|12536337|FG000|Overall Study|Device Explanted|1
7973380|NCT02907463|12536337|FG000|Overall Study|Missing Exit Form|1
7973381|NCT02907619|12536361|FG000|Overall Study|Study terminated by sponsor|18
7973382|NCT02907619|12536362|FG001|Overall Study|Study terminated by sponsor|18
7973383|NCT02907619|12536363|FG002|Overall Study|Study terminated by sponsor|19
7973384|NCT02907619|12536361|FG000|Overall Study|Death|0
7973385|NCT02907619|12536362|FG001|Overall Study|Death|0
7973386|NCT02907619|12536363|FG002|Overall Study|Death|1
7973387|NCT02907619|12536361|FG000|Overall Study|Withdrawal by Subject|1
7973388|NCT02907619|12536362|FG001|Overall Study|Withdrawal by Subject|1
7973389|NCT02907619|12536363|FG002|Overall Study|Withdrawal by Subject|0
7973390|NCT02907619|12536361|FG000|Overall Study|Other|0
7973391|NCT02907619|12536362|FG001|Overall Study|Other|1
7973392|NCT02907619|12536363|FG002|Overall Study|Other|0
7973393|NCT02907892|12536384|FG000|Overall Study|Lost to Follow-up|27
7973394|NCT02907892|12536385|FG001|Overall Study|Lost to Follow-up|40
7973395|NCT02908100|12536401|FG000|Overall Study|Adverse Event|7
7973396|NCT02908100|12536402|FG001|Overall Study|Adverse Event|6
7973397|NCT02908100|12536403|FG002|Overall Study|Adverse Event|9
7973398|NCT02908100|12536401|FG000|Overall Study|Death|2
7973399|NCT02908100|12536402|FG001|Overall Study|Death|0
7973400|NCT02908100|12536403|FG002|Overall Study|Death|0
7973401|NCT02908100|12536401|FG000|Overall Study|Lack of Efficacy|2
7973402|NCT02908100|12536402|FG001|Overall Study|Lack of Efficacy|3
7973403|NCT02908100|12536403|FG002|Overall Study|Lack of Efficacy|3
7973404|NCT02908100|12536401|FG000|Overall Study|Lost to Follow-up|0
7973405|NCT02908100|12536402|FG001|Overall Study|Lost to Follow-up|1
7973406|NCT02908100|12536403|FG002|Overall Study|Lost to Follow-up|2
7973407|NCT02908100|12536401|FG000|Overall Study|Non-Compliance With Study Drug|1
7973408|NCT02908100|12536402|FG001|Overall Study|Non-Compliance With Study Drug|1
7973409|NCT02908100|12536403|FG002|Overall Study|Non-Compliance With Study Drug|2
7973410|NCT02908100|12536401|FG000|Overall Study|Non-Compliance With Contraceptive Method|1
7973411|NCT02908100|12536402|FG001|Overall Study|Non-Compliance With Contraceptive Method|0
7973412|NCT02908100|12536403|FG002|Overall Study|Non-Compliance With Contraceptive Method|0
7973413|NCT02908100|12536401|FG000|Overall Study|Physician Decision|0
7973414|NCT02908100|12536402|FG001|Overall Study|Physician Decision|1
7973415|NCT02908100|12536403|FG002|Overall Study|Physician Decision|0
7973416|NCT02908100|12536401|FG000|Overall Study|Pregnancy|1
7973417|NCT02908100|12536402|FG001|Overall Study|Pregnancy|2
7973418|NCT02908100|12536403|FG002|Overall Study|Pregnancy|0
7973419|NCT02908100|12536401|FG000|Overall Study|Withdrawal by Subject|8
7973420|NCT02908100|12536402|FG001|Overall Study|Withdrawal by Subject|7
7973421|NCT02908100|12536403|FG002|Overall Study|Withdrawal by Subject|5
7973422|NCT02908100|12536401|FG000|Overall Study|Randomised in Error|1
7973423|NCT02908100|12536402|FG001|Overall Study|Randomised in Error|0
7973424|NCT02908100|12536403|FG002|Overall Study|Randomised in Error|0
7973425|NCT02908347|12536431|FG000|Overall Study|Adverse Event|0
7973426|NCT02908347|12536432|FG001|Overall Study|Adverse Event|1
7973427|NCT02908347|12536431|FG000|Overall Study|Lost to Follow-up|1
7973428|NCT02908347|12536432|FG001|Overall Study|Lost to Follow-up|0
7973429|NCT02908464|12536454|FG000|Overall Study|Withdrawal by Subject|2
7973430|NCT02908464|12536455|FG001|Overall Study|Withdrawal by Subject|1
7973431|NCT02908464|12536454|FG000|Overall Study|Found ineligible after randomization|0
7973432|NCT02908464|12536455|FG001|Overall Study|Found ineligible after randomization|2
7973433|NCT02908529|12536471|FG000|Overall Study|Lost to Follow-up|0
7973434|NCT02908529|12536472|FG001|Overall Study|Lost to Follow-up|2
7973435|NCT02908841|12536503|FG000|Overall Study|Physician Decision|4
7973436|NCT02908841|12536504|FG001|Overall Study|Physician Decision|0
7973437|NCT02908880|12536510|FG000|Overall Study|Lost to Follow-up|4
7973438|NCT02908880|12536510|FG000|Overall Study|Explantation of the device|1
7973439|NCT02908880|12536510|FG000|Overall Study|Withdrawal by Subject|17
7973440|NCT02908880|12536510|FG000|Overall Study|Death|5
7973441|NCT02909101|12536516|FG000|Overall Study|Lost to Follow-up|1
7973442|NCT02909101|12536517|FG001|Overall Study|Lost to Follow-up|1
7973443|NCT02909153|12536541|FG000|Overall Study|Withdrawal by Subject|0
7973444|NCT02909153|12536542|FG001|Overall Study|Withdrawal by Subject|1
7973445|NCT02909153|12536543|FG002|Overall Study|Withdrawal by Subject|0
7973446|NCT02909153|12536544|FG003|Overall Study|Withdrawal by Subject|0
7973447|NCT02909153|12536545|FG004|Overall Study|Withdrawal by Subject|0
7973448|NCT02909504|12536566|FG000|Overall Study|Adverse Event|2
7973449|NCT02909504|12536566|FG000|Overall Study|Lack of Efficacy|3
7973450|NCT02909504|12536566|FG000|Overall Study|Withdrawal by Subject|4
7973451|NCT02909504|12536566|FG000|Overall Study|Pregnancy|1
7973452|NCT02909504|12536566|FG000|Overall Study|Subject moved|1
7973453|NCT02909504|12536566|FG000|Overall Study|Lost to Follow-up|1
7973454|NCT02909907|12536585|FG000|Overall Study|Withdrawal by Subject|0
7973455|NCT02909907|12536586|FG001|Overall Study|Withdrawal by Subject|1
7973456|NCT02910011|12536601|FG000|Overall Study|Physician Decision|2
7973457|NCT02910037|12536607|FG000|Overall Study|Withdrawal by Subject|4
7973458|NCT02910037|12536607|FG000|Overall Study|Lost to Follow-up|6
7973459|NCT02910063|12536627|FG000|Phase 2|Withdrawal by Subject|3
7973460|NCT02910063|12536628|FG001|Phase 2|Withdrawal by Subject|0
7973461|NCT02910063|12536629|FG002|Phase 2|Withdrawal by Subject|0
7973462|NCT02910063|12536627|FG000|Phase 2|Lost to Follow-up|1
7973463|NCT02910063|12536628|FG001|Phase 2|Lost to Follow-up|0
7973464|NCT02910063|12536629|FG002|Phase 2|Lost to Follow-up|0
7973465|NCT02910063|12536627|FG000|Phase 2|Death|24
7973466|NCT02910063|12536628|FG001|Phase 2|Death|0
7973467|NCT02910063|12536629|FG002|Phase 2|Death|0
7973468|NCT02910089|12536640|FG000|Overall Study|Lost insurance eligibility|22
7973469|NCT02910089|12536641|FG001|Overall Study|Lost insurance eligibility|16
7973470|NCT02910167|12536661|FG000|Overall Study|Adverse Event|1
7973471|NCT02910167|12536661|FG000|Overall Study|Lost to Follow-up|18
7973472|NCT02910466|12536674|FG000|Overall Study|Adverse Event|1
7973473|NCT02910466|12536674|FG000|Overall Study|Withdrawal by Subject|3
7973474|NCT02910466|12536674|FG000|Overall Study|Lost to Follow-up|5
7973475|NCT02910466|12536674|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29
7973476|NCT02910466|12536674|FG000|Overall Study|Participant didn't meet inclusion criteria|1
7973477|NCT02910713|12536683|FG000|Overall Study|Protocol Violation|2
7973478|NCT02910713|12536683|FG000|Overall Study|Subject Choice|4
7973479|NCT02910713|12536683|FG000|Overall Study|Received One Application|10
7973480|NCT02910713|12536683|FG000|Overall Study|Received Neither Application|18
7973481|NCT02910713|12536683|FG000|Overall Study|Enrollment cap|7
7973482|NCT02910713|12536683|FG000|Overall Study|Investigator Discretion|1
7973483|NCT02910739|12536690|FG000|Overall Study|Adverse Event|1
7973484|NCT02910739|12536691|FG001|Overall Study|Adverse Event|0
7973485|NCT02910739|12536692|FG002|Overall Study|Adverse Event|0
7973486|NCT02910739|12536693|FG003|Overall Study|Adverse Event|0
7973487|NCT02911025|12536699|FG000|Overall Study|Lost to Follow-up|3
7973488|NCT02911116|12536705|FG000|Overall Study|Insufficient Therapeutic Response|1
7973489|NCT02911116|12536706|FG001|Overall Study|Insufficient Therapeutic Response|0
7973490|NCT02911116|12536705|FG000|Overall Study|Lost to Follow-up|0
7973491|NCT02911116|12536706|FG001|Overall Study|Lost to Follow-up|1
7973492|NCT02911285|12536714|FG000|Overall Study|Lost to Follow-up|8
7973493|NCT02911285|12536715|FG001|Overall Study|Lost to Follow-up|5
7973494|NCT02911285|12536714|FG000|Overall Study|Participant got a job and no longer had time to participate.|1
7973495|NCT02911285|12536715|FG001|Overall Study|Participant got a job and no longer had time to participate.|0
7973496|NCT02911519|12536737|FG000|Overall Study|Lost to Follow-up|2
7973497|NCT02911519|12536738|FG001|Overall Study|Lost to Follow-up|2
7973498|NCT02911519|12536737|FG000|Overall Study|Death|0
7973499|NCT02911519|12536738|FG001|Overall Study|Death|2
7973500|NCT02911688|12536746|FG000|Washout|Lost to Follow-up|1
7973501|NCT02911688|12536747|FG001|Washout|Lost to Follow-up|1
7973502|NCT02911688|12536746|FG000|Washout|Withdrawal by Subject|0
7973503|NCT02911688|12536747|FG001|Washout|Withdrawal by Subject|1
7973504|NCT02911948|12536846|FG000|Overall Study|Protocol Violation|0
7973505|NCT02911948|12536847|FG001|Overall Study|Protocol Violation|1
7973506|NCT02911948|12536846|FG000|Overall Study|Withdrawal by Subject|0
7973507|NCT02911948|12536847|FG001|Overall Study|Withdrawal by Subject|2
7973508|NCT02911948|12536846|FG000|Overall Study|Lack of Efficacy|0
7973509|NCT02911948|12536847|FG001|Overall Study|Lack of Efficacy|1
7973510|NCT02911948|12536846|FG000|Overall Study|Unclassified|0
7973511|NCT02911948|12536847|FG001|Overall Study|Unclassified|3
7973512|NCT02912455|12536874|FG000|Overall Study|Withdrawal by Subject|0
7973513|NCT02912455|12536875|FG001|Overall Study|Withdrawal by Subject|1
7973514|NCT02912455|12536874|FG000|Overall Study|Lack of Efficacy|0
7973515|NCT02912455|12536875|FG001|Overall Study|Lack of Efficacy|1
7973516|NCT02912455|12536874|FG000|Overall Study|Lost to Follow-up|2
7973517|NCT02912455|12536875|FG001|Overall Study|Lost to Follow-up|1
7973518|NCT02912468|12536883|FG000|Overall Study|Adverse Event|3
7973519|NCT02912468|12536884|FG001|Overall Study|Adverse Event|2
7973520|NCT02912468|12536883|FG000|Overall Study|Withdrawal by Subject|6
7973521|NCT02912468|12536884|FG001|Overall Study|Withdrawal by Subject|2
7973522|NCT02912468|12536883|FG000|Overall Study|Randomized and not treated|0
7973523|NCT02912468|12536884|FG001|Overall Study|Randomized and not treated|1
7973524|NCT02912650|12536895|FG000|Overall Study|Withdrawal by Subject|1
7973525|NCT02912650|12536896|FG001|Overall Study|Withdrawal by Subject|0
7973526|NCT02912650|12536897|FG002|Overall Study|Withdrawal by Subject|1
7973527|NCT02912650|12536898|FG003|Overall Study|Withdrawal by Subject|5
7973528|NCT02912650|12536895|FG000|Overall Study|Adverse Event|0
7973529|NCT02912650|12536896|FG001|Overall Study|Adverse Event|0
7973530|NCT02912650|12536897|FG002|Overall Study|Adverse Event|1
7973531|NCT02912650|12536898|FG003|Overall Study|Adverse Event|0
7973532|NCT02913105|12536911|FG000|Overall Study|Adverse Event|11
7973533|NCT02913105|12536912|FG001|Overall Study|Adverse Event|0
7973534|NCT02913105|12536913|FG002|Overall Study|Adverse Event|4
7973535|NCT02913105|12536911|FG000|Overall Study|Non-Compliance With Study Drug|0
7973536|NCT02913105|12536912|FG001|Overall Study|Non-Compliance With Study Drug|0
7973537|NCT02913105|12536913|FG002|Overall Study|Non-Compliance With Study Drug|1
7973538|NCT02913105|12536911|FG000|Overall Study|Reason Not Specified|3
7973539|NCT02913105|12536912|FG001|Overall Study|Reason Not Specified|1
7973540|NCT02913105|12536913|FG002|Overall Study|Reason Not Specified|1
7973541|NCT02913105|12536911|FG000|Overall Study|Physician Decision|1
7973542|NCT02913105|12536912|FG001|Overall Study|Physician Decision|1
7973543|NCT02913105|12536913|FG002|Overall Study|Physician Decision|0
7973544|NCT02913105|12536911|FG000|Overall Study|Withdrawal by Subject|0
7973545|NCT02913105|12536912|FG001|Overall Study|Withdrawal by Subject|3
7973546|NCT02913105|12536913|FG002|Overall Study|Withdrawal by Subject|1
7973547|NCT02913326|12536924|FG000|Overall Study|Reason not listed|0
7973548|NCT02913326|12536925|FG001|Overall Study|Reason not listed|1
7973549|NCT02913326|12536924|FG000|Overall Study|Lost to Follow-up|0
7973550|NCT02913326|12536925|FG001|Overall Study|Lost to Follow-up|1
7973551|NCT02913326|12536924|FG000|Overall Study|Adverse Event|1
7973552|NCT02913326|12536925|FG001|Overall Study|Adverse Event|0
7973553|NCT02914184|12536965|FG000|Overall Study|Lost to Follow-up|7
7973554|NCT02914184|12536966|FG001|Overall Study|Lost to Follow-up|10
7973555|NCT02914184|12536967|FG002|Overall Study|Lost to Follow-up|8
7973556|NCT02914184|12536968|FG003|Overall Study|Lost to Follow-up|7
7973557|NCT02914184|12536965|FG000|Overall Study|Withdrawal by Subject|4
7973558|NCT02914184|12536966|FG001|Overall Study|Withdrawal by Subject|2
7973559|NCT02914184|12536967|FG002|Overall Study|Withdrawal by Subject|7
7973560|NCT02914184|12536968|FG003|Overall Study|Withdrawal by Subject|3
7973561|NCT02914184|12536965|FG000|Overall Study|Other|1
7973562|NCT02914184|12536966|FG001|Overall Study|Other|0
7973563|NCT02914184|12536967|FG002|Overall Study|Other|0
7973564|NCT02914184|12536968|FG003|Overall Study|Other|0
7973565|NCT02914184|12536965|FG000|Overall Study|Migrated/moved from the study area|2
7973566|NCT02914184|12536966|FG001|Overall Study|Migrated/moved from the study area|1
7973567|NCT02914184|12536967|FG002|Overall Study|Migrated/moved from the study area|2
7973568|NCT02914184|12536968|FG003|Overall Study|Migrated/moved from the study area|1
7973569|NCT02914236|12536989|FG000|Overall Study|Lost to Follow-up|1
7973570|NCT02914275|12536995|FG000|Overall Study|Lost to Follow-up|84
7973571|NCT02914275|12536996|FG001|Overall Study|Lost to Follow-up|29
7973572|NCT02914275|12536995|FG000|Overall Study|Withdrawal by Subject|26
7973573|NCT02914275|12536996|FG001|Overall Study|Withdrawal by Subject|10
7973574|NCT02914275|12536995|FG000|Overall Study|Protocol Violation|1
7973575|NCT02914275|12536996|FG001|Overall Study|Protocol Violation|1
7973576|NCT02914275|12536995|FG000|Overall Study|Physician Decision|3
7973577|NCT02914275|12536996|FG001|Overall Study|Physician Decision|1
7973578|NCT02914275|12536995|FG000|Overall Study|Other|4
7973579|NCT02914275|12536996|FG001|Overall Study|Other|1
7973580|NCT02914275|12536995|FG000|Overall Study|Excluded due to invalid informed consent|3
7973581|NCT02914275|12536996|FG001|Overall Study|Excluded due to invalid informed consent|0
7973582|NCT02914457|12537006|FG000|Overall Study|Withdrawal by Subject|1
7973583|NCT02914457|12537006|FG000|Overall Study|Physician Decision|1
7973584|NCT02914457|12537006|FG000|Overall Study|No veins available for lead placement|1
7973585|NCT02914457|12537006|FG000|Overall Study|Electrical instability of patient|1
7973586|NCT02914457|12537006|FG000|Overall Study|ECG acquisition error due to sweating|1
7973587|NCT02914457|12537006|FG000|Overall Study|Protocol Violation|1
7973588|NCT02914522|12537027|FG000|Induction Study: Up to Week 11|Adverse Event|5
7973589|NCT02914522|12537028|FG001|Induction Study: Up to Week 11|Adverse Event|6
7973590|NCT02914522|12537029|FG002|Induction Study: Up to Week 11|Adverse Event|4
7973591|NCT02914522|12537030|FG003|Induction Study: Up to Week 11|Adverse Event|18
7973592|NCT02914522|12537031|FG004|Induction Study: Up to Week 11|Adverse Event|14
7973593|NCT02914522|12537032|FG005|Induction Study: Up to Week 11|Adverse Event|10
7973594|NCT02914522|12537033|FG006|Induction Study: Up to Week 11|Adverse Event|0
7973595|NCT02914522|12537034|FG007|Induction Study: Up to Week 11|Adverse Event|0
7973596|NCT02914522|12537035|FG008|Induction Study: Up to Week 11|Adverse Event|0
7973597|NCT02914522|12537036|FG009|Induction Study: Up to Week 11|Adverse Event|0
7973598|NCT02914522|12537037|FG010|Induction Study: Up to Week 11|Adverse Event|0
7973599|NCT02914522|12537027|FG000|Induction Study: Up to Week 11|Withdrew Consent|4
7973600|NCT02914522|12537028|FG001|Induction Study: Up to Week 11|Withdrew Consent|11
7973601|NCT02914522|12537029|FG002|Induction Study: Up to Week 11|Withdrew Consent|4
7973602|NCT02914522|12537030|FG003|Induction Study: Up to Week 11|Withdrew Consent|6
7973603|NCT02914522|12537031|FG004|Induction Study: Up to Week 11|Withdrew Consent|3
7973604|NCT02914522|12537032|FG005|Induction Study: Up to Week 11|Withdrew Consent|3
7973605|NCT02914522|12537033|FG006|Induction Study: Up to Week 11|Withdrew Consent|0
7973606|NCT02914522|12537034|FG007|Induction Study: Up to Week 11|Withdrew Consent|0
7973607|NCT02914522|12537035|FG008|Induction Study: Up to Week 11|Withdrew Consent|0
7973608|NCT02914522|12537036|FG009|Induction Study: Up to Week 11|Withdrew Consent|0
7973609|NCT02914522|12537037|FG010|Induction Study: Up to Week 11|Withdrew Consent|0
7973610|NCT02914522|12537027|FG000|Induction Study: Up to Week 11|Protocol Violation|0
7973611|NCT02914522|12537028|FG001|Induction Study: Up to Week 11|Protocol Violation|2
7973612|NCT02914522|12537029|FG002|Induction Study: Up to Week 11|Protocol Violation|1
7973613|NCT02914522|12537030|FG003|Induction Study: Up to Week 11|Protocol Violation|3
7973614|NCT02914522|12537031|FG004|Induction Study: Up to Week 11|Protocol Violation|4
7973615|NCT02914522|12537032|FG005|Induction Study: Up to Week 11|Protocol Violation|2
7973616|NCT02914522|12537033|FG006|Induction Study: Up to Week 11|Protocol Violation|0
7973617|NCT02914522|12537034|FG007|Induction Study: Up to Week 11|Protocol Violation|0
7973618|NCT02914522|12537035|FG008|Induction Study: Up to Week 11|Protocol Violation|0
7973619|NCT02914522|12537036|FG009|Induction Study: Up to Week 11|Protocol Violation|0
7973620|NCT02914522|12537037|FG010|Induction Study: Up to Week 11|Protocol Violation|0
7973621|NCT02914522|12537027|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0
7973622|NCT02914522|12537028|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2
7973623|NCT02914522|12537029|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1
7973624|NCT02914522|12537030|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1
7973625|NCT02914522|12537031|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0
7973626|NCT02914522|12537032|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0
7973627|NCT02914522|12537033|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0
7973628|NCT02914522|12537034|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0
7973629|NCT02914522|12537035|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0
7973630|NCT02914522|12537036|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0
7973631|NCT02914522|12537037|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0
7973632|NCT02914522|12537027|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0
7973633|NCT02914522|12537028|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0
7973634|NCT02914522|12537029|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0
7973635|NCT02914522|12537030|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0
7973636|NCT02914522|12537031|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1
7973637|NCT02914522|12537032|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0
7973638|NCT02914522|12537033|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0
7973639|NCT02914522|12537034|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0
7973640|NCT02914522|12537035|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0
7973641|NCT02914522|12537036|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0
7973642|NCT02914522|12537037|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0
7973643|NCT02914522|12537027|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1
7973644|NCT02914522|12537028|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7973645|NCT02914522|12537029|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7973646|NCT02914522|12537030|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7973647|NCT02914522|12537031|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7973648|NCT02914522|12537032|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7973649|NCT02914522|12537033|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7973650|NCT02914522|12537034|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7973651|NCT02914522|12537035|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7973652|NCT02914522|12537036|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7973653|NCT02914522|12537037|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7973654|NCT02914522|12537027|FG000|Induction Study: Up to Week 11|Pregnancy|0
7973655|NCT02914522|12537028|FG001|Induction Study: Up to Week 11|Pregnancy|0
7973656|NCT02914522|12537029|FG002|Induction Study: Up to Week 11|Pregnancy|0
7973657|NCT02914522|12537030|FG003|Induction Study: Up to Week 11|Pregnancy|0
7973658|NCT02914522|12537031|FG004|Induction Study: Up to Week 11|Pregnancy|1
7973659|NCT02914522|12537032|FG005|Induction Study: Up to Week 11|Pregnancy|0
7973660|NCT02914522|12537033|FG006|Induction Study: Up to Week 11|Pregnancy|0
7973661|NCT02914522|12537034|FG007|Induction Study: Up to Week 11|Pregnancy|0
7973662|NCT02914522|12537035|FG008|Induction Study: Up to Week 11|Pregnancy|0
7973663|NCT02914522|12537036|FG009|Induction Study: Up to Week 11|Pregnancy|0
7973664|NCT02914522|12537037|FG010|Induction Study: Up to Week 11|Pregnancy|0
7973665|NCT02914522|12537027|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7973666|NCT02914522|12537028|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1
7973667|NCT02914522|12537029|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7973668|NCT02914522|12537030|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7973669|NCT02914522|12537031|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1
7973670|NCT02914522|12537032|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1
7973671|NCT02914522|12537033|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7973672|NCT02914522|12537034|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7973673|NCT02914522|12537035|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7973674|NCT02914522|12537036|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7973675|NCT02914522|12537037|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7973676|NCT02914522|12537027|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7973677|NCT02914522|12537028|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7973678|NCT02914522|12537029|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7973679|NCT02914522|12537030|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7973680|NCT02914522|12537031|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7973681|NCT02914522|12537032|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7973682|NCT02914522|12537033|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34
7973683|NCT02914522|12537034|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49
7973684|NCT02914522|12537035|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53
7973685|NCT02914522|12537036|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39
7973686|NCT02914522|12537037|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21
7973687|NCT02914522|12537027|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7973688|NCT02914522|12537028|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7973689|NCT02914522|12537029|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7973690|NCT02914522|12537030|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7973691|NCT02914522|12537031|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7973692|NCT02914522|12537032|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7973693|NCT02914522|12537033|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7
7973694|NCT02914522|12537034|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2
7973695|NCT02914522|12537035|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10
7973696|NCT02914522|12537036|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4
7973697|NCT02914522|12537037|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3
7973698|NCT02914522|12537027|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7973699|NCT02914522|12537028|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7973700|NCT02914522|12537029|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7973701|NCT02914522|12537030|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7973702|NCT02914522|12537031|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7973703|NCT02914522|12537032|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7973704|NCT02914522|12537033|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5
7973705|NCT02914522|12537034|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5
7973706|NCT02914522|12537035|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3
7973707|NCT02914522|12537036|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7973708|NCT02914522|12537037|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1
7973709|NCT02914522|12537027|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7973710|NCT02914522|12537028|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7973711|NCT02914522|12537029|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7973712|NCT02914522|12537030|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7973713|NCT02914522|12537031|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7973714|NCT02914522|12537032|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7973715|NCT02914522|12537033|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4
7973716|NCT02914522|12537034|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1
7973717|NCT02914522|12537035|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6
7973718|NCT02914522|12537036|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3
7973719|NCT02914522|12537037|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4
7973720|NCT02914522|12537027|FG000|Maintenance Study: Week 11 to Week 58|Death|0
7973721|NCT02914522|12537028|FG001|Maintenance Study: Week 11 to Week 58|Death|0
7973722|NCT02914522|12537029|FG002|Maintenance Study: Week 11 to Week 58|Death|0
7973723|NCT02914522|12537030|FG003|Maintenance Study: Week 11 to Week 58|Death|0
7973724|NCT02914522|12537031|FG004|Maintenance Study: Week 11 to Week 58|Death|0
7973725|NCT02914522|12537032|FG005|Maintenance Study: Week 11 to Week 58|Death|0
7973726|NCT02914522|12537033|FG006|Maintenance Study: Week 11 to Week 58|Death|2
7973727|NCT02914522|12537034|FG007|Maintenance Study: Week 11 to Week 58|Death|0
7973728|NCT02914522|12537035|FG008|Maintenance Study: Week 11 to Week 58|Death|0
7973729|NCT02914522|12537036|FG009|Maintenance Study: Week 11 to Week 58|Death|0
7973730|NCT02914522|12537037|FG010|Maintenance Study: Week 11 to Week 58|Death|0
7973731|NCT02914522|12537027|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7973732|NCT02914522|12537028|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7973733|NCT02914522|12537029|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7973734|NCT02914522|12537030|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7973735|NCT02914522|12537031|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7973736|NCT02914522|12537032|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7973737|NCT02914522|12537033|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7973738|NCT02914522|12537034|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1
7973739|NCT02914522|12537035|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2
7973740|NCT02914522|12537036|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7973741|NCT02914522|12537037|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7973742|NCT02914522|12537027|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7973743|NCT02914522|12537028|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7973744|NCT02914522|12537029|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7973745|NCT02914522|12537030|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7973746|NCT02914522|12537031|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7973747|NCT02914522|12537032|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7973748|NCT02914522|12537033|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7973749|NCT02914522|12537034|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7973750|NCT02914522|12537035|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1
7973751|NCT02914522|12537036|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2
7973752|NCT02914522|12537037|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7973753|NCT02914522|12537027|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7717985|NCT00524043|12141667|FG000|Overall Study|Lost to Follow-up|3
7717986|NCT00524043|12141668|FG001|Overall Study|Lost to Follow-up|5
7717987|NCT00524043|12141669|FG002|Overall Study|Lost to Follow-up|3
7717988|NCT00524043|12141667|FG000|Overall Study|Various (eg, incarceration)|2
7717989|NCT00524043|12141668|FG001|Overall Study|Various (eg, incarceration)|1
7717990|NCT00524043|12141669|FG002|Overall Study|Various (eg, incarceration)|0
7717991|NCT00524121|12141677|FG000|Overall Study|Disease progression|6
7717992|NCT00524121|12141677|FG000|Overall Study|Adverse Event|4
7717993|NCT00524121|12141677|FG000|Overall Study|Patient refused|2
7973754|NCT02914522|12537028|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7973755|NCT02914522|12537029|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7973756|NCT02914522|12537030|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7973757|NCT02914522|12537031|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7973758|NCT02914522|12537032|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7973759|NCT02914522|12537033|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7973760|NCT02914522|12537034|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7973761|NCT02914522|12537035|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7973762|NCT02914522|12537036|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1
7973763|NCT02914522|12537037|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7973764|NCT02914548|12537067|FG000|Overall Study|Adverse Event|15
7973765|NCT02914548|12537068|FG001|Overall Study|Adverse Event|7
7973766|NCT02914548|12537069|FG002|Overall Study|Adverse Event|15
7973767|NCT02914548|12537067|FG000|Overall Study|Physician Decision|2
7973768|NCT02914548|12537068|FG001|Overall Study|Physician Decision|2
7973769|NCT02914548|12537069|FG002|Overall Study|Physician Decision|0
7973770|NCT02914548|12537067|FG000|Overall Study|Protocol Violation|1
7973771|NCT02914548|12537068|FG001|Overall Study|Protocol Violation|0
7973772|NCT02914548|12537069|FG002|Overall Study|Protocol Violation|0
7973773|NCT02914548|12537067|FG000|Overall Study|Withdrawal by Subject|3
7973774|NCT02914548|12537068|FG001|Overall Study|Withdrawal by Subject|4
7973775|NCT02914548|12537069|FG002|Overall Study|Withdrawal by Subject|4
7973776|NCT02914548|12537067|FG000|Overall Study|>40% of body surface area|0
7973777|NCT02914548|12537068|FG001|Overall Study|>40% of body surface area|1
7973778|NCT02914548|12537069|FG002|Overall Study|>40% of body surface area|1
7973779|NCT02914834|12537090|FG000|Overall Study|Study halted due to COVID|1
7973780|NCT02914834|12537091|FG001|Overall Study|Study halted due to COVID|1
7973781|NCT02914834|12537090|FG000|Overall Study|1 subject withdrew|0
7973782|NCT02914834|12537091|FG001|Overall Study|1 subject withdrew|1
7973783|NCT02915159|12537108|FG000|Overall Study|Participant no longer meets criteria|2
7973784|NCT02915159|12537109|FG001|Overall Study|Participant no longer meets criteria|0
7973785|NCT02915159|12537108|FG000|Overall Study|poor/non-compliance|1
7973786|NCT02915159|12537109|FG001|Overall Study|poor/non-compliance|0
7973787|NCT02915159|12537108|FG000|Overall Study|Participant withdrew consent|5
7973788|NCT02915159|12537109|FG001|Overall Study|Participant withdrew consent|1
7973789|NCT02915159|12537108|FG000|Overall Study|Request to discontinue treatment|1
7973790|NCT02915159|12537109|FG001|Overall Study|Request to discontinue treatment|2
7973791|NCT02915159|12537108|FG000|Overall Study|Adverse Event|2
7973792|NCT02915159|12537109|FG001|Overall Study|Adverse Event|2
7973793|NCT02915159|12537108|FG000|Overall Study|Lack of Efficacy|0
7973794|NCT02915159|12537109|FG001|Overall Study|Lack of Efficacy|3
7973795|NCT02915835|12537144|FG000|Overall Study|Physician Decision|1
7973796|NCT02915835|12537145|FG001|Overall Study|Physician Decision|0
7973797|NCT02915835|12537144|FG000|Overall Study|Withdrawal by Subject|0
7973798|NCT02915835|12537145|FG001|Overall Study|Withdrawal by Subject|1
7973799|NCT02915874|12537153|FG000|Overall Study|Lost to Follow-up|5
7973800|NCT02915874|12537154|FG001|Overall Study|Lost to Follow-up|4
7973801|NCT02915874|12537153|FG000|Overall Study|Withdrawal by Subject|1
7973802|NCT02915874|12537154|FG001|Overall Study|Withdrawal by Subject|1
7973803|NCT02915874|12537153|FG000|Overall Study|Started New Anxiety Medication|0
7973804|NCT02915874|12537154|FG001|Overall Study|Started New Anxiety Medication|1
7973805|NCT02915978|12537163|FG000|Overall Study|Adverse Event|2
7973806|NCT02915978|12537164|FG001|Overall Study|Adverse Event|1
7973807|NCT02915978|12537165|FG002|Overall Study|Adverse Event|0
7973808|NCT02916056|12537173|FG000|Overall Study|Adverse Event|6
7973809|NCT02916056|12537173|FG000|Overall Study|Lost to Follow-up|1
7973810|NCT02916056|12537173|FG000|Overall Study|Other|12
7973811|NCT02916056|12537173|FG000|Overall Study|Protocol Violation|1
7973812|NCT02916056|12537173|FG000|Overall Study|Withdrawal by Subject|8
7973813|NCT02916056|12537173|FG000|Overall Study|Study Terminated by Sponsor|269
7973814|NCT02916433|12537188|FG000|Overall Study|Withdrawal by Subject|1
7973815|NCT02916433|12537189|FG001|Overall Study|Withdrawal by Subject|0
7973816|NCT02916433|12537188|FG000|Overall Study|Physician Decision|1
7973817|NCT02916433|12537189|FG001|Overall Study|Physician Decision|0
7973818|NCT02916693|12537211|FG000|Overall Study|Lost to Follow-up|7
7973819|NCT02916927|12537225|FG000|Overall Study|Discharged prior to study drug receipt|0
7973820|NCT02916927|12537226|FG001|Overall Study|Discharged prior to study drug receipt|2
7973821|NCT02916927|12537225|FG000|Overall Study|At radiology for 45 & 60 min time points|0
7973822|NCT02916927|12537226|FG001|Overall Study|At radiology for 45 & 60 min time points|1
7973823|NCT02916927|12537225|FG000|Overall Study|Withdrawal before first time point|1
7973824|NCT02916927|12537226|FG001|Overall Study|Withdrawal before first time point|0
7973825|NCT02917031|12537235|FG000|Overall Study|Reason not specified|7
7973826|NCT02917031|12537236|FG001|Overall Study|Reason not specified|5
7973827|NCT02917031|12537237|FG002|Overall Study|Reason not specified|6
7973828|NCT02917031|12537235|FG000|Overall Study|Development of study-specific withdrawal criteria|1
7973829|NCT02917031|12537236|FG001|Overall Study|Development of study-specific withdrawal criteria|1
7973830|NCT02917031|12537237|FG002|Overall Study|Development of study-specific withdrawal criteria|0
7973831|NCT02917031|12537235|FG000|Overall Study|Withdrawal by Subject|3
7973832|NCT02917031|12537236|FG001|Overall Study|Withdrawal by Subject|3
7973833|NCT02917031|12537237|FG002|Overall Study|Withdrawal by Subject|0
7973834|NCT02917031|12537235|FG000|Overall Study|Physician Decision|1
7973835|NCT02917031|12537236|FG001|Overall Study|Physician Decision|0
7973836|NCT02917031|12537237|FG002|Overall Study|Physician Decision|0
7973837|NCT02917031|12537235|FG000|Overall Study|Adverse Event|4
7973838|NCT02917031|12537236|FG001|Overall Study|Adverse Event|1
7973839|NCT02917031|12537237|FG002|Overall Study|Adverse Event|5
7973840|NCT02917031|12537235|FG000|Overall Study|Death|2
7973841|NCT02917031|12537236|FG001|Overall Study|Death|3
7973842|NCT02917031|12537237|FG002|Overall Study|Death|4
7973843|NCT02917265|12537257|FG000|Overall Study|Physician Decision|1
7973844|NCT02917265|12537258|FG001|Overall Study|Physician Decision|0
7973845|NCT02917265|12537257|FG000|Overall Study|Withdrawal by Subject|1
7973846|NCT02917265|12537258|FG001|Overall Study|Withdrawal by Subject|0
7973847|NCT02917941|12537303|FG000|Treatment Period|Adverse Event|11
7973848|NCT02917941|12537303|FG000|Treatment Period|Progressive Disease|11
7973849|NCT02917941|12537303|FG000|Treatment Period|Reason not Specified|2
7973850|NCT02917941|12537303|FG000|Survival Follow-up Period|Lost to Follow-up|1
7973851|NCT02917941|12537303|FG000|Survival Follow-up Period|Withdrawal by Subject|4
7973852|NCT02918071|12537307|FG000|Overall Study|Withdrawal by Subject|2
7973853|NCT02918071|12537307|FG000|Overall Study|Lost to Follow-up|1
7973854|NCT02918266|12537326|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0
7973855|NCT02918266|12537327|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7973856|NCT02918266|12537328|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7973857|NCT02918266|12537329|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7973858|NCT02918266|12537330|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7973859|NCT02918266|12537331|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7973860|NCT02918266|12537332|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2
7973861|NCT02918266|12537333|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7973862|NCT02918266|12537334|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2
7973863|NCT02918266|12537335|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7973864|NCT02918266|12537336|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7973865|NCT02918279|12537358|FG000|Overall Study|Lost to Follow-up|3
7973866|NCT02918279|12537359|FG001|Overall Study|Lost to Follow-up|6
7973867|NCT02918279|12537358|FG000|Overall Study|Withdrawal by Subject|5
7973868|NCT02918279|12537359|FG001|Overall Study|Withdrawal by Subject|15
7973869|NCT02918279|12537358|FG000|Overall Study|Withdrawal by parent/guardian|2
7973870|NCT02918279|12537359|FG001|Overall Study|Withdrawal by parent/guardian|1
7973871|NCT02918279|12537358|FG000|Overall Study|Other|3
7973872|NCT02918279|12537359|FG001|Overall Study|Other|1
7973873|NCT02918318|12537369|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1
7973874|NCT02918318|12537370|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4
7973875|NCT02918318|12537371|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2
7973876|NCT02918318|12537372|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3
7973877|NCT02918318|12537373|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0
7973878|NCT02918318|12537369|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7973879|NCT02918318|12537370|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7973880|NCT02918318|12537371|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7973881|NCT02918318|12537372|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2
7973882|NCT02918318|12537373|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7973883|NCT02918318|12537369|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
7973884|NCT02918318|12537370|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
7973885|NCT02918318|12537371|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
7973886|NCT02918318|12537372|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1
7973887|NCT02918318|12537373|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
7973888|NCT02918318|12537369|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
7973889|NCT02918318|12537370|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
7973890|NCT02918318|12537371|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
7973891|NCT02918318|12537372|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
7973892|NCT02918318|12537373|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
7973893|NCT02918318|12537369|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7973894|NCT02918318|12537370|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7973895|NCT02918318|12537371|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7973896|NCT02918318|12537372|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1
7973897|NCT02918318|12537373|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7973898|NCT02918318|12537369|FG000|Double-blind Induction Phase: 4 Weeks|Other|0
7973899|NCT02918318|12537370|FG001|Double-blind Induction Phase: 4 Weeks|Other|2
7973900|NCT02918318|12537371|FG002|Double-blind Induction Phase: 4 Weeks|Other|0
7973901|NCT02918318|12537372|FG003|Double-blind Induction Phase: 4 Weeks|Other|1
7973902|NCT02918318|12537373|FG004|Double-blind Induction Phase: 4 Weeks|Other|0
7973903|NCT02918318|12537369|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7973904|NCT02918318|12537370|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7973905|NCT02918318|12537371|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7973906|NCT02918318|12537372|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2
7973907|NCT02918318|12537373|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7973908|NCT02918318|12537369|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
7973909|NCT02918318|12537370|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
7973910|NCT02918318|12537371|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
7973911|NCT02918318|12537372|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
7973912|NCT02918318|12537373|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
7973913|NCT02918318|12537369|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
7973914|NCT02918318|12537370|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
7973915|NCT02918318|12537371|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
7973916|NCT02918318|12537372|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
7973917|NCT02918318|12537373|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
7973918|NCT02918318|12537369|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0
7973919|NCT02918318|12537370|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3
7973920|NCT02918318|12537371|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1
7973921|NCT02918318|12537372|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1
7973922|NCT02918318|12537373|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0
7973923|NCT02918318|12537369|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7973924|NCT02918318|12537370|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7973925|NCT02918318|12537371|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7973926|NCT02918318|12537372|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7973927|NCT02918318|12537373|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1
7973928|NCT02918318|12537369|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7973929|NCT02918318|12537370|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7973930|NCT02918318|12537371|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7973931|NCT02918318|12537372|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7973932|NCT02918318|12537373|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1
7973933|NCT02918552|12537431|FG000|Overall Study|Failed Pharmacokinetics|1
7973934|NCT02918552|12537432|FG001|Overall Study|Failed Pharmacokinetics|0
7973935|NCT02918552|12537431|FG000|Overall Study|Withdrawal by Subject|0
7973936|NCT02918552|12537432|FG001|Overall Study|Withdrawal by Subject|1
7973937|NCT02918552|12537431|FG000|Overall Study|Lost to Follow-up|0
7973938|NCT02918552|12537432|FG001|Overall Study|Lost to Follow-up|1
7973939|NCT02918877|12537526|FG000|Overall Study|Withdrawal by Subject|2
7973940|NCT02918877|12537527|FG001|Overall Study|Withdrawal by Subject|2
7973941|NCT02918877|12537526|FG000|Overall Study|Surgery cancelled|1
7973942|NCT02918877|12537527|FG001|Overall Study|Surgery cancelled|0
7973943|NCT02918877|12537526|FG000|Overall Study|Physician Decision|1
7973944|NCT02918877|12537527|FG001|Overall Study|Physician Decision|0
7973945|NCT02918877|12537526|FG000|Overall Study|Received intraoperative steroids|1
7973946|NCT02918877|12537527|FG001|Overall Study|Received intraoperative steroids|0
7973947|NCT02918877|12537526|FG000|Overall Study|Unable to obtain lab samples|1
7973948|NCT02918877|12537527|FG001|Overall Study|Unable to obtain lab samples|0
7973949|NCT02918877|12537526|FG000|Overall Study|Unsafe to perform BAL|0
7973950|NCT02918877|12537527|FG001|Overall Study|Unsafe to perform BAL|1
7973951|NCT02918968|12537535|FG000|1st Line AAT|Progressive disease|9
7973952|NCT02918968|12537536|FG001|1st Line AAT|Progressive disease|4
7973953|NCT02918968|12537535|FG000|1st Line AAT|Adverse Event|12
7973954|NCT02918968|12537536|FG001|1st Line AAT|Adverse Event|3
7973955|NCT02918968|12537535|FG000|1st Line AAT|Physician Decision|4
7973956|NCT02918968|12537536|FG001|1st Line AAT|Physician Decision|2
7973957|NCT02918968|12537535|FG000|1st Line AAT|Withdrawal by Subject|2
7973958|NCT02918968|12537536|FG001|1st Line AAT|Withdrawal by Subject|1
7973959|NCT02918968|12537535|FG000|1st Line AAT|Lost to Follow-up|0
7973960|NCT02918968|12537536|FG001|1st Line AAT|Lost to Follow-up|1
7973961|NCT02918968|12537535|FG000|1st Line AAT|Death|1
7973962|NCT02918968|12537536|FG001|1st Line AAT|Death|0
7973963|NCT02918968|12537535|FG000|1st Line AAT|Miscellaneous|1
7973964|NCT02918968|12537536|FG001|1st Line AAT|Miscellaneous|0
7973965|NCT02918968|12537535|FG000|2nd Line AAT|Progressive disease|21
7973966|NCT02918968|12537536|FG001|2nd Line AAT|Progressive disease|3
7973967|NCT02918968|12537535|FG000|2nd Line AAT|Adverse Event|2
7973968|NCT02918968|12537536|FG001|2nd Line AAT|Adverse Event|5
7973969|NCT02918968|12537535|FG000|2nd Line AAT|Physician Decision|0
7973970|NCT02918968|12537536|FG001|2nd Line AAT|Physician Decision|1
7973971|NCT02918968|12537535|FG000|2nd Line AAT|Withdrawal by Subject|2
7973972|NCT02918968|12537536|FG001|2nd Line AAT|Withdrawal by Subject|2
7973973|NCT02918968|12537535|FG000|2nd Line AAT|Death|0
7973974|NCT02918968|12537536|FG001|2nd Line AAT|Death|1
7973975|NCT02919267|12537556|FG000|Overall Study|Protocol Violation|0
7973976|NCT02919267|12537557|FG001|Overall Study|Protocol Violation|3
7973977|NCT02919267|12537558|FG002|Overall Study|Protocol Violation|3
7973978|NCT02919267|12537559|FG003|Overall Study|Protocol Violation|4
7973979|NCT02919475|12537583|FG000|Overall Study|Adverse Event|3
7973980|NCT02919475|12537584|FG001|Overall Study|Adverse Event|3
7973981|NCT02919475|12537585|FG002|Overall Study|Adverse Event|3
7973982|NCT02919475|12537586|FG003|Overall Study|Adverse Event|9
7973983|NCT02919475|12537587|FG004|Overall Study|Adverse Event|2
7973984|NCT02919475|12537583|FG000|Overall Study|Death|0
7973985|NCT02919475|12537584|FG001|Overall Study|Death|1
7973986|NCT02919475|12537585|FG002|Overall Study|Death|0
7973987|NCT02919475|12537586|FG003|Overall Study|Death|0
7973988|NCT02919475|12537587|FG004|Overall Study|Death|0
7973989|NCT02919475|12537583|FG000|Overall Study|Lost to Follow-up|0
7973990|NCT02919475|12537584|FG001|Overall Study|Lost to Follow-up|0
7973991|NCT02919475|12537585|FG002|Overall Study|Lost to Follow-up|0
7973992|NCT02919475|12537586|FG003|Overall Study|Lost to Follow-up|1
7973993|NCT02919475|12537587|FG004|Overall Study|Lost to Follow-up|0
7973994|NCT02919475|12537583|FG000|Overall Study|Withdrawal by Subject|2
7973995|NCT02919475|12537584|FG001|Overall Study|Withdrawal by Subject|3
7973996|NCT02919475|12537585|FG002|Overall Study|Withdrawal by Subject|1
7973997|NCT02919475|12537586|FG003|Overall Study|Withdrawal by Subject|2
7973998|NCT02919475|12537587|FG004|Overall Study|Withdrawal by Subject|2
7973999|NCT02919475|12537583|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7974000|NCT02919475|12537584|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7974001|NCT02919475|12537585|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7974002|NCT02919475|12537586|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7974003|NCT02919475|12537587|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7974004|NCT02919696|12537608|FG000|Overall Study|Adverse Event|1
7974005|NCT02919696|12537609|FG001|Overall Study|Adverse Event|2
7974006|NCT02919696|12537608|FG000|Overall Study|Withdrawal by Subject|2
7974007|NCT02919696|12537609|FG001|Overall Study|Withdrawal by Subject|1
7974008|NCT02919696|12537608|FG000|Overall Study|Sponsor Decision|1
7974009|NCT02919696|12537609|FG001|Overall Study|Sponsor Decision|1
7974010|NCT02919696|12537608|FG000|Overall Study|Never Treated|0
7974011|NCT02919696|12537609|FG001|Overall Study|Never Treated|1
7974012|NCT02919761|12537621|FG000|Part 1: Open Label|Withdrawal by Subject|12
7974013|NCT02919761|12537622|FG001|Part 1: Open Label|Withdrawal by Subject|0
7974014|NCT02919761|12537623|FG002|Part 1: Open Label|Withdrawal by Subject|0
7974015|NCT02919761|12537621|FG000|Part 1: Open Label|Adverse Event|1
7974016|NCT02919761|12537622|FG001|Part 1: Open Label|Adverse Event|0
7974017|NCT02919761|12537623|FG002|Part 1: Open Label|Adverse Event|0
7974018|NCT02919761|12537621|FG000|Part 1: Open Label|Lost to Follow-up|1
7974019|NCT02919761|12537622|FG001|Part 1: Open Label|Lost to Follow-up|0
7974020|NCT02919761|12537623|FG002|Part 1: Open Label|Lost to Follow-up|0
7974021|NCT02919761|12537621|FG000|Part 1: Open Label|Met withdrawal criteria|5
7974022|NCT02919761|12537622|FG001|Part 1: Open Label|Met withdrawal criteria|0
7974023|NCT02919761|12537623|FG002|Part 1: Open Label|Met withdrawal criteria|0
7974024|NCT02919761|12537621|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2
7974025|NCT02919761|12537622|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
7974026|NCT02919761|12537623|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
7974027|NCT02919761|12537621|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1
7974028|NCT02919761|12537622|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0
7974029|NCT02919761|12537623|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0
7974030|NCT02919761|12537621|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1
7974031|NCT02919761|12537622|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0
7974032|NCT02919761|12537623|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0
7974033|NCT02919761|12537621|FG000|Part 1: Open Label|Termination by Sponsor|1
7974034|NCT02919761|12537622|FG001|Part 1: Open Label|Termination by Sponsor|0
7974035|NCT02919761|12537623|FG002|Part 1: Open Label|Termination by Sponsor|0
7974036|NCT02919761|12537621|FG000|Part 2: Double-blind|Withdrawal by Subject|0
7974037|NCT02919761|12537622|FG001|Part 2: Double-blind|Withdrawal by Subject|0
7974038|NCT02919761|12537623|FG002|Part 2: Double-blind|Withdrawal by Subject|2
7974039|NCT02919761|12537621|FG000|Part 2: Double-blind|Adverse Event|0
7974040|NCT02919761|12537622|FG001|Part 2: Double-blind|Adverse Event|1
7974041|NCT02919761|12537623|FG002|Part 2: Double-blind|Adverse Event|0
7974042|NCT02919761|12537621|FG000|Part 2: Double-blind|Lost to Follow-up|0
7974043|NCT02919761|12537622|FG001|Part 2: Double-blind|Lost to Follow-up|0
7974044|NCT02919761|12537623|FG002|Part 2: Double-blind|Lost to Follow-up|3
7974045|NCT02919761|12537621|FG000|Part 2: Double-blind|Met withdrawal criteria|0
7974046|NCT02919761|12537622|FG001|Part 2: Double-blind|Met withdrawal criteria|1
7974047|NCT02919761|12537623|FG002|Part 2: Double-blind|Met withdrawal criteria|2
7974048|NCT02919761|12537621|FG000|Part 2: Double-blind|Worsening of disease activity|0
7974049|NCT02919761|12537622|FG001|Part 2: Double-blind|Worsening of disease activity|4
7974050|NCT02919761|12537623|FG002|Part 2: Double-blind|Worsening of disease activity|10
7974051|NCT02919761|12537621|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0
7974052|NCT02919761|12537622|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0
7974053|NCT02919761|12537623|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1
7974054|NCT02919761|12537621|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0
7974055|NCT02919761|12537622|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0
7974056|NCT02919761|12537623|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1
7974057|NCT02919761|12537621|FG000|Part 2: Double-blind|Discontinued exclusion 16|0
7974058|NCT02919761|12537622|FG001|Part 2: Double-blind|Discontinued exclusion 16|0
7974059|NCT02919761|12537623|FG002|Part 2: Double-blind|Discontinued exclusion 16|2
7974060|NCT02919995|12537660|FG000|Overall Study|Adverse Event|0
7974061|NCT02919995|12537661|FG001|Overall Study|Adverse Event|0
7974062|NCT02919995|12537662|FG002|Overall Study|Adverse Event|0
7974063|NCT02919995|12537663|FG003|Overall Study|Adverse Event|0
7974064|NCT02919995|12537664|FG004|Overall Study|Adverse Event|0
7974065|NCT02919995|12537665|FG005|Overall Study|Adverse Event|1
7974066|NCT02920528|12537676|FG000|Overall Study|Incomplete Data|1
7974067|NCT02920528|12537677|FG001|Overall Study|Incomplete Data|1
7974068|NCT02920528|12537678|FG002|Overall Study|Incomplete Data|1
7974069|NCT02920528|12537676|FG000|Overall Study|Adverse Event|0
7974070|NCT02920528|12537677|FG001|Overall Study|Adverse Event|0
7974071|NCT02920528|12537678|FG002|Overall Study|Adverse Event|3
7974072|NCT02920528|12537676|FG000|Overall Study|Did not meet inclusion criteria|2
7974073|NCT02920528|12537677|FG001|Overall Study|Did not meet inclusion criteria|0
7974074|NCT02920528|12537678|FG002|Overall Study|Did not meet inclusion criteria|1
7974075|NCT02920957|12537716|FG000|First Intervention : 1 Month|Withdrawal by Subject|2
7974076|NCT02920957|12537717|FG001|First Intervention : 1 Month|Withdrawal by Subject|0
7974077|NCT02920957|12537716|FG000|First Intervention : 1 Month|Lost to Follow-up|1
7974078|NCT02920957|12537717|FG001|First Intervention : 1 Month|Lost to Follow-up|0
7974079|NCT02920957|12537716|FG000|First Intervention : 1 Month|Adverse Event|1
7974080|NCT02920957|12537717|FG001|First Intervention : 1 Month|Adverse Event|0
7974081|NCT02920957|12537716|FG000|Second Intervention: 1 Month|Lost to Follow-up|0
7974082|NCT02920957|12537717|FG001|Second Intervention: 1 Month|Lost to Follow-up|1
7974083|NCT02920970|12537734|FG000|First Intervention|Protocol Violation|0
7974084|NCT02920970|12537735|FG001|First Intervention|Protocol Violation|1
7974085|NCT02920970|12537734|FG000|First Intervention|Adverse Event|0
7974086|NCT02920970|12537735|FG001|First Intervention|Adverse Event|1
7974087|NCT02920970|12537734|FG000|Second Intervention|Poor Lens Fit|1
7974088|NCT02920970|12537735|FG001|Second Intervention|Poor Lens Fit|0
7974089|NCT02920983|12537743|FG000|Dispense 1|Unacceptable Lens Fit|0
7974090|NCT02920983|12537744|FG001|Dispense 1|Unacceptable Lens Fit|0
7974091|NCT02920983|12537745|FG002|Dispense 1|Unacceptable Lens Fit|0
7974092|NCT02920983|12537746|FG003|Dispense 1|Unacceptable Lens Fit|0
7974093|NCT02920983|12537747|FG004|Dispense 1|Unacceptable Lens Fit|1
7974094|NCT02920983|12537748|FG005|Dispense 1|Unacceptable Lens Fit|0
7974095|NCT02920983|12537743|FG000|Dispense 2|Unscceptable lens fit|1
7974096|NCT02920983|12537744|FG001|Dispense 2|Unscceptable lens fit|0
7974097|NCT02920983|12537745|FG002|Dispense 2|Unscceptable lens fit|0
7974098|NCT02920983|12537746|FG003|Dispense 2|Unscceptable lens fit|0
7974099|NCT02920983|12537747|FG004|Dispense 2|Unscceptable lens fit|1
7974100|NCT02920983|12537748|FG005|Dispense 2|Unscceptable lens fit|0
7974101|NCT02920983|12537743|FG000|Dispense 3|Unacceptable Lens Fit|1
7974102|NCT02920983|12537744|FG001|Dispense 3|Unacceptable Lens Fit|1
7974103|NCT02920983|12537745|FG002|Dispense 3|Unacceptable Lens Fit|0
7974104|NCT02920983|12537746|FG003|Dispense 3|Unacceptable Lens Fit|0
7974105|NCT02920983|12537747|FG004|Dispense 3|Unacceptable Lens Fit|1
7974106|NCT02920983|12537748|FG005|Dispense 3|Unacceptable Lens Fit|0
7974107|NCT02921087|12537762|FG000|Overall Study|Withdrawal by Subject|0
7974108|NCT02921087|12537763|FG001|Overall Study|Withdrawal by Subject|1
7974109|NCT02921425|12537807|FG000|Overall Study|Protocol Violation|9
7974110|NCT02921750|12537821|FG000|Overall Study|Adverse Event|1
7974111|NCT02921750|12537822|FG001|Overall Study|Adverse Event|2
7717994|NCT00524121|12141677|FG000|Overall Study|Other|1
7717995|NCT00524121|12141677|FG000|Overall Study|Death|1
7717996|NCT00524121|12141677|FG000|Overall Study|Not treated (became ineligible)|4
7717997|NCT00524121|12141677|FG000|Overall Study|Not treated (changed mind)|1
7717998|NCT00524173|12141694|FG000|Overall Study|Lost to Follow-up|0
7717999|NCT00524173|12141695|FG001|Overall Study|Lost to Follow-up|1
7718000|NCT00524173|12141694|FG000|Overall Study|Death|1
7718001|NCT00524173|12141695|FG001|Overall Study|Death|0
7718002|NCT00524173|12141694|FG000|Overall Study|Had not reached endpoint at study close|4
7718003|NCT00524173|12141695|FG001|Overall Study|Had not reached endpoint at study close|1
7718004|NCT00524303|12141718|FG000|Overall Study|Lost to Follow-up|6
7718005|NCT00524303|12141719|FG001|Overall Study|Lost to Follow-up|0
7718006|NCT00524303|12141720|FG002|Overall Study|Lost to Follow-up|3
7718007|NCT00524303|12141718|FG000|Overall Study|Protocol Violation|0
7718008|NCT00524303|12141719|FG001|Overall Study|Protocol Violation|1
7718009|NCT00524303|12141720|FG002|Overall Study|Protocol Violation|1
7718010|NCT00524303|12141718|FG000|Overall Study|Withdrawal by Subject|3
7718011|NCT00524303|12141719|FG001|Overall Study|Withdrawal by Subject|0
7718012|NCT00524303|12141720|FG002|Overall Study|Withdrawal by Subject|4
7718013|NCT00524303|12141718|FG000|Overall Study|Death|0
7718014|NCT00524303|12141719|FG001|Overall Study|Death|2
7974112|NCT02921750|12537821|FG000|Overall Study|Withdrawal by Subject|1
7974113|NCT02921750|12537822|FG001|Overall Study|Withdrawal by Subject|1
7974114|NCT02921750|12537821|FG000|Overall Study|Lost to Follow-up|3
7974115|NCT02921750|12537822|FG001|Overall Study|Lost to Follow-up|3
7974116|NCT02921750|12537821|FG000|Overall Study|Wound healed|3
7974117|NCT02921750|12537822|FG001|Overall Study|Wound healed|3
7974118|NCT02921750|12537821|FG000|Overall Study|Serious Adverse Event|1
7974119|NCT02921750|12537822|FG001|Overall Study|Serious Adverse Event|2
7974120|NCT02922153|12537842|FG000|Overall Study|Death|8
7974121|NCT02922153|12537843|FG001|Overall Study|Death|1
7974122|NCT02922153|12537842|FG000|Overall Study|Lost to Follow-up|1
7974123|NCT02922153|12537843|FG001|Overall Study|Lost to Follow-up|0
7974124|NCT02922153|12537842|FG000|Overall Study|Physician Decision|1
7974125|NCT02922153|12537843|FG001|Overall Study|Physician Decision|1
7974126|NCT02922634|12537866|FG000|Overall Study|Withdrawal by Subject|5
7974127|NCT02922634|12537866|FG000|Overall Study|Did not have their surgery|5
7974128|NCT02923115|12537912|FG000|Overall Study|Lost to Follow-up|0
7974129|NCT02923115|12537913|FG001|Overall Study|Lost to Follow-up|0
7974130|NCT02923115|12537914|FG002|Overall Study|Lost to Follow-up|0
7974131|NCT02923115|12537915|FG003|Overall Study|Lost to Follow-up|1
7974132|NCT02923115|12537916|FG004|Overall Study|Lost to Follow-up|0
7974133|NCT02923115|12537917|FG005|Overall Study|Lost to Follow-up|0
7974134|NCT02923115|12537912|FG000|Overall Study|Withdrawal by Subject|0
7974135|NCT02923115|12537913|FG001|Overall Study|Withdrawal by Subject|1
7974136|NCT02923115|12537914|FG002|Overall Study|Withdrawal by Subject|0
7974137|NCT02923115|12537915|FG003|Overall Study|Withdrawal by Subject|0
7974138|NCT02923115|12537916|FG004|Overall Study|Withdrawal by Subject|0
7974139|NCT02923115|12537917|FG005|Overall Study|Withdrawal by Subject|0
7974140|NCT02923115|12537912|FG000|Overall Study|Randomized, but not dosed|0
7974141|NCT02923115|12537913|FG001|Overall Study|Randomized, but not dosed|0
7974142|NCT02923115|12537914|FG002|Overall Study|Randomized, but not dosed|3
7974143|NCT02923115|12537915|FG003|Overall Study|Randomized, but not dosed|1
7974144|NCT02923115|12537916|FG004|Overall Study|Randomized, but not dosed|5
7974145|NCT02923115|12537917|FG005|Overall Study|Randomized, but not dosed|0
7974146|NCT02923245|12537938|FG000|Overall Study|ultrasound order was cancelled|2
7974147|NCT02923245|12537939|FG001|Overall Study|ultrasound order was cancelled|1
7974148|NCT02923349|12537962|FG000|Overall Study|Other|1
7974149|NCT02923349|12537963|FG001|Overall Study|Other|2
7974150|NCT02923349|12537964|FG002|Overall Study|Other|4
7974151|NCT02923349|12537965|FG003|Overall Study|Other|1
7974152|NCT02923349|12537966|FG004|Overall Study|Other|3
7974153|NCT02923349|12537967|FG005|Overall Study|Other|0
7974154|NCT02923349|12537968|FG006|Overall Study|Other|1
7974155|NCT02923349|12537962|FG000|Overall Study|Withdrawal by Subject|2
7974156|NCT02923349|12537963|FG001|Overall Study|Withdrawal by Subject|2
7974157|NCT02923349|12537964|FG002|Overall Study|Withdrawal by Subject|8
7974158|NCT02923349|12537965|FG003|Overall Study|Withdrawal by Subject|10
7974159|NCT02923349|12537966|FG004|Overall Study|Withdrawal by Subject|12
7974160|NCT02923349|12537967|FG005|Overall Study|Withdrawal by Subject|3
7974161|NCT02923349|12537968|FG006|Overall Study|Withdrawal by Subject|0
7974162|NCT02923349|12537962|FG000|Overall Study|Physician Decision|0
7974163|NCT02923349|12537963|FG001|Overall Study|Physician Decision|0
7974164|NCT02923349|12537964|FG002|Overall Study|Physician Decision|0
7974165|NCT02923349|12537965|FG003|Overall Study|Physician Decision|1
7974166|NCT02923349|12537966|FG004|Overall Study|Physician Decision|1
7974167|NCT02923349|12537967|FG005|Overall Study|Physician Decision|0
7974168|NCT02923349|12537968|FG006|Overall Study|Physician Decision|2
7974169|NCT02923349|12537962|FG000|Overall Study|Lost to Follow-up|0
7974170|NCT02923349|12537963|FG001|Overall Study|Lost to Follow-up|0
7974171|NCT02923349|12537964|FG002|Overall Study|Lost to Follow-up|3
7974172|NCT02923349|12537965|FG003|Overall Study|Lost to Follow-up|0
7974173|NCT02923349|12537966|FG004|Overall Study|Lost to Follow-up|1
7974174|NCT02923349|12537967|FG005|Overall Study|Lost to Follow-up|1
7974175|NCT02923349|12537968|FG006|Overall Study|Lost to Follow-up|0
7974176|NCT02923349|12537962|FG000|Overall Study|Death|1
7974177|NCT02923349|12537963|FG001|Overall Study|Death|0
7974178|NCT02923349|12537964|FG002|Overall Study|Death|2
7974179|NCT02923349|12537965|FG003|Overall Study|Death|4
7974180|NCT02923349|12537966|FG004|Overall Study|Death|2
7974181|NCT02923349|12537967|FG005|Overall Study|Death|3
7974182|NCT02923349|12537968|FG006|Overall Study|Death|0
7974183|NCT02923427|12537986|FG000|Overall Study|convert to laparatomy|2
7974184|NCT02923427|12537987|FG001|Overall Study|convert to laparatomy|2
7974185|NCT02923427|12537986|FG000|Overall Study|destaturation|1
7974186|NCT02923427|12537987|FG001|Overall Study|destaturation|0
7974187|NCT02923427|12537986|FG000|Overall Study|can not replace LMA|1
7974188|NCT02923427|12537987|FG001|Overall Study|can not replace LMA|0
7974189|NCT02923921|12538004|FG000|Overall Study|Sponsor Decision|39
7974190|NCT02923921|12538005|FG001|Overall Study|Sponsor Decision|38
7974191|NCT02923921|12538004|FG000|Overall Study|Lost to Follow-up|1
7974192|NCT02923921|12538005|FG001|Overall Study|Lost to Follow-up|0
7974193|NCT02923921|12538004|FG000|Overall Study|Withdrawal by Subject|6
7974194|NCT02923921|12538005|FG001|Overall Study|Withdrawal by Subject|13
7974195|NCT02923921|12538004|FG000|Overall Study|Unknown, Not Collected|7
7974196|NCT02923921|12538005|FG001|Overall Study|Unknown, Not Collected|6
7974197|NCT02924051|12538013|FG000|Overall Study|Withdrawal by Subject|1
7974198|NCT02924051|12538014|FG001|Overall Study|Withdrawal by Subject|9
7974199|NCT02924428|12538033|FG000|Overall Study|Adverse Event|1
7974200|NCT02924428|12538034|FG001|Overall Study|Adverse Event|0
7974201|NCT02924428|12538033|FG000|Overall Study|Physician Decision|1
7974202|NCT02924428|12538034|FG001|Overall Study|Physician Decision|0
7974203|NCT02924428|12538033|FG000|Overall Study|Lost to Follow-up|2
7974204|NCT02924428|12538034|FG001|Overall Study|Lost to Follow-up|4
7974205|NCT02924428|12538033|FG000|Overall Study|Pregnancy|0
7974206|NCT02924428|12538034|FG001|Overall Study|Pregnancy|1
7974207|NCT02924688|12538046|FG000|Overall Study|Adverse Event|9
7974208|NCT02924688|12538047|FG001|Overall Study|Adverse Event|3
7974209|NCT02924688|12538048|FG002|Overall Study|Adverse Event|2
7974210|NCT02924688|12538049|FG003|Overall Study|Adverse Event|2
7974211|NCT02924688|12538050|FG004|Overall Study|Adverse Event|3
7974212|NCT02924688|12538051|FG005|Overall Study|Adverse Event|2
7974213|NCT02924688|12538046|FG000|Overall Study|Lack of Efficacy|2
7974214|NCT02924688|12538047|FG001|Overall Study|Lack of Efficacy|3
7974215|NCT02924688|12538048|FG002|Overall Study|Lack of Efficacy|4
7974216|NCT02924688|12538049|FG003|Overall Study|Lack of Efficacy|2
7974217|NCT02924688|12538050|FG004|Overall Study|Lack of Efficacy|1
7974218|NCT02924688|12538051|FG005|Overall Study|Lack of Efficacy|1
7974219|NCT02924688|12538046|FG000|Overall Study|Protocol Violation|3
7974220|NCT02924688|12538047|FG001|Overall Study|Protocol Violation|7
7974221|NCT02924688|12538048|FG002|Overall Study|Protocol Violation|5
7974222|NCT02924688|12538049|FG003|Overall Study|Protocol Violation|6
7974223|NCT02924688|12538050|FG004|Overall Study|Protocol Violation|2
7974224|NCT02924688|12538051|FG005|Overall Study|Protocol Violation|2
7974225|NCT02924688|12538046|FG000|Overall Study|Protocol defined withdrawal criteria met|1
7974226|NCT02924688|12538047|FG001|Overall Study|Protocol defined withdrawal criteria met|0
7974227|NCT02924688|12538048|FG002|Overall Study|Protocol defined withdrawal criteria met|1
7974228|NCT02924688|12538049|FG003|Overall Study|Protocol defined withdrawal criteria met|1
7974229|NCT02924688|12538050|FG004|Overall Study|Protocol defined withdrawal criteria met|1
7974230|NCT02924688|12538051|FG005|Overall Study|Protocol defined withdrawal criteria met|0
7974231|NCT02924688|12538046|FG000|Overall Study|Lost to Follow-up|2
7974232|NCT02924688|12538047|FG001|Overall Study|Lost to Follow-up|4
7974233|NCT02924688|12538048|FG002|Overall Study|Lost to Follow-up|2
7974234|NCT02924688|12538049|FG003|Overall Study|Lost to Follow-up|4
7974235|NCT02924688|12538050|FG004|Overall Study|Lost to Follow-up|2
7974236|NCT02924688|12538051|FG005|Overall Study|Lost to Follow-up|4
7974237|NCT02924688|12538046|FG000|Overall Study|Physician Decision|2
7974238|NCT02924688|12538047|FG001|Overall Study|Physician Decision|1
7974239|NCT02924688|12538048|FG002|Overall Study|Physician Decision|0
7974240|NCT02924688|12538049|FG003|Overall Study|Physician Decision|1
7974241|NCT02924688|12538050|FG004|Overall Study|Physician Decision|1
7974242|NCT02924688|12538051|FG005|Overall Study|Physician Decision|1
7974243|NCT02924688|12538046|FG000|Overall Study|Withdrawal by Subject|14
7974244|NCT02924688|12538047|FG001|Overall Study|Withdrawal by Subject|13
7974245|NCT02924688|12538048|FG002|Overall Study|Withdrawal by Subject|9
7974246|NCT02924688|12538049|FG003|Overall Study|Withdrawal by Subject|12
7974247|NCT02924688|12538050|FG004|Overall Study|Withdrawal by Subject|13
7974248|NCT02924688|12538051|FG005|Overall Study|Withdrawal by Subject|14
7974249|NCT02924883|12538070|FG000|Overall Study|Death|39
7974250|NCT02924883|12538071|FG001|Overall Study|Death|20
7974251|NCT02924883|12538070|FG000|Overall Study|Lost to Follow-up|1
7974252|NCT02924883|12538071|FG001|Overall Study|Lost to Follow-up|0
7974253|NCT02924883|12538070|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0
7974254|NCT02924883|12538071|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1
7974255|NCT02924883|12538070|FG000|Overall Study|Protocol Violation|1
7974256|NCT02924883|12538071|FG001|Overall Study|Protocol Violation|0
7974257|NCT02924883|12538070|FG000|Overall Study|Withdrawal by Subject|22
7974258|NCT02924883|12538071|FG001|Overall Study|Withdrawal by Subject|16
7974259|NCT02924883|12538070|FG000|Overall Study|Progressive Disease|1
7974260|NCT02924883|12538071|FG001|Overall Study|Progressive Disease|0
7974261|NCT02924883|12538070|FG000|Overall Study|Study Terminated by Sponsor|69
7974262|NCT02924883|12538071|FG001|Overall Study|Study Terminated by Sponsor|32
7974263|NCT02925117|12538092|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1
7974264|NCT02925117|12538093|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3
7974265|NCT02925117|12538094|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1
7974266|NCT02925117|12538095|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2
7974267|NCT02925117|12538096|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0
7974268|NCT02925117|12538097|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0
7974269|NCT02925117|12538098|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0
7974270|NCT02925117|12538099|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0
7974271|NCT02925117|12538100|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0
7974272|NCT02925117|12538101|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0
7974273|NCT02925117|12538102|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0
7974274|NCT02925117|12538103|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0
7974275|NCT02925117|12538092|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10
7974276|NCT02925117|12538093|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
7974277|NCT02925117|12538094|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
7974278|NCT02925117|12538095|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7974279|NCT02925117|12538096|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7974280|NCT02925117|12538097|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7974281|NCT02925117|12538098|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7974282|NCT02925117|12538099|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7974283|NCT02925117|12538100|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7974284|NCT02925117|12538101|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7974285|NCT02925117|12538102|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7974286|NCT02925117|12538103|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7974287|NCT02925117|12538092|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2
7974288|NCT02925117|12538093|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1
7974289|NCT02925117|12538094|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7974290|NCT02925117|12538095|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7974291|NCT02925117|12538096|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7974292|NCT02925117|12538097|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7974293|NCT02925117|12538098|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7974294|NCT02925117|12538099|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7974295|NCT02925117|12538100|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7974296|NCT02925117|12538101|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7974297|NCT02925117|12538102|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7974298|NCT02925117|12538103|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7974299|NCT02925117|12538092|FG000|Period 1 (Weeks 0 - 16)|Other|5
7974300|NCT02925117|12538093|FG001|Period 1 (Weeks 0 - 16)|Other|4
7974301|NCT02925117|12538094|FG002|Period 1 (Weeks 0 - 16)|Other|1
7974302|NCT02925117|12538095|FG003|Period 1 (Weeks 0 - 16)|Other|1
7974303|NCT02925117|12538096|FG004|Period 1 (Weeks 0 - 16)|Other|0
7974304|NCT02925117|12538097|FG005|Period 1 (Weeks 0 - 16)|Other|0
7974305|NCT02925117|12538098|FG006|Period 1 (Weeks 0 - 16)|Other|0
7974306|NCT02925117|12538099|FG007|Period 1 (Weeks 0 - 16)|Other|0
7974307|NCT02925117|12538100|FG008|Period 1 (Weeks 0 - 16)|Other|0
7974308|NCT02925117|12538101|FG009|Period 1 (Weeks 0 - 16)|Other|0
7974309|NCT02925117|12538102|FG010|Period 1 (Weeks 0 - 16)|Other|0
7974310|NCT02925117|12538103|FG011|Period 1 (Weeks 0 - 16)|Other|0
7974311|NCT02925117|12538092|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0
7974312|NCT02925117|12538093|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0
7974313|NCT02925117|12538094|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0
7974314|NCT02925117|12538095|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0
7974315|NCT02925117|12538096|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0
7974316|NCT02925117|12538097|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1
7974317|NCT02925117|12538098|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0
7974318|NCT02925117|12538099|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0
7974319|NCT02925117|12538100|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0
7974320|NCT02925117|12538101|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0
7974321|NCT02925117|12538102|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3
7974322|NCT02925117|12538103|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2
7974323|NCT02925117|12538092|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7974324|NCT02925117|12538093|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7974325|NCT02925117|12538094|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7974326|NCT02925117|12538095|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7974327|NCT02925117|12538096|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7974328|NCT02925117|12538097|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1
7974329|NCT02925117|12538098|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4
7974330|NCT02925117|12538099|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3
7974331|NCT02925117|12538100|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7974332|NCT02925117|12538101|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7974333|NCT02925117|12538102|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7974334|NCT02925117|12538103|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7974335|NCT02925117|12538092|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7974336|NCT02925117|12538093|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7974337|NCT02925117|12538094|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7974338|NCT02925117|12538095|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7974339|NCT02925117|12538096|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7974340|NCT02925117|12538097|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2
7974341|NCT02925117|12538098|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7974342|NCT02925117|12538099|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7974343|NCT02925117|12538100|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7974344|NCT02925117|12538101|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7974345|NCT02925117|12538102|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7974346|NCT02925117|12538103|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7974347|NCT02925117|12538092|FG000|Period 2 (Weeks 16 - 88)|Other|0
7974348|NCT02925117|12538093|FG001|Period 2 (Weeks 16 - 88)|Other|0
7974349|NCT02925117|12538094|FG002|Period 2 (Weeks 16 - 88)|Other|0
7974350|NCT02925117|12538095|FG003|Period 2 (Weeks 16 - 88)|Other|0
7974351|NCT02925117|12538096|FG004|Period 2 (Weeks 16 - 88)|Other|1
7974352|NCT02925117|12538097|FG005|Period 2 (Weeks 16 - 88)|Other|1
7974353|NCT02925117|12538098|FG006|Period 2 (Weeks 16 - 88)|Other|1
7974354|NCT02925117|12538099|FG007|Period 2 (Weeks 16 - 88)|Other|1
7974355|NCT02925117|12538100|FG008|Period 2 (Weeks 16 - 88)|Other|3
7974356|NCT02925117|12538101|FG009|Period 2 (Weeks 16 - 88)|Other|4
7974357|NCT02925117|12538102|FG010|Period 2 (Weeks 16 - 88)|Other|3
7974358|NCT02925117|12538103|FG011|Period 2 (Weeks 16 - 88)|Other|0
7974359|NCT02925312|12538131|FG000|Overall Study|Lost to Follow-up|25
7974360|NCT02925312|12538132|FG001|Overall Study|Lost to Follow-up|0
7974361|NCT02925312|12538131|FG000|Overall Study|Adverse Event|2
7974362|NCT02925312|12538132|FG001|Overall Study|Adverse Event|0
7974363|NCT02925403|12538140|FG000|Overall Study|Lost to Follow-up|0
7974364|NCT02925403|12538141|FG001|Overall Study|Lost to Follow-up|1
7974365|NCT02925455|12538149|FG000|Overall Study|Withdrawal by Subject|2
7974366|NCT02925455|12538150|FG001|Overall Study|Withdrawal by Subject|0
7974367|NCT02925494|12538160|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
7974368|NCT02925494|12538161|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
7974369|NCT02925494|12538162|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
7974370|NCT02925494|12538163|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23
7974371|NCT02925494|12538160|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7974372|NCT02925494|12538161|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7974373|NCT02925494|12538162|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9
7974374|NCT02925494|12538163|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10
7974375|NCT02925494|12538160|FG000|Post-Treatment Follow-Up Period|Other|1
7974376|NCT02925494|12538161|FG001|Post-Treatment Follow-Up Period|Other|4
7974377|NCT02925494|12538162|FG002|Post-Treatment Follow-Up Period|Other|3
7974378|NCT02925494|12538163|FG003|Post-Treatment Follow-Up Period|Other|6
7974379|NCT02925494|12538160|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1
7974380|NCT02925494|12538161|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
7974381|NCT02925494|12538162|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
7974382|NCT02925494|12538163|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6
7974383|NCT02925494|12538160|FG000|Post-Treatment Follow-Up Period|Pregnancy|1
7974384|NCT02925494|12538161|FG001|Post-Treatment Follow-Up Period|Pregnancy|0
7974385|NCT02925494|12538162|FG002|Post-Treatment Follow-Up Period|Pregnancy|1
7974386|NCT02925494|12538163|FG003|Post-Treatment Follow-Up Period|Pregnancy|2
7974387|NCT02925494|12538160|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
7974388|NCT02925494|12538161|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0
7974389|NCT02925494|12538162|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1
7974390|NCT02925494|12538163|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2
7974391|NCT02925494|12538160|FG000|Post-Treatment Follow-Up Period|Adverse Event|0
7974392|NCT02925494|12538161|FG001|Post-Treatment Follow-Up Period|Adverse Event|0
7974393|NCT02925494|12538162|FG002|Post-Treatment Follow-Up Period|Adverse Event|0
7974394|NCT02925494|12538163|FG003|Post-Treatment Follow-Up Period|Adverse Event|1
7974395|NCT02925741|12538185|FG000|Overall Study|Withdrawal by Subject|11
7974396|NCT02925741|12538186|FG001|Overall Study|Withdrawal by Subject|0
7974397|NCT02925923|12538206|FG000|Overall Study|blood samples hemolyzed|0
7974398|NCT02925923|12538207|FG001|Overall Study|blood samples hemolyzed|2
7974399|NCT02926209|12538222|FG000|Study Cohort|Poor Bowel Preparation|1
7974400|NCT02926209|12538223|FG001|Study Cohort|Poor Bowel Preparation|0
7974401|NCT02926573|12538232|FG000|Overall Study|Nausea|1
7974402|NCT02926573|12538233|FG001|Overall Study|Nausea|0
7974403|NCT02926573|12538232|FG000|Overall Study|Remain intubated|2
7974404|NCT02926573|12538233|FG001|Overall Study|Remain intubated|2
7974405|NCT02926573|12538232|FG000|Overall Study|Change in surgery plan|3
7974406|NCT02926573|12538233|FG001|Overall Study|Change in surgery plan|1
7974407|NCT02926573|12538232|FG000|Overall Study|Change to outpatient status|5
7974408|NCT02926573|12538233|FG001|Overall Study|Change to outpatient status|1
7974409|NCT02926573|12538232|FG000|Overall Study|Withdrawal by Subject|0
7974410|NCT02926573|12538233|FG001|Overall Study|Withdrawal by Subject|2
7974411|NCT02926573|12538232|FG000|Overall Study|Return to operating room|0
7974412|NCT02926573|12538233|FG001|Overall Study|Return to operating room|2
7974413|NCT02926573|12538232|FG000|Overall Study|Delirium|0
7974414|NCT02926573|12538233|FG001|Overall Study|Delirium|1
7974415|NCT02926937|12538256|FG000|Overall Study|Adverse Event|0
7974416|NCT02926937|12538257|FG001|Overall Study|Adverse Event|1
7974417|NCT02926937|12538258|FG002|Overall Study|Adverse Event|1
7974418|NCT02926937|12538256|FG000|Overall Study|Poor Compliance to Protocol|1
7974419|NCT02926937|12538257|FG001|Overall Study|Poor Compliance to Protocol|0
7974420|NCT02926937|12538258|FG002|Overall Study|Poor Compliance to Protocol|0
7974421|NCT02926937|12538256|FG000|Overall Study|Lost to Follow-up|4
7974422|NCT02926937|12538257|FG001|Overall Study|Lost to Follow-up|5
7974423|NCT02926937|12538258|FG002|Overall Study|Lost to Follow-up|0
7974424|NCT02926937|12538256|FG000|Overall Study|At the Participant's own Request|11
7974425|NCT02926937|12538257|FG001|Overall Study|At the Participant's own Request|5
7974426|NCT02926937|12538258|FG002|Overall Study|At the Participant's own Request|8
7974427|NCT02926937|12538256|FG000|Overall Study|Reason not Specified|3
7974428|NCT02926937|12538257|FG001|Overall Study|Reason not Specified|4
7974429|NCT02926937|12538258|FG002|Overall Study|Reason not Specified|2
7974430|NCT02926950|12538269|FG000|Overall Study|Adverse Event|4
7974431|NCT02926950|12538270|FG001|Overall Study|Adverse Event|6
7974432|NCT02926950|12538269|FG000|Overall Study|At the participant's own request|21
7974433|NCT02926950|12538270|FG001|Overall Study|At the participant's own request|25
7974434|NCT02926950|12538269|FG000|Overall Study|Reason not Specified|17
7974435|NCT02926950|12538270|FG001|Overall Study|Reason not Specified|9
7974436|NCT02926950|12538269|FG000|Overall Study|Lost to Follow-up|7
7974437|NCT02926950|12538270|FG001|Overall Study|Lost to Follow-up|8
7974438|NCT02927171|12538279|FG000|Overall Study|Lost to Follow-up|0
7974439|NCT02927171|12538280|FG001|Overall Study|Lost to Follow-up|1
7974440|NCT02927366|12538303|FG000|Overall Study|Adverse Event|1
7974441|NCT02927366|12538304|FG001|Overall Study|Adverse Event|0
7974442|NCT02927366|12538303|FG000|Overall Study|Patient schedule|1
7974443|NCT02927366|12538304|FG001|Overall Study|Patient schedule|0
7974444|NCT02927431|12538313|FG000|Overall Study|Withdrawal by Subject|0
7974445|NCT02927431|12538314|FG001|Overall Study|Withdrawal by Subject|0
7974446|NCT02927431|12538315|FG002|Overall Study|Withdrawal by Subject|1
7974447|NCT02927795|12538347|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19
7974448|NCT02927795|12538347|FG000|Overall Study|Not Treated|4
7974449|NCT02927834|12538354|FG000|Overall Study|Lost to Follow-up|1
7974450|NCT02927834|12538355|FG001|Overall Study|Lost to Follow-up|2
7974451|NCT02927834|12538356|FG002|Overall Study|Lost to Follow-up|2
7974452|NCT02927873|12538370|FG000|Overall Study|Lost to Follow-up|0
7974453|NCT02927873|12538371|FG001|Overall Study|Lost to Follow-up|1
7974454|NCT02927873|12538372|FG002|Overall Study|Lost to Follow-up|0
7974455|NCT02927873|12538373|FG003|Overall Study|Lost to Follow-up|0
7974456|NCT02927873|12538374|FG004|Overall Study|Lost to Follow-up|0
7974457|NCT02927873|12538375|FG005|Overall Study|Lost to Follow-up|0
7974458|NCT02927873|12538370|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7974459|NCT02927873|12538371|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7974460|NCT02927873|12538372|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7974461|NCT02927873|12538373|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7974462|NCT02927873|12538374|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7974463|NCT02927873|12538375|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7974464|NCT02927873|12538370|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7974465|NCT02927873|12538371|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7974466|NCT02927873|12538372|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7974467|NCT02927873|12538373|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7974468|NCT02927873|12538374|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7974469|NCT02927873|12538375|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7974470|NCT02927873|12538370|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7974471|NCT02927873|12538371|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1
7974472|NCT02927873|12538372|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7974473|NCT02927873|12538373|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7974474|NCT02927873|12538374|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7974475|NCT02927873|12538375|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7974476|NCT02927873|12538370|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1
7974477|NCT02927873|12538371|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7974478|NCT02927873|12538372|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7974479|NCT02927873|12538373|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7974480|NCT02927873|12538374|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7974481|NCT02927873|12538375|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7974482|NCT02927873|12538370|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1
7974483|NCT02927873|12538371|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7974484|NCT02927873|12538372|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7974485|NCT02927873|12538373|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7974486|NCT02927873|12538374|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7974487|NCT02927873|12538375|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7974488|NCT02927925|12538389|FG000|Overall Study|Death|16
7974489|NCT02927925|12538389|FG000|Overall Study|Physician Decision|1
7974490|NCT02927925|12538389|FG000|Overall Study|Withdrawal by Subject|11
7974491|NCT02927925|12538389|FG000|Overall Study|Other|3
7974492|NCT02927925|12538389|FG000|Overall Study|Disease progression at clinical cutoff|1
7974493|NCT02928029|12538395|FG000|Overall Study|Withdrawal by Subject|0
7974494|NCT02928029|12538396|FG001|Overall Study|Withdrawal by Subject|1
7974495|NCT02928029|12538395|FG000|Overall Study|Radiological progression|1
7974496|NCT02928029|12538396|FG001|Overall Study|Radiological progression|0
7974497|NCT02928029|12538395|FG000|Overall Study|Clinical progression|1
7974498|NCT02928029|12538396|FG001|Overall Study|Clinical progression|2
7974499|NCT02928029|12538395|FG000|Overall Study|AE not related to clinical progression|1
7974500|NCT02928029|12538396|FG001|Overall Study|AE not related to clinical progression|1
7974501|NCT02928770|12538435|FG000|Overall Study|Withdrawal by Subject|2
7974502|NCT02928848|12538441|FG000|Arm 2|Withdrawal by Subject|1
7974503|NCT02928848|12538442|FG001|Arm 2|Withdrawal by Subject|0
7974504|NCT02928952|12538452|FG000|Overall Study|Lost to Follow-up|5
7974505|NCT02928952|12538453|FG001|Overall Study|Lost to Follow-up|5
7974506|NCT02928952|12538452|FG000|Overall Study|Withdrawal by Subject|5
7974507|NCT02928952|12538453|FG001|Overall Study|Withdrawal by Subject|1
7974508|NCT02928952|12538452|FG000|Overall Study|Physician Decision|0
7974509|NCT02928952|12538453|FG001|Overall Study|Physician Decision|1
7974510|NCT02929329|12538461|FG000|Overall Study|Withdrawal by Subject|24
7974511|NCT02929329|12538462|FG001|Overall Study|Withdrawal by Subject|21
7974512|NCT02929329|12538461|FG000|Overall Study|Lost to Follow-up|26
7974513|NCT02929329|12538462|FG001|Overall Study|Lost to Follow-up|20
7974514|NCT02929329|12538461|FG000|Overall Study|Death|1054
7974515|NCT02929329|12538462|FG001|Overall Study|Death|1051
7974516|NCT02929407|12538472|FG000|Overall Study|Adverse Event|1
7974517|NCT02929498|12538479|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3
7974518|NCT02929498|12538480|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
7974519|NCT02929498|12538481|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
7974520|NCT02929498|12538479|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2
7974521|NCT02929498|12538480|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
7974522|NCT02929498|12538481|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
7974523|NCT02930005|12538523|FG000|Overall Study|Lost to Follow-up|1
7974524|NCT02930005|12538524|FG001|Overall Study|Lost to Follow-up|5
7974525|NCT02930018|12538532|FG000|Overall Study|Lost to Follow-up|1
7974526|NCT02930018|12538533|FG001|Overall Study|Lost to Follow-up|1
7974527|NCT02930018|12538532|FG000|Overall Study|Withdrawal by Subject|5
7974528|NCT02930018|12538533|FG001|Overall Study|Withdrawal by Subject|2
7974529|NCT02930226|12538556|FG000|Overall Study|Technical Problems: Leak in plasma bag|0
7974530|NCT02930226|12538557|FG001|Overall Study|Technical Problems: Leak in plasma bag|0
7974531|NCT02930226|12538558|FG002|Overall Study|Technical Problems: Leak in plasma bag|0
7974532|NCT02930226|12538559|FG003|Overall Study|Technical Problems: Leak in plasma bag|0
7974533|NCT02930226|12538560|FG004|Overall Study|Technical Problems: Leak in plasma bag|1
7974534|NCT02930226|12538561|FG005|Overall Study|Technical Problems: Leak in plasma bag|0
7974535|NCT02930343|12538579|FG000|Overall Study|Lost to Follow-up|9
7974536|NCT02930343|12538580|FG001|Overall Study|Lost to Follow-up|7
7974537|NCT02930837|12538609|FG000|Overall Study|Adverse Event|6
7974538|NCT02930837|12538609|FG000|Overall Study|Lost to Follow-up|5
7974539|NCT02930837|12538609|FG000|Overall Study|Withdrawal by Subject|1
7974540|NCT02930941|12538615|FG000|Overall Study|Lost to Follow-up|1
7974541|NCT02930941|12538616|FG001|Overall Study|Lost to Follow-up|2
7974542|NCT02931396|12538650|FG000|Overall Study|Lost to Follow-up|3
7974543|NCT02931396|12538651|FG001|Overall Study|Lost to Follow-up|0
7974544|NCT02931396|12538650|FG000|Overall Study|Withdrawal by Subject|2
7974545|NCT02931396|12538651|FG001|Overall Study|Withdrawal by Subject|0
7974546|NCT02931539|12538659|FG000|Period 1: Treatment Phase|Investigator discretion|1
7974547|NCT02931539|12538660|FG001|Period 1: Treatment Phase|Investigator discretion|1
7974548|NCT02931539|12538661|FG002|Period 1: Treatment Phase|Investigator discretion|0
7974549|NCT02931539|12538659|FG000|Period 1: Treatment Phase|Adverse Event|5
7974550|NCT02931539|12538660|FG001|Period 1: Treatment Phase|Adverse Event|1
7974551|NCT02931539|12538661|FG002|Period 1: Treatment Phase|Adverse Event|0
7974552|NCT02931539|12538659|FG000|Period 1: Treatment Phase|Lost to Follow-up|1
7974553|NCT02931539|12538660|FG001|Period 1: Treatment Phase|Lost to Follow-up|2
7974554|NCT02931539|12538661|FG002|Period 1: Treatment Phase|Lost to Follow-up|0
7974555|NCT02931539|12538659|FG000|Period 1: Treatment Phase|Death|8
7974556|NCT02931539|12538660|FG001|Period 1: Treatment Phase|Death|24
7974557|NCT02931539|12538661|FG002|Period 1: Treatment Phase|Death|0
7974558|NCT02931539|12538659|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16
7974559|NCT02931539|12538660|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8
7974560|NCT02931539|12538661|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0
7974561|NCT02931539|12538659|FG000|Period 1: Treatment Phase|Protocol Violation|6
7974562|NCT02931539|12538660|FG001|Period 1: Treatment Phase|Protocol Violation|0
7974563|NCT02931539|12538661|FG002|Period 1: Treatment Phase|Protocol Violation|0
7974564|NCT02931539|12538659|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22
7974565|NCT02931539|12538660|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0
7974566|NCT02931539|12538661|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0
7974567|NCT02931539|12538659|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0
7974568|NCT02931539|12538660|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0
7974569|NCT02931539|12538661|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2
7974570|NCT02931838|12538690|FG000|Overall Study|Reason not provided by investigator|1
7974571|NCT02931838|12538691|FG001|Overall Study|Reason not provided by investigator|0
7974572|NCT02931838|12538692|FG002|Overall Study|Reason not provided by investigator|1
7974573|NCT02931838|12538693|FG003|Overall Study|Reason not provided by investigator|0
7974574|NCT02931838|12538694|FG004|Overall Study|Reason not provided by investigator|0
7974575|NCT02931838|12538695|FG005|Overall Study|Reason not provided by investigator|0
7974576|NCT02931838|12538690|FG000|Overall Study|Poor/non-compliance|0
7974577|NCT02931838|12538691|FG001|Overall Study|Poor/non-compliance|0
7974578|NCT02931838|12538692|FG002|Overall Study|Poor/non-compliance|1
7974579|NCT02931838|12538693|FG003|Overall Study|Poor/non-compliance|0
7974580|NCT02931838|12538694|FG004|Overall Study|Poor/non-compliance|0
7974581|NCT02931838|12538695|FG005|Overall Study|Poor/non-compliance|0
7974582|NCT02931838|12538690|FG000|Overall Study|Lack of Efficacy|5
7974583|NCT02931838|12538691|FG001|Overall Study|Lack of Efficacy|4
7974584|NCT02931838|12538692|FG002|Overall Study|Lack of Efficacy|0
7974585|NCT02931838|12538693|FG003|Overall Study|Lack of Efficacy|0
7974586|NCT02931838|12538694|FG004|Overall Study|Lack of Efficacy|0
7974587|NCT02931838|12538695|FG005|Overall Study|Lack of Efficacy|1
7974588|NCT02931838|12538690|FG000|Overall Study|Lost to Follow-up|1
7974589|NCT02931838|12538691|FG001|Overall Study|Lost to Follow-up|0
7974590|NCT02931838|12538692|FG002|Overall Study|Lost to Follow-up|1
7974591|NCT02931838|12538693|FG003|Overall Study|Lost to Follow-up|1
7974592|NCT02931838|12538694|FG004|Overall Study|Lost to Follow-up|2
7974593|NCT02931838|12538695|FG005|Overall Study|Lost to Follow-up|0
7974594|NCT02931838|12538690|FG000|Overall Study|Subject request to discontinue treatment|4
7974595|NCT02931838|12538691|FG001|Overall Study|Subject request to discontinue treatment|3
7974596|NCT02931838|12538692|FG002|Overall Study|Subject request to discontinue treatment|3
7974597|NCT02931838|12538693|FG003|Overall Study|Subject request to discontinue treatment|0
7974598|NCT02931838|12538694|FG004|Overall Study|Subject request to discontinue treatment|1
7974599|NCT02931838|12538695|FG005|Overall Study|Subject request to discontinue treatment|0
7974600|NCT02931838|12538690|FG000|Overall Study|Withdrawal by Subject|1
7974601|NCT02931838|12538691|FG001|Overall Study|Withdrawal by Subject|2
7974602|NCT02931838|12538692|FG002|Overall Study|Withdrawal by Subject|0
7974603|NCT02931838|12538693|FG003|Overall Study|Withdrawal by Subject|1
7974604|NCT02931838|12538694|FG004|Overall Study|Withdrawal by Subject|0
7974605|NCT02931838|12538695|FG005|Overall Study|Withdrawal by Subject|0
7974606|NCT02931838|12538690|FG000|Overall Study|Adverse Event|2
7974607|NCT02931838|12538691|FG001|Overall Study|Adverse Event|1
7974608|NCT02931838|12538692|FG002|Overall Study|Adverse Event|2
7974609|NCT02931838|12538693|FG003|Overall Study|Adverse Event|1
7974610|NCT02931838|12538694|FG004|Overall Study|Adverse Event|3
7974611|NCT02931838|12538695|FG005|Overall Study|Adverse Event|1
7974612|NCT02932228|12538716|FG000|Overall Study|Death|8
7974613|NCT02932228|12538717|FG001|Overall Study|Death|23
7974614|NCT02932228|12538716|FG000|Overall Study|not eligible upon chart review|2
7974615|NCT02932228|12538717|FG001|Overall Study|not eligible upon chart review|5
7974616|NCT02932267|12538725|FG000|Overall Study|Withdrawal by Subject|3
7974617|NCT02932267|12538725|FG000|Overall Study|Lost to Follow-up|4
7974618|NCT02932267|12538725|FG000|Overall Study|Pregnancy|1
7974619|NCT02932306|12538731|FG000|Overall Study|Withdrawal by Subject|16
7974620|NCT02932306|12538732|FG001|Overall Study|Withdrawal by Subject|25
7974621|NCT02932306|12538731|FG000|Overall Study|Adverse Event|3
7974622|NCT02932306|12538732|FG001|Overall Study|Adverse Event|0
7974623|NCT02932306|12538731|FG000|Overall Study|Pregnancy|2
7974624|NCT02932306|12538732|FG001|Overall Study|Pregnancy|0
7974625|NCT02932306|12538731|FG000|Overall Study|Protocol Violation|1
7974626|NCT02932306|12538732|FG001|Overall Study|Protocol Violation|1
7974627|NCT02932306|12538731|FG000|Overall Study|Noncompliance with Study Drug|1
7974628|NCT02932306|12538732|FG001|Overall Study|Noncompliance with Study Drug|1
7974629|NCT02932306|12538731|FG000|Overall Study|Lost to Follow-up|36
7974630|NCT02932306|12538732|FG001|Overall Study|Lost to Follow-up|40
7974631|NCT02932306|12538731|FG000|Overall Study|Withdrawal by Parent or Guardian|6
7974632|NCT02932306|12538732|FG001|Overall Study|Withdrawal by Parent or Guardian|8
7974633|NCT02932306|12538731|FG000|Overall Study|Lack of Efficacy|0
7974634|NCT02932306|12538732|FG001|Overall Study|Lack of Efficacy|2
7974635|NCT02932306|12538731|FG000|Overall Study|Worsening condition|2
7974636|NCT02932306|12538732|FG001|Overall Study|Worsening condition|0
7974637|NCT02932306|12538731|FG000|Overall Study|Withdrew due to burning,itching,stinging|1
7974638|NCT02932306|12538732|FG001|Overall Study|Withdrew due to burning,itching,stinging|0
7974639|NCT02932462|12538740|FG000|Overall Study|Adverse Event|1
7974640|NCT02932462|12538741|FG001|Overall Study|Adverse Event|2
7974641|NCT02932462|12538740|FG000|Overall Study|Lost to Follow-up|4
7974642|NCT02932462|12538741|FG001|Overall Study|Lost to Follow-up|1
7974643|NCT02932462|12538740|FG000|Overall Study|Protocol Violation|0
7974644|NCT02932462|12538741|FG001|Overall Study|Protocol Violation|5
7974645|NCT02932462|12538740|FG000|Overall Study|Withdrawal by Subject|1
7974646|NCT02932462|12538741|FG001|Overall Study|Withdrawal by Subject|4
7974647|NCT02932462|12538740|FG000|Overall Study|Non-Compliance With Study Drug|0
7974648|NCT02932462|12538741|FG001|Overall Study|Non-Compliance With Study Drug|1
7974649|NCT02932462|12538740|FG000|Overall Study|Progressive Disease|1
7974650|NCT02932462|12538741|FG001|Overall Study|Progressive Disease|0
7974651|NCT02932878|12538761|FG000|Overall Study|Due to Lab Results|2
7974652|NCT02932878|12538762|FG001|Overall Study|Due to Lab Results|1
7974653|NCT02932891|12538768|FG000|Overall Study|Lost to Follow-up|2
7974654|NCT02932891|12538768|FG000|Overall Study|HPA Suppress|2
7974655|NCT02932904|12538776|FG000|Overall Study|Reason not Specified|1
7974656|NCT02932904|12538777|FG001|Overall Study|Reason not Specified|0
7974657|NCT02932904|12538778|FG002|Overall Study|Reason not Specified|2
7974658|NCT02932904|12538779|FG003|Overall Study|Reason not Specified|2
7974659|NCT02932904|12538776|FG000|Overall Study|Noncompliance with Study Drug|2
7974660|NCT02932904|12538777|FG001|Overall Study|Noncompliance with Study Drug|3
7974661|NCT02932904|12538778|FG002|Overall Study|Noncompliance with Study Drug|3
7974662|NCT02932904|12538779|FG003|Overall Study|Noncompliance with Study Drug|4
7974663|NCT02932904|12538776|FG000|Overall Study|Pregnancy|0
7974664|NCT02932904|12538777|FG001|Overall Study|Pregnancy|1
7974665|NCT02932904|12538778|FG002|Overall Study|Pregnancy|1
7974666|NCT02932904|12538779|FG003|Overall Study|Pregnancy|0
7974667|NCT02932904|12538776|FG000|Overall Study|Study Termination|0
7974668|NCT02932904|12538777|FG001|Overall Study|Study Termination|1
7974669|NCT02932904|12538778|FG002|Overall Study|Study Termination|0
7974670|NCT02932904|12538779|FG003|Overall Study|Study Termination|0
7974671|NCT02932904|12538776|FG000|Overall Study|Voluntary Withdrawal|2
7974672|NCT02932904|12538777|FG001|Overall Study|Voluntary Withdrawal|1
7974673|NCT02932904|12538778|FG002|Overall Study|Voluntary Withdrawal|4
7974674|NCT02932904|12538779|FG003|Overall Study|Voluntary Withdrawal|2
7974675|NCT02932904|12538776|FG000|Overall Study|Lost to Follow-up|5
7974676|NCT02932904|12538777|FG001|Overall Study|Lost to Follow-up|3
7974677|NCT02932904|12538778|FG002|Overall Study|Lost to Follow-up|6
7974678|NCT02932904|12538779|FG003|Overall Study|Lost to Follow-up|0
7974679|NCT02932904|12538776|FG000|Overall Study|Significant Protocol Deviation|2
7974680|NCT02932904|12538777|FG001|Overall Study|Significant Protocol Deviation|3
7974681|NCT02932904|12538778|FG002|Overall Study|Significant Protocol Deviation|6
7974682|NCT02932904|12538779|FG003|Overall Study|Significant Protocol Deviation|1
7974683|NCT02932904|12538776|FG000|Overall Study|Pretreatment Event/Adverse Event|3
7974684|NCT02932904|12538777|FG001|Overall Study|Pretreatment Event/Adverse Event|5
7974685|NCT02932904|12538778|FG002|Overall Study|Pretreatment Event/Adverse Event|1
7974686|NCT02932904|12538779|FG003|Overall Study|Pretreatment Event/Adverse Event|3
7974687|NCT02932904|12538776|FG000|Overall Study|Randomized But Not Treated|1
7974688|NCT02932904|12538777|FG001|Overall Study|Randomized But Not Treated|1
7974689|NCT02932904|12538778|FG002|Overall Study|Randomized But Not Treated|0
7974690|NCT02932904|12538779|FG003|Overall Study|Randomized But Not Treated|2
7974691|NCT02932943|12538794|FG000|Overall Study|Lost to Follow-up|0
7974692|NCT02932943|12538795|FG001|Overall Study|Lost to Follow-up|2
7974693|NCT02932943|12538794|FG000|Overall Study|Adverse Event|2
7974694|NCT02932943|12538795|FG001|Overall Study|Adverse Event|2
7974695|NCT02932943|12538794|FG000|Overall Study|Withdrawal by Subject|3
7974696|NCT02932943|12538795|FG001|Overall Study|Withdrawal by Subject|3
7974697|NCT02933060|12538807|FG000|Overall Study|Withdrawal by Subject|0
7974698|NCT02933060|12538808|FG001|Overall Study|Withdrawal by Subject|1
7974699|NCT02933528|12538857|FG000|Overall Study|Lost to Follow-up|2
7974700|NCT02934178|12538887|FG000|Received Vaccination 2|Death|0
7974701|NCT02934178|12538888|FG001|Received Vaccination 2|Death|1
7974702|NCT02934178|12538887|FG000|Received Vaccination 3|Withdrawal by Subject|1
7974703|NCT02934178|12538888|FG001|Received Vaccination 3|Withdrawal by Subject|0
7974704|NCT02935192|12538970|FG000|Overall Study|Withdrawal by Subject|8
7974705|NCT02935192|12538971|FG001|Overall Study|Withdrawal by Subject|4
7974706|NCT02935452|12538979|FG000|Overall Study|work and life commintment|3
7974707|NCT02935452|12538980|FG001|Overall Study|work and life commintment|1
7974708|NCT02935673|12538993|FG000|Overall Study|Adverse Event|0
7974709|NCT02935673|12538994|FG001|Overall Study|Adverse Event|1
7974710|NCT02935673|12538995|FG002|Overall Study|Adverse Event|0
7974711|NCT02935673|12538993|FG000|Overall Study|Withdrawal by Subject|1
7974712|NCT02935673|12538994|FG001|Overall Study|Withdrawal by Subject|2
7974713|NCT02935673|12538995|FG002|Overall Study|Withdrawal by Subject|0
7974714|NCT02935842|12539035|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2
7974715|NCT02935842|12539036|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0
7974716|NCT02935842|12539037|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0
7974717|NCT02935842|12539038|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0
7974718|NCT02935842|12539035|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1
7974719|NCT02935842|12539036|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
7974720|NCT02935842|12539037|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
7974721|NCT02935842|12539038|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0
7974722|NCT02935842|12539035|FG000|Testing and Therapy Period 3|Accident prior to treatment|2
7974723|NCT02935842|12539036|FG001|Testing and Therapy Period 3|Accident prior to treatment|2
7974724|NCT02935842|12539037|FG002|Testing and Therapy Period 3|Accident prior to treatment|0
7974725|NCT02935842|12539038|FG003|Testing and Therapy Period 3|Accident prior to treatment|0
7974726|NCT02935842|12539035|FG000|Testing and Therapy Period 3|Lost to Follow-up|0
7974727|NCT02935842|12539036|FG001|Testing and Therapy Period 3|Lost to Follow-up|0
7974728|NCT02935842|12539037|FG002|Testing and Therapy Period 3|Lost to Follow-up|0
7974729|NCT02935842|12539038|FG003|Testing and Therapy Period 3|Lost to Follow-up|1
7974730|NCT02935842|12539035|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0
7974731|NCT02935842|12539036|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0
7974732|NCT02935842|12539037|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3
7974733|NCT02935842|12539038|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0
7974734|NCT02935894|12539055|FG000|Overall Study|Subject dismissed|1
7974735|NCT02936037|12539061|FG000|Double-Blind Treatment Period|Protocol Violation|1
7974736|NCT02936037|12539062|FG001|Double-Blind Treatment Period|Protocol Violation|4
7974737|NCT02936037|12539061|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2
7974738|NCT02936037|12539062|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8
7974739|NCT02936037|12539061|FG000|Double-Blind Treatment Period|Lack of Efficacy|4
7974740|NCT02936037|12539062|FG001|Double-Blind Treatment Period|Lack of Efficacy|12
7974741|NCT02936037|12539061|FG000|Double-Blind Treatment Period|Death|0
7974742|NCT02936037|12539062|FG001|Double-Blind Treatment Period|Death|1
7974743|NCT02936037|12539061|FG000|Double-Blind Treatment Period|Adverse Event|11
7974744|NCT02936037|12539062|FG001|Double-Blind Treatment Period|Adverse Event|11
7974745|NCT02936037|12539061|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31
7974746|NCT02936037|12539062|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28
7974747|NCT02936037|12539061|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7974748|NCT02936037|12539062|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
7974749|NCT02936037|12539061|FG000|Open Label Extension|Adverse Event|0
7974750|NCT02936037|12539062|FG001|Open Label Extension|Adverse Event|3
7974751|NCT02936037|12539061|FG000|Open Label Extension|Other|0
7974752|NCT02936037|12539062|FG001|Open Label Extension|Other|3
7974753|NCT02936037|12539061|FG000|Open Label Extension|Withdrawal by Subject|0
7974754|NCT02936037|12539062|FG001|Open Label Extension|Withdrawal by Subject|4
7974755|NCT02936635|12539083|FG000|Overall Study|Adverse Event|43
7974756|NCT02936635|12539084|FG001|Overall Study|Adverse Event|25
7974757|NCT02936635|12539083|FG000|Overall Study|Progressive Disease|10
7974758|NCT02936635|12539084|FG001|Overall Study|Progressive Disease|18
7974759|NCT02936635|12539083|FG000|Overall Study|Sponsor Discretion|10
7974760|NCT02936635|12539084|FG001|Overall Study|Sponsor Discretion|16
7974761|NCT02936635|12539083|FG000|Overall Study|Death|9
7974762|NCT02936635|12539084|FG001|Overall Study|Death|15
7974763|NCT02936635|12539083|FG000|Overall Study|Withdrawal by Subject|8
7974764|NCT02936635|12539084|FG001|Overall Study|Withdrawal by Subject|15
7974765|NCT02936635|12539083|FG000|Overall Study|Physician Decision|2
7974766|NCT02936635|12539084|FG001|Overall Study|Physician Decision|9
7974767|NCT02936635|12539083|FG000|Overall Study|Lost to Follow-up|1
7974768|NCT02936635|12539084|FG001|Overall Study|Lost to Follow-up|2
7974769|NCT02936635|12539083|FG000|Overall Study|Protocol Violation|1
7974770|NCT02936635|12539084|FG001|Overall Study|Protocol Violation|0
7974771|NCT02936635|12539083|FG000|Overall Study|Lack of effect/Entry into other study|31
7974772|NCT02936635|12539084|FG001|Overall Study|Lack of effect/Entry into other study|65
7974773|NCT02936869|12539096|FG000|Overall Study|Lost to Follow-up|1
7974774|NCT02936869|12539097|FG001|Overall Study|Lost to Follow-up|3
7974775|NCT02936869|12539096|FG000|Overall Study|Death|0
7974776|NCT02936869|12539097|FG001|Overall Study|Death|1
7974777|NCT02936869|12539096|FG000|Overall Study|Legal Case|0
7974778|NCT02936869|12539097|FG001|Overall Study|Legal Case|1
7974779|NCT02936869|12539096|FG000|Overall Study|Protocol Violation|1
7974780|NCT02936869|12539097|FG001|Overall Study|Protocol Violation|0
7974781|NCT02937350|12539173|FG000|Overall Study|Withdrawal by Subject|0
7974782|NCT02937350|12539174|FG001|Overall Study|Withdrawal by Subject|1
7974783|NCT02937350|12539175|FG002|Overall Study|Withdrawal by Subject|0
7974784|NCT02937454|12539183|FG000|Overall Study|Adverse Event|0
7974785|NCT02937454|12539184|FG001|Overall Study|Adverse Event|1
7974786|NCT02937454|12539183|FG000|Overall Study|Death|98
7974787|NCT02937454|12539184|FG001|Overall Study|Death|95
7974788|NCT02937454|12539183|FG000|Overall Study|Lost to Follow-up|1
7974789|NCT02937454|12539184|FG001|Overall Study|Lost to Follow-up|1
7974790|NCT02937454|12539183|FG000|Overall Study|Physician Decision|0
7974791|NCT02937454|12539184|FG001|Overall Study|Physician Decision|1
7974792|NCT02937454|12539183|FG000|Overall Study|Protocol Violation|6
7974793|NCT02937454|12539184|FG001|Overall Study|Protocol Violation|10
7974794|NCT02937454|12539183|FG000|Overall Study|Withdrawal by Subject|27
7974795|NCT02937454|12539184|FG001|Overall Study|Withdrawal by Subject|15
7974796|NCT02937454|12539183|FG000|Overall Study|Other|8
7974797|NCT02937454|12539184|FG001|Overall Study|Other|5
7974798|NCT02937545|12539202|FG000|Overall Study|Withdrawal by Subject|1
7974799|NCT02937545|12539203|FG001|Overall Study|Withdrawal by Subject|2
7974800|NCT02937545|12539204|FG002|Overall Study|Withdrawal by Subject|6
7974801|NCT02937545|12539205|FG003|Overall Study|Withdrawal by Subject|7
7974802|NCT02937545|12539202|FG000|Overall Study|Lost to Follow-up|1
7974803|NCT02937545|12539203|FG001|Overall Study|Lost to Follow-up|0
7974804|NCT02937545|12539204|FG002|Overall Study|Lost to Follow-up|0
7974805|NCT02937545|12539205|FG003|Overall Study|Lost to Follow-up|0
7974806|NCT02937584|12539226|FG000|Period 1|Adverse Event|1
7974807|NCT02937584|12539227|FG001|Period 1|Adverse Event|2
7974808|NCT02937584|12539226|FG000|Washout|Adverse Event|0
7974809|NCT02937584|12539227|FG001|Washout|Adverse Event|1
7974810|NCT02937636|12539244|FG000|Overall Study|Other (Not specified)|3
7974811|NCT02937636|12539245|FG001|Overall Study|Other (Not specified)|2
7974812|NCT02937701|12539254|FG000|Day 1 to Week 22|Adverse Event|11
7974813|NCT02937701|12539255|FG001|Day 1 to Week 22|Adverse Event|14
7974814|NCT02937701|12539256|FG002|Day 1 to Week 22|Adverse Event|0
7974815|NCT02937701|12539257|FG003|Day 1 to Week 22|Adverse Event|0
7974816|NCT02937701|12539258|FG004|Day 1 to Week 22|Adverse Event|0
7974817|NCT02937701|12539254|FG000|Day 1 to Week 22|Protocol Specified Criteria|7
7974818|NCT02937701|12539255|FG001|Day 1 to Week 22|Protocol Specified Criteria|7
7974819|NCT02937701|12539256|FG002|Day 1 to Week 22|Protocol Specified Criteria|0
7974820|NCT02937701|12539257|FG003|Day 1 to Week 22|Protocol Specified Criteria|0
7974821|NCT02937701|12539258|FG004|Day 1 to Week 22|Protocol Specified Criteria|0
7974822|NCT02937701|12539254|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5
7974823|NCT02937701|12539255|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9
7974824|NCT02937701|12539256|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
7974825|NCT02937701|12539257|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
7974826|NCT02937701|12539258|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
7974827|NCT02937701|12539254|FG000|Day 1 to Week 22|Withdrawal by Subject|6
7974828|NCT02937701|12539255|FG001|Day 1 to Week 22|Withdrawal by Subject|6
7974829|NCT02937701|12539256|FG002|Day 1 to Week 22|Withdrawal by Subject|0
7974830|NCT02937701|12539257|FG003|Day 1 to Week 22|Withdrawal by Subject|0
7974831|NCT02937701|12539258|FG004|Day 1 to Week 22|Withdrawal by Subject|0
7974832|NCT02937701|12539254|FG000|Day 1 to Week 22|Death|1
7974833|NCT02937701|12539255|FG001|Day 1 to Week 22|Death|1
7974834|NCT02937701|12539256|FG002|Day 1 to Week 22|Death|0
7974835|NCT02937701|12539257|FG003|Day 1 to Week 22|Death|0
7974836|NCT02937701|12539258|FG004|Day 1 to Week 22|Death|0
7974837|NCT02937701|12539254|FG000|Day 1 to Week 22|Protocol Violation|1
7974838|NCT02937701|12539255|FG001|Day 1 to Week 22|Protocol Violation|1
7974839|NCT02937701|12539256|FG002|Day 1 to Week 22|Protocol Violation|0
7974840|NCT02937701|12539257|FG003|Day 1 to Week 22|Protocol Violation|0
7974841|NCT02937701|12539258|FG004|Day 1 to Week 22|Protocol Violation|0
7974842|NCT02937701|12539254|FG000|Day 1 to Week 22|Lost to Follow-up|1
7974843|NCT02937701|12539255|FG001|Day 1 to Week 22|Lost to Follow-up|1
7974844|NCT02937701|12539256|FG002|Day 1 to Week 22|Lost to Follow-up|0
7974845|NCT02937701|12539257|FG003|Day 1 to Week 22|Lost to Follow-up|0
7974846|NCT02937701|12539258|FG004|Day 1 to Week 22|Lost to Follow-up|0
7974847|NCT02937701|12539254|FG000|Day 1 to Week 22|Physician Decision|2
7974848|NCT02937701|12539255|FG001|Day 1 to Week 22|Physician Decision|0
7974849|NCT02937701|12539256|FG002|Day 1 to Week 22|Physician Decision|0
7974850|NCT02937701|12539257|FG003|Day 1 to Week 22|Physician Decision|0
7974851|NCT02937701|12539258|FG004|Day 1 to Week 22|Physician Decision|0
7974852|NCT02937701|12539254|FG000|Day 1 to Week 22|Other|1
7974853|NCT02937701|12539255|FG001|Day 1 to Week 22|Other|0
7974854|NCT02937701|12539256|FG002|Day 1 to Week 22|Other|0
7974855|NCT02937701|12539257|FG003|Day 1 to Week 22|Other|0
7974856|NCT02937701|12539258|FG004|Day 1 to Week 22|Other|0
7974857|NCT02937701|12539254|FG000|Week 22 to Week 50|Adverse Event|0
7974858|NCT02937701|12539255|FG001|Week 22 to Week 50|Adverse Event|0
7974859|NCT02937701|12539256|FG002|Week 22 to Week 50|Adverse Event|10
7974860|NCT02937701|12539257|FG003|Week 22 to Week 50|Adverse Event|3
7974861|NCT02937701|12539258|FG004|Week 22 to Week 50|Adverse Event|3
7974862|NCT02937701|12539254|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
7974863|NCT02937701|12539255|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
7974864|NCT02937701|12539256|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10
7974865|NCT02937701|12539257|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3
7974866|NCT02937701|12539258|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2
7974867|NCT02937701|12539254|FG000|Week 22 to Week 50|Withdrawal by Subject|0
7974868|NCT02937701|12539255|FG001|Week 22 to Week 50|Withdrawal by Subject|0
7974869|NCT02937701|12539256|FG002|Week 22 to Week 50|Withdrawal by Subject|8
7974870|NCT02937701|12539257|FG003|Week 22 to Week 50|Withdrawal by Subject|2
7974871|NCT02937701|12539258|FG004|Week 22 to Week 50|Withdrawal by Subject|1
7974872|NCT02937701|12539254|FG000|Week 22 to Week 50|Lost to Follow-up|0
7974873|NCT02937701|12539255|FG001|Week 22 to Week 50|Lost to Follow-up|0
7974874|NCT02937701|12539256|FG002|Week 22 to Week 50|Lost to Follow-up|2
7974875|NCT02937701|12539257|FG003|Week 22 to Week 50|Lost to Follow-up|0
7974876|NCT02937701|12539258|FG004|Week 22 to Week 50|Lost to Follow-up|1
7974877|NCT02937701|12539254|FG000|Week 22 to Week 50|Physician Decision|0
7974878|NCT02937701|12539255|FG001|Week 22 to Week 50|Physician Decision|0
7974879|NCT02937701|12539256|FG002|Week 22 to Week 50|Physician Decision|2
7974880|NCT02937701|12539257|FG003|Week 22 to Week 50|Physician Decision|0
7974881|NCT02937701|12539258|FG004|Week 22 to Week 50|Physician Decision|1
7974882|NCT02937701|12539254|FG000|Week 22 to Week 50|Other|0
7974883|NCT02937701|12539255|FG001|Week 22 to Week 50|Other|0
7974884|NCT02937701|12539256|FG002|Week 22 to Week 50|Other|0
7974885|NCT02937701|12539257|FG003|Week 22 to Week 50|Other|0
7974886|NCT02937701|12539258|FG004|Week 22 to Week 50|Other|1
7974887|NCT02937740|12539272|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3
7974888|NCT02937740|12539273|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14
7974889|NCT02937740|12539272|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0
7974890|NCT02937740|12539273|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10
7974891|NCT02937740|12539272|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2
7974892|NCT02937740|12539273|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7
7974893|NCT02937740|12539272|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1
7974894|NCT02937740|12539273|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0
7974895|NCT02937740|12539272|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0
7974896|NCT02937740|12539273|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1
7974897|NCT02937740|12539272|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0
7974898|NCT02937740|12539273|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1
7974899|NCT02937870|12539285|FG000|Overall Study|Adverse Event|1
7974900|NCT02937870|12539285|FG000|Overall Study|Protocol Deviation|2
7974901|NCT02938585|12539348|FG000|Overall Study|Withdrawal by parent or guardian|0
7974902|NCT02938585|12539349|FG001|Overall Study|Withdrawal by parent or guardian|1
7974903|NCT02938585|12539350|FG002|Overall Study|Withdrawal by parent or guardian|0
7974904|NCT02938585|12539351|FG003|Overall Study|Withdrawal by parent or guardian|0
7974905|NCT02938585|12539348|FG000|Overall Study|Withdrawal by Subject|0
7974906|NCT02938585|12539349|FG001|Overall Study|Withdrawal by Subject|0
7974907|NCT02938585|12539350|FG002|Overall Study|Withdrawal by Subject|0
7974908|NCT02938585|12539351|FG003|Overall Study|Withdrawal by Subject|5
7974909|NCT02939014|12539386|FG000|Overall Study|Lost to Follow-up|1
7974910|NCT02939014|12539387|FG001|Overall Study|Lost to Follow-up|0
7974911|NCT02939014|12539386|FG000|Overall Study|Death|4
7974912|NCT02939014|12539387|FG001|Overall Study|Death|3
7974913|NCT02939079|12539396|FG000|Overall Study|Adverse Event|2
7974914|NCT02939079|12539397|FG001|Overall Study|Adverse Event|1
7974915|NCT02939079|12539396|FG000|Overall Study|Lost to Follow-up|0
7974916|NCT02939079|12539397|FG001|Overall Study|Lost to Follow-up|2
7974917|NCT02939079|12539396|FG000|Overall Study|Protocol Violation|1
7974918|NCT02939079|12539397|FG001|Overall Study|Protocol Violation|0
7974919|NCT02939079|12539396|FG000|Overall Study|Withdrawal by Subject|0
7974920|NCT02939079|12539397|FG001|Overall Study|Withdrawal by Subject|1
7974921|NCT02939079|12539396|FG000|Overall Study|relapse during the study|1
7974922|NCT02939079|12539397|FG001|Overall Study|relapse during the study|1
7974923|NCT02939131|12539410|FG000|Overall Study|Unable to get to clinic|6
7974924|NCT02939131|12539411|FG001|Overall Study|Unable to get to clinic|4
7974925|NCT02939131|12539410|FG000|Overall Study|Lost to Follow-up|2
7974926|NCT02939131|12539411|FG001|Overall Study|Lost to Follow-up|4
7974927|NCT02939131|12539410|FG000|Overall Study|severe debilitation|1
7974928|NCT02939131|12539411|FG001|Overall Study|severe debilitation|0
7974929|NCT02939131|12539410|FG000|Overall Study|Other|0
7974930|NCT02939131|12539411|FG001|Overall Study|Other|1
7974931|NCT02939131|12539410|FG000|Overall Study|not willing to adhere to protocol|2
7974932|NCT02939131|12539411|FG001|Overall Study|not willing to adhere to protocol|0
7974933|NCT02939560|12539461|FG000|Overall Study|Withdrawal by Subject|2
7974934|NCT02939560|12539461|FG000|Overall Study|Protocol Violation|1
7974935|NCT02939599|12539467|FG000|Overall Study|Adverse Event|1
7974936|NCT02939599|12539468|FG001|Overall Study|Adverse Event|0
7974937|NCT02939599|12539467|FG000|Overall Study|Study Terminated By Sponsor|2
7974938|NCT02939599|12539468|FG001|Overall Study|Study Terminated By Sponsor|2
7974939|NCT02939716|12539479|FG000|Overall Study|scanner failure|0
7974940|NCT02939716|12539480|FG001|Overall Study|scanner failure|0
7974941|NCT02939716|12539481|FG002|Overall Study|scanner failure|0
7974942|NCT02939716|12539482|FG003|Overall Study|scanner failure|1
7974943|NCT02939716|12539483|FG004|Overall Study|scanner failure|1
7974944|NCT02939716|12539484|FG005|Overall Study|scanner failure|1
7974945|NCT02939781|12539501|FG000|Overall Study|Protocol Violation|8
7974946|NCT02939781|12539501|FG000|Overall Study|Withdrawal by Subject|1
7974947|NCT02939937|12539508|FG000|Overall Study|Adverse Event|5
7974948|NCT02939937|12539509|FG001|Overall Study|Adverse Event|0
7974949|NCT02939937|12539508|FG000|Overall Study|Lost to Follow-up|1
7974950|NCT02939937|12539509|FG001|Overall Study|Lost to Follow-up|3
7974951|NCT02939950|12539517|FG000|Overall Study|Lost to Follow-up|13
7974952|NCT02939950|12539518|FG001|Overall Study|Lost to Follow-up|16
7974953|NCT02939950|12539517|FG000|Overall Study|Positive slit lamp findings|0
7974954|NCT02939950|12539518|FG001|Overall Study|Positive slit lamp findings|1
7974955|NCT02939950|12539517|FG000|Overall Study|Chalazion upper lid|0
7974956|NCT02939950|12539518|FG001|Overall Study|Chalazion upper lid|1
7974957|NCT02939950|12539517|FG000|Overall Study|Lack of motivation|0
7974958|NCT02939950|12539518|FG001|Overall Study|Lack of motivation|2
7974959|NCT02939950|12539517|FG000|Overall Study|Unacceptable distance lens visual acuity|1
7974960|NCT02939950|12539518|FG001|Overall Study|Unacceptable distance lens visual acuity|1
7974961|NCT02939950|12539517|FG000|Overall Study|Military orders|1
7974962|NCT02939950|12539518|FG001|Overall Study|Military orders|0
7974963|NCT02939950|12539517|FG000|Overall Study|Participant Relocated|5
7974964|NCT02939950|12539518|FG001|Overall Study|Participant Relocated|3
7974965|NCT02939950|12539517|FG000|Overall Study|Study related symptoms|8
7974966|NCT02939950|12539518|FG001|Overall Study|Study related symptoms|8
7974967|NCT02939950|12539517|FG000|Overall Study|Unacceptable lens movement|2
7974968|NCT02939950|12539518|FG001|Overall Study|Unacceptable lens movement|0
7974969|NCT02939950|12539517|FG000|Overall Study|Protocol Violation|6
7974970|NCT02939950|12539518|FG001|Overall Study|Protocol Violation|3
7974971|NCT02939950|12539517|FG000|Overall Study|Physician Decision|2
7974972|NCT02939950|12539518|FG001|Overall Study|Physician Decision|0
7974973|NCT02939950|12539517|FG000|Overall Study|Pregnancy|6
7974974|NCT02939950|12539518|FG001|Overall Study|Pregnancy|7
7974975|NCT02939950|12539517|FG000|Overall Study|Withdrawal by Subject|12
7974976|NCT02939950|12539518|FG001|Overall Study|Withdrawal by Subject|28
7974977|NCT02939950|12539517|FG000|Overall Study|Adverse Event|7
7974978|NCT02939950|12539518|FG001|Overall Study|Adverse Event|3
7974979|NCT02939950|12539517|FG000|Overall Study|Randomized, not dispensed|1
7974980|NCT02939950|12539518|FG001|Overall Study|Randomized, not dispensed|0
7974981|NCT02939950|12539517|FG000|Overall Study|Ineligible at Baseline|2
7974982|NCT02939950|12539518|FG001|Overall Study|Ineligible at Baseline|8
7974983|NCT02940392|12539539|FG000|Overall Study|Lost to Follow-up|3
7974984|NCT02940392|12539539|FG000|Overall Study|Retreatment|3
7974985|NCT02940392|12539539|FG000|Overall Study|Death|2
7974986|NCT02940574|12539545|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1
7974987|NCT02940574|12539546|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0
7974988|NCT02940574|12539545|FG000|1-year Follow-up|Lost to Follow-up|3
7974989|NCT02940574|12539546|FG001|1-year Follow-up|Lost to Follow-up|4
7974990|NCT02940626|12539558|FG000|Overall Study|Death|40
7974991|NCT02940626|12539559|FG001|Overall Study|Death|32
7974992|NCT02940626|12539558|FG000|Overall Study|Lost to Follow-up|5
7974993|NCT02940626|12539559|FG001|Overall Study|Lost to Follow-up|2
7974994|NCT02940626|12539558|FG000|Overall Study|Withdrawal by Subject|1
7974995|NCT02940626|12539559|FG001|Overall Study|Withdrawal by Subject|0
7974996|NCT02940626|12539558|FG000|Overall Study|Transfer to Hospice Care|1
7974997|NCT02940626|12539559|FG001|Overall Study|Transfer to Hospice Care|0
7974998|NCT02940626|12539558|FG000|Overall Study|Prohibited Concomitant Medication|0
7974999|NCT02940626|12539559|FG001|Overall Study|Prohibited Concomitant Medication|1
7975000|NCT02940691|12539567|FG000|Overall Study|Lost to Follow-up|5
7975001|NCT02940691|12539567|FG000|Overall Study|Incarceration|1
7975002|NCT02940730|12539574|FG000|Intervention 2|Physician Decision|7
7975003|NCT02940730|12539575|FG001|Intervention 2|Physician Decision|0
7975004|NCT02940860|12539583|FG000|Overall Study|Non-serious AE|1
7975005|NCT02940860|12539584|FG001|Overall Study|Non-serious AE|2
7975006|NCT02940860|12539583|FG000|Overall Study|Serious AE|7
7975007|NCT02940860|12539584|FG001|Overall Study|Serious AE|3
7975008|NCT02940860|12539583|FG000|Overall Study|Withdrawal by Subject|19
7975009|NCT02940860|12539584|FG001|Overall Study|Withdrawal by Subject|9
7975010|NCT02940860|12539583|FG000|Overall Study|Lost to Follow-up|13
7975011|NCT02940860|12539584|FG001|Overall Study|Lost to Follow-up|7
7975012|NCT02940860|12539583|FG000|Overall Study|Physician Decision|5
7975013|NCT02940860|12539584|FG001|Overall Study|Physician Decision|3
7975014|NCT02940860|12539583|FG000|Overall Study|Sponsor Decision|0
7975015|NCT02940860|12539584|FG001|Overall Study|Sponsor Decision|1
7975016|NCT02940860|12539583|FG000|Overall Study|Protocol Violation|0
7975017|NCT02940860|12539584|FG001|Overall Study|Protocol Violation|2
7975018|NCT02940860|12539583|FG000|Overall Study|Death|3
7975019|NCT02940860|12539584|FG001|Overall Study|Death|2
7975020|NCT02940860|12539583|FG000|Overall Study|Moved, poor venous access, transport|6
7975021|NCT02940860|12539584|FG001|Overall Study|Moved, poor venous access, transport|4
7975022|NCT02940860|12539583|FG000|Overall Study|Not treated|2
7975023|NCT02940860|12539584|FG001|Overall Study|Not treated|2
7975024|NCT02940886|12539594|FG000|Overall Study|Adverse Event|7
7975025|NCT02940886|12539595|FG001|Overall Study|Adverse Event|3
7975026|NCT02940886|12539594|FG000|Overall Study|Protocol Violation|0
7975027|NCT02940886|12539595|FG001|Overall Study|Protocol Violation|2
7975028|NCT02940886|12539594|FG000|Overall Study|Withdrawal by Subject|28
7975029|NCT02940886|12539595|FG001|Overall Study|Withdrawal by Subject|20
7975030|NCT02940886|12539594|FG000|Overall Study|Death|1
7975031|NCT02940886|12539595|FG001|Overall Study|Death|0
7975032|NCT02940886|12539594|FG000|Overall Study|Lack of Efficacy|1
7975033|NCT02940886|12539595|FG001|Overall Study|Lack of Efficacy|0
7975034|NCT02940886|12539594|FG000|Overall Study|Lost to Follow-up|49
7975035|NCT02940886|12539595|FG001|Overall Study|Lost to Follow-up|21
7975036|NCT02940886|12539594|FG000|Overall Study|Physician Decision|9
7975037|NCT02940886|12539595|FG001|Overall Study|Physician Decision|4
7975038|NCT02940886|12539594|FG000|Overall Study|Sponsor decision|0
7975039|NCT02940886|12539595|FG001|Overall Study|Sponsor decision|1
7975040|NCT02940886|12539594|FG000|Overall Study|No treatment|7
7975041|NCT02940886|12539595|FG001|Overall Study|No treatment|2
7975042|NCT02940886|12539594|FG000|Overall Study|Enrolment error|0
7975043|NCT02940886|12539595|FG001|Overall Study|Enrolment error|1
7975044|NCT02941523|12539605|FG000|Monotherapy|Withdrawal by Subject|0
7975045|NCT02941523|12539606|FG001|Monotherapy|Withdrawal by Subject|1
7975046|NCT02941523|12539605|FG000|Carboplatin Combination Therapy|Adverse Event|0
7975047|NCT02941523|12539606|FG001|Carboplatin Combination Therapy|Adverse Event|1
7975048|NCT02941523|12539605|FG000|Carboplatin Combination Therapy|Death|1
7975049|NCT02941523|12539606|FG001|Carboplatin Combination Therapy|Death|2
7975050|NCT02941523|12539605|FG000|Carboplatin Combination Therapy|Disease progression|2
7975051|NCT02941523|12539606|FG001|Carboplatin Combination Therapy|Disease progression|0
7975052|NCT02941523|12539605|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2
7975053|NCT02941523|12539606|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1
7975054|NCT02941627|12539631|FG000|Overall Study|Death|1
7975055|NCT02941627|12539631|FG000|Overall Study|Surgical failure|1
7975056|NCT02941627|12539631|FG000|Overall Study|cholesteatoma prevented implantation|1
7975057|NCT02942264|12539684|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7975058|NCT02942264|12539685|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1
7975059|NCT02942264|12539686|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7975060|NCT02942264|12539687|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7975061|NCT02942264|12539688|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7975062|NCT02942264|12539689|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7975063|NCT02942264|12539690|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1
7975064|NCT02942264|12539691|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7975065|NCT02942264|12539692|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7975066|NCT02942264|12539684|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7975067|NCT02942264|12539685|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7975068|NCT02942264|12539686|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7975069|NCT02942264|12539687|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7975070|NCT02942264|12539688|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7975071|NCT02942264|12539689|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7975072|NCT02942264|12539690|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7975073|NCT02942264|12539691|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7975074|NCT02942264|12539692|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1
7975075|NCT02942407|12539719|FG000|Overall Study|Lost to Follow-up|3
7975076|NCT02942407|12539720|FG001|Overall Study|Lost to Follow-up|2
7975077|NCT02942407|12539719|FG000|Overall Study|Withdrawal by Subject|7
7975078|NCT02942407|12539720|FG001|Overall Study|Withdrawal by Subject|9
7975079|NCT02942407|12539719|FG000|Overall Study|Death|16
7975080|NCT02942407|12539720|FG001|Overall Study|Death|13
7975081|NCT02942485|12539736|FG000|Overall Study|Lost to Follow-up|1
7975082|NCT02942485|12539737|FG001|Overall Study|Lost to Follow-up|0
7975083|NCT02942576|12539745|FG000|Overall Study|Adverse Event|28
7975084|NCT02942576|12539746|FG001|Overall Study|Adverse Event|6
7975085|NCT02942576|12539745|FG000|Overall Study|Withdrawal by Subject|7
7975086|NCT02942576|12539746|FG001|Overall Study|Withdrawal by Subject|5
7975087|NCT02942576|12539745|FG000|Overall Study|Physician Decision|1
7975088|NCT02942576|12539746|FG001|Overall Study|Physician Decision|4
7975089|NCT02942576|12539745|FG000|Overall Study|Other|10
7975090|NCT02942576|12539746|FG001|Overall Study|Other|8
7975091|NCT02942771|12539764|FG000|Overall Study|Adverse Event|1
7975092|NCT02942771|12539765|FG001|Overall Study|Adverse Event|0
7975093|NCT02942771|12539766|FG002|Overall Study|Adverse Event|0
7975094|NCT02942771|12539767|FG003|Overall Study|Adverse Event|0
7975095|NCT02942771|12539768|FG004|Overall Study|Adverse Event|2
7975096|NCT02942771|12539764|FG000|Overall Study|Lost to Follow-up|1
7975097|NCT02942771|12539765|FG001|Overall Study|Lost to Follow-up|0
7975098|NCT02942771|12539766|FG002|Overall Study|Lost to Follow-up|0
7975099|NCT02942771|12539767|FG003|Overall Study|Lost to Follow-up|0
7975100|NCT02942771|12539768|FG004|Overall Study|Lost to Follow-up|0
7975101|NCT02942771|12539764|FG000|Overall Study|Withdrawal by Subject|1
7975102|NCT02942771|12539765|FG001|Overall Study|Withdrawal by Subject|0
7975103|NCT02942771|12539766|FG002|Overall Study|Withdrawal by Subject|0
7975104|NCT02942771|12539767|FG003|Overall Study|Withdrawal by Subject|0
7975105|NCT02942771|12539768|FG004|Overall Study|Withdrawal by Subject|2
7975106|NCT02943070|12539789|FG000|Overall Study|Physician Decision|1
7975107|NCT02943070|12539789|FG000|Overall Study|Adverse Event|2
7975108|NCT02943070|12539789|FG000|Overall Study|Death|2
7975109|NCT02943070|12539789|FG000|Overall Study|Withdrawal by Subject|3
7975110|NCT02943070|12539789|FG000|Overall Study|Lost to Follow-up|4
7975111|NCT02943070|12539789|FG000|Overall Study|Retreatment or TURP|13
7975112|NCT02943070|12539789|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18
7975113|NCT02943096|12539802|FG000|Overall Study|Lack of Efficacy|0
7975114|NCT02943096|12539803|FG001|Overall Study|Lack of Efficacy|1
7975115|NCT02943447|12539827|FG000|Blinded Study Phase|Withdrew Consent|1
7975116|NCT02943447|12539828|FG001|Blinded Study Phase|Withdrew Consent|2
7975117|NCT02943447|12539829|FG002|Blinded Study Phase|Withdrew Consent|1
7975118|NCT02943447|12539827|FG000|Blinded Study Phase|Adverse Event|3
7975119|NCT02943447|12539828|FG001|Blinded Study Phase|Adverse Event|0
7975120|NCT02943447|12539829|FG002|Blinded Study Phase|Adverse Event|0
7975121|NCT02943447|12539827|FG000|Blinded Study Phase|Investigator's discretion|1
7975122|NCT02943447|12539828|FG001|Blinded Study Phase|Investigator's discretion|0
7975123|NCT02943447|12539829|FG002|Blinded Study Phase|Investigator's discretion|0
7975124|NCT02943447|12539827|FG000|Open-Label Extension Phase|Study terminated by sponsor|10
7975125|NCT02943447|12539828|FG001|Open-Label Extension Phase|Study terminated by sponsor|12
7975126|NCT02943447|12539829|FG002|Open-Label Extension Phase|Study terminated by sponsor|6
7975127|NCT02943447|12539827|FG000|Open-Label Extension Phase|Adverse Event|4
7975128|NCT02943447|12539828|FG001|Open-Label Extension Phase|Adverse Event|7
7975129|NCT02943447|12539829|FG002|Open-Label Extension Phase|Adverse Event|3
7975130|NCT02943447|12539827|FG000|Open-Label Extension Phase|Lack of Efficacy|3
7975131|NCT02943447|12539828|FG001|Open-Label Extension Phase|Lack of Efficacy|4
7975132|NCT02943447|12539829|FG002|Open-Label Extension Phase|Lack of Efficacy|0
7975133|NCT02943447|12539827|FG000|Open-Label Extension Phase|Withdrew consent|1
7975134|NCT02943447|12539828|FG001|Open-Label Extension Phase|Withdrew consent|1
7975135|NCT02943447|12539829|FG002|Open-Label Extension Phase|Withdrew consent|1
7975136|NCT02943447|12539827|FG000|Open-Label Extension Phase|Lost to Follow-up|0
7975137|NCT02943447|12539828|FG001|Open-Label Extension Phase|Lost to Follow-up|1
7975138|NCT02943447|12539829|FG002|Open-Label Extension Phase|Lost to Follow-up|0
7975139|NCT02943460|12539849|FG000|Blinded Study Phase|Adverse Event|3
7975140|NCT02943460|12539850|FG001|Blinded Study Phase|Adverse Event|0
7975141|NCT02943460|12539851|FG002|Blinded Study Phase|Adverse Event|0
7975142|NCT02943460|12539849|FG000|Blinded Study Phase|Withdrew Consent|0
7975143|NCT02943460|12539850|FG001|Blinded Study Phase|Withdrew Consent|1
7975144|NCT02943460|12539851|FG002|Blinded Study Phase|Withdrew Consent|0
7975145|NCT02943460|12539849|FG000|Open Label Extension (OLE) Phase|Adverse Event|2
7975146|NCT02943460|12539850|FG001|Open Label Extension (OLE) Phase|Adverse Event|5
7975147|NCT02943460|12539851|FG002|Open Label Extension (OLE) Phase|Adverse Event|2
7975148|NCT02943460|12539849|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2
7975149|NCT02943460|12539850|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1
7975150|NCT02943460|12539851|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0
7975151|NCT02943460|12539849|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1
7975152|NCT02943460|12539850|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1
7975153|NCT02943460|12539851|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0
7975154|NCT02943473|12539860|FG000|Overall Study|enrolled but not dosed|1
7975155|NCT02943473|12539860|FG000|Overall Study|screen failure|1
7975156|NCT02943473|12539860|FG000|Overall Study|Physician Decision|4
7975157|NCT02943564|12539876|FG000|Overall Study|Miscellaneous Reasons|0
7975158|NCT02943564|12539877|FG001|Overall Study|Miscellaneous Reasons|0
7975159|NCT02943564|12539878|FG002|Overall Study|Miscellaneous Reasons|3
7975160|NCT02943564|12539876|FG000|Overall Study|Site terminated by sponsor|0
7975161|NCT02943564|12539877|FG001|Overall Study|Site terminated by sponsor|1
7975162|NCT02943564|12539878|FG002|Overall Study|Site terminated by sponsor|0
7975163|NCT02943564|12539876|FG000|Overall Study|Non-compliance with study drug|0
7975164|NCT02943564|12539877|FG001|Overall Study|Non-compliance with study drug|1
7975165|NCT02943564|12539878|FG002|Overall Study|Non-compliance with study drug|0
7975166|NCT02943564|12539876|FG000|Overall Study|Pregnancy|0
7975167|NCT02943564|12539877|FG001|Overall Study|Pregnancy|1
7975168|NCT02943564|12539878|FG002|Overall Study|Pregnancy|1
7975169|NCT02943564|12539876|FG000|Overall Study|Protocol Violation|2
7975170|NCT02943564|12539877|FG001|Overall Study|Protocol Violation|2
7975171|NCT02943564|12539878|FG002|Overall Study|Protocol Violation|2
7975172|NCT02943564|12539876|FG000|Overall Study|Lost to Follow-up|1
7975173|NCT02943564|12539877|FG001|Overall Study|Lost to Follow-up|0
7975174|NCT02943564|12539878|FG002|Overall Study|Lost to Follow-up|0
7975175|NCT02943564|12539876|FG000|Overall Study|Withdrawal by Subject|6
7975176|NCT02943564|12539877|FG001|Overall Study|Withdrawal by Subject|5
7975177|NCT02943564|12539878|FG002|Overall Study|Withdrawal by Subject|2
7975178|NCT02943564|12539876|FG000|Overall Study|Adverse Event|1
7975179|NCT02943564|12539877|FG001|Overall Study|Adverse Event|2
7975180|NCT02943564|12539878|FG002|Overall Study|Adverse Event|1
7975181|NCT02943564|12539876|FG000|Overall Study|Lack of Efficacy|0
7975182|NCT02943564|12539877|FG001|Overall Study|Lack of Efficacy|1
7975183|NCT02943564|12539878|FG002|Overall Study|Lack of Efficacy|0
7975184|NCT02943577|12539888|FG000|Overall Study|Protocol Violation|0
7975185|NCT02943577|12539889|FG001|Overall Study|Protocol Violation|1
7975186|NCT02943577|12539888|FG000|Overall Study|Adverse Event|3
7975187|NCT02943577|12539889|FG001|Overall Study|Adverse Event|2
7975188|NCT02943577|12539888|FG000|Overall Study|Lost to Follow-up|0
7975189|NCT02943577|12539889|FG001|Overall Study|Lost to Follow-up|1
7975190|NCT02943577|12539888|FG000|Overall Study|Withdrawal by Subject|1
7975191|NCT02943577|12539889|FG001|Overall Study|Withdrawal by Subject|1
7975192|NCT02943577|12539888|FG000|Overall Study|Pregnancy|1
7975193|NCT02943577|12539889|FG001|Overall Study|Pregnancy|0
7975194|NCT02943668|12539895|FG000|Overall Study|Disease Progression|1
7975195|NCT02944383|12539910|FG000|Overall Study|Lost to Follow-up|0
7975196|NCT02944383|12539911|FG001|Overall Study|Lost to Follow-up|0
7975197|NCT02944383|12539912|FG002|Overall Study|Lost to Follow-up|1
7975198|NCT02944383|12539910|FG000|Overall Study|Withdrawal by Subject|1
7975199|NCT02944383|12539911|FG001|Overall Study|Withdrawal by Subject|0
7975200|NCT02944383|12539912|FG002|Overall Study|Withdrawal by Subject|0
7975201|NCT02944448|12539924|FG000|Overall Study|Adverse Event|37
7975202|NCT02944448|12539925|FG001|Overall Study|Adverse Event|6
7975203|NCT02944448|12539924|FG000|Overall Study|Lack of Efficacy|8
7975204|NCT02944448|12539925|FG001|Overall Study|Lack of Efficacy|5
7975205|NCT02944448|12539924|FG000|Overall Study|Lost to Follow-up|3
7975206|NCT02944448|12539925|FG001|Overall Study|Lost to Follow-up|1
7975207|NCT02944448|12539924|FG000|Overall Study|Protocol Violation|25
7975208|NCT02944448|12539925|FG001|Overall Study|Protocol Violation|7
7975209|NCT02944448|12539924|FG000|Overall Study|Withdrawal by Subject|14
7975210|NCT02944448|12539925|FG001|Overall Study|Withdrawal by Subject|4
7975211|NCT02944448|12539924|FG000|Overall Study|Sponsor did not supply drug in time|0
7975212|NCT02944448|12539925|FG001|Overall Study|Sponsor did not supply drug in time|1
7975213|NCT02944448|12539924|FG000|Overall Study|Noncompliant with dosing|1
7975214|NCT02944448|12539925|FG001|Overall Study|Noncompliant with dosing|0
7975215|NCT02944448|12539924|FG000|Overall Study|Abnormal laboratory values|1
7975216|NCT02944448|12539925|FG001|Overall Study|Abnormal laboratory values|0
7975217|NCT02944656|12539943|FG000|Overall Study|No longer eligible|3
7975218|NCT02944656|12539944|FG001|Overall Study|No longer eligible|0
7975219|NCT02944656|12539943|FG000|Overall Study|Lost to Follow-up|7
7975220|NCT02944656|12539944|FG001|Overall Study|Lost to Follow-up|10
7975221|NCT02944968|12539950|FG000|Overall Study|Subject excluded before study procedure|1
7975222|NCT02944968|12539950|FG000|Overall Study|Subject didn't meet eligibility criteria|2
7975223|NCT02945046|12539957|FG000|Overall Study|Adverse Event|1
7975224|NCT02945046|12539958|FG001|Overall Study|Adverse Event|0
7975225|NCT02945046|12539959|FG002|Overall Study|Adverse Event|2
7975226|NCT02945046|12539957|FG000|Overall Study|Withdrawal by Subject|3
7975227|NCT02945046|12539958|FG001|Overall Study|Withdrawal by Subject|3
7975228|NCT02945046|12539959|FG002|Overall Study|Withdrawal by Subject|3
7975229|NCT02945046|12539957|FG000|Overall Study|Protocol Violation|2
7975230|NCT02945046|12539958|FG001|Overall Study|Protocol Violation|3
7975231|NCT02945046|12539959|FG002|Overall Study|Protocol Violation|2
7975232|NCT02945046|12539957|FG000|Overall Study|Lost to Follow-up|1
7975233|NCT02945046|12539958|FG001|Overall Study|Lost to Follow-up|1
7975234|NCT02945046|12539959|FG002|Overall Study|Lost to Follow-up|0
7975235|NCT02945046|12539957|FG000|Overall Study|Lack of Efficacy|1
7975236|NCT02945046|12539958|FG001|Overall Study|Lack of Efficacy|2
7975237|NCT02945046|12539959|FG002|Overall Study|Lack of Efficacy|1
7975238|NCT02945046|12539957|FG000|Overall Study|Other than specified|5
7975239|NCT02945046|12539958|FG001|Overall Study|Other than specified|4
7975240|NCT02945046|12539959|FG002|Overall Study|Other than specified|7
7975241|NCT02945254|12539973|FG000|Overall Study|Lost to Follow-up|1
7975242|NCT02945254|12539974|FG001|Overall Study|Lost to Follow-up|0
7975243|NCT02945254|12539973|FG000|Overall Study|Withdrawal by Subject|1
7975244|NCT02945254|12539974|FG001|Overall Study|Withdrawal by Subject|0
7975245|NCT02945410|12539986|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0
7975246|NCT02945410|12539987|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3
7975247|NCT02945410|12539988|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0
7975248|NCT02945410|12539989|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0
7975249|NCT02945410|12539990|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0
7975250|NCT02945410|12539991|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0
7975251|NCT02945410|12539986|FG000|Intervention 1 (5 Days)|Adverse Event|1
7975252|NCT02945410|12539987|FG001|Intervention 1 (5 Days)|Adverse Event|0
7975253|NCT02945410|12539988|FG002|Intervention 1 (5 Days)|Adverse Event|0
7975254|NCT02945410|12539989|FG003|Intervention 1 (5 Days)|Adverse Event|0
7975255|NCT02945410|12539990|FG004|Intervention 1 (5 Days)|Adverse Event|0
7975256|NCT02945410|12539991|FG005|Intervention 1 (5 Days)|Adverse Event|1
7975257|NCT02945410|12539986|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0
7975258|NCT02945410|12539987|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0
7975259|NCT02945410|12539988|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2
7975260|NCT02945410|12539989|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0
7975261|NCT02945410|12539990|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1
7975262|NCT02945410|12539991|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0
7975263|NCT02945657|12540012|FG000|Overall Study|Adverse Event|1
7975264|NCT02945657|12540012|FG000|Overall Study|Withdrawal by Parent/Guardian|3
7975265|NCT02946385|12540068|FG000|Overall Study|Lost to Follow-up|0
7975266|NCT02946385|12540069|FG001|Overall Study|Lost to Follow-up|0
7975267|NCT02946385|12540070|FG002|Overall Study|Lost to Follow-up|3
7975268|NCT02946385|12540071|FG003|Overall Study|Lost to Follow-up|0
7975269|NCT02946385|12540072|FG004|Overall Study|Lost to Follow-up|2
7975270|NCT02946385|12540073|FG005|Overall Study|Lost to Follow-up|1
7975271|NCT02946515|12540099|FG000|Overall Study|Lost to Follow-up|2
7975272|NCT02946515|12540100|FG001|Overall Study|Lost to Follow-up|1
7975273|NCT02946580|12540108|FG000|Overall Study|Withdrawal by Subject|1
7975274|NCT02946580|12540109|FG001|Overall Study|Withdrawal by Subject|2
7975275|NCT02946580|12540108|FG000|Overall Study|Adverse Event|0
7975276|NCT02946580|12540109|FG001|Overall Study|Adverse Event|2
7975277|NCT02946580|12540108|FG000|Overall Study|Did not undergo posterior spinal fusion|0
7975278|NCT02946580|12540109|FG001|Overall Study|Did not undergo posterior spinal fusion|1
7975279|NCT02946918|12540124|FG000|Overall Study|Patient unblinded himself|1
7975280|NCT02946918|12540125|FG001|Overall Study|Patient unblinded himself|0
7975281|NCT02946918|12540124|FG000|Overall Study|Physician Decision|0
7975282|NCT02946918|12540125|FG001|Overall Study|Physician Decision|2
7975283|NCT02946918|12540124|FG000|Overall Study|Ran out of study medication|0
7975284|NCT02946918|12540125|FG001|Overall Study|Ran out of study medication|1
7975285|NCT02948582|12540167|FG000|Washout Period 1|Adverse Event|0
7975286|NCT02948582|12540168|FG001|Washout Period 1|Adverse Event|2
7975287|NCT02948582|12540169|FG002|Washout Period 1|Adverse Event|0
7975288|NCT02948582|12540170|FG003|Washout Period 1|Adverse Event|0
7975289|NCT02948582|12540171|FG004|Washout Period 1|Adverse Event|0
7975290|NCT02948582|12540172|FG005|Washout Period 1|Adverse Event|0
7975291|NCT02948582|12540167|FG000|Washout Period 1|Protocol Violation|0
7975292|NCT02948582|12540168|FG001|Washout Period 1|Protocol Violation|0
7975293|NCT02948582|12540169|FG002|Washout Period 1|Protocol Violation|0
7975294|NCT02948582|12540170|FG003|Washout Period 1|Protocol Violation|0
7975295|NCT02948582|12540171|FG004|Washout Period 1|Protocol Violation|0
7975296|NCT02948582|12540172|FG005|Washout Period 1|Protocol Violation|1
7975297|NCT02948582|12540167|FG000|Washout Period 2|Adverse Event|0
7975298|NCT02948582|12540168|FG001|Washout Period 2|Adverse Event|1
7975299|NCT02948582|12540169|FG002|Washout Period 2|Adverse Event|0
7975300|NCT02948582|12540170|FG003|Washout Period 2|Adverse Event|0
7975301|NCT02948582|12540171|FG004|Washout Period 2|Adverse Event|0
7975302|NCT02948582|12540172|FG005|Washout Period 2|Adverse Event|0
7975303|NCT02948582|12540167|FG000|Washout Period 2|personal reasons|0
7975304|NCT02948582|12540168|FG001|Washout Period 2|personal reasons|0
7975305|NCT02948582|12540169|FG002|Washout Period 2|personal reasons|0
7975306|NCT02948582|12540170|FG003|Washout Period 2|personal reasons|1
7975307|NCT02948582|12540171|FG004|Washout Period 2|personal reasons|0
7975308|NCT02948582|12540172|FG005|Washout Period 2|personal reasons|0
7975309|NCT02948582|12540167|FG000|Washout Period 4|Adverse Event|1
7975310|NCT02948582|12540168|FG001|Washout Period 4|Adverse Event|0
7975311|NCT02948582|12540169|FG002|Washout Period 4|Adverse Event|1
7975312|NCT02948582|12540170|FG003|Washout Period 4|Adverse Event|0
7975313|NCT02948582|12540171|FG004|Washout Period 4|Adverse Event|0
7975314|NCT02948582|12540172|FG005|Washout Period 4|Adverse Event|0
7975315|NCT02948634|12540188|FG000|Overall Study|Lack of efficacy and study suspended|10
7975316|NCT02948634|12540189|FG001|Overall Study|Lack of efficacy and study suspended|2
7975317|NCT02948777|12540195|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1
7975318|NCT02949011|12540203|FG000|Overall Study|Adverse Event|6
7975319|NCT02949011|12540204|FG001|Overall Study|Adverse Event|7
7975320|NCT02949011|12540205|FG002|Overall Study|Adverse Event|3
7975321|NCT02949011|12540203|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
7975322|NCT02949011|12540204|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0
7975323|NCT02949011|12540205|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3
7975324|NCT02949011|12540203|FG000|Overall Study|Protocol Deviation|5
7975325|NCT02949011|12540204|FG001|Overall Study|Protocol Deviation|3
7975326|NCT02949011|12540205|FG002|Overall Study|Protocol Deviation|3
7975327|NCT02949011|12540203|FG000|Overall Study|Lack of Efficacy|0
7975328|NCT02949011|12540204|FG001|Overall Study|Lack of Efficacy|2
7975329|NCT02949011|12540205|FG002|Overall Study|Lack of Efficacy|0
7975330|NCT02949011|12540203|FG000|Overall Study|Withdrawal by Subject|13
7975331|NCT02949011|12540204|FG001|Overall Study|Withdrawal by Subject|13
7975332|NCT02949011|12540205|FG002|Overall Study|Withdrawal by Subject|21
7975333|NCT02949011|12540203|FG000|Overall Study|Lost to Follow-up|7
7975334|NCT02949011|12540204|FG001|Overall Study|Lost to Follow-up|5
7975335|NCT02949011|12540205|FG002|Overall Study|Lost to Follow-up|5
7975336|NCT02949011|12540203|FG000|Overall Study|Death|0
7975337|NCT02949011|12540204|FG001|Overall Study|Death|0
7975338|NCT02949011|12540205|FG002|Overall Study|Death|1
7975339|NCT02949011|12540203|FG000|Overall Study|Miscellaneous|2
7975340|NCT02949011|12540204|FG001|Overall Study|Miscellaneous|4
7975341|NCT02949011|12540205|FG002|Overall Study|Miscellaneous|6
7975342|NCT02949024|12540215|FG000|Overall Study|Withdrawal by Subject|0
7975343|NCT02949024|12540216|FG001|Overall Study|Withdrawal by Subject|1
7975344|NCT02949271|12540233|FG000|Overall Study|Lack of Efficacy|5
7975345|NCT02949271|12540234|FG001|Overall Study|Lack of Efficacy|4
7975346|NCT02949271|12540233|FG000|Overall Study|Lost to Follow-up|3
7975347|NCT02949271|12540234|FG001|Overall Study|Lost to Follow-up|6
7975348|NCT02949271|12540233|FG000|Overall Study|Physician Decision|5
7975349|NCT02949271|12540234|FG001|Overall Study|Physician Decision|5
7975350|NCT02949271|12540233|FG000|Overall Study|Protocol Violation|6
7975351|NCT02949271|12540234|FG001|Overall Study|Protocol Violation|3
7975352|NCT02949271|12540233|FG000|Overall Study|Withdrawal by Subject|1
7975353|NCT02949271|12540234|FG001|Overall Study|Withdrawal by Subject|0
7975354|NCT02949271|12540233|FG000|Overall Study|Delivered prior to intervention|7
7975355|NCT02949271|12540234|FG001|Overall Study|Delivered prior to intervention|9
7975356|NCT02949271|12540233|FG000|Overall Study|Outside the window for cervical dilation|2
7975357|NCT02949271|12540234|FG001|Overall Study|Outside the window for cervical dilation|3
7975358|NCT02949362|12540242|FG000|Retrospective Period|Inform consent not signed by participant|4
7975359|NCT02949362|12540243|FG001|Retrospective Period|Inform consent not signed by participant|1
7975360|NCT02949362|12540244|FG002|Retrospective Period|Inform consent not signed by participant|0
7975361|NCT02949362|12540245|FG003|Retrospective Period|Inform consent not signed by participant|0
7975362|NCT02949362|12540242|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
7975363|NCT02949362|12540243|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
7975364|NCT02949362|12540244|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1
7975365|NCT02949362|12540245|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
7975366|NCT02949362|12540242|FG000|Prospective Period|Other|0
7975367|NCT02949362|12540243|FG001|Prospective Period|Other|0
7975368|NCT02949362|12540244|FG002|Prospective Period|Other|0
7975369|NCT02949362|12540245|FG003|Prospective Period|Other|4
7975370|NCT02949908|12540281|FG000|Overall Study|Study termination|2
7975371|NCT02949973|12540294|FG000|Overall Study|Physician Decision|1
7975372|NCT02950545|12540317|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0
7975373|NCT02950545|12540318|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0
7975374|NCT02950545|12540319|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0
7975375|NCT02950545|12540320|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0
7975376|NCT02950545|12540321|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0
7975377|NCT02950545|12540322|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1
7975378|NCT02950545|12540317|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1
7975379|NCT02950545|12540318|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0
7975380|NCT02950545|12540319|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0
7975381|NCT02950545|12540320|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1
7975382|NCT02950545|12540321|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0
7975383|NCT02950545|12540322|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1
7975384|NCT02950545|12540317|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0
7975385|NCT02950545|12540318|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0
7975386|NCT02950545|12540319|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0
7975387|NCT02950545|12540320|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0
7975388|NCT02950545|12540321|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1
7975389|NCT02950545|12540322|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0
7975390|NCT02950545|12540317|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1
7975391|NCT02950545|12540318|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7975392|NCT02950545|12540319|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7975393|NCT02950545|12540320|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7975394|NCT02950545|12540321|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7975395|NCT02950545|12540322|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7975396|NCT02950545|12540317|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0
7975397|NCT02950545|12540318|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0
7975398|NCT02950545|12540319|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0
7975399|NCT02950545|12540320|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0
7975400|NCT02950545|12540321|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0
7975401|NCT02950545|12540322|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1
7975402|NCT02950558|12540330|FG000|Overall Study|Lost to Follow-up|2
7975403|NCT02950558|12540331|FG001|Overall Study|Lost to Follow-up|0
7975404|NCT02950831|12540347|FG000|Overall Study|Lost to Follow-up|1
7975405|NCT02950831|12540347|FG000|Overall Study|Withdrawal by Subject|3
7975406|NCT02950831|12540347|FG000|Overall Study|stimulation trail failure|5
7975407|NCT02951156|12540379|FG000|Overall Study|Death|3
7975408|NCT02951156|12540380|FG001|Overall Study|Death|8
7975409|NCT02951156|12540381|FG002|Overall Study|Death|5
7975410|NCT02951156|12540379|FG000|Overall Study|Progressive disease|1
7975411|NCT02951156|12540380|FG001|Overall Study|Progressive disease|0
7975412|NCT02951156|12540381|FG002|Overall Study|Progressive disease|1
7975413|NCT02951156|12540379|FG000|Overall Study|Withdrawal by Subject|0
7975414|NCT02951156|12540380|FG001|Overall Study|Withdrawal by Subject|0
7975415|NCT02951156|12540381|FG002|Overall Study|Withdrawal by Subject|1
7975416|NCT02951156|12540379|FG000|Overall Study|Study terminated by sponsor|0
7975417|NCT02951156|12540380|FG001|Overall Study|Study terminated by sponsor|0
7975418|NCT02951156|12540381|FG002|Overall Study|Study terminated by sponsor|1
7975419|NCT02951156|12540379|FG000|Overall Study|Other|5
7975420|NCT02951156|12540380|FG001|Overall Study|Other|1
7975421|NCT02951156|12540381|FG002|Overall Study|Other|2
7975422|NCT02951429|12540506|FG000|Overall Study|Adverse Event|3
7975423|NCT02951429|12540507|FG001|Overall Study|Adverse Event|7
7975424|NCT02951429|12540506|FG000|Overall Study|Death|28
7975425|NCT02951429|12540507|FG001|Overall Study|Death|36
7975426|NCT02951429|12540506|FG000|Overall Study|Lack of Efficacy|0
7975427|NCT02951429|12540507|FG001|Overall Study|Lack of Efficacy|1
7975428|NCT02951429|12540506|FG000|Overall Study|Lost to Follow-up|0
7975429|NCT02951429|12540507|FG001|Overall Study|Lost to Follow-up|1
7975430|NCT02951429|12540506|FG000|Overall Study|Lung Transplantation|9
7975431|NCT02951429|12540507|FG001|Overall Study|Lung Transplantation|6
7975432|NCT02951429|12540506|FG000|Overall Study|Other|1
7975433|NCT02951429|12540507|FG001|Overall Study|Other|3
7975434|NCT02951429|12540506|FG000|Overall Study|Progressive Disease|1
7975435|NCT02951429|12540507|FG001|Overall Study|Progressive Disease|1
7975436|NCT02951429|12540506|FG000|Overall Study|Withdrawal by Subject|7
7975437|NCT02951429|12540507|FG001|Overall Study|Withdrawal by Subject|11
7975438|NCT02951429|12540506|FG000|Overall Study|Participant ongoing in the study|23
7975439|NCT02951429|12540507|FG001|Overall Study|Participant ongoing in the study|17
7975440|NCT02951533|12540515|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0
7975441|NCT02951533|12540516|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16
7975442|NCT02951533|12540517|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0
7975443|NCT02951533|12540515|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
7975444|NCT02951533|12540516|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
7975445|NCT02951533|12540517|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0
7975446|NCT02951533|12540515|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2
7975447|NCT02951533|12540516|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4
7975448|NCT02951533|12540517|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0
7975449|NCT02951533|12540515|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
7975450|NCT02951533|12540516|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1
7975451|NCT02951533|12540517|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
7975452|NCT02951533|12540515|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0
7975453|NCT02951533|12540516|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1
7975454|NCT02951533|12540517|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0
7975455|NCT02951533|12540515|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1
7975456|NCT02951533|12540516|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
7975457|NCT02951533|12540517|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
7975458|NCT02951533|12540515|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0
7975459|NCT02951533|12540516|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2
7975460|NCT02951533|12540517|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0
7975461|NCT02951533|12540515|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1
7975462|NCT02951533|12540516|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2
7975463|NCT02951533|12540517|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0
7975464|NCT02951533|12540515|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1
7975465|NCT02951533|12540516|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
7975466|NCT02951533|12540517|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
7975467|NCT02951533|12540515|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1
7975468|NCT02951533|12540516|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
7975469|NCT02951533|12540517|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
7975470|NCT02951533|12540515|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
7975471|NCT02951533|12540516|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0
7975472|NCT02951533|12540517|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
7975473|NCT02951780|12540552|FG000|Period 1|Adverse Event|0
7975474|NCT02951780|12540553|FG001|Period 1|Adverse Event|0
7975475|NCT02951780|12540554|FG002|Period 1|Adverse Event|0
7975476|NCT02951780|12540555|FG003|Period 1|Adverse Event|1
7975477|NCT02951780|12540556|FG004|Period 1|Adverse Event|0
7975478|NCT02951780|12540557|FG005|Period 1|Adverse Event|0
7975479|NCT02951780|12540558|FG006|Period 1|Adverse Event|0
7975480|NCT02951780|12540559|FG007|Period 1|Adverse Event|0
7975481|NCT02951780|12540560|FG008|Period 1|Adverse Event|0
7975482|NCT02951780|12540552|FG000|Period 1|Scheduling Conflicts|0
7975483|NCT02951780|12540553|FG001|Period 1|Scheduling Conflicts|0
7975484|NCT02951780|12540554|FG002|Period 1|Scheduling Conflicts|0
7975485|NCT02951780|12540555|FG003|Period 1|Scheduling Conflicts|0
7975486|NCT02951780|12540556|FG004|Period 1|Scheduling Conflicts|0
7975487|NCT02951780|12540557|FG005|Period 1|Scheduling Conflicts|0
7975488|NCT02951780|12540558|FG006|Period 1|Scheduling Conflicts|0
7975489|NCT02951780|12540559|FG007|Period 1|Scheduling Conflicts|1
7975490|NCT02951780|12540560|FG008|Period 1|Scheduling Conflicts|0
7975491|NCT02951780|12540552|FG000|Period 2|Scheduling Conflicts|0
7975492|NCT02951780|12540553|FG001|Period 2|Scheduling Conflicts|0
7975493|NCT02951780|12540554|FG002|Period 2|Scheduling Conflicts|0
7975494|NCT02951780|12540555|FG003|Period 2|Scheduling Conflicts|0
7975495|NCT02951780|12540556|FG004|Period 2|Scheduling Conflicts|0
7975496|NCT02951780|12540557|FG005|Period 2|Scheduling Conflicts|0
7975497|NCT02951780|12540558|FG006|Period 2|Scheduling Conflicts|0
7975498|NCT02951780|12540559|FG007|Period 2|Scheduling Conflicts|1
7975499|NCT02951780|12540560|FG008|Period 2|Scheduling Conflicts|0
7975500|NCT02951819|12540582|FG000|Overall Study|Death|9
7975501|NCT02951819|12540583|FG001|Overall Study|Death|7
7975502|NCT02951819|12540582|FG000|Overall Study|Withdrawal by Subject|3
7975503|NCT02951819|12540583|FG001|Overall Study|Withdrawal by Subject|0
7975504|NCT02951819|12540582|FG000|Overall Study|Adverse Event|1
7975505|NCT02951819|12540583|FG001|Overall Study|Adverse Event|0
7975506|NCT02951819|12540582|FG000|Overall Study|Lack of Efficacy|4
7975507|NCT02951819|12540583|FG001|Overall Study|Lack of Efficacy|0
7975508|NCT02951819|12540582|FG000|Overall Study|Lost to Follow-up|1
7975509|NCT02951819|12540583|FG001|Overall Study|Lost to Follow-up|0
7975510|NCT02951819|12540582|FG000|Overall Study|Progressive Disease|1
7975511|NCT02951819|12540583|FG001|Overall Study|Progressive Disease|0
7975512|NCT02951819|12540582|FG000|Overall Study|Other|9
7975513|NCT02951819|12540583|FG001|Overall Study|Other|0
7975514|NCT02951988|12540605|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8
7975515|NCT02951988|12540606|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0
7975516|NCT02951988|12540607|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0
7975517|NCT02951988|12540608|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0
7975518|NCT02951988|12540605|FG000|Open-Label Treatment Period|Study terminated by sponsor|9
7975519|NCT02951988|12540606|FG001|Open-Label Treatment Period|Study terminated by sponsor|0
7975520|NCT02951988|12540607|FG002|Open-Label Treatment Period|Study terminated by sponsor|0
7975521|NCT02951988|12540608|FG003|Open-Label Treatment Period|Study terminated by sponsor|0
7975522|NCT02951988|12540605|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2
7975523|NCT02951988|12540606|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0
7975524|NCT02951988|12540607|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0
7975525|NCT02951988|12540608|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0
7975526|NCT02951988|12540605|FG000|Open-Label Treatment Period|Non-compliance with study drug|5
7975527|NCT02951988|12540606|FG001|Open-Label Treatment Period|Non-compliance with study drug|0
7975528|NCT02951988|12540607|FG002|Open-Label Treatment Period|Non-compliance with study drug|0
7975529|NCT02951988|12540608|FG003|Open-Label Treatment Period|Non-compliance with study drug|0
7975530|NCT02951988|12540605|FG000|Open-Label Treatment Period|Protocol Violation|22
7975531|NCT02951988|12540606|FG001|Open-Label Treatment Period|Protocol Violation|0
7975532|NCT02951988|12540607|FG002|Open-Label Treatment Period|Protocol Violation|0
7975533|NCT02951988|12540608|FG003|Open-Label Treatment Period|Protocol Violation|0
7975534|NCT02951988|12540605|FG000|Open-Label Treatment Period|Pregnancy|2
7975535|NCT02951988|12540606|FG001|Open-Label Treatment Period|Pregnancy|0
7975536|NCT02951988|12540607|FG002|Open-Label Treatment Period|Pregnancy|0
7975537|NCT02951988|12540608|FG003|Open-Label Treatment Period|Pregnancy|0
7975538|NCT02951988|12540605|FG000|Open-Label Treatment Period|Lost to Follow-up|28
7975539|NCT02951988|12540606|FG001|Open-Label Treatment Period|Lost to Follow-up|0
7975540|NCT02951988|12540607|FG002|Open-Label Treatment Period|Lost to Follow-up|0
7975541|NCT02951988|12540608|FG003|Open-Label Treatment Period|Lost to Follow-up|0
7975542|NCT02951988|12540605|FG000|Open-Label Treatment Period|Withdrawal by Subject|78
7975543|NCT02951988|12540606|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
7975544|NCT02951988|12540607|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
7975545|NCT02951988|12540608|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
7975546|NCT02951988|12540605|FG000|Open-Label Treatment Period|Lack of Efficacy|49
7975547|NCT02951988|12540606|FG001|Open-Label Treatment Period|Lack of Efficacy|0
7975548|NCT02951988|12540607|FG002|Open-Label Treatment Period|Lack of Efficacy|0
7975549|NCT02951988|12540608|FG003|Open-Label Treatment Period|Lack of Efficacy|0
7975550|NCT02951988|12540605|FG000|Open-Label Treatment Period|Adverse Event|45
7975551|NCT02951988|12540606|FG001|Open-Label Treatment Period|Adverse Event|0
7975552|NCT02951988|12540607|FG002|Open-Label Treatment Period|Adverse Event|0
7975553|NCT02951988|12540608|FG003|Open-Label Treatment Period|Adverse Event|0
7975554|NCT02951988|12540605|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0
7975555|NCT02951988|12540606|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0
7975556|NCT02951988|12540607|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1
7975557|NCT02951988|12540608|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1
7975558|NCT02951988|12540605|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0
7975559|NCT02951988|12540606|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58
7975560|NCT02951988|12540607|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54
7975561|NCT02951988|12540608|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69
7975562|NCT02951988|12540605|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0
7975563|NCT02951988|12540606|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1
7975564|NCT02951988|12540607|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3
7975565|NCT02951988|12540608|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0
7975566|NCT02951988|12540605|FG000|Double-Blind Treatment Period|Protocol Violation|0
7975567|NCT02951988|12540606|FG001|Double-Blind Treatment Period|Protocol Violation|4
7975568|NCT02951988|12540607|FG002|Double-Blind Treatment Period|Protocol Violation|4
7975569|NCT02951988|12540608|FG003|Double-Blind Treatment Period|Protocol Violation|8
7975570|NCT02951988|12540605|FG000|Double-Blind Treatment Period|Pregnancy|0
7975571|NCT02951988|12540606|FG001|Double-Blind Treatment Period|Pregnancy|1
7975572|NCT02951988|12540607|FG002|Double-Blind Treatment Period|Pregnancy|1
7975573|NCT02951988|12540608|FG003|Double-Blind Treatment Period|Pregnancy|0
7975574|NCT02951988|12540605|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7975575|NCT02951988|12540606|FG001|Double-Blind Treatment Period|Lost to Follow-up|4
7975576|NCT02951988|12540607|FG002|Double-Blind Treatment Period|Lost to Follow-up|12
7975577|NCT02951988|12540608|FG003|Double-Blind Treatment Period|Lost to Follow-up|3
7975578|NCT02951988|12540605|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7975579|NCT02951988|12540606|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23
7975580|NCT02951988|12540607|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22
7975581|NCT02951988|12540608|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28
7975582|NCT02951988|12540605|FG000|Double-Blind Treatment Period|Adverse Event|0
7975583|NCT02951988|12540606|FG001|Double-Blind Treatment Period|Adverse Event|8
7975584|NCT02951988|12540607|FG002|Double-Blind Treatment Period|Adverse Event|3
7975585|NCT02951988|12540608|FG003|Double-Blind Treatment Period|Adverse Event|6
7975586|NCT02951988|12540605|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0
7975587|NCT02951988|12540606|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2
7975588|NCT02951988|12540607|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1
7975589|NCT02951988|12540608|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0
7975590|NCT02952001|12540620|FG000|Overall Study|Adverse Event|3
7975591|NCT02952001|12540621|FG001|Overall Study|Adverse Event|0
7975592|NCT02952001|12540620|FG000|Overall Study|Prohibited therapy|10
7975593|NCT02952001|12540621|FG001|Overall Study|Prohibited therapy|3
7975594|NCT02952001|12540620|FG000|Overall Study|Due to Posterior Capsular Opacity|1
7975595|NCT02952001|12540621|FG001|Overall Study|Due to Posterior Capsular Opacity|0
7975596|NCT02952261|12540630|FG000|Overall Study|Withdrawal by Subject|4
7975597|NCT02952261|12540631|FG001|Overall Study|Withdrawal by Subject|5
7975598|NCT02952261|12540630|FG000|Overall Study|Protocol Violation|1
7975599|NCT02952261|12540631|FG001|Overall Study|Protocol Violation|0
7975600|NCT02952313|12540637|FG000|Primary Endpoint|Lost to Follow-up|4
7975601|NCT02952313|12540637|FG000|Primary Endpoint|Withdrawal by Subject|1
7975602|NCT02952313|12540637|FG000|Primary Endpoint|Lack of Efficacy|1
7975603|NCT02952313|12540637|FG000|Primary Endpoint|Missed visit|1
7975604|NCT02952313|12540637|FG000|Long-term Follow-up|Lost to Follow-up|12
7975605|NCT02952313|12540637|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7
7975606|NCT02952313|12540637|FG000|Long-term Follow-up|Lack of Efficacy|6
7975607|NCT02952313|12540637|FG000|Long-term Follow-up|Withdrawal by Subject|5
7975608|NCT02952313|12540637|FG000|Long-term Follow-up|Physician Decision|1
7975609|NCT02952313|12540637|FG000|Long-term Follow-up|Death|1
7975610|NCT02952586|12540644|FG000|Lead-In Phase (7 Days)|Death|0
7975611|NCT02952586|12540645|FG001|Lead-In Phase (7 Days)|Death|1
7975612|NCT02952586|12540644|FG000|Lead-In Phase (7 Days)|Adverse Event|3
7975613|NCT02952586|12540645|FG001|Lead-In Phase (7 Days)|Adverse Event|0
7975614|NCT02952586|12540644|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0
7975615|NCT02952586|12540645|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1
7975616|NCT02952586|12540644|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2
7975617|NCT02952586|12540645|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2
7975618|NCT02952586|12540644|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5
7975619|NCT02952586|12540645|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8
7975620|NCT02952586|12540644|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12
7975621|NCT02952586|12540645|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12
7975622|NCT02952586|12540644|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2
7975623|NCT02952586|12540645|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1
7975624|NCT02952586|12540644|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1
7975625|NCT02952586|12540645|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0
7975626|NCT02952586|12540644|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10
7975627|NCT02952586|12540645|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4
7975628|NCT02952586|12540644|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
7975629|NCT02952586|12540645|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
7975630|NCT02952586|12540644|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2
7975631|NCT02952586|12540645|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1
7975632|NCT02952586|12540644|FG000|CRT for Cisplatin (63 Days)|Death|3
7975633|NCT02952586|12540645|FG001|CRT for Cisplatin (63 Days)|Death|8
7975634|NCT02952586|12540644|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82
7975635|NCT02952586|12540645|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81
7975636|NCT02952586|12540644|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12
7975637|NCT02952586|12540645|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10
7975638|NCT02952586|12540644|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1
7975639|NCT02952586|12540645|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0
7975640|NCT02952586|12540644|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11
7975641|NCT02952586|12540645|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3
7975642|NCT02952586|12540644|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
7975643|NCT02952586|12540645|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
7975644|NCT02952586|12540644|FG000|CRT for Cisplatin (63 Days)|Other|1
7975645|NCT02952586|12540645|FG001|CRT for Cisplatin (63 Days)|Other|1
7975646|NCT02952586|12540644|FG000|CRT for IMRT (63 Days)|Death|5
7975647|NCT02952586|12540645|FG001|CRT for IMRT (63 Days)|Death|8
7975648|NCT02952586|12540644|FG000|CRT for IMRT (63 Days)|Adverse Event|5
7975649|NCT02952586|12540645|FG001|CRT for IMRT (63 Days)|Adverse Event|5
7975650|NCT02952586|12540644|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1
7975651|NCT02952586|12540645|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0
7975652|NCT02952586|12540644|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10
7975653|NCT02952586|12540645|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6
7975654|NCT02952586|12540644|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1
7975655|NCT02952586|12540645|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1
7975656|NCT02952586|12540644|FG000|CRT for IMRT (63 Days)|Other|1
7975657|NCT02952586|12540645|FG001|CRT for IMRT (63 Days)|Other|0
7975658|NCT02952586|12540644|FG000|Maintenance Phase (12 Months)|Death|17
7975659|NCT02952586|12540645|FG001|Maintenance Phase (12 Months)|Death|11
7975660|NCT02952586|12540644|FG000|Maintenance Phase (12 Months)|Progressive disease|60
7975661|NCT02952586|12540645|FG001|Maintenance Phase (12 Months)|Progressive disease|54
7975662|NCT02952586|12540644|FG000|Maintenance Phase (12 Months)|Adverse Event|24
7975663|NCT02952586|12540645|FG001|Maintenance Phase (12 Months)|Adverse Event|21
7975664|NCT02952586|12540644|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1
7975665|NCT02952586|12540645|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1
7975666|NCT02952586|12540644|FG000|Maintenance Phase (12 Months)|Physician Decision|1
7975667|NCT02952586|12540645|FG001|Maintenance Phase (12 Months)|Physician Decision|1
7975668|NCT02952586|12540644|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14
7975669|NCT02952586|12540645|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5
7975670|NCT02952586|12540644|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31
7975671|NCT02952586|12540645|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25
7975672|NCT02952586|12540644|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1
7975673|NCT02952586|12540645|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2
7975674|NCT02952586|12540644|FG000|Maintenance Phase (12 Months)|Other|2
7975675|NCT02952586|12540645|FG001|Maintenance Phase (12 Months)|Other|1
7975676|NCT02952586|12540644|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1
7975677|NCT02952586|12540645|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6
7975678|NCT02952586|12540644|FG000|Follow-Up Phase (90 Days)|Death|12
7975679|NCT02952586|12540645|FG001|Follow-Up Phase (90 Days)|Death|10
7975680|NCT02952586|12540644|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6
7975681|NCT02952586|12540645|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2
7975682|NCT02952586|12540644|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1
7975683|NCT02952586|12540645|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1
7975684|NCT02952586|12540644|FG000|Follow-Up Phase (90 Days)|Other|7
7975685|NCT02952586|12540645|FG001|Follow-Up Phase (90 Days)|Other|5
7975686|NCT02952586|12540644|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32
7975687|NCT02952586|12540645|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50
7975688|NCT02952586|12540644|FG000|LT Follow-up (up to 45 Months)|Death|51
7975689|NCT02952586|12540645|FG001|LT Follow-up (up to 45 Months)|Death|31
7975690|NCT02952586|12540644|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7
7975691|NCT02952586|12540645|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1
7975692|NCT02952586|12540644|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2
7975693|NCT02952586|12540645|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4
7975694|NCT02952586|12540644|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187
7975695|NCT02952586|12540645|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201
7975696|NCT02952820|12540655|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8
7975697|NCT02952820|12540656|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9
7975698|NCT02952820|12540657|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16
7975699|NCT02952820|12540655|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
7975700|NCT02952820|12540656|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
7975701|NCT02952820|12540657|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6
7975702|NCT02952820|12540655|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15
7975703|NCT02952820|12540656|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12
7975704|NCT02952820|12540657|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17
7975705|NCT02952820|12540655|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17
7975706|NCT02952820|12540656|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12
7975707|NCT02952820|12540657|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11
7975708|NCT02952820|12540655|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0
7975709|NCT02952820|12540656|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14
7975710|NCT02952820|12540657|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13
7975711|NCT02952820|12540655|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13
7975712|NCT02952820|12540656|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11
7975713|NCT02952820|12540657|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21
7975714|NCT02952820|12540655|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4
7975715|NCT02952820|12540656|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4
7975716|NCT02952820|12540657|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4
7975717|NCT02952820|12540655|FG000|Active Treatment Period (6 Months)|Adverse Event|0
7975718|NCT02952820|12540656|FG001|Active Treatment Period (6 Months)|Adverse Event|6
7975719|NCT02952820|12540657|FG002|Active Treatment Period (6 Months)|Adverse Event|5
7975720|NCT02952820|12540655|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0
7975721|NCT02952820|12540656|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4
7975722|NCT02952820|12540657|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6
7975723|NCT02952820|12540655|FG000|Active Treatment Period (6 Months)|Subject choice|0
7975724|NCT02952820|12540656|FG001|Active Treatment Period (6 Months)|Subject choice|10
7975725|NCT02952820|12540657|FG002|Active Treatment Period (6 Months)|Subject choice|7
7975726|NCT02952820|12540655|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0
7975727|NCT02952820|12540656|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6
7975728|NCT02952820|12540657|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2
7975729|NCT02952820|12540655|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0
7975730|NCT02952820|12540656|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6
7975731|NCT02952820|12540657|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8
7975732|NCT02952820|12540655|FG000|Active Treatment Period (6 Months)|Other than specified|0
7975733|NCT02952820|12540656|FG001|Active Treatment Period (6 Months)|Other than specified|6
7975734|NCT02952820|12540657|FG002|Active Treatment Period (6 Months)|Other than specified|2
7975735|NCT02952820|12540655|FG000|Active Treatment Period (6 Months)|Not treated|0
7975736|NCT02952820|12540656|FG001|Active Treatment Period (6 Months)|Not treated|0
7975737|NCT02952820|12540657|FG002|Active Treatment Period (6 Months)|Not treated|1
7975738|NCT02952898|12540736|FG000|Overall Study|Withdrawal by Subject|10
7975739|NCT02952898|12540737|FG001|Overall Study|Withdrawal by Subject|8
7975740|NCT02952898|12540738|FG002|Overall Study|Withdrawal by Subject|8
7975741|NCT02952898|12540736|FG000|Overall Study|Adverse Event|8
7975742|NCT02952898|12540737|FG001|Overall Study|Adverse Event|8
7975743|NCT02952898|12540738|FG002|Overall Study|Adverse Event|3
7975744|NCT02952898|12540736|FG000|Overall Study|Lost to Follow-up|3
7975745|NCT02952898|12540737|FG001|Overall Study|Lost to Follow-up|2
7975746|NCT02952898|12540738|FG002|Overall Study|Lost to Follow-up|2
7975747|NCT02952898|12540736|FG000|Overall Study|Non-compliance with study drug|1
7975748|NCT02952898|12540737|FG001|Overall Study|Non-compliance with study drug|1
7975749|NCT02952898|12540738|FG002|Overall Study|Non-compliance with study drug|2
7975750|NCT02953262|12540750|FG000|Overall Study|Used portal during 6 months prior to randomization|3
7975751|NCT02953262|12540751|FG001|Overall Study|Used portal during 6 months prior to randomization|6
7975752|NCT02953262|12540752|FG002|Overall Study|Used portal during 6 months prior to randomization|3
7975753|NCT02953262|12540753|FG003|Overall Study|Used portal during 6 months prior to randomization|3
7975754|NCT02953314|12540769|FG000|Overall Study|Adverse Event|0
7975755|NCT02953314|12540770|FG001|Overall Study|Adverse Event|1
7975756|NCT02953314|12540769|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
7975757|NCT02953314|12540770|FG001|Overall Study|Withdrawal of consent (not due to AE)|2
7975758|NCT02953639|12540787|FG000|Overall Study|Adverse Event|2
7975759|NCT02953639|12540788|FG001|Overall Study|Adverse Event|0
7975760|NCT02953639|12540789|FG002|Overall Study|Adverse Event|1
7975761|NCT02953639|12540787|FG000|Overall Study|Lost to Follow-up|8
7975762|NCT02953639|12540788|FG001|Overall Study|Lost to Follow-up|4
7975763|NCT02953639|12540789|FG002|Overall Study|Lost to Follow-up|3
7975764|NCT02953639|12540787|FG000|Overall Study|Non-Compliance With Study Drug|0
7975765|NCT02953639|12540788|FG001|Overall Study|Non-Compliance With Study Drug|2
7975766|NCT02953639|12540789|FG002|Overall Study|Non-Compliance With Study Drug|1
7975767|NCT02953639|12540787|FG000|Overall Study|Multiple Reasons|1
7975768|NCT02953639|12540788|FG001|Overall Study|Multiple Reasons|0
7975769|NCT02953639|12540789|FG002|Overall Study|Multiple Reasons|1
7975770|NCT02953639|12540787|FG000|Overall Study|Physician Decision|1
7975771|NCT02953639|12540788|FG001|Overall Study|Physician Decision|0
7975772|NCT02953639|12540789|FG002|Overall Study|Physician Decision|0
7975773|NCT02953639|12540787|FG000|Overall Study|Withdrawal by Subject|7
7975774|NCT02953639|12540788|FG001|Overall Study|Withdrawal by Subject|8
7975775|NCT02953639|12540789|FG002|Overall Study|Withdrawal by Subject|10
7975776|NCT02953639|12540787|FG000|Overall Study|Completed or Discontinued information is missing|1
7975777|NCT02953639|12540788|FG001|Overall Study|Completed or Discontinued information is missing|0
7975778|NCT02953639|12540789|FG002|Overall Study|Completed or Discontinued information is missing|0
7975779|NCT02953678|12540799|FG000|Overall Study|Adverse Event|20
7975780|NCT02953678|12540799|FG000|Overall Study|Death|7
7975781|NCT02953678|12540799|FG000|Overall Study|Physician Decision|23
7975782|NCT02953678|12540799|FG000|Overall Study|Progressive Disease of GVHD|7
7975783|NCT02953678|12540799|FG000|Overall Study|Relapse of Underlying Malignancy|3
7975784|NCT02953678|12540799|FG000|Overall Study|Withdrawal by participant|3
7975785|NCT02953678|12540799|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5
7975786|NCT02953678|12540799|FG000|Overall Study|Participants were transferred to commercial product.|3
7975787|NCT02953782|12540812|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5
7975788|NCT02953782|12540813|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2
7975789|NCT02953782|12540814|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
7975790|NCT02953782|12540815|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
7975791|NCT02953782|12540816|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4
7975792|NCT02953782|12540817|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
7975793|NCT02953782|12540818|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
7975794|NCT02953782|12540819|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
7975795|NCT02953782|12540812|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
7975796|NCT02953782|12540813|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7975797|NCT02953782|12540814|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2
7975798|NCT02953782|12540815|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7975799|NCT02953782|12540816|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
7975800|NCT02953782|12540817|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7975801|NCT02953782|12540818|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7975802|NCT02953782|12540819|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7975803|NCT02953782|12540812|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7975804|NCT02953782|12540813|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
7975805|NCT02953782|12540814|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7975806|NCT02953782|12540815|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
7975807|NCT02953782|12540816|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
7975808|NCT02953782|12540817|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7975809|NCT02953782|12540818|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7975810|NCT02953782|12540819|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7975811|NCT02953782|12540812|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7975812|NCT02953782|12540813|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7975813|NCT02953782|12540814|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
7975814|NCT02953782|12540815|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
7975815|NCT02953782|12540816|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7975816|NCT02953782|12540817|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7975817|NCT02953782|12540818|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7975818|NCT02953782|12540819|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7975819|NCT02953782|12540812|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7975820|NCT02953782|12540813|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7975821|NCT02953782|12540814|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7975822|NCT02953782|12540815|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7975823|NCT02953782|12540816|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7975824|NCT02953782|12540817|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14
7975825|NCT02953782|12540818|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11
7975826|NCT02953782|12540819|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8
7975827|NCT02953782|12540812|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7975828|NCT02953782|12540813|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7975829|NCT02953782|12540814|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7975830|NCT02953782|12540815|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7975831|NCT02953782|12540816|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7975832|NCT02953782|12540817|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1
7975833|NCT02953782|12540818|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2
7975834|NCT02953782|12540819|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3
7975835|NCT02953782|12540812|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7975836|NCT02953782|12540813|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7975837|NCT02953782|12540814|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7975838|NCT02953782|12540815|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7975839|NCT02953782|12540816|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7975840|NCT02953782|12540817|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
7975841|NCT02953782|12540818|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
7975842|NCT02953782|12540819|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4
7975843|NCT02953782|12540812|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7975844|NCT02953782|12540813|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7975845|NCT02953782|12540814|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7975846|NCT02953782|12540815|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7975847|NCT02953782|12540816|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7975848|NCT02953782|12540817|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7975849|NCT02953782|12540818|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1
7975850|NCT02953782|12540819|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7975851|NCT02953821|12540842|FG000|Overall Study|Adverse Event|0
7975852|NCT02953821|12540843|FG001|Overall Study|Adverse Event|4
7975853|NCT02953821|12540842|FG000|Overall Study|Death|1
7975854|NCT02953821|12540843|FG001|Overall Study|Death|0
7975855|NCT02953821|12540842|FG000|Overall Study|Progressive Disease|5
7975856|NCT02953821|12540843|FG001|Overall Study|Progressive Disease|1
7975857|NCT02953821|12540842|FG000|Overall Study|Lost to Follow-up|2
7975858|NCT02953821|12540843|FG001|Overall Study|Lost to Follow-up|0
7975859|NCT02953821|12540842|FG000|Overall Study|Physician Decision|1
7975860|NCT02953821|12540843|FG001|Overall Study|Physician Decision|1
7975861|NCT02953821|12540842|FG000|Overall Study|Withdrawal by Subject|3
7975862|NCT02953821|12540843|FG001|Overall Study|Withdrawal by Subject|3
7975863|NCT02953821|12540842|FG000|Overall Study|Change of address|0
7975864|NCT02953821|12540843|FG001|Overall Study|Change of address|1
7975865|NCT02953821|12540842|FG000|Overall Study|Lack of Efficacy|1
7975866|NCT02953821|12540843|FG001|Overall Study|Lack of Efficacy|0
7975867|NCT02953821|12540842|FG000|Overall Study|Out of state for indeterminate time|0
7975868|NCT02953821|12540843|FG001|Overall Study|Out of state for indeterminate time|1
7975869|NCT02953821|12540842|FG000|Overall Study|No improvement|0
7975870|NCT02953821|12540843|FG001|Overall Study|No improvement|1
7975871|NCT02953821|12540842|FG000|Overall Study|Refused follow-up visit|2
7975872|NCT02953821|12540843|FG001|Overall Study|Refused follow-up visit|1
7975873|NCT02953938|12540865|FG000|Overall Study|Adverse Event|0
7975874|NCT02953938|12540866|FG001|Overall Study|Adverse Event|1
7975875|NCT02953938|12540865|FG000|Overall Study|Withdrawal by Subject|1
7975876|NCT02953938|12540866|FG001|Overall Study|Withdrawal by Subject|1
7975877|NCT02954172|12540875|FG000|Overall Study|Protocol Violation|3
7975878|NCT02954172|12540876|FG001|Overall Study|Protocol Violation|0
7975879|NCT02954172|12540875|FG000|Overall Study|allergic reaction|2
7975880|NCT02954172|12540876|FG001|Overall Study|allergic reaction|1
7975881|NCT02954172|12540875|FG000|Overall Study|non-measurable lesions at baseline|1
7975882|NCT02954172|12540876|FG001|Overall Study|non-measurable lesions at baseline|2
7975883|NCT02954354|12540895|FG000|Overall Study|Adverse Event|2
7975884|NCT02954354|12540896|FG001|Overall Study|Adverse Event|2
7975885|NCT02954354|12540897|FG002|Overall Study|Adverse Event|4
7975886|NCT02954354|12540895|FG000|Overall Study|Failure to Meet Eligibility Criteria|1
7975887|NCT02954354|12540896|FG001|Overall Study|Failure to Meet Eligibility Criteria|0
7975888|NCT02954354|12540897|FG002|Overall Study|Failure to Meet Eligibility Criteria|0
7975889|NCT02954354|12540895|FG000|Overall Study|Lack of Efficacy|0
7975890|NCT02954354|12540896|FG001|Overall Study|Lack of Efficacy|2
7975891|NCT02954354|12540897|FG002|Overall Study|Lack of Efficacy|0
7975892|NCT02954354|12540895|FG000|Overall Study|Withdrawal by Subject|17
7975893|NCT02954354|12540896|FG001|Overall Study|Withdrawal by Subject|9
7975894|NCT02954354|12540897|FG002|Overall Study|Withdrawal by Subject|11
7975895|NCT02954354|12540895|FG000|Overall Study|Lost to Follow-up|12
7975896|NCT02954354|12540896|FG001|Overall Study|Lost to Follow-up|5
7975897|NCT02954354|12540897|FG002|Overall Study|Lost to Follow-up|0
7975898|NCT02954354|12540895|FG000|Overall Study|Miscellaneous|2
7975899|NCT02954354|12540896|FG001|Overall Study|Miscellaneous|2
7975900|NCT02954354|12540897|FG002|Overall Study|Miscellaneous|1
7975901|NCT02954458|12540911|FG000|Overall Study|Adverse Event|0
7975902|NCT02954458|12540912|FG001|Overall Study|Adverse Event|0
7975903|NCT02954458|12540913|FG002|Overall Study|Adverse Event|0
7975904|NCT02954458|12540914|FG003|Overall Study|Adverse Event|1
7975905|NCT02954458|12540911|FG000|Overall Study|Withdrawal by Subject|0
7975906|NCT02954458|12540912|FG001|Overall Study|Withdrawal by Subject|0
7975907|NCT02954458|12540913|FG002|Overall Study|Withdrawal by Subject|0
7975908|NCT02954458|12540914|FG003|Overall Study|Withdrawal by Subject|1
7975909|NCT02954458|12540911|FG000|Overall Study|Physician Decision|0
7975910|NCT02954458|12540912|FG001|Overall Study|Physician Decision|0
7975911|NCT02954458|12540913|FG002|Overall Study|Physician Decision|1
7975912|NCT02954458|12540914|FG003|Overall Study|Physician Decision|1
7975913|NCT02954458|12540911|FG000|Overall Study|Lost to Follow-up|1
7975914|NCT02954458|12540912|FG001|Overall Study|Lost to Follow-up|0
7975915|NCT02954458|12540913|FG002|Overall Study|Lost to Follow-up|0
7975916|NCT02954458|12540914|FG003|Overall Study|Lost to Follow-up|1
7975917|NCT02954458|12540911|FG000|Overall Study|Death|0
7975918|NCT02954458|12540912|FG001|Overall Study|Death|0
7975919|NCT02954458|12540913|FG002|Overall Study|Death|0
7975920|NCT02954458|12540914|FG003|Overall Study|Death|1
7975921|NCT02954458|12540911|FG000|Overall Study|Other|0
7975922|NCT02954458|12540912|FG001|Overall Study|Other|0
7975923|NCT02954458|12540913|FG002|Overall Study|Other|0
7975924|NCT02954458|12540914|FG003|Overall Study|Other|7
7975925|NCT02954575|12540928|FG000|Overall Study|Withdrawal by Subject|2
7975926|NCT02954575|12540928|FG000|Overall Study|Adverse Event|1
7975927|NCT02954601|12540940|FG000|First Intervention (Five Days)|Withdrawal by Subject|0
7975928|NCT02954601|12540941|FG001|First Intervention (Five Days)|Withdrawal by Subject|0
7975929|NCT02954601|12540942|FG002|First Intervention (Five Days)|Withdrawal by Subject|1
7975930|NCT02954601|12540943|FG003|First Intervention (Five Days)|Withdrawal by Subject|0
7975931|NCT02954653|12540955|FG000|Overall Study|Death|3
7975932|NCT02954653|12540956|FG001|Overall Study|Death|1
7975933|NCT02954653|12540957|FG002|Overall Study|Death|0
7975934|NCT02954653|12540958|FG003|Overall Study|Death|0
7975935|NCT02954653|12540959|FG004|Overall Study|Death|0
7975936|NCT02954653|12540960|FG005|Overall Study|Death|0
7975937|NCT02954653|12540961|FG006|Overall Study|Death|0
7975938|NCT02954653|12540962|FG007|Overall Study|Death|0
7975939|NCT02954653|12540963|FG008|Overall Study|Death|0
7975940|NCT02954653|12540955|FG000|Overall Study|Randomized but did not receive treatment|1
7975941|NCT02954653|12540956|FG001|Overall Study|Randomized but did not receive treatment|0
7975942|NCT02954653|12540957|FG002|Overall Study|Randomized but did not receive treatment|0
7975943|NCT02954653|12540958|FG003|Overall Study|Randomized but did not receive treatment|0
7975944|NCT02954653|12540959|FG004|Overall Study|Randomized but did not receive treatment|0
7975945|NCT02954653|12540960|FG005|Overall Study|Randomized but did not receive treatment|0
7975946|NCT02954653|12540961|FG006|Overall Study|Randomized but did not receive treatment|0
7975947|NCT02954653|12540962|FG007|Overall Study|Randomized but did not receive treatment|0
7975948|NCT02954653|12540963|FG008|Overall Study|Randomized but did not receive treatment|0
7975949|NCT02954653|12540955|FG000|Overall Study|Started another anti-cancer therapy|0
7975950|NCT02954653|12540956|FG001|Overall Study|Started another anti-cancer therapy|1
7975951|NCT02954653|12540957|FG002|Overall Study|Started another anti-cancer therapy|0
7975952|NCT02954653|12540958|FG003|Overall Study|Started another anti-cancer therapy|0
7975953|NCT02954653|12540959|FG004|Overall Study|Started another anti-cancer therapy|0
7975954|NCT02954653|12540960|FG005|Overall Study|Started another anti-cancer therapy|0
7975955|NCT02954653|12540961|FG006|Overall Study|Started another anti-cancer therapy|0
7975956|NCT02954653|12540962|FG007|Overall Study|Started another anti-cancer therapy|0
7975957|NCT02954653|12540963|FG008|Overall Study|Started another anti-cancer therapy|0
7975958|NCT02954653|12540955|FG000|Overall Study|Treatment failure and consent withdrawal|0
7975959|NCT02954653|12540956|FG001|Overall Study|Treatment failure and consent withdrawal|1
7975960|NCT02954653|12540957|FG002|Overall Study|Treatment failure and consent withdrawal|0
7975961|NCT02954653|12540958|FG003|Overall Study|Treatment failure and consent withdrawal|0
7975962|NCT02954653|12540959|FG004|Overall Study|Treatment failure and consent withdrawal|0
7975963|NCT02954653|12540960|FG005|Overall Study|Treatment failure and consent withdrawal|0
7975964|NCT02954653|12540961|FG006|Overall Study|Treatment failure and consent withdrawal|0
7975965|NCT02954653|12540962|FG007|Overall Study|Treatment failure and consent withdrawal|0
7975966|NCT02954653|12540963|FG008|Overall Study|Treatment failure and consent withdrawal|0
7975967|NCT02954848|12540977|FG000|Overall Study|Randomized but Not Treated|0
7975968|NCT02954848|12540978|FG001|Overall Study|Randomized but Not Treated|1
7975969|NCT02954848|12540977|FG000|Overall Study|Adverse Event|2
7975970|NCT02954848|12540978|FG001|Overall Study|Adverse Event|3
7975971|NCT02954848|12540977|FG000|Overall Study|Withdrawal by Participant|0
7975972|NCT02954848|12540978|FG001|Overall Study|Withdrawal by Participant|1
7975973|NCT02955069|12540986|FG000|Overall Study|Adverse Event|7
7975974|NCT02955069|12540987|FG001|Overall Study|Adverse Event|2
7975975|NCT02955069|12540986|FG000|Overall Study|Death|7
7975976|NCT02955069|12540987|FG001|Overall Study|Death|3
7975977|NCT02955069|12540986|FG000|Overall Study|Physician Decision|10
7975978|NCT02955069|12540987|FG001|Overall Study|Physician Decision|2
7975979|NCT02955069|12540986|FG000|Overall Study|Progressive disease|64
7975980|NCT02955069|12540987|FG001|Overall Study|Progressive disease|13
7975981|NCT02955069|12540986|FG000|Overall Study|Study terminated by sponsor|4
7975982|NCT02955069|12540987|FG001|Overall Study|Study terminated by sponsor|0
7975983|NCT02955069|12540986|FG000|Overall Study|Subject/Guardian decision|3
7975984|NCT02955069|12540987|FG001|Overall Study|Subject/Guardian decision|1
7975985|NCT02955186|12541001|FG000|Overall Study|Withdrawal by Subject|6
7975986|NCT02955186|12541002|FG001|Overall Study|Withdrawal by Subject|2
7975987|NCT02955186|12541001|FG000|Overall Study|Protocol Violation|1
7975988|NCT02955186|12541002|FG001|Overall Study|Protocol Violation|0
7975989|NCT02955212|12541010|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4
7975990|NCT02955212|12541011|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7
7975991|NCT02955212|12541010|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8
7975992|NCT02955212|12541011|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3
7975993|NCT02955212|12541010|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1
7975994|NCT02955212|12541011|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0
7975995|NCT02955212|12541010|FG000|Period 1: Double-blind Treatment Period|Other|3
7975996|NCT02955212|12541011|FG001|Period 1: Double-blind Treatment Period|Other|2
7975997|NCT02955212|12541010|FG000|Period 2: Open-label Extension|Adverse Event|11
7975998|NCT02955212|12541011|FG001|Period 2: Open-label Extension|Adverse Event|7
7975999|NCT02955212|12541010|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1
7976000|NCT02955212|12541011|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4
7976001|NCT02955212|12541010|FG000|Period 2: Open-label Extension|Lack of Efficacy|3
7976002|NCT02955212|12541011|FG001|Period 2: Open-label Extension|Lack of Efficacy|2
7976003|NCT02955212|12541010|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0
7976004|NCT02955212|12541011|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1
7976005|NCT02955212|12541010|FG000|Period 2: Open-label Extension|Other|2
7976006|NCT02955212|12541011|FG001|Period 2: Open-label Extension|Other|4
7976007|NCT02956057|12541059|FG000|Overall Study|Discontinued intervention|14
7976008|NCT02956057|12541060|FG001|Overall Study|Discontinued intervention|10
7976009|NCT02956057|12541061|FG002|Overall Study|Discontinued intervention|7
7976010|NCT02956057|12541062|FG003|Overall Study|Discontinued intervention|14
7976011|NCT02956057|12541063|FG004|Overall Study|Discontinued intervention|4
7976012|NCT02956057|12541064|FG005|Overall Study|Discontinued intervention|17
7976013|NCT02956057|12541059|FG000|Overall Study|Lost to Follow-up|0
7976014|NCT02956057|12541060|FG001|Overall Study|Lost to Follow-up|2
7976015|NCT02956057|12541061|FG002|Overall Study|Lost to Follow-up|1
7976016|NCT02956057|12541062|FG003|Overall Study|Lost to Follow-up|1
7976017|NCT02956057|12541063|FG004|Overall Study|Lost to Follow-up|1
7976018|NCT02956057|12541064|FG005|Overall Study|Lost to Follow-up|0
7976019|NCT02956278|12541101|FG000|Overall Study|Withdrawal by Subject|6
7976020|NCT02956278|12541102|FG001|Overall Study|Withdrawal by Subject|2
7976021|NCT02956278|12541103|FG002|Overall Study|Withdrawal by Subject|0
7976022|NCT02956460|12541113|FG000|Lens 1|Lost to Follow-up|1
7976023|NCT02956460|12541114|FG001|Lens 1|Lost to Follow-up|0
7976024|NCT02956486|12541122|FG000|Core Phase|Adverse Event|51
7976025|NCT02956486|12541123|FG001|Core Phase|Adverse Event|88
7976026|NCT02956486|12541124|FG002|Core Phase|Adverse Event|0
7976027|NCT02956486|12541122|FG000|Core Phase|Lost to Follow-up|8
7976028|NCT02956486|12541123|FG001|Core Phase|Lost to Follow-up|6
7976029|NCT02956486|12541124|FG002|Core Phase|Lost to Follow-up|0
7976030|NCT02956486|12541122|FG000|Core Phase|Inadequate therapeutic effect|4
7976031|NCT02956486|12541123|FG001|Core Phase|Inadequate therapeutic effect|5
7976032|NCT02956486|12541124|FG002|Core Phase|Inadequate therapeutic effect|0
7976033|NCT02956486|12541122|FG000|Core Phase|Withdrawal by Subject|101
7976034|NCT02956486|12541123|FG001|Core Phase|Withdrawal by Subject|104
7976035|NCT02956486|12541124|FG002|Core Phase|Withdrawal by Subject|0
7976036|NCT02956486|12541122|FG000|Core Phase|Study terminated by sponsor|888
7976037|NCT02956486|12541123|FG001|Core Phase|Study terminated by sponsor|848
7976038|NCT02956486|12541124|FG002|Core Phase|Study terminated by sponsor|0
7976039|NCT02956486|12541122|FG000|Core Phase|Other|27
7976040|NCT02956486|12541123|FG001|Core Phase|Other|18
7976041|NCT02956486|12541124|FG002|Core Phase|Other|0
7976042|NCT02956486|12541122|FG000|Core Phase|Not treated|0
7976043|NCT02956486|12541123|FG001|Core Phase|Not treated|3
7976044|NCT02956486|12541124|FG002|Core Phase|Not treated|0
7976045|NCT02956486|12541122|FG000|Extension Phase|Adverse Event|0
7976046|NCT02956486|12541123|FG001|Extension Phase|Adverse Event|0
7976047|NCT02956486|12541124|FG002|Extension Phase|Adverse Event|2
7976048|NCT02956486|12541122|FG000|Extension Phase|Study terminated by sponsor|0
7976049|NCT02956486|12541123|FG001|Extension Phase|Study terminated by sponsor|0
7976050|NCT02956486|12541124|FG002|Extension Phase|Study terminated by sponsor|16
7976051|NCT02956486|12541122|FG000|Extension Phase|Not Treated|0
7976052|NCT02956486|12541123|FG001|Extension Phase|Not Treated|0
7976053|NCT02956486|12541124|FG002|Extension Phase|Not Treated|1
7976054|NCT02956629|12541148|FG000|Overall Study|Adverse Event|0
7976055|NCT02956629|12541149|FG001|Overall Study|Adverse Event|0
7976056|NCT02956629|12541150|FG002|Overall Study|Adverse Event|1
7976057|NCT02956629|12541151|FG003|Overall Study|Adverse Event|0
7976058|NCT02956629|12541152|FG004|Overall Study|Adverse Event|0
7976059|NCT02956629|12541153|FG005|Overall Study|Adverse Event|0
7976060|NCT02956629|12541148|FG000|Overall Study|Lost to Follow-up|2
7976061|NCT02956629|12541149|FG001|Overall Study|Lost to Follow-up|5
7976062|NCT02956629|12541150|FG002|Overall Study|Lost to Follow-up|3
7976063|NCT02956629|12541151|FG003|Overall Study|Lost to Follow-up|1
7976064|NCT02956629|12541152|FG004|Overall Study|Lost to Follow-up|0
7976065|NCT02956629|12541153|FG005|Overall Study|Lost to Follow-up|1
7976066|NCT02956629|12541148|FG000|Overall Study|Withdrawal by Subject|3
7976067|NCT02956629|12541149|FG001|Overall Study|Withdrawal by Subject|1
7976068|NCT02956629|12541150|FG002|Overall Study|Withdrawal by Subject|0
7976069|NCT02956629|12541151|FG003|Overall Study|Withdrawal by Subject|0
7976070|NCT02956629|12541152|FG004|Overall Study|Withdrawal by Subject|0
7976071|NCT02956629|12541153|FG005|Overall Study|Withdrawal by Subject|0
7976072|NCT02956837|12541189|FG000|Overall Study|Serious Adverse Events|0
7976073|NCT02956837|12541190|FG001|Overall Study|Serious Adverse Events|1
7976074|NCT02956837|12541191|FG002|Overall Study|Serious Adverse Events|0
7976075|NCT02956837|12541192|FG003|Overall Study|Serious Adverse Events|0
7976076|NCT02956837|12541189|FG000|Overall Study|Withdrawal by Subject|0
7976077|NCT02956837|12541190|FG001|Overall Study|Withdrawal by Subject|1
7976078|NCT02956837|12541191|FG002|Overall Study|Withdrawal by Subject|0
7976079|NCT02956837|12541192|FG003|Overall Study|Withdrawal by Subject|3
7976080|NCT02956837|12541189|FG000|Overall Study|Lost to Follow-up|0
7976081|NCT02956837|12541190|FG001|Overall Study|Lost to Follow-up|1
7976082|NCT02956837|12541191|FG002|Overall Study|Lost to Follow-up|2
7976083|NCT02956837|12541192|FG003|Overall Study|Lost to Follow-up|0
7976084|NCT02956967|12541205|FG000|Overall Study|Adverse Event|3
7976085|NCT02956967|12541205|FG000|Overall Study|Reason non-related to neutropenia|10
7976086|NCT02956967|12541205|FG000|Overall Study|Lost to Follow-up|5
7976087|NCT02956967|12541205|FG000|Overall Study|Missing|1
7976088|NCT02956967|12541205|FG000|Overall Study|Termination of Nivestim administration|29
7976089|NCT02957136|12541215|FG000|Overall Study|Withdrawal by Subject|2
7976090|NCT02957136|12541216|FG001|Overall Study|Withdrawal by Subject|1
7718015|NCT00524303|12141720|FG002|Overall Study|Death|3
7718016|NCT00524303|12141718|FG000|Overall Study|Adverse Event|1
7718017|NCT00524303|12141719|FG001|Overall Study|Adverse Event|2
7718018|NCT00524303|12141720|FG002|Overall Study|Adverse Event|3
7718019|NCT00524303|12141718|FG000|Overall Study|Did not Complete Study Dosing|1
7976091|NCT02957331|12541233|FG000|Overall Study|Protocol Violation|1
7976092|NCT02957331|12541234|FG001|Overall Study|Protocol Violation|0
7976093|NCT02957682|12541258|FG000|Overall Study|Adverse Event|64
7976094|NCT02957682|12541259|FG001|Overall Study|Adverse Event|67
7976095|NCT02957682|12541258|FG000|Overall Study|Poor Compliance to Protocol|30
7976096|NCT02957682|12541259|FG001|Overall Study|Poor Compliance to Protocol|26
7976097|NCT02957682|12541258|FG000|Overall Study|Physician Decision|4
7976098|NCT02957682|12541259|FG001|Overall Study|Physician Decision|4
7976099|NCT02957682|12541258|FG000|Overall Study|Study Terminated by Sponsor|4
7976100|NCT02957682|12541259|FG001|Overall Study|Study Terminated by Sponsor|3
7976101|NCT02957682|12541258|FG000|Overall Study|Subject Moved|10
7976102|NCT02957682|12541259|FG001|Overall Study|Subject Moved|16
7976103|NCT02957682|12541258|FG000|Overall Study|Withdrawal by Subject|64
7976104|NCT02957682|12541259|FG001|Overall Study|Withdrawal by Subject|33
7976105|NCT02957682|12541258|FG000|Overall Study|Related to IMP Administration|3
7976106|NCT02957682|12541259|FG001|Overall Study|Related to IMP Administration|6
7976107|NCT02957682|12541258|FG000|Overall Study|Non-disclosed|16
7976108|NCT02957682|12541259|FG001|Overall Study|Non-disclosed|12
7976109|NCT02957682|12541258|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3
7976110|NCT02957682|12541259|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2
7976111|NCT02957747|12541267|FG000|Overall Study|Withdrawal by Subject|0
7976112|NCT02957747|12541268|FG001|Overall Study|Withdrawal by Subject|3
7976113|NCT02957747|12541267|FG000|Overall Study|Lost to Follow-up|10
7976114|NCT02957747|12541268|FG001|Overall Study|Lost to Follow-up|5
7976115|NCT02957942|12541277|FG000|Overall Study|Withdrawal by Subject|0
7976116|NCT02957942|12541278|FG001|Overall Study|Withdrawal by Subject|1
7976117|NCT02957942|12541277|FG000|Overall Study|Practicing experiment protocol|0
7976118|NCT02957942|12541278|FG001|Overall Study|Practicing experiment protocol|6
7976119|NCT02958267|12541286|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1
7976120|NCT02958267|12541287|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0
7976121|NCT02958267|12541286|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1
7976122|NCT02958267|12541287|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0
7976123|NCT02958267|12541286|FG000|Follow-up Visits|Additional treatment pursued|2
7976124|NCT02958267|12541287|FG001|Follow-up Visits|Additional treatment pursued|1
7976125|NCT02958527|12541302|FG000|Overall Study|Not collected CRFs|12
7976126|NCT02958553|12541315|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1
7976127|NCT02958553|12541315|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2
7976128|NCT02959138|12541415|FG000|Overall Study|Enrolled but Never Treated|0
7976129|NCT02959138|12541416|FG001|Overall Study|Enrolled but Never Treated|1
7976130|NCT02959138|12541417|FG002|Overall Study|Enrolled but Never Treated|0
7976131|NCT02959177|12541432|FG000|Double-Blind Treatment Phase|Adverse Event|5
7976132|NCT02959177|12541433|FG001|Double-Blind Treatment Phase|Adverse Event|2
7976133|NCT02959177|12541434|FG002|Double-Blind Treatment Phase|Adverse Event|0
7976134|NCT02959177|12541432|FG000|Double-Blind Treatment Phase|Physician Decision|1
7976135|NCT02959177|12541433|FG001|Double-Blind Treatment Phase|Physician Decision|0
7976136|NCT02959177|12541434|FG002|Double-Blind Treatment Phase|Physician Decision|0
7976137|NCT02959177|12541432|FG000|Double-Blind Treatment Phase|Protocol Violation|0
7976138|NCT02959177|12541433|FG001|Double-Blind Treatment Phase|Protocol Violation|1
7976139|NCT02959177|12541434|FG002|Double-Blind Treatment Phase|Protocol Violation|0
7976140|NCT02959177|12541432|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5
7976141|NCT02959177|12541433|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0
7976142|NCT02959177|12541434|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5
7976143|NCT02959177|12541432|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1
7976144|NCT02959177|12541433|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0
7976145|NCT02959177|12541434|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0
7976146|NCT02959177|12541432|FG000|Follow-up Post Treatment Phase|Adverse Event|0
7976147|NCT02959177|12541433|FG001|Follow-up Post Treatment Phase|Adverse Event|1
7976148|NCT02959177|12541434|FG002|Follow-up Post Treatment Phase|Adverse Event|0
7976149|NCT02959177|12541432|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0
7976150|NCT02959177|12541433|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0
7976151|NCT02959177|12541434|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2
7976152|NCT02959190|12541452|FG000|Open Label|Adverse Event|5
7976153|NCT02959190|12541453|FG001|Open Label|Adverse Event|7
7976154|NCT02959190|12541454|FG002|Open Label|Adverse Event|3
7976155|NCT02959190|12541455|FG003|Open Label|Adverse Event|4
7976156|NCT02959190|12541452|FG000|Open Label|Pregnancy|0
7976157|NCT02959190|12541453|FG001|Open Label|Pregnancy|1
7976158|NCT02959190|12541454|FG002|Open Label|Pregnancy|0
7976159|NCT02959190|12541455|FG003|Open Label|Pregnancy|0
7976160|NCT02959190|12541452|FG000|Open Label|Withdrawal by Subject|2
7976161|NCT02959190|12541453|FG001|Open Label|Withdrawal by Subject|8
7976162|NCT02959190|12541454|FG002|Open Label|Withdrawal by Subject|0
7976163|NCT02959190|12541455|FG003|Open Label|Withdrawal by Subject|0
7976164|NCT02959190|12541452|FG000|Open Label|Physician Decision|0
7976165|NCT02959190|12541453|FG001|Open Label|Physician Decision|0
7976166|NCT02959190|12541454|FG002|Open Label|Physician Decision|1
7976167|NCT02959190|12541455|FG003|Open Label|Physician Decision|0
7976168|NCT02959190|12541452|FG000|Open Label|Protocol Violation|0
7976169|NCT02959190|12541453|FG001|Open Label|Protocol Violation|0
7976170|NCT02959190|12541454|FG002|Open Label|Protocol Violation|0
7976171|NCT02959190|12541455|FG003|Open Label|Protocol Violation|2
7976172|NCT02959190|12541452|FG000|Post Treatment Follow Up|Adverse Event|1
7976173|NCT02959190|12541453|FG001|Post Treatment Follow Up|Adverse Event|1
7976174|NCT02959190|12541454|FG002|Post Treatment Follow Up|Adverse Event|0
7976175|NCT02959190|12541455|FG003|Post Treatment Follow Up|Adverse Event|0
7976176|NCT02959190|12541452|FG000|Post Treatment Follow Up|Withdrawal by Subject|2
7976177|NCT02959190|12541453|FG001|Post Treatment Follow Up|Withdrawal by Subject|0
7976178|NCT02959190|12541454|FG002|Post Treatment Follow Up|Withdrawal by Subject|1
7976179|NCT02959190|12541455|FG003|Post Treatment Follow Up|Withdrawal by Subject|0
7976180|NCT02959437|12541487|FG000|Overall Study|Death|33
7976181|NCT02959437|12541488|FG001|Overall Study|Death|3
7976182|NCT02959437|12541489|FG002|Overall Study|Death|0
7976183|NCT02959437|12541490|FG003|Overall Study|Death|0
7976184|NCT02959437|12541487|FG000|Overall Study|Lost to Follow-up|3
7976185|NCT02959437|12541488|FG001|Overall Study|Lost to Follow-up|1
7976186|NCT02959437|12541489|FG002|Overall Study|Lost to Follow-up|0
7976187|NCT02959437|12541490|FG003|Overall Study|Lost to Follow-up|0
7976188|NCT02959437|12541487|FG000|Overall Study|Withdrawal by Subject|11
7976189|NCT02959437|12541488|FG001|Overall Study|Withdrawal by Subject|3
7976190|NCT02959437|12541489|FG002|Overall Study|Withdrawal by Subject|0
7976191|NCT02959437|12541490|FG003|Overall Study|Withdrawal by Subject|0
7976192|NCT02959437|12541487|FG000|Overall Study|Progressive Disease|9
7976193|NCT02959437|12541488|FG001|Overall Study|Progressive Disease|1
7976194|NCT02959437|12541489|FG002|Overall Study|Progressive Disease|0
7976195|NCT02959437|12541490|FG003|Overall Study|Progressive Disease|0
7976196|NCT02959437|12541487|FG000|Overall Study|Study Terminated by Sponsor|4
7976197|NCT02959437|12541488|FG001|Overall Study|Study Terminated by Sponsor|0
7976198|NCT02959437|12541489|FG002|Overall Study|Study Terminated by Sponsor|0
7976199|NCT02959437|12541490|FG003|Overall Study|Study Terminated by Sponsor|0
7976200|NCT02959437|12541487|FG000|Overall Study|Other Unspecified|2
7976201|NCT02959437|12541488|FG001|Overall Study|Other Unspecified|0
7976202|NCT02959437|12541489|FG002|Overall Study|Other Unspecified|0
7976203|NCT02959437|12541490|FG003|Overall Study|Other Unspecified|0
7976204|NCT02959671|12541501|FG000|Overall Study|Adverse Event|2
7976205|NCT02959671|12541501|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3
7976206|NCT02959814|12541505|FG000|Overall Study|Excluded based on diagnostic angiography|16
7976207|NCT02959814|12541505|FG000|Overall Study|Excluded based on anatomical criteria|2
7976208|NCT02959814|12541505|FG000|Overall Study|Protocol Violation|7
7976209|NCT02959814|12541505|FG000|Overall Study|FFR not measured|2
7976210|NCT02959814|12541505|FG000|Overall Study|In-procedure QFR not computed|6
7976211|NCT02959814|12541505|FG000|Overall Study|Excluded by FFR core-lab|24
7976212|NCT02959866|12541541|FG000|Overall Study|Withdrawal by Subject|1
7976213|NCT02959892|12541548|FG000|Overall Study|PET tracer synthesis failure|1
7976214|NCT02959892|12541549|FG001|Overall Study|PET tracer synthesis failure|0
7976215|NCT02959892|12541548|FG000|Overall Study|Study termination|0
7976216|NCT02959892|12541549|FG001|Overall Study|Study termination|1
7976217|NCT02959970|12541557|FG000|Overall Study|Adverse Event|1
7976218|NCT02959970|12541558|FG001|Overall Study|Adverse Event|0
7976219|NCT02959970|12541557|FG000|Overall Study|Withdrawal by Subject|0
7976220|NCT02959970|12541558|FG001|Overall Study|Withdrawal by Subject|2
7976221|NCT02959970|12541557|FG000|Overall Study|Lost to Follow-up|1
7976222|NCT02959970|12541558|FG001|Overall Study|Lost to Follow-up|5
7976223|NCT02959983|12541568|FG000|Overall Study|Protocol Violation|0
7976224|NCT02959983|12541569|FG001|Overall Study|Protocol Violation|1
7976225|NCT02959983|12541568|FG000|Overall Study|Lack of Efficacy|0
7976226|NCT02959983|12541569|FG001|Overall Study|Lack of Efficacy|1
7976227|NCT02959983|12541568|FG000|Overall Study|Lost to Follow-up|12
7976228|NCT02959983|12541569|FG001|Overall Study|Lost to Follow-up|9
7976229|NCT02959983|12541568|FG000|Overall Study|Other|1
7976230|NCT02959983|12541569|FG001|Overall Study|Other|1
7976231|NCT02959983|12541568|FG000|Overall Study|Physician Decision|1
7976232|NCT02959983|12541569|FG001|Overall Study|Physician Decision|0
7976233|NCT02959983|12541568|FG000|Overall Study|Adverse Event|5
7976234|NCT02959983|12541569|FG001|Overall Study|Adverse Event|1
7976235|NCT02959983|12541568|FG000|Overall Study|Withdrawal by Subject|7
7976236|NCT02959983|12541569|FG001|Overall Study|Withdrawal by Subject|12
7976237|NCT02960217|12541586|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1
7976238|NCT02960217|12541587|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0
7976239|NCT02960217|12541586|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0
7976240|NCT02960217|12541587|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1
7976241|NCT02960217|12541586|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0
7976242|NCT02960217|12541587|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1
7976243|NCT02960217|12541586|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1
7976244|NCT02960217|12541587|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0
7976245|NCT02960217|12541586|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0
7976246|NCT02960217|12541587|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1
7976247|NCT02960217|12541586|FG000|Open-Label Extension Phase|Adverse Event|1
7976248|NCT02960217|12541587|FG001|Open-Label Extension Phase|Adverse Event|0
7976249|NCT02960217|12541586|FG000|Open-Label Extension Phase|Sponsor Decision|18
7718020|NCT00524303|12141719|FG001|Overall Study|Did not Complete Study Dosing|0
7718021|NCT00524303|12141720|FG002|Overall Study|Did not Complete Study Dosing|0
7718022|NCT00524303|12141718|FG000|Overall Study|Worsening Peripheral Neuropathy|1
7718023|NCT00524303|12141719|FG001|Overall Study|Worsening Peripheral Neuropathy|0
7718024|NCT00524303|12141720|FG002|Overall Study|Worsening Peripheral Neuropathy|0
7718025|NCT00524303|12141718|FG000|Overall Study|Disease Progression|0
7718026|NCT00524303|12141719|FG001|Overall Study|Disease Progression|4
7976250|NCT02960217|12541587|FG001|Open-Label Extension Phase|Sponsor Decision|11
7976251|NCT02960217|12541586|FG000|Open-Label Extension Phase|Lack of Efficacy|1
7976252|NCT02960217|12541587|FG001|Open-Label Extension Phase|Lack of Efficacy|1
7976253|NCT02960217|12541586|FG000|Open-Label Extension Phase|Other, Not Specified|0
7976254|NCT02960217|12541587|FG001|Open-Label Extension Phase|Other, Not Specified|1
7976255|NCT02960438|12541606|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2
7976256|NCT02960438|12541607|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1
7976257|NCT02960438|12541608|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2
7976258|NCT02960438|12541609|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5
7976259|NCT02960438|12541606|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2
7976260|NCT02960438|12541607|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1
7976261|NCT02960438|12541608|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0
7976262|NCT02960438|12541609|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3
7976263|NCT02960438|12541606|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2
7976264|NCT02960438|12541607|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
7976265|NCT02960438|12541608|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
7976266|NCT02960438|12541609|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
7976267|NCT02960438|12541606|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1
7976268|NCT02960438|12541607|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0
7976269|NCT02960438|12541608|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1
7976270|NCT02960438|12541609|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0
7976271|NCT02960438|12541606|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0
7976272|NCT02960438|12541607|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0
7976273|NCT02960438|12541608|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1
7976274|NCT02960438|12541609|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0
7976275|NCT02960438|12541606|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2
7976276|NCT02960438|12541607|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1
7976277|NCT02960438|12541608|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0
7976278|NCT02960438|12541609|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1
7976279|NCT02960438|12541606|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1
7976280|NCT02960438|12541607|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2
7976281|NCT02960438|12541608|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4
7976282|NCT02960438|12541609|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1
7976283|NCT02960438|12541606|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
7976284|NCT02960438|12541607|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
7976285|NCT02960438|12541608|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1
7976286|NCT02960438|12541609|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
7976287|NCT02960438|12541606|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
7976288|NCT02960438|12541607|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
7976289|NCT02960438|12541608|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0
7976290|NCT02960438|12541609|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
7976291|NCT02960438|12541606|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7
7976292|NCT02960438|12541607|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5
7976293|NCT02960438|12541608|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7
7976294|NCT02960438|12541609|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6
7976295|NCT02960438|12541606|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2
7976296|NCT02960438|12541607|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1
7976297|NCT02960438|12541608|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1
7976298|NCT02960438|12541609|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2
7976299|NCT02960438|12541606|FG000|Extension Phase (Open-label): 80 Weeks|Other|0
7976300|NCT02960438|12541607|FG001|Extension Phase (Open-label): 80 Weeks|Other|0
7976301|NCT02960438|12541608|FG002|Extension Phase (Open-label): 80 Weeks|Other|1
7976302|NCT02960438|12541609|FG003|Extension Phase (Open-label): 80 Weeks|Other|1
7976303|NCT02960490|12541629|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3
7976304|NCT02960490|12541630|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2
7976305|NCT02960490|12541631|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7976306|NCT02960490|12541632|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7976307|NCT02960490|12541633|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7976308|NCT02960490|12541634|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7976309|NCT02960490|12541635|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7976310|NCT02960490|12541636|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7976311|NCT02960490|12541637|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7976312|NCT02960490|12541638|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7976313|NCT02960490|12541629|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7976314|NCT02960490|12541630|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1
7976315|NCT02960490|12541631|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7976316|NCT02960490|12541632|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7976317|NCT02960490|12541633|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7976318|NCT02960490|12541634|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7976319|NCT02960490|12541635|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7976320|NCT02960490|12541636|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7976321|NCT02960490|12541637|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7976322|NCT02960490|12541638|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7976323|NCT02960490|12541629|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1
7976324|NCT02960490|12541630|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2
7976325|NCT02960490|12541631|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7976326|NCT02960490|12541632|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7976327|NCT02960490|12541633|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7976328|NCT02960490|12541634|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7976329|NCT02960490|12541635|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7976330|NCT02960490|12541636|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7976331|NCT02960490|12541637|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7976332|NCT02960490|12541638|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7976333|NCT02960490|12541629|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1
7976334|NCT02960490|12541630|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1
7976335|NCT02960490|12541631|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7976336|NCT02960490|12541632|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7976337|NCT02960490|12541633|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7976338|NCT02960490|12541634|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7976339|NCT02960490|12541635|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7976340|NCT02960490|12541636|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7976341|NCT02960490|12541637|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7976342|NCT02960490|12541638|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7976343|NCT02960490|12541629|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7976344|NCT02960490|12541630|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7976345|NCT02960490|12541631|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1
7976346|NCT02960490|12541632|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1
7976347|NCT02960490|12541633|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7976348|NCT02960490|12541634|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2
7976349|NCT02960490|12541635|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7976350|NCT02960490|12541636|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7976351|NCT02960490|12541637|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7976352|NCT02960490|12541638|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7976353|NCT02960490|12541629|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0
7976354|NCT02960490|12541630|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0
7976355|NCT02960490|12541631|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1
7976356|NCT02960490|12541632|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0
7976357|NCT02960490|12541633|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1
7718027|NCT00524303|12141720|FG002|Overall Study|Disease Progression|1
7718028|NCT00524303|12141718|FG000|Overall Study|Disease Recurrence|0
7718029|NCT00524303|12141719|FG001|Overall Study|Disease Recurrence|1
7718030|NCT00524303|12141720|FG002|Overall Study|Disease Recurrence|0
7976358|NCT02960490|12541634|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0
7976359|NCT02960490|12541635|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0
7976360|NCT02960490|12541636|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0
7976361|NCT02960490|12541637|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0
7976362|NCT02960490|12541638|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0
7976363|NCT02960490|12541629|FG000|Re-randomized Participants: 12 Weeks|Other|0
7976364|NCT02960490|12541630|FG001|Re-randomized Participants: 12 Weeks|Other|0
7976365|NCT02960490|12541631|FG002|Re-randomized Participants: 12 Weeks|Other|0
7976366|NCT02960490|12541632|FG003|Re-randomized Participants: 12 Weeks|Other|1
7976367|NCT02960490|12541633|FG004|Re-randomized Participants: 12 Weeks|Other|0
7976368|NCT02960490|12541634|FG005|Re-randomized Participants: 12 Weeks|Other|0
7976369|NCT02960490|12541635|FG006|Re-randomized Participants: 12 Weeks|Other|0
7976370|NCT02960490|12541636|FG007|Re-randomized Participants: 12 Weeks|Other|0
7976371|NCT02960490|12541637|FG008|Re-randomized Participants: 12 Weeks|Other|0
7976372|NCT02960490|12541638|FG009|Re-randomized Participants: 12 Weeks|Other|0
7976373|NCT02960490|12541629|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7976374|NCT02960490|12541630|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7976375|NCT02960490|12541631|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7976376|NCT02960490|12541632|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7976377|NCT02960490|12541633|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7976378|NCT02960490|12541634|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7976379|NCT02960490|12541635|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3
7976380|NCT02960490|12541636|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1
7976381|NCT02960490|12541637|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1
7976382|NCT02960490|12541638|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7976383|NCT02960490|12541629|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7976384|NCT02960490|12541630|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7976385|NCT02960490|12541631|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7976386|NCT02960490|12541632|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7976387|NCT02960490|12541633|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7976388|NCT02960490|12541634|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7976389|NCT02960490|12541635|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7976390|NCT02960490|12541636|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1
7976391|NCT02960490|12541637|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7976392|NCT02960490|12541638|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7976393|NCT02960490|12541629|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7976394|NCT02960490|12541630|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7976395|NCT02960490|12541631|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7976396|NCT02960490|12541632|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7976397|NCT02960490|12541633|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7976398|NCT02960490|12541634|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7976399|NCT02960490|12541635|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4
7976400|NCT02960490|12541636|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3
7976401|NCT02960490|12541637|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3
7976402|NCT02960490|12541638|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7
7976403|NCT02960490|12541629|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7976404|NCT02960490|12541630|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7976405|NCT02960490|12541631|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7976406|NCT02960490|12541632|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7976407|NCT02960490|12541633|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7976408|NCT02960490|12541634|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7976409|NCT02960490|12541635|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2
7976410|NCT02960490|12541636|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7976411|NCT02960490|12541637|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7976412|NCT02960490|12541638|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7976413|NCT02960490|12541629|FG000|Extension Phase(Open-label): 80 Weeks|Other|0
7976414|NCT02960490|12541630|FG001|Extension Phase(Open-label): 80 Weeks|Other|0
7976415|NCT02960490|12541631|FG002|Extension Phase(Open-label): 80 Weeks|Other|0
7976416|NCT02960490|12541632|FG003|Extension Phase(Open-label): 80 Weeks|Other|0
7976417|NCT02960490|12541633|FG004|Extension Phase(Open-label): 80 Weeks|Other|0
7976418|NCT02960490|12541634|FG005|Extension Phase(Open-label): 80 Weeks|Other|0
7976419|NCT02960490|12541635|FG006|Extension Phase(Open-label): 80 Weeks|Other|0
7976420|NCT02960490|12541636|FG007|Extension Phase(Open-label): 80 Weeks|Other|1
7976421|NCT02960490|12541637|FG008|Extension Phase(Open-label): 80 Weeks|Other|0
7976422|NCT02960490|12541638|FG009|Extension Phase(Open-label): 80 Weeks|Other|0
7976423|NCT02960854|12541662|FG000|Overall Study|Not Disclosed|2
7976424|NCT02960854|12541663|FG001|Overall Study|Not Disclosed|2
7976425|NCT02960854|12541662|FG000|Overall Study|Subject No Longer Meets Study Criteria|1
7976426|NCT02960854|12541663|FG001|Overall Study|Subject No Longer Meets Study Criteria|0
7976427|NCT02960854|12541662|FG000|Overall Study|Subject Withdrew Consent|0
7976428|NCT02960854|12541663|FG001|Overall Study|Subject Withdrew Consent|1
7976429|NCT02960854|12541662|FG000|Overall Study|Death|4
7976430|NCT02960854|12541663|FG001|Overall Study|Death|6
7976431|NCT02961218|12541680|FG000|Overall Study|Lost to Follow-up|0
7976432|NCT02961218|12541681|FG001|Overall Study|Lost to Follow-up|2
7976433|NCT02961218|12541680|FG000|Overall Study|Physician Decision|0
7976434|NCT02961218|12541681|FG001|Overall Study|Physician Decision|2
7976435|NCT02961218|12541680|FG000|Overall Study|Subject/Guardian Decision|3
7976436|NCT02961218|12541681|FG001|Overall Study|Subject/Guardian Decision|1
7976437|NCT02961244|12541691|FG000|Overall Study|Protocol Violation|0
7976438|NCT02961244|12541692|FG001|Overall Study|Protocol Violation|1
7976439|NCT02961244|12541691|FG000|Overall Study|Withdrawal by Subject|1
7976440|NCT02961244|12541692|FG001|Overall Study|Withdrawal by Subject|2
7976441|NCT02961244|12541691|FG000|Overall Study|Surgery plan change after study approval|0
7976442|NCT02961244|12541692|FG001|Overall Study|Surgery plan change after study approval|2
7976443|NCT02961244|12541691|FG000|Overall Study|Lost to Follow-up|0
7976444|NCT02961244|12541692|FG001|Overall Study|Lost to Follow-up|2
7976445|NCT02961244|12541691|FG000|Overall Study|İnadequate data|0
7976446|NCT02961244|12541692|FG001|Overall Study|İnadequate data|2
7976447|NCT02961751|12541698|FG000|Overall Study|Lost to Follow-up|11
7976448|NCT02961751|12541698|FG000|Overall Study|Physician Decision|2
7976449|NCT02961751|12541698|FG000|Overall Study|Not Eligible at Enrollment|1
7976450|NCT02961751|12541698|FG000|Overall Study|Protocol Violation|1
7976451|NCT02961764|12541704|FG000|Overall Study|Protocol Violation|0
7976452|NCT02961764|12541705|FG001|Overall Study|Protocol Violation|1
7976453|NCT02961764|12541704|FG000|Overall Study|Death|2
7976454|NCT02961764|12541705|FG001|Overall Study|Death|0
7976455|NCT02961764|12541704|FG000|Overall Study|Lost to Follow-up|35
7976456|NCT02961764|12541705|FG001|Overall Study|Lost to Follow-up|24
7976457|NCT02961764|12541704|FG000|Overall Study|Withdrawal by Subject|2
7976458|NCT02961764|12541705|FG001|Overall Study|Withdrawal by Subject|0
7976459|NCT02961790|12541715|FG000|Overall Study|Canceled|4
7976460|NCT02961790|12541716|FG001|Overall Study|Canceled|5
7976461|NCT02961790|12541717|FG002|Overall Study|Canceled|1
7976462|NCT02961790|12541718|FG003|Overall Study|Canceled|4
7976463|NCT02961790|12541715|FG000|Overall Study|without baseline data|4
7976464|NCT02961790|12541716|FG001|Overall Study|without baseline data|0
7976465|NCT02961790|12541717|FG002|Overall Study|without baseline data|1
7976466|NCT02961790|12541718|FG003|Overall Study|without baseline data|0
7976467|NCT02961790|12541715|FG000|Overall Study|without post baseline data|7
7976468|NCT02961790|12541716|FG001|Overall Study|without post baseline data|6
7976469|NCT02961790|12541717|FG002|Overall Study|without post baseline data|4
7976470|NCT02961790|12541718|FG003|Overall Study|without post baseline data|1
7976471|NCT02961920|12541735|FG000|Overall Study|did not achive stydy protocol schedule|1
7976472|NCT02961920|12541736|FG001|Overall Study|did not achive stydy protocol schedule|1
7976473|NCT02962284|12541757|FG000|Overall Study|Death|2
7976474|NCT02962284|12541758|FG001|Overall Study|Death|0
7976475|NCT02962284|12541757|FG000|Overall Study|Progressive disease|2
7976476|NCT02962284|12541758|FG001|Overall Study|Progressive disease|3
7976477|NCT02962284|12541757|FG000|Overall Study|Withdrawal by Subject|1
7976478|NCT02962284|12541758|FG001|Overall Study|Withdrawal by Subject|0
7976479|NCT02962648|12541786|FG000|Overall Study|Withdrawal by Subject|3
7976480|NCT02962648|12541786|FG000|Overall Study|Lost to Follow-up|3
7976481|NCT02962648|12541786|FG000|Overall Study|Physician Decision|1
7976482|NCT02962648|12541786|FG000|Overall Study|Subject had problems with transportation|2
7976483|NCT02962674|12541790|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49
7976484|NCT02962739|12541807|FG000|Overall Study|Withdrawal by Subject|0
7976485|NCT02962739|12541808|FG001|Overall Study|Withdrawal by Subject|1
7976486|NCT02962739|12541809|FG002|Overall Study|Withdrawal by Subject|0
7976487|NCT02962739|12541810|FG003|Overall Study|Withdrawal by Subject|0
7976488|NCT02962739|12541811|FG004|Overall Study|Withdrawal by Subject|0
7976489|NCT02962739|12541812|FG005|Overall Study|Withdrawal by Subject|0
7976490|NCT02962739|12541807|FG000|Overall Study|Protocol Violation|0
7976491|NCT02962739|12541808|FG001|Overall Study|Protocol Violation|0
7976492|NCT02962739|12541809|FG002|Overall Study|Protocol Violation|1
7976493|NCT02962739|12541810|FG003|Overall Study|Protocol Violation|0
7976494|NCT02962739|12541811|FG004|Overall Study|Protocol Violation|1
7976495|NCT02962739|12541812|FG005|Overall Study|Protocol Violation|0
7976496|NCT02962765|12541818|FG000|Overall Study|Protocol Violation|9
7976497|NCT02962765|12541818|FG000|Overall Study|Withdrawal by Subject|3
7976498|NCT02962765|12541818|FG000|Overall Study|Lost to Follow-up|1
7976499|NCT02962765|12541818|FG000|Overall Study|Death|1
7976500|NCT02962765|12541818|FG000|Overall Study|Limited access to study medication|3
7976501|NCT02962882|12541829|FG000|Overall Study|Adverse Event|2
7976502|NCT02962882|12541829|FG000|Overall Study|Withdrawal by Subject|2
7976503|NCT02962882|12541829|FG000|Overall Study|Transfer from ICU|32
7976504|NCT02962908|12541838|FG000|Overall Study|Lost to Follow-up|0
7976505|NCT02962908|12541839|FG001|Overall Study|Lost to Follow-up|3
7976506|NCT02962908|12541840|FG002|Overall Study|Lost to Follow-up|0
7976507|NCT02962908|12541841|FG003|Overall Study|Lost to Follow-up|1
7976508|NCT02962908|12541838|FG000|Overall Study|Withdrawal by Subject|0
7976509|NCT02962908|12541839|FG001|Overall Study|Withdrawal by Subject|3
7976510|NCT02962908|12541840|FG002|Overall Study|Withdrawal by Subject|0
7976511|NCT02962908|12541841|FG003|Overall Study|Withdrawal by Subject|2
7976512|NCT02962908|12541838|FG000|Overall Study|Protocol Violation|0
7976513|NCT02962908|12541839|FG001|Overall Study|Protocol Violation|1
7976514|NCT02962908|12541840|FG002|Overall Study|Protocol Violation|0
7976515|NCT02962908|12541841|FG003|Overall Study|Protocol Violation|0
7976516|NCT02962908|12541838|FG000|Overall Study|Physician Decision|0
7976517|NCT02962908|12541839|FG001|Overall Study|Physician Decision|1
7976518|NCT02962908|12541840|FG002|Overall Study|Physician Decision|0
7976519|NCT02962908|12541841|FG003|Overall Study|Physician Decision|0
7976520|NCT02962960|12541869|FG000|Overall Study|Withdrawal by Subject|1
7976521|NCT02962960|12541870|FG001|Overall Study|Withdrawal by Subject|1
7976522|NCT02962960|12541871|FG002|Overall Study|Withdrawal by Subject|0
7976523|NCT02962960|12541869|FG000|Overall Study|Adverse Event|1
7976524|NCT02962960|12541870|FG001|Overall Study|Adverse Event|1
7976525|NCT02962960|12541871|FG002|Overall Study|Adverse Event|0
7976526|NCT02962960|12541869|FG000|Overall Study|Protocol Violation|1
7976527|NCT02962960|12541870|FG001|Overall Study|Protocol Violation|0
7976528|NCT02962960|12541871|FG002|Overall Study|Protocol Violation|0
7976529|NCT02963311|12541881|FG000|Overall Study|Withdrawal by Subject|1
7976530|NCT02963311|12541881|FG000|Overall Study|Screen Failure|4
7976531|NCT02963441|12541916|FG000|Overall Study|Protocol violation or withdrawn|8
7976532|NCT02963441|12541916|FG000|Overall Study|Ungradeable by FPRC or IDx|40
7976533|NCT02963441|12541916|FG000|Overall Study|IDx-DR insufficient quality|33
7976534|NCT02963701|12541932|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
7976535|NCT02963701|12541933|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
7976536|NCT02963922|12541941|FG000|Overall Study|Adverse Event|15
7976537|NCT02963922|12541942|FG001|Overall Study|Adverse Event|6
7976538|NCT02963922|12541941|FG000|Overall Study|Protocol deviation|6
7976539|NCT02963922|12541942|FG001|Overall Study|Protocol deviation|6
7976540|NCT02963922|12541941|FG000|Overall Study|Lack of Efficacy|1
7976541|NCT02963922|12541942|FG001|Overall Study|Lack of Efficacy|1
7976542|NCT02963922|12541941|FG000|Overall Study|Lost to Follow-up|2
7976543|NCT02963922|12541942|FG001|Overall Study|Lost to Follow-up|3
7976544|NCT02963922|12541941|FG000|Overall Study|Other|8
7976545|NCT02963922|12541942|FG001|Overall Study|Other|14
7976546|NCT02963935|12541950|FG000|Overall Study|Adverse Event|12
7976547|NCT02963935|12541951|FG001|Overall Study|Adverse Event|6
7976548|NCT02963935|12541950|FG000|Overall Study|Protocol Violation|2
7976549|NCT02963935|12541951|FG001|Overall Study|Protocol Violation|1
7976550|NCT02963935|12541950|FG000|Overall Study|Lack of Efficacy|0
7976551|NCT02963935|12541951|FG001|Overall Study|Lack of Efficacy|2
7976552|NCT02963935|12541950|FG000|Overall Study|Lost to Follow-up|1
7976553|NCT02963935|12541951|FG001|Overall Study|Lost to Follow-up|6
7976554|NCT02963935|12541950|FG000|Overall Study|Unclassified|13
7976555|NCT02963935|12541951|FG001|Overall Study|Unclassified|22
7976556|NCT02964234|12541972|FG000|Overall Study|Lost to Follow-up|22
7976557|NCT02964234|12541973|FG001|Overall Study|Lost to Follow-up|13
7976558|NCT02964247|12541981|FG000|Overall Study|Lost to Follow-up|2
7976559|NCT02964247|12541982|FG001|Overall Study|Lost to Follow-up|0
7976560|NCT02964247|12541981|FG000|Overall Study|Withdrawal by Subject|1
7976561|NCT02964247|12541982|FG001|Overall Study|Withdrawal by Subject|2
7976562|NCT02964312|12541988|FG000|Overall Study|Lost to Follow-up|28
7976563|NCT02964312|12541988|FG000|Overall Study|Withdrawal by Subject|11
7976564|NCT02964312|12541988|FG000|Overall Study|Lack of Efficacy|10
7976565|NCT02964312|12541988|FG000|Overall Study|Did not consent to long-term FU|14
7976566|NCT02964312|12541988|FG000|Overall Study|Death|1
7976567|NCT02964325|12541997|FG000|Overall Study|Lost to Follow-up|3
7976568|NCT02964325|12541998|FG001|Overall Study|Lost to Follow-up|3
7976569|NCT02964325|12541997|FG000|Overall Study|Physician Decision|5
7976570|NCT02964325|12541998|FG001|Overall Study|Physician Decision|4
7976571|NCT02964325|12541997|FG000|Overall Study|Death|1
7976572|NCT02964325|12541998|FG001|Overall Study|Death|3
7976573|NCT02964325|12541997|FG000|Overall Study|Withdrawal by Subject|2
7976574|NCT02964325|12541998|FG001|Overall Study|Withdrawal by Subject|1
7976575|NCT02964325|12541997|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10
7976576|NCT02964325|12541998|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12
7976577|NCT02964338|12542007|FG000|Overall Study|Sponsor terminated study for futility|12
7976578|NCT02964338|12542008|FG001|Overall Study|Sponsor terminated study for futility|15
7976579|NCT02964338|12542009|FG002|Overall Study|Sponsor terminated study for futility|14
7976580|NCT02964338|12542007|FG000|Overall Study|Lack of Efficacy|0
7976581|NCT02964338|12542008|FG001|Overall Study|Lack of Efficacy|3
7976582|NCT02964338|12542009|FG002|Overall Study|Lack of Efficacy|0
7976583|NCT02964338|12542007|FG000|Overall Study|Lost to Follow-up|1
7976584|NCT02964338|12542008|FG001|Overall Study|Lost to Follow-up|0
7976585|NCT02964338|12542009|FG002|Overall Study|Lost to Follow-up|3
7976586|NCT02964338|12542007|FG000|Overall Study|Protocol Violation|0
7976587|NCT02964338|12542008|FG001|Overall Study|Protocol Violation|1
7976588|NCT02964338|12542009|FG002|Overall Study|Protocol Violation|0
7976589|NCT02964338|12542007|FG000|Overall Study|Withdrawal by Subject|1
7976590|NCT02964338|12542008|FG001|Overall Study|Withdrawal by Subject|3
7976591|NCT02964338|12542009|FG002|Overall Study|Withdrawal by Subject|1
7976592|NCT02964338|12542007|FG000|Overall Study|Adverse Event|2
7976593|NCT02964338|12542008|FG001|Overall Study|Adverse Event|1
7976594|NCT02964338|12542009|FG002|Overall Study|Adverse Event|1
7976595|NCT02964338|12542007|FG000|Overall Study|Non-compliant with e-diary|0
7976596|NCT02964338|12542008|FG001|Overall Study|Non-compliant with e-diary|1
7976597|NCT02964338|12542009|FG002|Overall Study|Non-compliant with e-diary|0
7976598|NCT02964338|12542007|FG000|Overall Study|Did not meet criteria|1
7976599|NCT02964338|12542008|FG001|Overall Study|Did not meet criteria|0
7976600|NCT02964338|12542009|FG002|Overall Study|Did not meet criteria|0
7976601|NCT02965378|12542057|FG000|Overall Study|Progression|16
7976602|NCT02965378|12542058|FG001|Overall Study|Progression|4
7976603|NCT02965378|12542057|FG000|Overall Study|Adverse Event|5
7976604|NCT02965378|12542058|FG001|Overall Study|Adverse Event|2
7976605|NCT02965378|12542057|FG000|Overall Study|Death|2
7976606|NCT02965378|12542058|FG001|Overall Study|Death|0
7976607|NCT02965378|12542057|FG000|Overall Study|Refusal|2
7976608|NCT02965378|12542058|FG001|Overall Study|Refusal|1
7976609|NCT02965378|12542057|FG000|Overall Study|Not protocol specified|0
7976610|NCT02965378|12542058|FG001|Overall Study|Not protocol specified|2
7976611|NCT02965456|12542066|FG000|Overall Study|Lost to Follow-up|40
7976612|NCT02965456|12542067|FG001|Overall Study|Lost to Follow-up|18
7976613|NCT02965456|12542066|FG000|Overall Study|Subject Request|22
7976614|NCT02965456|12542067|FG001|Overall Study|Subject Request|13
7976615|NCT02965456|12542066|FG000|Overall Study|Withdrawal by Parent or Guardian|3
7976616|NCT02965456|12542067|FG001|Overall Study|Withdrawal by Parent or Guardian|6
7976617|NCT02965456|12542066|FG000|Overall Study|Adverse Event|3
7976618|NCT02965456|12542067|FG001|Overall Study|Adverse Event|0
7976619|NCT02965456|12542066|FG000|Overall Study|Noncompliance with Study Drug|1
7976620|NCT02965456|12542067|FG001|Overall Study|Noncompliance with Study Drug|1
7976621|NCT02965456|12542066|FG000|Overall Study|Worsening Condition|0
7976622|NCT02965456|12542067|FG001|Overall Study|Worsening Condition|2
7976623|NCT02965456|12542066|FG000|Overall Study|Lack of Efficacy|1
7976624|NCT02965456|12542067|FG001|Overall Study|Lack of Efficacy|0
7976625|NCT02965456|12542066|FG000|Overall Study|Physician Decision|0
7976626|NCT02965456|12542067|FG001|Overall Study|Physician Decision|1
7976627|NCT02965456|12542066|FG000|Overall Study|Pregnancy|1
7976628|NCT02965456|12542067|FG001|Overall Study|Pregnancy|0
7976629|NCT02965456|12542066|FG000|Overall Study|Protocol Violation|0
7976630|NCT02965456|12542067|FG001|Overall Study|Protocol Violation|1
7976631|NCT02965456|12542066|FG000|Overall Study|Participant ran out of study drug|0
7976632|NCT02965456|12542067|FG001|Overall Study|Participant ran out of study drug|1
7976633|NCT02965573|12542083|FG000|Overall Study|Lack of Efficacy|1
7976634|NCT02965573|12542084|FG001|Overall Study|Lack of Efficacy|0
7976635|NCT02965599|12542092|FG000|Overall Study|Protocol-defined stop criteria reached|1
7976636|NCT02965599|12542093|FG001|Overall Study|Protocol-defined stop criteria reached|0
7976637|NCT02965820|12542113|FG000|Period 2, Second 30 Days|Adverse Event|1
7976638|NCT02965820|12542114|FG001|Period 2, Second 30 Days|Adverse Event|1
7976639|NCT02965833|12542120|FG000|Period 1, First 30 Days of Wear|Adverse Event|0
7976640|NCT02965833|12542121|FG001|Period 1, First 30 Days of Wear|Adverse Event|1
7976641|NCT02965833|12542120|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7976642|NCT02965833|12542121|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7976643|NCT02965833|12542120|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1
7976644|NCT02965833|12542121|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0
7976645|NCT02965833|12542120|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
7976646|NCT02965833|12542121|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
7976647|NCT02965833|12542120|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2
7976648|NCT02965833|12542121|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0
7976649|NCT02966002|12542146|FG000|Overall Study|Withdrawal by Subject|2
7976650|NCT02966002|12542146|FG000|Overall Study|Adverse Event|1
7976651|NCT02966002|12542146|FG000|Overall Study|Lost to Follow-up|1
7976652|NCT02966015|12542152|FG000|Inclusion Visit|did not answer questionnaire|8
7976653|NCT02966015|12542153|FG001|Inclusion Visit|did not answer questionnaire|3
7976654|NCT02966028|12542162|FG000|Overall Study|Adverse Event|7
7976655|NCT02966028|12542163|FG001|Overall Study|Adverse Event|13
7976656|NCT02966028|12542164|FG002|Overall Study|Adverse Event|10
7976657|NCT02966028|12542162|FG000|Overall Study|Physician Decision|1
7976658|NCT02966028|12542163|FG001|Overall Study|Physician Decision|0
7976659|NCT02966028|12542164|FG002|Overall Study|Physician Decision|2
7976660|NCT02966028|12542162|FG000|Overall Study|Withdrawal by Subject|7
7976661|NCT02966028|12542163|FG001|Overall Study|Withdrawal by Subject|5
7976662|NCT02966028|12542164|FG002|Overall Study|Withdrawal by Subject|5
7976663|NCT02966028|12542162|FG000|Overall Study|Kidney transplant Changed dialysis units|9
7976664|NCT02966028|12542163|FG001|Overall Study|Kidney transplant Changed dialysis units|16
7976665|NCT02966028|12542164|FG002|Overall Study|Kidney transplant Changed dialysis units|14
7976666|NCT02966314|12542185|FG000|Overall Study|Lost to Follow-up|1
7976667|NCT02966314|12542186|FG001|Overall Study|Lost to Follow-up|0
7976668|NCT02966340|12542192|FG000|Overall Study|Adverse Event|0
7976669|NCT02966340|12542193|FG001|Overall Study|Adverse Event|1
7976670|NCT02966340|12542192|FG000|Overall Study|Lost to Follow-up|0
7976671|NCT02966340|12542193|FG001|Overall Study|Lost to Follow-up|1
7976672|NCT02966340|12542192|FG000|Overall Study|Withdrawal by Subject|1
7976673|NCT02966340|12542193|FG001|Overall Study|Withdrawal by Subject|0
7976674|NCT02966340|12542192|FG000|Overall Study|data acquisition error|1
7976675|NCT02966340|12542193|FG001|Overall Study|data acquisition error|0
7976676|NCT02966340|12542192|FG000|Overall Study|startle non-responder|1
7976677|NCT02966340|12542193|FG001|Overall Study|startle non-responder|1
7976678|NCT02966353|12542199|FG000|Overall Study|Withdrawal by Subject|7
7976679|NCT02966353|12542199|FG000|Overall Study|Adverse Event|4
7976680|NCT02966353|12542199|FG000|Overall Study|Death|4
7976681|NCT02966353|12542199|FG000|Overall Study|Physician Decision|3
7976682|NCT02966353|12542199|FG000|Overall Study|Progressive disease|2
7976683|NCT02966353|12542199|FG000|Overall Study|Protocol deviation|2
7976684|NCT02966509|12542205|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2
7976685|NCT02966509|12542206|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3
7976686|NCT02966509|12542205|FG000|Baseline Satisfaction Survey|Death|0
7976687|NCT02966509|12542206|FG001|Baseline Satisfaction Survey|Death|1
7976688|NCT02966509|12542205|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1
7976689|NCT02966509|12542206|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1
7976690|NCT02966509|12542205|FG000|Baseline Satisfaction Survey|Refused to Answer|1
7976691|NCT02966509|12542206|FG001|Baseline Satisfaction Survey|Refused to Answer|2
7976692|NCT02966509|12542205|FG000|6 Month Satisfaction Decision Survey|Death|22
7976693|NCT02966509|12542206|FG001|6 Month Satisfaction Decision Survey|Death|25
7976694|NCT02966509|12542205|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
7976695|NCT02966509|12542206|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
7976696|NCT02966509|12542205|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
7976697|NCT02966509|12542206|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
7976698|NCT02966509|12542205|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0
7976699|NCT02966509|12542206|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2
7976700|NCT02966509|12542205|FG000|6 Month Satisfaction Survey|Death|36
7976701|NCT02966509|12542206|FG001|6 Month Satisfaction Survey|Death|33
7976702|NCT02966509|12542205|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2
7976703|NCT02966509|12542206|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3
7976704|NCT02966509|12542205|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1
7976705|NCT02966509|12542206|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1
7976706|NCT02966509|12542205|FG000|6 Month Satisfaction Survey|Refused to Answer|8
7976707|NCT02966509|12542206|FG001|6 Month Satisfaction Survey|Refused to Answer|11
7976708|NCT02966509|12542205|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
7976709|NCT02966509|12542206|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
7976710|NCT02966509|12542205|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45
7976711|NCT02966509|12542206|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48
7976712|NCT02966795|12542214|FG000|Overall Study|Patient Left the Country|0
7976713|NCT02966795|12542215|FG001|Overall Study|Patient Left the Country|1
7976714|NCT02966834|12542226|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7976715|NCT02966834|12542227|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7976716|NCT02966834|12542228|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7976717|NCT02966834|12542229|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7976718|NCT02966834|12542230|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1
7976719|NCT02966834|12542231|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7976720|NCT02966834|12542226|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1
7976721|NCT02966834|12542227|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7976722|NCT02966834|12542228|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7976723|NCT02966834|12542229|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7976724|NCT02966834|12542230|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7976725|NCT02966834|12542231|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7976726|NCT02966834|12542226|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
7976727|NCT02966834|12542227|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
7976728|NCT02966834|12542228|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4
7976729|NCT02966834|12542229|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8
7976730|NCT02966834|12542230|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
7976731|NCT02966834|12542231|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5
7976732|NCT02966834|12542226|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0
7976733|NCT02966834|12542227|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0
7976734|NCT02966834|12542228|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1
7976735|NCT02966834|12542229|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2
7976736|NCT02966834|12542230|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0
7976737|NCT02966834|12542231|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1
7976738|NCT02966834|12542226|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7976739|NCT02966834|12542227|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7976740|NCT02966834|12542228|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7976741|NCT02966834|12542229|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2
7976742|NCT02966834|12542230|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7976743|NCT02966834|12542231|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7976744|NCT02966834|12542226|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7976745|NCT02966834|12542227|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7976746|NCT02966834|12542228|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7976747|NCT02966834|12542229|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1
7976748|NCT02966834|12542230|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7976749|NCT02966834|12542231|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7976750|NCT02967055|12542289|FG000|Overall Study|Excluded|40
7976751|NCT02967055|12542289|FG000|Overall Study|Screen fail|3
7976752|NCT02967055|12542289|FG000|Overall Study|Lost to Follow-up|2
7976753|NCT02967055|12542289|FG000|Overall Study|Stopped due to side effects|3
7976754|NCT02967055|12542289|FG000|Overall Study|Stopped due to drug cost|1
7976755|NCT02967562|12542358|FG000|Overall Study|Consent not obtained|1
7976756|NCT02967562|12542359|FG001|Overall Study|Consent not obtained|0
7976757|NCT02967562|12542358|FG000|Overall Study|High leak precluding analysis|1
7976758|NCT02967562|12542359|FG001|Overall Study|High leak precluding analysis|1
7976759|NCT02967679|12542365|FG000|Overall Study|Adverse Event|1
7976760|NCT02968173|12542384|FG000|Overall Study|Withdrawal by Subject|1
7976761|NCT02968433|12542430|FG000|Overall Study|Withdrawal by Subject|1
7976762|NCT02968576|12542440|FG000|Overall Study|Pregnancy|0
7976763|NCT02968576|12542441|FG001|Overall Study|Pregnancy|1
7976764|NCT02968979|12542462|FG000|Overall Study|Protocol Violation|7
7976765|NCT02968979|12542462|FG000|Overall Study|Withdrawal by Subject|1
7976766|NCT02969018|12542529|FG000|Overall Study|Adverse Event|2
7976767|NCT02969018|12542530|FG001|Overall Study|Adverse Event|4
7976768|NCT02969018|12542531|FG002|Overall Study|Adverse Event|1
7976769|NCT02969018|12542532|FG003|Overall Study|Adverse Event|2
7976770|NCT02969018|12542533|FG004|Overall Study|Adverse Event|0
7976771|NCT02969018|12542534|FG005|Overall Study|Adverse Event|1
7976772|NCT02969018|12542535|FG006|Overall Study|Adverse Event|2
7976773|NCT02969018|12542536|FG007|Overall Study|Adverse Event|0
7976774|NCT02969018|12542529|FG000|Overall Study|Lack of Efficacy|0
7976775|NCT02969018|12542530|FG001|Overall Study|Lack of Efficacy|1
7976776|NCT02969018|12542531|FG002|Overall Study|Lack of Efficacy|0
7976777|NCT02969018|12542532|FG003|Overall Study|Lack of Efficacy|0
7976778|NCT02969018|12542533|FG004|Overall Study|Lack of Efficacy|1
7976779|NCT02969018|12542534|FG005|Overall Study|Lack of Efficacy|1
7976780|NCT02969018|12542535|FG006|Overall Study|Lack of Efficacy|1
7976781|NCT02969018|12542536|FG007|Overall Study|Lack of Efficacy|1
7976782|NCT02969018|12542529|FG000|Overall Study|Lost to Follow-up|1
7976783|NCT02969018|12542530|FG001|Overall Study|Lost to Follow-up|2
7976784|NCT02969018|12542531|FG002|Overall Study|Lost to Follow-up|2
7976785|NCT02969018|12542532|FG003|Overall Study|Lost to Follow-up|0
7976786|NCT02969018|12542533|FG004|Overall Study|Lost to Follow-up|1
7976787|NCT02969018|12542534|FG005|Overall Study|Lost to Follow-up|1
7976788|NCT02969018|12542535|FG006|Overall Study|Lost to Follow-up|0
7976789|NCT02969018|12542536|FG007|Overall Study|Lost to Follow-up|1
7976790|NCT02969018|12542529|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7976791|NCT02969018|12542530|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7976792|NCT02969018|12542531|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
7976793|NCT02969018|12542532|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
7976794|NCT02969018|12542533|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
7976795|NCT02969018|12542534|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
7976796|NCT02969018|12542535|FG006|Overall Study|No Longer Meets Eligibility Criteria|1
7976797|NCT02969018|12542536|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
7976798|NCT02969018|12542529|FG000|Overall Study|Non-Compliance With Study Drug|1
7976799|NCT02969018|12542530|FG001|Overall Study|Non-Compliance With Study Drug|0
7976800|NCT02969018|12542531|FG002|Overall Study|Non-Compliance With Study Drug|0
7976801|NCT02969018|12542532|FG003|Overall Study|Non-Compliance With Study Drug|0
7976802|NCT02969018|12542533|FG004|Overall Study|Non-Compliance With Study Drug|0
7976803|NCT02969018|12542534|FG005|Overall Study|Non-Compliance With Study Drug|0
7976804|NCT02969018|12542535|FG006|Overall Study|Non-Compliance With Study Drug|0
7976805|NCT02969018|12542536|FG007|Overall Study|Non-Compliance With Study Drug|0
7976806|NCT02969018|12542529|FG000|Overall Study|Other|0
7976807|NCT02969018|12542530|FG001|Overall Study|Other|0
7976808|NCT02969018|12542531|FG002|Overall Study|Other|0
7976809|NCT02969018|12542532|FG003|Overall Study|Other|1
7976810|NCT02969018|12542533|FG004|Overall Study|Other|0
7976811|NCT02969018|12542534|FG005|Overall Study|Other|0
7976812|NCT02969018|12542535|FG006|Overall Study|Other|0
7976813|NCT02969018|12542536|FG007|Overall Study|Other|2
7976814|NCT02969018|12542529|FG000|Overall Study|Pregnancy|0
7976815|NCT02969018|12542530|FG001|Overall Study|Pregnancy|0
7976816|NCT02969018|12542531|FG002|Overall Study|Pregnancy|0
7976817|NCT02969018|12542532|FG003|Overall Study|Pregnancy|0
7976818|NCT02969018|12542533|FG004|Overall Study|Pregnancy|0
7976819|NCT02969018|12542534|FG005|Overall Study|Pregnancy|1
7976820|NCT02969018|12542535|FG006|Overall Study|Pregnancy|0
7976821|NCT02969018|12542536|FG007|Overall Study|Pregnancy|0
7976822|NCT02969018|12542529|FG000|Overall Study|Protocol Violation|0
7976823|NCT02969018|12542530|FG001|Overall Study|Protocol Violation|0
7976824|NCT02969018|12542531|FG002|Overall Study|Protocol Violation|1
7976825|NCT02969018|12542532|FG003|Overall Study|Protocol Violation|1
7976826|NCT02969018|12542533|FG004|Overall Study|Protocol Violation|0
7976827|NCT02969018|12542534|FG005|Overall Study|Protocol Violation|0
7976828|NCT02969018|12542535|FG006|Overall Study|Protocol Violation|0
7976829|NCT02969018|12542536|FG007|Overall Study|Protocol Violation|0
7976830|NCT02969018|12542529|FG000|Overall Study|Withdrawal by Subject|0
7976831|NCT02969018|12542530|FG001|Overall Study|Withdrawal by Subject|1
7976832|NCT02969018|12542531|FG002|Overall Study|Withdrawal by Subject|2
7976833|NCT02969018|12542532|FG003|Overall Study|Withdrawal by Subject|1
7976834|NCT02969018|12542533|FG004|Overall Study|Withdrawal by Subject|0
7976835|NCT02969018|12542534|FG005|Overall Study|Withdrawal by Subject|4
7976836|NCT02969018|12542535|FG006|Overall Study|Withdrawal by Subject|4
7976837|NCT02969018|12542536|FG007|Overall Study|Withdrawal by Subject|3
7976838|NCT02969044|12542568|FG000|Overall Study|Withdrawal by Subject|2
7976839|NCT02969044|12542569|FG001|Overall Study|Withdrawal by Subject|6
7976840|NCT02969044|12542568|FG000|Overall Study|Adverse Event|3
7976841|NCT02969044|12542569|FG001|Overall Study|Adverse Event|0
7976842|NCT02969187|12542577|FG000|Overall Study|Physician Decision|12
7976843|NCT02969187|12542578|FG001|Overall Study|Physician Decision|13
7976844|NCT02969382|12542593|FG000|Overall Study|Adverse Event|8
7976845|NCT02969382|12542594|FG001|Overall Study|Adverse Event|10
7976846|NCT02969382|12542593|FG000|Overall Study|Lack of Efficacy|4
7976847|NCT02969382|12542594|FG001|Overall Study|Lack of Efficacy|5
7976848|NCT02969382|12542593|FG000|Overall Study|Death|0
7976849|NCT02969382|12542594|FG001|Overall Study|Death|1
7976850|NCT02969382|12542593|FG000|Overall Study|PROTOCOL DEVIATION|0
7976851|NCT02969382|12542594|FG001|Overall Study|PROTOCOL DEVIATION|1
7976852|NCT02969382|12542593|FG000|Overall Study|Withdrawal by Subject|14
7976853|NCT02969382|12542594|FG001|Overall Study|Withdrawal by Subject|9
7976854|NCT02969408|12542600|FG000|Overall Study|Adverse Event|2
7976855|NCT02969408|12542600|FG000|Overall Study|Withdrawal by Subject|8
7976856|NCT02969408|12542600|FG000|Overall Study|Lost to Follow-up|4
7976857|NCT02969408|12542600|FG000|Overall Study|Protocol Violation|1
7976858|NCT02969408|12542600|FG000|Overall Study|Other than specified|1
7976859|NCT02969525|12542622|FG000|Double-Blind Period|Adverse Event|0
7976860|NCT02969525|12542623|FG001|Double-Blind Period|Adverse Event|0
7976861|NCT02969525|12542624|FG002|Double-Blind Period|Adverse Event|1
7976862|NCT02969525|12542625|FG003|Double-Blind Period|Adverse Event|1
7976863|NCT02969525|12542626|FG004|Double-Blind Period|Adverse Event|0
7976864|NCT02969525|12542627|FG005|Double-Blind Period|Adverse Event|0
7976865|NCT02969525|12542628|FG006|Double-Blind Period|Adverse Event|0
7976866|NCT02969525|12542629|FG007|Double-Blind Period|Adverse Event|0
7976867|NCT02969525|12542630|FG008|Double-Blind Period|Adverse Event|0
7976868|NCT02969525|12542631|FG009|Double-Blind Period|Adverse Event|0
7976869|NCT02969525|12542632|FG010|Double-Blind Period|Adverse Event|0
7976870|NCT02969525|12542633|FG011|Double-Blind Period|Adverse Event|0
7976871|NCT02969525|12542622|FG000|Double-Blind Period|LOW EGFR|0
7976872|NCT02969525|12542623|FG001|Double-Blind Period|LOW EGFR|0
7976873|NCT02969525|12542624|FG002|Double-Blind Period|LOW EGFR|0
7976874|NCT02969525|12542625|FG003|Double-Blind Period|LOW EGFR|1
7976875|NCT02969525|12542626|FG004|Double-Blind Period|LOW EGFR|0
7976876|NCT02969525|12542627|FG005|Double-Blind Period|LOW EGFR|0
7976877|NCT02969525|12542628|FG006|Double-Blind Period|LOW EGFR|0
7976878|NCT02969525|12542629|FG007|Double-Blind Period|LOW EGFR|0
7976879|NCT02969525|12542630|FG008|Double-Blind Period|LOW EGFR|0
7976880|NCT02969525|12542631|FG009|Double-Blind Period|LOW EGFR|0
7976881|NCT02969525|12542632|FG010|Double-Blind Period|LOW EGFR|0
7976882|NCT02969525|12542633|FG011|Double-Blind Period|LOW EGFR|0
7976883|NCT02969525|12542622|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2
7976884|NCT02969525|12542623|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0
7976885|NCT02969525|12542624|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0
7976886|NCT02969525|12542625|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2
7976887|NCT02969525|12542626|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0
7976888|NCT02969525|12542627|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0
7976889|NCT02969525|12542628|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0
7976890|NCT02969525|12542629|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0
7976891|NCT02969525|12542630|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0
7976892|NCT02969525|12542631|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0
7976893|NCT02969525|12542632|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0
7976894|NCT02969525|12542633|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0
7976895|NCT02969525|12542622|FG000|Dose-Blind Period|Adverse Event|0
7976896|NCT02969525|12542623|FG001|Dose-Blind Period|Adverse Event|0
7976897|NCT02969525|12542624|FG002|Dose-Blind Period|Adverse Event|0
7976898|NCT02969525|12542625|FG003|Dose-Blind Period|Adverse Event|0
7976899|NCT02969525|12542626|FG004|Dose-Blind Period|Adverse Event|0
7976900|NCT02969525|12542627|FG005|Dose-Blind Period|Adverse Event|0
7976901|NCT02969525|12542628|FG006|Dose-Blind Period|Adverse Event|0
7976902|NCT02969525|12542629|FG007|Dose-Blind Period|Adverse Event|0
7976903|NCT02969525|12542630|FG008|Dose-Blind Period|Adverse Event|0
7976904|NCT02969525|12542631|FG009|Dose-Blind Period|Adverse Event|1
7976905|NCT02969525|12542632|FG010|Dose-Blind Period|Adverse Event|1
7976906|NCT02969525|12542633|FG011|Dose-Blind Period|Adverse Event|1
7976907|NCT02969525|12542622|FG000|Dose-Blind Period|Withdrawal by Subject|0
7976908|NCT02969525|12542623|FG001|Dose-Blind Period|Withdrawal by Subject|0
7976909|NCT02969525|12542624|FG002|Dose-Blind Period|Withdrawal by Subject|0
7976910|NCT02969525|12542625|FG003|Dose-Blind Period|Withdrawal by Subject|0
7976911|NCT02969525|12542626|FG004|Dose-Blind Period|Withdrawal by Subject|0
7976912|NCT02969525|12542627|FG005|Dose-Blind Period|Withdrawal by Subject|0
7976913|NCT02969525|12542628|FG006|Dose-Blind Period|Withdrawal by Subject|2
7976914|NCT02969525|12542629|FG007|Dose-Blind Period|Withdrawal by Subject|0
7976915|NCT02969525|12542630|FG008|Dose-Blind Period|Withdrawal by Subject|1
7976916|NCT02969525|12542631|FG009|Dose-Blind Period|Withdrawal by Subject|2
7976917|NCT02969525|12542632|FG010|Dose-Blind Period|Withdrawal by Subject|0
7976918|NCT02969525|12542633|FG011|Dose-Blind Period|Withdrawal by Subject|0
7976919|NCT02969525|12542622|FG000|Dose-Blind Period|Non-cooperating patient|0
7976920|NCT02969525|12542623|FG001|Dose-Blind Period|Non-cooperating patient|0
7976921|NCT02969525|12542624|FG002|Dose-Blind Period|Non-cooperating patient|0
7976922|NCT02969525|12542625|FG003|Dose-Blind Period|Non-cooperating patient|0
7976923|NCT02969525|12542626|FG004|Dose-Blind Period|Non-cooperating patient|0
7976924|NCT02969525|12542627|FG005|Dose-Blind Period|Non-cooperating patient|0
7718031|NCT00524303|12141718|FG000|Overall Study|Sponsor Request|0
7718032|NCT00524303|12141719|FG001|Overall Study|Sponsor Request|0
7976925|NCT02969525|12542628|FG006|Dose-Blind Period|Non-cooperating patient|0
7976926|NCT02969525|12542629|FG007|Dose-Blind Period|Non-cooperating patient|0
7976927|NCT02969525|12542630|FG008|Dose-Blind Period|Non-cooperating patient|0
7976928|NCT02969525|12542631|FG009|Dose-Blind Period|Non-cooperating patient|0
7976929|NCT02969525|12542632|FG010|Dose-Blind Period|Non-cooperating patient|0
7976930|NCT02969525|12542633|FG011|Dose-Blind Period|Non-cooperating patient|1
7976931|NCT02969525|12542622|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7976932|NCT02969525|12542623|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7976933|NCT02969525|12542624|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7976934|NCT02969525|12542625|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7976935|NCT02969525|12542626|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7976936|NCT02969525|12542627|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7976937|NCT02969525|12542628|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7976938|NCT02969525|12542629|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7976939|NCT02969525|12542630|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7976940|NCT02969525|12542631|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7976941|NCT02969525|12542632|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1
7976942|NCT02969525|12542633|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7976943|NCT02969590|12542655|FG000|Screening Period|Hormones not suppressed post Lupron|1
7976944|NCT02969590|12542656|FG001|Screening Period|Hormones not suppressed post Lupron|0
7976945|NCT02969590|12542657|FG002|Screening Period|Hormones not suppressed post Lupron|0
7976946|NCT02969655|12542669|FG000|Overall Study|Withdrawal by Subject|3
7976947|NCT02969655|12542670|FG001|Overall Study|Withdrawal by Subject|2
7976948|NCT02969655|12542669|FG000|Overall Study|Physician Decision|4
7976949|NCT02969655|12542670|FG001|Overall Study|Physician Decision|3
7976950|NCT02969655|12542669|FG000|Overall Study|Protocol-specified withdrawal criteria|4
7976951|NCT02969655|12542670|FG001|Overall Study|Protocol-specified withdrawal criteria|2
7976952|NCT02969655|12542669|FG000|Overall Study|Adverse Event|10
7976953|NCT02969655|12542670|FG001|Overall Study|Adverse Event|8
7976954|NCT02969707|12542679|FG000|Overall Study|Adverse Event|1
7976955|NCT02969707|12542680|FG001|Overall Study|Adverse Event|2
7976956|NCT02969707|12542679|FG000|Overall Study|Lost to Follow-up|3
7976957|NCT02969707|12542680|FG001|Overall Study|Lost to Follow-up|0
7976958|NCT02969707|12542679|FG000|Overall Study|Physician Decision|0
7976959|NCT02969707|12542680|FG001|Overall Study|Physician Decision|1
7976960|NCT02969707|12542679|FG000|Overall Study|Protocol Violation|1
7976961|NCT02969707|12542680|FG001|Overall Study|Protocol Violation|1
7976962|NCT02969707|12542679|FG000|Overall Study|Withdrawal by Subject|3
7976963|NCT02969707|12542680|FG001|Overall Study|Withdrawal by Subject|4
7976964|NCT02969863|12542691|FG000|Overall Study|Physician Decision|1
7976965|NCT02969863|12542692|FG001|Overall Study|Physician Decision|0
7976966|NCT02969863|12542693|FG002|Overall Study|Physician Decision|0
7976967|NCT02969863|12542694|FG003|Overall Study|Physician Decision|0
7976968|NCT02969863|12542695|FG004|Overall Study|Physician Decision|0
7976969|NCT02969863|12542696|FG005|Overall Study|Physician Decision|0
7976970|NCT02970292|12542735|FG000|Overall Study|Physician Decision|1
7976971|NCT02970292|12542736|FG001|Overall Study|Physician Decision|1
7976972|NCT02970292|12542735|FG000|Overall Study|Withdrawal by Subject|11
7976973|NCT02970292|12542736|FG001|Overall Study|Withdrawal by Subject|5
7976974|NCT02970292|12542735|FG000|Overall Study|Noncompliance with study drug|2
7976975|NCT02970292|12542736|FG001|Overall Study|Noncompliance with study drug|2
7976976|NCT02970292|12542735|FG000|Overall Study|Adverse Event|5
7976977|NCT02970292|12542736|FG001|Overall Study|Adverse Event|0
7976978|NCT02970292|12542735|FG000|Overall Study|Lack of Efficacy|1
7976979|NCT02970292|12542736|FG001|Overall Study|Lack of Efficacy|0
7976980|NCT02970292|12542735|FG000|Overall Study|Lost to Follow-up|1
7976981|NCT02970292|12542736|FG001|Overall Study|Lost to Follow-up|0
7976982|NCT02970292|12542735|FG000|Overall Study|Protocol Violation|2
7976983|NCT02970292|12542736|FG001|Overall Study|Protocol Violation|0
7976984|NCT02970292|12542735|FG000|Overall Study|Other|1
7976985|NCT02970292|12542736|FG001|Overall Study|Other|0
7976986|NCT02970305|12542744|FG000|Overall Study|Adverse Event|10
7976987|NCT02970305|12542745|FG001|Overall Study|Adverse Event|6
7976988|NCT02970305|12542744|FG000|Overall Study|Lack of Efficacy|1
7976989|NCT02970305|12542745|FG001|Overall Study|Lack of Efficacy|1
7976990|NCT02970305|12542744|FG000|Overall Study|Noncompliance with study drug|2
7976991|NCT02970305|12542745|FG001|Overall Study|Noncompliance with study drug|4
7976992|NCT02970305|12542744|FG000|Overall Study|Protocol Violation|2
7976993|NCT02970305|12542745|FG001|Overall Study|Protocol Violation|2
7976994|NCT02970305|12542744|FG000|Overall Study|Withdrawal by Subject|12
7976995|NCT02970305|12542745|FG001|Overall Study|Withdrawal by Subject|11
7976996|NCT02970305|12542744|FG000|Overall Study|Not further specified|1
7976997|NCT02970305|12542745|FG001|Overall Study|Not further specified|2
7976998|NCT02970305|12542744|FG000|Overall Study|Lost to Follow-up|1
7976999|NCT02970305|12542745|FG001|Overall Study|Lost to Follow-up|2
7977000|NCT02970669|12542789|FG000|Double-blind Period|Adverse Event|4
7977001|NCT02970669|12542790|FG001|Double-blind Period|Adverse Event|0
7977002|NCT02970669|12542789|FG000|Double-blind Period|Death|1
7977003|NCT02970669|12542790|FG001|Double-blind Period|Death|0
7977004|NCT02970669|12542789|FG000|Double-blind Period|Study terminated by sponsor|1
7977005|NCT02970669|12542790|FG001|Double-blind Period|Study terminated by sponsor|2
7977006|NCT02970669|12542789|FG000|Double-blind Period|Physician Decision|0
7977007|NCT02970669|12542790|FG001|Double-blind Period|Physician Decision|2
7977008|NCT02970669|12542789|FG000|Double-blind Period|Withdrawal by Subject|2
7977009|NCT02970669|12542790|FG001|Double-blind Period|Withdrawal by Subject|2
7977010|NCT02970669|12542789|FG000|Open-label Period|Withdrawal by Subject|2
7977011|NCT02970669|12542790|FG001|Open-label Period|Withdrawal by Subject|2
7977012|NCT02970669|12542789|FG000|Open-label Period|Adverse Event|1
7977013|NCT02970669|12542790|FG001|Open-label Period|Adverse Event|0
7977014|NCT02970669|12542789|FG000|Open-label Period|Physician Decision|1
7977015|NCT02970669|12542790|FG001|Open-label Period|Physician Decision|0
7977016|NCT02970942|12542811|FG000|Overall Study|Death|0
7977017|NCT02970942|12542812|FG001|Overall Study|Death|1
7977018|NCT02970942|12542813|FG002|Overall Study|Death|0
7977019|NCT02970942|12542814|FG003|Overall Study|Death|0
7977020|NCT02970942|12542811|FG000|Overall Study|Lost to Follow-up|1
7977021|NCT02970942|12542812|FG001|Overall Study|Lost to Follow-up|0
7977022|NCT02970942|12542813|FG002|Overall Study|Lost to Follow-up|2
7977023|NCT02970942|12542814|FG003|Overall Study|Lost to Follow-up|1
7977024|NCT02970942|12542811|FG000|Overall Study|Withdrawal by Subject|3
7977025|NCT02970942|12542812|FG001|Overall Study|Withdrawal by Subject|5
7977026|NCT02970942|12542813|FG002|Overall Study|Withdrawal by Subject|3
7977027|NCT02970942|12542814|FG003|Overall Study|Withdrawal by Subject|2
7977028|NCT02971007|12542827|FG000|Overall Study|Adverse Event|1
7977029|NCT02971007|12542828|FG001|Overall Study|Adverse Event|0
7977030|NCT02971007|12542829|FG002|Overall Study|Adverse Event|0
7977031|NCT02971007|12542827|FG000|Overall Study|Lost to Follow-up|0
7977032|NCT02971007|12542828|FG001|Overall Study|Lost to Follow-up|1
7977033|NCT02971007|12542829|FG002|Overall Study|Lost to Follow-up|1
7977034|NCT02971007|12542827|FG000|Overall Study|Withdrawal by Subject|0
7977035|NCT02971007|12542828|FG001|Overall Study|Withdrawal by Subject|1
7977036|NCT02971007|12542829|FG002|Overall Study|Withdrawal by Subject|0
7977037|NCT02971007|12542827|FG000|Overall Study|Patient had yeast at Day 5 visit|1
7977038|NCT02971007|12542828|FG001|Overall Study|Patient had yeast at Day 5 visit|0
7977039|NCT02971007|12542829|FG002|Overall Study|Patient had yeast at Day 5 visit|0
7977040|NCT02971007|12542827|FG000|Overall Study|Patient discontinued study drug|0
7977041|NCT02971007|12542828|FG001|Overall Study|Patient discontinued study drug|1
7977042|NCT02971007|12542829|FG002|Overall Study|Patient discontinued study drug|0
7977043|NCT02971163|12542839|FG000|Overall Study|Lost to Follow-up|4
7977044|NCT02971163|12542840|FG001|Overall Study|Lost to Follow-up|2
7977045|NCT02971202|12542849|FG000|Overall Study|Pregnancy|1
7977046|NCT02971202|12542850|FG001|Overall Study|Pregnancy|0
7977047|NCT02971202|12542851|FG002|Overall Study|Pregnancy|0
7977048|NCT02971202|12542849|FG000|Overall Study|screen fail after consent|1
7977049|NCT02971202|12542850|FG001|Overall Study|screen fail after consent|0
7977050|NCT02971202|12542851|FG002|Overall Study|screen fail after consent|1
7977051|NCT02971228|12542859|FG000|Overall Study|Withdrawal by Subject|1
7977052|NCT02971228|12542860|FG001|Overall Study|Withdrawal by Subject|1
7977053|NCT02971228|12542861|FG002|Overall Study|Withdrawal by Subject|0
7977054|NCT02971228|12542862|FG003|Overall Study|Withdrawal by Subject|0
7977055|NCT02971228|12542863|FG004|Overall Study|Withdrawal by Subject|0
7977056|NCT02971228|12542859|FG000|Overall Study|Logistical challenges|0
7977057|NCT02971228|12542860|FG001|Overall Study|Logistical challenges|1
7977058|NCT02971228|12542861|FG002|Overall Study|Logistical challenges|0
7977059|NCT02971228|12542862|FG003|Overall Study|Logistical challenges|0
7977060|NCT02971228|12542863|FG004|Overall Study|Logistical challenges|0
7977061|NCT02971605|12542889|FG000|Overall Study|Withdrawal by Subject|1
7977062|NCT02971670|12542907|FG000|Overall Study|Withdrawal by Subject|4
7977063|NCT02971670|12542908|FG001|Overall Study|Withdrawal by Subject|1
7977064|NCT02971670|12542909|FG002|Overall Study|Withdrawal by Subject|1
7977065|NCT02971670|12542910|FG003|Overall Study|Withdrawal by Subject|2
7977066|NCT02971800|12542929|FG000|Overall Study|Protocol Violation|1
7977067|NCT02971800|12542929|FG000|Overall Study|Withdrawal by Subject|1
7977068|NCT02971800|12542929|FG000|Overall Study|Exclusion criteria prior intervention|1
7977069|NCT02971800|12542929|FG000|Overall Study|Number evaluable participant already reached|4
7977070|NCT02972242|12542935|FG000|Overall Study|Withdrawal by Subject|1
7977071|NCT02972242|12542936|FG001|Overall Study|Withdrawal by Subject|0
7977072|NCT02972359|12542942|FG000|Overall Study|Incl. criteria not met/Exclusion met|2
7977073|NCT02972359|12542942|FG000|Overall Study|Lack of Efficacy|1
7977074|NCT02972359|12542942|FG000|Overall Study|Adverse Event|4
7977075|NCT02972359|12542942|FG000|Overall Study|Death|1
7977076|NCT02972359|12542942|FG000|Overall Study|Withdrawal by Subject|30
7977077|NCT02972359|12542942|FG000|Overall Study|Protocol Violation|1
7977078|NCT02972359|12542942|FG000|Overall Study|Lost to Follow-up|26
7977079|NCT02972359|12542942|FG000|Overall Study|Other reasons|5
7977080|NCT02972359|12542942|FG000|Overall Study|Missing|1
7977081|NCT02972502|12542948|FG000|Overall Study|Lost to Follow-up|3
7977082|NCT02972502|12542949|FG001|Overall Study|Lost to Follow-up|1
7977083|NCT02972502|12542948|FG000|Overall Study|Withdrawal by Subject|1
7977084|NCT02972502|12542949|FG001|Overall Study|Withdrawal by Subject|1
7977085|NCT02972515|12542955|FG000|Overall Study|Lost to Follow-up|78
7977086|NCT02972632|12542968|FG000|Overall Study|Pretreatment Event/Adverse Event|3
7977087|NCT02972632|12542968|FG000|Overall Study|Lost to Follow-up|4
7977088|NCT02972632|12542968|FG000|Overall Study|Voluntary Withdrawal|10
7977089|NCT02972658|12542976|FG000|Overall Study|Adverse Event|0
7977090|NCT02972658|12542977|FG001|Overall Study|Adverse Event|3
7977091|NCT02972658|12542978|FG002|Overall Study|Adverse Event|0
7977092|NCT02972658|12542979|FG003|Overall Study|Adverse Event|2
7977093|NCT02972658|12542976|FG000|Overall Study|Other-determined by Investigator|1
7977094|NCT02972658|12542977|FG001|Overall Study|Other-determined by Investigator|1
7977095|NCT02972658|12542978|FG002|Overall Study|Other-determined by Investigator|0
7977096|NCT02972658|12542979|FG003|Overall Study|Other-determined by Investigator|0
7977097|NCT02972658|12542976|FG000|Overall Study|Death|0
7977098|NCT02972658|12542977|FG001|Overall Study|Death|0
7977099|NCT02972658|12542978|FG002|Overall Study|Death|0
7977100|NCT02972658|12542979|FG003|Overall Study|Death|1
7977101|NCT02972658|12542976|FG000|Overall Study|Lost to Follow-up|0
7977102|NCT02972658|12542977|FG001|Overall Study|Lost to Follow-up|1
7977103|NCT02972658|12542978|FG002|Overall Study|Lost to Follow-up|1
7977104|NCT02972658|12542979|FG003|Overall Study|Lost to Follow-up|2
7977105|NCT02972658|12542976|FG000|Overall Study|Progressive Disease|0
7977106|NCT02972658|12542977|FG001|Overall Study|Progressive Disease|1
7977107|NCT02972658|12542978|FG002|Overall Study|Progressive Disease|0
7977108|NCT02972658|12542979|FG003|Overall Study|Progressive Disease|1
7977109|NCT02972658|12542976|FG000|Overall Study|Withdrawal by Subject|4
7977110|NCT02972658|12542977|FG001|Overall Study|Withdrawal by Subject|4
7977111|NCT02972658|12542978|FG002|Overall Study|Withdrawal by Subject|1
7977112|NCT02972658|12542979|FG003|Overall Study|Withdrawal by Subject|6
7977113|NCT02972658|12542976|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1
7977114|NCT02972658|12542977|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1
7977115|NCT02972658|12542978|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1
7977116|NCT02972658|12542979|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0
7977117|NCT02972658|12542976|FG000|Overall Study|Sponsor Decision|70
7977118|NCT02972658|12542977|FG001|Overall Study|Sponsor Decision|127
7977119|NCT02972658|12542978|FG002|Overall Study|Sponsor Decision|72
7977120|NCT02972658|12542979|FG003|Overall Study|Sponsor Decision|119
7977121|NCT02973048|12542991|FG000|Overall Study|Epidural catheter insertion failure|1
7977122|NCT02973048|12542992|FG001|Overall Study|Epidural catheter insertion failure|0
7977123|NCT02973048|12542991|FG000|Overall Study|Withdrawal by Subject|0
7977124|NCT02973048|12542992|FG001|Overall Study|Withdrawal by Subject|3
7977125|NCT02973087|12543000|FG000|Overall Study|Withdrawal by Subject|2
7977126|NCT02973087|12543001|FG001|Overall Study|Withdrawal by Subject|1
7977127|NCT02973087|12543000|FG000|Overall Study|Adverse Event|1
7977128|NCT02973087|12543001|FG001|Overall Study|Adverse Event|0
7977129|NCT02973087|12543000|FG000|Overall Study|other|1
7977130|NCT02973087|12543001|FG001|Overall Study|other|1
7977131|NCT02973100|12543012|FG000|Overall Study|Adverse Event|1
7977132|NCT02973100|12543013|FG001|Overall Study|Adverse Event|2
7977133|NCT02973100|12543014|FG002|Overall Study|Adverse Event|1
7977134|NCT02973100|12543015|FG003|Overall Study|Adverse Event|2
7977135|NCT02973100|12543012|FG000|Overall Study|Lost to Follow-up|3
7977136|NCT02973100|12543013|FG001|Overall Study|Lost to Follow-up|1
7977137|NCT02973100|12543014|FG002|Overall Study|Lost to Follow-up|1
7977138|NCT02973100|12543015|FG003|Overall Study|Lost to Follow-up|0
7977139|NCT02973100|12543012|FG000|Overall Study|Withdrawal by Subject|3
7977140|NCT02973100|12543013|FG001|Overall Study|Withdrawal by Subject|5
7977141|NCT02973100|12543014|FG002|Overall Study|Withdrawal by Subject|1
7977142|NCT02973100|12543015|FG003|Overall Study|Withdrawal by Subject|4
7977143|NCT02973100|12543012|FG000|Overall Study|Notification of change in address|0
7977144|NCT02973100|12543013|FG001|Overall Study|Notification of change in address|0
7977145|NCT02973100|12543014|FG002|Overall Study|Notification of change in address|0
7977146|NCT02973100|12543015|FG003|Overall Study|Notification of change in address|1
7977147|NCT02973100|12543012|FG000|Overall Study|Failed to attend Safety followup period|0
7977148|NCT02973100|12543013|FG001|Overall Study|Failed to attend Safety followup period|0
7977149|NCT02973100|12543014|FG002|Overall Study|Failed to attend Safety followup period|1
7977150|NCT02973100|12543015|FG003|Overall Study|Failed to attend Safety followup period|0
7977151|NCT02973477|12543048|FG000|First Intervention|Lost to Follow-up|0
7977152|NCT02973477|12543049|FG001|First Intervention|Lost to Follow-up|2
7977153|NCT02973477|12543048|FG000|Washout|Withdrawal by Subject|1
7977154|NCT02973477|12543049|FG001|Washout|Withdrawal by Subject|0
7977155|NCT02973477|12543048|FG000|Second Intervention|Lost to Follow-up|1
7977156|NCT02973477|12543049|FG001|Second Intervention|Lost to Follow-up|0
7977157|NCT02973802|12543079|FG000|Overall Study|Lost to Follow-up|1
7977158|NCT02973802|12543079|FG000|Overall Study|Withdrawal by Subject|1
7977159|NCT02974010|12543088|FG000|Overall Study|Lost to Follow-up|3
7977160|NCT02974010|12543089|FG001|Overall Study|Lost to Follow-up|1
7977161|NCT02974010|12543090|FG002|Overall Study|Lost to Follow-up|0
7977162|NCT02974010|12543091|FG003|Overall Study|Lost to Follow-up|0
7977163|NCT02974010|12543088|FG000|Overall Study|Withdrawal by Subject|2
7977164|NCT02974010|12543089|FG001|Overall Study|Withdrawal by Subject|1
7977165|NCT02974010|12543090|FG002|Overall Study|Withdrawal by Subject|0
7977166|NCT02974010|12543091|FG003|Overall Study|Withdrawal by Subject|0
7977167|NCT02974010|12543088|FG000|Overall Study|Adverse Event|0
7977168|NCT02974010|12543089|FG001|Overall Study|Adverse Event|1
7977169|NCT02974010|12543090|FG002|Overall Study|Adverse Event|0
7977170|NCT02974010|12543091|FG003|Overall Study|Adverse Event|0
7977171|NCT02974010|12543088|FG000|Overall Study|Completed day 42 but did not return for day 70|1
7977172|NCT02974010|12543089|FG001|Overall Study|Completed day 42 but did not return for day 70|0
7977173|NCT02974010|12543090|FG002|Overall Study|Completed day 42 but did not return for day 70|1
7977174|NCT02974010|12543091|FG003|Overall Study|Completed day 42 but did not return for day 70|0
7977175|NCT02974010|12543088|FG000|Overall Study|Lack of Efficacy|0
7977176|NCT02974010|12543089|FG001|Overall Study|Lack of Efficacy|0
7977177|NCT02974010|12543090|FG002|Overall Study|Lack of Efficacy|1
7977178|NCT02974010|12543091|FG003|Overall Study|Lack of Efficacy|0
7977179|NCT02974088|12543103|FG000|Overall Study|Lost to Follow-up|0
7977180|NCT02974088|12543104|FG001|Overall Study|Lost to Follow-up|2
7977181|NCT02974088|12543103|FG000|Overall Study|Adverse Event|0
7977182|NCT02974088|12543104|FG001|Overall Study|Adverse Event|1
7977183|NCT02974114|12543113|FG000|Overall Study|Other (Not specified)|0
7977184|NCT02974114|12543114|FG001|Overall Study|Other (Not specified)|1
7977185|NCT02974114|12543115|FG002|Overall Study|Other (Not specified)|2
7977186|NCT02974140|12543125|FG000|Overall Study|Adverse Event|2
7977187|NCT02974140|12543125|FG000|Overall Study|Lost to Follow-up|1
7977188|NCT02974140|12543125|FG000|Overall Study|Study Terminated by Sponsor|36
7977189|NCT02974153|12543135|FG000|Overall Study|Adverse Event|6
7977190|NCT02974153|12543136|FG001|Overall Study|Adverse Event|0
7977191|NCT02974153|12543137|FG002|Overall Study|Adverse Event|1
7977192|NCT02974153|12543135|FG000|Overall Study|Lack of Efficacy|6
7977193|NCT02974153|12543136|FG001|Overall Study|Lack of Efficacy|5
7977194|NCT02974153|12543137|FG002|Overall Study|Lack of Efficacy|10
7977195|NCT02974153|12543135|FG000|Overall Study|Lost to Follow-up|9
7977196|NCT02974153|12543136|FG001|Overall Study|Lost to Follow-up|10
7977197|NCT02974153|12543137|FG002|Overall Study|Lost to Follow-up|17
7977198|NCT02974153|12543135|FG000|Overall Study|Physician Decision|0
7977199|NCT02974153|12543136|FG001|Overall Study|Physician Decision|2
7977200|NCT02974153|12543137|FG002|Overall Study|Physician Decision|1
7977201|NCT02974153|12543135|FG000|Overall Study|Withdrawal by Subject|9
7977202|NCT02974153|12543136|FG001|Overall Study|Withdrawal by Subject|16
7977203|NCT02974153|12543137|FG002|Overall Study|Withdrawal by Subject|11
7977204|NCT02974153|12543135|FG000|Overall Study|Study Burden|8
7977205|NCT02974153|12543136|FG001|Overall Study|Study Burden|7
7977206|NCT02974153|12543137|FG002|Overall Study|Study Burden|3
7977207|NCT02974153|12543135|FG000|Overall Study|Other|14
7977208|NCT02974153|12543136|FG001|Overall Study|Other|8
7977209|NCT02974153|12543137|FG002|Overall Study|Other|7
7977210|NCT02974543|12543156|FG000|Overall Study|Withdrawal by Subject|1
7977211|NCT02974543|12543157|FG001|Overall Study|Withdrawal by Subject|0
7977212|NCT02974634|12543173|FG000|Overall Study|Advanced disease|12
7977213|NCT02974634|12543174|FG001|Overall Study|Advanced disease|3
7977214|NCT02974634|12543173|FG000|Overall Study|Noncompliance|3
7977215|NCT02974634|12543174|FG001|Overall Study|Noncompliance|7
7977216|NCT02974634|12543173|FG000|Overall Study|intervention technology related issues|5
7977217|NCT02974634|12543174|FG001|Overall Study|intervention technology related issues|0
7977218|NCT02974634|12543173|FG000|Overall Study|Death|8
7977219|NCT02974634|12543174|FG001|Overall Study|Death|11
7977220|NCT02974842|12543181|FG000|Overall Study|Withdrawal by Subject|4
7977221|NCT02974842|12543181|FG000|Overall Study|Screen failures|4
7977222|NCT02974855|12543189|FG000|Overall Study|Adverse Event|0
7977223|NCT02974855|12543190|FG001|Overall Study|Adverse Event|1
7977224|NCT02974855|12543191|FG002|Overall Study|Adverse Event|0
7977225|NCT02974855|12543192|FG003|Overall Study|Adverse Event|1
7977226|NCT02974868|12543209|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1
7977227|NCT02974868|12543210|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1
7977228|NCT02974868|12543211|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2
7977229|NCT02974868|12543212|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4
7977230|NCT02974868|12543209|FG000|Initial 24-Week Treatment Period (TP)|others|3
7977231|NCT02974868|12543210|FG001|Initial 24-Week Treatment Period (TP)|others|8
7977232|NCT02974868|12543211|FG002|Initial 24-Week Treatment Period (TP)|others|1
7977233|NCT02974868|12543212|FG003|Initial 24-Week Treatment Period (TP)|others|8
7977234|NCT02974868|12543209|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2
7977235|NCT02974868|12543210|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1
7977236|NCT02974868|12543211|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11
7977237|NCT02974868|12543212|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6
7977238|NCT02974868|12543209|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2
7977239|NCT02974868|12543210|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1
7977240|NCT02974868|12543211|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3
7977241|NCT02974868|12543212|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0
7977242|NCT02975206|12543256|FG000|Overall Study|Withdrawal by Subject|14
7977243|NCT02975206|12543257|FG001|Overall Study|Withdrawal by Subject|11
7977244|NCT02975206|12543258|FG002|Overall Study|Withdrawal by Subject|11
7977245|NCT02975206|12543256|FG000|Overall Study|Other (e.g., lost to follow up)|13
7977246|NCT02975206|12543257|FG001|Overall Study|Other (e.g., lost to follow up)|6
7977247|NCT02975206|12543258|FG002|Overall Study|Other (e.g., lost to follow up)|6
7977248|NCT02975336|12543279|FG000|DBPC (52 Weeks)|Adverse Event|16
7977249|NCT02975336|12543280|FG001|DBPC (52 Weeks)|Adverse Event|17
7977250|NCT02975336|12543281|FG002|DBPC (52 Weeks)|Adverse Event|13
7977251|NCT02975336|12543282|FG003|DBPC (52 Weeks)|Adverse Event|18
7977252|NCT02975336|12543283|FG004|DBPC (52 Weeks)|Adverse Event|0
7977253|NCT02975336|12543284|FG005|DBPC (52 Weeks)|Adverse Event|0
7977254|NCT02975336|12543285|FG006|DBPC (52 Weeks)|Adverse Event|0
7977255|NCT02975336|12543286|FG007|DBPC (52 Weeks)|Adverse Event|0
7977256|NCT02975336|12543279|FG000|DBPC (52 Weeks)|Lost to Follow-up|2
7977257|NCT02975336|12543280|FG001|DBPC (52 Weeks)|Lost to Follow-up|1
7977258|NCT02975336|12543281|FG002|DBPC (52 Weeks)|Lost to Follow-up|2
7977259|NCT02975336|12543282|FG003|DBPC (52 Weeks)|Lost to Follow-up|4
7977260|NCT02975336|12543283|FG004|DBPC (52 Weeks)|Lost to Follow-up|0
7977261|NCT02975336|12543284|FG005|DBPC (52 Weeks)|Lost to Follow-up|0
7977262|NCT02975336|12543285|FG006|DBPC (52 Weeks)|Lost to Follow-up|0
7977263|NCT02975336|12543286|FG007|DBPC (52 Weeks)|Lost to Follow-up|0
7977264|NCT02975336|12543279|FG000|DBPC (52 Weeks)|Protocol Violation|4
7977265|NCT02975336|12543280|FG001|DBPC (52 Weeks)|Protocol Violation|1
7977266|NCT02975336|12543281|FG002|DBPC (52 Weeks)|Protocol Violation|3
7977267|NCT02975336|12543282|FG003|DBPC (52 Weeks)|Protocol Violation|1
7977268|NCT02975336|12543283|FG004|DBPC (52 Weeks)|Protocol Violation|0
7977269|NCT02975336|12543284|FG005|DBPC (52 Weeks)|Protocol Violation|0
7977270|NCT02975336|12543285|FG006|DBPC (52 Weeks)|Protocol Violation|0
7977271|NCT02975336|12543286|FG007|DBPC (52 Weeks)|Protocol Violation|0
7977272|NCT02975336|12543279|FG000|DBPC (52 Weeks)|Lack of Efficacy|4
7977273|NCT02975336|12543280|FG001|DBPC (52 Weeks)|Lack of Efficacy|4
7977274|NCT02975336|12543281|FG002|DBPC (52 Weeks)|Lack of Efficacy|2
7977275|NCT02975336|12543282|FG003|DBPC (52 Weeks)|Lack of Efficacy|3
7977276|NCT02975336|12543283|FG004|DBPC (52 Weeks)|Lack of Efficacy|0
7977277|NCT02975336|12543284|FG005|DBPC (52 Weeks)|Lack of Efficacy|0
7977278|NCT02975336|12543285|FG006|DBPC (52 Weeks)|Lack of Efficacy|0
7977279|NCT02975336|12543286|FG007|DBPC (52 Weeks)|Lack of Efficacy|0
7977280|NCT02975336|12543279|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1
7977281|NCT02975336|12543280|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0
7977282|NCT02975336|12543281|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1
7977283|NCT02975336|12543282|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3
7977284|NCT02975336|12543283|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0
7977285|NCT02975336|12543284|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0
7977286|NCT02975336|12543285|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0
7977287|NCT02975336|12543286|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0
7977288|NCT02975336|12543279|FG000|DBPC (52 Weeks)|Premature termination of the study|5
7977289|NCT02975336|12543280|FG001|DBPC (52 Weeks)|Premature termination of the study|6
7977290|NCT02975336|12543281|FG002|DBPC (52 Weeks)|Premature termination of the study|6
7977291|NCT02975336|12543282|FG003|DBPC (52 Weeks)|Premature termination of the study|4
7977292|NCT02975336|12543283|FG004|DBPC (52 Weeks)|Premature termination of the study|0
7977293|NCT02975336|12543284|FG005|DBPC (52 Weeks)|Premature termination of the study|0
7977294|NCT02975336|12543285|FG006|DBPC (52 Weeks)|Premature termination of the study|0
7977295|NCT02975336|12543286|FG007|DBPC (52 Weeks)|Premature termination of the study|0
7977296|NCT02975336|12543279|FG000|LTE (104 Weeks)|Adverse Event|0
7977297|NCT02975336|12543280|FG001|LTE (104 Weeks)|Adverse Event|0
7977298|NCT02975336|12543281|FG002|LTE (104 Weeks)|Adverse Event|0
7977299|NCT02975336|12543282|FG003|LTE (104 Weeks)|Adverse Event|0
7977300|NCT02975336|12543283|FG004|LTE (104 Weeks)|Adverse Event|7
7977301|NCT02975336|12543284|FG005|LTE (104 Weeks)|Adverse Event|4
7977302|NCT02975336|12543285|FG006|LTE (104 Weeks)|Adverse Event|2
7977303|NCT02975336|12543286|FG007|LTE (104 Weeks)|Adverse Event|0
7718033|NCT00524303|12141720|FG002|Overall Study|Sponsor Request|1
7718034|NCT00524303|12141718|FG000|Overall Study|Physician Decision|0
7718035|NCT00524303|12141719|FG001|Overall Study|Physician Decision|0
7718036|NCT00524303|12141720|FG002|Overall Study|Physician Decision|1
7977304|NCT02975336|12543279|FG000|LTE (104 Weeks)|Lost to Follow-up|0
7977305|NCT02975336|12543280|FG001|LTE (104 Weeks)|Lost to Follow-up|0
7977306|NCT02975336|12543281|FG002|LTE (104 Weeks)|Lost to Follow-up|0
7977307|NCT02975336|12543282|FG003|LTE (104 Weeks)|Lost to Follow-up|0
7977308|NCT02975336|12543283|FG004|LTE (104 Weeks)|Lost to Follow-up|0
7977309|NCT02975336|12543284|FG005|LTE (104 Weeks)|Lost to Follow-up|1
7977310|NCT02975336|12543285|FG006|LTE (104 Weeks)|Lost to Follow-up|0
7977311|NCT02975336|12543286|FG007|LTE (104 Weeks)|Lost to Follow-up|0
7977312|NCT02975336|12543279|FG000|LTE (104 Weeks)|Lack of Efficacy|0
7977313|NCT02975336|12543280|FG001|LTE (104 Weeks)|Lack of Efficacy|0
7977314|NCT02975336|12543281|FG002|LTE (104 Weeks)|Lack of Efficacy|0
7977315|NCT02975336|12543282|FG003|LTE (104 Weeks)|Lack of Efficacy|0
7977316|NCT02975336|12543283|FG004|LTE (104 Weeks)|Lack of Efficacy|0
7977317|NCT02975336|12543284|FG005|LTE (104 Weeks)|Lack of Efficacy|1
7977318|NCT02975336|12543285|FG006|LTE (104 Weeks)|Lack of Efficacy|2
7977319|NCT02975336|12543286|FG007|LTE (104 Weeks)|Lack of Efficacy|0
7977320|NCT02975336|12543279|FG000|LTE (104 Weeks)|Other|0
7977321|NCT02975336|12543280|FG001|LTE (104 Weeks)|Other|0
7977322|NCT02975336|12543281|FG002|LTE (104 Weeks)|Other|0
7977323|NCT02975336|12543282|FG003|LTE (104 Weeks)|Other|0
7977324|NCT02975336|12543283|FG004|LTE (104 Weeks)|Other|55
7977325|NCT02975336|12543284|FG005|LTE (104 Weeks)|Other|63
7977326|NCT02975336|12543285|FG006|LTE (104 Weeks)|Other|76
7977327|NCT02975336|12543286|FG007|LTE (104 Weeks)|Other|72
7977328|NCT02975349|12543305|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7977329|NCT02975349|12543306|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7977330|NCT02975349|12543307|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
7977331|NCT02975349|12543308|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
7977332|NCT02975349|12543309|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7977333|NCT02975349|12543310|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7977334|NCT02975349|12543305|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1
7977335|NCT02975349|12543306|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7977336|NCT02975349|12543307|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7977337|NCT02975349|12543308|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7977338|NCT02975349|12543309|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7977339|NCT02975349|12543310|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7977340|NCT02975349|12543305|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4
7977341|NCT02975349|12543306|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0
7977342|NCT02975349|12543307|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1
7977343|NCT02975349|12543308|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2
7977344|NCT02975349|12543309|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6
7977345|NCT02975349|12543310|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2
7977346|NCT02975349|12543305|FG000|Active Treatment Period (24 Weeks)|Un-specified|0
7977347|NCT02975349|12543306|FG001|Active Treatment Period (24 Weeks)|Un-specified|0
7977348|NCT02975349|12543307|FG002|Active Treatment Period (24 Weeks)|Un-specified|1
7977349|NCT02975349|12543308|FG003|Active Treatment Period (24 Weeks)|Un-specified|0
7977350|NCT02975349|12543309|FG004|Active Treatment Period (24 Weeks)|Un-specified|0
7977351|NCT02975349|12543310|FG005|Active Treatment Period (24 Weeks)|Un-specified|0
7977352|NCT02975349|12543305|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0
7977353|NCT02975349|12543306|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1
7977354|NCT02975349|12543307|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1
7977355|NCT02975349|12543308|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2
7977356|NCT02975349|12543309|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1
7977357|NCT02975349|12543310|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0
7977358|NCT02975349|12543305|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
7977359|NCT02975349|12543306|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5
7977360|NCT02975349|12543307|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2
7977361|NCT02975349|12543308|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
7977362|NCT02975349|12543309|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
7977363|NCT02975349|12543310|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
7977364|NCT02975349|12543305|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7977365|NCT02975349|12543306|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7977366|NCT02975349|12543307|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1
7977367|NCT02975349|12543308|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7977368|NCT02975349|12543309|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7977369|NCT02975349|12543310|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7977370|NCT02975349|12543305|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7977371|NCT02975349|12543306|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1
7977372|NCT02975349|12543307|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7977373|NCT02975349|12543308|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7977374|NCT02975349|12543309|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7977375|NCT02975349|12543310|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7977376|NCT02975349|12543305|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0
7977377|NCT02975349|12543306|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0
7977378|NCT02975349|12543307|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0
7977379|NCT02975349|12543308|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1
7977380|NCT02975349|12543309|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0
7977381|NCT02975349|12543310|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0
7977382|NCT02975973|12543355|FG000|Overall Study|Adverse Event|1
7977383|NCT02975973|12543356|FG001|Overall Study|Adverse Event|1
7977384|NCT02975973|12543357|FG002|Overall Study|Adverse Event|1
7977385|NCT02975973|12543358|FG003|Overall Study|Adverse Event|0
7977386|NCT02976103|12543370|FG000|Overall Study|Withdrawal by Subject|1
7977387|NCT02976103|12543371|FG001|Overall Study|Withdrawal by Subject|0
7977388|NCT02976103|12543370|FG000|Overall Study|Lost to Follow-up|12
7977389|NCT02976103|12543371|FG001|Overall Study|Lost to Follow-up|8
7977390|NCT02976519|12543390|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7977391|NCT02976519|12543391|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1
7977392|NCT02976519|12543392|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7977393|NCT02976519|12543393|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7977394|NCT02976519|12543394|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7977395|NCT02976519|12543395|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7977396|NCT02976519|12543396|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7977397|NCT02976519|12543390|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7977398|NCT02976519|12543391|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7977399|NCT02976519|12543392|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7977400|NCT02976519|12543393|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1
7977401|NCT02976519|12543394|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7977402|NCT02976519|12543395|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7977403|NCT02976519|12543396|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7977404|NCT02976519|12543390|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0
7977405|NCT02976519|12543391|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0
7977406|NCT02976519|12543392|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0
7977407|NCT02976519|12543393|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0
7977408|NCT02976519|12543394|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0
7977409|NCT02976519|12543395|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0
7977410|NCT02976519|12543396|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1
7977411|NCT02976519|12543390|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7977412|NCT02976519|12543391|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7977413|NCT02976519|12543392|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7977414|NCT02976519|12543393|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7977415|NCT02976519|12543394|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7977416|NCT02976519|12543395|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7977417|NCT02976519|12543396|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1
7977418|NCT02976519|12543390|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7977419|NCT02976519|12543391|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7977420|NCT02976519|12543392|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7977421|NCT02976519|12543393|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7977422|NCT02976519|12543394|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7977423|NCT02976519|12543395|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7977424|NCT02976519|12543396|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1
7977425|NCT02977507|12543416|FG000|Overall Study|Protocol Deviation|1
7977426|NCT02977507|12543417|FG001|Overall Study|Protocol Deviation|0
7977427|NCT02977507|12543416|FG000|Overall Study|Lost to Follow-up|1
7977428|NCT02977507|12543417|FG001|Overall Study|Lost to Follow-up|0
7977429|NCT02977572|12543426|FG000|Overall Study|Exclusion criterion|2
7977430|NCT02977572|12543427|FG001|Overall Study|Exclusion criterion|2
7977431|NCT02978417|12543461|FG000|Overall Study|Lost to Follow-up|2
7977432|NCT02978417|12543462|FG001|Overall Study|Lost to Follow-up|2
7977433|NCT02979197|12543489|FG000|Overall Study|Adverse Event|4
7977434|NCT02979197|12543490|FG001|Overall Study|Adverse Event|2
7977435|NCT02979197|12543491|FG002|Overall Study|Adverse Event|0
7977436|NCT02979197|12543489|FG000|Overall Study|Protocol Violation|0
7977437|NCT02979197|12543490|FG001|Overall Study|Protocol Violation|1
7977438|NCT02979197|12543491|FG002|Overall Study|Protocol Violation|0
7977439|NCT02979197|12543489|FG000|Overall Study|Subject unable to commit to study dates|0
7977440|NCT02979197|12543490|FG001|Overall Study|Subject unable to commit to study dates|1
7977441|NCT02979197|12543491|FG002|Overall Study|Subject unable to commit to study dates|0
7977442|NCT02979249|12543499|FG000|Overall Study|Lost to Follow-up|2
7977443|NCT02979249|12543499|FG000|Overall Study|Withdrawal by Subject|4
7977444|NCT02979431|12543525|FG000|Overall Study|Parent/guardian withdrew consent|2
7977445|NCT02979431|12543526|FG001|Overall Study|Parent/guardian withdrew consent|1
7977446|NCT02979431|12543527|FG002|Overall Study|Parent/guardian withdrew consent|1
7977447|NCT02979431|12543528|FG003|Overall Study|Parent/guardian withdrew consent|1
7977448|NCT02979431|12543525|FG000|Overall Study|Randomized but received no study drug|1
7977449|NCT02979431|12543526|FG001|Overall Study|Randomized but received no study drug|1
7977450|NCT02979431|12543527|FG002|Overall Study|Randomized but received no study drug|0
7977451|NCT02979431|12543528|FG003|Overall Study|Randomized but received no study drug|0
7977452|NCT02979431|12543525|FG000|Overall Study|Adverse Event|0
7977453|NCT02979431|12543526|FG001|Overall Study|Adverse Event|0
7977454|NCT02979431|12543527|FG002|Overall Study|Adverse Event|1
7977455|NCT02979431|12543528|FG003|Overall Study|Adverse Event|0
7977456|NCT02979431|12543525|FG000|Overall Study|Subject left country after Day14|1
7977457|NCT02979431|12543526|FG001|Overall Study|Subject left country after Day14|0
7977458|NCT02979431|12543527|FG002|Overall Study|Subject left country after Day14|0
7977459|NCT02979431|12543528|FG003|Overall Study|Subject left country after Day14|0
7977460|NCT02979613|12543553|FG000|Double-Blind Phase|Withdrew Consent|2
7977461|NCT02979613|12543554|FG001|Double-Blind Phase|Withdrew Consent|4
7977462|NCT02979613|12543553|FG000|Double-Blind Phase|Pregnancy|2
7977463|NCT02979613|12543554|FG001|Double-Blind Phase|Pregnancy|2
7977464|NCT02979613|12543553|FG000|Double-Blind Phase|Adverse Event|2
7977465|NCT02979613|12543554|FG001|Double-Blind Phase|Adverse Event|0
7977466|NCT02979613|12543553|FG000|Double-Blind Phase|Lost to Follow-up|1
7977467|NCT02979613|12543554|FG001|Double-Blind Phase|Lost to Follow-up|1
7977468|NCT02979613|12543553|FG000|Double-Blind Phase|Protocol Violation|1
7977469|NCT02979613|12543554|FG001|Double-Blind Phase|Protocol Violation|1
7977470|NCT02979613|12543553|FG000|Double-Blind Phase|Randomized but Never Treated|2
7977471|NCT02979613|12543554|FG001|Double-Blind Phase|Randomized but Never Treated|0
7977472|NCT02979613|12543553|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2
7977473|NCT02979613|12543554|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4
7977474|NCT02979613|12543553|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1
7977475|NCT02979613|12543554|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0
7977476|NCT02979613|12543553|FG000|Open-Label Extension (OLE) Phase|Death|0
7977477|NCT02979613|12543554|FG001|Open-Label Extension (OLE) Phase|Death|1
7977478|NCT02979613|12543553|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0
7977479|NCT02979613|12543554|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1
7977480|NCT02979639|12543571|FG000|Overall Study|Withdrawal based on medical judgement|1
7977481|NCT02979639|12543571|FG000|Overall Study|Lost to Follow-up|8
7977482|NCT02979639|12543571|FG000|Overall Study|Withdrawal by Subject|3
7977483|NCT02979639|12543571|FG000|Overall Study|Adverse Event|2
7977484|NCT02980042|12543595|FG000|Overall Study|Lost to Follow-up|5
7977485|NCT02980042|12543596|FG001|Overall Study|Lost to Follow-up|0
7977486|NCT02980042|12543595|FG000|Overall Study|Insurance issues/treatment plan changes|2
7977487|NCT02980042|12543596|FG001|Overall Study|Insurance issues/treatment plan changes|0
7977488|NCT02980107|12543616|FG000|Overall Study|Withdrawal by Subject|51
7977489|NCT02980107|12543617|FG001|Overall Study|Withdrawal by Subject|62
7977490|NCT02980133|12543627|FG000|Overall Study|Other than specified|1
7977491|NCT02980133|12543628|FG001|Overall Study|Other than specified|1
7977492|NCT02980133|12543629|FG002|Overall Study|Other than specified|2
7977493|NCT02980133|12543630|FG003|Overall Study|Other than specified|2
7977494|NCT02980133|12543627|FG000|Overall Study|Lost to Follow-up|0
7977495|NCT02980133|12543628|FG001|Overall Study|Lost to Follow-up|0
7977496|NCT02980133|12543629|FG002|Overall Study|Lost to Follow-up|1
7977497|NCT02980133|12543630|FG003|Overall Study|Lost to Follow-up|3
7977498|NCT02980133|12543627|FG000|Overall Study|Protocol Violation|0
7977499|NCT02980133|12543628|FG001|Overall Study|Protocol Violation|1
7977500|NCT02980133|12543629|FG002|Overall Study|Protocol Violation|0
7977501|NCT02980133|12543630|FG003|Overall Study|Protocol Violation|0
7977502|NCT02980133|12543627|FG000|Overall Study|Withdrawal by parent/guardian|6
7977503|NCT02980133|12543628|FG001|Overall Study|Withdrawal by parent/guardian|3
7977504|NCT02980133|12543629|FG002|Overall Study|Withdrawal by parent/guardian|3
7977505|NCT02980133|12543630|FG003|Overall Study|Withdrawal by parent/guardian|1
7977506|NCT02980133|12543627|FG000|Overall Study|Withdrawal by Subject|0
7977507|NCT02980133|12543628|FG001|Overall Study|Withdrawal by Subject|0
7977508|NCT02980133|12543629|FG002|Overall Study|Withdrawal by Subject|1
7977509|NCT02980133|12543630|FG003|Overall Study|Withdrawal by Subject|0
7977510|NCT02980224|12543649|FG000|Overall Study|Adverse Event|4
7977511|NCT02980224|12543650|FG001|Overall Study|Adverse Event|1
7977512|NCT02980224|12543649|FG000|Overall Study|Withdrawal by Subject|0
7977513|NCT02980224|12543650|FG001|Overall Study|Withdrawal by Subject|2
7977514|NCT02980523|12543661|FG000|Overall Study|Lost to Follow-up|1
7977515|NCT02980523|12543662|FG001|Overall Study|Lost to Follow-up|4
7977516|NCT02980523|12543663|FG002|Overall Study|Lost to Follow-up|1
7977517|NCT02980523|12543664|FG003|Overall Study|Lost to Follow-up|2
7977518|NCT02980523|12543665|FG004|Overall Study|Lost to Follow-up|1
7977519|NCT02980523|12543661|FG000|Overall Study|Excluded from analysis|1
7977520|NCT02980523|12543662|FG001|Overall Study|Excluded from analysis|3
7977521|NCT02980523|12543663|FG002|Overall Study|Excluded from analysis|1
7907551|NCT02020616|12422374|FG002|Overall Study|Adverse Event|0
7907552|NCT02020616|12422375|FG003|Overall Study|Adverse Event|0
7907553|NCT02020616|12422376|FG004|Overall Study|Adverse Event|0
7907554|NCT02020616|12422377|FG005|Overall Study|Adverse Event|1
7907555|NCT02020616|12422378|FG006|Overall Study|Adverse Event|1
7907556|NCT02020616|12422372|FG000|Overall Study|Physician Decision|0
7907557|NCT02020616|12422373|FG001|Overall Study|Physician Decision|0
7907558|NCT02020616|12422374|FG002|Overall Study|Physician Decision|0
7907559|NCT02020616|12422375|FG003|Overall Study|Physician Decision|0
7907560|NCT02020616|12422376|FG004|Overall Study|Physician Decision|0
7907561|NCT02020616|12422377|FG005|Overall Study|Physician Decision|1
7907562|NCT02020616|12422378|FG006|Overall Study|Physician Decision|2
7907563|NCT02020616|12422372|FG000|Overall Study|Withdrawal by Subject|0
7977522|NCT02980523|12543664|FG003|Overall Study|Excluded from analysis|1
7977523|NCT02980523|12543665|FG004|Overall Study|Excluded from analysis|1
7977524|NCT02980523|12543661|FG000|Overall Study|Lack of Efficacy|1
7977525|NCT02980523|12543662|FG001|Overall Study|Lack of Efficacy|4
7977526|NCT02980523|12543663|FG002|Overall Study|Lack of Efficacy|4
7977527|NCT02980523|12543664|FG003|Overall Study|Lack of Efficacy|5
7977528|NCT02980523|12543665|FG004|Overall Study|Lack of Efficacy|8
7977529|NCT02980523|12543661|FG000|Overall Study|Did not receive intervention|0
7977530|NCT02980523|12543662|FG001|Overall Study|Did not receive intervention|0
7977531|NCT02980523|12543663|FG002|Overall Study|Did not receive intervention|0
7977532|NCT02980523|12543664|FG003|Overall Study|Did not receive intervention|1
7977533|NCT02980523|12543665|FG004|Overall Study|Did not receive intervention|0
7977534|NCT02980601|12543682|FG000|Overall Study|Lost to Follow-up|2
7977535|NCT02980601|12543683|FG001|Overall Study|Lost to Follow-up|2
7977536|NCT02980601|12543682|FG000|Overall Study|Death|0
7977537|NCT02980601|12543683|FG001|Overall Study|Death|1
7977538|NCT02980601|12543682|FG000|Overall Study|Graft loss|1
7977539|NCT02980601|12543683|FG001|Overall Study|Graft loss|0
7977540|NCT02980601|12543682|FG000|Overall Study|Failed to sign consent|2
7977541|NCT02980601|12543683|FG001|Overall Study|Failed to sign consent|0
7977542|NCT02980692|12543694|FG000|Overall Study|Adverse Event|0
7977543|NCT02980692|12543695|FG001|Overall Study|Adverse Event|2
7977544|NCT02980692|12543696|FG002|Overall Study|Adverse Event|0
7977545|NCT02980692|12543697|FG003|Overall Study|Adverse Event|0
7977546|NCT02980692|12543698|FG004|Overall Study|Adverse Event|1
7977547|NCT02980692|12543694|FG000|Overall Study|Withdrawal by Subject|4
7977548|NCT02980692|12543695|FG001|Overall Study|Withdrawal by Subject|3
7977549|NCT02980692|12543696|FG002|Overall Study|Withdrawal by Subject|6
7977550|NCT02980692|12543697|FG003|Overall Study|Withdrawal by Subject|6
7977551|NCT02980692|12543698|FG004|Overall Study|Withdrawal by Subject|7
7977552|NCT02980692|12543694|FG000|Overall Study|Lost to Follow-up|3
7977553|NCT02980692|12543695|FG001|Overall Study|Lost to Follow-up|0
7977554|NCT02980692|12543696|FG002|Overall Study|Lost to Follow-up|4
7977555|NCT02980692|12543697|FG003|Overall Study|Lost to Follow-up|1
7977556|NCT02980692|12543698|FG004|Overall Study|Lost to Follow-up|1
7977557|NCT02980692|12543694|FG000|Overall Study|Death|1
7977558|NCT02980692|12543695|FG001|Overall Study|Death|0
7977559|NCT02980692|12543696|FG002|Overall Study|Death|0
7977560|NCT02980692|12543697|FG003|Overall Study|Death|0
7977561|NCT02980692|12543698|FG004|Overall Study|Death|0
7977562|NCT02980692|12543694|FG000|Overall Study|Physician Decision|0
7977563|NCT02980692|12543695|FG001|Overall Study|Physician Decision|0
7977564|NCT02980692|12543696|FG002|Overall Study|Physician Decision|1
7977565|NCT02980692|12543697|FG003|Overall Study|Physician Decision|1
7977566|NCT02980692|12543698|FG004|Overall Study|Physician Decision|0
7977567|NCT02980692|12543694|FG000|Overall Study|NON COMPLIANCE|1
7977568|NCT02980692|12543695|FG001|Overall Study|NON COMPLIANCE|0
7977569|NCT02980692|12543696|FG002|Overall Study|NON COMPLIANCE|0
7977570|NCT02980692|12543697|FG003|Overall Study|NON COMPLIANCE|0
7977571|NCT02980692|12543698|FG004|Overall Study|NON COMPLIANCE|0
7977572|NCT02980692|12543694|FG000|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
7977573|NCT02980692|12543695|FG001|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|1
7977574|NCT02980692|12543696|FG002|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
7977575|NCT02980692|12543697|FG003|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
7977576|NCT02980692|12543698|FG004|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
7977577|NCT02980692|12543694|FG000|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7977578|NCT02980692|12543695|FG001|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7977579|NCT02980692|12543696|FG002|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|1
7977580|NCT02980692|12543697|FG003|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7977581|NCT02980692|12543698|FG004|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7977582|NCT02980692|12543694|FG000|Overall Study|Lack of Efficacy|0
7977583|NCT02980692|12543695|FG001|Overall Study|Lack of Efficacy|0
7977584|NCT02980692|12543696|FG002|Overall Study|Lack of Efficacy|0
7977585|NCT02980692|12543697|FG003|Overall Study|Lack of Efficacy|1
7977586|NCT02980692|12543698|FG004|Overall Study|Lack of Efficacy|0
7977587|NCT02980692|12543694|FG000|Overall Study|RELOCATION|0
7977588|NCT02980692|12543695|FG001|Overall Study|RELOCATION|0
7977589|NCT02980692|12543696|FG002|Overall Study|RELOCATION|0
7977590|NCT02980692|12543697|FG003|Overall Study|RELOCATION|0
7977591|NCT02980692|12543698|FG004|Overall Study|RELOCATION|1
7977592|NCT02980692|12543694|FG000|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7977593|NCT02980692|12543695|FG001|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7977594|NCT02980692|12543696|FG002|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7977595|NCT02980692|12543697|FG003|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7977596|NCT02980692|12543698|FG004|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|1
7977597|NCT02980705|12543713|FG000|Overall Study|Adverse Event|0
7977598|NCT02980705|12543714|FG001|Overall Study|Adverse Event|1
7977599|NCT02980705|12543713|FG000|Overall Study|Withdrawal by Subject|6
7977600|NCT02980705|12543714|FG001|Overall Study|Withdrawal by Subject|9
7977601|NCT02980705|12543713|FG000|Overall Study|withdrew participation|0
7977602|NCT02980705|12543714|FG001|Overall Study|withdrew participation|1
7977603|NCT02980705|12543713|FG000|Overall Study|Lost to Follow-up|2
7977604|NCT02980705|12543714|FG001|Overall Study|Lost to Follow-up|0
7977605|NCT02980783|12543721|FG000|Overall Study|Lost to Follow-up|1
7977606|NCT02980874|12543727|FG000|Overall Study|Adverse Event|2
7977607|NCT02980874|12543728|FG001|Overall Study|Adverse Event|7
7977608|NCT02980874|12543727|FG000|Overall Study|Withdrawal by Subject|7
7977609|NCT02980874|12543728|FG001|Overall Study|Withdrawal by Subject|2
7977610|NCT02980874|12543727|FG000|Overall Study|Lost to Follow-up|5
7977611|NCT02980874|12543728|FG001|Overall Study|Lost to Follow-up|5
7977612|NCT02980874|12543727|FG000|Overall Study|Includes premature discontinuation due to study termination.|88
7977613|NCT02980874|12543728|FG001|Overall Study|Includes premature discontinuation due to study termination.|88
7977614|NCT02980874|12543727|FG000|Overall Study|Unknown study completion status|1
7977615|NCT02980874|12543728|FG001|Overall Study|Unknown study completion status|0
7977616|NCT02981342|12543747|FG000|Overall Study|Adverse Event|0
7977617|NCT02981342|12543748|FG001|Overall Study|Adverse Event|0
7977618|NCT02981342|12543749|FG002|Overall Study|Adverse Event|0
7977619|NCT02981342|12543750|FG003|Overall Study|Adverse Event|1
7977620|NCT02981342|12543747|FG000|Overall Study|Death|0
7977621|NCT02981342|12543748|FG001|Overall Study|Death|9
7977622|NCT02981342|12543749|FG002|Overall Study|Death|9
7977623|NCT02981342|12543750|FG003|Overall Study|Death|4
7977624|NCT02981342|12543747|FG000|Overall Study|Withdrawal by Subject|0
7977625|NCT02981342|12543748|FG001|Overall Study|Withdrawal by Subject|0
7977626|NCT02981342|12543749|FG002|Overall Study|Withdrawal by Subject|3
7977627|NCT02981342|12543750|FG003|Overall Study|Withdrawal by Subject|1
7977628|NCT02981342|12543747|FG000|Overall Study|Study closed by sponsor|0
7977629|NCT02981342|12543748|FG001|Overall Study|Study closed by sponsor|0
7977630|NCT02981342|12543749|FG002|Overall Study|Study closed by sponsor|1
7977631|NCT02981342|12543750|FG003|Overall Study|Study closed by sponsor|1
7977632|NCT02981342|12543747|FG000|Overall Study|Randomized, Never Treated|0
7977633|NCT02981342|12543748|FG001|Overall Study|Randomized, Never Treated|1
7977634|NCT02981342|12543749|FG002|Overall Study|Randomized, Never Treated|0
7977635|NCT02981342|12543750|FG003|Overall Study|Randomized, Never Treated|7
7977636|NCT02981342|12543747|FG000|Overall Study|Lost to Follow-up|0
7977637|NCT02981342|12543748|FG001|Overall Study|Lost to Follow-up|1
7977638|NCT02981342|12543749|FG002|Overall Study|Lost to Follow-up|0
7977639|NCT02981342|12543750|FG003|Overall Study|Lost to Follow-up|0
7977640|NCT02981524|12543798|FG000|Overall Study|Progressive Disease|14
7977641|NCT02981524|12543798|FG000|Overall Study|Death (unrelated)|1
7977642|NCT02981524|12543798|FG000|Overall Study|Treatment Related Toxicity|1
7977643|NCT02981524|12543798|FG000|Overall Study|Withdrawal by Subject|1
7977644|NCT02981602|12543807|FG000|Overall Study|Adverse Event|0
7977645|NCT02981602|12543808|FG001|Overall Study|Adverse Event|0
7977646|NCT02981602|12543809|FG002|Overall Study|Adverse Event|0
7977647|NCT02981602|12543810|FG003|Overall Study|Adverse Event|1
7977648|NCT02981602|12543811|FG004|Overall Study|Adverse Event|0
7977649|NCT02981953|12543824|FG000|Overall Study|Death|9
7977650|NCT02981953|12543824|FG000|Overall Study|Withdrawal by Subject|1
7977651|NCT02981953|12543824|FG000|Overall Study|Withdrawal to non-compliance|1
7977652|NCT02982018|12543830|FG000|Overall Study|Incorrect Lens Dispensed|1
7977653|NCT02982018|12543831|FG001|Overall Study|Incorrect Lens Dispensed|0
7977654|NCT02982018|12543830|FG000|Overall Study|Protocol Violation|1
7977655|NCT02982018|12543831|FG001|Overall Study|Protocol Violation|1
7977656|NCT02982018|12543830|FG000|Overall Study|Adverse Event|1
7977657|NCT02982018|12543831|FG001|Overall Study|Adverse Event|1
7977658|NCT02982018|12543830|FG000|Overall Study|Lens Discomfort|2
7977659|NCT02982018|12543831|FG001|Overall Study|Lens Discomfort|0
7977660|NCT02982018|12543830|FG000|Overall Study|Withdrawal by Subject|0
7977661|NCT02982018|12543831|FG001|Overall Study|Withdrawal by Subject|1
7977662|NCT02982187|12543839|FG000|Overall Study|Withdrawal by Subject|0
7977663|NCT02982187|12543840|FG001|Overall Study|Withdrawal by Subject|0
7977664|NCT02982187|12543841|FG002|Overall Study|Withdrawal by Subject|0
7977665|NCT02982187|12543842|FG003|Overall Study|Withdrawal by Subject|0
7977666|NCT02982187|12543843|FG004|Overall Study|Withdrawal by Subject|0
7977667|NCT02982187|12543844|FG005|Overall Study|Withdrawal by Subject|0
7977668|NCT02982187|12543845|FG006|Overall Study|Withdrawal by Subject|1
7977669|NCT02982187|12543846|FG007|Overall Study|Withdrawal by Subject|0
7977670|NCT02982213|12543858|FG000|Overall Study|Did not complete follow up questionnaire|5
7977671|NCT02982213|12543859|FG001|Overall Study|Did not complete follow up questionnaire|1
7977672|NCT02982239|12543867|FG000|Overall Study|Lost to Follow-up|3
7977673|NCT02982239|12543868|FG001|Overall Study|Lost to Follow-up|2
7977674|NCT02982590|12543877|FG000|Overall Study|Lost to Follow-up|0
7977675|NCT02982590|12543878|FG001|Overall Study|Lost to Follow-up|1
7977676|NCT02982590|12543877|FG000|Overall Study|Death|4
7977677|NCT02982590|12543878|FG001|Overall Study|Death|0
7977678|NCT02982772|12543886|FG000|Intervention|Lost to Follow-up|19
7977679|NCT02982772|12543887|FG001|Intervention|Lost to Follow-up|13
7977680|NCT02982772|12543886|FG000|1M Follow-Up|Lost to Follow-up|21
7977681|NCT02982772|12543887|FG001|1M Follow-Up|Lost to Follow-up|18
7977682|NCT02982772|12543886|FG000|3M Follow-Up|Lost to Follow-up|17
7977683|NCT02982772|12543887|FG001|3M Follow-Up|Lost to Follow-up|11
7977684|NCT02982772|12543886|FG000|6M Follow-Up|Lost to Follow-up|11
7977685|NCT02982772|12543887|FG001|6M Follow-Up|Lost to Follow-up|9
7977686|NCT02982772|12543886|FG000|12M Follow-Up|Lost to Follow-up|11
7977687|NCT02982772|12543887|FG001|12M Follow-Up|Lost to Follow-up|5
7977688|NCT02982863|12543900|FG000|Overall Study|Not eligible patients|809
7977689|NCT02982863|12543901|FG001|Overall Study|Not eligible patients|4261
7977690|NCT02982863|12543902|FG002|Overall Study|Not eligible patients|1852
7977691|NCT02982863|12543903|FG003|Overall Study|Not eligible patients|1400
7977692|NCT02982863|12543904|FG004|Overall Study|Not eligible patients|492
7977693|NCT02983227|12543935|FG000|Overall Study|Adverse Event|21
7977694|NCT02983227|12543936|FG001|Overall Study|Adverse Event|3
7977695|NCT02983227|12543935|FG000|Overall Study|Death|3
7977696|NCT02983227|12543936|FG001|Overall Study|Death|0
7977697|NCT02983227|12543935|FG000|Overall Study|Lack of Efficacy|8
7977698|NCT02983227|12543936|FG001|Overall Study|Lack of Efficacy|1
7977699|NCT02983227|12543935|FG000|Overall Study|Lost to Follow-up|3
7977700|NCT02983227|12543936|FG001|Overall Study|Lost to Follow-up|0
7977701|NCT02983227|12543935|FG000|Overall Study|Multiple Reasons|2
7977702|NCT02983227|12543936|FG001|Overall Study|Multiple Reasons|1
7977703|NCT02983227|12543935|FG000|Overall Study|Physician Decision|3
7977704|NCT02983227|12543936|FG001|Overall Study|Physician Decision|1
7977705|NCT02983227|12543935|FG000|Overall Study|Withdrawal by Subject|19
7977706|NCT02983227|12543936|FG001|Overall Study|Withdrawal by Subject|8
7977707|NCT02983305|12543944|FG000|Overall Study|incomplete data|2
7977708|NCT02983305|12543945|FG001|Overall Study|incomplete data|0
7977709|NCT02983604|12543985|FG000|Overall Study|Enrolled but not Treated|0
7977710|NCT02983604|12543986|FG001|Overall Study|Enrolled but not Treated|0
7977711|NCT02983604|12543987|FG002|Overall Study|Enrolled but not Treated|1
7977712|NCT02983604|12543988|FG003|Overall Study|Enrolled but not Treated|0
7977713|NCT02984267|12544013|FG000|Overall Study|Protocol Violation|1
7977714|NCT02984267|12544014|FG001|Overall Study|Protocol Violation|0
7977715|NCT02984267|12544013|FG000|Overall Study|Withdrawal by Subject|0
7977716|NCT02984267|12544014|FG001|Overall Study|Withdrawal by Subject|1
7977717|NCT02984683|12544052|FG000|Overall Study|Adverse Event|3
7977718|NCT02984683|12544053|FG001|Overall Study|Adverse Event|3
7977719|NCT02984683|12544052|FG000|Overall Study|Withdrawal by Subject|1
7977720|NCT02984683|12544053|FG001|Overall Study|Withdrawal by Subject|0
7977721|NCT02984683|12544052|FG000|Overall Study|Disease progression|7
7977722|NCT02984683|12544053|FG001|Overall Study|Disease progression|9
7977723|NCT02984943|12544082|FG000|Overall Study|Withdrawal by Subject|3
7977724|NCT02984943|12544082|FG000|Overall Study|Physician Decision|1
7977725|NCT02984982|12544088|FG000|Overall Study|Adverse Event|2
7977726|NCT02984982|12544089|FG001|Overall Study|Adverse Event|5
7977727|NCT02984982|12544088|FG000|Overall Study|Poor Compliance to Protocol|4
7977728|NCT02984982|12544089|FG001|Overall Study|Poor Compliance to Protocol|4
7977729|NCT02984982|12544088|FG000|Overall Study|Withdrawal by Subject|2
7977730|NCT02984982|12544089|FG001|Overall Study|Withdrawal by Subject|0
7977731|NCT02984982|12544088|FG000|Overall Study|Randomized but not treated|0
7977732|NCT02984982|12544089|FG001|Overall Study|Randomized but not treated|1
7977733|NCT02984995|12544098|FG000|Overall Study|Required stem cell transplant|13
7977734|NCT02984995|12544099|FG001|Overall Study|Required stem cell transplant|2
7977735|NCT02984995|12544098|FG000|Overall Study|Progressive disease|11
7977736|NCT02984995|12544099|FG001|Overall Study|Progressive disease|1
7977737|NCT02984995|12544098|FG000|Overall Study|Adverse Event|1
7977738|NCT02984995|12544099|FG001|Overall Study|Adverse Event|0
7977739|NCT02985021|12544111|FG000|Overall Study|Inability to comply with study procedures|1
7977740|NCT02985398|12544115|FG000|Overall Study|Adverse Event|1
7977741|NCT02985398|12544115|FG000|Overall Study|Lost to Follow-up|4
7977742|NCT02985398|12544115|FG000|Overall Study|Withdrawal by Subject|8
7977743|NCT02985398|12544115|FG000|Overall Study|Study Burden|9
7977744|NCT02985450|12544119|FG000|Overall Study|Lost to Follow-up|7
7977745|NCT02985879|12544147|FG000|Overall Study|Adverse Event|7
7977746|NCT02985879|12544148|FG001|Overall Study|Adverse Event|9
7977747|NCT02985879|12544149|FG002|Overall Study|Adverse Event|7
7977748|NCT02985879|12544147|FG000|Overall Study|Withdrew consent|6
7977749|NCT02985879|12544148|FG001|Overall Study|Withdrew consent|8
7977750|NCT02985879|12544149|FG002|Overall Study|Withdrew consent|10
7977751|NCT02985879|12544147|FG000|Overall Study|Lost to Follow-up|1
7977752|NCT02985879|12544148|FG001|Overall Study|Lost to Follow-up|0
7977753|NCT02985879|12544149|FG002|Overall Study|Lost to Follow-up|2
7977754|NCT02985879|12544147|FG000|Overall Study|Other, not specified|62
7977755|NCT02985879|12544148|FG001|Overall Study|Other, not specified|58
7977756|NCT02985879|12544149|FG002|Overall Study|Other, not specified|58
7977757|NCT02985996|12544168|FG000|Overall Study|Withdrawal by Subject|0
7977758|NCT02985996|12544169|FG001|Overall Study|Withdrawal by Subject|0
7977759|NCT02985996|12544170|FG002|Overall Study|Withdrawal by Subject|1
7977760|NCT02985996|12544171|FG003|Overall Study|Withdrawal by Subject|0
7977761|NCT02985996|12544172|FG004|Overall Study|Withdrawal by Subject|0
7977762|NCT02985996|12544168|FG000|Overall Study|Protocol Violation|0
7977763|NCT02985996|12544169|FG001|Overall Study|Protocol Violation|1
7977764|NCT02985996|12544170|FG002|Overall Study|Protocol Violation|0
7977765|NCT02985996|12544171|FG003|Overall Study|Protocol Violation|0
7977766|NCT02985996|12544172|FG004|Overall Study|Protocol Violation|0
7977767|NCT02986074|12544188|FG000|First Trial Period|Adverse Event|1
7977768|NCT02986074|12544189|FG001|First Trial Period|Adverse Event|0
7977769|NCT02986074|12544190|FG002|First Trial Period|Adverse Event|0
7977770|NCT02986074|12544191|FG003|First Trial Period|Adverse Event|0
7977771|NCT02986074|12544188|FG000|Follow up Period|system explant|0
7977772|NCT02986074|12544189|FG001|Follow up Period|system explant|0
7977773|NCT02986074|12544190|FG002|Follow up Period|system explant|1
7977774|NCT02986074|12544191|FG003|Follow up Period|system explant|2
7977775|NCT02986074|12544188|FG000|Follow up Period|Physician Decision|0
7977776|NCT02986074|12544189|FG001|Follow up Period|Physician Decision|0
7977777|NCT02986074|12544190|FG002|Follow up Period|Physician Decision|0
7977778|NCT02986074|12544191|FG003|Follow up Period|Physician Decision|1
7977779|NCT02986139|12544198|FG000|Overall Study|Sponsor Decision|1
7977780|NCT02986139|12544199|FG001|Overall Study|Sponsor Decision|2
7977781|NCT02986139|12544198|FG000|Overall Study|Withdrawal by Subject|0
7977782|NCT02986139|12544199|FG001|Overall Study|Withdrawal by Subject|1
7977783|NCT02986139|12544198|FG000|Overall Study|Lost to Follow-up|0
7977784|NCT02986139|12544199|FG001|Overall Study|Lost to Follow-up|1
7977785|NCT02986373|12544213|FG000|Overall Study|Adverse Event|4
7977786|NCT02986373|12544213|FG000|Overall Study|Lost to Follow-up|1
7977787|NCT02986373|12544213|FG000|Overall Study|Withdrawal by Subject|10
7977788|NCT02986373|12544213|FG000|Overall Study|Other|24
7977789|NCT02986854|12544246|FG000|Overall Study|Withdrawal by Subject|0
7977790|NCT02986854|12544247|FG001|Overall Study|Withdrawal by Subject|1
7977791|NCT02986854|12544248|FG002|Overall Study|Withdrawal by Subject|1
7977792|NCT02986854|12544246|FG000|Overall Study|Lost to Follow-up|3
7977793|NCT02986854|12544247|FG001|Overall Study|Lost to Follow-up|11
7977794|NCT02986854|12544248|FG002|Overall Study|Lost to Follow-up|2
7977795|NCT02987205|12544267|FG000|Overall Study|Adverse Event|1
7977796|NCT02987205|12544267|FG000|Overall Study|Withdrawal by Subject|3
7977797|NCT02987660|12544297|FG000|Overall Study|Study terminated by sponsor|10
7977798|NCT02987660|12544298|FG001|Overall Study|Study terminated by sponsor|10
7977799|NCT02987972|12544342|FG000|Overall Study|Adverse Event|1
7977800|NCT02987972|12544343|FG001|Overall Study|Adverse Event|1
7977801|NCT02987972|12544344|FG002|Overall Study|Adverse Event|0
7977802|NCT02987972|12544342|FG000|Overall Study|Death|1
7977803|NCT02987972|12544343|FG001|Overall Study|Death|0
7977804|NCT02987972|12544344|FG002|Overall Study|Death|0
7977805|NCT02987972|12544342|FG000|Overall Study|Lack of Efficacy|9
7977806|NCT02987972|12544343|FG001|Overall Study|Lack of Efficacy|12
7977807|NCT02987972|12544344|FG002|Overall Study|Lack of Efficacy|12
7977808|NCT02987972|12544342|FG000|Overall Study|Lost to Follow-up|7
7977809|NCT02987972|12544343|FG001|Overall Study|Lost to Follow-up|8
7977810|NCT02987972|12544344|FG002|Overall Study|Lost to Follow-up|4
7977811|NCT02987972|12544342|FG000|Overall Study|Physician Decision|1
7977812|NCT02987972|12544343|FG001|Overall Study|Physician Decision|6
7977813|NCT02987972|12544344|FG002|Overall Study|Physician Decision|0
7977814|NCT02987972|12544342|FG000|Overall Study|Protocol Violation|2
7977815|NCT02987972|12544343|FG001|Overall Study|Protocol Violation|1
7977816|NCT02987972|12544344|FG002|Overall Study|Protocol Violation|5
7977817|NCT02987972|12544342|FG000|Overall Study|Withdrawal by Subject|22
7977818|NCT02987972|12544343|FG001|Overall Study|Withdrawal by Subject|17
7977819|NCT02987972|12544344|FG002|Overall Study|Withdrawal by Subject|21
7977820|NCT02988115|12544363|FG000|Overall Study|Adverse Event|6
7977821|NCT02988115|12544364|FG001|Overall Study|Adverse Event|1
7977822|NCT02988115|12544363|FG000|Overall Study|Sponsor Decision|5
7977823|NCT02988115|12544364|FG001|Overall Study|Sponsor Decision|2
7977824|NCT02988115|12544363|FG000|Overall Study|Withdrawal by Subject|1
7977825|NCT02988115|12544364|FG001|Overall Study|Withdrawal by Subject|1
7977826|NCT02988115|12544363|FG000|Overall Study|Withdrawn by Mistake|1
7977827|NCT02988115|12544364|FG001|Overall Study|Withdrawn by Mistake|0
7977828|NCT02988115|12544363|FG000|Overall Study|Lost to Follow-up|1
7977829|NCT02988115|12544364|FG001|Overall Study|Lost to Follow-up|0
7977830|NCT02988219|12544381|FG000|Overall Study|Lack of Efficacy|1
7977831|NCT02988219|12544382|FG001|Overall Study|Lack of Efficacy|1
7977832|NCT02988219|12544381|FG000|Overall Study|Withdrawal by Subject|0
7977833|NCT02988219|12544382|FG001|Overall Study|Withdrawal by Subject|2
7977834|NCT02988622|12544397|FG000|Overall Study|Lost to Follow-up|17
7977835|NCT02989168|12544427|FG000|Overall Study|Withdrawal by Subject|2
7977836|NCT02989168|12544428|FG001|Overall Study|Withdrawal by Subject|0
7977837|NCT02989168|12544427|FG000|Overall Study|Physician Decision|0
7977838|NCT02989168|12544428|FG001|Overall Study|Physician Decision|1
7977839|NCT02989168|12544427|FG000|Overall Study|Adverse Event|1
7977840|NCT02989168|12544428|FG001|Overall Study|Adverse Event|2
7977841|NCT02989168|12544427|FG000|Overall Study|Sponsor stopped study.|1
7977842|NCT02989168|12544428|FG001|Overall Study|Sponsor stopped study.|0
7977843|NCT02989389|12544450|FG000|Period 1|Lost to Follow-up|0
7977844|NCT02989389|12544451|FG001|Period 1|Lost to Follow-up|1
7977845|NCT02989389|12544452|FG002|Period 1|Lost to Follow-up|0
7977846|NCT02989389|12544453|FG003|Period 1|Lost to Follow-up|0
7977847|NCT02989389|12544454|FG004|Period 1|Lost to Follow-up|0
7977848|NCT02989389|12544455|FG005|Period 1|Lost to Follow-up|0
7977849|NCT02989389|12544456|FG006|Period 1|Lost to Follow-up|0
7977850|NCT02989389|12544457|FG007|Period 1|Lost to Follow-up|0
7977851|NCT02989389|12544458|FG008|Period 1|Lost to Follow-up|0
7977852|NCT02989389|12544459|FG009|Period 1|Lost to Follow-up|0
7977853|NCT02989389|12544450|FG000|Period 1|Physician Decision|0
7977854|NCT02989389|12544451|FG001|Period 1|Physician Decision|0
7977855|NCT02989389|12544452|FG002|Period 1|Physician Decision|0
7977856|NCT02989389|12544453|FG003|Period 1|Physician Decision|0
7977857|NCT02989389|12544454|FG004|Period 1|Physician Decision|0
7977858|NCT02989389|12544455|FG005|Period 1|Physician Decision|0
7977859|NCT02989389|12544456|FG006|Period 1|Physician Decision|0
7977860|NCT02989389|12544457|FG007|Period 1|Physician Decision|0
7977861|NCT02989389|12544458|FG008|Period 1|Physician Decision|1
7977862|NCT02989389|12544459|FG009|Period 1|Physician Decision|0
7977863|NCT02989610|12544516|FG000|Overall Study|Withdrawal/Other reasons|39
7977864|NCT02989649|12544520|FG000|Overall Study|Patient/Investigator's Decision to Stop|403
7977865|NCT02989649|12544520|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1
7977866|NCT02989649|12544520|FG000|Overall Study|Lost For Observation During Study|3
7977867|NCT02989649|12544520|FG000|Overall Study|Reason Not Specified|13
7977868|NCT02989805|12544546|FG000|Overall Study|invalid consent|6
7977869|NCT02989805|12544547|FG001|Overall Study|invalid consent|4
7977870|NCT02990000|12544555|FG000|Overall Study|Failed to provide data beyond baseline|36
7977871|NCT02990000|12544556|FG001|Overall Study|Failed to provide data beyond baseline|34
7977872|NCT02990910|12544564|FG000|Overall Study|Lack of Efficacy|6
7977873|NCT02990910|12544565|FG001|Overall Study|Lack of Efficacy|10
7977874|NCT02991040|12544571|FG000|Overall Study|Withdrawal by Subject|2
7977875|NCT02991040|12544571|FG000|Overall Study|Lost to Follow-up|2
7977876|NCT02991118|12544579|FG000|Overall Study|Death|3
7977877|NCT02991118|12544580|FG001|Overall Study|Death|8
7977878|NCT02991118|12544579|FG000|Overall Study|Protocol Violation|0
7977879|NCT02991118|12544580|FG001|Overall Study|Protocol Violation|3
7977880|NCT02991118|12544579|FG000|Overall Study|Physician Decision|0
7977881|NCT02991118|12544580|FG001|Overall Study|Physician Decision|1
7977882|NCT02991118|12544579|FG000|Overall Study|Moved out of the country|0
7977883|NCT02991118|12544580|FG001|Overall Study|Moved out of the country|1
7977884|NCT02991118|12544579|FG000|Overall Study|Adverse Event|2
7977885|NCT02991118|12544580|FG001|Overall Study|Adverse Event|2
7977886|NCT02991118|12544579|FG000|Overall Study|Withdrawal by Subject|1
7977887|NCT02991118|12544580|FG001|Overall Study|Withdrawal by Subject|7
7977888|NCT02991118|12544579|FG000|Overall Study|Could not attend study visits|0
7977889|NCT02991118|12544580|FG001|Overall Study|Could not attend study visits|1
7977890|NCT02991118|12544579|FG000|Overall Study|Lost to Follow-up|1
7977891|NCT02991118|12544580|FG001|Overall Study|Lost to Follow-up|9
7977892|NCT02991859|12544625|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7977893|NCT02991859|12544626|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
7977894|NCT02991859|12544627|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7977895|NCT02991859|12544628|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7977896|NCT02991859|12544629|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
7977897|NCT02991859|12544630|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7977898|NCT02991859|12544631|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7977899|NCT02991859|12544632|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7977900|NCT02991859|12544633|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7977901|NCT02991859|12544634|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7977902|NCT02991859|12544635|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7977903|NCT02991859|12544636|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7977904|NCT02991859|12544637|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7977905|NCT02991859|12544638|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7977906|NCT02991859|12544639|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7977907|NCT02991859|12544640|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7977908|NCT02991859|12544641|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7977909|NCT02991859|12544625|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7977910|NCT02991859|12544626|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7977911|NCT02991859|12544627|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7977912|NCT02991859|12544628|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7977913|NCT02991859|12544629|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7977914|NCT02991859|12544630|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7977915|NCT02991859|12544631|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7977916|NCT02991859|12544632|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7977917|NCT02991859|12544633|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7977918|NCT02991859|12544634|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7977919|NCT02991859|12544635|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7977920|NCT02991859|12544636|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7977921|NCT02991859|12544637|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
7977922|NCT02991859|12544638|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
7977923|NCT02991859|12544639|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7977924|NCT02991859|12544640|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7977925|NCT02991859|12544641|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7977926|NCT02991859|12544625|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977927|NCT02991859|12544626|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977928|NCT02991859|12544627|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977929|NCT02991859|12544628|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977930|NCT02991859|12544629|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977931|NCT02991859|12544630|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1
7977932|NCT02991859|12544631|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977933|NCT02991859|12544632|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977934|NCT02991859|12544633|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977935|NCT02991859|12544634|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977936|NCT02991859|12544635|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977937|NCT02991859|12544636|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977938|NCT02991859|12544637|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977939|NCT02991859|12544638|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977940|NCT02991859|12544639|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977941|NCT02991859|12544640|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977942|NCT02991859|12544641|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0
7977943|NCT02991859|12544625|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0
7977944|NCT02991859|12544626|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0
7977945|NCT02991859|12544627|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0
7977946|NCT02991859|12544628|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0
7977947|NCT02991859|12544629|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0
7977948|NCT02991859|12544630|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0
7977949|NCT02991859|12544631|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0
7977950|NCT02991859|12544632|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0
7977951|NCT02991859|12544633|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0
7977952|NCT02991859|12544634|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1
7977953|NCT02991859|12544635|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0
7977954|NCT02991859|12544636|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0
7977955|NCT02991859|12544637|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0
7977956|NCT02991859|12544638|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0
7977957|NCT02991859|12544639|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0
7977958|NCT02991859|12544640|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0
7977959|NCT02991859|12544641|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0
7977960|NCT02991859|12544625|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977961|NCT02991859|12544626|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977962|NCT02991859|12544627|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977963|NCT02991859|12544628|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977964|NCT02991859|12544629|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977965|NCT02991859|12544630|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977966|NCT02991859|12544631|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977967|NCT02991859|12544632|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977968|NCT02991859|12544633|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1
7977969|NCT02991859|12544634|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977970|NCT02991859|12544635|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977971|NCT02991859|12544636|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977972|NCT02991859|12544637|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977973|NCT02991859|12544638|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977974|NCT02991859|12544639|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977975|NCT02991859|12544640|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977976|NCT02991859|12544641|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7977977|NCT02992132|12544727|FG000|Overall Study|Adverse Event|4
7977978|NCT02992132|12544728|FG001|Overall Study|Adverse Event|1
7977979|NCT02992132|12544729|FG002|Overall Study|Adverse Event|3
7977980|NCT02992132|12544727|FG000|Overall Study|Lack of Efficacy|2
7977981|NCT02992132|12544728|FG001|Overall Study|Lack of Efficacy|0
7977982|NCT02992132|12544729|FG002|Overall Study|Lack of Efficacy|0
7977983|NCT02992132|12544727|FG000|Overall Study|Non-compliance with study drug|2
7977984|NCT02992132|12544728|FG001|Overall Study|Non-compliance with study drug|0
7977985|NCT02992132|12544729|FG002|Overall Study|Non-compliance with study drug|0
7977986|NCT02992132|12544727|FG000|Overall Study|Progressive disease|1
7977987|NCT02992132|12544728|FG001|Overall Study|Progressive disease|0
7977988|NCT02992132|12544729|FG002|Overall Study|Progressive disease|0
7977989|NCT02992132|12544727|FG000|Overall Study|Protocol Violation|2
7977990|NCT02992132|12544728|FG001|Overall Study|Protocol Violation|2
7977991|NCT02992132|12544729|FG002|Overall Study|Protocol Violation|0
7977992|NCT02992132|12544727|FG000|Overall Study|Caregiver withdrew consent|2
7977993|NCT02992132|12544728|FG001|Overall Study|Caregiver withdrew consent|3
7977994|NCT02992132|12544729|FG002|Overall Study|Caregiver withdrew consent|2
7977995|NCT02992132|12544727|FG000|Overall Study|Withdrawal by Subject|0
7977996|NCT02992132|12544728|FG001|Overall Study|Withdrawal by Subject|2
7977997|NCT02992132|12544729|FG002|Overall Study|Withdrawal by Subject|1
7977998|NCT02992132|12544727|FG000|Overall Study|Physician Decision|0
7977999|NCT02992132|12544728|FG001|Overall Study|Physician Decision|0
7978000|NCT02992132|12544729|FG002|Overall Study|Physician Decision|1
7978001|NCT02992288|12544763|FG000|Overall Study|Adverse Event|8
7978002|NCT02992288|12544764|FG001|Overall Study|Adverse Event|2
7978003|NCT02992288|12544765|FG002|Overall Study|Adverse Event|2
7978004|NCT02992288|12544766|FG003|Overall Study|Adverse Event|2
7978005|NCT02992288|12544767|FG004|Overall Study|Adverse Event|2
7978006|NCT02992288|12544768|FG005|Overall Study|Adverse Event|7
7978007|NCT02992288|12544763|FG000|Overall Study|Non-compliance with study drug|0
7978008|NCT02992288|12544764|FG001|Overall Study|Non-compliance with study drug|1
7978009|NCT02992288|12544765|FG002|Overall Study|Non-compliance with study drug|1
7978010|NCT02992288|12544766|FG003|Overall Study|Non-compliance with study drug|0
7978011|NCT02992288|12544767|FG004|Overall Study|Non-compliance with study drug|1
7978012|NCT02992288|12544768|FG005|Overall Study|Non-compliance with study drug|0
7978013|NCT02992288|12544763|FG000|Overall Study|Physician Decision|3
7978014|NCT02992288|12544764|FG001|Overall Study|Physician Decision|0
7978015|NCT02992288|12544765|FG002|Overall Study|Physician Decision|1
7978016|NCT02992288|12544766|FG003|Overall Study|Physician Decision|0
7978017|NCT02992288|12544767|FG004|Overall Study|Physician Decision|0
7978018|NCT02992288|12544768|FG005|Overall Study|Physician Decision|1
7978019|NCT02992288|12544763|FG000|Overall Study|Death|2
7978020|NCT02992288|12544764|FG001|Overall Study|Death|0
7978021|NCT02992288|12544765|FG002|Overall Study|Death|2
7978022|NCT02992288|12544766|FG003|Overall Study|Death|1
7978023|NCT02992288|12544767|FG004|Overall Study|Death|2
7978024|NCT02992288|12544768|FG005|Overall Study|Death|0
7978025|NCT02992288|12544763|FG000|Overall Study|Lost to Follow-up|0
7978026|NCT02992288|12544764|FG001|Overall Study|Lost to Follow-up|0
7978027|NCT02992288|12544765|FG002|Overall Study|Lost to Follow-up|0
7978028|NCT02992288|12544766|FG003|Overall Study|Lost to Follow-up|1
7978029|NCT02992288|12544767|FG004|Overall Study|Lost to Follow-up|0
7978030|NCT02992288|12544768|FG005|Overall Study|Lost to Follow-up|0
7978031|NCT02992288|12544763|FG000|Overall Study|Protocol Violation|0
7978032|NCT02992288|12544764|FG001|Overall Study|Protocol Violation|0
7978033|NCT02992288|12544765|FG002|Overall Study|Protocol Violation|0
7978034|NCT02992288|12544766|FG003|Overall Study|Protocol Violation|0
7978035|NCT02992288|12544767|FG004|Overall Study|Protocol Violation|0
7978036|NCT02992288|12544768|FG005|Overall Study|Protocol Violation|1
7978037|NCT02992288|12544763|FG000|Overall Study|Withdrawal by Subject|4
7978038|NCT02992288|12544764|FG001|Overall Study|Withdrawal by Subject|2
7978039|NCT02992288|12544765|FG002|Overall Study|Withdrawal by Subject|1
7978040|NCT02992288|12544766|FG003|Overall Study|Withdrawal by Subject|5
7978041|NCT02992288|12544767|FG004|Overall Study|Withdrawal by Subject|3
7978042|NCT02992288|12544768|FG005|Overall Study|Withdrawal by Subject|4
7978043|NCT02992691|12544782|FG000|Overall Study|Adverse Event|2
7978044|NCT02992691|12544782|FG000|Overall Study|Withdrawal by Subject|1
7978045|NCT02992899|12544799|FG000|Overall Study|Withdrawal by Subject|1
7978046|NCT02992899|12544800|FG001|Overall Study|Withdrawal by Subject|0
7978047|NCT02992899|12544799|FG000|Overall Study|Lost to Follow-up|1
7978048|NCT02992899|12544800|FG001|Overall Study|Lost to Follow-up|3
7978049|NCT02993224|12544806|FG000|Core Phase - Period 1|Adverse Event|4
7978050|NCT02993224|12544806|FG000|Core Phase - Period 1|Withdrawal by Subject|1
7978051|NCT02993224|12544806|FG000|Core Phase - Period 1|Lost to Follow-up|3
7978052|NCT02993224|12544806|FG000|Core Phase- Period 2|Adverse Event|1
7978053|NCT02993224|12544806|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2
7978054|NCT02993224|12544806|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1
7978055|NCT02993224|12544806|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1
7978056|NCT02993224|12544806|FG000|Extension Phase|Adverse Event|3
7978057|NCT02993224|12544806|FG000|Extension Phase|Withdrawal by Subject|3
7978058|NCT02993224|12544806|FG000|Extension Phase|Lost to Follow-up|2
7978059|NCT02993224|12544806|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27
7978060|NCT02993250|12544814|FG000|Overall Study|Lost to Follow-up|0
7978061|NCT02993250|12544815|FG001|Overall Study|Lost to Follow-up|1
7978062|NCT02993471|12544839|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1
7978063|NCT02993471|12544839|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1
7978064|NCT02993783|12544863|FG000|Overall Study|Reason not Specified|6
7978065|NCT02993783|12544864|FG001|Overall Study|Reason not Specified|9
7978066|NCT02994056|12544870|FG000|Overall Study|Death|8
7978067|NCT02994056|12544870|FG000|Overall Study|Withdrew Consent|1
7978068|NCT02994108|12544885|FG000|Intervention Messages|Withdrawal by Subject|2
7978069|NCT02994108|12544886|FG001|Intervention Messages|Withdrawal by Subject|0
7978070|NCT02994108|12544885|FG000|Phase 1 Assessment|Lost to Follow-up|5
7978071|NCT02994108|12544886|FG001|Phase 1 Assessment|Lost to Follow-up|3
7978072|NCT02994108|12544885|FG000|Phase 2 Assessment|Lost to Follow-up|8
7978073|NCT02994108|12544886|FG001|Phase 2 Assessment|Lost to Follow-up|7
7978074|NCT02994108|12544885|FG000|Phase 2 Assessment|Withdrawal by Subject|1
7978075|NCT02994108|12544886|FG001|Phase 2 Assessment|Withdrawal by Subject|0
7978076|NCT02994394|12544904|FG000|Period 1 (Days 1 to 3)|Adverse Event|0
7978077|NCT02994394|12544905|FG001|Period 1 (Days 1 to 3)|Adverse Event|0
7978078|NCT02994394|12544906|FG002|Period 1 (Days 1 to 3)|Adverse Event|1
7978079|NCT02994394|12544907|FG003|Period 1 (Days 1 to 3)|Adverse Event|0
7978080|NCT02994394|12544908|FG004|Period 1 (Days 1 to 3)|Adverse Event|0
7978081|NCT02994394|12544909|FG005|Period 1 (Days 1 to 3)|Adverse Event|0
7978082|NCT02994394|12544904|FG000|Period 2 (Days 4 to 6)|Adverse Event|0
7978083|NCT02994394|12544905|FG001|Period 2 (Days 4 to 6)|Adverse Event|1
7978084|NCT02994394|12544906|FG002|Period 2 (Days 4 to 6)|Adverse Event|0
7978085|NCT02994394|12544907|FG003|Period 2 (Days 4 to 6)|Adverse Event|0
7978086|NCT02994394|12544908|FG004|Period 2 (Days 4 to 6)|Adverse Event|1
7978087|NCT02994394|12544909|FG005|Period 2 (Days 4 to 6)|Adverse Event|0
7978088|NCT02994654|12544923|FG000|Overall Study|Lost to Follow-up|1
7978089|NCT02994940|12544935|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6
7978090|NCT02994940|12544936|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0
7978091|NCT02994940|12544935|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1
7978092|NCT02994940|12544936|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0
7978093|NCT02994940|12544935|FG000|Overall Study|Did not receive study medications: red dye allergy|0
7978094|NCT02994940|12544936|FG001|Overall Study|Did not receive study medications: red dye allergy|1
7978095|NCT02995980|12544960|FG000|Overall Study|Lost to Follow-up|14
7978096|NCT02996097|12544965|FG000|Overall Study|Lost to Follow-up|11
7978097|NCT02996097|12544966|FG001|Overall Study|Lost to Follow-up|11
7978098|NCT02996448|12544971|FG000|Overall Study|Study terminated due to adverse effects|3
7978099|NCT02996474|12544976|FG000|Overall Study|Physician Decision|5
7978100|NCT02996500|12544986|FG000|Overall Study|Adverse Event|1
7978101|NCT02996500|12544987|FG001|Overall Study|Adverse Event|1
7978102|NCT02996500|12544988|FG002|Overall Study|Adverse Event|4
7978103|NCT02996500|12544989|FG003|Overall Study|Adverse Event|3
7978104|NCT02996500|12544990|FG004|Overall Study|Adverse Event|1
7978105|NCT02996500|12544991|FG005|Overall Study|Adverse Event|2
7978106|NCT02996500|12544986|FG000|Overall Study|Lack of Efficacy|0
7978107|NCT02996500|12544987|FG001|Overall Study|Lack of Efficacy|0
7978108|NCT02996500|12544988|FG002|Overall Study|Lack of Efficacy|0
7978109|NCT02996500|12544989|FG003|Overall Study|Lack of Efficacy|0
7978110|NCT02996500|12544990|FG004|Overall Study|Lack of Efficacy|2
7978111|NCT02996500|12544991|FG005|Overall Study|Lack of Efficacy|0
7978112|NCT02996500|12544986|FG000|Overall Study|Lost to Follow-up|1
7978113|NCT02996500|12544987|FG001|Overall Study|Lost to Follow-up|0
7978114|NCT02996500|12544988|FG002|Overall Study|Lost to Follow-up|0
7978115|NCT02996500|12544989|FG003|Overall Study|Lost to Follow-up|0
7978116|NCT02996500|12544990|FG004|Overall Study|Lost to Follow-up|0
7978117|NCT02996500|12544991|FG005|Overall Study|Lost to Follow-up|1
7978118|NCT02996500|12544986|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7978119|NCT02996500|12544987|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7978120|NCT02996500|12544988|FG002|Overall Study|No Longer Meets Eligibility Criteria|1
7978121|NCT02996500|12544989|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
7978122|NCT02996500|12544990|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
7978123|NCT02996500|12544991|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
7978124|NCT02996500|12544986|FG000|Overall Study|Non-Compliance With Study Drug|0
7978125|NCT02996500|12544987|FG001|Overall Study|Non-Compliance With Study Drug|0
7978126|NCT02996500|12544988|FG002|Overall Study|Non-Compliance With Study Drug|0
7978127|NCT02996500|12544989|FG003|Overall Study|Non-Compliance With Study Drug|0
7978128|NCT02996500|12544990|FG004|Overall Study|Non-Compliance With Study Drug|0
7978129|NCT02996500|12544991|FG005|Overall Study|Non-Compliance With Study Drug|1
7978130|NCT02996500|12544986|FG000|Overall Study|Progressive Disease|1
7978131|NCT02996500|12544987|FG001|Overall Study|Progressive Disease|0
7978132|NCT02996500|12544988|FG002|Overall Study|Progressive Disease|0
7978133|NCT02996500|12544989|FG003|Overall Study|Progressive Disease|0
7978134|NCT02996500|12544990|FG004|Overall Study|Progressive Disease|0
7978135|NCT02996500|12544991|FG005|Overall Study|Progressive Disease|0
7978136|NCT02996500|12544986|FG000|Overall Study|Other|2
7978137|NCT02996500|12544987|FG001|Overall Study|Other|0
7978138|NCT02996500|12544988|FG002|Overall Study|Other|2
7978139|NCT02996500|12544989|FG003|Overall Study|Other|0
7978140|NCT02996500|12544990|FG004|Overall Study|Other|0
7978141|NCT02996500|12544991|FG005|Overall Study|Other|0
7978142|NCT02996500|12544986|FG000|Overall Study|Protocol Violation|0
7978143|NCT02996500|12544987|FG001|Overall Study|Protocol Violation|0
7978144|NCT02996500|12544988|FG002|Overall Study|Protocol Violation|0
7978145|NCT02996500|12544989|FG003|Overall Study|Protocol Violation|1
7978146|NCT02996500|12544990|FG004|Overall Study|Protocol Violation|0
7978147|NCT02996500|12544991|FG005|Overall Study|Protocol Violation|0
7978148|NCT02996500|12544986|FG000|Overall Study|Withdrawal by Subject|3
7978149|NCT02996500|12544987|FG001|Overall Study|Withdrawal by Subject|0
7978150|NCT02996500|12544988|FG002|Overall Study|Withdrawal by Subject|3
7978151|NCT02996500|12544989|FG003|Overall Study|Withdrawal by Subject|0
7978152|NCT02996500|12544990|FG004|Overall Study|Withdrawal by Subject|2
7978153|NCT02996500|12544991|FG005|Overall Study|Withdrawal by Subject|0
7978154|NCT02996682|12545020|FG000|Overall Study|Death|0
7978155|NCT02996682|12545021|FG001|Overall Study|Death|3
7978156|NCT02996968|12545038|FG000|Overall Study|Withdrawal by Subject|1
7978157|NCT02996968|12545039|FG001|Overall Study|Withdrawal by Subject|0
7978158|NCT02997163|12545061|FG000|Overall Study|Adverse Event|1
7978159|NCT02997163|12545062|FG001|Overall Study|Adverse Event|0
7978160|NCT02997163|12545063|FG002|Overall Study|Adverse Event|0
7978161|NCT02997163|12545064|FG003|Overall Study|Adverse Event|1
7978162|NCT02997176|12545078|FG000|Overall Study|Adverse Event|0
7978163|NCT02997176|12545079|FG001|Overall Study|Adverse Event|0
7978164|NCT02997176|12545080|FG002|Overall Study|Adverse Event|0
7978165|NCT02997176|12545081|FG003|Overall Study|Adverse Event|8
7978166|NCT02997176|12545078|FG000|Overall Study|Progressive Disease|1
7978167|NCT02997176|12545079|FG001|Overall Study|Progressive Disease|0
7978168|NCT02997176|12545080|FG002|Overall Study|Progressive Disease|1
7978169|NCT02997176|12545081|FG003|Overall Study|Progressive Disease|1
7978170|NCT02997176|12545078|FG000|Overall Study|Death|0
7978171|NCT02997176|12545079|FG001|Overall Study|Death|0
7978172|NCT02997176|12545080|FG002|Overall Study|Death|1
7978173|NCT02997176|12545081|FG003|Overall Study|Death|1
7978174|NCT02997176|12545078|FG000|Overall Study|Withdrawal by Subject|0
7978175|NCT02997176|12545079|FG001|Overall Study|Withdrawal by Subject|2
7978176|NCT02997176|12545080|FG002|Overall Study|Withdrawal by Subject|0
7978177|NCT02997176|12545081|FG003|Overall Study|Withdrawal by Subject|1
7978178|NCT02998021|12545124|FG000|Overall Study|Withdrawal by Subject|3
7978179|NCT02998021|12545125|FG001|Overall Study|Withdrawal by Subject|1
7978180|NCT02998021|12545124|FG000|Overall Study|unsafe home|0
7978181|NCT02998021|12545125|FG001|Overall Study|unsafe home|1
7978182|NCT02998151|12545131|FG000|Overall Study|Withdrawal by Subject|3
7978183|NCT02998151|12545131|FG000|Overall Study|Participant declined to re-enroll for baclofen|8
7978184|NCT02998151|12545131|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13
7978185|NCT02998541|12545146|FG000|Overall Study|Adverse Event|4
7978186|NCT02998541|12545147|FG001|Overall Study|Adverse Event|5
7978187|NCT02998541|12545148|FG002|Overall Study|Adverse Event|1
7978188|NCT02998541|12545146|FG000|Overall Study|Protocol Violation|1
7978189|NCT02998541|12545147|FG001|Overall Study|Protocol Violation|0
7978190|NCT02998541|12545148|FG002|Overall Study|Protocol Violation|0
7978191|NCT02998541|12545146|FG000|Overall Study|Withdrawal by Subject|3
7978192|NCT02998541|12545147|FG001|Overall Study|Withdrawal by Subject|1
7978193|NCT02998541|12545148|FG002|Overall Study|Withdrawal by Subject|0
7978194|NCT02998541|12545146|FG000|Overall Study|Lost to Follow-up|0
7978195|NCT02998541|12545147|FG001|Overall Study|Lost to Follow-up|3
7978196|NCT02998541|12545148|FG002|Overall Study|Lost to Follow-up|1
7978197|NCT02998541|12545146|FG000|Overall Study|Physician Decision|0
7978198|NCT02998541|12545147|FG001|Overall Study|Physician Decision|0
7978199|NCT02998541|12545148|FG002|Overall Study|Physician Decision|3
7978200|NCT02998541|12545146|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7978201|NCT02998541|12545147|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7978202|NCT02998541|12545148|FG002|Overall Study|Withdrawal by Parent/Guardian|1
7978203|NCT02998554|12545158|FG000|Overall Study|Adverse Event|8
7978204|NCT02998554|12545159|FG001|Overall Study|Adverse Event|3
7978205|NCT02998554|12545158|FG000|Overall Study|Protocol deviation|1
7978206|NCT02998554|12545159|FG001|Overall Study|Protocol deviation|0
7978207|NCT02998554|12545158|FG000|Overall Study|Withdrawal by Subject|2
7978208|NCT02998554|12545159|FG001|Overall Study|Withdrawal by Subject|6
7978209|NCT02998554|12545158|FG000|Overall Study|Lost to Follow-up|0
7978210|NCT02998554|12545159|FG001|Overall Study|Lost to Follow-up|1
7978211|NCT02998554|12545158|FG000|Overall Study|Lack of Efficacy|0
7978212|NCT02998554|12545159|FG001|Overall Study|Lack of Efficacy|1
7978213|NCT02998996|12545182|FG000|Overall Study|Lost to Follow-up|0
7978214|NCT02998996|12545183|FG001|Overall Study|Lost to Follow-up|0
7978215|NCT02998996|12545184|FG002|Overall Study|Lost to Follow-up|1
7978216|NCT02998996|12545185|FG003|Overall Study|Lost to Follow-up|0
7978217|NCT02998996|12545186|FG004|Overall Study|Lost to Follow-up|0
7978218|NCT02998996|12545187|FG005|Overall Study|Lost to Follow-up|0
7978219|NCT02998996|12545182|FG000|Overall Study|Pregnancy|0
7978220|NCT02998996|12545183|FG001|Overall Study|Pregnancy|1
7978221|NCT02998996|12545184|FG002|Overall Study|Pregnancy|0
7978222|NCT02998996|12545185|FG003|Overall Study|Pregnancy|0
7978223|NCT02998996|12545186|FG004|Overall Study|Pregnancy|0
7978224|NCT02998996|12545187|FG005|Overall Study|Pregnancy|0
7978225|NCT02998996|12545182|FG000|Overall Study|Family reasons|0
7978226|NCT02998996|12545183|FG001|Overall Study|Family reasons|0
7978227|NCT02998996|12545184|FG002|Overall Study|Family reasons|0
7978228|NCT02998996|12545185|FG003|Overall Study|Family reasons|0
7978229|NCT02998996|12545186|FG004|Overall Study|Family reasons|1
7978230|NCT02998996|12545187|FG005|Overall Study|Family reasons|0
7978231|NCT02999100|12545207|FG000|Part 1 (up to 15 Days)|Adverse Event|0
7978232|NCT02999100|12545208|FG001|Part 1 (up to 15 Days)|Adverse Event|1
7978233|NCT02999100|12545209|FG002|Part 1 (up to 15 Days)|Adverse Event|0
7978234|NCT02999100|12545210|FG003|Part 1 (up to 15 Days)|Adverse Event|0
7978235|NCT02999100|12545211|FG004|Part 1 (up to 15 Days)|Adverse Event|0
7978236|NCT02999100|12545212|FG005|Part 1 (up to 15 Days)|Adverse Event|0
7978237|NCT02999100|12545207|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7978238|NCT02999100|12545208|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7978239|NCT02999100|12545209|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7978240|NCT02999100|12545210|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7978241|NCT02999100|12545211|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7978242|NCT02999100|12545212|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1
7978243|NCT02999100|12545207|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7978244|NCT02999100|12545208|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7978245|NCT02999100|12545209|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1
7978246|NCT02999100|12545210|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7978247|NCT02999100|12545211|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7978248|NCT02999100|12545212|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7978249|NCT02999178|12545236|FG000|Overall Study|Adverse Event|85
7978250|NCT02999178|12545237|FG001|Overall Study|Adverse Event|62
7978251|NCT02999178|12545236|FG000|Overall Study|Protocol Violation|1
7978252|NCT02999178|12545237|FG001|Overall Study|Protocol Violation|2
7978253|NCT02999178|12545236|FG000|Overall Study|Lost to Follow-up|0
7978254|NCT02999178|12545237|FG001|Overall Study|Lost to Follow-up|2
7978255|NCT02999178|12545236|FG000|Overall Study|Withdrawal by Subject|21
7978256|NCT02999178|12545237|FG001|Overall Study|Withdrawal by Subject|21
7978257|NCT02999178|12545236|FG000|Overall Study|Other reason not defined above|7
7978258|NCT02999178|12545237|FG001|Overall Study|Other reason not defined above|13
7978259|NCT02999191|12545246|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0
7978260|NCT02999191|12545247|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1
7978261|NCT02999191|12545248|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0
7978262|NCT02999672|12545258|FG000|Overall Study|Death|0
7978263|NCT02999672|12545259|FG001|Overall Study|Death|1
7978264|NCT02999672|12545258|FG000|Overall Study|Study Terminated by Sponsor|0
7978265|NCT02999672|12545259|FG001|Overall Study|Study Terminated by Sponsor|1
7978266|NCT02999672|12545258|FG000|Overall Study|Progressive Disease|9
7978267|NCT02999672|12545259|FG001|Overall Study|Progressive Disease|5
7978268|NCT02999672|12545258|FG000|Overall Study|Adverse Event|4
7978269|NCT02999672|12545259|FG001|Overall Study|Adverse Event|0
7978270|NCT03000075|12545281|FG000|Part A|Adverse Event|4
7978271|NCT03000075|12545282|FG001|Part A|Adverse Event|0
7978272|NCT03000075|12545283|FG002|Part A|Adverse Event|0
7978273|NCT03000075|12545284|FG003|Part A|Adverse Event|0
7978274|NCT03000075|12545285|FG004|Part A|Adverse Event|0
7978275|NCT03000075|12545286|FG005|Part A|Adverse Event|0
7978276|NCT03000075|12545287|FG006|Part A|Adverse Event|0
7978277|NCT03000075|12545281|FG000|Part B|Not dosed due to AE|0
7978278|NCT03000075|12545282|FG001|Part B|Not dosed due to AE|0
7978279|NCT03000075|12545283|FG002|Part B|Not dosed due to AE|0
7978280|NCT03000075|12545284|FG003|Part B|Not dosed due to AE|0
7978281|NCT03000075|12545285|FG004|Part B|Not dosed due to AE|0
7978282|NCT03000075|12545286|FG005|Part B|Not dosed due to AE|2
7978283|NCT03000075|12545287|FG006|Part B|Not dosed due to AE|1
7978284|NCT03000075|12545281|FG000|Part B|Adverse Event|0
7978285|NCT03000075|12545282|FG001|Part B|Adverse Event|0
7978286|NCT03000075|12545283|FG002|Part B|Adverse Event|0
7978287|NCT03000075|12545284|FG003|Part B|Adverse Event|0
7978288|NCT03000075|12545285|FG004|Part B|Adverse Event|1
7978289|NCT03000075|12545286|FG005|Part B|Adverse Event|0
7978290|NCT03000075|12545287|FG006|Part B|Adverse Event|0
7978291|NCT03000348|12545336|FG000|Overall Study|Adverse Event|1
7978292|NCT03000348|12545337|FG001|Overall Study|Adverse Event|1
7978293|NCT03000348|12545338|FG002|Overall Study|Adverse Event|1
7978294|NCT03000348|12545339|FG003|Overall Study|Adverse Event|1
7978295|NCT03000348|12545340|FG004|Overall Study|Adverse Event|1
7978296|NCT03000348|12545341|FG005|Overall Study|Adverse Event|1
7978297|NCT03000348|12545336|FG000|Overall Study|Lost to Follow-up|0
7978298|NCT03000348|12545337|FG001|Overall Study|Lost to Follow-up|0
7978299|NCT03000348|12545338|FG002|Overall Study|Lost to Follow-up|1
7978300|NCT03000348|12545339|FG003|Overall Study|Lost to Follow-up|0
7978301|NCT03000348|12545340|FG004|Overall Study|Lost to Follow-up|0
7978302|NCT03000348|12545341|FG005|Overall Study|Lost to Follow-up|0
7978303|NCT03000348|12545336|FG000|Overall Study|Withdrawal by Subject|0
7978304|NCT03000348|12545337|FG001|Overall Study|Withdrawal by Subject|1
7978305|NCT03000348|12545338|FG002|Overall Study|Withdrawal by Subject|0
7978306|NCT03000348|12545339|FG003|Overall Study|Withdrawal by Subject|0
7978307|NCT03000348|12545340|FG004|Overall Study|Withdrawal by Subject|0
7978308|NCT03000348|12545341|FG005|Overall Study|Withdrawal by Subject|0
7978309|NCT03000348|12545336|FG000|Overall Study|Consent|0
7978310|NCT03000348|12545337|FG001|Overall Study|Consent|0
7978311|NCT03000348|12545338|FG002|Overall Study|Consent|0
7978312|NCT03000348|12545339|FG003|Overall Study|Consent|0
7978313|NCT03000348|12545340|FG004|Overall Study|Consent|1
7978314|NCT03000348|12545341|FG005|Overall Study|Consent|0
7978315|NCT03000348|12545336|FG000|Overall Study|Failure to expectorate sputum|1
7978316|NCT03000348|12545337|FG001|Overall Study|Failure to expectorate sputum|0
7978317|NCT03000348|12545338|FG002|Overall Study|Failure to expectorate sputum|1
7978318|NCT03000348|12545339|FG003|Overall Study|Failure to expectorate sputum|0
7978319|NCT03000348|12545340|FG004|Overall Study|Failure to expectorate sputum|1
7978320|NCT03000348|12545341|FG005|Overall Study|Failure to expectorate sputum|0
7978321|NCT03000348|12545336|FG000|Overall Study|No gram negative|1
7978322|NCT03000348|12545337|FG001|Overall Study|No gram negative|2
7978323|NCT03000348|12545338|FG002|Overall Study|No gram negative|1
7978324|NCT03000348|12545339|FG003|Overall Study|No gram negative|1
7978325|NCT03000348|12545340|FG004|Overall Study|No gram negative|1
7978326|NCT03000348|12545341|FG005|Overall Study|No gram negative|1
7978327|NCT03000348|12545336|FG000|Overall Study|Patient had no transport|0
7978328|NCT03000348|12545337|FG001|Overall Study|Patient had no transport|0
7978329|NCT03000348|12545338|FG002|Overall Study|Patient had no transport|0
7978330|NCT03000348|12545339|FG003|Overall Study|Patient had no transport|1
7978331|NCT03000348|12545340|FG004|Overall Study|Patient had no transport|0
7978332|NCT03000348|12545341|FG005|Overall Study|Patient had no transport|0
7978333|NCT03000348|12545336|FG000|Overall Study|Dosing|0
7978334|NCT03000348|12545337|FG001|Overall Study|Dosing|0
7978335|NCT03000348|12545338|FG002|Overall Study|Dosing|0
7978336|NCT03000348|12545339|FG003|Overall Study|Dosing|0
7978337|NCT03000348|12545340|FG004|Overall Study|Dosing|1
7978338|NCT03000348|12545341|FG005|Overall Study|Dosing|0
7978339|NCT03000452|12545358|FG000|Treatment Period|Death|1
7978340|NCT03000452|12545358|FG000|Treatment Period|Progressive Disease (PD)|14
7978341|NCT03000452|12545358|FG000|Treatment Period|Physician Decision|1
7978342|NCT03000452|12545358|FG000|Treatment Period|Miscellaneous|2
7978343|NCT03000452|12545358|FG000|Follow-Up Period|Study Terminated by Sponsor|1
7978344|NCT03000452|12545358|FG000|Follow-Up Period|Death|3
7978345|NCT03000452|12545358|FG000|Follow-Up Period|Withdrawal by Subject|3
7978346|NCT03000673|12545375|FG000|Overall Study|Withdrawal by Subject|1
7978347|NCT03000673|12545376|FG001|Overall Study|Withdrawal by Subject|0
7978348|NCT03000673|12545377|FG002|Overall Study|Withdrawal by Subject|0
7978349|NCT03000673|12545378|FG003|Overall Study|Withdrawal by Subject|0
7978350|NCT03000686|12545391|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0
7978351|NCT03000686|12545392|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1
7978352|NCT03000686|12545393|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0
7978353|NCT03000686|12545394|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0
7978354|NCT03001076|12545408|FG000|Overall Study|Withdrawal by patient|2
7978355|NCT03001076|12545409|FG001|Overall Study|Withdrawal by patient|0
7978356|NCT03001076|12545408|FG000|Overall Study|Other|1
7978357|NCT03001076|12545409|FG001|Overall Study|Other|0
7978358|NCT03001076|12545408|FG000|Overall Study|Adverse Event|3
7978359|NCT03001076|12545409|FG001|Overall Study|Adverse Event|3
7978360|NCT03001076|12545408|FG000|Overall Study|Sponsor decision|1
7978361|NCT03001076|12545409|FG001|Overall Study|Sponsor decision|0
7978362|NCT03001076|12545408|FG000|Overall Study|Lost to Follow-up|0
7978363|NCT03001076|12545409|FG001|Overall Study|Lost to Follow-up|2
7978364|NCT03001219|12545417|FG000|Proof of Concept|Study Termination by Sponsor|0
7978365|NCT03001219|12545418|FG001|Proof of Concept|Study Termination by Sponsor|1
7978366|NCT03001219|12545417|FG000|Proof of Concept|Withdrawal by Subject|0
7978367|NCT03001219|12545418|FG001|Proof of Concept|Withdrawal by Subject|4
7978368|NCT03001219|12545417|FG000|Proof of Concept|Protocol Deviation|0
7978369|NCT03001219|12545418|FG001|Proof of Concept|Protocol Deviation|1
7978370|NCT03001219|12545417|FG000|Proof of Concept|Adverse Event|1
7978371|NCT03001219|12545418|FG001|Proof of Concept|Adverse Event|1
7978372|NCT03001219|12545417|FG000|Proof of Concept|Physician Decision|1
7978373|NCT03001219|12545418|FG001|Proof of Concept|Physician Decision|0
7978374|NCT03001219|12545417|FG000|Extension Period Analysis|Study Termination by Sponsor|0
7978375|NCT03001219|12545418|FG001|Extension Period Analysis|Study Termination by Sponsor|36
7978376|NCT03001219|12545417|FG000|Extension Period Analysis|Participant Non-Compliance|0
7978377|NCT03001219|12545418|FG001|Extension Period Analysis|Participant Non-Compliance|1
7978378|NCT03001219|12545417|FG000|Extension Period Analysis|Physician Decision|0
7978379|NCT03001219|12545418|FG001|Extension Period Analysis|Physician Decision|1
7978380|NCT03001219|12545417|FG000|Extension Period Analysis|Adverse Event|1
7978381|NCT03001219|12545418|FG001|Extension Period Analysis|Adverse Event|1
7978382|NCT03001219|12545417|FG000|Extension Period Analysis|Protocol Deviation|0
7978383|NCT03001219|12545418|FG001|Extension Period Analysis|Protocol Deviation|1
7978384|NCT03001219|12545417|FG000|Extension Period Analysis|Withdrawal by Subject|4
7978385|NCT03001219|12545418|FG001|Extension Period Analysis|Withdrawal by Subject|5
7978386|NCT03001557|12545456|FG000|Core Phase|Randomized but not treated|0
7978387|NCT03001557|12545457|FG001|Core Phase|Randomized but not treated|0
7978388|NCT03001557|12545458|FG002|Core Phase|Randomized but not treated|1
7978389|NCT03001557|12545459|FG003|Core Phase|Randomized but not treated|0
7978390|NCT03001557|12545460|FG004|Core Phase|Randomized but not treated|0
7978391|NCT03001557|12545461|FG005|Core Phase|Randomized but not treated|0
7978392|NCT03001557|12545462|FG006|Core Phase|Randomized but not treated|0
7978393|NCT03001557|12545463|FG007|Core Phase|Randomized but not treated|0
7978394|NCT03001557|12545456|FG000|Extension Phase|Adverse Event|0
7978395|NCT03001557|12545457|FG001|Extension Phase|Adverse Event|0
7978396|NCT03001557|12545458|FG002|Extension Phase|Adverse Event|0
7978397|NCT03001557|12545459|FG003|Extension Phase|Adverse Event|0
7978398|NCT03001557|12545460|FG004|Extension Phase|Adverse Event|0
7978399|NCT03001557|12545461|FG005|Extension Phase|Adverse Event|2
7978400|NCT03001557|12545462|FG006|Extension Phase|Adverse Event|0
7978401|NCT03001557|12545463|FG007|Extension Phase|Adverse Event|0
7978402|NCT03001557|12545456|FG000|Extension Phase|Withdrawal by Subject|0
7978403|NCT03001557|12545457|FG001|Extension Phase|Withdrawal by Subject|0
7978404|NCT03001557|12545458|FG002|Extension Phase|Withdrawal by Subject|0
7978405|NCT03001557|12545459|FG003|Extension Phase|Withdrawal by Subject|0
7978406|NCT03001557|12545460|FG004|Extension Phase|Withdrawal by Subject|0
7978407|NCT03001557|12545461|FG005|Extension Phase|Withdrawal by Subject|1
7978408|NCT03001557|12545462|FG006|Extension Phase|Withdrawal by Subject|5
7978409|NCT03001557|12545463|FG007|Extension Phase|Withdrawal by Subject|2
7718037|NCT00524303|12141718|FG000|Overall Study|Completed 5 years|0
7718038|NCT00524303|12141719|FG001|Overall Study|Completed 5 years|0
7718039|NCT00524303|12141720|FG002|Overall Study|Completed 5 years|1
7718040|NCT00524316|12141731|FG000|Overall Study|Withdrawal by Subject|2
7718041|NCT00524316|12141731|FG000|Overall Study|Adverse Event|7
7718042|NCT00524316|12141731|FG000|Overall Study|Disease Progression|7
7718043|NCT00524368|12141741|FG000|Overall Study|Adverse Event|10
7718044|NCT00524368|12141742|FG001|Overall Study|Adverse Event|12
7718045|NCT00524368|12141741|FG000|Overall Study|Lost to Follow-up|9
7978410|NCT03001557|12545456|FG000|Extension Phase|Lost to Follow-up|0
7978411|NCT03001557|12545457|FG001|Extension Phase|Lost to Follow-up|0
7978412|NCT03001557|12545458|FG002|Extension Phase|Lost to Follow-up|0
7978413|NCT03001557|12545459|FG003|Extension Phase|Lost to Follow-up|0
7978414|NCT03001557|12545460|FG004|Extension Phase|Lost to Follow-up|0
7978415|NCT03001557|12545461|FG005|Extension Phase|Lost to Follow-up|0
7978416|NCT03001557|12545462|FG006|Extension Phase|Lost to Follow-up|2
7978417|NCT03001557|12545463|FG007|Extension Phase|Lost to Follow-up|1
7978418|NCT03001557|12545456|FG000|Extension Phase|Administrative Reason|0
7978419|NCT03001557|12545457|FG001|Extension Phase|Administrative Reason|0
7978420|NCT03001557|12545458|FG002|Extension Phase|Administrative Reason|0
7978421|NCT03001557|12545459|FG003|Extension Phase|Administrative Reason|0
7978422|NCT03001557|12545460|FG004|Extension Phase|Administrative Reason|0
7978423|NCT03001557|12545461|FG005|Extension Phase|Administrative Reason|1
7978424|NCT03001557|12545462|FG006|Extension Phase|Administrative Reason|3
7978425|NCT03001557|12545463|FG007|Extension Phase|Administrative Reason|3
7978426|NCT03001557|12545456|FG000|Extension Phase|Loss of caregiver|0
7978427|NCT03001557|12545457|FG001|Extension Phase|Loss of caregiver|0
7978428|NCT03001557|12545458|FG002|Extension Phase|Loss of caregiver|0
7978429|NCT03001557|12545459|FG003|Extension Phase|Loss of caregiver|0
7978430|NCT03001557|12545460|FG004|Extension Phase|Loss of caregiver|0
7978431|NCT03001557|12545461|FG005|Extension Phase|Loss of caregiver|0
7978432|NCT03001557|12545462|FG006|Extension Phase|Loss of caregiver|1
7978433|NCT03001557|12545463|FG007|Extension Phase|Loss of caregiver|0
7978434|NCT03001557|12545456|FG000|Extension Phase|Others|0
7978435|NCT03001557|12545457|FG001|Extension Phase|Others|0
7978436|NCT03001557|12545458|FG002|Extension Phase|Others|0
7978437|NCT03001557|12545459|FG003|Extension Phase|Others|0
7978438|NCT03001557|12545460|FG004|Extension Phase|Others|0
7978439|NCT03001557|12545461|FG005|Extension Phase|Others|1
7978440|NCT03001557|12545462|FG006|Extension Phase|Others|3
7978441|NCT03001557|12545463|FG007|Extension Phase|Others|0
7978442|NCT03002038|12545523|FG000|Overall Study|Adverse Event|3
7978443|NCT03002038|12545524|FG001|Overall Study|Adverse Event|1
7978444|NCT03002038|12545523|FG000|Overall Study|Withdrawal by Subject|8
7978445|NCT03002038|12545524|FG001|Overall Study|Withdrawal by Subject|4
7978446|NCT03002038|12545523|FG000|Overall Study|Immigration to another region|0
7978447|NCT03002038|12545524|FG001|Overall Study|Immigration to another region|2
7978448|NCT03002077|12545530|FG000|Overall Study|Non-compliance with Study Drug|4
7978449|NCT03002077|12545530|FG000|Overall Study|Non-compliance w/Background ADT|1
7978450|NCT03002077|12545530|FG000|Overall Study|Study Terminated by Sponsor|257
7978451|NCT03002077|12545530|FG000|Overall Study|Site Terminated by Sponsor|5
7978452|NCT03002077|12545530|FG000|Overall Study|Miscellaneous Reasons|10
7978453|NCT03002077|12545530|FG000|Overall Study|Adverse Event|23
7978454|NCT03002077|12545530|FG000|Overall Study|Lack of Efficacy|20
7978455|NCT03002077|12545530|FG000|Overall Study|Withdrawal by Subject|72
7978456|NCT03002077|12545530|FG000|Overall Study|Lost to Follow-up|21
7978457|NCT03002077|12545530|FG000|Overall Study|Pregnancy|4
7978458|NCT03002077|12545530|FG000|Overall Study|Protocol Violation|21
7978459|NCT03002194|12545534|FG000|Overall Study|Lost to Follow-up|6
7978460|NCT03002194|12545534|FG000|Overall Study|Adverse Event|1
7978461|NCT03002194|12545534|FG000|Overall Study|Lack of Efficacy|1
7978462|NCT03002194|12545534|FG000|Overall Study|Withdrawal by Subject|2
7978463|NCT03002311|12545540|FG000|Overall Study|Lost to Follow-up|13
7978464|NCT03002311|12545541|FG001|Overall Study|Lost to Follow-up|26
7978465|NCT03002311|12545540|FG000|Overall Study|Referral provider called to schedule app|3
7978466|NCT03002311|12545541|FG001|Overall Study|Referral provider called to schedule app|3
7978467|NCT03002311|12545540|FG000|Overall Study|Physician Decision|3
7978468|NCT03002311|12545541|FG001|Overall Study|Physician Decision|1
7978469|NCT03002610|12545559|FG000|Overall Study|Withdrawal by Subject|6
7978470|NCT03002610|12545560|FG001|Overall Study|Withdrawal by Subject|25
7978471|NCT03002610|12545561|FG002|Overall Study|Withdrawal by Subject|13
7978472|NCT03002623|12545571|FG000|Overall Study|Lost to Follow-up|1
7978473|NCT03002623|12545572|FG001|Overall Study|Lost to Follow-up|0
7978474|NCT03002623|12545571|FG000|Overall Study|Physician Decision|1
7978475|NCT03002623|12545572|FG001|Overall Study|Physician Decision|1
7978476|NCT03002818|12545592|FG000|Overall Study|Decision of the investigator|1
7978477|NCT03003000|12545612|FG000|Overall Study|Adverse Event|1
7978478|NCT03003000|12545613|FG001|Overall Study|Adverse Event|2
7978479|NCT03003000|12545614|FG002|Overall Study|Adverse Event|3
7978480|NCT03003000|12545612|FG000|Overall Study|Lack of Efficacy|1
7978481|NCT03003000|12545613|FG001|Overall Study|Lack of Efficacy|0
7978482|NCT03003000|12545614|FG002|Overall Study|Lack of Efficacy|0
7978483|NCT03003000|12545612|FG000|Overall Study|Non-compliant with protocol|0
7978484|NCT03003000|12545613|FG001|Overall Study|Non-compliant with protocol|1
7978485|NCT03003000|12545614|FG002|Overall Study|Non-compliant with protocol|1
7978486|NCT03003000|12545612|FG000|Overall Study|Refused to continue medication|2
7978487|NCT03003000|12545613|FG001|Overall Study|Refused to continue medication|0
7978488|NCT03003000|12545614|FG002|Overall Study|Refused to continue medication|0
7978489|NCT03003000|12545612|FG000|Overall Study|Other than listed|1
7978490|NCT03003000|12545613|FG001|Overall Study|Other than listed|1
7978491|NCT03003000|12545614|FG002|Overall Study|Other than listed|1
7978492|NCT03003390|12545624|FG000|Overall Study|Physician Decision|2
7978493|NCT03003390|12545625|FG001|Overall Study|Physician Decision|0
7978494|NCT03003390|12545624|FG000|Overall Study|Parent refused intervention|2
7978495|NCT03003390|12545625|FG001|Overall Study|Parent refused intervention|0
7978496|NCT03003494|12545636|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28
7978497|NCT03003676|12545642|FG000|Overall Study|Lack of Efficacy|5
7978498|NCT03003676|12545643|FG001|Overall Study|Lack of Efficacy|7
7978499|NCT03003676|12545642|FG000|Overall Study|Withdrawal by Subject|0
7978500|NCT03003676|12545643|FG001|Overall Study|Withdrawal by Subject|1
7978501|NCT03003676|12545642|FG000|Overall Study|Hepatitis B infection|1
7978502|NCT03003676|12545643|FG001|Overall Study|Hepatitis B infection|0
7978503|NCT03004469|12545672|FG000|Overall Study|Adverse Event|6
7978504|NCT03004469|12545673|FG001|Overall Study|Adverse Event|4
7978505|NCT03004469|12545674|FG002|Overall Study|Adverse Event|6
7978506|NCT03004469|12545672|FG000|Overall Study|Lack of Efficacy|1
7978507|NCT03004469|12545673|FG001|Overall Study|Lack of Efficacy|0
7978508|NCT03004469|12545674|FG002|Overall Study|Lack of Efficacy|1
7978509|NCT03004469|12545672|FG000|Overall Study|Lost to Follow-up|23
7978510|NCT03004469|12545673|FG001|Overall Study|Lost to Follow-up|14
7978511|NCT03004469|12545674|FG002|Overall Study|Lost to Follow-up|6
7978512|NCT03004469|12545672|FG000|Overall Study|Non-Compliance with Study Drug|2
7978513|NCT03004469|12545673|FG001|Overall Study|Non-Compliance with Study Drug|0
7978514|NCT03004469|12545674|FG002|Overall Study|Non-Compliance with Study Drug|0
7978515|NCT03004469|12545672|FG000|Overall Study|Protocol Violation|0
7978516|NCT03004469|12545673|FG001|Overall Study|Protocol Violation|0
7978517|NCT03004469|12545674|FG002|Overall Study|Protocol Violation|1
7978518|NCT03004469|12545672|FG000|Overall Study|Withdrawal by Subject|29
7978519|NCT03004469|12545673|FG001|Overall Study|Withdrawal by Subject|27
7978520|NCT03004469|12545674|FG002|Overall Study|Withdrawal by Subject|10
7978521|NCT03004469|12545672|FG000|Overall Study|Other unspecified reason|0
7978522|NCT03004469|12545673|FG001|Overall Study|Other unspecified reason|4
7978523|NCT03004469|12545674|FG002|Overall Study|Other unspecified reason|1
7978524|NCT03004924|12545742|FG000|Overall Study|Adverse Event|6
7978525|NCT03004924|12545743|FG001|Overall Study|Adverse Event|5
7978526|NCT03004924|12545744|FG002|Overall Study|Adverse Event|10
7978527|NCT03004924|12545742|FG000|Overall Study|Protocol Violation|4
7978528|NCT03004924|12545743|FG001|Overall Study|Protocol Violation|0
7978529|NCT03004924|12545744|FG002|Overall Study|Protocol Violation|1
7978530|NCT03004924|12545742|FG000|Overall Study|Withdrawal by Subject|5
7978531|NCT03004924|12545743|FG001|Overall Study|Withdrawal by Subject|3
7978532|NCT03004924|12545744|FG002|Overall Study|Withdrawal by Subject|5
7978533|NCT03004924|12545742|FG000|Overall Study|Lost to Follow-up|6
7978534|NCT03004924|12545743|FG001|Overall Study|Lost to Follow-up|1
7978535|NCT03004924|12545744|FG002|Overall Study|Lost to Follow-up|4
7978536|NCT03004924|12545742|FG000|Overall Study|Lack of Efficacy|2
7978537|NCT03004924|12545743|FG001|Overall Study|Lack of Efficacy|4
7978538|NCT03004924|12545744|FG002|Overall Study|Lack of Efficacy|2
7978539|NCT03004924|12545742|FG000|Overall Study|Physician Decision|1
7978540|NCT03004924|12545743|FG001|Overall Study|Physician Decision|0
7978541|NCT03004924|12545744|FG002|Overall Study|Physician Decision|1
7978542|NCT03004924|12545742|FG000|Overall Study|Withdrawal by parent/guardian|1
7978543|NCT03004924|12545743|FG001|Overall Study|Withdrawal by parent/guardian|0
7978544|NCT03004924|12545744|FG002|Overall Study|Withdrawal by parent/guardian|2
7978545|NCT03004924|12545742|FG000|Overall Study|Screen Failure|1
7978546|NCT03004924|12545743|FG001|Overall Study|Screen Failure|0
7978547|NCT03004924|12545744|FG002|Overall Study|Screen Failure|0
7978548|NCT03004924|12545742|FG000|Overall Study|Pregnancy|0
7978549|NCT03004924|12545743|FG001|Overall Study|Pregnancy|1
7978550|NCT03004924|12545744|FG002|Overall Study|Pregnancy|0
7978551|NCT03004924|12545742|FG000|Overall Study|Terminated by Sponsor|0
7978552|NCT03004924|12545743|FG001|Overall Study|Terminated by Sponsor|0
7978553|NCT03004924|12545744|FG002|Overall Study|Terminated by Sponsor|1
7978554|NCT03004924|12545742|FG000|Overall Study|Missed Study Visit|0
7978555|NCT03004924|12545743|FG001|Overall Study|Missed Study Visit|0
7978556|NCT03004924|12545744|FG002|Overall Study|Missed Study Visit|2
7978557|NCT03004924|12545742|FG000|Overall Study|HSV1 Positive|1
7978558|NCT03004924|12545743|FG001|Overall Study|HSV1 Positive|0
7978559|NCT03004924|12545744|FG002|Overall Study|HSV1 Positive|0
7978560|NCT03005067|12545766|FG000|Overall Study|Withdrawal by Subject|3
7978561|NCT03005067|12545767|FG001|Overall Study|Withdrawal by Subject|2
7978562|NCT03005067|12545766|FG000|Overall Study|Adverse Event|4
7978563|NCT03005067|12545767|FG001|Overall Study|Adverse Event|3
7978564|NCT03005067|12545766|FG000|Overall Study|Other (reason not specified)|3
7978565|NCT03005067|12545767|FG001|Overall Study|Other (reason not specified)|1
7978566|NCT03005067|12545766|FG000|Overall Study|Protocol Violation|0
7978567|NCT03005067|12545767|FG001|Overall Study|Protocol Violation|1
7978568|NCT03005106|12545773|FG000|Overall Study|Lost to Follow-up|16
7978569|NCT03005106|12545773|FG000|Overall Study|Adverse Event|1
7978570|NCT03005106|12545773|FG000|Overall Study|Physician Decision|1
7978571|NCT03005106|12545773|FG000|Overall Study|Death|2
7978572|NCT03005288|12545779|FG000|Overall Study|Withdrawal by Subject|7
7978573|NCT03005288|12545780|FG001|Overall Study|Withdrawal by Subject|5
7978574|NCT03005288|12545779|FG000|Overall Study|Lost to Follow-up|0
7978575|NCT03005288|12545780|FG001|Overall Study|Lost to Follow-up|1
7978576|NCT03005288|12545779|FG000|Overall Study|Adverse Event|5
7978577|NCT03005288|12545780|FG001|Overall Study|Adverse Event|0
7978578|NCT03005288|12545779|FG000|Overall Study|Protocol deviation|0
7978579|NCT03005288|12545780|FG001|Overall Study|Protocol deviation|1
7978580|NCT03005288|12545779|FG000|Overall Study|Physician Decision|0
7978581|NCT03005288|12545780|FG001|Overall Study|Physician Decision|1
7978582|NCT03006341|12545790|FG000|Overall Study|Not linked in the EMR|25069
7978583|NCT03006341|12545791|FG001|Overall Study|Not linked in the EMR|67505
7978584|NCT03006341|12545792|FG002|Overall Study|Not linked in the EMR|30993
7978585|NCT03006341|12545793|FG003|Overall Study|Not linked in the EMR|10685
7978586|NCT03006393|12545803|FG000|Overall Study|Withdrawal by Subject|1
7978587|NCT03006393|12545804|FG001|Overall Study|Withdrawal by Subject|1
7978588|NCT03006393|12545803|FG000|Overall Study|Pregnancy|0
7978589|NCT03006393|12545804|FG001|Overall Study|Pregnancy|1
7978590|NCT03006393|12545803|FG000|Overall Study|Lost to Follow-up|0
7978591|NCT03006393|12545804|FG001|Overall Study|Lost to Follow-up|1
7978592|NCT03006458|12545810|FG000|First Intervention|Unsatisfied Vision|0
7978593|NCT03006458|12545811|FG001|First Intervention|Unsatisfied Vision|3
7978594|NCT03006562|12545828|FG000|Overall Study|Lost to Follow-up|0
7978595|NCT03006562|12545829|FG001|Overall Study|Lost to Follow-up|1
7978596|NCT03006887|12545835|FG000|Overall Study|Adverse Event|1
7978597|NCT03007472|12545857|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2
7978598|NCT03007472|12545857|FG000|Overall Study|Death|2
7978599|NCT03007472|12545857|FG000|Overall Study|Loss to Follow Up|1
7978600|NCT03007953|12545863|FG000|Overall Study|Withdrawal by Subject|5
7978601|NCT03007953|12545864|FG001|Overall Study|Withdrawal by Subject|2
7978602|NCT03007953|12545863|FG000|Overall Study|Death|5
7978603|NCT03007953|12545864|FG001|Overall Study|Death|7
7978604|NCT03007953|12545863|FG000|Overall Study|Lost to Follow-up|3
7978605|NCT03007953|12545864|FG001|Overall Study|Lost to Follow-up|2
7978606|NCT03007953|12545863|FG000|Overall Study|Enrolled in Hospice|3
7978607|NCT03007953|12545864|FG001|Overall Study|Enrolled in Hospice|2
7978608|NCT03007966|12545872|FG000|Overall Study|Did not meeting inclusion/exclusion|1
7978609|NCT03007966|12545873|FG001|Overall Study|Did not meeting inclusion/exclusion|0
7978610|NCT03008070|12545883|FG000|Overall Study|Adverse Event|3
7978611|NCT03008070|12545884|FG001|Overall Study|Adverse Event|3
7978612|NCT03008070|12545885|FG002|Overall Study|Adverse Event|3
7978613|NCT03008070|12545883|FG000|Overall Study|Lost to Follow-up|1
7978614|NCT03008070|12545884|FG001|Overall Study|Lost to Follow-up|1
7978615|NCT03008070|12545885|FG002|Overall Study|Lost to Follow-up|0
7978616|NCT03008070|12545883|FG000|Overall Study|Non compliance|0
7978617|NCT03008070|12545884|FG001|Overall Study|Non compliance|1
7978618|NCT03008070|12545885|FG002|Overall Study|Non compliance|1
7978619|NCT03008070|12545883|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0
7978620|NCT03008070|12545884|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1
7978621|NCT03008070|12545885|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0
7978622|NCT03008070|12545883|FG000|Overall Study|Withdrawal by Subject|2
7978623|NCT03008070|12545884|FG001|Overall Study|Withdrawal by Subject|0
7978624|NCT03008070|12545885|FG002|Overall Study|Withdrawal by Subject|1
7978625|NCT03008070|12545883|FG000|Overall Study|Use of prohibited drug|0
7978626|NCT03008070|12545884|FG001|Overall Study|Use of prohibited drug|0
7978627|NCT03008070|12545885|FG002|Overall Study|Use of prohibited drug|2
7978628|NCT03008460|12545910|FG000|Overall Study|Protocol deviation|0
7978629|NCT03008460|12545911|FG001|Overall Study|Protocol deviation|2
7978630|NCT03008460|12545910|FG000|Overall Study|Study drug not dispensed|0
7978631|NCT03008460|12545911|FG001|Overall Study|Study drug not dispensed|1
7978632|NCT03008460|12545910|FG000|Overall Study|Adverse Event|0
7978633|NCT03008460|12545911|FG001|Overall Study|Adverse Event|1
7978634|NCT03008460|12545910|FG000|Overall Study|Withdrawal by Subject|5
7978635|NCT03008460|12545911|FG001|Overall Study|Withdrawal by Subject|6
7978636|NCT03008460|12545910|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1
7978637|NCT03008460|12545911|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0
7978638|NCT03008460|12545910|FG000|Overall Study|End of study visit outside permitted time window|0
7978639|NCT03008460|12545911|FG001|Overall Study|End of study visit outside permitted time window|1
7978640|NCT03008460|12545910|FG000|Overall Study|Lost to Follow-up|1
7978641|NCT03008460|12545911|FG001|Overall Study|Lost to Follow-up|3
7978642|NCT03008915|12545957|FG000|Treatment 1|Withdrawal by Subject|0
7978643|NCT03008915|12545958|FG001|Treatment 1|Withdrawal by Subject|1
7978644|NCT03010254|12545993|FG000|Overall Study|Adverse Event|0
7978645|NCT03010254|12545994|FG001|Overall Study|Adverse Event|1
7978646|NCT03010254|12545993|FG000|Overall Study|Lost to Follow-up|4
7978647|NCT03010254|12545994|FG001|Overall Study|Lost to Follow-up|0
7978648|NCT03010254|12545993|FG000|Overall Study|Withdrawal by Subject|1
7978649|NCT03010254|12545994|FG001|Overall Study|Withdrawal by Subject|1
7978650|NCT03010254|12545993|FG000|Overall Study|Other|2
7978651|NCT03010254|12545994|FG001|Overall Study|Other|3
7978652|NCT03010462|12546009|FG000|Overall Study|Withdrawal by Subject|3
7978653|NCT03010462|12546010|FG001|Overall Study|Withdrawal by Subject|1
7978654|NCT03010501|12546025|FG000|Study Week 1|Withdrawal by Subject|2
7978655|NCT03010501|12546026|FG001|Study Week 1|Withdrawal by Subject|1
7978656|NCT03010501|12546027|FG002|Study Week 1|Withdrawal by Subject|0
7978657|NCT03010501|12546028|FG003|Study Week 1|Withdrawal by Subject|2
7978658|NCT03010501|12546029|FG004|Study Week 1|Withdrawal by Subject|0
7978659|NCT03010501|12546030|FG005|Study Week 1|Withdrawal by Subject|0
7978660|NCT03010501|12546025|FG000|Study Week 3|Withdrawal by Subject|0
7978661|NCT03010501|12546026|FG001|Study Week 3|Withdrawal by Subject|0
7978662|NCT03010501|12546027|FG002|Study Week 3|Withdrawal by Subject|0
7978663|NCT03010501|12546028|FG003|Study Week 3|Withdrawal by Subject|1
7978664|NCT03010501|12546029|FG004|Study Week 3|Withdrawal by Subject|0
7978665|NCT03010501|12546030|FG005|Study Week 3|Withdrawal by Subject|0
7978666|NCT03011099|12546079|FG000|Overall Study|Withdrawal by Subject|0
7978667|NCT03011099|12546080|FG001|Overall Study|Withdrawal by Subject|2
7978668|NCT03011333|12546095|FG000|Overall Study|Lost to Follow-up|0
7978669|NCT03011333|12546096|FG001|Overall Study|Lost to Follow-up|1
7978670|NCT03011333|12546097|FG002|Overall Study|Lost to Follow-up|0
7978671|NCT03011333|12546098|FG003|Overall Study|Lost to Follow-up|1
7978672|NCT03011333|12546099|FG004|Overall Study|Lost to Follow-up|4
7978673|NCT03011333|12546100|FG005|Overall Study|Lost to Follow-up|4
7978674|NCT03011333|12546101|FG006|Overall Study|Lost to Follow-up|5
7978675|NCT03011840|12546119|FG000|Overall Study|Not received PIL in post PIL phase|0
7978676|NCT03011840|12546120|FG001|Overall Study|Not received PIL in post PIL phase|21
7978677|NCT03011892|12546132|FG000|Double Blind (DB) Period|Adverse Event|0
7978678|NCT03011892|12546133|FG001|Double Blind (DB) Period|Adverse Event|1
7978679|NCT03011892|12546134|FG002|Double Blind (DB) Period|Adverse Event|1
7978680|NCT03011892|12546135|FG003|Double Blind (DB) Period|Adverse Event|0
7978681|NCT03011892|12546136|FG004|Double Blind (DB) Period|Adverse Event|0
7978682|NCT03011892|12546137|FG005|Double Blind (DB) Period|Adverse Event|0
7978683|NCT03011892|12546138|FG006|Double Blind (DB) Period|Adverse Event|0
7978684|NCT03011892|12546139|FG007|Double Blind (DB) Period|Adverse Event|0
7978685|NCT03011892|12546140|FG008|Double Blind (DB) Period|Adverse Event|0
7978686|NCT03011892|12546141|FG009|Double Blind (DB) Period|Adverse Event|0
7978687|NCT03011892|12546142|FG010|Double Blind (DB) Period|Adverse Event|0
7978688|NCT03011892|12546143|FG011|Double Blind (DB) Period|Adverse Event|0
7978689|NCT03011892|12546132|FG000|Double Blind (DB) Period|Lack of Efficacy|1
7978690|NCT03011892|12546133|FG001|Double Blind (DB) Period|Lack of Efficacy|0
7978691|NCT03011892|12546134|FG002|Double Blind (DB) Period|Lack of Efficacy|0
7978692|NCT03011892|12546135|FG003|Double Blind (DB) Period|Lack of Efficacy|0
7978693|NCT03011892|12546136|FG004|Double Blind (DB) Period|Lack of Efficacy|0
7978694|NCT03011892|12546137|FG005|Double Blind (DB) Period|Lack of Efficacy|0
7978695|NCT03011892|12546138|FG006|Double Blind (DB) Period|Lack of Efficacy|0
7978696|NCT03011892|12546139|FG007|Double Blind (DB) Period|Lack of Efficacy|0
7978697|NCT03011892|12546140|FG008|Double Blind (DB) Period|Lack of Efficacy|0
7978698|NCT03011892|12546141|FG009|Double Blind (DB) Period|Lack of Efficacy|0
7978699|NCT03011892|12546142|FG010|Double Blind (DB) Period|Lack of Efficacy|0
7978700|NCT03011892|12546143|FG011|Double Blind (DB) Period|Lack of Efficacy|0
7978701|NCT03011892|12546132|FG000|Double Blind (DB) Period|Lost to Follow-up|0
7978702|NCT03011892|12546133|FG001|Double Blind (DB) Period|Lost to Follow-up|3
7978703|NCT03011892|12546134|FG002|Double Blind (DB) Period|Lost to Follow-up|2
7978704|NCT03011892|12546135|FG003|Double Blind (DB) Period|Lost to Follow-up|5
7978705|NCT03011892|12546136|FG004|Double Blind (DB) Period|Lost to Follow-up|0
7978706|NCT03011892|12546137|FG005|Double Blind (DB) Period|Lost to Follow-up|2
7978707|NCT03011892|12546138|FG006|Double Blind (DB) Period|Lost to Follow-up|0
7978708|NCT03011892|12546139|FG007|Double Blind (DB) Period|Lost to Follow-up|0
7978709|NCT03011892|12546140|FG008|Double Blind (DB) Period|Lost to Follow-up|0
7978710|NCT03011892|12546141|FG009|Double Blind (DB) Period|Lost to Follow-up|0
7978711|NCT03011892|12546142|FG010|Double Blind (DB) Period|Lost to Follow-up|0
7978712|NCT03011892|12546143|FG011|Double Blind (DB) Period|Lost to Follow-up|0
7978713|NCT03011892|12546132|FG000|Double Blind (DB) Period|Other|1
7978714|NCT03011892|12546133|FG001|Double Blind (DB) Period|Other|1
7978715|NCT03011892|12546134|FG002|Double Blind (DB) Period|Other|1
7978716|NCT03011892|12546135|FG003|Double Blind (DB) Period|Other|0
7978717|NCT03011892|12546136|FG004|Double Blind (DB) Period|Other|1
7978718|NCT03011892|12546137|FG005|Double Blind (DB) Period|Other|0
7978719|NCT03011892|12546138|FG006|Double Blind (DB) Period|Other|0
7978720|NCT03011892|12546139|FG007|Double Blind (DB) Period|Other|0
7978721|NCT03011892|12546140|FG008|Double Blind (DB) Period|Other|0
7978722|NCT03011892|12546141|FG009|Double Blind (DB) Period|Other|0
7978723|NCT03011892|12546142|FG010|Double Blind (DB) Period|Other|0
7978724|NCT03011892|12546143|FG011|Double Blind (DB) Period|Other|0
7978725|NCT03011892|12546132|FG000|Double Blind (DB) Period|Physician Decision|1
7978726|NCT03011892|12546133|FG001|Double Blind (DB) Period|Physician Decision|0
7978727|NCT03011892|12546134|FG002|Double Blind (DB) Period|Physician Decision|1
7978728|NCT03011892|12546135|FG003|Double Blind (DB) Period|Physician Decision|0
7978729|NCT03011892|12546136|FG004|Double Blind (DB) Period|Physician Decision|0
7978730|NCT03011892|12546137|FG005|Double Blind (DB) Period|Physician Decision|0
7978731|NCT03011892|12546138|FG006|Double Blind (DB) Period|Physician Decision|0
7978732|NCT03011892|12546139|FG007|Double Blind (DB) Period|Physician Decision|0
7978733|NCT03011892|12546140|FG008|Double Blind (DB) Period|Physician Decision|0
7978734|NCT03011892|12546141|FG009|Double Blind (DB) Period|Physician Decision|0
7978735|NCT03011892|12546142|FG010|Double Blind (DB) Period|Physician Decision|0
7978736|NCT03011892|12546143|FG011|Double Blind (DB) Period|Physician Decision|0
7978737|NCT03011892|12546132|FG000|Double Blind (DB) Period|Pregnancy|0
7978738|NCT03011892|12546133|FG001|Double Blind (DB) Period|Pregnancy|0
7978739|NCT03011892|12546134|FG002|Double Blind (DB) Period|Pregnancy|0
7978740|NCT03011892|12546135|FG003|Double Blind (DB) Period|Pregnancy|0
7978741|NCT03011892|12546136|FG004|Double Blind (DB) Period|Pregnancy|1
7978742|NCT03011892|12546137|FG005|Double Blind (DB) Period|Pregnancy|0
7978743|NCT03011892|12546138|FG006|Double Blind (DB) Period|Pregnancy|0
7978744|NCT03011892|12546139|FG007|Double Blind (DB) Period|Pregnancy|0
7978745|NCT03011892|12546140|FG008|Double Blind (DB) Period|Pregnancy|0
7978746|NCT03011892|12546141|FG009|Double Blind (DB) Period|Pregnancy|0
7978747|NCT03011892|12546142|FG010|Double Blind (DB) Period|Pregnancy|0
7978748|NCT03011892|12546143|FG011|Double Blind (DB) Period|Pregnancy|0
7978749|NCT03011892|12546132|FG000|Double Blind (DB) Period|Protocol Violation|1
7978750|NCT03011892|12546133|FG001|Double Blind (DB) Period|Protocol Violation|0
7978751|NCT03011892|12546134|FG002|Double Blind (DB) Period|Protocol Violation|0
7978752|NCT03011892|12546135|FG003|Double Blind (DB) Period|Protocol Violation|0
7978753|NCT03011892|12546136|FG004|Double Blind (DB) Period|Protocol Violation|0
7978754|NCT03011892|12546137|FG005|Double Blind (DB) Period|Protocol Violation|0
7978755|NCT03011892|12546138|FG006|Double Blind (DB) Period|Protocol Violation|0
7978756|NCT03011892|12546139|FG007|Double Blind (DB) Period|Protocol Violation|0
7978757|NCT03011892|12546140|FG008|Double Blind (DB) Period|Protocol Violation|0
7978758|NCT03011892|12546141|FG009|Double Blind (DB) Period|Protocol Violation|0
7978759|NCT03011892|12546142|FG010|Double Blind (DB) Period|Protocol Violation|0
7978760|NCT03011892|12546143|FG011|Double Blind (DB) Period|Protocol Violation|0
7978761|NCT03011892|12546132|FG000|Double Blind (DB) Period|Withdrawal by Subject|7
7978762|NCT03011892|12546133|FG001|Double Blind (DB) Period|Withdrawal by Subject|5
7978763|NCT03011892|12546134|FG002|Double Blind (DB) Period|Withdrawal by Subject|1
7978764|NCT03011892|12546135|FG003|Double Blind (DB) Period|Withdrawal by Subject|2
7978765|NCT03011892|12546136|FG004|Double Blind (DB) Period|Withdrawal by Subject|4
7978766|NCT03011892|12546137|FG005|Double Blind (DB) Period|Withdrawal by Subject|3
7978767|NCT03011892|12546138|FG006|Double Blind (DB) Period|Withdrawal by Subject|0
7978768|NCT03011892|12546139|FG007|Double Blind (DB) Period|Withdrawal by Subject|0
7978769|NCT03011892|12546140|FG008|Double Blind (DB) Period|Withdrawal by Subject|0
7978770|NCT03011892|12546141|FG009|Double Blind (DB) Period|Withdrawal by Subject|0
7978771|NCT03011892|12546142|FG010|Double Blind (DB) Period|Withdrawal by Subject|0
7978772|NCT03011892|12546143|FG011|Double Blind (DB) Period|Withdrawal by Subject|0
7978773|NCT03011892|12546132|FG000|Double Blind (DB) Period|Randomized but not treated|0
7978774|NCT03011892|12546133|FG001|Double Blind (DB) Period|Randomized but not treated|0
7978775|NCT03011892|12546134|FG002|Double Blind (DB) Period|Randomized but not treated|0
7978776|NCT03011892|12546135|FG003|Double Blind (DB) Period|Randomized but not treated|0
7978777|NCT03011892|12546136|FG004|Double Blind (DB) Period|Randomized but not treated|1
7978778|NCT03011892|12546137|FG005|Double Blind (DB) Period|Randomized but not treated|0
7978779|NCT03011892|12546138|FG006|Double Blind (DB) Period|Randomized but not treated|0
7978780|NCT03011892|12546139|FG007|Double Blind (DB) Period|Randomized but not treated|0
7978781|NCT03011892|12546140|FG008|Double Blind (DB) Period|Randomized but not treated|0
7978782|NCT03011892|12546141|FG009|Double Blind (DB) Period|Randomized but not treated|0
7978783|NCT03011892|12546142|FG010|Double Blind (DB) Period|Randomized but not treated|0
7978784|NCT03011892|12546143|FG011|Double Blind (DB) Period|Randomized but not treated|0
7978785|NCT03011892|12546132|FG000|Open Label (OL) Period|Lost to Follow-up|0
7978786|NCT03011892|12546133|FG001|Open Label (OL) Period|Lost to Follow-up|0
7978787|NCT03011892|12546134|FG002|Open Label (OL) Period|Lost to Follow-up|0
7978788|NCT03011892|12546135|FG003|Open Label (OL) Period|Lost to Follow-up|0
7978789|NCT03011892|12546136|FG004|Open Label (OL) Period|Lost to Follow-up|0
7978790|NCT03011892|12546137|FG005|Open Label (OL) Period|Lost to Follow-up|0
7978791|NCT03011892|12546138|FG006|Open Label (OL) Period|Lost to Follow-up|4
7978792|NCT03011892|12546139|FG007|Open Label (OL) Period|Lost to Follow-up|2
7978793|NCT03011892|12546140|FG008|Open Label (OL) Period|Lost to Follow-up|1
7978794|NCT03011892|12546141|FG009|Open Label (OL) Period|Lost to Follow-up|0
7978795|NCT03011892|12546142|FG010|Open Label (OL) Period|Lost to Follow-up|1
7978796|NCT03011892|12546143|FG011|Open Label (OL) Period|Lost to Follow-up|1
7978797|NCT03011892|12546132|FG000|Open Label (OL) Period|Withdrawal by Subject|0
7978798|NCT03011892|12546133|FG001|Open Label (OL) Period|Withdrawal by Subject|0
7978799|NCT03011892|12546134|FG002|Open Label (OL) Period|Withdrawal by Subject|0
7978800|NCT03011892|12546135|FG003|Open Label (OL) Period|Withdrawal by Subject|0
7978801|NCT03011892|12546136|FG004|Open Label (OL) Period|Withdrawal by Subject|0
7978802|NCT03011892|12546137|FG005|Open Label (OL) Period|Withdrawal by Subject|0
7978803|NCT03011892|12546138|FG006|Open Label (OL) Period|Withdrawal by Subject|3
7978804|NCT03011892|12546139|FG007|Open Label (OL) Period|Withdrawal by Subject|0
7978805|NCT03011892|12546140|FG008|Open Label (OL) Period|Withdrawal by Subject|1
7978806|NCT03011892|12546141|FG009|Open Label (OL) Period|Withdrawal by Subject|0
7978807|NCT03011892|12546142|FG010|Open Label (OL) Period|Withdrawal by Subject|1
7978808|NCT03011892|12546143|FG011|Open Label (OL) Period|Withdrawal by Subject|2
7978809|NCT03011892|12546132|FG000|Open Label (OL) Period|Reason not specified|0
7978810|NCT03011892|12546133|FG001|Open Label (OL) Period|Reason not specified|0
7978811|NCT03011892|12546134|FG002|Open Label (OL) Period|Reason not specified|0
7978812|NCT03011892|12546135|FG003|Open Label (OL) Period|Reason not specified|0
7978813|NCT03011892|12546136|FG004|Open Label (OL) Period|Reason not specified|0
7978814|NCT03011892|12546137|FG005|Open Label (OL) Period|Reason not specified|0
7978815|NCT03011892|12546138|FG006|Open Label (OL) Period|Reason not specified|0
7978816|NCT03011892|12546139|FG007|Open Label (OL) Period|Reason not specified|1
7978817|NCT03011892|12546140|FG008|Open Label (OL) Period|Reason not specified|0
7978818|NCT03011892|12546141|FG009|Open Label (OL) Period|Reason not specified|0
7978819|NCT03011892|12546142|FG010|Open Label (OL) Period|Reason not specified|0
7978820|NCT03011892|12546143|FG011|Open Label (OL) Period|Reason not specified|0
7978821|NCT03012061|12546173|FG000|Overall Study|Withdrawal by Subject|1
7978822|NCT03012061|12546174|FG001|Overall Study|Withdrawal by Subject|5
7978823|NCT03012061|12546175|FG002|Overall Study|Withdrawal by Subject|4
7978824|NCT03012061|12546173|FG000|Overall Study|Investigator Site Closed|1
7978825|NCT03012061|12546174|FG001|Overall Study|Investigator Site Closed|2
7978826|NCT03012061|12546175|FG002|Overall Study|Investigator Site Closed|0
7978827|NCT03012061|12546173|FG000|Overall Study|Lost to Follow-up|2
7978828|NCT03012061|12546174|FG001|Overall Study|Lost to Follow-up|1
7978829|NCT03012061|12546175|FG002|Overall Study|Lost to Follow-up|0
7978830|NCT03012061|12546173|FG000|Overall Study|Study closed/ Terminated|0
7978831|NCT03012061|12546174|FG001|Overall Study|Study closed/ Terminated|0
7978832|NCT03012061|12546175|FG002|Overall Study|Study closed/ Terminated|1
7978833|NCT03012061|12546173|FG000|Overall Study|Met Protocol Withdrawal Criterion|0
7978834|NCT03012061|12546174|FG001|Overall Study|Met Protocol Withdrawal Criterion|0
7978835|NCT03012061|12546175|FG002|Overall Study|Met Protocol Withdrawal Criterion|1
7978836|NCT03012061|12546173|FG000|Overall Study|Protocol Violation|0
7978837|NCT03012061|12546174|FG001|Overall Study|Protocol Violation|0
7978838|NCT03012061|12546175|FG002|Overall Study|Protocol Violation|2
7978839|NCT03012061|12546173|FG000|Overall Study|Lack of Efficacy|0
7978840|NCT03012061|12546174|FG001|Overall Study|Lack of Efficacy|1
7978841|NCT03012061|12546175|FG002|Overall Study|Lack of Efficacy|0
7978842|NCT03012061|12546173|FG000|Overall Study|Adverse Event|2
7978843|NCT03012061|12546174|FG001|Overall Study|Adverse Event|0
7978844|NCT03012061|12546175|FG002|Overall Study|Adverse Event|0
7978845|NCT03012334|12546207|FG000|Period 1|Withdrawal by Subject|0
7978846|NCT03012334|12546208|FG001|Period 1|Withdrawal by Subject|0
7978847|NCT03012334|12546209|FG002|Period 1|Withdrawal by Subject|0
7978848|NCT03012334|12546210|FG003|Period 1|Withdrawal by Subject|0
7978849|NCT03012334|12546211|FG004|Period 1|Withdrawal by Subject|0
7978850|NCT03012334|12546212|FG005|Period 1|Withdrawal by Subject|0
7978851|NCT03012334|12546213|FG006|Period 1|Withdrawal by Subject|0
7978852|NCT03012334|12546214|FG007|Period 1|Withdrawal by Subject|0
7978853|NCT03012334|12546215|FG008|Period 1|Withdrawal by Subject|0
7978854|NCT03012334|12546216|FG009|Period 1|Withdrawal by Subject|1
7978855|NCT03012334|12546207|FG000|Period 2|Withdrawal by Subject|0
7978856|NCT03012334|12546208|FG001|Period 2|Withdrawal by Subject|1
7978857|NCT03012334|12546209|FG002|Period 2|Withdrawal by Subject|0
7978858|NCT03012334|12546210|FG003|Period 2|Withdrawal by Subject|0
7978859|NCT03012334|12546211|FG004|Period 2|Withdrawal by Subject|0
7978860|NCT03012334|12546212|FG005|Period 2|Withdrawal by Subject|0
7978861|NCT03012334|12546213|FG006|Period 2|Withdrawal by Subject|0
7978862|NCT03012334|12546214|FG007|Period 2|Withdrawal by Subject|0
7978863|NCT03012334|12546215|FG008|Period 2|Withdrawal by Subject|0
7978864|NCT03012334|12546216|FG009|Period 2|Withdrawal by Subject|0
7978865|NCT03012334|12546207|FG000|Period 2|Protocol Violation|0
7978866|NCT03012334|12546208|FG001|Period 2|Protocol Violation|0
7978867|NCT03012334|12546209|FG002|Period 2|Protocol Violation|1
7978868|NCT03012334|12546210|FG003|Period 2|Protocol Violation|0
7978869|NCT03012334|12546211|FG004|Period 2|Protocol Violation|0
7978870|NCT03012334|12546212|FG005|Period 2|Protocol Violation|0
7978871|NCT03012334|12546213|FG006|Period 2|Protocol Violation|0
7978872|NCT03012334|12546214|FG007|Period 2|Protocol Violation|1
7978873|NCT03012334|12546215|FG008|Period 2|Protocol Violation|0
7978874|NCT03012334|12546216|FG009|Period 2|Protocol Violation|0
7978875|NCT03012334|12546207|FG000|Period 4|Non-Compliance|0
7978876|NCT03012334|12546208|FG001|Period 4|Non-Compliance|0
7978877|NCT03012334|12546209|FG002|Period 4|Non-Compliance|0
7978878|NCT03012334|12546210|FG003|Period 4|Non-Compliance|0
7978879|NCT03012334|12546211|FG004|Period 4|Non-Compliance|0
7978880|NCT03012334|12546212|FG005|Period 4|Non-Compliance|0
7978881|NCT03012334|12546213|FG006|Period 4|Non-Compliance|1
7978882|NCT03012334|12546214|FG007|Period 4|Non-Compliance|0
7978883|NCT03012334|12546215|FG008|Period 4|Non-Compliance|0
7978884|NCT03012334|12546216|FG009|Period 4|Non-Compliance|0
7978885|NCT03012334|12546207|FG000|Period 4|Adverse Event|0
7978886|NCT03012334|12546208|FG001|Period 4|Adverse Event|0
7978887|NCT03012334|12546209|FG002|Period 4|Adverse Event|0
7978888|NCT03012334|12546210|FG003|Period 4|Adverse Event|0
7978889|NCT03012334|12546211|FG004|Period 4|Adverse Event|0
7978890|NCT03012334|12546212|FG005|Period 4|Adverse Event|0
7978891|NCT03012334|12546213|FG006|Period 4|Adverse Event|0
7978892|NCT03012334|12546214|FG007|Period 4|Adverse Event|0
7978893|NCT03012334|12546215|FG008|Period 4|Adverse Event|1
7978894|NCT03012334|12546216|FG009|Period 4|Adverse Event|0
7978895|NCT03012828|12546243|FG000|Overall Study|Lost to Follow-up|1
7978896|NCT03012828|12546244|FG001|Overall Study|Lost to Follow-up|0
7978897|NCT03012828|12546245|FG002|Overall Study|Lost to Follow-up|1
7978898|NCT03012828|12546246|FG003|Overall Study|Lost to Follow-up|0
7978899|NCT03012828|12546247|FG004|Overall Study|Lost to Follow-up|1
7978900|NCT03012828|12546248|FG005|Overall Study|Lost to Follow-up|0
7978901|NCT03012828|12546243|FG000|Overall Study|Withdrawal by Subject|0
7978902|NCT03012828|12546244|FG001|Overall Study|Withdrawal by Subject|0
7978903|NCT03012828|12546245|FG002|Overall Study|Withdrawal by Subject|1
7978904|NCT03012828|12546246|FG003|Overall Study|Withdrawal by Subject|0
7978905|NCT03012828|12546247|FG004|Overall Study|Withdrawal by Subject|0
7978906|NCT03012828|12546248|FG005|Overall Study|Withdrawal by Subject|1
7978907|NCT03012828|12546243|FG000|Overall Study|Non-compliance with protocol|0
7978908|NCT03012828|12546244|FG001|Overall Study|Non-compliance with protocol|0
7978909|NCT03012828|12546245|FG002|Overall Study|Non-compliance with protocol|0
7978910|NCT03012828|12546246|FG003|Overall Study|Non-compliance with protocol|0
7978911|NCT03012828|12546247|FG004|Overall Study|Non-compliance with protocol|1
7978912|NCT03012828|12546248|FG005|Overall Study|Non-compliance with protocol|0
7978913|NCT03012828|12546243|FG000|Overall Study|Delay to last visit would delay DBL|0
7978914|NCT03012828|12546244|FG001|Overall Study|Delay to last visit would delay DBL|0
7978915|NCT03012828|12546245|FG002|Overall Study|Delay to last visit would delay DBL|0
7978916|NCT03012828|12546246|FG003|Overall Study|Delay to last visit would delay DBL|0
7978917|NCT03012828|12546247|FG004|Overall Study|Delay to last visit would delay DBL|0
7978918|NCT03012828|12546248|FG005|Overall Study|Delay to last visit would delay DBL|1
7978919|NCT03012841|12546264|FG000|Overall Study|Protocol Violation|0
7978920|NCT03012841|12546265|FG001|Overall Study|Protocol Violation|10
7978921|NCT03012841|12546264|FG000|Overall Study|Lost to Follow-up|6
7978922|NCT03012841|12546265|FG001|Overall Study|Lost to Follow-up|1
7978923|NCT03012841|12546264|FG000|Overall Study|Withdrawal by Subject|6
7978924|NCT03012841|12546265|FG001|Overall Study|Withdrawal by Subject|0
7978925|NCT03012841|12546264|FG000|Overall Study|Unable to complete 12 month visit|6
7978926|NCT03012841|12546265|FG001|Overall Study|Unable to complete 12 month visit|0
7978927|NCT03012841|12546264|FG000|Overall Study|Subject relocation|1
7978928|NCT03012841|12546265|FG001|Overall Study|Subject relocation|0
7978929|NCT03012841|12546264|FG000|Overall Study|Seasonal winter travel|1
7978930|NCT03012841|12546265|FG001|Overall Study|Seasonal winter travel|0
7978931|NCT03012841|12546264|FG000|Overall Study|Physician Decision|0
7978932|NCT03012841|12546265|FG001|Overall Study|Physician Decision|2
7978933|NCT03012841|12546264|FG000|Overall Study|No ablation performed|0
7978934|NCT03012841|12546265|FG001|Overall Study|No ablation performed|2
7978935|NCT03012841|12546264|FG000|Overall Study|Study reached n=165 treated subject cap|0
7978936|NCT03012841|12546265|FG001|Overall Study|Study reached n=165 treated subject cap|5
7978937|NCT03012841|12546264|FG000|Overall Study|Insurance change|0
7978938|NCT03012841|12546265|FG001|Overall Study|Insurance change|1
7978939|NCT03013985|12546272|FG000|Overall Study|Protocol Violation|2
7978940|NCT03013985|12546273|FG001|Overall Study|Protocol Violation|2
7978941|NCT03013985|12546272|FG000|Overall Study|Withdrawal by Subject|14
7978942|NCT03013985|12546273|FG001|Overall Study|Withdrawal by Subject|17
7978943|NCT03014011|12546279|FG000|First Intervention|Withdrawal by Subject|1
7978944|NCT03014011|12546280|FG001|First Intervention|Withdrawal by Subject|0
7978945|NCT03014011|12546279|FG000|Washout|Withdrawal by Subject|1
7978946|NCT03014011|12546280|FG001|Washout|Withdrawal by Subject|0
7978947|NCT03014180|12546286|FG000|Overall Study|Protocol Violation|2
7978948|NCT03014206|12546294|FG000|Overall Study|Registration Violation|12
7978949|NCT03014453|12546298|FG000|Overall Study|Lost to Follow-up|12
7978950|NCT03014453|12546298|FG000|Overall Study|Discontinued GER|3
7978951|NCT03014453|12546298|FG000|Overall Study|Excluded|19
7978952|NCT03014453|12546298|FG000|Overall Study|Refused to take part in|37
7978953|NCT03014479|12546304|FG000|Overall Study|Adverse Event|0
7978954|NCT03014479|12546305|FG001|Overall Study|Adverse Event|1
7978955|NCT03014479|12546304|FG000|Overall Study|Voluntary Withdrawal|0
7978956|NCT03014479|12546305|FG001|Overall Study|Voluntary Withdrawal|2
7978957|NCT03014479|12546304|FG000|Overall Study|Unacceptable Inability of Site Visit|0
7978958|NCT03014479|12546305|FG001|Overall Study|Unacceptable Inability of Site Visit|1
7978959|NCT03014674|12546323|FG000|Overall Study|Withdrawal by Subject|1
7978960|NCT03014674|12546324|FG001|Overall Study|Withdrawal by Subject|0
7978961|NCT03014674|12546325|FG002|Overall Study|Withdrawal by Subject|0
7978962|NCT03015116|12546345|FG000|Overall Study|Lost to Follow-up|3
7978963|NCT03015116|12546346|FG001|Overall Study|Lost to Follow-up|0
7978964|NCT03015116|12546347|FG002|Overall Study|Lost to Follow-up|2
7978965|NCT03015116|12546345|FG000|Overall Study|Withdrawal by Subject|3
7978966|NCT03015116|12546346|FG001|Overall Study|Withdrawal by Subject|1
7978967|NCT03015116|12546347|FG002|Overall Study|Withdrawal by Subject|0
7978968|NCT03015116|12546345|FG000|Overall Study|Subject has New Medical Status|1
7978969|NCT03015116|12546346|FG001|Overall Study|Subject has New Medical Status|0
7978970|NCT03015116|12546347|FG002|Overall Study|Subject has New Medical Status|0
7978971|NCT03015116|12546345|FG000|Overall Study|Physician Decision|0
7978972|NCT03015116|12546346|FG001|Overall Study|Physician Decision|1
7978973|NCT03015116|12546347|FG002|Overall Study|Physician Decision|0
7978974|NCT03015181|12546364|FG000|Overall Study|Enrolled, but product never administered|1
7978975|NCT03015181|12546365|FG001|Overall Study|Enrolled, but product never administered|0
7978976|NCT03015181|12546366|FG002|Overall Study|Enrolled, but product never administered|0
7978977|NCT03015181|12546367|FG003|Overall Study|Enrolled, but product never administered|0
7978978|NCT03015181|12546368|FG004|Overall Study|Enrolled, but product never administered|0
7978979|NCT03015181|12546369|FG005|Overall Study|Enrolled, but product never administered|0
7978980|NCT03015181|12546370|FG006|Overall Study|Enrolled, but product never administered|0
7978981|NCT03015181|12546364|FG000|Overall Study|Withdrawal by Subject|0
7978982|NCT03015181|12546365|FG001|Overall Study|Withdrawal by Subject|0
7978983|NCT03015181|12546366|FG002|Overall Study|Withdrawal by Subject|0
7978984|NCT03015181|12546367|FG003|Overall Study|Withdrawal by Subject|0
7978985|NCT03015181|12546368|FG004|Overall Study|Withdrawal by Subject|0
7978986|NCT03015181|12546369|FG005|Overall Study|Withdrawal by Subject|1
7978987|NCT03015181|12546370|FG006|Overall Study|Withdrawal by Subject|0
7978988|NCT03015181|12546364|FG000|Overall Study|Physician Decision|0
7978989|NCT03015181|12546365|FG001|Overall Study|Physician Decision|0
7978990|NCT03015181|12546366|FG002|Overall Study|Physician Decision|0
7978991|NCT03015181|12546367|FG003|Overall Study|Physician Decision|0
7978992|NCT03015181|12546368|FG004|Overall Study|Physician Decision|0
7978993|NCT03015181|12546369|FG005|Overall Study|Physician Decision|0
7978994|NCT03015181|12546370|FG006|Overall Study|Physician Decision|1
7978995|NCT03015220|12546410|FG000|Overall Study|Withdrawal by Subject|3
7978996|NCT03015220|12546411|FG001|Overall Study|Withdrawal by Subject|2
7978997|NCT03015220|12546412|FG002|Overall Study|Withdrawal by Subject|2
7978998|NCT03015220|12546413|FG003|Overall Study|Withdrawal by Subject|2
7978999|NCT03015220|12546410|FG000|Overall Study|Lost to Follow-up|0
7979000|NCT03015220|12546411|FG001|Overall Study|Lost to Follow-up|0
7979001|NCT03015220|12546412|FG002|Overall Study|Lost to Follow-up|1
7979002|NCT03015220|12546413|FG003|Overall Study|Lost to Follow-up|0
7979003|NCT03015363|12546423|FG000|Overall Study|Physician Decision|14
7979004|NCT03015363|12546423|FG000|Overall Study|Withdrawal by Subject|3
7979005|NCT03015532|12546435|FG000|Overall Study|Adverse Event|0
7979006|NCT03015532|12546436|FG001|Overall Study|Adverse Event|0
7979007|NCT03015532|12546437|FG002|Overall Study|Adverse Event|0
7979008|NCT03015532|12546438|FG003|Overall Study|Adverse Event|0
7979009|NCT03015532|12546439|FG004|Overall Study|Adverse Event|0
7979010|NCT03015532|12546440|FG005|Overall Study|Adverse Event|2
7979011|NCT03015532|12546441|FG006|Overall Study|Adverse Event|1
7979012|NCT03015532|12546442|FG007|Overall Study|Adverse Event|0
7979013|NCT03015532|12546435|FG000|Overall Study|Withdrawal by Subject|0
7979014|NCT03015532|12546436|FG001|Overall Study|Withdrawal by Subject|0
7979015|NCT03015532|12546437|FG002|Overall Study|Withdrawal by Subject|0
7979016|NCT03015532|12546438|FG003|Overall Study|Withdrawal by Subject|0
7979017|NCT03015532|12546439|FG004|Overall Study|Withdrawal by Subject|0
7979018|NCT03015532|12546440|FG005|Overall Study|Withdrawal by Subject|0
7979019|NCT03015532|12546441|FG006|Overall Study|Withdrawal by Subject|1
7979020|NCT03015532|12546442|FG007|Overall Study|Withdrawal by Subject|0
7979021|NCT03016078|12546475|FG000|Overall Study|Protocol Violation|1
7979022|NCT03016078|12546475|FG000|Overall Study|Protocol Violation|1
7979023|NCT03016325|12546487|FG000|Treatment Period|Participant withdrew consent|0
7979024|NCT03016325|12546488|FG001|Treatment Period|Participant withdrew consent|1
7979025|NCT03016325|12546489|FG002|Treatment Period|Participant withdrew consent|0
7979026|NCT03016325|12546490|FG003|Treatment Period|Participant withdrew consent|0
7979027|NCT03016325|12546491|FG004|Treatment Period|Participant withdrew consent|0
7979028|NCT03016325|12546492|FG005|Treatment Period|Participant withdrew consent|0
7979029|NCT03016325|12546493|FG006|Treatment Period|Participant withdrew consent|0
7979030|NCT03016325|12546494|FG007|Treatment Period|Participant withdrew consent|0
7979031|NCT03016325|12546487|FG000|Treatment Period|Death|0
7979032|NCT03016325|12546488|FG001|Treatment Period|Death|0
7979033|NCT03016325|12546489|FG002|Treatment Period|Death|0
7979034|NCT03016325|12546490|FG003|Treatment Period|Death|0
7979035|NCT03016325|12546491|FG004|Treatment Period|Death|2
7979036|NCT03016325|12546492|FG005|Treatment Period|Death|0
7979037|NCT03016325|12546493|FG006|Treatment Period|Death|0
7979038|NCT03016325|12546494|FG007|Treatment Period|Death|0
7979039|NCT03016325|12546487|FG000|Treatment Period|Participant refuses assessments|0
7979040|NCT03016325|12546488|FG001|Treatment Period|Participant refuses assessments|0
7979041|NCT03016325|12546489|FG002|Treatment Period|Participant refuses assessments|1
7979042|NCT03016325|12546490|FG003|Treatment Period|Participant refuses assessments|0
7979043|NCT03016325|12546491|FG004|Treatment Period|Participant refuses assessments|0
7979044|NCT03016325|12546492|FG005|Treatment Period|Participant refuses assessments|0
7979045|NCT03016325|12546493|FG006|Treatment Period|Participant refuses assessments|0
7979046|NCT03016325|12546494|FG007|Treatment Period|Participant refuses assessments|0
7979047|NCT03016325|12546487|FG000|32-Day Follow-Up Period|Death|2
7979048|NCT03016325|12546488|FG001|32-Day Follow-Up Period|Death|0
7979049|NCT03016325|12546489|FG002|32-Day Follow-Up Period|Death|5
7979050|NCT03016325|12546490|FG003|32-Day Follow-Up Period|Death|6
7979051|NCT03016325|12546491|FG004|32-Day Follow-Up Period|Death|3
7979052|NCT03016325|12546492|FG005|32-Day Follow-Up Period|Death|0
7979053|NCT03016325|12546493|FG006|32-Day Follow-Up Period|Death|0
7979054|NCT03016325|12546494|FG007|32-Day Follow-Up Period|Death|0
7979055|NCT03016325|12546487|FG000|32-Day Follow-Up Period|Lost to Follow-up|1
7979056|NCT03016325|12546488|FG001|32-Day Follow-Up Period|Lost to Follow-up|0
7979057|NCT03016325|12546489|FG002|32-Day Follow-Up Period|Lost to Follow-up|1
7979058|NCT03016325|12546490|FG003|32-Day Follow-Up Period|Lost to Follow-up|1
7979059|NCT03016325|12546491|FG004|32-Day Follow-Up Period|Lost to Follow-up|0
7979060|NCT03016325|12546492|FG005|32-Day Follow-Up Period|Lost to Follow-up|0
7979061|NCT03016325|12546493|FG006|32-Day Follow-Up Period|Lost to Follow-up|0
7979062|NCT03016325|12546494|FG007|32-Day Follow-Up Period|Lost to Follow-up|0
7979063|NCT03016325|12546487|FG000|32-Day Follow-Up Period|Poor/non-compliance|1
7979064|NCT03016325|12546488|FG001|32-Day Follow-Up Period|Poor/non-compliance|0
7979065|NCT03016325|12546489|FG002|32-Day Follow-Up Period|Poor/non-compliance|0
7979066|NCT03016325|12546490|FG003|32-Day Follow-Up Period|Poor/non-compliance|1
7979067|NCT03016325|12546491|FG004|32-Day Follow-Up Period|Poor/non-compliance|1
7979068|NCT03016325|12546492|FG005|32-Day Follow-Up Period|Poor/non-compliance|0
7979069|NCT03016325|12546493|FG006|32-Day Follow-Up Period|Poor/non-compliance|0
7979070|NCT03016325|12546494|FG007|32-Day Follow-Up Period|Poor/non-compliance|0
7979071|NCT03016325|12546487|FG000|32-Day Follow-Up Period|Participant refused to visit|0
7979072|NCT03016325|12546488|FG001|32-Day Follow-Up Period|Participant refused to visit|1
7979073|NCT03016325|12546489|FG002|32-Day Follow-Up Period|Participant refused to visit|2
7979074|NCT03016325|12546490|FG003|32-Day Follow-Up Period|Participant refused to visit|0
7979075|NCT03016325|12546491|FG004|32-Day Follow-Up Period|Participant refused to visit|2
7979076|NCT03016325|12546492|FG005|32-Day Follow-Up Period|Participant refused to visit|0
7979077|NCT03016325|12546493|FG006|32-Day Follow-Up Period|Participant refused to visit|0
7979078|NCT03016325|12546494|FG007|32-Day Follow-Up Period|Participant refused to visit|0
7979079|NCT03016325|12546487|FG000|32-Day Follow-Up Period|Participant withdrew consent|0
7979080|NCT03016325|12546488|FG001|32-Day Follow-Up Period|Participant withdrew consent|0
7979081|NCT03016325|12546489|FG002|32-Day Follow-Up Period|Participant withdrew consent|0
7979082|NCT03016325|12546490|FG003|32-Day Follow-Up Period|Participant withdrew consent|0
7979083|NCT03016325|12546491|FG004|32-Day Follow-Up Period|Participant withdrew consent|2
7979084|NCT03016325|12546492|FG005|32-Day Follow-Up Period|Participant withdrew consent|0
7979085|NCT03016325|12546493|FG006|32-Day Follow-Up Period|Participant withdrew consent|1
7979086|NCT03016325|12546494|FG007|32-Day Follow-Up Period|Participant withdrew consent|0
7979087|NCT03016325|12546487|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7979088|NCT03016325|12546488|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7979089|NCT03016325|12546489|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1
7979090|NCT03016325|12546490|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7979091|NCT03016325|12546491|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7979092|NCT03016325|12546492|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7979093|NCT03016325|12546493|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7979094|NCT03016325|12546494|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7979095|NCT03016325|12546487|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7979096|NCT03016325|12546488|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1
7979097|NCT03016325|12546489|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7979098|NCT03016325|12546490|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7979099|NCT03016325|12546491|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7979100|NCT03016325|12546492|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7979101|NCT03016325|12546493|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7979102|NCT03016325|12546494|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7979103|NCT03016325|12546487|FG000|182-Day Follow-Up Period|Death|3
7979104|NCT03016325|12546488|FG001|182-Day Follow-Up Period|Death|3
7979105|NCT03016325|12546489|FG002|182-Day Follow-Up Period|Death|11
7979106|NCT03016325|12546490|FG003|182-Day Follow-Up Period|Death|12
7979107|NCT03016325|12546491|FG004|182-Day Follow-Up Period|Death|9
7979108|NCT03016325|12546492|FG005|182-Day Follow-Up Period|Death|0
7979109|NCT03016325|12546493|FG006|182-Day Follow-Up Period|Death|0
7979110|NCT03016325|12546494|FG007|182-Day Follow-Up Period|Death|1
7979111|NCT03016325|12546487|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1
7979112|NCT03016325|12546488|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0
7979113|NCT03016325|12546489|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0
7979114|NCT03016325|12546490|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0
7979115|NCT03016325|12546491|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0
7979116|NCT03016325|12546492|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0
7979117|NCT03016325|12546493|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0
7979118|NCT03016325|12546494|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0
7979119|NCT03016325|12546487|FG000|182-Day Follow-Up Period|Participant withdrew consent|0
7979120|NCT03016325|12546488|FG001|182-Day Follow-Up Period|Participant withdrew consent|0
7979121|NCT03016325|12546489|FG002|182-Day Follow-Up Period|Participant withdrew consent|0
7979122|NCT03016325|12546490|FG003|182-Day Follow-Up Period|Participant withdrew consent|0
7979123|NCT03016325|12546491|FG004|182-Day Follow-Up Period|Participant withdrew consent|1
7979124|NCT03016325|12546492|FG005|182-Day Follow-Up Period|Participant withdrew consent|0
7979125|NCT03016325|12546493|FG006|182-Day Follow-Up Period|Participant withdrew consent|1
7979126|NCT03016325|12546494|FG007|182-Day Follow-Up Period|Participant withdrew consent|0
7979127|NCT03016325|12546487|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0
7979128|NCT03016325|12546488|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0
7979129|NCT03016325|12546489|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0
7979130|NCT03016325|12546490|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0
7979131|NCT03016325|12546491|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1
7979132|NCT03016325|12546492|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0
7979133|NCT03016325|12546493|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0
7979134|NCT03016325|12546494|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0
7979135|NCT03016325|12546487|FG000|182-Day Follow-Up Period|Alive, per civil unit|0
7979136|NCT03016325|12546488|FG001|182-Day Follow-Up Period|Alive, per civil unit|0
7979137|NCT03016325|12546489|FG002|182-Day Follow-Up Period|Alive, per civil unit|0
7979138|NCT03016325|12546490|FG003|182-Day Follow-Up Period|Alive, per civil unit|0
7979139|NCT03016325|12546491|FG004|182-Day Follow-Up Period|Alive, per civil unit|1
7979140|NCT03016325|12546492|FG005|182-Day Follow-Up Period|Alive, per civil unit|0
7979141|NCT03016325|12546493|FG006|182-Day Follow-Up Period|Alive, per civil unit|0
7979142|NCT03016325|12546494|FG007|182-Day Follow-Up Period|Alive, per civil unit|0
7979143|NCT03016325|12546487|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0
7979144|NCT03016325|12546488|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0
7979145|NCT03016325|12546489|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0
7979146|NCT03016325|12546490|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1
7979147|NCT03016325|12546491|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0
7979148|NCT03016325|12546492|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0
7979149|NCT03016325|12546493|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0
7979150|NCT03016325|12546494|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0
7979151|NCT03016325|12546487|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7979152|NCT03016325|12546488|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1
7979153|NCT03016325|12546489|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7979154|NCT03016325|12546490|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7979155|NCT03016325|12546491|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7979156|NCT03016325|12546492|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7979157|NCT03016325|12546493|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7979158|NCT03016325|12546494|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7979159|NCT03016325|12546487|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7979160|NCT03016325|12546488|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7979161|NCT03016325|12546489|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7979162|NCT03016325|12546490|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7979163|NCT03016325|12546491|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7979164|NCT03016325|12546492|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5
7979165|NCT03016325|12546493|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3
7979166|NCT03016325|12546494|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4
7979167|NCT03016403|12546519|FG000|Baseline|Death|5
7979168|NCT03016403|12546520|FG001|Baseline|Death|8
7979169|NCT03016403|12546521|FG002|Baseline|Death|1
7979170|NCT03016403|12546522|FG003|Baseline|Death|0
7979171|NCT03016403|12546519|FG000|Baseline|Withdrawal by Subject|2
7979172|NCT03016403|12546520|FG001|Baseline|Withdrawal by Subject|8
7979173|NCT03016403|12546521|FG002|Baseline|Withdrawal by Subject|4
7979174|NCT03016403|12546522|FG003|Baseline|Withdrawal by Subject|10
7979175|NCT03016403|12546519|FG000|Baseline|Lost to Follow-up|9
7979176|NCT03016403|12546520|FG001|Baseline|Lost to Follow-up|11
7979177|NCT03016403|12546521|FG002|Baseline|Lost to Follow-up|6
7979178|NCT03016403|12546522|FG003|Baseline|Lost to Follow-up|24
7979179|NCT03016403|12546519|FG000|6-week Follow-up|Death|1
7979180|NCT03016403|12546520|FG001|6-week Follow-up|Death|4
7979181|NCT03016403|12546521|FG002|6-week Follow-up|Death|0
7979182|NCT03016403|12546522|FG003|6-week Follow-up|Death|0
7979183|NCT03016403|12546519|FG000|6-week Follow-up|Lost to Follow-up|2
7979184|NCT03016403|12546520|FG001|6-week Follow-up|Lost to Follow-up|7
7979185|NCT03016403|12546521|FG002|6-week Follow-up|Lost to Follow-up|4
7979186|NCT03016403|12546522|FG003|6-week Follow-up|Lost to Follow-up|8
7979187|NCT03016403|12546519|FG000|6-week Follow-up|Withdrawal by Subject|0
7979188|NCT03016403|12546520|FG001|6-week Follow-up|Withdrawal by Subject|2
7979189|NCT03016403|12546521|FG002|6-week Follow-up|Withdrawal by Subject|0
7979190|NCT03016403|12546522|FG003|6-week Follow-up|Withdrawal by Subject|1
7979191|NCT03016403|12546519|FG000|3-month Follow-up and 6-month Follow-up|Death|6
7979192|NCT03016403|12546520|FG001|3-month Follow-up and 6-month Follow-up|Death|4
7979193|NCT03016403|12546521|FG002|3-month Follow-up and 6-month Follow-up|Death|0
7979194|NCT03016403|12546522|FG003|3-month Follow-up and 6-month Follow-up|Death|0
7979195|NCT03016403|12546519|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6
7979196|NCT03016403|12546520|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7
7979197|NCT03016403|12546521|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8
7979198|NCT03016403|12546522|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6
7979199|NCT03016403|12546519|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
7979200|NCT03016403|12546520|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
7979201|NCT03016403|12546521|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
7979202|NCT03016403|12546522|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1
7979203|NCT03016598|12546536|FG000|Overall Study|Lost to Follow-up|0
7979204|NCT03016598|12546537|FG001|Overall Study|Lost to Follow-up|2
7979205|NCT03017079|12546545|FG000|Overall Study|Physician Decision|1
7979206|NCT03017079|12546546|FG001|Overall Study|Physician Decision|1
7979207|NCT03017079|12546545|FG000|Overall Study|Death|3
7979208|NCT03017079|12546546|FG001|Overall Study|Death|2
7979209|NCT03017079|12546545|FG000|Overall Study|Lack of Efficacy|2
7979210|NCT03017079|12546546|FG001|Overall Study|Lack of Efficacy|2
7979211|NCT03017079|12546545|FG000|Overall Study|Protocol Violation|0
7979212|NCT03017079|12546546|FG001|Overall Study|Protocol Violation|1
7979213|NCT03017235|12546561|FG000|Overall Study|Withdrawal by Subject|4
7979214|NCT03017235|12546562|FG001|Overall Study|Withdrawal by Subject|3
7979215|NCT03017235|12546561|FG000|Overall Study|Lost to Follow-up|2
7979216|NCT03017235|12546562|FG001|Overall Study|Lost to Follow-up|7
7979217|NCT03017235|12546561|FG000|Overall Study|Adverse Event|0
7979218|NCT03017235|12546562|FG001|Overall Study|Adverse Event|1
7979219|NCT03017235|12546561|FG000|Overall Study|Protocol Violation|2
7979220|NCT03017235|12546562|FG001|Overall Study|Protocol Violation|1
7979221|NCT03017235|12546561|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4
7979222|NCT03017235|12546562|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2
7979223|NCT03017612|12546581|FG000|Overall Study|Adverse Event|2
7979224|NCT03017846|12546585|FG000|Overall Study|Lost to Follow-up|3
7979225|NCT03017846|12546585|FG000|Overall Study|Adverse Event|2
7979226|NCT03018028|12546612|FG000|Overall Study|Withdrawal by Subject|3
7979227|NCT03018028|12546613|FG001|Overall Study|Withdrawal by Subject|0
7979228|NCT03018028|12546614|FG002|Overall Study|Withdrawal by Subject|1
7979229|NCT03018028|12546615|FG003|Overall Study|Withdrawal by Subject|2
7979230|NCT03018028|12546616|FG004|Overall Study|Withdrawal by Subject|0
7979231|NCT03018106|12546630|FG000|Overall Study|Lost to Follow-up|0
7979232|NCT03018106|12546631|FG001|Overall Study|Lost to Follow-up|1
7979233|NCT03018249|12546641|FG000|Overall Study|Withdrawal by Subject|2
7979234|NCT03018249|12546642|FG001|Overall Study|Withdrawal by Subject|2
7979235|NCT03018340|12546650|FG000|Overall Study|Adverse Event|1
7979236|NCT03018340|12546651|FG001|Overall Study|Adverse Event|2
7979237|NCT03018340|12546650|FG000|Overall Study|Withdrawal by Subject|0
7979238|NCT03018340|12546651|FG001|Overall Study|Withdrawal by Subject|8
7979239|NCT03018340|12546650|FG000|Overall Study|Lack of Efficacy|0
7979240|NCT03018340|12546651|FG001|Overall Study|Lack of Efficacy|1
7979241|NCT03018340|12546650|FG000|Overall Study|Non-compliance with study drug/procedure|3
7979242|NCT03018340|12546651|FG001|Overall Study|Non-compliance with study drug/procedure|4
7979243|NCT03018340|12546650|FG000|Overall Study|Lost to Follow-up|1
7979244|NCT03018340|12546651|FG001|Overall Study|Lost to Follow-up|7
7979245|NCT03018340|12546650|FG000|Overall Study|Protocol Violation|3
7979246|NCT03018340|12546651|FG001|Overall Study|Protocol Violation|7
7979247|NCT03018340|12546650|FG000|Overall Study|Not further specified|0
7979248|NCT03018340|12546651|FG001|Overall Study|Not further specified|1
7979249|NCT03018691|12546664|FG000|Overall Study|Adverse Event|1
7979250|NCT03018691|12546665|FG001|Overall Study|Adverse Event|1
7979251|NCT03018691|12546666|FG002|Overall Study|Adverse Event|4
7979252|NCT03018691|12546664|FG000|Overall Study|Lack of Efficacy|0
7979253|NCT03018691|12546665|FG001|Overall Study|Lack of Efficacy|0
7979254|NCT03018691|12546666|FG002|Overall Study|Lack of Efficacy|1
7979255|NCT03018691|12546664|FG000|Overall Study|Withdrawal by Subject|0
7979256|NCT03018691|12546665|FG001|Overall Study|Withdrawal by Subject|0
7979257|NCT03018691|12546666|FG002|Overall Study|Withdrawal by Subject|1
7979258|NCT03018691|12546664|FG000|Overall Study|Withdrawal by parent/guardian|1
7979259|NCT03018691|12546665|FG001|Overall Study|Withdrawal by parent/guardian|0
7979260|NCT03018691|12546666|FG002|Overall Study|Withdrawal by parent/guardian|1
7979261|NCT03018938|12546703|FG000|Overall Study|Death|0
7979262|NCT03018938|12546704|FG001|Overall Study|Death|1
7979263|NCT03018938|12546703|FG000|Overall Study|Lost to Follow-up|21
7979264|NCT03018938|12546704|FG001|Overall Study|Lost to Follow-up|32
7979265|NCT03018938|12546703|FG000|Overall Study|Withdrawal by Subject|38
7979266|NCT03018938|12546704|FG001|Overall Study|Withdrawal by Subject|45
7979267|NCT03018938|12546703|FG000|Overall Study|Physician Decision|3
7979268|NCT03018938|12546704|FG001|Overall Study|Physician Decision|2
7979269|NCT03018938|12546703|FG000|Overall Study|Sponsor Decision|0
7979270|NCT03018938|12546704|FG001|Overall Study|Sponsor Decision|1
7979271|NCT03018938|12546703|FG000|Overall Study|Screen failure-After randomization|4
7979272|NCT03018938|12546704|FG001|Overall Study|Screen failure-After randomization|2
7979273|NCT03018938|12546703|FG000|Overall Study|Not recorded|0
7979274|NCT03018938|12546704|FG001|Overall Study|Not recorded|2
7979275|NCT03019289|12546745|FG000|Overall Study|Adverse Event|1
7979276|NCT03019289|12546746|FG001|Overall Study|Adverse Event|0
7979277|NCT03019289|12546747|FG002|Overall Study|Adverse Event|0
7979278|NCT03019289|12546748|FG003|Overall Study|Adverse Event|0
7979279|NCT03019289|12546749|FG004|Overall Study|Adverse Event|0
7979280|NCT03019289|12546750|FG005|Overall Study|Adverse Event|0
7979281|NCT03019289|12546751|FG006|Overall Study|Adverse Event|0
7979282|NCT03019289|12546752|FG007|Overall Study|Adverse Event|0
7979283|NCT03019289|12546753|FG008|Overall Study|Adverse Event|1
7979284|NCT03019289|12546745|FG000|Overall Study|Other|1
7979285|NCT03019289|12546746|FG001|Overall Study|Other|0
7979286|NCT03019289|12546747|FG002|Overall Study|Other|0
7979287|NCT03019289|12546748|FG003|Overall Study|Other|0
7979288|NCT03019289|12546749|FG004|Overall Study|Other|0
7979289|NCT03019289|12546750|FG005|Overall Study|Other|0
7979290|NCT03019289|12546751|FG006|Overall Study|Other|0
7979291|NCT03019289|12546752|FG007|Overall Study|Other|0
7979292|NCT03019289|12546753|FG008|Overall Study|Other|0
7979293|NCT03019458|12546776|FG000|Overall Study|Death|0
7979294|NCT03019458|12546777|FG001|Overall Study|Death|1
7979295|NCT03019549|12546785|FG000|Washout|DId not meet genotype criteria|11
7979296|NCT03019549|12546785|FG000|Period 2|Adverse Event|2
7979297|NCT03019549|12546785|FG000|Period 2|Physician Decision|2
7979298|NCT03019549|12546785|FG000|Period 2|Withdrawal by Subject|1
7979299|NCT03019627|12546796|FG000|Overall Study|Adverse Event|8
7979300|NCT03019627|12546797|FG001|Overall Study|Adverse Event|0
7979301|NCT03019627|12546796|FG000|Overall Study|Unrelated to adverse event|1
7979302|NCT03019627|12546797|FG001|Overall Study|Unrelated to adverse event|3
7979303|NCT03019627|12546796|FG000|Overall Study|Lost to Follow-up|2
7979304|NCT03019627|12546797|FG001|Overall Study|Lost to Follow-up|1
7979305|NCT03019627|12546796|FG000|Overall Study|not compliance|2
7979306|NCT03019627|12546797|FG001|Overall Study|not compliance|2
7979307|NCT03019627|12546796|FG000|Overall Study|Other|2
7979308|NCT03019627|12546797|FG001|Overall Study|Other|2
7979309|NCT03019965|12546839|FG000|Overall Study|Withdrawal by Subject|1
7979310|NCT03019965|12546840|FG001|Overall Study|Withdrawal by Subject|0
7979311|NCT03019965|12546839|FG000|Overall Study|Protocol Violation|1
7979312|NCT03019965|12546840|FG001|Overall Study|Protocol Violation|3
7979313|NCT03019965|12546839|FG000|Overall Study|viral or fungal infection|3
7979314|NCT03019965|12546840|FG001|Overall Study|viral or fungal infection|4
7979315|NCT03019965|12546839|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4
7979316|NCT03019965|12546840|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5
7979317|NCT03019965|12546839|FG000|Overall Study|Physician Decision|1
7979318|NCT03019965|12546840|FG001|Overall Study|Physician Decision|1
7979319|NCT03020069|12546852|FG000|Overall Study|Lost to Follow-up|0
7979320|NCT03020069|12546853|FG001|Overall Study|Lost to Follow-up|1
7979321|NCT03020407|12546869|FG000|Overall Study|Withdrawal by Subject|2
7979322|NCT03020407|12546870|FG001|Overall Study|Withdrawal by Subject|1
7979323|NCT03020407|12546869|FG000|Overall Study|Lost to Follow-up|2
7979324|NCT03020407|12546870|FG001|Overall Study|Lost to Follow-up|3
7979325|NCT03020407|12546869|FG000|Overall Study|Protocol Violation|0
7979326|NCT03020407|12546870|FG001|Overall Study|Protocol Violation|1
7979327|NCT03020576|12546926|FG000|Overall Study|Withdrawal by Subject|1
7979328|NCT03020576|12546927|FG001|Overall Study|Withdrawal by Subject|2
7979329|NCT03020615|12546936|FG000|Overall Study|Physician Decision|3
7979330|NCT03020615|12546937|FG001|Overall Study|Physician Decision|1
7979331|NCT03020615|12546938|FG002|Overall Study|Physician Decision|2
7979332|NCT03020615|12546936|FG000|Overall Study|Parent/guardian/patient choice|3
7979333|NCT03020615|12546937|FG001|Overall Study|Parent/guardian/patient choice|0
7979334|NCT03020615|12546938|FG002|Overall Study|Parent/guardian/patient choice|4
7979335|NCT03020615|12546936|FG000|Overall Study|Screen failure|0
7979336|NCT03020615|12546937|FG001|Overall Study|Screen failure|0
7979337|NCT03020615|12546938|FG002|Overall Study|Screen failure|1
7979338|NCT03020615|12546936|FG000|Overall Study|Death|1
7979339|NCT03020615|12546937|FG001|Overall Study|Death|0
7979340|NCT03020615|12546938|FG002|Overall Study|Death|0
7979341|NCT03020615|12546936|FG000|Overall Study|Lost to Follow-up|0
7979342|NCT03020615|12546937|FG001|Overall Study|Lost to Follow-up|1
7979343|NCT03020615|12546938|FG002|Overall Study|Lost to Follow-up|0
7979344|NCT03020641|12546951|FG000|Overall Study|Lost to Follow-up|0
7979345|NCT03020641|12546952|FG001|Overall Study|Lost to Follow-up|1
7979346|NCT03020641|12546951|FG000|Overall Study|Converted to open surgery|2
7979347|NCT03020641|12546952|FG001|Overall Study|Converted to open surgery|1
7979348|NCT03020641|12546951|FG000|Overall Study|for surgery not performed|0
7979349|NCT03020641|12546952|FG001|Overall Study|for surgery not performed|1
7979350|NCT03020745|12546978|FG000|Part 2 (Up to 169 Days)|Adverse Event|0
7979351|NCT03020745|12546979|FG001|Part 2 (Up to 169 Days)|Adverse Event|0
7979352|NCT03020745|12546980|FG002|Part 2 (Up to 169 Days)|Adverse Event|0
7979353|NCT03020745|12546981|FG003|Part 2 (Up to 169 Days)|Adverse Event|0
7979354|NCT03020745|12546982|FG004|Part 2 (Up to 169 Days)|Adverse Event|0
7979355|NCT03020745|12546983|FG005|Part 2 (Up to 169 Days)|Adverse Event|0
7979356|NCT03020745|12546984|FG006|Part 2 (Up to 169 Days)|Adverse Event|0
7979357|NCT03020745|12546985|FG007|Part 2 (Up to 169 Days)|Adverse Event|0
7979358|NCT03020745|12546986|FG008|Part 2 (Up to 169 Days)|Adverse Event|1
7979359|NCT03020745|12546987|FG009|Part 2 (Up to 169 Days)|Adverse Event|0
7979360|NCT03020745|12546978|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7979361|NCT03020745|12546979|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7979362|NCT03020745|12546980|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7979363|NCT03020745|12546981|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7979364|NCT03020745|12546982|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7979365|NCT03020745|12546983|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7979366|NCT03020745|12546984|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7979367|NCT03020745|12546985|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1
7979368|NCT03020745|12546986|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7979369|NCT03020745|12546987|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7979370|NCT03020745|12546978|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7979371|NCT03020745|12546979|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7979372|NCT03020745|12546980|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7979373|NCT03020745|12546981|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7979374|NCT03020745|12546982|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7979375|NCT03020745|12546983|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
7979376|NCT03020745|12546984|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7979377|NCT03020745|12546985|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7979378|NCT03020745|12546986|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
7979379|NCT03020745|12546987|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7979380|NCT03020745|12546978|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7979381|NCT03020745|12546979|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7979382|NCT03020745|12546980|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7979383|NCT03020745|12546981|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7979384|NCT03020745|12546982|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7979385|NCT03020745|12546983|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7979386|NCT03020745|12546984|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7979387|NCT03020745|12546985|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7979388|NCT03020745|12546986|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2
7979389|NCT03020745|12546987|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7979390|NCT03020888|12547011|FG000|Overall Study|Physician Decision|4
7979391|NCT03020888|12547011|FG000|Overall Study|Withdrawal by Subject|6
7979392|NCT03020888|12547011|FG000|Overall Study|Insurance coverage|2
7979393|NCT03020888|12547011|FG000|Overall Study|Lost to Follow-up|1
7979394|NCT03020966|12547017|FG000|Overall Study|Withdrawal by Subject|2
7979395|NCT03020966|12547018|FG001|Overall Study|Withdrawal by Subject|0
7979396|NCT03020992|12547024|FG000|Overall Study|Adverse Event|5
7979397|NCT03020992|12547024|FG000|Overall Study|Withdrawal by Subject|1
7979398|NCT03021005|12547031|FG000|Overall Study|Lost to Follow-up|39
7979399|NCT03021005|12547032|FG001|Overall Study|Lost to Follow-up|26
7979400|NCT03021018|12547041|FG000|Overall Study|Adverse Event|1
7979401|NCT03021018|12547042|FG001|Overall Study|Adverse Event|0
7979402|NCT03021018|12547043|FG002|Overall Study|Adverse Event|0
7979403|NCT03021018|12547041|FG000|Overall Study|Fall with subsequent nasal fracture|1
7979404|NCT03021018|12547042|FG001|Overall Study|Fall with subsequent nasal fracture|0
7979405|NCT03021018|12547043|FG002|Overall Study|Fall with subsequent nasal fracture|0
7979406|NCT03021187|12547055|FG000|Overall Study|Death|0
7979407|NCT03021187|12547056|FG001|Overall Study|Death|0
7979408|NCT03021187|12547057|FG002|Overall Study|Death|3
7979409|NCT03021187|12547058|FG003|Overall Study|Death|0
7979410|NCT03021187|12547055|FG000|Overall Study|Withdrawal by Subject|0
7979411|NCT03021187|12547056|FG001|Overall Study|Withdrawal by Subject|6
7979412|NCT03021187|12547057|FG002|Overall Study|Withdrawal by Subject|2
7979413|NCT03021187|12547058|FG003|Overall Study|Withdrawal by Subject|5
7979414|NCT03021187|12547055|FG000|Overall Study|Lost to Follow-up|10
7979415|NCT03021187|12547056|FG001|Overall Study|Lost to Follow-up|3
7979416|NCT03021187|12547057|FG002|Overall Study|Lost to Follow-up|1
7979417|NCT03021187|12547058|FG003|Overall Study|Lost to Follow-up|4
7979418|NCT03021265|12547068|FG000|Overall Study|Adverse Event|29
7979419|NCT03021265|12547068|FG000|Overall Study|Lack of Efficacy|3
7979420|NCT03021265|12547068|FG000|Overall Study|Improved|17
7979421|NCT03021265|12547068|FG000|Overall Study|Lost to Follow-up|67
7979422|NCT03021265|12547068|FG000|Overall Study|No reason given|2
7979423|NCT03021265|12547068|FG000|Overall Study|No visit since the first visit|4
7979424|NCT03021304|12547072|FG000|Overall Study|Lack of Efficacy|1
7979425|NCT03021499|12547087|FG000|Overall Study|Adverse Event|1
7979426|NCT03021499|12547088|FG001|Overall Study|Adverse Event|0
7979427|NCT03021499|12547087|FG000|Overall Study|Death|1
7979428|NCT03021499|12547088|FG001|Overall Study|Death|5
7979429|NCT03021499|12547087|FG000|Overall Study|Lack of Efficacy|0
7979430|NCT03021499|12547088|FG001|Overall Study|Lack of Efficacy|1
7979431|NCT03021499|12547087|FG000|Overall Study|Lost to Follow-up|1
7979432|NCT03021499|12547088|FG001|Overall Study|Lost to Follow-up|3
7979433|NCT03021499|12547087|FG000|Overall Study|Physician Decision|2
7979434|NCT03021499|12547088|FG001|Overall Study|Physician Decision|3
7979435|NCT03021499|12547087|FG000|Overall Study|Pregnancy|1
7979436|NCT03021499|12547088|FG001|Overall Study|Pregnancy|0
7979437|NCT03021499|12547087|FG000|Overall Study|Withdrawal by Subject|7
7979438|NCT03021499|12547088|FG001|Overall Study|Withdrawal by Subject|14
7979439|NCT03021499|12547087|FG000|Overall Study|Prohibited medication required|1
7979440|NCT03021499|12547088|FG001|Overall Study|Prohibited medication required|0
7979441|NCT03021499|12547087|FG000|Overall Study|Protocol non-compliance|1
7979442|NCT03021499|12547088|FG001|Overall Study|Protocol non-compliance|1
7979443|NCT03021499|12547087|FG000|Overall Study|None of the above|0
7979444|NCT03021499|12547088|FG001|Overall Study|None of the above|4
7979445|NCT03021499|12547087|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1
7979446|NCT03021499|12547088|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0
7979447|NCT03021564|12547107|FG000|Overall Study|Death|84
7979448|NCT03021564|12547108|FG001|Overall Study|Death|466
7979449|NCT03021564|12547107|FG000|Overall Study|Lost to Follow-up|0
7979450|NCT03021564|12547108|FG001|Overall Study|Lost to Follow-up|2
7979451|NCT03021668|12547120|FG000|Overall Study|Physician Decision|0
7979452|NCT03021668|12547121|FG001|Overall Study|Physician Decision|1
7979453|NCT03022045|12547142|FG000|Overall Study|Adverse Event|0
7979454|NCT03022045|12547143|FG001|Overall Study|Adverse Event|1
7979455|NCT03022045|12547142|FG000|Overall Study|Withdrawal by Subject|1
7979456|NCT03022045|12547143|FG001|Overall Study|Withdrawal by Subject|1
7979457|NCT03022084|12547155|FG000|Overall Study|Lost to Follow-up|2
7979458|NCT03022084|12547156|FG001|Overall Study|Lost to Follow-up|3
7979459|NCT03022370|12547166|FG000|Overall Study|Death|6
7979460|NCT03022370|12547167|FG001|Overall Study|Death|12
7979461|NCT03022370|12547166|FG000|Overall Study|Lost to Follow-up|174
7979462|NCT03022370|12547167|FG001|Overall Study|Lost to Follow-up|109
7979463|NCT03022422|12547208|FG000|Overall Study|3 subjects consented but not vaccinated|0
7979464|NCT03022422|12547209|FG001|Overall Study|3 subjects consented but not vaccinated|0
7979465|NCT03022422|12547210|FG002|Overall Study|3 subjects consented but not vaccinated|3
7979466|NCT03022422|12547211|FG003|Overall Study|3 subjects consented but not vaccinated|0
7979467|NCT03022422|12547212|FG004|Overall Study|3 subjects consented but not vaccinated|0
7979468|NCT03022422|12547213|FG005|Overall Study|3 subjects consented but not vaccinated|0
7979469|NCT03022630|12547268|FG000|Overall Study|Death|9
7979470|NCT03022630|12547269|FG001|Overall Study|Death|7
7979471|NCT03022630|12547268|FG000|Overall Study|Withdrawal by Subject|0
7979472|NCT03022630|12547269|FG001|Overall Study|Withdrawal by Subject|5
7979473|NCT03022799|12547293|FG000|Overall Study|Adverse Event|0
7979474|NCT03022799|12547294|FG001|Overall Study|Adverse Event|0
7979475|NCT03022799|12547295|FG002|Overall Study|Adverse Event|0
7979476|NCT03022799|12547296|FG003|Overall Study|Adverse Event|0
7979477|NCT03022799|12547297|FG004|Overall Study|Adverse Event|0
7979478|NCT03022799|12547298|FG005|Overall Study|Adverse Event|0
7979479|NCT03022799|12547299|FG006|Overall Study|Adverse Event|0
7979480|NCT03022799|12547300|FG007|Overall Study|Adverse Event|0
7979481|NCT03022799|12547301|FG008|Overall Study|Adverse Event|0
7979482|NCT03022799|12547302|FG009|Overall Study|Adverse Event|1
7979483|NCT03022799|12547303|FG010|Overall Study|Adverse Event|1
7979484|NCT03022799|12547304|FG011|Overall Study|Adverse Event|0
7979485|NCT03022799|12547305|FG012|Overall Study|Adverse Event|0
7979486|NCT03022981|12547363|FG000|Overall Study|Adverse Event|0
7979487|NCT03022981|12547364|FG001|Overall Study|Adverse Event|1
7979488|NCT03022981|12547365|FG002|Overall Study|Adverse Event|0
7979489|NCT03022981|12547363|FG000|Overall Study|Investigator's Discretion|0
7979490|NCT03022981|12547364|FG001|Overall Study|Investigator's Discretion|1
7979491|NCT03022981|12547365|FG002|Overall Study|Investigator's Discretion|2
7979492|NCT03022981|12547363|FG000|Overall Study|Lost to Follow-up|6
7979493|NCT03022981|12547364|FG001|Overall Study|Lost to Follow-up|2
7979494|NCT03022981|12547365|FG002|Overall Study|Lost to Follow-up|1
7979495|NCT03022981|12547363|FG000|Overall Study|Non-Compliance With Study Drug|0
7979496|NCT03022981|12547364|FG001|Overall Study|Non-Compliance With Study Drug|0
7979497|NCT03022981|12547365|FG002|Overall Study|Non-Compliance With Study Drug|2
7979498|NCT03022981|12547363|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0
7979499|NCT03022981|12547364|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0
7979500|NCT03022981|12547365|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1
7979501|NCT03023137|12547385|FG000|Overall Study|Multiple pregnancy|2
7979502|NCT03023137|12547386|FG001|Overall Study|Multiple pregnancy|4
7979503|NCT03023137|12547385|FG000|Overall Study|Lost to Follow-up|1
7979504|NCT03023137|12547386|FG001|Overall Study|Lost to Follow-up|1
7979505|NCT03023137|12547385|FG000|Overall Study|Protocol Violation|0
7979506|NCT03023137|12547386|FG001|Overall Study|Protocol Violation|4
7979507|NCT03023137|12547385|FG000|Overall Study|Lost the baby in a car accident|1
7979508|NCT03023137|12547386|FG001|Overall Study|Lost the baby in a car accident|0
7979509|NCT03023397|12547400|FG000|Run-In|Failed screening allergen challenge|1
7979510|NCT03023397|12547401|FG001|Run-In|Failed screening allergen challenge|0
7979511|NCT03023397|12547402|FG002|Run-In|Failed screening allergen challenge|0
7979512|NCT03023397|12547400|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1
7979513|NCT03023397|12547401|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0
7979514|NCT03023397|12547402|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0
7979515|NCT03023423|12547414|FG000|Overall Study|Death|5
7979516|NCT03023423|12547415|FG001|Overall Study|Death|12
7979517|NCT03023423|12547416|FG002|Overall Study|Death|20
7979518|NCT03023423|12547414|FG000|Overall Study|Other|0
7979519|NCT03023423|12547415|FG001|Overall Study|Other|2
7979520|NCT03023423|12547416|FG002|Overall Study|Other|2
7979521|NCT03023423|12547414|FG000|Overall Study|Ongoing|2
7979522|NCT03023423|12547415|FG001|Overall Study|Ongoing|32
7979523|NCT03023423|12547416|FG002|Overall Study|Ongoing|24
7979524|NCT03023722|12547467|FG000|Overall Study|No follow-up assessment|4
7979525|NCT03023826|12547471|FG000|Period 1|Withdrawal by Subject|0
7979526|NCT03023826|12547472|FG001|Period 1|Withdrawal by Subject|0
7979527|NCT03023826|12547473|FG002|Period 1|Withdrawal by Subject|0
7979528|NCT03023826|12547474|FG003|Period 1|Withdrawal by Subject|0
7979529|NCT03023826|12547475|FG004|Period 1|Withdrawal by Subject|1
7979530|NCT03023826|12547476|FG005|Period 1|Withdrawal by Subject|0
7979531|NCT03023878|12547484|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11
7979532|NCT03023878|12547484|FG000|Pre-Study Run-In Period|Death|1
7979533|NCT03023878|12547484|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5
7979534|NCT03023878|12547484|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2
7979535|NCT03023878|12547484|FG000|Treatment Period|Disease Progression|1
7979536|NCT03023878|12547484|FG000|Treatment Period|Withdrawal by Subject|1
7979537|NCT03023878|12547484|FG000|Treatment Period|Adverse Event|1
7979538|NCT03023878|12547484|FG000|Long Term Follow-Up Period|Death|2
7979539|NCT03024606|12547503|FG000|Overall Study|Withdrawal by Subject|9
7979540|NCT03024606|12547504|FG001|Overall Study|Withdrawal by Subject|10
7979541|NCT03024970|12547510|FG000|First Intervention|Adverse Event|1
7979542|NCT03024970|12547511|FG001|First Intervention|Adverse Event|0
7979543|NCT03024970|12547510|FG000|Second Intervention|Lost to Follow-up|1
7979544|NCT03024970|12547511|FG001|Second Intervention|Lost to Follow-up|0
7979545|NCT03025217|12547517|FG000|Overall Study|Pregnancy|1
7979546|NCT03025217|12547517|FG000|Overall Study|Lost to Follow-up|1
7979547|NCT03025217|12547517|FG000|Overall Study|Not eligible, poor English|2
7979548|NCT03026075|12547530|FG000|Overall Study|Physician Decision|1
7979549|NCT03026088|12547534|FG000|Overall Study|Study termination|20
7979550|NCT03026166|12547540|FG000|Overall Study|Death|22
7979551|NCT03026166|12547541|FG001|Overall Study|Death|7
7979552|NCT03026166|12547540|FG000|Overall Study|Physician Decision|2
7979553|NCT03026166|12547541|FG001|Overall Study|Physician Decision|0
7979554|NCT03026166|12547540|FG000|Overall Study|Withdrawal by Subject|1
7979555|NCT03026166|12547541|FG001|Overall Study|Withdrawal by Subject|2
7979556|NCT03026166|12547540|FG000|Overall Study|Lost to Follow-up|1
7979557|NCT03026166|12547541|FG001|Overall Study|Lost to Follow-up|0
7979558|NCT03026166|12547540|FG000|Overall Study|Study Terminated by Sponsor|3
7979559|NCT03026166|12547541|FG001|Overall Study|Study Terminated by Sponsor|3
7979560|NCT03026166|12547540|FG000|Overall Study|Other|1
7979561|NCT03026166|12547541|FG001|Overall Study|Other|0
7979562|NCT03026257|12547553|FG000|Overall Study|Adverse Event|3
7979563|NCT03026257|12547554|FG001|Overall Study|Adverse Event|0
7979564|NCT03026257|12547555|FG002|Overall Study|Adverse Event|0
7979565|NCT03026257|12547556|FG003|Overall Study|Adverse Event|0
7979566|NCT03026257|12547557|FG004|Overall Study|Adverse Event|0
7979567|NCT03026257|12547558|FG005|Overall Study|Adverse Event|0
7979568|NCT03026257|12547553|FG000|Overall Study|Lost to Follow-up|1
7979569|NCT03026257|12547554|FG001|Overall Study|Lost to Follow-up|0
7979570|NCT03026257|12547555|FG002|Overall Study|Lost to Follow-up|0
7979571|NCT03026257|12547556|FG003|Overall Study|Lost to Follow-up|0
7979572|NCT03026257|12547557|FG004|Overall Study|Lost to Follow-up|0
7979573|NCT03026257|12547558|FG005|Overall Study|Lost to Follow-up|0
7979574|NCT03026257|12547553|FG000|Overall Study|Protocol Violation|1
7979575|NCT03026257|12547554|FG001|Overall Study|Protocol Violation|0
7979576|NCT03026257|12547555|FG002|Overall Study|Protocol Violation|0
7979577|NCT03026257|12547556|FG003|Overall Study|Protocol Violation|1
7979578|NCT03026257|12547557|FG004|Overall Study|Protocol Violation|1
7979579|NCT03026257|12547558|FG005|Overall Study|Protocol Violation|0
7979580|NCT03026257|12547553|FG000|Overall Study|Withdrawal by Subject|1
7979581|NCT03026257|12547554|FG001|Overall Study|Withdrawal by Subject|1
7979582|NCT03026257|12547555|FG002|Overall Study|Withdrawal by Subject|0
7979583|NCT03026257|12547556|FG003|Overall Study|Withdrawal by Subject|0
7979584|NCT03026257|12547557|FG004|Overall Study|Withdrawal by Subject|0
7979585|NCT03026257|12547558|FG005|Overall Study|Withdrawal by Subject|0
7979586|NCT03026283|12547572|FG000|CCTA Diagnosis|CCTA not performed as planned|9
7979587|NCT03026283|12547573|FG001|CCTA Diagnosis|CCTA not performed as planned|0
7979588|NCT03026283|12547574|FG002|CCTA Diagnosis|CCTA not performed as planned|0
7979589|NCT03026283|12547575|FG003|CCTA Diagnosis|CCTA not performed as planned|0
7979590|NCT03026283|12547576|FG004|CCTA Diagnosis|CCTA not performed as planned|0
7979591|NCT03026283|12547577|FG005|CCTA Diagnosis|CCTA not performed as planned|0
7979592|NCT03026283|12547578|FG006|CCTA Diagnosis|CCTA not performed as planned|0
7979593|NCT03026283|12547579|FG007|CCTA Diagnosis|CCTA not performed as planned|0
7979594|NCT03026283|12547572|FG000|CCTA Diagnosis|Withdrawal by Subject|5
7979595|NCT03026283|12547573|FG001|CCTA Diagnosis|Withdrawal by Subject|0
7979596|NCT03026283|12547574|FG002|CCTA Diagnosis|Withdrawal by Subject|0
7979597|NCT03026283|12547575|FG003|CCTA Diagnosis|Withdrawal by Subject|0
7979598|NCT03026283|12547576|FG004|CCTA Diagnosis|Withdrawal by Subject|0
7979599|NCT03026283|12547577|FG005|CCTA Diagnosis|Withdrawal by Subject|0
7979600|NCT03026283|12547578|FG006|CCTA Diagnosis|Withdrawal by Subject|0
7979601|NCT03026283|12547579|FG007|CCTA Diagnosis|Withdrawal by Subject|0
7979602|NCT03026283|12547572|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7979603|NCT03026283|12547573|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3
7979604|NCT03026283|12547574|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7979605|NCT03026283|12547575|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7979606|NCT03026283|12547576|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7979607|NCT03026283|12547577|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7979608|NCT03026283|12547578|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7979609|NCT03026283|12547579|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7979610|NCT03026283|12547572|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7979611|NCT03026283|12547573|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7979612|NCT03026283|12547574|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15
7979613|NCT03026283|12547575|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7979614|NCT03026283|12547576|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7979615|NCT03026283|12547577|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7979616|NCT03026283|12547578|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7979617|NCT03026283|12547579|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7979618|NCT03026283|12547572|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7979619|NCT03026283|12547573|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7979620|NCT03026283|12547574|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7979621|NCT03026283|12547575|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8
7979622|NCT03026283|12547576|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11
7979623|NCT03026283|12547577|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7979624|NCT03026283|12547578|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7979625|NCT03026283|12547579|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7979626|NCT03026283|12547572|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7979627|NCT03026283|12547573|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7979628|NCT03026283|12547574|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7979629|NCT03026283|12547575|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9
7979630|NCT03026283|12547576|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
7979631|NCT03026283|12547577|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
7979632|NCT03026283|12547578|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7979633|NCT03026283|12547579|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7979634|NCT03026283|12547572|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7979635|NCT03026283|12547573|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7979636|NCT03026283|12547574|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7979637|NCT03026283|12547575|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2
7979638|NCT03026283|12547576|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7979639|NCT03026283|12547577|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7
7979640|NCT03026283|12547578|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7979641|NCT03026283|12547579|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7979642|NCT03026283|12547572|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7979643|NCT03026283|12547573|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7979644|NCT03026283|12547574|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7979645|NCT03026283|12547575|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1
7979646|NCT03026283|12547576|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7979647|NCT03026283|12547577|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7979648|NCT03026283|12547578|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7979649|NCT03026283|12547579|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7979650|NCT03026283|12547572|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7979651|NCT03026283|12547573|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7979652|NCT03026283|12547574|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7979653|NCT03026283|12547575|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7979654|NCT03026283|12547576|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25
7979655|NCT03026283|12547577|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19
7979656|NCT03026283|12547578|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7979657|NCT03026283|12547579|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7979658|NCT03026530|12547594|FG000|Overall Study|Lost to Follow-up|19
7979659|NCT03026530|12547595|FG001|Overall Study|Lost to Follow-up|24
7979660|NCT03026530|12547594|FG000|Overall Study|Protocol Violation|2
7979661|NCT03026530|12547595|FG001|Overall Study|Protocol Violation|5
7979662|NCT03027466|12547632|FG000|Overall Study|Opting out of the app|1869
7979663|NCT03027466|12547633|FG001|Overall Study|Opting out of the app|1819
7979664|NCT03027466|12547634|FG002|Overall Study|Opting out of the app|1743
7979665|NCT03027466|12547635|FG003|Overall Study|Opting out of the app|1821
7979666|NCT03027557|12547648|FG000|Overall Study|Adverse Event|1
7979667|NCT03027557|12547649|FG001|Overall Study|Adverse Event|0
7979668|NCT03027557|12547650|FG002|Overall Study|Adverse Event|0
7979669|NCT03028012|12547670|FG000|Overall Study|Lost to Follow-up|2
7979670|NCT03028012|12547671|FG001|Overall Study|Lost to Follow-up|3
7979671|NCT03028012|12547672|FG002|Overall Study|Lost to Follow-up|3
7979672|NCT03028129|12547705|FG000|Overall Study|Adverse Event|13
7979673|NCT03028129|12547706|FG001|Overall Study|Adverse Event|2
7979674|NCT03028129|12547705|FG000|Overall Study|Lost to Follow-up|50
7979675|NCT03028129|12547706|FG001|Overall Study|Lost to Follow-up|38
7979676|NCT03028129|12547705|FG000|Overall Study|Physician Decision|0
7979677|NCT03028129|12547706|FG001|Overall Study|Physician Decision|1
7979678|NCT03028129|12547705|FG000|Overall Study|Protocol Violation|1
7979679|NCT03028129|12547706|FG001|Overall Study|Protocol Violation|1
7979680|NCT03028129|12547705|FG000|Overall Study|Withdrawal by Subject|62
7979681|NCT03028129|12547706|FG001|Overall Study|Withdrawal by Subject|45
7979682|NCT03028142|12547712|FG000|Overall Study|Adverse Event|1
7979683|NCT03028142|12547713|FG001|Overall Study|Adverse Event|1
7979684|NCT03028142|12547714|FG002|Overall Study|Adverse Event|0
7979685|NCT03028142|12547715|FG003|Overall Study|Adverse Event|0
7979686|NCT03028142|12547716|FG004|Overall Study|Adverse Event|0
7979687|NCT03028142|12547717|FG005|Overall Study|Adverse Event|1
7979688|NCT03028142|12547712|FG000|Overall Study|Withdrawal by Subject|0
7979689|NCT03028142|12547713|FG001|Overall Study|Withdrawal by Subject|0
7979690|NCT03028142|12547714|FG002|Overall Study|Withdrawal by Subject|0
7979691|NCT03028142|12547715|FG003|Overall Study|Withdrawal by Subject|0
7979692|NCT03028142|12547716|FG004|Overall Study|Withdrawal by Subject|1
7979693|NCT03028142|12547717|FG005|Overall Study|Withdrawal by Subject|0
7979694|NCT03028415|12547750|FG000|Overall Study|Lost to Follow-up|6
7979695|NCT03028415|12547751|FG001|Overall Study|Lost to Follow-up|3
7979696|NCT03028415|12547750|FG000|Overall Study|Withdrawal by Subject|1
7979697|NCT03028415|12547751|FG001|Overall Study|Withdrawal by Subject|0
7979698|NCT03028415|12547750|FG000|Overall Study|Discontinued due to COVID-19|1
7979699|NCT03028415|12547751|FG001|Overall Study|Discontinued due to COVID-19|0
7979700|NCT03028870|12547791|FG000|Overall Study|Adverse Event|7
7979701|NCT03028870|12547792|FG001|Overall Study|Adverse Event|4
7979702|NCT03028870|12547793|FG002|Overall Study|Adverse Event|3
7979703|NCT03028870|12547794|FG003|Overall Study|Adverse Event|3
7979704|NCT03028870|12547791|FG000|Overall Study|Withdrawal by Subject|1
7979705|NCT03028870|12547792|FG001|Overall Study|Withdrawal by Subject|1
7979706|NCT03028870|12547793|FG002|Overall Study|Withdrawal by Subject|1
7979707|NCT03028870|12547794|FG003|Overall Study|Withdrawal by Subject|2
7979708|NCT03028870|12547791|FG000|Overall Study|Lost to Follow-up|1
7979709|NCT03028870|12547792|FG001|Overall Study|Lost to Follow-up|0
7979710|NCT03028870|12547793|FG002|Overall Study|Lost to Follow-up|0
7979711|NCT03028870|12547794|FG003|Overall Study|Lost to Follow-up|0
7979712|NCT03028870|12547791|FG000|Overall Study|Lack of Efficacy|3
7979713|NCT03028870|12547792|FG001|Overall Study|Lack of Efficacy|0
7979714|NCT03028870|12547793|FG002|Overall Study|Lack of Efficacy|0
7979715|NCT03028870|12547794|FG003|Overall Study|Lack of Efficacy|0
7979716|NCT03028870|12547791|FG000|Overall Study|Administrative|5
7979717|NCT03028870|12547792|FG001|Overall Study|Administrative|5
7979718|NCT03028870|12547793|FG002|Overall Study|Administrative|12
7979719|NCT03028870|12547794|FG003|Overall Study|Administrative|4
7979720|NCT03029143|12547848|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8
7979721|NCT03029143|12547849|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0
7979722|NCT03029143|12547850|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0
7979723|NCT03029143|12547848|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12
7979724|NCT03029143|12547849|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0
7979725|NCT03029143|12547850|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0
7979726|NCT03029143|12547848|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1
7979727|NCT03029143|12547849|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0
7979728|NCT03029143|12547850|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0
7979729|NCT03029143|12547848|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6
7979730|NCT03029143|12547849|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0
7979731|NCT03029143|12547850|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0
7979732|NCT03029143|12547848|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142
7979733|NCT03029143|12547849|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0
7979734|NCT03029143|12547850|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0
7979735|NCT03029143|12547848|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0
7979736|NCT03029143|12547849|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3
7979737|NCT03029143|12547850|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9
7979738|NCT03029143|12547848|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0
7979739|NCT03029143|12547849|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1
7979740|NCT03029143|12547850|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3
7979741|NCT03029143|12547848|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0
7979742|NCT03029143|12547849|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1
7979743|NCT03029143|12547850|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3
7979744|NCT03029143|12547848|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0
7979745|NCT03029143|12547849|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10
7979746|NCT03029143|12547850|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1
7979747|NCT03029143|12547848|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0
7979748|NCT03029143|12547849|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6
7979749|NCT03029143|12547850|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7
7979750|NCT03029143|12547848|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0
7979751|NCT03029143|12547849|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2
7979752|NCT03029143|12547850|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1
7979753|NCT03029208|12547861|FG000|Overall Study|Withdrawal by Subject|2
7979754|NCT03029208|12547862|FG001|Overall Study|Withdrawal by Subject|3
7979755|NCT03029208|12547861|FG000|Overall Study|Lost to Follow-up|0
7979756|NCT03029208|12547862|FG001|Overall Study|Lost to Follow-up|1
7979757|NCT03029247|12547879|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3
7979758|NCT03029247|12547880|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0
7979759|NCT03029247|12547879|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1
7979760|NCT03029247|12547880|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1
7979761|NCT03029247|12547879|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7
7979762|NCT03029247|12547880|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4
7979763|NCT03029247|12547879|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2
7979764|NCT03029247|12547880|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2
7979765|NCT03029585|12547888|FG000|Overall Study|Death|1
7979766|NCT03029585|12547889|FG001|Overall Study|Death|1
7979767|NCT03029585|12547888|FG000|Overall Study|Withdrawal by Subject|1
7979768|NCT03029585|12547889|FG001|Overall Study|Withdrawal by Subject|0
7979769|NCT03029624|12547895|FG000|Overall Study|Adverse Event|1
7979770|NCT03029624|12547895|FG000|Overall Study|Withdrawal by Subject|1
7979771|NCT03029624|12547895|FG000|Overall Study|Lack of Efficacy|1
7979772|NCT03029624|12547895|FG000|Overall Study|MRI need|2
7979773|NCT03029650|12547901|FG000|Washout (1 Week)|Withdrawal by Subject|1
7979774|NCT03029650|12547902|FG001|Washout (1 Week)|Withdrawal by Subject|1
7979775|NCT03029650|12547901|FG000|Washout (1 Week)|Physician Decision|0
7979776|NCT03029650|12547902|FG001|Washout (1 Week)|Physician Decision|1
7979777|NCT03029819|12547923|FG000|Overall Study|Lost to Follow-up|3
7979778|NCT03029819|12547924|FG001|Overall Study|Lost to Follow-up|5
7979779|NCT03029819|12547923|FG000|Overall Study|Removed due to disruptive behavior|0
7979780|NCT03029819|12547924|FG001|Overall Study|Removed due to disruptive behavior|1
7979781|NCT03030599|12547938|FG000|Open Label Treatment and Titration|Protocol deviation|8
7979782|NCT03030599|12547939|FG001|Open Label Treatment and Titration|Protocol deviation|0
7979783|NCT03030599|12547940|FG002|Open Label Treatment and Titration|Protocol deviation|0
7979784|NCT03030599|12547938|FG000|Open Label Treatment and Titration|Other|1
7979785|NCT03030599|12547939|FG001|Open Label Treatment and Titration|Other|0
7979786|NCT03030599|12547940|FG002|Open Label Treatment and Titration|Other|0
7979787|NCT03030599|12547938|FG000|Open Label Treatment and Titration|Physician Decision|3
7979788|NCT03030599|12547939|FG001|Open Label Treatment and Titration|Physician Decision|0
7979789|NCT03030599|12547940|FG002|Open Label Treatment and Titration|Physician Decision|0
7979790|NCT03030599|12547938|FG000|Open Label Treatment and Titration|Lack of Efficacy|1
7979791|NCT03030599|12547939|FG001|Open Label Treatment and Titration|Lack of Efficacy|0
7979792|NCT03030599|12547940|FG002|Open Label Treatment and Titration|Lack of Efficacy|0
7979793|NCT03030599|12547938|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4
7979794|NCT03030599|12547939|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
7979795|NCT03030599|12547940|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
7979796|NCT03030599|12547938|FG000|Open Label Treatment and Titration|Adverse Event|18
7979797|NCT03030599|12547939|FG001|Open Label Treatment and Titration|Adverse Event|0
7979798|NCT03030599|12547940|FG002|Open Label Treatment and Titration|Adverse Event|0
7979799|NCT03030599|12547938|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6
7979800|NCT03030599|12547939|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0
7979801|NCT03030599|12547940|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0
7979802|NCT03030599|12547938|FG000|Open Label Treatment and Titration|Sponsor decision|2
7979803|NCT03030599|12547939|FG001|Open Label Treatment and Titration|Sponsor decision|0
7979804|NCT03030599|12547940|FG002|Open Label Treatment and Titration|Sponsor decision|0
7979805|NCT03030599|12547938|FG000|Open Label Treatment and Titration|Lost to Follow-up|3
7979806|NCT03030599|12547939|FG001|Open Label Treatment and Titration|Lost to Follow-up|0
7979807|NCT03030599|12547940|FG002|Open Label Treatment and Titration|Lost to Follow-up|0
7979808|NCT03030599|12547938|FG000|Stable Dose|Protocol deviation|3
7979809|NCT03030599|12547939|FG001|Stable Dose|Protocol deviation|0
7979810|NCT03030599|12547940|FG002|Stable Dose|Protocol deviation|0
7979811|NCT03030599|12547938|FG000|Stable Dose|Adverse Event|1
7979812|NCT03030599|12547939|FG001|Stable Dose|Adverse Event|0
7979813|NCT03030599|12547940|FG002|Stable Dose|Adverse Event|0
7979814|NCT03030599|12547938|FG000|Stable Dose|Lost to Follow-up|1
7979815|NCT03030599|12547939|FG001|Stable Dose|Lost to Follow-up|0
7979816|NCT03030599|12547940|FG002|Stable Dose|Lost to Follow-up|0
7979817|NCT03030599|12547938|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0
7979818|NCT03030599|12547939|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0
7979819|NCT03030599|12547940|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2
7979820|NCT03030599|12547938|FG000|Double Blind Randomized Withdrawal|Adverse Event|0
7979821|NCT03030599|12547939|FG001|Double Blind Randomized Withdrawal|Adverse Event|0
7979822|NCT03030599|12547940|FG002|Double Blind Randomized Withdrawal|Adverse Event|3
7979823|NCT03030599|12547938|FG000|Double Blind Randomized Withdrawal|Randomized in error|0
7979824|NCT03030599|12547939|FG001|Double Blind Randomized Withdrawal|Randomized in error|0
7979825|NCT03030599|12547940|FG002|Double Blind Randomized Withdrawal|Randomized in error|2
7979826|NCT03030599|12547938|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
7979827|NCT03030599|12547939|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
7979828|NCT03030599|12547940|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1
7979829|NCT03030599|12547938|FG000|Open-label Extension|Adverse Event|3
7979830|NCT03030599|12547939|FG001|Open-label Extension|Adverse Event|0
7979831|NCT03030599|12547940|FG002|Open-label Extension|Adverse Event|0
7979832|NCT03030599|12547938|FG000|Open-label Extension|Lost to Follow-up|2
7979833|NCT03030599|12547939|FG001|Open-label Extension|Lost to Follow-up|0
7979834|NCT03030599|12547940|FG002|Open-label Extension|Lost to Follow-up|0
7979835|NCT03030599|12547938|FG000|Open-label Extension|Lack of Efficacy|1
7979836|NCT03030599|12547939|FG001|Open-label Extension|Lack of Efficacy|0
7979837|NCT03030599|12547940|FG002|Open-label Extension|Lack of Efficacy|0
7979838|NCT03030599|12547938|FG000|Open-label Extension|Other Reason|1
7979839|NCT03030599|12547939|FG001|Open-label Extension|Other Reason|0
7979840|NCT03030599|12547940|FG002|Open-label Extension|Other Reason|0
7979841|NCT03030989|12547983|FG000|Overall Study|Fever|2
7979842|NCT03030989|12547984|FG001|Overall Study|Fever|2
7979843|NCT03030989|12547983|FG000|Overall Study|Rash|2
7979844|NCT03030989|12547984|FG001|Overall Study|Rash|1
7979845|NCT03030989|12547983|FG000|Overall Study|Fatigue/Overwhelmed|1
7979846|NCT03030989|12547984|FG001|Overall Study|Fatigue/Overwhelmed|5
7979847|NCT03030989|12547983|FG000|Overall Study|Positive Blood Cultures|2
7979848|NCT03030989|12547984|FG001|Overall Study|Positive Blood Cultures|1
7979849|NCT03030989|12547983|FG000|Overall Study|Line Removed|0
7979850|NCT03030989|12547984|FG001|Overall Study|Line Removed|2
7979851|NCT03030989|12547983|FG000|Overall Study|No longer interested|5
7979852|NCT03030989|12547984|FG001|Overall Study|No longer interested|3
7979853|NCT03031431|12547990|FG000|Overall Study|Infant removed by maternal request|1
7979854|NCT03031496|12547994|FG000|Period 1|Adverse Event|2
7979855|NCT03031496|12547995|FG001|Period 1|Adverse Event|0
7979856|NCT03031496|12547994|FG000|Period 1|Withdrawal by Subject|0
7979857|NCT03031496|12547995|FG001|Period 1|Withdrawal by Subject|2
7979858|NCT03031678|12548001|FG000|Overall Study|Study closed prior to completion|1
7979859|NCT03031899|12548018|FG000|Overall Study|Protocol Violation|1
7979860|NCT03031899|12548018|FG000|Overall Study|lesion disappeared after stopping habit|1
7979861|NCT03031938|12548028|FG000|Overall Study|Death|1
7979862|NCT03031938|12548029|FG001|Overall Study|Death|0
7979863|NCT03032380|12548046|FG000|Overall Study|Adverse Event|0
7979864|NCT03032380|12548047|FG001|Overall Study|Adverse Event|1
7979865|NCT03032380|12548046|FG000|Overall Study|Lack of Efficacy|1
7979866|NCT03032380|12548047|FG001|Overall Study|Lack of Efficacy|0
7979867|NCT03032380|12548046|FG000|Overall Study|Withdrawal by Subject|2
7979868|NCT03032380|12548047|FG001|Overall Study|Withdrawal by Subject|3
7979869|NCT03032380|12548046|FG000|Overall Study|Recovery|0
7979870|NCT03032380|12548047|FG001|Overall Study|Recovery|1
7979871|NCT03032380|12548046|FG000|Overall Study|Death|39
7979872|NCT03032380|12548047|FG001|Overall Study|Death|34
7979873|NCT03032380|12548046|FG000|Overall Study|Other - Miscellaneous|0
7979874|NCT03032380|12548047|FG001|Overall Study|Other - Miscellaneous|1
7979875|NCT03032523|12548064|FG000|Overall Study|Withdrawal by Subject|2
7979876|NCT03032523|12548065|FG001|Overall Study|Withdrawal by Subject|2
7979877|NCT03032523|12548064|FG000|Overall Study|Physician Decision|1
7979878|NCT03032523|12548065|FG001|Overall Study|Physician Decision|0
7979879|NCT03033394|12548105|FG000|Completed Pharmacokinetic Analysis|Missing data|1
7979880|NCT03033394|12548105|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3
7979881|NCT03033394|12548105|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1
7979882|NCT03033394|12548105|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1
7979883|NCT03033394|12548105|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1
7979884|NCT03033745|12548126|FG000|Overall Study|Protocol Violation|0
7979885|NCT03033745|12548127|FG001|Overall Study|Protocol Violation|0
7979886|NCT03033745|12548128|FG002|Overall Study|Protocol Violation|1
7979887|NCT03033745|12548126|FG000|Overall Study|Adverse Event|1
7979888|NCT03033745|12548127|FG001|Overall Study|Adverse Event|0
7979889|NCT03033745|12548128|FG002|Overall Study|Adverse Event|1
7979890|NCT03033745|12548126|FG000|Overall Study|Withdrawal by Subject|0
7979891|NCT03033745|12548127|FG001|Overall Study|Withdrawal by Subject|1
7979892|NCT03033745|12548128|FG002|Overall Study|Withdrawal by Subject|0
7979893|NCT03033784|12548145|FG000|Overall Study|Anxiety related to MRI scanner|0
7979894|NCT03033784|12548146|FG001|Overall Study|Anxiety related to MRI scanner|1
7979895|NCT03033784|12548147|FG002|Overall Study|Anxiety related to MRI scanner|0
7979896|NCT03033784|12548148|FG003|Overall Study|Anxiety related to MRI scanner|0
7979897|NCT03033784|12548149|FG004|Overall Study|Anxiety related to MRI scanner|0
7979898|NCT03033784|12548150|FG005|Overall Study|Anxiety related to MRI scanner|0
7979899|NCT03033784|12548151|FG006|Overall Study|Anxiety related to MRI scanner|0
7979900|NCT03033784|12548152|FG007|Overall Study|Anxiety related to MRI scanner|0
7979901|NCT03033784|12548153|FG008|Overall Study|Anxiety related to MRI scanner|0
7979902|NCT03033784|12548154|FG009|Overall Study|Anxiety related to MRI scanner|0
7979903|NCT03033784|12548155|FG010|Overall Study|Anxiety related to MRI scanner|0
7979904|NCT03033784|12548156|FG011|Overall Study|Anxiety related to MRI scanner|0
7979905|NCT03033784|12548157|FG012|Overall Study|Anxiety related to MRI scanner|0
7979906|NCT03033784|12548145|FG000|Overall Study|Withdrawal by Subject|0
7979907|NCT03033784|12548146|FG001|Overall Study|Withdrawal by Subject|0
7979908|NCT03033784|12548147|FG002|Overall Study|Withdrawal by Subject|0
7979909|NCT03033784|12548148|FG003|Overall Study|Withdrawal by Subject|0
7979910|NCT03033784|12548149|FG004|Overall Study|Withdrawal by Subject|0
7979911|NCT03033784|12548150|FG005|Overall Study|Withdrawal by Subject|0
7979912|NCT03033784|12548151|FG006|Overall Study|Withdrawal by Subject|0
7979913|NCT03033784|12548152|FG007|Overall Study|Withdrawal by Subject|0
7979914|NCT03033784|12548153|FG008|Overall Study|Withdrawal by Subject|0
7979915|NCT03033784|12548154|FG009|Overall Study|Withdrawal by Subject|0
7979916|NCT03033784|12548155|FG010|Overall Study|Withdrawal by Subject|0
7979917|NCT03033784|12548156|FG011|Overall Study|Withdrawal by Subject|0
7979918|NCT03033784|12548157|FG012|Overall Study|Withdrawal by Subject|2
7979919|NCT03034044|12548168|FG000|Overall Study|Enrolled, but not received Xyntha|1
7979920|NCT03034057|12548172|FG000|Overall Study|Withdrawal by Subject|10
7979921|NCT03034057|12548172|FG000|Overall Study|Protocol Violation|1
7979922|NCT03034057|12548172|FG000|Overall Study|Not defined|2
7979923|NCT03034057|12548172|FG000|Overall Study|Lost to Follow-up|19
7979924|NCT03034057|12548172|FG000|Overall Study|Adverse Event|22
7979925|NCT03034057|12548172|FG000|Overall Study|Medication error without associated AE|1
7979926|NCT03034135|12548176|FG000|Overall Study|Withdrawal by Subject|2
7979927|NCT03034460|12548182|FG000|Overall Study|Adverse Event|0
7979928|NCT03034460|12548183|FG001|Overall Study|Adverse Event|1
7979929|NCT03034460|12548182|FG000|Overall Study|Withdrawal by Subject|2
7979930|NCT03034460|12548183|FG001|Overall Study|Withdrawal by Subject|2
7979931|NCT03034460|12548182|FG000|Overall Study|Personal Reasons|1
7979932|NCT03034460|12548183|FG001|Overall Study|Personal Reasons|0
7979933|NCT03034577|12548195|FG000|Overall Study|Withdrawal by Subject|6
7979934|NCT03034577|12548196|FG001|Overall Study|Withdrawal by Subject|9
7979935|NCT03034577|12548195|FG000|Overall Study|Lost to Follow-up|25
7979936|NCT03034577|12548196|FG001|Overall Study|Lost to Follow-up|26
7979937|NCT03034772|12548206|FG000|Overall Study|Adverse Event|0
7979938|NCT03034772|12548207|FG001|Overall Study|Adverse Event|1
7979939|NCT03034772|12548206|FG000|Overall Study|Withdrawal by Subject|0
7979940|NCT03034772|12548207|FG001|Overall Study|Withdrawal by Subject|1
7979941|NCT03034915|12548216|FG000|Overall Study|Adverse Event|29
7979942|NCT03034915|12548217|FG001|Overall Study|Adverse Event|32
7979943|NCT03034915|12548218|FG002|Overall Study|Adverse Event|22
7979944|NCT03034915|12548216|FG000|Overall Study|Lost to Follow-up|5
7979945|NCT03034915|12548217|FG001|Overall Study|Lost to Follow-up|13
7979946|NCT03034915|12548218|FG002|Overall Study|Lost to Follow-up|3
7979947|NCT03034915|12548216|FG000|Overall Study|Withdrawal by Subject|29
7979948|NCT03034915|12548217|FG001|Overall Study|Withdrawal by Subject|46
7979949|NCT03034915|12548218|FG002|Overall Study|Withdrawal by Subject|41
7979950|NCT03034915|12548216|FG000|Overall Study|Protocol Deviation|2
7979951|NCT03034915|12548217|FG001|Overall Study|Protocol Deviation|14
7979952|NCT03034915|12548218|FG002|Overall Study|Protocol Deviation|7
7979953|NCT03034915|12548216|FG000|Overall Study|Lack of Efficacy|8
7979954|NCT03034915|12548217|FG001|Overall Study|Lack of Efficacy|16
7979955|NCT03034915|12548218|FG002|Overall Study|Lack of Efficacy|18
7979956|NCT03034915|12548216|FG000|Overall Study|Site closed|2
7979957|NCT03034915|12548217|FG001|Overall Study|Site closed|2
7979958|NCT03034915|12548218|FG002|Overall Study|Site closed|4
7979959|NCT03034915|12548216|FG000|Overall Study|Protocol-defined withdrawal criteria met|19
7979960|NCT03034915|12548217|FG001|Overall Study|Protocol-defined withdrawal criteria met|26
7979961|NCT03034915|12548218|FG002|Overall Study|Protocol-defined withdrawal criteria met|29
7979962|NCT03034915|12548216|FG000|Overall Study|Physician Decision|1
7979963|NCT03034915|12548217|FG001|Overall Study|Physician Decision|5
7979964|NCT03034915|12548218|FG002|Overall Study|Physician Decision|2
7979965|NCT03034954|12548240|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1
7979966|NCT03034954|12548241|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0
7979967|NCT03034967|12548253|FG000|Overall Study|Withdrawal by Subject|9
7979968|NCT03034967|12548254|FG001|Overall Study|Withdrawal by Subject|2
7979969|NCT03034967|12548255|FG002|Overall Study|Withdrawal by Subject|6
7979970|NCT03034967|12548256|FG003|Overall Study|Withdrawal by Subject|6
7979971|NCT03034967|12548257|FG004|Overall Study|Withdrawal by Subject|9
7979972|NCT03034967|12548258|FG005|Overall Study|Withdrawal by Subject|2
7979973|NCT03034967|12548253|FG000|Overall Study|Physician Decision|1
7979974|NCT03034967|12548254|FG001|Overall Study|Physician Decision|0
7979975|NCT03034967|12548255|FG002|Overall Study|Physician Decision|1
7979976|NCT03034967|12548256|FG003|Overall Study|Physician Decision|1
7979977|NCT03034967|12548257|FG004|Overall Study|Physician Decision|1
7979978|NCT03034967|12548258|FG005|Overall Study|Physician Decision|0
7979979|NCT03034967|12548253|FG000|Overall Study|Lost to Follow-up|0
7979980|NCT03034967|12548254|FG001|Overall Study|Lost to Follow-up|0
7979981|NCT03034967|12548255|FG002|Overall Study|Lost to Follow-up|0
7979982|NCT03034967|12548256|FG003|Overall Study|Lost to Follow-up|1
7979983|NCT03034967|12548257|FG004|Overall Study|Lost to Follow-up|0
7979984|NCT03034967|12548258|FG005|Overall Study|Lost to Follow-up|2
7979985|NCT03034967|12548253|FG000|Overall Study|Liver function test abnormality|0
7979986|NCT03034967|12548254|FG001|Overall Study|Liver function test abnormality|0
7979987|NCT03034967|12548255|FG002|Overall Study|Liver function test abnormality|1
7979988|NCT03034967|12548256|FG003|Overall Study|Liver function test abnormality|0
7979989|NCT03034967|12548257|FG004|Overall Study|Liver function test abnormality|0
7979990|NCT03034967|12548258|FG005|Overall Study|Liver function test abnormality|0
7979991|NCT03034967|12548253|FG000|Overall Study|Protocol Violation|1
7979992|NCT03034967|12548254|FG001|Overall Study|Protocol Violation|0
7979993|NCT03034967|12548255|FG002|Overall Study|Protocol Violation|0
7979994|NCT03034967|12548256|FG003|Overall Study|Protocol Violation|0
7979995|NCT03034967|12548257|FG004|Overall Study|Protocol Violation|0
7979996|NCT03034967|12548258|FG005|Overall Study|Protocol Violation|2
7979997|NCT03034967|12548253|FG000|Overall Study|Lack of Efficacy|0
7979998|NCT03034967|12548254|FG001|Overall Study|Lack of Efficacy|1
7979999|NCT03034967|12548255|FG002|Overall Study|Lack of Efficacy|2
7980000|NCT03034967|12548256|FG003|Overall Study|Lack of Efficacy|1
7980001|NCT03034967|12548257|FG004|Overall Study|Lack of Efficacy|1
7980002|NCT03034967|12548258|FG005|Overall Study|Lack of Efficacy|0
7980003|NCT03034967|12548253|FG000|Overall Study|Adverse Event, non-fatal|3
7980004|NCT03034967|12548254|FG001|Overall Study|Adverse Event, non-fatal|1
7980005|NCT03034967|12548255|FG002|Overall Study|Adverse Event, non-fatal|2
7980006|NCT03034967|12548256|FG003|Overall Study|Adverse Event, non-fatal|0
7980007|NCT03034967|12548257|FG004|Overall Study|Adverse Event, non-fatal|2
7980008|NCT03034967|12548258|FG005|Overall Study|Adverse Event, non-fatal|8
7980009|NCT03034967|12548253|FG000|Overall Study|Adverse Event, Serious Fatal|0
7980010|NCT03034967|12548254|FG001|Overall Study|Adverse Event, Serious Fatal|1
7980011|NCT03034967|12548255|FG002|Overall Study|Adverse Event, Serious Fatal|1
7980012|NCT03034967|12548256|FG003|Overall Study|Adverse Event, Serious Fatal|2
7980013|NCT03034967|12548257|FG004|Overall Study|Adverse Event, Serious Fatal|1
7980014|NCT03034967|12548258|FG005|Overall Study|Adverse Event, Serious Fatal|1
7980015|NCT03035032|12548277|FG000|Overall Study|Adverse Event|2
7980016|NCT03035032|12548277|FG000|Overall Study|Death|9
7980017|NCT03035032|12548277|FG000|Overall Study|Lost to Follow-up|1
7980018|NCT03035032|12548277|FG000|Overall Study|Progressive Disease|22
7980019|NCT03035032|12548277|FG000|Overall Study|Protocol Violation|2
7980020|NCT03035032|12548277|FG000|Overall Study|Withdrawal by Subject|2
7980021|NCT03035032|12548277|FG000|Overall Study|Physician Decision|5
7980022|NCT03035864|12548341|FG000|Treatment Period|Adverse Event|1
7980023|NCT03035864|12548342|FG001|Treatment Period|Adverse Event|0
7980024|NCT03035864|12548341|FG000|Treatment Period|Other|3
7980025|NCT03035864|12548342|FG001|Treatment Period|Other|1
7980026|NCT03035864|12548341|FG000|Follow-up Period|Adverse Event|1
7980027|NCT03035864|12548342|FG001|Follow-up Period|Adverse Event|0
7980028|NCT03035864|12548341|FG000|Follow-up Period|Lost to Follow-up|6
7980029|NCT03035864|12548342|FG001|Follow-up Period|Lost to Follow-up|2
7980030|NCT03035864|12548341|FG000|Follow-up Period|Physician Decision|1
7980031|NCT03035864|12548342|FG001|Follow-up Period|Physician Decision|0
7980032|NCT03035864|12548341|FG000|Follow-up Period|Other|3
7980033|NCT03035864|12548342|FG001|Follow-up Period|Other|2
7980034|NCT03035916|12548351|FG000|Overall Study|Puncture failed|0
7980035|NCT03035916|12548352|FG001|Overall Study|Puncture failed|2
7980036|NCT03035916|12548353|FG002|Overall Study|Puncture failed|0
7980037|NCT03035942|12548369|FG000|Overall Study|Adverse Event|8
7980038|NCT03035942|12548370|FG001|Overall Study|Adverse Event|4
7980039|NCT03035942|12548371|FG002|Overall Study|Adverse Event|5
7980040|NCT03036072|12548392|FG000|Overall Study|Death|0
7980041|NCT03036072|12548393|FG001|Overall Study|Death|1
7980042|NCT03036072|12548392|FG000|Overall Study|Withdrawal by Subject|0
7980043|NCT03036072|12548393|FG001|Overall Study|Withdrawal by Subject|1
7980044|NCT03036072|12548392|FG000|Overall Study|Physician Decision|0
7980045|NCT03036072|12548393|FG001|Overall Study|Physician Decision|1
7980046|NCT03036124|12548401|FG000|Overall Study|Lost to Follow-up|0
7980047|NCT03036124|12548402|FG001|Overall Study|Lost to Follow-up|2
7980048|NCT03036124|12548401|FG000|Overall Study|Withdrawal by Subject|5
7980049|NCT03036124|12548402|FG001|Overall Study|Withdrawal by Subject|4
7980050|NCT03036150|12548410|FG000|Overall Study|Withdrawal by Subject|8
7980051|NCT03036150|12548411|FG001|Overall Study|Withdrawal by Subject|3
7980052|NCT03036150|12548410|FG000|Overall Study|Lost to Follow-up|2
7980053|NCT03036150|12548411|FG001|Overall Study|Lost to Follow-up|2
7980054|NCT03036813|12548507|FG000|Overall Study|Adverse Event|6
7980055|NCT03036813|12548508|FG001|Overall Study|Adverse Event|11
7980056|NCT03036813|12548509|FG002|Overall Study|Adverse Event|6
7980057|NCT03036813|12548507|FG000|Overall Study|Withdrawal by Subject|12
7980058|NCT03036813|12548508|FG001|Overall Study|Withdrawal by Subject|6
7980059|NCT03036813|12548509|FG002|Overall Study|Withdrawal by Subject|10
7980060|NCT03036813|12548507|FG000|Overall Study|Lost to Follow-up|1
7980061|NCT03036813|12548508|FG001|Overall Study|Lost to Follow-up|1
7980062|NCT03036813|12548509|FG002|Overall Study|Lost to Follow-up|0
7980063|NCT03036813|12548507|FG000|Overall Study|Physician Decision|2
7980064|NCT03036813|12548508|FG001|Overall Study|Physician Decision|1
7980065|NCT03036813|12548509|FG002|Overall Study|Physician Decision|1
7980066|NCT03036813|12548507|FG000|Overall Study|Non-Compliance|1
7980067|NCT03036813|12548508|FG001|Overall Study|Non-Compliance|5
7980068|NCT03036813|12548509|FG002|Overall Study|Non-Compliance|3
7980069|NCT03036813|12548507|FG000|Overall Study|Pregnancy|0
7980070|NCT03036813|12548508|FG001|Overall Study|Pregnancy|0
7980071|NCT03036813|12548509|FG002|Overall Study|Pregnancy|1
7980072|NCT03036813|12548507|FG000|Overall Study|Other|0
7980073|NCT03036813|12548508|FG001|Overall Study|Other|3
7980074|NCT03036813|12548509|FG002|Overall Study|Other|5
7980075|NCT03036839|12548523|FG000|Overall Study|Adverse Event|0
7980076|NCT03036839|12548524|FG001|Overall Study|Adverse Event|0
7980077|NCT03036839|12548525|FG002|Overall Study|Adverse Event|1
7980078|NCT03036839|12548523|FG000|Overall Study|Death|3
7980079|NCT03036839|12548524|FG001|Overall Study|Death|0
7980080|NCT03036839|12548525|FG002|Overall Study|Death|3
7980081|NCT03036839|12548523|FG000|Overall Study|Withdrew Consent|0
7980082|NCT03036839|12548524|FG001|Overall Study|Withdrew Consent|0
7980083|NCT03036839|12548525|FG002|Overall Study|Withdrew Consent|1
7980084|NCT03036852|12548539|FG000|Overall Study|Death|2
7980085|NCT03036852|12548539|FG000|Overall Study|Lack of Efficacy|2
7980086|NCT03036852|12548539|FG000|Overall Study|Adverse Event|1
7980087|NCT03036852|12548539|FG000|Overall Study|Lost to Follow-up|1
7980088|NCT03037307|12548587|FG000|Period 1|Did Not Meet Study Criteria|0
7980089|NCT03037307|12548588|FG001|Period 1|Did Not Meet Study Criteria|0
7980090|NCT03037307|12548589|FG002|Period 1|Did Not Meet Study Criteria|0
7980091|NCT03037307|12548590|FG003|Period 1|Did Not Meet Study Criteria|1
7980092|NCT03037307|12548591|FG004|Period 1|Did Not Meet Study Criteria|0
7980093|NCT03037307|12548592|FG005|Period 1|Did Not Meet Study Criteria|0
7980094|NCT03037489|12548603|FG000|Overall Study|Adverse Event|4
7980095|NCT03037489|12548604|FG001|Overall Study|Adverse Event|0
7980096|NCT03037489|12548603|FG000|Overall Study|Withdrawal by Subject|3
7980097|NCT03037489|12548604|FG001|Overall Study|Withdrawal by Subject|0
7980098|NCT03037580|12548621|FG000|Overall Study|Withdrawal by Subject|3
7980099|NCT03037580|12548622|FG001|Overall Study|Withdrawal by Subject|0
7980100|NCT03037580|12548621|FG000|Overall Study|Adverse Event|1
7980101|NCT03037580|12548622|FG001|Overall Study|Adverse Event|0
7980102|NCT03037580|12548621|FG000|Overall Study|Study Terminated by Sponsor|12
7980103|NCT03037580|12548622|FG001|Overall Study|Study Terminated by Sponsor|15
7980104|NCT03037580|12548621|FG000|Overall Study|Death|0
7980105|NCT03037580|12548622|FG001|Overall Study|Death|1
7980106|NCT03037619|12548630|FG000|Overall Study|Lost to Follow-up|0
7980107|NCT03037619|12548631|FG001|Overall Study|Lost to Follow-up|1
7980108|NCT03038113|12548671|FG000|Overall Study|Withdrawal by Subject|0
7980109|NCT03038113|12548672|FG001|Overall Study|Withdrawal by Subject|0
7980110|NCT03038113|12548673|FG002|Overall Study|Withdrawal by Subject|1
7980111|NCT03038113|12548674|FG003|Overall Study|Withdrawal by Subject|0
7980112|NCT03038113|12548675|FG004|Overall Study|Withdrawal by Subject|0
7980113|NCT03038113|12548676|FG005|Overall Study|Withdrawal by Subject|0
7980114|NCT03038113|12548677|FG006|Overall Study|Withdrawal by Subject|0
7980115|NCT03038113|12548678|FG007|Overall Study|Withdrawal by Subject|0
7980116|NCT03038113|12548679|FG008|Overall Study|Withdrawal by Subject|0
7980117|NCT03038113|12548680|FG009|Overall Study|Withdrawal by Subject|0
7980118|NCT03038113|12548681|FG010|Overall Study|Withdrawal by Subject|0
7980119|NCT03038113|12548682|FG011|Overall Study|Withdrawal by Subject|0
7980120|NCT03038113|12548683|FG012|Overall Study|Withdrawal by Subject|0
7980121|NCT03038113|12548684|FG013|Overall Study|Withdrawal by Subject|1
7980122|NCT03038113|12548671|FG000|Overall Study|Lost to Follow-up|0
7980123|NCT03038113|12548672|FG001|Overall Study|Lost to Follow-up|0
7980124|NCT03038113|12548673|FG002|Overall Study|Lost to Follow-up|0
7980125|NCT03038113|12548674|FG003|Overall Study|Lost to Follow-up|0
7718046|NCT00524368|12141742|FG001|Overall Study|Lost to Follow-up|13
7718047|NCT00524368|12141741|FG000|Overall Study|Withdrawal by Subject|4
7718048|NCT00524368|12141742|FG001|Overall Study|Withdrawal by Subject|5
7718049|NCT00524368|12141741|FG000|Overall Study|Non-compliant|8
7980126|NCT03038113|12548675|FG004|Overall Study|Lost to Follow-up|0
7980127|NCT03038113|12548676|FG005|Overall Study|Lost to Follow-up|0
7980128|NCT03038113|12548677|FG006|Overall Study|Lost to Follow-up|1
7980129|NCT03038113|12548678|FG007|Overall Study|Lost to Follow-up|0
7980130|NCT03038113|12548679|FG008|Overall Study|Lost to Follow-up|0
7980131|NCT03038113|12548680|FG009|Overall Study|Lost to Follow-up|0
7980132|NCT03038113|12548681|FG010|Overall Study|Lost to Follow-up|0
7980133|NCT03038113|12548682|FG011|Overall Study|Lost to Follow-up|0
7980134|NCT03038113|12548683|FG012|Overall Study|Lost to Follow-up|0
7980135|NCT03038113|12548684|FG013|Overall Study|Lost to Follow-up|0
7980136|NCT03038126|12548733|FG000|Overall Study|Death|1
7980137|NCT03038126|12548734|FG001|Overall Study|Death|1
7980138|NCT03038126|12548733|FG000|Overall Study|Withdrawal by Subject|5
7980139|NCT03038126|12548734|FG001|Overall Study|Withdrawal by Subject|0
7980140|NCT03038126|12548733|FG000|Overall Study|Lost to Follow-up|0
7980141|NCT03038126|12548734|FG001|Overall Study|Lost to Follow-up|1
7980142|NCT03038126|12548733|FG000|Overall Study|Long Term Hospitalization|2
7980143|NCT03038126|12548734|FG001|Overall Study|Long Term Hospitalization|0
7980144|NCT03038126|12548733|FG000|Overall Study|Too Ill to Participate|1
7980145|NCT03038126|12548734|FG001|Overall Study|Too Ill to Participate|2
7980146|NCT03038620|12548765|FG000|Overall Study|Lost to Follow-up|18
7980147|NCT03038620|12548766|FG001|Overall Study|Lost to Follow-up|23
7980148|NCT03038620|12548765|FG000|Overall Study|Withdrawal by Subject|0
7980149|NCT03038620|12548766|FG001|Overall Study|Withdrawal by Subject|15
7980150|NCT03038620|12548765|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1
7980151|NCT03038620|12548766|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0
7980152|NCT03038880|12548794|FG000|Overall Study|Death|1
7980153|NCT03038880|12548795|FG001|Overall Study|Death|2
7980154|NCT03038880|12548796|FG002|Overall Study|Death|0
7980155|NCT03038880|12548794|FG000|Overall Study|Physician Decision|2
7980156|NCT03038880|12548795|FG001|Overall Study|Physician Decision|1
7980157|NCT03038880|12548796|FG002|Overall Study|Physician Decision|0
7980158|NCT03039023|12548809|FG000|Overall Study|Withdrawal by Subject|1
7980159|NCT03039023|12548810|FG001|Overall Study|Withdrawal by Subject|0
7980160|NCT03039023|12548811|FG002|Overall Study|Withdrawal by Subject|1
7980161|NCT03039023|12548812|FG003|Overall Study|Withdrawal by Subject|1
7980162|NCT03039023|12548813|FG004|Overall Study|Withdrawal by Subject|0
7980163|NCT03039023|12548809|FG000|Overall Study|Physician Decision|0
7980164|NCT03039023|12548810|FG001|Overall Study|Physician Decision|0
7980165|NCT03039023|12548811|FG002|Overall Study|Physician Decision|0
7980166|NCT03039023|12548812|FG003|Overall Study|Physician Decision|1
7980167|NCT03039023|12548813|FG004|Overall Study|Physician Decision|0
7980168|NCT03039192|12548845|FG000|Overall Study|Lost to Follow-up|4
7980169|NCT03039192|12548846|FG001|Overall Study|Lost to Follow-up|4
7980170|NCT03039192|12548845|FG000|Overall Study|Adverse event, serious fatal|0
7980171|NCT03039192|12548846|FG001|Overall Study|Adverse event, serious fatal|1
7980172|NCT03039192|12548845|FG000|Overall Study|Adverse event, non-fatal|0
7980173|NCT03039192|12548846|FG001|Overall Study|Adverse event, non-fatal|2
7980174|NCT03039192|12548845|FG000|Overall Study|Withdrawal by Subject|6
7980175|NCT03039192|12548846|FG001|Overall Study|Withdrawal by Subject|9
7980176|NCT03039192|12548845|FG000|Overall Study|Discontinued from treatment phase|19
7980177|NCT03039192|12548846|FG001|Overall Study|Discontinued from treatment phase|12
7980178|NCT03039192|12548845|FG000|Overall Study|Other|3
7980179|NCT03039192|12548846|FG001|Overall Study|Other|2
7980180|NCT03039283|12548852|FG000|Overall Study|Protocol Violation|2
7980181|NCT03039569|12548867|FG000|Overall Study|Lost to Follow-up|5
7980182|NCT03039569|12548868|FG001|Overall Study|Lost to Follow-up|4
7980183|NCT03039621|12548877|FG000|Overall Study|Violation of inclusion criteria|3
7980184|NCT03039621|12548878|FG001|Overall Study|Violation of inclusion criteria|2
7980185|NCT03039621|12548877|FG000|Overall Study|Non-compliance with protocol requirement|4
7980186|NCT03039621|12548878|FG001|Overall Study|Non-compliance with protocol requirement|5
7980187|NCT03039621|12548877|FG000|Overall Study|Necessity to use drugs forbidden by pro|4
7980188|NCT03039621|12548878|FG001|Overall Study|Necessity to use drugs forbidden by pro|7
7980189|NCT03039621|12548877|FG000|Overall Study|Violation of non-inclusion criteria|1
7980190|NCT03039621|12548878|FG001|Overall Study|Violation of non-inclusion criteria|2
7980191|NCT03039686|12548887|FG000|Double-blind Period|Administrative Reason by Sponsor|24
7980192|NCT03039686|12548888|FG001|Double-blind Period|Administrative Reason by Sponsor|25
7980193|NCT03039686|12548889|FG002|Double-blind Period|Administrative Reason by Sponsor|21
7980194|NCT03039686|12548887|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1
7980195|NCT03039686|12548888|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2
7980196|NCT03039686|12548889|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0
7980197|NCT03039686|12548887|FG000|Double-blind Period|Withdrawal by Subject|2
7980198|NCT03039686|12548888|FG001|Double-blind Period|Withdrawal by Subject|2
7980199|NCT03039686|12548889|FG002|Double-blind Period|Withdrawal by Subject|1
7980200|NCT03039686|12548887|FG000|Double-blind Period|Death|0
7980201|NCT03039686|12548888|FG001|Double-blind Period|Death|0
7980202|NCT03039686|12548889|FG002|Double-blind Period|Death|1
7980203|NCT03039686|12548887|FG000|Open Label Period|Administrative Reason by Sponsor|0
7980204|NCT03039686|12548888|FG001|Open Label Period|Administrative Reason by Sponsor|34
7980205|NCT03039686|12548889|FG002|Open Label Period|Administrative Reason by Sponsor|41
7980206|NCT03039686|12548887|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0
7980207|NCT03039686|12548888|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1
7980208|NCT03039686|12548889|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0
7980209|NCT03039686|12548887|FG000|Open Label Period|Withdrawal by Subject|0
7980210|NCT03039686|12548888|FG001|Open Label Period|Withdrawal by Subject|3
7980211|NCT03039686|12548889|FG002|Open Label Period|Withdrawal by Subject|1
7980212|NCT03039699|12548909|FG000|Overall Study|Incorrect inclusion|5
7980213|NCT03039699|12548910|FG001|Overall Study|Incorrect inclusion|4
7980214|NCT03039699|12548909|FG000|Overall Study|Lack of data to assess study endpoint|5
7980215|NCT03039699|12548910|FG001|Overall Study|Lack of data to assess study endpoint|3
7980216|NCT03039699|12548909|FG000|Overall Study|Bacterial infection|12
7980217|NCT03039699|12548910|FG001|Overall Study|Bacterial infection|28
7980218|NCT03039738|12548918|FG000|Overall Study|Incomplete data sets|54
7980219|NCT03039738|12548919|FG001|Overall Study|Incomplete data sets|0
7980220|NCT03040024|12548941|FG000|Overall Study|Adverse Event|0
7980221|NCT03040024|12548942|FG001|Overall Study|Adverse Event|1
7980222|NCT03040024|12548943|FG002|Overall Study|Adverse Event|0
7980223|NCT03040024|12548941|FG000|Overall Study|Death|0
7980224|NCT03040024|12548942|FG001|Overall Study|Death|1
7980225|NCT03040024|12548943|FG002|Overall Study|Death|0
7980226|NCT03040024|12548941|FG000|Overall Study|Physician Decision|0
7980227|NCT03040024|12548942|FG001|Overall Study|Physician Decision|0
7980228|NCT03040024|12548943|FG002|Overall Study|Physician Decision|1
7980229|NCT03040336|12548962|FG000|Overall Study|Death|1
7980230|NCT03040336|12548963|FG001|Overall Study|Death|0
7980231|NCT03040336|12548962|FG000|Overall Study|Withdrawal by Subject|2
7980232|NCT03040336|12548963|FG001|Overall Study|Withdrawal by Subject|3
7980233|NCT03040674|12549020|FG000|Overall Study|Lost to Follow-up|225
7980234|NCT03040674|12549020|FG000|Overall Study|Death|23
7980235|NCT03040687|12549028|FG000|Overall Study|Withdrawal by Subject|1
7980236|NCT03040687|12549029|FG001|Overall Study|Withdrawal by Subject|0
7980237|NCT03040687|12549030|FG002|Overall Study|Withdrawal by Subject|0
7980238|NCT03040713|12549038|FG000|Overall Study|Positive amyloid scan|3
7980239|NCT03040986|12549048|FG000|Overall Study|Hospice|1
7980240|NCT03040986|12549049|FG001|Overall Study|Hospice|0
7980241|NCT03040986|12549048|FG000|Overall Study|Adverse Event|2
7980242|NCT03040986|12549049|FG001|Overall Study|Adverse Event|1
7980243|NCT03040986|12549048|FG000|Overall Study|Disease progression on study|3
7980244|NCT03040986|12549049|FG001|Overall Study|Disease progression on study|1
7980245|NCT03041025|12549060|FG000|Overall Study|Adverse Event|0
7980246|NCT03041025|12549061|FG001|Overall Study|Adverse Event|0
7980247|NCT03041025|12549062|FG002|Overall Study|Adverse Event|1
7980248|NCT03041025|12549060|FG000|Overall Study|Lost to Follow-up|1
7980249|NCT03041025|12549061|FG001|Overall Study|Lost to Follow-up|0
7980250|NCT03041025|12549062|FG002|Overall Study|Lost to Follow-up|0
7980251|NCT03041025|12549060|FG000|Overall Study|Withdrawal by Subject|0
7980252|NCT03041025|12549061|FG001|Overall Study|Withdrawal by Subject|0
7980253|NCT03041025|12549062|FG002|Overall Study|Withdrawal by Subject|1
7980254|NCT03041038|12549075|FG000|Overall Study|Withdrawal by Subject|4
7980255|NCT03041038|12549076|FG001|Overall Study|Withdrawal by Subject|0
7980256|NCT03041038|12549075|FG000|Overall Study|Lost to Follow-up|1
7980257|NCT03041038|12549076|FG001|Overall Study|Lost to Follow-up|1
7980258|NCT03041038|12549075|FG000|Overall Study|Protocol Violation|1
7980259|NCT03041038|12549076|FG001|Overall Study|Protocol Violation|1
7980260|NCT03041090|12549086|FG000|Overall Study|technical error|0
7980261|NCT03041090|12549087|FG001|Overall Study|technical error|3
7980262|NCT03041116|12549095|FG000|Double-blind|Death|0
7980263|NCT03041116|12549096|FG001|Double-blind|Death|2
7980264|NCT03041116|12549095|FG000|Double-blind|Withdrawal by Subject|0
7980265|NCT03041116|12549096|FG001|Double-blind|Withdrawal by Subject|4
7980266|NCT03041116|12549095|FG000|Open-label|Death|1
7980267|NCT03041116|12549096|FG001|Open-label|Death|0
7980268|NCT03041116|12549095|FG000|Open-label|Termination of the study by Sponsor|39
7980269|NCT03041116|12549096|FG001|Open-label|Termination of the study by Sponsor|37
7980270|NCT03041116|12549095|FG000|Open-label|Withdrawal by Subject|1
7980271|NCT03041116|12549096|FG001|Open-label|Withdrawal by Subject|0
7980272|NCT03041792|12549121|FG000|Overall Study|Adverse Event|4
7980273|NCT03041792|12549122|FG001|Overall Study|Adverse Event|0
7980274|NCT03041792|12549121|FG000|Overall Study|Death in the family|0
7980275|NCT03041792|12549122|FG001|Overall Study|Death in the family|2
7980276|NCT03041792|12549121|FG000|Overall Study|Randomized but not treated|0
7980277|NCT03041792|12549122|FG001|Overall Study|Randomized but not treated|1
7980278|NCT03042312|12549173|FG000|Overall Study|Administrative Reason|1
7980279|NCT03042312|12549174|FG001|Overall Study|Administrative Reason|1
7980280|NCT03042312|12549173|FG000|Overall Study|Adverse Event|0
7980281|NCT03042312|12549174|FG001|Overall Study|Adverse Event|1
7980282|NCT03042312|12549173|FG000|Overall Study|Lost to Follow-up|1
7980283|NCT03042312|12549174|FG001|Overall Study|Lost to Follow-up|3
7980284|NCT03042312|12549173|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4
7980285|NCT03042312|12549174|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2
7980286|NCT03042312|12549173|FG000|Overall Study|Withdrawal by Subject|4
7980287|NCT03042312|12549174|FG001|Overall Study|Withdrawal by Subject|5
7980288|NCT03042559|12549182|FG000|Overall Study|drop out|1
7980289|NCT03042559|12549183|FG001|Overall Study|drop out|1
7980290|NCT03042767|12549200|FG000|Overall Study|Lost to Follow-up|1
7980291|NCT03042767|12549201|FG001|Overall Study|Lost to Follow-up|2
7980292|NCT03042910|12549207|FG000|Overall Study|Adverse Event|1
7980293|NCT03042910|12549207|FG000|Overall Study|Disease Progression|2
7980294|NCT03042910|12549207|FG000|Overall Study|Withdrawal by Subject|3
7980295|NCT03042910|12549207|FG000|Overall Study|Enrolled but not treated|1
7980296|NCT03043365|12549240|FG000|Weeks 0 to Week 8|Adverse Event|1
7980297|NCT03043365|12549241|FG001|Weeks 0 to Week 8|Adverse Event|3
7980298|NCT03043365|12549240|FG000|Weeks 0 to Week 8|Lost to Follow-up|2
7980299|NCT03043365|12549241|FG001|Weeks 0 to Week 8|Lost to Follow-up|0
7980300|NCT03043365|12549240|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1
7980301|NCT03043365|12549241|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0
7980302|NCT03043560|12549260|FG000|Overall Study|Discontinued Intervention|1
7980303|NCT03043560|12549261|FG001|Overall Study|Discontinued Intervention|2
7980304|NCT03043560|12549260|FG000|Overall Study|Lost to Follow-up|0
7980305|NCT03043560|12549261|FG001|Overall Study|Lost to Follow-up|1
7980306|NCT03043651|12549267|FG000|Overall Study|Death|1
7980307|NCT03043651|12549267|FG000|Overall Study|Progressive Disease|2
7980308|NCT03043651|12549267|FG000|Overall Study|Adverse Event|2
7980309|NCT03043651|12549267|FG000|Overall Study|Withdrawal by Subject|4
7980310|NCT03043651|12549267|FG000|Overall Study|Study Terminated by Sponsor|39
7980311|NCT03044106|12549302|FG000|Washout (1 Week)|Withdrawal by Subject|0
7980312|NCT03044106|12549303|FG001|Washout (1 Week)|Withdrawal by Subject|2
7980313|NCT03044197|12549318|FG000|Overall Study|Withdrawal by Subject|3
7980314|NCT03044197|12549319|FG001|Overall Study|Withdrawal by Subject|1
7980315|NCT03044249|12549327|FG000|Overall Study|Adverse Event|4
7980316|NCT03044249|12549328|FG001|Overall Study|Adverse Event|9
7980317|NCT03044249|12549327|FG000|Overall Study|Lost to Follow-up|1
7980318|NCT03044249|12549328|FG001|Overall Study|Lost to Follow-up|0
7980319|NCT03044249|12549327|FG000|Overall Study|Non-compliance with Study Drug|1
7980320|NCT03044249|12549328|FG001|Overall Study|Non-compliance with Study Drug|0
7980321|NCT03044249|12549327|FG000|Overall Study|Study Terminated by Sponsor|2
7980322|NCT03044249|12549328|FG001|Overall Study|Study Terminated by Sponsor|0
7980323|NCT03044249|12549327|FG000|Overall Study|Withdrawal by Subject|2
7980324|NCT03044249|12549328|FG001|Overall Study|Withdrawal by Subject|5
7980325|NCT03044353|12549342|FG000|Overall Study|Adverse Event|0
7980326|NCT03044353|12549343|FG001|Overall Study|Adverse Event|1
7980327|NCT03044353|12549344|FG002|Overall Study|Adverse Event|0
7980328|NCT03044431|12549355|FG000|Overall Study|Lost to Follow-up|59
7980329|NCT03044574|12549361|FG000|Overall Study|Lost to Follow-up|37
7980330|NCT03044574|12549362|FG001|Overall Study|Lost to Follow-up|45
7980331|NCT03044730|12549377|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1
7980332|NCT03044730|12549377|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1
7980333|NCT03044730|12549377|FG000|3 Cycles of Pembro + Capecitab|Death|1
7980334|NCT03044730|12549377|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1
7980335|NCT03044730|12549377|FG000|Cycles 4 and Beyond|Progressive Disease|9
7980336|NCT03044730|12549377|FG000|Cycles 4 and Beyond|Adverse Event|1
7980337|NCT03044730|12549377|FG000|On Follow-up for 2 Years|Still in follow-up|7
7980338|NCT03044730|12549377|FG000|On Follow-up for 2 Years|Lost to Follow-up|1
7980339|NCT03044730|12549377|FG000|On Follow-up for 2 Years|Death|17
7980340|NCT03044886|12549385|FG000|Overall Study|Lost to Follow-up|15
7980341|NCT03044886|12549386|FG001|Overall Study|Lost to Follow-up|10
7980342|NCT03044886|12549387|FG002|Overall Study|Lost to Follow-up|12
7980343|NCT03045081|12549397|FG000|Overall Study|Withdrawal by Subject|6
7980344|NCT03045081|12549398|FG001|Overall Study|Withdrawal by Subject|11
7980345|NCT03045302|12549404|FG000|Overall Study|Pre-treatment adverse event|1
7980346|NCT03045328|12549408|FG000|Overall Study|Withdrawal by Subject|2
7980347|NCT03045887|12549446|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3
7980348|NCT03045887|12549447|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7980349|NCT03045887|12549448|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7980350|NCT03045887|12549449|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7980351|NCT03045887|12549450|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7980352|NCT03045887|12549451|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7980353|NCT03045887|12549452|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7980354|NCT03045887|12549453|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7980355|NCT03045887|12549454|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7980356|NCT03045887|12549455|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7980357|NCT03045887|12549446|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7980358|NCT03045887|12549447|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7980359|NCT03045887|12549448|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7980360|NCT03045887|12549449|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1
7980361|NCT03045887|12549450|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7980362|NCT03045887|12549451|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7980363|NCT03045887|12549452|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7980364|NCT03045887|12549453|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7980365|NCT03045887|12549454|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7980366|NCT03045887|12549455|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7980367|NCT03045887|12549446|FG000|Part A, Period 2 (1 Day)|Adverse Event|1
7980368|NCT03045887|12549447|FG001|Part A, Period 2 (1 Day)|Adverse Event|0
7980369|NCT03045887|12549448|FG002|Part A, Period 2 (1 Day)|Adverse Event|0
7980370|NCT03045887|12549449|FG003|Part A, Period 2 (1 Day)|Adverse Event|0
7980371|NCT03045887|12549450|FG004|Part A, Period 2 (1 Day)|Adverse Event|0
7980372|NCT03045887|12549451|FG005|Part A, Period 2 (1 Day)|Adverse Event|0
7980373|NCT03045887|12549452|FG006|Part A, Period 2 (1 Day)|Adverse Event|0
7980374|NCT03045887|12549453|FG007|Part A, Period 2 (1 Day)|Adverse Event|0
7980375|NCT03045887|12549454|FG008|Part A, Period 2 (1 Day)|Adverse Event|0
7980376|NCT03045887|12549455|FG009|Part A, Period 2 (1 Day)|Adverse Event|0
7980377|NCT03045887|12549446|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7980378|NCT03045887|12549447|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7980379|NCT03045887|12549448|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
7980380|NCT03045887|12549449|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
7980381|NCT03045887|12549450|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7980382|NCT03045887|12549451|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7980383|NCT03045887|12549452|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7980384|NCT03045887|12549453|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7980385|NCT03045887|12549454|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7980386|NCT03045887|12549455|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7980387|NCT03045887|12549446|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7980388|NCT03045887|12549447|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7980389|NCT03045887|12549448|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7980390|NCT03045887|12549449|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1
7980391|NCT03045887|12549450|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7980392|NCT03045887|12549451|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7980393|NCT03045887|12549452|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7980394|NCT03045887|12549453|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7980395|NCT03045887|12549454|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7980396|NCT03045887|12549455|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7980397|NCT03046056|12549489|FG000|Overall Study|Non-responder at Week 10|6
7980398|NCT03046056|12549490|FG001|Overall Study|Non-responder at Week 10|6
7980399|NCT03046056|12549491|FG002|Overall Study|Non-responder at Week 10|4
7980400|NCT03046056|12549489|FG000|Overall Study|Protocol-specified Disease Worsening|3
7980401|NCT03046056|12549490|FG001|Overall Study|Protocol-specified Disease Worsening|3
7980402|NCT03046056|12549491|FG002|Overall Study|Protocol-specified Disease Worsening|1
7980403|NCT03046056|12549489|FG000|Overall Study|Adverse Event|1
7980404|NCT03046056|12549490|FG001|Overall Study|Adverse Event|5
7980405|NCT03046056|12549491|FG002|Overall Study|Adverse Event|0
7980406|NCT03046056|12549489|FG000|Overall Study|Non-compliance With Study Drug|0
7980407|NCT03046056|12549490|FG001|Overall Study|Non-compliance With Study Drug|0
7980408|NCT03046056|12549491|FG002|Overall Study|Non-compliance With Study Drug|2
7980409|NCT03046056|12549489|FG000|Overall Study|Protocol Violation|1
7980410|NCT03046056|12549490|FG001|Overall Study|Protocol Violation|1
7980411|NCT03046056|12549491|FG002|Overall Study|Protocol Violation|0
7980412|NCT03046056|12549489|FG000|Overall Study|Investigator's Discretion|0
7980413|NCT03046056|12549490|FG001|Overall Study|Investigator's Discretion|1
7980414|NCT03046056|12549491|FG002|Overall Study|Investigator's Discretion|0
7980415|NCT03046056|12549489|FG000|Overall Study|Withdrew Consent|1
7980416|NCT03046056|12549490|FG001|Overall Study|Withdrew Consent|0
7980417|NCT03046056|12549491|FG002|Overall Study|Withdrew Consent|0
7980418|NCT03046446|12549517|FG000|Overall Study|Lack of Efficacy|7
7980419|NCT03046446|12549517|FG000|Overall Study|Adverse Event|6
7980420|NCT03046446|12549517|FG000|Overall Study|Lost to Follow-up|3
7980421|NCT03046446|12549517|FG000|Overall Study|Withdrawal by Subject|14
7980422|NCT03046446|12549517|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3
7980423|NCT03046446|12549517|FG000|Overall Study|Disease Progression (see caveats)|25
7980424|NCT03046446|12549517|FG000|Overall Study|Non OA related knee surgery|1
7980425|NCT03047551|12549580|FG000|Overall Study|Did not receive TAS|1
7980426|NCT03047551|12549581|FG001|Overall Study|Did not receive TAS|0
7980427|NCT03047551|12549580|FG000|Overall Study|Physician Decision|1
7980428|NCT03047551|12549581|FG001|Overall Study|Physician Decision|0
7980429|NCT03047551|12549580|FG000|Overall Study|Withdrawal by Subject|0
7980430|NCT03047551|12549581|FG001|Overall Study|Withdrawal by Subject|1
7980431|NCT03047551|12549580|FG000|Overall Study|Probe malfunction|0
7980432|NCT03047551|12549581|FG001|Overall Study|Probe malfunction|1
7980433|NCT03047551|12549580|FG000|Overall Study|Ineligible|0
7980434|NCT03047551|12549581|FG001|Overall Study|Ineligible|1
7980435|NCT03047720|12549589|FG000|First Intervention (6weeks)|Participant data entry insufficient|7
7980436|NCT03047720|12549590|FG001|First Intervention (6weeks)|Participant data entry insufficient|0
7980437|NCT03047980|12549596|FG000|Overall Study|Adverse Event|1
7980438|NCT03048058|12549606|FG000|Overall Study|Lost to Follow-up|4
7980439|NCT03048058|12549607|FG001|Overall Study|Lost to Follow-up|0
7980440|NCT03048058|12549606|FG000|Overall Study|Withdrawal by Subject|0
7980441|NCT03048058|12549607|FG001|Overall Study|Withdrawal by Subject|4
7980442|NCT03048500|12549626|FG000|2 Cycles of Treatment|Withdrawal by Subject|1
7980443|NCT03048500|12549626|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4
7980444|NCT03048500|12549626|FG000|Reached 1st Response/Continued Treatment|Death|1
7980445|NCT03048500|12549626|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1
7980446|NCT03048500|12549626|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1
7980447|NCT03048500|12549626|FG000|Follow up for 3 Years|Currently in Follow-up|4
7980448|NCT03048500|12549626|FG000|Follow up for 3 Years|Death|12
7980449|NCT03048747|12549630|FG000|Overall Study|Adverse Event|2
7980450|NCT03048747|12549630|FG000|Overall Study|Participant Met Withdrawal Criteria|2
7980451|NCT03048747|12549630|FG000|Overall Study|Physician Decision|1
7980452|NCT03049280|12549644|FG000|Overall Study|Physician Decision|1
7980453|NCT03049488|12549656|FG000|Overall Study|Lost to Follow-up|1
7980454|NCT03049488|12549657|FG001|Overall Study|Lost to Follow-up|1
7980455|NCT03049488|12549658|FG002|Overall Study|Lost to Follow-up|0
7980456|NCT03049488|12549659|FG003|Overall Study|Lost to Follow-up|0
7980457|NCT03049488|12549660|FG004|Overall Study|Lost to Follow-up|0
7980458|NCT03049488|12549661|FG005|Overall Study|Lost to Follow-up|0
7980459|NCT03049488|12549656|FG000|Overall Study|Moved from Area|1
7980460|NCT03049488|12549657|FG001|Overall Study|Moved from Area|0
7980461|NCT03049488|12549658|FG002|Overall Study|Moved from Area|0
7980462|NCT03049488|12549659|FG003|Overall Study|Moved from Area|1
7980463|NCT03049488|12549660|FG004|Overall Study|Moved from Area|1
7980464|NCT03049488|12549661|FG005|Overall Study|Moved from Area|0
7980465|NCT03049488|12549656|FG000|Overall Study|Physician Decision|0
7980466|NCT03049488|12549657|FG001|Overall Study|Physician Decision|1
7980467|NCT03049488|12549658|FG002|Overall Study|Physician Decision|0
7980468|NCT03049488|12549659|FG003|Overall Study|Physician Decision|0
7980469|NCT03049488|12549660|FG004|Overall Study|Physician Decision|0
7980470|NCT03049488|12549661|FG005|Overall Study|Physician Decision|0
7980471|NCT03049488|12549656|FG000|Overall Study|Withdrawal by Subject|0
7980472|NCT03049488|12549657|FG001|Overall Study|Withdrawal by Subject|0
7980473|NCT03049488|12549658|FG002|Overall Study|Withdrawal by Subject|0
7980474|NCT03049488|12549659|FG003|Overall Study|Withdrawal by Subject|1
7980475|NCT03049488|12549660|FG004|Overall Study|Withdrawal by Subject|1
7980476|NCT03049488|12549661|FG005|Overall Study|Withdrawal by Subject|0
7980477|NCT03049748|12549687|FG000|Overall Study|Lost to Follow-up|1
7980478|NCT03049748|12549688|FG001|Overall Study|Lost to Follow-up|0
7980479|NCT03049748|12549687|FG000|Overall Study|Death|3
7980480|NCT03049748|12549688|FG001|Overall Study|Death|0
7980481|NCT03049748|12549687|FG000|Overall Study|Withdrawal by Subject|0
7980482|NCT03049748|12549688|FG001|Overall Study|Withdrawal by Subject|3
7980483|NCT03049748|12549687|FG000|Overall Study|Protocol Violation|0
7980484|NCT03049748|12549688|FG001|Overall Study|Protocol Violation|2
7980485|NCT03049748|12549687|FG000|Overall Study|Moved out of state (relocation)|0
7980486|NCT03049748|12549688|FG001|Overall Study|Moved out of state (relocation)|1
7980487|NCT03049852|12549697|FG000|Overall Study|Lost to Follow-up|0
7980488|NCT03049852|12549698|FG001|Overall Study|Lost to Follow-up|1
7980489|NCT03049852|12549699|FG002|Overall Study|Lost to Follow-up|0
7980490|NCT03050307|12549784|FG000|Overall Study|Adverse Event|4
7980491|NCT03050307|12549785|FG001|Overall Study|Adverse Event|2
7980492|NCT03050307|12549784|FG000|Overall Study|Significant Protocol Deviation|0
7980493|NCT03050307|12549785|FG001|Overall Study|Significant Protocol Deviation|1
7980494|NCT03050307|12549784|FG000|Overall Study|Lost to Follow-up|0
7980495|NCT03050307|12549785|FG001|Overall Study|Lost to Follow-up|1
7980496|NCT03050307|12549784|FG000|Overall Study|Voluntary Withdrawal|3
7980497|NCT03050307|12549785|FG001|Overall Study|Voluntary Withdrawal|4
7980498|NCT03050307|12549784|FG000|Overall Study|Reason not Specified|1
7980499|NCT03050307|12549785|FG001|Overall Study|Reason not Specified|1
7980500|NCT03050359|12549804|FG000|Overall Study|Randomized But Not Treated|2
7980501|NCT03050359|12549805|FG001|Overall Study|Randomized But Not Treated|0
7980502|NCT03050359|12549804|FG000|Overall Study|Pretreatment Event/Adverse Event|5
7980503|NCT03050359|12549805|FG001|Overall Study|Pretreatment Event/Adverse Event|10
7980504|NCT03050359|12549804|FG000|Overall Study|Significant Protocol Deviation|2
7980505|NCT03050359|12549805|FG001|Overall Study|Significant Protocol Deviation|3
7980506|NCT03050359|12549804|FG000|Overall Study|Lost to Follow-up|2
7980507|NCT03050359|12549805|FG001|Overall Study|Lost to Follow-up|1
7980508|NCT03050359|12549804|FG000|Overall Study|Voluntary Withdrawal|4
7980509|NCT03050359|12549805|FG001|Overall Study|Voluntary Withdrawal|6
7980510|NCT03050359|12549804|FG000|Overall Study|Pregnancy|1
7980511|NCT03050359|12549805|FG001|Overall Study|Pregnancy|0
7980512|NCT03050359|12549804|FG000|Overall Study|Reason Not Specified|1
7980513|NCT03050359|12549805|FG001|Overall Study|Reason Not Specified|0
7980514|NCT03050372|12549813|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1
7980515|NCT03050372|12549814|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0
7980516|NCT03050372|12549813|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0
7980517|NCT03050372|12549814|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1
7980518|NCT03050450|12549824|FG000|Overall Study|Physician Decision|1
7980519|NCT03050450|12549825|FG001|Overall Study|Physician Decision|0
7980520|NCT03050450|12549826|FG002|Overall Study|Physician Decision|0
7980521|NCT03050450|12549827|FG003|Overall Study|Physician Decision|0
7980522|NCT03050450|12549828|FG004|Overall Study|Physician Decision|0
7980523|NCT03050801|12549909|FG000|Experiment 1|Lost to Follow-up|0
7980524|NCT03050801|12549910|FG001|Experiment 1|Lost to Follow-up|1
7980525|NCT03050801|12549911|FG002|Experiment 1|Lost to Follow-up|0
7980526|NCT03050801|12549912|FG003|Experiment 1|Lost to Follow-up|0
7980527|NCT03050801|12549913|FG004|Experiment 1|Lost to Follow-up|0
7980528|NCT03050801|12549914|FG005|Experiment 1|Lost to Follow-up|0
7980529|NCT03050801|12549909|FG000|Experiment 1|Physician Decision|0
7980530|NCT03050801|12549910|FG001|Experiment 1|Physician Decision|3
7980531|NCT03050801|12549911|FG002|Experiment 1|Physician Decision|0
7980532|NCT03050801|12549912|FG003|Experiment 1|Physician Decision|0
7980533|NCT03050801|12549913|FG004|Experiment 1|Physician Decision|0
7980534|NCT03050801|12549914|FG005|Experiment 1|Physician Decision|0
7980535|NCT03050801|12549909|FG000|Experiment 1|Change of experimental design|0
7980536|NCT03050801|12549910|FG001|Experiment 1|Change of experimental design|3
7980537|NCT03050801|12549911|FG002|Experiment 1|Change of experimental design|0
7980538|NCT03050801|12549912|FG003|Experiment 1|Change of experimental design|0
7980539|NCT03050801|12549913|FG004|Experiment 1|Change of experimental design|0
7980540|NCT03050801|12549914|FG005|Experiment 1|Change of experimental design|0
7980541|NCT03050801|12549909|FG000|Experiment 1|Unable to obtain critical rTMS measure|0
7980542|NCT03050801|12549910|FG001|Experiment 1|Unable to obtain critical rTMS measure|0
7980543|NCT03050801|12549911|FG002|Experiment 1|Unable to obtain critical rTMS measure|2
7980544|NCT03050801|12549912|FG003|Experiment 1|Unable to obtain critical rTMS measure|0
7980545|NCT03050801|12549913|FG004|Experiment 1|Unable to obtain critical rTMS measure|0
7980546|NCT03050801|12549914|FG005|Experiment 1|Unable to obtain critical rTMS measure|0
7980547|NCT03050801|12549909|FG000|Experiment 2|Lost to Follow-up|0
7980548|NCT03050801|12549910|FG001|Experiment 2|Lost to Follow-up|0
7980549|NCT03050801|12549911|FG002|Experiment 2|Lost to Follow-up|0
7980550|NCT03050801|12549912|FG003|Experiment 2|Lost to Follow-up|1
7980551|NCT03050801|12549913|FG004|Experiment 2|Lost to Follow-up|1
7980552|NCT03050801|12549914|FG005|Experiment 2|Lost to Follow-up|0
7980553|NCT03050801|12549909|FG000|Experiment 2|Physician Decision|0
7980554|NCT03050801|12549910|FG001|Experiment 2|Physician Decision|0
7980555|NCT03050801|12549911|FG002|Experiment 2|Physician Decision|0
7980556|NCT03050801|12549912|FG003|Experiment 2|Physician Decision|0
7980557|NCT03050801|12549913|FG004|Experiment 2|Physician Decision|1
7980558|NCT03050801|12549914|FG005|Experiment 2|Physician Decision|0
7980559|NCT03050801|12549909|FG000|Experiment 2|Pregnancy|0
7980560|NCT03050801|12549910|FG001|Experiment 2|Pregnancy|0
7980561|NCT03050801|12549911|FG002|Experiment 2|Pregnancy|0
7980562|NCT03050801|12549912|FG003|Experiment 2|Pregnancy|0
7980563|NCT03050801|12549913|FG004|Experiment 2|Pregnancy|1
7980564|NCT03050801|12549914|FG005|Experiment 2|Pregnancy|0
7980565|NCT03050801|12549909|FG000|Experiment 2|Withdrawal by Subject|0
7980566|NCT03050801|12549910|FG001|Experiment 2|Withdrawal by Subject|0
7980567|NCT03050801|12549911|FG002|Experiment 2|Withdrawal by Subject|0
7980568|NCT03050801|12549912|FG003|Experiment 2|Withdrawal by Subject|1
7980569|NCT03050801|12549913|FG004|Experiment 2|Withdrawal by Subject|0
7980570|NCT03050801|12549914|FG005|Experiment 2|Withdrawal by Subject|0
7980571|NCT03050801|12549909|FG000|Experiment 2|Poor data quality|0
7980572|NCT03050801|12549910|FG001|Experiment 2|Poor data quality|0
7980573|NCT03050801|12549911|FG002|Experiment 2|Poor data quality|0
7980574|NCT03050801|12549912|FG003|Experiment 2|Poor data quality|4
7980575|NCT03050801|12549913|FG004|Experiment 2|Poor data quality|1
7980576|NCT03050801|12549914|FG005|Experiment 2|Poor data quality|0
7980577|NCT03050801|12549909|FG000|Experiment 2|Discomfort during stimulation|0
7980578|NCT03050801|12549910|FG001|Experiment 2|Discomfort during stimulation|0
7980579|NCT03050801|12549911|FG002|Experiment 2|Discomfort during stimulation|0
7980580|NCT03050801|12549912|FG003|Experiment 2|Discomfort during stimulation|0
7980581|NCT03050801|12549913|FG004|Experiment 2|Discomfort during stimulation|0
7980582|NCT03050801|12549914|FG005|Experiment 2|Discomfort during stimulation|2
7980583|NCT03051100|12549942|FG000|Overall Study|Withdrawal by Subject|1
7980584|NCT03051100|12549943|FG001|Overall Study|Withdrawal by Subject|0
7980585|NCT03051165|12549949|FG000|Overall Study|Withdrawal by Subject|1
7980586|NCT03051165|12549949|FG000|Overall Study|Early termination of study|12
7980587|NCT03051607|12549967|FG000|Overall Study|Adverse Event|66
7980588|NCT03051620|12549971|FG000|Overall Study|Lost to Follow-up|6
7980589|NCT03051620|12549971|FG000|Overall Study|n=124 enrolled in extension (all completed)|12
7980590|NCT03052322|12550011|FG000|Overall Study|Other un-specified|1
7980591|NCT03052322|12550012|FG001|Overall Study|Other un-specified|2
7980592|NCT03052322|12550011|FG000|Overall Study|Withdrawal by Subject|10
7980593|NCT03052322|12550012|FG001|Overall Study|Withdrawal by Subject|9
7980594|NCT03052322|12550011|FG000|Overall Study|Death|0
7980595|NCT03052322|12550012|FG001|Overall Study|Death|2
7980596|NCT03052322|12550011|FG000|Overall Study|Lack of Efficacy|1
7980597|NCT03052322|12550012|FG001|Overall Study|Lack of Efficacy|2
7980598|NCT03052322|12550011|FG000|Overall Study|Protocol Violation|1
7980599|NCT03052322|12550012|FG001|Overall Study|Protocol Violation|0
7980600|NCT03052322|12550011|FG000|Overall Study|Lost to Follow-up|2
7980601|NCT03052322|12550012|FG001|Overall Study|Lost to Follow-up|4
7980602|NCT03052322|12550011|FG000|Overall Study|Adverse Event|6
7980603|NCT03052322|12550012|FG001|Overall Study|Adverse Event|13
7980604|NCT03052426|12550021|FG000|Overall Study|Withdrawal by Subject|0
7980605|NCT03052426|12550022|FG001|Overall Study|Withdrawal by Subject|1
7980606|NCT03052426|12550023|FG002|Overall Study|Withdrawal by Subject|0
7980607|NCT03052426|12550021|FG000|Overall Study|Lost to Follow-up|2
7980608|NCT03052426|12550022|FG001|Overall Study|Lost to Follow-up|0
7980609|NCT03052426|12550023|FG002|Overall Study|Lost to Follow-up|1
7980610|NCT03052517|12550039|FG000|Overall Study|Study Terminated By Sponsor|928
7980611|NCT03052517|12550040|FG001|Overall Study|Study Terminated By Sponsor|938
7980612|NCT03052517|12550041|FG002|Overall Study|Study Terminated By Sponsor|296
7980613|NCT03052517|12550039|FG000|Overall Study|Subject/Guardian Decision|50
7980614|NCT03052517|12550040|FG001|Overall Study|Subject/Guardian Decision|45
7980615|NCT03052517|12550041|FG002|Overall Study|Subject/Guardian Decision|22
7980616|NCT03052517|12550039|FG000|Overall Study|Lack of Efficacy|23
7980617|NCT03052517|12550040|FG001|Overall Study|Lack of Efficacy|14
7980618|NCT03052517|12550041|FG002|Overall Study|Lack of Efficacy|7
7980619|NCT03052517|12550039|FG000|Overall Study|Adverse Event|6
7980620|NCT03052517|12550040|FG001|Overall Study|Adverse Event|5
7980621|NCT03052517|12550041|FG002|Overall Study|Adverse Event|0
7980622|NCT03052517|12550039|FG000|Overall Study|Physician Decision|4
7980623|NCT03052517|12550040|FG001|Overall Study|Physician Decision|5
7980624|NCT03052517|12550041|FG002|Overall Study|Physician Decision|1
7980625|NCT03052517|12550039|FG000|Overall Study|Death|3
7980626|NCT03052517|12550040|FG001|Overall Study|Death|0
7980627|NCT03052517|12550041|FG002|Overall Study|Death|1
7980628|NCT03052517|12550039|FG000|Overall Study|Lost to Follow-up|2
7980629|NCT03052517|12550040|FG001|Overall Study|Lost to Follow-up|4
7980630|NCT03052517|12550041|FG002|Overall Study|Lost to Follow-up|0
7980631|NCT03052517|12550039|FG000|Overall Study|Pregnancy|1
7980632|NCT03052517|12550040|FG001|Overall Study|Pregnancy|0
7980633|NCT03052517|12550041|FG002|Overall Study|Pregnancy|1
7980634|NCT03052517|12550039|FG000|Overall Study|Non-Compliance With Study Treatment|0
7980635|NCT03052517|12550040|FG001|Overall Study|Non-Compliance With Study Treatment|2
7980636|NCT03052517|12550041|FG002|Overall Study|Non-Compliance With Study Treatment|0
7980637|NCT03052517|12550039|FG000|Overall Study|Technical Problems|0
7980638|NCT03052517|12550040|FG001|Overall Study|Technical Problems|1
7980639|NCT03052517|12550041|FG002|Overall Study|Technical Problems|0
7980640|NCT03052725|12550055|FG000|Overall Study|Adverse Event|2
7980641|NCT03052725|12550056|FG001|Overall Study|Adverse Event|0
7980642|NCT03052725|12550055|FG000|Overall Study|Withdrawal by Subject|3
7980643|NCT03052725|12550056|FG001|Overall Study|Withdrawal by Subject|4
7980644|NCT03052725|12550055|FG000|Overall Study|Pregnancy|0
7980645|NCT03052725|12550056|FG001|Overall Study|Pregnancy|1
7980646|NCT03052725|12550055|FG000|Overall Study|Site closure|0
7980647|NCT03052725|12550056|FG001|Overall Study|Site closure|1
7980648|NCT03052725|12550055|FG000|Overall Study|Study terminated by sponsor|143
7980649|NCT03052725|12550056|FG001|Overall Study|Study terminated by sponsor|144
7980650|NCT03052751|12550063|FG000|Dosing Period 1|Adverse Event|0
7980651|NCT03052751|12550064|FG001|Dosing Period 1|Adverse Event|1
7980652|NCT03052751|12550065|FG002|Dosing Period 1|Adverse Event|0
7980653|NCT03052751|12550066|FG003|Dosing Period 1|Adverse Event|0
7980654|NCT03052751|12550067|FG004|Dosing Period 1|Adverse Event|0
7980655|NCT03052751|12550068|FG005|Dosing Period 1|Adverse Event|0
7980656|NCT03052751|12550063|FG000|Dosing Period 2|Adverse Event|0
7980657|NCT03052751|12550064|FG001|Dosing Period 2|Adverse Event|0
7980658|NCT03052751|12550065|FG002|Dosing Period 2|Adverse Event|3
7980659|NCT03052751|12550066|FG003|Dosing Period 2|Adverse Event|0
7980660|NCT03052751|12550067|FG004|Dosing Period 2|Adverse Event|0
7980661|NCT03052751|12550068|FG005|Dosing Period 2|Adverse Event|0
7980662|NCT03052751|12550063|FG000|Observation Period|Adverse Event|0
7980663|NCT03052751|12550064|FG001|Observation Period|Adverse Event|0
7980664|NCT03052751|12550065|FG002|Observation Period|Adverse Event|0
7980665|NCT03052751|12550066|FG003|Observation Period|Adverse Event|0
7980666|NCT03052751|12550067|FG004|Observation Period|Adverse Event|1
7980667|NCT03052751|12550068|FG005|Observation Period|Adverse Event|0
7980668|NCT03052764|12550080|FG000|Double-Blind Treatment Period|Adverse Event|2
7980669|NCT03052764|12550081|FG001|Double-Blind Treatment Period|Adverse Event|0
7980670|NCT03052764|12550080|FG000|Double-Blind Treatment Period|Lack of Efficacy|1
7980671|NCT03052764|12550081|FG001|Double-Blind Treatment Period|Lack of Efficacy|0
7980672|NCT03052764|12550080|FG000|Double-Blind Treatment Period|Protocol Violation|2
7980673|NCT03052764|12550081|FG001|Double-Blind Treatment Period|Protocol Violation|1
7980674|NCT03052764|12550080|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3
7980675|NCT03052764|12550081|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
7980676|NCT03052764|12550080|FG000|Double-Blind Treatment Period|Reason not Specified|2
7980677|NCT03052764|12550081|FG001|Double-Blind Treatment Period|Reason not Specified|1
7980678|NCT03052816|12550091|FG000|Overall Study|Withdrawal by Subject|1
7980679|NCT03052816|12550092|FG001|Overall Study|Withdrawal by Subject|0
7980680|NCT03052816|12550091|FG000|Overall Study|Desired opioids|2
7980681|NCT03052816|12550092|FG001|Overall Study|Desired opioids|0
7980682|NCT03052959|12550102|FG000|Overall Study|Lost to Follow-up|4
7980683|NCT03052959|12550103|FG001|Overall Study|Lost to Follow-up|5
7980684|NCT03053050|12550123|FG000|Randomized Phase|Study Terminated by Sponsor|259
7980685|NCT03053050|12550124|FG001|Randomized Phase|Study Terminated by Sponsor|260
7980686|NCT03053050|12550125|FG002|Randomized Phase|Study Terminated by Sponsor|128
7980687|NCT03053050|12550126|FG003|Randomized Phase|Study Terminated by Sponsor|0
7980688|NCT03053050|12550123|FG000|Randomized Phase|Withdrew Consent|16
7980689|NCT03053050|12550124|FG001|Randomized Phase|Withdrew Consent|8
7980690|NCT03053050|12550125|FG002|Randomized Phase|Withdrew Consent|9
7980691|NCT03053050|12550126|FG003|Randomized Phase|Withdrew Consent|0
7980692|NCT03053050|12550123|FG000|Randomized Phase|Investigator's Discretion|6
7980693|NCT03053050|12550124|FG001|Randomized Phase|Investigator's Discretion|6
7980694|NCT03053050|12550125|FG002|Randomized Phase|Investigator's Discretion|3
7980695|NCT03053050|12550126|FG003|Randomized Phase|Investigator's Discretion|0
7980696|NCT03053050|12550123|FG000|Randomized Phase|Lost to Follow-up|5
7980697|NCT03053050|12550124|FG001|Randomized Phase|Lost to Follow-up|1
7980698|NCT03053050|12550125|FG002|Randomized Phase|Lost to Follow-up|1
7980699|NCT03053050|12550126|FG003|Randomized Phase|Lost to Follow-up|0
7980700|NCT03053050|12550123|FG000|Randomized Phase|Adverse Event|0
7980701|NCT03053050|12550124|FG001|Randomized Phase|Adverse Event|1
7980702|NCT03053050|12550125|FG002|Randomized Phase|Adverse Event|0
7980703|NCT03053050|12550126|FG003|Randomized Phase|Adverse Event|0
7980704|NCT03053050|12550123|FG000|Randomized Phase|Randomized but Never Treated|2
7980705|NCT03053050|12550124|FG001|Randomized Phase|Randomized but Never Treated|2
7980706|NCT03053050|12550125|FG002|Randomized Phase|Randomized but Never Treated|2
7980707|NCT03053050|12550126|FG003|Randomized Phase|Randomized but Never Treated|0
7980708|NCT03053050|12550123|FG000|Randomized Phase|Entered the Open-Label Phase|36
7980709|NCT03053050|12550124|FG001|Randomized Phase|Entered the Open-Label Phase|45
7980710|NCT03053050|12550125|FG002|Randomized Phase|Entered the Open-Label Phase|18
7980711|NCT03053050|12550126|FG003|Randomized Phase|Entered the Open-Label Phase|0
7980712|NCT03053050|12550123|FG000|Open-label Phase|Study Terminated by Sponsor|0
7980713|NCT03053050|12550124|FG001|Open-label Phase|Study Terminated by Sponsor|0
7980714|NCT03053050|12550125|FG002|Open-label Phase|Study Terminated by Sponsor|0
7980715|NCT03053050|12550126|FG003|Open-label Phase|Study Terminated by Sponsor|89
7980716|NCT03053050|12550123|FG000|Open-label Phase|Withdrew Consent|0
7980717|NCT03053050|12550124|FG001|Open-label Phase|Withdrew Consent|0
7980718|NCT03053050|12550125|FG002|Open-label Phase|Withdrew Consent|0
7980719|NCT03053050|12550126|FG003|Open-label Phase|Withdrew Consent|6
7980720|NCT03053050|12550123|FG000|Open-label Phase|Investigator's Discretion|0
7980721|NCT03053050|12550124|FG001|Open-label Phase|Investigator's Discretion|0
7980722|NCT03053050|12550125|FG002|Open-label Phase|Investigator's Discretion|0
7980723|NCT03053050|12550126|FG003|Open-label Phase|Investigator's Discretion|4
7980724|NCT03053063|12550138|FG000|Randomized Phase|Study Terminated by Sponsor|326
7980725|NCT03053063|12550139|FG001|Randomized Phase|Study Terminated by Sponsor|317
7980726|NCT03053063|12550140|FG002|Randomized Phase|Study Terminated by Sponsor|161
7980727|NCT03053063|12550141|FG003|Randomized Phase|Study Terminated by Sponsor|0
7980728|NCT03053063|12550138|FG000|Randomized Phase|Withdrew consent|8
7980729|NCT03053063|12550139|FG001|Randomized Phase|Withdrew consent|11
7980730|NCT03053063|12550140|FG002|Randomized Phase|Withdrew consent|5
7980731|NCT03053063|12550141|FG003|Randomized Phase|Withdrew consent|0
7980732|NCT03053063|12550138|FG000|Randomized Phase|Investigator's Discretion|8
7980733|NCT03053063|12550139|FG001|Randomized Phase|Investigator's Discretion|6
7980734|NCT03053063|12550140|FG002|Randomized Phase|Investigator's Discretion|2
7980735|NCT03053063|12550141|FG003|Randomized Phase|Investigator's Discretion|0
7980736|NCT03053063|12550138|FG000|Randomized Phase|Lost to Follow-up|3
7980737|NCT03053063|12550139|FG001|Randomized Phase|Lost to Follow-up|5
7980738|NCT03053063|12550140|FG002|Randomized Phase|Lost to Follow-up|1
7980739|NCT03053063|12550141|FG003|Randomized Phase|Lost to Follow-up|0
7980740|NCT03053063|12550138|FG000|Randomized Phase|Adverse Event|0
7980741|NCT03053063|12550139|FG001|Randomized Phase|Adverse Event|1
7980742|NCT03053063|12550140|FG002|Randomized Phase|Adverse Event|0
7980743|NCT03053063|12550141|FG003|Randomized Phase|Adverse Event|0
7980744|NCT03053063|12550138|FG000|Randomized Phase|Randomized but Never Treated|1
7980745|NCT03053063|12550139|FG001|Randomized Phase|Randomized but Never Treated|3
7980746|NCT03053063|12550140|FG002|Randomized Phase|Randomized but Never Treated|2
7980747|NCT03053063|12550141|FG003|Randomized Phase|Randomized but Never Treated|0
7980748|NCT03053063|12550138|FG000|Randomized Phase|Entered the Open-Label Phase|9
7980749|NCT03053063|12550139|FG001|Randomized Phase|Entered the Open-Label Phase|11
7980750|NCT03053063|12550140|FG002|Randomized Phase|Entered the Open-Label Phase|3
7980751|NCT03053063|12550141|FG003|Randomized Phase|Entered the Open-Label Phase|0
7980752|NCT03053063|12550138|FG000|Open-Label Phase|Study Terminated by Sponsor|0
7980753|NCT03053063|12550139|FG001|Open-Label Phase|Study Terminated by Sponsor|0
7980754|NCT03053063|12550140|FG002|Open-Label Phase|Study Terminated by Sponsor|0
7980755|NCT03053063|12550141|FG003|Open-Label Phase|Study Terminated by Sponsor|19
7980756|NCT03053063|12550138|FG000|Open-Label Phase|Death|0
7980757|NCT03053063|12550139|FG001|Open-Label Phase|Death|0
7980758|NCT03053063|12550140|FG002|Open-Label Phase|Death|0
7980759|NCT03053063|12550141|FG003|Open-Label Phase|Death|2
7980760|NCT03053063|12550138|FG000|Open-Label Phase|Investigator's discretion|0
7980761|NCT03053063|12550139|FG001|Open-Label Phase|Investigator's discretion|0
7980762|NCT03053063|12550140|FG002|Open-Label Phase|Investigator's discretion|0
7980763|NCT03053063|12550141|FG003|Open-Label Phase|Investigator's discretion|2
7980764|NCT03053180|12550150|FG000|Overall Study|Failure to Return|1
7980765|NCT03053271|12550154|FG000|Overall Study|Did not meet randomization criteria|3
7980766|NCT03053271|12550154|FG000|Overall Study|Withdrawal by Subject|1
7980767|NCT03053427|12550170|FG000|Overall Study|Adverse Event|4
7980768|NCT03053427|12550171|FG001|Overall Study|Adverse Event|4
7980769|NCT03053427|12550170|FG000|Overall Study|Lack of Efficacy|1
7980770|NCT03053427|12550171|FG001|Overall Study|Lack of Efficacy|3
7980771|NCT03053427|12550170|FG000|Overall Study|Lost to Follow-up|2
7980772|NCT03053427|12550171|FG001|Overall Study|Lost to Follow-up|2
7980773|NCT03053427|12550170|FG000|Overall Study|Worsening of the target disease|0
7980774|NCT03053427|12550171|FG001|Overall Study|Worsening of the target disease|1
7980775|NCT03053427|12550170|FG000|Overall Study|Protocol Deviation|3
7980776|NCT03053427|12550171|FG001|Overall Study|Protocol Deviation|3
7980777|NCT03053427|12550170|FG000|Overall Study|Withdrawal by Subject|3
7980778|NCT03053427|12550171|FG001|Overall Study|Withdrawal by Subject|2
7980779|NCT03053427|12550170|FG000|Overall Study|Miscellaneous|0
7980780|NCT03053427|12550171|FG001|Overall Study|Miscellaneous|1
7980781|NCT03053492|12550179|FG000|Overall Study|Adverse Event|1
7980782|NCT03053492|12550180|FG001|Overall Study|Adverse Event|1
7980783|NCT03053492|12550179|FG000|Overall Study|Withdrawal by Subject|7
7980784|NCT03053492|12550180|FG001|Overall Study|Withdrawal by Subject|5
7980785|NCT03054064|12550197|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1
7980786|NCT03054064|12550197|FG000|Overall Study|Investigator Decision|2
7980787|NCT03054064|12550197|FG000|Overall Study|Bladder Issue|1
7980788|NCT03054064|12550197|FG000|Overall Study|High Blood Pressure|1
7980789|NCT03054064|12550197|FG000|Overall Study|Change in Status|1
7980790|NCT03054337|12550229|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1
7980791|NCT03054337|12550230|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2
7980792|NCT03054337|12550231|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1
7980793|NCT03054337|12550232|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0
7980794|NCT03054337|12550233|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0
7980795|NCT03054337|12550234|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1
7980796|NCT03054350|12550267|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4
7980797|NCT03054350|12550268|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2
7980798|NCT03054350|12550269|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1
7980799|NCT03054350|12550270|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2
7980800|NCT03054350|12550271|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4
7980801|NCT03054350|12550272|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3
7980802|NCT03054350|12550267|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7980803|NCT03054350|12550268|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7980804|NCT03054350|12550269|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1
7980805|NCT03054350|12550270|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7980806|NCT03054350|12550271|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7980807|NCT03054350|12550272|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7980808|NCT03054350|12550267|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1
7980809|NCT03054350|12550268|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7980810|NCT03054350|12550269|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7980811|NCT03054350|12550270|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1
7980812|NCT03054350|12550271|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7980813|NCT03054350|12550272|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7980814|NCT03054350|12550267|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0
7980815|NCT03054350|12550268|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0
7980816|NCT03054350|12550269|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1
7980817|NCT03054350|12550270|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0
7980818|NCT03054350|12550271|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0
7980819|NCT03054350|12550272|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0
7980820|NCT03054428|12550306|FG000|Overall Study|Physician Decision|0
7980821|NCT03054428|12550307|FG001|Overall Study|Physician Decision|1
7980822|NCT03054428|12550308|FG002|Overall Study|Physician Decision|1
7980823|NCT03054428|12550306|FG000|Overall Study|Lack of Efficacy|3
7980824|NCT03054428|12550307|FG001|Overall Study|Lack of Efficacy|1
7980825|NCT03054428|12550308|FG002|Overall Study|Lack of Efficacy|0
7980826|NCT03054428|12550306|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0
7980827|NCT03054428|12550307|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0
7980828|NCT03054428|12550308|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1
7980829|NCT03054428|12550306|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1
7980830|NCT03054428|12550307|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0
7980831|NCT03054428|12550308|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0
7980832|NCT03054428|12550306|FG000|Overall Study|Transitioned to OLE study|76
7980833|NCT03054428|12550307|FG001|Overall Study|Transitioned to OLE study|76
7980834|NCT03054428|12550308|FG002|Overall Study|Transitioned to OLE study|73
7980835|NCT03054428|12550306|FG000|Overall Study|Withdrawal by Subject|3
7980836|NCT03054428|12550307|FG001|Overall Study|Withdrawal by Subject|2
7980837|NCT03054428|12550308|FG002|Overall Study|Withdrawal by Subject|3
7980838|NCT03054428|12550306|FG000|Overall Study|Lost to Follow-up|0
7980839|NCT03054428|12550307|FG001|Overall Study|Lost to Follow-up|0
7980840|NCT03054428|12550308|FG002|Overall Study|Lost to Follow-up|1
7980841|NCT03054870|12550403|FG000|Day of Ventilation Imaging|Protocol Violation|4
7980842|NCT03054870|12550403|FG000|Day of Ventilation Imaging|Lost to Follow-up|1
7980843|NCT03055195|12550455|FG000|Overall Study|Lack of Efficacy|1
7980844|NCT03055195|12550456|FG001|Overall Study|Lack of Efficacy|0
7980845|NCT03055195|12550455|FG000|Overall Study|Withdrawal by Subject|6
7980846|NCT03055195|12550456|FG001|Overall Study|Withdrawal by Subject|7
7980847|NCT03055195|12550455|FG000|Overall Study|Study Terminated by Sponsor|2
7980848|NCT03055195|12550456|FG001|Overall Study|Study Terminated by Sponsor|6
7980849|NCT03055195|12550455|FG000|Overall Study|Protocol Violation|2
7980850|NCT03055195|12550456|FG001|Overall Study|Protocol Violation|1
7980851|NCT03055195|12550455|FG000|Overall Study|Physician Decision|1
7980852|NCT03055195|12550456|FG001|Overall Study|Physician Decision|0
7980853|NCT03055221|12550462|FG000|Overall Study|Adverse Event|2
7980854|NCT03055221|12550462|FG000|Overall Study|Withdrawal by Subject|4
7980855|NCT03055221|12550462|FG000|Overall Study|Death|6
7980856|NCT03055221|12550462|FG000|Overall Study|Physician Decision|1
7980857|NCT03055221|12550462|FG000|Overall Study|Study terminated by Sponsor|3
7980858|NCT03055260|12550468|FG000|Overall Study|Withdrawal by Subject|1
7980859|NCT03055260|12550469|FG001|Overall Study|Withdrawal by Subject|0
7980860|NCT03055338|12550478|FG000|Overall Study|Lost to Follow-up|9
7980861|NCT03055338|12550479|FG001|Overall Study|Lost to Follow-up|2
7980862|NCT03055338|12550480|FG002|Overall Study|Lost to Follow-up|3
7980863|NCT03055338|12550478|FG000|Overall Study|No Post-treatment Protocol Contact|0
7980864|NCT03055338|12550479|FG001|Overall Study|No Post-treatment Protocol Contact|1
7980865|NCT03055338|12550480|FG002|Overall Study|No Post-treatment Protocol Contact|0
7980866|NCT03055338|12550478|FG000|Overall Study|Physician Decision|0
7980867|NCT03055338|12550479|FG001|Overall Study|Physician Decision|0
7980868|NCT03055338|12550480|FG002|Overall Study|Physician Decision|2
7980869|NCT03055338|12550478|FG000|Overall Study|Withdrawal by Subject|9
7980870|NCT03055338|12550479|FG001|Overall Study|Withdrawal by Subject|8
7980871|NCT03055338|12550480|FG002|Overall Study|Withdrawal by Subject|7
7980872|NCT03055494|12550490|FG000|Overall Study|Lost to Follow-up|6
7980873|NCT03055494|12550491|FG001|Overall Study|Lost to Follow-up|0
7980874|NCT03055494|12550490|FG000|Overall Study|Physician Decision|2
7980875|NCT03055494|12550491|FG001|Overall Study|Physician Decision|0
7980876|NCT03055494|12550490|FG000|Overall Study|Withdrawal by Subject|1
7980877|NCT03055494|12550491|FG001|Overall Study|Withdrawal by Subject|0
7980878|NCT03055494|12550490|FG000|Overall Study|Adverse Event|0
7980879|NCT03055494|12550491|FG001|Overall Study|Adverse Event|1
7980880|NCT03055494|12550490|FG000|Overall Study|Non-compliance with study treatment|1
7980881|NCT03055494|12550491|FG001|Overall Study|Non-compliance with study treatment|0
7980882|NCT03055624|12550498|FG000|Overall Study|Study closed|9
7980883|NCT03055806|12550510|FG000|Overall Study|Adverse Event|0
7980884|NCT03055806|12550511|FG001|Overall Study|Adverse Event|0
7980885|NCT03055806|12550512|FG002|Overall Study|Adverse Event|1
7980886|NCT03055806|12550513|FG003|Overall Study|Adverse Event|1
7980887|NCT03055806|12550510|FG000|Overall Study|Lost to Follow-up|0
7980888|NCT03055806|12550511|FG001|Overall Study|Lost to Follow-up|3
7980889|NCT03055806|12550512|FG002|Overall Study|Lost to Follow-up|6
7980890|NCT03055806|12550513|FG003|Overall Study|Lost to Follow-up|7
7980891|NCT03055806|12550510|FG000|Overall Study|Physician Decision|1
7980892|NCT03055806|12550511|FG001|Overall Study|Physician Decision|0
7980893|NCT03055806|12550512|FG002|Overall Study|Physician Decision|0
7980894|NCT03055806|12550513|FG003|Overall Study|Physician Decision|1
7980895|NCT03055806|12550510|FG000|Overall Study|Protocol Violation|1
7980896|NCT03055806|12550511|FG001|Overall Study|Protocol Violation|0
7980897|NCT03055806|12550512|FG002|Overall Study|Protocol Violation|0
7980898|NCT03055806|12550513|FG003|Overall Study|Protocol Violation|0
7980899|NCT03055806|12550510|FG000|Overall Study|Withdrawal of consent to continue drug|1
7980900|NCT03055806|12550511|FG001|Overall Study|Withdrawal of consent to continue drug|1
7980901|NCT03055806|12550512|FG002|Overall Study|Withdrawal of consent to continue drug|2
7980902|NCT03055806|12550513|FG003|Overall Study|Withdrawal of consent to continue drug|0
7980903|NCT03055806|12550510|FG000|Overall Study|Withdrawal of consent to continue study|2
7980904|NCT03055806|12550511|FG001|Overall Study|Withdrawal of consent to continue study|3
7980905|NCT03055806|12550512|FG002|Overall Study|Withdrawal of consent to continue study|4
7980906|NCT03055806|12550513|FG003|Overall Study|Withdrawal of consent to continue study|6
7980907|NCT03055806|12550510|FG000|Overall Study|Partner not willing to try intercourse|1
7980908|NCT03055806|12550511|FG001|Overall Study|Partner not willing to try intercourse|0
7980909|NCT03055806|12550512|FG002|Overall Study|Partner not willing to try intercourse|0
7980910|NCT03055806|12550513|FG003|Overall Study|Partner not willing to try intercourse|0
7980911|NCT03055832|12550525|FG000|Week 2|Withdrawal by Subject|1
7980912|NCT03055832|12550526|FG001|Week 2|Withdrawal by Subject|0
7980913|NCT03055936|12550554|FG000|Overall Study|Adverse Event|0
7980914|NCT03055936|12550555|FG001|Overall Study|Adverse Event|1
7980915|NCT03055936|12550556|FG002|Overall Study|Adverse Event|1
7980916|NCT03055936|12550557|FG003|Overall Study|Adverse Event|1
7980917|NCT03055936|12550554|FG000|Overall Study|Personal reason|2
7980918|NCT03055936|12550555|FG001|Overall Study|Personal reason|0
7980919|NCT03055936|12550556|FG002|Overall Study|Personal reason|1
7980920|NCT03055936|12550557|FG003|Overall Study|Personal reason|0
7980921|NCT03055988|12550591|FG000|Period 1|Adverse Event|0
7980922|NCT03055988|12550592|FG001|Period 1|Adverse Event|1
7980923|NCT03055988|12550591|FG000|Period 1|Lost to Follow-up|1
7980924|NCT03055988|12550592|FG001|Period 1|Lost to Follow-up|0
7980925|NCT03055988|12550591|FG000|Period 1|Withdrawal by Subject|0
7980926|NCT03055988|12550592|FG001|Period 1|Withdrawal by Subject|4
7980927|NCT03055988|12550591|FG000|Period 2|Adverse Event|0
7980928|NCT03055988|12550592|FG001|Period 2|Adverse Event|1
7980929|NCT03055988|12550591|FG000|Period 2|Other than listed|1
7980930|NCT03055988|12550592|FG001|Period 2|Other than listed|1
7980931|NCT03056300|12550602|FG000|Overall Study|Surgical reason per study protocol|3
7980932|NCT03056352|12550606|FG000|Overall Study|Lost to Follow-up|1
7980933|NCT03056573|12550628|FG000|Overall Study|Death|2
7980934|NCT03056573|12550629|FG001|Overall Study|Death|4
7980935|NCT03056573|12550628|FG000|Overall Study|Withdrawal by Subject|2
7980936|NCT03056573|12550629|FG001|Overall Study|Withdrawal by Subject|0
7980937|NCT03056573|12550628|FG000|Overall Study|Lost to Follow-up|1
7980938|NCT03056573|12550629|FG001|Overall Study|Lost to Follow-up|1
7980939|NCT03056690|12550637|FG000|Overall Study|Adverse Event|3
7980940|NCT03056690|12550638|FG001|Overall Study|Adverse Event|2
7980941|NCT03056690|12550637|FG000|Overall Study|Lack of Efficacy|1
7980942|NCT03056690|12550638|FG001|Overall Study|Lack of Efficacy|2
7980943|NCT03056690|12550637|FG000|Overall Study|Lost to Follow-up|3
7980944|NCT03056690|12550638|FG001|Overall Study|Lost to Follow-up|2
7980945|NCT03056690|12550637|FG000|Overall Study|Protocol Violation|2
7980946|NCT03056690|12550638|FG001|Overall Study|Protocol Violation|2
7980947|NCT03056690|12550637|FG000|Overall Study|Withdrawal by Subject|3
7980948|NCT03056690|12550638|FG001|Overall Study|Withdrawal by Subject|6
7980949|NCT03056690|12550637|FG000|Overall Study|Non-compliance with Study Drug|1
7980950|NCT03056690|12550638|FG001|Overall Study|Non-compliance with Study Drug|0
7980951|NCT03056690|12550637|FG000|Overall Study|Miscellaneous|1
7980952|NCT03056690|12550638|FG001|Overall Study|Miscellaneous|2
7980953|NCT03057496|12550661|FG000|Overall Study|Withdrawal by Subject|8
7980954|NCT03057496|12550661|FG000|Overall Study|Lost to Follow-up|5
7980955|NCT03057496|12550661|FG000|Overall Study|Did not use device during home trial|3
7980956|NCT03057496|12550661|FG000|Overall Study|Device failure|2
7980957|NCT03057977|12550678|FG000|Discontinuation From Treatment|Withdrawal by Subject|124
7980958|NCT03057977|12550679|FG001|Discontinuation From Treatment|Withdrawal by Subject|92
7980959|NCT03057977|12550678|FG000|Discontinuation From Treatment|Lost to Follow-up|11
7980960|NCT03057977|12550679|FG001|Discontinuation From Treatment|Lost to Follow-up|17
7980961|NCT03057977|12550678|FG000|Discontinuation From Treatment|Protocol Violation|6
7980962|NCT03057977|12550679|FG001|Discontinuation From Treatment|Protocol Violation|5
7980963|NCT03057977|12550678|FG000|Discontinuation From Treatment|Not treated|4
7980964|NCT03057977|12550679|FG001|Discontinuation From Treatment|Not treated|0
7980965|NCT03057977|12550678|FG000|Discontinuation From Treatment|Adverse Event|343
7980966|NCT03057977|12550679|FG001|Discontinuation From Treatment|Adverse Event|337
7980967|NCT03057977|12550678|FG000|Discontinuation From Treatment|Reason Unknown|0
7980968|NCT03057977|12550679|FG001|Discontinuation From Treatment|Reason Unknown|1
7980969|NCT03057977|12550678|FG000|Discontinuation From Treatment|Personal Reasons|1
7980970|NCT03057977|12550679|FG001|Discontinuation From Treatment|Personal Reasons|1
7980971|NCT03057977|12550678|FG000|Discontinuation From Treatment|Unblinded medication|1
7980972|NCT03057977|12550679|FG001|Discontinuation From Treatment|Unblinded medication|0
7980973|NCT03057977|12550678|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1
7980974|NCT03057977|12550679|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1
7980975|NCT03057977|12550678|FG000|Discontinuation From Treatment|Principle Investigator Decision|2
7980976|NCT03057977|12550679|FG001|Discontinuation From Treatment|Principle Investigator Decision|0
7980977|NCT03057977|12550678|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2
7980978|NCT03057977|12550679|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4
7980979|NCT03057977|12550678|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4
7980980|NCT03057977|12550679|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3
7980981|NCT03057977|12550678|FG000|Discontinuation From Treatment|Unable to continue treatment|4
7980982|NCT03057977|12550679|FG001|Discontinuation From Treatment|Unable to continue treatment|1
7980983|NCT03057977|12550678|FG000|Discontinuation From Treatment|Not attending study visit|3
7980984|NCT03057977|12550679|FG001|Discontinuation From Treatment|Not attending study visit|10
7980985|NCT03057977|12550678|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1
7980986|NCT03057977|12550679|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4
7980987|NCT03057977|12550678|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8
7980988|NCT03057977|12550679|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6
7980989|NCT03057977|12550678|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9
7980990|NCT03057977|12550679|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9
7980991|NCT03057977|12550678|FG000|Discontinuation From Trial|Limited follow-up agreed|2
7980992|NCT03057977|12550679|FG001|Discontinuation From Trial|Limited follow-up agreed|2
7980993|NCT03057977|12550678|FG000|Discontinuation From Trial|Withdrawal by Subject|9
7980994|NCT03057977|12550679|FG001|Discontinuation From Trial|Withdrawal by Subject|11
7980995|NCT03058679|12550687|FG000|Baseline to Week 6|Lost to Follow-up|3
7980996|NCT03058679|12550688|FG001|Baseline to Week 6|Lost to Follow-up|2
7980997|NCT03058679|12550687|FG000|Baseline to Week 6|Change in Crohn's disease medication|4
7980998|NCT03058679|12550688|FG001|Baseline to Week 6|Change in Crohn's disease medication|2
7980999|NCT03058679|12550687|FG000|Baseline to Week 6|Adverse Event|6
7981000|NCT03058679|12550688|FG001|Baseline to Week 6|Adverse Event|6
7981001|NCT03058679|12550687|FG000|Baseline to Week 6|Withdrawal by Subject|4
7981002|NCT03058679|12550688|FG001|Baseline to Week 6|Withdrawal by Subject|3
7981003|NCT03058679|12550687|FG000|Baseline to Week 6|Difficulty following the diet|0
7981004|NCT03058679|12550688|FG001|Baseline to Week 6|Difficulty following the diet|2
7981005|NCT03058679|12550687|FG000|Baseline to Week 6|Physician Decision|1
7981006|NCT03058679|12550688|FG001|Baseline to Week 6|Physician Decision|0
7981007|NCT03058679|12550687|FG000|Week 6 to Week 12|Change in medication|5
7981008|NCT03058679|12550688|FG001|Week 6 to Week 12|Change in medication|7
7981009|NCT03058679|12550687|FG000|Week 6 to Week 12|Adverse Event|4
7981010|NCT03058679|12550688|FG001|Week 6 to Week 12|Adverse Event|3
7981011|NCT03058679|12550687|FG000|Week 6 to Week 12|Withdrawal by Subject|9
7981012|NCT03058679|12550688|FG001|Week 6 to Week 12|Withdrawal by Subject|4
7981013|NCT03058679|12550687|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2
7981014|NCT03058679|12550688|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3
7981015|NCT03058692|12550696|FG000|Overall Study|Lost to Follow-up|2
7981016|NCT03058692|12550697|FG001|Overall Study|Lost to Follow-up|1
7981017|NCT03058692|12550696|FG000|Overall Study|Withdrawal by Subject|1
7981018|NCT03058692|12550697|FG001|Overall Study|Withdrawal by Subject|1
7981019|NCT03058991|12550707|FG000|Overall Study|Lost to Follow-up|17
7981020|NCT03058991|12550708|FG001|Overall Study|Lost to Follow-up|12
7981021|NCT03058991|12550709|FG002|Overall Study|Lost to Follow-up|12
7981022|NCT03058991|12550707|FG000|Overall Study|Withdrawal by Subject|1
7981023|NCT03058991|12550708|FG001|Overall Study|Withdrawal by Subject|0
7981024|NCT03058991|12550709|FG002|Overall Study|Withdrawal by Subject|0
7981025|NCT03060447|12550732|FG000|Overall Study|Withdrawal by Subject|2
7981026|NCT03060447|12550733|FG001|Overall Study|Withdrawal by Subject|0
7981027|NCT03060512|12550751|FG000|Overall Study|Adverse Event|4
7981028|NCT03060512|12550752|FG001|Overall Study|Adverse Event|6
7981029|NCT03060512|12550751|FG000|Overall Study|Lost to Follow-up|1
7981030|NCT03060512|12550752|FG001|Overall Study|Lost to Follow-up|1
7981031|NCT03060512|12550751|FG000|Overall Study|Withdrawal by Subject|1
7981032|NCT03060512|12550752|FG001|Overall Study|Withdrawal by Subject|0
7981033|NCT03060512|12550751|FG000|Overall Study|Non-compliance with study medication|1
7981034|NCT03060512|12550752|FG001|Overall Study|Non-compliance with study medication|2
7981035|NCT03060551|12550763|FG000|Overall Study|Withdrawal by Subject|1
7981036|NCT03060551|12550763|FG000|Overall Study|Adverse Event|1
7981037|NCT03061097|12550778|FG000|Overall Study|Withdrawal by Subject|0
7981038|NCT03061097|12550779|FG001|Overall Study|Withdrawal by Subject|3
7981039|NCT03061175|12550787|FG000|Baseline|Participant was deemed ineligible|1
7981040|NCT03061175|12550788|FG001|Baseline|Participant was deemed ineligible|0
7981041|NCT03061175|12550787|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6
7981042|NCT03061175|12550788|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2
7981043|NCT03061175|12550787|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0
7981044|NCT03061175|12550788|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1
7981045|NCT03061175|12550787|FG000|Followup 2 at 6 Months|Lost to Follow-up|4
7981046|NCT03061175|12550788|FG001|Followup 2 at 6 Months|Lost to Follow-up|7
7981047|NCT03061188|12550798|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0
7981048|NCT03061188|12550799|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0
7981049|NCT03061188|12550800|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1
7981050|NCT03061188|12550801|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1
7981051|NCT03061188|12550798|FG000|On Follow-up for 3 Years|Death|0
7981052|NCT03061188|12550799|FG001|On Follow-up for 3 Years|Death|3
7981053|NCT03061188|12550800|FG002|On Follow-up for 3 Years|Death|5
7981054|NCT03061188|12550801|FG003|On Follow-up for 3 Years|Death|2
7981055|NCT03061188|12550798|FG000|On Follow-up for 3 Years|Still in follow-up|0
7981056|NCT03061188|12550799|FG001|On Follow-up for 3 Years|Still in follow-up|0
7981057|NCT03061188|12550800|FG002|On Follow-up for 3 Years|Still in follow-up|0
7981058|NCT03061188|12550801|FG003|On Follow-up for 3 Years|Still in follow-up|3
7981059|NCT03061214|12550819|FG000|Overall Study|Withdrawal by Subject|21
7981060|NCT03061214|12550820|FG001|Overall Study|Withdrawal by Subject|26
7981061|NCT03061214|12550821|FG002|Overall Study|Withdrawal by Subject|9
7981062|NCT03061214|12550819|FG000|Overall Study|Lost to Follow-up|3
7981063|NCT03061214|12550820|FG001|Overall Study|Lost to Follow-up|1
7981064|NCT03061214|12550821|FG002|Overall Study|Lost to Follow-up|1
7981065|NCT03061214|12550819|FG000|Overall Study|Death|1
7981066|NCT03061214|12550820|FG001|Overall Study|Death|1
7981067|NCT03061214|12550821|FG002|Overall Study|Death|0
7981068|NCT03061331|12550831|FG000|Washout Period (8 Weeks)|Adverse Event|2
7981069|NCT03061331|12550832|FG001|Washout Period (8 Weeks)|Adverse Event|1
7981070|NCT03062891|12550893|FG000|Overall Study|Withdrawal by Subject|2
7981071|NCT03062891|12550894|FG001|Overall Study|Withdrawal by Subject|0
7981072|NCT03062891|12550893|FG000|Overall Study|Lost to Follow-up|50
7981073|NCT03062891|12550894|FG001|Overall Study|Lost to Follow-up|38
7981074|NCT03063086|12550921|FG000|Overall Study|technical problems|1
7981075|NCT03063086|12550922|FG001|Overall Study|technical problems|0
7981076|NCT03063086|12550923|FG002|Overall Study|technical problems|0
7981077|NCT03063086|12550924|FG003|Overall Study|technical problems|0
7981078|NCT03063086|12550925|FG004|Overall Study|technical problems|0
7981079|NCT03063086|12550926|FG005|Overall Study|technical problems|0
7981080|NCT03063086|12550921|FG000|Overall Study|Adverse Event|1
7981081|NCT03063086|12550922|FG001|Overall Study|Adverse Event|1
7981082|NCT03063086|12550923|FG002|Overall Study|Adverse Event|1
7981083|NCT03063086|12550924|FG003|Overall Study|Adverse Event|1
7981084|NCT03063086|12550925|FG004|Overall Study|Adverse Event|0
7981085|NCT03063086|12550926|FG005|Overall Study|Adverse Event|0
7981086|NCT03063086|12550921|FG000|Overall Study|subject/guardian decision|1
7981087|NCT03063086|12550922|FG001|Overall Study|subject/guardian decision|0
7981088|NCT03063086|12550923|FG002|Overall Study|subject/guardian decision|0
7981089|NCT03063086|12550924|FG003|Overall Study|subject/guardian decision|0
7981090|NCT03063086|12550925|FG004|Overall Study|subject/guardian decision|0
7981091|NCT03063086|12550926|FG005|Overall Study|subject/guardian decision|0
7981092|NCT03063086|12550921|FG000|Overall Study|Non-compliance with study treatment|0
7981093|NCT03063086|12550922|FG001|Overall Study|Non-compliance with study treatment|0
7981094|NCT03063086|12550923|FG002|Overall Study|Non-compliance with study treatment|0
7981095|NCT03063086|12550924|FG003|Overall Study|Non-compliance with study treatment|1
7981096|NCT03063086|12550925|FG004|Overall Study|Non-compliance with study treatment|0
7981097|NCT03063086|12550926|FG005|Overall Study|Non-compliance with study treatment|1
7981098|NCT03063086|12550921|FG000|Overall Study|Physician Decision|0
7981099|NCT03063086|12550922|FG001|Overall Study|Physician Decision|0
7981100|NCT03063086|12550923|FG002|Overall Study|Physician Decision|0
7981101|NCT03063086|12550924|FG003|Overall Study|Physician Decision|1
7981102|NCT03063086|12550925|FG004|Overall Study|Physician Decision|0
7981103|NCT03063086|12550926|FG005|Overall Study|Physician Decision|0
7981104|NCT03064438|12550990|FG000|Overall Study|Lost to Follow-up|1
7981105|NCT03064438|12550991|FG001|Overall Study|Lost to Follow-up|0
7981106|NCT03064438|12550990|FG000|Overall Study|Withdrawal by Subject|0
7981107|NCT03064438|12550991|FG001|Overall Study|Withdrawal by Subject|1
7981108|NCT03064451|12550997|FG000|Overall Study|Lost to Follow-up|1
7981109|NCT03064451|12550997|FG000|Overall Study|Mapping Failure|4
7981110|NCT03064451|12550997|FG000|Overall Study|Exited prior to procedure|8
7981111|NCT03064451|12550997|FG000|Overall Study|Withdrew consent: 3-month FU visit|1
7981112|NCT03064841|12551001|FG000|Overall Study|Inclusion/exclusion criteria violation|4
7981113|NCT03064841|12551001|FG000|Overall Study|No glycated haemoglobinA1c measurement|11
7981114|NCT03064841|12551001|FG000|Overall Study|Screen failure|2
7981115|NCT03065023|12551009|FG000|Overall Study|Progressive Disease|0
7981116|NCT03065023|12551010|FG001|Overall Study|Progressive Disease|1
7981117|NCT03065023|12551011|FG002|Overall Study|Progressive Disease|0
7981118|NCT03065023|12551012|FG003|Overall Study|Progressive Disease|0
7981119|NCT03065023|12551013|FG004|Overall Study|Progressive Disease|0
7981120|NCT03065023|12551009|FG000|Overall Study|Death|2
7981121|NCT03065023|12551010|FG001|Overall Study|Death|0
7981122|NCT03065023|12551011|FG002|Overall Study|Death|1
7981123|NCT03065023|12551012|FG003|Overall Study|Death|1
7981124|NCT03065023|12551013|FG004|Overall Study|Death|0
7981125|NCT03065023|12551009|FG000|Overall Study|Lost to Follow-up|0
7981126|NCT03065023|12551010|FG001|Overall Study|Lost to Follow-up|1
7981127|NCT03065023|12551011|FG002|Overall Study|Lost to Follow-up|0
7981128|NCT03065023|12551012|FG003|Overall Study|Lost to Follow-up|0
7981129|NCT03065023|12551013|FG004|Overall Study|Lost to Follow-up|0
7981130|NCT03065023|12551009|FG000|Overall Study|Participant Decision|0
7981131|NCT03065023|12551010|FG001|Overall Study|Participant Decision|0
7981132|NCT03065023|12551011|FG002|Overall Study|Participant Decision|0
7981133|NCT03065023|12551012|FG003|Overall Study|Participant Decision|1
7981134|NCT03065023|12551013|FG004|Overall Study|Participant Decision|0
7981135|NCT03065023|12551009|FG000|Overall Study|Withdrawal by Subject|0
7981136|NCT03065023|12551010|FG001|Overall Study|Withdrawal by Subject|0
7981137|NCT03065023|12551011|FG002|Overall Study|Withdrawal by Subject|0
7981138|NCT03065023|12551012|FG003|Overall Study|Withdrawal by Subject|1
7981139|NCT03065023|12551013|FG004|Overall Study|Withdrawal by Subject|0
7981140|NCT03065400|12551050|FG000|Overall Study|Adverse Event|1
7981141|NCT03065400|12551050|FG000|Overall Study|Physician Decision|3
7981142|NCT03065400|12551050|FG000|Overall Study|Withdrawal by Subject|1
7981143|NCT03065400|12551050|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5
7981144|NCT03065530|12551058|FG000|Overall Study|Lack of Efficacy|1
7981145|NCT03065530|12551059|FG001|Overall Study|Lack of Efficacy|1
7981146|NCT03065530|12551060|FG002|Overall Study|Lack of Efficacy|0
7981147|NCT03065530|12551061|FG003|Overall Study|Lack of Efficacy|1
7981148|NCT03065530|12551058|FG000|Overall Study|Protocol Violation|1
7981149|NCT03065530|12551059|FG001|Overall Study|Protocol Violation|0
7981150|NCT03065530|12551060|FG002|Overall Study|Protocol Violation|1
7981151|NCT03065530|12551061|FG003|Overall Study|Protocol Violation|1
7981152|NCT03066193|12551092|FG000|Overall Study|Withdrawal by Subject|1
7981153|NCT03066609|12551099|FG000|INDUCTION|Pregnancy|0
7981154|NCT03066609|12551100|FG001|INDUCTION|Pregnancy|0
7981155|NCT03066609|12551101|FG002|INDUCTION|Pregnancy|1
7981156|NCT03066609|12551102|FG003|INDUCTION|Pregnancy|0
7981157|NCT03066609|12551099|FG000|INDUCTION|Lack of Efficacy|0
7981158|NCT03066609|12551100|FG001|INDUCTION|Lack of Efficacy|0
7981159|NCT03066609|12551101|FG002|INDUCTION|Lack of Efficacy|1
7981160|NCT03066609|12551102|FG003|INDUCTION|Lack of Efficacy|0
7981161|NCT03066609|12551099|FG000|INDUCTION|Adverse Event|2
7981162|NCT03066609|12551100|FG001|INDUCTION|Adverse Event|2
7981163|NCT03066609|12551101|FG002|INDUCTION|Adverse Event|0
7981164|NCT03066609|12551102|FG003|INDUCTION|Adverse Event|0
7981165|NCT03066609|12551099|FG000|MAINTENANCE|Adverse Event|0
7981166|NCT03066609|12551100|FG001|MAINTENANCE|Adverse Event|0
7981167|NCT03066609|12551101|FG002|MAINTENANCE|Adverse Event|0
7981168|NCT03066609|12551102|FG003|MAINTENANCE|Adverse Event|1
7981169|NCT03066609|12551099|FG000|MAINTENANCE|Withdrawal by Subject|4
7981170|NCT03066609|12551100|FG001|MAINTENANCE|Withdrawal by Subject|2
7981171|NCT03066609|12551101|FG002|MAINTENANCE|Withdrawal by Subject|1
7981172|NCT03066609|12551102|FG003|MAINTENANCE|Withdrawal by Subject|1
7981173|NCT03066609|12551099|FG000|MAINTENANCE|Lost to Follow-up|0
7981174|NCT03066609|12551100|FG001|MAINTENANCE|Lost to Follow-up|1
7981175|NCT03066609|12551101|FG002|MAINTENANCE|Lost to Follow-up|1
7981176|NCT03066609|12551102|FG003|MAINTENANCE|Lost to Follow-up|0
7981177|NCT03066609|12551099|FG000|MAINTENANCE|Pregnancy|1
7981178|NCT03066609|12551100|FG001|MAINTENANCE|Pregnancy|0
7981179|NCT03066609|12551101|FG002|MAINTENANCE|Pregnancy|0
7981180|NCT03066609|12551102|FG003|MAINTENANCE|Pregnancy|0
7981181|NCT03066609|12551099|FG000|MAINTENANCE|Lack of Efficacy|2
7981182|NCT03066609|12551100|FG001|MAINTENANCE|Lack of Efficacy|1
7981183|NCT03066609|12551101|FG002|MAINTENANCE|Lack of Efficacy|0
7981184|NCT03066609|12551102|FG003|MAINTENANCE|Lack of Efficacy|1
7981185|NCT03066609|12551099|FG000|OVERALL STUDY|Adverse Event|2
7981186|NCT03066609|12551100|FG001|OVERALL STUDY|Adverse Event|2
7981187|NCT03066609|12551101|FG002|OVERALL STUDY|Adverse Event|0
7981188|NCT03066609|12551102|FG003|OVERALL STUDY|Adverse Event|1
7981189|NCT03066609|12551099|FG000|OVERALL STUDY|Withdrawal by Subject|4
7981190|NCT03066609|12551100|FG001|OVERALL STUDY|Withdrawal by Subject|2
7981191|NCT03066609|12551101|FG002|OVERALL STUDY|Withdrawal by Subject|1
7981192|NCT03066609|12551102|FG003|OVERALL STUDY|Withdrawal by Subject|2
7981193|NCT03066609|12551099|FG000|OVERALL STUDY|Lost to Follow-up|1
7981194|NCT03066609|12551100|FG001|OVERALL STUDY|Lost to Follow-up|1
7981195|NCT03066609|12551101|FG002|OVERALL STUDY|Lost to Follow-up|1
7981196|NCT03066609|12551102|FG003|OVERALL STUDY|Lost to Follow-up|1
7981197|NCT03066609|12551099|FG000|OVERALL STUDY|Pregnancy|1
7981198|NCT03066609|12551100|FG001|OVERALL STUDY|Pregnancy|0
7981199|NCT03066609|12551101|FG002|OVERALL STUDY|Pregnancy|1
7981200|NCT03066609|12551102|FG003|OVERALL STUDY|Pregnancy|0
7981201|NCT03066609|12551099|FG000|OVERALL STUDY|Lack of Efficacy|2
7981202|NCT03066609|12551100|FG001|OVERALL STUDY|Lack of Efficacy|1
7981203|NCT03066609|12551101|FG002|OVERALL STUDY|Lack of Efficacy|1
7981204|NCT03066609|12551102|FG003|OVERALL STUDY|Lack of Efficacy|1
7981205|NCT03066609|12551099|FG000|OVERALL STUDY|discontinued follow up|0
7981206|NCT03066609|12551100|FG001|OVERALL STUDY|discontinued follow up|2
7981207|NCT03066609|12551101|FG002|OVERALL STUDY|discontinued follow up|0
7981208|NCT03066609|12551102|FG003|OVERALL STUDY|discontinued follow up|0
7981209|NCT03066778|12551115|FG000|Overall Study|Death|167
7981210|NCT03066778|12551116|FG001|Overall Study|Death|183
7981211|NCT03066778|12551115|FG000|Overall Study|Withdrawal by Subject|4
7981212|NCT03066778|12551116|FG001|Overall Study|Withdrawal by Subject|5
7981213|NCT03066778|12551115|FG000|Overall Study|Ongoing in Study|57
7981214|NCT03066778|12551116|FG001|Overall Study|Ongoing in Study|37
7981215|NCT03066804|12551124|FG000|Overall Study|Physician Decision|0
7981216|NCT03066804|12551125|FG001|Overall Study|Physician Decision|4
7981217|NCT03066804|12551124|FG000|Overall Study|Death|23
7981218|NCT03066804|12551125|FG001|Overall Study|Death|17
7981219|NCT03066804|12551124|FG000|Overall Study|Withdrawal by Subject|19
7981220|NCT03066804|12551125|FG001|Overall Study|Withdrawal by Subject|25
7981221|NCT03066804|12551124|FG000|Overall Study|Lost to Follow-up|2
7981222|NCT03066804|12551125|FG001|Overall Study|Lost to Follow-up|0
7981223|NCT03066804|12551124|FG000|Overall Study|Adverse Event|2
7981224|NCT03066804|12551125|FG001|Overall Study|Adverse Event|3
7981225|NCT03066804|12551124|FG000|Overall Study|Technical problems|5
7981226|NCT03066804|12551125|FG001|Overall Study|Technical problems|1
7981227|NCT03066830|12551134|FG000|Overall Study|At the Participant's own Request|16
7981228|NCT03066830|12551135|FG001|Overall Study|At the Participant's own Request|17
7981229|NCT03066830|12551134|FG000|Overall Study|Other|3
7981230|NCT03066830|12551135|FG001|Overall Study|Other|0
7981231|NCT03066830|12551134|FG000|Overall Study|Poor Compliance to Protocol|1
7981232|NCT03066830|12551135|FG001|Overall Study|Poor Compliance to Protocol|0
7981233|NCT03066830|12551134|FG000|Overall Study|Adverse Event|2
7981234|NCT03066830|12551135|FG001|Overall Study|Adverse Event|2
7981235|NCT03066830|12551134|FG000|Overall Study|Lost to Follow-up|11
7981236|NCT03066830|12551135|FG001|Overall Study|Lost to Follow-up|3
7981237|NCT03066999|12551149|FG000|Overall Study|abnormal urethraBladder neck contracture|0
7981238|NCT03066999|12551150|FG001|Overall Study|abnormal urethraBladder neck contracture|2
7981239|NCT03067311|12551159|FG000|Overall Study|Lost to Follow-up|1
7981240|NCT03067311|12551160|FG001|Overall Study|Lost to Follow-up|1
7981241|NCT03067311|12551159|FG000|Overall Study|Moved away|1
7981242|NCT03067311|12551160|FG001|Overall Study|Moved away|1
7981243|NCT03067441|12551168|FG000|Overall Study|Withdrawal by Subject|16
7981244|NCT03067441|12551169|FG001|Overall Study|Withdrawal by Subject|34
7981245|NCT03067441|12551168|FG000|Overall Study|Lost to Follow-up|7
7981246|NCT03067441|12551169|FG001|Overall Study|Lost to Follow-up|5
7981247|NCT03067441|12551168|FG000|Overall Study|Adverse Event|7
7981248|NCT03067441|12551169|FG001|Overall Study|Adverse Event|14
7981249|NCT03067441|12551168|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1
7981250|NCT03067441|12551169|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0
7981251|NCT03067441|12551168|FG000|Overall Study|Physician Decision|1
7981252|NCT03067441|12551169|FG001|Overall Study|Physician Decision|3
7981253|NCT03067441|12551168|FG000|Overall Study|Other|1
7981254|NCT03067441|12551169|FG001|Overall Study|Other|1
7981255|NCT03067987|12551188|FG000|Overall Study|Lost to Follow-up|7
7981256|NCT03067987|12551189|FG001|Overall Study|Lost to Follow-up|10
7981257|NCT03067987|12551188|FG000|Overall Study|Protocol Violation|1
7981258|NCT03067987|12551189|FG001|Overall Study|Protocol Violation|2
7981259|NCT03067987|12551188|FG000|Overall Study|Withdrawal by Subject|2
7981260|NCT03067987|12551189|FG001|Overall Study|Withdrawal by Subject|1
7981261|NCT03068455|12551211|FG000|Pre-treatment Period|Disease progression|0
7981262|NCT03068455|12551212|FG001|Pre-treatment Period|Disease progression|1
7981263|NCT03068455|12551211|FG000|Pre-treatment Period|Participant withdrew consent|1
7981264|NCT03068455|12551212|FG001|Pre-treatment Period|Participant withdrew consent|1
7981265|NCT03068455|12551211|FG000|Pre-treatment Period|Poor/non-compliance|0
7981266|NCT03068455|12551212|FG001|Pre-treatment Period|Poor/non-compliance|1
7981267|NCT03068455|12551211|FG000|Pre-treatment Period|Participant no longer meets study criteria|1
7981268|NCT03068455|12551212|FG001|Pre-treatment Period|Participant no longer meets study criteria|3
7981269|NCT03068455|12551211|FG000|Pre-treatment Period|Not reported|2
7981270|NCT03068455|12551212|FG001|Pre-treatment Period|Not reported|1
7981271|NCT03068455|12551211|FG000|Treatment Period|Disease progression|166
7981272|NCT03068455|12551212|FG001|Treatment Period|Disease progression|208
7981273|NCT03068455|12551211|FG000|Treatment Period|Study drug toxicity|317
7981274|NCT03068455|12551212|FG001|Treatment Period|Study drug toxicity|104
7981275|NCT03068455|12551211|FG000|Treatment Period|Adverse Event unrelated to study drug|15
7981276|NCT03068455|12551212|FG001|Treatment Period|Adverse Event unrelated to study drug|7
7981277|NCT03068455|12551211|FG000|Treatment Period|Participant request to stop therapy|33
7981278|NCT03068455|12551212|FG001|Treatment Period|Participant request to stop therapy|20
7981279|NCT03068455|12551211|FG000|Treatment Period|Participant withdrew consent|5
7981280|NCT03068455|12551212|FG001|Treatment Period|Participant withdrew consent|10
7981281|NCT03068455|12551211|FG000|Treatment Period|Poor/non-compliance|3
7981282|NCT03068455|12551212|FG001|Treatment Period|Poor/non-compliance|0
7981283|NCT03068455|12551211|FG000|Treatment Period|Participant no longer meets study criteria|1
7981284|NCT03068455|12551212|FG001|Treatment Period|Participant no longer meets study criteria|3
7981285|NCT03068455|12551211|FG000|Treatment Period|Other reasons|12
7981286|NCT03068455|12551212|FG001|Treatment Period|Other reasons|4
7981287|NCT03068468|12551220|FG000|Placebo-Controlled Period|Randomized but not Treated|1
7981288|NCT03068468|12551221|FG001|Placebo-Controlled Period|Randomized but not Treated|3
7981289|NCT03068468|12551222|FG002|Placebo-Controlled Period|Randomized but not Treated|0
7981290|NCT03068468|12551223|FG003|Placebo-Controlled Period|Randomized but not Treated|0
7981291|NCT03068468|12551220|FG000|Placebo-Controlled Period|Lack of Efficacy|0
7981292|NCT03068468|12551221|FG001|Placebo-Controlled Period|Lack of Efficacy|1
7981293|NCT03068468|12551222|FG002|Placebo-Controlled Period|Lack of Efficacy|0
7981294|NCT03068468|12551223|FG003|Placebo-Controlled Period|Lack of Efficacy|0
7981295|NCT03068468|12551220|FG000|Placebo-Controlled Period|Adverse Event|16
7981296|NCT03068468|12551221|FG001|Placebo-Controlled Period|Adverse Event|21
7981297|NCT03068468|12551222|FG002|Placebo-Controlled Period|Adverse Event|0
7981298|NCT03068468|12551223|FG003|Placebo-Controlled Period|Adverse Event|0
7981299|NCT03068468|12551220|FG000|Placebo-Controlled Period|Withdrawal by Subject|3
7981300|NCT03068468|12551221|FG001|Placebo-Controlled Period|Withdrawal by Subject|11
7981301|NCT03068468|12551222|FG002|Placebo-Controlled Period|Withdrawal by Subject|0
7981302|NCT03068468|12551223|FG003|Placebo-Controlled Period|Withdrawal by Subject|0
7981303|NCT03068468|12551220|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7981304|NCT03068468|12551221|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2
7981305|NCT03068468|12551222|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7981306|NCT03068468|12551223|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7981307|NCT03068468|12551220|FG000|Placebo-Controlled Period|Reason Not Specified|1
7981308|NCT03068468|12551221|FG001|Placebo-Controlled Period|Reason Not Specified|6
7981309|NCT03068468|12551222|FG002|Placebo-Controlled Period|Reason Not Specified|0
7981310|NCT03068468|12551223|FG003|Placebo-Controlled Period|Reason Not Specified|0
7981311|NCT03068468|12551220|FG000|Placebo-Controlled Period|Death|0
7981312|NCT03068468|12551221|FG001|Placebo-Controlled Period|Death|1
7981313|NCT03068468|12551222|FG002|Placebo-Controlled Period|Death|0
7981314|NCT03068468|12551223|FG003|Placebo-Controlled Period|Death|0
7981315|NCT03068468|12551220|FG000|Open-Label Extension Period|Lack of Efficacy|0
7981316|NCT03068468|12551221|FG001|Open-Label Extension Period|Lack of Efficacy|0
7981317|NCT03068468|12551222|FG002|Open-Label Extension Period|Lack of Efficacy|1
7981318|NCT03068468|12551223|FG003|Open-Label Extension Period|Lack of Efficacy|2
7981319|NCT03068468|12551220|FG000|Open-Label Extension Period|Adverse Event|0
7981320|NCT03068468|12551221|FG001|Open-Label Extension Period|Adverse Event|0
7981321|NCT03068468|12551222|FG002|Open-Label Extension Period|Adverse Event|13
7981322|NCT03068468|12551223|FG003|Open-Label Extension Period|Adverse Event|17
7981323|NCT03068468|12551220|FG000|Open-Label Extension Period|Withdrawal by Subject|0
7981324|NCT03068468|12551221|FG001|Open-Label Extension Period|Withdrawal by Subject|0
7981325|NCT03068468|12551222|FG002|Open-Label Extension Period|Withdrawal by Subject|7
7981326|NCT03068468|12551223|FG003|Open-Label Extension Period|Withdrawal by Subject|20
7981327|NCT03068468|12551220|FG000|Open-Label Extension Period|Death|0
7981328|NCT03068468|12551221|FG001|Open-Label Extension Period|Death|0
7981329|NCT03068468|12551222|FG002|Open-Label Extension Period|Death|0
7981330|NCT03068468|12551223|FG003|Open-Label Extension Period|Death|1
7981331|NCT03068468|12551220|FG000|Open-Label Extension Period|Lost to Follow-up|0
7981332|NCT03068468|12551221|FG001|Open-Label Extension Period|Lost to Follow-up|0
7981333|NCT03068468|12551222|FG002|Open-Label Extension Period|Lost to Follow-up|1
7981334|NCT03068468|12551223|FG003|Open-Label Extension Period|Lost to Follow-up|0
7981335|NCT03068468|12551220|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
7981336|NCT03068468|12551221|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
7981337|NCT03068468|12551222|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2
7981338|NCT03068468|12551223|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
7981339|NCT03068468|12551220|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0
7981340|NCT03068468|12551221|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0
7981341|NCT03068468|12551222|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115
7981342|NCT03068468|12551223|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228
7981343|NCT03068468|12551220|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
7981344|NCT03068468|12551221|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
7981345|NCT03068468|12551222|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
7981346|NCT03068468|12551223|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4
7981347|NCT03068468|12551220|FG000|Open-Label Extension Period|Reason not Specified|0
7981348|NCT03068468|12551221|FG001|Open-Label Extension Period|Reason not Specified|0
7981349|NCT03068468|12551222|FG002|Open-Label Extension Period|Reason not Specified|1
7981350|NCT03068468|12551223|FG003|Open-Label Extension Period|Reason not Specified|4
7981351|NCT03068754|12551242|FG000|Randomized Treatment Period (RTP)|Adverse Event|1
7981352|NCT03068754|12551243|FG001|Randomized Treatment Period (RTP)|Adverse Event|3
7981353|NCT03068754|12551244|FG002|Randomized Treatment Period (RTP)|Adverse Event|0
7981354|NCT03068754|12551245|FG003|Randomized Treatment Period (RTP)|Adverse Event|0
7981355|NCT03068754|12551242|FG000|Randomized Treatment Period (RTP)|Death|2
7981356|NCT03068754|12551243|FG001|Randomized Treatment Period (RTP)|Death|2
7981357|NCT03068754|12551244|FG002|Randomized Treatment Period (RTP)|Death|0
7981358|NCT03068754|12551245|FG003|Randomized Treatment Period (RTP)|Death|0
7981359|NCT03068754|12551242|FG000|Randomized Treatment Period (RTP)|Disease progression|1
7981360|NCT03068754|12551243|FG001|Randomized Treatment Period (RTP)|Disease progression|2
7981361|NCT03068754|12551244|FG002|Randomized Treatment Period (RTP)|Disease progression|0
7981362|NCT03068754|12551245|FG003|Randomized Treatment Period (RTP)|Disease progression|0
7981363|NCT03068754|12551242|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1
7981364|NCT03068754|12551243|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0
7981365|NCT03068754|12551244|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0
7981366|NCT03068754|12551245|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0
7981367|NCT03068754|12551242|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6
7981368|NCT03068754|12551243|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2
7981369|NCT03068754|12551244|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
7981370|NCT03068754|12551245|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
7981371|NCT03068754|12551242|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1
7981372|NCT03068754|12551243|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0
7981373|NCT03068754|12551244|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0
7981374|NCT03068754|12551245|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0
7981375|NCT03068754|12551242|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
7981376|NCT03068754|12551243|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1
7981377|NCT03068754|12551244|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
7981378|NCT03068754|12551245|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
7981379|NCT03068754|12551242|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55
7981380|NCT03068754|12551243|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29
7981381|NCT03068754|12551244|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
7981382|NCT03068754|12551245|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
7981383|NCT03068754|12551242|FG000|Open Label Extension Period (OLE)|Adverse Event|0
7981384|NCT03068754|12551243|FG001|Open Label Extension Period (OLE)|Adverse Event|0
7981385|NCT03068754|12551244|FG002|Open Label Extension Period (OLE)|Adverse Event|0
7981386|NCT03068754|12551245|FG003|Open Label Extension Period (OLE)|Adverse Event|1
7981387|NCT03068754|12551242|FG000|Open Label Extension Period (OLE)|Death|0
7981388|NCT03068754|12551243|FG001|Open Label Extension Period (OLE)|Death|0
7981389|NCT03068754|12551244|FG002|Open Label Extension Period (OLE)|Death|0
7981390|NCT03068754|12551245|FG003|Open Label Extension Period (OLE)|Death|1
7981391|NCT03068754|12551242|FG000|Open Label Extension Period (OLE)|Disease progression|0
7981392|NCT03068754|12551243|FG001|Open Label Extension Period (OLE)|Disease progression|0
7981393|NCT03068754|12551244|FG002|Open Label Extension Period (OLE)|Disease progression|3
7981394|NCT03068754|12551245|FG003|Open Label Extension Period (OLE)|Disease progression|1
7981395|NCT03068754|12551242|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0
7981396|NCT03068754|12551243|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0
7981397|NCT03068754|12551244|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5
7981398|NCT03068754|12551245|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0
7981399|NCT03068754|12551242|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
7981400|NCT03068754|12551243|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
7981401|NCT03068754|12551244|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1
7981402|NCT03068754|12551245|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
7981403|NCT03068754|12551242|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
7981404|NCT03068754|12551243|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
7981405|NCT03068754|12551244|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12
7981406|NCT03068754|12551245|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3
7981407|NCT03068767|12551257|FG000|Overall Study|Lost to Follow-up|7
7981408|NCT03068767|12551258|FG001|Overall Study|Lost to Follow-up|3
7981409|NCT03068767|12551257|FG000|Overall Study|Protocol Violation|3
7981410|NCT03068767|12551258|FG001|Overall Study|Protocol Violation|0
7981411|NCT03069313|12551298|FG000|Overall Study|Adverse Event|5
7981412|NCT03069365|12551302|FG000|Overall Study|Adverse Event|1
7981413|NCT03069482|12551308|FG000|Overall Study|Lost to Follow-up|0
7981414|NCT03069482|12551309|FG001|Overall Study|Lost to Follow-up|1
7981415|NCT03069482|12551308|FG000|Overall Study|Physician Decision|1
7981416|NCT03069482|12551309|FG001|Overall Study|Physician Decision|0
7981417|NCT03069716|12551329|FG000|Run-in Period (2 Weeks)|Adverse Event|1
7981418|NCT03069716|12551330|FG001|Run-in Period (2 Weeks)|Adverse Event|0
7981419|NCT03069716|12551331|FG002|Run-in Period (2 Weeks)|Adverse Event|0
7981420|NCT03069716|12551329|FG000|Run-in Period (2 Weeks)|Protocol Violation|1
7981421|NCT03069716|12551330|FG001|Run-in Period (2 Weeks)|Protocol Violation|0
7981422|NCT03069716|12551331|FG002|Run-in Period (2 Weeks)|Protocol Violation|0
7981423|NCT03069716|12551329|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5
7981424|NCT03069716|12551330|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0
7981425|NCT03069716|12551331|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0
7981426|NCT03069716|12551329|FG000|Randomized Treatment|Withdrawal by Subject|0
7981427|NCT03069716|12551330|FG001|Randomized Treatment|Withdrawal by Subject|2
7981428|NCT03069716|12551331|FG002|Randomized Treatment|Withdrawal by Subject|0
7981429|NCT03069989|12551340|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1
7981430|NCT03069989|12551341|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0
7981431|NCT03070171|12551350|FG000|Treatment Period 2 + Washout|Other Adverse Event|0
7981432|NCT03070171|12551351|FG001|Treatment Period 2 + Washout|Other Adverse Event|1
7981433|NCT03070171|12551350|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0
7981434|NCT03070171|12551351|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1
7981435|NCT03070431|12551357|FG000|Overall Study|Withdrawal by Subject|2
7981436|NCT03070431|12551357|FG000|Overall Study|Lost to Follow-up|2
7981437|NCT03070483|12551393|FG000|Overall Study|Lost to Follow-up|2
7981438|NCT03070782|12551421|FG000|Overall Study|Adverse Event|3
7981439|NCT03070782|12551422|FG001|Overall Study|Adverse Event|0
7981440|NCT03070782|12551423|FG002|Overall Study|Adverse Event|3
7981441|NCT03070782|12551424|FG003|Overall Study|Adverse Event|1
7981442|NCT03070782|12551425|FG004|Overall Study|Adverse Event|6
7981443|NCT03070782|12551426|FG005|Overall Study|Adverse Event|2
7981444|NCT03070782|12551421|FG000|Overall Study|Withdrawal by Subject|2
7981445|NCT03070782|12551422|FG001|Overall Study|Withdrawal by Subject|1
7981446|NCT03070782|12551423|FG002|Overall Study|Withdrawal by Subject|1
7981447|NCT03070782|12551424|FG003|Overall Study|Withdrawal by Subject|0
7981448|NCT03070782|12551425|FG004|Overall Study|Withdrawal by Subject|4
7981449|NCT03070782|12551426|FG005|Overall Study|Withdrawal by Subject|3
7981450|NCT03070782|12551421|FG000|Overall Study|Reason Not Specified|2
7981451|NCT03070782|12551422|FG001|Overall Study|Reason Not Specified|0
7981452|NCT03070782|12551423|FG002|Overall Study|Reason Not Specified|0
7981453|NCT03070782|12551424|FG003|Overall Study|Reason Not Specified|1
7981454|NCT03070782|12551425|FG004|Overall Study|Reason Not Specified|2
7981455|NCT03070782|12551426|FG005|Overall Study|Reason Not Specified|1
7981456|NCT03070782|12551421|FG000|Overall Study|Ineligibility|0
7981457|NCT03070782|12551422|FG001|Overall Study|Ineligibility|0
7981458|NCT03070782|12551423|FG002|Overall Study|Ineligibility|0
7981459|NCT03070782|12551424|FG003|Overall Study|Ineligibility|1
7981460|NCT03070782|12551425|FG004|Overall Study|Ineligibility|0
7981461|NCT03070782|12551426|FG005|Overall Study|Ineligibility|1
7981462|NCT03070782|12551421|FG000|Overall Study|Pregnancy|0
7981463|NCT03070782|12551422|FG001|Overall Study|Pregnancy|0
7981464|NCT03070782|12551423|FG002|Overall Study|Pregnancy|0
7981465|NCT03070782|12551424|FG003|Overall Study|Pregnancy|1
7981466|NCT03070782|12551425|FG004|Overall Study|Pregnancy|0
7981467|NCT03070782|12551426|FG005|Overall Study|Pregnancy|0
7981468|NCT03070782|12551421|FG000|Overall Study|Investigator Judgement|0
7981469|NCT03070782|12551422|FG001|Overall Study|Investigator Judgement|0
7981470|NCT03070782|12551423|FG002|Overall Study|Investigator Judgement|0
7981471|NCT03070782|12551424|FG003|Overall Study|Investigator Judgement|1
7981472|NCT03070782|12551425|FG004|Overall Study|Investigator Judgement|0
7981473|NCT03070782|12551426|FG005|Overall Study|Investigator Judgement|0
7981474|NCT03070964|12551440|FG000|Overall Study|Progressive disease|8
7981475|NCT03070964|12551440|FG000|Overall Study|Treatment-unrelated adverse event|2
7981476|NCT03070964|12551440|FG000|Overall Study|Never treated|1
7981477|NCT03070964|12551440|FG000|Overall Study|Physician Decision|1
7981478|NCT03070964|12551440|FG000|Overall Study|Withdrawal by Subject|1
7981479|NCT03070964|12551440|FG000|Overall Study|Adverse Event|1
7981480|NCT03071094|12551446|FG000|Overall Study|Death|1
7981481|NCT03071094|12551447|FG001|Overall Study|Death|1
7981482|NCT03071094|12551446|FG000|Overall Study|Adverse Event|1
7981483|NCT03071094|12551447|FG001|Overall Study|Adverse Event|0
7981484|NCT03071263|12551455|FG000|Overall Study|Adverse Event|1
7981485|NCT03071263|12551456|FG001|Overall Study|Adverse Event|3
7981486|NCT03071263|12551455|FG000|Overall Study|Withdrawal by Subject|1
7981487|NCT03071263|12551456|FG001|Overall Study|Withdrawal by Subject|3
7981488|NCT03071263|12551455|FG000|Overall Study|Physician Decision|1
7981489|NCT03071263|12551456|FG001|Overall Study|Physician Decision|0
7981490|NCT03071263|12551455|FG000|Overall Study|Participant moved to another city|0
7981491|NCT03071263|12551456|FG001|Overall Study|Participant moved to another city|1
7981492|NCT03071276|12551462|FG000|Overall Study|Adverse Event|1
7981493|NCT03071276|12551462|FG000|Overall Study|Lack of Efficacy|14
7981494|NCT03072160|12551476|FG000|Overall Study|Adverse Event|3
7981495|NCT03072160|12551477|FG001|Overall Study|Adverse Event|1
7981496|NCT03072160|12551476|FG000|Overall Study|Refused further treatment|6
7981497|NCT03072160|12551477|FG001|Overall Study|Refused further treatment|1
7981498|NCT03072160|12551476|FG000|Overall Study|Physician Decision|1
7981499|NCT03072160|12551477|FG001|Overall Study|Physician Decision|0
7981500|NCT03072160|12551476|FG000|Overall Study|Disease progression on study|1
7981501|NCT03072160|12551477|FG001|Overall Study|Disease progression on study|1
7981502|NCT03072160|12551476|FG000|Overall Study|No contact|0
7981503|NCT03072160|12551477|FG001|Overall Study|No contact|1
7981504|NCT03072719|12551534|FG000|Overall Study|Adverse Event|1
7981505|NCT03072719|12551535|FG001|Overall Study|Adverse Event|1
7981506|NCT03072875|12551550|FG000|Overall Study|Lost to Follow-up|1
7981507|NCT03073005|12551563|FG000|Overall Study|Death|6
7981508|NCT03073005|12551564|FG001|Overall Study|Death|0
7981509|NCT03073005|12551565|FG002|Overall Study|Death|7
7981510|NCT03073005|12551566|FG003|Overall Study|Death|0
7981511|NCT03073005|12551563|FG000|Overall Study|caregiver withdrew bc of pt death|0
7981512|NCT03073005|12551564|FG001|Overall Study|caregiver withdrew bc of pt death|6
7981513|NCT03073005|12551565|FG002|Overall Study|caregiver withdrew bc of pt death|0
7981514|NCT03073005|12551566|FG003|Overall Study|caregiver withdrew bc of pt death|7
7981515|NCT03073005|12551563|FG000|Overall Study|Lost to Follow-up|2
7981516|NCT03073005|12551564|FG001|Overall Study|Lost to Follow-up|2
7981517|NCT03073005|12551565|FG002|Overall Study|Lost to Follow-up|1
7981518|NCT03073005|12551566|FG003|Overall Study|Lost to Follow-up|2
7981519|NCT03073005|12551563|FG000|Overall Study|Withdrawal by Subject|0
7981520|NCT03073005|12551564|FG001|Overall Study|Withdrawal by Subject|4
7981521|NCT03073005|12551565|FG002|Overall Study|Withdrawal by Subject|4
7981522|NCT03073005|12551566|FG003|Overall Study|Withdrawal by Subject|4
7981523|NCT03073109|12551581|FG000|Overall Study|Adverse Event|0
7981524|NCT03073109|12551582|FG001|Overall Study|Adverse Event|1
7981525|NCT03073109|12551581|FG000|Overall Study|Other|2
7981526|NCT03073109|12551582|FG001|Overall Study|Other|0
7981527|NCT03073109|12551581|FG000|Overall Study|Lost to Follow-up|8
7981528|NCT03073109|12551582|FG001|Overall Study|Lost to Follow-up|1
7981529|NCT03073200|12551617|FG000|Double Blind Treatment Period|Protocol Violation|1
7981530|NCT03073200|12551618|FG001|Double Blind Treatment Period|Protocol Violation|0
7981531|NCT03073200|12551619|FG002|Double Blind Treatment Period|Protocol Violation|0
7981532|NCT03073200|12551620|FG003|Double Blind Treatment Period|Protocol Violation|0
7981533|NCT03073200|12551621|FG004|Double Blind Treatment Period|Protocol Violation|0
7981534|NCT03073200|12551622|FG005|Double Blind Treatment Period|Protocol Violation|0
7981535|NCT03073200|12551623|FG006|Double Blind Treatment Period|Protocol Violation|0
7981536|NCT03073200|12551624|FG007|Double Blind Treatment Period|Protocol Violation|0
7981537|NCT03073200|12551625|FG008|Double Blind Treatment Period|Protocol Violation|0
7981538|NCT03073200|12551626|FG009|Double Blind Treatment Period|Protocol Violation|0
7981539|NCT03073200|12551627|FG010|Double Blind Treatment Period|Protocol Violation|0
7981540|NCT03073200|12551628|FG011|Double Blind Treatment Period|Protocol Violation|0
7981541|NCT03073200|12551629|FG012|Double Blind Treatment Period|Protocol Violation|0
7981542|NCT03073200|12551630|FG013|Double Blind Treatment Period|Protocol Violation|0
7981543|NCT03073200|12551631|FG014|Double Blind Treatment Period|Protocol Violation|0
7981544|NCT03073200|12551617|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7981545|NCT03073200|12551618|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1
7981546|NCT03073200|12551619|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7981547|NCT03073200|12551620|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7981548|NCT03073200|12551621|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7981549|NCT03073200|12551622|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7981550|NCT03073200|12551623|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7981551|NCT03073200|12551624|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7981552|NCT03073200|12551625|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7981553|NCT03073200|12551626|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7981554|NCT03073200|12551627|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7981555|NCT03073200|12551628|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7981556|NCT03073200|12551629|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7981557|NCT03073200|12551630|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7981558|NCT03073200|12551631|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7981559|NCT03073200|12551617|FG000|Double Blind Treatment Period|Withdrawal by Subject|1
7981560|NCT03073200|12551618|FG001|Double Blind Treatment Period|Withdrawal by Subject|0
7981561|NCT03073200|12551619|FG002|Double Blind Treatment Period|Withdrawal by Subject|0
7981562|NCT03073200|12551620|FG003|Double Blind Treatment Period|Withdrawal by Subject|0
7981563|NCT03073200|12551621|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
7981564|NCT03073200|12551622|FG005|Double Blind Treatment Period|Withdrawal by Subject|0
7981565|NCT03073200|12551623|FG006|Double Blind Treatment Period|Withdrawal by Subject|0
7981566|NCT03073200|12551624|FG007|Double Blind Treatment Period|Withdrawal by Subject|0
7981567|NCT03073200|12551625|FG008|Double Blind Treatment Period|Withdrawal by Subject|0
7981568|NCT03073200|12551626|FG009|Double Blind Treatment Period|Withdrawal by Subject|0
7981569|NCT03073200|12551627|FG010|Double Blind Treatment Period|Withdrawal by Subject|0
7981570|NCT03073200|12551628|FG011|Double Blind Treatment Period|Withdrawal by Subject|0
7981571|NCT03073200|12551629|FG012|Double Blind Treatment Period|Withdrawal by Subject|0
7981572|NCT03073200|12551630|FG013|Double Blind Treatment Period|Withdrawal by Subject|0
7981573|NCT03073200|12551631|FG014|Double Blind Treatment Period|Withdrawal by Subject|0
7981574|NCT03073200|12551617|FG000|Open-Label Maintenance Period|Lost to Follow-up|0
7981575|NCT03073200|12551618|FG001|Open-Label Maintenance Period|Lost to Follow-up|0
7981576|NCT03073200|12551619|FG002|Open-Label Maintenance Period|Lost to Follow-up|0
7981577|NCT03073200|12551620|FG003|Open-Label Maintenance Period|Lost to Follow-up|1
7981578|NCT03073200|12551621|FG004|Open-Label Maintenance Period|Lost to Follow-up|2
7981579|NCT03073200|12551622|FG005|Open-Label Maintenance Period|Lost to Follow-up|0
7981580|NCT03073200|12551623|FG006|Open-Label Maintenance Period|Lost to Follow-up|0
7981581|NCT03073200|12551624|FG007|Open-Label Maintenance Period|Lost to Follow-up|0
7981582|NCT03073200|12551625|FG008|Open-Label Maintenance Period|Lost to Follow-up|0
7981583|NCT03073200|12551626|FG009|Open-Label Maintenance Period|Lost to Follow-up|0
7981584|NCT03073200|12551627|FG010|Open-Label Maintenance Period|Lost to Follow-up|0
7981585|NCT03073200|12551628|FG011|Open-Label Maintenance Period|Lost to Follow-up|0
7981586|NCT03073200|12551629|FG012|Open-Label Maintenance Period|Lost to Follow-up|0
7981587|NCT03073200|12551630|FG013|Open-Label Maintenance Period|Lost to Follow-up|0
7981588|NCT03073200|12551631|FG014|Open-Label Maintenance Period|Lost to Follow-up|0
7981589|NCT03073200|12551617|FG000|Open-Label Maintenance Period|Participant moved to another city|0
7981590|NCT03073200|12551618|FG001|Open-Label Maintenance Period|Participant moved to another city|0
7981591|NCT03073200|12551619|FG002|Open-Label Maintenance Period|Participant moved to another city|0
7981592|NCT03073200|12551620|FG003|Open-Label Maintenance Period|Participant moved to another city|1
7981593|NCT03073200|12551621|FG004|Open-Label Maintenance Period|Participant moved to another city|0
7981594|NCT03073200|12551622|FG005|Open-Label Maintenance Period|Participant moved to another city|0
7981595|NCT03073200|12551623|FG006|Open-Label Maintenance Period|Participant moved to another city|0
7981596|NCT03073200|12551624|FG007|Open-Label Maintenance Period|Participant moved to another city|0
7981597|NCT03073200|12551625|FG008|Open-Label Maintenance Period|Participant moved to another city|0
7981598|NCT03073200|12551626|FG009|Open-Label Maintenance Period|Participant moved to another city|0
7981599|NCT03073200|12551627|FG010|Open-Label Maintenance Period|Participant moved to another city|0
7981600|NCT03073200|12551628|FG011|Open-Label Maintenance Period|Participant moved to another city|0
7981601|NCT03073200|12551629|FG012|Open-Label Maintenance Period|Participant moved to another city|0
7981602|NCT03073200|12551630|FG013|Open-Label Maintenance Period|Participant moved to another city|0
7981603|NCT03073200|12551631|FG014|Open-Label Maintenance Period|Participant moved to another city|0
7981604|NCT03073200|12551617|FG000|Open-Label Maintenance Period|Lack of Efficacy|0
7981605|NCT03073200|12551618|FG001|Open-Label Maintenance Period|Lack of Efficacy|0
7981606|NCT03073200|12551619|FG002|Open-Label Maintenance Period|Lack of Efficacy|0
7981607|NCT03073200|12551620|FG003|Open-Label Maintenance Period|Lack of Efficacy|0
7981608|NCT03073200|12551621|FG004|Open-Label Maintenance Period|Lack of Efficacy|1
7981609|NCT03073200|12551622|FG005|Open-Label Maintenance Period|Lack of Efficacy|0
7981610|NCT03073200|12551623|FG006|Open-Label Maintenance Period|Lack of Efficacy|0
7981611|NCT03073200|12551624|FG007|Open-Label Maintenance Period|Lack of Efficacy|0
7981612|NCT03073200|12551625|FG008|Open-Label Maintenance Period|Lack of Efficacy|0
7981613|NCT03073200|12551626|FG009|Open-Label Maintenance Period|Lack of Efficacy|0
7981614|NCT03073200|12551627|FG010|Open-Label Maintenance Period|Lack of Efficacy|0
7981615|NCT03073200|12551628|FG011|Open-Label Maintenance Period|Lack of Efficacy|0
7981616|NCT03073200|12551629|FG012|Open-Label Maintenance Period|Lack of Efficacy|0
7981617|NCT03073200|12551630|FG013|Open-Label Maintenance Period|Lack of Efficacy|0
7981618|NCT03073200|12551631|FG014|Open-Label Maintenance Period|Lack of Efficacy|0
7981619|NCT03073200|12551617|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0
7981620|NCT03073200|12551618|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0
7981621|NCT03073200|12551619|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0
7981622|NCT03073200|12551620|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2
7981623|NCT03073200|12551621|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1
7981624|NCT03073200|12551622|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0
7981625|NCT03073200|12551623|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0
7981626|NCT03073200|12551624|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0
7981627|NCT03073200|12551625|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0
7981628|NCT03073200|12551626|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0
7981629|NCT03073200|12551627|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0
7981630|NCT03073200|12551628|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0
7981631|NCT03073200|12551629|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0
7981632|NCT03073200|12551630|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0
7981633|NCT03073200|12551631|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0
7981634|NCT03073200|12551617|FG000|Extension Period|Lost to Follow-up|0
7981635|NCT03073200|12551618|FG001|Extension Period|Lost to Follow-up|0
7981636|NCT03073200|12551619|FG002|Extension Period|Lost to Follow-up|0
7981637|NCT03073200|12551620|FG003|Extension Period|Lost to Follow-up|0
7981638|NCT03073200|12551621|FG004|Extension Period|Lost to Follow-up|0
7981639|NCT03073200|12551622|FG005|Extension Period|Lost to Follow-up|0
7981640|NCT03073200|12551623|FG006|Extension Period|Lost to Follow-up|1
7981641|NCT03073200|12551624|FG007|Extension Period|Lost to Follow-up|1
7981642|NCT03073200|12551625|FG008|Extension Period|Lost to Follow-up|0
7981643|NCT03073200|12551626|FG009|Extension Period|Lost to Follow-up|0
7981644|NCT03073200|12551627|FG010|Extension Period|Lost to Follow-up|0
7981645|NCT03073200|12551628|FG011|Extension Period|Lost to Follow-up|0
7981646|NCT03073200|12551629|FG012|Extension Period|Lost to Follow-up|0
7981647|NCT03073200|12551630|FG013|Extension Period|Lost to Follow-up|0
7981648|NCT03073200|12551631|FG014|Extension Period|Lost to Follow-up|0
7981649|NCT03073200|12551617|FG000|Extension Period|Sponsor Decision|0
7981650|NCT03073200|12551618|FG001|Extension Period|Sponsor Decision|0
7981651|NCT03073200|12551619|FG002|Extension Period|Sponsor Decision|0
7981652|NCT03073200|12551620|FG003|Extension Period|Sponsor Decision|0
7981653|NCT03073200|12551621|FG004|Extension Period|Sponsor Decision|0
7981654|NCT03073200|12551622|FG005|Extension Period|Sponsor Decision|0
7981655|NCT03073200|12551623|FG006|Extension Period|Sponsor Decision|0
7981656|NCT03073200|12551624|FG007|Extension Period|Sponsor Decision|0
7981657|NCT03073200|12551625|FG008|Extension Period|Sponsor Decision|1
7981658|NCT03073200|12551626|FG009|Extension Period|Sponsor Decision|0
7981659|NCT03073200|12551627|FG010|Extension Period|Sponsor Decision|0
7981660|NCT03073200|12551628|FG011|Extension Period|Sponsor Decision|0
7981661|NCT03073200|12551629|FG012|Extension Period|Sponsor Decision|0
7981662|NCT03073200|12551630|FG013|Extension Period|Sponsor Decision|0
7981663|NCT03073200|12551631|FG014|Extension Period|Sponsor Decision|0
7981664|NCT03073200|12551617|FG000|Extension Period|Withdrawal by Parent/Guardian|0
7981665|NCT03073200|12551618|FG001|Extension Period|Withdrawal by Parent/Guardian|0
7981666|NCT03073200|12551619|FG002|Extension Period|Withdrawal by Parent/Guardian|0
7981667|NCT03073200|12551620|FG003|Extension Period|Withdrawal by Parent/Guardian|0
7981668|NCT03073200|12551621|FG004|Extension Period|Withdrawal by Parent/Guardian|0
7981669|NCT03073200|12551622|FG005|Extension Period|Withdrawal by Parent/Guardian|0
7981670|NCT03073200|12551623|FG006|Extension Period|Withdrawal by Parent/Guardian|1
7981671|NCT03073200|12551624|FG007|Extension Period|Withdrawal by Parent/Guardian|3
7981672|NCT03073200|12551625|FG008|Extension Period|Withdrawal by Parent/Guardian|1
7981673|NCT03073200|12551626|FG009|Extension Period|Withdrawal by Parent/Guardian|0
7981674|NCT03073200|12551627|FG010|Extension Period|Withdrawal by Parent/Guardian|0
7981675|NCT03073200|12551628|FG011|Extension Period|Withdrawal by Parent/Guardian|0
7981676|NCT03073200|12551629|FG012|Extension Period|Withdrawal by Parent/Guardian|0
7981677|NCT03073200|12551630|FG013|Extension Period|Withdrawal by Parent/Guardian|0
7981678|NCT03073200|12551631|FG014|Extension Period|Withdrawal by Parent/Guardian|0
7981679|NCT03073200|12551617|FG000|Extension Period|Withdrawal by Subject|0
7981680|NCT03073200|12551618|FG001|Extension Period|Withdrawal by Subject|0
7981681|NCT03073200|12551619|FG002|Extension Period|Withdrawal by Subject|0
7981682|NCT03073200|12551620|FG003|Extension Period|Withdrawal by Subject|0
7981683|NCT03073200|12551621|FG004|Extension Period|Withdrawal by Subject|0
7981684|NCT03073200|12551622|FG005|Extension Period|Withdrawal by Subject|0
7981685|NCT03073200|12551623|FG006|Extension Period|Withdrawal by Subject|1
7981686|NCT03073200|12551624|FG007|Extension Period|Withdrawal by Subject|2
7981687|NCT03073200|12551625|FG008|Extension Period|Withdrawal by Subject|0
7981688|NCT03073200|12551626|FG009|Extension Period|Withdrawal by Subject|0
7981689|NCT03073200|12551627|FG010|Extension Period|Withdrawal by Subject|0
7981690|NCT03073200|12551628|FG011|Extension Period|Withdrawal by Subject|0
7981691|NCT03073200|12551629|FG012|Extension Period|Withdrawal by Subject|0
7981692|NCT03073200|12551630|FG013|Extension Period|Withdrawal by Subject|0
7981693|NCT03073200|12551631|FG014|Extension Period|Withdrawal by Subject|0
7981694|NCT03073200|12551617|FG000|Randomized Withdrawal Period|Lost to Follow-up|0
7981695|NCT03073200|12551618|FG001|Randomized Withdrawal Period|Lost to Follow-up|0
7981696|NCT03073200|12551619|FG002|Randomized Withdrawal Period|Lost to Follow-up|0
7981697|NCT03073200|12551620|FG003|Randomized Withdrawal Period|Lost to Follow-up|0
7981698|NCT03073200|12551621|FG004|Randomized Withdrawal Period|Lost to Follow-up|0
7981699|NCT03073200|12551622|FG005|Randomized Withdrawal Period|Lost to Follow-up|0
7981700|NCT03073200|12551623|FG006|Randomized Withdrawal Period|Lost to Follow-up|0
7981701|NCT03073200|12551624|FG007|Randomized Withdrawal Period|Lost to Follow-up|0
7981702|NCT03073200|12551625|FG008|Randomized Withdrawal Period|Lost to Follow-up|0
7981703|NCT03073200|12551626|FG009|Randomized Withdrawal Period|Lost to Follow-up|0
7981704|NCT03073200|12551627|FG010|Randomized Withdrawal Period|Lost to Follow-up|0
7981705|NCT03073200|12551628|FG011|Randomized Withdrawal Period|Lost to Follow-up|1
7981706|NCT03073200|12551629|FG012|Randomized Withdrawal Period|Lost to Follow-up|0
7981707|NCT03073200|12551630|FG013|Randomized Withdrawal Period|Lost to Follow-up|0
7981708|NCT03073200|12551631|FG014|Randomized Withdrawal Period|Lost to Follow-up|0
7981709|NCT03073200|12551617|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7981710|NCT03073200|12551618|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7981711|NCT03073200|12551619|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7981712|NCT03073200|12551620|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7981713|NCT03073200|12551621|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7981714|NCT03073200|12551622|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7981715|NCT03073200|12551623|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7981716|NCT03073200|12551624|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7981717|NCT03073200|12551625|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7981718|NCT03073200|12551626|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7981719|NCT03073200|12551627|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7981720|NCT03073200|12551628|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1
7981721|NCT03073200|12551629|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7981722|NCT03073200|12551630|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7981723|NCT03073200|12551631|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7981724|NCT03073200|12551617|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
7981725|NCT03073200|12551618|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0
7981726|NCT03073200|12551619|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0
7981727|NCT03073200|12551620|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0
7981728|NCT03073200|12551621|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0
7981729|NCT03073200|12551622|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0
7981730|NCT03073200|12551623|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0
7981731|NCT03073200|12551624|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0
7981732|NCT03073200|12551625|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0
7981733|NCT03073200|12551626|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0
7981734|NCT03073200|12551627|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1
7981735|NCT03073200|12551628|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1
7981736|NCT03073200|12551629|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0
7981737|NCT03073200|12551630|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0
7981738|NCT03073200|12551631|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0
7981739|NCT03073200|12551617|FG000|Randomized Withdrawal Period|Adverse Event|0
7981740|NCT03073200|12551618|FG001|Randomized Withdrawal Period|Adverse Event|0
7981741|NCT03073200|12551619|FG002|Randomized Withdrawal Period|Adverse Event|0
7981742|NCT03073200|12551620|FG003|Randomized Withdrawal Period|Adverse Event|0
7981743|NCT03073200|12551621|FG004|Randomized Withdrawal Period|Adverse Event|0
7981744|NCT03073200|12551622|FG005|Randomized Withdrawal Period|Adverse Event|0
7981745|NCT03073200|12551623|FG006|Randomized Withdrawal Period|Adverse Event|0
7981746|NCT03073200|12551624|FG007|Randomized Withdrawal Period|Adverse Event|0
7981747|NCT03073200|12551625|FG008|Randomized Withdrawal Period|Adverse Event|0
7981748|NCT03073200|12551626|FG009|Randomized Withdrawal Period|Adverse Event|0
7981749|NCT03073200|12551627|FG010|Randomized Withdrawal Period|Adverse Event|1
7981750|NCT03073200|12551628|FG011|Randomized Withdrawal Period|Adverse Event|0
7981751|NCT03073200|12551629|FG012|Randomized Withdrawal Period|Adverse Event|0
7981752|NCT03073200|12551630|FG013|Randomized Withdrawal Period|Adverse Event|0
7981753|NCT03073200|12551631|FG014|Randomized Withdrawal Period|Adverse Event|0
7981754|NCT03073200|12551617|FG000|Post-Treatment Follow-Up Period|Adverse Event|0
7981755|NCT03073200|12551618|FG001|Post-Treatment Follow-Up Period|Adverse Event|0
7981756|NCT03073200|12551619|FG002|Post-Treatment Follow-Up Period|Adverse Event|0
7981757|NCT03073200|12551620|FG003|Post-Treatment Follow-Up Period|Adverse Event|0
7981758|NCT03073200|12551621|FG004|Post-Treatment Follow-Up Period|Adverse Event|0
7981759|NCT03073200|12551622|FG005|Post-Treatment Follow-Up Period|Adverse Event|0
7981760|NCT03073200|12551623|FG006|Post-Treatment Follow-Up Period|Adverse Event|0
7981761|NCT03073200|12551624|FG007|Post-Treatment Follow-Up Period|Adverse Event|0
7981762|NCT03073200|12551625|FG008|Post-Treatment Follow-Up Period|Adverse Event|0
7981763|NCT03073200|12551626|FG009|Post-Treatment Follow-Up Period|Adverse Event|0
7981764|NCT03073200|12551627|FG010|Post-Treatment Follow-Up Period|Adverse Event|0
7981765|NCT03073200|12551628|FG011|Post-Treatment Follow-Up Period|Adverse Event|0
7981766|NCT03073200|12551629|FG012|Post-Treatment Follow-Up Period|Adverse Event|0
7981767|NCT03073200|12551630|FG013|Post-Treatment Follow-Up Period|Adverse Event|2
7981768|NCT03073200|12551631|FG014|Post-Treatment Follow-Up Period|Adverse Event|0
7981769|NCT03073200|12551617|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7981770|NCT03073200|12551618|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7981771|NCT03073200|12551619|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7981772|NCT03073200|12551620|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7981773|NCT03073200|12551621|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7981774|NCT03073200|12551622|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7981775|NCT03073200|12551623|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7981776|NCT03073200|12551624|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7981777|NCT03073200|12551625|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7981778|NCT03073200|12551626|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7981779|NCT03073200|12551627|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7981780|NCT03073200|12551628|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7981781|NCT03073200|12551629|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7981782|NCT03073200|12551630|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1
7981783|NCT03073200|12551631|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7981784|NCT03073200|12551617|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0
7981785|NCT03073200|12551618|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0
7981786|NCT03073200|12551619|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0
7981787|NCT03073200|12551620|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0
7981788|NCT03073200|12551621|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0
7981789|NCT03073200|12551622|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0
7981790|NCT03073200|12551623|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0
7981791|NCT03073200|12551624|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0
7981792|NCT03073200|12551625|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0
7981793|NCT03073200|12551626|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0
7981794|NCT03073200|12551627|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0
7981795|NCT03073200|12551628|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0
7981796|NCT03073200|12551629|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0
7981797|NCT03073200|12551630|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1
7981798|NCT03073200|12551631|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0
7981799|NCT03073200|12551617|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0
7981800|NCT03073200|12551618|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0
7981801|NCT03073200|12551619|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0
7981802|NCT03073200|12551620|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0
7981803|NCT03073200|12551621|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0
7981804|NCT03073200|12551622|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0
7981805|NCT03073200|12551623|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0
7981806|NCT03073200|12551624|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0
7981807|NCT03073200|12551625|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0
7981808|NCT03073200|12551626|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0
7981809|NCT03073200|12551627|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0
7981810|NCT03073200|12551628|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0
7981811|NCT03073200|12551629|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0
7981812|NCT03073200|12551630|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1
7981813|NCT03073200|12551631|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0
7981814|NCT03073200|12551617|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7981815|NCT03073200|12551618|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7981816|NCT03073200|12551619|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7981817|NCT03073200|12551620|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7981818|NCT03073200|12551621|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7981819|NCT03073200|12551622|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7981820|NCT03073200|12551623|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7981821|NCT03073200|12551624|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7981822|NCT03073200|12551625|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7981823|NCT03073200|12551626|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7981824|NCT03073200|12551627|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7981825|NCT03073200|12551628|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7981826|NCT03073200|12551629|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7981827|NCT03073200|12551630|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7981828|NCT03073200|12551631|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1
7981829|NCT03073200|12551617|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7981830|NCT03073200|12551618|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7981831|NCT03073200|12551619|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7981832|NCT03073200|12551620|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7981833|NCT03073200|12551621|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7981834|NCT03073200|12551622|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7981835|NCT03073200|12551623|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7981836|NCT03073200|12551624|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7981837|NCT03073200|12551625|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7981838|NCT03073200|12551626|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7981839|NCT03073200|12551627|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7981840|NCT03073200|12551628|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7981841|NCT03073200|12551629|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7981842|NCT03073200|12551630|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11
7981843|NCT03073200|12551631|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7981844|NCT03073200|12551617|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7981845|NCT03073200|12551618|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7981846|NCT03073200|12551619|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7981847|NCT03073200|12551620|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7981848|NCT03073200|12551621|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7981849|NCT03073200|12551622|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7981850|NCT03073200|12551623|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7981851|NCT03073200|12551624|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7981852|NCT03073200|12551625|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7981853|NCT03073200|12551626|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7981854|NCT03073200|12551627|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7981855|NCT03073200|12551628|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7981856|NCT03073200|12551629|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7981857|NCT03073200|12551630|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9
7981858|NCT03073200|12551631|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7981859|NCT03073200|12551617|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7981860|NCT03073200|12551618|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7981861|NCT03073200|12551619|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7981862|NCT03073200|12551620|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7981863|NCT03073200|12551621|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7981864|NCT03073200|12551622|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7981865|NCT03073200|12551623|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7981866|NCT03073200|12551624|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7981867|NCT03073200|12551625|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7981868|NCT03073200|12551626|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7981869|NCT03073200|12551627|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7981870|NCT03073200|12551628|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7981871|NCT03073200|12551629|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7981872|NCT03073200|12551630|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2
7981873|NCT03073200|12551631|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7981874|NCT03073213|12551656|FG000|Multiple Dose Period|Protocol Violation|0
7981875|NCT03073213|12551657|FG001|Multiple Dose Period|Protocol Violation|0
7981876|NCT03073213|12551658|FG002|Multiple Dose Period|Protocol Violation|1
7981877|NCT03073798|12551686|FG000|Overall Study|Adverse Event|1
7981878|NCT03073798|12551686|FG000|Overall Study|Withdrawal by Subject|1
7981879|NCT03074162|12551711|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0
7981880|NCT03074162|12551712|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0
7981881|NCT03074162|12551713|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1
7981882|NCT03074162|12551714|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0
7981883|NCT03074162|12551715|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0
7981884|NCT03074162|12551716|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0
7981885|NCT03074162|12551711|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0
7981886|NCT03074162|12551712|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0
7981887|NCT03074162|12551713|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1
7981888|NCT03074162|12551714|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0
7981889|NCT03074162|12551715|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0
7981890|NCT03074162|12551716|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1
7981891|NCT03074162|12551711|FG000|Period 3|Withdrawal by Subject|1
7981892|NCT03074162|12551712|FG001|Period 3|Withdrawal by Subject|0
7981893|NCT03074162|12551713|FG002|Period 3|Withdrawal by Subject|0
7981894|NCT03074162|12551714|FG003|Period 3|Withdrawal by Subject|0
7981895|NCT03074162|12551715|FG004|Period 3|Withdrawal by Subject|1
7981896|NCT03074162|12551716|FG005|Period 3|Withdrawal by Subject|0
7981897|NCT03074331|12551724|FG000|Overall Study|Enrolled but Not Treated|1
7981898|NCT03074331|12551724|FG000|Overall Study|Lost to Follow-up|5
7981899|NCT03074331|12551724|FG000|Overall Study|Withdrew Consent|1
7981900|NCT03074500|12551740|FG000|Overall Study|Lost to Follow-up|1
7981901|NCT03074500|12551741|FG001|Overall Study|Lost to Follow-up|0
7981902|NCT03074500|12551742|FG002|Overall Study|Lost to Follow-up|0
7981903|NCT03074500|12551740|FG000|Overall Study|Lack of Efficacy|0
7981904|NCT03074500|12551741|FG001|Overall Study|Lack of Efficacy|1
7981905|NCT03074500|12551742|FG002|Overall Study|Lack of Efficacy|0
7981906|NCT03074500|12551740|FG000|Overall Study|Adverse Event|0
7981907|NCT03074500|12551741|FG001|Overall Study|Adverse Event|0
7981908|NCT03074500|12551742|FG002|Overall Study|Adverse Event|1
7981909|NCT03075163|12551781|FG000|Overall Study|not eligible for treatment limb|138
7981910|NCT03075163|12551782|FG001|Overall Study|not eligible for treatment limb|138
7981911|NCT03075267|12551791|FG000|Overall Study|Protocol Violation|1
7981912|NCT03075267|12551792|FG001|Overall Study|Protocol Violation|0
7981913|NCT03075267|12551793|FG002|Overall Study|Protocol Violation|0
7981914|NCT03075410|12551810|FG000|Part A-Period 2 (14 Days)|Personal reasons|1
7981915|NCT03075410|12551811|FG001|Part A-Period 2 (14 Days)|Personal reasons|0
7981916|NCT03075410|12551812|FG002|Part A-Period 2 (14 Days)|Personal reasons|1
7981917|NCT03075410|12551813|FG003|Part A-Period 2 (14 Days)|Personal reasons|0
7981918|NCT03075410|12551814|FG004|Part A-Period 2 (14 Days)|Personal reasons|0
7981919|NCT03075410|12551815|FG005|Part A-Period 2 (14 Days)|Personal reasons|0
7981920|NCT03075410|12551816|FG006|Part A-Period 2 (14 Days)|Personal reasons|0
7981921|NCT03075410|12551817|FG007|Part A-Period 2 (14 Days)|Personal reasons|0
7981922|NCT03075410|12551818|FG008|Part A-Period 2 (14 Days)|Personal reasons|0
7981923|NCT03075410|12551810|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1
7981924|NCT03075410|12551811|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7981925|NCT03075410|12551812|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7981926|NCT03075410|12551813|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7981927|NCT03075410|12551814|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7981928|NCT03075410|12551815|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7981929|NCT03075410|12551816|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7981930|NCT03075410|12551817|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7981931|NCT03075410|12551818|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7981932|NCT03075501|12551848|FG000|Overall Study|Scheduling difficulties|15
7981933|NCT03075501|12551849|FG001|Overall Study|Scheduling difficulties|9
7981934|NCT03075644|12551862|FG000|Overall Study|Withdrawal by Subject|1
7981935|NCT03075644|12551863|FG001|Overall Study|Withdrawal by Subject|1
7981936|NCT03075761|12551872|FG000|Overall Study|Lost to Follow-up|1
7981937|NCT03075761|12551873|FG001|Overall Study|Lost to Follow-up|6
7981938|NCT03075839|12551884|FG000|Overall Study|Lost to Follow-up|4
7981939|NCT03075878|12551888|FG000|Overall Study|Physician Decision|1
7981940|NCT03075891|12551894|FG000|Overall Study|Withdrawal by Subject|3
7981941|NCT03075891|12551895|FG001|Overall Study|Withdrawal by Subject|6
7981942|NCT03075891|12551894|FG000|Overall Study|Lost to Follow-up|1
7981943|NCT03075891|12551895|FG001|Overall Study|Lost to Follow-up|0
7981944|NCT03075891|12551894|FG000|Overall Study|Pregnancy|3
7981945|NCT03075891|12551895|FG001|Overall Study|Pregnancy|1
7981946|NCT03075891|12551894|FG000|Overall Study|visits not performed (no time)|1
7981947|NCT03075891|12551895|FG001|Overall Study|visits not performed (no time)|0
7981948|NCT03075891|12551894|FG000|Overall Study|Drug abuse relapse issue|0
7981949|NCT03075891|12551895|FG001|Overall Study|Drug abuse relapse issue|1
7981950|NCT03075891|12551894|FG000|Overall Study|Participant requiring study withdrawal|0
7981951|NCT03075891|12551895|FG001|Overall Study|Participant requiring study withdrawal|1
7981952|NCT03075891|12551894|FG000|Overall Study|Adverse event, non-fatal|1
7981953|NCT03075891|12551895|FG001|Overall Study|Adverse event, non-fatal|4
7981954|NCT03075904|12551903|FG000|Overall Study|Physician Decision|3
7981955|NCT03075904|12551903|FG000|Overall Study|Need for Medication not Permitted|1
7981956|NCT03076190|12551909|FG000|Overall Study|Lost to Follow-up|9
7981957|NCT03076190|12551910|FG001|Overall Study|Lost to Follow-up|34
7981958|NCT03076190|12551909|FG000|Overall Study|Excluded from Analysis (zero duration ev|9
7981959|NCT03076190|12551910|FG001|Overall Study|Excluded from Analysis (zero duration ev|7
7981960|NCT03076515|12551936|FG000|Overall Study|DMC decision based on interim analysis|25
7981961|NCT03076515|12551937|FG001|Overall Study|DMC decision based on interim analysis|29
7981962|NCT03076970|12551943|FG000|Washout Period 2|Adverse Event|0
7981963|NCT03076970|12551944|FG001|Washout Period 2|Adverse Event|0
7981964|NCT03076970|12551945|FG002|Washout Period 2|Adverse Event|0
7981965|NCT03076970|12551946|FG003|Washout Period 2|Adverse Event|0
7981966|NCT03076970|12551947|FG004|Washout Period 2|Adverse Event|1
7981967|NCT03076970|12551948|FG005|Washout Period 2|Adverse Event|0
7981968|NCT03076970|12551943|FG000|Period 3|Withdrawal by Subject|0
7981969|NCT03076970|12551944|FG001|Period 3|Withdrawal by Subject|0
7981970|NCT03076970|12551945|FG002|Period 3|Withdrawal by Subject|0
7981971|NCT03076970|12551946|FG003|Period 3|Withdrawal by Subject|0
7981972|NCT03076970|12551947|FG004|Period 3|Withdrawal by Subject|0
7981973|NCT03076970|12551948|FG005|Period 3|Withdrawal by Subject|1
7981974|NCT03076970|12551943|FG000|Period 3|Failure to meet I/E criteria|0
7981975|NCT03076970|12551944|FG001|Period 3|Failure to meet I/E criteria|0
7981976|NCT03076970|12551945|FG002|Period 3|Failure to meet I/E criteria|0
7981977|NCT03076970|12551946|FG003|Period 3|Failure to meet I/E criteria|0
7981978|NCT03076970|12551947|FG004|Period 3|Failure to meet I/E criteria|1
7981979|NCT03076970|12551948|FG005|Period 3|Failure to meet I/E criteria|0
7981980|NCT03076996|12551968|FG000|Overall Study|Withdrawal by Subject|2
7981981|NCT03076996|12551968|FG000|Overall Study|Lost to Follow-up|3
7981982|NCT03076996|12551968|FG000|Overall Study|Literacy precluded participation|1
7981983|NCT03077607|12551999|FG000|Period 1 (15 Days)|Adverse Event|1
7981984|NCT03077607|12552000|FG001|Period 1 (15 Days)|Adverse Event|0
7981985|NCT03077607|12551999|FG000|Period 1 (15 Days)|Death|1
7981986|NCT03077607|12552000|FG001|Period 1 (15 Days)|Death|0
7981987|NCT03077607|12551999|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1
7981988|NCT03077607|12552000|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0
7981989|NCT03077607|12551999|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
7981990|NCT03077607|12552000|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
7981991|NCT03077646|12552020|FG000|Overall Study|Lost to Follow-up|29
7981992|NCT03077646|12552021|FG001|Overall Study|Lost to Follow-up|30
7981993|NCT03077646|12552022|FG002|Overall Study|Lost to Follow-up|31
7981994|NCT03077659|12552033|FG000|Overall Study|Withdrawal by Subject|0
7981995|NCT03077659|12552034|FG001|Overall Study|Withdrawal by Subject|0
7981996|NCT03077659|12552035|FG002|Overall Study|Withdrawal by Subject|1
7981997|NCT03077711|12552048|FG000|Overall Study|Lost to Follow-up|2
7981998|NCT03077711|12552049|FG001|Overall Study|Lost to Follow-up|2
7981999|NCT03077711|12552048|FG000|Overall Study|noncompliant taking medication|2
7982000|NCT03077711|12552049|FG001|Overall Study|noncompliant taking medication|0
7982001|NCT03077724|12552059|FG000|Overall Study|Lost to Follow-up|5
7718050|NCT00524368|12141742|FG001|Overall Study|Non-compliant|9
7718051|NCT00524368|12141741|FG000|Overall Study|Reached a Virologic Endpoint|3
7718052|NCT00524368|12141742|FG001|Overall Study|Reached a Virologic Endpoint|2
7982002|NCT03077724|12552060|FG001|Overall Study|Lost to Follow-up|1
7982003|NCT03077724|12552059|FG000|Overall Study|Withdrawal by Subject|3
7982004|NCT03077724|12552060|FG001|Overall Study|Withdrawal by Subject|1
7982005|NCT03077919|12552078|FG000|Overall Study|Lost to Follow-up|4
7982006|NCT03077919|12552079|FG001|Overall Study|Lost to Follow-up|1
7982007|NCT03078556|12552136|FG000|Treatment Period 1 (4 Days)|Adverse Event|0
7982008|NCT03078556|12552137|FG001|Treatment Period 1 (4 Days)|Adverse Event|1
7982009|NCT03078556|12552138|FG002|Treatment Period 1 (4 Days)|Adverse Event|0
7982010|NCT03078556|12552139|FG003|Treatment Period 1 (4 Days)|Adverse Event|0
7982011|NCT03078556|12552136|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2
7982012|NCT03078556|12552137|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0
7982013|NCT03078556|12552138|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1
7982014|NCT03078556|12552139|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0
7982015|NCT03078556|12552136|FG000|Washout Period 1 (7 Days)|Adverse Event|0
7982016|NCT03078556|12552137|FG001|Washout Period 1 (7 Days)|Adverse Event|1
7982017|NCT03078556|12552138|FG002|Washout Period 1 (7 Days)|Adverse Event|0
7982018|NCT03078556|12552139|FG003|Washout Period 1 (7 Days)|Adverse Event|1
7982019|NCT03078556|12552136|FG000|Washout Period 1 (7 Days)|Physician Decision|0
7982020|NCT03078556|12552137|FG001|Washout Period 1 (7 Days)|Physician Decision|1
7982021|NCT03078556|12552138|FG002|Washout Period 1 (7 Days)|Physician Decision|0
7982022|NCT03078556|12552139|FG003|Washout Period 1 (7 Days)|Physician Decision|0
7982023|NCT03078751|12552188|FG000|Overall Study|Adverse Event|4
7982024|NCT03078751|12552189|FG001|Overall Study|Adverse Event|0
7982025|NCT03078751|12552188|FG000|Overall Study|Physician Decision|1
7982026|NCT03078751|12552189|FG001|Overall Study|Physician Decision|0
7982027|NCT03078751|12552188|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0
7982028|NCT03078751|12552189|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23
7982029|NCT03078751|12552188|FG000|Overall Study|Subject/guardian decision|8
7982030|NCT03078751|12552189|FG001|Overall Study|Subject/guardian decision|1
7982031|NCT03078751|12552188|FG000|Overall Study|Untreated|0
7982032|NCT03078751|12552189|FG001|Overall Study|Untreated|4
7982033|NCT03078816|12552195|FG000|Overall Study|Withdrawal by Subject|1
7982034|NCT03078907|12552201|FG000|Overall Study|Adverse Event|2
7982035|NCT03078907|12552202|FG001|Overall Study|Adverse Event|0
7982036|NCT03078907|12552201|FG000|Overall Study|Other|1
7982037|NCT03078907|12552202|FG001|Overall Study|Other|0
7982038|NCT03078907|12552201|FG000|Overall Study|Protocol Violation|0
7982039|NCT03078907|12552202|FG001|Overall Study|Protocol Violation|1
7982040|NCT03080454|12552247|FG000|Baseline|Adverse Event|2
7982041|NCT03080454|12552247|FG000|Anodal Doublestim (5 Days)|Adverse Event|1
7982042|NCT03080454|12552247|FG000|Anodal FU (7 Days)|Lost to Follow-up|4
7982043|NCT03080493|12552256|FG000|Overall Study|Did not provide NRS pain results|1
7982044|NCT03080493|12552257|FG001|Overall Study|Did not provide NRS pain results|0
7982045|NCT03080493|12552256|FG000|Overall Study|Adverse Event|0
7982046|NCT03080493|12552257|FG001|Overall Study|Adverse Event|1
7982047|NCT03080493|12552256|FG000|Overall Study|Randomization error (parity group)|0
7982048|NCT03080493|12552257|FG001|Overall Study|Randomization error (parity group)|1
7982049|NCT03080961|12552263|FG000|Overall Study|Withdrawal by Subject|3
7982050|NCT03081884|12552281|FG000|Overall Study|deferred prostate cancer treatment|1
7982051|NCT03081884|12552281|FG000|Overall Study|metastasis managed with systemic therapy|3
7982052|NCT03082261|12552295|FG000|Overall Study|Death|4
7982053|NCT03082261|12552295|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1
7982054|NCT03082261|12552295|FG000|Overall Study|Insurance denial|1
7982055|NCT03082261|12552295|FG000|Overall Study|Peripheral lead added|1
7982056|NCT03082261|12552295|FG000|Overall Study|Withdrawal by Subject|40
7982057|NCT03082261|12552295|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2
7982058|NCT03082261|12552295|FG000|Overall Study|Subject implanted with device other than study device|1
7982059|NCT03082261|12552295|FG000|Overall Study|Lost to Follow-up|14
7982060|NCT03082261|12552295|FG000|Overall Study|Subject moved to a different state|1
7982061|NCT03082261|12552295|FG000|Overall Study|Subject non-compliance|2
7982062|NCT03082261|12552295|FG000|Overall Study|Subject participation terminated by investigator|9
7982063|NCT03082261|12552295|FG000|Overall Study|Subject participation terminated by sponsor|4
7982064|NCT03082261|12552295|FG000|Overall Study|System explant|19
7982065|NCT03082261|12552295|FG000|Overall Study|Unable to place lead(s)|2
7982066|NCT03082261|12552295|FG000|Overall Study|Unsuccessful trial evaluation period|19
7982067|NCT03082599|12552332|FG000|Overall Study|Lost to Follow-up|1
7982068|NCT03082599|12552333|FG001|Overall Study|Lost to Follow-up|0
7982069|NCT03083132|12552350|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0
7982070|NCT03083132|12552351|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2
7982071|NCT03083132|12552350|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1
7982072|NCT03083132|12552351|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0
7982073|NCT03083132|12552350|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0
7982074|NCT03083132|12552351|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1
7982075|NCT03083470|12552371|FG000|Overall Study|Lost to Follow-up|0
7982076|NCT03083470|12552372|FG001|Overall Study|Lost to Follow-up|0
7982077|NCT03083470|12552373|FG002|Overall Study|Lost to Follow-up|0
7982078|NCT03083470|12552374|FG003|Overall Study|Lost to Follow-up|0
7982079|NCT03083470|12552375|FG004|Overall Study|Lost to Follow-up|1
7982080|NCT03083470|12552371|FG000|Overall Study|Withdrawal by Subject|0
7982081|NCT03083470|12552372|FG001|Overall Study|Withdrawal by Subject|0
7982082|NCT03083470|12552373|FG002|Overall Study|Withdrawal by Subject|0
7982083|NCT03083470|12552374|FG003|Overall Study|Withdrawal by Subject|0
7982084|NCT03083470|12552375|FG004|Overall Study|Withdrawal by Subject|1
7982085|NCT03083483|12552390|FG000|Overall Study|Adverse Event|1
7982086|NCT03083483|12552391|FG001|Overall Study|Adverse Event|1
7982087|NCT03083483|12552392|FG002|Overall Study|Adverse Event|1
7982088|NCT03083483|12552390|FG000|Overall Study|Lost to Follow-up|2
7982089|NCT03083483|12552391|FG001|Overall Study|Lost to Follow-up|1
7982090|NCT03083483|12552392|FG002|Overall Study|Lost to Follow-up|1
7982091|NCT03083483|12552390|FG000|Overall Study|technological issues|1
7982092|NCT03083483|12552391|FG001|Overall Study|technological issues|0
7982093|NCT03083483|12552392|FG002|Overall Study|technological issues|1
7982094|NCT03083639|12552402|FG000|Washout Period (at Least 6 Days)|Pregnancy|0
7982095|NCT03083639|12552403|FG001|Washout Period (at Least 6 Days)|Pregnancy|1
7982096|NCT03083639|12552402|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1
7982097|NCT03083639|12552403|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0
7982098|NCT03083847|12552428|FG000|Main|Physician Decision|0
7982099|NCT03083847|12552429|FG001|Main|Physician Decision|0
7982100|NCT03083847|12552430|FG002|Main|Physician Decision|0
7982101|NCT03083847|12552431|FG003|Main|Physician Decision|0
7982102|NCT03083847|12552432|FG004|Main|Physician Decision|0
7982103|NCT03083847|12552433|FG005|Main|Physician Decision|1
7982104|NCT03083847|12552434|FG006|Main|Physician Decision|0
7982105|NCT03083847|12552435|FG007|Main|Physician Decision|0
7982106|NCT03083847|12552436|FG008|Main|Physician Decision|0
7982107|NCT03083847|12552437|FG009|Main|Physician Decision|0
7982108|NCT03083847|12552428|FG000|Main|Pregnancy|0
7982109|NCT03083847|12552429|FG001|Main|Pregnancy|0
7982110|NCT03083847|12552430|FG002|Main|Pregnancy|0
7982111|NCT03083847|12552431|FG003|Main|Pregnancy|0
7982112|NCT03083847|12552432|FG004|Main|Pregnancy|0
7982113|NCT03083847|12552433|FG005|Main|Pregnancy|0
7982114|NCT03083847|12552434|FG006|Main|Pregnancy|0
7982115|NCT03083847|12552435|FG007|Main|Pregnancy|1
7982116|NCT03083847|12552436|FG008|Main|Pregnancy|0
7982117|NCT03083847|12552437|FG009|Main|Pregnancy|0
7982118|NCT03083847|12552428|FG000|Main|Adverse Event|0
7982119|NCT03083847|12552429|FG001|Main|Adverse Event|0
7982120|NCT03083847|12552430|FG002|Main|Adverse Event|0
7982121|NCT03083847|12552431|FG003|Main|Adverse Event|0
7982122|NCT03083847|12552432|FG004|Main|Adverse Event|0
7982123|NCT03083847|12552433|FG005|Main|Adverse Event|0
7982124|NCT03083847|12552434|FG006|Main|Adverse Event|0
7982125|NCT03083847|12552435|FG007|Main|Adverse Event|2
7982126|NCT03083847|12552436|FG008|Main|Adverse Event|0
7982127|NCT03083847|12552437|FG009|Main|Adverse Event|0
7982128|NCT03083847|12552428|FG000|Main|Withdrawal by Subject|0
7982129|NCT03083847|12552429|FG001|Main|Withdrawal by Subject|0
7982130|NCT03083847|12552430|FG002|Main|Withdrawal by Subject|0
7982131|NCT03083847|12552431|FG003|Main|Withdrawal by Subject|0
7982132|NCT03083847|12552432|FG004|Main|Withdrawal by Subject|0
7982133|NCT03083847|12552433|FG005|Main|Withdrawal by Subject|0
7982134|NCT03083847|12552434|FG006|Main|Withdrawal by Subject|1
7982135|NCT03083847|12552435|FG007|Main|Withdrawal by Subject|1
7982136|NCT03083847|12552436|FG008|Main|Withdrawal by Subject|0
7982137|NCT03083847|12552437|FG009|Main|Withdrawal by Subject|0
7982138|NCT03083990|12552467|FG000|Overall Study|Adverse Event|1
7982139|NCT03083990|12552468|FG001|Overall Study|Adverse Event|0
7982140|NCT03084302|12552474|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9
7982141|NCT03084302|12552474|FG000|Overall Study|No valid objective monitor data|6
7982142|NCT03084315|12552481|FG000|Overall Study|Lost to Follow-up|8
7982143|NCT03084315|12552482|FG001|Overall Study|Lost to Follow-up|7
7982144|NCT03084315|12552481|FG000|Overall Study|Withdrawal by Subject|2
7982145|NCT03084315|12552482|FG001|Overall Study|Withdrawal by Subject|2
7982146|NCT03084796|12552494|FG000|Overall Study|Adverse Event|4
7982147|NCT03084796|12552495|FG001|Overall Study|Adverse Event|5
7982148|NCT03084796|12552496|FG002|Overall Study|Adverse Event|6
7982149|NCT03084796|12552497|FG003|Overall Study|Adverse Event|2
7982150|NCT03084796|12552498|FG004|Overall Study|Adverse Event|3
7982151|NCT03084796|12552499|FG005|Overall Study|Adverse Event|5
7982152|NCT03084796|12552494|FG000|Overall Study|Withdrawal by Subject|3
7982153|NCT03084796|12552495|FG001|Overall Study|Withdrawal by Subject|5
7982154|NCT03084796|12552496|FG002|Overall Study|Withdrawal by Subject|2
7982155|NCT03084796|12552497|FG003|Overall Study|Withdrawal by Subject|1
7982156|NCT03084796|12552498|FG004|Overall Study|Withdrawal by Subject|3
7982157|NCT03084796|12552499|FG005|Overall Study|Withdrawal by Subject|0
7982158|NCT03084796|12552494|FG000|Overall Study|Protocol Violation|0
7982159|NCT03084796|12552495|FG001|Overall Study|Protocol Violation|0
7982160|NCT03084796|12552496|FG002|Overall Study|Protocol Violation|1
7982161|NCT03084796|12552497|FG003|Overall Study|Protocol Violation|0
7982162|NCT03084796|12552498|FG004|Overall Study|Protocol Violation|1
7982163|NCT03084796|12552499|FG005|Overall Study|Protocol Violation|1
7982164|NCT03084796|12552494|FG000|Overall Study|Lack of Efficacy|0
7982165|NCT03084796|12552495|FG001|Overall Study|Lack of Efficacy|0
7982166|NCT03084796|12552496|FG002|Overall Study|Lack of Efficacy|1
7982167|NCT03084796|12552497|FG003|Overall Study|Lack of Efficacy|0
7982168|NCT03084796|12552498|FG004|Overall Study|Lack of Efficacy|1
7982169|NCT03084796|12552499|FG005|Overall Study|Lack of Efficacy|0
7982170|NCT03084796|12552494|FG000|Overall Study|Lost to Follow-up|0
7982171|NCT03084796|12552495|FG001|Overall Study|Lost to Follow-up|0
7982172|NCT03084796|12552496|FG002|Overall Study|Lost to Follow-up|1
7982173|NCT03084796|12552497|FG003|Overall Study|Lost to Follow-up|1
7982174|NCT03084796|12552498|FG004|Overall Study|Lost to Follow-up|3
7982175|NCT03084796|12552499|FG005|Overall Study|Lost to Follow-up|1
7982176|NCT03084796|12552494|FG000|Overall Study|Randomization error|0
7982177|NCT03084796|12552495|FG001|Overall Study|Randomization error|0
7982178|NCT03084796|12552496|FG002|Overall Study|Randomization error|1
7982179|NCT03084796|12552497|FG003|Overall Study|Randomization error|0
7982180|NCT03084796|12552498|FG004|Overall Study|Randomization error|0
7982181|NCT03084796|12552499|FG005|Overall Study|Randomization error|0
7982182|NCT03085017|12552515|FG000|Overall Study|Death|0
7982183|NCT03085017|12552516|FG001|Overall Study|Death|3
7982184|NCT03085238|12552522|FG000|Overall Study|Adverse Event|2
7982185|NCT03085238|12552522|FG000|Overall Study|Death|2
7982186|NCT03085758|12552538|FG000|Overall Study|Death|26
7982187|NCT03085758|12552539|FG001|Overall Study|Death|24
7982188|NCT03085758|12552540|FG002|Overall Study|Death|53
7982189|NCT03085758|12552538|FG000|Overall Study|Lost to Follow-up|1
7982190|NCT03085758|12552539|FG001|Overall Study|Lost to Follow-up|1
7982191|NCT03085758|12552540|FG002|Overall Study|Lost to Follow-up|1
7982192|NCT03085758|12552538|FG000|Overall Study|Withdrawal by Subject|2
7982193|NCT03085758|12552539|FG001|Overall Study|Withdrawal by Subject|2
7982194|NCT03085758|12552540|FG002|Overall Study|Withdrawal by Subject|1
7982195|NCT03085758|12552538|FG000|Overall Study|Refusal to recall it up to day 90|0
7982196|NCT03085758|12552539|FG001|Overall Study|Refusal to recall it up to day 90|0
7982197|NCT03085758|12552540|FG002|Overall Study|Refusal to recall it up to day 90|1
7982198|NCT03085758|12552538|FG000|Overall Study|Pt seen by doctor in digestive surgery|0
7982199|NCT03085758|12552539|FG001|Overall Study|Pt seen by doctor in digestive surgery|1
7982200|NCT03085758|12552540|FG002|Overall Study|Pt seen by doctor in digestive surgery|0
7982201|NCT03085797|12552554|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1
7982202|NCT03085797|12552555|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0
7982203|NCT03085797|12552554|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16
7982204|NCT03085797|12552555|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17
7982205|NCT03085797|12552554|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0
7982206|NCT03085797|12552555|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1
7982207|NCT03085927|12552580|FG000|Overall Study|Withdrawal by Subject|1
7982208|NCT03085927|12552581|FG001|Overall Study|Withdrawal by Subject|4
7982209|NCT03085927|12552580|FG000|Overall Study|Lost to Follow-up|3
7982210|NCT03085927|12552581|FG001|Overall Study|Lost to Follow-up|1
7982211|NCT03085927|12552580|FG000|Overall Study|Death|1
7982212|NCT03085927|12552581|FG001|Overall Study|Death|0
7982213|NCT03085927|12552580|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1
7982214|NCT03085927|12552581|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0
7982215|NCT03085927|12552580|FG000|Overall Study|Dyad Became Ineligible|0
7982216|NCT03085927|12552581|FG001|Overall Study|Dyad Became Ineligible|1
7982217|NCT03086018|12552589|FG000|Final Testing for End of Trial|Adverse Event|1
7982218|NCT03086018|12552589|FG000|Final Testing for End of Trial|Withdrawal by Subject|1
7982219|NCT03086057|12552599|FG000|Stage 1: PrEP Uptake|Incarcerated|3
7982220|NCT03086057|12552600|FG001|Stage 1: PrEP Uptake|Incarcerated|1
7982221|NCT03086057|12552601|FG002|Stage 1: PrEP Uptake|Incarcerated|0
7982222|NCT03086057|12552602|FG003|Stage 1: PrEP Uptake|Incarcerated|0
7982223|NCT03086057|12552599|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1
7982224|NCT03086057|12552600|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4
7982225|NCT03086057|12552601|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0
7982226|NCT03086057|12552602|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0
7982227|NCT03086057|12552599|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6
7982228|NCT03086057|12552600|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5
7982229|NCT03086057|12552601|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0
7982230|NCT03086057|12552602|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0
7982231|NCT03086057|12552599|FG000|Stage 1: PrEP Uptake|Death|1
7982232|NCT03086057|12552600|FG001|Stage 1: PrEP Uptake|Death|0
7982233|NCT03086057|12552601|FG002|Stage 1: PrEP Uptake|Death|0
7982234|NCT03086057|12552602|FG003|Stage 1: PrEP Uptake|Death|0
7982235|NCT03086057|12552599|FG000|Stage 2: PrEP Adherence|Incarcerated|0
7982236|NCT03086057|12552600|FG001|Stage 2: PrEP Adherence|Incarcerated|0
7982237|NCT03086057|12552601|FG002|Stage 2: PrEP Adherence|Incarcerated|2
7982238|NCT03086057|12552602|FG003|Stage 2: PrEP Adherence|Incarcerated|0
7982239|NCT03086057|12552599|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0
7982240|NCT03086057|12552600|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0
7982241|NCT03086057|12552601|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1
7982242|NCT03086057|12552602|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0
7982243|NCT03086057|12552599|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0
7982244|NCT03086057|12552600|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0
7982245|NCT03086057|12552601|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3
7982246|NCT03086057|12552602|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2
7982247|NCT03086135|12552612|FG000|Overall Study|Adverse Event|1
7982248|NCT03086135|12552612|FG000|Overall Study|Lost to Follow-up|2
7982249|NCT03086330|12552634|FG000|Overall Study|Withdrawal by Subject|3
7982250|NCT03086330|12552635|FG001|Overall Study|Withdrawal by Subject|2
7982251|NCT03086330|12552634|FG000|Overall Study|Lost to Follow-up|1
7982252|NCT03086330|12552635|FG001|Overall Study|Lost to Follow-up|2
7982253|NCT03086447|12552656|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7982254|NCT03086447|12552657|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
7982255|NCT03086447|12552656|FG000|Overall Study|Lost Lens|2
7982256|NCT03086447|12552657|FG001|Overall Study|Lost Lens|5
7982257|NCT03086447|12552656|FG000|Overall Study|Product quality complaint|0
7982258|NCT03086447|12552657|FG001|Overall Study|Product quality complaint|1
7982259|NCT03086447|12552656|FG000|Overall Study|Lens Damage|1
7982260|NCT03086447|12552657|FG001|Overall Study|Lens Damage|6
7982261|NCT03086447|12552656|FG000|Overall Study|Unsatisfactory Lens Fitting|0
7982262|NCT03086447|12552657|FG001|Overall Study|Unsatisfactory Lens Fitting|1
7982263|NCT03086447|12552656|FG000|Overall Study|Test Article No Longer Available|1
7982264|NCT03086447|12552657|FG001|Overall Study|Test Article No Longer Available|0
7982265|NCT03086447|12552656|FG000|Overall Study|Protocol Violation|2
7982266|NCT03086447|12552657|FG001|Overall Study|Protocol Violation|4
7982267|NCT03086447|12552656|FG000|Overall Study|Lost to Follow-up|0
7982268|NCT03086447|12552657|FG001|Overall Study|Lost to Follow-up|1
7982269|NCT03086447|12552656|FG000|Overall Study|Adverse Event|3
7982270|NCT03086447|12552657|FG001|Overall Study|Adverse Event|0
7982271|NCT03086447|12552656|FG000|Overall Study|Lens Discomfort|2
7982272|NCT03086447|12552657|FG001|Overall Study|Lens Discomfort|1
7982273|NCT03086460|12552663|FG000|Study Participants|Lost to Follow-up|2
7982274|NCT03086460|12552663|FG000|Study Participants|Protocol Violation|1
7982275|NCT03086460|12552663|FG000|Study Participants|Withdrawal by Subject|6
7982276|NCT03086460|12552663|FG000|Treatment A|Lost to Follow-up|1
7982277|NCT03086460|12552663|FG000|Treatment A|Protocol Violation|1
7982278|NCT03086460|12552663|FG000|Treatment A|Withdrawal by Subject|2
7982279|NCT03086460|12552663|FG000|Treatment C|Withdrawal by Subject|2
7982280|NCT03086460|12552663|FG000|Treatment E|Lost to Follow-up|1
7982281|NCT03086460|12552663|FG000|Treatment E|Withdrawal by Subject|3
7982282|NCT03086551|12552680|FG000|First Intervention|Failure to meet inclusion criterion|1
7982283|NCT03086551|12552681|FG001|First Intervention|Failure to meet inclusion criterion|0
7982284|NCT03086551|12552680|FG000|First Intervention|Lost to Follow-up|0
7982285|NCT03086551|12552681|FG001|First Intervention|Lost to Follow-up|1
7982286|NCT03086551|12552680|FG000|Washout|Lost to Follow-up|1
7982287|NCT03086551|12552681|FG001|Washout|Lost to Follow-up|2
7982288|NCT03086551|12552680|FG000|Washout|Withdrawal by Subject|2
7982289|NCT03086551|12552681|FG001|Washout|Withdrawal by Subject|1
7982290|NCT03087513|12552698|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2
7982291|NCT03087643|12552722|FG000|Overall Study|Withdrawal by Subject|2
7982292|NCT03087643|12552723|FG001|Overall Study|Withdrawal by Subject|4
7982293|NCT03087643|12552722|FG000|Overall Study|Death|2
7982294|NCT03087643|12552723|FG001|Overall Study|Death|2
7982295|NCT03087786|12552731|FG000|Overall Study|Withdrawal by Subject|2
7982296|NCT03087786|12552732|FG001|Overall Study|Withdrawal by Subject|0
7982297|NCT03087851|12552741|FG000|Overall Study|Withdraw on medical grounds|0
7982298|NCT03087851|12552742|FG001|Overall Study|Withdraw on medical grounds|1
7982299|NCT03087851|12552743|FG002|Overall Study|Withdraw on medical grounds|2
7982300|NCT03088917|12552790|FG000|Overall Study|In care/cured elsewhere|15
7982301|NCT03088917|12552790|FG000|Overall Study|Refuse re-evaluation|13
7982302|NCT03088917|12552790|FG000|Overall Study|Contact not established|13
7982303|NCT03088917|12552790|FG000|Overall Study|Severe comorbidity/short life expectancy|5
7982304|NCT03088917|12552790|FG000|Overall Study|Moved outside study region|50
7982305|NCT03089047|12552798|FG000|Overall Study|Lost to Follow-up|1
7982306|NCT03089047|12552799|FG001|Overall Study|Lost to Follow-up|0
7982307|NCT03089216|12552809|FG000|Overall Study|Adverse Event|0
7982308|NCT03089216|12552810|FG001|Overall Study|Adverse Event|0
7982309|NCT03089216|12552811|FG002|Overall Study|Adverse Event|0
7982310|NCT03089216|12552812|FG003|Overall Study|Adverse Event|1
7982311|NCT03089580|12552826|FG000|Overall Study|Lost to Follow-up|2
7982312|NCT03089697|12552834|FG000|Overall Study|Adverse Event|1
7982313|NCT03089697|12552835|FG001|Overall Study|Adverse Event|2
7982314|NCT03089697|12552834|FG000|Overall Study|Withdrawal by Subject|1
7982315|NCT03089697|12552835|FG001|Overall Study|Withdrawal by Subject|0
7982316|NCT03089944|12552855|FG000|Overall Study|Lost to Follow-up|8
7982317|NCT03089944|12552855|FG000|Overall Study|Withdrew Consent|2
7982318|NCT03089944|12552855|FG000|Overall Study|Adverse Event|1
7982319|NCT03089944|12552855|FG000|Overall Study|Other|1
7982320|NCT03090100|12552861|FG000|Overall Study|Adverse Event|9
7982321|NCT03090100|12552862|FG001|Overall Study|Adverse Event|11
7982322|NCT03090100|12552861|FG000|Overall Study|Pregnancy|1
7982323|NCT03090100|12552862|FG001|Overall Study|Pregnancy|1
7982324|NCT03090100|12552861|FG000|Overall Study|Lack of Efficacy|2
7982325|NCT03090100|12552862|FG001|Overall Study|Lack of Efficacy|7
7982326|NCT03090100|12552861|FG000|Overall Study|Lost to Follow-up|2
7982327|NCT03090100|12552862|FG001|Overall Study|Lost to Follow-up|2
7982328|NCT03090100|12552861|FG000|Overall Study|Withdrawal by Subject|7
7982329|NCT03090100|12552862|FG001|Overall Study|Withdrawal by Subject|19
7982330|NCT03090100|12552861|FG000|Overall Study|Protocol Violation|2
7982331|NCT03090100|12552862|FG001|Overall Study|Protocol Violation|6
7982332|NCT03090100|12552861|FG000|Overall Study|Non-compliance|2
7982333|NCT03090100|12552862|FG001|Overall Study|Non-compliance|0
7982334|NCT03090100|12552861|FG000|Overall Study|Other|2
7982335|NCT03090100|12552862|FG001|Overall Study|Other|2
7982336|NCT03091348|12552897|FG000|Overall Study|Lost to Follow-up|2
7982337|NCT03091348|12552898|FG001|Overall Study|Lost to Follow-up|1
7982338|NCT03091400|12552911|FG000|Washout - 2 Weeks|Withdrawal by Subject|1
7982339|NCT03091400|12552912|FG001|Washout - 2 Weeks|Withdrawal by Subject|0
7982340|NCT03091439|12552920|FG000|Overall Study|Study Terminated by the Sponsor|1
7982341|NCT03091439|12552921|FG001|Overall Study|Study Terminated by the Sponsor|0
7982342|NCT03091738|12552946|FG000|Overall Study|Adverse Event|1
7982343|NCT03091738|12552946|FG000|Overall Study|Lost to Follow-up|1
7982344|NCT03091777|12552957|FG000|Overall Study|Pregnancy|2
7982345|NCT03091777|12552958|FG001|Overall Study|Pregnancy|1
7982346|NCT03091777|12552959|FG002|Overall Study|Pregnancy|0
7982347|NCT03091777|12552957|FG000|Overall Study|Adverse Event|2
7982348|NCT03091777|12552958|FG001|Overall Study|Adverse Event|1
7982349|NCT03091777|12552959|FG002|Overall Study|Adverse Event|4
7982350|NCT03091777|12552957|FG000|Overall Study|Withdrawal by Subject|4
7982351|NCT03091777|12552958|FG001|Overall Study|Withdrawal by Subject|2
7982352|NCT03091777|12552959|FG002|Overall Study|Withdrawal by Subject|6
7982353|NCT03091777|12552957|FG000|Overall Study|Protocol Violation|2
7982354|NCT03091777|12552958|FG001|Overall Study|Protocol Violation|1
7982355|NCT03091777|12552959|FG002|Overall Study|Protocol Violation|1
7982356|NCT03091777|12552957|FG000|Overall Study|Lost to Follow-up|12
7982357|NCT03091777|12552958|FG001|Overall Study|Lost to Follow-up|14
7982358|NCT03091777|12552959|FG002|Overall Study|Lost to Follow-up|7
7982359|NCT03091777|12552957|FG000|Overall Study|Lack of Efficacy|0
7982360|NCT03091777|12552958|FG001|Overall Study|Lack of Efficacy|0
7982361|NCT03091777|12552959|FG002|Overall Study|Lack of Efficacy|5
7982362|NCT03091777|12552957|FG000|Overall Study|Noncompliance with study drug|2
7982363|NCT03091777|12552958|FG001|Overall Study|Noncompliance with study drug|3
7982364|NCT03091777|12552959|FG002|Overall Study|Noncompliance with study drug|1
7982365|NCT03091777|12552957|FG000|Overall Study|Physician Decision|1
7982366|NCT03091777|12552958|FG001|Overall Study|Physician Decision|0
7982367|NCT03091777|12552959|FG002|Overall Study|Physician Decision|1
7982368|NCT03091777|12552957|FG000|Overall Study|Abnormal Laboratory Value|7
7982369|NCT03091777|12552958|FG001|Overall Study|Abnormal Laboratory Value|11
7982370|NCT03091777|12552959|FG002|Overall Study|Abnormal Laboratory Value|12
7982371|NCT03091920|12552970|FG000|Overall Study|Adverse Event|0
7982372|NCT03091920|12552971|FG001|Overall Study|Adverse Event|1
7982373|NCT03091920|12552972|FG002|Overall Study|Adverse Event|0
7982374|NCT03092375|12553003|FG000|Overall Study|Lack of Efficacy|0
7982375|NCT03092375|12553004|FG001|Overall Study|Lack of Efficacy|1
7982376|NCT03092375|12553005|FG002|Overall Study|Lack of Efficacy|1
7982377|NCT03092375|12553006|FG003|Overall Study|Lack of Efficacy|0
7982378|NCT03092479|12553025|FG000|Overall Study|Lost to Follow-up|3
7982379|NCT03092479|12553026|FG001|Overall Study|Lost to Follow-up|2
7982380|NCT03092479|12553025|FG000|Overall Study|Withdrawal by Subject|4
7982381|NCT03092479|12553026|FG001|Overall Study|Withdrawal by Subject|0
7982382|NCT03092726|12553034|FG000|Overall Study|Adverse Event|3
7982383|NCT03092726|12553035|FG001|Overall Study|Adverse Event|10
7982384|NCT03092726|12553034|FG000|Overall Study|Lack of Efficacy|0
7982385|NCT03092726|12553035|FG001|Overall Study|Lack of Efficacy|1
7982386|NCT03092726|12553034|FG000|Overall Study|Lost to Follow-up|1
7982387|NCT03092726|12553035|FG001|Overall Study|Lost to Follow-up|0
7982388|NCT03092726|12553034|FG000|Overall Study|Withdrawal by Subject|5
7982389|NCT03092726|12553035|FG001|Overall Study|Withdrawal by Subject|3
7982390|NCT03092752|12553041|FG000|Overall Study|Aged <40 years|14209
7982391|NCT03092752|12553041|FG000|Overall Study|At least one claim with T2DM|61299
7982392|NCT03092752|12553041|FG000|Overall Study|Having no claim of study drugs|29282
7982393|NCT03092752|12553041|FG000|Overall Study|Average hospital visit interval >92 days|10779
7982394|NCT03092752|12553041|FG000|Overall Study|<6 month history|245900
7982395|NCT03092791|12553070|FG000|Overall Study|Lost to Follow-up|0
7982396|NCT03092791|12553071|FG001|Overall Study|Lost to Follow-up|0
7982397|NCT03092791|12553072|FG002|Overall Study|Lost to Follow-up|0
7982398|NCT03092791|12553073|FG003|Overall Study|Lost to Follow-up|0
7982399|NCT03092791|12553074|FG004|Overall Study|Lost to Follow-up|0
7982400|NCT03092791|12553075|FG005|Overall Study|Lost to Follow-up|0
7982401|NCT03092791|12553076|FG006|Overall Study|Lost to Follow-up|1
7982402|NCT03092791|12553077|FG007|Overall Study|Lost to Follow-up|0
7982403|NCT03092791|12553070|FG000|Overall Study|Withdrawal of Consent|0
7982404|NCT03092791|12553071|FG001|Overall Study|Withdrawal of Consent|0
7982405|NCT03092791|12553072|FG002|Overall Study|Withdrawal of Consent|0
7982406|NCT03092791|12553073|FG003|Overall Study|Withdrawal of Consent|0
7982407|NCT03092791|12553074|FG004|Overall Study|Withdrawal of Consent|4
7982408|NCT03092791|12553075|FG005|Overall Study|Withdrawal of Consent|12
7982409|NCT03092791|12553076|FG006|Overall Study|Withdrawal of Consent|6
7982410|NCT03092791|12553077|FG007|Overall Study|Withdrawal of Consent|4
7982411|NCT03092791|12553070|FG000|Overall Study|Study Termination|0
7982412|NCT03092791|12553071|FG001|Overall Study|Study Termination|0
7982413|NCT03092791|12553072|FG002|Overall Study|Study Termination|0
7982414|NCT03092791|12553073|FG003|Overall Study|Study Termination|0
7982415|NCT03092791|12553074|FG004|Overall Study|Study Termination|55
7982416|NCT03092791|12553075|FG005|Overall Study|Study Termination|46
7982417|NCT03092791|12553076|FG006|Overall Study|Study Termination|53
7982418|NCT03092791|12553077|FG007|Overall Study|Study Termination|55
7982419|NCT03092791|12553070|FG000|Overall Study|Death|0
7982420|NCT03092791|12553071|FG001|Overall Study|Death|0
7982421|NCT03092791|12553072|FG002|Overall Study|Death|0
7982422|NCT03092791|12553073|FG003|Overall Study|Death|0
7982423|NCT03092791|12553074|FG004|Overall Study|Death|0
7982424|NCT03092791|12553075|FG005|Overall Study|Death|1
7982425|NCT03092791|12553076|FG006|Overall Study|Death|0
7982426|NCT03092791|12553077|FG007|Overall Study|Death|1
7982427|NCT03092791|12553070|FG000|Overall Study|Reason Not Specified|0
7982428|NCT03092791|12553071|FG001|Overall Study|Reason Not Specified|0
7982429|NCT03092791|12553072|FG002|Overall Study|Reason Not Specified|0
7982430|NCT03092791|12553073|FG003|Overall Study|Reason Not Specified|0
7982431|NCT03092791|12553074|FG004|Overall Study|Reason Not Specified|1
7982432|NCT03092791|12553075|FG005|Overall Study|Reason Not Specified|1
7982433|NCT03092791|12553076|FG006|Overall Study|Reason Not Specified|0
7982434|NCT03092791|12553077|FG007|Overall Study|Reason Not Specified|0
7982435|NCT03093181|12553137|FG000|Overall Study|Withdrawal by Subject|2
7718053|NCT00524368|12141741|FG000|Overall Study|Sponsor's Decision|2
7718054|NCT00524368|12141742|FG001|Overall Study|Sponsor's Decision|0
7718055|NCT00524368|12141741|FG000|Overall Study|Ineligible to Continue the study|2
7718056|NCT00524368|12141742|FG001|Overall Study|Ineligible to Continue the study|5
7718057|NCT00524368|12141741|FG000|Overall Study|Other|3
7718058|NCT00524368|12141742|FG001|Overall Study|Other|2
7982436|NCT03093181|12553138|FG001|Overall Study|Withdrawal by Subject|1
7982437|NCT03093181|12553139|FG002|Overall Study|Withdrawal by Subject|2
7982438|NCT03093181|12553137|FG000|Overall Study|Other (Not specified)|1
7982439|NCT03093181|12553138|FG001|Overall Study|Other (Not specified)|0
7982440|NCT03093181|12553139|FG002|Overall Study|Other (Not specified)|0
7982441|NCT03093181|12553137|FG000|Overall Study|Adverse Event|0
7982442|NCT03093181|12553138|FG001|Overall Study|Adverse Event|1
7982443|NCT03093181|12553139|FG002|Overall Study|Adverse Event|0
7982444|NCT03093181|12553137|FG000|Overall Study|Other (Protocol violation)|0
7982445|NCT03093181|12553138|FG001|Overall Study|Other (Protocol violation)|0
7982446|NCT03093181|12553139|FG002|Overall Study|Other (Protocol violation)|1
7982447|NCT03093324|12553162|FG000|Overall Study|Adverse Event|4
7982448|NCT03093324|12553163|FG001|Overall Study|Adverse Event|15
7982449|NCT03093324|12553162|FG000|Overall Study|Lost to Follow-up|1
7982450|NCT03093324|12553163|FG001|Overall Study|Lost to Follow-up|0
7982451|NCT03093324|12553162|FG000|Overall Study|Protocol Deviation|2
7982452|NCT03093324|12553163|FG001|Overall Study|Protocol Deviation|2
7982453|NCT03093324|12553162|FG000|Overall Study|Withdrawal by Subject|2
7982454|NCT03093324|12553163|FG001|Overall Study|Withdrawal by Subject|2
7982455|NCT03093415|12553172|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17
7982456|NCT03093415|12553173|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36
7982457|NCT03093415|12553174|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0
7982458|NCT03093415|12553172|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40
7982459|NCT03093415|12553173|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
7982460|NCT03093415|12553174|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
7982461|NCT03093415|12553172|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28
7982462|NCT03093415|12553173|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6
7982463|NCT03093415|12553174|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0
7982464|NCT03093415|12553172|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
7982465|NCT03093415|12553173|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12
7982466|NCT03093415|12553174|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
7982467|NCT03093415|12553172|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18
7982468|NCT03093415|12553173|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12
7982469|NCT03093415|12553174|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0
7982470|NCT03093415|12553172|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
7982471|NCT03093415|12553173|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
7982472|NCT03093415|12553174|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0
7982473|NCT03093415|12553172|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15
7982474|NCT03093415|12553173|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32
7982475|NCT03093415|12553174|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0
7982476|NCT03093415|12553172|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5
7982477|NCT03093415|12553173|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3
7811412|NCT01182350|12275140|FG004|Overall Study|Withdrawal by Subject|0
7811413|NCT01182350|12275136|FG000|Overall Study|Alternative Therapy|2
7811414|NCT01182350|12275137|FG001|Overall Study|Alternative Therapy|0
7811415|NCT01182350|12275138|FG002|Overall Study|Alternative Therapy|1
7811416|NCT01182350|12275139|FG003|Overall Study|Alternative Therapy|0
7982478|NCT03093415|12553174|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0
7982479|NCT03093415|12553172|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4
7982480|NCT03093415|12553173|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2
7982481|NCT03093415|12553174|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0
7982482|NCT03093415|12553172|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9
7982483|NCT03093415|12553173|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3
7982484|NCT03093415|12553174|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0
7982485|NCT03093415|12553172|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1
7982486|NCT03093415|12553173|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8
7982487|NCT03093415|12553174|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3
7982488|NCT03093454|12553184|FG000|Overall Study|Withdrawal by Subject|1
7982489|NCT03093454|12553185|FG001|Overall Study|Withdrawal by Subject|1
7982490|NCT03093454|12553184|FG000|Overall Study|Scheduling conflict|3
7982491|NCT03093454|12553185|FG001|Overall Study|Scheduling conflict|1
7982492|NCT03093454|12553184|FG000|Overall Study|Physician Decision|2
7982493|NCT03093454|12553185|FG001|Overall Study|Physician Decision|1
7982494|NCT03093870|12553203|FG000|Overall Study|Withdrawal by Subject|2
7982495|NCT03093870|12553204|FG001|Overall Study|Withdrawal by Subject|6
7982496|NCT03093870|12553205|FG002|Overall Study|Withdrawal by Subject|5
7982497|NCT03093870|12553203|FG000|Overall Study|Death|1
7982498|NCT03093870|12553204|FG001|Overall Study|Death|35
7982499|NCT03093870|12553205|FG002|Overall Study|Death|35
7982500|NCT03093870|12553203|FG000|Overall Study|Radiographic disease progression|10
7982501|NCT03093870|12553204|FG001|Overall Study|Radiographic disease progression|0
7982502|NCT03093870|12553205|FG002|Overall Study|Radiographic disease progression|0
7982503|NCT03093870|12553203|FG000|Overall Study|Clinical disease progression|1
7982504|NCT03093870|12553204|FG001|Overall Study|Clinical disease progression|0
7982505|NCT03093870|12553205|FG002|Overall Study|Clinical disease progression|0
7982506|NCT03093870|12553203|FG000|Overall Study|Physician Decision|2
7982507|NCT03093870|12553204|FG001|Overall Study|Physician Decision|0
7982508|NCT03093870|12553205|FG002|Overall Study|Physician Decision|0
7982509|NCT03093870|12553203|FG000|Overall Study|Adverse Event|7
7982510|NCT03093870|12553204|FG001|Overall Study|Adverse Event|0
7982511|NCT03093870|12553205|FG002|Overall Study|Adverse Event|0
7982512|NCT03093870|12553203|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1
7982513|NCT03093870|12553204|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0
7982514|NCT03093870|12553205|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0
7982515|NCT03093870|12553203|FG000|Overall Study|Lost to Follow-up|0
7982516|NCT03093870|12553204|FG001|Overall Study|Lost to Follow-up|0
7982517|NCT03093870|12553205|FG002|Overall Study|Lost to Follow-up|1
7982518|NCT03094195|12553216|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12
7982519|NCT03094195|12553217|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10
7982520|NCT03094195|12553218|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11
7982521|NCT03094195|12553219|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7982522|NCT03094195|12553220|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7982523|NCT03094195|12553221|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7982524|NCT03094195|12553222|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7982525|NCT03094195|12553223|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7982526|NCT03094195|12553216|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3
7982527|NCT03094195|12553217|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2
7982528|NCT03094195|12553218|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1
7982529|NCT03094195|12553219|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0
7982530|NCT03094195|12553220|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0
7982531|NCT03094195|12553221|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0
7982532|NCT03094195|12553222|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0
7982533|NCT03094195|12553223|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0
7982534|NCT03094195|12553216|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0
7982535|NCT03094195|12553217|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0
7982536|NCT03094195|12553218|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1
7982537|NCT03094195|12553219|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0
7982538|NCT03094195|12553220|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0
7982539|NCT03094195|12553221|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0
7982540|NCT03094195|12553222|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0
7982541|NCT03094195|12553223|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0
7982542|NCT03094195|12553216|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7982543|NCT03094195|12553217|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
7982544|NCT03094195|12553218|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
7982545|NCT03094195|12553219|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7982546|NCT03094195|12553220|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7982547|NCT03094195|12553221|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7982548|NCT03094195|12553222|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7982549|NCT03094195|12553223|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7982550|NCT03094611|12553247|FG000|Overall Study|Lack of Efficacy|1
7982551|NCT03094611|12553247|FG000|Overall Study|Stem Cell Transplant|1
7982552|NCT03095027|12553260|FG000|Period 2, Second Week of Wear|Adverse Event|1
7982553|NCT03095027|12553261|FG001|Period 2, Second Week of Wear|Adverse Event|0
7982554|NCT03095508|12553278|FG000|Overall Study|Adverse Event|0
7982555|NCT03095508|12553279|FG001|Overall Study|Adverse Event|1
7982556|NCT03095521|12553287|FG000|Overall Study|Withdrawal by Subject|0
7982557|NCT03095521|12553288|FG001|Overall Study|Withdrawal by Subject|1
7982558|NCT03095521|12553287|FG000|Overall Study|Lost to Follow-up|0
7982559|NCT03095521|12553288|FG001|Overall Study|Lost to Follow-up|1
7982560|NCT03095599|12553296|FG000|Overall Study|Withdrawal by Subject|1
7982561|NCT03095599|12553297|FG001|Overall Study|Withdrawal by Subject|0
7982562|NCT03095599|12553296|FG000|Overall Study|Lost to Follow-up|1
7982563|NCT03095599|12553297|FG001|Overall Study|Lost to Follow-up|0
7982564|NCT03095599|12553296|FG000|Overall Study|Withdrawal prior to vaccination|1
7982565|NCT03095599|12553297|FG001|Overall Study|Withdrawal prior to vaccination|0
7982566|NCT03095651|12553342|FG000|Overall Study|Lost to Follow-up|1
7982567|NCT03095651|12553343|FG001|Overall Study|Lost to Follow-up|1
7982568|NCT03095651|12553344|FG002|Overall Study|Lost to Follow-up|0
7982569|NCT03095651|12553345|FG003|Overall Study|Lost to Follow-up|1
7982570|NCT03095651|12553346|FG004|Overall Study|Lost to Follow-up|0
7982571|NCT03095651|12553347|FG005|Overall Study|Lost to Follow-up|0
7982572|NCT03095651|12553348|FG006|Overall Study|Lost to Follow-up|0
7982573|NCT03095651|12553349|FG007|Overall Study|Lost to Follow-up|0
7982574|NCT03095651|12553342|FG000|Overall Study|Withdrawal by Subject|0
7982575|NCT03095651|12553343|FG001|Overall Study|Withdrawal by Subject|0
7982576|NCT03095651|12553344|FG002|Overall Study|Withdrawal by Subject|0
7982577|NCT03095651|12553345|FG003|Overall Study|Withdrawal by Subject|0
7982578|NCT03095651|12553346|FG004|Overall Study|Withdrawal by Subject|0
7982579|NCT03095651|12553347|FG005|Overall Study|Withdrawal by Subject|1
7982580|NCT03095651|12553348|FG006|Overall Study|Withdrawal by Subject|0
7982581|NCT03095651|12553349|FG007|Overall Study|Withdrawal by Subject|0
7982582|NCT03096314|12553377|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9
7982583|NCT03096314|12553378|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12
7982584|NCT03096483|12553405|FG000|Overall Study|Withdrawal by site|1
7982585|NCT03096847|12553433|FG000|Overall Study|Other|2
7982586|NCT03096847|12553434|FG001|Overall Study|Other|1
7982587|NCT03096847|12553435|FG002|Overall Study|Other|2
7982588|NCT03096847|12553433|FG000|Overall Study|Lost to Follow-up|1
7982589|NCT03096847|12553434|FG001|Overall Study|Lost to Follow-up|0
7982590|NCT03096847|12553435|FG002|Overall Study|Lost to Follow-up|1
7982591|NCT03096847|12553433|FG000|Overall Study|Death|6
7982592|NCT03096847|12553434|FG001|Overall Study|Death|0
7982593|NCT03096847|12553435|FG002|Overall Study|Death|2
7982594|NCT03096847|12553433|FG000|Overall Study|Protocol Violation|3
7982595|NCT03096847|12553434|FG001|Overall Study|Protocol Violation|0
7982596|NCT03096847|12553435|FG002|Overall Study|Protocol Violation|6
7982597|NCT03096847|12553433|FG000|Overall Study|Physician Decision|12
7982598|NCT03096847|12553434|FG001|Overall Study|Physician Decision|2
7982599|NCT03096847|12553435|FG002|Overall Study|Physician Decision|8
7982600|NCT03096847|12553433|FG000|Overall Study|Withdrawal by Subject|24
7982601|NCT03096847|12553434|FG001|Overall Study|Withdrawal by Subject|1
7982602|NCT03096847|12553435|FG002|Overall Study|Withdrawal by Subject|12
7982603|NCT03096847|12553433|FG000|Overall Study|Adverse Event|72
7982604|NCT03096847|12553434|FG001|Overall Study|Adverse Event|6
7982605|NCT03096847|12553435|FG002|Overall Study|Adverse Event|28
7982606|NCT03096847|12553433|FG000|Overall Study|Progressive disease|97
7982607|NCT03096847|12553434|FG001|Overall Study|Progressive disease|10
7982608|NCT03096847|12553435|FG002|Overall Study|Progressive disease|78
7982609|NCT03096847|12553433|FG000|Overall Study|Non-compliance with study medication|1
7982610|NCT03096847|12553434|FG001|Overall Study|Non-compliance with study medication|0
7982611|NCT03096847|12553435|FG002|Overall Study|Non-compliance with study medication|0
7982612|NCT03096847|12553433|FG000|Overall Study|New therapy for study indication|1
7982613|NCT03096847|12553434|FG001|Overall Study|New therapy for study indication|0
7982614|NCT03096847|12553435|FG002|Overall Study|New therapy for study indication|1
7982615|NCT03097029|12553462|FG000|Overall Study|Withdrawal by Subject|1
7982616|NCT03097133|12553468|FG000|Overall Study|Lost to Follow-up|3
7982617|NCT03097133|12553469|FG001|Overall Study|Lost to Follow-up|2
7982618|NCT03097133|12553468|FG000|Overall Study|Withdrawal by Subject|2
7982619|NCT03097133|12553469|FG001|Overall Study|Withdrawal by Subject|5
7982620|NCT03097133|12553468|FG000|Overall Study|Discontinued DB, not entered FU Phase|21
7982621|NCT03097133|12553469|FG001|Overall Study|Discontinued DB, not entered FU Phase|25
7982622|NCT03097133|12553468|FG000|Overall Study|Other|3
7982623|NCT03097133|12553469|FG001|Overall Study|Other|2
7982624|NCT03097133|12553468|FG000|Overall Study|Adverse Event|1
7982625|NCT03097133|12553469|FG001|Overall Study|Adverse Event|0
7982626|NCT03097289|12553475|FG000|Overall Study|Adverse Event|1
7982627|NCT03097289|12553475|FG000|Overall Study|Equipment failure|2
7982628|NCT03097289|12553475|FG000|Overall Study|Collected platelet product unusable|3
7982629|NCT03097315|12553480|FG000|Overall Study|Withdrawal by Subject|1
7982630|NCT03097588|12553514|FG000|Overall Study|Adverse Event|1
7982631|NCT03097614|12553518|FG000|Overall Study|Adverse Event|3
7982632|NCT03097861|12553534|FG000|Overall Study|Adverse Event|3
7982633|NCT03097861|12553535|FG001|Overall Study|Adverse Event|8
7982634|NCT03097861|12553536|FG002|Overall Study|Adverse Event|4
7982635|NCT03097861|12553534|FG000|Overall Study|Investigator Decision|0
7982636|NCT03097861|12553535|FG001|Overall Study|Investigator Decision|1
7982637|NCT03097861|12553536|FG002|Overall Study|Investigator Decision|0
7982638|NCT03097861|12553534|FG000|Overall Study|Lost to Follow-up|0
7982639|NCT03097861|12553535|FG001|Overall Study|Lost to Follow-up|7
7982640|NCT03097861|12553536|FG002|Overall Study|Lost to Follow-up|1
7982641|NCT03097861|12553534|FG000|Overall Study|Withdrawal by Subject|1
7982642|NCT03097861|12553535|FG001|Overall Study|Withdrawal by Subject|5
7982643|NCT03097861|12553536|FG002|Overall Study|Withdrawal by Subject|3
7982644|NCT03097861|12553534|FG000|Overall Study|Reason not provided|3
7982645|NCT03097861|12553535|FG001|Overall Study|Reason not provided|1
7982646|NCT03097861|12553536|FG002|Overall Study|Reason not provided|1
7982647|NCT03098030|12553550|FG000|Overall Study|Death|10
7982648|NCT03098030|12553551|FG001|Overall Study|Death|156
7982649|NCT03098030|12553552|FG002|Overall Study|Death|156
7982650|NCT03098030|12553553|FG003|Overall Study|Death|82
7982651|NCT03098030|12553550|FG000|Overall Study|Withdrawal by Subject|0
7982652|NCT03098030|12553551|FG001|Overall Study|Withdrawal by Subject|7
7982653|NCT03098030|12553552|FG002|Overall Study|Withdrawal by Subject|8
7982654|NCT03098030|12553553|FG003|Overall Study|Withdrawal by Subject|2
7982655|NCT03098030|12553550|FG000|Overall Study|Lost to Follow-up|0
7982656|NCT03098030|12553551|FG001|Overall Study|Lost to Follow-up|0
7982657|NCT03098030|12553552|FG002|Overall Study|Lost to Follow-up|2
7982658|NCT03098030|12553553|FG003|Overall Study|Lost to Follow-up|1
7982659|NCT03098433|12553586|FG000|Overall Study|Withdrawal by Subject|10
7982660|NCT03098550|12553594|FG000|Overall Study|Disease Progression|30
7982661|NCT03098550|12553595|FG001|Overall Study|Disease Progression|19
7982662|NCT03098550|12553596|FG002|Overall Study|Disease Progression|41
7982663|NCT03098550|12553594|FG000|Overall Study|Study Drug Toxicity|2
7982664|NCT03098550|12553595|FG001|Overall Study|Study Drug Toxicity|1
7982665|NCT03098550|12553596|FG002|Overall Study|Study Drug Toxicity|0
7982666|NCT03098550|12553594|FG000|Overall Study|Death|1
7982667|NCT03098550|12553595|FG001|Overall Study|Death|0
7982668|NCT03098550|12553596|FG002|Overall Study|Death|0
7982669|NCT03098550|12553594|FG000|Overall Study|Adverse Event unrelated to Study Drug|6
7982670|NCT03098550|12553595|FG001|Overall Study|Adverse Event unrelated to Study Drug|0
7982671|NCT03098550|12553596|FG002|Overall Study|Adverse Event unrelated to Study Drug|1
7982672|NCT03098550|12553594|FG000|Overall Study|Administrative reason by sponsor|0
7982673|NCT03098550|12553595|FG001|Overall Study|Administrative reason by sponsor|0
7982674|NCT03098550|12553596|FG002|Overall Study|Administrative reason by sponsor|1
7982675|NCT03098550|12553594|FG000|Overall Study|Other reasons|2
7982676|NCT03098550|12553595|FG001|Overall Study|Other reasons|0
7982677|NCT03098550|12553596|FG002|Overall Study|Other reasons|0
7982678|NCT03098979|12553641|FG000|Overall Study|Adverse Event|1
7982679|NCT03098979|12553642|FG001|Overall Study|Adverse Event|0
7982680|NCT03098979|12553643|FG002|Overall Study|Adverse Event|1
7982681|NCT03098979|12553644|FG003|Overall Study|Adverse Event|4
7982682|NCT03098979|12553645|FG004|Overall Study|Adverse Event|6
7982683|NCT03098979|12553646|FG005|Overall Study|Adverse Event|1
7982684|NCT03098979|12553641|FG000|Overall Study|Withdrawal by Subject|2
7982685|NCT03098979|12553642|FG001|Overall Study|Withdrawal by Subject|1
7982686|NCT03098979|12553643|FG002|Overall Study|Withdrawal by Subject|1
7982687|NCT03098979|12553644|FG003|Overall Study|Withdrawal by Subject|1
7982688|NCT03098979|12553645|FG004|Overall Study|Withdrawal by Subject|2
7982689|NCT03098979|12553646|FG005|Overall Study|Withdrawal by Subject|1
7982690|NCT03098979|12553641|FG000|Overall Study|Death|1
7982691|NCT03098979|12553642|FG001|Overall Study|Death|0
7982692|NCT03098979|12553643|FG002|Overall Study|Death|2
7982693|NCT03098979|12553644|FG003|Overall Study|Death|0
7982694|NCT03098979|12553645|FG004|Overall Study|Death|1
7982695|NCT03098979|12553646|FG005|Overall Study|Death|0
7982696|NCT03098979|12553641|FG000|Overall Study|Physician Decision|2
7982697|NCT03098979|12553642|FG001|Overall Study|Physician Decision|1
7982698|NCT03098979|12553643|FG002|Overall Study|Physician Decision|0
7982699|NCT03098979|12553644|FG003|Overall Study|Physician Decision|0
7982700|NCT03098979|12553645|FG004|Overall Study|Physician Decision|0
7982701|NCT03098979|12553646|FG005|Overall Study|Physician Decision|0
7982702|NCT03098979|12553641|FG000|Overall Study|Non-compliance|0
7982703|NCT03098979|12553642|FG001|Overall Study|Non-compliance|0
7982704|NCT03098979|12553643|FG002|Overall Study|Non-compliance|0
7982705|NCT03098979|12553644|FG003|Overall Study|Non-compliance|0
7982706|NCT03098979|12553645|FG004|Overall Study|Non-compliance|0
7982707|NCT03098979|12553646|FG005|Overall Study|Non-compliance|1
7982708|NCT03098979|12553641|FG000|Overall Study|Protocol Violation|0
7982709|NCT03098979|12553642|FG001|Overall Study|Protocol Violation|0
7982710|NCT03098979|12553643|FG002|Overall Study|Protocol Violation|0
7982711|NCT03098979|12553644|FG003|Overall Study|Protocol Violation|0
7982712|NCT03098979|12553645|FG004|Overall Study|Protocol Violation|0
7982713|NCT03098979|12553646|FG005|Overall Study|Protocol Violation|1
7982714|NCT03099096|12553660|FG000|Overall Study|Adverse Event|1
7982715|NCT03099096|12553660|FG000|Overall Study|Physician Decision|1
7982716|NCT03099161|12553667|FG000|Overall Study|Adverse Event|0
7982717|NCT03099161|12553668|FG001|Overall Study|Adverse Event|0
7982718|NCT03099161|12553669|FG002|Overall Study|Adverse Event|2
7982719|NCT03099161|12553667|FG000|Overall Study|Physician Decision|2
7982720|NCT03099161|12553668|FG001|Overall Study|Physician Decision|0
7982721|NCT03099161|12553669|FG002|Overall Study|Physician Decision|0
7982722|NCT03099161|12553667|FG000|Overall Study|Progressive Disease|1
7982723|NCT03099161|12553668|FG001|Overall Study|Progressive Disease|4
7982724|NCT03099161|12553669|FG002|Overall Study|Progressive Disease|1
7982725|NCT03099187|12553679|FG000|Double-blind Treatment|Adverse Event|19
7982726|NCT03099187|12553680|FG001|Double-blind Treatment|Adverse Event|1
7982727|NCT03099187|12553681|FG002|Double-blind Treatment|Adverse Event|0
7982728|NCT03099187|12553682|FG003|Double-blind Treatment|Adverse Event|0
7982729|NCT03099187|12553679|FG000|Double-blind Treatment|Death|1
7982730|NCT03099187|12553680|FG001|Double-blind Treatment|Death|3
7982731|NCT03099187|12553681|FG002|Double-blind Treatment|Death|0
7982732|NCT03099187|12553682|FG003|Double-blind Treatment|Death|0
7982733|NCT03099187|12553679|FG000|Double-blind Treatment|Lack of Efficacy|1
7982734|NCT03099187|12553680|FG001|Double-blind Treatment|Lack of Efficacy|0
7982735|NCT03099187|12553681|FG002|Double-blind Treatment|Lack of Efficacy|0
7982736|NCT03099187|12553682|FG003|Double-blind Treatment|Lack of Efficacy|0
7982737|NCT03099187|12553679|FG000|Double-blind Treatment|Physician Decision|2
7982738|NCT03099187|12553680|FG001|Double-blind Treatment|Physician Decision|1
7982739|NCT03099187|12553681|FG002|Double-blind Treatment|Physician Decision|0
7982740|NCT03099187|12553682|FG003|Double-blind Treatment|Physician Decision|0
7982741|NCT03099187|12553679|FG000|Double-blind Treatment|Withdrawal by Subject|9
7982742|NCT03099187|12553680|FG001|Double-blind Treatment|Withdrawal by Subject|4
7718059|NCT00524420|12141750|FG000|Overall Study|Lack of Efficacy|1
7718060|NCT00524420|12141751|FG001|Overall Study|Lack of Efficacy|0
7982743|NCT03099187|12553681|FG002|Double-blind Treatment|Withdrawal by Subject|0
7982744|NCT03099187|12553682|FG003|Double-blind Treatment|Withdrawal by Subject|0
7982745|NCT03099187|12553679|FG000|Double-blind Treatment|Lung transplantation|0
7982746|NCT03099187|12553680|FG001|Double-blind Treatment|Lung transplantation|1
7982747|NCT03099187|12553681|FG002|Double-blind Treatment|Lung transplantation|0
7982748|NCT03099187|12553682|FG003|Double-blind Treatment|Lung transplantation|0
7982749|NCT03099187|12553679|FG000|Double-blind Treatment|Non-compliance with study drug|0
7982750|NCT03099187|12553680|FG001|Double-blind Treatment|Non-compliance with study drug|2
7982751|NCT03099187|12553681|FG002|Double-blind Treatment|Non-compliance with study drug|0
7982752|NCT03099187|12553682|FG003|Double-blind Treatment|Non-compliance with study drug|0
7982753|NCT03099187|12553679|FG000|Double-blind Treatment|Disease progression|0
7982754|NCT03099187|12553680|FG001|Double-blind Treatment|Disease progression|1
7982755|NCT03099187|12553681|FG002|Double-blind Treatment|Disease progression|0
7982756|NCT03099187|12553682|FG003|Double-blind Treatment|Disease progression|0
7982757|NCT03099187|12553679|FG000|Double-blind Treatment|Randomization error|0
7982758|NCT03099187|12553680|FG001|Double-blind Treatment|Randomization error|2
7982759|NCT03099187|12553681|FG002|Double-blind Treatment|Randomization error|0
7982760|NCT03099187|12553682|FG003|Double-blind Treatment|Randomization error|0
7982761|NCT03099187|12553679|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1
7982762|NCT03099187|12553680|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1
7982763|NCT03099187|12553681|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0
7982764|NCT03099187|12553682|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0
7982765|NCT03099187|12553679|FG000|12-month Safety Follow-up|Adverse Event|0
7982766|NCT03099187|12553680|FG001|12-month Safety Follow-up|Adverse Event|0
7982767|NCT03099187|12553681|FG002|12-month Safety Follow-up|Adverse Event|5
7982768|NCT03099187|12553682|FG003|12-month Safety Follow-up|Adverse Event|12
7982769|NCT03099187|12553679|FG000|12-month Safety Follow-up|Death|0
7982770|NCT03099187|12553680|FG001|12-month Safety Follow-up|Death|0
7982771|NCT03099187|12553681|FG002|12-month Safety Follow-up|Death|7
7982772|NCT03099187|12553682|FG003|12-month Safety Follow-up|Death|9
7982773|NCT03099187|12553679|FG000|12-month Safety Follow-up|Lung transplantation|0
7982774|NCT03099187|12553680|FG001|12-month Safety Follow-up|Lung transplantation|0
7718061|NCT00524589|12141781|FG000|Overall Study|Withdrawal by Subject|2
7718062|NCT00524589|12141781|FG000|Overall Study|Disease Progression|16
7718063|NCT00524680|12141789|FG000|Overall Study|progression|0
7718064|NCT00524680|12141790|FG001|Overall Study|progression|0
7718065|NCT00524680|12141791|FG002|Overall Study|progression|0
7718066|NCT00524680|12141792|FG003|Overall Study|progression|1
7718067|NCT00524680|12141789|FG000|Overall Study|Adverse Event|2
7718068|NCT00524680|12141790|FG001|Overall Study|Adverse Event|0
7718069|NCT00524680|12141791|FG002|Overall Study|Adverse Event|0
7718070|NCT00524680|12141792|FG003|Overall Study|Adverse Event|1
7718071|NCT00524680|12141789|FG000|Overall Study|Other|0
7718072|NCT00524680|12141790|FG001|Overall Study|Other|1
7982775|NCT03099187|12553681|FG002|12-month Safety Follow-up|Lung transplantation|2
7982776|NCT03099187|12553682|FG003|12-month Safety Follow-up|Lung transplantation|1
7982777|NCT03099187|12553679|FG000|12-month Safety Follow-up|Lost to Follow-up|0
7982778|NCT03099187|12553680|FG001|12-month Safety Follow-up|Lost to Follow-up|0
7982779|NCT03099187|12553681|FG002|12-month Safety Follow-up|Lost to Follow-up|1
7718073|NCT00524680|12141791|FG002|Overall Study|Other|2
7982780|NCT03099187|12553682|FG003|12-month Safety Follow-up|Lost to Follow-up|0
7982781|NCT03099187|12553679|FG000|12-month Safety Follow-up|Symptomatic deterioration|0
7982782|NCT03099187|12553680|FG001|12-month Safety Follow-up|Symptomatic deterioration|0
7982783|NCT03099187|12553681|FG002|12-month Safety Follow-up|Symptomatic deterioration|1
7982784|NCT03099187|12553682|FG003|12-month Safety Follow-up|Symptomatic deterioration|1
7982785|NCT03099187|12553679|FG000|12-month Safety Follow-up|Withdrawal by Subject|0
7982786|NCT03099187|12553680|FG001|12-month Safety Follow-up|Withdrawal by Subject|0
7982787|NCT03099187|12553681|FG002|12-month Safety Follow-up|Withdrawal by Subject|3
7982788|NCT03099187|12553682|FG003|12-month Safety Follow-up|Withdrawal by Subject|2
7982789|NCT03099187|12553679|FG000|12-month Safety Follow-up|Due to hospitalization|0
7982790|NCT03099187|12553680|FG001|12-month Safety Follow-up|Due to hospitalization|0
7982791|NCT03099187|12553681|FG002|12-month Safety Follow-up|Due to hospitalization|0
7982792|NCT03099187|12553682|FG003|12-month Safety Follow-up|Due to hospitalization|1
7982793|NCT03099538|12553702|FG000|Overall Study|Lack of Efficacy|3
7982794|NCT03099694|12553715|FG000|Overall Study|Withdrawal by Subject|11
7982795|NCT03099694|12553716|FG001|Overall Study|Withdrawal by Subject|13
7982796|NCT03099694|12553715|FG000|Overall Study|Lost to Follow-up|9
7982797|NCT03099694|12553716|FG001|Overall Study|Lost to Follow-up|5
7982798|NCT03100058|12553732|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7982799|NCT03100058|12553733|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7982800|NCT03100058|12553734|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4
7982801|NCT03100058|12553735|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8
7982802|NCT03100058|12553736|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1
7982803|NCT03100058|12553737|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7982804|NCT03100058|12553738|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3
7982805|NCT03100058|12553739|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11
7982806|NCT03100058|12553740|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2
7982807|NCT03100058|12553741|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7982808|NCT03100058|12553742|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7982809|NCT03100058|12553743|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7982810|NCT03100058|12553744|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7982811|NCT03100058|12553732|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
7982812|NCT03100058|12553733|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
7982813|NCT03100058|12553734|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3
7982814|NCT03100058|12553735|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
7982815|NCT03100058|12553736|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
7982816|NCT03100058|12553737|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
7982817|NCT03100058|12553738|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
7982818|NCT03100058|12553739|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
7982819|NCT03100058|12553740|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
7982820|NCT03100058|12553741|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7982821|NCT03100058|12553742|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7982822|NCT03100058|12553743|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7982823|NCT03100058|12553744|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7982824|NCT03100058|12553732|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7982825|NCT03100058|12553733|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
7982826|NCT03100058|12553734|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
7982827|NCT03100058|12553735|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7982828|NCT03100058|12553736|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7982829|NCT03100058|12553737|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
7982830|NCT03100058|12553738|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
7982831|NCT03100058|12553739|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7982832|NCT03100058|12553740|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7982833|NCT03100058|12553741|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7982834|NCT03100058|12553742|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7982835|NCT03100058|12553743|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7982836|NCT03100058|12553744|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7982837|NCT03100058|12553732|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7982838|NCT03100058|12553733|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7982839|NCT03100058|12553734|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7982840|NCT03100058|12553735|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7982841|NCT03100058|12553736|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7982842|NCT03100058|12553737|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7982843|NCT03100058|12553738|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7982844|NCT03100058|12553739|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7982845|NCT03100058|12553740|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7982846|NCT03100058|12553741|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7982847|NCT03100058|12553742|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7982848|NCT03100058|12553743|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7982849|NCT03100058|12553744|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7982850|NCT03100058|12553732|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7982851|NCT03100058|12553733|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7982852|NCT03100058|12553734|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7982853|NCT03100058|12553735|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
7982854|NCT03100058|12553736|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7982855|NCT03100058|12553737|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7982856|NCT03100058|12553738|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7982857|NCT03100058|12553739|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
7982858|NCT03100058|12553740|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7982859|NCT03100058|12553741|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7982860|NCT03100058|12553742|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7982861|NCT03100058|12553743|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7982862|NCT03100058|12553744|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7982863|NCT03100058|12553732|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7982864|NCT03100058|12553733|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7982865|NCT03100058|12553734|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7982866|NCT03100058|12553735|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
7982867|NCT03100058|12553736|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7982868|NCT03100058|12553737|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7982869|NCT03100058|12553738|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
7982870|NCT03100058|12553739|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7982871|NCT03100058|12553740|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7982872|NCT03100058|12553741|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7982873|NCT03100058|12553742|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7982874|NCT03100058|12553743|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7982875|NCT03100058|12553744|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7982876|NCT03100058|12553732|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0
7982877|NCT03100058|12553733|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1
7982878|NCT03100058|12553734|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0
7982879|NCT03100058|12553735|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0
7982880|NCT03100058|12553736|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0
7982881|NCT03100058|12553737|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0
7982882|NCT03100058|12553738|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0
7982883|NCT03100058|12553739|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0
7982884|NCT03100058|12553740|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0
7982885|NCT03100058|12553741|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0
7982886|NCT03100058|12553742|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0
7982887|NCT03100058|12553743|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0
7982888|NCT03100058|12553744|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0
7982889|NCT03100058|12553732|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1
7982890|NCT03100058|12553733|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7982891|NCT03100058|12553734|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7982892|NCT03100058|12553735|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7982893|NCT03100058|12553736|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7982894|NCT03100058|12553737|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7982895|NCT03100058|12553738|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7907564|NCT02020616|12422373|FG001|Overall Study|Withdrawal by Subject|0
7907565|NCT02020616|12422374|FG002|Overall Study|Withdrawal by Subject|1
7907566|NCT02020616|12422375|FG003|Overall Study|Withdrawal by Subject|0
7907567|NCT02020616|12422376|FG004|Overall Study|Withdrawal by Subject|0
7907568|NCT02020616|12422377|FG005|Overall Study|Withdrawal by Subject|1
7907569|NCT02020616|12422378|FG006|Overall Study|Withdrawal by Subject|1
7907570|NCT02020616|12422372|FG000|Overall Study|Lost to Follow-up|0
7907571|NCT02020616|12422373|FG001|Overall Study|Lost to Follow-up|1
7907572|NCT02020616|12422374|FG002|Overall Study|Lost to Follow-up|0
7907573|NCT02020616|12422375|FG003|Overall Study|Lost to Follow-up|1
7907574|NCT02020616|12422376|FG004|Overall Study|Lost to Follow-up|1
7907575|NCT02020616|12422377|FG005|Overall Study|Lost to Follow-up|1
7907576|NCT02020616|12422378|FG006|Overall Study|Lost to Follow-up|0
7907577|NCT02020616|12422372|FG000|Overall Study|Early Termination Criteria Met|0
7907578|NCT02020616|12422373|FG001|Overall Study|Early Termination Criteria Met|0
7907579|NCT02020616|12422374|FG002|Overall Study|Early Termination Criteria Met|1
7907580|NCT02020616|12422375|FG003|Overall Study|Early Termination Criteria Met|0
7907581|NCT02020616|12422376|FG004|Overall Study|Early Termination Criteria Met|0
7907582|NCT02020616|12422377|FG005|Overall Study|Early Termination Criteria Met|1
7907583|NCT02020616|12422378|FG006|Overall Study|Early Termination Criteria Met|0
7907584|NCT02020616|12422372|FG000|Overall Study|Randomized in Error|0
7907585|NCT02020616|12422373|FG001|Overall Study|Randomized in Error|0
7907586|NCT02020616|12422374|FG002|Overall Study|Randomized in Error|0
7907587|NCT02020616|12422375|FG003|Overall Study|Randomized in Error|1
7907588|NCT02020616|12422376|FG004|Overall Study|Randomized in Error|0
7907589|NCT02020616|12422377|FG005|Overall Study|Randomized in Error|0
7907590|NCT02020616|12422378|FG006|Overall Study|Randomized in Error|0
7907591|NCT02020616|12422372|FG000|Overall Study|Lack of Efficacy|0
7907592|NCT02020616|12422373|FG001|Overall Study|Lack of Efficacy|0
7907593|NCT02020616|12422374|FG002|Overall Study|Lack of Efficacy|0
7907594|NCT02020616|12422375|FG003|Overall Study|Lack of Efficacy|0
7907595|NCT02020616|12422376|FG004|Overall Study|Lack of Efficacy|1
7907596|NCT02020616|12422377|FG005|Overall Study|Lack of Efficacy|0
7907597|NCT02020616|12422378|FG006|Overall Study|Lack of Efficacy|0
7907598|NCT02020863|12422417|FG000|Overall Study|Discovery of Metastatic disease|4
7907599|NCT02020863|12422417|FG000|Overall Study|Team chose not to place an a line|1
7907600|NCT02020889|12422423|FG000|Overall Study|Adverse Event|0
7907601|NCT02020889|12422424|FG001|Overall Study|Adverse Event|1
7907602|NCT02020889|12422423|FG000|Overall Study|Lack of Efficacy|1
7907603|NCT02020889|12422424|FG001|Overall Study|Lack of Efficacy|0
7907604|NCT02020889|12422423|FG000|Overall Study|Lost to Follow-up|1
7907605|NCT02020889|12422424|FG001|Overall Study|Lost to Follow-up|0
7907606|NCT02020889|12422423|FG000|Overall Study|Physician Decision|2
7907607|NCT02020889|12422424|FG001|Overall Study|Physician Decision|0
7907608|NCT02020889|12422423|FG000|Overall Study|Withdrawal by Subject|3
7907609|NCT02020889|12422424|FG001|Overall Study|Withdrawal by Subject|2
7964009|NCT02732938|12518970|FG002|Overall Study|Death|0
7964010|NCT02732938|12518968|FG000|Overall Study|Randomized but did not receive treatment|0
7964011|NCT02732938|12518969|FG001|Overall Study|Randomized but did not receive treatment|1
7964012|NCT02732938|12518970|FG002|Overall Study|Randomized but did not receive treatment|0
7964013|NCT02732938|12518968|FG000|Overall Study|Refused further follow-up|1
7964014|NCT02732938|12518969|FG001|Overall Study|Refused further follow-up|0
7964015|NCT02732938|12518970|FG002|Overall Study|Refused further follow-up|0
7964016|NCT02732938|12518968|FG000|Overall Study|Study terminated by sponsor|3
7964017|NCT02732938|12518969|FG001|Overall Study|Study terminated by sponsor|6
7964018|NCT02732938|12518970|FG002|Overall Study|Study terminated by sponsor|0
7964019|NCT02732951|12518980|FG000|Overall Study|Other than listed|1
7964020|NCT02732951|12518981|FG001|Overall Study|Other than listed|0
7964021|NCT02732951|12518980|FG000|Overall Study|Lost to Follow-up|0
7964022|NCT02732951|12518981|FG001|Overall Study|Lost to Follow-up|1
7964023|NCT02732951|12518980|FG000|Overall Study|Adverse Event|4
7964024|NCT02732951|12518981|FG001|Overall Study|Adverse Event|4
7982896|NCT03100058|12553739|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7982897|NCT03100058|12553740|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7982898|NCT03100058|12553741|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7982899|NCT03100058|12553742|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7982900|NCT03100058|12553743|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7982901|NCT03100058|12553744|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7982902|NCT03100058|12553732|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7982903|NCT03100058|12553733|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7982904|NCT03100058|12553734|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7982905|NCT03100058|12553735|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7982906|NCT03100058|12553736|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7982907|NCT03100058|12553737|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7982908|NCT03100058|12553738|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1
7982909|NCT03100058|12553739|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7982910|NCT03100058|12553740|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7982911|NCT03100058|12553741|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7982912|NCT03100058|12553742|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7982913|NCT03100058|12553743|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7982914|NCT03100058|12553744|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7982915|NCT03100058|12553732|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7982916|NCT03100058|12553733|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7982917|NCT03100058|12553734|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7982918|NCT03100058|12553735|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7982919|NCT03100058|12553736|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7982920|NCT03100058|12553737|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7982921|NCT03100058|12553738|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7982922|NCT03100058|12553739|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7982923|NCT03100058|12553740|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7982924|NCT03100058|12553741|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7982925|NCT03100058|12553742|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4
7982926|NCT03100058|12553743|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2
7982927|NCT03100058|12553744|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1
7982928|NCT03100058|12553732|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7982929|NCT03100058|12553733|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7982930|NCT03100058|12553734|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7982931|NCT03100058|12553735|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7982932|NCT03100058|12553736|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7982933|NCT03100058|12553737|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7982934|NCT03100058|12553738|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7982935|NCT03100058|12553739|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7982936|NCT03100058|12553740|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7982937|NCT03100058|12553741|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7982938|NCT03100058|12553742|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3
7982939|NCT03100058|12553743|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1
7982940|NCT03100058|12553744|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7982941|NCT03100058|12553732|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7982942|NCT03100058|12553733|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7982943|NCT03100058|12553734|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7982944|NCT03100058|12553735|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7982945|NCT03100058|12553736|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7982946|NCT03100058|12553737|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7982947|NCT03100058|12553738|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7982948|NCT03100058|12553739|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7982949|NCT03100058|12553740|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7982950|NCT03100058|12553741|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4
7982951|NCT03100058|12553742|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7
7982952|NCT03100058|12553743|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7982953|NCT03100058|12553744|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2
7982954|NCT03100058|12553732|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7982955|NCT03100058|12553733|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7982956|NCT03100058|12553734|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7982957|NCT03100058|12553735|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7982958|NCT03100058|12553736|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7982959|NCT03100058|12553737|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7982960|NCT03100058|12553738|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7982961|NCT03100058|12553739|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7982962|NCT03100058|12553740|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7982963|NCT03100058|12553741|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7982964|NCT03100058|12553742|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1
7982965|NCT03100058|12553743|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7982966|NCT03100058|12553744|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7982967|NCT03100058|12553732|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7982968|NCT03100058|12553733|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7982969|NCT03100058|12553734|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7982970|NCT03100058|12553735|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7982971|NCT03100058|12553736|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7982972|NCT03100058|12553737|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7982973|NCT03100058|12553738|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7982974|NCT03100058|12553739|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7982975|NCT03100058|12553740|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7982976|NCT03100058|12553741|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7982977|NCT03100058|12553742|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7982978|NCT03100058|12553743|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7982979|NCT03100058|12553744|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1
7982980|NCT03100058|12553732|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7982981|NCT03100058|12553733|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7982982|NCT03100058|12553734|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7982983|NCT03100058|12553735|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7982984|NCT03100058|12553736|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7982985|NCT03100058|12553737|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7982986|NCT03100058|12553738|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7982987|NCT03100058|12553739|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7982988|NCT03100058|12553740|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7982989|NCT03100058|12553741|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1
7982990|NCT03100058|12553742|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7982991|NCT03100058|12553743|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7982992|NCT03100058|12553744|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7982993|NCT03100344|12553791|FG000|Overall Study|Adverse Event|0
7982994|NCT03100344|12553792|FG001|Overall Study|Adverse Event|3
7982995|NCT03100344|12553793|FG002|Overall Study|Adverse Event|2
7982996|NCT03100344|12553794|FG003|Overall Study|Adverse Event|3
7982997|NCT03100344|12553791|FG000|Overall Study|Lack of Efficacy|2
7982998|NCT03100344|12553792|FG001|Overall Study|Lack of Efficacy|0
7982999|NCT03100344|12553793|FG002|Overall Study|Lack of Efficacy|0
7983000|NCT03100344|12553794|FG003|Overall Study|Lack of Efficacy|0
7983001|NCT03100344|12553791|FG000|Overall Study|Protocol Violation|1
7983002|NCT03100344|12553792|FG001|Overall Study|Protocol Violation|0
7983003|NCT03100344|12553793|FG002|Overall Study|Protocol Violation|0
7983004|NCT03100344|12553794|FG003|Overall Study|Protocol Violation|0
7983005|NCT03100344|12553791|FG000|Overall Study|Withdrawal by Subject|10
7983006|NCT03100344|12553792|FG001|Overall Study|Withdrawal by Subject|7
7983007|NCT03100344|12553793|FG002|Overall Study|Withdrawal by Subject|4
7983008|NCT03100344|12553794|FG003|Overall Study|Withdrawal by Subject|8
7983009|NCT03100344|12553791|FG000|Overall Study|Lost to Follow-up|1
7983010|NCT03100344|12553792|FG001|Overall Study|Lost to Follow-up|1
7983011|NCT03100344|12553793|FG002|Overall Study|Lost to Follow-up|1
7983012|NCT03100344|12553794|FG003|Overall Study|Lost to Follow-up|1
7983013|NCT03100825|12553809|FG000|Overall Study|Participant/Guardian Decision|7
7983014|NCT03100825|12553809|FG000|Overall Study|Physician Decision|1
7983015|NCT03100838|12553813|FG000|Overall Study|Adverse Event|1
7983016|NCT03100838|12553814|FG001|Overall Study|Adverse Event|0
7983017|NCT03100838|12553815|FG002|Overall Study|Adverse Event|0
7983018|NCT03100838|12553816|FG003|Overall Study|Adverse Event|0
7983019|NCT03100838|12553813|FG000|Overall Study|Physician Decision|1
7983020|NCT03100838|12553814|FG001|Overall Study|Physician Decision|1
7983021|NCT03100838|12553815|FG002|Overall Study|Physician Decision|1
7983022|NCT03100838|12553816|FG003|Overall Study|Physician Decision|1
7983023|NCT03100838|12553813|FG000|Overall Study|Pregnancy|0
7983024|NCT03100838|12553814|FG001|Overall Study|Pregnancy|1
7983025|NCT03100838|12553815|FG002|Overall Study|Pregnancy|0
7983026|NCT03100838|12553816|FG003|Overall Study|Pregnancy|0
7983027|NCT03100838|12553813|FG000|Overall Study|Lost to Follow-up|0
7983028|NCT03100838|12553814|FG001|Overall Study|Lost to Follow-up|0
7983029|NCT03100838|12553815|FG002|Overall Study|Lost to Follow-up|1
7983030|NCT03100838|12553816|FG003|Overall Study|Lost to Follow-up|0
7983031|NCT03100942|12553834|FG000|Randomized Treatment Period|Withdrew Consent|4
7983032|NCT03100942|12553835|FG001|Randomized Treatment Period|Withdrew Consent|5
7983033|NCT03100942|12553836|FG002|Randomized Treatment Period|Withdrew Consent|3
7983034|NCT03100942|12553837|FG003|Randomized Treatment Period|Withdrew Consent|3
7983035|NCT03100942|12553838|FG004|Randomized Treatment Period|Withdrew Consent|0
7983036|NCT03100942|12553839|FG005|Randomized Treatment Period|Withdrew Consent|0
7983037|NCT03100942|12553840|FG006|Randomized Treatment Period|Withdrew Consent|0
7983038|NCT03100942|12553834|FG000|Randomized Treatment Period|Adverse Event|5
7983039|NCT03100942|12553835|FG001|Randomized Treatment Period|Adverse Event|2
7983040|NCT03100942|12553836|FG002|Randomized Treatment Period|Adverse Event|1
7983041|NCT03100942|12553837|FG003|Randomized Treatment Period|Adverse Event|0
7983042|NCT03100942|12553838|FG004|Randomized Treatment Period|Adverse Event|0
7983043|NCT03100942|12553839|FG005|Randomized Treatment Period|Adverse Event|0
7983044|NCT03100942|12553840|FG006|Randomized Treatment Period|Adverse Event|0
7983045|NCT03100942|12553834|FG000|Randomized Treatment Period|Investigator's Discretion|2
7983046|NCT03100942|12553835|FG001|Randomized Treatment Period|Investigator's Discretion|1
7983047|NCT03100942|12553836|FG002|Randomized Treatment Period|Investigator's Discretion|0
7983048|NCT03100942|12553837|FG003|Randomized Treatment Period|Investigator's Discretion|0
7983049|NCT03100942|12553838|FG004|Randomized Treatment Period|Investigator's Discretion|0
7983050|NCT03100942|12553839|FG005|Randomized Treatment Period|Investigator's Discretion|0
7983051|NCT03100942|12553840|FG006|Randomized Treatment Period|Investigator's Discretion|0
7983052|NCT03100942|12553834|FG000|Randomized Treatment Period|Protocol Violation|0
7983053|NCT03100942|12553835|FG001|Randomized Treatment Period|Protocol Violation|1
7983054|NCT03100942|12553836|FG002|Randomized Treatment Period|Protocol Violation|1
7983055|NCT03100942|12553837|FG003|Randomized Treatment Period|Protocol Violation|1
7983056|NCT03100942|12553838|FG004|Randomized Treatment Period|Protocol Violation|0
7983057|NCT03100942|12553839|FG005|Randomized Treatment Period|Protocol Violation|0
7983058|NCT03100942|12553840|FG006|Randomized Treatment Period|Protocol Violation|0
7983059|NCT03100942|12553834|FG000|Randomized Treatment Period|Lost to Follow-up|0
7983060|NCT03100942|12553835|FG001|Randomized Treatment Period|Lost to Follow-up|0
7983061|NCT03100942|12553836|FG002|Randomized Treatment Period|Lost to Follow-up|1
7983062|NCT03100942|12553837|FG003|Randomized Treatment Period|Lost to Follow-up|0
7983063|NCT03100942|12553838|FG004|Randomized Treatment Period|Lost to Follow-up|0
7983064|NCT03100942|12553839|FG005|Randomized Treatment Period|Lost to Follow-up|0
7983065|NCT03100942|12553840|FG006|Randomized Treatment Period|Lost to Follow-up|0
7983066|NCT03100942|12553834|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
7983067|NCT03100942|12553835|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7983068|NCT03100942|12553836|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7983069|NCT03100942|12553837|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
7983070|NCT03100942|12553838|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7983071|NCT03100942|12553839|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7983072|NCT03100942|12553840|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7983073|NCT03100942|12553834|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0
7983074|NCT03100942|12553835|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0
7983075|NCT03100942|12553836|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0
7983076|NCT03100942|12553837|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0
7983077|NCT03100942|12553838|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0
7983078|NCT03100942|12553839|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0
7983079|NCT03100942|12553840|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1
7983080|NCT03101020|12553864|FG000|Overall Study|Lack of time to participate|1
7983081|NCT03101020|12553865|FG001|Overall Study|Lack of time to participate|0
7983082|NCT03101020|12553864|FG000|Overall Study|Ran over by a car|0
7983083|NCT03101020|12553865|FG001|Overall Study|Ran over by a car|1
7983084|NCT03101020|12553864|FG000|Overall Study|Withdrawal by Subject|0
7983085|NCT03101020|12553865|FG001|Overall Study|Withdrawal by Subject|2
7983086|NCT03101150|12553895|FG000|Overall Study|Lost to Follow-up|2
7983087|NCT03101150|12553896|FG001|Overall Study|Lost to Follow-up|4
7983088|NCT03101150|12553895|FG000|Overall Study|Miscarriage|3
7983089|NCT03101150|12553896|FG001|Overall Study|Miscarriage|6
7983090|NCT03101241|12553904|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4
7983091|NCT03101241|12553905|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2
7983092|NCT03101241|12553904|FG000|Overall Study|Participant withdrew consent|3
7983093|NCT03101241|12553905|FG001|Overall Study|Participant withdrew consent|1
7983094|NCT03101241|12553904|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2
7983095|NCT03101241|12553905|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0
7983096|NCT03101241|12553904|FG000|Overall Study|Lost to Follow-up|2
7983097|NCT03101241|12553905|FG001|Overall Study|Lost to Follow-up|0
7983098|NCT03101241|12553904|FG000|Overall Study|Lack of Efficacy|0
7983099|NCT03101241|12553905|FG001|Overall Study|Lack of Efficacy|1
7983100|NCT03101241|12553904|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0
7983101|NCT03101241|12553905|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1
7983102|NCT03101267|12553914|FG000|Primary Study Period|Withdrawal by Subject|1
7983103|NCT03101267|12553915|FG001|Primary Study Period|Withdrawal by Subject|2
7983104|NCT03101267|12553916|FG002|Primary Study Period|Withdrawal by Subject|3
7983105|NCT03101267|12553914|FG000|Primary Study Period|Miscellaneous|2
7983106|NCT03101267|12553915|FG001|Primary Study Period|Miscellaneous|0
7983107|NCT03101267|12553916|FG002|Primary Study Period|Miscellaneous|0
7983108|NCT03101293|12553926|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1
7983109|NCT03101293|12553927|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0
7983110|NCT03101358|12553937|FG000|Overall Study|Non-compliance with study schedule|1
7983111|NCT03101358|12553938|FG001|Overall Study|Non-compliance with study schedule|0
7983112|NCT03101358|12553939|FG002|Overall Study|Non-compliance with study schedule|0
7983113|NCT03101358|12553940|FG003|Overall Study|Non-compliance with study schedule|1
7983114|NCT03101358|12553937|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0
7983115|NCT03101358|12553938|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0
7983116|NCT03101358|12553939|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1
7983117|NCT03101358|12553940|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0
7983118|NCT03101358|12553937|FG000|Overall Study|Physician Decision|1
7983119|NCT03101358|12553938|FG001|Overall Study|Physician Decision|0
7983120|NCT03101358|12553939|FG002|Overall Study|Physician Decision|0
7983121|NCT03101358|12553940|FG003|Overall Study|Physician Decision|3
7983122|NCT03101358|12553937|FG000|Overall Study|Adverse Event|0
7983123|NCT03101358|12553938|FG001|Overall Study|Adverse Event|0
7983124|NCT03101358|12553939|FG002|Overall Study|Adverse Event|1
7983125|NCT03101358|12553940|FG003|Overall Study|Adverse Event|0
7983126|NCT03101358|12553937|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
7983127|NCT03101358|12553938|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
7983128|NCT03101358|12553939|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
7983129|NCT03101358|12553940|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1
7983130|NCT03101358|12553937|FG000|Overall Study|Lost to Follow-up|1
7983131|NCT03101358|12553938|FG001|Overall Study|Lost to Follow-up|0
7983132|NCT03101358|12553939|FG002|Overall Study|Lost to Follow-up|0
7983133|NCT03101358|12553940|FG003|Overall Study|Lost to Follow-up|1
7983134|NCT03101371|12553953|FG000|Overall Study|Physician Decision|0
7983135|NCT03101371|12553954|FG001|Overall Study|Physician Decision|1
7983136|NCT03101371|12553953|FG000|Overall Study|Lost to Follow-up|1
7983137|NCT03101371|12553954|FG001|Overall Study|Lost to Follow-up|4
7983138|NCT03101371|12553953|FG000|Overall Study|Did not meet eligibility criteria|2
7983139|NCT03101371|12553954|FG001|Overall Study|Did not meet eligibility criteria|1
7983140|NCT03101462|12553962|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1
7983141|NCT03101462|12553963|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1
7983142|NCT03101514|12553969|FG000|Overall Study|Withdrawal by Subject|4
7983143|NCT03101514|12553969|FG000|Overall Study|Protocol Violation|2
7983144|NCT03101514|12553969|FG000|Overall Study|patient's information was incomplete|1
7983145|NCT03101592|12553976|FG000|Overall Study|participant files could not be located|111
7983146|NCT03101592|12553977|FG001|Overall Study|participant files could not be located|170
7983147|NCT03101592|12553978|FG002|Overall Study|participant files could not be located|118
7983148|NCT03102710|12554023|FG000|Overall Study|Dental metal affected MRI scan quality|1
7983149|NCT03102710|12554024|FG001|Overall Study|Dental metal affected MRI scan quality|0
7983150|NCT03102710|12554025|FG002|Overall Study|Dental metal affected MRI scan quality|0
7983151|NCT03102710|12554023|FG000|Overall Study|Technical issues during final MRI scan|0
7983152|NCT03102710|12554024|FG001|Overall Study|Technical issues during final MRI scan|1
7983153|NCT03102710|12554025|FG002|Overall Study|Technical issues during final MRI scan|0
7983154|NCT03102710|12554023|FG000|Overall Study|Nausea during MRI scan|0
7983155|NCT03102710|12554024|FG001|Overall Study|Nausea during MRI scan|1
7983156|NCT03102710|12554025|FG002|Overall Study|Nausea during MRI scan|0
7983157|NCT03102710|12554023|FG000|Overall Study|Subject unable to attend final session|0
7983158|NCT03102710|12554024|FG001|Overall Study|Subject unable to attend final session|1
7983159|NCT03102710|12554025|FG002|Overall Study|Subject unable to attend final session|0
7983160|NCT03102762|12554044|FG000|Overall Study|Lost to Follow-up|1
7983161|NCT03102762|12554045|FG001|Overall Study|Lost to Follow-up|0
7983162|NCT03102918|12554067|FG000|Overall Study|Protocol Violation|1
7983163|NCT03102918|12554068|FG001|Overall Study|Protocol Violation|0
7983164|NCT03103100|12554081|FG000|Overall Study|Adverse Event|1
7983165|NCT03103100|12554082|FG001|Overall Study|Adverse Event|0
7983166|NCT03103100|12554083|FG002|Overall Study|Adverse Event|0
7983167|NCT03103100|12554081|FG000|Overall Study|Physician Decision|1
7983168|NCT03103100|12554082|FG001|Overall Study|Physician Decision|0
7983169|NCT03103100|12554083|FG002|Overall Study|Physician Decision|2
7983170|NCT03103503|12554124|FG000|Overall Study|Death|64
7983171|NCT03103503|12554124|FG000|Overall Study|Physician Decision|57
7983172|NCT03103503|12554124|FG000|Overall Study|Withdrawal by Subject|10
7983173|NCT03103503|12554124|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10
7983174|NCT03103503|12554124|FG000|Overall Study|Lost to Follow-up|3
7983175|NCT03103503|12554124|FG000|Overall Study|Study Closure|757
7983176|NCT03103763|12554131|FG000|Overall Study|Death|15
7983177|NCT03103763|12554132|FG001|Overall Study|Death|5
7983178|NCT03103763|12554133|FG002|Overall Study|Death|5
7983179|NCT03103763|12554131|FG000|Overall Study|Withdrawal by Subject|0
7983180|NCT03103763|12554132|FG001|Overall Study|Withdrawal by Subject|3
7983181|NCT03103763|12554133|FG002|Overall Study|Withdrawal by Subject|2
7983182|NCT03103906|12554143|FG000|Overall Study|Adverse Event|2
7983183|NCT03103906|12554144|FG001|Overall Study|Adverse Event|3
7983184|NCT03103906|12554143|FG000|Overall Study|Other|2
7983185|NCT03103906|12554144|FG001|Overall Study|Other|0
7983186|NCT03103919|12554152|FG000|Overall Study|Adverse Event|2
7983187|NCT03103919|12554153|FG001|Overall Study|Adverse Event|2
7983188|NCT03104816|12554213|FG000|Overall Study|Lack of Efficacy|0
7983189|NCT03104816|12554214|FG001|Overall Study|Lack of Efficacy|2
7983190|NCT03104816|12554215|FG002|Overall Study|Lack of Efficacy|0
7983191|NCT03104816|12554213|FG000|Overall Study|Protocol Violation|2
7983192|NCT03104816|12554214|FG001|Overall Study|Protocol Violation|0
7983193|NCT03104816|12554215|FG002|Overall Study|Protocol Violation|2
7983194|NCT03105297|12554232|FG000|Baseline Phase (Day 1)|Other|21
7983195|NCT03105297|12554232|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1
7983196|NCT03105297|12554232|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7
7983197|NCT03105362|12554243|FG000|Overall Study|Withdrawal by Subject|1
7983198|NCT03105362|12554243|FG000|Overall Study|Lost to Follow-up|1
7983199|NCT03106077|12554263|FG000|Overall Study|Screen Failure|94
7983200|NCT03106077|12554264|FG001|Overall Study|Screen Failure|0
7983201|NCT03106753|12554285|FG000|Overall Study|Withdrawal by Subject|0
7983202|NCT03106753|12554286|FG001|Overall Study|Withdrawal by Subject|1
7983203|NCT03107026|12554310|FG000|Overall Study|Adverse Event|2
7983204|NCT03107026|12554311|FG001|Overall Study|Adverse Event|14
7983205|NCT03107026|12554312|FG002|Overall Study|Adverse Event|23
7983206|NCT03107026|12554310|FG000|Overall Study|Lost to Follow-up|12
7983207|NCT03107026|12554311|FG001|Overall Study|Lost to Follow-up|12
7983208|NCT03107026|12554312|FG002|Overall Study|Lost to Follow-up|13
7983209|NCT03107026|12554310|FG000|Overall Study|Protocol Violation|1
7983210|NCT03107026|12554311|FG001|Overall Study|Protocol Violation|2
7983211|NCT03107026|12554312|FG002|Overall Study|Protocol Violation|0
7983212|NCT03107026|12554310|FG000|Overall Study|Pregnancy|1
7983213|NCT03107026|12554311|FG001|Overall Study|Pregnancy|0
7983214|NCT03107026|12554312|FG002|Overall Study|Pregnancy|0
7983215|NCT03107026|12554310|FG000|Overall Study|Withdrawal by Subject|13
7983216|NCT03107026|12554311|FG001|Overall Study|Withdrawal by Subject|5
7983217|NCT03107026|12554312|FG002|Overall Study|Withdrawal by Subject|17
7983218|NCT03107026|12554310|FG000|Overall Study|non compliance with study visits|1
7983219|NCT03107026|12554311|FG001|Overall Study|non compliance with study visits|2
7983220|NCT03107026|12554312|FG002|Overall Study|non compliance with study visits|0
7983221|NCT03107026|12554310|FG000|Overall Study|non-compliance with study drug|2
7983222|NCT03107026|12554311|FG001|Overall Study|non-compliance with study drug|2
7983223|NCT03107026|12554312|FG002|Overall Study|non-compliance with study drug|3
7983224|NCT03107026|12554310|FG000|Overall Study|Physician Decision|0
7983225|NCT03107026|12554311|FG001|Overall Study|Physician Decision|1
7983226|NCT03107026|12554312|FG002|Overall Study|Physician Decision|0
7983227|NCT03107052|12554323|FG000|Overall Study|Adverse Event|6
7983228|NCT03107052|12554324|FG001|Overall Study|Adverse Event|1
7983229|NCT03107052|12554325|FG002|Overall Study|Adverse Event|2
7983230|NCT03107052|12554323|FG000|Overall Study|Withdrawal by Subject|9
7983231|NCT03107052|12554324|FG001|Overall Study|Withdrawal by Subject|5
7983232|NCT03107052|12554325|FG002|Overall Study|Withdrawal by Subject|8
7983233|NCT03107052|12554323|FG000|Overall Study|Protocol Violation|6
7983234|NCT03107052|12554324|FG001|Overall Study|Protocol Violation|0
7983235|NCT03107052|12554325|FG002|Overall Study|Protocol Violation|3
7983236|NCT03107052|12554323|FG000|Overall Study|Lost to Follow-up|4
7983237|NCT03107052|12554324|FG001|Overall Study|Lost to Follow-up|0
7983238|NCT03107052|12554325|FG002|Overall Study|Lost to Follow-up|1
7983239|NCT03107052|12554323|FG000|Overall Study|Lack of Efficacy|23
7983240|NCT03107052|12554324|FG001|Overall Study|Lack of Efficacy|7
7983241|NCT03107052|12554325|FG002|Overall Study|Lack of Efficacy|4
7983242|NCT03107052|12554323|FG000|Overall Study|Other than specified|4
7983243|NCT03107052|12554324|FG001|Overall Study|Other than specified|2
7983244|NCT03107052|12554325|FG002|Overall Study|Other than specified|0
7983245|NCT03107052|12554323|FG000|Overall Study|Study terminated due to futility|67
7983246|NCT03107052|12554324|FG001|Overall Study|Study terminated due to futility|31
7983247|NCT03107052|12554325|FG002|Overall Study|Study terminated due to futility|23
7983248|NCT03107091|12554333|FG000|Overall Study|Physician Decision|1
7983249|NCT03107377|12554340|FG000|Overall Study|Adverse Event|3
7983250|NCT03107377|12554341|FG001|Overall Study|Adverse Event|3
7983251|NCT03107377|12554340|FG000|Overall Study|Protocol Violation|9
7983252|NCT03107377|12554341|FG001|Overall Study|Protocol Violation|12
7983253|NCT03107377|12554340|FG000|Overall Study|Physician Decision|3
7983254|NCT03107377|12554341|FG001|Overall Study|Physician Decision|6
7983255|NCT03107377|12554340|FG000|Overall Study|Pregnancy|7
7983256|NCT03107377|12554341|FG001|Overall Study|Pregnancy|7
7983257|NCT03107377|12554340|FG000|Overall Study|Withdrawal by Subject|16
7983258|NCT03107377|12554341|FG001|Overall Study|Withdrawal by Subject|22
7983259|NCT03107377|12554340|FG000|Overall Study|Lost to Follow-up|37
7983260|NCT03107377|12554341|FG001|Overall Study|Lost to Follow-up|34
7983261|NCT03107377|12554340|FG000|Overall Study|Other reason not specified|16
7983262|NCT03107377|12554341|FG001|Overall Study|Other reason not specified|15
7983263|NCT03107715|12554349|FG000|Overall Study|did not deliver at the home hospital|4
7983264|NCT03107715|12554350|FG001|Overall Study|did not deliver at the home hospital|6
7983265|NCT03107715|12554349|FG000|Overall Study|infant stillborn|0
7983266|NCT03107715|12554350|FG001|Overall Study|infant stillborn|1
7983267|NCT03107793|12554365|FG000|Induction Period (16 Weeks)|Adverse Event|5
7983268|NCT03107793|12554366|FG001|Induction Period (16 Weeks)|Adverse Event|0
7983269|NCT03107793|12554367|FG002|Induction Period (16 Weeks)|Adverse Event|0
7983270|NCT03107793|12554365|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3
7983271|NCT03107793|12554366|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0
7983272|NCT03107793|12554367|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
7983273|NCT03107793|12554365|FG000|Induction Period (16 Weeks)|Physician Decision|1
7983274|NCT03107793|12554366|FG001|Induction Period (16 Weeks)|Physician Decision|0
7983275|NCT03107793|12554367|FG002|Induction Period (16 Weeks)|Physician Decision|0
7983276|NCT03107793|12554365|FG000|Induction Period (16 Weeks)|Progressive Disease|1
7983277|NCT03107793|12554366|FG001|Induction Period (16 Weeks)|Progressive Disease|0
7983278|NCT03107793|12554367|FG002|Induction Period (16 Weeks)|Progressive Disease|0
7983279|NCT03107793|12554365|FG000|Maintenance Period (16-48 Week)|Adverse Event|0
7983280|NCT03107793|12554366|FG001|Maintenance Period (16-48 Week)|Adverse Event|6
7983281|NCT03107793|12554367|FG002|Maintenance Period (16-48 Week)|Adverse Event|10
7983282|NCT03107793|12554365|FG000|Maintenance Period (16-48 Week)|Death|0
7983283|NCT03107793|12554366|FG001|Maintenance Period (16-48 Week)|Death|2
7983284|NCT03107793|12554367|FG002|Maintenance Period (16-48 Week)|Death|0
7983285|NCT03107793|12554365|FG000|Maintenance Period (16-48 Week)|Lack of Efficacy|0
7983286|NCT03107793|12554366|FG001|Maintenance Period (16-48 Week)|Lack of Efficacy|21
7983287|NCT03107793|12554367|FG002|Maintenance Period (16-48 Week)|Lack of Efficacy|8
7983288|NCT03107793|12554365|FG000|Maintenance Period (16-48 Week)|Lost to Follow-up|0
7983289|NCT03107793|12554366|FG001|Maintenance Period (16-48 Week)|Lost to Follow-up|1
7983290|NCT03107793|12554367|FG002|Maintenance Period (16-48 Week)|Lost to Follow-up|0
7983291|NCT03107793|12554365|FG000|Maintenance Period (16-48 Week)|Withdrawal by Subject|0
7983292|NCT03107793|12554366|FG001|Maintenance Period (16-48 Week)|Withdrawal by Subject|12
7983293|NCT03107793|12554367|FG002|Maintenance Period (16-48 Week)|Withdrawal by Subject|4
7983294|NCT03107793|12554365|FG000|Maintenance Period (16-48 Week)|Physician Decision|0
7983295|NCT03107793|12554366|FG001|Maintenance Period (16-48 Week)|Physician Decision|1
7983296|NCT03107793|12554367|FG002|Maintenance Period (16-48 Week)|Physician Decision|2
7983297|NCT03107793|12554365|FG000|Maintenance Period (16-48 Week)|Pregnancy|0
7983298|NCT03107793|12554366|FG001|Maintenance Period (16-48 Week)|Pregnancy|1
7983299|NCT03107793|12554367|FG002|Maintenance Period (16-48 Week)|Pregnancy|1
7983300|NCT03107793|12554365|FG000|Maintenance Period (16-48 Week)|Disease Relapse|0
7983301|NCT03107793|12554366|FG001|Maintenance Period (16-48 Week)|Disease Relapse|2
7983302|NCT03107793|12554367|FG002|Maintenance Period (16-48 Week)|Disease Relapse|1
7983303|NCT03107793|12554365|FG000|Maintenance Period (16-48 Week)|Progressive Disease|0
7983304|NCT03107793|12554366|FG001|Maintenance Period (16-48 Week)|Progressive Disease|0
7983305|NCT03107793|12554367|FG002|Maintenance Period (16-48 Week)|Progressive Disease|1
7983306|NCT03107793|12554365|FG000|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|0
7983307|NCT03107793|12554366|FG001|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|0
7983308|NCT03107793|12554367|FG002|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|1
7983309|NCT03108027|12554374|FG000|Period 1|Subject/Guardian Decision|0
7983310|NCT03108027|12554375|FG001|Period 1|Subject/Guardian Decision|0
7983311|NCT03108027|12554376|FG002|Period 1|Subject/Guardian Decision|0
7983312|NCT03108027|12554377|FG003|Period 1|Subject/Guardian Decision|2
7983313|NCT03108027|12554378|FG004|Period 1|Subject/Guardian Decision|0
7983314|NCT03108027|12554379|FG005|Period 1|Subject/Guardian Decision|0
7983315|NCT03108027|12554374|FG000|Period 3|Adverse Event|0
7983316|NCT03108027|12554375|FG001|Period 3|Adverse Event|1
7983317|NCT03108027|12554376|FG002|Period 3|Adverse Event|0
7983318|NCT03108027|12554377|FG003|Period 3|Adverse Event|0
7983319|NCT03108027|12554378|FG004|Period 3|Adverse Event|0
7983320|NCT03108027|12554379|FG005|Period 3|Adverse Event|0
7983321|NCT03108157|12554389|FG000|Overall Study|Protocol Violation|15
7983322|NCT03108157|12554390|FG001|Overall Study|Protocol Violation|4
7983323|NCT03108521|12554425|FG000|Overall Study|Lost to Follow-up|3
7983324|NCT03108521|12554426|FG001|Overall Study|Lost to Follow-up|0
7983325|NCT03108521|12554425|FG000|Overall Study|Lack of Efficacy|2
7983326|NCT03108521|12554426|FG001|Overall Study|Lack of Efficacy|0
7983327|NCT03108521|12554425|FG000|Overall Study|Physician Decision|4
7983328|NCT03108521|12554426|FG001|Overall Study|Physician Decision|0
7983329|NCT03108521|12554425|FG000|Overall Study|Adverse Event|3
7983330|NCT03108521|12554426|FG001|Overall Study|Adverse Event|0
7983331|NCT03109184|12554447|FG000|Overall Study|Lost to Follow-up|6
7983332|NCT03109184|12554448|FG001|Overall Study|Lost to Follow-up|6
7983333|NCT03109184|12554447|FG000|Overall Study|Withdrawal by Subject|1
7983334|NCT03109184|12554448|FG001|Overall Study|Withdrawal by Subject|1
7983335|NCT03110029|12554478|FG000|Overall Study|Withdrawal by Subject|1
7983336|NCT03110029|12554479|FG001|Overall Study|Withdrawal by Subject|1
7983337|NCT03110185|12554487|FG000|Overall Study|Death|0
7983338|NCT03110185|12554488|FG001|Overall Study|Death|1
7983339|NCT03110185|12554487|FG000|Overall Study|Withdrawal by Subject|2
7983340|NCT03110185|12554488|FG001|Overall Study|Withdrawal by Subject|7
7983341|NCT03110185|12554487|FG000|Overall Study|Time Constraints|0
7983342|NCT03110185|12554488|FG001|Overall Study|Time Constraints|6
7983343|NCT03110185|12554487|FG000|Overall Study|Conflict with care|5
7983344|NCT03110185|12554488|FG001|Overall Study|Conflict with care|12
7983345|NCT03110185|12554487|FG000|Overall Study|Protocol Violation|1
7983346|NCT03110185|12554488|FG001|Overall Study|Protocol Violation|4
7983347|NCT03110185|12554487|FG000|Overall Study|MRI Incompatible|2
7983348|NCT03110185|12554488|FG001|Overall Study|MRI Incompatible|0
7983349|NCT03110185|12554487|FG000|Overall Study|Patient Refusal|0
7983350|NCT03110185|12554488|FG001|Overall Study|Patient Refusal|1
7983351|NCT03110562|12554519|FG000|Overall Study|Withdrawal by Subject|37
7983352|NCT03110562|12554520|FG001|Overall Study|Withdrawal by Subject|35
7983353|NCT03110562|12554519|FG000|Overall Study|Death|47
7983354|NCT03110562|12554520|FG001|Overall Study|Death|61
7983355|NCT03110562|12554519|FG000|Overall Study|Lost to Follow-up|7
7983356|NCT03110562|12554520|FG001|Overall Study|Lost to Follow-up|6
7983357|NCT03110562|12554519|FG000|Overall Study|Other|2
7983358|NCT03110562|12554520|FG001|Overall Study|Other|1
7983359|NCT03110562|12554519|FG000|Overall Study|Randomized but never treated|0
7983360|NCT03110562|12554520|FG001|Overall Study|Randomized but never treated|3
7983361|NCT03110562|12554519|FG000|Overall Study|Ongoing|102
7983362|NCT03110562|12554520|FG001|Overall Study|Ongoing|101
7983363|NCT03110770|12554547|FG000|Overall Study|Death|1
7983364|NCT03110770|12554548|FG001|Overall Study|Death|0
7983365|NCT03110770|12554549|FG002|Overall Study|Death|0
7983366|NCT03110770|12554550|FG003|Overall Study|Death|1
7983367|NCT03110770|12554551|FG004|Overall Study|Death|0
7983368|NCT03110770|12554547|FG000|Overall Study|Enrolled but did not receive product|0
7983369|NCT03110770|12554548|FG001|Overall Study|Enrolled but did not receive product|0
7983370|NCT03110770|12554549|FG002|Overall Study|Enrolled but did not receive product|0
7983371|NCT03110770|12554550|FG003|Overall Study|Enrolled but did not receive product|8
7983372|NCT03110770|12554551|FG004|Overall Study|Enrolled but did not receive product|7
7983373|NCT03110770|12554547|FG000|Overall Study|Lost to Follow-up|0
7983374|NCT03110770|12554548|FG001|Overall Study|Lost to Follow-up|0
7983375|NCT03110770|12554549|FG002|Overall Study|Lost to Follow-up|0
7983376|NCT03110770|12554550|FG003|Overall Study|Lost to Follow-up|53
7983377|NCT03110770|12554551|FG004|Overall Study|Lost to Follow-up|45
7983378|NCT03110770|12554547|FG000|Overall Study|Investigator Decision|0
7983379|NCT03110770|12554548|FG001|Overall Study|Investigator Decision|0
7983380|NCT03110770|12554549|FG002|Overall Study|Investigator Decision|0
7983381|NCT03110770|12554550|FG003|Overall Study|Investigator Decision|5
7983382|NCT03110770|12554551|FG004|Overall Study|Investigator Decision|3
7983383|NCT03110770|12554547|FG000|Overall Study|Withdrawal by Subject|0
7983384|NCT03110770|12554548|FG001|Overall Study|Withdrawal by Subject|0
7983385|NCT03110770|12554549|FG002|Overall Study|Withdrawal by Subject|0
7983386|NCT03110770|12554550|FG003|Overall Study|Withdrawal by Subject|24
7983387|NCT03110770|12554551|FG004|Overall Study|Withdrawal by Subject|24
7983388|NCT03110770|12554547|FG000|Overall Study|Moved from area|5
7983389|NCT03110770|12554548|FG001|Overall Study|Moved from area|0
7983390|NCT03110770|12554549|FG002|Overall Study|Moved from area|2
7983391|NCT03110770|12554550|FG003|Overall Study|Moved from area|42
7983392|NCT03110770|12554551|FG004|Overall Study|Moved from area|43
7983393|NCT03110770|12554547|FG000|Overall Study|Illness/Injury unrelated to product|0
7983394|NCT03110770|12554548|FG001|Overall Study|Illness/Injury unrelated to product|0
7983395|NCT03110770|12554549|FG002|Overall Study|Illness/Injury unrelated to product|0
7983396|NCT03110770|12554550|FG003|Overall Study|Illness/Injury unrelated to product|0
7983397|NCT03110770|12554551|FG004|Overall Study|Illness/Injury unrelated to product|1
7983398|NCT03111108|12554567|FG000|Overall Study|Death|0
7983399|NCT03111108|12554568|FG001|Overall Study|Death|1
7983400|NCT03111108|12554567|FG000|Overall Study|Withdrawal by Subject|1
7983401|NCT03111108|12554568|FG001|Overall Study|Withdrawal by Subject|0
7983402|NCT03113916|12554679|FG000|Overall Study|Withdrawal by Subject|9
7983403|NCT03113916|12554680|FG001|Overall Study|Withdrawal by Subject|7
7983404|NCT03113916|12554679|FG000|Overall Study|Pregnancy|1
7983405|NCT03113916|12554680|FG001|Overall Study|Pregnancy|3
7983406|NCT03113916|12554679|FG000|Overall Study|Lost to Follow-up|1
7983407|NCT03113916|12554680|FG001|Overall Study|Lost to Follow-up|2
7983408|NCT03114488|12554700|FG000|Time Period 2|Withdrawal by Subject|1
7983409|NCT03114488|12554701|FG001|Time Period 2|Withdrawal by Subject|3
7983410|NCT03114657|12554713|FG000|Overall Study|Adverse Event|9
7983411|NCT03114657|12554714|FG001|Overall Study|Adverse Event|6
7983412|NCT03114657|12554713|FG000|Overall Study|Death|4
7983413|NCT03114657|12554714|FG001|Overall Study|Death|0
7983414|NCT03114657|12554713|FG000|Overall Study|Multiple Reasons|1
7983415|NCT03114657|12554714|FG001|Overall Study|Multiple Reasons|2
7983416|NCT03114657|12554713|FG000|Overall Study|Physician Decision|2
7983417|NCT03114657|12554714|FG001|Overall Study|Physician Decision|2
7983418|NCT03114657|12554713|FG000|Overall Study|Study Terminated By Sponsor|355
7983419|NCT03114657|12554714|FG001|Overall Study|Study Terminated By Sponsor|374
7983420|NCT03114657|12554713|FG000|Overall Study|Symptomatic Deterioration|0
7983421|NCT03114657|12554714|FG001|Overall Study|Symptomatic Deterioration|1
7983422|NCT03114657|12554713|FG000|Overall Study|Withdrawal by Subject|28
7983423|NCT03114657|12554714|FG001|Overall Study|Withdrawal by Subject|22
7983424|NCT03114969|12554734|FG000|Overall Study|Lost to Follow-up|0
7983425|NCT03114969|12554735|FG001|Overall Study|Lost to Follow-up|0
7983426|NCT03114969|12554736|FG002|Overall Study|Lost to Follow-up|3
7983427|NCT03114969|12554737|FG003|Overall Study|Lost to Follow-up|2
7983428|NCT03114969|12554738|FG004|Overall Study|Lost to Follow-up|0
7983429|NCT03114969|12554739|FG005|Overall Study|Lost to Follow-up|0
7983430|NCT03114969|12554740|FG006|Overall Study|Lost to Follow-up|0
7983431|NCT03114969|12554741|FG007|Overall Study|Lost to Follow-up|0
7983432|NCT03114969|12554742|FG008|Overall Study|Lost to Follow-up|0
7983433|NCT03114969|12554734|FG000|Overall Study|Adverse Event|0
7983434|NCT03114969|12554735|FG001|Overall Study|Adverse Event|0
7983435|NCT03114969|12554736|FG002|Overall Study|Adverse Event|1
7983436|NCT03114969|12554737|FG003|Overall Study|Adverse Event|0
7983437|NCT03114969|12554738|FG004|Overall Study|Adverse Event|0
7983438|NCT03114969|12554739|FG005|Overall Study|Adverse Event|1
7983439|NCT03114969|12554740|FG006|Overall Study|Adverse Event|1
7983440|NCT03114969|12554741|FG007|Overall Study|Adverse Event|0
7983441|NCT03114969|12554742|FG008|Overall Study|Adverse Event|2
7983442|NCT03115112|12554784|FG000|Overall Study|Adverse Event|5
7983443|NCT03115112|12554785|FG001|Overall Study|Adverse Event|1
7983444|NCT03115112|12554784|FG000|Overall Study|Withdrawal by Subject|4
7983445|NCT03115112|12554785|FG001|Overall Study|Withdrawal by Subject|2
7983446|NCT03115112|12554784|FG000|Overall Study|Lost to Follow-up|0
7983447|NCT03115112|12554785|FG001|Overall Study|Lost to Follow-up|1
7983448|NCT03115112|12554784|FG000|Overall Study|Death|1
7983449|NCT03115112|12554785|FG001|Overall Study|Death|0
7983450|NCT03115112|12554784|FG000|Overall Study|Pregnancy|1
7983451|NCT03115112|12554785|FG001|Overall Study|Pregnancy|0
7983452|NCT03115112|12554784|FG000|Overall Study|Site closure|1
7983453|NCT03115112|12554785|FG001|Overall Study|Site closure|1
7718074|NCT00524680|12141792|FG003|Overall Study|Other|3
7718075|NCT00524680|12141789|FG000|Overall Study|Withdrawal by Subject|1
7718076|NCT00524680|12141790|FG001|Overall Study|Withdrawal by Subject|0
7718077|NCT00524680|12141791|FG002|Overall Study|Withdrawal by Subject|1
7718078|NCT00524680|12141792|FG003|Overall Study|Withdrawal by Subject|1
7718079|NCT00524745|12141806|FG000|Overall Study|subject withdrawal or lost to follow up|34
7718080|NCT00524745|12141807|FG001|Overall Study|subject withdrawal or lost to follow up|13
7718081|NCT00524745|12141808|FG002|Overall Study|subject withdrawal or lost to follow up|29
7718082|NCT00524745|12141809|FG003|Overall Study|subject withdrawal or lost to follow up|22
7718083|NCT00524771|12141821|FG000|Overall Study|Protocol Violation|220
7718084|NCT00524771|12141822|FG001|Overall Study|Protocol Violation|585
7718085|NCT00525031|12141835|FG000|Overall Study|Disease Progression|1
7718086|NCT00525031|12141836|FG001|Overall Study|Disease Progression|1
7718087|NCT00525044|12141845|FG000|Overall Study|Lost to Follow-up|0
7718088|NCT00525044|12141846|FG001|Overall Study|Lost to Follow-up|1
7718089|NCT00525148|12141869|FG000|Overall Study|Other Adverse Event|3
7983454|NCT03115476|12554809|FG000|LP0084-1369|Death|1
7983455|NCT03115476|12554810|FG001|LP0084-1369|Death|0
7983456|NCT03115476|12554811|FG002|LP0084-1369|Death|2
7983457|NCT03115476|12554809|FG000|LP0084-1369|Trial terminated by Sponsor|190
7983458|NCT03115476|12554810|FG001|LP0084-1369|Trial terminated by Sponsor|210
7983459|NCT03115476|12554811|FG002|LP0084-1369|Trial terminated by Sponsor|160
7983460|NCT03116152|12554843|FG000|Overall Study|Disease Progression|49
7983461|NCT03116152|12554844|FG001|Overall Study|Disease Progression|47
7983462|NCT03116152|12554843|FG000|Overall Study|Death|5
7983463|NCT03116152|12554844|FG001|Overall Study|Death|2
7983464|NCT03116152|12554843|FG000|Overall Study|Adverse Event|21
7983465|NCT03116152|12554844|FG001|Overall Study|Adverse Event|7
7983466|NCT03116152|12554843|FG000|Overall Study|Protocol Violation|2
7983467|NCT03116152|12554844|FG001|Overall Study|Protocol Violation|2
7983468|NCT03116152|12554843|FG000|Overall Study|Withdrawal by Subject|0
7983469|NCT03116152|12554844|FG001|Overall Study|Withdrawal by Subject|1
7983470|NCT03116152|12554843|FG000|Overall Study|Physician Decision|3
7983471|NCT03116152|12554844|FG001|Overall Study|Physician Decision|2
7983472|NCT03116152|12554843|FG000|Overall Study|other|11
7983473|NCT03116152|12554844|FG001|Overall Study|other|34
7983474|NCT03116698|12554863|FG000|Overall Study|Adverse Event|1
7983475|NCT03116698|12554864|FG001|Overall Study|Adverse Event|1
7718090|NCT00525148|12141870|FG001|Overall Study|Other Adverse Event|5
7718091|NCT00525148|12141871|FG002|Overall Study|Other Adverse Event|1
7718092|NCT00525148|12141872|FG003|Overall Study|Other Adverse Event|8
7718093|NCT00525148|12141869|FG000|Overall Study|Progressive disease|18
7718094|NCT00525148|12141870|FG001|Overall Study|Progressive disease|30
7718095|NCT00525148|12141871|FG002|Overall Study|Progressive disease|6
7718096|NCT00525148|12141872|FG003|Overall Study|Progressive disease|49
7718097|NCT00525148|12141869|FG000|Overall Study|Refused continuation of study medication|0
7983476|NCT03116698|12554865|FG002|Overall Study|Adverse Event|1
7983477|NCT03116698|12554866|FG003|Overall Study|Adverse Event|0
7983478|NCT03116698|12554863|FG000|Overall Study|Withdrawal by Subject|1
7983479|NCT03116698|12554864|FG001|Overall Study|Withdrawal by Subject|4
7983480|NCT03116698|12554865|FG002|Overall Study|Withdrawal by Subject|5
7983481|NCT03116698|12554866|FG003|Overall Study|Withdrawal by Subject|2
7983482|NCT03116698|12554863|FG000|Overall Study|Lost to Follow-up|2
7983483|NCT03116698|12554864|FG001|Overall Study|Lost to Follow-up|0
7983484|NCT03116698|12554865|FG002|Overall Study|Lost to Follow-up|0
7983485|NCT03116698|12554866|FG003|Overall Study|Lost to Follow-up|0
7983486|NCT03116698|12554863|FG000|Overall Study|Physician Decision|1
7983487|NCT03116698|12554864|FG001|Overall Study|Physician Decision|1
7983488|NCT03116698|12554865|FG002|Overall Study|Physician Decision|0
7983489|NCT03116698|12554866|FG003|Overall Study|Physician Decision|0
7983490|NCT03116698|12554863|FG000|Overall Study|Protocol Violation|1
7983491|NCT03116698|12554864|FG001|Overall Study|Protocol Violation|0
7983492|NCT03116698|12554865|FG002|Overall Study|Protocol Violation|0
7983493|NCT03116698|12554866|FG003|Overall Study|Protocol Violation|0
7983494|NCT03116698|12554863|FG000|Overall Study|Death|0
7983495|NCT03116698|12554864|FG001|Overall Study|Death|0
7983496|NCT03116698|12554865|FG002|Overall Study|Death|2
7983497|NCT03116698|12554866|FG003|Overall Study|Death|0
7983498|NCT03116828|12554878|FG000|Overall Study|Adverse Event|1
7983499|NCT03116828|12554879|FG001|Overall Study|Adverse Event|10
7983500|NCT03116828|12554878|FG000|Overall Study|Withdrawal by Subject|4
7983501|NCT03116828|12554879|FG001|Overall Study|Withdrawal by Subject|8
7983502|NCT03116828|12554878|FG000|Overall Study|OTHER|3
7983503|NCT03116828|12554879|FG001|Overall Study|OTHER|3
7983504|NCT03117361|12554909|FG000|Overall Study|Progressive disease|5
7983505|NCT03117361|12554909|FG000|Overall Study|Death|1
7983506|NCT03117361|12554909|FG000|Overall Study|Physician Decision|2
7983507|NCT03117361|12554909|FG000|Overall Study|On study treatment at the end of study|1
7983508|NCT03117361|12554909|FG000|Overall Study|Treatment-related adverse event|1
7983509|NCT03117738|12554950|FG000|Overall Study|Withdrawal by Subject|3
7983510|NCT03117738|12554951|FG001|Overall Study|Withdrawal by Subject|1
7983511|NCT03117738|12554950|FG000|Overall Study|Lost to Follow-up|1
7983512|NCT03117738|12554951|FG001|Overall Study|Lost to Follow-up|4
7983513|NCT03118297|12554959|FG000|Overall Study|Lost to Follow-up|0
7983514|NCT03118297|12554960|FG001|Overall Study|Lost to Follow-up|2
7983515|NCT03118518|12554972|FG000|Overall Study|Early Exit after treatment|2
7983516|NCT03118518|12554973|FG001|Overall Study|Early Exit after treatment|8
7983517|NCT03118518|12554972|FG000|Overall Study|Early Exit after randomization but prior to treatment|4
7983518|NCT03118518|12554973|FG001|Overall Study|Early Exit after randomization but prior to treatment|3
7983519|NCT03118739|12554990|FG000|Overall Study|Physician Decision|0
7983520|NCT03118739|12554991|FG001|Overall Study|Physician Decision|1
7983521|NCT03118739|12554990|FG000|Overall Study|Withdrawal by Subject|5
7983522|NCT03118739|12554991|FG001|Overall Study|Withdrawal by Subject|3
7983523|NCT03118739|12554990|FG000|Overall Study|Lost to Follow-up|2
7983524|NCT03118739|12554991|FG001|Overall Study|Lost to Follow-up|0
7983525|NCT03118765|12555002|FG000|Overall Study|Withdrawal by Subject|0
7983526|NCT03118765|12555003|FG001|Overall Study|Withdrawal by Subject|0
7983527|NCT03118765|12555004|FG002|Overall Study|Withdrawal by Subject|1
7983528|NCT03118765|12555005|FG003|Overall Study|Withdrawal by Subject|0
7983529|NCT03118765|12555006|FG004|Overall Study|Withdrawal by Subject|0
7983530|NCT03118765|12555002|FG000|Overall Study|Adverse Event|1
7983531|NCT03118765|12555003|FG001|Overall Study|Adverse Event|1
7983532|NCT03118765|12555004|FG002|Overall Study|Adverse Event|1
7983533|NCT03118765|12555005|FG003|Overall Study|Adverse Event|1
7983534|NCT03118765|12555006|FG004|Overall Study|Adverse Event|1
7983535|NCT03118765|12555002|FG000|Overall Study|Non compliance with Study Procedures|0
7983536|NCT03118765|12555003|FG001|Overall Study|Non compliance with Study Procedures|0
7983537|NCT03118765|12555004|FG002|Overall Study|Non compliance with Study Procedures|0
7983538|NCT03118765|12555005|FG003|Overall Study|Non compliance with Study Procedures|1
7983539|NCT03118765|12555006|FG004|Overall Study|Non compliance with Study Procedures|0
7983540|NCT03118765|12555002|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0
7983541|NCT03118765|12555003|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1
7983542|NCT03118765|12555004|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1
7983543|NCT03118765|12555005|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0
7983544|NCT03118765|12555006|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0
7983545|NCT03118765|12555002|FG000|Overall Study|COPD Exacerbation|1
7983546|NCT03118765|12555003|FG001|Overall Study|COPD Exacerbation|0
7983547|NCT03118765|12555004|FG002|Overall Study|COPD Exacerbation|0
7983548|NCT03118765|12555005|FG003|Overall Study|COPD Exacerbation|1
7983549|NCT03118765|12555006|FG004|Overall Study|COPD Exacerbation|0
7983550|NCT03118765|12555002|FG000|Overall Study|Lost to Follow-up|1
7983551|NCT03118765|12555003|FG001|Overall Study|Lost to Follow-up|0
7983552|NCT03118765|12555004|FG002|Overall Study|Lost to Follow-up|1
7718098|NCT00525148|12141870|FG001|Overall Study|Refused continuation of study medication|2
7718099|NCT00525148|12141871|FG002|Overall Study|Refused continuation of study medication|0
7718100|NCT00525148|12141872|FG003|Overall Study|Refused continuation of study medication|1
7718101|NCT00525148|12141869|FG000|Overall Study|Other than stated|2
7718102|NCT00525148|12141870|FG001|Overall Study|Other than stated|1
7718103|NCT00525148|12141871|FG002|Overall Study|Other than stated|0
7718104|NCT00525148|12141872|FG003|Overall Study|Other than stated|3
7718105|NCT00525161|12141882|FG000|Overall Study|Adverse Event|1
7718106|NCT00525265|12141897|FG000|Overall Study|Protocol Violation|1
7718107|NCT00525265|12141898|FG001|Overall Study|Protocol Violation|0
7718108|NCT00525499|12141917|FG000|Overall Study|Lost to Follow-up|2
7718109|NCT00525499|12141918|FG001|Overall Study|Lost to Follow-up|4
7718110|NCT00525499|12141919|FG002|Overall Study|Lost to Follow-up|1
7718111|NCT00525499|12141920|FG003|Overall Study|Lost to Follow-up|4
7718112|NCT00525499|12141917|FG000|Overall Study|Adverse Event|0
7718113|NCT00525499|12141918|FG001|Overall Study|Adverse Event|1
7718114|NCT00525499|12141919|FG002|Overall Study|Adverse Event|0
7718115|NCT00525499|12141920|FG003|Overall Study|Adverse Event|1
7718116|NCT00525499|12141917|FG000|Overall Study|Withdrawal by Subject|5
7983553|NCT03118765|12555005|FG003|Overall Study|Lost to Follow-up|0
7983554|NCT03118765|12555006|FG004|Overall Study|Lost to Follow-up|0
7983555|NCT03118765|12555002|FG000|Overall Study|Sponsor Decision|1
7983556|NCT03118765|12555003|FG001|Overall Study|Sponsor Decision|0
7983557|NCT03118765|12555004|FG002|Overall Study|Sponsor Decision|1
7983558|NCT03118765|12555005|FG003|Overall Study|Sponsor Decision|0
7983559|NCT03118765|12555006|FG004|Overall Study|Sponsor Decision|1
7983560|NCT03118934|12555026|FG000|Overall Study|Adverse Event|0
7983561|NCT03118934|12555027|FG001|Overall Study|Adverse Event|0
7983562|NCT03118934|12555028|FG002|Overall Study|Adverse Event|0
7983563|NCT03118934|12555029|FG003|Overall Study|Adverse Event|0
7983564|NCT03118934|12555030|FG004|Overall Study|Adverse Event|0
7983565|NCT03118934|12555031|FG005|Overall Study|Adverse Event|1
7983566|NCT03118934|12555026|FG000|Overall Study|Physician Decision|0
7983567|NCT03118934|12555027|FG001|Overall Study|Physician Decision|0
7983568|NCT03118934|12555028|FG002|Overall Study|Physician Decision|0
7983569|NCT03118934|12555029|FG003|Overall Study|Physician Decision|0
7983570|NCT03118934|12555030|FG004|Overall Study|Physician Decision|0
7983571|NCT03118934|12555031|FG005|Overall Study|Physician Decision|1
7983572|NCT03118934|12555026|FG000|Overall Study|Discontinued prior to exposure|0
7983573|NCT03118934|12555027|FG001|Overall Study|Discontinued prior to exposure|1
7983574|NCT03118934|12555028|FG002|Overall Study|Discontinued prior to exposure|1
7983575|NCT03118934|12555029|FG003|Overall Study|Discontinued prior to exposure|1
7983576|NCT03118934|12555030|FG004|Overall Study|Discontinued prior to exposure|2
7983577|NCT03118934|12555031|FG005|Overall Study|Discontinued prior to exposure|0
7983578|NCT03118947|12555041|FG000|Overall Study|Adverse Event|7
7983579|NCT03118947|12555041|FG000|Overall Study|Death|3
7983580|NCT03118947|12555041|FG000|Overall Study|Lack of Efficacy|4
7983581|NCT03118947|12555041|FG000|Overall Study|Non-compliance with study drug|1
7983582|NCT03118947|12555041|FG000|Overall Study|Protocol Violation|2
7983583|NCT03118947|12555041|FG000|Overall Study|Withdrawal by Subject|3
7983584|NCT03118947|12555041|FG000|Overall Study|Withdrawal by caregiver|3
7983585|NCT03118947|12555041|FG000|Overall Study|Change in patient's living situation|4
7983586|NCT03118947|12555041|FG000|Overall Study|Lost to Follow-up|2
7983587|NCT03119610|12555091|FG000|Overall Study|Adverse Event|1
7983588|NCT03119610|12555092|FG001|Overall Study|Adverse Event|0
7983589|NCT03119610|12555091|FG000|Overall Study|Lost to Follow-up|0
7983590|NCT03119610|12555092|FG001|Overall Study|Lost to Follow-up|1
7983591|NCT03119688|12555123|FG000|Overall Study|Adverse Event|4
7983592|NCT03119701|12555142|FG000|6-day Dosing|Death|4
7983593|NCT03119701|12555143|FG001|6-day Dosing|Death|1
7983594|NCT03119701|12555142|FG000|6-day Dosing|Adverse Event|3
7983595|NCT03119701|12555143|FG001|6-day Dosing|Adverse Event|0
7983596|NCT03119701|12555142|FG000|6-day Dosing|Physician Decision|0
7983597|NCT03119701|12555143|FG001|6-day Dosing|Physician Decision|1
7983598|NCT03119701|12555142|FG000|6-day Dosing|Withdrawal by Subject|0
7983599|NCT03119701|12555143|FG001|6-day Dosing|Withdrawal by Subject|1
7983600|NCT03119701|12555142|FG000|Mid-term (Final) Follow-up at D90|Death|3
7983601|NCT03119701|12555143|FG001|Mid-term (Final) Follow-up at D90|Death|1
7983602|NCT03120013|12555165|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0
7983603|NCT03120013|12555166|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1
7983604|NCT03120351|12555174|FG000|Overall Study|Physician Decision|1
7983605|NCT03120351|12555175|FG001|Overall Study|Physician Decision|1
7983606|NCT03120520|12555185|FG000|Overall Study|Lost to Follow-up|1
7983607|NCT03120520|12555186|FG001|Overall Study|Lost to Follow-up|1
7983608|NCT03120520|12555187|FG002|Overall Study|Lost to Follow-up|1
7983609|NCT03120520|12555188|FG003|Overall Study|Lost to Follow-up|1
7983610|NCT03120520|12555185|FG000|Overall Study|Withdrawal by Subject|3
7983611|NCT03120520|12555186|FG001|Overall Study|Withdrawal by Subject|2
7983612|NCT03120520|12555187|FG002|Overall Study|Withdrawal by Subject|3
7983613|NCT03120520|12555188|FG003|Overall Study|Withdrawal by Subject|2
7983614|NCT03120520|12555185|FG000|Overall Study|Other|0
7983615|NCT03120520|12555186|FG001|Overall Study|Other|1
7983616|NCT03120520|12555187|FG002|Overall Study|Other|0
7983617|NCT03120520|12555188|FG003|Overall Study|Other|0
7983618|NCT03121950|12555248|FG000|Overall Study|Withdrawal by Subject|11
7983619|NCT03121950|12555249|FG001|Overall Study|Withdrawal by Subject|2
7983620|NCT03122145|12555259|FG000|Overall Study|Concurrent respiratory disease|3
7983621|NCT03122145|12555260|FG001|Overall Study|Concurrent respiratory disease|0
7983622|NCT03122171|12555266|FG000|Overall Study|Withdrawal by Subject|1
7983623|NCT03122184|12555272|FG000|Overall Study|Lost to Follow-up|4
7983624|NCT03122184|12555273|FG001|Overall Study|Lost to Follow-up|6
7983625|NCT03122184|12555272|FG000|Overall Study|Withdrawal by Subject|3
7983626|NCT03122184|12555273|FG001|Overall Study|Withdrawal by Subject|0
7983627|NCT03122184|12555272|FG000|Overall Study|Terminated due to cognitive problem|1
7983628|NCT03122184|12555273|FG001|Overall Study|Terminated due to cognitive problem|0
7983629|NCT03122223|12555283|FG000|Overall Study|Withdrawal by Subject|2
7983630|NCT03122223|12555284|FG001|Overall Study|Withdrawal by Subject|2
7983631|NCT03122223|12555285|FG002|Overall Study|Withdrawal by Subject|1
7983632|NCT03122223|12555286|FG003|Overall Study|Withdrawal by Subject|0
7983633|NCT03122223|12555283|FG000|Overall Study|Lost to Follow-up|0
7983634|NCT03122223|12555284|FG001|Overall Study|Lost to Follow-up|2
7983635|NCT03122223|12555285|FG002|Overall Study|Lost to Follow-up|2
7983636|NCT03122223|12555286|FG003|Overall Study|Lost to Follow-up|0
7983637|NCT03122223|12555283|FG000|Overall Study|Participant unable to adhere|1
7983638|NCT03122223|12555284|FG001|Overall Study|Participant unable to adhere|1
7983639|NCT03122223|12555285|FG002|Overall Study|Participant unable to adhere|1
7983640|NCT03122223|12555286|FG003|Overall Study|Participant unable to adhere|0
7983641|NCT03122457|12555296|FG000|Overall Study|Withdrawal by Subject|6
7983642|NCT03122535|12555300|FG000|Overall Study|Lost to Follow-up|68
7983643|NCT03122535|12555301|FG001|Overall Study|Lost to Follow-up|68
7983644|NCT03122535|12555300|FG000|Overall Study|Physician Decision|3
7983645|NCT03122535|12555301|FG001|Overall Study|Physician Decision|3
7983646|NCT03122535|12555300|FG000|Overall Study|Withdrawal by Subject|2
7983647|NCT03122535|12555301|FG001|Overall Study|Withdrawal by Subject|2
7983648|NCT03122548|12555307|FG000|Overall Study|Death|2
7983649|NCT03122548|12555307|FG000|Overall Study|Progression - subject went into hospice|1
7983650|NCT03122548|12555307|FG000|Overall Study|Study Terminated by Sponsor|2
7983651|NCT03122860|12555330|FG000|Overall Study|Discontinued Before Treatment|1
7983652|NCT03122860|12555331|FG001|Overall Study|Discontinued Before Treatment|1
7983653|NCT03122860|12555332|FG002|Overall Study|Discontinued Before Treatment|2
7983654|NCT03122860|12555333|FG003|Overall Study|Discontinued Before Treatment|0
7983655|NCT03122860|12555334|FG004|Overall Study|Discontinued Before Treatment|1
7983656|NCT03122860|12555335|FG005|Overall Study|Discontinued Before Treatment|0
7983657|NCT03122860|12555330|FG000|Overall Study|Adverse Event|1
7983658|NCT03122860|12555331|FG001|Overall Study|Adverse Event|0
7983659|NCT03122860|12555332|FG002|Overall Study|Adverse Event|1
7983660|NCT03122860|12555333|FG003|Overall Study|Adverse Event|1
7983661|NCT03122860|12555334|FG004|Overall Study|Adverse Event|0
7983662|NCT03122860|12555335|FG005|Overall Study|Adverse Event|0
7983663|NCT03122860|12555330|FG000|Overall Study|Lost to Follow-up|5
7983664|NCT03122860|12555331|FG001|Overall Study|Lost to Follow-up|2
7983665|NCT03122860|12555332|FG002|Overall Study|Lost to Follow-up|3
7983666|NCT03122860|12555333|FG003|Overall Study|Lost to Follow-up|3
7983667|NCT03122860|12555334|FG004|Overall Study|Lost to Follow-up|5
7983668|NCT03122860|12555335|FG005|Overall Study|Lost to Follow-up|4
7983669|NCT03122860|12555330|FG000|Overall Study|Subject Non-Compliance|0
7983670|NCT03122860|12555331|FG001|Overall Study|Subject Non-Compliance|0
7983671|NCT03122860|12555332|FG002|Overall Study|Subject Non-Compliance|1
7983672|NCT03122860|12555333|FG003|Overall Study|Subject Non-Compliance|0
7983673|NCT03122860|12555334|FG004|Overall Study|Subject Non-Compliance|0
7983674|NCT03122860|12555335|FG005|Overall Study|Subject Non-Compliance|0
7983675|NCT03122860|12555330|FG000|Overall Study|Withdrawal by Subject|3
7983676|NCT03122860|12555331|FG001|Overall Study|Withdrawal by Subject|2
7983677|NCT03122860|12555332|FG002|Overall Study|Withdrawal by Subject|5
7983678|NCT03122860|12555333|FG003|Overall Study|Withdrawal by Subject|7
7983679|NCT03122860|12555334|FG004|Overall Study|Withdrawal by Subject|9
7983680|NCT03122860|12555335|FG005|Overall Study|Withdrawal by Subject|8
7983681|NCT03123120|12555366|FG000|Overall Study|Lost to Follow-up|0
7983682|NCT03123120|12555367|FG001|Overall Study|Lost to Follow-up|1
7983683|NCT03123120|12555366|FG000|Overall Study|Withdrawal by Subject|0
7983684|NCT03123120|12555367|FG001|Overall Study|Withdrawal by Subject|1
7983685|NCT03123354|12555382|FG000|Overall Study|Physician Decision|6
7983686|NCT03123471|12555388|FG000|Placebo-controlled Phase|Adverse Event|3
7983687|NCT03123471|12555389|FG001|Placebo-controlled Phase|Adverse Event|8
7983688|NCT03123471|12555388|FG000|Placebo-controlled Phase|Lack of Efficacy|3
7983689|NCT03123471|12555389|FG001|Placebo-controlled Phase|Lack of Efficacy|4
7983690|NCT03123471|12555388|FG000|Placebo-controlled Phase|Withdrawal by Subject|6
7983691|NCT03123471|12555389|FG001|Placebo-controlled Phase|Withdrawal by Subject|16
7983692|NCT03123471|12555388|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3
7983693|NCT03123471|12555389|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0
7983694|NCT03123471|12555388|FG000|Placebo-controlled Phase|Lost to Follow-up|1
7983695|NCT03123471|12555389|FG001|Placebo-controlled Phase|Lost to Follow-up|3
7983696|NCT03123471|12555388|FG000|Placebo-controlled Phase|Protocol Deviation|2
7983697|NCT03123471|12555389|FG001|Placebo-controlled Phase|Protocol Deviation|1
7983698|NCT03123471|12555388|FG000|Placebo-controlled Phase|Miscellaneous|0
7983699|NCT03123471|12555389|FG001|Placebo-controlled Phase|Miscellaneous|1
7983700|NCT03123471|12555388|FG000|Apremilast Extension Phase|Lost to Follow-up|2
7983701|NCT03123471|12555389|FG001|Apremilast Extension Phase|Lost to Follow-up|5
7983702|NCT03123471|12555388|FG000|Apremilast Extension Phase|Adverse Event|1
7983703|NCT03123471|12555389|FG001|Apremilast Extension Phase|Adverse Event|5
7983704|NCT03123471|12555388|FG000|Apremilast Extension Phase|Lack of Efficacy|2
7983705|NCT03123471|12555389|FG001|Apremilast Extension Phase|Lack of Efficacy|8
7983706|NCT03123471|12555388|FG000|Apremilast Extension Phase|Withdrawal by Subject|3
7983707|NCT03123471|12555389|FG001|Apremilast Extension Phase|Withdrawal by Subject|7
7983708|NCT03123588|12555403|FG000|Overall Study|Study Terminated by Sponsor|2
7983709|NCT03123588|12555404|FG001|Overall Study|Study Terminated by Sponsor|5
7983710|NCT03123588|12555403|FG000|Overall Study|Withdrawal by Subject|1
7983711|NCT03123588|12555404|FG001|Overall Study|Withdrawal by Subject|0
7983712|NCT03123588|12555403|FG000|Overall Study|Adverse Event|1
7983713|NCT03123588|12555404|FG001|Overall Study|Adverse Event|0
7983714|NCT03123588|12555403|FG000|Overall Study|Physician Decision|2
7983715|NCT03123588|12555404|FG001|Overall Study|Physician Decision|1
7983716|NCT03123861|12555428|FG000|Overall Study|Protocol Violation|1
7983717|NCT03123861|12555429|FG001|Overall Study|Protocol Violation|1
7983718|NCT03123861|12555428|FG000|Overall Study|Withdrawal by Subject|2
7983719|NCT03123861|12555429|FG001|Overall Study|Withdrawal by Subject|2
7983720|NCT03123939|12555448|FG000|Overall Study|Lack of Efficacy|6
7983721|NCT03123939|12555448|FG000|Overall Study|Death|5
7983722|NCT03123939|12555448|FG000|Overall Study|Physician Decision|2
7983723|NCT03123939|12555448|FG000|Overall Study|Subject/guardian decision|2
7983724|NCT03123939|12555448|FG000|Overall Study|Lost to Follow-up|1
7983725|NCT03123939|12555448|FG000|Overall Study|New therapy for study indication|1
7983726|NCT03123939|12555448|FG000|Overall Study|Protocol deviation|1
7983727|NCT03123939|12555448|FG000|Overall Study|Progressive disease|18
7983728|NCT03123939|12555448|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4
7983729|NCT03123939|12555448|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1
7983730|NCT03124108|12555461|FG000|Overall Study|Adverse Event|0
7983731|NCT03124108|12555462|FG001|Overall Study|Adverse Event|1
7983732|NCT03124108|12555463|FG002|Overall Study|Adverse Event|0
7983733|NCT03124199|12555484|FG000|Overall Study|Lost to Follow-up|4
7983734|NCT03124381|12555514|FG000|Overall Study|Lost to Follow-up|1
7983735|NCT03124381|12555515|FG001|Overall Study|Lost to Follow-up|1
7983736|NCT03124381|12555514|FG000|Overall Study|Withdrawal by Subject|6
7983737|NCT03124381|12555515|FG001|Overall Study|Withdrawal by Subject|3
7983738|NCT03124381|12555514|FG000|Overall Study|Protocol Violation|0
7983739|NCT03124381|12555515|FG001|Overall Study|Protocol Violation|1
7983740|NCT03124381|12555514|FG000|Overall Study|Adverse Event|1
7983741|NCT03124381|12555515|FG001|Overall Study|Adverse Event|1
7983742|NCT03124381|12555514|FG000|Overall Study|Non-Compliance with Study Treatment|1
7983743|NCT03124381|12555515|FG001|Overall Study|Non-Compliance with Study Treatment|0
7983744|NCT03124407|12555525|FG000|Overall Study|Lost to Follow-up|1
7983745|NCT03124407|12555526|FG001|Overall Study|Lost to Follow-up|0
7983746|NCT03124407|12555527|FG002|Overall Study|Lost to Follow-up|0
7983747|NCT03124407|12555528|FG003|Overall Study|Lost to Follow-up|0
7983748|NCT03124407|12555525|FG000|Overall Study|Adverse Event|0
7983749|NCT03124407|12555526|FG001|Overall Study|Adverse Event|0
7983750|NCT03124407|12555527|FG002|Overall Study|Adverse Event|1
7983751|NCT03124407|12555528|FG003|Overall Study|Adverse Event|0
7983752|NCT03124537|12555544|FG000|Overall Study|Lost to Follow-up|3
7983753|NCT03124537|12555545|FG001|Overall Study|Lost to Follow-up|5
7983754|NCT03124537|12555544|FG000|Overall Study|App Crash, Incomplete Data|7
7983755|NCT03124537|12555545|FG001|Overall Study|App Crash, Incomplete Data|8
7983756|NCT03124563|12555557|FG000|Overall Study|Lost to Follow-up|1
7983757|NCT03124563|12555558|FG001|Overall Study|Lost to Follow-up|1
7983758|NCT03124563|12555557|FG000|Overall Study|Withdrawal by Subject|1
7983759|NCT03124563|12555558|FG001|Overall Study|Withdrawal by Subject|1
7983760|NCT03124784|12555580|FG000|Overall Study|Adverse Event|1
7983761|NCT03124784|12555580|FG000|Overall Study|Computer/Equip Malfunction|1
7983762|NCT03125200|12555633|FG000|Overall Study|Study Termination|0
7983763|NCT03125200|12555634|FG001|Overall Study|Study Termination|0
7983764|NCT03125200|12555635|FG002|Overall Study|Study Termination|0
7983765|NCT03125200|12555636|FG003|Overall Study|Study Termination|1
7983766|NCT03125200|12555637|FG004|Overall Study|Study Termination|1
7983767|NCT03125200|12555638|FG005|Overall Study|Study Termination|2
7983768|NCT03125200|12555639|FG006|Overall Study|Study Termination|1
7983769|NCT03125200|12555633|FG000|Overall Study|Clinical Progression|0
7983770|NCT03125200|12555634|FG001|Overall Study|Clinical Progression|0
7983771|NCT03125200|12555635|FG002|Overall Study|Clinical Progression|0
7983772|NCT03125200|12555636|FG003|Overall Study|Clinical Progression|1
7983773|NCT03125200|12555637|FG004|Overall Study|Clinical Progression|0
7983774|NCT03125200|12555638|FG005|Overall Study|Clinical Progression|1
7983775|NCT03125200|12555639|FG006|Overall Study|Clinical Progression|0
7983776|NCT03125200|12555633|FG000|Overall Study|Progressive Disease|2
7983777|NCT03125200|12555634|FG001|Overall Study|Progressive Disease|1
7983778|NCT03125200|12555635|FG002|Overall Study|Progressive Disease|2
7983779|NCT03125200|12555636|FG003|Overall Study|Progressive Disease|1
7983780|NCT03125200|12555637|FG004|Overall Study|Progressive Disease|2
7983781|NCT03125200|12555638|FG005|Overall Study|Progressive Disease|0
7983782|NCT03125200|12555639|FG006|Overall Study|Progressive Disease|1
7983783|NCT03125200|12555633|FG000|Overall Study|Lack of Efficacy|0
7983784|NCT03125200|12555634|FG001|Overall Study|Lack of Efficacy|0
7983785|NCT03125200|12555635|FG002|Overall Study|Lack of Efficacy|0
7983786|NCT03125200|12555636|FG003|Overall Study|Lack of Efficacy|1
7983787|NCT03125200|12555637|FG004|Overall Study|Lack of Efficacy|0
7983788|NCT03125200|12555638|FG005|Overall Study|Lack of Efficacy|0
7983789|NCT03125200|12555639|FG006|Overall Study|Lack of Efficacy|0
7983790|NCT03125200|12555633|FG000|Overall Study|Toxicity|0
7983791|NCT03125200|12555634|FG001|Overall Study|Toxicity|0
7983792|NCT03125200|12555635|FG002|Overall Study|Toxicity|0
7983793|NCT03125200|12555636|FG003|Overall Study|Toxicity|1
7983794|NCT03125200|12555637|FG004|Overall Study|Toxicity|0
7983795|NCT03125200|12555638|FG005|Overall Study|Toxicity|0
7983796|NCT03125200|12555639|FG006|Overall Study|Toxicity|0
7983797|NCT03125200|12555633|FG000|Overall Study|Consent Withdrawn by Subject|0
7983798|NCT03125200|12555634|FG001|Overall Study|Consent Withdrawn by Subject|1
7983799|NCT03125200|12555635|FG002|Overall Study|Consent Withdrawn by Subject|0
7983800|NCT03125200|12555636|FG003|Overall Study|Consent Withdrawn by Subject|0
7983801|NCT03125200|12555637|FG004|Overall Study|Consent Withdrawn by Subject|1
7983802|NCT03125200|12555638|FG005|Overall Study|Consent Withdrawn by Subject|0
7983803|NCT03125200|12555639|FG006|Overall Study|Consent Withdrawn by Subject|1
7983804|NCT03125395|12555662|FG000|Overall Study|Adverse Event|2
7983805|NCT03125395|12555662|FG000|Overall Study|Withdrawal of consent (not due to AE)|1
7983806|NCT03125395|12555662|FG000|Overall Study|Physician Decision|2
7983807|NCT03125395|12555662|FG000|Overall Study|Commercial drug is available|5
7983808|NCT03125629|12555666|FG000|Overall Study|Withdrawal by Subject|2
7983809|NCT03125629|12555666|FG000|Overall Study|Equipment malfunction|1
7983810|NCT03125915|12555682|FG000|1 Month Follow up|Lost to Follow-up|3
7983811|NCT03125915|12555683|FG001|1 Month Follow up|Lost to Follow-up|3
7983812|NCT03125915|12555684|FG002|1 Month Follow up|Lost to Follow-up|2
7983813|NCT03125915|12555685|FG003|1 Month Follow up|Lost to Follow-up|3
7983814|NCT03125915|12555682|FG000|3 Month Follow-up|Lost to Follow-up|6
7983815|NCT03125915|12555683|FG001|3 Month Follow-up|Lost to Follow-up|4
7983816|NCT03125915|12555684|FG002|3 Month Follow-up|Lost to Follow-up|4
7983817|NCT03125915|12555685|FG003|3 Month Follow-up|Lost to Follow-up|2
7983818|NCT03125915|12555682|FG000|6 Month Follow-up|Lost to Follow-up|7
7983819|NCT03125915|12555683|FG001|6 Month Follow-up|Lost to Follow-up|3
7983820|NCT03125915|12555684|FG002|6 Month Follow-up|Lost to Follow-up|6
7983821|NCT03125915|12555685|FG003|6 Month Follow-up|Lost to Follow-up|3
7983822|NCT03125941|12555697|FG000|Overall Study|did not receive intervention|1
7983823|NCT03125941|12555698|FG001|Overall Study|did not receive intervention|2
7983824|NCT03126227|12555706|FG000|Overall Study|Adverse Event|43
7983825|NCT03126227|12555707|FG001|Overall Study|Adverse Event|4
7983826|NCT03126227|12555706|FG000|Overall Study|Death|0
7983827|NCT03126227|12555707|FG001|Overall Study|Death|1
7983828|NCT03126227|12555706|FG000|Overall Study|Lost to Follow-up|0
7983829|NCT03126227|12555707|FG001|Overall Study|Lost to Follow-up|1
7983830|NCT03126227|12555706|FG000|Overall Study|Physician Decision|2
7983831|NCT03126227|12555707|FG001|Overall Study|Physician Decision|0
7983832|NCT03126227|12555706|FG000|Overall Study|Protocol Violation|1
7983833|NCT03126227|12555707|FG001|Overall Study|Protocol Violation|0
7983834|NCT03126227|12555706|FG000|Overall Study|Withdrawal by Subject|19
7983835|NCT03126227|12555707|FG001|Overall Study|Withdrawal by Subject|3
7983836|NCT03126227|12555706|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8
7983837|NCT03126227|12555707|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1
7983838|NCT03126227|12555706|FG000|Overall Study|Lack of dosing compliance|2
7983839|NCT03126227|12555707|FG001|Overall Study|Lack of dosing compliance|0
7983840|NCT03126227|12555706|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2
7983841|NCT03126227|12555707|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0
7983842|NCT03126227|12555706|FG000|Overall Study|Scheduling conflict|1
7983843|NCT03126227|12555707|FG001|Overall Study|Scheduling conflict|0
7983844|NCT03126344|12555716|FG000|Overall Study|Lost to Follow-up|0
7983845|NCT03126344|12555717|FG001|Overall Study|Lost to Follow-up|0
7983846|NCT03126344|12555718|FG002|Overall Study|Lost to Follow-up|5
7983847|NCT03126786|12555767|FG000|Overall Study|Adverse Event|3
7983848|NCT03126786|12555768|FG001|Overall Study|Adverse Event|0
7983849|NCT03126786|12555767|FG000|Overall Study|Lost to Follow-up|0
7983850|NCT03126786|12555768|FG001|Overall Study|Lost to Follow-up|1
7983851|NCT03126786|12555767|FG000|Overall Study|Withdrawal by Subject|3
7983852|NCT03126786|12555768|FG001|Overall Study|Withdrawal by Subject|1
7983853|NCT03127644|12555814|FG000|Overall Study|Study-specific withdrawal criteria|0
7983854|NCT03127644|12555815|FG001|Overall Study|Study-specific withdrawal criteria|0
7983855|NCT03127644|12555816|FG002|Overall Study|Study-specific withdrawal criteria|2
7983856|NCT03128099|12555854|FG000|Overall Study|High dose task was too long|0
7983857|NCT03128099|12555855|FG001|Overall Study|High dose task was too long|4
7983858|NCT03128099|12555856|FG002|Overall Study|High dose task was too long|0
7983859|NCT03128099|12555854|FG000|Overall Study|Participant got a full time job.|1
7983860|NCT03128099|12555855|FG001|Overall Study|Participant got a full time job.|0
7983861|NCT03128099|12555856|FG002|Overall Study|Participant got a full time job.|0
7983862|NCT03128099|12555854|FG000|Overall Study|Became homeless and lost contact|1
7983863|NCT03128099|12555855|FG001|Overall Study|Became homeless and lost contact|0
7983864|NCT03128099|12555856|FG002|Overall Study|Became homeless and lost contact|0
7983865|NCT03128099|12555854|FG000|Overall Study|Did not complete all the assessments|0
7983866|NCT03128099|12555855|FG001|Overall Study|Did not complete all the assessments|0
7983867|NCT03128099|12555856|FG002|Overall Study|Did not complete all the assessments|1
7983868|NCT03128307|12555862|FG000|Overall Study|Lost to Follow-up|29
7983869|NCT03128307|12555862|FG000|Overall Study|Withdrawal by Subject|5
7983870|NCT03128723|12555870|FG000|Overall Study|Withdrawal by Subject|2
7983871|NCT03128892|12555874|FG000|Overall Study|Withdrawal by Subject|2
7983872|NCT03128892|12555874|FG000|Overall Study|Physician Decision|1
7983873|NCT03130257|12555904|FG000|Overall Study|Withdrawal by Subject|1
7983874|NCT03130257|12555905|FG001|Overall Study|Withdrawal by Subject|0
7983875|NCT03130257|12555906|FG002|Overall Study|Withdrawal by Subject|2
7983876|NCT03131167|12555940|FG000|Overall Study|Other (Unspecified)|0
7983877|NCT03131167|12555941|FG001|Overall Study|Other (Unspecified)|0
7983878|NCT03131167|12555942|FG002|Overall Study|Other (Unspecified)|0
7983879|NCT03131167|12555943|FG003|Overall Study|Other (Unspecified)|0
7983880|NCT03131167|12555944|FG004|Overall Study|Other (Unspecified)|0
7983881|NCT03131167|12555945|FG005|Overall Study|Other (Unspecified)|1
7983882|NCT03131167|12555946|FG006|Overall Study|Other (Unspecified)|0
7983883|NCT03131167|12555947|FG007|Overall Study|Other (Unspecified)|0
7983884|NCT03131167|12555948|FG008|Overall Study|Other (Unspecified)|0
7983885|NCT03131167|12555949|FG009|Overall Study|Other (Unspecified)|0
7983886|NCT03131167|12555950|FG010|Overall Study|Other (Unspecified)|0
7983887|NCT03131167|12555951|FG011|Overall Study|Other (Unspecified)|0
7983888|NCT03131167|12555952|FG012|Overall Study|Other (Unspecified)|0
7983889|NCT03131453|12556005|FG000|Overall Study|Study terminated by Sponsor|424
7983890|NCT03131453|12556006|FG001|Overall Study|Study terminated by Sponsor|222
7983891|NCT03131453|12556007|FG002|Overall Study|Study terminated by Sponsor|438
7983892|NCT03131453|12556005|FG000|Overall Study|Withdrawal by Subject|18
7983893|NCT03131453|12556006|FG001|Overall Study|Withdrawal by Subject|7
7983894|NCT03131453|12556007|FG002|Overall Study|Withdrawal by Subject|13
7983895|NCT03131453|12556005|FG000|Overall Study|Adverse Event|10
7983896|NCT03131453|12556006|FG001|Overall Study|Adverse Event|3
7983897|NCT03131453|12556007|FG002|Overall Study|Adverse Event|3
7983898|NCT03131453|12556005|FG000|Overall Study|Lost to Follow-up|1
7983899|NCT03131453|12556006|FG001|Overall Study|Lost to Follow-up|0
7983900|NCT03131453|12556007|FG002|Overall Study|Lost to Follow-up|1
7983901|NCT03131453|12556005|FG000|Overall Study|Physician Decision|1
7983902|NCT03131453|12556006|FG001|Overall Study|Physician Decision|0
7983903|NCT03131453|12556007|FG002|Overall Study|Physician Decision|1
7983904|NCT03131453|12556005|FG000|Overall Study|Non-compliance with study treatment|1
7983905|NCT03131453|12556006|FG001|Overall Study|Non-compliance with study treatment|0
7983906|NCT03131453|12556007|FG002|Overall Study|Non-compliance with study treatment|0
7983907|NCT03131453|12556005|FG000|Overall Study|Technical problems|1
7983908|NCT03131453|12556006|FG001|Overall Study|Technical problems|0
7983909|NCT03131453|12556007|FG002|Overall Study|Technical problems|0
7983910|NCT03131453|12556005|FG000|Overall Study|Protocol deviation|0
7983911|NCT03131453|12556006|FG001|Overall Study|Protocol deviation|1
7983912|NCT03131453|12556007|FG002|Overall Study|Protocol deviation|0
7983913|NCT03131479|12556020|FG000|Overall Study|Adverse Event|0
7983914|NCT03131479|12556021|FG001|Overall Study|Adverse Event|0
7983915|NCT03131479|12556022|FG002|Overall Study|Adverse Event|1
7983916|NCT03131479|12556023|FG003|Overall Study|Adverse Event|1
7983917|NCT03131479|12556024|FG004|Overall Study|Adverse Event|0
7983918|NCT03131479|12556020|FG000|Overall Study|Subject/Guardian Decision|0
7983919|NCT03131479|12556021|FG001|Overall Study|Subject/Guardian Decision|0
7983920|NCT03131479|12556022|FG002|Overall Study|Subject/Guardian Decision|0
7983921|NCT03131479|12556023|FG003|Overall Study|Subject/Guardian Decision|1
7983922|NCT03131479|12556024|FG004|Overall Study|Subject/Guardian Decision|0
7983923|NCT03131570|12556038|FG000|Overall Study|Adverse Event|1
7983924|NCT03131570|12556039|FG001|Overall Study|Adverse Event|0
7983925|NCT03131596|12556047|FG000|Overall Study|Protocol Violation|3
7983926|NCT03131596|12556048|FG001|Overall Study|Protocol Violation|3
7983927|NCT03131596|12556047|FG000|Overall Study|Lost to Follow-up|3
7983928|NCT03131596|12556048|FG001|Overall Study|Lost to Follow-up|0
7983929|NCT03131648|12556056|FG000|Initial Treatment Period|Not dosed|2
7983930|NCT03131648|12556057|FG001|Initial Treatment Period|Not dosed|2
7983931|NCT03131648|12556058|FG002|Initial Treatment Period|Not dosed|0
7983932|NCT03131648|12556059|FG003|Initial Treatment Period|Not dosed|0
7983933|NCT03131648|12556060|FG004|Initial Treatment Period|Not dosed|0
7983934|NCT03131648|12556061|FG005|Initial Treatment Period|Not dosed|0
7983935|NCT03131648|12556062|FG006|Initial Treatment Period|Not dosed|0
7983936|NCT03131648|12556063|FG007|Initial Treatment Period|Not dosed|0
7983937|NCT03131648|12556056|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51
7983938|NCT03131648|12556057|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18
7983939|NCT03131648|12556058|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0
7983940|NCT03131648|12556059|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0
7983941|NCT03131648|12556060|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0
7983942|NCT03131648|12556061|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0
7983943|NCT03131648|12556062|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0
7983944|NCT03131648|12556063|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0
7983945|NCT03131648|12556056|FG000|Open-label Treatment|Discontinued IMP|0
7983946|NCT03131648|12556057|FG001|Open-label Treatment|Discontinued IMP|0
7983947|NCT03131648|12556058|FG002|Open-label Treatment|Discontinued IMP|0
7983948|NCT03131648|12556059|FG003|Open-label Treatment|Discontinued IMP|0
7983949|NCT03131648|12556060|FG004|Open-label Treatment|Discontinued IMP|0
7983950|NCT03131648|12556061|FG005|Open-label Treatment|Discontinued IMP|0
7983951|NCT03131648|12556062|FG006|Open-label Treatment|Discontinued IMP|112
7983952|NCT03131648|12556063|FG007|Open-label Treatment|Discontinued IMP|0
7983953|NCT03131648|12556056|FG000|Open-label Treatment|Completed Week 50|0
7983954|NCT03131648|12556057|FG001|Open-label Treatment|Completed Week 50|0
7983955|NCT03131648|12556058|FG002|Open-label Treatment|Completed Week 50|0
7983956|NCT03131648|12556059|FG003|Open-label Treatment|Completed Week 50|0
7983957|NCT03131648|12556060|FG004|Open-label Treatment|Completed Week 50|0
7983958|NCT03131648|12556061|FG005|Open-label Treatment|Completed Week 50|0
7983959|NCT03131648|12556062|FG006|Open-label Treatment|Completed Week 50|6
7983960|NCT03131648|12556063|FG007|Open-label Treatment|Completed Week 50|0
7983961|NCT03131648|12556056|FG000|Maintenance Treatment Period|Not dosed|0
7983962|NCT03131648|12556057|FG001|Maintenance Treatment Period|Not dosed|0
7983963|NCT03131648|12556058|FG002|Maintenance Treatment Period|Not dosed|3
7983964|NCT03131648|12556059|FG003|Maintenance Treatment Period|Not dosed|2
7983965|NCT03131648|12556060|FG004|Maintenance Treatment Period|Not dosed|1
7983966|NCT03131648|12556061|FG005|Maintenance Treatment Period|Not dosed|0
7983967|NCT03131648|12556062|FG006|Maintenance Treatment Period|Not dosed|0
7983968|NCT03131648|12556063|FG007|Maintenance Treatment Period|Not dosed|0
7983969|NCT03131648|12556056|FG000|Maintenance Treatment Period|Discontinued IMP|0
7983970|NCT03131648|12556057|FG001|Maintenance Treatment Period|Discontinued IMP|0
7983971|NCT03131648|12556058|FG002|Maintenance Treatment Period|Discontinued IMP|3
7983972|NCT03131648|12556059|FG003|Maintenance Treatment Period|Discontinued IMP|5
7983973|NCT03131648|12556060|FG004|Maintenance Treatment Period|Discontinued IMP|4
7983974|NCT03131648|12556061|FG005|Maintenance Treatment Period|Discontinued IMP|4
7983975|NCT03131648|12556062|FG006|Maintenance Treatment Period|Discontinued IMP|0
7983976|NCT03131648|12556063|FG007|Maintenance Treatment Period|Discontinued IMP|0
7983977|NCT03131648|12556056|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0
7983978|NCT03131648|12556057|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0
7983979|NCT03131648|12556058|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21
7983980|NCT03131648|12556059|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18
7983981|NCT03131648|12556060|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9
7983982|NCT03131648|12556061|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10
7983983|NCT03131648|12556062|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0
7983984|NCT03131648|12556063|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0
7983985|NCT03131648|12556056|FG000|Maintenance Treatment Period|Completed Week 50|0
7983986|NCT03131648|12556057|FG001|Maintenance Treatment Period|Completed Week 50|0
7983987|NCT03131648|12556058|FG002|Maintenance Treatment Period|Completed Week 50|0
7983988|NCT03131648|12556059|FG003|Maintenance Treatment Period|Completed Week 50|0
7983989|NCT03131648|12556060|FG004|Maintenance Treatment Period|Completed Week 50|1
7983990|NCT03131648|12556061|FG005|Maintenance Treatment Period|Completed Week 50|0
7983991|NCT03131648|12556062|FG006|Maintenance Treatment Period|Completed Week 50|0
7983992|NCT03131648|12556063|FG007|Maintenance Treatment Period|Completed Week 50|0
7983993|NCT03131648|12556056|FG000|Open-label (Short Term Extension)|Discontinued IMP|0
7983994|NCT03131648|12556057|FG001|Open-label (Short Term Extension)|Discontinued IMP|0
7983995|NCT03131648|12556058|FG002|Open-label (Short Term Extension)|Discontinued IMP|0
7983996|NCT03131648|12556059|FG003|Open-label (Short Term Extension)|Discontinued IMP|0
7983997|NCT03131648|12556060|FG004|Open-label (Short Term Extension)|Discontinued IMP|0
7983998|NCT03131648|12556061|FG005|Open-label (Short Term Extension)|Discontinued IMP|0
7983999|NCT03131648|12556062|FG006|Open-label (Short Term Extension)|Discontinued IMP|0
7984000|NCT03131648|12556063|FG007|Open-label (Short Term Extension)|Discontinued IMP|3
7984001|NCT03131687|12556086|FG000|Overall Study|Adverse Event|0
7984002|NCT03131687|12556087|FG001|Overall Study|Adverse Event|1
7984003|NCT03131687|12556088|FG002|Overall Study|Adverse Event|0
7984004|NCT03131687|12556089|FG003|Overall Study|Adverse Event|1
7984005|NCT03131687|12556090|FG004|Overall Study|Adverse Event|2
7984006|NCT03131687|12556091|FG005|Overall Study|Adverse Event|2
7984007|NCT03131687|12556086|FG000|Overall Study|Death|1
7984008|NCT03131687|12556087|FG001|Overall Study|Death|0
7984009|NCT03131687|12556088|FG002|Overall Study|Death|0
7984010|NCT03131687|12556089|FG003|Overall Study|Death|0
7984011|NCT03131687|12556090|FG004|Overall Study|Death|0
7984012|NCT03131687|12556091|FG005|Overall Study|Death|0
7984013|NCT03131687|12556086|FG000|Overall Study|Withdrawal by Subject|3
7984014|NCT03131687|12556087|FG001|Overall Study|Withdrawal by Subject|3
7984015|NCT03131687|12556088|FG002|Overall Study|Withdrawal by Subject|3
7984016|NCT03131687|12556089|FG003|Overall Study|Withdrawal by Subject|1
7984017|NCT03131687|12556090|FG004|Overall Study|Withdrawal by Subject|2
7984018|NCT03131687|12556091|FG005|Overall Study|Withdrawal by Subject|1
7984019|NCT03131687|12556086|FG000|Overall Study|Lost to Follow-up|1
7984020|NCT03131687|12556087|FG001|Overall Study|Lost to Follow-up|4
7984021|NCT03131687|12556088|FG002|Overall Study|Lost to Follow-up|0
7984022|NCT03131687|12556089|FG003|Overall Study|Lost to Follow-up|1
7984023|NCT03131687|12556090|FG004|Overall Study|Lost to Follow-up|4
7984024|NCT03131687|12556091|FG005|Overall Study|Lost to Follow-up|2
7984025|NCT03131687|12556086|FG000|Overall Study|Participant Started New Diabetic Drug|1
7984026|NCT03131687|12556087|FG001|Overall Study|Participant Started New Diabetic Drug|0
7984027|NCT03131687|12556088|FG002|Overall Study|Participant Started New Diabetic Drug|0
7984028|NCT03131687|12556089|FG003|Overall Study|Participant Started New Diabetic Drug|0
7984029|NCT03131687|12556090|FG004|Overall Study|Participant Started New Diabetic Drug|0
7984030|NCT03131687|12556091|FG005|Overall Study|Participant Started New Diabetic Drug|0
7984031|NCT03131687|12556086|FG000|Overall Study|Principle Investigator Decision|0
7984032|NCT03131687|12556087|FG001|Overall Study|Principle Investigator Decision|1
7984033|NCT03131687|12556088|FG002|Overall Study|Principle Investigator Decision|0
7984034|NCT03131687|12556089|FG003|Overall Study|Principle Investigator Decision|0
7984035|NCT03131687|12556090|FG004|Overall Study|Principle Investigator Decision|0
7984036|NCT03131687|12556091|FG005|Overall Study|Principle Investigator Decision|0
7984037|NCT03131687|12556086|FG000|Overall Study|Inadvertent Enrollment|0
7984038|NCT03131687|12556087|FG001|Overall Study|Inadvertent Enrollment|0
7984039|NCT03131687|12556088|FG002|Overall Study|Inadvertent Enrollment|0
7984040|NCT03131687|12556089|FG003|Overall Study|Inadvertent Enrollment|1
7984041|NCT03131687|12556090|FG004|Overall Study|Inadvertent Enrollment|0
7984042|NCT03131687|12556091|FG005|Overall Study|Inadvertent Enrollment|0
7984043|NCT03131713|12556120|FG000|Overall Study|Lost to Follow-up|5
7984044|NCT03131713|12556121|FG001|Overall Study|Lost to Follow-up|0
7984045|NCT03131895|12556131|FG000|Washout Period (at Least 5 Days)|Adverse Event|1
7984046|NCT03131895|12556132|FG001|Washout Period (at Least 5 Days)|Adverse Event|0
7984047|NCT03131895|12556133|FG002|Washout Period (at Least 5 Days)|Adverse Event|0
7984048|NCT03131895|12556134|FG003|Washout Period (at Least 5 Days)|Adverse Event|1
7984049|NCT03131895|12556131|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0
7984050|NCT03131895|12556132|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3
7984051|NCT03131895|12556133|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2
7984052|NCT03131895|12556134|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3
7984053|NCT03131895|12556131|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7984054|NCT03131895|12556132|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2
7984055|NCT03131895|12556133|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7984056|NCT03131895|12556134|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
7984057|NCT03131895|12556131|FG000|Washout Period (at Least 5 Days)|Other|0
7984058|NCT03131895|12556132|FG001|Washout Period (at Least 5 Days)|Other|0
7984059|NCT03131895|12556133|FG002|Washout Period (at Least 5 Days)|Other|2
7984060|NCT03131895|12556134|FG003|Washout Period (at Least 5 Days)|Other|0
7984061|NCT03131895|12556131|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0
7984062|NCT03131895|12556132|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1
7984063|NCT03131895|12556133|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0
7984064|NCT03131895|12556134|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0
7984065|NCT03131895|12556131|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1
7984066|NCT03131895|12556132|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
7984067|NCT03131895|12556133|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
7984068|NCT03131895|12556134|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
7984069|NCT03131999|12556146|FG000|Overall Study|Withdrawal by Subject|0
7984070|NCT03131999|12556147|FG001|Overall Study|Withdrawal by Subject|1
7984071|NCT03132220|12556155|FG000|Overall Study|Lost to Follow-up|17
7984072|NCT03132220|12556156|FG001|Overall Study|Lost to Follow-up|8
7984073|NCT03132220|12556155|FG000|Overall Study|Withdrawal by Subject|1
7984074|NCT03132220|12556156|FG001|Overall Study|Withdrawal by Subject|4
7984075|NCT03133481|12556191|FG000|Overall Study|FC Catheter fell out post operative day1|0
7984076|NCT03133481|12556192|FG001|Overall Study|FC Catheter fell out post operative day1|4
7984077|NCT03133767|12556244|FG000|Overall Study|Lost to Follow-up|38
7984078|NCT03133767|12556245|FG001|Overall Study|Lost to Follow-up|24
7984079|NCT03133767|12556244|FG000|Overall Study|Protocol Violation|0
7984080|NCT03133767|12556245|FG001|Overall Study|Protocol Violation|1
7984081|NCT03134183|12556284|FG000|Overall Study|Withdrawal by Subject|1
7984082|NCT03134183|12556285|FG001|Overall Study|Withdrawal by Subject|1
7984083|NCT03134222|12556307|FG000|Treatment Period (Up to Week 12)|Adverse Event|4
7984084|NCT03134222|12556308|FG001|Treatment Period (Up to Week 12)|Adverse Event|1
7984085|NCT03134222|12556309|FG002|Treatment Period (Up to Week 12)|Adverse Event|0
7984086|NCT03134222|12556310|FG003|Treatment Period (Up to Week 12)|Adverse Event|0
7984087|NCT03134222|12556311|FG004|Treatment Period (Up to Week 12)|Adverse Event|0
7984088|NCT03134222|12556307|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1
7984089|NCT03134222|12556308|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1
7984090|NCT03134222|12556309|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1
7984091|NCT03134222|12556310|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0
7984092|NCT03134222|12556311|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0
7984093|NCT03134222|12556307|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0
7984094|NCT03134222|12556308|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1
7984095|NCT03134222|12556309|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0
7984096|NCT03134222|12556310|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0
7984097|NCT03134222|12556311|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0
7984098|NCT03134222|12556307|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0
7984099|NCT03134222|12556308|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1
7984100|NCT03134222|12556309|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1
7984101|NCT03134222|12556310|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0
7984102|NCT03134222|12556311|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0
7984103|NCT03134222|12556307|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0
7984104|NCT03134222|12556308|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2
7984105|NCT03134222|12556309|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0
7984106|NCT03134222|12556310|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0
7984107|NCT03134222|12556311|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1
7984108|NCT03134222|12556307|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2
7984109|NCT03134222|12556308|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7984110|NCT03134222|12556309|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7984111|NCT03134222|12556310|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7984112|NCT03134222|12556311|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7984113|NCT03134222|12556307|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7984114|NCT03134222|12556308|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7984115|NCT03134222|12556309|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7984116|NCT03134222|12556310|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1
7984117|NCT03134222|12556311|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7984118|NCT03134222|12556307|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7984119|NCT03134222|12556308|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1
7984120|NCT03134222|12556309|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7984121|NCT03134222|12556310|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7984122|NCT03134222|12556311|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7984123|NCT03134599|12556344|FG000|Week 1|Lost to Follow-up|0
7984124|NCT03134599|12556345|FG001|Week 1|Lost to Follow-up|0
7984125|NCT03134599|12556346|FG002|Week 1|Lost to Follow-up|0
7984126|NCT03134599|12556347|FG003|Week 1|Lost to Follow-up|0
7984127|NCT03134599|12556348|FG004|Week 1|Lost to Follow-up|1
7984128|NCT03134599|12556349|FG005|Week 1|Lost to Follow-up|0
7984129|NCT03134599|12556344|FG000|Week 2|Lost to Follow-up|1
7984130|NCT03134599|12556345|FG001|Week 2|Lost to Follow-up|0
7984131|NCT03134599|12556346|FG002|Week 2|Lost to Follow-up|0
7984132|NCT03134599|12556347|FG003|Week 2|Lost to Follow-up|1
7984133|NCT03134599|12556348|FG004|Week 2|Lost to Follow-up|1
7984134|NCT03134599|12556349|FG005|Week 2|Lost to Follow-up|0
7984135|NCT03134599|12556344|FG000|Week 3|Lost to Follow-up|0
7984136|NCT03134599|12556345|FG001|Week 3|Lost to Follow-up|0
7984137|NCT03134599|12556346|FG002|Week 3|Lost to Follow-up|0
7984138|NCT03134599|12556347|FG003|Week 3|Lost to Follow-up|1
7984139|NCT03134599|12556348|FG004|Week 3|Lost to Follow-up|0
7984140|NCT03134599|12556349|FG005|Week 3|Lost to Follow-up|1
7984141|NCT03134911|12556372|FG000|Overall Study|Screen failure|31
7984142|NCT03134911|12556372|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3
7984143|NCT03135028|12556455|FG000|Overall Study|Death|6
7984144|NCT03135028|12556455|FG000|Overall Study|Study Terminated by Sponsor|2
7984145|NCT03135028|12556455|FG000|Overall Study|Withdrew Consent|1
7984146|NCT03135210|12556461|FG000|Overall Study|Death|0
7984147|NCT03135210|12556462|FG001|Overall Study|Death|1
7984148|NCT03135431|12556479|FG000|Overall Study|Study Surgeon not available|2
7984149|NCT03135431|12556480|FG001|Overall Study|Study Surgeon not available|0
7984150|NCT03135522|12556488|FG000|Overall Study|Adverse Event|1
7984151|NCT03135522|12556489|FG001|Overall Study|Adverse Event|0
7984152|NCT03135548|12556502|FG000|Overall Study|Lost to Follow-up|3
7984153|NCT03135548|12556503|FG001|Overall Study|Lost to Follow-up|0
7984154|NCT03135548|12556504|FG002|Overall Study|Lost to Follow-up|0
7984155|NCT03135548|12556502|FG000|Overall Study|Withdrawal by Subject|2
7984156|NCT03135548|12556503|FG001|Overall Study|Withdrawal by Subject|2
7984157|NCT03135548|12556504|FG002|Overall Study|Withdrawal by Subject|1
7984158|NCT03135548|12556502|FG000|Overall Study|Other than listed|0
7984159|NCT03135548|12556503|FG001|Overall Study|Other than listed|2
7984160|NCT03135548|12556504|FG002|Overall Study|Other than listed|2
7984161|NCT03135899|12556520|FG000|Overall Study|Failed spirometry,unable to repeat visit|0
7984162|NCT03135899|12556521|FG001|Overall Study|Failed spirometry,unable to repeat visit|0
7984163|NCT03135899|12556522|FG002|Overall Study|Failed spirometry,unable to repeat visit|0
7984164|NCT03135899|12556523|FG003|Overall Study|Failed spirometry,unable to repeat visit|0
7984165|NCT03135899|12556524|FG004|Overall Study|Failed spirometry,unable to repeat visit|0
7984166|NCT03135899|12556525|FG005|Overall Study|Failed spirometry,unable to repeat visit|0
7984167|NCT03135899|12556526|FG006|Overall Study|Failed spirometry,unable to repeat visit|1
7984168|NCT03135899|12556527|FG007|Overall Study|Failed spirometry,unable to repeat visit|0
7984169|NCT03135899|12556520|FG000|Overall Study|Withdrawal by Subject|0
7984170|NCT03135899|12556521|FG001|Overall Study|Withdrawal by Subject|0
7984171|NCT03135899|12556522|FG002|Overall Study|Withdrawal by Subject|0
7984172|NCT03135899|12556523|FG003|Overall Study|Withdrawal by Subject|0
7984173|NCT03135899|12556524|FG004|Overall Study|Withdrawal by Subject|0
7984174|NCT03135899|12556525|FG005|Overall Study|Withdrawal by Subject|2
7984175|NCT03135899|12556526|FG006|Overall Study|Withdrawal by Subject|0
7984176|NCT03135899|12556527|FG007|Overall Study|Withdrawal by Subject|0
7984177|NCT03136068|12556543|FG000|Overall Study|Lost to Follow-up|1
7984178|NCT03136068|12556544|FG001|Overall Study|Lost to Follow-up|1
7984179|NCT03136068|12556543|FG000|Overall Study|Protocol Violation|1
7984180|NCT03136068|12556544|FG001|Overall Study|Protocol Violation|0
7984181|NCT03136107|12556550|FG000|Overall Study|Other (Not specified)|1
7984182|NCT03136159|12556560|FG000|Overall Study|chorioamnionitis|2
7984183|NCT03136159|12556561|FG001|Overall Study|chorioamnionitis|0
7984184|NCT03136159|12556560|FG000|Overall Study|vertical skin incision|1
7984185|NCT03136159|12556561|FG001|Overall Study|vertical skin incision|0
7984186|NCT03136159|12556560|FG000|Overall Study|additional dressing|1
7984187|NCT03136159|12556561|FG001|Overall Study|additional dressing|0
7984188|NCT03136159|12556560|FG000|Overall Study|never got dressing placed|1
7984189|NCT03136159|12556561|FG001|Overall Study|never got dressing placed|0
7984190|NCT03136198|12556569|FG000|Overall Study|Withdrawal by Subject|0
7984191|NCT03136198|12556570|FG001|Overall Study|Withdrawal by Subject|1
7984192|NCT03136367|12556584|FG000|T1 Consultation|discontinued mistakenly included|2
7984193|NCT03136367|12556585|FG001|T1 Consultation|discontinued mistakenly included|6
7984194|NCT03136367|12556586|FG002|T1 Consultation|discontinued mistakenly included|1
7984195|NCT03136367|12556584|FG000|T1 Consultation|Discontinued other|0
7984196|NCT03136367|12556585|FG001|T1 Consultation|Discontinued other|1
7984197|NCT03136367|12556586|FG002|T1 Consultation|Discontinued other|0
7984198|NCT03136367|12556584|FG000|T2 Post-consultation|Withdrawal by Subject|1
7984199|NCT03136367|12556585|FG001|T2 Post-consultation|Withdrawal by Subject|1
7984200|NCT03136367|12556586|FG002|T2 Post-consultation|Withdrawal by Subject|5
7984201|NCT03136367|12556584|FG000|T2 Post-consultation|discontinued mistakenly included|2
7984202|NCT03136367|12556585|FG001|T2 Post-consultation|discontinued mistakenly included|2
7984203|NCT03136367|12556586|FG002|T2 Post-consultation|discontinued mistakenly included|17
7984204|NCT03136367|12556584|FG000|T2 Post-consultation|Discontinued other|0
7984205|NCT03136367|12556585|FG001|T2 Post-consultation|Discontinued other|2
7984206|NCT03136367|12556586|FG002|T2 Post-consultation|Discontinued other|6
7984207|NCT03136367|12556584|FG000|T2 Post-consultation|Discontinued transferred care|0
7984208|NCT03136367|12556585|FG001|T2 Post-consultation|Discontinued transferred care|0
7984209|NCT03136367|12556586|FG002|T2 Post-consultation|Discontinued transferred care|3
7984210|NCT03136367|12556584|FG000|T2 Post-consultation|Discontinued lost contact|0
7984211|NCT03136367|12556585|FG001|T2 Post-consultation|Discontinued lost contact|1
7984212|NCT03136367|12556586|FG002|T2 Post-consultation|Discontinued lost contact|0
7984213|NCT03136367|12556584|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5
7984214|NCT03136367|12556585|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9
7984215|NCT03136367|12556586|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8
7984216|NCT03136367|12556584|FG000|T3 1 Week After Surgery|Discontinued transferred care|2
7984217|NCT03136367|12556585|FG001|T3 1 Week After Surgery|Discontinued transferred care|11
7984218|NCT03136367|12556586|FG002|T3 1 Week After Surgery|Discontinued transferred care|14
7984219|NCT03136367|12556584|FG000|T3 1 Week After Surgery|other discontinued|2
7984220|NCT03136367|12556585|FG001|T3 1 Week After Surgery|other discontinued|4
7984221|NCT03136367|12556586|FG002|T3 1 Week After Surgery|other discontinued|3
7984222|NCT03136367|12556584|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0
7984223|NCT03136367|12556585|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6
7984224|NCT03136367|12556586|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2
7984225|NCT03136367|12556584|FG000|T3 1 Week After Surgery|Discontinued lost contact|1
7984226|NCT03136367|12556585|FG001|T3 1 Week After Surgery|Discontinued lost contact|2
7984227|NCT03136367|12556586|FG002|T3 1 Week After Surgery|Discontinued lost contact|4
7984228|NCT03136367|12556584|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1
7984229|NCT03136367|12556585|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3
7984230|NCT03136367|12556586|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0
7984231|NCT03136367|12556584|FG000|T4 12 Weeks After Surgery|Death|0
7984232|NCT03136367|12556585|FG001|T4 12 Weeks After Surgery|Death|1
7984233|NCT03136367|12556586|FG002|T4 12 Weeks After Surgery|Death|3
7984234|NCT03136367|12556584|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1
7984235|NCT03136367|12556585|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0
7984236|NCT03136367|12556586|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0
7984237|NCT03136367|12556584|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0
7984238|NCT03136367|12556585|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1
7984239|NCT03136367|12556586|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5
7984240|NCT03136367|12556584|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0
7984241|NCT03136367|12556585|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0
7984242|NCT03136367|12556586|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1
7984243|NCT03136367|12556584|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1
7984244|NCT03136367|12556585|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1
7984245|NCT03136367|12556586|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1
7984246|NCT03136367|12556584|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1
7984247|NCT03136367|12556585|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0
7984248|NCT03136367|12556586|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0
7984249|NCT03136367|12556584|FG000|T5 1 Year After Surgery|Death|0
7984250|NCT03136367|12556585|FG001|T5 1 Year After Surgery|Death|0
7984251|NCT03136367|12556586|FG002|T5 1 Year After Surgery|Death|1
7984252|NCT03136367|12556584|FG000|T5 1 Year After Surgery|Discontinued lost contact|1
7984253|NCT03136367|12556585|FG001|T5 1 Year After Surgery|Discontinued lost contact|6
7984254|NCT03136367|12556586|FG002|T5 1 Year After Surgery|Discontinued lost contact|0
7984255|NCT03136367|12556584|FG000|T5 1 Year After Surgery|Lost to Follow-up|2
7984256|NCT03136367|12556585|FG001|T5 1 Year After Surgery|Lost to Follow-up|22
7984257|NCT03136367|12556586|FG002|T5 1 Year After Surgery|Lost to Follow-up|15
7984258|NCT03136367|12556584|FG000|T5 1 Year After Surgery|study ended before due|31
7984259|NCT03136367|12556585|FG001|T5 1 Year After Surgery|study ended before due|103
7984260|NCT03136367|12556586|FG002|T5 1 Year After Surgery|study ended before due|110
7984261|NCT03136367|12556584|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0
7984262|NCT03136367|12556585|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4
7984263|NCT03136367|12556586|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2
7984264|NCT03136380|12556599|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7984265|NCT03136380|12556600|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1
7984266|NCT03136380|12556601|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7984267|NCT03136380|12556602|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7984268|NCT03136380|12556603|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7984269|NCT03136484|12556623|FG000|Overall Study|Withdrawal by Subject|19
7984270|NCT03136484|12556624|FG001|Overall Study|Withdrawal by Subject|14
7984271|NCT03136484|12556623|FG000|Overall Study|Lost to Follow-up|7
7984272|NCT03136484|12556624|FG001|Overall Study|Lost to Follow-up|8
7984273|NCT03136484|12556623|FG000|Overall Study|Death|1
7984274|NCT03136484|12556624|FG001|Overall Study|Death|0
7984275|NCT03136861|12556637|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3
7984276|NCT03136861|12556638|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2
7984277|NCT03136861|12556639|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7984278|NCT03136861|12556640|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7984279|NCT03136861|12556641|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7984280|NCT03136861|12556642|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7984281|NCT03136861|12556643|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7984282|NCT03136861|12556637|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
7984283|NCT03136861|12556638|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
7984284|NCT03136861|12556639|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7984285|NCT03136861|12556640|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7984286|NCT03136861|12556641|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7984287|NCT03136861|12556642|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7984288|NCT03136861|12556643|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7984289|NCT03136861|12556637|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2
7984290|NCT03136861|12556638|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1
7984291|NCT03136861|12556639|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7984292|NCT03136861|12556640|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7984293|NCT03136861|12556641|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7984294|NCT03136861|12556642|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7984295|NCT03136861|12556643|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7984296|NCT03136861|12556637|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7984297|NCT03136861|12556638|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1
7984298|NCT03136861|12556639|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7984299|NCT03136861|12556640|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7984300|NCT03136861|12556641|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7984301|NCT03136861|12556642|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7984302|NCT03136861|12556643|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7984303|NCT03136861|12556637|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
7984304|NCT03136861|12556638|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
7984305|NCT03136861|12556639|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7984306|NCT03136861|12556640|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7984307|NCT03136861|12556641|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7984308|NCT03136861|12556642|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7984309|NCT03136861|12556643|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7984310|NCT03136861|12556637|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7984311|NCT03136861|12556638|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7984312|NCT03136861|12556639|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7984313|NCT03136861|12556640|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
7984314|NCT03136861|12556641|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2
7984315|NCT03136861|12556642|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7984316|NCT03136861|12556643|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
7984317|NCT03136861|12556637|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7984318|NCT03136861|12556638|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7984319|NCT03136861|12556639|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1
7984320|NCT03136861|12556640|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7984321|NCT03136861|12556641|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7984322|NCT03136861|12556642|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7984323|NCT03136861|12556643|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7984324|NCT03136861|12556637|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7984325|NCT03136861|12556638|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7984326|NCT03136861|12556639|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1
7984327|NCT03136861|12556640|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7984328|NCT03136861|12556641|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7984329|NCT03136861|12556642|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7984330|NCT03136861|12556643|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7984331|NCT03137069|12556667|FG000|Overall Study|Withdrawal by Subject|1
7984332|NCT03137069|12556668|FG001|Overall Study|Withdrawal by Subject|2
7984333|NCT03137069|12556669|FG002|Overall Study|Withdrawal by Subject|2
7984334|NCT03137069|12556670|FG003|Overall Study|Withdrawal by Subject|2
7984335|NCT03137069|12556671|FG004|Overall Study|Withdrawal by Subject|0
7984336|NCT03137069|12556672|FG005|Overall Study|Withdrawal by Subject|0
7984337|NCT03137069|12556667|FG000|Overall Study|Adverse Event|0
7984338|NCT03137069|12556668|FG001|Overall Study|Adverse Event|3
7984339|NCT03137069|12556669|FG002|Overall Study|Adverse Event|1
7984340|NCT03137069|12556670|FG003|Overall Study|Adverse Event|1
7984341|NCT03137069|12556671|FG004|Overall Study|Adverse Event|0
7984342|NCT03137069|12556672|FG005|Overall Study|Adverse Event|1
7984343|NCT03137069|12556667|FG000|Overall Study|Protocol Violation|0
7984344|NCT03137069|12556668|FG001|Overall Study|Protocol Violation|1
7984345|NCT03137069|12556669|FG002|Overall Study|Protocol Violation|0
7984346|NCT03137069|12556670|FG003|Overall Study|Protocol Violation|1
7984347|NCT03137069|12556671|FG004|Overall Study|Protocol Violation|1
7984348|NCT03137069|12556672|FG005|Overall Study|Protocol Violation|1
7984349|NCT03137069|12556667|FG000|Overall Study|Physician Decision|0
7984350|NCT03137069|12556668|FG001|Overall Study|Physician Decision|0
7984351|NCT03137069|12556669|FG002|Overall Study|Physician Decision|0
7984352|NCT03137069|12556670|FG003|Overall Study|Physician Decision|1
7984353|NCT03137069|12556671|FG004|Overall Study|Physician Decision|0
7984354|NCT03137069|12556672|FG005|Overall Study|Physician Decision|0
7984355|NCT03137069|12556667|FG000|Overall Study|Study Terminated by Sponsor|0
7984356|NCT03137069|12556668|FG001|Overall Study|Study Terminated by Sponsor|0
7984357|NCT03137069|12556669|FG002|Overall Study|Study Terminated by Sponsor|0
7984358|NCT03137069|12556670|FG003|Overall Study|Study Terminated by Sponsor|0
7984359|NCT03137069|12556671|FG004|Overall Study|Study Terminated by Sponsor|1
7984360|NCT03137069|12556672|FG005|Overall Study|Study Terminated by Sponsor|0
7984361|NCT03137069|12556667|FG000|Overall Study|Data Entry Error|0
7984362|NCT03137069|12556668|FG001|Overall Study|Data Entry Error|0
7984363|NCT03137069|12556669|FG002|Overall Study|Data Entry Error|0
7984364|NCT03137069|12556670|FG003|Overall Study|Data Entry Error|1
7984365|NCT03137069|12556671|FG004|Overall Study|Data Entry Error|0
7984366|NCT03137069|12556672|FG005|Overall Study|Data Entry Error|0
7984367|NCT03137121|12556692|FG000|Overall Study|Withdrawal by Subject|0
7984368|NCT03137121|12556693|FG001|Overall Study|Withdrawal by Subject|1
7984369|NCT03137303|12556701|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1
7984370|NCT03137303|12556702|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4
7984371|NCT03137303|12556701|FG000|T1: 3-month Follow-up|Lost to Follow-up|5
7984372|NCT03137303|12556702|FG001|T1: 3-month Follow-up|Lost to Follow-up|6
7984373|NCT03137303|12556701|FG000|T2: 6-month Follow-up|Lost to Follow-up|5
7984374|NCT03137303|12556702|FG001|T2: 6-month Follow-up|Lost to Follow-up|5
7984375|NCT03137303|12556701|FG000|T3: 9-month Follow-up|Death|1
7984376|NCT03137303|12556702|FG001|T3: 9-month Follow-up|Death|0
7984377|NCT03137303|12556701|FG000|T3: 9-month Follow-up|Lost to Follow-up|4
7984378|NCT03137303|12556702|FG001|T3: 9-month Follow-up|Lost to Follow-up|4
7984379|NCT03137303|12556701|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0
7984380|NCT03137303|12556702|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1
7984381|NCT03137303|12556701|FG000|T4: 12-month Follow-up|Lost to Follow-up|7
7984382|NCT03137303|12556702|FG001|T4: 12-month Follow-up|Lost to Follow-up|4
7984383|NCT03137459|12556710|FG000|2-month Assessment|Withdrawal by Subject|13
7984384|NCT03137459|12556711|FG001|2-month Assessment|Withdrawal by Subject|3
7984385|NCT03137459|12556710|FG000|2-month Assessment|Unable to reach|42
7984386|NCT03137459|12556711|FG001|2-month Assessment|Unable to reach|32
7984387|NCT03137459|12556710|FG000|2-month Assessment|Refused assessment|7
7984388|NCT03137459|12556711|FG001|2-month Assessment|Refused assessment|5
7984389|NCT03137459|12556710|FG000|2-month Assessment|Acutely ill|6
7984390|NCT03137459|12556711|FG001|2-month Assessment|Acutely ill|2
7984391|NCT03137459|12556710|FG000|4-month Assessment|Death|4
7984392|NCT03137459|12556711|FG001|4-month Assessment|Death|2
7984393|NCT03137459|12556710|FG000|4-month Assessment|Withdrawal by Subject|4
7984394|NCT03137459|12556711|FG001|4-month Assessment|Withdrawal by Subject|2
7984395|NCT03137459|12556710|FG000|4-month Assessment|Unable to reach|44
7984396|NCT03137459|12556711|FG001|4-month Assessment|Unable to reach|29
7984397|NCT03137459|12556710|FG000|4-month Assessment|Refused assessment|24
7984398|NCT03137459|12556711|FG001|4-month Assessment|Refused assessment|10
7984399|NCT03137459|12556710|FG000|4-month Assessment|Acutely ill|2
7984400|NCT03137459|12556711|FG001|4-month Assessment|Acutely ill|3
7984401|NCT03137459|12556710|FG000|6-months|Lost to Follow-up|14
7984402|NCT03137459|12556711|FG001|6-months|Lost to Follow-up|11
7984403|NCT03137459|12556710|FG000|6-months|Death|0
7984404|NCT03137459|12556711|FG001|6-months|Death|2
7984405|NCT03137459|12556710|FG000|6-months|Refused assessment|6
7984406|NCT03137459|12556711|FG001|6-months|Refused assessment|3
7984407|NCT03137459|12556710|FG000|6-months|Acutely ill|1
7984408|NCT03137459|12556711|FG001|6-months|Acutely ill|1
7984409|NCT03137784|12556718|FG000|Overall Study|Adverse Event|1
7984410|NCT03137784|12556719|FG001|Overall Study|Adverse Event|1
7984411|NCT03137784|12556720|FG002|Overall Study|Adverse Event|0
7984412|NCT03137784|12556721|FG003|Overall Study|Adverse Event|0
7984413|NCT03137784|12556722|FG004|Overall Study|Adverse Event|0
7984414|NCT03137784|12556723|FG005|Overall Study|Adverse Event|0
7984415|NCT03137784|12556718|FG000|Overall Study|Subject/guardian decision|1
7984416|NCT03137784|12556719|FG001|Overall Study|Subject/guardian decision|0
7984417|NCT03137784|12556720|FG002|Overall Study|Subject/guardian decision|0
7984418|NCT03137784|12556721|FG003|Overall Study|Subject/guardian decision|0
7984419|NCT03137784|12556722|FG004|Overall Study|Subject/guardian decision|0
7984420|NCT03137784|12556723|FG005|Overall Study|Subject/guardian decision|0
7984421|NCT03137784|12556718|FG000|Overall Study|Non-compliance with study treatment|0
7984422|NCT03137784|12556719|FG001|Overall Study|Non-compliance with study treatment|0
7984423|NCT03137784|12556720|FG002|Overall Study|Non-compliance with study treatment|0
7984424|NCT03137784|12556721|FG003|Overall Study|Non-compliance with study treatment|0
7984425|NCT03137784|12556722|FG004|Overall Study|Non-compliance with study treatment|1
7984426|NCT03137784|12556723|FG005|Overall Study|Non-compliance with study treatment|0
7984427|NCT03137992|12556731|FG000|Washout Period 1|Adverse Event|1
7984428|NCT03137992|12556732|FG001|Washout Period 1|Adverse Event|1
7984429|NCT03137992|12556733|FG002|Washout Period 1|Adverse Event|0
7984430|NCT03137992|12556734|FG003|Washout Period 1|Adverse Event|0
7984431|NCT03137992|12556735|FG004|Washout Period 1|Adverse Event|0
7984432|NCT03137992|12556736|FG005|Washout Period 1|Adverse Event|1
7984433|NCT03137992|12556731|FG000|Washout Period 1|Withdrawal by Subject|0
7984434|NCT03137992|12556732|FG001|Washout Period 1|Withdrawal by Subject|1
7984435|NCT03137992|12556733|FG002|Washout Period 1|Withdrawal by Subject|1
7984436|NCT03137992|12556734|FG003|Washout Period 1|Withdrawal by Subject|0
7984437|NCT03137992|12556735|FG004|Washout Period 1|Withdrawal by Subject|0
7984438|NCT03137992|12556736|FG005|Washout Period 1|Withdrawal by Subject|0
7984439|NCT03137992|12556731|FG000|Washout Period 1|Principal Investigator Discretion|0
7984440|NCT03137992|12556732|FG001|Washout Period 1|Principal Investigator Discretion|1
7984441|NCT03137992|12556733|FG002|Washout Period 1|Principal Investigator Discretion|0
7984442|NCT03137992|12556734|FG003|Washout Period 1|Principal Investigator Discretion|0
7984443|NCT03137992|12556735|FG004|Washout Period 1|Principal Investigator Discretion|0
7984444|NCT03137992|12556736|FG005|Washout Period 1|Principal Investigator Discretion|0
7984445|NCT03137992|12556731|FG000|Washout Period 1|COPD Exacerbation|1
7984446|NCT03137992|12556732|FG001|Washout Period 1|COPD Exacerbation|1
7984447|NCT03137992|12556733|FG002|Washout Period 1|COPD Exacerbation|1
7984448|NCT03137992|12556734|FG003|Washout Period 1|COPD Exacerbation|0
7984449|NCT03137992|12556735|FG004|Washout Period 1|COPD Exacerbation|1
7984450|NCT03137992|12556736|FG005|Washout Period 1|COPD Exacerbation|1
7984451|NCT03137992|12556731|FG000|Washout Period 1|Subject Noncompliance|1
7984452|NCT03137992|12556732|FG001|Washout Period 1|Subject Noncompliance|0
7984453|NCT03137992|12556733|FG002|Washout Period 1|Subject Noncompliance|0
7984454|NCT03137992|12556734|FG003|Washout Period 1|Subject Noncompliance|0
7984455|NCT03137992|12556735|FG004|Washout Period 1|Subject Noncompliance|1
7984456|NCT03137992|12556736|FG005|Washout Period 1|Subject Noncompliance|0
7984457|NCT03137992|12556731|FG000|Period 2 (Visit 3)|COPD Exacerbation|1
7984458|NCT03137992|12556732|FG001|Period 2 (Visit 3)|COPD Exacerbation|1
7984459|NCT03137992|12556733|FG002|Period 2 (Visit 3)|COPD Exacerbation|0
7984460|NCT03137992|12556734|FG003|Period 2 (Visit 3)|COPD Exacerbation|0
7984461|NCT03137992|12556735|FG004|Period 2 (Visit 3)|COPD Exacerbation|0
7984462|NCT03137992|12556736|FG005|Period 2 (Visit 3)|COPD Exacerbation|1
7984463|NCT03137992|12556731|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2
7984464|NCT03137992|12556732|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3
7984465|NCT03137992|12556733|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3
7984466|NCT03137992|12556734|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4
7984467|NCT03137992|12556735|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3
7984468|NCT03137992|12556736|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7
7984469|NCT03137992|12556731|FG000|Period 2 (Visit 3)|Adverse Event|0
7984470|NCT03137992|12556732|FG001|Period 2 (Visit 3)|Adverse Event|1
7984471|NCT03137992|12556733|FG002|Period 2 (Visit 3)|Adverse Event|0
7984472|NCT03137992|12556734|FG003|Period 2 (Visit 3)|Adverse Event|0
7984473|NCT03137992|12556735|FG004|Period 2 (Visit 3)|Adverse Event|0
7984474|NCT03137992|12556736|FG005|Period 2 (Visit 3)|Adverse Event|0
7984475|NCT03137992|12556731|FG000|Period 2 (Visit 3)|Lost to Follow-up|0
7984476|NCT03137992|12556732|FG001|Period 2 (Visit 3)|Lost to Follow-up|0
7984477|NCT03137992|12556733|FG002|Period 2 (Visit 3)|Lost to Follow-up|0
7984478|NCT03137992|12556734|FG003|Period 2 (Visit 3)|Lost to Follow-up|1
7984479|NCT03137992|12556735|FG004|Period 2 (Visit 3)|Lost to Follow-up|0
7984480|NCT03137992|12556736|FG005|Period 2 (Visit 3)|Lost to Follow-up|0
7984481|NCT03137992|12556731|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0
7984482|NCT03137992|12556732|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2
7984483|NCT03137992|12556733|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0
7984484|NCT03137992|12556734|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0
7984485|NCT03137992|12556735|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1
7984486|NCT03137992|12556736|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0
7984487|NCT03137992|12556731|FG000|Washout Period 2|COPD Exacerbation|1
7984488|NCT03137992|12556732|FG001|Washout Period 2|COPD Exacerbation|1
7984489|NCT03137992|12556733|FG002|Washout Period 2|COPD Exacerbation|0
7984490|NCT03137992|12556734|FG003|Washout Period 2|COPD Exacerbation|0
7984491|NCT03137992|12556735|FG004|Washout Period 2|COPD Exacerbation|1
7984492|NCT03137992|12556736|FG005|Washout Period 2|COPD Exacerbation|0
7984493|NCT03137992|12556731|FG000|Washout Period 2|Subject Non-compliance|0
7984494|NCT03137992|12556732|FG001|Washout Period 2|Subject Non-compliance|1
7984495|NCT03137992|12556733|FG002|Washout Period 2|Subject Non-compliance|0
7984496|NCT03137992|12556734|FG003|Washout Period 2|Subject Non-compliance|0
7984497|NCT03137992|12556735|FG004|Washout Period 2|Subject Non-compliance|0
7984498|NCT03137992|12556736|FG005|Washout Period 2|Subject Non-compliance|0
7984499|NCT03137992|12556731|FG000|Washout Period 2|Adverse Event|0
7984500|NCT03137992|12556732|FG001|Washout Period 2|Adverse Event|0
7984501|NCT03137992|12556733|FG002|Washout Period 2|Adverse Event|0
7984502|NCT03137992|12556734|FG003|Washout Period 2|Adverse Event|1
7984503|NCT03137992|12556735|FG004|Washout Period 2|Adverse Event|1
7984504|NCT03137992|12556736|FG005|Washout Period 2|Adverse Event|0
7984505|NCT03137992|12556731|FG000|Washout Period 2|Withdrawal by Subject|1
7984506|NCT03137992|12556732|FG001|Washout Period 2|Withdrawal by Subject|0
7984507|NCT03137992|12556733|FG002|Washout Period 2|Withdrawal by Subject|0
7984508|NCT03137992|12556734|FG003|Washout Period 2|Withdrawal by Subject|0
7984509|NCT03137992|12556735|FG004|Washout Period 2|Withdrawal by Subject|1
7984510|NCT03137992|12556736|FG005|Washout Period 2|Withdrawal by Subject|0
7984511|NCT03137992|12556731|FG000|Washout Period 2|Sponsor Decision|0
7984512|NCT03137992|12556732|FG001|Washout Period 2|Sponsor Decision|0
7984513|NCT03137992|12556733|FG002|Washout Period 2|Sponsor Decision|0
7984514|NCT03137992|12556734|FG003|Washout Period 2|Sponsor Decision|0
7984515|NCT03137992|12556735|FG004|Washout Period 2|Sponsor Decision|0
7984516|NCT03137992|12556736|FG005|Washout Period 2|Sponsor Decision|1
7984517|NCT03137992|12556731|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6
7984518|NCT03137992|12556732|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0
7984519|NCT03137992|12556733|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2
7984520|NCT03137992|12556734|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0
7984521|NCT03137992|12556735|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2
7984522|NCT03137992|12556736|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3
7984523|NCT03137992|12556731|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0
7984524|NCT03137992|12556732|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2
7984525|NCT03137992|12556733|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1
7984526|NCT03137992|12556734|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0
7984527|NCT03137992|12556735|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1
7984528|NCT03137992|12556736|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0
7984529|NCT03137992|12556731|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1
7984530|NCT03137992|12556732|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7984531|NCT03137992|12556733|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1
7984532|NCT03137992|12556734|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7984533|NCT03137992|12556735|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7984534|NCT03137992|12556736|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7984535|NCT03137992|12556731|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0
7984536|NCT03137992|12556732|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0
7984537|NCT03137992|12556733|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0
7984538|NCT03137992|12556734|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1
7984539|NCT03137992|12556735|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0
7984540|NCT03137992|12556736|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0
7984541|NCT03137992|12556731|FG000|Part 2 (Open-label Extension)|Per study team|1
7984542|NCT03137992|12556732|FG001|Part 2 (Open-label Extension)|Per study team|0
7984543|NCT03137992|12556733|FG002|Part 2 (Open-label Extension)|Per study team|0
7984544|NCT03137992|12556734|FG003|Part 2 (Open-label Extension)|Per study team|0
7984545|NCT03137992|12556735|FG004|Part 2 (Open-label Extension)|Per study team|0
7984546|NCT03137992|12556736|FG005|Part 2 (Open-label Extension)|Per study team|0
7984547|NCT03137992|12556731|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0
7984548|NCT03137992|12556732|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0
7984549|NCT03137992|12556733|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0
7984550|NCT03137992|12556734|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0
7984551|NCT03137992|12556735|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0
7984552|NCT03137992|12556736|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1
7984553|NCT03138655|12556796|FG000|Overall Study|Adverse Event|2
7984554|NCT03138655|12556797|FG001|Overall Study|Adverse Event|1
7984555|NCT03138655|12556798|FG002|Overall Study|Adverse Event|2
7984556|NCT03138655|12556799|FG003|Overall Study|Adverse Event|1
7984557|NCT03138655|12556800|FG004|Overall Study|Adverse Event|1
7984558|NCT03138655|12556801|FG005|Overall Study|Adverse Event|4
7984559|NCT03138655|12556802|FG006|Overall Study|Adverse Event|2
7984560|NCT03138655|12556803|FG007|Overall Study|Adverse Event|2
7984561|NCT03138655|12556796|FG000|Overall Study|Withdrawal by Subject|0
7984562|NCT03138655|12556797|FG001|Overall Study|Withdrawal by Subject|1
7984563|NCT03138655|12556798|FG002|Overall Study|Withdrawal by Subject|0
7984564|NCT03138655|12556799|FG003|Overall Study|Withdrawal by Subject|0
7984565|NCT03138655|12556800|FG004|Overall Study|Withdrawal by Subject|0
7984566|NCT03138655|12556801|FG005|Overall Study|Withdrawal by Subject|0
7984567|NCT03138655|12556802|FG006|Overall Study|Withdrawal by Subject|1
7984568|NCT03138655|12556803|FG007|Overall Study|Withdrawal by Subject|0
7984569|NCT03138655|12556796|FG000|Overall Study|Reason not Specified|1
7984570|NCT03138655|12556797|FG001|Overall Study|Reason not Specified|0
7984571|NCT03138655|12556798|FG002|Overall Study|Reason not Specified|0
7984572|NCT03138655|12556799|FG003|Overall Study|Reason not Specified|2
7984573|NCT03138655|12556800|FG004|Overall Study|Reason not Specified|1
7984574|NCT03138655|12556801|FG005|Overall Study|Reason not Specified|1
7984575|NCT03138655|12556802|FG006|Overall Study|Reason not Specified|0
7984576|NCT03138655|12556803|FG007|Overall Study|Reason not Specified|0
7984577|NCT03138967|12556841|FG000|Overall Study|Death|0
7984578|NCT03138967|12556842|FG001|Overall Study|Death|1
7984579|NCT03138967|12556841|FG000|Overall Study|Physician Decision|1
7984580|NCT03138967|12556842|FG001|Overall Study|Physician Decision|3
7984581|NCT03139240|12556857|FG000|Overall Study|Lost to Follow-up|0
7984582|NCT03139240|12556858|FG001|Overall Study|Lost to Follow-up|1
7984583|NCT03139240|12556859|FG002|Overall Study|Lost to Follow-up|1
7984584|NCT03139240|12556860|FG003|Overall Study|Lost to Follow-up|0
7984585|NCT03139279|12556870|FG000|Overall Study|Physician Decision|2
7984586|NCT03139279|12556871|FG001|Overall Study|Physician Decision|0
7984587|NCT03139279|12556870|FG000|Overall Study|Protocol Violation|5
7984588|NCT03139279|12556871|FG001|Overall Study|Protocol Violation|4
7984589|NCT03139279|12556870|FG000|Overall Study|Withdrawal by Subject|0
7984590|NCT03139279|12556871|FG001|Overall Study|Withdrawal by Subject|2
7984591|NCT03139448|12556879|FG000|Overall Study|Lack of Efficacy|6
7984592|NCT03139448|12556880|FG001|Overall Study|Lack of Efficacy|7
7984593|NCT03139448|12556879|FG000|Overall Study|Location of procedure changed|2
7984594|NCT03139448|12556880|FG001|Overall Study|Location of procedure changed|8
7984595|NCT03139448|12556879|FG000|Overall Study|Withdrawal by Subject|3
7984596|NCT03139448|12556880|FG001|Overall Study|Withdrawal by Subject|6
7984597|NCT03139448|12556879|FG000|Overall Study|Screen fail|1
7984598|NCT03139448|12556880|FG001|Overall Study|Screen fail|3
7984599|NCT03139448|12556879|FG000|Overall Study|Physician Decision|0
7984600|NCT03139448|12556880|FG001|Overall Study|Physician Decision|2
7984601|NCT03139552|12556886|FG000|Overall Study|unable to attend tasting due to schedule|3
7984602|NCT03139604|12556912|FG000|Overall Study|Other|7
7984603|NCT03139604|12556913|FG001|Overall Study|Other|3
7984604|NCT03139604|12556912|FG000|Overall Study|Withdrawal by Subject|16
7984605|NCT03139604|12556913|FG001|Overall Study|Withdrawal by Subject|17
7984606|NCT03139604|12556912|FG000|Overall Study|Physician Decision|1
7984607|NCT03139604|12556913|FG001|Overall Study|Physician Decision|2
7984608|NCT03139604|12556912|FG000|Overall Study|Lost to Follow-up|3
7984609|NCT03139604|12556913|FG001|Overall Study|Lost to Follow-up|1
7984610|NCT03139604|12556912|FG000|Overall Study|Death|65
7984611|NCT03139604|12556913|FG001|Overall Study|Death|67
7984612|NCT03139604|12556912|FG000|Overall Study|Study Terminated by Sponsor|122
7984613|NCT03139604|12556913|FG001|Overall Study|Study Terminated by Sponsor|127
7984614|NCT03139604|12556912|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5
7984615|NCT03139604|12556913|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3
7984616|NCT03141086|12556947|FG000|Overall Study|Study Terminated By Sponsor|1
7984617|NCT03141086|12556948|FG001|Overall Study|Study Terminated By Sponsor|1
7984618|NCT03141086|12556947|FG000|Overall Study|Withdrawal by Subject|0
7984619|NCT03141086|12556948|FG001|Overall Study|Withdrawal by Subject|1
7984620|NCT03141086|12556947|FG000|Overall Study|Protocol Violation|0
7984621|NCT03141086|12556948|FG001|Overall Study|Protocol Violation|1
7984622|NCT03141086|12556947|FG000|Overall Study|Adverse Event|0
7984623|NCT03141086|12556948|FG001|Overall Study|Adverse Event|2
7984624|NCT03141151|12556956|FG000|Overall Study|Lost to Follow-up|3
7984625|NCT03141151|12556957|FG001|Overall Study|Lost to Follow-up|2
7984626|NCT03141151|12556956|FG000|Overall Study|Withdrawal by Subject|3
7984627|NCT03141151|12556957|FG001|Overall Study|Withdrawal by Subject|2
7984628|NCT03141307|12556992|FG000|In-Hospital|Withdrawal by Subject|0
7984629|NCT03141307|12556993|FG001|In-Hospital|Withdrawal by Subject|2
7984630|NCT03141307|12556992|FG000|In-Hospital|Protocol Violation|4
7984631|NCT03141307|12556993|FG001|In-Hospital|Protocol Violation|0
7984632|NCT03141307|12556992|FG000|Follow-Up|Lost to Follow-up|97
7984633|NCT03141307|12556993|FG001|Follow-Up|Lost to Follow-up|54
7984634|NCT03141788|12557019|FG000|Overall Study|Lost to Follow-up|1
7984635|NCT03141788|12557019|FG000|Overall Study|Protocol Violation|3
7984636|NCT03141788|12557019|FG000|Overall Study|Withdrawal by Subject|4
7984637|NCT03141905|12557028|FG000|Overall Study|Death|3
7984638|NCT03141905|12557029|FG001|Overall Study|Death|2
7984639|NCT03141905|12557028|FG000|Overall Study|Withdrawal by Subject|1
7984640|NCT03141905|12557029|FG001|Overall Study|Withdrawal by Subject|0
7984641|NCT03141905|12557028|FG000|Overall Study|Lost to Follow-up|3
7984642|NCT03141905|12557029|FG001|Overall Study|Lost to Follow-up|7
7984643|NCT03141905|12557028|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17
7984644|NCT03141905|12557029|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10
7984645|NCT03142451|12557051|FG000|Overall Study|Adverse Event|5
7984646|NCT03142451|12557052|FG001|Overall Study|Adverse Event|2
7984647|NCT03142451|12557051|FG000|Overall Study|Lost to Follow-up|25
7984648|NCT03142451|12557052|FG001|Overall Study|Lost to Follow-up|8
7984649|NCT03142451|12557051|FG000|Overall Study|Participant request|24
7984650|NCT03142451|12557052|FG001|Overall Study|Participant request|12
7984651|NCT03142451|12557051|FG000|Overall Study|Protocol Violation|3
7984652|NCT03142451|12557052|FG001|Overall Study|Protocol Violation|1
7984653|NCT03142451|12557051|FG000|Overall Study|Other|1
7984654|NCT03142451|12557052|FG001|Overall Study|Other|1
7984655|NCT03142750|12557060|FG000|Overall Study|Lost to Follow-up|4
7984656|NCT03142750|12557061|FG001|Overall Study|Lost to Follow-up|1
7984657|NCT03142932|12557073|FG000|Overall Study|Lost to Follow-up|2
7984658|NCT03142932|12557074|FG001|Overall Study|Lost to Follow-up|11
7984659|NCT03143101|12557083|FG000|Overall Study|Withdrawal by Subject|0
7984660|NCT03143101|12557084|FG001|Overall Study|Withdrawal by Subject|1
7984661|NCT03143101|12557085|FG002|Overall Study|Withdrawal by Subject|0
7984662|NCT03143101|12557083|FG000|Overall Study|Lost to Follow-up|2
7984663|NCT03143101|12557084|FG001|Overall Study|Lost to Follow-up|2
7984664|NCT03143101|12557085|FG002|Overall Study|Lost to Follow-up|0
7984665|NCT03143166|12557093|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1
7984666|NCT03143855|12557112|FG000|Overall Study|Withdrawal by Subject|4
7984667|NCT03143855|12557113|FG001|Overall Study|Withdrawal by Subject|3
7984668|NCT03143855|12557112|FG000|Overall Study|Protocol Violation|1
7984669|NCT03143855|12557113|FG001|Overall Study|Protocol Violation|0
7984670|NCT03143855|12557112|FG000|Overall Study|Participant experienced withdrawal|0
7984671|NCT03143855|12557113|FG001|Overall Study|Participant experienced withdrawal|1
7984672|NCT03144180|12557143|FG000|Overall Study|STAT Delivery|1
7984673|NCT03144180|12557144|FG001|Overall Study|STAT Delivery|1
7984674|NCT03144180|12557143|FG000|Overall Study|Provider forgot to fill out forms|1
7984675|NCT03144180|12557144|FG001|Overall Study|Provider forgot to fill out forms|3
7984676|NCT03144180|12557143|FG000|Overall Study|Provider forgot to use the Q-cup|0
7984677|NCT03144180|12557144|FG001|Overall Study|Provider forgot to use the Q-cup|1
7984678|NCT03144180|12557143|FG000|Overall Study|Scrub tech removed tube cap|0
7984679|NCT03144180|12557144|FG001|Overall Study|Scrub tech removed tube cap|1
7984680|NCT03144804|12557168|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4
7984681|NCT03145064|12557172|FG000|Overall Study|Death|24
7984682|NCT03145064|12557172|FG000|Overall Study|Lost to Follow-up|3
7984683|NCT03145064|12557172|FG000|Overall Study|Withdrawal by Subject|6
7984684|NCT03145064|12557172|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4
7984685|NCT03145064|12557172|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4
7984686|NCT03145207|12557177|FG000|Overall Study|volunteer started taking allergy shots|1
7984687|NCT03145207|12557177|FG000|Overall Study|baseline blood pressure high|1
7984688|NCT03146403|12557216|FG000|Overall Study|Withdrawal by Subject|0
7984689|NCT03146403|12557217|FG001|Overall Study|Withdrawal by Subject|3
7984690|NCT03146403|12557216|FG000|Overall Study|Lost to Follow-up|2
7984691|NCT03146403|12557217|FG001|Overall Study|Lost to Follow-up|0
7984692|NCT03146663|12557238|FG000|Overall Study|Did not receive study treatment|1
7984693|NCT03146663|12557239|FG001|Overall Study|Did not receive study treatment|1
7984694|NCT03146741|12557246|FG000|Overall Study|Txp with non-HCV+ heart|4
7984695|NCT03146741|12557246|FG000|Overall Study|Listeted for MOT|2
7984696|NCT03146741|12557246|FG000|Overall Study|Physician Decision|2
7984697|NCT03146741|12557246|FG000|Overall Study|Awaiting txp|2
7984698|NCT03147248|12557272|FG000|Overall Study|Adverse Event|0
7984699|NCT03147248|12557273|FG001|Overall Study|Adverse Event|2
7984700|NCT03147248|12557274|FG002|Overall Study|Adverse Event|2
7984701|NCT03147248|12557275|FG003|Overall Study|Adverse Event|2
7984702|NCT03147248|12557276|FG004|Overall Study|Adverse Event|6
7984703|NCT03147248|12557277|FG005|Overall Study|Adverse Event|11
7984704|NCT03147248|12557272|FG000|Overall Study|Disease progression|1
7984705|NCT03147248|12557273|FG001|Overall Study|Disease progression|0
7984706|NCT03147248|12557274|FG002|Overall Study|Disease progression|0
7984707|NCT03147248|12557275|FG003|Overall Study|Disease progression|0
7984708|NCT03147248|12557276|FG004|Overall Study|Disease progression|0
7984709|NCT03147248|12557277|FG005|Overall Study|Disease progression|2
7984710|NCT03147248|12557272|FG000|Overall Study|Withdrawal by Subject|0
7984711|NCT03147248|12557273|FG001|Overall Study|Withdrawal by Subject|0
7984712|NCT03147248|12557274|FG002|Overall Study|Withdrawal by Subject|0
7984713|NCT03147248|12557275|FG003|Overall Study|Withdrawal by Subject|0
7984714|NCT03147248|12557276|FG004|Overall Study|Withdrawal by Subject|12
7984715|NCT03147248|12557277|FG005|Overall Study|Withdrawal by Subject|9
7984716|NCT03147248|12557272|FG000|Overall Study|Protocol Violation|0
7984717|NCT03147248|12557273|FG001|Overall Study|Protocol Violation|0
7984718|NCT03147248|12557274|FG002|Overall Study|Protocol Violation|0
7984719|NCT03147248|12557275|FG003|Overall Study|Protocol Violation|0
7984720|NCT03147248|12557276|FG004|Overall Study|Protocol Violation|2
7984721|NCT03147248|12557277|FG005|Overall Study|Protocol Violation|0
7984722|NCT03147248|12557272|FG000|Overall Study|Lost to Follow-up|0
7984723|NCT03147248|12557273|FG001|Overall Study|Lost to Follow-up|0
7984724|NCT03147248|12557274|FG002|Overall Study|Lost to Follow-up|0
7984725|NCT03147248|12557275|FG003|Overall Study|Lost to Follow-up|0
7984726|NCT03147248|12557276|FG004|Overall Study|Lost to Follow-up|2
7984727|NCT03147248|12557277|FG005|Overall Study|Lost to Follow-up|0
7984728|NCT03147248|12557272|FG000|Overall Study|Pregnancy|0
7984729|NCT03147248|12557273|FG001|Overall Study|Pregnancy|0
7984730|NCT03147248|12557274|FG002|Overall Study|Pregnancy|0
7984731|NCT03147248|12557275|FG003|Overall Study|Pregnancy|0
7984732|NCT03147248|12557276|FG004|Overall Study|Pregnancy|1
7984733|NCT03147248|12557277|FG005|Overall Study|Pregnancy|0
7984734|NCT03147248|12557272|FG000|Overall Study|Death|0
7984735|NCT03147248|12557273|FG001|Overall Study|Death|0
7984736|NCT03147248|12557274|FG002|Overall Study|Death|0
7984737|NCT03147248|12557275|FG003|Overall Study|Death|0
7984738|NCT03147248|12557276|FG004|Overall Study|Death|0
7984739|NCT03147248|12557277|FG005|Overall Study|Death|4
7984740|NCT03147248|12557272|FG000|Overall Study|Physician Decision|0
7984741|NCT03147248|12557273|FG001|Overall Study|Physician Decision|0
7984742|NCT03147248|12557274|FG002|Overall Study|Physician Decision|0
7984743|NCT03147248|12557275|FG003|Overall Study|Physician Decision|0
7984744|NCT03147248|12557276|FG004|Overall Study|Physician Decision|2
7984745|NCT03147248|12557277|FG005|Overall Study|Physician Decision|4
7984746|NCT03147248|12557272|FG000|Overall Study|Prolonged Dosing Interval|0
7984747|NCT03147248|12557273|FG001|Overall Study|Prolonged Dosing Interval|0
7984748|NCT03147248|12557274|FG002|Overall Study|Prolonged Dosing Interval|0
7984749|NCT03147248|12557275|FG003|Overall Study|Prolonged Dosing Interval|0
7984750|NCT03147248|12557276|FG004|Overall Study|Prolonged Dosing Interval|1
7984751|NCT03147248|12557277|FG005|Overall Study|Prolonged Dosing Interval|1
7984752|NCT03147495|12557293|FG000|Overall Study|Physician Decision|0
7984753|NCT03147495|12557294|FG001|Overall Study|Physician Decision|6
7984754|NCT03148067|12557317|FG000|Overall Study|Lost to Follow-up|3
7984755|NCT03148067|12557317|FG000|Overall Study|Death|1
7984756|NCT03148691|12557360|FG000|Overall Study|Protocol Violation|1
7984757|NCT03148691|12557361|FG001|Overall Study|Protocol Violation|2
7984758|NCT03148691|12557362|FG002|Overall Study|Protocol Violation|7
7984759|NCT03148691|12557360|FG000|Overall Study|Lost to Follow-up|0
7984760|NCT03148691|12557361|FG001|Overall Study|Lost to Follow-up|0
7984761|NCT03148691|12557362|FG002|Overall Study|Lost to Follow-up|1
7984762|NCT03148691|12557360|FG000|Overall Study|Other|1
7984763|NCT03148691|12557361|FG001|Overall Study|Other|0
7984764|NCT03148691|12557362|FG002|Overall Study|Other|0
7984765|NCT03148691|12557360|FG000|Overall Study|Withdrawal by Subject|1
7984766|NCT03148691|12557361|FG001|Overall Study|Withdrawal by Subject|0
7984767|NCT03148691|12557362|FG002|Overall Study|Withdrawal by Subject|0
7984768|NCT03149042|12557370|FG000|Overall Study|Invasive FFR not performed|21
7984769|NCT03149042|12557370|FG000|Overall Study|Poor CT Image Quality|1
7984770|NCT03149042|12557370|FG000|Overall Study|Invasive FFR Measurement cancelled|1
7984771|NCT03149055|12557375|FG000|Overall Study|Not treated|4
7984772|NCT03149328|12557394|FG000|Overall Study|Withdrawal by Subject|30
7984773|NCT03149328|12557395|FG001|Overall Study|Withdrawal by Subject|26
7984774|NCT03149328|12557394|FG000|Overall Study|Changed Dialysis Modality|18
7984775|NCT03149328|12557395|FG001|Overall Study|Changed Dialysis Modality|1
7984776|NCT03149328|12557394|FG000|Overall Study|Transplant|9
7984777|NCT03149328|12557395|FG001|Overall Study|Transplant|1
7984778|NCT03149328|12557394|FG000|Overall Study|Lost to Follow-up|25
7984779|NCT03149328|12557395|FG001|Overall Study|Lost to Follow-up|16
7984780|NCT03149328|12557394|FG000|Overall Study|Left Study Site|1
7984781|NCT03149328|12557395|FG001|Overall Study|Left Study Site|2
7984782|NCT03149328|12557394|FG000|Overall Study|Language Barrier|1
7984783|NCT03149328|12557395|FG001|Overall Study|Language Barrier|0
7984784|NCT03149848|12557401|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1
7984785|NCT03149848|12557401|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2
7984786|NCT03150082|12557431|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
7984787|NCT03150082|12557432|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
7984788|NCT03150485|12557468|FG000|Overall Study|Unsatisfactory Lens Fitting|0
7984789|NCT03150485|12557469|FG001|Overall Study|Unsatisfactory Lens Fitting|1
7984790|NCT03150485|12557470|FG002|Overall Study|Unsatisfactory Lens Fitting|0
7984791|NCT03150485|12557471|FG003|Overall Study|Unsatisfactory Lens Fitting|0
7984792|NCT03150485|12557472|FG004|Overall Study|Unsatisfactory Lens Fitting|0
7984793|NCT03150485|12557473|FG005|Overall Study|Unsatisfactory Lens Fitting|0
7984794|NCT03150589|12557480|FG000|Overall Study|Withdrawal by Subject|16
7984795|NCT03150589|12557481|FG001|Overall Study|Withdrawal by Subject|9
7984796|NCT03150589|12557480|FG000|Overall Study|Adverse Event|7
7984797|NCT03150589|12557481|FG001|Overall Study|Adverse Event|6
7984798|NCT03150589|12557480|FG000|Overall Study|Protocol Violation|4
7984799|NCT03150589|12557481|FG001|Overall Study|Protocol Violation|3
7984800|NCT03150589|12557480|FG000|Overall Study|Lost to Follow-up|3
7984801|NCT03150589|12557481|FG001|Overall Study|Lost to Follow-up|3
7984802|NCT03150589|12557480|FG000|Overall Study|Death|2
7984803|NCT03150589|12557481|FG001|Overall Study|Death|3
7984804|NCT03150589|12557480|FG000|Overall Study|IP non-compliance and other reasons|12
7984805|NCT03150589|12557481|FG001|Overall Study|IP non-compliance and other reasons|3
7984806|NCT03150719|12557489|FG000|Overall Study|Adverse Event|0
7984807|NCT03150719|12557490|FG001|Overall Study|Adverse Event|1
7984808|NCT03150719|12557489|FG000|Overall Study|Death|0
7984809|NCT03150719|12557490|FG001|Overall Study|Death|1
7984810|NCT03150719|12557489|FG000|Overall Study|Other|1
7984811|NCT03150719|12557490|FG001|Overall Study|Other|0
7984812|NCT03151148|12557511|FG000|Overall Study|Lost to Follow-up|1
7984813|NCT03151148|12557512|FG001|Overall Study|Lost to Follow-up|0
7984814|NCT03151148|12557511|FG000|Overall Study|Withdrawal by Subject|1
7984815|NCT03151148|12557512|FG001|Overall Study|Withdrawal by Subject|0
7984816|NCT03151395|12557528|FG000|Overall Study|Adverse Event|2
7984817|NCT03151395|12557528|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
7984818|NCT03151395|12557528|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3
7984819|NCT03151395|12557528|FG000|Overall Study|Unspecified reason|4
7984820|NCT03151551|12557550|FG000|Open-Label Treatment Period|Adverse Event|0
7984821|NCT03151551|12557551|FG001|Open-Label Treatment Period|Adverse Event|2
7984822|NCT03151551|12557550|FG000|Open-Label Treatment Period|Lost to Follow-up|1
7984823|NCT03151551|12557551|FG001|Open-Label Treatment Period|Lost to Follow-up|1
7984824|NCT03151551|12557550|FG000|Open-Label Treatment Period|Withdrawal by Subject|12
7984825|NCT03151551|12557551|FG001|Open-Label Treatment Period|Withdrawal by Subject|18
7984826|NCT03151551|12557550|FG000|Open-Label Treatment Period|Lack of Efficacy|1
7984827|NCT03151551|12557551|FG001|Open-Label Treatment Period|Lack of Efficacy|1
7984828|NCT03151551|12557550|FG000|Open-Label Treatment Period|Physician Decision|3
7984829|NCT03151551|12557551|FG001|Open-Label Treatment Period|Physician Decision|0
7984830|NCT03151551|12557550|FG000|Open-Label Treatment Period|Protocol Deviation|1
7984831|NCT03151551|12557551|FG001|Open-Label Treatment Period|Protocol Deviation|2
7984832|NCT03151551|12557550|FG000|Post-Treatment Follow-Up Period|Adverse Event|1
7984833|NCT03151551|12557551|FG001|Post-Treatment Follow-Up Period|Adverse Event|3
7984834|NCT03151551|12557550|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4
7984835|NCT03151551|12557551|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7984836|NCT03151551|12557550|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20
7984837|NCT03151551|12557551|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22
7984838|NCT03151551|12557550|FG000|Post-Treatment Follow-Up Period|Physician Decision|0
7984839|NCT03151551|12557551|FG001|Post-Treatment Follow-Up Period|Physician Decision|1
7984840|NCT03152019|12557561|FG000|Overall Study|Adverse Event|0
7984841|NCT03152019|12557562|FG001|Overall Study|Adverse Event|1
7984842|NCT03152110|12557577|FG000|Overall Study|Withdrawal by Subject|3
7984843|NCT03152552|12557599|FG000|Treatment Period 1 (12 Weeks)|Death|0
7984844|NCT03152552|12557600|FG001|Treatment Period 1 (12 Weeks)|Death|1
7984845|NCT03152552|12557601|FG002|Treatment Period 1 (12 Weeks)|Death|0
7718117|NCT00525499|12141918|FG001|Overall Study|Withdrawal by Subject|1
7718118|NCT00525499|12141919|FG002|Overall Study|Withdrawal by Subject|5
7718119|NCT00525499|12141920|FG003|Overall Study|Withdrawal by Subject|2
7718120|NCT00525499|12141917|FG000|Overall Study|Protocol Violation|0
7718121|NCT00525499|12141918|FG001|Overall Study|Protocol Violation|1
7718122|NCT00525499|12141919|FG002|Overall Study|Protocol Violation|1
7718123|NCT00525499|12141920|FG003|Overall Study|Protocol Violation|0
7718124|NCT00525512|12141932|FG000|Double-Blind Phase|Adverse Event|48
7718125|NCT00525512|12141933|FG001|Double-Blind Phase|Adverse Event|28
7718126|NCT00525512|12141934|FG002|Double-Blind Phase|Adverse Event|0
7718127|NCT00525512|12141935|FG003|Double-Blind Phase|Adverse Event|0
7718128|NCT00525512|12141932|FG000|Double-Blind Phase|Protocol Violation|3
7718129|NCT00525512|12141933|FG001|Double-Blind Phase|Protocol Violation|1
7718130|NCT00525512|12141934|FG002|Double-Blind Phase|Protocol Violation|0
7718131|NCT00525512|12141935|FG003|Double-Blind Phase|Protocol Violation|0
7718132|NCT00525512|12141932|FG000|Double-Blind Phase|Lost to Follow-up|3
7718133|NCT00525512|12141933|FG001|Double-Blind Phase|Lost to Follow-up|7
7718134|NCT00525512|12141934|FG002|Double-Blind Phase|Lost to Follow-up|0
7718135|NCT00525512|12141935|FG003|Double-Blind Phase|Lost to Follow-up|0
7984846|NCT03152552|12557602|FG003|Treatment Period 1 (12 Weeks)|Death|0
7718136|NCT00525512|12141932|FG000|Double-Blind Phase|Withdrawal by Subject|17
7718137|NCT00525512|12141933|FG001|Double-Blind Phase|Withdrawal by Subject|12
7718138|NCT00525512|12141934|FG002|Double-Blind Phase|Withdrawal by Subject|0
7718139|NCT00525512|12141935|FG003|Double-Blind Phase|Withdrawal by Subject|0
7718140|NCT00525512|12141932|FG000|Double-Blind Phase|Lack of Efficacy|13
7718141|NCT00525512|12141933|FG001|Double-Blind Phase|Lack of Efficacy|5
7718142|NCT00525512|12141934|FG002|Double-Blind Phase|Lack of Efficacy|0
7718143|NCT00525512|12141935|FG003|Double-Blind Phase|Lack of Efficacy|0
7718144|NCT00525512|12141932|FG000|Double-Blind Phase|Other reason (not specified)|12
7718145|NCT00525512|12141933|FG001|Double-Blind Phase|Other reason (not specified)|13
7718146|NCT00525512|12141934|FG002|Double-Blind Phase|Other reason (not specified)|0
7718147|NCT00525512|12141935|FG003|Double-Blind Phase|Other reason (not specified)|0
7718148|NCT00525512|12141932|FG000|Open-Label Phase|Adverse Event|0
7718149|NCT00525512|12141933|FG001|Open-Label Phase|Adverse Event|0
7718150|NCT00525512|12141934|FG002|Open-Label Phase|Adverse Event|1
7718151|NCT00525512|12141935|FG003|Open-Label Phase|Adverse Event|0
7718152|NCT00525512|12141932|FG000|Open-Label Phase|Lost to Follow-up|0
7718153|NCT00525512|12141933|FG001|Open-Label Phase|Lost to Follow-up|0
7718154|NCT00525512|12141934|FG002|Open-Label Phase|Lost to Follow-up|1
7718155|NCT00525512|12141935|FG003|Open-Label Phase|Lost to Follow-up|0
7718156|NCT00525512|12141932|FG000|Open-Label Phase|Other reason (not specified)|0
7984847|NCT03152552|12557603|FG004|Treatment Period 1 (12 Weeks)|Death|1
7984848|NCT03152552|12557599|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7984849|NCT03152552|12557600|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1
7984850|NCT03152552|12557601|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7984851|NCT03152552|12557602|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7984852|NCT03152552|12557603|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7984853|NCT03152552|12557599|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8
7984854|NCT03152552|12557600|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9
7984855|NCT03152552|12557601|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
7984856|NCT03152552|12557602|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
7984857|NCT03152552|12557603|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20
7984858|NCT03152552|12557599|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7984859|NCT03152552|12557600|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7984860|NCT03152552|12557601|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7984861|NCT03152552|12557602|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7984862|NCT03152552|12557603|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7984863|NCT03152552|12557599|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0
7984864|NCT03152552|12557600|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0
7984865|NCT03152552|12557601|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1
7984866|NCT03152552|12557602|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0
7984867|NCT03152552|12557603|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0
7984868|NCT03152552|12557599|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7984869|NCT03152552|12557600|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7984870|NCT03152552|12557601|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7984871|NCT03152552|12557602|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1
7984872|NCT03152552|12557603|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7984873|NCT03152552|12557599|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6
7984874|NCT03152552|12557600|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5
7984875|NCT03152552|12557601|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
7984876|NCT03152552|12557602|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
7984877|NCT03152552|12557603|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11
7984878|NCT03154047|12557634|FG000|Overall Study|Death|1
7984879|NCT03154047|12557634|FG000|Overall Study|Study terminated by sponsor|76
7984880|NCT03154047|12557634|FG000|Overall Study|Withdrawal by Subject|3
7984881|NCT03154086|12557653|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7984882|NCT03154086|12557654|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7984883|NCT03154086|12557655|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7984884|NCT03154086|12557656|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1
7984885|NCT03154086|12557657|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7984886|NCT03154086|12557658|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7984887|NCT03154086|12557659|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7984888|NCT03154086|12557660|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7984889|NCT03154086|12557661|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7984890|NCT03154086|12557662|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7984891|NCT03154086|12557663|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7984892|NCT03154086|12557664|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7984893|NCT03154086|12557665|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7984894|NCT03154086|12557666|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7984895|NCT03154086|12557667|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7984896|NCT03154086|12557653|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7984897|NCT03154086|12557654|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1
7984898|NCT03154086|12557655|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7984899|NCT03154086|12557656|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7984900|NCT03154086|12557657|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7984901|NCT03154086|12557658|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7984902|NCT03154086|12557659|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7984903|NCT03154086|12557660|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7984904|NCT03154086|12557661|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7984905|NCT03154086|12557662|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7984906|NCT03154086|12557663|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7984907|NCT03154086|12557664|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7984908|NCT03154086|12557665|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7984909|NCT03154086|12557666|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7984910|NCT03154086|12557667|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7984911|NCT03154086|12557653|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7984912|NCT03154086|12557654|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7984913|NCT03154086|12557655|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1
7984914|NCT03154086|12557656|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7984915|NCT03154086|12557657|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7984916|NCT03154086|12557658|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7984917|NCT03154086|12557659|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7984918|NCT03154086|12557660|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7984919|NCT03154086|12557661|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7984920|NCT03154086|12557662|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7984921|NCT03154086|12557663|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7984922|NCT03154086|12557664|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7984923|NCT03154086|12557665|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7984924|NCT03154086|12557666|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7984925|NCT03154086|12557667|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7984926|NCT03154086|12557653|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1
7984927|NCT03154086|12557654|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7984928|NCT03154086|12557655|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7984929|NCT03154086|12557656|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7984930|NCT03154086|12557657|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7984931|NCT03154086|12557658|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7984932|NCT03154086|12557659|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7984933|NCT03154086|12557660|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7984934|NCT03154086|12557661|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7984935|NCT03154086|12557662|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7984936|NCT03154086|12557663|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7984937|NCT03154086|12557664|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7984938|NCT03154086|12557665|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7984939|NCT03154086|12557666|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7984940|NCT03154086|12557667|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7984941|NCT03154086|12557653|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7984942|NCT03154086|12557654|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7984943|NCT03154086|12557655|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7984944|NCT03154086|12557656|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7984945|NCT03154086|12557657|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7984946|NCT03154086|12557658|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7984947|NCT03154086|12557659|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7984948|NCT03154086|12557660|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7984949|NCT03154086|12557661|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1
7984950|NCT03154086|12557662|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7984951|NCT03154086|12557663|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7984952|NCT03154086|12557664|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7984953|NCT03154086|12557665|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7984954|NCT03154086|12557666|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7984955|NCT03154086|12557667|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7984956|NCT03154086|12557653|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7984957|NCT03154086|12557654|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7984958|NCT03154086|12557655|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7984959|NCT03154086|12557656|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7984960|NCT03154086|12557657|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7984961|NCT03154086|12557658|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7984962|NCT03154086|12557659|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7984963|NCT03154086|12557660|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1
7984964|NCT03154086|12557661|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7984965|NCT03154086|12557662|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7984966|NCT03154086|12557663|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7984967|NCT03154086|12557664|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7984968|NCT03154086|12557665|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7984969|NCT03154086|12557666|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7984970|NCT03154086|12557667|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7984971|NCT03154086|12557653|FG000|Part B (Up to 25 Days)|Adverse Event|0
7984972|NCT03154086|12557654|FG001|Part B (Up to 25 Days)|Adverse Event|0
7984973|NCT03154086|12557655|FG002|Part B (Up to 25 Days)|Adverse Event|0
7984974|NCT03154086|12557656|FG003|Part B (Up to 25 Days)|Adverse Event|0
7984975|NCT03154086|12557657|FG004|Part B (Up to 25 Days)|Adverse Event|0
7984976|NCT03154086|12557658|FG005|Part B (Up to 25 Days)|Adverse Event|0
7984977|NCT03154086|12557659|FG006|Part B (Up to 25 Days)|Adverse Event|0
7984978|NCT03154086|12557660|FG007|Part B (Up to 25 Days)|Adverse Event|0
7984979|NCT03154086|12557661|FG008|Part B (Up to 25 Days)|Adverse Event|0
7984980|NCT03154086|12557662|FG009|Part B (Up to 25 Days)|Adverse Event|0
7984981|NCT03154086|12557663|FG010|Part B (Up to 25 Days)|Adverse Event|1
7984982|NCT03154086|12557664|FG011|Part B (Up to 25 Days)|Adverse Event|0
7984983|NCT03154086|12557665|FG012|Part B (Up to 25 Days)|Adverse Event|0
7984984|NCT03154086|12557666|FG013|Part B (Up to 25 Days)|Adverse Event|0
7984985|NCT03154086|12557667|FG014|Part B (Up to 25 Days)|Adverse Event|0
7984986|NCT03154476|12557735|FG000|Overall Study|Lost to Follow-up|4
7984987|NCT03154476|12557736|FG001|Overall Study|Lost to Follow-up|4
7984988|NCT03155178|12557764|FG000|Overall Study|Did not meet treatment day baseline|7
7984989|NCT03155178|12557765|FG001|Overall Study|Did not meet treatment day baseline|7
7984990|NCT03155178|12557766|FG002|Overall Study|Did not meet treatment day baseline|7
7984991|NCT03155178|12557767|FG003|Overall Study|Did not meet treatment day baseline|7
7984992|NCT03155269|12557783|FG000|Overall Study|Withdrawal by Subject|4
7984993|NCT03155269|12557784|FG001|Overall Study|Withdrawal by Subject|5
7984994|NCT03155269|12557783|FG000|Overall Study|Lost to Follow-up|1
7984995|NCT03155269|12557784|FG001|Overall Study|Lost to Follow-up|2
7984996|NCT03155724|12557790|FG000|Overall Study|Death|3
7984997|NCT03155724|12557790|FG000|Overall Study|Physician Decision|1
7984998|NCT03155724|12557790|FG000|Overall Study|Study closure|7
7984999|NCT03155945|12557796|FG000|Overall Study|Lost to Follow-up|0
7985000|NCT03155945|12557797|FG001|Overall Study|Lost to Follow-up|1
7985001|NCT03155945|12557796|FG000|Overall Study|Withdrawal by Subject|0
7985002|NCT03155945|12557797|FG001|Overall Study|Withdrawal by Subject|1
7985003|NCT03155945|12557796|FG000|Overall Study|Other Reason|0
7985004|NCT03155945|12557797|FG001|Overall Study|Other Reason|1
7985005|NCT03156270|12557803|FG000|Overall Study|Failed pre-treatment screening|1
7985006|NCT03156270|12557803|FG000|Overall Study|Lost to Follow-up|1
7985007|NCT03156543|12557811|FG000|Overall Study|Withdrawal by Subject|1
7985008|NCT03156543|12557812|FG001|Overall Study|Withdrawal by Subject|0
7985009|NCT03156621|12557820|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0
7985010|NCT03156621|12557821|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2
7985011|NCT03156621|12557820|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0
7985012|NCT03156621|12557821|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1
7985013|NCT03157089|12557832|FG000|Overall Study|Treated only with pembrolizumab|1
7985014|NCT03157089|12557833|FG001|Overall Study|Treated only with pembrolizumab|0
7985015|NCT03157089|12557832|FG000|Overall Study|Adverse Event|5
7985016|NCT03157089|12557833|FG001|Overall Study|Adverse Event|4
7985017|NCT03157089|12557832|FG000|Overall Study|Progressive disease|6
7985018|NCT03157089|12557833|FG001|Overall Study|Progressive disease|8
7985019|NCT03157531|12557844|FG000|Overall Study|Death|2
7985020|NCT03157531|12557844|FG000|Overall Study|Lost to Follow-up|4
7985021|NCT03157583|12557848|FG000|Overall Study|Other (did not meet study criteria)|1
7985022|NCT03158012|12557868|FG000|Overall Study|Withdrawal by Subject|0
7985023|NCT03158012|12557869|FG001|Overall Study|Withdrawal by Subject|1
7985024|NCT03158220|12557890|FG000|Overall Study|Screen Failure|0
7985025|NCT03158220|12557891|FG001|Overall Study|Screen Failure|1
7985026|NCT03158220|12557890|FG000|Overall Study|Withdrawal by Subject|8
7985027|NCT03158220|12557891|FG001|Overall Study|Withdrawal by Subject|9
7985028|NCT03158220|12557890|FG000|Overall Study|Status unknown|0
7985029|NCT03158220|12557891|FG001|Overall Study|Status unknown|1
7985030|NCT03158220|12557890|FG000|Overall Study|Lost to Follow-up|8
7985031|NCT03158220|12557891|FG001|Overall Study|Lost to Follow-up|5
7985032|NCT03158220|12557890|FG000|Overall Study|Physician Decision|1
7985033|NCT03158220|12557891|FG001|Overall Study|Physician Decision|0
7985034|NCT03158272|12557901|FG000|Overall Study|Disease progression|3
7985035|NCT03158272|12557902|FG001|Overall Study|Disease progression|3
7985036|NCT03158272|12557903|FG002|Overall Study|Disease progression|4
7985037|NCT03158272|12557904|FG003|Overall Study|Disease progression|6
7985038|NCT03158272|12557901|FG000|Overall Study|Death|0
7985039|NCT03158272|12557902|FG001|Overall Study|Death|0
7985040|NCT03158272|12557903|FG002|Overall Study|Death|1
7985041|NCT03158272|12557904|FG003|Overall Study|Death|0
7985042|NCT03158272|12557901|FG000|Overall Study|Other reasons|0
7985043|NCT03158272|12557902|FG001|Overall Study|Other reasons|0
7985044|NCT03158272|12557903|FG002|Overall Study|Other reasons|1
7985045|NCT03158272|12557904|FG003|Overall Study|Other reasons|0
7985046|NCT03158272|12557901|FG000|Overall Study|Adverse event unrelated to the drug|0
7985047|NCT03158272|12557902|FG001|Overall Study|Adverse event unrelated to the drug|1
7985048|NCT03158272|12557903|FG002|Overall Study|Adverse event unrelated to the drug|0
7985049|NCT03158272|12557904|FG003|Overall Study|Adverse event unrelated to the drug|0
7985050|NCT03158311|12557919|FG000|Overall Study|Subject/Guardian Decision|10
7985051|NCT03158311|12557920|FG001|Overall Study|Subject/Guardian Decision|6
7985052|NCT03158311|12557921|FG002|Overall Study|Subject/Guardian Decision|11
7985053|NCT03158311|12557919|FG000|Overall Study|Adverse Event|5
7985054|NCT03158311|12557920|FG001|Overall Study|Adverse Event|3
7985055|NCT03158311|12557921|FG002|Overall Study|Adverse Event|3
7985056|NCT03158311|12557919|FG000|Overall Study|Techinical Problems|3
7985057|NCT03158311|12557920|FG001|Overall Study|Techinical Problems|1
7985058|NCT03158311|12557921|FG002|Overall Study|Techinical Problems|5
7985059|NCT03158311|12557919|FG000|Overall Study|Physician Decision|2
7985060|NCT03158311|12557920|FG001|Overall Study|Physician Decision|3
7985061|NCT03158311|12557921|FG002|Overall Study|Physician Decision|7
7985062|NCT03158311|12557919|FG000|Overall Study|Lost to Follow-up|1
7985063|NCT03158311|12557920|FG001|Overall Study|Lost to Follow-up|1
7985064|NCT03158311|12557921|FG002|Overall Study|Lost to Follow-up|1
7985065|NCT03158311|12557919|FG000|Overall Study|Sponsor decision|1
7985066|NCT03158311|12557920|FG001|Overall Study|Sponsor decision|0
7985067|NCT03158311|12557921|FG002|Overall Study|Sponsor decision|0
7985068|NCT03158311|12557919|FG000|Overall Study|Pregnancy|0
7985069|NCT03158311|12557920|FG001|Overall Study|Pregnancy|2
7985070|NCT03158311|12557921|FG002|Overall Study|Pregnancy|0
7985071|NCT03158311|12557919|FG000|Overall Study|Randomized in error|0
7985072|NCT03158311|12557920|FG001|Overall Study|Randomized in error|0
7985073|NCT03158311|12557921|FG002|Overall Study|Randomized in error|1
7985074|NCT03159091|12557944|FG000|Overall Study|Incorrect inclusion ineligible patient|5
7985075|NCT03159091|12557945|FG001|Overall Study|Incorrect inclusion ineligible patient|3
7985076|NCT03159091|12557944|FG000|Overall Study|Patient has taken no dose of study drug|0
7985077|NCT03159091|12557945|FG001|Overall Study|Patient has taken no dose of study drug|1
7985078|NCT03159455|12557979|FG000|Overall Study|Adverse Event|0
7985079|NCT03159455|12557980|FG001|Overall Study|Adverse Event|0
7985080|NCT03159455|12557981|FG002|Overall Study|Adverse Event|0
7985081|NCT03159455|12557982|FG003|Overall Study|Adverse Event|0
7985082|NCT03159455|12557983|FG004|Overall Study|Adverse Event|0
7985083|NCT03159455|12557984|FG005|Overall Study|Adverse Event|1
7985084|NCT03159468|12558008|FG000|Overall Study|Withdrawal by Subject|0
7985085|NCT03159468|12558009|FG001|Overall Study|Withdrawal by Subject|0
7985086|NCT03159468|12558010|FG002|Overall Study|Withdrawal by Subject|3
7985087|NCT03159468|12558011|FG003|Overall Study|Withdrawal by Subject|0
7985088|NCT03159468|12558012|FG004|Overall Study|Withdrawal by Subject|0
7985089|NCT03159468|12558013|FG005|Overall Study|Withdrawal by Subject|0
7985090|NCT03159611|12558029|FG000|Overall Study|Did Not Meet Inclusion Criteria|9
7985091|NCT03159611|12558030|FG001|Overall Study|Did Not Meet Inclusion Criteria|5
7985092|NCT03159611|12558029|FG000|Overall Study|Did Not Meet Exclusion Criteria|1
7985093|NCT03159611|12558030|FG001|Overall Study|Did Not Meet Exclusion Criteria|3
7985094|NCT03159611|12558029|FG000|Overall Study|Protocol Violation|7
7985095|NCT03159611|12558030|FG001|Overall Study|Protocol Violation|4
7985096|NCT03159611|12558029|FG000|Overall Study|Adverse Event|1
7985097|NCT03159611|12558030|FG001|Overall Study|Adverse Event|0
7985098|NCT03159611|12558029|FG000|Overall Study|Withdrawal by Subject|1
7985099|NCT03159611|12558030|FG001|Overall Study|Withdrawal by Subject|1
7985100|NCT03159611|12558029|FG000|Overall Study|Non-compliance with protocol requirement|3
7985101|NCT03159611|12558030|FG001|Overall Study|Non-compliance with protocol requirement|2
7985102|NCT03159611|12558029|FG000|Overall Study|Inability to perform procedures|1
7985103|NCT03159611|12558030|FG001|Overall Study|Inability to perform procedures|0
7985104|NCT03160560|12558080|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2
7985105|NCT03160560|12558081|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
7985106|NCT03160560|12558082|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1
7985107|NCT03160560|12558083|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0
7985108|NCT03160560|12558080|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1
7985109|NCT03160560|12558081|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7985110|NCT03160560|12558082|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7985111|NCT03160560|12558083|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7985112|NCT03160573|12558097|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1
7985113|NCT03160573|12558098|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3
7985114|NCT03160573|12558099|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2
7985115|NCT03160573|12558100|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2
7985116|NCT03160703|12558114|FG000|Overall Study|Withdrawal by Subject|0
7985117|NCT03160703|12558115|FG001|Overall Study|Withdrawal by Subject|0
7985118|NCT03160703|12558116|FG002|Overall Study|Withdrawal by Subject|0
7985119|NCT03160703|12558117|FG003|Overall Study|Withdrawal by Subject|1
7985120|NCT03160885|12558129|FG000|Initial Treatment Period|Not dosed|2
7985121|NCT03160885|12558130|FG001|Initial Treatment Period|Not dosed|0
7985122|NCT03160885|12558131|FG002|Initial Treatment Period|Not dosed|0
7985123|NCT03160885|12558132|FG003|Initial Treatment Period|Not dosed|0
7985124|NCT03160885|12558133|FG004|Initial Treatment Period|Not dosed|0
7985125|NCT03160885|12558134|FG005|Initial Treatment Period|Not dosed|0
7985126|NCT03160885|12558135|FG006|Initial Treatment Period|Not dosed|0
7985127|NCT03160885|12558129|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33
7985128|NCT03160885|12558130|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22
7985129|NCT03160885|12558131|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0
7985130|NCT03160885|12558132|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0
7985131|NCT03160885|12558133|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0
7985132|NCT03160885|12558134|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0
7985133|NCT03160885|12558135|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0
7985134|NCT03160885|12558129|FG000|Open-label Treatment|Not dosed|0
7985135|NCT03160885|12558130|FG001|Open-label Treatment|Not dosed|0
7985136|NCT03160885|12558131|FG002|Open-label Treatment|Not dosed|0
7985137|NCT03160885|12558132|FG003|Open-label Treatment|Not dosed|0
7985138|NCT03160885|12558133|FG004|Open-label Treatment|Not dosed|0
7985139|NCT03160885|12558134|FG005|Open-label Treatment|Not dosed|0
7985140|NCT03160885|12558135|FG006|Open-label Treatment|Not dosed|2
7985141|NCT03160885|12558129|FG000|Open-label Treatment|Discontinued IMP|0
7985142|NCT03160885|12558130|FG001|Open-label Treatment|Discontinued IMP|0
7985143|NCT03160885|12558131|FG002|Open-label Treatment|Discontinued IMP|0
7985144|NCT03160885|12558132|FG003|Open-label Treatment|Discontinued IMP|0
7985145|NCT03160885|12558133|FG004|Open-label Treatment|Discontinued IMP|0
7985146|NCT03160885|12558134|FG005|Open-label Treatment|Discontinued IMP|0
7985147|NCT03160885|12558135|FG006|Open-label Treatment|Discontinued IMP|131
7985148|NCT03160885|12558129|FG000|Open-label Treatment|Completed Week 50|0
7985149|NCT03160885|12558130|FG001|Open-label Treatment|Completed Week 50|0
7985150|NCT03160885|12558131|FG002|Open-label Treatment|Completed Week 50|0
7985151|NCT03160885|12558132|FG003|Open-label Treatment|Completed Week 50|0
7985152|NCT03160885|12558133|FG004|Open-label Treatment|Completed Week 50|0
7985153|NCT03160885|12558134|FG005|Open-label Treatment|Completed Week 50|0
7985154|NCT03160885|12558135|FG006|Open-label Treatment|Completed Week 50|4
7985155|NCT03160885|12558129|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7985156|NCT03160885|12558130|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7985157|NCT03160885|12558131|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7985158|NCT03160885|12558132|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1
7985159|NCT03160885|12558133|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7985160|NCT03160885|12558134|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7985161|NCT03160885|12558135|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7985162|NCT03160885|12558129|FG000|Maintenance Treatment Period|Discontinued IMP|0
7985163|NCT03160885|12558130|FG001|Maintenance Treatment Period|Discontinued IMP|0
7985164|NCT03160885|12558131|FG002|Maintenance Treatment Period|Discontinued IMP|9
7985165|NCT03160885|12558132|FG003|Maintenance Treatment Period|Discontinued IMP|13
7985166|NCT03160885|12558133|FG004|Maintenance Treatment Period|Discontinued IMP|5
7985167|NCT03160885|12558134|FG005|Maintenance Treatment Period|Discontinued IMP|7
7985168|NCT03160885|12558135|FG006|Maintenance Treatment Period|Discontinued IMP|0
7985169|NCT03160885|12558129|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0
7985170|NCT03160885|12558130|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0
7985171|NCT03160885|12558131|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29
7985172|NCT03160885|12558132|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26
7985173|NCT03160885|12558133|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26
7985174|NCT03160885|12558134|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8
7985175|NCT03160885|12558135|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0
7985176|NCT03160885|12558129|FG000|Maintenance Treatment Period|Completed Week 50|0
7985177|NCT03160885|12558130|FG001|Maintenance Treatment Period|Completed Week 50|0
7985178|NCT03160885|12558131|FG002|Maintenance Treatment Period|Completed Week 50|1
7985179|NCT03160885|12558132|FG003|Maintenance Treatment Period|Completed Week 50|0
7985180|NCT03160885|12558133|FG004|Maintenance Treatment Period|Completed Week 50|0
7985181|NCT03160885|12558134|FG005|Maintenance Treatment Period|Completed Week 50|0
7985182|NCT03160885|12558135|FG006|Maintenance Treatment Period|Completed Week 50|0
7985183|NCT03160898|12558156|FG000|Overall Study|Adverse Event|4
7985184|NCT03160898|12558157|FG001|Overall Study|Adverse Event|8
7985185|NCT03160898|12558158|FG002|Overall Study|Adverse Event|7
7985186|NCT03160898|12558159|FG003|Overall Study|Adverse Event|10
7985187|NCT03160898|12558156|FG000|Overall Study|Death|1
7985188|NCT03160898|12558157|FG001|Overall Study|Death|0
7985189|NCT03160898|12558158|FG002|Overall Study|Death|0
7985190|NCT03160898|12558159|FG003|Overall Study|Death|1
7985191|NCT03160898|12558156|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3
7985192|NCT03160898|12558157|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0
7985193|NCT03160898|12558158|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0
7985194|NCT03160898|12558159|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1
7985195|NCT03160898|12558156|FG000|Overall Study|Lost to Follow-up|1
7985196|NCT03160898|12558157|FG001|Overall Study|Lost to Follow-up|1
7985197|NCT03160898|12558158|FG002|Overall Study|Lost to Follow-up|1
7985198|NCT03160898|12558159|FG003|Overall Study|Lost to Follow-up|2
7985199|NCT03160898|12558156|FG000|Overall Study|Physician Decision|1
7985200|NCT03160898|12558157|FG001|Overall Study|Physician Decision|0
7985201|NCT03160898|12558158|FG002|Overall Study|Physician Decision|0
7985202|NCT03160898|12558159|FG003|Overall Study|Physician Decision|1
7985203|NCT03160898|12558156|FG000|Overall Study|Progressive Disease|4
7985204|NCT03160898|12558157|FG001|Overall Study|Progressive Disease|1
7985205|NCT03160898|12558158|FG002|Overall Study|Progressive Disease|2
7985206|NCT03160898|12558159|FG003|Overall Study|Progressive Disease|1
7985207|NCT03160898|12558156|FG000|Overall Study|Protocol Violation|1
7985208|NCT03160898|12558157|FG001|Overall Study|Protocol Violation|0
7985209|NCT03160898|12558158|FG002|Overall Study|Protocol Violation|2
7985210|NCT03160898|12558159|FG003|Overall Study|Protocol Violation|0
7985211|NCT03160898|12558156|FG000|Overall Study|Sponsor Discretion|2
7985212|NCT03160898|12558157|FG001|Overall Study|Sponsor Discretion|0
7985213|NCT03160898|12558158|FG002|Overall Study|Sponsor Discretion|0
7985214|NCT03160898|12558159|FG003|Overall Study|Sponsor Discretion|0
7985215|NCT03160898|12558156|FG000|Overall Study|Withdrawal by Subject|1
7985216|NCT03160898|12558157|FG001|Overall Study|Withdrawal by Subject|3
7985217|NCT03160898|12558158|FG002|Overall Study|Withdrawal by Subject|2
7985218|NCT03160898|12558159|FG003|Overall Study|Withdrawal by Subject|1
7985219|NCT03160898|12558156|FG000|Overall Study|Other|2
7985220|NCT03160898|12558157|FG001|Overall Study|Other|0
7985221|NCT03160898|12558158|FG002|Overall Study|Other|2
7985222|NCT03160898|12558159|FG003|Overall Study|Other|2
7985223|NCT03161405|12558184|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1
7985224|NCT03161483|12558195|FG000|Overall Study|Death|1
7985225|NCT03161483|12558196|FG001|Overall Study|Death|0
7985226|NCT03161483|12558197|FG002|Overall Study|Death|0
7985227|NCT03161483|12558198|FG003|Overall Study|Death|0
7985228|NCT03161483|12558195|FG000|Overall Study|Adverse Event|5
7985229|NCT03161483|12558196|FG001|Overall Study|Adverse Event|1
7985230|NCT03161483|12558197|FG002|Overall Study|Adverse Event|11
7985231|NCT03161483|12558198|FG003|Overall Study|Adverse Event|2
7985232|NCT03161483|12558195|FG000|Overall Study|Pregnancy|1
7985233|NCT03161483|12558196|FG001|Overall Study|Pregnancy|0
7985234|NCT03161483|12558197|FG002|Overall Study|Pregnancy|0
7985235|NCT03161483|12558198|FG003|Overall Study|Pregnancy|0
7985236|NCT03161483|12558195|FG000|Overall Study|Lack of Efficacy|0
7985237|NCT03161483|12558196|FG001|Overall Study|Lack of Efficacy|0
7985238|NCT03161483|12558197|FG002|Overall Study|Lack of Efficacy|1
7985239|NCT03161483|12558198|FG003|Overall Study|Lack of Efficacy|0
7985240|NCT03161483|12558195|FG000|Overall Study|Withdrawal by Subject|2
7985241|NCT03161483|12558196|FG001|Overall Study|Withdrawal by Subject|2
7985242|NCT03161483|12558197|FG002|Overall Study|Withdrawal by Subject|6
7985243|NCT03161483|12558198|FG003|Overall Study|Withdrawal by Subject|5
7985244|NCT03161483|12558195|FG000|Overall Study|Lost to Follow-up|0
7985245|NCT03161483|12558196|FG001|Overall Study|Lost to Follow-up|0
7985246|NCT03161483|12558197|FG002|Overall Study|Lost to Follow-up|1
7985247|NCT03161483|12558198|FG003|Overall Study|Lost to Follow-up|0
7985248|NCT03161483|12558195|FG000|Overall Study|Protocol Violation|0
7985249|NCT03161483|12558196|FG001|Overall Study|Protocol Violation|0
7985250|NCT03161483|12558197|FG002|Overall Study|Protocol Violation|1
7985251|NCT03161483|12558198|FG003|Overall Study|Protocol Violation|0
7985252|NCT03161483|12558195|FG000|Overall Study|Other reasons|1
7985253|NCT03161483|12558196|FG001|Overall Study|Other reasons|0
7985254|NCT03161483|12558197|FG002|Overall Study|Other reasons|0
7985255|NCT03161483|12558198|FG003|Overall Study|Other reasons|1
7985256|NCT03162055|12558219|FG000|Overall Study|Adverse Event|6
7985257|NCT03162055|12558220|FG001|Overall Study|Adverse Event|5
7985258|NCT03162055|12558219|FG000|Overall Study|Death|3
7985259|NCT03162055|12558220|FG001|Overall Study|Death|3
7985260|NCT03162055|12558219|FG000|Overall Study|Lost to Follow-up|0
7985261|NCT03162055|12558220|FG001|Overall Study|Lost to Follow-up|1
7985262|NCT03162055|12558219|FG000|Overall Study|Study-specific withdrawal criteria|22
7985263|NCT03162055|12558220|FG001|Overall Study|Study-specific withdrawal criteria|14
7985264|NCT03162055|12558219|FG000|Overall Study|Withdrawal by Subject|17
7985265|NCT03162055|12558220|FG001|Overall Study|Withdrawal by Subject|2
7985266|NCT03162055|12558219|FG000|Overall Study|Did not receive treatment|2
7985267|NCT03162055|12558220|FG001|Overall Study|Did not receive treatment|0
7985268|NCT03162055|12558219|FG000|Overall Study|Incorrect randomization|4
7985269|NCT03162055|12558220|FG001|Overall Study|Incorrect randomization|3
7985270|NCT03162055|12558219|FG000|Overall Study|Other|8
7985271|NCT03162055|12558220|FG001|Overall Study|Other|15
7985272|NCT03162328|12558226|FG000|Screening Period|Did not meet inclusion/exclusion|21
7985273|NCT03162328|12558227|FG001|Screening Period|Did not meet inclusion/exclusion|0
7985274|NCT03162328|12558228|FG002|Screening Period|Did not meet inclusion/exclusion|0
7985275|NCT03162328|12558226|FG000|Screening Period|Withdrawal by Subject|1
7985276|NCT03162328|12558227|FG001|Screening Period|Withdrawal by Subject|0
7985277|NCT03162328|12558228|FG002|Screening Period|Withdrawal by Subject|0
7985278|NCT03162328|12558226|FG000|Study Period|Withdrawal by Subject|0
7985279|NCT03162328|12558227|FG001|Study Period|Withdrawal by Subject|0
7985280|NCT03162328|12558228|FG002|Study Period|Withdrawal by Subject|1
7985281|NCT03162614|12558268|FG000|Overall Study|Lost to Follow-up|2
7985282|NCT03162614|12558269|FG001|Overall Study|Lost to Follow-up|1
7985283|NCT03162614|12558270|FG002|Overall Study|Lost to Follow-up|1
7985284|NCT03162614|12558271|FG003|Overall Study|Lost to Follow-up|1
7985285|NCT03162614|12558272|FG004|Overall Study|Lost to Follow-up|2
7985286|NCT03162614|12558273|FG005|Overall Study|Lost to Follow-up|0
7985287|NCT03162614|12558268|FG000|Overall Study|Protocol Violation|0
7985288|NCT03162614|12558269|FG001|Overall Study|Protocol Violation|1
7985289|NCT03162614|12558270|FG002|Overall Study|Protocol Violation|0
7985290|NCT03162614|12558271|FG003|Overall Study|Protocol Violation|1
7985291|NCT03162614|12558272|FG004|Overall Study|Protocol Violation|0
7985292|NCT03162614|12558273|FG005|Overall Study|Protocol Violation|0
7985293|NCT03162614|12558268|FG000|Overall Study|Withdrawal by Subject|2
7985294|NCT03162614|12558269|FG001|Overall Study|Withdrawal by Subject|1
7985295|NCT03162614|12558270|FG002|Overall Study|Withdrawal by Subject|1
7985296|NCT03162614|12558271|FG003|Overall Study|Withdrawal by Subject|1
7985297|NCT03162614|12558272|FG004|Overall Study|Withdrawal by Subject|0
7985298|NCT03162614|12558273|FG005|Overall Study|Withdrawal by Subject|0
7985299|NCT03162614|12558268|FG000|Overall Study|Missed vaccination, exclusion criteria|2
7985300|NCT03162614|12558269|FG001|Overall Study|Missed vaccination, exclusion criteria|2
7985301|NCT03162614|12558270|FG002|Overall Study|Missed vaccination, exclusion criteria|2
7985302|NCT03162614|12558271|FG003|Overall Study|Missed vaccination, exclusion criteria|4
7985303|NCT03162614|12558272|FG004|Overall Study|Missed vaccination, exclusion criteria|3
7985304|NCT03162614|12558273|FG005|Overall Study|Missed vaccination, exclusion criteria|0
7985305|NCT03162796|12558290|FG000|Placebo Controlled Period: Week 0 - 24|Other|0
7985306|NCT03162796|12558291|FG001|Placebo Controlled Period: Week 0 - 24|Other|1
7985307|NCT03162796|12558292|FG002|Placebo Controlled Period: Week 0 - 24|Other|1
7985308|NCT03162796|12558290|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1
7985309|NCT03162796|12558291|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
7985310|NCT03162796|12558292|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
7985311|NCT03162796|12558290|FG000|Placebo Controlled Period: Week 0 - 24|Death|1
7985312|NCT03162796|12558291|FG001|Placebo Controlled Period: Week 0 - 24|Death|0
7985313|NCT03162796|12558292|FG002|Placebo Controlled Period: Week 0 - 24|Death|0
7985314|NCT03162796|12558290|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1
7985315|NCT03162796|12558291|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
7985316|NCT03162796|12558292|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
7985317|NCT03162796|12558290|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3
7985318|NCT03162796|12558291|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0
7985319|NCT03162796|12558292|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1
7985320|NCT03162796|12558290|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4
7985321|NCT03162796|12558291|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
7985322|NCT03162796|12558292|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
7985323|NCT03162796|12558290|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2
7985324|NCT03162796|12558291|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3
7985325|NCT03162796|12558292|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1
7985326|NCT03162796|12558290|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
7985327|NCT03162796|12558291|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
7985328|NCT03162796|12558292|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
7985329|NCT03162796|12558290|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
7985330|NCT03162796|12558291|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
7985331|NCT03162796|12558292|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1
7985332|NCT03162796|12558290|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3
7985333|NCT03162796|12558291|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2
7985334|NCT03162796|12558292|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0
7985335|NCT03162796|12558290|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
7985336|NCT03162796|12558291|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2
7985337|NCT03162796|12558292|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
7985338|NCT03163446|12558333|FG000|Overall Study|Unable to return for Day 180 visit|2
7985339|NCT03163446|12558334|FG001|Overall Study|Unable to return for Day 180 visit|0
7985340|NCT03163446|12558333|FG000|Overall Study|Withdrawal by Subject|2
7985341|NCT03163446|12558334|FG001|Overall Study|Withdrawal by Subject|6
7985342|NCT03163446|12558333|FG000|Overall Study|Death|16
7985343|NCT03163446|12558334|FG001|Overall Study|Death|5
7985344|NCT03163446|12558333|FG000|Overall Study|Lost to Follow-up|6
7985345|NCT03163446|12558334|FG001|Overall Study|Lost to Follow-up|5
7985346|NCT03163446|12558333|FG000|Overall Study|Physician Decision|1
7985347|NCT03163446|12558334|FG001|Overall Study|Physician Decision|1
7985348|NCT03163446|12558333|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1
7985349|NCT03163446|12558334|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0
7985350|NCT03164551|12558377|FG000|Overall Study|Imaging discontinued prior completion|8
7985351|NCT03164551|12558378|FG001|Overall Study|Imaging discontinued prior completion|0
7985352|NCT03164551|12558377|FG000|Overall Study|Participant was non-compliant|1
7985353|NCT03164551|12558378|FG001|Overall Study|Participant was non-compliant|0
7985354|NCT03164551|12558377|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12
7985355|NCT03164551|12558378|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14
7985356|NCT03164551|12558377|FG000|Overall Study|Other|8
7985357|NCT03164551|12558378|FG001|Overall Study|Other|2
7985358|NCT03165045|12558393|FG000|Visit 1|No registration after visit 1|9
7985359|NCT03165045|12558393|FG000|Visit 1|No treatment documented|10
7985360|NCT03165045|12558393|FG000|Visit 1|No visit 1|10
7985361|NCT03165045|12558393|FG000|Visit 2|Available CCQ score at visit 1 only|109
7985362|NCT03165045|12558393|FG000|Visit 2|No available total CCQ score at all|29
7985363|NCT03165045|12558393|FG000|Visit 2|Available total CCQ score at vist 2 only|44
7985364|NCT03165110|12558408|FG000|Overall Study|Anroid phone software incompatibility|1
7985365|NCT03166124|12558459|FG000|Treatment Period 1|Adverse Event|0
7985366|NCT03166124|12558460|FG001|Treatment Period 1|Adverse Event|0
7985367|NCT03166124|12558461|FG002|Treatment Period 1|Adverse Event|1
7985368|NCT03166124|12558462|FG003|Treatment Period 1|Adverse Event|0
7985369|NCT03166124|12558459|FG000|Wash-out Period|Withdrawal by Subject|0
7985370|NCT03166124|12558460|FG001|Wash-out Period|Withdrawal by Subject|1
7985371|NCT03166124|12558461|FG002|Wash-out Period|Withdrawal by Subject|0
7985372|NCT03166124|12558462|FG003|Wash-out Period|Withdrawal by Subject|1
7985373|NCT03166124|12558459|FG000|Wash-out Period|Adverse Event|0
7985374|NCT03166124|12558460|FG001|Wash-out Period|Adverse Event|1
7985375|NCT03166124|12558461|FG002|Wash-out Period|Adverse Event|1
7985376|NCT03166124|12558462|FG003|Wash-out Period|Adverse Event|0
7985377|NCT03166215|12558475|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
7985378|NCT03166215|12558476|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2
7985379|NCT03166215|12558477|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
7985380|NCT03166215|12558475|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
7985381|NCT03166215|12558476|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
7985382|NCT03166215|12558477|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2
7985383|NCT03166735|12558493|FG000|Overall Study|Not Treated|1
7985384|NCT03166735|12558494|FG001|Overall Study|Not Treated|0
7985385|NCT03166735|12558495|FG002|Overall Study|Not Treated|0
7985386|NCT03166735|12558496|FG003|Overall Study|Not Treated|0
7985387|NCT03166735|12558497|FG004|Overall Study|Not Treated|0
7985388|NCT03166735|12558493|FG000|Overall Study|follow-up not completed as planned|0
7985389|NCT03166735|12558494|FG001|Overall Study|follow-up not completed as planned|1
7985390|NCT03166735|12558495|FG002|Overall Study|follow-up not completed as planned|1
7985391|NCT03166735|12558496|FG003|Overall Study|follow-up not completed as planned|0
7985392|NCT03166735|12558497|FG004|Overall Study|follow-up not completed as planned|1
7985393|NCT03166735|12558493|FG000|Overall Study|Withdrawal by Subject|0
7985394|NCT03166735|12558494|FG001|Overall Study|Withdrawal by Subject|0
7985395|NCT03166735|12558495|FG002|Overall Study|Withdrawal by Subject|1
7985396|NCT03166735|12558496|FG003|Overall Study|Withdrawal by Subject|1
7985397|NCT03166735|12558497|FG004|Overall Study|Withdrawal by Subject|2
7985398|NCT03166735|12558493|FG000|Overall Study|Lost to Follow-up|0
7985399|NCT03166735|12558494|FG001|Overall Study|Lost to Follow-up|2
7985400|NCT03166735|12558495|FG002|Overall Study|Lost to Follow-up|1
7985401|NCT03166735|12558496|FG003|Overall Study|Lost to Follow-up|0
7985402|NCT03166735|12558497|FG004|Overall Study|Lost to Follow-up|1
7985403|NCT03167073|12558512|FG000|Overall Study|Stillbirth|1
7985404|NCT03167073|12558513|FG001|Overall Study|Stillbirth|0
7985405|NCT03167151|12558522|FG000|Overall Study|Withdrawal by Subject|1
7985406|NCT03167151|12558523|FG001|Overall Study|Withdrawal by Subject|0
7985407|NCT03167151|12558524|FG002|Overall Study|Withdrawal by Subject|0
7985408|NCT03167151|12558522|FG000|Overall Study|No evidence of tumour at surgery|0
7985409|NCT03167151|12558523|FG001|Overall Study|No evidence of tumour at surgery|1
7985410|NCT03167151|12558524|FG002|Overall Study|No evidence of tumour at surgery|1
7985411|NCT03167359|12558532|FG000|Overall Study|Physician Decision|1
7985412|NCT03167359|12558532|FG000|Overall Study|Lost to Follow-up|1
7985413|NCT03167411|12558538|FG000|Overall Study|Adverse Event|0
7985414|NCT03167411|12558539|FG001|Overall Study|Adverse Event|1
7985415|NCT03168425|12558609|FG000|Overall Study|Lost to Follow-up|5
7985416|NCT03168425|12558610|FG001|Overall Study|Lost to Follow-up|8
7985417|NCT03168425|12558609|FG000|Overall Study|unable to confirm post op opioids|2
7985418|NCT03168425|12558610|FG001|Overall Study|unable to confirm post op opioids|3
7985419|NCT03168711|12558626|FG000|Overall Study|Adverse Event|2
7985420|NCT03168711|12558627|FG001|Overall Study|Adverse Event|0
7985421|NCT03168711|12558626|FG000|Overall Study|Withdrawal by Subject|0
7985422|NCT03168711|12558627|FG001|Overall Study|Withdrawal by Subject|1
7985423|NCT03168711|12558626|FG000|Overall Study|Death|0
7985424|NCT03168711|12558627|FG001|Overall Study|Death|1
7985425|NCT03168919|12558637|FG000|Overall Study|Withdrawal by Subject|2
7985426|NCT03169153|12558649|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7985427|NCT03169153|12558650|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7985428|NCT03169153|12558649|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2
7985429|NCT03169153|12558650|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3
7985430|NCT03169153|12558649|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1
7985431|NCT03169153|12558650|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2
7985432|NCT03169153|12558649|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1
7985433|NCT03169153|12558650|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0
7985434|NCT03169244|12558658|FG000|Overall Study|Lost to Follow-up|1
7985435|NCT03169244|12558659|FG001|Overall Study|Lost to Follow-up|2
7985436|NCT03169244|12558658|FG000|Overall Study|Adverse Event|1
7985437|NCT03169244|12558659|FG001|Overall Study|Adverse Event|0
7985438|NCT03169244|12558658|FG000|Overall Study|Withdrawal by Subject|2
7985439|NCT03169244|12558659|FG001|Overall Study|Withdrawal by Subject|2
7985440|NCT03169244|12558658|FG000|Overall Study|Physician Decision|1
7985441|NCT03169244|12558659|FG001|Overall Study|Physician Decision|0
7985442|NCT03170154|12558674|FG000|Overall Study|Lost to Follow-up|4
7985443|NCT03170154|12558674|FG000|Overall Study|Death|2
7985444|NCT03170154|12558674|FG000|Overall Study|Withdrawal by Subject|2
7985445|NCT03170193|12558690|FG000|Overall Study|Withdrawal by Subject|0
7985446|NCT03170193|12558691|FG001|Overall Study|Withdrawal by Subject|0
7985447|NCT03170193|12558692|FG002|Overall Study|Withdrawal by Subject|0
7985448|NCT03170193|12558693|FG003|Overall Study|Withdrawal by Subject|1
7985449|NCT03170193|12558694|FG004|Overall Study|Withdrawal by Subject|0
7985450|NCT03170193|12558695|FG005|Overall Study|Withdrawal by Subject|0
7985451|NCT03170193|12558696|FG006|Overall Study|Withdrawal by Subject|0
7985452|NCT03170193|12558690|FG000|Overall Study|Lost to Follow-up|1
7985453|NCT03170193|12558691|FG001|Overall Study|Lost to Follow-up|1
7985454|NCT03170193|12558692|FG002|Overall Study|Lost to Follow-up|0
7985455|NCT03170193|12558693|FG003|Overall Study|Lost to Follow-up|0
7985456|NCT03170193|12558694|FG004|Overall Study|Lost to Follow-up|0
7985457|NCT03170193|12558695|FG005|Overall Study|Lost to Follow-up|0
7985458|NCT03170193|12558696|FG006|Overall Study|Lost to Follow-up|0
7985459|NCT03170232|12558729|FG000|Overall Study|Adverse Event|0
7985460|NCT03170232|12558730|FG001|Overall Study|Adverse Event|1
7985461|NCT03170232|12558729|FG000|Overall Study|Protocol Violation|0
7985462|NCT03170232|12558730|FG001|Overall Study|Protocol Violation|1
7985463|NCT03170232|12558729|FG000|Overall Study|Lack of Efficacy|0
7985464|NCT03170232|12558730|FG001|Overall Study|Lack of Efficacy|1
7985465|NCT03170232|12558729|FG000|Overall Study|Study closed/terminated|26
7985466|NCT03170232|12558730|FG001|Overall Study|Study closed/terminated|23
7985467|NCT03170232|12558729|FG000|Overall Study|Lost to Follow-up|1
7985468|NCT03170232|12558730|FG001|Overall Study|Lost to Follow-up|0
7985469|NCT03170232|12558729|FG000|Overall Study|Withdrawal by Subject|0
7985470|NCT03170232|12558730|FG001|Overall Study|Withdrawal by Subject|1
7985471|NCT03170271|12558738|FG000|Overall Study|Adverse Event|7
7985472|NCT03170271|12558739|FG001|Overall Study|Adverse Event|2
7985473|NCT03170271|12558738|FG000|Overall Study|Lost to Follow-up|0
7985474|NCT03170271|12558739|FG001|Overall Study|Lost to Follow-up|1
7985475|NCT03170271|12558738|FG000|Overall Study|Physician Decision|1
7985476|NCT03170271|12558739|FG001|Overall Study|Physician Decision|0
7985477|NCT03170271|12558738|FG000|Overall Study|Protocol-specified withdrawal criterion|2
7985478|NCT03170271|12558739|FG001|Overall Study|Protocol-specified withdrawal criterion|1
7985479|NCT03170271|12558738|FG000|Overall Study|Withdrawal by Subject|17
7985480|NCT03170271|12558739|FG001|Overall Study|Withdrawal by Subject|5
7985481|NCT03170271|12558738|FG000|Overall Study|Other|2
7985482|NCT03170271|12558739|FG001|Overall Study|Other|2
7985483|NCT03170271|12558738|FG000|Overall Study|Randomized in error|4
7985484|NCT03170271|12558739|FG001|Overall Study|Randomized in error|0
7985485|NCT03170544|12558778|FG000|Part 1|Lost to Follow-up|1
7985486|NCT03170544|12558779|FG001|Part 1|Lost to Follow-up|0
7985487|NCT03170544|12558780|FG002|Part 1|Lost to Follow-up|0
7985488|NCT03170544|12558781|FG003|Part 1|Lost to Follow-up|0
7985489|NCT03170544|12558782|FG004|Part 1|Lost to Follow-up|0
7985490|NCT03170544|12558783|FG005|Part 1|Lost to Follow-up|0
7985491|NCT03170544|12558784|FG006|Part 1|Lost to Follow-up|0
7985492|NCT03170544|12558785|FG007|Part 1|Lost to Follow-up|0
7985493|NCT03170544|12558786|FG008|Part 1|Lost to Follow-up|0
7985494|NCT03170544|12558787|FG009|Part 1|Lost to Follow-up|0
7985495|NCT03170544|12558788|FG010|Part 1|Lost to Follow-up|0
7985496|NCT03170544|12558789|FG011|Part 1|Lost to Follow-up|0
7985497|NCT03170544|12558778|FG000|Part 1|Not treated|0
7985498|NCT03170544|12558779|FG001|Part 1|Not treated|0
7985499|NCT03170544|12558780|FG002|Part 1|Not treated|0
7985500|NCT03170544|12558781|FG003|Part 1|Not treated|1
7985501|NCT03170544|12558782|FG004|Part 1|Not treated|0
7985502|NCT03170544|12558783|FG005|Part 1|Not treated|0
7985503|NCT03170544|12558784|FG006|Part 1|Not treated|0
7985504|NCT03170544|12558785|FG007|Part 1|Not treated|0
7985505|NCT03170544|12558786|FG008|Part 1|Not treated|0
7985506|NCT03170544|12558787|FG009|Part 1|Not treated|0
7985507|NCT03170544|12558788|FG010|Part 1|Not treated|0
7985508|NCT03170544|12558789|FG011|Part 1|Not treated|0
7985509|NCT03170609|12558879|FG000|Overall Study|Death|0
7985510|NCT03170609|12558880|FG001|Overall Study|Death|0
7985511|NCT03170609|12558881|FG002|Overall Study|Death|1
7985512|NCT03170609|12558882|FG003|Overall Study|Death|0
7985513|NCT03170609|12558883|FG004|Overall Study|Death|0
7985514|NCT03170609|12558884|FG005|Overall Study|Death|0
7985515|NCT03170609|12558885|FG006|Overall Study|Death|0
7985516|NCT03170609|12558879|FG000|Overall Study|Withdrawal by Subject|1
7985517|NCT03170609|12558880|FG001|Overall Study|Withdrawal by Subject|2
7985518|NCT03170609|12558881|FG002|Overall Study|Withdrawal by Subject|0
7985519|NCT03170609|12558882|FG003|Overall Study|Withdrawal by Subject|0
7985520|NCT03170609|12558883|FG004|Overall Study|Withdrawal by Subject|0
7985521|NCT03170609|12558884|FG005|Overall Study|Withdrawal by Subject|0
7985522|NCT03170609|12558885|FG006|Overall Study|Withdrawal by Subject|1
7985523|NCT03170609|12558879|FG000|Overall Study|Lost to Follow-up|1
7985524|NCT03170609|12558880|FG001|Overall Study|Lost to Follow-up|0
7985525|NCT03170609|12558881|FG002|Overall Study|Lost to Follow-up|5
7985526|NCT03170609|12558882|FG003|Overall Study|Lost to Follow-up|2
7985527|NCT03170609|12558883|FG004|Overall Study|Lost to Follow-up|1
7985528|NCT03170609|12558884|FG005|Overall Study|Lost to Follow-up|1
7985529|NCT03170609|12558885|FG006|Overall Study|Lost to Follow-up|0
7985530|NCT03170609|12558879|FG000|Overall Study|Other|1
7985531|NCT03170609|12558880|FG001|Overall Study|Other|0
7985532|NCT03170609|12558881|FG002|Overall Study|Other|0
7985533|NCT03170609|12558882|FG003|Overall Study|Other|0
7985534|NCT03170609|12558883|FG004|Overall Study|Other|0
7985535|NCT03170609|12558884|FG005|Overall Study|Other|1
7985536|NCT03170609|12558885|FG006|Overall Study|Other|0
7985537|NCT03171415|12558922|FG000|Overall Study|Lost to Follow-up|0
7985538|NCT03171415|12558923|FG001|Overall Study|Lost to Follow-up|0
7985539|NCT03171415|12558924|FG002|Overall Study|Lost to Follow-up|0
7985540|NCT03171415|12558925|FG003|Overall Study|Lost to Follow-up|0
7985541|NCT03171415|12558926|FG004|Overall Study|Lost to Follow-up|2
7985542|NCT03172130|12558951|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3
7985543|NCT03172130|12558952|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1
7985544|NCT03172325|12558960|FG000|Overall Study|Adverse Event|2
7985545|NCT03172325|12558961|FG001|Overall Study|Adverse Event|3
7985546|NCT03172325|12558960|FG000|Overall Study|Positive PPD|1
7985547|NCT03172325|12558961|FG001|Overall Study|Positive PPD|0
7985548|NCT03172325|12558960|FG000|Overall Study|Poor Compliance|1
7985549|NCT03172325|12558961|FG001|Overall Study|Poor Compliance|1
7985550|NCT03172364|12558969|FG000|Overall Study|Adverse Event|1
7985551|NCT03172364|12558970|FG001|Overall Study|Adverse Event|1
7985552|NCT03172364|12558969|FG000|Overall Study|Protocol Violation|1
7985553|NCT03172364|12558970|FG001|Overall Study|Protocol Violation|0
7985554|NCT03172481|12558978|FG000|Double-blind|Withdrawal by Subject|1
7985555|NCT03172481|12558979|FG001|Double-blind|Withdrawal by Subject|0
7985556|NCT03172494|12558988|FG000|Overall Study|Adverse Event|5
7985557|NCT03172494|12558989|FG001|Overall Study|Adverse Event|1
7985558|NCT03172494|12558990|FG002|Overall Study|Adverse Event|15
7985559|NCT03172494|12558988|FG000|Overall Study|Protocol Violation|3
7985560|NCT03172494|12558989|FG001|Overall Study|Protocol Violation|2
7985561|NCT03172494|12558990|FG002|Overall Study|Protocol Violation|1
7985562|NCT03172494|12558988|FG000|Overall Study|Lack of Efficacy|0
7985563|NCT03172494|12558989|FG001|Overall Study|Lack of Efficacy|0
7985564|NCT03172494|12558990|FG002|Overall Study|Lack of Efficacy|4
7985565|NCT03172494|12558988|FG000|Overall Study|Pregnancy|0
7985566|NCT03172494|12558989|FG001|Overall Study|Pregnancy|1
7985567|NCT03172494|12558990|FG002|Overall Study|Pregnancy|0
7985568|NCT03172494|12558988|FG000|Overall Study|Withdrawal by Subject|10
7985569|NCT03172494|12558989|FG001|Overall Study|Withdrawal by Subject|8
7985570|NCT03172494|12558990|FG002|Overall Study|Withdrawal by Subject|8
7985571|NCT03172494|12558988|FG000|Overall Study|Severe hypoglycaemic episode|0
7985572|NCT03172494|12558989|FG001|Overall Study|Severe hypoglycaemic episode|0
7985573|NCT03172494|12558990|FG002|Overall Study|Severe hypoglycaemic episode|1
7985574|NCT03172494|12558988|FG000|Overall Study|Non-compliance towards treatment|2
7985575|NCT03172494|12558989|FG001|Overall Study|Non-compliance towards treatment|0
7985576|NCT03172494|12558990|FG002|Overall Study|Non-compliance towards treatment|0
7985577|NCT03172702|12558999|FG000|Overall Study|Adverse Event|9
7985578|NCT03172702|12558999|FG000|Overall Study|Death|2
7985579|NCT03172702|12558999|FG000|Overall Study|Study-specific Withdrawal Criteria|10
7985580|NCT03172702|12558999|FG000|Overall Study|Withdrawal by Subject|5
7985581|NCT03172702|12558999|FG000|Overall Study|Other|2
7985582|NCT03173313|12559031|FG000|Overall Study|Lost to Follow-up|2
7985583|NCT03173313|12559032|FG001|Overall Study|Lost to Follow-up|3
7985584|NCT03173313|12559031|FG000|Overall Study|Withdrawal by Subject|0
7985585|NCT03173313|12559032|FG001|Overall Study|Withdrawal by Subject|1
7985586|NCT03173313|12559031|FG000|Overall Study|Death|5
7985587|NCT03173313|12559032|FG001|Overall Study|Death|0
7985588|NCT03173313|12559031|FG000|Overall Study|Physician Decision|1
7985589|NCT03173313|12559032|FG001|Overall Study|Physician Decision|0
7985590|NCT03173313|12559031|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0
7985591|NCT03173313|12559032|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1
7985592|NCT03173313|12559031|FG000|Overall Study|Bone Fracture|1
7985593|NCT03173313|12559032|FG001|Overall Study|Bone Fracture|0
7985594|NCT03173547|12559040|FG000|Overall Study|Adverse Event|2
7985595|NCT03173547|12559041|FG001|Overall Study|Adverse Event|0
7985596|NCT03173547|12559040|FG000|Overall Study|Withdrawal by Subject|2
7985597|NCT03173547|12559041|FG001|Overall Study|Withdrawal by Subject|2
7985598|NCT03174925|12559076|FG000|Overall Study|Elastographic images not retrievable|2
7985599|NCT03174925|12559076|FG000|Overall Study|Elastography image not interpretable|1
7985600|NCT03175120|12559082|FG000|Overall Study|Adverse Event|2
7985601|NCT03175120|12559083|FG001|Overall Study|Adverse Event|2
7985602|NCT03175120|12559082|FG000|Overall Study|Protocol Violation|5
7985603|NCT03175120|12559083|FG001|Overall Study|Protocol Violation|2
7985604|NCT03175120|12559082|FG000|Overall Study|Lost to Follow-up|1
7985605|NCT03175120|12559083|FG001|Overall Study|Lost to Follow-up|0
7985606|NCT03175120|12559082|FG000|Overall Study|Withdrawal by Subject|2
7985607|NCT03175120|12559083|FG001|Overall Study|Withdrawal by Subject|5
7985608|NCT03175120|12559082|FG000|Overall Study|Other|2
7985609|NCT03175120|12559083|FG001|Overall Study|Other|3
7985610|NCT03175172|12559089|FG000|Overall Study|Death|3
7985611|NCT03175172|12559089|FG000|Overall Study|Withdrawal by Subject|3
7985612|NCT03175172|12559089|FG000|Overall Study|Lost to Follow-up|1
7985613|NCT03175172|12559089|FG000|Overall Study|Study Terminated by Sponsor|3
7985614|NCT03175562|12559093|FG000|Overall Study|Adverse Event|1
7985615|NCT03175562|12559093|FG000|Overall Study|Lost to Follow-up|3
7985616|NCT03175562|12559093|FG000|Overall Study|Withdrawal by Subject|7
7985617|NCT03175562|12559093|FG000|Overall Study|Other (Not Specified)|5
7985618|NCT03176238|12559111|FG000|Overall Study|Unacceptable AEs|15
7985619|NCT03176238|12559112|FG001|Overall Study|Unacceptable AEs|8
7985620|NCT03176238|12559111|FG000|Overall Study|Abnormal lab value(s)|2
7985621|NCT03176238|12559112|FG001|Overall Study|Abnormal lab value(s)|0
7985622|NCT03176238|12559111|FG000|Overall Study|Inter-current illness|0
7985623|NCT03176238|12559112|FG001|Overall Study|Inter-current illness|1
7985624|NCT03176238|12559111|FG000|Overall Study|Consent withdrawal|14
7985625|NCT03176238|12559112|FG001|Overall Study|Consent withdrawal|2
7985626|NCT03176238|12559111|FG000|Overall Study|Lost to Follow-up|3
7985627|NCT03176238|12559112|FG001|Overall Study|Lost to Follow-up|0
7985628|NCT03176238|12559111|FG000|Overall Study|Administrative problems|1
7985629|NCT03176238|12559112|FG001|Overall Study|Administrative problems|0
7985630|NCT03176238|12559111|FG000|Overall Study|Death|3
7985631|NCT03176238|12559112|FG001|Overall Study|Death|0
7985632|NCT03176238|12559111|FG000|Overall Study|Disease Progression|133
7985633|NCT03176238|12559112|FG001|Overall Study|Disease Progression|22
7985634|NCT03176238|12559111|FG000|Overall Study|Tx duration completed per EAP|0
7985635|NCT03176238|12559112|FG001|Overall Study|Tx duration completed per EAP|1
7985636|NCT03176238|12559111|FG000|Overall Study|Patient is switched to commercial drug|16
7985637|NCT03176238|12559112|FG001|Overall Study|Patient is switched to commercial drug|1
7985638|NCT03176238|12559111|FG000|Overall Study|Protocol Violation|1
7985639|NCT03176238|12559112|FG001|Overall Study|Protocol Violation|0
7985640|NCT03176238|12559111|FG000|Overall Study|Changes in the patient's condition|2
7985641|NCT03176238|12559112|FG001|Overall Study|Changes in the patient's condition|1
7985642|NCT03176238|12559111|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9
7985643|NCT03176238|12559112|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0
7985644|NCT03176407|12559122|FG000|Overall Study|Protocol Violation|1
7985645|NCT03176407|12559122|FG000|Overall Study|human failure|1
7985646|NCT03176407|12559122|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1
7985647|NCT03176459|12559130|FG000|Overall Study|Lost to Follow-up|5
7985648|NCT03176459|12559131|FG001|Overall Study|Lost to Follow-up|7
7985649|NCT03176784|12559150|FG000|Overall Study|Lost to Follow-up|77
7985650|NCT03176784|12559151|FG001|Overall Study|Lost to Follow-up|79
7985651|NCT03176784|12559152|FG002|Overall Study|Lost to Follow-up|79
7985652|NCT03176784|12559153|FG003|Overall Study|Lost to Follow-up|49
7985653|NCT03176784|12559150|FG000|Overall Study|Withdrawal by Subject|28
7985654|NCT03176784|12559151|FG001|Overall Study|Withdrawal by Subject|34
7985655|NCT03176784|12559152|FG002|Overall Study|Withdrawal by Subject|34
7985656|NCT03176784|12559153|FG003|Overall Study|Withdrawal by Subject|21
7985657|NCT03178266|12559221|FG000|Overall Study|Death|0
7985658|NCT03178266|12559222|FG001|Overall Study|Death|1
7985659|NCT03178266|12559221|FG000|Overall Study|Disont. Early|0
7985660|NCT03178266|12559222|FG001|Overall Study|Disont. Early|1
7985661|NCT03178266|12559221|FG000|Overall Study|Withdrawal by Subject|0
7985662|NCT03178266|12559222|FG001|Overall Study|Withdrawal by Subject|2
7985663|NCT03178669|12559240|FG000|Overall Study|Adverse Event|4
7985664|NCT03178669|12559241|FG001|Overall Study|Adverse Event|1
7985665|NCT03178669|12559242|FG002|Overall Study|Adverse Event|4
7985666|NCT03178669|12559243|FG003|Overall Study|Adverse Event|2
7985667|NCT03178669|12559244|FG004|Overall Study|Adverse Event|2
7985668|NCT03178669|12559240|FG000|Overall Study|Lack of Efficacy|0
7985669|NCT03178669|12559241|FG001|Overall Study|Lack of Efficacy|0
7985670|NCT03178669|12559242|FG002|Overall Study|Lack of Efficacy|2
7985671|NCT03178669|12559243|FG003|Overall Study|Lack of Efficacy|0
7985672|NCT03178669|12559244|FG004|Overall Study|Lack of Efficacy|1
7985673|NCT03178669|12559240|FG000|Overall Study|Physician Decision|0
7985674|NCT03178669|12559241|FG001|Overall Study|Physician Decision|0
7985675|NCT03178669|12559242|FG002|Overall Study|Physician Decision|0
7985676|NCT03178669|12559243|FG003|Overall Study|Physician Decision|0
7985677|NCT03178669|12559244|FG004|Overall Study|Physician Decision|1
7985678|NCT03178669|12559240|FG000|Overall Study|Withdrawal by Subject|1
7985679|NCT03178669|12559241|FG001|Overall Study|Withdrawal by Subject|0
7985680|NCT03178669|12559242|FG002|Overall Study|Withdrawal by Subject|1
7985681|NCT03178669|12559243|FG003|Overall Study|Withdrawal by Subject|1
7985682|NCT03178669|12559244|FG004|Overall Study|Withdrawal by Subject|0
7985683|NCT03178669|12559240|FG000|Overall Study|Lost to Follow-up|0
7985684|NCT03178669|12559241|FG001|Overall Study|Lost to Follow-up|0
7985685|NCT03178669|12559242|FG002|Overall Study|Lost to Follow-up|0
7985686|NCT03178669|12559243|FG003|Overall Study|Lost to Follow-up|1
7985687|NCT03178669|12559244|FG004|Overall Study|Lost to Follow-up|0
7985688|NCT03178773|12559258|FG000|Overall Study|Death|0
7985689|NCT03178773|12559259|FG001|Overall Study|Death|1
7985690|NCT03178773|12559258|FG000|Overall Study|Lost to Follow-up|29
7985691|NCT03178773|12559259|FG001|Overall Study|Lost to Follow-up|25
7985692|NCT03178773|12559258|FG000|Overall Study|Withdrawal by Subject|10
7985693|NCT03178773|12559259|FG001|Overall Study|Withdrawal by Subject|14
7985694|NCT03178851|12559269|FG000|Overall Study|Death|48
7985695|NCT03178851|12559270|FG001|Overall Study|Death|2
7985696|NCT03178851|12559271|FG002|Overall Study|Death|25
7985697|NCT03178851|12559269|FG000|Overall Study|Withdrawal by Subject|8
7985698|NCT03178851|12559270|FG001|Overall Study|Withdrawal by Subject|0
7985699|NCT03178851|12559271|FG002|Overall Study|Withdrawal by Subject|0
7985700|NCT03178851|12559269|FG000|Overall Study|Lost to Follow-up|5
7985701|NCT03178851|12559270|FG001|Overall Study|Lost to Follow-up|2
7985702|NCT03178851|12559271|FG002|Overall Study|Lost to Follow-up|0
7985703|NCT03178851|12559269|FG000|Overall Study|Adverse Event|0
7985704|NCT03178851|12559270|FG001|Overall Study|Adverse Event|0
7985705|NCT03178851|12559271|FG002|Overall Study|Adverse Event|1
7985706|NCT03178851|12559269|FG000|Overall Study|Study Termination by Sponsor|31
7985707|NCT03178851|12559270|FG001|Overall Study|Study Termination by Sponsor|7
7985708|NCT03178851|12559271|FG002|Overall Study|Study Termination by Sponsor|26
7985709|NCT03178942|12559282|FG000|Overall Study|Withdrawal by Subject|2
7985710|NCT03178942|12559283|FG001|Overall Study|Withdrawal by Subject|0
7985711|NCT03178942|12559282|FG000|Overall Study|Lost to Follow-up|1
7985712|NCT03178942|12559283|FG001|Overall Study|Lost to Follow-up|2
7985713|NCT03179319|12559291|FG000|Overall Study|Lost to Follow-up|6
7985714|NCT03179319|12559292|FG001|Overall Study|Lost to Follow-up|0
7985715|NCT03179787|12559325|FG000|Overall Study|Lost to Follow-up|15
7985716|NCT03179787|12559325|FG000|Overall Study|Case report failures|2
7985717|NCT03179787|12559325|FG000|Overall Study|Treatment not administered|1
7985718|NCT03179891|12559329|FG000|First Intervention|Withdrawal by Subject|1
7985719|NCT03179891|12559330|FG001|First Intervention|Withdrawal by Subject|1
7985720|NCT03179891|12559329|FG000|First Intervention|Unspecified reason|1
7985721|NCT03179891|12559330|FG001|First Intervention|Unspecified reason|0
7985722|NCT03179891|12559329|FG000|First Intervention|Protocol Violation|0
7985723|NCT03179891|12559330|FG001|First Intervention|Protocol Violation|1
7985724|NCT03180138|12559342|FG000|Overall Study|Mobile-phone could not be verified|2
7985725|NCT03180138|12559343|FG001|Overall Study|Mobile-phone could not be verified|13
7985726|NCT03180138|12559344|FG002|Overall Study|Mobile-phone could not be verified|15
7985727|NCT03180138|12559342|FG000|Overall Study|No prior immunization records|17
7985728|NCT03180138|12559343|FG001|Overall Study|No prior immunization records|0
7985729|NCT03180138|12559344|FG002|Overall Study|No prior immunization records|6
7985730|NCT03180138|12559342|FG000|Overall Study|Found to be >24 mon after randomization|3
7985731|NCT03180138|12559343|FG001|Overall Study|Found to be >24 mon after randomization|0
7985732|NCT03180138|12559344|FG002|Overall Study|Found to be >24 mon after randomization|3
7985733|NCT03180528|12559386|FG000|Overall Study|Adverse Event|1
7985734|NCT03180528|12559386|FG000|Overall Study|Withdrawal by Subject|1
7985735|NCT03180528|12559386|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1
7985736|NCT03180619|12559393|FG000|Overall Study|Withdrew Consent|5
7985737|NCT03180619|12559394|FG001|Overall Study|Withdrew Consent|0
7985738|NCT03180619|12559395|FG002|Overall Study|Withdrew Consent|2
7985739|NCT03180619|12559393|FG000|Overall Study|Death|2
7985740|NCT03180619|12559394|FG001|Overall Study|Death|1
7985741|NCT03180619|12559395|FG002|Overall Study|Death|2
7985742|NCT03180619|12559393|FG000|Overall Study|Adverse Event|2
7985743|NCT03180619|12559394|FG001|Overall Study|Adverse Event|0
7985744|NCT03180619|12559395|FG002|Overall Study|Adverse Event|1
7985745|NCT03180619|12559393|FG000|Overall Study|Investigator's discretion|2
7985746|NCT03180619|12559394|FG001|Overall Study|Investigator's discretion|0
7985747|NCT03180619|12559395|FG002|Overall Study|Investigator's discretion|1
7985748|NCT04448756|12559432|FG000|Overall Study|Adverse Event|0
7985749|NCT04448756|12559433|FG001|Overall Study|Adverse Event|1
7985750|NCT04448756|12559434|FG002|Overall Study|Adverse Event|0
7985751|NCT04448756|12559432|FG000|Overall Study|Participant unable to attend Day 60 visit|1
7985752|NCT04448756|12559433|FG001|Overall Study|Participant unable to attend Day 60 visit|0
7985753|NCT04448756|12559434|FG002|Overall Study|Participant unable to attend Day 60 visit|0
7985754|NCT04448756|12559432|FG000|Overall Study|Withdrawal by Subject|0
7985755|NCT04448756|12559433|FG001|Overall Study|Withdrawal by Subject|3
7985756|NCT04448756|12559434|FG002|Overall Study|Withdrawal by Subject|1
7985757|NCT04448756|12559432|FG000|Overall Study|Death|2
7985758|NCT04448756|12559433|FG001|Overall Study|Death|1
7985759|NCT04448756|12559434|FG002|Overall Study|Death|0
7985760|NCT04397718|12559444|FG000|Overall Study|Death|7
7985761|NCT04397718|12559445|FG001|Overall Study|Death|11
7985762|NCT04397718|12559444|FG000|Overall Study|Lost to Follow-up|0
7985763|NCT04397718|12559445|FG001|Overall Study|Lost to Follow-up|4
7985764|NCT04352127|12559454|FG000|Overall Study|Unable to obtain readings|4
7985765|NCT04352127|12559455|FG001|Overall Study|Unable to obtain readings|1
7985766|NCT04352127|12559456|FG002|Overall Study|Unable to obtain readings|0
7985767|NCT03975920|12559472|FG000|Overall Study|Lost to Follow-up|1
7985768|NCT03975920|12559473|FG001|Overall Study|Lost to Follow-up|2
7985769|NCT03975920|12559472|FG000|Overall Study|Protocol Violation|1
7985770|NCT03975920|12559473|FG001|Overall Study|Protocol Violation|1
7985771|NCT03975920|12559472|FG000|Overall Study|Did not complete survey|2
7985772|NCT03975920|12559473|FG001|Overall Study|Did not complete survey|1
7985773|NCT03746483|12559481|FG000|Overall Study|Adverse Event|0
7985774|NCT03746483|12559482|FG001|Overall Study|Adverse Event|1
7985775|NCT03746483|12559481|FG000|Overall Study|Lack of Efficacy|3
7985776|NCT03746483|12559482|FG001|Overall Study|Lack of Efficacy|2
7985777|NCT03746483|12559481|FG000|Overall Study|Lost to Follow-up|1
7985778|NCT03746483|12559482|FG001|Overall Study|Lost to Follow-up|0
7985779|NCT03746483|12559481|FG000|Overall Study|Protocol Violation|2
7985780|NCT03746483|12559482|FG001|Overall Study|Protocol Violation|0
7985781|NCT03694327|12559496|FG000|Overall Study|Lost to Follow-up|13
7985782|NCT03694327|12559497|FG001|Overall Study|Lost to Follow-up|23
7985783|NCT03624036|12559507|FG000|Overall Study|Still on Study|5
7985784|NCT03624036|12559508|FG001|Overall Study|Still on Study|1
7985785|NCT03624036|12559509|FG002|Overall Study|Still on Study|3
7985786|NCT03624036|12559510|FG003|Overall Study|Still on Study|3
7985787|NCT03624036|12559507|FG000|Overall Study|Death|1
7985788|NCT03624036|12559508|FG001|Overall Study|Death|2
7985789|NCT03624036|12559509|FG002|Overall Study|Death|0
7985790|NCT03624036|12559510|FG003|Overall Study|Death|0
7985791|NCT03624036|12559507|FG000|Overall Study|Enrolled but Never Treated|1
7985792|NCT03624036|12559508|FG001|Overall Study|Enrolled but Never Treated|0
7985793|NCT03624036|12559509|FG002|Overall Study|Enrolled but Never Treated|0
7985794|NCT03624036|12559510|FG003|Overall Study|Enrolled but Never Treated|0
7985795|NCT03057951|12559526|FG000|Overall Study|Adverse Event|553
7985796|NCT03057951|12559527|FG001|Overall Study|Adverse Event|575
7985797|NCT03057951|12559526|FG000|Overall Study|Protocol Violation|30
7985798|NCT03057951|12559527|FG001|Overall Study|Protocol Violation|24
7985799|NCT03057951|12559526|FG000|Overall Study|Lost to Follow-up|6
7985800|NCT03057951|12559527|FG001|Overall Study|Lost to Follow-up|16
7985801|NCT03057951|12559526|FG000|Overall Study|Patient refusal to continue, not due to AE|304
7985802|NCT03057951|12559527|FG001|Overall Study|Patient refusal to continue, not due to AE|284
7985803|NCT03057951|12559526|FG000|Overall Study|Study drug stopped, reason missing|6
7985804|NCT03057951|12559527|FG001|Overall Study|Study drug stopped, reason missing|1
7985805|NCT03057951|12559526|FG000|Overall Study|Medical advice|6
7985806|NCT03057951|12559527|FG001|Overall Study|Medical advice|2
7985807|NCT03057951|12559526|FG000|Overall Study|Due to Covid-19 Pandemic|2
7985808|NCT03057951|12559527|FG001|Overall Study|Due to Covid-19 Pandemic|8
7985809|NCT03057951|12559526|FG000|Overall Study|Investigator decision|2
7985810|NCT03057951|12559527|FG001|Overall Study|Investigator decision|0
7985811|NCT03057951|12559526|FG000|Overall Study|Patient decision|5
7985812|NCT03057951|12559527|FG001|Overall Study|Patient decision|2
7985813|NCT03057951|12559526|FG000|Overall Study|Not attending study visits|3
7985814|NCT03057951|12559527|FG001|Overall Study|Not attending study visits|0
7985815|NCT03057951|12559526|FG000|Overall Study|Patient moved away|3
7985816|NCT03057951|12559527|FG001|Overall Study|Patient moved away|4
7985817|NCT03057951|12559526|FG000|Overall Study|Other reason than stated above|23
7985818|NCT03057951|12559527|FG001|Overall Study|Other reason than stated above|29
7985819|NCT03057951|12559526|FG000|Overall Study|Not treated|2
7985820|NCT03057951|12559527|FG001|Overall Study|Not treated|1
7985821|NCT03007888|12559533|FG000|First Intervention (14 Days)|Adverse Event|1
7985822|NCT03007888|12559534|FG001|First Intervention (14 Days)|Adverse Event|0
7985823|NCT02949934|12559562|FG000|Natural Drinking Period|Adverse Event|1
7985824|NCT02949934|12559563|FG001|Natural Drinking Period|Adverse Event|0
7985825|NCT02949934|12559564|FG002|Natural Drinking Period|Adverse Event|0
7985826|NCT02949934|12559565|FG003|Natural Drinking Period|Adverse Event|1
7985827|NCT02949934|12559566|FG004|Natural Drinking Period|Adverse Event|0
7985828|NCT02949934|12559567|FG005|Natural Drinking Period|Adverse Event|0
7985829|NCT02949934|12559562|FG000|Natural Drinking Period|Lost to Follow-up|0
7985830|NCT02949934|12559563|FG001|Natural Drinking Period|Lost to Follow-up|0
7985831|NCT02949934|12559564|FG002|Natural Drinking Period|Lost to Follow-up|0
7985832|NCT02949934|12559565|FG003|Natural Drinking Period|Lost to Follow-up|0
7985833|NCT02949934|12559566|FG004|Natural Drinking Period|Lost to Follow-up|1
7985834|NCT02949934|12559567|FG005|Natural Drinking Period|Lost to Follow-up|0
7985835|NCT02949934|12559562|FG000|Neuroimaging|Protocol Violation|2
7985836|NCT02949934|12559563|FG001|Neuroimaging|Protocol Violation|0
7985837|NCT02949934|12559564|FG002|Neuroimaging|Protocol Violation|0
7985838|NCT02949934|12559565|FG003|Neuroimaging|Protocol Violation|0
7985839|NCT02949934|12559566|FG004|Neuroimaging|Protocol Violation|1
7985840|NCT02949934|12559567|FG005|Neuroimaging|Protocol Violation|0
7985841|NCT02949934|12559562|FG000|Neuroimaging|Motion artifacts in imaging data|1
7985842|NCT02949934|12559563|FG001|Neuroimaging|Motion artifacts in imaging data|0
7985843|NCT02949934|12559564|FG002|Neuroimaging|Motion artifacts in imaging data|1
7985844|NCT02949934|12559565|FG003|Neuroimaging|Motion artifacts in imaging data|0
7985845|NCT02949934|12559566|FG004|Neuroimaging|Motion artifacts in imaging data|1
7985846|NCT02949934|12559567|FG005|Neuroimaging|Motion artifacts in imaging data|0
7985847|NCT02949934|12559562|FG000|Neuroimaging|Not scanned|0
7985848|NCT02949934|12559563|FG001|Neuroimaging|Not scanned|0
7985849|NCT02949934|12559564|FG002|Neuroimaging|Not scanned|1
7985850|NCT02949934|12559565|FG003|Neuroimaging|Not scanned|0
7985851|NCT02949934|12559566|FG004|Neuroimaging|Not scanned|0
7985852|NCT02949934|12559567|FG005|Neuroimaging|Not scanned|2
7985853|NCT02949934|12559562|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0
7985854|NCT02949934|12559563|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5
7985855|NCT02949934|12559564|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5
7985856|NCT02949934|12559565|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3
7985857|NCT02949934|12559566|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5
7985858|NCT02949934|12559567|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1
7985859|NCT02949934|12559562|FG000|Bar Laboratory|Adverse Event|1
7985860|NCT02949934|12559563|FG001|Bar Laboratory|Adverse Event|0
7985861|NCT02949934|12559564|FG002|Bar Laboratory|Adverse Event|2
7985862|NCT02949934|12559565|FG003|Bar Laboratory|Adverse Event|0
7985863|NCT02949934|12559566|FG004|Bar Laboratory|Adverse Event|1
7985864|NCT02949934|12559567|FG005|Bar Laboratory|Adverse Event|0
7985865|NCT02949934|12559562|FG000|Bar Laboratory|Protocol Violation|0
7985866|NCT02949934|12559563|FG001|Bar Laboratory|Protocol Violation|0
7985867|NCT02949934|12559564|FG002|Bar Laboratory|Protocol Violation|0
7985868|NCT02949934|12559565|FG003|Bar Laboratory|Protocol Violation|1
7985869|NCT02949934|12559566|FG004|Bar Laboratory|Protocol Violation|0
7985870|NCT02949934|12559567|FG005|Bar Laboratory|Protocol Violation|0
7985871|NCT02658656|12559595|FG000|Screening|Failed eligibility criteria|0
7985872|NCT02658656|12559596|FG001|Screening|Failed eligibility criteria|0
7985873|NCT02658656|12559597|FG002|Screening|Failed eligibility criteria|263
7985874|NCT02658656|12559595|FG000|Randomization|Withdrawal by Subject|8
7985875|NCT02658656|12559596|FG001|Randomization|Withdrawal by Subject|7
7985876|NCT02658656|12559597|FG002|Randomization|Withdrawal by Subject|0
7985877|NCT02658656|12559595|FG000|Randomization|Lost to Follow-up|1
7985878|NCT02658656|12559596|FG001|Randomization|Lost to Follow-up|3
7985879|NCT02658656|12559597|FG002|Randomization|Lost to Follow-up|0
7985880|NCT02658656|12559595|FG000|Randomization|Adverse Event|4
7985881|NCT02658656|12559596|FG001|Randomization|Adverse Event|0
7985882|NCT02658656|12559597|FG002|Randomization|Adverse Event|0
7985883|NCT02658656|12559595|FG000|Randomization|Administrative Termination|3
7985884|NCT02658656|12559596|FG001|Randomization|Administrative Termination|1
7985885|NCT02658656|12559597|FG002|Randomization|Administrative Termination|0
7985886|NCT02658656|12559595|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13
7985887|NCT02658656|12559596|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15
7985888|NCT02658656|12559597|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0
7985889|NCT02658656|12559595|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2
7985890|NCT02658656|12559596|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0
7985891|NCT02658656|12559597|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0
7985892|NCT02658656|12559595|FG000|Randomization|Not eligible for Randomization|1
7985893|NCT02658656|12559596|FG001|Randomization|Not eligible for Randomization|0
7985894|NCT02658656|12559597|FG002|Randomization|Not eligible for Randomization|0
7985895|NCT02658656|12559595|FG000|Randomization|Protocol Violation|1
7985896|NCT02658656|12559596|FG001|Randomization|Protocol Violation|0
7985897|NCT02658656|12559597|FG002|Randomization|Protocol Violation|0
7985898|NCT01667081|12559628|FG000|Overall Study|Death|43
7985899|NCT01667081|12559629|FG001|Overall Study|Death|3
7985900|NCT01667081|12559628|FG000|Overall Study|Lost to Follow-up|99
7985901|NCT01667081|12559629|FG001|Overall Study|Lost to Follow-up|48
7985902|NCT01667081|12559628|FG000|Overall Study|Physician Decision|16
7985903|NCT01667081|12559629|FG001|Overall Study|Physician Decision|2
7985904|NCT01667081|12559628|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529
7985905|NCT01667081|12559629|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269
7985906|NCT01667081|12559628|FG000|Overall Study|Withdrawal by Subject|90
7985907|NCT01667081|12559629|FG001|Overall Study|Withdrawal by Subject|35
7985908|NCT00634504|12559648|FG000|Overall Study|Protocol Violation|1
7985909|NCT00634504|12559649|FG001|Overall Study|Protocol Violation|0
7985910|NCT00352027|12559666|FG000|Overall Study|Progressive disease|3
7985911|NCT00104676|12559694|FG000|Overall Study|Death|3
7985912|NCT00104676|12559695|FG001|Overall Study|Death|2
7985913|NCT00104676|12559694|FG000|Overall Study|Withdrawal by Subject|0
7985914|NCT00104676|12559695|FG001|Overall Study|Withdrawal by Subject|2
7985915|NCT00104676|12559694|FG000|Overall Study|treatment interruption|4
7985916|NCT00104676|12559695|FG001|Overall Study|treatment interruption|10
7718157|NCT00525512|12141933|FG001|Open-Label Phase|Other reason (not specified)|0
7985917|NCT04042103|12559714|FG000|Overall Study|Lost to Follow-up|1
7985918|NCT04042103|12559714|FG000|Overall Study|Withdrawal by Subject|1
7985919|NCT04004208|12559720|FG000|Overall Study|Withdrawal by parent/guardian|1
7985920|NCT04004208|12559721|FG001|Overall Study|Withdrawal by parent/guardian|1
7985921|NCT04004208|12559720|FG000|Overall Study|Death|3
7985922|NCT04004208|12559721|FG001|Overall Study|Death|0
7985923|NCT04004208|12559720|FG000|Overall Study|COVID-19 pandemic|1
7985924|NCT04004208|12559721|FG001|Overall Study|COVID-19 pandemic|0
7985925|NCT04004208|12559720|FG000|Overall Study|Physician Decision|1
7985926|NCT04004208|12559721|FG001|Overall Study|Physician Decision|0
7985927|NCT04004208|12559720|FG000|Overall Study|Adverse Event|1
7985928|NCT04004208|12559721|FG001|Overall Study|Adverse Event|1
7985929|NCT03817190|12559729|FG000|Overall Study|Early Termination|13
7985930|NCT03817190|12559730|FG001|Overall Study|Early Termination|20
7985931|NCT03817190|12559729|FG000|Overall Study|Adverse Event|10
7985932|NCT03817190|12559730|FG001|Overall Study|Adverse Event|17
7985933|NCT03817190|12559729|FG000|Overall Study|Withdrawal by Subject|12
7985934|NCT03817190|12559730|FG001|Overall Study|Withdrawal by Subject|8
7985935|NCT03817190|12559729|FG000|Overall Study|Lost to Follow-up|11
7985936|NCT03817190|12559730|FG001|Overall Study|Lost to Follow-up|7
7985937|NCT03817190|12559729|FG000|Overall Study|Lack of Efficacy|7
7985938|NCT03817190|12559730|FG001|Overall Study|Lack of Efficacy|5
7985939|NCT03817190|12559729|FG000|Overall Study|Investigator Decision|5
7985940|NCT03817190|12559730|FG001|Overall Study|Investigator Decision|1
7985941|NCT03817190|12559729|FG000|Overall Study|Missing Effect|2
7985942|NCT03817190|12559730|FG001|Overall Study|Missing Effect|1
7985943|NCT03041311|12559742|FG000|Overall Study|Death|39
7985944|NCT03041311|12559743|FG001|Overall Study|Death|42
7985945|NCT03041311|12559742|FG000|Overall Study|Lost to Follow-up|0
7985946|NCT03041311|12559743|FG001|Overall Study|Lost to Follow-up|1
7985947|NCT03041311|12559742|FG000|Overall Study|Withdrawal by Subject|8
7985948|NCT03041311|12559743|FG001|Overall Study|Withdrawal by Subject|5
7985949|NCT03041311|12559742|FG000|Overall Study|Sponsor Terminated Study|2
7985950|NCT03041311|12559743|FG001|Overall Study|Sponsor Terminated Study|4
7985951|NCT03041311|12559742|FG000|Overall Study|Disease Progression|3
7985952|NCT03041311|12559743|FG001|Overall Study|Disease Progression|1
7985953|NCT03041311|12559742|FG000|Overall Study|Randomized in error, did not receive drug|2
7985954|NCT03041311|12559743|FG001|Overall Study|Randomized in error, did not receive drug|0
7985955|NCT03020914|12559759|FG000|Overall Study|Surgery Cancelled|1
7985956|NCT03020914|12559760|FG001|Overall Study|Surgery Cancelled|0
7985957|NCT02698891|12559775|FG000|Overall Study|Withdrawal by Subject|2
7985958|NCT02698891|12559775|FG000|Overall Study|deemed ineligible|1
7985959|NCT02698891|12559775|FG000|Overall Study|Adverse Event|9
7985960|NCT02537678|12559781|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4
7985961|NCT02537678|12559782|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3
7985962|NCT02537678|12559781|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4
7985963|NCT02537678|12559782|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4
7985964|NCT02537678|12559781|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6
7985965|NCT02537678|12559782|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5
7985966|NCT02537678|12559781|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2
7985967|NCT02537678|12559782|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3
7985968|NCT02537678|12559781|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14
7985969|NCT02537678|12559782|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6
7985970|NCT02537678|12559781|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8
7985971|NCT02537678|12559782|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7
7985972|NCT02537678|12559781|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0
7985973|NCT02537678|12559782|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1
7985974|NCT02400476|12559798|FG000|Overall Study|Adverse Event|57
7985975|NCT02400476|12559799|FG001|Overall Study|Adverse Event|10
7985976|NCT02400476|12559800|FG002|Overall Study|Adverse Event|22
7985977|NCT02400476|12559801|FG003|Overall Study|Adverse Event|19
7985978|NCT02400476|12559802|FG004|Overall Study|Adverse Event|5
7985979|NCT02400476|12559803|FG005|Overall Study|Adverse Event|8
7985980|NCT02400476|12559798|FG000|Overall Study|Withdrawal by Subject|4
7985981|NCT02400476|12559799|FG001|Overall Study|Withdrawal by Subject|1
7985982|NCT02400476|12559800|FG002|Overall Study|Withdrawal by Subject|12
7985983|NCT02400476|12559801|FG003|Overall Study|Withdrawal by Subject|7
7985984|NCT02400476|12559802|FG004|Overall Study|Withdrawal by Subject|5
7985985|NCT02400476|12559803|FG005|Overall Study|Withdrawal by Subject|5
7985986|NCT02400476|12559798|FG000|Overall Study|Lost to Follow-up|0
7985987|NCT02400476|12559799|FG001|Overall Study|Lost to Follow-up|0
7985988|NCT02400476|12559800|FG002|Overall Study|Lost to Follow-up|0
7985989|NCT02400476|12559801|FG003|Overall Study|Lost to Follow-up|1
7985990|NCT02400476|12559802|FG004|Overall Study|Lost to Follow-up|3
7985991|NCT02400476|12559803|FG005|Overall Study|Lost to Follow-up|1
7985992|NCT02400476|12559798|FG000|Overall Study|Physician Decision|0
7985993|NCT02400476|12559799|FG001|Overall Study|Physician Decision|0
7985994|NCT02400476|12559800|FG002|Overall Study|Physician Decision|1
7985995|NCT02400476|12559801|FG003|Overall Study|Physician Decision|1
7985996|NCT02400476|12559802|FG004|Overall Study|Physician Decision|0
7985997|NCT02400476|12559803|FG005|Overall Study|Physician Decision|1
7985998|NCT02400476|12559798|FG000|Overall Study|Other, Disease Progression|0
7985999|NCT02400476|12559799|FG001|Overall Study|Other, Disease Progression|1
7986000|NCT02400476|12559800|FG002|Overall Study|Other, Disease Progression|2
7986001|NCT02400476|12559801|FG003|Overall Study|Other, Disease Progression|1
7986002|NCT02400476|12559802|FG004|Overall Study|Other, Disease Progression|2
7986003|NCT02400476|12559803|FG005|Overall Study|Other, Disease Progression|1
7986004|NCT02400476|12559798|FG000|Overall Study|Other, Decreased Quality of Life|0
7986005|NCT02400476|12559799|FG001|Overall Study|Other, Decreased Quality of Life|0
7986006|NCT02400476|12559800|FG002|Overall Study|Other, Decreased Quality of Life|2
7986007|NCT02400476|12559801|FG003|Overall Study|Other, Decreased Quality of Life|0
7986008|NCT02400476|12559802|FG004|Overall Study|Other, Decreased Quality of Life|0
7986009|NCT02400476|12559803|FG005|Overall Study|Other, Decreased Quality of Life|0
7986010|NCT02400476|12559798|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0
7986011|NCT02400476|12559799|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0
7986012|NCT02400476|12559800|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2
7986013|NCT02400476|12559801|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1
7986014|NCT02400476|12559802|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0
7986015|NCT02400476|12559803|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0
7986016|NCT01507545|12559823|FG000|Overall Study|Withdrawal by Subject|6
7986017|NCT01507545|12559824|FG001|Overall Study|Withdrawal by Subject|2
7986018|NCT01507545|12559823|FG000|Overall Study|Lost to Follow-up|1
7986019|NCT01507545|12559824|FG001|Overall Study|Lost to Follow-up|0
7986020|NCT01507545|12559823|FG000|Overall Study|Discontinuation of the study by sponsor|11
7986021|NCT01507545|12559824|FG001|Overall Study|Discontinuation of the study by sponsor|9
7986022|NCT01507545|12559823|FG000|Overall Study|Progressive disease|60
7986023|NCT01507545|12559824|FG001|Overall Study|Progressive disease|27
7986024|NCT01507545|12559823|FG000|Overall Study|Other|6
7986025|NCT01507545|12559824|FG001|Overall Study|Other|4
7986026|NCT00920816|12559838|FG000|Overall Study|Death|116
7986027|NCT00920816|12559839|FG001|Overall Study|Death|63
7986028|NCT00920816|12559840|FG002|Overall Study|Death|8
7986029|NCT00920816|12559841|FG003|Overall Study|Death|3
7986030|NCT00920816|12559838|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11
7986031|NCT00920816|12559839|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5
7986032|NCT00920816|12559840|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1
7986033|NCT00920816|12559841|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0
7986034|NCT00920816|12559838|FG000|Overall Study|Global deterioration of health status|2
7986035|NCT00920816|12559839|FG001|Overall Study|Global deterioration of health status|0
7986036|NCT00920816|12559840|FG002|Overall Study|Global deterioration of health status|0
7986037|NCT00920816|12559841|FG003|Overall Study|Global deterioration of health status|0
7986038|NCT00920816|12559838|FG000|Overall Study|Objective progression or relapse|6
7986039|NCT00920816|12559839|FG001|Overall Study|Objective progression or relapse|2
7986040|NCT00920816|12559840|FG002|Overall Study|Objective progression or relapse|0
7986041|NCT00920816|12559841|FG003|Overall Study|Objective progression or relapse|0
7986042|NCT00920816|12559838|FG000|Overall Study|Other|26
7986043|NCT00920816|12559839|FG001|Overall Study|Other|15
7986044|NCT00920816|12559840|FG002|Overall Study|Other|1
7986045|NCT00920816|12559841|FG003|Overall Study|Other|2
7986046|NCT00920816|12559838|FG000|Overall Study|Lost to Follow-up|11
7986047|NCT00920816|12559839|FG001|Overall Study|Lost to Follow-up|2
7986048|NCT00920816|12559840|FG002|Overall Study|Lost to Follow-up|0
7986049|NCT00920816|12559841|FG003|Overall Study|Lost to Follow-up|0
7986050|NCT00920816|12559838|FG000|Overall Study|Adverse Event|1
7986051|NCT00920816|12559839|FG001|Overall Study|Adverse Event|1
7986052|NCT00920816|12559840|FG002|Overall Study|Adverse Event|1
7986053|NCT00920816|12559841|FG003|Overall Study|Adverse Event|0
7986054|NCT00920816|12559838|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16
7986055|NCT00920816|12559839|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8
7986056|NCT00920816|12559840|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124
7986057|NCT00920816|12559841|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64
7986058|NCT00920816|12559838|FG000|Overall Study|Randomized but not treated|3
7986059|NCT00920816|12559839|FG001|Overall Study|Randomized but not treated|0
7986060|NCT00920816|12559840|FG002|Overall Study|Randomized but not treated|0
7986061|NCT00920816|12559841|FG003|Overall Study|Randomized but not treated|0
7986062|NCT03180645|12559854|FG000|Overall Study|Adverse Event|0
7986063|NCT03180645|12559855|FG001|Overall Study|Adverse Event|1
7986064|NCT03180645|12559856|FG002|Overall Study|Adverse Event|2
7986065|NCT03180801|12559871|FG000|Overall Study|Physician Decision|3
7986066|NCT03180801|12559872|FG001|Overall Study|Physician Decision|3
7986067|NCT03180801|12559873|FG002|Overall Study|Physician Decision|1
7986068|NCT03180801|12559871|FG000|Overall Study|Non-compliance|1
7986069|NCT03180801|12559872|FG001|Overall Study|Non-compliance|4
7986070|NCT03180801|12559873|FG002|Overall Study|Non-compliance|0
7986071|NCT03180801|12559871|FG000|Overall Study|Inoculation Target Reached|1
7986072|NCT03180801|12559872|FG001|Overall Study|Inoculation Target Reached|1
7986073|NCT03180801|12559873|FG002|Overall Study|Inoculation Target Reached|3
7986074|NCT03180801|12559871|FG000|Overall Study|Adverse Event|1
7986075|NCT03180801|12559872|FG001|Overall Study|Adverse Event|0
7986076|NCT03180801|12559873|FG002|Overall Study|Adverse Event|2
7986077|NCT03180801|12559871|FG000|Overall Study|Withdrawal by Subject|2
7986078|NCT03180801|12559872|FG001|Overall Study|Withdrawal by Subject|2
7986079|NCT03180801|12559873|FG002|Overall Study|Withdrawal by Subject|1
7986080|NCT03180801|12559871|FG000|Overall Study|Lost to Follow-up|0
7986081|NCT03180801|12559872|FG001|Overall Study|Lost to Follow-up|2
7986082|NCT03180801|12559873|FG002|Overall Study|Lost to Follow-up|3
7986083|NCT03181451|12559905|FG000|Overall Study|Adverse Event|0
7986084|NCT03181451|12559906|FG001|Overall Study|Adverse Event|1
7986085|NCT03181451|12559907|FG002|Overall Study|Adverse Event|0
7986086|NCT03181451|12559905|FG000|Overall Study|Withdrawal by Subject|0
7986087|NCT03181451|12559906|FG001|Overall Study|Withdrawal by Subject|1
7986088|NCT03181451|12559907|FG002|Overall Study|Withdrawal by Subject|0
7986089|NCT03181503|12559919|FG000|Overall Study|Adverse Event|2
7986090|NCT03181503|12559920|FG001|Overall Study|Adverse Event|2
7986091|NCT03181503|12559919|FG000|Overall Study|Protocol Violation|1
7986092|NCT03181503|12559920|FG001|Overall Study|Protocol Violation|0
7986093|NCT03181503|12559919|FG000|Overall Study|Withdrawal by Subject|3
7986094|NCT03181503|12559920|FG001|Overall Study|Withdrawal by Subject|0
7986095|NCT03181503|12559919|FG000|Overall Study|Lost to Follow-up|1
7986096|NCT03181503|12559920|FG001|Overall Study|Lost to Follow-up|1
7986097|NCT03181594|12559929|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4
7986098|NCT03181594|12559929|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3
7986099|NCT03181594|12559929|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1
7986100|NCT03181594|12559929|FG000|Initial Study Protocol (12-month FU)|Death|1
7986101|NCT03181594|12559929|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3
7986102|NCT03181594|12559929|FG000|Long-term Extension (15-24 Month FU)|Death|2
7986103|NCT03181932|12559944|FG000|Period 1 (Double-blind Period)|Adverse Event|5
7986104|NCT03181932|12559945|FG001|Period 1 (Double-blind Period)|Adverse Event|1
7986105|NCT03181932|12559944|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0
7986106|NCT03181932|12559945|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1
7986107|NCT03181932|12559944|FG000|Period 1 (Double-blind Period)|Protocol Violation|1
7986108|NCT03181932|12559945|FG001|Period 1 (Double-blind Period)|Protocol Violation|2
7986109|NCT03181932|12559944|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5
7986110|NCT03181932|12559945|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9
7986111|NCT03181932|12559944|FG000|Period 2 (Open-label Period)|Adverse Event|1
7986112|NCT03181932|12559945|FG001|Period 2 (Open-label Period)|Adverse Event|6
7986113|NCT03181932|12559944|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0
7986114|NCT03181932|12559945|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1
7986115|NCT03181932|12559944|FG000|Period 2 (Open-label Period)|Protocol Violation|3
7986116|NCT03181932|12559945|FG001|Period 2 (Open-label Period)|Protocol Violation|1
7986117|NCT03181932|12559944|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2
7986118|NCT03181932|12559945|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5
7986119|NCT03181932|12559944|FG000|Period 2 (Open-label Period)|Reason missing|2
7986120|NCT03181932|12559945|FG001|Period 2 (Open-label Period)|Reason missing|0
7986121|NCT03181958|12559955|FG000|Overall Study|Lost to Follow-up|17
7986122|NCT03181958|12559956|FG001|Overall Study|Lost to Follow-up|21
7986123|NCT03181958|12559957|FG002|Overall Study|Lost to Follow-up|15
7986124|NCT03182738|12559988|FG000|Overall Study|Lost to Follow-up|9
7986125|NCT03182738|12559989|FG001|Overall Study|Lost to Follow-up|3
7986126|NCT03182738|12559988|FG000|Overall Study|Pregnancy|0
7986127|NCT03182738|12559989|FG001|Overall Study|Pregnancy|1
7986128|NCT03182738|12559988|FG000|Overall Study|Withdrawal by Subject|0
7986129|NCT03182738|12559989|FG001|Overall Study|Withdrawal by Subject|1
7986130|NCT03183063|12560018|FG000|Overall Study|Withdrawal by Subject|2
7986131|NCT03183063|12560019|FG001|Overall Study|Withdrawal by Subject|0
7986132|NCT03183063|12560020|FG002|Overall Study|Withdrawal by Subject|0
7986133|NCT03183063|12560018|FG000|Overall Study|Physician Decision|3
7986134|NCT03183063|12560019|FG001|Overall Study|Physician Decision|4
7986135|NCT03183063|12560020|FG002|Overall Study|Physician Decision|4
7986136|NCT03183518|12560034|FG000|Overall Study|Other (Not specified)|2
7986137|NCT03183518|12560034|FG000|Overall Study|Other (Withdrawal of consent)|1
7986138|NCT03183908|12560050|FG000|Overall Study|Missing Symptom Diary Data|0
7986139|NCT03183908|12560051|FG001|Overall Study|Missing Symptom Diary Data|2
7986140|NCT03184077|12560063|FG000|Overall Study|Lost to Follow-up|21
7986141|NCT03184077|12560064|FG001|Overall Study|Lost to Follow-up|21
7986142|NCT03184441|12560086|FG000|Overall Study|Withdrawal by Subject|1
7986143|NCT03184519|12560093|FG000|Overall Study|Lost to Follow-up|6
7986144|NCT03184519|12560093|FG000|Overall Study|Physician Decision|21
7986145|NCT03184558|12560097|FG000|Overall Study|Withdrawal by Subject|2
7986146|NCT03184558|12560097|FG000|Overall Study|Death|16
7986147|NCT03184558|12560097|FG000|Overall Study|Lost to Follow-up|2
7986148|NCT03184558|12560097|FG000|Overall Study|Other|9
7986149|NCT03184701|12560101|FG000|Overall Study|Death|3
7986150|NCT03184701|12560101|FG000|Overall Study|Physician Decision|3
7986151|NCT03184701|12560101|FG000|Overall Study|Withdrawal by Subject|6
7986152|NCT03184701|12560101|FG000|Overall Study|Lost to Follow-up|5
7986153|NCT03184987|12560108|FG000|Overall Study|Withdrawal by Subject|0
7986154|NCT03184987|12560109|FG001|Overall Study|Withdrawal by Subject|1
7986155|NCT03184987|12560110|FG002|Overall Study|Withdrawal by Subject|2
7986156|NCT03184987|12560108|FG000|Overall Study|Physician Decision|0
7986157|NCT03184987|12560109|FG001|Overall Study|Physician Decision|0
7986158|NCT03184987|12560110|FG002|Overall Study|Physician Decision|1
7986159|NCT03184987|12560108|FG000|Overall Study|Adverse Event|1
7986160|NCT03184987|12560109|FG001|Overall Study|Adverse Event|0
7986161|NCT03184987|12560110|FG002|Overall Study|Adverse Event|1
7986162|NCT03185481|12560150|FG000|Overall Study|Adverse Event|1
7986163|NCT03185481|12560150|FG000|Overall Study|Study Terminated by Sponsor|4
7986164|NCT03186378|12560199|FG000|Overall Study|Lost to Follow-up|1
7986165|NCT03186378|12560200|FG001|Overall Study|Lost to Follow-up|0
7986166|NCT03186781|12560233|FG000|Overall Study|Lost to Follow-up|0
7986167|NCT03186781|12560234|FG001|Overall Study|Lost to Follow-up|0
7986168|NCT03186781|12560235|FG002|Overall Study|Lost to Follow-up|1
7986169|NCT03186781|12560236|FG003|Overall Study|Lost to Follow-up|0
7986170|NCT03186781|12560237|FG004|Overall Study|Lost to Follow-up|1
7986171|NCT03186781|12560238|FG005|Overall Study|Lost to Follow-up|0
7986172|NCT03186781|12560233|FG000|Overall Study|Moved from Area|0
7986173|NCT03186781|12560234|FG001|Overall Study|Moved from Area|0
7986174|NCT03186781|12560235|FG002|Overall Study|Moved from Area|0
7986175|NCT03186781|12560236|FG003|Overall Study|Moved from Area|0
7986176|NCT03186781|12560237|FG004|Overall Study|Moved from Area|1
7986177|NCT03186781|12560238|FG005|Overall Study|Moved from Area|0
7986178|NCT03186781|12560233|FG000|Overall Study|Withdrawal by Subject|0
7986179|NCT03186781|12560234|FG001|Overall Study|Withdrawal by Subject|0
7986180|NCT03186781|12560235|FG002|Overall Study|Withdrawal by Subject|0
7986181|NCT03186781|12560236|FG003|Overall Study|Withdrawal by Subject|0
7986182|NCT03186781|12560237|FG004|Overall Study|Withdrawal by Subject|1
7986183|NCT03186781|12560238|FG005|Overall Study|Withdrawal by Subject|0
7986184|NCT03187132|12560276|FG000|Inpatient Trauma Only|Lost to Follow-up|3
7986185|NCT03187132|12560277|FG001|Inpatient Trauma Only|Lost to Follow-up|12
7986186|NCT03187132|12560276|FG000|Inpatient Trauma Only|socioeconomic burden|1
7986187|NCT03187132|12560277|FG001|Inpatient Trauma Only|socioeconomic burden|0
7986188|NCT03187132|12560276|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0
7986189|NCT03187132|12560277|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5
7986190|NCT03187132|12560276|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1
7986191|NCT03187132|12560277|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0
7986192|NCT03187132|12560276|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2
7986193|NCT03187132|12560277|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5
7986194|NCT03187132|12560276|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1
7986195|NCT03187132|12560277|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0
7986196|NCT03187132|12560276|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0
7986197|NCT03187132|12560277|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2
7986198|NCT03187132|12560276|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27
7986199|NCT03187132|12560277|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47
7986200|NCT03187132|12560276|FG000|Pain Clinic Only, Fully Remote|Disease burden|6
7986201|NCT03187132|12560277|FG001|Pain Clinic Only, Fully Remote|Disease burden|5
7986202|NCT03187132|12560276|FG000|Pain Clinic Only, Fully Remote|Language barrier|0
7986203|NCT03187132|12560277|FG001|Pain Clinic Only, Fully Remote|Language barrier|1
7986204|NCT03187132|12560276|FG000|Pain Clinic Only, Fully Remote|EMR|0
7986205|NCT03187132|12560277|FG001|Pain Clinic Only, Fully Remote|EMR|1
7986206|NCT03187197|12560286|FG000|Overall Study|Stopped Pradaxa®/VKA|11
7986207|NCT03187197|12560287|FG001|Overall Study|Stopped Pradaxa®/VKA|65
7986208|NCT03187197|12560288|FG002|Overall Study|Stopped Pradaxa®/VKA|4
7986209|NCT03187197|12560286|FG000|Overall Study|Withdrawal by Subject|8
7986210|NCT03187197|12560287|FG001|Overall Study|Withdrawal by Subject|63
7986211|NCT03187197|12560288|FG002|Overall Study|Withdrawal by Subject|4
7986212|NCT03187197|12560286|FG000|Overall Study|Lost to Follow-up|1
7986213|NCT03187197|12560287|FG001|Overall Study|Lost to Follow-up|60
7986214|NCT03187197|12560288|FG002|Overall Study|Lost to Follow-up|7
7986215|NCT03187197|12560286|FG000|Overall Study|Adverse Event|6
7986216|NCT03187197|12560287|FG001|Overall Study|Adverse Event|29
7986217|NCT03187197|12560288|FG002|Overall Study|Adverse Event|0
7986218|NCT03187197|12560286|FG000|Overall Study|Death|0
7986219|NCT03187197|12560287|FG001|Overall Study|Death|11
7986220|NCT03187197|12560288|FG002|Overall Study|Death|0
7986221|NCT03187197|12560286|FG000|Overall Study|Administrative problem|1
7986222|NCT03187197|12560287|FG001|Overall Study|Administrative problem|1
7986223|NCT03187197|12560288|FG002|Overall Study|Administrative problem|0
7986224|NCT03187197|12560286|FG000|Overall Study|Reason not listed|2
7986225|NCT03187197|12560287|FG001|Overall Study|Reason not listed|54
7986226|NCT03187197|12560288|FG002|Overall Study|Reason not listed|1
7986227|NCT03187197|12560286|FG000|Overall Study|Missing|1
7986228|NCT03187197|12560287|FG001|Overall Study|Missing|32
7986229|NCT03187197|12560288|FG002|Overall Study|Missing|3
7986230|NCT03187197|12560286|FG000|Overall Study|Status missing|2
7986231|NCT03187197|12560287|FG001|Overall Study|Status missing|33
7986232|NCT03187197|12560288|FG002|Overall Study|Status missing|3
7986233|NCT03187197|12560286|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14
7986234|NCT03187197|12560287|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45
7986235|NCT03187197|12560288|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1
7986236|NCT03187301|12560296|FG000|Titration Period|Adverse Event|0
7986237|NCT03187301|12560297|FG001|Titration Period|Adverse Event|0
7986238|NCT03187301|12560298|FG002|Titration Period|Adverse Event|0
7986239|NCT03187301|12560299|FG003|Titration Period|Adverse Event|0
7986240|NCT03187301|12560300|FG004|Titration Period|Adverse Event|0
7986241|NCT03187301|12560301|FG005|Titration Period|Adverse Event|0
7986242|NCT03187301|12560302|FG006|Titration Period|Adverse Event|5
7986243|NCT03187301|12560296|FG000|Titration Period|Withdrawal by Subject|0
7986244|NCT03187301|12560297|FG001|Titration Period|Withdrawal by Subject|0
7986245|NCT03187301|12560298|FG002|Titration Period|Withdrawal by Subject|0
7986246|NCT03187301|12560299|FG003|Titration Period|Withdrawal by Subject|0
7986247|NCT03187301|12560300|FG004|Titration Period|Withdrawal by Subject|0
7986248|NCT03187301|12560301|FG005|Titration Period|Withdrawal by Subject|0
7986249|NCT03187301|12560302|FG006|Titration Period|Withdrawal by Subject|1
7986250|NCT03187301|12560296|FG000|Titration Period|Exclusion Criteria Met|0
7986251|NCT03187301|12560297|FG001|Titration Period|Exclusion Criteria Met|0
7986252|NCT03187301|12560298|FG002|Titration Period|Exclusion Criteria Met|0
7986253|NCT03187301|12560299|FG003|Titration Period|Exclusion Criteria Met|0
7986254|NCT03187301|12560300|FG004|Titration Period|Exclusion Criteria Met|0
7986255|NCT03187301|12560301|FG005|Titration Period|Exclusion Criteria Met|0
7986256|NCT03187301|12560302|FG006|Titration Period|Exclusion Criteria Met|1
7986257|NCT03187301|12560296|FG000|Pre-Intervention|Withdrawal by Subject|1
7986258|NCT03187301|12560297|FG001|Pre-Intervention|Withdrawal by Subject|0
7986259|NCT03187301|12560298|FG002|Pre-Intervention|Withdrawal by Subject|0
7986260|NCT03187301|12560299|FG003|Pre-Intervention|Withdrawal by Subject|0
7986261|NCT03187301|12560300|FG004|Pre-Intervention|Withdrawal by Subject|0
7986262|NCT03187301|12560301|FG005|Pre-Intervention|Withdrawal by Subject|0
7986263|NCT03187301|12560302|FG006|Pre-Intervention|Withdrawal by Subject|0
7986264|NCT03187756|12560340|FG000|Overall Study|Termination of study|4
7986265|NCT03188055|12560346|FG000|Overall Study|Unavailable for training|0
7986266|NCT03188055|12560347|FG001|Overall Study|Unavailable for training|0
7986267|NCT03188055|12560348|FG002|Overall Study|Unavailable for training|19
7986268|NCT03188055|12560349|FG003|Overall Study|Unavailable for training|0
7986269|NCT03188055|12560350|FG004|Overall Study|Unavailable for training|0
7986270|NCT03188055|12560351|FG005|Overall Study|Unavailable for training|
7986271|NCT03188055|12560346|FG000|Overall Study|Lost to Follow-up|0
7986272|NCT03188055|12560347|FG001|Overall Study|Lost to Follow-up|18
7986273|NCT03188055|12560348|FG002|Overall Study|Lost to Follow-up|0
7986274|NCT03188055|12560349|FG003|Overall Study|Lost to Follow-up|11
7986275|NCT03188055|12560350|FG004|Overall Study|Lost to Follow-up|0
7986276|NCT03188055|12560351|FG005|Overall Study|Lost to Follow-up|
7986277|NCT03188055|12560346|FG000|Overall Study|Withdrawal by Subject|0
7986278|NCT03188055|12560347|FG001|Overall Study|Withdrawal by Subject|1
7986279|NCT03188055|12560348|FG002|Overall Study|Withdrawal by Subject|0
7986280|NCT03188055|12560349|FG003|Overall Study|Withdrawal by Subject|1
7986281|NCT03188055|12560350|FG004|Overall Study|Withdrawal by Subject|0
7986282|NCT03188055|12560351|FG005|Overall Study|Withdrawal by Subject|
7986283|NCT03188120|12560362|FG000|Overall Study|Adverse Event|4
7986284|NCT03188120|12560362|FG000|Overall Study|Insufficient Effectiveness|8
7986285|NCT03188120|12560362|FG000|Overall Study|Improved|12
7986286|NCT03188120|12560362|FG000|Overall Study|Lost to Follow-up|7
7986287|NCT03188120|12560362|FG000|Overall Study|Other than specified|3
7986288|NCT03188120|12560362|FG000|Overall Study|No visit after the first visit|13
7986289|NCT03188185|12560368|FG000|Stage 1|Adverse Event|4
7986290|NCT03188185|12560369|FG001|Stage 1|Adverse Event|12
7986291|NCT03188185|12560370|FG002|Stage 1|Adverse Event|0
7986292|NCT03188185|12560371|FG003|Stage 1|Adverse Event|0
7986293|NCT03188185|12560368|FG000|Stage 1|Lack of Efficacy|0
7986294|NCT03188185|12560369|FG001|Stage 1|Lack of Efficacy|2
7986295|NCT03188185|12560370|FG002|Stage 1|Lack of Efficacy|0
7986296|NCT03188185|12560371|FG003|Stage 1|Lack of Efficacy|0
7986297|NCT03188185|12560368|FG000|Stage 1|Lost to Follow-up|6
7986298|NCT03188185|12560369|FG001|Stage 1|Lost to Follow-up|1
7986299|NCT03188185|12560370|FG002|Stage 1|Lost to Follow-up|0
7986300|NCT03188185|12560371|FG003|Stage 1|Lost to Follow-up|0
7986301|NCT03188185|12560368|FG000|Stage 1|Withdrawal by Subject|9
7986302|NCT03188185|12560369|FG001|Stage 1|Withdrawal by Subject|0
7986303|NCT03188185|12560370|FG002|Stage 1|Withdrawal by Subject|0
7986304|NCT03188185|12560371|FG003|Stage 1|Withdrawal by Subject|0
7986305|NCT03188185|12560368|FG000|Stage 1|Identified as a professional patient|0
7986306|NCT03188185|12560369|FG001|Stage 1|Identified as a professional patient|1
7986307|NCT03188185|12560370|FG002|Stage 1|Identified as a professional patient|0
7986308|NCT03188185|12560371|FG003|Stage 1|Identified as a professional patient|0
7986309|NCT03188185|12560368|FG000|Stage 2|Adverse Event|0
7986310|NCT03188185|12560369|FG001|Stage 2|Adverse Event|0
7986311|NCT03188185|12560370|FG002|Stage 2|Adverse Event|2
7986312|NCT03188185|12560371|FG003|Stage 2|Adverse Event|4
7986313|NCT03188185|12560368|FG000|Stage 2|Lack of Efficacy|0
7986314|NCT03188185|12560369|FG001|Stage 2|Lack of Efficacy|0
7986315|NCT03188185|12560370|FG002|Stage 2|Lack of Efficacy|3
7986316|NCT03188185|12560371|FG003|Stage 2|Lack of Efficacy|0
7986317|NCT03188185|12560368|FG000|Stage 2|Lost to Follow-up|0
7986318|NCT03188185|12560369|FG001|Stage 2|Lost to Follow-up|0
7986319|NCT03188185|12560370|FG002|Stage 2|Lost to Follow-up|1
7986320|NCT03188185|12560371|FG003|Stage 2|Lost to Follow-up|0
7986321|NCT03188185|12560368|FG000|Stage 2|Physician Decision|0
7986322|NCT03188185|12560369|FG001|Stage 2|Physician Decision|0
7986323|NCT03188185|12560370|FG002|Stage 2|Physician Decision|0
7986324|NCT03188185|12560371|FG003|Stage 2|Physician Decision|1
7986325|NCT03188185|12560368|FG000|Stage 2|Withdrawal by Subject|0
7986326|NCT03188185|12560369|FG001|Stage 2|Withdrawal by Subject|0
7986327|NCT03188185|12560370|FG002|Stage 2|Withdrawal by Subject|3
7986328|NCT03188185|12560371|FG003|Stage 2|Withdrawal by Subject|1
7986329|NCT03188263|12560383|FG000|Overall Study|Withdrawal by Subject|3
7986330|NCT03188263|12560384|FG001|Overall Study|Withdrawal by Subject|0
7986331|NCT03188263|12560383|FG000|Overall Study|Physician Decision|1
7986332|NCT03188263|12560384|FG001|Overall Study|Physician Decision|0
7986333|NCT03188536|12560401|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5
7986334|NCT03188536|12560401|FG000|Overall Study|Not participated/met inclusion criteria|1
7986335|NCT03188718|12560405|FG000|Overall Study|Participant noncompliance|4
7986336|NCT03188718|12560405|FG000|Overall Study|Withdrawal by Subject|1
7986337|NCT03188718|12560405|FG000|Overall Study|Device failure|3
7986338|NCT03188991|12560413|FG000|Overall Study|Withdrawal by Subject|0
7986339|NCT03188991|12560414|FG001|Overall Study|Withdrawal by Subject|0
7986340|NCT03188991|12560415|FG002|Overall Study|Withdrawal by Subject|0
7986341|NCT03188991|12560416|FG003|Overall Study|Withdrawal by Subject|1
7986342|NCT03189446|12560430|FG000|Overall Study|Adverse Event|2
7986343|NCT03189446|12560430|FG000|Overall Study|Withdrawal by Subject|2
7986344|NCT03189446|12560430|FG000|Overall Study|Physician Decision|1
7986345|NCT03189524|12560437|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7
7986346|NCT03189524|12560438|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5
7986347|NCT03189524|12560439|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11
7986348|NCT03189524|12560437|FG000|Overall Study|Death|2
7986349|NCT03189524|12560438|FG001|Overall Study|Death|2
7986350|NCT03189524|12560439|FG002|Overall Study|Death|1
7986351|NCT03189524|12560437|FG000|Overall Study|Lost to Follow-up|1
7986352|NCT03189524|12560438|FG001|Overall Study|Lost to Follow-up|0
7986353|NCT03189524|12560439|FG002|Overall Study|Lost to Follow-up|8
7986354|NCT03189524|12560437|FG000|Overall Study|Withdrawal by Subject|1
7986355|NCT03189524|12560438|FG001|Overall Study|Withdrawal by Subject|1
7986356|NCT03189524|12560439|FG002|Overall Study|Withdrawal by Subject|3
7986357|NCT03189524|12560437|FG000|Overall Study|Progressive Disease|0
7986358|NCT03189524|12560438|FG001|Overall Study|Progressive Disease|2
7986359|NCT03189524|12560439|FG002|Overall Study|Progressive Disease|0
7986360|NCT03189745|12560462|FG000|Overall Study|Conflict in work schedule of participant|1
7986361|NCT03189745|12560463|FG001|Overall Study|Conflict in work schedule of participant|1
7986362|NCT03191396|12560517|FG000|Overall Study|Lost to Follow-up|0
7986363|NCT03191396|12560518|FG001|Overall Study|Lost to Follow-up|3
7986364|NCT03191396|12560517|FG000|Overall Study|Withdrawal by Subject|3
7986365|NCT03191396|12560518|FG001|Overall Study|Withdrawal by Subject|2
7986366|NCT03191552|12560527|FG000|Overall Study|Lost to Follow-up|1
7986367|NCT03191552|12560528|FG001|Overall Study|Lost to Follow-up|0
7986368|NCT03191552|12560529|FG002|Overall Study|Lost to Follow-up|0
7986369|NCT03191552|12560527|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0
7986370|NCT03191552|12560528|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1
7986371|NCT03191552|12560529|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0
7986372|NCT03191630|12560543|FG000|Overall Study|Lost to Follow-up|7
7986373|NCT03191630|12560544|FG001|Overall Study|Lost to Follow-up|7
7986374|NCT03191799|12560552|FG000|Overall Study|Withdrawal by Subject|4
7986375|NCT03191799|12560552|FG000|Overall Study|Physician Decision|2
7986376|NCT03191799|12560552|FG000|Overall Study|Lost to Follow-up|1
7986377|NCT03191799|12560552|FG000|Overall Study|Death|2
7986378|NCT03192137|12560558|FG000|Overall Study|Adverse Event|10
7986379|NCT03192137|12560559|FG001|Overall Study|Adverse Event|11
7986380|NCT03192137|12560558|FG000|Overall Study|Physician Decision|1
7986381|NCT03192137|12560559|FG001|Overall Study|Physician Decision|0
7986382|NCT03192137|12560558|FG000|Overall Study|Lack of Efficacy|20
7986383|NCT03192137|12560559|FG001|Overall Study|Lack of Efficacy|37
7986384|NCT03192137|12560558|FG000|Overall Study|Withdrawal by Subject|3
7986385|NCT03192137|12560559|FG001|Overall Study|Withdrawal by Subject|3
7986386|NCT03192137|12560558|FG000|Overall Study|Protocol Violation|4
7986387|NCT03192137|12560559|FG001|Overall Study|Protocol Violation|3
7986388|NCT03192137|12560558|FG000|Overall Study|Surgery Cancelled|4
7986389|NCT03192137|12560559|FG001|Overall Study|Surgery Cancelled|1
7986390|NCT03192137|12560558|FG000|Overall Study|Other - Various Administrative Reasons|8
7986391|NCT03192137|12560559|FG001|Overall Study|Other - Various Administrative Reasons|3
7986392|NCT03192150|12560567|FG000|Overall Study|Adverse Event|14
7986393|NCT03192150|12560568|FG001|Overall Study|Adverse Event|12
7986394|NCT03192150|12560567|FG000|Overall Study|Lack of Efficacy|23
7986395|NCT03192150|12560568|FG001|Overall Study|Lack of Efficacy|30
7986396|NCT03192150|12560567|FG000|Overall Study|Lost to Follow-up|1
7986397|NCT03192150|12560568|FG001|Overall Study|Lost to Follow-up|1
7986398|NCT03192150|12560567|FG000|Overall Study|Withdrawal by Subject|4
7986399|NCT03192150|12560568|FG001|Overall Study|Withdrawal by Subject|2
7986400|NCT03192150|12560567|FG000|Overall Study|Protocol Violation|5
7986401|NCT03192150|12560568|FG001|Overall Study|Protocol Violation|2
7986402|NCT03192150|12560567|FG000|Overall Study|Surgery Canceled|6
7986403|NCT03192150|12560568|FG001|Overall Study|Surgery Canceled|2
7718158|NCT00525512|12141934|FG002|Open-Label Phase|Other reason (not specified)|4
7718159|NCT00525512|12141935|FG003|Open-Label Phase|Other reason (not specified)|5
7986404|NCT03192150|12560567|FG000|Overall Study|Other-Various Administrative Reasons|2
7986405|NCT03192150|12560568|FG001|Overall Study|Other-Various Administrative Reasons|5
7986406|NCT03192176|12560582|FG000|Overall Study|Adverse Event|1
7986407|NCT03192176|12560583|FG001|Overall Study|Adverse Event|0
7986408|NCT03192176|12560584|FG002|Overall Study|Adverse Event|4
7986409|NCT03192176|12560585|FG003|Overall Study|Adverse Event|5
7986410|NCT03192176|12560586|FG004|Overall Study|Adverse Event|3
7986411|NCT03192176|12560587|FG005|Overall Study|Adverse Event|2
7986412|NCT03192176|12560588|FG006|Overall Study|Adverse Event|3
7986413|NCT03192176|12560589|FG007|Overall Study|Adverse Event|3
7986414|NCT03192176|12560582|FG000|Overall Study|Lost to Follow-up|0
7986415|NCT03192176|12560583|FG001|Overall Study|Lost to Follow-up|0
7986416|NCT03192176|12560584|FG002|Overall Study|Lost to Follow-up|1
7986417|NCT03192176|12560585|FG003|Overall Study|Lost to Follow-up|2
7986418|NCT03192176|12560586|FG004|Overall Study|Lost to Follow-up|3
7986419|NCT03192176|12560587|FG005|Overall Study|Lost to Follow-up|1
7986420|NCT03192176|12560588|FG006|Overall Study|Lost to Follow-up|1
7986421|NCT03192176|12560589|FG007|Overall Study|Lost to Follow-up|1
7986422|NCT03192176|12560582|FG000|Overall Study|Physician Decision|1
7986423|NCT03192176|12560583|FG001|Overall Study|Physician Decision|0
7986424|NCT03192176|12560584|FG002|Overall Study|Physician Decision|0
7986425|NCT03192176|12560585|FG003|Overall Study|Physician Decision|0
7986426|NCT03192176|12560586|FG004|Overall Study|Physician Decision|0
7986427|NCT03192176|12560587|FG005|Overall Study|Physician Decision|2
7986428|NCT03192176|12560588|FG006|Overall Study|Physician Decision|1
7986429|NCT03192176|12560589|FG007|Overall Study|Physician Decision|0
7986430|NCT03192176|12560582|FG000|Overall Study|Protocol Deviation|1
7986431|NCT03192176|12560583|FG001|Overall Study|Protocol Deviation|1
7986432|NCT03192176|12560584|FG002|Overall Study|Protocol Deviation|0
7986433|NCT03192176|12560585|FG003|Overall Study|Protocol Deviation|0
7986434|NCT03192176|12560586|FG004|Overall Study|Protocol Deviation|2
7986435|NCT03192176|12560587|FG005|Overall Study|Protocol Deviation|0
7986436|NCT03192176|12560588|FG006|Overall Study|Protocol Deviation|0
7986437|NCT03192176|12560589|FG007|Overall Study|Protocol Deviation|0
7986438|NCT03192176|12560582|FG000|Overall Study|Withdrawal by Subject|3
7986439|NCT03192176|12560583|FG001|Overall Study|Withdrawal by Subject|4
7986440|NCT03192176|12560584|FG002|Overall Study|Withdrawal by Subject|0
7986441|NCT03192176|12560585|FG003|Overall Study|Withdrawal by Subject|4
7986442|NCT03192176|12560586|FG004|Overall Study|Withdrawal by Subject|3
7986443|NCT03192176|12560587|FG005|Overall Study|Withdrawal by Subject|4
7718160|NCT00525590|12141956|FG000|Overall Study|Adverse Event|3
7718161|NCT00525590|12141956|FG000|Overall Study|Physician Decision|3
7718162|NCT00525590|12141956|FG000|Overall Study|Withdrawal by Subject|16
7718163|NCT00525590|12141956|FG000|Overall Study|Lost to Follow-up|1
7718164|NCT00525590|12141956|FG000|Overall Study|Death|9
7718165|NCT00525590|12141956|FG000|Overall Study|Other|13
7718166|NCT00525785|12141980|FG000|Overall Study|Withdrawal by Subject|1
7718167|NCT00525785|12141980|FG000|Overall Study|Lack of Efficacy|1
7718168|NCT00525785|12141980|FG000|Overall Study|Physician Decision|1
7718169|NCT00525824|12141997|FG000|Overall Study|Adverse Event|7
7718170|NCT00525824|12141998|FG001|Overall Study|Adverse Event|11
7718171|NCT00525824|12141999|FG002|Overall Study|Adverse Event|6
7986444|NCT03192176|12560588|FG006|Overall Study|Withdrawal by Subject|4
7986445|NCT03192176|12560589|FG007|Overall Study|Withdrawal by Subject|2
7986446|NCT03192176|12560582|FG000|Overall Study|Miscellaneous|1
7986447|NCT03192176|12560583|FG001|Overall Study|Miscellaneous|0
7986448|NCT03192176|12560584|FG002|Overall Study|Miscellaneous|1
7986449|NCT03192176|12560585|FG003|Overall Study|Miscellaneous|1
7986450|NCT03192176|12560586|FG004|Overall Study|Miscellaneous|1
7986451|NCT03192176|12560587|FG005|Overall Study|Miscellaneous|2
7986452|NCT03192176|12560588|FG006|Overall Study|Miscellaneous|0
7986453|NCT03192176|12560589|FG007|Overall Study|Miscellaneous|1
7986454|NCT03192306|12560610|FG000|Overall Study|Did not treat cold sore during study|149
7986455|NCT03192306|12560611|FG001|Overall Study|Did not treat cold sore during study|143
7986456|NCT03192306|12560610|FG000|Overall Study|Withdrawal by Subject|1
7986457|NCT03192306|12560611|FG001|Overall Study|Withdrawal by Subject|1
7986458|NCT03192306|12560610|FG000|Overall Study|Lost to Follow-up|1
7986459|NCT03192306|12560611|FG001|Overall Study|Lost to Follow-up|0
7986460|NCT03192306|12560610|FG000|Overall Study|Protocol Violation|1
7986461|NCT03192306|12560611|FG001|Overall Study|Protocol Violation|1
7986462|NCT03192475|12560619|FG000|Overall Study|Death|0
7986463|NCT03192475|12560620|FG001|Overall Study|Death|1
7986464|NCT03192475|12560619|FG000|Overall Study|Lost to Follow-up|13
7986465|NCT03192475|12560620|FG001|Overall Study|Lost to Follow-up|8
7986466|NCT03192488|12560627|FG000|First Washout (>6d)|Withdrawal by Subject|0
7986467|NCT03192488|12560628|FG001|First Washout (>6d)|Withdrawal by Subject|0
7986468|NCT03192488|12560629|FG002|First Washout (>6d)|Withdrawal by Subject|1
7986469|NCT03192488|12560630|FG003|First Washout (>6d)|Withdrawal by Subject|0
7986470|NCT03192488|12560631|FG004|First Washout (>6d)|Withdrawal by Subject|0
7986471|NCT03192488|12560632|FG005|First Washout (>6d)|Withdrawal by Subject|1
7986472|NCT03192488|12560627|FG000|Third Intervention (d1)|Adverse Event|0
7986473|NCT03192488|12560628|FG001|Third Intervention (d1)|Adverse Event|0
7986474|NCT03192488|12560629|FG002|Third Intervention (d1)|Adverse Event|0
7986475|NCT03192488|12560630|FG003|Third Intervention (d1)|Adverse Event|0
7986476|NCT03192488|12560631|FG004|Third Intervention (d1)|Adverse Event|1
7986477|NCT03192488|12560632|FG005|Third Intervention (d1)|Adverse Event|0
7986478|NCT03192904|12560661|FG000|Overall Study|Physician Decision|3
7986479|NCT03192904|12560662|FG001|Overall Study|Physician Decision|1
7986480|NCT03192904|12560661|FG000|Overall Study|Lost to Follow-up|0
7986481|NCT03192904|12560662|FG001|Overall Study|Lost to Follow-up|1
7986482|NCT03193021|12560670|FG000|Overall Study|Lost to Follow-up|1
7986483|NCT03193021|12560671|FG001|Overall Study|Lost to Follow-up|1
7986484|NCT03193047|12560679|FG000|Overall Study|Physician Decision|1
7986485|NCT03193047|12560680|FG001|Overall Study|Physician Decision|0
7986486|NCT03193047|12560679|FG000|Overall Study|Participant Left State|1
7986487|NCT03193047|12560680|FG001|Overall Study|Participant Left State|0
7986488|NCT03193736|12560726|FG000|Overall Study|Death|2
7986489|NCT03193736|12560726|FG000|Overall Study|Withdrawal by Subject|1
7986490|NCT03193736|12560726|FG000|Overall Study|Lost to Follow-up|1
7986491|NCT03193736|12560726|FG000|Overall Study|implant not received|1
7986492|NCT03194217|12560734|FG000|Overall Study|Adverse Event|0
7986493|NCT03194217|12560735|FG001|Overall Study|Adverse Event|2
7986494|NCT03194217|12560736|FG002|Overall Study|Adverse Event|3
7986495|NCT03194217|12560737|FG003|Overall Study|Adverse Event|3
7986496|NCT03194217|12560734|FG000|Overall Study|Failure to meet randomisation criteria|0
7986497|NCT03194217|12560735|FG001|Overall Study|Failure to meet randomisation criteria|0
7986498|NCT03194217|12560736|FG002|Overall Study|Failure to meet randomisation criteria|0
7986499|NCT03194217|12560737|FG003|Overall Study|Failure to meet randomisation criteria|1
7986500|NCT03194217|12560734|FG000|Overall Study|Other|0
7986501|NCT03194217|12560735|FG001|Overall Study|Other|1
7986502|NCT03194217|12560736|FG002|Overall Study|Other|1
7986503|NCT03194217|12560737|FG003|Overall Study|Other|0
7986504|NCT03194464|12560765|FG000|Overall Study|data not usable|2
7986505|NCT03194490|12560773|FG000|Overall Study|Lost to Follow-up|1
7986506|NCT03194490|12560774|FG001|Overall Study|Lost to Follow-up|3
7986507|NCT03194490|12560773|FG000|Overall Study|participant developed specific neck pain|1
7986508|NCT03194490|12560774|FG001|Overall Study|participant developed specific neck pain|0
7986509|NCT03196193|12560854|FG000|Overall Study|Adverse Event|1
7986510|NCT03196193|12560855|FG001|Overall Study|Adverse Event|0
7986511|NCT03196193|12560854|FG000|Overall Study|Computed Tomography (CT) data missing|2
7986512|NCT03196193|12560855|FG001|Overall Study|Computed Tomography (CT) data missing|0
7986513|NCT03196284|12560867|FG000|Main Part|Withdrawal by Subject|0
7986514|NCT03196284|12560868|FG001|Main Part|Withdrawal by Subject|1
7986515|NCT03196284|12560869|FG002|Main Part|Withdrawal by Subject|0
7986516|NCT03196284|12560867|FG000|Extension Part|Lack of Efficacy|0
7986517|NCT03196284|12560868|FG001|Extension Part|Lack of Efficacy|0
7986518|NCT03196284|12560869|FG002|Extension Part|Lack of Efficacy|1
7986519|NCT03196284|12560867|FG000|Extension Part|Withdrawal by Subject|0
7986520|NCT03196284|12560868|FG001|Extension Part|Withdrawal by Subject|0
7986521|NCT03196284|12560869|FG002|Extension Part|Withdrawal by Subject|1
7986522|NCT03196284|12560867|FG000|Extension Part|Physician Decision|0
7986523|NCT03196284|12560868|FG001|Extension Part|Physician Decision|0
7986524|NCT03196284|12560869|FG002|Extension Part|Physician Decision|1
7986525|NCT03196297|12560889|FG000|Main Period|Withdrawal by Subject|4
7986526|NCT03196297|12560889|FG000|Extension Period|Withdrawal by Subject|1
7986527|NCT03196297|12560889|FG000|Extension Period|Lack of Efficacy|2
7986528|NCT03196349|12560908|FG000|Overall Study|Did not receive study drug|0
7986529|NCT03196349|12560909|FG001|Overall Study|Did not receive study drug|1
7986530|NCT03196349|12560910|FG002|Overall Study|Did not receive study drug|2
7986531|NCT03196349|12560908|FG000|Overall Study|No data entered|2
7986532|NCT03196349|12560909|FG001|Overall Study|No data entered|4
7986533|NCT03196349|12560910|FG002|Overall Study|No data entered|0
7986534|NCT03196349|12560908|FG000|Overall Study|Study Terminated early|15
7986535|NCT03196349|12560909|FG001|Overall Study|Study Terminated early|9
7986536|NCT03196349|12560910|FG002|Overall Study|Study Terminated early|11
7986537|NCT03196505|12560920|FG000|Overall Study|Physician Decision|26
7986538|NCT03196505|12560921|FG001|Overall Study|Physician Decision|26
7986539|NCT03196635|12560927|FG000|Overall Study|Withdrawal by Subject|1
7986540|NCT03196791|12560947|FG000|Overall Study|Protocol Violation|7
7986541|NCT03196791|12560948|FG001|Overall Study|Protocol Violation|3
7986542|NCT03196791|12560947|FG000|Overall Study|Withdrawal by Subject|3
7986543|NCT03196791|12560948|FG001|Overall Study|Withdrawal by Subject|2
7986544|NCT03196973|12560957|FG000|Overall Study|Adverse Event|1
7986545|NCT03196973|12560958|FG001|Overall Study|Adverse Event|1
7986546|NCT03196973|12560959|FG002|Overall Study|Adverse Event|2
7986547|NCT03196973|12560957|FG000|Overall Study|Lack of Efficacy|2
7986548|NCT03196973|12560958|FG001|Overall Study|Lack of Efficacy|6
7986549|NCT03196973|12560959|FG002|Overall Study|Lack of Efficacy|1
7986550|NCT03196973|12560957|FG000|Overall Study|Lost to Follow-up|4
7986551|NCT03196973|12560958|FG001|Overall Study|Lost to Follow-up|3
7986552|NCT03196973|12560959|FG002|Overall Study|Lost to Follow-up|2
7986553|NCT03196973|12560957|FG000|Overall Study|Consent withdrawn|2
7986554|NCT03196973|12560958|FG001|Overall Study|Consent withdrawn|1
7986555|NCT03196973|12560959|FG002|Overall Study|Consent withdrawn|0
7986556|NCT03196973|12560957|FG000|Overall Study|Administration of a wrong kit of study medication|0
7986557|NCT03196973|12560958|FG001|Overall Study|Administration of a wrong kit of study medication|1
7986558|NCT03196973|12560959|FG002|Overall Study|Administration of a wrong kit of study medication|0
7986559|NCT03197129|12560982|FG000|Overall Study|did not answer the VPT: shyness|4
7986560|NCT03197129|12560983|FG001|Overall Study|did not answer the VPT: shyness|5
7986561|NCT03197324|12560991|FG000|Overall Study|Adverse Event|0
7986562|NCT03197324|12560992|FG001|Overall Study|Adverse Event|1
7986563|NCT03197376|12561002|FG000|Primary and Booster Phase|Adverse Event|0
7986564|NCT03197376|12561003|FG001|Primary and Booster Phase|Adverse Event|0
7986565|NCT03197376|12561004|FG002|Primary and Booster Phase|Adverse Event|0
7986566|NCT03197376|12561005|FG003|Primary and Booster Phase|Adverse Event|1
7986567|NCT03197376|12561002|FG000|Primary and Booster Phase|Death|1
7986568|NCT03197376|12561003|FG001|Primary and Booster Phase|Death|0
7986569|NCT03197376|12561004|FG002|Primary and Booster Phase|Death|0
7986570|NCT03197376|12561005|FG003|Primary and Booster Phase|Death|2
7986571|NCT03197376|12561002|FG000|Primary and Booster Phase|Lost to Follow-up|0
7986572|NCT03197376|12561003|FG001|Primary and Booster Phase|Lost to Follow-up|0
7986573|NCT03197376|12561004|FG002|Primary and Booster Phase|Lost to Follow-up|1
7986574|NCT03197376|12561005|FG003|Primary and Booster Phase|Lost to Follow-up|0
7986575|NCT03197376|12561002|FG000|Primary and Booster Phase|Physician Decision|1
7986576|NCT03197376|12561003|FG001|Primary and Booster Phase|Physician Decision|0
7986577|NCT03197376|12561004|FG002|Primary and Booster Phase|Physician Decision|1
7986578|NCT03197376|12561005|FG003|Primary and Booster Phase|Physician Decision|3
7986579|NCT03197376|12561002|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11
7986580|NCT03197376|12561003|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10
7986581|NCT03197376|12561004|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14
7986582|NCT03197376|12561005|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11
7986583|NCT03197376|12561002|FG000|Primary and Booster Phase|Ineligibility criteria|1
7986584|NCT03197376|12561003|FG001|Primary and Booster Phase|Ineligibility criteria|1
7986585|NCT03197376|12561004|FG002|Primary and Booster Phase|Ineligibility criteria|4
7986586|NCT03197376|12561005|FG003|Primary and Booster Phase|Ineligibility criteria|2
7986587|NCT03197376|12561002|FG000|Primary and Booster Phase|Not vaccine related|1
7986588|NCT03197376|12561003|FG001|Primary and Booster Phase|Not vaccine related|2
7986589|NCT03197376|12561004|FG002|Primary and Booster Phase|Not vaccine related|0
7986590|NCT03197376|12561005|FG003|Primary and Booster Phase|Not vaccine related|6
7986591|NCT03197376|12561002|FG000|Immune Persistence Phase|Lost to Follow-up|0
7986592|NCT03197376|12561003|FG001|Immune Persistence Phase|Lost to Follow-up|0
7986593|NCT03197376|12561004|FG002|Immune Persistence Phase|Lost to Follow-up|2
7986594|NCT03197376|12561005|FG003|Immune Persistence Phase|Lost to Follow-up|1
7986595|NCT03197376|12561002|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4
7986596|NCT03197376|12561003|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4
7986597|NCT03197376|12561004|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2
7986598|NCT03197376|12561005|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3
7986599|NCT03197376|12561002|FG000|Immune Persistence Phase|Not vaccine related|1
7986600|NCT03197376|12561003|FG001|Immune Persistence Phase|Not vaccine related|0
7986601|NCT03197376|12561004|FG002|Immune Persistence Phase|Not vaccine related|1
7986602|NCT03197376|12561005|FG003|Immune Persistence Phase|Not vaccine related|1
7986603|NCT03197558|12561063|FG000|Overall Study|Tubes not placed|1
7986604|NCT03197883|12561069|FG000|Overall Study|Adverse Event|1
7986605|NCT03197883|12561070|FG001|Overall Study|Adverse Event|1
7986606|NCT03197883|12561069|FG000|Overall Study|Lost to Follow-up|1
7986607|NCT03197883|12561070|FG001|Overall Study|Lost to Follow-up|0
7986608|NCT03197883|12561069|FG000|Overall Study|Protocol Violation|1
7986609|NCT03197883|12561070|FG001|Overall Study|Protocol Violation|0
7986610|NCT03197883|12561069|FG000|Overall Study|Other (Not Specified)|0
7986611|NCT03197883|12561070|FG001|Overall Study|Other (Not Specified)|5
7986612|NCT03198507|12561108|FG000|Overall Study|Withdrawal by Subject|1
7986613|NCT03198507|12561109|FG001|Overall Study|Withdrawal by Subject|0
7986614|NCT03198520|12561115|FG000|Overall Study|Physician Decision|2
7986615|NCT03198520|12561115|FG000|Overall Study|Protocol Violation|2
7986616|NCT03198520|12561115|FG000|Overall Study|Withdrawal by Subject|1
7986617|NCT03198520|12561115|FG000|Overall Study|Study Ended|1
7986618|NCT03198715|12561132|FG000|Overall Study|Death|0
7986619|NCT03198715|12561133|FG001|Overall Study|Death|0
7986620|NCT03198715|12561134|FG002|Overall Study|Death|1
7986621|NCT03198715|12561135|FG003|Overall Study|Death|0
7986622|NCT03198715|12561136|FG004|Overall Study|Death|2
7986623|NCT03198715|12561132|FG000|Overall Study|Other|0
7986624|NCT03198715|12561133|FG001|Overall Study|Other|1
7986625|NCT03198715|12561134|FG002|Overall Study|Other|1
7986626|NCT03198715|12561135|FG003|Overall Study|Other|0
7986627|NCT03198715|12561136|FG004|Overall Study|Other|0
7986628|NCT03198754|12561150|FG000|Overall Study|Withdrawal by Subject|5
7986629|NCT03198754|12561151|FG001|Overall Study|Withdrawal by Subject|4
7986630|NCT03198754|12561150|FG000|Overall Study|Lost to Follow-up|4
7986631|NCT03198754|12561151|FG001|Overall Study|Lost to Follow-up|3
7986632|NCT03198754|12561150|FG000|Overall Study|Ineligible|2
7986633|NCT03198754|12561151|FG001|Overall Study|Ineligible|1
7986634|NCT03198767|12561164|FG000|Overall Study|Protocol Violation|0
7986635|NCT03198767|12561165|FG001|Overall Study|Protocol Violation|0
7986636|NCT03198767|12561166|FG002|Overall Study|Protocol Violation|0
7986637|NCT03198767|12561167|FG003|Overall Study|Protocol Violation|6
7986638|NCT03198767|12561168|FG004|Overall Study|Protocol Violation|0
7986639|NCT03198767|12561169|FG005|Overall Study|Protocol Violation|0
7986640|NCT03198767|12561170|FG006|Overall Study|Protocol Violation|0
7986641|NCT03199911|12561237|FG000|Overall Study|Lost to Follow-up|5
7986642|NCT03199911|12561238|FG001|Overall Study|Lost to Follow-up|5
7986643|NCT03199911|12561237|FG000|Overall Study|Did not proceed with surgery|2
7986644|NCT03199911|12561238|FG001|Overall Study|Did not proceed with surgery|1
7986645|NCT03200366|12561247|FG000|Patient Navigation Intervention Given|Death|0
7986646|NCT03200366|12561248|FG001|Patient Navigation Intervention Given|Death|2
7986647|NCT03200366|12561249|FG002|Patient Navigation Intervention Given|Death|0
7986648|NCT03200366|12561247|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0
7986649|NCT03200366|12561248|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25
7986650|NCT03200366|12561249|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0
7986651|NCT03200366|12561247|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0
7986652|NCT03200366|12561248|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1
7986653|NCT03200366|12561249|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0
7986654|NCT03200366|12561247|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0
7986655|NCT03200366|12561248|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2
7986656|NCT03200366|12561249|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0
7986657|NCT03200366|12561247|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0
7986658|NCT03200366|12561248|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1
7986659|NCT03200366|12561249|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0
7986660|NCT03200366|12561247|FG000|6 Month Post-Baseline Interview|Death|1
7986661|NCT03200366|12561248|FG001|6 Month Post-Baseline Interview|Death|1
7986662|NCT03200366|12561249|FG002|6 Month Post-Baseline Interview|Death|1
7986663|NCT03200366|12561247|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27
7986664|NCT03200366|12561248|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21
7986665|NCT03200366|12561249|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17
7986666|NCT03200366|12561247|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1
7986667|NCT03200366|12561248|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1
7986668|NCT03200366|12561249|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0
7986669|NCT03200366|12561247|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1
7986670|NCT03200366|12561248|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0
7986671|NCT03200366|12561249|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0
7986672|NCT03200366|12561247|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0
7986673|NCT03200366|12561248|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0
7986674|NCT03200366|12561249|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1
7986675|NCT03200366|12561247|FG000|9 Month Post-Baseline Interview|Death|1
7986676|NCT03200366|12561248|FG001|9 Month Post-Baseline Interview|Death|1
7986677|NCT03200366|12561249|FG002|9 Month Post-Baseline Interview|Death|1
7986678|NCT03200366|12561247|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23
7986679|NCT03200366|12561248|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18
7986680|NCT03200366|12561249|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9
7986681|NCT03200366|12561247|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0
7986682|NCT03200366|12561248|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0
7986683|NCT03200366|12561249|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1
7986684|NCT03200366|12561247|FG000|9 Month Post-Baseline Interview|Refused interview|0
7986685|NCT03200366|12561248|FG001|9 Month Post-Baseline Interview|Refused interview|2
7986686|NCT03200366|12561249|FG002|9 Month Post-Baseline Interview|Refused interview|0
7986687|NCT03200860|12561278|FG000|Overall Study|Withdrawal by Subject|1
7986688|NCT03200860|12561279|FG001|Overall Study|Withdrawal by Subject|0
7986689|NCT03200912|12561288|FG000|Overall Study|Adverse Event|3
7986690|NCT03200912|12561289|FG001|Overall Study|Adverse Event|0
7986691|NCT03200912|12561290|FG002|Overall Study|Adverse Event|0
7986692|NCT03200912|12561288|FG000|Overall Study|Withdrawal by Subject|1
7986693|NCT03200912|12561289|FG001|Overall Study|Withdrawal by Subject|2
7986694|NCT03200912|12561290|FG002|Overall Study|Withdrawal by Subject|4
7986695|NCT03200912|12561288|FG000|Overall Study|Non-compliance with study drug|0
7986696|NCT03200912|12561289|FG001|Overall Study|Non-compliance with study drug|1
7986697|NCT03200912|12561290|FG002|Overall Study|Non-compliance with study drug|0
7986698|NCT03201003|12561309|FG000|Overall Study|Adverse Event|14
7986699|NCT03201003|12561310|FG001|Overall Study|Adverse Event|1
7986700|NCT03201003|12561309|FG000|Overall Study|Other reasons|5
7986701|NCT03201003|12561310|FG001|Overall Study|Other reasons|1
7986702|NCT03201003|12561309|FG000|Overall Study|Withdrawal by Subject|4
7986703|NCT03201003|12561310|FG001|Overall Study|Withdrawal by Subject|1
7986704|NCT03201003|12561309|FG000|Overall Study|Lost to Follow-up|2
7986705|NCT03201003|12561310|FG001|Overall Study|Lost to Follow-up|0
7986706|NCT03201003|12561309|FG000|Overall Study|Protocol Violation|1
7986707|NCT03201003|12561310|FG001|Overall Study|Protocol Violation|0
7986708|NCT03201211|12561319|FG000|Overall Study|Adverse Event|1
7986709|NCT03201211|12561320|FG001|Overall Study|Adverse Event|0
7986710|NCT03201211|12561321|FG002|Overall Study|Adverse Event|0
7986711|NCT03201211|12561319|FG000|Overall Study|Protocol Violation|1
7986712|NCT03201211|12561320|FG001|Overall Study|Protocol Violation|0
7986713|NCT03201211|12561321|FG002|Overall Study|Protocol Violation|0
7986714|NCT03201211|12561319|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7986715|NCT03201211|12561320|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7986716|NCT03201211|12561321|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7986717|NCT03201211|12561319|FG000|Overall Study|OTHER unknown reasons|0
7986718|NCT03201211|12561320|FG001|Overall Study|OTHER unknown reasons|1
7986719|NCT03201211|12561321|FG002|Overall Study|OTHER unknown reasons|0
7986720|NCT03201809|12561331|FG000|Overall Study|Lost to Follow-up|2
7986721|NCT03201809|12561332|FG001|Overall Study|Lost to Follow-up|0
7986722|NCT03201900|12561338|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9
7986723|NCT03201900|12561338|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1
7986724|NCT03201900|12561338|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6
7986725|NCT03201900|12561338|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2
7986726|NCT03201900|12561338|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6
7986727|NCT03201900|12561338|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11
7986728|NCT03201900|12561338|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2
7986729|NCT03201900|12561338|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1
7986730|NCT03201900|12561338|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1
7986731|NCT03201900|12561338|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1
7986732|NCT03201900|12561338|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1
7986733|NCT03201900|12561338|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3
7986734|NCT03201900|12561338|FG000|Extension Phase (From Week 63 to 156)|Other|1
7986735|NCT03202511|12561361|FG000|Overall Study|Withdrawal by Subject|1
7986736|NCT03202511|12561362|FG001|Overall Study|Withdrawal by Subject|0
7986737|NCT03203291|12561377|FG000|Overall Study|Withdrawal by Subject|1
7986738|NCT03203447|12561383|FG000|Overall Study|Withdrawal by Subject|2
7986739|NCT03203447|12561384|FG001|Overall Study|Withdrawal by Subject|1
7986740|NCT03203447|12561383|FG000|Overall Study|Lost to Follow-up|1
7986741|NCT03203447|12561384|FG001|Overall Study|Lost to Follow-up|10
7986742|NCT03203447|12561383|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159
7986743|NCT03203447|12561384|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152
7986744|NCT03204279|12561413|FG000|Overall Study|Withdrawal by Subject|0
7986745|NCT03204279|12561414|FG001|Overall Study|Withdrawal by Subject|1
7986746|NCT03204981|12561443|FG000|Overall Study|Physician Decision|2
7986747|NCT03204981|12561443|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4
7986748|NCT03205046|12561451|FG000|Overall Study|Death|10
7986749|NCT03205046|12561452|FG001|Overall Study|Death|6
7986750|NCT03205046|12561451|FG000|Overall Study|Withdrawal by Subject|1
7986751|NCT03205046|12561452|FG001|Overall Study|Withdrawal by Subject|2
7986752|NCT03205046|12561451|FG000|Overall Study|Lost to Follow-up|0
7986753|NCT03205046|12561452|FG001|Overall Study|Lost to Follow-up|1
7986754|NCT03205046|12561451|FG000|Overall Study|Study terminated by sponsor|2
7986755|NCT03205046|12561452|FG001|Overall Study|Study terminated by sponsor|1
7986756|NCT03205150|12561461|FG000|Overall Study|Protocol deviation|1
7986757|NCT03205150|12561462|FG001|Overall Study|Protocol deviation|3
7986758|NCT03205150|12561463|FG002|Overall Study|Protocol deviation|0
7986759|NCT03205150|12561461|FG000|Overall Study|Patient/guardian decision|0
7986760|NCT03205150|12561462|FG001|Overall Study|Patient/guardian decision|3
7986761|NCT03205150|12561463|FG002|Overall Study|Patient/guardian decision|0
7986762|NCT03205150|12561461|FG000|Overall Study|Adverse Event|1
7986763|NCT03205150|12561462|FG001|Overall Study|Adverse Event|1
7986764|NCT03205150|12561463|FG002|Overall Study|Adverse Event|1
7986765|NCT03205150|12561461|FG000|Overall Study|Lost to Follow-up|0
7986766|NCT03205150|12561462|FG001|Overall Study|Lost to Follow-up|0
7986767|NCT03205150|12561463|FG002|Overall Study|Lost to Follow-up|1
7986768|NCT03205488|12561475|FG000|Overall Study|Adverse Event|1
7986769|NCT03205488|12561476|FG001|Overall Study|Adverse Event|2
7986770|NCT03205488|12561477|FG002|Overall Study|Adverse Event|4
7986771|NCT03205488|12561475|FG000|Overall Study|Protocol Violation|0
7986772|NCT03205488|12561476|FG001|Overall Study|Protocol Violation|0
7986773|NCT03205488|12561477|FG002|Overall Study|Protocol Violation|1
7986774|NCT03205566|12561491|FG000|Phase 1|Protocol Violation|1
7986775|NCT03205566|12561492|FG001|Phase 1|Protocol Violation|1
7986776|NCT03206749|12561505|FG000|Overall Study|Withdrawal of consent|5
7986777|NCT03206749|12561506|FG001|Overall Study|Withdrawal of consent|3
7986778|NCT03206749|12561507|FG002|Overall Study|Withdrawal of consent|6
7986779|NCT03206749|12561505|FG000|Overall Study|Lost to Follow-up|0
7986780|NCT03206749|12561506|FG001|Overall Study|Lost to Follow-up|0
7986781|NCT03206749|12561507|FG002|Overall Study|Lost to Follow-up|1
7986782|NCT03206788|12561518|FG000|Overall Study|Withdrawal by Subject|0
7986783|NCT03206788|12561519|FG001|Overall Study|Withdrawal by Subject|1
7986784|NCT03206788|12561518|FG000|Overall Study|Adverse Event|0
7986785|NCT03206788|12561519|FG001|Overall Study|Adverse Event|1
7986786|NCT03206788|12561518|FG000|Overall Study|Physician Decision|0
7986787|NCT03206788|12561519|FG001|Overall Study|Physician Decision|1
7986788|NCT03206918|12561525|FG000|Overall Study|Death|11
7986789|NCT03206918|12561525|FG000|Overall Study|Withdrawal by Subject|5
7986790|NCT03206918|12561525|FG000|Overall Study|Study terminated by sponsor|12
7986791|NCT03206918|12561525|FG000|Overall Study|Lost to Follow-up|3
7986792|NCT03206918|12561525|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60
7986793|NCT03206970|12561530|FG000|Overall Study|Death|21
7986794|NCT03206970|12561530|FG000|Overall Study|Withdrawal by Subject|13
7986795|NCT03206970|12561530|FG000|Overall Study|Lost to Follow-up|3
7986796|NCT03206970|12561530|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49
7986797|NCT03207243|12561558|FG000|Overall Study|Adverse Event|2
7986798|NCT03207243|12561559|FG001|Overall Study|Adverse Event|2
7986799|NCT03207243|12561558|FG000|Overall Study|Loss of Asthma Control|47
7986800|NCT03207243|12561559|FG001|Overall Study|Loss of Asthma Control|31
7986801|NCT03207243|12561558|FG000|Overall Study|Withdrawal by Subject|2
7986802|NCT03207243|12561559|FG001|Overall Study|Withdrawal by Subject|4
7986803|NCT03207243|12561558|FG000|Overall Study|Physician Decision|1
7986804|NCT03207243|12561559|FG001|Overall Study|Physician Decision|1
7986805|NCT03207243|12561558|FG000|Overall Study|Lost to Follow-up|0
7986806|NCT03207243|12561559|FG001|Overall Study|Lost to Follow-up|1
7986807|NCT03207243|12561558|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7
7986808|NCT03207243|12561559|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2
7986809|NCT03207243|12561558|FG000|Overall Study|Protocol Violation|0
7986810|NCT03207243|12561559|FG001|Overall Study|Protocol Violation|3
7986811|NCT03207750|12561599|FG000|Overall Study|Adverse Event|3
7986812|NCT03207750|12561600|FG001|Overall Study|Adverse Event|2
7986813|NCT03207750|12561599|FG000|Overall Study|Lost to Follow-up|21
7986814|NCT03207750|12561600|FG001|Overall Study|Lost to Follow-up|29
7986815|NCT03207750|12561599|FG000|Overall Study|Protocol Violation|0
7986816|NCT03207750|12561600|FG001|Overall Study|Protocol Violation|1
7986817|NCT03207750|12561599|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11
7986818|NCT03207750|12561600|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13
7986819|NCT03207750|12561599|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7
7986820|NCT03207750|12561600|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10
7986821|NCT03207750|12561599|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10
7986822|NCT03207750|12561600|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5
7986823|NCT03207750|12561599|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1
7986824|NCT03207750|12561600|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2
7986825|NCT03207750|12561599|FG000|Overall Study|OTHER, NOT SPECIFIED|5
7986826|NCT03207750|12561600|FG001|Overall Study|OTHER, NOT SPECIFIED|4
7986827|NCT03207763|12561608|FG000|Overall Study|Lost to Follow-up|1
7986828|NCT03207763|12561609|FG001|Overall Study|Lost to Follow-up|0
7986829|NCT03208088|12561624|FG000|Period 2|Withdrawal by Subject|0
7986830|NCT03208088|12561625|FG001|Period 2|Withdrawal by Subject|0
7986831|NCT03208088|12561626|FG002|Period 2|Withdrawal by Subject|0
7986832|NCT03208088|12561627|FG003|Period 2|Withdrawal by Subject|0
7986833|NCT03208088|12561628|FG004|Period 2|Withdrawal by Subject|0
7986834|NCT03208088|12561629|FG005|Period 2|Withdrawal by Subject|0
7986835|NCT03208088|12561630|FG006|Period 2|Withdrawal by Subject|0
7986836|NCT03208088|12561631|FG007|Period 2|Withdrawal by Subject|0
7986837|NCT03208088|12561632|FG008|Period 2|Withdrawal by Subject|1
7986838|NCT03208088|12561633|FG009|Period 2|Withdrawal by Subject|0
7986839|NCT03208088|12561624|FG000|Period 3|Unsatisfactory Test Article|0
7986840|NCT03208088|12561625|FG001|Period 3|Unsatisfactory Test Article|0
7986841|NCT03208088|12561626|FG002|Period 3|Unsatisfactory Test Article|0
7986842|NCT03208088|12561627|FG003|Period 3|Unsatisfactory Test Article|1
7986843|NCT03208088|12561628|FG004|Period 3|Unsatisfactory Test Article|0
7986844|NCT03208088|12561629|FG005|Period 3|Unsatisfactory Test Article|0
7986845|NCT03208088|12561630|FG006|Period 3|Unsatisfactory Test Article|0
7986846|NCT03208088|12561631|FG007|Period 3|Unsatisfactory Test Article|0
7986847|NCT03208088|12561632|FG008|Period 3|Unsatisfactory Test Article|0
7986848|NCT03208088|12561633|FG009|Period 3|Unsatisfactory Test Article|0
7986849|NCT03208088|12561624|FG000|Period 4|Unsatisfactory Test Article|0
7986850|NCT03208088|12561625|FG001|Period 4|Unsatisfactory Test Article|0
7986851|NCT03208088|12561626|FG002|Period 4|Unsatisfactory Test Article|0
7986852|NCT03208088|12561627|FG003|Period 4|Unsatisfactory Test Article|1
7986853|NCT03208088|12561628|FG004|Period 4|Unsatisfactory Test Article|0
7986854|NCT03208088|12561629|FG005|Period 4|Unsatisfactory Test Article|0
7986855|NCT03208088|12561630|FG006|Period 4|Unsatisfactory Test Article|0
7986856|NCT03208088|12561631|FG007|Period 4|Unsatisfactory Test Article|0
7986857|NCT03208088|12561632|FG008|Period 4|Unsatisfactory Test Article|0
7986858|NCT03208088|12561633|FG009|Period 4|Unsatisfactory Test Article|0
7986859|NCT03208933|12561669|FG000|Overall Study|Death|3
7986860|NCT03208933|12561669|FG000|Overall Study|Withdrawal by Subject|3
7986861|NCT03208933|12561669|FG000|Overall Study|Adverse Event|1
7986862|NCT03208933|12561669|FG000|Overall Study|Lost to Follow-up|2
7986863|NCT03208933|12561669|FG000|Overall Study|Physician Decision|3
7986864|NCT03208933|12561669|FG000|Overall Study|Protocol Violation|1
7986865|NCT03209362|12561680|FG000|Overall Study|Adverse Event|0
7986866|NCT03209362|12561681|FG001|Overall Study|Adverse Event|1
7986867|NCT03209362|12561680|FG000|Overall Study|Lost to Follow-up|0
7986868|NCT03209362|12561681|FG001|Overall Study|Lost to Follow-up|1
7986869|NCT03209362|12561680|FG000|Overall Study|Withdrawal by Subject|2
7986870|NCT03209362|12561681|FG001|Overall Study|Withdrawal by Subject|0
7986871|NCT03209362|12561680|FG000|Overall Study|Other|0
7986872|NCT03209362|12561681|FG001|Overall Study|Other|1
7986873|NCT03209492|12561687|FG000|Overall Study|Case Report Forms Uncollected|5
7986874|NCT03209518|12561698|FG000|Overall Study|Case Report Forms Uncollected|1
7986875|NCT03209518|12561698|FG000|Overall Study|Protocol Deviation|1
7986876|NCT03209570|12561704|FG000|Overall Study|Death|1
7986877|NCT03209570|12561705|FG001|Overall Study|Death|0
7986878|NCT03209570|12561704|FG000|Overall Study|Incomplete Data|8
7986879|NCT03209570|12561705|FG001|Overall Study|Incomplete Data|10
7986880|NCT03209570|12561704|FG000|Overall Study|Protocol Violation|1
7986881|NCT03209570|12561705|FG001|Overall Study|Protocol Violation|0
7986882|NCT03209570|12561704|FG000|Overall Study|Withdrawal by Subject|0
7986883|NCT03209570|12561705|FG001|Overall Study|Withdrawal by Subject|3
7986884|NCT03209973|12561722|FG000|Overall Study|Withdrawal by Subject|7
7986885|NCT03209973|12561722|FG000|Overall Study|Lost to Follow-up|2
7986886|NCT03209973|12561722|FG000|Overall Study|Death|8
7986887|NCT03209973|12561722|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32
7986888|NCT03209973|12561722|FG000|Overall Study|Sponsor Decision|18
7986889|NCT03209973|12561722|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1
7986890|NCT03209973|12561722|FG000|Overall Study|Participant Refused to Return to Treatment|2
7986891|NCT03210220|12561739|FG000|Overall Study|Physician Decision|1
7986892|NCT03210220|12561740|FG001|Overall Study|Physician Decision|0
7986893|NCT03210259|12561748|FG000|12-Week Run-in Period|Adverse Event|1
7986894|NCT03210259|12561749|FG001|12-Week Run-in Period|Adverse Event|0
7986895|NCT03210259|12561750|FG002|12-Week Run-in Period|Adverse Event|0
7986896|NCT03210259|12561748|FG000|12-Week Run-in Period|Death|1
7986897|NCT03210259|12561749|FG001|12-Week Run-in Period|Death|0
7986898|NCT03210259|12561750|FG002|12-Week Run-in Period|Death|0
7986899|NCT03210259|12561748|FG000|12-Week Run-in Period|Withdrawal by Subject|9
7986900|NCT03210259|12561749|FG001|12-Week Run-in Period|Withdrawal by Subject|0
7986901|NCT03210259|12561750|FG002|12-Week Run-in Period|Withdrawal by Subject|0
7986902|NCT03210259|12561748|FG000|12-Week Run-in Period|Lost to Follow-up|4
7986903|NCT03210259|12561749|FG001|12-Week Run-in Period|Lost to Follow-up|0
7986904|NCT03210259|12561750|FG002|12-Week Run-in Period|Lost to Follow-up|0
7986905|NCT03210259|12561748|FG000|12-Week Run-in Period|Lack of Efficacy|6
7986906|NCT03210259|12561749|FG001|12-Week Run-in Period|Lack of Efficacy|0
7986907|NCT03210259|12561750|FG002|12-Week Run-in Period|Lack of Efficacy|0
7986908|NCT03210259|12561748|FG000|48-Week Randomized Responder Period|Missed study visit|0
7986909|NCT03210259|12561749|FG001|48-Week Randomized Responder Period|Missed study visit|1
7986910|NCT03210259|12561750|FG002|48-Week Randomized Responder Period|Missed study visit|2
7986911|NCT03210259|12561748|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0
7986912|NCT03210259|12561749|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3
7986913|NCT03210259|12561750|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8
7986914|NCT03210259|12561748|FG000|48-Week Randomized Responder Period|Pregnancy|0
7986915|NCT03210259|12561749|FG001|48-Week Randomized Responder Period|Pregnancy|1
7986916|NCT03210259|12561750|FG002|48-Week Randomized Responder Period|Pregnancy|0
7986917|NCT03210259|12561748|FG000|48-Week Randomized Responder Period|Physician Decision|0
7986918|NCT03210259|12561749|FG001|48-Week Randomized Responder Period|Physician Decision|0
7986919|NCT03210259|12561750|FG002|48-Week Randomized Responder Period|Physician Decision|1
7986920|NCT03210259|12561748|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0
7986921|NCT03210259|12561749|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5
7986922|NCT03210259|12561750|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17
7986923|NCT03210259|12561748|FG000|48-Week Randomized Responder Period|Adverse Event|0
7986924|NCT03210259|12561749|FG001|48-Week Randomized Responder Period|Adverse Event|1
7986925|NCT03210259|12561750|FG002|48-Week Randomized Responder Period|Adverse Event|1
7986926|NCT03210519|12561777|FG000|Overall Study|Adverse Event|2
7986927|NCT03210519|12561778|FG001|Overall Study|Adverse Event|0
7986928|NCT03210961|12561803|FG000|Overall Study|Adverse Event|0
7986929|NCT03210961|12561804|FG001|Overall Study|Adverse Event|0
7986930|NCT03210961|12561805|FG002|Overall Study|Adverse Event|0
7986931|NCT03210961|12561806|FG003|Overall Study|Adverse Event|0
7986932|NCT03210961|12561807|FG004|Overall Study|Adverse Event|0
7986933|NCT03210961|12561808|FG005|Overall Study|Adverse Event|0
7986934|NCT03210961|12561809|FG006|Overall Study|Adverse Event|0
7986935|NCT03210961|12561810|FG007|Overall Study|Adverse Event|0
7986936|NCT03210961|12561811|FG008|Overall Study|Adverse Event|0
7986937|NCT03210961|12561812|FG009|Overall Study|Adverse Event|0
7986938|NCT03210961|12561813|FG010|Overall Study|Adverse Event|0
7986939|NCT03210961|12561814|FG011|Overall Study|Adverse Event|0
7986940|NCT03210961|12561815|FG012|Overall Study|Adverse Event|0
7986941|NCT03210961|12561816|FG013|Overall Study|Adverse Event|1
7986942|NCT03210961|12561817|FG014|Overall Study|Adverse Event|0
7986943|NCT03210961|12561803|FG000|Overall Study|Lost to Follow-up|0
7986944|NCT03210961|12561804|FG001|Overall Study|Lost to Follow-up|0
7986945|NCT03210961|12561805|FG002|Overall Study|Lost to Follow-up|0
7986946|NCT03210961|12561806|FG003|Overall Study|Lost to Follow-up|0
7986947|NCT03210961|12561807|FG004|Overall Study|Lost to Follow-up|0
7986948|NCT03210961|12561808|FG005|Overall Study|Lost to Follow-up|0
7986949|NCT03210961|12561809|FG006|Overall Study|Lost to Follow-up|0
7986950|NCT03210961|12561810|FG007|Overall Study|Lost to Follow-up|0
7986951|NCT03210961|12561811|FG008|Overall Study|Lost to Follow-up|0
7986952|NCT03210961|12561812|FG009|Overall Study|Lost to Follow-up|0
7986953|NCT03210961|12561813|FG010|Overall Study|Lost to Follow-up|0
7986954|NCT03210961|12561814|FG011|Overall Study|Lost to Follow-up|0
7986955|NCT03210961|12561815|FG012|Overall Study|Lost to Follow-up|0
7986956|NCT03210961|12561816|FG013|Overall Study|Lost to Follow-up|0
7986957|NCT03210961|12561817|FG014|Overall Study|Lost to Follow-up|1
7986958|NCT03210961|12561803|FG000|Overall Study|Withdrawal by Subject|0
7986959|NCT03210961|12561804|FG001|Overall Study|Withdrawal by Subject|0
7986960|NCT03210961|12561805|FG002|Overall Study|Withdrawal by Subject|0
7986961|NCT03210961|12561806|FG003|Overall Study|Withdrawal by Subject|0
7986962|NCT03210961|12561807|FG004|Overall Study|Withdrawal by Subject|0
7986963|NCT03210961|12561808|FG005|Overall Study|Withdrawal by Subject|0
7986964|NCT03210961|12561809|FG006|Overall Study|Withdrawal by Subject|0
7986965|NCT03210961|12561810|FG007|Overall Study|Withdrawal by Subject|0
7986966|NCT03210961|12561811|FG008|Overall Study|Withdrawal by Subject|0
7986967|NCT03210961|12561812|FG009|Overall Study|Withdrawal by Subject|0
7986968|NCT03210961|12561813|FG010|Overall Study|Withdrawal by Subject|0
7986969|NCT03210961|12561814|FG011|Overall Study|Withdrawal by Subject|0
7986970|NCT03210961|12561815|FG012|Overall Study|Withdrawal by Subject|0
7986971|NCT03210961|12561816|FG013|Overall Study|Withdrawal by Subject|0
7986972|NCT03210961|12561817|FG014|Overall Study|Withdrawal by Subject|1
7986973|NCT03210961|12561803|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7986974|NCT03210961|12561804|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7986975|NCT03210961|12561805|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
7986976|NCT03210961|12561806|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
7986977|NCT03210961|12561807|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
7986978|NCT03210961|12561808|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
7986979|NCT03210961|12561809|FG006|Overall Study|No Longer Meets Eligibility Criteria|0
7986980|NCT03210961|12561810|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
7986981|NCT03210961|12561811|FG008|Overall Study|No Longer Meets Eligibility Criteria|0
7986982|NCT03210961|12561812|FG009|Overall Study|No Longer Meets Eligibility Criteria|0
7986983|NCT03210961|12561813|FG010|Overall Study|No Longer Meets Eligibility Criteria|0
7986984|NCT03210961|12561814|FG011|Overall Study|No Longer Meets Eligibility Criteria|0
7986985|NCT03210961|12561815|FG012|Overall Study|No Longer Meets Eligibility Criteria|0
7986986|NCT03210961|12561816|FG013|Overall Study|No Longer Meets Eligibility Criteria|1
7986987|NCT03210961|12561817|FG014|Overall Study|No Longer Meets Eligibility Criteria|0
7986988|NCT03210961|12561803|FG000|Overall Study|Other|0
7986989|NCT03210961|12561804|FG001|Overall Study|Other|0
7986990|NCT03210961|12561805|FG002|Overall Study|Other|0
7986991|NCT03210961|12561806|FG003|Overall Study|Other|1
7986992|NCT03210961|12561807|FG004|Overall Study|Other|0
7986993|NCT03210961|12561808|FG005|Overall Study|Other|0
7986994|NCT03210961|12561809|FG006|Overall Study|Other|1
7986995|NCT03210961|12561810|FG007|Overall Study|Other|0
7986996|NCT03210961|12561811|FG008|Overall Study|Other|0
7986997|NCT03210961|12561812|FG009|Overall Study|Other|0
7986998|NCT03210961|12561813|FG010|Overall Study|Other|1
7986999|NCT03210961|12561814|FG011|Overall Study|Other|0
7987000|NCT03210961|12561815|FG012|Overall Study|Other|2
7987001|NCT03210961|12561816|FG013|Overall Study|Other|2
7987002|NCT03210961|12561817|FG014|Overall Study|Other|0
7987003|NCT03211156|12561877|FG000|Overall Study|Withdrawal by Subject|0
7987004|NCT03211156|12561878|FG001|Overall Study|Withdrawal by Subject|2
7987005|NCT03211156|12561877|FG000|Overall Study|Lost to Follow-up|1
7987006|NCT03211156|12561878|FG001|Overall Study|Lost to Follow-up|1
7987007|NCT03211156|12561877|FG000|Overall Study|Adverse Event|1
7987008|NCT03211156|12561878|FG001|Overall Study|Adverse Event|0
7987009|NCT03212261|12561897|FG000|Overall Study|Became ineligible d/t tech|2
7987010|NCT03212261|12561897|FG000|Overall Study|Tech Trouble- No first study visit|1
7987011|NCT03212261|12561897|FG000|Overall Study|Lost to Follow-up|7
7987012|NCT03212261|12561897|FG000|Overall Study|Family Emergency|1
7987013|NCT03212261|12561897|FG000|Overall Study|Too busy/ No time|5
7987014|NCT03212326|12561902|FG000|Overall Study|Physician Decision|4
7987015|NCT03212365|12561908|FG000|Overall Study|Discharged prior to Xa level|12
7987016|NCT03212365|12561909|FG001|Overall Study|Discharged prior to Xa level|8
7987017|NCT03212365|12561908|FG000|Overall Study|Bled requiring enoxaparin cessation|4
7987018|NCT03212365|12561909|FG001|Overall Study|Bled requiring enoxaparin cessation|2
7987019|NCT03212365|12561908|FG000|Overall Study|Refused study medication|3
7987020|NCT03212365|12561909|FG001|Overall Study|Refused study medication|0
7987021|NCT03212365|12561908|FG000|Overall Study|Initiated heparin infusion on floor|1
7987022|NCT03212365|12561909|FG001|Overall Study|Initiated heparin infusion on floor|1
7987023|NCT03212365|12561908|FG000|Overall Study|Unexpected return to OR|1
7987024|NCT03212365|12561909|FG001|Overall Study|Unexpected return to OR|1
7987025|NCT03212365|12561908|FG000|Overall Study|Medication distribution error|1
7987026|NCT03212365|12561909|FG001|Overall Study|Medication distribution error|0
7987027|NCT03212365|12561908|FG000|Overall Study|Required epidural placement|1
7987028|NCT03212365|12561909|FG001|Overall Study|Required epidural placement|0
7987029|NCT03212365|12561908|FG000|Overall Study|Withdrawal by Subject|0
7987030|NCT03212365|12561909|FG001|Overall Study|Withdrawal by Subject|1
7987031|NCT03212365|12561908|FG000|Overall Study|developed acute renal failure|0
7987032|NCT03212365|12561909|FG001|Overall Study|developed acute renal failure|1
7987033|NCT03212521|12561915|FG000|Overall Study|Adverse Event|1
7987034|NCT03212521|12561915|FG000|Overall Study|Lost to Follow-up|4
7987035|NCT03212521|12561915|FG000|Overall Study|Withdrawal by Subject|1
7987036|NCT03212521|12561915|FG000|Overall Study|Other|1
7987037|NCT03212690|12561937|FG000|Overall Study|Protocol Violation|1
7987038|NCT03213210|12561941|FG000|Overall Study|Lost to Follow-up|2
7987039|NCT03213210|12561941|FG000|Overall Study|Study termination|3
7987040|NCT03213366|12561947|FG000|Overall Study|Lost to Follow-up|9
7987041|NCT03213366|12561948|FG001|Overall Study|Lost to Follow-up|4
7987042|NCT03213509|12561973|FG000|Overall Study|Did not consent for verbal autopsy|4
7987043|NCT03213509|12561974|FG001|Overall Study|Did not consent for verbal autopsy|5
7987044|NCT03213626|12561981|FG000|Overall Study|Adverse Event|1
7987045|NCT03213626|12561981|FG000|Overall Study|Progressive Disease|6
7987046|NCT03214081|12561985|FG000|Overall Study|Case Report Forms Uncollected|9
7987047|NCT03214081|12561985|FG000|Overall Study|Protocol Deviation|54
7987048|NCT03214094|12561989|FG000|Overall Study|Case Report Forms Uncollected|14
7987049|NCT03214094|12561989|FG000|Overall Study|Protocol Deviation|46
7987050|NCT03214198|12561993|FG000|Overall Study|Case Report Forms Uncollected|18
7987051|NCT03214198|12561993|FG000|Overall Study|Protocol Deviation|18
7987052|NCT03214224|12561997|FG000|Overall Study|Protocol Violation|1
7987053|NCT03214224|12561997|FG000|Overall Study|Withdrawal by Subject|2
7987054|NCT03214224|12561997|FG000|Overall Study|Practice controls or therapists|6
7987055|NCT03214367|12562007|FG000|Lead-in Period|Withdrawal by Subject|50
7987056|NCT03214367|12562008|FG001|Lead-in Period|Withdrawal by Subject|0
7987057|NCT03214367|12562009|FG002|Lead-in Period|Withdrawal by Subject|0
7987058|NCT03214367|12562010|FG003|Lead-in Period|Withdrawal by Subject|0
7987059|NCT03214367|12562011|FG004|Lead-in Period|Withdrawal by Subject|2
7987060|NCT03214367|12562012|FG005|Lead-in Period|Withdrawal by Subject|0
7987061|NCT03214367|12562013|FG006|Lead-in Period|Withdrawal by Subject|0
7987062|NCT03214367|12562014|FG007|Lead-in Period|Withdrawal by Subject|0
7987063|NCT03214367|12562007|FG000|Lead-in Period|Adverse Event|3
7987064|NCT03214367|12562008|FG001|Lead-in Period|Adverse Event|0
7987065|NCT03214367|12562009|FG002|Lead-in Period|Adverse Event|0
7987066|NCT03214367|12562010|FG003|Lead-in Period|Adverse Event|0
7987067|NCT03214367|12562011|FG004|Lead-in Period|Adverse Event|0
7987068|NCT03214367|12562012|FG005|Lead-in Period|Adverse Event|0
7987069|NCT03214367|12562013|FG006|Lead-in Period|Adverse Event|0
7987070|NCT03214367|12562014|FG007|Lead-in Period|Adverse Event|0
7987071|NCT03214367|12562007|FG000|Lead-in Period|Lost to Follow-up|12
7987072|NCT03214367|12562008|FG001|Lead-in Period|Lost to Follow-up|0
7987073|NCT03214367|12562009|FG002|Lead-in Period|Lost to Follow-up|0
7987074|NCT03214367|12562010|FG003|Lead-in Period|Lost to Follow-up|0
7987075|NCT03214367|12562011|FG004|Lead-in Period|Lost to Follow-up|0
7987076|NCT03214367|12562012|FG005|Lead-in Period|Lost to Follow-up|0
7987077|NCT03214367|12562013|FG006|Lead-in Period|Lost to Follow-up|0
7987078|NCT03214367|12562014|FG007|Lead-in Period|Lost to Follow-up|0
7987079|NCT03214367|12562007|FG000|Lead-in Period|Sponsor Decision|11
7987080|NCT03214367|12562008|FG001|Lead-in Period|Sponsor Decision|0
7987081|NCT03214367|12562009|FG002|Lead-in Period|Sponsor Decision|0
7987082|NCT03214367|12562010|FG003|Lead-in Period|Sponsor Decision|0
7987083|NCT03214367|12562011|FG004|Lead-in Period|Sponsor Decision|0
7987084|NCT03214367|12562012|FG005|Lead-in Period|Sponsor Decision|0
7987085|NCT03214367|12562013|FG006|Lead-in Period|Sponsor Decision|0
7987086|NCT03214367|12562014|FG007|Lead-in Period|Sponsor Decision|0
7987087|NCT03214367|12562007|FG000|Lead-in Period|Physician Decision|12
7987088|NCT03214367|12562008|FG001|Lead-in Period|Physician Decision|0
7987089|NCT03214367|12562009|FG002|Lead-in Period|Physician Decision|0
7987090|NCT03214367|12562010|FG003|Lead-in Period|Physician Decision|0
7987091|NCT03214367|12562011|FG004|Lead-in Period|Physician Decision|0
7987092|NCT03214367|12562012|FG005|Lead-in Period|Physician Decision|0
7987093|NCT03214367|12562013|FG006|Lead-in Period|Physician Decision|0
7987094|NCT03214367|12562014|FG007|Lead-in Period|Physician Decision|0
7987095|NCT03214367|12562007|FG000|Lead-in Period|Protocol Violation|5
7987096|NCT03214367|12562008|FG001|Lead-in Period|Protocol Violation|0
7987097|NCT03214367|12562009|FG002|Lead-in Period|Protocol Violation|0
7987098|NCT03214367|12562010|FG003|Lead-in Period|Protocol Violation|0
7987099|NCT03214367|12562011|FG004|Lead-in Period|Protocol Violation|0
7987100|NCT03214367|12562012|FG005|Lead-in Period|Protocol Violation|0
7987101|NCT03214367|12562013|FG006|Lead-in Period|Protocol Violation|0
7987102|NCT03214367|12562014|FG007|Lead-in Period|Protocol Violation|0
7987103|NCT03214367|12562007|FG000|Lead-in Period|Treatment Interruption|1
7987104|NCT03214367|12562008|FG001|Lead-in Period|Treatment Interruption|0
7987105|NCT03214367|12562009|FG002|Lead-in Period|Treatment Interruption|0
7987106|NCT03214367|12562010|FG003|Lead-in Period|Treatment Interruption|0
7987107|NCT03214367|12562011|FG004|Lead-in Period|Treatment Interruption|0
7987108|NCT03214367|12562012|FG005|Lead-in Period|Treatment Interruption|0
7987109|NCT03214367|12562013|FG006|Lead-in Period|Treatment Interruption|0
7987110|NCT03214367|12562014|FG007|Lead-in Period|Treatment Interruption|0
7987111|NCT03214367|12562007|FG000|Treatment Period|Adverse Event|0
7987112|NCT03214367|12562008|FG001|Treatment Period|Adverse Event|1
7987113|NCT03214367|12562009|FG002|Treatment Period|Adverse Event|4
7987114|NCT03214367|12562010|FG003|Treatment Period|Adverse Event|2
7987115|NCT03214367|12562011|FG004|Treatment Period|Adverse Event|0
7987116|NCT03214367|12562012|FG005|Treatment Period|Adverse Event|0
7987117|NCT03214367|12562013|FG006|Treatment Period|Adverse Event|0
7987118|NCT03214367|12562014|FG007|Treatment Period|Adverse Event|0
7987119|NCT03214367|12562007|FG000|Treatment Period|Death|0
7987120|NCT03214367|12562008|FG001|Treatment Period|Death|1
7987121|NCT03214367|12562009|FG002|Treatment Period|Death|1
7987122|NCT03214367|12562010|FG003|Treatment Period|Death|1
7987123|NCT03214367|12562011|FG004|Treatment Period|Death|0
7987124|NCT03214367|12562012|FG005|Treatment Period|Death|0
7987125|NCT03214367|12562013|FG006|Treatment Period|Death|0
7987126|NCT03214367|12562014|FG007|Treatment Period|Death|0
7987127|NCT03214367|12562007|FG000|Treatment Period|Lost to Follow-up|0
7987128|NCT03214367|12562008|FG001|Treatment Period|Lost to Follow-up|5
7987129|NCT03214367|12562009|FG002|Treatment Period|Lost to Follow-up|3
7987130|NCT03214367|12562010|FG003|Treatment Period|Lost to Follow-up|2
7987131|NCT03214367|12562011|FG004|Treatment Period|Lost to Follow-up|0
7987132|NCT03214367|12562012|FG005|Treatment Period|Lost to Follow-up|2
7987133|NCT03214367|12562013|FG006|Treatment Period|Lost to Follow-up|1
7987134|NCT03214367|12562014|FG007|Treatment Period|Lost to Follow-up|0
7987135|NCT03214367|12562007|FG000|Treatment Period|Sponsor Decision|0
7987136|NCT03214367|12562008|FG001|Treatment Period|Sponsor Decision|3
7987137|NCT03214367|12562009|FG002|Treatment Period|Sponsor Decision|0
7987138|NCT03214367|12562010|FG003|Treatment Period|Sponsor Decision|0
7987139|NCT03214367|12562011|FG004|Treatment Period|Sponsor Decision|0
7987140|NCT03214367|12562012|FG005|Treatment Period|Sponsor Decision|0
7987141|NCT03214367|12562013|FG006|Treatment Period|Sponsor Decision|0
7987142|NCT03214367|12562014|FG007|Treatment Period|Sponsor Decision|0
7987143|NCT03214367|12562007|FG000|Treatment Period|Physician Decision|0
7987144|NCT03214367|12562008|FG001|Treatment Period|Physician Decision|1
7987145|NCT03214367|12562009|FG002|Treatment Period|Physician Decision|2
7987146|NCT03214367|12562010|FG003|Treatment Period|Physician Decision|0
7987147|NCT03214367|12562011|FG004|Treatment Period|Physician Decision|0
7987148|NCT03214367|12562012|FG005|Treatment Period|Physician Decision|0
7987149|NCT03214367|12562013|FG006|Treatment Period|Physician Decision|0
7987150|NCT03214367|12562014|FG007|Treatment Period|Physician Decision|0
7987151|NCT03214367|12562007|FG000|Treatment Period|Protocol Violation|0
7987152|NCT03214367|12562008|FG001|Treatment Period|Protocol Violation|3
7987153|NCT03214367|12562009|FG002|Treatment Period|Protocol Violation|0
7987154|NCT03214367|12562010|FG003|Treatment Period|Protocol Violation|0
7987155|NCT03214367|12562011|FG004|Treatment Period|Protocol Violation|0
7987156|NCT03214367|12562012|FG005|Treatment Period|Protocol Violation|0
7987157|NCT03214367|12562013|FG006|Treatment Period|Protocol Violation|0
7987158|NCT03214367|12562014|FG007|Treatment Period|Protocol Violation|0
7987159|NCT03214367|12562007|FG000|Treatment Period|Withdrawal by Subject|0
7987160|NCT03214367|12562008|FG001|Treatment Period|Withdrawal by Subject|20
7987161|NCT03214367|12562009|FG002|Treatment Period|Withdrawal by Subject|23
7987162|NCT03214367|12562010|FG003|Treatment Period|Withdrawal by Subject|14
7987163|NCT03214367|12562011|FG004|Treatment Period|Withdrawal by Subject|0
7987164|NCT03214367|12562012|FG005|Treatment Period|Withdrawal by Subject|1
7987165|NCT03214367|12562013|FG006|Treatment Period|Withdrawal by Subject|1
7987166|NCT03214367|12562014|FG007|Treatment Period|Withdrawal by Subject|1
7987167|NCT03214380|12562032|FG000|Lead-in|Adverse Event|3
7987168|NCT03214380|12562033|FG001|Lead-in|Adverse Event|0
7987169|NCT03214380|12562034|FG002|Lead-in|Adverse Event|0
7987170|NCT03214380|12562035|FG003|Lead-in|Adverse Event|1
7987171|NCT03214380|12562036|FG004|Lead-in|Adverse Event|0
7987172|NCT03214380|12562037|FG005|Lead-in|Adverse Event|0
7987173|NCT03214380|12562032|FG000|Lead-in|Lost to Follow-up|4
7987174|NCT03214380|12562033|FG001|Lead-in|Lost to Follow-up|0
7987175|NCT03214380|12562034|FG002|Lead-in|Lost to Follow-up|0
7987176|NCT03214380|12562035|FG003|Lead-in|Lost to Follow-up|1
7987177|NCT03214380|12562036|FG004|Lead-in|Lost to Follow-up|0
7987178|NCT03214380|12562037|FG005|Lead-in|Lost to Follow-up|0
7987179|NCT03214380|12562032|FG000|Lead-in|Eligibility Criteria|3
7987180|NCT03214380|12562033|FG001|Lead-in|Eligibility Criteria|0
7987181|NCT03214380|12562034|FG002|Lead-in|Eligibility Criteria|0
7987182|NCT03214380|12562035|FG003|Lead-in|Eligibility Criteria|0
7987183|NCT03214380|12562036|FG004|Lead-in|Eligibility Criteria|0
7987184|NCT03214380|12562037|FG005|Lead-in|Eligibility Criteria|0
7987185|NCT03214380|12562032|FG000|Lead-in|Physician Decision|6
7987186|NCT03214380|12562033|FG001|Lead-in|Physician Decision|0
7987187|NCT03214380|12562034|FG002|Lead-in|Physician Decision|0
7987188|NCT03214380|12562035|FG003|Lead-in|Physician Decision|0
7987189|NCT03214380|12562036|FG004|Lead-in|Physician Decision|0
7987190|NCT03214380|12562037|FG005|Lead-in|Physician Decision|0
7987191|NCT03214380|12562032|FG000|Lead-in|Protocol Deviation|7
7987192|NCT03214380|12562033|FG001|Lead-in|Protocol Deviation|0
7987193|NCT03214380|12562034|FG002|Lead-in|Protocol Deviation|0
7987194|NCT03214380|12562035|FG003|Lead-in|Protocol Deviation|3
7987195|NCT03214380|12562036|FG004|Lead-in|Protocol Deviation|0
7987196|NCT03214380|12562037|FG005|Lead-in|Protocol Deviation|0
7987197|NCT03214380|12562032|FG000|Lead-in|Withdrawal by Subject|41
7987198|NCT03214380|12562033|FG001|Lead-in|Withdrawal by Subject|0
7987199|NCT03214380|12562034|FG002|Lead-in|Withdrawal by Subject|0
7987200|NCT03214380|12562035|FG003|Lead-in|Withdrawal by Subject|14
7987201|NCT03214380|12562036|FG004|Lead-in|Withdrawal by Subject|0
7987202|NCT03214380|12562037|FG005|Lead-in|Withdrawal by Subject|0
7987203|NCT03214380|12562032|FG000|Lead-in|Family Emergency|1
7987204|NCT03214380|12562033|FG001|Lead-in|Family Emergency|0
7987205|NCT03214380|12562034|FG002|Lead-in|Family Emergency|0
7987206|NCT03214380|12562035|FG003|Lead-in|Family Emergency|0
7987207|NCT03214380|12562036|FG004|Lead-in|Family Emergency|0
7987208|NCT03214380|12562037|FG005|Lead-in|Family Emergency|0
7987209|NCT03214380|12562032|FG000|Lead-in|Natural Disaster|9
7987210|NCT03214380|12562033|FG001|Lead-in|Natural Disaster|0
7987211|NCT03214380|12562034|FG002|Lead-in|Natural Disaster|0
7987212|NCT03214380|12562035|FG003|Lead-in|Natural Disaster|0
7987213|NCT03214380|12562036|FG004|Lead-in|Natural Disaster|0
7987214|NCT03214380|12562037|FG005|Lead-in|Natural Disaster|0
7987215|NCT03214380|12562032|FG000|Lead-in|Non Compliance|1
7987216|NCT03214380|12562033|FG001|Lead-in|Non Compliance|0
7987217|NCT03214380|12562034|FG002|Lead-in|Non Compliance|0
7987218|NCT03214380|12562035|FG003|Lead-in|Non Compliance|0
7987219|NCT03214380|12562036|FG004|Lead-in|Non Compliance|0
7987220|NCT03214380|12562037|FG005|Lead-in|Non Compliance|0
7987221|NCT03214380|12562032|FG000|Lead-in|Participant Schedule|2
7987222|NCT03214380|12562033|FG001|Lead-in|Participant Schedule|0
7987223|NCT03214380|12562034|FG002|Lead-in|Participant Schedule|0
7987224|NCT03214380|12562035|FG003|Lead-in|Participant Schedule|0
7987225|NCT03214380|12562036|FG004|Lead-in|Participant Schedule|0
7987226|NCT03214380|12562037|FG005|Lead-in|Participant Schedule|0
7987227|NCT03214380|12562032|FG000|Treatment Period|Adverse Event|0
7987228|NCT03214380|12562033|FG001|Treatment Period|Adverse Event|1
7987229|NCT03214380|12562034|FG002|Treatment Period|Adverse Event|1
7987230|NCT03214380|12562035|FG003|Treatment Period|Adverse Event|0
7987231|NCT03214380|12562036|FG004|Treatment Period|Adverse Event|1
7987232|NCT03214380|12562037|FG005|Treatment Period|Adverse Event|0
7987233|NCT03214380|12562032|FG000|Treatment Period|Non-Compliance with Study Drug|0
7987234|NCT03214380|12562033|FG001|Treatment Period|Non-Compliance with Study Drug|0
7987235|NCT03214380|12562034|FG002|Treatment Period|Non-Compliance with Study Drug|0
7987236|NCT03214380|12562035|FG003|Treatment Period|Non-Compliance with Study Drug|0
7987237|NCT03214380|12562036|FG004|Treatment Period|Non-Compliance with Study Drug|1
7987238|NCT03214380|12562037|FG005|Treatment Period|Non-Compliance with Study Drug|0
7987239|NCT03214380|12562032|FG000|Treatment Period|Withdrawal by Subject|0
7987240|NCT03214380|12562033|FG001|Treatment Period|Withdrawal by Subject|10
7987241|NCT03214380|12562034|FG002|Treatment Period|Withdrawal by Subject|8
7987242|NCT03214380|12562035|FG003|Treatment Period|Withdrawal by Subject|0
7987243|NCT03214380|12562036|FG004|Treatment Period|Withdrawal by Subject|7
7987244|NCT03214380|12562037|FG005|Treatment Period|Withdrawal by Subject|11
7987245|NCT03214380|12562032|FG000|Treatment Period|Death|0
7987246|NCT03214380|12562033|FG001|Treatment Period|Death|1
7987247|NCT03214380|12562034|FG002|Treatment Period|Death|2
7987248|NCT03214380|12562035|FG003|Treatment Period|Death|0
7987249|NCT03214380|12562036|FG004|Treatment Period|Death|0
7987250|NCT03214380|12562037|FG005|Treatment Period|Death|0
7987251|NCT03214380|12562032|FG000|Treatment Period|Lost to Follow-up|0
7987252|NCT03214380|12562033|FG001|Treatment Period|Lost to Follow-up|6
7987253|NCT03214380|12562034|FG002|Treatment Period|Lost to Follow-up|3
7987254|NCT03214380|12562035|FG003|Treatment Period|Lost to Follow-up|0
7987255|NCT03214380|12562036|FG004|Treatment Period|Lost to Follow-up|0
7987256|NCT03214380|12562037|FG005|Treatment Period|Lost to Follow-up|0
7987257|NCT03214380|12562032|FG000|Treatment Period|Participant schedule|0
7987258|NCT03214380|12562033|FG001|Treatment Period|Participant schedule|0
7987259|NCT03214380|12562034|FG002|Treatment Period|Participant schedule|1
7987260|NCT03214380|12562035|FG003|Treatment Period|Participant schedule|0
7987261|NCT03214380|12562036|FG004|Treatment Period|Participant schedule|0
7987262|NCT03214380|12562037|FG005|Treatment Period|Participant schedule|0
7987263|NCT03214380|12562032|FG000|Treatment Period|Treatment Interruption|0
7987264|NCT03214380|12562033|FG001|Treatment Period|Treatment Interruption|0
7987265|NCT03214380|12562034|FG002|Treatment Period|Treatment Interruption|1
7987266|NCT03214380|12562035|FG003|Treatment Period|Treatment Interruption|0
7987267|NCT03214380|12562036|FG004|Treatment Period|Treatment Interruption|0
7987268|NCT03214380|12562037|FG005|Treatment Period|Treatment Interruption|0
7987269|NCT03214406|12562051|FG000|Overall Study|did not meet enrollment criteria|9
7987270|NCT03214406|12562052|FG001|Overall Study|did not meet enrollment criteria|13
7987271|NCT03214406|12562051|FG000|Overall Study|Withdrawal by Subject|1
7987272|NCT03214406|12562052|FG001|Overall Study|Withdrawal by Subject|0
7987273|NCT03214406|12562051|FG000|Overall Study|Lost to Follow-up|0
7987274|NCT03214406|12562052|FG001|Overall Study|Lost to Follow-up|2
7987275|NCT03214588|12562061|FG000|Overall Study|Adverse Event|1
7987276|NCT03214588|12562062|FG001|Overall Study|Adverse Event|0
7987277|NCT03214588|12562063|FG002|Overall Study|Adverse Event|2
7987278|NCT03214588|12562061|FG000|Overall Study|Reason Not Specified|0
7987279|NCT03214588|12562062|FG001|Overall Study|Reason Not Specified|1
7987280|NCT03214588|12562063|FG002|Overall Study|Reason Not Specified|0
7987281|NCT03214640|12562075|FG000|Overall Study|Protocol Violation|1
7987282|NCT03214640|12562076|FG001|Overall Study|Protocol Violation|2
7987283|NCT03214640|12562077|FG002|Overall Study|Protocol Violation|1
7987284|NCT03214640|12562078|FG003|Overall Study|Protocol Violation|4
7987285|NCT03214952|12562088|FG000|Overall Study|Protocol Deviation|45
7987286|NCT03214952|12562088|FG000|Overall Study|Case Report Forms Uncollected|13
7987287|NCT03215667|12562092|FG000|Overall Study|Physician Decision|4
7987288|NCT03215758|12562098|FG000|Overall Study|Technical Problems|1
7987289|NCT03215758|12562099|FG001|Overall Study|Technical Problems|0
7987290|NCT03215758|12562098|FG000|Overall Study|Protocol deviation|0
7987291|NCT03215758|12562099|FG001|Overall Study|Protocol deviation|1
7987292|NCT03215758|12562098|FG000|Overall Study|Physician Decision|0
7987293|NCT03215758|12562099|FG001|Overall Study|Physician Decision|1
7987294|NCT03215758|12562098|FG000|Overall Study|Death|0
7987295|NCT03215758|12562099|FG001|Overall Study|Death|1
7987296|NCT03215758|12562098|FG000|Overall Study|Adverse Event|1
7987297|NCT03215758|12562099|FG001|Overall Study|Adverse Event|2
7987298|NCT03215758|12562098|FG000|Overall Study|Subject/Guardian Decision|3
7987299|NCT03215758|12562099|FG001|Overall Study|Subject/Guardian Decision|3
7987300|NCT03215771|12562105|FG000|Overall Study|Withdrawal by Subject|2
7987301|NCT03215771|12562105|FG000|Overall Study|Physician Decision|1
7987302|NCT03216226|12562129|FG000|Overall Study|Adverse Event|3
7987303|NCT03216226|12562130|FG001|Overall Study|Adverse Event|0
7987304|NCT03216226|12562129|FG000|Overall Study|Protocol Violation|1
7987305|NCT03216226|12562130|FG001|Overall Study|Protocol Violation|3
7987306|NCT03216226|12562129|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1
7987307|NCT03216226|12562130|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0
7987308|NCT03216226|12562129|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0
7811417|NCT01182350|12275140|FG004|Overall Study|Alternative Therapy|0
7811418|NCT01182350|12275136|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2
7811419|NCT01182350|12275137|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0
7811420|NCT01182350|12275138|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1
7811421|NCT01182350|12275139|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1
7811422|NCT01182350|12275140|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0
7811423|NCT01182350|12275136|FG000|Overall Study|Unevaluable for Biopsy|0
7811424|NCT01182350|12275137|FG001|Overall Study|Unevaluable for Biopsy|0
7811425|NCT01182350|12275138|FG002|Overall Study|Unevaluable for Biopsy|0
7811426|NCT01182350|12275139|FG003|Overall Study|Unevaluable for Biopsy|0
7811427|NCT01182350|12275140|FG004|Overall Study|Unevaluable for Biopsy|3
7811428|NCT01182415|12275165|FG000|Overall Study|Lost to Follow-up|1
7811429|NCT01182428|12275171|FG000|Overall Study|Physician Decision|1
7811430|NCT01182428|12275172|FG001|Overall Study|Physician Decision|0
7811431|NCT01182428|12275171|FG000|Overall Study|Lost to Follow-up|9
7811432|NCT01182428|12275172|FG001|Overall Study|Lost to Follow-up|1
7811433|NCT01182428|12275171|FG000|Overall Study|Withdrawal by Subject|1
7811434|NCT01182428|12275172|FG001|Overall Study|Withdrawal by Subject|0
7811435|NCT01182441|12275180|FG000|Overall Study|Patient Still in Follow-up|152
7811436|NCT01182441|12275181|FG001|Overall Study|Patient Still in Follow-up|72
7811437|NCT01182441|12275180|FG000|Overall Study|Death|37
7811438|NCT01182441|12275181|FG001|Overall Study|Death|25
7811439|NCT01182441|12275180|FG000|Overall Study|Implant Attempt Unsuccessful|13
7811440|NCT01182441|12275181|FG001|Overall Study|Implant Attempt Unsuccessful|0
7811441|NCT01182441|12275180|FG000|Overall Study|Lost to Follow-up|5
7811442|NCT01182441|12275181|FG001|Overall Study|Lost to Follow-up|8
7811443|NCT01182441|12275180|FG000|Overall Study|Withdrawal by Subject|6
7811444|NCT01182441|12275181|FG001|Overall Study|Withdrawal by Subject|13
7811445|NCT01182441|12275180|FG000|Overall Study|Implant Not Attempted|4
7811446|NCT01182441|12275181|FG001|Overall Study|Implant Not Attempted|0
7811447|NCT01182441|12275180|FG000|Overall Study|Adverse Event|2
7811448|NCT01182441|12275181|FG001|Overall Study|Adverse Event|0
7811449|NCT01182441|12275180|FG000|Overall Study|Physician Decision|1
7987309|NCT03216226|12562130|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1
7987310|NCT03216226|12562129|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0
7987311|NCT03216226|12562130|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1
7987312|NCT03216265|12562139|FG000|Overall Study|Adverse Event|2
7987313|NCT03216265|12562140|FG001|Overall Study|Adverse Event|0
7987314|NCT03216265|12562141|FG002|Overall Study|Adverse Event|2
7987315|NCT03216265|12562139|FG000|Overall Study|Lost to Follow-up|0
7987316|NCT03216265|12562140|FG001|Overall Study|Lost to Follow-up|1
7987317|NCT03216265|12562141|FG002|Overall Study|Lost to Follow-up|0
7987318|NCT03216265|12562139|FG000|Overall Study|Withdrawal by Subject|0
7987319|NCT03216265|12562140|FG001|Overall Study|Withdrawal by Subject|0
7987320|NCT03216265|12562141|FG002|Overall Study|Withdrawal by Subject|1
7987321|NCT03216746|12562180|FG000|Overall Study|Lost to Follow-up|6
7987322|NCT03216746|12562181|FG001|Overall Study|Lost to Follow-up|8
7987323|NCT03216746|12562182|FG002|Overall Study|Lost to Follow-up|5
7987324|NCT03216746|12562183|FG003|Overall Study|Lost to Follow-up|6
7987325|NCT03216850|12562193|FG000|Overall Study|Pre-analytical error|6
7987326|NCT03216954|12562230|FG000|Overall Study|Adverse Event|0
7987327|NCT03216954|12562231|FG001|Overall Study|Adverse Event|0
7987328|NCT03216954|12562232|FG002|Overall Study|Adverse Event|1
7987329|NCT03216954|12562233|FG003|Overall Study|Adverse Event|0
7987330|NCT03216954|12562234|FG004|Overall Study|Adverse Event|1
7987331|NCT03216954|12562230|FG000|Overall Study|Withdrawal by Subject|2
7987332|NCT03216954|12562231|FG001|Overall Study|Withdrawal by Subject|0
7987333|NCT03216954|12562232|FG002|Overall Study|Withdrawal by Subject|0
7987334|NCT03216954|12562233|FG003|Overall Study|Withdrawal by Subject|0
7987335|NCT03216954|12562234|FG004|Overall Study|Withdrawal by Subject|0
7987336|NCT03216954|12562230|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7987337|NCT03216954|12562231|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1
7987338|NCT03216954|12562232|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7987339|NCT03216954|12562233|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7987340|NCT03216954|12562234|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7987341|NCT03217968|12562242|FG000|Overall Study|Withdrawal by Subject|4
7987342|NCT03217968|12562242|FG000|Overall Study|Lost to Follow-up|1
7987343|NCT03217968|12562242|FG000|Overall Study|Protocol Violation|6
7987344|NCT03218397|12562248|FG000|Overall Study|Prior positive blood culture|8
7987345|NCT03218397|12562249|FG001|Overall Study|Prior positive blood culture|13
7987346|NCT03218397|12562248|FG000|Overall Study|Comfort care|8
7987347|NCT03218397|12562249|FG001|Overall Study|Comfort care|5
7987348|NCT03218397|12562248|FG000|Overall Study|Comfort care and positive blood culture|1
7987349|NCT03218397|12562249|FG001|Overall Study|Comfort care and positive blood culture|0
7987350|NCT03218397|12562248|FG000|Overall Study|Comfort care and mixed culture|0
7811450|NCT01182441|12275181|FG001|Overall Study|Physician Decision|1
7987351|NCT03218397|12562249|FG001|Overall Study|Comfort care and mixed culture|1
7987352|NCT03218397|12562248|FG000|Overall Study|Mixed culture|2
7987353|NCT03218397|12562249|FG001|Overall Study|Mixed culture|2
7987354|NCT03218397|12562248|FG000|Overall Study|Inaccessible hospital records|2
7987355|NCT03218397|12562249|FG001|Overall Study|Inaccessible hospital records|5
7987356|NCT03218397|12562248|FG000|Overall Study|No gram-negative bacilli (GNB)|0
7987357|NCT03218397|12562249|FG001|Overall Study|No gram-negative bacilli (GNB)|2
7987358|NCT03218397|12562248|FG000|Overall Study|Randomized during laboratory off hours|2
7987359|NCT03218397|12562249|FG001|Overall Study|Randomized during laboratory off hours|1
7987360|NCT03218787|12562277|FG000|Overall Study|Lost to Follow-up|12
7987361|NCT03218787|12562277|FG000|Overall Study|Withdrawal by Subject|72
7987362|NCT03218787|12562277|FG000|Overall Study|Physician Decision|11
7987363|NCT03218787|12562277|FG000|Overall Study|Death|111
7987364|NCT03219216|12562283|FG000|Overall Study|Lost to Follow-up|0
7987365|NCT03219216|12562284|FG001|Overall Study|Lost to Follow-up|1
7987366|NCT03219723|12562315|FG000|Overall Study|Case Report Forms Uncollected|6
7987367|NCT03219723|12562315|FG000|Overall Study|Protocol Deviation|4
7987368|NCT03220217|12562381|FG000|Overall Study|Withdrawal by Subject|0
7987369|NCT03220217|12562382|FG001|Overall Study|Withdrawal by Subject|1
7987370|NCT03220217|12562383|FG002|Overall Study|Withdrawal by Subject|0
7987371|NCT03220217|12562381|FG000|Overall Study|Subject Missed Procedure|0
7987372|NCT03220217|12562382|FG001|Overall Study|Subject Missed Procedure|0
7987373|NCT03220217|12562383|FG002|Overall Study|Subject Missed Procedure|1
7987374|NCT03220737|12562434|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4
7987375|NCT03220737|12562435|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1
7987376|NCT03220737|12562436|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4
7987377|NCT03220737|12562437|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1
7987378|NCT03220737|12562438|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4
7987379|NCT03220737|12562439|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0
7987380|NCT03220737|12562440|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0
7987381|NCT03220737|12562434|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2
7987382|NCT03220737|12562435|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1
7987383|NCT03220737|12562436|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6
7987384|NCT03220737|12562437|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1
7987385|NCT03220737|12562438|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13
7987386|NCT03220737|12562439|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1
7987387|NCT03220737|12562440|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0
7987388|NCT03220737|12562434|FG000|Main Study (Day 1 - 181)|Protocol Violation|0
7987389|NCT03220737|12562435|FG001|Main Study (Day 1 - 181)|Protocol Violation|0
7987390|NCT03220737|12562436|FG002|Main Study (Day 1 - 181)|Protocol Violation|1
7987391|NCT03220737|12562437|FG003|Main Study (Day 1 - 181)|Protocol Violation|1
7987392|NCT03220737|12562438|FG004|Main Study (Day 1 - 181)|Protocol Violation|3
7987393|NCT03220737|12562439|FG005|Main Study (Day 1 - 181)|Protocol Violation|0
7987394|NCT03220737|12562440|FG006|Main Study (Day 1 - 181)|Protocol Violation|1
7987395|NCT03220737|12562434|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7987396|NCT03220737|12562435|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7987397|NCT03220737|12562436|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1
7987398|NCT03220737|12562437|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7987399|NCT03220737|12562438|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7987400|NCT03220737|12562439|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7987401|NCT03220737|12562440|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7987402|NCT03220737|12562434|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7987403|NCT03220737|12562435|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7987404|NCT03220737|12562436|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7987405|NCT03220737|12562437|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7987406|NCT03220737|12562438|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2
7987407|NCT03220737|12562439|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7987408|NCT03220737|12562440|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7987409|NCT03220737|12562434|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1
7987410|NCT03220737|12562435|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7987411|NCT03220737|12562436|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7987412|NCT03220737|12562437|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7987413|NCT03220737|12562438|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7987414|NCT03220737|12562439|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7987415|NCT03220737|12562440|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7987416|NCT03220737|12562434|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9
7987417|NCT03220737|12562435|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7987418|NCT03220737|12562436|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7987419|NCT03220737|12562437|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7987420|NCT03220737|12562438|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7987421|NCT03220737|12562439|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7987422|NCT03220737|12562440|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7987423|NCT03220737|12562434|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1
7987424|NCT03220737|12562435|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7987425|NCT03220737|12562436|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7987426|NCT03220737|12562437|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7987427|NCT03220737|12562438|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7987428|NCT03220737|12562439|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7987429|NCT03220737|12562440|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7987430|NCT03221387|12562475|FG000|Overall Study|Lost to Follow-up|1
7987431|NCT03221387|12562475|FG000|Overall Study|Lung transplant|1
7987432|NCT03222141|12562503|FG000|Overall Study|Death|15
7987433|NCT03222141|12562503|FG000|Overall Study|Lost to Follow-up|3
7987434|NCT03222349|12562508|FG000|Overall Study|Treatment B not done|5
7987435|NCT03222349|12562509|FG001|Overall Study|Treatment B not done|0
7987436|NCT03222349|12562508|FG000|Overall Study|Lost to Follow-up|1
7987437|NCT03222349|12562509|FG001|Overall Study|Lost to Follow-up|2
7987438|NCT03222349|12562508|FG000|Overall Study|Withdrawal by Subject|1
7987439|NCT03222349|12562509|FG001|Overall Study|Withdrawal by Subject|0
7987440|NCT03222349|12562508|FG000|Overall Study|Treatment A not done|0
7987441|NCT03222349|12562509|FG001|Overall Study|Treatment A not done|5
7987442|NCT03222349|12562508|FG000|Overall Study|Study terminated by sponsor|1
7987443|NCT03222349|12562509|FG001|Overall Study|Study terminated by sponsor|0
7987444|NCT03222583|12562548|FG000|Overall Study|Withdrawal by Subject|3
7987445|NCT03222583|12562549|FG001|Overall Study|Withdrawal by Subject|3
7987446|NCT03222583|12562548|FG000|Overall Study|Lost to Follow-up|1
7987447|NCT03222583|12562549|FG001|Overall Study|Lost to Follow-up|0
7987448|NCT03222583|12562548|FG000|Overall Study|Other|1
7987449|NCT03222583|12562549|FG001|Overall Study|Other|3
7987450|NCT03223909|12562597|FG000|Overall Study|Protocol Violation|48
7987451|NCT03223909|12562598|FG001|Overall Study|Protocol Violation|45
7987452|NCT03223909|12562599|FG002|Overall Study|Protocol Violation|16
7987453|NCT03224130|12562609|FG000|Overall Study|consent issue|0
7987454|NCT03224130|12562610|FG001|Overall Study|consent issue|1
7987455|NCT03224182|12562618|FG000|Overall Study|Study Drug Not Instilled|6
7987456|NCT03224182|12562619|FG001|Overall Study|Study Drug Not Instilled|1
7987457|NCT03224182|12562618|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22
7987458|NCT03224182|12562619|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11
7987459|NCT03224182|12562618|FG000|Overall Study|Withdrew of Consent|4
7987460|NCT03224182|12562619|FG001|Overall Study|Withdrew of Consent|2
7987461|NCT03224182|12562618|FG000|Overall Study|Investigator Decision|3
7987462|NCT03224182|12562619|FG001|Overall Study|Investigator Decision|1
7987463|NCT03224182|12562618|FG000|Overall Study|Sponsor Decision|26
7987464|NCT03224182|12562619|FG001|Overall Study|Sponsor Decision|12
7987465|NCT03224182|12562618|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4
7987466|NCT03224182|12562619|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0
7987467|NCT03224182|12562618|FG000|Overall Study|Lost to Follow-up|1
7987468|NCT03224182|12562619|FG001|Overall Study|Lost to Follow-up|0
7987469|NCT03224182|12562618|FG000|Overall Study|Participant Had Recurrence|11
7987470|NCT03224182|12562619|FG001|Overall Study|Participant Had Recurrence|5
7987471|NCT03224182|12562618|FG000|Overall Study|Death|0
7987472|NCT03224182|12562619|FG001|Overall Study|Death|1
7987473|NCT03224182|12562618|FG000|Overall Study|Reason not Specified|3
7987474|NCT03224182|12562619|FG001|Overall Study|Reason not Specified|3
7987475|NCT03224182|12562618|FG000|Overall Study|Other|1
7987476|NCT03224182|12562619|FG001|Overall Study|Other|0
7987477|NCT03224234|12562629|FG000|Main Study|Lost to Follow-up|5
7987478|NCT03224234|12562630|FG001|Main Study|Lost to Follow-up|5
7987479|NCT03224325|12562664|FG000|Overall Study|Adverse Event|1
7987480|NCT03224325|12562665|FG001|Overall Study|Adverse Event|0
7987481|NCT03224325|12562666|FG002|Overall Study|Adverse Event|0
7987482|NCT03224325|12562667|FG003|Overall Study|Adverse Event|0
7987483|NCT03224325|12562668|FG004|Overall Study|Adverse Event|0
7987484|NCT03224325|12562669|FG005|Overall Study|Adverse Event|0
7987485|NCT03224325|12562670|FG006|Overall Study|Adverse Event|1
7987486|NCT03224325|12562664|FG000|Overall Study|Withdrawal by Subject|0
7987487|NCT03224325|12562665|FG001|Overall Study|Withdrawal by Subject|0
7987488|NCT03224325|12562666|FG002|Overall Study|Withdrawal by Subject|0
7987489|NCT03224325|12562667|FG003|Overall Study|Withdrawal by Subject|1
7987490|NCT03224325|12562668|FG004|Overall Study|Withdrawal by Subject|0
7987491|NCT03224325|12562669|FG005|Overall Study|Withdrawal by Subject|0
7987492|NCT03224325|12562670|FG006|Overall Study|Withdrawal by Subject|0
7987493|NCT03224598|12562789|FG000|Overall Study|Lost to Follow-up|0
7987494|NCT03224598|12562790|FG001|Overall Study|Lost to Follow-up|2
7987495|NCT03224598|12562791|FG002|Overall Study|Lost to Follow-up|0
7987496|NCT03224598|12562789|FG000|Overall Study|Other|0
7987497|NCT03224598|12562790|FG001|Overall Study|Other|1
7987498|NCT03224598|12562791|FG002|Overall Study|Other|0
7987499|NCT03226249|12562839|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1
7987500|NCT03226249|12562839|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29
7987501|NCT03226249|12562839|FG000|Survival Follow-up|Patients still in follow-up.|30
7987502|NCT03226275|12562847|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
7987503|NCT03226275|12562848|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
7987504|NCT03226275|12562849|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1
7987505|NCT03226275|12562850|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
7987506|NCT03226275|12562847|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0
7987507|NCT03226275|12562848|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0
7987508|NCT03226275|12562849|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0
7987509|NCT03226275|12562850|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1
7987510|NCT03226353|12562860|FG000|Overall Study|Withdrawal by Subject|1
7987511|NCT03226353|12562860|FG000|Overall Study|Screen Failure|5
7987512|NCT03226392|12562886|FG000|Overall Study|Protocol Deviation|1
7987513|NCT03226392|12562887|FG001|Overall Study|Protocol Deviation|0
7987514|NCT03226392|12562886|FG000|Overall Study|Physician Decision|1
7987515|NCT03226392|12562887|FG001|Overall Study|Physician Decision|0
7987516|NCT03226392|12562886|FG000|Overall Study|Lost to Follow-up|1
7987517|NCT03226392|12562887|FG001|Overall Study|Lost to Follow-up|0
7987518|NCT03226392|12562886|FG000|Overall Study|Adverse Event|1
7987519|NCT03226392|12562887|FG001|Overall Study|Adverse Event|0
7987520|NCT03226392|12562886|FG000|Overall Study|Technical Problems|0
7987521|NCT03226392|12562887|FG001|Overall Study|Technical Problems|2
7987522|NCT03226392|12562886|FG000|Overall Study|Subject/Guardian Decision|7
7987523|NCT03226392|12562887|FG001|Overall Study|Subject/Guardian Decision|6
7987524|NCT03226769|12562910|FG000|Overall Study|Withdrawal by Subject|0
7987525|NCT03226769|12562911|FG001|Overall Study|Withdrawal by Subject|1
7987526|NCT03227445|12562926|FG000|Period 1 (28 Days)|Adverse Event|1
7987527|NCT03227445|12562927|FG001|Period 1 (28 Days)|Adverse Event|2
7987528|NCT03227445|12562928|FG002|Period 1 (28 Days)|Adverse Event|0
7987529|NCT03227445|12562929|FG003|Period 1 (28 Days)|Adverse Event|1
7987530|NCT03227445|12562926|FG000|Period 1 (28 Days)|Protocol Violation|1
7987531|NCT03227445|12562927|FG001|Period 1 (28 Days)|Protocol Violation|0
7987532|NCT03227445|12562928|FG002|Period 1 (28 Days)|Protocol Violation|0
7987533|NCT03227445|12562929|FG003|Period 1 (28 Days)|Protocol Violation|0
7987534|NCT03227445|12562926|FG000|Period 1 (28 Days)|Withdrawal by Subject|0
7987535|NCT03227445|12562927|FG001|Period 1 (28 Days)|Withdrawal by Subject|0
7987536|NCT03227445|12562928|FG002|Period 1 (28 Days)|Withdrawal by Subject|1
7987537|NCT03227445|12562929|FG003|Period 1 (28 Days)|Withdrawal by Subject|1
7987538|NCT03227445|12562926|FG000|Period 2 (28 Days)|Adverse Event|1
7987539|NCT03227445|12562927|FG001|Period 2 (28 Days)|Adverse Event|0
7987540|NCT03227445|12562928|FG002|Period 2 (28 Days)|Adverse Event|2
7987541|NCT03227445|12562929|FG003|Period 2 (28 Days)|Adverse Event|1
7987542|NCT03227445|12562926|FG000|Period 2 (28 Days)|Protocol Violation|0
7987543|NCT03227445|12562927|FG001|Period 2 (28 Days)|Protocol Violation|0
7987544|NCT03227445|12562928|FG002|Period 2 (28 Days)|Protocol Violation|0
7987545|NCT03227445|12562929|FG003|Period 2 (28 Days)|Protocol Violation|1
7987546|NCT03227445|12562926|FG000|Period 2 (28 Days)|Withdrawal by Subject|0
7987547|NCT03227445|12562927|FG001|Period 2 (28 Days)|Withdrawal by Subject|1
7987548|NCT03227445|12562928|FG002|Period 2 (28 Days)|Withdrawal by Subject|0
7987549|NCT03227445|12562929|FG003|Period 2 (28 Days)|Withdrawal by Subject|1
7987550|NCT03227692|12562940|FG000|Overall Study|Protocol Violation|1
7987551|NCT03227692|12562941|FG001|Overall Study|Protocol Violation|1
7987552|NCT03227692|12562940|FG000|Overall Study|Lost to Follow-up|4
7987553|NCT03227692|12562941|FG001|Overall Study|Lost to Follow-up|2
7987554|NCT03227692|12562940|FG000|Overall Study|Adverse Event|0
7987555|NCT03227692|12562941|FG001|Overall Study|Adverse Event|2
7987556|NCT03227861|12562947|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4
7987557|NCT03227861|12562947|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1
7987558|NCT03227861|12562947|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1
7987559|NCT03227861|12562947|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1
7987560|NCT03227861|12562947|FG000|Main Study Period (Week 0 to Week 48)|Other|5
7987561|NCT03227861|12562947|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55
7987562|NCT03227861|12562947|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16
7987563|NCT03227861|12562947|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6
7987564|NCT03227861|12562947|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1
7987565|NCT03227861|12562947|FG000|Extension Period (Week 48 to Week 96)|Other|2
7987566|NCT03228212|12562962|FG000|Period 1|Adverse Event|1
7987567|NCT03228212|12562963|FG001|Period 1|Adverse Event|0
7987568|NCT03228212|12562962|FG000|Period 1|no longer meets eligibility criteria|0
7987569|NCT03228212|12562963|FG001|Period 1|no longer meets eligibility criteria|1
7987570|NCT03228212|12562962|FG000|Period 2|Lost to Follow-up|1
7987571|NCT03228212|12562963|FG001|Period 2|Lost to Follow-up|0
7987572|NCT03228420|12562971|FG000|Overall Study|Lost to Follow-up|5
7987573|NCT03228420|12562972|FG001|Overall Study|Lost to Follow-up|3
7987574|NCT03228420|12562971|FG000|Overall Study|Withdrawal by Subject|10
7987575|NCT03228420|12562972|FG001|Overall Study|Withdrawal by Subject|0
7987576|NCT03228420|12562971|FG000|Overall Study|Adverse Event|5
7987577|NCT03228420|12562972|FG001|Overall Study|Adverse Event|2
7987578|NCT03228433|12562984|FG000|Overall Study|Lost to Follow-up|1
7987579|NCT03228433|12562985|FG001|Overall Study|Lost to Follow-up|0
7987580|NCT03228433|12562986|FG002|Overall Study|Lost to Follow-up|0
7987581|NCT03228433|12562987|FG003|Overall Study|Lost to Follow-up|0
7987582|NCT03228433|12562988|FG004|Overall Study|Lost to Follow-up|0
7987583|NCT03228433|12562989|FG005|Overall Study|Lost to Follow-up|0
7987584|NCT03228433|12562984|FG000|Overall Study|Positive alcohol test|0
7987585|NCT03228433|12562985|FG001|Overall Study|Positive alcohol test|0
7987586|NCT03228433|12562986|FG002|Overall Study|Positive alcohol test|0
7987587|NCT03228433|12562987|FG003|Overall Study|Positive alcohol test|1
7987588|NCT03228433|12562988|FG004|Overall Study|Positive alcohol test|0
7987589|NCT03228433|12562989|FG005|Overall Study|Positive alcohol test|0
7987590|NCT03228836|12563011|FG000|Overall Study|Adverse Event|3
7987591|NCT03228836|12563011|FG000|Overall Study|Withdrawal by Subject|1
7987592|NCT03228836|12563011|FG000|Overall Study|Death|1
7987593|NCT03228836|12563011|FG000|Overall Study|Physician Decision|1
7987594|NCT03228836|12563011|FG000|Overall Study|Disease Progression|7
7987595|NCT03228836|12563011|FG000|Overall Study|Other|4
7987596|NCT03229109|12563026|FG000|Overall Study|Withdrawal by Subject|0
7987597|NCT03229109|12563027|FG001|Overall Study|Withdrawal by Subject|0
7987598|NCT03229109|12563028|FG002|Overall Study|Withdrawal by Subject|0
7987599|NCT03229109|12563029|FG003|Overall Study|Withdrawal by Subject|1
7987600|NCT03229486|12563054|FG000|Overall Study|Protocol Violation|0
7987601|NCT03229486|12563055|FG001|Overall Study|Protocol Violation|1
7987602|NCT03229759|12563061|FG000|Overall Study|Screen Failure|30
7987603|NCT03230864|12563074|FG000|Prospective Confirmation (PC) Period|Adverse Event|3
7987604|NCT03230864|12563075|FG001|Prospective Confirmation (PC) Period|Adverse Event|0
7987605|NCT03230864|12563076|FG002|Prospective Confirmation (PC) Period|Adverse Event|0
7987606|NCT03230864|12563077|FG003|Prospective Confirmation (PC) Period|Adverse Event|0
7987607|NCT03230864|12563074|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7987608|NCT03230864|12563075|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2
7987609|NCT03230864|12563076|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7987610|NCT03230864|12563077|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7987611|NCT03230864|12563074|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1
7987612|NCT03230864|12563075|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2
7987613|NCT03230864|12563076|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0
7987614|NCT03230864|12563077|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0
7987615|NCT03230864|12563074|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4
7987616|NCT03230864|12563075|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1
7987617|NCT03230864|12563076|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7987618|NCT03230864|12563077|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7987619|NCT03230864|12563074|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14
7987620|NCT03230864|12563075|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5
7987621|NCT03230864|12563076|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
7987622|NCT03230864|12563077|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
7987623|NCT03230864|12563074|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9
7987624|NCT03230864|12563075|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9
7987625|NCT03230864|12563076|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0
7987626|NCT03230864|12563077|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0
7987627|NCT03230864|12563074|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1
7987628|NCT03230864|12563075|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0
7987629|NCT03230864|12563076|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0
7987630|NCT03230864|12563077|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0
7987631|NCT03230864|12563074|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0
7987632|NCT03230864|12563075|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0
7987633|NCT03230864|12563076|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5
7987634|NCT03230864|12563077|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1
7987635|NCT03230864|12563074|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
7987636|NCT03230864|12563075|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
7987637|NCT03230864|12563076|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
7987638|NCT03230864|12563077|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
7987639|NCT03230864|12563074|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0
7987640|NCT03230864|12563075|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0
7987641|NCT03230864|12563076|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2
7987642|NCT03230864|12563077|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0
7987643|NCT03231228|12563089|FG000|Overall Study|Lost to Follow-up|2
7987644|NCT03231228|12563090|FG001|Overall Study|Lost to Follow-up|0
7987645|NCT03231228|12563089|FG000|Overall Study|Physician Decision|1
7987646|NCT03231228|12563090|FG001|Overall Study|Physician Decision|0
7987647|NCT03231371|12563100|FG000|Overall Study|Withdrawal by Subject|1
7987648|NCT03231371|12563100|FG000|Overall Study|chose or were ineligible to have MRI|12
7987649|NCT03231709|12563106|FG000|Treatment Period 1|Reason not Specified|0
7987650|NCT03231709|12563107|FG001|Treatment Period 1|Reason not Specified|1
7987651|NCT03231709|12563106|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0
7987652|NCT03231709|12563107|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1
7987653|NCT03231800|12563119|FG000|Overall Study|Lost to Follow-up|0
7987654|NCT03231800|12563120|FG001|Overall Study|Lost to Follow-up|2
7987655|NCT03231800|12563119|FG000|Overall Study|Protocol Violation|1
7987656|NCT03231800|12563120|FG001|Overall Study|Protocol Violation|1
7987657|NCT03231800|12563119|FG000|Overall Study|reason not provided|2
7987658|NCT03231800|12563120|FG001|Overall Study|reason not provided|0
7987659|NCT03231943|12563142|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7987660|NCT03231943|12563143|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1
7987661|NCT03231943|12563144|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1
7987662|NCT03231943|12563145|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7987663|NCT03231943|12563146|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7987664|NCT03231943|12563147|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7987665|NCT03231943|12563148|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7987666|NCT03231943|12563149|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7987667|NCT03231943|12563150|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7987668|NCT03231943|12563151|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7987669|NCT03231943|12563152|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7987670|NCT03231943|12563153|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7987671|NCT03231943|12563154|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7987672|NCT03231943|12563142|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7987673|NCT03231943|12563143|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1
7987674|NCT03231943|12563144|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7987675|NCT03231943|12563145|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7987676|NCT03231943|12563146|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7987677|NCT03231943|12563147|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7987678|NCT03231943|12563148|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7987679|NCT03231943|12563149|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7987680|NCT03231943|12563150|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7987681|NCT03231943|12563151|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7987682|NCT03231943|12563152|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7987683|NCT03231943|12563153|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7987684|NCT03231943|12563154|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7987685|NCT03231943|12563142|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1
7987686|NCT03231943|12563143|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7987687|NCT03231943|12563144|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7987688|NCT03231943|12563145|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7987689|NCT03231943|12563146|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7987690|NCT03231943|12563147|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7987691|NCT03231943|12563148|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7987692|NCT03231943|12563149|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7987693|NCT03231943|12563150|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7987694|NCT03231943|12563151|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7987695|NCT03231943|12563152|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7987696|NCT03231943|12563153|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7987697|NCT03231943|12563154|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7987698|NCT03231943|12563142|FG000|Part 2|Adverse Event|0
7987699|NCT03231943|12563143|FG001|Part 2|Adverse Event|0
7987700|NCT03231943|12563144|FG002|Part 2|Adverse Event|0
7987701|NCT03231943|12563145|FG003|Part 2|Adverse Event|0
7987702|NCT03231943|12563146|FG004|Part 2|Adverse Event|0
7987703|NCT03231943|12563147|FG005|Part 2|Adverse Event|0
7987704|NCT03231943|12563148|FG006|Part 2|Adverse Event|0
7987705|NCT03231943|12563149|FG007|Part 2|Adverse Event|0
7987706|NCT03231943|12563150|FG008|Part 2|Adverse Event|0
7987707|NCT03231943|12563151|FG009|Part 2|Adverse Event|0
7987708|NCT03231943|12563152|FG010|Part 2|Adverse Event|1
7987709|NCT03231943|12563153|FG011|Part 2|Adverse Event|0
7987710|NCT03231943|12563154|FG012|Part 2|Adverse Event|0
7987711|NCT03231943|12563142|FG000|Part 2|Withdrawal by Subject|0
7987712|NCT03231943|12563143|FG001|Part 2|Withdrawal by Subject|0
7987713|NCT03231943|12563144|FG002|Part 2|Withdrawal by Subject|0
7987714|NCT03231943|12563145|FG003|Part 2|Withdrawal by Subject|0
7987715|NCT03231943|12563146|FG004|Part 2|Withdrawal by Subject|0
7987716|NCT03231943|12563147|FG005|Part 2|Withdrawal by Subject|0
7987717|NCT03231943|12563148|FG006|Part 2|Withdrawal by Subject|0
7987718|NCT03231943|12563149|FG007|Part 2|Withdrawal by Subject|0
7987719|NCT03231943|12563150|FG008|Part 2|Withdrawal by Subject|0
7987720|NCT03231943|12563151|FG009|Part 2|Withdrawal by Subject|0
7987721|NCT03231943|12563152|FG010|Part 2|Withdrawal by Subject|0
7987722|NCT03231943|12563153|FG011|Part 2|Withdrawal by Subject|1
7987723|NCT03231943|12563154|FG012|Part 2|Withdrawal by Subject|0
7987724|NCT03232281|12563203|FG000|Overall Study|Adverse Event|1
7987725|NCT03232281|12563204|FG001|Overall Study|Adverse Event|1
7987726|NCT03232281|12563203|FG000|Overall Study|Withdrawal by Subject|5
7987727|NCT03232281|12563204|FG001|Overall Study|Withdrawal by Subject|4
7987728|NCT03232281|12563203|FG000|Overall Study|Protocol Deviation|1
7987729|NCT03232281|12563204|FG001|Overall Study|Protocol Deviation|1
7987730|NCT03232333|12563210|FG000|Overall Study|Infection or Osteomyelitis|9
7987731|NCT03232333|12563210|FG000|Overall Study|Lost to Follow-up|4
7987732|NCT03232333|12563210|FG000|Overall Study|Withdrawal by Subject|2
7987733|NCT03232567|12563218|FG000|Overall Study|Withdrawal by Subject|0
7987734|NCT03232567|12563219|FG001|Overall Study|Withdrawal by Subject|1
7987735|NCT03232567|12563220|FG002|Overall Study|Withdrawal by Subject|0
7987736|NCT03232567|12563221|FG003|Overall Study|Withdrawal by Subject|0
7987737|NCT03232983|12563254|FG000|Period 1|Physician Decision|0
7987738|NCT03232983|12563255|FG001|Period 1|Physician Decision|0
7987739|NCT03232983|12563256|FG002|Period 1|Physician Decision|1
7987740|NCT03232983|12563257|FG003|Period 1|Physician Decision|0
7987741|NCT03232983|12563254|FG000|Washout Period 2|Physician Decision|0
7987742|NCT03232983|12563255|FG001|Washout Period 2|Physician Decision|0
7987743|NCT03232983|12563256|FG002|Washout Period 2|Physician Decision|1
7987744|NCT03232983|12563257|FG003|Washout Period 2|Physician Decision|0
7987745|NCT03232983|12563254|FG000|Washout Period 2|Withdrawal by Subject|0
7987746|NCT03232983|12563255|FG001|Washout Period 2|Withdrawal by Subject|0
7987747|NCT03232983|12563256|FG002|Washout Period 2|Withdrawal by Subject|0
7987748|NCT03232983|12563257|FG003|Washout Period 2|Withdrawal by Subject|1
7987749|NCT03232983|12563254|FG000|Period 4|Withdrawal by Subject|1
7987750|NCT03232983|12563255|FG001|Period 4|Withdrawal by Subject|0
7987751|NCT03232983|12563256|FG002|Period 4|Withdrawal by Subject|0
7987752|NCT03232983|12563257|FG003|Period 4|Withdrawal by Subject|0
7987753|NCT03233009|12563269|FG000|Overall Study|Lost to Follow-up|1
7987754|NCT03233230|12563286|FG000|Overall Study|Adverse Event|6
7987755|NCT03233230|12563287|FG001|Overall Study|Adverse Event|3
7987756|NCT03233230|12563288|FG002|Overall Study|Adverse Event|6
7987757|NCT03233230|12563289|FG003|Overall Study|Adverse Event|3
7987758|NCT03233230|12563286|FG000|Overall Study|Protocol Violation|1
7987759|NCT03233230|12563287|FG001|Overall Study|Protocol Violation|2
7987760|NCT03233230|12563288|FG002|Overall Study|Protocol Violation|1
7987761|NCT03233230|12563289|FG003|Overall Study|Protocol Violation|1
7987762|NCT03233230|12563286|FG000|Overall Study|Lack of Efficacy|1
7987763|NCT03233230|12563287|FG001|Overall Study|Lack of Efficacy|0
7987764|NCT03233230|12563288|FG002|Overall Study|Lack of Efficacy|0
7987765|NCT03233230|12563289|FG003|Overall Study|Lack of Efficacy|0
7987766|NCT03233230|12563286|FG000|Overall Study|Other|5
7987767|NCT03233230|12563287|FG001|Overall Study|Other|5
7987768|NCT03233230|12563288|FG002|Overall Study|Other|5
7987769|NCT03233230|12563289|FG003|Overall Study|Other|3
7987770|NCT03233230|12563286|FG000|Overall Study|Withdrawal by Subject|2
7987771|NCT03233230|12563287|FG001|Overall Study|Withdrawal by Subject|2
7987772|NCT03233230|12563288|FG002|Overall Study|Withdrawal by Subject|0
7987773|NCT03233230|12563289|FG003|Overall Study|Withdrawal by Subject|1
7987774|NCT03233230|12563286|FG000|Overall Study|Lost to Follow-up|0
7987775|NCT03233230|12563287|FG001|Overall Study|Lost to Follow-up|3
7987776|NCT03233230|12563288|FG002|Overall Study|Lost to Follow-up|0
7987777|NCT03233230|12563289|FG003|Overall Study|Lost to Follow-up|0
7987778|NCT03233308|12563299|FG000|Overall Study|Adverse Event|1
7987779|NCT03233308|12563299|FG000|Overall Study|Protocol Violation|1
7987780|NCT03233438|12563312|FG000|Overall Study|Lost to Follow-up|4
7987781|NCT03233438|12563313|FG001|Overall Study|Lost to Follow-up|9
7987782|NCT03233438|12563312|FG000|Overall Study|Withdrawal by Subject|2
7987783|NCT03233438|12563313|FG001|Overall Study|Withdrawal by Subject|1
7987784|NCT03233438|12563312|FG000|Overall Study|No recording of dalbavancin|0
7987785|NCT03233438|12563313|FG001|Overall Study|No recording of dalbavancin|1
7987786|NCT03233529|12563319|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1
7987787|NCT03233529|12563319|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1
7987788|NCT03234036|12563352|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
7987789|NCT03234036|12563353|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
7987790|NCT03234036|12563354|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
7987791|NCT03234036|12563355|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
7987792|NCT03234465|12563382|FG000|Overall Study|Adverse Event|4
7987793|NCT03234465|12563383|FG001|Overall Study|Adverse Event|2
7987794|NCT03234465|12563382|FG000|Overall Study|Death|0
7987795|NCT03234465|12563383|FG001|Overall Study|Death|1
7987796|NCT03234465|12563382|FG000|Overall Study|Lost to Follow-up|1
7987797|NCT03234465|12563383|FG001|Overall Study|Lost to Follow-up|1
7987798|NCT03234465|12563382|FG000|Overall Study|Withdrawal by Subject|12
7987799|NCT03234465|12563383|FG001|Overall Study|Withdrawal by Subject|27
7987800|NCT03234465|12563382|FG000|Overall Study|Symptomatic deterioration|0
7987801|NCT03234465|12563383|FG001|Overall Study|Symptomatic deterioration|1
7987802|NCT03234465|12563382|FG000|Overall Study|Non-compliance|2
7987803|NCT03234465|12563383|FG001|Overall Study|Non-compliance|0
7987804|NCT03234465|12563382|FG000|Overall Study|Other|14
7987805|NCT03234465|12563383|FG001|Overall Study|Other|8
7987806|NCT03234608|12563391|FG000|Overall Study|Lost to Follow-up|23
7987807|NCT03234608|12563392|FG001|Overall Study|Lost to Follow-up|21
7987808|NCT03235050|12563403|FG000|Overall Study|Adverse Event|0
7987809|NCT03235050|12563404|FG001|Overall Study|Adverse Event|0
7987810|NCT03235050|12563405|FG002|Overall Study|Adverse Event|1
7987811|NCT03235050|12563406|FG003|Overall Study|Adverse Event|4
7987812|NCT03235050|12563407|FG004|Overall Study|Adverse Event|1
7987813|NCT03235050|12563403|FG000|Overall Study|Death|0
7987814|NCT03235050|12563404|FG001|Overall Study|Death|0
7987815|NCT03235050|12563405|FG002|Overall Study|Death|0
7987816|NCT03235050|12563406|FG003|Overall Study|Death|2
7987817|NCT03235050|12563407|FG004|Overall Study|Death|1
7987818|NCT03235050|12563403|FG000|Overall Study|Lost to Follow-up|1
7987819|NCT03235050|12563404|FG001|Overall Study|Lost to Follow-up|2
7987820|NCT03235050|12563405|FG002|Overall Study|Lost to Follow-up|1
7987821|NCT03235050|12563406|FG003|Overall Study|Lost to Follow-up|2
7987822|NCT03235050|12563407|FG004|Overall Study|Lost to Follow-up|0
7987823|NCT03235050|12563403|FG000|Overall Study|Withdrawal by Subject|3
7987824|NCT03235050|12563404|FG001|Overall Study|Withdrawal by Subject|2
7987825|NCT03235050|12563405|FG002|Overall Study|Withdrawal by Subject|2
7987826|NCT03235050|12563406|FG003|Overall Study|Withdrawal by Subject|5
7987827|NCT03235050|12563407|FG004|Overall Study|Withdrawal by Subject|7
7987828|NCT03235050|12563403|FG000|Overall Study|Other reasons|0
7987829|NCT03235050|12563404|FG001|Overall Study|Other reasons|1
7987830|NCT03235050|12563405|FG002|Overall Study|Other reasons|0
7987831|NCT03235050|12563406|FG003|Overall Study|Other reasons|1
7987832|NCT03235050|12563407|FG004|Overall Study|Other reasons|2
7987833|NCT03235089|12563419|FG000|Overall Study|Lost to Follow-up|1
7987834|NCT03235089|12563420|FG001|Overall Study|Lost to Follow-up|1
7987835|NCT03235089|12563419|FG000|Overall Study|Physician Decision|2
7987836|NCT03235089|12563420|FG001|Overall Study|Physician Decision|2
7987837|NCT03235115|12563427|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7987838|NCT03235115|12563428|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7987839|NCT03235115|12563429|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7987840|NCT03235115|12563430|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7987841|NCT03235115|12563431|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7987842|NCT03235115|12563432|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
7987843|NCT03235154|12563440|FG000|Overall Study|Withdrawal by Subject|1
7987844|NCT03235154|12563440|FG000|Overall Study|Adverse Event|1
7987845|NCT03235154|12563440|FG000|Overall Study|Lost to Follow-up|2
7987846|NCT03235284|12563453|FG000|Overall Study|Adverse Event|1
7987847|NCT03235284|12563454|FG001|Overall Study|Adverse Event|2
7987848|NCT03235284|12563455|FG002|Overall Study|Adverse Event|1
7987849|NCT03235349|12563463|FG000|Overall Study|Adverse Event|1
7987850|NCT03235349|12563463|FG000|Overall Study|Other|1
7987851|NCT03235479|12563473|FG000|Overall Study|Lost to Follow-up|8
7987852|NCT03235479|12563474|FG001|Overall Study|Lost to Follow-up|11
7987853|NCT03235479|12563473|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23
7987854|NCT03235479|12563474|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17
7987855|NCT03235479|12563473|FG000|Overall Study|Pregnancy|1
7987856|NCT03235479|12563474|FG001|Overall Study|Pregnancy|0
7987857|NCT03235479|12563473|FG000|Overall Study|Protocol Deviation|1
7987858|NCT03235479|12563474|FG001|Overall Study|Protocol Deviation|3
7987859|NCT03235479|12563473|FG000|Overall Study|Technical Problems|3
7987860|NCT03235479|12563474|FG001|Overall Study|Technical Problems|2
7987861|NCT03235479|12563473|FG000|Overall Study|Withdrawal by Subject|2
7987862|NCT03235479|12563474|FG001|Overall Study|Withdrawal by Subject|2
7987863|NCT03235479|12563473|FG000|Overall Study|Other Reasons|3
7987864|NCT03235479|12563474|FG001|Overall Study|Other Reasons|5
7987865|NCT03235726|12563488|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7987866|NCT03235726|12563489|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7987867|NCT03235726|12563490|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7987868|NCT03235726|12563491|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7987869|NCT03235726|12563492|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1
7987870|NCT03235726|12563493|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7987871|NCT03235726|12563494|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7987872|NCT03235726|12563495|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7987873|NCT03235726|12563496|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7987874|NCT03235726|12563497|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7987875|NCT03235726|12563488|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7987876|NCT03235726|12563489|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7987877|NCT03235726|12563490|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7987878|NCT03235726|12563491|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7987879|NCT03235726|12563492|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1
7987880|NCT03235726|12563493|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7987881|NCT03235726|12563494|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7987882|NCT03235726|12563495|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7987883|NCT03235726|12563496|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7987884|NCT03235726|12563497|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7987885|NCT03236246|12563538|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8
7987886|NCT03236246|12563539|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7
7987887|NCT03236246|12563538|FG000|24-Week Dose Titration Period|Lost to Follow-up|0
7987888|NCT03236246|12563539|FG001|24-Week Dose Titration Period|Lost to Follow-up|2
7987889|NCT03236246|12563538|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3
7987890|NCT03236246|12563539|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2
7987891|NCT03236246|12563538|FG000|24-Week Dose Titration Period|Investigator Judgement|1
7987892|NCT03236246|12563539|FG001|24-Week Dose Titration Period|Investigator Judgement|1
7987893|NCT03236246|12563538|FG000|24-Week Dose Titration Period|Prohibited Therapy|1
7987894|NCT03236246|12563539|FG001|24-Week Dose Titration Period|Prohibited Therapy|1
7987895|NCT03236246|12563538|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0
7987896|NCT03236246|12563539|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1
7987897|NCT03236246|12563538|FG000|24-Week Dose Titration Period|Death|3
7987898|NCT03236246|12563539|FG001|24-Week Dose Titration Period|Death|1
7987899|NCT03236246|12563538|FG000|24-Week Dose Titration Period|Protocol Violation|0
7987900|NCT03236246|12563539|FG001|24-Week Dose Titration Period|Protocol Violation|2
7987901|NCT03236246|12563538|FG000|24-Week Dose Titration Period|Adverse Event|7
7987902|NCT03236246|12563539|FG001|24-Week Dose Titration Period|Adverse Event|8
7987903|NCT03236246|12563538|FG000|24-Week Dose Titration Period|Captured as Other|1
7987904|NCT03236246|12563539|FG001|24-Week Dose Titration Period|Captured as Other|2
7987905|NCT03236246|12563538|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1
7987906|NCT03236246|12563539|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3
7987907|NCT03236246|12563538|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1
7987908|NCT03236246|12563539|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1
7987909|NCT03236246|12563538|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1
7987910|NCT03236246|12563539|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0
7987911|NCT03236246|12563538|FG000|24-Week Dose Maintenance Period|Death|0
7987912|NCT03236246|12563539|FG001|24-Week Dose Maintenance Period|Death|1
7987913|NCT03236246|12563538|FG000|24-Week Dose Maintenance Period|Adverse Event|0
7987914|NCT03236246|12563539|FG001|24-Week Dose Maintenance Period|Adverse Event|1
7987915|NCT03236506|12563548|FG000|Overall Study|Death|1
7987916|NCT03236506|12563549|FG001|Overall Study|Death|1
7987917|NCT03236506|12563550|FG002|Overall Study|Death|1
7987918|NCT03236506|12563548|FG000|Overall Study|Withdrawal by Subject|3
7987919|NCT03236506|12563549|FG001|Overall Study|Withdrawal by Subject|3
7987920|NCT03236506|12563550|FG002|Overall Study|Withdrawal by Subject|4
7987921|NCT03236506|12563548|FG000|Overall Study|Did not initiate treatment|2
7987922|NCT03236506|12563549|FG001|Overall Study|Did not initiate treatment|1
7987923|NCT03236506|12563550|FG002|Overall Study|Did not initiate treatment|2
7987924|NCT03236779|12563560|FG000|Overall Study|Lost to Follow-up|13
7987925|NCT03236779|12563561|FG001|Overall Study|Lost to Follow-up|21
7987926|NCT03237013|12563572|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43
7987927|NCT03237013|12563573|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30
7987928|NCT03237013|12563574|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37
7987929|NCT03237065|12563584|FG000|Overall Study|Adverse Event|0
7987930|NCT03237065|12563585|FG001|Overall Study|Adverse Event|2
7987931|NCT03237065|12563584|FG000|Overall Study|Protocol Violation|0
7987932|NCT03237065|12563585|FG001|Overall Study|Protocol Violation|1
7987933|NCT03237065|12563584|FG000|Overall Study|Withdrawal by Subject|3
7987934|NCT03237065|12563585|FG001|Overall Study|Withdrawal by Subject|0
7987935|NCT03237065|12563584|FG000|Overall Study|Lost to Follow-up|1
7987936|NCT03237065|12563585|FG001|Overall Study|Lost to Follow-up|0
7987937|NCT03237065|12563584|FG000|Overall Study|Unable to obtain venous access|0
7987938|NCT03237065|12563585|FG001|Overall Study|Unable to obtain venous access|1
7987939|NCT03237481|12563614|FG000|Overall Study|Lost to Follow-up|1
7987940|NCT03237481|12563615|FG001|Overall Study|Lost to Follow-up|0
7987941|NCT03237481|12563616|FG002|Overall Study|Lost to Follow-up|0
7987942|NCT03237481|12563614|FG000|Overall Study|Protocol Violation|1
7987943|NCT03237481|12563615|FG001|Overall Study|Protocol Violation|0
7987944|NCT03237481|12563616|FG002|Overall Study|Protocol Violation|0
7987945|NCT03237481|12563614|FG000|Overall Study|Withdrawal by Subject|3
7987946|NCT03237481|12563615|FG001|Overall Study|Withdrawal by Subject|2
7987947|NCT03237481|12563616|FG002|Overall Study|Withdrawal by Subject|1
7987948|NCT03237845|12563626|FG000|Overall Study|Adverse Event|0
7987949|NCT03237845|12563627|FG001|Overall Study|Adverse Event|1
7987950|NCT03237845|12563626|FG000|Overall Study|Lost to Follow-up|13
7987951|NCT03237845|12563627|FG001|Overall Study|Lost to Follow-up|10
7987952|NCT03237845|12563626|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26
7987953|NCT03237845|12563627|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31
7987954|NCT03237845|12563626|FG000|Overall Study|Non-Compliance With Study Treatment|0
7987955|NCT03237845|12563627|FG001|Overall Study|Non-Compliance With Study Treatment|1
7987956|NCT03237845|12563626|FG000|Overall Study|Physician Decision|1
7987957|NCT03237845|12563627|FG001|Overall Study|Physician Decision|2
7987958|NCT03237845|12563626|FG000|Overall Study|Pregnancy|1
7987959|NCT03237845|12563627|FG001|Overall Study|Pregnancy|0
7987960|NCT03237845|12563626|FG000|Overall Study|Protocol Deviation|0
7987961|NCT03237845|12563627|FG001|Overall Study|Protocol Deviation|1
7987962|NCT03237845|12563626|FG000|Overall Study|Technical Problems|8
7987963|NCT03237845|12563627|FG001|Overall Study|Technical Problems|1
7987964|NCT03237845|12563626|FG000|Overall Study|Withdrawal by Subject|3
7987965|NCT03237845|12563627|FG001|Overall Study|Withdrawal by Subject|3
7987966|NCT03237845|12563626|FG000|Overall Study|Other Reasons|4
7987967|NCT03237845|12563627|FG001|Overall Study|Other Reasons|0
7987968|NCT03238001|12563637|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
7987969|NCT03238001|12563637|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
7987970|NCT03238001|12563637|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
7987971|NCT03238001|12563637|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
7987972|NCT03238001|12563637|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
7987973|NCT03238001|12563637|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
7987974|NCT03238001|12563637|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
7987975|NCT03238001|12563637|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
7987976|NCT03238352|12563652|FG000|Overall Study|Lost to Follow-up|0
7987977|NCT03238352|12563653|FG001|Overall Study|Lost to Follow-up|2
7987978|NCT03238352|12563654|FG002|Overall Study|Lost to Follow-up|1
7987979|NCT03238352|12563652|FG000|Overall Study|Withdrawal by Subject|0
7987980|NCT03238352|12563653|FG001|Overall Study|Withdrawal by Subject|1
7987981|NCT03238352|12563654|FG002|Overall Study|Withdrawal by Subject|0
7987982|NCT03238417|12563664|FG000|Overall|non-response|955
7987983|NCT03238417|12563665|FG001|Overall|non-response|1920
7987984|NCT03238417|12563664|FG000|Overall|partial completion|48
7987985|NCT03238417|12563665|FG001|Overall|partial completion|68
7987986|NCT03238417|12563664|FG000|Baseline|Partial completion|17
7987987|NCT03238417|12563665|FG001|Baseline|Partial completion|48
7987988|NCT03238417|12563664|FG000|Baseline|non-response|372
7987989|NCT03238417|12563665|FG001|Baseline|non-response|669
7987990|NCT03238417|12563664|FG000|12-month|non-response|296
7987991|NCT03238417|12563665|FG001|12-month|non-response|669
7987992|NCT03238417|12563664|FG000|12-month|partial completion|23
7987993|NCT03238417|12563665|FG001|12-month|partial completion|37
7987994|NCT03238417|12563664|FG000|24-month|non-response|287
7987995|NCT03238417|12563665|FG001|24-month|non-response|594
7987996|NCT03238417|12563664|FG000|24-month|partial completion|8
7987997|NCT03238417|12563665|FG001|24-month|partial completion|31
7987998|NCT03238651|12563676|FG000|Overall Study|Other|0
7987999|NCT03238651|12563677|FG001|Overall Study|Other|0
7988000|NCT03238651|12563678|FG002|Overall Study|Other|0
7988001|NCT03238651|12563679|FG003|Overall Study|Other|0
7988002|NCT03238651|12563680|FG004|Overall Study|Other|1
7988003|NCT03238651|12563676|FG000|Overall Study|Progressive Disease|2
7988004|NCT03238651|12563677|FG001|Overall Study|Progressive Disease|2
7988005|NCT03238651|12563678|FG002|Overall Study|Progressive Disease|2
7988006|NCT03238651|12563679|FG003|Overall Study|Progressive Disease|2
7988007|NCT03238651|12563680|FG004|Overall Study|Progressive Disease|0
7988008|NCT03238651|12563676|FG000|Overall Study|Withdrawal by Subject|0
7988009|NCT03238651|12563677|FG001|Overall Study|Withdrawal by Subject|1
7988010|NCT03238651|12563678|FG002|Overall Study|Withdrawal by Subject|0
7988011|NCT03238651|12563679|FG003|Overall Study|Withdrawal by Subject|1
7988012|NCT03238651|12563680|FG004|Overall Study|Withdrawal by Subject|0
7988013|NCT03238651|12563676|FG000|Overall Study|Adverse Event|1
7988014|NCT03238651|12563677|FG001|Overall Study|Adverse Event|3
7988015|NCT03238651|12563678|FG002|Overall Study|Adverse Event|2
7988016|NCT03238651|12563679|FG003|Overall Study|Adverse Event|0
7988017|NCT03238651|12563680|FG004|Overall Study|Adverse Event|0
7988018|NCT03238781|12563696|FG000|Overall Study|Adverse Event|1
7988019|NCT03238781|12563697|FG001|Overall Study|Adverse Event|1
7988020|NCT03238781|12563698|FG002|Overall Study|Adverse Event|2
7988021|NCT03238781|12563696|FG000|Overall Study|Lost to Follow-up|2
7988022|NCT03238781|12563697|FG001|Overall Study|Lost to Follow-up|1
7988023|NCT03238781|12563698|FG002|Overall Study|Lost to Follow-up|2
7988024|NCT03238781|12563696|FG000|Overall Study|Withdrawal by Subject|23
7988025|NCT03238781|12563697|FG001|Overall Study|Withdrawal by Subject|14
7988026|NCT03238781|12563698|FG002|Overall Study|Withdrawal by Subject|16
7988027|NCT03238781|12563696|FG000|Overall Study|Decision by sponsor|0
7988028|NCT03238781|12563697|FG001|Overall Study|Decision by sponsor|1
7988029|NCT03238781|12563698|FG002|Overall Study|Decision by sponsor|0
7988030|NCT03238911|12563708|FG000|Overall Study|Withdrawal by Subject|1
7988031|NCT03238911|12563709|FG001|Overall Study|Withdrawal by Subject|2
7988032|NCT03238911|12563708|FG000|Overall Study|Lost to Follow-up|2
7988033|NCT03238911|12563709|FG001|Overall Study|Lost to Follow-up|1
7988034|NCT03238924|12563718|FG000|Overall Study|Withdrawal by Subject|2
7988035|NCT03238924|12563719|FG001|Overall Study|Withdrawal by Subject|2
7988036|NCT03238963|12563727|FG000|Overall Study|Prohibited medication given due to hospital stay|1
7988037|NCT03238963|12563728|FG001|Overall Study|Prohibited medication given due to hospital stay|0
7988038|NCT03238963|12563727|FG000|Overall Study|Withdrawal by Subject|1
7988039|NCT03238963|12563728|FG001|Overall Study|Withdrawal by Subject|1
7988040|NCT03238963|12563727|FG000|Overall Study|Lost to Follow-up|1
7988041|NCT03238963|12563728|FG001|Overall Study|Lost to Follow-up|0
7988042|NCT03238963|12563727|FG000|Overall Study|Protocol Violation|1
7988043|NCT03238963|12563728|FG001|Overall Study|Protocol Violation|1
7988044|NCT03238963|12563727|FG000|Overall Study|Adverse Event|1
7988045|NCT03238963|12563728|FG001|Overall Study|Adverse Event|0
7988046|NCT03239470|12563739|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1
7988047|NCT03239470|12563740|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0
7988048|NCT03239483|12563746|FG000|Overall Study|Lost to Follow-up|1
7988049|NCT03239483|12563747|FG001|Overall Study|Lost to Follow-up|0
7988050|NCT03239483|12563746|FG000|Overall Study|Withdrawal by Subject|1
7988051|NCT03239483|12563747|FG001|Overall Study|Withdrawal by Subject|0
7988052|NCT03239873|12563800|FG000|Overall Study|Lost to Follow-up|15
7988053|NCT03239873|12563801|FG001|Overall Study|Lost to Follow-up|16
7988054|NCT03239873|12563800|FG000|Overall Study|Physician Decision|1
7988055|NCT03239873|12563801|FG001|Overall Study|Physician Decision|0
7988056|NCT03239873|12563800|FG000|Overall Study|Withdrawal by Parent/Guardian|12
7988057|NCT03239873|12563801|FG001|Overall Study|Withdrawal by Parent/Guardian|11
7988058|NCT03239873|12563800|FG000|Overall Study|Withdrawal by Subject|2
7988059|NCT03239873|12563801|FG001|Overall Study|Withdrawal by Subject|0
7988060|NCT03239873|12563800|FG000|Overall Study|Contraindication to study medication|1
7988061|NCT03239873|12563801|FG001|Overall Study|Contraindication to study medication|0
7988062|NCT03239873|12563800|FG000|Overall Study|Protocol Violation|1
7988063|NCT03239873|12563801|FG001|Overall Study|Protocol Violation|0
7988064|NCT03240081|12563809|FG000|Overall Study|Withdrawal by Subject|0
7988065|NCT03240081|12563810|FG001|Overall Study|Withdrawal by Subject|2
7988066|NCT03240081|12563809|FG000|Overall Study|Lost to Follow-up|0
7988067|NCT03240081|12563810|FG001|Overall Study|Lost to Follow-up|1
7988068|NCT03240133|12563819|FG000|Overall Study|Withdrawal by Subject|0
7988069|NCT03240133|12563820|FG001|Overall Study|Withdrawal by Subject|1
7988070|NCT03240133|12563821|FG002|Overall Study|Withdrawal by Subject|0
7988071|NCT03240133|12563819|FG000|Overall Study|Adverse Event|1
7988072|NCT03240133|12563820|FG001|Overall Study|Adverse Event|1
7988073|NCT03240133|12563821|FG002|Overall Study|Adverse Event|0
7988074|NCT03240133|12563819|FG000|Overall Study|Rash|1
7988075|NCT03240133|12563820|FG001|Overall Study|Rash|0
7988076|NCT03240133|12563821|FG002|Overall Study|Rash|0
7988077|NCT03240133|12563819|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1
7988078|NCT03240133|12563820|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0
7988079|NCT03240133|12563821|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0
7988080|NCT03240133|12563819|FG000|Overall Study|Intercurrent illness.|0
7988081|NCT03240133|12563820|FG001|Overall Study|Intercurrent illness.|1
7988082|NCT03240133|12563821|FG002|Overall Study|Intercurrent illness.|0
7988083|NCT03240133|12563819|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0
7988084|NCT03240133|12563820|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0
7988085|NCT03240133|12563821|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1
7988086|NCT03240575|12563849|FG000|Overall Study|Adverse Event|0
7988087|NCT03240575|12563850|FG001|Overall Study|Adverse Event|2
7988088|NCT03240575|12563851|FG002|Overall Study|Adverse Event|0
7988089|NCT03240575|12563852|FG003|Overall Study|Adverse Event|1
7988090|NCT03240575|12563849|FG000|Overall Study|Withdrawal by Subject|2
7988091|NCT03240575|12563850|FG001|Overall Study|Withdrawal by Subject|11
7988092|NCT03240575|12563851|FG002|Overall Study|Withdrawal by Subject|0
7988093|NCT03240575|12563852|FG003|Overall Study|Withdrawal by Subject|1
7988094|NCT03240575|12563849|FG000|Overall Study|Other|0
7988095|NCT03240575|12563850|FG001|Overall Study|Other|1
7988096|NCT03240575|12563851|FG002|Overall Study|Other|0
7988097|NCT03240575|12563852|FG003|Overall Study|Other|0
7988098|NCT03241342|12563872|FG000|Overall Study|Adverse Event|5
7988099|NCT03241342|12563873|FG001|Overall Study|Adverse Event|8
7988100|NCT03241342|12563874|FG002|Overall Study|Adverse Event|4
7988101|NCT03241342|12563872|FG000|Overall Study|Lack of Efficacy|0
7988102|NCT03241342|12563873|FG001|Overall Study|Lack of Efficacy|0
7988103|NCT03241342|12563874|FG002|Overall Study|Lack of Efficacy|1
7988104|NCT03241342|12563872|FG000|Overall Study|noncompliance with study drug|2
7988105|NCT03241342|12563873|FG001|Overall Study|noncompliance with study drug|1
7988106|NCT03241342|12563874|FG002|Overall Study|noncompliance with study drug|1
7988107|NCT03241342|12563872|FG000|Overall Study|sponsor decision|0
7988108|NCT03241342|12563873|FG001|Overall Study|sponsor decision|1
7988109|NCT03241342|12563874|FG002|Overall Study|sponsor decision|2
7988110|NCT03241342|12563872|FG000|Overall Study|not reported|15
7988111|NCT03241342|12563873|FG001|Overall Study|not reported|21
7988112|NCT03241342|12563874|FG002|Overall Study|not reported|19
7988113|NCT03241368|12563882|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25
7988114|NCT03241368|12563882|FG000|Overall Study|Lost to Follow-up|1
7988115|NCT03241368|12563882|FG000|Overall Study|Physician Decision|6
7988116|NCT03241368|12563882|FG000|Overall Study|Withdrawal by Subject|6
7988117|NCT03241368|12563882|FG000|Overall Study|Protocol Violation|1
7988118|NCT03241927|12563914|FG000|Overall Study|study terminated|1
7988119|NCT03241927|12563915|FG001|Overall Study|study terminated|0
7988120|NCT03242018|12563924|FG000|Overall Study|Adverse Event|7
7988121|NCT03242018|12563925|FG001|Overall Study|Adverse Event|7
7988122|NCT03242018|12563926|FG002|Overall Study|Adverse Event|6
7988123|NCT03242018|12563924|FG000|Overall Study|Lost to Follow-up|2
7988124|NCT03242018|12563925|FG001|Overall Study|Lost to Follow-up|2
7988125|NCT03242018|12563926|FG002|Overall Study|Lost to Follow-up|2
7988126|NCT03242018|12563924|FG000|Overall Study|At the Participant's Own Request|5
7988127|NCT03242018|12563925|FG001|Overall Study|At the Participant's Own Request|1
7988128|NCT03242018|12563926|FG002|Overall Study|At the Participant's Own Request|4
7988129|NCT03242018|12563924|FG000|Overall Study|Reason Not Specified|3
7988130|NCT03242018|12563925|FG001|Overall Study|Reason Not Specified|4
7988131|NCT03242018|12563926|FG002|Overall Study|Reason Not Specified|1
7988132|NCT03242018|12563924|FG000|Overall Study|Study Terminated by Sponsor|1
7988133|NCT03242018|12563925|FG001|Overall Study|Study Terminated by Sponsor|0
7988134|NCT03242018|12563926|FG002|Overall Study|Study Terminated by Sponsor|1
7988135|NCT03242252|12563942|FG000|Overall Study|At the Participant's own Request|18
7988136|NCT03242252|12563943|FG001|Overall Study|At the Participant's own Request|10
7988137|NCT03242252|12563944|FG002|Overall Study|At the Participant's own Request|15
7988138|NCT03242252|12563942|FG000|Overall Study|Adverse Event|8
7988139|NCT03242252|12563943|FG001|Overall Study|Adverse Event|6
7988140|NCT03242252|12563944|FG002|Overall Study|Adverse Event|9
7988141|NCT03242252|12563942|FG000|Overall Study|Poor Compliance to Protocol|0
7988142|NCT03242252|12563943|FG001|Overall Study|Poor Compliance to Protocol|2
7988143|NCT03242252|12563944|FG002|Overall Study|Poor Compliance to Protocol|3
7988144|NCT03242252|12563942|FG000|Overall Study|Study Terminated by Sponsor|1
7988145|NCT03242252|12563943|FG001|Overall Study|Study Terminated by Sponsor|0
7988146|NCT03242252|12563944|FG002|Overall Study|Study Terminated by Sponsor|0
7988147|NCT03242252|12563942|FG000|Overall Study|Reason not Specified|4
7988148|NCT03242252|12563943|FG001|Overall Study|Reason not Specified|4
7988149|NCT03242252|12563944|FG002|Overall Study|Reason not Specified|1
7988150|NCT03242252|12563942|FG000|Overall Study|Lost to Follow-up|5
7988151|NCT03242252|12563943|FG001|Overall Study|Lost to Follow-up|1
7988152|NCT03242252|12563944|FG002|Overall Study|Lost to Follow-up|4
7988153|NCT03242434|12563964|FG000|Overall Study|Death|0
7988154|NCT03242434|12563965|FG001|Overall Study|Death|2
7988155|NCT03242759|12563978|FG000|Overall Study|Adverse Event|5
7988156|NCT03242759|12563979|FG001|Overall Study|Adverse Event|1
7988157|NCT03242759|12563978|FG000|Overall Study|Withdrawal by Subject|4
7988158|NCT03242759|12563979|FG001|Overall Study|Withdrawal by Subject|3
7988159|NCT03242759|12563978|FG000|Overall Study|Lost to Follow-up|3
7988160|NCT03242759|12563979|FG001|Overall Study|Lost to Follow-up|1
7988161|NCT03242759|12563978|FG000|Overall Study|Administrative problems|1
7988162|NCT03242759|12563979|FG001|Overall Study|Administrative problems|1
7988163|NCT03242759|12563978|FG000|Overall Study|Death|22
7988164|NCT03242759|12563979|FG001|Overall Study|Death|0
7988165|NCT03242759|12563978|FG000|Overall Study|Change visit schedule|0
7988166|NCT03242759|12563979|FG001|Overall Study|Change visit schedule|1
7988167|NCT03242863|12563985|FG000|Study Week 1|Withdrawal by Subject|0
7988168|NCT03242863|12563986|FG001|Study Week 1|Withdrawal by Subject|1
7988169|NCT03242863|12563987|FG002|Study Week 1|Withdrawal by Subject|0
7988170|NCT03242863|12563988|FG003|Study Week 1|Withdrawal by Subject|0
7988171|NCT03242863|12563989|FG004|Study Week 1|Withdrawal by Subject|3
7988172|NCT03242863|12563990|FG005|Study Week 1|Withdrawal by Subject|0
7988173|NCT03242928|12564000|FG000|Overall Study|Adverse Event|2
7988174|NCT03242928|12564001|FG001|Overall Study|Adverse Event|1
7988175|NCT03242928|12564000|FG000|Overall Study|Lost to Follow-up|2
7988176|NCT03242928|12564001|FG001|Overall Study|Lost to Follow-up|0
7988177|NCT03242928|12564000|FG000|Overall Study|Physician Decision|0
7988178|NCT03242928|12564001|FG001|Overall Study|Physician Decision|1
7988179|NCT03242928|12564000|FG000|Overall Study|Withdrawal by Subject|5
7988180|NCT03242928|12564001|FG001|Overall Study|Withdrawal by Subject|3
7988181|NCT03243084|12564031|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1
7988182|NCT03243084|12564032|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0
7988183|NCT03243305|12564039|FG000|Overall Study|Lost to Follow-up|250
7988184|NCT03243305|12564039|FG000|Overall Study|Withdrawal by Subject|170
7988185|NCT03243305|12564039|FG000|Overall Study|Pregnancy|104
7988186|NCT03243305|12564039|FG000|Overall Study|Non-Compliance with Study Drug|38
7988187|NCT03243305|12564039|FG000|Overall Study|Adverse Event|23
7988188|NCT03243305|12564039|FG000|Overall Study|No sexually active|26
7988189|NCT03243305|12564039|FG000|Overall Study|Physician Decision|22
7988190|NCT03243305|12564039|FG000|Overall Study|Protocol Violation|22
7988191|NCT03243305|12564039|FG000|Overall Study|Study method no longer primary method|12
7988192|NCT03243305|12564039|FG000|Overall Study|Study Terminated by Sponsor|1
7988193|NCT03243305|12564039|FG000|Overall Study|Early terminations|267
7988194|NCT03243630|12564043|FG000|Overall Study|Protocol Violation|1
7988195|NCT03243630|12564043|FG000|Overall Study|Physician Decision|1
7988196|NCT03244618|12564062|FG000|Overall Study|Lost to Follow-up|3
7988197|NCT03244618|12564063|FG001|Overall Study|Lost to Follow-up|4
7988198|NCT03244618|12564062|FG000|Overall Study|Protocol Violation|4
7988199|NCT03244618|12564063|FG001|Overall Study|Protocol Violation|3
7988200|NCT03244618|12564062|FG000|Overall Study|Withdrawal by Subject|0
7988201|NCT03244618|12564063|FG001|Overall Study|Withdrawal by Subject|2
7988202|NCT03244800|12564073|FG000|Overall Study|Adverse Event|0
7988203|NCT03244800|12564074|FG001|Overall Study|Adverse Event|1
7988204|NCT03244800|12564075|FG002|Overall Study|Adverse Event|0
7988205|NCT03244800|12564076|FG003|Overall Study|Adverse Event|1
7988206|NCT03244800|12564073|FG000|Overall Study|Withdrew treatment|0
7988207|NCT03244800|12564074|FG001|Overall Study|Withdrew treatment|0
7988208|NCT03244800|12564075|FG002|Overall Study|Withdrew treatment|0
7988209|NCT03244800|12564076|FG003|Overall Study|Withdrew treatment|1
7988210|NCT03244917|12564095|FG000|Overall Study|Lost to Follow-up|2
7988211|NCT03244917|12564096|FG001|Overall Study|Lost to Follow-up|2
7988212|NCT03245398|12564113|FG000|Overall Study|Travelled to another island|1
7988213|NCT03245398|12564114|FG001|Overall Study|Travelled to another island|0
7988214|NCT03245619|12564148|FG000|Part A (Up to Day 22)|Physician Decision|4
7988215|NCT03245619|12564149|FG001|Part A (Up to Day 22)|Physician Decision|6
7988216|NCT03245619|12564150|FG002|Part A (Up to Day 22)|Physician Decision|6
7988217|NCT03245619|12564151|FG003|Part A (Up to Day 22)|Physician Decision|0
7988218|NCT03245619|12564152|FG004|Part A (Up to Day 22)|Physician Decision|0
7988219|NCT03245619|12564153|FG005|Part A (Up to Day 22)|Physician Decision|0
7988220|NCT03245619|12564154|FG006|Part A (Up to Day 22)|Physician Decision|0
7988221|NCT03245619|12564155|FG007|Part A (Up to Day 22)|Physician Decision|0
7988222|NCT03245619|12564156|FG008|Part A (Up to Day 22)|Physician Decision|0
7988223|NCT03245619|12564157|FG009|Part A (Up to Day 22)|Physician Decision|0
7988224|NCT03245619|12564158|FG010|Part A (Up to Day 22)|Physician Decision|0
7988225|NCT03245619|12564159|FG011|Part A (Up to Day 22)|Physician Decision|0
7988226|NCT03245619|12564160|FG012|Part A (Up to Day 22)|Physician Decision|0
7988227|NCT03245619|12564161|FG013|Part A (Up to Day 22)|Physician Decision|0
7988228|NCT03245619|12564162|FG014|Part A (Up to Day 22)|Physician Decision|0
7988229|NCT03245619|12564163|FG015|Part A (Up to Day 22)|Physician Decision|0
7988230|NCT03245619|12564164|FG016|Part A (Up to Day 22)|Physician Decision|0
7988231|NCT03245723|12564225|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1
7988232|NCT03245723|12564226|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0
7988233|NCT03245723|12564225|FG000|Overall Study|Claustrophobia from wearing the mask|1
7988234|NCT03245723|12564226|FG001|Overall Study|Claustrophobia from wearing the mask|0
7988235|NCT03245723|12564225|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2
7988236|NCT03245723|12564226|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0
7988237|NCT03245723|12564225|FG000|Overall Study|Image acquisition/reconstruction failure|1
7988238|NCT03245723|12564226|FG001|Overall Study|Image acquisition/reconstruction failure|1
7988239|NCT03245736|12564232|FG000|Overall Study|Adverse Event|1
7988240|NCT03245736|12564232|FG000|Overall Study|Progressive Disease|4
7988241|NCT03246152|12564245|FG000|Overall Study|Lost to Follow-up|2
7988242|NCT03246152|12564245|FG000|Overall Study|Protocol Violation|1
7988243|NCT03246646|12564251|FG000|Overall Study|deemed ineligible and administratively withdrawn|1
7988244|NCT03246646|12564252|FG001|Overall Study|deemed ineligible and administratively withdrawn|0
7988245|NCT03246646|12564251|FG000|Overall Study|Withdrawal by Subject|3
7988246|NCT03246646|12564252|FG001|Overall Study|Withdrawal by Subject|0
7988247|NCT03246646|12564251|FG000|Overall Study|Lost to Follow-up|7
7988248|NCT03246646|12564252|FG001|Overall Study|Lost to Follow-up|0
7988249|NCT03246672|12564258|FG000|Overall Study|Lost to Follow-up|2
7988250|NCT03246724|12564266|FG000|Overall Study|Withdrawal by Subject|5
7988251|NCT03246724|12564267|FG001|Overall Study|Withdrawal by Subject|2
7988252|NCT03246724|12564268|FG002|Overall Study|Withdrawal by Subject|4
7988253|NCT03246724|12564269|FG003|Overall Study|Withdrawal by Subject|2
7988254|NCT03246724|12564266|FG000|Overall Study|Ineligible on day of surgery|7
7988255|NCT03246724|12564267|FG001|Overall Study|Ineligible on day of surgery|2
7988256|NCT03246724|12564268|FG002|Overall Study|Ineligible on day of surgery|0
7988257|NCT03246724|12564269|FG003|Overall Study|Ineligible on day of surgery|3
7988258|NCT03246724|12564266|FG000|Overall Study|Study completed before surgical date|2
7988259|NCT03246724|12564267|FG001|Overall Study|Study completed before surgical date|1
7988260|NCT03246724|12564268|FG002|Overall Study|Study completed before surgical date|8
7988261|NCT03246724|12564269|FG003|Overall Study|Study completed before surgical date|1
7988262|NCT03246724|12564266|FG000|Overall Study|Transferred to other arm|0
7988263|NCT03246724|12564267|FG001|Overall Study|Transferred to other arm|0
7988264|NCT03246724|12564268|FG002|Overall Study|Transferred to other arm|1
7988265|NCT03246724|12564269|FG003|Overall Study|Transferred to other arm|0
7988266|NCT03246724|12564266|FG000|Overall Study|Unable to obtain medication timely|0
7988267|NCT03246724|12564267|FG001|Overall Study|Unable to obtain medication timely|2
7988268|NCT03246724|12564268|FG002|Overall Study|Unable to obtain medication timely|2
7988269|NCT03246724|12564269|FG003|Overall Study|Unable to obtain medication timely|1
7988270|NCT03246724|12564266|FG000|Overall Study|Re-consented to participate|0
7988271|NCT03246724|12564267|FG001|Overall Study|Re-consented to participate|0
7988272|NCT03246724|12564268|FG002|Overall Study|Re-consented to participate|0
7988273|NCT03246724|12564269|FG003|Overall Study|Re-consented to participate|1
7988274|NCT03247517|12564293|FG000|Overall Study|Adverse Event|0
7988275|NCT03247517|12564294|FG001|Overall Study|Adverse Event|4
7988276|NCT03247517|12564295|FG002|Overall Study|Adverse Event|2
7988277|NCT03247517|12564293|FG000|Overall Study|Lost to Follow-up|2
7988278|NCT03247517|12564294|FG001|Overall Study|Lost to Follow-up|6
7988279|NCT03247517|12564295|FG002|Overall Study|Lost to Follow-up|4
7988280|NCT03247517|12564293|FG000|Overall Study|Consent withdrawn by caregiver|1
7988281|NCT03247517|12564294|FG001|Overall Study|Consent withdrawn by caregiver|4
7988282|NCT03247517|12564295|FG002|Overall Study|Consent withdrawn by caregiver|7
7988283|NCT03247517|12564293|FG000|Overall Study|Assent/consent withdrawn by subject|2
7988284|NCT03247517|12564294|FG001|Overall Study|Assent/consent withdrawn by subject|3
7988285|NCT03247517|12564295|FG002|Overall Study|Assent/consent withdrawn by subject|1
7988286|NCT03247517|12564293|FG000|Overall Study|Protocol Violation|0
7988287|NCT03247517|12564294|FG001|Overall Study|Protocol Violation|2
7988288|NCT03247517|12564295|FG002|Overall Study|Protocol Violation|0
7988289|NCT03247517|12564293|FG000|Overall Study|Multiple reasons|3
7988290|NCT03247517|12564294|FG001|Overall Study|Multiple reasons|1
7988291|NCT03247517|12564295|FG002|Overall Study|Multiple reasons|0
7988292|NCT03247530|12564306|FG000|Overall Study|Withdrawal by caregiver|19
7988293|NCT03247530|12564307|FG001|Overall Study|Withdrawal by caregiver|8
7988294|NCT03247530|12564308|FG002|Overall Study|Withdrawal by caregiver|10
7988295|NCT03247530|12564306|FG000|Overall Study|Lost to Follow-up|3
7988296|NCT03247530|12564307|FG001|Overall Study|Lost to Follow-up|9
7988297|NCT03247530|12564308|FG002|Overall Study|Lost to Follow-up|6
7988298|NCT03247530|12564306|FG000|Overall Study|Adverse Event|2
7988299|NCT03247530|12564307|FG001|Overall Study|Adverse Event|5
7988300|NCT03247530|12564308|FG002|Overall Study|Adverse Event|2
7988301|NCT03247530|12564306|FG000|Overall Study|Failure to follow procedure|1
7988302|NCT03247530|12564307|FG001|Overall Study|Failure to follow procedure|1
7988303|NCT03247530|12564308|FG002|Overall Study|Failure to follow procedure|1
7988304|NCT03247530|12564306|FG000|Overall Study|Withdrawal by Subject|1
7988305|NCT03247530|12564307|FG001|Overall Study|Withdrawal by Subject|1
7988306|NCT03247530|12564308|FG002|Overall Study|Withdrawal by Subject|0
7988307|NCT03247530|12564306|FG000|Overall Study|Study medication misuse|0
7988308|NCT03247530|12564307|FG001|Overall Study|Study medication misuse|1
7988309|NCT03247530|12564308|FG002|Overall Study|Study medication misuse|0
7988310|NCT03247530|12564306|FG000|Overall Study|Other, multiple categories|1
7988311|NCT03247530|12564307|FG001|Overall Study|Other, multiple categories|3
7988312|NCT03247530|12564308|FG002|Overall Study|Other, multiple categories|1
7988313|NCT03247543|12564322|FG000|Overall Study|Adverse Event|3
7988314|NCT03247543|12564323|FG001|Overall Study|Adverse Event|6
7988315|NCT03247543|12564324|FG002|Overall Study|Adverse Event|4
7988316|NCT03247543|12564322|FG000|Overall Study|Lost to Follow-up|10
7988317|NCT03247543|12564323|FG001|Overall Study|Lost to Follow-up|7
7988318|NCT03247543|12564324|FG002|Overall Study|Lost to Follow-up|8
7988319|NCT03247543|12564322|FG000|Overall Study|Consent withdrawn by caregiver|2
7988320|NCT03247543|12564323|FG001|Overall Study|Consent withdrawn by caregiver|2
7988321|NCT03247543|12564324|FG002|Overall Study|Consent withdrawn by caregiver|9
7988322|NCT03247543|12564322|FG000|Overall Study|Withdrawal by Subject|0
7988323|NCT03247543|12564323|FG001|Overall Study|Withdrawal by Subject|0
7988324|NCT03247543|12564324|FG002|Overall Study|Withdrawal by Subject|1
7988325|NCT03247543|12564322|FG000|Overall Study|Failure to Follow study procedures|1
7988326|NCT03247543|12564323|FG001|Overall Study|Failure to Follow study procedures|3
7988327|NCT03247543|12564324|FG002|Overall Study|Failure to Follow study procedures|1
7988328|NCT03247543|12564322|FG000|Overall Study|Lack of Efficacy|1
7988329|NCT03247543|12564323|FG001|Overall Study|Lack of Efficacy|0
7988330|NCT03247543|12564324|FG002|Overall Study|Lack of Efficacy|0
7988331|NCT03247543|12564322|FG000|Overall Study|Non-compliance with study visits|0
7988332|NCT03247543|12564323|FG001|Overall Study|Non-compliance with study visits|1
7988333|NCT03247543|12564324|FG002|Overall Study|Non-compliance with study visits|0
7988334|NCT03247556|12564337|FG000|Overall Study|Adverse Event|1
7988335|NCT03247556|12564338|FG001|Overall Study|Adverse Event|4
7988336|NCT03247556|12564339|FG002|Overall Study|Adverse Event|5
7988337|NCT03247556|12564337|FG000|Overall Study|Lost to Follow-up|5
7988338|NCT03247556|12564338|FG001|Overall Study|Lost to Follow-up|5
7988339|NCT03247556|12564339|FG002|Overall Study|Lost to Follow-up|4
7988340|NCT03247556|12564337|FG000|Overall Study|Consent Withdrawn by Caregiver|4
7988341|NCT03247556|12564338|FG001|Overall Study|Consent Withdrawn by Caregiver|1
7988342|NCT03247556|12564339|FG002|Overall Study|Consent Withdrawn by Caregiver|5
7988343|NCT03247556|12564337|FG000|Overall Study|Assent/consent Withdrawn by Subject|0
7988344|NCT03247556|12564338|FG001|Overall Study|Assent/consent Withdrawn by Subject|2
7988345|NCT03247556|12564339|FG002|Overall Study|Assent/consent Withdrawn by Subject|2
7988346|NCT03247556|12564337|FG000|Overall Study|Protocol Violation|2
7988347|NCT03247556|12564338|FG001|Overall Study|Protocol Violation|0
7988348|NCT03247556|12564339|FG002|Overall Study|Protocol Violation|1
7988349|NCT03247556|12564337|FG000|Overall Study|Subject did not meet inclusion criteria|0
7988350|NCT03247556|12564338|FG001|Overall Study|Subject did not meet inclusion criteria|0
7988351|NCT03247556|12564339|FG002|Overall Study|Subject did not meet inclusion criteria|1
7988352|NCT03247673|12564350|FG000|Overall Study|Withdrawal by Subject|1
7988353|NCT03247673|12564351|FG001|Overall Study|Withdrawal by Subject|0
7988354|NCT03247673|12564352|FG002|Overall Study|Withdrawal by Subject|3
7988355|NCT03247673|12564350|FG000|Overall Study|Lost to Follow-up|0
7988356|NCT03247673|12564351|FG001|Overall Study|Lost to Follow-up|0
7988357|NCT03247673|12564352|FG002|Overall Study|Lost to Follow-up|1
7988358|NCT03247686|12564362|FG000|Overall Study|Withdrawal by Subject|1
7988359|NCT03247686|12564363|FG001|Overall Study|Withdrawal by Subject|2
7988360|NCT03247816|12564387|FG000|Overall Study|Adverse Event|12
7988361|NCT03247816|12564387|FG000|Overall Study|Physician Decision|3
7988362|NCT03247816|12564387|FG000|Overall Study|Lack of Efficacy|1
7988363|NCT03247816|12564387|FG000|Overall Study|Lost to Follow-up|10
7988364|NCT03247816|12564387|FG000|Overall Study|Missing Feraccru stop date|3
7988365|NCT03248037|12564404|FG000|Overall Study|Withdrawal by Subject|6
7988366|NCT03248037|12564405|FG001|Overall Study|Withdrawal by Subject|9
7988367|NCT03248037|12564404|FG000|Overall Study|Adverse Event|15
7988368|NCT03248037|12564405|FG001|Overall Study|Adverse Event|0
7988369|NCT03248492|12564425|FG000|Overall Study|Ongoing|23
7988370|NCT03248492|12564426|FG001|Overall Study|Ongoing|26
7988371|NCT03248492|12564427|FG002|Overall Study|Ongoing|3
7988372|NCT03248492|12564428|FG003|Overall Study|Ongoing|85
7988373|NCT03248492|12564429|FG004|Overall Study|Ongoing|2
7988374|NCT03248492|12564425|FG000|Overall Study|Progressive disease per RECIST v1.1|16
7988375|NCT03248492|12564426|FG001|Overall Study|Progressive disease per RECIST v1.1|12
7988376|NCT03248492|12564427|FG002|Overall Study|Progressive disease per RECIST v1.1|9
7988377|NCT03248492|12564428|FG003|Overall Study|Progressive disease per RECIST v1.1|22
7988378|NCT03248492|12564429|FG004|Overall Study|Progressive disease per RECIST v1.1|0
7988379|NCT03248492|12564425|FG000|Overall Study|Adverse Event|6
7988380|NCT03248492|12564426|FG001|Overall Study|Adverse Event|6
7988381|NCT03248492|12564427|FG002|Overall Study|Adverse Event|8
7988382|NCT03248492|12564428|FG003|Overall Study|Adverse Event|8
7988383|NCT03248492|12564429|FG004|Overall Study|Adverse Event|1
7988384|NCT03248492|12564425|FG000|Overall Study|Withdrawal by Subject|3
7988385|NCT03248492|12564426|FG001|Overall Study|Withdrawal by Subject|3
7988386|NCT03248492|12564427|FG002|Overall Study|Withdrawal by Subject|0
7988387|NCT03248492|12564428|FG003|Overall Study|Withdrawal by Subject|3
7988388|NCT03248492|12564429|FG004|Overall Study|Withdrawal by Subject|1
7988389|NCT03248492|12564425|FG000|Overall Study|Physician Decision|1
7988390|NCT03248492|12564426|FG001|Overall Study|Physician Decision|0
7988391|NCT03248492|12564427|FG002|Overall Study|Physician Decision|1
7988392|NCT03248492|12564428|FG003|Overall Study|Physician Decision|2
7988393|NCT03248492|12564429|FG004|Overall Study|Physician Decision|0
7988394|NCT03248492|12564425|FG000|Overall Study|Death|1
7988395|NCT03248492|12564426|FG001|Overall Study|Death|0
7988396|NCT03248492|12564427|FG002|Overall Study|Death|0
7988397|NCT03248492|12564428|FG003|Overall Study|Death|6
7988398|NCT03248492|12564429|FG004|Overall Study|Death|0
7988399|NCT03248492|12564425|FG000|Overall Study|Other|0
7988400|NCT03248492|12564426|FG001|Overall Study|Other|1
7988401|NCT03248492|12564427|FG002|Overall Study|Other|0
7988402|NCT03248492|12564428|FG003|Overall Study|Other|4
7988403|NCT03248492|12564429|FG004|Overall Study|Other|0
7988404|NCT03248882|12564454|FG000|Overall Study|Adverse Event|3
7988405|NCT03248882|12564455|FG001|Overall Study|Adverse Event|3
7988406|NCT03248882|12564456|FG002|Overall Study|Adverse Event|2
7988407|NCT03248882|12564457|FG003|Overall Study|Adverse Event|6
7988408|NCT03248882|12564458|FG004|Overall Study|Adverse Event|9
7988409|NCT03248882|12564454|FG000|Overall Study|Lost to Follow-up|0
7988410|NCT03248882|12564455|FG001|Overall Study|Lost to Follow-up|0
7988411|NCT03248882|12564456|FG002|Overall Study|Lost to Follow-up|0
7988412|NCT03248882|12564457|FG003|Overall Study|Lost to Follow-up|0
7988413|NCT03248882|12564458|FG004|Overall Study|Lost to Follow-up|1
7988414|NCT03248882|12564454|FG000|Overall Study|Protocol Violation|2
7988415|NCT03248882|12564455|FG001|Overall Study|Protocol Violation|0
7988416|NCT03248882|12564456|FG002|Overall Study|Protocol Violation|2
7988417|NCT03248882|12564457|FG003|Overall Study|Protocol Violation|0
7988418|NCT03248882|12564458|FG004|Overall Study|Protocol Violation|1
7988419|NCT03248882|12564454|FG000|Overall Study|Withdrawal by Subject|2
7988420|NCT03248882|12564455|FG001|Overall Study|Withdrawal by Subject|2
7988421|NCT03248882|12564456|FG002|Overall Study|Withdrawal by Subject|3
7988422|NCT03248882|12564457|FG003|Overall Study|Withdrawal by Subject|4
7988423|NCT03248882|12564458|FG004|Overall Study|Withdrawal by Subject|2
7988424|NCT03249454|12564517|FG000|Overall Study|Withdrawal by Subject|0
7988425|NCT03249454|12564518|FG001|Overall Study|Withdrawal by Subject|0
7988426|NCT03249454|12564519|FG002|Overall Study|Withdrawal by Subject|0
7988427|NCT03249454|12564520|FG003|Overall Study|Withdrawal by Subject|0
7988428|NCT03249454|12564521|FG004|Overall Study|Withdrawal by Subject|0
7988429|NCT03249454|12564522|FG005|Overall Study|Withdrawal by Subject|0
7988430|NCT03249454|12564523|FG006|Overall Study|Withdrawal by Subject|0
7988431|NCT03249454|12564524|FG007|Overall Study|Withdrawal by Subject|0
7988432|NCT03249454|12564525|FG008|Overall Study|Withdrawal by Subject|0
7988433|NCT03249454|12564526|FG009|Overall Study|Withdrawal by Subject|1
7988434|NCT03249454|12564527|FG010|Overall Study|Withdrawal by Subject|1
7988435|NCT03249909|12564553|FG000|Overall Study|Withdrawal by Subject|3
7988436|NCT03249909|12564554|FG001|Overall Study|Withdrawal by Subject|0
7988437|NCT03249909|12564555|FG002|Overall Study|Withdrawal by Subject|0
7988438|NCT03249909|12564553|FG000|Overall Study|Adverse Event|3
7988439|NCT03249909|12564554|FG001|Overall Study|Adverse Event|0
7988440|NCT03249909|12564555|FG002|Overall Study|Adverse Event|0
7988441|NCT03249909|12564553|FG000|Overall Study|Lost to Follow-up|0
7988442|NCT03249909|12564554|FG001|Overall Study|Lost to Follow-up|1
7988443|NCT03249909|12564555|FG002|Overall Study|Lost to Follow-up|0
7988444|NCT03249935|12564566|FG000|Overall Study|Discharged from facility early|36
7988445|NCT03249935|12564566|FG000|Overall Study|Negative for chlamydia at enrollment|4
7988446|NCT03249935|12564566|FG000|Overall Study|Protocol Violation|5
7988447|NCT03250182|12564572|FG000|Overall Study|Withdrawal by Subject|1
7988448|NCT03251482|12564606|FG000|Overall Study|Withdrawal by Subject|0
7988449|NCT03251482|12564607|FG001|Overall Study|Withdrawal by Subject|1
7988450|NCT03251482|12564608|FG002|Overall Study|Withdrawal by Subject|0
7988451|NCT03251482|12564609|FG003|Overall Study|Withdrawal by Subject|0
7988452|NCT03251482|12564610|FG004|Overall Study|Withdrawal by Subject|0
7988453|NCT03251963|12564628|FG000|Overall Study|inappropriate Xa level timing|6
7988454|NCT03251963|12564629|FG001|Overall Study|inappropriate Xa level timing|3
7988455|NCT03251963|12564628|FG000|Overall Study|no peak Xa level drawn|2
7988456|NCT03251963|12564629|FG001|Overall Study|no peak Xa level drawn|0
7988457|NCT03251963|12564628|FG000|Overall Study|bled prior to Xa level|1
7988458|NCT03251963|12564629|FG001|Overall Study|bled prior to Xa level|2
7988459|NCT03252015|12564639|FG000|Overall Study|Withdrawal by Subject|0
7988460|NCT03252015|12564640|FG001|Overall Study|Withdrawal by Subject|1
7988461|NCT03252015|12564641|FG002|Overall Study|Withdrawal by Subject|1
7988462|NCT03252015|12564642|FG003|Overall Study|Withdrawal by Subject|0
7988463|NCT03252015|12564639|FG000|Overall Study|Adverse Event|1
7988464|NCT03252015|12564640|FG001|Overall Study|Adverse Event|0
7988465|NCT03252015|12564641|FG002|Overall Study|Adverse Event|0
7988466|NCT03252015|12564642|FG003|Overall Study|Adverse Event|1
7988467|NCT03252145|12564668|FG000|Overall Study|Withdrawal by Subject|1
7988468|NCT03252145|12564669|FG001|Overall Study|Withdrawal by Subject|0
7988469|NCT03252145|12564668|FG000|Overall Study|Complicating Disease|1
7988470|NCT03252145|12564669|FG001|Overall Study|Complicating Disease|2
7988471|NCT03253094|12564706|FG000|Overall Study|Adverse Event|2
7988472|NCT03253094|12564707|FG001|Overall Study|Adverse Event|0
7988473|NCT03253094|12564708|FG002|Overall Study|Adverse Event|0
7988474|NCT03253094|12564709|FG003|Overall Study|Adverse Event|0
7988475|NCT03253094|12564710|FG004|Overall Study|Adverse Event|0
7988476|NCT03253094|12564711|FG005|Overall Study|Adverse Event|0
7988477|NCT03253094|12564706|FG000|Overall Study|Lack of Efficacy|0
7988478|NCT03253094|12564707|FG001|Overall Study|Lack of Efficacy|0
7988479|NCT03253094|12564708|FG002|Overall Study|Lack of Efficacy|2
7988480|NCT03253094|12564709|FG003|Overall Study|Lack of Efficacy|1
7988481|NCT03253094|12564710|FG004|Overall Study|Lack of Efficacy|2
7988482|NCT03253094|12564711|FG005|Overall Study|Lack of Efficacy|1
7988483|NCT03253094|12564706|FG000|Overall Study|Lost to Follow-up|0
7988484|NCT03253094|12564707|FG001|Overall Study|Lost to Follow-up|0
7988485|NCT03253094|12564708|FG002|Overall Study|Lost to Follow-up|1
7988486|NCT03253094|12564709|FG003|Overall Study|Lost to Follow-up|1
7988487|NCT03253094|12564710|FG004|Overall Study|Lost to Follow-up|0
7988488|NCT03253094|12564711|FG005|Overall Study|Lost to Follow-up|1
7988489|NCT03253094|12564706|FG000|Overall Study|Physician Decision|1
7988490|NCT03253094|12564707|FG001|Overall Study|Physician Decision|0
7988491|NCT03253094|12564708|FG002|Overall Study|Physician Decision|0
7988492|NCT03253094|12564709|FG003|Overall Study|Physician Decision|1
7988493|NCT03253094|12564710|FG004|Overall Study|Physician Decision|0
7988494|NCT03253094|12564711|FG005|Overall Study|Physician Decision|2
7988495|NCT03253094|12564706|FG000|Overall Study|Withdrawal by Subject|1
7988496|NCT03253094|12564707|FG001|Overall Study|Withdrawal by Subject|2
7988497|NCT03253094|12564708|FG002|Overall Study|Withdrawal by Subject|1
7988498|NCT03253094|12564709|FG003|Overall Study|Withdrawal by Subject|0
7988499|NCT03253094|12564710|FG004|Overall Study|Withdrawal by Subject|3
7988500|NCT03253094|12564711|FG005|Overall Study|Withdrawal by Subject|0
7988501|NCT03253094|12564706|FG000|Overall Study|Other|0
7988502|NCT03253094|12564707|FG001|Overall Study|Other|1
7988503|NCT03253094|12564708|FG002|Overall Study|Other|2
7988504|NCT03253094|12564709|FG003|Overall Study|Other|1
7988505|NCT03253094|12564710|FG004|Overall Study|Other|0
7988506|NCT03253094|12564711|FG005|Overall Study|Other|0
7988507|NCT03254108|12564730|FG000|Overall Study|Adverse Event|0
7988508|NCT03254108|12564731|FG001|Overall Study|Adverse Event|2
7988509|NCT03254108|12564732|FG002|Overall Study|Adverse Event|0
7988510|NCT03254108|12564733|FG003|Overall Study|Adverse Event|1
7988511|NCT03254108|12564734|FG004|Overall Study|Adverse Event|1
7988512|NCT03254108|12564730|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7988513|NCT03254108|12564731|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7988514|NCT03254108|12564732|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7988515|NCT03254108|12564733|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7988516|NCT03254108|12564734|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2
7988517|NCT03254134|12564748|FG000|Overall Study|Not eligible patients|599
7988518|NCT03254134|12564749|FG001|Overall Study|Not eligible patients|3630
7988519|NCT03254459|12564761|FG000|Overall Study|Adverse Event|7
7988520|NCT03254459|12564762|FG001|Overall Study|Adverse Event|20
7988521|NCT03254459|12564761|FG000|Overall Study|Withdrawal by Subject Consent|3
7988522|NCT03254459|12564762|FG001|Overall Study|Withdrawal by Subject Consent|1
7988523|NCT03254459|12564761|FG000|Overall Study|Lost to Follow-up|0
7988524|NCT03254459|12564762|FG001|Overall Study|Lost to Follow-up|1
7988525|NCT03254459|12564761|FG000|Overall Study|Miscellaneous|0
7988526|NCT03254459|12564762|FG001|Overall Study|Miscellaneous|1
7988527|NCT03254602|12564768|FG000|Overall Study|Lost to Follow-up|4
7988528|NCT03255291|12564782|FG000|Overall Study|Determined to be ineligible|10
7988529|NCT03255291|12564783|FG001|Overall Study|Determined to be ineligible|12
7988530|NCT03255291|12564784|FG002|Overall Study|Determined to be ineligible|6
7988531|NCT03255291|12564785|FG003|Overall Study|Determined to be ineligible|6
7988532|NCT03255291|12564786|FG004|Overall Study|Determined to be ineligible|5
7988533|NCT03255291|12564787|FG005|Overall Study|Determined to be ineligible|10
7988534|NCT03255291|12564782|FG000|Overall Study|Baseline data collection issues|3
7988535|NCT03255291|12564783|FG001|Overall Study|Baseline data collection issues|0
7988536|NCT03255291|12564784|FG002|Overall Study|Baseline data collection issues|0
7988537|NCT03255291|12564785|FG003|Overall Study|Baseline data collection issues|0
7988538|NCT03255291|12564786|FG004|Overall Study|Baseline data collection issues|2
7988539|NCT03255291|12564787|FG005|Overall Study|Baseline data collection issues|0
7988540|NCT03255382|12564807|FG000|Overall Study|Adverse Event|3
7988541|NCT03255382|12564808|FG001|Overall Study|Adverse Event|0
7988542|NCT03255382|12564807|FG000|Overall Study|Lost to Follow-up|2
7988543|NCT03255382|12564808|FG001|Overall Study|Lost to Follow-up|0
7988544|NCT03255382|12564807|FG000|Overall Study|Withdrawal by Subject|2
7988545|NCT03255382|12564808|FG001|Overall Study|Withdrawal by Subject|0
7988546|NCT03255382|12564807|FG000|Overall Study|Other|6
7988547|NCT03255382|12564808|FG001|Overall Study|Other|0
7988548|NCT03255655|12564817|FG000|Overall Study|Lost to Follow-up|7
7988549|NCT03255655|12564818|FG001|Overall Study|Lost to Follow-up|4
7988550|NCT03255733|12564824|FG000|Overall Study|Lost to Follow-up|4
7988551|NCT03255824|12564830|FG000|Overall Study|Under-sedation|2
7988552|NCT03255824|12564831|FG001|Overall Study|Under-sedation|1
7988553|NCT03255941|12564845|FG000|Overall Study|Not eligible or refused injection|37
7988554|NCT03255941|12564846|FG001|Overall Study|Not eligible or refused injection|44
7988555|NCT03255941|12564847|FG002|Overall Study|Not eligible or refused injection|5
7988556|NCT03255941|12564848|FG003|Overall Study|Not eligible or refused injection|6
7988557|NCT03255941|12564845|FG000|Overall Study|Did not complete exit interview|1
7988558|NCT03255941|12564846|FG001|Overall Study|Did not complete exit interview|2
7988559|NCT03255941|12564847|FG002|Overall Study|Did not complete exit interview|0
7988560|NCT03255941|12564848|FG003|Overall Study|Did not complete exit interview|0
7988561|NCT03255980|12564874|FG000|Overall Study|Grade =>3 Skin Toxicity|1
7988562|NCT03255980|12564875|FG001|Overall Study|Grade =>3 Skin Toxicity|4
7988563|NCT03255980|12564876|FG002|Overall Study|Grade =>3 Skin Toxicity|6
7988564|NCT03255980|12564877|FG003|Overall Study|Grade =>3 Skin Toxicity|5
7988565|NCT03255980|12564874|FG000|Overall Study|Adverse Event|1
7988566|NCT03255980|12564875|FG001|Overall Study|Adverse Event|1
7988567|NCT03255980|12564876|FG002|Overall Study|Adverse Event|0
7988568|NCT03255980|12564877|FG003|Overall Study|Adverse Event|1
7988569|NCT03255980|12564874|FG000|Overall Study|Lack of compliance to study or assessmen|0
7988570|NCT03255980|12564875|FG001|Overall Study|Lack of compliance to study or assessmen|1
7988571|NCT03255980|12564876|FG002|Overall Study|Lack of compliance to study or assessmen|0
7988572|NCT03255980|12564877|FG003|Overall Study|Lack of compliance to study or assessmen|0
7988573|NCT03255980|12564874|FG000|Overall Study|Lost to Follow-up|1
7988574|NCT03255980|12564875|FG001|Overall Study|Lost to Follow-up|1
7988575|NCT03255980|12564876|FG002|Overall Study|Lost to Follow-up|0
7988576|NCT03255980|12564877|FG003|Overall Study|Lost to Follow-up|3
7988577|NCT03255980|12564874|FG000|Overall Study|Withdrawal by Subject|0
7988578|NCT03255980|12564875|FG001|Overall Study|Withdrawal by Subject|1
7988579|NCT03255980|12564876|FG002|Overall Study|Withdrawal by Subject|0
7988580|NCT03255980|12564877|FG003|Overall Study|Withdrawal by Subject|3
7988581|NCT03256526|12564920|FG000|Overall Study|Adverse Event|1
7988582|NCT03256526|12564921|FG001|Overall Study|Adverse Event|0
7988583|NCT03256526|12564922|FG002|Overall Study|Adverse Event|1
7988584|NCT03256526|12564920|FG000|Overall Study|Lost to Follow-up|1
7988585|NCT03256526|12564921|FG001|Overall Study|Lost to Follow-up|0
7988586|NCT03256526|12564922|FG002|Overall Study|Lost to Follow-up|2
7988587|NCT03256552|12564930|FG000|Overall Study|Protocol Violation|1
7988588|NCT03256552|12564930|FG000|Overall Study|Physician Decision|1
7988589|NCT03256552|12564930|FG000|Overall Study|Adverse Event|1
7988590|NCT03256552|12564930|FG000|Overall Study|Withdrawal by Subject|2
7988591|NCT03256578|12564942|FG000|Overall Study|Excluded Post Randomization|66
7988592|NCT03256578|12564943|FG001|Overall Study|Excluded Post Randomization|56
7988593|NCT03256695|12564949|FG000|Overall Study|Adverse Event|8
7988594|NCT03256695|12564949|FG000|Overall Study|Death|2
7988595|NCT03256695|12564949|FG000|Overall Study|Withdrawal by Subject|14
7988596|NCT03256695|12564949|FG000|Overall Study|Non-compliance with study drug|1
7988597|NCT03256695|12564949|FG000|Overall Study|Lost to Follow-up|3
7988598|NCT03256695|12564949|FG000|Overall Study|Lack of Efficacy|3
7988599|NCT03256695|12564949|FG000|Overall Study|Protocol Violation|5
7988600|NCT03256695|12564949|FG000|Overall Study|Other than specified|3
7988601|NCT03256851|12564959|FG000|Overall Study|Withdrawal by Subject|1
7988602|NCT03256851|12564960|FG001|Overall Study|Withdrawal by Subject|0
7988603|NCT03257358|12564986|FG000|Overall Study|Adverse Event|25
7988604|NCT03257358|12564987|FG001|Overall Study|Adverse Event|12
7988605|NCT03257358|12564986|FG000|Overall Study|Lack of Efficacy|1
7988606|NCT03257358|12564987|FG001|Overall Study|Lack of Efficacy|1
7988607|NCT03257358|12564986|FG000|Overall Study|Lost to Follow-up|12
7988608|NCT03257358|12564987|FG001|Overall Study|Lost to Follow-up|4
7988609|NCT03257358|12564986|FG000|Overall Study|Non-compliance with fingolimod treatment|4
7988610|NCT03257358|12564987|FG001|Overall Study|Non-compliance with fingolimod treatment|2
7988611|NCT03257358|12564986|FG000|Overall Study|Physician Decision|2
7988612|NCT03257358|12564987|FG001|Overall Study|Physician Decision|2
7988613|NCT03257358|12564986|FG000|Overall Study|Protocol Violation|5
7988614|NCT03257358|12564987|FG001|Overall Study|Protocol Violation|3
7988615|NCT03257358|12564986|FG000|Overall Study|Technical problems|4
7988616|NCT03257358|12564987|FG001|Overall Study|Technical problems|1
7988617|NCT03257358|12564986|FG000|Overall Study|Withdrawal by Subject|8
7988618|NCT03257358|12564987|FG001|Overall Study|Withdrawal by Subject|3
7988619|NCT03257358|12564986|FG000|Overall Study|Withdrawal of informed consent|9
7988620|NCT03257358|12564987|FG001|Overall Study|Withdrawal of informed consent|5
7988621|NCT03257358|12564986|FG000|Overall Study|New therapy for study indication|1
7988622|NCT03257358|12564987|FG001|Overall Study|New therapy for study indication|0
7988623|NCT03257358|12564986|FG000|Overall Study|No longer requires treatment|0
7988624|NCT03257358|12564987|FG001|Overall Study|No longer requires treatment|1
7988625|NCT03257371|12564993|FG000|Overall Study|Lost to Follow-up|1
7988626|NCT03257410|12564999|FG000|Overall Study|Adverse Event|2
7988627|NCT03257410|12565000|FG001|Overall Study|Adverse Event|3
7988628|NCT03257410|12564999|FG000|Overall Study|Protocol Violation|1
7988629|NCT03257410|12565000|FG001|Overall Study|Protocol Violation|2
7988630|NCT03257410|12564999|FG000|Overall Study|Lost to Follow-up|1
7988631|NCT03257410|12565000|FG001|Overall Study|Lost to Follow-up|0
7988632|NCT03257410|12564999|FG000|Overall Study|Withdrawal by Subject|1
7988633|NCT03257410|12565000|FG001|Overall Study|Withdrawal by Subject|2
7988634|NCT03257410|12564999|FG000|Overall Study|Physician Decision|1
7988635|NCT03257410|12565000|FG001|Overall Study|Physician Decision|1
7988636|NCT03257410|12564999|FG000|Overall Study|Renal transplantation|2
7988637|NCT03257410|12565000|FG001|Overall Study|Renal transplantation|0
7988638|NCT03257410|12564999|FG000|Overall Study|Switch to peritoneal dialysis|1
7988639|NCT03257410|12565000|FG001|Overall Study|Switch to peritoneal dialysis|0
7988640|NCT03257410|12564999|FG000|Overall Study|Death|3
7988641|NCT03257410|12565000|FG001|Overall Study|Death|2
7988642|NCT03257410|12564999|FG000|Overall Study|Change to another dialysis center|2
7988643|NCT03257410|12565000|FG001|Overall Study|Change to another dialysis center|2
7988644|NCT03257410|12564999|FG000|Overall Study|Missing 3 consecutive study treatments|5
7988645|NCT03257410|12565000|FG001|Overall Study|Missing 3 consecutive study treatments|6
7988646|NCT03257410|12564999|FG000|Overall Study|Miscellaneous|2
7988647|NCT03257410|12565000|FG001|Overall Study|Miscellaneous|2
7988648|NCT03257410|12564999|FG000|Overall Study|Other|0
7988649|NCT03257410|12565000|FG001|Overall Study|Other|1
7988650|NCT03257657|12565008|FG000|Overall Study|Lost to Follow-up|0
7988651|NCT03257657|12565009|FG001|Overall Study|Lost to Follow-up|3
7988652|NCT03257657|12565008|FG000|Overall Study|Withdrawn|0
7988653|NCT03257657|12565009|FG001|Overall Study|Withdrawn|1
7988654|NCT03257657|12565008|FG000|Overall Study|Noted not eligible right after enrolled|0
7988655|NCT03257657|12565009|FG001|Overall Study|Noted not eligible right after enrolled|1
7988656|NCT03257813|12565018|FG000|Overall Study|Protocol Violation|6
7988657|NCT03257813|12565019|FG001|Overall Study|Protocol Violation|3
7988658|NCT03257865|12565030|FG000|Overall Study|Adverse Event|4
7811451|NCT01182844|12275219|FG000|Overall Study|Withdrawal by Subject|0
7988659|NCT03257865|12565031|FG001|Overall Study|Adverse Event|8
7988660|NCT03257865|12565030|FG000|Overall Study|Lack of Efficacy|1
7988661|NCT03257865|12565031|FG001|Overall Study|Lack of Efficacy|2
7988662|NCT03257865|12565030|FG000|Overall Study|Non-compliance with Study Drug|0
7988663|NCT03257865|12565031|FG001|Overall Study|Non-compliance with Study Drug|2
7988664|NCT03257865|12565030|FG000|Overall Study|Withdrawal by Subject|23
7988665|NCT03257865|12565031|FG001|Overall Study|Withdrawal by Subject|17
7988666|NCT03257865|12565030|FG000|Overall Study|Physician Decision|3
7988667|NCT03257865|12565031|FG001|Overall Study|Physician Decision|1
7988668|NCT03257865|12565030|FG000|Overall Study|Other|0
7988669|NCT03257865|12565031|FG001|Overall Study|Other|1
7988670|NCT03257865|12565030|FG000|Overall Study|Lost to Follow-up|4
7718172|NCT00525824|12142000|FG003|Overall Study|Adverse Event|7
7718173|NCT00525824|12141997|FG000|Overall Study|Withdrawal by Subject|5
7718174|NCT00525824|12141998|FG001|Overall Study|Withdrawal by Subject|9
7718175|NCT00525824|12141999|FG002|Overall Study|Withdrawal by Subject|3
7718176|NCT00525824|12142000|FG003|Overall Study|Withdrawal by Subject|4
7718177|NCT00525824|12141997|FG000|Overall Study|Lost to Follow-up|4
7718178|NCT00525824|12141998|FG001|Overall Study|Lost to Follow-up|2
7718179|NCT00525824|12141999|FG002|Overall Study|Lost to Follow-up|4
7718180|NCT00525824|12142000|FG003|Overall Study|Lost to Follow-up|0
7718181|NCT00525824|12141997|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1
7988671|NCT03257865|12565031|FG001|Overall Study|Lost to Follow-up|4
7988672|NCT03257995|12565037|FG000|Overall Study|Adverse Event|0
7988673|NCT03257995|12565038|FG001|Overall Study|Adverse Event|1
7988674|NCT03257995|12565039|FG002|Overall Study|Adverse Event|0
7988675|NCT03257995|12565040|FG003|Overall Study|Adverse Event|0
7718182|NCT00525824|12141998|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2
7718183|NCT00525824|12141999|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1
7718184|NCT00525824|12142000|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2
7718185|NCT00525824|12141997|FG000|Overall Study|Severe non-compliance|0
7718186|NCT00525824|12141998|FG001|Overall Study|Severe non-compliance|1
7718187|NCT00525824|12141999|FG002|Overall Study|Severe non-compliance|1
7718188|NCT00525824|12142000|FG003|Overall Study|Severe non-compliance|1
7718189|NCT00525824|12141997|FG000|Overall Study|Safety reasons|1
7718190|NCT00525824|12141998|FG001|Overall Study|Safety reasons|0
7718191|NCT00525824|12141999|FG002|Overall Study|Safety reasons|1
7718192|NCT00525824|12142000|FG003|Overall Study|Safety reasons|0
7718193|NCT00525824|12141997|FG000|Overall Study|Other|1
7718194|NCT00525824|12141998|FG001|Overall Study|Other|3
7718195|NCT00525824|12141999|FG002|Overall Study|Other|3
7718196|NCT00525824|12142000|FG003|Overall Study|Other|1
7767825|NCT00856206|12210596|FG001|Overall Study|Other than specified above|10
7988676|NCT03257995|12565041|FG004|Overall Study|Adverse Event|0
7988677|NCT03257995|12565042|FG005|Overall Study|Adverse Event|0
7988678|NCT03257995|12565037|FG000|Overall Study|Protocol deviation|0
7988679|NCT03257995|12565038|FG001|Overall Study|Protocol deviation|0
7988680|NCT03257995|12565039|FG002|Overall Study|Protocol deviation|0
7988681|NCT03257995|12565040|FG003|Overall Study|Protocol deviation|0
7988682|NCT03257995|12565041|FG004|Overall Study|Protocol deviation|0
7988683|NCT03257995|12565042|FG005|Overall Study|Protocol deviation|2
7988684|NCT03258710|12565064|FG000|Overall Study|Adverse Event|1
7988685|NCT03258710|12565064|FG000|Overall Study|Protocol-defined stopping criteria|1
7988686|NCT03258710|12565064|FG000|Overall Study|Physician Decision|1
7988687|NCT03258762|12565070|FG000|Overall Study|Lost to Follow-up|0
7988688|NCT03258762|12565071|FG001|Overall Study|Lost to Follow-up|1
7988689|NCT03258814|12565080|FG000|Overall Study|Early Termination|4
7988690|NCT03258814|12565081|FG001|Overall Study|Early Termination|3
7988691|NCT03258814|12565082|FG002|Overall Study|Early Termination|10
7988692|NCT03259087|12565094|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0
7988693|NCT03259087|12565095|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0
7988694|NCT03259087|12565096|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0
7988695|NCT03259087|12565097|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0
7988696|NCT03259087|12565098|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1
7988697|NCT03259087|12565094|FG000|Period 2 of Part 2|Adverse Event|0
7988698|NCT03259087|12565095|FG001|Period 2 of Part 2|Adverse Event|0
7988699|NCT03259087|12565096|FG002|Period 2 of Part 2|Adverse Event|0
7988700|NCT03259087|12565097|FG003|Period 2 of Part 2|Adverse Event|0
7988701|NCT03259087|12565098|FG004|Period 2 of Part 2|Adverse Event|1
7988702|NCT03259308|12565151|FG000|Overall Study|Adverse Event|5
7988703|NCT03259308|12565152|FG001|Overall Study|Adverse Event|4
7988704|NCT03259308|12565153|FG002|Overall Study|Adverse Event|1
7988705|NCT03259308|12565151|FG000|Overall Study|Withdrawal by Subject|2
7988706|NCT03259308|12565152|FG001|Overall Study|Withdrawal by Subject|1
7988707|NCT03259308|12565153|FG002|Overall Study|Withdrawal by Subject|3
7988708|NCT03259308|12565151|FG000|Overall Study|Lost to Follow-up|0
7988709|NCT03259308|12565152|FG001|Overall Study|Lost to Follow-up|0
7988710|NCT03259308|12565153|FG002|Overall Study|Lost to Follow-up|1
7988711|NCT03259308|12565151|FG000|Overall Study|Pregnancy|0
7988712|NCT03259308|12565152|FG001|Overall Study|Pregnancy|0
7988713|NCT03259308|12565153|FG002|Overall Study|Pregnancy|1
7988714|NCT03259308|12565151|FG000|Overall Study|Protocol Deviation|0
7988715|NCT03259308|12565152|FG001|Overall Study|Protocol Deviation|3
7988716|NCT03259308|12565153|FG002|Overall Study|Protocol Deviation|0
7988717|NCT03259308|12565151|FG000|Overall Study|Lack of Efficacy|0
7988718|NCT03259308|12565152|FG001|Overall Study|Lack of Efficacy|0
7988719|NCT03259308|12565153|FG002|Overall Study|Lack of Efficacy|1
7988720|NCT03259334|12565164|FG000|Overall Study|Adverse Event|3
7988721|NCT03259334|12565165|FG001|Overall Study|Adverse Event|8
7988722|NCT03259334|12565166|FG002|Overall Study|Adverse Event|5
7988723|NCT03259334|12565164|FG000|Overall Study|Withdrawal by Subject|4
7988724|NCT03259334|12565165|FG001|Overall Study|Withdrawal by Subject|2
7988725|NCT03259334|12565166|FG002|Overall Study|Withdrawal by Subject|4
7988726|NCT03259334|12565164|FG000|Overall Study|Physician Decision|1
7988727|NCT03259334|12565165|FG001|Overall Study|Physician Decision|0
7988728|NCT03259334|12565166|FG002|Overall Study|Physician Decision|0
7988729|NCT03259334|12565164|FG000|Overall Study|Lost to Follow-up|0
7988730|NCT03259334|12565165|FG001|Overall Study|Lost to Follow-up|2
7988731|NCT03259334|12565166|FG002|Overall Study|Lost to Follow-up|1
7988732|NCT03259334|12565164|FG000|Overall Study|Protocol Deviation|0
7988733|NCT03259334|12565165|FG001|Overall Study|Protocol Deviation|3
7988734|NCT03259334|12565166|FG002|Overall Study|Protocol Deviation|2
7988735|NCT03259334|12565164|FG000|Overall Study|Lack of Efficacy|2
7988736|NCT03259334|12565165|FG001|Overall Study|Lack of Efficacy|0
7988737|NCT03259334|12565166|FG002|Overall Study|Lack of Efficacy|1
7988738|NCT03259334|12565164|FG000|Overall Study|Randomized but never treated|0
7988739|NCT03259334|12565165|FG001|Overall Study|Randomized but never treated|2
7988740|NCT03259334|12565166|FG002|Overall Study|Randomized but never treated|0
7988741|NCT03259490|12565176|FG000|Period 1|Withdrawal by Subject|0
7988742|NCT03259490|12565177|FG001|Period 1|Withdrawal by Subject|1
7988743|NCT03259490|12565176|FG000|Period 2|Protocol Violation|1
7988744|NCT03259490|12565177|FG001|Period 2|Protocol Violation|0
7988745|NCT03259555|12565185|FG000|Overall Study|Adverse Event|6
7988746|NCT03259555|12565186|FG001|Overall Study|Adverse Event|4
7988747|NCT03259555|12565185|FG000|Overall Study|Lack of Efficacy|6
7988748|NCT03259555|12565186|FG001|Overall Study|Lack of Efficacy|4
7988749|NCT03259555|12565185|FG000|Overall Study|Lost to Follow-up|0
7988750|NCT03259555|12565186|FG001|Overall Study|Lost to Follow-up|2
7988751|NCT03259555|12565185|FG000|Overall Study|Non-Compliance With Study Drug|1
7988752|NCT03259555|12565186|FG001|Overall Study|Non-Compliance With Study Drug|0
7988753|NCT03259555|12565185|FG000|Overall Study|Progressive Disease|0
7988754|NCT03259555|12565186|FG001|Overall Study|Progressive Disease|2
7988755|NCT03259555|12565185|FG000|Overall Study|Withdrawal by Subject|19
7988756|NCT03259555|12565186|FG001|Overall Study|Withdrawal by Subject|16
7988757|NCT03259555|12565185|FG000|Overall Study|Physician Decision|1
7988758|NCT03259555|12565186|FG001|Overall Study|Physician Decision|2
7988759|NCT03259555|12565185|FG000|Overall Study|Other|1
7988760|NCT03259555|12565186|FG001|Overall Study|Other|0
7988761|NCT03259789|12565195|FG000|Overall Study|Adverse Event|3
7988762|NCT03259789|12565196|FG001|Overall Study|Adverse Event|2
7988763|NCT03259789|12565197|FG002|Overall Study|Adverse Event|1
7988764|NCT03259789|12565195|FG000|Overall Study|Withdrawal by Subject|9
7988765|NCT03259789|12565196|FG001|Overall Study|Withdrawal by Subject|5
7988766|NCT03259789|12565197|FG002|Overall Study|Withdrawal by Subject|1
7988767|NCT03259789|12565195|FG000|Overall Study|Lost to Follow-up|5
7988768|NCT03259789|12565196|FG001|Overall Study|Lost to Follow-up|9
7988769|NCT03259789|12565197|FG002|Overall Study|Lost to Follow-up|4
7988770|NCT03259789|12565195|FG000|Overall Study|Physician Decision|0
7988771|NCT03259789|12565196|FG001|Overall Study|Physician Decision|1
7988772|NCT03259789|12565197|FG002|Overall Study|Physician Decision|0
7988773|NCT03260205|12565211|FG000|Overall Study|Adverse Event|2
7988774|NCT03260205|12565212|FG001|Overall Study|Adverse Event|0
7988775|NCT03260205|12565213|FG002|Overall Study|Adverse Event|2
7988776|NCT03260205|12565214|FG003|Overall Study|Adverse Event|2
7988777|NCT03260205|12565215|FG004|Overall Study|Adverse Event|4
7988778|NCT03260205|12565211|FG000|Overall Study|Lost to Follow-up|2
7988779|NCT03260205|12565212|FG001|Overall Study|Lost to Follow-up|2
7988780|NCT03260205|12565213|FG002|Overall Study|Lost to Follow-up|1
7988781|NCT03260205|12565214|FG003|Overall Study|Lost to Follow-up|1
7988782|NCT03260205|12565215|FG004|Overall Study|Lost to Follow-up|5
7988783|NCT03260205|12565211|FG000|Overall Study|Protocol Violation|0
7988784|NCT03260205|12565212|FG001|Overall Study|Protocol Violation|0
7988785|NCT03260205|12565213|FG002|Overall Study|Protocol Violation|2
7988786|NCT03260205|12565214|FG003|Overall Study|Protocol Violation|0
7988787|NCT03260205|12565215|FG004|Overall Study|Protocol Violation|1
7988788|NCT03260205|12565211|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4
7988789|NCT03260205|12565212|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5
7988790|NCT03260205|12565213|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1
7988791|NCT03260205|12565214|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0
7988792|NCT03260205|12565215|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2
7988793|NCT03260205|12565211|FG000|Overall Study|Other: Unspecified|0
7988794|NCT03260205|12565212|FG001|Overall Study|Other: Unspecified|0
7988795|NCT03260205|12565213|FG002|Overall Study|Other: Unspecified|3
7988796|NCT03260205|12565214|FG003|Overall Study|Other: Unspecified|1
7988797|NCT03260205|12565215|FG004|Overall Study|Other: Unspecified|1
7988798|NCT03260205|12565211|FG000|Overall Study|Participant Who Did Not Received AnyDose|1
7988799|NCT03260205|12565212|FG001|Overall Study|Participant Who Did Not Received AnyDose|1
7988800|NCT03260205|12565213|FG002|Overall Study|Participant Who Did Not Received AnyDose|2
7988801|NCT03260205|12565214|FG003|Overall Study|Participant Who Did Not Received AnyDose|3
7988802|NCT03260205|12565215|FG004|Overall Study|Participant Who Did Not Received AnyDose|1
7988803|NCT03261037|12565276|FG000|Overall Study|Withdrawal by Subject|2
7988804|NCT03261037|12565277|FG001|Overall Study|Withdrawal by Subject|13
7988805|NCT03261037|12565278|FG002|Overall Study|Withdrawal by Subject|0
7988806|NCT03261037|12565279|FG003|Overall Study|Withdrawal by Subject|18
7988807|NCT03261037|12565276|FG000|Overall Study|Non-compliance with study procedures|0
7988808|NCT03261037|12565277|FG001|Overall Study|Non-compliance with study procedures|2
7988809|NCT03261037|12565278|FG002|Overall Study|Non-compliance with study procedures|0
7988810|NCT03261037|12565279|FG003|Overall Study|Non-compliance with study procedures|6
7988811|NCT03261037|12565276|FG000|Overall Study|Participant moving away and can no longer be in study|0
7988812|NCT03261037|12565277|FG001|Overall Study|Participant moving away and can no longer be in study|1
7988813|NCT03261037|12565278|FG002|Overall Study|Participant moving away and can no longer be in study|0
7718197|NCT00525902|12142028|FG000|Overall Study|Lack of Efficacy|1
7988814|NCT03261037|12565279|FG003|Overall Study|Participant moving away and can no longer be in study|0
7988815|NCT03261037|12565276|FG000|Overall Study|Participant came out of study due to investigator discretion|0
7988816|NCT03261037|12565277|FG001|Overall Study|Participant came out of study due to investigator discretion|2
7988817|NCT03261037|12565278|FG002|Overall Study|Participant came out of study due to investigator discretion|0
7988818|NCT03261037|12565279|FG003|Overall Study|Participant came out of study due to investigator discretion|0
7988819|NCT03261037|12565276|FG000|Overall Study|Diagnosed but protocol deviation|1
7988820|NCT03261037|12565277|FG001|Overall Study|Diagnosed but protocol deviation|0
7988821|NCT03261037|12565278|FG002|Overall Study|Diagnosed but protocol deviation|0
7988822|NCT03261037|12565279|FG003|Overall Study|Diagnosed but protocol deviation|0
7988823|NCT03261037|12565276|FG000|Overall Study|Participant did not want to continue the study|0
7988824|NCT03261037|12565277|FG001|Overall Study|Participant did not want to continue the study|1
7988825|NCT03261037|12565278|FG002|Overall Study|Participant did not want to continue the study|0
7988826|NCT03261037|12565279|FG003|Overall Study|Participant did not want to continue the study|0
7988827|NCT03261037|12565276|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0
7988828|NCT03261037|12565277|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0
7988829|NCT03261037|12565278|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0
7988830|NCT03261037|12565279|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1
7988831|NCT03261037|12565276|FG000|Overall Study|Participant presented clinical improvement|0
7988832|NCT03261037|12565277|FG001|Overall Study|Participant presented clinical improvement|2
7988833|NCT03261037|12565278|FG002|Overall Study|Participant presented clinical improvement|0
7988834|NCT03261037|12565279|FG003|Overall Study|Participant presented clinical improvement|0
7988835|NCT03261037|12565276|FG000|Overall Study|Technical difficulties|0
7988836|NCT03261037|12565277|FG001|Overall Study|Technical difficulties|0
7988837|NCT03261037|12565278|FG002|Overall Study|Technical difficulties|0
7988838|NCT03261037|12565279|FG003|Overall Study|Technical difficulties|1
7988839|NCT03261037|12565276|FG000|Overall Study|Equipment failed to work|0
7988840|NCT03261037|12565277|FG001|Overall Study|Equipment failed to work|0
7988841|NCT03261037|12565278|FG002|Overall Study|Equipment failed to work|0
7988842|NCT03261037|12565279|FG003|Overall Study|Equipment failed to work|1
7988843|NCT03261037|12565276|FG000|Overall Study|End of study for participant and no follow up|0
7988844|NCT03261037|12565277|FG001|Overall Study|End of study for participant and no follow up|0
7988845|NCT03261037|12565278|FG002|Overall Study|End of study for participant and no follow up|0
7988846|NCT03261037|12565279|FG003|Overall Study|End of study for participant and no follow up|1
7988847|NCT03261037|12565276|FG000|Overall Study|Participant was too weak to continue in study|1
7988848|NCT03261037|12565277|FG001|Overall Study|Participant was too weak to continue in study|0
7988849|NCT03261037|12565278|FG002|Overall Study|Participant was too weak to continue in study|0
7988850|NCT03261037|12565279|FG003|Overall Study|Participant was too weak to continue in study|0
7988851|NCT03261167|12565292|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0
7988852|NCT03261167|12565293|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3
7988853|NCT03261167|12565292|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3
7988854|NCT03261167|12565293|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1
7988855|NCT03261167|12565292|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1
7988856|NCT03261167|12565293|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0
7988857|NCT03261167|12565292|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1
7988858|NCT03261167|12565293|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0
7988859|NCT03261167|12565292|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
7988860|NCT03261167|12565293|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
7988861|NCT03261336|12565305|FG000|Overall Study|Adverse Event|1
7988862|NCT03261947|12565314|FG000|Overall Study|Death|10
7988863|NCT03261947|12565315|FG001|Overall Study|Death|13
7988864|NCT03261947|12565316|FG002|Overall Study|Death|17
7988865|NCT03261947|12565317|FG003|Overall Study|Death|12
7988866|NCT03261947|12565318|FG004|Overall Study|Death|8
7988867|NCT03261947|12565314|FG000|Overall Study|Lost to Follow-up|0
7988868|NCT03261947|12565315|FG001|Overall Study|Lost to Follow-up|0
7988869|NCT03261947|12565316|FG002|Overall Study|Lost to Follow-up|2
7988870|NCT03261947|12565317|FG003|Overall Study|Lost to Follow-up|1
7988871|NCT03261947|12565318|FG004|Overall Study|Lost to Follow-up|0
7988872|NCT03261947|12565314|FG000|Overall Study|Withdrawal by Subject|0
7988873|NCT03261947|12565315|FG001|Overall Study|Withdrawal by Subject|0
7988874|NCT03261947|12565316|FG002|Overall Study|Withdrawal by Subject|3
7988875|NCT03261947|12565317|FG003|Overall Study|Withdrawal by Subject|0
7988876|NCT03261947|12565318|FG004|Overall Study|Withdrawal by Subject|1
7988877|NCT03261947|12565314|FG000|Overall Study|Site Terminated by Sponsor|0
7988878|NCT03261947|12565315|FG001|Overall Study|Site Terminated by Sponsor|0
7988879|NCT03261947|12565316|FG002|Overall Study|Site Terminated by Sponsor|4
7988880|NCT03261947|12565317|FG003|Overall Study|Site Terminated by Sponsor|7
7988881|NCT03261947|12565318|FG004|Overall Study|Site Terminated by Sponsor|5
7988882|NCT03261947|12565314|FG000|Overall Study|Reason not Specified|2
7988883|NCT03261947|12565315|FG001|Overall Study|Reason not Specified|0
7988884|NCT03261947|12565316|FG002|Overall Study|Reason not Specified|4
7988885|NCT03261947|12565317|FG003|Overall Study|Reason not Specified|1
7988886|NCT03261947|12565318|FG004|Overall Study|Reason not Specified|3
7988887|NCT03262012|12565355|FG000|Overall Study|Withdrawal by Subject|15
7988888|NCT03262012|12565356|FG001|Overall Study|Withdrawal by Subject|13
7988889|NCT03262012|12565357|FG002|Overall Study|Withdrawal by Subject|8
7988890|NCT03262012|12565358|FG003|Overall Study|Withdrawal by Subject|7
7988891|NCT03262012|12565355|FG000|Overall Study|Adverse Event|10
7718198|NCT00525915|12142034|FG000|Overall Study|Non-Compliance|0
7718199|NCT00525915|12142035|FG001|Overall Study|Non-Compliance|1
7718200|NCT00525915|12142034|FG000|Overall Study|Disease Progression|5
7718201|NCT00525915|12142035|FG001|Overall Study|Disease Progression|6
7718202|NCT00525915|12142034|FG000|Overall Study|Withdrawal by Subject|1
7718203|NCT00525915|12142035|FG001|Overall Study|Withdrawal by Subject|0
7718204|NCT00525915|12142034|FG000|Overall Study|Refused Surgery|1
7718205|NCT00525915|12142035|FG001|Overall Study|Refused Surgery|2
7718206|NCT00525915|12142034|FG000|Overall Study|Unrelated illness|1
7718207|NCT00525915|12142035|FG001|Overall Study|Unrelated illness|0
7718208|NCT00526071|12142050|FG000|Overall Study|Adverse Event|1
7988892|NCT03262012|12565356|FG001|Overall Study|Adverse Event|12
7988893|NCT03262012|12565357|FG002|Overall Study|Adverse Event|4
7988894|NCT03262012|12565358|FG003|Overall Study|Adverse Event|6
7988895|NCT03262012|12565355|FG000|Overall Study|Physician Decision|2
7988896|NCT03262012|12565356|FG001|Overall Study|Physician Decision|5
7988897|NCT03262012|12565357|FG002|Overall Study|Physician Decision|1
7988898|NCT03262012|12565358|FG003|Overall Study|Physician Decision|0
7988899|NCT03262012|12565355|FG000|Overall Study|Lack of Efficacy|0
7988900|NCT03262012|12565356|FG001|Overall Study|Lack of Efficacy|5
7988901|NCT03262012|12565357|FG002|Overall Study|Lack of Efficacy|1
7988902|NCT03262012|12565358|FG003|Overall Study|Lack of Efficacy|2
7988903|NCT03262012|12565355|FG000|Overall Study|Protocol Discontinuation Criteria|0
7988904|NCT03262012|12565356|FG001|Overall Study|Protocol Discontinuation Criteria|1
7988905|NCT03262012|12565357|FG002|Overall Study|Protocol Discontinuation Criteria|0
7988906|NCT03262012|12565358|FG003|Overall Study|Protocol Discontinuation Criteria|0
7988907|NCT03262038|12565370|FG000|Overall Study|Withdrawal by Subject|0
7988908|NCT03262038|12565371|FG001|Overall Study|Withdrawal by Subject|1
7988909|NCT03262233|12565381|FG000|Overall Study|Withdrawal by Subject|12
7988910|NCT03262233|12565382|FG001|Overall Study|Withdrawal by Subject|8
7988911|NCT03262233|12565383|FG002|Overall Study|Withdrawal by Subject|21
7988912|NCT03262233|12565384|FG003|Overall Study|Withdrawal by Subject|13
7988913|NCT03262233|12565381|FG000|Overall Study|Declined due to shock|1
7988914|NCT03262233|12565382|FG001|Overall Study|Declined due to shock|2
7988915|NCT03262233|12565383|FG002|Overall Study|Declined due to shock|2
7988916|NCT03262233|12565384|FG003|Overall Study|Declined due to shock|3
7988917|NCT03262233|12565381|FG000|Overall Study|Protocol Violation|5
7988918|NCT03262233|12565382|FG001|Overall Study|Protocol Violation|10
7988919|NCT03262233|12565383|FG002|Overall Study|Protocol Violation|2
7988920|NCT03262233|12565384|FG003|Overall Study|Protocol Violation|13
7988921|NCT03262233|12565381|FG000|Overall Study|data collection artifact|0
7988922|NCT03262233|12565382|FG001|Overall Study|data collection artifact|1
7988923|NCT03262233|12565383|FG002|Overall Study|data collection artifact|0
7988924|NCT03262233|12565384|FG003|Overall Study|data collection artifact|0
7988925|NCT03262389|12565395|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1
7988926|NCT03262389|12565395|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1
7988927|NCT03262389|12565395|FG000|Overall Study|opted out of PET/MR|1
7988928|NCT03262441|12565399|FG000|Overall Study|Withdrawal by Subject|1
7988929|NCT03263442|12565405|FG000|Inpatient Phase|Death|1
7988930|NCT03263442|12565406|FG001|Inpatient Phase|Death|0
7988931|NCT03263442|12565405|FG000|Inpatient Phase|Withdrawal by Subject|1
7988932|NCT03263442|12565406|FG001|Inpatient Phase|Withdrawal by Subject|0
7988933|NCT03263442|12565405|FG000|Inpatient Phase|Inadequate Drug Exposure|0
7988934|NCT03263442|12565406|FG001|Inpatient Phase|Inadequate Drug Exposure|1
7988935|NCT03263442|12565405|FG000|1-month Follow-Up|Lost to Follow-up|1
7988936|NCT03263442|12565406|FG001|1-month Follow-Up|Lost to Follow-up|0
7988937|NCT03263442|12565405|FG000|3-month Follow-Up|Lost to Follow-up|1
7988938|NCT03263442|12565406|FG001|3-month Follow-Up|Lost to Follow-up|3
7988939|NCT03263442|12565405|FG000|6-month Follow-Up|Lost to Follow-up|2
7988940|NCT03263442|12565406|FG001|6-month Follow-Up|Lost to Follow-up|2
7988941|NCT03263702|12565416|FG000|Overall Study|Lost to Follow-up|2
7988942|NCT03263702|12565417|FG001|Overall Study|Lost to Follow-up|2
7988943|NCT03263702|12565416|FG000|Overall Study|Withdrawal by Subject|1
7988944|NCT03263702|12565417|FG001|Overall Study|Withdrawal by Subject|2
7988945|NCT03263780|12565423|FG000|Overall Study|Withdrawal by Subject|3
7988946|NCT03263780|12565423|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7
7988947|NCT03264066|12565433|FG000|Overall Study|Adverse Event|1
7988948|NCT03264066|12565434|FG001|Overall Study|Adverse Event|1
7988949|NCT03264066|12565435|FG002|Overall Study|Adverse Event|0
7988950|NCT03264066|12565436|FG003|Overall Study|Adverse Event|0
7988951|NCT03264066|12565437|FG004|Overall Study|Adverse Event|0
7988952|NCT03264066|12565438|FG005|Overall Study|Adverse Event|0
7988953|NCT03264066|12565433|FG000|Overall Study|Death|12
7988954|NCT03264066|12565434|FG001|Overall Study|Death|12
7988955|NCT03264066|12565435|FG002|Overall Study|Death|8
7988956|NCT03264066|12565436|FG003|Overall Study|Death|10
7988957|NCT03264066|12565437|FG004|Overall Study|Death|6
7988958|NCT03264066|12565438|FG005|Overall Study|Death|1
7988959|NCT03264066|12565433|FG000|Overall Study|Lost to Follow-up|1
7988960|NCT03264066|12565434|FG001|Overall Study|Lost to Follow-up|0
7988961|NCT03264066|12565435|FG002|Overall Study|Lost to Follow-up|0
7988962|NCT03264066|12565436|FG003|Overall Study|Lost to Follow-up|0
7988963|NCT03264066|12565437|FG004|Overall Study|Lost to Follow-up|0
7988964|NCT03264066|12565438|FG005|Overall Study|Lost to Follow-up|0
7988965|NCT03264066|12565433|FG000|Overall Study|Progressive Disease|0
7988966|NCT03264066|12565434|FG001|Overall Study|Progressive Disease|2
7988967|NCT03264066|12565435|FG002|Overall Study|Progressive Disease|1
7988968|NCT03264066|12565436|FG003|Overall Study|Progressive Disease|0
7988969|NCT03264066|12565437|FG004|Overall Study|Progressive Disease|0
7988970|NCT03264066|12565438|FG005|Overall Study|Progressive Disease|0
7988971|NCT03264066|12565433|FG000|Overall Study|Study Terminated by Sponsor|5
7988972|NCT03264066|12565434|FG001|Overall Study|Study Terminated by Sponsor|5
7988973|NCT03264066|12565435|FG002|Overall Study|Study Terminated by Sponsor|8
7988974|NCT03264066|12565436|FG003|Overall Study|Study Terminated by Sponsor|5
7988975|NCT03264066|12565437|FG004|Overall Study|Study Terminated by Sponsor|1
7988976|NCT03264066|12565438|FG005|Overall Study|Study Terminated by Sponsor|2
7988977|NCT03264066|12565433|FG000|Overall Study|Withdrawal by Subject|1
7988978|NCT03264066|12565434|FG001|Overall Study|Withdrawal by Subject|0
7988979|NCT03264066|12565435|FG002|Overall Study|Withdrawal by Subject|0
7988980|NCT03264066|12565436|FG003|Overall Study|Withdrawal by Subject|5
7988981|NCT03264066|12565437|FG004|Overall Study|Withdrawal by Subject|0
7988982|NCT03264066|12565438|FG005|Overall Study|Withdrawal by Subject|0
7988983|NCT03264456|12565487|FG000|Overall Study|Withdrawal by Subject|3
7988984|NCT03264456|12565487|FG000|Overall Study|Lost to Follow-up|1
7988985|NCT03265119|12565493|FG000|Overall Study|Adverse Event|2
7988986|NCT03265119|12565494|FG001|Overall Study|Adverse Event|1
7988987|NCT03265119|12565493|FG000|Overall Study|Lack of Efficacy|3
7988988|NCT03265119|12565494|FG001|Overall Study|Lack of Efficacy|0
7988989|NCT03265119|12565493|FG000|Overall Study|Protocol Violation|1
7988990|NCT03265119|12565494|FG001|Overall Study|Protocol Violation|2
7988991|NCT03265119|12565493|FG000|Overall Study|Withdrawal by Subject|2
7988992|NCT03265119|12565494|FG001|Overall Study|Withdrawal by Subject|4
7988993|NCT03265119|12565493|FG000|Overall Study|Lost to Follow-up|1
7988994|NCT03265119|12565494|FG001|Overall Study|Lost to Follow-up|0
7988995|NCT03265119|12565493|FG000|Overall Study|Lack of Compliance|1
7988996|NCT03265119|12565494|FG001|Overall Study|Lack of Compliance|0
7988997|NCT03265132|12565502|FG000|Overall Study|Adverse Event|0
7988998|NCT03265132|12565503|FG001|Overall Study|Adverse Event|1
7988999|NCT03265132|12565502|FG000|Overall Study|Lack of Efficacy|0
7989000|NCT03265132|12565503|FG001|Overall Study|Lack of Efficacy|2
7989001|NCT03265132|12565502|FG000|Overall Study|Progressive disease|0
7989002|NCT03265132|12565503|FG001|Overall Study|Progressive disease|2
7989003|NCT03265132|12565502|FG000|Overall Study|Withdrawal by Subject|0
7989004|NCT03265132|12565503|FG001|Overall Study|Withdrawal by Subject|1
7989005|NCT03265600|12565513|FG000|Overall Study|Lost to Follow-up|17
7989006|NCT03265600|12565514|FG001|Overall Study|Lost to Follow-up|5
7989007|NCT03265600|12565513|FG000|Overall Study|Withdrawal by Subject|4
7989008|NCT03265600|12565514|FG001|Overall Study|Withdrawal by Subject|2
7989009|NCT03265600|12565513|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3
7989010|NCT03265600|12565514|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5
7989011|NCT03265938|12565520|FG000|Overall Study|Withdrawal by Subject|1
7989012|NCT03265938|12565520|FG000|Overall Study|Physician Decision|1
7989013|NCT03265938|12565520|FG000|Overall Study|friable mass|6
7989014|NCT03266094|12565525|FG000|Overall Study|Lost to Follow-up|1
7989015|NCT03266094|12565525|FG000|Overall Study|Withdrawal by Subject|1
7989016|NCT03266107|12565531|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1
7989017|NCT03266107|12565531|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2
7989018|NCT03266107|12565531|FG000|3-Month Follow-up Visit|Lost to Follow-up|1
7989019|NCT03266107|12565531|FG000|12-Month Follow-up Visit|Lost to Follow-up|1
7989020|NCT03266172|12565540|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1
7989021|NCT03266172|12565541|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0
7989022|NCT03266172|12565542|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0
7989023|NCT03266172|12565540|FG000|Part A: Washout Period (7 Days)|Adverse Event|1
7989024|NCT03266172|12565541|FG001|Part A: Washout Period (7 Days)|Adverse Event|0
7989025|NCT03266172|12565542|FG002|Part A: Washout Period (7 Days)|Adverse Event|0
7989026|NCT03266172|12565540|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1
7989027|NCT03266172|12565541|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
7989028|NCT03266172|12565542|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
7989029|NCT03266172|12565540|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0
7989030|NCT03266172|12565541|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2
7989031|NCT03266172|12565542|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0
7989032|NCT03266172|12565540|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7989033|NCT03266172|12565541|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7989034|NCT03266172|12565542|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1
7989035|NCT03266172|12565540|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7989036|NCT03266172|12565541|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7989037|NCT03266172|12565542|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1
7989038|NCT03266588|12565604|FG000|Observational Period|Screen Failure: Eligibility Criteria|439
7989039|NCT03266588|12565605|FG001|Observational Period|Screen Failure: Eligibility Criteria|228
7989040|NCT03266588|12565606|FG002|Observational Period|Screen Failure: Eligibility Criteria|140
7989041|NCT03266588|12565604|FG000|Observational Period|Withdrawal by Subject|44
7989042|NCT03266588|12565605|FG001|Observational Period|Withdrawal by Subject|22
7989043|NCT03266588|12565606|FG002|Observational Period|Withdrawal by Subject|13
7989044|NCT03266588|12565604|FG000|Observational Period|Non-compliance|18
7989045|NCT03266588|12565605|FG001|Observational Period|Non-compliance|12
7989046|NCT03266588|12565606|FG002|Observational Period|Non-compliance|10
7989047|NCT03266588|12565604|FG000|Observational Period|Lost to Follow-up|8
7989048|NCT03266588|12565605|FG001|Observational Period|Lost to Follow-up|12
7989049|NCT03266588|12565606|FG002|Observational Period|Lost to Follow-up|4
7989050|NCT03266588|12565604|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3
7989051|NCT03266588|12565605|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1
7989052|NCT03266588|12565606|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0
7989053|NCT03266588|12565604|FG000|Observational Period|Protocol Deviation|1
7989054|NCT03266588|12565605|FG001|Observational Period|Protocol Deviation|0
7989055|NCT03266588|12565606|FG002|Observational Period|Protocol Deviation|0
7989056|NCT03266588|12565604|FG000|Observational Period|Other Reasons|3
7989057|NCT03266588|12565605|FG001|Observational Period|Other Reasons|0
7989058|NCT03266588|12565606|FG002|Observational Period|Other Reasons|1
7989059|NCT03266588|12565604|FG000|Long-term Treatment Period|Adverse Event|33
7989060|NCT03266588|12565605|FG001|Long-term Treatment Period|Adverse Event|17
7989061|NCT03266588|12565606|FG002|Long-term Treatment Period|Adverse Event|8
7989062|NCT03266588|12565604|FG000|Long-term Treatment Period|Lack of Efficacy|41
7989063|NCT03266588|12565605|FG001|Long-term Treatment Period|Lack of Efficacy|31
7989064|NCT03266588|12565606|FG002|Long-term Treatment Period|Lack of Efficacy|5
7989065|NCT03266588|12565604|FG000|Long-term Treatment Period|Lost to Follow-up|39
7989066|NCT03266588|12565605|FG001|Long-term Treatment Period|Lost to Follow-up|37
7989067|NCT03266588|12565606|FG002|Long-term Treatment Period|Lost to Follow-up|8
7989068|NCT03266588|12565604|FG000|Long-term Treatment Period|Non-Compliance|126
7989069|NCT03266588|12565605|FG001|Long-term Treatment Period|Non-Compliance|57
7989070|NCT03266588|12565606|FG002|Long-term Treatment Period|Non-Compliance|7
7989071|NCT03266588|12565604|FG000|Long-term Treatment Period|Pregnancy|11
7989072|NCT03266588|12565605|FG001|Long-term Treatment Period|Pregnancy|5
7718209|NCT00526071|12142050|FG000|Overall Study|Withdrawal by Subject|1
7718210|NCT00526071|12142050|FG000|Overall Study|Lack of Response to Study Drug|4
7718211|NCT00526097|12142060|FG000|Overall Study|Adverse Event|6
7718212|NCT00526097|12142061|FG001|Overall Study|Adverse Event|44
7718213|NCT00526097|12142060|FG000|Overall Study|Protocol Violation|4
7718214|NCT00526097|12142061|FG001|Overall Study|Protocol Violation|10
7718215|NCT00526097|12142060|FG000|Overall Study|Withdrawal by Subject|3
7718216|NCT00526097|12142061|FG001|Overall Study|Withdrawal by Subject|1
7718217|NCT00526097|12142060|FG000|Overall Study|Other|2
7718218|NCT00526097|12142061|FG001|Overall Study|Other|1
7989073|NCT03266588|12565606|FG002|Long-term Treatment Period|Pregnancy|0
7989074|NCT03266588|12565604|FG000|Long-term Treatment Period|Protocol Deviation|17
7989075|NCT03266588|12565605|FG001|Long-term Treatment Period|Protocol Deviation|10
7989076|NCT03266588|12565606|FG002|Long-term Treatment Period|Protocol Deviation|4
7989077|NCT03266588|12565604|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33
7989078|NCT03266588|12565605|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
7989079|NCT03266588|12565606|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
7989080|NCT03266588|12565604|FG000|Long-term Treatment Period|Withdrawal by Subject|100
7989081|NCT03266588|12565605|FG001|Long-term Treatment Period|Withdrawal by Subject|63
7989082|NCT03266588|12565606|FG002|Long-term Treatment Period|Withdrawal by Subject|16
7989083|NCT03266588|12565604|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1
7989084|NCT03266588|12565605|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2
7989085|NCT03266588|12565606|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0
7989086|NCT03266588|12565604|FG000|Long-term Treatment Period|Other Reasons|5
7989087|NCT03266588|12565605|FG001|Long-term Treatment Period|Other Reasons|0
7989088|NCT03266588|12565606|FG002|Long-term Treatment Period|Other Reasons|0
7989089|NCT03266588|12565604|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
7989090|NCT03266588|12565605|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1
7989091|NCT03266588|12565606|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
7989092|NCT03267212|12565614|FG000|First Intervention|Lost to Follow-up|0
7989093|NCT03267212|12565615|FG001|First Intervention|Lost to Follow-up|2
7989094|NCT03267212|12565614|FG000|First Intervention|Withdrawal by Subject|1
7989095|NCT03267212|12565615|FG001|First Intervention|Withdrawal by Subject|1
7989096|NCT03267212|12565614|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1
7989097|NCT03267212|12565615|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0
7989098|NCT03267264|12565625|FG000|Overall Study|Withdrawal by Subject|1
7989099|NCT03267264|12565626|FG001|Overall Study|Withdrawal by Subject|0
7989100|NCT03267264|12565627|FG002|Overall Study|Withdrawal by Subject|2
7989101|NCT03267264|12565628|FG003|Overall Study|Withdrawal by Subject|4
7989102|NCT03267511|12565645|FG000|Overall Study|Lost to Follow-up|0
7989103|NCT03267511|12565646|FG001|Overall Study|Lost to Follow-up|0
7989104|NCT03267511|12565647|FG002|Overall Study|Lost to Follow-up|0
7989105|NCT03267511|12565648|FG003|Overall Study|Lost to Follow-up|1
7989106|NCT03267576|12565662|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0
7989107|NCT03267576|12565663|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1
7989108|NCT03267576|12565662|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1
7989109|NCT03267576|12565663|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1
7989110|NCT03267940|12565675|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1
7989111|NCT03267940|12565676|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2
7989112|NCT03267940|12565677|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7989113|NCT03267940|12565678|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7989114|NCT03267940|12565679|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7989115|NCT03267940|12565680|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7989116|NCT03267940|12565675|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7718219|NCT00526110|12142069|FG000|Overall Study|Adverse Event|2
7989117|NCT03267940|12565676|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1
7989118|NCT03267940|12565677|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7989119|NCT03267940|12565678|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7989120|NCT03267940|12565679|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7989121|NCT03267940|12565680|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7989122|NCT03267940|12565675|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7989123|NCT03267940|12565676|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1
7989124|NCT03267940|12565677|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7989125|NCT03267940|12565678|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7989126|NCT03267940|12565679|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7989127|NCT03267940|12565680|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7989128|NCT03267940|12565675|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7
7989129|NCT03267940|12565676|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3
7989130|NCT03267940|12565677|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0
7989131|NCT03267940|12565678|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0
7989132|NCT03267940|12565679|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0
7989133|NCT03267940|12565680|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0
7989134|NCT03267940|12565675|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7989135|NCT03267940|12565676|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7989136|NCT03267940|12565677|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7989137|NCT03267940|12565678|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3
7989138|NCT03267940|12565679|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2
7989139|NCT03267940|12565680|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7989140|NCT03267940|12565675|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
7989141|NCT03267940|12565676|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
7989142|NCT03267940|12565677|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
7989143|NCT03267940|12565678|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1
7989144|NCT03267940|12565679|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
7989145|NCT03267940|12565680|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
7989146|NCT03267940|12565675|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
7989147|NCT03267940|12565676|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
7989148|NCT03267940|12565677|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2
7989149|NCT03267940|12565678|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
7989150|NCT03267940|12565679|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
7989151|NCT03267940|12565680|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
7989152|NCT03267940|12565675|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
7989153|NCT03267940|12565676|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
7989154|NCT03267940|12565677|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7
7989155|NCT03267940|12565678|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4
7989156|NCT03267940|12565679|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5
7989157|NCT03267940|12565680|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3
7989158|NCT03267940|12565675|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0
7989159|NCT03267940|12565676|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0
7989160|NCT03267940|12565677|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10
7989161|NCT03267940|12565678|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13
7989162|NCT03267940|12565679|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0
7989163|NCT03267940|12565680|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6
7989164|NCT03268590|12565706|FG000|Overall Study|Previously unknown exclusion criteria|1
7989165|NCT03268746|12565713|FG000|Overall Study|Withdrawal by Subject|1
7989166|NCT03268941|12565728|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7989167|NCT03268941|12565729|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7989168|NCT03268941|12565730|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7989169|NCT03268941|12565731|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1
7989170|NCT03268941|12565732|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7989171|NCT03268941|12565733|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7989172|NCT03268941|12565734|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7989173|NCT03268941|12565728|FG000|Part 1 (Days 1 to 9)|Adverse Event|0
7989174|NCT03268941|12565729|FG001|Part 1 (Days 1 to 9)|Adverse Event|0
7989175|NCT03268941|12565730|FG002|Part 1 (Days 1 to 9)|Adverse Event|0
7989176|NCT03268941|12565731|FG003|Part 1 (Days 1 to 9)|Adverse Event|1
7989177|NCT03268941|12565732|FG004|Part 1 (Days 1 to 9)|Adverse Event|0
7989178|NCT03268941|12565733|FG005|Part 1 (Days 1 to 9)|Adverse Event|0
7989179|NCT03268941|12565734|FG006|Part 1 (Days 1 to 9)|Adverse Event|0
7989180|NCT03268941|12565728|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1
7989181|NCT03268941|12565729|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0
7989182|NCT03268941|12565730|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0
7989183|NCT03268941|12565731|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0
7989184|NCT03268941|12565732|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0
7989185|NCT03268941|12565733|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0
7989186|NCT03268941|12565734|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0
7989187|NCT03268941|12565728|FG000|Part 2: Days 17 to 25|Reason not specified|0
7989188|NCT03268941|12565729|FG001|Part 2: Days 17 to 25|Reason not specified|0
7989189|NCT03268941|12565730|FG002|Part 2: Days 17 to 25|Reason not specified|0
7989190|NCT03268941|12565731|FG003|Part 2: Days 17 to 25|Reason not specified|0
7989191|NCT03268941|12565732|FG004|Part 2: Days 17 to 25|Reason not specified|0
7989192|NCT03268941|12565733|FG005|Part 2: Days 17 to 25|Reason not specified|0
7989193|NCT03268941|12565734|FG006|Part 2: Days 17 to 25|Reason not specified|1
7989194|NCT03268941|12565728|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0
7989195|NCT03268941|12565729|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0
7989196|NCT03268941|12565730|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0
7989197|NCT03268941|12565731|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0
7989198|NCT03268941|12565732|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0
7989199|NCT03268941|12565733|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0
7989200|NCT03268941|12565734|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1
7989201|NCT03269552|12565762|FG000|Overall Study|Adverse Event|2
7989202|NCT03270085|12565769|FG000|Overall Study|Withdrawal by Subject|1
7989203|NCT03270085|12565770|FG001|Overall Study|Withdrawal by Subject|0
7989204|NCT03270644|12565805|FG000|Day 1 Lasmiditan Reference|Physician Decision|1
7989205|NCT03270644|12565805|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1
7989206|NCT03270657|12565816|FG000|Overall Study|Withdrawal by Subject|1
7989207|NCT03271307|12565834|FG000|Overall Study|Lost to Follow-up|0
7989208|NCT03271307|12565835|FG001|Overall Study|Lost to Follow-up|0
7989209|NCT03271307|12565836|FG002|Overall Study|Lost to Follow-up|0
7989210|NCT03271307|12565837|FG003|Overall Study|Lost to Follow-up|28
7989211|NCT03271307|12565838|FG004|Overall Study|Lost to Follow-up|91
7989212|NCT03271528|12565870|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1
7989213|NCT03271528|12565871|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0
7989214|NCT03271528|12565870|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1
7989215|NCT03271528|12565871|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0
7989216|NCT03271528|12565870|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0
7989217|NCT03271528|12565871|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1
7989218|NCT03271528|12565870|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0
7989219|NCT03271528|12565871|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1
7989220|NCT03271528|12565870|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1
7989221|NCT03271528|12565871|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1
7989222|NCT03271528|12565870|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1
7989223|NCT03271528|12565871|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0
7989224|NCT03271528|12565870|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1
7989225|NCT03271528|12565871|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0
7989226|NCT03273166|12565877|FG000|Overall Study|Withdrawn prior to Completion|31
7989227|NCT03273257|12565884|FG000|Overall Study|Death|0
7989228|NCT03273257|12565885|FG001|Overall Study|Death|1
7989229|NCT03273257|12565884|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1
7989230|NCT03273257|12565885|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1
7989231|NCT03273257|12565884|FG000|Overall Study|Study terminated|3
7989232|NCT03273257|12565885|FG001|Overall Study|Study terminated|2
7989233|NCT03273387|12565911|FG000|Overall Study|Death|2
7989234|NCT03273387|12565912|FG001|Overall Study|Death|2
7989235|NCT03273387|12565911|FG000|Overall Study|Withdrawal by Subject|1
7989236|NCT03273387|12565912|FG001|Overall Study|Withdrawal by Subject|1
7989237|NCT03273946|12565946|FG000|Overall Study|Withdrawal by Subject|5
7989238|NCT03273946|12565946|FG000|Overall Study|Unwillingness of the guardian|1
7989239|NCT03273946|12565946|FG000|Overall Study|Participant refused to use the drug|2
7989240|NCT03273946|12565946|FG000|Overall Study|Participant relative refused to use drug|1
7989241|NCT03274076|12565952|FG000|24 Weeks Double Blind|Withdrawal by Subject|0
7989242|NCT03274076|12565953|FG001|24 Weeks Double Blind|Withdrawal by Subject|1
7989243|NCT03274076|12565954|FG002|24 Weeks Double Blind|Withdrawal by Subject|0
7989244|NCT03274076|12565955|FG003|24 Weeks Double Blind|Withdrawal by Subject|0
7989245|NCT03274076|12565952|FG000|24 Weeks Open Label|Adverse Event|0
7989246|NCT03274076|12565953|FG001|24 Weeks Open Label|Adverse Event|0
7989247|NCT03274076|12565954|FG002|24 Weeks Open Label|Adverse Event|2
7989248|NCT03274076|12565955|FG003|24 Weeks Open Label|Adverse Event|0
7989249|NCT03274076|12565952|FG000|24 Weeks Open Label|Withdrawal by Subject|0
7989250|NCT03274076|12565953|FG001|24 Weeks Open Label|Withdrawal by Subject|0
7989251|NCT03274076|12565954|FG002|24 Weeks Open Label|Withdrawal by Subject|0
7989252|NCT03274076|12565955|FG003|24 Weeks Open Label|Withdrawal by Subject|1
7989253|NCT03274440|12565974|FG000|Overall Study|Time commitment too great|1
7989254|NCT03274440|12565975|FG001|Overall Study|Time commitment too great|0
7989255|NCT03274440|12565976|FG002|Overall Study|Time commitment too great|0
7989256|NCT03274440|12565977|FG003|Overall Study|Time commitment too great|1
7989257|NCT03274440|12565978|FG004|Overall Study|Time commitment too great|0
7989258|NCT03274440|12565979|FG005|Overall Study|Time commitment too great|0
7989259|NCT03274453|12565991|FG000|Overall Study|Lost to Follow-up|2
7989260|NCT03274453|12565992|FG001|Overall Study|Lost to Follow-up|5
7989261|NCT03274453|12565993|FG002|Overall Study|Lost to Follow-up|4
7989262|NCT03274453|12565994|FG003|Overall Study|Lost to Follow-up|1
7989263|NCT03274453|12565991|FG000|Overall Study|Physician Decision|2
7989264|NCT03274453|12565992|FG001|Overall Study|Physician Decision|0
7989265|NCT03274453|12565993|FG002|Overall Study|Physician Decision|0
7989266|NCT03274453|12565994|FG003|Overall Study|Physician Decision|3
7989267|NCT03274453|12565991|FG000|Overall Study|Surgery Cancelled|0
7989268|NCT03274453|12565992|FG001|Overall Study|Surgery Cancelled|1
7989269|NCT03274453|12565993|FG002|Overall Study|Surgery Cancelled|0
7989270|NCT03274453|12565994|FG003|Overall Study|Surgery Cancelled|0
7989271|NCT03274986|12566026|FG000|Overall Study|Withdrawal by Subject|0
7989272|NCT03274986|12566027|FG001|Overall Study|Withdrawal by Subject|1
7989273|NCT03274986|12566026|FG000|Overall Study|Lost to Follow-up|0
7989274|NCT03274986|12566027|FG001|Overall Study|Lost to Follow-up|1
7989275|NCT03275246|12566047|FG000|Overall Study|Protocol Violation|5
7989276|NCT03275246|12566047|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1
7989277|NCT03275389|12566061|FG000|Overall Study|Lost to Follow-up|10
7989278|NCT03275389|12566062|FG001|Overall Study|Lost to Follow-up|10
7989279|NCT03275389|12566063|FG002|Overall Study|Lost to Follow-up|19
7989280|NCT03275389|12566064|FG003|Overall Study|Lost to Follow-up|12
7989281|NCT03275389|12566065|FG004|Overall Study|Lost to Follow-up|11
7989282|NCT03275389|12566066|FG005|Overall Study|Lost to Follow-up|12
7989283|NCT03275389|12566067|FG006|Overall Study|Lost to Follow-up|21
7989284|NCT03275389|12566068|FG007|Overall Study|Lost to Follow-up|15
7989285|NCT03275389|12566069|FG008|Overall Study|Lost to Follow-up|12
7989286|NCT03275389|12566070|FG009|Overall Study|Lost to Follow-up|14
7989287|NCT03275389|12566061|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7989288|NCT03275389|12566062|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7989289|NCT03275389|12566063|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7989290|NCT03275389|12566064|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7989291|NCT03275389|12566065|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7989292|NCT03275389|12566066|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1
7989293|NCT03275389|12566067|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7989294|NCT03275389|12566068|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7989295|NCT03275389|12566069|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7989296|NCT03275389|12566070|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1
7989297|NCT03275389|12566061|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7989298|NCT03275389|12566062|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7989299|NCT03275389|12566063|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7989300|NCT03275389|12566064|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
7989301|NCT03275389|12566065|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
7989302|NCT03275389|12566066|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
7989303|NCT03275389|12566067|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
7989304|NCT03275389|12566068|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
7989305|NCT03275389|12566069|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7989306|NCT03275389|12566070|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7989307|NCT03275389|12566061|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7989308|NCT03275389|12566062|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
7989309|NCT03275389|12566063|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7989310|NCT03275389|12566064|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
7989311|NCT03275389|12566065|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7989312|NCT03275389|12566066|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7989313|NCT03275389|12566067|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7989314|NCT03275389|12566068|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7989315|NCT03275389|12566069|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7989316|NCT03275389|12566070|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7989317|NCT03275389|12566061|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7989318|NCT03275389|12566062|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7989319|NCT03275389|12566063|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
7989320|NCT03275389|12566064|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7989321|NCT03275389|12566065|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7989322|NCT03275389|12566066|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7989323|NCT03275389|12566067|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7989324|NCT03275389|12566068|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7989325|NCT03275389|12566069|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7989326|NCT03275389|12566070|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
7989327|NCT03275389|12566061|FG000|Overall Study|Other|0
7989328|NCT03275389|12566062|FG001|Overall Study|Other|4
7989329|NCT03275389|12566063|FG002|Overall Study|Other|3
7989330|NCT03275389|12566064|FG003|Overall Study|Other|2
7989331|NCT03275389|12566065|FG004|Overall Study|Other|2
7989332|NCT03275389|12566066|FG005|Overall Study|Other|2
7989333|NCT03275389|12566067|FG006|Overall Study|Other|0
7989334|NCT03275389|12566068|FG007|Overall Study|Other|0
7989335|NCT03275389|12566069|FG008|Overall Study|Other|1
7989336|NCT03275389|12566070|FG009|Overall Study|Other|0
7989337|NCT03276026|12566124|FG000|Overall Study|Protocol Violation|1
7989338|NCT03276026|12566125|FG001|Overall Study|Protocol Violation|0
7989339|NCT03276078|12566131|FG000|Overall Study|Adverse Event|1
7989340|NCT03276975|12566155|FG000|Overall Study|Withdrawal by Subject|1
7989341|NCT03276975|12566156|FG001|Overall Study|Withdrawal by Subject|0
7989342|NCT03277352|12566175|FG000|Overall Study|Study Terminated By Sponsor|2
7989343|NCT03277352|12566175|FG000|Overall Study|Withdrawal by Subject|4
7989344|NCT03277352|12566175|FG000|Overall Study|Death|4
7989345|NCT03277794|12566195|FG000|Overall Study|Lost to Follow-up|2
7989346|NCT03277794|12566196|FG001|Overall Study|Lost to Follow-up|4
7989347|NCT03277794|12566195|FG000|Overall Study|Withdrew due to high acuity|1
7989348|NCT03277794|12566196|FG001|Overall Study|Withdrew due to high acuity|0
7989349|NCT03277846|12566205|FG000|Overall Study|Inpatient stay too brief|12
7989350|NCT03277846|12566206|FG001|Overall Study|Inpatient stay too brief|11
7989351|NCT03278028|12566214|FG000|Overall Study|Lost to Follow-up|1
7989352|NCT03278028|12566215|FG001|Overall Study|Lost to Follow-up|0
7989353|NCT03278028|12566214|FG000|Overall Study|Withdrawal by Subject|3
7989354|NCT03278028|12566215|FG001|Overall Study|Withdrawal by Subject|1
7989355|NCT03278028|12566214|FG000|Overall Study|Pregnancy|0
7989356|NCT03278028|12566215|FG001|Overall Study|Pregnancy|1
7989357|NCT03278106|12566239|FG000|Overall Study|No protocol treatment|1
7989358|NCT03278613|12566254|FG000|Overall Study|Lost to Follow-up|3
7989359|NCT03278613|12566255|FG001|Overall Study|Lost to Follow-up|1
7989360|NCT03280108|12566293|FG000|Overall Study|Lost to Follow-up|2
7989361|NCT03280108|12566294|FG001|Overall Study|Lost to Follow-up|0
7989362|NCT03280121|12566305|FG000|Overall Study|Physician Decision|1
7989363|NCT03280121|12566305|FG000|Overall Study|Lost to Follow-up|1
7989364|NCT03280121|12566305|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4
7989365|NCT03280264|12566309|FG000|Overall Study|Adverse Event|1
7989366|NCT03280264|12566309|FG000|Overall Study|Physician Decision|1
7989367|NCT03280264|12566309|FG000|Overall Study|Withdrawal by Subject|1
7989368|NCT03280381|12566316|FG000|Overall Study|Physician Decision|0
7989369|NCT03280381|12566317|FG001|Overall Study|Physician Decision|2
7989370|NCT03280537|12566326|FG000|Overall Study|Withdrawal by Subject|2
7989371|NCT03280537|12566327|FG001|Overall Study|Withdrawal by Subject|4
7989372|NCT03280550|12566335|FG000|Overall Study|Withdrawal by Subject|2
7989373|NCT03280550|12566336|FG001|Overall Study|Withdrawal by Subject|2
7989374|NCT03280550|12566335|FG000|Overall Study|Physician Decision|0
7989375|NCT03280550|12566336|FG001|Overall Study|Physician Decision|1
7989376|NCT03280615|12566344|FG000|Overall Study|Lost to Follow-up|1
7989377|NCT03280615|12566345|FG001|Overall Study|Lost to Follow-up|2
7989378|NCT03280615|12566344|FG000|Overall Study|Adverse Event|1
7989379|NCT03280615|12566345|FG001|Overall Study|Adverse Event|1
7989380|NCT03280615|12566344|FG000|Overall Study|Withdrawal by Subject|2
7989381|NCT03280615|12566345|FG001|Overall Study|Withdrawal by Subject|2
7989382|NCT03281577|12566363|FG000|Overall Study|Adverse Event|0
7989383|NCT03281577|12566364|FG001|Overall Study|Adverse Event|0
7989384|NCT03281577|12566365|FG002|Overall Study|Adverse Event|0
7989385|NCT03281577|12566366|FG003|Overall Study|Adverse Event|1
7989386|NCT03281577|12566363|FG000|Overall Study|Withdrawal by Subject|1
7989387|NCT03281577|12566364|FG001|Overall Study|Withdrawal by Subject|0
7989388|NCT03281577|12566365|FG002|Overall Study|Withdrawal by Subject|0
7989389|NCT03281577|12566366|FG003|Overall Study|Withdrawal by Subject|0
7989390|NCT03281668|12566379|FG000|Overall Study|Physician Decision|1
7989391|NCT03281668|12566379|FG000|Overall Study|scheduling conflict, family circumstance|2
7989392|NCT03281668|12566379|FG000|Overall Study|Withdrawal by Subject|4
7989393|NCT03281668|12566379|FG000|Overall Study|Lost to Follow-up|1
7989394|NCT03281876|12566385|FG000|Overall Study|Adverse Event|4
7989395|NCT03281876|12566386|FG001|Overall Study|Adverse Event|15
7989396|NCT03281876|12566385|FG000|Overall Study|Lost to Follow-up|1
7989397|NCT03281876|12566386|FG001|Overall Study|Lost to Follow-up|4
7989398|NCT03281876|12566385|FG000|Overall Study|Withdrawal by Subject|11
7989399|NCT03281876|12566386|FG001|Overall Study|Withdrawal by Subject|15
7989400|NCT03281876|12566385|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
7989401|NCT03281876|12566386|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7989402|NCT03281876|12566385|FG000|Overall Study|OTHER|5
7989403|NCT03281876|12566386|FG001|Overall Study|OTHER|5
7989404|NCT03282227|12566403|FG000|Overall Study|Exposure Goals Achieved|60
7989405|NCT03282227|12566403|FG000|Overall Study|Non-compliance w/ protocol requirements|79
7989406|NCT03282227|12566403|FG000|Overall Study|Adverse Event|15
7989407|NCT03282227|12566403|FG000|Overall Study|Lost to Follow-up|21
7989408|NCT03282227|12566403|FG000|Overall Study|Withdrawal by Subject|20
7989409|NCT03282227|12566403|FG000|Overall Study|Lack of Efficacy|12
7989410|NCT03282227|12566403|FG000|Overall Study|Sponsor decision|3
7989411|NCT03282227|12566403|FG000|Overall Study|Physician Decision|2
7989412|NCT03282227|12566403|FG000|Overall Study|Pregnancy|2
7989413|NCT03282227|12566403|FG000|Overall Study|Other|1
7989414|NCT03282357|12566407|FG000|Overall Study|Lost to Follow-up|3
7989415|NCT03282357|12566407|FG000|Overall Study|Withdrawal by Subject|4
7989416|NCT03282357|12566407|FG000|Overall Study|Adverse Event|1
7989417|NCT03282357|12566407|FG000|Overall Study|Other|9
7989418|NCT03283098|12566437|FG000|Overall Study|Withdrawal by Subject|0
7989419|NCT03283098|12566438|FG001|Overall Study|Withdrawal by Subject|1
7989420|NCT03283319|12566450|FG000|Overall Study|Lost to Follow-up|5
7989421|NCT03283319|12566451|FG001|Overall Study|Lost to Follow-up|4
7989422|NCT03283319|12566452|FG002|Overall Study|Lost to Follow-up|5
7989423|NCT03283319|12566453|FG003|Overall Study|Lost to Follow-up|5
7989424|NCT03283319|12566454|FG004|Overall Study|Lost to Follow-up|4
7989425|NCT03283319|12566455|FG005|Overall Study|Lost to Follow-up|3
7989426|NCT03283319|12566450|FG000|Overall Study|Withdrawal by Subject|2
7989427|NCT03283319|12566451|FG001|Overall Study|Withdrawal by Subject|2
7989428|NCT03283319|12566452|FG002|Overall Study|Withdrawal by Subject|2
7989429|NCT03283319|12566453|FG003|Overall Study|Withdrawal by Subject|1
7989430|NCT03283319|12566454|FG004|Overall Study|Withdrawal by Subject|0
7989431|NCT03283319|12566455|FG005|Overall Study|Withdrawal by Subject|1
7989432|NCT03283319|12566450|FG000|Overall Study|BARDA regulatory agency or IRB decision|0
7989433|NCT03283319|12566451|FG001|Overall Study|BARDA regulatory agency or IRB decision|0
7989434|NCT03283319|12566452|FG002|Overall Study|BARDA regulatory agency or IRB decision|0
7989435|NCT03283319|12566453|FG003|Overall Study|BARDA regulatory agency or IRB decision|1
7989436|NCT03283319|12566454|FG004|Overall Study|BARDA regulatory agency or IRB decision|0
7989437|NCT03283319|12566455|FG005|Overall Study|BARDA regulatory agency or IRB decision|0
7989438|NCT03283553|12566480|FG000|Patient Participant Flow|Death|5
7989439|NCT03283553|12566481|FG001|Patient Participant Flow|Death|10
7989440|NCT03283553|12566480|FG000|Patient Participant Flow|Withdrawal by Subject|4
7989441|NCT03283553|12566481|FG001|Patient Participant Flow|Withdrawal by Subject|2
7989442|NCT03283553|12566480|FG000|Patient Participant Flow|Lost to Follow-up|1
7989443|NCT03283553|12566481|FG001|Patient Participant Flow|Lost to Follow-up|1
7989444|NCT03283553|12566480|FG000|Care Partner Participant Flow|Withdrawal by Subject|4
7989445|NCT03283553|12566481|FG001|Care Partner Participant Flow|Withdrawal by Subject|3
7989446|NCT03283553|12566480|FG000|Care Partner Participant Flow|Lost to Follow-up|1
7989447|NCT03283553|12566481|FG001|Care Partner Participant Flow|Lost to Follow-up|1
7989448|NCT03283553|12566480|FG000|Care Partner Participant Flow|Discontinued because patient death|5
7989449|NCT03283553|12566481|FG001|Care Partner Participant Flow|Discontinued because patient death|11
7989450|NCT03283696|12566491|FG000|Overall Study|Physician Decision|5
7989451|NCT03283696|12566492|FG001|Overall Study|Physician Decision|6
7989452|NCT03283696|12566491|FG000|Overall Study|Withdrawal by Subject|2
7989453|NCT03283696|12566492|FG001|Overall Study|Withdrawal by Subject|0
7989454|NCT03284229|12566514|FG000|Overall Study|Lost to Follow-up|3
7989455|NCT03284710|12566552|FG000|Overall Study|Withdrawal by Subject|1
7989456|NCT03284710|12566553|FG001|Overall Study|Withdrawal by Subject|0
7989457|NCT03284710|12566554|FG002|Overall Study|Withdrawal by Subject|1
7989458|NCT03284710|12566555|FG003|Overall Study|Withdrawal by Subject|6
7989459|NCT03284710|12566552|FG000|Overall Study|Lost to Follow-up|3
7989460|NCT03284710|12566553|FG001|Overall Study|Lost to Follow-up|3
7989461|NCT03284710|12566554|FG002|Overall Study|Lost to Follow-up|1
7989462|NCT03284710|12566555|FG003|Overall Study|Lost to Follow-up|0
7989463|NCT03284710|12566552|FG000|Overall Study|Physician Decision|1
7989464|NCT03284710|12566553|FG001|Overall Study|Physician Decision|0
7989465|NCT03284710|12566554|FG002|Overall Study|Physician Decision|0
7989466|NCT03284710|12566555|FG003|Overall Study|Physician Decision|0
7989467|NCT03284710|12566552|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1
7989468|NCT03284710|12566553|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0
7989469|NCT03284710|12566554|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0
7989470|NCT03284710|12566555|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1
7989471|NCT03284710|12566552|FG000|Overall Study|HIV Infection|0
7989472|NCT03284710|12566553|FG001|Overall Study|HIV Infection|2
7989473|NCT03284710|12566554|FG002|Overall Study|HIV Infection|2
7989474|NCT03284710|12566555|FG003|Overall Study|HIV Infection|1
7989475|NCT03285113|12566579|FG000|Overall Study|Unable to implant leads|2
7989476|NCT03285295|12566588|FG000|Alinity s HBsAg|Protocol Violation|11
7989477|NCT03285295|12566589|FG001|Alinity s HBsAg|Protocol Violation|0
7989478|NCT03285295|12566590|FG002|Alinity s HBsAg|Protocol Violation|0
7989479|NCT03285295|12566591|FG003|Alinity s HBsAg|Protocol Violation|0
7989480|NCT03285295|12566592|FG004|Alinity s HBsAg|Protocol Violation|0
7989481|NCT03285295|12566588|FG000|Alinity s HBsAg|No Result on Comparator Assay|17
7989482|NCT03285295|12566589|FG001|Alinity s HBsAg|No Result on Comparator Assay|0
7989483|NCT03285295|12566590|FG002|Alinity s HBsAg|No Result on Comparator Assay|0
7989484|NCT03285295|12566591|FG003|Alinity s HBsAg|No Result on Comparator Assay|0
7989485|NCT03285295|12566592|FG004|Alinity s HBsAg|No Result on Comparator Assay|0
7989486|NCT03285295|12566588|FG000|Alinity s HBsAg|No Results Generated|74
7989487|NCT03285295|12566589|FG001|Alinity s HBsAg|No Results Generated|6
7989488|NCT03285295|12566590|FG002|Alinity s HBsAg|No Results Generated|0
7989489|NCT03285295|12566591|FG003|Alinity s HBsAg|No Results Generated|0
7989490|NCT03285295|12566592|FG004|Alinity s HBsAg|No Results Generated|0
7989491|NCT03285295|12566588|FG000|Alinity s HTLV I/II|Protocol Violation|6
7989492|NCT03285295|12566589|FG001|Alinity s HTLV I/II|Protocol Violation|0
7989493|NCT03285295|12566590|FG002|Alinity s HTLV I/II|Protocol Violation|0
7989494|NCT03285295|12566591|FG003|Alinity s HTLV I/II|Protocol Violation|0
7989495|NCT03285295|12566592|FG004|Alinity s HTLV I/II|Protocol Violation|0
7989496|NCT03285295|12566588|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15
7989497|NCT03285295|12566589|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0
7989498|NCT03285295|12566590|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0
7989499|NCT03285295|12566591|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0
7989500|NCT03285295|12566592|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0
7989501|NCT03285295|12566588|FG000|Alinity s HTLV I/II|No Results Generated|70
7989502|NCT03285295|12566589|FG001|Alinity s HTLV I/II|No Results Generated|0
7989503|NCT03285295|12566590|FG002|Alinity s HTLV I/II|No Results Generated|0
7989504|NCT03285295|12566591|FG003|Alinity s HTLV I/II|No Results Generated|0
7989505|NCT03285295|12566592|FG004|Alinity s HTLV I/II|No Results Generated|0
7989506|NCT03285295|12566588|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4
7989507|NCT03285295|12566589|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
7989508|NCT03285295|12566590|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
7989509|NCT03285295|12566591|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
7989510|NCT03285295|12566592|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
7989511|NCT03285295|12566588|FG000|Alinity s Anti-HCV|Protocol Violation|12
7989512|NCT03285295|12566589|FG001|Alinity s Anti-HCV|Protocol Violation|0
7989513|NCT03285295|12566590|FG002|Alinity s Anti-HCV|Protocol Violation|0
7989514|NCT03285295|12566591|FG003|Alinity s Anti-HCV|Protocol Violation|0
7989515|NCT03285295|12566592|FG004|Alinity s Anti-HCV|Protocol Violation|0
7989516|NCT03285295|12566588|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13
7989517|NCT03285295|12566589|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0
7989518|NCT03285295|12566590|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0
7989519|NCT03285295|12566591|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0
7989520|NCT03285295|12566592|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0
7989521|NCT03285295|12566588|FG000|Alinity s Anti-HCV|No Results Generated|71
7989522|NCT03285295|12566589|FG001|Alinity s Anti-HCV|No Results Generated|0
7989523|NCT03285295|12566590|FG002|Alinity s Anti-HCV|No Results Generated|0
7989524|NCT03285295|12566591|FG003|Alinity s Anti-HCV|No Results Generated|0
7989525|NCT03285295|12566592|FG004|Alinity s Anti-HCV|No Results Generated|0
7989526|NCT03285295|12566588|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18
7989527|NCT03285295|12566589|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7989528|NCT03285295|12566590|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7989529|NCT03285295|12566591|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7989530|NCT03285295|12566592|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7989531|NCT03285295|12566588|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11
7989532|NCT03285295|12566589|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7989533|NCT03285295|12566590|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7989534|NCT03285295|12566591|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7989535|NCT03285295|12566592|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7989536|NCT03285295|12566588|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16
7989537|NCT03285295|12566589|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7989538|NCT03285295|12566590|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7989539|NCT03285295|12566591|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7989540|NCT03285295|12566592|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7989541|NCT03285295|12566588|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72
7989542|NCT03285295|12566589|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7989543|NCT03285295|12566590|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7989544|NCT03285295|12566591|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7989545|NCT03285295|12566592|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7989546|NCT03285295|12566588|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11
7989547|NCT03285295|12566589|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7989548|NCT03285295|12566590|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7989549|NCT03285295|12566591|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7989550|NCT03285295|12566592|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7989551|NCT03285295|12566588|FG000|Alinity s Anti-HBc|Protocol Violation|8
7989552|NCT03285295|12566589|FG001|Alinity s Anti-HBc|Protocol Violation|0
7989553|NCT03285295|12566590|FG002|Alinity s Anti-HBc|Protocol Violation|0
7989554|NCT03285295|12566591|FG003|Alinity s Anti-HBc|Protocol Violation|0
7989555|NCT03285295|12566592|FG004|Alinity s Anti-HBc|Protocol Violation|0
7989556|NCT03285295|12566588|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13
7989557|NCT03285295|12566589|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1
7989558|NCT03285295|12566590|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0
7989559|NCT03285295|12566591|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0
7989560|NCT03285295|12566592|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0
7989561|NCT03285295|12566588|FG000|Alinity s Anti-HBc|No Results Generated|70
7989562|NCT03285295|12566589|FG001|Alinity s Anti-HBc|No Results Generated|0
7989563|NCT03285295|12566590|FG002|Alinity s Anti-HBc|No Results Generated|0
7989564|NCT03285295|12566591|FG003|Alinity s Anti-HBc|No Results Generated|0
7989565|NCT03285295|12566592|FG004|Alinity s Anti-HBc|No Results Generated|0
7989566|NCT03285295|12566588|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14
7989567|NCT03285295|12566589|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7989568|NCT03285295|12566590|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7989569|NCT03285295|12566591|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7989570|NCT03285295|12566592|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7989571|NCT03285295|12566588|FG000|Alinity s Chagas|Protocol Violation|76
7989572|NCT03285295|12566589|FG001|Alinity s Chagas|Protocol Violation|0
7989573|NCT03285295|12566590|FG002|Alinity s Chagas|Protocol Violation|0
7989574|NCT03285295|12566591|FG003|Alinity s Chagas|Protocol Violation|0
7989575|NCT03285295|12566592|FG004|Alinity s Chagas|Protocol Violation|0
7989576|NCT03285295|12566588|FG000|Alinity s Chagas|No Results on Comparator Assay|38
7989577|NCT03285295|12566589|FG001|Alinity s Chagas|No Results on Comparator Assay|0
7989578|NCT03285295|12566590|FG002|Alinity s Chagas|No Results on Comparator Assay|0
7989579|NCT03285295|12566591|FG003|Alinity s Chagas|No Results on Comparator Assay|0
7989580|NCT03285295|12566592|FG004|Alinity s Chagas|No Results on Comparator Assay|0
7989581|NCT03285295|12566588|FG000|Alinity s Chagas|No Results Generated|105
7989582|NCT03285295|12566589|FG001|Alinity s Chagas|No Results Generated|0
7989583|NCT03285295|12566590|FG002|Alinity s Chagas|No Results Generated|0
7989584|NCT03285295|12566591|FG003|Alinity s Chagas|No Results Generated|0
7989585|NCT03285295|12566592|FG004|Alinity s Chagas|No Results Generated|0
7989586|NCT03285295|12566588|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13
7989587|NCT03285295|12566589|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7989588|NCT03285295|12566590|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7989589|NCT03285295|12566591|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7989590|NCT03285295|12566592|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7989591|NCT03285308|12566623|FG000|Overall Study|Adverse Event|3
7989592|NCT03285308|12566624|FG001|Overall Study|Adverse Event|7
7989593|NCT03285308|12566623|FG000|Overall Study|Withdrawal by Subject|8
7989594|NCT03285308|12566624|FG001|Overall Study|Withdrawal by Subject|9
7989595|NCT03285308|12566623|FG000|Overall Study|Lost to Follow-up|3
7989596|NCT03285308|12566624|FG001|Overall Study|Lost to Follow-up|1
7989597|NCT03285308|12566623|FG000|Overall Study|Protocol Deviation|6
7989598|NCT03285308|12566624|FG001|Overall Study|Protocol Deviation|5
7989599|NCT03285308|12566623|FG000|Overall Study|Reason not Specified|0
7989600|NCT03285308|12566624|FG001|Overall Study|Reason not Specified|1
7989601|NCT03285477|12566645|FG000|Treatment and Response Assessment Period|Death|1
7989602|NCT03285477|12566646|FG001|Treatment and Response Assessment Period|Death|0
7989603|NCT03285477|12566645|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1
7989604|NCT03285477|12566646|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0
7989605|NCT03285477|12566645|FG000|Recurrence Follow-up Period|Lost to Follow-up|0
7989606|NCT03285477|12566646|FG001|Recurrence Follow-up Period|Lost to Follow-up|1
7989607|NCT03285477|12566645|FG000|Recurrence Follow-up Period|Withdrawal of consent|1
7989608|NCT03285477|12566646|FG001|Recurrence Follow-up Period|Withdrawal of consent|3
7989609|NCT03285477|12566645|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5
7989610|NCT03285477|12566646|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51
7989611|NCT03285490|12566655|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0
7989612|NCT03285490|12566656|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1
7989613|NCT03285490|12566655|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18
7989614|NCT03285490|12566656|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60
7989615|NCT03285594|12566693|FG000|Overall Study|At the Participant's Own Request|10
7989616|NCT03285594|12566694|FG001|Overall Study|At the Participant's Own Request|5
7989617|NCT03285594|12566695|FG002|Overall Study|At the Participant's Own Request|21
7989618|NCT03285594|12566693|FG000|Overall Study|Adverse Event|2
7989619|NCT03285594|12566694|FG001|Overall Study|Adverse Event|2
7989620|NCT03285594|12566695|FG002|Overall Study|Adverse Event|6
7989621|NCT03285594|12566693|FG000|Overall Study|Poor Compliance to Protocol|0
7989622|NCT03285594|12566694|FG001|Overall Study|Poor Compliance to Protocol|0
7989623|NCT03285594|12566695|FG002|Overall Study|Poor Compliance to Protocol|1
7989624|NCT03285594|12566693|FG000|Overall Study|Lost to Follow-up|0
7989625|NCT03285594|12566694|FG001|Overall Study|Lost to Follow-up|0
7989626|NCT03285594|12566695|FG002|Overall Study|Lost to Follow-up|1
7989627|NCT03285594|12566693|FG000|Overall Study|Reason Not Specified|3
7989628|NCT03285594|12566694|FG001|Overall Study|Reason Not Specified|4
7989629|NCT03285594|12566695|FG002|Overall Study|Reason Not Specified|8
7989630|NCT03285646|12566706|FG000|Overall Study|Adverse Event|1
7989631|NCT03285646|12566707|FG001|Overall Study|Adverse Event|0
7989632|NCT03285646|12566706|FG000|Overall Study|Withdrawal by Subject|10
7989633|NCT03285646|12566707|FG001|Overall Study|Withdrawal by Subject|2
7989634|NCT03285646|12566706|FG000|Overall Study|Lost to Follow-up|2
7989635|NCT03285646|12566707|FG001|Overall Study|Lost to Follow-up|1
7989636|NCT03285646|12566706|FG000|Overall Study|Investigator/Sponsor Decision|0
7989637|NCT03285646|12566707|FG001|Overall Study|Investigator/Sponsor Decision|1
7989638|NCT03285711|12566716|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2
7989639|NCT03285711|12566717|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1
7989640|NCT03285711|12566718|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0
7989641|NCT03285711|12566719|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0
7989642|NCT03285711|12566716|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1
7989643|NCT03285711|12566717|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0
7989644|NCT03285711|12566718|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0
7989645|NCT03285711|12566719|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0
7989646|NCT03285711|12566716|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
7989647|NCT03285711|12566717|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
7989648|NCT03285711|12566718|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1
7989649|NCT03285711|12566719|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
7989650|NCT03285711|12566716|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
7989651|NCT03285711|12566717|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1
7989652|NCT03285711|12566718|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
7989653|NCT03285711|12566719|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
7989654|NCT03285958|12566735|FG000|Overall Study|Lost to Follow-up|1
7989655|NCT03285958|12566736|FG001|Overall Study|Lost to Follow-up|1
7989656|NCT03285958|12566735|FG000|Overall Study|Withdrawal by Subject|1
7989657|NCT03285958|12566736|FG001|Overall Study|Withdrawal by Subject|0
7989658|NCT03285958|12566735|FG000|Overall Study|Not able to attend required orientation|3
7989659|NCT03285958|12566736|FG001|Overall Study|Not able to attend required orientation|0
7989660|NCT03286218|12566755|FG000|Qualification Phase Period 1|Adverse Event|1
7989661|NCT03286218|12566756|FG001|Qualification Phase Period 1|Adverse Event|0
7989662|NCT03286218|12566757|FG002|Qualification Phase Period 1|Adverse Event|0
7989663|NCT03286218|12566758|FG003|Qualification Phase Period 1|Adverse Event|0
7989664|NCT03286218|12566759|FG004|Qualification Phase Period 1|Adverse Event|0
7989665|NCT03286218|12566760|FG005|Qualification Phase Period 1|Adverse Event|0
7989666|NCT03286218|12566761|FG006|Qualification Phase Period 1|Adverse Event|0
7989667|NCT03286218|12566762|FG007|Qualification Phase Period 1|Adverse Event|0
7989668|NCT03286218|12566763|FG008|Qualification Phase Period 1|Adverse Event|0
7989669|NCT03286218|12566764|FG009|Qualification Phase Period 1|Adverse Event|0
7989670|NCT03286218|12566765|FG010|Qualification Phase Period 1|Adverse Event|0
7989671|NCT03286218|12566766|FG011|Qualification Phase Period 1|Adverse Event|0
7989672|NCT03286218|12566755|FG000|Qualification Phase Period 1|Withdrawal by Subject|0
7989673|NCT03286218|12566756|FG001|Qualification Phase Period 1|Withdrawal by Subject|1
7989674|NCT03286218|12566757|FG002|Qualification Phase Period 1|Withdrawal by Subject|0
7989675|NCT03286218|12566758|FG003|Qualification Phase Period 1|Withdrawal by Subject|0
7989676|NCT03286218|12566759|FG004|Qualification Phase Period 1|Withdrawal by Subject|0
7989677|NCT03286218|12566760|FG005|Qualification Phase Period 1|Withdrawal by Subject|0
7989678|NCT03286218|12566761|FG006|Qualification Phase Period 1|Withdrawal by Subject|0
7989679|NCT03286218|12566762|FG007|Qualification Phase Period 1|Withdrawal by Subject|0
7989680|NCT03286218|12566763|FG008|Qualification Phase Period 1|Withdrawal by Subject|0
7989681|NCT03286218|12566764|FG009|Qualification Phase Period 1|Withdrawal by Subject|0
7989682|NCT03286218|12566765|FG010|Qualification Phase Period 1|Withdrawal by Subject|0
7989683|NCT03286218|12566766|FG011|Qualification Phase Period 1|Withdrawal by Subject|0
7989684|NCT03286218|12566755|FG000|Qualification Phase Period 2|Adverse Event|0
7989685|NCT03286218|12566756|FG001|Qualification Phase Period 2|Adverse Event|1
7989686|NCT03286218|12566757|FG002|Qualification Phase Period 2|Adverse Event|0
7989687|NCT03286218|12566758|FG003|Qualification Phase Period 2|Adverse Event|0
7989688|NCT03286218|12566759|FG004|Qualification Phase Period 2|Adverse Event|0
7989689|NCT03286218|12566760|FG005|Qualification Phase Period 2|Adverse Event|0
7989690|NCT03286218|12566761|FG006|Qualification Phase Period 2|Adverse Event|0
7989691|NCT03286218|12566762|FG007|Qualification Phase Period 2|Adverse Event|0
7989692|NCT03286218|12566763|FG008|Qualification Phase Period 2|Adverse Event|0
7989693|NCT03286218|12566764|FG009|Qualification Phase Period 2|Adverse Event|0
7989694|NCT03286218|12566765|FG010|Qualification Phase Period 2|Adverse Event|0
7989695|NCT03286218|12566766|FG011|Qualification Phase Period 2|Adverse Event|0
7989696|NCT03286218|12566755|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14
7989697|NCT03286218|12566756|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15
7989698|NCT03286218|12566757|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0
7989699|NCT03286218|12566758|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0
7989700|NCT03286218|12566759|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0
7989701|NCT03286218|12566760|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0
7989702|NCT03286218|12566761|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0
7989703|NCT03286218|12566762|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0
7989704|NCT03286218|12566763|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0
7989705|NCT03286218|12566764|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0
7989706|NCT03286218|12566765|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0
7989707|NCT03286218|12566766|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0
7989708|NCT03286218|12566755|FG000|Qualification Phase Period 2|Lost to Follow-up|0
7989709|NCT03286218|12566756|FG001|Qualification Phase Period 2|Lost to Follow-up|1
7989710|NCT03286218|12566757|FG002|Qualification Phase Period 2|Lost to Follow-up|0
7989711|NCT03286218|12566758|FG003|Qualification Phase Period 2|Lost to Follow-up|0
7989712|NCT03286218|12566759|FG004|Qualification Phase Period 2|Lost to Follow-up|0
7989713|NCT03286218|12566760|FG005|Qualification Phase Period 2|Lost to Follow-up|0
7989714|NCT03286218|12566761|FG006|Qualification Phase Period 2|Lost to Follow-up|0
7989715|NCT03286218|12566762|FG007|Qualification Phase Period 2|Lost to Follow-up|0
7989716|NCT03286218|12566763|FG008|Qualification Phase Period 2|Lost to Follow-up|0
7989717|NCT03286218|12566764|FG009|Qualification Phase Period 2|Lost to Follow-up|0
7989718|NCT03286218|12566765|FG010|Qualification Phase Period 2|Lost to Follow-up|0
7989719|NCT03286218|12566766|FG011|Qualification Phase Period 2|Lost to Follow-up|0
7989720|NCT03286218|12566755|FG000|Qualification Phase Period 2|Protocol Violation|2
7989721|NCT03286218|12566756|FG001|Qualification Phase Period 2|Protocol Violation|0
7989722|NCT03286218|12566757|FG002|Qualification Phase Period 2|Protocol Violation|0
7989723|NCT03286218|12566758|FG003|Qualification Phase Period 2|Protocol Violation|0
7989724|NCT03286218|12566759|FG004|Qualification Phase Period 2|Protocol Violation|0
7989725|NCT03286218|12566760|FG005|Qualification Phase Period 2|Protocol Violation|0
7989726|NCT03286218|12566761|FG006|Qualification Phase Period 2|Protocol Violation|0
7989727|NCT03286218|12566762|FG007|Qualification Phase Period 2|Protocol Violation|0
7989728|NCT03286218|12566763|FG008|Qualification Phase Period 2|Protocol Violation|0
7989729|NCT03286218|12566764|FG009|Qualification Phase Period 2|Protocol Violation|0
7989730|NCT03286218|12566765|FG010|Qualification Phase Period 2|Protocol Violation|0
7989731|NCT03286218|12566766|FG011|Qualification Phase Period 2|Protocol Violation|0
7989732|NCT03286218|12566755|FG000|Qualification Phase Period 2|Withdrawal by Subject|1
7989733|NCT03286218|12566756|FG001|Qualification Phase Period 2|Withdrawal by Subject|2
7989734|NCT03286218|12566757|FG002|Qualification Phase Period 2|Withdrawal by Subject|0
7989735|NCT03286218|12566758|FG003|Qualification Phase Period 2|Withdrawal by Subject|0
7989736|NCT03286218|12566759|FG004|Qualification Phase Period 2|Withdrawal by Subject|0
7989737|NCT03286218|12566760|FG005|Qualification Phase Period 2|Withdrawal by Subject|0
7989738|NCT03286218|12566761|FG006|Qualification Phase Period 2|Withdrawal by Subject|0
7989739|NCT03286218|12566762|FG007|Qualification Phase Period 2|Withdrawal by Subject|0
7989740|NCT03286218|12566763|FG008|Qualification Phase Period 2|Withdrawal by Subject|0
7989741|NCT03286218|12566764|FG009|Qualification Phase Period 2|Withdrawal by Subject|0
7989742|NCT03286218|12566765|FG010|Qualification Phase Period 2|Withdrawal by Subject|0
7989743|NCT03286218|12566766|FG011|Qualification Phase Period 2|Withdrawal by Subject|0
7989744|NCT03286218|12566755|FG000|Treatment Phase Period 1|Withdrawal by Subject|0
7989745|NCT03286218|12566756|FG001|Treatment Phase Period 1|Withdrawal by Subject|0
7989746|NCT03286218|12566757|FG002|Treatment Phase Period 1|Withdrawal by Subject|1
7989747|NCT03286218|12566758|FG003|Treatment Phase Period 1|Withdrawal by Subject|1
7989748|NCT03286218|12566759|FG004|Treatment Phase Period 1|Withdrawal by Subject|0
7989749|NCT03286218|12566760|FG005|Treatment Phase Period 1|Withdrawal by Subject|1
7989750|NCT03286218|12566761|FG006|Treatment Phase Period 1|Withdrawal by Subject|0
7989751|NCT03286218|12566762|FG007|Treatment Phase Period 1|Withdrawal by Subject|0
7989752|NCT03286218|12566763|FG008|Treatment Phase Period 1|Withdrawal by Subject|0
7989753|NCT03286218|12566764|FG009|Treatment Phase Period 1|Withdrawal by Subject|0
7989754|NCT03286218|12566765|FG010|Treatment Phase Period 1|Withdrawal by Subject|0
7989755|NCT03286218|12566766|FG011|Treatment Phase Period 1|Withdrawal by Subject|1
7989756|NCT03286218|12566755|FG000|Treatment Phase Period 4|Withdrawal by Subject|0
7989757|NCT03286218|12566756|FG001|Treatment Phase Period 4|Withdrawal by Subject|0
7989758|NCT03286218|12566757|FG002|Treatment Phase Period 4|Withdrawal by Subject|0
7989759|NCT03286218|12566758|FG003|Treatment Phase Period 4|Withdrawal by Subject|0
7989760|NCT03286218|12566759|FG004|Treatment Phase Period 4|Withdrawal by Subject|0
7989761|NCT03286218|12566760|FG005|Treatment Phase Period 4|Withdrawal by Subject|0
7989762|NCT03286218|12566761|FG006|Treatment Phase Period 4|Withdrawal by Subject|0
7989763|NCT03286218|12566762|FG007|Treatment Phase Period 4|Withdrawal by Subject|0
7989764|NCT03286218|12566763|FG008|Treatment Phase Period 4|Withdrawal by Subject|0
7989765|NCT03286218|12566764|FG009|Treatment Phase Period 4|Withdrawal by Subject|0
7989766|NCT03286218|12566765|FG010|Treatment Phase Period 4|Withdrawal by Subject|0
7989767|NCT03286218|12566766|FG011|Treatment Phase Period 4|Withdrawal by Subject|1
7989768|NCT03286400|12566793|FG000|Overall Study|Death|10
7989769|NCT03286400|12566793|FG000|Overall Study|Lost to Follow-up|10
7989770|NCT03286400|12566793|FG000|Overall Study|Physician Decision|1
7989771|NCT03286400|12566793|FG000|Overall Study|Scheduling difficulty|4
7989772|NCT03286543|12566808|FG000|Consented|Screen failure before randomization|2
7989773|NCT03286543|12566809|FG001|Consented|Screen failure before randomization|0
7989774|NCT03286543|12566810|FG002|Consented|Screen failure before randomization|0
7989775|NCT03286543|12566808|FG000|Consented|Screen failure before enrollment|4
7989776|NCT03286543|12566809|FG001|Consented|Screen failure before enrollment|0
7989777|NCT03286543|12566810|FG002|Consented|Screen failure before enrollment|0
7989778|NCT03286543|12566808|FG000|Consented|TKA cancelled after enrollment|1
7989779|NCT03286543|12566809|FG001|Consented|TKA cancelled after enrollment|0
7989780|NCT03286543|12566810|FG002|Consented|TKA cancelled after enrollment|0
7989781|NCT03286543|12566808|FG000|Consented|Withdrawn from study|12
7989782|NCT03286543|12566809|FG001|Consented|Withdrawn from study|0
7989783|NCT03286543|12566810|FG002|Consented|Withdrawn from study|0
7989784|NCT03286543|12566808|FG000|Study Enrollment|TKA cancelled after enrollment|0
7989785|NCT03286543|12566809|FG001|Study Enrollment|TKA cancelled after enrollment|0
7989786|NCT03286543|12566810|FG002|Study Enrollment|TKA cancelled after enrollment|1
7989787|NCT03286543|12566808|FG000|Study Enrollment|Withdrawn from study|0
7989788|NCT03286543|12566809|FG001|Study Enrollment|Withdrawn from study|6
7989789|NCT03286543|12566810|FG002|Study Enrollment|Withdrawn from study|6
7989790|NCT03286751|12566816|FG000|Washout Period 1|Withdrawal by Subject|0
7989791|NCT03286751|12566817|FG001|Washout Period 1|Withdrawal by Subject|0
7989792|NCT03286751|12566818|FG002|Washout Period 1|Withdrawal by Subject|0
7989793|NCT03286751|12566819|FG003|Washout Period 1|Withdrawal by Subject|0
7989794|NCT03286751|12566820|FG004|Washout Period 1|Withdrawal by Subject|1
7989795|NCT03286751|12566821|FG005|Washout Period 1|Withdrawal by Subject|0
7989796|NCT03286751|12566816|FG000|Washout Period 2|Personal Reasons|0
7989797|NCT03286751|12566817|FG001|Washout Period 2|Personal Reasons|1
7989798|NCT03286751|12566818|FG002|Washout Period 2|Personal Reasons|0
7989799|NCT03286751|12566819|FG003|Washout Period 2|Personal Reasons|0
7989800|NCT03286751|12566820|FG004|Washout Period 2|Personal Reasons|0
7989801|NCT03286751|12566821|FG005|Washout Period 2|Personal Reasons|0
7989802|NCT03286751|12566816|FG000|Washout Period 5|Adverse Event|0
7989803|NCT03286751|12566817|FG001|Washout Period 5|Adverse Event|0
7989804|NCT03286751|12566818|FG002|Washout Period 5|Adverse Event|0
7989805|NCT03286751|12566819|FG003|Washout Period 5|Adverse Event|0
7989806|NCT03286751|12566820|FG004|Washout Period 5|Adverse Event|1
7989807|NCT03286751|12566821|FG005|Washout Period 5|Adverse Event|0
7989808|NCT03287219|12566856|FG000|Overall Study|Protocol Violation|0
7989809|NCT03287219|12566857|FG001|Overall Study|Protocol Violation|2
7989810|NCT03287622|12566931|FG000|Overall Study|Withdrawal by Subject|1
7989811|NCT03287622|12566932|FG001|Overall Study|Withdrawal by Subject|0
7989812|NCT03287622|12566931|FG000|Overall Study|Lost to Follow-up|27
7989813|NCT03287622|12566932|FG001|Overall Study|Lost to Follow-up|15
7989814|NCT03287622|12566931|FG000|Overall Study|No prescripion after surgery|28
7989815|NCT03287622|12566932|FG001|Overall Study|No prescripion after surgery|31
7989816|NCT03287622|12566931|FG000|Overall Study|prolonged Length of stay|2
7989817|NCT03287622|12566932|FG001|Overall Study|prolonged Length of stay|0
7989818|NCT03287622|12566931|FG000|Overall Study|surgery related|0
7989819|NCT03287622|12566932|FG001|Overall Study|surgery related|2
7989820|NCT03287635|12566945|FG000|Overall Study|Lost to Follow-up|5
7989821|NCT03287635|12566945|FG000|Overall Study|Withdrawal by Subject|1
7989822|NCT03287635|12566945|FG000|Overall Study|Physician Decision|1
7989823|NCT03287791|12566957|FG000|Overall Study|Insufficient Therapeutic Response|0
7989824|NCT03287791|12566958|FG001|Overall Study|Insufficient Therapeutic Response|0
7989825|NCT03287791|12566959|FG002|Overall Study|Insufficient Therapeutic Response|1
7989826|NCT03287791|12566957|FG000|Overall Study|Adverse Event|0
7989827|NCT03287791|12566958|FG001|Overall Study|Adverse Event|4
7989828|NCT03287791|12566959|FG002|Overall Study|Adverse Event|3
7989829|NCT03287791|12566957|FG000|Overall Study|Withdrawal by Subject|12
7989830|NCT03287791|12566958|FG001|Overall Study|Withdrawal by Subject|12
7989831|NCT03287791|12566959|FG002|Overall Study|Withdrawal by Subject|17
7989832|NCT03287791|12566957|FG000|Overall Study|Missed more than 6 consecutive doses|3
7989833|NCT03287791|12566958|FG001|Overall Study|Missed more than 6 consecutive doses|2
7989834|NCT03287791|12566959|FG002|Overall Study|Missed more than 6 consecutive doses|2
7989835|NCT03287791|12566957|FG000|Overall Study|Lost to Follow-up|8
7989836|NCT03287791|12566958|FG001|Overall Study|Lost to Follow-up|14
7989837|NCT03287791|12566959|FG002|Overall Study|Lost to Follow-up|11
7989838|NCT03287791|12566957|FG000|Overall Study|Protocol Violation|7
7989839|NCT03287791|12566958|FG001|Overall Study|Protocol Violation|2
7989840|NCT03287791|12566959|FG002|Overall Study|Protocol Violation|1
7989841|NCT03287791|12566957|FG000|Overall Study|Participant was enrolled at 2 sites|1
7989842|NCT03287791|12566958|FG001|Overall Study|Participant was enrolled at 2 sites|0
7989843|NCT03287791|12566959|FG002|Overall Study|Participant was enrolled at 2 sites|1
7989844|NCT03287791|12566957|FG000|Overall Study|Too much time between 2 visits|0
7989845|NCT03287791|12566958|FG001|Overall Study|Too much time between 2 visits|1
7989846|NCT03287791|12566959|FG002|Overall Study|Too much time between 2 visits|0
7989847|NCT03287791|12566957|FG000|Overall Study|Non-compliance|0
7989848|NCT03287791|12566958|FG001|Overall Study|Non-compliance|1
7989849|NCT03287791|12566959|FG002|Overall Study|Non-compliance|0
7989850|NCT03287791|12566957|FG000|Overall Study|Did not meet inclusion criteria|1
7989851|NCT03287791|12566958|FG001|Overall Study|Did not meet inclusion criteria|0
7989852|NCT03287791|12566959|FG002|Overall Study|Did not meet inclusion criteria|0
7989853|NCT03287804|12566967|FG000|Overall Study|Death|1
7989854|NCT03287804|12566967|FG000|Overall Study|Physician Decision|2
7989855|NCT03287804|12566967|FG000|Overall Study|Progressive disease|8
7989856|NCT03287869|12566974|FG000|Overall Study|Adverse Event|14
7989857|NCT03287869|12566975|FG001|Overall Study|Adverse Event|12
7989858|NCT03287869|12566974|FG000|Overall Study|Lack of Efficacy|1
7989859|NCT03287869|12566975|FG001|Overall Study|Lack of Efficacy|0
7989860|NCT03287869|12566974|FG000|Overall Study|Lost to Follow-up|13
7989861|NCT03287869|12566975|FG001|Overall Study|Lost to Follow-up|19
7989862|NCT03287869|12566974|FG000|Overall Study|Non-Compliance With Study Drug|5
7989863|NCT03287869|12566975|FG001|Overall Study|Non-Compliance With Study Drug|9
7989864|NCT03287869|12566974|FG000|Overall Study|Progressive Disease|1
7989865|NCT03287869|12566975|FG001|Overall Study|Progressive Disease|0
7989866|NCT03287869|12566974|FG000|Overall Study|Protocol Deviation|2
7989867|NCT03287869|12566975|FG001|Overall Study|Protocol Deviation|1
7989868|NCT03287869|12566974|FG000|Overall Study|Withdrawal by Subject|36
7989869|NCT03287869|12566975|FG001|Overall Study|Withdrawal by Subject|43
7989870|NCT03287869|12566974|FG000|Overall Study|Early Closure of the Site|0
7989871|NCT03287869|12566975|FG001|Overall Study|Early Closure of the Site|1
7989872|NCT03287869|12566974|FG000|Overall Study|Physician Decision|5
7989873|NCT03287869|12566975|FG001|Overall Study|Physician Decision|5
7989874|NCT03287869|12566974|FG000|Overall Study|Reason not Specified|6
7989875|NCT03287869|12566975|FG001|Overall Study|Reason not Specified|3
7989876|NCT03288714|12566983|FG000|Overall Study|Lost to Follow-up|2
7989877|NCT03288714|12566984|FG001|Overall Study|Lost to Follow-up|1
7989878|NCT03288714|12566983|FG000|Overall Study|Non-compliance with study schedule|2
7989879|NCT03288714|12566984|FG001|Overall Study|Non-compliance with study schedule|0
7989880|NCT03288714|12566983|FG000|Overall Study|Withdrawal by Subject|3
7989881|NCT03288714|12566984|FG001|Overall Study|Withdrawal by Subject|1
7989882|NCT03288714|12566983|FG000|Overall Study|Clinical Worsening|2
7989883|NCT03288714|12566984|FG001|Overall Study|Clinical Worsening|1
7989884|NCT03288714|12566983|FG000|Overall Study|Adverse Event|1
7989885|NCT03288714|12566984|FG001|Overall Study|Adverse Event|0
7989886|NCT03288779|12566992|FG000|Overall Study|Withdrawal by Subject|3
7989887|NCT03288987|12566998|FG000|Overall Study|Protocol Violation|10
7989888|NCT03288987|12566999|FG001|Overall Study|Protocol Violation|4
7989889|NCT03289208|12567008|FG000|Overall Study|Adverse Event|1
7989890|NCT03289208|12567009|FG001|Overall Study|Adverse Event|0
7989891|NCT03289208|12567010|FG002|Overall Study|Adverse Event|0
7989892|NCT03289455|12567034|FG000|Overall Study|Death|1
7989893|NCT03289455|12567035|FG001|Overall Study|Death|0
7989894|NCT03289455|12567036|FG002|Overall Study|Death|0
7989895|NCT03289455|12567034|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0
7989896|NCT03289455|12567035|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1
7989897|NCT03289455|12567036|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0
7989898|NCT03289455|12567034|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
7989899|NCT03289455|12567035|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
7989900|NCT03289455|12567036|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1
7989901|NCT03289455|12567034|FG000|Overall Study|Progressive disease|3
7989902|NCT03289455|12567035|FG001|Overall Study|Progressive disease|4
7989903|NCT03289455|12567036|FG002|Overall Study|Progressive disease|5
7989904|NCT03289533|12567055|FG000|Overall Study|Death|12
7989905|NCT03289533|12567055|FG000|Overall Study|Terminated from study by sponsor|10
7989906|NCT03289676|12567061|FG000|Overall Study|Withdrawal by Subject|2
7989907|NCT03289676|12567062|FG001|Overall Study|Withdrawal by Subject|0
7989908|NCT03289676|12567061|FG000|Overall Study|Protocol Violation|2
7989909|NCT03289676|12567062|FG001|Overall Study|Protocol Violation|0
7989910|NCT03289676|12567061|FG000|Overall Study|Lost to Follow-up|0
7989911|NCT03289676|12567062|FG001|Overall Study|Lost to Follow-up|1
7989912|NCT03291288|12567130|FG000|Drug-drug Interaction Phase|Adverse Event|2
7989913|NCT03291288|12567131|FG001|Drug-drug Interaction Phase|Adverse Event|0
7989914|NCT03291288|12567130|FG000|Drug-drug Interaction Phase|Disease progression|1
7989915|NCT03291288|12567131|FG001|Drug-drug Interaction Phase|Disease progression|0
7989916|NCT03291288|12567130|FG000|Drug-drug Interaction Phase|Other|3
7989917|NCT03291288|12567131|FG001|Drug-drug Interaction Phase|Other|0
7989918|NCT03291288|12567130|FG000|Pexidartinib Only|Ongoing|0
7989919|NCT03291288|12567131|FG001|Pexidartinib Only|Ongoing|2
7989920|NCT03292016|12567160|FG000|Second Washout|Adverse Event|0
7989921|NCT03292016|12567161|FG001|Second Washout|Adverse Event|1
7989922|NCT03292016|12567162|FG002|Second Washout|Adverse Event|0
7989923|NCT03292016|12567163|FG003|Second Washout|Adverse Event|0
7989924|NCT03292016|12567164|FG004|Second Washout|Adverse Event|0
7989925|NCT03292016|12567165|FG005|Second Washout|Adverse Event|0
7989926|NCT03292406|12567176|FG000|Overall Study|Progressive Disease|6
7989927|NCT03292406|12567177|FG001|Overall Study|Progressive Disease|3
7989928|NCT03292406|12567178|FG002|Overall Study|Progressive Disease|4
7989929|NCT03292406|12567176|FG000|Overall Study|Adverse Event|7
7989930|NCT03292406|12567177|FG001|Overall Study|Adverse Event|1
7989931|NCT03292406|12567178|FG002|Overall Study|Adverse Event|4
7989932|NCT03292406|12567176|FG000|Overall Study|Withdrawal by Subject|0
7989933|NCT03292406|12567177|FG001|Overall Study|Withdrawal by Subject|7
7989934|NCT03292406|12567178|FG002|Overall Study|Withdrawal by Subject|2
7989935|NCT03292406|12567176|FG000|Overall Study|Protocol Violation|0
7989936|NCT03292406|12567177|FG001|Overall Study|Protocol Violation|1
7989937|NCT03292406|12567178|FG002|Overall Study|Protocol Violation|1
7989938|NCT03292406|12567176|FG000|Overall Study|Other|0
7989939|NCT03292406|12567177|FG001|Overall Study|Other|1
7989940|NCT03292406|12567178|FG002|Overall Study|Other|2
7989941|NCT03292432|12567188|FG000|Overall Study|Lost to Follow-up|11
7989942|NCT03292432|12567189|FG001|Overall Study|Lost to Follow-up|8
7989943|NCT03292432|12567188|FG000|Overall Study|Death|2
7989944|NCT03292432|12567189|FG001|Overall Study|Death|1
7989945|NCT03292432|12567188|FG000|Overall Study|Withdrawal by Subject|1
7989946|NCT03292432|12567189|FG001|Overall Study|Withdrawal by Subject|2
7989947|NCT03292432|12567188|FG000|Overall Study|Site closed before any data collected|1
7989948|NCT03292432|12567189|FG001|Overall Study|Site closed before any data collected|0
7989949|NCT03292640|12567210|FG000|Overall Study|Withdrawal by Subject|17
7989950|NCT03292640|12567211|FG001|Overall Study|Withdrawal by Subject|16
7989951|NCT03292640|12567210|FG000|Overall Study|Adverse Event|20
7989952|NCT03292640|12567211|FG001|Overall Study|Adverse Event|2
7989953|NCT03292640|12567210|FG000|Overall Study|Lost to Follow-up|24
7989954|NCT03292640|12567211|FG001|Overall Study|Lost to Follow-up|24
7989955|NCT03292653|12567224|FG000|Overall Study|Adverse Event|0
7989956|NCT03292653|12567225|FG001|Overall Study|Adverse Event|0
7989957|NCT03292653|12567226|FG002|Overall Study|Adverse Event|1
7989958|NCT03292653|12567224|FG000|Overall Study|Did not Receive Treatment|1
7989959|NCT03292653|12567225|FG001|Overall Study|Did not Receive Treatment|0
7989960|NCT03292653|12567226|FG002|Overall Study|Did not Receive Treatment|0
7989961|NCT03293394|12567268|FG000|Follow-up (6 Months)|Adverse Event|4
7989962|NCT03293394|12567269|FG001|Follow-up (6 Months)|Adverse Event|2
7989963|NCT03293485|12567275|FG000|Overall Study|Death|1
7989964|NCT03293485|12567275|FG000|Overall Study|Screen Failure|2
7989965|NCT03293485|12567275|FG000|Overall Study|Withdrawal by Subject|2
7989966|NCT03293654|12567284|FG000|Overall Study|Lost to Follow-up|0
7989967|NCT03293654|12567285|FG001|Overall Study|Lost to Follow-up|1
7989968|NCT03293654|12567286|FG002|Overall Study|Lost to Follow-up|0
7989969|NCT03294317|12567298|FG000|Overall Study|Physician Decision|1
7989970|NCT03294317|12567298|FG000|Overall Study|Withdrawal by Subject|6
7989971|NCT03294317|12567298|FG000|Overall Study|Lost to Follow-up|1
7989972|NCT03294317|12567298|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1
7989973|NCT03294317|12567298|FG000|Overall Study|Failed HB lead implant|8
7989974|NCT03294317|12567298|FG000|Overall Study|Received CRT instead|1
7989975|NCT03294317|12567298|FG000|Overall Study|Exited after lead revision|2
7989976|NCT03294538|12567305|FG000|Overall Study|Adverse Event|0
7989977|NCT03294538|12567306|FG001|Overall Study|Adverse Event|1
7989978|NCT03294538|12567307|FG002|Overall Study|Adverse Event|1
7989979|NCT03294538|12567305|FG000|Overall Study|Lost to Follow-up|1
7989980|NCT03294538|12567306|FG001|Overall Study|Lost to Follow-up|0
7989981|NCT03294538|12567307|FG002|Overall Study|Lost to Follow-up|0
7989982|NCT03294538|12567305|FG000|Overall Study|Outside of Visit Window|4
7989983|NCT03294538|12567306|FG001|Overall Study|Outside of Visit Window|4
7989984|NCT03294538|12567307|FG002|Overall Study|Outside of Visit Window|1
7989985|NCT03294681|12567324|FG000|Overall Study|Withdrawal by Subject|1
7989986|NCT03294941|12567339|FG000|Overall Study|Withdrawal by Subject|0
7989987|NCT03294941|12567340|FG001|Overall Study|Withdrawal by Subject|2
7989988|NCT03295201|12567349|FG000|Overall Study|Lost to Follow-up|1
7989989|NCT03295201|12567350|FG001|Overall Study|Lost to Follow-up|1
7989990|NCT03295201|12567349|FG000|Overall Study|Hospital admission|0
7989991|NCT03295201|12567350|FG001|Overall Study|Hospital admission|1
7989992|NCT03295318|12567368|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1
7989993|NCT03295318|12567369|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0
7989994|NCT03295318|12567370|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0
7989995|NCT03295318|12567368|FG000|Overall Study|Death|1
7989996|NCT03295318|12567369|FG001|Overall Study|Death|1
7989997|NCT03295318|12567370|FG002|Overall Study|Death|1
7989998|NCT03295318|12567368|FG000|Overall Study|Protocol Violation|4
7989999|NCT03295318|12567369|FG001|Overall Study|Protocol Violation|3
7990000|NCT03295318|12567370|FG002|Overall Study|Protocol Violation|3
7990001|NCT03295318|12567368|FG000|Overall Study|Withdrawal by Subject|0
7990002|NCT03295318|12567369|FG001|Overall Study|Withdrawal by Subject|0
7990003|NCT03295318|12567370|FG002|Overall Study|Withdrawal by Subject|1
7990004|NCT03295318|12567368|FG000|Overall Study|Subject discontinued due to travel|0
7990005|NCT03295318|12567369|FG001|Overall Study|Subject discontinued due to travel|1
7990006|NCT03295318|12567370|FG002|Overall Study|Subject discontinued due to travel|0
7990007|NCT03295721|12567404|FG000|Overall Study|Adverse Event|1
7990008|NCT03295721|12567405|FG001|Overall Study|Adverse Event|0
7990009|NCT03295721|12567406|FG002|Overall Study|Adverse Event|0
7990010|NCT03295721|12567404|FG000|Overall Study|Lost to Follow-up|1
7990011|NCT03295721|12567405|FG001|Overall Study|Lost to Follow-up|1
7990012|NCT03295721|12567406|FG002|Overall Study|Lost to Follow-up|1
7990013|NCT03295721|12567404|FG000|Overall Study|Withdrawal by Subject|1
7990014|NCT03295721|12567405|FG001|Overall Study|Withdrawal by Subject|0
7990015|NCT03295721|12567406|FG002|Overall Study|Withdrawal by Subject|1
7990016|NCT03295721|12567404|FG000|Overall Study|Death|0
7990017|NCT03295721|12567405|FG001|Overall Study|Death|0
7990018|NCT03295721|12567406|FG002|Overall Study|Death|1
7990019|NCT03296527|12567454|FG000|Overall Study|Adverse Event|15
7990020|NCT03296527|12567455|FG001|Overall Study|Adverse Event|33
7990021|NCT03296527|12567454|FG000|Overall Study|Protocol Deviation|4
7990022|NCT03296527|12567455|FG001|Overall Study|Protocol Deviation|0
7990023|NCT03296527|12567454|FG000|Overall Study|Subject withdrew consent|3
7990024|NCT03296527|12567455|FG001|Overall Study|Subject withdrew consent|1
7990025|NCT03296527|12567454|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9
7990026|NCT03296527|12567455|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14
7990027|NCT03296527|12567454|FG000|Overall Study|Discontinuations due to withdrawal from trial|2
7990028|NCT03296527|12567455|FG001|Overall Study|Discontinuations due to withdrawal from trial|3
7990029|NCT03296527|12567454|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0
7990030|NCT03296527|12567455|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2
7990031|NCT03296527|12567454|FG000|Overall Study|Discontinuation due to liquid in uterus|1
7990032|NCT03296527|12567455|FG001|Overall Study|Discontinuation due to liquid in uterus|0
7990033|NCT03296527|12567454|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1
7990034|NCT03296527|12567455|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0
7990035|NCT03296566|12567464|FG000|Overall Study|Lost to Follow-up|19
7990036|NCT03296566|12567465|FG001|Overall Study|Lost to Follow-up|46
7990037|NCT03296566|12567464|FG000|Overall Study|Withdrawal by Subject|0
7990038|NCT03296566|12567465|FG001|Overall Study|Withdrawal by Subject|3
7990039|NCT03297021|12567520|FG000|Overall Study|Incomplete/illegible data sheet|4
7990040|NCT03297021|12567521|FG001|Overall Study|Incomplete/illegible data sheet|2
7990041|NCT03297021|12567522|FG002|Overall Study|Incomplete/illegible data sheet|3
7990042|NCT03297021|12567520|FG000|Overall Study|Missing Post-Op Data|1
7990043|NCT03297021|12567521|FG001|Overall Study|Missing Post-Op Data|2
7990044|NCT03297021|12567522|FG002|Overall Study|Missing Post-Op Data|1
7990045|NCT03297216|12567536|FG000|Overall Study|Death|0
7990046|NCT03297216|12567537|FG001|Overall Study|Death|1
7990047|NCT03297216|12567536|FG000|Overall Study|Miscarriage|0
7990048|NCT03297216|12567537|FG001|Overall Study|Miscarriage|2
7990049|NCT03297216|12567536|FG000|Overall Study|Lost to Follow-up|3
7990050|NCT03297216|12567537|FG001|Overall Study|Lost to Follow-up|2
7990051|NCT03297294|12567552|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30
7990052|NCT03297294|12567553|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31
7990053|NCT03297294|12567554|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7990054|NCT03297294|12567555|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7990055|NCT03297294|12567556|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7990056|NCT03297294|12567552|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
7990057|NCT03297294|12567553|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
7990058|NCT03297294|12567554|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7990059|NCT03297294|12567555|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7990060|NCT03297294|12567556|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7990061|NCT03297294|12567552|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3
7990062|NCT03297294|12567553|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1
7990063|NCT03297294|12567554|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0
7990064|NCT03297294|12567555|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0
7990065|NCT03297294|12567556|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0
7990066|NCT03297294|12567552|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1
7990067|NCT03297294|12567553|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1
7990068|NCT03297294|12567554|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0
7990069|NCT03297294|12567555|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0
7990070|NCT03297294|12567556|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0
7990071|NCT03297294|12567552|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7990072|NCT03297294|12567553|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7990073|NCT03297294|12567554|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7990074|NCT03297294|12567555|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1
7990075|NCT03297294|12567556|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7990076|NCT03297398|12567571|FG000|Overall Study|Sponsor's decision|6
7990077|NCT03297398|12567572|FG001|Overall Study|Sponsor's decision|9
7990078|NCT03297398|12567573|FG002|Overall Study|Sponsor's decision|7
7990079|NCT03297398|12567571|FG000|Overall Study|Adverse Event|1
7990080|NCT03297398|12567572|FG001|Overall Study|Adverse Event|4
7990081|NCT03297398|12567573|FG002|Overall Study|Adverse Event|4
7990082|NCT03297398|12567571|FG000|Overall Study|Withdrawal by Subject|1
7990083|NCT03297398|12567572|FG001|Overall Study|Withdrawal by Subject|2
7990084|NCT03297398|12567573|FG002|Overall Study|Withdrawal by Subject|2
7990085|NCT03297398|12567571|FG000|Overall Study|Protocol Violation|0
7990086|NCT03297398|12567572|FG001|Overall Study|Protocol Violation|2
7990087|NCT03297398|12567573|FG002|Overall Study|Protocol Violation|0
7990088|NCT03297398|12567571|FG000|Overall Study|Physician Decision|0
7990089|NCT03297398|12567572|FG001|Overall Study|Physician Decision|0
7990090|NCT03297398|12567573|FG002|Overall Study|Physician Decision|1
7990091|NCT03297398|12567571|FG000|Overall Study|Lost to Follow-up|0
7990092|NCT03297398|12567572|FG001|Overall Study|Lost to Follow-up|0
7990093|NCT03297398|12567573|FG002|Overall Study|Lost to Follow-up|1
7990094|NCT03298412|12567621|FG000|Run-in Period|Other, Not Specified|1
7990095|NCT03298412|12567621|FG000|Run-in Period|Disease Progression|1
7990096|NCT03298412|12567621|FG000|Run-in Period|Ineligibility Determined|1
7990097|NCT03298412|12567621|FG000|Run-in Period|Decision by Sponsor|6
7990098|NCT03299101|12567646|FG000|Overall Study|Lost to Follow-up|1
7990099|NCT03299101|12567646|FG000|Overall Study|Withdrawal by Subject|5
7990100|NCT03299101|12567646|FG000|Overall Study|Surgery was changed|3
7990101|NCT03299101|12567646|FG000|Overall Study|Not enough time to complete prehab|1
7990102|NCT03299244|12567652|FG000|Overall Study|Withdrawal by Subject|34
7990103|NCT03299244|12567653|FG001|Overall Study|Withdrawal by Subject|29
7990104|NCT03299244|12567652|FG000|Overall Study|Decision by Sponsor|4
7990105|NCT03299244|12567653|FG001|Overall Study|Decision by Sponsor|5
7990106|NCT03299244|12567652|FG000|Overall Study|Death|9
7990107|NCT03299244|12567653|FG001|Overall Study|Death|4
7990108|NCT03299686|12567662|FG000|Treatment Epoch|Subject/Guardian Decision|2
7990109|NCT03299686|12567663|FG001|Treatment Epoch|Subject/Guardian Decision|0
7990110|NCT03299686|12567662|FG000|Treatment Epoch|Physician Decision|1
7990111|NCT03299686|12567663|FG001|Treatment Epoch|Physician Decision|0
7990112|NCT03299686|12567662|FG000|Treatment Epoch|Adverse Event|8
7990113|NCT03299686|12567663|FG001|Treatment Epoch|Adverse Event|4
7990114|NCT03299686|12567662|FG000|Follow-up Epoch|Subject/Guardian Decision|0
7990115|NCT03299686|12567663|FG001|Follow-up Epoch|Subject/Guardian Decision|1
7990116|NCT03299881|12567671|FG000|Overall Study|Study Termination|17
7990117|NCT03299881|12567672|FG001|Overall Study|Study Termination|13
7990118|NCT03300050|12567683|FG000|Overall Study|Lost to Follow-up|2
7990119|NCT03300050|12567684|FG001|Overall Study|Lost to Follow-up|1
7990120|NCT03300050|12567685|FG002|Overall Study|Lost to Follow-up|0
7990121|NCT03300050|12567686|FG003|Overall Study|Lost to Follow-up|0
7990122|NCT03300050|12567687|FG004|Overall Study|Lost to Follow-up|1
7990123|NCT03300050|12567683|FG000|Overall Study|Withdrawal by Subject|1
7990124|NCT03300050|12567684|FG001|Overall Study|Withdrawal by Subject|1
7990125|NCT03300050|12567685|FG002|Overall Study|Withdrawal by Subject|1
7990126|NCT03300050|12567686|FG003|Overall Study|Withdrawal by Subject|0
7990127|NCT03300050|12567687|FG004|Overall Study|Withdrawal by Subject|0
7990128|NCT03300050|12567683|FG000|Overall Study|Death|0
7990129|NCT03300050|12567684|FG001|Overall Study|Death|0
7990130|NCT03300050|12567685|FG002|Overall Study|Death|1
7990131|NCT03300050|12567686|FG003|Overall Study|Death|0
7990132|NCT03300050|12567687|FG004|Overall Study|Death|0
7990133|NCT03300050|12567683|FG000|Overall Study|Not Eligible at Randomization|0
7990134|NCT03300050|12567684|FG001|Overall Study|Not Eligible at Randomization|0
7990135|NCT03300050|12567685|FG002|Overall Study|Not Eligible at Randomization|1
7990136|NCT03300050|12567686|FG003|Overall Study|Not Eligible at Randomization|1
7990137|NCT03300050|12567687|FG004|Overall Study|Not Eligible at Randomization|0
7990138|NCT03300570|12567701|FG000|Overall Study|Adverse Event|0
7990139|NCT03300570|12567702|FG001|Overall Study|Adverse Event|1
7990140|NCT03300570|12567701|FG000|Overall Study|Withdrawal by Subject|1
7990141|NCT03300570|12567702|FG001|Overall Study|Withdrawal by Subject|0
7990142|NCT03300570|12567701|FG000|Overall Study|Inadequate bowel prep|1
7990143|NCT03300570|12567702|FG001|Overall Study|Inadequate bowel prep|0
7990144|NCT03301155|12567733|FG000|Overall Study|Сompliance with exclusion criteria|8
7990145|NCT03301155|12567734|FG001|Overall Study|Сompliance with exclusion criteria|7
7990146|NCT03301623|12567781|FG000|Overall Study|Death|3
7990147|NCT03301623|12567782|FG001|Overall Study|Death|1
7990148|NCT03301623|12567781|FG000|Overall Study|Withdrawal by Subject|11
7990149|NCT03301623|12567782|FG001|Overall Study|Withdrawal by Subject|13
7990150|NCT03301623|12567781|FG000|Overall Study|Lost to Follow-up|3
7990151|NCT03301623|12567782|FG001|Overall Study|Lost to Follow-up|1
7990152|NCT03301649|12567791|FG000|Overall Study|Need alternate therapy due to live lice|17
7990153|NCT03301649|12567792|FG001|Overall Study|Need alternate therapy due to live lice|25
7990154|NCT03301649|12567793|FG002|Overall Study|Need alternate therapy due to live lice|81
7990155|NCT03301649|12567791|FG000|Overall Study|Lost to Follow-up|11
7990156|NCT03301649|12567792|FG001|Overall Study|Lost to Follow-up|11
7990157|NCT03301649|12567793|FG002|Overall Study|Lost to Follow-up|3
7990158|NCT03301649|12567791|FG000|Overall Study|Protocol Violation|0
7990159|NCT03301649|12567792|FG001|Overall Study|Protocol Violation|1
7990160|NCT03301649|12567793|FG002|Overall Study|Protocol Violation|1
7990161|NCT03301649|12567791|FG000|Overall Study|Withdrawal by Subject|10
7990162|NCT03301649|12567792|FG001|Overall Study|Withdrawal by Subject|4
7990163|NCT03301649|12567793|FG002|Overall Study|Withdrawal by Subject|0
7990164|NCT03301649|12567791|FG000|Overall Study|Other than specified|5
7990165|NCT03301649|12567792|FG001|Overall Study|Other than specified|3
7990166|NCT03301649|12567793|FG002|Overall Study|Other than specified|0
7990167|NCT03301714|12567804|FG000|Overall Study|Lost to Follow-up|10
7990168|NCT03301714|12567805|FG001|Overall Study|Lost to Follow-up|4
7990169|NCT03301714|12567806|FG002|Overall Study|Lost to Follow-up|4
7990170|NCT03301714|12567804|FG000|Overall Study|Did not receive allocated intervention|0
7990171|NCT03301714|12567805|FG001|Overall Study|Did not receive allocated intervention|2
7990172|NCT03301714|12567806|FG002|Overall Study|Did not receive allocated intervention|3
7990173|NCT03301740|12567819|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1
7990174|NCT03301740|12567820|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0
7990175|NCT03301740|12567819|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1
7990176|NCT03301740|12567820|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0
7990177|NCT03301831|12567835|FG000|Overall Study|Lost to Follow-up|5
7990178|NCT03301831|12567836|FG001|Overall Study|Lost to Follow-up|3
7990179|NCT03301831|12567835|FG000|Overall Study|Protocol Violation|4
7990180|NCT03301831|12567836|FG001|Overall Study|Protocol Violation|0
7990181|NCT03301831|12567835|FG000|Overall Study|Withdrawal by Subject|11
7990182|NCT03301831|12567836|FG001|Overall Study|Withdrawal by Subject|0
7990183|NCT03301844|12567844|FG000|Overall Study|suspected colon cancer|1
7990184|NCT03301844|12567845|FG001|Overall Study|suspected colon cancer|1
7990185|NCT03302559|12567864|FG000|Overall Study|Adverse Event|2
7990186|NCT03302559|12567864|FG000|Overall Study|Lost to Follow-up|1
7990187|NCT03302559|12567864|FG000|Overall Study|Withdrew Consent|3
7990188|NCT03302936|12567897|FG000|Overall Study|Protocol Violation|3
7990189|NCT03302936|12567898|FG001|Overall Study|Protocol Violation|4
7990190|NCT03302975|12567908|FG000|Overall Study|Lost to Follow-up|4
7990191|NCT03303079|12567915|FG000|Overall Study|Adverse Event|0
7990192|NCT03303079|12567916|FG001|Overall Study|Adverse Event|1
7990193|NCT03303079|12567917|FG002|Overall Study|Adverse Event|3
7990194|NCT03303079|12567915|FG000|Overall Study|Protocol Violation|5
7990195|NCT03303079|12567916|FG001|Overall Study|Protocol Violation|4
7990196|NCT03303079|12567917|FG002|Overall Study|Protocol Violation|7
7990197|NCT03303079|12567915|FG000|Overall Study|Withdrawal by Subject|2
7990198|NCT03303079|12567916|FG001|Overall Study|Withdrawal by Subject|4
7990199|NCT03303079|12567917|FG002|Overall Study|Withdrawal by Subject|2
7990200|NCT03303079|12567915|FG000|Overall Study|Other than specified|0
7990201|NCT03303079|12567916|FG001|Overall Study|Other than specified|2
7990202|NCT03303079|12567917|FG002|Overall Study|Other than specified|0
7990203|NCT03303092|12567928|FG000|Overall Study|Adverse Event|1
7990204|NCT03303092|12567929|FG001|Overall Study|Adverse Event|0
7990205|NCT03303092|12567930|FG002|Overall Study|Adverse Event|1
7990206|NCT03303092|12567928|FG000|Overall Study|Protocol Violation|1
7990207|NCT03303092|12567929|FG001|Overall Study|Protocol Violation|5
7990208|NCT03303092|12567930|FG002|Overall Study|Protocol Violation|1
7990209|NCT03303092|12567928|FG000|Overall Study|Withdrawal by Subject|1
7990210|NCT03303092|12567929|FG001|Overall Study|Withdrawal by Subject|1
7990211|NCT03303092|12567930|FG002|Overall Study|Withdrawal by Subject|3
7990212|NCT03303105|12567940|FG000|Overall Study|Adverse Event|0
7990213|NCT03303105|12567941|FG001|Overall Study|Adverse Event|2
7990214|NCT03303105|12567940|FG000|Overall Study|Lack of Efficacy|1
7990215|NCT03303105|12567941|FG001|Overall Study|Lack of Efficacy|0
7990216|NCT03303105|12567940|FG000|Overall Study|Protocol Violation|1
7990217|NCT03303105|12567941|FG001|Overall Study|Protocol Violation|0
7990218|NCT03303105|12567940|FG000|Overall Study|Withdrawal by Subject|0
7990219|NCT03303105|12567941|FG001|Overall Study|Withdrawal by Subject|2
7990220|NCT03303417|12567970|FG000|Overall Study|Withdrawal by Subject|1
7990221|NCT03303417|12567971|FG001|Overall Study|Withdrawal by Subject|1
7990222|NCT03303521|12567979|FG000|Overall Study|Withdrawal by Subject|2
7990223|NCT03303521|12567980|FG001|Overall Study|Withdrawal by Subject|0
7990224|NCT03303521|12567979|FG000|Overall Study|Death|1
7990225|NCT03303521|12567980|FG001|Overall Study|Death|0
7990226|NCT03303521|12567979|FG000|Overall Study|Kidney transplantation|0
7990227|NCT03303521|12567980|FG001|Overall Study|Kidney transplantation|1
7990228|NCT03303521|12567979|FG000|Overall Study|Investigational product discontinuation|0
7990229|NCT03303521|12567980|FG001|Overall Study|Investigational product discontinuation|1
7990230|NCT03303521|12567979|FG000|Overall Study|Transferred to non-study dialysis center|1
7990231|NCT03303521|12567980|FG001|Overall Study|Transferred to non-study dialysis center|0
7990232|NCT03303521|12567979|FG000|Overall Study|Non-comliance to study protocol|0
7990233|NCT03303521|12567980|FG001|Overall Study|Non-comliance to study protocol|1
7990234|NCT03303521|12567979|FG000|Overall Study|Adverse Event|1
7990235|NCT03303521|12567980|FG001|Overall Study|Adverse Event|0
7990236|NCT03304184|12568041|FG000|Overall Study|Withdrawal by Subject|1
7990237|NCT03304184|12568042|FG001|Overall Study|Withdrawal by Subject|2
7990238|NCT03304522|12568051|FG000|Overall Study|Adverse Event|0
7990239|NCT03304522|12568052|FG001|Overall Study|Adverse Event|4
7990240|NCT03304522|12568051|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
7990241|NCT03304522|12568052|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
7990242|NCT03304522|12568051|FG000|Overall Study|Withdrawal of consent (for other reason)|0
7990243|NCT03304522|12568052|FG001|Overall Study|Withdrawal of consent (for other reason)|2
7990244|NCT03304522|12568051|FG000|Overall Study|Other|0
7990245|NCT03304522|12568052|FG001|Overall Study|Other|1
7990246|NCT03304626|12568060|FG000|Overall Study|Adverse Event|1
7990247|NCT03304626|12568061|FG001|Overall Study|Adverse Event|0
7990248|NCT03304626|12568060|FG000|Overall Study|Lack of Efficacy|1
7990249|NCT03304626|12568061|FG001|Overall Study|Lack of Efficacy|1
7990250|NCT03304873|12568070|FG000|Overall Study|Lost to Follow-up|1
7990251|NCT03304873|12568071|FG001|Overall Study|Lost to Follow-up|8
7990252|NCT03305081|12568079|FG000|Overall Study|Lost to Follow-up|10
7990253|NCT03305081|12568080|FG001|Overall Study|Lost to Follow-up|15
7990254|NCT03305419|12568103|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7990255|NCT03305419|12568104|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1
7990256|NCT03305419|12568105|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7990257|NCT03305419|12568106|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7990258|NCT03305419|12568107|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7990259|NCT03305419|12568108|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7990260|NCT03305419|12568109|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7990261|NCT03305419|12568110|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7990262|NCT03305419|12568103|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1
7990263|NCT03305419|12568104|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7990264|NCT03305419|12568105|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7990265|NCT03305419|12568106|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7990266|NCT03305419|12568107|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7990267|NCT03305419|12568108|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7990268|NCT03305419|12568109|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7990269|NCT03305419|12568110|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7990270|NCT03305419|12568103|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1
7990271|NCT03305419|12568104|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7990272|NCT03305419|12568105|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7990273|NCT03305419|12568106|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7990274|NCT03305419|12568107|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7990275|NCT03305419|12568108|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7990276|NCT03305419|12568109|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7990277|NCT03305419|12568110|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7990278|NCT03305419|12568103|FG000|Part B (14 Days)|Adverse Event|0
7990279|NCT03305419|12568104|FG001|Part B (14 Days)|Adverse Event|0
7990280|NCT03305419|12568105|FG002|Part B (14 Days)|Adverse Event|0
7990281|NCT03305419|12568106|FG003|Part B (14 Days)|Adverse Event|0
7990282|NCT03305419|12568107|FG004|Part B (14 Days)|Adverse Event|1
7990283|NCT03305419|12568108|FG005|Part B (14 Days)|Adverse Event|2
7990284|NCT03305419|12568109|FG006|Part B (14 Days)|Adverse Event|4
7990285|NCT03305419|12568110|FG007|Part B (14 Days)|Adverse Event|0
7990286|NCT03305419|12568103|FG000|Part B (14 Days)|Physician Decision|0
7990287|NCT03305419|12568104|FG001|Part B (14 Days)|Physician Decision|0
7990288|NCT03305419|12568105|FG002|Part B (14 Days)|Physician Decision|0
7990289|NCT03305419|12568106|FG003|Part B (14 Days)|Physician Decision|0
7990290|NCT03305419|12568107|FG004|Part B (14 Days)|Physician Decision|2
7990291|NCT03305419|12568108|FG005|Part B (14 Days)|Physician Decision|8
7990292|NCT03305419|12568109|FG006|Part B (14 Days)|Physician Decision|1
7990293|NCT03305419|12568110|FG007|Part B (14 Days)|Physician Decision|0
7990294|NCT03305575|12568135|FG000|Overall Study|Physician Decision|1
7990295|NCT03305575|12568136|FG001|Overall Study|Physician Decision|0
7990296|NCT03305666|12568148|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2
7990297|NCT03305666|12568149|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0
7990298|NCT03305731|12568155|FG000|Overall Study|Protocol Violation|1
7990299|NCT03305770|12568161|FG000|Overall Study|Physician Decision - prior to dispense|0
7990300|NCT03305770|12568162|FG001|Overall Study|Physician Decision - prior to dispense|1
7990301|NCT03305770|12568161|FG000|Overall Study|Subject moved|1
7990302|NCT03305770|12568162|FG001|Overall Study|Subject moved|0
7990303|NCT03305809|12568174|FG000|Overall Study|Adverse Event|2
7990304|NCT03305809|12568175|FG001|Overall Study|Adverse Event|2
7990305|NCT03305809|12568176|FG002|Overall Study|Adverse Event|6
7990306|NCT03305809|12568177|FG003|Overall Study|Adverse Event|6
7990307|NCT03305809|12568174|FG000|Overall Study|Death|0
7990308|NCT03305809|12568175|FG001|Overall Study|Death|0
7990309|NCT03305809|12568176|FG002|Overall Study|Death|1
7990310|NCT03305809|12568177|FG003|Overall Study|Death|1
7990311|NCT03305809|12568174|FG000|Overall Study|Lost to Follow-up|1
7990312|NCT03305809|12568175|FG001|Overall Study|Lost to Follow-up|2
7990313|NCT03305809|12568176|FG002|Overall Study|Lost to Follow-up|0
7990314|NCT03305809|12568177|FG003|Overall Study|Lost to Follow-up|0
7990315|NCT03305809|12568174|FG000|Overall Study|Sponsor Decision|1
7990316|NCT03305809|12568175|FG001|Overall Study|Sponsor Decision|0
7990317|NCT03305809|12568176|FG002|Overall Study|Sponsor Decision|1
7990318|NCT03305809|12568177|FG003|Overall Study|Sponsor Decision|8
7990319|NCT03305809|12568174|FG000|Overall Study|Physician Decision|0
7990320|NCT03305809|12568175|FG001|Overall Study|Physician Decision|0
7990321|NCT03305809|12568176|FG002|Overall Study|Physician Decision|2
7990322|NCT03305809|12568177|FG003|Overall Study|Physician Decision|4
7990323|NCT03305809|12568174|FG000|Overall Study|Progressive Disease|0
7990324|NCT03305809|12568175|FG001|Overall Study|Progressive Disease|0
7990325|NCT03305809|12568176|FG002|Overall Study|Progressive Disease|1
7990326|NCT03305809|12568177|FG003|Overall Study|Progressive Disease|0
7990327|NCT03305809|12568174|FG000|Overall Study|Protocol Violation|1
7990328|NCT03305809|12568175|FG001|Overall Study|Protocol Violation|0
7990329|NCT03305809|12568176|FG002|Overall Study|Protocol Violation|2
7990330|NCT03305809|12568177|FG003|Overall Study|Protocol Violation|3
7990331|NCT03305809|12568174|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0
7990332|NCT03305809|12568175|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0
7990333|NCT03305809|12568176|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0
7990334|NCT03305809|12568177|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2
7990335|NCT03305809|12568174|FG000|Overall Study|Withdrawal by Subject|2
7990336|NCT03305809|12568175|FG001|Overall Study|Withdrawal by Subject|4
7990337|NCT03305809|12568176|FG002|Overall Study|Withdrawal by Subject|5
7990338|NCT03305809|12568177|FG003|Overall Study|Withdrawal by Subject|2
7990339|NCT03305809|12568174|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0
7990340|NCT03305809|12568175|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0
7990341|NCT03305809|12568176|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1
7990342|NCT03305809|12568177|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1
7990343|NCT03306043|12568206|FG000|Overall Study|Adverse Event|1
7990344|NCT03306043|12568206|FG000|Overall Study|Lost to Follow-up|1
7990345|NCT03306043|12568206|FG000|Overall Study|Withdrawal by Subject|2
7990346|NCT03306433|12568235|FG000|Overall Study|Lost to Follow-up|3
7990347|NCT03306433|12568235|FG000|Overall Study|Patient did not have teeth extracted|1
7990348|NCT03306433|12568235|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3
7990349|NCT03307174|12568290|FG000|Overall Study|Unplanned ICU Administrion|5
7990350|NCT03307174|12568291|FG001|Overall Study|Unplanned ICU Administrion|3
7990351|NCT03307174|12568290|FG000|Overall Study|Aborted Surgery|1
7990352|NCT03307174|12568291|FG001|Overall Study|Aborted Surgery|2
7990353|NCT03307174|12568290|FG000|Overall Study|Hypotension|6
7990354|NCT03307174|12568291|FG001|Overall Study|Hypotension|0
7990355|NCT03307174|12568290|FG000|Overall Study|Nonfunctional epidural|1
7990356|NCT03307174|12568291|FG001|Overall Study|Nonfunctional epidural|1
7990357|NCT03307174|12568290|FG000|Overall Study|Planned epidural removal|1
7990358|NCT03307174|12568291|FG001|Overall Study|Planned epidural removal|0
7990359|NCT03307174|12568290|FG000|Overall Study|Intrathecal catheter placement|0
7990360|NCT03307174|12568291|FG001|Overall Study|Intrathecal catheter placement|1
7990361|NCT03307252|12568308|FG000|Part 2, Period 1|Treatment not received|0
7990362|NCT03307252|12568309|FG001|Part 2, Period 1|Treatment not received|0
7990363|NCT03307252|12568310|FG002|Part 2, Period 1|Treatment not received|0
7990364|NCT03307252|12568311|FG003|Part 2, Period 1|Treatment not received|0
7990365|NCT03307252|12568312|FG004|Part 2, Period 1|Treatment not received|0
7990366|NCT03307252|12568313|FG005|Part 2, Period 1|Treatment not received|1
7990367|NCT03307252|12568314|FG006|Part 2, Period 1|Treatment not received|0
7990368|NCT03307252|12568315|FG007|Part 2, Period 1|Treatment not received|0
7990369|NCT03307252|12568316|FG008|Part 2, Period 1|Treatment not received|0
7990370|NCT03307252|12568317|FG009|Part 2, Period 1|Treatment not received|0
7990371|NCT03307252|12568318|FG010|Part 2, Period 1|Treatment not received|0
7990372|NCT03307252|12568308|FG000|Part 2, Period 3|Other than listed|0
7990373|NCT03307252|12568309|FG001|Part 2, Period 3|Other than listed|0
7990374|NCT03307252|12568310|FG002|Part 2, Period 3|Other than listed|0
7990375|NCT03307252|12568311|FG003|Part 2, Period 3|Other than listed|0
7990376|NCT03307252|12568312|FG004|Part 2, Period 3|Other than listed|1
7990377|NCT03307252|12568313|FG005|Part 2, Period 3|Other than listed|0
7990378|NCT03307252|12568314|FG006|Part 2, Period 3|Other than listed|0
7990379|NCT03307252|12568315|FG007|Part 2, Period 3|Other than listed|0
7990380|NCT03307252|12568316|FG008|Part 2, Period 3|Other than listed|0
7990381|NCT03307252|12568317|FG009|Part 2, Period 3|Other than listed|0
7990382|NCT03307252|12568318|FG010|Part 2, Period 3|Other than listed|0
7990383|NCT03307252|12568308|FG000|Part 2, Period 4|Other than listed|0
7990384|NCT03307252|12568309|FG001|Part 2, Period 4|Other than listed|0
7990385|NCT03307252|12568310|FG002|Part 2, Period 4|Other than listed|0
7990386|NCT03307252|12568311|FG003|Part 2, Period 4|Other than listed|0
7990387|NCT03307252|12568312|FG004|Part 2, Period 4|Other than listed|0
7990388|NCT03307252|12568313|FG005|Part 2, Period 4|Other than listed|0
7990389|NCT03307252|12568314|FG006|Part 2, Period 4|Other than listed|1
7990390|NCT03307252|12568315|FG007|Part 2, Period 4|Other than listed|0
7990391|NCT03307252|12568316|FG008|Part 2, Period 4|Other than listed|0
7990392|NCT03307252|12568317|FG009|Part 2, Period 4|Other than listed|0
7990393|NCT03307252|12568318|FG010|Part 2, Period 4|Other than listed|0
7990394|NCT03307252|12568308|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7990395|NCT03307252|12568309|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7990396|NCT03307252|12568310|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7990397|NCT03307252|12568311|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7990398|NCT03307252|12568312|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7990399|NCT03307252|12568313|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7990400|NCT03307252|12568314|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7990401|NCT03307252|12568315|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7990402|NCT03307252|12568316|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7990403|NCT03307252|12568317|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7990404|NCT03307252|12568318|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1
7990405|NCT03307837|12568340|FG000|Overall Study|Withdrawal by Subject|0
7990406|NCT03307837|12568341|FG001|Overall Study|Withdrawal by Subject|0
7990407|NCT03307837|12568342|FG002|Overall Study|Withdrawal by Subject|1
7990408|NCT03307837|12568343|FG003|Overall Study|Withdrawal by Subject|0
7990409|NCT03307837|12568344|FG004|Overall Study|Withdrawal by Subject|0
7990410|NCT03307837|12568345|FG005|Overall Study|Withdrawal by Subject|1
7990411|NCT03307837|12568340|FG000|Overall Study|Lost to Follow-up|1
7990412|NCT03307837|12568341|FG001|Overall Study|Lost to Follow-up|1
7990413|NCT03307837|12568342|FG002|Overall Study|Lost to Follow-up|0
7990414|NCT03307837|12568343|FG003|Overall Study|Lost to Follow-up|0
7990415|NCT03307837|12568344|FG004|Overall Study|Lost to Follow-up|0
7990416|NCT03307837|12568345|FG005|Overall Study|Lost to Follow-up|1
7990417|NCT03308968|12568419|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3
7990418|NCT03308968|12568420|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1
7990419|NCT03308968|12568421|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4
7990420|NCT03308968|12568419|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
7990421|NCT03308968|12568420|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
7990422|NCT03308968|12568421|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3
7990423|NCT03308968|12568419|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6
7990424|NCT03308968|12568420|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0
7990425|NCT03308968|12568421|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2
7990426|NCT03308968|12568419|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
7990427|NCT03308968|12568420|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
7990428|NCT03308968|12568421|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0
7990429|NCT03308968|12568419|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1
7990430|NCT03308968|12568420|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
7990431|NCT03308968|12568421|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
7990432|NCT03308968|12568419|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
7990433|NCT03308968|12568420|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
7990434|NCT03308968|12568421|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0
7990435|NCT03308968|12568419|FG000|Double-Blind Period (12 Weeks)|Other than specified|1
7990436|NCT03308968|12568420|FG001|Double-Blind Period (12 Weeks)|Other than specified|0
7990437|NCT03308968|12568421|FG002|Double-Blind Period (12 Weeks)|Other than specified|2
7990438|NCT03308968|12568419|FG000|Open-Label Period (12 Weeks)|Other than specified|1
7990439|NCT03308968|12568420|FG001|Open-Label Period (12 Weeks)|Other than specified|2
7990440|NCT03308968|12568421|FG002|Open-Label Period (12 Weeks)|Other than specified|1
7990441|NCT03308968|12568419|FG000|Open-Label Period (12 Weeks)|Adverse Event|4
7990442|NCT03308968|12568420|FG001|Open-Label Period (12 Weeks)|Adverse Event|1
7990443|NCT03308968|12568421|FG002|Open-Label Period (12 Weeks)|Adverse Event|1
7990444|NCT03308968|12568419|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
7990445|NCT03308968|12568420|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
7990446|NCT03308968|12568421|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7
7990447|NCT03308968|12568419|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0
7990448|NCT03308968|12568420|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1
7990449|NCT03308968|12568421|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1
7990450|NCT03308968|12568419|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
7990451|NCT03308968|12568420|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
7990452|NCT03308968|12568421|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1
7990453|NCT03308968|12568419|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0
7990454|NCT03308968|12568420|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1
7990455|NCT03308968|12568421|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1
7990456|NCT03308968|12568419|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1
7990457|NCT03308968|12568420|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2
7990458|NCT03308968|12568421|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0
7990459|NCT03309020|12568434|FG000|Overall Study|Death|1
7990460|NCT03309020|12568435|FG001|Overall Study|Death|0
7990461|NCT03309020|12568434|FG000|Overall Study|Did not undergo surgery|2
7990462|NCT03309020|12568435|FG001|Overall Study|Did not undergo surgery|1
7990463|NCT03309202|12568447|FG000|Overall Study|Lost to Follow-up|1
7990464|NCT03309202|12568448|FG001|Overall Study|Lost to Follow-up|0
7990465|NCT03309202|12568449|FG002|Overall Study|Lost to Follow-up|0
7990466|NCT03309202|12568450|FG003|Overall Study|Lost to Follow-up|0
7990467|NCT03309605|12568481|FG000|Overall Study|Adverse Event|0
7990468|NCT03309605|12568482|FG001|Overall Study|Adverse Event|0
7990469|NCT03309605|12568483|FG002|Overall Study|Adverse Event|0
7990470|NCT03309605|12568484|FG003|Overall Study|Adverse Event|1
7990471|NCT03309605|12568485|FG004|Overall Study|Adverse Event|0
7990472|NCT03309605|12568486|FG005|Overall Study|Adverse Event|0
7990473|NCT03309605|12568487|FG006|Overall Study|Adverse Event|2
7990474|NCT03309605|12568488|FG007|Overall Study|Adverse Event|1
7990475|NCT03309605|12568481|FG000|Overall Study|Withdrawal by Subject|0
7990476|NCT03309605|12568482|FG001|Overall Study|Withdrawal by Subject|0
7990477|NCT03309605|12568483|FG002|Overall Study|Withdrawal by Subject|0
7990478|NCT03309605|12568484|FG003|Overall Study|Withdrawal by Subject|0
7990479|NCT03309605|12568485|FG004|Overall Study|Withdrawal by Subject|1
7990480|NCT03309605|12568486|FG005|Overall Study|Withdrawal by Subject|0
7990481|NCT03309605|12568487|FG006|Overall Study|Withdrawal by Subject|1
7990482|NCT03309605|12568488|FG007|Overall Study|Withdrawal by Subject|1
7990483|NCT03309696|12568508|FG000|Overall Study|Analysis of TEP data could not be completed|0
7990484|NCT03309696|12568509|FG001|Overall Study|Analysis of TEP data could not be completed|5
7990485|NCT03309696|12568510|FG002|Overall Study|Analysis of TEP data could not be completed|0
7990486|NCT03309696|12568511|FG003|Overall Study|Analysis of TEP data could not be completed|0
7990487|NCT03309943|12568540|FG000|Overall Study|Withdrawal by Subject|0
7990488|NCT03309943|12568541|FG001|Overall Study|Withdrawal by Subject|1
7990489|NCT03309943|12568540|FG000|Overall Study|Inappropriate behavior towards staff|0
7990490|NCT03309943|12568541|FG001|Overall Study|Inappropriate behavior towards staff|1
7990491|NCT03310021|12568567|FG000|Overall Study|Withdrawal by Subject|0
7990492|NCT03310021|12568568|FG001|Overall Study|Withdrawal by Subject|0
7990493|NCT03310021|12568569|FG002|Overall Study|Withdrawal by Subject|0
7990494|NCT03310021|12568570|FG003|Overall Study|Withdrawal by Subject|0
7990495|NCT03310021|12568571|FG004|Overall Study|Withdrawal by Subject|0
7990496|NCT03310021|12568572|FG005|Overall Study|Withdrawal by Subject|0
7990497|NCT03310021|12568573|FG006|Overall Study|Withdrawal by Subject|1
7990498|NCT03310021|12568574|FG007|Overall Study|Withdrawal by Subject|0
7990499|NCT03310021|12568575|FG008|Overall Study|Withdrawal by Subject|0
7990500|NCT03310021|12568576|FG009|Overall Study|Withdrawal by Subject|0
7990501|NCT03310021|12568577|FG010|Overall Study|Withdrawal by Subject|0
7990502|NCT03310021|12568578|FG011|Overall Study|Withdrawal by Subject|0
7990503|NCT03310021|12568579|FG012|Overall Study|Withdrawal by Subject|0
7990504|NCT03310021|12568580|FG013|Overall Study|Withdrawal by Subject|0
7990505|NCT03310021|12568581|FG014|Overall Study|Withdrawal by Subject|0
7990506|NCT03310021|12568582|FG015|Overall Study|Withdrawal by Subject|0
7990507|NCT03310021|12568583|FG016|Overall Study|Withdrawal by Subject|0
7990508|NCT03310021|12568584|FG017|Overall Study|Withdrawal by Subject|0
7990509|NCT03310021|12568585|FG018|Overall Study|Withdrawal by Subject|0
7990510|NCT03310021|12568586|FG019|Overall Study|Withdrawal by Subject|0
7990511|NCT03310021|12568567|FG000|Overall Study|Lost to Follow-up|0
7990512|NCT03310021|12568568|FG001|Overall Study|Lost to Follow-up|0
7990513|NCT03310021|12568569|FG002|Overall Study|Lost to Follow-up|0
7990514|NCT03310021|12568570|FG003|Overall Study|Lost to Follow-up|0
7990515|NCT03310021|12568571|FG004|Overall Study|Lost to Follow-up|0
7990516|NCT03310021|12568572|FG005|Overall Study|Lost to Follow-up|0
7990517|NCT03310021|12568573|FG006|Overall Study|Lost to Follow-up|0
7990518|NCT03310021|12568574|FG007|Overall Study|Lost to Follow-up|0
7990519|NCT03310021|12568575|FG008|Overall Study|Lost to Follow-up|0
7990520|NCT03310021|12568576|FG009|Overall Study|Lost to Follow-up|0
7990521|NCT03310021|12568577|FG010|Overall Study|Lost to Follow-up|1
7990522|NCT03310021|12568578|FG011|Overall Study|Lost to Follow-up|0
7990523|NCT03310021|12568579|FG012|Overall Study|Lost to Follow-up|0
7990524|NCT03310021|12568580|FG013|Overall Study|Lost to Follow-up|0
7990525|NCT03310021|12568581|FG014|Overall Study|Lost to Follow-up|0
7990526|NCT03310021|12568582|FG015|Overall Study|Lost to Follow-up|0
7990527|NCT03310021|12568583|FG016|Overall Study|Lost to Follow-up|0
7990528|NCT03310021|12568584|FG017|Overall Study|Lost to Follow-up|0
7990529|NCT03310021|12568585|FG018|Overall Study|Lost to Follow-up|0
7990530|NCT03310021|12568586|FG019|Overall Study|Lost to Follow-up|0
7990531|NCT03310268|12568631|FG000|Overall Study|(Not specified)|1
7990532|NCT03310268|12568632|FG001|Overall Study|(Not specified)|5
7990533|NCT03310268|12568633|FG002|Overall Study|(Not specified)|0
7990534|NCT03310411|12568641|FG000|Period 1|Adverse Event|0
7990535|NCT03310411|12568642|FG001|Period 1|Adverse Event|0
7990536|NCT03310411|12568643|FG002|Period 1|Adverse Event|0
7990537|NCT03310411|12568644|FG003|Period 1|Adverse Event|1
7990538|NCT03310580|12568679|FG000|Overall Study|Adverse Event|0
7990539|NCT03310580|12568680|FG001|Overall Study|Adverse Event|1
7990540|NCT03310580|12568681|FG002|Overall Study|Adverse Event|0
7990541|NCT03310723|12568692|FG000|Overall Study|Withdrawal by Subject|0
7990542|NCT03310723|12568693|FG001|Overall Study|Withdrawal by Subject|1
7990543|NCT03310723|12568692|FG000|Overall Study|Protocol Violation|0
7990544|NCT03310723|12568693|FG001|Overall Study|Protocol Violation|2
7990545|NCT03310775|12568701|FG000|Overall Study|Lost to Follow-up|2
7990546|NCT03310775|12568702|FG001|Overall Study|Lost to Follow-up|3
7990547|NCT03310775|12568701|FG000|Overall Study|aggravation of depression|0
7990548|NCT03310775|12568702|FG001|Overall Study|aggravation of depression|1
7990549|NCT03310970|12568708|FG000|Overall Study|Withdrawal by Subject|0
7990550|NCT03310970|12568709|FG001|Overall Study|Withdrawal by Subject|1
7990551|NCT03311230|12568720|FG000|Overall Study|Withdrawal by Subject|1
7990552|NCT03311230|12568721|FG001|Overall Study|Withdrawal by Subject|4
7990553|NCT03311230|12568722|FG002|Overall Study|Withdrawal by Subject|2
7990554|NCT03311230|12568723|FG003|Overall Study|Withdrawal by Subject|7
7990555|NCT03311230|12568720|FG000|Overall Study|Unrelated injury|0
7990556|NCT03311230|12568721|FG001|Overall Study|Unrelated injury|1
7990557|NCT03311230|12568722|FG002|Overall Study|Unrelated injury|0
7990558|NCT03311230|12568723|FG003|Overall Study|Unrelated injury|0
7990559|NCT03311373|12568733|FG000|Overall Study|Adverse Event|1
7990560|NCT03311373|12568733|FG000|Overall Study|Protocol Discontinuation Criteria|3
7990561|NCT03311373|12568733|FG000|Overall Study|Lost to Follow-up|1
7990562|NCT03311373|12568733|FG000|Overall Study|Physician Decision|1
7990563|NCT03311373|12568733|FG000|Overall Study|Withdrawal by Subject|3
7990564|NCT03311646|12568743|FG000|Overall Study|Physician Decision|1
7990565|NCT03311646|12568743|FG000|Overall Study|Withdrawal by Subject|5
7990566|NCT03311646|12568743|FG000|Overall Study|Lost to Follow-up|5
7990567|NCT03311646|12568743|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4
7990568|NCT03311659|12568748|FG000|Overall Study|Protocol Violation|1
7990569|NCT03311724|12568756|FG000|Overall Study|Physician Decision|0
7990570|NCT03311724|12568757|FG001|Overall Study|Physician Decision|0
7990571|NCT03311724|12568758|FG002|Overall Study|Physician Decision|0
7990572|NCT03311724|12568759|FG003|Overall Study|Physician Decision|1
7990573|NCT03311724|12568756|FG000|Overall Study|Protocol Violation|1
7990574|NCT03311724|12568757|FG001|Overall Study|Protocol Violation|0
7990575|NCT03311724|12568758|FG002|Overall Study|Protocol Violation|1
7990576|NCT03311724|12568759|FG003|Overall Study|Protocol Violation|0
7990577|NCT03311724|12568756|FG000|Overall Study|Withdrawal by Subject|1
7990578|NCT03311724|12568757|FG001|Overall Study|Withdrawal by Subject|1
7990579|NCT03311724|12568758|FG002|Overall Study|Withdrawal by Subject|0
7990580|NCT03311724|12568759|FG003|Overall Study|Withdrawal by Subject|0
7990581|NCT03311724|12568756|FG000|Overall Study|Lost to Follow-up|1
7990582|NCT03311724|12568757|FG001|Overall Study|Lost to Follow-up|0
7990583|NCT03311724|12568758|FG002|Overall Study|Lost to Follow-up|0
7990584|NCT03311724|12568759|FG003|Overall Study|Lost to Follow-up|0
7990585|NCT03311724|12568756|FG000|Overall Study|Sponsor Decision|0
7990586|NCT03311724|12568757|FG001|Overall Study|Sponsor Decision|0
7990587|NCT03311724|12568758|FG002|Overall Study|Sponsor Decision|1
7990588|NCT03311724|12568759|FG003|Overall Study|Sponsor Decision|0
7990589|NCT03311841|12568777|FG000|14-day Wash-out|Adverse Event|0
7990590|NCT03311841|12568778|FG001|14-day Wash-out|Adverse Event|1
7990591|NCT03311841|12568779|FG002|14-day Wash-out|Adverse Event|0
7990592|NCT03311841|12568780|FG003|14-day Wash-out|Adverse Event|0
7990593|NCT03311841|12568781|FG004|14-day Wash-out|Adverse Event|0
7990594|NCT03311841|12568777|FG000|14-day Wash-out|Non-Compliance With Study Drug|0
7990595|NCT03311841|12568778|FG001|14-day Wash-out|Non-Compliance With Study Drug|0
7718220|NCT00526110|12142070|FG001|Overall Study|Adverse Event|9
7990596|NCT03311841|12568779|FG002|14-day Wash-out|Non-Compliance With Study Drug|0
7990597|NCT03311841|12568780|FG003|14-day Wash-out|Non-Compliance With Study Drug|1
7990598|NCT03311841|12568781|FG004|14-day Wash-out|Non-Compliance With Study Drug|0
7990599|NCT03312114|12568820|FG000|Overall Study|All the five enrolled dropped out of the|5
7990600|NCT03312218|12568827|FG000|Overall Study|Never signed in to access the app|54
7990601|NCT03312218|12568828|FG001|Overall Study|Never signed in to access the app|58
7990602|NCT03312231|12568839|FG000|Overall Study|Lost to Follow-up|2
7990603|NCT03312231|12568840|FG001|Overall Study|Lost to Follow-up|6
7990604|NCT03312231|12568841|FG002|Overall Study|Lost to Follow-up|1
7990605|NCT03312231|12568842|FG003|Overall Study|Lost to Follow-up|3
7990606|NCT03312231|12568843|FG004|Overall Study|Lost to Follow-up|1
7990607|NCT03312231|12568839|FG000|Overall Study|Withdrawal by Subject|0
7990608|NCT03312231|12568840|FG001|Overall Study|Withdrawal by Subject|3
7990609|NCT03312231|12568841|FG002|Overall Study|Withdrawal by Subject|1
7990610|NCT03312231|12568842|FG003|Overall Study|Withdrawal by Subject|0
7990611|NCT03312231|12568843|FG004|Overall Study|Withdrawal by Subject|0
7990612|NCT03312231|12568839|FG000|Overall Study|Death|0
7990613|NCT03312231|12568840|FG001|Overall Study|Death|1
7990614|NCT03312231|12568841|FG002|Overall Study|Death|1
7990615|NCT03312231|12568842|FG003|Overall Study|Death|0
7990616|NCT03312231|12568843|FG004|Overall Study|Death|0
7990617|NCT03312231|12568839|FG000|Overall Study|Study Vaccination not Received|1
7990618|NCT03312231|12568840|FG001|Overall Study|Study Vaccination not Received|1
7990619|NCT03312231|12568841|FG002|Overall Study|Study Vaccination not Received|1
7990620|NCT03312231|12568842|FG003|Overall Study|Study Vaccination not Received|0
7990621|NCT03312231|12568843|FG004|Overall Study|Study Vaccination not Received|0
7990622|NCT03312543|12568874|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0
7990623|NCT03312543|12568875|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2
7990624|NCT03312543|12568874|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1
7990625|NCT03312543|12568875|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2
7990626|NCT03312543|12568874|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3
7990627|NCT03312543|12568875|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4
7990628|NCT03312543|12568874|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1
7990629|NCT03312543|12568875|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1
7990630|NCT03312543|12568874|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1
7990631|NCT03312543|12568875|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1
7990632|NCT03312543|12568874|FG000|Regression (Week 12 to Week 24)|Death|0
7990633|NCT03312543|12568875|FG001|Regression (Week 12 to Week 24)|Death|1
7990634|NCT03312933|12568885|FG000|Overall Study|Protocol Violation|15
7990635|NCT03312933|12568885|FG000|Overall Study|Lost to Follow-up|36
7990636|NCT03312933|12568885|FG000|Overall Study|Withdrawal by Subject|3
7990637|NCT03313037|12568891|FG000|Overall Study|Protocol Violation|4
7990638|NCT03313037|12568892|FG001|Overall Study|Protocol Violation|1
7990639|NCT03313037|12568891|FG000|Overall Study|Other|1
7990640|NCT03313037|12568892|FG001|Overall Study|Other|1
7990641|NCT03313037|12568891|FG000|Overall Study|Withdrawal by Subject|4
7990642|NCT03313037|12568892|FG001|Overall Study|Withdrawal by Subject|3
7990643|NCT03313037|12568891|FG000|Overall Study|No longer meets eligibility criteria|1
7990644|NCT03313037|12568892|FG001|Overall Study|No longer meets eligibility criteria|7
7990645|NCT03313037|12568891|FG000|Overall Study|Lost to Follow-up|9
7990646|NCT03313037|12568892|FG001|Overall Study|Lost to Follow-up|8
7990647|NCT03313037|12568891|FG000|Overall Study|Randomized but not treated|1
7990648|NCT03313037|12568892|FG001|Overall Study|Randomized but not treated|0
7990649|NCT03313050|12568902|FG000|Stage 2: 12 Months|Adverse Event|0
7990650|NCT03313050|12568903|FG001|Stage 2: 12 Months|Adverse Event|0
7990651|NCT03313050|12568904|FG002|Stage 2: 12 Months|Adverse Event|0
7990652|NCT03313050|12568905|FG003|Stage 2: 12 Months|Adverse Event|1
7990653|NCT03313050|12568902|FG000|Stage 2: 12 Months|Death|0
7990654|NCT03313050|12568903|FG001|Stage 2: 12 Months|Death|0
7990655|NCT03313050|12568904|FG002|Stage 2: 12 Months|Death|3
7990656|NCT03313050|12568905|FG003|Stage 2: 12 Months|Death|0
7990657|NCT03313050|12568902|FG000|Stage 2: 12 Months|Lost to Follow-up|0
7990658|NCT03313050|12568903|FG001|Stage 2: 12 Months|Lost to Follow-up|0
7990659|NCT03313050|12568904|FG002|Stage 2: 12 Months|Lost to Follow-up|1
7990660|NCT03313050|12568905|FG003|Stage 2: 12 Months|Lost to Follow-up|5
7990661|NCT03313050|12568902|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
7990662|NCT03313050|12568903|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
7990663|NCT03313050|12568904|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
7990664|NCT03313050|12568905|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3
7990665|NCT03313050|12568902|FG000|Stage 2: 12 Months|Protocol deviation|0
7990666|NCT03313050|12568903|FG001|Stage 2: 12 Months|Protocol deviation|0
7990667|NCT03313050|12568904|FG002|Stage 2: 12 Months|Protocol deviation|7
7990668|NCT03313050|12568905|FG003|Stage 2: 12 Months|Protocol deviation|7
7990669|NCT03313050|12568902|FG000|Stage 2: 12 Months|Withdrawal by Subject|0
7990670|NCT03313050|12568903|FG001|Stage 2: 12 Months|Withdrawal by Subject|0
7990671|NCT03313050|12568904|FG002|Stage 2: 12 Months|Withdrawal by Subject|0
7990672|NCT03313050|12568905|FG003|Stage 2: 12 Months|Withdrawal by Subject|3
7990673|NCT03313050|12568902|FG000|Stage 2: 12 Months|Other|0
7990674|NCT03313050|12568903|FG001|Stage 2: 12 Months|Other|0
7990675|NCT03313050|12568904|FG002|Stage 2: 12 Months|Other|0
7990676|NCT03313050|12568905|FG003|Stage 2: 12 Months|Other|1
7990677|NCT03313076|12568919|FG000|Overall Study|Withdrawal by Subject|2
7990678|NCT03313076|12568920|FG001|Overall Study|Withdrawal by Subject|0
7990679|NCT03313076|12568921|FG002|Overall Study|Withdrawal by Subject|0
7990680|NCT03313076|12568922|FG003|Overall Study|Withdrawal by Subject|0
7990681|NCT03313076|12568919|FG000|Overall Study|Lost to Follow-up|0
7990682|NCT03313076|12568920|FG001|Overall Study|Lost to Follow-up|2
7990683|NCT03313076|12568921|FG002|Overall Study|Lost to Follow-up|2
7990684|NCT03313076|12568922|FG003|Overall Study|Lost to Follow-up|2
7990685|NCT03313310|12568940|FG000|Phase 2|Lost to Follow-up|4
7990686|NCT03313310|12568941|FG001|Phase 2|Lost to Follow-up|0
7990687|NCT03313310|12568940|FG000|Phase 3|Lost to Follow-up|0
7990688|NCT03313310|12568941|FG001|Phase 3|Lost to Follow-up|1
7990689|NCT03314233|12568947|FG000|Overall Study|No longer eligible at time of delivery|1
7990690|NCT03314519|12568953|FG000|Overall Study|Protocol Violation|3
7990691|NCT03314519|12568954|FG001|Overall Study|Protocol Violation|2
7990692|NCT03314662|12568963|FG000|Overall Study|Withdrawal by Subject|1
7990693|NCT03314662|12568964|FG001|Overall Study|Withdrawal by Subject|1
7990694|NCT03314662|12568965|FG002|Overall Study|Withdrawal by Subject|1
7990695|NCT03314662|12568963|FG000|Overall Study|Lost to Follow-up|5
7990696|NCT03314662|12568964|FG001|Overall Study|Lost to Follow-up|4
7990697|NCT03314662|12568965|FG002|Overall Study|Lost to Follow-up|4
7990698|NCT03314662|12568963|FG000|Overall Study|Death|2
7990699|NCT03314662|12568964|FG001|Overall Study|Death|0
7990700|NCT03314662|12568965|FG002|Overall Study|Death|0
7990701|NCT03315208|12569005|FG000|Overall Study|Lost to Follow-up|11
7990702|NCT03315208|12569006|FG001|Overall Study|Lost to Follow-up|6
7990703|NCT03315208|12569005|FG000|Overall Study|Withdrawal by Subject|2
7990704|NCT03315208|12569006|FG001|Overall Study|Withdrawal by Subject|0
7990705|NCT03315286|12569015|FG000|Overall Study|Lost to Follow-up|0
7990706|NCT03315286|12569016|FG001|Overall Study|Lost to Follow-up|3
7990707|NCT03315286|12569015|FG000|Overall Study|Withdrawal by Subject|1
7990708|NCT03315286|12569016|FG001|Overall Study|Withdrawal by Subject|0
7990709|NCT03315286|12569015|FG000|Overall Study|Protocol Violation|0
7990710|NCT03315286|12569016|FG001|Overall Study|Protocol Violation|1
7990711|NCT03315689|12569041|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1
7990712|NCT03315689|12569042|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0
7990713|NCT03315689|12569041|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0
7990714|NCT03315689|12569042|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2
7990715|NCT03315689|12569041|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0
7990716|NCT03315689|12569042|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1
7990717|NCT03315793|12569064|FG000|Overall Study|Adverse Event|4
7990718|NCT03315793|12569065|FG001|Overall Study|Adverse Event|2
7990719|NCT03315793|12569064|FG000|Overall Study|Protocol Deviation|1
7990720|NCT03315793|12569065|FG001|Overall Study|Protocol Deviation|0
7990721|NCT03315793|12569064|FG000|Overall Study|Difficult for regular visit|0
7990722|NCT03315793|12569065|FG001|Overall Study|Difficult for regular visit|1
7990723|NCT03316131|12569082|FG000|Treatment Period 2|Protocol deviation|1
7990724|NCT03316131|12569083|FG001|Treatment Period 2|Protocol deviation|0
7990725|NCT03316170|12569091|FG000|Overall Study|Death|1
7990726|NCT03316170|12569092|FG001|Overall Study|Death|0
7990727|NCT03316170|12569091|FG000|Overall Study|Lost to Follow-up|6
7990728|NCT03316170|12569092|FG001|Overall Study|Lost to Follow-up|7
7990729|NCT03316547|12569111|FG000|Overall Study|Death|3
7990730|NCT03316547|12569112|FG001|Overall Study|Death|1
7990731|NCT03316547|12569111|FG000|Overall Study|Lost to Follow-up|6
7990732|NCT03316547|12569112|FG001|Overall Study|Lost to Follow-up|6
7990733|NCT03316547|12569111|FG000|Overall Study|Withdrawal by Subject|3
7990734|NCT03316547|12569112|FG001|Overall Study|Withdrawal by Subject|2
7990735|NCT03316547|12569111|FG000|Overall Study|Transfer to another hospital|6
7990736|NCT03316547|12569112|FG001|Overall Study|Transfer to another hospital|4
7990737|NCT03316911|12569122|FG000|Overall Study|Lost to Follow-up|33
7990738|NCT03316911|12569123|FG001|Overall Study|Lost to Follow-up|29
7990739|NCT03317379|12569172|FG000|Overall Study|Lost to Follow-up|0
7990740|NCT03317379|12569173|FG001|Overall Study|Lost to Follow-up|3
7990741|NCT03317379|12569174|FG002|Overall Study|Lost to Follow-up|2
7990742|NCT03318315|12569198|FG000|Overall Study|Lost to Follow-up|3
7990743|NCT03318315|12569199|FG001|Overall Study|Lost to Follow-up|2
7990744|NCT03318315|12569200|FG002|Overall Study|Lost to Follow-up|1
7990745|NCT03318315|12569198|FG000|Overall Study|Protocol Violation|1
7990746|NCT03318315|12569199|FG001|Overall Study|Protocol Violation|1
7990747|NCT03318315|12569200|FG002|Overall Study|Protocol Violation|1
7990748|NCT03318315|12569198|FG000|Overall Study|Withdrawal by Subject|0
7990749|NCT03318315|12569199|FG001|Overall Study|Withdrawal by Subject|0
7990750|NCT03318315|12569200|FG002|Overall Study|Withdrawal by Subject|2
7990751|NCT03318783|12569222|FG000|Overall Study|Withdrawal by Subject|0
7990752|NCT03318783|12569223|FG001|Overall Study|Withdrawal by Subject|1
7990753|NCT03318783|12569222|FG000|Overall Study|Death|0
7990754|NCT03318783|12569223|FG001|Overall Study|Death|1
7990755|NCT03319212|12569257|FG000|Overall Study|Discontinued as moving out of local area|0
7990756|NCT03319212|12569258|FG001|Overall Study|Discontinued as moving out of local area|1
7990757|NCT03319212|12569257|FG000|Overall Study|Adverse Event|2
7990758|NCT03319212|12569258|FG001|Overall Study|Adverse Event|2
7990759|NCT03319212|12569257|FG000|Overall Study|Withdrawal by Subject|0
7990760|NCT03319212|12569258|FG001|Overall Study|Withdrawal by Subject|1
7990761|NCT03319212|12569257|FG000|Overall Study|Lost to Follow-up|0
7990762|NCT03319212|12569258|FG001|Overall Study|Lost to Follow-up|1
7990763|NCT03319212|12569257|FG000|Overall Study|Physician Decision|1
7990764|NCT03319212|12569258|FG001|Overall Study|Physician Decision|0
7990765|NCT03319719|12569272|FG000|Overall Study|Lost to Follow-up|1
7990766|NCT03319953|12569286|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1
7990767|NCT03319953|12569287|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
7990768|NCT03319953|12569288|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
7990769|NCT03319953|12569289|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
7990770|NCT03319953|12569286|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0
7990771|NCT03319953|12569287|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0
7990772|NCT03319953|12569288|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1
7990773|NCT03319953|12569289|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1
7990774|NCT03320057|12569297|FG000|Overall Study|Lost to Follow-up|4
7990775|NCT03320057|12569298|FG001|Overall Study|Lost to Follow-up|17
7990776|NCT03320057|12569297|FG000|Overall Study|Did not take mifepristone or misoprostol|2
7990777|NCT03320057|12569298|FG001|Overall Study|Did not take mifepristone or misoprostol|0
7990778|NCT03320369|12569308|FG000|Overall Study|Adverse Event|1
7990779|NCT03320369|12569308|FG000|Overall Study|Withdrawal by Subject|2
7990780|NCT03320850|12569322|FG000|Overall Study|Lost to Follow-up|0
7990781|NCT03320850|12569323|FG001|Overall Study|Lost to Follow-up|0
7990782|NCT03320850|12569324|FG002|Overall Study|Lost to Follow-up|0
7990783|NCT03320850|12569325|FG003|Overall Study|Lost to Follow-up|0
7990784|NCT03320850|12569326|FG004|Overall Study|Lost to Follow-up|1
7990785|NCT03320850|12569327|FG005|Overall Study|Lost to Follow-up|2
7990786|NCT03320850|12569328|FG006|Overall Study|Lost to Follow-up|2
7990787|NCT03320850|12569329|FG007|Overall Study|Lost to Follow-up|0
7990788|NCT03320850|12569330|FG008|Overall Study|Lost to Follow-up|6
7990789|NCT03320850|12569331|FG009|Overall Study|Lost to Follow-up|4
7990790|NCT03320850|12569322|FG000|Overall Study|Withdrawal by Subject|0
7990791|NCT03320850|12569323|FG001|Overall Study|Withdrawal by Subject|0
7990792|NCT03320850|12569324|FG002|Overall Study|Withdrawal by Subject|0
7990793|NCT03320850|12569325|FG003|Overall Study|Withdrawal by Subject|0
7990794|NCT03320850|12569326|FG004|Overall Study|Withdrawal by Subject|1
7990795|NCT03320850|12569327|FG005|Overall Study|Withdrawal by Subject|2
7990796|NCT03320850|12569328|FG006|Overall Study|Withdrawal by Subject|4
7990797|NCT03320850|12569329|FG007|Overall Study|Withdrawal by Subject|5
7990798|NCT03320850|12569330|FG008|Overall Study|Withdrawal by Subject|2
7990799|NCT03320850|12569331|FG009|Overall Study|Withdrawal by Subject|1
7990800|NCT03320850|12569322|FG000|Overall Study|Lack of Efficacy|0
7990801|NCT03320850|12569323|FG001|Overall Study|Lack of Efficacy|0
7990802|NCT03320850|12569324|FG002|Overall Study|Lack of Efficacy|0
7990803|NCT03320850|12569325|FG003|Overall Study|Lack of Efficacy|1
7990804|NCT03320850|12569326|FG004|Overall Study|Lack of Efficacy|0
7990805|NCT03320850|12569327|FG005|Overall Study|Lack of Efficacy|1
7990806|NCT03320850|12569328|FG006|Overall Study|Lack of Efficacy|0
7990807|NCT03320850|12569329|FG007|Overall Study|Lack of Efficacy|2
7990808|NCT03320850|12569330|FG008|Overall Study|Lack of Efficacy|0
7990809|NCT03320850|12569331|FG009|Overall Study|Lack of Efficacy|3
7990810|NCT03320850|12569322|FG000|Overall Study|Failure to Meet Randomization Criteria|0
7990811|NCT03320850|12569323|FG001|Overall Study|Failure to Meet Randomization Criteria|0
7990812|NCT03320850|12569324|FG002|Overall Study|Failure to Meet Randomization Criteria|0
7990813|NCT03320850|12569325|FG003|Overall Study|Failure to Meet Randomization Criteria|0
7990814|NCT03320850|12569326|FG004|Overall Study|Failure to Meet Randomization Criteria|0
7990815|NCT03320850|12569327|FG005|Overall Study|Failure to Meet Randomization Criteria|1
7990816|NCT03320850|12569328|FG006|Overall Study|Failure to Meet Randomization Criteria|0
7990817|NCT03320850|12569329|FG007|Overall Study|Failure to Meet Randomization Criteria|0
7990818|NCT03320850|12569330|FG008|Overall Study|Failure to Meet Randomization Criteria|0
7990819|NCT03320850|12569331|FG009|Overall Study|Failure to Meet Randomization Criteria|0
7990820|NCT03320850|12569322|FG000|Overall Study|Adverse Event|0
7990821|NCT03320850|12569323|FG001|Overall Study|Adverse Event|0
7990822|NCT03320850|12569324|FG002|Overall Study|Adverse Event|0
7990823|NCT03320850|12569325|FG003|Overall Study|Adverse Event|0
7990824|NCT03320850|12569326|FG004|Overall Study|Adverse Event|0
7990825|NCT03320850|12569327|FG005|Overall Study|Adverse Event|2
7990826|NCT03320850|12569328|FG006|Overall Study|Adverse Event|1
7990827|NCT03320850|12569329|FG007|Overall Study|Adverse Event|0
7990828|NCT03320850|12569330|FG008|Overall Study|Adverse Event|2
7990829|NCT03320850|12569331|FG009|Overall Study|Adverse Event|0
7990830|NCT03320850|12569322|FG000|Overall Study|Reason Not Specified|0
7990831|NCT03320850|12569323|FG001|Overall Study|Reason Not Specified|0
7990832|NCT03320850|12569324|FG002|Overall Study|Reason Not Specified|0
7990833|NCT03320850|12569325|FG003|Overall Study|Reason Not Specified|0
7990834|NCT03320850|12569326|FG004|Overall Study|Reason Not Specified|0
7990835|NCT03320850|12569327|FG005|Overall Study|Reason Not Specified|1
7990836|NCT03320850|12569328|FG006|Overall Study|Reason Not Specified|0
7990837|NCT03320850|12569329|FG007|Overall Study|Reason Not Specified|0
7990838|NCT03320850|12569330|FG008|Overall Study|Reason Not Specified|0
7990839|NCT03320850|12569331|FG009|Overall Study|Reason Not Specified|1
7990840|NCT03320941|12569363|FG000|Overall Study|subject/guardian decision|0
7990841|NCT03320941|12569364|FG001|Overall Study|subject/guardian decision|0
7990842|NCT03320941|12569365|FG002|Overall Study|subject/guardian decision|0
7990843|NCT03320941|12569366|FG003|Overall Study|subject/guardian decision|1
7990844|NCT03320941|12569367|FG004|Overall Study|subject/guardian decision|0
7990845|NCT03321006|12569381|FG000|Overall Study|Death|1
7990846|NCT03321006|12569382|FG001|Overall Study|Death|0
7990847|NCT03321006|12569381|FG000|Overall Study|Lack of Efficacy|1
7990848|NCT03321006|12569382|FG001|Overall Study|Lack of Efficacy|0
7990849|NCT03321396|12569401|FG000|Overall Study|Physician Decision|1
7990850|NCT03321721|12569408|FG000|Overall Study|Lost to Follow-up|4
7990851|NCT03321721|12569409|FG001|Overall Study|Lost to Follow-up|8
7990852|NCT03321721|12569410|FG002|Overall Study|Lost to Follow-up|11
7990853|NCT03322423|12569419|FG000|Period 1|Subject no longer eligible|0
7990854|NCT03322423|12569420|FG001|Period 1|Subject no longer eligible|1
7990855|NCT03322423|12569419|FG000|Period 1|Withdrawal by Subject|0
7990856|NCT03322423|12569420|FG001|Period 1|Withdrawal by Subject|1
7990857|NCT03322423|12569419|FG000|Period 1|Incorrect Lens Dispensed|1
7990858|NCT03322423|12569420|FG001|Period 1|Incorrect Lens Dispensed|0
7990859|NCT03322423|12569419|FG000|Period 1|Unsatisfactory Lens Fitting|1
7990860|NCT03322423|12569420|FG001|Period 1|Unsatisfactory Lens Fitting|0
7990861|NCT03322423|12569419|FG000|Period 2|Dispensed incorrect lens in left eye|0
7990862|NCT03322423|12569420|FG001|Period 2|Dispensed incorrect lens in left eye|1
7990863|NCT03322423|12569419|FG000|Period 2|Protocol Violation|1
7990864|NCT03322423|12569420|FG001|Period 2|Protocol Violation|0
7990865|NCT03322423|12569419|FG000|Period 2|Subject not eligible for Pytergiumectomy|0
7990866|NCT03322423|12569420|FG001|Period 2|Subject not eligible for Pytergiumectomy|1
7990867|NCT03322462|12569426|FG000|Overall Study|Technical difficulties|2
7990868|NCT03322462|12569426|FG000|Overall Study|Other|1
7990869|NCT03322514|12569434|FG000|Overall Study|Withdrawal by Subject|1
7990870|NCT03322514|12569435|FG001|Overall Study|Withdrawal by Subject|1
7990871|NCT03323086|12569461|FG000|Overall Study|Lost to Follow-up|3
7990872|NCT03323086|12569462|FG001|Overall Study|Lost to Follow-up|2
7990873|NCT03323164|12569470|FG000|Overall Study|Poor quality imaging/scans|2
7990874|NCT03323164|12569471|FG001|Overall Study|Poor quality imaging/scans|2
7990875|NCT03324581|12569516|FG000|Overall Study|Adverse Event|18
7990876|NCT03324581|12569517|FG001|Overall Study|Adverse Event|11
7990877|NCT03324581|12569518|FG002|Overall Study|Adverse Event|7
7990878|NCT03324581|12569516|FG000|Overall Study|Lack of Efficacy|0
7990879|NCT03324581|12569517|FG001|Overall Study|Lack of Efficacy|1
7990880|NCT03324581|12569518|FG002|Overall Study|Lack of Efficacy|0
7990881|NCT03324581|12569516|FG000|Overall Study|Lost to Follow-up|5
7990882|NCT03324581|12569517|FG001|Overall Study|Lost to Follow-up|3
7990883|NCT03324581|12569518|FG002|Overall Study|Lost to Follow-up|6
7990884|NCT03324581|12569516|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2
7990885|NCT03324581|12569517|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2
7990886|NCT03324581|12569518|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0
7990887|NCT03324581|12569516|FG000|Overall Study|Physician Decision|0
7990888|NCT03324581|12569517|FG001|Overall Study|Physician Decision|1
7990889|NCT03324581|12569518|FG002|Overall Study|Physician Decision|2
7990890|NCT03324581|12569516|FG000|Overall Study|Protocol Deviation|8
7990891|NCT03324581|12569517|FG001|Overall Study|Protocol Deviation|9
7990892|NCT03324581|12569518|FG002|Overall Study|Protocol Deviation|4
7990893|NCT03324581|12569516|FG000|Overall Study|Withdrawal by Subject|6
7990894|NCT03324581|12569517|FG001|Overall Study|Withdrawal by Subject|8
7990895|NCT03324581|12569518|FG002|Overall Study|Withdrawal by Subject|6
7990896|NCT03324581|12569516|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0
7990897|NCT03324581|12569517|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1
7990898|NCT03324581|12569518|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0
7990899|NCT03325010|12569535|FG000|Overall Study|Adverse Event|3
7990900|NCT03325010|12569536|FG001|Overall Study|Adverse Event|8
7990901|NCT03325010|12569535|FG000|Overall Study|Protocol Violation|1
7990902|NCT03325010|12569536|FG001|Overall Study|Protocol Violation|8
7990903|NCT03325010|12569535|FG000|Overall Study|Withdrawal by Subject|1
7990904|NCT03325010|12569536|FG001|Overall Study|Withdrawal by Subject|3
7990905|NCT03325010|12569535|FG000|Overall Study|Lost to Follow-up|1
7990906|NCT03325010|12569536|FG001|Overall Study|Lost to Follow-up|0
7990907|NCT03325010|12569535|FG000|Overall Study|Physician Decision|1
7990908|NCT03325010|12569536|FG001|Overall Study|Physician Decision|1
7990909|NCT03325010|12569535|FG000|Overall Study|Lack of Efficacy|2
7990910|NCT03325010|12569536|FG001|Overall Study|Lack of Efficacy|0
7990911|NCT03325556|12569542|FG000|Open-label Period|Lack of Response in OL period|70
7990912|NCT03325556|12569543|FG001|Open-label Period|Lack of Response in OL period|0
7990913|NCT03325556|12569544|FG002|Open-label Period|Lack of Response in OL period|0
7990914|NCT03325556|12569542|FG000|Open-label Period|Adverse Event|27
7990915|NCT03325556|12569543|FG001|Open-label Period|Adverse Event|0
7990916|NCT03325556|12569544|FG002|Open-label Period|Adverse Event|0
7990917|NCT03325556|12569542|FG000|Open-label Period|Death|1
7990918|NCT03325556|12569543|FG001|Open-label Period|Death|0
7990919|NCT03325556|12569544|FG002|Open-label Period|Death|0
7990920|NCT03325556|12569542|FG000|Open-label Period|Lost to Follow-up|1
7990921|NCT03325556|12569543|FG001|Open-label Period|Lost to Follow-up|0
7990922|NCT03325556|12569544|FG002|Open-label Period|Lost to Follow-up|0
7990923|NCT03325556|12569542|FG000|Open-label Period|Non-compliance with study drug|5
7990924|NCT03325556|12569543|FG001|Open-label Period|Non-compliance with study drug|0
7990925|NCT03325556|12569544|FG002|Open-label Period|Non-compliance with study drug|0
7990926|NCT03325556|12569542|FG000|Open-label Period|Use of prohibited medication|1
7990927|NCT03325556|12569543|FG001|Open-label Period|Use of prohibited medication|0
7990928|NCT03325556|12569544|FG002|Open-label Period|Use of prohibited medication|0
7990929|NCT03325556|12569542|FG000|Open-label Period|Protocol Violation|4
7990930|NCT03325556|12569543|FG001|Open-label Period|Protocol Violation|0
7990931|NCT03325556|12569544|FG002|Open-label Period|Protocol Violation|0
7990932|NCT03325556|12569542|FG000|Open-label Period|Withdrawal by Subject|17
7990933|NCT03325556|12569543|FG001|Open-label Period|Withdrawal by Subject|0
7990934|NCT03325556|12569544|FG002|Open-label Period|Withdrawal by Subject|0
7990935|NCT03325556|12569542|FG000|Open-label Period|Not otherwise specified|8
7990936|NCT03325556|12569543|FG001|Open-label Period|Not otherwise specified|0
7990937|NCT03325556|12569544|FG002|Open-label Period|Not otherwise specified|0
7990938|NCT03325556|12569542|FG000|Open-label Period|Administrative discont. at study termination|41
7990939|NCT03325556|12569543|FG001|Open-label Period|Administrative discont. at study termination|0
7990940|NCT03325556|12569544|FG002|Open-label Period|Administrative discont. at study termination|0
7990941|NCT03325556|12569542|FG000|Double-blind Period|Relapse|0
7990942|NCT03325556|12569543|FG001|Double-blind Period|Relapse|15
7990943|NCT03325556|12569544|FG002|Double-blind Period|Relapse|34
7990944|NCT03325556|12569542|FG000|Double-blind Period|Adverse Event|0
7990945|NCT03325556|12569543|FG001|Double-blind Period|Adverse Event|3
7990946|NCT03325556|12569544|FG002|Double-blind Period|Adverse Event|1
7990947|NCT03325556|12569542|FG000|Double-blind Period|Noncompliance with study drug|0
7990948|NCT03325556|12569543|FG001|Double-blind Period|Noncompliance with study drug|0
7990949|NCT03325556|12569544|FG002|Double-blind Period|Noncompliance with study drug|1
7990950|NCT03325556|12569542|FG000|Double-blind Period|Use of prohibited medication|0
7990951|NCT03325556|12569543|FG001|Double-blind Period|Use of prohibited medication|1
7990952|NCT03325556|12569544|FG002|Double-blind Period|Use of prohibited medication|0
7990953|NCT03325556|12569542|FG000|Double-blind Period|Physician Decision|0
7990954|NCT03325556|12569543|FG001|Double-blind Period|Physician Decision|0
7990955|NCT03325556|12569544|FG002|Double-blind Period|Physician Decision|1
7990956|NCT03325556|12569542|FG000|Double-blind Period|Withdrawal by Subject|0
7990957|NCT03325556|12569543|FG001|Double-blind Period|Withdrawal by Subject|6
7990958|NCT03325556|12569544|FG002|Double-blind Period|Withdrawal by Subject|4
7990959|NCT03325556|12569542|FG000|Double-blind Period|Not otherwise specified|0
7990960|NCT03325556|12569543|FG001|Double-blind Period|Not otherwise specified|1
7990961|NCT03325556|12569544|FG002|Double-blind Period|Not otherwise specified|5
7990962|NCT03325556|12569542|FG000|Double-blind Period|Administrative discont. at study termination|0
7990963|NCT03325556|12569543|FG001|Double-blind Period|Administrative discont. at study termination|35
7990964|NCT03325556|12569544|FG002|Double-blind Period|Administrative discont. at study termination|31
7990965|NCT03325673|12569553|FG000|Overall Study|Adverse Event|4
7990966|NCT03325673|12569554|FG001|Overall Study|Adverse Event|0
7990967|NCT03325881|12569573|FG000|Overall Study|Protocol Violation|0
7990968|NCT03325881|12569574|FG001|Overall Study|Protocol Violation|1
7990969|NCT03325881|12569573|FG000|Overall Study|Withdrawal by Subject|0
7990970|NCT03325881|12569574|FG001|Overall Study|Withdrawal by Subject|2
7990971|NCT03325881|12569573|FG000|Overall Study|Lack of Efficacy|2
7990972|NCT03325881|12569574|FG001|Overall Study|Lack of Efficacy|0
7990973|NCT03325881|12569573|FG000|Overall Study|Not treated|1
7990974|NCT03325881|12569574|FG001|Overall Study|Not treated|0
7990975|NCT03325894|12569584|FG000|Overall Study|Adverse Event|2
7990976|NCT03325894|12569585|FG001|Overall Study|Adverse Event|3
7990977|NCT03325894|12569584|FG000|Overall Study|Protocol Violation|1
7990978|NCT03325894|12569585|FG001|Overall Study|Protocol Violation|2
7990979|NCT03325894|12569584|FG000|Overall Study|Withdrawal by Subject|10
7990980|NCT03325894|12569585|FG001|Overall Study|Withdrawal by Subject|6
7990981|NCT03325894|12569584|FG000|Overall Study|Lost to Follow-up|4
7990982|NCT03325894|12569585|FG001|Overall Study|Lost to Follow-up|9
7990983|NCT03325894|12569584|FG000|Overall Study|Lack of Efficacy|8
7990984|NCT03325894|12569585|FG001|Overall Study|Lack of Efficacy|14
7990985|NCT03325894|12569584|FG000|Overall Study|Study Terminated by Sponsor|38
7990986|NCT03325894|12569585|FG001|Overall Study|Study Terminated by Sponsor|43
7990987|NCT03325894|12569584|FG000|Overall Study|Other (Not received Treatment)|1
7990988|NCT03325894|12569585|FG001|Overall Study|Other (Not received Treatment)|0
7990989|NCT03326323|12569594|FG000|Overall Study|Unable to receive ANH protocol|3
7990990|NCT03326518|12569601|FG000|Overall Study|Protocol Violation|1
7990991|NCT03326518|12569602|FG001|Overall Study|Protocol Violation|0
7990992|NCT03326518|12569603|FG002|Overall Study|Protocol Violation|0
7990993|NCT03326518|12569601|FG000|Overall Study|Withdrawal by Subject|1
7990994|NCT03326518|12569602|FG001|Overall Study|Withdrawal by Subject|0
7990995|NCT03326518|12569603|FG002|Overall Study|Withdrawal by Subject|0
7990996|NCT03326518|12569601|FG000|Overall Study|Lost to Follow-up|1
7990997|NCT03326518|12569602|FG001|Overall Study|Lost to Follow-up|0
7990998|NCT03326518|12569603|FG002|Overall Study|Lost to Follow-up|1
7990999|NCT03327220|12569686|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1
7991000|NCT03327220|12569687|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2
7991001|NCT03327220|12569686|FG000|Overall Study|Investigator Decision|2
7991002|NCT03327220|12569687|FG001|Overall Study|Investigator Decision|0
7991003|NCT03327220|12569686|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0
7991004|NCT03327220|12569687|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1
7991005|NCT03327220|12569686|FG000|Overall Study|Fungal infection|1
7991006|NCT03327220|12569687|FG001|Overall Study|Fungal infection|0
7991007|NCT03327220|12569686|FG000|Overall Study|Discharged to Rehabilitation|0
7991008|NCT03327220|12569687|FG001|Overall Study|Discharged to Rehabilitation|1
7991009|NCT03327220|12569686|FG000|Overall Study|Missing|1
7991010|NCT03327220|12569687|FG001|Overall Study|Missing|0
7991011|NCT03327402|12569693|FG000|Overall Study|Withdrawal by Subject|1
7991012|NCT03327402|12569693|FG000|Overall Study|Other (Visit Out-Of-Window)|1
7991013|NCT03328182|12569707|FG000|Overall Study|Withdrawal by Subject|1
7991014|NCT03328182|12569707|FG000|Overall Study|Protocol Violation|2
7991015|NCT03328182|12569707|FG000|Overall Study|No Product Evaluated|1
7991016|NCT03328325|12569720|FG000|Overall Study|Lost to Follow-up|4
7991017|NCT03328325|12569720|FG000|Overall Study|Physician Decision|1
7991018|NCT03328325|12569720|FG000|Overall Study|Withdrawal by Subject|3
7991019|NCT03328325|12569720|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3
7991020|NCT03328832|12569730|FG000|Overall Study|Lost to Follow-up|0
7991021|NCT03328832|12569731|FG001|Overall Study|Lost to Follow-up|1
7991022|NCT03328897|12569740|FG000|Randomized-treatment Epoch|Adverse Event|4
7991023|NCT03328897|12569741|FG001|Randomized-treatment Epoch|Adverse Event|1
7991024|NCT03328897|12569742|FG002|Randomized-treatment Epoch|Adverse Event|1
7991025|NCT03328897|12569740|FG000|Randomized-treatment Epoch|Lost to Follow-up|0
7991026|NCT03328897|12569741|FG001|Randomized-treatment Epoch|Lost to Follow-up|1
7991027|NCT03328897|12569742|FG002|Randomized-treatment Epoch|Lost to Follow-up|0
7991028|NCT03328897|12569740|FG000|Randomized-treatment Epoch|Pregnancy|3
7991029|NCT03328897|12569741|FG001|Randomized-treatment Epoch|Pregnancy|0
7991030|NCT03328897|12569742|FG002|Randomized-treatment Epoch|Pregnancy|0
7991031|NCT03328897|12569740|FG000|Randomized-treatment Epoch|Patient/guardian decision|8
7991032|NCT03328897|12569741|FG001|Randomized-treatment Epoch|Patient/guardian decision|3
7991033|NCT03328897|12569742|FG002|Randomized-treatment Epoch|Patient/guardian decision|1
7991034|NCT03328897|12569740|FG000|Randomized-treatment Epoch|Lack of Efficacy|1
7991035|NCT03328897|12569741|FG001|Randomized-treatment Epoch|Lack of Efficacy|0
7991036|NCT03328897|12569742|FG002|Randomized-treatment Epoch|Lack of Efficacy|0
7991037|NCT03328897|12569740|FG000|Follow-up Epoch|Adverse Event|4
7991038|NCT03328897|12569741|FG001|Follow-up Epoch|Adverse Event|0
7991039|NCT03328897|12569742|FG002|Follow-up Epoch|Adverse Event|1
7991040|NCT03328897|12569740|FG000|Follow-up Epoch|Lack of Efficacy|1
7991041|NCT03328897|12569741|FG001|Follow-up Epoch|Lack of Efficacy|1
7991042|NCT03328897|12569742|FG002|Follow-up Epoch|Lack of Efficacy|1
7991043|NCT03328897|12569740|FG000|Follow-up Epoch|Lost to Follow-up|0
7991044|NCT03328897|12569741|FG001|Follow-up Epoch|Lost to Follow-up|1
7991045|NCT03328897|12569742|FG002|Follow-up Epoch|Lost to Follow-up|0
7991046|NCT03328897|12569740|FG000|Follow-up Epoch|Pregnancy|1
7991047|NCT03328897|12569741|FG001|Follow-up Epoch|Pregnancy|0
7991048|NCT03328897|12569742|FG002|Follow-up Epoch|Pregnancy|0
7991049|NCT03328897|12569740|FG000|Follow-up Epoch|Patient/guardian decision|2
7991050|NCT03328897|12569741|FG001|Follow-up Epoch|Patient/guardian decision|1
7991051|NCT03328897|12569742|FG002|Follow-up Epoch|Patient/guardian decision|0
7991052|NCT03329196|12569757|FG000|Overall Study|Adverse Event|10
7991053|NCT03329196|12569758|FG001|Overall Study|Adverse Event|5
7991054|NCT03329196|12569757|FG000|Overall Study|Physician Decision|2
7991055|NCT03329196|12569758|FG001|Overall Study|Physician Decision|2
7991056|NCT03329196|12569757|FG000|Overall Study|Withdrawal by Subject|11
7991057|NCT03329196|12569758|FG001|Overall Study|Withdrawal by Subject|3
7991058|NCT03329196|12569757|FG000|Overall Study|Hepatic function abnormalities|0
7991059|NCT03329196|12569758|FG001|Overall Study|Hepatic function abnormalities|1
7991060|NCT03329196|12569757|FG000|Overall Study|Conducting rescue therapy before Week 24|2
7991061|NCT03329196|12569758|FG001|Overall Study|Conducting rescue therapy before Week 24|1
7991062|NCT03329196|12569757|FG000|Overall Study|Difficult to control Hb|2
7991063|NCT03329196|12569758|FG001|Overall Study|Difficult to control Hb|3
7991064|NCT03329196|12569757|FG000|Overall Study|Dialysis or renal transplant|13
7991065|NCT03329196|12569758|FG001|Overall Study|Dialysis or renal transplant|15
7991066|NCT03329573|12569778|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
7991067|NCT03329573|12569779|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1
7991068|NCT03329573|12569780|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
7991069|NCT03329573|12569781|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
7991070|NCT03329573|12569778|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1
7991071|NCT03329573|12569779|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2
7991072|NCT03329573|12569780|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
7991073|NCT03329573|12569781|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
7991074|NCT03329573|12569778|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1
7991075|NCT03329573|12569779|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
7991076|NCT03329573|12569780|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
7991077|NCT03329573|12569781|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
7991078|NCT03329573|12569778|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
7991079|NCT03329573|12569779|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1
7991080|NCT03329573|12569780|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
7991081|NCT03329573|12569781|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
7991082|NCT03329846|12569793|FG000|Overall Study|Disease progression|4
7991083|NCT03329846|12569794|FG001|Overall Study|Disease progression|6
7991084|NCT03329846|12569793|FG000|Overall Study|Study drug toxicity|1
7991085|NCT03329846|12569794|FG001|Overall Study|Study drug toxicity|0
7991086|NCT03329846|12569793|FG000|Overall Study|Participant request to discontinue treatment|0
7991087|NCT03329846|12569794|FG001|Overall Study|Participant request to discontinue treatment|1
7991088|NCT03329846|12569793|FG000|Overall Study|Participant withdrew consent|1
7991089|NCT03329846|12569794|FG001|Overall Study|Participant withdrew consent|0
7991090|NCT03329846|12569793|FG000|Overall Study|Other reasons|2
7991091|NCT03329846|12569794|FG001|Overall Study|Other reasons|2
7991092|NCT03329885|12569806|FG000|Overall Study|Sponsor discontinued the study early|0
7991093|NCT03329885|12569807|FG001|Overall Study|Sponsor discontinued the study early|0
7991094|NCT03329885|12569808|FG002|Overall Study|Sponsor discontinued the study early|0
7991095|NCT03329885|12569809|FG003|Overall Study|Sponsor discontinued the study early|0
7991096|NCT03329885|12569810|FG004|Overall Study|Sponsor discontinued the study early|0
7991097|NCT03329885|12569811|FG005|Overall Study|Sponsor discontinued the study early|0
7991098|NCT03329885|12569812|FG006|Overall Study|Sponsor discontinued the study early|1
7991099|NCT03329885|12569813|FG007|Overall Study|Sponsor discontinued the study early|1
7991100|NCT03329885|12569814|FG008|Overall Study|Sponsor discontinued the study early|0
7991101|NCT03329989|12569847|FG000|Overall Study|Withdrawal by Subject|9
7991102|NCT03329989|12569847|FG000|Overall Study|Lost to Follow-up|8
7991103|NCT03329989|12569847|FG000|Overall Study|Adverse Event|5
7991104|NCT03329989|12569847|FG000|Overall Study|Protocol Violation|1
7991105|NCT03330002|12569851|FG000|Overall Study|Lost to Follow-up|15
7991106|NCT03330002|12569851|FG000|Overall Study|Death|7
7991107|NCT03330119|12569863|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166
7991108|NCT03330119|12569864|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282
7991109|NCT03330236|12569872|FG000|Overall Study|Death|2
7991110|NCT03330236|12569873|FG001|Overall Study|Death|1
7991111|NCT03330236|12569872|FG000|Overall Study|Withdrawal by Subject|2
7991112|NCT03330236|12569873|FG001|Overall Study|Withdrawal by Subject|4
7991113|NCT03330236|12569872|FG000|Overall Study|Lost to Follow-up|0
7991114|NCT03330236|12569873|FG001|Overall Study|Lost to Follow-up|2
7991115|NCT03330236|12569872|FG000|Overall Study|Physician Decision|2
7991116|NCT03330236|12569873|FG001|Overall Study|Physician Decision|0
7991117|NCT03330236|12569872|FG000|Overall Study|Protocol Violation|4
7991118|NCT03330236|12569873|FG001|Overall Study|Protocol Violation|3
7991119|NCT03330236|12569872|FG000|Overall Study|SedLine malfunction/blinding|19
7991120|NCT03330236|12569873|FG001|Overall Study|SedLine malfunction/blinding|14
7991121|NCT03330236|12569872|FG000|Overall Study|Volatile anesthetics used|11
7991122|NCT03330236|12569873|FG001|Overall Study|Volatile anesthetics used|8
7991123|NCT03330236|12569872|FG000|Overall Study|Surgery aborted/converted to open|60
7991124|NCT03330236|12569873|FG001|Overall Study|Surgery aborted/converted to open|52
7991125|NCT03330288|12569910|FG000|Overall Study|Other reason|1
7991126|NCT03330288|12569911|FG001|Overall Study|Other reason|1
7991127|NCT03330288|12569910|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1
7991128|NCT03330288|12569911|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0
7991129|NCT03330288|12569910|FG000|Overall Study|Adverse Event|1
7991130|NCT03330288|12569911|FG001|Overall Study|Adverse Event|0
7991131|NCT03330288|12569910|FG000|Overall Study|Withdrawal by Subject|1
7991132|NCT03330288|12569911|FG001|Overall Study|Withdrawal by Subject|0
7991133|NCT03330288|12569910|FG000|Overall Study|Lost to Follow-up|26
7991134|NCT03330288|12569911|FG001|Overall Study|Lost to Follow-up|7
7991135|NCT03331042|12569942|FG000|Overall Study|Protocol Violation|1
7991136|NCT03331042|12569943|FG001|Overall Study|Protocol Violation|0
7991137|NCT03331042|12569944|FG002|Overall Study|Protocol Violation|0
7991138|NCT03331042|12569945|FG003|Overall Study|Protocol Violation|0
7991139|NCT03331042|12569942|FG000|Overall Study|Physician Decision|0
7991140|NCT03331042|12569943|FG001|Overall Study|Physician Decision|0
7991141|NCT03331042|12569944|FG002|Overall Study|Physician Decision|1
7991142|NCT03331042|12569945|FG003|Overall Study|Physician Decision|0
7991143|NCT03331042|12569942|FG000|Overall Study|Lost to Follow-up|0
7991144|NCT03331042|12569943|FG001|Overall Study|Lost to Follow-up|0
7991145|NCT03331042|12569944|FG002|Overall Study|Lost to Follow-up|0
7991146|NCT03331042|12569945|FG003|Overall Study|Lost to Follow-up|1
7991147|NCT03331315|12569972|FG000|Overall Study|Physician Decision|18
7991148|NCT03331315|12569973|FG001|Overall Study|Physician Decision|14
7991149|NCT03331666|12569983|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2
7991150|NCT03331666|12569984|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2
7991151|NCT03332160|12570010|FG000|Overall Study|Withdrawal by Subject|1
7991152|NCT03332160|12570011|FG001|Overall Study|Withdrawal by Subject|1
7991153|NCT03332160|12570010|FG000|Overall Study|Adverse Event|0
7991154|NCT03332160|12570011|FG001|Overall Study|Adverse Event|1
7991155|NCT03332160|12570010|FG000|Overall Study|Developed Exclusion Criteria|0
7991156|NCT03332160|12570011|FG001|Overall Study|Developed Exclusion Criteria|1
7991157|NCT03332160|12570010|FG000|Overall Study|Non-adherence to treatment|0
7991158|NCT03332160|12570011|FG001|Overall Study|Non-adherence to treatment|2
7991159|NCT03332212|12570022|FG000|Overall Study|Not treated|0
7991160|NCT03332212|12570023|FG001|Overall Study|Not treated|1
7991161|NCT03332212|12570024|FG002|Overall Study|Not treated|0
7991162|NCT03332212|12570025|FG003|Overall Study|Not treated|0
7991163|NCT03332212|12570022|FG000|Overall Study|Adverse Event|0
7991164|NCT03332212|12570023|FG001|Overall Study|Adverse Event|0
7991165|NCT03332212|12570024|FG002|Overall Study|Adverse Event|0
7991166|NCT03332212|12570025|FG003|Overall Study|Adverse Event|1
7991167|NCT03332212|12570022|FG000|Overall Study|worsening of disease under study|1
7991168|NCT03332212|12570023|FG001|Overall Study|worsening of disease under study|1
7991169|NCT03332212|12570024|FG002|Overall Study|worsening of disease under study|0
7991170|NCT03332212|12570025|FG003|Overall Study|worsening of disease under study|0
7991171|NCT03332628|12570046|FG000|Overall Study|Physician Decision|2
7991172|NCT03332771|12570055|FG000|Overall Study|Adverse Event|6
7991173|NCT03332771|12570056|FG001|Overall Study|Adverse Event|4
7991174|NCT03332771|12570057|FG002|Overall Study|Adverse Event|1
7991175|NCT03332771|12570058|FG003|Overall Study|Adverse Event|3
7991176|NCT03332771|12570055|FG000|Overall Study|Poor Compliance to Protocol|0
7991177|NCT03332771|12570056|FG001|Overall Study|Poor Compliance to Protocol|1
7991178|NCT03332771|12570057|FG002|Overall Study|Poor Compliance to Protocol|0
7991179|NCT03332771|12570058|FG003|Overall Study|Poor Compliance to Protocol|1
7991180|NCT03332771|12570055|FG000|Overall Study|Lost to Follow-up|2
7991181|NCT03332771|12570056|FG001|Overall Study|Lost to Follow-up|2
7991182|NCT03332771|12570057|FG002|Overall Study|Lost to Follow-up|1
7991183|NCT03332771|12570058|FG003|Overall Study|Lost to Follow-up|2
7991184|NCT03332771|12570055|FG000|Overall Study|At the Participant's own request|20
7991185|NCT03332771|12570056|FG001|Overall Study|At the Participant's own request|26
7991186|NCT03332771|12570057|FG002|Overall Study|At the Participant's own request|14
7991187|NCT03332771|12570058|FG003|Overall Study|At the Participant's own request|23
7991188|NCT03332771|12570055|FG000|Overall Study|Reason Not Specified|6
7991189|NCT03332771|12570056|FG001|Overall Study|Reason Not Specified|18
7991190|NCT03332771|12570057|FG002|Overall Study|Reason Not Specified|16
7991191|NCT03332771|12570058|FG003|Overall Study|Reason Not Specified|19
7991192|NCT03332784|12570088|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991193|NCT03332784|12570089|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
7991194|NCT03332784|12570090|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991195|NCT03332784|12570091|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991196|NCT03332784|12570092|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991197|NCT03332784|12570093|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991198|NCT03332784|12570094|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991199|NCT03332784|12570095|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991200|NCT03332784|12570096|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991201|NCT03332784|12570097|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991202|NCT03332784|12570098|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991203|NCT03332784|12570099|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991204|NCT03332784|12570100|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991205|NCT03332784|12570101|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991206|NCT03332784|12570102|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
7991207|NCT03332784|12570103|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991208|NCT03332784|12570104|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991209|NCT03332784|12570105|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991210|NCT03332784|12570106|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991211|NCT03332784|12570107|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7991212|NCT03333109|12570168|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0
7991213|NCT03333109|12570169|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0
7991214|NCT03333109|12570170|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2
7991215|NCT03333109|12570168|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0
7991216|NCT03333109|12570169|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0
7991217|NCT03333109|12570170|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1
7991218|NCT03333109|12570168|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4
7991219|NCT03333109|12570169|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0
7991220|NCT03333109|12570170|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1
7991221|NCT03333109|12570168|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1
7991222|NCT03333109|12570169|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0
7991223|NCT03333109|12570170|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0
7991224|NCT03333109|12570168|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9
7991225|NCT03333109|12570169|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6
7991226|NCT03333109|12570170|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5
7991227|NCT03333109|12570168|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3
7991228|NCT03333109|12570169|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0
7991229|NCT03333109|12570170|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3
7991230|NCT03333109|12570168|FG000|Safety Follow-up Period|Lost to Follow-up|6
7991231|NCT03333109|12570169|FG001|Safety Follow-up Period|Lost to Follow-up|2
7991232|NCT03333109|12570170|FG002|Safety Follow-up Period|Lost to Follow-up|1
7991233|NCT03333109|12570168|FG000|Safety Follow-up Period|Withdrawal by Subject|7
7991234|NCT03333109|12570169|FG001|Safety Follow-up Period|Withdrawal by Subject|2
7991235|NCT03333109|12570170|FG002|Safety Follow-up Period|Withdrawal by Subject|12
7991236|NCT03333876|12570199|FG000|Screening Period|Screen Failure|4
7991237|NCT03333876|12570199|FG000|Nasal Dilator|Bed Partner Lost to follow up|6
7991238|NCT03333876|12570199|FG000|Mandibular Advancement|Adverse Event|2
7991239|NCT03333876|12570199|FG000|Mandibular Advancement|Product Damage|2
7991240|NCT03333941|12570212|FG000|Overall Study|Lost to Follow-up|10
7991241|NCT03333941|12570212|FG000|Overall Study|Death|2
7991242|NCT03333941|12570212|FG000|Overall Study|Adverse Event|1
7991243|NCT03334175|12570218|FG000|Overall Study|Lost to Follow-up|0
7991244|NCT03334175|12570219|FG001|Overall Study|Lost to Follow-up|1
7991245|NCT03334188|12570227|FG000|Overall Study|Withdrawal by Subject|0
7991246|NCT03334188|12570228|FG001|Overall Study|Withdrawal by Subject|1
7991247|NCT03334188|12570227|FG000|Overall Study|Death|1
7991248|NCT03334188|12570228|FG001|Overall Study|Death|0
7991249|NCT03334188|12570227|FG000|Overall Study|Never had qualifying clinic visit|7
7991250|NCT03334188|12570228|FG001|Overall Study|Never had qualifying clinic visit|7
7991251|NCT03334214|12570237|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
7991252|NCT03334214|12570238|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
7991253|NCT03334214|12570237|FG000|Overall Study|Withdrawal by Subject|0
7991254|NCT03334214|12570238|FG001|Overall Study|Withdrawal by Subject|1
7991255|NCT03334214|12570237|FG000|Overall Study|Other|1
7991256|NCT03334214|12570238|FG001|Overall Study|Other|0
7991257|NCT03334396|12570253|FG000|Overall Study|Adverse Event|1
7991258|NCT03334396|12570254|FG001|Overall Study|Adverse Event|0
7991259|NCT03334396|12570255|FG002|Overall Study|Adverse Event|1
7991260|NCT03334396|12570256|FG003|Overall Study|Adverse Event|0
7991261|NCT03334396|12570257|FG004|Overall Study|Adverse Event|0
7991262|NCT03334396|12570258|FG005|Overall Study|Adverse Event|0
7991263|NCT03334396|12570259|FG006|Overall Study|Adverse Event|0
7991264|NCT03334396|12570260|FG007|Overall Study|Adverse Event|0
7991265|NCT03334396|12570253|FG000|Overall Study|Lack of Efficacy|10
7991266|NCT03334396|12570254|FG001|Overall Study|Lack of Efficacy|4
7991267|NCT03334396|12570255|FG002|Overall Study|Lack of Efficacy|1
7991268|NCT03334396|12570256|FG003|Overall Study|Lack of Efficacy|3
7991269|NCT03334396|12570257|FG004|Overall Study|Lack of Efficacy|1
7991270|NCT03334396|12570258|FG005|Overall Study|Lack of Efficacy|0
7991271|NCT03334396|12570259|FG006|Overall Study|Lack of Efficacy|0
7991272|NCT03334396|12570260|FG007|Overall Study|Lack of Efficacy|1
7991273|NCT03334396|12570253|FG000|Overall Study|Lost to Follow-up|0
7991274|NCT03334396|12570254|FG001|Overall Study|Lost to Follow-up|0
7991275|NCT03334396|12570255|FG002|Overall Study|Lost to Follow-up|1
7991276|NCT03334396|12570256|FG003|Overall Study|Lost to Follow-up|0
7991277|NCT03334396|12570257|FG004|Overall Study|Lost to Follow-up|0
7991278|NCT03334396|12570258|FG005|Overall Study|Lost to Follow-up|0
7991279|NCT03334396|12570259|FG006|Overall Study|Lost to Follow-up|1
7991280|NCT03334396|12570260|FG007|Overall Study|Lost to Follow-up|0
7991281|NCT03334396|12570253|FG000|Overall Study|Physician Decision|1
7991282|NCT03334396|12570254|FG001|Overall Study|Physician Decision|0
7991283|NCT03334396|12570255|FG002|Overall Study|Physician Decision|0
7991284|NCT03334396|12570256|FG003|Overall Study|Physician Decision|0
7991285|NCT03334396|12570257|FG004|Overall Study|Physician Decision|0
7991286|NCT03334396|12570258|FG005|Overall Study|Physician Decision|0
7991287|NCT03334396|12570259|FG006|Overall Study|Physician Decision|0
7991288|NCT03334396|12570260|FG007|Overall Study|Physician Decision|0
7991289|NCT03334396|12570253|FG000|Overall Study|Withdrawal by Subject|10
7991290|NCT03334396|12570254|FG001|Overall Study|Withdrawal by Subject|5
7991291|NCT03334396|12570255|FG002|Overall Study|Withdrawal by Subject|7
7991292|NCT03334396|12570256|FG003|Overall Study|Withdrawal by Subject|2
7991293|NCT03334396|12570257|FG004|Overall Study|Withdrawal by Subject|2
7991294|NCT03334396|12570258|FG005|Overall Study|Withdrawal by Subject|1
7991295|NCT03334396|12570259|FG006|Overall Study|Withdrawal by Subject|2
7991296|NCT03334396|12570260|FG007|Overall Study|Withdrawal by Subject|0
7991297|NCT03334396|12570253|FG000|Overall Study|Pregnancy|0
7991298|NCT03334396|12570254|FG001|Overall Study|Pregnancy|1
7991299|NCT03334396|12570255|FG002|Overall Study|Pregnancy|0
7991300|NCT03334396|12570256|FG003|Overall Study|Pregnancy|0
7991301|NCT03334396|12570257|FG004|Overall Study|Pregnancy|0
7991302|NCT03334396|12570258|FG005|Overall Study|Pregnancy|0
7991303|NCT03334396|12570259|FG006|Overall Study|Pregnancy|0
7991304|NCT03334396|12570260|FG007|Overall Study|Pregnancy|0
7991305|NCT03334396|12570253|FG000|Overall Study|Ineligible|0
7991306|NCT03334396|12570254|FG001|Overall Study|Ineligible|1
7991307|NCT03334396|12570255|FG002|Overall Study|Ineligible|0
7991308|NCT03334396|12570256|FG003|Overall Study|Ineligible|0
7991309|NCT03334396|12570257|FG004|Overall Study|Ineligible|0
7991310|NCT03334396|12570258|FG005|Overall Study|Ineligible|0
7991311|NCT03334396|12570259|FG006|Overall Study|Ineligible|0
7991312|NCT03334396|12570260|FG007|Overall Study|Ineligible|0
7991313|NCT03334396|12570253|FG000|Overall Study|Started New Job|1
7991314|NCT03334396|12570254|FG001|Overall Study|Started New Job|0
7991315|NCT03334396|12570255|FG002|Overall Study|Started New Job|0
7991316|NCT03334396|12570256|FG003|Overall Study|Started New Job|0
7991317|NCT03334396|12570257|FG004|Overall Study|Started New Job|0
7991318|NCT03334396|12570258|FG005|Overall Study|Started New Job|0
7991319|NCT03334396|12570259|FG006|Overall Study|Started New Job|0
7991320|NCT03334396|12570260|FG007|Overall Study|Started New Job|0
7991321|NCT03334422|12570281|FG000|Overall Study|Adverse Event|1
7991322|NCT03334422|12570282|FG001|Overall Study|Adverse Event|3
7991323|NCT03334422|12570283|FG002|Overall Study|Adverse Event|2
7991324|NCT03334422|12570284|FG003|Overall Study|Adverse Event|2
7991325|NCT03334422|12570281|FG000|Overall Study|Lack of Efficacy|10
7991326|NCT03334422|12570282|FG001|Overall Study|Lack of Efficacy|2
7991327|NCT03334422|12570283|FG002|Overall Study|Lack of Efficacy|7
7991328|NCT03334422|12570284|FG003|Overall Study|Lack of Efficacy|3
7991329|NCT03334422|12570281|FG000|Overall Study|Withdrawal by Subject|8
7991330|NCT03334422|12570282|FG001|Overall Study|Withdrawal by Subject|3
7991331|NCT03334422|12570283|FG002|Overall Study|Withdrawal by Subject|1
7991332|NCT03334422|12570284|FG003|Overall Study|Withdrawal by Subject|0
7991333|NCT03334422|12570281|FG000|Overall Study|Lost to Follow-up|0
7991334|NCT03334422|12570282|FG001|Overall Study|Lost to Follow-up|0
7991335|NCT03334422|12570283|FG002|Overall Study|Lost to Follow-up|0
7991336|NCT03334422|12570284|FG003|Overall Study|Lost to Follow-up|1
7991337|NCT03334422|12570281|FG000|Overall Study|Inability to obtain laboratory samples|0
7991338|NCT03334422|12570282|FG001|Overall Study|Inability to obtain laboratory samples|1
7991339|NCT03334422|12570283|FG002|Overall Study|Inability to obtain laboratory samples|0
7991340|NCT03334422|12570284|FG003|Overall Study|Inability to obtain laboratory samples|0
7991341|NCT03334422|12570281|FG000|Overall Study|Pregnancy|0
7991342|NCT03334422|12570282|FG001|Overall Study|Pregnancy|1
7991343|NCT03334422|12570283|FG002|Overall Study|Pregnancy|0
7991344|NCT03334422|12570284|FG003|Overall Study|Pregnancy|0
7991345|NCT03334448|12570299|FG000|Washout|Personal Reason|0
7991346|NCT03334448|12570300|FG001|Washout|Personal Reason|1
7991347|NCT03334448|12570301|FG002|Washout|Personal Reason|0
7991348|NCT03334448|12570302|FG003|Washout|Personal Reason|0
7991349|NCT03334448|12570299|FG000|Washout|Protocol Violation|0
7991350|NCT03334448|12570300|FG001|Washout|Protocol Violation|0
7991351|NCT03334448|12570301|FG002|Washout|Protocol Violation|0
7991352|NCT03334448|12570302|FG003|Washout|Protocol Violation|1
7991353|NCT03334630|12570310|FG000|Overall Study|Withdrawal by Subject|7
7991354|NCT03334630|12570311|FG001|Overall Study|Withdrawal by Subject|7
7991355|NCT03334630|12570310|FG000|Overall Study|Lost to Follow-up|3
7991356|NCT03334630|12570311|FG001|Overall Study|Lost to Follow-up|1
7991357|NCT03334630|12570310|FG000|Overall Study|Adverse Event|0
7991358|NCT03334630|12570311|FG001|Overall Study|Adverse Event|1
7991359|NCT03334630|12570310|FG000|Overall Study|Physician Decision|1
7991360|NCT03334630|12570311|FG001|Overall Study|Physician Decision|1
7991361|NCT03334630|12570310|FG000|Overall Study|Enrollment closed|2
7991362|NCT03334630|12570311|FG001|Overall Study|Enrollment closed|1
7991363|NCT03334630|12570310|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0
7991364|NCT03334630|12570311|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1
7991365|NCT03334630|12570310|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1
7991366|NCT03334630|12570311|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1
7991367|NCT03334695|12570319|FG000|Overall Study|Lost to Follow-up|3
7991368|NCT03334695|12570320|FG001|Overall Study|Lost to Follow-up|3
7991369|NCT03334695|12570319|FG000|Overall Study|Physician Decision|1
7991370|NCT03334695|12570320|FG001|Overall Study|Physician Decision|2
7991371|NCT03334695|12570319|FG000|Overall Study|Protocol Violation|0
7991372|NCT03334695|12570320|FG001|Overall Study|Protocol Violation|1
7991373|NCT03334721|12570330|FG000|Overall Study|Withdrawal by Subject|1
7991374|NCT03334721|12570331|FG001|Overall Study|Withdrawal by Subject|0
7991375|NCT03334721|12570330|FG000|Overall Study|No longer met inclusion/exclusion criter|1
7991376|NCT03334721|12570331|FG001|Overall Study|No longer met inclusion/exclusion criter|0
7991377|NCT03334747|12570363|FG000|Treatment Phase|Technical problems|0
7991378|NCT03334747|12570364|FG001|Treatment Phase|Technical problems|0
7991379|NCT03334747|12570365|FG002|Treatment Phase|Technical problems|0
7991380|NCT03334747|12570366|FG003|Treatment Phase|Technical problems|0
7991381|NCT03334747|12570367|FG004|Treatment Phase|Technical problems|1
7991382|NCT03334747|12570368|FG005|Treatment Phase|Technical problems|0
7991383|NCT03334747|12570369|FG006|Treatment Phase|Technical problems|0
7991384|NCT03334747|12570370|FG007|Treatment Phase|Technical problems|0
7991385|NCT03334747|12570371|FG008|Treatment Phase|Technical problems|0
7991386|NCT03334747|12570363|FG000|Treatment Phase|Subject/guardian decision|1
7991387|NCT03334747|12570364|FG001|Treatment Phase|Subject/guardian decision|0
7991388|NCT03334747|12570365|FG002|Treatment Phase|Subject/guardian decision|0
7991389|NCT03334747|12570366|FG003|Treatment Phase|Subject/guardian decision|0
7991390|NCT03334747|12570367|FG004|Treatment Phase|Subject/guardian decision|0
7991391|NCT03334747|12570368|FG005|Treatment Phase|Subject/guardian decision|1
7991392|NCT03334747|12570369|FG006|Treatment Phase|Subject/guardian decision|0
7991393|NCT03334747|12570370|FG007|Treatment Phase|Subject/guardian decision|0
7991394|NCT03334747|12570371|FG008|Treatment Phase|Subject/guardian decision|0
7991395|NCT03334747|12570363|FG000|Follow-Up Phase|Subject/guardian decision|0
7991396|NCT03334747|12570364|FG001|Follow-Up Phase|Subject/guardian decision|0
7991397|NCT03334747|12570365|FG002|Follow-Up Phase|Subject/guardian decision|0
7991398|NCT03334747|12570366|FG003|Follow-Up Phase|Subject/guardian decision|0
7991399|NCT03334747|12570367|FG004|Follow-Up Phase|Subject/guardian decision|0
7991400|NCT03334747|12570368|FG005|Follow-Up Phase|Subject/guardian decision|0
7991401|NCT03334747|12570369|FG006|Follow-Up Phase|Subject/guardian decision|1
7991402|NCT03334747|12570370|FG007|Follow-Up Phase|Subject/guardian decision|0
7991403|NCT03334747|12570371|FG008|Follow-Up Phase|Subject/guardian decision|1
7991404|NCT03334903|12570413|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1
7991405|NCT03334903|12570414|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0
7991406|NCT03334903|12570413|FG000|Overall Study|Protocol Violation|1
7991407|NCT03334903|12570414|FG001|Overall Study|Protocol Violation|3
7991408|NCT03334903|12570413|FG000|Overall Study|Surgery postponed|1
7991409|NCT03334903|12570414|FG001|Overall Study|Surgery postponed|0
7991410|NCT03334903|12570413|FG000|Overall Study|Adverse Event|1
7991411|NCT03334903|12570414|FG001|Overall Study|Adverse Event|1
7991412|NCT03334903|12570413|FG000|Overall Study|Withdrawal by Subject|0
7991413|NCT03334903|12570414|FG001|Overall Study|Withdrawal by Subject|1
7991414|NCT03335150|12570422|FG000|Overall Study|Withdrawal by Subject|10
7991415|NCT03335150|12570423|FG001|Overall Study|Withdrawal by Subject|4
7991416|NCT03335150|12570422|FG000|Overall Study|Adverse Event|0
7991417|NCT03335150|12570423|FG001|Overall Study|Adverse Event|1
7991418|NCT03335566|12570499|FG000|Overall Study|Adverse Event|0
7991419|NCT03335566|12570500|FG001|Overall Study|Adverse Event|1
7991420|NCT03335566|12570499|FG000|Overall Study|Lost to Follow-up|1
7991421|NCT03335566|12570500|FG001|Overall Study|Lost to Follow-up|0
7991422|NCT03335566|12570499|FG000|Overall Study|Technical Problems|1
7991423|NCT03335566|12570500|FG001|Overall Study|Technical Problems|0
7991424|NCT03335566|12570499|FG000|Overall Study|Protocol Violation|1
7991425|NCT03335566|12570500|FG001|Overall Study|Protocol Violation|0
7991426|NCT03335566|12570499|FG000|Overall Study|Other than specified above|1
7991427|NCT03335566|12570500|FG001|Overall Study|Other than specified above|2
7991428|NCT03336502|12570529|FG000|Overall Study|Physician Decision|0
7991429|NCT03336502|12570530|FG001|Overall Study|Physician Decision|1
7991430|NCT03336502|12570529|FG000|Overall Study|Prohibited Drugs|1
7991431|NCT03336502|12570530|FG001|Overall Study|Prohibited Drugs|1
7991432|NCT03336502|12570529|FG000|Overall Study|Death|1
7991433|NCT03336502|12570530|FG001|Overall Study|Death|2
7991434|NCT03336502|12570529|FG000|Overall Study|Adverse Event|2
7991435|NCT03336502|12570530|FG001|Overall Study|Adverse Event|5
7991436|NCT03337139|12570551|FG000|Phase I|Withdrawal by Subject|10
7991437|NCT03337139|12570552|FG001|Phase I|Withdrawal by Subject|0
7991438|NCT03337152|12570560|FG000|Overall Study|Physician Decision|1
7991439|NCT03337152|12570561|FG001|Overall Study|Physician Decision|0
7991440|NCT03337152|12570560|FG000|Overall Study|Lost to Follow-up|1
7991441|NCT03337152|12570561|FG001|Overall Study|Lost to Follow-up|3
7991442|NCT03337152|12570560|FG000|Overall Study|Adverse Event|3
7991443|NCT03337152|12570561|FG001|Overall Study|Adverse Event|1
7991444|NCT03337152|12570560|FG000|Overall Study|Stopped drug dosing due to study halt|6
7991445|NCT03337152|12570561|FG001|Overall Study|Stopped drug dosing due to study halt|7
7991446|NCT03337308|12570573|FG000|Overall Study|Adverse Event|2
7991447|NCT03337308|12570574|FG001|Overall Study|Adverse Event|3
7991448|NCT03337308|12570575|FG002|Overall Study|Adverse Event|3
7991449|NCT03337308|12570576|FG003|Overall Study|Adverse Event|1
7991450|NCT03337308|12570573|FG000|Overall Study|Lost to Follow-up|1
7991451|NCT03337308|12570574|FG001|Overall Study|Lost to Follow-up|2
7991452|NCT03337308|12570575|FG002|Overall Study|Lost to Follow-up|0
7991453|NCT03337308|12570576|FG003|Overall Study|Lost to Follow-up|0
7991454|NCT03337308|12570573|FG000|Overall Study|Withdrawal by Subject|2
7991455|NCT03337308|12570574|FG001|Overall Study|Withdrawal by Subject|1
7991456|NCT03337308|12570575|FG002|Overall Study|Withdrawal by Subject|2
7991457|NCT03337308|12570576|FG003|Overall Study|Withdrawal by Subject|1
7991458|NCT03337308|12570573|FG000|Overall Study|Protocol Violation|0
7991459|NCT03337308|12570574|FG001|Overall Study|Protocol Violation|1
7991460|NCT03337308|12570575|FG002|Overall Study|Protocol Violation|0
7991461|NCT03337308|12570576|FG003|Overall Study|Protocol Violation|0
7991462|NCT03337477|12570588|FG000|Overall Study|not categorized into the listed ones|11
7991463|NCT03337477|12570589|FG001|Overall Study|not categorized into the listed ones|9
7991464|NCT03337477|12570588|FG000|Overall Study|Withdrawal by Subject|0
7991465|NCT03337477|12570589|FG001|Overall Study|Withdrawal by Subject|1
7991466|NCT03337477|12570588|FG000|Overall Study|Death|0
7991467|NCT03337477|12570589|FG001|Overall Study|Death|1
7991468|NCT03337477|12570588|FG000|Overall Study|Lost to Follow-up|0
7991469|NCT03337477|12570589|FG001|Overall Study|Lost to Follow-up|2
7991470|NCT03337490|12570600|FG000|Overall Study|Withdrawal by Subject|1
7991471|NCT03337490|12570601|FG001|Overall Study|Withdrawal by Subject|0
7991472|NCT03337490|12570602|FG002|Overall Study|Withdrawal by Subject|0
7991473|NCT03337490|12570600|FG000|Overall Study|Lack of Efficacy|10
7991474|NCT03337490|12570601|FG001|Overall Study|Lack of Efficacy|12
7991475|NCT03337490|12570602|FG002|Overall Study|Lack of Efficacy|35
7991476|NCT03337490|12570600|FG000|Overall Study|Physician Decision|0
7991477|NCT03337490|12570601|FG001|Overall Study|Physician Decision|1
7991478|NCT03337490|12570602|FG002|Overall Study|Physician Decision|0
7991479|NCT03337490|12570600|FG000|Overall Study|Lost to Follow-up|0
7991480|NCT03337490|12570601|FG001|Overall Study|Lost to Follow-up|1
7991481|NCT03337490|12570602|FG002|Overall Study|Lost to Follow-up|0
7991482|NCT03337542|12570610|FG000|Overall Study|Withdrew Consent|17
7991483|NCT03337542|12570610|FG000|Overall Study|Allergic Adverse Event|1
7991484|NCT03337542|12570610|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1
7991485|NCT03337542|12570610|FG000|Overall Study|Lost to Follow-up|1
7991486|NCT03337542|12570610|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1
7991487|NCT03338010|12570617|FG000|Overall Study|Withdrawal by Subject|14
7991488|NCT03338010|12570618|FG001|Overall Study|Withdrawal by Subject|8
7991489|NCT03338010|12570617|FG000|Overall Study|Lost to Follow-up|4
7991490|NCT03338010|12570618|FG001|Overall Study|Lost to Follow-up|2
7991491|NCT03338010|12570617|FG000|Overall Study|Adverse Event|3
7991492|NCT03338010|12570618|FG001|Overall Study|Adverse Event|2
7991493|NCT03338010|12570617|FG000|Overall Study|Physician Decision|2
7991494|NCT03338010|12570618|FG001|Overall Study|Physician Decision|2
7991495|NCT03338010|12570617|FG000|Overall Study|Non-Compliance with Study Drug|0
7991496|NCT03338010|12570618|FG001|Overall Study|Non-Compliance with Study Drug|3
7991497|NCT03338010|12570617|FG000|Overall Study|Protocol Violation|0
7991498|NCT03338010|12570618|FG001|Overall Study|Protocol Violation|1
7991499|NCT03338023|12570626|FG000|Overall Study|Withdrawal by Subject|3
7991500|NCT03338023|12570627|FG001|Overall Study|Withdrawal by Subject|4
7991501|NCT03338023|12570626|FG000|Overall Study|Protocol Violation|3
7991502|NCT03338023|12570627|FG001|Overall Study|Protocol Violation|3
7991503|NCT03338023|12570626|FG000|Overall Study|Lost to Follow-up|2
7991504|NCT03338023|12570627|FG001|Overall Study|Lost to Follow-up|1
7991505|NCT03338023|12570626|FG000|Overall Study|Physician Decision|1
7991506|NCT03338023|12570627|FG001|Overall Study|Physician Decision|2
7991507|NCT03338062|12570635|FG000|Overall Study|Alternative Therapy|1
7991508|NCT03338062|12570636|FG001|Overall Study|Alternative Therapy|0
7991509|NCT03338296|12570645|FG000|Overall Study|Adverse Event|0
7991510|NCT03338296|12570646|FG001|Overall Study|Adverse Event|1
7991511|NCT03338296|12570645|FG000|Overall Study|Withdrawal by Subject|14
7991512|NCT03338296|12570646|FG001|Overall Study|Withdrawal by Subject|13
7991513|NCT03338296|12570645|FG000|Overall Study|Lost to Follow-up|10
7991514|NCT03338296|12570646|FG001|Overall Study|Lost to Follow-up|10
7991515|NCT03338296|12570645|FG000|Overall Study|Study Terminated by Sponsor|77
7991516|NCT03338296|12570646|FG001|Overall Study|Study Terminated by Sponsor|76
7991517|NCT03338296|12570645|FG000|Overall Study|Other|2
7991518|NCT03338296|12570646|FG001|Overall Study|Other|7
7991519|NCT03338296|12570645|FG000|Overall Study|Missing|0
7991520|NCT03338296|12570646|FG001|Overall Study|Missing|1
7991521|NCT03338400|12570654|FG000|Overall Study|Lost to Follow-up|1
7991522|NCT03338400|12570655|FG001|Overall Study|Lost to Follow-up|2
7991523|NCT03338569|12570688|FG000|Overall Study|Physician Decision|8
7991524|NCT03338569|12570689|FG001|Overall Study|Physician Decision|3
7991525|NCT03338569|12570688|FG000|Overall Study|Withdrawal by Subject|0
7991526|NCT03338569|12570689|FG001|Overall Study|Withdrawal by Subject|1
7991527|NCT03338569|12570688|FG000|Overall Study|Lost to Follow-up|0
7991528|NCT03338569|12570689|FG001|Overall Study|Lost to Follow-up|1
7991529|NCT03338673|12570697|FG000|Overall Study|Lost to Follow-up|1
7991530|NCT03338673|12570698|FG001|Overall Study|Lost to Follow-up|1
7991531|NCT03338855|12570722|FG000|Overall Study|Withdrawn as birth control pill stopped|1
7991532|NCT03338855|12570723|FG001|Overall Study|Withdrawn as birth control pill stopped|0
7991533|NCT03339219|12570742|FG000|Overall Study|Death|12
7991534|NCT03339219|12570742|FG000|Overall Study|Site Terminated by Sponsor|22
7991535|NCT03339219|12570742|FG000|Overall Study|Withdrawal by Subject|1
7991536|NCT03339297|12570748|FG000|Overall Study|Relapse of Hematologic Disease|1
7991537|NCT03339297|12570749|FG001|Overall Study|Relapse of Hematologic Disease|0
7991538|NCT03339297|12570748|FG000|Overall Study|Death|10
7991539|NCT03339297|12570749|FG001|Overall Study|Death|7
7991540|NCT03339297|12570748|FG000|Overall Study|Hepatic Candidosis|1
7991541|NCT03339297|12570749|FG001|Overall Study|Hepatic Candidosis|0
7991542|NCT03339297|12570748|FG000|Overall Study|Adverse Event, Serious Fatal|0
7991543|NCT03339297|12570749|FG001|Overall Study|Adverse Event, Serious Fatal|2
7991544|NCT03339297|12570748|FG000|Overall Study|Consent Withdrawn by Participant|3
7991545|NCT03339297|12570749|FG001|Overall Study|Consent Withdrawn by Participant|3
7991546|NCT03339297|12570748|FG000|Overall Study|Disease Relapse|2
7991547|NCT03339297|12570749|FG001|Overall Study|Disease Relapse|0
7991548|NCT03339297|12570748|FG000|Overall Study|Physician Decision|1
7991549|NCT03339297|12570749|FG001|Overall Study|Physician Decision|1
7991550|NCT03339297|12570748|FG000|Overall Study|Relapse of Disease New Transplant Performed|1
7991551|NCT03339297|12570749|FG001|Overall Study|Relapse of Disease New Transplant Performed|0
7991552|NCT03339297|12570748|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1
7991553|NCT03339297|12570749|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0
7991554|NCT03339297|12570748|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1
7991555|NCT03339297|12570749|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0
7991556|NCT03339297|12570748|FG000|Overall Study|Adverse Event, Non-fatal|1
7991557|NCT03339297|12570749|FG001|Overall Study|Adverse Event, Non-fatal|0
7991558|NCT03339297|12570748|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0
7991559|NCT03339297|12570749|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1
7991560|NCT03339297|12570748|FG000|Overall Study|Patient Was Not Eligible|1
7991561|NCT03339297|12570749|FG001|Overall Study|Patient Was Not Eligible|0
7991562|NCT03339453|12570757|FG000|First Visit of Glucagon Treatment|Adverse Event|0
7991563|NCT03339453|12570758|FG001|First Visit of Glucagon Treatment|Adverse Event|1
7991564|NCT03339583|12570779|FG000|First Intervention (14 Days)|Adverse Event|1
7991565|NCT03339583|12570780|FG001|First Intervention (14 Days)|Adverse Event|0
7991566|NCT03339583|12570779|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0
7991567|NCT03339583|12570780|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1
7991568|NCT03339583|12570779|FG000|Second Intervention (14 Days)|Adverse Event|0
7991569|NCT03339583|12570780|FG001|Second Intervention (14 Days)|Adverse Event|1
7991570|NCT03339583|12570779|FG000|Follow-up (14 Days)|Physician Decision|6
7991571|NCT03339583|12570780|FG001|Follow-up (14 Days)|Physician Decision|3
7991572|NCT03339713|12570790|FG000|Overall Study|Lost to Follow-up|2
7991573|NCT03339713|12570791|FG001|Overall Study|Lost to Follow-up|1
7991574|NCT03339713|12570790|FG000|Overall Study|Protocol Violation|1
7991575|NCT03339713|12570791|FG001|Overall Study|Protocol Violation|0
7991576|NCT03339713|12570790|FG000|Overall Study|Withdrawal by Subject|1
7991577|NCT03339713|12570791|FG001|Overall Study|Withdrawal by Subject|1
7991578|NCT03339726|12570802|FG000|Overall Study|Withdrawal by Subject|1
7991579|NCT03339726|12570803|FG001|Overall Study|Withdrawal by Subject|0
7991580|NCT03339726|12570804|FG002|Overall Study|Withdrawal by Subject|0
7991581|NCT03339726|12570802|FG000|Overall Study|Lost to Follow-up|0
7991582|NCT03339726|12570803|FG001|Overall Study|Lost to Follow-up|1
7991583|NCT03339726|12570804|FG002|Overall Study|Lost to Follow-up|0
7991584|NCT03339999|12570816|FG000|Overall Study|Adverse Event|1
7991585|NCT03339999|12570817|FG001|Overall Study|Adverse Event|2
7991586|NCT03339999|12570818|FG002|Overall Study|Adverse Event|2
7991587|NCT03339999|12570819|FG003|Overall Study|Adverse Event|1
7991588|NCT03339999|12570816|FG000|Overall Study|Lack of Efficacy|0
7991589|NCT03339999|12570817|FG001|Overall Study|Lack of Efficacy|1
7991590|NCT03339999|12570818|FG002|Overall Study|Lack of Efficacy|0
7991591|NCT03339999|12570819|FG003|Overall Study|Lack of Efficacy|0
7991592|NCT03339999|12570816|FG000|Overall Study|Lost to Follow-up|0
7991593|NCT03339999|12570817|FG001|Overall Study|Lost to Follow-up|0
7991594|NCT03339999|12570818|FG002|Overall Study|Lost to Follow-up|0
7991595|NCT03339999|12570819|FG003|Overall Study|Lost to Follow-up|1
7991596|NCT03339999|12570816|FG000|Overall Study|Study Terminated by Sponsor|6
7991597|NCT03339999|12570817|FG001|Overall Study|Study Terminated by Sponsor|3
7991598|NCT03339999|12570818|FG002|Overall Study|Study Terminated by Sponsor|4
7991599|NCT03339999|12570819|FG003|Overall Study|Study Terminated by Sponsor|3
7991600|NCT03340025|12570834|FG000|Overall Study|Lost to Follow-up|2
7991601|NCT03340025|12570835|FG001|Overall Study|Lost to Follow-up|2
7991602|NCT03340961|12570919|FG000|Overall Study|Adverse Event|1
7991603|NCT03340961|12570920|FG001|Overall Study|Adverse Event|3
7991604|NCT03340961|12570921|FG002|Overall Study|Adverse Event|2
7991605|NCT03340961|12570922|FG003|Overall Study|Adverse Event|4
7991606|NCT03340961|12570919|FG000|Overall Study|Lost to Follow-up|0
7991607|NCT03340961|12570920|FG001|Overall Study|Lost to Follow-up|1
7991608|NCT03340961|12570921|FG002|Overall Study|Lost to Follow-up|0
7991609|NCT03340961|12570922|FG003|Overall Study|Lost to Follow-up|1
7991610|NCT03340961|12570919|FG000|Overall Study|Withdrawal by Subject|3
7991611|NCT03340961|12570920|FG001|Overall Study|Withdrawal by Subject|2
7991612|NCT03340961|12570921|FG002|Overall Study|Withdrawal by Subject|4
7991613|NCT03340961|12570922|FG003|Overall Study|Withdrawal by Subject|7
7991614|NCT03340961|12570919|FG000|Overall Study|Use of prohibited treatment|0
7991615|NCT03340961|12570920|FG001|Overall Study|Use of prohibited treatment|3
7991616|NCT03340961|12570921|FG002|Overall Study|Use of prohibited treatment|2
7991617|NCT03340961|12570922|FG003|Overall Study|Use of prohibited treatment|4
7991618|NCT03340961|12570919|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0
7991619|NCT03340961|12570920|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1
7991620|NCT03340961|12570921|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0
7991621|NCT03340961|12570922|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1
7991622|NCT03340961|12570919|FG000|Overall Study|Subject developed an exclusion criterion|0
7991623|NCT03340961|12570920|FG001|Overall Study|Subject developed an exclusion criterion|1
7991624|NCT03340961|12570921|FG002|Overall Study|Subject developed an exclusion criterion|0
7991625|NCT03340961|12570922|FG003|Overall Study|Subject developed an exclusion criterion|0
7991626|NCT03340961|12570919|FG000|Overall Study|Protocol Violation|1
7991627|NCT03340961|12570920|FG001|Overall Study|Protocol Violation|0
7991628|NCT03340961|12570921|FG002|Overall Study|Protocol Violation|1
7991629|NCT03340961|12570922|FG003|Overall Study|Protocol Violation|0
7991630|NCT03340961|12570919|FG000|Overall Study|Adverse Event|1
7991631|NCT03340961|12570920|FG001|Overall Study|Adverse Event|1
7991632|NCT03340961|12570921|FG002|Overall Study|Adverse Event|0
7991633|NCT03340961|12570922|FG003|Overall Study|Adverse Event|0
7991634|NCT03340961|12570919|FG000|Overall Study|Lack of Efficacy|0
7991635|NCT03340961|12570920|FG001|Overall Study|Lack of Efficacy|0
7991636|NCT03340961|12570921|FG002|Overall Study|Lack of Efficacy|0
7991637|NCT03340961|12570922|FG003|Overall Study|Lack of Efficacy|1
7991638|NCT03341273|12570934|FG000|Overall Study|Lost to Follow-up|7
7991639|NCT03341273|12570935|FG001|Overall Study|Lost to Follow-up|7
7991640|NCT03341273|12570934|FG000|Overall Study|Withdrawal by Subject|4
7991641|NCT03341273|12570935|FG001|Overall Study|Withdrawal by Subject|2
7991642|NCT03341273|12570934|FG000|Overall Study|Physician Decision|1
7991643|NCT03341273|12570935|FG001|Overall Study|Physician Decision|0
7991644|NCT03341273|12570934|FG000|Overall Study|Protocol Violation|0
7991645|NCT03341273|12570935|FG001|Overall Study|Protocol Violation|1
7991646|NCT03341273|12570934|FG000|Overall Study|Enrolled but Treatment Not Administered|6
7991647|NCT03341273|12570935|FG001|Overall Study|Enrolled but Treatment Not Administered|1
7991648|NCT03341273|12570934|FG000|Overall Study|Became ineligible after enrollment|1
7991649|NCT03341273|12570935|FG001|Overall Study|Became ineligible after enrollment|0
7991650|NCT03341273|12570934|FG000|Overall Study|Not Eligible at Enrollment|0
7991651|NCT03341273|12570935|FG001|Overall Study|Not Eligible at Enrollment|1
7991652|NCT03341273|12570934|FG000|Overall Study|Participant incarcerated|1
7991653|NCT03341273|12570935|FG001|Overall Study|Participant incarcerated|0
7991654|NCT03341299|12570941|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0
7991655|NCT03341299|12570942|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0
7991656|NCT03341299|12570943|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1
7991657|NCT03341299|12570944|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0
7991658|NCT03341312|12570956|FG000|Period 1|Withdrawal by Subject|0
7991659|NCT03341312|12570957|FG001|Period 1|Withdrawal by Subject|1
7991660|NCT03341312|12570958|FG002|Period 1|Withdrawal by Subject|0
7991661|NCT03341312|12570959|FG003|Period 1|Withdrawal by Subject|0
7991662|NCT03341507|12570971|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34
7991663|NCT03341533|12570977|FG000|Overall Study|Withdrawal by Subject|1
7991664|NCT03341533|12570978|FG001|Overall Study|Withdrawal by Subject|1
7991665|NCT03341533|12570977|FG000|Overall Study|Not eligible after randomization|2
7991666|NCT03341533|12570978|FG001|Overall Study|Not eligible after randomization|1
7991667|NCT03341637|12570990|FG000|Overall Study|Lost to Follow-up|1
7991668|NCT03341637|12570991|FG001|Overall Study|Lost to Follow-up|0
7991669|NCT03341637|12570990|FG000|Overall Study|Withdrawal by Subject|3
7991670|NCT03341637|12570991|FG001|Overall Study|Withdrawal by Subject|3
7991671|NCT03341637|12570990|FG000|Overall Study|Reason not Specified|1
7991672|NCT03341637|12570991|FG001|Overall Study|Reason not Specified|1
7991673|NCT03341923|12571021|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0
7991674|NCT03341923|12571022|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1
7991675|NCT03342469|12571041|FG000|Overall Study|Withdrawal by Subject|0
7991676|NCT03342469|12571042|FG001|Overall Study|Withdrawal by Subject|1
7991677|NCT03342469|12571043|FG002|Overall Study|Withdrawal by Subject|0
7991678|NCT03342469|12571044|FG003|Overall Study|Withdrawal by Subject|0
7991679|NCT03342560|12571055|FG000|Overall Study|Lost to Follow-up|2
7991680|NCT03342690|12571063|FG000|Overall Study|Missing Information|9
7991681|NCT03342690|12571063|FG000|Overall Study|Protocol Violation|16
7991682|NCT03342898|12571070|FG000|Overall Study|Adverse Event|3
7991683|NCT03342898|12571071|FG001|Overall Study|Adverse Event|1
7991684|NCT03342898|12571072|FG002|Overall Study|Adverse Event|0
7991685|NCT03342898|12571070|FG000|Overall Study|Lost to Follow-up|44
7991686|NCT03342898|12571071|FG001|Overall Study|Lost to Follow-up|40
7991687|NCT03342898|12571072|FG002|Overall Study|Lost to Follow-up|42
7991688|NCT03342898|12571070|FG000|Overall Study|Withdrawal of Consent|5
7991689|NCT03342898|12571071|FG001|Overall Study|Withdrawal of Consent|9
7991690|NCT03342898|12571072|FG002|Overall Study|Withdrawal of Consent|11
7991691|NCT03342898|12571070|FG000|Overall Study|Death|0
7991692|NCT03342898|12571071|FG001|Overall Study|Death|1
7991693|NCT03342898|12571072|FG002|Overall Study|Death|1
7991694|NCT03342898|12571070|FG000|Overall Study|Reason not Specified|2
7991695|NCT03342898|12571071|FG001|Overall Study|Reason not Specified|2
7991696|NCT03342898|12571072|FG002|Overall Study|Reason not Specified|0
7991697|NCT03342963|12571084|FG000|Overall Study|Adverse Event|1
7991698|NCT03342963|12571085|FG001|Overall Study|Adverse Event|2
7991699|NCT03342963|12571086|FG002|Overall Study|Adverse Event|0
7991700|NCT03342963|12571087|FG003|Overall Study|Adverse Event|0
7991701|NCT03342963|12571084|FG000|Overall Study|Withdrawal by Subject|1
7991702|NCT03342963|12571085|FG001|Overall Study|Withdrawal by Subject|0
7991703|NCT03342963|12571086|FG002|Overall Study|Withdrawal by Subject|0
7991704|NCT03342963|12571087|FG003|Overall Study|Withdrawal by Subject|0
7991705|NCT03343067|12571100|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0
7991706|NCT03343067|12571101|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3
7991707|NCT03343067|12571102|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1
7991708|NCT03343639|12571121|FG000|Overall Study|Withdrawal by Subject|10
7991709|NCT03343639|12571122|FG001|Overall Study|Withdrawal by Subject|6
7991710|NCT03343639|12571121|FG000|Overall Study|Lost to Follow-up|4
7991711|NCT03343639|12571122|FG001|Overall Study|Lost to Follow-up|5
7991712|NCT03343639|12571121|FG000|Overall Study|Protocol Violation|0
7991713|NCT03343639|12571122|FG001|Overall Study|Protocol Violation|1
7991714|NCT03344172|12571130|FG000|Overall Study|Received <1 dose of treatment|1
7991715|NCT03344172|12571131|FG001|Overall Study|Received <1 dose of treatment|0
7991716|NCT03344640|12571147|FG000|Overall Study|Adverse Event|1
7991717|NCT03344640|12571148|FG001|Overall Study|Adverse Event|0
7991718|NCT03344640|12571147|FG000|Overall Study|Physician Decision|1
7991719|NCT03344640|12571148|FG001|Overall Study|Physician Decision|1
7991720|NCT03344640|12571147|FG000|Overall Study|Withdrawal by Subject|1
7991721|NCT03344640|12571148|FG001|Overall Study|Withdrawal by Subject|2
7991722|NCT03344640|12571147|FG000|Follow-up Epoch|Withdrawal by Subject|0
7991723|NCT03344640|12571148|FG001|Follow-up Epoch|Withdrawal by Subject|2
7991724|NCT03345407|12571191|FG000|Overall Study|Withdrawal by Subject|11
7991725|NCT03345407|12571192|FG001|Overall Study|Withdrawal by Subject|1
7991726|NCT03345407|12571193|FG002|Overall Study|Withdrawal by Subject|5
7991727|NCT03345407|12571194|FG003|Overall Study|Withdrawal by Subject|6
7991728|NCT03345407|12571195|FG004|Overall Study|Withdrawal by Subject|3
7991729|NCT03345407|12571196|FG005|Overall Study|Withdrawal by Subject|6
7991730|NCT03345407|12571197|FG006|Overall Study|Withdrawal by Subject|16
7991731|NCT03345407|12571191|FG000|Overall Study|Physician Decision|3
7991732|NCT03345407|12571192|FG001|Overall Study|Physician Decision|1
7991733|NCT03345407|12571193|FG002|Overall Study|Physician Decision|0
7991734|NCT03345407|12571194|FG003|Overall Study|Physician Decision|0
7991735|NCT03345407|12571195|FG004|Overall Study|Physician Decision|1
7991736|NCT03345407|12571196|FG005|Overall Study|Physician Decision|2
7991737|NCT03345407|12571197|FG006|Overall Study|Physician Decision|3
7991738|NCT03345407|12571191|FG000|Overall Study|Lost to Follow-up|2
7991739|NCT03345407|12571192|FG001|Overall Study|Lost to Follow-up|0
7991740|NCT03345407|12571193|FG002|Overall Study|Lost to Follow-up|1
7991741|NCT03345407|12571194|FG003|Overall Study|Lost to Follow-up|0
7991742|NCT03345407|12571195|FG004|Overall Study|Lost to Follow-up|1
7991743|NCT03345407|12571196|FG005|Overall Study|Lost to Follow-up|2
7991744|NCT03345407|12571197|FG006|Overall Study|Lost to Follow-up|3
7991745|NCT03345407|12571191|FG000|Overall Study|Protocol-defined stopping criteria|9
7991746|NCT03345407|12571192|FG001|Overall Study|Protocol-defined stopping criteria|0
7991747|NCT03345407|12571193|FG002|Overall Study|Protocol-defined stopping criteria|0
7991748|NCT03345407|12571194|FG003|Overall Study|Protocol-defined stopping criteria|0
7991749|NCT03345407|12571195|FG004|Overall Study|Protocol-defined stopping criteria|2
7991750|NCT03345407|12571196|FG005|Overall Study|Protocol-defined stopping criteria|1
7991751|NCT03345407|12571197|FG006|Overall Study|Protocol-defined stopping criteria|1
7991752|NCT03345407|12571191|FG000|Overall Study|Protocol Violation|2
7991753|NCT03345407|12571192|FG001|Overall Study|Protocol Violation|0
7991754|NCT03345407|12571193|FG002|Overall Study|Protocol Violation|0
7991755|NCT03345407|12571194|FG003|Overall Study|Protocol Violation|0
7991756|NCT03345407|12571195|FG004|Overall Study|Protocol Violation|1
7991757|NCT03345407|12571196|FG005|Overall Study|Protocol Violation|0
7991758|NCT03345407|12571197|FG006|Overall Study|Protocol Violation|3
7991759|NCT03345407|12571191|FG000|Overall Study|Lack of Efficacy|1
7991760|NCT03345407|12571192|FG001|Overall Study|Lack of Efficacy|1
7991761|NCT03345407|12571193|FG002|Overall Study|Lack of Efficacy|1
7991762|NCT03345407|12571194|FG003|Overall Study|Lack of Efficacy|1
7991763|NCT03345407|12571195|FG004|Overall Study|Lack of Efficacy|1
7991764|NCT03345407|12571196|FG005|Overall Study|Lack of Efficacy|0
7991765|NCT03345407|12571197|FG006|Overall Study|Lack of Efficacy|3
7991766|NCT03345407|12571191|FG000|Overall Study|Adverse Event|4
7991767|NCT03345407|12571192|FG001|Overall Study|Adverse Event|0
7991768|NCT03345407|12571193|FG002|Overall Study|Adverse Event|5
7991769|NCT03345407|12571194|FG003|Overall Study|Adverse Event|4
7991770|NCT03345407|12571195|FG004|Overall Study|Adverse Event|6
7991771|NCT03345407|12571196|FG005|Overall Study|Adverse Event|5
7991772|NCT03345407|12571197|FG006|Overall Study|Adverse Event|16
7991773|NCT03345472|12571219|FG000|Implant to 3 Months|Withdrawal by Subject|2
7991774|NCT03345472|12571219|FG000|Implant to 3 Months|Physician Decision|1
7991775|NCT03345472|12571219|FG000|Implant to 3 Months|Adverse Event|1
7991776|NCT03345472|12571219|FG000|3 Months to 12 Months|Physician Decision|3
7991777|NCT03345472|12571219|FG000|3 Months to 12 Months|Lost to Follow-up|2
7991778|NCT03345472|12571219|FG000|3 Months to 12 Months|Withdrawal by Subject|1
7991779|NCT03345472|12571219|FG000|3 Months to 12 Months|Adverse Event|1
7991780|NCT03345472|12571219|FG000|3 Months to 12 Months|Death|1
7991781|NCT03345914|12571226|FG000|Overall Study|Transition to another study at week 16|80
7991782|NCT03345914|12571227|FG001|Overall Study|Transition to another study at week 16|86
7991783|NCT03345914|12571228|FG002|Overall Study|Transition to another study at week 16|78
7991784|NCT03345914|12571226|FG000|Overall Study|Transition to OLE during follow-up|37
7991785|NCT03345914|12571227|FG001|Overall Study|Transition to OLE during follow-up|33
7991786|NCT03345914|12571228|FG002|Overall Study|Transition to OLE during follow-up|39
7991787|NCT03345914|12571226|FG000|Overall Study|Physician Decision|0
7991788|NCT03345914|12571227|FG001|Overall Study|Physician Decision|1
7991789|NCT03345914|12571228|FG002|Overall Study|Physician Decision|1
7991790|NCT03345914|12571226|FG000|Overall Study|Withdrawal by Subject|5
7991791|NCT03345914|12571227|FG001|Overall Study|Withdrawal by Subject|1
7991792|NCT03345914|12571228|FG002|Overall Study|Withdrawal by Subject|2
7991793|NCT03345914|12571226|FG000|Overall Study|Other|1
7991794|NCT03345914|12571227|FG001|Overall Study|Other|1
7991795|NCT03345914|12571228|FG002|Overall Study|Other|1
7991796|NCT03345914|12571226|FG000|Overall Study|Ongoing|0
7991797|NCT03345914|12571227|FG001|Overall Study|Ongoing|0
7991798|NCT03345914|12571228|FG002|Overall Study|Ongoing|1
7991799|NCT03345979|12571238|FG000|Overall Study|Withdrawal by Subject|20
7991800|NCT03345979|12571239|FG001|Overall Study|Withdrawal by Subject|31
7991801|NCT03345979|12571238|FG000|Overall Study|Adverse Event|10
7991802|NCT03345979|12571239|FG001|Overall Study|Adverse Event|11
7991803|NCT03345979|12571238|FG000|Overall Study|Lost to Follow-up|8
7991804|NCT03345979|12571239|FG001|Overall Study|Lost to Follow-up|9
7991805|NCT03345979|12571238|FG000|Overall Study|Lack of Efficacy|4
7991806|NCT03345979|12571239|FG001|Overall Study|Lack of Efficacy|2
7991807|NCT03345979|12571238|FG000|Overall Study|Protocol Violation|1
7991808|NCT03345979|12571239|FG001|Overall Study|Protocol Violation|3
7991809|NCT03345979|12571238|FG000|Overall Study|Physician Decision|0
7991810|NCT03345979|12571239|FG001|Overall Study|Physician Decision|2
7991811|NCT03346057|12571249|FG000|Overall Study|Death|1
7991812|NCT03346057|12571250|FG001|Overall Study|Death|2
7991813|NCT03346057|12571251|FG002|Overall Study|Death|0
7991814|NCT03346057|12571252|FG003|Overall Study|Death|0
7991815|NCT03346057|12571249|FG000|Overall Study|Lost to Follow-up|0
7991816|NCT03346057|12571250|FG001|Overall Study|Lost to Follow-up|2
7991817|NCT03346057|12571251|FG002|Overall Study|Lost to Follow-up|1
7991818|NCT03346057|12571252|FG003|Overall Study|Lost to Follow-up|0
7991819|NCT03346057|12571249|FG000|Overall Study|Ineligible For Study - Not Treated|0
7991820|NCT03346057|12571250|FG001|Overall Study|Ineligible For Study - Not Treated|1
7991821|NCT03346057|12571251|FG002|Overall Study|Ineligible For Study - Not Treated|0
7991822|NCT03346057|12571252|FG003|Overall Study|Ineligible For Study - Not Treated|0
7991823|NCT03346057|12571249|FG000|Overall Study|Renal Insufficiency - Not Treated|1
7991824|NCT03346057|12571250|FG001|Overall Study|Renal Insufficiency - Not Treated|0
7991825|NCT03346057|12571251|FG002|Overall Study|Renal Insufficiency - Not Treated|0
7991826|NCT03346057|12571252|FG003|Overall Study|Renal Insufficiency - Not Treated|0
7991827|NCT03346057|12571249|FG000|Overall Study|Physician Decision|3
7991828|NCT03346057|12571250|FG001|Overall Study|Physician Decision|2
7991829|NCT03346057|12571251|FG002|Overall Study|Physician Decision|0
7991830|NCT03346057|12571252|FG003|Overall Study|Physician Decision|2
7991831|NCT03346057|12571249|FG000|Overall Study|Randomization Mistake - Not Treated|1
7991832|NCT03346057|12571250|FG001|Overall Study|Randomization Mistake - Not Treated|1
7991833|NCT03346057|12571251|FG002|Overall Study|Randomization Mistake - Not Treated|0
7991834|NCT03346057|12571252|FG003|Overall Study|Randomization Mistake - Not Treated|0
7991835|NCT03346057|12571249|FG000|Overall Study|Withdrawal by Subject|1
7991836|NCT03346057|12571250|FG001|Overall Study|Withdrawal by Subject|0
7991837|NCT03346057|12571251|FG002|Overall Study|Withdrawal by Subject|0
7991838|NCT03346057|12571252|FG003|Overall Study|Withdrawal by Subject|0
7991839|NCT03346070|12571267|FG000|Overall Study|Death|0
7991840|NCT03346070|12571268|FG001|Overall Study|Death|0
7991841|NCT03346070|12571269|FG002|Overall Study|Death|0
7991842|NCT03346070|12571270|FG003|Overall Study|Death|0
7991843|NCT03346070|12571271|FG004|Overall Study|Death|1
7991844|NCT03346070|12571267|FG000|Overall Study|Lost to Follow-up|0
7991845|NCT03346070|12571268|FG001|Overall Study|Lost to Follow-up|1
7991846|NCT03346070|12571269|FG002|Overall Study|Lost to Follow-up|2
7991847|NCT03346070|12571270|FG003|Overall Study|Lost to Follow-up|0
7991848|NCT03346070|12571271|FG004|Overall Study|Lost to Follow-up|0
7991849|NCT03346070|12571267|FG000|Overall Study|Physician Decision|0
7991850|NCT03346070|12571268|FG001|Overall Study|Physician Decision|0
7991851|NCT03346070|12571269|FG002|Overall Study|Physician Decision|0
7991852|NCT03346070|12571270|FG003|Overall Study|Physician Decision|1
7991853|NCT03346070|12571271|FG004|Overall Study|Physician Decision|1
7991854|NCT03346070|12571267|FG000|Overall Study|Withdrawal by Subject|1
7991855|NCT03346070|12571268|FG001|Overall Study|Withdrawal by Subject|0
7991856|NCT03346070|12571269|FG002|Overall Study|Withdrawal by Subject|0
7991857|NCT03346070|12571270|FG003|Overall Study|Withdrawal by Subject|1
7991858|NCT03346070|12571271|FG004|Overall Study|Withdrawal by Subject|0
7991859|NCT03346070|12571267|FG000|Overall Study|Study medication not received as planned|2
7991860|NCT03346070|12571268|FG001|Overall Study|Study medication not received as planned|3
7991861|NCT03346070|12571269|FG002|Overall Study|Study medication not received as planned|2
7991862|NCT03346070|12571270|FG003|Overall Study|Study medication not received as planned|3
7991863|NCT03346070|12571271|FG004|Overall Study|Study medication not received as planned|2
7991864|NCT03346070|12571267|FG000|Overall Study|Screen Failure|0
7991865|NCT03346070|12571268|FG001|Overall Study|Screen Failure|0
7991866|NCT03346070|12571269|FG002|Overall Study|Screen Failure|0
7991867|NCT03346070|12571270|FG003|Overall Study|Screen Failure|1
7991868|NCT03346070|12571271|FG004|Overall Study|Screen Failure|1
7991869|NCT03346759|12571296|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2
7991870|NCT03346759|12571297|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3
7991871|NCT03346759|12571296|FG000|First Menstrual Cycle|Withdrawal by Subject|1
7991872|NCT03346759|12571297|FG001|First Menstrual Cycle|Withdrawal by Subject|0
7991873|NCT03346759|12571296|FG000|Second Menstrual Cycle|Lost to Follow-up|1
7991874|NCT03346759|12571297|FG001|Second Menstrual Cycle|Lost to Follow-up|0
7991875|NCT03347188|12571324|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2
7991876|NCT03347188|12571325|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2
7991877|NCT03347188|12571324|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4
7991878|NCT03347188|12571325|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8
7991879|NCT03347188|12571324|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7
7991880|NCT03347188|12571325|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4
7991881|NCT03347188|12571324|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1
7991882|NCT03347188|12571325|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1
7991883|NCT03347188|12571324|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1
7991884|NCT03347188|12571325|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2
7991885|NCT03347188|12571324|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26
7991886|NCT03347188|12571325|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28
7991887|NCT03347188|12571324|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1
7991888|NCT03347188|12571325|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0
7991889|NCT03347188|12571324|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0
7991890|NCT03347188|12571325|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1
7991891|NCT03347279|12571333|FG000|Overall Study|Withdrawal by Subject|8
7991892|NCT03347279|12571334|FG001|Overall Study|Withdrawal by Subject|15
7991893|NCT03347279|12571333|FG000|Overall Study|Death|0
7991894|NCT03347279|12571334|FG001|Overall Study|Death|2
7991895|NCT03347279|12571333|FG000|Overall Study|Lost to Follow-up|5
7991896|NCT03347279|12571334|FG001|Overall Study|Lost to Follow-up|2
7991897|NCT03347279|12571333|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3
7991898|NCT03347279|12571334|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4
7991899|NCT03347695|12571342|FG000|Overall Study|Death|0
7991900|NCT03347695|12571343|FG001|Overall Study|Death|4
7991901|NCT03347695|12571342|FG000|Overall Study|Lost to Follow-up|0
7991902|NCT03347695|12571343|FG001|Overall Study|Lost to Follow-up|1
7991903|NCT03349034|12571362|FG000|Overall Study|catheters dislodged during transport|2
7991904|NCT03349034|12571363|FG001|Overall Study|catheters dislodged during transport|0
7991905|NCT03349034|12571362|FG000|Overall Study|intubated for >48 hrs following surgery|1
7991906|NCT03349034|12571363|FG001|Overall Study|intubated for >48 hrs following surgery|1
7991907|NCT03349034|12571362|FG000|Overall Study|soft tissue flap used|1
7991908|NCT03349034|12571363|FG001|Overall Study|soft tissue flap used|0
7991909|NCT03349034|12571362|FG000|Overall Study|Other|0
7991910|NCT03349034|12571363|FG001|Overall Study|Other|1
7991911|NCT03349060|12571374|FG000|Overall Study|Adverse Event|9
7991912|NCT03349060|12571375|FG001|Overall Study|Adverse Event|9
7991913|NCT03349060|12571376|FG002|Overall Study|Adverse Event|7
7991914|NCT03349060|12571374|FG000|Overall Study|Lack of Efficacy|1
7991915|NCT03349060|12571375|FG001|Overall Study|Lack of Efficacy|0
7991916|NCT03349060|12571376|FG002|Overall Study|Lack of Efficacy|2
7991917|NCT03349060|12571374|FG000|Overall Study|Lost to Follow-up|2
7991918|NCT03349060|12571375|FG001|Overall Study|Lost to Follow-up|1
7991919|NCT03349060|12571376|FG002|Overall Study|Lost to Follow-up|1
7991920|NCT03349060|12571374|FG000|Overall Study|Protocol Violation|2
7991921|NCT03349060|12571375|FG001|Overall Study|Protocol Violation|2
7991922|NCT03349060|12571376|FG002|Overall Study|Protocol Violation|1
7991923|NCT03349060|12571374|FG000|Overall Study|Withdrawal by Subject|5
7991924|NCT03349060|12571375|FG001|Overall Study|Withdrawal by Subject|3
7991925|NCT03349060|12571376|FG002|Overall Study|Withdrawal by Subject|4
7991926|NCT03349060|12571374|FG000|Overall Study|Medication error,no linked adverse event|0
7991927|NCT03349060|12571375|FG001|Overall Study|Medication error,no linked adverse event|0
7991928|NCT03349060|12571376|FG002|Overall Study|Medication error,no linked adverse event|1
7991929|NCT03349060|12571374|FG000|Overall Study|Withdrawal By Parent/Guardian|0
7991930|NCT03349060|12571375|FG001|Overall Study|Withdrawal By Parent/Guardian|1
7991931|NCT03349060|12571376|FG002|Overall Study|Withdrawal By Parent/Guardian|0
7991932|NCT03349060|12571374|FG000|Overall Study|Other|2
7991933|NCT03349060|12571375|FG001|Overall Study|Other|1
7991934|NCT03349060|12571376|FG002|Overall Study|Other|0
7991935|NCT03349099|12571386|FG000|Overall Study|Physician Decision|3
7991936|NCT03349099|12571387|FG001|Overall Study|Physician Decision|4
7991937|NCT03349099|12571386|FG000|Overall Study|Stone migrated from the kidney|1
7991938|NCT03349099|12571387|FG001|Overall Study|Stone migrated from the kidney|0
7991939|NCT03349333|12571393|FG000|Overall Study|Progression of Disease|36
7991940|NCT03349333|12571393|FG000|Overall Study|Adverse Event|11
7991941|NCT03349333|12571393|FG000|Overall Study|Other|6
7991942|NCT03349333|12571393|FG000|Overall Study|Withdrawal by Subject|5
7991943|NCT03349333|12571393|FG000|Overall Study|Conditions interfere with participation|2
7991944|NCT03349333|12571393|FG000|Overall Study|Physician Decision|2
7991945|NCT03349333|12571393|FG000|Overall Study|3-week lapse between pralatrexate doses|1
7991946|NCT03349333|12571393|FG000|Overall Study|Patients in treatment less than 24 month|8
7991947|NCT03349437|12571397|FG000|Screening|Screen Fail|4
7991948|NCT03349437|12571398|FG001|Screening|Screen Fail|0
7991949|NCT03349437|12571399|FG002|Screening|Screen Fail|0
7991950|NCT03349437|12571397|FG000|Screening|Withdrawn|1
7991951|NCT03349437|12571398|FG001|Screening|Withdrawn|0
7991952|NCT03349437|12571399|FG002|Screening|Withdrawn|0
7991953|NCT03349515|12571408|FG000|Overall Study|Lack of Efficacy|2
7991954|NCT03349515|12571409|FG001|Overall Study|Lack of Efficacy|0
7991955|NCT03349515|12571408|FG000|Overall Study|Physician Decision|3
7991956|NCT03349515|12571409|FG001|Overall Study|Physician Decision|1
7991957|NCT03349710|12571451|FG000|Treatment Period|Death|0
7991958|NCT03349710|12571452|FG001|Treatment Period|Death|0
7991959|NCT03349710|12571453|FG002|Treatment Period|Death|1
7991960|NCT03349710|12571454|FG003|Treatment Period|Death|0
7991961|NCT03349710|12571451|FG000|Treatment Period|Disease Progression|0
7991962|NCT03349710|12571452|FG001|Treatment Period|Disease Progression|2
7991963|NCT03349710|12571453|FG002|Treatment Period|Disease Progression|0
7991964|NCT03349710|12571454|FG003|Treatment Period|Disease Progression|1
7991965|NCT03349710|12571451|FG000|Treatment Period|Study Drug Toxicity|1
7991966|NCT03349710|12571452|FG001|Treatment Period|Study Drug Toxicity|0
7991967|NCT03349710|12571453|FG002|Treatment Period|Study Drug Toxicity|1
7991968|NCT03349710|12571454|FG003|Treatment Period|Study Drug Toxicity|1
7991969|NCT03349710|12571451|FG000|Treatment Period|Adverse event unrelated to Study Drug|2
7991970|NCT03349710|12571452|FG001|Treatment Period|Adverse event unrelated to Study Drug|1
7991971|NCT03349710|12571453|FG002|Treatment Period|Adverse event unrelated to Study Drug|1
7991972|NCT03349710|12571454|FG003|Treatment Period|Adverse event unrelated to Study Drug|1
7991973|NCT03349710|12571451|FG000|Treatment Period|admin reason by sponsor|0
7991974|NCT03349710|12571452|FG001|Treatment Period|admin reason by sponsor|7
7991975|NCT03349710|12571453|FG002|Treatment Period|admin reason by sponsor|0
7991976|NCT03349710|12571454|FG003|Treatment Period|admin reason by sponsor|19
7991977|NCT03349710|12571451|FG000|Treatment Period|Other Reason|2
7991978|NCT03349710|12571452|FG001|Treatment Period|Other Reason|0
7991979|NCT03349710|12571453|FG002|Treatment Period|Other Reason|2
7991980|NCT03349710|12571454|FG003|Treatment Period|Other Reason|1
7991981|NCT03349710|12571451|FG000|Treatment Period|completed|6
7991982|NCT03349710|12571452|FG001|Treatment Period|completed|0
7991983|NCT03349710|12571453|FG002|Treatment Period|completed|18
7991984|NCT03349710|12571454|FG003|Treatment Period|completed|1
7991985|NCT03349710|12571451|FG000|Treatment Period|participant request to discontinue|0
7991986|NCT03349710|12571452|FG001|Treatment Period|participant request to discontinue|0
7991987|NCT03349710|12571453|FG002|Treatment Period|participant request to discontinue|4
7991988|NCT03349710|12571454|FG003|Treatment Period|participant request to discontinue|0
7991989|NCT03349710|12571451|FG000|Treatment Period|participant withdrew consent|1
7991990|NCT03349710|12571452|FG001|Treatment Period|participant withdrew consent|0
7991991|NCT03349710|12571453|FG002|Treatment Period|participant withdrew consent|0
7991992|NCT03349710|12571454|FG003|Treatment Period|participant withdrew consent|0
7991993|NCT03350256|12571477|FG000|Overall Study|Inclusion/exclusion violation|4
7991994|NCT03350256|12571477|FG000|Overall Study|Recommended for other therapies|2
7991995|NCT03350256|12571477|FG000|Overall Study|Protocol Violation|3
7991996|NCT03350256|12571477|FG000|Overall Study|Non compliance|2
7991997|NCT03350256|12571477|FG000|Overall Study|Denial by insurance|1
7991998|NCT03350256|12571477|FG000|Overall Study|Adverse Event|2
7991999|NCT03350256|12571477|FG000|Overall Study|Trial failure|12
7992000|NCT03350256|12571477|FG000|Overall Study|Did not proceed to permanent implant|3
7992001|NCT03350256|12571477|FG000|Overall Study|Withdrawal by Subject|3
7992002|NCT03350256|12571477|FG000|Overall Study|Subject moving out of state|1
7992003|NCT03350256|12571477|FG000|Overall Study|Lost to Follow-up|1
7992004|NCT03350256|12571477|FG000|Overall Study|Lack of Efficacy|2
7992005|NCT03350672|12571488|FG000|Overall Study|Withdrawal by Subject|7
7992006|NCT03350672|12571489|FG001|Overall Study|Withdrawal by Subject|0
7992007|NCT03350672|12571490|FG002|Overall Study|Withdrawal by Subject|0
7992008|NCT03351114|12571527|FG000|Overall Study|Withdrawal by Subject|1
7992009|NCT03351231|12571531|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1
7992010|NCT03351231|12571531|FG000|Combination Therapy Period|Disease progression|2
7992011|NCT03351231|12571531|FG000|Combination Therapy Period|Study drug toxicity|1
7992012|NCT03351231|12571531|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1
7992013|NCT03351231|12571531|FG000|Safety Follow-Up Period|Participant withdrew consent|1
7992014|NCT03351231|12571531|FG000|Safety Follow-Up Period|Other reason|2
7992015|NCT03351335|12571538|FG000|Overall Study|Failure to maintain inclusion/exclusion|0
7992016|NCT03351335|12571539|FG001|Overall Study|Failure to maintain inclusion/exclusion|0
7992017|NCT03351335|12571540|FG002|Overall Study|Failure to maintain inclusion/exclusion|4
7992018|NCT03351478|12571551|FG000|Overall Study|At the subject's own request|11
7992019|NCT03351478|12571552|FG001|Overall Study|At the subject's own request|12
7992020|NCT03351478|12571553|FG002|Overall Study|At the subject's own request|5
7992021|NCT03351478|12571551|FG000|Overall Study|Adverse Event|1
7992022|NCT03351478|12571552|FG001|Overall Study|Adverse Event|2
7992023|NCT03351478|12571553|FG002|Overall Study|Adverse Event|1
7992024|NCT03351478|12571551|FG000|Overall Study|Poor compliance to protocol|1
7992025|NCT03351478|12571552|FG001|Overall Study|Poor compliance to protocol|0
7992026|NCT03351478|12571553|FG002|Overall Study|Poor compliance to protocol|0
7992027|NCT03351478|12571551|FG000|Overall Study|Reason not Specified|1
7992028|NCT03351478|12571552|FG001|Overall Study|Reason not Specified|3
7992029|NCT03351478|12571553|FG002|Overall Study|Reason not Specified|0
7992030|NCT03351478|12571551|FG000|Overall Study|Lost to Follow-up|0
7992031|NCT03351478|12571552|FG001|Overall Study|Lost to Follow-up|0
7992032|NCT03351478|12571553|FG002|Overall Study|Lost to Follow-up|1
7992033|NCT03351608|12571566|FG000|Overall Study|Lost to Follow-up|0
7992034|NCT03351608|12571567|FG001|Overall Study|Lost to Follow-up|1
7992035|NCT03351608|12571568|FG002|Overall Study|Lost to Follow-up|1
7992036|NCT03351608|12571569|FG003|Overall Study|Lost to Follow-up|1
7992037|NCT03351608|12571570|FG004|Overall Study|Lost to Follow-up|1
7992038|NCT03351608|12571566|FG000|Overall Study|Physician Decision|1
7992039|NCT03351608|12571567|FG001|Overall Study|Physician Decision|0
7992040|NCT03351608|12571568|FG002|Overall Study|Physician Decision|0
7992041|NCT03351608|12571569|FG003|Overall Study|Physician Decision|2
7992042|NCT03351608|12571570|FG004|Overall Study|Physician Decision|1
7992043|NCT03351608|12571566|FG000|Overall Study|Randomized by mistake, no treatment given|0
7992044|NCT03351608|12571567|FG001|Overall Study|Randomized by mistake, no treatment given|0
7992045|NCT03351608|12571568|FG002|Overall Study|Randomized by mistake, no treatment given|0
7992046|NCT03351608|12571569|FG003|Overall Study|Randomized by mistake, no treatment given|1
7992047|NCT03351608|12571570|FG004|Overall Study|Randomized by mistake, no treatment given|0
7992048|NCT03351608|12571566|FG000|Overall Study|Withdrawal by parent/guardian|0
7992049|NCT03351608|12571567|FG001|Overall Study|Withdrawal by parent/guardian|0
7992050|NCT03351608|12571568|FG002|Overall Study|Withdrawal by parent/guardian|1
7992051|NCT03351608|12571569|FG003|Overall Study|Withdrawal by parent/guardian|1
7992052|NCT03351608|12571570|FG004|Overall Study|Withdrawal by parent/guardian|0
7992053|NCT03351608|12571566|FG000|Overall Study|Other|0
7992054|NCT03351608|12571567|FG001|Overall Study|Other|1
7992055|NCT03351608|12571568|FG002|Overall Study|Other|1
7992056|NCT03351608|12571569|FG003|Overall Study|Other|3
7992057|NCT03351608|12571570|FG004|Overall Study|Other|0
7992058|NCT03351738|12571626|FG000|Overall Study|Withdrawal by Subject|0
7811452|NCT01182844|12275220|FG001|Overall Study|Withdrawal by Subject|2
7811453|NCT01183013|12275233|FG000|Overall Study|Adverse Event|6
7811454|NCT01183013|12275234|FG001|Overall Study|Adverse Event|8
7811455|NCT01183013|12275235|FG002|Overall Study|Adverse Event|5
7992059|NCT03351738|12571627|FG001|Overall Study|Withdrawal by Subject|1
7992060|NCT03351738|12571628|FG002|Overall Study|Withdrawal by Subject|0
7992061|NCT03351738|12571629|FG003|Overall Study|Withdrawal by Subject|1
7992062|NCT03351738|12571630|FG004|Overall Study|Withdrawal by Subject|0
7992063|NCT03351738|12571631|FG005|Overall Study|Withdrawal by Subject|0
7992064|NCT03352414|12571669|FG000|Overall Study|Ineligible by operative criteria|12
7992065|NCT03352414|12571670|FG001|Overall Study|Ineligible by operative criteria|10
7992066|NCT03352453|12571680|FG000|Overall Study|Miscellaneous Reasons|1
7992067|NCT03352453|12571681|FG001|Overall Study|Miscellaneous Reasons|2
7992068|NCT03352453|12571680|FG000|Overall Study|Lack of Efficacy|1
7992069|NCT03352453|12571681|FG001|Overall Study|Lack of Efficacy|0
7992070|NCT03352453|12571680|FG000|Overall Study|Withdrawal by Subject|8
7992071|NCT03352453|12571681|FG001|Overall Study|Withdrawal by Subject|14
7992072|NCT03352453|12571680|FG000|Overall Study|Study Terminated by Sponsor|2
7992073|NCT03352453|12571681|FG001|Overall Study|Study Terminated by Sponsor|1
7992074|NCT03352453|12571680|FG000|Overall Study|Protocol Deviation|1
7992075|NCT03352453|12571681|FG001|Overall Study|Protocol Deviation|0
7992076|NCT03352453|12571680|FG000|Overall Study|Lost to Follow-up|7
7992077|NCT03352453|12571681|FG001|Overall Study|Lost to Follow-up|6
7992078|NCT03352453|12571680|FG000|Overall Study|Adverse Event|2
7992079|NCT03352453|12571681|FG001|Overall Study|Adverse Event|9
7992080|NCT03352713|12571696|FG000|Overall Study|Lost to Follow-up|8
7992081|NCT03352713|12571696|FG000|Overall Study|Withdrawn by investigator|5
7992082|NCT03352713|12571696|FG000|Overall Study|Completed 0 EMAs|8
7992083|NCT03352713|12571696|FG000|Overall Study|Device incompatible/stolen|5
7992084|NCT03353220|12571700|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4
7992085|NCT03353220|12571701|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7
7992086|NCT03353740|12571711|FG000|Overall Study|Images for these participants not viable|52
7992087|NCT03354429|12571735|FG000|Overall Study|Withdrawal by Subject|8
7992088|NCT03354429|12571736|FG001|Overall Study|Withdrawal by Subject|7
7992089|NCT03354429|12571735|FG000|Overall Study|Lost to Follow-up|1
7992090|NCT03354429|12571736|FG001|Overall Study|Lost to Follow-up|0
7992091|NCT03354637|12571754|FG000|Double-blind Period|Protocol Violation|2
7992092|NCT03354637|12571755|FG001|Double-blind Period|Protocol Violation|0
7992093|NCT03354637|12571756|FG002|Double-blind Period|Protocol Violation|0
7992094|NCT03354637|12571754|FG000|Double-blind Period|Adverse Event|1
7992095|NCT03354637|12571755|FG001|Double-blind Period|Adverse Event|2
7992096|NCT03354637|12571756|FG002|Double-blind Period|Adverse Event|0
7992097|NCT03354637|12571754|FG000|Double-blind Period|Lost to Follow-up|3
7992098|NCT03354637|12571755|FG001|Double-blind Period|Lost to Follow-up|4
7992099|NCT03354637|12571756|FG002|Double-blind Period|Lost to Follow-up|3
7992100|NCT03354637|12571754|FG000|Double-blind Period|Withdrawal by Subject|10
7992101|NCT03354637|12571755|FG001|Double-blind Period|Withdrawal by Subject|6
7992102|NCT03354637|12571756|FG002|Double-blind Period|Withdrawal by Subject|4
7992103|NCT03354637|12571754|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1
7992104|NCT03354637|12571755|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1
7992105|NCT03354637|12571756|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0
7992106|NCT03354637|12571754|FG000|Open Label Extension|Adverse Event|0
7992107|NCT03354637|12571755|FG001|Open Label Extension|Adverse Event|0
7992108|NCT03354637|12571756|FG002|Open Label Extension|Adverse Event|1
7992109|NCT03354637|12571754|FG000|Open Label Extension|Lost to Follow-up|0
7992110|NCT03354637|12571755|FG001|Open Label Extension|Lost to Follow-up|0
7992111|NCT03354637|12571756|FG002|Open Label Extension|Lost to Follow-up|2
7992112|NCT03354637|12571754|FG000|Open Label Extension|Withdrawal by Subject|0
7992113|NCT03354637|12571755|FG001|Open Label Extension|Withdrawal by Subject|0
7992114|NCT03354637|12571756|FG002|Open Label Extension|Withdrawal by Subject|5
7992115|NCT03354637|12571754|FG000|Open Label Extension|Study Terminated by Sponsor|0
7992116|NCT03354637|12571755|FG001|Open Label Extension|Study Terminated by Sponsor|0
7992117|NCT03354637|12571756|FG002|Open Label Extension|Study Terminated by Sponsor|17
7992118|NCT03354637|12571754|FG000|Open Label Extension|Subject Noncompliance|0
7992119|NCT03354637|12571755|FG001|Open Label Extension|Subject Noncompliance|0
7992120|NCT03354637|12571756|FG002|Open Label Extension|Subject Noncompliance|1
7992121|NCT03354637|12571754|FG000|Open Label Extension|Lack of Efficacy|0
7992122|NCT03354637|12571755|FG001|Open Label Extension|Lack of Efficacy|0
7992123|NCT03354637|12571756|FG002|Open Label Extension|Lack of Efficacy|1
7992124|NCT03354637|12571754|FG000|Open Label Extension|Physician Decision|0
7992125|NCT03354637|12571755|FG001|Open Label Extension|Physician Decision|0
7992126|NCT03354637|12571756|FG002|Open Label Extension|Physician Decision|1
7992127|NCT03354663|12571765|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4
7992128|NCT03354663|12571765|FG000|Enrollment to Catheter Insertion|Adverse Event|1
7992129|NCT03354663|12571765|FG000|Completed 30-day Visit|Withdrawal by Subject|1
7992130|NCT03354663|12571765|FG000|Completed 30-day Visit|Missed Visit|1
7992131|NCT03355326|12571784|FG000|Overall Study|Protocol Violation|3
7992132|NCT03355326|12571785|FG001|Overall Study|Protocol Violation|3
7992133|NCT03355742|12571791|FG000|Overall Study|Lost to Follow-up|4
7992134|NCT03355742|12571791|FG000|Overall Study|Withdrawal by Subject|29
7992135|NCT03355742|12571791|FG000|Overall Study|Physician Decision|6
7992136|NCT03355742|12571791|FG000|Overall Study|Death|55
7992137|NCT03355742|12571791|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5
7992138|NCT03356145|12571801|FG000|Overall Study|Withdrawal by Subject|2
7992139|NCT03356145|12571802|FG001|Overall Study|Withdrawal by Subject|1
7992140|NCT03356145|12571801|FG000|Overall Study|Did not meet inclusion criteria|1
7992141|NCT03356145|12571802|FG001|Overall Study|Did not meet inclusion criteria|0
7992142|NCT03356977|12571808|FG000|Overall Study|Lost to Follow-up|3
7992143|NCT03356977|12571808|FG000|Overall Study|Withdrawal by parent/guardian|2
7992144|NCT03357341|12571814|FG000|Overall Study|Withdrawal by Subject|3
7992145|NCT03357341|12571815|FG001|Overall Study|Withdrawal by Subject|6
7992146|NCT03357341|12571814|FG000|Overall Study|Lost to Follow-up|4
7992147|NCT03357341|12571815|FG001|Overall Study|Lost to Follow-up|5
7992148|NCT03357341|12571814|FG000|Overall Study|Death|0
7992149|NCT03357341|12571815|FG001|Overall Study|Death|1
7992150|NCT03357471|12571837|FG000|Overall Study|Adverse Event|1
7992151|NCT03357471|12571838|FG001|Overall Study|Adverse Event|0
7992152|NCT03357471|12571837|FG000|Overall Study|Lost to Follow-up|1
7992153|NCT03357471|12571838|FG001|Overall Study|Lost to Follow-up|0
7992154|NCT03357731|12571853|FG000|Overall Study|Withdrew consent due to personal reasons|0
7992155|NCT03357731|12571854|FG001|Overall Study|Withdrew consent due to personal reasons|0
7992156|NCT03357731|12571855|FG002|Overall Study|Withdrew consent due to personal reasons|0
7992157|NCT03357731|12571856|FG003|Overall Study|Withdrew consent due to personal reasons|0
7992158|NCT03357731|12571857|FG004|Overall Study|Withdrew consent due to personal reasons|1
7992159|NCT03357731|12571858|FG005|Overall Study|Withdrew consent due to personal reasons|0
7992160|NCT03357731|12571853|FG000|Overall Study|Acute bradycardia and hypotension|0
7992161|NCT03357731|12571854|FG001|Overall Study|Acute bradycardia and hypotension|0
7992162|NCT03357731|12571855|FG002|Overall Study|Acute bradycardia and hypotension|0
7992163|NCT03357731|12571856|FG003|Overall Study|Acute bradycardia and hypotension|1
7992164|NCT03357731|12571857|FG004|Overall Study|Acute bradycardia and hypotension|0
7992165|NCT03357731|12571858|FG005|Overall Study|Acute bradycardia and hypotension|0
7992166|NCT03357731|12571853|FG000|Overall Study|Adverse Event|0
7992167|NCT03357731|12571854|FG001|Overall Study|Adverse Event|0
7992168|NCT03357731|12571855|FG002|Overall Study|Adverse Event|0
7992169|NCT03357731|12571856|FG003|Overall Study|Adverse Event|0
7992170|NCT03357731|12571857|FG004|Overall Study|Adverse Event|0
7992171|NCT03357731|12571858|FG005|Overall Study|Adverse Event|1
7992172|NCT03357731|12571853|FG000|Overall Study|Hypotension|0
7992173|NCT03357731|12571854|FG001|Overall Study|Hypotension|0
7992174|NCT03357731|12571855|FG002|Overall Study|Hypotension|1
7992175|NCT03357731|12571856|FG003|Overall Study|Hypotension|1
7992176|NCT03357731|12571857|FG004|Overall Study|Hypotension|0
7992177|NCT03357731|12571858|FG005|Overall Study|Hypotension|0
7992178|NCT03357731|12571853|FG000|Overall Study|Lost to Follow-up|0
7992179|NCT03357731|12571854|FG001|Overall Study|Lost to Follow-up|0
7992180|NCT03357731|12571855|FG002|Overall Study|Lost to Follow-up|0
7992181|NCT03357731|12571856|FG003|Overall Study|Lost to Follow-up|1
7992182|NCT03357731|12571857|FG004|Overall Study|Lost to Follow-up|0
7992183|NCT03357731|12571858|FG005|Overall Study|Lost to Follow-up|0
7992184|NCT03358147|12571871|FG000|Overall Study|Withdrawal by Subject|13
7992185|NCT03358147|12571872|FG001|Overall Study|Withdrawal by Subject|19
7992186|NCT03358147|12571873|FG002|Overall Study|Withdrawal by Subject|16
7992187|NCT03358147|12571874|FG003|Overall Study|Withdrawal by Subject|10
7992188|NCT03358147|12571875|FG004|Overall Study|Withdrawal by Subject|5
7992189|NCT03358147|12571871|FG000|Overall Study|Adverse Event|3
7992190|NCT03358147|12571872|FG001|Overall Study|Adverse Event|9
7992191|NCT03358147|12571873|FG002|Overall Study|Adverse Event|7
7992192|NCT03358147|12571874|FG003|Overall Study|Adverse Event|5
7992193|NCT03358147|12571875|FG004|Overall Study|Adverse Event|2
7992194|NCT03358147|12571871|FG000|Overall Study|Lost to Follow-up|4
7992195|NCT03358147|12571872|FG001|Overall Study|Lost to Follow-up|3
7992196|NCT03358147|12571873|FG002|Overall Study|Lost to Follow-up|7
7992197|NCT03358147|12571874|FG003|Overall Study|Lost to Follow-up|6
7992198|NCT03358147|12571875|FG004|Overall Study|Lost to Follow-up|4
7992199|NCT03358147|12571871|FG000|Overall Study|Major Protocol Deviation|11
7992200|NCT03358147|12571872|FG001|Overall Study|Major Protocol Deviation|3
7992201|NCT03358147|12571873|FG002|Overall Study|Major Protocol Deviation|2
7992202|NCT03358147|12571874|FG003|Overall Study|Major Protocol Deviation|3
7992203|NCT03358147|12571875|FG004|Overall Study|Major Protocol Deviation|1
7992204|NCT03358147|12571871|FG000|Overall Study|Protocol specified criteria|2
7992205|NCT03358147|12571872|FG001|Overall Study|Protocol specified criteria|3
7992206|NCT03358147|12571873|FG002|Overall Study|Protocol specified criteria|0
7992207|NCT03358147|12571874|FG003|Overall Study|Protocol specified criteria|3
7992208|NCT03358147|12571875|FG004|Overall Study|Protocol specified criteria|1
7992209|NCT03358147|12571871|FG000|Overall Study|Physician Decision|1
7992210|NCT03358147|12571872|FG001|Overall Study|Physician Decision|0
7992211|NCT03358147|12571873|FG002|Overall Study|Physician Decision|1
7992212|NCT03358147|12571874|FG003|Overall Study|Physician Decision|6
7992213|NCT03358147|12571875|FG004|Overall Study|Physician Decision|1
7992214|NCT03358147|12571871|FG000|Overall Study|Administrative reasons|0
7992215|NCT03358147|12571872|FG001|Overall Study|Administrative reasons|1
7992216|NCT03358147|12571873|FG002|Overall Study|Administrative reasons|0
7992217|NCT03358147|12571874|FG003|Overall Study|Administrative reasons|3
7992218|NCT03358147|12571875|FG004|Overall Study|Administrative reasons|0
7992219|NCT03358147|12571871|FG000|Overall Study|Lack of Efficacy|0
7992220|NCT03358147|12571872|FG001|Overall Study|Lack of Efficacy|1
7992221|NCT03358147|12571873|FG002|Overall Study|Lack of Efficacy|1
7992222|NCT03358147|12571874|FG003|Overall Study|Lack of Efficacy|0
7992223|NCT03358147|12571875|FG004|Overall Study|Lack of Efficacy|0
7992224|NCT03358238|12571889|FG000|Overall Study|Withdrawal by Subject|0
7992225|NCT03358238|12571890|FG001|Overall Study|Withdrawal by Subject|1
7992226|NCT03358290|12571912|FG000|Overall Study|Study discontinued by Sponsor|0
7992227|NCT03358290|12571913|FG001|Overall Study|Study discontinued by Sponsor|1
7992228|NCT03358290|12571914|FG002|Overall Study|Study discontinued by Sponsor|1
7992229|NCT03358290|12571915|FG003|Overall Study|Study discontinued by Sponsor|0
7992230|NCT03358290|12571916|FG004|Overall Study|Study discontinued by Sponsor|0
7992231|NCT03358290|12571912|FG000|Overall Study|Adverse Event|0
7992232|NCT03358290|12571913|FG001|Overall Study|Adverse Event|0
7992233|NCT03358290|12571914|FG002|Overall Study|Adverse Event|1
7992234|NCT03358290|12571915|FG003|Overall Study|Adverse Event|2
7992235|NCT03358290|12571916|FG004|Overall Study|Adverse Event|0
7992236|NCT03358290|12571912|FG000|Overall Study|Withdrawal by Subject|0
7992237|NCT03358290|12571913|FG001|Overall Study|Withdrawal by Subject|0
7992238|NCT03358290|12571914|FG002|Overall Study|Withdrawal by Subject|0
7992239|NCT03358290|12571915|FG003|Overall Study|Withdrawal by Subject|0
7992240|NCT03358290|12571916|FG004|Overall Study|Withdrawal by Subject|1
7992241|NCT03358329|12571928|FG000|Overall Study|Lost to Follow-up|2
7992242|NCT03358329|12571928|FG000|Overall Study|Withdrawal by Subject|2
7992243|NCT03358407|12571953|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7992244|NCT03358407|12571954|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7992245|NCT03358407|12571955|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1
7992246|NCT03358407|12571956|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7992247|NCT03358407|12571957|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7992248|NCT03358407|12571958|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7992249|NCT03358407|12571959|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7992250|NCT03358407|12571960|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7992251|NCT03358407|12571961|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7992252|NCT03358407|12571962|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7992253|NCT03358407|12571953|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7992254|NCT03358407|12571954|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7992255|NCT03358407|12571955|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7992256|NCT03358407|12571956|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7992257|NCT03358407|12571957|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1
7992258|NCT03358407|12571958|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7992259|NCT03358407|12571959|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7992260|NCT03358407|12571960|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7992261|NCT03358407|12571961|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7992262|NCT03358407|12571962|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7992263|NCT03358407|12571953|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7992264|NCT03358407|12571954|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7992265|NCT03358407|12571955|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7992266|NCT03358407|12571956|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7992267|NCT03358407|12571957|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7992268|NCT03358407|12571958|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1
7992269|NCT03358407|12571959|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7992270|NCT03358407|12571960|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2
7992271|NCT03358407|12571961|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7992272|NCT03358407|12571962|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7992273|NCT03358407|12571953|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7992274|NCT03358407|12571954|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7992275|NCT03358407|12571955|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7992276|NCT03358407|12571956|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7992277|NCT03358407|12571957|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7992278|NCT03358407|12571958|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
7992279|NCT03358407|12571959|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7992280|NCT03358407|12571960|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
7992281|NCT03358407|12571961|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7992282|NCT03358407|12571962|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7992283|NCT03358407|12571953|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7992284|NCT03358407|12571954|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7992285|NCT03358407|12571955|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7992286|NCT03358407|12571956|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7992287|NCT03358407|12571957|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7718221|NCT00526110|12142069|FG000|Overall Study|Disease Progression|0
7992288|NCT03358407|12571958|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
7992289|NCT03358407|12571959|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
7992290|NCT03358407|12571960|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7992291|NCT03358407|12571961|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7992292|NCT03358407|12571962|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7992293|NCT03358407|12571953|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7992294|NCT03358407|12571954|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7992295|NCT03358407|12571955|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7992296|NCT03358407|12571956|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7992297|NCT03358407|12571957|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7992298|NCT03358407|12571958|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
7992299|NCT03358407|12571959|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
7718222|NCT00526110|12142070|FG001|Overall Study|Disease Progression|19
7718223|NCT00526110|12142069|FG000|Overall Study|Maximal Response|0
7718224|NCT00526110|12142070|FG001|Overall Study|Maximal Response|6
7718225|NCT00526110|12142069|FG000|Overall Study|Withdrawal by Subject|0
7718226|NCT00526110|12142070|FG001|Overall Study|Withdrawal by Subject|2
7992300|NCT03358407|12571960|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6
7992301|NCT03358407|12571961|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7992302|NCT03358407|12571962|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7992303|NCT03359395|12572001|FG000|First Intervention A / B|Withdrawal by Subject|1
7992304|NCT03359395|12572002|FG001|First Intervention A / B|Withdrawal by Subject|0
7992305|NCT03359395|12572001|FG000|First Intervention A / B|Lost to Follow-up|2
7992306|NCT03359395|12572002|FG001|First Intervention A / B|Lost to Follow-up|3
7992307|NCT03359395|12572001|FG000|Second Intervention B/A|Exclusion criteria|0
7992308|NCT03359395|12572002|FG001|Second Intervention B/A|Exclusion criteria|1
7992309|NCT03359395|12572001|FG000|Second Intervention B/A|Lost to Follow-up|3
7992310|NCT03359395|12572002|FG001|Second Intervention B/A|Lost to Follow-up|2
7992311|NCT03359473|12572012|FG000|Overall Study|Adverse Event|0
7992312|NCT03359473|12572013|FG001|Overall Study|Adverse Event|2
7992313|NCT03359473|12572014|FG002|Overall Study|Adverse Event|5
7992314|NCT03359473|12572015|FG003|Overall Study|Adverse Event|3
7992315|NCT03359473|12572012|FG000|Overall Study|Lost to Follow-up|0
7992316|NCT03359473|12572013|FG001|Overall Study|Lost to Follow-up|1
7992317|NCT03359473|12572014|FG002|Overall Study|Lost to Follow-up|0
7992318|NCT03359473|12572015|FG003|Overall Study|Lost to Follow-up|0
7992319|NCT03359473|12572012|FG000|Overall Study|Physician Decision|0
7992320|NCT03359473|12572013|FG001|Overall Study|Physician Decision|1
7992321|NCT03359473|12572014|FG002|Overall Study|Physician Decision|0
7992322|NCT03359473|12572015|FG003|Overall Study|Physician Decision|1
7992323|NCT03359473|12572012|FG000|Overall Study|Withdrawal by Subject|1
7992324|NCT03359473|12572013|FG001|Overall Study|Withdrawal by Subject|2
7992325|NCT03359473|12572014|FG002|Overall Study|Withdrawal by Subject|1
7992326|NCT03359473|12572015|FG003|Overall Study|Withdrawal by Subject|0
7992327|NCT03359473|12572012|FG000|Overall Study|Protocol-defined stopping criteria|1
7992328|NCT03359473|12572013|FG001|Overall Study|Protocol-defined stopping criteria|0
7992329|NCT03359473|12572014|FG002|Overall Study|Protocol-defined stopping criteria|0
7992330|NCT03359473|12572015|FG003|Overall Study|Protocol-defined stopping criteria|1
7992331|NCT03359590|12572028|FG000|First Intervention|Withdrawal by Subject|1
7992332|NCT03359590|12572029|FG001|First Intervention|Withdrawal by Subject|1
7992333|NCT03359590|12572028|FG000|First Intervention|Protocol Violation|0
7992334|NCT03359590|12572029|FG001|First Intervention|Protocol Violation|1
7992335|NCT03359850|12572046|FG000|PK Phase (Up to Day 8)|Physician Decision|0
7992336|NCT03359850|12572047|FG001|PK Phase (Up to Day 8)|Physician Decision|1
7992337|NCT03359850|12572046|FG000|PK Phase (Up to Day 8)|Adverse Event|1
7992338|NCT03359850|12572047|FG001|PK Phase (Up to Day 8)|Adverse Event|0
7992339|NCT03359850|12572046|FG000|Extension Phase (Up to 28 Months)|Death|2
7992340|NCT03359850|12572047|FG001|Extension Phase (Up to 28 Months)|Death|4
7992341|NCT03359850|12572046|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1
7992342|NCT03359850|12572047|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2
7992343|NCT03359850|12572046|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5
7992344|NCT03359850|12572047|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0
7992345|NCT03360071|12572061|FG000|Overall Study|Lost to Follow-up|1
7992346|NCT03360071|12572062|FG001|Overall Study|Lost to Follow-up|0
7992347|NCT03360344|12572090|FG000|Overall Study|Withdrawal by Subject|0
7992348|NCT03360344|12572091|FG001|Overall Study|Withdrawal by Subject|1
7992349|NCT03360344|12572092|FG002|Overall Study|Withdrawal by Subject|1
7992350|NCT03360747|12572100|FG000|Overall Study|Voluntary Withdrawal|1
7992351|NCT03361137|12572109|FG000|Overall Study|Reason not specified|1
7992352|NCT03361137|12572110|FG001|Overall Study|Reason not specified|0
7992353|NCT03361137|12572111|FG002|Overall Study|Reason not specified|0
7992354|NCT03361137|12572112|FG003|Overall Study|Reason not specified|0
7992355|NCT03361137|12572113|FG004|Overall Study|Reason not specified|0
7992356|NCT03361176|12572129|FG000|Overall Study|Lost to Follow-up|1
7992357|NCT03361176|12572130|FG001|Overall Study|Lost to Follow-up|2
7992358|NCT03361176|12572129|FG000|Overall Study|Adverse Event|0
7992359|NCT03361176|12572130|FG001|Overall Study|Adverse Event|2
7992360|NCT03361176|12572129|FG000|Overall Study|Withdrawal by Subject|0
7992361|NCT03361176|12572130|FG001|Overall Study|Withdrawal by Subject|1
7992362|NCT03361293|12572138|FG000|Overall Study|Lost to Follow-up|0
7992363|NCT03361293|12572139|FG001|Overall Study|Lost to Follow-up|2
7992364|NCT03361293|12572138|FG000|Overall Study|Withdrawal by Subject|1
7992365|NCT03361293|12572139|FG001|Overall Study|Withdrawal by Subject|3
7992366|NCT03361423|12572147|FG000|Overall Study|Withdrawal by Subject|4
7992367|NCT03361423|12572148|FG001|Overall Study|Withdrawal by Subject|3
7992368|NCT03361423|12572147|FG000|Overall Study|Did not treat|19
7992369|NCT03361423|12572148|FG001|Overall Study|Did not treat|18
7992370|NCT03361423|12572147|FG000|Overall Study|Started >60 minutes from migraine onset|0
7992371|NCT03361423|12572148|FG001|Overall Study|Started >60 minutes from migraine onset|1
7992372|NCT03361423|12572147|FG000|Overall Study|Missing data|4
7992373|NCT03361423|12572148|FG001|Overall Study|Missing data|1
7992374|NCT03361605|12572154|FG000|Overall Study|Analyzable data not available|3
7992375|NCT03363321|12572195|FG000|Overall Study|Withdrawal by Subject|0
7992376|NCT03363321|12572196|FG001|Overall Study|Withdrawal by Subject|1
7992377|NCT03363321|12572197|FG002|Overall Study|Withdrawal by Subject|0
7992378|NCT03363321|12572198|FG003|Overall Study|Withdrawal by Subject|1
7992379|NCT03363321|12572199|FG004|Overall Study|Withdrawal by Subject|0
7992380|NCT03363776|12572215|FG000|Overall Study|Progressive disease|2
7992381|NCT03363776|12572216|FG001|Overall Study|Progressive disease|3
7992382|NCT03363776|12572217|FG002|Overall Study|Progressive disease|1
7992383|NCT03363776|12572215|FG000|Overall Study|Study drug toxicity|0
7992384|NCT03363776|12572216|FG001|Overall Study|Study drug toxicity|0
7992385|NCT03363776|12572217|FG002|Overall Study|Study drug toxicity|1
7992386|NCT03363776|12572215|FG000|Overall Study|Death|1
7992387|NCT03363776|12572216|FG001|Overall Study|Death|0
7992388|NCT03363776|12572217|FG002|Overall Study|Death|0
7992389|NCT03363906|12572257|FG000|Period 1 (Reference or Test)|Adverse Event|1
7992390|NCT03363906|12572258|FG001|Period 1 (Reference or Test)|Adverse Event|2
7992391|NCT03363906|12572257|FG000|Period 2 (Test or Reference)|Adverse Event|2
7992392|NCT03363906|12572258|FG001|Period 2 (Test or Reference)|Adverse Event|0
7992393|NCT03363906|12572257|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1
7992394|NCT03363906|12572258|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1
7992395|NCT03363906|12572257|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1
7992396|NCT03363906|12572258|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0
7992397|NCT03364023|12572264|FG000|Overall Study|Lost to Follow-up|3
7992398|NCT03364023|12572264|FG000|Overall Study|Death|14
7992399|NCT03364049|12572272|FG000|Overall Study|Death|6
7992400|NCT03364049|12572273|FG001|Overall Study|Death|4
7992401|NCT03364049|12572274|FG002|Overall Study|Death|5
7992402|NCT03364049|12572275|FG003|Overall Study|Death|14
7992403|NCT03364049|12572272|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
7992404|NCT03364049|12572273|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1
7992405|NCT03364049|12572274|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
7992406|NCT03364049|12572275|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
7992407|NCT03364049|12572272|FG000|Overall Study|Withdrawal by Subject|0
7992408|NCT03364049|12572273|FG001|Overall Study|Withdrawal by Subject|1
7992409|NCT03364049|12572274|FG002|Overall Study|Withdrawal by Subject|1
7992410|NCT03364049|12572275|FG003|Overall Study|Withdrawal by Subject|1
7992411|NCT03364192|12572285|FG000|Overall Study|Ineligible|10
7992412|NCT03364192|12572285|FG000|Overall Study|Withdrawal by Subject|5
7992413|NCT03364192|12572285|FG000|Overall Study|Lost to Follow-up|1
7992414|NCT03364309|12572293|FG000|Induction Period|Adverse Event|4
7992415|NCT03364309|12572294|FG001|Induction Period|Adverse Event|0
7992416|NCT03364309|12572295|FG002|Induction Period|Adverse Event|1
7992417|NCT03364309|12572296|FG003|Induction Period|Adverse Event|0
7992418|NCT03364309|12572297|FG004|Induction Period|Adverse Event|0
7992419|NCT03364309|12572298|FG005|Induction Period|Adverse Event|0
7992420|NCT03364309|12572299|FG006|Induction Period|Adverse Event|0
7992421|NCT03364309|12572300|FG007|Induction Period|Adverse Event|0
7992422|NCT03364309|12572301|FG008|Induction Period|Adverse Event|0
7992423|NCT03364309|12572302|FG009|Induction Period|Adverse Event|0
7992424|NCT03364309|12572303|FG010|Induction Period|Adverse Event|0
7992425|NCT03364309|12572304|FG011|Induction Period|Adverse Event|0
7992426|NCT03364309|12572305|FG012|Induction Period|Adverse Event|0
7992427|NCT03364309|12572306|FG013|Induction Period|Adverse Event|0
7992428|NCT03364309|12572307|FG014|Induction Period|Adverse Event|0
7992429|NCT03364309|12572308|FG015|Induction Period|Adverse Event|0
7992430|NCT03364309|12572309|FG016|Induction Period|Adverse Event|0
7992431|NCT03364309|12572310|FG017|Induction Period|Adverse Event|0
7992432|NCT03364309|12572311|FG018|Induction Period|Adverse Event|0
7992433|NCT03364309|12572293|FG000|Induction Period|Withdrawal by Subject|1
7992434|NCT03364309|12572294|FG001|Induction Period|Withdrawal by Subject|3
7992435|NCT03364309|12572295|FG002|Induction Period|Withdrawal by Subject|0
7992436|NCT03364309|12572296|FG003|Induction Period|Withdrawal by Subject|0
7992437|NCT03364309|12572297|FG004|Induction Period|Withdrawal by Subject|0
7992438|NCT03364309|12572298|FG005|Induction Period|Withdrawal by Subject|0
7992439|NCT03364309|12572299|FG006|Induction Period|Withdrawal by Subject|0
7992440|NCT03364309|12572300|FG007|Induction Period|Withdrawal by Subject|0
7992441|NCT03364309|12572301|FG008|Induction Period|Withdrawal by Subject|0
7992442|NCT03364309|12572302|FG009|Induction Period|Withdrawal by Subject|0
7992443|NCT03364309|12572303|FG010|Induction Period|Withdrawal by Subject|0
7992444|NCT03364309|12572304|FG011|Induction Period|Withdrawal by Subject|0
7992445|NCT03364309|12572305|FG012|Induction Period|Withdrawal by Subject|0
7992446|NCT03364309|12572306|FG013|Induction Period|Withdrawal by Subject|0
7992447|NCT03364309|12572307|FG014|Induction Period|Withdrawal by Subject|0
7992448|NCT03364309|12572308|FG015|Induction Period|Withdrawal by Subject|0
7992449|NCT03364309|12572309|FG016|Induction Period|Withdrawal by Subject|0
7992450|NCT03364309|12572310|FG017|Induction Period|Withdrawal by Subject|0
7992451|NCT03364309|12572311|FG018|Induction Period|Withdrawal by Subject|0
7992452|NCT03364309|12572293|FG000|Induction Period|Lost to Follow-up|1
7992453|NCT03364309|12572294|FG001|Induction Period|Lost to Follow-up|0
7992454|NCT03364309|12572295|FG002|Induction Period|Lost to Follow-up|0
7992455|NCT03364309|12572296|FG003|Induction Period|Lost to Follow-up|0
7992456|NCT03364309|12572297|FG004|Induction Period|Lost to Follow-up|0
7992457|NCT03364309|12572298|FG005|Induction Period|Lost to Follow-up|0
7992458|NCT03364309|12572299|FG006|Induction Period|Lost to Follow-up|0
7992459|NCT03364309|12572300|FG007|Induction Period|Lost to Follow-up|0
7992460|NCT03364309|12572301|FG008|Induction Period|Lost to Follow-up|0
7992461|NCT03364309|12572302|FG009|Induction Period|Lost to Follow-up|0
7992462|NCT03364309|12572303|FG010|Induction Period|Lost to Follow-up|0
7992463|NCT03364309|12572304|FG011|Induction Period|Lost to Follow-up|0
7992464|NCT03364309|12572305|FG012|Induction Period|Lost to Follow-up|0
7992465|NCT03364309|12572306|FG013|Induction Period|Lost to Follow-up|0
7992466|NCT03364309|12572307|FG014|Induction Period|Lost to Follow-up|0
7992467|NCT03364309|12572308|FG015|Induction Period|Lost to Follow-up|0
7992468|NCT03364309|12572309|FG016|Induction Period|Lost to Follow-up|0
7992469|NCT03364309|12572310|FG017|Induction Period|Lost to Follow-up|0
7992470|NCT03364309|12572311|FG018|Induction Period|Lost to Follow-up|0
7992471|NCT03364309|12572293|FG000|Induction Period|Physician Decision|0
7992472|NCT03364309|12572294|FG001|Induction Period|Physician Decision|1
7992473|NCT03364309|12572295|FG002|Induction Period|Physician Decision|0
7992474|NCT03364309|12572296|FG003|Induction Period|Physician Decision|0
7992475|NCT03364309|12572297|FG004|Induction Period|Physician Decision|0
7992476|NCT03364309|12572298|FG005|Induction Period|Physician Decision|0
7992477|NCT03364309|12572299|FG006|Induction Period|Physician Decision|0
7992478|NCT03364309|12572300|FG007|Induction Period|Physician Decision|0
7992479|NCT03364309|12572301|FG008|Induction Period|Physician Decision|0
7992480|NCT03364309|12572302|FG009|Induction Period|Physician Decision|0
7992481|NCT03364309|12572303|FG010|Induction Period|Physician Decision|0
7992482|NCT03364309|12572304|FG011|Induction Period|Physician Decision|0
7992483|NCT03364309|12572305|FG012|Induction Period|Physician Decision|0
7992484|NCT03364309|12572306|FG013|Induction Period|Physician Decision|0
7992485|NCT03364309|12572307|FG014|Induction Period|Physician Decision|0
7992486|NCT03364309|12572308|FG015|Induction Period|Physician Decision|0
7992487|NCT03364309|12572309|FG016|Induction Period|Physician Decision|0
7992488|NCT03364309|12572310|FG017|Induction Period|Physician Decision|0
7992489|NCT03364309|12572311|FG018|Induction Period|Physician Decision|0
7992490|NCT03364309|12572293|FG000|Maintenance Period|Withdrawal by Subject|0
7992491|NCT03364309|12572294|FG001|Maintenance Period|Withdrawal by Subject|0
7992492|NCT03364309|12572295|FG002|Maintenance Period|Withdrawal by Subject|0
7992493|NCT03364309|12572296|FG003|Maintenance Period|Withdrawal by Subject|1
7992494|NCT03364309|12572297|FG004|Maintenance Period|Withdrawal by Subject|3
7992495|NCT03364309|12572298|FG005|Maintenance Period|Withdrawal by Subject|1
7992496|NCT03364309|12572299|FG006|Maintenance Period|Withdrawal by Subject|3
7992497|NCT03364309|12572300|FG007|Maintenance Period|Withdrawal by Subject|0
7992498|NCT03364309|12572301|FG008|Maintenance Period|Withdrawal by Subject|1
7992499|NCT03364309|12572302|FG009|Maintenance Period|Withdrawal by Subject|1
7992500|NCT03364309|12572303|FG010|Maintenance Period|Withdrawal by Subject|2
7992501|NCT03364309|12572304|FG011|Maintenance Period|Withdrawal by Subject|0
7992502|NCT03364309|12572305|FG012|Maintenance Period|Withdrawal by Subject|0
7992503|NCT03364309|12572306|FG013|Maintenance Period|Withdrawal by Subject|0
7992504|NCT03364309|12572307|FG014|Maintenance Period|Withdrawal by Subject|0
7992505|NCT03364309|12572308|FG015|Maintenance Period|Withdrawal by Subject|0
7992506|NCT03364309|12572309|FG016|Maintenance Period|Withdrawal by Subject|0
7992507|NCT03364309|12572310|FG017|Maintenance Period|Withdrawal by Subject|0
7992508|NCT03364309|12572311|FG018|Maintenance Period|Withdrawal by Subject|0
7992509|NCT03364309|12572293|FG000|Maintenance Period|Adverse Event|0
7992510|NCT03364309|12572294|FG001|Maintenance Period|Adverse Event|0
7992511|NCT03364309|12572295|FG002|Maintenance Period|Adverse Event|0
7992512|NCT03364309|12572296|FG003|Maintenance Period|Adverse Event|0
7992513|NCT03364309|12572297|FG004|Maintenance Period|Adverse Event|2
7992514|NCT03364309|12572298|FG005|Maintenance Period|Adverse Event|0
7992515|NCT03364309|12572299|FG006|Maintenance Period|Adverse Event|3
7992516|NCT03364309|12572300|FG007|Maintenance Period|Adverse Event|0
7992517|NCT03364309|12572301|FG008|Maintenance Period|Adverse Event|1
7992518|NCT03364309|12572302|FG009|Maintenance Period|Adverse Event|0
7992519|NCT03364309|12572303|FG010|Maintenance Period|Adverse Event|2
7992520|NCT03364309|12572304|FG011|Maintenance Period|Adverse Event|0
7992521|NCT03364309|12572305|FG012|Maintenance Period|Adverse Event|0
7992522|NCT03364309|12572306|FG013|Maintenance Period|Adverse Event|0
7992523|NCT03364309|12572307|FG014|Maintenance Period|Adverse Event|0
7992524|NCT03364309|12572308|FG015|Maintenance Period|Adverse Event|0
7992525|NCT03364309|12572309|FG016|Maintenance Period|Adverse Event|0
7992526|NCT03364309|12572310|FG017|Maintenance Period|Adverse Event|0
7992527|NCT03364309|12572311|FG018|Maintenance Period|Adverse Event|0
7992528|NCT03364309|12572293|FG000|Maintenance Period|Relapsed|0
7992529|NCT03364309|12572294|FG001|Maintenance Period|Relapsed|0
7992530|NCT03364309|12572295|FG002|Maintenance Period|Relapsed|0
7992531|NCT03364309|12572296|FG003|Maintenance Period|Relapsed|43
7992532|NCT03364309|12572297|FG004|Maintenance Period|Relapsed|7
7992533|NCT03364309|12572298|FG005|Maintenance Period|Relapsed|45
7992534|NCT03364309|12572299|FG006|Maintenance Period|Relapsed|10
7992535|NCT03364309|12572300|FG007|Maintenance Period|Relapsed|2
7992536|NCT03364309|12572301|FG008|Maintenance Period|Relapsed|0
7992537|NCT03364309|12572302|FG009|Maintenance Period|Relapsed|0
7992538|NCT03364309|12572303|FG010|Maintenance Period|Relapsed|0
7992539|NCT03364309|12572304|FG011|Maintenance Period|Relapsed|0
7992540|NCT03364309|12572305|FG012|Maintenance Period|Relapsed|0
7992541|NCT03364309|12572306|FG013|Maintenance Period|Relapsed|0
7992542|NCT03364309|12572307|FG014|Maintenance Period|Relapsed|0
7992543|NCT03364309|12572308|FG015|Maintenance Period|Relapsed|0
7992544|NCT03364309|12572309|FG016|Maintenance Period|Relapsed|0
7992545|NCT03364309|12572310|FG017|Maintenance Period|Relapsed|0
7992546|NCT03364309|12572311|FG018|Maintenance Period|Relapsed|0
7992547|NCT03364309|12572293|FG000|Maintenance Period|Lack of Efficacy|0
7992548|NCT03364309|12572294|FG001|Maintenance Period|Lack of Efficacy|0
7992549|NCT03364309|12572295|FG002|Maintenance Period|Lack of Efficacy|0
7992550|NCT03364309|12572296|FG003|Maintenance Period|Lack of Efficacy|0
7992551|NCT03364309|12572297|FG004|Maintenance Period|Lack of Efficacy|0
7992552|NCT03364309|12572298|FG005|Maintenance Period|Lack of Efficacy|0
7992553|NCT03364309|12572299|FG006|Maintenance Period|Lack of Efficacy|0
7992554|NCT03364309|12572300|FG007|Maintenance Period|Lack of Efficacy|0
7992555|NCT03364309|12572301|FG008|Maintenance Period|Lack of Efficacy|1
7992556|NCT03364309|12572302|FG009|Maintenance Period|Lack of Efficacy|3
7992557|NCT03364309|12572303|FG010|Maintenance Period|Lack of Efficacy|2
7992558|NCT03364309|12572304|FG011|Maintenance Period|Lack of Efficacy|0
7992559|NCT03364309|12572305|FG012|Maintenance Period|Lack of Efficacy|0
7992560|NCT03364309|12572306|FG013|Maintenance Period|Lack of Efficacy|0
7992561|NCT03364309|12572307|FG014|Maintenance Period|Lack of Efficacy|0
7992562|NCT03364309|12572308|FG015|Maintenance Period|Lack of Efficacy|0
7992563|NCT03364309|12572309|FG016|Maintenance Period|Lack of Efficacy|0
7992564|NCT03364309|12572310|FG017|Maintenance Period|Lack of Efficacy|0
7992565|NCT03364309|12572311|FG018|Maintenance Period|Lack of Efficacy|0
7992566|NCT03364309|12572293|FG000|Maintenance Period|Death|0
7992567|NCT03364309|12572294|FG001|Maintenance Period|Death|0
7992568|NCT03364309|12572295|FG002|Maintenance Period|Death|0
7992569|NCT03364309|12572296|FG003|Maintenance Period|Death|0
7992570|NCT03364309|12572297|FG004|Maintenance Period|Death|0
7992571|NCT03364309|12572298|FG005|Maintenance Period|Death|0
7992572|NCT03364309|12572299|FG006|Maintenance Period|Death|0
7992573|NCT03364309|12572300|FG007|Maintenance Period|Death|0
7992574|NCT03364309|12572301|FG008|Maintenance Period|Death|1
7992575|NCT03364309|12572302|FG009|Maintenance Period|Death|0
7992576|NCT03364309|12572303|FG010|Maintenance Period|Death|0
7992577|NCT03364309|12572304|FG011|Maintenance Period|Death|0
7992578|NCT03364309|12572305|FG012|Maintenance Period|Death|0
7992579|NCT03364309|12572306|FG013|Maintenance Period|Death|0
7992580|NCT03364309|12572307|FG014|Maintenance Period|Death|0
7992581|NCT03364309|12572308|FG015|Maintenance Period|Death|0
7992582|NCT03364309|12572309|FG016|Maintenance Period|Death|0
7992583|NCT03364309|12572310|FG017|Maintenance Period|Death|0
7992584|NCT03364309|12572311|FG018|Maintenance Period|Death|0
7992585|NCT03364309|12572293|FG000|Maintenance Period|Lost to Follow-up|0
7992586|NCT03364309|12572294|FG001|Maintenance Period|Lost to Follow-up|0
7992587|NCT03364309|12572295|FG002|Maintenance Period|Lost to Follow-up|0
7992588|NCT03364309|12572296|FG003|Maintenance Period|Lost to Follow-up|0
7992589|NCT03364309|12572297|FG004|Maintenance Period|Lost to Follow-up|0
7992590|NCT03364309|12572298|FG005|Maintenance Period|Lost to Follow-up|0
7992591|NCT03364309|12572299|FG006|Maintenance Period|Lost to Follow-up|0
7992592|NCT03364309|12572300|FG007|Maintenance Period|Lost to Follow-up|0
7992593|NCT03364309|12572301|FG008|Maintenance Period|Lost to Follow-up|1
7992594|NCT03364309|12572302|FG009|Maintenance Period|Lost to Follow-up|0
7992595|NCT03364309|12572303|FG010|Maintenance Period|Lost to Follow-up|0
7992596|NCT03364309|12572304|FG011|Maintenance Period|Lost to Follow-up|0
7992597|NCT03364309|12572305|FG012|Maintenance Period|Lost to Follow-up|0
7992598|NCT03364309|12572306|FG013|Maintenance Period|Lost to Follow-up|0
7992599|NCT03364309|12572307|FG014|Maintenance Period|Lost to Follow-up|0
7992600|NCT03364309|12572308|FG015|Maintenance Period|Lost to Follow-up|0
7992601|NCT03364309|12572309|FG016|Maintenance Period|Lost to Follow-up|0
7992602|NCT03364309|12572310|FG017|Maintenance Period|Lost to Follow-up|0
7992603|NCT03364309|12572311|FG018|Maintenance Period|Lost to Follow-up|0
7992604|NCT03364309|12572293|FG000|Maintenance Period|Miscellaneous|0
7992605|NCT03364309|12572294|FG001|Maintenance Period|Miscellaneous|0
7992606|NCT03364309|12572295|FG002|Maintenance Period|Miscellaneous|0
7992607|NCT03364309|12572296|FG003|Maintenance Period|Miscellaneous|0
7992608|NCT03364309|12572297|FG004|Maintenance Period|Miscellaneous|0
7992609|NCT03364309|12572298|FG005|Maintenance Period|Miscellaneous|0
7992610|NCT03364309|12572299|FG006|Maintenance Period|Miscellaneous|0
7992611|NCT03364309|12572300|FG007|Maintenance Period|Miscellaneous|0
7992612|NCT03364309|12572301|FG008|Maintenance Period|Miscellaneous|1
7992613|NCT03364309|12572302|FG009|Maintenance Period|Miscellaneous|0
7992614|NCT03364309|12572303|FG010|Maintenance Period|Miscellaneous|0
7992615|NCT03364309|12572304|FG011|Maintenance Period|Miscellaneous|0
7992616|NCT03364309|12572305|FG012|Maintenance Period|Miscellaneous|0
7992617|NCT03364309|12572306|FG013|Maintenance Period|Miscellaneous|0
7992618|NCT03364309|12572307|FG014|Maintenance Period|Miscellaneous|0
7992619|NCT03364309|12572308|FG015|Maintenance Period|Miscellaneous|0
7992620|NCT03364309|12572309|FG016|Maintenance Period|Miscellaneous|0
7992621|NCT03364309|12572310|FG017|Maintenance Period|Miscellaneous|0
7992622|NCT03364309|12572311|FG018|Maintenance Period|Miscellaneous|0
7992623|NCT03364309|12572293|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992624|NCT03364309|12572294|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992625|NCT03364309|12572295|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992626|NCT03364309|12572296|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992627|NCT03364309|12572297|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992628|NCT03364309|12572298|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992629|NCT03364309|12572299|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992630|NCT03364309|12572300|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992631|NCT03364309|12572301|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992632|NCT03364309|12572302|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992633|NCT03364309|12572303|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992634|NCT03364309|12572304|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992635|NCT03364309|12572305|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992636|NCT03364309|12572306|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
7992637|NCT03364309|12572307|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
7992638|NCT03364309|12572308|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
7992639|NCT03364309|12572309|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992640|NCT03364309|12572310|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992641|NCT03364309|12572311|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7992642|NCT03364309|12572293|FG000|Re-treatment (Maintenance) Period|Adverse Event|0
7992643|NCT03364309|12572294|FG001|Re-treatment (Maintenance) Period|Adverse Event|0
7992644|NCT03364309|12572295|FG002|Re-treatment (Maintenance) Period|Adverse Event|0
7992645|NCT03364309|12572296|FG003|Re-treatment (Maintenance) Period|Adverse Event|0
7992646|NCT03364309|12572297|FG004|Re-treatment (Maintenance) Period|Adverse Event|0
7992647|NCT03364309|12572298|FG005|Re-treatment (Maintenance) Period|Adverse Event|0
7992648|NCT03364309|12572299|FG006|Re-treatment (Maintenance) Period|Adverse Event|0
7992649|NCT03364309|12572300|FG007|Re-treatment (Maintenance) Period|Adverse Event|0
7992650|NCT03364309|12572301|FG008|Re-treatment (Maintenance) Period|Adverse Event|0
7992651|NCT03364309|12572302|FG009|Re-treatment (Maintenance) Period|Adverse Event|0
7992652|NCT03364309|12572303|FG010|Re-treatment (Maintenance) Period|Adverse Event|0
7992653|NCT03364309|12572304|FG011|Re-treatment (Maintenance) Period|Adverse Event|0
7992654|NCT03364309|12572305|FG012|Re-treatment (Maintenance) Period|Adverse Event|0
7992655|NCT03364309|12572306|FG013|Re-treatment (Maintenance) Period|Adverse Event|0
7992656|NCT03364309|12572307|FG014|Re-treatment (Maintenance) Period|Adverse Event|1
7992657|NCT03364309|12572308|FG015|Re-treatment (Maintenance) Period|Adverse Event|0
7992658|NCT03364309|12572309|FG016|Re-treatment (Maintenance) Period|Adverse Event|0
7992659|NCT03364309|12572310|FG017|Re-treatment (Maintenance) Period|Adverse Event|0
7992660|NCT03364309|12572311|FG018|Re-treatment (Maintenance) Period|Adverse Event|0
7992661|NCT03364309|12572293|FG000|Re-treatment (Maintenance) Period|Relapse|0
7992662|NCT03364309|12572294|FG001|Re-treatment (Maintenance) Period|Relapse|0
7992663|NCT03364309|12572295|FG002|Re-treatment (Maintenance) Period|Relapse|0
7992664|NCT03364309|12572296|FG003|Re-treatment (Maintenance) Period|Relapse|0
7992665|NCT03364309|12572297|FG004|Re-treatment (Maintenance) Period|Relapse|0
7992666|NCT03364309|12572298|FG005|Re-treatment (Maintenance) Period|Relapse|0
7992667|NCT03364309|12572299|FG006|Re-treatment (Maintenance) Period|Relapse|0
7992668|NCT03364309|12572300|FG007|Re-treatment (Maintenance) Period|Relapse|0
7992669|NCT03364309|12572301|FG008|Re-treatment (Maintenance) Period|Relapse|0
7992670|NCT03364309|12572302|FG009|Re-treatment (Maintenance) Period|Relapse|0
7992671|NCT03364309|12572303|FG010|Re-treatment (Maintenance) Period|Relapse|0
7992672|NCT03364309|12572304|FG011|Re-treatment (Maintenance) Period|Relapse|0
7992673|NCT03364309|12572305|FG012|Re-treatment (Maintenance) Period|Relapse|1
7992674|NCT03364309|12572306|FG013|Re-treatment (Maintenance) Period|Relapse|0
7992675|NCT03364309|12572307|FG014|Re-treatment (Maintenance) Period|Relapse|0
7992676|NCT03364309|12572308|FG015|Re-treatment (Maintenance) Period|Relapse|1
7992677|NCT03364309|12572309|FG016|Re-treatment (Maintenance) Period|Relapse|0
7992678|NCT03364309|12572310|FG017|Re-treatment (Maintenance) Period|Relapse|0
7992679|NCT03364309|12572311|FG018|Re-treatment (Maintenance) Period|Relapse|0
7992680|NCT03364309|12572293|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0
7992681|NCT03364309|12572294|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0
7992682|NCT03364309|12572295|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0
7992683|NCT03364309|12572296|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0
7992684|NCT03364309|12572297|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0
7992685|NCT03364309|12572298|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0
7992686|NCT03364309|12572299|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0
7992687|NCT03364309|12572300|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0
7992688|NCT03364309|12572301|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0
7992689|NCT03364309|12572302|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0
7992690|NCT03364309|12572303|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0
7992691|NCT03364309|12572304|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0
7992692|NCT03364309|12572305|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0
7992693|NCT03364309|12572306|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0
7992694|NCT03364309|12572307|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0
7992695|NCT03364309|12572308|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0
7992696|NCT03364309|12572309|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3
7992697|NCT03364309|12572310|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19
7992698|NCT03364309|12572311|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1
7992699|NCT03364309|12572293|FG000|Post-Treatment Followup Period|Adverse Event|0
7992700|NCT03364309|12572294|FG001|Post-Treatment Followup Period|Adverse Event|0
7992701|NCT03364309|12572295|FG002|Post-Treatment Followup Period|Adverse Event|0
7992702|NCT03364309|12572296|FG003|Post-Treatment Followup Period|Adverse Event|0
7992703|NCT03364309|12572297|FG004|Post-Treatment Followup Period|Adverse Event|0
7992704|NCT03364309|12572298|FG005|Post-Treatment Followup Period|Adverse Event|0
7992705|NCT03364309|12572299|FG006|Post-Treatment Followup Period|Adverse Event|0
7992706|NCT03364309|12572300|FG007|Post-Treatment Followup Period|Adverse Event|0
7992707|NCT03364309|12572301|FG008|Post-Treatment Followup Period|Adverse Event|0
7992708|NCT03364309|12572302|FG009|Post-Treatment Followup Period|Adverse Event|0
7992709|NCT03364309|12572303|FG010|Post-Treatment Followup Period|Adverse Event|0
7992710|NCT03364309|12572304|FG011|Post-Treatment Followup Period|Adverse Event|0
7992711|NCT03364309|12572305|FG012|Post-Treatment Followup Period|Adverse Event|0
7992712|NCT03364309|12572306|FG013|Post-Treatment Followup Period|Adverse Event|0
7992713|NCT03364309|12572307|FG014|Post-Treatment Followup Period|Adverse Event|0
7992714|NCT03364309|12572308|FG015|Post-Treatment Followup Period|Adverse Event|0
7992715|NCT03364309|12572309|FG016|Post-Treatment Followup Period|Adverse Event|2
7992716|NCT03364309|12572310|FG017|Post-Treatment Followup Period|Adverse Event|6
7992717|NCT03364309|12572311|FG018|Post-Treatment Followup Period|Adverse Event|1
7992718|NCT03364309|12572293|FG000|Post-Treatment Followup Period|Lost to Follow-up|0
7992719|NCT03364309|12572294|FG001|Post-Treatment Followup Period|Lost to Follow-up|0
7992720|NCT03364309|12572295|FG002|Post-Treatment Followup Period|Lost to Follow-up|0
7992721|NCT03364309|12572296|FG003|Post-Treatment Followup Period|Lost to Follow-up|0
7992722|NCT03364309|12572297|FG004|Post-Treatment Followup Period|Lost to Follow-up|0
7992723|NCT03364309|12572298|FG005|Post-Treatment Followup Period|Lost to Follow-up|0
7992724|NCT03364309|12572299|FG006|Post-Treatment Followup Period|Lost to Follow-up|0
7992725|NCT03364309|12572300|FG007|Post-Treatment Followup Period|Lost to Follow-up|0
7992726|NCT03364309|12572301|FG008|Post-Treatment Followup Period|Lost to Follow-up|0
7992727|NCT03364309|12572302|FG009|Post-Treatment Followup Period|Lost to Follow-up|0
7992728|NCT03364309|12572303|FG010|Post-Treatment Followup Period|Lost to Follow-up|0
7992729|NCT03364309|12572304|FG011|Post-Treatment Followup Period|Lost to Follow-up|0
7992730|NCT03364309|12572305|FG012|Post-Treatment Followup Period|Lost to Follow-up|0
7992731|NCT03364309|12572306|FG013|Post-Treatment Followup Period|Lost to Follow-up|0
7992732|NCT03364309|12572307|FG014|Post-Treatment Followup Period|Lost to Follow-up|0
7992733|NCT03364309|12572308|FG015|Post-Treatment Followup Period|Lost to Follow-up|0
7992734|NCT03364309|12572309|FG016|Post-Treatment Followup Period|Lost to Follow-up|0
7992735|NCT03364309|12572310|FG017|Post-Treatment Followup Period|Lost to Follow-up|2
7992736|NCT03364309|12572311|FG018|Post-Treatment Followup Period|Lost to Follow-up|0
7992737|NCT03364309|12572293|FG000|Post-Treatment Followup Period|Miscellaneous|0
7992738|NCT03364309|12572294|FG001|Post-Treatment Followup Period|Miscellaneous|0
7992739|NCT03364309|12572295|FG002|Post-Treatment Followup Period|Miscellaneous|0
7992740|NCT03364309|12572296|FG003|Post-Treatment Followup Period|Miscellaneous|0
7992741|NCT03364309|12572297|FG004|Post-Treatment Followup Period|Miscellaneous|0
7992742|NCT03364309|12572298|FG005|Post-Treatment Followup Period|Miscellaneous|0
7992743|NCT03364309|12572299|FG006|Post-Treatment Followup Period|Miscellaneous|0
7992744|NCT03364309|12572300|FG007|Post-Treatment Followup Period|Miscellaneous|0
7992745|NCT03364309|12572301|FG008|Post-Treatment Followup Period|Miscellaneous|0
7992746|NCT03364309|12572302|FG009|Post-Treatment Followup Period|Miscellaneous|0
7992747|NCT03364309|12572303|FG010|Post-Treatment Followup Period|Miscellaneous|0
7992748|NCT03364309|12572304|FG011|Post-Treatment Followup Period|Miscellaneous|0
7992749|NCT03364309|12572305|FG012|Post-Treatment Followup Period|Miscellaneous|0
7992750|NCT03364309|12572306|FG013|Post-Treatment Followup Period|Miscellaneous|0
7992751|NCT03364309|12572307|FG014|Post-Treatment Followup Period|Miscellaneous|0
7992752|NCT03364309|12572308|FG015|Post-Treatment Followup Period|Miscellaneous|0
7992753|NCT03364309|12572309|FG016|Post-Treatment Followup Period|Miscellaneous|0
7992754|NCT03364309|12572310|FG017|Post-Treatment Followup Period|Miscellaneous|4
7992755|NCT03364309|12572311|FG018|Post-Treatment Followup Period|Miscellaneous|0
7992756|NCT03364335|12572340|FG000|Overall Study|Adverse Event|3
7992757|NCT03364335|12572341|FG001|Overall Study|Adverse Event|4
7992758|NCT03364335|12572342|FG002|Overall Study|Adverse Event|1
7992759|NCT03364335|12572343|FG003|Overall Study|Adverse Event|2
7992760|NCT03364335|12572344|FG004|Overall Study|Adverse Event|0
7992761|NCT03364335|12572340|FG000|Overall Study|Lost to Follow-up|7
7992762|NCT03364335|12572341|FG001|Overall Study|Lost to Follow-up|7
7992763|NCT03364335|12572342|FG002|Overall Study|Lost to Follow-up|10
7992764|NCT03364335|12572343|FG003|Overall Study|Lost to Follow-up|11
7992765|NCT03364335|12572344|FG004|Overall Study|Lost to Follow-up|11
7992766|NCT03364608|12572356|FG000|Overall Study|Withdrawal by Subject|4
7992767|NCT03364608|12572356|FG000|Overall Study|Protocol Violation|2
7992768|NCT03364608|12572356|FG000|Overall Study|Lost to Follow-up|2
7992769|NCT03364738|12572368|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6
7992770|NCT03364738|12572368|FG000|Overall Study|Withdrawal by Subject|1
7992771|NCT03364738|12572368|FG000|Overall Study|Adverse Event|1
7992772|NCT03364751|12572377|FG000|Overall Study|Withdrawal by Subject|1
7992773|NCT03364751|12572378|FG001|Overall Study|Withdrawal by Subject|0
7992774|NCT03364751|12572379|FG002|Overall Study|Withdrawal by Subject|0
7992775|NCT03364751|12572380|FG003|Overall Study|Withdrawal by Subject|0
7992776|NCT03364751|12572377|FG000|Overall Study|Lost to Follow-up|0
7992777|NCT03364751|12572378|FG001|Overall Study|Lost to Follow-up|1
7992778|NCT03364751|12572379|FG002|Overall Study|Lost to Follow-up|0
7992779|NCT03364751|12572380|FG003|Overall Study|Lost to Follow-up|0
7992780|NCT03365011|12572396|FG000|Overall Study|Withdrawal by Subject|1
7992781|NCT03365011|12572397|FG001|Overall Study|Withdrawal by Subject|2
7992782|NCT03365934|12572420|FG000|Overall Study|Adverse Event|1
7992783|NCT03365934|12572420|FG000|Overall Study|Withdrawal by Subject|1
7992784|NCT03367793|12572439|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7992785|NCT03367793|12572440|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7992786|NCT03367793|12572441|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1
7992787|NCT03367793|12572442|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7992788|NCT03367793|12572443|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7992789|NCT03367793|12572444|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7992790|NCT03368807|12572468|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3
7992791|NCT03368807|12572468|FG000|Period 1 (Blinded CGM)|Protocol Violation|1
7992792|NCT03368807|12572468|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1
7992793|NCT03368807|12572468|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1
7992794|NCT03368859|12572476|FG000|Overall Study|Withdrew Consent|5
7992795|NCT03368859|12572477|FG001|Overall Study|Withdrew Consent|4
7992796|NCT03368859|12572476|FG000|Overall Study|Death|12
7992797|NCT03368859|12572477|FG001|Overall Study|Death|6
7992798|NCT03368859|12572476|FG000|Overall Study|Study terminated by Sponsor|18
7992799|NCT03368859|12572477|FG001|Overall Study|Study terminated by Sponsor|23
7992800|NCT03368859|12572476|FG000|Overall Study|Other|1
7992801|NCT03368859|12572477|FG001|Overall Study|Other|1
7992802|NCT03369236|12572507|FG000|Double-blind Treatment Period|Accidental unblinding|0
7992803|NCT03369236|12572508|FG001|Double-blind Treatment Period|Accidental unblinding|1
7992804|NCT03369236|12572507|FG000|Open-label Extension Period|Lack of Efficacy|2
7992805|NCT03369236|12572508|FG001|Open-label Extension Period|Lack of Efficacy|1
7992806|NCT03369236|12572507|FG000|Open-label Extension Period|Adverse Event|0
7992807|NCT03369236|12572508|FG001|Open-label Extension Period|Adverse Event|1
7992808|NCT03369236|12572507|FG000|Open-label Extension Period|Sponsor decision to close study|3
7992809|NCT03369236|12572508|FG001|Open-label Extension Period|Sponsor decision to close study|4
7992810|NCT03369418|12572537|FG000|Overall Study|Withdrawal by Subject|3
7992811|NCT03369418|12572538|FG001|Overall Study|Withdrawal by Subject|3
7992812|NCT03369704|12572546|FG000|Treatment Epoch|technical problems|1
7992813|NCT03369704|12572547|FG001|Treatment Epoch|technical problems|0
7992814|NCT03369704|12572546|FG000|Treatment Epoch|Protocol Violation|1
7992815|NCT03369704|12572547|FG001|Treatment Epoch|Protocol Violation|0
7992816|NCT03369704|12572546|FG000|Treatment Epoch|Lost to Follow-up|0
7992817|NCT03369704|12572547|FG001|Treatment Epoch|Lost to Follow-up|1
7992818|NCT03369704|12572546|FG000|Treatment Epoch|Lack of Efficacy|0
7992819|NCT03369704|12572547|FG001|Treatment Epoch|Lack of Efficacy|2
7992820|NCT03369704|12572546|FG000|Treatment Epoch|Adverse Event|2
7992821|NCT03369704|12572547|FG001|Treatment Epoch|Adverse Event|0
7992822|NCT03369704|12572546|FG000|Follow-up Epoch|Lost to Follow-up|1
7992823|NCT03369704|12572547|FG001|Follow-up Epoch|Lost to Follow-up|0
7992824|NCT03369951|12572557|FG000|Overall Study|Withdrawal by Subject|3
7992825|NCT03369951|12572557|FG000|Overall Study|Death|1
7992826|NCT03369951|12572557|FG000|Overall Study|Lost to Follow-up|1
7992827|NCT03369951|12572557|FG000|Overall Study|Protocol Violation|1
7992828|NCT03370289|12572574|FG000|Overall Study|Screen Failure|1
7992829|NCT03370289|12572574|FG000|Overall Study|Sample Size Sufficient|4
7992830|NCT03370302|12572584|FG000|Dose Escalation Phase|Other|0
7992831|NCT03370302|12572585|FG001|Dose Escalation Phase|Other|1
7992832|NCT03370302|12572586|FG002|Dose Escalation Phase|Other|1
7992833|NCT03370302|12572587|FG003|Dose Escalation Phase|Other|0
7992834|NCT03370302|12572588|FG004|Dose Escalation Phase|Other|0
7992835|NCT03370302|12572589|FG005|Dose Escalation Phase|Other|0
7992836|NCT03370302|12572584|FG000|Dose Escalation Phase|Withdrawal by Subject|0
7992837|NCT03370302|12572585|FG001|Dose Escalation Phase|Withdrawal by Subject|1
7992838|NCT03370302|12572586|FG002|Dose Escalation Phase|Withdrawal by Subject|2
7992839|NCT03370302|12572587|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7992840|NCT03370302|12572588|FG004|Dose Escalation Phase|Withdrawal by Subject|0
7992841|NCT03370302|12572589|FG005|Dose Escalation Phase|Withdrawal by Subject|2
7992842|NCT03370302|12572584|FG000|Dose Escalation Phase|Adverse Event|1
7992843|NCT03370302|12572585|FG001|Dose Escalation Phase|Adverse Event|0
7992844|NCT03370302|12572586|FG002|Dose Escalation Phase|Adverse Event|2
7992845|NCT03370302|12572587|FG003|Dose Escalation Phase|Adverse Event|0
7992846|NCT03370302|12572588|FG004|Dose Escalation Phase|Adverse Event|0
7992847|NCT03370302|12572589|FG005|Dose Escalation Phase|Adverse Event|0
7992848|NCT03370302|12572584|FG000|Dose Escalation Phase|Progressive Disease|2
7992849|NCT03370302|12572585|FG001|Dose Escalation Phase|Progressive Disease|4
7992850|NCT03370302|12572586|FG002|Dose Escalation Phase|Progressive Disease|2
7992851|NCT03370302|12572587|FG003|Dose Escalation Phase|Progressive Disease|0
7992852|NCT03370302|12572588|FG004|Dose Escalation Phase|Progressive Disease|3
7992853|NCT03370302|12572589|FG005|Dose Escalation Phase|Progressive Disease|1
7992854|NCT03370302|12572584|FG000|Dose Expansion Phase|Progressive Disease|0
7992855|NCT03370302|12572585|FG001|Dose Expansion Phase|Progressive Disease|0
7992856|NCT03370302|12572586|FG002|Dose Expansion Phase|Progressive Disease|0
7992857|NCT03370302|12572587|FG003|Dose Expansion Phase|Progressive Disease|6
7992858|NCT03370302|12572588|FG004|Dose Expansion Phase|Progressive Disease|0
7992859|NCT03370302|12572589|FG005|Dose Expansion Phase|Progressive Disease|0
7992860|NCT03370419|12572607|FG000|Overall Study|Lost to Follow-up|16
7992861|NCT03370471|12572613|FG000|Overall Study|Withdrawal by Subject|6
7992862|NCT03370471|12572614|FG001|Overall Study|Withdrawal by Subject|1
7992863|NCT03370471|12572613|FG000|Overall Study|Unable to access veins for blood draw|0
7992864|NCT03370471|12572614|FG001|Overall Study|Unable to access veins for blood draw|1
7992865|NCT03370471|12572613|FG000|Overall Study|Screen fail|1
7992866|NCT03370471|12572614|FG001|Overall Study|Screen fail|0
7992867|NCT03370770|12572622|FG000|Overall Study|Patient was followed in another hospital center|1
7992868|NCT03370770|12572622|FG000|Overall Study|Progressive Disease|98
7992869|NCT03370770|12572622|FG000|Overall Study|Adverse Event|2
7992870|NCT03370770|12572622|FG000|Overall Study|Death|5
7992871|NCT03371355|12572630|FG000|Overall Study|Investigator judgment|0
7992872|NCT03371355|12572631|FG001|Overall Study|Investigator judgment|0
7992873|NCT03371355|12572632|FG002|Overall Study|Investigator judgment|1
7992874|NCT03371355|12572633|FG003|Overall Study|Investigator judgment|1
7992875|NCT03371355|12572630|FG000|Overall Study|Voluntary withdrawal|1
7992876|NCT03371355|12572631|FG001|Overall Study|Voluntary withdrawal|0
7992877|NCT03371355|12572632|FG002|Overall Study|Voluntary withdrawal|1
7992878|NCT03371355|12572633|FG003|Overall Study|Voluntary withdrawal|2
7992879|NCT03371355|12572630|FG000|Overall Study|Adverse Event|0
7992880|NCT03371355|12572631|FG001|Overall Study|Adverse Event|1
7992881|NCT03371355|12572632|FG002|Overall Study|Adverse Event|2
7992882|NCT03371355|12572633|FG003|Overall Study|Adverse Event|3
7992883|NCT03371355|12572630|FG000|Overall Study|Reason not Specified|0
7992884|NCT03371355|12572631|FG001|Overall Study|Reason not Specified|1
7992885|NCT03371355|12572632|FG002|Overall Study|Reason not Specified|0
7992886|NCT03371355|12572633|FG003|Overall Study|Reason not Specified|1
7992887|NCT03371381|12572647|FG000|Overall Study|Death|5
7992888|NCT03371381|12572647|FG000|Overall Study|Study terminated by sponsor|3
7992889|NCT03371381|12572647|FG000|Overall Study|Other|4
7992890|NCT03371459|12572651|FG000|Washout|Lost to Follow-up|0
7992891|NCT03371459|12572652|FG001|Washout|Lost to Follow-up|1
7992892|NCT03371732|12572660|FG000|Overall Study|Withdrawal by Subject|9
7992893|NCT03371732|12572661|FG001|Overall Study|Withdrawal by Subject|3
7992894|NCT03371732|12572660|FG000|Overall Study|Refusal to continue|3
7992895|NCT03371732|12572661|FG001|Overall Study|Refusal to continue|4
7992896|NCT03372083|12572673|FG000|Overall Study|Adverse Event|3
7992897|NCT03372083|12572673|FG000|Overall Study|Physician Decision|1
7992898|NCT03372083|12572673|FG000|Overall Study|Withdrawal by Subject|1
7992899|NCT03372096|12572677|FG000|Overall Study|Study Closed|8
7992900|NCT03372369|12572686|FG000|Qualification Period|Withdrawal by Subject|16
7992901|NCT03372369|12572687|FG001|Qualification Period|Withdrawal by Subject|13
7992902|NCT03372369|12572686|FG000|Qualification Period|Inconsistent Eligibility Results|10
7992903|NCT03372369|12572687|FG001|Qualification Period|Inconsistent Eligibility Results|9
7992904|NCT03372369|12572686|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3
7992905|NCT03372369|12572687|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3
7992906|NCT03372551|12572717|FG000|First Intervention (1 Week)|Withdrawal by Subject|1
7992907|NCT03372551|12572718|FG001|First Intervention (1 Week)|Withdrawal by Subject|0
7992908|NCT03372603|12572731|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1
7992909|NCT03372603|12572732|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0
7992910|NCT03372603|12572731|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1
7992911|NCT03372603|12572732|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0
7992912|NCT03373383|12572769|FG000|Treatment Period: Wk0-16|Adverse Event|7
7992913|NCT03373383|12572770|FG001|Treatment Period: Wk0-16|Adverse Event|6
7992914|NCT03373383|12572771|FG002|Treatment Period: Wk0-16|Adverse Event|11
7992915|NCT03373383|12572772|FG003|Treatment Period: Wk0-16|Adverse Event|15
7992916|NCT03373383|12572773|FG004|Treatment Period: Wk0-16|Adverse Event|21
7992917|NCT03373383|12572769|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2
7992918|NCT03373383|12572770|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1
7992919|NCT03373383|12572771|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0
7992920|NCT03373383|12572772|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0
7992921|NCT03373383|12572773|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0
7992922|NCT03373383|12572769|FG000|Treatment Period: Wk0-16|Protocol Violation|0
7992923|NCT03373383|12572770|FG001|Treatment Period: Wk0-16|Protocol Violation|4
7992924|NCT03373383|12572771|FG002|Treatment Period: Wk0-16|Protocol Violation|2
7992925|NCT03373383|12572772|FG003|Treatment Period: Wk0-16|Protocol Violation|1
7992926|NCT03373383|12572773|FG004|Treatment Period: Wk0-16|Protocol Violation|0
7992927|NCT03373383|12572769|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2
7992928|NCT03373383|12572770|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0
7992929|NCT03373383|12572771|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0
7992930|NCT03373383|12572772|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0
7992931|NCT03373383|12572773|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0
7992932|NCT03373383|12572769|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2
7992933|NCT03373383|12572770|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3
7992934|NCT03373383|12572771|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2
7992935|NCT03373383|12572772|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3
7992936|NCT03373383|12572773|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3
7992937|NCT03373383|12572769|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0
7992938|NCT03373383|12572770|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1
7992939|NCT03373383|12572771|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0
7992940|NCT03373383|12572772|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0
7992941|NCT03373383|12572773|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0
7992942|NCT03373383|12572769|FG000|Treatment Period: Wk0-16|By opinion of investigator|0
7992943|NCT03373383|12572770|FG001|Treatment Period: Wk0-16|By opinion of investigator|0
7992944|NCT03373383|12572771|FG002|Treatment Period: Wk0-16|By opinion of investigator|0
7992945|NCT03373383|12572772|FG003|Treatment Period: Wk0-16|By opinion of investigator|1
7992946|NCT03373383|12572773|FG004|Treatment Period: Wk0-16|By opinion of investigator|0
7992947|NCT03373383|12572769|FG000|Treatment Period: Wk0-16|Sponsor decision|0
7992948|NCT03373383|12572770|FG001|Treatment Period: Wk0-16|Sponsor decision|0
7992949|NCT03373383|12572771|FG002|Treatment Period: Wk0-16|Sponsor decision|0
7992950|NCT03373383|12572772|FG003|Treatment Period: Wk0-16|Sponsor decision|1
7992951|NCT03373383|12572773|FG004|Treatment Period: Wk0-16|Sponsor decision|0
7992952|NCT03373383|12572769|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1
7992953|NCT03373383|12572770|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7992954|NCT03373383|12572771|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7992955|NCT03373383|12572772|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7992956|NCT03373383|12572773|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7992957|NCT03374189|12572835|FG000|Overall Study|Lost to Follow-up|1
7992958|NCT03374189|12572836|FG001|Overall Study|Lost to Follow-up|0
7992959|NCT03374358|12572844|FG000|Overall Study|Withdrawal by Subject|0
7992960|NCT03374358|12572845|FG001|Overall Study|Withdrawal by Subject|2
7992961|NCT03374488|12572853|FG000|Overall Study|Death|13
7992962|NCT03374488|12572854|FG001|Overall Study|Death|13
7992963|NCT03374488|12572853|FG000|Overall Study|Withdrawal by Subject|3
7992964|NCT03374488|12572854|FG001|Overall Study|Withdrawal by Subject|1
7992965|NCT03374488|12572853|FG000|Overall Study|Physician Decision|3
7992966|NCT03374488|12572854|FG001|Overall Study|Physician Decision|0
7992967|NCT03374995|12572876|FG000|Overall Study|Withdrawal by Subject|0
7992968|NCT03374995|12572877|FG001|Overall Study|Withdrawal by Subject|1
7992969|NCT03376321|12572917|FG000|Overall Study|Other|5
7992970|NCT03376321|12572918|FG001|Overall Study|Other|1
7992971|NCT03376321|12572917|FG000|Overall Study|Withdrawal by Subject|8
7992972|NCT03376321|12572918|FG001|Overall Study|Withdrawal by Subject|14
7992973|NCT03376321|12572917|FG000|Overall Study|Lost to Follow-up|1
7992974|NCT03376321|12572918|FG001|Overall Study|Lost to Follow-up|7
7992975|NCT03376321|12572917|FG000|Overall Study|Death|4
7992976|NCT03376321|12572918|FG001|Overall Study|Death|0
7992977|NCT03376321|12572917|FG000|Overall Study|Randomized, not treated|5
7992978|NCT03376321|12572918|FG001|Overall Study|Randomized, not treated|3
7992979|NCT03376516|12572924|FG000|Overall Study|Not treated|1
7992980|NCT03376516|12572924|FG000|Overall Study|Consent withdrawn|1
7992981|NCT03377556|12572961|FG000|Overall Study|Adverse Event|5
7992982|NCT03377556|12572961|FG000|Overall Study|Refusal unrelated to adverse events|1
7992983|NCT03377556|12572961|FG000|Overall Study|Progression/relapse|38
7992984|NCT03377556|12572961|FG000|Overall Study|Death|3
7992985|NCT03377634|12572967|FG000|Study Period|Adverse Event|1
7992986|NCT03377634|12572968|FG001|Study Period|Adverse Event|0
7992987|NCT03377634|12572967|FG000|Study Period|Withdrawal by Subject|1
7992988|NCT03377634|12572968|FG001|Study Period|Withdrawal by Subject|0
7992989|NCT03378635|12572986|FG000|Overall Study|Adverse Event|1
7992990|NCT03378635|12572987|FG001|Overall Study|Adverse Event|0
7992991|NCT03378635|12572988|FG002|Overall Study|Adverse Event|0
7992992|NCT03378635|12572986|FG000|Overall Study|Withdrawal by Subject|1
7992993|NCT03378635|12572987|FG001|Overall Study|Withdrawal by Subject|0
7992994|NCT03378635|12572988|FG002|Overall Study|Withdrawal by Subject|0
7992995|NCT03379259|12573021|FG000|Overall Study|Commenced new anti-cancer therapy|1
7992996|NCT03379259|12573022|FG001|Overall Study|Commenced new anti-cancer therapy|0
7992997|NCT03379259|12573023|FG002|Overall Study|Commenced new anti-cancer therapy|0
7992998|NCT03379259|12573024|FG003|Overall Study|Commenced new anti-cancer therapy|0
7992999|NCT03379259|12573025|FG004|Overall Study|Commenced new anti-cancer therapy|0
7993000|NCT03379259|12573026|FG005|Overall Study|Commenced new anti-cancer therapy|0
7993001|NCT03379259|12573021|FG000|Overall Study|Death|0
7993002|NCT03379259|12573022|FG001|Overall Study|Death|1
7993003|NCT03379259|12573023|FG002|Overall Study|Death|2
7993004|NCT03379259|12573024|FG003|Overall Study|Death|1
7993005|NCT03379259|12573025|FG004|Overall Study|Death|4
7993006|NCT03379259|12573026|FG005|Overall Study|Death|2
7993007|NCT03379259|12573021|FG000|Overall Study|Withdrawal by Subject|0
7993008|NCT03379259|12573022|FG001|Overall Study|Withdrawal by Subject|0
7993009|NCT03379259|12573023|FG002|Overall Study|Withdrawal by Subject|1
7993010|NCT03379259|12573024|FG003|Overall Study|Withdrawal by Subject|0
7993011|NCT03379259|12573025|FG004|Overall Study|Withdrawal by Subject|2
7993012|NCT03379259|12573026|FG005|Overall Study|Withdrawal by Subject|0
7993013|NCT03379259|12573021|FG000|Overall Study|Study terminated by sponsor|0
7993014|NCT03379259|12573022|FG001|Overall Study|Study terminated by sponsor|0
7993015|NCT03379259|12573023|FG002|Overall Study|Study terminated by sponsor|0
7993016|NCT03379259|12573024|FG003|Overall Study|Study terminated by sponsor|1
7993017|NCT03379259|12573025|FG004|Overall Study|Study terminated by sponsor|1
7993018|NCT03379259|12573026|FG005|Overall Study|Study terminated by sponsor|4
7993019|NCT03379259|12573021|FG000|Overall Study|Disease progression|0
7993020|NCT03379259|12573022|FG001|Overall Study|Disease progression|0
7993021|NCT03379259|12573023|FG002|Overall Study|Disease progression|0
7993022|NCT03379259|12573024|FG003|Overall Study|Disease progression|1
7993023|NCT03379259|12573025|FG004|Overall Study|Disease progression|0
7993024|NCT03379259|12573026|FG005|Overall Study|Disease progression|1
7993025|NCT03379259|12573021|FG000|Overall Study|Lost to Follow-up|0
7993026|NCT03379259|12573022|FG001|Overall Study|Lost to Follow-up|0
7993027|NCT03379259|12573023|FG002|Overall Study|Lost to Follow-up|0
7993028|NCT03379259|12573024|FG003|Overall Study|Lost to Follow-up|0
7993029|NCT03379259|12573025|FG004|Overall Study|Lost to Follow-up|1
7993030|NCT03379259|12573026|FG005|Overall Study|Lost to Follow-up|0
7993031|NCT03379259|12573021|FG000|Overall Study|Deteriorating condition|0
7993032|NCT03379259|12573022|FG001|Overall Study|Deteriorating condition|0
7993033|NCT03379259|12573023|FG002|Overall Study|Deteriorating condition|0
7993034|NCT03379259|12573024|FG003|Overall Study|Deteriorating condition|0
7993035|NCT03379259|12573025|FG004|Overall Study|Deteriorating condition|1
7993036|NCT03379259|12573026|FG005|Overall Study|Deteriorating condition|0
7993037|NCT03379376|12573043|FG000|Overall Study|Lost to Follow-up|2
7993038|NCT03379376|12573043|FG000|Overall Study|Did not wish to complete follow up|1
7993039|NCT03379376|12573043|FG000|Overall Study|Overwhelmed, didn't want to continue|1
7993040|NCT03379376|12573043|FG000|Overall Study|Death|1
7993041|NCT03379753|12573096|FG000|Overall Study|Withdrawal by Subject|2
7993042|NCT03379753|12573097|FG001|Overall Study|Withdrawal by Subject|1
7993043|NCT03379753|12573096|FG000|Overall Study|not having correct procedure|1
7993044|NCT03379753|12573097|FG001|Overall Study|not having correct procedure|2
7993045|NCT03379753|12573096|FG000|Overall Study|No primary outcome|12
7993046|NCT03379753|12573097|FG001|Overall Study|No primary outcome|22
7993047|NCT03380091|12573112|FG000|Overall Study|Withdrawal by Subject|2
7993048|NCT03380091|12573113|FG001|Overall Study|Withdrawal by Subject|1
7993049|NCT03380390|12573121|FG000|Overall Study|Adverse Event|3
7993050|NCT03380429|12573130|FG000|Overall Study|Physician Decision|0
7993051|NCT03380429|12573131|FG001|Overall Study|Physician Decision|1
7993052|NCT03380429|12573132|FG002|Overall Study|Physician Decision|0
7993053|NCT03380429|12573133|FG003|Overall Study|Physician Decision|1
7993054|NCT03380429|12573134|FG004|Overall Study|Physician Decision|1
7993055|NCT03380429|12573130|FG000|Overall Study|Withdrawal by Subject|3
7993056|NCT03380429|12573131|FG001|Overall Study|Withdrawal by Subject|3
7993057|NCT03380429|12573132|FG002|Overall Study|Withdrawal by Subject|5
7993058|NCT03380429|12573133|FG003|Overall Study|Withdrawal by Subject|2
7993059|NCT03380429|12573134|FG004|Overall Study|Withdrawal by Subject|1
7993060|NCT03380429|12573130|FG000|Overall Study|Lost to Follow-up|0
7993061|NCT03380429|12573131|FG001|Overall Study|Lost to Follow-up|2
7993062|NCT03380429|12573132|FG002|Overall Study|Lost to Follow-up|4
7993063|NCT03380429|12573133|FG003|Overall Study|Lost to Follow-up|3
7993064|NCT03380429|12573134|FG004|Overall Study|Lost to Follow-up|1
7993065|NCT03380429|12573130|FG000|Overall Study|Protocol Violation|1
7993066|NCT03380429|12573131|FG001|Overall Study|Protocol Violation|0
7993067|NCT03380429|12573132|FG002|Overall Study|Protocol Violation|1
7993068|NCT03380429|12573133|FG003|Overall Study|Protocol Violation|0
7993069|NCT03380429|12573134|FG004|Overall Study|Protocol Violation|1
7993070|NCT03380429|12573130|FG000|Overall Study|Lack of Efficacy|0
7993071|NCT03380429|12573131|FG001|Overall Study|Lack of Efficacy|0
7993072|NCT03380429|12573132|FG002|Overall Study|Lack of Efficacy|0
7993073|NCT03380429|12573133|FG003|Overall Study|Lack of Efficacy|2
7993074|NCT03380429|12573134|FG004|Overall Study|Lack of Efficacy|1
7993075|NCT03380429|12573130|FG000|Overall Study|Adverse Event|1
7993076|NCT03380429|12573131|FG001|Overall Study|Adverse Event|1
7993077|NCT03380429|12573132|FG002|Overall Study|Adverse Event|1
7993078|NCT03380429|12573133|FG003|Overall Study|Adverse Event|2
7993079|NCT03380429|12573134|FG004|Overall Study|Adverse Event|0
7993080|NCT03381196|12573179|FG000|Overall Study|Withdrawal by Subject|7
7993081|NCT03381196|12573180|FG001|Overall Study|Withdrawal by Subject|7
7993082|NCT03381196|12573179|FG000|Overall Study|Other|0
7993083|NCT03381196|12573180|FG001|Overall Study|Other|1
7993084|NCT03381196|12573179|FG000|Overall Study|Lost to Follow-up|5
7993085|NCT03381196|12573180|FG001|Overall Study|Lost to Follow-up|4
7993086|NCT03381196|12573179|FG000|Overall Study|Death|0
7993087|NCT03381196|12573180|FG001|Overall Study|Death|1
7993088|NCT03381196|12573179|FG000|Overall Study|Adverse Event|1
7993089|NCT03381196|12573180|FG001|Overall Study|Adverse Event|0
7993090|NCT03381196|12573179|FG000|Overall Study|Randomized, not treated|3
7993091|NCT03381196|12573180|FG001|Overall Study|Randomized, not treated|6
7993092|NCT03381248|12573188|FG000|Overall Study|Withdrawal by Subject|5
7993093|NCT03381248|12573189|FG001|Overall Study|Withdrawal by Subject|3
7993094|NCT03381248|12573188|FG000|Overall Study|Lost to Follow-up|3
7993095|NCT03381248|12573189|FG001|Overall Study|Lost to Follow-up|2
7993096|NCT03381248|12573188|FG000|Overall Study|Lack of Efficacy|1
7993097|NCT03381248|12573189|FG001|Overall Study|Lack of Efficacy|0
7993098|NCT03381248|12573188|FG000|Overall Study|Adverse Event|2
7993099|NCT03381248|12573189|FG001|Overall Study|Adverse Event|0
7993100|NCT03381248|12573188|FG000|Overall Study|Protocol Violation|2
7993101|NCT03381248|12573189|FG001|Overall Study|Protocol Violation|1
7993102|NCT03381339|12573197|FG000|Overall Study|Protocol Violation|4
7993103|NCT03381339|12573198|FG001|Overall Study|Protocol Violation|3
7993104|NCT03381339|12573197|FG000|Overall Study|Lost to Follow-up|0
7993105|NCT03381339|12573198|FG001|Overall Study|Lost to Follow-up|1
7993106|NCT03382262|12573230|FG000|Overall Study|Physician Decision|0
7993107|NCT03382262|12573231|FG001|Overall Study|Physician Decision|0
7993108|NCT03382262|12573232|FG002|Overall Study|Physician Decision|1
7993109|NCT03382262|12573233|FG003|Overall Study|Physician Decision|0
7993110|NCT03382262|12573230|FG000|Overall Study|Withdrawal by Subject|0
7993111|NCT03382262|12573231|FG001|Overall Study|Withdrawal by Subject|0
7993112|NCT03382262|12573232|FG002|Overall Study|Withdrawal by Subject|0
7993113|NCT03382262|12573233|FG003|Overall Study|Withdrawal by Subject|1
7993114|NCT03382418|12573246|FG000|Overall Study|Withdrawal by Subject|1
7993115|NCT03382418|12573247|FG001|Overall Study|Withdrawal by Subject|0
7993116|NCT03382418|12573248|FG002|Overall Study|Withdrawal by Subject|0
7993117|NCT03382418|12573246|FG000|Overall Study|Lost to Follow-up|2
7993118|NCT03382418|12573247|FG001|Overall Study|Lost to Follow-up|3
7993119|NCT03382418|12573248|FG002|Overall Study|Lost to Follow-up|0
7993120|NCT03382821|12573277|FG000|Overall Study|Did not receive allocated intervention.|0
7993121|NCT03382821|12573278|FG001|Overall Study|Did not receive allocated intervention.|3
7993122|NCT03382899|12573291|FG000|Overall Study|Ineligibility Determined|0
7993123|NCT03382899|12573292|FG001|Overall Study|Ineligibility Determined|1
7993124|NCT03382899|12573291|FG000|Overall Study|Lost to Follow-up|0
7993125|NCT03382899|12573292|FG001|Overall Study|Lost to Follow-up|1
7993126|NCT03382899|12573291|FG000|Overall Study|Sponsor's decision|31
7993127|NCT03382899|12573292|FG001|Overall Study|Sponsor's decision|28
7993128|NCT03382899|12573291|FG000|Overall Study|Withdrawal by Subject|0
7993129|NCT03382899|12573292|FG001|Overall Study|Withdrawal by Subject|5
7993130|NCT03382912|12573300|FG000|Overall Study|Physician Decision|0
7993131|NCT03382912|12573301|FG001|Overall Study|Physician Decision|1
7993132|NCT03382912|12573300|FG000|Overall Study|Sponsor Decision|6
7993133|NCT03382912|12573301|FG001|Overall Study|Sponsor Decision|6
7993134|NCT03382912|12573300|FG000|Overall Study|Withdrawal by Subject|0
7993135|NCT03382912|12573301|FG001|Overall Study|Withdrawal by Subject|5
7993136|NCT03383146|12573309|FG000|Overall Study|Screen Failure|1
7993137|NCT03383146|12573310|FG001|Overall Study|Screen Failure|0
7993138|NCT03383146|12573309|FG000|Overall Study|Adverse Event|6
7993139|NCT03383146|12573310|FG001|Overall Study|Adverse Event|18
7993140|NCT03383146|12573309|FG000|Overall Study|Lack of Efficacy|0
7993141|NCT03383146|12573310|FG001|Overall Study|Lack of Efficacy|3
7993142|NCT03383146|12573309|FG000|Overall Study|Withdrawal by Subject|20
7993143|NCT03383146|12573310|FG001|Overall Study|Withdrawal by Subject|36
7993144|NCT03383146|12573309|FG000|Overall Study|Lost to Follow-up|5
7993145|NCT03383146|12573310|FG001|Overall Study|Lost to Follow-up|15
7993146|NCT03383146|12573309|FG000|Overall Study|Death|0
7993147|NCT03383146|12573310|FG001|Overall Study|Death|2
7993148|NCT03383146|12573309|FG000|Overall Study|Physician Decision|0
7993149|NCT03383146|12573310|FG001|Overall Study|Physician Decision|1
7993150|NCT03383146|12573309|FG000|Overall Study|Protocol Deviation|1
7993151|NCT03383146|12573310|FG001|Overall Study|Protocol Deviation|8
7993152|NCT03383146|12573309|FG000|Overall Study|Study Terminated by the Sponsor|48
7993153|NCT03383146|12573310|FG001|Overall Study|Study Terminated by the Sponsor|95
7993154|NCT03383146|12573309|FG000|Overall Study|Reason not Specified|4
7993155|NCT03383146|12573310|FG001|Overall Study|Reason not Specified|6
7993156|NCT03383614|12573372|FG000|Overall Study|Withdrawal by Subject|0
7993157|NCT03383614|12573373|FG001|Overall Study|Withdrawal by Subject|1
7993158|NCT03383614|12573374|FG002|Overall Study|Withdrawal by Subject|0
7993159|NCT03383614|12573375|FG003|Overall Study|Withdrawal by Subject|0
7993160|NCT03383783|12573398|FG000|Overall Study|Withdrawal by Subject|2
7993161|NCT03383887|12573414|FG000|Overall Study|Lost to Follow-up|0
7993162|NCT03383887|12573415|FG001|Overall Study|Lost to Follow-up|1
7993163|NCT03384316|12573435|FG000|Overall Study|Screen failure|0
7993164|NCT03384316|12573436|FG001|Overall Study|Screen failure|1
7993165|NCT03384693|12573453|FG000|Overall Study|Adverse Event|3
7993166|NCT03384745|12573463|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
7993167|NCT03384745|12573464|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
7993168|NCT03384745|12573465|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1
7993169|NCT03384745|12573466|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2
7993170|NCT03384745|12573467|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
7993171|NCT03384745|12573468|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
7993172|NCT03384745|12573463|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7993173|NCT03384745|12573464|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7993174|NCT03384745|12573465|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7993175|NCT03384745|12573466|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7993176|NCT03384745|12573467|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3
7993177|NCT03384745|12573468|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1
7993178|NCT03384745|12573463|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
7993179|NCT03384745|12573464|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
7993180|NCT03384745|12573465|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
7993181|NCT03384745|12573466|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
7993182|NCT03384745|12573467|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
7993183|NCT03384745|12573468|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
7993184|NCT03384745|12573463|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7993185|NCT03384745|12573464|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7993186|NCT03384745|12573465|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1
7993187|NCT03384745|12573466|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7993188|NCT03384745|12573467|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7993189|NCT03384745|12573468|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7993190|NCT03384745|12573463|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0
7993191|NCT03384745|12573464|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0
7993192|NCT03384745|12573465|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0
7993193|NCT03384745|12573466|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1
7993194|NCT03384745|12573467|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1
7993195|NCT03384745|12573468|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0
7993196|NCT03384745|12573463|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7993197|NCT03384745|12573464|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7993198|NCT03384745|12573465|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7993199|NCT03384745|12573466|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7993200|NCT03384745|12573467|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1
7993201|NCT03384745|12573468|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7993202|NCT03384745|12573463|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7993203|NCT03384745|12573464|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7718227|NCT00526110|12142069|FG000|Overall Study|Poor Tolerance|0
7993204|NCT03384745|12573465|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1
7993205|NCT03384745|12573466|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1
7993206|NCT03384745|12573467|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7993207|NCT03384745|12573468|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7993208|NCT03384745|12573463|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
7993209|NCT03384745|12573464|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
7993210|NCT03384745|12573465|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3
7993211|NCT03384745|12573466|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0
7993212|NCT03384745|12573467|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
7993213|NCT03384745|12573468|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0
7993214|NCT03384745|12573463|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0
7993215|NCT03384745|12573464|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1
7993216|NCT03384745|12573465|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1
7993217|NCT03384745|12573466|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2
7993218|NCT03384745|12573467|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0
7993219|NCT03384745|12573468|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2
7993220|NCT03384745|12573463|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7993221|NCT03384745|12573464|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7993222|NCT03384745|12573465|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7993223|NCT03384745|12573466|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2
7993224|NCT03384745|12573467|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7993225|NCT03384745|12573468|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7993226|NCT03384745|12573463|FG000|Response Assess/Dose Hold (W24-W48)|Death|0
7993227|NCT03384745|12573464|FG001|Response Assess/Dose Hold (W24-W48)|Death|1
7993228|NCT03384745|12573465|FG002|Response Assess/Dose Hold (W24-W48)|Death|0
7993229|NCT03384745|12573466|FG003|Response Assess/Dose Hold (W24-W48)|Death|0
7993230|NCT03384745|12573467|FG004|Response Assess/Dose Hold (W24-W48)|Death|0
7993231|NCT03384745|12573468|FG005|Response Assess/Dose Hold (W24-W48)|Death|0
7993232|NCT03384940|12573491|FG000|Overall Study|Progressive disease|36
7993233|NCT03384940|12573492|FG001|Overall Study|Progressive disease|11
7993234|NCT03384940|12573493|FG002|Overall Study|Progressive disease|13
7993235|NCT03384940|12573491|FG000|Overall Study|Clinical progression|4
7993236|NCT03384940|12573492|FG001|Overall Study|Clinical progression|0
7993237|NCT03384940|12573493|FG002|Overall Study|Clinical progression|3
7993238|NCT03384940|12573491|FG000|Overall Study|Adverse Event|7
7993239|NCT03384940|12573492|FG001|Overall Study|Adverse Event|1
7993240|NCT03384940|12573493|FG002|Overall Study|Adverse Event|1
7993241|NCT03384940|12573491|FG000|Overall Study|Withdrawal by Subject|3
7993242|NCT03384940|12573492|FG001|Overall Study|Withdrawal by Subject|1
7993243|NCT03384940|12573493|FG002|Overall Study|Withdrawal by Subject|0
7993244|NCT03384940|12573491|FG000|Overall Study|Physician Decision|1
7993245|NCT03384940|12573492|FG001|Overall Study|Physician Decision|1
7993246|NCT03384940|12573493|FG002|Overall Study|Physician Decision|0
7993247|NCT03384940|12573491|FG000|Overall Study|Death|2
7993248|NCT03384940|12573492|FG001|Overall Study|Death|1
7993249|NCT03384940|12573493|FG002|Overall Study|Death|0
7993250|NCT03384940|12573491|FG000|Overall Study|Other|0
7993251|NCT03384940|12573492|FG001|Overall Study|Other|0
7993252|NCT03384940|12573493|FG002|Overall Study|Other|1
7993253|NCT03384966|12573513|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1
7993254|NCT03384966|12573514|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0
7993255|NCT03384966|12573515|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0
7993256|NCT03384966|12573513|FG000|Follow-up Period|Adverse Event|1
7993257|NCT03384966|12573514|FG001|Follow-up Period|Adverse Event|0
7993258|NCT03384966|12573515|FG002|Follow-up Period|Adverse Event|0
7993259|NCT03386032|12573535|FG000|Overall Study|Lack of Efficacy|6
7993260|NCT03386032|12573536|FG001|Overall Study|Lack of Efficacy|2
7993261|NCT03386032|12573537|FG002|Overall Study|Lack of Efficacy|0
7993262|NCT03386032|12573535|FG000|Overall Study|Adverse Event|2
7993263|NCT03386032|12573536|FG001|Overall Study|Adverse Event|2
7993264|NCT03386032|12573537|FG002|Overall Study|Adverse Event|0
7993265|NCT03386032|12573535|FG000|Overall Study|Withdrawal by Subject|1
7993266|NCT03386032|12573536|FG001|Overall Study|Withdrawal by Subject|0
7993267|NCT03386032|12573537|FG002|Overall Study|Withdrawal by Subject|0
7993268|NCT03386032|12573535|FG000|Overall Study|Lost to Follow-up|9
7993269|NCT03386032|12573536|FG001|Overall Study|Lost to Follow-up|3
7993270|NCT03386032|12573537|FG002|Overall Study|Lost to Follow-up|0
7993271|NCT03386344|12573557|FG000|Overall Study|Adverse Event|6
7993272|NCT03386344|12573558|FG001|Overall Study|Adverse Event|3
7993273|NCT03386344|12573559|FG002|Overall Study|Adverse Event|1
7993274|NCT03386344|12573557|FG000|Overall Study|Poor Compliance to Protocol|0
7993275|NCT03386344|12573558|FG001|Overall Study|Poor Compliance to Protocol|1
7993276|NCT03386344|12573559|FG002|Overall Study|Poor Compliance to Protocol|0
7993277|NCT03386344|12573557|FG000|Overall Study|Study Terminated by Sponsor|101
7993278|NCT03386344|12573558|FG001|Overall Study|Study Terminated by Sponsor|102
7993279|NCT03386344|12573559|FG002|Overall Study|Study Terminated by Sponsor|106
7993280|NCT03386344|12573557|FG000|Overall Study|Lost to Follow-up|3
7993281|NCT03386344|12573558|FG001|Overall Study|Lost to Follow-up|2
7993282|NCT03386344|12573559|FG002|Overall Study|Lost to Follow-up|1
7993283|NCT03386344|12573557|FG000|Overall Study|At the Participant's own Request|7
7993284|NCT03386344|12573558|FG001|Overall Study|At the Participant's own Request|7
7993285|NCT03386344|12573559|FG002|Overall Study|At the Participant's own Request|8
7993286|NCT03386344|12573557|FG000|Overall Study|Reason not Specified|0
7993287|NCT03386344|12573558|FG001|Overall Study|Reason not Specified|1
7993288|NCT03386344|12573559|FG002|Overall Study|Reason not Specified|0
7993289|NCT03386435|12573569|FG000|Overall Study|Protocol Violation|5
7993290|NCT03386435|12573570|FG001|Overall Study|Protocol Violation|7
7993291|NCT03386448|12573578|FG000|Overall Study|Adverse Event|0
7993292|NCT03386448|12573579|FG001|Overall Study|Adverse Event|2
7993293|NCT03386474|12573587|FG000|Overall Study|Death|1
7993294|NCT03386474|12573588|FG001|Overall Study|Death|0
7993295|NCT03386474|12573587|FG000|Overall Study|Adverse Event|0
7993296|NCT03386474|12573588|FG001|Overall Study|Adverse Event|1
7993297|NCT03386994|12573602|FG000|Overall Study|Lung transplant|1
7993298|NCT03386994|12573602|FG000|Overall Study|Adverse Event|14
7993299|NCT03386994|12573602|FG000|Overall Study|Lost to Follow-up|4
7993300|NCT03386994|12573602|FG000|Overall Study|Withdrawal by Subject|3
7993301|NCT03386994|12573602|FG000|Overall Study|Death|16
7993302|NCT03387020|12573620|FG000|Overall Study|Adverse Event|0
7993303|NCT03387020|12573621|FG001|Overall Study|Adverse Event|2
7993304|NCT03387020|12573622|FG002|Overall Study|Adverse Event|0
7993305|NCT03387020|12573620|FG000|Overall Study|Withdrawal by Subject|2
7993306|NCT03387020|12573621|FG001|Overall Study|Withdrawal by Subject|0
7993307|NCT03387020|12573622|FG002|Overall Study|Withdrawal by Subject|0
7993308|NCT03387046|12573646|FG000|Overall Study|Adverse Event|1
7993309|NCT03387046|12573647|FG001|Overall Study|Adverse Event|1
7993310|NCT03387462|12573667|FG000|Overall Study|Lost to Follow-up|1
7993311|NCT03387683|12573673|FG000|Overall Study|In receipt of disallowed medication|1
7993312|NCT03387683|12573674|FG001|Overall Study|In receipt of disallowed medication|0
7993313|NCT03387683|12573673|FG000|Overall Study|Did not receive treatment|1
7993314|NCT03387683|12573674|FG001|Overall Study|Did not receive treatment|0
7993315|NCT03388164|12573682|FG000|Overall Study|Withdrawal by Subject|3
7993316|NCT03388164|12573683|FG001|Overall Study|Withdrawal by Subject|1
7993317|NCT03389308|12573716|FG000|Overall Study|Withdrawal by Subject|5
7993318|NCT03389308|12573716|FG000|Overall Study|Lost to Follow-up|3
7993319|NCT03389308|12573716|FG000|Overall Study|Adverse Event|2
7993320|NCT03389308|12573716|FG000|Overall Study|Sponsor Request|2
7993321|NCT03389555|12573722|FG000|Overall Study|Protocol Violation|1
7993322|NCT03389555|12573723|FG001|Overall Study|Protocol Violation|3
7993323|NCT03389555|12573722|FG000|Overall Study|Death|1
7993324|NCT03389555|12573723|FG001|Overall Study|Death|0
7993325|NCT03389893|12573752|FG000|Randomized Double Blind Period|Withdrawal by Subject|1
7993326|NCT03389893|12573753|FG001|Randomized Double Blind Period|Withdrawal by Subject|0
7993327|NCT03389893|12573754|FG002|Randomized Double Blind Period|Withdrawal by Subject|0
7993328|NCT03389893|12573755|FG003|Randomized Double Blind Period|Withdrawal by Subject|0
7993329|NCT03389893|12573752|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0
7993330|NCT03389893|12573753|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0
7993331|NCT03389893|12573754|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2
7993332|NCT03389893|12573755|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1
7993333|NCT03389893|12573752|FG000|Open Label Extension and Follow-Up|Physician Decision|0
7993334|NCT03389893|12573753|FG001|Open Label Extension and Follow-Up|Physician Decision|0
7993335|NCT03389893|12573754|FG002|Open Label Extension and Follow-Up|Physician Decision|1
7993336|NCT03389893|12573755|FG003|Open Label Extension and Follow-Up|Physician Decision|0
7993337|NCT03389893|12573752|FG000|Open Label Extension and Follow-Up|Participant Moved|0
7993338|NCT03389893|12573753|FG001|Open Label Extension and Follow-Up|Participant Moved|0
7993339|NCT03389893|12573754|FG002|Open Label Extension and Follow-Up|Participant Moved|1
7993340|NCT03389893|12573755|FG003|Open Label Extension and Follow-Up|Participant Moved|0
7993341|NCT03390166|12573772|FG000|Overall Study|Death|0
7993342|NCT03390166|12573773|FG001|Overall Study|Death|1
7993343|NCT03390166|12573772|FG000|Overall Study|Lost to Follow-up|6
7993344|NCT03390166|12573773|FG001|Overall Study|Lost to Follow-up|4
7993345|NCT03390166|12573772|FG000|Overall Study|Physician Decision|2
7993346|NCT03390166|12573773|FG001|Overall Study|Physician Decision|1
7993347|NCT03390166|12573772|FG000|Overall Study|Move from study area|3
7993348|NCT03390166|12573773|FG001|Overall Study|Move from study area|2
7993349|NCT03390166|12573772|FG000|Overall Study|To militarycamp for conscript|1
7993350|NCT03390166|12573773|FG001|Overall Study|To militarycamp for conscript|0
7993351|NCT03390166|12573772|FG000|Overall Study|To drug therapy course|0
7993352|NCT03390166|12573773|FG001|Overall Study|To drug therapy course|1
7993353|NCT03390166|12573772|FG000|Overall Study|Move to work oversea|0
7993354|NCT03390166|12573773|FG001|Overall Study|Move to work oversea|1
7993355|NCT03390426|12573787|FG000|Overall Study|Protocol Violation|0
7993356|NCT03390426|12573788|FG001|Overall Study|Protocol Violation|1
7993357|NCT03391765|12573821|FG000|Overall Study|Adverse Event|2
7993358|NCT03391765|12573822|FG001|Overall Study|Adverse Event|0
7993359|NCT03391765|12573823|FG002|Overall Study|Adverse Event|0
7993360|NCT03391765|12573824|FG003|Overall Study|Adverse Event|2
7993361|NCT03391765|12573821|FG000|Overall Study|Withdrew consent|5
7993362|NCT03391765|12573822|FG001|Overall Study|Withdrew consent|7
7993363|NCT03391765|12573823|FG002|Overall Study|Withdrew consent|2
7993364|NCT03391765|12573824|FG003|Overall Study|Withdrew consent|5
7993365|NCT03391765|12573821|FG000|Overall Study|Other, not specified|44
7993366|NCT03391765|12573822|FG001|Overall Study|Other, not specified|38
7993367|NCT03391765|12573823|FG002|Overall Study|Other, not specified|21
7993368|NCT03391765|12573824|FG003|Overall Study|Other, not specified|16
7993369|NCT03392194|12573849|FG000|Overall Study|Withdrawal by Subject|1
7993370|NCT03392194|12573850|FG001|Overall Study|Withdrawal by Subject|2
7993371|NCT03392194|12573849|FG000|Overall Study|Conflicts with personal schedule|1
7993372|NCT03392194|12573850|FG001|Overall Study|Conflicts with personal schedule|0
7993373|NCT03393000|12573867|FG000|Overall Study|Death|11
7993374|NCT03393000|12573867|FG000|Overall Study|Withdrawal by Subject|2
7993375|NCT03393000|12573867|FG000|Overall Study|Physician Decision|1
7993376|NCT03393806|12573914|FG000|Overall Study|Physician Decision|1
7993377|NCT03393806|12573915|FG001|Overall Study|Physician Decision|0
7993378|NCT03394391|12573924|FG000|Overall Study|Lost to Follow-up|1
7993379|NCT03394391|12573925|FG001|Overall Study|Lost to Follow-up|2
7993380|NCT03394508|12573933|FG000|Overall Study|Protocol Violation|0
7993381|NCT03394508|12573934|FG001|Overall Study|Protocol Violation|3
7993382|NCT03394508|12573933|FG000|Overall Study|Lost to Follow-up|1
7993383|NCT03394508|12573934|FG001|Overall Study|Lost to Follow-up|0
7993384|NCT03394885|12573948|FG000|Overall Study|Adverse Event|4
7993385|NCT03394885|12573948|FG000|Overall Study|Lack of Efficacy|1
7993386|NCT03394885|12573948|FG000|Overall Study|Physician Decision|1
7993387|NCT03394885|12573948|FG000|Overall Study|Withdrawal by Subject|8
7993388|NCT03394885|12573948|FG000|Overall Study|Alternative Therapy|1
7993389|NCT03394924|12573955|FG000|Overall Study|Adverse Event|0
7993390|NCT03394924|12573956|FG001|Overall Study|Adverse Event|5
7993391|NCT03394924|12573957|FG002|Overall Study|Adverse Event|0
7993392|NCT03394924|12573955|FG000|Overall Study|Withdrawal by Subject|2
7993393|NCT03394924|12573956|FG001|Overall Study|Withdrawal by Subject|0
7993394|NCT03394924|12573957|FG002|Overall Study|Withdrawal by Subject|0
7993395|NCT03394924|12573955|FG000|Overall Study|Lost to Follow-up|0
7993396|NCT03394924|12573956|FG001|Overall Study|Lost to Follow-up|1
7993397|NCT03394924|12573957|FG002|Overall Study|Lost to Follow-up|0
7993398|NCT03394924|12573955|FG000|Overall Study|Did not meet all inclusion criteria|1
7993399|NCT03394924|12573956|FG001|Overall Study|Did not meet all inclusion criteria|0
7993400|NCT03394924|12573957|FG002|Overall Study|Did not meet all inclusion criteria|0
7993401|NCT03395353|12573967|FG000|Overall Study|Adverse Event|20
7993402|NCT03395353|12573967|FG000|Overall Study|Protocol Violation|1
7993403|NCT03395353|12573967|FG000|Overall Study|Lack of Efficacy|3
7993404|NCT03395353|12573967|FG000|Overall Study|Withdrawal by Subject|24
7993405|NCT03395353|12573967|FG000|Overall Study|Discontinued visit|1
7993406|NCT03395353|12573967|FG000|Overall Study|Refrain from visit due to COVID-19|1
7993407|NCT03395353|12573967|FG000|Overall Study|Physician Decision|4
7993408|NCT03395353|12573967|FG000|Overall Study|Early termination of overall study|33
7993409|NCT03396835|12574008|FG000|Overall Study|Withdrawn prior to completion|1
7993410|NCT03396835|12574008|FG000|Overall Study|Did not meet criteria for data analysis|1
7993411|NCT03396913|12574014|FG000|Overall Study|Lost to Follow-up|0
7993412|NCT03396913|12574015|FG001|Overall Study|Lost to Follow-up|6
7993413|NCT03397771|12574048|FG000|Overall Study|2 erroneously randomized, never treated|3
7993414|NCT03397771|12574049|FG001|Overall Study|2 erroneously randomized, never treated|1
7993415|NCT03397771|12574048|FG000|Overall Study|Withdrawal by Subject|1
7993416|NCT03397771|12574049|FG001|Overall Study|Withdrawal by Subject|3
7993417|NCT03397771|12574048|FG000|Overall Study|Protocol Violation|2
7993418|NCT03397771|12574049|FG001|Overall Study|Protocol Violation|2
7993419|NCT03397771|12574048|FG000|Overall Study|Adverse Event|2
7993420|NCT03397771|12574049|FG001|Overall Study|Adverse Event|1
7993421|NCT03399786|12574171|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1
7993422|NCT03399786|12574172|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
7993423|NCT03399786|12574173|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
7993424|NCT03399786|12574174|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
7993425|NCT03399786|12574171|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
7993426|NCT03399786|12574172|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
7993427|NCT03399786|12574173|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1
7993428|NCT03399786|12574174|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
7993429|NCT03399786|12574171|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0
7993430|NCT03399786|12574172|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0
7993431|NCT03399786|12574173|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0
7993432|NCT03399786|12574174|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1
7993433|NCT03400033|12574184|FG000|Overall Study|Withdrawal by Subject|1
7993434|NCT03400033|12574185|FG001|Overall Study|Withdrawal by Subject|2
7993435|NCT03400787|12574240|FG000|Overall Study|Lost to Follow-up|1
7993436|NCT03400787|12574241|FG001|Overall Study|Lost to Follow-up|0
7993437|NCT03400787|12574240|FG000|Overall Study|Death|1
7993438|NCT03400787|12574241|FG001|Overall Study|Death|0
7993439|NCT03400787|12574240|FG000|Overall Study|Protocol Violation|0
7993440|NCT03400787|12574241|FG001|Overall Study|Protocol Violation|2
7993441|NCT03400787|12574240|FG000|Overall Study|Unblinded before 3-month follow-upa-|0
7993442|NCT03400787|12574241|FG001|Overall Study|Unblinded before 3-month follow-upa-|6
7993443|NCT03400852|12574258|FG000|Blinded Treatment Period|Physician Decision|0
7993444|NCT03400852|12574259|FG001|Blinded Treatment Period|Physician Decision|1
7993445|NCT03400852|12574260|FG002|Blinded Treatment Period|Physician Decision|0
7993446|NCT03400852|12574258|FG000|Blinded Treatment Period|Adverse Event|1
7993447|NCT03400852|12574259|FG001|Blinded Treatment Period|Adverse Event|1
7993448|NCT03400852|12574260|FG002|Blinded Treatment Period|Adverse Event|0
7993449|NCT03400852|12574258|FG000|Blinded Treatment Period|Study terminated by sponsor|8
7993450|NCT03400852|12574259|FG001|Blinded Treatment Period|Study terminated by sponsor|4
7993451|NCT03400852|12574260|FG002|Blinded Treatment Period|Study terminated by sponsor|0
7993452|NCT03400852|12574258|FG000|Open Label Period|Physician Decision|0
7993453|NCT03400852|12574259|FG001|Open Label Period|Physician Decision|0
7993454|NCT03400852|12574260|FG002|Open Label Period|Physician Decision|1
7993455|NCT03400852|12574258|FG000|Open Label Period|Study terminated by sponsor|0
7993456|NCT03400852|12574259|FG001|Open Label Period|Study terminated by sponsor|0
7993457|NCT03400852|12574260|FG002|Open Label Period|Study terminated by sponsor|21
7993458|NCT03401229|12574270|FG000|Overall Study|Lost to Follow-up|2
7993459|NCT03401229|12574271|FG001|Overall Study|Lost to Follow-up|1
7993460|NCT03401229|12574270|FG000|Overall Study|Other|1
7993461|NCT03401229|12574271|FG001|Overall Study|Other|3
7993462|NCT03401229|12574270|FG000|Overall Study|Adverse Event|8
7993463|NCT03401229|12574271|FG001|Overall Study|Adverse Event|6
7993464|NCT03401229|12574270|FG000|Overall Study|Withdrawal by Subject|29
7993465|NCT03401229|12574271|FG001|Overall Study|Withdrawal by Subject|26
7993466|NCT03401229|12574270|FG000|Overall Study|COVID-19|0
7993467|NCT03401229|12574271|FG001|Overall Study|COVID-19|1
7993468|NCT03401450|12574279|FG000|Overall Study|Lost to Follow-up|4
7993469|NCT03401450|12574280|FG001|Overall Study|Lost to Follow-up|6
7993470|NCT03401450|12574279|FG000|Overall Study|Anesthesia plan changed|2
7993471|NCT03401450|12574280|FG001|Overall Study|Anesthesia plan changed|2
7993472|NCT03401450|12574279|FG000|Overall Study|Did not complete medication diary|4
7993473|NCT03401450|12574280|FG001|Overall Study|Did not complete medication diary|2
7993474|NCT03401450|12574279|FG000|Overall Study|post surgery medication change|2
7993475|NCT03401450|12574280|FG001|Overall Study|post surgery medication change|1
7993476|NCT03401450|12574279|FG000|Overall Study|Cancelled surgery|0
7993477|NCT03401450|12574280|FG001|Overall Study|Cancelled surgery|2
7993478|NCT03402126|12574295|FG000|Overall Study|Lost to Follow-up|6
7993479|NCT03402126|12574295|FG000|Overall Study|Protocol Violation|10
7993480|NCT03402126|12574295|FG000|Overall Study|Sponsor request/Study termination|29
7993481|NCT03402126|12574295|FG000|Overall Study|Study product no longer in use|1
7993482|NCT03402126|12574295|FG000|Overall Study|Technical problems|1
7993483|NCT03402126|12574295|FG000|Overall Study|Withdrawal by Subject|6
7993484|NCT03402126|12574295|FG000|Overall Study|Physician Decision|2
7993485|NCT03402126|12574295|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3
7993486|NCT03402126|12574295|FG000|Overall Study|Death|4
7993487|NCT03402386|12574312|FG000|Overall Study|Adverse Event|3
7993488|NCT03402386|12574312|FG000|Overall Study|Physician Decision|1
7993489|NCT03402386|12574312|FG000|Overall Study|Difficult to control Hb|2
7993490|NCT03402750|12574331|FG000|Overall Study|Lost to Follow-up|2
7993491|NCT03402750|12574332|FG001|Overall Study|Lost to Follow-up|1
7993492|NCT03402893|12574338|FG000|Overall Study|Withdrawal by Subject|1
7993493|NCT03403036|12574364|FG000|Overall Study|Lack of Efficacy|5
7993494|NCT03403192|12574372|FG000|Overall Study|Lost to Follow-up|1
7993495|NCT03403192|12574373|FG001|Overall Study|Lost to Follow-up|2
7993496|NCT03403192|12574374|FG002|Overall Study|Lost to Follow-up|0
7993497|NCT03403192|12574375|FG003|Overall Study|Lost to Follow-up|0
7993498|NCT03403192|12574372|FG000|Overall Study|Unable to respond|0
7993499|NCT03403192|12574373|FG001|Overall Study|Unable to respond|1
7993500|NCT03403192|12574374|FG002|Overall Study|Unable to respond|0
7993501|NCT03403192|12574375|FG003|Overall Study|Unable to respond|0
7993502|NCT03403192|12574372|FG000|Overall Study|Incomplete|3
7993503|NCT03403192|12574373|FG001|Overall Study|Incomplete|1
7993504|NCT03403192|12574374|FG002|Overall Study|Incomplete|3
7993505|NCT03403192|12574375|FG003|Overall Study|Incomplete|6
7993506|NCT03403374|12574450|FG000|Overall Study|Lost to Follow-up|1
7993507|NCT03403400|12574457|FG000|Overall Study|Lost to Follow-up|1
7993508|NCT03403400|12574458|FG001|Overall Study|Lost to Follow-up|0
7993509|NCT03403400|12574459|FG002|Overall Study|Lost to Follow-up|1
7993510|NCT03403400|12574457|FG000|Overall Study|Hospitalization|1
7993511|NCT03403400|12574458|FG001|Overall Study|Hospitalization|0
7993512|NCT03403400|12574459|FG002|Overall Study|Hospitalization|0
7993513|NCT03403400|12574457|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0
7993514|NCT03403400|12574458|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0
7993515|NCT03403400|12574459|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1
7993516|NCT03403413|12574482|FG000|Overall Study|Lack of Efficacy|2
7993517|NCT03403426|12574488|FG000|Overall Study|Death|1
7993518|NCT03403426|12574488|FG000|Overall Study|Lost to Follow-up|2
7993519|NCT03403751|12574590|FG000|Overall Study|Death|5
7993520|NCT03403751|12574591|FG001|Overall Study|Death|6
7993521|NCT03403751|12574590|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2
7993522|NCT03403751|12574591|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2
7993523|NCT03404206|12574608|FG000|Overall Study|Withdrawal by Subject|1
7993524|NCT03404206|12574609|FG001|Overall Study|Withdrawal by Subject|1
7993525|NCT03404206|12574610|FG002|Overall Study|Withdrawal by Subject|0
7993526|NCT03404206|12574608|FG000|Overall Study|Lost to Follow-up|3
7993527|NCT03404206|12574609|FG001|Overall Study|Lost to Follow-up|1
7993528|NCT03404206|12574610|FG002|Overall Study|Lost to Follow-up|0
7993529|NCT03404674|12574655|FG000|Overall Study|Inability to Attend Future Visits|0
7993530|NCT03404674|12574656|FG001|Overall Study|Inability to Attend Future Visits|1
7993531|NCT03404674|12574657|FG002|Overall Study|Inability to Attend Future Visits|1
7993532|NCT03404674|12574658|FG003|Overall Study|Inability to Attend Future Visits|0
7993533|NCT03404674|12574659|FG004|Overall Study|Inability to Attend Future Visits|0
7993534|NCT03404674|12574660|FG005|Overall Study|Inability to Attend Future Visits|0
7993535|NCT03404674|12574655|FG000|Overall Study|Behavioral Problems|0
7993536|NCT03404674|12574656|FG001|Overall Study|Behavioral Problems|0
7993537|NCT03404674|12574657|FG002|Overall Study|Behavioral Problems|1
7993538|NCT03404674|12574658|FG003|Overall Study|Behavioral Problems|0
7993539|NCT03404674|12574659|FG004|Overall Study|Behavioral Problems|0
7993540|NCT03404674|12574660|FG005|Overall Study|Behavioral Problems|0
7993541|NCT03404674|12574655|FG000|Overall Study|Started a Medication that Precluded Eligibility|0
7993542|NCT03404674|12574656|FG001|Overall Study|Started a Medication that Precluded Eligibility|0
7993543|NCT03404674|12574657|FG002|Overall Study|Started a Medication that Precluded Eligibility|0
7993544|NCT03404674|12574658|FG003|Overall Study|Started a Medication that Precluded Eligibility|1
7993545|NCT03404674|12574659|FG004|Overall Study|Started a Medication that Precluded Eligibility|0
7993546|NCT03404674|12574660|FG005|Overall Study|Started a Medication that Precluded Eligibility|1
7993547|NCT03404843|12574677|FG000|Overall Study|Study difficulties unrelated to Tx|4
7993548|NCT03404843|12574678|FG001|Overall Study|Study difficulties unrelated to Tx|1
7993549|NCT03405818|12574706|FG000|Overall Study|Withdrawal by Subject|4
7993550|NCT03405818|12574706|FG000|Overall Study|Lost to Follow-up|4
7993551|NCT03405935|12574710|FG000|Overall Study|Adverse Event|3
7993552|NCT03405935|12574710|FG000|Overall Study|Death|2
7993553|NCT03405935|12574710|FG000|Overall Study|Withdrawal by Subject|1
7993554|NCT03405935|12574710|FG000|Overall Study|Lost to Follow-up|2
7993555|NCT03406260|12574720|FG000|Period 1|Adverse Event|0
7993556|NCT03406260|12574721|FG001|Period 1|Adverse Event|0
7993557|NCT03406260|12574722|FG002|Period 1|Adverse Event|0
7993558|NCT03406260|12574723|FG003|Period 1|Adverse Event|0
7993559|NCT03406260|12574724|FG004|Period 1|Adverse Event|1
7993560|NCT03406260|12574725|FG005|Period 1|Adverse Event|0
7993561|NCT03406962|12574791|FG000|Overall Study|Death|2
7993562|NCT03406962|12574791|FG000|Overall Study|Adverse Event|1
7993563|NCT03407118|12574805|FG000|Period 2|Withdrawal by Subject|1
7993564|NCT03407118|12574806|FG001|Period 2|Withdrawal by Subject|0
7993565|NCT03407170|12574812|FG000|Overall Study|Adverse Event|1
7993566|NCT03407430|12574822|FG000|Washout|Protocol Violation|1
7993567|NCT03407430|12574823|FG001|Washout|Protocol Violation|0
7993568|NCT03407482|12574836|FG000|Overall Study|Adverse Event|12
7993569|NCT03407482|12574836|FG000|Overall Study|Disease Relapse|1
7993570|NCT03407482|12574836|FG000|Overall Study|Lost to Follow-up|1
7993571|NCT03407482|12574836|FG000|Overall Study|Non-Compliance With Study Drug|1
7993572|NCT03407482|12574836|FG000|Overall Study|Pregnancy|2
7993573|NCT03407482|12574836|FG000|Overall Study|Protocol Violation|1
7993574|NCT03407482|12574836|FG000|Overall Study|Study Terminated By Sponsor|106
7993575|NCT03407482|12574836|FG000|Overall Study|Withdrawal by Subject|6
7993576|NCT03407482|12574836|FG000|Overall Study|Data Entry Error|1
7993577|NCT03408483|12574896|FG000|Overall Study|Physician Decision|3
7993578|NCT03408483|12574897|FG001|Overall Study|Physician Decision|3
7993579|NCT03408483|12574896|FG000|Overall Study|Lost to Follow-up|3
7993580|NCT03408483|12574897|FG001|Overall Study|Lost to Follow-up|0
7993581|NCT03408639|12574905|FG000|Overall Study|Death|5
7993582|NCT03408639|12574906|FG001|Overall Study|Death|5
7993583|NCT03408639|12574905|FG000|Overall Study|Lost to Follow-up|1
7993584|NCT03408639|12574906|FG001|Overall Study|Lost to Follow-up|4
7993585|NCT03408639|12574905|FG000|Overall Study|Withdrawal by Subject|2
7993586|NCT03408639|12574906|FG001|Overall Study|Withdrawal by Subject|7
7993587|NCT03408639|12574905|FG000|Overall Study|Physician Decision|3
7993588|NCT03408639|12574906|FG001|Overall Study|Physician Decision|6
7993589|NCT03409107|12574944|FG000|Overall Study|Withdrawal by Subject|4
7993590|NCT03409107|12574945|FG001|Overall Study|Withdrawal by Subject|2
7993591|NCT03409107|12574944|FG000|Overall Study|Physician Decision|1
7993592|NCT03409107|12574945|FG001|Overall Study|Physician Decision|0
7993593|NCT03409107|12574944|FG000|Overall Study|Lost to Follow-up|7
7993594|NCT03409107|12574945|FG001|Overall Study|Lost to Follow-up|2
7993595|NCT03409107|12574944|FG000|Overall Study|Adverse Event|5
7993596|NCT03409107|12574945|FG001|Overall Study|Adverse Event|3
7993597|NCT03410056|12574955|FG000|Overall Study|Decision by Sponsor|0
7993598|NCT03410056|12574956|FG001|Overall Study|Decision by Sponsor|0
7993599|NCT03410056|12574957|FG002|Overall Study|Decision by Sponsor|3
7993600|NCT03410056|12574958|FG003|Overall Study|Decision by Sponsor|0
7993601|NCT03410056|12574959|FG004|Overall Study|Decision by Sponsor|0
7993602|NCT03410056|12574960|FG005|Overall Study|Decision by Sponsor|0
7993603|NCT03410056|12574961|FG006|Overall Study|Decision by Sponsor|0
7993604|NCT03410056|12574955|FG000|Overall Study|Withdrawal by Subject|0
7993605|NCT03410056|12574956|FG001|Overall Study|Withdrawal by Subject|2
7993606|NCT03410056|12574957|FG002|Overall Study|Withdrawal by Subject|5
7993607|NCT03410056|12574958|FG003|Overall Study|Withdrawal by Subject|5
7993608|NCT03410056|12574959|FG004|Overall Study|Withdrawal by Subject|0
7993609|NCT03410056|12574960|FG005|Overall Study|Withdrawal by Subject|0
7993610|NCT03410056|12574961|FG006|Overall Study|Withdrawal by Subject|0
7993611|NCT03411902|12575005|FG000|Overall Study|Lost to Follow-up|3
7993612|NCT03411902|12575006|FG001|Overall Study|Lost to Follow-up|0
7993613|NCT03412019|12575014|FG000|Overall Study|Withdrawal by Subject|1
7993614|NCT03412019|12575015|FG001|Overall Study|Withdrawal by Subject|1
7993615|NCT03412084|12575023|FG000|Overall Study|Withdrawal by Subject|2
7993616|NCT03412084|12575024|FG001|Overall Study|Withdrawal by Subject|0
7993617|NCT03412084|12575023|FG000|Overall Study|Participant moved|1
7993618|NCT03412084|12575024|FG001|Overall Study|Participant moved|0
7993619|NCT03412084|12575023|FG000|Overall Study|Lost to Follow-up|1
7993620|NCT03412084|12575024|FG001|Overall Study|Lost to Follow-up|1
7993621|NCT03412734|12575032|FG000|Overall Study|Incorrect labeling of samples|2
7993622|NCT03412734|12575033|FG001|Overall Study|Incorrect labeling of samples|0
7993623|NCT03412734|12575032|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1
7993624|NCT03412734|12575033|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0
7993625|NCT03412929|12575039|FG000|Overall Study|Protocol Violation|3
7993626|NCT03414359|12575054|FG000|Overall Study|Lack of Efficacy|1
7993627|NCT03414359|12575055|FG001|Overall Study|Lack of Efficacy|1
7993628|NCT03414359|12575054|FG000|Overall Study|Protocol Violation|0
7993629|NCT03414359|12575055|FG001|Overall Study|Protocol Violation|1
7993630|NCT03415178|12575070|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0
7993631|NCT03415178|12575071|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2
7993632|NCT03415178|12575070|FG000|Single Arm Period (up to Week 16)|Adverse Event|0
7993633|NCT03415178|12575071|FG001|Single Arm Period (up to Week 16)|Adverse Event|1
7993634|NCT03416127|12575104|FG000|Overall Study|Withdrawal by Subject|0
7993635|NCT03416127|12575105|FG001|Overall Study|Withdrawal by Subject|1
7993636|NCT03416127|12575106|FG002|Overall Study|Withdrawal by Subject|1
7993637|NCT03417024|12575155|FG000|Overall Study|Study Termination prior to follow-up|11
7993638|NCT03417024|12575155|FG000|Overall Study|Physician Decision|2
7993639|NCT03417141|12575159|FG000|Overall Study|Withdrawal by Subject|1
7993640|NCT03417141|12575159|FG000|Overall Study|Protocol Violation|3
7993641|NCT03417219|12575165|FG000|Overall Study|Lost to Follow-up|0
7993642|NCT03417219|12575166|FG001|Overall Study|Lost to Follow-up|3
7993643|NCT03417505|12575176|FG000|First Lens Type (30 Days)|Lost to Follow-up|1
7993644|NCT03417505|12575177|FG001|First Lens Type (30 Days)|Lost to Follow-up|1
7993645|NCT03417830|12575227|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1
7993646|NCT03417830|12575228|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0
7993647|NCT03418324|12575265|FG000|Overall Study|Death|0
7993648|NCT03418324|12575266|FG001|Overall Study|Death|1
7993649|NCT03418324|12575265|FG000|Overall Study|Physician Decision|1
7993650|NCT03418324|12575266|FG001|Overall Study|Physician Decision|1
7993651|NCT03418376|12575276|FG000|Overall Study|Musculoskeletal injury|1
7993652|NCT03418376|12575277|FG001|Overall Study|Musculoskeletal injury|2
7993653|NCT03418376|12575278|FG002|Overall Study|Musculoskeletal injury|1
7993654|NCT03418376|12575279|FG003|Overall Study|Musculoskeletal injury|0
7993655|NCT03418376|12575276|FG000|Overall Study|Personal reasons|0
7993656|NCT03418376|12575277|FG001|Overall Study|Personal reasons|2
7993657|NCT03418376|12575278|FG002|Overall Study|Personal reasons|2
7993658|NCT03418376|12575279|FG003|Overall Study|Personal reasons|1
7993659|NCT03418376|12575276|FG000|Overall Study|Exacerbation|0
7993660|NCT03418376|12575277|FG001|Overall Study|Exacerbation|1
7993661|NCT03418376|12575278|FG002|Overall Study|Exacerbation|0
7993662|NCT03418376|12575279|FG003|Overall Study|Exacerbation|0
7993663|NCT03418545|12575291|FG000|Overall Study|Withdrawal by Participant|2
7993664|NCT03418545|12575292|FG001|Overall Study|Withdrawal by Participant|4
7993665|NCT03418545|12575291|FG000|Overall Study|Lost to Follow-up|3
7993666|NCT03418545|12575292|FG001|Overall Study|Lost to Follow-up|5
7993667|NCT03418545|12575291|FG000|Overall Study|Reason Not Specified|0
7993668|NCT03418545|12575292|FG001|Overall Study|Reason Not Specified|1
7993669|NCT03418545|12575291|FG000|Overall Study|Missing Completion Status|0
7993670|NCT03418545|12575292|FG001|Overall Study|Missing Completion Status|1
7993671|NCT03418571|12575303|FG000|Overall Study|Consent withdrawn by legal guardian|1
7993672|NCT03418571|12575304|FG001|Overall Study|Consent withdrawn by legal guardian|0
7993673|NCT03419403|12575339|FG000|Overall Study|Withdrawal by Subject|5
7993674|NCT03419403|12575340|FG001|Overall Study|Withdrawal by Subject|2
7993675|NCT03419403|12575341|FG002|Overall Study|Withdrawal by Subject|5
7993676|NCT03419403|12575342|FG003|Overall Study|Withdrawal by Subject|1
7993677|NCT03419403|12575339|FG000|Overall Study|Progressive disease (per protocol)|0
7993678|NCT03419403|12575340|FG001|Overall Study|Progressive disease (per protocol)|2
7993679|NCT03419403|12575341|FG002|Overall Study|Progressive disease (per protocol)|2
7993680|NCT03419403|12575342|FG003|Overall Study|Progressive disease (per protocol)|0
7993681|NCT03419403|12575339|FG000|Overall Study|Other, not specified|6
7993682|NCT03419403|12575340|FG001|Overall Study|Other, not specified|4
7993683|NCT03419403|12575341|FG002|Overall Study|Other, not specified|5
7993684|NCT03419403|12575342|FG003|Overall Study|Other, not specified|1
7993685|NCT03419403|12575339|FG000|Overall Study|Left study due to COVID-19 restrictions|1
7993686|NCT03419403|12575340|FG001|Overall Study|Left study due to COVID-19 restrictions|1
7993687|NCT03419403|12575341|FG002|Overall Study|Left study due to COVID-19 restrictions|0
7993688|NCT03419403|12575342|FG003|Overall Study|Left study due to COVID-19 restrictions|0
7993689|NCT03419598|12575367|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2
7993690|NCT03419962|12575382|FG000|Overall Study|Change to other medication|1
7993691|NCT03419962|12575382|FG000|Overall Study|Refusal of continuing with trial drug|1
7993692|NCT03419962|12575382|FG000|Overall Study|Lost to Follow-up|3
7993693|NCT03419962|12575382|FG000|Overall Study|Difficulty in inhaling the doses|1
7993694|NCT03419962|12575382|FG000|Overall Study|Missing completion data|31
7993695|NCT03420300|12575386|FG000|Overall Study|Death|2
7993696|NCT03421379|12575412|FG000|Period 1|Withdrawal by Subject|0
7993697|NCT03421379|12575413|FG001|Period 1|Withdrawal by Subject|1
7993698|NCT03421379|12575412|FG000|Period 1|Physician Decision|1
7993699|NCT03421379|12575413|FG001|Period 1|Physician Decision|1
7993700|NCT03421379|12575412|FG000|Period 1|Did not receive treatment|1
7993701|NCT03421379|12575413|FG001|Period 1|Did not receive treatment|2
7993702|NCT03421431|12575422|FG000|Overall Study|Adverse Event|2
7993703|NCT03421431|12575423|FG001|Overall Study|Adverse Event|1
7993704|NCT03421431|12575424|FG002|Overall Study|Adverse Event|12
7993705|NCT03421431|12575422|FG000|Overall Study|Lost to Follow-up|1
7993706|NCT03421431|12575423|FG001|Overall Study|Lost to Follow-up|1
7993707|NCT03421431|12575424|FG002|Overall Study|Lost to Follow-up|1
7993708|NCT03421431|12575422|FG000|Overall Study|Withdrawal by Subject|3
7993709|NCT03421431|12575423|FG001|Overall Study|Withdrawal by Subject|2
7993710|NCT03421431|12575424|FG002|Overall Study|Withdrawal by Subject|1
7993711|NCT03421431|12575422|FG000|Overall Study|Protocol Violation|0
7993712|NCT03421431|12575423|FG001|Overall Study|Protocol Violation|1
7993713|NCT03421431|12575424|FG002|Overall Study|Protocol Violation|0
7993714|NCT03421431|12575422|FG000|Overall Study|Participant met Stopping Rules|0
7993715|NCT03421431|12575423|FG001|Overall Study|Participant met Stopping Rules|1
7993716|NCT03421431|12575424|FG002|Overall Study|Participant met Stopping Rules|0
7993717|NCT03421730|12575434|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7993718|NCT03421730|12575435|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2
7993719|NCT03421730|12575436|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7993720|NCT03421730|12575437|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7993721|NCT03421730|12575438|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7993722|NCT03421730|12575439|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7993723|NCT03421730|12575440|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7993724|NCT03421730|12575441|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7993725|NCT03421730|12575442|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7993726|NCT03421730|12575443|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7993727|NCT03421730|12575444|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7993728|NCT03421730|12575445|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7993729|NCT03421730|12575434|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7993730|NCT03421730|12575435|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7993731|NCT03421730|12575436|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7993732|NCT03421730|12575437|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7993733|NCT03421730|12575438|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2
7993734|NCT03421730|12575439|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7993735|NCT03421730|12575440|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7993736|NCT03421730|12575441|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7993737|NCT03421730|12575442|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7993738|NCT03421730|12575443|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7993739|NCT03421730|12575444|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7993740|NCT03421730|12575445|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7993741|NCT03422159|12575470|FG000|Overall Study|Exclusion due to terminal disease|2
7993742|NCT03422159|12575471|FG001|Overall Study|Exclusion due to terminal disease|1
7993743|NCT03422172|12575479|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1
7993744|NCT03422172|12575479|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1
7993745|NCT03422172|12575479|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3
7993746|NCT03422250|12575492|FG000|Intervention|Adverse Event|0
7993747|NCT03422250|12575493|FG001|Intervention|Adverse Event|1
7993748|NCT03422250|12575494|FG002|Intervention|Adverse Event|0
7993749|NCT03422250|12575495|FG003|Intervention|Adverse Event|1
7993750|NCT03422250|12575492|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1
7993751|NCT03422250|12575493|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0
7993752|NCT03422250|12575494|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2
7993753|NCT03422250|12575495|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0
7993754|NCT03422250|12575492|FG000|Follow-up|Withdrawal by Subject|0
7993755|NCT03422250|12575493|FG001|Follow-up|Withdrawal by Subject|0
7993756|NCT03422250|12575494|FG002|Follow-up|Withdrawal by Subject|0
7993757|NCT03422250|12575495|FG003|Follow-up|Withdrawal by Subject|1
7993758|NCT03422250|12575492|FG000|Follow-up|Adverse Event|0
7993759|NCT03422250|12575493|FG001|Follow-up|Adverse Event|0
7993760|NCT03422250|12575494|FG002|Follow-up|Adverse Event|0
7993761|NCT03422250|12575495|FG003|Follow-up|Adverse Event|1
7993762|NCT03423173|12575515|FG000|Overall Study|Randomized but not vaccinated|1
7993763|NCT03423173|12575516|FG001|Overall Study|Randomized but not vaccinated|0
7993764|NCT03423173|12575517|FG002|Overall Study|Randomized but not vaccinated|2
7993765|NCT03423173|12575518|FG003|Overall Study|Randomized but not vaccinated|1
7993766|NCT03423173|12575515|FG000|Overall Study|Adverse Event|1
7993767|NCT03423173|12575516|FG001|Overall Study|Adverse Event|1
7993768|NCT03423173|12575517|FG002|Overall Study|Adverse Event|1
7993769|NCT03423173|12575518|FG003|Overall Study|Adverse Event|1
7993770|NCT03423173|12575515|FG000|Overall Study|Lost to Follow-up|10
7993771|NCT03423173|12575516|FG001|Overall Study|Lost to Follow-up|19
7993772|NCT03423173|12575517|FG002|Overall Study|Lost to Follow-up|17
7993773|NCT03423173|12575518|FG003|Overall Study|Lost to Follow-up|22
7993774|NCT03423173|12575515|FG000|Overall Study|Withdrawal of consent|4
7993775|NCT03423173|12575516|FG001|Overall Study|Withdrawal of consent|10
7993776|NCT03423173|12575517|FG002|Overall Study|Withdrawal of consent|4
7993777|NCT03423173|12575518|FG003|Overall Study|Withdrawal of consent|5
7993778|NCT03423173|12575515|FG000|Overall Study|Death|1
7993779|NCT03423173|12575516|FG001|Overall Study|Death|0
7993780|NCT03423173|12575517|FG002|Overall Study|Death|0
7993781|NCT03423173|12575518|FG003|Overall Study|Death|0
7993782|NCT03423173|12575515|FG000|Overall Study|Reason not Specified|2
7993783|NCT03423173|12575516|FG001|Overall Study|Reason not Specified|5
7993784|NCT03423173|12575517|FG002|Overall Study|Reason not Specified|3
7993785|NCT03423173|12575518|FG003|Overall Study|Reason not Specified|1
7993786|NCT03423238|12575539|FG000|Overall Study|Lost to Follow-up|1
7993787|NCT03423238|12575540|FG001|Overall Study|Lost to Follow-up|0
7993788|NCT03423238|12575539|FG000|Overall Study|Withdrawal by Subject|1
7993789|NCT03423238|12575540|FG001|Overall Study|Withdrawal by Subject|0
7993790|NCT03424044|12575556|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7993791|NCT03424044|12575557|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7993792|NCT03424044|12575558|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1
7993793|NCT03424044|12575559|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7993794|NCT03424044|12575560|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7993795|NCT03424044|12575561|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7993796|NCT03424044|12575562|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7993797|NCT03424044|12575563|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7993798|NCT03424044|12575564|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7993799|NCT03424044|12575556|FG000|First Intervention (76 Hours)|Adverse Event|0
7993800|NCT03424044|12575557|FG001|First Intervention (76 Hours)|Adverse Event|0
7993801|NCT03424044|12575558|FG002|First Intervention (76 Hours)|Adverse Event|0
7993802|NCT03424044|12575559|FG003|First Intervention (76 Hours)|Adverse Event|0
7993803|NCT03424044|12575560|FG004|First Intervention (76 Hours)|Adverse Event|1
7993804|NCT03424044|12575561|FG005|First Intervention (76 Hours)|Adverse Event|0
7993805|NCT03424044|12575562|FG006|First Intervention (76 Hours)|Adverse Event|0
7993806|NCT03424044|12575563|FG007|First Intervention (76 Hours)|Adverse Event|0
7993807|NCT03424044|12575564|FG008|First Intervention (76 Hours)|Adverse Event|0
7993808|NCT03424044|12575556|FG000|First Intervention (76 Hours)|device issues|0
7993809|NCT03424044|12575557|FG001|First Intervention (76 Hours)|device issues|0
7993810|NCT03424044|12575558|FG002|First Intervention (76 Hours)|device issues|0
7993811|NCT03424044|12575559|FG003|First Intervention (76 Hours)|device issues|0
7993812|NCT03424044|12575560|FG004|First Intervention (76 Hours)|device issues|0
7993813|NCT03424044|12575561|FG005|First Intervention (76 Hours)|device issues|0
7993814|NCT03424044|12575562|FG006|First Intervention (76 Hours)|device issues|1
7993815|NCT03424044|12575563|FG007|First Intervention (76 Hours)|device issues|1
7993816|NCT03424044|12575564|FG008|First Intervention (76 Hours)|device issues|1
7993817|NCT03424044|12575556|FG000|Third Intervention (76 Hours)|Adverse Event|1
7993818|NCT03424044|12575557|FG001|Third Intervention (76 Hours)|Adverse Event|0
7993819|NCT03424044|12575558|FG002|Third Intervention (76 Hours)|Adverse Event|0
7993820|NCT03424044|12575559|FG003|Third Intervention (76 Hours)|Adverse Event|0
7993821|NCT03424044|12575560|FG004|Third Intervention (76 Hours)|Adverse Event|0
7993822|NCT03424044|12575561|FG005|Third Intervention (76 Hours)|Adverse Event|0
7993823|NCT03424044|12575562|FG006|Third Intervention (76 Hours)|Adverse Event|1
7993824|NCT03424044|12575563|FG007|Third Intervention (76 Hours)|Adverse Event|0
7993825|NCT03424044|12575564|FG008|Third Intervention (76 Hours)|Adverse Event|0
7993826|NCT03424044|12575556|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0
7993827|NCT03424044|12575557|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0
7993828|NCT03424044|12575558|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0
7993829|NCT03424044|12575559|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1
7993830|NCT03424044|12575560|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0
7993831|NCT03424044|12575561|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0
7993832|NCT03424044|12575562|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0
7993833|NCT03424044|12575563|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0
7993834|NCT03424044|12575564|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0
7993835|NCT03424239|12575598|FG000|Overall Study|Withdrawal by Subject|2
7993836|NCT03424265|12575604|FG000|Overall Study|screening failure|1
7993837|NCT03424265|12575605|FG001|Overall Study|screening failure|0
7993838|NCT03424265|12575604|FG000|Overall Study|Withdrawal by Subject|0
7993839|NCT03424265|12575605|FG001|Overall Study|Withdrawal by Subject|2
7993840|NCT03425188|12575635|FG000|Overall Study|Withdrawal by Subject|1
7993841|NCT03425253|12575640|FG000|Overall Study|Adverse Event|2
7993842|NCT03425253|12575640|FG000|Overall Study|Lost to Follow-up|3
7993843|NCT03425253|12575640|FG000|Overall Study|Withdrew Consent|6
7993844|NCT03425253|12575640|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5
7993845|NCT03425396|12575650|FG000|Overall Study|Lost to Follow-up|2
7993846|NCT03425396|12575651|FG001|Overall Study|Lost to Follow-up|5
7993847|NCT03425396|12575652|FG002|Overall Study|Lost to Follow-up|2
7993848|NCT03425396|12575653|FG003|Overall Study|Lost to Follow-up|0
7993849|NCT03425396|12575654|FG004|Overall Study|Lost to Follow-up|0
7993850|NCT03425396|12575650|FG000|Overall Study|Withdrawal by Subject|0
7993851|NCT03425396|12575651|FG001|Overall Study|Withdrawal by Subject|1
7993852|NCT03425396|12575652|FG002|Overall Study|Withdrawal by Subject|0
7993853|NCT03425396|12575653|FG003|Overall Study|Withdrawal by Subject|1
7993854|NCT03425396|12575654|FG004|Overall Study|Withdrawal by Subject|0
7993855|NCT03425396|12575650|FG000|Overall Study|Other|0
7993856|NCT03425396|12575651|FG001|Overall Study|Other|1
7993857|NCT03425396|12575652|FG002|Overall Study|Other|1
7993858|NCT03425396|12575653|FG003|Overall Study|Other|0
7993859|NCT03425396|12575654|FG004|Overall Study|Other|1
7993860|NCT03426267|12575679|FG000|Overall Study|Physician Decision|1
7993861|NCT03426267|12575680|FG001|Overall Study|Physician Decision|4
7993862|NCT03426267|12575679|FG000|Overall Study|Lost to Follow-up|1
7993863|NCT03426267|12575680|FG001|Overall Study|Lost to Follow-up|0
7993864|NCT03426267|12575679|FG000|Overall Study|Withdrawal by Subject|4
7993865|NCT03426267|12575680|FG001|Overall Study|Withdrawal by Subject|10
7993866|NCT03426267|12575679|FG000|Overall Study|Protocol Violation|1
7993867|NCT03426267|12575680|FG001|Overall Study|Protocol Violation|3
7993868|NCT03426267|12575679|FG000|Overall Study|Adverse Event|9
7993869|NCT03426267|12575680|FG001|Overall Study|Adverse Event|27
7993870|NCT03426267|12575679|FG000|Overall Study|Prohibited Treatment Intake|2
7993871|NCT03426267|12575680|FG001|Overall Study|Prohibited Treatment Intake|3
7993872|NCT03426267|12575679|FG000|Overall Study|Lack of Efficacy|0
7993873|NCT03426267|12575680|FG001|Overall Study|Lack of Efficacy|25
7993874|NCT03426267|12575679|FG000|Overall Study|other|3
7993875|NCT03426267|12575680|FG001|Overall Study|other|0
7993876|NCT03426345|12575688|FG000|Overall Study|Adverse Event|4
7993877|NCT03426345|12575689|FG001|Overall Study|Adverse Event|4
7993878|NCT03426345|12575688|FG000|Overall Study|Lack of Efficacy|1
7993879|NCT03426345|12575689|FG001|Overall Study|Lack of Efficacy|0
7993880|NCT03426345|12575688|FG000|Overall Study|Withdrawal by Subject|5
7993881|NCT03426345|12575689|FG001|Overall Study|Withdrawal by Subject|6
7993882|NCT03426345|12575688|FG000|Overall Study|Lost to Follow-up|3
7993883|NCT03426345|12575689|FG001|Overall Study|Lost to Follow-up|1
7993884|NCT03426345|12575688|FG000|Overall Study|Protocol Deviation|3
7993885|NCT03426345|12575689|FG001|Overall Study|Protocol Deviation|4
7993886|NCT03426345|12575688|FG000|Overall Study|Reason Not Specified|1
7993887|NCT03426345|12575689|FG001|Overall Study|Reason Not Specified|2
7993888|NCT03426345|12575688|FG000|Overall Study|Missing Completion Status|1
7993889|NCT03426345|12575689|FG001|Overall Study|Missing Completion Status|0
7993890|NCT03426436|12575696|FG000|Overall Study|Incorrect lead placement|12
7993891|NCT03426436|12575696|FG000|Overall Study|Withdrawal by Subject|2
7993892|NCT03426436|12575696|FG000|Overall Study|Consent issue|1
7993893|NCT03426436|12575696|FG000|Overall Study|ECGs not saved|4
7993894|NCT03426631|12575700|FG000|Overall Study|Lost to Follow-up|0
7993895|NCT03426631|12575701|FG001|Overall Study|Lost to Follow-up|1
7993896|NCT03426787|12575707|FG000|Overall Study|Withdrawal by Subject|6
7993897|NCT03426787|12575707|FG000|Overall Study|Lost to Follow-up|7
7993898|NCT03426787|12575707|FG000|Overall Study|Unrelated to intervention death|1
7993899|NCT03426995|12575736|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993900|NCT03426995|12575737|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993901|NCT03426995|12575738|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1
7993902|NCT03426995|12575739|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993903|NCT03426995|12575740|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993904|NCT03426995|12575741|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993905|NCT03426995|12575742|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993906|NCT03426995|12575743|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993907|NCT03426995|12575744|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993908|NCT03426995|12575745|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993909|NCT03426995|12575746|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993910|NCT03426995|12575747|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993911|NCT03426995|12575748|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993912|NCT03426995|12575749|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993913|NCT03426995|12575750|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993914|NCT03426995|12575751|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993915|NCT03426995|12575752|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993916|NCT03426995|12575753|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993917|NCT03426995|12575754|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7993918|NCT03426995|12575736|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993919|NCT03426995|12575737|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993920|NCT03426995|12575738|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993921|NCT03426995|12575739|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993922|NCT03426995|12575740|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993923|NCT03426995|12575741|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1
7993924|NCT03426995|12575742|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993925|NCT03426995|12575743|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993926|NCT03426995|12575744|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993927|NCT03426995|12575745|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993928|NCT03426995|12575746|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993929|NCT03426995|12575747|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993930|NCT03426995|12575748|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993931|NCT03426995|12575749|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993932|NCT03426995|12575750|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993933|NCT03426995|12575751|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993934|NCT03426995|12575752|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993935|NCT03426995|12575753|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993936|NCT03426995|12575754|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7993937|NCT03426995|12575736|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993938|NCT03426995|12575737|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993939|NCT03426995|12575738|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993940|NCT03426995|12575739|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993941|NCT03426995|12575740|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
7993942|NCT03426995|12575741|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
7993943|NCT03426995|12575742|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993944|NCT03426995|12575743|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993945|NCT03426995|12575744|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993946|NCT03426995|12575745|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993947|NCT03426995|12575746|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993948|NCT03426995|12575747|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993949|NCT03426995|12575748|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993950|NCT03426995|12575749|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993951|NCT03426995|12575750|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993952|NCT03426995|12575751|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993953|NCT03426995|12575752|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993954|NCT03426995|12575753|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993955|NCT03426995|12575754|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7993956|NCT03426995|12575736|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993957|NCT03426995|12575737|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993958|NCT03426995|12575738|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993959|NCT03426995|12575739|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993960|NCT03426995|12575740|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993961|NCT03426995|12575741|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993962|NCT03426995|12575742|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993963|NCT03426995|12575743|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993964|NCT03426995|12575744|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993965|NCT03426995|12575745|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993966|NCT03426995|12575746|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1
7993967|NCT03426995|12575747|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993968|NCT03426995|12575748|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993969|NCT03426995|12575749|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993970|NCT03426995|12575750|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993971|NCT03426995|12575751|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993972|NCT03426995|12575752|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993973|NCT03426995|12575753|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993974|NCT03426995|12575754|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7993975|NCT03426995|12575736|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993976|NCT03426995|12575737|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993977|NCT03426995|12575738|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993978|NCT03426995|12575739|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993979|NCT03426995|12575740|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993980|NCT03426995|12575741|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993981|NCT03426995|12575742|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993982|NCT03426995|12575743|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1
7993983|NCT03426995|12575744|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993984|NCT03426995|12575745|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993985|NCT03426995|12575746|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993986|NCT03426995|12575747|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993987|NCT03426995|12575748|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993988|NCT03426995|12575749|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993989|NCT03426995|12575750|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993990|NCT03426995|12575751|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993991|NCT03426995|12575752|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993992|NCT03426995|12575753|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993993|NCT03426995|12575754|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7993994|NCT03426995|12575736|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7993995|NCT03426995|12575737|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7993996|NCT03426995|12575738|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7993997|NCT03426995|12575739|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7993998|NCT03426995|12575740|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7993999|NCT03426995|12575741|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7994000|NCT03426995|12575742|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7994001|NCT03426995|12575743|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7994002|NCT03426995|12575744|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7994003|NCT03426995|12575745|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7994004|NCT03426995|12575746|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7994005|NCT03426995|12575747|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7994006|NCT03426995|12575748|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7994007|NCT03426995|12575749|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7994008|NCT03426995|12575750|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8
7994009|NCT03426995|12575751|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9
7994010|NCT03426995|12575752|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7994011|NCT03426995|12575753|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7994012|NCT03426995|12575754|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7994013|NCT03426995|12575736|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994014|NCT03426995|12575737|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994015|NCT03426995|12575738|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994016|NCT03426995|12575739|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994017|NCT03426995|12575740|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994018|NCT03426995|12575741|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994019|NCT03426995|12575742|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994020|NCT03426995|12575743|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994021|NCT03426995|12575744|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994022|NCT03426995|12575745|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994023|NCT03426995|12575746|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994024|NCT03426995|12575747|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994025|NCT03426995|12575748|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994026|NCT03426995|12575749|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994027|NCT03426995|12575750|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1
7994028|NCT03426995|12575751|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3
7994029|NCT03426995|12575752|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994030|NCT03426995|12575753|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994031|NCT03426995|12575754|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7994032|NCT03427073|12575809|FG000|Overall Study|Disease Progression|1
7994033|NCT03427073|12575810|FG001|Overall Study|Disease Progression|1
7994034|NCT03427073|12575811|FG002|Overall Study|Disease Progression|1
7994035|NCT03427073|12575812|FG003|Overall Study|Disease Progression|3
7994036|NCT03427073|12575813|FG004|Overall Study|Disease Progression|3
7994037|NCT03427073|12575814|FG005|Overall Study|Disease Progression|4
7994038|NCT03427073|12575815|FG006|Overall Study|Disease Progression|2
7994039|NCT03427073|12575816|FG007|Overall Study|Disease Progression|3
7994040|NCT03427073|12575809|FG000|Overall Study|Physician Decision|0
7994041|NCT03427073|12575810|FG001|Overall Study|Physician Decision|0
7994042|NCT03427073|12575811|FG002|Overall Study|Physician Decision|0
7994043|NCT03427073|12575812|FG003|Overall Study|Physician Decision|0
7994044|NCT03427073|12575813|FG004|Overall Study|Physician Decision|0
7994045|NCT03427073|12575814|FG005|Overall Study|Physician Decision|0
7994046|NCT03427073|12575815|FG006|Overall Study|Physician Decision|1
7994047|NCT03427073|12575816|FG007|Overall Study|Physician Decision|1
7994048|NCT03427268|12575843|FG000|Overall Study|Progressive disease|25
7994049|NCT03427268|12575843|FG000|Overall Study|Never treated|2
7994050|NCT03427268|12575843|FG000|Overall Study|Compassionate use|1
7994051|NCT03427268|12575843|FG000|Overall Study|Withdrawal by Subject|1
7994052|NCT03427268|12575843|FG000|Overall Study|Adverse Event|3
7994053|NCT03427619|12575847|FG000|Overall Study|Physician Decision|3
7994054|NCT03427619|12575847|FG000|Overall Study|Withdrawal by Subject|4
7994055|NCT03427619|12575847|FG000|Overall Study|Lost to Follow-up|5
7994056|NCT03427619|12575847|FG000|Overall Study|Administrative|4
7994057|NCT03427619|12575847|FG000|Overall Study|Other|2
7994058|NCT03427619|12575847|FG000|Overall Study|Unknown or Missing Completion Status|48
7994059|NCT03427892|12575851|FG000|Overall Study|Lost to Follow-up|2
7994060|NCT03428152|12575861|FG000|Overall Study|Physician Decision|4
7994061|NCT03428152|12575862|FG001|Overall Study|Physician Decision|2
7994062|NCT03428152|12575861|FG000|Overall Study|Protocol Violation|3
7994063|NCT03428152|12575862|FG001|Overall Study|Protocol Violation|5
7994064|NCT03428152|12575861|FG000|Overall Study|Lack of Efficacy|0
7994065|NCT03428152|12575862|FG001|Overall Study|Lack of Efficacy|4
7994066|NCT03428360|12575885|FG000|Overall Study|Informed consent withdrawn|5
7994067|NCT03428360|12575885|FG000|Overall Study|Withdrawal by Subject|4
7994068|NCT03428360|12575885|FG000|Overall Study|Lost to Follow-up|5
7994069|NCT03428360|12575885|FG000|Overall Study|Physician Decision|2
7994070|NCT03428360|12575885|FG000|Overall Study|Informed consent withdrawn|5
7994071|NCT03428360|12575885|FG000|Overall Study|Study terminated by sponsor|10
7994072|NCT03428360|12575885|FG000|Overall Study|Non-compliant with study|1
7994073|NCT03428360|12575885|FG000|Overall Study|Non-compliant with study drug|3
7994074|NCT03428360|12575885|FG000|Overall Study|Death|3
7994075|NCT03428360|12575885|FG000|Overall Study|Adverse Event|1
7994076|NCT03428360|12575885|FG000|Overall Study|Not on antiepileptic drug|1
7994077|NCT03428750|12575895|FG000|Overall Study|Withdrawal by Subject|11
7994078|NCT03428750|12575896|FG001|Overall Study|Withdrawal by Subject|10
7994079|NCT03428750|12575895|FG000|Overall Study|Lost to Follow-up|3
7994080|NCT03428750|12575896|FG001|Overall Study|Lost to Follow-up|9
7994081|NCT03428750|12575895|FG000|Overall Study|Adverse Event|9
7994082|NCT03428750|12575896|FG001|Overall Study|Adverse Event|1
7994083|NCT03428750|12575895|FG000|Overall Study|Protocol Violation|1
7994084|NCT03428750|12575896|FG001|Overall Study|Protocol Violation|0
7994085|NCT03428750|12575895|FG000|Overall Study|Administrative|0
7994086|NCT03428750|12575896|FG001|Overall Study|Administrative|1
7994087|NCT03428815|12575927|FG000|Overall Study|Lost to Follow-up|2
7994088|NCT03428815|12575928|FG001|Overall Study|Lost to Follow-up|2
7994089|NCT03428815|12575927|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5
7994090|NCT03428815|12575928|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2
7994091|NCT03428815|12575927|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3
7994092|NCT03428815|12575928|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1
7994093|NCT03429556|12575953|FG000|Overall Study|Lost to Follow-up|0
7994094|NCT03429556|12575954|FG001|Overall Study|Lost to Follow-up|1
7994095|NCT03429556|12575955|FG002|Overall Study|Lost to Follow-up|0
7994096|NCT03429556|12575956|FG003|Overall Study|Lost to Follow-up|0
7994097|NCT03430245|12575984|FG000|Overall Study|Withdrawal by Subject|6
7994098|NCT03430245|12575984|FG000|Overall Study|Lost to Follow-up|1
7994099|NCT03430856|12576001|FG000|Overall Study|Adverse Event|0
7994100|NCT03430856|12576002|FG001|Overall Study|Adverse Event|1
7994101|NCT03430856|12576003|FG002|Overall Study|Adverse Event|0
7994102|NCT03430856|12576001|FG000|Overall Study|Rescue criteria|1
7994103|NCT03430856|12576002|FG001|Overall Study|Rescue criteria|1
7994104|NCT03430856|12576003|FG002|Overall Study|Rescue criteria|0
7994105|NCT03430856|12576001|FG000|Overall Study|Voluntary withdrawal of consent|1
7994106|NCT03430856|12576002|FG001|Overall Study|Voluntary withdrawal of consent|1
7994107|NCT03430856|12576003|FG002|Overall Study|Voluntary withdrawal of consent|1
7994108|NCT03430986|12576016|FG000|24-week Control Period|Adverse Event|1
7994109|NCT03430986|12576017|FG001|24-week Control Period|Adverse Event|0
7994110|NCT03430986|12576016|FG000|24-week Control Period|Lost to Follow-up|2
7994111|NCT03430986|12576017|FG001|24-week Control Period|Lost to Follow-up|2
7994112|NCT03430986|12576016|FG000|24-week Control Period|Withdrawal by Participant|5
7994113|NCT03430986|12576017|FG001|24-week Control Period|Withdrawal by Participant|0
7994114|NCT03430986|12576016|FG000|24-week Control Period|Protocol Deviation|0
7994115|NCT03430986|12576017|FG001|24-week Control Period|Protocol Deviation|2
7994116|NCT03430986|12576016|FG000|24-week Post-Control Period|Lost to Follow-up|1
7994117|NCT03430986|12576017|FG001|24-week Post-Control Period|Lost to Follow-up|1
7994118|NCT03430986|12576016|FG000|24-week Post-Control Period|Withdrawal by Participant|0
7994119|NCT03430986|12576017|FG001|24-week Post-Control Period|Withdrawal by Participant|1
7994120|NCT03431337|12576049|FG000|Overall Study|Lost to Follow-up|21
7994121|NCT03431337|12576050|FG001|Overall Study|Lost to Follow-up|19
7994122|NCT03431337|12576049|FG000|Overall Study|Withdrawal by Subject|8
7994123|NCT03431337|12576050|FG001|Overall Study|Withdrawal by Subject|3
7994124|NCT03431441|12576060|FG000|Overall Study|Withdrawal by Subject|2
7994125|NCT03431441|12576060|FG000|Overall Study|Adverse Event|2
7994126|NCT03431441|12576060|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1
7994127|NCT03431857|12576064|FG000|Overall Study|Death|6
7994128|NCT03431857|12576064|FG000|Overall Study|Lost to Follow-up|41
7994129|NCT03431857|12576064|FG000|Overall Study|Adverse Event|6
7994130|NCT03431857|12576064|FG000|Overall Study|Withdrawal by Subject|1
7994131|NCT03432390|12576070|FG000|Apnea Period|Protocol Violation|2
7994132|NCT03432390|12576071|FG001|Apnea Period|Protocol Violation|2
7994133|NCT03432533|12576079|FG000|Overall Study|Lost to Follow-up|1
7994134|NCT03432533|12576080|FG001|Overall Study|Lost to Follow-up|2
7994135|NCT03432533|12576079|FG000|Overall Study|Withdrawal by Subject|14
7994136|NCT03432533|12576080|FG001|Overall Study|Withdrawal by Subject|9
7994137|NCT03432858|12576089|FG000|Overall Study|Protocol Violation|2
7994138|NCT03432858|12576090|FG001|Overall Study|Protocol Violation|1
7994139|NCT03432858|12576091|FG002|Overall Study|Protocol Violation|9
7994140|NCT03432858|12576089|FG000|Overall Study|Withdrawal by Subject|0
7994141|NCT03432858|12576090|FG001|Overall Study|Withdrawal by Subject|1
7994142|NCT03432858|12576091|FG002|Overall Study|Withdrawal by Subject|1
7994143|NCT03432858|12576089|FG000|Overall Study|Procedure canceled/rescheduled|0
7994144|NCT03432858|12576090|FG001|Overall Study|Procedure canceled/rescheduled|9
7994145|NCT03432858|12576091|FG002|Overall Study|Procedure canceled/rescheduled|6
7994146|NCT03432858|12576089|FG000|Overall Study|Required postop mobilization with splinting|0
7994147|NCT03432858|12576090|FG001|Overall Study|Required postop mobilization with splinting|0
7994148|NCT03432858|12576091|FG002|Overall Study|Required postop mobilization with splinting|1
7994149|NCT03433482|12576103|FG000|Overall Study|Lost to Follow-up|1
7994150|NCT03433482|12576104|FG001|Overall Study|Lost to Follow-up|0
7994151|NCT03433482|12576105|FG002|Overall Study|Lost to Follow-up|1
7994152|NCT03433482|12576106|FG003|Overall Study|Lost to Follow-up|1
7994153|NCT03433482|12576103|FG000|Overall Study|Withdrawal by Subject|0
7994154|NCT03433482|12576104|FG001|Overall Study|Withdrawal by Subject|0
7994155|NCT03433482|12576105|FG002|Overall Study|Withdrawal by Subject|1
7994156|NCT03433482|12576106|FG003|Overall Study|Withdrawal by Subject|0
7994157|NCT03433482|12576103|FG000|Overall Study|Unknown reason|0
7994158|NCT03433482|12576104|FG001|Overall Study|Unknown reason|0
7994159|NCT03433482|12576105|FG002|Overall Study|Unknown reason|2
7994160|NCT03433482|12576106|FG003|Overall Study|Unknown reason|0
7994161|NCT03433677|12576118|FG000|Period 1|Protocol Violation|1
7994162|NCT03433677|12576119|FG001|Period 1|Protocol Violation|0
7994163|NCT03433677|12576118|FG000|Period 2|Withdrawal by Subject|1
7994164|NCT03433677|12576119|FG001|Period 2|Withdrawal by Subject|1
7994165|NCT03433703|12576126|FG000|Overall Study|Study terminated by Sponsor|2
7994166|NCT03433755|12576134|FG000|Overall Study|Lost to Follow-up|1
7994167|NCT03433755|12576135|FG001|Overall Study|Lost to Follow-up|0
7994168|NCT03433755|12576136|FG002|Overall Study|Lost to Follow-up|0
7994169|NCT03433755|12576137|FG003|Overall Study|Lost to Follow-up|0
7994170|NCT03433755|12576134|FG000|Overall Study|Decision by Sponsor|1
7994171|NCT03433755|12576135|FG001|Overall Study|Decision by Sponsor|0
7994172|NCT03433755|12576136|FG002|Overall Study|Decision by Sponsor|0
7994173|NCT03433755|12576137|FG003|Overall Study|Decision by Sponsor|0
7994174|NCT03434249|12576164|FG000|Overall Study|Adverse Event|1
7994175|NCT03434249|12576165|FG001|Overall Study|Adverse Event|0
7994176|NCT03434249|12576164|FG000|Overall Study|Lost to Follow-up|0
7994177|NCT03434249|12576165|FG001|Overall Study|Lost to Follow-up|1
7994178|NCT03434249|12576164|FG000|Overall Study|Non-compliance of family|2
7994179|NCT03434249|12576165|FG001|Overall Study|Non-compliance of family|1
7994180|NCT03434249|12576164|FG000|Overall Study|Difficulties in completing daily diary|2
7994181|NCT03434249|12576165|FG001|Overall Study|Difficulties in completing daily diary|1
7994182|NCT03434834|12576175|FG000|Overall Study|unable to swallow OCT probe|16
7994183|NCT03434977|12576181|FG000|Washout Period (at Least 6 Days)|Adverse Event|0
7994184|NCT03434977|12576182|FG001|Washout Period (at Least 6 Days)|Adverse Event|1
7994185|NCT03435055|12576188|FG000|Screening|Physician Decision|2
7994186|NCT03435055|12576188|FG000|Received Intervention|Did not complete nitrous administration|3
7994187|NCT03435211|12576199|FG000|Overall Study|Unable to achieve minimum desaturation level|1
7994188|NCT03435224|12576203|FG000|Overall Study|Unable to achieve a minimum desaturation level|4
7994189|NCT03435497|12576209|FG000|Overall Study|Lost to Follow-up|1
7994190|NCT03435497|12576210|FG001|Overall Study|Lost to Follow-up|0
7994191|NCT03435497|12576209|FG000|Overall Study|Death|1
7994192|NCT03435497|12576210|FG001|Overall Study|Death|0
7994193|NCT03435497|12576209|FG000|Overall Study|Withdrawal by Subject|0
7994194|NCT03435497|12576210|FG001|Overall Study|Withdrawal by Subject|4
7994195|NCT03435497|12576209|FG000|Overall Study|Wrong survey administered|0
7994196|NCT03435497|12576210|FG001|Overall Study|Wrong survey administered|2
7994197|NCT03435692|12576240|FG000|Overall Study|Lack of Efficacy|2
7994198|NCT03435692|12576241|FG001|Overall Study|Lack of Efficacy|2
7994199|NCT03435692|12576242|FG002|Overall Study|Lack of Efficacy|0
7994200|NCT03436082|12576265|FG000|Overall Study|Did not undergo procedure|1
7994201|NCT03436082|12576266|FG001|Overall Study|Did not undergo procedure|0
7994202|NCT03436420|12576283|FG000|Overall Study|Lack of Efficacy|3
7994203|NCT03436732|12576289|FG000|Overall Study|Not treated-enrolled in different study|1
7994204|NCT03436732|12576290|FG001|Overall Study|Not treated-enrolled in different study|0
7994205|NCT03436732|12576289|FG000|Overall Study|Off study after cycle 1|1
7994206|NCT03436732|12576290|FG001|Overall Study|Off study after cycle 1|0
7994207|NCT03436732|12576289|FG000|Overall Study|Adverse Event|2
7994208|NCT03436732|12576290|FG001|Overall Study|Adverse Event|0
7994209|NCT03436732|12576289|FG000|Overall Study|Death|0
7994210|NCT03436732|12576290|FG001|Overall Study|Death|1
7994211|NCT03437265|12576326|FG000|Overall Study|Protocol Violation|6
7994212|NCT03437447|12576333|FG000|Treatment Period 1|Withdrawal by Subject|0
7994213|NCT03437447|12576334|FG001|Treatment Period 1|Withdrawal by Subject|0
7994214|NCT03437447|12576335|FG002|Treatment Period 1|Withdrawal by Subject|1
7994215|NCT03437512|12576345|FG000|Randomized|Withdrawal by Subject|0
7994216|NCT03437512|12576346|FG001|Randomized|Withdrawal by Subject|2
7994217|NCT03437512|12576345|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2
7994218|NCT03437512|12576346|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1
7994219|NCT03437577|12576364|FG000|Pre-Randomization|Withdrawal by Subject|0
7994220|NCT03437577|12576365|FG001|Pre-Randomization|Withdrawal by Subject|0
7994221|NCT03437577|12576366|FG002|Pre-Randomization|Withdrawal by Subject|10
7994222|NCT03437577|12576364|FG000|Post-Randomization|Physician Decision|0
7994223|NCT03437577|12576365|FG001|Post-Randomization|Physician Decision|2
7994224|NCT03437577|12576366|FG002|Post-Randomization|Physician Decision|0
7994225|NCT03437733|12576374|FG000|Overall Study|Eligibility criteria not met|0
7994226|NCT03437733|12576375|FG001|Overall Study|Eligibility criteria not met|3
7994227|NCT03438006|12576384|FG000|Overall Study|Adverse Event|1
7994228|NCT03438006|12576384|FG000|Overall Study|Lost to Follow-up|67
7994229|NCT03438006|12576384|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47
7994230|NCT03438006|12576384|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3
7994231|NCT03438383|12576400|FG000|Overall Study|Protocol Violation|9
7994232|NCT03438383|12576401|FG001|Overall Study|Protocol Violation|3
7994233|NCT03438539|12576413|FG000|Overall Study|Lost to Follow-up|8
7994234|NCT03438539|12576414|FG001|Overall Study|Lost to Follow-up|4
7994235|NCT03438539|12576415|FG002|Overall Study|Lost to Follow-up|10
7994236|NCT03438539|12576416|FG003|Overall Study|Lost to Follow-up|9
7994237|NCT03438539|12576417|FG004|Overall Study|Lost to Follow-up|3
7994238|NCT03438539|12576418|FG005|Overall Study|Lost to Follow-up|8
7994239|NCT03439072|12576441|FG000|Overall Study|Withdrawal by Subject|2
7994240|NCT03439072|12576442|FG001|Overall Study|Withdrawal by Subject|3
7994241|NCT03439072|12576441|FG000|Overall Study|Physician Decision|0
7994242|NCT03439072|12576442|FG001|Overall Study|Physician Decision|1
7994243|NCT03439137|12576450|FG000|Overall Study|Adverse Event|16
7994244|NCT03439137|12576451|FG001|Overall Study|Adverse Event|12
7994245|NCT03439137|12576450|FG000|Overall Study|Physician Decision|0
7994246|NCT03439137|12576451|FG001|Overall Study|Physician Decision|5
7994247|NCT03439137|12576450|FG000|Overall Study|Withdrawal by Subject|14
7994248|NCT03439137|12576451|FG001|Overall Study|Withdrawal by Subject|4
7994249|NCT03439137|12576450|FG000|Overall Study|Conducting rescue therapy|2
7994250|NCT03439137|12576451|FG001|Overall Study|Conducting rescue therapy|1
7994251|NCT03439137|12576450|FG000|Overall Study|Difficult to control Hb|10
7994252|NCT03439137|12576451|FG001|Overall Study|Difficult to control Hb|2
7994253|NCT03439137|12576450|FG000|Overall Study|Initiation of a renal transplant|0
7994254|NCT03439137|12576451|FG001|Overall Study|Initiation of a renal transplant|2
7994255|NCT03439189|12576457|FG000|Overall Study|Protocol Violation|19
7994256|NCT03439189|12576457|FG000|Overall Study|Lack of Efficacy|63
7994257|NCT03440320|12576475|FG000|Overall Study|Withdrawal by Subject|0
7994258|NCT03440320|12576476|FG001|Overall Study|Withdrawal by Subject|1
7994259|NCT03440411|12576488|FG000|Overall Study|Adverse Event|0
7994260|NCT03440411|12576489|FG001|Overall Study|Adverse Event|0
7994261|NCT03440411|12576490|FG002|Overall Study|Adverse Event|1
7994262|NCT03440411|12576491|FG003|Overall Study|Adverse Event|0
7994263|NCT03440411|12576488|FG000|Overall Study|PD|2
7994264|NCT03440411|12576489|FG001|Overall Study|PD|1
7994265|NCT03440411|12576490|FG002|Overall Study|PD|1
7994266|NCT03440411|12576491|FG003|Overall Study|PD|1
7994267|NCT03440411|12576488|FG000|Overall Study|Withdrawal by Subject|1
7994268|NCT03440411|12576489|FG001|Overall Study|Withdrawal by Subject|0
7994269|NCT03440411|12576490|FG002|Overall Study|Withdrawal by Subject|0
7994270|NCT03440411|12576491|FG003|Overall Study|Withdrawal by Subject|0
7994271|NCT03440411|12576488|FG000|Overall Study|Closed study by sponsor|0
7994272|NCT03440411|12576489|FG001|Overall Study|Closed study by sponsor|0
7994273|NCT03440411|12576490|FG002|Overall Study|Closed study by sponsor|0
7994274|NCT03440411|12576491|FG003|Overall Study|Closed study by sponsor|1
7994275|NCT03440918|12576535|FG000|Overall Study|Protocol Violation|0
7994276|NCT03440918|12576536|FG001|Overall Study|Protocol Violation|16
7994277|NCT03440944|12576544|FG000|Overall Study|Physician Decision|1
7994278|NCT03440944|12576545|FG001|Overall Study|Physician Decision|0
7994279|NCT03440944|12576544|FG000|Overall Study|No Acceptable Vasculature|0
7994280|NCT03440944|12576545|FG001|Overall Study|No Acceptable Vasculature|1
7994281|NCT03441789|12576637|FG000|Overall Study|Withdrawal by Subject|1
7994282|NCT03441789|12576638|FG001|Overall Study|Withdrawal by Subject|1
7994283|NCT03441789|12576637|FG000|Overall Study|Adverse Event|0
7994284|NCT03441789|12576638|FG001|Overall Study|Adverse Event|1
7994285|NCT03441789|12576637|FG000|Overall Study|Protocol Violation|0
7994286|NCT03441789|12576638|FG001|Overall Study|Protocol Violation|1
7994287|NCT03441789|12576637|FG000|Overall Study|Lost to Follow-up|0
7994288|NCT03441789|12576638|FG001|Overall Study|Lost to Follow-up|1
7994289|NCT03441984|12576646|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7994290|NCT03441984|12576647|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7994291|NCT03441984|12576648|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1
7994292|NCT03441984|12576649|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7994293|NCT03441984|12576650|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7994294|NCT03441984|12576651|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7994295|NCT03441984|12576652|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7994296|NCT03441984|12576653|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7994297|NCT03441984|12576654|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7994298|NCT03441984|12576655|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7994299|NCT03441984|12576656|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7994300|NCT03441984|12576657|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7994301|NCT03442296|12576685|FG000|3 Month Follow-up|Death|3
7994302|NCT03442296|12576686|FG001|3 Month Follow-up|Death|1
7994303|NCT03442296|12576685|FG000|3 Month Follow-up|Lost to Follow-up|1
7994304|NCT03442296|12576686|FG001|3 Month Follow-up|Lost to Follow-up|1
7994305|NCT03442296|12576685|FG000|3 Month Follow-up|Withdrawal by Subject|1
7994306|NCT03442296|12576686|FG001|3 Month Follow-up|Withdrawal by Subject|0
7994307|NCT03442296|12576685|FG000|3 Month Follow-up|Obtained Hearing Aids|0
7994308|NCT03442296|12576686|FG001|3 Month Follow-up|Obtained Hearing Aids|1
7994309|NCT03442296|12576685|FG000|12 Month Follow-up|Incomplete measurement|1
7994310|NCT03442296|12576686|FG001|12 Month Follow-up|Incomplete measurement|1
7994311|NCT03442569|12576692|FG000|Overall Study|Subject was ineligible after enrollment|1
7994312|NCT03442595|12576698|FG000|Overall Study|Lost to Follow-up|94
7994313|NCT03442595|12576699|FG001|Overall Study|Lost to Follow-up|0
7994314|NCT03442777|12576722|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8
7994315|NCT03442777|12576723|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13
7994316|NCT03442777|12576724|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7
7994317|NCT03442829|12576732|FG000|Overall Study|Scheduling clash|3
7994318|NCT03442829|12576733|FG001|Overall Study|Scheduling clash|1
7994319|NCT03442829|12576732|FG000|Overall Study|Illness unrelated to study|1
7994320|NCT03442829|12576733|FG001|Overall Study|Illness unrelated to study|1
7994321|NCT03443024|12576757|FG000|Overall Study|Adverse Event|2
7994322|NCT03443024|12576758|FG001|Overall Study|Adverse Event|4
7994323|NCT03443024|12576759|FG002|Overall Study|Adverse Event|3
7994324|NCT03443024|12576760|FG003|Overall Study|Adverse Event|1
7994325|NCT03443024|12576757|FG000|Overall Study|Lost to Follow-up|9
7994326|NCT03443024|12576758|FG001|Overall Study|Lost to Follow-up|9
7994327|NCT03443024|12576759|FG002|Overall Study|Lost to Follow-up|7
7994328|NCT03443024|12576760|FG003|Overall Study|Lost to Follow-up|5
7994329|NCT03443024|12576757|FG000|Overall Study|Withdrawal by Subject|8
7994330|NCT03443024|12576758|FG001|Overall Study|Withdrawal by Subject|15
7994331|NCT03443024|12576759|FG002|Overall Study|Withdrawal by Subject|9
7994332|NCT03443024|12576760|FG003|Overall Study|Withdrawal by Subject|23
7994333|NCT03443024|12576757|FG000|Overall Study|Physician Decision|1
7994334|NCT03443024|12576758|FG001|Overall Study|Physician Decision|2
7994335|NCT03443024|12576759|FG002|Overall Study|Physician Decision|0
7994336|NCT03443024|12576760|FG003|Overall Study|Physician Decision|1
7994337|NCT03443024|12576757|FG000|Overall Study|Sponsor Decision|1
7994338|NCT03443024|12576758|FG001|Overall Study|Sponsor Decision|1
7994339|NCT03443024|12576759|FG002|Overall Study|Sponsor Decision|0
7994340|NCT03443024|12576760|FG003|Overall Study|Sponsor Decision|0
7994341|NCT03443024|12576757|FG000|Overall Study|Protocol Deviation|0
7994342|NCT03443024|12576758|FG001|Overall Study|Protocol Deviation|0
7994343|NCT03443024|12576759|FG002|Overall Study|Protocol Deviation|0
7994344|NCT03443024|12576760|FG003|Overall Study|Protocol Deviation|2
7718228|NCT00526110|12142070|FG001|Overall Study|Poor Tolerance|5
7994345|NCT03443414|12576786|FG000|Overall Study|Adverse Event|6
7994346|NCT03443414|12576787|FG001|Overall Study|Adverse Event|0
7994347|NCT03443414|12576788|FG002|Overall Study|Adverse Event|4
7994348|NCT03443414|12576789|FG003|Overall Study|Adverse Event|2
7994349|NCT03443414|12576790|FG004|Overall Study|Adverse Event|3
7994350|NCT03443414|12576786|FG000|Overall Study|Withdrawal by Subject|3
7994351|NCT03443414|12576787|FG001|Overall Study|Withdrawal by Subject|2
7994352|NCT03443414|12576788|FG002|Overall Study|Withdrawal by Subject|2
7994353|NCT03443414|12576789|FG003|Overall Study|Withdrawal by Subject|2
7994354|NCT03443414|12576790|FG004|Overall Study|Withdrawal by Subject|1
7994355|NCT03443414|12576786|FG000|Overall Study|Death|0
7994356|NCT03443414|12576787|FG001|Overall Study|Death|1
7994357|NCT03443414|12576788|FG002|Overall Study|Death|0
7994358|NCT03443414|12576789|FG003|Overall Study|Death|1
7994359|NCT03443414|12576790|FG004|Overall Study|Death|0
7994360|NCT03443414|12576786|FG000|Overall Study|Reason not specified|2
7994361|NCT03443414|12576787|FG001|Overall Study|Reason not specified|0
7994362|NCT03443414|12576788|FG002|Overall Study|Reason not specified|0
7994363|NCT03443414|12576789|FG003|Overall Study|Reason not specified|0
7994364|NCT03443414|12576790|FG004|Overall Study|Reason not specified|1
7994365|NCT03443427|12576804|FG000|Overall Study|Adverse Event|2
7994366|NCT03443427|12576805|FG001|Overall Study|Adverse Event|3
7994367|NCT03443427|12576804|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
7994368|NCT03443427|12576805|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7994369|NCT03443427|12576804|FG000|Overall Study|Other|4
7994370|NCT03443427|12576805|FG001|Overall Study|Other|6
7994371|NCT03443713|12576814|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0
7994372|NCT03443713|12576815|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0
7994373|NCT03443713|12576816|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1
7994374|NCT03444155|12576839|FG000|First Intervention (6 Weeks)|Adverse Event|1
7994375|NCT03444155|12576840|FG001|First Intervention (6 Weeks)|Adverse Event|0
7994376|NCT03444584|12576848|FG000|Overall Study|Withdrawal by Subject|0
7994377|NCT03444584|12576849|FG001|Overall Study|Withdrawal by Subject|1
7994378|NCT03444584|12576848|FG000|Overall Study|Other|0
7994379|NCT03444584|12576849|FG001|Overall Study|Other|1
7994380|NCT03444766|12576856|FG000|Overall Study|Other Reasons|2
7994381|NCT03444766|12576856|FG000|Overall Study|Participant Withdrew Consent|5
7994382|NCT03444766|12576856|FG000|Overall Study|Lost to Follow-up|2
7994383|NCT03444766|12576856|FG000|Overall Study|Death|2
7994384|NCT03444766|12576856|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6
7994385|NCT03444766|12576856|FG000|Overall Study|Disease Progression|49
7994386|NCT03445065|12576872|FG000|Overall Study|Withdrawal by Subject|3
7994387|NCT03445065|12576873|FG001|Overall Study|Withdrawal by Subject|6
7994388|NCT03445065|12576874|FG002|Overall Study|Withdrawal by Subject|2
7994389|NCT03445065|12576875|FG003|Overall Study|Withdrawal by Subject|2
7994390|NCT03445065|12576872|FG000|Overall Study|Other|4
7994391|NCT03445065|12576873|FG001|Overall Study|Other|3
7994392|NCT03445065|12576874|FG002|Overall Study|Other|3
7994393|NCT03445065|12576875|FG003|Overall Study|Other|1
7994394|NCT03446781|12576982|FG000|Overall Study|Lost to Follow-up|11
7994395|NCT03446781|12576983|FG001|Overall Study|Lost to Follow-up|5
7994396|NCT03446781|12576982|FG000|Overall Study|Withdrawal by Subject|9
7994397|NCT03446781|12576983|FG001|Overall Study|Withdrawal by Subject|7
7994398|NCT03446781|12576982|FG000|Overall Study|Adverse Event|8
7994399|NCT03446781|12576983|FG001|Overall Study|Adverse Event|2
7994400|NCT03446781|12576982|FG000|Overall Study|Protocol Violation|0
7994401|NCT03446781|12576983|FG001|Overall Study|Protocol Violation|3
7994402|NCT03446885|12577024|FG000|Overall Study|Lost to Follow-up|1
7994403|NCT03446885|12577025|FG001|Overall Study|Lost to Follow-up|0
7994404|NCT03446885|12577024|FG000|Overall Study|Did not complete entire visit|1
7994405|NCT03446885|12577025|FG001|Overall Study|Did not complete entire visit|0
7994406|NCT03447249|12577044|FG000|Overall Study|Adverse Event|1
7994407|NCT03447249|12577045|FG001|Overall Study|Adverse Event|0
7994408|NCT03447249|12577044|FG000|Overall Study|Withdrawal of consent (not due to AE)|1
7994409|NCT03447249|12577045|FG001|Overall Study|Withdrawal of consent (not due to AE)|0
7994410|NCT03447249|12577044|FG000|Overall Study|Other|3
7994411|NCT03447249|12577045|FG001|Overall Study|Other|0
7994412|NCT03447353|12577053|FG000|Overall Study|Failure at Screening Visit|2
7994413|NCT03447353|12577053|FG000|Overall Study|Lost to Follow-up|4
7994414|NCT03447353|12577053|FG000|Overall Study|Scheduling Conflicts|3
7994415|NCT03447353|12577053|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
7994416|NCT03447730|12577066|FG000|Overall Study|Adverse Event|0
7994417|NCT03447730|12577067|FG001|Overall Study|Adverse Event|2
7994418|NCT03447730|12577068|FG002|Overall Study|Adverse Event|0
7994419|NCT03447821|12577079|FG000|Overall Study|Withdrawal by Subject|1
7994420|NCT03447821|12577080|FG001|Overall Study|Withdrawal by Subject|1
7718229|NCT00526162|12142085|FG000|Overall Study|Device not implanted|3
7718230|NCT00526630|12142121|FG000|First Intervention Period - 12 Weeks|Withdrawn|0
7718231|NCT00526630|12142122|FG001|First Intervention Period - 12 Weeks|Withdrawn|3
7718232|NCT00526630|12142121|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2
7718233|NCT00526630|12142122|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1
7718234|NCT00526656|12142130|FG000|Overall Study|Death|1
7718235|NCT00526656|12142130|FG000|Overall Study|Refused surgery|1
7994421|NCT03447821|12577081|FG002|Overall Study|Withdrawal by Subject|0
7718236|NCT00526669|12142135|FG000|Combined Treatment Phase|Lost to Follow-up|0
7718237|NCT00526669|12142136|FG001|Combined Treatment Phase|Lost to Follow-up|2
7718238|NCT00526669|12142135|FG000|Combined Treatment Phase|Withdrawal by Subject|0
7718239|NCT00526669|12142136|FG001|Combined Treatment Phase|Withdrawal by Subject|2
7718240|NCT00526669|12142135|FG000|Combined Treatment Phase|Sponsor Terminated Study|0
7718241|NCT00526669|12142136|FG001|Combined Treatment Phase|Sponsor Terminated Study|2
7994422|NCT03447821|12577079|FG000|Overall Study|Lost to Follow-up|0
7994423|NCT03447821|12577080|FG001|Overall Study|Lost to Follow-up|0
7994424|NCT03447821|12577081|FG002|Overall Study|Lost to Follow-up|1
7994425|NCT03448224|12577100|FG000|Overall Study|Provided same answer to every question|1
7994426|NCT03448224|12577101|FG001|Overall Study|Provided same answer to every question|0
7994427|NCT03448406|12577109|FG000|Overall Study|Noncompliance of scheduled visits|1
7994428|NCT03448406|12577110|FG001|Overall Study|Noncompliance of scheduled visits|2
7994429|NCT03448406|12577109|FG000|Overall Study|Withdrawal by Subject|1
7994430|NCT03448406|12577110|FG001|Overall Study|Withdrawal by Subject|2
7994431|NCT03448406|12577109|FG000|Overall Study|Protocol Violation|1
7994432|NCT03448406|12577110|FG001|Overall Study|Protocol Violation|0
7994433|NCT03448406|12577109|FG000|Overall Study|Adverse Event|8
7994434|NCT03448406|12577110|FG001|Overall Study|Adverse Event|9
7994435|NCT03448419|12577118|FG000|Overall Study|Adverse Event|10
7994436|NCT03448419|12577119|FG001|Overall Study|Adverse Event|9
7994437|NCT03448419|12577118|FG000|Overall Study|Lost to Follow-up|0
7994438|NCT03448419|12577119|FG001|Overall Study|Lost to Follow-up|2
7994439|NCT03448419|12577118|FG000|Overall Study|Withdrawal by Subject|3
7994440|NCT03448419|12577119|FG001|Overall Study|Withdrawal by Subject|1
7718242|NCT00526669|12142135|FG000|Combined Treatment Phase|Death|0
7718243|NCT00526669|12142136|FG001|Combined Treatment Phase|Death|2
7718244|NCT00526799|12142144|FG000|Overall Study|Withdrawal by Subject|1
7718245|NCT00526799|12142145|FG001|Overall Study|Withdrawal by Subject|0
7718246|NCT00526799|12142144|FG000|Overall Study|Intercurrent Complicating Disease|0
7718247|NCT00526799|12142145|FG001|Overall Study|Intercurrent Complicating Disease|1
7718248|NCT00526890|12142151|FG000|Overall Study|Adverse Event|2
7718249|NCT00526994|12142158|FG000|Overall Study|Lost to Follow-up|98
7718250|NCT00526994|12142159|FG001|Overall Study|Lost to Follow-up|108
7718251|NCT00526994|12142160|FG002|Overall Study|Lost to Follow-up|96
7718252|NCT00526994|12142158|FG000|Overall Study|Death|4
7718253|NCT00526994|12142159|FG001|Overall Study|Death|3
7718254|NCT00526994|12142160|FG002|Overall Study|Death|3
7718255|NCT00526994|12142158|FG000|Overall Study|Withdrawal by Subject|2
7718256|NCT00526994|12142159|FG001|Overall Study|Withdrawal by Subject|7
7718257|NCT00526994|12142160|FG002|Overall Study|Withdrawal by Subject|5
7718258|NCT00526994|12142158|FG000|Overall Study|incarcerated, impaired, incomplete|4
7718259|NCT00526994|12142159|FG001|Overall Study|incarcerated, impaired, incomplete|3
7718260|NCT00526994|12142160|FG002|Overall Study|incarcerated, impaired, incomplete|3
7718261|NCT00527072|12142168|FG000|Overall Study|Adverse Event|13
7718262|NCT00527072|12142168|FG000|Overall Study|Lack of Efficacy|11
7718263|NCT00527072|12142168|FG000|Overall Study|Lost to Follow-up|3
7718264|NCT00527072|12142168|FG000|Overall Study|Protocol Violation|2
7994441|NCT03448419|12577118|FG000|Overall Study|Not treated|0
7994442|NCT03448419|12577119|FG001|Overall Study|Not treated|1
7994443|NCT03448419|12577118|FG000|Overall Study|Patient did not attend all visits|0
7994444|NCT03448419|12577119|FG001|Overall Study|Patient did not attend all visits|2
7994445|NCT03448419|12577118|FG000|Overall Study|Withdrawn by Sponsor|0
7994446|NCT03448419|12577119|FG001|Overall Study|Withdrawn by Sponsor|1
7994447|NCT03448536|12577129|FG000|Overall Study|Protocol Violation|2
7994448|NCT03448536|12577130|FG001|Overall Study|Protocol Violation|0
7994449|NCT03448536|12577129|FG000|Overall Study|Pregnancy|1
7994450|NCT03448536|12577130|FG001|Overall Study|Pregnancy|0
7994451|NCT03448536|12577129|FG000|Overall Study|Withdrawal by Subject|1
7994452|NCT03448536|12577130|FG001|Overall Study|Withdrawal by Subject|2
7994453|NCT03448536|12577129|FG000|Overall Study|Lost to Follow-up|3
7994454|NCT03448536|12577130|FG001|Overall Study|Lost to Follow-up|2
7994455|NCT03448536|12577129|FG000|Overall Study|Inadequate pain reporter|1
7994456|NCT03448536|12577130|FG001|Overall Study|Inadequate pain reporter|0
7994457|NCT03448536|12577129|FG000|Overall Study|Other|3
7994458|NCT03448536|12577130|FG001|Overall Study|Other|0
7994459|NCT03448536|12577129|FG000|Overall Study|Physician Decision|1
7994460|NCT03448536|12577130|FG001|Overall Study|Physician Decision|0
7994461|NCT03449030|12577146|FG000|Overall Study|Withdrawal by Subject|0
7994462|NCT03449030|12577147|FG001|Overall Study|Withdrawal by Subject|0
7994463|NCT03449030|12577148|FG002|Overall Study|Withdrawal by Subject|0
7994464|NCT03449030|12577149|FG003|Overall Study|Withdrawal by Subject|1
7994465|NCT03449030|12577150|FG004|Overall Study|Withdrawal by Subject|1
7994466|NCT03449030|12577151|FG005|Overall Study|Withdrawal by Subject|1
7994467|NCT03449030|12577152|FG006|Overall Study|Withdrawal by Subject|1
7994468|NCT03449030|12577153|FG007|Overall Study|Withdrawal by Subject|2
7994469|NCT03449030|12577154|FG008|Overall Study|Withdrawal by Subject|0
7994470|NCT03449030|12577155|FG009|Overall Study|Withdrawal by Subject|0
7994471|NCT03449030|12577146|FG000|Overall Study|Symptomatic Deterioration|0
7994472|NCT03449030|12577147|FG001|Overall Study|Symptomatic Deterioration|1
7994473|NCT03449030|12577148|FG002|Overall Study|Symptomatic Deterioration|0
7994474|NCT03449030|12577149|FG003|Overall Study|Symptomatic Deterioration|0
7994475|NCT03449030|12577150|FG004|Overall Study|Symptomatic Deterioration|0
7994476|NCT03449030|12577151|FG005|Overall Study|Symptomatic Deterioration|1
7994477|NCT03449030|12577152|FG006|Overall Study|Symptomatic Deterioration|1
7994478|NCT03449030|12577153|FG007|Overall Study|Symptomatic Deterioration|0
7994479|NCT03449030|12577154|FG008|Overall Study|Symptomatic Deterioration|2
7994480|NCT03449030|12577155|FG009|Overall Study|Symptomatic Deterioration|0
7994481|NCT03449030|12577146|FG000|Overall Study|Progressive Disease|1
7994482|NCT03449030|12577147|FG001|Overall Study|Progressive Disease|0
7994483|NCT03449030|12577148|FG002|Overall Study|Progressive Disease|1
7994484|NCT03449030|12577149|FG003|Overall Study|Progressive Disease|4
7994485|NCT03449030|12577150|FG004|Overall Study|Progressive Disease|5
7994486|NCT03449030|12577151|FG005|Overall Study|Progressive Disease|3
7994487|NCT03449030|12577152|FG006|Overall Study|Progressive Disease|0
7994488|NCT03449030|12577153|FG007|Overall Study|Progressive Disease|1
7994489|NCT03449030|12577154|FG008|Overall Study|Progressive Disease|1
7994490|NCT03449030|12577155|FG009|Overall Study|Progressive Disease|1
7994491|NCT03449030|12577146|FG000|Overall Study|Adverse Event|0
7994492|NCT03449030|12577147|FG001|Overall Study|Adverse Event|0
7994493|NCT03449030|12577148|FG002|Overall Study|Adverse Event|0
7994494|NCT03449030|12577149|FG003|Overall Study|Adverse Event|0
7994495|NCT03449030|12577150|FG004|Overall Study|Adverse Event|0
7994496|NCT03449030|12577151|FG005|Overall Study|Adverse Event|2
7994497|NCT03449030|12577152|FG006|Overall Study|Adverse Event|0
7994498|NCT03449030|12577153|FG007|Overall Study|Adverse Event|0
7994499|NCT03449030|12577154|FG008|Overall Study|Adverse Event|0
7994500|NCT03449030|12577155|FG009|Overall Study|Adverse Event|0
7994501|NCT03449030|12577146|FG000|Overall Study|Death|0
7994502|NCT03449030|12577147|FG001|Overall Study|Death|0
7994503|NCT03449030|12577148|FG002|Overall Study|Death|0
7994504|NCT03449030|12577149|FG003|Overall Study|Death|0
7994505|NCT03449030|12577150|FG004|Overall Study|Death|1
7994506|NCT03449030|12577151|FG005|Overall Study|Death|0
7994507|NCT03449030|12577152|FG006|Overall Study|Death|0
7994508|NCT03449030|12577153|FG007|Overall Study|Death|0
7994509|NCT03449030|12577154|FG008|Overall Study|Death|0
7994510|NCT03449030|12577155|FG009|Overall Study|Death|0
7994511|NCT03449134|12577181|FG000|52-Week Treatment Period|Death|2
7994512|NCT03449134|12577182|FG001|52-Week Treatment Period|Death|1
7994513|NCT03449134|12577183|FG002|52-Week Treatment Period|Death|0
7994514|NCT03449134|12577181|FG000|52-Week Treatment Period|Lost to Follow-up|2
7994515|NCT03449134|12577182|FG001|52-Week Treatment Period|Lost to Follow-up|1
7994516|NCT03449134|12577183|FG002|52-Week Treatment Period|Lost to Follow-up|1
7994517|NCT03449134|12577181|FG000|52-Week Treatment Period|Physician Decision|2
7994518|NCT03449134|12577182|FG001|52-Week Treatment Period|Physician Decision|3
7994519|NCT03449134|12577183|FG002|52-Week Treatment Period|Physician Decision|3
7994520|NCT03449134|12577181|FG000|52-Week Treatment Period|Screen Failure|1
7994521|NCT03449134|12577182|FG001|52-Week Treatment Period|Screen Failure|0
7994522|NCT03449134|12577183|FG002|52-Week Treatment Period|Screen Failure|1
7994523|NCT03449134|12577181|FG000|52-Week Treatment Period|Withdrawal by Subject|37
7994524|NCT03449134|12577182|FG001|52-Week Treatment Period|Withdrawal by Subject|39
7994525|NCT03449134|12577183|FG002|52-Week Treatment Period|Withdrawal by Subject|55
7994526|NCT03449134|12577181|FG000|52-Week Treatment Period|Site Closure|1
7994527|NCT03449134|12577182|FG001|52-Week Treatment Period|Site Closure|0
7994528|NCT03449134|12577183|FG002|52-Week Treatment Period|Site Closure|0
7994529|NCT03449147|12577197|FG000|52-week Treatment Period|Death|0
7994530|NCT03449147|12577198|FG001|52-week Treatment Period|Death|1
7994531|NCT03449147|12577199|FG002|52-week Treatment Period|Death|0
7994532|NCT03449147|12577197|FG000|52-week Treatment Period|Lost to Follow-up|6
7994533|NCT03449147|12577198|FG001|52-week Treatment Period|Lost to Follow-up|2
7994534|NCT03449147|12577199|FG002|52-week Treatment Period|Lost to Follow-up|5
7994535|NCT03449147|12577197|FG000|52-week Treatment Period|Other|0
7994536|NCT03449147|12577198|FG001|52-week Treatment Period|Other|1
7994537|NCT03449147|12577199|FG002|52-week Treatment Period|Other|2
7994538|NCT03449147|12577197|FG000|52-week Treatment Period|Physician Decision|1
7994539|NCT03449147|12577198|FG001|52-week Treatment Period|Physician Decision|0
7994540|NCT03449147|12577199|FG002|52-week Treatment Period|Physician Decision|3
7994541|NCT03449147|12577197|FG000|52-week Treatment Period|Screen Failure|1
7994542|NCT03449147|12577198|FG001|52-week Treatment Period|Screen Failure|2
7994543|NCT03449147|12577199|FG002|52-week Treatment Period|Screen Failure|0
7994544|NCT03449147|12577197|FG000|52-week Treatment Period|Withdrawal by Subject|46
7994545|NCT03449147|12577198|FG001|52-week Treatment Period|Withdrawal by Subject|68
7994546|NCT03449147|12577199|FG002|52-week Treatment Period|Withdrawal by Subject|74
7994547|NCT03449147|12577197|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1
7994548|NCT03449147|12577198|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0
7994549|NCT03449147|12577199|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0
7994550|NCT03449147|12577197|FG000|12-Week Off-Treatment Durability Period|Other|0
7994551|NCT03449147|12577198|FG001|12-Week Off-Treatment Durability Period|Other|1
7994552|NCT03449147|12577199|FG002|12-Week Off-Treatment Durability Period|Other|0
7994553|NCT03449446|12577247|FG000|Overall Study|Randomized but Never Treated|0
7994554|NCT03449446|12577248|FG001|Overall Study|Randomized but Never Treated|0
7994555|NCT03449446|12577249|FG002|Overall Study|Randomized but Never Treated|1
7994556|NCT03449446|12577250|FG003|Overall Study|Randomized but Never Treated|1
7994557|NCT03449446|12577251|FG004|Overall Study|Randomized but Never Treated|1
7994558|NCT03449446|12577252|FG005|Overall Study|Randomized but Never Treated|0
7994559|NCT03449446|12577253|FG006|Overall Study|Randomized but Never Treated|0
7994560|NCT03449446|12577247|FG000|Overall Study|Unknown Reason|33
7994561|NCT03449446|12577248|FG001|Overall Study|Unknown Reason|1
7994562|NCT03449446|12577249|FG002|Overall Study|Unknown Reason|1
7994563|NCT03449446|12577250|FG003|Overall Study|Unknown Reason|1
7994564|NCT03449446|12577251|FG004|Overall Study|Unknown Reason|2
7994565|NCT03449446|12577252|FG005|Overall Study|Unknown Reason|2
7994566|NCT03449446|12577253|FG006|Overall Study|Unknown Reason|0
7994567|NCT03449446|12577247|FG000|Overall Study|Withdrew Consent|1
7994568|NCT03449446|12577248|FG001|Overall Study|Withdrew Consent|3
7994569|NCT03449446|12577249|FG002|Overall Study|Withdrew Consent|1
7994570|NCT03449446|12577250|FG003|Overall Study|Withdrew Consent|4
7994571|NCT03449446|12577251|FG004|Overall Study|Withdrew Consent|4
7994572|NCT03449446|12577252|FG005|Overall Study|Withdrew Consent|4
7994573|NCT03449446|12577253|FG006|Overall Study|Withdrew Consent|1
7994574|NCT03449446|12577247|FG000|Overall Study|Adverse Event|1
7994575|NCT03449446|12577248|FG001|Overall Study|Adverse Event|2
7994576|NCT03449446|12577249|FG002|Overall Study|Adverse Event|1
7994577|NCT03449446|12577250|FG003|Overall Study|Adverse Event|0
7994578|NCT03449446|12577251|FG004|Overall Study|Adverse Event|0
7994579|NCT03449446|12577252|FG005|Overall Study|Adverse Event|2
7994580|NCT03449446|12577253|FG006|Overall Study|Adverse Event|0
7994581|NCT03449446|12577247|FG000|Overall Study|Lost to Follow-up|0
7994582|NCT03449446|12577248|FG001|Overall Study|Lost to Follow-up|0
7994583|NCT03449446|12577249|FG002|Overall Study|Lost to Follow-up|2
7994584|NCT03449446|12577250|FG003|Overall Study|Lost to Follow-up|1
7994585|NCT03449446|12577251|FG004|Overall Study|Lost to Follow-up|3
7994586|NCT03449446|12577252|FG005|Overall Study|Lost to Follow-up|0
7994587|NCT03449446|12577253|FG006|Overall Study|Lost to Follow-up|0
7994588|NCT03449446|12577247|FG000|Overall Study|Investigator's Discretion|0
7994589|NCT03449446|12577248|FG001|Overall Study|Investigator's Discretion|1
7994590|NCT03449446|12577249|FG002|Overall Study|Investigator's Discretion|1
7994591|NCT03449446|12577250|FG003|Overall Study|Investigator's Discretion|2
7994592|NCT03449446|12577251|FG004|Overall Study|Investigator's Discretion|0
7994593|NCT03449446|12577252|FG005|Overall Study|Investigator's Discretion|0
7994594|NCT03449446|12577253|FG006|Overall Study|Investigator's Discretion|0
7994595|NCT03449446|12577247|FG000|Overall Study|Non Compliance with Study Drug|1
7994596|NCT03449446|12577248|FG001|Overall Study|Non Compliance with Study Drug|0
7994597|NCT03449446|12577249|FG002|Overall Study|Non Compliance with Study Drug|0
7994598|NCT03449446|12577250|FG003|Overall Study|Non Compliance with Study Drug|0
7994599|NCT03449446|12577251|FG004|Overall Study|Non Compliance with Study Drug|0
7994600|NCT03449446|12577252|FG005|Overall Study|Non Compliance with Study Drug|0
7994601|NCT03449446|12577253|FG006|Overall Study|Non Compliance with Study Drug|0
7994602|NCT03449446|12577247|FG000|Overall Study|Protocol Violation|0
7994603|NCT03449446|12577248|FG001|Overall Study|Protocol Violation|0
7994604|NCT03449446|12577249|FG002|Overall Study|Protocol Violation|0
7994605|NCT03449446|12577250|FG003|Overall Study|Protocol Violation|0
7994606|NCT03449446|12577251|FG004|Overall Study|Protocol Violation|1
7994607|NCT03449446|12577252|FG005|Overall Study|Protocol Violation|1
7994608|NCT03449446|12577253|FG006|Overall Study|Protocol Violation|0
7994609|NCT03449446|12577247|FG000|Overall Study|Death|0
7994610|NCT03449446|12577248|FG001|Overall Study|Death|0
7994611|NCT03449446|12577249|FG002|Overall Study|Death|0
7994612|NCT03449446|12577250|FG003|Overall Study|Death|0
7994613|NCT03449446|12577251|FG004|Overall Study|Death|1
7994614|NCT03449446|12577252|FG005|Overall Study|Death|0
7994615|NCT03449446|12577253|FG006|Overall Study|Death|0
7994616|NCT03449979|12577273|FG000|Overall Study|Technical difficulty|0
7994617|NCT03449979|12577274|FG001|Overall Study|Technical difficulty|0
7994618|NCT03449979|12577275|FG002|Overall Study|Technical difficulty|0
7994619|NCT03449979|12577276|FG003|Overall Study|Technical difficulty|1
7994620|NCT03450070|12577286|FG000|Overall Study|Withdrawal by Subject|8
7994621|NCT03451071|12577317|FG000|First Vaccine|Withdrawal by Subject|1
7994622|NCT03451071|12577317|FG000|Second Vaccine|Lost to Follow-up|19
7994623|NCT03451071|12577317|FG000|Third Vaccine|Lost to Follow-up|22
7994624|NCT03451071|12577317|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4
7994625|NCT03451084|12577325|FG000|Overall Study|Withdrawal by Subject|2
7994626|NCT03451084|12577326|FG001|Overall Study|Withdrawal by Subject|1
7994627|NCT03451084|12577327|FG002|Overall Study|Withdrawal by Subject|2
7994628|NCT03451084|12577328|FG003|Overall Study|Withdrawal by Subject|1
7994629|NCT03451084|12577325|FG000|Overall Study|Disease recurrence|0
7994630|NCT03451084|12577326|FG001|Overall Study|Disease recurrence|2
7994631|NCT03451084|12577327|FG002|Overall Study|Disease recurrence|0
7994632|NCT03451084|12577328|FG003|Overall Study|Disease recurrence|0
7994633|NCT03451084|12577325|FG000|Overall Study|Lack of Efficacy|0
7994634|NCT03451084|12577326|FG001|Overall Study|Lack of Efficacy|3
7994635|NCT03451084|12577327|FG002|Overall Study|Lack of Efficacy|0
7994636|NCT03451084|12577328|FG003|Overall Study|Lack of Efficacy|1
7994637|NCT03451084|12577325|FG000|Overall Study|Death|1
7994638|NCT03451084|12577326|FG001|Overall Study|Death|0
7994639|NCT03451084|12577327|FG002|Overall Study|Death|2
7994640|NCT03451084|12577328|FG003|Overall Study|Death|0
7994641|NCT03451084|12577325|FG000|Overall Study|Physician Decision|0
7994642|NCT03451084|12577326|FG001|Overall Study|Physician Decision|0
7994643|NCT03451084|12577327|FG002|Overall Study|Physician Decision|2
7994644|NCT03451084|12577328|FG003|Overall Study|Physician Decision|2
7994645|NCT03451084|12577325|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3
7994646|NCT03451084|12577326|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0
7994647|NCT03451084|12577327|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0
7994648|NCT03451084|12577328|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2
7994649|NCT03451721|12577338|FG000|Overall Study|Death|1
7994650|NCT03451773|12577344|FG000|Overall Study|Death on study|1
7994651|NCT03451773|12577345|FG001|Overall Study|Death on study|5
7994652|NCT03451773|12577344|FG000|Overall Study|Death during follow-up period|0
7994653|NCT03451773|12577345|FG001|Overall Study|Death during follow-up period|1
7994654|NCT03452189|12577369|FG000|First Intervention (3 Months)|Adverse Event|1
7994655|NCT03452189|12577370|FG001|First Intervention (3 Months)|Adverse Event|0
7994656|NCT03452189|12577369|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4
7994657|NCT03452189|12577370|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0
7994658|NCT03452527|12577387|FG000|Overall Study|Withdrawal by Subject|1
7994659|NCT03452527|12577388|FG001|Overall Study|Withdrawal by Subject|1
7994660|NCT03452527|12577387|FG000|Overall Study|Study Terminated|2
7994661|NCT03452527|12577388|FG001|Overall Study|Study Terminated|3
7994662|NCT03452943|12577396|FG000|Titration Period (7 Weeks)|Adverse Event|1
7994663|NCT03452943|12577397|FG001|Titration Period (7 Weeks)|Adverse Event|1
7994664|NCT03452943|12577396|FG000|Titration Period (7 Weeks)|Protocol Violation|0
7994665|NCT03452943|12577397|FG001|Titration Period (7 Weeks)|Protocol Violation|1
7994666|NCT03452943|12577396|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3
7994667|NCT03452943|12577397|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2
7994668|NCT03452943|12577396|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1
7994669|NCT03452943|12577397|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0
7994670|NCT03452943|12577396|FG000|Maintenance Period (5 Weeks)|Adverse Event|1
7994671|NCT03452943|12577397|FG001|Maintenance Period (5 Weeks)|Adverse Event|0
7994672|NCT03452943|12577396|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2
7994673|NCT03452943|12577397|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0
7994674|NCT03453151|12577424|FG000|Overall Study|Withdrawal by Subject|1
7994675|NCT03453151|12577424|FG000|Overall Study|Physician Decision|3
7994676|NCT03454412|12577456|FG000|Baseline Assesment|Physician Decision|12
7994677|NCT03455543|12577498|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2
7994678|NCT03455543|12577499|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5
7994679|NCT03455543|12577500|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0
7994680|NCT03455543|12577498|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7
7994681|NCT03455543|12577499|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2
7994682|NCT03455543|12577500|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0
7994683|NCT03455543|12577498|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2
7994684|NCT03455543|12577499|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
7994685|NCT03455543|12577500|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
7994686|NCT03455543|12577498|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
7994687|NCT03455543|12577499|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
7994688|NCT03455543|12577500|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3
7994689|NCT03455543|12577498|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
7994690|NCT03455543|12577499|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
7994691|NCT03455543|12577500|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20
7994692|NCT03455543|12577498|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
7994693|NCT03455543|12577499|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
7994694|NCT03455543|12577500|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7
7994695|NCT03455543|12577498|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
7994696|NCT03455543|12577499|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
7994697|NCT03455543|12577500|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4
7994698|NCT03455543|12577498|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
7994699|NCT03455543|12577499|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
7994700|NCT03455543|12577500|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2
7994701|NCT03455543|12577498|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
7994702|NCT03455543|12577499|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
7994703|NCT03455543|12577500|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1
7994704|NCT03456856|12577517|FG000|Overall Study|Lost to Follow-up|2
7994705|NCT03456856|12577517|FG000|Overall Study|Withdrawal by Subject|1
7994706|NCT03456960|12577527|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7994707|NCT03456960|12577528|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7994708|NCT03456960|12577529|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
7994709|NCT03456960|12577530|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2
7994710|NCT03456960|12577531|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7994711|NCT03456960|12577532|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7994712|NCT03456960|12577527|FG000|Period 2 (1 Day)|Adverse Event|1
7994713|NCT03456960|12577528|FG001|Period 2 (1 Day)|Adverse Event|0
7994714|NCT03456960|12577529|FG002|Period 2 (1 Day)|Adverse Event|0
7994715|NCT03456960|12577530|FG003|Period 2 (1 Day)|Adverse Event|1
7994716|NCT03456960|12577531|FG004|Period 2 (1 Day)|Adverse Event|0
7994717|NCT03456960|12577532|FG005|Period 2 (1 Day)|Adverse Event|0
7994718|NCT03457103|12577550|FG000|Overall Study|illness/hospitalization|4
7994719|NCT03457103|12577551|FG001|Overall Study|illness/hospitalization|2
7994720|NCT03457103|12577550|FG000|Overall Study|Lost to Follow-up|2
7994721|NCT03457103|12577551|FG001|Overall Study|Lost to Follow-up|1
7994722|NCT03457103|12577550|FG000|Overall Study|Withdrawal by Subject|1
7994723|NCT03457103|12577551|FG001|Overall Study|Withdrawal by Subject|2
7994724|NCT03457103|12577550|FG000|Overall Study|financial/ insurance issues|1
7994725|NCT03457103|12577551|FG001|Overall Study|financial/ insurance issues|1
7994726|NCT03457636|12577566|FG000|Overall Study|Lost to Follow-up|2
7994727|NCT03457727|12577574|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
7994728|NCT03457727|12577575|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
7994729|NCT03457727|12577576|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
7994730|NCT03457727|12577577|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1
7994731|NCT03458702|12577613|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4
7994732|NCT03458702|12577614|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6
7994733|NCT03458702|12577613|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4
7994734|NCT03458702|12577614|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2
7994735|NCT03459040|12577624|FG000|Overall Study|Death|8
7994736|NCT03459040|12577624|FG000|Overall Study|Withdrawal by Subject|1
7994737|NCT03459196|12577636|FG000|Overall Study|Subject didn't receive study catheter|2
7994738|NCT03461146|12577697|FG000|Overall Study|Adverse Event|2
7994739|NCT03461146|12577697|FG000|Overall Study|Physician Decision|1
7994740|NCT03461757|12577703|FG000|Overall Study|Adverse Event|1
7994741|NCT03461757|12577704|FG001|Overall Study|Adverse Event|0
7994742|NCT03461757|12577703|FG000|Overall Study|Lost to Follow-up|13
7994743|NCT03461757|12577704|FG001|Overall Study|Lost to Follow-up|7
7994744|NCT03461757|12577703|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28
7994745|NCT03461757|12577704|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25
7994746|NCT03461757|12577703|FG000|Overall Study|Non-compliance with study treatment|0
7994747|NCT03461757|12577704|FG001|Overall Study|Non-compliance with study treatment|1
7994748|NCT03461757|12577703|FG000|Overall Study|Pregnancy|2
7994749|NCT03461757|12577704|FG001|Overall Study|Pregnancy|0
7994750|NCT03461757|12577703|FG000|Overall Study|Protocol Violation|1
7994751|NCT03461757|12577704|FG001|Overall Study|Protocol Violation|1
7994752|NCT03461757|12577703|FG000|Overall Study|Withdrawal by Subject|7
7994753|NCT03461757|12577704|FG001|Overall Study|Withdrawal by Subject|7
7994754|NCT03461757|12577703|FG000|Overall Study|Other Reasons|1
7994755|NCT03461757|12577704|FG001|Overall Study|Other Reasons|4
7994756|NCT03462082|12577719|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0
7994757|NCT03462082|12577720|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0
7994758|NCT03462082|12577721|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0
7994759|NCT03462082|12577722|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0
7994760|NCT03462082|12577723|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0
7994761|NCT03462082|12577724|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0
7994762|NCT03462082|12577725|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1
7994763|NCT03462082|12577726|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2
7994764|NCT03462576|12577739|FG000|Overall Study|Protocol Violation|5
7994765|NCT03462576|12577740|FG001|Overall Study|Protocol Violation|11
7994766|NCT03462576|12577741|FG002|Overall Study|Protocol Violation|7
7994767|NCT03462576|12577739|FG000|Overall Study|Device Malfunction|0
7994768|NCT03462576|12577740|FG001|Overall Study|Device Malfunction|0
7994769|NCT03462576|12577741|FG002|Overall Study|Device Malfunction|1
7994770|NCT03462680|12577751|FG000|Overall Study|Withdrawal by Subject|3
7994771|NCT03462680|12577752|FG001|Overall Study|Withdrawal by Subject|5
7994772|NCT03463031|12577780|FG000|Overall Study|Withdrawal by Subject|4
7994773|NCT03463031|12577781|FG001|Overall Study|Withdrawal by Subject|2
7994774|NCT03463031|12577780|FG000|Overall Study|Investigator/Sponsor Decision|0
7994775|NCT03463031|12577781|FG001|Overall Study|Investigator/Sponsor Decision|1
7994776|NCT03463031|12577780|FG000|Overall Study|Lost to Follow-up|1
7994777|NCT03463031|12577781|FG001|Overall Study|Lost to Follow-up|1
7994778|NCT03463031|12577780|FG000|Overall Study|Adverse Event|4
7994779|NCT03463031|12577781|FG001|Overall Study|Adverse Event|1
7994780|NCT03463031|12577780|FG000|Overall Study|Use of prohibited medication by subject|1
7994781|NCT03463031|12577781|FG001|Overall Study|Use of prohibited medication by subject|0
7994782|NCT03464383|12577823|FG000|Overall Study|Lost to Follow-up|1
7994783|NCT03464383|12577824|FG001|Overall Study|Lost to Follow-up|0
7994784|NCT03464383|12577825|FG002|Overall Study|Lost to Follow-up|0
7994785|NCT03464383|12577823|FG000|Overall Study|Withdrawal by Subject|0
7994786|NCT03464383|12577824|FG001|Overall Study|Withdrawal by Subject|1
7994787|NCT03464383|12577825|FG002|Overall Study|Withdrawal by Subject|0
7994788|NCT03464422|12577834|FG000|Overall Study|Lost to Follow-up|2
7994789|NCT03464422|12577834|FG000|Overall Study|Withdrawal by Subject|2
7994790|NCT03465436|12577844|FG000|Period 1|Protocol Violation|0
7994791|NCT03465436|12577845|FG001|Period 1|Protocol Violation|0
7994792|NCT03465436|12577846|FG002|Period 1|Protocol Violation|1
7994793|NCT03465436|12577847|FG003|Period 1|Protocol Violation|0
7994794|NCT03465436|12577844|FG000|Period 2|Protocol Violation|0
7994795|NCT03465436|12577845|FG001|Period 2|Protocol Violation|1
7994796|NCT03465436|12577846|FG002|Period 2|Protocol Violation|0
7994797|NCT03465436|12577847|FG003|Period 2|Protocol Violation|0
7994798|NCT03465436|12577844|FG000|Period 3|Protocol Violation|1
7994799|NCT03465436|12577845|FG001|Period 3|Protocol Violation|1
7994800|NCT03465436|12577846|FG002|Period 3|Protocol Violation|0
7994801|NCT03465436|12577847|FG003|Period 3|Protocol Violation|0
7994802|NCT03465436|12577844|FG000|Period 4|Protocol Violation|0
7994803|NCT03465436|12577845|FG001|Period 4|Protocol Violation|0
7994804|NCT03465436|12577846|FG002|Period 4|Protocol Violation|1
7994805|NCT03465436|12577847|FG003|Period 4|Protocol Violation|0
7994806|NCT03465709|12577859|FG000|Overall Study|Study/Site Terminated by Sponsor|14
7994807|NCT03465709|12577859|FG000|Overall Study|Withdrawal by Subject|3
7994808|NCT03465722|12577867|FG000|End of Treatment|Patient Refused Treatment|3
7994809|NCT03465722|12577868|FG001|End of Treatment|Patient Refused Treatment|1
7994810|NCT03465722|12577867|FG000|End of Treatment|Withdrawal by Subject|6
7994811|NCT03465722|12577868|FG001|End of Treatment|Withdrawal by Subject|1
7994812|NCT03465722|12577867|FG000|End of Treatment|Adverse Event|30
7994813|NCT03465722|12577868|FG001|End of Treatment|Adverse Event|23
7994814|NCT03465722|12577867|FG000|End of Treatment|Disease Progression (Confirmed by Central Review)|102
7994815|NCT03465722|12577868|FG001|End of Treatment|Disease Progression (Confirmed by Central Review)|101
7994816|NCT03465722|12577867|FG000|End of Treatment|Clinical Progression|17
7994817|NCT03465722|12577868|FG001|End of Treatment|Clinical Progression|5
7994818|NCT03465722|12577867|FG000|End of Treatment|Physician Decision|4
7994819|NCT03465722|12577868|FG001|End of Treatment|Physician Decision|5
7994820|NCT03465722|12577867|FG000|End of Treatment|Lost to Follow-up|3
7994821|NCT03465722|12577868|FG001|End of Treatment|Lost to Follow-up|1
7994822|NCT03465722|12577867|FG000|End of Treatment|Administrative/Other|6
7994823|NCT03465722|12577868|FG001|End of Treatment|Administrative/Other|3
7994824|NCT03465722|12577867|FG000|End of Treatment|Treatment Ongoing|68
7994825|NCT03465722|12577868|FG001|End of Treatment|Treatment Ongoing|94
7994826|NCT03465722|12577867|FG000|End of Treatment|Randomized But Not Treated|1
7994827|NCT03465722|12577868|FG001|End of Treatment|Randomized But Not Treated|2
7994828|NCT03465722|12577867|FG000|End of Study|Withdrawal by Subject|17
7994829|NCT03465722|12577868|FG001|End of Study|Withdrawal by Subject|7
7994830|NCT03465722|12577867|FG000|End of Study|Death|57
7994831|NCT03465722|12577868|FG001|End of Study|Death|57
7994832|NCT03465722|12577867|FG000|End of Study|Lost to Follow-up|5
7994833|NCT03465722|12577868|FG001|End of Study|Lost to Follow-up|2
7994834|NCT03465722|12577867|FG000|End of Study|Administrative/Other|4
7994835|NCT03465722|12577868|FG001|End of Study|Administrative/Other|2
7994836|NCT03465722|12577867|FG000|End of Study|On Treatment or in Follow Up|157
7994837|NCT03465722|12577868|FG001|End of Study|On Treatment or in Follow Up|168
7994838|NCT03465878|12577876|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
7994839|NCT03465878|12577877|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1
7994840|NCT03465878|12577878|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
7994841|NCT03465878|12577879|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
7994842|NCT03465878|12577876|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
7994843|NCT03465878|12577877|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
7994844|NCT03465878|12577878|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
7994845|NCT03465878|12577879|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1
7994846|NCT03465878|12577876|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0
7994847|NCT03465878|12577877|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0
7994848|NCT03465878|12577878|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0
7994849|NCT03465878|12577879|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1
7994850|NCT03465904|12577907|FG000|Overall Study|Withdrawal by Subject|9
7994851|NCT03465904|12577908|FG001|Overall Study|Withdrawal by Subject|5
7994852|NCT03465904|12577907|FG000|Overall Study|Lost to Follow-up|10
7994853|NCT03465904|12577908|FG001|Overall Study|Lost to Follow-up|9
7994854|NCT03465904|12577907|FG000|Overall Study|Protocol Violation|8
7994855|NCT03465904|12577908|FG001|Overall Study|Protocol Violation|5
7994856|NCT03465904|12577907|FG000|Overall Study|Ineligible for mITT analysis|62
7994857|NCT03465904|12577908|FG001|Overall Study|Ineligible for mITT analysis|47
7994858|NCT03466060|12577943|FG000|Period 1|Test Lens Damage|0
7994859|NCT03466060|12577944|FG001|Period 1|Test Lens Damage|2
7994860|NCT03466060|12577945|FG002|Period 1|Test Lens Damage|0
7994861|NCT03466060|12577946|FG003|Period 1|Test Lens Damage|0
7994862|NCT03466060|12577947|FG004|Period 1|Test Lens Damage|0
7994863|NCT03466060|12577948|FG005|Period 1|Test Lens Damage|0
7994864|NCT03466060|12577943|FG000|Period 1|Withdrawal by Subject|0
7994865|NCT03466060|12577944|FG001|Period 1|Withdrawal by Subject|0
7994866|NCT03466060|12577945|FG002|Period 1|Withdrawal by Subject|2
7994867|NCT03466060|12577946|FG003|Period 1|Withdrawal by Subject|0
7994868|NCT03466060|12577947|FG004|Period 1|Withdrawal by Subject|0
7994869|NCT03466060|12577948|FG005|Period 1|Withdrawal by Subject|0
7994870|NCT03466060|12577943|FG000|Period 1|Lost to Follow-up|0
7994871|NCT03466060|12577944|FG001|Period 1|Lost to Follow-up|0
7994872|NCT03466060|12577945|FG002|Period 1|Lost to Follow-up|0
7994873|NCT03466060|12577946|FG003|Period 1|Lost to Follow-up|1
7994874|NCT03466060|12577947|FG004|Period 1|Lost to Follow-up|0
7994875|NCT03466060|12577948|FG005|Period 1|Lost to Follow-up|0
7994876|NCT03466060|12577943|FG000|Period 1|Grade 2 Conjunctivitis|0
7994877|NCT03466060|12577944|FG001|Period 1|Grade 2 Conjunctivitis|0
7994878|NCT03466060|12577945|FG002|Period 1|Grade 2 Conjunctivitis|1
7994879|NCT03466060|12577946|FG003|Period 1|Grade 2 Conjunctivitis|0
7994880|NCT03466060|12577947|FG004|Period 1|Grade 2 Conjunctivitis|0
7994881|NCT03466060|12577948|FG005|Period 1|Grade 2 Conjunctivitis|0
7994882|NCT03466060|12577943|FG000|Period 2|Lens Handling Difficulties|0
7994883|NCT03466060|12577944|FG001|Period 2|Lens Handling Difficulties|0
7994884|NCT03466060|12577945|FG002|Period 2|Lens Handling Difficulties|1
7994885|NCT03466060|12577946|FG003|Period 2|Lens Handling Difficulties|0
7994886|NCT03466060|12577947|FG004|Period 2|Lens Handling Difficulties|0
7994887|NCT03466060|12577948|FG005|Period 2|Lens Handling Difficulties|0
7994888|NCT03466073|12577968|FG000|Overall Study|Death|1
7994889|NCT03466073|12577969|FG001|Overall Study|Death|0
7994890|NCT03466073|12577970|FG002|Overall Study|Death|0
7994891|NCT03466073|12577971|FG003|Overall Study|Death|0
7994892|NCT03466073|12577972|FG004|Overall Study|Death|0
7994893|NCT03466073|12577973|FG005|Overall Study|Death|1
7994894|NCT03466086|12577994|FG000|Period 1|Sponsor decision due to study timeline|1
7994895|NCT03466086|12577995|FG001|Period 1|Sponsor decision due to study timeline|0
7994896|NCT03466086|12577994|FG000|Period 1|Withdrawal by Subject|1
7994897|NCT03466086|12577995|FG001|Period 1|Withdrawal by Subject|0
7994898|NCT03466099|12578004|FG000|Overall Study|Adverse Event|1
7994899|NCT03466099|12578005|FG001|Overall Study|Adverse Event|1
7994900|NCT03466099|12578006|FG002|Overall Study|Adverse Event|1
7994901|NCT03466099|12578004|FG000|Overall Study|Withdrawal by Subject|2
7994902|NCT03466099|12578005|FG001|Overall Study|Withdrawal by Subject|3
7994903|NCT03466099|12578006|FG002|Overall Study|Withdrawal by Subject|1
7994904|NCT03466099|12578004|FG000|Overall Study|Use of rescue medication|8
7994905|NCT03466099|12578005|FG001|Overall Study|Use of rescue medication|9
7994906|NCT03466099|12578006|FG002|Overall Study|Use of rescue medication|13
7994907|NCT03466099|12578004|FG000|Overall Study|Rescued without meeting criteria|4
7994908|NCT03466099|12578005|FG001|Overall Study|Rescued without meeting criteria|1
7994909|NCT03466099|12578006|FG002|Overall Study|Rescued without meeting criteria|1
7994910|NCT03466099|12578004|FG000|Overall Study|Subject compliance|2
7994911|NCT03466099|12578005|FG001|Overall Study|Subject compliance|0
7994912|NCT03466099|12578006|FG002|Overall Study|Subject compliance|0
7994913|NCT03466099|12578004|FG000|Overall Study|Worsening disease|0
7994914|NCT03466099|12578005|FG001|Overall Study|Worsening disease|0
7994915|NCT03466099|12578006|FG002|Overall Study|Worsening disease|1
7994916|NCT03467217|12578025|FG000|Overall Study|Trial stopped early|5
7994917|NCT03467217|12578026|FG001|Overall Study|Trial stopped early|2
7994918|NCT03467217|12578025|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5
7994919|NCT03467217|12578026|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2
7994920|NCT03467217|12578025|FG000|Overall Study|Lost to Follow-up|0
7994921|NCT03467217|12578026|FG001|Overall Study|Lost to Follow-up|2
7994922|NCT03467425|12578057|FG000|Overall Study|Adverse Event|9
7994923|NCT03467425|12578058|FG001|Overall Study|Adverse Event|9
7994924|NCT03467425|12578057|FG000|Overall Study|Lack of Efficacy|3
7994925|NCT03467425|12578058|FG001|Overall Study|Lack of Efficacy|1
7994926|NCT03467425|12578057|FG000|Overall Study|Protocol Violation|0
7994927|NCT03467425|12578058|FG001|Overall Study|Protocol Violation|1
7994928|NCT03467425|12578057|FG000|Overall Study|Lost to Follow-up|18
7994929|NCT03467425|12578058|FG001|Overall Study|Lost to Follow-up|25
7994930|NCT03467425|12578057|FG000|Overall Study|Physician Decision|2
7994931|NCT03467425|12578058|FG001|Overall Study|Physician Decision|1
7994932|NCT03467425|12578057|FG000|Overall Study|Withdrawal by Subject|15
7994933|NCT03467425|12578058|FG001|Overall Study|Withdrawal by Subject|17
7994934|NCT03467763|12578080|FG000|Overall Study|Lost to Follow-up|1
7994935|NCT03467763|12578080|FG000|Overall Study|Protocol Violation|2
7994936|NCT03467945|12578090|FG000|Treatment Period 2|Withdrawal by Subject|0
7994937|NCT03467945|12578091|FG001|Treatment Period 2|Withdrawal by Subject|1
7994938|NCT03467945|12578092|FG002|Treatment Period 2|Withdrawal by Subject|0
7994939|NCT03467945|12578093|FG003|Treatment Period 2|Withdrawal by Subject|0
7994940|NCT03467945|12578090|FG000|Treatment Period 3|Withdrawal by Subject|1
7994941|NCT03467945|12578091|FG001|Treatment Period 3|Withdrawal by Subject|0
7994942|NCT03467945|12578092|FG002|Treatment Period 3|Withdrawal by Subject|2
7994943|NCT03467945|12578093|FG003|Treatment Period 3|Withdrawal by Subject|1
7994944|NCT03467971|12578106|FG000|Treatment Period 2|Withdrawal by Subject|0
7994945|NCT03467971|12578107|FG001|Treatment Period 2|Withdrawal by Subject|1
7994946|NCT03468543|12578125|FG000|Overall Study|Protocol stopping rules met|3
7994947|NCT03468855|12578140|FG000|Overall Study|Adverse Event|2
7994948|NCT03468855|12578140|FG000|Overall Study|Lost to Follow-up|5
7994949|NCT03468855|12578140|FG000|Overall Study|Withdrawal by Subject|3
7994950|NCT03468855|12578140|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1
7994951|NCT03469336|12578162|FG000|Overall Study|Adverse Event|1
7994952|NCT03469349|12578174|FG000|Overall Study|Withdrawal by Subject|1
7994953|NCT03469349|12578175|FG001|Overall Study|Withdrawal by Subject|3
7994954|NCT03469349|12578174|FG000|Overall Study|Progressive Disease|0
7994955|NCT03469349|12578175|FG001|Overall Study|Progressive Disease|1
7994956|NCT03469349|12578174|FG000|Overall Study|Lost to Follow-up|2
7994957|NCT03469349|12578175|FG001|Overall Study|Lost to Follow-up|2
7994958|NCT03469349|12578174|FG000|Overall Study|Adverse Event|2
7994959|NCT03469349|12578175|FG001|Overall Study|Adverse Event|4
7994960|NCT03470194|12578187|FG000|Overall Study|Lost to Follow-up|11
7994961|NCT03470194|12578188|FG001|Overall Study|Lost to Follow-up|17
7994962|NCT03470545|12578200|FG000|Overall Study|Death|0
7994963|NCT03470545|12578201|FG001|Overall Study|Death|1
7994964|NCT03470545|12578200|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1
7994965|NCT03470545|12578201|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0
7994966|NCT03470545|12578200|FG000|Overall Study|Adverse Event|2
7994967|NCT03470545|12578201|FG001|Overall Study|Adverse Event|0
7994968|NCT03470545|12578200|FG000|Overall Study|Withdrawal by Subject|1
7994969|NCT03470545|12578201|FG001|Overall Study|Withdrawal by Subject|1
7994970|NCT03470545|12578200|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0
7994971|NCT03470545|12578201|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1
7994972|NCT03471078|12578224|FG000|Overall Study|Withdrawal by Subject|9
7994973|NCT03471078|12578225|FG001|Overall Study|Withdrawal by Subject|1
7994974|NCT03471078|12578224|FG000|Overall Study|Adverse Event|4
7994975|NCT03471078|12578225|FG001|Overall Study|Adverse Event|1
7994976|NCT03471078|12578224|FG000|Overall Study|Physician Decision|3
7994977|NCT03471078|12578225|FG001|Overall Study|Physician Decision|2
7994978|NCT03471078|12578224|FG000|Overall Study|Death|2
7994979|NCT03471078|12578225|FG001|Overall Study|Death|0
7994980|NCT03471078|12578224|FG000|Overall Study|Other|3
7994981|NCT03471078|12578225|FG001|Overall Study|Other|2
7994982|NCT03471871|12578242|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7994983|NCT03471871|12578243|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7994984|NCT03471871|12578244|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1
7994985|NCT03471871|12578245|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7994986|NCT03471871|12578246|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7994987|NCT03471871|12578242|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
7994988|NCT03471871|12578243|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
7994989|NCT03471871|12578244|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
7994990|NCT03471871|12578245|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
7994991|NCT03471871|12578246|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
7994992|NCT03471871|12578242|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7994993|NCT03471871|12578243|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7994994|NCT03471871|12578244|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7994995|NCT03471871|12578245|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7994996|NCT03471871|12578246|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1
7994997|NCT03471871|12578242|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7994998|NCT03471871|12578243|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7994999|NCT03471871|12578244|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7995000|NCT03471871|12578245|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7995001|NCT03471871|12578246|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1
7995002|NCT03471871|12578242|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7995003|NCT03471871|12578243|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7995004|NCT03471871|12578244|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7995005|NCT03471871|12578245|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1
7995006|NCT03471871|12578246|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7995007|NCT03472014|12578267|FG000|Overall Study|Lost to Follow-up|4
7995008|NCT03472326|12578282|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0
7995009|NCT03472326|12578283|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0
7995010|NCT03472326|12578284|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1
7995011|NCT03472326|12578285|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2
7995012|NCT03472326|12578282|FG000|Part 2: Combination Therapy|Pregnancy|0
7995013|NCT03472326|12578283|FG001|Part 2: Combination Therapy|Pregnancy|0
7995014|NCT03472326|12578284|FG002|Part 2: Combination Therapy|Pregnancy|0
7995015|NCT03472326|12578285|FG003|Part 2: Combination Therapy|Pregnancy|1
7995016|NCT03472534|12578303|FG000|Overall Study|Withdrawal by Subject|9
7995017|NCT03472534|12578303|FG000|Overall Study|Adverse Event|2
7995018|NCT03472547|12578307|FG000|Overall Study|Withdrawal by Subject|30
7995019|NCT03473197|12578319|FG000|Overall Study|Adverse Event|4
7995020|NCT03473197|12578319|FG000|Overall Study|Lost to Follow-up|1
7995021|NCT03473197|12578319|FG000|Overall Study|Withdrawal by Subject|5
7995022|NCT03473236|12578333|FG000|Overall Study|Withdrawal by Subject|0
7995023|NCT03473236|12578334|FG001|Overall Study|Withdrawal by Subject|0
7995024|NCT03473236|12578335|FG002|Overall Study|Withdrawal by Subject|0
7995025|NCT03473236|12578336|FG003|Overall Study|Withdrawal by Subject|0
7995026|NCT03473236|12578337|FG004|Overall Study|Withdrawal by Subject|0
7995027|NCT03473236|12578338|FG005|Overall Study|Withdrawal by Subject|1
7995028|NCT03473236|12578339|FG006|Overall Study|Withdrawal by Subject|0
7995029|NCT03473236|12578340|FG007|Overall Study|Withdrawal by Subject|0
7995030|NCT03473236|12578341|FG008|Overall Study|Withdrawal by Subject|1
7995031|NCT03473236|12578342|FG009|Overall Study|Withdrawal by Subject|0
7995032|NCT03473301|12578375|FG000|Overall Study|Protocol Violation|4
7995033|NCT03473301|12578376|FG001|Overall Study|Protocol Violation|0
7995034|NCT03473301|12578377|FG002|Overall Study|Protocol Violation|0
7995035|NCT03473301|12578375|FG000|Overall Study|Withdrawal by Subject|0
7995036|NCT03473301|12578376|FG001|Overall Study|Withdrawal by Subject|1
7995037|NCT03473301|12578377|FG002|Overall Study|Withdrawal by Subject|0
7995038|NCT03473301|12578375|FG000|Overall Study|Missed study visit due to pandemic restrictions|7
7995039|NCT03473301|12578376|FG001|Overall Study|Missed study visit due to pandemic restrictions|5
7995040|NCT03473301|12578377|FG002|Overall Study|Missed study visit due to pandemic restrictions|6
7995041|NCT03473808|12578396|FG000|Overall Study|Withdrawal by Subject|1
7995042|NCT03474081|12578406|FG000|Overall Study|Adverse Event|6
7995043|NCT03474081|12578407|FG001|Overall Study|Adverse Event|3
7995044|NCT03474081|12578406|FG000|Overall Study|Lost to Follow-up|2
7995045|NCT03474081|12578407|FG001|Overall Study|Lost to Follow-up|1
7995046|NCT03474081|12578406|FG000|Overall Study|Physician Decision|3
7995047|NCT03474081|12578407|FG001|Overall Study|Physician Decision|2
7995048|NCT03474081|12578406|FG000|Overall Study|Withdrawal by Subject|5
7995049|NCT03474081|12578407|FG001|Overall Study|Withdrawal by Subject|7
7995050|NCT03474081|12578406|FG000|Overall Study|Investigator site closed|1
7995051|NCT03474081|12578407|FG001|Overall Study|Investigator site closed|0
7995052|NCT03475316|12578437|FG000|6 Month Intervention|Adverse Event|2
7995053|NCT03475316|12578438|FG001|6 Month Intervention|Adverse Event|1
7995054|NCT03475316|12578437|FG000|6 Month Intervention|Withdrawal by Subject|2
7995055|NCT03475316|12578438|FG001|6 Month Intervention|Withdrawal by Subject|0
7995056|NCT03475316|12578437|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1
7995057|NCT03475316|12578438|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3
7995058|NCT03475316|12578437|FG000|9 Months|Study stopped due to COVID pandemic|3
7995059|NCT03475316|12578438|FG001|9 Months|Study stopped due to COVID pandemic|4
7995060|NCT03475875|12578444|FG000|Period 1|Lost to Follow-up|1
7995061|NCT03475875|12578445|FG001|Period 1|Lost to Follow-up|0
7995062|NCT03475875|12578444|FG000|Period 1|Adverse Event|2
7995063|NCT03475875|12578445|FG001|Period 1|Adverse Event|1
7995064|NCT03475875|12578444|FG000|Period 2|Adverse Event|3
7995065|NCT03475875|12578445|FG001|Period 2|Adverse Event|0
7995066|NCT03475875|12578444|FG000|Period 2|Protocol Violation|0
7995067|NCT03475875|12578445|FG001|Period 2|Protocol Violation|1
7995068|NCT03477838|12578518|FG000|Overall Study|Lost to Follow-up|14
7995069|NCT03478371|12578536|FG000|Overall Study|non-compliance|1
7995070|NCT03478371|12578536|FG000|Overall Study|Lost to Follow-up|4
7995071|NCT03478644|12578548|FG000|Phase 2|Withdrawal by Subject|2
7995072|NCT03478644|12578549|FG001|Phase 2|Withdrawal by Subject|1
7995073|NCT03478644|12578548|FG000|Phase 2|Lost to Follow-up|1
7995074|NCT03478644|12578549|FG001|Phase 2|Lost to Follow-up|0
7995075|NCT03478657|12578557|FG000|Overall Study|Withdrawal by Subject|0
7995076|NCT03478657|12578558|FG001|Overall Study|Withdrawal by Subject|1
7995077|NCT03478683|12578566|FG000|Overall Study|Adverse Event|5
7995078|NCT03478683|12578567|FG001|Overall Study|Adverse Event|3
7995079|NCT03478683|12578566|FG000|Overall Study|Lost to Follow-up|0
7995080|NCT03478683|12578567|FG001|Overall Study|Lost to Follow-up|5
7995081|NCT03478683|12578566|FG000|Overall Study|Physician Decision|1
7995082|NCT03478683|12578567|FG001|Overall Study|Physician Decision|3
7995083|NCT03478683|12578566|FG000|Overall Study|Withdrawal by Subject|7
7995084|NCT03478683|12578567|FG001|Overall Study|Withdrawal by Subject|7
7995085|NCT03478696|12578575|FG000|Overall Study|Adverse Event|1
7995086|NCT03478696|12578576|FG001|Overall Study|Adverse Event|5
7995087|NCT03478696|12578575|FG000|Overall Study|Lost to Follow-up|1
7995088|NCT03478696|12578576|FG001|Overall Study|Lost to Follow-up|0
7995089|NCT03478696|12578575|FG000|Overall Study|Physician Decision|6
7995090|NCT03478696|12578576|FG001|Overall Study|Physician Decision|3
7995091|NCT03478696|12578575|FG000|Overall Study|Withdrawal by Subject|9
7995092|NCT03478696|12578576|FG001|Overall Study|Withdrawal by Subject|4
7995093|NCT03478787|12578584|FG000|Overall Study|Adverse Event|5
7995094|NCT03478787|12578585|FG001|Overall Study|Adverse Event|1
7995095|NCT03478787|12578584|FG000|Overall Study|Protocol Violation|3
7995096|NCT03478787|12578585|FG001|Overall Study|Protocol Violation|0
7995097|NCT03478787|12578584|FG000|Overall Study|Lack of Efficacy|7
7995098|NCT03478787|12578585|FG001|Overall Study|Lack of Efficacy|1
7995099|NCT03478787|12578584|FG000|Overall Study|Lost to Follow-up|9
7995100|NCT03478787|12578585|FG001|Overall Study|Lost to Follow-up|5
7995101|NCT03478787|12578584|FG000|Overall Study|Withdrawal by Subject|2
7995102|NCT03478787|12578585|FG001|Overall Study|Withdrawal by Subject|6
7995103|NCT03478787|12578584|FG000|Overall Study|Other, Not Specified|3
7995104|NCT03478787|12578585|FG001|Overall Study|Other, Not Specified|0
7995105|NCT03478891|12578594|FG000|Overall Study|Enrolled, but product never administered|0
7995106|NCT03478891|12578595|FG001|Overall Study|Enrolled, but product never administered|0
7995107|NCT03478891|12578596|FG002|Overall Study|Enrolled, but product never administered|1
7995108|NCT03478891|12578594|FG000|Overall Study|Moved from area|0
7995109|NCT03478891|12578595|FG001|Overall Study|Moved from area|0
7995110|NCT03478891|12578596|FG002|Overall Study|Moved from area|1
7995111|NCT03478891|12578594|FG000|Overall Study|Lost to Follow-up|1
7995112|NCT03478891|12578595|FG001|Overall Study|Lost to Follow-up|0
7995113|NCT03478891|12578596|FG002|Overall Study|Lost to Follow-up|1
7995114|NCT03478969|12578622|FG000|Overall Study|Withdrawal by Subject|4
7995115|NCT03478969|12578623|FG001|Overall Study|Withdrawal by Subject|7
7995116|NCT03478969|12578624|FG002|Overall Study|Withdrawal by Subject|6
7995117|NCT03478969|12578622|FG000|Overall Study|Adverse Event|2
7995118|NCT03478969|12578623|FG001|Overall Study|Adverse Event|0
7995119|NCT03478969|12578624|FG002|Overall Study|Adverse Event|1
7995120|NCT03478969|12578622|FG000|Overall Study|Pregnancy|1
7995121|NCT03478969|12578623|FG001|Overall Study|Pregnancy|0
7995122|NCT03478969|12578624|FG002|Overall Study|Pregnancy|0
7995123|NCT03478969|12578622|FG000|Overall Study|Personal Reasons|1
7995124|NCT03478969|12578623|FG001|Overall Study|Personal Reasons|0
7995125|NCT03478969|12578624|FG002|Overall Study|Personal Reasons|1
7995126|NCT03478969|12578622|FG000|Overall Study|Covid-19|1
7995127|NCT03478969|12578623|FG001|Overall Study|Covid-19|4
7995128|NCT03478969|12578624|FG002|Overall Study|Covid-19|3
7995129|NCT03478969|12578622|FG000|Overall Study|Multiple Reasons|0
7995130|NCT03478969|12578623|FG001|Overall Study|Multiple Reasons|1
7995131|NCT03478969|12578624|FG002|Overall Study|Multiple Reasons|1
7995132|NCT03478969|12578622|FG000|Overall Study|Eligibility Criteria|0
7995133|NCT03478969|12578623|FG001|Overall Study|Eligibility Criteria|0
7995134|NCT03478969|12578624|FG002|Overall Study|Eligibility Criteria|5
7995135|NCT03478969|12578622|FG000|Overall Study|Lost to Follow-up|0
7995136|NCT03478969|12578623|FG001|Overall Study|Lost to Follow-up|0
7995137|NCT03478969|12578624|FG002|Overall Study|Lost to Follow-up|1
7995138|NCT03479216|12578653|FG000|Overall Study|Withdrawal by Subject|3
7995139|NCT03479216|12578654|FG001|Overall Study|Withdrawal by Subject|2
7995140|NCT03479216|12578653|FG000|Overall Study|Physician Decision|2
7995141|NCT03479216|12578654|FG001|Overall Study|Physician Decision|3
7995142|NCT03480009|12578672|FG000|Overall Study|Lost to Follow-up|4
7995143|NCT03480009|12578673|FG001|Overall Study|Lost to Follow-up|5
7995144|NCT03480009|12578674|FG002|Overall Study|Lost to Follow-up|4
7995145|NCT03480009|12578675|FG003|Overall Study|Lost to Follow-up|0
7995146|NCT03480022|12578690|FG000|Overall Study|Pregnancy|2
7995147|NCT03480022|12578691|FG001|Overall Study|Pregnancy|0
7995148|NCT03480022|12578690|FG000|Overall Study|Adverse Event|6
7995149|NCT03480022|12578691|FG001|Overall Study|Adverse Event|0
7995150|NCT03480022|12578690|FG000|Overall Study|Lack of Efficacy|0
7995151|NCT03480022|12578691|FG001|Overall Study|Lack of Efficacy|2
7995152|NCT03480022|12578690|FG000|Overall Study|Physician Decision|0
7995153|NCT03480022|12578691|FG001|Overall Study|Physician Decision|1
7995154|NCT03480022|12578690|FG000|Overall Study|Withdrawal by Subject|2
7995155|NCT03480022|12578691|FG001|Overall Study|Withdrawal by Subject|0
7995156|NCT03480022|12578690|FG000|Overall Study|Medication concerns|1
7995157|NCT03480022|12578691|FG001|Overall Study|Medication concerns|0
7995158|NCT03480022|12578690|FG000|Overall Study|Family member COVID exposure|0
7995159|NCT03480022|12578691|FG001|Overall Study|Family member COVID exposure|1
7995160|NCT03480152|12578708|FG000|Phase I|Signed consent. Died before treatment.|1
7995161|NCT03480152|12578709|FG001|Phase I|Signed consent. Died before treatment.|0
7995162|NCT03480152|12578710|FG002|Phase I|Signed consent. Died before treatment.|0
7995163|NCT03480243|12578718|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1
7995164|NCT03480243|12578718|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1
7995165|NCT03480425|12578731|FG000|Overall Study|Force transducer technical failure|1
7995166|NCT03480750|12578747|FG000|Overall Study|Withdrawal by Subject|0
7995167|NCT03480750|12578748|FG001|Overall Study|Withdrawal by Subject|1
7995168|NCT03480750|12578749|FG002|Overall Study|Withdrawal by Subject|0
7995169|NCT03480750|12578750|FG003|Overall Study|Withdrawal by Subject|0
7995170|NCT03480750|12578751|FG004|Overall Study|Withdrawal by Subject|0
7995171|NCT03480750|12578752|FG005|Overall Study|Withdrawal by Subject|0
7995172|NCT03480750|12578747|FG000|Overall Study|The interruption in Trientine shippment|0
7995173|NCT03480750|12578748|FG001|Overall Study|The interruption in Trientine shippment|0
7995174|NCT03480750|12578749|FG002|Overall Study|The interruption in Trientine shippment|0
7995175|NCT03480750|12578750|FG003|Overall Study|The interruption in Trientine shippment|0
7995176|NCT03480750|12578751|FG004|Overall Study|The interruption in Trientine shippment|0
7995177|NCT03480750|12578752|FG005|Overall Study|The interruption in Trientine shippment|1
7995178|NCT03480763|12578777|FG000|Overall Study|Withdrawal by Subject|18
7995179|NCT03480763|12578778|FG001|Overall Study|Withdrawal by Subject|10
7995180|NCT03480763|12578777|FG000|Overall Study|Lost to Follow-up|4
7995181|NCT03480763|12578778|FG001|Overall Study|Lost to Follow-up|7
7995182|NCT03480763|12578777|FG000|Overall Study|non-study pneumococcal vaccine|1
7995183|NCT03480763|12578778|FG001|Overall Study|non-study pneumococcal vaccine|0
7995184|NCT03480763|12578777|FG000|Overall Study|oncological treatment|0
7995185|NCT03480763|12578778|FG001|Overall Study|oncological treatment|2
7995186|NCT03480763|12578777|FG000|Overall Study|pain with vaccination|1
7995187|NCT03480763|12578778|FG001|Overall Study|pain with vaccination|0
7995188|NCT03480841|12578790|FG000|Overall Study|Lost to Follow-up|2
7995189|NCT03480932|12578810|FG000|Overall Study|Death|1
7995190|NCT03480932|12578811|FG001|Overall Study|Death|1
7995191|NCT03480932|12578812|FG002|Overall Study|Death|0
7995192|NCT03480932|12578810|FG000|Overall Study|Lost to Follow-up|0
7995193|NCT03480932|12578811|FG001|Overall Study|Lost to Follow-up|2
7995194|NCT03480932|12578812|FG002|Overall Study|Lost to Follow-up|3
7995195|NCT03480932|12578810|FG000|Overall Study|Incarcerated|2
7995196|NCT03480932|12578811|FG001|Overall Study|Incarcerated|2
7995197|NCT03480932|12578812|FG002|Overall Study|Incarcerated|2
7995198|NCT03481309|12578835|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1
7995199|NCT03481309|12578836|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0
7995200|NCT03481309|12578837|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0
7995201|NCT03481309|12578838|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0
7995202|NCT03481309|12578839|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0
7995203|NCT03481309|12578840|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0
7995204|NCT03481725|12578859|FG000|Overall Study|Withdrawal by Subject|1
7995205|NCT03481725|12578860|FG001|Overall Study|Withdrawal by Subject|0
7995206|NCT03481816|12578870|FG000|Starting Dose|Refused further vaccines after 1 dose|1
7995207|NCT03481816|12578871|FG001|Starting Dose|Refused further vaccines after 1 dose|0
7995208|NCT03481816|12578870|FG000|Dose Expansion|Off treatment due to progressive disease|0
7995209|NCT03481816|12578871|FG001|Dose Expansion|Off treatment due to progressive disease|5
7995210|NCT03481816|12578870|FG000|Dose Expansion|Withdrawal by Subject|0
7995211|NCT03481816|12578871|FG001|Dose Expansion|Withdrawal by Subject|2
7995212|NCT03481816|12578870|FG000|Dose Expansion|Physician Decision|0
7995213|NCT03481816|12578871|FG001|Dose Expansion|Physician Decision|5
7995214|NCT03482011|12578881|FG000|Induction Period (16 Weeks)|Adverse Event|1
7995215|NCT03482011|12578882|FG001|Induction Period (16 Weeks)|Adverse Event|3
7995216|NCT03482011|12578883|FG002|Induction Period (16 Weeks)|Adverse Event|0
7995217|NCT03482011|12578884|FG003|Induction Period (16 Weeks)|Adverse Event|0
7995218|NCT03482011|12578885|FG004|Induction Period (16 Weeks)|Adverse Event|0
7995219|NCT03482011|12578886|FG005|Induction Period (16 Weeks)|Adverse Event|0
7995220|NCT03482011|12578887|FG006|Induction Period (16 Weeks)|Adverse Event|0
7995221|NCT03482011|12578888|FG007|Induction Period (16 Weeks)|Adverse Event|0
7995222|NCT03482011|12578881|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3
7995223|NCT03482011|12578882|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1
7995224|NCT03482011|12578883|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0
7995225|NCT03482011|12578884|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0
7995226|NCT03482011|12578885|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0
7995227|NCT03482011|12578886|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0
7995228|NCT03482011|12578887|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0
7995229|NCT03482011|12578888|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0
7995230|NCT03482011|12578881|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0
7995231|NCT03482011|12578882|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1
7995232|NCT03482011|12578883|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0
7995233|NCT03482011|12578884|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0
7995234|NCT03482011|12578885|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0
7995235|NCT03482011|12578886|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0
7995236|NCT03482011|12578887|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0
7995237|NCT03482011|12578888|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0
7995238|NCT03482011|12578881|FG000|Induction Period (16 Weeks)|Screen Failure|0
7995239|NCT03482011|12578882|FG001|Induction Period (16 Weeks)|Screen Failure|1
7995240|NCT03482011|12578883|FG002|Induction Period (16 Weeks)|Screen Failure|0
7995241|NCT03482011|12578884|FG003|Induction Period (16 Weeks)|Screen Failure|0
7995242|NCT03482011|12578885|FG004|Induction Period (16 Weeks)|Screen Failure|0
7995243|NCT03482011|12578886|FG005|Induction Period (16 Weeks)|Screen Failure|0
7995244|NCT03482011|12578887|FG006|Induction Period (16 Weeks)|Screen Failure|0
7995245|NCT03482011|12578888|FG007|Induction Period (16 Weeks)|Screen Failure|0
7995246|NCT03482011|12578881|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2
7995247|NCT03482011|12578882|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5
7995248|NCT03482011|12578883|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
7995249|NCT03482011|12578884|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0
7995250|NCT03482011|12578885|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
7995251|NCT03482011|12578886|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
7995252|NCT03482011|12578887|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
7995253|NCT03482011|12578888|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
7995254|NCT03482011|12578881|FG000|Maintenance Period (36 Weeks)|Adverse Event|0
7995255|NCT03482011|12578882|FG001|Maintenance Period (36 Weeks)|Adverse Event|0
7995256|NCT03482011|12578883|FG002|Maintenance Period (36 Weeks)|Adverse Event|0
7995257|NCT03482011|12578884|FG003|Maintenance Period (36 Weeks)|Adverse Event|0
7995258|NCT03482011|12578885|FG004|Maintenance Period (36 Weeks)|Adverse Event|0
7995259|NCT03482011|12578886|FG005|Maintenance Period (36 Weeks)|Adverse Event|1
7995260|NCT03482011|12578887|FG006|Maintenance Period (36 Weeks)|Adverse Event|1
7995261|NCT03482011|12578888|FG007|Maintenance Period (36 Weeks)|Adverse Event|4
7995262|NCT03482011|12578881|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0
7995263|NCT03482011|12578882|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0
7995264|NCT03482011|12578883|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1
7995265|NCT03482011|12578884|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2
7995266|NCT03482011|12578885|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1
7995267|NCT03482011|12578886|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1
7995268|NCT03482011|12578887|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0
7995269|NCT03482011|12578888|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9
7995270|NCT03482011|12578881|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7995271|NCT03482011|12578882|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7995272|NCT03482011|12578883|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7995273|NCT03482011|12578884|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7995274|NCT03482011|12578885|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2
7995275|NCT03482011|12578886|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7995276|NCT03482011|12578887|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7995277|NCT03482011|12578888|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1
7995278|NCT03482011|12578881|FG000|Maintenance Period (36 Weeks)|Physician Decision|0
7995279|NCT03482011|12578882|FG001|Maintenance Period (36 Weeks)|Physician Decision|0
7995280|NCT03482011|12578883|FG002|Maintenance Period (36 Weeks)|Physician Decision|0
7995281|NCT03482011|12578884|FG003|Maintenance Period (36 Weeks)|Physician Decision|1
7995282|NCT03482011|12578885|FG004|Maintenance Period (36 Weeks)|Physician Decision|0
7995283|NCT03482011|12578886|FG005|Maintenance Period (36 Weeks)|Physician Decision|1
7995284|NCT03482011|12578887|FG006|Maintenance Period (36 Weeks)|Physician Decision|1
7995285|NCT03482011|12578888|FG007|Maintenance Period (36 Weeks)|Physician Decision|1
7995286|NCT03482011|12578881|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7995287|NCT03482011|12578882|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7995288|NCT03482011|12578883|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7995289|NCT03482011|12578884|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
7995290|NCT03482011|12578885|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
7995291|NCT03482011|12578886|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
7995292|NCT03482011|12578887|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
7995293|NCT03482011|12578888|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
7995294|NCT03482011|12578881|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7995295|NCT03482011|12578882|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7995296|NCT03482011|12578883|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7995297|NCT03482011|12578884|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2
7995298|NCT03482011|12578885|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7995299|NCT03482011|12578886|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
7995300|NCT03482011|12578887|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
7995301|NCT03482011|12578888|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5
7995302|NCT03482011|12578881|FG000|Follow-up Period (12 Weeks)|Adverse Event|0
7995303|NCT03482011|12578882|FG001|Follow-up Period (12 Weeks)|Adverse Event|0
7995304|NCT03482011|12578883|FG002|Follow-up Period (12 Weeks)|Adverse Event|0
7995305|NCT03482011|12578884|FG003|Follow-up Period (12 Weeks)|Adverse Event|0
7995306|NCT03482011|12578885|FG004|Follow-up Period (12 Weeks)|Adverse Event|0
7995307|NCT03482011|12578886|FG005|Follow-up Period (12 Weeks)|Adverse Event|0
7995308|NCT03482011|12578887|FG006|Follow-up Period (12 Weeks)|Adverse Event|1
7995309|NCT03482011|12578888|FG007|Follow-up Period (12 Weeks)|Adverse Event|4
7995310|NCT03482011|12578881|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7995311|NCT03482011|12578882|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7995312|NCT03482011|12578883|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1
7995313|NCT03482011|12578884|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3
7995314|NCT03482011|12578885|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7995315|NCT03482011|12578886|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7995316|NCT03482011|12578887|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7995317|NCT03482011|12578888|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6
7995318|NCT03482011|12578881|FG000|Follow-up Period (12 Weeks)|Physician Decision|0
7995319|NCT03482011|12578882|FG001|Follow-up Period (12 Weeks)|Physician Decision|0
7995320|NCT03482011|12578883|FG002|Follow-up Period (12 Weeks)|Physician Decision|0
7995321|NCT03482011|12578884|FG003|Follow-up Period (12 Weeks)|Physician Decision|0
7995322|NCT03482011|12578885|FG004|Follow-up Period (12 Weeks)|Physician Decision|0
7995323|NCT03482011|12578886|FG005|Follow-up Period (12 Weeks)|Physician Decision|0
7995324|NCT03482011|12578887|FG006|Follow-up Period (12 Weeks)|Physician Decision|0
7995325|NCT03482011|12578888|FG007|Follow-up Period (12 Weeks)|Physician Decision|1
7995326|NCT03482011|12578881|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7995327|NCT03482011|12578882|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7995328|NCT03482011|12578883|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7995329|NCT03482011|12578884|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7995330|NCT03482011|12578885|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7995331|NCT03482011|12578886|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7995332|NCT03482011|12578887|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7995333|NCT03482011|12578888|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1
7995334|NCT03482453|12578925|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7995335|NCT03482453|12578926|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7995336|NCT03482453|12578927|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7995337|NCT03482453|12578928|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7995338|NCT03482453|12578929|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7995339|NCT03482453|12578930|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7995340|NCT03482453|12578931|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7995341|NCT03482453|12578932|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7995342|NCT03482453|12578933|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7995343|NCT03482453|12578934|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7995344|NCT03482453|12578935|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1
7995345|NCT03482453|12578936|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7995346|NCT03482635|12578990|FG000|Overall Study|Lack of Efficacy|0
7995347|NCT03482635|12578991|FG001|Overall Study|Lack of Efficacy|0
7995348|NCT03482635|12578992|FG002|Overall Study|Lack of Efficacy|1
7995349|NCT03482635|12578993|FG003|Overall Study|Lack of Efficacy|3
7995350|NCT03482635|12578990|FG000|Overall Study|Adverse Event|2
7995351|NCT03482635|12578991|FG001|Overall Study|Adverse Event|2
7995352|NCT03482635|12578992|FG002|Overall Study|Adverse Event|0
7995353|NCT03482635|12578993|FG003|Overall Study|Adverse Event|3
7995354|NCT03482635|12578990|FG000|Overall Study|Withdrawal by Subject|2
7995355|NCT03482635|12578991|FG001|Overall Study|Withdrawal by Subject|1
7995356|NCT03482635|12578992|FG002|Overall Study|Withdrawal by Subject|0
7995357|NCT03482635|12578993|FG003|Overall Study|Withdrawal by Subject|1
7995358|NCT03482635|12578990|FG000|Overall Study|Withdrawn by Principle Investigator|1
7995359|NCT03482635|12578991|FG001|Overall Study|Withdrawn by Principle Investigator|0
7995360|NCT03482635|12578992|FG002|Overall Study|Withdrawn by Principle Investigator|0
7995361|NCT03482635|12578993|FG003|Overall Study|Withdrawn by Principle Investigator|0
7995362|NCT03482635|12578990|FG000|Overall Study|Not treated|0
7995363|NCT03482635|12578991|FG001|Overall Study|Not treated|0
7995364|NCT03482635|12578992|FG002|Overall Study|Not treated|0
7995365|NCT03482635|12578993|FG003|Overall Study|Not treated|1
7995366|NCT03482882|12579012|FG000|Overall Study|Adverse Event|3
7995367|NCT03482882|12579012|FG000|Overall Study|Lost to Follow-up|1
7995368|NCT03482882|12579012|FG000|Overall Study|Protocol Violation|2
7995369|NCT03482882|12579012|FG000|Overall Study|Not further specified|1
7995370|NCT03483623|12579031|FG000|Overall Study|43 complete sets achieved|1
7995371|NCT03483961|12579074|FG000|Overall Study|Lost to Follow-up|7
7995372|NCT03483961|12579075|FG001|Overall Study|Lost to Follow-up|6
7995373|NCT03483961|12579076|FG002|Overall Study|Lost to Follow-up|6
7995374|NCT03483961|12579077|FG003|Overall Study|Lost to Follow-up|6
7995375|NCT03483961|12579078|FG004|Overall Study|Lost to Follow-up|6
7995376|NCT03483961|12579079|FG005|Overall Study|Lost to Follow-up|4
7995377|NCT03483961|12579080|FG006|Overall Study|Lost to Follow-up|4
7995378|NCT03483961|12579081|FG007|Overall Study|Lost to Follow-up|11
7995379|NCT03483961|12579082|FG008|Overall Study|Lost to Follow-up|1
7995380|NCT03483961|12579083|FG009|Overall Study|Lost to Follow-up|0
7995381|NCT03483961|12579074|FG000|Overall Study|Withdrawal by Subject|3
7995382|NCT03483961|12579075|FG001|Overall Study|Withdrawal by Subject|4
7995383|NCT03483961|12579076|FG002|Overall Study|Withdrawal by Subject|5
7995384|NCT03483961|12579077|FG003|Overall Study|Withdrawal by Subject|3
7995385|NCT03483961|12579078|FG004|Overall Study|Withdrawal by Subject|4
7995386|NCT03483961|12579079|FG005|Overall Study|Withdrawal by Subject|2
7995387|NCT03483961|12579080|FG006|Overall Study|Withdrawal by Subject|1
7995388|NCT03483961|12579081|FG007|Overall Study|Withdrawal by Subject|2
7995389|NCT03483961|12579082|FG008|Overall Study|Withdrawal by Subject|1
7995390|NCT03483961|12579083|FG009|Overall Study|Withdrawal by Subject|0
7995391|NCT03483961|12579074|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1
7995392|NCT03483961|12579075|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7995393|NCT03483961|12579076|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7995394|NCT03483961|12579077|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7995395|NCT03483961|12579078|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7995396|NCT03483961|12579079|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7995397|NCT03483961|12579080|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7995398|NCT03483961|12579081|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7995399|NCT03483961|12579082|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7995400|NCT03483961|12579083|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7995401|NCT03483961|12579074|FG000|Overall Study|Adverse Event|0
7995402|NCT03483961|12579075|FG001|Overall Study|Adverse Event|0
7995403|NCT03483961|12579076|FG002|Overall Study|Adverse Event|1
7995404|NCT03483961|12579077|FG003|Overall Study|Adverse Event|0
7995405|NCT03483961|12579078|FG004|Overall Study|Adverse Event|0
7995406|NCT03483961|12579079|FG005|Overall Study|Adverse Event|0
7995407|NCT03483961|12579080|FG006|Overall Study|Adverse Event|0
7995408|NCT03483961|12579081|FG007|Overall Study|Adverse Event|0
7995409|NCT03483961|12579082|FG008|Overall Study|Adverse Event|0
7995410|NCT03483961|12579083|FG009|Overall Study|Adverse Event|0
7995411|NCT03484273|12579104|FG000|Overall Study|Equipment Malfunction|1
7995412|NCT03484273|12579104|FG000|Overall Study|Data excluded from analysis|1
7995413|NCT03484429|12579118|FG000|Overall Study|Withdrawal by Subject|1
7995414|NCT03484429|12579119|FG001|Overall Study|Withdrawal by Subject|0
7995415|NCT03484429|12579118|FG000|Overall Study|Adverse Event|2
7995416|NCT03484429|12579119|FG001|Overall Study|Adverse Event|0
7995417|NCT03485222|12579127|FG000|Overall Study|Death|0
7995418|NCT03485222|12579128|FG001|Overall Study|Death|1
7995419|NCT03485222|12579127|FG000|Overall Study|Lost to Follow-up|2
7995420|NCT03485222|12579128|FG001|Overall Study|Lost to Follow-up|1
7995421|NCT03485495|12579136|FG000|Overall Study|Non-compliance with inclusion criteria|1
7995422|NCT03485495|12579137|FG001|Overall Study|Non-compliance with inclusion criteria|0
7995423|NCT03486392|12579152|FG000|Overall Study|Lost to Follow-up|0
7995424|NCT03486392|12579153|FG001|Overall Study|Lost to Follow-up|0
7995425|NCT03486392|12579154|FG002|Overall Study|Lost to Follow-up|8
7995426|NCT03486392|12579155|FG003|Overall Study|Lost to Follow-up|5
7995427|NCT03486392|12579156|FG004|Overall Study|Lost to Follow-up|2
7995428|NCT03486392|12579152|FG000|Overall Study|Withdrawal by Subject|3
7995429|NCT03486392|12579153|FG001|Overall Study|Withdrawal by Subject|0
7995430|NCT03486392|12579154|FG002|Overall Study|Withdrawal by Subject|6
7995431|NCT03486392|12579155|FG003|Overall Study|Withdrawal by Subject|4
7995432|NCT03486392|12579156|FG004|Overall Study|Withdrawal by Subject|1
7995433|NCT03486392|12579152|FG000|Overall Study|Death|0
7995434|NCT03486392|12579153|FG001|Overall Study|Death|0
7995435|NCT03486392|12579154|FG002|Overall Study|Death|0
7995436|NCT03486392|12579155|FG003|Overall Study|Death|0
7995437|NCT03486392|12579156|FG004|Overall Study|Death|1
7995438|NCT03486834|12579171|FG000|Overall Study|Withdrawal by Subject|46
7995439|NCT03486834|12579172|FG001|Overall Study|Withdrawal by Subject|46
7995440|NCT03486834|12579173|FG002|Overall Study|Withdrawal by Subject|52
7995441|NCT03486834|12579171|FG000|Overall Study|Adverse Event|8
7995442|NCT03486834|12579172|FG001|Overall Study|Adverse Event|7
7995443|NCT03486834|12579173|FG002|Overall Study|Adverse Event|0
7995444|NCT03486834|12579171|FG000|Overall Study|Lost to Follow-up|41
7995445|NCT03486834|12579172|FG001|Overall Study|Lost to Follow-up|24
7995446|NCT03486834|12579173|FG002|Overall Study|Lost to Follow-up|39
7995447|NCT03486834|12579171|FG000|Overall Study|Non-compliance with Study Drug|2
7995448|NCT03486834|12579172|FG001|Overall Study|Non-compliance with Study Drug|2
7995449|NCT03486834|12579173|FG002|Overall Study|Non-compliance with Study Drug|0
7995450|NCT03486834|12579171|FG000|Overall Study|Physician Decision|5
7995451|NCT03486834|12579172|FG001|Overall Study|Physician Decision|2
7995452|NCT03486834|12579173|FG002|Overall Study|Physician Decision|3
7995453|NCT03486834|12579171|FG000|Overall Study|Pregnancy|10
7995454|NCT03486834|12579172|FG001|Overall Study|Pregnancy|12
7995455|NCT03486834|12579173|FG002|Overall Study|Pregnancy|12
7995456|NCT03486834|12579171|FG000|Overall Study|Protocol Deviation|2
7995457|NCT03486834|12579172|FG001|Overall Study|Protocol Deviation|3
7995458|NCT03486834|12579173|FG002|Overall Study|Protocol Deviation|3
7995459|NCT03486834|12579171|FG000|Overall Study|Withdrawal by Parent/Guardian|1
7995460|NCT03486834|12579172|FG001|Overall Study|Withdrawal by Parent/Guardian|2
7995461|NCT03486834|12579173|FG002|Overall Study|Withdrawal by Parent/Guardian|2
7995462|NCT03486834|12579171|FG000|Overall Study|Randomized but not treated|4
7995463|NCT03486834|12579172|FG001|Overall Study|Randomized but not treated|4
7995464|NCT03486834|12579173|FG002|Overall Study|Randomized but not treated|1
7995465|NCT03487445|12579268|FG000|Randomization|Not treated for administrative reasons|1
7995466|NCT03487445|12579269|FG001|Randomization|Not treated for administrative reasons|0
7995467|NCT03487549|12579277|FG000|Overall Study|Protocol Violation|0
7995468|NCT03487549|12579278|FG001|Overall Study|Protocol Violation|1
7995469|NCT03487549|12579277|FG000|Overall Study|Lost to Follow-up|2
7995470|NCT03487549|12579278|FG001|Overall Study|Lost to Follow-up|1
7995471|NCT03487549|12579277|FG000|Overall Study|Withdrawal by Subject|2
7995472|NCT03487549|12579278|FG001|Overall Study|Withdrawal by Subject|0
7995473|NCT03487848|12579297|FG000|Overall Study|Lost to Follow-up|1
7995474|NCT03488108|12579303|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0
7995475|NCT03488108|12579304|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1
7995476|NCT03488108|12579303|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1
7995477|NCT03488108|12579304|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0
7995478|NCT03488225|12579312|FG000|Overall Study|Off Protocol Therapy|2
7995479|NCT03488225|12579312|FG000|Overall Study|Stem Cell Transplant|2
7995480|NCT03488238|12579316|FG000|Overall Study|Equipment malfunction|1
7995481|NCT03488238|12579316|FG000|Overall Study|Adverse Event|1
7995482|NCT03488927|12579336|FG000|Overall Study|Withdrawal by Subject|44
7995483|NCT03488927|12579337|FG001|Overall Study|Withdrawal by Subject|118
7995484|NCT03488927|12579338|FG002|Overall Study|Withdrawal by Subject|217
7995485|NCT03489304|12579346|FG000|Overall Study|Lost to Follow-up|4
7995486|NCT03489343|12579357|FG000|Overall Study|Documented progressive disease|1
7995487|NCT03489343|12579358|FG001|Overall Study|Documented progressive disease|0
7995488|NCT03489343|12579359|FG002|Overall Study|Documented progressive disease|3
7995489|NCT03489343|12579360|FG003|Overall Study|Documented progressive disease|1
7995490|NCT03489343|12579361|FG004|Overall Study|Documented progressive disease|3
7995491|NCT03489343|12579362|FG005|Overall Study|Documented progressive disease|5
7995492|NCT03489343|12579363|FG006|Overall Study|Documented progressive disease|4
7995493|NCT03489343|12579357|FG000|Overall Study|Adverse Event|0
7995494|NCT03489343|12579358|FG001|Overall Study|Adverse Event|1
7995495|NCT03489343|12579359|FG002|Overall Study|Adverse Event|0
7995496|NCT03489343|12579360|FG003|Overall Study|Adverse Event|0
7995497|NCT03489343|12579361|FG004|Overall Study|Adverse Event|0
7995498|NCT03489343|12579362|FG005|Overall Study|Adverse Event|1
7995499|NCT03489343|12579363|FG006|Overall Study|Adverse Event|0
7995500|NCT03489343|12579357|FG000|Overall Study|Withdrawal by Subject|0
7995501|NCT03489343|12579358|FG001|Overall Study|Withdrawal by Subject|0
7995502|NCT03489343|12579359|FG002|Overall Study|Withdrawal by Subject|0
7995503|NCT03489343|12579360|FG003|Overall Study|Withdrawal by Subject|1
7995504|NCT03489343|12579361|FG004|Overall Study|Withdrawal by Subject|0
7995505|NCT03489343|12579362|FG005|Overall Study|Withdrawal by Subject|1
7995506|NCT03489343|12579363|FG006|Overall Study|Withdrawal by Subject|1
7995507|NCT03489343|12579357|FG000|Overall Study|Clinical progression|0
7995508|NCT03489343|12579358|FG001|Overall Study|Clinical progression|0
7995509|NCT03489343|12579359|FG002|Overall Study|Clinical progression|0
7995510|NCT03489343|12579360|FG003|Overall Study|Clinical progression|1
7995511|NCT03489343|12579361|FG004|Overall Study|Clinical progression|0
7995512|NCT03489343|12579362|FG005|Overall Study|Clinical progression|0
7995513|NCT03489343|12579363|FG006|Overall Study|Clinical progression|1
7995514|NCT03489369|12579383|FG000|Overall Study|Documented Progressive Disease|3
7995515|NCT03489369|12579384|FG001|Overall Study|Documented Progressive Disease|2
7995516|NCT03489369|12579385|FG002|Overall Study|Documented Progressive Disease|3
7995517|NCT03489369|12579386|FG003|Overall Study|Documented Progressive Disease|6
7995518|NCT03489369|12579383|FG000|Overall Study|Clinical Progression (Worsening of Clini|0
7995519|NCT03489369|12579384|FG001|Overall Study|Clinical Progression (Worsening of Clini|1
7995520|NCT03489369|12579385|FG002|Overall Study|Clinical Progression (Worsening of Clini|0
7995521|NCT03489369|12579386|FG003|Overall Study|Clinical Progression (Worsening of Clini|0
7995522|NCT03489551|12579396|FG000|Overall Study|Withdrawal by Subject|2
7995523|NCT03489720|12579402|FG000|Overall Study|Withdrawal by Subject|2
7995524|NCT03489720|12579403|FG001|Overall Study|Withdrawal by Subject|0
7995525|NCT03489863|12579424|FG000|Overall Study|Withdrawal by Subject|0
7995526|NCT03489863|12579425|FG001|Overall Study|Withdrawal by Subject|1
7995527|NCT03490032|12579442|FG000|Overall Study|family issue (child custody)|1
7995528|NCT03490032|12579443|FG001|Overall Study|family issue (child custody)|0
7995529|NCT03490032|12579444|FG002|Overall Study|family issue (child custody)|0
7995530|NCT03490981|12579477|FG000|Overall Study|Lost to Follow-up|1
7995531|NCT03490981|12579478|FG001|Overall Study|Lost to Follow-up|2
7995532|NCT03491150|12579486|FG000|Overall Study|Adverse Event|1
7995533|NCT03491150|12579487|FG001|Overall Study|Adverse Event|0
7995534|NCT03491150|12579486|FG000|Overall Study|Study Terminated by Sponsor|74
7995535|NCT03491150|12579487|FG001|Overall Study|Study Terminated by Sponsor|70
7995536|NCT03491150|12579486|FG000|Overall Study|Other|0
7995537|NCT03491150|12579487|FG001|Overall Study|Other|1
7995538|NCT03491150|12579486|FG000|Overall Study|Withdrawal by Subject|1
7995539|NCT03491150|12579487|FG001|Overall Study|Withdrawal by Subject|2
7995540|NCT03491553|12579503|FG000|Main Study (Up to Week 48)|Adverse Event|0
7995541|NCT03491553|12579504|FG001|Main Study (Up to Week 48)|Adverse Event|0
7995542|NCT03491553|12579505|FG002|Main Study (Up to Week 48)|Adverse Event|0
7995543|NCT03491553|12579506|FG003|Main Study (Up to Week 48)|Adverse Event|1
7995544|NCT03491553|12579507|FG004|Main Study (Up to Week 48)|Adverse Event|0
7995545|NCT03491553|12579508|FG005|Main Study (Up to Week 48)|Adverse Event|0
7995546|NCT03491553|12579503|FG000|Main Study (Up to Week 48)|Withdrew Consent|1
7995547|NCT03491553|12579504|FG001|Main Study (Up to Week 48)|Withdrew Consent|1
7995548|NCT03491553|12579505|FG002|Main Study (Up to Week 48)|Withdrew Consent|0
7995549|NCT03491553|12579506|FG003|Main Study (Up to Week 48)|Withdrew Consent|0
7995550|NCT03491553|12579507|FG004|Main Study (Up to Week 48)|Withdrew Consent|0
7995551|NCT03491553|12579508|FG005|Main Study (Up to Week 48)|Withdrew Consent|0
7995552|NCT03492281|12579557|FG000|Overall Study|Withdrawal by Subject|21
7995553|NCT03492281|12579558|FG001|Overall Study|Withdrawal by Subject|14
7995554|NCT03492281|12579559|FG002|Overall Study|Withdrawal by Subject|13
7995555|NCT03492281|12579557|FG000|Overall Study|Lost to Follow-up|14
7995556|NCT03492281|12579558|FG001|Overall Study|Lost to Follow-up|15
7995557|NCT03492281|12579559|FG002|Overall Study|Lost to Follow-up|10
7995558|NCT03492281|12579557|FG000|Overall Study|Adverse Event|6
7995559|NCT03492281|12579558|FG001|Overall Study|Adverse Event|8
7995560|NCT03492281|12579559|FG002|Overall Study|Adverse Event|13
7995561|NCT03492281|12579557|FG000|Overall Study|Lack of Efficacy|3
7995562|NCT03492281|12579558|FG001|Overall Study|Lack of Efficacy|0
7995563|NCT03492281|12579559|FG002|Overall Study|Lack of Efficacy|1
7995564|NCT03492281|12579557|FG000|Overall Study|Physician Decision|1
7995565|NCT03492281|12579558|FG001|Overall Study|Physician Decision|0
7995566|NCT03492281|12579559|FG002|Overall Study|Physician Decision|3
7995567|NCT03492281|12579557|FG000|Overall Study|Protocol Violation|0
7995568|NCT03492281|12579558|FG001|Overall Study|Protocol Violation|2
7995569|NCT03492281|12579559|FG002|Overall Study|Protocol Violation|1
7995570|NCT03492281|12579557|FG000|Overall Study|Withdrawn Due to Sponsor|1
7995571|NCT03492281|12579558|FG001|Overall Study|Withdrawn Due to Sponsor|0
7995572|NCT03492281|12579559|FG002|Overall Study|Withdrawn Due to Sponsor|1
7995573|NCT03492281|12579557|FG000|Overall Study|Death|0
7995574|NCT03492281|12579558|FG001|Overall Study|Death|0
7995575|NCT03492281|12579559|FG002|Overall Study|Death|1
7995576|NCT03492281|12579557|FG000|Overall Study|Captured as Other in Database|8
7995577|NCT03492281|12579558|FG001|Overall Study|Captured as Other in Database|6
7995578|NCT03492281|12579559|FG002|Overall Study|Captured as Other in Database|3
7995579|NCT03492554|12579609|FG000|Overall Study|Protocol Violation|0
7995580|NCT03492554|12579610|FG001|Overall Study|Protocol Violation|14
7995581|NCT03493386|12579619|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7995582|NCT03493386|12579620|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1
7995583|NCT03493386|12579621|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7995584|NCT03493386|12579622|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7995585|NCT03493542|12579641|FG000|Overall Study|Ongoing|2
7995586|NCT03493542|12579642|FG001|Overall Study|Ongoing|3
7995587|NCT03493542|12579641|FG000|Overall Study|Withdrawal by parent or guardian|3
7995588|NCT03493542|12579642|FG001|Overall Study|Withdrawal by parent or guardian|0
7995589|NCT03493542|12579641|FG000|Overall Study|Withdrawal by Subject|2
7995590|NCT03493542|12579642|FG001|Overall Study|Withdrawal by Subject|6
7995591|NCT03493698|12579652|FG000|Treatment Period C|Adverse Event|1
7995592|NCT03493698|12579652|FG000|Treatment Period C|Withdrawal by Subject|1
7995593|NCT03494725|12579690|FG000|Overall Study|Withdrawal by Subject|0
7995594|NCT03494725|12579691|FG001|Overall Study|Withdrawal by Subject|2
7995595|NCT03494725|12579690|FG000|Overall Study|Antibiotic use|1
7995596|NCT03494725|12579691|FG001|Overall Study|Antibiotic use|0
7995597|NCT03494816|12579703|FG000|Overall Study|Protocol Violation|2
7995598|NCT03494816|12579703|FG000|Overall Study|Physician Decision|2
7995599|NCT03494816|12579703|FG000|Overall Study|Did not start trial treatment|1
7995600|NCT03494816|12579703|FG000|Overall Study|Adverse Event|1
7995601|NCT03494985|12579715|FG000|Overall Study|Adverse Event|3
7995602|NCT03494985|12579716|FG001|Overall Study|Adverse Event|2
7995603|NCT03494985|12579717|FG002|Overall Study|Adverse Event|3
7995604|NCT03494985|12579718|FG003|Overall Study|Adverse Event|0
7995605|NCT03494985|12579715|FG000|Overall Study|Other (Withdrawal of consent)|2
7995606|NCT03494985|12579716|FG001|Overall Study|Other (Withdrawal of consent)|3
7995607|NCT03494985|12579717|FG002|Overall Study|Other (Withdrawal of consent)|2
7995608|NCT03494985|12579718|FG003|Overall Study|Other (Withdrawal of consent)|5
7995609|NCT03494985|12579715|FG000|Overall Study|Other (Not specified)|0
7995610|NCT03494985|12579716|FG001|Overall Study|Other (Not specified)|1
7995611|NCT03494985|12579717|FG002|Overall Study|Other (Not specified)|1
7995612|NCT03494985|12579718|FG003|Overall Study|Other (Not specified)|0
7995613|NCT03495102|12579731|FG000|Overall Study|Adverse Event|5
7995614|NCT03495102|12579732|FG001|Overall Study|Adverse Event|7
7995615|NCT03495102|12579733|FG002|Overall Study|Adverse Event|10
7995616|NCT03495102|12579731|FG000|Overall Study|Death|3
7995617|NCT03495102|12579732|FG001|Overall Study|Death|4
7995618|NCT03495102|12579733|FG002|Overall Study|Death|4
7995619|NCT03495102|12579731|FG000|Overall Study|Lost to Follow-up|15
7995620|NCT03495102|12579732|FG001|Overall Study|Lost to Follow-up|16
7995621|NCT03495102|12579733|FG002|Overall Study|Lost to Follow-up|17
7995622|NCT03495102|12579731|FG000|Overall Study|Physician Decision|2
7995623|NCT03495102|12579732|FG001|Overall Study|Physician Decision|0
7995624|NCT03495102|12579733|FG002|Overall Study|Physician Decision|2
7995625|NCT03495102|12579731|FG000|Overall Study|Withdrawal by Subject|25
7995626|NCT03495102|12579732|FG001|Overall Study|Withdrawal by Subject|36
7995627|NCT03495102|12579733|FG002|Overall Study|Withdrawal by Subject|18
7995628|NCT03495102|12579731|FG000|Overall Study|Protocol Violation|1
7995629|NCT03495102|12579732|FG001|Overall Study|Protocol Violation|1
7995630|NCT03495102|12579733|FG002|Overall Study|Protocol Violation|0
7995631|NCT03495102|12579731|FG000|Overall Study|Site Closure|3
7995632|NCT03495102|12579732|FG001|Overall Study|Site Closure|1
7995633|NCT03495102|12579733|FG002|Overall Study|Site Closure|2
7995634|NCT03495102|12579731|FG000|Overall Study|Non-compliance|1
7995635|NCT03495102|12579732|FG001|Overall Study|Non-compliance|0
7995636|NCT03495102|12579733|FG002|Overall Study|Non-compliance|0
7995637|NCT03495102|12579731|FG000|Overall Study|Participant Duplicated at Another Site|0
7995638|NCT03495102|12579732|FG001|Overall Study|Participant Duplicated at Another Site|0
7995639|NCT03495102|12579733|FG002|Overall Study|Participant Duplicated at Another Site|1
7995640|NCT03495102|12579731|FG000|Overall Study|Primary Care Physician Recommendation|0
7995641|NCT03495102|12579732|FG001|Overall Study|Primary Care Physician Recommendation|1
7995642|NCT03495102|12579733|FG002|Overall Study|Primary Care Physician Recommendation|0
7995643|NCT03495102|12579731|FG000|Overall Study|Relocated to Another Country|0
7995644|NCT03495102|12579732|FG001|Overall Study|Relocated to Another Country|1
7995645|NCT03495102|12579733|FG002|Overall Study|Relocated to Another Country|0
7995646|NCT03495102|12579731|FG000|Overall Study|Participant was in Rehabilitation|1
7995647|NCT03495102|12579732|FG001|Overall Study|Participant was in Rehabilitation|0
7995648|NCT03495102|12579733|FG002|Overall Study|Participant was in Rehabilitation|0
7995649|NCT03495817|12579750|FG000|26 Week Open Label|Adverse Event|3
7995650|NCT03495817|12579750|FG000|26 Week Open Label|Withdrawal by Subject|4
7995651|NCT03495817|12579750|FG000|26 Week Open Label|Lost to Follow-up|1
7995652|NCT03495817|12579750|FG000|26 Week Extension|Lost to Follow-up|2
7995653|NCT03495869|12579762|FG000|Overall Study|Lost to Follow-up|4
7995654|NCT03495869|12579763|FG001|Overall Study|Lost to Follow-up|17
7995655|NCT03495869|12579764|FG002|Overall Study|Lost to Follow-up|8
7995656|NCT03495869|12579765|FG003|Overall Study|Lost to Follow-up|14
7995657|NCT03495869|12579762|FG000|Overall Study|Withdrawal by Subject|0
7995658|NCT03495869|12579763|FG001|Overall Study|Withdrawal by Subject|3
7995659|NCT03495869|12579764|FG002|Overall Study|Withdrawal by Subject|0
7995660|NCT03495869|12579765|FG003|Overall Study|Withdrawal by Subject|3
7995661|NCT03495869|12579762|FG000|Overall Study|Dropped from study|0
7995662|NCT03495869|12579763|FG001|Overall Study|Dropped from study|7
7995663|NCT03495869|12579764|FG002|Overall Study|Dropped from study|2
7995664|NCT03495869|12579765|FG003|Overall Study|Dropped from study|4
7995665|NCT03495908|12579777|FG000|Overall Study|Withdrawal by Subject|3
7995666|NCT03495908|12579778|FG001|Overall Study|Withdrawal by Subject|1
7995667|NCT03495908|12579777|FG000|Overall Study|Lost to Follow-up|1
7995668|NCT03495908|12579778|FG001|Overall Study|Lost to Follow-up|4
7995669|NCT03495908|12579777|FG000|Overall Study|Adverse Event|0
7995670|NCT03495908|12579778|FG001|Overall Study|Adverse Event|2
7995671|NCT03495908|12579777|FG000|Overall Study|Death|1
7995672|NCT03495908|12579778|FG001|Overall Study|Death|0
7995673|NCT03495908|12579777|FG000|Overall Study|Physician Decision|5
7995674|NCT03495908|12579778|FG001|Overall Study|Physician Decision|4
7995675|NCT03495908|12579777|FG000|Overall Study|No documented reason|0
7995676|NCT03495908|12579778|FG001|Overall Study|No documented reason|2
7995677|NCT03496298|12579797|FG000|Overall Study|Adverse Event|49
7995678|NCT03496298|12579798|FG001|Overall Study|Adverse Event|68
7995679|NCT03496298|12579799|FG002|Overall Study|Adverse Event|79
7995680|NCT03496298|12579797|FG000|Overall Study|Study terminated by Sponsor|1050
7995681|NCT03496298|12579798|FG001|Overall Study|Study terminated by Sponsor|1063
7995682|NCT03496298|12579799|FG002|Overall Study|Study terminated by Sponsor|1071
7995683|NCT03496298|12579797|FG000|Overall Study|Physician decision (other than Adverse event)|12
7995684|NCT03496298|12579798|FG001|Overall Study|Physician decision (other than Adverse event)|17
7995685|NCT03496298|12579799|FG002|Overall Study|Physician decision (other than Adverse event)|10
7995686|NCT03496298|12579797|FG000|Overall Study|Withdrawal by Subject|176
7995687|NCT03496298|12579798|FG001|Overall Study|Withdrawal by Subject|154
7995688|NCT03496298|12579799|FG002|Overall Study|Withdrawal by Subject|151
7995689|NCT03496298|12579797|FG000|Overall Study|Other|29
7995690|NCT03496298|12579798|FG001|Overall Study|Other|20
7995691|NCT03496298|12579799|FG002|Overall Study|Other|23
7995692|NCT03496298|12579797|FG000|Overall Study|Randomized and not treated|1
7995693|NCT03496298|12579798|FG001|Overall Study|Randomized and not treated|1
7995694|NCT03496298|12579799|FG002|Overall Study|Randomized and not treated|1
7995695|NCT03497039|12579871|FG000|Overall Study|Withdrawal by Subject|1
7995696|NCT03497039|12579872|FG001|Overall Study|Withdrawal by Subject|0
7995697|NCT03497039|12579871|FG000|Overall Study|Protocol Violation|0
7995698|NCT03497039|12579872|FG001|Overall Study|Protocol Violation|1
7995699|NCT03497130|12579880|FG000|Overall Study|Lost to Follow-up|1
7995700|NCT03497130|12579881|FG001|Overall Study|Lost to Follow-up|1
7995701|NCT03497429|12579889|FG000|Overall Study|Progressive disease|3
7995702|NCT03497429|12579890|FG001|Overall Study|Progressive disease|4
7995703|NCT03497429|12579889|FG000|Overall Study|Adverse Event|0
7995704|NCT03497429|12579890|FG001|Overall Study|Adverse Event|2
7995705|NCT03498287|12579961|FG000|Overall Study|Withdrawal by Subject|3
7995706|NCT03498287|12579962|FG001|Overall Study|Withdrawal by Subject|0
7995707|NCT03498287|12579961|FG000|Overall Study|Protocol Violation|0
7995708|NCT03498287|12579962|FG001|Overall Study|Protocol Violation|4
7995709|NCT03498287|12579961|FG000|Overall Study|Adverse Event|0
7995710|NCT03498287|12579962|FG001|Overall Study|Adverse Event|1
7995711|NCT03499028|12579980|FG000|Overall Study|Lost to Follow-up|12
7995712|NCT03499028|12579981|FG001|Overall Study|Lost to Follow-up|9
7995713|NCT03499028|12579980|FG000|Overall Study|Withdrawal by Subject|5
7995714|NCT03499028|12579981|FG001|Overall Study|Withdrawal by Subject|8
7995715|NCT03499028|12579980|FG000|Overall Study|Unplanned SNF discharge|5
7995716|NCT03499028|12579981|FG001|Overall Study|Unplanned SNF discharge|8
7995717|NCT03499067|12579989|FG000|First Intervention|Physician Decision|2
7995718|NCT03499067|12579990|FG001|First Intervention|Physician Decision|1
7995719|NCT03499067|12579989|FG000|First Intervention|Withdrawal by Subject|3
7995720|NCT03499067|12579990|FG001|First Intervention|Withdrawal by Subject|6
7995721|NCT03499353|12579996|FG000|Treatment|Adverse Event|3
7995722|NCT03499353|12579996|FG000|Treatment|Progressive Disease|10
7995723|NCT03499353|12579996|FG000|Treatment|Other|1
7995724|NCT03499353|12579996|FG000|Treatment|Withdrawal by Subject|2
7995725|NCT03499353|12579996|FG000|Long-Term Follow-up|Death|2
7995726|NCT03499353|12579996|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55
7995727|NCT03499353|12579996|FG000|Long-Term Follow-up|Withdrawal by Subject|1
7995728|NCT03499873|12580003|FG000|Overall Study|Withdrawal by Subject|4
7995729|NCT03499873|12580004|FG001|Overall Study|Withdrawal by Subject|6
7995730|NCT03499873|12580005|FG002|Overall Study|Withdrawal by Subject|1
7995731|NCT03499873|12580003|FG000|Overall Study|Subjects condition worsened|0
7995732|NCT03499873|12580004|FG001|Overall Study|Subjects condition worsened|3
7995733|NCT03499873|12580005|FG002|Overall Study|Subjects condition worsened|11
7995734|NCT03499873|12580003|FG000|Overall Study|Adverse Event|8
7995735|NCT03499873|12580004|FG001|Overall Study|Adverse Event|3
7995736|NCT03499873|12580005|FG002|Overall Study|Adverse Event|6
7995737|NCT03499873|12580003|FG000|Overall Study|Physician Decision|1
7995738|NCT03499873|12580004|FG001|Overall Study|Physician Decision|0
7995739|NCT03499873|12580005|FG002|Overall Study|Physician Decision|0
7995740|NCT03499873|12580003|FG000|Overall Study|Administrative reasons|0
7995741|NCT03499873|12580004|FG001|Overall Study|Administrative reasons|1
7995742|NCT03499873|12580005|FG002|Overall Study|Administrative reasons|0
7995743|NCT03499873|12580003|FG000|Overall Study|Concomitant therapy|5
7995744|NCT03499873|12580004|FG001|Overall Study|Concomitant therapy|4
7995745|NCT03499873|12580005|FG002|Overall Study|Concomitant therapy|7
7995746|NCT03499873|12580003|FG000|Overall Study|Miscellaneous|1
7995747|NCT03499873|12580004|FG001|Overall Study|Miscellaneous|2
7995748|NCT03499873|12580005|FG002|Overall Study|Miscellaneous|2
7995749|NCT03499873|12580003|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1
7995750|NCT03499873|12580004|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1
7995751|NCT03499873|12580005|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0
7995752|NCT03500094|12580013|FG000|Overall Study|Withdrawal by Subject|1
7995753|NCT03500094|12580013|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1
7995754|NCT03500094|12580013|FG000|Overall Study|Lost to Follow-up|1
7995755|NCT03500198|12580021|FG000|Overall Study|Lost to Follow-up|0
7995756|NCT03500198|12580022|FG001|Overall Study|Lost to Follow-up|1
7995757|NCT03500211|12580032|FG000|Overall Study|Withdrawal by Subject|1
7995758|NCT03500211|12580033|FG001|Overall Study|Withdrawal by Subject|1
7995759|NCT03500224|12580039|FG000|Overall Study|Withdrawal by Subject|2
7995760|NCT03500419|12580058|FG000|Overall Study|Withdrawal by Subject|2
7995761|NCT03500419|12580059|FG001|Overall Study|Withdrawal by Subject|25
7995762|NCT03500679|12580067|FG000|Overall Study|Lost to Follow-up|6
7995763|NCT03500679|12580068|FG001|Overall Study|Lost to Follow-up|3
7995764|NCT03500679|12580067|FG000|Overall Study|Withdrawal by Subject|3
7995765|NCT03500679|12580068|FG001|Overall Study|Withdrawal by Subject|0
7995766|NCT03501277|12580147|FG000|Intervention Period 1 (4 Days)|Other|0
7995767|NCT03501277|12580148|FG001|Intervention Period 1 (4 Days)|Other|0
7995768|NCT03501277|12580149|FG002|Intervention Period 1 (4 Days)|Other|1
7995769|NCT03501277|12580150|FG003|Intervention Period 1 (4 Days)|Other|0
7995770|NCT03501277|12580147|FG000|Intervention Period 1 (4 Days)|Adverse Event|0
7995771|NCT03501277|12580148|FG001|Intervention Period 1 (4 Days)|Adverse Event|0
7995772|NCT03501277|12580149|FG002|Intervention Period 1 (4 Days)|Adverse Event|0
7995773|NCT03501277|12580150|FG003|Intervention Period 1 (4 Days)|Adverse Event|1
7995774|NCT03501277|12580147|FG000|Intervention Period 2 (4 Days)|Adverse Event|0
7995775|NCT03501277|12580148|FG001|Intervention Period 2 (4 Days)|Adverse Event|0
7995776|NCT03501277|12580149|FG002|Intervention Period 2 (4 Days)|Adverse Event|0
7995777|NCT03501277|12580150|FG003|Intervention Period 2 (4 Days)|Adverse Event|1
7995778|NCT03501277|12580147|FG000|Intervention Period 3 (4 Days)|Adverse Event|0
7995779|NCT03501277|12580148|FG001|Intervention Period 3 (4 Days)|Adverse Event|0
7995780|NCT03501277|12580149|FG002|Intervention Period 3 (4 Days)|Adverse Event|0
7995781|NCT03501277|12580150|FG003|Intervention Period 3 (4 Days)|Adverse Event|1
7995782|NCT03502616|12580177|FG000|Up to Week 16|Withdrawal by Subject|1
7995783|NCT03502616|12580178|FG001|Up to Week 16|Withdrawal by Subject|2
7995784|NCT03502616|12580177|FG000|Up to Week 16|Lost to Follow-up|0
7995785|NCT03502616|12580178|FG001|Up to Week 16|Lost to Follow-up|1
7995786|NCT03502616|12580177|FG000|Up to Week 16|Randomized, but not treated|1
7995787|NCT03502616|12580178|FG001|Up to Week 16|Randomized, but not treated|0
7995788|NCT03502616|12580177|FG000|Week 16 to Week 48|Withdrawal by Subject|6
7995789|NCT03502616|12580178|FG001|Week 16 to Week 48|Withdrawal by Subject|6
7995790|NCT03502616|12580177|FG000|Week 16 to Week 48|Lost to Follow-up|1
7995791|NCT03502616|12580178|FG001|Week 16 to Week 48|Lost to Follow-up|0
7995792|NCT03502798|12580188|FG000|Overall Study|equipment failure|0
7995793|NCT03502798|12580189|FG001|Overall Study|equipment failure|7
7995794|NCT03503162|12580217|FG000|Overall Study|did not meet eligibility|1
7995795|NCT03503188|12580223|FG000|Overall Study|Non eligible in the sub study|0
7995796|NCT03503188|12580224|FG001|Overall Study|Non eligible in the sub study|1
7995797|NCT03504189|12580252|FG000|Overall Study|Withdrawal by Subject|1
7995798|NCT03504189|12580252|FG000|Overall Study|Screening Failure|1
7995799|NCT03504189|12580252|FG000|Overall Study|Device Failure|2
7995800|NCT03504852|12580268|FG000|Overall Study|Withdrawal of informed consent|2
7995801|NCT03504852|12580269|FG001|Overall Study|Withdrawal of informed consent|1
7995802|NCT03504852|12580270|FG002|Overall Study|Withdrawal of informed consent|0
7995803|NCT03504852|12580268|FG000|Overall Study|Withdrawal by Subject|5
7995804|NCT03504852|12580269|FG001|Overall Study|Withdrawal by Subject|5
7995805|NCT03504852|12580270|FG002|Overall Study|Withdrawal by Subject|1
7995806|NCT03504852|12580268|FG000|Overall Study|Lost to Follow-up|4
7995807|NCT03504852|12580269|FG001|Overall Study|Lost to Follow-up|1
7995808|NCT03504852|12580270|FG002|Overall Study|Lost to Follow-up|0
7995809|NCT03504852|12580268|FG000|Overall Study|New therapy for study indication|1
7995810|NCT03504852|12580269|FG001|Overall Study|New therapy for study indication|0
7995811|NCT03504852|12580270|FG002|Overall Study|New therapy for study indication|0
7995812|NCT03504852|12580268|FG000|Overall Study|Lack of Efficacy|1
7995813|NCT03504852|12580269|FG001|Overall Study|Lack of Efficacy|2
7995814|NCT03504852|12580270|FG002|Overall Study|Lack of Efficacy|0
7995815|NCT03504852|12580268|FG000|Overall Study|Death|0
7995816|NCT03504852|12580269|FG001|Overall Study|Death|1
7995817|NCT03504852|12580270|FG002|Overall Study|Death|0
7995818|NCT03504852|12580268|FG000|Overall Study|Adverse Event|4
7995819|NCT03504852|12580269|FG001|Overall Study|Adverse Event|8
7995820|NCT03504852|12580270|FG002|Overall Study|Adverse Event|2
7995821|NCT03504917|12580282|FG000|Blinded Treatment Period|Protocol Violation|1
7995822|NCT03504917|12580283|FG001|Blinded Treatment Period|Protocol Violation|0
7995823|NCT03504917|12580282|FG000|Blinded Treatment Period|Withdrawal by Subject|12
7995824|NCT03504917|12580283|FG001|Blinded Treatment Period|Withdrawal by Subject|9
7995825|NCT03504917|12580282|FG000|Blinded Treatment Period|Lack of Efficacy|1
7995826|NCT03504917|12580283|FG001|Blinded Treatment Period|Lack of Efficacy|1
7995827|NCT03504917|12580282|FG000|Blinded Treatment Period|Lost to Follow-up|1
7995828|NCT03504917|12580283|FG001|Blinded Treatment Period|Lost to Follow-up|4
7995829|NCT03504917|12580282|FG000|Blinded Treatment Period|Adverse Event|4
7995830|NCT03504917|12580283|FG001|Blinded Treatment Period|Adverse Event|4
7995831|NCT03504917|12580282|FG000|Blinded Treatment Period|Physician Decision|1
7995832|NCT03504917|12580283|FG001|Blinded Treatment Period|Physician Decision|0
7995833|NCT03504917|12580282|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1
7995834|NCT03504917|12580283|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3
7995835|NCT03504917|12580282|FG000|Blinded Treatment Period|Study terminated by sponsor|39
7995836|NCT03504917|12580283|FG001|Blinded Treatment Period|Study terminated by sponsor|34
7995837|NCT03504917|12580282|FG000|Blinded Treatment Period|Non-compliance with study drug|0
7995838|NCT03504917|12580283|FG001|Blinded Treatment Period|Non-compliance with study drug|1
7995839|NCT03504917|12580282|FG000|Open Label Extension Treatment Period|The participant left the study site|0
7995840|NCT03504917|12580283|FG001|Open Label Extension Treatment Period|The participant left the study site|1
7995841|NCT03504917|12580282|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8
7995842|NCT03504917|12580283|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2
7995843|NCT03504917|12580282|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1
7995844|NCT03504917|12580283|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4
7995845|NCT03504917|12580282|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3
7995846|NCT03504917|12580283|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1
7995847|NCT03504917|12580282|FG000|Open Label Extension Treatment Period|Adverse Event|7
7995848|NCT03504917|12580283|FG001|Open Label Extension Treatment Period|Adverse Event|0
7995849|NCT03504917|12580282|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0
7995850|NCT03504917|12580283|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1
7995851|NCT03504917|12580282|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81
7995852|NCT03504917|12580283|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88
7995853|NCT03505593|12580316|FG000|Overall Study|Withdrawal by Subject|1
7995854|NCT03505593|12580316|FG000|Overall Study|Died before procedure|1
7995855|NCT03505593|12580316|FG000|Overall Study|Anatomical abnormality|1
7995856|NCT03505593|12580316|FG000|Overall Study|Unable to pass through esophagus|1
7995857|NCT03505593|12580316|FG000|Overall Study|Obstruction by Endotracheal tube|1
7995858|NCT03506425|12580342|FG000|Overall Study|Adverse Event|1
7995859|NCT03506425|12580343|FG001|Overall Study|Adverse Event|3
7995860|NCT03506425|12580344|FG002|Overall Study|Adverse Event|0
7995861|NCT03506425|12580342|FG000|Overall Study|Death|1
7995862|NCT03506425|12580343|FG001|Overall Study|Death|0
7995863|NCT03506425|12580344|FG002|Overall Study|Death|0
7995864|NCT03506425|12580342|FG000|Overall Study|Withdrawal by Subject|0
7995865|NCT03506425|12580343|FG001|Overall Study|Withdrawal by Subject|0
7995866|NCT03506425|12580344|FG002|Overall Study|Withdrawal by Subject|1
7995867|NCT03506477|12580355|FG000|Overall Study|Withdrawal by Subject|1
7995868|NCT03506477|12580356|FG001|Overall Study|Withdrawal by Subject|0
7995869|NCT03508050|12580397|FG000|Overall Study|Pleural adhesions|1
7995870|NCT03508050|12580398|FG001|Overall Study|Pleural adhesions|0
7995871|NCT03508050|12580397|FG000|Overall Study|Mucus plug|1
7995872|NCT03508050|12580398|FG001|Overall Study|Mucus plug|0
7995873|NCT03508050|12580397|FG000|Overall Study|Negative biopsy, surgery cancelled|3
7995874|NCT03508050|12580398|FG001|Overall Study|Negative biopsy, surgery cancelled|1
7995875|NCT03508050|12580397|FG000|Overall Study|Sustained desaturation|0
7995876|NCT03508050|12580398|FG001|Overall Study|Sustained desaturation|1
7995877|NCT03508609|12580405|FG000|Overall Study|Withdrawal by Subject|1
7995878|NCT03508830|12580426|FG000|Overall Study|Withdrawal by Subject|3
7995879|NCT03508830|12580427|FG001|Overall Study|Withdrawal by Subject|4
7995880|NCT03508830|12580426|FG000|Overall Study|Physician Decision|2
7995881|NCT03508830|12580427|FG001|Overall Study|Physician Decision|2
7995882|NCT03508843|12580433|FG000|Overall Study|Withdrawal by Subject|1
7995883|NCT03508843|12580433|FG000|Overall Study|technical difficulties|2
7995884|NCT03509350|12580439|FG000|Overall Study|Withdrawal by Subject|0
7995885|NCT03509350|12580440|FG001|Overall Study|Withdrawal by Subject|2
7995886|NCT03509675|12580448|FG000|First Intervention (7 Days)|Lost to Follow-up|3
7995887|NCT03509675|12580449|FG001|First Intervention (7 Days)|Lost to Follow-up|3
7995888|NCT03509675|12580448|FG000|First Intervention (7 Days)|Lack of Efficacy|2
7995889|NCT03509675|12580449|FG001|First Intervention (7 Days)|Lack of Efficacy|1
7995890|NCT03509675|12580448|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1
7995891|NCT03509675|12580449|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0
7995892|NCT03509675|12580448|FG000|Second Intervention )7 Days)|Lost Rinse B|1
7995893|NCT03509675|12580449|FG001|Second Intervention )7 Days)|Lost Rinse B|0
7995894|NCT03509948|12580470|FG000|Overall Study|Protocol Violation|0
7995895|NCT03509948|12580471|FG001|Overall Study|Protocol Violation|1
7995896|NCT03510182|12580481|FG000|Overall Study|Withdrawal by Subject|2
7995897|NCT03510273|12580499|FG000|Overall Study|Withdrawal by Subject|2
7995898|NCT03510273|12580499|FG000|Overall Study|Care outside study, ineligible to cont.|3
7995899|NCT03510273|12580499|FG000|Overall Study|Moved away from study area|4
7995900|NCT03510455|12580507|FG000|Overall Study|Physician Decision|1
7995901|NCT03510663|12580540|FG000|Overall Study|Withdrawal by Subject|0
7995902|NCT03510663|12580541|FG001|Overall Study|Withdrawal by Subject|1
7995903|NCT03510663|12580542|FG002|Overall Study|Withdrawal by Subject|0
7995904|NCT03510663|12580543|FG003|Overall Study|Withdrawal by Subject|0
7995905|NCT03510663|12580544|FG004|Overall Study|Withdrawal by Subject|0
7995906|NCT03510663|12580545|FG005|Overall Study|Withdrawal by Subject|0
7995907|NCT03510663|12580546|FG006|Overall Study|Withdrawal by Subject|0
7995908|NCT03510663|12580547|FG007|Overall Study|Withdrawal by Subject|0
7995909|NCT03510715|12580559|FG000|Overall Study|Adverse Event|1
7995910|NCT03510715|12580560|FG001|Overall Study|Adverse Event|0
7995911|NCT03510910|12580569|FG000|Overall Study|Incomplete Survey|2
7995912|NCT03510910|12580570|FG001|Overall Study|Incomplete Survey|3
7995913|NCT03511053|12580585|FG000|Overall Study|Withdrawal by Subject|1
7995914|NCT03511105|12580591|FG000|Overall Study|Adverse Event|1
7995915|NCT03511105|12580592|FG001|Overall Study|Adverse Event|0
7995916|NCT03511105|12580591|FG000|Overall Study|Withdrew consent|1
7995917|NCT03511105|12580592|FG001|Overall Study|Withdrew consent|0
7995918|NCT03511326|12580599|FG000|Overall Study|Withdrawal by Subject|1
7995919|NCT03511378|12580605|FG000|Overall Study|Withdrawal by Subject|2
7995920|NCT03511378|12580606|FG001|Overall Study|Withdrawal by Subject|2
7995921|NCT03511378|12580605|FG000|Overall Study|Patient not coming or schedule visit|1
7995922|NCT03511378|12580606|FG001|Overall Study|Patient not coming or schedule visit|0
7995923|NCT03512028|12580643|FG000|Overall Study|Withdrawal by Subject|2
7995924|NCT03512028|12580644|FG001|Overall Study|Withdrawal by Subject|0
7995925|NCT03512028|12580643|FG000|Overall Study|Protocol Violation|2
7995926|NCT03512028|12580644|FG001|Overall Study|Protocol Violation|0
7995927|NCT03512288|12580673|FG000|Overall Study|Adverse Event|1
7995928|NCT03512288|12580674|FG001|Overall Study|Adverse Event|0
7995929|NCT03512288|12580673|FG000|Overall Study|Lost to Follow-up|12
7995930|NCT03512288|12580674|FG001|Overall Study|Lost to Follow-up|15
7995931|NCT03512288|12580673|FG000|Overall Study|Physician Decision|0
7995932|NCT03512288|12580674|FG001|Overall Study|Physician Decision|2
7995933|NCT03512288|12580673|FG000|Overall Study|Protocol Violation|6
7995934|NCT03512288|12580674|FG001|Overall Study|Protocol Violation|4
7995935|NCT03512288|12580673|FG000|Overall Study|Medication error without associated adverse event|1
7995936|NCT03512288|12580674|FG001|Overall Study|Medication error without associated adverse event|0
7995937|NCT03512288|12580673|FG000|Overall Study|No longer met eligibility criteria|5
7995938|NCT03512288|12580674|FG001|Overall Study|No longer met eligibility criteria|2
7995939|NCT03512288|12580673|FG000|Overall Study|Withdrawal by parent/guardian|14
7995940|NCT03512288|12580674|FG001|Overall Study|Withdrawal by parent/guardian|18
7995941|NCT03512288|12580673|FG000|Overall Study|Other|1
7995942|NCT03512288|12580674|FG001|Overall Study|Other|1
7995943|NCT03512288|12580673|FG000|Overall Study|Randomized but not treated|1
7995944|NCT03512288|12580674|FG001|Overall Study|Randomized but not treated|1
7995945|NCT03512353|12580680|FG000|Overall Study|Sponsor Decision|3
7995946|NCT03512353|12580680|FG000|Overall Study|Death|1
7995947|NCT03513588|12580700|FG000|Overall Study|Lost to Follow-up|0
7995948|NCT03513588|12580701|FG001|Overall Study|Lost to Follow-up|1
7995949|NCT03513588|12580702|FG002|Overall Study|Lost to Follow-up|1
7995950|NCT03513588|12580700|FG000|Overall Study|Study dosing paused by sponsor|1
7995951|NCT03513588|12580701|FG001|Overall Study|Study dosing paused by sponsor|1
7995952|NCT03513588|12580702|FG002|Overall Study|Study dosing paused by sponsor|0
7995953|NCT03513588|12580700|FG000|Overall Study|Death|0
7995954|NCT03513588|12580701|FG001|Overall Study|Death|0
7995955|NCT03513588|12580702|FG002|Overall Study|Death|1
7995956|NCT03514641|12580754|FG000|603A: 0-12 Week Study Period|Protocol Violation|3
7995957|NCT03514641|12580755|FG001|603A: 0-12 Week Study Period|Protocol Violation|3
7995958|NCT03514641|12580756|FG002|603A: 0-12 Week Study Period|Protocol Violation|0
7995959|NCT03514641|12580757|FG003|603A: 0-12 Week Study Period|Protocol Violation|0
7995960|NCT03514641|12580754|FG000|603A: 0-12 Week Study Period|Adverse Event|5
7995961|NCT03514641|12580755|FG001|603A: 0-12 Week Study Period|Adverse Event|2
7995962|NCT03514641|12580756|FG002|603A: 0-12 Week Study Period|Adverse Event|0
7995963|NCT03514641|12580757|FG003|603A: 0-12 Week Study Period|Adverse Event|0
7995964|NCT03514641|12580754|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7
7995965|NCT03514641|12580755|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5
7995966|NCT03514641|12580756|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0
7995967|NCT03514641|12580757|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0
7995968|NCT03514641|12580754|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10
7995969|NCT03514641|12580755|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9
7995970|NCT03514641|12580756|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0
7995971|NCT03514641|12580757|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0
7995972|NCT03514641|12580754|FG000|603A: 0-12 Week Study Period|Physician Decision|1
7995973|NCT03514641|12580755|FG001|603A: 0-12 Week Study Period|Physician Decision|0
7995974|NCT03514641|12580756|FG002|603A: 0-12 Week Study Period|Physician Decision|0
7995975|NCT03514641|12580757|FG003|603A: 0-12 Week Study Period|Physician Decision|0
7995976|NCT03514641|12580754|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1
7995977|NCT03514641|12580755|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0
7995978|NCT03514641|12580756|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0
7995979|NCT03514641|12580757|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0
7995980|NCT03514641|12580754|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
7995981|NCT03514641|12580755|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1
7995982|NCT03514641|12580756|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
7995983|NCT03514641|12580757|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
7995984|NCT03514641|12580754|FG000|603B: 24-36 Week Study Period|Protocol Violation|0
7995985|NCT03514641|12580755|FG001|603B: 24-36 Week Study Period|Protocol Violation|0
7995986|NCT03514641|12580756|FG002|603B: 24-36 Week Study Period|Protocol Violation|0
7995987|NCT03514641|12580757|FG003|603B: 24-36 Week Study Period|Protocol Violation|2
7995988|NCT03514641|12580754|FG000|603B: 24-36 Week Study Period|Adverse Event|0
7995989|NCT03514641|12580755|FG001|603B: 24-36 Week Study Period|Adverse Event|0
7995990|NCT03514641|12580756|FG002|603B: 24-36 Week Study Period|Adverse Event|3
7995991|NCT03514641|12580757|FG003|603B: 24-36 Week Study Period|Adverse Event|1
7995992|NCT03514641|12580754|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0
7995993|NCT03514641|12580755|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0
7995994|NCT03514641|12580756|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2
7995995|NCT03514641|12580757|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3
7995996|NCT03514641|12580754|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0
7995997|NCT03514641|12580755|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0
7995998|NCT03514641|12580756|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6
7995999|NCT03514641|12580757|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6
7996000|NCT03514641|12580754|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0
7996001|NCT03514641|12580755|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0
7996002|NCT03514641|12580756|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3
7996003|NCT03514641|12580757|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3
7996004|NCT03515824|12580790|FG000|Overall Study|Death|3
7996005|NCT03515824|12580791|FG001|Overall Study|Death|2
7996006|NCT03515824|12580792|FG002|Overall Study|Death|6
7996007|NCT03515824|12580793|FG003|Overall Study|Death|0
7996008|NCT03515824|12580790|FG000|Overall Study|Lost to Follow-up|0
7996009|NCT03515824|12580791|FG001|Overall Study|Lost to Follow-up|1
7996010|NCT03515824|12580792|FG002|Overall Study|Lost to Follow-up|1
7996011|NCT03515824|12580793|FG003|Overall Study|Lost to Follow-up|0
7996012|NCT03515824|12580790|FG000|Overall Study|Study terminated by sponsor|0
7996013|NCT03515824|12580791|FG001|Overall Study|Study terminated by sponsor|1
7996014|NCT03515824|12580792|FG002|Overall Study|Study terminated by sponsor|6
7996015|NCT03515824|12580793|FG003|Overall Study|Study terminated by sponsor|0
7996016|NCT03515824|12580790|FG000|Overall Study|Status not recorded|0
7996017|NCT03515824|12580791|FG001|Overall Study|Status not recorded|0
7996018|NCT03515824|12580792|FG002|Overall Study|Status not recorded|2
7996019|NCT03515824|12580793|FG003|Overall Study|Status not recorded|0
7996020|NCT03515941|12580803|FG000|Overall Study|Adverse Event|1
7996021|NCT03515941|12580804|FG001|Overall Study|Adverse Event|0
7996022|NCT03517436|12580820|FG000|Overall Study|Death|3
7996023|NCT03517436|12580820|FG000|Overall Study|Withdrawal by Subject|4
7996024|NCT03517436|12580820|FG000|Overall Study|Did not receive study valve.|1
7996025|NCT03517566|12580829|FG000|Overall Study|Adverse Event|5
7996026|NCT03517566|12580830|FG001|Overall Study|Adverse Event|2
7996027|NCT03517566|12580831|FG002|Overall Study|Adverse Event|2
7996028|NCT03517566|12580832|FG003|Overall Study|Adverse Event|8
7996029|NCT03517566|12580833|FG004|Overall Study|Adverse Event|7
7996030|NCT03517566|12580829|FG000|Overall Study|Lack of Efficacy|3
7996031|NCT03517566|12580830|FG001|Overall Study|Lack of Efficacy|2
7996032|NCT03517566|12580831|FG002|Overall Study|Lack of Efficacy|1
7996033|NCT03517566|12580832|FG003|Overall Study|Lack of Efficacy|1
7996034|NCT03517566|12580833|FG004|Overall Study|Lack of Efficacy|4
7996035|NCT03517566|12580829|FG000|Overall Study|Lost to Follow-up|3
7996036|NCT03517566|12580830|FG001|Overall Study|Lost to Follow-up|1
7996037|NCT03517566|12580831|FG002|Overall Study|Lost to Follow-up|1
7996038|NCT03517566|12580832|FG003|Overall Study|Lost to Follow-up|1
7996039|NCT03517566|12580833|FG004|Overall Study|Lost to Follow-up|0
7996040|NCT03517566|12580829|FG000|Overall Study|Physician Decision|1
7996041|NCT03517566|12580830|FG001|Overall Study|Physician Decision|1
7996042|NCT03517566|12580831|FG002|Overall Study|Physician Decision|0
7996043|NCT03517566|12580832|FG003|Overall Study|Physician Decision|1
7996044|NCT03517566|12580833|FG004|Overall Study|Physician Decision|0
7996045|NCT03517566|12580829|FG000|Overall Study|Pregnancy|0
7996046|NCT03517566|12580830|FG001|Overall Study|Pregnancy|1
7996047|NCT03517566|12580831|FG002|Overall Study|Pregnancy|0
7996048|NCT03517566|12580832|FG003|Overall Study|Pregnancy|0
7996049|NCT03517566|12580833|FG004|Overall Study|Pregnancy|0
7996050|NCT03517566|12580829|FG000|Overall Study|Protocol Deviation|0
7996051|NCT03517566|12580830|FG001|Overall Study|Protocol Deviation|1
7996052|NCT03517566|12580831|FG002|Overall Study|Protocol Deviation|0
7996053|NCT03517566|12580832|FG003|Overall Study|Protocol Deviation|1
7996054|NCT03517566|12580833|FG004|Overall Study|Protocol Deviation|1
7996055|NCT03517566|12580829|FG000|Overall Study|Study terminated by Sponsor|11
7996056|NCT03517566|12580830|FG001|Overall Study|Study terminated by Sponsor|5
7996057|NCT03517566|12580831|FG002|Overall Study|Study terminated by Sponsor|6
7996058|NCT03517566|12580832|FG003|Overall Study|Study terminated by Sponsor|14
7996059|NCT03517566|12580833|FG004|Overall Study|Study terminated by Sponsor|12
7996060|NCT03517566|12580829|FG000|Overall Study|Subject Decision /Guardian Decision|9
7996061|NCT03517566|12580830|FG001|Overall Study|Subject Decision /Guardian Decision|8
7996062|NCT03517566|12580831|FG002|Overall Study|Subject Decision /Guardian Decision|5
7996063|NCT03517566|12580832|FG003|Overall Study|Subject Decision /Guardian Decision|8
7996064|NCT03517566|12580833|FG004|Overall Study|Subject Decision /Guardian Decision|8
7996065|NCT03518008|12580846|FG000|Period 2, Second Week of Wear|Family emergency|0
7996066|NCT03518008|12580847|FG001|Period 2, Second Week of Wear|Family emergency|1
7996067|NCT03518125|12580859|FG000|Overall Study|Lost to Follow-up|0
7996068|NCT03518125|12580860|FG001|Overall Study|Lost to Follow-up|2
7996069|NCT03518125|12580861|FG002|Overall Study|Lost to Follow-up|0
7996070|NCT03518125|12580862|FG003|Overall Study|Lost to Follow-up|0
7996071|NCT03518125|12580863|FG004|Overall Study|Lost to Follow-up|3
7996072|NCT03518125|12580864|FG005|Overall Study|Lost to Follow-up|5
7996073|NCT03518125|12580859|FG000|Overall Study|Physician Decision|0
7996074|NCT03518125|12580860|FG001|Overall Study|Physician Decision|1
7996075|NCT03518125|12580861|FG002|Overall Study|Physician Decision|0
7996076|NCT03518125|12580862|FG003|Overall Study|Physician Decision|0
7996077|NCT03518125|12580863|FG004|Overall Study|Physician Decision|0
7996078|NCT03518125|12580864|FG005|Overall Study|Physician Decision|0
7996079|NCT03518125|12580859|FG000|Overall Study|Withdrawal by Subject|1
7996080|NCT03518125|12580860|FG001|Overall Study|Withdrawal by Subject|1
7996081|NCT03518125|12580861|FG002|Overall Study|Withdrawal by Subject|0
7996082|NCT03518125|12580862|FG003|Overall Study|Withdrawal by Subject|1
7996083|NCT03518125|12580863|FG004|Overall Study|Withdrawal by Subject|1
7996084|NCT03518125|12580864|FG005|Overall Study|Withdrawal by Subject|3
7996085|NCT03518125|12580859|FG000|Overall Study|Missed Day 394 Visit|1
7996086|NCT03518125|12580860|FG001|Overall Study|Missed Day 394 Visit|0
7996087|NCT03518125|12580861|FG002|Overall Study|Missed Day 394 Visit|0
7996088|NCT03518125|12580862|FG003|Overall Study|Missed Day 394 Visit|0
7996089|NCT03518125|12580863|FG004|Overall Study|Missed Day 394 Visit|0
7996090|NCT03518125|12580864|FG005|Overall Study|Missed Day 394 Visit|0
7996091|NCT03518658|12580881|FG000|Overall Study|Other|51
7996092|NCT03518658|12580882|FG001|Overall Study|Other|0
7996093|NCT03518840|12580890|FG000|Overall Study|Lost to Follow-up|6
7996094|NCT03519087|12580899|FG000|Clinic Evaluation|Physician Decision|15
7996095|NCT03519087|12580900|FG001|Clinic Evaluation|Physician Decision|18
7996096|NCT03519087|12580901|FG002|Clinic Evaluation|Physician Decision|0
7996097|NCT03519087|12580902|FG003|Clinic Evaluation|Physician Decision|0
7996098|NCT03519087|12580903|FG004|Clinic Evaluation|Physician Decision|0
7996099|NCT03519087|12580899|FG000|Clinic Evaluation|Protocol Violation|1
7996100|NCT03519087|12580900|FG001|Clinic Evaluation|Protocol Violation|0
7996101|NCT03519087|12580901|FG002|Clinic Evaluation|Protocol Violation|0
7996102|NCT03519087|12580902|FG003|Clinic Evaluation|Protocol Violation|0
7996103|NCT03519087|12580903|FG004|Clinic Evaluation|Protocol Violation|0
7996104|NCT03519087|12580899|FG000|Re-randomization for Treatment|Withdrawal by Subject|25
7996105|NCT03519087|12580900|FG001|Re-randomization for Treatment|Withdrawal by Subject|29
7996106|NCT03519087|12580901|FG002|Re-randomization for Treatment|Withdrawal by Subject|0
7996107|NCT03519087|12580902|FG003|Re-randomization for Treatment|Withdrawal by Subject|0
7996108|NCT03519087|12580903|FG004|Re-randomization for Treatment|Withdrawal by Subject|0
7996109|NCT03519087|12580899|FG000|Re-randomization for Treatment|Not appropriate|2
7996110|NCT03519087|12580900|FG001|Re-randomization for Treatment|Not appropriate|3
7996111|NCT03519087|12580901|FG002|Re-randomization for Treatment|Not appropriate|0
7996112|NCT03519087|12580902|FG003|Re-randomization for Treatment|Not appropriate|0
7996113|NCT03519087|12580903|FG004|Re-randomization for Treatment|Not appropriate|0
7996114|NCT03519087|12580899|FG000|Laboratory Testing|Lost to Follow-up|0
7996115|NCT03519087|12580900|FG001|Laboratory Testing|Lost to Follow-up|0
7996116|NCT03519087|12580901|FG002|Laboratory Testing|Lost to Follow-up|2
7996117|NCT03519087|12580902|FG003|Laboratory Testing|Lost to Follow-up|3
7996118|NCT03519087|12580903|FG004|Laboratory Testing|Lost to Follow-up|6
7996119|NCT03519087|12580899|FG000|Laboratory Testing|Protocol Violation|0
7996120|NCT03519087|12580900|FG001|Laboratory Testing|Protocol Violation|0
7996121|NCT03519087|12580901|FG002|Laboratory Testing|Protocol Violation|0
7996122|NCT03519087|12580902|FG003|Laboratory Testing|Protocol Violation|1
7996123|NCT03519087|12580903|FG004|Laboratory Testing|Protocol Violation|0
7996124|NCT03519204|12580921|FG000|Overall Study|Lost to Follow-up|3
7996125|NCT03519204|12580922|FG001|Overall Study|Lost to Follow-up|8
7996126|NCT03519204|12580921|FG000|Overall Study|Withdrawal by Subject|9
7996127|NCT03519204|12580922|FG001|Overall Study|Withdrawal by Subject|7
7996128|NCT03519204|12580921|FG000|Overall Study|Other Miscellaneous Reasons|1
7996129|NCT03519204|12580922|FG001|Overall Study|Other Miscellaneous Reasons|0
7996130|NCT03519516|12580955|FG000|Overall Study|Adverse Event|0
7996131|NCT03519516|12580956|FG001|Overall Study|Adverse Event|1
7996132|NCT03519854|12580980|FG000|Overall Study|Technical Error|0
7996133|NCT03519854|12580981|FG001|Overall Study|Technical Error|0
7996134|NCT03519854|12580982|FG002|Overall Study|Technical Error|1
7996135|NCT03519854|12580983|FG003|Overall Study|Technical Error|0
7996136|NCT03519854|12580984|FG004|Overall Study|Technical Error|0
7996137|NCT03519854|12580985|FG005|Overall Study|Technical Error|0
7996138|NCT03519854|12580986|FG006|Overall Study|Technical Error|0
7996139|NCT03519854|12580987|FG007|Overall Study|Technical Error|0
7996140|NCT03519854|12580988|FG008|Overall Study|Technical Error|0
7996141|NCT03519854|12580989|FG009|Overall Study|Technical Error|0
7996142|NCT03519854|12580990|FG010|Overall Study|Technical Error|0
7996143|NCT03519854|12580991|FG011|Overall Study|Technical Error|0
7996144|NCT03519854|12580992|FG012|Overall Study|Technical Error|0
7996145|NCT03519854|12580993|FG013|Overall Study|Technical Error|0
7996146|NCT03519854|12580994|FG014|Overall Study|Technical Error|0
7996147|NCT03519854|12580995|FG015|Overall Study|Technical Error|0
7996148|NCT03519854|12580996|FG016|Overall Study|Technical Error|0
7996149|NCT03519854|12580997|FG017|Overall Study|Technical Error|0
7996150|NCT03519867|12581045|FG000|Overall Study|Adverse Event|1
7996151|NCT03519867|12581046|FG001|Overall Study|Adverse Event|1
7996152|NCT03519867|12581047|FG002|Overall Study|Adverse Event|0
7996153|NCT03519867|12581048|FG003|Overall Study|Adverse Event|0
7996154|NCT03519867|12581049|FG004|Overall Study|Adverse Event|0
7996155|NCT03519867|12581050|FG005|Overall Study|Adverse Event|0
7996156|NCT03519867|12581051|FG006|Overall Study|Adverse Event|0
7996157|NCT03519867|12581052|FG007|Overall Study|Adverse Event|0
7996158|NCT03519867|12581053|FG008|Overall Study|Adverse Event|0
7996159|NCT03519867|12581054|FG009|Overall Study|Adverse Event|0
7996160|NCT03519867|12581045|FG000|Overall Study|Protocol Violation|0
7996161|NCT03519867|12581046|FG001|Overall Study|Protocol Violation|0
7996162|NCT03519867|12581047|FG002|Overall Study|Protocol Violation|0
7996163|NCT03519867|12581048|FG003|Overall Study|Protocol Violation|0
7996164|NCT03519867|12581049|FG004|Overall Study|Protocol Violation|0
7996165|NCT03519867|12581050|FG005|Overall Study|Protocol Violation|1
7996166|NCT03519867|12581051|FG006|Overall Study|Protocol Violation|0
7996167|NCT03519867|12581052|FG007|Overall Study|Protocol Violation|0
7996168|NCT03519867|12581053|FG008|Overall Study|Protocol Violation|0
7996169|NCT03519867|12581054|FG009|Overall Study|Protocol Violation|0
7996170|NCT03519867|12581045|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0
7996171|NCT03519867|12581046|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0
7996172|NCT03519867|12581047|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0
7996173|NCT03519867|12581048|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0
7996174|NCT03519867|12581049|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0
7996175|NCT03519867|12581050|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0
7996176|NCT03519867|12581051|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1
7996177|NCT03519867|12581052|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0
7996178|NCT03519867|12581053|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0
7996179|NCT03519867|12581054|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0
7996180|NCT03519867|12581045|FG000|Overall Study|Admin. of other reversal agent|1
7996181|NCT03519867|12581046|FG001|Overall Study|Admin. of other reversal agent|1
7996182|NCT03519867|12581047|FG002|Overall Study|Admin. of other reversal agent|0
7996183|NCT03519867|12581048|FG003|Overall Study|Admin. of other reversal agent|0
7996184|NCT03519867|12581049|FG004|Overall Study|Admin. of other reversal agent|0
7996185|NCT03519867|12581050|FG005|Overall Study|Admin. of other reversal agent|1
7996186|NCT03519867|12581051|FG006|Overall Study|Admin. of other reversal agent|0
7996187|NCT03519867|12581052|FG007|Overall Study|Admin. of other reversal agent|0
7996188|NCT03519867|12581053|FG008|Overall Study|Admin. of other reversal agent|0
7996189|NCT03519867|12581054|FG009|Overall Study|Admin. of other reversal agent|0
7996190|NCT03519867|12581045|FG000|Overall Study|Reason not provided|1
7996191|NCT03519867|12581046|FG001|Overall Study|Reason not provided|1
7996192|NCT03519867|12581047|FG002|Overall Study|Reason not provided|1
7996193|NCT03519867|12581048|FG003|Overall Study|Reason not provided|1
7996194|NCT03519867|12581049|FG004|Overall Study|Reason not provided|0
7996195|NCT03519867|12581050|FG005|Overall Study|Reason not provided|1
7996196|NCT03519867|12581051|FG006|Overall Study|Reason not provided|0
7996197|NCT03519867|12581052|FG007|Overall Study|Reason not provided|1
7996198|NCT03519867|12581053|FG008|Overall Study|Reason not provided|1
7996199|NCT03519867|12581054|FG009|Overall Study|Reason not provided|0
7996200|NCT03519919|12581076|FG000|Overall Study|Withdrawal by Subject|1
7996201|NCT03519919|12581076|FG000|Overall Study|Lack of Efficacy|1
7996202|NCT03519919|12581076|FG000|Overall Study|Screen Failure|1
7996203|NCT03519932|12581106|FG000|First Intervention|Adverse Event|1
7996204|NCT03519932|12581107|FG001|First Intervention|Adverse Event|3
7996205|NCT03520387|12581150|FG000|Pre-Randomization|Withdrawal by Subject|1
7996206|NCT03520387|12581151|FG001|Pre-Randomization|Withdrawal by Subject|0
7996207|NCT03520387|12581152|FG002|Pre-Randomization|Withdrawal by Subject|0
7996208|NCT03520387|12581153|FG003|Pre-Randomization|Withdrawal by Subject|0
7996209|NCT03520387|12581154|FG004|Pre-Randomization|Withdrawal by Subject|0
7718265|NCT00527072|12142168|FG000|Overall Study|Withdrawal by Subject|7
7718266|NCT00527111|12142183|FG000|Overall Study|Adverse Event|14
7718267|NCT00527111|12142184|FG001|Overall Study|Adverse Event|13
7718268|NCT00527111|12142183|FG000|Overall Study|Death|0
7718269|NCT00527111|12142184|FG001|Overall Study|Death|1
7718270|NCT00527111|12142183|FG000|Overall Study|Investigator Request|2
7718271|NCT00527111|12142184|FG001|Overall Study|Investigator Request|1
7718272|NCT00527111|12142183|FG000|Overall Study|Patient Request|2
7996210|NCT03520387|12581150|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2
7996211|NCT03520387|12581151|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7996212|NCT03520387|12581152|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7996213|NCT03520387|12581153|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7996214|NCT03520387|12581154|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7996215|NCT03520400|12581167|FG000|Overall Study|Physician Decision|15
7996216|NCT03520400|12581168|FG001|Overall Study|Physician Decision|7
7996217|NCT03520920|12581177|FG000|Overall Study|Death|13
7996218|NCT03520920|12581178|FG001|Overall Study|Death|1
7996219|NCT03520920|12581179|FG002|Overall Study|Death|0
7996220|NCT03520920|12581177|FG000|Overall Study|Withdrawal by Subject|2
7996221|NCT03520920|12581178|FG001|Overall Study|Withdrawal by Subject|1
7996222|NCT03520920|12581179|FG002|Overall Study|Withdrawal by Subject|0
7996223|NCT03520920|12581177|FG000|Overall Study|Study Terminated by the Sponsor|5
7996224|NCT03520920|12581178|FG001|Overall Study|Study Terminated by the Sponsor|14
7996225|NCT03520920|12581179|FG002|Overall Study|Study Terminated by the Sponsor|5
7996226|NCT03520959|12581195|FG000|Overall Study|Study terminated by Sponsor|0
7996227|NCT03520959|12581196|FG001|Overall Study|Study terminated by Sponsor|1
7996228|NCT03521115|12581222|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56
7996229|NCT03521115|12581223|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40
7996230|NCT03521115|12581222|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3
7996231|NCT03521115|12581223|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1
7996232|NCT03521141|12581238|FG000|Overall Study|Death|1
7996233|NCT03521141|12581239|FG001|Overall Study|Death|0
7996234|NCT03521141|12581240|FG002|Overall Study|Death|1
7996235|NCT03521635|12581276|FG000|Overall Study|Adverse Event|1
7996236|NCT03521635|12581277|FG001|Overall Study|Adverse Event|1
7996237|NCT03521635|12581276|FG000|Overall Study|Refused to complete study visit|1
7996238|NCT03521635|12581277|FG001|Overall Study|Refused to complete study visit|0
7996239|NCT03521635|12581276|FG000|Overall Study|Refused to continue trial medication|2
7996240|NCT03521635|12581277|FG001|Overall Study|Refused to continue trial medication|2
7996241|NCT03521635|12581276|FG000|Overall Study|Lost to Follow-up|0
7996242|NCT03521635|12581277|FG001|Overall Study|Lost to Follow-up|1
7996243|NCT03521635|12581276|FG000|Overall Study|Meet exclusion criteria|0
7996244|NCT03521635|12581277|FG001|Overall Study|Meet exclusion criteria|1
7996245|NCT03521635|12581276|FG000|Overall Study|Patient not taken study medicine|0
7996246|NCT03521635|12581277|FG001|Overall Study|Patient not taken study medicine|1
7996247|NCT03521791|12581285|FG000|Overall Study|Protocol Violation|7
7996248|NCT03521791|12581286|FG001|Overall Study|Protocol Violation|17
7996249|NCT03521817|12581294|FG000|Overall Study|Protocol Violation|0
7996250|NCT03521817|12581295|FG001|Overall Study|Protocol Violation|1
7996251|NCT03522506|12581324|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7996252|NCT03522506|12581325|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7996253|NCT03522506|12581326|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7996254|NCT03522506|12581327|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7996255|NCT03522506|12581324|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0
7996256|NCT03522506|12581325|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0
7996257|NCT03522506|12581326|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0
7996258|NCT03522506|12581327|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1
7996259|NCT03522675|12581341|FG000|Overall Study|Screen fail|1
7996260|NCT03522675|12581341|FG000|Overall Study|Non-reactive to histamine|1
7996261|NCT03522948|12581349|FG000|Overall Study|Lost to Follow-up|1
7996262|NCT03523715|12581355|FG000|Overall Study|Lost to Follow-up|11
7996263|NCT03523715|12581356|FG001|Overall Study|Lost to Follow-up|14
7996264|NCT03523715|12581355|FG000|Overall Study|Did not meet inclusion criteria|1
7996265|NCT03523715|12581356|FG001|Overall Study|Did not meet inclusion criteria|0
7996266|NCT03523715|12581355|FG000|Overall Study|Internally inconsistent reporting|0
7996267|NCT03523715|12581356|FG001|Overall Study|Internally inconsistent reporting|2
7996268|NCT03523871|12581362|FG000|Overall Study|Death|1
7996269|NCT03524157|12581382|FG000|Overall Study|cytology not readable|0
7996270|NCT03524157|12581383|FG001|Overall Study|cytology not readable|0
7996271|NCT03524157|12581384|FG002|Overall Study|cytology not readable|1
7996272|NCT03525444|12581414|FG000|Overall Study|Adverse Event|0
7996273|NCT03525444|12581415|FG001|Overall Study|Adverse Event|1
7996274|NCT03525444|12581414|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
7996275|NCT03525444|12581415|FG001|Overall Study|Withdrawal of consent (not due to AE)|1
7996276|NCT03525444|12581414|FG000|Overall Study|Other|0
7996277|NCT03525444|12581415|FG001|Overall Study|Other|1
7996278|NCT03525834|12581431|FG000|Overall Study|Progressive disease|1
7996279|NCT03526458|12581445|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2
7996280|NCT03526458|12581446|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2
7996281|NCT03526458|12581445|FG000|Overall Study|Stone passed, surgery cancelled|2
7996282|NCT03526458|12581446|FG001|Overall Study|Stone passed, surgery cancelled|1
7996283|NCT03526458|12581445|FG000|Overall Study|Withdrawal by Subject|1
7996284|NCT03526458|12581446|FG001|Overall Study|Withdrawal by Subject|0
7996285|NCT03526458|12581445|FG000|Overall Study|Physician Decision|2
7996286|NCT03526458|12581446|FG001|Overall Study|Physician Decision|1
7996287|NCT03526458|12581445|FG000|Overall Study|Lack of equipment|1
7996288|NCT03526458|12581446|FG001|Overall Study|Lack of equipment|1
7996289|NCT03527160|12581454|FG000|Overall Study|No urine collected|13
7996290|NCT03527160|12581454|FG000|Overall Study|No clinical serum creatinine collected|6
7996291|NCT03527160|12581454|FG000|Overall Study|Did not meet inclusion|2
7996292|NCT03527173|12581463|FG000|Overall Study|Lost to Follow-up|4
7996293|NCT03527173|12581464|FG001|Overall Study|Lost to Follow-up|2
7996294|NCT03527173|12581463|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1
7996295|NCT03527173|12581464|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0
7996296|NCT03527173|12581463|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7996297|NCT03527173|12581464|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
7996298|NCT03527173|12581463|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
7996299|NCT03527173|12581464|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7996300|NCT03527550|12581472|FG000|Overall Study|Lost to Follow-up|4
7996301|NCT03527550|12581473|FG001|Overall Study|Lost to Follow-up|2
7996302|NCT03527550|12581472|FG000|Overall Study|Withdrawal by Subject|4
7996303|NCT03527550|12581473|FG001|Overall Study|Withdrawal by Subject|1
7996304|NCT03527550|12581472|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1
7996305|NCT03527550|12581473|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0
7996306|NCT03527745|12581507|FG000|Overall Study|Lost to Follow-up|3
7996307|NCT03527745|12581508|FG001|Overall Study|Lost to Follow-up|6
7996308|NCT03527745|12581509|FG002|Overall Study|Lost to Follow-up|7
7996309|NCT03527745|12581510|FG003|Overall Study|Lost to Follow-up|9
7996310|NCT03527745|12581511|FG004|Overall Study|Lost to Follow-up|0
7996311|NCT03527745|12581512|FG005|Overall Study|Lost to Follow-up|2
7996312|NCT03527745|12581513|FG006|Overall Study|Lost to Follow-up|3
7996313|NCT03527745|12581514|FG007|Overall Study|Lost to Follow-up|2
7996314|NCT03527745|12581515|FG008|Overall Study|Lost to Follow-up|3
7996315|NCT03527745|12581516|FG009|Overall Study|Lost to Follow-up|2
7996316|NCT03527745|12581517|FG010|Overall Study|Lost to Follow-up|1
7996317|NCT03527745|12581518|FG011|Overall Study|Lost to Follow-up|1
7996318|NCT03527745|12581519|FG012|Overall Study|Lost to Follow-up|0
7996319|NCT03527745|12581520|FG013|Overall Study|Lost to Follow-up|0
7996320|NCT03527745|12581521|FG014|Overall Study|Lost to Follow-up|0
7996321|NCT03527745|12581522|FG015|Overall Study|Lost to Follow-up|0
7996322|NCT03527745|12581523|FG016|Overall Study|Lost to Follow-up|1
7996323|NCT03527745|12581524|FG017|Overall Study|Lost to Follow-up|0
7996324|NCT03527745|12581525|FG018|Overall Study|Lost to Follow-up|0
7996325|NCT03527745|12581526|FG019|Overall Study|Lost to Follow-up|1
7996326|NCT03527745|12581527|FG020|Overall Study|Lost to Follow-up|1
7996327|NCT03527745|12581528|FG021|Overall Study|Lost to Follow-up|5
7996328|NCT03527745|12581529|FG022|Overall Study|Lost to Follow-up|6
7996329|NCT03527745|12581530|FG023|Overall Study|Lost to Follow-up|8
7996330|NCT03527745|12581531|FG024|Overall Study|Lost to Follow-up|1
7996331|NCT03527745|12581532|FG025|Overall Study|Lost to Follow-up|3
7996332|NCT03527966|12581590|FG000|Overall Study|Lost to Follow-up|3
7996333|NCT03527966|12581591|FG001|Overall Study|Lost to Follow-up|0
7996334|NCT03528174|12581597|FG000|Overall Study|Adverse Event|1
7996335|NCT03528174|12581597|FG000|Overall Study|sensors dislodged|1
7996336|NCT03528369|12581604|FG000|Overall Study|Withdrawal by Subject|2
7996337|NCT03528369|12581605|FG001|Overall Study|Withdrawal by Subject|0
7996338|NCT03528369|12581606|FG002|Overall Study|Withdrawal by Subject|0
7996339|NCT03528369|12581604|FG000|Overall Study|Lost to Follow-up|1
7996340|NCT03528369|12581605|FG001|Overall Study|Lost to Follow-up|0
7996341|NCT03528369|12581606|FG002|Overall Study|Lost to Follow-up|0
7996342|NCT03528369|12581604|FG000|Overall Study|Adverse Event|0
7996343|NCT03528369|12581605|FG001|Overall Study|Adverse Event|1
7996344|NCT03528369|12581606|FG002|Overall Study|Adverse Event|0
7996345|NCT03528551|12581626|FG000|Overall Study|Lost to Follow-up|0
7996346|NCT03528551|12581627|FG001|Overall Study|Lost to Follow-up|1
7996347|NCT03528551|12581628|FG002|Overall Study|Lost to Follow-up|0
7996348|NCT03528551|12581626|FG000|Overall Study|Transferred to other arm/group|2
7996349|NCT03528551|12581627|FG001|Overall Study|Transferred to other arm/group|3
7996350|NCT03528551|12581628|FG002|Overall Study|Transferred to other arm/group|0
7996351|NCT03528551|12581626|FG000|Overall Study|Withdrawal by parent/guardian|0
7996352|NCT03528551|12581627|FG001|Overall Study|Withdrawal by parent/guardian|5
7996353|NCT03528551|12581628|FG002|Overall Study|Withdrawal by parent/guardian|0
7996354|NCT03528551|12581626|FG000|Overall Study|Protocol Violation|0
7996355|NCT03528551|12581627|FG001|Overall Study|Protocol Violation|3
7996356|NCT03528551|12581628|FG002|Overall Study|Protocol Violation|0
7996357|NCT03528551|12581626|FG000|Overall Study|Withdrawal by Subject|0
7996358|NCT03528551|12581627|FG001|Overall Study|Withdrawal by Subject|7
7996359|NCT03528551|12581628|FG002|Overall Study|Withdrawal by Subject|0
7996360|NCT03528577|12581637|FG000|Sequence 1|Failed Spirometry|1
7996361|NCT03528577|12581637|FG000|Sequence 1|Restricted medication|1
7996362|NCT03528577|12581637|FG000|Sequence 2|Adverse Event|1
7996363|NCT03528577|12581637|FG000|Sequence 2|Withdrawal by Subject|1
7996364|NCT03528577|12581637|FG000|Sequence 2|Failed Spirometry|1
7996365|NCT03528577|12581637|FG000|Sequence 3|Failed Spirometry|1
7996366|NCT03528577|12581637|FG000|Sequence 4|Failed Spirometry|2
7996367|NCT03528577|12581637|FG000|Sequence 4|Adverse Event|1
7996368|NCT03529162|12581646|FG000|Overall Study|Lost to Follow-up|2
7996369|NCT03529162|12581647|FG001|Overall Study|Lost to Follow-up|2
7996370|NCT03530345|12581677|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
7996371|NCT03530345|12581678|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0
7996372|NCT03530345|12581677|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
7996373|NCT03530345|12581678|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
7996374|NCT03530345|12581677|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17
7996375|NCT03530345|12581678|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21
7996376|NCT03530345|12581677|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5
7996377|NCT03530345|12581678|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7
7996378|NCT03531840|12581768|FG000|Overall Study|Death on study|3
7996379|NCT03531840|12581769|FG001|Overall Study|Death on study|2
7996380|NCT03531840|12581770|FG002|Overall Study|Death on study|1
7996381|NCT03531840|12581771|FG003|Overall Study|Death on study|2
7996382|NCT03531840|12581768|FG000|Overall Study|Death during follow up|2
7996383|NCT03531840|12581769|FG001|Overall Study|Death during follow up|3
7996384|NCT03531840|12581770|FG002|Overall Study|Death during follow up|4
7996385|NCT03531840|12581771|FG003|Overall Study|Death during follow up|1
7996386|NCT03531905|12581789|FG000|Overall Study|Withdrawal by Subject|3
7996387|NCT03531905|12581790|FG001|Overall Study|Withdrawal by Subject|3
7996388|NCT03531905|12581791|FG002|Overall Study|Withdrawal by Subject|2
7996389|NCT03531905|12581789|FG000|Overall Study|Lost to Follow-up|2
7996390|NCT03531905|12581790|FG001|Overall Study|Lost to Follow-up|2
7996391|NCT03531905|12581791|FG002|Overall Study|Lost to Follow-up|1
7996392|NCT03531905|12581789|FG000|Overall Study|Participant was out of town|1
7996393|NCT03531905|12581790|FG001|Overall Study|Participant was out of town|0
7996394|NCT03531905|12581791|FG002|Overall Study|Participant was out of town|0
7996395|NCT03531905|12581789|FG000|Overall Study|Could not speak with the participant|1
7996396|NCT03531905|12581790|FG001|Overall Study|Could not speak with the participant|0
7996397|NCT03531905|12581791|FG002|Overall Study|Could not speak with the participant|0
7996398|NCT03532009|12581803|FG000|Overall Study|Other|1
7996399|NCT03532009|12581804|FG001|Overall Study|Other|1
7996400|NCT03532009|12581803|FG000|Overall Study|Death|1
7996401|NCT03532009|12581804|FG001|Overall Study|Death|1
7996402|NCT03532009|12581803|FG000|Overall Study|Withdrawal by Patient|0
7996403|NCT03532009|12581804|FG001|Overall Study|Withdrawal by Patient|2
7996404|NCT03532048|12581812|FG000|Overall Study|Lost to Follow-up|12
7996405|NCT03532048|12581813|FG001|Overall Study|Lost to Follow-up|17
7996406|NCT03532048|12581812|FG000|Overall Study|Withdrawal by Subject|7
7996407|NCT03532048|12581813|FG001|Overall Study|Withdrawal by Subject|0
7996408|NCT03533114|12581853|FG000|Overall|Adverse Event|16
7996409|NCT03533114|12581854|FG001|Overall|Adverse Event|11
7996410|NCT03533114|12581853|FG000|Overall|Consent Withdrawal by Participant|7
7996411|NCT03533114|12581854|FG001|Overall|Consent Withdrawal by Participant|6
7996412|NCT03533114|12581853|FG000|Overall|Lack of Efficacy|5
7996413|NCT03533114|12581854|FG001|Overall|Lack of Efficacy|3
7996414|NCT03533114|12581853|FG000|Overall|Lost to Follow-up|1
7996415|NCT03533114|12581854|FG001|Overall|Lost to Follow-up|1
7996416|NCT03533114|12581853|FG000|Overall|Physician Decision|0
7996417|NCT03533114|12581854|FG001|Overall|Physician Decision|2
7996418|NCT03533114|12581853|FG000|Overall|Protocol deviation|1
7996419|NCT03533114|12581854|FG001|Overall|Protocol deviation|1
7996420|NCT03533114|12581853|FG000|Overall|Failure to meet randomization criteria|1
7996421|NCT03533114|12581854|FG001|Overall|Failure to meet randomization criteria|2
7996422|NCT03533114|12581853|FG000|Overall|Non-Compliance with study drug|0
7996423|NCT03533114|12581854|FG001|Overall|Non-Compliance with study drug|1
7996424|NCT03533114|12581853|FG000|Overall|Other|0
7996425|NCT03533114|12581854|FG001|Overall|Other|1
7996426|NCT03533114|12581853|FG000|Open Label Titration and Optimization|Adverse Event|11
7996427|NCT03533114|12581854|FG001|Open Label Titration and Optimization|Adverse Event|8
7996428|NCT03533114|12581853|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2
7996429|NCT03533114|12581854|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1
7996430|NCT03533114|12581853|FG000|Open Label Titration and Optimization|Lack of Efficacy|3
7996431|NCT03533114|12581854|FG001|Open Label Titration and Optimization|Lack of Efficacy|1
7996432|NCT03533114|12581853|FG000|Open Label Titration and Optimization|Lost to Follow-up|0
7996433|NCT03533114|12581854|FG001|Open Label Titration and Optimization|Lost to Follow-up|1
7996434|NCT03533114|12581853|FG000|Open Label Titration and Optimization|Protocol Deviation|0
7996435|NCT03533114|12581854|FG001|Open Label Titration and Optimization|Protocol Deviation|1
7996436|NCT03533114|12581853|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0
7996437|NCT03533114|12581854|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1
7996438|NCT03533114|12581853|FG000|Stable Dose|Adverse Event|0
7996439|NCT03533114|12581854|FG001|Stable Dose|Adverse Event|2
7996440|NCT03533114|12581853|FG000|Stable Dose|Consent Withdrawal by Participant|1
7996441|NCT03533114|12581854|FG001|Stable Dose|Consent Withdrawal by Participant|0
7996442|NCT03533114|12581853|FG000|Stable Dose|Lack of Efficacy|1
7996443|NCT03533114|12581854|FG001|Stable Dose|Lack of Efficacy|0
7996444|NCT03533114|12581853|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1
7996445|NCT03533114|12581854|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1
7996446|NCT03533114|12581853|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1
7996447|NCT03533114|12581854|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0
7996448|NCT03533114|12581853|FG000|Open-Label Safety Extension|Adverse Event|3
7996449|NCT03533114|12581854|FG001|Open-Label Safety Extension|Adverse Event|0
7996450|NCT03533114|12581853|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2
7996451|NCT03533114|12581854|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3
7996452|NCT03533114|12581853|FG000|Open-Label Safety Extension|Lack of Efficacy|1
7996453|NCT03533114|12581854|FG001|Open-Label Safety Extension|Lack of Efficacy|0
7996454|NCT03533114|12581853|FG000|Open-Label Safety Extension|Lost to Follow-up|1
7996455|NCT03533114|12581854|FG001|Open-Label Safety Extension|Lost to Follow-up|0
7996456|NCT03533114|12581853|FG000|Open-Label Safety Extension|Protocol Deviation|1
7996457|NCT03533114|12581854|FG001|Open-Label Safety Extension|Protocol Deviation|0
7996458|NCT03533608|12581884|FG000|Overall Study|Withdrawal by Subject|3
7996459|NCT03533608|12581884|FG000|Overall Study|Physician Decision|2
7996460|NCT03535194|12581929|FG000|Induction Period|Adverse Event|2
7996461|NCT03535194|12581930|FG001|Induction Period|Adverse Event|2
7996462|NCT03535194|12581931|FG002|Induction Period|Adverse Event|1
7996463|NCT03535194|12581932|FG003|Induction Period|Adverse Event|3
7996464|NCT03535194|12581933|FG004|Induction Period|Adverse Event|0
7996465|NCT03535194|12581929|FG000|Induction Period|Death|0
7996466|NCT03535194|12581930|FG001|Induction Period|Death|1
7996467|NCT03535194|12581931|FG002|Induction Period|Death|0
7996468|NCT03535194|12581932|FG003|Induction Period|Death|0
7996469|NCT03535194|12581933|FG004|Induction Period|Death|0
7996470|NCT03535194|12581929|FG000|Induction Period|Lack of Efficacy|1
7996471|NCT03535194|12581930|FG001|Induction Period|Lack of Efficacy|3
7996472|NCT03535194|12581931|FG002|Induction Period|Lack of Efficacy|2
7996473|NCT03535194|12581932|FG003|Induction Period|Lack of Efficacy|2
7996474|NCT03535194|12581933|FG004|Induction Period|Lack of Efficacy|0
7996475|NCT03535194|12581929|FG000|Induction Period|Lost to Follow-up|3
7996476|NCT03535194|12581930|FG001|Induction Period|Lost to Follow-up|5
7996477|NCT03535194|12581931|FG002|Induction Period|Lost to Follow-up|2
7996478|NCT03535194|12581932|FG003|Induction Period|Lost to Follow-up|3
7996479|NCT03535194|12581933|FG004|Induction Period|Lost to Follow-up|0
7996480|NCT03535194|12581929|FG000|Induction Period|Physician Decision|1
7996481|NCT03535194|12581930|FG001|Induction Period|Physician Decision|1
7996482|NCT03535194|12581931|FG002|Induction Period|Physician Decision|0
7996483|NCT03535194|12581932|FG003|Induction Period|Physician Decision|0
7996484|NCT03535194|12581933|FG004|Induction Period|Physician Decision|0
7996485|NCT03535194|12581929|FG000|Induction Period|Protocol Violation|1
7996486|NCT03535194|12581930|FG001|Induction Period|Protocol Violation|0
7996487|NCT03535194|12581931|FG002|Induction Period|Protocol Violation|0
7996488|NCT03535194|12581932|FG003|Induction Period|Protocol Violation|1
7996489|NCT03535194|12581933|FG004|Induction Period|Protocol Violation|0
7996490|NCT03535194|12581929|FG000|Induction Period|Screen Failure|0
7996491|NCT03535194|12581930|FG001|Induction Period|Screen Failure|1
7996492|NCT03535194|12581931|FG002|Induction Period|Screen Failure|0
7996493|NCT03535194|12581932|FG003|Induction Period|Screen Failure|0
7996494|NCT03535194|12581933|FG004|Induction Period|Screen Failure|0
7996495|NCT03535194|12581929|FG000|Induction Period|Withdrawal by Subject|3
7996496|NCT03535194|12581930|FG001|Induction Period|Withdrawal by Subject|4
7996497|NCT03535194|12581931|FG002|Induction Period|Withdrawal by Subject|3
7996498|NCT03535194|12581932|FG003|Induction Period|Withdrawal by Subject|2
7996499|NCT03535194|12581933|FG004|Induction Period|Withdrawal by Subject|0
7996500|NCT03535194|12581929|FG000|Maintenance Period|Adverse Event|6
7996501|NCT03535194|12581930|FG001|Maintenance Period|Adverse Event|5
7996502|NCT03535194|12581931|FG002|Maintenance Period|Adverse Event|1
7996503|NCT03535194|12581932|FG003|Maintenance Period|Adverse Event|11
7996504|NCT03535194|12581933|FG004|Maintenance Period|Adverse Event|4
7996505|NCT03535194|12581929|FG000|Maintenance Period|Lack of Efficacy|3
7996506|NCT03535194|12581930|FG001|Maintenance Period|Lack of Efficacy|2
7996507|NCT03535194|12581931|FG002|Maintenance Period|Lack of Efficacy|5
7996508|NCT03535194|12581932|FG003|Maintenance Period|Lack of Efficacy|9
7996509|NCT03535194|12581933|FG004|Maintenance Period|Lack of Efficacy|0
7996510|NCT03535194|12581929|FG000|Maintenance Period|Lost to Follow-up|4
7996511|NCT03535194|12581930|FG001|Maintenance Period|Lost to Follow-up|2
7996512|NCT03535194|12581931|FG002|Maintenance Period|Lost to Follow-up|1
7996513|NCT03535194|12581932|FG003|Maintenance Period|Lost to Follow-up|5
7996514|NCT03535194|12581933|FG004|Maintenance Period|Lost to Follow-up|2
7996515|NCT03535194|12581929|FG000|Maintenance Period|Other|1
7718273|NCT00527111|12142184|FG001|Overall Study|Patient Request|5
7718274|NCT00527111|12142183|FG000|Overall Study|Other|2
7718275|NCT00527111|12142184|FG001|Overall Study|Other|2
7718276|NCT00527319|12142202|FG000|Overall Study|Withdrawal by Subject|5
7718277|NCT00527319|12142203|FG001|Overall Study|Withdrawal by Subject|0
7718278|NCT00527319|12142204|FG002|Overall Study|Withdrawal by Subject|1
7718279|NCT00527319|12142202|FG000|Overall Study|Lost to Follow-up|1
7718280|NCT00527319|12142203|FG001|Overall Study|Lost to Follow-up|0
7718281|NCT00527319|12142204|FG002|Overall Study|Lost to Follow-up|0
7996516|NCT03535194|12581930|FG001|Maintenance Period|Other|2
7996517|NCT03535194|12581931|FG002|Maintenance Period|Other|0
7996518|NCT03535194|12581932|FG003|Maintenance Period|Other|0
7996519|NCT03535194|12581933|FG004|Maintenance Period|Other|0
7996520|NCT03535194|12581929|FG000|Maintenance Period|Physician Decision|1
7996521|NCT03535194|12581930|FG001|Maintenance Period|Physician Decision|2
7996522|NCT03535194|12581931|FG002|Maintenance Period|Physician Decision|0
7996523|NCT03535194|12581932|FG003|Maintenance Period|Physician Decision|2
7996524|NCT03535194|12581933|FG004|Maintenance Period|Physician Decision|0
7996525|NCT03535194|12581929|FG000|Maintenance Period|Pregnancy|0
7996526|NCT03535194|12581930|FG001|Maintenance Period|Pregnancy|0
7996527|NCT03535194|12581931|FG002|Maintenance Period|Pregnancy|0
7996528|NCT03535194|12581932|FG003|Maintenance Period|Pregnancy|2
7996529|NCT03535194|12581933|FG004|Maintenance Period|Pregnancy|0
7996530|NCT03535194|12581929|FG000|Maintenance Period|Protocol Violation|0
7996531|NCT03535194|12581930|FG001|Maintenance Period|Protocol Violation|1
7996532|NCT03535194|12581931|FG002|Maintenance Period|Protocol Violation|0
7996533|NCT03535194|12581932|FG003|Maintenance Period|Protocol Violation|0
7996534|NCT03535194|12581933|FG004|Maintenance Period|Protocol Violation|0
7996535|NCT03535194|12581929|FG000|Maintenance Period|Withdrawal by Subject|7
7996536|NCT03535194|12581930|FG001|Maintenance Period|Withdrawal by Subject|2
7996537|NCT03535194|12581931|FG002|Maintenance Period|Withdrawal by Subject|1
7996538|NCT03535194|12581932|FG003|Maintenance Period|Withdrawal by Subject|8
7996539|NCT03535194|12581933|FG004|Maintenance Period|Withdrawal by Subject|0
7996540|NCT03535194|12581929|FG000|Post-Treatment Followup Period|Adverse Event|4
7996541|NCT03535194|12581930|FG001|Post-Treatment Followup Period|Adverse Event|5
7996542|NCT03535194|12581931|FG002|Post-Treatment Followup Period|Adverse Event|1
7996543|NCT03535194|12581932|FG003|Post-Treatment Followup Period|Adverse Event|8
7996544|NCT03535194|12581933|FG004|Post-Treatment Followup Period|Adverse Event|0
7996545|NCT03535194|12581929|FG000|Post-Treatment Followup Period|Lack of Efficacy|3
7996546|NCT03535194|12581930|FG001|Post-Treatment Followup Period|Lack of Efficacy|4
7996547|NCT03535194|12581931|FG002|Post-Treatment Followup Period|Lack of Efficacy|5
7996548|NCT03535194|12581932|FG003|Post-Treatment Followup Period|Lack of Efficacy|4
7996549|NCT03535194|12581933|FG004|Post-Treatment Followup Period|Lack of Efficacy|0
7996550|NCT03535194|12581929|FG000|Post-Treatment Followup Period|Lost to Follow-up|1
7996551|NCT03535194|12581930|FG001|Post-Treatment Followup Period|Lost to Follow-up|1
7996552|NCT03535194|12581931|FG002|Post-Treatment Followup Period|Lost to Follow-up|1
7996553|NCT03535194|12581932|FG003|Post-Treatment Followup Period|Lost to Follow-up|0
7996554|NCT03535194|12581933|FG004|Post-Treatment Followup Period|Lost to Follow-up|0
7996555|NCT03535194|12581929|FG000|Post-Treatment Followup Period|Other|1
7996556|NCT03535194|12581930|FG001|Post-Treatment Followup Period|Other|0
7996557|NCT03535194|12581931|FG002|Post-Treatment Followup Period|Other|0
7996558|NCT03535194|12581932|FG003|Post-Treatment Followup Period|Other|5
7996559|NCT03535194|12581933|FG004|Post-Treatment Followup Period|Other|0
7996560|NCT03535194|12581929|FG000|Post-Treatment Followup Period|Physician Decision|0
7996561|NCT03535194|12581930|FG001|Post-Treatment Followup Period|Physician Decision|2
7996562|NCT03535194|12581931|FG002|Post-Treatment Followup Period|Physician Decision|1
7996563|NCT03535194|12581932|FG003|Post-Treatment Followup Period|Physician Decision|1
7996564|NCT03535194|12581933|FG004|Post-Treatment Followup Period|Physician Decision|0
7996565|NCT03535194|12581929|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2
7996566|NCT03535194|12581930|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2
7996567|NCT03535194|12581931|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3
7996568|NCT03535194|12581932|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6
7996569|NCT03535194|12581933|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0
7996570|NCT03535844|12581969|FG000|Overall Study|Withdrawal by Subject|0
7996571|NCT03535844|12581970|FG001|Overall Study|Withdrawal by Subject|1
7996572|NCT03535974|12581979|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
7996573|NCT03535974|12581980|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1
7996574|NCT03535974|12581981|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
7996575|NCT03535974|12581979|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2
7996576|NCT03535974|12581980|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1
7996577|NCT03535974|12581981|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0
7996578|NCT03536663|12581989|FG000|Endexo|Protocol Violation|1
7996579|NCT03536949|12582017|FG000|Overall Study|Adverse Event|4
7996580|NCT03536949|12582018|FG001|Overall Study|Adverse Event|0
7996581|NCT03536949|12582017|FG000|Overall Study|Lost to Follow-up|2
7996582|NCT03536949|12582018|FG001|Overall Study|Lost to Follow-up|1
7996583|NCT03536949|12582017|FG000|Overall Study|Withdrawal by Subject|6
7996584|NCT03536949|12582018|FG001|Overall Study|Withdrawal by Subject|0
7996585|NCT03536949|12582017|FG000|Overall Study|Non-compliance|2
7996586|NCT03536949|12582018|FG001|Overall Study|Non-compliance|1
7996587|NCT03537261|12582030|FG000|Overall Study|Lost to Follow-up|4
7996588|NCT03537261|12582031|FG001|Overall Study|Lost to Follow-up|5
7996589|NCT03537261|12582030|FG000|Overall Study|Withdrawal by Subject|4
7996590|NCT03537261|12582031|FG001|Overall Study|Withdrawal by Subject|6
7996591|NCT03537261|12582030|FG000|Overall Study|Did not return study questionnaires|0
7996592|NCT03537261|12582031|FG001|Overall Study|Did not return study questionnaires|1
7996593|NCT03537651|12582082|FG000|Overall Study|Adverse Event|2
7996594|NCT03537651|12582082|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2
7996595|NCT03537651|12582082|FG000|Overall Study|Commercial Drug is Available for Participant|56
7996596|NCT03537651|12582082|FG000|Overall Study|Other|1
7996597|NCT03538431|12582101|FG000|Overall Study|Physician Decision|0
7996598|NCT03538431|12582102|FG001|Overall Study|Physician Decision|1
7996599|NCT03538431|12582101|FG000|Overall Study|Withdrawal by Subject|1
7996600|NCT03538431|12582102|FG001|Overall Study|Withdrawal by Subject|0
7996601|NCT03538743|12582128|FG000|Overall Study|Adverse Event|0
7996602|NCT03538743|12582129|FG001|Overall Study|Adverse Event|0
7996603|NCT03538743|12582130|FG002|Overall Study|Adverse Event|1
7996604|NCT03538743|12582131|FG003|Overall Study|Adverse Event|1
7996605|NCT03538743|12582132|FG004|Overall Study|Adverse Event|0
7996606|NCT03538743|12582133|FG005|Overall Study|Adverse Event|0
7996607|NCT03538743|12582134|FG006|Overall Study|Adverse Event|0
7996608|NCT03538743|12582135|FG007|Overall Study|Adverse Event|0
7996609|NCT03538743|12582136|FG008|Overall Study|Adverse Event|0
7996610|NCT03538743|12582128|FG000|Overall Study|Non-Treatment-Related Reasons|0
7996611|NCT03538743|12582129|FG001|Overall Study|Non-Treatment-Related Reasons|0
7996612|NCT03538743|12582130|FG002|Overall Study|Non-Treatment-Related Reasons|0
7996613|NCT03538743|12582131|FG003|Overall Study|Non-Treatment-Related Reasons|0
7996614|NCT03538743|12582132|FG004|Overall Study|Non-Treatment-Related Reasons|0
7996615|NCT03538743|12582133|FG005|Overall Study|Non-Treatment-Related Reasons|0
7996616|NCT03538743|12582134|FG006|Overall Study|Non-Treatment-Related Reasons|0
7996617|NCT03538743|12582135|FG007|Overall Study|Non-Treatment-Related Reasons|0
7996618|NCT03538743|12582136|FG008|Overall Study|Non-Treatment-Related Reasons|3
7996619|NCT03538743|12582128|FG000|Overall Study|Withdrawal by Subject|0
7996620|NCT03538743|12582129|FG001|Overall Study|Withdrawal by Subject|0
7996621|NCT03538743|12582130|FG002|Overall Study|Withdrawal by Subject|0
7996622|NCT03538743|12582131|FG003|Overall Study|Withdrawal by Subject|1
7996623|NCT03538743|12582132|FG004|Overall Study|Withdrawal by Subject|0
7996624|NCT03538743|12582133|FG005|Overall Study|Withdrawal by Subject|0
7996625|NCT03538743|12582134|FG006|Overall Study|Withdrawal by Subject|0
7996626|NCT03538743|12582135|FG007|Overall Study|Withdrawal by Subject|0
7996627|NCT03538743|12582136|FG008|Overall Study|Withdrawal by Subject|0
7996628|NCT03539432|12582196|FG000|Overall Study|Lost to Follow-up|0
7996629|NCT03539432|12582197|FG001|Overall Study|Lost to Follow-up|1
7996630|NCT03539484|12582210|FG000|Overall Study|Death|1
7996631|NCT03539484|12582211|FG001|Overall Study|Death|0
7996632|NCT03539484|12582212|FG002|Overall Study|Death|0
7996633|NCT03539484|12582213|FG003|Overall Study|Death|2
7996634|NCT03539484|12582214|FG004|Overall Study|Death|8
7996635|NCT03539484|12582215|FG005|Overall Study|Death|3
7996636|NCT03539484|12582216|FG006|Overall Study|Death|0
7996637|NCT03539484|12582210|FG000|Overall Study|Lost to Follow-up|0
7996638|NCT03539484|12582211|FG001|Overall Study|Lost to Follow-up|1
7996639|NCT03539484|12582212|FG002|Overall Study|Lost to Follow-up|0
7996640|NCT03539484|12582213|FG003|Overall Study|Lost to Follow-up|0
7996641|NCT03539484|12582214|FG004|Overall Study|Lost to Follow-up|1
7996642|NCT03539484|12582215|FG005|Overall Study|Lost to Follow-up|0
7996643|NCT03539484|12582216|FG006|Overall Study|Lost to Follow-up|0
7996644|NCT03539484|12582210|FG000|Overall Study|Withdrawal by Subject|0
7996645|NCT03539484|12582211|FG001|Overall Study|Withdrawal by Subject|0
7996646|NCT03539484|12582212|FG002|Overall Study|Withdrawal by Subject|0
7996647|NCT03539484|12582213|FG003|Overall Study|Withdrawal by Subject|0
7996648|NCT03539484|12582214|FG004|Overall Study|Withdrawal by Subject|2
7996649|NCT03539484|12582215|FG005|Overall Study|Withdrawal by Subject|0
7996650|NCT03539484|12582216|FG006|Overall Study|Withdrawal by Subject|1
7996651|NCT03539484|12582210|FG000|Overall Study|Study Terminated by Sponsor|0
7996652|NCT03539484|12582211|FG001|Overall Study|Study Terminated by Sponsor|0
7996653|NCT03539484|12582212|FG002|Overall Study|Study Terminated by Sponsor|1
7996654|NCT03539484|12582213|FG003|Overall Study|Study Terminated by Sponsor|1
7996655|NCT03539484|12582214|FG004|Overall Study|Study Terminated by Sponsor|2
7996656|NCT03539484|12582215|FG005|Overall Study|Study Terminated by Sponsor|2
7996657|NCT03539484|12582216|FG006|Overall Study|Study Terminated by Sponsor|1
7996658|NCT03539549|12582237|FG000|Overall Study|Adverse Event|12
7996659|NCT03539549|12582237|FG000|Overall Study|Lost to Follow-up|1
7996660|NCT03539549|12582237|FG000|Overall Study|Death|2
7996661|NCT03539549|12582237|FG000|Overall Study|Progressive Disease|1
7996662|NCT03539549|12582237|FG000|Overall Study|Reason not Specified|1
7996663|NCT03540030|12582243|FG000|Overall Study|Withdrawal by Subject|2
7996664|NCT03540030|12582244|FG001|Overall Study|Withdrawal by Subject|1
7996665|NCT03540030|12582243|FG000|Overall Study|screen fail|7
7996666|NCT03540030|12582244|FG001|Overall Study|screen fail|1
7996667|NCT03540030|12582243|FG000|Overall Study|never had surgery after signing consent|9
7996668|NCT03540030|12582244|FG001|Overall Study|never had surgery after signing consent|1
7996669|NCT03540160|12582266|FG000|Overall Study|Protocol Violation|1
7996670|NCT03540160|12582266|FG000|Overall Study|Physician Decision|8
7996671|NCT03540160|12582266|FG000|Overall Study|Lack of Efficacy|60
7996672|NCT03540160|12582266|FG000|Overall Study|Pregnancy|1
7996673|NCT03540160|12582266|FG000|Overall Study|Adverse Event|20
7996674|NCT03540160|12582266|FG000|Overall Study|Withdrawal by Subject|68
7996675|NCT03540160|12582266|FG000|Overall Study|COVID-19|2
7996676|NCT03540160|12582266|FG000|Overall Study|Study Closure|10
7996677|NCT03540160|12582266|FG000|Overall Study|Lost to Follow-up|18
7996678|NCT03540160|12582266|FG000|Overall Study|Sponsor decision|191
7996679|NCT03541044|12582270|FG000|Study Period 2: Up to Day 8|Protocol Violation|1
7996680|NCT03541044|12582271|FG001|Study Period 2: Up to Day 8|Protocol Violation|0
7996681|NCT03541044|12582270|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1
7996682|NCT03541044|12582271|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0
7996683|NCT03543137|12582371|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1
7996684|NCT03543137|12582372|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0
7996685|NCT03543137|12582371|FG000|Study Period 2: Up to Day 8|Protocol Violation|1
7996686|NCT03543137|12582372|FG001|Study Period 2: Up to Day 8|Protocol Violation|0
7996687|NCT03543137|12582371|FG000|Study Period 2: Up to Day 8|Adverse Event|0
7996688|NCT03543137|12582372|FG001|Study Period 2: Up to Day 8|Adverse Event|1
7996689|NCT03544333|12582420|FG000|Overall Study|Withdrawal by Subject|1
7996690|NCT03544333|12582421|FG001|Overall Study|Withdrawal by Subject|0
7996691|NCT03545503|12582448|FG000|Overall Study|Protocol Violation|14
7996692|NCT03545503|12582449|FG001|Overall Study|Protocol Violation|16
7996693|NCT03545984|12582466|FG000|Overall Study|CSF cases not present during rotation|11
7996694|NCT03545984|12582467|FG001|Overall Study|CSF cases not present during rotation|9
7996695|NCT03546621|12582496|FG000|Overall Study|Withdrawal by Subject|0
7996696|NCT03546621|12582497|FG001|Overall Study|Withdrawal by Subject|1
7996697|NCT03546621|12582498|FG002|Overall Study|Withdrawal by Subject|2
7996698|NCT03546621|12582499|FG003|Overall Study|Withdrawal by Subject|1
7996699|NCT03546621|12582496|FG000|Overall Study|Lost to Follow-up|0
7996700|NCT03546621|12582497|FG001|Overall Study|Lost to Follow-up|1
7996701|NCT03546621|12582498|FG002|Overall Study|Lost to Follow-up|0
7996702|NCT03546621|12582499|FG003|Overall Study|Lost to Follow-up|0
7996703|NCT03546621|12582496|FG000|Overall Study|Adverse Event|0
7996704|NCT03546621|12582497|FG001|Overall Study|Adverse Event|1
7996705|NCT03546621|12582498|FG002|Overall Study|Adverse Event|0
7996706|NCT03546621|12582499|FG003|Overall Study|Adverse Event|1
7996707|NCT03546621|12582496|FG000|Overall Study|Progressive disease|0
7996708|NCT03546621|12582497|FG001|Overall Study|Progressive disease|0
7996709|NCT03546621|12582498|FG002|Overall Study|Progressive disease|0
7996710|NCT03546621|12582499|FG003|Overall Study|Progressive disease|1
7996711|NCT03546647|12582509|FG000|Overall Study|Adverse Event|1
7996712|NCT03546647|12582510|FG001|Overall Study|Adverse Event|0
7996713|NCT03546816|12582518|FG000|Overall Study|Adverse Event|5
7996714|NCT03546816|12582519|FG001|Overall Study|Adverse Event|3
7996715|NCT03546816|12582518|FG000|Overall Study|Lack of Efficacy|2
7996716|NCT03546816|12582519|FG001|Overall Study|Lack of Efficacy|4
7996717|NCT03546816|12582518|FG000|Overall Study|Pregnancy|1
7996718|NCT03546816|12582519|FG001|Overall Study|Pregnancy|0
7996719|NCT03546816|12582518|FG000|Overall Study|Physician Decision|2
7996720|NCT03546816|12582519|FG001|Overall Study|Physician Decision|0
7996721|NCT03546816|12582518|FG000|Overall Study|Withdrawal by Subject|8
7996722|NCT03546816|12582519|FG001|Overall Study|Withdrawal by Subject|10
7996723|NCT03546816|12582518|FG000|Overall Study|Lost to Follow-up|3
7996724|NCT03546816|12582519|FG001|Overall Study|Lost to Follow-up|2
7996725|NCT03546842|12582527|FG000|Overall Study|Protocol Violation|1
7996726|NCT03546842|12582527|FG000|Overall Study|Withdrawal by Subject|2
7996727|NCT03547154|12582533|FG000|Overall Study|Disease Progression/Recurrence|6
7996728|NCT03547154|12582534|FG001|Overall Study|Disease Progression/Recurrence|14
7996729|NCT03547154|12582533|FG000|Overall Study|Adverse Event|26
7996730|NCT03547154|12582534|FG001|Overall Study|Adverse Event|31
7996731|NCT03547154|12582533|FG000|Overall Study|Protocol Violation|6
7996732|NCT03547154|12582534|FG001|Overall Study|Protocol Violation|1
7996733|NCT03547154|12582533|FG000|Overall Study|Physician Decision|4
7996734|NCT03547154|12582534|FG001|Overall Study|Physician Decision|3
7996735|NCT03547154|12582533|FG000|Overall Study|Insufficient Therapeutic Response|13
7996736|NCT03547154|12582534|FG001|Overall Study|Insufficient Therapeutic Response|10
7996737|NCT03547154|12582533|FG000|Overall Study|Withdrawal by Subject|10
7996738|NCT03547154|12582534|FG001|Overall Study|Withdrawal by Subject|6
7996739|NCT03547154|12582533|FG000|Overall Study|Not Selected|0
7996740|NCT03547154|12582534|FG001|Overall Study|Not Selected|1
7996741|NCT03547154|12582533|FG000|Overall Study|Continued treatment beyond 12 mo.|58
7996742|NCT03547154|12582534|FG001|Overall Study|Continued treatment beyond 12 mo.|50
7996743|NCT03547167|12582542|FG000|Overall Study|Withdrawal by Subject|34
7996744|NCT03547167|12582543|FG001|Overall Study|Withdrawal by Subject|12
7996745|NCT03547167|12582542|FG000|Overall Study|Screen Failure|0
7996746|NCT03547167|12582543|FG001|Overall Study|Screen Failure|1
7996747|NCT03547167|12582542|FG000|Overall Study|Lost to Follow-up|59
7996748|NCT03547167|12582543|FG001|Overall Study|Lost to Follow-up|15
7996749|NCT03547167|12582542|FG000|Overall Study|Death|4
7996750|NCT03547167|12582543|FG001|Overall Study|Death|2
7996751|NCT03547531|12582555|FG000|Overall Study|not coming in data collection : sick|2
7996752|NCT03547531|12582556|FG001|Overall Study|not coming in data collection : sick|2
7996753|NCT03547531|12582555|FG000|Overall Study|having family occasion|0
7996754|NCT03547531|12582556|FG001|Overall Study|having family occasion|2
7996755|NCT03547583|12582565|FG000|Overall Study|Adverse Event|16
7996756|NCT03547583|12582566|FG001|Overall Study|Adverse Event|11
7996757|NCT03547583|12582567|FG002|Overall Study|Adverse Event|10
7996758|NCT03547583|12582565|FG000|Overall Study|Death|11
7996759|NCT03547583|12582566|FG001|Overall Study|Death|7
7996760|NCT03547583|12582567|FG002|Overall Study|Death|4
7996761|NCT03547583|12582565|FG000|Overall Study|Lost to Follow-up|1
7996762|NCT03547583|12582566|FG001|Overall Study|Lost to Follow-up|0
7996763|NCT03547583|12582567|FG002|Overall Study|Lost to Follow-up|0
7996764|NCT03547583|12582565|FG000|Overall Study|Non-compliance with study drug|0
7996765|NCT03547583|12582566|FG001|Overall Study|Non-compliance with study drug|0
7996766|NCT03547583|12582567|FG002|Overall Study|Non-compliance with study drug|1
7996767|NCT03547583|12582565|FG000|Overall Study|Physician Decision|1
7996768|NCT03547583|12582566|FG001|Overall Study|Physician Decision|0
7996769|NCT03547583|12582567|FG002|Overall Study|Physician Decision|3
7996770|NCT03547583|12582565|FG000|Overall Study|Protocol Violation|2
7996771|NCT03547583|12582566|FG001|Overall Study|Protocol Violation|1
7996772|NCT03547583|12582567|FG002|Overall Study|Protocol Violation|1
7996773|NCT03547583|12582565|FG000|Overall Study|Withdrawal by Subject|12
7996774|NCT03547583|12582566|FG001|Overall Study|Withdrawal by Subject|19
7996775|NCT03547583|12582567|FG002|Overall Study|Withdrawal by Subject|10
7996776|NCT03547583|12582565|FG000|Overall Study|Other|2
7996777|NCT03547583|12582566|FG001|Overall Study|Other|2
7996778|NCT03547583|12582567|FG002|Overall Study|Other|3
7996779|NCT03547635|12582581|FG000|Overall Study|Adverse Event|5
7996780|NCT03547635|12582582|FG001|Overall Study|Adverse Event|2
7996781|NCT03547635|12582583|FG002|Overall Study|Adverse Event|3
7996782|NCT03547635|12582581|FG000|Overall Study|Lost to Follow-up|1
7996783|NCT03547635|12582582|FG001|Overall Study|Lost to Follow-up|3
7996784|NCT03547635|12582583|FG002|Overall Study|Lost to Follow-up|4
7996785|NCT03547635|12582581|FG000|Overall Study|Withdrawal by Subject|1
7996786|NCT03547635|12582582|FG001|Overall Study|Withdrawal by Subject|0
7996787|NCT03547635|12582583|FG002|Overall Study|Withdrawal by Subject|0
7996788|NCT03547635|12582581|FG000|Overall Study|Withdrawal By PI|0
7996789|NCT03547635|12582582|FG001|Overall Study|Withdrawal By PI|1
7996790|NCT03547635|12582583|FG002|Overall Study|Withdrawal By PI|0
7996791|NCT03547635|12582581|FG000|Overall Study|Withdrawal by Sponsor|0
7996792|NCT03547635|12582582|FG001|Overall Study|Withdrawal by Sponsor|0
7996793|NCT03547635|12582583|FG002|Overall Study|Withdrawal by Sponsor|1
7996794|NCT03547635|12582581|FG000|Overall Study|Errant Randomization before Treatment|0
7996795|NCT03547635|12582582|FG001|Overall Study|Errant Randomization before Treatment|1
7996796|NCT03547635|12582583|FG002|Overall Study|Errant Randomization before Treatment|0
7996797|NCT03547635|12582581|FG000|Overall Study|Withdrawal by Subject|1
7996798|NCT03547635|12582582|FG001|Overall Study|Withdrawal by Subject|0
7996799|NCT03547635|12582583|FG002|Overall Study|Withdrawal by Subject|0
7996800|NCT03547687|12582591|FG000|Overall Study|Withdrawal by Subject|1
7996801|NCT03547687|12582591|FG000|Overall Study|Death|1
7996802|NCT03548337|12582597|FG000|Infant Series|Withdrawal by Parent/Guardian|8
7996803|NCT03548337|12582598|FG001|Infant Series|Withdrawal by Parent/Guardian|8
7996804|NCT03548337|12582597|FG000|Infant Series|No Longer Met Eligibility Criteria|1
7996805|NCT03548337|12582598|FG001|Infant Series|No Longer Met Eligibility Criteria|0
7996806|NCT03548337|12582597|FG000|Infant Series|Lost to Follow-up|2
7996807|NCT03548337|12582598|FG001|Infant Series|Lost to Follow-up|1
7996808|NCT03548337|12582597|FG000|Infant Series|Adverse Event|0
7996809|NCT03548337|12582598|FG001|Infant Series|Adverse Event|2
7996810|NCT03548337|12582597|FG000|Infant Series|Randomized but Not Vaccinated|1
7996811|NCT03548337|12582598|FG001|Infant Series|Randomized but Not Vaccinated|0
7996812|NCT03548337|12582597|FG000|Toddler Dose|Withdrawal by parent/guardian|1
7996813|NCT03548337|12582598|FG001|Toddler Dose|Withdrawal by parent/guardian|1
7996814|NCT03548935|12582612|FG000|Overall Study|Withdrawal by Subject|26
7996815|NCT03548935|12582613|FG001|Overall Study|Withdrawal by Subject|17
7996816|NCT03548935|12582612|FG000|Overall Study|Lost to Follow-up|39
7996817|NCT03548935|12582613|FG001|Overall Study|Lost to Follow-up|28
7996818|NCT03548935|12582612|FG000|Overall Study|Death|1
7996819|NCT03548935|12582613|FG001|Overall Study|Death|1
7996820|NCT03549117|12582621|FG000|Overall Study|Withdrawal by Subject|1
7996821|NCT03549117|12582622|FG001|Overall Study|Withdrawal by Subject|0
7996822|NCT03549130|12582630|FG000|Overall Study|Adverse Event|0
7996823|NCT03549130|12582631|FG001|Overall Study|Adverse Event|1
7996824|NCT03549130|12582630|FG000|Overall Study|Lost to Follow-up|0
7996825|NCT03549130|12582631|FG001|Overall Study|Lost to Follow-up|1
7996826|NCT03549338|12582651|FG000|Overall Study|Progressive Disease|1
7996827|NCT03549338|12582652|FG001|Overall Study|Progressive Disease|0
7996828|NCT03549338|12582653|FG002|Overall Study|Progressive Disease|0
7996829|NCT03549338|12582651|FG000|Overall Study|Clinical Progression|0
7996830|NCT03549338|12582652|FG001|Overall Study|Clinical Progression|1
7996831|NCT03549338|12582653|FG002|Overall Study|Clinical Progression|0
7996832|NCT03549429|12582661|FG000|Overall Study|Protocol Violation|5
7996833|NCT03549429|12582662|FG001|Overall Study|Protocol Violation|3
7996834|NCT03550209|12582689|FG000|Overall Study|Lost to Follow-up|1
7996835|NCT03550209|12582690|FG001|Overall Study|Lost to Follow-up|0
7996836|NCT03550209|12582691|FG002|Overall Study|Lost to Follow-up|1
7996837|NCT03550209|12582692|FG003|Overall Study|Lost to Follow-up|0
7996838|NCT03550209|12582689|FG000|Overall Study|Withdrawal by Subject|0
7996839|NCT03550209|12582690|FG001|Overall Study|Withdrawal by Subject|3
7996840|NCT03550209|12582691|FG002|Overall Study|Withdrawal by Subject|1
7996841|NCT03550209|12582692|FG003|Overall Study|Withdrawal by Subject|2
7996842|NCT03550209|12582689|FG000|Overall Study|Excluded due to ineligibility after randomization|0
7996843|NCT03550209|12582690|FG001|Overall Study|Excluded due to ineligibility after randomization|0
7996844|NCT03550209|12582691|FG002|Overall Study|Excluded due to ineligibility after randomization|0
7996845|NCT03550209|12582692|FG003|Overall Study|Excluded due to ineligibility after randomization|2
7996846|NCT03550313|12582705|FG000|Overall Study|Adverse Event|0
7996847|NCT03550313|12582706|FG001|Overall Study|Adverse Event|1
7996848|NCT03550313|12582707|FG002|Overall Study|Adverse Event|0
7996849|NCT03550313|12582705|FG000|Overall Study|Lost to Follow-up|5
7996850|NCT03550313|12582706|FG001|Overall Study|Lost to Follow-up|7
7996851|NCT03550313|12582707|FG002|Overall Study|Lost to Follow-up|12
7996852|NCT03550313|12582705|FG000|Overall Study|Study terminated by sponsor|44
7996853|NCT03550313|12582706|FG001|Overall Study|Study terminated by sponsor|37
7996854|NCT03550313|12582707|FG002|Overall Study|Study terminated by sponsor|48
7996855|NCT03550313|12582705|FG000|Overall Study|No longer met eligibility criteria|3
7996856|NCT03550313|12582706|FG001|Overall Study|No longer met eligibility criteria|5
7996857|NCT03550313|12582707|FG002|Overall Study|No longer met eligibility criteria|6
7996858|NCT03550313|12582705|FG000|Overall Study|Withdrawal by parent/guardian|20
7996859|NCT03550313|12582706|FG001|Overall Study|Withdrawal by parent/guardian|18
7996860|NCT03550313|12582707|FG002|Overall Study|Withdrawal by parent/guardian|26
7996861|NCT03550313|12582705|FG000|Overall Study|Other|4
7996862|NCT03550313|12582706|FG001|Overall Study|Other|2
7996863|NCT03550313|12582707|FG002|Overall Study|Other|2
7996864|NCT03550313|12582705|FG000|Overall Study|Randomized but not vaccinated|3
7996865|NCT03550313|12582706|FG001|Overall Study|Randomized but not vaccinated|23
7996866|NCT03550313|12582707|FG002|Overall Study|Randomized but not vaccinated|2
7996867|NCT03550313|12582705|FG000|Overall Study|Sites terminated due to quality issues|18
7996868|NCT03550313|12582706|FG001|Overall Study|Sites terminated due to quality issues|17
7996869|NCT03550313|12582707|FG002|Overall Study|Sites terminated due to quality issues|18
7996870|NCT03550378|12582718|FG000|Overall Study|Death|0
7996871|NCT03550378|12582719|FG001|Overall Study|Death|1
7996872|NCT03551730|12582751|FG000|Overall Study|Adverse Event|1
7996873|NCT03551730|12582752|FG001|Overall Study|Adverse Event|0
7996874|NCT03551730|12582753|FG002|Overall Study|Adverse Event|0
7996875|NCT03551730|12582754|FG003|Overall Study|Adverse Event|0
7996876|NCT03551743|12582768|FG000|Overall Study|Adverse Event|1
7996877|NCT03551743|12582769|FG001|Overall Study|Adverse Event|0
7996878|NCT03551743|12582770|FG002|Overall Study|Adverse Event|0
7996879|NCT03551743|12582771|FG003|Overall Study|Adverse Event|0
7996880|NCT03551743|12582768|FG000|Overall Study|Withdrawal by Subject|1
7996881|NCT03551743|12582769|FG001|Overall Study|Withdrawal by Subject|0
7996882|NCT03551743|12582770|FG002|Overall Study|Withdrawal by Subject|0
7996883|NCT03551743|12582771|FG003|Overall Study|Withdrawal by Subject|0
7996884|NCT03552198|12582789|FG000|Overall Study|Lost to Follow-up|42
7996885|NCT03552198|12582790|FG001|Overall Study|Lost to Follow-up|48
7996886|NCT03552198|12582791|FG002|Overall Study|Lost to Follow-up|15
7996887|NCT03552198|12582792|FG003|Overall Study|Lost to Follow-up|19
7996888|NCT03552198|12582789|FG000|Overall Study|Incomplete/unmatched questionnaire|6
7996889|NCT03552198|12582790|FG001|Overall Study|Incomplete/unmatched questionnaire|7
7996890|NCT03552198|12582791|FG002|Overall Study|Incomplete/unmatched questionnaire|2
7996891|NCT03552198|12582792|FG003|Overall Study|Incomplete/unmatched questionnaire|2
7996892|NCT03552198|12582789|FG000|Overall Study|Did not receive air alerts|1
7996893|NCT03552198|12582790|FG001|Overall Study|Did not receive air alerts|0
7996894|NCT03552198|12582791|FG002|Overall Study|Did not receive air alerts|0
7996895|NCT03552198|12582792|FG003|Overall Study|Did not receive air alerts|1
7996896|NCT03552523|12582811|FG000|Overall Study|Withdrawal by Subject|1
7996897|NCT03552523|12582812|FG001|Overall Study|Withdrawal by Subject|1
7996898|NCT03552549|12582831|FG000|Overall Study|Disease progression|25
7996899|NCT03552549|12582832|FG001|Overall Study|Disease progression|17
7996900|NCT03552549|12582831|FG000|Overall Study|Adverse event in first 12 months|12
7996901|NCT03552549|12582832|FG001|Overall Study|Adverse event in first 12 months|8
7996902|NCT03552549|12582831|FG000|Overall Study|Withdrawal by Subject|7
7996903|NCT03552549|12582832|FG001|Overall Study|Withdrawal by Subject|7
7996904|NCT03552549|12582831|FG000|Overall Study|Unknown (no reason provided)|4
7996905|NCT03552549|12582832|FG001|Overall Study|Unknown (no reason provided)|2
7996906|NCT03552549|12582831|FG000|Overall Study|Not in participant's best interest|2
7996907|NCT03552549|12582832|FG001|Overall Study|Not in participant's best interest|1
7996908|NCT03552549|12582831|FG000|Overall Study|Did not complete study treatment|2
7996909|NCT03552549|12582832|FG001|Overall Study|Did not complete study treatment|3
7996910|NCT03552549|12582831|FG000|Overall Study|Did not meet eligibility criteria|1
7996911|NCT03552549|12582832|FG001|Overall Study|Did not meet eligibility criteria|0
7996912|NCT03552549|12582831|FG000|Overall Study|Administrative|0
7996913|NCT03552549|12582832|FG001|Overall Study|Administrative|14
7996914|NCT03552757|12582841|FG000|Overall Study|Withdrawal by Subject|10
7996915|NCT03552757|12582842|FG001|Overall Study|Withdrawal by Subject|5
7996916|NCT03552757|12582843|FG002|Overall Study|Withdrawal by Subject|12
7996917|NCT03552757|12582841|FG000|Overall Study|Lost to Follow-up|2
7996918|NCT03552757|12582842|FG001|Overall Study|Lost to Follow-up|7
7996919|NCT03552757|12582843|FG002|Overall Study|Lost to Follow-up|7
7996920|NCT03552757|12582841|FG000|Overall Study|Death|1
7996921|NCT03552757|12582842|FG001|Overall Study|Death|1
7996922|NCT03552757|12582843|FG002|Overall Study|Death|1
7996923|NCT03553758|12582854|FG000|Overall Study|Lost to Follow-up|1
7996924|NCT03553823|12582862|FG000|Overall Study|Physician Decision|0
7996925|NCT03553823|12582863|FG001|Overall Study|Physician Decision|1
7996926|NCT03554005|12582884|FG000|Overall Study|Not in participant's best interest|0
7996927|NCT03554005|12582885|FG001|Overall Study|Not in participant's best interest|0
7996928|NCT03554005|12582886|FG002|Overall Study|Not in participant's best interest|0
7996929|NCT03554005|12582887|FG003|Overall Study|Not in participant's best interest|0
7996930|NCT03554005|12582888|FG004|Overall Study|Not in participant's best interest|0
7996931|NCT03554005|12582889|FG005|Overall Study|Not in participant's best interest|1
7996932|NCT03554005|12582884|FG000|Overall Study|Disease Progression|1
7996933|NCT03554005|12582885|FG001|Overall Study|Disease Progression|1
7996934|NCT03554005|12582886|FG002|Overall Study|Disease Progression|1
7996935|NCT03554005|12582887|FG003|Overall Study|Disease Progression|1
7996936|NCT03554005|12582888|FG004|Overall Study|Disease Progression|5
7996937|NCT03554005|12582889|FG005|Overall Study|Disease Progression|6
7996938|NCT03554005|12582884|FG000|Overall Study|Adverse Event|0
7996939|NCT03554005|12582885|FG001|Overall Study|Adverse Event|0
7996940|NCT03554005|12582886|FG002|Overall Study|Adverse Event|0
7996941|NCT03554005|12582887|FG003|Overall Study|Adverse Event|0
7996942|NCT03554005|12582888|FG004|Overall Study|Adverse Event|0
7996943|NCT03554005|12582889|FG005|Overall Study|Adverse Event|3
7996944|NCT03554005|12582884|FG000|Overall Study|Physician Decision|0
7996945|NCT03554005|12582885|FG001|Overall Study|Physician Decision|0
7996946|NCT03554005|12582886|FG002|Overall Study|Physician Decision|0
7996947|NCT03554005|12582887|FG003|Overall Study|Physician Decision|0
7996948|NCT03554005|12582888|FG004|Overall Study|Physician Decision|1
7996949|NCT03554005|12582889|FG005|Overall Study|Physician Decision|0
7996950|NCT03554005|12582884|FG000|Overall Study|Other|0
7996951|NCT03554005|12582885|FG001|Overall Study|Other|0
7996952|NCT03554005|12582886|FG002|Overall Study|Other|0
7996953|NCT03554005|12582887|FG003|Overall Study|Other|0
7996954|NCT03554005|12582888|FG004|Overall Study|Other|0
7996955|NCT03554005|12582889|FG005|Overall Study|Other|1
7996956|NCT03554018|12582905|FG000|Overall Study|Lost to Follow-up|3
7996957|NCT03554018|12582906|FG001|Overall Study|Lost to Follow-up|7
7996958|NCT03554486|12582914|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1
7996959|NCT03554486|12582915|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0
7996960|NCT03554486|12582916|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0
7996961|NCT03554486|12582914|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2
7996962|NCT03554486|12582915|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0
7996963|NCT03554486|12582916|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0
7996964|NCT03554486|12582914|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0
7996965|NCT03554486|12582915|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1
7996966|NCT03554486|12582916|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1
7996967|NCT03554629|12582923|FG000|Overall Study|Inadequate data|6
7996968|NCT03554772|12582964|FG000|Overall Study|Lost to Follow-up|0
7996969|NCT03554772|12582965|FG001|Overall Study|Lost to Follow-up|0
7996970|NCT03554772|12582966|FG002|Overall Study|Lost to Follow-up|0
7996971|NCT03554772|12582967|FG003|Overall Study|Lost to Follow-up|2
7996972|NCT03555266|12582987|FG000|Overall Study|Protocol Violation|6
7996973|NCT03555266|12582988|FG001|Overall Study|Protocol Violation|4
7996974|NCT03555305|12582994|FG000|Period 1|Physician Decision|0
7996975|NCT03555305|12582995|FG001|Period 1|Physician Decision|1
7996976|NCT03555305|12582994|FG000|Period 1|Adverse Event|0
7996977|NCT03555305|12582995|FG001|Period 1|Adverse Event|1
7996978|NCT03555435|12583004|FG000|Overall Study|Lost to Follow-up|17
7996979|NCT03555435|12583005|FG001|Overall Study|Lost to Follow-up|19
7996980|NCT03555435|12583006|FG002|Overall Study|Lost to Follow-up|8
7996981|NCT03555565|12583014|FG000|Overall Study|Case Report Forms Uncollected|2
7996982|NCT03555565|12583014|FG000|Overall Study|Protocol Deviation|13
7996983|NCT03555890|12583022|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7996984|NCT03555890|12583023|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7996985|NCT03555890|12583024|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7996986|NCT03555890|12583025|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1
7996987|NCT03556891|12583057|FG000|Overall Study|Adverse Event|4
7996988|NCT03556891|12583057|FG000|Overall Study|MRI Need|3
7996989|NCT03556891|12583057|FG000|Overall Study|Device Failure|1
7996990|NCT03556891|12583057|FG000|Overall Study|Death|1
7996991|NCT03556891|12583057|FG000|Overall Study|Lost to Follow-up|1
7996992|NCT03556891|12583057|FG000|Overall Study|Missing at random|1
7996993|NCT03556891|12583057|FG000|Overall Study|Missing due to COVID|1
7996994|NCT03556891|12583057|FG000|Overall Study|Protocol Violation|1
7996995|NCT03557034|12583063|FG000|Overall Study|Withdrawal by Subject|1
7996996|NCT03557034|12583064|FG001|Overall Study|Withdrawal by Subject|0
7996997|NCT03557775|12583121|FG000|Overall Study|Withdrawal by Subject|1
7996998|NCT03557775|12583122|FG001|Overall Study|Withdrawal by Subject|2
7996999|NCT03557775|12583123|FG002|Overall Study|Withdrawal by Subject|4
7997000|NCT03557775|12583121|FG000|Overall Study|Physician Decision|0
7997001|NCT03557775|12583122|FG001|Overall Study|Physician Decision|1
7997002|NCT03557775|12583123|FG002|Overall Study|Physician Decision|0
7997003|NCT03557801|12583134|FG000|Overall Study|Protocol Violation|1
7997004|NCT03557801|12583135|FG001|Overall Study|Protocol Violation|0
7997005|NCT03557801|12583136|FG002|Overall Study|Protocol Violation|0
7997006|NCT03557801|12583134|FG000|Overall Study|Withdrawal by Subject|1
7997007|NCT03557801|12583135|FG001|Overall Study|Withdrawal by Subject|0
7997008|NCT03557801|12583136|FG002|Overall Study|Withdrawal by Subject|3
7997009|NCT03557801|12583134|FG000|Overall Study|Lost to Follow-up|0
7997010|NCT03557801|12583135|FG001|Overall Study|Lost to Follow-up|1
7997011|NCT03557801|12583136|FG002|Overall Study|Lost to Follow-up|0
7997012|NCT03558516|12583164|FG000|Overall Study|Protocol Violation|2
7997013|NCT03558516|12583165|FG001|Overall Study|Protocol Violation|2
7997014|NCT03558555|12583173|FG000|Overall Study|Lost to Follow-up|2
7997015|NCT03558555|12583174|FG001|Overall Study|Lost to Follow-up|1
7997016|NCT03558672|12583180|FG000|Overall Study|Study Early Termination|10
7997017|NCT03558997|12583188|FG000|Overall Study|Adverse Event|0
7997018|NCT03558997|12583189|FG001|Overall Study|Adverse Event|2
7997019|NCT03558997|12583190|FG002|Overall Study|Adverse Event|5
7997020|NCT03558997|12583191|FG003|Overall Study|Adverse Event|1
7997021|NCT03558997|12583188|FG000|Overall Study|Physician Decision|0
7997022|NCT03558997|12583189|FG001|Overall Study|Physician Decision|0
7997023|NCT03558997|12583190|FG002|Overall Study|Physician Decision|1
7997024|NCT03558997|12583191|FG003|Overall Study|Physician Decision|0
7997025|NCT03558997|12583188|FG000|Overall Study|Withdrawal by Subject|1
7997026|NCT03558997|12583189|FG001|Overall Study|Withdrawal by Subject|0
7997027|NCT03558997|12583190|FG002|Overall Study|Withdrawal by Subject|1
7997028|NCT03558997|12583191|FG003|Overall Study|Withdrawal by Subject|1
7997029|NCT03558997|12583188|FG000|Overall Study|Lost to Follow-up|0
7997030|NCT03558997|12583189|FG001|Overall Study|Lost to Follow-up|0
7997031|NCT03558997|12583190|FG002|Overall Study|Lost to Follow-up|1
7997032|NCT03558997|12583191|FG003|Overall Study|Lost to Follow-up|0
7997033|NCT03559062|12583207|FG000|Overall Study|Other|0
7997034|NCT03559062|12583208|FG001|Overall Study|Other|1
7997035|NCT03559062|12583209|FG002|Overall Study|Other|0
7997036|NCT03559218|12583251|FG000|Overall Study|Withdrawal by Subject|1
7997037|NCT03559218|12583252|FG001|Overall Study|Withdrawal by Subject|0
7997038|NCT03559257|12583260|FG000|Double Blind Treatment Period|Withdrawal by Subject|2
7997039|NCT03559257|12583261|FG001|Double Blind Treatment Period|Withdrawal by Subject|1
7997040|NCT03559257|12583260|FG000|Double Blind Treatment Period|Protocol Violation|1
7997041|NCT03559257|12583261|FG001|Double Blind Treatment Period|Protocol Violation|4
7997042|NCT03559257|12583260|FG000|Double Blind Treatment Period|Lack of Efficacy|1
7997043|NCT03559257|12583261|FG001|Double Blind Treatment Period|Lack of Efficacy|1
7997044|NCT03559257|12583260|FG000|Double Blind Treatment Period|Adverse Event|0
7997045|NCT03559257|12583261|FG001|Double Blind Treatment Period|Adverse Event|1
7997046|NCT03559257|12583260|FG000|Double Blind Treatment Period|Screen Failure|0
7997047|NCT03559257|12583261|FG001|Double Blind Treatment Period|Screen Failure|1
7997048|NCT03559257|12583260|FG000|Open-label Treatment Period|Adverse Event|1
7997049|NCT03559257|12583261|FG001|Open-label Treatment Period|Adverse Event|4
7997050|NCT03559257|12583260|FG000|Open-label Treatment Period|Lack of Efficacy|3
7997051|NCT03559257|12583261|FG001|Open-label Treatment Period|Lack of Efficacy|2
7997052|NCT03559257|12583260|FG000|Open-label Treatment Period|Withdrawal by Subject|3
7997053|NCT03559257|12583261|FG001|Open-label Treatment Period|Withdrawal by Subject|0
7997054|NCT03559257|12583260|FG000|Open-label Treatment Period|Protocol Violation|2
7997055|NCT03559257|12583261|FG001|Open-label Treatment Period|Protocol Violation|0
7997056|NCT03559257|12583260|FG000|Open-label Treatment Period|Lost to Follow-up|1
7997057|NCT03559257|12583261|FG001|Open-label Treatment Period|Lost to Follow-up|0
7997058|NCT03559257|12583260|FG000|Open-label Treatment Period|Physician Decision|0
7997059|NCT03559257|12583261|FG001|Open-label Treatment Period|Physician Decision|1
7997060|NCT03559517|12583273|FG000|Overall Study|Withdrawal by Subject|1
7997061|NCT03559517|12583274|FG001|Overall Study|Withdrawal by Subject|0
7997062|NCT03559517|12583275|FG002|Overall Study|Withdrawal by Subject|0
7997063|NCT03559530|12583283|FG000|Overall Study|non-location of medical records|44
7997064|NCT03559530|12583284|FG001|Overall Study|non-location of medical records|0
7997065|NCT03559530|12583283|FG000|Overall Study|culture results not considered for treat|29
7997066|NCT03559530|12583284|FG001|Overall Study|culture results not considered for treat|0
7997067|NCT03559530|12583283|FG000|Overall Study|duplicate cases|8
7997068|NCT03559530|12583284|FG001|Overall Study|duplicate cases|0
7997069|NCT03559530|12583283|FG000|Overall Study|other species of Acinetobacte|7
7997070|NCT03559530|12583284|FG001|Overall Study|other species of Acinetobacte|0
7997071|NCT03559530|12583283|FG000|Overall Study|contamination / colonization|3
7997072|NCT03559530|12583284|FG001|Overall Study|contamination / colonization|0
7997073|NCT03560245|12583324|FG000|Overall Study|Withdrawal by Subject|3
7997074|NCT03560245|12583325|FG001|Overall Study|Withdrawal by Subject|2
7997075|NCT03560245|12583324|FG000|Overall Study|Adverse Event|1
7997076|NCT03560245|12583325|FG001|Overall Study|Adverse Event|1
7997077|NCT03560245|12583324|FG000|Overall Study|Protocol Violation|1
7997078|NCT03560245|12583325|FG001|Overall Study|Protocol Violation|0
7997079|NCT03560245|12583324|FG000|Overall Study|Death|0
7997080|NCT03560245|12583325|FG001|Overall Study|Death|1
7997081|NCT03560245|12583324|FG000|Overall Study|Lost to Follow-up|0
7997082|NCT03560245|12583325|FG001|Overall Study|Lost to Follow-up|1
7997083|NCT03560245|12583324|FG000|Overall Study|Physician Decision|0
7997084|NCT03560245|12583325|FG001|Overall Study|Physician Decision|1
7997085|NCT03560245|12583324|FG000|Overall Study|Other|0
7997086|NCT03560245|12583325|FG001|Overall Study|Other|1
7997087|NCT03560518|12583336|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1
7997088|NCT03560518|12583337|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0
7997089|NCT03560518|12583338|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0
7997090|NCT03560518|12583336|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6
7997091|NCT03560518|12583337|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9
7997092|NCT03560518|12583338|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10
7997093|NCT03560518|12583336|FG000|Double Blind Treatment Period|Protocol Violation|1
7997094|NCT03560518|12583337|FG001|Double Blind Treatment Period|Protocol Violation|2
7997095|NCT03560518|12583338|FG002|Double Blind Treatment Period|Protocol Violation|0
7997096|NCT03560518|12583336|FG000|Double Blind Treatment Period|Pregnancy|0
7997097|NCT03560518|12583337|FG001|Double Blind Treatment Period|Pregnancy|2
7997098|NCT03560518|12583338|FG002|Double Blind Treatment Period|Pregnancy|0
7997099|NCT03560518|12583336|FG000|Double Blind Treatment Period|Lost to Follow-up|5
7997100|NCT03560518|12583337|FG001|Double Blind Treatment Period|Lost to Follow-up|6
7997101|NCT03560518|12583338|FG002|Double Blind Treatment Period|Lost to Follow-up|6
7997102|NCT03560518|12583336|FG000|Double Blind Treatment Period|Withdrawal by Subject|10
7997103|NCT03560518|12583337|FG001|Double Blind Treatment Period|Withdrawal by Subject|6
7997104|NCT03560518|12583338|FG002|Double Blind Treatment Period|Withdrawal by Subject|5
7997105|NCT03560518|12583336|FG000|Double Blind Treatment Period|Lack of Efficacy|2
7997106|NCT03560518|12583337|FG001|Double Blind Treatment Period|Lack of Efficacy|1
7997107|NCT03560518|12583338|FG002|Double Blind Treatment Period|Lack of Efficacy|1
7997108|NCT03560518|12583336|FG000|Double Blind Treatment Period|Adverse Event|0
7997109|NCT03560518|12583337|FG001|Double Blind Treatment Period|Adverse Event|3
7997110|NCT03560518|12583338|FG002|Double Blind Treatment Period|Adverse Event|1
7997111|NCT03560739|12583350|FG000|Overall Study|Adverse Event|0
7997112|NCT03560739|12583351|FG001|Overall Study|Adverse Event|1
7997113|NCT03560739|12583352|FG002|Overall Study|Adverse Event|0
7997114|NCT03560739|12583353|FG003|Overall Study|Adverse Event|0
7997115|NCT03560869|12583363|FG000|Overall Study|Withdrawal by Subject|3
7997116|NCT03560869|12583364|FG001|Overall Study|Withdrawal by Subject|4
7997117|NCT03560869|12583363|FG000|Overall Study|Screening failure|4
7997118|NCT03560869|12583364|FG001|Overall Study|Screening failure|4
7997119|NCT03560869|12583363|FG000|Overall Study|Withdrawal by PI|0
7997120|NCT03560869|12583364|FG001|Overall Study|Withdrawal by PI|1
7997121|NCT03560986|12583372|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
7997122|NCT03560986|12583373|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
7997123|NCT03560986|12583372|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
7997124|NCT03560986|12583373|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
7997125|NCT03560986|12583372|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0
7997126|NCT03560986|12583373|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1
7997127|NCT03560986|12583372|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32
7997128|NCT03560986|12583373|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35
7997129|NCT03560986|12583372|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1
7997130|NCT03560986|12583373|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0
7997131|NCT03560986|12583372|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0
7997132|NCT03560986|12583373|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1
7997133|NCT03560986|12583372|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
7997134|NCT03560986|12583373|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
7997135|NCT03561090|12583387|FG000|Overall Study|Adverse Event|11
7997136|NCT03561090|12583388|FG001|Overall Study|Adverse Event|7
7997137|NCT03561090|12583387|FG000|Overall Study|Non-Compliance With Study Drug|2
7997138|NCT03561090|12583388|FG001|Overall Study|Non-Compliance With Study Drug|0
7997139|NCT03561090|12583387|FG000|Overall Study|Protocol Violation|2
7997140|NCT03561090|12583388|FG001|Overall Study|Protocol Violation|2
7997141|NCT03561090|12583387|FG000|Overall Study|Withdrawal by Subject|7
7997142|NCT03561090|12583388|FG001|Overall Study|Withdrawal by Subject|7
7997143|NCT03561090|12583387|FG000|Overall Study|Lost to Follow-up|7
7997144|NCT03561090|12583388|FG001|Overall Study|Lost to Follow-up|2
7997145|NCT03561090|12583387|FG000|Overall Study|Study Terminated by Sponsor|10
7997146|NCT03561090|12583388|FG001|Overall Study|Study Terminated by Sponsor|15
7997147|NCT03561090|12583387|FG000|Overall Study|Randomized by Mistake|1
7997148|NCT03561090|12583388|FG001|Overall Study|Randomized by Mistake|1
7997149|NCT03561090|12583387|FG000|Overall Study|Other Not Specified|0
7997150|NCT03561090|12583388|FG001|Overall Study|Other Not Specified|2
7997151|NCT03561883|12583398|FG000|Overall Study|Adverse Event|10
7997152|NCT03561883|12583399|FG001|Overall Study|Adverse Event|13
7997153|NCT03561883|12583398|FG000|Overall Study|Non-Compliance With Study Drug|1
7997154|NCT03561883|12583399|FG001|Overall Study|Non-Compliance With Study Drug|2
7997155|NCT03561883|12583398|FG000|Overall Study|Protocol Violation|2
7997156|NCT03561883|12583399|FG001|Overall Study|Protocol Violation|3
7997157|NCT03561883|12583398|FG000|Overall Study|Withdrawal by Subject|14
7997158|NCT03561883|12583399|FG001|Overall Study|Withdrawal by Subject|6
7997159|NCT03561883|12583398|FG000|Overall Study|Lost to Follow-up|2
7997160|NCT03561883|12583399|FG001|Overall Study|Lost to Follow-up|6
7997161|NCT03561883|12583398|FG000|Overall Study|Study Terminated by Sponsor|12
7997162|NCT03561883|12583399|FG001|Overall Study|Study Terminated by Sponsor|11
7997163|NCT03561883|12583398|FG000|Overall Study|Physician Decision|1
7997164|NCT03561883|12583399|FG001|Overall Study|Physician Decision|0
7997165|NCT03561883|12583398|FG000|Overall Study|Randomized by Mistake|1
7997166|NCT03561883|12583399|FG001|Overall Study|Randomized by Mistake|0
7997167|NCT03561883|12583398|FG000|Overall Study|Other, Not Specified|3
7997168|NCT03561883|12583399|FG001|Overall Study|Other, Not Specified|2
7997169|NCT03562117|12583408|FG000|Part 1, Up to 3 Days|Adverse Event|1
7997170|NCT03562117|12583409|FG001|Part 1, Up to 3 Days|Adverse Event|0
7997171|NCT03562117|12583410|FG002|Part 1, Up to 3 Days|Adverse Event|0
7997172|NCT03562481|12583429|FG000|First Intervention|Lost to Follow-up|1
7997173|NCT03562481|12583430|FG001|First Intervention|Lost to Follow-up|0
7997174|NCT03565068|12583544|FG000|Overall Study|Protocol Violation|0
7997175|NCT03565068|12583545|FG001|Overall Study|Protocol Violation|0
7997176|NCT03565068|12583546|FG002|Overall Study|Protocol Violation|0
7997177|NCT03565068|12583547|FG003|Overall Study|Protocol Violation|0
7997178|NCT03565068|12583548|FG004|Overall Study|Protocol Violation|1
7997179|NCT03565068|12583549|FG005|Overall Study|Protocol Violation|0
7997180|NCT03565068|12583550|FG006|Overall Study|Protocol Violation|0
7997181|NCT03565068|12583551|FG007|Overall Study|Protocol Violation|1
7997182|NCT03565068|12583552|FG008|Overall Study|Protocol Violation|0
7997183|NCT03565068|12583544|FG000|Overall Study|Sponsor decision|0
7997184|NCT03565068|12583545|FG001|Overall Study|Sponsor decision|0
7997185|NCT03565068|12583546|FG002|Overall Study|Sponsor decision|0
7997186|NCT03565068|12583547|FG003|Overall Study|Sponsor decision|0
7997187|NCT03565068|12583548|FG004|Overall Study|Sponsor decision|1
7997188|NCT03565068|12583549|FG005|Overall Study|Sponsor decision|1
7997189|NCT03565068|12583550|FG006|Overall Study|Sponsor decision|0
7997190|NCT03565068|12583551|FG007|Overall Study|Sponsor decision|0
7997191|NCT03565068|12583552|FG008|Overall Study|Sponsor decision|0
7997192|NCT03565068|12583544|FG000|Overall Study|Withdrawal by Subject|0
7997193|NCT03565068|12583545|FG001|Overall Study|Withdrawal by Subject|0
7997194|NCT03565068|12583546|FG002|Overall Study|Withdrawal by Subject|1
7997195|NCT03565068|12583547|FG003|Overall Study|Withdrawal by Subject|0
7997196|NCT03565068|12583548|FG004|Overall Study|Withdrawal by Subject|2
7997197|NCT03565068|12583549|FG005|Overall Study|Withdrawal by Subject|0
7997198|NCT03565068|12583550|FG006|Overall Study|Withdrawal by Subject|1
7997199|NCT03565068|12583551|FG007|Overall Study|Withdrawal by Subject|5
7997200|NCT03565068|12583552|FG008|Overall Study|Withdrawal by Subject|1
7997201|NCT03565068|12583544|FG000|Overall Study|Physician Decision|0
7997202|NCT03565068|12583545|FG001|Overall Study|Physician Decision|0
7997203|NCT03565068|12583546|FG002|Overall Study|Physician Decision|0
7997204|NCT03565068|12583547|FG003|Overall Study|Physician Decision|0
7997205|NCT03565068|12583548|FG004|Overall Study|Physician Decision|0
7997206|NCT03565068|12583549|FG005|Overall Study|Physician Decision|0
7997207|NCT03565068|12583550|FG006|Overall Study|Physician Decision|0
7997208|NCT03565068|12583551|FG007|Overall Study|Physician Decision|1
7997209|NCT03565068|12583552|FG008|Overall Study|Physician Decision|0
7997210|NCT03565068|12583544|FG000|Overall Study|Lost to Follow-up|0
7997211|NCT03565068|12583545|FG001|Overall Study|Lost to Follow-up|0
7997212|NCT03565068|12583546|FG002|Overall Study|Lost to Follow-up|0
7997213|NCT03565068|12583547|FG003|Overall Study|Lost to Follow-up|0
7997214|NCT03565068|12583548|FG004|Overall Study|Lost to Follow-up|0
7997215|NCT03565068|12583549|FG005|Overall Study|Lost to Follow-up|0
7997216|NCT03565068|12583550|FG006|Overall Study|Lost to Follow-up|0
7997217|NCT03565068|12583551|FG007|Overall Study|Lost to Follow-up|1
7997218|NCT03565068|12583552|FG008|Overall Study|Lost to Follow-up|0
7997219|NCT03565211|12583609|FG000|Overall Study|Withdrawal by Subject|2
7997220|NCT03565211|12583609|FG000|Overall Study|Lost to Follow-up|1
7997221|NCT03565211|12583609|FG000|Overall Study|Adverse Event|44
7997222|NCT03565211|12583609|FG000|Overall Study|Personal issues|1
7997223|NCT03565315|12583617|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
7997224|NCT03565315|12583618|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
7997225|NCT03565315|12583619|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
7997226|NCT03565315|12583620|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1
7997227|NCT03565887|12583669|FG000|Overall Study|Adverse Event|1
7997228|NCT03565887|12583670|FG001|Overall Study|Adverse Event|0
7997229|NCT03565887|12583669|FG000|Overall Study|Withdrawal by Subject|0
7997230|NCT03565887|12583670|FG001|Overall Study|Withdrawal by Subject|2
7997231|NCT03566238|12583679|FG000|Overall Study|Adverse Event|0
7997232|NCT03566238|12583680|FG001|Overall Study|Adverse Event|1
7997233|NCT03566238|12583681|FG002|Overall Study|Adverse Event|0
7997234|NCT03566238|12583679|FG000|Overall Study|Lack of Efficacy|4
7997235|NCT03566238|12583680|FG001|Overall Study|Lack of Efficacy|2
7997236|NCT03566238|12583681|FG002|Overall Study|Lack of Efficacy|5
7997237|NCT03566238|12583679|FG000|Overall Study|Other|1
7997238|NCT03566238|12583680|FG001|Overall Study|Other|0
7997239|NCT03566238|12583681|FG002|Overall Study|Other|0
7997240|NCT03566485|12583691|FG000|Overall Study|Disease progression|5
7997241|NCT03566485|12583692|FG001|Overall Study|Disease progression|4
7997242|NCT03566485|12583691|FG000|Overall Study|Clinical progression|0
7997243|NCT03566485|12583692|FG001|Overall Study|Clinical progression|1
7997244|NCT03566485|12583691|FG000|Overall Study|Toxicity|0
7997245|NCT03566485|12583692|FG001|Overall Study|Toxicity|2
7997246|NCT03566550|12583700|FG000|Overall Study|Withdrawal by Subject|0
7997247|NCT03566550|12583701|FG001|Overall Study|Withdrawal by Subject|1
7997248|NCT03566680|12583707|FG000|Overall Study|Pregnancy|1
7997249|NCT03566680|12583707|FG000|Overall Study|Lost to Follow-up|13
7997250|NCT03566680|12583707|FG000|Overall Study|Withdrawal by Subject|3
7997251|NCT03566810|12583715|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
7997252|NCT03566810|12583716|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1
7997253|NCT03566810|12583717|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
7997254|NCT03566810|12583718|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
7997255|NCT03566823|12583731|FG000|Overall Study|Lack of Efficacy|0
7997256|NCT03566823|12583732|FG001|Overall Study|Lack of Efficacy|1
7997257|NCT03566823|12583733|FG002|Overall Study|Lack of Efficacy|0
7997258|NCT03566823|12583731|FG000|Overall Study|Withdrawal by Subject|1
7997259|NCT03566823|12583732|FG001|Overall Study|Withdrawal by Subject|2
7997260|NCT03566823|12583733|FG002|Overall Study|Withdrawal by Subject|0
7997261|NCT03566823|12583731|FG000|Overall Study|Adverse Event|1
7997262|NCT03566823|12583732|FG001|Overall Study|Adverse Event|0
7997263|NCT03566823|12583733|FG002|Overall Study|Adverse Event|2
7997264|NCT03566979|12583745|FG000|Overall Study|Withdrawal by Subject|2
7997265|NCT03566979|12583746|FG001|Overall Study|Withdrawal by Subject|0
7997266|NCT03566979|12583747|FG002|Overall Study|Withdrawal by Subject|1
7997267|NCT03566979|12583748|FG003|Overall Study|Withdrawal by Subject|1
7997268|NCT03566979|12583745|FG000|Overall Study|Lost to Follow-up|2
7997269|NCT03566979|12583746|FG001|Overall Study|Lost to Follow-up|7
7997270|NCT03566979|12583747|FG002|Overall Study|Lost to Follow-up|9
7997271|NCT03566979|12583748|FG003|Overall Study|Lost to Follow-up|5
7997272|NCT03566979|12583745|FG000|Overall Study|Adverse Event|1
7997273|NCT03566979|12583746|FG001|Overall Study|Adverse Event|0
7997274|NCT03566979|12583747|FG002|Overall Study|Adverse Event|0
7997275|NCT03566979|12583748|FG003|Overall Study|Adverse Event|0
7997276|NCT03567291|12583774|FG000|Period I|Adverse Event|14
7997277|NCT03567291|12583775|FG001|Period I|Adverse Event|0
7997278|NCT03567291|12583776|FG002|Period I|Adverse Event|0
7997279|NCT03567291|12583777|FG003|Period I|Adverse Event|0
7997280|NCT03567291|12583774|FG000|Period I|Protocol Violation|1
7997281|NCT03567291|12583775|FG001|Period I|Protocol Violation|0
7997282|NCT03567291|12583776|FG002|Period I|Protocol Violation|0
7997283|NCT03567291|12583777|FG003|Period I|Protocol Violation|0
7997284|NCT03567291|12583774|FG000|Period I|Withdrawal by Subject|23
7997285|NCT03567291|12583775|FG001|Period I|Withdrawal by Subject|0
7997286|NCT03567291|12583776|FG002|Period I|Withdrawal by Subject|0
7997287|NCT03567291|12583777|FG003|Period I|Withdrawal by Subject|0
7997288|NCT03567291|12583774|FG000|Period I|Lost to Follow-up|2
7997289|NCT03567291|12583775|FG001|Period I|Lost to Follow-up|0
7997290|NCT03567291|12583776|FG002|Period I|Lost to Follow-up|0
7997291|NCT03567291|12583777|FG003|Period I|Lost to Follow-up|0
7997292|NCT03567291|12583774|FG000|Period I|Terminated by sponsor|44
7997293|NCT03567291|12583775|FG001|Period I|Terminated by sponsor|0
7997294|NCT03567291|12583776|FG002|Period I|Terminated by sponsor|0
7997295|NCT03567291|12583777|FG003|Period I|Terminated by sponsor|0
7997296|NCT03567291|12583774|FG000|Period I|Missing or unknown|7
7997297|NCT03567291|12583775|FG001|Period I|Missing or unknown|0
7997298|NCT03567291|12583776|FG002|Period I|Missing or unknown|0
7997299|NCT03567291|12583777|FG003|Period I|Missing or unknown|0
7997300|NCT03567291|12583774|FG000|Period II|Adverse Event|0
7997301|NCT03567291|12583775|FG001|Period II|Adverse Event|1
7997302|NCT03567291|12583776|FG002|Period II|Adverse Event|0
7997303|NCT03567291|12583777|FG003|Period II|Adverse Event|0
7997304|NCT03567291|12583774|FG000|Period II|Missing or unknown|0
7997305|NCT03567291|12583775|FG001|Period II|Missing or unknown|2
7997306|NCT03567291|12583776|FG002|Period II|Missing or unknown|1
7997307|NCT03567291|12583777|FG003|Period II|Missing or unknown|0
7997308|NCT03567291|12583774|FG000|Period III|Adverse Event|0
7997309|NCT03567291|12583775|FG001|Period III|Adverse Event|0
7997310|NCT03567291|12583776|FG002|Period III|Adverse Event|0
7997311|NCT03567291|12583777|FG003|Period III|Adverse Event|4
7997312|NCT03567291|12583774|FG000|Period III|Withdrawal by Subject|0
7997313|NCT03567291|12583775|FG001|Period III|Withdrawal by Subject|0
7997314|NCT03567291|12583776|FG002|Period III|Withdrawal by Subject|0
7997315|NCT03567291|12583777|FG003|Period III|Withdrawal by Subject|4
7997316|NCT03567291|12583774|FG000|Period III|Lost to Follow-up|0
7997317|NCT03567291|12583775|FG001|Period III|Lost to Follow-up|0
7997318|NCT03567291|12583776|FG002|Period III|Lost to Follow-up|0
7997319|NCT03567291|12583777|FG003|Period III|Lost to Follow-up|1
7997320|NCT03567291|12583774|FG000|Period III|Terminated by sponsor|0
7997321|NCT03567291|12583775|FG001|Period III|Terminated by sponsor|0
7997322|NCT03567291|12583776|FG002|Period III|Terminated by sponsor|0
7997323|NCT03567291|12583777|FG003|Period III|Terminated by sponsor|68
7997324|NCT03567291|12583774|FG000|Period III|Missing or unknown|0
7997325|NCT03567291|12583775|FG001|Period III|Missing or unknown|0
7997326|NCT03567291|12583776|FG002|Period III|Missing or unknown|0
7997327|NCT03567291|12583777|FG003|Period III|Missing or unknown|8
7997328|NCT03567382|12583785|FG000|Overall Study|Lost to Follow-up|1
7997329|NCT03567382|12583786|FG001|Overall Study|Lost to Follow-up|21
7997330|NCT03567382|12583787|FG002|Overall Study|Lost to Follow-up|1
7997331|NCT03567382|12583788|FG003|Overall Study|Lost to Follow-up|21
7997332|NCT03567382|12583785|FG000|Overall Study|Withdrawal by Subject|2
7997333|NCT03567382|12583786|FG001|Overall Study|Withdrawal by Subject|14
7997334|NCT03567382|12583787|FG002|Overall Study|Withdrawal by Subject|1
7997335|NCT03567382|12583788|FG003|Overall Study|Withdrawal by Subject|12
7997336|NCT03567616|12583801|FG000|Overall Study|Disease progression|4
7997337|NCT03567616|12583801|FG000|Overall Study|Withdrawal by Subject|1
7997338|NCT03567616|12583801|FG000|Overall Study|Physician Decision|1
7997339|NCT03567616|12583801|FG000|Overall Study|Death|1
7997340|NCT03567616|12583801|FG000|Overall Study|Adverse Event|1
7997341|NCT03567980|12583808|FG000|Overall Study|Adverse Event|1
7997342|NCT03568500|12583815|FG000|Overall Study|Lost to Follow-up|1
7997343|NCT03568500|12583816|FG001|Overall Study|Lost to Follow-up|1
7997344|NCT03568500|12583817|FG002|Overall Study|Lost to Follow-up|2
7997345|NCT03568500|12583815|FG000|Overall Study|Adverse Event|1
7997346|NCT03568500|12583816|FG001|Overall Study|Adverse Event|1
7997347|NCT03568500|12583817|FG002|Overall Study|Adverse Event|2
7997348|NCT03568500|12583815|FG000|Overall Study|Physician Decision|1
7997349|NCT03568500|12583816|FG001|Overall Study|Physician Decision|0
7997350|NCT03568500|12583817|FG002|Overall Study|Physician Decision|0
7997351|NCT03568500|12583815|FG000|Overall Study|Withdrawal by Subject|4
7997352|NCT03568500|12583816|FG001|Overall Study|Withdrawal by Subject|2
7997353|NCT03568500|12583817|FG002|Overall Study|Withdrawal by Subject|0
7997354|NCT03568500|12583815|FG000|Overall Study|Technical Problems|2
7997355|NCT03568500|12583816|FG001|Overall Study|Technical Problems|1
7997356|NCT03568500|12583817|FG002|Overall Study|Technical Problems|0
7997357|NCT03568500|12583815|FG000|Overall Study|Participant Noncompliance|1
7997358|NCT03568500|12583816|FG001|Overall Study|Participant Noncompliance|1
7997359|NCT03568500|12583817|FG002|Overall Study|Participant Noncompliance|0
7997360|NCT03568942|12583840|FG000|Overall Study|Family emergency|1
7997361|NCT03568942|12583840|FG000|Overall Study|Lost to Follow-up|1
7997362|NCT03569098|12583869|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5
7997363|NCT03569098|12583870|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2
7718282|NCT00527319|12142202|FG000|Overall Study|Death|0
7718283|NCT00527319|12142203|FG001|Overall Study|Death|3
7718284|NCT00527319|12142204|FG002|Overall Study|Death|1
7718285|NCT00527319|12142202|FG000|Overall Study|Intercurrent Medical Illness|0
7718286|NCT00527319|12142203|FG001|Overall Study|Intercurrent Medical Illness|1
7718287|NCT00527319|12142204|FG002|Overall Study|Intercurrent Medical Illness|3
7718288|NCT00527319|12142202|FG000|Overall Study|Adverse Event|0
7718289|NCT00527319|12142203|FG001|Overall Study|Adverse Event|0
7718290|NCT00527319|12142204|FG002|Overall Study|Adverse Event|1
7718291|NCT00527332|12142214|FG000|Overall Study|Protocol Violation|4
7718292|NCT00527332|12142215|FG001|Overall Study|Protocol Violation|8
7718293|NCT00527332|12142214|FG000|Overall Study|Withdrew consent|5
7718294|NCT00527332|12142215|FG001|Overall Study|Withdrew consent|1
7718295|NCT00527397|12142221|FG000|Overall Study|Adverse Event|3
7718296|NCT00527397|12142221|FG000|Overall Study|Lack of Efficacy|1
7718297|NCT00527397|12142221|FG000|Overall Study|Protocol Violation|1
7718298|NCT00527397|12142221|FG000|Overall Study|Withdrawal by Subject|6
7718299|NCT00527397|12142221|FG000|Overall Study|Study terminated by sponsor|13
7718300|NCT00527423|12142228|FG000|Overall Study|Protocol Violation|1
7718301|NCT00527423|12142228|FG000|Overall Study|Adverse Event|5
7718302|NCT00527423|12142228|FG000|Overall Study|Physician Decision|4
7718303|NCT00527423|12142228|FG000|Overall Study|Withdrawal by Subject|10
7718304|NCT00527423|12142228|FG000|Overall Study|Lost to Follow-up|4
7718305|NCT00527423|12142228|FG000|Overall Study|OTHER|4
7718306|NCT00527423|12142228|FG000|Overall Study|Death|9
7718307|NCT00527488|12142247|FG000|Overall Study|Withdrawn prior to dosing|0
7718308|NCT00527488|12142248|FG001|Overall Study|Withdrawn prior to dosing|1
7718309|NCT00527488|12142249|FG002|Overall Study|Withdrawn prior to dosing|1
7718310|NCT00527488|12142250|FG003|Overall Study|Withdrawn prior to dosing|0
7718311|NCT00527514|12142260|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
7718312|NCT00527514|12142260|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
7718313|NCT00527514|12142260|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
7718314|NCT00527514|12142260|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
7718315|NCT00527514|12142260|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
7718316|NCT00527514|12142260|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
7718317|NCT00527514|12142260|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
7718318|NCT00527605|12142285|FG000|Overall Study|Adverse Event|3
7718319|NCT00527605|12142286|FG001|Overall Study|Adverse Event|0
7718320|NCT00527605|12142285|FG000|Overall Study|Withdrawal by Subject|3
7997364|NCT03569098|12583871|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5
7997365|NCT03569098|12583869|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0
7997366|NCT03569098|12583870|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6
7997367|NCT03569098|12583871|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3
7997368|NCT03569098|12583869|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1
7997369|NCT03569098|12583870|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1
7997370|NCT03569098|12583871|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0
7997371|NCT03569098|12583869|FG000|Double-Blind Treatment Cycle 1|Technical problems|0
7997372|NCT03569098|12583870|FG001|Double-Blind Treatment Cycle 1|Technical problems|0
7997373|NCT03569098|12583871|FG002|Double-Blind Treatment Cycle 1|Technical problems|2
7997374|NCT03569098|12583869|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1
7997375|NCT03569098|12583870|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0
7997376|NCT03569098|12583871|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0
7997377|NCT03569098|12583869|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0
7997378|NCT03569098|12583870|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1
7997379|NCT03569098|12583871|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0
7997380|NCT03569098|12583869|FG000|Double-Blind Treatment Cycle 1|Other|1
7997381|NCT03569098|12583870|FG001|Double-Blind Treatment Cycle 1|Other|0
7997382|NCT03569098|12583871|FG002|Double-Blind Treatment Cycle 1|Other|1
7997383|NCT03569098|12583869|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0
7997384|NCT03569098|12583870|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21
7997385|NCT03569098|12583871|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0
7997386|NCT03569098|12583869|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0
7997387|NCT03569098|12583870|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11
7997388|NCT03569098|12583871|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0
7997389|NCT03569098|12583869|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0
7997390|NCT03569098|12583870|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3
7997391|NCT03569098|12583871|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0
7997392|NCT03569098|12583869|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0
7997393|NCT03569098|12583870|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0
7997394|NCT03569098|12583871|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4
7997395|NCT03569098|12583869|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0
7997396|NCT03569098|12583870|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1
7997397|NCT03569098|12583871|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1
7997398|NCT03569098|12583869|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0
7997399|NCT03569098|12583870|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0
7997400|NCT03569098|12583871|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1
7997401|NCT03569202|12583884|FG000|Part 3|Physician Decision|1
7997402|NCT03569202|12583885|FG001|Part 3|Physician Decision|0
7997403|NCT03569202|12583884|FG000|Part 3|Other|1
7997404|NCT03569202|12583885|FG001|Part 3|Other|1
7997405|NCT03570554|12583958|FG000|Overall Study|Non-compliance with study drug|0
7997406|NCT03570554|12583959|FG001|Overall Study|Non-compliance with study drug|0
7997407|NCT03570554|12583960|FG002|Overall Study|Non-compliance with study drug|1
7997408|NCT03570554|12583961|FG003|Overall Study|Non-compliance with study drug|0
7997409|NCT03570554|12583958|FG000|Overall Study|Adverse Event|0
7997410|NCT03570554|12583959|FG001|Overall Study|Adverse Event|0
7997411|NCT03570554|12583960|FG002|Overall Study|Adverse Event|0
7997412|NCT03570554|12583961|FG003|Overall Study|Adverse Event|1
7997413|NCT03571256|12584005|FG000|Overall Study|Adverse Event|3
7997414|NCT03571256|12584006|FG001|Overall Study|Adverse Event|0
7997415|NCT03571256|12584007|FG002|Overall Study|Adverse Event|1
7997416|NCT03571256|12584005|FG000|Overall Study|Withdrawal by Subject|3
7997417|NCT03571256|12584006|FG001|Overall Study|Withdrawal by Subject|1
7997418|NCT03571256|12584007|FG002|Overall Study|Withdrawal by Subject|1
7997419|NCT03571256|12584005|FG000|Overall Study|Other than specified|0
7997420|NCT03571256|12584006|FG001|Overall Study|Other than specified|1
7997421|NCT03571256|12584007|FG002|Overall Study|Other than specified|1
7997422|NCT03571256|12584005|FG000|Overall Study|Protocol Violation|0
7997423|NCT03571256|12584006|FG001|Overall Study|Protocol Violation|1
7997424|NCT03571256|12584007|FG002|Overall Study|Protocol Violation|1
7997425|NCT03571516|12584019|FG000|Overall Study|Severe diarrhea|1
7997426|NCT03571516|12584020|FG001|Overall Study|Severe diarrhea|0
7997427|NCT03571516|12584019|FG000|Overall Study|Withdrawal by Subject|0
7997428|NCT03571516|12584020|FG001|Overall Study|Withdrawal by Subject|1
7997429|NCT03572062|12584090|FG000|Overall Study|Adverse Event|0
7997430|NCT03572062|12584091|FG001|Overall Study|Adverse Event|0
7997431|NCT03572062|12584092|FG002|Overall Study|Adverse Event|0
7997432|NCT03572062|12584093|FG003|Overall Study|Adverse Event|0
7997433|NCT03572062|12584094|FG004|Overall Study|Adverse Event|0
7997434|NCT03572062|12584095|FG005|Overall Study|Adverse Event|0
7997435|NCT03572062|12584096|FG006|Overall Study|Adverse Event|0
7997436|NCT03572062|12584097|FG007|Overall Study|Adverse Event|0
7997437|NCT03572062|12584098|FG008|Overall Study|Adverse Event|1
7997438|NCT03572062|12584099|FG009|Overall Study|Adverse Event|3
7997439|NCT03572062|12584090|FG000|Overall Study|Death|0
7997440|NCT03572062|12584091|FG001|Overall Study|Death|0
7997441|NCT03572062|12584092|FG002|Overall Study|Death|0
7997442|NCT03572062|12584093|FG003|Overall Study|Death|0
7997443|NCT03572062|12584094|FG004|Overall Study|Death|0
7997444|NCT03572062|12584095|FG005|Overall Study|Death|1
7997445|NCT03572062|12584096|FG006|Overall Study|Death|0
7997446|NCT03572062|12584097|FG007|Overall Study|Death|0
7997447|NCT03572062|12584098|FG008|Overall Study|Death|0
7997448|NCT03572062|12584099|FG009|Overall Study|Death|0
7997449|NCT03572062|12584090|FG000|Overall Study|Lost to Follow-up|0
7997450|NCT03572062|12584091|FG001|Overall Study|Lost to Follow-up|0
7997451|NCT03572062|12584092|FG002|Overall Study|Lost to Follow-up|0
7997452|NCT03572062|12584093|FG003|Overall Study|Lost to Follow-up|0
7997453|NCT03572062|12584094|FG004|Overall Study|Lost to Follow-up|0
7997454|NCT03572062|12584095|FG005|Overall Study|Lost to Follow-up|1
7997455|NCT03572062|12584096|FG006|Overall Study|Lost to Follow-up|1
7997456|NCT03572062|12584097|FG007|Overall Study|Lost to Follow-up|0
7997457|NCT03572062|12584098|FG008|Overall Study|Lost to Follow-up|0
7997458|NCT03572062|12584099|FG009|Overall Study|Lost to Follow-up|0
7997459|NCT03572062|12584090|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7997460|NCT03572062|12584091|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7997461|NCT03572062|12584092|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
7997462|NCT03572062|12584093|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
7997463|NCT03572062|12584094|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
7997464|NCT03572062|12584095|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
7997465|NCT03572062|12584096|FG006|Overall Study|No Longer Meets Eligibility Criteria|0
7997466|NCT03572062|12584097|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
7997467|NCT03572062|12584098|FG008|Overall Study|No Longer Meets Eligibility Criteria|1
7997468|NCT03572062|12584099|FG009|Overall Study|No Longer Meets Eligibility Criteria|0
7997469|NCT03572062|12584090|FG000|Overall Study|Study Terminated By Sponsor|0
7997470|NCT03572062|12584091|FG001|Overall Study|Study Terminated By Sponsor|0
7997471|NCT03572062|12584092|FG002|Overall Study|Study Terminated By Sponsor|0
7997472|NCT03572062|12584093|FG003|Overall Study|Study Terminated By Sponsor|0
7997473|NCT03572062|12584094|FG004|Overall Study|Study Terminated By Sponsor|0
7997474|NCT03572062|12584095|FG005|Overall Study|Study Terminated By Sponsor|0
7997475|NCT03572062|12584096|FG006|Overall Study|Study Terminated By Sponsor|0
7997476|NCT03572062|12584097|FG007|Overall Study|Study Terminated By Sponsor|0
7997477|NCT03572062|12584098|FG008|Overall Study|Study Terminated By Sponsor|29
7997478|NCT03572062|12584099|FG009|Overall Study|Study Terminated By Sponsor|27
7997479|NCT03572062|12584090|FG000|Overall Study|Physician Decision|0
7997480|NCT03572062|12584091|FG001|Overall Study|Physician Decision|0
7997481|NCT03572062|12584092|FG002|Overall Study|Physician Decision|0
7997482|NCT03572062|12584093|FG003|Overall Study|Physician Decision|0
7997483|NCT03572062|12584094|FG004|Overall Study|Physician Decision|0
7997484|NCT03572062|12584095|FG005|Overall Study|Physician Decision|0
7997485|NCT03572062|12584096|FG006|Overall Study|Physician Decision|0
7997486|NCT03572062|12584097|FG007|Overall Study|Physician Decision|0
7997487|NCT03572062|12584098|FG008|Overall Study|Physician Decision|1
7997488|NCT03572062|12584099|FG009|Overall Study|Physician Decision|0
7997489|NCT03572062|12584090|FG000|Overall Study|Withdrawal by Subject|0
7997490|NCT03572062|12584091|FG001|Overall Study|Withdrawal by Subject|0
7997491|NCT03572062|12584092|FG002|Overall Study|Withdrawal by Subject|0
7997492|NCT03572062|12584093|FG003|Overall Study|Withdrawal by Subject|0
7997493|NCT03572062|12584094|FG004|Overall Study|Withdrawal by Subject|0
7997494|NCT03572062|12584095|FG005|Overall Study|Withdrawal by Subject|0
7997495|NCT03572062|12584096|FG006|Overall Study|Withdrawal by Subject|0
7997496|NCT03572062|12584097|FG007|Overall Study|Withdrawal by Subject|0
7997497|NCT03572062|12584098|FG008|Overall Study|Withdrawal by Subject|0
7997498|NCT03572062|12584099|FG009|Overall Study|Withdrawal by Subject|1
7997499|NCT03572062|12584090|FG000|Overall Study|Randomized But Not Treated|0
7997500|NCT03572062|12584091|FG001|Overall Study|Randomized But Not Treated|0
7997501|NCT03572062|12584092|FG002|Overall Study|Randomized But Not Treated|0
7997502|NCT03572062|12584093|FG003|Overall Study|Randomized But Not Treated|0
7997503|NCT03572062|12584094|FG004|Overall Study|Randomized But Not Treated|1
7997504|NCT03572062|12584095|FG005|Overall Study|Randomized But Not Treated|2
7997505|NCT03572062|12584096|FG006|Overall Study|Randomized But Not Treated|0
7997506|NCT03572062|12584097|FG007|Overall Study|Randomized But Not Treated|1
7997507|NCT03572062|12584098|FG008|Overall Study|Randomized But Not Treated|0
7997508|NCT03572062|12584099|FG009|Overall Study|Randomized But Not Treated|0
7997509|NCT03572218|12584121|FG000|Overall Study|Lost to Follow-up|3
7997510|NCT03572218|12584122|FG001|Overall Study|Lost to Follow-up|2
7997511|NCT03572218|12584121|FG000|Overall Study|No longer available for study visits|2
7997512|NCT03572218|12584122|FG001|Overall Study|No longer available for study visits|1
7997513|NCT03572218|12584121|FG000|Overall Study|No longer interested|1
7997514|NCT03572218|12584122|FG001|Overall Study|No longer interested|2
7997515|NCT03573323|12584167|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
7997516|NCT03573323|12584168|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
7997517|NCT03573323|12584167|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15
7997518|NCT03573323|12584168|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8
7997519|NCT03573323|12584167|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3
7997520|NCT03573323|12584168|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8
7997521|NCT03573323|12584167|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17
7997522|NCT03573323|12584168|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9
7997523|NCT03573323|12584167|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2
7997524|NCT03573323|12584168|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3
7997525|NCT03573323|12584167|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1
7997526|NCT03573323|12584168|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2
7997527|NCT03573323|12584167|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1
7997528|NCT03573323|12584168|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0
7997529|NCT03573323|12584167|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14
7997530|NCT03573323|12584168|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13
7997531|NCT03573323|12584167|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0
7997532|NCT03573323|12584168|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1
7997533|NCT03573323|12584167|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0
7997534|NCT03573323|12584168|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1
7997535|NCT03573323|12584167|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1
7997536|NCT03573323|12584168|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2
7997537|NCT03573323|12584167|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22
7997538|NCT03573323|12584168|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12
7997539|NCT03573323|12584167|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8
7997540|NCT03573323|12584168|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19
7997541|NCT03573323|12584167|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4
7997542|NCT03573323|12584168|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3
7997543|NCT03573323|12584167|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3
7997544|NCT03573323|12584168|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2
7997545|NCT03573323|12584167|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14
7997546|NCT03573323|12584168|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8
7997547|NCT03573323|12584167|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8
7997548|NCT03573323|12584168|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11
7997549|NCT03573323|12584167|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0
7997550|NCT03573323|12584168|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1
7997551|NCT03573323|12584167|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0
7997552|NCT03573323|12584168|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1
7997553|NCT03573505|12584180|FG000|Overall Study|Adverse Event|1
7997554|NCT03573505|12584181|FG001|Overall Study|Adverse Event|1
7997555|NCT03573505|12584180|FG000|Overall Study|Consent withdrawn|0
7997556|NCT03573505|12584181|FG001|Overall Study|Consent withdrawn|1
7997557|NCT03573505|12584180|FG000|Overall Study|Disease progression|0
7997558|NCT03573505|12584181|FG001|Overall Study|Disease progression|1
7997559|NCT03573505|12584180|FG000|Overall Study|Site Terminated by Sponsor|1
7997560|NCT03573505|12584181|FG001|Overall Study|Site Terminated by Sponsor|1
7997561|NCT03573505|12584180|FG000|Overall Study|Study terminated by sponsor|50
7997562|NCT03573505|12584181|FG001|Overall Study|Study terminated by sponsor|45
7997563|NCT03573505|12584180|FG000|Overall Study|Reason not specified|0
7997564|NCT03573505|12584181|FG001|Overall Study|Reason not specified|1
7997565|NCT03573505|12584180|FG000|Overall Study|Death|0
7997566|NCT03573505|12584181|FG001|Overall Study|Death|4
7997567|NCT03573804|12584188|FG000|Overall Study|claustrophobia or MRI table problems|10
7997568|NCT03573830|12584200|FG000|Overall Study|Dropped without completing treatment|0
7997569|NCT03573830|12584201|FG001|Overall Study|Dropped without completing treatment|7
7997570|NCT03573830|12584200|FG000|Overall Study|Lost to Follow-up|4
7997571|NCT03573830|12584201|FG001|Overall Study|Lost to Follow-up|0
7997572|NCT03573908|12584208|FG000|Treatment Period|Adverse Event|4
7997573|NCT03573908|12584209|FG001|Treatment Period|Adverse Event|9
7997574|NCT03573908|12584210|FG002|Treatment Period|Adverse Event|0
7997575|NCT03573908|12584211|FG003|Treatment Period|Adverse Event|0
7997576|NCT03573908|12584212|FG004|Treatment Period|Adverse Event|0
7997577|NCT03573908|12584208|FG000|Treatment Period|Protocol Violation|1
7997578|NCT03573908|12584209|FG001|Treatment Period|Protocol Violation|0
7997579|NCT03573908|12584210|FG002|Treatment Period|Protocol Violation|0
7997580|NCT03573908|12584211|FG003|Treatment Period|Protocol Violation|0
7997581|NCT03573908|12584212|FG004|Treatment Period|Protocol Violation|0
7997582|NCT03573908|12584208|FG000|Treatment Period|Withdrawal by Subject|7
7997583|NCT03573908|12584209|FG001|Treatment Period|Withdrawal by Subject|5
7997584|NCT03573908|12584210|FG002|Treatment Period|Withdrawal by Subject|0
7997585|NCT03573908|12584211|FG003|Treatment Period|Withdrawal by Subject|0
7997586|NCT03573908|12584212|FG004|Treatment Period|Withdrawal by Subject|0
7997587|NCT03573908|12584208|FG000|Treatment Period|Lost to Follow-up|7
7997588|NCT03573908|12584209|FG001|Treatment Period|Lost to Follow-up|6
7997589|NCT03573908|12584210|FG002|Treatment Period|Lost to Follow-up|0
7997590|NCT03573908|12584211|FG003|Treatment Period|Lost to Follow-up|0
7997591|NCT03573908|12584212|FG004|Treatment Period|Lost to Follow-up|0
7997592|NCT03573908|12584208|FG000|Treatment Period|Pregnancy|1
7997593|NCT03573908|12584209|FG001|Treatment Period|Pregnancy|0
7997594|NCT03573908|12584210|FG002|Treatment Period|Pregnancy|0
7997595|NCT03573908|12584211|FG003|Treatment Period|Pregnancy|0
7997596|NCT03573908|12584212|FG004|Treatment Period|Pregnancy|0
7997597|NCT03573908|12584208|FG000|Treatment Period|Other, Not Specified|4
7997598|NCT03573908|12584209|FG001|Treatment Period|Other, Not Specified|6
7997599|NCT03573908|12584210|FG002|Treatment Period|Other, Not Specified|0
7997600|NCT03573908|12584211|FG003|Treatment Period|Other, Not Specified|0
7997601|NCT03573908|12584212|FG004|Treatment Period|Other, Not Specified|0
7997602|NCT03573908|12584208|FG000|Randomized Withdrawal Period|Adverse Event|0
7997603|NCT03573908|12584209|FG001|Randomized Withdrawal Period|Adverse Event|0
7997604|NCT03573908|12584210|FG002|Randomized Withdrawal Period|Adverse Event|3
7997605|NCT03573908|12584211|FG003|Randomized Withdrawal Period|Adverse Event|0
7997606|NCT03573908|12584212|FG004|Randomized Withdrawal Period|Adverse Event|0
7997607|NCT03573908|12584208|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
7997608|NCT03573908|12584209|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0
7997609|NCT03573908|12584210|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0
7997610|NCT03573908|12584211|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0
7997611|NCT03573908|12584212|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2
7997612|NCT03573908|12584208|FG000|Randomized Withdrawal Period|Lost to Follow-up|0
7997613|NCT03573908|12584209|FG001|Randomized Withdrawal Period|Lost to Follow-up|0
7997614|NCT03573908|12584210|FG002|Randomized Withdrawal Period|Lost to Follow-up|1
7997615|NCT03573908|12584211|FG003|Randomized Withdrawal Period|Lost to Follow-up|0
7997616|NCT03573908|12584212|FG004|Randomized Withdrawal Period|Lost to Follow-up|0
7997617|NCT03573908|12584208|FG000|Randomized Withdrawal Period|Other, Not Specified|0
7997618|NCT03573908|12584209|FG001|Randomized Withdrawal Period|Other, Not Specified|0
7997619|NCT03573908|12584210|FG002|Randomized Withdrawal Period|Other, Not Specified|4
7997620|NCT03573908|12584211|FG003|Randomized Withdrawal Period|Other, Not Specified|2
7997621|NCT03573908|12584212|FG004|Randomized Withdrawal Period|Other, Not Specified|0
7997622|NCT03574753|12584238|FG000|Overall Study|Adverse Event|3
7997623|NCT03574753|12584238|FG000|Overall Study|Progression/relapse|19
7997624|NCT03574753|12584238|FG000|Overall Study|Death|1
7997625|NCT03575702|12584249|FG000|Overall Study|Withdrawal by Subject|1
7997626|NCT03575702|12584250|FG001|Overall Study|Withdrawal by Subject|1
7997627|NCT03575702|12584249|FG000|Overall Study|Lost to Follow-up|1
7997628|NCT03575702|12584250|FG001|Overall Study|Lost to Follow-up|2
7997629|NCT03575702|12584249|FG000|Overall Study|Protocol Violation|0
7997630|NCT03575702|12584250|FG001|Overall Study|Protocol Violation|1
7997631|NCT03575702|12584249|FG000|Overall Study|Patient non compliance|4
7997632|NCT03575702|12584250|FG001|Overall Study|Patient non compliance|0
7997633|NCT03575806|12584267|FG000|Overall Study|Withdrawal by Subject|0
7997634|NCT03575806|12584268|FG001|Overall Study|Withdrawal by Subject|2
7997635|NCT03575806|12584267|FG000|Overall Study|Protocol Violation|0
7997636|NCT03575806|12584268|FG001|Overall Study|Protocol Violation|2
7997637|NCT03575871|12584277|FG000|Overall Study|Adverse Event|5
7997638|NCT03575871|12584278|FG001|Overall Study|Adverse Event|5
7997639|NCT03575871|12584279|FG002|Overall Study|Adverse Event|8
7997640|NCT03575871|12584277|FG000|Overall Study|Death|1
7997641|NCT03575871|12584278|FG001|Overall Study|Death|0
7997642|NCT03575871|12584279|FG002|Overall Study|Death|0
7997643|NCT03575871|12584277|FG000|Overall Study|Lack of Efficacy|5
7997644|NCT03575871|12584278|FG001|Overall Study|Lack of Efficacy|4
7997645|NCT03575871|12584279|FG002|Overall Study|Lack of Efficacy|7
7997646|NCT03575871|12584277|FG000|Overall Study|Lost to Follow-up|1
7997647|NCT03575871|12584278|FG001|Overall Study|Lost to Follow-up|1
7997648|NCT03575871|12584279|FG002|Overall Study|Lost to Follow-up|1
7997649|NCT03575871|12584277|FG000|Overall Study|Protocol Deviation|1
7997650|NCT03575871|12584278|FG001|Overall Study|Protocol Deviation|1
7997651|NCT03575871|12584279|FG002|Overall Study|Protocol Deviation|1
7997652|NCT03575871|12584277|FG000|Overall Study|Withdrawal by Subject|6
7997653|NCT03575871|12584278|FG001|Overall Study|Withdrawal by Subject|1
7997654|NCT03575871|12584279|FG002|Overall Study|Withdrawal by Subject|9
7997655|NCT03575871|12584277|FG000|Overall Study|Other than specified|2
7997656|NCT03575871|12584278|FG001|Overall Study|Other than specified|2
7997657|NCT03575871|12584279|FG002|Overall Study|Other than specified|0
7997658|NCT03575975|12584297|FG000|Overall Study|Lost to Follow-up|1
7997659|NCT03575975|12584298|FG001|Overall Study|Lost to Follow-up|0
7997660|NCT03575975|12584299|FG002|Overall Study|Lost to Follow-up|0
7997661|NCT03576066|12584307|FG000|Overall Study|Noncompliance with study drug|0
7997662|NCT03576066|12584308|FG001|Overall Study|Noncompliance with study drug|1
7997663|NCT03576768|12584340|FG000|Overall Study|Lost to Follow-up|3
7997664|NCT03576768|12584341|FG001|Overall Study|Lost to Follow-up|3
7997665|NCT03576768|12584342|FG002|Overall Study|Lost to Follow-up|0
7997666|NCT03576768|12584343|FG003|Overall Study|Lost to Follow-up|0
7997667|NCT03577730|12584378|FG000|Overall Study|Physician Decision|3
7997668|NCT03577730|12584379|FG001|Overall Study|Physician Decision|1
7997669|NCT03577730|12584378|FG000|Overall Study|Did not receive allocated intervention|1
7997670|NCT03577730|12584379|FG001|Overall Study|Did not receive allocated intervention|0
7997671|NCT03578146|12584391|FG000|Overall Study|Did Not Receive Treatment|1
7997672|NCT03578146|12584392|FG001|Overall Study|Did Not Receive Treatment|0
7997673|NCT03578146|12584393|FG002|Overall Study|Did Not Receive Treatment|0
7997674|NCT03578146|12584394|FG003|Overall Study|Did Not Receive Treatment|0
7997675|NCT03578146|12584395|FG004|Overall Study|Did Not Receive Treatment|0
7997676|NCT03578146|12584396|FG005|Overall Study|Did Not Receive Treatment|2
7997677|NCT03578146|12584391|FG000|Overall Study|Lost to Follow-up|0
7997678|NCT03578146|12584392|FG001|Overall Study|Lost to Follow-up|1
7997679|NCT03578146|12584393|FG002|Overall Study|Lost to Follow-up|1
7997680|NCT03578146|12584394|FG003|Overall Study|Lost to Follow-up|0
7997681|NCT03578146|12584395|FG004|Overall Study|Lost to Follow-up|0
7997682|NCT03578146|12584396|FG005|Overall Study|Lost to Follow-up|1
7997683|NCT03579290|12584423|FG000|Overall Study|Lost to Follow-up|9
7997684|NCT03579719|12584435|FG000|Overall Study|Protocol deviation, pre-existent disease|1
7997685|NCT03579940|12584450|FG000|Period 2|Withdrawal by Subject|0
7997686|NCT03579940|12584451|FG001|Period 2|Withdrawal by Subject|0
7997687|NCT03579940|12584452|FG002|Period 2|Withdrawal by Subject|1
7997688|NCT03579940|12584453|FG003|Period 2|Withdrawal by Subject|0
7997689|NCT03579940|12584454|FG004|Period 2|Withdrawal by Subject|0
7997690|NCT03579940|12584455|FG005|Period 2|Withdrawal by Subject|0
7997691|NCT03579940|12584456|FG006|Period 2|Withdrawal by Subject|0
7997692|NCT03579940|12584457|FG007|Period 2|Withdrawal by Subject|0
7997693|NCT03579940|12584458|FG008|Period 2|Withdrawal by Subject|0
7997694|NCT03579940|12584459|FG009|Period 2|Withdrawal by Subject|0
7997695|NCT03579940|12584460|FG010|Period 2|Withdrawal by Subject|0
7997696|NCT03581825|12584515|FG000|Period 1|Lens Discomfort|1
7997697|NCT03581825|12584516|FG001|Period 1|Lens Discomfort|0
7997698|NCT03581825|12584515|FG000|Period 2|Unsatisfactory Vision to Test|0
7997699|NCT03581825|12584516|FG001|Period 2|Unsatisfactory Vision to Test|1
7997700|NCT03582215|12584530|FG000|Overall Study|Adverse Event|1
7997701|NCT03582215|12584531|FG001|Overall Study|Adverse Event|0
7997702|NCT03582215|12584532|FG002|Overall Study|Adverse Event|0
7997703|NCT03582215|12584533|FG003|Overall Study|Adverse Event|0
7997704|NCT03582215|12584534|FG004|Overall Study|Adverse Event|0
7997705|NCT03582215|12584535|FG005|Overall Study|Adverse Event|0
7997706|NCT03582215|12584536|FG006|Overall Study|Adverse Event|2
7997707|NCT03582215|12584537|FG007|Overall Study|Adverse Event|2
7997708|NCT03582813|12584597|FG000|Overall Study|Lost to Follow-up|18
7997709|NCT03582813|12584598|FG001|Overall Study|Lost to Follow-up|21
7997710|NCT03582813|12584597|FG000|Overall Study|Withdrawal by Subject|1
7997711|NCT03582813|12584598|FG001|Overall Study|Withdrawal by Subject|0
7997712|NCT03582826|12584606|FG000|Overall Study|Lost to Follow-up|39
7997713|NCT03582826|12584607|FG001|Overall Study|Lost to Follow-up|0
7997714|NCT03582826|12584606|FG000|Overall Study|Withdrawal by Subject|2
7997715|NCT03582826|12584607|FG001|Overall Study|Withdrawal by Subject|0
7997716|NCT03582943|12584624|FG000|Allocated to Groups|Withdrawal by Subject|1
7997717|NCT03582943|12584625|FG001|Allocated to Groups|Withdrawal by Subject|1
7997718|NCT03582943|12584624|FG000|Intervention and Follow up|Withdrawal by Subject|4
7997719|NCT03582943|12584625|FG001|Intervention and Follow up|Withdrawal by Subject|2
7997720|NCT03582943|12584624|FG000|Analyzed|Protocol Violation|4
7997721|NCT03582943|12584625|FG001|Analyzed|Protocol Violation|1
7997722|NCT03583372|12584635|FG000|Overall Study|Withdrawal by Subject|6
7997723|NCT03583372|12584636|FG001|Overall Study|Withdrawal by Subject|11
7997724|NCT03583372|12584637|FG002|Overall Study|Withdrawal by Subject|7
7997725|NCT03583372|12584638|FG003|Overall Study|Withdrawal by Subject|8
7997726|NCT03583372|12584635|FG000|Overall Study|Lost to Follow-up|4
7997727|NCT03583372|12584636|FG001|Overall Study|Lost to Follow-up|6
7997728|NCT03583372|12584637|FG002|Overall Study|Lost to Follow-up|3
7997729|NCT03583372|12584638|FG003|Overall Study|Lost to Follow-up|2
7997730|NCT03583372|12584635|FG000|Overall Study|Adverse Event|1
7997731|NCT03583372|12584636|FG001|Overall Study|Adverse Event|3
7997732|NCT03583372|12584637|FG002|Overall Study|Adverse Event|4
7997733|NCT03583372|12584638|FG003|Overall Study|Adverse Event|4
7997734|NCT03583372|12584635|FG000|Overall Study|Physician Decision|0
7997735|NCT03583372|12584636|FG001|Overall Study|Physician Decision|1
7997736|NCT03583372|12584637|FG002|Overall Study|Physician Decision|1
7997737|NCT03583372|12584638|FG003|Overall Study|Physician Decision|1
7997738|NCT03583372|12584635|FG000|Overall Study|Lack of Efficacy|0
7997739|NCT03583372|12584636|FG001|Overall Study|Lack of Efficacy|1
7997740|NCT03583372|12584637|FG002|Overall Study|Lack of Efficacy|0
7997741|NCT03583372|12584638|FG003|Overall Study|Lack of Efficacy|1
7997742|NCT03583372|12584635|FG000|Overall Study|Death|1
7997743|NCT03583372|12584636|FG001|Overall Study|Death|0
7997744|NCT03583372|12584637|FG002|Overall Study|Death|0
7997745|NCT03583372|12584638|FG003|Overall Study|Death|0
7997746|NCT03583372|12584635|FG000|Overall Study|Protocol Violation|0
7997747|NCT03583372|12584636|FG001|Overall Study|Protocol Violation|1
7997748|NCT03583372|12584637|FG002|Overall Study|Protocol Violation|0
7997749|NCT03583372|12584638|FG003|Overall Study|Protocol Violation|0
7997750|NCT03583372|12584635|FG000|Overall Study|Subject Withdrawn due to Sponsor|0
7997751|NCT03583372|12584636|FG001|Overall Study|Subject Withdrawn due to Sponsor|0
7997752|NCT03583372|12584637|FG002|Overall Study|Subject Withdrawn due to Sponsor|0
7997753|NCT03583372|12584638|FG003|Overall Study|Subject Withdrawn due to Sponsor|1
7997754|NCT03583372|12584635|FG000|Overall Study|Did Not Receive Study Drug|0
7997755|NCT03583372|12584636|FG001|Overall Study|Did Not Receive Study Drug|1
7997756|NCT03583372|12584637|FG002|Overall Study|Did Not Receive Study Drug|0
7997757|NCT03583372|12584638|FG003|Overall Study|Did Not Receive Study Drug|0
7997758|NCT03583372|12584635|FG000|Overall Study|Captured as Other in the Database|1
7997759|NCT03583372|12584636|FG001|Overall Study|Captured as Other in the Database|2
7997760|NCT03583372|12584637|FG002|Overall Study|Captured as Other in the Database|4
7997761|NCT03583372|12584638|FG003|Overall Study|Captured as Other in the Database|1
7997762|NCT03583385|12584648|FG000|Treatment Period 1|Withdrawal by Subject|1
7997763|NCT03583385|12584649|FG001|Treatment Period 1|Withdrawal by Subject|1
7997764|NCT03583385|12584648|FG000|Treatment Period 2|Adverse Event|1
7997765|NCT03583385|12584649|FG001|Treatment Period 2|Adverse Event|0
7997766|NCT03583450|12584657|FG000|Overall Study|hardware malfunction (battery depletion)|1
7997767|NCT03583450|12584658|FG001|Overall Study|hardware malfunction (battery depletion)|0
7997768|NCT03583606|12584669|FG000|Overall Study|Lost to Follow-up|0
7997769|NCT03583606|12584670|FG001|Overall Study|Lost to Follow-up|1
7997770|NCT03583606|12584671|FG002|Overall Study|Lost to Follow-up|0
7997771|NCT03583606|12584669|FG000|Overall Study|Ineligible at baseline|1
7997772|NCT03583606|12584670|FG001|Overall Study|Ineligible at baseline|0
7997773|NCT03583606|12584671|FG002|Overall Study|Ineligible at baseline|0
7997774|NCT03585244|12584687|FG000|Overall Study|Withdrawal by Subject|15
7997775|NCT03585296|12584691|FG000|Overall Study|Adverse Event|1
7997776|NCT03585296|12584691|FG000|Overall Study|Lost to Follow-up|2
7997777|NCT03585296|12584691|FG000|Overall Study|Withdrawal by Subject|2
7997778|NCT03585504|12584697|FG000|Overall Study|Lost to Follow-up|26
7997779|NCT03585504|12584698|FG001|Overall Study|Lost to Follow-up|29
7997780|NCT03585712|12584709|FG000|Treatment Period 1|Protocol Violation|1
7997781|NCT03585712|12584710|FG001|Treatment Period 1|Protocol Violation|0
7997782|NCT03585712|12584711|FG002|Treatment Period 1|Protocol Violation|0
7997783|NCT03585712|12584709|FG000|Treatment Periods 2 and 3|Protocol Violation|0
7997784|NCT03585712|12584710|FG001|Treatment Periods 2 and 3|Protocol Violation|1
7997785|NCT03585712|12584711|FG002|Treatment Periods 2 and 3|Protocol Violation|1
7997786|NCT03585712|12584709|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0
7997787|NCT03585712|12584710|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2
7997788|NCT03585712|12584711|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0
7997789|NCT03585712|12584709|FG000|Treatment Periods 2 and 3|Physician Decision|0
7997790|NCT03585712|12584710|FG001|Treatment Periods 2 and 3|Physician Decision|0
7997791|NCT03585712|12584711|FG002|Treatment Periods 2 and 3|Physician Decision|2
7997792|NCT03585959|12584738|FG000|Overall Study|Physician Decision|1
7997793|NCT03585959|12584738|FG000|Overall Study|Unsuccessful Procedure|2
7997794|NCT03586167|12584746|FG000|Overall Study|Other|1
7997795|NCT03586167|12584747|FG001|Overall Study|Other|0
7997796|NCT03586544|12584755|FG000|First Intervention|Adverse Event|0
7997797|NCT03586544|12584756|FG001|First Intervention|Adverse Event|1
7997798|NCT03586544|12584755|FG000|Second Intervention|Withdrawal by Subject|0
7997799|NCT03586544|12584756|FG001|Second Intervention|Withdrawal by Subject|1
7997800|NCT03586648|12584767|FG000|Period 1|Withdrawal by Subject|0
7997801|NCT03586648|12584768|FG001|Period 1|Withdrawal by Subject|1
7997802|NCT03586648|12584767|FG000|Period 1|Lost to Follow-up|1
7997803|NCT03586648|12584768|FG001|Period 1|Lost to Follow-up|1
7997804|NCT03586648|12584767|FG000|Period 1|Adverse Event|1
7997805|NCT03586648|12584768|FG001|Period 1|Adverse Event|0
7997806|NCT03586648|12584767|FG000|Period 1|Study related symptoms or complaints|2
7997807|NCT03586648|12584768|FG001|Period 1|Study related symptoms or complaints|1
7997808|NCT03586648|12584767|FG000|Period 1|Physician Decision|0
7997809|NCT03586648|12584768|FG001|Period 1|Physician Decision|1
7997810|NCT03586648|12584767|FG000|Period 2|Adverse Event|1
7997811|NCT03586648|12584768|FG001|Period 2|Adverse Event|0
7997812|NCT03586726|12584774|FG000|Overall Study|Withdrawal by Subject|1
7997813|NCT03586830|12584782|FG000|Overall Study|Site terminated by Sponsor|1
7997814|NCT03586830|12584783|FG001|Overall Study|Site terminated by Sponsor|4
7997815|NCT03586830|12584784|FG002|Overall Study|Site terminated by Sponsor|3
7997816|NCT03586830|12584785|FG003|Overall Study|Site terminated by Sponsor|3
7997817|NCT03586830|12584782|FG000|Overall Study|Lost to Follow-up|0
7997818|NCT03586830|12584783|FG001|Overall Study|Lost to Follow-up|2
7997819|NCT03586830|12584784|FG002|Overall Study|Lost to Follow-up|2
7997820|NCT03586830|12584785|FG003|Overall Study|Lost to Follow-up|1
7997821|NCT03586830|12584782|FG000|Overall Study|Withdrawal by Subject|1
7997822|NCT03586830|12584783|FG001|Overall Study|Withdrawal by Subject|0
7997823|NCT03586830|12584784|FG002|Overall Study|Withdrawal by Subject|3
7997824|NCT03586830|12584785|FG003|Overall Study|Withdrawal by Subject|1
7997825|NCT03587974|12584831|FG000|Overall Study|caregiver demented, care recipient died|3
7997826|NCT03587974|12584832|FG001|Overall Study|caregiver demented, care recipient died|3
7997827|NCT03587974|12584831|FG000|Overall Study|Withdrawal by Subject|2
7997828|NCT03587974|12584832|FG001|Overall Study|Withdrawal by Subject|1
7997829|NCT03588572|12584840|FG000|Visitation 1|Lack of Efficacy|1
7997830|NCT03588572|12584841|FG001|Visitation 1|Lack of Efficacy|1
7997831|NCT03588572|12584840|FG000|Visitation 2|Lost to Follow-up|1
7997832|NCT03588572|12584841|FG001|Visitation 2|Lost to Follow-up|1
7997833|NCT03588572|12584840|FG000|Visitation 2|Lack of Efficacy|0
7997834|NCT03588572|12584841|FG001|Visitation 2|Lack of Efficacy|1
7997835|NCT03588572|12584840|FG000|Visitation 2|Withdrawal by Subject|1
7997836|NCT03588572|12584841|FG001|Visitation 2|Withdrawal by Subject|0
7997837|NCT03588572|12584840|FG000|Visitation 3|Lost to Follow-up|1
7997838|NCT03588572|12584841|FG001|Visitation 3|Lost to Follow-up|1
7997839|NCT03588572|12584840|FG000|Visitation 3|Physician Decision|1
7997840|NCT03588572|12584841|FG001|Visitation 3|Physician Decision|1
7997841|NCT03588572|12584840|FG000|Visitation 3|Withdrawal by Subject|1
7997842|NCT03588572|12584841|FG001|Visitation 3|Withdrawal by Subject|0
7997843|NCT03588741|12584847|FG000|Overall Study|Withdrawal by Subject|1
7997844|NCT03588910|12584857|FG000|Overall Study|Withdrawal by Subject|1
7997845|NCT03588910|12584858|FG001|Overall Study|Withdrawal by Subject|0
7997846|NCT03588910|12584857|FG000|Overall Study|Allergy|2
7997847|NCT03588910|12584858|FG001|Overall Study|Allergy|0
7997848|NCT03588910|12584857|FG000|Overall Study|Protocol Violation|0
7997849|NCT03588910|12584858|FG001|Overall Study|Protocol Violation|3
7997850|NCT03588910|12584857|FG000|Overall Study|Did not complete Day 1 Survey|5
7997851|NCT03588910|12584858|FG001|Overall Study|Did not complete Day 1 Survey|10
7997852|NCT03588910|12584857|FG000|Overall Study|Did not complete Day 7 Survey|5
7997853|NCT03588910|12584858|FG001|Overall Study|Did not complete Day 7 Survey|2
7997854|NCT03589807|12584870|FG000|Overall Study|Lost to Follow-up|0
7997855|NCT03589807|12584871|FG001|Overall Study|Lost to Follow-up|2
7997856|NCT03589807|12584872|FG002|Overall Study|Lost to Follow-up|2
7997857|NCT03589807|12584873|FG003|Overall Study|Lost to Follow-up|3
7997858|NCT03589807|12584874|FG004|Overall Study|Lost to Follow-up|1
7997859|NCT03589807|12584875|FG005|Overall Study|Lost to Follow-up|1
7997860|NCT03589807|12584870|FG000|Overall Study|Withdrawal by Subject|0
7997861|NCT03589807|12584871|FG001|Overall Study|Withdrawal by Subject|5
7997862|NCT03589807|12584872|FG002|Overall Study|Withdrawal by Subject|0
7997863|NCT03589807|12584873|FG003|Overall Study|Withdrawal by Subject|0
7997864|NCT03589807|12584874|FG004|Overall Study|Withdrawal by Subject|0
7997865|NCT03589807|12584875|FG005|Overall Study|Withdrawal by Subject|0
7997866|NCT03589807|12584870|FG000|Overall Study|Protocol Violation|0
7997867|NCT03589807|12584871|FG001|Overall Study|Protocol Violation|0
7997868|NCT03589807|12584872|FG002|Overall Study|Protocol Violation|0
7997869|NCT03589807|12584873|FG003|Overall Study|Protocol Violation|1
7997870|NCT03589807|12584874|FG004|Overall Study|Protocol Violation|0
7997871|NCT03589807|12584875|FG005|Overall Study|Protocol Violation|0
7997872|NCT03589807|12584870|FG000|Overall Study|Enrolled but treatment not administered|0
7997873|NCT03589807|12584871|FG001|Overall Study|Enrolled but treatment not administered|0
7997874|NCT03589807|12584872|FG002|Overall Study|Enrolled but treatment not administered|0
7997875|NCT03589807|12584873|FG003|Overall Study|Enrolled but treatment not administered|0
7997876|NCT03589807|12584874|FG004|Overall Study|Enrolled but treatment not administered|1
7997877|NCT03589807|12584875|FG005|Overall Study|Enrolled but treatment not administered|0
7997878|NCT03589885|12584895|FG000|Treatment Period 1-Randomized Set|Adverse Event|0
7997879|NCT03589885|12584896|FG001|Treatment Period 1-Randomized Set|Adverse Event|1
7997880|NCT03589885|12584897|FG002|Treatment Period 1-Randomized Set|Adverse Event|0
7997881|NCT03589885|12584898|FG003|Treatment Period 1-Randomized Set|Adverse Event|0
7997882|NCT03589885|12584899|FG004|Treatment Period 1-Randomized Set|Adverse Event|0
7997883|NCT03589885|12584895|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7997884|NCT03589885|12584896|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7997885|NCT03589885|12584897|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2
7997886|NCT03589885|12584898|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7997887|NCT03589885|12584899|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7997888|NCT03589885|12584895|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7997889|NCT03589885|12584896|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1
7997890|NCT03589885|12584897|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7997891|NCT03589885|12584898|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7997892|NCT03589885|12584899|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7997893|NCT03589885|12584895|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7997894|NCT03589885|12584896|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7997895|NCT03589885|12584897|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1
7997896|NCT03589885|12584898|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7997897|NCT03589885|12584899|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7997898|NCT03589885|12584895|FG000|Treatment Period 2-Randomized Set|Adverse Event|0
7997899|NCT03589885|12584896|FG001|Treatment Period 2-Randomized Set|Adverse Event|1
7997900|NCT03589885|12584897|FG002|Treatment Period 2-Randomized Set|Adverse Event|0
7997901|NCT03589885|12584898|FG003|Treatment Period 2-Randomized Set|Adverse Event|0
7997902|NCT03589885|12584899|FG004|Treatment Period 2-Randomized Set|Adverse Event|0
7997903|NCT03589885|12584895|FG000|Treatment Period 2-Randomized Set|Pregnancy|1
7997904|NCT03589885|12584896|FG001|Treatment Period 2-Randomized Set|Pregnancy|0
7997905|NCT03589885|12584897|FG002|Treatment Period 2-Randomized Set|Pregnancy|0
7997906|NCT03589885|12584898|FG003|Treatment Period 2-Randomized Set|Pregnancy|0
7997907|NCT03589885|12584899|FG004|Treatment Period 2-Randomized Set|Pregnancy|0
7997908|NCT03589885|12584895|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0
7997909|NCT03589885|12584896|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3
7997910|NCT03589885|12584897|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1
7997911|NCT03589885|12584898|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0
7997912|NCT03589885|12584899|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1
7997913|NCT03589885|12584895|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7997914|NCT03589885|12584896|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1
7997915|NCT03589885|12584897|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7997916|NCT03589885|12584898|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7997917|NCT03589885|12584899|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7997918|NCT03590613|12584917|FG000|Period 2, 4 Days|Physician Decision|0
7997919|NCT03590613|12584918|FG001|Period 2, 4 Days|Physician Decision|0
7997920|NCT03590613|12584919|FG002|Period 2, 4 Days|Physician Decision|0
7997921|NCT03590613|12584920|FG003|Period 2, 4 Days|Physician Decision|1
7997922|NCT03591146|12584944|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7997923|NCT03591146|12584945|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7997924|NCT03591146|12584946|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7997925|NCT03591146|12584947|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7997926|NCT03591146|12584948|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1
7997927|NCT03591146|12584944|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7997928|NCT03591146|12584945|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1
7997929|NCT03591146|12584946|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7718321|NCT00527605|12142286|FG001|Overall Study|Withdrawal by Subject|7
7718322|NCT00527605|12142285|FG000|Overall Study|Lost to Follow-up|6
7718323|NCT00527605|12142286|FG001|Overall Study|Lost to Follow-up|2
7718324|NCT00527605|12142285|FG000|Overall Study|Protocol Violation|1
7718325|NCT00527605|12142286|FG001|Overall Study|Protocol Violation|2
7718326|NCT00527618|12142292|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3
7718327|NCT00527618|12142293|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1
7718328|NCT00527618|12142292|FG000|Week 1-12 (First Intervention)|Adverse Event|0
7718329|NCT00527618|12142293|FG001|Week 1-12 (First Intervention)|Adverse Event|1
7718330|NCT00527618|12142292|FG000|Week 13-14 (Washout)|Lost to Follow-up|1
7718331|NCT00527618|12142293|FG001|Week 13-14 (Washout)|Lost to Follow-up|0
7718332|NCT00527618|12142292|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0
7718333|NCT00527618|12142293|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1
7718334|NCT00527618|12142292|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
7718335|NCT00527618|12142293|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
7718336|NCT00527618|12142292|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
7718337|NCT00527618|12142293|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
7718338|NCT00527735|12142316|FG000|Overall Study|Disease progression|47
7718339|NCT00527735|12142317|FG001|Overall Study|Disease progression|61
7718340|NCT00527735|12142318|FG002|Overall Study|Disease progression|53
7718341|NCT00527735|12142316|FG000|Overall Study|Death|23
7718342|NCT00527735|12142317|FG001|Overall Study|Death|13
7997930|NCT03591146|12584947|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7997931|NCT03591146|12584948|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7997932|NCT03591146|12584944|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7997933|NCT03591146|12584945|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7997934|NCT03591146|12584946|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7997935|NCT03591146|12584947|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7997936|NCT03591146|12584948|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1
7997937|NCT03591146|12584944|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
7997938|NCT03591146|12584945|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
7997939|NCT03591146|12584946|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1
7997940|NCT03591146|12584947|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
7997941|NCT03591146|12584948|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1
7997942|NCT03591406|12584962|FG000|Overall Study|Adverse Event|5
7997943|NCT03591406|12584963|FG001|Overall Study|Adverse Event|3
7997944|NCT03591406|12584962|FG000|Overall Study|Protocol Violation|2
7997945|NCT03591406|12584963|FG001|Overall Study|Protocol Violation|1
7997946|NCT03591406|12584962|FG000|Overall Study|Withdrawal by Subject|0
7997947|NCT03591406|12584963|FG001|Overall Study|Withdrawal by Subject|5
7997948|NCT03592745|12584980|FG000|Overall Study|Adverse Event|0
7997949|NCT03592745|12584981|FG001|Overall Study|Adverse Event|2
7997950|NCT03592745|12584980|FG000|Overall Study|Lost to Follow-up|2
7997951|NCT03592745|12584981|FG001|Overall Study|Lost to Follow-up|0
7997952|NCT03592745|12584980|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1
7997953|NCT03592745|12584981|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1
7997954|NCT03593681|12585004|FG000|Overall Study|Inadequate sample collected|12
7997955|NCT03593681|12585004|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11
7997956|NCT03593681|12585004|FG000|Overall Study|Protocol Violation|3
7997957|NCT03593681|12585004|FG000|Overall Study|Withdrawal by Subject|3
7997958|NCT03593681|12585004|FG000|Overall Study|Procedure not attempted|3
7997959|NCT03593681|12585004|FG000|Overall Study|Adverse Event|2
7997960|NCT03593681|12585004|FG000|Overall Study|Physician Decision|1
7997961|NCT03593876|12585025|FG000|Overall Study|Withdrawal by Subject|1
7997962|NCT03593876|12585025|FG000|Overall Study|Discharged home before intervention completion|2
7997963|NCT03594071|12585042|FG000|Overall Study|Re-operation|3
7997964|NCT03594071|12585042|FG000|Overall Study|Missed visit|2
7997965|NCT03594227|12585050|FG000|Overall Study|Adverse Event|2
7997966|NCT03594227|12585051|FG001|Overall Study|Adverse Event|1
7997967|NCT03594227|12585052|FG002|Overall Study|Adverse Event|0
7997968|NCT03594227|12585053|FG003|Overall Study|Adverse Event|2
7997969|NCT03594227|12585050|FG000|Overall Study|Lost to Follow-up|1
7997970|NCT03594227|12585051|FG001|Overall Study|Lost to Follow-up|1
7997971|NCT03594227|12585052|FG002|Overall Study|Lost to Follow-up|1
7997972|NCT03594227|12585053|FG003|Overall Study|Lost to Follow-up|0
7997973|NCT03594227|12585050|FG000|Overall Study|Withdrawal by Subject|1
7997974|NCT03594227|12585051|FG001|Overall Study|Withdrawal by Subject|1
7997975|NCT03594227|12585052|FG002|Overall Study|Withdrawal by Subject|1
7997976|NCT03594227|12585053|FG003|Overall Study|Withdrawal by Subject|1
7997977|NCT03594227|12585050|FG000|Overall Study|Pregnancy|0
7997978|NCT03594227|12585051|FG001|Overall Study|Pregnancy|1
7997979|NCT03594227|12585052|FG002|Overall Study|Pregnancy|0
7997980|NCT03594227|12585053|FG003|Overall Study|Pregnancy|0
7997981|NCT03594227|12585050|FG000|Overall Study|Sponsor Decision|0
7997982|NCT03594227|12585051|FG001|Overall Study|Sponsor Decision|0
7997983|NCT03594227|12585052|FG002|Overall Study|Sponsor Decision|0
7997984|NCT03594227|12585053|FG003|Overall Study|Sponsor Decision|1
7997985|NCT03594227|12585050|FG000|Overall Study|Programmatic Analysis Non-completer|1
7997986|NCT03594227|12585051|FG001|Overall Study|Programmatic Analysis Non-completer|0
7997987|NCT03594227|12585052|FG002|Overall Study|Programmatic Analysis Non-completer|1
7997988|NCT03594227|12585053|FG003|Overall Study|Programmatic Analysis Non-completer|1
7997989|NCT03595280|12585093|FG000|Overall Study|Lost to Follow-up|6
7997990|NCT03595280|12585094|FG001|Overall Study|Lost to Follow-up|9
7997991|NCT03595280|12585095|FG002|Overall Study|Lost to Follow-up|15
7997992|NCT03595618|12585125|FG000|Overall Study|Adverse Event|16
7997993|NCT03595618|12585126|FG001|Overall Study|Adverse Event|17
7997994|NCT03595618|12585127|FG002|Overall Study|Adverse Event|20
7997995|NCT03595618|12585128|FG003|Overall Study|Adverse Event|8
7997996|NCT03595618|12585125|FG000|Overall Study|Withdrawal by Subject|12
7997997|NCT03595618|12585126|FG001|Overall Study|Withdrawal by Subject|14
7997998|NCT03595618|12585127|FG002|Overall Study|Withdrawal by Subject|14
7997999|NCT03595618|12585128|FG003|Overall Study|Withdrawal by Subject|10
7998000|NCT03595618|12585125|FG000|Overall Study|Lost to Follow-up|6
7998001|NCT03595618|12585126|FG001|Overall Study|Lost to Follow-up|4
7998002|NCT03595618|12585127|FG002|Overall Study|Lost to Follow-up|5
7998003|NCT03595618|12585128|FG003|Overall Study|Lost to Follow-up|6
7998004|NCT03595618|12585125|FG000|Overall Study|Protocol Violation|2
7998005|NCT03595618|12585126|FG001|Overall Study|Protocol Violation|0
7998006|NCT03595618|12585127|FG002|Overall Study|Protocol Violation|6
7998007|NCT03595618|12585128|FG003|Overall Study|Protocol Violation|2
7998008|NCT03595618|12585125|FG000|Overall Study|Physician Decision|0
7998009|NCT03595618|12585126|FG001|Overall Study|Physician Decision|0
7998010|NCT03595618|12585127|FG002|Overall Study|Physician Decision|1
7998011|NCT03595618|12585128|FG003|Overall Study|Physician Decision|2
7998012|NCT03595618|12585125|FG000|Overall Study|Miscellaneous|7
7998013|NCT03595618|12585126|FG001|Overall Study|Miscellaneous|5
7998014|NCT03595618|12585127|FG002|Overall Study|Miscellaneous|10
7998015|NCT03595618|12585128|FG003|Overall Study|Miscellaneous|6
7998016|NCT03595904|12585140|FG000|Overall Study|Protocol Violation|3
7998017|NCT03595904|12585141|FG001|Overall Study|Protocol Violation|1
7998018|NCT03595904|12585140|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4
7998019|NCT03595904|12585141|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3
7998020|NCT03595904|12585140|FG000|Overall Study|Insurance complications|1
7998021|NCT03595904|12585141|FG001|Overall Study|Insurance complications|0
7998022|NCT03595904|12585140|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2
7998023|NCT03595904|12585141|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1
7998024|NCT03596151|12585147|FG000|Overall Study|Withdrawal by Subject|1
7998025|NCT03596177|12585153|FG000|Single Blind Period|Withdrawal by Subject|1
7998026|NCT03596177|12585154|FG001|Single Blind Period|Withdrawal by Subject|1
7998027|NCT03596177|12585153|FG000|Single Blind Period|Other|1
7998028|NCT03596177|12585154|FG001|Single Blind Period|Other|0
7998029|NCT03596177|12585153|FG000|Double Blind Period|Withdrawal by Subject|0
7998030|NCT03596177|12585154|FG001|Double Blind Period|Withdrawal by Subject|1
7998031|NCT03596177|12585153|FG000|Double Blind Period|Other|0
7998032|NCT03596177|12585154|FG001|Double Blind Period|Other|4
7998033|NCT03596177|12585153|FG000|Double Blind Period|Death during safety follow-up|0
7998034|NCT03596177|12585154|FG001|Double Blind Period|Death during safety follow-up|1
7998035|NCT03597022|12585176|FG000|Overall Study|Premature termination of the study|7
7998036|NCT03597022|12585177|FG001|Overall Study|Premature termination of the study|7
7998037|NCT03597022|12585178|FG002|Overall Study|Premature termination of the study|8
7998038|NCT03597022|12585176|FG000|Overall Study|Serious adverse event|1
7998039|NCT03597022|12585177|FG001|Overall Study|Serious adverse event|1
7998040|NCT03597022|12585178|FG002|Overall Study|Serious adverse event|0
7998041|NCT03597061|12585188|FG000|Overall Study|Lost to Follow-up|1
7998042|NCT03597061|12585189|FG001|Overall Study|Lost to Follow-up|0
7998043|NCT03597061|12585188|FG000|Overall Study|Protocol Violation|0
7998044|NCT03597061|12585189|FG001|Overall Study|Protocol Violation|1
7998045|NCT03597139|12585197|FG000|Overall Study|Adverse Event|3
7998046|NCT03597139|12585198|FG001|Overall Study|Adverse Event|0
7998047|NCT03597139|12585197|FG000|Overall Study|Protocol Non-compliance|1
7998048|NCT03597139|12585198|FG001|Overall Study|Protocol Non-compliance|0
7998049|NCT03597347|12585211|FG000|Overall Study|Withdrawal by Subject|1
7998050|NCT03597347|12585212|FG001|Overall Study|Withdrawal by Subject|1
7998051|NCT03597347|12585213|FG002|Overall Study|Withdrawal by Subject|0
7998052|NCT03597347|12585211|FG000|Overall Study|Withdrawal due to Covid-19|3
7998053|NCT03597347|12585212|FG001|Overall Study|Withdrawal due to Covid-19|0
7998054|NCT03597347|12585213|FG002|Overall Study|Withdrawal due to Covid-19|0
7998055|NCT03597347|12585211|FG000|Overall Study|Sponsor decision to terminate study|3
7998056|NCT03597347|12585212|FG001|Overall Study|Sponsor decision to terminate study|2
7998057|NCT03597347|12585213|FG002|Overall Study|Sponsor decision to terminate study|4
7998058|NCT03597529|12585223|FG000|Overall Study|Lost to Follow-up|10
7998059|NCT03597529|12585224|FG001|Overall Study|Lost to Follow-up|12
7998060|NCT03597529|12585223|FG000|Overall Study|Physician Decision|3
7998061|NCT03597529|12585224|FG001|Overall Study|Physician Decision|1
7998062|NCT03597529|12585223|FG000|Overall Study|Withdrawal by Subject|6
7998063|NCT03597529|12585224|FG001|Overall Study|Withdrawal by Subject|3
7998064|NCT03597529|12585223|FG000|Overall Study|Non-compliant with study activities|1
7998065|NCT03597529|12585224|FG001|Overall Study|Non-compliant with study activities|2
7998066|NCT03599089|12585253|FG000|Overall Study|Lost to Follow-up|1
7998067|NCT03599089|12585254|FG001|Overall Study|Lost to Follow-up|0
7998068|NCT03599089|12585255|FG002|Overall Study|Lost to Follow-up|0
7998069|NCT03599089|12585256|FG003|Overall Study|Lost to Follow-up|0
7998070|NCT03599089|12585253|FG000|Overall Study|Withdrawal by Subject|2
7998071|NCT03599089|12585254|FG001|Overall Study|Withdrawal by Subject|1
7998072|NCT03599089|12585255|FG002|Overall Study|Withdrawal by Subject|0
7998073|NCT03599089|12585256|FG003|Overall Study|Withdrawal by Subject|0
7998074|NCT03599089|12585253|FG000|Overall Study|Lack of Efficacy|0
7998075|NCT03599089|12585254|FG001|Overall Study|Lack of Efficacy|0
7998076|NCT03599089|12585255|FG002|Overall Study|Lack of Efficacy|1
7998077|NCT03599089|12585256|FG003|Overall Study|Lack of Efficacy|2
7998078|NCT03599193|12585268|FG000|Overall Study|Adverse Event|0
7998079|NCT03599193|12585269|FG001|Overall Study|Adverse Event|2
7998080|NCT03599193|12585268|FG000|Overall Study|Withdrawal by Subject|1
7998081|NCT03599193|12585269|FG001|Overall Study|Withdrawal by Subject|0
7998082|NCT03599193|12585268|FG000|Overall Study|Protocol Violation|1
7998083|NCT03599193|12585269|FG001|Overall Study|Protocol Violation|0
7998084|NCT03599193|12585268|FG000|Overall Study|Lost to Follow-up|0
7998085|NCT03599193|12585269|FG001|Overall Study|Lost to Follow-up|1
7998086|NCT03599349|12585287|FG000|Overall Study|Lost to Follow-up|1
7998087|NCT03599362|12585291|FG000|Overall Study|Screen Failure|3
7998088|NCT03600376|12585324|FG000|Overall Study|Adverse Event|1
7998089|NCT03600376|12585325|FG001|Overall Study|Adverse Event|1
7998090|NCT03600376|12585324|FG000|Overall Study|Transferred to other facility|1
7998091|NCT03600376|12585325|FG001|Overall Study|Transferred to other facility|0
7998092|NCT03600376|12585324|FG000|Overall Study|Investigator Decision|0
7998093|NCT03600376|12585325|FG001|Overall Study|Investigator Decision|4
7998094|NCT03600376|12585324|FG000|Overall Study|Determined to be ineligible for study|0
7998095|NCT03600376|12585325|FG001|Overall Study|Determined to be ineligible for study|1
7998096|NCT03600428|12585333|FG000|Overall Study|Not eligible|0
7998097|NCT03600428|12585334|FG001|Overall Study|Not eligible|1
7998098|NCT03600428|12585333|FG000|Overall Study|Lost to Follow-up|5
7998099|NCT03600428|12585334|FG001|Overall Study|Lost to Follow-up|4
7998100|NCT03601052|12585340|FG000|Overall Study|Lost to Follow-up|2
7998101|NCT03601715|12585352|FG000|Second Intervention|Lost to Follow-up|1
7998102|NCT03601715|12585353|FG001|Second Intervention|Lost to Follow-up|1
7998103|NCT03601715|12585354|FG002|Second Intervention|Lost to Follow-up|0
7998104|NCT03602053|12585365|FG000|Overall Study|Withdrawal by Subject|7
7998105|NCT03602053|12585366|FG001|Overall Study|Withdrawal by Subject|9
7998106|NCT03602053|12585367|FG002|Overall Study|Withdrawal by Subject|7
7998107|NCT03602053|12585365|FG000|Overall Study|Lost to Follow-up|5
7998108|NCT03602053|12585366|FG001|Overall Study|Lost to Follow-up|6
7998109|NCT03602053|12585367|FG002|Overall Study|Lost to Follow-up|0
7998110|NCT03602053|12585365|FG000|Overall Study|Protocol Violation|3
7998111|NCT03602053|12585366|FG001|Overall Study|Protocol Violation|0
7998112|NCT03602053|12585367|FG002|Overall Study|Protocol Violation|4
7998113|NCT03602053|12585365|FG000|Overall Study|Physician Decision|1
7998114|NCT03602053|12585366|FG001|Overall Study|Physician Decision|0
7998115|NCT03602053|12585367|FG002|Overall Study|Physician Decision|0
7998116|NCT03602053|12585365|FG000|Overall Study|migration|2
7998117|NCT03602053|12585366|FG001|Overall Study|migration|3
7998118|NCT03602053|12585367|FG002|Overall Study|migration|0
7998119|NCT03602053|12585365|FG000|Overall Study|Other|1
7998120|NCT03602053|12585366|FG001|Overall Study|Other|0
7998121|NCT03602053|12585367|FG002|Overall Study|Other|0
7998122|NCT03602339|12585379|FG000|Overall Study|Withdrawal by Subject|9
7998123|NCT03602339|12585379|FG000|Overall Study|Physician Decision|2
7998124|NCT03602339|12585379|FG000|Overall Study|Other reason|4
7998125|NCT03602482|12585388|FG000|Overall Study|Withdrawal by Subject|6
7998126|NCT03602482|12585389|FG001|Overall Study|Withdrawal by Subject|7
7998127|NCT03602482|12585390|FG002|Overall Study|Withdrawal by Subject|0
7998128|NCT03602482|12585391|FG003|Overall Study|Withdrawal by Subject|0
7998129|NCT03603028|12585404|FG000|Overall Study|Withdrawal by Subject|1
7998130|NCT03603652|12585462|FG000|Overall Study|Death|2
7998131|NCT03604341|12585472|FG000|Overall Study|Withdrawal by Subject|1
7998132|NCT03604341|12585473|FG001|Overall Study|Withdrawal by Subject|1
7998133|NCT03604341|12585472|FG000|Overall Study|Adverse Event|1
7998134|NCT03604341|12585473|FG001|Overall Study|Adverse Event|0
7998135|NCT03604341|12585472|FG000|Overall Study|Protocol Violation|0
7998136|NCT03604341|12585473|FG001|Overall Study|Protocol Violation|1
7998137|NCT03604497|12585479|FG000|Overall Study|Protocol Violation|52
7998138|NCT03604523|12585489|FG000|Overall Study|Physician Decision|1
7998139|NCT03604523|12585490|FG001|Overall Study|Physician Decision|0
7998140|NCT03605212|12585513|FG000|Treatment Period|Adverse Event|1
7998141|NCT03605212|12585514|FG001|Treatment Period|Adverse Event|0
7998142|NCT03605212|12585515|FG002|Treatment Period|Adverse Event|0
7998143|NCT03605212|12585516|FG003|Treatment Period|Adverse Event|0
7998144|NCT03605212|12585517|FG004|Treatment Period|Adverse Event|0
7998145|NCT03605212|12585513|FG000|Treatment Period|Physician Decision|0
7998146|NCT03605212|12585514|FG001|Treatment Period|Physician Decision|0
7998147|NCT03605212|12585515|FG002|Treatment Period|Physician Decision|0
7998148|NCT03605212|12585516|FG003|Treatment Period|Physician Decision|0
7998149|NCT03605212|12585517|FG004|Treatment Period|Physician Decision|1
7998150|NCT03605693|12585532|FG000|Overall Study|Lost to Follow-up|4
7998151|NCT03605693|12585533|FG001|Overall Study|Lost to Follow-up|0
7998152|NCT03605693|12585532|FG000|Overall Study|Physician Decision|1
7998153|NCT03605693|12585533|FG001|Overall Study|Physician Decision|0
7998154|NCT03605745|12585539|FG000|Overall Study|Study was terminated for business reasons|47
7998155|NCT03605836|12585547|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2
7998156|NCT03605836|12585548|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0
7998157|NCT03605836|12585549|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0
7998158|NCT03605836|12585550|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0
7998159|NCT03605836|12585547|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2
7998160|NCT03605836|12585548|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
7998161|NCT03605836|12585549|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
7998162|NCT03605836|12585550|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
7998163|NCT03605836|12585547|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8
7998164|NCT03605836|12585548|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
7998165|NCT03605836|12585549|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
7998166|NCT03605836|12585550|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
7998167|NCT03605836|12585547|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4
7998168|NCT03605836|12585548|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
7998169|NCT03605836|12585549|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
7998170|NCT03605836|12585550|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
7998171|NCT03605836|12585547|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4
7998172|NCT03605836|12585548|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
7998173|NCT03605836|12585549|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
7998174|NCT03605836|12585550|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
7998175|NCT03605836|12585547|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17
7998176|NCT03605836|12585548|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
7998177|NCT03605836|12585549|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
7998178|NCT03605836|12585550|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
7998179|NCT03605836|12585547|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5
7998180|NCT03605836|12585548|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
7998181|NCT03605836|12585549|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
7998182|NCT03605836|12585550|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
7998183|NCT03605836|12585547|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7
7998184|NCT03605836|12585548|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0
7998185|NCT03605836|12585549|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0
7998186|NCT03605836|12585550|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0
7998187|NCT03605836|12585547|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85
7998188|NCT03605836|12585548|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
7998189|NCT03605836|12585549|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
7998190|NCT03605836|12585550|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
7998191|NCT03605836|12585547|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15
7998192|NCT03605836|12585548|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
7998193|NCT03605836|12585549|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
7998194|NCT03605836|12585550|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
7998195|NCT03605836|12585547|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1
7998196|NCT03605836|12585548|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
7998197|NCT03605836|12585549|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
7998198|NCT03605836|12585550|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
7998199|NCT03605836|12585547|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0
7998200|NCT03605836|12585548|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2
7998201|NCT03605836|12585549|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4
7998202|NCT03605836|12585550|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4
7998203|NCT03605836|12585547|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0
7998204|NCT03605836|12585548|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5
7998205|NCT03605836|12585549|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8
7998206|NCT03605836|12585550|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0
7998207|NCT03605836|12585547|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0
7998208|NCT03605836|12585548|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0
7998209|NCT03605836|12585549|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2
7998210|NCT03605836|12585550|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1
7998211|NCT03605836|12585547|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0
7998212|NCT03605836|12585548|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3
7998213|NCT03605836|12585549|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5
7998214|NCT03605836|12585550|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1
7998215|NCT03605836|12585547|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0
7998216|NCT03605836|12585548|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1
7998217|NCT03605836|12585549|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0
7998218|NCT03605836|12585550|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4
7998219|NCT03605836|12585547|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
7998220|NCT03605836|12585548|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1
7998221|NCT03605836|12585549|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
7998222|NCT03605836|12585550|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
7998223|NCT03605836|12585547|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0
7998224|NCT03605836|12585548|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5
7998225|NCT03605836|12585549|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1
7998226|NCT03605836|12585550|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1
7998227|NCT03605836|12585547|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0
7998228|NCT03605836|12585548|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10
7998229|NCT03605836|12585549|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6
7998230|NCT03605836|12585550|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4
7998231|NCT03605836|12585547|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0
7998232|NCT03605836|12585548|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3
7998233|NCT03605836|12585549|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1
7998234|NCT03605836|12585550|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0
7998235|NCT03605836|12585547|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0
7998236|NCT03605836|12585548|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6
7998237|NCT03605836|12585549|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16
7998238|NCT03605836|12585550|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7
7998239|NCT03605836|12585547|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0
7998240|NCT03605836|12585548|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0
7998241|NCT03605836|12585549|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2
7998242|NCT03605836|12585550|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1
7998243|NCT03606460|12585583|FG000|Overall Study|Lost to Follow-up|1
7998244|NCT03606460|12585584|FG001|Overall Study|Lost to Follow-up|8
7998245|NCT03607682|12585600|FG000|Overall Study|Withdrawal by Subject|1
7998246|NCT03607682|12585600|FG000|Overall Study|Disease progression|1
7998247|NCT03607695|12585604|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1
7998248|NCT03607695|12585604|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2
7998249|NCT03608774|12585627|FG000|Overall Study|Lost to Follow-up|5
7998250|NCT03608774|12585628|FG001|Overall Study|Lost to Follow-up|5
7998251|NCT03608774|12585627|FG000|Overall Study|Withdrawal by Subject|1
7998252|NCT03608774|12585628|FG001|Overall Study|Withdrawal by Subject|0
7998253|NCT03608774|12585627|FG000|Overall Study|Protocol Violation|1
7998254|NCT03608774|12585628|FG001|Overall Study|Protocol Violation|0
7998255|NCT03608774|12585627|FG000|Overall Study|Not eligible at enrollment|0
7998256|NCT03608774|12585628|FG001|Overall Study|Not eligible at enrollment|1
7998257|NCT03608774|12585627|FG000|Overall Study|Health related event|0
7998258|NCT03608774|12585628|FG001|Overall Study|Health related event|1
7998259|NCT03609619|12585649|FG000|Overall Study|Adverse Event|1
7998260|NCT03609619|12585650|FG001|Overall Study|Adverse Event|0
7998261|NCT03609619|12585649|FG000|Overall Study|Lack of Efficacy|1
7998262|NCT03609619|12585650|FG001|Overall Study|Lack of Efficacy|2
7998263|NCT03609619|12585649|FG000|Overall Study|Protocol Violation|5
7998264|NCT03609619|12585650|FG001|Overall Study|Protocol Violation|0
7998265|NCT03609619|12585649|FG000|Overall Study|Withdrawal by Subject|2
7998266|NCT03609619|12585650|FG001|Overall Study|Withdrawal by Subject|3
7998267|NCT03609619|12585649|FG000|Overall Study|Lost to Follow-up|1
7998268|NCT03609619|12585650|FG001|Overall Study|Lost to Follow-up|1
7998269|NCT03610048|12585665|FG000|Overall Study|Study terminated by sponsor|84
7998270|NCT03610048|12585665|FG000|Overall Study|Adverse Event|32
7998271|NCT03610048|12585665|FG000|Overall Study|Withdrawal by Subject|31
7998272|NCT03610048|12585665|FG000|Overall Study|Lost to Follow-up|8
7998273|NCT03610048|12585665|FG000|Overall Study|Other|4
7998274|NCT03610048|12585665|FG000|Overall Study|Physician Decision|1
7998275|NCT03610048|12585665|FG000|Overall Study|Pregnancy|1
7998276|NCT03610165|12585671|FG000|Overall Study|Device didn't work|0
7998277|NCT03610165|12585672|FG001|Overall Study|Device didn't work|1
7998278|NCT03610269|12585678|FG000|Overall Study|Physician Decision|10
7998279|NCT03610269|12585678|FG000|Overall Study|Protocol Violation|1
7998280|NCT03610269|12585678|FG000|Overall Study|Unable to draw blood|1
7998281|NCT03610269|12585678|FG000|Overall Study|Screen fail|4
7998282|NCT03610581|12585702|FG000|Overall Study|Study terminated by sponsor|2
7998283|NCT03610581|12585703|FG001|Overall Study|Study terminated by sponsor|0
7998284|NCT03610581|12585702|FG000|Overall Study|Other|0
7998285|NCT03610581|12585703|FG001|Overall Study|Other|1
7998286|NCT03610581|12585702|FG000|Overall Study|Withdrawal by Subject|1
7998287|NCT03610581|12585703|FG001|Overall Study|Withdrawal by Subject|0
7998288|NCT03611582|12585729|FG000|Overall Study|Adverse Event|26
7998289|NCT03611582|12585730|FG001|Overall Study|Adverse Event|6
7998290|NCT03611582|12585729|FG000|Overall Study|Protocol Violation|0
7998291|NCT03611582|12585730|FG001|Overall Study|Protocol Violation|1
7998292|NCT03611582|12585729|FG000|Overall Study|Pregnancy|1
7998293|NCT03611582|12585730|FG001|Overall Study|Pregnancy|2
7998294|NCT03611582|12585729|FG000|Overall Study|Lack of Efficacy|0
7998295|NCT03611582|12585730|FG001|Overall Study|Lack of Efficacy|1
7998296|NCT03611582|12585729|FG000|Overall Study|At the discretion of the investigator|1
7998297|NCT03611582|12585730|FG001|Overall Study|At the discretion of the investigator|0
7998298|NCT03611582|12585729|FG000|Overall Study|Safety concern as judged by the investigator|1
7998299|NCT03611582|12585730|FG001|Overall Study|Safety concern as judged by the investigator|2
7998300|NCT03611582|12585729|FG000|Overall Study|Withdrawal by Subject|4
7998301|NCT03611582|12585730|FG001|Overall Study|Withdrawal by Subject|3
7998302|NCT03611582|12585729|FG000|Overall Study|Lost to Follow-up|18
7998303|NCT03611582|12585730|FG001|Overall Study|Lost to Follow-up|7
7998304|NCT03611582|12585729|FG000|Overall Study|other|17
7998305|NCT03611582|12585730|FG001|Overall Study|other|16
7998306|NCT03613129|12585762|FG000|Pre-treatment Assessment|Protocol Violation|2
7998307|NCT03613129|12585763|FG001|Pre-treatment Assessment|Protocol Violation|0
7998308|NCT03613129|12585764|FG002|Pre-treatment Assessment|Protocol Violation|0
7998309|NCT03613129|12585765|FG003|Pre-treatment Assessment|Protocol Violation|0
7998310|NCT03613129|12585766|FG004|Pre-treatment Assessment|Protocol Violation|0
7998311|NCT03613129|12585762|FG000|Pre-treatment Assessment|Withdrawal by Subject|1
7998312|NCT03613129|12585763|FG001|Pre-treatment Assessment|Withdrawal by Subject|0
7998313|NCT03613129|12585764|FG002|Pre-treatment Assessment|Withdrawal by Subject|0
7998314|NCT03613129|12585765|FG003|Pre-treatment Assessment|Withdrawal by Subject|0
7998315|NCT03613129|12585766|FG004|Pre-treatment Assessment|Withdrawal by Subject|0
7998316|NCT03613454|12585780|FG000|Overall Study|Protocol Violation|1
7998317|NCT03613454|12585781|FG001|Overall Study|Protocol Violation|0
7998318|NCT03613454|12585780|FG000|Overall Study|Protocol Violation|0
7998319|NCT03613454|12585781|FG001|Overall Study|Protocol Violation|1
7998320|NCT03613649|12585815|FG000|Second Treatment|Lost to Follow-up|0
7998321|NCT03613649|12585816|FG001|Second Treatment|Lost to Follow-up|0
7998322|NCT03613649|12585817|FG002|Second Treatment|Lost to Follow-up|1
7998323|NCT03613649|12585818|FG003|Second Treatment|Lost to Follow-up|0
7998324|NCT03613649|12585819|FG004|Second Treatment|Lost to Follow-up|0
7998325|NCT03613649|12585820|FG005|Second Treatment|Lost to Follow-up|0
7998326|NCT03613649|12585821|FG006|Second Treatment|Lost to Follow-up|0
7998327|NCT03613649|12585822|FG007|Second Treatment|Lost to Follow-up|0
7998328|NCT03613649|12585823|FG008|Second Treatment|Lost to Follow-up|0
7998329|NCT03613649|12585824|FG009|Second Treatment|Lost to Follow-up|0
7998330|NCT03613649|12585825|FG010|Second Treatment|Lost to Follow-up|0
7998331|NCT03613649|12585826|FG011|Second Treatment|Lost to Follow-up|0
7998332|NCT03613649|12585815|FG000|Second Treatment|Withdrawal by Subject|0
7998333|NCT03613649|12585816|FG001|Second Treatment|Withdrawal by Subject|0
7998334|NCT03613649|12585817|FG002|Second Treatment|Withdrawal by Subject|0
7998335|NCT03613649|12585818|FG003|Second Treatment|Withdrawal by Subject|0
7998336|NCT03613649|12585819|FG004|Second Treatment|Withdrawal by Subject|1
7998337|NCT03613649|12585820|FG005|Second Treatment|Withdrawal by Subject|0
7998338|NCT03613649|12585821|FG006|Second Treatment|Withdrawal by Subject|0
7998339|NCT03613649|12585822|FG007|Second Treatment|Withdrawal by Subject|0
7998340|NCT03613649|12585823|FG008|Second Treatment|Withdrawal by Subject|0
7998341|NCT03613649|12585824|FG009|Second Treatment|Withdrawal by Subject|0
7998342|NCT03613649|12585825|FG010|Second Treatment|Withdrawal by Subject|0
7998343|NCT03613649|12585826|FG011|Second Treatment|Withdrawal by Subject|0
7998344|NCT03613649|12585815|FG000|Third Treatment|Lost to Follow-up|0
7998345|NCT03613649|12585816|FG001|Third Treatment|Lost to Follow-up|0
7998346|NCT03613649|12585817|FG002|Third Treatment|Lost to Follow-up|0
7998347|NCT03613649|12585818|FG003|Third Treatment|Lost to Follow-up|0
7998348|NCT03613649|12585819|FG004|Third Treatment|Lost to Follow-up|1
7998349|NCT03613649|12585820|FG005|Third Treatment|Lost to Follow-up|0
7998350|NCT03613649|12585821|FG006|Third Treatment|Lost to Follow-up|0
7998351|NCT03613649|12585822|FG007|Third Treatment|Lost to Follow-up|0
7998352|NCT03613649|12585823|FG008|Third Treatment|Lost to Follow-up|0
7998353|NCT03613649|12585824|FG009|Third Treatment|Lost to Follow-up|0
7998354|NCT03613649|12585825|FG010|Third Treatment|Lost to Follow-up|0
7998355|NCT03613649|12585826|FG011|Third Treatment|Lost to Follow-up|1
7998356|NCT03613649|12585815|FG000|Third Treatment|Protocol Violation|0
7998357|NCT03613649|12585816|FG001|Third Treatment|Protocol Violation|0
7998358|NCT03613649|12585817|FG002|Third Treatment|Protocol Violation|0
7998359|NCT03613649|12585818|FG003|Third Treatment|Protocol Violation|0
7998360|NCT03613649|12585819|FG004|Third Treatment|Protocol Violation|0
7998361|NCT03613649|12585820|FG005|Third Treatment|Protocol Violation|0
7998362|NCT03613649|12585821|FG006|Third Treatment|Protocol Violation|1
7998363|NCT03613649|12585822|FG007|Third Treatment|Protocol Violation|0
7998364|NCT03613649|12585823|FG008|Third Treatment|Protocol Violation|0
7998365|NCT03613649|12585824|FG009|Third Treatment|Protocol Violation|0
7998366|NCT03613649|12585825|FG010|Third Treatment|Protocol Violation|0
7998367|NCT03613649|12585826|FG011|Third Treatment|Protocol Violation|1
7998368|NCT03613649|12585815|FG000|Fourth Treatment|Protocol Violation|1
7998369|NCT03613649|12585816|FG001|Fourth Treatment|Protocol Violation|0
7998370|NCT03613649|12585817|FG002|Fourth Treatment|Protocol Violation|0
7998371|NCT03613649|12585818|FG003|Fourth Treatment|Protocol Violation|0
7998372|NCT03613649|12585819|FG004|Fourth Treatment|Protocol Violation|1
7998373|NCT03613649|12585820|FG005|Fourth Treatment|Protocol Violation|0
7998374|NCT03613649|12585821|FG006|Fourth Treatment|Protocol Violation|0
7998375|NCT03613649|12585822|FG007|Fourth Treatment|Protocol Violation|0
7998376|NCT03613649|12585823|FG008|Fourth Treatment|Protocol Violation|0
7998377|NCT03613649|12585824|FG009|Fourth Treatment|Protocol Violation|0
7998378|NCT03613649|12585825|FG010|Fourth Treatment|Protocol Violation|0
7998379|NCT03613649|12585826|FG011|Fourth Treatment|Protocol Violation|0
7998380|NCT03613649|12585815|FG000|Fourth Treatment|Physician Decision|0
7998381|NCT03613649|12585816|FG001|Fourth Treatment|Physician Decision|0
7998382|NCT03613649|12585817|FG002|Fourth Treatment|Physician Decision|0
7998383|NCT03613649|12585818|FG003|Fourth Treatment|Physician Decision|0
7998384|NCT03613649|12585819|FG004|Fourth Treatment|Physician Decision|0
7998385|NCT03613649|12585820|FG005|Fourth Treatment|Physician Decision|0
7998386|NCT03613649|12585821|FG006|Fourth Treatment|Physician Decision|1
7998387|NCT03613649|12585822|FG007|Fourth Treatment|Physician Decision|0
7998388|NCT03613649|12585823|FG008|Fourth Treatment|Physician Decision|0
7998389|NCT03613649|12585824|FG009|Fourth Treatment|Physician Decision|0
7998390|NCT03613649|12585825|FG010|Fourth Treatment|Physician Decision|0
7998391|NCT03613649|12585826|FG011|Fourth Treatment|Physician Decision|0
7998392|NCT03614078|12585856|FG000|Overall Study|Withdrawal by Subject|2
7998393|NCT03614078|12585857|FG001|Overall Study|Withdrawal by Subject|2
7998394|NCT03614078|12585858|FG002|Overall Study|Withdrawal by Subject|3
7998395|NCT03614078|12585856|FG000|Overall Study|Participant Did Not Return for Visit|0
7998396|NCT03614078|12585857|FG001|Overall Study|Participant Did Not Return for Visit|1
7998397|NCT03614078|12585858|FG002|Overall Study|Participant Did Not Return for Visit|0
7998398|NCT03614078|12585856|FG000|Overall Study|High Neutrophils|0
7998399|NCT03614078|12585857|FG001|Overall Study|High Neutrophils|0
7998400|NCT03614078|12585858|FG002|Overall Study|High Neutrophils|2
7998401|NCT03614078|12585856|FG000|Overall Study|Patient Did Not Meet Eligibility|1
7998402|NCT03614078|12585857|FG001|Overall Study|Patient Did Not Meet Eligibility|0
7998403|NCT03614078|12585858|FG002|Overall Study|Patient Did Not Meet Eligibility|0
7998404|NCT03614078|12585856|FG000|Overall Study|Exacerbation of Psoriasis|0
7998405|NCT03614078|12585857|FG001|Overall Study|Exacerbation of Psoriasis|1
7998406|NCT03614078|12585858|FG002|Overall Study|Exacerbation of Psoriasis|0
7998407|NCT03614078|12585856|FG000|Overall Study|Adverse Event|0
7998408|NCT03614078|12585857|FG001|Overall Study|Adverse Event|2
7998409|NCT03614078|12585858|FG002|Overall Study|Adverse Event|0
7998410|NCT03614078|12585856|FG000|Overall Study|Dizziness and Rash|0
7998411|NCT03614078|12585857|FG001|Overall Study|Dizziness and Rash|1
7998412|NCT03614078|12585858|FG002|Overall Study|Dizziness and Rash|0
7998413|NCT03614156|12585880|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6
7998414|NCT03614156|12585881|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0
7998415|NCT03614156|12585882|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0
7998416|NCT03614156|12585883|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0
7998417|NCT03614156|12585880|FG000|Open-Label Treatment Period|Adverse Event|7
7998418|NCT03614156|12585881|FG001|Open-Label Treatment Period|Adverse Event|0
7998419|NCT03614156|12585882|FG002|Open-Label Treatment Period|Adverse Event|0
7998420|NCT03614156|12585883|FG003|Open-Label Treatment Period|Adverse Event|0
7998421|NCT03614156|12585880|FG000|Open-Label Treatment Period|Lack of Efficacy|18
7998422|NCT03614156|12585881|FG001|Open-Label Treatment Period|Lack of Efficacy|0
7998423|NCT03614156|12585882|FG002|Open-Label Treatment Period|Lack of Efficacy|0
7998424|NCT03614156|12585883|FG003|Open-Label Treatment Period|Lack of Efficacy|0
7998425|NCT03614156|12585880|FG000|Open-Label Treatment Period|Withdrawal by Subject|36
7998426|NCT03614156|12585881|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
7998427|NCT03614156|12585882|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
7998428|NCT03614156|12585883|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
7998429|NCT03614156|12585880|FG000|Open-Label Treatment Period|Lost to Follow-up|10
7998430|NCT03614156|12585881|FG001|Open-Label Treatment Period|Lost to Follow-up|0
7998431|NCT03614156|12585882|FG002|Open-Label Treatment Period|Lost to Follow-up|0
7998432|NCT03614156|12585883|FG003|Open-Label Treatment Period|Lost to Follow-up|0
7998433|NCT03614156|12585880|FG000|Open-Label Treatment Period|Protocol Violation|2
7998434|NCT03614156|12585881|FG001|Open-Label Treatment Period|Protocol Violation|0
7998435|NCT03614156|12585882|FG002|Open-Label Treatment Period|Protocol Violation|0
7998436|NCT03614156|12585883|FG003|Open-Label Treatment Period|Protocol Violation|0
7998437|NCT03614156|12585880|FG000|Open-Label Treatment Period|Non-compliance with study drug|1
7998438|NCT03614156|12585881|FG001|Open-Label Treatment Period|Non-compliance with study drug|0
7998439|NCT03614156|12585882|FG002|Open-Label Treatment Period|Non-compliance with study drug|0
7998440|NCT03614156|12585883|FG003|Open-Label Treatment Period|Non-compliance with study drug|0
7998441|NCT03614156|12585880|FG000|Open-Label Treatment Period|Study terminated by sponsor|74
7998442|NCT03614156|12585881|FG001|Open-Label Treatment Period|Study terminated by sponsor|0
7998443|NCT03614156|12585882|FG002|Open-Label Treatment Period|Study terminated by sponsor|0
7998444|NCT03614156|12585883|FG003|Open-Label Treatment Period|Study terminated by sponsor|0
7998445|NCT03614156|12585880|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0
7998446|NCT03614156|12585881|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2
7998447|NCT03614156|12585882|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0
7998448|NCT03614156|12585883|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1
7998449|NCT03614156|12585880|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0
7998450|NCT03614156|12585881|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4
7998451|NCT03614156|12585882|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
7998452|NCT03614156|12585883|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
7998453|NCT03614156|12585880|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
7998454|NCT03614156|12585881|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
7998455|NCT03614156|12585882|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3
7998456|NCT03614156|12585883|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4
7998457|NCT03614156|12585880|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0
7998458|NCT03614156|12585881|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
7998459|NCT03614156|12585882|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
7998460|NCT03614156|12585883|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
7998461|NCT03614156|12585880|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0
7998462|NCT03614156|12585881|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22
7998463|NCT03614156|12585882|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26
7998464|NCT03614156|12585883|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38
7998465|NCT03614156|12585880|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
7998466|NCT03614156|12585881|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1
7998467|NCT03614156|12585882|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
7998468|NCT03614156|12585883|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
7998469|NCT03614156|12585880|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2
7998470|NCT03614156|12585881|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0
7998471|NCT03614156|12585882|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0
7998472|NCT03614156|12585883|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0
7998473|NCT03614156|12585880|FG000|Safety Follow-Up Period|Withdrawal by Subject|0
7998474|NCT03614156|12585881|FG001|Safety Follow-Up Period|Withdrawal by Subject|0
7998475|NCT03614156|12585882|FG002|Safety Follow-Up Period|Withdrawal by Subject|1
7998476|NCT03614156|12585883|FG003|Safety Follow-Up Period|Withdrawal by Subject|0
7998477|NCT03614156|12585880|FG000|Safety Follow-Up Period|Lost to Follow-up|1
7998478|NCT03614156|12585881|FG001|Safety Follow-Up Period|Lost to Follow-up|0
7998479|NCT03614156|12585882|FG002|Safety Follow-Up Period|Lost to Follow-up|0
7998480|NCT03614156|12585883|FG003|Safety Follow-Up Period|Lost to Follow-up|1
7998481|NCT03614975|12585900|FG000|Overall Study|Physician Decision|7
7998482|NCT03614975|12585901|FG001|Overall Study|Physician Decision|5
7998483|NCT03614975|12585900|FG000|Overall Study|Withdrawal by Subject|2
7998484|NCT03614975|12585901|FG001|Overall Study|Withdrawal by Subject|2
7998485|NCT03614975|12585900|FG000|Overall Study|Specimens not in lab batch shipment|1
7998486|NCT03614975|12585901|FG001|Overall Study|Specimens not in lab batch shipment|1
7998487|NCT03615404|12585932|FG000|Overall Study|Death|1
7998488|NCT03615404|12585932|FG000|Overall Study|vaccine did not pass quality assurance|1
7998489|NCT03615924|12585975|FG000|Overall Study|Withdrawal by Subject|2
7998490|NCT03615924|12585976|FG001|Overall Study|Withdrawal by Subject|5
7998491|NCT03615924|12585975|FG000|Overall Study|Death|3
7998492|NCT03615924|12585976|FG001|Overall Study|Death|1
7998493|NCT03615924|12585975|FG000|Overall Study|Lost to Follow-up|1
7998494|NCT03615924|12585976|FG001|Overall Study|Lost to Follow-up|0
7998495|NCT03615924|12585975|FG000|Overall Study|Randomized in error|1
7998496|NCT03615924|12585976|FG001|Overall Study|Randomized in error|0
7998497|NCT03615924|12585975|FG000|Overall Study|Study termination by Sponsor|94
7998498|NCT03615924|12585976|FG001|Overall Study|Study termination by Sponsor|86
7998499|NCT03616106|12585984|FG000|Overall Study|Removed by PI|6
7998500|NCT03616106|12585985|FG001|Overall Study|Removed by PI|0
7998501|NCT03616106|12585984|FG000|Overall Study|Withdrawal by Subject|1
7998502|NCT03616106|12585985|FG001|Overall Study|Withdrawal by Subject|1
7998503|NCT03616106|12585984|FG000|Overall Study|Lost to Follow-up|7
7998504|NCT03616106|12585985|FG001|Overall Study|Lost to Follow-up|0
7998505|NCT03616600|12586002|FG000|Overall Study|Withdrawal by Subject|1
7998506|NCT03616600|12586003|FG001|Overall Study|Withdrawal by Subject|0
7998507|NCT03616977|12586019|FG000|Period 1|Physician Decision|0
7998508|NCT03616977|12586020|FG001|Period 1|Physician Decision|1
7998509|NCT03616977|12586019|FG000|Period 3|Adverse Event|1
7998510|NCT03616977|12586020|FG001|Period 3|Adverse Event|1
7998511|NCT03617588|12586033|FG000|Overall Study|Withdrawal by Subject|1
7998512|NCT03617588|12586034|FG001|Overall Study|Withdrawal by Subject|0
7998513|NCT03617770|12586046|FG000|Overall Study|Lost to Follow-up|1
7998514|NCT03617770|12586047|FG001|Overall Study|Lost to Follow-up|0
7998515|NCT03617861|12586055|FG000|Second Intervention (1 Day)|Adverse Event|0
7998516|NCT03617861|12586056|FG001|Second Intervention (1 Day)|Adverse Event|0
7998517|NCT03617861|12586057|FG002|Second Intervention (1 Day)|Adverse Event|1
7998518|NCT03617861|12586058|FG003|Second Intervention (1 Day)|Adverse Event|0
7998519|NCT03618628|12586110|FG000|Overall Study|Death|1
7998520|NCT03618628|12586110|FG000|Overall Study|Lost to Follow-up|1
7998521|NCT03618823|12586116|FG000|Overall Study|Lost to Follow-up|63
7998522|NCT03618823|12586117|FG001|Overall Study|Lost to Follow-up|61
7998523|NCT03619837|12586143|FG000|Screening|received organs from HCV-negative donors|47
7998524|NCT03619837|12586143|FG000|Screening|died on the wait-list|2
7998525|NCT03619837|12586143|FG000|Screening|remained on the wait list|40
7998526|NCT03619837|12586143|FG000|Screening|didn't meet eligibility criteria|3
7998527|NCT03619837|12586143|FG000|Screening|withdrew consent|2
7998528|NCT03619837|12586143|FG000|Screening|never listed for HCV-viremic donor|1
7998529|NCT03619837|12586143|FG000|Screening|developed exclusion criteria|2
7998530|NCT03619837|12586143|FG000|Screening|excluded by the investigator due to non-compliance|1
7998531|NCT03620162|12586161|FG000|Overall Study|Physician Decision|4
7998532|NCT03620162|12586162|FG001|Overall Study|Physician Decision|0
7998533|NCT03620162|12586163|FG002|Overall Study|Physician Decision|1
7998534|NCT03620162|12586164|FG003|Overall Study|Physician Decision|0
7998535|NCT03620162|12586165|FG004|Overall Study|Physician Decision|2
7998536|NCT03620162|12586161|FG000|Overall Study|Lost to Follow-up|2
7998537|NCT03620162|12586162|FG001|Overall Study|Lost to Follow-up|6
7998538|NCT03620162|12586163|FG002|Overall Study|Lost to Follow-up|7
7998539|NCT03620162|12586164|FG003|Overall Study|Lost to Follow-up|3
7998540|NCT03620162|12586165|FG004|Overall Study|Lost to Follow-up|2
7998541|NCT03620162|12586161|FG000|Overall Study|Consent withdrawn by parent/guardian|9
7998542|NCT03620162|12586162|FG001|Overall Study|Consent withdrawn by parent/guardian|8
7998543|NCT03620162|12586163|FG002|Overall Study|Consent withdrawn by parent/guardian|25
7998544|NCT03620162|12586164|FG003|Overall Study|Consent withdrawn by parent/guardian|17
7998545|NCT03620162|12586165|FG004|Overall Study|Consent withdrawn by parent/guardian|9
7998546|NCT03620708|12586191|FG000|Overall Study|Lost to Follow-up|1
7998547|NCT03620708|12586192|FG001|Overall Study|Lost to Follow-up|1
7998548|NCT03620708|12586193|FG002|Overall Study|Lost to Follow-up|2
7998549|NCT03620708|12586191|FG000|Overall Study|Withdrawal by Subject|0
7998550|NCT03620708|12586192|FG001|Overall Study|Withdrawal by Subject|0
7998551|NCT03620708|12586193|FG002|Overall Study|Withdrawal by Subject|1
7998552|NCT03621189|12586219|FG000|Overall Study|Withdrawal by Subject|0
7998553|NCT03621189|12586220|FG001|Overall Study|Withdrawal by Subject|3
7998554|NCT03621189|12586219|FG000|Overall Study|Physician Decision|0
7998555|NCT03621189|12586220|FG001|Overall Study|Physician Decision|2
7998556|NCT03622112|12586255|FG000|Overall Study|Withdrawal by Subject|6
7998557|NCT03622112|12586256|FG001|Overall Study|Withdrawal by Subject|2
7998558|NCT03622112|12586257|FG002|Overall Study|Withdrawal by Subject|4
7998559|NCT03622112|12586258|FG003|Overall Study|Withdrawal by Subject|2
7998560|NCT03622112|12586259|FG004|Overall Study|Withdrawal by Subject|1
7998561|NCT03622112|12586260|FG005|Overall Study|Withdrawal by Subject|2
7998562|NCT03622112|12586261|FG006|Overall Study|Withdrawal by Subject|2
7998563|NCT03622112|12586255|FG000|Overall Study|Death|0
7998564|NCT03622112|12586256|FG001|Overall Study|Death|0
7998565|NCT03622112|12586257|FG002|Overall Study|Death|0
7998566|NCT03622112|12586258|FG003|Overall Study|Death|1
7998567|NCT03622112|12586259|FG004|Overall Study|Death|0
7998568|NCT03622112|12586260|FG005|Overall Study|Death|0
7998569|NCT03622112|12586261|FG006|Overall Study|Death|0
7998570|NCT03622112|12586255|FG000|Overall Study|Lost to Follow-up|1
7998571|NCT03622112|12586256|FG001|Overall Study|Lost to Follow-up|1
7998572|NCT03622112|12586257|FG002|Overall Study|Lost to Follow-up|0
7998573|NCT03622112|12586258|FG003|Overall Study|Lost to Follow-up|0
7998574|NCT03622112|12586259|FG004|Overall Study|Lost to Follow-up|0
7998575|NCT03622112|12586260|FG005|Overall Study|Lost to Follow-up|0
7998576|NCT03622112|12586261|FG006|Overall Study|Lost to Follow-up|0
7998577|NCT03622112|12586255|FG000|Overall Study|Study-specific withdrawal criteria|10
7998578|NCT03622112|12586256|FG001|Overall Study|Study-specific withdrawal criteria|8
7998579|NCT03622112|12586257|FG002|Overall Study|Study-specific withdrawal criteria|7
7998580|NCT03622112|12586258|FG003|Overall Study|Study-specific withdrawal criteria|6
7998581|NCT03622112|12586259|FG004|Overall Study|Study-specific withdrawal criteria|4
7998582|NCT03622112|12586260|FG005|Overall Study|Study-specific withdrawal criteria|18
7998583|NCT03622112|12586261|FG006|Overall Study|Study-specific withdrawal criteria|4
7998584|NCT03622112|12586255|FG000|Overall Study|Protocol Violation|2
7998585|NCT03622112|12586256|FG001|Overall Study|Protocol Violation|0
7998586|NCT03622112|12586257|FG002|Overall Study|Protocol Violation|1
7998587|NCT03622112|12586258|FG003|Overall Study|Protocol Violation|1
7998588|NCT03622112|12586259|FG004|Overall Study|Protocol Violation|0
7998589|NCT03622112|12586260|FG005|Overall Study|Protocol Violation|0
7998590|NCT03622112|12586261|FG006|Overall Study|Protocol Violation|0
7998591|NCT03622112|12586255|FG000|Overall Study|Adverse Event|6
7998592|NCT03622112|12586256|FG001|Overall Study|Adverse Event|8
7998593|NCT03622112|12586257|FG002|Overall Study|Adverse Event|4
7998594|NCT03622112|12586258|FG003|Overall Study|Adverse Event|11
7998595|NCT03622112|12586259|FG004|Overall Study|Adverse Event|4
7998596|NCT03622112|12586260|FG005|Overall Study|Adverse Event|20
7998597|NCT03622112|12586261|FG006|Overall Study|Adverse Event|2
7998598|NCT03622112|12586255|FG000|Overall Study|Reason not specified|0
7998599|NCT03622112|12586256|FG001|Overall Study|Reason not specified|1
7998600|NCT03622112|12586257|FG002|Overall Study|Reason not specified|0
7998601|NCT03622112|12586258|FG003|Overall Study|Reason not specified|1
7998602|NCT03622112|12586259|FG004|Overall Study|Reason not specified|1
7998603|NCT03622112|12586260|FG005|Overall Study|Reason not specified|2
7998604|NCT03622112|12586261|FG006|Overall Study|Reason not specified|1
7998605|NCT03624192|12586314|FG000|Overall Study|Lost to Follow-up|1
7998606|NCT03624192|12586315|FG001|Overall Study|Lost to Follow-up|1
7998607|NCT03624504|12586323|FG000|Overall Study|Unsuccessful Implant|1
7998608|NCT03624946|12586348|FG000|Overall Study|Lost to Follow-up|0
7998609|NCT03624946|12586349|FG001|Overall Study|Lost to Follow-up|1
7998610|NCT03624972|12586362|FG000|Overall Study|Lost to Follow-up|2
7998611|NCT03624972|12586363|FG001|Overall Study|Lost to Follow-up|0
7998612|NCT03624972|12586364|FG002|Overall Study|Lost to Follow-up|0
7998613|NCT03624972|12586362|FG000|Overall Study|Withdrawal by Subject|0
7998614|NCT03624972|12586363|FG001|Overall Study|Withdrawal by Subject|2
7998615|NCT03624972|12586364|FG002|Overall Study|Withdrawal by Subject|0
7998616|NCT03627065|12586399|FG000|Overall Study|Study Terminated by sponsor|1
7998617|NCT03627065|12586399|FG000|Overall Study|Withdrawal by Subject|2
7998618|NCT03627195|12586409|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1
7998619|NCT03627195|12586410|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0
7998620|NCT03627195|12586411|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0
7998621|NCT03627195|12586412|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0
7998622|NCT03627195|12586413|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0
7998623|NCT03627195|12586414|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0
7998624|NCT03627416|12586434|FG000|Overall Study|Adverse Event|0
7998625|NCT03627416|12586435|FG001|Overall Study|Adverse Event|1
7998626|NCT03627494|12586453|FG000|Part A Washout 2 (7 Days)|Adverse Event|1
7998627|NCT03627494|12586454|FG001|Part A Washout 2 (7 Days)|Adverse Event|0
7998628|NCT03627494|12586455|FG002|Part A Washout 2 (7 Days)|Adverse Event|1
7998629|NCT03627494|12586456|FG003|Part A Washout 2 (7 Days)|Adverse Event|0
7998630|NCT03627494|12586457|FG004|Part A Washout 2 (7 Days)|Adverse Event|0
7998631|NCT03627494|12586458|FG005|Part A Washout 2 (7 Days)|Adverse Event|0
7998632|NCT03627494|12586459|FG006|Part A Washout 2 (7 Days)|Adverse Event|0
7998633|NCT03627494|12586460|FG007|Part A Washout 2 (7 Days)|Adverse Event|0
7998634|NCT03627494|12586461|FG008|Part A Washout 2 (7 Days)|Adverse Event|0
7998635|NCT03627494|12586462|FG009|Part A Washout 2 (7 Days)|Adverse Event|0
7998636|NCT03627494|12586463|FG010|Part A Washout 2 (7 Days)|Adverse Event|0
7998637|NCT03627494|12586464|FG011|Part A Washout 2 (7 Days)|Adverse Event|0
7998638|NCT03627494|12586453|FG000|Part B (Maximum of 34 Days)|Adverse Event|0
7998639|NCT03627494|12586454|FG001|Part B (Maximum of 34 Days)|Adverse Event|0
7998640|NCT03627494|12586455|FG002|Part B (Maximum of 34 Days)|Adverse Event|0
7998641|NCT03627494|12586456|FG003|Part B (Maximum of 34 Days)|Adverse Event|0
7998642|NCT03627494|12586457|FG004|Part B (Maximum of 34 Days)|Adverse Event|0
7998643|NCT03627494|12586458|FG005|Part B (Maximum of 34 Days)|Adverse Event|0
7998644|NCT03627494|12586459|FG006|Part B (Maximum of 34 Days)|Adverse Event|0
7998645|NCT03627494|12586460|FG007|Part B (Maximum of 34 Days)|Adverse Event|0
7998646|NCT03627494|12586461|FG008|Part B (Maximum of 34 Days)|Adverse Event|2
7998647|NCT03627494|12586462|FG009|Part B (Maximum of 34 Days)|Adverse Event|0
7998648|NCT03627494|12586463|FG010|Part B (Maximum of 34 Days)|Adverse Event|0
7998649|NCT03627494|12586464|FG011|Part B (Maximum of 34 Days)|Adverse Event|0
7998650|NCT03627494|12586453|FG000|Part C Washout 1 (7 Days)|Adverse Event|0
7998651|NCT03627494|12586454|FG001|Part C Washout 1 (7 Days)|Adverse Event|0
7998652|NCT03627494|12586455|FG002|Part C Washout 1 (7 Days)|Adverse Event|0
7998653|NCT03627494|12586456|FG003|Part C Washout 1 (7 Days)|Adverse Event|0
7998654|NCT03627494|12586457|FG004|Part C Washout 1 (7 Days)|Adverse Event|0
7998655|NCT03627494|12586458|FG005|Part C Washout 1 (7 Days)|Adverse Event|0
7998656|NCT03627494|12586459|FG006|Part C Washout 1 (7 Days)|Adverse Event|0
7998657|NCT03627494|12586460|FG007|Part C Washout 1 (7 Days)|Adverse Event|0
7998658|NCT03627494|12586461|FG008|Part C Washout 1 (7 Days)|Adverse Event|0
7998659|NCT03627494|12586462|FG009|Part C Washout 1 (7 Days)|Adverse Event|0
7998660|NCT03627494|12586463|FG010|Part C Washout 1 (7 Days)|Adverse Event|1
7998661|NCT03627494|12586464|FG011|Part C Washout 1 (7 Days)|Adverse Event|1
7998662|NCT03627767|12586506|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48
7998663|NCT03627767|12586507|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7998664|NCT03627767|12586508|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7998665|NCT03627767|12586509|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7998666|NCT03627767|12586510|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7998667|NCT03627767|12586506|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1
7998668|NCT03627767|12586507|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0
7998669|NCT03627767|12586508|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0
7998670|NCT03627767|12586509|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0
7998671|NCT03627767|12586510|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0
7998672|NCT03627767|12586506|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315
7998673|NCT03627767|12586507|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7998674|NCT03627767|12586508|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7998675|NCT03627767|12586509|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7998676|NCT03627767|12586510|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7998677|NCT03627767|12586506|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13
7998678|NCT03627767|12586507|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7998679|NCT03627767|12586508|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7998680|NCT03627767|12586509|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7998681|NCT03627767|12586510|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7998682|NCT03627767|12586506|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11
7998683|NCT03627767|12586507|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7998684|NCT03627767|12586508|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7998685|NCT03627767|12586509|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7998686|NCT03627767|12586510|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7998687|NCT03627767|12586506|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40
7998688|NCT03627767|12586507|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7998689|NCT03627767|12586508|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7998690|NCT03627767|12586509|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7998691|NCT03627767|12586510|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7998692|NCT03627767|12586506|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1
7998693|NCT03627767|12586507|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7998694|NCT03627767|12586508|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7998695|NCT03627767|12586509|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7998696|NCT03627767|12586510|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7998697|NCT03627767|12586506|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2
7998698|NCT03627767|12586507|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7998699|NCT03627767|12586508|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7998700|NCT03627767|12586509|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7998701|NCT03627767|12586510|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7998702|NCT03627767|12586506|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4
7998703|NCT03627767|12586507|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7998704|NCT03627767|12586508|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7998705|NCT03627767|12586509|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7998706|NCT03627767|12586510|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7998707|NCT03627767|12586506|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2
7998708|NCT03627767|12586507|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7998709|NCT03627767|12586508|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7998710|NCT03627767|12586509|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7998711|NCT03627767|12586510|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7998712|NCT03627767|12586506|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0
7998713|NCT03627767|12586507|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6
7998714|NCT03627767|12586508|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7
7998715|NCT03627767|12586509|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19
7998716|NCT03627767|12586510|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0
7998717|NCT03627767|12586506|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
7998718|NCT03627767|12586507|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
7998719|NCT03627767|12586508|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2
7998720|NCT03627767|12586509|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3
7998721|NCT03627767|12586510|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
7998722|NCT03627767|12586506|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0
7998723|NCT03627767|12586507|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1
7998724|NCT03627767|12586508|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5
7998725|NCT03627767|12586509|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2
7998726|NCT03627767|12586510|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0
7998727|NCT03627767|12586506|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0
7998728|NCT03627767|12586507|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9
7998729|NCT03627767|12586508|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6
7998730|NCT03627767|12586509|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10
7998731|NCT03627767|12586510|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0
7998732|NCT03627767|12586506|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7998733|NCT03627767|12586507|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7998734|NCT03627767|12586508|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1
7998735|NCT03627767|12586509|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7998736|NCT03627767|12586510|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7998737|NCT03627767|12586506|FG000|Double-blind Treatment Period (40 Weeks)|Other|0
7998738|NCT03627767|12586507|FG001|Double-blind Treatment Period (40 Weeks)|Other|0
7998739|NCT03627767|12586508|FG002|Double-blind Treatment Period (40 Weeks)|Other|1
7998740|NCT03627767|12586509|FG003|Double-blind Treatment Period (40 Weeks)|Other|1
7998741|NCT03627767|12586510|FG004|Double-blind Treatment Period (40 Weeks)|Other|0
7998742|NCT03627767|12586506|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7998743|NCT03627767|12586507|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7998744|NCT03627767|12586508|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7998745|NCT03627767|12586509|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7998746|NCT03627767|12586510|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9
7998747|NCT03627767|12586506|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7998748|NCT03627767|12586507|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7998749|NCT03627767|12586508|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7998750|NCT03627767|12586509|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7998751|NCT03627767|12586510|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1
7998752|NCT03627767|12586506|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7998753|NCT03627767|12586507|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7998754|NCT03627767|12586508|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7998755|NCT03627767|12586509|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7998756|NCT03627767|12586510|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9
7998757|NCT03627767|12586506|FG000|Open-label Rescue Period (12 Weeks)|Other|0
7998758|NCT03627767|12586507|FG001|Open-label Rescue Period (12 Weeks)|Other|0
7998759|NCT03627767|12586508|FG002|Open-label Rescue Period (12 Weeks)|Other|0
7998760|NCT03627767|12586509|FG003|Open-label Rescue Period (12 Weeks)|Other|0
7998761|NCT03627767|12586510|FG004|Open-label Rescue Period (12 Weeks)|Other|1
7998762|NCT03627832|12586523|FG000|Overall Study|Withdrawal by Subject|10
7998763|NCT03627832|12586524|FG001|Overall Study|Withdrawal by Subject|1
7998764|NCT03628417|12586530|FG000|Overall Study|Death|1
7998765|NCT03628417|12586531|FG001|Overall Study|Death|1
7998766|NCT03628508|12586549|FG000|Overall Study|Lost to Follow-up|1
7998767|NCT03628599|12586555|FG000|Overall Study|Adverse Event|0
7998768|NCT03628599|12586556|FG001|Overall Study|Adverse Event|1
7998769|NCT03628898|12586579|FG000|Overall Study|Device deficiency|1
7998770|NCT03628924|12586586|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2
7998771|NCT03628924|12586587|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7998772|NCT03628924|12586588|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7998773|NCT03628924|12586589|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7998774|NCT03628924|12586590|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7998775|NCT03628924|12586591|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7998776|NCT03628924|12586592|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7998777|NCT03628924|12586586|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7998778|NCT03628924|12586587|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7998779|NCT03628924|12586588|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
7998780|NCT03628924|12586589|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7998781|NCT03628924|12586590|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7998782|NCT03628924|12586591|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7998783|NCT03628924|12586592|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7998784|NCT03628924|12586586|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1
7998785|NCT03628924|12586587|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2
7998786|NCT03628924|12586588|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1
7998787|NCT03628924|12586589|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7998788|NCT03628924|12586590|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7998789|NCT03628924|12586591|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7998790|NCT03628924|12586592|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7998791|NCT03628924|12586586|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7998792|NCT03628924|12586587|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
7998793|NCT03628924|12586588|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7998794|NCT03628924|12586589|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7998795|NCT03628924|12586590|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7998796|NCT03628924|12586591|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7998797|NCT03628924|12586592|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7998798|NCT03628924|12586586|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3
7998799|NCT03628924|12586587|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7998800|NCT03628924|12586588|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1
7998801|NCT03628924|12586589|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7998802|NCT03628924|12586590|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7998803|NCT03628924|12586591|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7998804|NCT03628924|12586592|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7998805|NCT03628924|12586586|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
7998806|NCT03628924|12586587|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
7998807|NCT03628924|12586588|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
7998808|NCT03628924|12586589|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
7998809|NCT03628924|12586590|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
7998810|NCT03628924|12586591|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2
7998811|NCT03628924|12586592|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
7998812|NCT03628924|12586586|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0
7998813|NCT03628924|12586587|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0
7998814|NCT03628924|12586588|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0
7998815|NCT03628924|12586589|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1
7998816|NCT03628924|12586590|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0
7998817|NCT03628924|12586591|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2
7998818|NCT03628924|12586592|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4
7998819|NCT03628924|12586586|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0
7998820|NCT03628924|12586587|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0
7998821|NCT03628924|12586588|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0
7998822|NCT03628924|12586589|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1
7998823|NCT03628924|12586590|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1
7998824|NCT03628924|12586591|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0
7998825|NCT03628924|12586592|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1
7998826|NCT03628924|12586586|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
7998827|NCT03628924|12586587|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
7998828|NCT03628924|12586588|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
7998829|NCT03628924|12586589|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5
7998830|NCT03628924|12586590|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1
7998831|NCT03628924|12586591|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4
7998832|NCT03628924|12586592|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2
7998833|NCT03628924|12586586|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7998834|NCT03628924|12586587|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7998835|NCT03628924|12586588|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7998836|NCT03628924|12586589|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7998837|NCT03628924|12586590|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1
7998838|NCT03628924|12586591|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5
7998839|NCT03628924|12586592|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3
7998840|NCT03629028|12586606|FG000|Overall Study|Lost to Follow-up|26
7998841|NCT03629028|12586607|FG001|Overall Study|Lost to Follow-up|23
7998842|NCT03629028|12586606|FG000|Overall Study|Pregnancy|4
7998843|NCT03629028|12586607|FG001|Overall Study|Pregnancy|2
7998844|NCT03629028|12586606|FG000|Overall Study|intolerance to examination|2
7998845|NCT03629028|12586607|FG001|Overall Study|intolerance to examination|0
7998846|NCT03629041|12586623|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
7998847|NCT03629041|12586624|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1
7998848|NCT03629041|12586625|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
7998849|NCT03629041|12586626|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
7998850|NCT03629054|12586646|FG000|Period 2 (4 Days)|Not treated|0
7998851|NCT03629054|12586647|FG001|Period 2 (4 Days)|Not treated|1
7998852|NCT03629184|12586655|FG000|Overall Study|Withdrawal by Subject|2
7998853|NCT03629184|12586656|FG001|Overall Study|Withdrawal by Subject|1
7998854|NCT03629184|12586655|FG000|Overall Study|Physician Decision|1
7998855|NCT03629184|12586656|FG001|Overall Study|Physician Decision|0
7998856|NCT03629249|12586665|FG000|Overall Study|Study terminated by sponsor|197
7998857|NCT03629249|12586666|FG001|Overall Study|Study terminated by sponsor|197
7998858|NCT03629249|12586667|FG002|Overall Study|Study terminated by sponsor|194
7998859|NCT03629249|12586665|FG000|Overall Study|Protocol deviation|0
7998860|NCT03629249|12586666|FG001|Overall Study|Protocol deviation|2
7998861|NCT03629249|12586667|FG002|Overall Study|Protocol deviation|5
7998862|NCT03629249|12586665|FG000|Overall Study|Subject decision|1
7998863|NCT03629249|12586666|FG001|Overall Study|Subject decision|1
7998864|NCT03629249|12586667|FG002|Overall Study|Subject decision|3
7998865|NCT03629249|12586665|FG000|Overall Study|Adverse Event|1
7998866|NCT03629249|12586666|FG001|Overall Study|Adverse Event|1
7998867|NCT03629249|12586667|FG002|Overall Study|Adverse Event|0
7998868|NCT03629249|12586665|FG000|Overall Study|Death|1
7998869|NCT03629249|12586666|FG001|Overall Study|Death|0
7998870|NCT03629249|12586667|FG002|Overall Study|Death|0
7998871|NCT03629249|12586665|FG000|Overall Study|Physician Decision|1
7998872|NCT03629249|12586666|FG001|Overall Study|Physician Decision|0
7998873|NCT03629249|12586667|FG002|Overall Study|Physician Decision|0
7998874|NCT03629886|12586681|FG000|Overall Study|Migrated / moved from the study area|0
7998875|NCT03629886|12586682|FG001|Overall Study|Migrated / moved from the study area|55
7998876|NCT03629886|12586681|FG000|Overall Study|Consent withdrawal, not due to an AE|0
7998877|NCT03629886|12586682|FG001|Overall Study|Consent withdrawal, not due to an AE|50
7998878|NCT03629886|12586681|FG000|Overall Study|Study vaccine not administrated|0
7998879|NCT03629886|12586682|FG001|Overall Study|Study vaccine not administrated|3
7998880|NCT03629886|12586681|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0
7998881|NCT03629886|12586682|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28
7998882|NCT03629886|12586681|FG000|Overall Study|Refused vaccination step of the study|0
7998883|NCT03629886|12586682|FG001|Overall Study|Refused vaccination step of the study|44
7998884|NCT03630016|12586698|FG000|Overall Study|Poor Sensor Placement|1
7998885|NCT03630302|12586720|FG000|Surgery|hardware issue prevented LFP recordings|1
7998886|NCT03630302|12586720|FG000|3 Month Visit|Adverse Event|2
7998887|NCT03630302|12586720|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2
7998888|NCT03631355|12586735|FG000|Overall Study|Lost to Follow-up|1
7998889|NCT03631355|12586736|FG001|Overall Study|Lost to Follow-up|2
7998890|NCT03631732|12586753|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3
7998891|NCT03631732|12586754|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0
7998892|NCT03631732|12586753|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1
7998893|NCT03631732|12586754|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2
7998894|NCT03631732|12586753|FG000|Randomized Phase Up to Week 24|Adverse Event|2
7998895|NCT03631732|12586754|FG001|Randomized Phase Up to Week 24|Adverse Event|0
7998896|NCT03631732|12586753|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1
7998897|NCT03631732|12586754|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0
7998898|NCT03631732|12586753|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6
7998899|NCT03631732|12586754|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1
7998900|NCT03631732|12586753|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3
7998901|NCT03631732|12586754|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3
7998902|NCT03631732|12586753|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4
7998903|NCT03631732|12586754|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1
7998904|NCT03631732|12586753|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1
7998905|NCT03631732|12586754|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0
7998906|NCT03631732|12586753|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1
7998907|NCT03631732|12586754|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0
7998908|NCT03631732|12586753|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1
7998909|NCT03631732|12586754|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0
7998910|NCT03633331|12586811|FG000|Overall Study|Withdrawal by Subject|1
7998911|NCT03633825|12586849|FG000|Enrollment|Did not post on network|5066
7998912|NCT03633825|12586850|FG001|Enrollment|Did not post on network|5080
7998913|NCT03633825|12586849|FG000|Enrollment|Post not classified as crisis|13967
7998914|NCT03633825|12586850|FG001|Enrollment|Post not classified as crisis|13757
7998915|NCT03633825|12586849|FG000|Follow up|Lost to Follow-up|478
7998916|NCT03633825|12586850|FG001|Follow up|Lost to Follow-up|450
7998917|NCT03633903|12586858|FG000|Overall Study|Withdrawal by Subject|1
7998918|NCT03633903|12586859|FG001|Overall Study|Withdrawal by Subject|2
7998919|NCT03633903|12586858|FG000|Overall Study|Lost to Follow-up|5
7998920|NCT03633903|12586859|FG001|Overall Study|Lost to Follow-up|5
7998921|NCT03633929|12586865|FG000|Overall Study|Lost to Follow-up|1
7998922|NCT03633929|12586865|FG000|Overall Study|Did not login to software. Did not participate|3
7998923|NCT03634085|12586871|FG000|Overall Study|Adverse Event|1
7998924|NCT03634085|12586872|FG001|Overall Study|Adverse Event|0
7998925|NCT03634085|12586871|FG000|Overall Study|Withdrawal by Subject|0
7998926|NCT03634085|12586872|FG001|Overall Study|Withdrawal by Subject|2
7998927|NCT03634579|12586898|FG000|Overall Study|study termination|9
7998928|NCT03634800|12586902|FG000|Overall Study|Adverse Event|1
7998929|NCT03634800|12586902|FG000|Overall Study|Disease Progression|4
7998930|NCT03634800|12586902|FG000|Overall Study|Withdrawal by Subject|1
7998931|NCT03635086|12586921|FG000|Overall Study|Withdrawal of consent|0
7998932|NCT03635086|12586922|FG001|Overall Study|Withdrawal of consent|0
7998933|NCT03635086|12586923|FG002|Overall Study|Withdrawal of consent|1
7998934|NCT03635086|12586924|FG003|Overall Study|Withdrawal of consent|0
7998935|NCT03635086|12586925|FG004|Overall Study|Withdrawal of consent|0
7998936|NCT03635086|12586921|FG000|Overall Study|Adverse Event|0
7998937|NCT03635086|12586922|FG001|Overall Study|Adverse Event|1
7998938|NCT03635086|12586923|FG002|Overall Study|Adverse Event|0
7998939|NCT03635086|12586924|FG003|Overall Study|Adverse Event|0
7998940|NCT03635086|12586925|FG004|Overall Study|Adverse Event|0
7998941|NCT03635086|12586921|FG000|Overall Study|Lost to Follow-up|1
7998942|NCT03635086|12586922|FG001|Overall Study|Lost to Follow-up|0
7998943|NCT03635086|12586923|FG002|Overall Study|Lost to Follow-up|0
7998944|NCT03635086|12586924|FG003|Overall Study|Lost to Follow-up|0
7998945|NCT03635086|12586925|FG004|Overall Study|Lost to Follow-up|0
7998946|NCT03635320|12586940|FG000|Overall Study|not implanted the device|1
7998947|NCT03635320|12586941|FG001|Overall Study|not implanted the device|2
7998948|NCT03635320|12586940|FG000|Overall Study|Withdrawal by Subject|11
7998949|NCT03635320|12586941|FG001|Overall Study|Withdrawal by Subject|6
7998950|NCT03635775|12586951|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
7998951|NCT03635775|12586952|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
7998952|NCT03635775|12586953|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
7998953|NCT03635775|12586954|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1
7998954|NCT03635957|12586964|FG000|Run-In Period|Lost to Follow-up|1
7998955|NCT03635957|12586964|FG000|Pegloticase + IMM Period|Lack of Efficacy|3
7998956|NCT03636893|12587000|FG000|Overall Study|Death|0
7998957|NCT03636893|12587001|FG001|Overall Study|Death|1
7998958|NCT03636893|12587000|FG000|Overall Study|Protocol Violation|0
7998959|NCT03636893|12587001|FG001|Overall Study|Protocol Violation|3
7998960|NCT03636893|12587000|FG000|Overall Study|Withdrawal by Subject|1
7998961|NCT03636893|12587001|FG001|Overall Study|Withdrawal by Subject|2
7998962|NCT03636893|12587000|FG000|Overall Study|Refusal to surgery|4
7998963|NCT03636893|12587001|FG001|Overall Study|Refusal to surgery|3
7998964|NCT03636893|12587000|FG000|Overall Study|Early surgery (for acute bleeding)|3
7998965|NCT03636893|12587001|FG001|Overall Study|Early surgery (for acute bleeding)|0
7998966|NCT03636893|12587000|FG000|Overall Study|Adverse Event|1
7998967|NCT03636893|12587001|FG001|Overall Study|Adverse Event|1
7998968|NCT03638635|12587068|FG000|Initial Hospitalization|Study terminated prematurely|0
7998969|NCT03638635|12587069|FG001|Initial Hospitalization|Study terminated prematurely|1
7998970|NCT03638635|12587068|FG000|Initial Hospitalization|Withdrawal by study personnel|0
7998971|NCT03638635|12587069|FG001|Initial Hospitalization|Withdrawal by study personnel|1
7998972|NCT03638635|12587068|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39
7998973|NCT03638635|12587069|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22
7998974|NCT03639675|12587083|FG000|Overall Study|Withdrawal by Subject|1
7998975|NCT03639779|12587093|FG000|Overall Study|Lost to Follow-up|1
7998976|NCT03639987|12587111|FG000|Overall Study|Study terminated by sponsor|26
7998977|NCT03639987|12587112|FG001|Overall Study|Study terminated by sponsor|25
7998978|NCT03639987|12587111|FG000|Overall Study|Lost to Follow-up|0
7998979|NCT03639987|12587112|FG001|Overall Study|Lost to Follow-up|1
7998980|NCT03640052|12587118|FG000|Overall Study|Lost to Follow-up|0
7998981|NCT03640052|12587119|FG001|Overall Study|Lost to Follow-up|1
7998982|NCT03640052|12587120|FG002|Overall Study|Lost to Follow-up|0
7998983|NCT03640052|12587121|FG003|Overall Study|Lost to Follow-up|0
7998984|NCT03640052|12587122|FG004|Overall Study|Lost to Follow-up|0
7998985|NCT03640507|12587137|FG000|Overall Study|Withdrawal by Subject|0
7998986|NCT03640507|12587138|FG001|Overall Study|Withdrawal by Subject|0
7998987|NCT03640507|12587139|FG002|Overall Study|Withdrawal by Subject|1
7998988|NCT03640559|12587149|FG000|Overall Study|Physician Decision|1
7998989|NCT03640559|12587150|FG001|Overall Study|Physician Decision|1
7998990|NCT03640559|12587149|FG000|Overall Study|Withdrawal by Subject|1
7998991|NCT03640559|12587150|FG001|Overall Study|Withdrawal by Subject|0
7998992|NCT03641508|12587167|FG000|First Injection|Lost to Follow-up|2
7998993|NCT03641508|12587168|FG001|First Injection|Lost to Follow-up|0
7998994|NCT03642262|12587178|FG000|Period 1|Withdrawal by Subject|1
7998995|NCT03642262|12587179|FG001|Period 1|Withdrawal by Subject|1
7998996|NCT03642262|12587178|FG000|Period 1|Adverse Event|0
7998997|NCT03642262|12587179|FG001|Period 1|Adverse Event|1
7998998|NCT03642717|12587195|FG000|Overall Study|Lost to Follow-up|2
7998999|NCT03642717|12587195|FG000|Overall Study|Inclusion/exclusion criteria violation|33
7999000|NCT03642717|12587195|FG000|Overall Study|Taken study drug prior to contract date|3
7999001|NCT03642873|12587200|FG000|Third Intervention (1 Day)|Screen failure|0
7999002|NCT03642873|12587201|FG001|Third Intervention (1 Day)|Screen failure|0
7999003|NCT03642873|12587202|FG002|Third Intervention (1 Day)|Screen failure|0
7999004|NCT03642873|12587203|FG003|Third Intervention (1 Day)|Screen failure|0
7999005|NCT03642873|12587204|FG004|Third Intervention (1 Day)|Screen failure|1
7999006|NCT03642873|12587205|FG005|Third Intervention (1 Day)|Screen failure|0
7999007|NCT03643432|12587219|FG000|Overall Study|Lost to Follow-up|1
7999008|NCT03643432|12587220|FG001|Overall Study|Lost to Follow-up|0
7999009|NCT03643575|12587226|FG000|Washout: 7 Days|Withdrew consent due to illness|0
7999010|NCT03643575|12587227|FG001|Washout: 7 Days|Withdrew consent due to illness|0
7999011|NCT03643575|12587228|FG002|Washout: 7 Days|Withdrew consent due to illness|0
7999012|NCT03643575|12587229|FG003|Washout: 7 Days|Withdrew consent due to illness|1
7999013|NCT03643575|12587230|FG004|Washout: 7 Days|Withdrew consent due to illness|0
7999014|NCT03643575|12587231|FG005|Washout: 7 Days|Withdrew consent due to illness|0
7999015|NCT03643575|12587226|FG000|Washout: 7 Days|Adverse Event|1
7999016|NCT03643575|12587227|FG001|Washout: 7 Days|Adverse Event|0
7999017|NCT03643575|12587228|FG002|Washout: 7 Days|Adverse Event|0
7999018|NCT03643575|12587229|FG003|Washout: 7 Days|Adverse Event|0
7999019|NCT03643575|12587230|FG004|Washout: 7 Days|Adverse Event|0
7999020|NCT03643575|12587231|FG005|Washout: 7 Days|Adverse Event|0
7999021|NCT03643575|12587226|FG000|Washout: 7 Days|Non compliance check in|0
7999022|NCT03643575|12587227|FG001|Washout: 7 Days|Non compliance check in|1
7999023|NCT03643575|12587228|FG002|Washout: 7 Days|Non compliance check in|0
7999024|NCT03643575|12587229|FG003|Washout: 7 Days|Non compliance check in|0
7999025|NCT03643575|12587230|FG004|Washout: 7 Days|Non compliance check in|0
7999026|NCT03643575|12587231|FG005|Washout: 7 Days|Non compliance check in|0
7999027|NCT03643952|12587243|FG000|Overall Study|Lack of Efficacy|1
7999028|NCT03644173|12587266|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21
7999029|NCT03644173|12587266|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2
7999030|NCT03644173|12587266|FG000|Participants at the 1-month Follow up|Death|2
7999031|NCT03644173|12587266|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2
7999032|NCT03645421|12587284|FG000|Overall Study|Adverse Event|0
7999033|NCT03645421|12587285|FG001|Overall Study|Adverse Event|0
7999034|NCT03645421|12587286|FG002|Overall Study|Adverse Event|4
7999035|NCT03645421|12587287|FG003|Overall Study|Adverse Event|1
7999036|NCT03645421|12587284|FG000|Overall Study|Withdrawal by patient|0
7999037|NCT03645421|12587285|FG001|Overall Study|Withdrawal by patient|0
7999038|NCT03645421|12587286|FG002|Overall Study|Withdrawal by patient|0
7999039|NCT03645421|12587287|FG003|Overall Study|Withdrawal by patient|3
7999040|NCT03645421|12587284|FG000|Overall Study|Study specific withdrawal criteria|0
7999041|NCT03645421|12587285|FG001|Overall Study|Study specific withdrawal criteria|0
7999042|NCT03645421|12587286|FG002|Overall Study|Study specific withdrawal criteria|1
7999043|NCT03645421|12587287|FG003|Overall Study|Study specific withdrawal criteria|0
7999044|NCT03645434|12587300|FG000|Period 1|Adverse Event|0
7999045|NCT03645434|12587301|FG001|Period 1|Adverse Event|0
7999046|NCT03645434|12587302|FG002|Period 1|Adverse Event|0
7999047|NCT03645434|12587303|FG003|Period 1|Adverse Event|1
7999048|NCT03645434|12587304|FG004|Period 1|Adverse Event|0
7999049|NCT03645434|12587305|FG005|Period 1|Adverse Event|0
7999050|NCT03645434|12587300|FG000|Period 1|COPD exacerbation|0
7999051|NCT03645434|12587301|FG001|Period 1|COPD exacerbation|0
7999052|NCT03645434|12587302|FG002|Period 1|COPD exacerbation|0
7999053|NCT03645434|12587303|FG003|Period 1|COPD exacerbation|0
7999054|NCT03645434|12587304|FG004|Period 1|COPD exacerbation|1
7999055|NCT03645434|12587305|FG005|Period 1|COPD exacerbation|0
7999056|NCT03646305|12587355|FG000|Overall Study|Lost to Follow-up|4
7999057|NCT03646305|12587356|FG001|Overall Study|Lost to Follow-up|2
7999058|NCT03646305|12587357|FG002|Overall Study|Lost to Follow-up|2
7999059|NCT03646305|12587358|FG003|Overall Study|Lost to Follow-up|1
7999060|NCT03646305|12587355|FG000|Overall Study|Withdrawal by Subject|1
7999061|NCT03646305|12587356|FG001|Overall Study|Withdrawal by Subject|0
7999062|NCT03646305|12587357|FG002|Overall Study|Withdrawal by Subject|0
7999063|NCT03646305|12587358|FG003|Overall Study|Withdrawal by Subject|1
7999064|NCT03646656|12587374|FG000|Overall Study|Lost to Follow-up|1
7999065|NCT03646656|12587375|FG001|Overall Study|Lost to Follow-up|0
7999066|NCT03646656|12587374|FG000|Overall Study|Withdrawal by Subject|2
7999067|NCT03646656|12587375|FG001|Overall Study|Withdrawal by Subject|0
7999068|NCT03647709|12587402|FG000|Overall Study|Lost to Follow-up|5
7999069|NCT03647709|12587402|FG000|Overall Study|Physician Decision|6
7999070|NCT03647709|12587402|FG000|Overall Study|Withdrawal by Subject|3
7999071|NCT03648879|12587412|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1
7999072|NCT03649412|12587418|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1
7999073|NCT03649412|12587419|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0
7999074|NCT03649412|12587418|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1
7999075|NCT03649412|12587419|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0
7999076|NCT03649412|12587418|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1
7999077|NCT03649412|12587419|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0
7999078|NCT03649412|12587418|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1
7999079|NCT03649412|12587419|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0
7999080|NCT03649412|12587418|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0
7999081|NCT03649412|12587419|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1
7999082|NCT03649412|12587418|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0
7999083|NCT03649412|12587419|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1
7999084|NCT03650387|12587499|FG000|Overall Study|Withdrawal by Subject|13
7999085|NCT03650387|12587499|FG000|Overall Study|Lost to Follow-up|12
7999086|NCT03650387|12587499|FG000|Overall Study|Adverse Event (Not related)|1
7999087|NCT03650387|12587499|FG000|Overall Study|Due to COVID-19 Pandemic|8
7999088|NCT03650400|12587514|FG000|Overall Study|Study terminated by sponsor|0
7999089|NCT03650400|12587515|FG001|Overall Study|Study terminated by sponsor|5
7999090|NCT03650452|12587523|FG000|Overall Study|Physician Decision|1
7999091|NCT03650452|12587524|FG001|Overall Study|Physician Decision|0
7999092|NCT03650452|12587523|FG000|Overall Study|Withdrawal by Parent/Guardian|3
7999093|NCT03650452|12587524|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7999094|NCT03650452|12587523|FG000|Overall Study|Adverse Event|3
7999095|NCT03650452|12587524|FG001|Overall Study|Adverse Event|4
7999096|NCT03650452|12587523|FG000|Overall Study|Early Withdrawal from Study Treatment|3
7999097|NCT03650452|12587524|FG001|Overall Study|Early Withdrawal from Study Treatment|0
7999098|NCT03652610|12587549|FG000|Overall Study|Lost to Follow-up|1
7999099|NCT03652610|12587550|FG001|Overall Study|Lost to Follow-up|0
7999100|NCT03652610|12587549|FG000|Overall Study|Withdrawal by Subject|3
7999101|NCT03652610|12587550|FG001|Overall Study|Withdrawal by Subject|5
7999102|NCT03652662|12587558|FG000|Overall Study|Withdrawal by Subject|2
7999103|NCT03652662|12587559|FG001|Overall Study|Withdrawal by Subject|1
7999104|NCT03652662|12587558|FG000|Overall Study|Lost to Follow-up|1
7999105|NCT03652662|12587559|FG001|Overall Study|Lost to Follow-up|0
7999106|NCT03652675|12587567|FG000|Overall Study|Lost to Follow-up|4
7999107|NCT03652675|12587568|FG001|Overall Study|Lost to Follow-up|4
7999108|NCT03652818|12587579|FG000|Overall Study|Adverse Event|1
7999109|NCT03652818|12587580|FG001|Overall Study|Adverse Event|0
7999110|NCT03652818|12587581|FG002|Overall Study|Adverse Event|0
7999111|NCT03652818|12587582|FG003|Overall Study|Adverse Event|0
7999112|NCT03652818|12587583|FG004|Overall Study|Adverse Event|0
7999113|NCT03652818|12587579|FG000|Overall Study|Physician Decision|1
7999114|NCT03652818|12587580|FG001|Overall Study|Physician Decision|0
7999115|NCT03652818|12587581|FG002|Overall Study|Physician Decision|0
7999116|NCT03652818|12587582|FG003|Overall Study|Physician Decision|0
7999117|NCT03652818|12587583|FG004|Overall Study|Physician Decision|0
7999118|NCT03652818|12587579|FG000|Overall Study|Lost to Follow-up|0
7999119|NCT03652818|12587580|FG001|Overall Study|Lost to Follow-up|1
7999120|NCT03652818|12587581|FG002|Overall Study|Lost to Follow-up|2
7999121|NCT03652818|12587582|FG003|Overall Study|Lost to Follow-up|1
7999122|NCT03652818|12587583|FG004|Overall Study|Lost to Follow-up|1
7999123|NCT03653208|12587604|FG000|Overall Study|Withdrawal by Subject|0
7999124|NCT03653208|12587605|FG001|Overall Study|Withdrawal by Subject|0
7999125|NCT03653208|12587606|FG002|Overall Study|Withdrawal by Subject|0
7999126|NCT03653208|12587607|FG003|Overall Study|Withdrawal by Subject|0
7999127|NCT03653208|12587608|FG004|Overall Study|Withdrawal by Subject|1
7999128|NCT03653208|12587609|FG005|Overall Study|Withdrawal by Subject|0
7999129|NCT03653208|12587610|FG006|Overall Study|Withdrawal by Subject|0
7999130|NCT03653208|12587611|FG007|Overall Study|Withdrawal by Subject|1
7999131|NCT03653208|12587612|FG008|Overall Study|Withdrawal by Subject|1
7999132|NCT03653416|12587643|FG000|Overall Study|Protocol Violation|6
7999133|NCT03653416|12587644|FG001|Overall Study|Protocol Violation|1
7999134|NCT03653429|12587652|FG000|Overall Study|Physician Decision|4
7999135|NCT03653429|12587653|FG001|Overall Study|Physician Decision|10
7999136|NCT03654326|12587661|FG000|Overall Study|Withdrawal by Subject|5
7999137|NCT03654326|12587662|FG001|Overall Study|Withdrawal by Subject|3
7999138|NCT03654326|12587661|FG000|Overall Study|Physician Decision|0
7999139|NCT03654326|12587662|FG001|Overall Study|Physician Decision|1
7999140|NCT03654326|12587661|FG000|Overall Study|Unable to adhere to study schedule|0
7999141|NCT03654326|12587662|FG001|Overall Study|Unable to adhere to study schedule|1
7999142|NCT03654326|12587661|FG000|Overall Study|Lost to Follow-up|1
7999143|NCT03654326|12587662|FG001|Overall Study|Lost to Follow-up|1
7999144|NCT03654560|12587679|FG000|Overall Study|Death|3
7999145|NCT03654560|12587680|FG001|Overall Study|Death|1
7999146|NCT03654560|12587679|FG000|Overall Study|Lost to Follow-up|1
7999147|NCT03654560|12587680|FG001|Overall Study|Lost to Follow-up|0
7999148|NCT03655106|12587692|FG000|Overall Study|Withdrawal by Subject|3
7999149|NCT03655106|12587693|FG001|Overall Study|Withdrawal by Subject|2
7999150|NCT03655106|12587692|FG000|Overall Study|Lost to Follow-up|2
7999151|NCT03655106|12587693|FG001|Overall Study|Lost to Follow-up|1
7999152|NCT03655106|12587692|FG000|Overall Study|Duplicate Enrollment|1
7999153|NCT03655106|12587693|FG001|Overall Study|Duplicate Enrollment|1
7999154|NCT03655106|12587692|FG000|Overall Study|Protocol Violation|3
7999155|NCT03655106|12587693|FG001|Overall Study|Protocol Violation|0
7999156|NCT03655405|12587705|FG000|Overall Study|Death after initial data collection|4
7999157|NCT03655405|12587706|FG001|Overall Study|Death after initial data collection|2
7999158|NCT03655405|12587705|FG000|Overall Study|Died before initial data collection|1
7999159|NCT03655405|12587706|FG001|Overall Study|Died before initial data collection|2
7999160|NCT03655405|12587705|FG000|Overall Study|Protocol Violation|0
7999161|NCT03655405|12587706|FG001|Overall Study|Protocol Violation|1
7999162|NCT03655951|12587723|FG000|Overall Study|Lost to Follow-up|39
7999163|NCT03655951|12587724|FG001|Overall Study|Lost to Follow-up|20
7999164|NCT03655951|12587723|FG000|Overall Study|Withdrawal by Subject|0
7999165|NCT03655951|12587724|FG001|Overall Study|Withdrawal by Subject|1
7999166|NCT03657095|12587738|FG000|Overall Study|Withdrawal by Subject|1
7999167|NCT03657095|12587739|FG001|Overall Study|Withdrawal by Subject|1
7999168|NCT03657095|12587738|FG000|Overall Study|Adverse Event|0
7999169|NCT03657095|12587739|FG001|Overall Study|Adverse Event|3
7999170|NCT03657095|12587738|FG000|Overall Study|Study Terminated by Sponsor|58
7999171|NCT03657095|12587739|FG001|Overall Study|Study Terminated by Sponsor|49
7999172|NCT03657277|12587750|FG000|Overall Study|Physician Decision|2
7999173|NCT03657277|12587750|FG000|Overall Study|Lost to Follow-up|1
7999174|NCT03657277|12587750|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8
7999175|NCT03658811|12587763|FG000|Overall Study|Lost to Follow-up|3
7999176|NCT03658876|12587769|FG000|Overall Study|Protocol Violation|3
7999177|NCT03658876|12587770|FG001|Overall Study|Protocol Violation|2
7999178|NCT03658876|12587769|FG000|Overall Study|Withdrawal by Subject|2
7999179|NCT03658876|12587770|FG001|Overall Study|Withdrawal by Subject|0
7999180|NCT03658876|12587769|FG000|Overall Study|Death|0
7999181|NCT03658876|12587770|FG001|Overall Study|Death|1
7999182|NCT03658876|12587769|FG000|Overall Study|Intercurrent illness|6
7999183|NCT03658876|12587770|FG001|Overall Study|Intercurrent illness|4
7999184|NCT03658876|12587769|FG000|Overall Study|Transplantation/other operation|1
7999185|NCT03658876|12587770|FG001|Overall Study|Transplantation/other operation|5
7999186|NCT03661983|12587842|FG000|Open Label Stabilization Phase|Adverse Event|5
7999187|NCT03661983|12587843|FG001|Open Label Stabilization Phase|Adverse Event|0
7999188|NCT03661983|12587844|FG002|Open Label Stabilization Phase|Adverse Event|0
7999189|NCT03661983|12587845|FG003|Open Label Stabilization Phase|Adverse Event|0
7999190|NCT03661983|12587842|FG000|Open Label Stabilization Phase|Lack of Efficacy|1
7999191|NCT03661983|12587843|FG001|Open Label Stabilization Phase|Lack of Efficacy|0
7999192|NCT03661983|12587844|FG002|Open Label Stabilization Phase|Lack of Efficacy|0
7999193|NCT03661983|12587845|FG003|Open Label Stabilization Phase|Lack of Efficacy|0
7999194|NCT03661983|12587842|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2
7999195|NCT03661983|12587843|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
7999196|NCT03661983|12587844|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
7999197|NCT03661983|12587845|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
7999198|NCT03661983|12587842|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3
7999199|NCT03661983|12587843|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0
7999200|NCT03661983|12587844|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0
7999201|NCT03661983|12587845|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0
7999202|NCT03661983|12587842|FG000|Double-blind Randomized Phase|Adverse Event|0
7999203|NCT03661983|12587843|FG001|Double-blind Randomized Phase|Adverse Event|1
7999204|NCT03661983|12587844|FG002|Double-blind Randomized Phase|Adverse Event|0
7999205|NCT03661983|12587845|FG003|Double-blind Randomized Phase|Adverse Event|0
7999206|NCT03661983|12587842|FG000|Double-blind Randomized Phase|Disease Relapse|0
7999207|NCT03661983|12587843|FG001|Double-blind Randomized Phase|Disease Relapse|0
7999208|NCT03661983|12587844|FG002|Double-blind Randomized Phase|Disease Relapse|0
7999209|NCT03661983|12587845|FG003|Double-blind Randomized Phase|Disease Relapse|6
7999210|NCT03661983|12587842|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
7999211|NCT03661983|12587843|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
7999212|NCT03661983|12587844|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
7999213|NCT03661983|12587845|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1
7999214|NCT03661983|12587842|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0
7999215|NCT03661983|12587843|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1
7999216|NCT03661983|12587844|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1
7999217|NCT03661983|12587845|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1
7999218|NCT03662334|12587871|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1
7999219|NCT03662334|12587872|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0
7999220|NCT03662750|12587888|FG000|Overall Study|Withdrawal by Subject|1
7999221|NCT03662789|12587894|FG000|Overall Study|Lost to Follow-up|1
7999222|NCT03662789|12587895|FG001|Overall Study|Lost to Follow-up|2
7999223|NCT03662789|12587894|FG000|Overall Study|Could not perform treadmill test|4
7999224|NCT03662789|12587895|FG001|Overall Study|Could not perform treadmill test|4
7999225|NCT03662789|12587894|FG000|Overall Study|Death|0
7999226|NCT03662789|12587895|FG001|Overall Study|Death|1
7999227|NCT03662997|12587905|FG000|Overall Study|Adverse Event|0
7999228|NCT03662997|12587906|FG001|Overall Study|Adverse Event|2
7999229|NCT03662997|12587907|FG002|Overall Study|Adverse Event|0
7999230|NCT03662997|12587908|FG003|Overall Study|Adverse Event|0
7999231|NCT03663569|12587955|FG000|Overall Study|Discontinuation of study|11
7999232|NCT03663569|12587955|FG000|Overall Study|Never taken Spiolto® Respimat®|1
7999233|NCT03663569|12587955|FG000|Overall Study|Deceased patient|6
7999234|NCT03663569|12587955|FG000|Overall Study|Lost to Follow-up|18
7999235|NCT03663569|12587955|FG000|Overall Study|Withdrawal of consent|5
7999236|NCT03663569|12587955|FG000|Overall Study|Patient's request|11
7999237|NCT03663569|12587955|FG000|Overall Study|Adverse Event|4
7999238|NCT03663569|12587955|FG000|Overall Study|Not come to second visit|3
7999239|NCT03663569|12587955|FG000|Overall Study|Not meet inclusion / exclusion criterion|3
7999240|NCT03663569|12587955|FG000|Overall Study|Serious adverse event|1
7999241|NCT03663582|12587959|FG000|Overall Study|Physician Decision|1
7999242|NCT03666858|12588025|FG000|Cohort 1|Adverse Event|1
7999243|NCT03666858|12588026|FG001|Cohort 1|Adverse Event|0
7999244|NCT03666858|12588025|FG000|Cohort 2|Adverse Event|0
7999245|NCT03666858|12588026|FG001|Cohort 2|Adverse Event|1
7999246|NCT03667053|12588035|FG000|Overall Study|Withdrawal by Subject|1
7999247|NCT03667053|12588036|FG001|Overall Study|Withdrawal by Subject|0
7999248|NCT03667053|12588037|FG002|Overall Study|Withdrawal by Subject|0
7999249|NCT03668600|12588056|FG000|Overall Study|Study Terminated by the Sponsor|157
7999250|NCT03668600|12588056|FG000|Overall Study|Protocol Violation|1
7999251|NCT03668600|12588056|FG000|Overall Study|Pregnancy|1
7999252|NCT03668600|12588056|FG000|Overall Study|Lost to Follow-up|7
7999253|NCT03668600|12588056|FG000|Overall Study|Withdrawal by Subject|56
7999254|NCT03668600|12588056|FG000|Overall Study|Lack of Efficacy|7
7999255|NCT03668600|12588056|FG000|Overall Study|Adverse Event|1
7999256|NCT03668613|12588062|FG000|Overall Study|Adverse Event|0
7999257|NCT03668613|12588063|FG001|Overall Study|Adverse Event|2
7999258|NCT03668613|12588062|FG000|Overall Study|Lack of Efficacy|0
7999259|NCT03668613|12588063|FG001|Overall Study|Lack of Efficacy|1
7999260|NCT03669081|12588072|FG000|Overall Study|Data could not be validated|1
7999261|NCT03669081|12588073|FG001|Overall Study|Data could not be validated|1
7999262|NCT03669549|12588097|FG000|Overall Study|Adverse Event|4
7999263|NCT03669549|12588097|FG000|Overall Study|Withdrawal by Subject|1
7999264|NCT03669549|12588097|FG000|Overall Study|Study terminated by the Sponsor|1
7999265|NCT03669861|12588105|FG000|Overall Study|Disease Flare|5
7999266|NCT03669861|12588105|FG000|Overall Study|Lack of Efficacy|2
7999267|NCT03670537|12588139|FG000|Overall Study|Protocol Violation|1
7999268|NCT03670641|12588143|FG000|Overall Study|Lost to Follow-up|3
7999269|NCT03672006|12588152|FG000|Overall Study|exclusion criteria met|0
7999270|NCT03672006|12588153|FG001|Overall Study|exclusion criteria met|1
7999271|NCT03672097|12588170|FG000|Period 1|Withdrawal by Subject|2
7999272|NCT03672097|12588170|FG000|Period 1|Adverse Event|1
7999273|NCT03672097|12588170|FG000|Period 1|Did not receive treatment|1
7999274|NCT03672097|12588170|FG000|Period 2|Withdrawal by Subject|3
7999275|NCT03672097|12588170|FG000|Period 2|Other|1
7999276|NCT03672396|12588178|FG000|Overall Study|Withdrawal by Subject|4
7999277|NCT03672396|12588178|FG000|Overall Study|Physician Decision|1
7999278|NCT03672396|12588178|FG000|Overall Study|Adverse Event|1
7999279|NCT03673670|12588188|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1
7999280|NCT03673670|12588189|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7999281|NCT03673670|12588190|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7999282|NCT03673670|12588191|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7999283|NCT03673670|12588192|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7999284|NCT03673670|12588193|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7999285|NCT03673670|12588188|FG000|Treatment Period 1 (3 Days)|Physician Decision|0
7999286|NCT03673670|12588189|FG001|Treatment Period 1 (3 Days)|Physician Decision|0
7999287|NCT03673670|12588190|FG002|Treatment Period 1 (3 Days)|Physician Decision|1
7999288|NCT03673670|12588191|FG003|Treatment Period 1 (3 Days)|Physician Decision|0
7999289|NCT03673670|12588192|FG004|Treatment Period 1 (3 Days)|Physician Decision|0
7999290|NCT03673670|12588193|FG005|Treatment Period 1 (3 Days)|Physician Decision|0
7999291|NCT03673670|12588188|FG000|Treatment Period 1 (3 Days)|Adverse Event|0
7999292|NCT03673670|12588189|FG001|Treatment Period 1 (3 Days)|Adverse Event|0
7999293|NCT03673670|12588190|FG002|Treatment Period 1 (3 Days)|Adverse Event|0
7999294|NCT03673670|12588191|FG003|Treatment Period 1 (3 Days)|Adverse Event|0
7999295|NCT03673670|12588192|FG004|Treatment Period 1 (3 Days)|Adverse Event|0
7999296|NCT03673670|12588193|FG005|Treatment Period 1 (3 Days)|Adverse Event|1
7999297|NCT03673670|12588188|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7999298|NCT03673670|12588189|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7999299|NCT03673670|12588190|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7999300|NCT03673670|12588191|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7999301|NCT03673670|12588192|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7999302|NCT03673670|12588193|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1
7999303|NCT03673670|12588188|FG000|Treatment Period 2 (3 Days)|Adverse Event|0
7999304|NCT03673670|12588189|FG001|Treatment Period 2 (3 Days)|Adverse Event|0
7999305|NCT03673670|12588190|FG002|Treatment Period 2 (3 Days)|Adverse Event|1
7999306|NCT03673670|12588191|FG003|Treatment Period 2 (3 Days)|Adverse Event|0
7999307|NCT03673670|12588192|FG004|Treatment Period 2 (3 Days)|Adverse Event|1
7999308|NCT03673670|12588193|FG005|Treatment Period 2 (3 Days)|Adverse Event|0
7999309|NCT03673670|12588188|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7999310|NCT03673670|12588189|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7999311|NCT03673670|12588190|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7999312|NCT03673670|12588191|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7999313|NCT03673670|12588192|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1
7999314|NCT03673670|12588193|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7999315|NCT03673670|12588188|FG000|Treatment Period 3 (3 Days)|Adverse Event|0
7999316|NCT03673670|12588189|FG001|Treatment Period 3 (3 Days)|Adverse Event|0
7999317|NCT03673670|12588190|FG002|Treatment Period 3 (3 Days)|Adverse Event|0
7999318|NCT03673670|12588191|FG003|Treatment Period 3 (3 Days)|Adverse Event|0
7999319|NCT03673670|12588192|FG004|Treatment Period 3 (3 Days)|Adverse Event|1
7999320|NCT03673670|12588193|FG005|Treatment Period 3 (3 Days)|Adverse Event|0
7999321|NCT03674177|12588214|FG000|Overall Study|Lost to Follow-up|2
7999322|NCT03674177|12588215|FG001|Overall Study|Lost to Follow-up|1
7999323|NCT03674177|12588216|FG002|Overall Study|Lost to Follow-up|0
7999324|NCT03674177|12588217|FG003|Overall Study|Lost to Follow-up|2
7999325|NCT03674281|12588230|FG000|Overall Study|screen failure|2
7999326|NCT03674281|12588231|FG001|Overall Study|screen failure|0
7999327|NCT03674281|12588232|FG002|Overall Study|screen failure|0
7999328|NCT03674281|12588230|FG000|Overall Study|Withdrawal by Subject|1
7999329|NCT03674281|12588231|FG001|Overall Study|Withdrawal by Subject|3
7999330|NCT03674281|12588232|FG002|Overall Study|Withdrawal by Subject|3
7999331|NCT03675776|12588291|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5
7999332|NCT03675776|12588292|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6
7999333|NCT03675776|12588293|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8
7999334|NCT03675776|12588291|FG000|Double Blind Treatment Period|Lack of Efficacy|1
7999335|NCT03675776|12588292|FG001|Double Blind Treatment Period|Lack of Efficacy|0
7999336|NCT03675776|12588293|FG002|Double Blind Treatment Period|Lack of Efficacy|0
7999337|NCT03676634|12588305|FG000|Overall Study|Red blood cell loss|1
7999338|NCT03676634|12588305|FG000|Overall Study|Out-of-limit pulse|2
7999339|NCT03677375|12588357|FG000|Overall Study|Incomplete procedure|8
7999340|NCT03677375|12588357|FG000|Overall Study|Adverse Event|3
7999341|NCT03677375|12588357|FG000|Overall Study|Physician Decision|1
7999342|NCT03677401|12588363|FG000|Overall Study|Adverse Event|4
7999343|NCT03677401|12588364|FG001|Overall Study|Adverse Event|14
7999344|NCT03677401|12588363|FG000|Overall Study|Lack of Efficacy|3
7999345|NCT03677401|12588364|FG001|Overall Study|Lack of Efficacy|1
7999346|NCT03677401|12588363|FG000|Overall Study|Withdrawal by Subject|2
7999347|NCT03677401|12588364|FG001|Overall Study|Withdrawal by Subject|2
7999348|NCT03677401|12588363|FG000|Overall Study|Sponsor decision|0
7999349|NCT03677401|12588364|FG001|Overall Study|Sponsor decision|1
7999350|NCT03677401|12588363|FG000|Overall Study|Reason Unspecified|1
7999351|NCT03677401|12588364|FG001|Overall Study|Reason Unspecified|0
7999352|NCT03678103|12588370|FG000|Overall Study|Withdrawn prior to completion|4
7999353|NCT03678285|12588374|FG000|Overall Study|Adverse Event|2
7999354|NCT03678285|12588374|FG000|Overall Study|Withdrawal by subject prior to start of workout|1
7999355|NCT03678285|12588374|FG000|Overall Study|Dehydrated prior to start of workout|1
7999356|NCT03678870|12588384|FG000|Overall Study|prescribed non- protocol medications|10
7999357|NCT03678870|12588385|FG001|Overall Study|prescribed non- protocol medications|6
7999358|NCT03678870|12588384|FG000|Overall Study|Lost to Follow-up|3
7999359|NCT03678870|12588385|FG001|Overall Study|Lost to Follow-up|2
7999360|NCT03679741|12588400|FG000|Period 1|No longer meet eligibility criteria|1
7999361|NCT03679741|12588401|FG001|Period 1|No longer meet eligibility criteria|0
7999362|NCT03679741|12588400|FG000|Period 1|Lost to Follow-up|0
7999363|NCT03679741|12588401|FG001|Period 1|Lost to Follow-up|1
7999364|NCT03679741|12588400|FG000|Period 1|Adverse Event|1
7999365|NCT03679741|12588401|FG001|Period 1|Adverse Event|1
7999366|NCT03679741|12588400|FG000|Period 1|Withdrawal by Subject|0
7999367|NCT03679741|12588401|FG001|Period 1|Withdrawal by Subject|1
7999368|NCT03679741|12588400|FG000|Period 2|Adverse Event|2
7999369|NCT03679741|12588401|FG001|Period 2|Adverse Event|1
7999370|NCT03679741|12588400|FG000|Period 2|Withdrawal by Subject|1
7999371|NCT03679741|12588401|FG001|Period 2|Withdrawal by Subject|1
7999372|NCT03680521|12588454|FG000|Overall Study|Ongoing in long-term follow up|7
7999373|NCT03680521|12588455|FG001|Overall Study|Ongoing in long-term follow up|11
7999374|NCT03680742|12588464|FG000|Overall Study|Unsuccessful Implant Attempt|2
7999375|NCT03681093|12588471|FG000|Overall Study|Subject decision|0
7999376|NCT03681093|12588472|FG001|Overall Study|Subject decision|2
7999377|NCT03681093|12588473|FG002|Overall Study|Subject decision|1
7999378|NCT03681119|12588483|FG000|Overall Study|No specific reason|4
7999379|NCT03681119|12588484|FG001|Overall Study|No specific reason|0
7999380|NCT03681119|12588483|FG000|Overall Study|Sickness|2
7999381|NCT03681119|12588484|FG001|Overall Study|Sickness|0
7999382|NCT03681353|12588488|FG000|Overall Study|Lost to Follow-up|2
7999383|NCT03681353|12588488|FG000|Overall Study|Withdrawal by Subject|3
7999384|NCT03681353|12588488|FG000|Overall Study|withdrawn by PI|2
7999385|NCT03681405|12588494|FG000|Overall Study|Found to be ineligible after randomized|1
7999386|NCT03681405|12588495|FG001|Overall Study|Found to be ineligible after randomized|0
7999387|NCT03681951|12588541|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1
7999388|NCT03681951|12588542|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7999389|NCT03681951|12588543|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7999390|NCT03681951|12588544|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7999391|NCT03681951|12588545|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7999392|NCT03681951|12588546|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7999393|NCT03681951|12588547|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7999394|NCT03681951|12588548|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7999395|NCT03681951|12588541|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4
7999396|NCT03681951|12588542|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7999397|NCT03681951|12588543|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7999398|NCT03681951|12588544|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7999399|NCT03681951|12588545|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7999400|NCT03681951|12588546|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7999401|NCT03681951|12588547|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7999402|NCT03681951|12588548|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7999403|NCT03681951|12588541|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3
7999404|NCT03681951|12588542|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7999405|NCT03681951|12588543|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7999406|NCT03681951|12588544|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7999407|NCT03681951|12588545|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7999408|NCT03681951|12588546|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7999409|NCT03681951|12588547|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7999410|NCT03681951|12588548|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7999411|NCT03682107|12588576|FG000|Overall Study|Withdrawal by Subject|0
7999412|NCT03682107|12588577|FG001|Overall Study|Withdrawal by Subject|1
7999413|NCT03682107|12588578|FG002|Overall Study|Withdrawal by Subject|0
7999414|NCT03682107|12588579|FG003|Overall Study|Withdrawal by Subject|0
7999415|NCT03682107|12588580|FG004|Overall Study|Withdrawal by Subject|0
7999416|NCT03682120|12588596|FG000|Overall Study|Lost to Follow-up|11
7999417|NCT03682120|12588597|FG001|Overall Study|Lost to Follow-up|4
7999418|NCT03682120|12588598|FG002|Overall Study|Lost to Follow-up|5
7999419|NCT03682120|12588599|FG003|Overall Study|Lost to Follow-up|2
7999420|NCT03682120|12588596|FG000|Overall Study|Physician Decision|1
7999421|NCT03682120|12588597|FG001|Overall Study|Physician Decision|0
7999422|NCT03682120|12588598|FG002|Overall Study|Physician Decision|0
7999423|NCT03682120|12588599|FG003|Overall Study|Physician Decision|0
7999424|NCT03682120|12588596|FG000|Overall Study|Withdrawal by Subject|1
7999425|NCT03682120|12588597|FG001|Overall Study|Withdrawal by Subject|2
7999426|NCT03682120|12588598|FG002|Overall Study|Withdrawal by Subject|3
7999427|NCT03682120|12588599|FG003|Overall Study|Withdrawal by Subject|0
7999428|NCT03682120|12588596|FG000|Overall Study|Death|0
7999429|NCT03682120|12588597|FG001|Overall Study|Death|1
7999430|NCT03682120|12588598|FG002|Overall Study|Death|0
7999431|NCT03682120|12588599|FG003|Overall Study|Death|0
7999432|NCT03682120|12588596|FG000|Overall Study|Enrolled but Treatment Not Administered|0
7999433|NCT03682120|12588597|FG001|Overall Study|Enrolled but Treatment Not Administered|1
7999434|NCT03682120|12588598|FG002|Overall Study|Enrolled but Treatment Not Administered|0
7999435|NCT03682120|12588599|FG003|Overall Study|Enrolled but Treatment Not Administered|0
7999436|NCT03682302|12588615|FG000|Overall Study|Lost to Follow-up|1
7999437|NCT03682302|12588616|FG001|Overall Study|Lost to Follow-up|2
7999438|NCT03682302|12588617|FG002|Overall Study|Lost to Follow-up|0
7999439|NCT03682302|12588618|FG003|Overall Study|Lost to Follow-up|1
7999440|NCT03682302|12588615|FG000|Overall Study|Study drug was not administered|0
7999441|NCT03682302|12588616|FG001|Overall Study|Study drug was not administered|0
7999442|NCT03682302|12588617|FG002|Overall Study|Study drug was not administered|1
7999443|NCT03682302|12588618|FG003|Overall Study|Study drug was not administered|1
7999444|NCT03682705|12588634|FG000|Overall Study|Adverse Event|1
7999445|NCT03682705|12588635|FG001|Overall Study|Adverse Event|1
7999446|NCT03682705|12588636|FG002|Overall Study|Adverse Event|1
7999447|NCT03682705|12588637|FG003|Overall Study|Adverse Event|0
7999448|NCT03682705|12588638|FG004|Overall Study|Adverse Event|1
7999449|NCT03682705|12588639|FG005|Overall Study|Adverse Event|1
7999450|NCT03682705|12588634|FG000|Overall Study|Withdrawal by Subject|1
7999451|NCT03682705|12588635|FG001|Overall Study|Withdrawal by Subject|3
7999452|NCT03682705|12588636|FG002|Overall Study|Withdrawal by Subject|2
7999453|NCT03682705|12588637|FG003|Overall Study|Withdrawal by Subject|4
7999454|NCT03682705|12588638|FG004|Overall Study|Withdrawal by Subject|0
7999455|NCT03682705|12588639|FG005|Overall Study|Withdrawal by Subject|1
7999456|NCT03682705|12588634|FG000|Overall Study|Other, not specified|0
7999457|NCT03682705|12588635|FG001|Overall Study|Other, not specified|0
7999458|NCT03682705|12588636|FG002|Overall Study|Other, not specified|0
7999459|NCT03682705|12588637|FG003|Overall Study|Other, not specified|1
7999460|NCT03682705|12588638|FG004|Overall Study|Other, not specified|2
7999461|NCT03682705|12588639|FG005|Overall Study|Other, not specified|0
7999462|NCT03682705|12588634|FG000|Overall Study|Lost to Follow-up|0
7999463|NCT03682705|12588635|FG001|Overall Study|Lost to Follow-up|0
7999464|NCT03682705|12588636|FG002|Overall Study|Lost to Follow-up|0
7999465|NCT03682705|12588637|FG003|Overall Study|Lost to Follow-up|0
7999466|NCT03682705|12588638|FG004|Overall Study|Lost to Follow-up|3
7999467|NCT03682705|12588639|FG005|Overall Study|Lost to Follow-up|0
7999468|NCT03683576|12588675|FG000|Overall Study|Withdrawal by Subject|2
7999469|NCT03683576|12588676|FG001|Overall Study|Withdrawal by Subject|0
7999470|NCT03683576|12588677|FG002|Overall Study|Withdrawal by Subject|8
7999471|NCT03683576|12588678|FG003|Overall Study|Withdrawal by Subject|3
7999472|NCT03683576|12588675|FG000|Overall Study|Adverse Event|3
7999473|NCT03683576|12588676|FG001|Overall Study|Adverse Event|0
7999474|NCT03683576|12588677|FG002|Overall Study|Adverse Event|0
7999475|NCT03683576|12588678|FG003|Overall Study|Adverse Event|4
7999476|NCT03683576|12588675|FG000|Overall Study|Lack of Efficacy|1
7999477|NCT03683576|12588676|FG001|Overall Study|Lack of Efficacy|0
7999478|NCT03683576|12588677|FG002|Overall Study|Lack of Efficacy|1
7999479|NCT03683576|12588678|FG003|Overall Study|Lack of Efficacy|1
7999480|NCT03683576|12588675|FG000|Overall Study|Lost to Follow-up|0
7999481|NCT03683576|12588676|FG001|Overall Study|Lost to Follow-up|1
7999482|NCT03683576|12588677|FG002|Overall Study|Lost to Follow-up|2
7999483|NCT03683576|12588678|FG003|Overall Study|Lost to Follow-up|0
7999484|NCT03683576|12588675|FG000|Overall Study|Other, Not Specified|0
7999485|NCT03683576|12588676|FG001|Overall Study|Other, Not Specified|2
7999486|NCT03683576|12588677|FG002|Overall Study|Other, Not Specified|0
7999487|NCT03683576|12588678|FG003|Overall Study|Other, Not Specified|0
7999488|NCT03683576|12588675|FG000|Overall Study|Protocol Violation|0
7999489|NCT03683576|12588676|FG001|Overall Study|Protocol Violation|1
7999490|NCT03683576|12588677|FG002|Overall Study|Protocol Violation|1
7999491|NCT03683576|12588678|FG003|Overall Study|Protocol Violation|0
7999492|NCT03683719|12588693|FG000|Overall Study|Lack of Efficacy|1
7999493|NCT03683719|12588694|FG001|Overall Study|Lack of Efficacy|3
7999494|NCT03683719|12588695|FG002|Overall Study|Lack of Efficacy|4
7999495|NCT03683719|12588696|FG003|Overall Study|Lack of Efficacy|0
7999496|NCT03683719|12588697|FG004|Overall Study|Lack of Efficacy|4
7999497|NCT03683719|12588693|FG000|Overall Study|Adverse Event|6
7999498|NCT03683719|12588694|FG001|Overall Study|Adverse Event|6
7999499|NCT03683719|12588695|FG002|Overall Study|Adverse Event|0
7999500|NCT03683719|12588696|FG003|Overall Study|Adverse Event|1
7999501|NCT03683719|12588697|FG004|Overall Study|Adverse Event|3
7999502|NCT03683719|12588693|FG000|Overall Study|Withdrawal by Subject|4
7999503|NCT03683719|12588694|FG001|Overall Study|Withdrawal by Subject|4
7999504|NCT03683719|12588695|FG002|Overall Study|Withdrawal by Subject|3
7999505|NCT03683719|12588696|FG003|Overall Study|Withdrawal by Subject|5
7999506|NCT03683719|12588697|FG004|Overall Study|Withdrawal by Subject|5
7999507|NCT03683719|12588693|FG000|Overall Study|Lost to Follow-up|1
7999508|NCT03683719|12588694|FG001|Overall Study|Lost to Follow-up|0
7999509|NCT03683719|12588695|FG002|Overall Study|Lost to Follow-up|0
7999510|NCT03683719|12588696|FG003|Overall Study|Lost to Follow-up|1
7999511|NCT03683719|12588697|FG004|Overall Study|Lost to Follow-up|1
7999512|NCT03683719|12588693|FG000|Overall Study|Other personal reasons|0
7999513|NCT03683719|12588694|FG001|Overall Study|Other personal reasons|0
7999514|NCT03683719|12588695|FG002|Overall Study|Other personal reasons|1
7999515|NCT03683719|12588696|FG003|Overall Study|Other personal reasons|0
7999516|NCT03683719|12588697|FG004|Overall Study|Other personal reasons|1
7999517|NCT03683758|12588711|FG000|Overall Study|Non-study commitment conflict|1
7999518|NCT03683758|12588712|FG001|Overall Study|Non-study commitment conflict|3
7999519|NCT03683758|12588711|FG000|Overall Study|Illness preventing participation|1
7999520|NCT03683758|12588712|FG001|Overall Study|Illness preventing participation|0
7999521|NCT03683758|12588711|FG000|Overall Study|Adverse Event|1
7999522|NCT03683758|12588712|FG001|Overall Study|Adverse Event|0
7999523|NCT03684044|12588726|FG000|Overall Study|Adverse Event|3
7999524|NCT03684044|12588727|FG001|Overall Study|Adverse Event|0
7999525|NCT03684044|12588726|FG000|Overall Study|Death|4
7999526|NCT03684044|12588727|FG001|Overall Study|Death|7
7999527|NCT03684044|12588726|FG000|Overall Study|Lost to Follow-up|3
7999528|NCT03684044|12588727|FG001|Overall Study|Lost to Follow-up|2
7999529|NCT03684044|12588726|FG000|Overall Study|Patient Not Available|0
7999530|NCT03684044|12588727|FG001|Overall Study|Patient Not Available|2
7999531|NCT03684044|12588726|FG000|Overall Study|Physician Decision|1
7999532|NCT03684044|12588727|FG001|Overall Study|Physician Decision|0
7999533|NCT03684044|12588726|FG000|Overall Study|Withdrawal by Subject|11
7999534|NCT03684044|12588727|FG001|Overall Study|Withdrawal by Subject|9
7999535|NCT03684642|12588745|FG000|Overall Study|Adverse Event|6
7999536|NCT03684642|12588746|FG001|Overall Study|Adverse Event|15
7999537|NCT03684642|12588747|FG002|Overall Study|Adverse Event|11
7999538|NCT03684642|12588745|FG000|Overall Study|Withdrawal by Subject|35
7999539|NCT03684642|12588746|FG001|Overall Study|Withdrawal by Subject|53
7999540|NCT03684642|12588747|FG002|Overall Study|Withdrawal by Subject|23
7999541|NCT03684642|12588745|FG000|Overall Study|Lack of Efficacy|0
7999542|NCT03684642|12588746|FG001|Overall Study|Lack of Efficacy|0
7999543|NCT03684642|12588747|FG002|Overall Study|Lack of Efficacy|1
7999544|NCT03684642|12588745|FG000|Overall Study|Poor compliance to protocol|0
7999545|NCT03684642|12588746|FG001|Overall Study|Poor compliance to protocol|4
7999546|NCT03684642|12588747|FG002|Overall Study|Poor compliance to protocol|1
7999547|NCT03684642|12588745|FG000|Overall Study|Other than specified|62
7999548|NCT03684642|12588746|FG001|Overall Study|Other than specified|60
7999549|NCT03684642|12588747|FG002|Overall Study|Other than specified|67
7999550|NCT03684642|12588745|FG000|Overall Study|Randomized and not treated|0
7999551|NCT03684642|12588746|FG001|Overall Study|Randomized and not treated|0
7999552|NCT03684642|12588747|FG002|Overall Study|Randomized and not treated|1
7999553|NCT03684642|12588745|FG000|Overall Study|Missing completion status but alive at last contact|0
7999554|NCT03684642|12588746|FG001|Overall Study|Missing completion status but alive at last contact|1
7999555|NCT03684642|12588747|FG002|Overall Study|Missing completion status but alive at last contact|2
7999556|NCT03684928|12588755|FG000|First Intervention|Lost to Follow-up|0
7999557|NCT03684928|12588756|FG001|First Intervention|Lost to Follow-up|1
7999558|NCT03684928|12588755|FG000|First Intervention|Withdrawal by Subject|0
7999559|NCT03684928|12588756|FG001|First Intervention|Withdrawal by Subject|2
7999560|NCT03684928|12588755|FG000|Second Intervention|Soft Tissue Injury|1
7999561|NCT03684928|12588756|FG001|Second Intervention|Soft Tissue Injury|0
7999562|NCT03685344|12588766|FG000|Overall Study|Withdrawal by Subject|1
7999563|NCT03685344|12588767|FG001|Overall Study|Withdrawal by Subject|1
7999564|NCT03685344|12588768|FG002|Overall Study|Withdrawal by Subject|2
7999565|NCT03685344|12588769|FG003|Overall Study|Withdrawal by Subject|0
7999566|NCT03685344|12588766|FG000|Overall Study|Physician Decision|1
7999567|NCT03685344|12588767|FG001|Overall Study|Physician Decision|1
7999568|NCT03685344|12588768|FG002|Overall Study|Physician Decision|5
7999569|NCT03685344|12588769|FG003|Overall Study|Physician Decision|0
7999570|NCT03685344|12588766|FG000|Overall Study|Death|1
7999571|NCT03685344|12588767|FG001|Overall Study|Death|1
7999572|NCT03685344|12588768|FG002|Overall Study|Death|0
7999573|NCT03685344|12588769|FG003|Overall Study|Death|0
7999574|NCT03685643|12588790|FG000|Overall Study|Lost to Follow-up|14
7999575|NCT03685643|12588791|FG001|Overall Study|Lost to Follow-up|22
7999576|NCT03686033|12588810|FG000|Treatment Period 2 (1 Day)|Adverse Event|0
7999577|NCT03686033|12588811|FG001|Treatment Period 2 (1 Day)|Adverse Event|0
7999578|NCT03686033|12588812|FG002|Treatment Period 2 (1 Day)|Adverse Event|0
7999579|NCT03686033|12588813|FG003|Treatment Period 2 (1 Day)|Adverse Event|0
7999580|NCT03686033|12588814|FG004|Treatment Period 2 (1 Day)|Adverse Event|1
7999581|NCT03686033|12588815|FG005|Treatment Period 2 (1 Day)|Adverse Event|0
7999582|NCT03686176|12588832|FG000|Overall Study|Procedure cancelled|1
7999583|NCT03686176|12588833|FG001|Overall Study|Procedure cancelled|0
7999584|NCT03686176|12588834|FG002|Overall Study|Procedure cancelled|0
7999585|NCT03686176|12588832|FG000|Overall Study|VR Malfunction|1
7999586|NCT03686176|12588833|FG001|Overall Study|VR Malfunction|0
7999587|NCT03686176|12588834|FG002|Overall Study|VR Malfunction|0
7999588|NCT03687125|12588844|FG000|Overall Study|Progressive Disease|2
7999589|NCT03687125|12588845|FG001|Overall Study|Progressive Disease|1
7999590|NCT03687125|12588844|FG000|Overall Study|Protocol Violation|1
7999591|NCT03687125|12588845|FG001|Overall Study|Protocol Violation|0
7718343|NCT00527735|12142318|FG002|Overall Study|Death|15
7718344|NCT00527735|12142316|FG000|Overall Study|Completed treatment in treatment phase|14
7718345|NCT00527735|12142317|FG001|Overall Study|Completed treatment in treatment phase|13
7718346|NCT00527735|12142318|FG002|Overall Study|Completed treatment in treatment phase|18
7718347|NCT00527735|12142316|FG000|Overall Study|Adverse Event|10
7718348|NCT00527735|12142317|FG001|Overall Study|Adverse Event|6
7718349|NCT00527735|12142318|FG002|Overall Study|Adverse Event|7
7718350|NCT00527735|12142316|FG000|Overall Study|Not identified|5
7718351|NCT00527735|12142317|FG001|Overall Study|Not identified|5
7718352|NCT00527735|12142318|FG002|Overall Study|Not identified|5
7999592|NCT03687372|12588855|FG000|Overall Study|Lost to Follow-up|12
7999593|NCT03687372|12588856|FG001|Overall Study|Lost to Follow-up|21
7999594|NCT03687372|12588855|FG000|Overall Study|Withdrawal by Subject|4
7999595|NCT03687372|12588856|FG001|Overall Study|Withdrawal by Subject|17
7999596|NCT03687372|12588855|FG000|Overall Study|Investigator Decision|1
7999597|NCT03687372|12588856|FG001|Overall Study|Investigator Decision|1
7999598|NCT03687827|12588920|FG000|Treatment Period 1|Death|0
7999599|NCT03687827|12588921|FG001|Treatment Period 1|Death|1
7999600|NCT03687827|12588920|FG000|Treatment Period 1|Lost to Follow-up|2
7999601|NCT03687827|12588921|FG001|Treatment Period 1|Lost to Follow-up|2
7999602|NCT03687827|12588920|FG000|Treatment Period 1|Physician Decision|5
7999603|NCT03687827|12588921|FG001|Treatment Period 1|Physician Decision|2
7999604|NCT03687827|12588920|FG000|Treatment Period 1|Withdrawal by Subject|7
7999605|NCT03687827|12588921|FG001|Treatment Period 1|Withdrawal by Subject|3
7999606|NCT03687827|12588920|FG000|Treatment Period 2|Physician Decision|4
7999607|NCT03687827|12588921|FG001|Treatment Period 2|Physician Decision|1
7999608|NCT03687827|12588920|FG000|Treatment Period 2|Withdrawal by Subject|1
7999609|NCT03687827|12588921|FG001|Treatment Period 2|Withdrawal by Subject|2
7999610|NCT03687970|12588929|FG000|Overall Study|visit scheduling conflicts|2
7999611|NCT03687970|12588930|FG001|Overall Study|visit scheduling conflicts|0
7999612|NCT03688620|12588956|FG000|Overall Study|Other|0
7999613|NCT03688620|12588957|FG001|Overall Study|Other|0
7999614|NCT03688620|12588958|FG002|Overall Study|Other|1
7999615|NCT03688620|12588956|FG000|Overall Study|Unwilling to attend the scheduled visit|0
7999616|NCT03688620|12588957|FG001|Overall Study|Unwilling to attend the scheduled visit|1
7999617|NCT03688620|12588958|FG002|Overall Study|Unwilling to attend the scheduled visit|0
7999618|NCT03688620|12588956|FG000|Overall Study|Lost to Follow-up|16
7999619|NCT03688620|12588957|FG001|Overall Study|Lost to Follow-up|0
7999620|NCT03688620|12588958|FG002|Overall Study|Lost to Follow-up|1
7999621|NCT03688620|12588956|FG000|Overall Study|Withdrawal by Subject|0
7999622|NCT03688620|12588957|FG001|Overall Study|Withdrawal by Subject|0
7999623|NCT03688620|12588958|FG002|Overall Study|Withdrawal by Subject|6
7999624|NCT03688711|12588974|FG000|Overall Study|Withdrawal by Subject|0
7999625|NCT03688711|12588975|FG001|Overall Study|Withdrawal by Subject|1
7999626|NCT03688880|12588983|FG000|Overall Study|Withdrawal by Subject|0
7999627|NCT03688880|12588984|FG001|Overall Study|Withdrawal by Subject|2
7999628|NCT03688880|12588983|FG000|Overall Study|Use of non-permitted concurrent therapy|0
7999629|NCT03688880|12588984|FG001|Overall Study|Use of non-permitted concurrent therapy|2
7999630|NCT03688880|12588983|FG000|Overall Study|Lost to Follow-up|4
7999631|NCT03688880|12588984|FG001|Overall Study|Lost to Follow-up|7
7999632|NCT03688880|12588983|FG000|Overall Study|Adverse Event|0
7999633|NCT03688880|12588984|FG001|Overall Study|Adverse Event|2
7999634|NCT03688880|12588983|FG000|Overall Study|Device deficiencies|0
7999635|NCT03688880|12588984|FG001|Overall Study|Device deficiencies|2
7999636|NCT03688880|12588983|FG000|Overall Study|Other|10
7999637|NCT03688880|12588984|FG001|Overall Study|Other|16
7999638|NCT03689452|12588992|FG000|Overall Study|Lost to Follow-up|1
7999639|NCT03689452|12588993|FG001|Overall Study|Lost to Follow-up|1
7999640|NCT03691779|12589020|FG000|Part B (24 Weeks)|Adverse Event|0
7999641|NCT03691779|12589021|FG001|Part B (24 Weeks)|Adverse Event|1
7999642|NCT03691779|12589020|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0
7999643|NCT03691779|12589021|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1
7999644|NCT03691831|12589030|FG000|Overall Study|Lost to Follow-up|16
7999645|NCT03691831|12589031|FG001|Overall Study|Lost to Follow-up|12
7999646|NCT03691831|12589030|FG000|Overall Study|Withdrawal by Subject|9
7999647|NCT03691831|12589031|FG001|Overall Study|Withdrawal by Subject|17
7999648|NCT03691831|12589030|FG000|Overall Study|Investigator Decision|2
7999649|NCT03691831|12589031|FG001|Overall Study|Investigator Decision|2
7999650|NCT03691948|12589058|FG000|Overall Study|Lost to Follow-up|1
7999651|NCT03691948|12589059|FG001|Overall Study|Lost to Follow-up|3
7999652|NCT03692676|12589070|FG000|Overall Study|exclude patients with prior use|4424
7999653|NCT03692676|12589071|FG001|Overall Study|exclude patients with prior use|24726
7999654|NCT03692676|12589072|FG002|Overall Study|exclude patients with prior use|0
7999655|NCT03692676|12589073|FG003|Overall Study|exclude patients with prior use|0
7999656|NCT03692676|12589070|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480
7999657|NCT03692676|12589071|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037
7999658|NCT03692676|12589072|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
7999659|NCT03692676|12589073|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
7999660|NCT03692676|12589070|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881
7999661|NCT03692676|12589071|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563
7999662|NCT03692676|12589072|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281
7999663|NCT03692676|12589073|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558
7999664|NCT03692676|12589070|FG000|Overall Study|exclude patients less than 18 years of age on index date|8
7999665|NCT03692676|12589071|FG001|Overall Study|exclude patients less than 18 years of age on index date|613
7999666|NCT03692676|12589072|FG002|Overall Study|exclude patients less than 18 years of age on index date|836
7999667|NCT03692676|12589073|FG003|Overall Study|exclude patients less than 18 years of age on index date|193
7999668|NCT03692676|12589070|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149
7999669|NCT03692676|12589071|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717
7999670|NCT03692676|12589072|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723
7999671|NCT03692676|12589073|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273
7999672|NCT03692676|12589070|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208
7999673|NCT03692676|12589071|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759
7999674|NCT03692676|12589072|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419
7999675|NCT03692676|12589073|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684
7999676|NCT03692676|12589070|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275
7999677|NCT03692676|12589071|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218
7999678|NCT03692676|12589072|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515
7999679|NCT03692676|12589073|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173
7999680|NCT03692676|12589070|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
7999681|NCT03692676|12589071|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
7999682|NCT03692676|12589072|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147
7999683|NCT03692676|12589073|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4
7999684|NCT03692676|12589070|FG000|Overall Study|exclude patients with prior use of same substances and device|0
7999685|NCT03692676|12589071|FG001|Overall Study|exclude patients with prior use of same substances and device|0
7999686|NCT03692676|12589072|FG002|Overall Study|exclude patients with prior use of same substances and device|3700
7999687|NCT03692676|12589073|FG003|Overall Study|exclude patients with prior use of same substances and device|0
7999688|NCT03692676|12589070|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
7999689|NCT03692676|12589071|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
7999690|NCT03692676|12589072|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965
7999691|NCT03692676|12589073|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198
7999692|NCT03692676|12589070|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
7999693|NCT03692676|12589071|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
7999694|NCT03692676|12589072|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
7999695|NCT03692676|12589073|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223
7999696|NCT03692676|12589070|FG000|Overall Study|Other|0
7999697|NCT03692676|12589071|FG001|Overall Study|Other|805
7999698|NCT03692676|12589072|FG002|Overall Study|Other|758
7999699|NCT03692676|12589073|FG003|Overall Study|Other|277
7999700|NCT03692676|12589070|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
7999701|NCT03692676|12589071|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
7999702|NCT03692676|12589072|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
7999703|NCT03692676|12589073|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3
7999704|NCT03693625|12589085|FG000|Overall Study|Adverse Event|2
7999705|NCT03693625|12589086|FG001|Overall Study|Adverse Event|0
7999706|NCT03693625|12589085|FG000|Overall Study|Study Terminated By Sponsor|20
7999707|NCT03693625|12589086|FG001|Overall Study|Study Terminated By Sponsor|7
7999708|NCT03693625|12589085|FG000|Overall Study|Withdrawal by Subject|1
7999709|NCT03693625|12589086|FG001|Overall Study|Withdrawal by Subject|1
7999710|NCT03693950|12589109|FG000|Overall Study|Withdrawal by Subject|1
7999711|NCT03693950|12589110|FG001|Overall Study|Withdrawal by Subject|0
7999712|NCT03693989|12589118|FG000|Overall Study|Protocol Violation|3
7999713|NCT03693989|12589119|FG001|Overall Study|Protocol Violation|4
7999714|NCT03694197|12589125|FG000|Overall Study|Adverse Event|9
7999715|NCT03694197|12589125|FG000|Overall Study|Protocol became inconvenient to participate|1
7999716|NCT03694197|12589125|FG000|Overall Study|Physician Decision|4
7999717|NCT03694197|12589125|FG000|Overall Study|Study terminated by sponsor|1350
7999718|NCT03694197|12589125|FG000|Overall Study|Participant moved|5
7999719|NCT03694197|12589125|FG000|Overall Study|Participant withdrew consent|10
7999720|NCT03694197|12589125|FG000|Overall Study|Related to IMP administration|1
7999721|NCT03694197|12589125|FG000|Overall Study|Not disclosed|5
7999722|NCT03694210|12589129|FG000|Overall Study|Death|1
7999723|NCT03694210|12589129|FG000|Overall Study|Screen Failure|7
7999724|NCT03694548|12589137|FG000|Part A Survey|Protocol Violation|3
7999725|NCT03694548|12589138|FG001|Part A Survey|Protocol Violation|3
7999726|NCT03694548|12589139|FG002|Part A Survey|Protocol Violation|0
7999727|NCT03694548|12589137|FG000|Part B Yoga Program|Protocol Violation|0
7999728|NCT03694548|12589138|FG001|Part B Yoga Program|Protocol Violation|0
7999729|NCT03694548|12589139|FG002|Part B Yoga Program|Protocol Violation|3
7999730|NCT03694548|12589137|FG000|Part B Yoga Program|Did not attend intervention|0
7999731|NCT03694548|12589138|FG001|Part B Yoga Program|Did not attend intervention|0
7999732|NCT03694548|12589139|FG002|Part B Yoga Program|Did not attend intervention|8
7999733|NCT03694925|12589165|FG000|Overall Study|Inadequate laboratory testing|0
7999734|NCT03694925|12589166|FG001|Overall Study|Inadequate laboratory testing|3
7999735|NCT03694925|12589167|FG002|Overall Study|Inadequate laboratory testing|0
7999736|NCT03695094|12589179|FG000|Overall Study|Adverse Event|1
7999737|NCT03695094|12589180|FG001|Overall Study|Adverse Event|1
7999738|NCT03695094|12589179|FG000|Overall Study|Withdrawal by Subject|1
7999739|NCT03695094|12589180|FG001|Overall Study|Withdrawal by Subject|0
7999740|NCT03695367|12589190|FG000|Overall Study|Missed the Day 28 visit.|1
7999741|NCT03695367|12589191|FG001|Overall Study|Missed the Day 28 visit.|0
7999742|NCT03695367|12589190|FG000|Overall Study|Lost to Follow-up|0
7999743|NCT03695367|12589191|FG001|Overall Study|Lost to Follow-up|1
7999744|NCT03695367|12589190|FG000|Overall Study|Withdrawal by Subject|0
7999745|NCT03695367|12589191|FG001|Overall Study|Withdrawal by Subject|1
7999746|NCT03695367|12589190|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0
7999747|NCT03695367|12589191|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2
7999748|NCT03695393|12589199|FG000|Overall Study|Death|3
7999749|NCT03695393|12589200|FG001|Overall Study|Death|1
7999750|NCT03695393|12589199|FG000|Overall Study|Lost to Follow-up|0
7999751|NCT03695393|12589200|FG001|Overall Study|Lost to Follow-up|1
7999752|NCT03696108|12589212|FG000|Overall Study|Physician Decision|1
7999753|NCT03696108|12589213|FG001|Overall Study|Physician Decision|0
7999754|NCT03696108|12589212|FG000|Overall Study|Withdrawal by Subject|3
7999755|NCT03696108|12589213|FG001|Overall Study|Withdrawal by Subject|6
7999756|NCT03696342|12589221|FG000|Overall Study|Lost to Follow-up|1
7999757|NCT03696342|12589222|FG001|Overall Study|Lost to Follow-up|0
7999758|NCT03696576|12589230|FG000|Overall Study|Soreness of throat after therapy|1
7999759|NCT03696576|12589231|FG001|Overall Study|Soreness of throat after therapy|1
7999760|NCT03696576|12589230|FG000|Overall Study|Lost to Follow-up|2
7999761|NCT03696576|12589231|FG001|Overall Study|Lost to Follow-up|4
7999762|NCT03697252|12589276|FG000|Overall Study|Adverse Event|3
7999763|NCT03697252|12589277|FG001|Overall Study|Adverse Event|2
7999764|NCT03697252|12589276|FG000|Overall Study|Withdrawal by Subject|14
7999765|NCT03697252|12589277|FG001|Overall Study|Withdrawal by Subject|14
7999766|NCT03697252|12589276|FG000|Overall Study|Lost to Follow-up|0
7999767|NCT03697252|12589277|FG001|Overall Study|Lost to Follow-up|1
7999768|NCT03697252|12589276|FG000|Overall Study|Physician Decision|1
7999769|NCT03697252|12589277|FG001|Overall Study|Physician Decision|1
7999770|NCT03697252|12589276|FG000|Overall Study|Other|0
7999771|NCT03697252|12589277|FG001|Overall Study|Other|1
7999772|NCT03697460|12589283|FG000|Overall Study|Withdrawal by Subject|3
7999773|NCT03697993|12589289|FG000|Overall Study|Became Ineligible after Enrollment|1
7999774|NCT03697993|12589290|FG001|Overall Study|Became Ineligible after Enrollment|3
7999775|NCT03697993|12589289|FG000|Overall Study|Enrolled but Treatment not Administered|2
7999776|NCT03697993|12589290|FG001|Overall Study|Enrolled but Treatment not Administered|1
7999777|NCT03697993|12589289|FG000|Overall Study|Lost to Follow-up|3
7999778|NCT03697993|12589290|FG001|Overall Study|Lost to Follow-up|0
7999779|NCT03697993|12589289|FG000|Overall Study|Physician Decision|4
7999780|NCT03697993|12589290|FG001|Overall Study|Physician Decision|0
7999781|NCT03697993|12589289|FG000|Overall Study|Initial Urine Culture Negative|0
7999782|NCT03697993|12589290|FG001|Overall Study|Initial Urine Culture Negative|1
7999783|NCT03698331|12589299|FG000|Overall Study|Adverse Event|2
7999784|NCT03698331|12589300|FG001|Overall Study|Adverse Event|3
7999785|NCT03698331|12589299|FG000|Overall Study|Withdrawal by Subject|1
7999786|NCT03698331|12589300|FG001|Overall Study|Withdrawal by Subject|1
7999787|NCT03698331|12589299|FG000|Overall Study|Lost to Follow-up|0
7999788|NCT03698331|12589300|FG001|Overall Study|Lost to Follow-up|2
7999789|NCT03698331|12589299|FG000|Overall Study|Non-compliance with study drug|1
7999790|NCT03698331|12589300|FG001|Overall Study|Non-compliance with study drug|0
7999791|NCT03698591|12589308|FG000|Overall Study|Withdrawal by Subject|2
7999792|NCT03698591|12589309|FG001|Overall Study|Withdrawal by Subject|2
7999793|NCT03698591|12589308|FG000|Overall Study|Failed drug screen|1
7999794|NCT03698591|12589309|FG001|Overall Study|Failed drug screen|1
7999795|NCT03698591|12589308|FG000|Overall Study|Failed health screen|0
7999796|NCT03698591|12589309|FG001|Overall Study|Failed health screen|1
7999797|NCT03698591|12589308|FG000|Overall Study|Ineligible for financial compensation|1
7999798|NCT03698591|12589309|FG001|Overall Study|Ineligible for financial compensation|0
7999799|NCT03698591|12589308|FG000|Overall Study|Equipment Error|1
7999800|NCT03698591|12589309|FG001|Overall Study|Equipment Error|0
7999801|NCT03698591|12589308|FG000|Overall Study|Could not establish TMS dosage|0
7999802|NCT03698591|12589309|FG001|Overall Study|Could not establish TMS dosage|1
7999803|NCT03699124|12589318|FG000|Overall Study|Adverse Event|6
7999804|NCT03699124|12589319|FG001|Overall Study|Adverse Event|5
7999805|NCT03699124|12589320|FG002|Overall Study|Adverse Event|2
7999806|NCT03699124|12589318|FG000|Overall Study|Death|0
7999807|NCT03699124|12589319|FG001|Overall Study|Death|2
7999808|NCT03699124|12589320|FG002|Overall Study|Death|0
7999809|NCT03699124|12589318|FG000|Overall Study|Lost to Follow-up|20
7999810|NCT03699124|12589319|FG001|Overall Study|Lost to Follow-up|16
7999811|NCT03699124|12589320|FG002|Overall Study|Lost to Follow-up|15
7999812|NCT03699124|12589318|FG000|Overall Study|Protocol Violation|1
7999813|NCT03699124|12589319|FG001|Overall Study|Protocol Violation|0
7999814|NCT03699124|12589320|FG002|Overall Study|Protocol Violation|0
7999815|NCT03699124|12589318|FG000|Overall Study|Withdrawal by Subject|13
7999816|NCT03699124|12589319|FG001|Overall Study|Withdrawal by Subject|14
7999817|NCT03699124|12589320|FG002|Overall Study|Withdrawal by Subject|13
7999818|NCT03699124|12589318|FG000|Overall Study|Other reasons|5
7999819|NCT03699124|12589319|FG001|Overall Study|Other reasons|3
7999820|NCT03699124|12589320|FG002|Overall Study|Other reasons|10
7999821|NCT03700320|12589330|FG000|Overall Study|Adverse Event|5
7999822|NCT03700320|12589331|FG001|Overall Study|Adverse Event|31
7999823|NCT03700320|12589330|FG000|Overall Study|Lack of Efficacy|2
7999824|NCT03700320|12589331|FG001|Overall Study|Lack of Efficacy|5
7999825|NCT03700320|12589330|FG000|Overall Study|Withdrawal by Subject|29
7999826|NCT03700320|12589331|FG001|Overall Study|Withdrawal by Subject|75
7999827|NCT03700320|12589330|FG000|Overall Study|Lost to Follow-up|16
7999828|NCT03700320|12589331|FG001|Overall Study|Lost to Follow-up|23
7999829|NCT03700320|12589330|FG000|Overall Study|Pregnancy|2
7999830|NCT03700320|12589331|FG001|Overall Study|Pregnancy|4
7999831|NCT03700320|12589330|FG000|Overall Study|Protocol Deviation|7
7999832|NCT03700320|12589331|FG001|Overall Study|Protocol Deviation|31
7999833|NCT03700320|12589330|FG000|Overall Study|Non-compliance with Study Drug|1
7999834|NCT03700320|12589331|FG001|Overall Study|Non-compliance with Study Drug|3
7999835|NCT03700320|12589330|FG000|Overall Study|Reason not Specified|0
7999836|NCT03700320|12589331|FG001|Overall Study|Reason not Specified|1
7999837|NCT03700385|12589341|FG000|Overall Study|Lost to Follow-up|1
7999838|NCT03700671|12589347|FG000|Overall Study|Lack of Efficacy|1
7999839|NCT03700671|12589348|FG001|Overall Study|Lack of Efficacy|2
7999840|NCT03700736|12589358|FG000|Overall Study|Pregnancy|1
7999841|NCT03700736|12589359|FG001|Overall Study|Pregnancy|1
7999842|NCT03700736|12589358|FG000|Overall Study|Withdrawal by Subject|2
7999843|NCT03700736|12589359|FG001|Overall Study|Withdrawal by Subject|6
7999844|NCT03700892|12589370|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0
7999845|NCT03700892|12589371|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1
7999846|NCT03700892|12589372|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0
7999847|NCT03701074|12589392|FG000|Overall Study|Physician Decision|1
7999848|NCT03701074|12589393|FG001|Overall Study|Physician Decision|0
7999849|NCT03702010|12589401|FG000|Follow-up (30days)|Lack of Efficacy|2
7999850|NCT03702010|12589402|FG001|Follow-up (30days)|Lack of Efficacy|2
7999851|NCT03702166|12589414|FG000|Overall Study|Lost to Follow-up|1
7999852|NCT03702166|12589414|FG000|Overall Study|Withdrawal by Subject|1
7999853|NCT03703336|12589425|FG000|Overall Study|Parent withdrew consent|29
7999854|NCT03703336|12589426|FG001|Overall Study|Parent withdrew consent|8
7999855|NCT03703336|12589425|FG000|Overall Study|Migration|3
7999856|NCT03703336|12589426|FG001|Overall Study|Migration|3
7999857|NCT03703336|12589425|FG000|Overall Study|Protocol Violation|3
7999858|NCT03703336|12589426|FG001|Overall Study|Protocol Violation|1
7999859|NCT03703336|12589425|FG000|Overall Study|Physician Decision|2
7999860|NCT03703336|12589426|FG001|Overall Study|Physician Decision|0
7999861|NCT03703336|12589425|FG000|Overall Study|Adverse Event|0
7999862|NCT03703336|12589426|FG001|Overall Study|Adverse Event|2
7999863|NCT03703336|12589425|FG000|Overall Study|Lost to Follow-up|1
7999864|NCT03703336|12589426|FG001|Overall Study|Lost to Follow-up|0
7999865|NCT03703817|12589434|FG000|Overall Study|Not meeting eligibility criteria|7
7999866|NCT03703817|12589435|FG001|Overall Study|Not meeting eligibility criteria|4
7999867|NCT03704194|12589443|FG000|Overall Study|Withdrawal by Subject|0
7999868|NCT03704194|12589444|FG001|Overall Study|Withdrawal by Subject|1
7718353|NCT00527735|12142316|FG000|Overall Study|Withdrawal by Subject|5
7718354|NCT00527735|12142317|FG001|Overall Study|Withdrawal by Subject|4
7718355|NCT00527735|12142318|FG002|Overall Study|Withdrawal by Subject|3
7718356|NCT00527735|12142316|FG000|Overall Study|No longer met study criteria|2
7718357|NCT00527735|12142317|FG001|Overall Study|No longer met study criteria|2
7718358|NCT00527735|12142318|FG002|Overall Study|No longer met study criteria|1
7718359|NCT00527735|12142316|FG000|Overall Study|Lost to Follow-up|0
7718360|NCT00527735|12142317|FG001|Overall Study|Lost to Follow-up|0
7999869|NCT03705494|12589483|FG000|Overall Study|Lost to Follow-up|2
7999870|NCT03705494|12589484|FG001|Overall Study|Lost to Follow-up|1
7999871|NCT03705494|12589483|FG000|Overall Study|Withdrawal by Subject|5
7999872|NCT03705494|12589484|FG001|Overall Study|Withdrawal by Subject|2
7999873|NCT03706040|12589493|FG000|Period A (Week 0 to Week 16)|Adverse Event|3
7999874|NCT03706040|12589494|FG001|Period A (Week 0 to Week 16)|Adverse Event|2
7999875|NCT03706040|12589495|FG002|Period A (Week 0 to Week 16)|Adverse Event|1
7999876|NCT03706040|12589496|FG003|Period A (Week 0 to Week 16)|Adverse Event|0
7999877|NCT03706040|12589497|FG004|Period A (Week 0 to Week 16)|Adverse Event|0
7999878|NCT03706040|12589498|FG005|Period A (Week 0 to Week 16)|Adverse Event|0
7999879|NCT03706040|12589499|FG006|Period A (Week 0 to Week 16)|Adverse Event|0
7999880|NCT03706040|12589493|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3
7999881|NCT03706040|12589494|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5
7999882|NCT03706040|12589495|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4
7999883|NCT03706040|12589496|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0
7999884|NCT03706040|12589497|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0
7999885|NCT03706040|12589498|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0
7999886|NCT03706040|12589499|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0
7999887|NCT03706040|12589493|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1
7999888|NCT03706040|12589494|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1
7999889|NCT03706040|12589495|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4
7999890|NCT03706040|12589496|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0
7999891|NCT03706040|12589497|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0
7999892|NCT03706040|12589498|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0
7999893|NCT03706040|12589499|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0
7999894|NCT03706040|12589493|FG000|Period A (Week 0 to Week 16)|Other|2
7999895|NCT03706040|12589494|FG001|Period A (Week 0 to Week 16)|Other|0
7999896|NCT03706040|12589495|FG002|Period A (Week 0 to Week 16)|Other|2
7999897|NCT03706040|12589496|FG003|Period A (Week 0 to Week 16)|Other|0
7999898|NCT03706040|12589497|FG004|Period A (Week 0 to Week 16)|Other|0
7999899|NCT03706040|12589498|FG005|Period A (Week 0 to Week 16)|Other|0
7999900|NCT03706040|12589499|FG006|Period A (Week 0 to Week 16)|Other|0
7999901|NCT03706040|12589493|FG000|Period B (Week 16 to Week 52)|Adverse Event|0
7999902|NCT03706040|12589494|FG001|Period B (Week 16 to Week 52)|Adverse Event|0
7999903|NCT03706040|12589495|FG002|Period B (Week 16 to Week 52)|Adverse Event|0
7999904|NCT03706040|12589496|FG003|Period B (Week 16 to Week 52)|Adverse Event|1
7999905|NCT03706040|12589497|FG004|Period B (Week 16 to Week 52)|Adverse Event|2
7999906|NCT03706040|12589498|FG005|Period B (Week 16 to Week 52)|Adverse Event|3
7999907|NCT03706040|12589499|FG006|Period B (Week 16 to Week 52)|Adverse Event|0
7999908|NCT03706040|12589493|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0
7999909|NCT03706040|12589494|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0
7999910|NCT03706040|12589495|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0
7999911|NCT03706040|12589496|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3
7999912|NCT03706040|12589497|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2
7999913|NCT03706040|12589498|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1
7999914|NCT03706040|12589499|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10
7999915|NCT03706040|12589493|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0
7999916|NCT03706040|12589494|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0
7999917|NCT03706040|12589495|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0
7999918|NCT03706040|12589496|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0
7999919|NCT03706040|12589497|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0
7999920|NCT03706040|12589498|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1
7999921|NCT03706040|12589499|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1
7999922|NCT03706040|12589493|FG000|Period B (Week 16 to Week 52)|Other|0
7999923|NCT03706040|12589494|FG001|Period B (Week 16 to Week 52)|Other|0
7999924|NCT03706040|12589495|FG002|Period B (Week 16 to Week 52)|Other|0
7999925|NCT03706040|12589496|FG003|Period B (Week 16 to Week 52)|Other|4
7999926|NCT03706040|12589497|FG004|Period B (Week 16 to Week 52)|Other|5
7999927|NCT03706040|12589498|FG005|Period B (Week 16 to Week 52)|Other|23
7999928|NCT03706040|12589499|FG006|Period B (Week 16 to Week 52)|Other|17
7999929|NCT03707522|12589572|FG000|Overall Study|Lost to Follow-up|24
7999930|NCT03707522|12589573|FG001|Overall Study|Lost to Follow-up|27
7999931|NCT03707522|12589574|FG002|Overall Study|Lost to Follow-up|41
7999932|NCT03707522|12589575|FG003|Overall Study|Lost to Follow-up|36
7999933|NCT03707821|12589587|FG000|Overall Study|Protocol Violation|0
7999934|NCT03707821|12589588|FG001|Overall Study|Protocol Violation|1
7999935|NCT03707821|12589587|FG000|Overall Study|Unsatisfactory Visual Response|1
7999936|NCT03707821|12589588|FG001|Overall Study|Unsatisfactory Visual Response|0
7999937|NCT03707821|12589587|FG000|Overall Study|Unsatisfactory Lens Fitting|1
7999938|NCT03707821|12589588|FG001|Overall Study|Unsatisfactory Lens Fitting|0
7999939|NCT03707912|12589596|FG000|Overall Study|Violation of inclusion criteria|1
7999940|NCT03707912|12589597|FG001|Overall Study|Violation of inclusion criteria|0
7999941|NCT03708211|12589605|FG000|Overall Study|Progressive Disease|10
7999942|NCT03708211|12589606|FG001|Overall Study|Progressive Disease|7
7999943|NCT03708211|12589605|FG000|Overall Study|Withdrawal by Subject|0
7999944|NCT03708211|12589606|FG001|Overall Study|Withdrawal by Subject|1
7999945|NCT03708211|12589605|FG000|Overall Study|Other|2
7999946|NCT03708211|12589606|FG001|Overall Study|Other|0
7999947|NCT03708744|12589637|FG000|Overall Study|Withdrawal by Subject|0
7999948|NCT03708744|12589638|FG001|Overall Study|Withdrawal by Subject|0
7999949|NCT03708744|12589639|FG002|Overall Study|Withdrawal by Subject|1
7999950|NCT03708744|12589640|FG003|Overall Study|Withdrawal by Subject|0
7999951|NCT03709654|12589667|FG000|Overall Study|Lost to Follow-up|1
7999952|NCT03709654|12589668|FG001|Overall Study|Lost to Follow-up|1
7999953|NCT03709654|12589667|FG000|Overall Study|Withdrawal by Subject|1
7999954|NCT03709654|12589668|FG001|Overall Study|Withdrawal by Subject|1
7999955|NCT03709654|12589667|FG000|Overall Study|Adverse Event|1
7999956|NCT03709654|12589668|FG001|Overall Study|Adverse Event|0
7999957|NCT03709823|12589687|FG000|Overall Study|Adverse Event|0
7999958|NCT03709823|12589688|FG001|Overall Study|Adverse Event|0
7999959|NCT03709823|12589689|FG002|Overall Study|Adverse Event|1
7999960|NCT03709823|12589690|FG003|Overall Study|Adverse Event|0
7999961|NCT03709823|12589691|FG004|Overall Study|Adverse Event|0
7999962|NCT03709823|12589692|FG005|Overall Study|Adverse Event|0
7999963|NCT03709823|12589687|FG000|Overall Study|Lost to Follow-up|2
7999964|NCT03709823|12589688|FG001|Overall Study|Lost to Follow-up|2
7999965|NCT03709823|12589689|FG002|Overall Study|Lost to Follow-up|2
7999966|NCT03709823|12589690|FG003|Overall Study|Lost to Follow-up|1
7999967|NCT03709823|12589691|FG004|Overall Study|Lost to Follow-up|1
7999968|NCT03709823|12589692|FG005|Overall Study|Lost to Follow-up|0
7999969|NCT03709823|12589687|FG000|Overall Study|Withdrawal by Subject|1
7999970|NCT03709823|12589688|FG001|Overall Study|Withdrawal by Subject|3
7999971|NCT03709823|12589689|FG002|Overall Study|Withdrawal by Subject|0
7999972|NCT03709823|12589690|FG003|Overall Study|Withdrawal by Subject|0
7999973|NCT03709823|12589691|FG004|Overall Study|Withdrawal by Subject|0
7999974|NCT03709823|12589692|FG005|Overall Study|Withdrawal by Subject|0
7999975|NCT03709823|12589687|FG000|Overall Study|Other, Not Specified|0
7999976|NCT03709823|12589688|FG001|Overall Study|Other, Not Specified|0
7999977|NCT03709823|12589689|FG002|Overall Study|Other, Not Specified|0
7999978|NCT03709823|12589690|FG003|Overall Study|Other, Not Specified|1
7999979|NCT03709823|12589691|FG004|Overall Study|Other, Not Specified|0
7999980|NCT03709823|12589692|FG005|Overall Study|Other, Not Specified|0
7999981|NCT03710083|12589709|FG000|Overall Study|Withdrawal by Subject|2
7999982|NCT03710083|12589709|FG000|Overall Study|Unsuccessful Procedure|1
7999983|NCT03710161|12589715|FG000|Overall Study|Study halted due to COVID pandemic|3
7999984|NCT03710161|12589716|FG001|Overall Study|Study halted due to COVID pandemic|2
7999985|NCT03710590|12589742|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10
7999986|NCT03710590|12589743|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8
7999987|NCT03710889|12589749|FG000|Overall Study|Adverse Event|2
7999988|NCT03710889|12589749|FG000|Overall Study|Protocol Deviation|1
7999989|NCT03712280|12589778|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0
7999990|NCT03712280|12589779|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1
7999991|NCT03712280|12589780|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0
7999992|NCT03712280|12589781|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1
7999993|NCT03712280|12589778|FG000|Overall Study|Withdrawal by Participant or Caregiver|1
7999994|NCT03712280|12589779|FG001|Overall Study|Withdrawal by Participant or Caregiver|0
7999995|NCT03712280|12589780|FG002|Overall Study|Withdrawal by Participant or Caregiver|0
7999996|NCT03712280|12589781|FG003|Overall Study|Withdrawal by Participant or Caregiver|0
7999997|NCT03712280|12589778|FG000|Overall Study|Adverse Event|0
7999998|NCT03712280|12589779|FG001|Overall Study|Adverse Event|0
7999999|NCT03712280|12589780|FG002|Overall Study|Adverse Event|1
8000000|NCT03712280|12589781|FG003|Overall Study|Adverse Event|0
8000001|NCT03712449|12589793|FG000|Overall Study|Withdraw Consent|0
8000002|NCT03712449|12589794|FG001|Overall Study|Withdraw Consent|1
8000003|NCT03712917|12589816|FG000|Overall Study|Pregnancy|0
8000004|NCT03712917|12589817|FG001|Overall Study|Pregnancy|0
8000005|NCT03712917|12589818|FG002|Overall Study|Pregnancy|1
8000006|NCT03712917|12589816|FG000|Overall Study|Adverse Event|0
8000007|NCT03712917|12589817|FG001|Overall Study|Adverse Event|4
8000008|NCT03712917|12589818|FG002|Overall Study|Adverse Event|3
8000009|NCT03712917|12589816|FG000|Overall Study|Lost to Follow-up|9
8000010|NCT03712917|12589817|FG001|Overall Study|Lost to Follow-up|4
8000011|NCT03712917|12589818|FG002|Overall Study|Lost to Follow-up|5
8000012|NCT03712930|12589826|FG000|Overall Study|Death|7
8000013|NCT03712930|12589826|FG000|Overall Study|Physician Decision|1
8000014|NCT03712930|12589826|FG000|Overall Study|Study Terminated by Sponsor|3
8000015|NCT03712930|12589826|FG000|Overall Study|Progressive Disease|2
8000016|NCT03714022|12589841|FG000|Overall Study|Adverse Event|1
8000017|NCT03714022|12589842|FG001|Overall Study|Adverse Event|0
8000018|NCT03714022|12589841|FG000|Overall Study|Consent withdrawal|0
8000019|NCT03714022|12589842|FG001|Overall Study|Consent withdrawal|1
8000020|NCT03714022|12589841|FG000|Overall Study|Lost to Follow-up|3
8000021|NCT03714022|12589842|FG001|Overall Study|Lost to Follow-up|2
8000022|NCT03714672|12589865|FG000|Overall Study|Adverse Event|0
8000023|NCT03714672|12589866|FG001|Overall Study|Adverse Event|0
8000024|NCT03714672|12589867|FG002|Overall Study|Adverse Event|3
8000025|NCT03714672|12589868|FG003|Overall Study|Adverse Event|0
8000026|NCT03714672|12589865|FG000|Overall Study|Physician Decision|0
8000027|NCT03714672|12589866|FG001|Overall Study|Physician Decision|1
8000028|NCT03714672|12589867|FG002|Overall Study|Physician Decision|0
8000029|NCT03714672|12589868|FG003|Overall Study|Physician Decision|0
8000030|NCT03714672|12589865|FG000|Overall Study|Other Reason|1
8000031|NCT03714672|12589866|FG001|Overall Study|Other Reason|2
8000032|NCT03714672|12589867|FG002|Overall Study|Other Reason|1
8000033|NCT03714672|12589868|FG003|Overall Study|Other Reason|1
8000034|NCT03714672|12589865|FG000|Overall Study|Lost to Follow-up|1
8000035|NCT03714672|12589866|FG001|Overall Study|Lost to Follow-up|1
8000036|NCT03714672|12589867|FG002|Overall Study|Lost to Follow-up|0
8000037|NCT03714672|12589868|FG003|Overall Study|Lost to Follow-up|0
8000038|NCT03715530|12589899|FG000|Overall Study|Lost to Follow-up|3
8000039|NCT03715530|12589900|FG001|Overall Study|Lost to Follow-up|1
8000040|NCT03715530|12589901|FG002|Overall Study|Lost to Follow-up|2
8000041|NCT03716024|12589920|FG000|Overall Study|Randomized, not Treated|7
8000042|NCT03716024|12589921|FG001|Overall Study|Randomized, not Treated|8
8000043|NCT03716024|12589920|FG000|Overall Study|Adverse Event|1
8000044|NCT03716024|12589921|FG001|Overall Study|Adverse Event|2
8000045|NCT03716024|12589920|FG000|Overall Study|Treatment Failure|1
8000046|NCT03716024|12589921|FG001|Overall Study|Treatment Failure|0
8000047|NCT03716024|12589920|FG000|Overall Study|Lost to Follow-up|2
8000048|NCT03716024|12589921|FG001|Overall Study|Lost to Follow-up|6
8000049|NCT03716024|12589920|FG000|Overall Study|Withdrawal by Subject|0
8000050|NCT03716024|12589921|FG001|Overall Study|Withdrawal by Subject|1
8000051|NCT03716024|12589920|FG000|Overall Study|Missing Reason|0
8000052|NCT03716024|12589921|FG001|Overall Study|Missing Reason|1
8000053|NCT03716050|12589935|FG000|Overall Study|Lost to Follow-up|0
8000054|NCT03716050|12589936|FG001|Overall Study|Lost to Follow-up|0
8000055|NCT03716050|12589937|FG002|Overall Study|Lost to Follow-up|1
8000056|NCT03716050|12589938|FG003|Overall Study|Lost to Follow-up|0
8000057|NCT03716050|12589939|FG004|Overall Study|Lost to Follow-up|0
8000058|NCT03716050|12589940|FG005|Overall Study|Lost to Follow-up|0
8000059|NCT03716050|12589941|FG006|Overall Study|Lost to Follow-up|0
8000060|NCT03716050|12589942|FG007|Overall Study|Lost to Follow-up|0
8000061|NCT03716050|12589935|FG000|Overall Study|Physician Decision|0
8000062|NCT03716050|12589936|FG001|Overall Study|Physician Decision|0
8000063|NCT03716050|12589937|FG002|Overall Study|Physician Decision|0
8000064|NCT03716050|12589938|FG003|Overall Study|Physician Decision|1
8000065|NCT03716050|12589939|FG004|Overall Study|Physician Decision|0
8000066|NCT03716050|12589940|FG005|Overall Study|Physician Decision|0
8000067|NCT03716050|12589941|FG006|Overall Study|Physician Decision|0
8000068|NCT03716050|12589942|FG007|Overall Study|Physician Decision|0
8000069|NCT03716050|12589935|FG000|Overall Study|Protocol Violation|0
8000070|NCT03716050|12589936|FG001|Overall Study|Protocol Violation|0
8000071|NCT03716050|12589937|FG002|Overall Study|Protocol Violation|0
8000072|NCT03716050|12589938|FG003|Overall Study|Protocol Violation|1
8000073|NCT03716050|12589939|FG004|Overall Study|Protocol Violation|0
8000074|NCT03716050|12589940|FG005|Overall Study|Protocol Violation|0
8000075|NCT03716050|12589941|FG006|Overall Study|Protocol Violation|0
8000076|NCT03716050|12589942|FG007|Overall Study|Protocol Violation|2
8000077|NCT03717012|12589970|FG000|Overall Study|Due to trial termination|1
8000078|NCT03717012|12589971|FG001|Overall Study|Due to trial termination|2
8000079|NCT03717012|12589970|FG000|Overall Study|Protocol Violation|0
8000080|NCT03717012|12589971|FG001|Overall Study|Protocol Violation|2
8000081|NCT03717012|12589970|FG000|Overall Study|Adverse Event|0
8000082|NCT03717012|12589971|FG001|Overall Study|Adverse Event|1
8000083|NCT03717012|12589970|FG000|Overall Study|Lung transplant|0
8000084|NCT03717012|12589971|FG001|Overall Study|Lung transplant|1
8000085|NCT03717064|12589986|FG000|Period 2|Adverse Event|1
8000086|NCT03719586|12590030|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8
8000087|NCT03719586|12590031|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7
8000088|NCT03719586|12590032|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4
8000089|NCT03719586|12590033|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0
8000090|NCT03720470|12590067|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5
8000091|NCT03720470|12590068|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0
8000092|NCT03720470|12590069|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0
8000093|NCT03720470|12590070|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5
8000094|NCT03720470|12590071|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8
8000095|NCT03720470|12590072|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6
8000096|NCT03720470|12590067|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
8000097|NCT03720470|12590068|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
8000098|NCT03720470|12590069|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
8000099|NCT03720470|12590070|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
8000100|NCT03720470|12590071|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
8000101|NCT03720470|12590072|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
8000102|NCT03720470|12590067|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
8000103|NCT03720470|12590068|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
8000104|NCT03720470|12590069|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
8000105|NCT03720470|12590070|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
8000106|NCT03720470|12590071|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
8000107|NCT03720470|12590072|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
8000108|NCT03720470|12590067|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0
8000109|NCT03720470|12590068|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0
8000110|NCT03720470|12590069|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0
8000111|NCT03720470|12590070|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0
8000112|NCT03720470|12590071|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1
8000113|NCT03720470|12590072|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1
8000114|NCT03720470|12590067|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2
8000115|NCT03720470|12590068|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0
8000116|NCT03720470|12590069|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0
8000117|NCT03720470|12590070|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2
8000118|NCT03720470|12590071|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2
8000119|NCT03720470|12590072|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1
8000120|NCT03720470|12590067|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5
8000121|NCT03720470|12590068|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
8000122|NCT03720470|12590069|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
8000123|NCT03720470|12590070|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9
8000124|NCT03720470|12590071|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3
8000125|NCT03720470|12590072|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6
8000126|NCT03720470|12590067|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
8000127|NCT03720470|12590068|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
8000128|NCT03720470|12590069|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
8000129|NCT03720470|12590070|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
8000130|NCT03720470|12590071|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
8000131|NCT03720470|12590072|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
8000132|NCT03720470|12590067|FG000|Treatment Period: First Part 16 Weeks|Other|1
8000133|NCT03720470|12590068|FG001|Treatment Period: First Part 16 Weeks|Other|0
8000134|NCT03720470|12590069|FG002|Treatment Period: First Part 16 Weeks|Other|0
8000135|NCT03720470|12590070|FG003|Treatment Period: First Part 16 Weeks|Other|1
8000136|NCT03720470|12590071|FG004|Treatment Period: First Part 16 Weeks|Other|2
8000137|NCT03720470|12590072|FG005|Treatment Period: First Part 16 Weeks|Other|2
8000138|NCT03720470|12590067|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
8000139|NCT03720470|12590068|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
8000140|NCT03720470|12590069|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
8000141|NCT03720470|12590070|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
8000142|NCT03720470|12590071|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
8000143|NCT03720470|12590072|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1
8000144|NCT03720470|12590067|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0
8000145|NCT03720470|12590068|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0
8000146|NCT03720470|12590069|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0
8000147|NCT03720470|12590070|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2
8000148|NCT03720470|12590071|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1
8000149|NCT03720470|12590072|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1
8000150|NCT03720470|12590067|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
8000151|NCT03720470|12590068|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
8000152|NCT03720470|12590069|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1
8000153|NCT03720470|12590070|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
8000154|NCT03720470|12590071|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
8000155|NCT03720470|12590072|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
8000156|NCT03720470|12590067|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
8000157|NCT03720470|12590068|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
8000158|NCT03720470|12590069|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
8000159|NCT03720470|12590070|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
8000160|NCT03720470|12590071|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
8000161|NCT03720470|12590072|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
8000162|NCT03720470|12590067|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0
8000163|NCT03720470|12590068|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0
8000164|NCT03720470|12590069|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0
8000165|NCT03720470|12590070|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0
8000166|NCT03720470|12590071|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0
8000167|NCT03720470|12590072|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1
8000168|NCT03720470|12590067|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0
8000169|NCT03720470|12590068|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0
8000170|NCT03720470|12590069|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1
8000171|NCT03720470|12590070|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0
8000172|NCT03720470|12590071|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0
8000173|NCT03720470|12590072|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0
8000174|NCT03720470|12590067|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
8000175|NCT03720470|12590068|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1
8000176|NCT03720470|12590069|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
8000177|NCT03720470|12590070|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
8000178|NCT03720470|12590071|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
8000179|NCT03720470|12590072|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
8000180|NCT03720470|12590067|FG000|Treatment Period: Final 4 Weeks|Other|0
8000181|NCT03720470|12590068|FG001|Treatment Period: Final 4 Weeks|Other|1
8000182|NCT03720470|12590069|FG002|Treatment Period: Final 4 Weeks|Other|0
8000183|NCT03720470|12590070|FG003|Treatment Period: Final 4 Weeks|Other|2
8000184|NCT03720470|12590071|FG004|Treatment Period: Final 4 Weeks|Other|1
8000185|NCT03720470|12590072|FG005|Treatment Period: Final 4 Weeks|Other|0
8000186|NCT03720652|12590094|FG000|Overall Study|Withdrawal by Subject|2
8000187|NCT03720652|12590095|FG001|Overall Study|Withdrawal by Subject|7
8000188|NCT03720652|12590094|FG000|Overall Study|Lost to Follow-up|0
8000189|NCT03720652|12590095|FG001|Overall Study|Lost to Follow-up|4
8000190|NCT03720847|12590103|FG000|Washout|Physician Decision|1
8000191|NCT03720847|12590104|FG001|Washout|Physician Decision|2
8000192|NCT03722030|12590142|FG000|Overall Study|Withdrawal by Subject|1
8000193|NCT03722030|12590143|FG001|Overall Study|Withdrawal by Subject|0
8000194|NCT03722238|12590152|FG000|Overall Study|Protocol Violation|1
8000195|NCT03722238|12590153|FG001|Overall Study|Protocol Violation|0
8000196|NCT03722238|12590152|FG000|Overall Study|Physician Decision|1
8000197|NCT03722238|12590153|FG001|Overall Study|Physician Decision|0
8000198|NCT03722238|12590152|FG000|Overall Study|Death|1
8000199|NCT03722238|12590153|FG001|Overall Study|Death|0
8000200|NCT03722238|12590152|FG000|Overall Study|Lost to Follow-up|6
8000201|NCT03722238|12590153|FG001|Overall Study|Lost to Follow-up|0
8000202|NCT03722238|12590152|FG000|Overall Study|Partial missing data|44
8000203|NCT03722238|12590153|FG001|Overall Study|Partial missing data|1
8000204|NCT03722238|12590152|FG000|Overall Study|Withdrawal by Subject|2
8000205|NCT03722238|12590153|FG001|Overall Study|Withdrawal by Subject|0
8000206|NCT03722238|12590152|FG000|Overall Study|Other|4
8000207|NCT03722238|12590153|FG001|Overall Study|Other|0
8000208|NCT03722238|12590152|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2
8000209|NCT03722238|12590153|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0
8000210|NCT03722238|12590152|FG000|Overall Study|Did not meet risk classification group criteria|90
8000211|NCT03722238|12590153|FG001|Overall Study|Did not meet risk classification group criteria|0
8000212|NCT03722238|12590152|FG000|Overall Study|Did not sign consent|17
8000213|NCT03722238|12590153|FG001|Overall Study|Did not sign consent|0
8000214|NCT03722238|12590152|FG000|Overall Study|Other eligibility criteria not met pre-consent|22
8000215|NCT03722238|12590153|FG001|Overall Study|Other eligibility criteria not met pre-consent|0
8000216|NCT03722238|12590152|FG000|Overall Study|Not willing to purchase study medication|142
8000217|NCT03722238|12590153|FG001|Overall Study|Not willing to purchase study medication|0
8000218|NCT03722238|12590152|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133
8000219|NCT03722238|12590153|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0
8000220|NCT03722264|12590159|FG000|Overall Study|Physician Decision|3
8000221|NCT03722446|12590167|FG000|Overall Study|Protocol Violation|15
8000222|NCT03722446|12590168|FG001|Overall Study|Protocol Violation|2
8000223|NCT03722524|12590174|FG000|Overall Study|Protocol Violation|86
8000224|NCT03722524|12590174|FG000|Overall Study|Adverse Event|7
8000225|NCT03722524|12590174|FG000|Overall Study|Lost to Follow-up|1
8000226|NCT03722524|12590174|FG000|Overall Study|Reason is not stated|1
8000227|NCT03722524|12590174|FG000|Overall Study|Physician Decision|1
8000228|NCT03722524|12590174|FG000|Overall Study|Patient's decision (refusal to continue participation)|3
8000229|NCT03722576|12590178|FG000|Overall Study|Withdrawal by Subject|3
8000230|NCT03722576|12590178|FG000|Overall Study|Adverse Event|2
8000231|NCT03722576|12590178|FG000|Overall Study|Physician Decision|1
8000232|NCT03722576|12590178|FG000|Overall Study|Lost to Follow-up|1
8000233|NCT03722784|12590184|FG000|Overall Study|Withdrawal by Subject|1
8000234|NCT03722784|12590185|FG001|Overall Study|Withdrawal by Subject|0
8000235|NCT03722784|12590184|FG000|Overall Study|Physician Decision|1
8000236|NCT03722784|12590185|FG001|Overall Study|Physician Decision|1
8000237|NCT03722784|12590184|FG000|Overall Study|Protocol Violation|0
8000238|NCT03722784|12590185|FG001|Overall Study|Protocol Violation|1
8000239|NCT03723915|12590192|FG000|Screening|Failed to meet screening requirements.|2
8000240|NCT03723915|12590192|FG000|On Treatment|Failed to meet treatment requirements|2
8000241|NCT03724812|12590196|FG000|Overall Study|Missed Visit|1
8000242|NCT03724812|12590196|FG000|Overall Study|Death|2
8000243|NCT03724812|12590196|FG000|Overall Study|Withdrawal by Subject|1
8000244|NCT03725982|12590203|FG000|First Intervention|Withdrawal by Subject|0
8000245|NCT03725982|12590204|FG001|First Intervention|Withdrawal by Subject|1
8000246|NCT03725982|12590203|FG000|First Intervention|Physician Decision|1
8000247|NCT03725982|12590204|FG001|First Intervention|Physician Decision|1
8000248|NCT03736967|12590220|FG000|Overall Study|Withdrawal by Subject|26
8000249|NCT03736967|12590221|FG001|Overall Study|Withdrawal by Subject|25
8000250|NCT03736967|12590222|FG002|Overall Study|Withdrawal by Subject|23
8000251|NCT03736967|12590223|FG003|Overall Study|Withdrawal by Subject|26
8000252|NCT03736967|12590220|FG000|Overall Study|Lost to Follow-up|3
8000253|NCT03736967|12590221|FG001|Overall Study|Lost to Follow-up|2
8000254|NCT03736967|12590222|FG002|Overall Study|Lost to Follow-up|1
8000255|NCT03736967|12590223|FG003|Overall Study|Lost to Follow-up|1
8000256|NCT03736967|12590220|FG000|Overall Study|Physician Decision|1
8000257|NCT03736967|12590221|FG001|Overall Study|Physician Decision|0
8000258|NCT03736967|12590222|FG002|Overall Study|Physician Decision|0
8000259|NCT03736967|12590223|FG003|Overall Study|Physician Decision|1
8000260|NCT03736967|12590220|FG000|Overall Study|Adverse Event|0
8000261|NCT03736967|12590221|FG001|Overall Study|Adverse Event|1
8000262|NCT03736967|12590222|FG002|Overall Study|Adverse Event|0
8000263|NCT03736967|12590223|FG003|Overall Study|Adverse Event|1
8000264|NCT03736967|12590220|FG000|Overall Study|Death|0
8000265|NCT03736967|12590221|FG001|Overall Study|Death|0
8000266|NCT03736967|12590222|FG002|Overall Study|Death|0
8000267|NCT03736967|12590223|FG003|Overall Study|Death|1
8000268|NCT03736967|12590220|FG000|Overall Study|Randomized but never treated|1
8000269|NCT03736967|12590221|FG001|Overall Study|Randomized but never treated|0
8000270|NCT03736967|12590222|FG002|Overall Study|Randomized but never treated|0
8000271|NCT03736967|12590223|FG003|Overall Study|Randomized but never treated|0
8000272|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Adverse Event|2
8000273|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Adverse Event|6
8000274|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Adverse Event|6
8000275|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Adverse Event|12
8000276|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0
8000277|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1
8000278|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0
8000279|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3
8000280|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Protocol Violation|0
8000281|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Protocol Violation|0
8000282|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Protocol Violation|1
8000283|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Protocol Violation|0
8000284|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1
8000285|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3
8000286|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1
8000287|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1
8000288|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Program Termination|3
8000289|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Program Termination|0
8000290|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Program Termination|1
8000291|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Program Termination|1
8000292|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1
8000293|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
8000294|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
8000295|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
8000296|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Sponsors Decision|3
8000297|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Sponsors Decision|2
8000298|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Sponsors Decision|1
8000299|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Sponsors Decision|3
8000300|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Promotor Decision|0
8000301|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Promotor Decision|1
8000302|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Promotor Decision|0
8000303|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Promotor Decision|0
8000304|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
8000305|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1
8000306|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
8000307|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
8000308|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Premature Program Termination|0
8000309|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Premature Program Termination|1
8000310|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Premature Program Termination|0
8000311|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Premature Program Termination|0
8000312|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
8000313|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1
8000314|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
8000315|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
8000316|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Study Early Closure|0
8000317|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Study Early Closure|0
8000318|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Study Early Closure|1
8000319|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Study Early Closure|0
8000320|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
8000321|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
8000322|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1
8000323|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
8000324|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0
8000325|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0
8000326|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1
8000327|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0
8000328|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
8000329|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
8000330|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
8000331|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1
8000332|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
8000333|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
8000334|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
8000335|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1
8000336|NCT03739840|12590240|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
8000337|NCT03739840|12590241|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
8000338|NCT03739840|12590242|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
8000339|NCT03739840|12590243|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1
8000340|NCT03739840|12590240|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3
8000341|NCT03739840|12590241|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0
8000342|NCT03739840|12590242|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0
8000343|NCT03739840|12590243|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0
8000344|NCT03739840|12590240|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
8000345|NCT03739840|12590241|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
8000346|NCT03739840|12590242|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
8000347|NCT03739840|12590243|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1
8000348|NCT03739840|12590240|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1
8000349|NCT03739840|12590241|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
8000350|NCT03739840|12590242|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
8000351|NCT03739840|12590243|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
8000352|NCT03739840|12590240|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
8000353|NCT03739840|12590241|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1
8000354|NCT03739840|12590242|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
8000355|NCT03739840|12590243|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
8000356|NCT03739840|12590240|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
8000357|NCT03739840|12590241|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1
8000358|NCT03739840|12590242|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
8000359|NCT03739840|12590243|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
8000360|NCT03739840|12590240|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
8000361|NCT03739840|12590241|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
8000362|NCT03739840|12590242|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1
8000363|NCT03739840|12590243|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
8000364|NCT03739840|12590240|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0
8000365|NCT03739840|12590241|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0
8000366|NCT03739840|12590242|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1
8000367|NCT03739840|12590243|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0
8000368|NCT03739840|12590240|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
8000369|NCT03739840|12590241|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
8000370|NCT03739840|12590242|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1
8000371|NCT03739840|12590243|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
8000372|NCT03753763|12590302|FG000|Overall Study|Adverse Event|2
8000373|NCT03753763|12590303|FG001|Overall Study|Adverse Event|0
8000374|NCT03753763|12590302|FG000|Overall Study|Withdrawal by Subject|3
8000375|NCT03753763|12590303|FG001|Overall Study|Withdrawal by Subject|1
8000376|NCT03753763|12590302|FG000|Overall Study|clinical deterioration|1
8000377|NCT03753763|12590303|FG001|Overall Study|clinical deterioration|0
8000378|NCT03756571|12590311|FG000|Overall Study|Lost to Follow-up|1
8000379|NCT03756571|12590312|FG001|Overall Study|Lost to Follow-up|1
8000380|NCT03763877|12590339|FG000|Overall Study|Withdrawal by Subject|3
8000381|NCT03763877|12590340|FG001|Overall Study|Withdrawal by Subject|1
8000382|NCT03763877|12590341|FG002|Overall Study|Withdrawal by Subject|3
8000383|NCT03763877|12590342|FG003|Overall Study|Withdrawal by Subject|4
8000384|NCT03763877|12590339|FG000|Overall Study|Adverse Event|1
8000385|NCT03763877|12590340|FG001|Overall Study|Adverse Event|1
8000386|NCT03763877|12590341|FG002|Overall Study|Adverse Event|3
8000387|NCT03763877|12590342|FG003|Overall Study|Adverse Event|1
8000388|NCT03763877|12590339|FG000|Overall Study|Protocol Violation|1
8000389|NCT03763877|12590340|FG001|Overall Study|Protocol Violation|1
8000390|NCT03763877|12590341|FG002|Overall Study|Protocol Violation|0
8000391|NCT03763877|12590342|FG003|Overall Study|Protocol Violation|0
8000392|NCT03763877|12590339|FG000|Overall Study|Lost to Follow-up|0
8000393|NCT03763877|12590340|FG001|Overall Study|Lost to Follow-up|1
8000394|NCT03763877|12590341|FG002|Overall Study|Lost to Follow-up|1
8000395|NCT03763877|12590342|FG003|Overall Study|Lost to Follow-up|0
8000396|NCT03772587|12590365|FG000|Overall Study|COVID-19|0
8000397|NCT03772587|12590366|FG001|Overall Study|COVID-19|0
8000398|NCT03772587|12590367|FG002|Overall Study|COVID-19|1
8000399|NCT03772587|12590368|FG003|Overall Study|COVID-19|1
8000400|NCT03772587|12590369|FG004|Overall Study|COVID-19|0
8000401|NCT03772587|12590365|FG000|Overall Study|Withdrawal by Subject|1
8000402|NCT03772587|12590366|FG001|Overall Study|Withdrawal by Subject|0
8000403|NCT03772587|12590367|FG002|Overall Study|Withdrawal by Subject|0
8000404|NCT03772587|12590368|FG003|Overall Study|Withdrawal by Subject|0
8000405|NCT03772587|12590369|FG004|Overall Study|Withdrawal by Subject|0
8000406|NCT03789292|12590393|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7
8000407|NCT03789292|12590394|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8
8000408|NCT03789292|12590395|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0
8000409|NCT03789292|12590393|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2
8000410|NCT03789292|12590394|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0
8000411|NCT03789292|12590395|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0
8000412|NCT03789292|12590393|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1
8000413|NCT03789292|12590394|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0
8000414|NCT03789292|12590395|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0
8000415|NCT03789292|12590393|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1
8000416|NCT03789292|12590394|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1
8000417|NCT03789292|12590395|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0
8000418|NCT03789292|12590393|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9
8000419|NCT03789292|12590394|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8
8000420|NCT03789292|12590395|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0
8000421|NCT03789292|12590393|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1
8000422|NCT03789292|12590394|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0
8000423|NCT03789292|12590395|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0
8000424|NCT03789292|12590393|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0
8000425|NCT03789292|12590394|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2
8000426|NCT03789292|12590395|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0
8000427|NCT03789292|12590393|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3
8000428|NCT03789292|12590394|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3
8000429|NCT03789292|12590395|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6
8000430|NCT03789292|12590393|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0
8000431|NCT03789292|12590394|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0
8000432|NCT03789292|12590395|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1
8000433|NCT03789292|12590393|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1
8000434|NCT03789292|12590394|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0
8000435|NCT03789292|12590395|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0
8000436|NCT03789292|12590393|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9
8000437|NCT03789292|12590394|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2
8000438|NCT03789292|12590395|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2
8000439|NCT03789292|12590393|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1
8000440|NCT03789292|12590394|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0
8000441|NCT03789292|12590395|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0
8000442|NCT03789292|12590393|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2
8000443|NCT03789292|12590394|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1
8000444|NCT03789292|12590395|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0
8000445|NCT03805438|12590422|FG000|Overall Study|Lack of Efficacy|1
8000446|NCT03805438|12590422|FG000|Overall Study|Protocol Violation|1
8000447|NCT03817528|12590434|FG000|Overall Study|Withdrawal by Subject|1
8000448|NCT03817528|12590434|FG000|Overall Study|Adverse Event|2
8000449|NCT03829228|12590461|FG000|Overall Study|Protocol Violation|1
8000450|NCT03830333|12590480|FG000|Overall Study|Death|0
8000451|NCT03830333|12590481|FG001|Overall Study|Death|1
8000452|NCT03830333|12590480|FG000|Overall Study|Withdrawal by Subject|5
8000453|NCT03830333|12590481|FG001|Overall Study|Withdrawal by Subject|1
8000454|NCT03830333|12590480|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3
8000455|NCT03830333|12590481|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2
8000456|NCT03831880|12590489|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0
8000457|NCT03831880|12590490|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1
8000458|NCT03831880|12590489|FG000|Period 2 (12 Weeks)|Protocol Deviation|0
8000459|NCT03831880|12590490|FG001|Period 2 (12 Weeks)|Protocol Deviation|1
8000460|NCT03831945|12590500|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4
8000461|NCT03831945|12590501|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4
8000462|NCT03831945|12590500|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1
8000463|NCT03831945|12590501|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1
8000464|NCT03831945|12590500|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2
8000465|NCT03831945|12590501|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1
8000466|NCT03840174|12590520|FG000|Overall Study|Withdrawal by Subject|1
8000467|NCT03840174|12590521|FG001|Overall Study|Withdrawal by Subject|0
8000468|NCT03840174|12590522|FG002|Overall Study|Withdrawal by Subject|0
8000469|NCT03840174|12590523|FG003|Overall Study|Withdrawal by Subject|0
8000470|NCT03857841|12590552|FG000|Overall Study|Death|1
8000471|NCT03857841|12590553|FG001|Overall Study|Death|0
8000472|NCT03857841|12590554|FG002|Overall Study|Death|0
7718361|NCT00527735|12142318|FG002|Overall Study|Lost to Follow-up|3
8000473|NCT03857841|12590555|FG003|Overall Study|Death|0
8000474|NCT03857841|12590552|FG000|Overall Study|Study Terminated by Sponsor|1
8000475|NCT03857841|12590553|FG001|Overall Study|Study Terminated by Sponsor|0
8000476|NCT03857841|12590554|FG002|Overall Study|Study Terminated by Sponsor|0
8000477|NCT03857841|12590555|FG003|Overall Study|Study Terminated by Sponsor|0
8000478|NCT03862625|12590580|FG000|Overall Study|Lost to Follow-up|0
8000479|NCT03862625|12590581|FG001|Overall Study|Lost to Follow-up|1
8000480|NCT03877224|12590609|FG000|Overall Study|Death|3
8000481|NCT03877224|12590610|FG001|Overall Study|Death|2
8000482|NCT03877224|12590609|FG000|Overall Study|Withdrawal by Subject|1
8000483|NCT03877224|12590610|FG001|Overall Study|Withdrawal by Subject|6
8000484|NCT03877224|12590609|FG000|Overall Study|Participant is alive, just unable to come for visits|1
8000485|NCT03877224|12590610|FG001|Overall Study|Participant is alive, just unable to come for visits|0
8000486|NCT03885596|12590629|FG000|Overall Study|Withdrawal by Subject|2
8000487|NCT03885596|12590630|FG001|Overall Study|Withdrawal by Subject|1
8000488|NCT03885596|12590631|FG002|Overall Study|Withdrawal by Subject|0
8000489|NCT03885596|12590632|FG003|Overall Study|Withdrawal by Subject|0
8000490|NCT03885661|12590647|FG000|Overall Study|Withdrawal by Subject|0
8000491|NCT03885661|12590648|FG001|Overall Study|Withdrawal by Subject|1
8000492|NCT03885661|12590647|FG000|Overall Study|Unwilling to undergo required study procedure|1
8000493|NCT03885661|12590648|FG001|Overall Study|Unwilling to undergo required study procedure|0
8000494|NCT03886493|12590654|FG000|Overall Study|Adverse Event|1
8000495|NCT03888235|12590661|FG000|Overall Study|Lost to Follow-up|1
8000496|NCT03888235|12590662|FG001|Overall Study|Lost to Follow-up|1
8000497|NCT03888235|12590663|FG002|Overall Study|Lost to Follow-up|0
8000498|NCT03900416|12590719|FG000|Six Week Follow-up|Lost to Follow-up|1
8000499|NCT03900416|12590720|FG001|Six Week Follow-up|Lost to Follow-up|0
8000500|NCT03900416|12590719|FG000|Six Week Follow-up|Withdrawal by Subject|1
8000501|NCT03900416|12590720|FG001|Six Week Follow-up|Withdrawal by Subject|0
8000502|NCT03900416|12590719|FG000|Twelve Week Follow-up|Lost to Follow-up|0
8000503|NCT03900416|12590720|FG001|Twelve Week Follow-up|Lost to Follow-up|2
8000504|NCT03900416|12590719|FG000|Twelve Week Follow-up|Withdrawal by Subject|0
8000505|NCT03900416|12590720|FG001|Twelve Week Follow-up|Withdrawal by Subject|1
8000506|NCT03900416|12590719|FG000|Twelve Week Follow-up|Adverse Event|1
8000507|NCT03900416|12590720|FG001|Twelve Week Follow-up|Adverse Event|1
8000508|NCT03900416|12590719|FG000|Six Month Follow-up|Lost to Follow-up|4
8000509|NCT03900416|12590720|FG001|Six Month Follow-up|Lost to Follow-up|3
8000510|NCT03900416|12590719|FG000|Six Month Follow-up|Withdrawal by Subject|1
8000511|NCT03900416|12590720|FG001|Six Month Follow-up|Withdrawal by Subject|1
8000512|NCT03905863|12590728|FG000|Overall Study|Adverse Event|2
8000513|NCT03905863|12590729|FG001|Overall Study|Adverse Event|4
8000514|NCT03905863|12590728|FG000|Overall Study|Withdrawal by Subject|2
8000515|NCT03905863|12590729|FG001|Overall Study|Withdrawal by Subject|2
8000516|NCT03905863|12590728|FG000|Overall Study|Physician Decision|0
8000517|NCT03905863|12590729|FG001|Overall Study|Physician Decision|3
8000518|NCT03905863|12590728|FG000|Overall Study|Lost to Follow-up|1
8000519|NCT03905863|12590729|FG001|Overall Study|Lost to Follow-up|0
8000520|NCT03905863|12590728|FG000|Overall Study|Protocol Violation|0
8000521|NCT03905863|12590729|FG001|Overall Study|Protocol Violation|2
8000522|NCT03905863|12590728|FG000|Overall Study|Death|0
8000523|NCT03905863|12590729|FG001|Overall Study|Death|1
8000524|NCT03909971|12590746|FG000|Overall Study|Other Reasons Not Specified|0
8000525|NCT03909971|12590747|FG001|Overall Study|Other Reasons Not Specified|1
8000526|NCT03909971|12590746|FG000|Overall Study|Global Deterioration of Health Status|2
8000527|NCT03909971|12590747|FG001|Overall Study|Global Deterioration of Health Status|1
8000528|NCT03909971|12590746|FG000|Overall Study|Progressive Disease|6
8000529|NCT03909971|12590747|FG001|Overall Study|Progressive Disease|14
8000530|NCT03909971|12590746|FG000|Overall Study|Death|2
8000531|NCT03909971|12590747|FG001|Overall Study|Death|6
8000532|NCT03920215|12590758|FG000|Overall Study|Lost to Follow-up|1
8000533|NCT03920215|12590759|FG001|Overall Study|Lost to Follow-up|2
8000534|NCT03920215|12590760|FG002|Overall Study|Lost to Follow-up|0
8000535|NCT03920215|12590761|FG003|Overall Study|Lost to Follow-up|0
8000536|NCT03920215|12590758|FG000|Overall Study|Death|0
8000537|NCT03920215|12590759|FG001|Overall Study|Death|0
8000538|NCT03920215|12590760|FG002|Overall Study|Death|0
8000539|NCT03920215|12590761|FG003|Overall Study|Death|1
8000540|NCT03921151|12590773|FG000|Overall Study|Withdrawal by Subject|11
8000541|NCT03921151|12590774|FG001|Overall Study|Withdrawal by Subject|16
8000542|NCT03927911|12590795|FG000|Overall Study|problems with eDiary|0
8000543|NCT03927911|12590796|FG001|Overall Study|problems with eDiary|1
8000544|NCT03927911|12590797|FG002|Overall Study|problems with eDiary|0
8000545|NCT03927911|12590798|FG003|Overall Study|problems with eDiary|1
8000546|NCT03927911|12590799|FG004|Overall Study|problems with eDiary|0
8000547|NCT03927911|12590800|FG005|Overall Study|problems with eDiary|4
8000548|NCT03927911|12590795|FG000|Overall Study|Adverse Event|0
8000549|NCT03927911|12590796|FG001|Overall Study|Adverse Event|0
8000550|NCT03927911|12590797|FG002|Overall Study|Adverse Event|0
8000551|NCT03927911|12590798|FG003|Overall Study|Adverse Event|0
8000552|NCT03927911|12590799|FG004|Overall Study|Adverse Event|0
8000553|NCT03927911|12590800|FG005|Overall Study|Adverse Event|1
8000554|NCT03927911|12590795|FG000|Overall Study|not treated -study terminated by sponsor|0
8000555|NCT03927911|12590796|FG001|Overall Study|not treated -study terminated by sponsor|1
8000556|NCT03927911|12590797|FG002|Overall Study|not treated -study terminated by sponsor|0
8000557|NCT03927911|12590798|FG003|Overall Study|not treated -study terminated by sponsor|0
8000558|NCT03927911|12590799|FG004|Overall Study|not treated -study terminated by sponsor|0
8000559|NCT03927911|12590800|FG005|Overall Study|not treated -study terminated by sponsor|0
8000560|NCT03927911|12590795|FG000|Overall Study|Surgery cancelled|0
8000561|NCT03927911|12590796|FG001|Overall Study|Surgery cancelled|0
8000562|NCT03927911|12590797|FG002|Overall Study|Surgery cancelled|0
8000563|NCT03927911|12590798|FG003|Overall Study|Surgery cancelled|1
8000564|NCT03927911|12590799|FG004|Overall Study|Surgery cancelled|0
8000565|NCT03927911|12590800|FG005|Overall Study|Surgery cancelled|1
8000566|NCT03927911|12590795|FG000|Overall Study|Protocol Violation|0
8000567|NCT03927911|12590796|FG001|Overall Study|Protocol Violation|0
8000568|NCT03927911|12590797|FG002|Overall Study|Protocol Violation|0
8000569|NCT03927911|12590798|FG003|Overall Study|Protocol Violation|0
8000570|NCT03927911|12590799|FG004|Overall Study|Protocol Violation|0
8000571|NCT03927911|12590800|FG005|Overall Study|Protocol Violation|1
8000572|NCT03938857|12590827|FG000|Overall Study|Physician Decision|1
8000573|NCT03938857|12590828|FG001|Overall Study|Physician Decision|0
8000574|NCT03938857|12590829|FG002|Overall Study|Physician Decision|0
8000575|NCT03938857|12590830|FG003|Overall Study|Physician Decision|0
8000576|NCT03945981|12590844|FG000|Overall Study|Lost to Follow-up|12
8000577|NCT03945981|12590844|FG000|Overall Study|Physician Decision|4
8000578|NCT03945981|12590844|FG000|Overall Study|Withdrawal by Subject|6
8000579|NCT03945981|12590844|FG000|Overall Study|Protocol Violation|1
8000580|NCT03954834|12590861|FG000|Overall Study|Adverse Event|1
8000581|NCT03954834|12590862|FG001|Overall Study|Adverse Event|3
8000582|NCT03954834|12590863|FG002|Overall Study|Adverse Event|1
8000583|NCT03954834|12590864|FG003|Overall Study|Adverse Event|1
8000584|NCT03954834|12590861|FG000|Overall Study|Death|0
8000585|NCT03954834|12590862|FG001|Overall Study|Death|0
8000586|NCT03954834|12590863|FG002|Overall Study|Death|0
8000587|NCT03954834|12590864|FG003|Overall Study|Death|1
8000588|NCT03954834|12590861|FG000|Overall Study|Physician Decision|0
8000589|NCT03954834|12590862|FG001|Overall Study|Physician Decision|1
8000590|NCT03954834|12590863|FG002|Overall Study|Physician Decision|0
8000591|NCT03954834|12590864|FG003|Overall Study|Physician Decision|2
8000592|NCT03954834|12590861|FG000|Overall Study|Protocol Violation|1
8000593|NCT03954834|12590862|FG001|Overall Study|Protocol Violation|0
8000594|NCT03954834|12590863|FG002|Overall Study|Protocol Violation|0
8000595|NCT03954834|12590864|FG003|Overall Study|Protocol Violation|1
8000596|NCT03954834|12590861|FG000|Overall Study|Withdrawal by Subject|2
8000597|NCT03954834|12590862|FG001|Overall Study|Withdrawal by Subject|3
8000598|NCT03954834|12590863|FG002|Overall Study|Withdrawal by Subject|13
8000599|NCT03954834|12590864|FG003|Overall Study|Withdrawal by Subject|6
8000600|NCT03954834|12590861|FG000|Overall Study|Participant left the country|0
8000601|NCT03954834|12590862|FG001|Overall Study|Participant left the country|0
8000602|NCT03954834|12590863|FG002|Overall Study|Participant left the country|1
8000603|NCT03954834|12590864|FG003|Overall Study|Participant left the country|0
8000604|NCT03954834|12590861|FG000|Overall Study|Lost to Follow-up|3
8000605|NCT03954834|12590862|FG001|Overall Study|Lost to Follow-up|2
8000606|NCT03954834|12590863|FG002|Overall Study|Lost to Follow-up|3
8000607|NCT03954834|12590864|FG003|Overall Study|Lost to Follow-up|5
8000608|NCT03961529|12590891|FG000|Overall Study|Adverse Event|13
8000609|NCT03961529|12590892|FG001|Overall Study|Adverse Event|5
8000610|NCT03961529|12590893|FG002|Overall Study|Adverse Event|2
8000611|NCT03961529|12590891|FG000|Overall Study|Withdrawal by Subject|17
8000612|NCT03961529|12590892|FG001|Overall Study|Withdrawal by Subject|2
8000613|NCT03961529|12590893|FG002|Overall Study|Withdrawal by Subject|1
8000614|NCT03961529|12590891|FG000|Overall Study|Withdrawal by parent/guardian|0
8000615|NCT03961529|12590892|FG001|Overall Study|Withdrawal by parent/guardian|7
8000616|NCT03961529|12590893|FG002|Overall Study|Withdrawal by parent/guardian|0
8000617|NCT03961529|12590891|FG000|Overall Study|Physician Decision|2
8000618|NCT03961529|12590892|FG001|Overall Study|Physician Decision|1
8000619|NCT03961529|12590893|FG002|Overall Study|Physician Decision|1
8000620|NCT03961529|12590891|FG000|Overall Study|Lost to Follow-up|2
8000621|NCT03961529|12590892|FG001|Overall Study|Lost to Follow-up|1
8000622|NCT03961529|12590893|FG002|Overall Study|Lost to Follow-up|0
8000623|NCT03961529|12590891|FG000|Overall Study|Lack of Efficacy|2
8000624|NCT03961529|12590892|FG001|Overall Study|Lack of Efficacy|0
8000625|NCT03961529|12590893|FG002|Overall Study|Lack of Efficacy|1
8000626|NCT03961529|12590891|FG000|Overall Study|Other|6
8000627|NCT03961529|12590892|FG001|Overall Study|Other|1
8000628|NCT03961529|12590893|FG002|Overall Study|Other|0
8000629|NCT03968159|12590903|FG000|Overall Study|Adverse Event|4
8000630|NCT03968159|12590904|FG001|Overall Study|Adverse Event|4
8000631|NCT03968159|12590903|FG000|Overall Study|Lost to Follow-up|1
8000632|NCT03968159|12590904|FG001|Overall Study|Lost to Follow-up|1
8000633|NCT03968159|12590903|FG000|Overall Study|Use of prohibited medication|0
8000634|NCT03968159|12590904|FG001|Overall Study|Use of prohibited medication|1
8000635|NCT03968159|12590903|FG000|Overall Study|Protocol Violation|2
8000636|NCT03968159|12590904|FG001|Overall Study|Protocol Violation|2
8000637|NCT03968159|12590903|FG000|Overall Study|Withdrawal by Subject|4
8000638|NCT03968159|12590904|FG001|Overall Study|Withdrawal by Subject|6
8000639|NCT03968159|12590903|FG000|Overall Study|Lack of Efficacy|0
8000640|NCT03968159|12590904|FG001|Overall Study|Lack of Efficacy|1
8000641|NCT03968159|12590903|FG000|Overall Study|Not further specified|2
8000642|NCT03968159|12590904|FG001|Overall Study|Not further specified|0
8000643|NCT03970824|12590922|FG000|Overall Study|Withdrawal by Subject|1
8000644|NCT03970824|12590923|FG001|Overall Study|Withdrawal by Subject|1
8000645|NCT03970824|12590924|FG002|Overall Study|Withdrawal by Subject|3
8000646|NCT03970824|12590922|FG000|Overall Study|Lost to Follow-up|0
8000647|NCT03970824|12590923|FG001|Overall Study|Lost to Follow-up|2
8000648|NCT03970824|12590924|FG002|Overall Study|Lost to Follow-up|1
8000649|NCT03970824|12590922|FG000|Overall Study|Adverse Event|1
8000650|NCT03970824|12590923|FG001|Overall Study|Adverse Event|0
8000651|NCT03970824|12590924|FG002|Overall Study|Adverse Event|0
8000652|NCT03982069|12590970|FG000|Overall Study|Lost to Follow-up|5
8000653|NCT03982069|12590971|FG001|Overall Study|Lost to Follow-up|5
8000654|NCT03982069|12590972|FG002|Overall Study|Lost to Follow-up|3
8000655|NCT03982069|12590973|FG003|Overall Study|Lost to Follow-up|5
8000656|NCT03982069|12590970|FG000|Overall Study|Physician Decision|0
8000657|NCT03982069|12590971|FG001|Overall Study|Physician Decision|1
8000658|NCT03982069|12590972|FG002|Overall Study|Physician Decision|0
8000659|NCT03982069|12590973|FG003|Overall Study|Physician Decision|0
8000660|NCT03982069|12590970|FG000|Overall Study|Withdrawal by Subject|2
8000661|NCT03982069|12590971|FG001|Overall Study|Withdrawal by Subject|1
8000662|NCT03982069|12590972|FG002|Overall Study|Withdrawal by Subject|5
8000663|NCT03982069|12590973|FG003|Overall Study|Withdrawal by Subject|2
8000664|NCT03982069|12590970|FG000|Overall Study|Specimen loss|3
8000665|NCT03982069|12590971|FG001|Overall Study|Specimen loss|3
8000666|NCT03982069|12590972|FG002|Overall Study|Specimen loss|1
8000667|NCT03982069|12590973|FG003|Overall Study|Specimen loss|1
8000668|NCT03984812|12590992|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0
8000669|NCT03984812|12590993|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0
8000670|NCT03984812|12590994|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1
8000671|NCT03984812|12590995|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0
8000672|NCT03984812|12590996|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0
8000673|NCT03984812|12590997|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0
8000674|NCT03984812|12590998|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0
8000675|NCT03984812|12590999|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0
8000676|NCT03984812|12591000|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0
8000677|NCT03984812|12591001|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0
8000678|NCT03984812|12591002|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0
8000679|NCT04006171|12591056|FG000|Overall Study|Withdrawal by Subject|8
8000680|NCT04006171|12591057|FG001|Overall Study|Withdrawal by Subject|7
8000681|NCT04006171|12591056|FG000|Overall Study|missing serum samples|2
8000682|NCT04006171|12591057|FG001|Overall Study|missing serum samples|2
8000683|NCT04006171|12591056|FG000|Overall Study|insufficient sample volume|2
8000684|NCT04006171|12591057|FG001|Overall Study|insufficient sample volume|3
8000685|NCT04013529|12591084|FG000|Overall Study|Withdrawal by Subject|1
8000686|NCT04013529|12591085|FG001|Overall Study|Withdrawal by Subject|1
8000687|NCT04018066|12591100|FG000|Overall Study|participants started taking medications during the study period|3
8000688|NCT04018066|12591100|FG000|Overall Study|participant dropped out due to schedule conflicts.|1
8000689|NCT04041440|12591145|FG000|Overall Study|Withdrawal by Subject|0
8000690|NCT04041440|12591146|FG001|Overall Study|Withdrawal by Subject|1
8000691|NCT04041440|12591145|FG000|Overall Study|Lost to Follow-up|0
8000692|NCT04041440|12591146|FG001|Overall Study|Lost to Follow-up|1
8000693|NCT04041570|12591155|FG000|Overall Study|Moved from Area|0
8000694|NCT04041570|12591156|FG001|Overall Study|Moved from Area|2
8000695|NCT04043143|12591165|FG000|Overall Study|Lost to Follow-up|5
8000696|NCT04043143|12591166|FG001|Overall Study|Lost to Follow-up|5
8000697|NCT04043143|12591165|FG000|Overall Study|screen failure|1
8000698|NCT04043143|12591166|FG001|Overall Study|screen failure|0
8000699|NCT04052204|12591191|FG000|Overall Study|Death|1
8000700|NCT04052204|12591192|FG001|Overall Study|Death|0
8000701|NCT04052204|12591193|FG002|Overall Study|Death|0
8000702|NCT04052204|12591191|FG000|Overall Study|Progressive disease|1
8000703|NCT04052204|12591192|FG001|Overall Study|Progressive disease|0
8000704|NCT04052204|12591193|FG002|Overall Study|Progressive disease|0
8000705|NCT04052204|12591191|FG000|Overall Study|Other|1
8000706|NCT04052204|12591192|FG001|Overall Study|Other|0
8000707|NCT04052204|12591193|FG002|Overall Study|Other|0
8000708|NCT04067011|12591213|FG000|Overall Study|Not Treated|8
8000709|NCT04067011|12591214|FG001|Overall Study|Not Treated|7
8000710|NCT04067011|12591215|FG002|Overall Study|Not Treated|5
8000711|NCT04067011|12591213|FG000|Overall Study|Adverse Event|2
8000712|NCT04067011|12591214|FG001|Overall Study|Adverse Event|1
8000713|NCT04067011|12591215|FG002|Overall Study|Adverse Event|0
8000714|NCT04067011|12591213|FG000|Overall Study|Withdrawal by Subject|6
8000715|NCT04067011|12591214|FG001|Overall Study|Withdrawal by Subject|2
8000716|NCT04067011|12591215|FG002|Overall Study|Withdrawal by Subject|1
8000717|NCT04067011|12591213|FG000|Overall Study|Lost to Follow-up|0
8000718|NCT04067011|12591214|FG001|Overall Study|Lost to Follow-up|0
8000719|NCT04067011|12591215|FG002|Overall Study|Lost to Follow-up|1
8000720|NCT04067011|12591213|FG000|Overall Study|Physician Decision|1
8000721|NCT04067011|12591214|FG001|Overall Study|Physician Decision|1
8000722|NCT04067011|12591215|FG002|Overall Study|Physician Decision|0
8000723|NCT04067011|12591213|FG000|Overall Study|Other Reasons|2
8000724|NCT04067011|12591214|FG001|Overall Study|Other Reasons|0
8000725|NCT04067011|12591215|FG002|Overall Study|Other Reasons|1
8000726|NCT04067011|12591213|FG000|Overall Study|Missing|0
8000727|NCT04067011|12591214|FG001|Overall Study|Missing|2
8000728|NCT04067011|12591215|FG002|Overall Study|Missing|0
8000729|NCT04072159|12591227|FG000|Overall Study|Lost to Follow-up|6
8000730|NCT04072159|12591228|FG001|Overall Study|Lost to Follow-up|6
8000731|NCT04072159|12591227|FG000|Overall Study|Withdrawal by Subject|2
8000732|NCT04072159|12591228|FG001|Overall Study|Withdrawal by Subject|0
8000733|NCT04094870|12591247|FG000|Overall Study|Lost to Follow-up|1
8000734|NCT04094870|12591248|FG001|Overall Study|Lost to Follow-up|1
8000735|NCT04123405|12591289|FG000|Overall Study|Adverse Event|1
8000736|NCT04123405|12591290|FG001|Overall Study|Adverse Event|2
8000737|NCT04123405|12591291|FG002|Overall Study|Adverse Event|3
8000738|NCT04123405|12591292|FG003|Overall Study|Adverse Event|3
8000739|NCT04123405|12591289|FG000|Overall Study|Exclusion criteria met|1
8000740|NCT04123405|12591290|FG001|Overall Study|Exclusion criteria met|2
8000741|NCT04123405|12591291|FG002|Overall Study|Exclusion criteria met|0
8000742|NCT04123405|12591292|FG003|Overall Study|Exclusion criteria met|2
8000743|NCT04123405|12591289|FG000|Overall Study|Withdrawal by Subject|1
8000744|NCT04123405|12591290|FG001|Overall Study|Withdrawal by Subject|3
8000745|NCT04123405|12591291|FG002|Overall Study|Withdrawal by Subject|0
8000746|NCT04123405|12591292|FG003|Overall Study|Withdrawal by Subject|2
8000747|NCT04123405|12591289|FG000|Overall Study|Contact to subject lost|0
8000748|NCT04123405|12591290|FG001|Overall Study|Contact to subject lost|0
8000749|NCT04123405|12591291|FG002|Overall Study|Contact to subject lost|0
8000750|NCT04123405|12591292|FG003|Overall Study|Contact to subject lost|1
8000751|NCT04123405|12591289|FG000|Overall Study|screening failure|1
8000752|NCT04123405|12591290|FG001|Overall Study|screening failure|0
8000753|NCT04123405|12591291|FG002|Overall Study|screening failure|0
8000754|NCT04123405|12591292|FG003|Overall Study|screening failure|0
8000755|NCT04147715|12591335|FG000|Overall Study|Adverse Event|0
8000756|NCT04147715|12591336|FG001|Overall Study|Adverse Event|0
8000757|NCT04147715|12591337|FG002|Overall Study|Adverse Event|0
8000758|NCT04147715|12591338|FG003|Overall Study|Adverse Event|0
8000759|NCT04147715|12591339|FG004|Overall Study|Adverse Event|0
8000760|NCT04147715|12591340|FG005|Overall Study|Adverse Event|0
8000761|NCT04147715|12591341|FG006|Overall Study|Adverse Event|0
8000762|NCT04147715|12591342|FG007|Overall Study|Adverse Event|2
8000763|NCT04147715|12591343|FG008|Overall Study|Adverse Event|1
8000764|NCT04147715|12591344|FG009|Overall Study|Adverse Event|0
8000765|NCT04147715|12591345|FG010|Overall Study|Adverse Event|0
8000766|NCT04147715|12591346|FG011|Overall Study|Adverse Event|0
8000767|NCT04154605|12591420|FG000|Overall Study|Procedure Canceled|1
8000768|NCT04154605|12591421|FG001|Overall Study|Procedure Canceled|1
8000769|NCT04154605|12591420|FG000|Overall Study|Missed follow up|1
8000770|NCT04154605|12591421|FG001|Overall Study|Missed follow up|1
8000771|NCT04154605|12591420|FG000|Overall Study|Withdrawal by Subject|1
8000772|NCT04154605|12591421|FG001|Overall Study|Withdrawal by Subject|0
8000773|NCT04160091|12591431|FG000|Overall Study|Terminated by Sponsor|7
8000774|NCT04160091|12591432|FG001|Overall Study|Terminated by Sponsor|3
8000775|NCT04160091|12591433|FG002|Overall Study|Terminated by Sponsor|5
8000776|NCT04160091|12591434|FG003|Overall Study|Terminated by Sponsor|2
8000777|NCT04160091|12591431|FG000|Overall Study|Noncompliance|0
8000778|NCT04160091|12591432|FG001|Overall Study|Noncompliance|0
8000779|NCT04160091|12591433|FG002|Overall Study|Noncompliance|0
8000780|NCT04160091|12591434|FG003|Overall Study|Noncompliance|1
8000781|NCT04160091|12591431|FG000|Overall Study|Withdrawal by Subject|0
8000782|NCT04160091|12591432|FG001|Overall Study|Withdrawal by Subject|0
8000783|NCT04160091|12591433|FG002|Overall Study|Withdrawal by Subject|0
8000784|NCT04160091|12591434|FG003|Overall Study|Withdrawal by Subject|1
8000785|NCT04164758|12591451|FG000|Overall Study|COVID-19 withdrawal of consent|1
8000786|NCT04164758|12591452|FG001|Overall Study|COVID-19 withdrawal of consent|0
8000787|NCT04164758|12591453|FG002|Overall Study|COVID-19 withdrawal of consent|0
7718362|NCT00527735|12142316|FG000|Overall Study|Poor compliance or noncompliance|0
7718363|NCT00527735|12142317|FG001|Overall Study|Poor compliance or noncompliance|1
7718364|NCT00527735|12142318|FG002|Overall Study|Poor compliance or noncompliance|1
7718365|NCT00527735|12142316|FG000|Overall Study|Completed treatment during maintenance|2
8000788|NCT04164758|12591451|FG000|Overall Study|Adverse Event|0
8000789|NCT04164758|12591452|FG001|Overall Study|Adverse Event|1
8000790|NCT04164758|12591453|FG002|Overall Study|Adverse Event|0
8000791|NCT04165031|12591467|FG000|Overall Study|Adverse Event|1
8000792|NCT04165031|12591468|FG001|Overall Study|Adverse Event|1
8000793|NCT04165031|12591469|FG002|Overall Study|Adverse Event|0
8000794|NCT04165031|12591470|FG003|Overall Study|Adverse Event|0
8000795|NCT04165031|12591471|FG004|Overall Study|Adverse Event|0
8000796|NCT04165031|12591472|FG005|Overall Study|Adverse Event|0
8000797|NCT04165031|12591467|FG000|Overall Study|Withdrawal by Subject|0
8000798|NCT04165031|12591468|FG001|Overall Study|Withdrawal by Subject|0
8000799|NCT04165031|12591469|FG002|Overall Study|Withdrawal by Subject|1
8000800|NCT04165031|12591470|FG003|Overall Study|Withdrawal by Subject|0
8000801|NCT04165031|12591471|FG004|Overall Study|Withdrawal by Subject|0
8000802|NCT04165031|12591472|FG005|Overall Study|Withdrawal by Subject|0
8000803|NCT04171414|12591491|FG000|Overall Study|Death|1
8000804|NCT04171414|12591491|FG000|Overall Study|Withdrawal by Subject|1
8000805|NCT04175808|12591495|FG000|Part A|Miscellaneous|2
8000806|NCT04175808|12591496|FG001|Part A|Miscellaneous|0
8000807|NCT04175808|12591497|FG002|Part A|Miscellaneous|0
8000808|NCT04175808|12591498|FG003|Part A|Miscellaneous|0
8000809|NCT04175808|12591499|FG004|Part A|Miscellaneous|0
8000810|NCT04175808|12591500|FG005|Part A|Miscellaneous|0
8000811|NCT04175808|12591501|FG006|Part A|Miscellaneous|0
8000812|NCT04178720|12591519|FG000|Overall Study|Withdrawal by Subject|2
8000813|NCT04178720|12591520|FG001|Overall Study|Withdrawal by Subject|0
8000814|NCT04178720|12591519|FG000|Overall Study|Relocation|0
8000815|NCT04178720|12591520|FG001|Overall Study|Relocation|1
8000816|NCT04218110|12591563|FG000|Overall Study|Withdrawal by Subject|0
8000817|NCT04218110|12591564|FG001|Overall Study|Withdrawal by Subject|0
8000818|NCT04218110|12591565|FG002|Overall Study|Withdrawal by Subject|0
8000819|NCT04218110|12591566|FG003|Overall Study|Withdrawal by Subject|1
8000820|NCT04222725|12591580|FG000|Overall Study|Adverse Event|0
8000821|NCT04222725|12591581|FG001|Overall Study|Adverse Event|1
8000822|NCT04222725|12591582|FG002|Overall Study|Adverse Event|0
8000823|NCT04222725|12591583|FG003|Overall Study|Adverse Event|0
8000824|NCT04258995|12591669|FG000|Overall Study|Lost to Follow-up|1
8000825|NCT04258995|12591670|FG001|Overall Study|Lost to Follow-up|1
8000826|NCT04317040|12591709|FG000|Overall Study|Lost to Follow-up|2
8000827|NCT04317040|12591710|FG001|Overall Study|Lost to Follow-up|0
8000828|NCT04317040|12591709|FG000|Overall Study|Death|16
8000829|NCT04317040|12591710|FG001|Overall Study|Death|18
8000830|NCT04317040|12591709|FG000|Overall Study|Withdrawal by Subject|0
8000831|NCT04317040|12591710|FG001|Overall Study|Withdrawal by Subject|1
8000832|NCT04317040|12591709|FG000|Overall Study|Incomplete assessments|0
8000833|NCT04317040|12591710|FG001|Overall Study|Incomplete assessments|1
8000834|NCT04319159|12591727|FG000|Overall Study|Screening failure|13
8000835|NCT04319159|12591727|FG000|Overall Study|Re-screening due to COVID-19 implications|2
8000836|NCT04319159|12591727|FG000|Overall Study|Withdrawal by Subject|1
8000837|NCT04331899|12591757|FG000|Trial Period (28 Days)|Withdrawal by Subject|2
8000838|NCT04331899|12591758|FG001|Trial Period (28 Days)|Withdrawal by Subject|2
8000839|NCT04334148|12591766|FG000|Overall Study|positive nasal swab at baseline|0
8000840|NCT04334148|12591767|FG001|Overall Study|positive nasal swab at baseline|1
8000841|NCT04347954|12591787|FG000|Overall Study|Did not present to study site for allocated intervention|3
8000842|NCT04347954|12591788|FG001|Overall Study|Did not present to study site for allocated intervention|0
8000843|NCT04347954|12591789|FG002|Overall Study|Did not present to study site for allocated intervention|3
8000844|NCT04347954|12591787|FG000|Overall Study|Lost to Follow-up|0
8000845|NCT04347954|12591788|FG001|Overall Study|Lost to Follow-up|1
8000846|NCT04347954|12591789|FG002|Overall Study|Lost to Follow-up|0
8000847|NCT04349098|12591799|FG000|Overall Study|Death|16
8000848|NCT04349098|12591800|FG001|Overall Study|Death|8
8000849|NCT04349098|12591799|FG000|Overall Study|Lost to Follow-up|11
8000850|NCT04349098|12591800|FG001|Overall Study|Lost to Follow-up|8
8000851|NCT04349098|12591799|FG000|Overall Study|Withdrawal by Subject|8
8000852|NCT04349098|12591800|FG001|Overall Study|Withdrawal by Subject|5
8000853|NCT04349098|12591799|FG000|Overall Study|Other|3
8000854|NCT04349098|12591800|FG001|Overall Study|Other|5
8000855|NCT04353037|12591810|FG000|Overall Study|Lost to Follow-up|0
8000856|NCT04353037|12591811|FG001|Overall Study|Lost to Follow-up|1
8000857|NCT04353037|12591812|FG002|Overall Study|Lost to Follow-up|2
8000858|NCT04353037|12591813|FG003|Overall Study|Lost to Follow-up|3
8000859|NCT04353037|12591810|FG000|Overall Study|Withdrawal by Subject|0
8000860|NCT04353037|12591811|FG001|Overall Study|Withdrawal by Subject|2
8000861|NCT04353037|12591812|FG002|Overall Study|Withdrawal by Subject|3
8000862|NCT04353037|12591813|FG003|Overall Study|Withdrawal by Subject|5
8000863|NCT04353037|12591810|FG000|Overall Study|Adverse Event|0
8000864|NCT04353037|12591811|FG001|Overall Study|Adverse Event|0
8000865|NCT04353037|12591812|FG002|Overall Study|Adverse Event|2
8000866|NCT04353037|12591813|FG003|Overall Study|Adverse Event|0
8000867|NCT04353037|12591810|FG000|Overall Study|Exposure Change|0
8000868|NCT04353037|12591811|FG001|Overall Study|Exposure Change|0
8000869|NCT04353037|12591812|FG002|Overall Study|Exposure Change|0
8000870|NCT04353037|12591813|FG003|Overall Study|Exposure Change|2
8000871|NCT04355767|12591833|FG000|Overall Study|Withdrawal by Subject|2
8000872|NCT04355767|12591834|FG001|Overall Study|Withdrawal by Subject|2
8000873|NCT04355767|12591833|FG000|Overall Study|Death|5
8000874|NCT04355767|12591834|FG001|Overall Study|Death|1
8000875|NCT04356573|12591842|FG000|Overall Study|Didn't Qualify|1
8000876|NCT04356573|12591843|FG001|Overall Study|Didn't Qualify|0
8000877|NCT04358068|12591855|FG000|Overall Study|Did not initiate study treatment|2
8000878|NCT04358068|12591856|FG001|Overall Study|Did not initiate study treatment|2
8000879|NCT04366349|12591868|FG000|Overall Study|Withdrawal by Subject|1
8000880|NCT04366349|12591869|FG001|Overall Study|Withdrawal by Subject|0
8000881|NCT04366349|12591870|FG002|Overall Study|Withdrawal by Subject|0
8000882|NCT04366349|12591871|FG003|Overall Study|Withdrawal by Subject|0
8000883|NCT04366349|12591872|FG004|Overall Study|Withdrawal by Subject|0
8000884|NCT04366349|12591873|FG005|Overall Study|Withdrawal by Subject|0
8000885|NCT04398732|12591921|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50
8000886|NCT04401293|12591929|FG000|Overall Study|Withdrawal by Subject|1
8000887|NCT04401293|12591930|FG001|Overall Study|Withdrawal by Subject|3
8000888|NCT04411628|12591940|FG000|Overall Study|Withdrawal by Subject|1
8000889|NCT04411628|12591941|FG001|Overall Study|Withdrawal by Subject|1
8000890|NCT04411628|12591942|FG002|Overall Study|Withdrawal by Subject|2
8000891|NCT04411628|12591943|FG003|Overall Study|Withdrawal by Subject|0
8000892|NCT04411628|12591940|FG000|Overall Study|Lost to Follow-up|0
8000893|NCT04411628|12591941|FG001|Overall Study|Lost to Follow-up|1
8000894|NCT04411628|12591942|FG002|Overall Study|Lost to Follow-up|0
8000895|NCT04411628|12591943|FG003|Overall Study|Lost to Follow-up|0
8000896|NCT04428411|12591995|FG000|Overall Study|Lost to Follow-up|114
8000897|NCT04435184|12592004|FG000|Overall Study|follow-up blood draws missing|3
8000898|NCT04435184|12592005|FG001|Overall Study|follow-up blood draws missing|5
8000899|NCT04476784|12592013|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1
8000900|NCT04476784|12592014|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0
8000901|NCT04495283|12592046|FG000|Overall Study|Physician Decision|0
8000902|NCT04495283|12592047|FG001|Overall Study|Physician Decision|0
8000903|NCT04495283|12592048|FG002|Overall Study|Physician Decision|1
8000904|NCT04495283|12592046|FG000|Overall Study|Withdrawal by Subject|0
8000905|NCT04495283|12592047|FG001|Overall Study|Withdrawal by Subject|1
8000906|NCT04495283|12592048|FG002|Overall Study|Withdrawal by Subject|1
8000907|NCT04495283|12592046|FG000|Overall Study|Other|1
8000908|NCT04495283|12592047|FG001|Overall Study|Other|0
8000909|NCT04495283|12592048|FG002|Overall Study|Other|1
8000910|NCT04497948|12592059|FG000|Overall Study|Death|2
8000911|NCT04501952|12592086|FG000|Overall Study|Adverse Event|0
8000912|NCT04501952|12592087|FG001|Overall Study|Adverse Event|3
8000913|NCT04501952|12592086|FG000|Overall Study|Investigator's Discretion|0
8000914|NCT04501952|12592087|FG001|Overall Study|Investigator's Discretion|1
8000915|NCT04501952|12592086|FG000|Overall Study|Protocol Violation|1
8000916|NCT04501952|12592087|FG001|Overall Study|Protocol Violation|1
8000917|NCT04501952|12592086|FG000|Overall Study|Withdrew Consent|5
8000918|NCT04501952|12592087|FG001|Overall Study|Withdrew Consent|4
8000919|NCT04501952|12592086|FG000|Overall Study|Lost to Follow-up|7
8000920|NCT04501952|12592087|FG001|Overall Study|Lost to Follow-up|2
8000921|NCT04501952|12592086|FG000|Overall Study|Randomized and Never Treated|13
8000922|NCT04501952|12592087|FG001|Overall Study|Randomized and Never Treated|9
8000923|NCT04504032|12592096|FG000|Overall Study|Adverse Event|1
8000924|NCT04504032|12592097|FG001|Overall Study|Adverse Event|2
8000925|NCT04504032|12592096|FG000|Overall Study|Lost to Follow-up|6
8000926|NCT04504032|12592097|FG001|Overall Study|Lost to Follow-up|9
8000927|NCT04504032|12592096|FG000|Overall Study|Protocol Violation|2
8000928|NCT04504032|12592097|FG001|Overall Study|Protocol Violation|0
8000929|NCT04504032|12592096|FG000|Overall Study|Study terminated by sponsor|1
8000930|NCT04504032|12592097|FG001|Overall Study|Study terminated by sponsor|2
8000931|NCT04504032|12592096|FG000|Overall Study|Withdrawal by Subject|9
8000932|NCT04504032|12592097|FG001|Overall Study|Withdrawal by Subject|11
8000933|NCT04504032|12592096|FG000|Overall Study|Disease progression prior to dosing|15
8000934|NCT04504032|12592097|FG001|Overall Study|Disease progression prior to dosing|3
8000935|NCT04504032|12592096|FG000|Overall Study|Drug supply issues|1
8000936|NCT04504032|12592097|FG001|Overall Study|Drug supply issues|1
8000937|NCT04504032|12592096|FG000|Overall Study|Progressed to moderate/severe COVID-19|1
8000938|NCT04504032|12592097|FG001|Overall Study|Progressed to moderate/severe COVID-19|0
8000939|NCT04507763|12592103|FG000|Overall Study|Participants did not meet entrance criteria|201
8000940|NCT04507867|12592112|FG000|Overall Study|Death|7
8000941|NCT04507867|12592113|FG001|Overall Study|Death|1
8000942|NCT04527978|12592158|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1
8000943|NCT04527978|12592159|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0
8000944|NCT04529109|12592180|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0
8000945|NCT04529109|12592181|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1
8000946|NCT04601103|12592296|FG000|Overall Study|Needed crown & cleaning|0
8000947|NCT04601103|12592297|FG001|Overall Study|Needed crown & cleaning|0
8000948|NCT04601103|12592298|FG002|Overall Study|Needed crown & cleaning|1
8000949|NCT04601103|12592296|FG000|Overall Study|study was terminated|18
8000950|NCT04601103|12592297|FG001|Overall Study|study was terminated|18
8000951|NCT04601103|12592298|FG002|Overall Study|study was terminated|16
8000952|NCT04664855|12592326|FG000|Overall Study|Withdrawal by Subject|0
8000953|NCT04664855|12592327|FG001|Overall Study|Withdrawal by Subject|2
8000954|NCT04701658|12592333|FG000|Overall Study|Lost to Follow-up|6
8000955|NCT04706416|12592339|FG000|Overall Study|Lost to Follow-up|2
8000956|NCT04706416|12592340|FG001|Overall Study|Lost to Follow-up|0
8000957|NCT04727749|12592360|FG000|Overall Study|Lost to Follow-up|10
8000958|NCT04727749|12592361|FG001|Overall Study|Lost to Follow-up|3
8000959|NCT04854707|12592383|FG000|Overall Study|Lack of Efficacy|78
8000960|NCT04854707|12592384|FG001|Overall Study|Lack of Efficacy|59
8000961|NCT04854707|12592385|FG002|Overall Study|Lack of Efficacy|30
8000962|NCT04947436|12592480|FG000|Overall Study|Lost to Follow-up|3
8000963|NCT04947436|12592481|FG001|Overall Study|Lost to Follow-up|7
8000964|NCT04947436|12592482|FG002|Overall Study|Lost to Follow-up|5
8000965|NCT04947436|12592480|FG000|Overall Study|Death|1
8000966|NCT04947436|12592481|FG001|Overall Study|Death|1
8000967|NCT04947436|12592482|FG002|Overall Study|Death|1
8000968|NCT05002972|12592490|FG000|Overall Study|Withdrawal by Subject|2
8000969|NCT05002985|12592494|FG000|Overall Study|Withdrawal by Subject|1
8000970|NCT04512482|12592500|FG000|Second Intervention (1 Day)|Protocol Violation|2
8000971|NCT04512482|12592501|FG001|Second Intervention (1 Day)|Protocol Violation|1
8000972|NCT04523831|12592526|FG000|Overall Study|Lost to Follow-up|15
8000973|NCT04523831|12592527|FG001|Overall Study|Lost to Follow-up|17
8000974|NCT04523831|12592526|FG000|Overall Study|Death|0
8000975|NCT04523831|12592527|FG001|Overall Study|Death|3
8000976|NCT04523831|12592526|FG000|Overall Study|Adverse Event|2
8000977|NCT04523831|12592527|FG001|Overall Study|Adverse Event|0
8000978|NCT04521777|12592536|FG000|Overall Study|Death|2
8000979|NCT04521777|12592536|FG000|Overall Study|Withdrawal by Subject|2
8000980|NCT04507776|12592566|FG000|Overall Study|Participants did not meet the entrance criteria|201
8000981|NCT04502979|12592577|FG000|Overall Study|Lost to Follow-up|1
8000982|NCT04502979|12592578|FG001|Overall Study|Lost to Follow-up|3
8000983|NCT04502979|12592577|FG000|Overall Study|Withdrawal by Subject|2
8000984|NCT04502979|12592578|FG001|Overall Study|Withdrawal by Subject|1
8000985|NCT04498403|12592621|FG000|Overall Study|Adverse Event|1
8000986|NCT04498403|12592622|FG001|Overall Study|Adverse Event|0
8000987|NCT04498403|12592621|FG000|Overall Study|Study Terminated By Sponsor|29
8000988|NCT04498403|12592622|FG001|Overall Study|Study Terminated By Sponsor|10
8000989|NCT04495374|12592630|FG000|Overall Study|Protocol Violation|2
8000990|NCT04495374|12592631|FG001|Overall Study|Protocol Violation|1
8000991|NCT04491994|12592655|FG000|Overall Study|Withdrawal by Subject|10
8000992|NCT04491994|12592656|FG001|Overall Study|Withdrawal by Subject|5
8000993|NCT04491994|12592655|FG000|Overall Study|developed fever > 3 days|4
8000994|NCT04491994|12592656|FG001|Overall Study|developed fever > 3 days|1
8000995|NCT04491994|12592655|FG000|Overall Study|Protocol Violation|11
8000996|NCT04491994|12592656|FG001|Overall Study|Protocol Violation|2
8000997|NCT04491994|12592655|FG000|Overall Study|Lost to Follow-up|4
8000998|NCT04491994|12592656|FG001|Overall Study|Lost to Follow-up|3
8000999|NCT04486235|12592685|FG000|Overall Study|Pregnancy|1
8001000|NCT04486235|12592686|FG001|Overall Study|Pregnancy|0
8001001|NCT04486235|12592685|FG000|Overall Study|Lost to Follow-up|1
8001002|NCT04486235|12592686|FG001|Overall Study|Lost to Follow-up|0
8001003|NCT04483011|12592695|FG000|Washout (7 Days)|Withdrawal by Subject|0
8001004|NCT04483011|12592696|FG001|Washout (7 Days)|Withdrawal by Subject|1
8001005|NCT04475588|12592706|FG000|Overall Study|Adverse Event|2
8001006|NCT04475588|12592707|FG001|Overall Study|Adverse Event|0
8001007|NCT04474405|12592733|FG000|Overall Study|Withdrawal by Subject|0
8001008|NCT04474405|12592734|FG001|Overall Study|Withdrawal by Subject|0
8001009|NCT04474405|12592735|FG002|Overall Study|Withdrawal by Subject|1
8001010|NCT04474405|12592736|FG003|Overall Study|Withdrawal by Subject|0
8001011|NCT04474405|12592737|FG004|Overall Study|Withdrawal by Subject|1
8001012|NCT04474405|12592738|FG005|Overall Study|Withdrawal by Subject|0
8001013|NCT04474405|12592733|FG000|Overall Study|Other|0
8001014|NCT04474405|12592734|FG001|Overall Study|Other|0
8001015|NCT04474405|12592735|FG002|Overall Study|Other|0
8001016|NCT04474405|12592736|FG003|Overall Study|Other|0
8001017|NCT04474405|12592737|FG004|Overall Study|Other|3
8001018|NCT04474405|12592738|FG005|Overall Study|Other|0
8001019|NCT04468347|12592760|FG000|Overall Study|Withdrawal by Subject|0
8001020|NCT04468347|12592761|FG001|Overall Study|Withdrawal by Subject|1
8001021|NCT04468347|12592762|FG002|Overall Study|Withdrawal by Subject|3
8001022|NCT04468347|12592763|FG003|Overall Study|Withdrawal by Subject|3
8001023|NCT04468347|12592760|FG000|Overall Study|Lost to Follow-up|0
8001024|NCT04468347|12592761|FG001|Overall Study|Lost to Follow-up|0
8001025|NCT04468347|12592762|FG002|Overall Study|Lost to Follow-up|1
8001026|NCT04468347|12592763|FG003|Overall Study|Lost to Follow-up|1
8001027|NCT04468347|12592760|FG000|Overall Study|Physician Decision|1
8001028|NCT04468347|12592761|FG001|Overall Study|Physician Decision|0
8001029|NCT04468347|12592762|FG002|Overall Study|Physician Decision|2
8001030|NCT04468347|12592763|FG003|Overall Study|Physician Decision|0
8001031|NCT04468347|12592760|FG000|Overall Study|Protocol Violation|1
8001032|NCT04468347|12592761|FG001|Overall Study|Protocol Violation|0
8001033|NCT04468347|12592762|FG002|Overall Study|Protocol Violation|0
8001034|NCT04468347|12592763|FG003|Overall Study|Protocol Violation|0
8001035|NCT04465422|12592788|FG000|Overall Study|Lost to Follow-up|0
8001036|NCT04465422|12592789|FG001|Overall Study|Lost to Follow-up|2
8001037|NCT04448561|12592808|FG000|Overall Study|Noncompliance|1
8001038|NCT04448561|12592809|FG001|Overall Study|Noncompliance|0
8001039|NCT04450381|12592884|FG000|Overall Study|Protocol Violation|4
8001040|NCT04450381|12592884|FG000|Overall Study|Wrong device setting|2
8001041|NCT04449341|12592890|FG000|Overall Study|Protocol Violation|1
8001042|NCT04449341|12592891|FG001|Overall Study|Protocol Violation|0
8001043|NCT04439214|12592906|FG000|Overall Study|Adverse Event|13
8001044|NCT04439214|12592906|FG000|Overall Study|Disease progression|16
8001045|NCT04439214|12592906|FG000|Overall Study|Death|1
8001046|NCT04439214|12592906|FG000|Overall Study|Withdrawal by Subject|2
8001047|NCT04439214|12592906|FG000|Overall Study|Declining health|1
8001048|NCT04439214|12592906|FG000|Overall Study|Still receiving treatment at the time of the analysis|9
8001049|NCT04439214|12592906|FG000|Overall Study|Ineligible|5
8001050|NCT04439240|12592910|FG000|Overall Study|Ineligible|2
8001051|NCT04439240|12592910|FG000|Overall Study|Never started treatment|2
8001052|NCT04439240|12592910|FG000|Overall Study|Adverse Event|12
8001053|NCT04439240|12592910|FG000|Overall Study|Death|2
8001054|NCT04439240|12592910|FG000|Overall Study|Disease progression|25
8001055|NCT04439240|12592910|FG000|Overall Study|Other diseases|2
8001056|NCT04439240|12592910|FG000|Overall Study|Withdrawal by Subject|3
8001057|NCT04439240|12592910|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1
8001058|NCT04439240|12592910|FG000|Overall Study|Symptomatic decline|1
8001059|NCT04439240|12592910|FG000|Overall Study|Pogression of the lymphadenopathy|1
8001060|NCT04439240|12592910|FG000|Overall Study|Clinical progression|1
8001061|NCT04438785|12592916|FG000|Overall Study|change of weight, give up intervention|2
8001062|NCT04438785|12592917|FG001|Overall Study|change of weight, give up intervention|10
8001063|NCT04428502|12593006|FG000|Overall Study|Did not meet entrance criteria|14
8001064|NCT04428424|12593011|FG000|Overall Study|Does not meet entrance criteria|132
8001065|NCT04428424|12593011|FG000|Overall Study|Lost to Follow-up|115
8001066|NCT04425863|12593055|FG000|Overall Study|Death|0
8001067|NCT04425863|12593056|FG001|Overall Study|Death|0
8001068|NCT04425863|12593057|FG002|Overall Study|Death|1
8001069|NCT04422561|12593090|FG000|Overall Study|Lost to Follow-up|25
8001070|NCT04422561|12593091|FG001|Overall Study|Lost to Follow-up|11
8001071|NCT04419311|12593108|FG000|Overall Study|Lost to Follow-up|1
8001072|NCT04419311|12593109|FG001|Overall Study|Lost to Follow-up|0
8001073|NCT04411667|12593129|FG000|Overall Study|Physician Decision|1
8001074|NCT04411667|12593130|FG001|Overall Study|Physician Decision|0
8001075|NCT04407507|12593142|FG000|Overall Study|Withdrawal by Subject|0
8001076|NCT04407507|12593143|FG001|Overall Study|Withdrawal by Subject|1
8001077|NCT04406194|12593151|FG000|Period 1|Withdrawal by Subject|0
8001078|NCT04406194|12593152|FG001|Period 1|Withdrawal by Subject|1
8001079|NCT04403399|12593172|FG000|Period 2|Physician Decision|0
8001080|NCT04403399|12593173|FG001|Period 2|Physician Decision|1
8001081|NCT04401202|12593203|FG000|Overall Study|Lost to Follow-up|2
8001082|NCT04401202|12593204|FG001|Overall Study|Lost to Follow-up|2
8001083|NCT04401202|12593203|FG000|Overall Study|Adverse Event|0
8001084|NCT04401202|12593204|FG001|Overall Study|Adverse Event|1
8001085|NCT04401202|12593203|FG000|Overall Study|Hospitalized|4
8001086|NCT04401202|12593204|FG001|Overall Study|Hospitalized|1
8001087|NCT04400682|12593213|FG000|Period 1|Withdrawal by Subject|1
8001088|NCT04400682|12593214|FG001|Period 1|Withdrawal by Subject|4
8001089|NCT04399161|12593223|FG000|Overall Study|Withdrawal by Subject|1
8001090|NCT04399161|12593224|FG001|Overall Study|Withdrawal by Subject|0
8001091|NCT04399161|12593225|FG002|Overall Study|Withdrawal by Subject|2
8001092|NCT04399161|12593223|FG000|Overall Study|Protocol Violation|1
8001093|NCT04399161|12593224|FG001|Overall Study|Protocol Violation|2
8001094|NCT04399161|12593225|FG002|Overall Study|Protocol Violation|0
8001095|NCT04399122|12593244|FG000|Overall Study|Lost to Follow-up|2
8001096|NCT04399122|12593245|FG001|Overall Study|Lost to Follow-up|0
8001097|NCT04399122|12593244|FG000|Overall Study|Withdrawal by Subject|1
8001098|NCT04399122|12593245|FG001|Overall Study|Withdrawal by Subject|0
8001099|NCT04397445|12593251|FG000|Overall Study|Withdrawal by Subject|1
8001100|NCT04397445|12593252|FG001|Overall Study|Withdrawal by Subject|0
8001101|NCT04397445|12593253|FG002|Overall Study|Withdrawal by Subject|0
8001102|NCT04397445|12593254|FG003|Overall Study|Withdrawal by Subject|0
8001103|NCT04396639|12593280|FG000|Overall Study|Withdrawal by Subject|1
8001104|NCT04396639|12593280|FG000|Overall Study|Other|1
8001105|NCT04393493|12593299|FG000|First 4 Days of Intervention|Early improvement|5
8001106|NCT04393493|12593300|FG001|First 4 Days of Intervention|Early improvement|7
8001107|NCT04391842|12593399|FG000|Overall Study|Withdrawal by Subject|2
8001108|NCT04386902|12593412|FG000|Overall Study|Withdrawal by Subject|5
8001109|NCT04386902|12593412|FG000|Overall Study|Technical problems in the recording|5
8001110|NCT04384523|12593431|FG000|Overall Study|Lost to Follow-up|0
8001111|NCT04384523|12593432|FG001|Overall Study|Lost to Follow-up|0
8001112|NCT04384523|12593433|FG002|Overall Study|Lost to Follow-up|0
8001113|NCT04384523|12593434|FG003|Overall Study|Lost to Follow-up|0
8001114|NCT04384523|12593435|FG004|Overall Study|Lost to Follow-up|0
8001115|NCT04384523|12593436|FG005|Overall Study|Lost to Follow-up|1
8001116|NCT04384523|12593431|FG000|Overall Study|Protocol Violation|0
8001117|NCT04384523|12593432|FG001|Overall Study|Protocol Violation|1
8001118|NCT04384523|12593433|FG002|Overall Study|Protocol Violation|0
8001119|NCT04384523|12593434|FG003|Overall Study|Protocol Violation|0
8001120|NCT04384523|12593435|FG004|Overall Study|Protocol Violation|0
8001121|NCT04384523|12593436|FG005|Overall Study|Protocol Violation|0
8001122|NCT04384523|12593431|FG000|Overall Study|Withdrawal by Subject|1
8001123|NCT04384523|12593432|FG001|Overall Study|Withdrawal by Subject|0
8001124|NCT04384523|12593433|FG002|Overall Study|Withdrawal by Subject|0
8001125|NCT04384523|12593434|FG003|Overall Study|Withdrawal by Subject|0
8001126|NCT04384523|12593435|FG004|Overall Study|Withdrawal by Subject|0
8001127|NCT04384523|12593436|FG005|Overall Study|Withdrawal by Subject|0
8001128|NCT04380688|12593529|FG000|Overall Study|Death|2
8001129|NCT04380688|12593530|FG001|Overall Study|Death|2
8001130|NCT04380688|12593529|FG000|Overall Study|Lost to Follow-up|2
8001131|NCT04380688|12593530|FG001|Overall Study|Lost to Follow-up|4
8001132|NCT04380688|12593529|FG000|Overall Study|Withdrawal by Subject|3
8001133|NCT04380688|12593530|FG001|Overall Study|Withdrawal by Subject|3
8001134|NCT04376060|12593536|FG000|Overall Study|Physician Decision|1
8001135|NCT04372186|12593555|FG000|Overall Study|Death|24
8001136|NCT04372186|12593556|FG001|Overall Study|Death|11
8001137|NCT04372186|12593555|FG000|Overall Study|Transferred to a different facility for care|0
8001138|NCT04372186|12593556|FG001|Overall Study|Transferred to a different facility for care|2
8001139|NCT04370028|12593630|FG000|Overall Study|Withdrawal by Subject|695
8001140|NCT04370028|12593630|FG000|Overall Study|Protocol Violation|9
8001141|NCT04370028|12593630|FG000|Overall Study|Adverse Event|3
8001142|NCT04365699|12593653|FG000|Overall Study|Death|2
8001143|NCT04365699|12593654|FG001|Overall Study|Death|5
8001144|NCT04365699|12593655|FG002|Overall Study|Death|15
8001145|NCT04362137|12593688|FG000|Overall Study|Death|9
7718366|NCT00527735|12142317|FG001|Overall Study|Completed treatment during maintenance|2
7718367|NCT00527735|12142318|FG002|Overall Study|Completed treatment during maintenance|1
7718368|NCT00527787|12142340|FG000|Overall Study|Adverse Event|14
7718369|NCT00527787|12142341|FG001|Overall Study|Adverse Event|24
8001146|NCT04362137|12593689|FG001|Overall Study|Death|3
8001147|NCT04362137|12593688|FG000|Overall Study|Patient decision|6
8001148|NCT04362137|12593689|FG001|Overall Study|Patient decision|3
8001149|NCT04362137|12593688|FG000|Overall Study|Adverse Event|1
8001150|NCT04362137|12593689|FG001|Overall Study|Adverse Event|0
8001151|NCT04362137|12593688|FG000|Overall Study|Lost to Follow-up|1
8001152|NCT04362137|12593689|FG001|Overall Study|Lost to Follow-up|0
8001153|NCT04362137|12593688|FG000|Overall Study|Protocol deviation|1
8001154|NCT04362137|12593689|FG001|Overall Study|Protocol deviation|0
8001155|NCT04359771|12593697|FG000|Overall Study|Lack of Efficacy|2
8001156|NCT04359771|12593698|FG001|Overall Study|Lack of Efficacy|2
8001157|NCT04358081|12593711|FG000|Treatment Phase of Study|Withdrawal by Subject|0
8001158|NCT04358081|12593712|FG001|Treatment Phase of Study|Withdrawal by Subject|1
8001159|NCT04358081|12593713|FG002|Treatment Phase of Study|Withdrawal by Subject|1
8001160|NCT04358081|12593711|FG000|Treatment Phase of Study|Adverse Event|1
8001161|NCT04358081|12593712|FG001|Treatment Phase of Study|Adverse Event|0
8001162|NCT04358081|12593713|FG002|Treatment Phase of Study|Adverse Event|1
8001163|NCT04358081|12593711|FG000|Treatment Phase of Study|Physician Decision|2
8001164|NCT04358081|12593712|FG001|Treatment Phase of Study|Physician Decision|0
8001165|NCT04358081|12593713|FG002|Treatment Phase of Study|Physician Decision|1
8001166|NCT04358081|12593711|FG000|Treatment Phase of Study|Protocol Violation|1
8001167|NCT04358081|12593712|FG001|Treatment Phase of Study|Protocol Violation|0
8001168|NCT04358081|12593713|FG002|Treatment Phase of Study|Protocol Violation|0
8001169|NCT04358081|12593711|FG000|Study Completion Phase|Death|0
8001170|NCT04358081|12593712|FG001|Study Completion Phase|Death|0
8001171|NCT04358081|12593713|FG002|Study Completion Phase|Death|1
8001172|NCT04358081|12593711|FG000|Study Completion Phase|Lost to Follow-up|1
8001173|NCT04358081|12593712|FG001|Study Completion Phase|Lost to Follow-up|0
8001174|NCT04358081|12593713|FG002|Study Completion Phase|Lost to Follow-up|1
8001175|NCT04356937|12593725|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0
8001176|NCT04356937|12593726|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1
8001177|NCT04355663|12593735|FG000|Overall Study|Physician Decision|2
8001178|NCT04355663|12593736|FG001|Overall Study|Physician Decision|7
8001179|NCT04355663|12593737|FG002|Overall Study|Physician Decision|0
8001180|NCT04355663|12593735|FG000|Overall Study|Adverse Event|0
8001181|NCT04355663|12593736|FG001|Overall Study|Adverse Event|0
8001182|NCT04355663|12593737|FG002|Overall Study|Adverse Event|1
8001183|NCT04355663|12593735|FG000|Overall Study|Withdrawal by Subject|0
8001184|NCT04355663|12593736|FG001|Overall Study|Withdrawal by Subject|8
8001185|NCT04355663|12593737|FG002|Overall Study|Withdrawal by Subject|3
8001186|NCT04354870|12593747|FG000|Overall Study|Lost to Follow-up|32
8001187|NCT04354870|12593748|FG001|Overall Study|Lost to Follow-up|12
8001188|NCT04354870|12593747|FG000|Overall Study|Withdrawal by Subject|10
8001189|NCT04354870|12593748|FG001|Overall Study|Withdrawal by Subject|16
8001190|NCT04354870|12593747|FG000|Overall Study|Did not complete all study visits|6
8001191|NCT04354870|12593748|FG001|Overall Study|Did not complete all study visits|5
8001192|NCT04350788|12593774|FG000|Overall Study|Lost to Follow-up|6
8001193|NCT04350788|12593775|FG001|Overall Study|Lost to Follow-up|2
8001194|NCT04350788|12593774|FG000|Overall Study|Withdrawal by Subject|2
8001195|NCT04350788|12593775|FG001|Overall Study|Withdrawal by Subject|4
8001196|NCT04350788|12593774|FG000|Overall Study|Protocol Violation|4
8001197|NCT04350788|12593775|FG001|Overall Study|Protocol Violation|0
8001198|NCT04349917|12593788|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0
8001199|NCT04349917|12593789|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1
8001200|NCT04349917|12593788|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0
8001201|NCT04349917|12593789|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1
8001202|NCT04348851|12593800|FG000|Post-Test 1|Withdrawal by Subject|0
8001203|NCT04348851|12593801|FG001|Post-Test 1|Withdrawal by Subject|1
8001204|NCT04348851|12593802|FG002|Post-Test 1|Withdrawal by Subject|0
8001205|NCT04348851|12593803|FG003|Post-Test 1|Withdrawal by Subject|0
8001206|NCT04348851|12593800|FG000|Post-Test 1|Lost to Follow-up|0
8001207|NCT04348851|12593801|FG001|Post-Test 1|Lost to Follow-up|1
8001208|NCT04348851|12593802|FG002|Post-Test 1|Lost to Follow-up|0
8001209|NCT04348851|12593803|FG003|Post-Test 1|Lost to Follow-up|0
8001210|NCT04348851|12593800|FG000|Post-Test 2|Stroke survivor death|0
8001211|NCT04348851|12593801|FG001|Post-Test 2|Stroke survivor death|1
8001212|NCT04348851|12593802|FG002|Post-Test 2|Stroke survivor death|0
8001213|NCT04348851|12593803|FG003|Post-Test 2|Stroke survivor death|1
8001214|NCT04346199|12593824|FG000|Overall Study|Death|8
8001215|NCT04346199|12593825|FG001|Overall Study|Death|9
8001216|NCT04346199|12593824|FG000|Overall Study|Lost to Follow-up|0
8001217|NCT04346199|12593825|FG001|Overall Study|Lost to Follow-up|1
8001218|NCT04346199|12593824|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2
8001219|NCT04346199|12593825|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0
8001220|NCT04346199|12593824|FG000|Overall Study|Withdrawal by Subject|5
8001221|NCT04346199|12593825|FG001|Overall Study|Withdrawal by Subject|1
8001222|NCT04345653|12593831|FG000|Overall Study|Withdrawal by Subject|2
8001223|NCT04343261|12593836|FG000|Overall Study|Adverse Event|1
8001224|NCT04343261|12593836|FG000|Overall Study|received inadequate amount of antibodies|7
8001225|NCT04342897|12593868|FG000|Overall Study|Death|7
8001226|NCT04342897|12593869|FG001|Overall Study|Death|4
8001227|NCT04342897|12593868|FG000|Overall Study|Lost to Follow-up|6
8001228|NCT04342897|12593869|FG001|Overall Study|Lost to Follow-up|6
8001229|NCT04342897|12593868|FG000|Overall Study|Withdrawal by Subject|1
8001230|NCT04342897|12593869|FG001|Overall Study|Withdrawal by Subject|2
8001231|NCT04340557|12593881|FG000|Overall Study|Transferred to ICU and/or death|1
8001232|NCT04340557|12593882|FG001|Overall Study|Transferred to ICU and/or death|2
8001233|NCT04339972|12593890|FG000|Overall Study|Scheduling Issues|3
8001234|NCT04339972|12593891|FG001|Overall Study|Scheduling Issues|3
8001235|NCT04339972|12593890|FG000|Overall Study|dropout|1
8001236|NCT04339972|12593891|FG001|Overall Study|dropout|1
8001237|NCT04339972|12593890|FG000|Overall Study|Technical issues|1
8001238|NCT04339972|12593891|FG001|Overall Study|Technical issues|0
8001239|NCT04339972|12593890|FG000|Overall Study|Claustraphobia|0
8001240|NCT04339972|12593891|FG001|Overall Study|Claustraphobia|1
8001241|NCT04339296|12593899|FG000|Overall Study|Refuse to participate after allocation|1
8001242|NCT04339296|12593900|FG001|Overall Study|Refuse to participate after allocation|1
8001243|NCT04339296|12593899|FG000|Overall Study|Withdrew after completion of baseline|2
8001244|NCT04339296|12593900|FG001|Overall Study|Withdrew after completion of baseline|1
8001245|NCT04339296|12593899|FG000|Overall Study|Lost to Follow-up|0
8001246|NCT04339296|12593900|FG001|Overall Study|Lost to Follow-up|4
8001247|NCT04339296|12593899|FG000|Overall Study|Discontinued intervention|5
8001248|NCT04339296|12593900|FG001|Overall Study|Discontinued intervention|3
8001249|NCT04336475|12593930|FG000|Overall Study|pain|1
8001250|NCT04336475|12593931|FG001|Overall Study|pain|0
8001251|NCT04336475|12593930|FG000|Overall Study|upper respiratory infection|1
8001252|NCT04336475|12593931|FG001|Overall Study|upper respiratory infection|0
8001253|NCT04336475|12593930|FG000|Overall Study|Lost to Follow-up|0
8001254|NCT04336475|12593931|FG001|Overall Study|Lost to Follow-up|2
8001255|NCT04335929|12593937|FG000|Overall Study|Lost to Follow-up|10
8001256|NCT04335812|12593943|FG000|Overall Study|Withdrawal by Subject|1
8001257|NCT04335812|12593944|FG001|Overall Study|Withdrawal by Subject|3
8001258|NCT04335812|12593943|FG000|Overall Study|Lost to Follow-up|12
8001259|NCT04335812|12593944|FG001|Overall Study|Lost to Follow-up|12
8001260|NCT04335812|12593943|FG000|Overall Study|Did not engage in the intervention|22
8001261|NCT04335812|12593944|FG001|Overall Study|Did not engage in the intervention|18
8001262|NCT04335136|12593952|FG000|Overall Study|Death|8
8001263|NCT04335136|12593953|FG001|Overall Study|Death|4
8001264|NCT04335136|12593952|FG000|Overall Study|Lost to Follow-up|2
8001265|NCT04335136|12593953|FG001|Overall Study|Lost to Follow-up|0
8001266|NCT04335136|12593952|FG000|Overall Study|Protocol Violation|1
8001267|NCT04335136|12593953|FG001|Overall Study|Protocol Violation|0
8001268|NCT04335136|12593952|FG000|Overall Study|Withdrawal by Subject|1
8001269|NCT04335136|12593953|FG001|Overall Study|Withdrawal by Subject|1
8001270|NCT04335136|12593952|FG000|Overall Study|Health-threatening condition|0
8001271|NCT04335136|12593953|FG001|Overall Study|Health-threatening condition|1
8001272|NCT04335136|12593952|FG000|Overall Study|Adverse Event|0
8001273|NCT04335136|12593953|FG001|Overall Study|Adverse Event|1
8001274|NCT04335136|12593952|FG000|Overall Study|Erroneously randomized|2
8001275|NCT04335136|12593953|FG001|Overall Study|Erroneously randomized|0
8001276|NCT04333199|12594003|FG000|Evaluated Patients|Lost to Follow-up|0
8001277|NCT04333199|12594004|FG001|Evaluated Patients|Lost to Follow-up|1
8001278|NCT04333199|12594005|FG002|Evaluated Patients|Lost to Follow-up|2
8001279|NCT04332107|12594077|FG000|Day 3|Lost to Follow-up|23
8001280|NCT04332107|12594078|FG001|Day 3|Lost to Follow-up|14
8001281|NCT04332107|12594077|FG000|Day 3|Missing outcome data|3
8001282|NCT04332107|12594078|FG001|Day 3|Missing outcome data|6
8001283|NCT04332107|12594077|FG000|Day 14|Lost to Follow-up|13
8001284|NCT04332107|12594078|FG001|Day 14|Lost to Follow-up|4
8001285|NCT04332107|12594077|FG000|Day 14|Missing outcome data|4
8001286|NCT04332107|12594078|FG001|Day 14|Missing outcome data|4
8001287|NCT04332107|12594077|FG000|Day 21|Lost to Follow-up|10
8001288|NCT04332107|12594078|FG001|Day 21|Lost to Follow-up|2
8001289|NCT04329923|12594112|FG000|Overall Study|Withdrawal by Subject|1
8001290|NCT04329923|12594113|FG001|Overall Study|Withdrawal by Subject|4
8001291|NCT04329923|12594114|FG002|Overall Study|Withdrawal by Subject|1
8001292|NCT04329923|12594115|FG003|Overall Study|Withdrawal by Subject|1
8001293|NCT04329923|12594116|FG004|Overall Study|Withdrawal by Subject|1
8001294|NCT04329923|12594117|FG005|Overall Study|Withdrawal by Subject|1
8001295|NCT04329923|12594112|FG000|Overall Study|early termination of study|0
8001296|NCT04329923|12594113|FG001|Overall Study|early termination of study|0
8001297|NCT04329923|12594114|FG002|Overall Study|early termination of study|0
8001298|NCT04329923|12594115|FG003|Overall Study|early termination of study|0
8001299|NCT04329923|12594116|FG004|Overall Study|early termination of study|1
8001300|NCT04329923|12594117|FG005|Overall Study|early termination of study|2
8001301|NCT04329923|12594112|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0
8001302|NCT04329923|12594113|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0
8001303|NCT04329923|12594114|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0
8001304|NCT04329923|12594115|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0
8001305|NCT04329923|12594116|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0
8001306|NCT04329923|12594117|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2
8001307|NCT04328467|12594134|FG000|Overall Study|Did not meet inclusion criteria after randomization|4
8001308|NCT04328467|12594135|FG001|Overall Study|Did not meet inclusion criteria after randomization|2
8001309|NCT04328467|12594136|FG002|Overall Study|Did not meet inclusion criteria after randomization|1
8001310|NCT04322526|12594146|FG000|First Intervention (1 Day)|Withdrawal by Subject|1
8001311|NCT04322526|12594147|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
8001312|NCT04322526|12594146|FG000|Washout (1 Week)|Lost to Follow-up|1
8001313|NCT04322526|12594147|FG001|Washout (1 Week)|Lost to Follow-up|2
8001314|NCT04322682|12594164|FG000|Overall Study|Withdrawal by Subject|33
8001315|NCT04322682|12594165|FG001|Overall Study|Withdrawal by Subject|47
8001316|NCT04322682|12594164|FG000|Overall Study|Death|5
8001317|NCT04322682|12594165|FG001|Overall Study|Death|9
8001318|NCT04322682|12594164|FG000|Overall Study|Lost to Follow-up|4
8001319|NCT04322682|12594165|FG001|Overall Study|Lost to Follow-up|8
8001320|NCT04322682|12594164|FG000|Overall Study|Admitted to Hospital and Intubated|1
8001321|NCT04322682|12594165|FG001|Overall Study|Admitted to Hospital and Intubated|0
8001322|NCT04320615|12594216|FG000|Overall Study|Withdrawal by Subject|4
8001323|NCT04320615|12594217|FG001|Overall Study|Withdrawal by Subject|10
8001324|NCT04320615|12594216|FG000|Overall Study|Physician Decision|2
8001325|NCT04320615|12594217|FG001|Overall Study|Physician Decision|0
8001326|NCT04320615|12594216|FG000|Overall Study|Other|2
8001327|NCT04320615|12594217|FG001|Overall Study|Other|0
8001328|NCT04320615|12594216|FG000|Overall Study|Lost to Follow-up|5
8001329|NCT04320615|12594217|FG001|Overall Study|Lost to Follow-up|23
8001330|NCT04320615|12594216|FG000|Overall Study|Death|35
8001331|NCT04320615|12594217|FG001|Overall Study|Death|71
8001332|NCT04318535|12594227|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
8001333|NCT04318535|12594228|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1
8001334|NCT04318535|12594229|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
8001335|NCT04314037|12594250|FG000|Treatment Period 2|Adverse Event|1
8001336|NCT04314037|12594251|FG001|Treatment Period 2|Adverse Event|0
8001337|NCT04314037|12594250|FG000|Treatment Period 3|Protocol Violation|1
8001338|NCT04314037|12594251|FG001|Treatment Period 3|Protocol Violation|0
8001339|NCT04314037|12594250|FG000|Treatment Period 3|Adverse Event|0
8001340|NCT04314037|12594251|FG001|Treatment Period 3|Adverse Event|1
8001341|NCT04315298|12594282|FG000|Overall Study|Withdrawal by Subject|0
8001342|NCT04315298|12594283|FG001|Overall Study|Withdrawal by Subject|0
8001343|NCT04315298|12594284|FG002|Overall Study|Withdrawal by Subject|0
8001344|NCT04315298|12594285|FG003|Overall Study|Withdrawal by Subject|2
8001345|NCT04315298|12594286|FG004|Overall Study|Withdrawal by Subject|2
8001346|NCT04315298|12594287|FG005|Overall Study|Withdrawal by Subject|2
8001347|NCT04315298|12594288|FG006|Overall Study|Withdrawal by Subject|0
8001348|NCT04315298|12594289|FG007|Overall Study|Withdrawal by Subject|1
8001349|NCT04315298|12594290|FG008|Overall Study|Withdrawal by Subject|1
8001350|NCT04315298|12594291|FG009|Overall Study|Withdrawal by Subject|1
8001351|NCT04315298|12594292|FG010|Overall Study|Withdrawal by Subject|0
8001352|NCT04315298|12594293|FG011|Overall Study|Withdrawal by Subject|0
8001353|NCT04315298|12594294|FG012|Overall Study|Withdrawal by Subject|0
8001354|NCT04315298|12594295|FG013|Overall Study|Withdrawal by Subject|0
8001355|NCT04315298|12594296|FG014|Overall Study|Withdrawal by Subject|0
8001356|NCT04315298|12594297|FG015|Overall Study|Withdrawal by Subject|0
8001357|NCT04315298|12594298|FG016|Overall Study|Withdrawal by Subject|0
8001358|NCT04315298|12594299|FG017|Overall Study|Withdrawal by Subject|0
8001359|NCT04315298|12594300|FG018|Overall Study|Withdrawal by Subject|0
8001360|NCT04315298|12594282|FG000|Overall Study|Physician Decision|0
8001361|NCT04315298|12594283|FG001|Overall Study|Physician Decision|0
8001362|NCT04315298|12594284|FG002|Overall Study|Physician Decision|0
8001363|NCT04315298|12594285|FG003|Overall Study|Physician Decision|0
8001364|NCT04315298|12594286|FG004|Overall Study|Physician Decision|1
8001365|NCT04315298|12594287|FG005|Overall Study|Physician Decision|0
8001366|NCT04315298|12594288|FG006|Overall Study|Physician Decision|0
8001367|NCT04315298|12594289|FG007|Overall Study|Physician Decision|0
8001368|NCT04315298|12594290|FG008|Overall Study|Physician Decision|0
8001369|NCT04315298|12594291|FG009|Overall Study|Physician Decision|0
8001370|NCT04315298|12594292|FG010|Overall Study|Physician Decision|0
8001371|NCT04315298|12594293|FG011|Overall Study|Physician Decision|0
8001372|NCT04315298|12594294|FG012|Overall Study|Physician Decision|0
8001373|NCT04315298|12594295|FG013|Overall Study|Physician Decision|0
8001374|NCT04315298|12594296|FG014|Overall Study|Physician Decision|0
8001375|NCT04315298|12594297|FG015|Overall Study|Physician Decision|0
8001376|NCT04315298|12594298|FG016|Overall Study|Physician Decision|0
8001377|NCT04315298|12594299|FG017|Overall Study|Physician Decision|0
8001378|NCT04315298|12594300|FG018|Overall Study|Physician Decision|0
8001379|NCT04315298|12594282|FG000|Overall Study|Lost to Follow-up|5
8001380|NCT04315298|12594283|FG001|Overall Study|Lost to Follow-up|10
8001381|NCT04315298|12594284|FG002|Overall Study|Lost to Follow-up|6
8001382|NCT04315298|12594285|FG003|Overall Study|Lost to Follow-up|8
8001383|NCT04315298|12594286|FG004|Overall Study|Lost to Follow-up|12
8001384|NCT04315298|12594287|FG005|Overall Study|Lost to Follow-up|13
8001385|NCT04315298|12594288|FG006|Overall Study|Lost to Follow-up|9
8001386|NCT04315298|12594289|FG007|Overall Study|Lost to Follow-up|16
8001387|NCT04315298|12594290|FG008|Overall Study|Lost to Follow-up|14
8001388|NCT04315298|12594291|FG009|Overall Study|Lost to Follow-up|0
8001389|NCT04315298|12594292|FG010|Overall Study|Lost to Follow-up|2
8001390|NCT04315298|12594293|FG011|Overall Study|Lost to Follow-up|1
8001391|NCT04315298|12594294|FG012|Overall Study|Lost to Follow-up|0
8001392|NCT04315298|12594295|FG013|Overall Study|Lost to Follow-up|0
8001393|NCT04315298|12594296|FG014|Overall Study|Lost to Follow-up|0
8001394|NCT04315298|12594297|FG015|Overall Study|Lost to Follow-up|2
8001395|NCT04315298|12594298|FG016|Overall Study|Lost to Follow-up|0
8001396|NCT04315298|12594299|FG017|Overall Study|Lost to Follow-up|0
8001397|NCT04315298|12594300|FG018|Overall Study|Lost to Follow-up|0
8001398|NCT04315298|12594282|FG000|Overall Study|Death|24
8001399|NCT04315298|12594283|FG001|Overall Study|Death|60
8001400|NCT04315298|12594284|FG002|Overall Study|Death|49
8001401|NCT04315298|12594285|FG003|Overall Study|Death|59
8001402|NCT04315298|12594286|FG004|Overall Study|Death|70
8001403|NCT04315298|12594287|FG005|Overall Study|Death|114
8001404|NCT04315298|12594288|FG006|Overall Study|Death|9
8001405|NCT04315298|12594289|FG007|Overall Study|Death|12
8001406|NCT04315298|12594290|FG008|Overall Study|Death|21
8001407|NCT04315298|12594291|FG009|Overall Study|Death|16
8001408|NCT04315298|12594292|FG010|Overall Study|Death|40
8001409|NCT04315298|12594293|FG011|Overall Study|Death|40
8001410|NCT04315298|12594294|FG012|Overall Study|Death|3
8001411|NCT04315298|12594295|FG013|Overall Study|Death|4
8001412|NCT04315298|12594296|FG014|Overall Study|Death|6
8001413|NCT04315298|12594297|FG015|Overall Study|Death|4
8001414|NCT04315298|12594298|FG016|Overall Study|Death|3
8001415|NCT04315298|12594299|FG017|Overall Study|Death|1
8001416|NCT04315298|12594300|FG018|Overall Study|Death|0
8001417|NCT04308239|12594410|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2
8001418|NCT04308239|12594411|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1
8001419|NCT04308239|12594410|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1
8001420|NCT04308239|12594411|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2
8001421|NCT04308239|12594410|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1
8001422|NCT04308239|12594411|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2
8001423|NCT04308239|12594410|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0
8001424|NCT04308239|12594411|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2
8001425|NCT04308668|12594423|FG000|Overall Study|Lost to Follow-up|32
8001426|NCT04308668|12594424|FG001|Overall Study|Lost to Follow-up|38
8001427|NCT04308668|12594423|FG000|Overall Study|Withdrawal by Subject|4
8001428|NCT04308668|12594424|FG001|Overall Study|Withdrawal by Subject|4
8001429|NCT04307940|12594433|FG000|Overall Study|Adverse Event|1
8001430|NCT04307940|12594434|FG001|Overall Study|Adverse Event|0
8001431|NCT04307940|12594435|FG002|Overall Study|Adverse Event|0
8001432|NCT04307940|12594433|FG000|Overall Study|Withdrawal by Subject|2
8001433|NCT04307940|12594434|FG001|Overall Study|Withdrawal by Subject|3
8001434|NCT04307940|12594435|FG002|Overall Study|Withdrawal by Subject|1
8001435|NCT04307940|12594433|FG000|Overall Study|Lost to Follow-up|2
8001436|NCT04307940|12594434|FG001|Overall Study|Lost to Follow-up|0
8001437|NCT04307940|12594435|FG002|Overall Study|Lost to Follow-up|1
8001438|NCT04302545|12594445|FG000|Overall Study|Lost to Follow-up|3
8001439|NCT04302545|12594446|FG001|Overall Study|Lost to Follow-up|4
8001440|NCT04297241|12594468|FG000|Overall Study|Withdrawal by Subject|1
8001441|NCT04297241|12594468|FG000|Overall Study|Adverse Event|1
8001442|NCT04297241|12594468|FG000|Overall Study|Physician Decision|3
8001443|NCT04295356|12594497|FG000|Overall Study|Physician Decision|1
8001444|NCT04295356|12594498|FG001|Overall Study|Physician Decision|0
8001445|NCT04295356|12594497|FG000|Overall Study|Lost to Follow-up|0
8001446|NCT04295356|12594498|FG001|Overall Study|Lost to Follow-up|3
8001447|NCT04295356|12594497|FG000|Overall Study|Protocol Violation|0
8001448|NCT04295356|12594498|FG001|Overall Study|Protocol Violation|1
8001449|NCT04292535|12594522|FG000|Overall Study|Withdrawal by Subject|0
8001450|NCT04292535|12594523|FG001|Overall Study|Withdrawal by Subject|0
8001451|NCT04292535|12594524|FG002|Overall Study|Withdrawal by Subject|0
8001452|NCT04292535|12594525|FG003|Overall Study|Withdrawal by Subject|0
8001453|NCT04292535|12594526|FG004|Overall Study|Withdrawal by Subject|0
8001454|NCT04292535|12594527|FG005|Overall Study|Withdrawal by Subject|0
8001455|NCT04292535|12594528|FG006|Overall Study|Withdrawal by Subject|0
8001456|NCT04292535|12594529|FG007|Overall Study|Withdrawal by Subject|1
8001457|NCT04292535|12594530|FG008|Overall Study|Withdrawal by Subject|0
8001458|NCT04292535|12594531|FG009|Overall Study|Withdrawal by Subject|0
8001459|NCT04292535|12594532|FG010|Overall Study|Withdrawal by Subject|0
8001460|NCT04292535|12594533|FG011|Overall Study|Withdrawal by Subject|0
8001461|NCT04292535|12594534|FG012|Overall Study|Withdrawal by Subject|0
8001462|NCT04292535|12594535|FG013|Overall Study|Withdrawal by Subject|0
8001463|NCT04292535|12594522|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
8001464|NCT04292535|12594523|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
8001465|NCT04292535|12594524|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
8001466|NCT04292535|12594525|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
8001467|NCT04292535|12594526|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
8001468|NCT04292535|12594527|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
8001469|NCT04292535|12594528|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
8001470|NCT04292535|12594529|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
8001471|NCT04292535|12594530|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
8001472|NCT04292535|12594531|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
8001473|NCT04292535|12594532|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
8001474|NCT04292535|12594533|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
8001475|NCT04292535|12594534|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
8001476|NCT04292535|12594535|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
8001477|NCT04292535|12594522|FG000|Overall Study|Report of Dizziness|0
8001478|NCT04292535|12594523|FG001|Overall Study|Report of Dizziness|0
8001479|NCT04292535|12594524|FG002|Overall Study|Report of Dizziness|0
8001480|NCT04292535|12594525|FG003|Overall Study|Report of Dizziness|0
8001481|NCT04292535|12594526|FG004|Overall Study|Report of Dizziness|0
8001482|NCT04292535|12594527|FG005|Overall Study|Report of Dizziness|0
8001483|NCT04292535|12594528|FG006|Overall Study|Report of Dizziness|0
8001484|NCT04292535|12594529|FG007|Overall Study|Report of Dizziness|0
8001485|NCT04292535|12594530|FG008|Overall Study|Report of Dizziness|0
8001486|NCT04292535|12594531|FG009|Overall Study|Report of Dizziness|0
8001487|NCT04292535|12594532|FG010|Overall Study|Report of Dizziness|0
8001488|NCT04292535|12594533|FG011|Overall Study|Report of Dizziness|0
8001489|NCT04292535|12594534|FG012|Overall Study|Report of Dizziness|0
8001490|NCT04292535|12594535|FG013|Overall Study|Report of Dizziness|1
8001491|NCT04292535|12594522|FG000|Overall Study|Equipment Failure|0
8001492|NCT04292535|12594523|FG001|Overall Study|Equipment Failure|0
8001493|NCT04292535|12594524|FG002|Overall Study|Equipment Failure|0
8001494|NCT04292535|12594525|FG003|Overall Study|Equipment Failure|0
8001495|NCT04292535|12594526|FG004|Overall Study|Equipment Failure|0
8001496|NCT04292535|12594527|FG005|Overall Study|Equipment Failure|0
8001497|NCT04292535|12594528|FG006|Overall Study|Equipment Failure|0
8001498|NCT04292535|12594529|FG007|Overall Study|Equipment Failure|0
8001499|NCT04292535|12594530|FG008|Overall Study|Equipment Failure|0
8001500|NCT04292535|12594531|FG009|Overall Study|Equipment Failure|0
8001501|NCT04292535|12594532|FG010|Overall Study|Equipment Failure|0
8001502|NCT04292535|12594533|FG011|Overall Study|Equipment Failure|1
8001503|NCT04292535|12594534|FG012|Overall Study|Equipment Failure|0
8001504|NCT04292535|12594535|FG013|Overall Study|Equipment Failure|0
8001505|NCT04292171|12594567|FG000|Overall Study|Pharmacy error|2
8001506|NCT04292171|12594568|FG001|Overall Study|Pharmacy error|0
8001507|NCT04292171|12594567|FG000|Overall Study|Delivered prior to procedure|0
8001508|NCT04292171|12594568|FG001|Overall Study|Delivered prior to procedure|1
8001509|NCT04292899|12594578|FG000|Overall Study|Death|21
8001510|NCT04292899|12594579|FG001|Overall Study|Death|28
8001511|NCT04292899|12594580|FG002|Overall Study|Death|188
8001512|NCT04292899|12594581|FG003|Overall Study|Death|371
8001513|NCT04292899|12594578|FG000|Overall Study|Lost to Follow-up|8
8001514|NCT04292899|12594579|FG001|Overall Study|Lost to Follow-up|4
8001515|NCT04292899|12594580|FG002|Overall Study|Lost to Follow-up|22
8001516|NCT04292899|12594581|FG003|Overall Study|Lost to Follow-up|235
8001517|NCT04292899|12594578|FG000|Overall Study|Withdrew consent|1
8001518|NCT04292899|12594579|FG001|Overall Study|Withdrew consent|0
8001519|NCT04292899|12594580|FG002|Overall Study|Withdrew consent|11
8001520|NCT04292899|12594581|FG003|Overall Study|Withdrew consent|32
8001521|NCT04292899|12594578|FG000|Overall Study|Adverse Event|2
8001522|NCT04292899|12594579|FG001|Overall Study|Adverse Event|1
8001523|NCT04292899|12594580|FG002|Overall Study|Adverse Event|2
8001524|NCT04292899|12594581|FG003|Overall Study|Adverse Event|2
8001525|NCT04292899|12594578|FG000|Overall Study|Investigator's Discretion|0
8001526|NCT04292899|12594579|FG001|Overall Study|Investigator's Discretion|0
8001527|NCT04292899|12594580|FG002|Overall Study|Investigator's Discretion|0
8001528|NCT04292899|12594581|FG003|Overall Study|Investigator's Discretion|3
8001529|NCT04292899|12594578|FG000|Overall Study|Non-compliance With Study Drug|0
8001530|NCT04292899|12594579|FG001|Overall Study|Non-compliance With Study Drug|0
8001531|NCT04292899|12594580|FG002|Overall Study|Non-compliance With Study Drug|0
8001532|NCT04292899|12594581|FG003|Overall Study|Non-compliance With Study Drug|1
8001533|NCT04292899|12594578|FG000|Overall Study|Protocol Violation|0
8001534|NCT04292899|12594579|FG001|Overall Study|Protocol Violation|0
8001535|NCT04292899|12594580|FG002|Overall Study|Protocol Violation|0
8001536|NCT04292899|12594581|FG003|Overall Study|Protocol Violation|1
8001537|NCT04292730|12594593|FG000|Overall Study|Lost to Follow-up|8
8001538|NCT04292730|12594594|FG001|Overall Study|Lost to Follow-up|12
8001539|NCT04292730|12594595|FG002|Overall Study|Lost to Follow-up|12
8001540|NCT04292730|12594596|FG003|Overall Study|Lost to Follow-up|48
8001541|NCT04292730|12594593|FG000|Overall Study|Death|2
8001542|NCT04292730|12594594|FG001|Overall Study|Death|2
8001543|NCT04292730|12594595|FG002|Overall Study|Death|4
8001544|NCT04292730|12594596|FG003|Overall Study|Death|12
8001545|NCT04292730|12594593|FG000|Overall Study|Withdrew Consent|2
8001546|NCT04292730|12594594|FG001|Overall Study|Withdrew Consent|2
8001547|NCT04292730|12594595|FG002|Overall Study|Withdrew Consent|5
8001548|NCT04292730|12594596|FG003|Overall Study|Withdrew Consent|6
8001549|NCT04292730|12594593|FG000|Overall Study|Non-Compliance with Study Drug|0
8001550|NCT04292730|12594594|FG001|Overall Study|Non-Compliance with Study Drug|1
8001551|NCT04292730|12594595|FG002|Overall Study|Non-Compliance with Study Drug|0
8001552|NCT04292730|12594596|FG003|Overall Study|Non-Compliance with Study Drug|0
8001553|NCT04292730|12594593|FG000|Overall Study|Protocol Violation|0
8001554|NCT04292730|12594594|FG001|Overall Study|Protocol Violation|0
8001555|NCT04292730|12594595|FG002|Overall Study|Protocol Violation|1
8001556|NCT04292730|12594596|FG003|Overall Study|Protocol Violation|0
8001557|NCT04292730|12594593|FG000|Overall Study|Randomized but not Treated|8
8001558|NCT04292730|12594594|FG001|Overall Study|Randomized but not Treated|4
8001559|NCT04292730|12594595|FG002|Overall Study|Randomized but not Treated|0
8001560|NCT04292730|12594596|FG003|Overall Study|Randomized but not Treated|14
8001561|NCT04289623|12594629|FG000|Wave 1 Emails|Email was not delivered|268
8001562|NCT04289623|12594630|FG001|Wave 1 Emails|Email was not delivered|257
8001563|NCT04289623|12594631|FG002|Wave 1 Emails|Email was not delivered|0
8001564|NCT04289623|12594632|FG003|Wave 1 Emails|Email was not delivered|0
8001565|NCT04289623|12594633|FG004|Wave 1 Emails|Email was not delivered|0
8001566|NCT04289623|12594634|FG005|Wave 1 Emails|Email was not delivered|0
8001567|NCT04276207|12594648|FG000|Period 1|Withdrawal by Subject|0
8001568|NCT04276207|12594649|FG001|Period 1|Withdrawal by Subject|1
8001569|NCT04287517|12594679|FG000|Overall Study|Withdrawal by Subject|1
8001570|NCT04287517|12594680|FG001|Overall Study|Withdrawal by Subject|1
8001571|NCT04275336|12594746|FG000|Overall Study|First venipuncture failed|4
8001572|NCT04275336|12594747|FG001|Overall Study|First venipuncture failed|6
8001573|NCT04275336|12594748|FG002|Overall Study|First venipuncture failed|5
8001574|NCT04275336|12594746|FG000|Overall Study|Unscheduled venipuncture|9
8001575|NCT04275336|12594747|FG001|Overall Study|Unscheduled venipuncture|13
8001576|NCT04275336|12594748|FG002|Overall Study|Unscheduled venipuncture|7
8001577|NCT04275336|12594746|FG000|Overall Study|Failed specimen of saliva|4
8001578|NCT04275336|12594747|FG001|Overall Study|Failed specimen of saliva|3
8001579|NCT04275336|12594748|FG002|Overall Study|Failed specimen of saliva|4
8001580|NCT04272775|12594761|FG000|Overall Study|Study Terminated by Sponsor|1
8001581|NCT04272775|12594762|FG001|Overall Study|Study Terminated by Sponsor|0
8001582|NCT04272775|12594761|FG000|Overall Study|Protocol Violation|0
8001583|NCT04272775|12594762|FG001|Overall Study|Protocol Violation|1
8001584|NCT04272775|12594761|FG000|Overall Study|Symptomatic Deterioration|1
8001585|NCT04272775|12594762|FG001|Overall Study|Symptomatic Deterioration|1
8001586|NCT04272775|12594761|FG000|Overall Study|Withdrawal by Subject|1
8001587|NCT04272775|12594762|FG001|Overall Study|Withdrawal by Subject|2
8001588|NCT04272775|12594761|FG000|Overall Study|Adverse Event|1
8001589|NCT04272775|12594762|FG001|Overall Study|Adverse Event|2
8001590|NCT04272775|12594761|FG000|Overall Study|Progressive Disease|3
8001591|NCT04272775|12594762|FG001|Overall Study|Progressive Disease|1
8001592|NCT04271605|12594794|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5
8001593|NCT04268316|12594805|FG000|Overall Study|Withdrawal by Subject|2
8001594|NCT04268316|12594806|FG001|Overall Study|Withdrawal by Subject|1
8001595|NCT04268316|12594807|FG002|Overall Study|Withdrawal by Subject|0
8001596|NCT04263142|12594850|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0
8001597|NCT04263142|12594851|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0
8001598|NCT04263142|12594852|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0
8001599|NCT04263142|12594853|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0
8001600|NCT04263142|12594854|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1
8001601|NCT04263142|12594850|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0
8001602|NCT04263142|12594851|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0
8001603|NCT04263142|12594852|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0
8001604|NCT04263142|12594853|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0
8001605|NCT04263142|12594854|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1
8001606|NCT04256785|12594869|FG000|Overall Study|Adverse Event|8
8001607|NCT04256785|12594870|FG001|Overall Study|Adverse Event|6
8001608|NCT04256785|12594869|FG000|Overall Study|Lack of Efficacy|3
8001609|NCT04256785|12594870|FG001|Overall Study|Lack of Efficacy|4
8001610|NCT04256785|12594869|FG000|Overall Study|Lost to Follow-up|7
8001611|NCT04256785|12594870|FG001|Overall Study|Lost to Follow-up|7
8001612|NCT04256785|12594869|FG000|Overall Study|Protocol Violation|1
8001613|NCT04256785|12594870|FG001|Overall Study|Protocol Violation|0
8001614|NCT04256785|12594869|FG000|Overall Study|Withdrawal by Subject|4
8001615|NCT04256785|12594870|FG001|Overall Study|Withdrawal by Subject|1
8001616|NCT04256785|12594869|FG000|Overall Study|Surgery or quarantined due to Covid-19|5
8001617|NCT04256785|12594870|FG001|Overall Study|Surgery or quarantined due to Covid-19|7
8001618|NCT04249336|12594895|FG000|Overall Study|Lost to Follow-up|3
8001619|NCT04249336|12594896|FG001|Overall Study|Lost to Follow-up|3
8001620|NCT04249336|12594897|FG002|Overall Study|Lost to Follow-up|3
8001621|NCT04249336|12594898|FG003|Overall Study|Lost to Follow-up|3
8001622|NCT04247061|12594917|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6
8001623|NCT04247061|12594917|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2
8001624|NCT04247061|12594917|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1
8001625|NCT04245202|12594923|FG000|Overall Study|Lack of Efficacy|10
8001626|NCT04245202|12594924|FG001|Overall Study|Lack of Efficacy|1
8001627|NCT04238650|12594955|FG000|Overall Study|Withdrawal by Subject|0
8001628|NCT04238650|12594956|FG001|Overall Study|Withdrawal by Subject|1
8001629|NCT04238663|12594965|FG000|Overall Study|Lost to Follow-up|0
8001630|NCT04238663|12594966|FG001|Overall Study|Lost to Follow-up|1
8001631|NCT04238663|12594967|FG002|Overall Study|Lost to Follow-up|0
8001632|NCT04222699|12595041|FG000|Overall Study|Lost to Follow-up|2
8001633|NCT04206293|12595064|FG000|Overall Study|Consent withdrawal|1
8001634|NCT04228302|12595075|FG000|Overall Study|Adverse Event|0
8001635|NCT04228302|12595076|FG001|Overall Study|Adverse Event|0
8001636|NCT04228302|12595077|FG002|Overall Study|Adverse Event|0
8001637|NCT04228302|12595078|FG003|Overall Study|Adverse Event|0
8001638|NCT04228302|12595079|FG004|Overall Study|Adverse Event|1
8001639|NCT04228302|12595080|FG005|Overall Study|Adverse Event|0
8001640|NCT04223687|12595118|FG000|Overall Study|Missing primary outcome|1
8001641|NCT04223687|12595119|FG001|Overall Study|Missing primary outcome|0
8001642|NCT04223232|12595125|FG000|Overall Study|Withdrawal by Subject|1
8001643|NCT04189224|12595129|FG000|Period 2|Adverse Event|0
8001644|NCT04189224|12595130|FG001|Period 2|Adverse Event|1
8001645|NCT04214600|12595138|FG000|Overall Study|Lost to Follow-up|9
8001646|NCT04214600|12595139|FG001|Overall Study|Lost to Follow-up|14
8001647|NCT04202497|12595146|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1
8001648|NCT04202497|12595147|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
8001649|NCT04202497|12595148|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
8001650|NCT04202497|12595149|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
8001651|NCT04209530|12595176|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4
8001652|NCT04209530|12595177|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2
8001653|NCT04209530|12595176|FG000|Overall Study|Withdrawal by Subject|0
8001654|NCT04209530|12595177|FG001|Overall Study|Withdrawal by Subject|1
8001655|NCT04207840|12595197|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0
8001656|NCT04207840|12595198|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0
8001657|NCT04207840|12595199|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1
8001658|NCT04207840|12595197|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0
8001659|NCT04207840|12595198|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0
8001660|NCT04207840|12595199|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1
8001661|NCT04206384|12595234|FG000|Overall Study|Withdrawal by Subject|8
8001662|NCT04206384|12595234|FG000|Overall Study|Adverse Event|2
8001663|NCT04195893|12595255|FG000|Second Intervention|Withdrawal by Subject|1
8001664|NCT04195893|12595256|FG001|Second Intervention|Withdrawal by Subject|0
8001665|NCT04195581|12595271|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4
8001666|NCT04195581|12595271|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5
8001667|NCT04195581|12595271|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1
8001668|NCT04195581|12595271|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1
8001669|NCT04195581|12595271|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3
8001670|NCT04195581|12595271|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2
8001671|NCT04194151|12595295|FG000|Overall Study|Physician Decision|1
8001672|NCT04194151|12595296|FG001|Overall Study|Physician Decision|1
8001673|NCT04194151|12595297|FG002|Overall Study|Physician Decision|1
8001674|NCT04194151|12595298|FG003|Overall Study|Physician Decision|1
8001675|NCT04194151|12595299|FG004|Overall Study|Physician Decision|0
8001676|NCT04194151|12595300|FG005|Overall Study|Physician Decision|1
8001677|NCT04194151|12595295|FG000|Overall Study|Monitorization problem|0
8001678|NCT04194151|12595296|FG001|Overall Study|Monitorization problem|1
8001679|NCT04194151|12595297|FG002|Overall Study|Monitorization problem|0
8001680|NCT04194151|12595298|FG003|Overall Study|Monitorization problem|0
8001681|NCT04194151|12595299|FG004|Overall Study|Monitorization problem|0
8001682|NCT04194151|12595300|FG005|Overall Study|Monitorization problem|0
8001683|NCT04194008|12595314|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19
8001684|NCT04194008|12595314|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6
8001685|NCT04194008|12595314|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2
8001686|NCT04194008|12595314|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3
8001687|NCT04194008|12595314|FG000|Treatment Phase With Nerivio|Missing data|4
8001688|NCT04194008|12595314|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1
8001689|NCT04189081|12595325|FG000|Overall Study|Lost to Follow-up|1
8001690|NCT04189081|12595326|FG001|Overall Study|Lost to Follow-up|0
8001691|NCT04189081|12595327|FG002|Overall Study|Lost to Follow-up|0
8001692|NCT04189081|12595325|FG000|Overall Study|Withdrawal by Subject|0
8001693|NCT04189081|12595326|FG001|Overall Study|Withdrawal by Subject|0
8001694|NCT04189081|12595327|FG002|Overall Study|Withdrawal by Subject|1
8001695|NCT04186806|12595348|FG000|Period 1: 7 Days|Adverse Event|1
8001696|NCT04186806|12595349|FG001|Period 1: 7 Days|Adverse Event|0
8001697|NCT04179838|12595383|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
8001698|NCT04179838|12595384|FG001|First Intervention (1 Day)|Withdrawal by Subject|3
8001699|NCT04179838|12595383|FG000|Second Intervention (1 Day)|Protocol Violation|0
8001700|NCT04179838|12595384|FG001|Second Intervention (1 Day)|Protocol Violation|1
8001701|NCT04179461|12595390|FG000|Overall Study|Lost to Follow-up|4
8001702|NCT04178590|12595418|FG000|Overall Study|Pregnancy|1
8001703|NCT04178590|12595418|FG000|Overall Study|Lost to Follow-up|1
8001704|NCT04177862|12595446|FG000|Overall Study|Protocol Violation|2
8001705|NCT04177862|12595447|FG001|Overall Study|Protocol Violation|7
8001706|NCT04173741|12595522|FG000|Overall Study|IVC measurement cannot be done|1
8001707|NCT04173741|12595523|FG001|Overall Study|IVC measurement cannot be done|1
8001708|NCT04169061|12595529|FG000|Overall Study|Adverse Event|2
8001709|NCT04169061|12595529|FG000|Overall Study|Death|1
8001710|NCT04169061|12595529|FG000|Overall Study|Withdrawal by Subject|1
8001711|NCT04169061|12595529|FG000|Overall Study|Protocol Violation|1
8001712|NCT04157738|12595535|FG000|Overall Study|Moved out of state|0
8001713|NCT04157738|12595536|FG001|Overall Study|Moved out of state|2
8001714|NCT04157738|12595535|FG000|Overall Study|Did not show up to the Follow-up appointment|1
8001715|NCT04157738|12595536|FG001|Overall Study|Did not show up to the Follow-up appointment|0
8001716|NCT04156646|12595544|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0
8001717|NCT04156646|12595545|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1
8001718|NCT04170686|12595556|FG000|Screening|Physician Decision|12
8001719|NCT04170686|12595557|FG001|Screening|Physician Decision|13
8001720|NCT04170686|12595556|FG000|Randomization and Treatment|Lost to Follow-up|26
8001721|NCT04170686|12595557|FG001|Randomization and Treatment|Lost to Follow-up|15
8001722|NCT04162795|12595609|FG000|Overall Study|Other|16
8001723|NCT04162795|12595609|FG000|Overall Study|Screen failures|10
8001724|NCT04161807|12595613|FG000|Overall Study|Withdrawal by Subject|2
8001725|NCT04161807|12595613|FG000|Overall Study|Performed only 1 treatment|2
8001726|NCT04161144|12595619|FG000|Overall Study|Withdrawal by Subject|0
8001727|NCT04161144|12595620|FG001|Overall Study|Withdrawal by Subject|1
8001728|NCT04161144|12595619|FG000|Overall Study|Protocol Violation|1
8001729|NCT04161144|12595620|FG001|Overall Study|Protocol Violation|0
8001730|NCT04161079|12595626|FG000|Clinical Investigation 2010-040|Adverse Event|1
8001731|NCT04152083|12595645|FG000|Overall Study|Lost to Follow-up|2
8001732|NCT04152083|12595646|FG001|Overall Study|Lost to Follow-up|1
8001733|NCT04152083|12595645|FG000|Overall Study|Adverse Event|1
8001734|NCT04152083|12595646|FG001|Overall Study|Adverse Event|0
8001735|NCT04152083|12595645|FG000|Overall Study|Randomized but not treated|3
8001736|NCT04152083|12595646|FG001|Overall Study|Randomized but not treated|2
8001737|NCT04155047|12595658|FG000|Overall Study|Adverse Event|1
8001738|NCT04155047|12595659|FG001|Overall Study|Adverse Event|0
8001739|NCT04155047|12595658|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1
8001740|NCT04155047|12595659|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0
8001741|NCT04150250|12595688|FG000|Overall Study|Lost to Follow-up|0
8001742|NCT04150250|12595689|FG001|Overall Study|Lost to Follow-up|2
8001743|NCT04149353|12595774|FG000|Overall Study|Study terminated|1
8001744|NCT04136444|12595794|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0
8001745|NCT04136444|12595795|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1
8001746|NCT04147611|12595829|FG000|Overall Study|Physician Decision|0
8001747|NCT04147611|12595830|FG001|Overall Study|Physician Decision|1
8001748|NCT04142216|12595899|FG000|Overall Study|Hospitalization|0
8001749|NCT04142216|12595900|FG001|Overall Study|Hospitalization|2
8001750|NCT04142216|12595899|FG000|Overall Study|Death|3
8001751|NCT04142216|12595900|FG001|Overall Study|Death|1
8001752|NCT04142216|12595899|FG000|Overall Study|Referral to another hemodialysis unit|3
8001753|NCT04142216|12595900|FG001|Overall Study|Referral to another hemodialysis unit|2
8001754|NCT04142216|12595899|FG000|Overall Study|Use of clove|0
8001755|NCT04142216|12595900|FG001|Overall Study|Use of clove|1
8001756|NCT04142450|12595911|FG000|Overall Study|Screen Failure|1
8001757|NCT04142450|12595911|FG000|Overall Study|Lost to Follow-up|1
8001758|NCT04140890|12595917|FG000|Overall Study|Withdrawal by Subject|0
8001759|NCT04140890|12595918|FG001|Overall Study|Withdrawal by Subject|1
8001760|NCT04139018|12595929|FG000|Overall Study|Screen fail|1
8001761|NCT04139018|12595930|FG001|Overall Study|Screen fail|0
8001762|NCT04139018|12595929|FG000|Overall Study|Withdrawal by Subject|2
8001763|NCT04139018|12595930|FG001|Overall Study|Withdrawal by Subject|0
8001764|NCT04139018|12595929|FG000|Overall Study|Lost to Follow-up|0
8001765|NCT04139018|12595930|FG001|Overall Study|Lost to Follow-up|1
8001766|NCT04138810|12595938|FG000|Overall Study|Withdrawal by Subject|0
8001767|NCT04138810|12595939|FG001|Overall Study|Withdrawal by Subject|1
8001768|NCT04138810|12595938|FG000|Overall Study|Subject cancelled surgery|1
8001769|NCT04138810|12595939|FG001|Overall Study|Subject cancelled surgery|0
8001770|NCT04131556|12595945|FG000|Overall Study|Adverse Event|1
8001771|NCT04131556|12595945|FG000|Overall Study|Withdrawal by Subject|1
8001772|NCT04126174|12595952|FG000|Overall Study|Lost to Follow-up|3
8001773|NCT04126174|12595953|FG001|Overall Study|Lost to Follow-up|3
8001774|NCT04138043|12595997|FG000|Overall Study|Withdrawal by Subject|0
8001775|NCT04138043|12595998|FG001|Overall Study|Withdrawal by Subject|1
8001776|NCT04132336|12596031|FG000|Overall Study|Investigator Decision|0
8001777|NCT04132336|12596032|FG001|Overall Study|Investigator Decision|1
8001778|NCT04132336|12596033|FG002|Overall Study|Investigator Decision|0
8001779|NCT04132336|12596034|FG003|Overall Study|Investigator Decision|0
8001780|NCT04132336|12596035|FG004|Overall Study|Investigator Decision|0
8001781|NCT04132336|12596036|FG005|Overall Study|Investigator Decision|0
8001782|NCT04132336|12596037|FG006|Overall Study|Investigator Decision|0
8001783|NCT04128293|12596077|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
8001784|NCT04128293|12596078|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
8001785|NCT04128293|12596079|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
8001786|NCT04128293|12596080|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
8001787|NCT04126343|12596101|FG000|Overall Study|Adverse Event|0
8001788|NCT04126343|12596102|FG001|Overall Study|Adverse Event|0
8001789|NCT04126343|12596103|FG002|Overall Study|Adverse Event|0
8001790|NCT04126343|12596104|FG003|Overall Study|Adverse Event|0
8001791|NCT04126343|12596105|FG004|Overall Study|Adverse Event|0
8001792|NCT04126343|12596106|FG005|Overall Study|Adverse Event|1
8001793|NCT04126343|12596101|FG000|Overall Study|Withdrawal by Subject|0
8001794|NCT04126343|12596102|FG001|Overall Study|Withdrawal by Subject|0
8001795|NCT04126343|12596103|FG002|Overall Study|Withdrawal by Subject|0
8001796|NCT04126343|12596104|FG003|Overall Study|Withdrawal by Subject|1
8001797|NCT04126343|12596105|FG004|Overall Study|Withdrawal by Subject|0
8001798|NCT04126343|12596106|FG005|Overall Study|Withdrawal by Subject|0
8001799|NCT04126343|12596101|FG000|Overall Study|Related to COVID-19 pandemic|3
8001800|NCT04126343|12596102|FG001|Overall Study|Related to COVID-19 pandemic|4
8001801|NCT04126343|12596103|FG002|Overall Study|Related to COVID-19 pandemic|3
8001802|NCT04126343|12596104|FG003|Overall Study|Related to COVID-19 pandemic|3
8001803|NCT04126343|12596105|FG004|Overall Study|Related to COVID-19 pandemic|3
8001804|NCT04126343|12596106|FG005|Overall Study|Related to COVID-19 pandemic|3
8001805|NCT04124952|12596125|FG000|Overall Study|Lost to Follow-up|1
8001806|NCT04123665|12596131|FG000|Overall Study|Withdrawal by Subject|7
8001807|NCT04123665|12596132|FG001|Overall Study|Withdrawal by Subject|0
8001808|NCT04123665|12596131|FG000|Overall Study|Lost to Follow-up|1
8001809|NCT04123665|12596132|FG001|Overall Study|Lost to Follow-up|0
8001810|NCT04122534|12596138|FG000|Overall Study|Lost to Follow-up|4
8001811|NCT04117607|12596154|FG000|Overall Study|Early Termination|0
8001812|NCT04117607|12596155|FG001|Overall Study|Early Termination|1
8001813|NCT04117607|12596156|FG002|Overall Study|Early Termination|0
8001814|NCT04117607|12596157|FG003|Overall Study|Early Termination|0
8001815|NCT04117607|12596158|FG004|Overall Study|Early Termination|0
8001816|NCT04117607|12596159|FG005|Overall Study|Early Termination|0
8001817|NCT04117607|12596160|FG006|Overall Study|Early Termination|1
8001818|NCT04117607|12596161|FG007|Overall Study|Early Termination|0
8001819|NCT04117607|12596162|FG008|Overall Study|Early Termination|0
8001820|NCT04117607|12596163|FG009|Overall Study|Early Termination|0
8001821|NCT04117607|12596164|FG010|Overall Study|Early Termination|0
8001822|NCT04117607|12596165|FG011|Overall Study|Early Termination|0
8001823|NCT04117607|12596166|FG012|Overall Study|Early Termination|0
8001824|NCT04117607|12596167|FG013|Overall Study|Early Termination|0
8001825|NCT04096365|12596192|FG000|Overall Study|Adverse Event|1
8001826|NCT04080297|12596198|FG000|Overall Study|Adverse Event|1
8001827|NCT04080297|12596199|FG001|Overall Study|Adverse Event|3
8001828|NCT04080297|12596198|FG000|Overall Study|concurrent illness|1
8001829|NCT04080297|12596199|FG001|Overall Study|concurrent illness|0
8001830|NCT04115358|12596208|FG000|Overall Study|exfoliation|0
8001831|NCT04115358|12596209|FG001|Overall Study|exfoliation|0
8001832|NCT04115358|12596210|FG002|Overall Study|exfoliation|1
8001833|NCT04113694|12596234|FG000|Overall Study|Adverse Event|2
8001834|NCT04113694|12596234|FG000|Overall Study|Lost to Follow-up|2
8001835|NCT04113694|12596234|FG000|Overall Study|Withdrawal by Subject|6
8001836|NCT04113694|12596234|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1
8001837|NCT04106817|12596290|FG000|Overall Study|Lost to Follow-up|1
8001838|NCT04106817|12596291|FG001|Overall Study|Lost to Follow-up|0
8001839|NCT04106817|12596292|FG002|Overall Study|Lost to Follow-up|0
8001840|NCT04105972|12596302|FG000|Overall Study|Adverse Event|2
8001841|NCT04105972|12596303|FG001|Overall Study|Adverse Event|1
8001842|NCT04105218|12596311|FG000|Overall Study|Withdrawal by Subject|3
8001843|NCT04105218|12596312|FG001|Overall Study|Withdrawal by Subject|2
8001844|NCT04105218|12596311|FG000|Overall Study|Study was terminated; unable to complete study visits|1
8001845|NCT04105218|12596312|FG001|Overall Study|Study was terminated; unable to complete study visits|3
8001846|NCT04105218|12596311|FG000|Overall Study|Failed screening tests|2
8001847|NCT04105218|12596312|FG001|Overall Study|Failed screening tests|1
8001848|NCT04102540|12596327|FG000|Overall Study|Withdrawn by PI|2
8001849|NCT04102540|12596327|FG000|Overall Study|Lost to Follow-up|6
8001850|NCT04102345|12596333|FG000|Overall Study|Withdrawal by Subject|1
8001851|NCT04102345|12596334|FG001|Overall Study|Withdrawal by Subject|0
8001852|NCT04099277|12596374|FG000|Overall Study|Physician Decision|1
8001853|NCT04099277|12596374|FG000|Overall Study|Withdrawal by Subject|1
8001854|NCT04098809|12596380|FG000|Overall Study|Withdrawal by Subject|1
8001855|NCT04098809|12596381|FG001|Overall Study|Withdrawal by Subject|3
8001856|NCT04098809|12596380|FG000|Overall Study|Physician Decision|2
8001857|NCT04098809|12596381|FG001|Overall Study|Physician Decision|1
8001858|NCT04098458|12596400|FG000|Overall Study|Death|1
8001859|NCT04098458|12596400|FG000|Overall Study|did not meet study inclusion criteria|3
8001860|NCT04095286|12596405|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
8001861|NCT04095286|12596406|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1
8001862|NCT04095286|12596407|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
8001863|NCT04095286|12596408|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
8001864|NCT04095286|12596409|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
8001865|NCT04095286|12596410|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
8001866|NCT04095286|12596405|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1
8001867|NCT04095286|12596406|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
8001868|NCT04095286|12596407|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
8001869|NCT04095286|12596408|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
8001870|NCT04095286|12596409|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
8001871|NCT04095286|12596410|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
8001872|NCT04095286|12596405|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
8001873|NCT04095286|12596406|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
8001874|NCT04095286|12596407|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1
8001875|NCT04095286|12596408|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
8001876|NCT04095286|12596409|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
8001877|NCT04095286|12596410|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
8001878|NCT04095286|12596405|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
8001879|NCT04095286|12596406|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
8001880|NCT04095286|12596407|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2
8001881|NCT04095286|12596408|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
8001882|NCT04095286|12596409|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
8001883|NCT04095286|12596410|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
8001884|NCT04095286|12596405|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
8001885|NCT04095286|12596406|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
8001886|NCT04095286|12596407|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
8001887|NCT04095286|12596408|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
8001888|NCT04095286|12596409|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1
8001889|NCT04095286|12596410|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
8001890|NCT04094883|12596418|FG000|Overall Study|Withdrawal by Subject|1
8001891|NCT04091659|12596424|FG000|Overall Study|Protocol Violation|3
8001892|NCT04091659|12596425|FG001|Overall Study|Protocol Violation|0
8001893|NCT04091659|12596424|FG000|Overall Study|Lost to Follow-up|0
8001894|NCT04091659|12596425|FG001|Overall Study|Lost to Follow-up|1
8001895|NCT04090242|12596450|FG000|Overall Study|Withdrawal by Subject|1
8001896|NCT04090242|12596451|FG001|Overall Study|Withdrawal by Subject|0
8001897|NCT04089761|12596458|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14
8001898|NCT04089761|12596458|FG000|"Run In Phase"|Lost to Follow-up|1
8001899|NCT04089761|12596458|FG000|"Treatment Phase"|No evaluable data|5
8001900|NCT04089761|12596458|FG000|"Treatment Phase"|Lost to Follow-up|1
8001901|NCT04079803|12596465|FG000|Overall Study|Withdrawal by Subject|0
8001902|NCT04079803|12596466|FG001|Overall Study|Withdrawal by Subject|0
8001903|NCT04079803|12596467|FG002|Overall Study|Withdrawal by Subject|1
8001904|NCT04086641|12596510|FG000|Foot 1 (Two Week Utilization)|COVID-19|1
8001905|NCT04086641|12596511|FG001|Foot 1 (Two Week Utilization)|COVID-19|2
8001906|NCT04085289|12596520|FG000|Overall Study|Withdrawal by Subject|0
8001907|NCT04085289|12596521|FG001|Overall Study|Withdrawal by Subject|0
8001908|NCT04085289|12596522|FG002|Overall Study|Withdrawal by Subject|1
8001909|NCT04082663|12596533|FG000|Overall Study|Adverse Event|6
8001910|NCT04082663|12596533|FG000|Overall Study|Lost to Follow-up|1
8001911|NCT04079790|12596614|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1
8001912|NCT04079790|12596615|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
8001913|NCT04079790|12596616|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
8001914|NCT04079790|12596617|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
8001915|NCT04079790|12596614|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
8001916|NCT04079790|12596615|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
8001917|NCT04079790|12596616|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1
8001918|NCT04079790|12596617|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
8001919|NCT04079790|12596614|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
8001920|NCT04079790|12596615|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
8001921|NCT04079790|12596616|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2
8001922|NCT04079790|12596617|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
8001923|NCT04073407|12596708|FG000|Part 1|Withdrawal by Subject|1
8001924|NCT04073407|12596709|FG001|Part 1|Withdrawal by Subject|0
8001925|NCT04073407|12596708|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4
8001926|NCT04073407|12596709|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1
8001927|NCT04073407|12596708|FG000|Part 2|Withdrawal by Subject|0
8001928|NCT04073407|12596709|FG001|Part 2|Withdrawal by Subject|1
8001929|NCT04073368|12596719|FG000|Overall Study|Adverse Event|2
8001930|NCT04073368|12596720|FG001|Overall Study|Adverse Event|0
8001931|NCT04073368|12596721|FG002|Overall Study|Adverse Event|1
8001932|NCT04073368|12596722|FG003|Overall Study|Adverse Event|1
8001933|NCT04073368|12596719|FG000|Overall Study|Withdrawal by Subject|2
8001934|NCT04073368|12596720|FG001|Overall Study|Withdrawal by Subject|2
8001935|NCT04073368|12596721|FG002|Overall Study|Withdrawal by Subject|1
8001936|NCT04073368|12596722|FG003|Overall Study|Withdrawal by Subject|1
8001937|NCT04073368|12596719|FG000|Overall Study|Lost to Follow-up|1
8001938|NCT04073368|12596720|FG001|Overall Study|Lost to Follow-up|1
8001939|NCT04073368|12596721|FG002|Overall Study|Lost to Follow-up|1
8001940|NCT04073368|12596722|FG003|Overall Study|Lost to Follow-up|0
8001941|NCT04073368|12596719|FG000|Overall Study|Protocol Violation|0
8001942|NCT04073368|12596720|FG001|Overall Study|Protocol Violation|1
8001943|NCT04073368|12596721|FG002|Overall Study|Protocol Violation|0
8001944|NCT04073368|12596722|FG003|Overall Study|Protocol Violation|0
8001945|NCT04073368|12596719|FG000|Overall Study|Subject noncompliance|7
8001946|NCT04073368|12596720|FG001|Overall Study|Subject noncompliance|4
8001947|NCT04073368|12596721|FG002|Overall Study|Subject noncompliance|0
8001948|NCT04073368|12596722|FG003|Overall Study|Subject noncompliance|0
8001949|NCT04071301|12596795|FG000|Overall Study|Withdrawal by Subject|6
8001950|NCT04071301|12596795|FG000|Overall Study|Death|1
8001951|NCT04071158|12596804|FG000|Overall Study|Lost to Follow-up|1
8001952|NCT04071158|12596805|FG001|Overall Study|Lost to Follow-up|2
8001953|NCT04071158|12596806|FG002|Overall Study|Lost to Follow-up|3
8001954|NCT04071158|12596807|FG003|Overall Study|Lost to Follow-up|3
8001955|NCT04071158|12596808|FG004|Overall Study|Lost to Follow-up|5
8001956|NCT04071158|12596804|FG000|Overall Study|Randomized but not treated|2
8001957|NCT04071158|12596805|FG001|Overall Study|Randomized but not treated|2
8001958|NCT04071158|12596806|FG002|Overall Study|Randomized but not treated|0
8001959|NCT04071158|12596807|FG003|Overall Study|Randomized but not treated|0
8001960|NCT04071158|12596808|FG004|Overall Study|Randomized but not treated|0
8001961|NCT04069715|12596849|FG000|Overall Study|Lost to Follow-up|1
8001962|NCT04069715|12596850|FG001|Overall Study|Lost to Follow-up|1
8001963|NCT04069715|12596849|FG000|Overall Study|Physician Decision|1
8001964|NCT04069715|12596850|FG001|Overall Study|Physician Decision|1
8001965|NCT04069715|12596849|FG000|Overall Study|Withdrawal by Subject|3
8001966|NCT04069715|12596850|FG001|Overall Study|Withdrawal by Subject|3
8001967|NCT04050722|12596858|FG000|Overall Study|Withdrawal by Subject|1
8001968|NCT04050722|12596859|FG001|Overall Study|Withdrawal by Subject|0
8001969|NCT04067141|12596880|FG000|First Intervention|Withdrawal by Subject|0
8001970|NCT04067141|12596881|FG001|First Intervention|Withdrawal by Subject|1
8001971|NCT04067141|12596880|FG000|Second Intervention|Adverse Event|0
8001972|NCT04067141|12596881|FG001|Second Intervention|Adverse Event|2
8001973|NCT04049578|12596887|FG000|Overall Study|Physician Decision|1
8001974|NCT04067401|12596893|FG000|Overall Study|Withdrawal by Subject|7
8001975|NCT04067401|12596894|FG001|Overall Study|Withdrawal by Subject|0
8001976|NCT04067401|12596893|FG000|Overall Study|no data provided|1
8001977|NCT04067401|12596894|FG001|Overall Study|no data provided|0
8001978|NCT04067050|12596902|FG000|One Month|Lost to Follow-up|4
8001979|NCT04067050|12596903|FG001|One Month|Lost to Follow-up|0
8001980|NCT04067050|12596902|FG000|Two Month|Lost to Follow-up|1
8001981|NCT04067050|12596903|FG001|Two Month|Lost to Follow-up|0
8001982|NCT04067050|12596902|FG000|Two Month|Adverse Event|1
8001983|NCT04067050|12596903|FG001|Two Month|Adverse Event|0
8001984|NCT04060654|12596939|FG000|Overall Study|Withdrawal by Subject|1
8001985|NCT04060654|12596939|FG000|Overall Study|Lost to Follow-up|5
8001986|NCT04058353|12596952|FG000|Overall Study|Adverse Event|2
8001987|NCT04058353|12596953|FG001|Overall Study|Adverse Event|1
8001988|NCT04058353|12596952|FG000|Overall Study|Physician Decision|1
8001989|NCT04058353|12596953|FG001|Overall Study|Physician Decision|0
8001990|NCT04058353|12596952|FG000|Overall Study|Other|1
8001991|NCT04058353|12596953|FG001|Overall Study|Other|0
8001992|NCT04054765|12596985|FG000|Baseline|Withdrawal by Subject|5
8001993|NCT04054765|12596986|FG001|Baseline|Withdrawal by Subject|3
8001994|NCT04054765|12596985|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8
8001995|NCT04054765|12596986|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3
8001996|NCT04054765|12596985|FG000|3-month Follow up|Withdrawal by Subject|0
8001997|NCT04054765|12596986|FG001|3-month Follow up|Withdrawal by Subject|3
8001998|NCT04054765|12596985|FG000|6-month Follow up|Lost to Follow-up|32
8001999|NCT04054765|12596986|FG001|6-month Follow up|Lost to Follow-up|32
8002000|NCT04054011|12596992|FG000|Overall Study|COVID|3
8002001|NCT04059094|12597003|FG000|Overall Study|Adverse Event|0
8002002|NCT04059094|12597004|FG001|Overall Study|Adverse Event|0
8002003|NCT04059094|12597005|FG002|Overall Study|Adverse Event|0
8002004|NCT04059094|12597006|FG003|Overall Study|Adverse Event|0
8002005|NCT04059094|12597007|FG004|Overall Study|Adverse Event|1
8002006|NCT04059094|12597003|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0
8002007|NCT04059094|12597004|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2
8002008|NCT04059094|12597005|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0
8002009|NCT04059094|12597006|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0
8002010|NCT04059094|12597007|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0
8002011|NCT04046341|12597032|FG000|Overall Study|Lost to Follow-up|2
8002012|NCT04046341|12597032|FG000|Overall Study|Withdrawal by Subject|1
8002013|NCT04043416|12597047|FG000|Washout|Change in health condition|0
8002014|NCT04043416|12597048|FG001|Washout|Change in health condition|1
8002015|NCT04054193|12597110|FG000|Cycle 1|Physician Decision|1
8002016|NCT04054193|12597110|FG000|Cycle 1|Consent withdrawn by parent/guardian|1
8002017|NCT04054193|12597110|FG000|Cycle 1|Allocated but not treated|3
8002018|NCT04054193|12597110|FG000|Cycles 2-3|Physician Decision|2
8002019|NCT04054193|12597110|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2
8002020|NCT04054193|12597110|FG000|Cycles 2-3|Various reasons|17
8002021|NCT04050618|12597117|FG000|First Intervention|Withdrawal by Subject|2
8002022|NCT04050618|12597118|FG001|First Intervention|Withdrawal by Subject|0
8002023|NCT04050618|12597117|FG000|Second Intervention|Withdrawal by Subject|1
8002024|NCT04050618|12597118|FG001|Second Intervention|Withdrawal by Subject|0
8002025|NCT04053465|12597131|FG000|Overall Study|Withdrawal by Subject|4
8002026|NCT04053465|12597132|FG001|Overall Study|Withdrawal by Subject|4
8002027|NCT04049552|12597151|FG000|Overall Study|Lost to Follow-up|1
8002028|NCT04053023|12597159|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1
8002029|NCT04053023|12597160|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0
8002030|NCT04050865|12597185|FG000|Overall Study|Adverse Event|1
8002031|NCT04050865|12597186|FG001|Overall Study|Adverse Event|0
8002032|NCT04050865|12597185|FG000|Overall Study|no insert|1
8002033|NCT04050865|12597186|FG001|Overall Study|no insert|0
8002034|NCT04050865|12597185|FG000|Overall Study|Only 1 insert|2
8002035|NCT04050865|12597186|FG001|Overall Study|Only 1 insert|3
8002036|NCT04050865|12597185|FG000|Overall Study|Physician Decision|0
8002037|NCT04050865|12597186|FG001|Overall Study|Physician Decision|1
8002038|NCT04050865|12597185|FG000|Overall Study|Withdrawal by Subject|0
8002039|NCT04050865|12597186|FG001|Overall Study|Withdrawal by Subject|1
8002040|NCT04050371|12597204|FG000|Overall Study|Withdrawal by Subject|1
8002041|NCT04050371|12597205|FG001|Overall Study|Withdrawal by Subject|0
8002042|NCT04048681|12597215|FG000|Overall Study|family emergency|0
8002043|NCT04048681|12597216|FG001|Overall Study|family emergency|0
8002044|NCT04048681|12597217|FG002|Overall Study|family emergency|0
8002045|NCT04048681|12597218|FG003|Overall Study|family emergency|1
8002046|NCT04048681|12597219|FG004|Overall Study|family emergency|0
8002047|NCT04046250|12597229|FG000|Overall Study|Death|0
8002048|NCT04046250|12597230|FG001|Overall Study|Death|1
8002049|NCT04046250|12597229|FG000|Overall Study|Withdrawal by Subject|3
8002050|NCT04046250|12597230|FG001|Overall Study|Withdrawal by Subject|3
8002051|NCT04044352|12597245|FG000|Overall Study|Lost to Follow-up|9
8002052|NCT04044352|12597245|FG000|Overall Study|Withdrawal by Subject|2
8002053|NCT04043728|12597253|FG000|Overall Study|Lost to Follow-up|1
8002054|NCT04043728|12597254|FG001|Overall Study|Lost to Follow-up|2
8002055|NCT04043728|12597255|FG002|Overall Study|Lost to Follow-up|0
8002056|NCT04041414|12597284|FG000|Overall Study|Lost to Follow-up|1
8002057|NCT04041414|12597285|FG001|Overall Study|Lost to Follow-up|2
8002058|NCT04041700|12597298|FG000|Overall Study|Pregnancy|1
8002059|NCT04041700|12597298|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1
8002060|NCT04029519|12597332|FG000|Overall Study|Protocol Violation|1
8002061|NCT04029519|12597332|FG000|Overall Study|Withdrawal by Subject|3
8002062|NCT04029519|12597332|FG000|Overall Study|Lost to Follow-up|1
8002063|NCT04039919|12597341|FG000|Treatment Period 1|Withdrawal by Subject|1
8002064|NCT04039919|12597342|FG001|Treatment Period 1|Withdrawal by Subject|0
8002065|NCT04039919|12597343|FG002|Treatment Period 1|Withdrawal by Subject|0
8002066|NCT04039919|12597344|FG003|Treatment Period 1|Withdrawal by Subject|0
8002067|NCT04039919|12597345|FG004|Treatment Period 1|Withdrawal by Subject|0
8002068|NCT04039919|12597341|FG000|Treatment Period 1|Sponsor's decision|0
8002069|NCT04039919|12597342|FG001|Treatment Period 1|Sponsor's decision|0
8002070|NCT04039919|12597343|FG002|Treatment Period 1|Sponsor's decision|0
8002071|NCT04039919|12597344|FG003|Treatment Period 1|Sponsor's decision|0
8002072|NCT04039919|12597345|FG004|Treatment Period 1|Sponsor's decision|16
8002073|NCT04039919|12597341|FG000|Treatment Period 5|Withdrawal by Subject|1
8002074|NCT04039919|12597342|FG001|Treatment Period 5|Withdrawal by Subject|0
8002075|NCT04039919|12597343|FG002|Treatment Period 5|Withdrawal by Subject|0
8002076|NCT04039919|12597344|FG003|Treatment Period 5|Withdrawal by Subject|0
8002077|NCT04039919|12597345|FG004|Treatment Period 5|Withdrawal by Subject|0
8002078|NCT04037748|12597394|FG000|Treatment Period 1|Withdrawal by Subject|3
8002079|NCT04037748|12597395|FG001|Treatment Period 1|Withdrawal by Subject|0
8002080|NCT04037748|12597394|FG000|Treatment Period 1|Adverse Event|1
8002081|NCT04037748|12597395|FG001|Treatment Period 1|Adverse Event|1
8002082|NCT04037748|12597394|FG000|Treatment Period 1|Protocol Violation|4
8002083|NCT04037748|12597395|FG001|Treatment Period 1|Protocol Violation|5
8002084|NCT04037748|12597394|FG000|Treatment Period 2|Adverse Event|0
8002085|NCT04037748|12597395|FG001|Treatment Period 2|Adverse Event|1
8002086|NCT04037748|12597394|FG000|Treatment Period 2|Protocol Violation|2
8002087|NCT04037748|12597395|FG001|Treatment Period 2|Protocol Violation|0
8002088|NCT04027686|12597412|FG000|Overall Study|Lost to Follow-up|2
8002089|NCT04027686|12597413|FG001|Overall Study|Lost to Follow-up|0
8002090|NCT04027686|12597412|FG000|Overall Study|Withdrawal by Subject|0
8002091|NCT04027686|12597413|FG001|Overall Study|Withdrawal by Subject|1
8002092|NCT04036110|12597443|FG000|Overall Study|Lost to Follow-up|3
8002093|NCT04036110|12597444|FG001|Overall Study|Lost to Follow-up|2
8002094|NCT04036110|12597445|FG002|Overall Study|Lost to Follow-up|1
8002095|NCT04036110|12597443|FG000|Overall Study|Study Suspended|4
8002096|NCT04036110|12597444|FG001|Overall Study|Study Suspended|5
8002097|NCT04036110|12597445|FG002|Overall Study|Study Suspended|1
8002098|NCT04035577|12597462|FG000|Overall Study|Lost to Follow-up|1
8002099|NCT04035577|12597462|FG000|Overall Study|Withdrawal by Subject|1
8002100|NCT04035564|12597470|FG000|Overall Study|Protocol Violation|1
8002101|NCT04035564|12597471|FG001|Overall Study|Protocol Violation|2
8002102|NCT04035564|12597470|FG000|Overall Study|No laboratory available|2
8002103|NCT04035564|12597471|FG001|Overall Study|No laboratory available|2
8002104|NCT04035564|12597470|FG000|Overall Study|Guardian declined consent|1
8002105|NCT04035564|12597471|FG001|Overall Study|Guardian declined consent|2
8002106|NCT04032977|12597479|FG000|Overall Study|Withdrawal by Subject|6
8002107|NCT04032977|12597480|FG001|Overall Study|Withdrawal by Subject|1
8002108|NCT04032977|12597479|FG000|Overall Study|Lost to Follow-up|2
8002109|NCT04032977|12597480|FG001|Overall Study|Lost to Follow-up|7
8002110|NCT04032977|12597479|FG000|Overall Study|Pregnancy|1
8002111|NCT04032977|12597480|FG001|Overall Study|Pregnancy|0
8002112|NCT04032652|12597488|FG000|Overall Study|The study was terminated and the PI has|1
8002113|NCT04032652|12597489|FG001|Overall Study|The study was terminated and the PI has|1
8002114|NCT04032613|12597509|FG000|Overall Study|Did not complete post-program assessment|5
8002115|NCT04032613|12597510|FG001|Overall Study|Did not complete post-program assessment|2
8002116|NCT04032171|12597518|FG000|Overall Study|Study Termination|1
8002117|NCT04032171|12597519|FG001|Overall Study|Study Termination|0
8002118|NCT04032158|12597527|FG000|Overall Study|Study Termination|2
8002119|NCT04032158|12597528|FG001|Overall Study|Study Termination|1
8002120|NCT04031404|12597534|FG000|Baseline|Lost to Follow-up|0
8002121|NCT04031404|12597535|FG001|Baseline|Lost to Follow-up|1
8002122|NCT04031404|12597534|FG000|Baseline|Did not meet full inclusion/exclusion.|2
8002123|NCT04031404|12597535|FG001|Baseline|Did not meet full inclusion/exclusion.|4
8002124|NCT04031404|12597534|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1
8002125|NCT04031404|12597535|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3
8002126|NCT04031404|12597534|FG000|Pre-randomization|Disqualified by TMS safety screening|1
8002127|NCT04031404|12597535|FG001|Pre-randomization|Disqualified by TMS safety screening|0
8002128|NCT04031404|12597534|FG000|Washout (5 Day Min)|Lost to Follow-up|1
8002129|NCT04031404|12597535|FG001|Washout (5 Day Min)|Lost to Follow-up|0
8002130|NCT04029961|12597580|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1
8002131|NCT04029961|12597581|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0
8002132|NCT04029961|12597580|FG000|Overall Study|Change in Treatment Course|0
8002133|NCT04029961|12597581|FG001|Overall Study|Change in Treatment Course|1
8002134|NCT04025684|12597591|FG000|Overall Study|Withdrawal by Subject|1
8002135|NCT04025684|12597592|FG001|Overall Study|Withdrawal by Subject|1
8002136|NCT04025684|12597593|FG002|Overall Study|Withdrawal by Subject|0
8002137|NCT04025684|12597594|FG003|Overall Study|Withdrawal by Subject|0
8002138|NCT04025684|12597591|FG000|Overall Study|Multiple reasons|1
8002139|NCT04025684|12597592|FG001|Overall Study|Multiple reasons|3
8002140|NCT04025684|12597593|FG002|Overall Study|Multiple reasons|0
8002141|NCT04025684|12597594|FG003|Overall Study|Multiple reasons|1
8002142|NCT04019054|12597606|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0
8002143|NCT04019054|12597607|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1
8002144|NCT04019054|12597606|FG000|Overall Study|Withdrawal by Subject|3
8002145|NCT04019054|12597607|FG001|Overall Study|Withdrawal by Subject|1
8002146|NCT04016311|12597740|FG000|Overall Study|Withdrawal by Subject|1
8002147|NCT04016311|12597741|FG001|Overall Study|Withdrawal by Subject|0
8002148|NCT04023682|12597789|FG000|Overall Study|Clinical schedules did not allow continued participation|6
8002149|NCT04023994|12597836|FG000|Overall Study|Lost to Follow-up|0
8002150|NCT04023994|12597837|FG001|Overall Study|Lost to Follow-up|1
8002151|NCT04023994|12597838|FG002|Overall Study|Lost to Follow-up|2
8002152|NCT04023994|12597839|FG003|Overall Study|Lost to Follow-up|0
8002153|NCT04023994|12597840|FG004|Overall Study|Lost to Follow-up|0
8002154|NCT04023994|12597841|FG005|Overall Study|Lost to Follow-up|0
8002155|NCT04023994|12597836|FG000|Overall Study|Withdrawal by Subject|0
8002156|NCT04023994|12597837|FG001|Overall Study|Withdrawal by Subject|0
8002157|NCT04023994|12597838|FG002|Overall Study|Withdrawal by Subject|0
8002158|NCT04023994|12597839|FG003|Overall Study|Withdrawal by Subject|1
8002159|NCT04023994|12597840|FG004|Overall Study|Withdrawal by Subject|0
8002160|NCT04023994|12597841|FG005|Overall Study|Withdrawal by Subject|0
8002161|NCT04017611|12597884|FG000|Overall Study|Withdrawn prior to completion|1
8002162|NCT04015232|12597890|FG000|Overall Study|Withdrawal by Subject|7
8002163|NCT04015232|12597891|FG001|Overall Study|Withdrawal by Subject|4
8002164|NCT04015232|12597890|FG000|Overall Study|Protocol Violation|1
8002165|NCT04015232|12597891|FG001|Overall Study|Protocol Violation|0
8002166|NCT04015232|12597890|FG000|Overall Study|Medical Grounds|3
8002167|NCT04015232|12597891|FG001|Overall Study|Medical Grounds|3
8002168|NCT04014062|12597931|FG000|Period I: Dosing|Medical Grounds|4
8002169|NCT04014062|12597932|FG001|Period I: Dosing|Medical Grounds|5
8002170|NCT04014062|12597931|FG000|Period I: Dosing|Withdrawal by Subject|3
8002171|NCT04014062|12597932|FG001|Period I: Dosing|Withdrawal by Subject|1
8002172|NCT04013191|12597969|FG000|Overall Study|Adverse Event|1
8002173|NCT04013191|12597970|FG001|Overall Study|Adverse Event|0
8002174|NCT04011735|12597987|FG000|Overall Study|Withdrawal by Subject|1
8002175|NCT04011735|12597988|FG001|Overall Study|Withdrawal by Subject|0
8002176|NCT04011735|12597989|FG002|Overall Study|Withdrawal by Subject|1
8002177|NCT04011735|12597987|FG000|Overall Study|Met exclusion criteria after study entry|0
8002178|NCT04011735|12597988|FG001|Overall Study|Met exclusion criteria after study entry|1
8002179|NCT04011735|12597989|FG002|Overall Study|Met exclusion criteria after study entry|0
8002180|NCT04009577|12598003|FG000|Core Study|Adverse Event|1
8002181|NCT04009577|12598004|FG001|Core Study|Adverse Event|0
8002182|NCT04009577|12598005|FG002|Core Study|Adverse Event|2
8002183|NCT04009577|12598006|FG003|Core Study|Adverse Event|4
8002184|NCT04009577|12598003|FG000|Core Study|Withdrawal by Subject|0
8002185|NCT04009577|12598004|FG001|Core Study|Withdrawal by Subject|0
8002186|NCT04009577|12598005|FG002|Core Study|Withdrawal by Subject|2
8002187|NCT04009577|12598006|FG003|Core Study|Withdrawal by Subject|0
8002188|NCT04009577|12598003|FG000|Core Study|Other|0
8002189|NCT04009577|12598004|FG001|Core Study|Other|0
8002190|NCT04009577|12598005|FG002|Core Study|Other|0
8002191|NCT04009577|12598006|FG003|Core Study|Other|1
8002192|NCT04009577|12598003|FG000|Extension Phase|Adverse Event|0
8002193|NCT04009577|12598004|FG001|Extension Phase|Adverse Event|0
8002194|NCT04009577|12598005|FG002|Extension Phase|Adverse Event|0
8002195|NCT04009577|12598006|FG003|Extension Phase|Adverse Event|1
8002196|NCT04009577|12598003|FG000|Extension Phase|Inadequate therapeutic effect|0
8002197|NCT04009577|12598004|FG001|Extension Phase|Inadequate therapeutic effect|0
8002198|NCT04009577|12598005|FG002|Extension Phase|Inadequate therapeutic effect|1
8002199|NCT04009577|12598006|FG003|Extension Phase|Inadequate therapeutic effect|0
8002200|NCT04009577|12598003|FG000|Extension Phase|Withdrawal by Subject|0
8002201|NCT04009577|12598004|FG001|Extension Phase|Withdrawal by Subject|0
8002202|NCT04009577|12598005|FG002|Extension Phase|Withdrawal by Subject|1
8002203|NCT04009577|12598006|FG003|Extension Phase|Withdrawal by Subject|0
8002204|NCT04009577|12598003|FG000|Extension Phase|Not Treated|0
8002205|NCT04009577|12598004|FG001|Extension Phase|Not Treated|0
8002206|NCT04009577|12598005|FG002|Extension Phase|Not Treated|2
8002207|NCT04009577|12598006|FG003|Extension Phase|Not Treated|0
8002208|NCT04007159|12598032|FG000|Induction Phase|(missed study visits)|16
8002209|NCT04007159|12598032|FG000|Induction Phase|Withdrawal by Subject|4
8002210|NCT04007159|12598032|FG000|Induction Phase|Adverse Event|2
8002211|NCT04007159|12598032|FG000|Challenge Phase|missed study visits|3
7718370|NCT00527787|12142340|FG000|Overall Study|Withdrawal by Subject|13
8002212|NCT04007107|12598043|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
8002213|NCT04007107|12598044|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1
8002214|NCT04007107|12598045|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
8002215|NCT04007107|12598046|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
8002216|NCT04005885|12598062|FG000|First Intervention|Withdrawal by Subject|1
8002217|NCT04005885|12598063|FG001|First Intervention|Withdrawal by Subject|1
8002218|NCT04005885|12598062|FG000|Second Intervention|Withdrawal by Subject|0
8002219|NCT04005885|12598063|FG001|Second Intervention|Withdrawal by Subject|2
8002220|NCT04000815|12598077|FG000|Overall Study|Lost to Follow-up|9
8002221|NCT04000815|12598078|FG001|Overall Study|Lost to Follow-up|2
8002222|NCT04000815|12598079|FG002|Overall Study|Lost to Follow-up|3
8002223|NCT04000815|12598077|FG000|Overall Study|Withdrawal by Subject|4
8002224|NCT04000815|12598078|FG001|Overall Study|Withdrawal by Subject|3
8002225|NCT04000815|12598079|FG002|Overall Study|Withdrawal by Subject|2
8002226|NCT04000815|12598077|FG000|Overall Study|Right ovarian cyst occured|1
8002227|NCT04000815|12598078|FG001|Overall Study|Right ovarian cyst occured|0
8002228|NCT04000815|12598079|FG002|Overall Study|Right ovarian cyst occured|0
8002229|NCT04000815|12598077|FG000|Overall Study|Hypertension occured on follow up|0
8002230|NCT04000815|12598078|FG001|Overall Study|Hypertension occured on follow up|0
8002231|NCT04000815|12598079|FG002|Overall Study|Hypertension occured on follow up|2
8002232|NCT04006366|12598104|FG000|Overall Study|Withdrawal by Subject|1
8002233|NCT04006145|12598110|FG000|Overall Study|Lost to Follow-up|0
8002234|NCT04006145|12598111|FG001|Overall Study|Lost to Follow-up|1
8002235|NCT04006145|12598110|FG000|Overall Study|Other|1
8002236|NCT04006145|12598111|FG001|Overall Study|Other|2
8002237|NCT04005755|12598117|FG000|Overall Study|Adverse Event|6
8002238|NCT04005755|12598117|FG000|Overall Study|Physician Decision|3
8002239|NCT04005755|12598117|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4
8002240|NCT04005755|12598117|FG000|Overall Study|Withdrawal by Subject|3
8002241|NCT04005755|12598117|FG000|Overall Study|Lost to Follow-up|1
8002242|NCT03993288|12598140|FG000|Overall Study|Lost to Follow-up|2
8002243|NCT03993288|12598141|FG001|Overall Study|Lost to Follow-up|1
8002244|NCT03993288|12598140|FG000|Overall Study|non-compliance to the inclusion criteria|0
8002245|NCT03993288|12598141|FG001|Overall Study|non-compliance to the inclusion criteria|1
8002246|NCT03993288|12598140|FG000|Overall Study|wrong randomization|0
8002247|NCT03993288|12598141|FG001|Overall Study|wrong randomization|1
8002248|NCT03993288|12598140|FG000|Overall Study|improper enrollment|0
8002249|NCT03993288|12598141|FG001|Overall Study|improper enrollment|1
8002250|NCT03993288|12598140|FG000|Overall Study|prescribed with prohibited concomitant therapy|1
8002251|NCT03993288|12598141|FG001|Overall Study|prescribed with prohibited concomitant therapy|0
8002252|NCT03993288|12598140|FG000|Overall Study|developed SAE|2
8002253|NCT03993288|12598141|FG001|Overall Study|developed SAE|0
8002254|NCT03993288|12598140|FG000|Overall Study|consent withdrawal|1
8002255|NCT03993288|12598141|FG001|Overall Study|consent withdrawal|0
8002256|NCT03993288|12598140|FG000|Overall Study|did not follow the treatment schedule|1
8002257|NCT03993288|12598141|FG001|Overall Study|did not follow the treatment schedule|0
8002258|NCT03993288|12598140|FG000|Overall Study|did not follow the treatment regimen|1
8002259|NCT03993288|12598141|FG001|Overall Study|did not follow the treatment regimen|0
8002260|NCT03993288|12598140|FG000|Overall Study|Adverse Event|1
8002261|NCT03993288|12598141|FG001|Overall Study|Adverse Event|0
8002262|NCT03993288|12598140|FG000|Overall Study|Withdrawal by Subject|1
8002263|NCT03993288|12598141|FG001|Overall Study|Withdrawal by Subject|1
8002264|NCT03978832|12598172|FG000|Overall Study|Adverse Event|1
8002265|NCT03978832|12598172|FG000|Overall Study|Lost to Follow-up|1
8002266|NCT03978832|12598172|FG000|Overall Study|Withdrawal by Subject|6
8002267|NCT03978832|12598172|FG000|Overall Study|Physician Decision|2
8002268|NCT03978832|12598172|FG000|Overall Study|did not pass screening criteria|44
8002269|NCT04004260|12598213|FG000|Overall Study|Withdrawal by Subject|7
8002270|NCT04004260|12598214|FG001|Overall Study|Withdrawal by Subject|3
8002271|NCT04004260|12598213|FG000|Overall Study|Lost to Follow-up|22
8002272|NCT04004260|12598214|FG001|Overall Study|Lost to Follow-up|12
8002273|NCT04004260|12598213|FG000|Overall Study|Did not engage in intervention|13
8002274|NCT04004260|12598214|FG001|Overall Study|Did not engage in intervention|17
8002275|NCT04002960|12598247|FG000|Overall Study|Withdrawn prior to Completion|2
8002276|NCT04002648|12598257|FG000|Overall Study|Lost to Follow-up|2
8002277|NCT04002648|12598258|FG001|Overall Study|Lost to Follow-up|0
8002278|NCT03990649|12598287|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0
8002279|NCT03990649|12598288|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1
8002280|NCT03990649|12598289|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0
8002281|NCT03990649|12598287|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0
8002282|NCT03990649|12598288|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1
8002283|NCT03990649|12598289|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0
8002284|NCT03990649|12598287|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2
8002285|NCT03990649|12598288|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0
8002286|NCT03990649|12598289|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0
8002287|NCT03990649|12598287|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1
8002288|NCT03990649|12598288|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1
8002289|NCT03990649|12598289|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0
8002290|NCT03990649|12598287|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0
8002291|NCT03990649|12598288|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0
8002292|NCT03990649|12598289|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1
8002293|NCT03990649|12598287|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0
8002294|NCT03990649|12598288|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0
8002295|NCT03990649|12598289|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2
7718371|NCT00527787|12142341|FG001|Overall Study|Withdrawal by Subject|25
7718372|NCT00527787|12142340|FG000|Overall Study|Lost to Follow-up|5
8002296|NCT03990649|12598287|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0
8002297|NCT03990649|12598288|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0
8002298|NCT03990649|12598289|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1
8002299|NCT03996694|12598305|FG000|First Washout (7 Days)|positive urine drug screen|0
8002300|NCT03996694|12598306|FG001|First Washout (7 Days)|positive urine drug screen|0
8002301|NCT03996694|12598307|FG002|First Washout (7 Days)|positive urine drug screen|1
8002302|NCT03996694|12598308|FG003|First Washout (7 Days)|positive urine drug screen|0
8002303|NCT03996694|12598309|FG004|First Washout (7 Days)|positive urine drug screen|0
8002304|NCT03996694|12598310|FG005|First Washout (7 Days)|positive urine drug screen|0
8002305|NCT03996694|12598305|FG000|First Washout (7 Days)|Adverse Event|0
8002306|NCT03996694|12598306|FG001|First Washout (7 Days)|Adverse Event|1
8002307|NCT03996694|12598307|FG002|First Washout (7 Days)|Adverse Event|0
8002308|NCT03996694|12598308|FG003|First Washout (7 Days)|Adverse Event|0
8002309|NCT03996694|12598309|FG004|First Washout (7 Days)|Adverse Event|0
8002310|NCT03996694|12598310|FG005|First Washout (7 Days)|Adverse Event|0
8002311|NCT03996694|12598305|FG000|First Washout (7 Days)|Lost to Follow-up|0
8002312|NCT03996694|12598306|FG001|First Washout (7 Days)|Lost to Follow-up|0
8002313|NCT03996694|12598307|FG002|First Washout (7 Days)|Lost to Follow-up|1
8002314|NCT03996694|12598308|FG003|First Washout (7 Days)|Lost to Follow-up|0
8002315|NCT03996694|12598309|FG004|First Washout (7 Days)|Lost to Follow-up|0
8002316|NCT03996694|12598310|FG005|First Washout (7 Days)|Lost to Follow-up|0
8002317|NCT03996694|12598305|FG000|Third Washout (7 Days)|Withdrawal by Subject|0
8002318|NCT03996694|12598306|FG001|Third Washout (7 Days)|Withdrawal by Subject|0
8002319|NCT03996694|12598307|FG002|Third Washout (7 Days)|Withdrawal by Subject|0
8002320|NCT03996694|12598308|FG003|Third Washout (7 Days)|Withdrawal by Subject|0
8002321|NCT03996694|12598309|FG004|Third Washout (7 Days)|Withdrawal by Subject|1
8002322|NCT03996694|12598310|FG005|Third Washout (7 Days)|Withdrawal by Subject|0
8002323|NCT03988907|12598326|FG000|Overall Study|Unable to complete visit|0
8002324|NCT03988907|12598327|FG001|Overall Study|Unable to complete visit|1
8002325|NCT03988088|12598341|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0
8002326|NCT03988088|12598342|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1
8002327|NCT03988088|12598343|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0
8002328|NCT03988088|12598344|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0
8002329|NCT03988088|12598341|FG000|Open-Label Addendum|Lost to Follow-up|0
8002330|NCT03988088|12598342|FG001|Open-Label Addendum|Lost to Follow-up|0
8002331|NCT03988088|12598343|FG002|Open-Label Addendum|Lost to Follow-up|1
8002332|NCT03988088|12598344|FG003|Open-Label Addendum|Lost to Follow-up|0
8002333|NCT03980522|12598357|FG000|Treatment Period|Adverse Event|1
8002334|NCT03980522|12598358|FG001|Treatment Period|Adverse Event|0
8002335|NCT03980522|12598359|FG002|Treatment Period|Adverse Event|0
8002336|NCT03980522|12598360|FG003|Treatment Period|Adverse Event|0
8002337|NCT03980522|12598361|FG004|Treatment Period|Adverse Event|0
8002338|NCT03995784|12598377|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1
8002339|NCT03993392|12598388|FG000|Overall Study|Withdrawal by Subject|3
8002340|NCT03993392|12598388|FG000|Overall Study|Lost to Follow-up|2
8002341|NCT03993392|12598388|FG000|Overall Study|Did not meet Day 1 check-in criteria|1
8002342|NCT03981822|12598411|FG000|Overall Study|Lost to Follow-up|0
8002343|NCT03981822|12598412|FG001|Overall Study|Lost to Follow-up|1
8002344|NCT03981822|12598413|FG002|Overall Study|Lost to Follow-up|1
8002345|NCT03981822|12598414|FG003|Overall Study|Lost to Follow-up|0
8002346|NCT03981822|12598415|FG004|Overall Study|Lost to Follow-up|6
8002347|NCT03981822|12598416|FG005|Overall Study|Lost to Follow-up|4
8002348|NCT03981822|12598417|FG006|Overall Study|Lost to Follow-up|4
8002349|NCT03981822|12598418|FG007|Overall Study|Lost to Follow-up|2
8002350|NCT03981822|12598411|FG000|Overall Study|Withdrawal by Subject|0
8002351|NCT03981822|12598412|FG001|Overall Study|Withdrawal by Subject|1
8002352|NCT03981822|12598413|FG002|Overall Study|Withdrawal by Subject|0
8002353|NCT03981822|12598414|FG003|Overall Study|Withdrawal by Subject|0
8002354|NCT03981822|12598415|FG004|Overall Study|Withdrawal by Subject|0
8002355|NCT03981822|12598416|FG005|Overall Study|Withdrawal by Subject|1
8002356|NCT03981822|12598417|FG006|Overall Study|Withdrawal by Subject|0
8002357|NCT03981822|12598418|FG007|Overall Study|Withdrawal by Subject|2
8002358|NCT03981822|12598411|FG000|Overall Study|COVID-19 Related|0
8002359|NCT03981822|12598412|FG001|Overall Study|COVID-19 Related|0
8002360|NCT03981822|12598413|FG002|Overall Study|COVID-19 Related|0
8002361|NCT03981822|12598414|FG003|Overall Study|COVID-19 Related|0
8002362|NCT03981822|12598415|FG004|Overall Study|COVID-19 Related|2
8002363|NCT03981822|12598416|FG005|Overall Study|COVID-19 Related|1
8002364|NCT03981822|12598417|FG006|Overall Study|COVID-19 Related|2
8002365|NCT03981822|12598418|FG007|Overall Study|COVID-19 Related|1
8002366|NCT03991494|12598471|FG000|Overall Study|Progressive Disease|4
8002367|NCT03988803|12598490|FG000|Period 2|Prematurely discontinued from medication|2
8002368|NCT03988803|12598490|FG000|Period 2|Adverse Event|1
8002369|NCT03987932|12598501|FG000|Overall Study|Lost to Follow-up|2
8002370|NCT03987932|12598502|FG001|Overall Study|Lost to Follow-up|1
8002371|NCT03987932|12598503|FG002|Overall Study|Lost to Follow-up|1
8002372|NCT03987932|12598501|FG000|Overall Study|Non-study related elective surgery|0
8002373|NCT03987932|12598502|FG001|Overall Study|Non-study related elective surgery|0
8002374|NCT03987932|12598503|FG002|Overall Study|Non-study related elective surgery|1
8002375|NCT03987191|12598513|FG000|Overall Study|COVID-19 related research disruption|0
8002376|NCT03987191|12598514|FG001|Overall Study|COVID-19 related research disruption|2
8002377|NCT03988842|12598520|FG000|Overall Study|Death|1
8002378|NCT03981861|12598525|FG000|Overall Study|Withdrawal by Subject|3
8002379|NCT03974334|12598529|FG000|Overall Study|Lost to Follow-up|1
8002380|NCT03987074|12598557|FG000|Overall Study|Withdrew Consent|1
8002381|NCT03987074|12598558|FG001|Overall Study|Withdrew Consent|1
8002382|NCT03987074|12598559|FG002|Overall Study|Withdrew Consent|0
8002383|NCT03987074|12598560|FG003|Overall Study|Withdrew Consent|2
8002384|NCT03987074|12598561|FG004|Overall Study|Withdrew Consent|1
8002385|NCT03987074|12598557|FG000|Overall Study|Adverse Event|2
8002386|NCT03987074|12598558|FG001|Overall Study|Adverse Event|1
8002387|NCT03987074|12598559|FG002|Overall Study|Adverse Event|0
8002388|NCT03987074|12598560|FG003|Overall Study|Adverse Event|0
8002389|NCT03987074|12598561|FG004|Overall Study|Adverse Event|1
8002390|NCT03987074|12598557|FG000|Overall Study|Lost to Follow-up|0
8002391|NCT03987074|12598558|FG001|Overall Study|Lost to Follow-up|0
8002392|NCT03987074|12598559|FG002|Overall Study|Lost to Follow-up|1
8002393|NCT03987074|12598560|FG003|Overall Study|Lost to Follow-up|1
8002394|NCT03987074|12598561|FG004|Overall Study|Lost to Follow-up|0
8002395|NCT03987074|12598557|FG000|Overall Study|Investigator's Discretion|0
8002396|NCT03987074|12598558|FG001|Overall Study|Investigator's Discretion|0
8002397|NCT03987074|12598559|FG002|Overall Study|Investigator's Discretion|0
8002398|NCT03987074|12598560|FG003|Overall Study|Investigator's Discretion|1
8002399|NCT03987074|12598561|FG004|Overall Study|Investigator's Discretion|0
8002400|NCT03979820|12598595|FG000|Overall Study|Protocol Violation|1
8002401|NCT03979820|12598596|FG001|Overall Study|Protocol Violation|0
8002402|NCT03979820|12598597|FG002|Overall Study|Protocol Violation|0
8002403|NCT03979820|12598598|FG003|Overall Study|Protocol Violation|0
8002404|NCT03979820|12598595|FG000|Overall Study|Withdrawal by Subject|0
8002405|NCT03979820|12598596|FG001|Overall Study|Withdrawal by Subject|0
8002406|NCT03979820|12598597|FG002|Overall Study|Withdrawal by Subject|1
8002407|NCT03979820|12598598|FG003|Overall Study|Withdrawal by Subject|0
8002408|NCT03979820|12598595|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5
8002409|NCT03979820|12598596|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0
8002410|NCT03979820|12598597|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0
8002411|NCT03979820|12598598|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10
8002412|NCT03972137|12598612|FG000|Overall Study|Lost to Follow-up|2
8002413|NCT03972137|12598612|FG000|Overall Study|Withdrawal by Subject|4
8002414|NCT03970395|12598630|FG000|Overall Study|Withdrawal by Subject|3
8002415|NCT03970395|12598631|FG001|Overall Study|Withdrawal by Subject|4
8002416|NCT03970395|12598630|FG000|Overall Study|Lost to Follow-up|4
8002417|NCT03970395|12598631|FG001|Overall Study|Lost to Follow-up|8
8002418|NCT03987620|12598643|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43
8002419|NCT03987620|12598644|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41
8002420|NCT03987620|12598643|FG000|Overall Study|Adverse Event|3
8002421|NCT03987620|12598644|FG001|Overall Study|Adverse Event|0
8002422|NCT03987620|12598643|FG000|Overall Study|Lost to Follow-up|1
8002423|NCT03987620|12598644|FG001|Overall Study|Lost to Follow-up|2
8002424|NCT03987620|12598643|FG000|Overall Study|Physician Decision|0
8002425|NCT03987620|12598644|FG001|Overall Study|Physician Decision|1
8002426|NCT03987620|12598643|FG000|Overall Study|Pregnancy|1
8002427|NCT03987620|12598644|FG001|Overall Study|Pregnancy|0
8002428|NCT03987620|12598643|FG000|Overall Study|Withdrawal by Subject|7
8002429|NCT03987620|12598644|FG001|Overall Study|Withdrawal by Subject|1
8002430|NCT03987620|12598643|FG000|Overall Study|Other|2
8002431|NCT03987620|12598644|FG001|Overall Study|Other|5
8002432|NCT03983317|12598650|FG000|Overall Study|Physician Decision|5
8002433|NCT03984825|12598713|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2
8002434|NCT03984825|12598713|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1
8002435|NCT03984825|12598713|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3
8002436|NCT03982433|12598726|FG000|Overall Study|Lost to Follow-up|1
8002437|NCT03976466|12598736|FG000|Overall Study|Lost to Follow-up|1
8002438|NCT03976466|12598737|FG001|Overall Study|Lost to Follow-up|3
8002439|NCT03979638|12598747|FG000|Period 1|Physician Decision|1
8002440|NCT03979638|12598748|FG001|Period 1|Physician Decision|1
8002441|NCT03979638|12598747|FG000|Period 1|Withdrawal by Subject|4
8002442|NCT03979638|12598748|FG001|Period 1|Withdrawal by Subject|3
8002443|NCT03979638|12598747|FG000|Period 1|Study terminated by Sponsor|1
8002444|NCT03979638|12598748|FG001|Period 1|Study terminated by Sponsor|3
8002445|NCT03979638|12598747|FG000|Period 1|Protocol Violation|1
8002446|NCT03979638|12598748|FG001|Period 1|Protocol Violation|0
8002447|NCT03979638|12598747|FG000|Period 2|Study terminated by Sponsor|1
8002448|NCT03979638|12598748|FG001|Period 2|Study terminated by Sponsor|1
8002449|NCT03979274|12598763|FG000|Treatment Period 2|Withdrawal by Subject|0
8002450|NCT03979274|12598764|FG001|Treatment Period 2|Withdrawal by Subject|1
8002451|NCT03977727|12598781|FG000|Second Treatment|Lost to Follow-up|0
8002452|NCT03977727|12598782|FG001|Second Treatment|Lost to Follow-up|3
8002453|NCT03977155|12598791|FG000|Overall Study|Adverse Event|3
8002454|NCT03977155|12598792|FG001|Overall Study|Adverse Event|0
8002455|NCT03977155|12598793|FG002|Overall Study|Adverse Event|0
8002456|NCT03977155|12598791|FG000|Overall Study|Lost to Follow-up|0
8002457|NCT03977155|12598792|FG001|Overall Study|Lost to Follow-up|1
8002458|NCT03977155|12598793|FG002|Overall Study|Lost to Follow-up|0
8002459|NCT03977155|12598791|FG000|Overall Study|Withdrawal by Subject|1
8002460|NCT03977155|12598792|FG001|Overall Study|Withdrawal by Subject|1
8002461|NCT03977155|12598793|FG002|Overall Study|Withdrawal by Subject|2
8002462|NCT03977155|12598791|FG000|Overall Study|Participant was unable to come in for the Visit|1
8002463|NCT03977155|12598792|FG001|Overall Study|Participant was unable to come in for the Visit|0
8002464|NCT03977155|12598793|FG002|Overall Study|Participant was unable to come in for the Visit|0
8002465|NCT03970733|12598815|FG000|Overall Study|Withdrawal by Subject|0
8002466|NCT03970733|12598816|FG001|Overall Study|Withdrawal by Subject|5
8002467|NCT03970733|12598817|FG002|Overall Study|Withdrawal by Subject|1
8002468|NCT03970733|12598815|FG000|Overall Study|e.g.: moved from study area|1
8002469|NCT03970733|12598816|FG001|Overall Study|e.g.: moved from study area|0
8002470|NCT03970733|12598817|FG002|Overall Study|e.g.: moved from study area|0
8002471|NCT03970733|12598815|FG000|Overall Study|Lost to Follow-up|2
8002472|NCT03970733|12598816|FG001|Overall Study|Lost to Follow-up|1
8002473|NCT03970733|12598817|FG002|Overall Study|Lost to Follow-up|1
8002474|NCT03970733|12598815|FG000|Overall Study|Other|1
8002475|NCT03970733|12598816|FG001|Overall Study|Other|0
8002476|NCT03970733|12598817|FG002|Overall Study|Other|0
8002477|NCT03968978|12598827|FG000|Overall Study|Adverse Event|1
8002478|NCT03968978|12598828|FG001|Overall Study|Adverse Event|0
8002479|NCT03966911|12598849|FG000|Overall Study|Adverse Event|1
8002480|NCT03966911|12598850|FG001|Overall Study|Adverse Event|1
8002481|NCT03966911|12598849|FG000|Overall Study|Withdrawal by Subject|8
8002482|NCT03966911|12598850|FG001|Overall Study|Withdrawal by Subject|2
8002483|NCT03966911|12598849|FG000|Overall Study|Unable to complete study visits due to COVID-19|0
8002484|NCT03966911|12598850|FG001|Overall Study|Unable to complete study visits due to COVID-19|13
8002485|NCT03966365|12598860|FG000|Overall Study|Protocol Violation|1
8002486|NCT03966365|12598861|FG001|Overall Study|Protocol Violation|0
8002487|NCT03965403|12598867|FG000|Overall Study|Subject not meeting eligibility criteria|1
8002488|NCT03965351|12598924|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0
8002489|NCT03965351|12598925|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1
8002490|NCT03965351|12598924|FG000|Second Intervention (4 Weeks)|Adverse Event|0
8002491|NCT03965351|12598925|FG001|Second Intervention (4 Weeks)|Adverse Event|1
8002492|NCT03958955|12598940|FG000|Overall Study|Adverse Event|1
8002493|NCT03965052|12598948|FG000|Overall Study|Protocol Violation|1
8002494|NCT03965052|12598949|FG001|Overall Study|Protocol Violation|0
8002495|NCT03963401|12598978|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1
8002496|NCT03963401|12598979|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2
8002497|NCT03963401|12598980|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0
8002498|NCT03963401|12598981|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0
8002499|NCT03963401|12598982|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1
8002500|NCT03963401|12598983|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2
8002501|NCT03963401|12598978|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
8002502|NCT03963401|12598979|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
8002503|NCT03963401|12598980|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1
8002504|NCT03963401|12598981|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1
8002505|NCT03963401|12598982|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
8002506|NCT03963401|12598983|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
8002507|NCT03963401|12598978|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2
8002508|NCT03963401|12598979|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
8002509|NCT03963401|12598980|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
8002510|NCT03963401|12598981|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
8002511|NCT03963401|12598982|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2
8002512|NCT03963401|12598983|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0
8002513|NCT03963401|12598978|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
8002514|NCT03963401|12598979|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1
8002515|NCT03963401|12598980|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
8002516|NCT03963401|12598981|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
8002517|NCT03963401|12598982|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
8002518|NCT03963401|12598983|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
8002519|NCT03963401|12598978|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6
8002520|NCT03963401|12598979|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3
8002521|NCT03963401|12598980|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2
8002522|NCT03963401|12598981|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0
8002523|NCT03963401|12598982|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4
8002524|NCT03963401|12598983|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3
8002525|NCT03963401|12598978|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1
8002526|NCT03963401|12598979|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
8002527|NCT03963401|12598980|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1
8002528|NCT03963401|12598981|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
8002529|NCT03963401|12598982|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
8002530|NCT03963401|12598983|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
8002531|NCT03963401|12598978|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
8002532|NCT03963401|12598979|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
8002533|NCT03963401|12598980|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1
8002534|NCT03963401|12598981|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
8002535|NCT03963401|12598982|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
8002536|NCT03963401|12598983|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
8002537|NCT03963401|12598978|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1
8002538|NCT03963401|12598979|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
8002539|NCT03963401|12598980|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
8002540|NCT03963401|12598981|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
8002541|NCT03963401|12598982|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
8002542|NCT03963401|12598983|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
8002543|NCT03963401|12598978|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4
8002544|NCT03963401|12598979|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
8002545|NCT03963401|12598980|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0
8002546|NCT03963401|12598981|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0
8002547|NCT03963401|12598982|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
8002548|NCT03963401|12598983|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
8002549|NCT03963401|12598978|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1
8002550|NCT03963401|12598979|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
8002551|NCT03963401|12598980|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
8002552|NCT03963401|12598981|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
8002553|NCT03963401|12598982|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
8002554|NCT03963401|12598983|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
8002555|NCT03963401|12598978|FG000|Extension Period (Week 17 - Week 52)|Other|1
8002556|NCT03963401|12598979|FG001|Extension Period (Week 17 - Week 52)|Other|1
8002557|NCT03963401|12598980|FG002|Extension Period (Week 17 - Week 52)|Other|0
8002558|NCT03963401|12598981|FG003|Extension Period (Week 17 - Week 52)|Other|1
8002559|NCT03963401|12598982|FG004|Extension Period (Week 17 - Week 52)|Other|1
8002560|NCT03963401|12598983|FG005|Extension Period (Week 17 - Week 52)|Other|1
8002561|NCT03962790|12599010|FG000|Period 1|Adverse Event|0
8002562|NCT03962790|12599011|FG001|Period 1|Adverse Event|1
8002563|NCT03962790|12599010|FG000|Period 1|Failed to meet all eligibility criteria|1
8002564|NCT03962790|12599011|FG001|Period 1|Failed to meet all eligibility criteria|1
8002565|NCT03962790|12599010|FG000|Period 1|No Longer Meets Eligibility Criteria|1
8002566|NCT03962790|12599011|FG001|Period 1|No Longer Meets Eligibility Criteria|0
8002567|NCT03962790|12599010|FG000|Period 1|Withdrawal by Subject|1
8002568|NCT03962790|12599011|FG001|Period 1|Withdrawal by Subject|0
8002569|NCT03956225|12599019|FG000|Overall Study|Lack of Efficacy|1
8002570|NCT03956225|12599020|FG001|Overall Study|Lack of Efficacy|1
8002571|NCT03956225|12599019|FG000|Overall Study|Lost to Follow-up|0
8002572|NCT03956225|12599020|FG001|Overall Study|Lost to Follow-up|1
8002573|NCT03956225|12599019|FG000|Overall Study|Withdrawal by Subject|2
8002574|NCT03956225|12599020|FG001|Overall Study|Withdrawal by Subject|1
8002575|NCT03956225|12599019|FG000|Overall Study|Other Reasons|2
8002576|NCT03956225|12599020|FG001|Overall Study|Other Reasons|1
8002577|NCT03958149|12599038|FG000|Overall Study|Withdrawal by Subject|0
8002578|NCT03958149|12599039|FG001|Overall Study|Withdrawal by Subject|1
8002579|NCT03953183|12599051|FG000|Overall Study|Physician Decision|0
8002580|NCT03953183|12599052|FG001|Overall Study|Physician Decision|1
8002581|NCT03953183|12599051|FG000|Overall Study|Withdrawal by Subject|0
8002582|NCT03953183|12599052|FG001|Overall Study|Withdrawal by Subject|1
8002583|NCT03962738|12599073|FG000|Overall Study|Protocol Deviation|3
8002584|NCT03962738|12599074|FG001|Overall Study|Protocol Deviation|0
8002585|NCT03962738|12599075|FG002|Overall Study|Protocol Deviation|1
8002586|NCT03962738|12599076|FG003|Overall Study|Protocol Deviation|1
8002587|NCT03962738|12599073|FG000|Overall Study|Withdrawal by Subject|4
8002588|NCT03962738|12599074|FG001|Overall Study|Withdrawal by Subject|0
8002589|NCT03962738|12599075|FG002|Overall Study|Withdrawal by Subject|0
8002590|NCT03962738|12599076|FG003|Overall Study|Withdrawal by Subject|0
8002591|NCT03962738|12599073|FG000|Overall Study|Lost to Follow-up|0
8002592|NCT03962738|12599074|FG001|Overall Study|Lost to Follow-up|0
8002593|NCT03962738|12599075|FG002|Overall Study|Lost to Follow-up|1
8002594|NCT03962738|12599076|FG003|Overall Study|Lost to Follow-up|0
8002595|NCT03962101|12599094|FG000|Overall Study|Adverse Event|1
8002596|NCT03962101|12599094|FG000|Overall Study|Physician Decision|2
8002597|NCT03962101|12599094|FG000|Overall Study|Not related to medical events|1
8002598|NCT03959137|12599099|FG000|Overall Study|Protocol Violation|6
8002599|NCT03946124|12599103|FG000|Overall Study|Withdrawal by Subject|19
8002600|NCT03961308|12599109|FG000|Overall Study|Withdrawal by Subject|1
8002601|NCT03961308|12599110|FG001|Overall Study|Withdrawal by Subject|0
8002602|NCT03961308|12599109|FG000|Overall Study|Other|1
8002603|NCT03961308|12599110|FG001|Overall Study|Other|0
8002604|NCT03961308|12599109|FG000|Overall Study|Lost to Follow-up|0
8002605|NCT03961308|12599110|FG001|Overall Study|Lost to Follow-up|1
8002606|NCT03961308|12599109|FG000|Overall Study|Adverse Event|0
8002607|NCT03961308|12599110|FG001|Overall Study|Adverse Event|1
8002608|NCT03956862|12599127|FG000|Overall Study|Lost to Follow-up|1
8002609|NCT03956862|12599128|FG001|Overall Study|Lost to Follow-up|1
8002610|NCT03956862|12599127|FG000|Overall Study|Withdrawal by Subject|1
8002611|NCT03956862|12599128|FG001|Overall Study|Withdrawal by Subject|1
8002612|NCT03954444|12599137|FG000|Overall Study|Withdrawal by Subject|5
8002613|NCT03954444|12599138|FG001|Overall Study|Withdrawal by Subject|5
8002614|NCT03954444|12599139|FG002|Overall Study|Withdrawal by Subject|5
8002615|NCT03954444|12599137|FG000|Overall Study|Adverse Event|1
8002616|NCT03954444|12599138|FG001|Overall Study|Adverse Event|3
8002617|NCT03954444|12599139|FG002|Overall Study|Adverse Event|2
8002618|NCT03954444|12599137|FG000|Overall Study|Protocol Violation|0
8002619|NCT03954444|12599138|FG001|Overall Study|Protocol Violation|3
8002620|NCT03954444|12599139|FG002|Overall Study|Protocol Violation|5
8002621|NCT03954444|12599137|FG000|Overall Study|Use of prohibited therapy|1
8002622|NCT03954444|12599138|FG001|Overall Study|Use of prohibited therapy|1
8002623|NCT03954444|12599139|FG002|Overall Study|Use of prohibited therapy|2
8002624|NCT03954444|12599137|FG000|Overall Study|Lost to Follow-up|1
8002625|NCT03954444|12599138|FG001|Overall Study|Lost to Follow-up|0
8002626|NCT03954444|12599139|FG002|Overall Study|Lost to Follow-up|1
8002627|NCT03954444|12599137|FG000|Overall Study|Non-compliant with study drug application|2
8002628|NCT03954444|12599138|FG001|Overall Study|Non-compliant with study drug application|2
8002629|NCT03954444|12599139|FG002|Overall Study|Non-compliant with study drug application|0
8002630|NCT03954444|12599137|FG000|Overall Study|Administrative reasons|0
8002631|NCT03954444|12599138|FG001|Overall Study|Administrative reasons|0
8002632|NCT03954444|12599139|FG002|Overall Study|Administrative reasons|1
8002633|NCT03954444|12599137|FG000|Overall Study|Miscellaneous|3
8002634|NCT03954444|12599138|FG001|Overall Study|Miscellaneous|2
8002635|NCT03954444|12599139|FG002|Overall Study|Miscellaneous|1
8002636|NCT03953820|12599147|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1
8002637|NCT03953820|12599148|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0
8002638|NCT03953820|12599149|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0
8002639|NCT03953820|12599147|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1
8002640|NCT03953820|12599148|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0
8002641|NCT03953820|12599149|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0
8002642|NCT03950856|12599187|FG000|Overall Study|Death|1
8002643|NCT03950856|12599188|FG001|Overall Study|Death|2
8002644|NCT03950856|12599189|FG002|Overall Study|Death|0
8002645|NCT03950856|12599190|FG003|Overall Study|Death|0
8002646|NCT03950856|12599187|FG000|Overall Study|Lost to Follow-up|5
8002647|NCT03950856|12599188|FG001|Overall Study|Lost to Follow-up|6
8002648|NCT03950856|12599189|FG002|Overall Study|Lost to Follow-up|8
8002649|NCT03950856|12599190|FG003|Overall Study|Lost to Follow-up|2
8002650|NCT03950856|12599187|FG000|Overall Study|Protocol Violation|2
8002651|NCT03950856|12599188|FG001|Overall Study|Protocol Violation|0
8002652|NCT03950856|12599189|FG002|Overall Study|Protocol Violation|0
8002653|NCT03950856|12599190|FG003|Overall Study|Protocol Violation|1
8002654|NCT03950856|12599187|FG000|Overall Study|Withdrawal by Subject|4
8002655|NCT03950856|12599188|FG001|Overall Study|Withdrawal by Subject|1
8002656|NCT03950856|12599189|FG002|Overall Study|Withdrawal by Subject|3
8002657|NCT03950856|12599190|FG003|Overall Study|Withdrawal by Subject|1
8002658|NCT03950856|12599187|FG000|Overall Study|Unable to phone|7
8002659|NCT03950856|12599188|FG001|Overall Study|Unable to phone|6
8002660|NCT03950856|12599189|FG002|Overall Study|Unable to phone|7
8002661|NCT03950856|12599190|FG003|Overall Study|Unable to phone|2
8002662|NCT03956550|12599243|FG000|Overall Study|Sponsor decision|65
8002663|NCT03956550|12599244|FG001|Overall Study|Sponsor decision|66
8002664|NCT03956550|12599245|FG002|Overall Study|Sponsor decision|64
8002665|NCT03956550|12599243|FG000|Overall Study|Adverse Event|0
8002666|NCT03956550|12599244|FG001|Overall Study|Adverse Event|1
8002667|NCT03956550|12599245|FG002|Overall Study|Adverse Event|0
8002668|NCT03956550|12599243|FG000|Overall Study|Withdrawal by Subject|5
8002669|NCT03956550|12599244|FG001|Overall Study|Withdrawal by Subject|5
8002670|NCT03956550|12599245|FG002|Overall Study|Withdrawal by Subject|6
8002671|NCT03958656|12599297|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0
8002672|NCT03958656|12599298|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1
8002673|NCT03958656|12599299|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0
8002674|NCT03958656|12599300|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0
8002675|NCT03958656|12599297|FG000|Overall Study|No longer meets eligibility criteria|0
8002676|NCT03958656|12599298|FG001|Overall Study|No longer meets eligibility criteria|0
8002677|NCT03958656|12599299|FG002|Overall Study|No longer meets eligibility criteria|1
8002678|NCT03958656|12599300|FG003|Overall Study|No longer meets eligibility criteria|0
8002679|NCT03958656|12599297|FG000|Overall Study|Started anti-cancer treatment|0
8002680|NCT03958656|12599298|FG001|Overall Study|Started anti-cancer treatment|0
8002681|NCT03958656|12599299|FG002|Overall Study|Started anti-cancer treatment|1
8002682|NCT03958656|12599300|FG003|Overall Study|Started anti-cancer treatment|0
8002683|NCT03951805|12599323|FG000|Overall Study|Adverse Event|1
8002684|NCT03951805|12599324|FG001|Overall Study|Adverse Event|0
8002685|NCT03951805|12599325|FG002|Overall Study|Adverse Event|0
8002686|NCT03951805|12599326|FG003|Overall Study|Adverse Event|0
8002687|NCT03950622|12599351|FG000|Overall Study|Withdrawal by Subject|1
8002688|NCT03950622|12599352|FG001|Overall Study|Withdrawal by Subject|0
8002689|NCT03950622|12599351|FG000|Overall Study|Protocol Deviation|0
8002690|NCT03950622|12599352|FG001|Overall Study|Protocol Deviation|1
8002691|NCT03950622|12599351|FG000|Overall Study|Physician Decision|1
8002692|NCT03950622|12599352|FG001|Overall Study|Physician Decision|0
8002693|NCT03950622|12599351|FG000|Overall Study|Lost to Follow-up|5
8002694|NCT03950622|12599352|FG001|Overall Study|Lost to Follow-up|5
8002695|NCT03950622|12599351|FG000|Overall Study|Death|1
8002696|NCT03950622|12599352|FG001|Overall Study|Death|1
8002697|NCT03948334|12599395|FG000|Overall Study|Adverse Event|1
8002698|NCT03948334|12599396|FG001|Overall Study|Adverse Event|4
8002699|NCT03948334|12599395|FG000|Overall Study|Lack of Efficacy|2
8002700|NCT03948334|12599396|FG001|Overall Study|Lack of Efficacy|0
8002701|NCT03948334|12599395|FG000|Overall Study|Lost to Follow-up|1
8002702|NCT03948334|12599396|FG001|Overall Study|Lost to Follow-up|0
8002703|NCT03948334|12599395|FG000|Overall Study|Physician Decision|1
8002704|NCT03948334|12599396|FG001|Overall Study|Physician Decision|0
8002705|NCT03948334|12599395|FG000|Overall Study|Pregnancy|0
8002706|NCT03948334|12599396|FG001|Overall Study|Pregnancy|1
8002707|NCT03948334|12599395|FG000|Overall Study|Protocol Deviation|1
8002708|NCT03948334|12599396|FG001|Overall Study|Protocol Deviation|0
8002709|NCT03948334|12599395|FG000|Overall Study|Study terminated by Sponsor|50
8002710|NCT03948334|12599396|FG001|Overall Study|Study terminated by Sponsor|51
8002711|NCT03948334|12599395|FG000|Overall Study|Subject Decision /Guardian Decision|4
8002712|NCT03948334|12599396|FG001|Overall Study|Subject Decision /Guardian Decision|7
8002713|NCT03944707|12599423|FG000|Overall Study|Adverse Event|0
8002714|NCT03944707|12599424|FG001|Overall Study|Adverse Event|2
8002715|NCT03944707|12599423|FG000|Overall Study|Study terminated by sponsor|12
8002716|NCT03944707|12599424|FG001|Overall Study|Study terminated by sponsor|7
8002717|NCT03944707|12599423|FG000|Overall Study|Subject decision|0
8002718|NCT03944707|12599424|FG001|Overall Study|Subject decision|1
8002719|NCT03943095|12599441|FG000|Overall Study|Incorrectly dispensed wrong box kit|0
8002720|NCT03943095|12599442|FG001|Overall Study|Incorrectly dispensed wrong box kit|1
8002721|NCT03943095|12599441|FG000|Overall Study|Withdrawal by Subject|1
8002722|NCT03943095|12599442|FG001|Overall Study|Withdrawal by Subject|0
8002723|NCT03942042|12599451|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0
8002724|NCT03942042|12599452|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1
8002725|NCT03942042|12599451|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1
8002726|NCT03942042|12599452|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0
8002727|NCT03923530|12599471|FG000|Overall Study|Withdrawal by Subject|1
8002728|NCT03923530|12599471|FG000|Overall Study|screen failure|3
8002729|NCT03914417|12599475|FG000|Overall Study|Withdrawal by Subject|2
8002730|NCT03913377|12599481|FG000|Period 1|Test Article no longer available|0
8002731|NCT03913377|12599482|FG001|Period 1|Test Article no longer available|1
8002732|NCT03913377|12599483|FG002|Period 1|Test Article no longer available|0
8002733|NCT03913377|12599481|FG000|Period 1|No Longer Meets Eligibility Criteria|0
8002734|NCT03913377|12599482|FG001|Period 1|No Longer Meets Eligibility Criteria|0
8002735|NCT03913377|12599483|FG002|Period 1|No Longer Meets Eligibility Criteria|1
8002736|NCT03937778|12599494|FG000|Overall Study|Withdrawal by Subject|1
8002737|NCT03937778|12599494|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1
8002738|NCT03937479|12599503|FG000|Overall Study|Adverse Event|2
8002739|NCT03937479|12599504|FG001|Overall Study|Adverse Event|3
8002740|NCT03937479|12599505|FG002|Overall Study|Adverse Event|0
8002741|NCT03937479|12599506|FG003|Overall Study|Adverse Event|0
8002742|NCT03937479|12599507|FG004|Overall Study|Adverse Event|1
8002743|NCT03937479|12599503|FG000|Overall Study|Withdrawal by Subject|3
8002744|NCT03937479|12599504|FG001|Overall Study|Withdrawal by Subject|5
8002745|NCT03937479|12599505|FG002|Overall Study|Withdrawal by Subject|2
8002746|NCT03937479|12599506|FG003|Overall Study|Withdrawal by Subject|2
8002747|NCT03937479|12599507|FG004|Overall Study|Withdrawal by Subject|1
8002748|NCT03937479|12599503|FG000|Overall Study|Protocol Violation|5
8002749|NCT03937479|12599504|FG001|Overall Study|Protocol Violation|6
8002750|NCT03937479|12599505|FG002|Overall Study|Protocol Violation|4
8002751|NCT03937479|12599506|FG003|Overall Study|Protocol Violation|3
8002752|NCT03937479|12599507|FG004|Overall Study|Protocol Violation|2
8002753|NCT03937479|12599503|FG000|Overall Study|Lost to Follow-up|0
8002754|NCT03937479|12599504|FG001|Overall Study|Lost to Follow-up|1
8002755|NCT03937479|12599505|FG002|Overall Study|Lost to Follow-up|0
8002756|NCT03937479|12599506|FG003|Overall Study|Lost to Follow-up|1
8002757|NCT03937479|12599507|FG004|Overall Study|Lost to Follow-up|0
8002758|NCT03937479|12599503|FG000|Overall Study|Physician Decision|0
8002759|NCT03937479|12599504|FG001|Overall Study|Physician Decision|0
8002760|NCT03937479|12599505|FG002|Overall Study|Physician Decision|1
8002761|NCT03937479|12599506|FG003|Overall Study|Physician Decision|0
8002762|NCT03937479|12599507|FG004|Overall Study|Physician Decision|1
8002763|NCT03936244|12599543|FG000|Overall Study|Lost to Follow-up|5
8002764|NCT03936244|12599544|FG001|Overall Study|Lost to Follow-up|1
8002765|NCT03936244|12599543|FG000|Overall Study|Physician Decision|7
8002766|NCT03936244|12599544|FG001|Overall Study|Physician Decision|3
8002767|NCT03935126|12599551|FG000|Overall Study|Study termination by sponsor|3
8002768|NCT03933462|12599570|FG000|Overall Study|Adverse Event|2
8002769|NCT03933462|12599571|FG001|Overall Study|Adverse Event|0
8002770|NCT03931330|12599586|FG000|Overall Study|Physician Decision|1
8002771|NCT03931785|12599629|FG000|Overall Study|Lost to Follow-up|4
8002772|NCT03931785|12599630|FG001|Overall Study|Lost to Follow-up|1
8002773|NCT03931785|12599631|FG002|Overall Study|Lost to Follow-up|4
8002774|NCT03931785|12599632|FG003|Overall Study|Lost to Follow-up|3
8002775|NCT03931785|12599629|FG000|Overall Study|Adverse Event|1
8002776|NCT03931785|12599630|FG001|Overall Study|Adverse Event|0
8002777|NCT03931785|12599631|FG002|Overall Study|Adverse Event|3
8002778|NCT03931785|12599632|FG003|Overall Study|Adverse Event|4
8002779|NCT03931785|12599629|FG000|Overall Study|Protocol Violation|0
8002780|NCT03931785|12599630|FG001|Overall Study|Protocol Violation|1
8002781|NCT03931785|12599631|FG002|Overall Study|Protocol Violation|0
8002782|NCT03931785|12599632|FG003|Overall Study|Protocol Violation|0
8002783|NCT03931785|12599629|FG000|Overall Study|Noncompliance With Study drug|0
8002784|NCT03931785|12599630|FG001|Overall Study|Noncompliance With Study drug|1
8002785|NCT03931785|12599631|FG002|Overall Study|Noncompliance With Study drug|0
8002786|NCT03931785|12599632|FG003|Overall Study|Noncompliance With Study drug|0
8002787|NCT03931785|12599629|FG000|Overall Study|Other Not specified|0
8002788|NCT03931785|12599630|FG001|Overall Study|Other Not specified|2
8002789|NCT03931785|12599631|FG002|Overall Study|Other Not specified|2
8002790|NCT03931785|12599632|FG003|Overall Study|Other Not specified|2
8002791|NCT03931785|12599629|FG000|Overall Study|Withdrawal by Subject|0
8002792|NCT03931785|12599630|FG001|Overall Study|Withdrawal by Subject|2
8002793|NCT03931785|12599631|FG002|Overall Study|Withdrawal by Subject|4
8002794|NCT03931785|12599632|FG003|Overall Study|Withdrawal by Subject|1
8002795|NCT03931785|12599629|FG000|Overall Study|Pregnancy|0
8002796|NCT03931785|12599630|FG001|Overall Study|Pregnancy|0
8002797|NCT03931785|12599631|FG002|Overall Study|Pregnancy|0
8002798|NCT03931785|12599632|FG003|Overall Study|Pregnancy|1
8002799|NCT03927846|12599648|FG000|Overall Study|Lost to Follow-up|10
8002800|NCT03927846|12599649|FG001|Overall Study|Lost to Follow-up|11
8002801|NCT03927105|12599655|FG000|Overall Study|Death|1
8002802|NCT03927105|12599655|FG000|Overall Study|In observation for potential re-treatment|2
8002803|NCT03927105|12599655|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1
8002804|NCT03923933|12599661|FG000|Overall Study|Lost to Follow-up|1
8002805|NCT03923933|12599662|FG001|Overall Study|Lost to Follow-up|0
8002806|NCT03923933|12599661|FG000|Overall Study|Withdrawal by Subject|0
8002807|NCT03923933|12599662|FG001|Overall Study|Withdrawal by Subject|1
8002808|NCT03909295|12599668|FG000|Overall Study|Adverse Event|2
8002809|NCT03909295|12599668|FG000|Overall Study|Study terminated by sponsor|50
8002810|NCT03908970|12599674|FG000|Overall Study|Adverse Event|7
8002811|NCT03908970|12599675|FG001|Overall Study|Adverse Event|21
8002812|NCT03908970|12599674|FG000|Overall Study|Physician Decision|1
8002813|NCT03908970|12599675|FG001|Overall Study|Physician Decision|4
8002814|NCT03908970|12599674|FG000|Overall Study|Withdrawal by Subject|9
8002815|NCT03908970|12599675|FG001|Overall Study|Withdrawal by Subject|22
8002816|NCT03897179|12599681|FG000|Overall Study|Withdrawal by Subject|1
8002817|NCT03927950|12599745|FG000|Overall Study|Adverse Event|9
8002818|NCT03920670|12599767|FG000|Overall Study|Protocol Violation|2
8002819|NCT03920670|12599768|FG001|Overall Study|Protocol Violation|2
8002820|NCT03920670|12599767|FG000|Overall Study|Adverse Event|1
8002821|NCT03920670|12599768|FG001|Overall Study|Adverse Event|0
8002822|NCT03898063|12599789|FG000|Overall Study|Withdrawal by Subject|10
8002823|NCT03898063|12599790|FG001|Overall Study|Withdrawal by Subject|8
8002824|NCT03909100|12599836|FG000|Overall Study|Protocol Deviation|2
8002825|NCT03909100|12599836|FG000|Overall Study|Technical Problems|4
8002826|NCT03909100|12599836|FG000|Overall Study|Withdrawal by Subject|4
8002827|NCT03909100|12599836|FG000|Overall Study|Lost to Follow-up|1
8002828|NCT03909100|12599836|FG000|Overall Study|Reason not Specified|4
8002829|NCT03905642|12599843|FG000|Overall Study|Withdrawal by Subject|3
8002830|NCT03905642|12599843|FG000|Overall Study|Pregnancy|1
8002831|NCT03905642|12599843|FG000|Overall Study|Adverse Event|1
8002832|NCT03905642|12599843|FG000|Overall Study|Lack of Efficacy|1
8002833|NCT03905642|12599843|FG000|Overall Study|Completed study but not 24 of 28 days|2
8002834|NCT03892889|12599847|FG000|Overall Study|Adverse Event|17
8002835|NCT03892889|12599847|FG000|Overall Study|Lack of Efficacy|1
8002836|NCT03892889|12599847|FG000|Overall Study|Lost to Follow-up|46
8002837|NCT03892889|12599847|FG000|Overall Study|Non-compliance with study drug|22
8002838|NCT03892889|12599847|FG000|Overall Study|Pregnancy|1
8002839|NCT03892889|12599847|FG000|Overall Study|Protocol Deviation|3
8002840|NCT03892889|12599847|FG000|Overall Study|Withdrawal by Subject|50
8002841|NCT03892889|12599847|FG000|Overall Study|Withdrawal by Caregiver|1
8002842|NCT03892889|12599847|FG000|Overall Study|Study Terminated by Sponsor|50
8002843|NCT03892889|12599847|FG000|Overall Study|Physician Decision|8
8002844|NCT03892889|12599847|FG000|Overall Study|Reason not Specified|5
8002845|NCT03921723|12599851|FG000|Period 2 (4 Days)|Withdrawal by Subject|3
8002846|NCT03921723|12599851|FG000|Period 3 (4 Days)|Withdrawal by Subject|1
8002847|NCT03918239|12599895|FG000|Overall Study|Lost to Follow-up|3
8002848|NCT03918239|12599896|FG001|Overall Study|Lost to Follow-up|1
8002849|NCT03918239|12599895|FG000|Overall Study|Pregnancy|0
8002850|NCT03918239|12599896|FG001|Overall Study|Pregnancy|2
8002851|NCT03918239|12599895|FG000|Overall Study|Withdrawal by Subject|3
8002852|NCT03918239|12599896|FG001|Overall Study|Withdrawal by Subject|3
8002853|NCT03918239|12599895|FG000|Overall Study|positive urine drug screening results|4
8002854|NCT03918239|12599896|FG001|Overall Study|positive urine drug screening results|1
8002855|NCT03917823|12599904|FG000|Overall Study|Lost to Follow-up|1
8002856|NCT03917823|12599905|FG001|Overall Study|Lost to Follow-up|1
8002857|NCT03917823|12599904|FG000|Overall Study|Withdrawal by Subject|0
8002858|NCT03917823|12599905|FG001|Overall Study|Withdrawal by Subject|1
8002859|NCT03902613|12599926|FG000|Overall Study|Physician Decision|1
8002860|NCT03902574|12599933|FG000|Overall Study|Urinary drug test was positive on Day 20|0
8002861|NCT03902574|12599934|FG001|Overall Study|Urinary drug test was positive on Day 20|0
8002862|NCT03902574|12599935|FG002|Overall Study|Urinary drug test was positive on Day 20|1
8002863|NCT03914950|12599943|FG000|Overall Study|Physician Decision|54
8002864|NCT03911843|12599955|FG000|Overall Study|Adverse Event|2
8002865|NCT03911843|12599956|FG001|Overall Study|Adverse Event|0
8002866|NCT03911843|12599955|FG000|Overall Study|Protocol Violation|2
8002867|NCT03911843|12599956|FG001|Overall Study|Protocol Violation|0
8002868|NCT03911843|12599955|FG000|Overall Study|Lost to Follow-up|0
8002869|NCT03911843|12599956|FG001|Overall Study|Lost to Follow-up|1
8002870|NCT03894813|12599973|FG000|Overall Study|Adverse Event|1
8002871|NCT03894813|12599974|FG001|Overall Study|Adverse Event|1
8002872|NCT03894813|12599973|FG000|Overall Study|Lack of Efficacy|3
8002873|NCT03894813|12599974|FG001|Overall Study|Lack of Efficacy|3
8002874|NCT03894813|12599973|FG000|Overall Study|Lost to Follow-up|1
8002875|NCT03894813|12599974|FG001|Overall Study|Lost to Follow-up|0
8002876|NCT03894813|12599973|FG000|Overall Study|Pregnancy|2
8002877|NCT03894813|12599974|FG001|Overall Study|Pregnancy|1
8002878|NCT03894813|12599973|FG000|Overall Study|Protocol Violation|3
8002879|NCT03894813|12599974|FG001|Overall Study|Protocol Violation|7
8002880|NCT03894813|12599973|FG000|Overall Study|Withdrawal by Subject|1
8002881|NCT03894813|12599974|FG001|Overall Study|Withdrawal by Subject|3
8002882|NCT03894813|12599973|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0
8002883|NCT03894813|12599974|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1
8002884|NCT03911960|12599982|FG000|Overall Study|Lost to Follow-up|5
8002885|NCT03911960|12599983|FG001|Overall Study|Lost to Follow-up|3
8002886|NCT03907072|12599993|FG000|Overall Study|Study Terminated by Sponsor|2
8002887|NCT03907072|12599994|FG001|Overall Study|Study Terminated by Sponsor|2
8002888|NCT03907072|12599995|FG002|Overall Study|Study Terminated by Sponsor|2
8002889|NCT03911401|12600015|FG000|Overall Study|Adverse Event|1
8002890|NCT03911401|12600016|FG001|Overall Study|Adverse Event|2
8002891|NCT03911401|12600017|FG002|Overall Study|Adverse Event|5
8002892|NCT03911401|12600015|FG000|Overall Study|Lack of Efficacy|1
8002893|NCT03911401|12600016|FG001|Overall Study|Lack of Efficacy|1
8002894|NCT03911401|12600017|FG002|Overall Study|Lack of Efficacy|8
8002895|NCT03911401|12600015|FG000|Overall Study|Physician Decision|0
8002896|NCT03911401|12600016|FG001|Overall Study|Physician Decision|0
8002897|NCT03911401|12600017|FG002|Overall Study|Physician Decision|1
8002898|NCT03911401|12600015|FG000|Overall Study|Withdrawal by Subject|1
8002899|NCT03911401|12600016|FG001|Overall Study|Withdrawal by Subject|2
8002900|NCT03911401|12600017|FG002|Overall Study|Withdrawal by Subject|0
8002901|NCT03911401|12600015|FG000|Overall Study|Withdrawal by parent/guardian|4
8002902|NCT03911401|12600016|FG001|Overall Study|Withdrawal by parent/guardian|4
8002903|NCT03911401|12600017|FG002|Overall Study|Withdrawal by parent/guardian|11
8002904|NCT03904420|12600044|FG000|Overall Study|Study terminated|2
8002905|NCT03904420|12600045|FG001|Overall Study|Study terminated|2
8002906|NCT03903822|12600059|FG000|Treatment Phase (6 Weeks)|Adverse Event|3
8002907|NCT03903822|12600060|FG001|Treatment Phase (6 Weeks)|Adverse Event|3
8002908|NCT03903822|12600061|FG002|Treatment Phase (6 Weeks)|Adverse Event|1
8002909|NCT03903822|12600062|FG003|Treatment Phase (6 Weeks)|Adverse Event|1
8002910|NCT03903822|12600063|FG004|Treatment Phase (6 Weeks)|Adverse Event|1
8002911|NCT03903822|12600064|FG005|Treatment Phase (6 Weeks)|Adverse Event|6
8002912|NCT03903822|12600065|FG006|Treatment Phase (6 Weeks)|Adverse Event|1
8002913|NCT03903822|12600066|FG007|Treatment Phase (6 Weeks)|Adverse Event|0
8002914|NCT03903822|12600059|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0
8002915|NCT03903822|12600060|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0
8002916|NCT03903822|12600061|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0
8002917|NCT03903822|12600062|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0
8002918|NCT03903822|12600063|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1
8002919|NCT03903822|12600064|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1
8002920|NCT03903822|12600065|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0
8002921|NCT03903822|12600066|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0
8002922|NCT03903822|12600059|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0
8002923|NCT03903822|12600060|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0
8002924|NCT03903822|12600061|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0
8002925|NCT03903822|12600062|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0
8002926|NCT03903822|12600063|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0
8002927|NCT03903822|12600064|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0
8002928|NCT03903822|12600065|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1
8002929|NCT03903822|12600066|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1
8002930|NCT03903822|12600059|FG000|Treatment Phase (6 Weeks)|Physician Decision|0
8002931|NCT03903822|12600060|FG001|Treatment Phase (6 Weeks)|Physician Decision|2
8002932|NCT03903822|12600061|FG002|Treatment Phase (6 Weeks)|Physician Decision|0
8002933|NCT03903822|12600062|FG003|Treatment Phase (6 Weeks)|Physician Decision|0
8002934|NCT03903822|12600063|FG004|Treatment Phase (6 Weeks)|Physician Decision|0
8002935|NCT03903822|12600064|FG005|Treatment Phase (6 Weeks)|Physician Decision|0
8002936|NCT03903822|12600065|FG006|Treatment Phase (6 Weeks)|Physician Decision|0
8002937|NCT03903822|12600066|FG007|Treatment Phase (6 Weeks)|Physician Decision|0
8002938|NCT03903822|12600059|FG000|Treatment Phase (6 Weeks)|Pregnancy|0
8002939|NCT03903822|12600060|FG001|Treatment Phase (6 Weeks)|Pregnancy|0
8002940|NCT03903822|12600061|FG002|Treatment Phase (6 Weeks)|Pregnancy|0
8002941|NCT03903822|12600062|FG003|Treatment Phase (6 Weeks)|Pregnancy|1
8002942|NCT03903822|12600063|FG004|Treatment Phase (6 Weeks)|Pregnancy|1
8002943|NCT03903822|12600064|FG005|Treatment Phase (6 Weeks)|Pregnancy|0
8002944|NCT03903822|12600065|FG006|Treatment Phase (6 Weeks)|Pregnancy|0
8002945|NCT03903822|12600066|FG007|Treatment Phase (6 Weeks)|Pregnancy|0
8002946|NCT03903822|12600059|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0
8002947|NCT03903822|12600060|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0
8002948|NCT03903822|12600061|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0
8002949|NCT03903822|12600062|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1
8002950|NCT03903822|12600063|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0
8002951|NCT03903822|12600064|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0
8002952|NCT03903822|12600065|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0
8002953|NCT03903822|12600066|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0
8002954|NCT03903822|12600059|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
8002955|NCT03903822|12600060|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4
8002956|NCT03903822|12600061|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
8002957|NCT03903822|12600062|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
8002958|NCT03903822|12600063|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1
8002959|NCT03903822|12600064|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
8002960|NCT03903822|12600065|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3
8002961|NCT03903822|12600066|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3
8002962|NCT03903822|12600059|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2
8002963|NCT03903822|12600060|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0
8002964|NCT03903822|12600061|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0
8002965|NCT03903822|12600062|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0
8002966|NCT03903822|12600063|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0
8002967|NCT03903822|12600064|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1
8002968|NCT03903822|12600065|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0
8002969|NCT03903822|12600066|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0
8002970|NCT03903822|12600059|FG000|Treatment Phase (6 Weeks)|Other|2
8002971|NCT03903822|12600060|FG001|Treatment Phase (6 Weeks)|Other|1
8002972|NCT03903822|12600061|FG002|Treatment Phase (6 Weeks)|Other|0
8002973|NCT03903822|12600062|FG003|Treatment Phase (6 Weeks)|Other|0
8002974|NCT03903822|12600063|FG004|Treatment Phase (6 Weeks)|Other|1
8002975|NCT03903822|12600064|FG005|Treatment Phase (6 Weeks)|Other|1
8002976|NCT03903822|12600065|FG006|Treatment Phase (6 Weeks)|Other|0
8002977|NCT03903822|12600066|FG007|Treatment Phase (6 Weeks)|Other|0
8002978|NCT03903822|12600059|FG000|Follow up Phase (4 Weeks)|Adverse Event|3
8002979|NCT03903822|12600060|FG001|Follow up Phase (4 Weeks)|Adverse Event|2
8002980|NCT03903822|12600061|FG002|Follow up Phase (4 Weeks)|Adverse Event|1
8002981|NCT03903822|12600062|FG003|Follow up Phase (4 Weeks)|Adverse Event|1
8002982|NCT03903822|12600063|FG004|Follow up Phase (4 Weeks)|Adverse Event|0
8002983|NCT03903822|12600064|FG005|Follow up Phase (4 Weeks)|Adverse Event|5
8002984|NCT03903822|12600065|FG006|Follow up Phase (4 Weeks)|Adverse Event|1
8002985|NCT03903822|12600066|FG007|Follow up Phase (4 Weeks)|Adverse Event|0
8002986|NCT03903822|12600059|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0
8002987|NCT03903822|12600060|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0
8002988|NCT03903822|12600061|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0
8002989|NCT03903822|12600062|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0
8002990|NCT03903822|12600063|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1
8002991|NCT03903822|12600064|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0
8002992|NCT03903822|12600065|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0
8002993|NCT03903822|12600066|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0
8002994|NCT03903822|12600059|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2
8002995|NCT03903822|12600060|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0
8002996|NCT03903822|12600061|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0
8002997|NCT03903822|12600062|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0
8002998|NCT03903822|12600063|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0
8002999|NCT03903822|12600064|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0
8003000|NCT03903822|12600065|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1
8003001|NCT03903822|12600066|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3
8003002|NCT03903822|12600059|FG000|Follow up Phase (4 Weeks)|Pregnancy|0
8003003|NCT03903822|12600060|FG001|Follow up Phase (4 Weeks)|Pregnancy|0
8003004|NCT03903822|12600061|FG002|Follow up Phase (4 Weeks)|Pregnancy|0
8003005|NCT03903822|12600062|FG003|Follow up Phase (4 Weeks)|Pregnancy|1
8003006|NCT03903822|12600063|FG004|Follow up Phase (4 Weeks)|Pregnancy|1
8003007|NCT03903822|12600064|FG005|Follow up Phase (4 Weeks)|Pregnancy|0
8003008|NCT03903822|12600065|FG006|Follow up Phase (4 Weeks)|Pregnancy|0
8003009|NCT03903822|12600066|FG007|Follow up Phase (4 Weeks)|Pregnancy|0
8003010|NCT03903822|12600059|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
8003011|NCT03903822|12600060|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5
8003012|NCT03903822|12600061|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
8003013|NCT03903822|12600062|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
8003014|NCT03903822|12600063|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
8003015|NCT03903822|12600064|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
8003016|NCT03903822|12600065|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
8003017|NCT03903822|12600066|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
8003018|NCT03903822|12600059|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
8003019|NCT03903822|12600060|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
8003020|NCT03903822|12600061|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
8003021|NCT03903822|12600062|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
8003022|NCT03903822|12600063|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
8003023|NCT03903822|12600064|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1
8003024|NCT03903822|12600065|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
8003025|NCT03903822|12600066|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
8003026|NCT03903822|12600059|FG000|Follow up Phase (4 Weeks)|Other|1
8003027|NCT03903822|12600060|FG001|Follow up Phase (4 Weeks)|Other|1
8003028|NCT03903822|12600061|FG002|Follow up Phase (4 Weeks)|Other|0
8003029|NCT03903822|12600062|FG003|Follow up Phase (4 Weeks)|Other|0
8003030|NCT03903822|12600063|FG004|Follow up Phase (4 Weeks)|Other|0
8003031|NCT03903822|12600064|FG005|Follow up Phase (4 Weeks)|Other|0
8003032|NCT03903822|12600065|FG006|Follow up Phase (4 Weeks)|Other|0
8003033|NCT03903822|12600066|FG007|Follow up Phase (4 Weeks)|Other|0
8003034|NCT03905096|12600086|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1
8003035|NCT03905096|12600087|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0
8003036|NCT03899064|12600100|FG000|Overall Study|Lost to Follow-up|1
8003037|NCT03899064|12600100|FG000|Overall Study|Protocol Violation|2
8003038|NCT03899064|12600100|FG000|Overall Study|Withdrawal by Subject|2
8003039|NCT03899064|12600100|FG000|Overall Study|Other|2
8003040|NCT03903159|12600104|FG000|Overall Study|Discharged with Staff Approval|2
8003041|NCT03903159|12600104|FG000|Overall Study|Discharged at Staff Request|2
8003042|NCT03903159|12600104|FG000|Overall Study|Discharged Against Staff Advice|1
8003043|NCT03902392|12600110|FG000|Overall Study|Lost to Follow-up|7
8003044|NCT03902392|12600111|FG001|Overall Study|Lost to Follow-up|7
8003045|NCT03900728|12600167|FG000|Overall Study|No text responses|0
8003046|NCT03900728|12600168|FG001|Overall Study|No text responses|0
8003047|NCT03900728|12600169|FG002|Overall Study|No text responses|4
8003048|NCT03895372|12600208|FG000|Investigational Treatment Period|Adverse Event|1
8003049|NCT03895372|12600209|FG001|Investigational Treatment Period|Adverse Event|0
8003050|NCT03895372|12600210|FG002|Investigational Treatment Period|Adverse Event|0
8003051|NCT03895372|12600211|FG003|Investigational Treatment Period|Adverse Event|0
8003052|NCT03895372|12600212|FG004|Investigational Treatment Period|Adverse Event|0
8003053|NCT03895372|12600213|FG005|Investigational Treatment Period|Adverse Event|0
8003054|NCT03895372|12600214|FG006|Investigational Treatment Period|Adverse Event|4
8003055|NCT03895372|12600215|FG007|Investigational Treatment Period|Adverse Event|3
8003056|NCT03895372|12600208|FG000|Investigational Treatment Period|Lack of Efficacy|1
8003057|NCT03895372|12600209|FG001|Investigational Treatment Period|Lack of Efficacy|0
8003058|NCT03895372|12600210|FG002|Investigational Treatment Period|Lack of Efficacy|0
8003059|NCT03895372|12600211|FG003|Investigational Treatment Period|Lack of Efficacy|0
8003060|NCT03895372|12600212|FG004|Investigational Treatment Period|Lack of Efficacy|0
8003061|NCT03895372|12600213|FG005|Investigational Treatment Period|Lack of Efficacy|0
8003062|NCT03895372|12600214|FG006|Investigational Treatment Period|Lack of Efficacy|0
8003063|NCT03895372|12600215|FG007|Investigational Treatment Period|Lack of Efficacy|0
8003064|NCT03895372|12600208|FG000|Investigational Treatment Period|Lost to Follow-up|0
8003065|NCT03895372|12600209|FG001|Investigational Treatment Period|Lost to Follow-up|0
8003066|NCT03895372|12600210|FG002|Investigational Treatment Period|Lost to Follow-up|0
8003067|NCT03895372|12600211|FG003|Investigational Treatment Period|Lost to Follow-up|0
8003068|NCT03895372|12600212|FG004|Investigational Treatment Period|Lost to Follow-up|0
8003069|NCT03895372|12600213|FG005|Investigational Treatment Period|Lost to Follow-up|0
8003070|NCT03895372|12600214|FG006|Investigational Treatment Period|Lost to Follow-up|1
8003071|NCT03895372|12600215|FG007|Investigational Treatment Period|Lost to Follow-up|0
8003072|NCT03895372|12600208|FG000|Investigational Treatment Period|Other|0
8003073|NCT03895372|12600209|FG001|Investigational Treatment Period|Other|0
8003074|NCT03895372|12600210|FG002|Investigational Treatment Period|Other|0
8003075|NCT03895372|12600211|FG003|Investigational Treatment Period|Other|0
8003076|NCT03895372|12600212|FG004|Investigational Treatment Period|Other|0
8003077|NCT03895372|12600213|FG005|Investigational Treatment Period|Other|1
8003078|NCT03895372|12600214|FG006|Investigational Treatment Period|Other|0
8003079|NCT03895372|12600215|FG007|Investigational Treatment Period|Other|2
8003080|NCT03895372|12600208|FG000|Investigational Treatment Period|Protocol Violation|0
8003081|NCT03895372|12600209|FG001|Investigational Treatment Period|Protocol Violation|0
8003082|NCT03895372|12600210|FG002|Investigational Treatment Period|Protocol Violation|0
8003083|NCT03895372|12600211|FG003|Investigational Treatment Period|Protocol Violation|1
8003084|NCT03895372|12600212|FG004|Investigational Treatment Period|Protocol Violation|0
8003085|NCT03895372|12600213|FG005|Investigational Treatment Period|Protocol Violation|0
8003086|NCT03895372|12600214|FG006|Investigational Treatment Period|Protocol Violation|0
8003087|NCT03895372|12600215|FG007|Investigational Treatment Period|Protocol Violation|0
8003088|NCT03895372|12600208|FG000|Investigational Treatment Period|Withdrawal by Subject|2
8003089|NCT03895372|12600209|FG001|Investigational Treatment Period|Withdrawal by Subject|3
8003090|NCT03895372|12600210|FG002|Investigational Treatment Period|Withdrawal by Subject|1
8003091|NCT03895372|12600211|FG003|Investigational Treatment Period|Withdrawal by Subject|1
8003092|NCT03895372|12600212|FG004|Investigational Treatment Period|Withdrawal by Subject|0
8003093|NCT03895372|12600213|FG005|Investigational Treatment Period|Withdrawal by Subject|1
8003094|NCT03895372|12600214|FG006|Investigational Treatment Period|Withdrawal by Subject|3
8003095|NCT03895372|12600215|FG007|Investigational Treatment Period|Withdrawal by Subject|0
8003096|NCT03895372|12600208|FG000|Extension Treatment Period|Adverse Event|0
8003097|NCT03895372|12600209|FG001|Extension Treatment Period|Adverse Event|1
8003098|NCT03895372|12600210|FG002|Extension Treatment Period|Adverse Event|0
8003099|NCT03895372|12600211|FG003|Extension Treatment Period|Adverse Event|1
8003100|NCT03895372|12600212|FG004|Extension Treatment Period|Adverse Event|0
8003101|NCT03895372|12600213|FG005|Extension Treatment Period|Adverse Event|0
8003102|NCT03895372|12600214|FG006|Extension Treatment Period|Adverse Event|3
8003103|NCT03895372|12600215|FG007|Extension Treatment Period|Adverse Event|3
8003104|NCT03895372|12600208|FG000|Extension Treatment Period|Other|1
8003105|NCT03895372|12600209|FG001|Extension Treatment Period|Other|3
8003106|NCT03895372|12600210|FG002|Extension Treatment Period|Other|0
8003107|NCT03895372|12600211|FG003|Extension Treatment Period|Other|0
8003108|NCT03895372|12600212|FG004|Extension Treatment Period|Other|1
8003109|NCT03895372|12600213|FG005|Extension Treatment Period|Other|0
8003110|NCT03895372|12600214|FG006|Extension Treatment Period|Other|0
8003111|NCT03895372|12600215|FG007|Extension Treatment Period|Other|2
8003112|NCT03895372|12600208|FG000|Extension Treatment Period|Pregnancy|0
8003113|NCT03895372|12600209|FG001|Extension Treatment Period|Pregnancy|0
8003114|NCT03895372|12600210|FG002|Extension Treatment Period|Pregnancy|0
8003115|NCT03895372|12600211|FG003|Extension Treatment Period|Pregnancy|0
8003116|NCT03895372|12600212|FG004|Extension Treatment Period|Pregnancy|1
8003117|NCT03895372|12600213|FG005|Extension Treatment Period|Pregnancy|0
8003118|NCT03895372|12600214|FG006|Extension Treatment Period|Pregnancy|0
8003119|NCT03895372|12600215|FG007|Extension Treatment Period|Pregnancy|0
8003120|NCT03895372|12600208|FG000|Extension Treatment Period|Withdrawal by Subject|2
8003121|NCT03895372|12600209|FG001|Extension Treatment Period|Withdrawal by Subject|1
8003122|NCT03895372|12600210|FG002|Extension Treatment Period|Withdrawal by Subject|0
8003123|NCT03895372|12600211|FG003|Extension Treatment Period|Withdrawal by Subject|0
8003124|NCT03895372|12600212|FG004|Extension Treatment Period|Withdrawal by Subject|1
8003125|NCT03895372|12600213|FG005|Extension Treatment Period|Withdrawal by Subject|1
8003126|NCT03895372|12600214|FG006|Extension Treatment Period|Withdrawal by Subject|1
8003127|NCT03895372|12600215|FG007|Extension Treatment Period|Withdrawal by Subject|1
8003128|NCT03896022|12600241|FG000|Overall Study|Withdrawal by Subject|1
8003129|NCT03896022|12600242|FG001|Overall Study|Withdrawal by Subject|0
8003130|NCT03896022|12600243|FG002|Overall Study|Withdrawal by Subject|0
8003131|NCT03896022|12600241|FG000|Overall Study|Did not have procedure|3
8003132|NCT03896022|12600242|FG001|Overall Study|Did not have procedure|0
8003133|NCT03896022|12600243|FG002|Overall Study|Did not have procedure|0
8003134|NCT03891862|12600255|FG000|Open-label Period|Adverse Event|2
8003135|NCT03891862|12600256|FG001|Open-label Period|Adverse Event|0
8003136|NCT03891862|12600257|FG002|Open-label Period|Adverse Event|0
8003137|NCT03891862|12600255|FG000|Open-label Period|Protocol Violation|5
8003138|NCT03891862|12600256|FG001|Open-label Period|Protocol Violation|0
8003139|NCT03891862|12600257|FG002|Open-label Period|Protocol Violation|0
8003140|NCT03891862|12600255|FG000|Open-label Period|Withdrawal by Subject|6
8003141|NCT03891862|12600256|FG001|Open-label Period|Withdrawal by Subject|0
8003142|NCT03891862|12600257|FG002|Open-label Period|Withdrawal by Subject|0
8003143|NCT03891862|12600255|FG000|Open-label Period|Death|1
8003144|NCT03891862|12600256|FG001|Open-label Period|Death|0
8003145|NCT03891862|12600257|FG002|Open-label Period|Death|0
8003146|NCT03891862|12600255|FG000|Open-label Period|Lost to Follow-up|2
8003147|NCT03891862|12600256|FG001|Open-label Period|Lost to Follow-up|0
8003148|NCT03891862|12600257|FG002|Open-label Period|Lost to Follow-up|0
8003149|NCT03891862|12600255|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0
8003150|NCT03891862|12600256|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1
8003151|NCT03891862|12600257|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1
8003152|NCT03891862|12600255|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0
8003153|NCT03891862|12600256|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2
8003154|NCT03891862|12600257|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1
8003155|NCT03891862|12600255|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0
8003156|NCT03891862|12600256|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1
8003157|NCT03891862|12600257|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2
8003158|NCT03891862|12600255|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0
8003159|NCT03891862|12600256|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2
8003160|NCT03891862|12600257|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0
8003161|NCT03892564|12600285|FG000|Overall Study|Withdrawal by Subject|2
8003162|NCT03892707|12600292|FG000|Overall Study|Screen failure|6
8003163|NCT03892707|12600293|FG001|Overall Study|Screen failure|0
8003164|NCT03892707|12600292|FG000|Overall Study|Pain resolution|0
8003165|NCT03892707|12600293|FG001|Overall Study|Pain resolution|4
8003166|NCT03892707|12600292|FG000|Overall Study|Withdrawal by Subject|0
8003167|NCT03892707|12600293|FG001|Overall Study|Withdrawal by Subject|1
8003168|NCT03892707|12600292|FG000|Overall Study|Other (long business trip)|0
8003169|NCT03892707|12600293|FG001|Overall Study|Other (long business trip)|1
8003170|NCT03891641|12600312|FG000|Overall Study|Study Stoppage Due to COVID-19|2
8003171|NCT03891641|12600313|FG001|Overall Study|Study Stoppage Due to COVID-19|2
8003172|NCT03889704|12600319|FG000|Overall Study|Study terminated due to pandemic|1
8003173|NCT03888391|12600333|FG000|Overall Study|Lost to Follow-up|15
8003174|NCT03888482|12600339|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0
8003175|NCT03888482|12600340|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1
8003176|NCT03888482|12600339|FG000|Second Wear (8 -1/+2 Days)|Other|1
8003177|NCT03888482|12600340|FG001|Second Wear (8 -1/+2 Days)|Other|0
8003178|NCT03887442|12600375|FG000|Overall Study|Adverse Event|1
8003179|NCT03887442|12600376|FG001|Overall Study|Adverse Event|0
8003180|NCT03878602|12600400|FG000|Overall Study|cord blood donation|7
8003181|NCT03878602|12600401|FG001|Overall Study|cord blood donation|1
8003182|NCT03878602|12600400|FG000|Overall Study|incomplete data collection|2
8003183|NCT03878602|12600401|FG001|Overall Study|incomplete data collection|0
8003184|NCT03875118|12600411|FG000|Overall Study|Withdrawal by Subject|4
8003185|NCT03875118|12600412|FG001|Overall Study|Withdrawal by Subject|4
8003186|NCT03873987|12600420|FG000|Overall Study|Adverse Event|1
8003187|NCT03873987|12600421|FG001|Overall Study|Adverse Event|0
8003188|NCT03873987|12600420|FG000|Overall Study|staff was unable to start a new IV line|1
8003189|NCT03873987|12600421|FG001|Overall Study|staff was unable to start a new IV line|0
8003190|NCT03873987|12600420|FG000|Overall Study|Lost to Follow-up|0
8003191|NCT03873987|12600421|FG001|Overall Study|Lost to Follow-up|1
8003192|NCT03878758|12600447|FG000|Overall Study|Withdrawal by Subject|1
8003193|NCT03878758|12600447|FG000|Overall Study|Protocol defined|2
8003194|NCT03878758|12600447|FG000|Overall Study|Improper consent documentation|1
8003195|NCT03849300|12600464|FG000|Overall Study|move out to different area|1
8003196|NCT03849300|12600465|FG001|Overall Study|move out to different area|3
8003197|NCT03849300|12600466|FG002|Overall Study|move out to different area|1
8003198|NCT03849300|12600467|FG003|Overall Study|move out to different area|4
8003199|NCT03849300|12600464|FG000|Overall Study|scheduling/transportation conflict|4
8003200|NCT03849300|12600465|FG001|Overall Study|scheduling/transportation conflict|4
8003201|NCT03849300|12600466|FG002|Overall Study|scheduling/transportation conflict|3
8003202|NCT03849300|12600467|FG003|Overall Study|scheduling/transportation conflict|2
8003203|NCT03883113|12600509|FG000|Overall Study|Physician Decision|4
8003204|NCT03883113|12600510|FG001|Overall Study|Physician Decision|2
8003205|NCT03883113|12600509|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9
8003206|NCT03883113|12600510|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7
8003207|NCT03883113|12600509|FG000|Overall Study|Pregnancy|1
8003208|NCT03883113|12600510|FG001|Overall Study|Pregnancy|0
8003209|NCT03883113|12600509|FG000|Overall Study|Adverse Event|0
8003210|NCT03883113|12600510|FG001|Overall Study|Adverse Event|1
8003211|NCT03883113|12600509|FG000|Overall Study|Withdrawal by Subject|1
8003212|NCT03883113|12600510|FG001|Overall Study|Withdrawal by Subject|2
8003213|NCT03883113|12600509|FG000|Overall Study|Lost to Follow-up|1
8003214|NCT03883113|12600510|FG001|Overall Study|Lost to Follow-up|0
8003215|NCT03880227|12600532|FG000|First Visit|Withdrawal by Subject|1
8003216|NCT03880227|12600533|FG001|First Visit|Withdrawal by Subject|0
8003217|NCT03880227|12600534|FG002|First Visit|Withdrawal by Subject|0
8003218|NCT03880227|12600535|FG003|First Visit|Withdrawal by Subject|0
8003219|NCT03880227|12600532|FG000|1 Week Washout/ Delay|Lost to Follow-up|0
8003220|NCT03880227|12600533|FG001|1 Week Washout/ Delay|Lost to Follow-up|1
8003221|NCT03880227|12600534|FG002|1 Week Washout/ Delay|Lost to Follow-up|0
8003222|NCT03880227|12600535|FG003|1 Week Washout/ Delay|Lost to Follow-up|0
8003223|NCT03880227|12600532|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0
8003224|NCT03880227|12600533|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0
8003225|NCT03880227|12600534|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2
8003226|NCT03880227|12600535|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0
8003227|NCT03880227|12600532|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
8003228|NCT03880227|12600533|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
8003229|NCT03880227|12600534|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1
8003230|NCT03880227|12600535|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
8003231|NCT03876743|12600549|FG000|Overall Study|Lost to Follow-up|6
8003232|NCT03876743|12600550|FG001|Overall Study|Lost to Follow-up|4
8003233|NCT03876743|12600551|FG002|Overall Study|Lost to Follow-up|4
8003234|NCT03876743|12600552|FG003|Overall Study|Lost to Follow-up|7
8003235|NCT03885934|12600572|FG000|Overall Study|Withdrawn by Parent/Guardian|1
8003236|NCT03885934|12600573|FG001|Overall Study|Withdrawn by Parent/Guardian|0
8003237|NCT03885934|12600574|FG002|Overall Study|Withdrawn by Parent/Guardian|0
8003238|NCT03885934|12600575|FG003|Overall Study|Withdrawn by Parent/Guardian|0
8003239|NCT03885934|12600576|FG004|Overall Study|Withdrawn by Parent/Guardian|0
8003240|NCT03885934|12600577|FG005|Overall Study|Withdrawn by Parent/Guardian|0
8003241|NCT03885726|12600591|FG000|Overall Study|Staffing issues/lost interest|1
8003242|NCT03885726|12600591|FG000|Overall Study|Early discharge from hospital|3
7718373|NCT00527787|12142341|FG001|Overall Study|Lost to Follow-up|2
7718374|NCT00527787|12142340|FG000|Overall Study|Duodenal Ulcer|1
7718375|NCT00527787|12142341|FG001|Overall Study|Duodenal Ulcer|10
7718376|NCT00527787|12142340|FG000|Overall Study|misc|5
7718377|NCT00527787|12142341|FG001|Overall Study|misc|2
8003243|NCT03883386|12600616|FG000|First Assignment|Lost to Follow-up|1
8003244|NCT03883386|12600617|FG001|First Assignment|Lost to Follow-up|0
8003245|NCT03883386|12600616|FG000|First Assignment|Withdrawal by Subject|1
8003246|NCT03883386|12600617|FG001|First Assignment|Withdrawal by Subject|1
8003247|NCT03882801|12600629|FG000|Period 1|Adverse Event|0
8003248|NCT03882801|12600630|FG001|Period 1|Adverse Event|1
8003249|NCT03882801|12600629|FG000|Period 1|Non-compliance with study drug|1
8003250|NCT03882801|12600630|FG001|Period 1|Non-compliance with study drug|1
8003251|NCT03882801|12600629|FG000|Period 1|Never treated with study drug|1
8003252|NCT03882801|12600630|FG001|Period 1|Never treated with study drug|0
8003253|NCT03882801|12600629|FG000|Washout Period|Physician Decision|0
8003254|NCT03882801|12600630|FG001|Washout Period|Physician Decision|1
8003255|NCT03882801|12600629|FG000|Period 2|Non-compliance with study drug|0
8003256|NCT03882801|12600630|FG001|Period 2|Non-compliance with study drug|1
8003257|NCT03882424|12600641|FG000|Overall Study|Lost to Follow-up|3
8003258|NCT03882424|12600642|FG001|Overall Study|Lost to Follow-up|0
8003259|NCT03882424|12600643|FG002|Overall Study|Lost to Follow-up|0
8003260|NCT03882424|12600641|FG000|Overall Study|schedule conflict|1
8003261|NCT03882424|12600642|FG001|Overall Study|schedule conflict|0
8003262|NCT03882424|12600643|FG002|Overall Study|schedule conflict|0
8003263|NCT03880266|12600676|FG000|Overall Study|Withdrawal by Subject|0
8003264|NCT03880266|12600677|FG001|Overall Study|Withdrawal by Subject|1
8003265|NCT03880266|12600678|FG002|Overall Study|Withdrawal by Subject|1
8003266|NCT03880266|12600679|FG003|Overall Study|Withdrawal by Subject|0
8003267|NCT03880266|12600680|FG004|Overall Study|Withdrawal by Subject|0
8003268|NCT03880266|12600681|FG005|Overall Study|Withdrawal by Subject|0
8003269|NCT03880266|12600682|FG006|Overall Study|Withdrawal by Subject|0
8003270|NCT03880266|12600683|FG007|Overall Study|Withdrawal by Subject|0
8003271|NCT03878160|12600726|FG000|Overall Study|Lost to Follow-up|1
8003272|NCT03878160|12600727|FG001|Overall Study|Lost to Follow-up|1
8003273|NCT03878160|12600728|FG002|Overall Study|Lost to Follow-up|1
8003274|NCT03878160|12600726|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1
8003275|NCT03878160|12600727|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0
8003276|NCT03878160|12600728|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0
8003277|NCT03864627|12600738|FG000|Overall Study|Adverse Event|0
8003278|NCT03864627|12600739|FG001|Overall Study|Adverse Event|1
8003279|NCT03864627|12600738|FG000|Overall Study|Lack of Efficacy|0
8003280|NCT03864627|12600739|FG001|Overall Study|Lack of Efficacy|1
8003281|NCT03864627|12600738|FG000|Overall Study|Lost to Follow-up|0
8003282|NCT03864627|12600739|FG001|Overall Study|Lost to Follow-up|1
8003283|NCT03864627|12600738|FG000|Overall Study|Withdrawal by Subject|4
8003284|NCT03864627|12600739|FG001|Overall Study|Withdrawal by Subject|8
8003285|NCT03864627|12600738|FG000|Overall Study|Study terminated by sponsor|0
8003286|NCT03864627|12600739|FG001|Overall Study|Study terminated by sponsor|1
8003287|NCT03848403|12600754|FG000|Period 2 (Day 8)|Adverse Event|1
8003288|NCT03848403|12600755|FG001|Period 2 (Day 8)|Adverse Event|2
8003289|NCT03848403|12600756|FG002|Period 2 (Day 8)|Adverse Event|2
8003290|NCT03848403|12600754|FG000|Period 2 (Day 8)|Physician Decision|0
8003291|NCT03848403|12600755|FG001|Period 2 (Day 8)|Physician Decision|1
8003292|NCT03848403|12600756|FG002|Period 2 (Day 8)|Physician Decision|0
8003293|NCT03848403|12600754|FG000|Period 2 (Day 8)|Sponsor Decision|8
8003294|NCT03848403|12600755|FG001|Period 2 (Day 8)|Sponsor Decision|6
8003295|NCT03848403|12600756|FG002|Period 2 (Day 8)|Sponsor Decision|5
8003296|NCT03878108|12600823|FG000|Overall Study|Adverse Event|1
8003297|NCT03878108|12600824|FG001|Overall Study|Adverse Event|0
8003298|NCT03877237|12600840|FG000|Overall Study|Adverse Event|1
8003299|NCT03877237|12600841|FG001|Overall Study|Adverse Event|2
8003300|NCT03877237|12600840|FG000|Overall Study|Death|3
8003301|NCT03877237|12600841|FG001|Overall Study|Death|2
8003302|NCT03877237|12600840|FG000|Overall Study|Physician Decision|1
8003303|NCT03877237|12600841|FG001|Overall Study|Physician Decision|0
8003304|NCT03877237|12600840|FG000|Overall Study|Withdrawal by Subject|0
8003305|NCT03877237|12600841|FG001|Overall Study|Withdrawal by Subject|2
8003306|NCT03859323|12600870|FG000|Overall Study|Lost to Follow-up|0
8003307|NCT03859323|12600871|FG001|Overall Study|Lost to Follow-up|0
8003308|NCT03859323|12600872|FG002|Overall Study|Lost to Follow-up|0
8003309|NCT03859323|12600873|FG003|Overall Study|Lost to Follow-up|0
8003310|NCT03859323|12600874|FG004|Overall Study|Lost to Follow-up|0
8003311|NCT03859323|12600875|FG005|Overall Study|Lost to Follow-up|0
8003312|NCT03859323|12600876|FG006|Overall Study|Lost to Follow-up|1
8003313|NCT03859323|12600877|FG007|Overall Study|Lost to Follow-up|0
8003314|NCT03859323|12600878|FG008|Overall Study|Lost to Follow-up|0
8003315|NCT03859323|12600879|FG009|Overall Study|Lost to Follow-up|0
8003316|NCT03859323|12600880|FG010|Overall Study|Lost to Follow-up|0
8003317|NCT03859323|12600881|FG011|Overall Study|Lost to Follow-up|0
8003318|NCT03859323|12600882|FG012|Overall Study|Lost to Follow-up|0
8003319|NCT03859323|12600870|FG000|Overall Study|Withdrawal by Subject|0
8003320|NCT03859323|12600871|FG001|Overall Study|Withdrawal by Subject|0
8003321|NCT03859323|12600872|FG002|Overall Study|Withdrawal by Subject|1
8003322|NCT03859323|12600873|FG003|Overall Study|Withdrawal by Subject|0
8003323|NCT03859323|12600874|FG004|Overall Study|Withdrawal by Subject|0
8003324|NCT03859323|12600875|FG005|Overall Study|Withdrawal by Subject|1
8003325|NCT03859323|12600876|FG006|Overall Study|Withdrawal by Subject|0
8003326|NCT03859323|12600877|FG007|Overall Study|Withdrawal by Subject|0
8003327|NCT03859323|12600878|FG008|Overall Study|Withdrawal by Subject|0
8003328|NCT03859323|12600879|FG009|Overall Study|Withdrawal by Subject|1
8003329|NCT03859323|12600880|FG010|Overall Study|Withdrawal by Subject|1
8003330|NCT03859323|12600881|FG011|Overall Study|Withdrawal by Subject|2
8003331|NCT03859323|12600882|FG012|Overall Study|Withdrawal by Subject|1
8003332|NCT03859323|12600870|FG000|Overall Study|Pregnancy|0
8003333|NCT03859323|12600871|FG001|Overall Study|Pregnancy|0
8003334|NCT03859323|12600872|FG002|Overall Study|Pregnancy|0
8003335|NCT03859323|12600873|FG003|Overall Study|Pregnancy|0
8003336|NCT03859323|12600874|FG004|Overall Study|Pregnancy|0
8003337|NCT03859323|12600875|FG005|Overall Study|Pregnancy|0
8003338|NCT03859323|12600876|FG006|Overall Study|Pregnancy|0
8003339|NCT03859323|12600877|FG007|Overall Study|Pregnancy|0
8003340|NCT03859323|12600878|FG008|Overall Study|Pregnancy|0
8003341|NCT03859323|12600879|FG009|Overall Study|Pregnancy|1
8003342|NCT03859323|12600880|FG010|Overall Study|Pregnancy|0
8003343|NCT03859323|12600881|FG011|Overall Study|Pregnancy|0
8003344|NCT03859323|12600882|FG012|Overall Study|Pregnancy|0
8003345|NCT03875508|12600947|FG000|Overall Study|Adverse Event|1
8003346|NCT03875508|12600947|FG000|Overall Study|Lost to Follow-up|8
8003347|NCT03875508|12600947|FG000|Overall Study|Lack of Efficacy|1
8003348|NCT03875508|12600947|FG000|Overall Study|Other, not specified|2
8003349|NCT03869333|12600955|FG000|Overall Study|Lost to Follow-up|1
8003350|NCT03869333|12600956|FG001|Overall Study|Lost to Follow-up|0
8003351|NCT03869333|12600957|FG002|Overall Study|Lost to Follow-up|0
8003352|NCT03869333|12600958|FG003|Overall Study|Lost to Follow-up|0
8003353|NCT03869333|12600955|FG000|Overall Study|Pregnancy|1
8003354|NCT03869333|12600956|FG001|Overall Study|Pregnancy|0
8003355|NCT03869333|12600957|FG002|Overall Study|Pregnancy|0
8003356|NCT03869333|12600958|FG003|Overall Study|Pregnancy|0
8003357|NCT03869333|12600955|FG000|Overall Study|Physician Decision|0
8003358|NCT03869333|12600956|FG001|Overall Study|Physician Decision|1
8003359|NCT03869333|12600957|FG002|Overall Study|Physician Decision|0
8003360|NCT03869333|12600958|FG003|Overall Study|Physician Decision|0
8003361|NCT03864900|12600970|FG000|Overall Study|Withdrawal by Subject|1
8003362|NCT03864900|12600971|FG001|Overall Study|Withdrawal by Subject|1
8003363|NCT03864900|12600970|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2
8003364|NCT03864900|12600971|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5
8003365|NCT03875482|12600996|FG000|Overall Study|Adverse Event|0
8003366|NCT03875482|12600997|FG001|Overall Study|Adverse Event|1
8003367|NCT03875482|12600996|FG000|Overall Study|Withdrew consent|5
8003368|NCT03875482|12600997|FG001|Overall Study|Withdrew consent|6
8003369|NCT03875482|12600996|FG000|Overall Study|Lost to Follow-up|8
8003370|NCT03875482|12600997|FG001|Overall Study|Lost to Follow-up|2
8003371|NCT03875482|12600996|FG000|Overall Study|Lack of Efficacy|0
8003372|NCT03875482|12600997|FG001|Overall Study|Lack of Efficacy|11
8003373|NCT03874013|12601015|FG000|Overall Study|Adverse Event|0
8003374|NCT03874013|12601016|FG001|Overall Study|Adverse Event|1
8003375|NCT03873116|12601025|FG000|Overall Study|Study drug discontinuation due to rash|0
8003376|NCT03873116|12601026|FG001|Overall Study|Study drug discontinuation due to rash|0
8003377|NCT03873116|12601027|FG002|Overall Study|Study drug discontinuation due to rash|1
8003378|NCT03872843|12601037|FG000|Overall Study|Lost to Follow-up|5
8003379|NCT03872843|12601038|FG001|Overall Study|Lost to Follow-up|7
8003380|NCT03870997|12601050|FG000|Overall Study|Did not complete mid-study/final survey|10544
8003381|NCT03870997|12601051|FG001|Overall Study|Did not complete mid-study/final survey|10431
8003382|NCT03870997|12601052|FG002|Overall Study|Did not complete mid-study/final survey|10978
8003383|NCT03870997|12601053|FG003|Overall Study|Did not complete mid-study/final survey|10947
8003384|NCT03870997|12601054|FG004|Overall Study|Did not complete mid-study/final survey|10588
8003385|NCT03870997|12601055|FG005|Overall Study|Did not complete mid-study/final survey|10531
8003386|NCT03869684|12601067|FG000|Overall Study|Adverse Event|0
8003387|NCT03869684|12601068|FG001|Overall Study|Adverse Event|3
8003388|NCT03869684|12601069|FG002|Overall Study|Adverse Event|1
8003389|NCT03869684|12601067|FG000|Overall Study|Withdrawal by Subject|1
8003390|NCT03869684|12601068|FG001|Overall Study|Withdrawal by Subject|0
8003391|NCT03869684|12601069|FG002|Overall Study|Withdrawal by Subject|0
8003392|NCT03869684|12601067|FG000|Overall Study|Lost to Follow-up|1
8003393|NCT03869684|12601068|FG001|Overall Study|Lost to Follow-up|0
8003394|NCT03869684|12601069|FG002|Overall Study|Lost to Follow-up|0
8003395|NCT03869684|12601067|FG000|Overall Study|Study prematurely terminated by sponsor|0
8003396|NCT03869684|12601068|FG001|Overall Study|Study prematurely terminated by sponsor|0
8003397|NCT03869684|12601069|FG002|Overall Study|Study prematurely terminated by sponsor|2
8003398|NCT03848416|12601123|FG000|Overall Study|Withdrawal by Subject|1
8003399|NCT03848416|12601124|FG001|Overall Study|Withdrawal by Subject|0
8003400|NCT03848416|12601125|FG002|Overall Study|Withdrawal by Subject|0
8003401|NCT03848416|12601123|FG000|Overall Study|Death|0
8003402|NCT03848416|12601124|FG001|Overall Study|Death|0
8003403|NCT03848416|12601125|FG002|Overall Study|Death|1
8003404|NCT03847987|12601135|FG000|Overall Study|Lost to Follow-up|1
8003405|NCT03847987|12601136|FG001|Overall Study|Lost to Follow-up|0
8003406|NCT03847987|12601135|FG000|Overall Study|Adverse Event|2
8003407|NCT03847987|12601136|FG001|Overall Study|Adverse Event|0
8003408|NCT03853551|12601198|FG000|Overall Study|Death|2
8003409|NCT03853551|12601198|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7
8003410|NCT03870555|12601205|FG000|Period 3 (2 Days)|Adverse Event|1
8003411|NCT03870555|12601206|FG001|Period 3 (2 Days)|Adverse Event|0
8003412|NCT03870555|12601207|FG002|Period 3 (2 Days)|Adverse Event|0
8003413|NCT03851094|12601233|FG000|Overall Study|Withdrawal by Subject|0
8003414|NCT03851094|12601234|FG001|Overall Study|Withdrawal by Subject|1
8003415|NCT03851094|12601233|FG000|Overall Study|Participant lost device|0
8003416|NCT03851094|12601234|FG001|Overall Study|Participant lost device|1
8003417|NCT03851094|12601233|FG000|Overall Study|Participant returned device|0
8003418|NCT03851094|12601234|FG001|Overall Study|Participant returned device|2
8003419|NCT03868631|12601244|FG000|Baseline to Week 6|Adverse Event|0
8003420|NCT03868631|12601245|FG001|Baseline to Week 6|Adverse Event|3
8003421|NCT03868631|12601244|FG000|Baseline to Week 6|Protocol Violation|1
8003422|NCT03868631|12601245|FG001|Baseline to Week 6|Protocol Violation|1
8003423|NCT03868631|12601244|FG000|Baseline to Week 6|Withdrawal by Subject|3
8003424|NCT03868631|12601245|FG001|Baseline to Week 6|Withdrawal by Subject|0
8003425|NCT03868631|12601244|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2
8003426|NCT03868631|12601245|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0
8003427|NCT03868631|12601244|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1
8003428|NCT03868631|12601245|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0
8003429|NCT03868631|12601244|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
8003430|NCT03868631|12601245|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
8003431|NCT03865953|12601253|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2
8003432|NCT03865953|12601254|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0
8003433|NCT03865953|12601253|FG000|First Intervention (4 Weeks)|Protocol Violation|0
8003434|NCT03865953|12601254|FG001|First Intervention (4 Weeks)|Protocol Violation|1
8003435|NCT03865953|12601253|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0
8003436|NCT03865953|12601254|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2
8003437|NCT03865381|12601260|FG000|Overall Study|Protocol Violation/Non-Compliance|3
8003438|NCT03865381|12601260|FG000|Overall Study|Withdrawal by Subject|2
8003439|NCT03868059|12601288|FG000|Overall Study|Adverse Event|3
8003440|NCT03868059|12601288|FG000|Overall Study|Lost to Follow-up|3
8003441|NCT03868059|12601288|FG000|Overall Study|Withdrawal by Subject|6
8003442|NCT03865407|12601303|FG000|Overall Study|Adverse Event|1
8003443|NCT03865407|12601304|FG001|Overall Study|Adverse Event|0
8003444|NCT03865407|12601303|FG000|Overall Study|Withdrawal by Subject|1
8003445|NCT03865407|12601304|FG001|Overall Study|Withdrawal by Subject|0
8003446|NCT03865407|12601303|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1
8003447|NCT03865407|12601304|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0
8003448|NCT03864653|12601323|FG000|Overall Study|Withdrawal by Subject|1
8003449|NCT03853213|12601340|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1
8003450|NCT03853213|12601341|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0
8003451|NCT03853213|12601340|FG000|Overall Study|Other (e.g., too busy)|0
8003452|NCT03853213|12601341|FG001|Overall Study|Other (e.g., too busy)|2
8003453|NCT03847610|12601347|FG000|Overall Study|Withdrawal by Subject|1
8003454|NCT03850093|12601354|FG000|Overall Study|Withdrawal by Subject|1
8003455|NCT03850093|12601355|FG001|Overall Study|Withdrawal by Subject|0
8003456|NCT03850093|12601356|FG002|Overall Study|Withdrawal by Subject|2
8003457|NCT03861936|12601437|FG000|Overall Study|Withdrawal by Subject|4
8003458|NCT03861936|12601438|FG001|Overall Study|Withdrawal by Subject|1
8003459|NCT03861936|12601439|FG002|Overall Study|Withdrawal by Subject|3
8003460|NCT03861936|12601437|FG000|Overall Study|Lost to Follow-up|5
8003461|NCT03861936|12601438|FG001|Overall Study|Lost to Follow-up|3
8003462|NCT03861936|12601439|FG002|Overall Study|Lost to Follow-up|3
8003463|NCT03861936|12601437|FG000|Overall Study|Physician Decision|0
8003464|NCT03861936|12601438|FG001|Overall Study|Physician Decision|1
8003465|NCT03861936|12601439|FG002|Overall Study|Physician Decision|0
8003466|NCT03861936|12601437|FG000|Overall Study|Protocol Deviation|0
8003467|NCT03861936|12601438|FG001|Overall Study|Protocol Deviation|0
8003468|NCT03861936|12601439|FG002|Overall Study|Protocol Deviation|1
8003469|NCT03861936|12601437|FG000|Overall Study|Reason not Specified|5
8003470|NCT03861936|12601438|FG001|Overall Study|Reason not Specified|5
8003471|NCT03861936|12601439|FG002|Overall Study|Reason not Specified|3
8003472|NCT03850509|12601479|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2
8003473|NCT03850509|12601480|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1
8003474|NCT03851016|12601565|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
8003475|NCT03851016|12601566|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2
8003476|NCT03850496|12601575|FG000|Overall Study|Withdrawal by Subject|1
8003477|NCT03850496|12601576|FG001|Overall Study|Withdrawal by Subject|0
8003478|NCT03850496|12601577|FG002|Overall Study|Withdrawal by Subject|0
8003479|NCT03850496|12601575|FG000|Overall Study|Lost to Follow-up|0
8003480|NCT03850496|12601576|FG001|Overall Study|Lost to Follow-up|1
8003481|NCT03850496|12601577|FG002|Overall Study|Lost to Follow-up|4
8003482|NCT03848949|12601587|FG000|Overall Study|Lost to Follow-up|5
8003483|NCT03848949|12601588|FG001|Overall Study|Lost to Follow-up|7
8003484|NCT03844945|12601616|FG000|Overall Study|Adverse Event|1
8003485|NCT03844945|12601617|FG001|Overall Study|Adverse Event|1
8003486|NCT03844945|12601618|FG002|Overall Study|Adverse Event|4
8003487|NCT03844945|12601619|FG003|Overall Study|Adverse Event|0
8003488|NCT03844945|12601616|FG000|Overall Study|Withdrawal by Subject|0
8003489|NCT03844945|12601617|FG001|Overall Study|Withdrawal by Subject|0
8003490|NCT03844945|12601618|FG002|Overall Study|Withdrawal by Subject|1
8003491|NCT03844945|12601619|FG003|Overall Study|Withdrawal by Subject|0
8003492|NCT03844945|12601616|FG000|Overall Study|Lack of Efficacy|0
8003493|NCT03844945|12601617|FG001|Overall Study|Lack of Efficacy|0
8003494|NCT03844945|12601618|FG002|Overall Study|Lack of Efficacy|0
8003495|NCT03844945|12601619|FG003|Overall Study|Lack of Efficacy|1
8003496|NCT03843632|12601642|FG000|Overall Study|Withdrawal by Subject|1
8003497|NCT03843632|12601643|FG001|Overall Study|Withdrawal by Subject|0
8003498|NCT03843632|12601644|FG002|Overall Study|Withdrawal by Subject|0
8003499|NCT03843632|12601645|FG003|Overall Study|Withdrawal by Subject|0
8003500|NCT03840811|12601658|FG000|Overall Study|Lost to Follow-up|0
8003501|NCT03840811|12601659|FG001|Overall Study|Lost to Follow-up|0
8003502|NCT03840811|12601660|FG002|Overall Study|Lost to Follow-up|1
8003503|NCT03837028|12601672|FG000|Overall Study|Lost to Follow-up|4
8003504|NCT03837028|12601673|FG001|Overall Study|Lost to Follow-up|0
8003505|NCT03837028|12601674|FG002|Overall Study|Lost to Follow-up|2
8003506|NCT03837028|12601675|FG003|Overall Study|Lost to Follow-up|0
8003507|NCT03837028|12601672|FG000|Overall Study|Withdrawal by Subject|12
8003508|NCT03837028|12601673|FG001|Overall Study|Withdrawal by Subject|11
8003509|NCT03837028|12601674|FG002|Overall Study|Withdrawal by Subject|11
8003510|NCT03837028|12601675|FG003|Overall Study|Withdrawal by Subject|7
8003511|NCT03841331|12601718|FG000|Overall Study|Withdrawal by Subject|4
8003512|NCT03841331|12601719|FG001|Overall Study|Withdrawal by Subject|9
8003513|NCT03841331|12601718|FG000|Overall Study|Lost to Follow-up|5
8003514|NCT03841331|12601719|FG001|Overall Study|Lost to Follow-up|1
8003515|NCT03840135|12601734|FG000|Overall Study|Protocol Violation|6
8003516|NCT03840135|12601735|FG001|Overall Study|Protocol Violation|1
8003517|NCT03840135|12601734|FG000|Overall Study|Withdrawal by Subject|1
8003518|NCT03840135|12601735|FG001|Overall Study|Withdrawal by Subject|0
8003519|NCT03839641|12601747|FG000|Overall Study|Withdrawal by Subject|1
8003520|NCT03839641|12601748|FG001|Overall Study|Withdrawal by Subject|1
8003521|NCT03839212|12601756|FG000|Overall Study|COVID-19 related suspension of research activities.|4
8003522|NCT03839355|12601762|FG000|Overall Study|Withdrawal by Subject|1
8003523|NCT03839355|12601763|FG001|Overall Study|Withdrawal by Subject|0
8003524|NCT03838731|12601780|FG000|Overall Study|Pregnancy|0
8003525|NCT03838731|12601781|FG001|Overall Study|Pregnancy|1
8003526|NCT03838731|12601780|FG000|Overall Study|Withdrawal of consent|1
8003527|NCT03838731|12601781|FG001|Overall Study|Withdrawal of consent|0
8003528|NCT03838198|12601789|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
8003529|NCT03838198|12601790|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
8003530|NCT03838198|12601791|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1
8003531|NCT03838198|12601792|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
8003532|NCT03838198|12601789|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0
8003533|NCT03838198|12601790|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22
8003534|NCT03838198|12601791|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0
8003535|NCT03838198|12601792|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22
8003536|NCT03836677|12601911|FG000|Period 1|Adverse Event|0
8003537|NCT03836677|12601912|FG001|Period 1|Adverse Event|1
8003538|NCT03836677|12601911|FG000|Period 2|Severe non-compliance to protocol|1
8003539|NCT03836677|12601912|FG001|Period 2|Severe non-compliance to protocol|0
8003540|NCT03827564|12601932|FG000|Overall Study|Discontinued due to Study Termination|1
8003541|NCT03827564|12601933|FG001|Overall Study|Discontinued due to Study Termination|0
8003542|NCT03824236|12601942|FG000|Overall Study|Lost to Follow-up|0
8003543|NCT03824236|12601943|FG001|Overall Study|Lost to Follow-up|0
8003544|NCT03824236|12601944|FG002|Overall Study|Lost to Follow-up|1
8003545|NCT03810235|12601965|FG000|Overall Study|Withdrawal by Subject|2
8003546|NCT03810235|12601966|FG001|Overall Study|Withdrawal by Subject|0
8003547|NCT03836664|12601985|FG000|Overall Study|Didn't complete forms and lost drug|3
8003548|NCT03836664|12601986|FG001|Overall Study|Didn't complete forms and lost drug|3
8003549|NCT03832738|12601999|FG000|Overall Study|Withdrawal by Subject|6
8003550|NCT03832738|12602000|FG001|Overall Study|Withdrawal by Subject|7
8003551|NCT03832738|12602001|FG002|Overall Study|Withdrawal by Subject|16
8003552|NCT03832738|12601999|FG000|Overall Study|Physician Decision|0
8003553|NCT03832738|12602000|FG001|Overall Study|Physician Decision|1
8003554|NCT03832738|12602001|FG002|Overall Study|Physician Decision|2
8003555|NCT03832738|12601999|FG000|Overall Study|Adverse Event|2
8003556|NCT03832738|12602000|FG001|Overall Study|Adverse Event|3
8003557|NCT03832738|12602001|FG002|Overall Study|Adverse Event|1
8003558|NCT03832738|12601999|FG000|Overall Study|Pregnancy|0
8003559|NCT03832738|12602000|FG001|Overall Study|Pregnancy|1
8003560|NCT03832738|12602001|FG002|Overall Study|Pregnancy|0
8003561|NCT03823391|12602011|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1
8003562|NCT03823391|12602012|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1
8003563|NCT03823391|12602011|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1
8003564|NCT03823391|12602012|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0
8003565|NCT03808298|12602034|FG000|Overall Study|Adverse Event|3
8003566|NCT03808298|12602034|FG000|Overall Study|Physician Decision|1
8003567|NCT03808298|12602034|FG000|Overall Study|Withdrawal by Subject|1
8003568|NCT03808298|12602034|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3
8003569|NCT03836729|12602063|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1
8003570|NCT03835975|12602076|FG000|Overall Study|Lost to Follow-up|1
8003571|NCT03835975|12602077|FG001|Overall Study|Lost to Follow-up|1
8003572|NCT03835975|12602078|FG002|Overall Study|Lost to Follow-up|0
8003573|NCT03835975|12602079|FG003|Overall Study|Lost to Follow-up|0
8003574|NCT03835975|12602080|FG004|Overall Study|Lost to Follow-up|0
8003575|NCT03835975|12602076|FG000|Overall Study|No longer met eligibility criteria|0
8003576|NCT03835975|12602077|FG001|Overall Study|No longer met eligibility criteria|1
8003577|NCT03835975|12602078|FG002|Overall Study|No longer met eligibility criteria|0
8003578|NCT03835975|12602079|FG003|Overall Study|No longer met eligibility criteria|0
8003579|NCT03835975|12602080|FG004|Overall Study|No longer met eligibility criteria|0
8003580|NCT03835975|12602076|FG000|Overall Study|Protocol Violation|1
8003581|NCT03835975|12602077|FG001|Overall Study|Protocol Violation|1
8003582|NCT03835975|12602078|FG002|Overall Study|Protocol Violation|2
8003583|NCT03835975|12602079|FG003|Overall Study|Protocol Violation|0
8003584|NCT03835975|12602080|FG004|Overall Study|Protocol Violation|0
8003585|NCT03835975|12602076|FG000|Overall Study|Withdrawal by Subject|1
8003586|NCT03835975|12602077|FG001|Overall Study|Withdrawal by Subject|0
8003587|NCT03835975|12602078|FG002|Overall Study|Withdrawal by Subject|1
8003588|NCT03835975|12602079|FG003|Overall Study|Withdrawal by Subject|1
8003589|NCT03835975|12602080|FG004|Overall Study|Withdrawal by Subject|0
8003590|NCT03835221|12602126|FG000|Methafilcon A|Withdrawal by Subject|1
8003591|NCT03819634|12602132|FG000|Overall Study|Physician Decision|2
8003592|NCT03812679|12602136|FG000|Overall Study|Adverse Event|2
8003593|NCT03812679|12602136|FG000|Overall Study|Missed >4 consecutive therapy days|1
8003594|NCT03812679|12602136|FG000|Overall Study|Renal transplant|1
8003595|NCT03812679|12602136|FG000|Overall Study|Withdrawal by Subject|1
8003596|NCT03812679|12602136|FG000|Overall Study|Termination of study|2
8003597|NCT03812679|12602136|FG000|Overall Study|Water device replacement|1
8003598|NCT03801148|12602191|FG000|Period 1 (2 Days)|Adverse Event|1
8003599|NCT03801148|12602192|FG001|Period 1 (2 Days)|Adverse Event|1
8003600|NCT03801148|12602193|FG002|Period 1 (2 Days)|Adverse Event|0
8003601|NCT03801148|12602194|FG003|Period 1 (2 Days)|Adverse Event|0
8003602|NCT03801148|12602191|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0
8003603|NCT03801148|12602192|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0
8003604|NCT03801148|12602193|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0
8003605|NCT03801148|12602194|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1
8003606|NCT03801148|12602191|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
8003607|NCT03801148|12602192|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
8003608|NCT03801148|12602193|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
8003609|NCT03801148|12602194|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
8003610|NCT03801148|12602191|FG000|Follow-Up (12 Days)|Lost to Follow-up|0
8003611|NCT03801148|12602192|FG001|Follow-Up (12 Days)|Lost to Follow-up|1
8003612|NCT03801148|12602193|FG002|Follow-Up (12 Days)|Lost to Follow-up|1
8003613|NCT03801148|12602194|FG003|Follow-Up (12 Days)|Lost to Follow-up|0
8003614|NCT03832322|12602210|FG000|Overall Study|Failed cecal intubation in 2nd exam|3
8003615|NCT03832322|12602211|FG001|Overall Study|Failed cecal intubation in 2nd exam|1
8003616|NCT03832387|12602221|FG000|Overall Study|Protocol Violation|2
8003617|NCT03832387|12602222|FG001|Overall Study|Protocol Violation|6
8003618|NCT03832387|12602221|FG000|Overall Study|EXCLUSION CRITERIA|3
8003619|NCT03832387|12602222|FG001|Overall Study|EXCLUSION CRITERIA|1
8003620|NCT03807739|12602245|FG000|Overall Study|Adverse Event|1
8003621|NCT03807739|12602246|FG001|Overall Study|Adverse Event|0
8003622|NCT03807739|12602247|FG002|Overall Study|Adverse Event|0
8003623|NCT03807739|12602248|FG003|Overall Study|Adverse Event|0
8003624|NCT03807739|12602245|FG000|Overall Study|Withdrawal by Subject|1
8003625|NCT03807739|12602246|FG001|Overall Study|Withdrawal by Subject|0
8003626|NCT03807739|12602247|FG002|Overall Study|Withdrawal by Subject|0
8003627|NCT03807739|12602248|FG003|Overall Study|Withdrawal by Subject|0
8003628|NCT03831282|12602258|FG000|Overall Study|Could not place sensor|1
8003629|NCT03824912|12602265|FG000|Overall Study|Lost to Follow-up|18
8003630|NCT03824912|12602266|FG001|Overall Study|Lost to Follow-up|15
8003631|NCT03824912|12602267|FG002|Overall Study|Lost to Follow-up|8
8003632|NCT03824912|12602265|FG000|Overall Study|Negative Baseline Culture Result|118
8003633|NCT03824912|12602266|FG001|Overall Study|Negative Baseline Culture Result|112
8003634|NCT03824912|12602267|FG002|Overall Study|Negative Baseline Culture Result|57
8003635|NCT03824912|12602265|FG000|Overall Study|Non-Compliance with Study Drug|0
8003636|NCT03824912|12602266|FG001|Overall Study|Non-Compliance with Study Drug|0
8003637|NCT03824912|12602267|FG002|Overall Study|Non-Compliance with Study Drug|1
8003638|NCT03824912|12602265|FG000|Overall Study|Protocol Violation|1
8003639|NCT03824912|12602266|FG001|Overall Study|Protocol Violation|4
8003640|NCT03824912|12602267|FG002|Overall Study|Protocol Violation|1
8003641|NCT03824912|12602265|FG000|Overall Study|Withdrawal by Subject|3
8003642|NCT03824912|12602266|FG001|Overall Study|Withdrawal by Subject|2
8003643|NCT03824912|12602267|FG002|Overall Study|Withdrawal by Subject|1
8003644|NCT03824912|12602265|FG000|Overall Study|Participation in another study|0
8003645|NCT03824912|12602266|FG001|Overall Study|Participation in another study|1
8003646|NCT03824912|12602267|FG002|Overall Study|Participation in another study|0
8003647|NCT03822884|12602281|FG000|Overall Study|Withdrawal by Subject|0
8003648|NCT03822884|12602282|FG001|Overall Study|Withdrawal by Subject|0
8003649|NCT03822884|12602283|FG002|Overall Study|Withdrawal by Subject|0
8003650|NCT03822884|12602284|FG003|Overall Study|Withdrawal by Subject|0
8003651|NCT03822884|12602285|FG004|Overall Study|Withdrawal by Subject|1
8003652|NCT03822884|12602286|FG005|Overall Study|Withdrawal by Subject|0
8003653|NCT03810014|12602302|FG000|Overall Study|Pregnancy|2
8003654|NCT03810014|12602303|FG001|Overall Study|Pregnancy|2
8003655|NCT03810014|12602304|FG002|Overall Study|Pregnancy|0
8003656|NCT03810014|12602305|FG003|Overall Study|Pregnancy|2
8003657|NCT03830892|12602330|FG000|Overall Study|Physician Decision|2
8003658|NCT03830892|12602331|FG001|Overall Study|Physician Decision|3
8003659|NCT03830892|12602330|FG000|Overall Study|Study terminated due to COVID|4
8003660|NCT03830892|12602331|FG001|Overall Study|Study terminated due to COVID|0
8003661|NCT03830892|12602330|FG000|Overall Study|Protocol Violation|0
8003662|NCT03830892|12602331|FG001|Overall Study|Protocol Violation|1
8003663|NCT03830892|12602330|FG000|Overall Study|Withdrawal by Subject|0
8003664|NCT03830892|12602331|FG001|Overall Study|Withdrawal by Subject|2
8003665|NCT03825042|12602343|FG000|Overall Study|Adverse Event|1
8003666|NCT03825042|12602344|FG001|Overall Study|Adverse Event|0
8003667|NCT03825042|12602343|FG000|Overall Study|Withdrawal by Subject|1
8003668|NCT03825042|12602344|FG001|Overall Study|Withdrawal by Subject|0
8003669|NCT03823378|12602356|FG000|Overall Study|Adverse Event|2
8003670|NCT03823378|12602357|FG001|Overall Study|Adverse Event|2
8003671|NCT03823378|12602358|FG002|Overall Study|Adverse Event|0
8003672|NCT03823378|12602359|FG003|Overall Study|Adverse Event|0
8003673|NCT03823378|12602360|FG004|Overall Study|Adverse Event|0
8003674|NCT03823378|12602361|FG005|Overall Study|Adverse Event|0
8003675|NCT03823378|12602356|FG000|Overall Study|Lost to Follow-up|0
8003676|NCT03823378|12602357|FG001|Overall Study|Lost to Follow-up|1
8003677|NCT03823378|12602358|FG002|Overall Study|Lost to Follow-up|0
8003678|NCT03823378|12602359|FG003|Overall Study|Lost to Follow-up|0
8003679|NCT03823378|12602360|FG004|Overall Study|Lost to Follow-up|1
8003680|NCT03823378|12602361|FG005|Overall Study|Lost to Follow-up|0
8003681|NCT03823378|12602356|FG000|Overall Study|Withdrawal by Subject|0
8003682|NCT03823378|12602357|FG001|Overall Study|Withdrawal by Subject|1
8003683|NCT03823378|12602358|FG002|Overall Study|Withdrawal by Subject|4
8003684|NCT03823378|12602359|FG003|Overall Study|Withdrawal by Subject|2
8003685|NCT03823378|12602360|FG004|Overall Study|Withdrawal by Subject|0
8003686|NCT03823378|12602361|FG005|Overall Study|Withdrawal by Subject|1
8003687|NCT03823378|12602356|FG000|Overall Study|Other, not specified|19
8003688|NCT03823378|12602357|FG001|Overall Study|Other, not specified|12
8003689|NCT03823378|12602358|FG002|Overall Study|Other, not specified|6
8003690|NCT03823378|12602359|FG003|Overall Study|Other, not specified|8
8003691|NCT03823378|12602360|FG004|Overall Study|Other, not specified|17
8003692|NCT03823378|12602361|FG005|Overall Study|Other, not specified|7
8003693|NCT03831191|12602379|FG000|Induction Period (16 Weeks)|Adverse Event|2
8003694|NCT03831191|12602380|FG001|Induction Period (16 Weeks)|Adverse Event|1
8003695|NCT03831191|12602381|FG002|Induction Period (16 Weeks)|Adverse Event|3
8003696|NCT03831191|12602382|FG003|Induction Period (16 Weeks)|Adverse Event|4
8003697|NCT03831191|12602383|FG004|Induction Period (16 Weeks)|Adverse Event|0
8003698|NCT03831191|12602384|FG005|Induction Period (16 Weeks)|Adverse Event|0
8003699|NCT03831191|12602385|FG006|Induction Period (16 Weeks)|Adverse Event|0
8003700|NCT03831191|12602386|FG007|Induction Period (16 Weeks)|Adverse Event|0
8003701|NCT03831191|12602387|FG008|Induction Period (16 Weeks)|Adverse Event|0
8003702|NCT03831191|12602388|FG009|Induction Period (16 Weeks)|Adverse Event|0
8003703|NCT03831191|12602389|FG010|Induction Period (16 Weeks)|Adverse Event|0
8003704|NCT03831191|12602390|FG011|Induction Period (16 Weeks)|Adverse Event|0
8003705|NCT03831191|12602391|FG012|Induction Period (16 Weeks)|Adverse Event|0
8003706|NCT03831191|12602392|FG013|Induction Period (16 Weeks)|Adverse Event|0
8003707|NCT03831191|12602393|FG014|Induction Period (16 Weeks)|Adverse Event|0
8003708|NCT03831191|12602379|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2
8003709|NCT03831191|12602380|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3
8003710|NCT03831191|12602381|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0
8003711|NCT03831191|12602382|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0
8003712|NCT03831191|12602383|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0
8003713|NCT03831191|12602384|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0
8003714|NCT03831191|12602385|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0
8003715|NCT03831191|12602386|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0
8003716|NCT03831191|12602387|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0
8003717|NCT03831191|12602388|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0
8003718|NCT03831191|12602389|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0
8003719|NCT03831191|12602390|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0
8003720|NCT03831191|12602391|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0
8003721|NCT03831191|12602392|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0
8003722|NCT03831191|12602393|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0
8003723|NCT03831191|12602379|FG000|Induction Period (16 Weeks)|Pregnancy|0
8003724|NCT03831191|12602380|FG001|Induction Period (16 Weeks)|Pregnancy|0
8003725|NCT03831191|12602381|FG002|Induction Period (16 Weeks)|Pregnancy|1
8003726|NCT03831191|12602382|FG003|Induction Period (16 Weeks)|Pregnancy|0
8003727|NCT03831191|12602383|FG004|Induction Period (16 Weeks)|Pregnancy|0
8003728|NCT03831191|12602384|FG005|Induction Period (16 Weeks)|Pregnancy|0
8003729|NCT03831191|12602385|FG006|Induction Period (16 Weeks)|Pregnancy|0
8003730|NCT03831191|12602386|FG007|Induction Period (16 Weeks)|Pregnancy|0
7718378|NCT00527826|12142349|FG000|Overall Study|Adverse Event|10
8003731|NCT03831191|12602387|FG008|Induction Period (16 Weeks)|Pregnancy|0
8003732|NCT03831191|12602388|FG009|Induction Period (16 Weeks)|Pregnancy|0
8003733|NCT03831191|12602389|FG010|Induction Period (16 Weeks)|Pregnancy|0
8003734|NCT03831191|12602390|FG011|Induction Period (16 Weeks)|Pregnancy|0
8003735|NCT03831191|12602391|FG012|Induction Period (16 Weeks)|Pregnancy|0
8003736|NCT03831191|12602392|FG013|Induction Period (16 Weeks)|Pregnancy|0
8003737|NCT03831191|12602393|FG014|Induction Period (16 Weeks)|Pregnancy|0
8003738|NCT03831191|12602379|FG000|Induction Period (16 Weeks)|Protocol Violation|0
8003739|NCT03831191|12602380|FG001|Induction Period (16 Weeks)|Protocol Violation|0
8003740|NCT03831191|12602381|FG002|Induction Period (16 Weeks)|Protocol Violation|0
8003741|NCT03831191|12602382|FG003|Induction Period (16 Weeks)|Protocol Violation|2
8003742|NCT03831191|12602383|FG004|Induction Period (16 Weeks)|Protocol Violation|0
8003743|NCT03831191|12602384|FG005|Induction Period (16 Weeks)|Protocol Violation|0
8003744|NCT03831191|12602385|FG006|Induction Period (16 Weeks)|Protocol Violation|0
8003745|NCT03831191|12602386|FG007|Induction Period (16 Weeks)|Protocol Violation|0
8003746|NCT03831191|12602387|FG008|Induction Period (16 Weeks)|Protocol Violation|0
8003747|NCT03831191|12602388|FG009|Induction Period (16 Weeks)|Protocol Violation|0
8003748|NCT03831191|12602389|FG010|Induction Period (16 Weeks)|Protocol Violation|0
8003749|NCT03831191|12602390|FG011|Induction Period (16 Weeks)|Protocol Violation|0
8003750|NCT03831191|12602391|FG012|Induction Period (16 Weeks)|Protocol Violation|0
8003751|NCT03831191|12602392|FG013|Induction Period (16 Weeks)|Protocol Violation|0
8003752|NCT03831191|12602393|FG014|Induction Period (16 Weeks)|Protocol Violation|0
8003753|NCT03831191|12602379|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7
8003754|NCT03831191|12602380|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2
8003755|NCT03831191|12602381|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1
8003756|NCT03831191|12602382|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3
8003757|NCT03831191|12602383|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
8003758|NCT03831191|12602384|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
8003759|NCT03831191|12602385|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
8003760|NCT03831191|12602386|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
8003761|NCT03831191|12602387|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0
8003762|NCT03831191|12602388|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0
8003763|NCT03831191|12602389|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0
8003764|NCT03831191|12602390|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0
8003765|NCT03831191|12602391|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0
8003766|NCT03831191|12602392|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0
8003767|NCT03831191|12602393|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0
8003768|NCT03831191|12602379|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12
8003769|NCT03831191|12602380|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15
8003770|NCT03831191|12602381|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16
8003771|NCT03831191|12602382|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13
8003772|NCT03831191|12602383|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
8003773|NCT03831191|12602384|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
8003774|NCT03831191|12602385|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
8003775|NCT03831191|12602386|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
8003776|NCT03831191|12602387|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
8003777|NCT03831191|12602388|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
8003778|NCT03831191|12602389|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
8003779|NCT03831191|12602390|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
8003780|NCT03831191|12602391|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
8003781|NCT03831191|12602392|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
8003782|NCT03831191|12602393|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
8003783|NCT03831191|12602379|FG000|Induction Period (16 Weeks)|Sponsor Decision|0
8003784|NCT03831191|12602380|FG001|Induction Period (16 Weeks)|Sponsor Decision|0
8003785|NCT03831191|12602381|FG002|Induction Period (16 Weeks)|Sponsor Decision|0
8003786|NCT03831191|12602382|FG003|Induction Period (16 Weeks)|Sponsor Decision|1
8003787|NCT03831191|12602383|FG004|Induction Period (16 Weeks)|Sponsor Decision|0
8003788|NCT03831191|12602384|FG005|Induction Period (16 Weeks)|Sponsor Decision|0
8003789|NCT03831191|12602385|FG006|Induction Period (16 Weeks)|Sponsor Decision|0
8003790|NCT03831191|12602386|FG007|Induction Period (16 Weeks)|Sponsor Decision|0
8003791|NCT03831191|12602387|FG008|Induction Period (16 Weeks)|Sponsor Decision|0
8003792|NCT03831191|12602388|FG009|Induction Period (16 Weeks)|Sponsor Decision|0
8003793|NCT03831191|12602389|FG010|Induction Period (16 Weeks)|Sponsor Decision|0
8003794|NCT03831191|12602390|FG011|Induction Period (16 Weeks)|Sponsor Decision|0
8003795|NCT03831191|12602391|FG012|Induction Period (16 Weeks)|Sponsor Decision|0
8003796|NCT03831191|12602392|FG013|Induction Period (16 Weeks)|Sponsor Decision|0
8003797|NCT03831191|12602393|FG014|Induction Period (16 Weeks)|Sponsor Decision|0
8003798|NCT03831191|12602379|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
8003799|NCT03831191|12602380|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
8003800|NCT03831191|12602381|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
8003801|NCT03831191|12602382|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
8003802|NCT03831191|12602383|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
8003803|NCT03831191|12602384|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5
8003804|NCT03831191|12602385|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2
8003805|NCT03831191|12602386|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
8003806|NCT03831191|12602387|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8
8003807|NCT03831191|12602388|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
8003808|NCT03831191|12602389|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
8003809|NCT03831191|12602390|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7
8003810|NCT03831191|12602391|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
8003811|NCT03831191|12602392|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
8003812|NCT03831191|12602393|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6
8003813|NCT03831191|12602379|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
8003814|NCT03831191|12602380|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
8003815|NCT03831191|12602381|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
8003816|NCT03831191|12602382|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
8003817|NCT03831191|12602383|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
8003818|NCT03831191|12602384|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
8003819|NCT03831191|12602385|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
8003820|NCT03831191|12602386|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
8003821|NCT03831191|12602387|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
8003822|NCT03831191|12602388|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
8003823|NCT03831191|12602389|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
8003824|NCT03831191|12602390|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
8003825|NCT03831191|12602391|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
8003826|NCT03831191|12602392|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
8003827|NCT03831191|12602393|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
8003828|NCT03831191|12602379|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0
8003829|NCT03831191|12602380|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0
8003830|NCT03831191|12602381|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0
8003831|NCT03831191|12602382|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0
8003832|NCT03831191|12602383|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0
8003833|NCT03831191|12602384|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0
8003834|NCT03831191|12602385|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0
8003835|NCT03831191|12602386|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0
8003836|NCT03831191|12602387|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0
8003837|NCT03831191|12602388|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0
8003838|NCT03831191|12602389|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0
8003839|NCT03831191|12602390|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0
8003840|NCT03831191|12602391|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0
8003841|NCT03831191|12602392|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0
8003842|NCT03831191|12602393|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1
8003843|NCT03830281|12602428|FG000|Lead-in Period (2 Weeks)|Adverse Event|2
8003844|NCT03830281|12602429|FG001|Lead-in Period (2 Weeks)|Adverse Event|0
8003845|NCT03830281|12602428|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6
8003846|NCT03830281|12602429|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0
8003847|NCT03830281|12602428|FG000|Lead-in Period (2 Weeks)|Physician Decision|2
8003848|NCT03830281|12602429|FG001|Lead-in Period (2 Weeks)|Physician Decision|0
8003849|NCT03830281|12602428|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29
8003850|NCT03830281|12602429|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0
8003851|NCT03830281|12602428|FG000|Treatment Period (16 Weeks)|Adverse Event|1
8003852|NCT03830281|12602429|FG001|Treatment Period (16 Weeks)|Adverse Event|7
8003853|NCT03830281|12602428|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4
8003854|NCT03830281|12602429|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3
8003855|NCT03830281|12602428|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1
8003856|NCT03830281|12602429|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1
8003857|NCT03830281|12602428|FG000|Treatment Period (16 Weeks)|Physician Decision|1
8003858|NCT03830281|12602429|FG001|Treatment Period (16 Weeks)|Physician Decision|0
8003859|NCT03830281|12602428|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5
8003860|NCT03830281|12602429|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6
8003861|NCT03827395|12602445|FG000|Overall Study|Lost to Follow-up|1
8003862|NCT03827395|12602446|FG001|Overall Study|Lost to Follow-up|0
8003863|NCT03827395|12602445|FG000|Overall Study|Protocol Violation|1
8003864|NCT03827395|12602446|FG001|Overall Study|Protocol Violation|0
8003865|NCT03827395|12602445|FG000|Overall Study|Became ineligible after enrollment|1
8003866|NCT03827395|12602446|FG001|Overall Study|Became ineligible after enrollment|2
8003867|NCT03819218|12602452|FG000|Overall Study|Protocol Violation|1
8003868|NCT03828487|12602465|FG000|Overall Study|Physician Decision|1
8003869|NCT03828617|12602473|FG000|Overall Study|Lost to Follow-up|22
8003870|NCT03828617|12602474|FG001|Overall Study|Lost to Follow-up|12
8003871|NCT03828617|12602475|FG002|Overall Study|Lost to Follow-up|23
8003872|NCT03828617|12602476|FG003|Overall Study|Lost to Follow-up|7
8003873|NCT03828617|12602473|FG000|Overall Study|No longer met eligibility criteria|0
8003874|NCT03828617|12602474|FG001|Overall Study|No longer met eligibility criteria|1
8003875|NCT03828617|12602475|FG002|Overall Study|No longer met eligibility criteria|1
8003876|NCT03828617|12602476|FG003|Overall Study|No longer met eligibility criteria|3
8003877|NCT03828617|12602473|FG000|Overall Study|Protocol Violation|0
8003878|NCT03828617|12602474|FG001|Overall Study|Protocol Violation|2
8003879|NCT03828617|12602475|FG002|Overall Study|Protocol Violation|0
8003880|NCT03828617|12602476|FG003|Overall Study|Protocol Violation|0
8003881|NCT03828617|12602473|FG000|Overall Study|Withdrawal by Subject|2
8003882|NCT03828617|12602474|FG001|Overall Study|Withdrawal by Subject|0
8003883|NCT03828617|12602475|FG002|Overall Study|Withdrawal by Subject|2
8003884|NCT03828617|12602476|FG003|Overall Study|Withdrawal by Subject|0
8003885|NCT03828539|12602487|FG000|Overall Study|Adverse Event|3
8003886|NCT03828539|12602488|FG001|Overall Study|Adverse Event|12
8003887|NCT03828539|12602487|FG000|Overall Study|Patient's/guardian's decision|3
8003888|NCT03828539|12602488|FG001|Overall Study|Patient's/guardian's decision|5
8003889|NCT03828539|12602487|FG000|Overall Study|Lost to Follow-up|4
8003890|NCT03828539|12602488|FG001|Overall Study|Lost to Follow-up|2
8003891|NCT03828539|12602487|FG000|Overall Study|Protocol Violation|3
8003892|NCT03828539|12602488|FG001|Overall Study|Protocol Violation|2
8003893|NCT03828539|12602487|FG000|Overall Study|Withdrawal of informed consent|2
8003894|NCT03828539|12602488|FG001|Overall Study|Withdrawal of informed consent|1
8003895|NCT03828539|12602487|FG000|Overall Study|New therapy for study indication|1
8003896|NCT03828539|12602488|FG001|Overall Study|New therapy for study indication|0
8003897|NCT03824704|12602494|FG000|Overall Study|Study Terminated by Sponsor|1
8003898|NCT03817879|12602509|FG000|Overall Study|Drop out|5
8003899|NCT03817879|12602510|FG001|Overall Study|Drop out|12
8003900|NCT03817879|12602509|FG000|Overall Study|Withdrawal by Subject|0
8003901|NCT03817879|12602510|FG001|Overall Study|Withdrawal by Subject|1
8003902|NCT03811834|12602516|FG000|Period 1 ( 7 Days)|Adverse Event|1
8003903|NCT03806127|12602531|FG000|Overall Study|Withdrawal by Subject|4
8003904|NCT03806127|12602532|FG001|Overall Study|Withdrawal by Subject|5
8003905|NCT03806127|12602531|FG000|Overall Study|Protocol Violation|3
8003906|NCT03806127|12602532|FG001|Overall Study|Protocol Violation|1
8003907|NCT03806127|12602531|FG000|Overall Study|Adverse Event|3
8003908|NCT03806127|12602532|FG001|Overall Study|Adverse Event|0
8003909|NCT03806127|12602531|FG000|Overall Study|Unable to Complete Procedures|0
8003910|NCT03806127|12602532|FG001|Overall Study|Unable to Complete Procedures|1
8003911|NCT03806127|12602531|FG000|Overall Study|Pregnancy|0
8003912|NCT03806127|12602532|FG001|Overall Study|Pregnancy|1
8003913|NCT03806127|12602531|FG000|Overall Study|Lost to Follow-up|5
8003914|NCT03806127|12602532|FG001|Overall Study|Lost to Follow-up|1
8003915|NCT03806127|12602531|FG000|Overall Study|Physician Decision|1
8003916|NCT03806127|12602532|FG001|Overall Study|Physician Decision|1
8003917|NCT03806127|12602531|FG000|Overall Study|Could Not Come Due to Covid|1
8003918|NCT03806127|12602532|FG001|Overall Study|Could Not Come Due to Covid|0
8003919|NCT03806127|12602531|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1
8003920|NCT03806127|12602532|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0
8003921|NCT03806127|12602531|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1
8003922|NCT03806127|12602532|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0
8003923|NCT03806127|12602531|FG000|Overall Study|Covid 19 Restrictions|2
8003924|NCT03806127|12602532|FG001|Overall Study|Covid 19 Restrictions|0
8003925|NCT03806127|12602531|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0
8003926|NCT03806127|12602532|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1
8003927|NCT03806127|12602531|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0
8003928|NCT03806127|12602532|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1
8003929|NCT03827473|12602540|FG000|Overall Study|Withdrawal by Subject|1
8003930|NCT03827473|12602541|FG001|Overall Study|Withdrawal by Subject|0
8003931|NCT03826914|12602549|FG000|Overall Study|Withdrawal by Subject|1
8003932|NCT03826914|12602550|FG001|Overall Study|Withdrawal by Subject|1
8003933|NCT03808688|12602573|FG000|Overall Study|Adverse Event|13
8003934|NCT03808688|12602574|FG001|Overall Study|Adverse Event|17
8003935|NCT03808688|12602573|FG000|Overall Study|Lack of Efficacy|2
8003936|NCT03808688|12602574|FG001|Overall Study|Lack of Efficacy|0
8003937|NCT03808688|12602573|FG000|Overall Study|Lost to Follow-up|0
8003938|NCT03808688|12602574|FG001|Overall Study|Lost to Follow-up|2
8003939|NCT03808688|12602573|FG000|Overall Study|Withdrawal by Subject|1
8003940|NCT03808688|12602574|FG001|Overall Study|Withdrawal by Subject|0
8003941|NCT03808688|12602573|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1
8003942|NCT03808688|12602574|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0
8003943|NCT03808688|12602573|FG000|Overall Study|IOP Too High|1
8003944|NCT03808688|12602574|FG001|Overall Study|IOP Too High|1
8003945|NCT03808688|12602573|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0
8003946|NCT03808688|12602574|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1
8003947|NCT03808688|12602573|FG000|Overall Study|Visit Out of Window|0
8003948|NCT03808688|12602574|FG001|Overall Study|Visit Out of Window|1
8003949|NCT03808688|12602573|FG000|Overall Study|Medication Non-Compliance|0
8003950|NCT03808688|12602574|FG001|Overall Study|Medication Non-Compliance|1
8003951|NCT03822182|12602585|FG000|Overall Study|Protocol Violation|0
8003952|NCT03822182|12602586|FG001|Overall Study|Protocol Violation|1
8003953|NCT03822182|12602587|FG002|Overall Study|Protocol Violation|1
8003954|NCT03822416|12602598|FG000|Overall Study|Lost to Follow-up|1
8003955|NCT03822416|12602599|FG001|Overall Study|Lost to Follow-up|0
8003956|NCT03822416|12602598|FG000|Overall Study|Withdrawal by Subject|0
8003957|NCT03822416|12602599|FG001|Overall Study|Withdrawal by Subject|1
8003958|NCT03809104|12602605|FG000|Overall Study|Withdrawal by Subject|3
8003959|NCT03806231|12602620|FG000|Overall Study|Physician Decision|1
8003960|NCT03806231|12602621|FG001|Overall Study|Physician Decision|0
8003961|NCT03806231|12602620|FG000|Overall Study|Withdrawal by Subject|1
8003962|NCT03806231|12602621|FG001|Overall Study|Withdrawal by Subject|0
8003963|NCT03804710|12602629|FG000|Overall Study|Adverse Event|0
8003964|NCT03804710|12602630|FG001|Overall Study|Adverse Event|3
8003965|NCT03804710|12602629|FG000|Overall Study|Withdrawal by Subject|2
8003966|NCT03804710|12602630|FG001|Overall Study|Withdrawal by Subject|1
8003967|NCT03804710|12602629|FG000|Overall Study|Other|0
8003968|NCT03804710|12602630|FG001|Overall Study|Other|1
8003969|NCT03821064|12602674|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1
8003970|NCT03820024|12602689|FG000|Overall Study|Physician Decision|1
8003971|NCT03820024|12602690|FG001|Overall Study|Physician Decision|2
8003972|NCT03816761|12602715|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0
8003973|NCT03816761|12602716|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0
8003974|NCT03816761|12602717|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0
8003975|NCT03816761|12602718|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0
8003976|NCT03816761|12602719|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0
8003977|NCT03816761|12602720|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1
8003978|NCT03816761|12602715|FG000|Second Treatment Period (7 Days)|Unclassified|0
8003979|NCT03816761|12602716|FG001|Second Treatment Period (7 Days)|Unclassified|0
8003980|NCT03816761|12602717|FG002|Second Treatment Period (7 Days)|Unclassified|0
8003981|NCT03816761|12602718|FG003|Second Treatment Period (7 Days)|Unclassified|1
8003982|NCT03816761|12602719|FG004|Second Treatment Period (7 Days)|Unclassified|0
8003983|NCT03816761|12602720|FG005|Second Treatment Period (7 Days)|Unclassified|0
8003984|NCT03812510|12602785|FG000|Overall Study|Lost to Follow-up|39
8003985|NCT03812510|12602785|FG000|Overall Study|Withdrawal by Subject|42
8003986|NCT03812510|12602785|FG000|Overall Study|Physician Decision|2
8003987|NCT03812510|12602785|FG000|Overall Study|Study Terminated by Sponsor|9
8003988|NCT03812510|12602785|FG000|Overall Study|Did Not Start Study Medication|55
8003989|NCT03812510|12602785|FG000|Overall Study|Adverse Event|5
8003990|NCT03802994|12602795|FG000|Overall Study|Lost to Follow-up|0
8003991|NCT03802994|12602796|FG001|Overall Study|Lost to Follow-up|2
8003992|NCT03802994|12602797|FG002|Overall Study|Lost to Follow-up|3
8003993|NCT03802994|12602798|FG003|Overall Study|Lost to Follow-up|2
8003994|NCT03802994|12602799|FG004|Overall Study|Lost to Follow-up|2
8003995|NCT03810183|12602824|FG000|Overall Study|Study terminated by Sponsor|2
8003996|NCT03810183|12602825|FG001|Overall Study|Study terminated by Sponsor|1
8003997|NCT03805971|12602865|FG000|Overall Study|Withdrawal by Subject|1
8003998|NCT03805971|12602865|FG000|Overall Study|Protocol Violation|2
8003999|NCT03802916|12602872|FG000|Overall Study|Adverse Event|0
8004000|NCT03802916|12602873|FG001|Overall Study|Adverse Event|1
8004001|NCT03802916|12602872|FG000|Overall Study|Withdrawal by Subject|0
8004002|NCT03802916|12602873|FG001|Overall Study|Withdrawal by Subject|1
8004003|NCT03809039|12602890|FG000|Part 1|Withdrawal by Subject|1
8004004|NCT03809039|12602891|FG001|Part 1|Withdrawal by Subject|0
8004005|NCT03809039|12602892|FG002|Part 1|Withdrawal by Subject|0
8004006|NCT03809039|12602893|FG003|Part 1|Withdrawal by Subject|1
8004007|NCT03809039|12602894|FG004|Part 1|Withdrawal by Subject|0
8004008|NCT03809039|12602895|FG005|Part 1|Withdrawal by Subject|0
8004009|NCT03809039|12602896|FG006|Part 1|Withdrawal by Subject|0
8004010|NCT03809039|12602897|FG007|Part 1|Withdrawal by Subject|0
8004011|NCT03809039|12602898|FG008|Part 1|Withdrawal by Subject|0
8004012|NCT03809039|12602890|FG000|Part 3|Withdrawn by study termination|0
8004013|NCT03809039|12602891|FG001|Part 3|Withdrawn by study termination|0
8004014|NCT03809039|12602892|FG002|Part 3|Withdrawn by study termination|0
8004015|NCT03809039|12602893|FG003|Part 3|Withdrawn by study termination|0
8004016|NCT03809039|12602894|FG004|Part 3|Withdrawn by study termination|0
8004017|NCT03809039|12602895|FG005|Part 3|Withdrawn by study termination|0
8004018|NCT03809039|12602896|FG006|Part 3|Withdrawn by study termination|0
8004019|NCT03809039|12602897|FG007|Part 3|Withdrawn by study termination|2
8004020|NCT03809039|12602898|FG008|Part 3|Withdrawn by study termination|6
8004021|NCT03807700|12602933|FG000|Overall Study|Withdrawal by Subject|2
8004022|NCT03807700|12602934|FG001|Overall Study|Withdrawal by Subject|1
8004023|NCT03804918|12602941|FG000|Overall Study|Participant did not use the app|1
8004024|NCT03803475|12602957|FG000|Overall Study|Physician Decision|1
8004025|NCT03801928|12603010|FG000|Overall Study|Adverse Event|1
8004026|NCT03801928|12603011|FG001|Overall Study|Adverse Event|0
8004027|NCT03801928|12603012|FG002|Overall Study|Adverse Event|1
8004028|NCT03801928|12603013|FG003|Overall Study|Adverse Event|2
8004029|NCT03801928|12603014|FG004|Overall Study|Adverse Event|0
8004030|NCT03801928|12603015|FG005|Overall Study|Adverse Event|2
8004031|NCT03801928|12603010|FG000|Overall Study|Lack of Efficacy|0
8004032|NCT03801928|12603011|FG001|Overall Study|Lack of Efficacy|0
8004033|NCT03801928|12603012|FG002|Overall Study|Lack of Efficacy|1
8004034|NCT03801928|12603013|FG003|Overall Study|Lack of Efficacy|0
8004035|NCT03801928|12603014|FG004|Overall Study|Lack of Efficacy|0
8004036|NCT03801928|12603015|FG005|Overall Study|Lack of Efficacy|0
8004037|NCT03801928|12603010|FG000|Overall Study|Lost to Follow-up|5
8004038|NCT03801928|12603011|FG001|Overall Study|Lost to Follow-up|1
8004039|NCT03801928|12603012|FG002|Overall Study|Lost to Follow-up|1
8004040|NCT03801928|12603013|FG003|Overall Study|Lost to Follow-up|4
8004041|NCT03801928|12603014|FG004|Overall Study|Lost to Follow-up|4
8004042|NCT03801928|12603015|FG005|Overall Study|Lost to Follow-up|2
8004043|NCT03801928|12603010|FG000|Overall Study|Withdrawal by Subject|0
8004044|NCT03801928|12603011|FG001|Overall Study|Withdrawal by Subject|0
8004045|NCT03801928|12603012|FG002|Overall Study|Withdrawal by Subject|2
8004046|NCT03801928|12603013|FG003|Overall Study|Withdrawal by Subject|1
8004047|NCT03801928|12603014|FG004|Overall Study|Withdrawal by Subject|0
8004048|NCT03801928|12603015|FG005|Overall Study|Withdrawal by Subject|0
8004049|NCT03801928|12603010|FG000|Overall Study|Other|0
8004050|NCT03801928|12603011|FG001|Overall Study|Other|2
8004051|NCT03801928|12603012|FG002|Overall Study|Other|0
8004052|NCT03801928|12603013|FG003|Overall Study|Other|1
8004053|NCT03801928|12603014|FG004|Overall Study|Other|0
8004054|NCT03801928|12603015|FG005|Overall Study|Other|1
8004055|NCT03800173|12603037|FG000|Overall Study|Lost to Follow-up|0
8004056|NCT03800173|12603038|FG001|Overall Study|Lost to Follow-up|0
8004057|NCT03800173|12603039|FG002|Overall Study|Lost to Follow-up|0
8004058|NCT03800173|12603040|FG003|Overall Study|Lost to Follow-up|0
8004059|NCT03800173|12603041|FG004|Overall Study|Lost to Follow-up|1
8004060|NCT03799211|12603076|FG000|Overall Study|Lost to Follow-up|2
8004061|NCT03799211|12603077|FG001|Overall Study|Lost to Follow-up|13
8004062|NCT03799211|12603076|FG000|Overall Study|Withdrawal by Subject|2
8004063|NCT03799211|12603077|FG001|Overall Study|Withdrawal by Subject|0
8004064|NCT03798717|12603091|FG000|Overall Study|Failed Screening|0
8004065|NCT03798717|12603092|FG001|Overall Study|Failed Screening|0
8004066|NCT03798717|12603093|FG002|Overall Study|Failed Screening|0
8004067|NCT03798717|12603094|FG003|Overall Study|Failed Screening|0
8004068|NCT03798717|12603095|FG004|Overall Study|Failed Screening|0
8004069|NCT03798717|12603096|FG005|Overall Study|Failed Screening|1
8004070|NCT03798717|12603091|FG000|Overall Study|Physician Decision|1
8004071|NCT03798717|12603092|FG001|Overall Study|Physician Decision|0
8004072|NCT03798717|12603093|FG002|Overall Study|Physician Decision|1
8004073|NCT03798717|12603094|FG003|Overall Study|Physician Decision|0
8004074|NCT03798717|12603095|FG004|Overall Study|Physician Decision|0
8004075|NCT03798717|12603096|FG005|Overall Study|Physician Decision|0
8004076|NCT03798717|12603091|FG000|Overall Study|Withdrawal by Subject|0
8004077|NCT03798717|12603092|FG001|Overall Study|Withdrawal by Subject|0
8004078|NCT03798717|12603093|FG002|Overall Study|Withdrawal by Subject|0
8004079|NCT03798717|12603094|FG003|Overall Study|Withdrawal by Subject|1
8004080|NCT03798717|12603095|FG004|Overall Study|Withdrawal by Subject|0
8004081|NCT03798717|12603096|FG005|Overall Study|Withdrawal by Subject|0
8004082|NCT03798717|12603091|FG000|Overall Study|Lost to Follow-up|1
8004083|NCT03798717|12603092|FG001|Overall Study|Lost to Follow-up|0
8004084|NCT03798717|12603093|FG002|Overall Study|Lost to Follow-up|0
8004085|NCT03798717|12603094|FG003|Overall Study|Lost to Follow-up|1
8004086|NCT03798717|12603095|FG004|Overall Study|Lost to Follow-up|0
8004087|NCT03798717|12603096|FG005|Overall Study|Lost to Follow-up|0
8004088|NCT03798717|12603091|FG000|Overall Study|Adverse Event|0
8004089|NCT03798717|12603092|FG001|Overall Study|Adverse Event|1
8004090|NCT03798717|12603093|FG002|Overall Study|Adverse Event|0
8004091|NCT03798717|12603094|FG003|Overall Study|Adverse Event|0
8004092|NCT03798717|12603095|FG004|Overall Study|Adverse Event|0
8004093|NCT03798717|12603096|FG005|Overall Study|Adverse Event|0
8004094|NCT03798717|12603091|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
8004095|NCT03798717|12603092|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
8004096|NCT03798717|12603093|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
8004097|NCT03798717|12603094|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
8004098|NCT03798717|12603095|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1
8004099|NCT03798717|12603096|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
8004100|NCT03798483|12603105|FG000|Overall Study|Lost to Follow-up|2
8004101|NCT03798366|12603115|FG000|Overall Study|Lost to Follow-up|0
8004102|NCT03798366|12603116|FG001|Overall Study|Lost to Follow-up|1
8004103|NCT03799952|12603124|FG000|Overall Study|Program was too easy, discontinued|1
8004104|NCT03799952|12603125|FG001|Overall Study|Program was too easy, discontinued|0
8004105|NCT03799952|12603124|FG000|Overall Study|Lost to Follow-up|0
8004106|NCT03799952|12603125|FG001|Overall Study|Lost to Follow-up|2
8004107|NCT03796728|12603159|FG000|Overall Study|Lost to Follow-up|8
8004108|NCT03796728|12603159|FG000|Overall Study|Reason not Specified|16
8004109|NCT03797144|12603165|FG000|Enrollment|Protocol Violation|4
8004110|NCT03797144|12603166|FG001|Enrollment|Protocol Violation|1
8004111|NCT03797144|12603165|FG000|Surgery|Protocol Violation|1
8004112|NCT03797144|12603166|FG001|Surgery|Protocol Violation|0
8004113|NCT03797144|12603165|FG000|3 Month|Early termination cut-off date|2
8004114|NCT03797144|12603166|FG001|3 Month|Early termination cut-off date|0
8004115|NCT03797144|12603165|FG000|12 Month|Early termination cut-off date|8
8004116|NCT03797144|12603166|FG001|12 Month|Early termination cut-off date|9
8004117|NCT03797144|12603165|FG000|24 Month|Early termination cut-off date|1
8004118|NCT03797144|12603166|FG001|24 Month|Early termination cut-off date|1
8004119|NCT03782571|12603173|FG000|Period 1|Withdrawal by Subject|1
8004120|NCT03782571|12603174|FG001|Period 1|Withdrawal by Subject|0
8004121|NCT03782571|12603175|FG002|Period 1|Withdrawal by Subject|0
8004122|NCT03782571|12603176|FG003|Period 1|Withdrawal by Subject|0
8004123|NCT03782571|12603173|FG000|Period 3|Subject Unable to Attend V5|1
8004124|NCT03782571|12603174|FG001|Period 3|Subject Unable to Attend V5|0
8004125|NCT03782571|12603175|FG002|Period 3|Subject Unable to Attend V5|0
8004126|NCT03782571|12603176|FG003|Period 3|Subject Unable to Attend V5|0
8004127|NCT03782571|12603173|FG000|Period 3|Adverse Event|1
8004128|NCT03782571|12603174|FG001|Period 3|Adverse Event|0
8004129|NCT03782571|12603175|FG002|Period 3|Adverse Event|0
8004130|NCT03782571|12603176|FG003|Period 3|Adverse Event|0
8004131|NCT03796039|12603199|FG000|Overall Study|Death|2
8004132|NCT03796039|12603200|FG001|Overall Study|Death|1
8004133|NCT03796039|12603199|FG000|Overall Study|Withdrawal by Subject|7
8004134|NCT03796039|12603200|FG001|Overall Study|Withdrawal by Subject|4
8004135|NCT03783780|12603206|FG000|Overall Study|Withdrawn prior to completion|1
8004136|NCT03780959|12603214|FG000|Part 1|Adverse Event|1
8004137|NCT03780959|12603215|FG001|Part 1|Adverse Event|0
8004138|NCT03780959|12603216|FG002|Part 1|Adverse Event|0
8004139|NCT03780959|12603214|FG000|Part 1|Withdrawal by Subject|1
8004140|NCT03780959|12603215|FG001|Part 1|Withdrawal by Subject|0
8004141|NCT03780959|12603216|FG002|Part 1|Withdrawal by Subject|0
8004142|NCT03780959|12603214|FG000|Part 1|Withdrawal by Parent/Guardian|1
8004143|NCT03780959|12603215|FG001|Part 1|Withdrawal by Parent/Guardian|0
8004144|NCT03780959|12603216|FG002|Part 1|Withdrawal by Parent/Guardian|0
8004145|NCT03780959|12603214|FG000|Part 1|Response Status|2
8004146|NCT03780959|12603215|FG001|Part 1|Response Status|0
8004147|NCT03780959|12603216|FG002|Part 1|Response Status|0
8004148|NCT03780959|12603214|FG000|Part 2|Withdrawal by Parent/Guardian|0
8004149|NCT03780959|12603215|FG001|Part 2|Withdrawal by Parent/Guardian|1
8004150|NCT03780959|12603216|FG002|Part 2|Withdrawal by Parent/Guardian|0
8004151|NCT03780959|12603214|FG000|Part 2|Response Status|0
8004152|NCT03780959|12603215|FG001|Part 2|Response Status|18
8004153|NCT03780959|12603216|FG002|Part 2|Response Status|6
8004154|NCT03792477|12603256|FG000|Overall Study|Adverse Event|0
8004155|NCT03792477|12603257|FG001|Overall Study|Adverse Event|0
8004156|NCT03792477|12603258|FG002|Overall Study|Adverse Event|0
8004157|NCT03792477|12603259|FG003|Overall Study|Adverse Event|1
8004158|NCT03792477|12603260|FG004|Overall Study|Adverse Event|0
8004159|NCT03792477|12603256|FG000|Overall Study|Lost to Follow-up|0
8004160|NCT03792477|12603257|FG001|Overall Study|Lost to Follow-up|0
8004161|NCT03792477|12603258|FG002|Overall Study|Lost to Follow-up|2
8004162|NCT03792477|12603259|FG003|Overall Study|Lost to Follow-up|0
8004163|NCT03792477|12603260|FG004|Overall Study|Lost to Follow-up|0
8004164|NCT03792477|12603256|FG000|Overall Study|Other|0
8004165|NCT03792477|12603257|FG001|Overall Study|Other|0
8004166|NCT03792477|12603258|FG002|Overall Study|Other|0
8004167|NCT03792477|12603259|FG003|Overall Study|Other|0
8004168|NCT03792477|12603260|FG004|Overall Study|Other|1
8004169|NCT03783962|12603268|FG000|Overall Study|Lost to Follow-up|3
8004170|NCT03783962|12603269|FG001|Overall Study|Lost to Follow-up|6
8004171|NCT03783962|12603268|FG000|Overall Study|Protocol Violation|0
8004172|NCT03783962|12603269|FG001|Overall Study|Protocol Violation|1
8004173|NCT03793556|12603324|FG000|Overall Study|Withdrawal by Subject|12
8004174|NCT03793556|12603325|FG001|Overall Study|Withdrawal by Subject|1
8004175|NCT03793556|12603324|FG000|Overall Study|Lost to Follow-up|1
8004176|NCT03793556|12603325|FG001|Overall Study|Lost to Follow-up|1
8004177|NCT03785548|12603336|FG000|Overall Study|age > 80|1
8004178|NCT03785548|12603337|FG001|Overall Study|age > 80|0
8004179|NCT03785548|12603336|FG000|Overall Study|no Postop queries|1
8004180|NCT03785548|12603337|FG001|Overall Study|no Postop queries|0
8004181|NCT03792672|12603349|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1
8004182|NCT03792672|12603350|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0
8004183|NCT03792672|12603351|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0
8004184|NCT03792672|12603352|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2
8004185|NCT03792672|12603353|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0
8004186|NCT03792672|12603354|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0
8004187|NCT03792672|12603349|FG000|Washout Period 3 (10 Days)|Physician Decision|0
8004188|NCT03792672|12603350|FG001|Washout Period 3 (10 Days)|Physician Decision|0
8004189|NCT03792672|12603351|FG002|Washout Period 3 (10 Days)|Physician Decision|1
8004190|NCT03792672|12603352|FG003|Washout Period 3 (10 Days)|Physician Decision|0
8004191|NCT03792672|12603353|FG004|Washout Period 3 (10 Days)|Physician Decision|0
8004192|NCT03792672|12603354|FG005|Washout Period 3 (10 Days)|Physician Decision|0
8004193|NCT03792672|12603349|FG000|Treatment Period 4 (2 Days)|Other|1
8004194|NCT03792672|12603350|FG001|Treatment Period 4 (2 Days)|Other|0
8004195|NCT03792672|12603351|FG002|Treatment Period 4 (2 Days)|Other|0
8004196|NCT03792672|12603352|FG003|Treatment Period 4 (2 Days)|Other|0
8004197|NCT03792672|12603353|FG004|Treatment Period 4 (2 Days)|Other|0
8004198|NCT03792672|12603354|FG005|Treatment Period 4 (2 Days)|Other|0
8004199|NCT03787615|12603463|FG000|Overall Study|Withdrawal by Subject|2
8004200|NCT03787615|12603463|FG000|Overall Study|Lost to Follow-up|2
8004201|NCT03786718|12603468|FG000|Overall Study|Lost to Follow-up|3
8004202|NCT03786718|12603468|FG000|Overall Study|Withdrawal by Subject|1
8004203|NCT03786718|12603468|FG000|Overall Study|Did not use the intervention|2
8004204|NCT03786718|12603468|FG000|Overall Study|diagnosis changed from type 2 to type 1|1
8004205|NCT03784963|12603477|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12
8004206|NCT03784963|12603478|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10
8004207|NCT03784963|12603479|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1
8004208|NCT03784963|12603480|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0
8004209|NCT03787212|12603501|FG000|Period 1|Study Termination|2
8004210|NCT03787212|12603502|FG001|Period 1|Study Termination|2
8004211|NCT03783702|12603523|FG000|Overall Study|Lost to Follow-up|6
8004212|NCT03783702|12603524|FG001|Overall Study|Lost to Follow-up|8
8004213|NCT03783702|12603523|FG000|Overall Study|Protocol Violation|1
8004214|NCT03783702|12603524|FG001|Overall Study|Protocol Violation|3
8004215|NCT03783039|12603582|FG000|Overall Study|Death|2
8004216|NCT03783039|12603583|FG001|Overall Study|Death|1
8004217|NCT03776175|12603611|FG000|Treatment Period (42 Days)|Adverse Event|0
8004218|NCT03776175|12603612|FG001|Treatment Period (42 Days)|Adverse Event|1
8004219|NCT03776175|12603613|FG002|Treatment Period (42 Days)|Adverse Event|1
8004220|NCT03776175|12603614|FG003|Treatment Period (42 Days)|Adverse Event|0
8004221|NCT03776175|12603611|FG000|Treatment Period (42 Days)|Lost to Follow-up|0
8004222|NCT03776175|12603612|FG001|Treatment Period (42 Days)|Lost to Follow-up|0
8004223|NCT03776175|12603613|FG002|Treatment Period (42 Days)|Lost to Follow-up|0
8004224|NCT03776175|12603614|FG003|Treatment Period (42 Days)|Lost to Follow-up|2
8004225|NCT03776175|12603611|FG000|Treatment Period (42 Days)|Participants screened at other site|0
8004226|NCT03776175|12603612|FG001|Treatment Period (42 Days)|Participants screened at other site|2
8004227|NCT03776175|12603613|FG002|Treatment Period (42 Days)|Participants screened at other site|0
8004228|NCT03776175|12603614|FG003|Treatment Period (42 Days)|Participants screened at other site|0
8004229|NCT03776175|12603611|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1
8004230|NCT03776175|12603612|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2
8004231|NCT03776175|12603613|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3
8004232|NCT03776175|12603614|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0
8004233|NCT03776175|12603611|FG000|Treatment Period (42 Days)|Unable to attend study visits|0
8004234|NCT03776175|12603612|FG001|Treatment Period (42 Days)|Unable to attend study visits|2
8004235|NCT03776175|12603613|FG002|Treatment Period (42 Days)|Unable to attend study visits|0
8004236|NCT03776175|12603614|FG003|Treatment Period (42 Days)|Unable to attend study visits|0
8004237|NCT03776175|12603611|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0
8004238|NCT03776175|12603612|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0
8004239|NCT03776175|12603613|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0
8004240|NCT03776175|12603614|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2
8004241|NCT03771963|12603624|FG000|Overall Study|Lost to Follow-up|22
8004242|NCT03771963|12603624|FG000|Overall Study|Withdrawal of Consent|10
8004243|NCT03771352|12603628|FG000|Overall Study|Screen failure|2
8004244|NCT03771352|12603628|FG000|Overall Study|Withdrawal by Subject|2
8004245|NCT03773796|12603632|FG000|Overall Study|Adverse Event|1
8004246|NCT03773796|12603632|FG000|Overall Study|Withdrawal by Subject|1
8004247|NCT03773796|12603632|FG000|Overall Study|Lack of Efficacy|1
8004248|NCT03781375|12603649|FG000|Double-blind Phase|Adverse Event|0
8004249|NCT03781375|12603650|FG001|Double-blind Phase|Adverse Event|1
8004250|NCT03781375|12603649|FG000|Double-blind Phase|Lack of Response|6
8004251|NCT03781375|12603650|FG001|Double-blind Phase|Lack of Response|2
8004252|NCT03781375|12603649|FG000|Double-blind Phase|Other|1
8004253|NCT03781375|12603650|FG001|Double-blind Phase|Other|3
8004254|NCT03781375|12603649|FG000|Open-label Phase|Protocol Issues|0
8004255|NCT03781375|12603650|FG001|Open-label Phase|Protocol Issues|1
8004256|NCT03781375|12603649|FG000|Open-label Phase|Suboptimal Clinical Response|1
8004257|NCT03781375|12603650|FG001|Open-label Phase|Suboptimal Clinical Response|0
8004258|NCT03781375|12603649|FG000|Open-label Phase|Other|2
8004259|NCT03781375|12603650|FG001|Open-label Phase|Other|2
8004260|NCT03781336|12603659|FG000|Overall Study|Withdrawal by Subject|2
8004261|NCT03781336|12603660|FG001|Overall Study|Withdrawal by Subject|2
8004262|NCT03780400|12603666|FG000|Overall Study|Lost to Follow-up|5
8004263|NCT03780400|12603666|FG000|Overall Study|Withdrawal by Subject|2
8004264|NCT03779503|12603679|FG000|First Intervention|Adverse Event|0
8004265|NCT03779503|12603680|FG001|First Intervention|Adverse Event|1
8004266|NCT03779503|12603679|FG000|First Intervention|Withdrawal by Subject|1
8004267|NCT03779503|12603680|FG001|First Intervention|Withdrawal by Subject|0
8004268|NCT03777059|12603714|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6
8004269|NCT03777059|12603715|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9
8004270|NCT03777059|12603716|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4
8004271|NCT03777059|12603717|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6
8004272|NCT03777059|12603714|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1
8004273|NCT03777059|12603715|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0
8004274|NCT03777059|12603716|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0
8004275|NCT03777059|12603717|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1
8004276|NCT03777059|12603714|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8
8004277|NCT03777059|12603715|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9
8004278|NCT03777059|12603716|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8
8004279|NCT03777059|12603717|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10
8004280|NCT03777059|12603714|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3
8004281|NCT03777059|12603715|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3
8004282|NCT03777059|12603716|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4
8004283|NCT03777059|12603717|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5
8004284|NCT03777059|12603714|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0
8004285|NCT03777059|12603715|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1
8004286|NCT03777059|12603716|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0
8004287|NCT03777059|12603717|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0
8004288|NCT03777059|12603714|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4
8004289|NCT03777059|12603715|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5
8004290|NCT03777059|12603716|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7
8004291|NCT03777059|12603717|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8
8004292|NCT03777059|12603714|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0
8004293|NCT03777059|12603715|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2
8004294|NCT03777059|12603716|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0
8004295|NCT03777059|12603717|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1
8004296|NCT03777059|12603714|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5
8004297|NCT03777059|12603715|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3
8004298|NCT03777059|12603716|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4
8004299|NCT03777059|12603717|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5
8004300|NCT03777059|12603714|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0
8004301|NCT03777059|12603715|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1
8004302|NCT03777059|12603716|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0
8004303|NCT03777059|12603717|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3
8004304|NCT03777059|12603714|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0
8004305|NCT03777059|12603715|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1
8004306|NCT03777059|12603716|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1
8004307|NCT03777059|12603717|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0
8004308|NCT03777059|12603714|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0
8004309|NCT03777059|12603715|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0
8004310|NCT03777059|12603716|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1
8004311|NCT03777059|12603717|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1
8004312|NCT03772522|12603729|FG000|Pre-intervention|Withdrawal by Subject|3
8004313|NCT03772522|12603730|FG001|Pre-intervention|Withdrawal by Subject|4
8004314|NCT03772522|12603729|FG000|Intervention|Withdrawal by Subject|1
8004315|NCT03772522|12603730|FG001|Intervention|Withdrawal by Subject|0
8004316|NCT03772522|12603729|FG000|Post-intervention Follow-up|Lost to Follow-up|1
8004317|NCT03772522|12603730|FG001|Post-intervention Follow-up|Lost to Follow-up|0
8004318|NCT03772327|12603742|FG000|Overall Study|Lost to Follow-up|3
8004319|NCT03772327|12603743|FG001|Overall Study|Lost to Follow-up|4
8004320|NCT03772327|12603742|FG000|Overall Study|Withdrawal by Subject|2
8004321|NCT03772327|12603743|FG001|Overall Study|Withdrawal by Subject|3
8004322|NCT03774576|12603753|FG000|Period 2|Adverse Event|1
8004323|NCT03772041|12603781|FG000|Overall Study|Adverse Event|8
8004324|NCT03772041|12603782|FG001|Overall Study|Adverse Event|3
8004325|NCT03772041|12603781|FG000|Overall Study|Withdrawal by Subject|0
8004326|NCT03772041|12603782|FG001|Overall Study|Withdrawal by Subject|2
8004327|NCT03772041|12603781|FG000|Overall Study|Protocol Violation|4
8004328|NCT03772041|12603782|FG001|Overall Study|Protocol Violation|2
8004329|NCT03772041|12603781|FG000|Overall Study|Physician Decision|2
8004330|NCT03772041|12603782|FG001|Overall Study|Physician Decision|3
8004331|NCT03775681|12603788|FG000|Overall Study|Physician Decision|3
8004332|NCT03774823|12603794|FG000|Overall Study|Withdrawal by Subject|1
8004333|NCT03774823|12603795|FG001|Overall Study|Withdrawal by Subject|1
8004334|NCT03774433|12603810|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14
8004335|NCT03769896|12603833|FG000|Open-label Phase|Lack of Efficacy|5
8004336|NCT03769896|12603834|FG001|Open-label Phase|Lack of Efficacy|0
8004337|NCT03769896|12603833|FG000|Open-label Phase|Adverse Event|3
8004338|NCT03769896|12603834|FG001|Open-label Phase|Adverse Event|0
8004339|NCT03769896|12603833|FG000|Open-label Phase|Withdrawal by Subject|1
8004340|NCT03769896|12603834|FG001|Open-label Phase|Withdrawal by Subject|0
8004341|NCT03768726|12603851|FG000|Treatment Phase|Adverse Event|2
8004342|NCT03768726|12603852|FG001|Treatment Phase|Adverse Event|2
8004343|NCT03768726|12603851|FG000|Treatment Phase|Lost to Follow-up|1
8004344|NCT03768726|12603852|FG001|Treatment Phase|Lost to Follow-up|0
8004345|NCT03768726|12603851|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2
8004346|NCT03768726|12603852|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0
8004347|NCT03768726|12603851|FG000|Treatment Phase|Withdrawal by Subject|3
8004348|NCT03768726|12603852|FG001|Treatment Phase|Withdrawal by Subject|1
8004349|NCT03768726|12603851|FG000|Follow-Up|Adverse Event|2
8004350|NCT03768726|12603852|FG001|Follow-Up|Adverse Event|2
8004351|NCT03768726|12603851|FG000|Follow-Up|Withdrawal By Parent/Guardian|1
8004352|NCT03768726|12603852|FG001|Follow-Up|Withdrawal By Parent/Guardian|1
8004353|NCT03768726|12603851|FG000|Follow-Up|Withdrawal by Subject|2
8004354|NCT03768726|12603852|FG001|Follow-Up|Withdrawal by Subject|0
8004355|NCT03768726|12603851|FG000|Follow-Up|Other|1
8004356|NCT03768726|12603852|FG001|Follow-Up|Other|0
8004357|NCT03768206|12603860|FG000|Overall Study|Lost to Follow-up|2
8004358|NCT03768206|12603861|FG001|Overall Study|Lost to Follow-up|1
8004359|NCT03768206|12603860|FG000|Overall Study|Withdrawal by Subject|0
8004360|NCT03768206|12603861|FG001|Overall Study|Withdrawal by Subject|1
8004361|NCT03767894|12603868|FG000|Overall Study|Withdrawal by Subject|1
8004362|NCT03766646|12603901|FG000|Overall Study|Withdrawal by Subject|1
8004363|NCT03766646|12603902|FG001|Overall Study|Withdrawal by Subject|0
8004364|NCT03766646|12603901|FG000|Overall Study|Protocol Violation|0
8004365|NCT03766646|12603902|FG001|Overall Study|Protocol Violation|3
8004366|NCT03765164|12603974|FG000|Pre-intervention|Withdrawal by Subject|5
8004367|NCT03765164|12603975|FG001|Pre-intervention|Withdrawal by Subject|6
8004368|NCT03765138|12603981|FG000|Overall Study|Lost to Follow-up|1
8004369|NCT03762681|12604036|FG000|Part 1|Withdrawal by Subject|0
8004370|NCT03762681|12604037|FG001|Part 1|Withdrawal by Subject|0
8004371|NCT03762681|12604038|FG002|Part 1|Withdrawal by Subject|0
8004372|NCT03762681|12604039|FG003|Part 1|Withdrawal by Subject|1
8004373|NCT03762681|12604040|FG004|Part 1|Withdrawal by Subject|0
8004374|NCT03762681|12604041|FG005|Part 1|Withdrawal by Subject|0
8004375|NCT03762681|12604042|FG006|Part 1|Withdrawal by Subject|0
8004376|NCT03762681|12604043|FG007|Part 1|Withdrawal by Subject|0
8004377|NCT03762681|12604036|FG000|Part 2a|Pandemic Travel Restrictions|0
8004378|NCT03762681|12604037|FG001|Part 2a|Pandemic Travel Restrictions|0
8004379|NCT03762681|12604038|FG002|Part 2a|Pandemic Travel Restrictions|0
8004380|NCT03762681|12604039|FG003|Part 2a|Pandemic Travel Restrictions|0
8004381|NCT03762681|12604040|FG004|Part 2a|Pandemic Travel Restrictions|0
8004382|NCT03762681|12604041|FG005|Part 2a|Pandemic Travel Restrictions|0
8004383|NCT03762681|12604042|FG006|Part 2a|Pandemic Travel Restrictions|0
8004384|NCT03762681|12604043|FG007|Part 2a|Pandemic Travel Restrictions|1
8004385|NCT03762668|12604072|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0
8004386|NCT03762668|12604073|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1
8004387|NCT03762616|12604079|FG000|Overall Study|Protocol Violation|2
8004388|NCT03762200|12604094|FG000|Overall Study|Death|2
8004389|NCT03761147|12604109|FG000|Overall Study|Withdrawal by Subject|6
8004390|NCT03761147|12604110|FG001|Overall Study|Withdrawal by Subject|1
8004391|NCT03761147|12604109|FG000|Overall Study|Adverse Event|1
8004392|NCT03761147|12604110|FG001|Overall Study|Adverse Event|3
8004393|NCT03760510|12604224|FG000|Overall Study|Not ventilated for 24 hours|105
8004394|NCT03760510|12604225|FG001|Overall Study|Not ventilated for 24 hours|97
8004395|NCT03760250|12604231|FG000|Overall Study|Withdrawal by Subject|1
8004396|NCT03760250|12604231|FG000|Overall Study|Physician Decision|1
8004397|NCT03759600|12604235|FG000|Overall Study|Ongoing at Data Cut-off|16
8004398|NCT03759600|12604235|FG000|Overall Study|Adverse Event|1
8004399|NCT03759600|12604235|FG000|Overall Study|Progressive Disease|3
8004400|NCT03759340|12604239|FG000|Overall Study|Adverse Event|2
8004401|NCT03759340|12604239|FG000|Overall Study|Lost to Follow-up|1
8004402|NCT03759340|12604239|FG000|Overall Study|Withdrawal by Subject|15
8004403|NCT03759340|12604239|FG000|Overall Study|Study Terminated by Sponsor|38
8004404|NCT03757988|12604262|FG000|Overall Study|Withdrawal by Subject|1
8004405|NCT03757234|12604283|FG000|Overall Study|Adverse Event|0
8004406|NCT03757234|12604284|FG001|Overall Study|Adverse Event|0
8004407|NCT03757234|12604285|FG002|Overall Study|Adverse Event|0
8004408|NCT03757234|12604286|FG003|Overall Study|Adverse Event|0
8004409|NCT03757234|12604287|FG004|Overall Study|Adverse Event|1
8004410|NCT03757234|12604283|FG000|Overall Study|Lost to Follow-up|1
8004411|NCT03757234|12604284|FG001|Overall Study|Lost to Follow-up|0
8004412|NCT03757234|12604285|FG002|Overall Study|Lost to Follow-up|0
8004413|NCT03757234|12604286|FG003|Overall Study|Lost to Follow-up|0
8004414|NCT03757234|12604287|FG004|Overall Study|Lost to Follow-up|1
8004415|NCT03757234|12604283|FG000|Overall Study|Withdrawal by Subject|1
8004416|NCT03757234|12604284|FG001|Overall Study|Withdrawal by Subject|1
8004417|NCT03757234|12604285|FG002|Overall Study|Withdrawal by Subject|0
8004418|NCT03757234|12604286|FG003|Overall Study|Withdrawal by Subject|1
8004419|NCT03757234|12604287|FG004|Overall Study|Withdrawal by Subject|2
8004420|NCT03757234|12604283|FG000|Overall Study|Other|1
8004421|NCT03757234|12604284|FG001|Overall Study|Other|1
8004422|NCT03757234|12604285|FG002|Overall Study|Other|0
8004423|NCT03757234|12604286|FG003|Overall Study|Other|0
8004424|NCT03757234|12604287|FG004|Overall Study|Other|0
8004425|NCT03756883|12604315|FG000|Overall Study|Adverse Event|2
8004426|NCT03756883|12604316|FG001|Overall Study|Adverse Event|2
8004427|NCT03756883|12604317|FG002|Overall Study|Adverse Event|2
8004428|NCT03756883|12604315|FG000|Overall Study|Lack of Efficacy|0
8004429|NCT03756883|12604316|FG001|Overall Study|Lack of Efficacy|1
8004430|NCT03756883|12604317|FG002|Overall Study|Lack of Efficacy|2
8004431|NCT03756883|12604315|FG000|Overall Study|Lost to Follow-up|3
8004432|NCT03756883|12604316|FG001|Overall Study|Lost to Follow-up|3
8004433|NCT03756883|12604317|FG002|Overall Study|Lost to Follow-up|0
8004434|NCT03756883|12604315|FG000|Overall Study|Protocol Violation|2
8004435|NCT03756883|12604316|FG001|Overall Study|Protocol Violation|0
8004436|NCT03756883|12604317|FG002|Overall Study|Protocol Violation|1
8004437|NCT03756883|12604315|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0
8004438|NCT03756883|12604316|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0
8004439|NCT03756883|12604317|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2
8004440|NCT03756883|12604315|FG000|Overall Study|Withdrawal by Subject|4
8004441|NCT03756883|12604316|FG001|Overall Study|Withdrawal by Subject|1
8004442|NCT03756883|12604317|FG002|Overall Study|Withdrawal by Subject|0
8004443|NCT03756883|12604315|FG000|Overall Study|Other Reasons|2
8004444|NCT03756883|12604316|FG001|Overall Study|Other Reasons|4
8004445|NCT03756883|12604317|FG002|Overall Study|Other Reasons|0
8004446|NCT03756285|12604336|FG000|Overall Study|Lost to Follow-up|0
8004447|NCT03756285|12604337|FG001|Overall Study|Lost to Follow-up|1
8004448|NCT03756285|12604336|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0
8004449|NCT03756285|12604337|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1
8004450|NCT03756285|12604336|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3
8004451|NCT03756285|12604337|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3
8004452|NCT03756129|12604350|FG000|Overall Study|Adverse Event|1
8004453|NCT03756129|12604351|FG001|Overall Study|Adverse Event|1
8004454|NCT03756129|12604352|FG002|Overall Study|Adverse Event|0
8004455|NCT03756129|12604353|FG003|Overall Study|Adverse Event|2
8004456|NCT03756129|12604354|FG004|Overall Study|Adverse Event|0
8004457|NCT03756129|12604355|FG005|Overall Study|Adverse Event|0
8004458|NCT03756129|12604350|FG000|Overall Study|Withdrawal by Subject|2
8004459|NCT03756129|12604351|FG001|Overall Study|Withdrawal by Subject|1
8004460|NCT03756129|12604352|FG002|Overall Study|Withdrawal by Subject|3
8004461|NCT03756129|12604353|FG003|Overall Study|Withdrawal by Subject|1
8004462|NCT03756129|12604354|FG004|Overall Study|Withdrawal by Subject|1
8004463|NCT03756129|12604355|FG005|Overall Study|Withdrawal by Subject|3
8004464|NCT03756129|12604350|FG000|Overall Study|Lost to Follow-up|0
8004465|NCT03756129|12604351|FG001|Overall Study|Lost to Follow-up|0
8004466|NCT03756129|12604352|FG002|Overall Study|Lost to Follow-up|0
8004467|NCT03756129|12604353|FG003|Overall Study|Lost to Follow-up|0
8004468|NCT03756129|12604354|FG004|Overall Study|Lost to Follow-up|0
8004469|NCT03756129|12604355|FG005|Overall Study|Lost to Follow-up|1
8004470|NCT03756129|12604350|FG000|Overall Study|Physician Decision|0
8004471|NCT03756129|12604351|FG001|Overall Study|Physician Decision|0
8004472|NCT03756129|12604352|FG002|Overall Study|Physician Decision|0
8004473|NCT03756129|12604353|FG003|Overall Study|Physician Decision|0
8004474|NCT03756129|12604354|FG004|Overall Study|Physician Decision|0
8004475|NCT03756129|12604355|FG005|Overall Study|Physician Decision|1
8004476|NCT03755882|12604391|FG000|Period 1|Protocol Violation|1
8004477|NCT03755882|12604392|FG001|Period 1|Protocol Violation|0
8004478|NCT03755882|12604391|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3
8004479|NCT03755882|12604392|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0
8004480|NCT03755661|12604400|FG000|Overall Study|Lost to Follow-up|1
8004481|NCT03755661|12604401|FG001|Overall Study|Lost to Follow-up|0
8004482|NCT03754582|12604407|FG000|Treatment Phase|Adverse Event|0
8004483|NCT03754582|12604408|FG001|Treatment Phase|Adverse Event|1
8004484|NCT03754582|12604409|FG002|Treatment Phase|Adverse Event|0
8004485|NCT03754582|12604407|FG000|Follow-up Phase|Other|0
8004486|NCT03754582|12604408|FG001|Follow-up Phase|Other|0
8004487|NCT03754582|12604409|FG002|Follow-up Phase|Other|1
8004488|NCT03752528|12604442|FG000|Part A|Lost to Follow-up|1
8004489|NCT03752528|12604442|FG000|Part A|Protocol Violation|1
8004490|NCT03752528|12604442|FG000|Part B|Protocol Violation|1
8004491|NCT03752528|12604442|FG000|Part B|Study terminated by sponsor|3
8004492|NCT03752151|12604449|FG000|Overall Study|Withdrawal by Subject|1
8004493|NCT03752151|12604449|FG000|Overall Study|Protocol Violation|1
8004494|NCT03751657|12604456|FG000|Overall Study|Physician Decision|0
8004495|NCT03751657|12604457|FG001|Overall Study|Physician Decision|1
8004496|NCT03751657|12604456|FG000|Overall Study|Withdrawal by Subject|1
8004497|NCT03751657|12604457|FG001|Overall Study|Withdrawal by Subject|1
8004498|NCT03751657|12604456|FG000|Overall Study|Lost to Follow-up|2
8004499|NCT03751657|12604457|FG001|Overall Study|Lost to Follow-up|1
8004500|NCT03751280|12604465|FG000|Overall Study|Adverse Event|0
8004501|NCT03751280|12604466|FG001|Overall Study|Adverse Event|1
8004502|NCT03751280|12604465|FG000|Overall Study|Lost to Follow-up|3
8004503|NCT03751280|12604466|FG001|Overall Study|Lost to Follow-up|5
8004504|NCT03751280|12604465|FG000|Overall Study|Physician Decision|0
8004505|NCT03751280|12604466|FG001|Overall Study|Physician Decision|2
8004506|NCT03751280|12604465|FG000|Overall Study|Protocol Violation|0
8004507|NCT03751280|12604466|FG001|Overall Study|Protocol Violation|2
8004508|NCT03751280|12604465|FG000|Overall Study|Withdrawal by Subject|5
8004509|NCT03751280|12604466|FG001|Overall Study|Withdrawal by Subject|2
8004510|NCT03751020|12604476|FG000|Overall Study|Withdrawal by Subject|2
8004511|NCT03751020|12604477|FG001|Overall Study|Withdrawal by Subject|0
8004512|NCT03751020|12604478|FG002|Overall Study|Withdrawal by Subject|0
8004513|NCT03751020|12604476|FG000|Overall Study|Lost to Follow-up|7
8004514|NCT03751020|12604477|FG001|Overall Study|Lost to Follow-up|4
8004515|NCT03751020|12604478|FG002|Overall Study|Lost to Follow-up|10
8004516|NCT03750955|12604488|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2
8004517|NCT03750955|12604489|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2
8004518|NCT03750955|12604488|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1
8004519|NCT03750955|12604489|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1
8004520|NCT03750695|12604497|FG000|Overall Study|Lost to Follow-up|0
8004521|NCT03750695|12604498|FG001|Overall Study|Lost to Follow-up|1
8004522|NCT03748706|12604606|FG000|Overall Study|Lost to Follow-up|1
8004523|NCT03746405|12604634|FG000|Overall Study|Withdrawal by Subject|3
8004524|NCT03746405|12604635|FG001|Overall Study|Withdrawal by Subject|0
8004525|NCT03746405|12604634|FG000|Overall Study|technical difficulties|0
8004526|NCT03746405|12604635|FG001|Overall Study|technical difficulties|2
8004527|NCT03745937|12604645|FG000|Overall Study|Withdrawal by Subject|0
8004528|NCT03745937|12604646|FG001|Overall Study|Withdrawal by Subject|0
8004529|NCT03745937|12604647|FG002|Overall Study|Withdrawal by Subject|0
8004530|NCT03745937|12604648|FG003|Overall Study|Withdrawal by Subject|1
8004531|NCT03745937|12604645|FG000|Overall Study|Not-specifed|0
8004532|NCT03745937|12604646|FG001|Overall Study|Not-specifed|1
8004533|NCT03745937|12604647|FG002|Overall Study|Not-specifed|0
8004534|NCT03745937|12604648|FG003|Overall Study|Not-specifed|1
8004535|NCT03745222|12604662|FG000|Overall Study|Withdrawal by Subject|0
8004536|NCT03745222|12604663|FG001|Overall Study|Withdrawal by Subject|1
8004537|NCT03745222|12604664|FG002|Overall Study|Withdrawal by Subject|0
8004538|NCT03743038|12604699|FG000|Overall Study|Physician Decision|1
8004539|NCT03742271|12604722|FG000|Overall Study|Unsatisfactory Visual Response|1
8004540|NCT03742271|12604722|FG000|Overall Study|Withdrawal by Subject|3
8004541|NCT03742271|12604722|FG000|Overall Study|Lost to Follow-up|4
8004542|NCT03742271|12604722|FG000|Overall Study|Failed Insertion & removal|3
8004543|NCT03742271|12604722|FG000|Overall Study|Protocol Violation|1
8004544|NCT03741062|12604757|FG000|Overall Study|Protocol Violation|1
8004545|NCT03741062|12604758|FG001|Overall Study|Protocol Violation|0
8004546|NCT03739866|12604789|FG000|Overall Study|Lost to Follow-up|0
8004547|NCT03739866|12604790|FG001|Overall Study|Lost to Follow-up|0
8004548|NCT03739866|12604791|FG002|Overall Study|Lost to Follow-up|0
8004549|NCT03739866|12604792|FG003|Overall Study|Lost to Follow-up|1
8004550|NCT03739866|12604793|FG004|Overall Study|Lost to Follow-up|0
8004551|NCT03739866|12604794|FG005|Overall Study|Lost to Follow-up|0
8004552|NCT03739866|12604795|FG006|Overall Study|Lost to Follow-up|0
8004553|NCT03739866|12604796|FG007|Overall Study|Lost to Follow-up|0
8004554|NCT03739866|12604789|FG000|Overall Study|Enrolled but not treated|0
8004555|NCT03739866|12604790|FG001|Overall Study|Enrolled but not treated|0
8004556|NCT03739866|12604791|FG002|Overall Study|Enrolled but not treated|1
8004557|NCT03739866|12604792|FG003|Overall Study|Enrolled but not treated|0
8004558|NCT03739866|12604793|FG004|Overall Study|Enrolled but not treated|1
8004559|NCT03739866|12604794|FG005|Overall Study|Enrolled but not treated|0
8004560|NCT03739866|12604795|FG006|Overall Study|Enrolled but not treated|0
8004561|NCT03739866|12604796|FG007|Overall Study|Enrolled but not treated|0
8004562|NCT03739528|12604824|FG000|Overall Study|Not treated|8
8004563|NCT03739528|12604825|FG001|Overall Study|Not treated|12
8004564|NCT03739528|12604824|FG000|Overall Study|Treatment and study discontinued|6
8004565|NCT03739528|12604825|FG001|Overall Study|Treatment and study discontinued|2
8004566|NCT03739528|12604824|FG000|Overall Study|Treatment discontinued + study completed|1
8004567|NCT03739528|12604825|FG001|Overall Study|Treatment discontinued + study completed|3
8004568|NCT03739242|12604836|FG000|Overall Study|Withdrawal by Subject|1
8004569|NCT03739242|12604837|FG001|Overall Study|Withdrawal by Subject|1
8004570|NCT03739242|12604836|FG000|Overall Study|Protocol Violation|0
8004571|NCT03739242|12604837|FG001|Overall Study|Protocol Violation|1
8004572|NCT03738865|12604845|FG000|Overall Study|Withdrawal by Subject|3
8004573|NCT03738865|12604846|FG001|Overall Study|Withdrawal by Subject|3
8004574|NCT03738865|12604845|FG000|Overall Study|Adverse Event|2
8004575|NCT03738865|12604846|FG001|Overall Study|Adverse Event|0
8004576|NCT03738865|12604845|FG000|Overall Study|Physician Decision|0
8004577|NCT03738865|12604846|FG001|Overall Study|Physician Decision|1
8004578|NCT03738475|12604863|FG000|Overall Study|Participant Non-Compliance|1
8004579|NCT03738475|12604864|FG001|Overall Study|Participant Non-Compliance|0
8004580|NCT03738241|12604880|FG000|Overall Study|Withdrawal by Subject|0
8004581|NCT03738241|12604881|FG001|Overall Study|Withdrawal by Subject|0
8004582|NCT03738241|12604882|FG002|Overall Study|Withdrawal by Subject|0
8004583|NCT03738241|12604883|FG003|Overall Study|Withdrawal by Subject|0
8004584|NCT03738241|12604884|FG004|Overall Study|Withdrawal by Subject|0
8004585|NCT03738241|12604885|FG005|Overall Study|Withdrawal by Subject|0
8004586|NCT03738241|12604886|FG006|Overall Study|Withdrawal by Subject|0
8004587|NCT03738241|12604887|FG007|Overall Study|Withdrawal by Subject|0
8004588|NCT03738241|12604888|FG008|Overall Study|Withdrawal by Subject|0
8004589|NCT03738241|12604889|FG009|Overall Study|Withdrawal by Subject|1
8004590|NCT03738241|12604880|FG000|Overall Study|Physician Decision|0
8004591|NCT03738241|12604881|FG001|Overall Study|Physician Decision|0
8004592|NCT03738241|12604882|FG002|Overall Study|Physician Decision|0
8004593|NCT03738241|12604883|FG003|Overall Study|Physician Decision|0
8004594|NCT03738241|12604884|FG004|Overall Study|Physician Decision|0
8004595|NCT03738241|12604885|FG005|Overall Study|Physician Decision|0
7718379|NCT00527826|12142350|FG001|Overall Study|Adverse Event|10
7718380|NCT00527826|12142349|FG000|Overall Study|Lost to Follow-up|3
7718381|NCT00527826|12142350|FG001|Overall Study|Lost to Follow-up|2
7718382|NCT00527826|12142349|FG000|Overall Study|Withdrawal by Subject|5
7718383|NCT00527826|12142350|FG001|Overall Study|Withdrawal by Subject|8
7718384|NCT00527826|12142349|FG000|Overall Study|Inclusion Criteria Not Met|3
7718385|NCT00527826|12142350|FG001|Overall Study|Inclusion Criteria Not Met|3
7718386|NCT00527826|12142349|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0
7718387|NCT00527826|12142350|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1
7718388|NCT00527826|12142349|FG000|Overall Study|Additional Intake of Viani forte|0
7718389|NCT00527826|12142350|FG001|Overall Study|Additional Intake of Viani forte|1
8004596|NCT03738241|12604886|FG006|Overall Study|Physician Decision|0
8004597|NCT03738241|12604887|FG007|Overall Study|Physician Decision|0
8004598|NCT03738241|12604888|FG008|Overall Study|Physician Decision|1
8004599|NCT03738241|12604889|FG009|Overall Study|Physician Decision|0
8004600|NCT03738241|12604880|FG000|Overall Study|Adverse Event|1
8004601|NCT03738241|12604881|FG001|Overall Study|Adverse Event|0
8004602|NCT03738241|12604882|FG002|Overall Study|Adverse Event|0
8004603|NCT03738241|12604883|FG003|Overall Study|Adverse Event|0
8004604|NCT03738241|12604884|FG004|Overall Study|Adverse Event|0
8004605|NCT03738241|12604885|FG005|Overall Study|Adverse Event|0
8004606|NCT03738241|12604886|FG006|Overall Study|Adverse Event|0
8004607|NCT03738241|12604887|FG007|Overall Study|Adverse Event|0
8004608|NCT03738241|12604888|FG008|Overall Study|Adverse Event|0
8004609|NCT03738241|12604889|FG009|Overall Study|Adverse Event|0
8004610|NCT03736785|12604925|FG000|Overall Study|Adverse Event|1
8004611|NCT03736785|12604926|FG001|Overall Study|Adverse Event|1
8004612|NCT03736785|12604927|FG002|Overall Study|Adverse Event|1
8004613|NCT03736785|12604925|FG000|Overall Study|Death|1
8004614|NCT03736785|12604926|FG001|Overall Study|Death|0
8004615|NCT03736785|12604927|FG002|Overall Study|Death|1
8004616|NCT03736785|12604925|FG000|Overall Study|Lost to Follow-up|0
8004617|NCT03736785|12604926|FG001|Overall Study|Lost to Follow-up|2
8004618|NCT03736785|12604927|FG002|Overall Study|Lost to Follow-up|3
8004619|NCT03736785|12604925|FG000|Overall Study|Non compliance with study drug|1
8004620|NCT03736785|12604926|FG001|Overall Study|Non compliance with study drug|1
8004621|NCT03736785|12604927|FG002|Overall Study|Non compliance with study drug|0
8004622|NCT03736785|12604925|FG000|Overall Study|Physician Decision|0
8004623|NCT03736785|12604926|FG001|Overall Study|Physician Decision|1
8004624|NCT03736785|12604927|FG002|Overall Study|Physician Decision|1
8004625|NCT03736785|12604925|FG000|Overall Study|Protocol Violation|1
8004626|NCT03736785|12604926|FG001|Overall Study|Protocol Violation|4
8004627|NCT03736785|12604927|FG002|Overall Study|Protocol Violation|3
8004628|NCT03736785|12604925|FG000|Overall Study|Sponsor Decision|1
8004629|NCT03736785|12604926|FG001|Overall Study|Sponsor Decision|0
8004630|NCT03736785|12604927|FG002|Overall Study|Sponsor Decision|0
8004631|NCT03736785|12604925|FG000|Overall Study|Unknown/Missing data|3
8004632|NCT03736785|12604926|FG001|Overall Study|Unknown/Missing data|2
8004633|NCT03736785|12604927|FG002|Overall Study|Unknown/Missing data|1
8004634|NCT03736785|12604925|FG000|Overall Study|Withdrawal by Subject|9
8004635|NCT03736785|12604926|FG001|Overall Study|Withdrawal by Subject|6
8004636|NCT03736785|12604927|FG002|Overall Study|Withdrawal by Subject|4
8004637|NCT03736031|12604938|FG000|Overall Study|Death|2
8004638|NCT03736031|12604939|FG001|Overall Study|Death|4
8004639|NCT03736031|12604938|FG000|Overall Study|Lost to Follow-up|21
8004640|NCT03736031|12604939|FG001|Overall Study|Lost to Follow-up|2
8004641|NCT03736031|12604938|FG000|Overall Study|Withdrawal by Subject|9
8004642|NCT03736031|12604939|FG001|Overall Study|Withdrawal by Subject|0
8004643|NCT03734991|12604951|FG000|Overall Study|Adverse Event|4
8004644|NCT03734991|12604952|FG001|Overall Study|Adverse Event|0
8004645|NCT03734991|12604951|FG000|Overall Study|Lost to Follow-up|4
8004646|NCT03734991|12604952|FG001|Overall Study|Lost to Follow-up|0
8004647|NCT03734991|12604951|FG000|Overall Study|Physician Decision|0
8004648|NCT03734991|12604952|FG001|Overall Study|Physician Decision|1
8004649|NCT03734991|12604951|FG000|Overall Study|Pregnancy|1
8004650|NCT03734991|12604952|FG001|Overall Study|Pregnancy|0
8004651|NCT03734991|12604951|FG000|Overall Study|Withdrawal by Subject|6
8004652|NCT03734991|12604952|FG001|Overall Study|Withdrawal by Subject|3
8004653|NCT03734991|12604951|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49
8004654|NCT03734991|12604952|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41
8004655|NCT03734991|12604951|FG000|Overall Study|Other|2
8004656|NCT03734991|12604952|FG001|Overall Study|Other|2
8004657|NCT03733899|12604966|FG000|Period 1|Protocol Violation|0
8004658|NCT03733899|12604967|FG001|Period 1|Protocol Violation|0
8004659|NCT03733899|12604968|FG002|Period 1|Protocol Violation|0
8004660|NCT03733899|12604969|FG003|Period 1|Protocol Violation|0
8004661|NCT03733899|12604970|FG004|Period 1|Protocol Violation|0
8004662|NCT03733899|12604971|FG005|Period 1|Protocol Violation|1
8004663|NCT03733899|12604966|FG000|Period 2|Unscuccessful Treatment|0
8004664|NCT03733899|12604967|FG001|Period 2|Unscuccessful Treatment|1
8004665|NCT03733899|12604968|FG002|Period 2|Unscuccessful Treatment|0
8004666|NCT03733899|12604969|FG003|Period 2|Unscuccessful Treatment|0
8004667|NCT03733899|12604970|FG004|Period 2|Unscuccessful Treatment|0
8004668|NCT03733899|12604971|FG005|Period 2|Unscuccessful Treatment|0
8004669|NCT03733899|12604966|FG000|Period 3|Withdrawal by Subject|1
8004670|NCT03733899|12604967|FG001|Period 3|Withdrawal by Subject|0
8004671|NCT03733899|12604968|FG002|Period 3|Withdrawal by Subject|0
8004672|NCT03733899|12604969|FG003|Period 3|Withdrawal by Subject|0
8004673|NCT03733899|12604970|FG004|Period 3|Withdrawal by Subject|0
8004674|NCT03733899|12604971|FG005|Period 3|Withdrawal by Subject|0
8004675|NCT03733470|12604990|FG000|Overall Study|PI Decision|1
8004676|NCT03733470|12604991|FG001|Overall Study|PI Decision|1
8004677|NCT03733301|12605000|FG000|Overall Study|Screen Fail|1
8004678|NCT03733301|12605001|FG001|Overall Study|Screen Fail|0
8004679|NCT03733301|12605002|FG002|Overall Study|Screen Fail|0
8004680|NCT03733301|12605000|FG000|Overall Study|Non-compliance|1
8004681|NCT03733301|12605001|FG001|Overall Study|Non-compliance|0
8004682|NCT03733301|12605002|FG002|Overall Study|Non-compliance|0
8004683|NCT03733301|12605000|FG000|Overall Study|Lack of Efficacy|2
8004684|NCT03733301|12605001|FG001|Overall Study|Lack of Efficacy|3
8004685|NCT03733301|12605002|FG002|Overall Study|Lack of Efficacy|0
8004686|NCT03733301|12605000|FG000|Overall Study|Adverse Event|0
8004687|NCT03733301|12605001|FG001|Overall Study|Adverse Event|1
8004688|NCT03733301|12605002|FG002|Overall Study|Adverse Event|3
8004689|NCT03733301|12605000|FG000|Overall Study|Withdrawal by Subject|3
8004690|NCT03733301|12605001|FG001|Overall Study|Withdrawal by Subject|5
8004691|NCT03733301|12605002|FG002|Overall Study|Withdrawal by Subject|1
8004692|NCT03732638|12605013|FG000|Overall Study|Adverse Event|5
8004693|NCT03732638|12605014|FG001|Overall Study|Adverse Event|2
8004694|NCT03732638|12605013|FG000|Overall Study|Eligibility failure due to baseline laboratory values|8
8004695|NCT03732638|12605014|FG001|Overall Study|Eligibility failure due to baseline laboratory values|13
8004696|NCT03732638|12605013|FG000|Overall Study|Lack of Efficacy|1
8004697|NCT03732638|12605014|FG001|Overall Study|Lack of Efficacy|1
8004698|NCT03732638|12605013|FG000|Overall Study|Lost to Follow-up|19
8004699|NCT03732638|12605014|FG001|Overall Study|Lost to Follow-up|12
8004700|NCT03732638|12605013|FG000|Overall Study|Non-compliance|6
8004701|NCT03732638|12605014|FG001|Overall Study|Non-compliance|5
8004702|NCT03732638|12605013|FG000|Overall Study|Physician Decision|0
8004703|NCT03732638|12605014|FG001|Overall Study|Physician Decision|1
8004704|NCT03732638|12605013|FG000|Overall Study|Protocol deviation|4
8004705|NCT03732638|12605014|FG001|Overall Study|Protocol deviation|5
8004706|NCT03732638|12605013|FG000|Overall Study|Withdrawal by Subject|11
8004707|NCT03732638|12605014|FG001|Overall Study|Withdrawal by Subject|22
8004708|NCT03732248|12605023|FG000|Overall Study|Withdrawal by Subject|1
8004709|NCT03732248|12605024|FG001|Overall Study|Withdrawal by Subject|0
8004710|NCT03731182|12605032|FG000|Overall Study|Lost to Follow-up|2
8004711|NCT03731182|12605033|FG001|Overall Study|Lost to Follow-up|0
8004712|NCT03731182|12605032|FG000|Overall Study|Physician Decision|1
8004713|NCT03731182|12605033|FG001|Overall Study|Physician Decision|0
8004714|NCT03731182|12605032|FG000|Overall Study|Withdrawal By Parent/Guardian|2
8004715|NCT03731182|12605033|FG001|Overall Study|Withdrawal By Parent/Guardian|0
8004716|NCT03730961|12605042|FG000|Overall Study|Adverse Event|0
8004717|NCT03730961|12605043|FG001|Overall Study|Adverse Event|1
8004718|NCT03730103|12605059|FG000|Overall Study|Did not meet inclusion criteria|0
8004719|NCT03730103|12605060|FG001|Overall Study|Did not meet inclusion criteria|5
8004720|NCT03728140|12605090|FG000|Overall Study|Abnormal embryo transfer operation|10
8004721|NCT03728140|12605091|FG001|Overall Study|Abnormal embryo transfer operation|7
8004722|NCT03727347|12605110|FG000|Overall Study|Withdrawal by Subject|2
8004723|NCT03727347|12605110|FG000|Overall Study|Lost to Follow-up|1
8004724|NCT03726996|12605123|FG000|Overall Study|Parent's decision|2
8004725|NCT03726996|12605123|FG000|Overall Study|Study early termination|2
8004726|NCT03725852|12605138|FG000|Overall Study|Death|1
8004727|NCT03725852|12605139|FG001|Overall Study|Death|0
8004728|NCT03725852|12605138|FG000|Overall Study|Withdrawal by Subject|1
8004729|NCT03725852|12605139|FG001|Overall Study|Withdrawal by Subject|0
8004730|NCT03725852|12605138|FG000|Overall Study|Travel restrictions due to COVID-19|2
8004731|NCT03725852|12605139|FG001|Overall Study|Travel restrictions due to COVID-19|0
8004732|NCT03725722|12605150|FG000|Overall Study|Lack of Efficacy|2
8004733|NCT03725722|12605151|FG001|Overall Study|Lack of Efficacy|1
8004734|NCT03725722|12605152|FG002|Overall Study|Lack of Efficacy|2
8004735|NCT03725722|12605153|FG003|Overall Study|Lack of Efficacy|0
8004736|NCT03725722|12605154|FG004|Overall Study|Lack of Efficacy|2
8004737|NCT03725722|12605150|FG000|Overall Study|Adverse Event|2
8004738|NCT03725722|12605151|FG001|Overall Study|Adverse Event|2
8004739|NCT03725722|12605152|FG002|Overall Study|Adverse Event|1
8004740|NCT03725722|12605153|FG003|Overall Study|Adverse Event|0
8004741|NCT03725722|12605154|FG004|Overall Study|Adverse Event|6
8004742|NCT03725722|12605150|FG000|Overall Study|Withdrawal by Subject|4
8004743|NCT03725722|12605151|FG001|Overall Study|Withdrawal by Subject|1
8004744|NCT03725722|12605152|FG002|Overall Study|Withdrawal by Subject|0
8004745|NCT03725722|12605153|FG003|Overall Study|Withdrawal by Subject|4
8004746|NCT03725722|12605154|FG004|Overall Study|Withdrawal by Subject|4
8004747|NCT03725722|12605150|FG000|Overall Study|Lost to Follow-up|3
8004748|NCT03725722|12605151|FG001|Overall Study|Lost to Follow-up|1
8004749|NCT03725722|12605152|FG002|Overall Study|Lost to Follow-up|2
8004750|NCT03725722|12605153|FG003|Overall Study|Lost to Follow-up|2
8004751|NCT03725722|12605154|FG004|Overall Study|Lost to Follow-up|1
8004752|NCT03725722|12605150|FG000|Overall Study|Personal reasons|0
8004753|NCT03725722|12605151|FG001|Overall Study|Personal reasons|0
8004754|NCT03725722|12605152|FG002|Overall Study|Personal reasons|1
8004755|NCT03725722|12605153|FG003|Overall Study|Personal reasons|0
8004756|NCT03725722|12605154|FG004|Overall Study|Personal reasons|1
8004757|NCT03725722|12605150|FG000|Overall Study|COVID-19 situation|0
8004758|NCT03725722|12605151|FG001|Overall Study|COVID-19 situation|1
8004759|NCT03725722|12605152|FG002|Overall Study|COVID-19 situation|0
8004760|NCT03725722|12605153|FG003|Overall Study|COVID-19 situation|0
8004761|NCT03725722|12605154|FG004|Overall Study|COVID-19 situation|0
8004762|NCT03725085|12605175|FG000|Overall Study|Lost to Follow-up|2
8004763|NCT03724981|12605191|FG000|First Device|Protocol Violation|1
8004764|NCT03724981|12605192|FG001|First Device|Protocol Violation|1
8004765|NCT03724968|12605202|FG000|Overall Study|Insurance issues|0
8004766|NCT03724968|12605203|FG001|Overall Study|Insurance issues|1
8004767|NCT03724968|12605202|FG000|Overall Study|Study closed|0
8004768|NCT03724968|12605203|FG001|Overall Study|Study closed|1
8004769|NCT03723070|12605267|FG000|Overall Study|Lost to Follow-up|2
8004770|NCT03723070|12605267|FG000|Overall Study|Physician Decision|1
8004771|NCT03723070|12605267|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6
8004772|NCT03720210|12605271|FG000|Overall Study|Lost to Follow-up|1
8004773|NCT03718143|12605279|FG000|Overall Study|Death|1
8004774|NCT03718143|12605280|FG001|Overall Study|Death|0
8004775|NCT03718143|12605281|FG002|Overall Study|Death|0
8004776|NCT03718143|12605279|FG000|Overall Study|Progression of Disease|1
8004777|NCT03718143|12605280|FG001|Overall Study|Progression of Disease|0
8004778|NCT03718143|12605281|FG002|Overall Study|Progression of Disease|0
8004779|NCT03718143|12605279|FG000|Overall Study|Withdrawal of Informed Consent|1
8004780|NCT03718143|12605280|FG001|Overall Study|Withdrawal of Informed Consent|2
8004781|NCT03718143|12605281|FG002|Overall Study|Withdrawal of Informed Consent|1
8004782|NCT03709576|12605289|FG000|Overall Study|progression prior to enrollment|1
8004783|NCT03704636|12605294|FG000|Overall Study|Inadequate Venous Flow|3
8004784|NCT03694821|12605318|FG000|Overall Study|Study terminated|4
8004785|NCT03694821|12605319|FG001|Overall Study|Study terminated|8
8004786|NCT03694821|12605320|FG002|Overall Study|Study terminated|4
8004787|NCT03686969|12605330|FG000|Overall Study|Study terminated|1
8004788|NCT03686969|12605331|FG001|Overall Study|Study terminated|0
8004789|NCT03682367|12605339|FG000|Overall Study|Protocol Violation|2
8004790|NCT03682367|12605340|FG001|Overall Study|Protocol Violation|1
8004791|NCT03682367|12605339|FG000|Overall Study|Closed Study Early|0
8004792|NCT03682367|12605340|FG001|Overall Study|Closed Study Early|3
8004793|NCT03680911|12605348|FG000|At Home Treatment|Study Termination|3
8004794|NCT03680911|12605349|FG001|At Home Treatment|Study Termination|0
8004795|NCT03680911|12605348|FG000|At Home Treatment|Lost to Follow-up|0
8004796|NCT03680911|12605349|FG001|At Home Treatment|Lost to Follow-up|1
8004797|NCT03680911|12605348|FG000|At Home Treatment|Withdrawal by Subject|0
8004798|NCT03680911|12605349|FG001|At Home Treatment|Withdrawal by Subject|2
8004799|NCT03680911|12605348|FG000|Visit 3 (4 Month Follow up)|Study Termination|0
8004800|NCT03680911|12605349|FG001|Visit 3 (4 Month Follow up)|Study Termination|1
8004801|NCT03656692|12605355|FG000|Overall Study|Worsening of disease activity|2
8004802|NCT03656692|12605355|FG000|Overall Study|Physician Decision|1
8004803|NCT03648983|12605359|FG000|Overall Study|Study was terminated due to PI departure|95
8004804|NCT03643159|12605366|FG000|Overall Study|Adverse Event|1
8004805|NCT03643159|12605366|FG000|Overall Study|Withdrawal by Subject|1
8004806|NCT03630120|12605384|FG000|Overall Study|Disease progression|0
8004807|NCT03630120|12605385|FG001|Overall Study|Disease progression|1
8004808|NCT03630120|12605386|FG002|Overall Study|Disease progression|1
8004809|NCT03630120|12605387|FG003|Overall Study|Disease progression|1
8004810|NCT03615144|12605414|FG000|Overall Study|Participant no longer eligible for this protocol|1
8004811|NCT03615144|12605415|FG001|Overall Study|Participant no longer eligible for this protocol|0
8004812|NCT03605303|12605421|FG000|Period 1|Study Terminated|2
8004813|NCT03605303|12605422|FG001|Period 1|Study Terminated|1
8004814|NCT03600740|12605428|FG000|Overall Study|Surgical plan was altered-subject not eligible|1
8004815|NCT03598140|12605434|FG000|Overall Study|enrolled but didn't start|1
8004816|NCT03598140|12605435|FG001|Overall Study|enrolled but didn't start|0
8004817|NCT03598036|12605443|FG000|Overall Study|Withdrawal by Subject|1
8004818|NCT03598036|12605444|FG001|Overall Study|Withdrawal by Subject|0
8004819|NCT03590743|12605463|FG000|Overall Study|Withdrawal by Subject|0
8004820|NCT03590743|12605464|FG001|Overall Study|Withdrawal by Subject|1
8004821|NCT03580382|12605472|FG000|Overall Study|Early Termination of Study|0
8004822|NCT03580382|12605473|FG001|Overall Study|Early Termination of Study|3
8004823|NCT03571646|12605480|FG000|Overall Study|Adverse Event|1
8004824|NCT03571646|12605481|FG001|Overall Study|Adverse Event|0
8004825|NCT03571646|12605480|FG000|Overall Study|Withdrawal by Subject|1
8004826|NCT03571646|12605481|FG001|Overall Study|Withdrawal by Subject|1
8004827|NCT03543358|12605504|FG000|Overall Study|Death|1
8004828|NCT03543358|12605505|FG001|Overall Study|Death|0
8004829|NCT03543358|12605504|FG000|Overall Study|Disease Progression|1
8004830|NCT03543358|12605505|FG001|Overall Study|Disease Progression|0
8004831|NCT03543358|12605504|FG000|Overall Study|Parent Study Closure|1
8004832|NCT03543358|12605505|FG001|Overall Study|Parent Study Closure|0
8004833|NCT03509207|12605533|FG000|Overall Study|Death|2
8004834|NCT03500341|12605550|FG000|Overall Study|Withdrawn prior to Completion|2
8004835|NCT03500159|12605556|FG000|Overall Study|Study Terminated|2
8004836|NCT03500159|12605557|FG001|Overall Study|Study Terminated|1
8004837|NCT03477903|12605583|FG000|Overall Study|Study Terminated by Sponsor|1
8004838|NCT03469258|12605587|FG000|Overall Study|Upon surgery, did not meet criteria|4
8004839|NCT03466658|12605591|FG000|Overall Study|Withdrawal by Subject|3
8004840|NCT03465891|12605599|FG000|Overall Study|Withdrawal by Subject|0
8004841|NCT03465891|12605600|FG001|Overall Study|Withdrawal by Subject|1
8004842|NCT03465891|12605599|FG000|Overall Study|Disease progression|1
8004843|NCT03465891|12605600|FG001|Overall Study|Disease progression|0
8004844|NCT03387059|12605669|FG000|Overall Study|Study termination|5
8004845|NCT03387059|12605670|FG001|Overall Study|Study termination|4
8004846|NCT03379233|12605687|FG000|Overall Study|Technical issues with Concept 2 inhalers|1
8004847|NCT03379233|12605688|FG001|Overall Study|Technical issues with Concept 2 inhalers|6
8004848|NCT03361228|12605704|FG000|Overall Study|Other|1
8004849|NCT03361228|12605705|FG001|Overall Study|Other|1
8004850|NCT03361228|12605704|FG000|Overall Study|Death|3
8004851|NCT03361228|12605705|FG001|Overall Study|Death|0
8004852|NCT03359174|12605720|FG000|Overall Study|Adverse Event|1
8004853|NCT03348904|12605731|FG000|Overall Study|Administrative reason by the sponsor|0
8004854|NCT03348904|12605732|FG001|Overall Study|Administrative reason by the sponsor|1
8004855|NCT03348904|12605733|FG002|Overall Study|Administrative reason by the sponsor|0
8004856|NCT03345901|12605741|FG000|Overall Study|The study was terminated|18
8004857|NCT03344562|12605748|FG000|Overall Study|Withdrawal by Subject|2
8004858|NCT03344562|12605749|FG001|Overall Study|Withdrawal by Subject|0
8004859|NCT03342638|12605757|FG000|Overall Study|Withdrawal by Subject|1
8004860|NCT03342638|12605758|FG001|Overall Study|Withdrawal by Subject|0
8004861|NCT03342638|12605757|FG000|Overall Study|Physician Decision|0
8004862|NCT03342638|12605758|FG001|Overall Study|Physician Decision|1
8004863|NCT03339401|12605775|FG000|Overall Study|Death|2
8004864|NCT03339401|12605776|FG001|Overall Study|Death|1
8004865|NCT03339401|12605775|FG000|Overall Study|Withdrawal by Subject|2
8004866|NCT03339401|12605776|FG001|Overall Study|Withdrawal by Subject|0
8004867|NCT03339401|12605775|FG000|Overall Study|Study terminated|4
8004868|NCT03339401|12605776|FG001|Overall Study|Study terminated|3
8004869|NCT03339401|12605775|FG000|Overall Study|Investigator Decision|1
8004870|NCT03339401|12605776|FG001|Overall Study|Investigator Decision|0
8004871|NCT03339245|12605784|FG000|Overall Study|Adverse Event|1
8004872|NCT03339245|12605785|FG001|Overall Study|Adverse Event|1
8004873|NCT03339245|12605784|FG000|Overall Study|Withdrawal by Subject|1
8004874|NCT03339245|12605785|FG001|Overall Study|Withdrawal by Subject|0
8004875|NCT03329404|12605797|FG000|Overall Study|The study was suspended.|1
8004876|NCT03329404|12605798|FG001|Overall Study|The study was suspended.|4
8004877|NCT03326869|12605806|FG000|Overall Study|Study data has been lost to natural disa|1
8004878|NCT03326869|12605807|FG001|Overall Study|Study data has been lost to natural disa|1
8004879|NCT03305055|12605832|FG000|Overall Study|Withdrawal by Subject|0
8004880|NCT03305055|12605833|FG001|Overall Study|Withdrawal by Subject|1
8004881|NCT03305055|12605832|FG000|Overall Study|Adverse Event|1
8004882|NCT03305055|12605833|FG001|Overall Study|Adverse Event|1
8004883|NCT03303469|12605839|FG000|Overall Study|Lost to Follow-up|2
8004884|NCT03302247|12605843|FG000|Overall Study|the study has closed prematurely|2
8004885|NCT03302247|12605843|FG000|Overall Study|Death|1
8004886|NCT03300024|12605849|FG000|Overall Study|Physician Decision|4
8004887|NCT03300024|12605850|FG001|Overall Study|Physician Decision|6
8004888|NCT03283709|12605860|FG000|Overall Study|trial terminated|0
8004889|NCT03283709|12605861|FG001|Overall Study|trial terminated|1
8004890|NCT03263806|12605896|FG000|Overall Study|Elevated Troponin (failed screen)|1
8004891|NCT03263806|12605897|FG001|Overall Study|Elevated Troponin (failed screen)|0
8004892|NCT03263806|12605896|FG000|Overall Study|Withdrawal by Subject|0
8004893|NCT03263806|12605897|FG001|Overall Study|Withdrawal by Subject|1
8004894|NCT03263806|12605896|FG000|Overall Study|Study Termination|5
8004895|NCT03263806|12605897|FG001|Overall Study|Study Termination|6
8004896|NCT03261531|12605903|FG000|Overall Study|Withdrawal by Subject|4
8004897|NCT03219372|12605909|FG000|Overall Study|Withdrawal by Subject|1
8004898|NCT03219372|12605910|FG001|Overall Study|Withdrawal by Subject|0
8004899|NCT03217175|12605916|FG000|Overall Study|Physician Decision|4
8004900|NCT03217175|12605917|FG001|Overall Study|Physician Decision|1
8004901|NCT03223662|12605944|FG000|Overall Study|Physician Decision|1
8004902|NCT03223662|12605944|FG000|Overall Study|Study closure|1
8004903|NCT03212144|12605950|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1
8004904|NCT03212144|12605951|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0
8004905|NCT03212144|12605950|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1
8004906|NCT03212144|12605951|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1
8004907|NCT03204539|12605967|FG000|Overall Study|Loss of funding|0
8004908|NCT03204539|12605968|FG001|Overall Study|Loss of funding|1
8004909|NCT03206216|12605976|FG000|Overall Study|Withdrawal by Subject|0
8004910|NCT03206216|12605977|FG001|Overall Study|Withdrawal by Subject|1
8004911|NCT03195660|12605983|FG000|Overall Study|The study was terminated|2
8004912|NCT03166618|12605993|FG000|Overall Study|Study was Terminated|0
8004913|NCT03166618|12605994|FG001|Overall Study|Study was Terminated|1
8004914|NCT03169530|12606002|FG000|Overall Study|Study ended by NIH|15
8004915|NCT03169530|12606003|FG001|Overall Study|Study ended by NIH|17
8004916|NCT03151226|12606018|FG000|Overall Study|Withdrawal by Subject|2
8004917|NCT03151226|12606018|FG000|Overall Study|not wear device correctly|1
8004918|NCT03168906|12606033|FG000|Overall Study|Lack of Efficacy|6
8004919|NCT03168906|12606034|FG001|Overall Study|Lack of Efficacy|6
8004920|NCT03178201|12606041|FG000|Overall Study|Off study|5
8004921|NCT03172026|12606047|FG000|Overall Study|Withdrawal by Subject|1
8004922|NCT03172026|12606048|FG001|Overall Study|Withdrawal by Subject|0
8004923|NCT03172026|12606047|FG000|Overall Study|COVID restrictions|1
8004924|NCT03172026|12606048|FG001|Overall Study|COVID restrictions|0
8004925|NCT03152526|12606057|FG000|Overall Study|Withdrawal by Subject|0
8004926|NCT03152526|12606058|FG001|Overall Study|Withdrawal by Subject|1
8004927|NCT03123393|12606093|FG000|Overall Study|Study Terminated by Sponsor|6
8004928|NCT03123393|12606094|FG001|Overall Study|Study Terminated by Sponsor|9
8004929|NCT03123393|12606093|FG000|Overall Study|Withdrawal by Subject|2
8004930|NCT03123393|12606094|FG001|Overall Study|Withdrawal by Subject|1
8004931|NCT03123393|12606093|FG000|Overall Study|Reason not Specified|13
8004932|NCT03123393|12606094|FG001|Overall Study|Reason not Specified|13
8004933|NCT03119662|12606106|FG000|Overall Study|Withdrawal by Subject|0
8004934|NCT03119662|12606107|FG001|Overall Study|Withdrawal by Subject|1
8004935|NCT03120676|12606122|FG000|Overall Study|Not treated|1
8004936|NCT03113071|12606147|FG000|Overall Study|Withdrawal by Subject|1
8004937|NCT03113071|12606148|FG001|Overall Study|Withdrawal by Subject|0
8004938|NCT03110900|12606156|FG000|Overall Study|Sponsor withdrew|1
8004939|NCT03110900|12606157|FG001|Overall Study|Sponsor withdrew|1
8004940|NCT03078868|12606163|FG000|Overall Study|Physician Decision|3
8004941|NCT03065933|12606176|FG000|Overall Study|study terminated|5
8004942|NCT03070002|12606180|FG000|Follow up for 2 Years|Death|1
8004943|NCT03058705|12606184|FG000|Overall Study|Withdrawal by Subject|2
8004944|NCT03058705|12606184|FG000|Overall Study|Physician Decision|2
8004945|NCT03053518|12606206|FG000|Overall Study|Withdrawal by Subject|3
8004946|NCT03053518|12606206|FG000|Overall Study|Lost to Follow-up|2
8004947|NCT03053518|12606206|FG000|Overall Study|Ineligible|5
8004948|NCT03050398|12606210|FG000|Overall Study|Study terminated by sponsor|8
8004949|NCT03029832|12606228|FG000|Overall Study|Safety Follow-Up Completed|2
8004950|NCT03029832|12606229|FG001|Overall Study|Safety Follow-Up Completed|0
8004951|NCT03029832|12606228|FG000|Overall Study|Death due to Disease Progression|1
8004952|NCT03029832|12606229|FG001|Overall Study|Death due to Disease Progression|0
8004953|NCT03029832|12606228|FG000|Overall Study|Study Terminated By Sponsor|1
8004954|NCT03029832|12606229|FG001|Overall Study|Study Terminated By Sponsor|1
8004955|NCT03010423|12606264|FG000|Overall Study|Study termination|8
8004956|NCT02991430|12606280|FG000|Treatment Period 1|Adverse Event|1
8004957|NCT02991430|12606281|FG001|Treatment Period 1|Adverse Event|0
8004958|NCT02991430|12606282|FG002|Treatment Period 1|Adverse Event|2
8004959|NCT02991430|12606280|FG000|Treatment Period 1|Withdrawal by Subject|0
8004960|NCT02991430|12606281|FG001|Treatment Period 1|Withdrawal by Subject|4
8004961|NCT02991430|12606282|FG002|Treatment Period 1|Withdrawal by Subject|0
8004962|NCT02991430|12606280|FG000|Treatment Period 2|Study Termination|6
8004963|NCT02991430|12606281|FG001|Treatment Period 2|Study Termination|3
8004964|NCT02991430|12606282|FG002|Treatment Period 2|Study Termination|3
8004965|NCT02991430|12606280|FG000|Treatment Period 2|Lost to Follow-up|0
8004966|NCT02991430|12606281|FG001|Treatment Period 2|Lost to Follow-up|0
8004967|NCT02991430|12606282|FG002|Treatment Period 2|Lost to Follow-up|1
8004968|NCT02991430|12606280|FG000|Post-treatment Observation Period|Study Termination|3
8004969|NCT02991430|12606281|FG001|Post-treatment Observation Period|Study Termination|6
8004970|NCT02991430|12606282|FG002|Post-treatment Observation Period|Study Termination|5
8004971|NCT02978833|12606315|FG000|Overall Study|Study terminated|1
8004972|NCT02978833|12606316|FG001|Overall Study|Study terminated|1
8004973|NCT02966223|12606353|FG000|Overall Study|Physician Decision|3
8004974|NCT02966223|12606353|FG000|Overall Study|Withdrawal by Subject|11
8004975|NCT02966223|12606353|FG000|Overall Study|Lost to Follow-up|1
8004976|NCT02965846|12606360|FG000|Overall Study|Lost to Follow-up|1
8004977|NCT02965846|12606361|FG001|Overall Study|Lost to Follow-up|0
8004978|NCT02965846|12606362|FG002|Overall Study|Lost to Follow-up|0
8004979|NCT02965846|12606360|FG000|Overall Study|Withdrawal by Subject|0
8004980|NCT02965846|12606361|FG001|Overall Study|Withdrawal by Subject|1
8004981|NCT02965846|12606362|FG002|Overall Study|Withdrawal by Subject|0
8004982|NCT02965846|12606360|FG000|Overall Study|Study Terminated By Sponsor|4
8004983|NCT02965846|12606361|FG001|Overall Study|Study Terminated By Sponsor|4
8004984|NCT02965846|12606362|FG002|Overall Study|Study Terminated By Sponsor|0
8004985|NCT02965846|12606360|FG000|Overall Study|Participants not randomized|0
8004986|NCT02965846|12606361|FG001|Overall Study|Participants not randomized|0
8004987|NCT02965846|12606362|FG002|Overall Study|Participants not randomized|33
8004988|NCT02956005|12606383|FG000|Overall Study|Not eligible|1
8004989|NCT02956005|12606383|FG000|Overall Study|Withdrawal by Subject|3
8004990|NCT02956005|12606383|FG000|Overall Study|Physician Decision|12
8004991|NCT02940223|12606398|FG000|Overall Study|Failed Requirement|2
8004992|NCT02940223|12606399|FG001|Overall Study|Failed Requirement|0
8004993|NCT02954159|12606407|FG000|Overall Study|Study ended prematurely due to low enrol|1
8004994|NCT02954159|12606408|FG001|Overall Study|Study ended prematurely due to low enrol|0
8004995|NCT02954159|12606407|FG000|Overall Study|Withdrawal by Subject|0
8004996|NCT02954159|12606408|FG001|Overall Study|Withdrawal by Subject|1
8004997|NCT02954952|12606417|FG000|Overall Study|Withdrawal by Subject|1
8004998|NCT02954952|12606418|FG001|Overall Study|Withdrawal by Subject|0
8004999|NCT02954952|12606419|FG002|Overall Study|Withdrawal by Subject|0
8005000|NCT02954952|12606417|FG000|Overall Study|No data collected|0
8005001|NCT02954952|12606418|FG001|Overall Study|No data collected|1
8005002|NCT02954952|12606419|FG002|Overall Study|No data collected|0
8005003|NCT02947022|12606431|FG000|Overall Study|Study Stopped|1
8005004|NCT02950480|12606446|FG000|Overall Study|Withdrawal by Subject|1
8005005|NCT02950480|12606447|FG001|Overall Study|Withdrawal by Subject|0
8005006|NCT02949947|12606455|FG000|Overall Study|Non Compliance|0
8005007|NCT02949947|12606456|FG001|Overall Study|Non Compliance|1
8005008|NCT02949947|12606455|FG000|Overall Study|Insurance change|1
8005009|NCT02949947|12606456|FG001|Overall Study|Insurance change|0
8005010|NCT02947100|12606462|FG000|Overall Study|study terminated early|3
8005011|NCT02947100|12606462|FG000|Overall Study|did not meet inclusion criteria|1
8005012|NCT02908516|12606483|FG000|Overall Study|Study Terminated|3
8005013|NCT02908516|12606484|FG001|Overall Study|Study Terminated|3
8005014|NCT02923830|12606492|FG000|Overall Study|Physician Decision|13
8005015|NCT02923830|12606493|FG001|Overall Study|Physician Decision|15
8005016|NCT02920450|12606499|FG000|Overall Study|Death|1
8005017|NCT02920450|12606500|FG001|Overall Study|Death|0
8005018|NCT02920450|12606501|FG002|Overall Study|Death|0
8005019|NCT02920450|12606502|FG003|Overall Study|Death|0
8005020|NCT02920450|12606499|FG000|Overall Study|Withdrawal by Subject|1
8005021|NCT02920450|12606500|FG001|Overall Study|Withdrawal by Subject|0
8005022|NCT02920450|12606501|FG002|Overall Study|Withdrawal by Subject|0
8005023|NCT02920450|12606502|FG003|Overall Study|Withdrawal by Subject|0
8005024|NCT02920177|12606511|FG000|Overall Study|Withdrawal by Subject|1
8005025|NCT02920177|12606512|FG001|Overall Study|Withdrawal by Subject|1
8005026|NCT02920177|12606511|FG000|Overall Study|Physician Decision|1
8005027|NCT02920177|12606512|FG001|Overall Study|Physician Decision|0
8005028|NCT02920177|12606511|FG000|Overall Study|Lost to Follow-up|0
8005029|NCT02920177|12606512|FG001|Overall Study|Lost to Follow-up|1
8005030|NCT02926638|12606520|FG000|Overall Study|Progression|2
8005031|NCT02926638|12606521|FG001|Overall Study|Progression|5
8005032|NCT02926638|12606520|FG000|Overall Study|Ineligible|1
8005033|NCT02926638|12606521|FG001|Overall Study|Ineligible|0
8005034|NCT02926638|12606520|FG000|Overall Study|Not protocol specified|1
8005035|NCT02926638|12606521|FG001|Overall Study|Not protocol specified|0
8005036|NCT02920242|12606530|FG000|Overall Study|Withdrawal by Subject|1
8005037|NCT02920242|12606531|FG001|Overall Study|Withdrawal by Subject|0
8005038|NCT02920242|12606532|FG002|Overall Study|Withdrawal by Subject|1
8005039|NCT02920242|12606530|FG000|Overall Study|Did not meet inc./exc. criteria|1
8005040|NCT02920242|12606531|FG001|Overall Study|Did not meet inc./exc. criteria|0
8005041|NCT02920242|12606532|FG002|Overall Study|Did not meet inc./exc. criteria|0
8005042|NCT02899728|12606564|FG000|Overall Study|Withdrawal by Subject|1
8005043|NCT02899728|12606565|FG001|Overall Study|Withdrawal by Subject|1
8005044|NCT02875067|12606571|FG000|Overall Study|Withdrawal by Subject|1
8005045|NCT02875067|12606571|FG000|Overall Study|Withdrawal by Termination of Study|5
8005046|NCT02860169|12606586|FG000|Part A|Withdrawal by Subject|1
8005047|NCT02860169|12606586|FG000|Part A|Other (Screening failure)|6
8005048|NCT02860169|12606586|FG000|Part A|Other (Survey not completed)|3
8005049|NCT02860169|12606586|FG000|Part A|Other (did not completed consent)|1
8005050|NCT02860169|12606586|FG000|Part B|Other (Screening failure)|10
8005051|NCT02860169|12606586|FG000|Part B|Withdrawal by Subject|1
8005052|NCT02860169|12606586|FG000|Part C|Other (Screening failure)|1
8005053|NCT02865395|12606595|FG000|Overall Study|Physician Decision|6
8005054|NCT02865395|12606596|FG001|Overall Study|Physician Decision|10
8005055|NCT02865395|12606597|FG002|Overall Study|Physician Decision|7
8005056|NCT02868892|12606605|FG000|Overall Study|Investigator left site and no follow-up|6
8005057|NCT02865083|12606611|FG000|Overall Study|Early Termination|3
8005058|NCT02865083|12606612|FG001|Overall Study|Early Termination|1
8005059|NCT02865122|12606621|FG000|Overall Study|Adverse Event|1
8005060|NCT02865122|12606622|FG001|Overall Study|Adverse Event|0
8005061|NCT02865122|12606623|FG002|Overall Study|Adverse Event|0
8005062|NCT02865915|12606633|FG000|Overall Study|Pregnancy|1
8005063|NCT02865915|12606634|FG001|Overall Study|Pregnancy|0
8005064|NCT02865915|12606633|FG000|Overall Study|Withdrawal by Subject|1
8005065|NCT02865915|12606634|FG001|Overall Study|Withdrawal by Subject|1
8005066|NCT02865915|12606633|FG000|Overall Study|Adverse Event|0
8005067|NCT02865915|12606634|FG001|Overall Study|Adverse Event|4
8005068|NCT02865915|12606633|FG000|Overall Study|Lost to Follow-up|0
8005069|NCT02865915|12606634|FG001|Overall Study|Lost to Follow-up|1
8005070|NCT02865915|12606633|FG000|Overall Study|Protocol Violation|0
8005071|NCT02865915|12606634|FG001|Overall Study|Protocol Violation|1
8005072|NCT02865915|12606633|FG000|Overall Study|Study terminated by sponsor|23
8005073|NCT02865915|12606634|FG001|Overall Study|Study terminated by sponsor|18
8005074|NCT02865915|12606633|FG000|Overall Study|Dosing group discontinued|0
8005075|NCT02865915|12606634|FG001|Overall Study|Dosing group discontinued|5
8005076|NCT02855411|12606640|FG000|Overall Study|Study terminated by sponsor|21
8005077|NCT02855411|12606640|FG000|Overall Study|Does not meet entrance criteria|14
8005078|NCT02828124|12606648|FG000|Overall Study|Disease Progression|1
8005079|NCT02828124|12606649|FG001|Overall Study|Disease Progression|2
8005080|NCT02828124|12606650|FG002|Overall Study|Disease Progression|1
8005081|NCT02828124|12606651|FG003|Overall Study|Disease Progression|4
8005082|NCT02828124|12606648|FG000|Overall Study|AE Unrelated to Study Drug|0
8005083|NCT02828124|12606649|FG001|Overall Study|AE Unrelated to Study Drug|0
8005084|NCT02828124|12606650|FG002|Overall Study|AE Unrelated to Study Drug|0
8005085|NCT02828124|12606651|FG003|Overall Study|AE Unrelated to Study Drug|1
8005086|NCT02828124|12606648|FG000|Overall Study|Subject Withdrew Consent|0
8005087|NCT02828124|12606649|FG001|Overall Study|Subject Withdrew Consent|0
8005088|NCT02828124|12606650|FG002|Overall Study|Subject Withdrew Consent|0
8005089|NCT02828124|12606651|FG003|Overall Study|Subject Withdrew Consent|1
7718390|NCT00527826|12142349|FG000|Overall Study|Participant moved away|0
7718391|NCT00527826|12142350|FG001|Overall Study|Participant moved away|1
7718392|NCT00527904|12142366|FG000|Overall Study|Adverse Event|45
7718393|NCT00527904|12142366|FG000|Overall Study|Withdrawal by Subject|21
7718394|NCT00527904|12142366|FG000|Overall Study|Lost to Follow-up|8
7718395|NCT00527904|12142366|FG000|Overall Study|misc|22
8005090|NCT02825043|12606670|FG000|Overall Study|Lost to Follow-up|4
8005091|NCT02819804|12606674|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1
8005092|NCT02809118|12606681|FG000|Overall Study|Withdrawal by Subject|0
8005093|NCT02809118|12606682|FG001|Overall Study|Withdrawal by Subject|1
8005094|NCT02809118|12606683|FG002|Overall Study|Withdrawal by Subject|1
8005095|NCT02806960|12606719|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3
8005096|NCT02806960|12606720|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3
8005097|NCT02806960|12606721|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3
8005098|NCT02806960|12606722|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3
8005099|NCT02815397|12606732|FG000|Overall Study|Physician Decision|2
8005100|NCT02802592|12606736|FG000|Overall Study|Study terminated due to loss of funding|4
8005101|NCT02730793|12606761|FG000|Overall Study|Physician Decision|0
8005102|NCT02730793|12606762|FG001|Overall Study|Physician Decision|1
8005103|NCT02730793|12606761|FG000|Overall Study|Withdrawal by Subject|0
8005104|NCT02730793|12606762|FG001|Overall Study|Withdrawal by Subject|1
8005105|NCT02760602|12606779|FG000|Overall Study|Withdrawal by Subject|1
8005106|NCT02760602|12606780|FG001|Overall Study|Withdrawal by Subject|0
8005107|NCT02760602|12606779|FG000|Overall Study|Terminated by sponsor|12
8005108|NCT02760602|12606780|FG001|Overall Study|Terminated by sponsor|13
8005109|NCT02757521|12606788|FG000|Overall Study|Adverse Event|1
8005110|NCT02757521|12606789|FG001|Overall Study|Adverse Event|0
8005111|NCT02725671|12606842|FG000|Overall Study|Lost to Follow-up|1
8005112|NCT02732327|12606863|FG000|Overall Study|Protocol Violation|0
8005113|NCT02732327|12606864|FG001|Overall Study|Protocol Violation|1
8005114|NCT02726399|12606870|FG000|Overall Study|Participant Non-Compliance|1
8005115|NCT02726399|12606870|FG000|Overall Study|Adverse Event|2
7718396|NCT00528112|12142381|FG000|Treatment up to 3 Years|Adverse Event|313
7718397|NCT00528112|12142382|FG001|Treatment up to 3 Years|Adverse Event|278
7718398|NCT00528112|12142381|FG000|Treatment up to 3 Years|Withdrawal by Subject|26
8005116|NCT02726399|12606870|FG000|Overall Study|Progression of disease|4
8005117|NCT02720510|12606876|FG000|Overall Study|Study Terminated by the sponsor|2
8005118|NCT02720510|12606877|FG001|Overall Study|Study Terminated by the sponsor|0
8005119|NCT02720510|12606876|FG000|Overall Study|Adverse Event|0
8005120|NCT02720510|12606877|FG001|Overall Study|Adverse Event|1
8005121|NCT02720510|12606876|FG000|Overall Study|Physician Decision|1
8005122|NCT02720510|12606877|FG001|Overall Study|Physician Decision|2
8005123|NCT02715765|12606886|FG000|Overall Study|Study Termination|3
8005124|NCT02715765|12606887|FG001|Overall Study|Study Termination|0
8005125|NCT02715765|12606888|FG002|Overall Study|Study Termination|0
8005126|NCT02717130|12606907|FG000|Overall Study|Withdrawal by Subject|1
8005127|NCT02717130|12606907|FG000|Overall Study|Adverse Event|1
8005128|NCT02717130|12606907|FG000|Overall Study|Physician Decision|1
8005129|NCT02717130|12606907|FG000|Overall Study|Study Closure|4
8005130|NCT02685202|12606911|FG000|Overall Study|Lost to Follow-up|9
8005131|NCT02709083|12606915|FG000|Overall Study|Original PI left institution|7
8005132|NCT02693171|12606919|FG000|Overall Study|Adverse Event|1
8005133|NCT02693171|12606919|FG000|Overall Study|Discontinuation of Study by Sponsor|8
8005134|NCT02696226|12606927|FG000|Overall Study|Study terminated - lack of enrollment|1
8005135|NCT02696226|12606928|FG001|Overall Study|Study terminated - lack of enrollment|0
8005136|NCT02696226|12606929|FG002|Overall Study|Study terminated - lack of enrollment|2
8005137|NCT02696226|12606930|FG003|Overall Study|Study terminated - lack of enrollment|0
8005138|NCT02693743|12606942|FG000|Overall Study|Physician Decision|1
8005139|NCT02693743|12606943|FG001|Overall Study|Physician Decision|0
8005140|NCT02706691|12606949|FG000|Overall Study|Adverse Event|1
8005141|NCT02694757|12606967|FG000|Overall Study|Lack of Efficacy|3
8005142|NCT02693002|12606973|FG000|Overall Study|Withdrawal by Subject|1
8005143|NCT02693002|12606974|FG001|Overall Study|Withdrawal by Subject|0
8005144|NCT02689518|12606980|FG000|Overall Study|Withdrawal by Subject|3
8005145|NCT02673684|12607011|FG000|Overall Study|Study not completed d/t loss of funding|9
8005146|NCT02673684|12607012|FG001|Overall Study|Study not completed d/t loss of funding|8
8005147|NCT02674204|12607022|FG000|Overall Study|Adverse Event|1
8005148|NCT02674204|12607023|FG001|Overall Study|Adverse Event|0
8005149|NCT02671461|12607045|FG000|Treatment|Adverse Event|0
8005150|NCT02671461|12607046|FG001|Treatment|Adverse Event|0
8005151|NCT02671461|12607047|FG002|Treatment|Adverse Event|1
8005152|NCT02671461|12607045|FG000|Treatment|Administrative Reason by Sponsor|1
8005153|NCT02671461|12607046|FG001|Treatment|Administrative Reason by Sponsor|3
8005154|NCT02671461|12607047|FG002|Treatment|Administrative Reason by Sponsor|4
8005155|NCT02671461|12607045|FG000|Treatment|Randomized, not treated|1
8005156|NCT02671461|12607046|FG001|Treatment|Randomized, not treated|0
8005157|NCT02671461|12607047|FG002|Treatment|Randomized, not treated|0
8005158|NCT02671461|12607045|FG000|Follow-up|Withdrawal by Subject|1
8005159|NCT02671461|12607046|FG001|Follow-up|Withdrawal by Subject|0
8005160|NCT02671461|12607047|FG002|Follow-up|Withdrawal by Subject|0
8005161|NCT02671461|12607045|FG000|Follow-up|Lost to Follow-up|0
8005162|NCT02671461|12607046|FG001|Follow-up|Lost to Follow-up|0
8005163|NCT02671461|12607047|FG002|Follow-up|Lost to Follow-up|1
8005164|NCT02671461|12607045|FG000|Follow-up|Administrative Reason by Sponsor|0
8005165|NCT02671461|12607046|FG001|Follow-up|Administrative Reason by Sponsor|1
8005166|NCT02671461|12607047|FG002|Follow-up|Administrative Reason by Sponsor|0
8005167|NCT02653495|12607118|FG000|Overall Study|Lost to Follow-up|2
8005168|NCT02653495|12607119|FG001|Overall Study|Lost to Follow-up|0
8005169|NCT02653495|12607118|FG000|Overall Study|Screening Failure|10
8005170|NCT02653495|12607119|FG001|Overall Study|Screening Failure|0
8005171|NCT02639390|12607131|FG000|Overall Study|Subject unable to comply with treatment schedule.|0
8005172|NCT02639390|12607132|FG001|Overall Study|Subject unable to comply with treatment schedule.|2
8005173|NCT02634606|12607138|FG000|Overall Study|unable to obtain the drug at start|13
8005174|NCT02636283|12607152|FG000|Overall Study|Adverse Event|2
8005175|NCT02636283|12607153|FG001|Overall Study|Adverse Event|0
8005176|NCT02636283|12607152|FG000|Overall Study|Trial Terminated Prematurely|0
8005177|NCT02636283|12607153|FG001|Overall Study|Trial Terminated Prematurely|3
8005178|NCT02638129|12607161|FG000|Overall Study|Study terminated|28
8005179|NCT02638129|12607162|FG001|Overall Study|Study terminated|30
8005180|NCT02615990|12607170|FG000|Overall Study|study terminated|1
8005181|NCT02615990|12607171|FG001|Overall Study|study terminated|1
8005182|NCT02640677|12607177|FG000|Overall Study|Lost to Follow-up|1
8005183|NCT02640677|12607177|FG000|Overall Study|Withdrawal by Subject|1
8005184|NCT02623959|12607187|FG000|Overall Study|Progression|0
8005185|NCT02623959|12607188|FG001|Overall Study|Progression|1
8005186|NCT02631148|12607198|FG000|Overall Study|8 were ineligible|8
8005187|NCT02631148|12607199|FG001|Overall Study|8 were ineligible|0
8005188|NCT02631148|12607198|FG000|Overall Study|Withdrawal by Subject|1
8005189|NCT02631148|12607199|FG001|Overall Study|Withdrawal by Subject|0
8005190|NCT02631148|12607198|FG000|Overall Study|PAH not available to study participant|1
8005191|NCT02631148|12607199|FG001|Overall Study|PAH not available to study participant|0
8005192|NCT02630472|12607207|FG000|Overall Study|Physician Decision|10
8005193|NCT02630472|12607208|FG001|Overall Study|Physician Decision|0
8005194|NCT02626520|12607217|FG000|Overall Study|Physician Decision|1
8005195|NCT02626520|12607218|FG001|Overall Study|Physician Decision|1
8005196|NCT02626520|12607217|FG000|Overall Study|Adverse Event|0
8005197|NCT02626520|12607218|FG001|Overall Study|Adverse Event|4
8005198|NCT02626520|12607217|FG000|Overall Study|Lack of Efficacy|0
8005199|NCT02626520|12607218|FG001|Overall Study|Lack of Efficacy|2
8005200|NCT02626520|12607217|FG000|Overall Study|Did not start protocol therapy|0
8005201|NCT02626520|12607218|FG001|Overall Study|Did not start protocol therapy|2
8005202|NCT02626520|12607217|FG000|Overall Study|Study terminated|0
8005203|NCT02626520|12607218|FG001|Overall Study|Study terminated|1
8005204|NCT02614898|12607226|FG000|Overall Study|Participated until study termination|10
8005205|NCT02614898|12607227|FG001|Overall Study|Participated until study termination|26
8005206|NCT02614898|12607226|FG000|Overall Study|Lost to Follow-up|0
8005207|NCT02614898|12607227|FG001|Overall Study|Lost to Follow-up|2
8005208|NCT02614898|12607226|FG000|Overall Study|Physician Decision|1
8005209|NCT02614898|12607227|FG001|Overall Study|Physician Decision|8
8005210|NCT02614898|12607226|FG000|Overall Study|Study Terminated by Sponsor|3
8005211|NCT02614898|12607227|FG001|Overall Study|Study Terminated by Sponsor|0
8005212|NCT02614898|12607226|FG000|Overall Study|Withdrawal by Subject|0
8005213|NCT02614898|12607227|FG001|Overall Study|Withdrawal by Subject|2
8005214|NCT02614898|12607226|FG000|Overall Study|Withdrawal by Parent/Guardian|1
8005215|NCT02614898|12607227|FG001|Overall Study|Withdrawal by Parent/Guardian|1
8005216|NCT02614898|12607226|FG000|Overall Study|Other-Additional Information Unavailable|0
8005217|NCT02614898|12607227|FG001|Overall Study|Other-Additional Information Unavailable|11
8005218|NCT02614898|12607226|FG000|Overall Study|Missing|0
8005219|NCT02614898|12607227|FG001|Overall Study|Missing|1
8005220|NCT02622828|12607234|FG000|Overall Study|participant withdrew|3
8005221|NCT02619812|12607260|FG000|Overall Study|Withdrawal by Subject|0
8005222|NCT02619812|12607261|FG001|Overall Study|Withdrawal by Subject|0
8005223|NCT02619812|12607262|FG002|Overall Study|Withdrawal by Subject|1
8005224|NCT02619812|12607263|FG003|Overall Study|Withdrawal by Subject|2
8005225|NCT02612285|12607273|FG000|Overall Study|Withdrawal by Subject|1
8005226|NCT02606279|12607283|FG000|Overall Study|Lost to Follow-up|0
8005227|NCT02606279|12607284|FG001|Overall Study|Lost to Follow-up|1
8005228|NCT02605824|12607292|FG000|Overall Study|Physician Decision|1
8005229|NCT02605824|12607293|FG001|Overall Study|Physician Decision|0
8005230|NCT02598622|12607301|FG000|Overall Study|Withdrawal by Subject|3
8005231|NCT02598622|12607302|FG001|Overall Study|Withdrawal by Subject|0
8005232|NCT02598622|12607301|FG000|Overall Study|Physician Decision|3
8005233|NCT02598622|12607302|FG001|Overall Study|Physician Decision|0
8005234|NCT02569957|12607348|FG000|Overall Study|Withdrawal by Subject|0
8005235|NCT02569957|12607349|FG001|Overall Study|Withdrawal by Subject|1
8005236|NCT02575365|12607368|FG000|Overall Study|Lost to Follow-up|4
8005237|NCT02547129|12607378|FG000|Overall Study|Difficulty with ongoing infection|1
8005238|NCT02547129|12607379|FG001|Overall Study|Difficulty with ongoing infection|0
8005239|NCT02533531|12607414|FG000|Overall Study|Device did not turn on|1
8005240|NCT02520726|12607430|FG000|Overall Study|Lost to Follow-up|3
8005241|NCT02520726|12607431|FG001|Overall Study|Lost to Follow-up|2
8005242|NCT02519712|12607441|FG000|Overall Study|Disease Relapse|1
8005243|NCT02519712|12607441|FG000|Overall Study|Disease Progression|1
8005244|NCT02519712|12607441|FG000|Overall Study|Accruals are donors|2
8005245|NCT02516228|12607449|FG000|Overall Study|Lost to Follow-up|1
8005246|NCT02516228|12607449|FG000|Overall Study|Withdrawal by Subject|1
8005247|NCT02516228|12607449|FG000|Overall Study|Physician Decision|1
8005248|NCT02506101|12607489|FG000|Overall Study|Transportation issues|1
8005249|NCT02506101|12607490|FG001|Overall Study|Transportation issues|0
8005250|NCT02506101|12607489|FG000|Overall Study|No enrollment and staff unavailability|1
8005251|NCT02506101|12607490|FG001|Overall Study|No enrollment and staff unavailability|0
8005252|NCT02500901|12607509|FG000|Overall Study|Disease ProgressionDD|2
8005253|NCT02483533|12607515|FG000|Overall Study|Lack of Efficacy|50
8005254|NCT02483533|12607516|FG001|Overall Study|Lack of Efficacy|50
8005255|NCT02496039|12607522|FG000|Overall Study|Adverse Event|3
8005256|NCT02496039|12607522|FG000|Overall Study|Protocol Violation|1
8005257|NCT02494206|12607531|FG000|Overall Study|Adverse Event|1
8005258|NCT02494206|12607531|FG000|Overall Study|Disease Progression|1
8005259|NCT02473445|12607535|FG000|Overall Study|Withdrawal by Subject|2
8005260|NCT02473445|12607535|FG000|Overall Study|Sponsor Decision|20
8005261|NCT02491411|12607539|FG000|Overall Study|Physician Decision|4
8005262|NCT02476994|12607545|FG000|Overall Study|Based on feedback from FDA|1
8005263|NCT02476994|12607546|FG001|Overall Study|Based on feedback from FDA|0
8005264|NCT02473523|12607552|FG000|Overall Study|Death|1
8005265|NCT02473523|12607552|FG000|Overall Study|Lost to Follow-up|1
8005266|NCT02472639|12607571|FG000|Overall Study|Physician Decision|4
8005267|NCT02472639|12607572|FG001|Overall Study|Physician Decision|3
8005268|NCT02469415|12607578|FG000|Overall Study|Withdrawal by Subject|1
8005269|NCT02469415|12607578|FG000|Overall Study|Investigational agent placed on hold|2
8005270|NCT02452359|12607590|FG000|Overall Study|Adverse Event|1
8005271|NCT02452359|12607590|FG000|Overall Study|Lost to Follow-up|15
8005272|NCT02452359|12607590|FG000|Overall Study|Pregnancy|1
8005273|NCT02452359|12607590|FG000|Overall Study|Withdrawal by Subject|4
8005274|NCT02452398|12607598|FG000|Overall Study|Adverse Event|1
8005275|NCT02452398|12607598|FG000|Overall Study|Lost to Follow-up|28
8005276|NCT02452398|12607598|FG000|Overall Study|Physician Decision|2
8005277|NCT02452398|12607598|FG000|Overall Study|Withdrawal by Subject|6
8005278|NCT02452398|12607598|FG000|Overall Study|Moved away|4
8005279|NCT02447887|12607602|FG000|Overall Study|Study was terminated|3
8005280|NCT02439970|12607623|FG000|Overall Study|Study Terminated|2
8005281|NCT02439970|12607624|FG001|Overall Study|Study Terminated|3
8005282|NCT02439957|12607632|FG000|Overall Study|Study Terminated|3
8005283|NCT02439957|12607633|FG001|Overall Study|Study Terminated|3
8005284|NCT02441036|12607644|FG000|Overall Study|No tissue resected|0
8005285|NCT02441036|12607645|FG001|Overall Study|No tissue resected|1
8005286|NCT02441036|12607646|FG002|Overall Study|No tissue resected|0
8005287|NCT02441036|12607647|FG003|Overall Study|No tissue resected|1
8005288|NCT02441036|12607648|FG004|Overall Study|No tissue resected|0
8005289|NCT02430532|12607685|FG000|Overall Study|Sponsor Decision to Stop Study Early|30
8005290|NCT02430532|12607686|FG001|Overall Study|Sponsor Decision to Stop Study Early|25
8005291|NCT02430532|12607685|FG000|Overall Study|Consent Withdrawn|0
8005292|NCT02430532|12607686|FG001|Overall Study|Consent Withdrawn|2
8005293|NCT02430532|12607685|FG000|Overall Study|Adverse Event|0
8005294|NCT02430532|12607686|FG001|Overall Study|Adverse Event|1
8005295|NCT02428231|12607696|FG000|Overall Study|Other|10
8005296|NCT02428231|12607697|FG001|Overall Study|Other|16
8005297|NCT02428231|12607696|FG000|Overall Study|Required Symptomatic Therapy|0
8005298|NCT02428231|12607697|FG001|Overall Study|Required Symptomatic Therapy|1
8005299|NCT02428231|12607696|FG000|Overall Study|Adverse Event|3
8005300|NCT02428231|12607697|FG001|Overall Study|Adverse Event|0
8005301|NCT02424565|12607703|FG000|Period 1 (D0)|Protocol Violation|0
8005302|NCT02424565|12607704|FG001|Period 1 (D0)|Protocol Violation|1
8005303|NCT02422303|12607725|FG000|Overall Study|Lost to Follow-up|1
8005304|NCT02422303|12607726|FG001|Overall Study|Lost to Follow-up|1
8005305|NCT02414152|12607749|FG000|Overall Study|Withdrawal by Subject|1
8005306|NCT02414152|12607749|FG000|Overall Study|Lack of Efficacy|1
8005307|NCT02410551|12607753|FG000|Overall Study|Adverse Event|1
8005308|NCT02410551|12607753|FG000|Overall Study|Withdrawal by Subject|1
8005309|NCT02410551|12607753|FG000|Overall Study|FDA Clinical hold-patients taken off|2
8005310|NCT02410954|12607764|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6
8005311|NCT02410954|12607765|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0
8005312|NCT02410954|12607764|FG000|Overall Study|Instrument malfunction generated unusable data|8
8005313|NCT02410954|12607765|FG001|Overall Study|Instrument malfunction generated unusable data|0
8005314|NCT02409355|12607777|FG000|Overall Study|Withdrawal by Subject|1
8005315|NCT02409355|12607778|FG001|Overall Study|Withdrawal by Subject|0
8005316|NCT02409355|12607777|FG000|Overall Study|Death|1
8005317|NCT02409355|12607778|FG001|Overall Study|Death|1
8005318|NCT02409355|12607777|FG000|Overall Study|Study terminated by Sponsor|2
8005319|NCT02409355|12607778|FG001|Overall Study|Study terminated by Sponsor|3
8005320|NCT02404545|12607803|FG000|Overall Study|Sponsor Termination|6
8005321|NCT02404545|12607804|FG001|Overall Study|Sponsor Termination|6
8005322|NCT02392377|12607813|FG000|Overall Study|Withdrawal by Subject|0
8005323|NCT02392377|12607814|FG001|Overall Study|Withdrawal by Subject|1
8005324|NCT02394665|12607848|FG000|Overall Study|Physician Decision|1
8005325|NCT02394665|12607849|FG001|Overall Study|Physician Decision|0
8005326|NCT02394665|12607850|FG002|Overall Study|Physician Decision|0
8005327|NCT02390362|12607869|FG000|Overall Study|Withdrawal by Subject|0
8005328|NCT02390362|12607870|FG001|Overall Study|Withdrawal by Subject|1
8005329|NCT02388776|12607876|FG000|Overall Study|Death|1
8005330|NCT02388776|12607876|FG000|Overall Study|Lost to Follow-up|1
8005331|NCT02383433|12607881|FG000|Overall Study|Disease progression|2
8005332|NCT02379390|12607909|FG000|Overall Study|Adverse Event|1
8005333|NCT02379390|12607910|FG001|Overall Study|Adverse Event|1
8005334|NCT02379390|12607909|FG000|Overall Study|Investigator's decision|1
8005335|NCT02379390|12607910|FG001|Overall Study|Investigator's decision|0
8005336|NCT02379390|12607909|FG000|Overall Study|Study Termination|0
8005337|NCT02379390|12607910|FG001|Overall Study|Study Termination|1
8005338|NCT02361580|12607934|FG000|Overall Study|Lost to Follow-up|6
8005339|NCT02361580|12607935|FG001|Overall Study|Lost to Follow-up|3
8005340|NCT02370888|12607966|FG000|Overall Study|disease progression|2
8005341|NCT02370888|12607966|FG000|Overall Study|did not meet chimerism criteria|6
8005342|NCT02365233|12607990|FG000|Overall Study|IRB withheld the data|1
8005343|NCT02365233|12607991|FG001|Overall Study|IRB withheld the data|2
8005344|NCT02365233|12607992|FG002|Overall Study|IRB withheld the data|2
8005345|NCT02347943|12608003|FG000|Overall Study|Study was cancelled|140
8005346|NCT02347943|12608004|FG001|Overall Study|Study was cancelled|67
8005347|NCT02347943|12608005|FG002|Overall Study|Study was cancelled|45
8005348|NCT02365207|12608013|FG000|Overall Study|Withdrawal by Subject|1
8005349|NCT02365207|12608013|FG000|Overall Study|Physician Decision|1
8005350|NCT02360111|12608017|FG000|Overall Study|Death|2
8005351|NCT02353468|12608021|FG000|Overall Study|Study terminated|3
8005352|NCT02346877|12608049|FG000|Overall Study|Adverse Event|1
8005353|NCT02346877|12608050|FG001|Overall Study|Adverse Event|0
8005354|NCT02346877|12608049|FG000|Overall Study|Administrative Decision|1
8005355|NCT02346877|12608050|FG001|Overall Study|Administrative Decision|0
8005356|NCT02346877|12608049|FG000|Overall Study|Sponsor Decision|12
8005357|NCT02346877|12608050|FG001|Overall Study|Sponsor Decision|0
8005358|NCT02346877|12608049|FG000|Overall Study|Missing|5
8005359|NCT02346877|12608050|FG001|Overall Study|Missing|0
8005360|NCT02353572|12608073|FG000|Overall Study|Withdrawal by Subject|1
8005361|NCT02353572|12608073|FG000|Overall Study|Study terminated|2
8005362|NCT02343263|12608089|FG000|Overall Study|Physician Decision|5
8005363|NCT02343263|12608090|FG001|Overall Study|Physician Decision|3
8005364|NCT02343263|12608091|FG002|Overall Study|Physician Decision|1
8005365|NCT02343159|12608106|FG000|Overall Study|Early Study Termination|16
8005366|NCT02343159|12608107|FG001|Overall Study|Early Study Termination|19
8005367|NCT02343159|12608108|FG002|Overall Study|Early Study Termination|23
8005368|NCT02343159|12608106|FG000|Overall Study|Physician Decision|2
8005369|NCT02343159|12608107|FG001|Overall Study|Physician Decision|0
8005370|NCT02343159|12608108|FG002|Overall Study|Physician Decision|1
8005371|NCT02343159|12608106|FG000|Overall Study|Withdrawal by Subject|3
8005372|NCT02343159|12608107|FG001|Overall Study|Withdrawal by Subject|0
8005373|NCT02343159|12608108|FG002|Overall Study|Withdrawal by Subject|2
8005374|NCT02343159|12608106|FG000|Overall Study|Lost to Follow-up|0
8005375|NCT02343159|12608107|FG001|Overall Study|Lost to Follow-up|2
8005376|NCT02343159|12608108|FG002|Overall Study|Lost to Follow-up|2
8005377|NCT02343159|12608106|FG000|Overall Study|Adverse Event|4
8005378|NCT02343159|12608107|FG001|Overall Study|Adverse Event|4
8005379|NCT02343159|12608108|FG002|Overall Study|Adverse Event|2
8005380|NCT02343159|12608106|FG000|Overall Study|Sponsor Decision|0
8005381|NCT02343159|12608107|FG001|Overall Study|Sponsor Decision|1
8005382|NCT02343159|12608108|FG002|Overall Study|Sponsor Decision|0
8005383|NCT02343159|12608106|FG000|Overall Study|Enrollment Error|1
8005384|NCT02343159|12608107|FG001|Overall Study|Enrollment Error|0
8005385|NCT02343159|12608108|FG002|Overall Study|Enrollment Error|0
8005386|NCT02336425|12608125|FG000|Overall Study|Study terminated.|2
8005387|NCT02336425|12608126|FG001|Overall Study|Study terminated.|2
8005388|NCT02336425|12608127|FG002|Overall Study|Study terminated.|3
8005389|NCT02336425|12608128|FG003|Overall Study|Study terminated.|3
8005390|NCT02308735|12608189|FG000|Overall Study|Physician Decision|2
8005391|NCT02308735|12608190|FG001|Overall Study|Physician Decision|0
8005392|NCT02308735|12608191|FG002|Overall Study|Physician Decision|0
8005393|NCT02308735|12608192|FG003|Overall Study|Physician Decision|2
8005394|NCT02299206|12608202|FG000|Overall Study|Lost to Follow-up|1
8005395|NCT02299206|12608202|FG000|Overall Study|Withdrawal by Subject|1
8005396|NCT02302859|12608208|FG000|Overall Study|Lost Phone|1
8005397|NCT02302859|12608209|FG001|Overall Study|Lost Phone|1
8005398|NCT02302859|12608208|FG000|Overall Study|Withdrawal by Subject|0
8005399|NCT02302859|12608209|FG001|Overall Study|Withdrawal by Subject|1
8005400|NCT02299934|12608215|FG000|Overall Study|Termination of study|13
8005401|NCT02294981|12608242|FG000|Overall Study|Lost to Follow-up|1
8005402|NCT02284906|12608249|FG000|Overall Study|Pretreatment Event/Adverse Event|0
8005403|NCT02284906|12608250|FG001|Overall Study|Pretreatment Event/Adverse Event|1
8005404|NCT02284906|12608251|FG002|Overall Study|Pretreatment Event/Adverse Event|0
8005405|NCT02284906|12608249|FG000|Overall Study|Major Protocol Deviation|0
8005406|NCT02284906|12608250|FG001|Overall Study|Major Protocol Deviation|1
8005407|NCT02284906|12608251|FG002|Overall Study|Major Protocol Deviation|0
8005408|NCT02284906|12608249|FG000|Overall Study|Voluntary Withdrawal|2
8005409|NCT02284906|12608250|FG001|Overall Study|Voluntary Withdrawal|4
8005410|NCT02284906|12608251|FG002|Overall Study|Voluntary Withdrawal|5
8005411|NCT02284906|12608249|FG000|Overall Study|Study Termination|0
8005412|NCT02284906|12608250|FG001|Overall Study|Study Termination|11
8005413|NCT02284906|12608251|FG002|Overall Study|Study Termination|14
8005414|NCT02284906|12608249|FG000|Overall Study|Reason not Specified|1
8005415|NCT02284906|12608250|FG001|Overall Study|Reason not Specified|1
8005416|NCT02284906|12608251|FG002|Overall Study|Reason not Specified|0
8005417|NCT02287025|12608261|FG000|Overall Study|Not treated|2
8005418|NCT02287025|12608262|FG001|Overall Study|Not treated|0
8005419|NCT02287025|12608261|FG000|Overall Study|Progression of disease|3
8005420|NCT02287025|12608262|FG001|Overall Study|Progression of disease|2
8005421|NCT02287025|12608261|FG000|Overall Study|Adverse Event|2
8005422|NCT02287025|12608262|FG001|Overall Study|Adverse Event|4
8005423|NCT02287025|12608261|FG000|Overall Study|Withdrawal by Subject|2
8005424|NCT02287025|12608262|FG001|Overall Study|Withdrawal by Subject|2
8005425|NCT02287025|12608261|FG000|Overall Study|Screening failed|1
8005426|NCT02287025|12608262|FG001|Overall Study|Screening failed|1
8005427|NCT02276560|12608277|FG000|Overall Study|Adverse Event|1
8005428|NCT02276560|12608278|FG001|Overall Study|Adverse Event|0
8005429|NCT02276560|12608279|FG002|Overall Study|Adverse Event|0
8005430|NCT02284373|12608294|FG000|Overall Study|Withdrawal by Subject|0
8005431|NCT02284373|12608295|FG001|Overall Study|Withdrawal by Subject|1
8005432|NCT02284373|12608296|FG002|Overall Study|Withdrawal by Subject|0
8005433|NCT02284373|12608294|FG000|Overall Study|Other|0
8005434|NCT02284373|12608295|FG001|Overall Study|Other|1
8005435|NCT02284373|12608296|FG002|Overall Study|Other|0
8005436|NCT02284373|12608294|FG000|Overall Study|Lost to Follow-up|0
8005437|NCT02284373|12608295|FG001|Overall Study|Lost to Follow-up|1
8005438|NCT02284373|12608296|FG002|Overall Study|Lost to Follow-up|0
8005439|NCT02285270|12608304|FG000|Overall Study|Lost to Follow-up|1
8005440|NCT02285270|12608304|FG000|Overall Study|Physician Decision|3
8005441|NCT02285270|12608304|FG000|Overall Study|Determined to be ineligible|1
8005442|NCT02275481|12608310|FG000|Overall Study|Death|2
8005443|NCT02275481|12608311|FG001|Overall Study|Death|1
8005444|NCT02275481|12608310|FG000|Overall Study|Lost to Follow-up|2
8005445|NCT02275481|12608311|FG001|Overall Study|Lost to Follow-up|0
8005446|NCT02275481|12608310|FG000|Overall Study|Withdrawal by Subject|3
8005447|NCT02275481|12608311|FG001|Overall Study|Withdrawal by Subject|0
8005448|NCT02275481|12608310|FG000|Overall Study|all other reasons combined|2
8005449|NCT02275481|12608311|FG001|Overall Study|all other reasons combined|1
8005450|NCT02275481|12608310|FG000|Overall Study|Physician Decision|0
8005451|NCT02275481|12608311|FG001|Overall Study|Physician Decision|1
8005452|NCT02273752|12608321|FG000|Overall Study|Trial was terminated early|2
8005453|NCT02270684|12608327|FG000|Overall Study|Lost to Follow-up|0
8005454|NCT02270684|12608328|FG001|Overall Study|Lost to Follow-up|3
8005455|NCT02270684|12608327|FG000|Overall Study|Study terminated|1
8005456|NCT02270684|12608328|FG001|Overall Study|Study terminated|0
8005457|NCT02271594|12608345|FG000|Overall Study|Study closed; recruiting failure|19
8005458|NCT02271594|12608346|FG001|Overall Study|Study closed; recruiting failure|12
8005459|NCT02263365|12608356|FG000|Overall Study|Physician Decision|22
8005460|NCT02263365|12608357|FG001|Overall Study|Physician Decision|18
8005461|NCT02241551|12608391|FG000|Overall Study|Adverse Event|1
8005462|NCT02241551|12608392|FG001|Overall Study|Adverse Event|0
8005463|NCT02246114|12608402|FG000|Overall Study|miscarriage|1
8005464|NCT02246114|12608403|FG001|Overall Study|miscarriage|0
8005465|NCT02232880|12608409|FG000|Overall Study|study stopped prior to randomization|1
8005466|NCT02244944|12608431|FG000|Overall Study|Withdrawal by Subject|1
8005467|NCT02244944|12608431|FG000|Overall Study|Study Terminated|1
8005468|NCT02241187|12608435|FG000|Overall Study|Protocol closed due to lack of accrual.|2
8005469|NCT02239926|12608441|FG000|Overall Study|Withdrawal by Subject|0
8005470|NCT02239926|12608442|FG001|Overall Study|Withdrawal by Subject|1
8005471|NCT02231892|12608451|FG000|Overall Study|Lost to Follow-up|1
8005472|NCT02231892|12608452|FG001|Overall Study|Lost to Follow-up|0
8005473|NCT02231892|12608453|FG002|Overall Study|Lost to Follow-up|3
8005474|NCT02231892|12608451|FG000|Overall Study|Withdrawal by Subject|4
8005475|NCT02231892|12608452|FG001|Overall Study|Withdrawal by Subject|3
8005476|NCT02231892|12608453|FG002|Overall Study|Withdrawal by Subject|15
8005477|NCT02231892|12608451|FG000|Overall Study|Physician Decision|0
8005478|NCT02231892|12608452|FG001|Overall Study|Physician Decision|2
8005479|NCT02231892|12608453|FG002|Overall Study|Physician Decision|4
8005480|NCT02231892|12608451|FG000|Overall Study|Motor activity when stimulating ante ACC|4
8005481|NCT02231892|12608452|FG001|Overall Study|Motor activity when stimulating ante ACC|7
8005482|NCT02231892|12608453|FG002|Overall Study|Motor activity when stimulating ante ACC|12
8005483|NCT02231892|12608451|FG000|Overall Study|Participant motor threshold was >83%|0
8005484|NCT02231892|12608452|FG001|Overall Study|Participant motor threshold was >83%|0
8005485|NCT02231892|12608453|FG002|Overall Study|Participant motor threshold was >83%|9
8005486|NCT02231892|12608451|FG000|Overall Study|Could not find motor threshold|2
8005487|NCT02231892|12608452|FG001|Overall Study|Could not find motor threshold|0
8005488|NCT02231892|12608453|FG002|Overall Study|Could not find motor threshold|1
8005489|NCT02231892|12608451|FG000|Overall Study|Could not find reliable motor hotspot|0
8005490|NCT02231892|12608452|FG001|Overall Study|Could not find reliable motor hotspot|0
8005491|NCT02231892|12608453|FG002|Overall Study|Could not find reliable motor hotspot|1
8005492|NCT02241343|12608467|FG000|Overall Study|Adverse Event|1
8005493|NCT02224599|12608502|FG000|Overall Study|Physician Decision|1
8005494|NCT02224599|12608502|FG000|Overall Study|Progression of Disease|1
8005495|NCT02201472|12608506|FG000|Overall Study|Lack of Efficacy|2
8005496|NCT02200042|12608529|FG000|Overall Study|Withdrawal by Subject|0
8005497|NCT02200042|12608530|FG001|Overall Study|Withdrawal by Subject|1
8005498|NCT02181790|12608538|FG000|Overall Study|study terminated|2
8005499|NCT02181790|12608539|FG001|Overall Study|study terminated|0
8005500|NCT02177266|12608567|FG000|Overall Study|Adverse Event|0
8005501|NCT02177266|12608568|FG001|Overall Study|Adverse Event|1
8005502|NCT02177266|12608567|FG000|Overall Study|Withdrawal by Subject|1
8005503|NCT02177266|12608568|FG001|Overall Study|Withdrawal by Subject|0
8005504|NCT02170298|12608585|FG000|Overall Study|Withdrawal by Subject|0
8005505|NCT02170298|12608586|FG001|Overall Study|Withdrawal by Subject|1
8005506|NCT02170298|12608585|FG000|Overall Study|unblinded, rerandomized to intervention|1
8005507|NCT02170298|12608586|FG001|Overall Study|unblinded, rerandomized to intervention|0
8005508|NCT02169830|12608608|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0
8005509|NCT02169830|12608609|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0
8005510|NCT02169830|12608610|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1
8005511|NCT02169830|12608608|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1
8005512|NCT02169830|12608609|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0
8005513|NCT02169830|12608610|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0
8005514|NCT02169830|12608608|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2
8005515|NCT02169830|12608609|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5
8005516|NCT02169830|12608610|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0
8005517|NCT02169830|12608608|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0
8005518|NCT02169830|12608609|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1
8005519|NCT02169830|12608610|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0
8005520|NCT02169830|12608608|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0
8005521|NCT02169830|12608609|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1
8005522|NCT02169830|12608610|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0
8005523|NCT02163187|12608620|FG000|Overall Study|Device removed|1
8005524|NCT02163187|12608621|FG001|Overall Study|Device removed|0
8005525|NCT02163187|12608620|FG000|Overall Study|Progressive disease|1
8005526|NCT02163187|12608621|FG001|Overall Study|Progressive disease|0
8005527|NCT02161016|12608627|FG000|Overall Study|withdrawn by IRB|1
8005528|NCT02159040|12608631|FG000|Overall Study|Death|1
8005529|NCT02168270|12608635|FG000|Overall Study|Lack of Efficacy|4
8005530|NCT02157116|12608639|FG000|Overall Study|Withdrawal by Subject|4
8005531|NCT02157116|12608639|FG000|Overall Study|Physician Decision|3
8005532|NCT02157116|12608639|FG000|Overall Study|Failed Screening|2
8005533|NCT02154087|12608643|FG000|Overall Study|Study Termination|1
8005534|NCT02152566|12608651|FG000|Overall Study|Lost to Follow-up|1
8005535|NCT02152566|12608651|FG000|Overall Study|Withdrawal by Subject|2
8005536|NCT02145390|12608668|FG000|Overall Study|Withdrawal by Subject|1
8005537|NCT02150863|12608701|FG000|Overall Study|Lost to Follow-up|0
8005538|NCT02150863|12608702|FG001|Overall Study|Lost to Follow-up|1
8005539|NCT02150863|12608703|FG002|Overall Study|Lost to Follow-up|0
8005540|NCT02131155|12608739|FG000|Overall Study|Adverse Event|1
8005541|NCT02131155|12608740|FG001|Overall Study|Adverse Event|0
8005542|NCT02131155|12608739|FG000|Overall Study|Treatment completed|1
8005543|NCT02131155|12608740|FG001|Overall Study|Treatment completed|0
8005544|NCT02131155|12608739|FG000|Overall Study|Primary tumour recurrence|2
8005545|NCT02131155|12608740|FG001|Overall Study|Primary tumour recurrence|1
8005546|NCT02131155|12608739|FG000|Overall Study|Refused to continue study medication|1
8005547|NCT02131155|12608740|FG001|Overall Study|Refused to continue study medication|0
8005548|NCT02131155|12608739|FG000|Overall Study|Study early termination|20
8005549|NCT02131155|12608740|FG001|Overall Study|Study early termination|10
8005550|NCT02117050|12608746|FG000|Overall Study|Subject Enrolled but not Dosed|1
8005551|NCT02105116|12608768|FG000|Overall Study|not eligible for step 2 of trial|5
8005552|NCT02105116|12608768|FG000|Overall Study|Death|1
8005553|NCT02099344|12608785|FG000|Overall Study|Physician Decision|1
8005554|NCT02099344|12608786|FG001|Overall Study|Physician Decision|0
8005555|NCT02096042|12608803|FG000|Overall Study|Disease Progression|1
8005556|NCT02096042|12608804|FG001|Overall Study|Disease Progression|0
8005557|NCT02096042|12608805|FG002|Overall Study|Disease Progression|0
8005558|NCT02088957|12608812|FG000|Overall Study|Lack of Efficacy|1
8005559|NCT02088957|12608813|FG001|Overall Study|Lack of Efficacy|0
8005560|NCT02093689|12608822|FG000|Overall Study|Physician Decision|4
8005561|NCT02093689|12608823|FG001|Overall Study|Physician Decision|0
8005562|NCT02093689|12608824|FG002|Overall Study|Physician Decision|0
8005563|NCT02091752|12608830|FG000|Overall Study|Study terminated by Sponsor|2
8005564|NCT02091752|12608830|FG000|Overall Study|Adverse Event|1
8005565|NCT02068547|12608836|FG000|Overall Study|Lost to Follow-up|3
8005566|NCT02068547|12608837|FG001|Overall Study|Lost to Follow-up|3
8005567|NCT02068547|12608836|FG000|Overall Study|Physician Decision|1
8005568|NCT02068547|12608837|FG001|Overall Study|Physician Decision|0
8005569|NCT02081183|12608875|FG000|Overall Study|Lost to Follow-up|0
8005570|NCT02081183|12608876|FG001|Overall Study|Lost to Follow-up|1
8005571|NCT02081183|12608875|FG000|Overall Study|Protocol Violation|1
8005572|NCT02081183|12608876|FG001|Overall Study|Protocol Violation|0
8005573|NCT02081183|12608875|FG000|Overall Study|Other|3
8005574|NCT02081183|12608876|FG001|Overall Study|Other|3
8005575|NCT02067104|12608896|FG000|Overall Study|Study termination due to low accrual|4
8005576|NCT02067104|12608897|FG001|Overall Study|Study termination due to low accrual|5
8005577|NCT02057874|12608907|FG000|Overall Study|participant did not return for scan|1
8005578|NCT02058537|12608921|FG000|Overall Study|Withdrawal by Subject|1
8005579|NCT02038153|12608934|FG000|Overall Study|Withdrawal by Subject|1
8005580|NCT02054910|12608940|FG000|Overall Study|Lost to Follow-up|4
8005581|NCT02054910|12608941|FG001|Overall Study|Lost to Follow-up|1
8005582|NCT02044302|12608951|FG000|Overall Study|study terminated|2
8005583|NCT02044302|12608952|FG001|Overall Study|study terminated|0
8005584|NCT02046226|12608956|FG000|Overall Study|Lost to Follow-up|7
8005585|NCT02044848|12608963|FG000|Overall Study|Administrative Problems|2
8005586|NCT02044848|12608964|FG001|Overall Study|Administrative Problems|3
8005587|NCT02042950|12608970|FG000|Overall Study|Progressive Disease|4
8005588|NCT02048904|12608974|FG000|Overall Study|Withdrawal by Subject|7
8005589|NCT02048904|12608974|FG000|Overall Study|Physician Decision|70
8005590|NCT02044822|12608978|FG000|Overall Study|Study Terminated by Sponsor|77
8005591|NCT02044822|12608978|FG000|Overall Study|Investigator's Discretion|10
8005592|NCT02044822|12608978|FG000|Overall Study|Withdrew Consent|3
8005593|NCT02044822|12608978|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2
8005594|NCT02044822|12608978|FG000|Overall Study|Lost to Follow-up|1
8005595|NCT02042924|12608982|FG000|Overall Study|Early Death|1
8005596|NCT02017522|12608990|FG000|Overall Study|Withdrawal by Subject|1
8005597|NCT02030015|12608995|FG000|Overall Study|Withdrawal by Subject|3
8005598|NCT02030015|12608995|FG000|Overall Study|Death|13
8005599|NCT02015663|12609001|FG000|Overall Study|unsatisfactory therapeutic effect|1
8005600|NCT02015663|12609002|FG001|Overall Study|unsatisfactory therapeutic effect|0
8005601|NCT02015663|12609001|FG000|Overall Study|Withdrawal by Subject|1
8005602|NCT02015663|12609002|FG001|Overall Study|Withdrawal by Subject|0
8005603|NCT02015663|12609001|FG000|Overall Study|Protocol Violation|0
8005604|NCT02015663|12609002|FG001|Overall Study|Protocol Violation|1
8005605|NCT02015663|12609001|FG000|Overall Study|Adverse Event|3
8005606|NCT02015663|12609002|FG001|Overall Study|Adverse Event|0
8005607|NCT02015663|12609001|FG000|Overall Study|Administrative problems|10
8005608|NCT02015663|12609002|FG001|Overall Study|Administrative problems|11
8005609|NCT02029846|12609011|FG000|Overall Study|n=1 each arm|1
8005610|NCT02029846|12609012|FG001|Overall Study|n=1 each arm|1
8005611|NCT02011542|12609049|FG000|Overall Study|Physician Decision|1
8005612|NCT02008370|12609053|FG000|Overall Study|Lost to Follow-up|7
8005613|NCT02005445|12609074|FG000|Overall Study|Dual study enrollment|0
8005614|NCT02005445|12609075|FG001|Overall Study|Dual study enrollment|1
8005615|NCT02006927|12609094|FG000|Overall Study|Adverse Event|2
8005616|NCT02006927|12609094|FG000|Overall Study|Withdrawal by Subject|1
8005617|NCT01996982|12609098|FG000|Overall Study|PI/team left institution|7
8005618|NCT01986751|12609108|FG000|Overall Study|improperly consented|10
8005619|NCT01986751|12609109|FG001|Overall Study|improperly consented|2
8005620|NCT01977729|12609168|FG000|Overall Study|Study terminated|1
8005621|NCT01982253|12609181|FG000|Overall Study|Withdrawal by Subject|1
8005622|NCT01982253|12609182|FG001|Overall Study|Withdrawal by Subject|0
8005623|NCT01982253|12609183|FG002|Overall Study|Withdrawal by Subject|0
8005624|NCT01982253|12609181|FG000|Overall Study|Study terminated by sponsor|1
8005625|NCT01982253|12609182|FG001|Overall Study|Study terminated by sponsor|4
8005626|NCT01982253|12609183|FG002|Overall Study|Study terminated by sponsor|4
8005627|NCT01984268|12609191|FG000|Overall Study|Study Terminated|15
8005628|NCT01980875|12609211|FG000|Overall Study|Withdrew Consent|1
8005629|NCT01980875|12609212|FG001|Overall Study|Withdrew Consent|1
8005630|NCT01980875|12609213|FG002|Overall Study|Withdrew Consent|1
8005631|NCT01980875|12609211|FG000|Overall Study|Study Terminated by Sponsor|7
8005632|NCT01980875|12609212|FG001|Overall Study|Study Terminated by Sponsor|24
8005633|NCT01980875|12609213|FG002|Overall Study|Study Terminated by Sponsor|22
8005634|NCT01980875|12609211|FG000|Overall Study|Lost to Follow-up|0
8005635|NCT01980875|12609212|FG001|Overall Study|Lost to Follow-up|0
8005636|NCT01980875|12609213|FG002|Overall Study|Lost to Follow-up|1
8005637|NCT01970462|12609259|FG000|Overall Study|Lost to Follow-up|0
8005638|NCT01970462|12609260|FG001|Overall Study|Lost to Follow-up|2
8005639|NCT01969565|12609266|FG000|Overall Study|Withdrawal by Subject|1
8005640|NCT01968226|12609271|FG000|Overall Study|[F-18] RDG-K5 was not available|2
8005641|NCT01962974|12609290|FG000|Overall Study|Study termination|7
8005642|NCT01951378|12609307|FG000|Overall Study|Study Terminated-Not completed|23
8005643|NCT01951378|12609308|FG001|Overall Study|Study Terminated-Not completed|17
8005644|NCT01944059|12609331|FG000|Overall Study|Lost to Follow-up|1
8005645|NCT01944059|12609331|FG000|Overall Study|Physician Decision|3
8005646|NCT01944059|12609331|FG000|Overall Study|Withdrawal by Subject|1
8005647|NCT01944059|12609331|FG000|Overall Study|Adverse Event|2
8005648|NCT01935947|12609339|FG000|Overall Study|Adverse Event|0
8005649|NCT01935947|12609340|FG001|Overall Study|Adverse Event|2
8005650|NCT01935947|12609341|FG002|Overall Study|Adverse Event|0
8005651|NCT01935947|12609339|FG000|Overall Study|Diease Progression|2
8005652|NCT01935947|12609340|FG001|Overall Study|Diease Progression|2
8005653|NCT01935947|12609341|FG002|Overall Study|Diease Progression|2
8005654|NCT01935947|12609339|FG000|Overall Study|Death|1
8005655|NCT01935947|12609340|FG001|Overall Study|Death|0
8005656|NCT01935947|12609341|FG002|Overall Study|Death|0
8005657|NCT01939223|12609354|FG000|Overall Study|AE not assoc. with disease recurrence|1
8005658|NCT01939223|12609355|FG001|Overall Study|AE not assoc. with disease recurrence|1
8005659|NCT01939223|12609354|FG000|Overall Study|Disease recurrence (radiological)|1
8005660|NCT01939223|12609355|FG001|Overall Study|Disease recurrence (radiological)|3
8005661|NCT01939223|12609354|FG000|Overall Study|Study stopped by Sponsor|5
8005662|NCT01939223|12609355|FG001|Overall Study|Study stopped by Sponsor|7
8005663|NCT01939223|12609354|FG000|Overall Study|Withdrawal by Subject|6
8005664|NCT01939223|12609355|FG001|Overall Study|Withdrawal by Subject|0
8005665|NCT01938716|12609361|FG000|Overall Study|Physician Decision|2
8005666|NCT01938716|12609361|FG000|Overall Study|Withdrawal by Subject|2
8005667|NCT01936974|12609367|FG000|Overall Study|Physician Decision|2
8005668|NCT01936974|12609368|FG001|Overall Study|Physician Decision|5
8005669|NCT01934504|12609395|FG000|Overall Study|Protocol Deviation|0
8005670|NCT01934504|12609396|FG001|Overall Study|Protocol Deviation|0
8005671|NCT01934504|12609397|FG002|Overall Study|Protocol Deviation|0
8005672|NCT01934504|12609398|FG003|Overall Study|Protocol Deviation|2
8005673|NCT01934504|12609395|FG000|Overall Study|Study Terminated by Sponsor|1
8005674|NCT01934504|12609396|FG001|Overall Study|Study Terminated by Sponsor|0
8005675|NCT01934504|12609397|FG002|Overall Study|Study Terminated by Sponsor|5
8005676|NCT01934504|12609398|FG003|Overall Study|Study Terminated by Sponsor|5
8005677|NCT01928082|12609408|FG000|Overall Study|Study terminated.|1
8005678|NCT01928615|12609412|FG000|Overall Study|Study Terminated by Sponsor|2
8005679|NCT01911793|12609419|FG000|Overall Study|Physician Decision|1
8005680|NCT01911793|12609420|FG001|Overall Study|Physician Decision|5
8005681|NCT01912404|12609428|FG000|Overall Study|Due to personal reasons|1
8005682|NCT01912404|12609429|FG001|Overall Study|Due to personal reasons|0
8005683|NCT01910389|12609437|FG000|Overall Study|Withdrawal by Subject|2
8005684|NCT01910389|12609438|FG001|Overall Study|Withdrawal by Subject|0
8005685|NCT01910389|12609437|FG000|Overall Study|Study Closed|13
8005686|NCT01910389|12609438|FG001|Overall Study|Study Closed|8
8005687|NCT01913327|12609464|FG000|Overall Study|Withdrawal by Subject|0
8005688|NCT01913327|12609465|FG001|Overall Study|Withdrawal by Subject|1
8005689|NCT01902888|12609471|FG000|Overall Study|Study Terminated|3
8005690|NCT01901224|12609475|FG000|Overall Study|study was not funded and terminated|2
8005691|NCT01910441|12609481|FG000|Overall Study|Sponsor decision|0
8005692|NCT01910441|12609482|FG001|Overall Study|Sponsor decision|2
8005693|NCT01910441|12609481|FG000|Overall Study|Lost to Follow-up|6
8005694|NCT01910441|12609482|FG001|Overall Study|Lost to Follow-up|5
8005695|NCT01910441|12609481|FG000|Overall Study|Withdrawal by Subject|0
8005696|NCT01910441|12609482|FG001|Overall Study|Withdrawal by Subject|1
8005697|NCT01910441|12609481|FG000|Overall Study|Non-compliance|0
8005698|NCT01910441|12609482|FG001|Overall Study|Non-compliance|1
8005699|NCT01910441|12609481|FG000|Overall Study|Adverse Event|1
8005700|NCT01910441|12609482|FG001|Overall Study|Adverse Event|0
8005701|NCT01910441|12609481|FG000|Overall Study|Physician Decision|0
8005702|NCT01910441|12609482|FG001|Overall Study|Physician Decision|1
8005703|NCT01902966|12609488|FG000|Overall Study|Death|1
8005704|NCT01902966|12609488|FG000|Overall Study|Physician Decision|1
8005705|NCT01902966|12609488|FG000|Overall Study|Withdrawal by Subject|1
8005706|NCT01900730|12609503|FG000|Overall Study|Withdrawal by Subject|1
8005707|NCT01900730|12609504|FG001|Overall Study|Withdrawal by Subject|0
8005708|NCT01900730|12609503|FG000|Overall Study|Screen Failure|1
8005709|NCT01900730|12609504|FG001|Overall Study|Screen Failure|0
8005710|NCT01900626|12609532|FG000|Overall Study|study was closed due to low enrollment|1
8005711|NCT01900626|12609533|FG001|Overall Study|study was closed due to low enrollment|1
8005712|NCT01884077|12609555|FG000|Overall Study|screen fail|0
8005713|NCT01884077|12609556|FG001|Overall Study|screen fail|2
8005714|NCT01884077|12609555|FG000|Overall Study|canceled surgery|2
8005715|NCT01884077|12609556|FG001|Overall Study|canceled surgery|0
8005716|NCT01884077|12609555|FG000|Overall Study|Lost to Follow-up|0
8005717|NCT01884077|12609556|FG001|Overall Study|Lost to Follow-up|4
8005718|NCT01884077|12609555|FG000|Overall Study|study closed|6
8005719|NCT01884077|12609556|FG001|Overall Study|study closed|4
8005720|NCT01887288|12609588|FG000|Overall Study|The study was terminated and the PI has|16
8005721|NCT01861717|12609631|FG000|Overall Study|Lost to Follow-up|1
8005722|NCT01861717|12609631|FG000|Overall Study|Withdrawal by Subject|1
8005723|NCT01866709|12609638|FG000|Overall Study|Adverse Event|1
8005724|NCT01866709|12609639|FG001|Overall Study|Adverse Event|0
8005725|NCT01860040|12609647|FG000|Overall Study|Withdrawal by Subject|1
8005726|NCT01860040|12609648|FG001|Overall Study|Withdrawal by Subject|0
8005727|NCT01856322|12609693|FG000|Overall Study|off study due to lack of accrual|0
8005728|NCT01856322|12609694|FG001|Overall Study|off study due to lack of accrual|0
8005729|NCT01856322|12609695|FG002|Overall Study|off study due to lack of accrual|3
8005730|NCT01853176|12609704|FG000|Overall Study|Study terminated|4
8005731|NCT01853176|12609705|FG001|Overall Study|Study terminated|0
8005732|NCT01857271|12609711|FG000|Overall Study|Lost to Follow-up|1
8005733|NCT01853982|12609726|FG000|Overall Study|Withdrawal by Subject|1
8005734|NCT01853982|12609727|FG001|Overall Study|Withdrawal by Subject|0
8005735|NCT01853982|12609726|FG000|Overall Study|Death|1
8005736|NCT01853982|12609727|FG001|Overall Study|Death|0
8005737|NCT01853982|12609726|FG000|Overall Study|Lost to Follow-up|0
8005738|NCT01853982|12609727|FG001|Overall Study|Lost to Follow-up|1
8005739|NCT01821963|12609767|FG000|Overall Study|Adverse Event|1
8005740|NCT01821898|12609773|FG000|Overall Study|Withdrawal by Subject|2
8005741|NCT01821898|12609774|FG001|Overall Study|Withdrawal by Subject|1
8005742|NCT01829477|12609805|FG000|Overall Study|Study Terminated by Sponsor|15
8005743|NCT01829477|12609806|FG001|Overall Study|Study Terminated by Sponsor|15
8005744|NCT01829477|12609805|FG000|Overall Study|Withdrawal by Subject|1
8005745|NCT01829477|12609806|FG001|Overall Study|Withdrawal by Subject|0
8005746|NCT01803711|12609814|FG000|Overall Study|Adverse Event|1
8005747|NCT01803711|12609815|FG001|Overall Study|Adverse Event|1
8005748|NCT01806051|12609843|FG000|Overall Study|Withdrawal by Subject|6
8005749|NCT01810302|12609870|FG000|Overall Study|Death|1
8005750|NCT01810302|12609871|FG001|Overall Study|Death|0
8005751|NCT01810302|12609870|FG000|Overall Study|Physician Decision|0
8005752|NCT01810302|12609871|FG001|Overall Study|Physician Decision|1
8005753|NCT01806961|12609877|FG000|Overall Study|sponsor decision|16
8005754|NCT01783015|12609887|FG000|Blinded Treatment|Adverse Event|0
8005755|NCT01783015|12609888|FG001|Blinded Treatment|Adverse Event|1
8005756|NCT01783015|12609889|FG002|Blinded Treatment|Adverse Event|0
8005757|NCT01783015|12609887|FG000|Blinded Treatment|Protocol Violation|0
8005758|NCT01783015|12609888|FG001|Blinded Treatment|Protocol Violation|1
8005759|NCT01783015|12609889|FG002|Blinded Treatment|Protocol Violation|0
8005760|NCT01783015|12609887|FG000|Blinded Treatment|Withdrawal by Subject|0
8005761|NCT01783015|12609888|FG001|Blinded Treatment|Withdrawal by Subject|1
8005762|NCT01783015|12609889|FG002|Blinded Treatment|Withdrawal by Subject|0
8005763|NCT01783015|12609887|FG000|Blinded Treatment|Study Terminated by Sponsor|2
8005764|NCT01783015|12609888|FG001|Blinded Treatment|Study Terminated by Sponsor|0
8005765|NCT01783015|12609889|FG002|Blinded Treatment|Study Terminated by Sponsor|0
8005766|NCT01783015|12609887|FG000|Open Label Treatment|Study Terminated by Sponsor|0
8005767|NCT01783015|12609888|FG001|Open Label Treatment|Study Terminated by Sponsor|0
8005768|NCT01783015|12609889|FG002|Open Label Treatment|Study Terminated by Sponsor|6
8005769|NCT01781026|12609923|FG000|Overall Study|Lack of Efficacy|2
8005770|NCT01777854|12609949|FG000|Overall Study|Physician Decision|3
8005771|NCT01777854|12609950|FG001|Overall Study|Physician Decision|3
8005772|NCT01772719|12609958|FG000|Overall Study|Withdrawal by Subject|3
8005773|NCT01772719|12609958|FG000|Overall Study|Adverse Event|2
8005774|NCT01772719|12609958|FG000|Overall Study|Protocol Violation|1
8005775|NCT01772719|12609958|FG000|Overall Study|Lost to Follow-up|1
8005776|NCT01764997|12609970|FG000|Run-in Period|Adverse Event|15
8005777|NCT01764997|12609971|FG001|Run-in Period|Adverse Event|0
8005778|NCT01764997|12609972|FG002|Run-in Period|Adverse Event|0
8005779|NCT01764997|12609973|FG003|Run-in Period|Adverse Event|0
8005780|NCT01764997|12609974|FG004|Run-in Period|Adverse Event|0
8005781|NCT01764997|12609970|FG000|Run-in Period|Lack of Efficacy|5
8005782|NCT01764997|12609971|FG001|Run-in Period|Lack of Efficacy|0
8005783|NCT01764997|12609972|FG002|Run-in Period|Lack of Efficacy|0
8005784|NCT01764997|12609973|FG003|Run-in Period|Lack of Efficacy|0
8005785|NCT01764997|12609974|FG004|Run-in Period|Lack of Efficacy|0
8005786|NCT01764997|12609970|FG000|Run-in Period|Poor compliance to protocol|1
8005787|NCT01764997|12609971|FG001|Run-in Period|Poor compliance to protocol|0
8005788|NCT01764997|12609972|FG002|Run-in Period|Poor compliance to protocol|0
8005789|NCT01764997|12609973|FG003|Run-in Period|Poor compliance to protocol|0
8005790|NCT01764997|12609974|FG004|Run-in Period|Poor compliance to protocol|0
8005791|NCT01764997|12609970|FG000|Run-in Period|Other than specified above|17
8005792|NCT01764997|12609971|FG001|Run-in Period|Other than specified above|0
8005793|NCT01764997|12609972|FG002|Run-in Period|Other than specified above|0
8005794|NCT01764997|12609973|FG003|Run-in Period|Other than specified above|0
8005795|NCT01764997|12609974|FG004|Run-in Period|Other than specified above|0
8005796|NCT01764997|12609970|FG000|Study Drug Treatment Period|Adverse Event|0
8005797|NCT01764997|12609971|FG001|Study Drug Treatment Period|Adverse Event|1
8005798|NCT01764997|12609972|FG002|Study Drug Treatment Period|Adverse Event|0
8005799|NCT01764997|12609973|FG003|Study Drug Treatment Period|Adverse Event|0
8005800|NCT01764997|12609974|FG004|Study Drug Treatment Period|Adverse Event|24
8005801|NCT01764997|12609970|FG000|Study Drug Treatment Period|Lack of Efficacy|0
8005802|NCT01764997|12609971|FG001|Study Drug Treatment Period|Lack of Efficacy|0
8005803|NCT01764997|12609972|FG002|Study Drug Treatment Period|Lack of Efficacy|0
8005804|NCT01764997|12609973|FG003|Study Drug Treatment Period|Lack of Efficacy|0
8005805|NCT01764997|12609974|FG004|Study Drug Treatment Period|Lack of Efficacy|2
8005806|NCT01764997|12609970|FG000|Study Drug Treatment Period|Other than specified above|0
8005807|NCT01764997|12609971|FG001|Study Drug Treatment Period|Other than specified above|0
8005808|NCT01764997|12609972|FG002|Study Drug Treatment Period|Other than specified above|0
8005809|NCT01764997|12609973|FG003|Study Drug Treatment Period|Other than specified above|0
8005810|NCT01764997|12609974|FG004|Study Drug Treatment Period|Other than specified above|10
8005811|NCT01769443|12609990|FG000|Overall Study|Study closure|1
8005812|NCT01769443|12609991|FG001|Overall Study|Study closure|0
8005813|NCT01749826|12610013|FG000|Overall Study|Study Terminated|20
8005814|NCT01749826|12610014|FG001|Overall Study|Study Terminated|0
8005815|NCT01752023|12610075|FG000|Overall Study|Physician Decision|2
8005816|NCT01752023|12610076|FG001|Overall Study|Physician Decision|1
8005817|NCT01740154|12610086|FG000|Overall Study|Adverse Event|1
8005818|NCT01748890|12610090|FG000|Overall Study|Insufficient recruitment for analysis|4
8005819|NCT01748162|12610096|FG000|Overall Study|no additional croup episodes to evaluate|2
8005820|NCT01748162|12610097|FG001|Overall Study|no additional croup episodes to evaluate|2
8005821|NCT01748162|12610096|FG000|Overall Study|participant consented but did not begin|0
8005822|NCT01748162|12610097|FG001|Overall Study|participant consented but did not begin|1
8005823|NCT01748162|12610096|FG000|Overall Study|reasons not available|3
8005824|NCT01748162|12610097|FG001|Overall Study|reasons not available|2
8005825|NCT01732926|12610122|FG000|Overall Study|Study Terminated by Sponsor|168
8005826|NCT01732926|12610123|FG001|Overall Study|Study Terminated by Sponsor|80
8005827|NCT01732926|12610122|FG000|Overall Study|Withdrawal by Subject|46
8005828|NCT01732926|12610123|FG001|Overall Study|Withdrawal by Subject|8
8005829|NCT01732926|12610122|FG000|Overall Study|Physician Decision|24
8005830|NCT01732926|12610123|FG001|Overall Study|Physician Decision|11
8005831|NCT01732926|12610122|FG000|Overall Study|Other Reason|21
8005832|NCT01732926|12610123|FG001|Overall Study|Other Reason|4
8005833|NCT01732926|12610122|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7
8005834|NCT01732926|12610123|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6
8005835|NCT01732926|12610122|FG000|Overall Study|Blind Broken by Subject or Study Site|1
8005836|NCT01732926|12610123|FG001|Overall Study|Blind Broken by Subject or Study Site|1
8005837|NCT01732913|12610140|FG000|Overall Study|Study Terminated by Sponsor|105
8005838|NCT01732913|12610141|FG001|Overall Study|Study Terminated by Sponsor|55
8005839|NCT01732913|12610140|FG000|Overall Study|Withdrawal by Subject|27
8005840|NCT01732913|12610141|FG001|Overall Study|Withdrawal by Subject|4
8005841|NCT01732913|12610140|FG000|Overall Study|Physician Decision|14
8005842|NCT01732913|12610141|FG001|Overall Study|Physician Decision|7
8005843|NCT01732913|12610140|FG000|Overall Study|Other|7
8005844|NCT01732913|12610141|FG001|Overall Study|Other|1
8005845|NCT01732913|12610140|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3
8005846|NCT01732913|12610141|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2
8005847|NCT01716052|12610153|FG000|Overall Study|Withdrawal of funding|1
8005848|NCT01716052|12610154|FG001|Overall Study|Withdrawal of funding|1
8005849|NCT01712854|12610169|FG000|Overall Study|Physician Decision|1
8005850|NCT01708057|12610196|FG000|Overall Study|Withdrawal due to study termination.|1
8005851|NCT01708057|12610197|FG001|Overall Study|Withdrawal due to study termination.|1
8005852|NCT01708057|12610198|FG002|Overall Study|Withdrawal due to study termination.|1
8005853|NCT01693367|12610218|FG000|Overall Study|Withdrawal by Subject|1
8005854|NCT01693367|12610219|FG001|Overall Study|Withdrawal by Subject|1
8005855|NCT01693367|12610218|FG000|Overall Study|Physician Decision|0
8005856|NCT01693367|12610219|FG001|Overall Study|Physician Decision|1
8005857|NCT01697800|12610240|FG000|Overall Study|Death|0
8005858|NCT01697800|12610241|FG001|Overall Study|Death|1
8005859|NCT01700348|12610247|FG000|Overall Study|Withdrawal by Subject|22
8005860|NCT01700348|12610247|FG000|Overall Study|Lost to Follow-up|1
8005861|NCT01689974|12610292|FG000|Overall Study|Termination of Study|5
8005862|NCT01689974|12610293|FG001|Overall Study|Termination of Study|5
8005863|NCT01676961|12610299|FG000|Overall Study|Death|3
8005864|NCT01676961|12610299|FG000|Overall Study|Lost to Follow-up|1
8005865|NCT01676961|12610299|FG000|Overall Study|Withdrawal by Subject|1
8005866|NCT01675011|12610367|FG000|Overall Study|Trial terminated by Sponsor|3
8005867|NCT01675011|12610368|FG001|Overall Study|Trial terminated by Sponsor|1
8005868|NCT01668147|12610396|FG000|Overall Study|Withdrawal by Subject|6
8005869|NCT01676701|12610406|FG000|Overall Study|Protocol Violation|1
8005870|NCT01676701|12610407|FG001|Overall Study|Protocol Violation|0
8005871|NCT01676701|12610406|FG000|Overall Study|Sponsor Decision|3
8005872|NCT01676701|12610407|FG001|Overall Study|Sponsor Decision|4
8005873|NCT01662102|12610422|FG000|Overall Study|Sponsor's decision|1
8005874|NCT01662102|12610423|FG001|Overall Study|Sponsor's decision|0
8005875|NCT01659554|12610430|FG000|Overall Study|Study Termination|4
8005876|NCT01658813|12610434|FG000|Overall Study|Disease progression|3
8005877|NCT01642732|12610462|FG000|Overall Study|Withdrawal by Subject|1
8005878|NCT01648270|12610475|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12
8005879|NCT01641601|12610491|FG000|Overall Study|Study discontinued.|3
8005880|NCT01641601|12610492|FG001|Overall Study|Study discontinued.|5
8005881|NCT01627899|12610520|FG000|Overall Study|Study terminated early by sponsor.|5
8005882|NCT01632020|12610526|FG000|Overall Study|Withdrawal by Subject|1
8005883|NCT01632020|12610527|FG001|Overall Study|Withdrawal by Subject|0
8005884|NCT01632020|12610526|FG000|Overall Study|Adverse Event|1
8005885|NCT01632020|12610527|FG001|Overall Study|Adverse Event|0
8005886|NCT01619800|12610539|FG000|Overall Study|study terminated|2
8005887|NCT01619800|12610540|FG001|Overall Study|study terminated|0
8005888|NCT01614067|12610557|FG000|Overall Study|Pregnancy|1
8005889|NCT01614067|12610558|FG001|Overall Study|Pregnancy|0
8005890|NCT01614067|12610557|FG000|Overall Study|Physician Decision|6
8005891|NCT01614067|12610558|FG001|Overall Study|Physician Decision|5
8005892|NCT01614067|12610557|FG000|Overall Study|Withdrawal by Subject|0
8005893|NCT01614067|12610558|FG001|Overall Study|Withdrawal by Subject|1
8005894|NCT01614067|12610557|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8
8005895|NCT01614067|12610558|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9
8005896|NCT01605019|12610571|FG000|Overall Study|pt did not meet transplant endpoint|3
8005897|NCT01605019|12610572|FG001|Overall Study|pt did not meet transplant endpoint|0
8005898|NCT01609231|12610580|FG000|Overall Study|Adverse Event|1
8005899|NCT01609231|12610581|FG001|Overall Study|Adverse Event|3
8005900|NCT01609231|12610580|FG000|Overall Study|Physician Decision|1
8005901|NCT01609231|12610581|FG001|Overall Study|Physician Decision|0
8005902|NCT01609231|12610580|FG000|Overall Study|Withdrawal by Subject|1
8005903|NCT01609231|12610581|FG001|Overall Study|Withdrawal by Subject|0
8005904|NCT01603043|12610607|FG000|Overall Study|Study Futility|7
8005905|NCT01603043|12610608|FG001|Overall Study|Study Futility|3
8005906|NCT01605370|12610616|FG000|Overall Study|Adverse Event|1
8005907|NCT01605370|12610617|FG001|Overall Study|Adverse Event|0
8005908|NCT01605617|12610625|FG000|First Intervention|Adverse Event|0
8005909|NCT01605617|12610626|FG001|First Intervention|Adverse Event|1
8005910|NCT01605617|12610625|FG000|Washout Period of 4 Weeks|Study Terminated|2
8005911|NCT01605617|12610626|FG001|Washout Period of 4 Weeks|Study Terminated|1
8005912|NCT01603121|12610643|FG000|Second Intervention, 10 Hours|Adverse Event|1
8005913|NCT01603121|12610644|FG001|Second Intervention, 10 Hours|Adverse Event|0
8005914|NCT01603394|12610657|FG000|Overall Study|Adverse Event|1
8005915|NCT01592383|12610661|FG000|Overall Study|Adverse Event|1
8005916|NCT01591096|12610683|FG000|Overall Study|Adverse Event|1
8005917|NCT01576575|12610700|FG000|Buprenorphine Control|Withdrawal by Subject|3
8005918|NCT01576575|12610700|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3
8005919|NCT01576575|12610700|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1
8005920|NCT01582100|12610724|FG000|Overall Study|Adverse Event|1
8005921|NCT01582100|12610724|FG000|Overall Study|Withdrawal by Subject|1
8005922|NCT01575028|12610737|FG000|Overall Study|Physician Decision|0
8005923|NCT01575028|12610738|FG001|Overall Study|Physician Decision|1
8005924|NCT01578785|12610746|FG000|Overall Study|Withdrawal by Subject|0
8005925|NCT01578785|12610747|FG001|Overall Study|Withdrawal by Subject|1
8005926|NCT01578785|12610746|FG000|Overall Study|Study terminated by sponsor|59
8005927|NCT01578785|12610747|FG001|Overall Study|Study terminated by sponsor|118
8005928|NCT01576549|12610753|FG000|Overall Study|Sponsor Decision|2
8005929|NCT01561989|12610773|FG000|Overall Study|accural target not met.|5
8005930|NCT01561989|12610774|FG001|Overall Study|accural target not met.|6
8005931|NCT01564732|12610782|FG000|Overall Study|Early termination by the study sponsor|6
8005932|NCT01564732|12610783|FG001|Overall Study|Early termination by the study sponsor|5
8005933|NCT01560507|12610792|FG000|Overall Study|Lost to Follow-up|3
8005934|NCT01560507|12610793|FG001|Overall Study|Lost to Follow-up|1
8005935|NCT01560507|12610794|FG002|Overall Study|Lost to Follow-up|2
8005936|NCT01560507|12610792|FG000|Overall Study|Withdrawal by Subject|1
8005937|NCT01560507|12610793|FG001|Overall Study|Withdrawal by Subject|1
8005938|NCT01560507|12610794|FG002|Overall Study|Withdrawal by Subject|0
8005939|NCT01555073|12610838|FG000|Overall Study|Lost to Follow-up|1
8005940|NCT01555073|12610839|FG001|Overall Study|Lost to Follow-up|2
8005941|NCT01555073|12610840|FG002|Overall Study|Lost to Follow-up|0
8005942|NCT01555073|12610841|FG003|Overall Study|Lost to Follow-up|5
8005943|NCT01541397|12610876|FG000|Overall Study|Study ended prior to data collection|4
8005944|NCT01541397|12610877|FG001|Overall Study|Study ended prior to data collection|2
8005945|NCT01546207|12610883|FG000|Overall Study|Death|1
8005946|NCT01547728|12610891|FG000|Overall Study|Change in procedure and equipment|1
8005947|NCT01547728|12610891|FG000|Overall Study|Drug not ready for subject|1
8005948|NCT01547728|12610891|FG000|Overall Study|Screen failure|39
8005949|NCT01546883|12610908|FG000|Overall Study|Withdrawal by Subject|3
8005950|NCT01546883|12610908|FG000|Overall Study|Adverse Event|4
8005951|NCT01546883|12610908|FG000|Overall Study|Lost to Follow-up|2
8005952|NCT01546883|12610908|FG000|Overall Study|early closure of study|2
8005953|NCT01546883|12610908|FG000|Overall Study|other unrelated illness|1
8005954|NCT01536015|12610918|FG000|Overall Study|Adverse Event|1
8005955|NCT01536015|12610919|FG001|Overall Study|Adverse Event|4
8005956|NCT01536015|12610918|FG000|Overall Study|Lost to Follow-up|0
8005957|NCT01536015|12610919|FG001|Overall Study|Lost to Follow-up|1
8005958|NCT01536015|12610918|FG000|Overall Study|Inclusion Criterion not met|2
8005959|NCT01536015|12610919|FG001|Overall Study|Inclusion Criterion not met|0
8005960|NCT01536015|12610918|FG000|Overall Study|Study closure|5
8005961|NCT01536015|12610919|FG001|Overall Study|Study closure|5
8005962|NCT01534676|12610936|FG000|Overall Study|Study closed due to poor enrollment|2
8005963|NCT01534676|12610937|FG001|Overall Study|Study closed due to poor enrollment|1
8005964|NCT01530087|12610961|FG000|Overall Study|Physician Decision|2
8005965|NCT01531387|12610998|FG000|Overall Study|Early termination of study|11
8005966|NCT01531387|12610999|FG001|Overall Study|Early termination of study|11
8005967|NCT01527292|12611018|FG000|Overall Study|Physician Decision|0
7718399|NCT00528112|12142382|FG001|Treatment up to 3 Years|Withdrawal by Subject|31
7718400|NCT00528112|12142381|FG000|Treatment up to 3 Years|Protocol Violation|16
7718401|NCT00528112|12142382|FG001|Treatment up to 3 Years|Protocol Violation|16
7718402|NCT00528112|12142381|FG000|Treatment up to 3 Years|Death|0
7718403|NCT00528112|12142382|FG001|Treatment up to 3 Years|Death|1
7718404|NCT00528112|12142381|FG000|Treatment up to 3 Years|Lost to Follow-up|63
7718405|NCT00528112|12142382|FG001|Treatment up to 3 Years|Lost to Follow-up|61
8005968|NCT01527292|12611019|FG001|Overall Study|Physician Decision|3
8005969|NCT01528696|12611038|FG000|Overall Study|See detailed description|18
8005970|NCT01528696|12611039|FG001|Overall Study|See detailed description|19
8005971|NCT01520714|12611073|FG000|Overall Study|Protocol Violation|0
8005972|NCT01520714|12611074|FG001|Overall Study|Protocol Violation|3
8005973|NCT01520714|12611073|FG000|Overall Study|Adverse Event|0
8005974|NCT01520714|12611074|FG001|Overall Study|Adverse Event|2
8005975|NCT01520714|12611073|FG000|Overall Study|Lack of Efficacy|0
8005976|NCT01520714|12611074|FG001|Overall Study|Lack of Efficacy|1
8005977|NCT01516034|12611089|FG000|Overall Study|Physician Decision|1
8005978|NCT01516034|12611089|FG000|Overall Study|Lack of Efficacy|7
8005979|NCT01510756|12611114|FG000|Overall Study|Death|1
8005980|NCT01510756|12611114|FG000|Overall Study|Lack of Efficacy|2
8005981|NCT01510756|12611114|FG000|Overall Study|Physician Decision|1
8005982|NCT01509053|12611140|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
8005983|NCT01509053|12611140|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
8005984|NCT01509053|12611140|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
8005985|NCT01509053|12611140|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
8005986|NCT01509053|12611140|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
8005987|NCT01509053|12611140|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
8005988|NCT01478113|12611189|FG000|Overall Study|Withdrawal by Subject|0
8005989|NCT01478113|12611190|FG001|Overall Study|Withdrawal by Subject|1
8005990|NCT01478113|12611189|FG000|Overall Study|Physician Decision|1
8005991|NCT01478113|12611190|FG001|Overall Study|Physician Decision|0
8005992|NCT01482598|12611208|FG000|Overall Study|Death|7
8005993|NCT01482598|12611209|FG001|Overall Study|Death|10
8005994|NCT01482598|12611208|FG000|Overall Study|Physician Decision|0
8005995|NCT01482598|12611209|FG001|Overall Study|Physician Decision|3
8005996|NCT01482598|12611208|FG000|Overall Study|Withdrawal by Subject|4
8005997|NCT01482598|12611209|FG001|Overall Study|Withdrawal by Subject|5
8005998|NCT01482598|12611208|FG000|Overall Study|Lost to Follow-up|5
8005999|NCT01482598|12611209|FG001|Overall Study|Lost to Follow-up|4
8006000|NCT01473732|12611229|FG000|Overall Study|Adverse Event|1
8006001|NCT01473732|12611230|FG001|Overall Study|Adverse Event|0
8006002|NCT01473732|12611229|FG000|Overall Study|Death|1
8006003|NCT01473732|12611230|FG001|Overall Study|Death|0
8006004|NCT01465230|12611245|FG000|Overall Study|Withdrawal by Subject|2
8006005|NCT01463293|12611267|FG000|Overall Study|Lost to Follow-up|1
8006006|NCT01463293|12611268|FG001|Overall Study|Lost to Follow-up|4
8006007|NCT01463293|12611269|FG002|Overall Study|Lost to Follow-up|5
8006008|NCT01463293|12611267|FG000|Overall Study|Adverse Event|1
8006009|NCT01463293|12611268|FG001|Overall Study|Adverse Event|2
8006010|NCT01463293|12611269|FG002|Overall Study|Adverse Event|0
8006011|NCT01463293|12611267|FG000|Overall Study|Withdrawal by Subject|4
8006012|NCT01463293|12611268|FG001|Overall Study|Withdrawal by Subject|10
8006013|NCT01463293|12611269|FG002|Overall Study|Withdrawal by Subject|5
8006014|NCT01463293|12611267|FG000|Overall Study|Other|0
8006015|NCT01463293|12611268|FG001|Overall Study|Other|0
8006016|NCT01463293|12611269|FG002|Overall Study|Other|2
8006017|NCT01457053|12611277|FG000|Overall Study|Unable to undergo selected treatment|1
8006018|NCT01457053|12611278|FG001|Overall Study|Unable to undergo selected treatment|1
8006019|NCT01451723|12611286|FG000|Overall Study|study halted|6
8006020|NCT01451723|12611287|FG001|Overall Study|study halted|5
8006021|NCT01440517|12611293|FG000|Overall Study|Subject withdrawn prior to dosing|1
8006022|NCT01440595|12611299|FG000|Overall Study|Lost to Follow-up|0
8006023|NCT01440595|12611300|FG001|Overall Study|Lost to Follow-up|1
8006024|NCT01440595|12611301|FG002|Overall Study|Lost to Follow-up|0
8006025|NCT01440595|12611299|FG000|Overall Study|Study terminated by sponsor.|1
8006026|NCT01440595|12611300|FG001|Overall Study|Study terminated by sponsor.|2
8006027|NCT01440595|12611301|FG002|Overall Study|Study terminated by sponsor.|1
8006028|NCT01446796|12611307|FG000|Overall Study|Withdrawal by Subject|1
8006029|NCT01446796|12611308|FG001|Overall Study|Withdrawal by Subject|0
8006030|NCT01443923|12611318|FG000|Overall Study|Adverse Event|1
8006031|NCT01443923|12611319|FG001|Overall Study|Adverse Event|0
8006032|NCT01439347|12611327|FG000|Overall Study|Death|10
8006033|NCT01439347|12611328|FG001|Overall Study|Death|9
8006034|NCT01439347|12611327|FG000|Overall Study|Withdrawal by Subject|0
8006035|NCT01439347|12611328|FG001|Overall Study|Withdrawal by Subject|1
8006036|NCT01439347|12611327|FG000|Overall Study|Physician Decision|1
8006037|NCT01439347|12611328|FG001|Overall Study|Physician Decision|0
8006038|NCT01439347|12611327|FG000|Overall Study|Sponsor Terminated Study|2
8006039|NCT01439347|12611328|FG001|Overall Study|Sponsor Terminated Study|3
8006040|NCT01433471|12611353|FG000|Overall Study|Withdrawal by Subject|0
8006041|NCT01433471|12611354|FG001|Overall Study|Withdrawal by Subject|1
8006042|NCT01436084|12611362|FG000|Overall Study|Disease Progression|2
8006043|NCT01436084|12611362|FG000|Overall Study|Withdrawal by Subject|1
8006044|NCT01436084|12611362|FG000|Overall Study|Early Closure of Study|1
8006045|NCT01415986|12611390|FG000|Overall Study|Lost to Follow-up|1
8006046|NCT01410799|12611395|FG000|Overall Study|PI decision|13
8006047|NCT01426113|12611401|FG000|Overall Study|Study Discontinued|1
8006048|NCT01426113|12611402|FG001|Overall Study|Study Discontinued|1
8006049|NCT01426113|12611401|FG000|Overall Study|Adverse Event|0
8006050|NCT01426113|12611402|FG001|Overall Study|Adverse Event|1
8006051|NCT01420965|12611420|FG000|Overall Study|Withdrawal by Subject|1
8006052|NCT01420965|12611421|FG001|Overall Study|Withdrawal by Subject|0
8006053|NCT01420965|12611422|FG002|Overall Study|Withdrawal by Subject|0
8006054|NCT01420965|12611420|FG000|Overall Study|Adverse Event|0
8006055|NCT01420965|12611421|FG001|Overall Study|Adverse Event|1
8006056|NCT01420965|12611422|FG002|Overall Study|Adverse Event|0
8006057|NCT01417377|12611430|FG000|Overall Study|Lost to Follow-up|12
8006058|NCT01417377|12611430|FG000|Overall Study|Enrolled, but not treated|1
8006059|NCT01416272|12611434|FG000|Overall Study|Unacceptable distance visual acuity|2
8006060|NCT01416272|12611434|FG000|Overall Study|Lost to Follow-up|1
8006061|NCT01416272|12611434|FG000|Overall Study|Study related complaints|1
8006062|NCT01414166|12611440|FG000|Overall Study|Adverse Event|10
8006063|NCT01414166|12611441|FG001|Overall Study|Adverse Event|2
8006064|NCT01414166|12611440|FG000|Overall Study|Lost to Follow-up|4
8006065|NCT01414166|12611441|FG001|Overall Study|Lost to Follow-up|1
8006066|NCT01414166|12611440|FG000|Overall Study|Non-compliance with study drug|2
8006067|NCT01414166|12611441|FG001|Overall Study|Non-compliance with study drug|0
8006068|NCT01414166|12611440|FG000|Overall Study|Physician Decision|2
8006069|NCT01414166|12611441|FG001|Overall Study|Physician Decision|0
7718406|NCT00528112|12142381|FG000|Treatment up to 3 Years|Pregnancy|9
8006070|NCT01414166|12611440|FG000|Overall Study|Protocol Violation|2
8006071|NCT01414166|12611441|FG001|Overall Study|Protocol Violation|0
8006072|NCT01414166|12611440|FG000|Overall Study|Study terminated by Sponsor|68
8006073|NCT01414166|12611441|FG001|Overall Study|Study terminated by Sponsor|75
8006074|NCT01414166|12611440|FG000|Overall Study|Withdrawal by Subject|3
8006075|NCT01414166|12611441|FG001|Overall Study|Withdrawal by Subject|5
8006076|NCT01409031|12611468|FG000|Overall Study|transferred to other hosp|1
8006077|NCT01409031|12611469|FG001|Overall Study|transferred to other hosp|0
8006078|NCT01403194|12611492|FG000|Overall Study|Screen Failure|2
8006079|NCT01403194|12611492|FG000|Overall Study|Lost to Follow-up|8
8006080|NCT01397552|12611498|FG000|Overall Study|Adverse Event|1
8006081|NCT01397552|12611499|FG001|Overall Study|Adverse Event|0
8006082|NCT01397552|12611498|FG000|Overall Study|Withdrawal by Subject|2
8006083|NCT01397552|12611499|FG001|Overall Study|Withdrawal by Subject|1
8006084|NCT01392170|12611505|FG000|Overall Study|Withdrawal by Subject|1
8006085|NCT01392170|12611505|FG000|Overall Study|Ineligible|1
8006086|NCT01389817|12611511|FG000|Overall Study|Physician Decision|1
8006087|NCT01389817|12611512|FG001|Overall Study|Physician Decision|0
8006088|NCT01389817|12611511|FG000|Overall Study|Lost to Follow-up|1
8006089|NCT01389817|12611512|FG001|Overall Study|Lost to Follow-up|0
8006090|NCT01389817|12611511|FG000|Overall Study|Withdrawal by Subject|2
8006091|NCT01389817|12611512|FG001|Overall Study|Withdrawal by Subject|0
8006092|NCT01390181|12611522|FG000|Overall Study|Lost to Follow-up|1
8006093|NCT01390181|12611522|FG000|Overall Study|Study Terminated due to Low Accrual|3
8006094|NCT01372618|12611557|FG000|Overall Study|PI Died. Study Terminated|9
8006095|NCT01379274|12611565|FG000|Overall Study|funding withdrawn|1
8006096|NCT01369641|12611578|FG000|Overall Study|Withdrawal by Subject|1
8006097|NCT01359254|12611593|FG000|Overall Study|Death|1
8006098|NCT01359254|12611594|FG001|Overall Study|Death|0
8006099|NCT01352416|12611631|FG000|Overall Study|Physician Decision|1
8006100|NCT01352416|12611632|FG001|Overall Study|Physician Decision|2
8006101|NCT01352416|12611633|FG002|Overall Study|Physician Decision|2
8006102|NCT01352416|12611634|FG003|Overall Study|Physician Decision|1
8006103|NCT01349595|12611650|FG000|Overall Study|Lack of funding|2
8006104|NCT01349595|12611651|FG001|Overall Study|Lack of funding|2
8006105|NCT01347840|12611670|FG000|Overall Study|Withdrawal by Subject|1
8006106|NCT01335997|12611681|FG000|Period I and II|Adverse Event|63
8006107|NCT01335997|12611682|FG001|Period I and II|Adverse Event|43
8006108|NCT01335997|12611681|FG000|Period I and II|Noncompliance with Study Drug|1
8006109|NCT01335997|12611682|FG001|Period I and II|Noncompliance with Study Drug|1
8006110|NCT01335997|12611681|FG000|Period I and II|Lost to Follow-up|3
8006111|NCT01335997|12611682|FG001|Period I and II|Lost to Follow-up|5
8006112|NCT01335997|12611681|FG000|Period I and II|Withdrawal by Subject|9
8006113|NCT01335997|12611682|FG001|Period I and II|Withdrawal by Subject|4
8006114|NCT01335997|12611681|FG000|Period I and II|Study Terminated by Sponsor|406
8006115|NCT01335997|12611682|FG001|Period I and II|Study Terminated by Sponsor|415
8006116|NCT01335997|12611681|FG000|Period I and II|Protocol Violation|9
8006117|NCT01335997|12611682|FG001|Period I and II|Protocol Violation|10
8006118|NCT01335997|12611681|FG000|Period I and II|Physician Decision|2
8006119|NCT01335997|12611682|FG001|Period I and II|Physician Decision|1
8006120|NCT01335997|12611681|FG000|Period III|Adverse Event|0
8006121|NCT01335997|12611682|FG001|Period III|Adverse Event|2
8006122|NCT01335997|12611681|FG000|Period III|Study Terminated by Sponsor|77
8006123|NCT01335997|12611682|FG001|Period III|Study Terminated by Sponsor|76
8006124|NCT01335997|12611681|FG000|Period III|Protocol Violation|0
8006125|NCT01335997|12611682|FG001|Period III|Protocol Violation|1
8006126|NCT01335997|12611681|FG000|Period III|Lost to Follow-up|1
8006127|NCT01335997|12611682|FG001|Period III|Lost to Follow-up|0
8006128|NCT01341587|12611705|FG000|Overall Study|Lost to Follow-up|2
8006129|NCT01341587|12611706|FG001|Overall Study|Lost to Follow-up|0
8006130|NCT01341587|12611705|FG000|Overall Study|stopped using the meters|2
8006131|NCT01341587|12611706|FG001|Overall Study|stopped using the meters|10
8006132|NCT01332799|12611718|FG000|Overall Study|Insufficient funding|10
8006133|NCT01332799|12611719|FG001|Overall Study|Insufficient funding|10
8006134|NCT01329549|12611725|FG000|Overall Study|Withdrawal by Subject|1
8006135|NCT01329549|12611725|FG000|Overall Study|Adverse Event|1
8006136|NCT01326845|12611731|FG000|Overall Study|Administrative Problems|5
8006137|NCT01326845|12611732|FG001|Overall Study|Administrative Problems|2
8006138|NCT01326845|12611731|FG000|Overall Study|Adverse Event|1
8006139|NCT01326845|12611732|FG001|Overall Study|Adverse Event|0
8006140|NCT01326845|12611731|FG000|Overall Study|Misisng|1
8006141|NCT01326845|12611732|FG001|Overall Study|Misisng|3
8006142|NCT01329341|12611738|FG000|Overall Study|Withdrawal by Subject|44
8006143|NCT01320683|12611751|FG000|Overall Study|Positive antibody response|1
8006144|NCT01313273|12611757|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
8006145|NCT01313273|12611758|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
8006146|NCT01313273|12611757|FG000|Overall Study|Withdrawal by Subject|1
8006147|NCT01313273|12611758|FG001|Overall Study|Withdrawal by Subject|0
8006148|NCT01313273|12611757|FG000|Overall Study|Screening Chromogranin A-in normal range|0
8006149|NCT01313273|12611758|FG001|Overall Study|Screening Chromogranin A-in normal range|1
8006150|NCT01321008|12611764|FG000|Overall Study|Early Study Termination|1
8006151|NCT01310803|12611770|FG000|Overall Study|Subject terminated by Sponsor|1
8006152|NCT01310803|12611771|FG001|Overall Study|Subject terminated by Sponsor|0
8006153|NCT01313923|12611790|FG000|Overall Study|Physician Decision|3
8006154|NCT01321697|12611794|FG000|Overall Study|Study Terminated|7
8006155|NCT01312428|12611800|FG000|Overall Study|Study Termination|3
8006156|NCT01312428|12611801|FG001|Overall Study|Study Termination|4
8006157|NCT01290822|12611859|FG000|Overall Study|Withdrawal by Subject|1
8006158|NCT01290822|12611859|FG000|Overall Study|Physician Decision|10
8006159|NCT01290718|12611863|FG000|Overall Study|Early termination of the study|4
8006160|NCT01293123|12611869|FG000|Overall Study|Lost to Follow-up|0
8006161|NCT01293123|12611870|FG001|Overall Study|Lost to Follow-up|1
8006162|NCT01294046|12611876|FG000|Overall Study|Infection and surgical explant|1
8006163|NCT01294046|12611876|FG000|Overall Study|Eligibility criteria expanded|1
8006164|NCT01294046|12611876|FG000|Overall Study|Stimulation response inadqequate|1
8006165|NCT01281124|12611920|FG000|Overall Study|Death|1
8006166|NCT01282216|12611932|FG000|Overall Study|Graft failure|0
8006167|NCT01282216|12611933|FG001|Overall Study|Graft failure|0
8006168|NCT01282216|12611934|FG002|Overall Study|Graft failure|3
8006169|NCT01282216|12611935|FG003|Overall Study|Graft failure|2
8006170|NCT01282216|12611932|FG000|Overall Study|Physician Decision|0
8006171|NCT01282216|12611933|FG001|Overall Study|Physician Decision|0
8006172|NCT01282216|12611934|FG002|Overall Study|Physician Decision|11
8006173|NCT01282216|12611935|FG003|Overall Study|Physician Decision|0
8006174|NCT01282216|12611932|FG000|Overall Study|Relapse|0
8006175|NCT01282216|12611933|FG001|Overall Study|Relapse|0
8006176|NCT01282216|12611934|FG002|Overall Study|Relapse|17
8006177|NCT01282216|12611935|FG003|Overall Study|Relapse|6
8006178|NCT01282216|12611932|FG000|Overall Study|Death|0
8006179|NCT01282216|12611933|FG001|Overall Study|Death|0
8006180|NCT01282216|12611934|FG002|Overall Study|Death|2
8006181|NCT01282216|12611935|FG003|Overall Study|Death|0
8006182|NCT01284491|12611941|FG000|Overall Study|Study termination|13
8006183|NCT01274533|12611973|FG000|Overall Study|Withdrawal by Subject|1
8006184|NCT01274533|12611973|FG000|Overall Study|Non-compliance|1
8006185|NCT01274533|12611973|FG000|Overall Study|Disease progression|2
8006186|NCT01279616|12611977|FG000|Overall Study|donor could not be located|5
8006187|NCT01279616|12611977|FG000|Overall Study|no signs of sickle cell disease|2
8006188|NCT01276054|12611983|FG000|Overall Study|No one to oversee trial after P.I. left|2
8006189|NCT01276054|12611984|FG001|Overall Study|No one to oversee trial after P.I. left|2
8006190|NCT01264965|12611990|FG000|Overall Study|Withdrawal by Subject|10
8006191|NCT01266824|12611996|FG000|Overall Study|Study terminated prior to completion|2
8006192|NCT01266824|12611997|FG001|Overall Study|Study terminated prior to completion|3
8006193|NCT01264835|12612003|FG000|Overall Study|Lost to Follow-up|1
8006194|NCT01274429|12612007|FG000|Overall Study|Study closed do to lack of funding|5
8006195|NCT01273064|12612016|FG000|Overall Study|Adverse Event|5
8006196|NCT01273064|12612017|FG001|Overall Study|Adverse Event|1
8006197|NCT01273064|12612018|FG002|Overall Study|Adverse Event|3
8006198|NCT01273064|12612019|FG003|Overall Study|Adverse Event|2
8006199|NCT01273064|12612020|FG004|Overall Study|Adverse Event|1
8006200|NCT01273064|12612016|FG000|Overall Study|Withdrawal by Subject|4
8006201|NCT01273064|12612017|FG001|Overall Study|Withdrawal by Subject|2
8006202|NCT01273064|12612018|FG002|Overall Study|Withdrawal by Subject|2
8006203|NCT01273064|12612019|FG003|Overall Study|Withdrawal by Subject|2
8006204|NCT01273064|12612020|FG004|Overall Study|Withdrawal by Subject|0
8006205|NCT01273064|12612016|FG000|Overall Study|Study Termination|13
8006206|NCT01273064|12612017|FG001|Overall Study|Study Termination|27
8006207|NCT01273064|12612018|FG002|Overall Study|Study Termination|26
8006208|NCT01273064|12612019|FG003|Overall Study|Study Termination|16
8006209|NCT01273064|12612020|FG004|Overall Study|Study Termination|8
8006210|NCT01273064|12612016|FG000|Overall Study|Lost to Follow-up|1
8006211|NCT01273064|12612017|FG001|Overall Study|Lost to Follow-up|0
8006212|NCT01273064|12612018|FG002|Overall Study|Lost to Follow-up|0
8006213|NCT01273064|12612019|FG003|Overall Study|Lost to Follow-up|0
8006214|NCT01273064|12612020|FG004|Overall Study|Lost to Follow-up|0
8006215|NCT01273064|12612016|FG000|Overall Study|Physician Decision|0
8006216|NCT01273064|12612017|FG001|Overall Study|Physician Decision|0
8006217|NCT01273064|12612018|FG002|Overall Study|Physician Decision|0
8006218|NCT01273064|12612019|FG003|Overall Study|Physician Decision|0
8006219|NCT01273064|12612020|FG004|Overall Study|Physician Decision|1
8006220|NCT01274559|12612034|FG000|Overall Study|Adverse Event|57
8006221|NCT01274559|12612035|FG001|Overall Study|Adverse Event|13
8006222|NCT01274559|12612034|FG000|Overall Study|Death|1
8006223|NCT01274559|12612035|FG001|Overall Study|Death|1
8006224|NCT01274559|12612034|FG000|Overall Study|Lost to Follow-up|3
8006225|NCT01274559|12612035|FG001|Overall Study|Lost to Follow-up|3
8006226|NCT01274559|12612034|FG000|Overall Study|Non-compliance with Study Drug|2
8006227|NCT01274559|12612035|FG001|Overall Study|Non-compliance with Study Drug|4
8006228|NCT01274559|12612034|FG000|Overall Study|Physician Decision|2
8006229|NCT01274559|12612035|FG001|Overall Study|Physician Decision|1
8006230|NCT01274559|12612034|FG000|Overall Study|Protocol Violation|28
8006231|NCT01274559|12612035|FG001|Overall Study|Protocol Violation|23
8006232|NCT01274559|12612034|FG000|Overall Study|Study Terminated by Sponsor|79
8006233|NCT01274559|12612035|FG001|Overall Study|Study Terminated by Sponsor|87
8006234|NCT01274559|12612034|FG000|Overall Study|Withdrawal by Subject|25
8006235|NCT01274559|12612035|FG001|Overall Study|Withdrawal by Subject|13
8006236|NCT01267825|12612069|FG000|Overall Study|study terminated. no data collected.|1
8006237|NCT01267825|12612070|FG001|Overall Study|study terminated. no data collected.|0
8006238|NCT01259284|12612079|FG000|Overall Study|Study Termination|2
8006239|NCT01259284|12612080|FG001|Overall Study|Study Termination|0
8006240|NCT01259284|12612081|FG002|Overall Study|Study Termination|0
8006241|NCT01249157|12612089|FG000|Overall Study|Withdrawal by Subject|1
8006242|NCT01263028|12612093|FG000|Overall Study|Withdrawal by Subject|1
8006243|NCT01263028|12612093|FG000|Overall Study|Adverse Event|1
8006244|NCT01263028|12612093|FG000|Overall Study|Study terminated due to low enrollment.|4
8006245|NCT01259024|12612105|FG000|Overall Study|Physician Decision|1
8006246|NCT01251952|12612109|FG000|Overall Study|Adverse Event|1
8006247|NCT01251120|12612115|FG000|Overall Study|Lack of Efficacy|0
8006248|NCT01251120|12612116|FG001|Overall Study|Lack of Efficacy|1
8006249|NCT01248130|12612124|FG000|Overall Study|Protocol Violation|1
8006250|NCT01248130|12612125|FG001|Overall Study|Protocol Violation|0
8006251|NCT01248130|12612124|FG000|Overall Study|Ineligible|1
8006252|NCT01248130|12612125|FG001|Overall Study|Ineligible|0
8006253|NCT01243892|12612133|FG000|Overall Study|Did not meet eligibility criteria|2
8006254|NCT01243892|12612134|FG001|Overall Study|Did not meet eligibility criteria|0
8006255|NCT01246011|12612143|FG000|Overall Study|If needed warfarin clinically, withdrawn|0
8006256|NCT01246011|12612144|FG001|Overall Study|If needed warfarin clinically, withdrawn|0
8006257|NCT01246011|12612145|FG002|Overall Study|If needed warfarin clinically, withdrawn|3
8006258|NCT01246011|12612143|FG000|Overall Study|Withdrawal by Subject|0
8006259|NCT01246011|12612144|FG001|Overall Study|Withdrawal by Subject|0
8006260|NCT01246011|12612145|FG002|Overall Study|Withdrawal by Subject|1
8006261|NCT01242020|12612156|FG000|Overall Study|Withdrawal by Subject|2
8006262|NCT01242020|12612157|FG001|Overall Study|Withdrawal by Subject|0
8006263|NCT01242020|12612156|FG000|Overall Study|Failed screening|1
8006264|NCT01242020|12612157|FG001|Overall Study|Failed screening|0
8006265|NCT01244620|12612163|FG000|Overall Study|Study terminated|4
8006266|NCT01244620|12612164|FG001|Overall Study|Study terminated|4
8006267|NCT01244620|12612165|FG002|Overall Study|Study terminated|4
8006268|NCT01244620|12612166|FG003|Overall Study|Study terminated|4
8006269|NCT01241279|12612182|FG000|Overall Study|Lost to Follow-up|0
8006270|NCT01241279|12612183|FG001|Overall Study|Lost to Follow-up|1
8006271|NCT01230788|12612189|FG000|Overall Study|Prescribed exclusion drug|1
8006272|NCT01239680|12612195|FG000|Overall Study|Withdrawal by Subject|2
8006273|NCT01239680|12612196|FG001|Overall Study|Withdrawal by Subject|0
8006274|NCT01230307|12612227|FG000|Overall Study|LVAD Placement|0
8006275|NCT01230307|12612228|FG001|Overall Study|LVAD Placement|2
8006276|NCT01230489|12612234|FG000|Overall Study|Death|2
8006277|NCT01230489|12612234|FG000|Overall Study|Adverse Event|2
8006278|NCT01230489|12612234|FG000|Overall Study|Treatment modality changed|1
8006279|NCT01217060|12612290|FG000|Overall Study|Withdrawal by Subject|1
8006280|NCT01217047|12612298|FG000|Overall Study|Lost to Follow-up|0
8006281|NCT01217047|12612299|FG001|Overall Study|Lost to Follow-up|1
8006282|NCT01217047|12612300|FG002|Overall Study|Lost to Follow-up|0
8006283|NCT01206101|12612311|FG000|Overall Study|Adverse Event|1
8006284|NCT01206101|12612312|FG001|Overall Study|Adverse Event|0
8006285|NCT01206101|12612311|FG000|Overall Study|Physician Decision|0
8006286|NCT01206101|12612312|FG001|Overall Study|Physician Decision|1
8006287|NCT01206101|12612311|FG000|Overall Study|Unclassified|1
8006288|NCT01206101|12612312|FG001|Overall Study|Unclassified|0
8006289|NCT01209520|12612335|FG000|Overall Study|Withdrawal by Subject|3
8006290|NCT01207102|12612356|FG000|Overall Study|Withdrawal by Subject|5
8006291|NCT01207102|12612356|FG000|Overall Study|Adverse Event|2
8006292|NCT01207102|12612356|FG000|Overall Study|progression|2
8006293|NCT01207102|12612356|FG000|Overall Study|Withdrawal by Treating Physician|1
8006294|NCT01206439|12612374|FG000|Overall Study|subject did not meet inclusion criteria|1
8006295|NCT01198548|12612396|FG000|Overall Study|Disease Progression|9
8006296|NCT01198548|12612396|FG000|Overall Study|Administrative Decision|1
8006297|NCT01193556|12612419|FG000|Overall Study|Study termination|26
8006298|NCT01193556|12612420|FG001|Overall Study|Study termination|25
8006299|NCT01189435|12612426|FG000|Overall Study|Withdrawal by Subject|1
8006300|NCT01189435|12612426|FG000|Overall Study|Physician Decision|1
8006301|NCT01193530|12612432|FG000|Overall Study|Withdrawal by Subject|2
8006302|NCT01193530|12612433|FG001|Overall Study|Withdrawal by Subject|2
8006303|NCT01193530|12612432|FG000|Overall Study|Began Contraindicated Therapy|1
8006304|NCT01193530|12612433|FG001|Overall Study|Began Contraindicated Therapy|0
8006305|NCT01193530|12612432|FG000|Overall Study|Lost Light Box|0
8006306|NCT01193530|12612433|FG001|Overall Study|Lost Light Box|1
8006307|NCT01193530|12612432|FG000|Overall Study|Returned home - out of state|0
8006308|NCT01193530|12612433|FG001|Overall Study|Returned home - out of state|1
8006309|NCT01193530|12612432|FG000|Overall Study|Non-Compliance|0
8006310|NCT01193530|12612433|FG001|Overall Study|Non-Compliance|1
8006311|NCT01183221|12612467|FG000|3 Weeks Wash Out|Lost to Follow-up|1
8006312|NCT01183221|12612468|FG001|3 Weeks Wash Out|Lost to Follow-up|1
8006313|NCT01189227|12612476|FG000|Overall Study|Study terminated due to low accrual|6
8006314|NCT01189227|12612477|FG001|Overall Study|Study terminated due to low accrual|3
8006315|NCT01179737|12612487|FG000|Cohort 1 & Cohort 2|Adverse Event|3
8006316|NCT01179737|12612488|FG001|Cohort 1 & Cohort 2|Adverse Event|1
8006317|NCT01179737|12612489|FG002|Cohort 1 & Cohort 2|Adverse Event|1
8006318|NCT01179737|12612490|FG003|Cohort 1 & Cohort 2|Adverse Event|0
8006319|NCT01179737|12612487|FG000|Cohort 1 & Cohort 2|Withdrew consent|2
8006320|NCT01179737|12612488|FG001|Cohort 1 & Cohort 2|Withdrew consent|0
8006321|NCT01179737|12612489|FG002|Cohort 1 & Cohort 2|Withdrew consent|0
8006322|NCT01179737|12612490|FG003|Cohort 1 & Cohort 2|Withdrew consent|0
8006323|NCT01179737|12612487|FG000|Cohort 1 & Cohort 2|Administrative problems|0
8006324|NCT01179737|12612488|FG001|Cohort 1 & Cohort 2|Administrative problems|0
8006325|NCT01179737|12612489|FG002|Cohort 1 & Cohort 2|Administrative problems|2
8006326|NCT01179737|12612490|FG003|Cohort 1 & Cohort 2|Administrative problems|4
8006327|NCT01179737|12612487|FG000|Cohort 1 & Cohort 2|Death|0
8006328|NCT01179737|12612488|FG001|Cohort 1 & Cohort 2|Death|0
8006329|NCT01179737|12612489|FG002|Cohort 1 & Cohort 2|Death|1
8006330|NCT01179737|12612490|FG003|Cohort 1 & Cohort 2|Death|0
8006331|NCT01179737|12612487|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
8006332|NCT01179737|12612488|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
8006333|NCT01179737|12612489|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
8006334|NCT01179737|12612490|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
8006335|NCT01179737|12612487|FG000|Cohort 1 & Cohort 2 Expansion|Death|1
8006336|NCT01179737|12612488|FG001|Cohort 1 & Cohort 2 Expansion|Death|0
8006337|NCT01179737|12612489|FG002|Cohort 1 & Cohort 2 Expansion|Death|0
8006338|NCT01179737|12612490|FG003|Cohort 1 & Cohort 2 Expansion|Death|0
8006339|NCT01179737|12612487|FG000|Extension|The study was terminated|3
8006340|NCT01179737|12612488|FG001|Extension|The study was terminated|0
8006341|NCT01179737|12612489|FG002|Extension|The study was terminated|0
8006342|NCT01179737|12612490|FG003|Extension|The study was terminated|0
8006343|NCT01183468|12612503|FG000|Overall Study|Lost to Follow-up|2
8006344|NCT01183468|12612504|FG001|Overall Study|Lost to Follow-up|1
8006345|NCT01183468|12612505|FG002|Overall Study|Lost to Follow-up|0
8006346|NCT01183468|12612506|FG003|Overall Study|Lost to Follow-up|0
8006347|NCT01183468|12612503|FG000|Overall Study|Physician Decision|1
8006348|NCT01183468|12612504|FG001|Overall Study|Physician Decision|0
8006349|NCT01183468|12612505|FG002|Overall Study|Physician Decision|0
8006350|NCT01183468|12612506|FG003|Overall Study|Physician Decision|0
8006351|NCT01183468|12612503|FG000|Overall Study|Withdrawal by Subject|0
8006352|NCT01183468|12612504|FG001|Overall Study|Withdrawal by Subject|1
8006353|NCT01183468|12612505|FG002|Overall Study|Withdrawal by Subject|0
8006354|NCT01183468|12612506|FG003|Overall Study|Withdrawal by Subject|0
8006355|NCT01181921|12612514|FG000|Overall Study|Lost to Follow-up|1
8006356|NCT01188798|12612520|FG000|Overall Study|Death|0
8006357|NCT01188798|12612521|FG001|Overall Study|Death|1
8006358|NCT01188798|12612520|FG000|Overall Study|Required additional transplant|1
8006359|NCT01188798|12612521|FG001|Overall Study|Required additional transplant|1
8006360|NCT01188798|12612520|FG000|Overall Study|Protocol closure|1
8006361|NCT01188798|12612521|FG001|Overall Study|Protocol closure|1
8006362|NCT01174368|12612528|FG000|Overall Study|Withdrawal by Subject|1
8006363|NCT01183884|12612536|FG000|Overall Study|Progressive Disease|26
8006364|NCT01183884|12612536|FG000|Overall Study|Adverse Event|3
8006365|NCT01183884|12612536|FG000|Overall Study|Withdrawal by Subject|1
8006366|NCT01183884|12612536|FG000|Overall Study|Other Complicating Disease|3
8006367|NCT01183884|12612536|FG000|Overall Study|Not Treated|1
8006368|NCT01183884|12612536|FG000|Overall Study|Other|4
8006369|NCT01166178|12612546|FG000|Overall Study|Withdrawal by Subject|1
8006370|NCT01166178|12612547|FG001|Overall Study|Withdrawal by Subject|0
8006371|NCT01166178|12612546|FG000|Overall Study|Study was terminated|20
8006372|NCT01166178|12612547|FG001|Overall Study|Study was terminated|8
8006373|NCT01176513|12612553|FG000|Overall Study|Withdrew subjects prior to dosing|3
8006374|NCT01179399|12612561|FG000|Overall Study|Adverse Event|1
8006375|NCT01179399|12612561|FG000|Overall Study|Lack of Efficacy|30
8006376|NCT01179399|12612561|FG000|Overall Study|Withdrawal by Subject|1
8006377|NCT01171534|12612576|FG000|Overall Study|Lost to Follow-up|0
8006378|NCT01171534|12612577|FG001|Overall Study|Lost to Follow-up|2
8006379|NCT01171534|12612576|FG000|Overall Study|screen failure|0
8006380|NCT01171534|12612577|FG001|Overall Study|screen failure|1
8006381|NCT01162304|12612613|FG000|Overall Study|Beck scale to high|11
8006382|NCT01147393|12612665|FG000|Dose Level 1|Dose limiting Toxicity|2
8006383|NCT01147393|12612665|FG000|Dose Level -1|Dose Limited Toxicity|1
8006384|NCT01147536|12612678|FG000|Overall Study|Administrative study close|2
8006385|NCT01147536|12612678|FG000|Overall Study|Death|1
8006386|NCT01133288|12612691|FG000|Eligibility Assessment|met exclusion criteria|5
8006387|NCT01133288|12612691|FG000|Intervention Allocation|study terminated|2
8006388|NCT01142128|12612699|FG000|Overall Study|Physician Decision|1
8006389|NCT01142128|12612699|FG000|Overall Study|Lost to Follow-up|1
8006390|NCT01142128|12612699|FG000|Overall Study|Withdrawal by Subject|2
8006391|NCT01128114|12612718|FG000|Overall Study|Treatment Withdrawn|6
8006392|NCT01128114|12612718|FG000|Overall Study|Screening Failed|2
7718407|NCT00528112|12142382|FG001|Treatment up to 3 Years|Pregnancy|10
7718408|NCT00528112|12142381|FG000|Treatment up to 3 Years|Other reasons|186
7718409|NCT00528112|12142382|FG001|Treatment up to 3 Years|Other reasons|186
7718410|NCT00528112|12142381|FG000|Extension Phase|Withdrawal by Subject|0
7718411|NCT00528112|12142382|FG001|Extension Phase|Withdrawal by Subject|3
7718412|NCT00528112|12142381|FG000|Extension Phase|Other reasons|0
7718413|NCT00528112|12142382|FG001|Extension Phase|Other reasons|100
7718414|NCT00528112|12142381|FG000|Extension Phase|Pregnancy|0
7718415|NCT00528112|12142382|FG001|Extension Phase|Pregnancy|3
8006393|NCT01126879|12612724|FG000|Overall Study|Progressive Disease|3
8006394|NCT01126879|12612725|FG001|Overall Study|Progressive Disease|1
8006395|NCT01126879|12612724|FG000|Overall Study|Withdrawal by Subject|1
8006396|NCT01126879|12612725|FG001|Overall Study|Withdrawal by Subject|0
8006397|NCT01126879|12612724|FG000|Overall Study|Adverse Event|0
8006398|NCT01126879|12612725|FG001|Overall Study|Adverse Event|1
8006399|NCT01126879|12612724|FG000|Overall Study|Physician Decision|1
8006400|NCT01126879|12612725|FG001|Overall Study|Physician Decision|0
8006401|NCT01136811|12612731|FG000|Overall Study|Physician Decision|11
8006402|NCT01139125|12612744|FG000|Overall Study|Withdrawal by Subject|1
8006403|NCT01131455|12612768|FG000|Overall Study|Death of PI|6
8006404|NCT01131455|12612769|FG001|Overall Study|Death of PI|4
8006405|NCT01131455|12612770|FG002|Overall Study|Death of PI|0
8006406|NCT01123850|12612787|FG000|Overall Study|Slow enrollment|45
8006407|NCT01122381|12612820|FG000|Overall Study|study terminated early|0
8006408|NCT01122381|12612821|FG001|Overall Study|study terminated early|1
8006409|NCT01116232|12612827|FG000|Overall Study|Progressive diease|4
8006410|NCT01108523|12612855|FG000|Overall Study|Protocol Violation|4
8006411|NCT01106534|12612863|FG000|Overall Study|Withdrawal by Subject|18
8006412|NCT01106534|12612863|FG000|Overall Study|Lost to Follow-up|2
8006413|NCT01106534|12612863|FG000|Overall Study|Death|16
8006414|NCT01106534|12612863|FG000|Overall Study|Physician Decision|1
8006415|NCT01100658|12612872|FG000|Overall Study|Withdrawal by Subject|1
8006416|NCT01103180|12612878|FG000|Overall Study|Withdrawal by Subject|8
8006417|NCT01103180|12612879|FG001|Overall Study|Withdrawal by Subject|13
8006418|NCT01103180|12612878|FG000|Overall Study|Lost to Follow-up|13
8006419|NCT01103180|12612879|FG001|Overall Study|Lost to Follow-up|7
8006420|NCT01103180|12612878|FG000|Overall Study|Physician Decision|1
8006421|NCT01103180|12612879|FG001|Overall Study|Physician Decision|0
8006422|NCT01103180|12612878|FG000|Overall Study|Protocol Violation|0
8006423|NCT01103180|12612879|FG001|Overall Study|Protocol Violation|1
8006424|NCT01102140|12612896|FG000|Overall Study|Lost to Follow-up|1
8006425|NCT01102140|12612897|FG001|Overall Study|Lost to Follow-up|0
8006426|NCT01102140|12612896|FG000|Overall Study|Investigator terminated study|2
8006427|NCT01102140|12612897|FG001|Overall Study|Investigator terminated study|2
8006428|NCT01095250|12612909|FG000|Overall Study|administrative reasons|8
8006429|NCT01095250|12612910|FG001|Overall Study|administrative reasons|10
8006430|NCT01095250|12612911|FG002|Overall Study|administrative reasons|7
8006431|NCT01095250|12612912|FG003|Overall Study|administrative reasons|5
8006432|NCT01095250|12612909|FG000|Overall Study|Withdrawal by Subject|0
8006433|NCT01095250|12612910|FG001|Overall Study|Withdrawal by Subject|0
8006434|NCT01095250|12612911|FG002|Overall Study|Withdrawal by Subject|1
8006435|NCT01095250|12612912|FG003|Overall Study|Withdrawal by Subject|0
8006436|NCT01093846|12612929|FG000|Overall Study|Adverse Event|0
8006437|NCT01093846|12612930|FG001|Overall Study|Adverse Event|0
8006438|NCT01093846|12612931|FG002|Overall Study|Adverse Event|1
8006439|NCT01093846|12612929|FG000|Overall Study|Lack of Efficacy|0
8006440|NCT01093846|12612930|FG001|Overall Study|Lack of Efficacy|0
8006441|NCT01093846|12612931|FG002|Overall Study|Lack of Efficacy|4
8006442|NCT01093846|12612929|FG000|Overall Study|Condition no longer required study drug|1
8006443|NCT01093846|12612930|FG001|Overall Study|Condition no longer required study drug|1
8006444|NCT01093846|12612931|FG002|Overall Study|Condition no longer required study drug|1
8006445|NCT01093846|12612929|FG000|Overall Study|Administrative Problems|18
8006446|NCT01093846|12612930|FG001|Overall Study|Administrative Problems|17
8006447|NCT01093846|12612931|FG002|Overall Study|Administrative Problems|15
8006448|NCT01081886|12612944|FG000|Overall Study|Study termination|11
8006449|NCT01081886|12612945|FG001|Overall Study|Study termination|13
8006450|NCT01080768|12612966|FG000|Overall Study|Protocol Deviation|2
8006451|NCT01080768|12612967|FG001|Overall Study|Protocol Deviation|1
8006452|NCT01074502|12612977|FG000|Overall Study|Withdrawal by Subject|1
8006453|NCT01069861|12612990|FG000|Overall Study|Death|1
8006454|NCT01069861|12612990|FG000|Overall Study|Adverse Event|1
8006455|NCT01069861|12612990|FG000|Overall Study|Did not meet entrance criteria|1
8006456|NCT01069120|12613023|FG000|Overall Study|Study prematurely terminated|27
8006457|NCT01058642|12613042|FG000|Treatment Period 1|Adverse Event|0
8006458|NCT01058642|12613043|FG001|Treatment Period 1|Adverse Event|1
8006459|NCT01058642|12613044|FG002|Treatment Period 1|Adverse Event|1
8006460|NCT01058642|12613045|FG003|Treatment Period 1|Adverse Event|0
8006461|NCT01058642|12613042|FG000|Treatment Period 1|Physician Decision|0
8006462|NCT01058642|12613043|FG001|Treatment Period 1|Physician Decision|0
8006463|NCT01058642|12613044|FG002|Treatment Period 1|Physician Decision|1
8006464|NCT01058642|12613045|FG003|Treatment Period 1|Physician Decision|0
8006465|NCT01058642|12613042|FG000|Treatment Period 1|Withdrawal by Subject|1
8006466|NCT01058642|12613043|FG001|Treatment Period 1|Withdrawal by Subject|0
8006467|NCT01058642|12613044|FG002|Treatment Period 1|Withdrawal by Subject|0
8006468|NCT01058642|12613045|FG003|Treatment Period 1|Withdrawal by Subject|0
8006469|NCT01058642|12613042|FG000|Treatment Period 1|Lack of Efficacy|0
8006470|NCT01058642|12613043|FG001|Treatment Period 1|Lack of Efficacy|0
8006471|NCT01058642|12613044|FG002|Treatment Period 1|Lack of Efficacy|0
8006472|NCT01058642|12613045|FG003|Treatment Period 1|Lack of Efficacy|1
8006473|NCT01058642|12613042|FG000|Treatment Period 1|Protocol Violation|0
8006474|NCT01058642|12613043|FG001|Treatment Period 1|Protocol Violation|0
8006475|NCT01058642|12613044|FG002|Treatment Period 1|Protocol Violation|0
8006476|NCT01058642|12613045|FG003|Treatment Period 1|Protocol Violation|1
8006477|NCT01058642|12613042|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1
8006478|NCT01058642|12613043|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0
8006479|NCT01058642|12613044|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0
8006480|NCT01058642|12613045|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0
8006481|NCT01065818|12613053|FG000|Overall Study|Withdrawal by Subject|1
8006482|NCT01065818|12613053|FG000|Overall Study|Not a candidate for surgery|1
8006483|NCT01051921|12613057|FG000|Overall Study|Physician Decision|9
8006484|NCT01051921|12613057|FG000|Overall Study|Adverse Event|8
8006485|NCT01051921|12613057|FG000|Overall Study|Withdrawal by Subject|7
8006486|NCT01051921|12613057|FG000|Overall Study|Lost to Follow-up|4
8006487|NCT01051921|12613057|FG000|Overall Study|virological failure|1
8006488|NCT01051921|12613057|FG000|Overall Study|patient moved|1
8006489|NCT01058369|12613079|FG000|Overall Study|Adverse Event|1
8006490|NCT01058369|12613079|FG000|Overall Study|Early termination study|1
8006491|NCT01053221|12613089|FG000|Overall Study|The study was closed prematurely|5
8006492|NCT01053221|12613090|FG001|Overall Study|The study was closed prematurely|9
8006493|NCT01038752|12613098|FG000|Overall Study|Tumor Progression|2
8006494|NCT01038752|12613099|FG001|Overall Study|Tumor Progression|2
8006495|NCT01038752|12613098|FG000|Overall Study|Lost to Follow-up|3
8006496|NCT01038752|12613099|FG001|Overall Study|Lost to Follow-up|3
8006497|NCT01050218|12613105|FG000|Overall Study|Adverse Event|37
8006498|NCT01050218|12613105|FG000|Overall Study|Lack of Efficacy|8
8006499|NCT01050218|12613105|FG000|Overall Study|Protocol Violation|3
8006500|NCT01050218|12613105|FG000|Overall Study|Withdrawal by Subject|18
8006501|NCT01050218|12613105|FG000|Overall Study|Discontinued by sponsor|18
8006502|NCT01050218|12613105|FG000|Overall Study|Compliance|2
8006503|NCT01050218|12613105|FG000|Overall Study|Failed to return|7
8006504|NCT01050218|12613105|FG000|Overall Study|Serious Adverse Event|1
8006505|NCT01050218|12613105|FG000|Overall Study|Family emergency|1
8006506|NCT01045694|12613109|FG000|Overall Study|Withdrawal by Subject|2
8006507|NCT01031628|12613134|FG000|Overall Study|Study terminated early|0
8006508|NCT01031628|12613135|FG001|Overall Study|Study terminated early|1
8006509|NCT01031628|12613136|FG002|Overall Study|Study terminated early|3
8006510|NCT01031628|12613137|FG003|Overall Study|Study terminated early|0
8006511|NCT01030198|12613168|FG000|Overall Study|Could not measure efficacy accurately|0
8006512|NCT01030198|12613169|FG001|Overall Study|Could not measure efficacy accurately|7
8006513|NCT01028300|12613175|FG000|Overall Study|Study Terminated|4
8006514|NCT01022398|12613186|FG000|Overall Study|Study terminated|2
8006515|NCT01022398|12613187|FG001|Overall Study|Study terminated|2
8006516|NCT01019980|12613194|FG000|Overall Study|Drug not available.|2
8006517|NCT01019980|12613195|FG001|Overall Study|Drug not available.|0
8006518|NCT01017263|12613205|FG000|Overall Study|not eligible|12
8006519|NCT01018810|12613232|FG000|Overall Study|Withdrawal by Subject|0
8006520|NCT01018810|12613233|FG001|Overall Study|Withdrawal by Subject|1
8006521|NCT01018810|12613234|FG002|Overall Study|Withdrawal by Subject|0
8006522|NCT01018810|12613235|FG003|Overall Study|Withdrawal by Subject|0
8006523|NCT01018810|12613236|FG004|Overall Study|Withdrawal by Subject|0
8006524|NCT01018810|12613232|FG000|Overall Study|Sponsor Decision|2
8006525|NCT01018810|12613233|FG001|Overall Study|Sponsor Decision|0
8006526|NCT01018810|12613234|FG002|Overall Study|Sponsor Decision|1
8006527|NCT01018810|12613235|FG003|Overall Study|Sponsor Decision|1
8006528|NCT01018810|12613236|FG004|Overall Study|Sponsor Decision|1
8006529|NCT01014767|12613265|FG000|Overall Study|PI left institution, data unavailable|12
8006530|NCT01014767|12613266|FG001|Overall Study|PI left institution, data unavailable|1
8006531|NCT01014767|12613267|FG002|Overall Study|PI left institution, data unavailable|4
8006532|NCT01014767|12613268|FG003|Overall Study|PI left institution, data unavailable|1
8006533|NCT01013701|12613278|FG000|Overall Study|study prematurely terminated|7
8006534|NCT01012414|12613283|FG000|Overall Study|Withdrawal by Subject|2
8006535|NCT01012414|12613283|FG000|Overall Study|Lost to Follow-up|1
8006536|NCT01012414|12613283|FG000|Overall Study|Trial was stopped before completed|7
8006537|NCT01001390|12613302|FG000|Overall Study|Failure to wear AFO device|2
8006538|NCT01001390|12613303|FG001|Overall Study|Failure to wear AFO device|0
8006539|NCT01004510|12613321|FG000|Overall Study|Adverse Event|1
8006540|NCT01005914|12613325|FG000|Overall Study|Adverse Event|4
8006541|NCT01005914|12613325|FG000|Overall Study|Death|4
8006542|NCT01005914|12613325|FG000|Overall Study|Lack of Efficacy|1
8006543|NCT01005914|12613325|FG000|Overall Study|Withdrawal by Subject|1
8006544|NCT00996333|12613329|FG000|Overall Study|Screen failure|1
8006545|NCT00996333|12613329|FG000|Overall Study|Withdrawal by Subject|1
8006546|NCT00996333|12613329|FG000|Overall Study|Death|4
8006547|NCT00996333|12613329|FG000|Overall Study|Adverse Event|1
8006548|NCT00996333|12613329|FG000|Overall Study|Physician Decision|1
8006549|NCT00996333|12613329|FG000|Overall Study|Other|5
8006550|NCT00998738|12613333|FG000|Overall Study|Uknown|1
8006551|NCT00997386|12613341|FG000|Overall Study|Death|7
8006552|NCT00985738|12613347|FG000|Overall Study|Study closed prematurely|8
8006553|NCT00985738|12613348|FG001|Overall Study|Study closed prematurely|8
8006554|NCT00975611|12613441|FG000|Overall Study|Screen Fail|16
8006555|NCT00975611|12613441|FG000|Overall Study|Physician Decision|1
8006556|NCT00974922|12613466|FG000|Overall Study|study terminated|24
8006557|NCT00965146|12613481|FG000|Overall Study|Death|7
8006558|NCT00965146|12613481|FG000|Overall Study|Lost to Follow-up|22
8006559|NCT00965146|12613481|FG000|Overall Study|Withdrawal by Subject|17
8006560|NCT00965146|12613481|FG000|Overall Study|Unable to return|1
8006561|NCT00965146|12613481|FG000|Overall Study|Unwilling to return|11
8006562|NCT00965146|12613481|FG000|Overall Study|Intercurrent illness|1
8006563|NCT00965146|12613481|FG000|Overall Study|Revision / Removal of Study Implant|6
8006564|NCT00965146|12613481|FG000|Overall Study|Overall Study Termination|145
8006565|NCT00972023|12613485|FG000|Overall Study|Withdrawal by Subject|1
8006566|NCT00953329|12613504|FG000|Overall Study|Lack of Efficacy|1
8006567|NCT00958893|12613521|FG000|Overall Study|Study prematurely terminated|4
8006568|NCT00966654|12613525|FG000|Overall Study|Study was terminated,PI left institution|12
8006569|NCT00960154|12613533|FG000|Overall Study|Study termination|25
8006570|NCT00960154|12613534|FG001|Overall Study|Study termination|25
8006571|NCT00960752|12613543|FG000|Overall Study|Adverse Event|0
8006572|NCT00960752|12613544|FG001|Overall Study|Adverse Event|0
8006573|NCT00960752|12613545|FG002|Overall Study|Adverse Event|1
8006574|NCT00960752|12613543|FG000|Overall Study|Progression|0
8006575|NCT00960752|12613544|FG001|Overall Study|Progression|0
8006576|NCT00960752|12613545|FG002|Overall Study|Progression|1
8006577|NCT00958347|12613553|FG000|Overall Study|Death|43
8006578|NCT00958347|12613553|FG000|Overall Study|Withdrawal by Subject|23
8006579|NCT00958347|12613553|FG000|Overall Study|Lost to Follow-up|15
8006580|NCT00958347|12613553|FG000|Overall Study|revision/removal|10
8006581|NCT00958347|12613553|FG000|Overall Study|study termination|135
8006582|NCT00953615|12613566|FG000|Overall Study|Adverse Event|1
8006583|NCT00957034|12613578|FG000|Overall Study|Adverse Event|0
8006584|NCT00957034|12613579|FG001|Overall Study|Adverse Event|1
8006585|NCT00957034|12613580|FG002|Overall Study|Adverse Event|1
8006586|NCT00957034|12613578|FG000|Overall Study|Sponsor Terminated Study|6
8006587|NCT00957034|12613579|FG001|Overall Study|Sponsor Terminated Study|1
8006588|NCT00957034|12613580|FG002|Overall Study|Sponsor Terminated Study|5
8006589|NCT00957034|12613578|FG000|Overall Study|Withdrawal by Subject|0
8006590|NCT00957034|12613579|FG001|Overall Study|Withdrawal by Subject|2
8006591|NCT00957034|12613580|FG002|Overall Study|Withdrawal by Subject|0
8006592|NCT00949988|12613588|FG000|Overall Study|Withdrawal by Subject|3
8006593|NCT00948194|12613594|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1
8006594|NCT00948194|12613595|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0
8006595|NCT00946985|12613601|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4
8006596|NCT00946985|12613601|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
8006597|NCT00946985|12613601|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
8006598|NCT00946985|12613601|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
8006599|NCT00946985|12613601|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
8006600|NCT00946985|12613601|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
8006601|NCT00946985|12613601|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
8006602|NCT00946985|12613601|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2
8006603|NCT00946985|12613601|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
8006604|NCT00950690|12613609|FG000|Overall Study|Death|4
8006605|NCT00950690|12613609|FG000|Overall Study|Adverse Event|15
8006606|NCT00950690|12613609|FG000|Overall Study|Lack of Efficacy|22
8006607|NCT00950690|12613609|FG000|Overall Study|Lost to Follow-up|40
8006608|NCT00950690|12613609|FG000|Overall Study|Other|163
8006609|NCT00944229|12613613|FG000|Overall Study|Withdrawal by Subject|11
8006610|NCT00944229|12613613|FG000|Overall Study|Physician Decision|14
8006611|NCT00941928|12613617|FG000|Overall Study|Withdrawal by Subject|1
8006612|NCT00941928|12613617|FG000|Overall Study|Disease Progression|1
8006613|NCT00947011|12613634|FG000|Overall Study|Study was terminated,PI left institution|12
8006614|NCT00943605|12613642|FG000|Overall Study|Study termination|30
8006615|NCT00943605|12613643|FG001|Overall Study|Study termination|30
8006616|NCT00942409|12613649|FG000|Overall Study|Lack of Efficacy|1
8006617|NCT00942409|12613649|FG000|Overall Study|study drug unavailable|2
8006618|NCT00936598|12613659|FG000|Overall Study|Withdrawal by Subject|1
8006619|NCT00936598|12613660|FG001|Overall Study|Withdrawal by Subject|0
8006620|NCT00936598|12613659|FG000|Overall Study|Ineligible after consent|1
8006621|NCT00936598|12613660|FG001|Overall Study|Ineligible after consent|0
8006622|NCT00934791|12613684|FG000|Overall Study|Withdrawal by Subject|1
8006623|NCT00934791|12613685|FG001|Overall Study|Withdrawal by Subject|0
8006624|NCT00925548|12613733|FG000|Overall Study|Discontinuation of trial by sponsor|10
8006625|NCT00925548|12613734|FG001|Overall Study|Discontinuation of trial by sponsor|5
8006626|NCT00926575|12613743|FG000|Overall Study|Adverse Event|1
8006627|NCT00926575|12613744|FG001|Overall Study|Adverse Event|1
8006628|NCT00926575|12613743|FG000|Overall Study|Death|4
8006629|NCT00926575|12613744|FG001|Overall Study|Death|4
8006630|NCT00926575|12613743|FG000|Overall Study|Lost to Follow-up|1
8006631|NCT00926575|12613744|FG001|Overall Study|Lost to Follow-up|1
8006632|NCT00926575|12613743|FG000|Overall Study|Physician Decision|1
8006633|NCT00926575|12613744|FG001|Overall Study|Physician Decision|2
8006634|NCT00926575|12613743|FG000|Overall Study|Protocol Violation|1
8006635|NCT00926575|12613744|FG001|Overall Study|Protocol Violation|0
8006636|NCT00926575|12613743|FG000|Overall Study|Withdrawal by Subject|8
8006637|NCT00926575|12613744|FG001|Overall Study|Withdrawal by Subject|9
8006638|NCT00918463|12613771|FG000|Overall Study|Death|1
8006639|NCT00918463|12613771|FG000|Overall Study|Lack of Efficacy|1
8006640|NCT00913692|12613775|FG000|Screening (4 Months)|Physician Decision|3
8006641|NCT00913692|12613775|FG000|Screening (4 Months)|Not eligible after screening phase.|6
8006642|NCT00913692|12613775|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1
8006643|NCT00918645|12613782|FG000|Overall Study|Withdrawal by Subject|1
8006644|NCT00906035|12613815|FG000|Overall Study|Withdrawal by Subject|2
8006645|NCT00906035|12613816|FG001|Overall Study|Withdrawal by Subject|3
8006646|NCT00906035|12613817|FG002|Overall Study|Withdrawal by Subject|0
8006647|NCT00894790|12613848|FG000|Overall Study|Protocol Violation|0
8006648|NCT00894790|12613849|FG001|Overall Study|Protocol Violation|1
8006649|NCT00894790|12613848|FG000|Overall Study|Lost to Follow-up|0
8006650|NCT00894790|12613849|FG001|Overall Study|Lost to Follow-up|1
8006651|NCT00894790|12613848|FG000|Overall Study|Did not meet entrance criteria|1
8006652|NCT00894790|12613849|FG001|Overall Study|Did not meet entrance criteria|0
8006653|NCT00902668|12613855|FG000|Overall Study|Protocol stopped due to slow accrual.|3
8006654|NCT00881205|12613861|FG000|Overall Study|Adverse Event|8
8006655|NCT00881205|12613862|FG001|Overall Study|Adverse Event|3
8006656|NCT00881205|12613861|FG000|Overall Study|Withdrawal by Subject|1
8006657|NCT00881205|12613862|FG001|Overall Study|Withdrawal by Subject|2
8006658|NCT00881205|12613861|FG000|Overall Study|Lost to Follow-up|0
8006659|NCT00881205|12613862|FG001|Overall Study|Lost to Follow-up|1
8006660|NCT00881205|12613861|FG000|Overall Study|Administrative problems|1
8006661|NCT00881205|12613862|FG001|Overall Study|Administrative problems|1
8006662|NCT00881205|12613861|FG000|Overall Study|Condition no longer requires drug|1
8006663|NCT00881205|12613862|FG001|Overall Study|Condition no longer requires drug|0
8006664|NCT00903006|12613879|FG000|Overall Study|Withdrawal by Subject|2
8006665|NCT00903006|12613880|FG001|Overall Study|Withdrawal by Subject|0
8006666|NCT00903006|12613881|FG002|Overall Study|Withdrawal by Subject|0
8006667|NCT00903006|12613882|FG003|Overall Study|Withdrawal by Subject|0
8006668|NCT00903006|12613879|FG000|Overall Study|Progressive Disease|0
8006669|NCT00903006|12613880|FG001|Overall Study|Progressive Disease|3
8006670|NCT00903006|12613881|FG002|Overall Study|Progressive Disease|1
8006671|NCT00903006|12613882|FG003|Overall Study|Progressive Disease|0
8006672|NCT00887315|12613899|FG000|Overall Study|Study termination|7
8006673|NCT00887315|12613900|FG001|Overall Study|Study termination|4
8006674|NCT00891904|12613906|FG000|Overall Study|Death|1
8006675|NCT00891904|12613906|FG000|Overall Study|Adverse Event|1
8006676|NCT00881608|12613915|FG000|Overall Study|Study prematurely terminated|11
8006677|NCT00889421|12613927|FG000|Overall Study|Lack of Efficacy|3
8006678|NCT00882310|12613944|FG000|Overall Study|Screen Failure|10
8006679|NCT00882310|12613944|FG000|Overall Study|Never received treatment|1
8006680|NCT00882310|12613944|FG000|Overall Study|Death|6
8006681|NCT00882310|12613944|FG000|Overall Study|Progression of disease|4
8006682|NCT00882310|12613944|FG000|Overall Study|Adverse Event|1
8006683|NCT00880542|12613948|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
8006684|NCT00880542|12613948|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
8006685|NCT00880542|12613948|FG000|REP: Surgical Resection|progressive disease|1
8006686|NCT00874939|12613956|FG000|Overall Study|Study terminated|4
8006687|NCT00877071|12613983|FG000|Overall Study|disease progression|2
8006688|NCT00878969|12613990|FG000|Overall Study|Physician Decision|5
8006689|NCT00878969|12613991|FG001|Overall Study|Physician Decision|3
8006690|NCT00878969|12613992|FG002|Overall Study|Physician Decision|2
8006691|NCT00878969|12613990|FG000|Overall Study|Withdrawal by Subject|1
8006692|NCT00878969|12613991|FG001|Overall Study|Withdrawal by Subject|6
8006693|NCT00878969|12613992|FG002|Overall Study|Withdrawal by Subject|3
8006694|NCT00878969|12613990|FG000|Overall Study|kidney transplant|2
8006695|NCT00878969|12613991|FG001|Overall Study|kidney transplant|3
8006696|NCT00878969|12613992|FG002|Overall Study|kidney transplant|2
8006697|NCT00878969|12613990|FG000|Overall Study|Adverse Event|3
8006698|NCT00878969|12613991|FG001|Overall Study|Adverse Event|1
8006699|NCT00878969|12613992|FG002|Overall Study|Adverse Event|2
8006700|NCT00878969|12613990|FG000|Overall Study|Lost to Follow-up|2
8006701|NCT00878969|12613991|FG001|Overall Study|Lost to Follow-up|1
8006702|NCT00878969|12613992|FG002|Overall Study|Lost to Follow-up|0
8006703|NCT00878969|12613990|FG000|Overall Study|Protocol Violation|2
8006704|NCT00878969|12613991|FG001|Overall Study|Protocol Violation|0
8006705|NCT00878969|12613992|FG002|Overall Study|Protocol Violation|0
8006706|NCT00878969|12613990|FG000|Overall Study|Death|0
8006707|NCT00878969|12613991|FG001|Overall Study|Death|0
8006708|NCT00878969|12613992|FG002|Overall Study|Death|2
8006709|NCT00878969|12613990|FG000|Overall Study|Pregnancy|0
8006710|NCT00878969|12613991|FG001|Overall Study|Pregnancy|1
8006711|NCT00878969|12613992|FG002|Overall Study|Pregnancy|0
8006712|NCT00865514|12614000|FG000|Overall Study|Infusion cost exceeded funding|2
8006713|NCT00863512|12614017|FG000|Overall Study|Adverse Event|2
8006714|NCT00863512|12614018|FG001|Overall Study|Adverse Event|0
8006715|NCT00863512|12614017|FG000|Overall Study|Withdrawal by Subject|11
8006716|NCT00863512|12614018|FG001|Overall Study|Withdrawal by Subject|0
8006717|NCT00863512|12614017|FG000|Overall Study|Physician Decision|1
8006718|NCT00863512|12614018|FG001|Overall Study|Physician Decision|0
8006719|NCT00868998|12614024|FG000|Overall Study|Screen Failure|1
8006720|NCT00868998|12614024|FG000|Overall Study|Withdrawal by Subject|1
8006721|NCT00868998|12614024|FG000|Overall Study|Progression of disease|2
8006722|NCT00868998|12614024|FG000|Overall Study|Death|1
8006723|NCT00869258|12614028|FG000|Overall Study|Physician Decision|1
8006724|NCT00863330|12614032|FG000|Overall Study|study terminated early due to administra|6
8006725|NCT00853229|12614038|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
8006726|NCT00853229|12614039|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
8006727|NCT00860249|12614050|FG000|Overall Study|trial was terminated prior to completion|21
8006728|NCT00860249|12614051|FG001|Overall Study|trial was terminated prior to completion|18
8006729|NCT00860249|12614052|FG002|Overall Study|trial was terminated prior to completion|21
8006730|NCT00860158|12614060|FG000|Overall Study|Study Terminated|1
8006731|NCT00853567|12614067|FG000|Overall Study|Study prematurely terminated|71
8006732|NCT00849524|12614075|FG000|Overall Study|Lack of Efficacy|3
8006733|NCT00851682|12614090|FG000|Overall Study|screen failure|5
8006734|NCT00851682|12614091|FG001|Overall Study|screen failure|0
8006735|NCT00851747|12614113|FG000|Overall Study|Physician Decision|6
8006736|NCT00851747|12614114|FG001|Overall Study|Physician Decision|6
8006737|NCT00851747|12614115|FG002|Overall Study|Physician Decision|6
8006738|NCT00852241|12614122|FG000|Overall Study|Physician Decision|18
8006739|NCT00851552|12614126|FG000|Overall Study|Death|2
8006740|NCT00851552|12614126|FG000|Overall Study|Adverse Event|1
8006741|NCT00851552|12614126|FG000|Overall Study|Disease Progression|4
8006742|NCT00845845|12614136|FG000|Overall Study|Lost to Follow-up|0
8006743|NCT00845845|12614137|FG001|Overall Study|Lost to Follow-up|4
8006744|NCT00851591|12614145|FG000|Overall Study|Withdrawal by Subject|2
8006745|NCT00851591|12614146|FG001|Overall Study|Withdrawal by Subject|0
8006746|NCT00835679|12614183|FG000|Overall Study|Withdrawal by Subject|1
8006747|NCT00835679|12614184|FG001|Overall Study|Withdrawal by Subject|0
8006748|NCT00835679|12614185|FG002|Overall Study|Withdrawal by Subject|0
8006749|NCT00835679|12614186|FG003|Overall Study|Withdrawal by Subject|0
8006750|NCT00841035|12614200|FG000|Phase 1 Overall Study|Physician Decision|13
8006751|NCT00840827|12614218|FG000|Overall Study|Adverse Event|1
8006752|NCT00840827|12614218|FG000|Overall Study|Lack of Efficacy|4
8006753|NCT00840827|12614218|FG000|Overall Study|Physician Decision|1
8006754|NCT00832624|12614252|FG000|Overall Study|Study Terminated|10
8006755|NCT00827567|12614295|FG000|Overall Study|Progression of Disease/Screen Failure|4
8006756|NCT00815633|12614299|FG000|Overall Study|study terminated|1
8006757|NCT00814983|12614305|FG000|Overall Study|Screen failure|1
8006758|NCT00814983|12614306|FG001|Overall Study|Screen failure|0
8006759|NCT00814983|12614305|FG000|Overall Study|Withdrawal by Subject|1
8006760|NCT00814983|12614306|FG001|Overall Study|Withdrawal by Subject|0
8006761|NCT00814983|12614305|FG000|Overall Study|Graft failure|1
8006762|NCT00814983|12614306|FG001|Overall Study|Graft failure|0
8006763|NCT00819832|12614329|FG000|Overall Study|Sponsor Termination of Study|3
8006764|NCT00819832|12614330|FG001|Overall Study|Sponsor Termination of Study|0
8006765|NCT00819832|12614331|FG002|Overall Study|Sponsor Termination of Study|0
8006766|NCT00819832|12614332|FG003|Overall Study|Sponsor Termination of Study|0
8006767|NCT00819832|12614333|FG004|Overall Study|Sponsor Termination of Study|0
8006768|NCT00819832|12614334|FG005|Overall Study|Sponsor Termination of Study|0
8006769|NCT00814892|12614357|FG000|Overall Study|Disease Progression|1
8006770|NCT00814892|12614357|FG000|Overall Study|Study Termination|1
8006771|NCT00802659|12614374|FG000|Overall Study|Physician Decision|0
8006772|NCT00802659|12614375|FG001|Overall Study|Physician Decision|1
8006773|NCT00802659|12614376|FG002|Overall Study|Physician Decision|0
8006774|NCT00802659|12614377|FG003|Overall Study|Physician Decision|0
8006775|NCT00807365|12614387|FG000|Overall Study|Study Terminated|5
8006776|NCT00814333|12614393|FG000|Enrollment|Lost to Follow-up|1
8006777|NCT00814333|12614394|FG001|Enrollment|Lost to Follow-up|0
8006778|NCT00808080|12614400|FG000|Overall Study|Patients Became Ineligible for infusion|6
8006779|NCT00802893|12614405|FG000|Overall Study|study terminated|3
8006780|NCT00809341|12614411|FG000|Overall Study|Physician Decision|0
8006781|NCT00809341|12614412|FG001|Overall Study|Physician Decision|1
8006782|NCT00808899|12614440|FG000|Overall Study|Death|1
8006783|NCT00808899|12614440|FG000|Overall Study|Physician Decision|3
8006784|NCT00803179|12614451|FG000|Overall Study|Lost to Follow-up|3
8006785|NCT00790452|12614490|FG000|Overall Study|Drug supply issue|1
8006786|NCT00790452|12614491|FG001|Overall Study|Drug supply issue|0
8006787|NCT00787917|12614503|FG000|Blinded Treatment|Adverse Event|1
8006788|NCT00787917|12614504|FG001|Blinded Treatment|Adverse Event|0
8006789|NCT00787917|12614503|FG000|Blinded Treatment|Lack of Efficacy|1
8006790|NCT00787917|12614504|FG001|Blinded Treatment|Lack of Efficacy|0
8006791|NCT00787917|12614503|FG000|Blinded Treatment|Administrative problems|3
8006792|NCT00787917|12614504|FG001|Blinded Treatment|Administrative problems|2
8006793|NCT00787917|12614503|FG000|Open Label|Unsatisfactory therapeutic effect|1
8006794|NCT00787917|12614504|FG001|Open Label|Unsatisfactory therapeutic effect|0
8006795|NCT00787917|12614503|FG000|Open Label|Administrative problems|3
8006796|NCT00787917|12614504|FG001|Open Label|Administrative problems|0
8006797|NCT00798590|12614514|FG000|Overall Study|P.I, Left institution. Study terminated|11
8006798|NCT00798590|12614515|FG001|Overall Study|P.I, Left institution. Study terminated|8
8006799|NCT00796510|12614523|FG000|Overall Study|Death|1
8006800|NCT00796510|12614524|FG001|Overall Study|Death|0
8006801|NCT00796510|12614523|FG000|Overall Study|Study Terminated|2
8006802|NCT00796510|12614524|FG001|Overall Study|Study Terminated|0
8006803|NCT00796861|12614530|FG000|Overall Study|Withdrawal by Subject|2
8006804|NCT00796861|12614530|FG000|Overall Study|Death|2
8006805|NCT00791076|12614534|FG000|Overall Study|Study was terminated,PI left institution|8
8006806|NCT00796107|12614549|FG000|Overall Study|Lack of Efficacy|1
8006807|NCT00796107|12614549|FG000|Overall Study|Progressive Disease|5
8006808|NCT00785356|12614573|FG000|Overall Study|Study prematurely terminated|8
8006809|NCT00782483|12614581|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6
8006810|NCT00784043|12614591|FG000|Overall Study|Withdrawal by Subject|8
8006811|NCT00784043|12614592|FG001|Overall Study|Withdrawal by Subject|5
8006812|NCT00784043|12614591|FG000|Overall Study|Protocol Terminated|23
8006813|NCT00784043|12614592|FG001|Overall Study|Protocol Terminated|1
8006814|NCT00774306|12614615|FG000|Overall Study|Adverse Event|3
8006815|NCT00774306|12614616|FG001|Overall Study|Adverse Event|0
8006816|NCT00774306|12614617|FG002|Overall Study|Adverse Event|0
8006817|NCT00774306|12614618|FG003|Overall Study|Adverse Event|0
8006818|NCT00774306|12614615|FG000|Overall Study|Protocol Violation|2
8006819|NCT00774306|12614616|FG001|Overall Study|Protocol Violation|0
8006820|NCT00774306|12614617|FG002|Overall Study|Protocol Violation|3
8006821|NCT00774306|12614618|FG003|Overall Study|Protocol Violation|0
8006822|NCT00774306|12614615|FG000|Overall Study|Withdrawal by Subject|6
8006823|NCT00774306|12614616|FG001|Overall Study|Withdrawal by Subject|1
8006824|NCT00774306|12614617|FG002|Overall Study|Withdrawal by Subject|1
8006825|NCT00774306|12614618|FG003|Overall Study|Withdrawal by Subject|0
8006826|NCT00774306|12614615|FG000|Overall Study|Lost to Follow-up|6
8006827|NCT00774306|12614616|FG001|Overall Study|Lost to Follow-up|0
8006828|NCT00774306|12614617|FG002|Overall Study|Lost to Follow-up|4
8006829|NCT00774306|12614618|FG003|Overall Study|Lost to Follow-up|5
8006830|NCT00774306|12614615|FG000|Overall Study|Death|1
8006831|NCT00774306|12614616|FG001|Overall Study|Death|1
8006832|NCT00774306|12614617|FG002|Overall Study|Death|0
8006833|NCT00774306|12614618|FG003|Overall Study|Death|0
8006834|NCT00779038|12614641|FG000|Overall Study|Study Prematurely Terminated|13
8006835|NCT00776100|12614656|FG000|Overall Study|Disease Progression|1
8006836|NCT00776100|12614657|FG001|Overall Study|Disease Progression|0
8006837|NCT00771316|12614665|FG000|Overall Study|Adverse Event|0
8006838|NCT00771316|12614666|FG001|Overall Study|Adverse Event|1
8006839|NCT00771316|12614665|FG000|Overall Study|Patient withdrew consent|1
8006840|NCT00771316|12614666|FG001|Overall Study|Patient withdrew consent|0
8006841|NCT00771316|12614665|FG000|Overall Study|Discontinued due to early termination|1
8006842|NCT00771316|12614666|FG001|Overall Study|Discontinued due to early termination|0
8006843|NCT00768040|12614687|FG000|Overall Study|Adverse Event|3
8006844|NCT00768040|12614688|FG001|Overall Study|Adverse Event|2
8006845|NCT00768040|12614687|FG000|Overall Study|Abnormal laboratory value|1
8006846|NCT00768040|12614688|FG001|Overall Study|Abnormal laboratory value|1
8006847|NCT00776555|12614696|FG000|Overall Study|Study terminated|3
8006848|NCT00776555|12614697|FG001|Overall Study|Study terminated|0
8006849|NCT00775190|12614705|FG000|Overall Study|Lost to Follow-up|2
8006850|NCT00775190|12614706|FG001|Overall Study|Lost to Follow-up|3
8006851|NCT00775190|12614705|FG000|Overall Study|Withdrawal by Subject|1
8006852|NCT00775190|12614706|FG001|Overall Study|Withdrawal by Subject|2
8006853|NCT00775190|12614705|FG000|Overall Study|Protocol Violation|1
8006854|NCT00775190|12614706|FG001|Overall Study|Protocol Violation|0
8006855|NCT00762723|12614719|FG000|Overall Study|Study Terminated slow enrollement|5
8006856|NCT00762723|12614720|FG001|Overall Study|Study Terminated slow enrollement|5
8006857|NCT00762723|12614721|FG002|Overall Study|Study Terminated slow enrollement|3
8006858|NCT00770965|12614733|FG000|Safety Set|Withdrawal by Subject|0
8006859|NCT00770965|12614734|FG001|Safety Set|Withdrawal by Subject|0
8006860|NCT00770965|12614735|FG002|Safety Set|Withdrawal by Subject|0
8006861|NCT00770965|12614736|FG003|Safety Set|Withdrawal by Subject|1
8006862|NCT00770965|12614733|FG000|Safety Set|Protocol deviation|0
8006863|NCT00770965|12614734|FG001|Safety Set|Protocol deviation|0
8006864|NCT00770965|12614735|FG002|Safety Set|Protocol deviation|1
8006865|NCT00770965|12614736|FG003|Safety Set|Protocol deviation|0
8006866|NCT00770965|12614733|FG000|Excluded Set|Administrative problems|14
8006867|NCT00770965|12614734|FG001|Excluded Set|Administrative problems|12
8006868|NCT00770965|12614735|FG002|Excluded Set|Administrative problems|12
8006869|NCT00770965|12614736|FG003|Excluded Set|Administrative problems|10
8006870|NCT00770965|12614733|FG000|Excluded Set|Withdrawal by Subject|1
8006871|NCT00770965|12614734|FG001|Excluded Set|Withdrawal by Subject|1
8006872|NCT00770965|12614735|FG002|Excluded Set|Withdrawal by Subject|2
8006873|NCT00770965|12614736|FG003|Excluded Set|Withdrawal by Subject|3
8006874|NCT00769002|12614750|FG000|Overall Study|Study was not completed, no data|9
8006875|NCT00769002|12614751|FG001|Overall Study|Study was not completed, no data|9
8006876|NCT00766636|12614758|FG000|Overall Study|Withdrawal by Subject|1
8006877|NCT00766636|12614759|FG001|Overall Study|Withdrawal by Subject|1
8006878|NCT00766636|12614758|FG000|Overall Study|Incomplete Treatment|0
8006879|NCT00766636|12614759|FG001|Overall Study|Incomplete Treatment|1
8006880|NCT00766636|12614758|FG000|Overall Study|Adverse Event|1
8006881|NCT00766636|12614759|FG001|Overall Study|Adverse Event|0
8006882|NCT00766636|12614758|FG000|Overall Study|Disease Progression|1
8006883|NCT00766636|12614759|FG001|Overall Study|Disease Progression|0
8006884|NCT00768248|12614767|FG000|Overall Study|Research coordinator didn't collect data|1
8006885|NCT00768248|12614768|FG001|Overall Study|Research coordinator didn't collect data|1
8006886|NCT00764699|12614778|FG000|Overall Study|PI left and study terminated|3
8006887|NCT00763009|12614786|FG000|Overall Study|Coronary Anatomy unsuitable|1
8006888|NCT00761176|12614793|FG000|Overall Study|Death|1
8006889|NCT00761176|12614794|FG001|Overall Study|Death|0
8006890|NCT00761176|12614793|FG000|Overall Study|Withdrawal by Subject|1
8006891|NCT00761176|12614794|FG001|Overall Study|Withdrawal by Subject|1
8006892|NCT00754793|12614819|FG000|Overall Study|voluntary withdrawn from study|0
8006893|NCT00754793|12614820|FG001|Overall Study|voluntary withdrawn from study|1
8006894|NCT00754052|12614828|FG000|Overall Study|Study terminated by Sponsor|5
8006895|NCT00754052|12614829|FG001|Overall Study|Study terminated by Sponsor|3
8006896|NCT00750204|12614851|FG000|Overall Study|study halted prematurely|1
8006897|NCT00750204|12614852|FG001|Overall Study|study halted prematurely|1
8006898|NCT00752986|12614874|FG000|Overall Study|Withdrawal by Subject|2
8006899|NCT00752986|12614875|FG001|Overall Study|Withdrawal by Subject|1
8006900|NCT00752986|12614876|FG002|Overall Study|Withdrawal by Subject|2
8006901|NCT00752986|12614874|FG000|Overall Study|Protocol Violation|3
8006902|NCT00752986|12614875|FG001|Overall Study|Protocol Violation|0
8006903|NCT00752986|12614876|FG002|Overall Study|Protocol Violation|0
8006904|NCT00754013|12614899|FG000|Overall Study|Lost to Follow-up|1
8006905|NCT00754013|12614900|FG001|Overall Study|Lost to Follow-up|1
8006906|NCT00754013|12614899|FG000|Overall Study|didn't return after study termed|3
8006907|NCT00754013|12614900|FG001|Overall Study|didn't return after study termed|4
8006908|NCT00735553|12614909|FG000|Overall Study|Study prematurely terminated|77
8006909|NCT00751933|12614917|FG000|Overall Study|Withdrawal by Subject|0
8006910|NCT00751933|12614918|FG001|Overall Study|Withdrawal by Subject|1
8006911|NCT00751933|12614919|FG002|Overall Study|Withdrawal by Subject|0
8006912|NCT00751933|12614920|FG003|Overall Study|Withdrawal by Subject|0
8006913|NCT00751933|12614917|FG000|Overall Study|Physician Decision|0
8006914|NCT00751933|12614918|FG001|Overall Study|Physician Decision|0
8006915|NCT00751933|12614919|FG002|Overall Study|Physician Decision|1
8006916|NCT00751933|12614920|FG003|Overall Study|Physician Decision|1
8006917|NCT00747461|12614937|FG000|Overall Study|study terminated by sponsor|5
8006918|NCT00736385|12614952|FG000|Overall Study|Withdrawal by Subject|2
8006919|NCT00736385|12614953|FG001|Overall Study|Withdrawal by Subject|2
8006920|NCT00736385|12614952|FG000|Overall Study|Adverse Event|0
8006921|NCT00736385|12614953|FG001|Overall Study|Adverse Event|1
8006922|NCT00739063|12614976|FG000|Overall Study|Screen failures|8
8006923|NCT00740597|12614980|FG000|Overall Study|insurance would not cover treatment|1
8006924|NCT00737282|12614999|FG000|Overall Study|Study prematurely terminated|175
8006925|NCT00739882|12615007|FG000|Double-blind Period|Adverse Event|1
8006926|NCT00739882|12615008|FG001|Double-blind Period|Adverse Event|2
8006927|NCT00739882|12615007|FG000|Double-blind Period|Protocol Violation|1
8006928|NCT00739882|12615008|FG001|Double-blind Period|Protocol Violation|0
8006929|NCT00739882|12615007|FG000|Double-blind Period|Lack of Efficacy|1
8006930|NCT00739882|12615008|FG001|Double-blind Period|Lack of Efficacy|1
8006931|NCT00739882|12615007|FG000|Double-blind Period|Other|16
8006932|NCT00739882|12615008|FG001|Double-blind Period|Other|8
8006933|NCT00739882|12615007|FG000|Open-label Period|Adverse Event|1
8006934|NCT00739882|12615008|FG001|Open-label Period|Adverse Event|0
8006935|NCT00739882|12615007|FG000|Open-label Period|Other|9
8006936|NCT00739882|12615008|FG001|Open-label Period|Other|5
8006937|NCT00735254|12615040|FG000|Overall Study|Protocol Violation|1
8006938|NCT00735254|12615041|FG001|Overall Study|Protocol Violation|1
8006939|NCT00735254|12615042|FG002|Overall Study|Protocol Violation|1
8006940|NCT00735254|12615043|FG003|Overall Study|Protocol Violation|0
8006941|NCT00729365|12615056|FG000|Overall Study|Physician Decision|33
8006942|NCT00729365|12615057|FG001|Overall Study|Physician Decision|6
8006943|NCT00729365|12615058|FG002|Overall Study|Physician Decision|7
8006944|NCT00724282|12615076|FG000|Overall Study|Withdrawal by Subject|3
8006945|NCT00724282|12615076|FG000|Overall Study|Physician Decision|1
8006946|NCT00730886|12615082|FG000|Overall Study|Lost to Follow-up|1
8006947|NCT00730886|12615083|FG001|Overall Study|Lost to Follow-up|0
8006948|NCT00730886|12615082|FG000|Overall Study|Physician Decision|1
8006949|NCT00730886|12615083|FG001|Overall Study|Physician Decision|0
8006950|NCT00729560|12615111|FG000|Overall Study|Withdrawal by Subject|3
8006951|NCT00714948|12615132|FG000|Overall Study|Adverse Event|2
8006952|NCT00720343|12615136|FG000|Overall Study|Physician Decision|3
8006953|NCT00720343|12615136|FG000|Overall Study|No data|3
8006954|NCT00718640|12615151|FG000|Overall Study|Adverse Event|4
8006955|NCT00718640|12615151|FG000|Overall Study|Death|1
8006956|NCT00718640|12615151|FG000|Overall Study|Unresolved toxicity after 2 weeks|2
8006957|NCT00720083|12615157|FG000|Overall Study|Ineligible|1
8006958|NCT00720083|12615158|FG001|Overall Study|Ineligible|2
8006959|NCT00717275|12615164|FG000|Overall Study|Premature study termination.|3
8006960|NCT00708734|12615168|FG000|Overall Study|scheduling conflict|2
8006961|NCT00708734|12615168|FG000|Overall Study|moved|1
8006962|NCT00708734|12615168|FG000|Overall Study|leg injury|1
8006963|NCT00708734|12615168|FG000|Overall Study|knee replacement|1
8006964|NCT00708734|12615168|FG000|Overall Study|vertigo|1
8006965|NCT00708734|12615168|FG000|Overall Study|leg fracture|1
8006966|NCT00711087|12615174|FG000|Overall Study|Lost to Follow-up|1
8006967|NCT00711087|12615175|FG001|Overall Study|Lost to Follow-up|0
8006968|NCT00706797|12615183|FG000|Overall Study|Lack of Efficacy|3
8006969|NCT00706797|12615184|FG001|Overall Study|Lack of Efficacy|0
8006970|NCT00706797|12615183|FG000|Overall Study|Adverse Event|0
8006971|NCT00706797|12615184|FG001|Overall Study|Adverse Event|3
8006972|NCT00706797|12615183|FG000|Overall Study|Withdrawal by Subject|8
8006973|NCT00706797|12615184|FG001|Overall Study|Withdrawal by Subject|1
8006974|NCT00706797|12615183|FG000|Overall Study|Death|1
8006975|NCT00706797|12615184|FG001|Overall Study|Death|0
8006976|NCT00706797|12615183|FG000|Overall Study|Discontinuation of study by sponsor|52
8006977|NCT00706797|12615184|FG001|Overall Study|Discontinuation of study by sponsor|63
8006978|NCT00706797|12615183|FG000|Overall Study|Protocol Violation|3
8006979|NCT00706797|12615184|FG001|Overall Study|Protocol Violation|2
8006980|NCT00706797|12615183|FG000|Overall Study|Lost to Follow-up|1
8006981|NCT00706797|12615184|FG001|Overall Study|Lost to Follow-up|2
8006982|NCT00706797|12615183|FG000|Overall Study|Other|1
8006983|NCT00706797|12615184|FG001|Overall Study|Other|0
8006984|NCT00713596|12615193|FG000|Overall Study|Study was terminated|2
8006985|NCT00713596|12615194|FG001|Overall Study|Study was terminated|3
8006986|NCT00713596|12615195|FG002|Overall Study|Study was terminated|2
8006987|NCT00703092|12615208|FG000|Overall Study|Withdrawal by Subject|2
8006988|NCT00713258|12615214|FG000|Overall Study|Adverse Event|2
8006989|NCT00713258|12615215|FG001|Overall Study|Adverse Event|4
8006990|NCT00713258|12615214|FG000|Overall Study|Non-Compliance|2
8006991|NCT00713258|12615215|FG001|Overall Study|Non-Compliance|1
8006992|NCT00713258|12615214|FG000|Overall Study|Other|1
8006993|NCT00713258|12615215|FG001|Overall Study|Other|1
8006994|NCT00707434|12615225|FG000|Overall Study|Adverse Event|1
8006995|NCT00707161|12615229|FG000|Overall Study|Physician Decision|6
8006996|NCT00708916|12615242|FG000|Overall Study|Subject Noncompliance|2
8006997|NCT00708916|12615242|FG000|Overall Study|Adverse Event|2
8006998|NCT00700778|12615247|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2
8006999|NCT00699842|12615254|FG000|Overall Study|Death|0
8007000|NCT00699842|12615255|FG001|Overall Study|Death|1
8007001|NCT00699842|12615256|FG002|Overall Study|Death|0
8007002|NCT00702962|12615266|FG000|Overall Study|Progressive disease|0
8007003|NCT00702962|12615267|FG001|Overall Study|Progressive disease|1
8007004|NCT00702962|12615266|FG000|Overall Study|Hospitalized for other health disorder|1
8007005|NCT00702962|12615267|FG001|Overall Study|Hospitalized for other health disorder|0
8007006|NCT00703534|12615277|FG000|Overall Study|Adverse Event|14
8007007|NCT00703534|12615278|FG001|Overall Study|Adverse Event|3
8007008|NCT00703534|12615277|FG000|Overall Study|Withdrawal by Subject|8
8007009|NCT00703534|12615278|FG001|Overall Study|Withdrawal by Subject|7
8007010|NCT00703534|12615277|FG000|Overall Study|Incorrect Enrollment|6
8007011|NCT00703534|12615278|FG001|Overall Study|Incorrect Enrollment|6
8007012|NCT00703534|12615277|FG000|Overall Study|Lost to Follow-up|1
8007013|NCT00703534|12615278|FG001|Overall Study|Lost to Follow-up|4
8007014|NCT00703534|12615277|FG000|Overall Study|Severe Non Compliance|1
8007015|NCT00703534|12615278|FG001|Overall Study|Severe Non Compliance|5
8007016|NCT00698009|12615284|FG000|Overall Study|Withdrawal by Subject|1
8007017|NCT00702702|12615308|FG000|Overall Study|Study prematurely terminated|56
8007018|NCT00699413|12615327|FG000|Overall Study|Withdrawal by Subject|0
8007019|NCT00699413|12615328|FG001|Overall Study|Withdrawal by Subject|2
8007020|NCT00699413|12615327|FG000|Overall Study|Study terminated by sponsor|4
8007021|NCT00699413|12615328|FG001|Overall Study|Study terminated by sponsor|2
8007022|NCT00686972|12615338|FG000|Overall Study|P.I, Left institution. Study terminated|51
8007023|NCT00693017|12615344|FG000|Overall Study|Sponsor Decision|2
8007024|NCT00693017|12615345|FG001|Overall Study|Sponsor Decision|1
8007025|NCT00693017|12615344|FG000|Overall Study|Death|0
8007026|NCT00693017|12615345|FG001|Overall Study|Death|1
8007027|NCT00692003|12615384|FG000|Overall Study|Sponsor Decision|5
8007028|NCT00692003|12615385|FG001|Overall Study|Sponsor Decision|1
8007029|NCT00678288|12615393|FG000|Overall Study|Adverse Event|0
8007030|NCT00678288|12615394|FG001|Overall Study|Adverse Event|2
8007031|NCT00678288|12615393|FG000|Overall Study|Withdrawal by Subject|1
8007032|NCT00678288|12615394|FG001|Overall Study|Withdrawal by Subject|1
8007033|NCT00678288|12615393|FG000|Overall Study|Study terminated by the sponsor|2
8007034|NCT00678288|12615394|FG001|Overall Study|Study terminated by the sponsor|0
8007035|NCT00678288|12615393|FG000|Overall Study|Not compliant with study medication|0
8007036|NCT00678288|12615394|FG001|Overall Study|Not compliant with study medication|1
8007037|NCT00678288|12615393|FG000|Overall Study|Switch to commercial drug|0
8007038|NCT00678288|12615394|FG001|Overall Study|Switch to commercial drug|1
8007039|NCT00678288|12615393|FG000|Overall Study|Reason not reported|1
8007040|NCT00678288|12615394|FG001|Overall Study|Reason not reported|0
8007041|NCT00678288|12615393|FG000|Overall Study|Disease progression/recurrence/relapse|6
8007042|NCT00678288|12615394|FG001|Overall Study|Disease progression/recurrence/relapse|1
8007043|NCT00689052|12615406|FG000|Overall Study|Adverse Event|4
8007044|NCT00689052|12615407|FG001|Overall Study|Adverse Event|6
8007045|NCT00689052|12615406|FG000|Overall Study|Protocol Violation|1
8007046|NCT00689052|12615407|FG001|Overall Study|Protocol Violation|0
8007047|NCT00689052|12615406|FG000|Overall Study|Lost to Follow-up|2
8007048|NCT00689052|12615407|FG001|Overall Study|Lost to Follow-up|0
8007049|NCT00689052|12615406|FG000|Overall Study|Withdrawal by Subject|2
8007050|NCT00689052|12615407|FG001|Overall Study|Withdrawal by Subject|0
8007051|NCT00689052|12615406|FG000|Overall Study|Early termination of the trial|22
8007052|NCT00689052|12615407|FG001|Overall Study|Early termination of the trial|24
8007053|NCT00683917|12615427|FG000|Overall Study|Study prematurely terminated|10
8007054|NCT00686036|12615450|FG000|Overall Study|Adverse Event|3
8007055|NCT00686036|12615451|FG001|Overall Study|Adverse Event|0
8007056|NCT00686036|12615450|FG000|Overall Study|Withdrawal by Subject|3
8007057|NCT00686036|12615451|FG001|Overall Study|Withdrawal by Subject|1
8007058|NCT00686036|12615450|FG000|Overall Study|Study terminated by AstraZeneca|2
8007059|NCT00686036|12615451|FG001|Overall Study|Study terminated by AstraZeneca|1
8007060|NCT00686036|12615450|FG000|Overall Study|PSA ≥ 10ng/mL|1
8007061|NCT00686036|12615451|FG001|Overall Study|PSA ≥ 10ng/mL|0
8007062|NCT00686036|12615450|FG000|Overall Study|Other reasons not identified|0
8007063|NCT00686036|12615451|FG001|Overall Study|Other reasons not identified|4
8007064|NCT00683787|12615473|FG000|Overall Study|Progression|3
8007065|NCT00683787|12615474|FG001|Overall Study|Progression|3
8007066|NCT00683787|12615475|FG002|Overall Study|Progression|0
8007067|NCT00683787|12615473|FG000|Overall Study|Adverse Event|0
8007068|NCT00683787|12615474|FG001|Overall Study|Adverse Event|0
8007069|NCT00683787|12615475|FG002|Overall Study|Adverse Event|2
8007070|NCT00678041|12615490|FG000|Overall Study|Physician Decision|5
8007071|NCT00678041|12615491|FG001|Overall Study|Physician Decision|5
8007072|NCT00681629|12615509|FG000|Overall Study|Study termination|4
8007073|NCT00681629|12615510|FG001|Overall Study|Study termination|2
8007074|NCT00681629|12615509|FG000|Overall Study|Adverse Event|1
8007075|NCT00681629|12615510|FG001|Overall Study|Adverse Event|0
8007076|NCT00673361|12615570|FG000|Overall Study|Screen Failure|2
8007077|NCT00673179|12615587|FG000|Overall Study|Toxicity/Complications|3
8007078|NCT00673179|12615588|FG001|Overall Study|Toxicity/Complications|0
8007079|NCT00660348|12615607|FG000|Overall Study|Withdrawal by Subject|1
8007080|NCT00660348|12615608|FG001|Overall Study|Withdrawal by Subject|0
8007081|NCT00664066|12615614|FG000|Overall Study|Study terminated|3
8007082|NCT00667017|12615618|FG000|Overall Study|Withdrawal by Subject|1
8007083|NCT00665444|12615622|FG000|Overall Study|Physician Decision|1
8007084|NCT00665444|12615622|FG000|Overall Study|Study Terminated by Study Sponsor|1
8007085|NCT00660595|12615637|FG000|Overall Study|Lost to Follow-up|0
8007086|NCT00660595|12615638|FG001|Overall Study|Lost to Follow-up|1
8007087|NCT00660595|12615637|FG000|Overall Study|Did not consent to participate in study|12
8007088|NCT00660595|12615638|FG001|Overall Study|Did not consent to participate in study|8
8007089|NCT00660595|12615637|FG000|Overall Study|Participant left hospital|1
8007090|NCT00660595|12615638|FG001|Overall Study|Participant left hospital|0
8007091|NCT00660595|12615637|FG000|Overall Study|Non Specified reasons|5
8007092|NCT00660595|12615638|FG001|Overall Study|Non Specified reasons|0
8007093|NCT00646282|12615655|FG000|Overall Study|Protocol terminated|4
8007094|NCT00646282|12615656|FG001|Overall Study|Protocol terminated|4
8007095|NCT00657553|12615664|FG000|Overall Study|low accrual, no analysis run|5
8007096|NCT00657553|12615665|FG001|Overall Study|low accrual, no analysis run|5
8007097|NCT00648895|12615686|FG000|Overall Study|Lack of Efficacy|0
8007098|NCT00648895|12615687|FG001|Overall Study|Lack of Efficacy|1
8007099|NCT00647426|12615693|FG000|Overall Study|Withdrawal by Subject|2
8007100|NCT00645567|12615698|FG000|Overall Study|Adverse Event|1
8007101|NCT00637806|12615709|FG000|Double-blind Phase|Study Discontinued|2
8007102|NCT00637806|12615710|FG001|Double-blind Phase|Study Discontinued|0
8007103|NCT00637806|12615711|FG002|Double-blind Phase|Study Discontinued|1
8007104|NCT00637806|12615712|FG003|Double-blind Phase|Study Discontinued|0
8007105|NCT00637806|12615709|FG000|Extension Phase|Study Discontinued|0
8007106|NCT00637806|12615710|FG001|Extension Phase|Study Discontinued|0
8007107|NCT00637806|12615711|FG002|Extension Phase|Study Discontinued|0
8007108|NCT00637806|12615712|FG003|Extension Phase|Study Discontinued|1
8007109|NCT00629798|12615737|FG000|Overall Study|Not Treated|4
8007110|NCT00637728|12615747|FG000|Double-blind Phase|Adverse Event|1
8007111|NCT00637728|12615748|FG001|Double-blind Phase|Adverse Event|0
8007112|NCT00637728|12615749|FG002|Double-blind Phase|Adverse Event|0
8007113|NCT00637728|12615747|FG000|Double-blind Phase|Non-compliance|2
8007114|NCT00637728|12615748|FG001|Double-blind Phase|Non-compliance|0
8007115|NCT00637728|12615749|FG002|Double-blind Phase|Non-compliance|0
8007116|NCT00637728|12615747|FG000|Double-blind Phase|Study Discontinued|1
8007117|NCT00637728|12615748|FG001|Double-blind Phase|Study Discontinued|1
8007118|NCT00637728|12615749|FG002|Double-blind Phase|Study Discontinued|0
8007119|NCT00637416|12615784|FG000|Overall Study|Lost to Follow-up|1
8007120|NCT00637416|12615785|FG001|Overall Study|Lost to Follow-up|1
8007121|NCT00637416|12615784|FG000|Overall Study|Unable to take study drug|0
8007122|NCT00637416|12615785|FG001|Overall Study|Unable to take study drug|1
8007123|NCT00631137|12615835|FG000|Overall Study|Withdrawal by Subject|1
8007124|NCT00631137|12615836|FG001|Overall Study|Withdrawal by Subject|0
8007125|NCT00633061|12615853|FG000|Overall Study|Study closed|86
8007126|NCT00633061|12615854|FG001|Overall Study|Study closed|0
8007127|NCT00630292|12615866|FG000|Overall Study|Withdrawal by Subject|1
8007128|NCT00634010|12615872|FG000|Overall Study|Adverse Event|2
8007129|NCT00634010|12615873|FG001|Overall Study|Adverse Event|5
8007130|NCT00634010|12615872|FG000|Overall Study|Withdrawal by Subject|5
8007131|NCT00634010|12615873|FG001|Overall Study|Withdrawal by Subject|6
8007132|NCT00634010|12615872|FG000|Overall Study|Physician Decision|1
8007133|NCT00634010|12615873|FG001|Overall Study|Physician Decision|1
8007134|NCT00634010|12615872|FG000|Overall Study|Disease Progression|1
8007135|NCT00634010|12615873|FG001|Overall Study|Disease Progression|1
8007136|NCT00634010|12615872|FG000|Overall Study|Non-Compliant|1
8007137|NCT00634010|12615873|FG001|Overall Study|Non-Compliant|1
8007138|NCT00626561|12615923|FG000|Overall Study|Withdrawal by Subject|2
8007139|NCT00626561|12615923|FG000|Overall Study|Disease Progression|2
8007140|NCT00613730|12615927|FG000|Overall Study|Disease progression|2
8007141|NCT00613730|12615927|FG000|Overall Study|Administrative decision|1
8007142|NCT00625586|12615931|FG000|Overall Study|Adverse Event|1
8007143|NCT00625742|12615939|FG000|Overall Study|Disease Progression|2
8007144|NCT00625742|12615939|FG000|Overall Study|Withdrawal by Subject|1
8007145|NCT00625742|12615939|FG000|Overall Study|Adverse Event|4
8007146|NCT00625742|12615939|FG000|Overall Study|Lost to Follow-up|4
8007147|NCT00625742|12615939|FG000|Overall Study|Ineligible|1
8007148|NCT00619151|12615949|FG000|Overall Study|Study terminated prior to followup|1
8007149|NCT00619151|12615950|FG001|Overall Study|Study terminated prior to followup|0
8007150|NCT00622167|12615956|FG000|Overall Study|Did not meet angiographic criteria|20
8007151|NCT00616759|12615975|FG000|Overall Study|Physician Decision|2
8007152|NCT00616759|12615976|FG001|Overall Study|Physician Decision|0
8007153|NCT00616759|12615975|FG000|Overall Study|Withdrawal by Subject|1
8007154|NCT00616759|12615976|FG001|Overall Study|Withdrawal by Subject|2
8007155|NCT00616642|12615984|FG000|Overall Study|Withdrawal by Subject|0
8007156|NCT00616642|12615985|FG001|Overall Study|Withdrawal by Subject|1
8007157|NCT00619515|12615991|FG000|Overall Study|Study Termination by IRB|73
8007158|NCT00612677|12615999|FG000|Overall Study|study closed before treatment started|1
8007159|NCT00616603|12616006|FG000|Overall Study|Physician Decision|2
8007160|NCT00616603|12616007|FG001|Overall Study|Physician Decision|0
8007161|NCT00616603|12616008|FG002|Overall Study|Physician Decision|2
8007162|NCT00609765|12616049|FG000|Overall Study|Study ended prior to 12 months|1
8007163|NCT00595920|12616074|FG000|Overall Study|The OLTERMS study was discontinued by th|116
8007164|NCT00596947|12616080|FG000|Overall Study|study halted due to low enrollment|5
8007165|NCT00596947|12616081|FG001|Overall Study|study halted due to low enrollment|3
8007166|NCT00596947|12616080|FG000|Overall Study|Lost to Follow-up|1
8007167|NCT00596947|12616081|FG001|Overall Study|Lost to Follow-up|0
8007168|NCT00584012|12616087|FG000|Overall Study|Withdrawal by Subject|1
8007169|NCT00577772|12616123|FG000|Overall Study|Lost to Follow-up|0
8007170|NCT00577772|12616124|FG001|Overall Study|Lost to Follow-up|1
8007171|NCT00592007|12616130|FG000|Overall Study|Withdrawal by Subject|1
8007172|NCT00592007|12616130|FG000|Overall Study|patient ineligible (out of lab range)|1
8007173|NCT00595582|12616134|FG000|Overall Study|Pilot study that PI terminated|2
8007174|NCT00595582|12616134|FG000|Overall Study|Lost to Follow-up|1
8007175|NCT00595582|12616134|FG000|Overall Study|Adverse Event|2
8007176|NCT00595582|12616134|FG000|Overall Study|Physician Decision|5
8007177|NCT00588146|12616138|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4
8007178|NCT00588146|12616139|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3
8007179|NCT00590538|12616154|FG000|Overall Study|Study terminated before completed|2
8007180|NCT00583115|12616158|FG000|Overall Study|Death|1
8007181|NCT00582712|12616162|FG000|Overall Study|Adverse Event|1
8007182|NCT00582712|12616162|FG000|Overall Study|Lack of Efficacy|1
8007183|NCT00582712|12616162|FG000|Overall Study|Withdrawal by Subject|1
8007184|NCT00582712|12616162|FG000|Overall Study|Complicating disease requiring treatment|1
8007185|NCT00587795|12616193|FG000|Overall Study|Withdrawal by Subject|1
8007186|NCT00587795|12616194|FG001|Overall Study|Withdrawal by Subject|0
8007187|NCT00590135|12616200|FG000|Overall Study|Primary endpoint measure not obtainable|59
8007188|NCT00582036|12616207|FG000|Overall Study|Withdrawal by Subject|0
8007189|NCT00582036|12616208|FG001|Overall Study|Withdrawal by Subject|1
8007190|NCT00585585|12616214|FG000|Overall Study|Adverse Event|1
8007191|NCT00585221|12616218|FG000|Overall Study|Protocol Violation|8
8007192|NCT00581113|12616224|FG000|Overall Study|Withdrawal by Subject|0
8007193|NCT00581113|12616225|FG001|Overall Study|Withdrawal by Subject|1
8007194|NCT00579254|12616231|FG000|Overall Study|Lost to Follow-up|39
8007195|NCT00579254|12616231|FG000|Overall Study|Discontinued when study terminated|73
8007196|NCT00587223|12616235|FG000|Overall Study|Adverse Event|1
8007197|NCT00577395|12616266|FG000|Overall Study|Study was terminated early by Sponsor|7
8007198|NCT00577395|12616267|FG001|Overall Study|Study was terminated early by Sponsor|6
8007199|NCT00573391|12616275|FG000|Overall Study|study stopped|2
8007200|NCT00573391|12616276|FG001|Overall Study|study stopped|2
8007201|NCT00573391|12616275|FG000|Overall Study|Death|1
8007202|NCT00573391|12616276|FG001|Overall Study|Death|0
8007203|NCT00574080|12616320|FG000|Overall Study|Death|10
8007204|NCT00574080|12616321|FG001|Overall Study|Death|10
8007205|NCT00558558|12616327|FG000|Overall Study|Unable to swallow|1
8007206|NCT00558558|12616327|FG000|Overall Study|Withdrawal by Subject|1
8007207|NCT00558558|12616327|FG000|Overall Study|Lack of Efficacy|4
8007208|NCT00573937|12616337|FG000|Overall Study|Study Terminated|0
8007209|NCT00573937|12616338|FG001|Overall Study|Study Terminated|1
8007210|NCT00577317|12616346|FG000|Overall Study|Study Terminated|0
8007211|NCT00577317|12616347|FG001|Overall Study|Study Terminated|2
8007212|NCT00571922|12616355|FG000|Overall Study|Completion unknown|36
8007213|NCT00571922|12616356|FG001|Overall Study|Completion unknown|36
8007214|NCT00573157|12616368|FG000|Overall Study|Adverse Event|3
8007215|NCT00573157|12616369|FG001|Overall Study|Adverse Event|1
8007216|NCT00573157|12616368|FG000|Overall Study|Other|1
8007217|NCT00573157|12616369|FG001|Overall Study|Other|1
8007218|NCT00561912|12616388|FG000|Overall Study|ineligible|1
8007219|NCT00561795|12616394|FG000|Overall Study|Adverse Event|3
8007220|NCT00561795|12616395|FG001|Overall Study|Adverse Event|3
8007221|NCT00561795|12616396|FG002|Overall Study|Adverse Event|0
8007222|NCT00561795|12616397|FG003|Overall Study|Adverse Event|0
8007223|NCT00561795|12616394|FG000|Overall Study|Study Closed/Terminated|0
8007224|NCT00561795|12616395|FG001|Overall Study|Study Closed/Terminated|3
8007225|NCT00561795|12616396|FG002|Overall Study|Study Closed/Terminated|0
8007226|NCT00561795|12616397|FG003|Overall Study|Study Closed/Terminated|0
8007227|NCT00561795|12616394|FG000|Overall Study|Physician Decision|1
8007228|NCT00561795|12616395|FG001|Overall Study|Physician Decision|0
8007229|NCT00561795|12616396|FG002|Overall Study|Physician Decision|0
8007230|NCT00561795|12616397|FG003|Overall Study|Physician Decision|0
8007231|NCT00556075|12616433|FG000|Overall Study|Lost to Follow-up|3
8007232|NCT00556075|12616434|FG001|Overall Study|Lost to Follow-up|0
8007233|NCT00556075|12616435|FG002|Overall Study|Lost to Follow-up|3
8007234|NCT00556075|12616433|FG000|Overall Study|Withdrawal by Subject|3
8007235|NCT00556075|12616434|FG001|Overall Study|Withdrawal by Subject|3
8007236|NCT00556075|12616435|FG002|Overall Study|Withdrawal by Subject|0
8007237|NCT00556075|12616433|FG000|Overall Study|Protocol Violation|1
8007238|NCT00556075|12616434|FG001|Overall Study|Protocol Violation|1
8007239|NCT00556075|12616435|FG002|Overall Study|Protocol Violation|3
8007240|NCT00556075|12616433|FG000|Overall Study|Not eligible|1
8007241|NCT00556075|12616434|FG001|Overall Study|Not eligible|1
8007242|NCT00556075|12616435|FG002|Overall Study|Not eligible|2
8007243|NCT00556075|12616433|FG000|Overall Study|Adverse Event|1
8007244|NCT00556075|12616434|FG001|Overall Study|Adverse Event|2
8007245|NCT00556075|12616435|FG002|Overall Study|Adverse Event|0
8007246|NCT00556075|12616433|FG000|Overall Study|Personal issues|4
8007247|NCT00556075|12616434|FG001|Overall Study|Personal issues|1
8007248|NCT00556075|12616435|FG002|Overall Study|Personal issues|0
8007249|NCT00556075|12616433|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0
8007250|NCT00556075|12616434|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1
8007251|NCT00556075|12616435|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0
8007252|NCT00556166|12616447|FG000|Overall Study|Withdrawal by Subject|1
8007253|NCT00539838|12616471|FG000|Overall Study|Fail to return|2
8007254|NCT00539838|12616472|FG001|Overall Study|Fail to return|0
8007255|NCT00539838|12616473|FG002|Overall Study|Fail to return|0
8007256|NCT00539838|12616471|FG000|Overall Study|Withdrawal by Subject|0
8007257|NCT00539838|12616472|FG001|Overall Study|Withdrawal by Subject|4
8007258|NCT00539838|12616473|FG002|Overall Study|Withdrawal by Subject|0
8007259|NCT00539838|12616471|FG000|Overall Study|Death|0
8007260|NCT00539838|12616472|FG001|Overall Study|Death|2
8007261|NCT00539838|12616473|FG002|Overall Study|Death|0
8007262|NCT00539838|12616471|FG000|Overall Study|Did not cooperate|1
8007263|NCT00539838|12616472|FG001|Overall Study|Did not cooperate|0
8007264|NCT00539838|12616473|FG002|Overall Study|Did not cooperate|1
8007265|NCT00539838|12616471|FG000|Overall Study|Administrative|4
8007266|NCT00539838|12616472|FG001|Overall Study|Administrative|0
8007267|NCT00539838|12616473|FG002|Overall Study|Administrative|8
8007268|NCT00549328|12616483|FG000|Overall Study|Adverse Event|2
8007269|NCT00549328|12616483|FG000|Overall Study|Disease Progression|10
8007270|NCT00549328|12616483|FG000|Overall Study|Death|1
8007271|NCT00549328|12616483|FG000|Overall Study|Use of Prohibited Medication|1
8007272|NCT00548327|12616489|FG000|Overall Study|Adverse Event|0
8007273|NCT00548327|12616490|FG001|Overall Study|Adverse Event|1
8007274|NCT00547300|12616521|FG000|Overall Study|Study was Administratively Terminated|25
8007275|NCT00547300|12616522|FG001|Overall Study|Study was Administratively Terminated|24
8007276|NCT00547300|12616521|FG000|Overall Study|Did not Meet Entry Criteria|0
8007277|NCT00547300|12616522|FG001|Overall Study|Did not Meet Entry Criteria|2
8007278|NCT00535262|12616554|FG000|Overall Study|No funding|3
8007279|NCT00537199|12616571|FG000|Overall Study|Study Terminated|1
8007280|NCT00536978|12616581|FG000|Overall Study|Not eligible for Adback Infusion|22
8007281|NCT00524485|12616585|FG000|Overall Study|Withdrawal by Subject|5
8007282|NCT00524134|12616607|FG000|Overall Study|Withdrawal by Subject|1
8007283|NCT00524134|12616607|FG000|Overall Study|Physician Decision|1
8007284|NCT00527748|12616611|FG000|Overall Study|Other|3
8007285|NCT00517699|12616615|FG000|Overall Study|Withdrawal by Subject|1
8007286|NCT00517699|12616615|FG000|Overall Study|Lack of Efficacy|1
8007287|NCT00517699|12616615|FG000|Overall Study|Administrative error|1
8007288|NCT00517699|12616615|FG000|Overall Study|Study terminated by Sponsor|2
8007289|NCT00528775|12616619|FG000|Overall Study|Other not specified|1
8007290|NCT00527982|12616655|FG000|Overall Study|Physician Decision|1
8007291|NCT00527982|12616656|FG001|Overall Study|Physician Decision|0
8007292|NCT00524459|12616662|FG000|Overall Study|Withdrawal by Subject|1
8007293|NCT00524459|12616662|FG000|Overall Study|Other|1
8007294|NCT00517361|12616666|FG000|Overall Study|Death|6
8007295|NCT00517361|12616666|FG000|Overall Study|The study was terminated|5
8007296|NCT00522457|12616678|FG000|Overall Study|Due to disease progression|16
8007297|NCT00522457|12616678|FG000|Overall Study|Adverse Event|2
8007298|NCT00526331|12616682|FG000|Overall Study|Sponsor Termination|55
8007299|NCT00522301|12616703|FG000|Overall Study|Withdrawal by Subject|1
8007300|NCT00522301|12616703|FG000|Overall Study|Adverse Event|5
8007301|NCT00517192|12616709|FG000|Overall Study|Adverse Event|1
8007302|NCT00517192|12616710|FG001|Overall Study|Adverse Event|1
8007303|NCT00517192|12616709|FG000|Overall Study|Lost to Follow-up|1
8007304|NCT00517192|12616710|FG001|Overall Study|Lost to Follow-up|1
8007305|NCT00517192|12616709|FG000|Overall Study|Withdrawal by Subject|1
8007306|NCT00517192|12616710|FG001|Overall Study|Withdrawal by Subject|0
8007307|NCT00517192|12616709|FG000|Overall Study|Early termination of the trial|16
8007308|NCT00517192|12616710|FG001|Overall Study|Early termination of the trial|18
8007309|NCT00503581|12616723|FG000|Overall Study|Study closed|3
8007310|NCT00503581|12616724|FG001|Overall Study|Study closed|4
8007311|NCT00503581|12616725|FG002|Overall Study|Study closed|2
8007312|NCT00509600|12616733|FG000|Overall Study|Adverse Event|1
8007313|NCT00515112|12616739|FG000|Overall Study|Death|0
8007314|NCT00515112|12616740|FG001|Overall Study|Death|1
8007315|NCT00515112|12616739|FG000|Overall Study|The study was terminated|3
8007316|NCT00515112|12616740|FG001|Overall Study|The study was terminated|2
8007317|NCT00508872|12616746|FG000|Overall Study|Lost to Follow-up|1
8007318|NCT00508872|12616746|FG000|Overall Study|Physician Decision|1
8007319|NCT00514813|12616754|FG000|Overall Study|Study terminated|14
8007320|NCT00514813|12616755|FG001|Overall Study|Study terminated|74
8007321|NCT00514813|12616756|FG002|Overall Study|Study terminated|40
8007322|NCT00514813|12616757|FG003|Overall Study|Study terminated|2
8007323|NCT00514813|12616754|FG000|Overall Study|Adverse Event|0
8007324|NCT00514813|12616755|FG001|Overall Study|Adverse Event|2
8007325|NCT00514813|12616756|FG002|Overall Study|Adverse Event|2
8007326|NCT00514813|12616757|FG003|Overall Study|Adverse Event|0
8007327|NCT00514813|12616754|FG000|Overall Study|Protocol Violation|1
8007328|NCT00514813|12616755|FG001|Overall Study|Protocol Violation|0
8007329|NCT00514813|12616756|FG002|Overall Study|Protocol Violation|0
8007330|NCT00514813|12616757|FG003|Overall Study|Protocol Violation|0
8007331|NCT00514813|12616754|FG000|Overall Study|Withdrawal by Subject|0
8007332|NCT00514813|12616755|FG001|Overall Study|Withdrawal by Subject|1
8007333|NCT00514813|12616756|FG002|Overall Study|Withdrawal by Subject|0
8007334|NCT00514813|12616757|FG003|Overall Study|Withdrawal by Subject|0
8007335|NCT00514813|12616754|FG000|Overall Study|Lack of Efficacy|0
8007336|NCT00514813|12616755|FG001|Overall Study|Lack of Efficacy|1
8007337|NCT00514813|12616756|FG002|Overall Study|Lack of Efficacy|0
8007338|NCT00514813|12616757|FG003|Overall Study|Lack of Efficacy|0
8007339|NCT00514813|12616754|FG000|Overall Study|Kidney transplant|0
8007340|NCT00514813|12616755|FG001|Overall Study|Kidney transplant|6
8007341|NCT00514813|12616756|FG002|Overall Study|Kidney transplant|2
8007342|NCT00514813|12616757|FG003|Overall Study|Kidney transplant|0
8007343|NCT00514813|12616754|FG000|Overall Study|Death|0
8007344|NCT00514813|12616755|FG001|Overall Study|Death|2
8007345|NCT00514813|12616756|FG002|Overall Study|Death|3
8007346|NCT00514813|12616757|FG003|Overall Study|Death|2
8007347|NCT00501228|12616790|FG000|Overall Study|Withdrawal by Subject|1
8007348|NCT00496782|12616796|FG000|Overall Study|Protocol Violation|1
8007349|NCT00496782|12616797|FG001|Overall Study|Protocol Violation|2
8007350|NCT00487578|12616809|FG000|Overall Study|Adverse Event|1
8007351|NCT00487578|12616810|FG001|Overall Study|Adverse Event|2
8007352|NCT00487578|12616809|FG000|Overall Study|Lack of Efficacy|0
8007353|NCT00487578|12616810|FG001|Overall Study|Lack of Efficacy|1
8007354|NCT00487578|12616809|FG000|Overall Study|Lost to Follow-up|0
8007355|NCT00487578|12616810|FG001|Overall Study|Lost to Follow-up|1
8007356|NCT00503009|12616819|FG000|Overall Study|Protocol Violation|1
8007357|NCT00503009|12616820|FG001|Overall Study|Protocol Violation|0
8007358|NCT00503009|12616821|FG002|Overall Study|Protocol Violation|1
8007359|NCT00503009|12616819|FG000|Overall Study|Withdrawal by Subject|0
8007360|NCT00503009|12616820|FG001|Overall Study|Withdrawal by Subject|1
8007361|NCT00503009|12616821|FG002|Overall Study|Withdrawal by Subject|1
8007362|NCT00503009|12616819|FG000|Overall Study|Physician Decision|0
8007363|NCT00503009|12616820|FG001|Overall Study|Physician Decision|1
8007364|NCT00503009|12616821|FG002|Overall Study|Physician Decision|1
8007365|NCT00499590|12616836|FG000|Overall Study|Study Terminated|112
8007366|NCT00499590|12616837|FG001|Overall Study|Study Terminated|112
8007367|NCT00499590|12616838|FG002|Overall Study|Study Terminated|112
8007368|NCT00499590|12616836|FG000|Overall Study|Not treated|1
8007369|NCT00499590|12616837|FG001|Overall Study|Not treated|0
8007370|NCT00499590|12616838|FG002|Overall Study|Not treated|1
8007371|NCT00503841|12616873|FG000|Overall Study|All screen failures|44
8007372|NCT00493025|12616879|FG000|Overall Study|Physician Decision|19
8007373|NCT00491400|12616886|FG000|Overall Study|Withdrawal by Subject|5
8007374|NCT00491400|12616887|FG001|Overall Study|Withdrawal by Subject|4
8007375|NCT00490776|12616895|FG000|Overall Study|Withdrawal by Subject|1
8007376|NCT00490776|12616895|FG000|Overall Study|Administrative Problems|1
8007377|NCT00490776|12616895|FG000|Overall Study|Death|1
8007378|NCT00490776|12616895|FG000|Overall Study|New Cancer Therapy|1
8007379|NCT00490776|12616895|FG000|Overall Study|Disease Progression|5
8007380|NCT00487162|12616901|FG000|Overall Study|Adverse Event|0
8007381|NCT00487162|12616902|FG001|Overall Study|Adverse Event|1
8007382|NCT00487162|12616901|FG000|Overall Study|Physician Decision|0
8007383|NCT00487162|12616902|FG001|Overall Study|Physician Decision|1
8007384|NCT00487162|12616901|FG000|Overall Study|Withdrawal by Subject|2
8007385|NCT00487162|12616902|FG001|Overall Study|Withdrawal by Subject|3
8007386|NCT00487981|12616908|FG000|Overall Study|Hypothyroidism diagnosis|1
8007387|NCT00491387|12616912|FG000|Overall Study|study terminated|20
8007388|NCT00483119|12616923|FG000|Overall Study|Adverse Event|0
8007389|NCT00483119|12616924|FG001|Overall Study|Adverse Event|1
8007390|NCT00483119|12616923|FG000|Overall Study|Physician Decision|1
8007391|NCT00483119|12616924|FG001|Overall Study|Physician Decision|0
8007392|NCT00470067|12616965|FG000|Overall Study|Death|1
8007393|NCT00470067|12616965|FG000|Overall Study|Disease Progression|6
8007394|NCT00475657|12616992|FG000|Overall Study|Death|1
8007395|NCT00475657|12616992|FG000|Overall Study|Sponsor's Decision|3
8007396|NCT00472082|12616996|FG000|Overall Study|Study prematurely terminated|5
8007397|NCT00467753|12617010|FG000|Overall Study|Lost to Follow-up|1
8007398|NCT00467753|12617011|FG001|Overall Study|Lost to Follow-up|2
8007399|NCT00467753|12617010|FG000|Overall Study|Adverse Event|2
8007400|NCT00467753|12617011|FG001|Overall Study|Adverse Event|0
8007401|NCT00456612|12617021|FG000|Overall Study|Withdrawal by Subject|3
8007402|NCT00469612|12617028|FG000|Overall Study|Study terminated before data collected|2
8007403|NCT00469612|12617029|FG001|Overall Study|Study terminated before data collected|0
8007404|NCT00461812|12617035|FG000|Overall Study|study terminated|10
8007405|NCT00461682|12617045|FG000|Overall Study|Protocol Violation|1
8007406|NCT00462904|12617051|FG000|Overall Study|Lost to Follow-up|1
8007407|NCT00450333|12617059|FG000|Overall Study|Study terminated|47
8007408|NCT00450333|12617060|FG001|Overall Study|Study terminated|54
8007409|NCT00450333|12617061|FG002|Overall Study|Study terminated|16
8007410|NCT00450333|12617062|FG003|Overall Study|Study terminated|21
8007411|NCT00450333|12617059|FG000|Overall Study|Adverse Event|1
8007412|NCT00450333|12617060|FG001|Overall Study|Adverse Event|7
8007413|NCT00450333|12617061|FG002|Overall Study|Adverse Event|2
8007414|NCT00450333|12617062|FG003|Overall Study|Adverse Event|2
8007415|NCT00450333|12617059|FG000|Overall Study|Protocol Violation|1
8007416|NCT00450333|12617060|FG001|Overall Study|Protocol Violation|0
8007417|NCT00450333|12617061|FG002|Overall Study|Protocol Violation|1
8007418|NCT00450333|12617062|FG003|Overall Study|Protocol Violation|0
8007419|NCT00450333|12617059|FG000|Overall Study|Withdrawal by Subject|1
8007420|NCT00450333|12617060|FG001|Overall Study|Withdrawal by Subject|0
8007421|NCT00450333|12617061|FG002|Overall Study|Withdrawal by Subject|3
8007422|NCT00450333|12617062|FG003|Overall Study|Withdrawal by Subject|0
8007423|NCT00450333|12617059|FG000|Overall Study|Kidney transplant|1
8007424|NCT00450333|12617060|FG001|Overall Study|Kidney transplant|0
8007425|NCT00450333|12617061|FG002|Overall Study|Kidney transplant|1
8007426|NCT00450333|12617062|FG003|Overall Study|Kidney transplant|3
8007427|NCT00450333|12617059|FG000|Overall Study|Death|3
8007428|NCT00450333|12617060|FG001|Overall Study|Death|2
8007429|NCT00450333|12617061|FG002|Overall Study|Death|2
8007430|NCT00450333|12617062|FG003|Overall Study|Death|2
8007431|NCT00455143|12617072|FG000|Overall Study|Physician Decision|1
8007432|NCT00455143|12617072|FG000|Overall Study|Withdrawal by Subject|1
8007433|NCT00455143|12617072|FG000|Overall Study|Staff was not avail to follow patient|2
8007434|NCT00455143|12617072|FG000|Overall Study|No longer met Inclusion Criteria|1
8007435|NCT00455143|12617072|FG000|Overall Study|Surgical time, staff not available|1
8007436|NCT00454571|12617088|FG000|Overall Study|Adverse Event|2
8007437|NCT00454571|12617089|FG001|Overall Study|Adverse Event|0
8007438|NCT00454571|12617088|FG000|Overall Study|Physician Decision|0
8007439|NCT00454571|12617089|FG001|Overall Study|Physician Decision|1
8007440|NCT00454571|12617088|FG000|Overall Study|Protocol Violation|1
8007441|NCT00454571|12617089|FG001|Overall Study|Protocol Violation|0
8007442|NCT00454571|12617088|FG000|Overall Study|Withdrawal by Subject|10
8007443|NCT00454571|12617089|FG001|Overall Study|Withdrawal by Subject|5
8007444|NCT00452361|12617097|FG000|Overall Study|Adverse Event|8
8007445|NCT00452361|12617098|FG001|Overall Study|Adverse Event|0
8007446|NCT00452361|12617097|FG000|Overall Study|Withdrawal by Subject|0
8007447|NCT00452361|12617098|FG001|Overall Study|Withdrawal by Subject|1
8007448|NCT00452361|12617097|FG000|Overall Study|Premature termination|13
8007449|NCT00452361|12617098|FG001|Overall Study|Premature termination|9
8007450|NCT00443040|12617107|FG000|Overall Study|Withdrawal by Subject|1
8007451|NCT00443040|12617108|FG001|Overall Study|Withdrawal by Subject|0
8007452|NCT00443040|12617109|FG002|Overall Study|Withdrawal by Subject|0
8007453|NCT00443040|12617107|FG000|Overall Study|Converted to an open laparotomy|3
8007454|NCT00443040|12617108|FG001|Overall Study|Converted to an open laparotomy|0
8007455|NCT00443040|12617109|FG002|Overall Study|Converted to an open laparotomy|1
8007456|NCT00447421|12617117|FG000|Overall Study|Lack of Efficacy|1
8007457|NCT00447421|12617117|FG000|Overall Study|Adverse Event|3
8007458|NCT00447421|12617117|FG000|Overall Study|Sponsor Decision|2
8007459|NCT00441272|12617123|FG000|Overall Study|Study terminated prior to enrollment|25
8007460|NCT00441272|12617124|FG001|Overall Study|Study terminated prior to enrollment|25
8007461|NCT00440271|12617136|FG000|Overall Study|Protocol Violation|1
8007462|NCT00440271|12617137|FG001|Overall Study|Protocol Violation|1
8007463|NCT00440271|12617136|FG000|Overall Study|Adverse Event|0
8007464|NCT00440271|12617137|FG001|Overall Study|Adverse Event|1
8007465|NCT00440271|12617136|FG000|Overall Study|Lost to Follow-up|1
8007466|NCT00440271|12617137|FG001|Overall Study|Lost to Follow-up|0
8007467|NCT00440271|12617136|FG000|Overall Study|Withdrawal by Subject|0
8007468|NCT00440271|12617137|FG001|Overall Study|Withdrawal by Subject|2
8007469|NCT00440271|12617136|FG000|Overall Study|Lack of Efficacy|0
8007470|NCT00440271|12617137|FG001|Overall Study|Lack of Efficacy|1
8007471|NCT00440271|12617136|FG000|Overall Study|Due to closure of trial|8
8007472|NCT00440271|12617137|FG001|Overall Study|Due to closure of trial|10
8007473|NCT00440271|12617136|FG000|Overall Study|Other|2
8007474|NCT00440271|12617137|FG001|Overall Study|Other|0
8007475|NCT00429026|12617147|FG000|Overall Study|Inevaluable for response.|40
8007476|NCT00439569|12617158|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
8007477|NCT00439569|12617158|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
8007478|NCT00439569|12617158|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
8007479|NCT00422669|12617165|FG000|Overall Study|The study was terminated early.|98
8007480|NCT00422669|12617166|FG001|Overall Study|The study was terminated early.|100
8007481|NCT00422669|12617167|FG002|Overall Study|The study was terminated early.|7
8007482|NCT00434590|12617179|FG000|Overall Study|Administrative problems|5
8007483|NCT00434590|12617180|FG001|Overall Study|Administrative problems|5
8007484|NCT00424645|12617188|FG000|Overall Study|Death|1
8007485|NCT00424645|12617189|FG001|Overall Study|Death|0
8007486|NCT00430027|12617195|FG000|Overall Study|Study terminated|8
8007487|NCT00429858|12617199|FG000|Overall Study|Withdrawal by Subject|1
8007488|NCT00429858|12617199|FG000|Overall Study|Study Termination|1
8007489|NCT00425438|12617206|FG000|Overall Study|Termination by Sponsor|25
8007490|NCT00425438|12617207|FG001|Overall Study|Termination by Sponsor|27
8007491|NCT00422942|12617217|FG000|Overall Study|Study terminated by Sponsor|3
8007492|NCT00409344|12617223|FG000|Overall Study|no enrollment|0
8007493|NCT00409344|12617224|FG001|Overall Study|no enrollment|0
8007494|NCT00414453|12617230|FG000|Overall Study|Abnormal lab work|16
8007495|NCT00417248|12617240|FG000|Overall Study|Study Terminated|6
8007496|NCT00417248|12617240|FG000|Overall Study|Death|1
8007497|NCT00417248|12617240|FG000|Overall Study|Lack of Efficacy|1
8007498|NCT00418145|12617245|FG000|Overall Study|study terminated|6
8007499|NCT00409331|12617251|FG000|Overall Study|Physician Decision|1
8007500|NCT00391430|12617268|FG000|Overall Study|Withdrawal by Subject|3
8007501|NCT00391430|12617269|FG001|Overall Study|Withdrawal by Subject|0
8007502|NCT00391430|12617270|FG002|Overall Study|Withdrawal by Subject|12
8007503|NCT00384293|12617303|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
8007504|NCT00384293|12617304|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
8007505|NCT00384293|12617305|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
8007506|NCT00384293|12617303|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
8007507|NCT00384293|12617304|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
8007508|NCT00384293|12617305|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
8007509|NCT00384293|12617303|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
8007510|NCT00384293|12617304|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
8007511|NCT00384293|12617305|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
8007512|NCT00384293|12617303|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
8007513|NCT00384293|12617304|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
8007514|NCT00384293|12617305|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
8007515|NCT00384293|12617303|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
8007516|NCT00384293|12617304|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
8007517|NCT00384293|12617305|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
8007518|NCT00384293|12617303|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
8007519|NCT00384293|12617304|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
7718416|NCT00528112|12142381|FG000|Extension Phase|Lost to Follow-up|0
7718417|NCT00528112|12142382|FG001|Extension Phase|Lost to Follow-up|12
7718418|NCT00528112|12142381|FG000|Extension Phase|Death|0
7718419|NCT00528112|12142382|FG001|Extension Phase|Death|1
7718420|NCT00528112|12142381|FG000|Extension Phase|Adverse Event|0
7718421|NCT00528112|12142382|FG001|Extension Phase|Adverse Event|36
7718422|NCT00528112|12142381|FG000|Extension Phase|Protocol Violation|0
7718423|NCT00528112|12142382|FG001|Extension Phase|Protocol Violation|2
7718424|NCT00528372|12142417|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
7718425|NCT00528372|12142418|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7718426|NCT00528372|12142419|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7718427|NCT00528372|12142420|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7718428|NCT00528372|12142421|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7718429|NCT00528372|12142422|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7718430|NCT00528372|12142423|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7718431|NCT00528372|12142424|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7718432|NCT00528372|12142425|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7718433|NCT00528372|12142417|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
7718434|NCT00528372|12142418|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
7718435|NCT00528372|12142419|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
7718436|NCT00528372|12142420|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
7718437|NCT00528372|12142421|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
7718438|NCT00528372|12142422|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
7718439|NCT00528372|12142423|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
7718440|NCT00528372|12142424|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
8007520|NCT00384293|12617305|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
8007521|NCT00384293|12617303|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
8007522|NCT00384293|12617304|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
8007523|NCT00384293|12617305|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
8007524|NCT00384293|12617303|FG000|Post-randomization Period|Adverse Event|0
8007525|NCT00384293|12617304|FG001|Post-randomization Period|Adverse Event|23
8007526|NCT00384293|12617305|FG002|Post-randomization Period|Adverse Event|7
8007527|NCT00384293|12617303|FG000|Post-randomization Period|Lost to Follow-up|0
8007528|NCT00384293|12617304|FG001|Post-randomization Period|Lost to Follow-up|2
8007529|NCT00384293|12617305|FG002|Post-randomization Period|Lost to Follow-up|1
8007530|NCT00384293|12617303|FG000|Post-randomization Period|Protocol Violation|0
8007531|NCT00384293|12617304|FG001|Post-randomization Period|Protocol Violation|1
8007532|NCT00384293|12617305|FG002|Post-randomization Period|Protocol Violation|0
8007533|NCT00384293|12617303|FG000|Post-randomization Period|Withdrawal by Subject|0
8007534|NCT00384293|12617304|FG001|Post-randomization Period|Withdrawal by Subject|8
8007535|NCT00384293|12617305|FG002|Post-randomization Period|Withdrawal by Subject|6
8007536|NCT00384293|12617303|FG000|Post-randomization Period|Trial Termination|0
8007537|NCT00384293|12617304|FG001|Post-randomization Period|Trial Termination|180
8007538|NCT00384293|12617305|FG002|Post-randomization Period|Trial Termination|204
8007539|NCT00384293|12617303|FG000|Post-randomization Period|Patient Randomized in Error|0
8007540|NCT00384293|12617304|FG001|Post-randomization Period|Patient Randomized in Error|0
8007541|NCT00384293|12617305|FG002|Post-randomization Period|Patient Randomized in Error|1
8007542|NCT00377455|12617326|FG000|Overall Study|Withdrawal by Subject|1
8007543|NCT00371462|12617332|FG000|Overall Study|Withdrawal by Subject|1
8007544|NCT00371462|12617333|FG001|Overall Study|Withdrawal by Subject|0
8007545|NCT00371462|12617332|FG000|Overall Study|Other|7
8007546|NCT00371462|12617333|FG001|Overall Study|Other|8
8007547|NCT00369265|12617341|FG000|Overall Study|Study terminated|4
8007548|NCT00369265|12617342|FG001|Overall Study|Study terminated|7
8007549|NCT00364689|12617355|FG000|Overall Study|Lost to Follow-up|1
8007550|NCT00352118|12617361|FG000|Overall Study|Physician Decision|4
8007551|NCT00356421|12617384|FG000|Overall Study|Lack of Efficacy|3
8007552|NCT00356421|12617385|FG001|Overall Study|Lack of Efficacy|0
8007553|NCT00356421|12617384|FG000|Overall Study|Withdrawal by Subject|9
8007554|NCT00356421|12617385|FG001|Overall Study|Withdrawal by Subject|2
8007555|NCT00356421|12617384|FG000|Overall Study|Related to study drug|15
8007556|NCT00356421|12617385|FG001|Overall Study|Related to study drug|12
8007557|NCT00356421|12617384|FG000|Overall Study|Not related to study drug|5
8007558|NCT00356421|12617385|FG001|Overall Study|Not related to study drug|3
8007559|NCT00350623|12617394|FG000|Overall Study|Lost to Follow-up|8
8007560|NCT00350623|12617395|FG001|Overall Study|Lost to Follow-up|3
8007561|NCT00350623|12617396|FG002|Overall Study|Lost to Follow-up|4
8007562|NCT00350623|12617394|FG000|Overall Study|Withdrawal by Subject|0
8007563|NCT00350623|12617395|FG001|Overall Study|Withdrawal by Subject|1
8007564|NCT00350623|12617396|FG002|Overall Study|Withdrawal by Subject|1
8007565|NCT00350623|12617394|FG000|Overall Study|patient traveling outside the country|0
8007566|NCT00350623|12617395|FG001|Overall Study|patient traveling outside the country|0
8007567|NCT00350623|12617396|FG002|Overall Study|patient traveling outside the country|1
8007568|NCT00350844|12617424|FG000|Overall Study|Lost to Follow-up|1
8007569|NCT00348556|12617428|FG000|Overall Study|Adverse Event|1
8007570|NCT00319839|12617432|FG000|Overall Study|Adverse Event|5
8007571|NCT00319839|12617432|FG000|Overall Study|Withdrawal by Subject|1
8007572|NCT00344019|12617439|FG000|Overall Study|did not meet final inclusion criteria|0
8007573|NCT00344019|12617440|FG001|Overall Study|did not meet final inclusion criteria|0
8007574|NCT00344019|12617441|FG002|Overall Study|did not meet final inclusion criteria|74
8007575|NCT00338455|12617454|FG000|Overall Study|Death|2
8007576|NCT00338455|12617455|FG001|Overall Study|Death|1
8007577|NCT00338455|12617454|FG000|Overall Study|Physician Decision|1
8007578|NCT00338455|12617455|FG001|Overall Study|Physician Decision|0
8007579|NCT00329108|12617463|FG000|Overall Study|Adverse Event|2
8007580|NCT00329108|12617464|FG001|Overall Study|Adverse Event|2
8007581|NCT00329108|12617463|FG000|Overall Study|Lack of Efficacy|3
8007582|NCT00329108|12617464|FG001|Overall Study|Lack of Efficacy|3
8007583|NCT00329108|12617463|FG000|Overall Study|Withdrawal by Subject|0
8007584|NCT00329108|12617464|FG001|Overall Study|Withdrawal by Subject|2
8007585|NCT00329108|12617463|FG000|Overall Study|symptomatic deterioration|1
8007586|NCT00329108|12617464|FG001|Overall Study|symptomatic deterioration|1
8007587|NCT00329108|12617463|FG000|Overall Study|Subject no longer willing to participate|2
8007588|NCT00329108|12617464|FG001|Overall Study|Subject no longer willing to participate|2
8007589|NCT00329108|12617463|FG000|Overall Study|study terminated by sponsor|1
8007590|NCT00329108|12617464|FG001|Overall Study|study terminated by sponsor|0
8007591|NCT00329108|12617463|FG000|Overall Study|withdrew patient after SAE resolved|1
8007592|NCT00329108|12617464|FG001|Overall Study|withdrew patient after SAE resolved|0
8007593|NCT00329108|12617463|FG000|Overall Study|Protocol Violation|0
8007594|NCT00329108|12617464|FG001|Overall Study|Protocol Violation|2
8007595|NCT00333229|12617485|FG000|Overall Study|Lack of Efficacy|0
8007596|NCT00333229|12617486|FG001|Overall Study|Lack of Efficacy|1
8007597|NCT00314327|12617532|FG000|Overall Study|Withdrawal by Subject|1
8007598|NCT00308113|12617540|FG000|Overall Study|Protocol closure|0
8007599|NCT00308113|12617541|FG001|Overall Study|Protocol closure|0
8007600|NCT00308113|12617542|FG002|Overall Study|Protocol closure|0
8007601|NCT00308113|12617543|FG003|Overall Study|Protocol closure|1
8007602|NCT00298740|12617563|FG000|Overall Study|Lack of Efficacy|6
8007603|NCT00298740|12617563|FG000|Overall Study|Withdrawal by Subject|3
8007604|NCT00301080|12617567|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1
8007605|NCT00301080|12617568|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0
8007606|NCT00301080|12617569|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0
8007607|NCT00301080|12617570|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0
8007608|NCT00301080|12617571|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0
8007609|NCT00290407|12617589|FG000|Overall Study|Physician Decision|2
8007610|NCT00295490|12617597|FG000|Overall Study|Protocol Violation|0
8007611|NCT00295490|12617598|FG001|Overall Study|Protocol Violation|0
8007612|NCT00295490|12617599|FG002|Overall Study|Protocol Violation|3
8007613|NCT00295490|12617600|FG003|Overall Study|Protocol Violation|3
8007614|NCT00295490|12617597|FG000|Overall Study|Withdrawal by Subject|0
8007615|NCT00295490|12617598|FG001|Overall Study|Withdrawal by Subject|2
8007616|NCT00295490|12617599|FG002|Overall Study|Withdrawal by Subject|0
8007617|NCT00295490|12617600|FG003|Overall Study|Withdrawal by Subject|1
8007618|NCT00295490|12617597|FG000|Overall Study|Lost to Follow-up|0
8007619|NCT00295490|12617598|FG001|Overall Study|Lost to Follow-up|0
8007620|NCT00295490|12617599|FG002|Overall Study|Lost to Follow-up|1
8007621|NCT00295490|12617600|FG003|Overall Study|Lost to Follow-up|0
8007622|NCT00295490|12617597|FG000|Overall Study|Adverse Event|1
8007623|NCT00295490|12617598|FG001|Overall Study|Adverse Event|0
8007624|NCT00295490|12617599|FG002|Overall Study|Adverse Event|0
8007625|NCT00295490|12617600|FG003|Overall Study|Adverse Event|0
8007626|NCT00295490|12617597|FG000|Overall Study|Other|0
8007627|NCT00295490|12617598|FG001|Overall Study|Other|2
8007628|NCT00295490|12617599|FG002|Overall Study|Other|0
8007629|NCT00295490|12617600|FG003|Overall Study|Other|1
8007630|NCT00268463|12617612|FG000|Overall Study|study terminated due to low accrual|10
8007631|NCT00268463|12617613|FG001|Overall Study|study terminated due to low accrual|12
8007632|NCT00276419|12617630|FG000|First Intervention|Adverse Event|1
8007633|NCT00276419|12617631|FG001|First Intervention|Adverse Event|0
8007634|NCT00276419|12617630|FG000|First Intervention|Withdrawal by Subject|0
8007635|NCT00276419|12617631|FG001|First Intervention|Withdrawal by Subject|2
8007636|NCT00271947|12617679|FG000|Overall Study|Lost to Follow-up|1
8007637|NCT00252174|12617699|FG000|Overall Study|Withdrawal by Subject|0
8007638|NCT00252174|12617700|FG001|Overall Study|Withdrawal by Subject|1
8007639|NCT00252174|12617701|FG002|Overall Study|Withdrawal by Subject|0
8007640|NCT00256295|12617709|FG000|Overall Study|Withdrawal by Subject|3
8007641|NCT00256295|12617709|FG000|Overall Study|Death|1
8007642|NCT00239720|12617723|FG000|Overall Study|Adverse Event|1
8007643|NCT00239720|12617724|FG001|Overall Study|Adverse Event|0
8007644|NCT00239720|12617723|FG000|Overall Study|Lost to Follow-up|0
8007645|NCT00239720|12617724|FG001|Overall Study|Lost to Follow-up|1
8007646|NCT00250718|12617730|FG000|Overall Study|Death|1
8007647|NCT00250718|12617730|FG000|Overall Study|Adverse Event|1
8007648|NCT00250718|12617730|FG000|Overall Study|Withdrawal by Subject|1
8007649|NCT00206375|12617778|FG000|Overall Study|Lost to Follow-up|1
8007650|NCT00206375|12617779|FG001|Overall Study|Lost to Follow-up|0
8007651|NCT00206375|12617780|FG002|Overall Study|Lost to Follow-up|0
8007652|NCT00206375|12617778|FG000|Overall Study|Withdrawal by Subject|2
8007653|NCT00206375|12617779|FG001|Overall Study|Withdrawal by Subject|1
8007654|NCT00206375|12617780|FG002|Overall Study|Withdrawal by Subject|3
8007655|NCT00206375|12617778|FG000|Overall Study|Study terminated due to lack of funds|0
8007656|NCT00206375|12617779|FG001|Overall Study|Study terminated due to lack of funds|1
8007657|NCT00206375|12617780|FG002|Overall Study|Study terminated due to lack of funds|1
8007658|NCT00229931|12617790|FG000|Overall Study|Death|1
8007659|NCT00229931|12617791|FG001|Overall Study|Death|0
8007660|NCT00229931|12617790|FG000|Overall Study|Lost to Follow-up|3
8007661|NCT00229931|12617791|FG001|Overall Study|Lost to Follow-up|2
8007662|NCT00209131|12617799|FG000|Overall Study|Lack of personnel due to turnovers.|15
8007663|NCT00209131|12617800|FG001|Overall Study|Lack of personnel due to turnovers.|11
8007664|NCT00209027|12617830|FG000|Overall Study|study terminated|10
8007665|NCT00209027|12617831|FG001|Overall Study|study terminated|0
8007666|NCT00182637|12617837|FG000|Overall Study|Adverse Event|2
8007667|NCT00182637|12617837|FG000|Overall Study|Disease Progression|1
8007668|NCT00176488|12617842|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1
8007669|NCT00162773|12617879|FG000|Overall Study|P.I, Left institution. Study terminated|22
8007670|NCT00147238|12617909|FG000|Overall Study|Inevaluable|8
8007671|NCT00165503|12617913|FG000|Overall Study|Death|1
8007672|NCT00165503|12617913|FG000|Overall Study|Lost to Follow-up|12
8007673|NCT00165503|12617913|FG000|Overall Study|Unresectable|3
8007674|NCT00160563|12617920|FG000|Overall Study|Adverse Event|1
8007675|NCT00160563|12617921|FG001|Overall Study|Adverse Event|1
8007676|NCT00160563|12617922|FG002|Overall Study|Adverse Event|1
8007677|NCT00160563|12617920|FG000|Overall Study|Lost to Follow-up|1
8007678|NCT00160563|12617921|FG001|Overall Study|Lost to Follow-up|1
8007679|NCT00160563|12617922|FG002|Overall Study|Lost to Follow-up|2
8007680|NCT00160563|12617920|FG000|Overall Study|Protocol Violation|0
8007681|NCT00160563|12617921|FG001|Overall Study|Protocol Violation|0
8007682|NCT00160563|12617922|FG002|Overall Study|Protocol Violation|3
8007683|NCT00160563|12617920|FG000|Overall Study|Withdrawal by Subject|1
8007684|NCT00160563|12617921|FG001|Overall Study|Withdrawal by Subject|2
8007685|NCT00160563|12617922|FG002|Overall Study|Withdrawal by Subject|3
8007686|NCT00160563|12617920|FG000|Overall Study|Other (listed in the study report)|48
8007687|NCT00160563|12617921|FG001|Overall Study|Other (listed in the study report)|40
8007688|NCT00160563|12617922|FG002|Overall Study|Other (listed in the study report)|81
8007689|NCT00160563|12617920|FG000|Overall Study|Missing reason|0
8007690|NCT00160563|12617921|FG001|Overall Study|Missing reason|1
8007691|NCT00160563|12617922|FG002|Overall Study|Missing reason|0
8007692|NCT00142519|12617933|FG000|Overall Study|Not Treated|7
8007693|NCT00142519|12617934|FG001|Overall Study|Not Treated|9
8007694|NCT00142519|12617933|FG000|Overall Study|Protocol Violation|1
8007695|NCT00142519|12617934|FG001|Overall Study|Protocol Violation|0
8007696|NCT00142519|12617933|FG000|Overall Study|Withdrawal by Subject|10
8007697|NCT00142519|12617934|FG001|Overall Study|Withdrawal by Subject|7
8007698|NCT00138073|12617949|FG000|Overall Study|lack of resources|55
8007699|NCT00113386|12617955|FG000|Overall Study|Withdrawal by Subject|1
8007700|NCT00113386|12617956|FG001|Overall Study|Withdrawal by Subject|0
8007701|NCT00113386|12617955|FG000|Overall Study|Physician Decision|0
8007702|NCT00113386|12617956|FG001|Overall Study|Physician Decision|1
8007703|NCT00113386|12617955|FG000|Overall Study|Toxicity|3
7718441|NCT00528372|12142425|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
7718442|NCT00528372|12142417|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
7718443|NCT00528372|12142418|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
7718444|NCT00528372|12142419|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
8007704|NCT00113386|12617956|FG001|Overall Study|Toxicity|0
7718445|NCT00528372|12142420|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
7718446|NCT00528372|12142421|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
7718447|NCT00528372|12142422|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
7718448|NCT00528372|12142423|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
7718449|NCT00528372|12142424|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
7718450|NCT00528372|12142425|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
7718451|NCT00528372|12142417|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
7718452|NCT00528372|12142418|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
7718453|NCT00528372|12142419|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
7718454|NCT00528372|12142420|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
7718455|NCT00528372|12142421|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
7718456|NCT00528372|12142422|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
8007705|NCT00113386|12617955|FG000|Overall Study|Ineligible|1
8007706|NCT00113386|12617956|FG001|Overall Study|Ineligible|2
8007707|NCT00113386|12617955|FG000|Overall Study|Unknown - Lost to Follow-Up|2
8007708|NCT00113386|12617956|FG001|Overall Study|Unknown - Lost to Follow-Up|1
8007709|NCT00138151|12617962|FG000|Overall Study|Withdrawal by Subject|3
8007710|NCT00138151|12617962|FG000|Overall Study|Physician Decision|1
8007711|NCT00129974|12617966|FG000|Overall Study|Other|1
8007712|NCT00126659|12617973|FG000|Overall Study|Adverse Event|0
8007713|NCT00126659|12617974|FG001|Overall Study|Adverse Event|0
8007714|NCT00126659|12617975|FG002|Overall Study|Adverse Event|2
8007715|NCT00125268|12617992|FG000|Overall Study|Withdrawal by Subject|1
8007716|NCT00125268|12617993|FG001|Overall Study|Withdrawal by Subject|1
8007717|NCT00113399|12618001|FG000|Overall Study|Death|1
8007718|NCT00113399|12618002|FG001|Overall Study|Death|1
8007719|NCT00113399|12618001|FG000|Overall Study|Withdrawal by Subject|1
8007720|NCT00113399|12618002|FG001|Overall Study|Withdrawal by Subject|2
8007721|NCT00113399|12618001|FG000|Overall Study|Complete Response|0
8007722|NCT00113399|12618002|FG001|Overall Study|Complete Response|1
8007723|NCT00113399|12618001|FG000|Overall Study|Other|0
8007724|NCT00113399|12618002|FG001|Overall Study|Other|1
8007725|NCT00107614|12618012|FG000|Overall Study|Physician Decision|10
8007726|NCT00107614|12618012|FG000|Overall Study|Death|2
8007727|NCT00107315|12618016|FG000|Overall Study|Disease Progression|9
8007728|NCT00107315|12618016|FG000|Overall Study|Adverse Event|4
8007729|NCT00107315|12618016|FG000|Overall Study|Withdrawal by Subject|2
8007730|NCT00108433|12618022|FG000|Overall Study|Lack of Efficacy|1
8007731|NCT00108433|12618023|FG001|Overall Study|Lack of Efficacy|2
8007732|NCT00108433|12618022|FG000|Overall Study|Death|3
8007733|NCT00108433|12618023|FG001|Overall Study|Death|0
8007734|NCT00108433|12618022|FG000|Overall Study|Adverse Event|3
8007735|NCT00108433|12618023|FG001|Overall Study|Adverse Event|1
8007736|NCT00108433|12618022|FG000|Overall Study|Other|14
8007737|NCT00108433|12618023|FG001|Overall Study|Other|14
8007738|NCT00113919|12618029|FG000|Overall Study|Physician Decision|8
8007739|NCT00113919|12618029|FG000|Overall Study|Death|6
8007740|NCT00100828|12618042|FG000|Overall Study|Physician Decision|6
8007741|NCT00104728|12618046|FG000|Overall Study|screen failures|19
8007742|NCT00083915|12618065|FG000|Overall Study|Death|6
8007743|NCT00083915|12618066|FG001|Overall Study|Death|3
8007744|NCT00083915|12618065|FG000|Overall Study|Physician Decision|11
8007745|NCT00083915|12618066|FG001|Overall Study|Physician Decision|6
8007746|NCT00083915|12618065|FG000|Overall Study|Withdrawal by Subject|8
8007747|NCT00083915|12618066|FG001|Overall Study|Withdrawal by Subject|3
8007748|NCT00083915|12618065|FG000|Overall Study|disease progression|18
8007749|NCT00083915|12618066|FG001|Overall Study|disease progression|23
8007750|NCT00083915|12618065|FG000|Overall Study|Failure to collect|3
8007751|NCT00083915|12618066|FG001|Overall Study|Failure to collect|0
8007752|NCT00083915|12618065|FG000|Overall Study|No response|3
8007753|NCT00083915|12618066|FG001|Overall Study|No response|1
8007754|NCT00083915|12618065|FG000|Overall Study|Insurance issues|1
8007755|NCT00083915|12618066|FG001|Overall Study|Insurance issues|1
8007756|NCT00088829|12618085|FG000|Overall Study|PI left institution and study was close|22
8007757|NCT00085631|12618108|FG000|Overall Study|Missing Data|4
8007758|NCT00085631|12618109|FG001|Overall Study|Missing Data|11
8007759|NCT00085631|12618110|FG002|Overall Study|Missing Data|7
8007760|NCT00062751|12618122|FG000|Overall Study|Disease progression|24
8007761|NCT00062751|12618123|FG001|Overall Study|Disease progression|17
8007762|NCT00062751|12618124|FG002|Overall Study|Disease progression|24
8007763|NCT00062751|12618125|FG003|Overall Study|Disease progression|2
8007764|NCT00062751|12618126|FG004|Overall Study|Disease progression|2
8007765|NCT00062751|12618122|FG000|Overall Study|Adverse Event|4
8007766|NCT00062751|12618123|FG001|Overall Study|Adverse Event|7
8007767|NCT00062751|12618124|FG002|Overall Study|Adverse Event|2
8007768|NCT00062751|12618125|FG003|Overall Study|Adverse Event|2
8007769|NCT00062751|12618126|FG004|Overall Study|Adverse Event|2
8007770|NCT00062751|12618122|FG000|Overall Study|Other|2
8007771|NCT00062751|12618123|FG001|Overall Study|Other|3
8007772|NCT00062751|12618124|FG002|Overall Study|Other|1
8007773|NCT00062751|12618125|FG003|Overall Study|Other|0
8007774|NCT00062751|12618126|FG004|Overall Study|Other|1
8007775|NCT00062751|12618122|FG000|Overall Study|Withdrawal by Subject|1
8007776|NCT00062751|12618123|FG001|Overall Study|Withdrawal by Subject|2
8007777|NCT00062751|12618124|FG002|Overall Study|Withdrawal by Subject|2
8007778|NCT00062751|12618125|FG003|Overall Study|Withdrawal by Subject|1
8007779|NCT00062751|12618126|FG004|Overall Study|Withdrawal by Subject|0
8007780|NCT00062751|12618122|FG000|Overall Study|Symptomatic deterioration|1
8007781|NCT00062751|12618123|FG001|Overall Study|Symptomatic deterioration|1
8007782|NCT00062751|12618124|FG002|Overall Study|Symptomatic deterioration|0
8007783|NCT00062751|12618125|FG003|Overall Study|Symptomatic deterioration|0
8007784|NCT00062751|12618126|FG004|Overall Study|Symptomatic deterioration|1
8007785|NCT00062751|12618122|FG000|Overall Study|Death|1
8007786|NCT00062751|12618123|FG001|Overall Study|Death|0
8007787|NCT00062751|12618124|FG002|Overall Study|Death|1
8007788|NCT00062751|12618125|FG003|Overall Study|Death|0
8007789|NCT00062751|12618126|FG004|Overall Study|Death|0
7718457|NCT00528372|12142423|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
7718458|NCT00528372|12142424|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
7718459|NCT00528372|12142425|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
7718460|NCT00528372|12142417|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7718461|NCT00528372|12142418|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7718462|NCT00528372|12142419|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7718463|NCT00528372|12142420|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
7718464|NCT00528372|12142421|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7718465|NCT00528372|12142422|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
7718466|NCT00528372|12142423|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7718467|NCT00528372|12142424|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7718468|NCT00528372|12142425|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7718469|NCT00528372|12142417|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
7718470|NCT00528372|12142418|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7718471|NCT00528372|12142419|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
7718472|NCT00528372|12142420|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7718473|NCT00528372|12142421|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7718474|NCT00528372|12142422|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
7718475|NCT00528372|12142423|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7718476|NCT00528372|12142424|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7718477|NCT00528372|12142425|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7718478|NCT00528372|12142417|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3
7718479|NCT00528372|12142418|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0
7718480|NCT00528372|12142419|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0
7718481|NCT00528372|12142420|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1
7718482|NCT00528372|12142421|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0
7718483|NCT00528372|12142422|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0
7718484|NCT00528372|12142423|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0
7718485|NCT00528372|12142424|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1
7718486|NCT00528372|12142425|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0
7718487|NCT00528372|12142417|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
7718488|NCT00528372|12142418|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
7718489|NCT00528372|12142419|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
7718490|NCT00528372|12142420|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
7718491|NCT00528372|12142421|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
7718492|NCT00528372|12142422|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
7718493|NCT00528372|12142423|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
7718494|NCT00528372|12142424|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
7718495|NCT00528372|12142425|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
7718496|NCT00528372|12142417|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
7718497|NCT00528372|12142418|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
7718498|NCT00528372|12142419|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
7718499|NCT00528372|12142420|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
7718500|NCT00528372|12142421|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
7718501|NCT00528372|12142422|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
7718502|NCT00528372|12142423|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
7718503|NCT00528372|12142424|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
7718504|NCT00528372|12142425|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
7718505|NCT00528372|12142417|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
7718506|NCT00528372|12142418|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
7718507|NCT00528372|12142419|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
7718508|NCT00528372|12142420|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
7718509|NCT00528372|12142421|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
7718510|NCT00528372|12142422|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
7718511|NCT00528372|12142423|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
7718512|NCT00528372|12142424|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
7718513|NCT00528372|12142425|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
7718514|NCT00528372|12142417|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
7718515|NCT00528372|12142418|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
7718516|NCT00528372|12142419|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
7718517|NCT00528372|12142420|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
7718518|NCT00528372|12142421|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
7718519|NCT00528372|12142422|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
7718520|NCT00528372|12142423|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
7718521|NCT00528372|12142424|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
7718522|NCT00528372|12142425|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
7718523|NCT00528372|12142417|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
7718524|NCT00528372|12142418|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
7718525|NCT00528372|12142419|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
7718526|NCT00528372|12142420|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
7718527|NCT00528372|12142421|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
7718528|NCT00528372|12142422|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
7718529|NCT00528372|12142423|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
7718530|NCT00528372|12142424|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
7718531|NCT00528372|12142425|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
7718532|NCT00528372|12142417|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
8007790|NCT00066807|12618141|FG000|Overall Study|Study was terminated early|14
8007791|NCT00066807|12618142|FG001|Overall Study|Study was terminated early|15
8007792|NCT00038142|12618163|FG000|Overall Study|Ineligible|1
8007793|NCT00038142|12618164|FG001|Overall Study|Ineligible|0
8007794|NCT00038142|12618163|FG000|Overall Study|Progressive Disease|11
8007795|NCT00038142|12618164|FG001|Overall Study|Progressive Disease|7
8007796|NCT00038142|12618163|FG000|Overall Study|Death|1
8007797|NCT00038142|12618164|FG001|Overall Study|Death|0
8007798|NCT00038142|12618163|FG000|Overall Study|Adverse Event|1
8007799|NCT00038142|12618164|FG001|Overall Study|Adverse Event|0
8007800|NCT00038142|12618163|FG000|Overall Study|Unknown Reason|8
8007801|NCT00038142|12618164|FG001|Overall Study|Unknown Reason|0
8007802|NCT00006478|12618179|FG000|Overall Study|Vaccine could not be produced|1
8007803|NCT00006478|12618179|FG000|Overall Study|Physician Decision|6
8007804|NCT00006916|12618192|FG000|Overall Study|Device not inserted|4
8007805|NCT00006916|12618192|FG000|Overall Study|Complication of device insertion|1
8007806|NCT02009384|12618266|FG000|Overall Study|Death|2
8007807|NCT04558125|12618270|FG000|Overall Study|Death|1
8007808|NCT02401308|12618276|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0
8007809|NCT02401308|12618277|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1
8007810|NCT04381988|12618285|FG000|Overall Study|The study was terminated|4
8007811|NCT04381988|12618286|FG001|Overall Study|The study was terminated|0
8007812|NCT00479167|12618314|FG000|Overall Study|Withdrawal by Subject|1
8007813|NCT03998189|12618321|FG000|Overall Study|Lack of Efficacy|0
8007814|NCT03998189|12618322|FG001|Overall Study|Lack of Efficacy|1
8007815|NCT02934503|12618436|FG000|Overall Study|progression of disease|3
8007816|NCT02934503|12618436|FG000|Overall Study|Withdrawal by Subject|1
8007817|NCT02137252|12618442|FG000|Overall Study|trial terminated early|2
8007818|NCT02137252|12618443|FG001|Overall Study|trial terminated early|1
8007819|NCT01294670|12618458|FG000|Overall Study|Not treated|1
8007820|NCT01294670|12618459|FG001|Overall Study|Not treated|0
8007821|NCT01294670|12618460|FG002|Overall Study|Not treated|0
8007822|NCT01294670|12618461|FG003|Overall Study|Not treated|0
8007823|NCT01294670|12618462|FG004|Overall Study|Not treated|0
8007824|NCT03095287|12618474|FG000|Overall Study|Treatment Failure|1
8007825|NCT03095287|12618474|FG000|Overall Study|Adverse Event|1
8007826|NCT02930122|12618484|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3
8007827|NCT02930122|12618485|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3
8007828|NCT04144166|12618505|FG000|Overall Study|Discharged before study start|1
8007829|NCT04144166|12618505|FG000|Overall Study|Pregnancy|1
8007830|NCT04144166|12618505|FG000|Overall Study|Nail polish could not be removed from finger|1
8007831|NCT04090164|12618516|FG000|Overall Study|incomplete data on file|245
8007832|NCT04090164|12618517|FG001|Overall Study|incomplete data on file|0
8007833|NCT03997825|12618606|FG000|Overall Study|Death|3
8007834|NCT03997825|12618606|FG000|Overall Study|Lost to Follow-up|10
8007835|NCT03997825|12618606|FG000|Overall Study|Withdrawal by Subject|3
8007836|NCT03997825|12618606|FG000|Overall Study|Refused participation|1
8007837|NCT03764813|12618639|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
8007838|NCT03764813|12618640|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
8007839|NCT03764813|12618641|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
8007840|NCT03764813|12618642|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
8007841|NCT04584788|12618662|FG000|Overall Study|Physician Decision|8
8007842|NCT04584788|12618662|FG000|Overall Study|Withdrawal by Subject|1
8007843|NCT04584788|12618662|FG000|Overall Study|Adverse Event|3
8007935|NCT04377308|12618862|FG000|Overall Study|Withdrawal by Subject|0
8007936|NCT04377308|12618863|FG001|Overall Study|Withdrawal by Subject|1
8007937|NCT04128007|12618888|FG000|Overall Study|Withdrawal by Subject|9
8007938|NCT04128007|12618889|FG001|Overall Study|Withdrawal by Subject|6
8007939|NCT04128007|12618888|FG000|Overall Study|Protocol Violation|1
8007940|NCT04128007|12618889|FG001|Overall Study|Protocol Violation|0
8007941|NCT04128007|12618888|FG000|Overall Study|Lost to Follow-up|8
8007942|NCT04128007|12618889|FG001|Overall Study|Lost to Follow-up|7
8007943|NCT04128007|12618888|FG000|Overall Study|Adverse Event|5
8007944|NCT04128007|12618889|FG001|Overall Study|Adverse Event|2
8007945|NCT04128007|12618888|FG000|Overall Study|Not reported|0
8007946|NCT04128007|12618889|FG001|Overall Study|Not reported|2
8007947|NCT03847896|12618909|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0
8007948|NCT03847896|12618910|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0
8007949|NCT03847896|12618911|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1
8007950|NCT03847896|12618912|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0
8007951|NCT03847896|12618913|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0
8007952|NCT03847896|12618909|FG000|Overall Study|Withdrawal by Subject|2
8007953|NCT03847896|12618910|FG001|Overall Study|Withdrawal by Subject|10
8007954|NCT03847896|12618911|FG002|Overall Study|Withdrawal by Subject|5
8007955|NCT03847896|12618912|FG003|Overall Study|Withdrawal by Subject|9
8007956|NCT03847896|12618913|FG004|Overall Study|Withdrawal by Subject|8
8007957|NCT03847896|12618909|FG000|Overall Study|Withdrawal by parent/guardian|0
8007958|NCT03847896|12618910|FG001|Overall Study|Withdrawal by parent/guardian|0
8007959|NCT03847896|12618911|FG002|Overall Study|Withdrawal by parent/guardian|1
8007960|NCT03847896|12618912|FG003|Overall Study|Withdrawal by parent/guardian|0
8007961|NCT03847896|12618913|FG004|Overall Study|Withdrawal by parent/guardian|0
8007962|NCT03847896|12618909|FG000|Overall Study|Adverse Event|2
8007963|NCT03847896|12618910|FG001|Overall Study|Adverse Event|1
8007964|NCT03847896|12618911|FG002|Overall Study|Adverse Event|3
8007965|NCT03847896|12618912|FG003|Overall Study|Adverse Event|2
8007966|NCT03847896|12618913|FG004|Overall Study|Adverse Event|4
8007967|NCT03847896|12618909|FG000|Overall Study|A severe exacerbation event|0
8007968|NCT03847896|12618910|FG001|Overall Study|A severe exacerbation event|0
8007969|NCT03847896|12618911|FG002|Overall Study|A severe exacerbation event|0
8007970|NCT03847896|12618912|FG003|Overall Study|A severe exacerbation event|0
8007971|NCT03847896|12618913|FG004|Overall Study|A severe exacerbation event|3
8007972|NCT03847896|12618909|FG000|Overall Study|Protocol Violation|0
8007973|NCT03847896|12618910|FG001|Overall Study|Protocol Violation|2
8007974|NCT03847896|12618911|FG002|Overall Study|Protocol Violation|1
8007975|NCT03847896|12618912|FG003|Overall Study|Protocol Violation|0
8007976|NCT03847896|12618913|FG004|Overall Study|Protocol Violation|2
8007977|NCT03847896|12618909|FG000|Overall Study|Lost to Follow-up|0
8007978|NCT03847896|12618910|FG001|Overall Study|Lost to Follow-up|0
8007979|NCT03847896|12618911|FG002|Overall Study|Lost to Follow-up|0
8007980|NCT03847896|12618912|FG003|Overall Study|Lost to Follow-up|1
8007981|NCT03847896|12618913|FG004|Overall Study|Lost to Follow-up|0
8007982|NCT03847896|12618909|FG000|Overall Study|Condition under investigation worsened|0
8007983|NCT03847896|12618910|FG001|Overall Study|Condition under investigation worsened|0
8007984|NCT03847896|12618911|FG002|Overall Study|Condition under investigation worsened|0
8007985|NCT03847896|12618912|FG003|Overall Study|Condition under investigation worsened|1
8007986|NCT03847896|12618913|FG004|Overall Study|Condition under investigation worsened|1
8007987|NCT03847896|12618909|FG000|Overall Study|Lack of Efficacy|0
8007988|NCT03847896|12618910|FG001|Overall Study|Lack of Efficacy|0
8007989|NCT03847896|12618911|FG002|Overall Study|Lack of Efficacy|0
8007990|NCT03847896|12618912|FG003|Overall Study|Lack of Efficacy|2
8007991|NCT03847896|12618913|FG004|Overall Study|Lack of Efficacy|2
8007992|NCT03847896|12618909|FG000|Overall Study|Other reasons|3
8007993|NCT03847896|12618910|FG001|Overall Study|Other reasons|3
8007994|NCT03847896|12618911|FG002|Overall Study|Other reasons|1
8007995|NCT03847896|12618912|FG003|Overall Study|Other reasons|2
8007996|NCT03847896|12618913|FG004|Overall Study|Other reasons|1
8007997|NCT03257631|12618929|FG000|Overall Study|Death|8
8007998|NCT03257631|12618930|FG001|Overall Study|Death|5
8007999|NCT03257631|12618931|FG002|Overall Study|Death|13
8008000|NCT03257631|12618932|FG003|Overall Study|Death|5
8008001|NCT03257631|12618929|FG000|Overall Study|Progressive Disease|0
8008002|NCT03257631|12618930|FG001|Overall Study|Progressive Disease|0
8008003|NCT03257631|12618931|FG002|Overall Study|Progressive Disease|1
8008004|NCT03257631|12618932|FG003|Overall Study|Progressive Disease|0
8008005|NCT03257631|12618929|FG000|Overall Study|Withdrawal by Parent/Guardian|0
8008006|NCT03257631|12618930|FG001|Overall Study|Withdrawal by Parent/Guardian|2
8008007|NCT03257631|12618931|FG002|Overall Study|Withdrawal by Parent/Guardian|4
8008008|NCT03257631|12618932|FG003|Overall Study|Withdrawal by Parent/Guardian|1
8008009|NCT03257631|12618929|FG000|Overall Study|Lost to Follow-up|0
8008010|NCT03257631|12618930|FG001|Overall Study|Lost to Follow-up|0
8008011|NCT03257631|12618931|FG002|Overall Study|Lost to Follow-up|1
8008012|NCT03257631|12618932|FG003|Overall Study|Lost to Follow-up|0
8008013|NCT03257631|12618929|FG000|Overall Study|Still on Study|3
8007844|NCT03783923|12618677|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3
8007845|NCT03783923|12618678|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2
8007846|NCT03783923|12618677|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1
8007847|NCT03783923|12618678|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0
8007848|NCT03783923|12618677|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0
8007849|NCT03783923|12618678|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2
8007850|NCT03783923|12618677|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1
8007851|NCT03783923|12618678|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1
8007852|NCT03783923|12618677|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0
8007853|NCT03783923|12618678|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1
8007854|NCT03718429|12618686|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0
8007855|NCT03718429|12618687|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1
8007856|NCT03718429|12618688|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1
8007857|NCT03718429|12618689|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0
8008014|NCT03257631|12618930|FG001|Overall Study|Still on Study|2
8008015|NCT03257631|12618931|FG002|Overall Study|Still on Study|4
8008016|NCT03257631|12618932|FG003|Overall Study|Still on Study|4
8008017|NCT03164616|12618945|FG000|Overall Study|Death|250
8008018|NCT03164616|12618946|FG001|Overall Study|Death|264
8008019|NCT03164616|12618947|FG002|Overall Study|Death|279
8008020|NCT03164616|12618945|FG000|Overall Study|Lost to Follow-up|2
8008021|NCT03164616|12618946|FG001|Overall Study|Lost to Follow-up|2
8008022|NCT03164616|12618947|FG002|Overall Study|Lost to Follow-up|2
8008023|NCT03164616|12618945|FG000|Overall Study|Withdrawal by Subject|6
8008024|NCT03164616|12618946|FG001|Overall Study|Withdrawal by Subject|7
8008025|NCT03164616|12618947|FG002|Overall Study|Withdrawal by Subject|16
8008026|NCT03093428|12618959|FG000|Overall Study|Not eligible for treatment|2
8008027|NCT03093428|12618960|FG001|Overall Study|Not eligible for treatment|1
8008028|NCT03093428|12618959|FG000|Overall Study|Progression|14
8008029|NCT03093428|12618960|FG001|Overall Study|Progression|4
8008030|NCT03093428|12618959|FG000|Overall Study|Death|1
8008031|NCT03093428|12618960|FG001|Overall Study|Death|0
8008032|NCT03093428|12618959|FG000|Overall Study|Adverse Event|1
8008033|NCT03093428|12618960|FG001|Overall Study|Adverse Event|0
8008034|NCT03093428|12618959|FG000|Overall Study|Withdrawal by Subject|1
8008035|NCT03093428|12618960|FG001|Overall Study|Withdrawal by Subject|1
8008036|NCT03067129|12618970|FG000|Overall Study|Ongoing|45
8008037|NCT03067129|12618971|FG001|Overall Study|Ongoing|28
8008038|NCT03067129|12618972|FG002|Overall Study|Ongoing|27
8008039|NCT03067129|12618973|FG003|Overall Study|Ongoing|23
8008040|NCT03067129|12618970|FG000|Overall Study|Partially dosed; refused to swallow entire dose|0
8008041|NCT03067129|12618971|FG001|Overall Study|Partially dosed; refused to swallow entire dose|0
8008042|NCT03067129|12618972|FG002|Overall Study|Partially dosed; refused to swallow entire dose|0
8008043|NCT03067129|12618973|FG003|Overall Study|Partially dosed; refused to swallow entire dose|1
8008044|NCT02927301|12618991|FG000|Overall Study|Adverse Event|7
8008045|NCT02927301|12618991|FG000|Overall Study|Withdrawal by Subject|1
8008046|NCT02927301|12618991|FG000|Overall Study|Physician Decision|2
8008047|NCT02927262|12618997|FG000|Overall Study|Adverse Event|7
8008048|NCT02927262|12618998|FG001|Overall Study|Adverse Event|1
8008049|NCT02927262|12618997|FG000|Overall Study|Death|1
8008050|NCT02927262|12618998|FG001|Overall Study|Death|0
8008051|NCT02927262|12618997|FG000|Overall Study|Withdrawal by Subject|3
8008052|NCT02927262|12618998|FG001|Overall Study|Withdrawal by Subject|0
8008053|NCT02927262|12618997|FG000|Overall Study|Disease Relapse|23
8008054|NCT02927262|12618998|FG001|Overall Study|Disease Relapse|18
8008055|NCT02927262|12618997|FG000|Overall Study|Miscellaneous|5
8008056|NCT02927262|12618998|FG001|Overall Study|Miscellaneous|4
8008057|NCT02927262|12618997|FG000|Overall Study|Ongoing|4
8008058|NCT02927262|12618998|FG001|Overall Study|Ongoing|0
8008059|NCT02924129|12619006|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2
8008060|NCT02924129|12619007|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1
8008061|NCT02924129|12619006|FG000|Overall Study|Withdrawal by Subject|2
8008062|NCT02924129|12619007|FG001|Overall Study|Withdrawal by Subject|2
8008063|NCT02924129|12619006|FG000|Overall Study|Physician Decision|1
8008064|NCT02924129|12619007|FG001|Overall Study|Physician Decision|0
8008065|NCT02924129|12619006|FG000|Overall Study|Missed Visit|0
8008066|NCT02924129|12619007|FG001|Overall Study|Missed Visit|1
8008067|NCT02574481|12619026|FG000|Overall Study|Withdrawal by Subject|6
8008068|NCT02574481|12619027|FG001|Overall Study|Withdrawal by Subject|4
8008069|NCT02574481|12619028|FG002|Overall Study|Withdrawal by Subject|1
8008070|NCT02574481|12619029|FG003|Overall Study|Withdrawal by Subject|0
8008071|NCT02574481|12619026|FG000|Overall Study|Adverse Event|2
8008072|NCT02574481|12619027|FG001|Overall Study|Adverse Event|0
8008073|NCT02574481|12619028|FG002|Overall Study|Adverse Event|0
8008074|NCT02574481|12619029|FG003|Overall Study|Adverse Event|0
8008075|NCT02574481|12619026|FG000|Overall Study|Visit Missed|12
8008076|NCT02574481|12619027|FG001|Overall Study|Visit Missed|4
8008077|NCT02574481|12619028|FG002|Overall Study|Visit Missed|2
8008078|NCT02574481|12619029|FG003|Overall Study|Visit Missed|0
8008079|NCT02574481|12619026|FG000|Overall Study|Other|1
8008080|NCT02574481|12619027|FG001|Overall Study|Other|0
8008081|NCT02574481|12619028|FG002|Overall Study|Other|0
8008082|NCT02574481|12619029|FG003|Overall Study|Other|0
8007858|NCT03022461|12618727|FG000|Overall Study|Death|3
8007859|NCT02689349|12618738|FG000|Overall Study|Not implanted|4
8007860|NCT02689349|12618739|FG001|Overall Study|Not implanted|0
8007861|NCT02689349|12618738|FG000|Overall Study|Withdrawal by Subject|9
8007862|NCT02689349|12618739|FG001|Overall Study|Withdrawal by Subject|0
8007863|NCT02680574|12618750|FG000|Overall Study|Death|137
8007864|NCT02680574|12618751|FG001|Overall Study|Death|137
8007865|NCT02680574|12618750|FG000|Overall Study|Withdrawal by Subject|17
8007866|NCT02680574|12618751|FG001|Overall Study|Withdrawal by Subject|9
8007867|NCT02680574|12618750|FG000|Overall Study|Lost to Follow-up|4
8007868|NCT02680574|12618751|FG001|Overall Study|Lost to Follow-up|6
8007869|NCT02648347|12618759|FG000|Overall Study|Death|174
8007870|NCT02648347|12618760|FG001|Overall Study|Death|167
8007871|NCT02648347|12618759|FG000|Overall Study|Withdrawal by Subject|16
8007872|NCT02648347|12618760|FG001|Overall Study|Withdrawal by Subject|9
8007873|NCT02648347|12618759|FG000|Overall Study|Lost to Follow-up|18
8007874|NCT02648347|12618760|FG001|Overall Study|Lost to Follow-up|21
8007875|NCT02648347|12618759|FG000|Overall Study|Missing|1
8007876|NCT02648347|12618760|FG001|Overall Study|Missing|0
8007877|NCT02224755|12618781|FG000|Randomization to Device Implant|Withdrawn prior to implant|7
8007878|NCT02224755|12618782|FG001|Randomization to Device Implant|Withdrawn prior to implant|1
8007879|NCT02224755|12618781|FG000|Two Year Follow up Post-implant|Death|103
8007880|NCT02224755|12618782|FG001|Two Year Follow up Post-implant|Death|98
8007881|NCT02224755|12618781|FG000|Two Year Follow up Post-implant|Heart transplant|137
8007882|NCT02224755|12618782|FG001|Two Year Follow up Post-implant|Heart transplant|119
8007883|NCT02224755|12618781|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
8007884|NCT02224755|12618782|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
8007885|NCT02224755|12618781|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15
8007886|NCT02224755|12618782|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6
8007887|NCT02090114|12618802|FG000|Overall Study|Withdrawal by Subject|3
8007888|NCT02090114|12618803|FG001|Overall Study|Withdrawal by Subject|6
8007889|NCT02090114|12618804|FG002|Overall Study|Withdrawal by Subject|2
8007890|NCT02090114|12618805|FG003|Overall Study|Withdrawal by Subject|1
8007891|NCT02090114|12618802|FG000|Overall Study|Physician Decision|5
8007892|NCT02090114|12618803|FG001|Overall Study|Physician Decision|0
8007893|NCT02090114|12618804|FG002|Overall Study|Physician Decision|1
8007894|NCT02090114|12618805|FG003|Overall Study|Physician Decision|1
8007895|NCT02090114|12618802|FG000|Overall Study|Adverse Event|1
8007896|NCT02090114|12618803|FG001|Overall Study|Adverse Event|2
8007897|NCT02090114|12618804|FG002|Overall Study|Adverse Event|2
8007898|NCT02090114|12618805|FG003|Overall Study|Adverse Event|0
8007899|NCT02090114|12618802|FG000|Overall Study|Progressive Disease|20
8007900|NCT02090114|12618803|FG001|Overall Study|Progressive Disease|21
8007901|NCT02090114|12618804|FG002|Overall Study|Progressive Disease|23
8007902|NCT02090114|12618805|FG003|Overall Study|Progressive Disease|6
8007903|NCT02090114|12618802|FG000|Overall Study|Death|1
8007904|NCT02090114|12618803|FG001|Overall Study|Death|0
8007905|NCT02090114|12618804|FG002|Overall Study|Death|1
8007906|NCT02090114|12618805|FG003|Overall Study|Death|0
8007907|NCT00121485|12618826|FG000|Overall Study|Not implanted|1
8007908|NCT00121485|12618827|FG001|Overall Study|Not implanted|5
8007909|NCT00121485|12618826|FG000|Overall Study|Crossover|0
8007910|NCT00121485|12618827|FG001|Overall Study|Crossover|2
8008083|NCT02574481|12619026|FG000|Overall Study|Death|6
8008084|NCT02574481|12619027|FG001|Overall Study|Death|6
8008085|NCT02574481|12619028|FG002|Overall Study|Death|0
8008086|NCT02574481|12619029|FG003|Overall Study|Death|0
8008087|NCT02500121|12619044|FG000|Overall Study|Lost to Follow-up|0
8008088|NCT02500121|12619045|FG001|Overall Study|Lost to Follow-up|1
8008089|NCT02500121|12619044|FG000|Overall Study|Withdrawal by Subject|1
8008090|NCT02500121|12619045|FG001|Overall Study|Withdrawal by Subject|1
8008091|NCT02500121|12619044|FG000|Overall Study|Death|26
8008092|NCT02500121|12619045|FG001|Overall Study|Death|24
8008093|NCT02258451|12619055|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|88
8008094|NCT02258451|12619056|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|95
8008095|NCT02258451|12619055|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|6
8008096|NCT02258451|12619056|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7
8008097|NCT02258451|12619055|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8
8008098|NCT02258451|12619056|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1
8008099|NCT02258451|12619055|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8
8008100|NCT02258451|12619056|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6
8008101|NCT02258451|12619055|FG000|Overall Study|Death|4
8008102|NCT02258451|12619056|FG001|Overall Study|Death|3
8008103|NCT02258451|12619055|FG000|Overall Study|Withdrawal by Subject|21
8008104|NCT02258451|12619056|FG001|Overall Study|Withdrawal by Subject|12
8008105|NCT02258451|12619055|FG000|Overall Study|Discontinuation all treatment due to TS-1 started|1
8008106|NCT02258451|12619056|FG001|Overall Study|Discontinuation all treatment due to TS-1 started|0
8008107|NCT02258451|12619055|FG000|Overall Study|Discontinuation all treatment due to event point reached|1
8007911|NCT00078806|12618842|FG000|Part 1A|Adverse Event|2
8007912|NCT00078806|12618843|FG001|Part 1A|Adverse Event|0
8007913|NCT00078806|12618844|FG002|Part 1A|Adverse Event|0
8007914|NCT00078806|12618845|FG003|Part 1A|Adverse Event|0
8007915|NCT00078806|12618842|FG000|Part 1A|Lack of Efficacy|7
8007916|NCT00078806|12618843|FG001|Part 1A|Lack of Efficacy|0
8007917|NCT00078806|12618844|FG002|Part 1A|Lack of Efficacy|0
8007918|NCT00078806|12618845|FG003|Part 1A|Lack of Efficacy|0
8007919|NCT00078806|12618842|FG000|Part 1A|Other|1
8007920|NCT00078806|12618843|FG001|Part 1A|Other|0
8007921|NCT00078806|12618844|FG002|Part 1A|Other|0
8007922|NCT00078806|12618845|FG003|Part 1A|Other|0
8007923|NCT00078806|12618842|FG000|Part 1B|Adverse Event|1
8007924|NCT00078806|12618843|FG001|Part 1B|Adverse Event|0
8007925|NCT00078806|12618844|FG002|Part 1B|Adverse Event|0
8007926|NCT00078806|12618845|FG003|Part 1B|Adverse Event|0
8007927|NCT00078806|12618842|FG000|Part 1B|Lack of Efficacy|7
8007928|NCT00078806|12618843|FG001|Part 1B|Lack of Efficacy|0
8007929|NCT00078806|12618844|FG002|Part 1B|Lack of Efficacy|0
8007930|NCT00078806|12618845|FG003|Part 1B|Lack of Efficacy|0
8007931|NCT00078806|12618842|FG000|Part 2|Adverse Event|0
8007932|NCT00078806|12618843|FG001|Part 2|Adverse Event|1
8007933|NCT00078806|12618844|FG002|Part 2|Adverse Event|0
8007934|NCT00078806|12618845|FG003|Part 2|Adverse Event|0
8008108|NCT02258451|12619056|FG001|Overall Study|Discontinuation all treatment due to event point reached|1
8008109|NCT02258451|12619055|FG000|Overall Study|Physician Decision|0
8008110|NCT02258451|12619056|FG001|Overall Study|Physician Decision|2
8008111|NCT02258451|12619055|FG000|Overall Study|Never treated|2
8008112|NCT02258451|12619056|FG001|Overall Study|Never treated|3
8008113|NCT02258451|12619055|FG000|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|3
8008114|NCT02258451|12619056|FG001|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|11
8008115|NCT02242942|12619067|FG000|Overall Study|Death|17
8008116|NCT02242942|12619068|FG001|Overall Study|Death|20
8008117|NCT02242942|12619069|FG002|Overall Study|Death|2
8008118|NCT02242942|12619067|FG000|Overall Study|Physician Decision|1
8008119|NCT02242942|12619068|FG001|Overall Study|Physician Decision|0
8008120|NCT02242942|12619069|FG002|Overall Study|Physician Decision|0
8008121|NCT02242942|12619067|FG000|Overall Study|Withdrawal by Subject|8
8008122|NCT02242942|12619068|FG001|Overall Study|Withdrawal by Subject|10
8008123|NCT02242942|12619069|FG002|Overall Study|Withdrawal by Subject|0
8008124|NCT02242942|12619067|FG000|Overall Study|On-going in Study|190
8008125|NCT02242942|12619068|FG001|Overall Study|On-going in Study|186
8008126|NCT02242942|12619069|FG002|Overall Study|On-going in Study|11
8008127|NCT02184156|12619082|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0
8008128|NCT02184156|12619083|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1
8008129|NCT02184156|12619082|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1
8008130|NCT02184156|12619083|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0
8008131|NCT02158091|12619096|FG000|Overall Study|DLT|2
8008132|NCT02158091|12619097|FG001|Overall Study|DLT|1
8008133|NCT02158091|12619098|FG002|Overall Study|DLT|0
8008134|NCT02005471|12619117|FG000|Overall Study|Ongoing in Study|144
8008135|NCT02005471|12619118|FG001|Overall Study|Ongoing in Study|171
8008136|NCT02005471|12619117|FG000|Overall Study|Adverse Event|1
8008137|NCT02005471|12619118|FG001|Overall Study|Adverse Event|0
8008138|NCT02005471|12619117|FG000|Overall Study|Death|26
8008139|NCT02005471|12619118|FG001|Overall Study|Death|15
8008140|NCT02005471|12619117|FG000|Overall Study|Lost to Follow-up|1
8008141|NCT02005471|12619118|FG001|Overall Study|Lost to Follow-up|0
8008142|NCT02005471|12619117|FG000|Overall Study|Physician Decision|2
8008143|NCT02005471|12619118|FG001|Overall Study|Physician Decision|1
8008144|NCT02005471|12619117|FG000|Overall Study|Progressive Disease|3
8008145|NCT02005471|12619118|FG001|Overall Study|Progressive Disease|0
8008146|NCT02005471|12619117|FG000|Overall Study|Withdrawal by Subject|18
8008147|NCT02005471|12619118|FG001|Overall Study|Withdrawal by Subject|7
8008148|NCT01946139|12619127|FG000|Overall Study|Withdrawal by Subject|8
8008149|NCT01946139|12619127|FG000|Overall Study|ineligible|8
8008150|NCT01946139|12619127|FG000|Overall Study|Specimens not available|4
8008151|NCT01828099|12619133|FG000|Overall Study|Adverse Event|15
8008152|NCT01828099|12619134|FG001|Overall Study|Adverse Event|18
8008153|NCT01828099|12619133|FG000|Overall Study|Death|9
8008154|NCT01828099|12619134|FG001|Overall Study|Death|11
8008155|NCT01828099|12619133|FG000|Overall Study|Lost to Follow-up|2
8008156|NCT01828099|12619134|FG001|Overall Study|Lost to Follow-up|0
8008157|NCT01828099|12619133|FG000|Overall Study|Non-compliance with study treatment|2
8008158|NCT01828099|12619134|FG001|Overall Study|Non-compliance with study treatment|0
8008159|NCT01828099|12619133|FG000|Overall Study|Physician Decision|7
8008160|NCT01828099|12619134|FG001|Overall Study|Physician Decision|11
8008161|NCT01828099|12619133|FG000|Overall Study|Progressive disease|51
8008162|NCT01828099|12619134|FG001|Overall Study|Progressive disease|94
8008163|NCT01828099|12619133|FG000|Overall Study|Protocol Violation|1
8008164|NCT01828099|12619134|FG001|Overall Study|Protocol Violation|0
8008165|NCT01828099|12619133|FG000|Overall Study|Subject/guardian decision|7
8008166|NCT01828099|12619134|FG001|Overall Study|Subject/guardian decision|23
8008167|NCT01593254|12619142|FG000|Treatment Period|Treatment Failure|1
8008168|NCT01593254|12619143|FG001|Treatment Period|Treatment Failure|2
8008169|NCT01593254|12619142|FG000|Treatment Period|Pregnancy|0
8008170|NCT01593254|12619143|FG001|Treatment Period|Pregnancy|1
8008171|NCT01593254|12619142|FG000|Treatment Period|Poor/Non-Compliance|2
8008172|NCT01593254|12619143|FG001|Treatment Period|Poor/Non-Compliance|1
8008173|NCT01593254|12619142|FG000|Treatment Period|Maximum clinical benefit|1
8008174|NCT01593254|12619143|FG001|Treatment Period|Maximum clinical benefit|0
8008175|NCT01593254|12619142|FG000|Treatment Period|Subject withdrew consent|0
8008176|NCT01593254|12619143|FG001|Treatment Period|Subject withdrew consent|5
8008177|NCT01593254|12619142|FG000|Treatment Period|Subject Request to Discontinue|1
8008178|NCT01593254|12619143|FG001|Treatment Period|Subject Request to Discontinue|1
8008179|NCT01593254|12619142|FG000|Treatment Period|AE unrelated to Study Drug|0
8008180|NCT01593254|12619143|FG001|Treatment Period|AE unrelated to Study Drug|1
8008181|NCT01593254|12619142|FG000|Treatment Period|Death|2
8008182|NCT01593254|12619143|FG001|Treatment Period|Death|1
8008183|NCT01593254|12619142|FG000|Treatment Period|Study Drug Toxicity|3
8008184|NCT01593254|12619143|FG001|Treatment Period|Study Drug Toxicity|9
8008185|NCT01593254|12619142|FG000|Treatment Period|Disease Progression|1
8008186|NCT01593254|12619143|FG001|Treatment Period|Disease Progression|6
8008187|NCT01593254|12619142|FG000|Treatment Period|Did Not Achieve RCC|0
8008188|NCT01593254|12619143|FG001|Treatment Period|Did Not Achieve RCC|1
8008189|NCT01593254|12619142|FG000|Treatment Period|Patient Refused to Return|0
8008190|NCT01593254|12619143|FG001|Treatment Period|Patient Refused to Return|1
8008191|NCT01593254|12619142|FG000|Treatment Period|No Response|1
8008192|NCT01593254|12619143|FG001|Treatment Period|No Response|0
8008193|NCT01593254|12619142|FG000|Treatment Period|T315I MUTATION|0
8008194|NCT01593254|12619143|FG001|Treatment Period|T315I MUTATION|1
8008195|NCT01593254|12619142|FG000|Treatment Period|Investigator Decision|2
8008196|NCT01593254|12619143|FG001|Treatment Period|Investigator Decision|1
8008197|NCT01593254|12619142|FG000|Follow-Up Period|Withdrawal by Subject|0
8008198|NCT01593254|12619143|FG001|Follow-Up Period|Withdrawal by Subject|2
8008199|NCT01593254|12619142|FG000|Follow-Up Period|Non-Compliance|1
8008200|NCT01593254|12619143|FG001|Follow-Up Period|Non-Compliance|0
8008201|NCT01593254|12619142|FG000|Follow-Up Period|Death|2
8008202|NCT01593254|12619143|FG001|Follow-Up Period|Death|2
8008203|NCT01593254|12619142|FG000|Follow-Up Period|Subject request to Discontinue|0
8008204|NCT01593254|12619143|FG001|Follow-Up Period|Subject request to Discontinue|1
8008205|NCT01593254|12619142|FG000|Follow-Up Period|Pregnancy|0
8008206|NCT01593254|12619143|FG001|Follow-Up Period|Pregnancy|1
8008207|NCT01593254|12619142|FG000|Follow-Up Period|Study Drug Toxicity|0
8008208|NCT01593254|12619143|FG001|Follow-Up Period|Study Drug Toxicity|1
8008209|NCT01593254|12619142|FG000|Follow-Up Period|Patient refused to return|0
8008210|NCT01593254|12619143|FG001|Follow-Up Period|Patient refused to return|1
8008211|NCT01593254|12619142|FG000|Follow-Up Period|Fundus Hemorrhage|0
8008212|NCT01593254|12619143|FG001|Follow-Up Period|Fundus Hemorrhage|1
8008213|NCT01593254|12619142|FG000|Follow-Up Period|Disease Progression|0
8008214|NCT01593254|12619143|FG001|Follow-Up Period|Disease Progression|1
8008215|NCT01593254|12619142|FG000|Follow-Up Period|Study Drug Side Effects|0
8008216|NCT01593254|12619143|FG001|Follow-Up Period|Study Drug Side Effects|1
8008217|NCT01574274|12619152|FG000|Overall Study|Ineligible|0
8008218|NCT01574274|12619153|FG001|Overall Study|Ineligible|1
8008219|NCT01574274|12619152|FG000|Overall Study|Withdrawal of Consent During Induction|1
8008220|NCT01574274|12619153|FG001|Overall Study|Withdrawal of Consent During Induction|1
8008221|NCT01574274|12619152|FG000|Overall Study|Ph+ B-ALL|3
8008222|NCT01574274|12619153|FG001|Overall Study|Ph+ B-ALL|4
8008223|NCT01574274|12619152|FG000|Overall Study|Induction Death|2
8008224|NCT01574274|12619153|FG001|Overall Study|Induction Death|0
8008225|NCT01574274|12619152|FG000|Overall Study|Induction Failure|4
8008226|NCT01574274|12619153|FG001|Overall Study|Induction Failure|1
8008227|NCT01574274|12619152|FG000|Overall Study|Adverse Event|16
8008228|NCT01574274|12619153|FG001|Overall Study|Adverse Event|13
8008229|NCT01574274|12619152|FG000|Overall Study|Remission Death|1
8008230|NCT01574274|12619153|FG001|Overall Study|Remission Death|0
8008231|NCT01574274|12619152|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2
8008232|NCT01574274|12619153|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0
8008233|NCT01574274|12619152|FG000|Overall Study|Other, unknown|3
8008234|NCT01574274|12619153|FG001|Overall Study|Other, unknown|2
8008235|NCT01335399|12619161|FG000|Pre-treatment Period|No longer meeting study criteria|0
8008236|NCT01335399|12619162|FG001|Pre-treatment Period|No longer meeting study criteria|1
8008237|NCT01335399|12619161|FG000|Pre-treatment Period|Participant request to discontinue|0
8008238|NCT01335399|12619162|FG001|Pre-treatment Period|Participant request to discontinue|1
8008239|NCT01335399|12619161|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0
8008240|NCT01335399|12619162|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1
8008241|NCT01335399|12619161|FG000|Pre-treatment Period|Consent withdrawal|3
8008242|NCT01335399|12619162|FG001|Pre-treatment Period|Consent withdrawal|0
8008243|NCT01335399|12619161|FG000|Treatment Period|Disease progression|117
8008244|NCT01335399|12619162|FG001|Treatment Period|Disease progression|145
8008245|NCT01335399|12619161|FG000|Treatment Period|Adverse event unrelated to study drug|110
8008246|NCT01335399|12619162|FG001|Treatment Period|Adverse event unrelated to study drug|73
8008247|NCT01335399|12619161|FG000|Treatment Period|Study drug toxicity|52
8008248|NCT01335399|12619162|FG001|Treatment Period|Study drug toxicity|64
8008249|NCT01335399|12619161|FG000|Treatment Period|Participant request to discontinue|30
8008250|NCT01335399|12619162|FG001|Treatment Period|Participant request to discontinue|22
8008251|NCT01335399|12619161|FG000|Treatment Period|Other reasons|30
8008252|NCT01335399|12619162|FG001|Treatment Period|Other reasons|30
8008253|NCT01335399|12619161|FG000|Treatment Period|Consent withdrawal|10
8008254|NCT01335399|12619162|FG001|Treatment Period|Consent withdrawal|7
8008255|NCT01335399|12619161|FG000|Treatment Period|Death|7
8008256|NCT01335399|12619162|FG001|Treatment Period|Death|6
8008257|NCT01335399|12619161|FG000|Treatment Period|Poor/Non-compliance|3
8008258|NCT01335399|12619162|FG001|Treatment Period|Poor/Non-compliance|4
8008259|NCT01335399|12619161|FG000|Treatment Period|Lost to Follow-up|2
8008260|NCT01335399|12619162|FG001|Treatment Period|Lost to Follow-up|2
8008261|NCT01335399|12619161|FG000|Treatment Period|Maximum clinical benefit|1
8008262|NCT01335399|12619162|FG001|Treatment Period|Maximum clinical benefit|1
8008263|NCT01335399|12619161|FG000|Treatment Period|No longer meet study criteria|1
8008264|NCT01335399|12619162|FG001|Treatment Period|No longer meet study criteria|1
8008265|NCT01335399|12619161|FG000|Treatment Period|Administrative reasons by Sponsor|8
8008266|NCT01335399|12619162|FG001|Treatment Period|Administrative reasons by Sponsor|16
8008267|NCT01036087|12619168|FG000|Overall Study|Adverse Event|2
8008268|NCT01036087|12619168|FG000|Overall Study|Lack of Efficacy|1
8008269|NCT00608023|12619175|FG000|Overall Study|Withdrawal by Subject|8
8008270|NCT00608023|12619176|FG001|Overall Study|Withdrawal by Subject|10
8008271|NCT00608023|12619177|FG002|Overall Study|Withdrawal by Subject|7
8008272|NCT00608023|12619175|FG000|Overall Study|Adverse Event|1
8008273|NCT00608023|12619176|FG001|Overall Study|Adverse Event|4
8008274|NCT00608023|12619177|FG002|Overall Study|Adverse Event|5
8008275|NCT00608023|12619175|FG000|Overall Study|Lost to Follow-up|2
8008276|NCT00608023|12619176|FG001|Overall Study|Lost to Follow-up|2
8008277|NCT00608023|12619177|FG002|Overall Study|Lost to Follow-up|1
8008278|NCT00608023|12619175|FG000|Overall Study|Protocol Violation|1
8008279|NCT00608023|12619176|FG001|Overall Study|Protocol Violation|3
8008280|NCT00608023|12619177|FG002|Overall Study|Protocol Violation|1
8008281|NCT00608023|12619175|FG000|Overall Study|Unknown reason|0
8008282|NCT00608023|12619176|FG001|Overall Study|Unknown reason|3
8008283|NCT00608023|12619177|FG002|Overall Study|Unknown reason|0
7718533|NCT00528372|12142418|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7718534|NCT00528372|12142419|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7718535|NCT00528372|12142420|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7718536|NCT00528372|12142421|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
7718537|NCT00528372|12142422|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
7718538|NCT00528372|12142423|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7718539|NCT00528372|12142424|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7718540|NCT00528372|12142425|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7718541|NCT00528372|12142417|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7718542|NCT00528372|12142418|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
7767826|NCT00856245|12210617|FG000|Overall Study|Was not transplanted|5
7718543|NCT00528372|12142419|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7718544|NCT00528372|12142420|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7718545|NCT00528372|12142421|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7718546|NCT00528372|12142422|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7718547|NCT00528372|12142423|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
7718548|NCT00528372|12142424|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7718549|NCT00528372|12142425|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
7718550|NCT00528372|12142417|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2
7718551|NCT00528372|12142418|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2
7718552|NCT00528372|12142419|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1
7718553|NCT00528372|12142420|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2
7718554|NCT00528372|12142421|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3
7718555|NCT00528372|12142422|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0
7718556|NCT00528372|12142423|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3
7718557|NCT00528372|12142424|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1
7718558|NCT00528372|12142425|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0
7718559|NCT00528411|12142478|FG000|Overall Study|Adverse Event|4
7718560|NCT00528411|12142479|FG001|Overall Study|Adverse Event|0
7718561|NCT00528411|12142480|FG002|Overall Study|Adverse Event|1
7718562|NCT00528411|12142478|FG000|Overall Study|Incorrect Enrolment|1
7718563|NCT00528411|12142479|FG001|Overall Study|Incorrect Enrolment|1
7718564|NCT00528411|12142480|FG002|Overall Study|Incorrect Enrolment|0
7718565|NCT00528411|12142478|FG000|Overall Study|Severe non-compliance to protocol|0
7907610|NCT02020941|12422430|FG000|Overall Study|Adverse Event|1
7907611|NCT02020941|12422430|FG000|Overall Study|Physician Decision|2
7907612|NCT02020941|12422430|FG000|Overall Study|Withdrawal by Subject|1
7907613|NCT02020941|12422430|FG000|Overall Study|Disease Progression|4
7907614|NCT02020967|12422436|FG000|Overall Study|Withdrawal by Subject|51
7907615|NCT02021292|12422444|FG000|Overall Study|Physician Decision|0
7907616|NCT02021292|12422445|FG001|Overall Study|Physician Decision|1
7907617|NCT02021292|12422444|FG000|Overall Study|Lost to Follow-up|0
7907618|NCT02021292|12422445|FG001|Overall Study|Lost to Follow-up|1
7907619|NCT02021292|12422444|FG000|Overall Study|Death|0
7907620|NCT02021292|12422445|FG001|Overall Study|Death|1
7907621|NCT02021318|12422455|FG000|Overall Study|Adverse Event|2
7907622|NCT02021318|12422456|FG001|Overall Study|Adverse Event|1
7907623|NCT02021318|12422455|FG000|Overall Study|Death|33
7907624|NCT02021318|12422456|FG001|Overall Study|Death|34
7811456|NCT01183013|12275236|FG003|Overall Study|Adverse Event|5
7811457|NCT01183013|12275237|FG004|Overall Study|Adverse Event|10
7718566|NCT00528411|12142479|FG001|Overall Study|Severe non-compliance to protocol|1
7718567|NCT00528411|12142480|FG002|Overall Study|Severe non-compliance to protocol|0
7718568|NCT00528411|12142478|FG000|Overall Study|Prior commitment medication|0
7718569|NCT00528411|12142479|FG001|Overall Study|Prior commitment medication|1
7718570|NCT00528411|12142480|FG002|Overall Study|Prior commitment medication|0
7718571|NCT00528424|12142488|FG000|Overall Study|Lost to Follow-up|13
7718572|NCT00528424|12142488|FG000|Overall Study|Withdrew consent|2
7718573|NCT00528424|12142488|FG000|Overall Study|Administrative reason|2
7718574|NCT00528424|12142488|FG000|Overall Study|Other|12
7718575|NCT00528528|12142500|FG000|Overall Study|Lost to Follow-up|0
7718576|NCT00528528|12142501|FG001|Overall Study|Lost to Follow-up|0
7718577|NCT00528528|12142502|FG002|Overall Study|Lost to Follow-up|1
7718578|NCT00528528|12142503|FG003|Overall Study|Lost to Follow-up|1
7718579|NCT00528528|12142500|FG000|Overall Study|Ineligible to continue the trial|0
7718580|NCT00528528|12142501|FG001|Overall Study|Ineligible to continue the trial|0
7718581|NCT00528528|12142502|FG002|Overall Study|Ineligible to continue the trial|0
7718582|NCT00528528|12142503|FG003|Overall Study|Ineligible to continue the trial|1
7718583|NCT00528528|12142500|FG000|Overall Study|Other|0
7718584|NCT00528528|12142501|FG001|Overall Study|Other|1
7718585|NCT00528528|12142502|FG002|Overall Study|Other|0
7718586|NCT00528528|12142503|FG003|Overall Study|Other|0
7718587|NCT00528528|12142500|FG000|Overall Study|Withdrawal by Subject|3
7718588|NCT00528528|12142501|FG001|Overall Study|Withdrawal by Subject|2
7718589|NCT00528528|12142502|FG002|Overall Study|Withdrawal by Subject|1
7718590|NCT00528528|12142503|FG003|Overall Study|Withdrawal by Subject|1
7718591|NCT00528528|12142500|FG000|Overall Study|Ongoing participant|0
7718592|NCT00528528|12142501|FG001|Overall Study|Ongoing participant|0
7718593|NCT00528528|12142502|FG002|Overall Study|Ongoing participant|1
7718594|NCT00528528|12142503|FG003|Overall Study|Ongoing participant|0
7718595|NCT00528567|12142526|FG000|Overall Study|Death|4
7718596|NCT00528567|12142527|FG001|Overall Study|Death|5
7718597|NCT00528567|12142526|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30
7718598|NCT00528567|12142527|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60
7718599|NCT00528567|12142526|FG000|Overall Study|Adverse Event/Intermittent Illness|255
7718600|NCT00528567|12142527|FG001|Overall Study|Adverse Event/Intermittent Illness|29
7718601|NCT00528567|12142526|FG000|Overall Study|Violation Criteria at Entry|3
7718602|NCT00528567|12142527|FG001|Overall Study|Violation Criteria at Entry|17
7718603|NCT00528567|12142526|FG000|Overall Study|Withdrew Consent|59
7718604|NCT00528567|12142527|FG001|Overall Study|Withdrew Consent|55
7718605|NCT00528567|12142526|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52
7718606|NCT00528567|12142527|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42
7718607|NCT00528567|12142526|FG000|Overall Study|Failure to Return|1
7718608|NCT00528567|12142527|FG001|Overall Study|Failure to Return|4
7718609|NCT00528567|12142526|FG000|Overall Study|Other Protocol Violation|5
7718610|NCT00528567|12142527|FG001|Overall Study|Other Protocol Violation|21
7718611|NCT00528567|12142526|FG000|Overall Study|Administrative/Other|22
7718612|NCT00528567|12142527|FG001|Overall Study|Administrative/Other|75
7718613|NCT00528606|12142551|FG000|Overall Study|Withdrew consent|4
7718614|NCT00528606|12142552|FG001|Overall Study|Withdrew consent|3
7718615|NCT00528606|12142551|FG000|Overall Study|Lost to Follow-up|4
7718616|NCT00528606|12142552|FG001|Overall Study|Lost to Follow-up|1
7718617|NCT00528606|12142551|FG000|Overall Study|Adverse Event|3
7718618|NCT00528606|12142552|FG001|Overall Study|Adverse Event|0
7718619|NCT00528606|12142551|FG000|Overall Study|Other|2
7718620|NCT00528606|12142552|FG001|Overall Study|Other|0
7718621|NCT00528645|12142558|FG000|Overall Study|Adverse Event|3
7718622|NCT00528801|12142569|FG000|Overall Study|Withdrawal by Subject|1
7718623|NCT00528801|12142570|FG001|Overall Study|Withdrawal by Subject|1
7718624|NCT00528801|12142569|FG000|Overall Study|Protocol Violation|11
7718625|NCT00528801|12142570|FG001|Overall Study|Protocol Violation|5
7718626|NCT00528801|12142569|FG000|Overall Study|Lost to Follow-up|15
7718627|NCT00528801|12142570|FG001|Overall Study|Lost to Follow-up|4
7718628|NCT00528801|12142569|FG000|Overall Study|Administrative Reasons|0
7718629|NCT00528801|12142570|FG001|Overall Study|Administrative Reasons|1
7718630|NCT00528840|12142576|FG000|Overall Study|Lost to Follow-up|10
7718631|NCT00528840|12142576|FG000|Overall Study|Adverse Event|1
7718632|NCT00528840|12142576|FG000|Overall Study|Withdrawal by Subject|17
7718633|NCT00528840|12142576|FG000|Overall Study|Death|2
7718634|NCT00528840|12142576|FG000|Overall Study|Administrative Reasons|1
7718635|NCT00528840|12142576|FG000|Overall Study|Other|2
7718636|NCT00528866|12142580|FG000|Overall Study|Protocol Violation|6
7718637|NCT00528879|12142589|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
7718638|NCT00528879|12142590|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
7718639|NCT00528879|12142591|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
7718640|NCT00528879|12142592|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
7718641|NCT00528879|12142589|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4
7718642|NCT00528879|12142590|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4
7718643|NCT00528879|12142591|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2
7718644|NCT00528879|12142592|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4
7718645|NCT00528879|12142589|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
7718646|NCT00528879|12142590|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
7718647|NCT00528879|12142591|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
7718648|NCT00528879|12142592|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
7718649|NCT00528879|12142589|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
7718650|NCT00528879|12142590|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
7718651|NCT00528879|12142591|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
7767827|NCT00856284|12210624|FG000|Overall Study|Hyperglycemic rescue|231
7718652|NCT00528879|12142592|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
7718653|NCT00528879|12142589|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
7718654|NCT00528879|12142590|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
7718655|NCT00528879|12142591|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
7718656|NCT00528879|12142592|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
7718657|NCT00528879|12142589|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
7718658|NCT00528879|12142590|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
7718659|NCT00528879|12142591|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
7718660|NCT00528879|12142592|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
7767828|NCT00856284|12210625|FG001|Overall Study|Hyperglycemic rescue|201
7718661|NCT00528879|12142589|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
7718662|NCT00528879|12142590|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
7718663|NCT00528879|12142591|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
7718664|NCT00528879|12142592|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
7718665|NCT00528879|12142589|FG000|Short-term Period (Day 1 to Week 24)|Other|0
7718666|NCT00528879|12142590|FG001|Short-term Period (Day 1 to Week 24)|Other|0
7718667|NCT00528879|12142591|FG002|Short-term Period (Day 1 to Week 24)|Other|1
7718668|NCT00528879|12142592|FG003|Short-term Period (Day 1 to Week 24)|Other|1
7718669|NCT00528879|12142589|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
7718670|NCT00528879|12142590|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
7718671|NCT00528879|12142591|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
7718672|NCT00528879|12142592|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
7718673|NCT00528879|12142589|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5
7718674|NCT00528879|12142590|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4
7718675|NCT00528879|12142591|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3
7718676|NCT00528879|12142592|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2
7718677|NCT00528879|12142589|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
7718678|NCT00528879|12142590|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
7718679|NCT00528879|12142591|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
7718680|NCT00528879|12142592|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
7718681|NCT00528879|12142589|FG000|Long-term Period (Weeks 24 to 102)|Death|0
7718682|NCT00528879|12142590|FG001|Long-term Period (Weeks 24 to 102)|Death|1
7718683|NCT00528879|12142591|FG002|Long-term Period (Weeks 24 to 102)|Death|0
7718684|NCT00528879|12142592|FG003|Long-term Period (Weeks 24 to 102)|Death|0
7718685|NCT00528879|12142589|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
7718686|NCT00528879|12142590|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
7718687|NCT00528879|12142591|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
7718688|NCT00528879|12142592|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
7718689|NCT00528879|12142589|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
7718690|NCT00528879|12142590|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
7718691|NCT00528879|12142591|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
7718692|NCT00528879|12142592|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
7718693|NCT00528879|12142589|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1
7718694|NCT00528879|12142590|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0
7718695|NCT00528879|12142591|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0
7718696|NCT00528879|12142592|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0
7718697|NCT00528879|12142589|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
7718698|NCT00528879|12142590|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
7718699|NCT00528879|12142591|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
7718700|NCT00528879|12142592|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
7718701|NCT00528931|12142602|FG000|Overall Study|Lost to Follow-up|1
7718702|NCT00528957|12142609|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
7718703|NCT00528957|12142610|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
7718704|NCT00528957|12142609|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
7718705|NCT00528957|12142610|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
7718706|NCT00528957|12142609|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
7718707|NCT00528957|12142610|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
7718708|NCT00528957|12142609|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
7718709|NCT00528957|12142610|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
7718710|NCT00528957|12142609|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0
7718711|NCT00528957|12142610|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1
7718712|NCT00528957|12142609|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
7718713|NCT00528957|12142610|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
7718714|NCT00528957|12142609|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
7718715|NCT00528957|12142610|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
7718716|NCT00528957|12142609|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
7718717|NCT00528957|12142610|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
7718718|NCT00528957|12142609|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
7718719|NCT00528957|12142610|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
7718720|NCT00528957|12142609|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
7718721|NCT00528957|12142610|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
7718722|NCT00528957|12142609|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
7718723|NCT00528957|12142610|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
7718724|NCT00528957|12142609|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
7718725|NCT00528957|12142610|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
7718726|NCT00528957|12142609|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
7718727|NCT00528957|12142610|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
7718728|NCT00528957|12142609|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
7718729|NCT00528957|12142610|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
7718730|NCT00528957|12142609|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
7718731|NCT00528957|12142610|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
7718732|NCT00528957|12142609|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
7718733|NCT00528957|12142610|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
7718734|NCT00528970|12142629|FG000|Overall Study|Adverse Event|6
7718735|NCT00528970|12142630|FG001|Overall Study|Adverse Event|8
7718736|NCT00528970|12142631|FG002|Overall Study|Adverse Event|5
7718737|NCT00528970|12142629|FG000|Overall Study|Lost to Follow-up|0
7718738|NCT00528970|12142630|FG001|Overall Study|Lost to Follow-up|0
7718739|NCT00528970|12142631|FG002|Overall Study|Lost to Follow-up|1
7718740|NCT00528970|12142629|FG000|Overall Study|Other than specified|2
7718741|NCT00528970|12142630|FG001|Overall Study|Other than specified|3
7718742|NCT00528970|12142631|FG002|Overall Study|Other than specified|3
7718743|NCT00528970|12142629|FG000|Overall Study|Protocol Violation|2
7718744|NCT00528970|12142630|FG001|Overall Study|Protocol Violation|1
7718745|NCT00528970|12142631|FG002|Overall Study|Protocol Violation|4
7718746|NCT00528970|12142629|FG000|Overall Study|Lack of Efficacy|0
7718747|NCT00528970|12142630|FG001|Overall Study|Lack of Efficacy|0
7718748|NCT00528970|12142631|FG002|Overall Study|Lack of Efficacy|1
7718749|NCT00528970|12142629|FG000|Overall Study|Withdrawal by Subject|4
7718750|NCT00528970|12142630|FG001|Overall Study|Withdrawal by Subject|3
7718751|NCT00528970|12142631|FG002|Overall Study|Withdrawal by Subject|5
7718752|NCT00528970|12142629|FG000|Overall Study|Randomized but not treated|0
7811458|NCT01183013|12275238|FG005|Overall Study|Adverse Event|10
7907625|NCT02021318|12422455|FG000|Overall Study|Lost to Follow-up|3
7907626|NCT02021318|12422456|FG001|Overall Study|Lost to Follow-up|3
7907627|NCT02021318|12422455|FG000|Overall Study|Progressive Disease|0
7907628|NCT02021318|12422456|FG001|Overall Study|Progressive Disease|1
7907629|NCT02021318|12422455|FG000|Overall Study|Withdrawal by Subject|30
7907630|NCT02021318|12422456|FG001|Overall Study|Withdrawal by Subject|18
7907631|NCT02021318|12422455|FG000|Overall Study|Physician Decision|3
7907632|NCT02021318|12422456|FG001|Overall Study|Physician Decision|3
7907633|NCT02021318|12422455|FG000|Overall Study|Miscellaneous|2
7907634|NCT02021318|12422456|FG001|Overall Study|Miscellaneous|3
7907635|NCT02021331|12422465|FG000|Overall Study|Adverse Event|0
7907636|NCT02021331|12422466|FG001|Overall Study|Adverse Event|2
7907637|NCT02021565|12422480|FG000|Baseline Through Intervention|Death|0
7907638|NCT02021565|12422481|FG001|Baseline Through Intervention|Death|1
7907639|NCT02021565|12422480|FG000|Baseline Through Intervention|Withdrawal by Subject|8
7907640|NCT02021565|12422481|FG001|Baseline Through Intervention|Withdrawal by Subject|8
7907641|NCT02021565|12422480|FG000|Baseline Through Intervention|Protocol Violation|0
7907642|NCT02021565|12422481|FG001|Baseline Through Intervention|Protocol Violation|7
7907643|NCT02021565|12422480|FG000|Baseline Through Intervention|Lost to Follow-up|4
7718753|NCT00528970|12142630|FG001|Overall Study|Randomized but not treated|0
7718754|NCT00528970|12142631|FG002|Overall Study|Randomized but not treated|1
7718755|NCT00528996|12142644|FG000|Overall Study|Other reasons than listing|6
7718756|NCT00528996|12142645|FG001|Overall Study|Other reasons than listing|7
7718757|NCT00528996|12142646|FG002|Overall Study|Other reasons than listing|14
7718758|NCT00528996|12142647|FG003|Overall Study|Other reasons than listing|11
7718759|NCT00528996|12142648|FG004|Overall Study|Other reasons than listing|5
7718760|NCT00528996|12142644|FG000|Overall Study|Refused continue medication|16
7718761|NCT00528996|12142645|FG001|Overall Study|Refused continue medication|0
7718762|NCT00528996|12142646|FG002|Overall Study|Refused continue medication|3
7718763|NCT00528996|12142647|FG003|Overall Study|Refused continue medication|3
7718764|NCT00528996|12142648|FG004|Overall Study|Refused continue medication|6
7718765|NCT00528996|12142644|FG000|Overall Study|Lost to Follow-up|2
7718766|NCT00528996|12142645|FG001|Overall Study|Lost to Follow-up|0
7718767|NCT00528996|12142646|FG002|Overall Study|Lost to Follow-up|4
7718768|NCT00528996|12142647|FG003|Overall Study|Lost to Follow-up|1
7718769|NCT00528996|12142648|FG004|Overall Study|Lost to Follow-up|3
7718770|NCT00528996|12142644|FG000|Overall Study|Protocol Violation|1
7907644|NCT02021565|12422481|FG001|Baseline Through Intervention|Lost to Follow-up|2
7907645|NCT02021565|12422480|FG000|3-month Follow-up|Death|3
7718771|NCT00528996|12142645|FG001|Overall Study|Protocol Violation|2
7718772|NCT00528996|12142646|FG002|Overall Study|Protocol Violation|3
7718773|NCT00528996|12142647|FG003|Overall Study|Protocol Violation|3
7718774|NCT00528996|12142648|FG004|Overall Study|Protocol Violation|2
7718775|NCT00528996|12142644|FG000|Overall Study|Lack of Efficacy|7
7718776|NCT00528996|12142645|FG001|Overall Study|Lack of Efficacy|2
7718777|NCT00528996|12142646|FG002|Overall Study|Lack of Efficacy|1
7718778|NCT00528996|12142647|FG003|Overall Study|Lack of Efficacy|3
7718779|NCT00528996|12142648|FG004|Overall Study|Lack of Efficacy|3
7718780|NCT00528996|12142644|FG000|Overall Study|Adverse Event|32
7718781|NCT00528996|12142645|FG001|Overall Study|Adverse Event|13
7718782|NCT00528996|12142646|FG002|Overall Study|Adverse Event|18
7718783|NCT00528996|12142647|FG003|Overall Study|Adverse Event|29
7718784|NCT00528996|12142648|FG004|Overall Study|Adverse Event|18
7718785|NCT00529035|12142663|FG000|Overall Study|Withdrawal by Subject|1
7718786|NCT00529087|12142677|FG000|Overall Study|Adverse Event|10
7718787|NCT00529087|12142678|FG001|Overall Study|Adverse Event|13
7718788|NCT00529087|12142679|FG002|Overall Study|Adverse Event|4
7718789|NCT00529087|12142677|FG000|Overall Study|Lost to Follow-up|6
7718790|NCT00529087|12142678|FG001|Overall Study|Lost to Follow-up|4
7718791|NCT00529087|12142679|FG002|Overall Study|Lost to Follow-up|1
7718792|NCT00529087|12142677|FG000|Overall Study|Protocol Violation|8
7907646|NCT02021565|12422481|FG001|3-month Follow-up|Death|0
7907647|NCT02021565|12422480|FG000|3-month Follow-up|Withdrawal by Subject|4
7907648|NCT02021565|12422481|FG001|3-month Follow-up|Withdrawal by Subject|0
7907649|NCT02021565|12422480|FG000|3-month Follow-up|Protocol Violation|3
7907650|NCT02021565|12422481|FG001|3-month Follow-up|Protocol Violation|2
7907651|NCT02021643|12422495|FG000|Overall Study|Enrolled but Never Treated|1
7907652|NCT02021643|12422496|FG001|Overall Study|Enrolled but Never Treated|0
7907653|NCT02021643|12422497|FG002|Overall Study|Enrolled but Never Treated|0
7907654|NCT02021643|12422498|FG003|Overall Study|Enrolled but Never Treated|0
7907655|NCT02021643|12422495|FG000|Overall Study|Adverse Event|0
7907656|NCT02021643|12422496|FG001|Overall Study|Adverse Event|1
7907657|NCT02021643|12422497|FG002|Overall Study|Adverse Event|0
7907658|NCT02021643|12422498|FG003|Overall Study|Adverse Event|0
7907659|NCT02021643|12422495|FG000|Overall Study|Death|0
7907660|NCT02021643|12422496|FG001|Overall Study|Death|1
7907661|NCT02021643|12422497|FG002|Overall Study|Death|0
7907662|NCT02021643|12422498|FG003|Overall Study|Death|0
7907663|NCT02021643|12422495|FG000|Overall Study|Investigator's Discretion|1
7907664|NCT02021643|12422496|FG001|Overall Study|Investigator's Discretion|0
7907665|NCT02021643|12422497|FG002|Overall Study|Investigator's Discretion|0
7907666|NCT02021643|12422498|FG003|Overall Study|Investigator's Discretion|0
7907667|NCT02021643|12422495|FG000|Overall Study|Lack of Efficacy|7
7907668|NCT02021643|12422496|FG001|Overall Study|Lack of Efficacy|6
7907669|NCT02021643|12422497|FG002|Overall Study|Lack of Efficacy|0
7907670|NCT02021643|12422498|FG003|Overall Study|Lack of Efficacy|12
7907671|NCT02021643|12422495|FG000|Overall Study|Lost to Follow-up|0
7907672|NCT02021643|12422496|FG001|Overall Study|Lost to Follow-up|1
7907673|NCT02021643|12422497|FG002|Overall Study|Lost to Follow-up|0
7907674|NCT02021643|12422498|FG003|Overall Study|Lost to Follow-up|0
7907675|NCT02021643|12422495|FG000|Overall Study|Withdrew Consent|0
7907676|NCT02021643|12422496|FG001|Overall Study|Withdrew Consent|1
7907677|NCT02021643|12422497|FG002|Overall Study|Withdrew Consent|0
7907678|NCT02021643|12422498|FG003|Overall Study|Withdrew Consent|0
7907679|NCT02021656|12422514|FG000|Overall Study|Adverse Event|1
7907680|NCT02021656|12422514|FG000|Overall Study|Lack of Efficacy|2
7907681|NCT02021656|12422514|FG000|Overall Study|Lost to Follow-up|1
7907682|NCT02021656|12422514|FG000|Overall Study|Withdrew Consent|2
7907683|NCT02022007|12422557|FG000|Overall Study|Withdrawal by Subject|1
7907684|NCT02022007|12422558|FG001|Overall Study|Withdrawal by Subject|1
7907685|NCT02022007|12422559|FG002|Overall Study|Withdrawal by Subject|1
7907686|NCT02022007|12422557|FG000|Overall Study|Noncompliant|0
7907687|NCT02022007|12422558|FG001|Overall Study|Noncompliant|0
7907688|NCT02022007|12422559|FG002|Overall Study|Noncompliant|1
7811459|NCT01183013|12275239|FG006|Overall Study|Adverse Event|6
7811460|NCT01183013|12275233|FG000|Overall Study|Lack of Efficacy|3
7811461|NCT01183013|12275234|FG001|Overall Study|Lack of Efficacy|2
7811462|NCT01183013|12275235|FG002|Overall Study|Lack of Efficacy|1
7811463|NCT01183013|12275236|FG003|Overall Study|Lack of Efficacy|2
7811464|NCT01183013|12275237|FG004|Overall Study|Lack of Efficacy|1
7811465|NCT01183013|12275238|FG005|Overall Study|Lack of Efficacy|2
7811466|NCT01183013|12275239|FG006|Overall Study|Lack of Efficacy|0
7811467|NCT01183013|12275233|FG000|Overall Study|Protocol Violation|5
7811468|NCT01183013|12275234|FG001|Overall Study|Protocol Violation|2
7811469|NCT01183013|12275235|FG002|Overall Study|Protocol Violation|4
7811470|NCT01183013|12275236|FG003|Overall Study|Protocol Violation|0
7811471|NCT01183013|12275237|FG004|Overall Study|Protocol Violation|4
7811472|NCT01183013|12275238|FG005|Overall Study|Protocol Violation|3
7811473|NCT01183013|12275239|FG006|Overall Study|Protocol Violation|3
7811474|NCT01183013|12275233|FG000|Overall Study|Lost to Follow-up|7
7811475|NCT01183013|12275234|FG001|Overall Study|Lost to Follow-up|3
7811476|NCT01183013|12275235|FG002|Overall Study|Lost to Follow-up|4
7811477|NCT01183013|12275236|FG003|Overall Study|Lost to Follow-up|3
7811478|NCT01183013|12275237|FG004|Overall Study|Lost to Follow-up|2
7811479|NCT01183013|12275238|FG005|Overall Study|Lost to Follow-up|6
7811480|NCT01183013|12275239|FG006|Overall Study|Lost to Follow-up|5
7811481|NCT01183013|12275233|FG000|Overall Study|Withdrawal by Subject|9
7811482|NCT01183013|12275234|FG001|Overall Study|Withdrawal by Subject|13
7811483|NCT01183013|12275235|FG002|Overall Study|Withdrawal by Subject|10
7811484|NCT01183013|12275236|FG003|Overall Study|Withdrawal by Subject|8
7811485|NCT01183013|12275237|FG004|Overall Study|Withdrawal by Subject|7
7811486|NCT01183013|12275238|FG005|Overall Study|Withdrawal by Subject|9
7811487|NCT01183013|12275239|FG006|Overall Study|Withdrawal by Subject|10
7811488|NCT01183013|12275233|FG000|Overall Study|Reasons other than stated above|15
7811489|NCT01183013|12275234|FG001|Overall Study|Reasons other than stated above|11
7811490|NCT01183013|12275235|FG002|Overall Study|Reasons other than stated above|17
7811491|NCT01183013|12275236|FG003|Overall Study|Reasons other than stated above|12
7811492|NCT01183013|12275237|FG004|Overall Study|Reasons other than stated above|12
7811493|NCT01183013|12275238|FG005|Overall Study|Reasons other than stated above|15
7811494|NCT01183013|12275239|FG006|Overall Study|Reasons other than stated above|13
7811495|NCT01183065|12275256|FG000|Overall Study|Patient no longer fits eligibility crite|1
7811496|NCT01183104|12275262|FG000|Overall Study|Adverse Event|8
7811497|NCT01183104|12275263|FG001|Overall Study|Adverse Event|6
7811498|NCT01183104|12275262|FG000|Overall Study|Death|0
7811499|NCT01183104|12275263|FG001|Overall Study|Death|1
7811500|NCT01183104|12275262|FG000|Overall Study|Lost to Follow-up|14
7811501|NCT01183104|12275263|FG001|Overall Study|Lost to Follow-up|7
7811502|NCT01183104|12275262|FG000|Overall Study|Physician Decision|5
7811503|NCT01183104|12275263|FG001|Overall Study|Physician Decision|8
7811504|NCT01183104|12275262|FG000|Overall Study|Withdrawal by Subject|6
7811505|NCT01183104|12275263|FG001|Overall Study|Withdrawal by Subject|11
7811506|NCT01183104|12275262|FG000|Overall Study|Nonparticipation in Extension Study|39
7811507|NCT01183104|12275263|FG001|Overall Study|Nonparticipation in Extension Study|50
7811508|NCT01183104|12275262|FG000|Overall Study|Did not receive study drug|5
7811509|NCT01183104|12275263|FG001|Overall Study|Did not receive study drug|9
7811510|NCT01183143|12275269|FG000|Overall Study|Protocol Violation|115
7811511|NCT01183143|12275269|FG000|Overall Study|Withdrawal by Subject|19
7718793|NCT00529087|12142678|FG001|Overall Study|Protocol Violation|7
7718794|NCT00529087|12142679|FG002|Overall Study|Protocol Violation|6
7718795|NCT00529087|12142677|FG000|Overall Study|Withdrawal by Subject|3
7718796|NCT00529087|12142678|FG001|Overall Study|Withdrawal by Subject|3
7718797|NCT00529087|12142679|FG002|Overall Study|Withdrawal by Subject|3
7718798|NCT00529087|12142677|FG000|Overall Study|Protocol deviation|1
7811512|NCT01183143|12275269|FG000|Overall Study|Subject Questionnaires not returned|5
7811513|NCT01183143|12275269|FG000|Overall Study|Subjects enrolled, but not treated|11
7811514|NCT01183234|12275303|FG000|First Intervention|Adverse Event|1
7811515|NCT01183234|12275304|FG001|First Intervention|Adverse Event|0
7811516|NCT01183260|12275312|FG000|Overall Study|Intraop screen failure|2
7811517|NCT01183260|12275313|FG001|Overall Study|Intraop screen failure|0
7811518|NCT01183260|12275312|FG000|Overall Study|Withdrawal by Subject|1
7811519|NCT01183260|12275313|FG001|Overall Study|Withdrawal by Subject|1
7811520|NCT01183260|12275312|FG000|Overall Study|Revised within 30 days|0
7811521|NCT01183260|12275313|FG001|Overall Study|Revised within 30 days|1
7811522|NCT01183260|12275312|FG000|Overall Study|Death|1
7811523|NCT01183260|12275313|FG001|Overall Study|Death|0
7811524|NCT01183390|12275330|FG000|First Intervention|Adverse Event|0
7811525|NCT01183390|12275331|FG001|First Intervention|Adverse Event|1
7811526|NCT01183780|12275386|FG000|Overall Study|Withdrawal by Subject|25
7811527|NCT01183780|12275387|FG001|Overall Study|Withdrawal by Subject|14
7811528|NCT01183780|12275386|FG000|Overall Study|Lost to Follow-up|6
7811529|NCT01183780|12275387|FG001|Overall Study|Lost to Follow-up|11
7811530|NCT01183858|12275395|FG000|Overall Study|Death not related to Progressive Disease|5
7811531|NCT01183858|12275396|FG001|Overall Study|Death not related to Progressive Disease|6
7811532|NCT01183858|12275395|FG000|Overall Study|Adverse Event|14
7811533|NCT01183858|12275396|FG001|Overall Study|Adverse Event|11
7811534|NCT01183858|12275395|FG000|Overall Study|Investigator's Decision|0
7811535|NCT01183858|12275396|FG001|Overall Study|Investigator's Decision|3
7811536|NCT01183858|12275395|FG000|Overall Study|Insufficient Therapeutic Response|2
7811537|NCT01183858|12275396|FG001|Overall Study|Insufficient Therapeutic Response|0
7811538|NCT01183858|12275395|FG000|Overall Study|Refused Treatment|1
7811539|NCT01183858|12275396|FG001|Overall Study|Refused Treatment|4
7811540|NCT01183858|12275395|FG000|Overall Study|Withdrew Consent|4
7811541|NCT01183858|12275396|FG001|Overall Study|Withdrew Consent|4
7811542|NCT01183858|12275395|FG000|Overall Study|Discontinued Smoking|3
7811543|NCT01183858|12275396|FG001|Overall Study|Discontinued Smoking|1
7811544|NCT01183858|12275395|FG000|Overall Study|Protocol Violation|1
7811545|NCT01183858|12275396|FG001|Overall Study|Protocol Violation|0
7811546|NCT01183858|12275395|FG000|Overall Study|Administrative/Other|6
7811547|NCT01183858|12275396|FG001|Overall Study|Administrative/Other|6
7811548|NCT01183858|12275395|FG000|Overall Study|Progressive Disease|112
7811549|NCT01183858|12275396|FG001|Overall Study|Progressive Disease|115
7811550|NCT01183858|12275395|FG000|Overall Study|Death related to Progressive Disease|4
7811551|NCT01183858|12275396|FG001|Overall Study|Death related to Progressive Disease|5
7811552|NCT01183858|12275395|FG000|Overall Study|Lost to Follow-up|1
7811553|NCT01183858|12275396|FG001|Overall Study|Lost to Follow-up|1
7811554|NCT01183975|12275408|FG000|Overall Study|Lost to Follow-up|73
7811555|NCT01184053|12275421|FG000|Overall Study|progression while on treatment|3
7811556|NCT01184079|12275428|FG000|Overall Study|Lost to Follow-up|14
7811557|NCT01184079|12275429|FG001|Overall Study|Lost to Follow-up|2
7811558|NCT01184118|12275437|FG000|Overall Study|Only asthma step 1 - screen fail|1
7811559|NCT01184118|12275437|FG000|Overall Study|No physiologic confirmation of asthma|8
7811560|NCT01184118|12275437|FG000|Overall Study|FEV1 <60% predicted|2
7811561|NCT01184118|12275437|FG000|Overall Study|Exclusionary medical condition|2
7811562|NCT01184118|12275437|FG000|Overall Study|Withdrawal by Subject|5
7811563|NCT01184326|12275444|FG000|Overall Study|Adverse Event|1
7811564|NCT01184326|12275445|FG001|Overall Study|Adverse Event|2
7811565|NCT01184326|12275446|FG002|Overall Study|Adverse Event|0
7811566|NCT01184326|12275444|FG000|Overall Study|Death|0
7811567|NCT01184326|12275445|FG001|Overall Study|Death|0
7811568|NCT01184326|12275446|FG002|Overall Study|Death|1
7811569|NCT01184326|12275444|FG000|Overall Study|Withdrawal by Subject|0
7811570|NCT01184326|12275445|FG001|Overall Study|Withdrawal by Subject|0
7811571|NCT01184326|12275446|FG002|Overall Study|Withdrawal by Subject|1
7811572|NCT01184326|12275444|FG000|Overall Study|Physician Decision|1
7811573|NCT01184326|12275445|FG001|Overall Study|Physician Decision|1
7811574|NCT01184326|12275446|FG002|Overall Study|Physician Decision|0
7811575|NCT01184326|12275444|FG000|Overall Study|Disease Progression|1
7811576|NCT01184326|12275445|FG001|Overall Study|Disease Progression|3
7811577|NCT01184326|12275446|FG002|Overall Study|Disease Progression|12
7811578|NCT01184508|12275468|FG000|Overall Study|Adverse Event|4
7811579|NCT01184508|12275469|FG001|Overall Study|Adverse Event|6
7811580|NCT01184508|12275468|FG000|Overall Study|Lack of Efficacy|1
7811581|NCT01184508|12275469|FG001|Overall Study|Lack of Efficacy|1
7811582|NCT01184508|12275468|FG000|Overall Study|Lost to Follow-up|1
7811583|NCT01184508|12275469|FG001|Overall Study|Lost to Follow-up|1
7811584|NCT01184508|12275468|FG000|Overall Study|Physician Decision|1
7811585|NCT01184508|12275469|FG001|Overall Study|Physician Decision|0
7811586|NCT01184508|12275468|FG000|Overall Study|Protocol Violation|3
7811587|NCT01184508|12275469|FG001|Overall Study|Protocol Violation|1
7811588|NCT01184508|12275468|FG000|Overall Study|Sponsor Decision|5
7811589|NCT01184508|12275469|FG001|Overall Study|Sponsor Decision|2
7811590|NCT01184508|12275468|FG000|Overall Study|Withdrawal by Subject|1
7811591|NCT01184508|12275469|FG001|Overall Study|Withdrawal by Subject|3
7811592|NCT01184508|12275468|FG000|Overall Study|Randomized, Not Treated|0
7811593|NCT01184508|12275469|FG001|Overall Study|Randomized, Not Treated|1
7811594|NCT01184846|12275489|FG000|Overall Study|Adverse Event|2
7811595|NCT01184846|12275489|FG000|Overall Study|Insufficient response|1
7811596|NCT01184859|12275500|FG000|Period 1: Single Dose|Insufficient urine production|0
7811597|NCT01184859|12275501|FG001|Period 1: Single Dose|Insufficient urine production|1
7811598|NCT01184859|12275502|FG002|Period 1: Single Dose|Insufficient urine production|0
7718799|NCT00529087|12142678|FG001|Overall Study|Protocol deviation|1
7718800|NCT00529087|12142679|FG002|Overall Study|Protocol deviation|2
7718801|NCT00529100|12142700|FG000|Overall Study|Adverse Event|0
7718802|NCT00529100|12142701|FG001|Overall Study|Adverse Event|5
7718803|NCT00529100|12142700|FG000|Overall Study|Protocol Violation|0
7718804|NCT00529100|12142701|FG001|Overall Study|Protocol Violation|1
7718805|NCT00529100|12142700|FG000|Overall Study|Progressive Disease|0
7718806|NCT00529100|12142701|FG001|Overall Study|Progressive Disease|1
7718807|NCT00529100|12142700|FG000|Overall Study|Withdrawal by Subject|0
7718808|NCT00529100|12142701|FG001|Overall Study|Withdrawal by Subject|1
7718809|NCT00529100|12142700|FG000|Overall Study|Participant Ineligibility|0
7718810|NCT00529100|12142701|FG001|Overall Study|Participant Ineligibility|1
7718811|NCT00529217|12142750|FG000|Overall Study|Lack of Efficacy|2
7718812|NCT00529217|12142750|FG000|Overall Study|Unable to adhere to study schedule|2
7718813|NCT00529243|12142755|FG000|Overall Study|Adverse Event|1
7718814|NCT00529243|12142755|FG000|Overall Study|Death|1
7718815|NCT00529243|12142755|FG000|Overall Study|Relocated|1
7718816|NCT00529308|12142761|FG000|Overall Study|Withdrawal by Subject|1
7718817|NCT00529308|12142762|FG001|Overall Study|Withdrawal by Subject|1
7718818|NCT00529373|12142770|FG000|Base Study|Adverse Event|525
7718819|NCT00529373|12142771|FG001|Base Study|Adverse Event|470
7718820|NCT00529373|12142770|FG000|Base Study|Lack of Efficacy|16
7718821|NCT00529373|12142771|FG001|Base Study|Lack of Efficacy|75
7718822|NCT00529373|12142770|FG000|Base Study|Lost to Follow-up|221
7718823|NCT00529373|12142771|FG001|Base Study|Lost to Follow-up|208
7718824|NCT00529373|12142770|FG000|Base Study|Other Protocol Specified Criteria|19
7718825|NCT00529373|12142771|FG001|Base Study|Other Protocol Specified Criteria|20
7718826|NCT00529373|12142770|FG000|Base Study|Physician Decision|60
7718827|NCT00529373|12142771|FG001|Base Study|Physician Decision|52
7718828|NCT00529373|12142770|FG000|Base Study|Protocol Violation|48
7718829|NCT00529373|12142771|FG001|Base Study|Protocol Violation|38
7718830|NCT00529373|12142770|FG000|Base Study|Withdrawal by Subject|1062
7718831|NCT00529373|12142771|FG001|Base Study|Withdrawal by Subject|967
7718832|NCT00529373|12142770|FG000|Base Study|Did not continue into Extension|1795
7718833|NCT00529373|12142771|FG001|Base Study|Did not continue into Extension|2238
7718834|NCT00529373|12142770|FG000|First Extension Study|Adverse Event|162
7718835|NCT00529373|12142771|FG001|First Extension Study|Adverse Event|142
7718836|NCT00529373|12142770|FG000|First Extension Study|Lack of Efficacy|65
7718837|NCT00529373|12142771|FG001|First Extension Study|Lack of Efficacy|427
7718838|NCT00529373|12142770|FG000|First Extension Study|Lost to Follow-up|41
7718839|NCT00529373|12142771|FG001|First Extension Study|Lost to Follow-up|37
7718840|NCT00529373|12142770|FG000|First Extension Study|Other|27
7718841|NCT00529373|12142771|FG001|First Extension Study|Other|47
7718842|NCT00529373|12142770|FG000|First Extension Study|Physician Decision|50
7718843|NCT00529373|12142771|FG001|First Extension Study|Physician Decision|45
7718844|NCT00529373|12142770|FG000|First Extension Study|Protocol Violation|16
7718845|NCT00529373|12142771|FG001|First Extension Study|Protocol Violation|13
7718846|NCT00529373|12142770|FG000|First Extension Study|Withdrawal by Subject|296
7718847|NCT00529373|12142771|FG001|First Extension Study|Withdrawal by Subject|287
7718848|NCT00529373|12142770|FG000|First Extension Study|Disposition record non-existing|0
7718849|NCT00529373|12142771|FG001|First Extension Study|Disposition record non-existing|1
7718850|NCT00529373|12142770|FG000|First Extension Study|Discontinued after 5 years completion|208
7718851|NCT00529373|12142771|FG001|First Extension Study|Discontinued after 5 years completion|346
7718852|NCT00529373|12142770|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256
7718853|NCT00529373|12142771|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281
7718854|NCT00529373|12142770|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32
7718855|NCT00529373|12142771|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25
7718856|NCT00529373|12142770|FG000|Second Extension Study|Adverse Event|101
7718857|NCT00529373|12142771|FG001|Second Extension Study|Adverse Event|51
7718858|NCT00529373|12142770|FG000|Second Extension Study|Lack of Efficacy|7
7718859|NCT00529373|12142771|FG001|Second Extension Study|Lack of Efficacy|15
7718860|NCT00529373|12142770|FG000|Second Extension Study|Lost to Follow-up|18
7718861|NCT00529373|12142771|FG001|Second Extension Study|Lost to Follow-up|12
7718862|NCT00529373|12142770|FG000|Second Extension Study|Other|7
7718863|NCT00529373|12142771|FG001|Second Extension Study|Other|12
7718864|NCT00529373|12142770|FG000|Second Extension Study|Physician Decision|63
7718865|NCT00529373|12142771|FG001|Second Extension Study|Physician Decision|26
7718866|NCT00529373|12142770|FG000|Second Extension Study|Protocol Violation|2
7718867|NCT00529373|12142771|FG001|Second Extension Study|Protocol Violation|1
7718868|NCT00529373|12142770|FG000|Second Extension Study|Withdrawal by Subject|97
7718869|NCT00529373|12142771|FG001|Second Extension Study|Withdrawal by Subject|75
7718870|NCT00529373|12142770|FG000|Second Extension Study|Status Missing|5
7718871|NCT00529373|12142771|FG001|Second Extension Study|Status Missing|5
7718872|NCT00529386|12142785|FG000|Overall Study|Lost to Follow-up|1
7718873|NCT00529399|12142792|FG000|Overall Study|Lost to Follow-up|1
7718874|NCT00529399|12142793|FG001|Overall Study|Lost to Follow-up|0
7718875|NCT00529399|12142794|FG002|Overall Study|Lost to Follow-up|1
7718876|NCT00529399|12142792|FG000|Overall Study|Withdrawal by Subject|1
7718877|NCT00529399|12142793|FG001|Overall Study|Withdrawal by Subject|0
7718878|NCT00529399|12142794|FG002|Overall Study|Withdrawal by Subject|1
7718879|NCT00529399|12142792|FG000|Overall Study|Non-compliant|0
7718880|NCT00529399|12142793|FG001|Overall Study|Non-compliant|1
7718881|NCT00529399|12142794|FG002|Overall Study|Non-compliant|0
7718882|NCT00529451|12142806|FG000|Overall Study|Subject withdrew consent|16
7718883|NCT00529451|12142807|FG001|Overall Study|Subject withdrew consent|21
7718884|NCT00529451|12142808|FG002|Overall Study|Subject withdrew consent|13
7718885|NCT00529451|12142809|FG003|Overall Study|Subject withdrew consent|12
7718886|NCT00529451|12142806|FG000|Overall Study|Adverse Event|9
7718887|NCT00529451|12142807|FG001|Overall Study|Adverse Event|16
7907689|NCT02022657|12422586|FG000|Overall Study|Withdrawal by Subject|2
7907690|NCT02022657|12422587|FG001|Overall Study|Withdrawal by Subject|0
7907691|NCT02022657|12422588|FG002|Overall Study|Withdrawal by Subject|1
7718888|NCT00529451|12142808|FG002|Overall Study|Adverse Event|14
7718889|NCT00529451|12142809|FG003|Overall Study|Adverse Event|8
7718890|NCT00529451|12142806|FG000|Overall Study|Unsatisfactory therapeutic response|6
7718891|NCT00529451|12142807|FG001|Overall Study|Unsatisfactory therapeutic response|2
7718892|NCT00529451|12142808|FG002|Overall Study|Unsatisfactory therapeutic response|5
7718893|NCT00529451|12142809|FG003|Overall Study|Unsatisfactory therapeutic response|4
7718894|NCT00529451|12142806|FG000|Overall Study|Lost to Follow-up|4
7718895|NCT00529451|12142807|FG001|Overall Study|Lost to Follow-up|7
7718896|NCT00529451|12142808|FG002|Overall Study|Lost to Follow-up|4
7718897|NCT00529451|12142809|FG003|Overall Study|Lost to Follow-up|4
7718898|NCT00529451|12142806|FG000|Overall Study|Protocol deviation|1
7718899|NCT00529451|12142807|FG001|Overall Study|Protocol deviation|1
7718900|NCT00529451|12142808|FG002|Overall Study|Protocol deviation|4
7718901|NCT00529451|12142809|FG003|Overall Study|Protocol deviation|1
7718902|NCT00529451|12142806|FG000|Overall Study|Administrative problems|1
7718903|NCT00529451|12142807|FG001|Overall Study|Administrative problems|1
7718904|NCT00529451|12142808|FG002|Overall Study|Administrative problems|0
7718905|NCT00529451|12142809|FG003|Overall Study|Administrative problems|2
7718906|NCT00529516|12142825|FG000|Overall Study|Adverse Event|2
7718907|NCT00529516|12142826|FG001|Overall Study|Adverse Event|1
7718908|NCT00529516|12142827|FG002|Overall Study|Adverse Event|0
7718909|NCT00529516|12142825|FG000|Overall Study|Withdrawal by Subject|1
7718910|NCT00529516|12142826|FG001|Overall Study|Withdrawal by Subject|1
7718911|NCT00529516|12142827|FG002|Overall Study|Withdrawal by Subject|0
7718912|NCT00529516|12142825|FG000|Overall Study|Lost to Follow-up|0
7718913|NCT00529516|12142826|FG001|Overall Study|Lost to Follow-up|0
7718914|NCT00529516|12142827|FG002|Overall Study|Lost to Follow-up|1
7718915|NCT00529529|12142838|FG000|Overall Study|Adverse Event|12
7718916|NCT00529529|12142839|FG001|Overall Study|Adverse Event|17
7718917|NCT00529529|12142840|FG002|Overall Study|Adverse Event|8
7718918|NCT00529529|12142838|FG000|Overall Study|Subject withdrew consent|12
7718919|NCT00529529|12142839|FG001|Overall Study|Subject withdrew consent|9
7718920|NCT00529529|12142840|FG002|Overall Study|Subject withdrew consent|12
7718921|NCT00529529|12142838|FG000|Overall Study|Protocol deviation|8
7718922|NCT00529529|12142839|FG001|Overall Study|Protocol deviation|12
7718923|NCT00529529|12142840|FG002|Overall Study|Protocol deviation|5
7718924|NCT00529529|12142838|FG000|Overall Study|Lost to Follow-up|5
7718925|NCT00529529|12142839|FG001|Overall Study|Lost to Follow-up|3
7718926|NCT00529529|12142840|FG002|Overall Study|Lost to Follow-up|1
7718927|NCT00529529|12142838|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7718928|NCT00529529|12142839|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7718929|NCT00529529|12142840|FG002|Overall Study|Unsatisfactory therapeutic effect|2
7718930|NCT00529529|12142838|FG000|Overall Study|Death|2
7718931|NCT00529529|12142839|FG001|Overall Study|Death|0
7907692|NCT02022657|12422589|FG003|Overall Study|Withdrawal by Subject|0
7718932|NCT00529529|12142840|FG002|Overall Study|Death|0
7718933|NCT00529529|12142838|FG000|Overall Study|Abnormal test procedure result(s)|1
7718934|NCT00529529|12142839|FG001|Overall Study|Abnormal test procedure result(s)|0
7811599|NCT01184859|12275503|FG003|Period 1: Single Dose|Insufficient urine production|0
7811600|NCT01184859|12275504|FG004|Period 1: Single Dose|Insufficient urine production|0
7811601|NCT01184859|12275500|FG000|Period 1: Single Dose|Protocol Violation|0
7811602|NCT01184859|12275501|FG001|Period 1: Single Dose|Protocol Violation|1
7811603|NCT01184859|12275502|FG002|Period 1: Single Dose|Protocol Violation|0
7811604|NCT01184859|12275503|FG003|Period 1: Single Dose|Protocol Violation|0
7811605|NCT01184859|12275504|FG004|Period 1: Single Dose|Protocol Violation|0
7811606|NCT01184859|12275500|FG000|Period 1: Single Dose|Adverse Event|0
7811607|NCT01184859|12275501|FG001|Period 1: Single Dose|Adverse Event|0
7811608|NCT01184859|12275502|FG002|Period 1: Single Dose|Adverse Event|0
7811609|NCT01184859|12275503|FG003|Period 1: Single Dose|Adverse Event|0
7718935|NCT00529529|12142840|FG002|Overall Study|Abnormal test procedure result(s)|0
7718936|NCT00529529|12142838|FG000|Overall Study|Administrative problems|1
7718937|NCT00529529|12142839|FG001|Overall Study|Administrative problems|0
7718938|NCT00529529|12142840|FG002|Overall Study|Administrative problems|3
7718939|NCT00529542|12142850|FG000|Overall Study|Withdrawal by Subject|1
7718940|NCT00529542|12142851|FG001|Overall Study|Withdrawal by Subject|0
7718941|NCT00529542|12142850|FG000|Overall Study|Lost to Follow-up|0
7718942|NCT00529542|12142851|FG001|Overall Study|Lost to Follow-up|1
7718943|NCT00529568|12142872|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
7718944|NCT00529568|12142873|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
7718945|NCT00529568|12142874|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
7718946|NCT00529568|12142872|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
7718947|NCT00529568|12142873|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
7718948|NCT00529568|12142874|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
7718949|NCT00529568|12142872|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
7718950|NCT00529568|12142873|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
7718951|NCT00529568|12142874|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
7718952|NCT00529568|12142872|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
7718953|NCT00529568|12142873|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
7718954|NCT00529568|12142874|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
7718955|NCT00529568|12142872|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
7718956|NCT00529568|12142873|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
7718957|NCT00529568|12142874|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
7718958|NCT00529568|12142872|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
7718959|NCT00529568|12142873|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
7718960|NCT00529568|12142874|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
7718961|NCT00529568|12142872|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
7718962|NCT00529568|12142873|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
7718963|NCT00529568|12142874|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
7718964|NCT00529568|12142872|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
7718965|NCT00529568|12142873|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
7718966|NCT00529568|12142874|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
7718967|NCT00529568|12142872|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
7718968|NCT00529568|12142873|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
7718969|NCT00529568|12142874|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
7718970|NCT00529568|12142872|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
7718971|NCT00529568|12142873|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
7718972|NCT00529568|12142874|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
7718973|NCT00529568|12142872|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
7718974|NCT00529568|12142873|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
7718975|NCT00529568|12142874|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
7718976|NCT00529633|12142885|FG000|Overall Study|Withdrawal by Subject|1
7718977|NCT00529633|12142886|FG001|Overall Study|Withdrawal by Subject|1
7718978|NCT00529659|12142894|FG000|Overall Study|Adverse Event|8
7718979|NCT00529659|12142895|FG001|Overall Study|Adverse Event|7
7718980|NCT00529659|12142894|FG000|Overall Study|Lost to Follow-up|0
7718981|NCT00529659|12142895|FG001|Overall Study|Lost to Follow-up|2
7718982|NCT00529659|12142894|FG000|Overall Study|Physician Decision|0
7718983|NCT00529659|12142895|FG001|Overall Study|Physician Decision|2
7718984|NCT00529659|12142894|FG000|Overall Study|Protocol Violation|2
7718985|NCT00529659|12142895|FG001|Overall Study|Protocol Violation|6
7718986|NCT00529659|12142894|FG000|Overall Study|Withdrawal by Subject|1
7718987|NCT00529659|12142895|FG001|Overall Study|Withdrawal by Subject|6
7718988|NCT00529789|12142901|FG000|Study Period II/III|Parent/Caregiver Decision|9
7718989|NCT00529789|12142901|FG000|Study Period II/III|Adverse Event|3
7907693|NCT02022657|12422590|FG004|Overall Study|Withdrawal by Subject|0
7907694|NCT02022657|12422591|FG005|Overall Study|Withdrawal by Subject|0
7907695|NCT02022657|12422586|FG000|Overall Study|Physician Decision|0
7907696|NCT02022657|12422587|FG001|Overall Study|Physician Decision|0
7907697|NCT02022657|12422588|FG002|Overall Study|Physician Decision|0
7907698|NCT02022657|12422589|FG003|Overall Study|Physician Decision|0
7907699|NCT02022657|12422590|FG004|Overall Study|Physician Decision|0
7907700|NCT02022657|12422591|FG005|Overall Study|Physician Decision|1
7907701|NCT02022670|12422600|FG000|Overall Study|Adverse Event|1
7907702|NCT02022670|12422601|FG001|Overall Study|Adverse Event|0
7907703|NCT02022670|12422602|FG002|Overall Study|Adverse Event|1
7907704|NCT02022748|12422623|FG000|Overall Study|Adverse Event|1
7907705|NCT02022748|12422624|FG001|Overall Study|Adverse Event|1
7907706|NCT02022748|12422625|FG002|Overall Study|Adverse Event|0
7907707|NCT02022748|12422623|FG000|Overall Study|Withdrawal by Subject|0
7907708|NCT02022748|12422624|FG001|Overall Study|Withdrawal by Subject|1
7907709|NCT02022748|12422625|FG002|Overall Study|Withdrawal by Subject|0
7907710|NCT02023099|12422640|FG000|Overall Study|Non-fatal Adverse Event (AE)|0
7907711|NCT02023099|12422641|FG001|Overall Study|Non-fatal Adverse Event (AE)|0
7907712|NCT02023099|12422642|FG002|Overall Study|Non-fatal Adverse Event (AE)|1
7907713|NCT02023099|12422640|FG000|Overall Study|Withdrawn Consent|3
7907714|NCT02023099|12422641|FG001|Overall Study|Withdrawn Consent|0
7907715|NCT02023099|12422642|FG002|Overall Study|Withdrawn Consent|1
7907716|NCT02023099|12422640|FG000|Overall Study|Non-treatment-emergent Fatal AE|0
7907717|NCT02023099|12422641|FG001|Overall Study|Non-treatment-emergent Fatal AE|0
7907718|NCT02023099|12422642|FG002|Overall Study|Non-treatment-emergent Fatal AE|1
7907719|NCT02023112|12422652|FG000|Overall Study|Withdrawal by Subject|2
7907720|NCT02023112|12422653|FG001|Overall Study|Withdrawal by Subject|1
7907721|NCT02023151|12422677|FG000|Overall Study|Lost to Follow-up|4
7907722|NCT02023242|12422683|FG000|Overall Study|Lost to Follow-up|3
7907723|NCT02023242|12422684|FG001|Overall Study|Lost to Follow-up|1
7907724|NCT02023242|12422683|FG000|Overall Study|Death|0
7907725|NCT02023242|12422684|FG001|Overall Study|Death|1
7907726|NCT02023268|12422692|FG000|Overall Study|Lack of Efficacy|0
7907727|NCT02023268|12422693|FG001|Overall Study|Lack of Efficacy|1
7907728|NCT02023268|12422692|FG000|Overall Study|Adverse Event|0
7907729|NCT02023268|12422693|FG001|Overall Study|Adverse Event|2
7907730|NCT02023268|12422692|FG000|Overall Study|Withdrawal by Subject|0
7907731|NCT02023268|12422693|FG001|Overall Study|Withdrawal by Subject|1
7907732|NCT02023697|12422721|FG000|Treatment Period|Radiological progression|13
7907733|NCT02023697|12422722|FG001|Treatment Period|Radiological progression|17
7907734|NCT02023697|12422723|FG002|Treatment Period|Radiological progression|26
7907735|NCT02023697|12422721|FG000|Treatment Period|Never Treated|5
7907736|NCT02023697|12422722|FG001|Treatment Period|Never Treated|6
7907737|NCT02023697|12422723|FG002|Treatment Period|Never Treated|10
7907738|NCT02023697|12422721|FG000|Treatment Period|Adverse Event|13
7907739|NCT02023697|12422722|FG001|Treatment Period|Adverse Event|25
7907740|NCT02023697|12422723|FG002|Treatment Period|Adverse Event|23
7907741|NCT02023697|12422721|FG000|Treatment Period|Logistical difficulties|1
7907742|NCT02023697|12422722|FG001|Treatment Period|Logistical difficulties|1
7907743|NCT02023697|12422723|FG002|Treatment Period|Logistical difficulties|1
7907744|NCT02023697|12422721|FG000|Treatment Period|Clinical progression|10
7907745|NCT02023697|12422722|FG001|Treatment Period|Clinical progression|8
7907746|NCT02023697|12422723|FG002|Treatment Period|Clinical progression|28
7907747|NCT02023697|12422721|FG000|Treatment Period|Withdrawal by Subject|4
7907748|NCT02023697|12422722|FG001|Treatment Period|Withdrawal by Subject|5
7907749|NCT02023697|12422723|FG002|Treatment Period|Withdrawal by Subject|13
7907750|NCT02023697|12422721|FG000|Treatment Period|Safety outcome reached|0
7907751|NCT02023697|12422722|FG001|Treatment Period|Safety outcome reached|1
7907752|NCT02023697|12422723|FG002|Treatment Period|Safety outcome reached|0
7907753|NCT02023697|12422721|FG000|Treatment Period|Physician Decision|0
7907754|NCT02023697|12422722|FG001|Treatment Period|Physician Decision|0
7907755|NCT02023697|12422723|FG002|Treatment Period|Physician Decision|1
7907756|NCT02023697|12422721|FG000|Active Follow-up Period|Withdrawal by Subject|5
7907757|NCT02023697|12422722|FG001|Active Follow-up Period|Withdrawal by Subject|13
7907758|NCT02023697|12422723|FG002|Active Follow-up Period|Withdrawal by Subject|7
7907759|NCT02023697|12422721|FG000|Active Follow-up Period|Lost to Follow-up|1
7907760|NCT02023697|12422722|FG001|Active Follow-up Period|Lost to Follow-up|1
7907761|NCT02023697|12422723|FG002|Active Follow-up Period|Lost to Follow-up|1
7907762|NCT02023697|12422721|FG000|Active Follow-up Period|Deterioration of general condition|1
7907763|NCT02023697|12422722|FG001|Active Follow-up Period|Deterioration of general condition|1
7907764|NCT02023697|12422723|FG002|Active Follow-up Period|Deterioration of general condition|1
7907765|NCT02023697|12422721|FG000|Active Follow-up Period|Other unspecified|2
7907766|NCT02023697|12422722|FG001|Active Follow-up Period|Other unspecified|0
7907767|NCT02023697|12422723|FG002|Active Follow-up Period|Other unspecified|1
7907768|NCT02023697|12422721|FG000|Active Follow-up Period|Clinical progression|0
7907769|NCT02023697|12422722|FG001|Active Follow-up Period|Clinical progression|2
7907770|NCT02023697|12422723|FG002|Active Follow-up Period|Clinical progression|1
7907771|NCT02023697|12422721|FG000|Active Follow-up Period|Radiological progression|0
7907772|NCT02023697|12422722|FG001|Active Follow-up Period|Radiological progression|0
7907773|NCT02023697|12422723|FG002|Active Follow-up Period|Radiological progression|1
7907774|NCT02023697|12422721|FG000|Active Follow-up Period|Death|83
7907775|NCT02023697|12422722|FG001|Active Follow-up Period|Death|82
7811610|NCT01184859|12275504|FG004|Period 1: Single Dose|Adverse Event|1
7811611|NCT01184859|12275500|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
7811612|NCT01184859|12275501|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
7811613|NCT01184859|12275502|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
7811614|NCT01184859|12275503|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
7811615|NCT01184859|12275504|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
7811616|NCT01184859|12275500|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1
7811617|NCT01184859|12275501|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0
7811618|NCT01184859|12275502|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0
7811619|NCT01184859|12275503|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0
7811620|NCT01184859|12275504|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0
7811621|NCT01184872|12275523|FG000|Overall Study|Adverse Event|3
7811622|NCT01184872|12275524|FG001|Overall Study|Adverse Event|4
7811623|NCT01184872|12275523|FG000|Overall Study|Unsatisfactory therapeutic effect|3
7811624|NCT01184872|12275524|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7811625|NCT01184872|12275523|FG000|Overall Study|Withdrawal by Subject|2
7811626|NCT01184872|12275524|FG001|Overall Study|Withdrawal by Subject|0
7811627|NCT01184872|12275523|FG000|Overall Study|Lost to Follow-up|0
7811628|NCT01184872|12275524|FG001|Overall Study|Lost to Follow-up|1
7811629|NCT01184872|12275523|FG000|Overall Study|Administrative problems|1
7811630|NCT01184872|12275524|FG001|Overall Study|Administrative problems|1
7811631|NCT01184872|12275523|FG000|Overall Study|Protocol deviation|1
7811632|NCT01184872|12275524|FG001|Overall Study|Protocol deviation|0
7811633|NCT01184989|12275539|FG000|Overall Study|Adverse Event|11
7811634|NCT01184989|12275539|FG000|Overall Study|Withdrawal by Subject|1
7811635|NCT01185080|12275550|FG000|Overall Study|Adverse Event|1
7811636|NCT01185080|12275551|FG001|Overall Study|Adverse Event|1
7811637|NCT01185080|12275552|FG002|Overall Study|Adverse Event|0
7811638|NCT01185080|12275550|FG000|Overall Study|Personal reasons|0
7811639|NCT01185080|12275551|FG001|Overall Study|Personal reasons|0
7811640|NCT01185080|12275552|FG002|Overall Study|Personal reasons|1
7811641|NCT01185171|12275560|FG000|Induction Chemotherapy|Withdrawal by Subject|1
7811642|NCT01185171|12275560|FG000|Induction Chemotherapy|Duodenal Ulcer|1
7811643|NCT01185171|12275560|FG000|Concurrent Chemo and Radiation Treatment|Death|3
7811644|NCT01185171|12275560|FG000|Maintenance|Elevated liver transaminases|3
7811645|NCT01185171|12275560|FG000|Maintenance|Rush|2
7811646|NCT01185171|12275560|FG000|Maintenance|Diarrhea|1
7811647|NCT01185171|12275560|FG000|Maintenance|Xerostomia|1
7811648|NCT01185171|12275560|FG000|Maintenance|Nausea|1
7811649|NCT01185171|12275560|FG000|Maintenance|Comorbid Illness|2
7811650|NCT01185171|12275560|FG000|Maintenance|Withdrawal by Subject|1
7811651|NCT01185171|12275560|FG000|Maintenance|Disease Recurrence|1
7811652|NCT01185249|12275564|FG000|Overall Study|Patients discharged or change in status|42
7811653|NCT01185288|12275571|FG000|Overall Study|Adverse Event|7
7811654|NCT01185288|12275572|FG001|Overall Study|Adverse Event|6
7907776|NCT02023697|12422723|FG002|Active Follow-up Period|Death|87
7907777|NCT02023697|12422721|FG000|Long-term Follow-up Period|Death|9
7907778|NCT02023697|12422722|FG001|Long-term Follow-up Period|Death|6
7907779|NCT02023697|12422723|FG002|Long-term Follow-up Period|Death|4
7907780|NCT02023697|12422721|FG000|Long-term Follow-up Period|Withdrawal by Subject|6
7907781|NCT02023697|12422722|FG001|Long-term Follow-up Period|Withdrawal by Subject|3
7907782|NCT02023697|12422723|FG002|Long-term Follow-up Period|Withdrawal by Subject|0
7907783|NCT02023697|12422721|FG000|Long-term Follow-up Period|Lost to Follow-up|1
7907784|NCT02023697|12422722|FG001|Long-term Follow-up Period|Lost to Follow-up|0
7907785|NCT02023697|12422723|FG002|Long-term Follow-up Period|Lost to Follow-up|1
7907786|NCT02023697|12422721|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6
7907787|NCT02023697|12422722|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9
7907788|NCT02023697|12422723|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6
7907789|NCT02023697|12422721|FG000|Long-term Follow-up Period|Technical problems|0
7907790|NCT02023697|12422722|FG001|Long-term Follow-up Period|Technical problems|0
7907791|NCT02023697|12422723|FG002|Long-term Follow-up Period|Technical problems|1
7907792|NCT02023697|12422721|FG000|Long-term Follow-up Period|Other unspecified|6
7907793|NCT02023697|12422722|FG001|Long-term Follow-up Period|Other unspecified|3
7907794|NCT02023697|12422723|FG002|Long-term Follow-up Period|Other unspecified|5
7907795|NCT02023866|12422742|FG000|Overall Study|Non-compliance|2
7907796|NCT02023866|12422742|FG000|Overall Study|Adverse Event|3
7907797|NCT02023866|12422742|FG000|Overall Study|Withdrawal by Subject|1
7907798|NCT02023879|12422749|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
7907799|NCT02023879|12422750|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
7907800|NCT02023879|12422751|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
7907801|NCT02023879|12422749|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
7907802|NCT02023879|12422750|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
7907803|NCT02023879|12422751|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
7907804|NCT02023879|12422749|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
7907805|NCT02023879|12422750|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
7907806|NCT02023879|12422751|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
7907807|NCT02023879|12422749|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
7907808|NCT02023879|12422750|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
7907809|NCT02023879|12422751|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
7907810|NCT02023879|12422749|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
7907811|NCT02023879|12422750|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
7907812|NCT02023879|12422751|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
7907813|NCT02023879|12422749|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
7907814|NCT02023879|12422750|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
7907815|NCT02023879|12422751|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
7907816|NCT02023879|12422749|FG000|Extension Open Label Treatment|Adverse Event|1
7907817|NCT02023879|12422750|FG001|Extension Open Label Treatment|Adverse Event|7
7907818|NCT02023879|12422751|FG002|Extension Open Label Treatment|Adverse Event|3
7907819|NCT02023879|12422749|FG000|Extension Open Label Treatment|Poor compliance to protocol|1
7907820|NCT02023879|12422750|FG001|Extension Open Label Treatment|Poor compliance to protocol|1
7907821|NCT02023879|12422751|FG002|Extension Open Label Treatment|Poor compliance to protocol|0
7907822|NCT02023879|12422749|FG000|Extension Open Label Treatment|Participant moved|1
7907823|NCT02023879|12422750|FG001|Extension Open Label Treatment|Participant moved|2
7907824|NCT02023879|12422751|FG002|Extension Open Label Treatment|Participant moved|0
7907825|NCT02023879|12422749|FG000|Extension Open Label Treatment|Other than specified above|2
7907826|NCT02023879|12422750|FG001|Extension Open Label Treatment|Other than specified above|7
7907827|NCT02023879|12422751|FG002|Extension Open Label Treatment|Other than specified above|2
7907828|NCT02024698|12422839|FG000|First Intervention (7 Days)|Withdrawal by Subject|0
7907829|NCT02024698|12422840|FG001|First Intervention (7 Days)|Withdrawal by Subject|1
7907830|NCT02024750|12422866|FG000|Overall Study|Withdrawal by Subject|2
7907831|NCT02024750|12422867|FG001|Overall Study|Withdrawal by Subject|1
7907832|NCT02024867|12422875|FG000|Overall Study|Protocol Violation|3
7907833|NCT02024867|12422876|FG001|Overall Study|Protocol Violation|3
7907834|NCT02024867|12422875|FG000|Overall Study|Lost to Follow-up|6
7907835|NCT02024867|12422876|FG001|Overall Study|Lost to Follow-up|4
7907836|NCT02024932|12422888|FG000|Overall Study|Adverse Event|2
7907837|NCT02024932|12422889|FG001|Overall Study|Adverse Event|3
7907838|NCT02024932|12422890|FG002|Overall Study|Adverse Event|0
7907839|NCT02024932|12422891|FG003|Overall Study|Adverse Event|0
7907840|NCT02024932|12422892|FG004|Overall Study|Adverse Event|2
7907841|NCT02024932|12422893|FG005|Overall Study|Adverse Event|0
7907842|NCT02024932|12422888|FG000|Overall Study|Abnormal laboratory value|0
7907843|NCT02024932|12422889|FG001|Overall Study|Abnormal laboratory value|0
7907844|NCT02024932|12422890|FG002|Overall Study|Abnormal laboratory value|0
7907845|NCT02024932|12422891|FG003|Overall Study|Abnormal laboratory value|2
7907846|NCT02024932|12422892|FG004|Overall Study|Abnormal laboratory value|0
7907847|NCT02024932|12422893|FG005|Overall Study|Abnormal laboratory value|0
7907848|NCT02024971|12422913|FG000|Overall Study|Data Not Available|30
7907849|NCT02024971|12422913|FG000|Overall Study|Lost to Follow-up|6
7907850|NCT02025179|12422935|FG000|Overall Study|Lost to Follow-up|0
7907851|NCT02025179|12422936|FG001|Overall Study|Lost to Follow-up|0
7907852|NCT02025179|12422937|FG002|Overall Study|Lost to Follow-up|1
7907853|NCT02025205|12422947|FG000|Overall Study|Withdrawal by Subject|1
7907854|NCT02025205|12422948|FG001|Overall Study|Withdrawal by Subject|1
7907855|NCT02025205|12422947|FG000|Overall Study|Protocol Violation|2
7907856|NCT02025205|12422948|FG001|Overall Study|Protocol Violation|1
7907857|NCT02025205|12422947|FG000|Overall Study|Death|0
7907858|NCT02025205|12422948|FG001|Overall Study|Death|1
7907859|NCT02025530|12422976|FG000|Overall Study|No longer met elligibility criteria|5
7907860|NCT02025530|12422977|FG001|Overall Study|No longer met elligibility criteria|1
7907861|NCT02025621|12422985|FG000|Overall Study|Withdrawal by Subject|1
7907862|NCT02025621|12422986|FG001|Overall Study|Withdrawal by Subject|0
7907863|NCT02025621|12422985|FG000|Overall Study|Death|0
7907864|NCT02025621|12422986|FG001|Overall Study|Death|1
7907865|NCT02025621|12422985|FG000|Overall Study|No longer eligible|10
7907866|NCT02025621|12422986|FG001|Overall Study|No longer eligible|15
7907867|NCT02025621|12422985|FG000|Overall Study|Surgery initiated before infusion|3
7907868|NCT02025621|12422986|FG001|Overall Study|Surgery initiated before infusion|3
7907869|NCT02025725|12423007|FG000|Overall Study|Adverse Event|5
7907870|NCT02025725|12423008|FG001|Overall Study|Adverse Event|0
7907871|NCT02025725|12423007|FG000|Overall Study|Lost to Follow-up|2
7907872|NCT02025725|12423008|FG001|Overall Study|Lost to Follow-up|0
7907873|NCT02025725|12423007|FG000|Overall Study|Protocol Violation|1
7907874|NCT02025725|12423008|FG001|Overall Study|Protocol Violation|1
7907875|NCT02025725|12423007|FG000|Overall Study|Withdrawal by Subject|3
7907876|NCT02025725|12423008|FG001|Overall Study|Withdrawal by Subject|2
7907877|NCT02025725|12423007|FG000|Overall Study|Post-dose QTcB > 270 msec|0
7907878|NCT02025725|12423008|FG001|Overall Study|Post-dose QTcB > 270 msec|1
7907879|NCT02025751|12423018|FG000|Overall Study|Lost to Follow-up|1
7907880|NCT02025751|12423019|FG001|Overall Study|Lost to Follow-up|0
7907881|NCT02025751|12423018|FG000|Overall Study|Adverse Event|0
7718990|NCT00529789|12142901|FG000|Study Period II/III|Lack of Efficacy|2
7907882|NCT02025751|12423019|FG001|Overall Study|Adverse Event|1
7907883|NCT02025751|12423018|FG000|Overall Study|Physician Decision|0
7907884|NCT02025751|12423019|FG001|Overall Study|Physician Decision|1
7907885|NCT02025751|12423018|FG000|Overall Study|Withdrawal by Subject|0
7907886|NCT02025751|12423019|FG001|Overall Study|Withdrawal by Subject|1
7907887|NCT02025907|12423037|FG000|Overall Study|Lack of Efficacy|1
7907888|NCT02025907|12423038|FG001|Overall Study|Lack of Efficacy|0
7907889|NCT02025907|12423037|FG000|Overall Study|Withdrawal by Subject|15
7907890|NCT02025907|12423038|FG001|Overall Study|Withdrawal by Subject|8
7907891|NCT02025907|12423037|FG000|Overall Study|Protocol Violation|2
7907892|NCT02025907|12423038|FG001|Overall Study|Protocol Violation|0
7907893|NCT02025907|12423037|FG000|Overall Study|Physician Decision|2
7907894|NCT02025907|12423038|FG001|Overall Study|Physician Decision|0
7907895|NCT02025907|12423037|FG000|Overall Study|Lost to Follow-up|2
7907896|NCT02025907|12423038|FG001|Overall Study|Lost to Follow-up|2
7907897|NCT02025907|12423037|FG000|Overall Study|Adverse Event|3
7907898|NCT02025907|12423038|FG001|Overall Study|Adverse Event|1
7907899|NCT02025907|12423037|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2
7907900|NCT02025907|12423038|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1
7907901|NCT02025985|12423049|FG000|Overall Study|Consent withdrawn|0
7907902|NCT02025985|12423050|FG001|Overall Study|Consent withdrawn|0
7907903|NCT02025985|12423051|FG002|Overall Study|Consent withdrawn|1
7907904|NCT02025985|12423052|FG003|Overall Study|Consent withdrawn|0
7907905|NCT02025985|12423053|FG004|Overall Study|Consent withdrawn|0
7907906|NCT02025985|12423049|FG000|Overall Study|Termination of study by Sponsor|4
7907907|NCT02025985|12423050|FG001|Overall Study|Termination of study by Sponsor|3
7907908|NCT02025985|12423051|FG002|Overall Study|Termination of study by Sponsor|1
7907909|NCT02025985|12423052|FG003|Overall Study|Termination of study by Sponsor|1
7907910|NCT02025985|12423053|FG004|Overall Study|Termination of study by Sponsor|3
7907911|NCT02025985|12423049|FG000|Overall Study|Death|21
7907912|NCT02025985|12423050|FG001|Overall Study|Death|20
7907913|NCT02025985|12423051|FG002|Overall Study|Death|23
7907914|NCT02025985|12423052|FG003|Overall Study|Death|20
7907915|NCT02025985|12423053|FG004|Overall Study|Death|17
7907916|NCT02026011|12423069|FG000|Allocation 1 (First Set of Medication)|Side Effects|6
7907917|NCT02026011|12423070|FG001|Allocation 1 (First Set of Medication)|Side Effects|0
7907918|NCT02026011|12423069|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1
7907919|NCT02026011|12423070|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2
7907920|NCT02026011|12423069|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1
7907921|NCT02026011|12423070|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0
7907922|NCT02026011|12423069|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1
7907923|NCT02026011|12423070|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2
7907924|NCT02026063|12423081|FG000|Overall Study|Physician Decision|0
7907925|NCT02026063|12423082|FG001|Overall Study|Physician Decision|10
7907926|NCT02026063|12423081|FG000|Overall Study|Noncompliance with Study Drug|1
7907927|NCT02026063|12423082|FG001|Overall Study|Noncompliance with Study Drug|1
7907928|NCT02026063|12423081|FG000|Overall Study|Withdrawal of Consent|1
7907929|NCT02026063|12423082|FG001|Overall Study|Withdrawal of Consent|6
7907930|NCT02026063|12423081|FG000|Overall Study|Adverse Event|5
7907931|NCT02026063|12423082|FG001|Overall Study|Adverse Event|20
7907932|NCT02026063|12423081|FG000|Overall Study|Lack of Efficacy|0
7907933|NCT02026063|12423082|FG001|Overall Study|Lack of Efficacy|4
7907934|NCT02026063|12423081|FG000|Overall Study|Lost to Follow-up|0
7907935|NCT02026063|12423082|FG001|Overall Study|Lost to Follow-up|1
7907936|NCT02026063|12423081|FG000|Overall Study|Reason not Specified|2
7907937|NCT02026063|12423082|FG001|Overall Study|Reason not Specified|7
7907938|NCT02026141|12423091|FG000|Overall Study|Protocol Violation|0
7907939|NCT02026141|12423092|FG001|Overall Study|Protocol Violation|1
7907940|NCT02026258|12423118|FG000|Randomized|Did not start treatment|2
7907941|NCT02026258|12423119|FG001|Randomized|Did not start treatment|1
7907942|NCT02026258|12423118|FG000|Randomized|Change in treatment plan|1
7907943|NCT02026258|12423119|FG001|Randomized|Change in treatment plan|0
7907944|NCT02026258|12423118|FG000|Randomized|Presence of periodontal disease|1
7907945|NCT02026258|12423119|FG001|Randomized|Presence of periodontal disease|1
7907946|NCT02026258|12423118|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1
7907947|NCT02026258|12423119|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1
7907948|NCT02026258|12423118|FG000|Recieved Allocated Intervention|Lost to Follow-up|0
7718991|NCT00529789|12142901|FG000|Study Period II/III|Withdrawal by Subject|1
7718992|NCT00529789|12142901|FG000|Study Period II/III|Protocol Violation|3
7907949|NCT02026258|12423119|FG001|Recieved Allocated Intervention|Lost to Follow-up|1
7907950|NCT02027025|12423160|FG000|Overall Study|Adverse Event|0
7907951|NCT02027025|12423161|FG001|Overall Study|Adverse Event|1
7907952|NCT02027025|12423162|FG002|Overall Study|Adverse Event|1
7907953|NCT02027025|12423160|FG000|Overall Study|Protocol Violation|1
7907954|NCT02027025|12423161|FG001|Overall Study|Protocol Violation|0
7907955|NCT02027025|12423162|FG002|Overall Study|Protocol Violation|0
7907956|NCT02027025|12423160|FG000|Overall Study|Lost to Follow-up|0
7907957|NCT02027025|12423161|FG001|Overall Study|Lost to Follow-up|2
7907958|NCT02027025|12423162|FG002|Overall Study|Lost to Follow-up|0
7907959|NCT02027025|12423160|FG000|Overall Study|Withdrawal by Subject|0
7907960|NCT02027025|12423161|FG001|Overall Study|Withdrawal by Subject|1
7907961|NCT02027025|12423162|FG002|Overall Study|Withdrawal by Subject|0
7907962|NCT02027025|12423160|FG000|Overall Study|Sponsor's decision|0
7907963|NCT02027025|12423161|FG001|Overall Study|Sponsor's decision|1
7718993|NCT00529789|12142901|FG000|Study Period II/III|Physician Decision|3
7718994|NCT00529789|12142901|FG000|Study Period II/III|Lost to Follow-up|3
7718995|NCT00529789|12142901|FG000|Study Period IV|Parent/Caregiver Decision|1
7718996|NCT00529789|12142901|FG000|Study Period IV|Adverse Event|1
7718997|NCT00529789|12142901|FG000|Study Period IV|Lack of Efficacy|1
7718998|NCT00529789|12142901|FG000|Study Period IV|Lost to Follow-up|3
7718999|NCT00529802|12142911|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
7719000|NCT00529802|12142911|FG000|Evaluable for Primary Endpoint|Worsening performance status|2
7719001|NCT00529802|12142911|FG000|Evaluable for Primary Endpoint|Adverse Event|2
7719002|NCT00529802|12142911|FG000|Evaluable for Primary Endpoint|Death|1
7719003|NCT00529802|12142911|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1
7719004|NCT00529802|12142911|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1
7719005|NCT00529802|12142911|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
7719006|NCT00529958|12142920|FG000|2-Year Follow-up|Lost to Follow-up|1
7719007|NCT00529958|12142921|FG001|2-Year Follow-up|Lost to Follow-up|2
7719008|NCT00529958|12142922|FG002|2-Year Follow-up|Lost to Follow-up|2
7719009|NCT00529958|12142920|FG000|2-Year Follow-up|Withdrawal by Subject|3
7719010|NCT00529958|12142921|FG001|2-Year Follow-up|Withdrawal by Subject|0
7719011|NCT00529958|12142922|FG002|2-Year Follow-up|Withdrawal by Subject|0
7719012|NCT00529958|12142920|FG000|5-Year Follow-up|Lost to Follow-up|2
7719013|NCT00529958|12142921|FG001|5-Year Follow-up|Lost to Follow-up|3
7719014|NCT00529958|12142922|FG002|5-Year Follow-up|Lost to Follow-up|1
7719015|NCT00529958|12142920|FG000|5-Year Follow-up|Withdrawal by Subject|1
7719016|NCT00529958|12142921|FG001|5-Year Follow-up|Withdrawal by Subject|0
7719017|NCT00529958|12142922|FG002|5-Year Follow-up|Withdrawal by Subject|0
7719018|NCT00530023|12142932|FG000|Overall Study|Withdrawal by Subject|0
7719019|NCT00530023|12142933|FG001|Overall Study|Withdrawal by Subject|1
7719020|NCT00530075|12142939|FG000|Overall Study|Adverse Event|1
7719021|NCT00530075|12142939|FG000|Overall Study|Death|1
7719022|NCT00530075|12142939|FG000|Overall Study|Lack of Efficacy|3
7719023|NCT00530075|12142939|FG000|Overall Study|Protocol Violation|1
7719024|NCT00530075|12142939|FG000|Overall Study|Withdrawal by Subject|1
7719025|NCT00530088|12142943|FG000|Overall Study|Disease Progression|4
7719026|NCT00530088|12142943|FG000|Overall Study|Physician Decision|4
7719027|NCT00530088|12142943|FG000|Overall Study|Other Not Specified|2
7719028|NCT00530218|12142947|FG000|Overall Study|CMV Not Detected|13
7719029|NCT00530218|12142947|FG000|Overall Study|Death|12
7719030|NCT00530257|12142954|FG000|Overall Study|Lost to Follow-up|1
7719031|NCT00530270|12142963|FG000|Overall Study|Protocol Violation|1
7907964|NCT02027025|12423162|FG002|Overall Study|Sponsor's decision|0
7907965|NCT02027311|12423183|FG000|Overall Study|Protocol Violation|3
7907966|NCT02027311|12423184|FG001|Overall Study|Protocol Violation|2
7907967|NCT02027376|12423192|FG000|Overall Study|Death|1
7907968|NCT02027376|12423193|FG001|Overall Study|Death|0
7907969|NCT02027376|12423194|FG002|Overall Study|Death|0
7907970|NCT02027402|12423206|FG000|Overall Study|Withdrawal by Subject|4
7907971|NCT02027402|12423207|FG001|Overall Study|Withdrawal by Subject|1
7907972|NCT02027428|12423217|FG000|Induction|Never treated|7
7907973|NCT02027428|12423218|FG001|Induction|Never treated|0
7907974|NCT02027428|12423219|FG002|Induction|Never treated|0
7907975|NCT02027428|12423217|FG000|Induction|Progressive disease|77
7907976|NCT02027428|12423218|FG001|Induction|Progressive disease|0
7907977|NCT02027428|12423219|FG002|Induction|Progressive disease|0
7907978|NCT02027428|12423217|FG000|Induction|Adverse Event|51
7907979|NCT02027428|12423218|FG001|Induction|Adverse Event|0
7907980|NCT02027428|12423219|FG002|Induction|Adverse Event|0
7907981|NCT02027428|12423217|FG000|Induction|Withdrawal by Subject|22
7811655|NCT01185288|12275571|FG000|Overall Study|Withdrawal by Subject|6
7811656|NCT01185288|12275572|FG001|Overall Study|Withdrawal by Subject|4
7811657|NCT01185288|12275571|FG000|Overall Study|Lost to Follow-up|2
7811658|NCT01185288|12275572|FG001|Overall Study|Lost to Follow-up|5
7811659|NCT01185288|12275571|FG000|Overall Study|Lack of Efficacy|2
7811660|NCT01185288|12275572|FG001|Overall Study|Lack of Efficacy|0
7811661|NCT01185288|12275571|FG000|Overall Study|Investigator discretion|1
7811662|NCT01185288|12275572|FG001|Overall Study|Investigator discretion|0
7811663|NCT01185288|12275571|FG000|Overall Study|Did not meet inclusion criteria|1
7811664|NCT01185288|12275572|FG001|Overall Study|Did not meet inclusion criteria|0
7811665|NCT01185288|12275571|FG000|Overall Study|Noncompliance|0
7811666|NCT01185288|12275572|FG001|Overall Study|Noncompliance|1
7811667|NCT01185301|12275582|FG000|Overall Study|Adverse Event|3
7811668|NCT01185301|12275583|FG001|Overall Study|Adverse Event|0
7811669|NCT01185301|12275584|FG002|Overall Study|Adverse Event|2
7811670|NCT01185301|12275585|FG003|Overall Study|Adverse Event|3
7811671|NCT01185301|12275582|FG000|Overall Study|Withdrawal by Subject|7
7811672|NCT01185301|12275583|FG001|Overall Study|Withdrawal by Subject|5
7811673|NCT01185301|12275584|FG002|Overall Study|Withdrawal by Subject|2
7811674|NCT01185301|12275585|FG003|Overall Study|Withdrawal by Subject|3
7811675|NCT01185301|12275582|FG000|Overall Study|Lost to Follow-up|2
7811676|NCT01185301|12275583|FG001|Overall Study|Lost to Follow-up|0
7811677|NCT01185301|12275584|FG002|Overall Study|Lost to Follow-up|0
7811678|NCT01185301|12275585|FG003|Overall Study|Lost to Follow-up|1
7811679|NCT01185301|12275582|FG000|Overall Study|Other Reason|3
7811680|NCT01185301|12275583|FG001|Overall Study|Other Reason|2
7811681|NCT01185301|12275584|FG002|Overall Study|Other Reason|2
7811682|NCT01185301|12275585|FG003|Overall Study|Other Reason|2
7811683|NCT01185340|12275598|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
7811684|NCT01185340|12275599|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7811685|NCT01185340|12275600|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7811686|NCT01185340|12275601|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7811687|NCT01185340|12275598|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
7811688|NCT01185340|12275599|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7811689|NCT01185340|12275600|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7811690|NCT01185340|12275601|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7907982|NCT02027428|12423218|FG001|Induction|Withdrawal by Subject|0
7907983|NCT02027428|12423219|FG002|Induction|Withdrawal by Subject|0
7883587|NCT01782885|12383313|FG000|Overall Study|Lost to Follow-up|4
7907984|NCT02027428|12423217|FG000|Induction|Death|21
7907985|NCT02027428|12423218|FG001|Induction|Death|0
7907986|NCT02027428|12423219|FG002|Induction|Death|0
7907987|NCT02027428|12423217|FG000|Induction|Symptomatic deterioration|16
7907988|NCT02027428|12423218|FG001|Induction|Symptomatic deterioration|0
7907989|NCT02027428|12423219|FG002|Induction|Symptomatic deterioration|0
7907990|NCT02027428|12423217|FG000|Induction|Study terminated by sponsor|12
7907991|NCT02027428|12423218|FG001|Induction|Study terminated by sponsor|0
7907992|NCT02027428|12423219|FG002|Induction|Study terminated by sponsor|0
7907993|NCT02027428|12423217|FG000|Induction|Protocol Violation|1
7907994|NCT02027428|12423218|FG001|Induction|Protocol Violation|0
7907995|NCT02027428|12423219|FG002|Induction|Protocol Violation|0
7907996|NCT02027428|12423217|FG000|Induction|Miscellaneous|14
7907997|NCT02027428|12423218|FG001|Induction|Miscellaneous|0
7907998|NCT02027428|12423219|FG002|Induction|Miscellaneous|0
7907999|NCT02027428|12423217|FG000|Induction|Induction Treatment Ongoing|4
7908000|NCT02027428|12423218|FG001|Induction|Induction Treatment Ongoing|0
7908001|NCT02027428|12423219|FG002|Induction|Induction Treatment Ongoing|0
7908002|NCT02027428|12423217|FG000|Maintenance|Death|0
7908003|NCT02027428|12423218|FG001|Maintenance|Death|3
7908004|NCT02027428|12423219|FG002|Maintenance|Death|2
7908005|NCT02027428|12423217|FG000|Maintenance|Adverse Event|0
7908006|NCT02027428|12423218|FG001|Maintenance|Adverse Event|21
7908007|NCT02027428|12423219|FG002|Maintenance|Adverse Event|1
7908008|NCT02027428|12423217|FG000|Maintenance|Progressive disease|0
7908009|NCT02027428|12423218|FG001|Maintenance|Progressive disease|84
7908010|NCT02027428|12423219|FG002|Maintenance|Progressive disease|47
7908011|NCT02027428|12423217|FG000|Maintenance|Symptomatic deterioration|0
7908012|NCT02027428|12423218|FG001|Maintenance|Symptomatic deterioration|4
7908013|NCT02027428|12423219|FG002|Maintenance|Symptomatic deterioration|1
7908014|NCT02027428|12423217|FG000|Maintenance|Withdrawal by Subject|0
7908015|NCT02027428|12423218|FG001|Maintenance|Withdrawal by Subject|6
7908016|NCT02027428|12423219|FG002|Maintenance|Withdrawal by Subject|5
7908017|NCT02027428|12423217|FG000|Maintenance|Protocol Violation|0
7908018|NCT02027428|12423218|FG001|Maintenance|Protocol Violation|0
7908019|NCT02027428|12423219|FG002|Maintenance|Protocol Violation|1
7908020|NCT02027428|12423217|FG000|Maintenance|Other|0
7908021|NCT02027428|12423218|FG001|Maintenance|Other|6
7908022|NCT02027428|12423219|FG002|Maintenance|Other|3
7908023|NCT02027428|12423217|FG000|Survival Follow-up|Death|0
7908024|NCT02027428|12423218|FG001|Survival Follow-up|Death|78
7908025|NCT02027428|12423219|FG002|Survival Follow-up|Death|45
7908026|NCT02027428|12423217|FG000|Survival Follow-up|Lost to Follow-up|0
7908027|NCT02027428|12423218|FG001|Survival Follow-up|Lost to Follow-up|1
7908028|NCT02027428|12423219|FG002|Survival Follow-up|Lost to Follow-up|1
7908029|NCT02027545|12423244|FG000|Overall Study|Failed to sign HIPAA|0
7908030|NCT02027545|12423245|FG001|Overall Study|Failed to sign HIPAA|2
7908031|NCT02027545|12423244|FG000|Overall Study|Failed to attend study visit|2
7908032|NCT02027545|12423245|FG001|Overall Study|Failed to attend study visit|0
7908033|NCT02027558|12423253|FG000|Overall Study|Death|0
7908034|NCT02027558|12423254|FG001|Overall Study|Death|1
7908035|NCT02027558|12423253|FG000|Overall Study|Withdrawal by Subject|2
7908036|NCT02027558|12423254|FG001|Overall Study|Withdrawal by Subject|0
7908037|NCT02027558|12423253|FG000|Overall Study|Lost to Follow-up|4
7908038|NCT02027558|12423254|FG001|Overall Study|Lost to Follow-up|1
7908039|NCT02027558|12423253|FG000|Overall Study|Refused assessment|3
7908040|NCT02027558|12423254|FG001|Overall Study|Refused assessment|0
7908041|NCT02027623|12423264|FG000|Overall Study|Lost to Follow-up|3
7908042|NCT02027623|12423265|FG001|Overall Study|Lost to Follow-up|3
7908043|NCT02027623|12423264|FG000|Overall Study|Withdrawal by Subject|6
7883588|NCT01782885|12383314|FG001|Overall Study|Lost to Follow-up|6
7883589|NCT01783418|12383356|FG000|Overall Study|Withdrawal by Subject|1
7883590|NCT01783418|12383357|FG001|Overall Study|Withdrawal by Subject|0
7883591|NCT01783444|12383366|FG000|Treatment Phase|Adverse Event|9
7883592|NCT01783444|12383367|FG001|Treatment Phase|Adverse Event|20
7883593|NCT01783444|12383368|FG002|Treatment Phase|Adverse Event|19
7883594|NCT01783444|12383366|FG000|Treatment Phase|Disease Progression|76
7883595|NCT01783444|12383367|FG001|Treatment Phase|Disease Progression|66
7883596|NCT01783444|12383368|FG002|Treatment Phase|Disease Progression|64
7883597|NCT01783444|12383366|FG000|Treatment Phase|Death|2
7883598|NCT01783444|12383367|FG001|Treatment Phase|Death|2
7883599|NCT01783444|12383368|FG002|Treatment Phase|Death|2
7883600|NCT01783444|12383366|FG000|Treatment Phase|Protocol Violation|1
7883601|NCT01783444|12383367|FG001|Treatment Phase|Protocol Violation|1
7883602|NCT01783444|12383368|FG002|Treatment Phase|Protocol Violation|2
7908044|NCT02027623|12423265|FG001|Overall Study|Withdrawal by Subject|9
7908045|NCT02027701|12423272|FG000|Overall Study|Adverse Event|3
7908046|NCT02027701|12423272|FG000|Overall Study|Lack of Efficacy|8
7908047|NCT02027701|12423272|FG000|Overall Study|Physician Decision|2
7908048|NCT02027701|12423272|FG000|Overall Study|Withdrawal by Subject|3
7908049|NCT02027844|12423281|FG000|Overall Study|Withdrawal by Subject|3
7908050|NCT02027844|12423282|FG001|Overall Study|Withdrawal by Subject|2
7908051|NCT02027844|12423283|FG002|Overall Study|Withdrawal by Subject|1
7908052|NCT02027844|12423281|FG000|Overall Study|Lost to Follow-up|0
7908053|NCT02027844|12423282|FG001|Overall Study|Lost to Follow-up|2
7908054|NCT02027844|12423283|FG002|Overall Study|Lost to Follow-up|1
7908055|NCT02027844|12423281|FG000|Overall Study|Protocol Violation|0
7908056|NCT02027844|12423282|FG001|Overall Study|Protocol Violation|2
7908057|NCT02027844|12423283|FG002|Overall Study|Protocol Violation|0
7908058|NCT02027844|12423281|FG000|Overall Study|Incomlete data|2
7908059|NCT02027844|12423282|FG001|Overall Study|Incomlete data|0
7908060|NCT02027844|12423283|FG002|Overall Study|Incomlete data|0
7908061|NCT02028065|12423307|FG000|Randomization Through Start Treatment|Not treated|1
7908062|NCT02028065|12423308|FG001|Randomization Through Start Treatment|Not treated|3
7908063|NCT02028065|12423309|FG002|Randomization Through Start Treatment|Not treated|3
7908064|NCT02028065|12423307|FG000|Treatment Through Study Completion|Lost to Follow-up|2
7908065|NCT02028065|12423308|FG001|Treatment Through Study Completion|Lost to Follow-up|4
7811691|NCT01185340|12275598|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
7719032|NCT00530270|12142964|FG001|Overall Study|Protocol Violation|0
7719033|NCT00530335|12142970|FG000|Overall Study|Adverse Event|3
7719034|NCT00530335|12142970|FG000|Overall Study|Protocol Violation|1
7719035|NCT00530335|12142970|FG000|Overall Study|Withdrawal by Subject|1
7719036|NCT00530335|12142970|FG000|Overall Study|Physician Decision|1
7719037|NCT00530348|12142976|FG000|Overall Study|Adverse Event|5
7719038|NCT00530348|12142977|FG001|Overall Study|Adverse Event|1
7719039|NCT00530348|12142976|FG000|Overall Study|Death|0
7719040|NCT00530348|12142977|FG001|Overall Study|Death|1
7719041|NCT00530348|12142976|FG000|Overall Study|Lack of Efficacy|2
7719042|NCT00530348|12142977|FG001|Overall Study|Lack of Efficacy|0
7719043|NCT00530348|12142976|FG000|Overall Study|Lost to Follow-up|0
7719044|NCT00530348|12142977|FG001|Overall Study|Lost to Follow-up|2
7719045|NCT00530348|12142976|FG000|Overall Study|Physician Decision|1
7719046|NCT00530348|12142977|FG001|Overall Study|Physician Decision|2
7811692|NCT01185340|12275599|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7811693|NCT01185340|12275600|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7811694|NCT01185340|12275601|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7811695|NCT01185340|12275598|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
7811696|NCT01185340|12275599|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7811697|NCT01185340|12275600|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7811698|NCT01185340|12275601|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7811699|NCT01185340|12275598|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
7811700|NCT01185340|12275599|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7811701|NCT01185340|12275600|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7811702|NCT01185340|12275601|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7811703|NCT01185340|12275598|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
7811704|NCT01185340|12275599|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7908066|NCT02028065|12423309|FG002|Treatment Through Study Completion|Lost to Follow-up|6
7908067|NCT02028065|12423307|FG000|Treatment Through Study Completion|Physician Decision|1
7719047|NCT00530348|12142976|FG000|Overall Study|Pregnancy|1
7719048|NCT00530348|12142977|FG001|Overall Study|Pregnancy|0
7719049|NCT00530348|12142976|FG000|Overall Study|Withdrawal by Subject|12
7719050|NCT00530348|12142977|FG001|Overall Study|Withdrawal by Subject|12
7719051|NCT00530348|12142976|FG000|Overall Study|Randomised in error|1
7719052|NCT00530348|12142977|FG001|Overall Study|Randomised in error|0
7719053|NCT00530348|12142976|FG000|Overall Study|Noncompliance with inclusion criterion 3|0
7719054|NCT00530348|12142977|FG001|Overall Study|Noncompliance with inclusion criterion 3|1
7719055|NCT00530439|12142985|FG000|Overall Study|GDM|9
7719056|NCT00530439|12142986|FG001|Overall Study|GDM|3
7719057|NCT00530439|12142985|FG000|Overall Study|Withdraw|18
7719058|NCT00530439|12142986|FG001|Overall Study|Withdraw|14
7719059|NCT00530439|12142985|FG000|Overall Study|Missed abortion|1
7719060|NCT00530439|12142986|FG001|Overall Study|Missed abortion|4
7908068|NCT02028065|12423308|FG001|Treatment Through Study Completion|Physician Decision|0
7908069|NCT02028065|12423309|FG002|Treatment Through Study Completion|Physician Decision|0
7908070|NCT02028065|12423307|FG000|Treatment Through Study Completion|Protocol Violation|1
7908071|NCT02028065|12423308|FG001|Treatment Through Study Completion|Protocol Violation|4
7908072|NCT02028065|12423309|FG002|Treatment Through Study Completion|Protocol Violation|0
7908073|NCT02028065|12423307|FG000|Treatment Through Study Completion|Withdrawal by Subject|5
7908074|NCT02028065|12423308|FG001|Treatment Through Study Completion|Withdrawal by Subject|4
7908075|NCT02028065|12423309|FG002|Treatment Through Study Completion|Withdrawal by Subject|3
7908076|NCT02028065|12423307|FG000|Treatment Through Study Completion|Adverse Event|3
7908077|NCT02028065|12423308|FG001|Treatment Through Study Completion|Adverse Event|3
7908078|NCT02028065|12423309|FG002|Treatment Through Study Completion|Adverse Event|5
7908079|NCT02028169|12423317|FG000|Overall Study|Lost to Follow-up|21
7908080|NCT02028169|12423317|FG000|Overall Study|Lack of Efficacy|2
7908081|NCT02028169|12423317|FG000|Overall Study|Withdrawal by Subject|2
7908082|NCT02028169|12423317|FG000|Overall Study|Adverse Event|1
7908083|NCT02028169|12423317|FG000|Overall Study|Cessation of Drug|1
7908084|NCT02028169|12423317|FG000|Overall Study|Concomitant Medication Usage|1
7908085|NCT02028182|12423321|FG000|Overall Study|Protocol Violation|2
7908086|NCT02028715|12423399|FG000|Overall Study|Adverse Event|2
7908087|NCT02028715|12423400|FG001|Overall Study|Adverse Event|2
7908088|NCT02028715|12423399|FG000|Overall Study|Physician Decision|1
7908089|NCT02028715|12423400|FG001|Overall Study|Physician Decision|0
7908090|NCT02028715|12423399|FG000|Overall Study|Did not complete satisfaction surveys|2
7908091|NCT02028715|12423400|FG001|Overall Study|Did not complete satisfaction surveys|2
7908092|NCT02028767|12423415|FG000|Treatment Period 2|Non compliant with protocol|1
7908093|NCT02028767|12423416|FG001|Treatment Period 2|Non compliant with protocol|0
7908094|NCT02028767|12423415|FG000|Treatment Period 2|Reason other than those specified above|1
7908095|NCT02028767|12423416|FG001|Treatment Period 2|Reason other than those specified above|0
7908096|NCT02028871|12423491|FG000|Overall Study|Positive urine drug screen|1
7908097|NCT02028871|12423492|FG001|Overall Study|Positive urine drug screen|1
7908098|NCT02028871|12423491|FG000|Overall Study|Withdrawal by Subject|1
7908099|NCT02028871|12423492|FG001|Overall Study|Withdrawal by Subject|2
7908100|NCT02028871|12423491|FG000|Overall Study|IV placement difficulty|1
7908101|NCT02028871|12423492|FG001|Overall Study|IV placement difficulty|0
7908102|NCT02028871|12423491|FG000|Overall Study|Current Illness|1
7908103|NCT02028871|12423492|FG001|Overall Study|Current Illness|0
7908104|NCT02029235|12423521|FG000|Overall Study|Non-compliance with study meds or diary|4
7908105|NCT02029235|12423522|FG001|Overall Study|Non-compliance with study meds or diary|1
7908106|NCT02029274|12423532|FG000|Overall Study|Adverse Event|1
7908107|NCT02029274|12423533|FG001|Overall Study|Adverse Event|0
7908108|NCT02029274|12423534|FG002|Overall Study|Adverse Event|2
7908109|NCT02029274|12423535|FG003|Overall Study|Adverse Event|2
7908110|NCT02029417|12423549|FG000|Overall Study|Death|1
7908111|NCT02029417|12423549|FG000|Overall Study|Adverse Event|1
7964025|NCT02732951|12518980|FG000|Overall Study|Protocol Violation|0
7964026|NCT02732951|12518981|FG001|Overall Study|Protocol Violation|1
7964027|NCT02733367|12518987|FG000|Overall Study|Withdrawal by Subject|6
7964028|NCT02733627|12519000|FG000|Overall Study|Adverse Event|0
7964029|NCT02733627|12519001|FG001|Overall Study|Adverse Event|1
7964030|NCT02733627|12519002|FG002|Overall Study|Adverse Event|1
7964031|NCT02733627|12519003|FG003|Overall Study|Adverse Event|0
7964032|NCT02733627|12519000|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
7964033|NCT02733627|12519001|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
7966873|NCT02757352|12523230|FG008|Follow-Up Period|Withdrawal by Subject|6
7719061|NCT00530439|12142985|FG000|Overall Study|Misclassification|2
7719062|NCT00530439|12142986|FG001|Overall Study|Misclassification|0
7908112|NCT02029521|12423568|FG000|Overall Study|Protocol Violation|1
7908113|NCT02029521|12423569|FG001|Overall Study|Protocol Violation|0
7908114|NCT02029521|12423568|FG000|Overall Study|Withdrawal by Subject|1
7908115|NCT02029521|12423569|FG001|Overall Study|Withdrawal by Subject|1
7908116|NCT02029638|12423581|FG000|Overall Study|Death|0
7908117|NCT02029638|12423582|FG001|Overall Study|Death|0
7908118|NCT02029638|12423583|FG002|Overall Study|Death|1
7908119|NCT02029638|12423581|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2
7719063|NCT00530439|12142985|FG000|Overall Study|Twin pregnancy|0
7719064|NCT00530439|12142986|FG001|Overall Study|Twin pregnancy|2
7719065|NCT00530439|12142985|FG000|Overall Study|Severe malformation/abortion|0
7719066|NCT00530439|12142986|FG001|Overall Study|Severe malformation/abortion|3
7719067|NCT00530504|12142992|FG000|Overall Study|Death|54
7811705|NCT01185340|12275600|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7811706|NCT01185340|12275601|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7811707|NCT01185340|12275598|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
7908120|NCT02029638|12423582|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0
7908121|NCT02029638|12423583|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0
7908122|NCT02029976|12423628|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12
7908123|NCT02029976|12423629|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8
7908124|NCT02029976|12423628|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8
7908125|NCT02029976|12423629|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4
7908126|NCT02029976|12423628|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
7719068|NCT00530504|12142992|FG000|Overall Study|Lost to Follow-up|26
7719069|NCT00530504|12142992|FG000|Overall Study|Withdrawal by Subject|39
7719070|NCT00530504|12142992|FG000|Overall Study|Exited study due to other reasons|33
7719071|NCT00530621|12142998|FG000|Overall Study|Adverse Event|11
7719072|NCT00530621|12142999|FG001|Overall Study|Adverse Event|8
7719073|NCT00530621|12142998|FG000|Overall Study|Physician Decision|2
7719074|NCT00530621|12142999|FG001|Overall Study|Physician Decision|4
7719075|NCT00530621|12142998|FG000|Overall Study|Progressive Disease (PD)|47
7719076|NCT00530621|12142999|FG001|Overall Study|Progressive Disease (PD)|40
7719077|NCT00530621|12142998|FG000|Overall Study|Sponsor Decision|12
7719078|NCT00530621|12142999|FG001|Overall Study|Sponsor Decision|15
7719079|NCT00530621|12142998|FG000|Overall Study|Subject Decision|4
7719080|NCT00530621|12142999|FG001|Overall Study|Subject Decision|7
7719081|NCT00530621|12142998|FG000|Overall Study|Death|3
7719082|NCT00530621|12142999|FG001|Overall Study|Death|6
7719083|NCT00530621|12142998|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1
7719084|NCT00530621|12142999|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0
7719085|NCT00530712|12143013|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2
7719086|NCT00530712|12143013|FG000|30 Day Follow-up Visit|Missed Visit|5
7719087|NCT00530712|12143013|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4
7719088|NCT00530712|12143013|FG000|6 Month Follow-up Visit|Missed Visit|3
7719089|NCT00530712|12143013|FG000|6 Month Follow-up Visit|Lost to Follow-up|3
7719090|NCT00530712|12143013|FG000|6 Month Follow-up Visit|Death|2
7719091|NCT00530712|12143013|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5
7719092|NCT00530712|12143013|FG000|12 Month Follow-up Visit|Missed Visit|3
7719093|NCT00530712|12143013|FG000|12 Month Follow-up Visit|Lost to Follow-up|7
7719094|NCT00530712|12143013|FG000|12 Month Follow-up Visit|Death|9
7767829|NCT00856284|12210626|FG002|Overall Study|Hyperglycemic rescue|235
7767830|NCT00856284|12210624|FG000|Overall Study|Adverse Event|60
7767831|NCT00856284|12210625|FG001|Overall Study|Adverse Event|74
7767832|NCT00856284|12210626|FG002|Overall Study|Adverse Event|82
7767833|NCT00856284|12210624|FG000|Overall Study|Major protocol deviation|24
7767834|NCT00856284|12210625|FG001|Overall Study|Major protocol deviation|16
7908127|NCT02029976|12423629|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
7908128|NCT02029976|12423628|FG000|YR-2 Follow Up vs Baseline|Moved from area|0
7908129|NCT02029976|12423629|FG001|YR-2 Follow Up vs Baseline|Moved from area|2
7908130|NCT02029989|12423637|FG000|Overall Study|Withdrawal by Subject|1
7908131|NCT02029989|12423638|FG001|Overall Study|Withdrawal by Subject|0
7908132|NCT02029989|12423637|FG000|Overall Study|Withdrawal: Fear of needles|1
7908133|NCT02029989|12423638|FG001|Overall Study|Withdrawal: Fear of needles|0
7908134|NCT02029989|12423637|FG000|Overall Study|Change of location|2
7908135|NCT02029989|12423638|FG001|Overall Study|Change of location|3
7908136|NCT02029989|12423637|FG000|Overall Study|Physician Decision|2
7908137|NCT02029989|12423638|FG001|Overall Study|Physician Decision|0
7908138|NCT02029989|12423637|FG000|Overall Study|Lost to Follow-up|9
7908139|NCT02029989|12423638|FG001|Overall Study|Lost to Follow-up|7
7908140|NCT02029989|12423637|FG000|Overall Study|Death|0
7908141|NCT02029989|12423638|FG001|Overall Study|Death|1
7908142|NCT02029989|12423637|FG000|Overall Study|Protocol Violation|1
7767835|NCT00856284|12210626|FG002|Overall Study|Major protocol deviation|15
7767836|NCT00856284|12210624|FG000|Overall Study|Lost to Follow-up|20
7908143|NCT02029989|12423638|FG001|Overall Study|Protocol Violation|0
7908144|NCT02030002|12423644|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1
7908145|NCT02030002|12423644|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4
7908146|NCT02030002|12423644|FG000|Follow-up|Lost to Follow-up|2
7908147|NCT02030041|12423653|FG000|Overall Study|Withdrawal by Subject|2
7908148|NCT02030041|12423654|FG001|Overall Study|Withdrawal by Subject|2
7908149|NCT02030041|12423655|FG002|Overall Study|Withdrawal by Subject|1
7719095|NCT00530777|12143040|FG000|Overall Study|Lost to Follow-up|0
7719096|NCT00530777|12143041|FG001|Overall Study|Lost to Follow-up|1
7719097|NCT00530777|12143040|FG000|Overall Study|Death|1
7719098|NCT00530777|12143041|FG001|Overall Study|Death|2
7719099|NCT00530777|12143040|FG000|Overall Study|Physician Decision|1
7719100|NCT00530777|12143041|FG001|Overall Study|Physician Decision|0
7719101|NCT00530777|12143040|FG000|Overall Study|Withdrawal by Subject|0
7719102|NCT00530777|12143041|FG001|Overall Study|Withdrawal by Subject|1
7719103|NCT00530777|12143040|FG000|Overall Study|Unable to adhere to visit schedule|5
7719104|NCT00530777|12143041|FG001|Overall Study|Unable to adhere to visit schedule|1
7719105|NCT00530790|12143047|FG000|Overall Study|Adverse Event|2
7719106|NCT00530790|12143047|FG000|Overall Study|Withdrawal by Subject|2
7719107|NCT00530790|12143047|FG000|Overall Study|Physician Decision|1
7719108|NCT00530816|12143063|FG000|Overall Study|Progressive Disease|16
7719109|NCT00530816|12143064|FG001|Overall Study|Progressive Disease|24
7719110|NCT00530816|12143065|FG002|Overall Study|Progressive Disease|24
7908150|NCT02030119|12423684|FG000|Overall Study|Withdrawal by Subject|3
7908151|NCT02030119|12423685|FG001|Overall Study|Withdrawal by Subject|1
7908152|NCT02030119|12423686|FG002|Overall Study|Withdrawal by Subject|5
7908153|NCT02030119|12423687|FG003|Overall Study|Withdrawal by Subject|3
7908154|NCT02030119|12423684|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0
7908155|NCT02030119|12423685|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1
7908156|NCT02030119|12423686|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1
7908157|NCT02030119|12423687|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0
7908158|NCT02030405|12423710|FG000|Overall Study|Withdrawal by Subject|1
7908159|NCT02030405|12423710|FG000|Overall Study|Lost to Follow-up|1
7908160|NCT02030535|12423715|FG000|Washout Period 1 (21 Days)|Adverse Event|1
7908161|NCT02030600|12423735|FG000|Treatment Period 1|Adverse Event|5
7908162|NCT02030600|12423736|FG001|Treatment Period 1|Adverse Event|7
7908163|NCT02030600|12423735|FG000|Treatment Period 1|Lack of Efficacy|0
7908164|NCT02030600|12423736|FG001|Treatment Period 1|Lack of Efficacy|1
7908165|NCT02030600|12423735|FG000|Treatment Period 1|Lost to Follow-up|11
7908166|NCT02030600|12423736|FG001|Treatment Period 1|Lost to Follow-up|3
7908167|NCT02030600|12423735|FG000|Treatment Period 1|Protocol Violation|22
7908168|NCT02030600|12423736|FG001|Treatment Period 1|Protocol Violation|17
7908169|NCT02030600|12423735|FG000|Treatment Period 1|Withdrawal by Subject|13
7908170|NCT02030600|12423736|FG001|Treatment Period 1|Withdrawal by Subject|17
7908171|NCT02030600|12423735|FG000|Treatment Period 1|Casebook Unsigned|1
7908172|NCT02030600|12423736|FG001|Treatment Period 1|Casebook Unsigned|0
7908173|NCT02030600|12423735|FG000|Treatment Period 1|Unclassified|1
7908174|NCT02030600|12423736|FG001|Treatment Period 1|Unclassified|0
7908175|NCT02030600|12423735|FG000|Treatment Period 2|Adverse Event|4
7908176|NCT02030600|12423736|FG001|Treatment Period 2|Adverse Event|4
7908177|NCT02030600|12423735|FG000|Treatment Period 2|Lack of Efficacy|2
7908178|NCT02030600|12423736|FG001|Treatment Period 2|Lack of Efficacy|1
7908179|NCT02030600|12423735|FG000|Treatment Period 2|Lost to Follow-up|4
7908180|NCT02030600|12423736|FG001|Treatment Period 2|Lost to Follow-up|2
7908181|NCT02030600|12423735|FG000|Treatment Period 2|Protocol Violation|1
7908182|NCT02030600|12423736|FG001|Treatment Period 2|Protocol Violation|2
7908183|NCT02030600|12423735|FG000|Treatment Period 2|Withdrawal by Subject|13
7908184|NCT02030600|12423736|FG001|Treatment Period 2|Withdrawal by Subject|9
7908185|NCT02030600|12423735|FG000|Treatment Period 2|Unclassified|1
7908186|NCT02030600|12423736|FG001|Treatment Period 2|Unclassified|0
7908187|NCT02030821|12423748|FG000|Overall Study|Physician Decision|2
7908188|NCT02030821|12423749|FG001|Overall Study|Physician Decision|2
7908189|NCT02030821|12423750|FG002|Overall Study|Physician Decision|5
7908190|NCT02030821|12423751|FG003|Overall Study|Physician Decision|2
7908191|NCT02030834|12423764|FG000|Overall Study|Death|4
7908192|NCT02030834|12423765|FG001|Overall Study|Death|0
7908193|NCT02030834|12423766|FG002|Overall Study|Death|0
7908194|NCT02030834|12423764|FG000|Overall Study|Manufacturing failure|2
7908195|NCT02030834|12423765|FG001|Overall Study|Manufacturing failure|0
7908196|NCT02030834|12423766|FG002|Overall Study|Manufacturing failure|1
7908197|NCT02030834|12423764|FG000|Overall Study|Disease progression|2
7908198|NCT02030834|12423765|FG001|Overall Study|Disease progression|0
7908199|NCT02030834|12423766|FG002|Overall Study|Disease progression|2
7908200|NCT02030834|12423764|FG000|Overall Study|Lost to Follow-up|1
7908201|NCT02030834|12423765|FG001|Overall Study|Lost to Follow-up|0
7908202|NCT02030834|12423766|FG002|Overall Study|Lost to Follow-up|0
7908203|NCT02030834|12423764|FG000|Overall Study|Withdrawal by Subject|1
7908204|NCT02030834|12423765|FG001|Overall Study|Withdrawal by Subject|0
7908205|NCT02030834|12423766|FG002|Overall Study|Withdrawal by Subject|0
7908206|NCT02030834|12423764|FG000|Overall Study|Lack of funding|1
7908207|NCT02030834|12423765|FG001|Overall Study|Lack of funding|0
7908208|NCT02030834|12423766|FG002|Overall Study|Lack of funding|0
7908209|NCT02030847|12423774|FG000|Overall Study|Death|10
7908210|NCT02030847|12423774|FG000|Overall Study|Disease Progression|15
7908211|NCT02030847|12423774|FG000|Overall Study|New Cancer Therapy|8
7908212|NCT02030847|12423774|FG000|Overall Study|Physician Decision|3
7908213|NCT02030847|12423774|FG000|Overall Study|Withdrawal by Subject|1
7908214|NCT02031146|12423792|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0
7908215|NCT02031146|12423793|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0
7908216|NCT02031146|12423794|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0
7908217|NCT02031146|12423795|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100
7908218|NCT02031146|12423796|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26
7908219|NCT02031146|12423797|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4
7908220|NCT02031146|12423798|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5
7908221|NCT02031237|12423810|FG000|Overall Study|Death|1
7908222|NCT02031237|12423811|FG001|Overall Study|Death|5
7908223|NCT02031237|12423812|FG002|Overall Study|Death|0
7908224|NCT02031237|12423810|FG000|Overall Study|Physician Decision|0
7908225|NCT02031237|12423811|FG001|Overall Study|Physician Decision|1
7908226|NCT02031237|12423812|FG002|Overall Study|Physician Decision|0
7908227|NCT02031237|12423810|FG000|Overall Study|Withdrawal by Subject|2
7908228|NCT02031237|12423811|FG001|Overall Study|Withdrawal by Subject|2
7908229|NCT02031237|12423812|FG002|Overall Study|Withdrawal by Subject|0
7908230|NCT02031237|12423810|FG000|Overall Study|Protocol Violation|2
7908231|NCT02031237|12423811|FG001|Overall Study|Protocol Violation|6
7908232|NCT02031237|12423812|FG002|Overall Study|Protocol Violation|0
7908233|NCT02031237|12423810|FG000|Overall Study|Alternate Treatment Given|0
7908234|NCT02031237|12423811|FG001|Overall Study|Alternate Treatment Given|0
7908235|NCT02031237|12423812|FG002|Overall Study|Alternate Treatment Given|3
7908236|NCT02031276|12423822|FG000|Period 1 Double-blind IV|Adverse Event|6
7908237|NCT02031276|12423823|FG001|Period 1 Double-blind IV|Adverse Event|5
7908238|NCT02031276|12423824|FG002|Period 1 Double-blind IV|Adverse Event|1
7908239|NCT02031276|12423822|FG000|Period 1 Double-blind IV|Other|0
7908240|NCT02031276|12423823|FG001|Period 1 Double-blind IV|Other|1
7908241|NCT02031276|12423824|FG002|Period 1 Double-blind IV|Other|0
7908242|NCT02031276|12423822|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1
7908243|NCT02031276|12423823|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0
7908244|NCT02031276|12423824|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0
7908245|NCT02031276|12423822|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
7908246|NCT02031276|12423823|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
7908247|NCT02031276|12423824|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
7908248|NCT02031276|12423822|FG000|Period 2 Open-label Risankizumab IV|Other|0
7908249|NCT02031276|12423823|FG001|Period 2 Open-label Risankizumab IV|Other|2
7908250|NCT02031276|12423824|FG002|Period 2 Open-label Risankizumab IV|Other|1
7719111|NCT00530816|12143063|FG000|Overall Study|Adverse Event|6
7719112|NCT00530816|12143064|FG001|Overall Study|Adverse Event|13
7719113|NCT00530816|12143065|FG002|Overall Study|Adverse Event|7
7719114|NCT00530816|12143063|FG000|Overall Study|Other|3
7719115|NCT00530816|12143064|FG001|Overall Study|Other|3
7719116|NCT00530816|12143065|FG002|Overall Study|Other|4
7719117|NCT00530816|12143063|FG000|Overall Study|Withdrawal by Subject|1
7719118|NCT00530816|12143064|FG001|Overall Study|Withdrawal by Subject|2
7719119|NCT00530816|12143065|FG002|Overall Study|Withdrawal by Subject|6
7719120|NCT00530842|12143075|FG000|Overall Study|Adverse Event|10
7719121|NCT00530842|12143076|FG001|Overall Study|Adverse Event|6
7719122|NCT00530842|12143075|FG000|Overall Study|Lack of Efficacy|2
7719123|NCT00530842|12143076|FG001|Overall Study|Lack of Efficacy|1
7719124|NCT00530842|12143075|FG000|Overall Study|Lost to Follow-up|0
7719125|NCT00530842|12143076|FG001|Overall Study|Lost to Follow-up|4
7719126|NCT00530842|12143075|FG000|Overall Study|Protocol Violation|3
7719127|NCT00530842|12143076|FG001|Overall Study|Protocol Violation|2
7719128|NCT00530842|12143075|FG000|Overall Study|Withdrawal by Subject|4
7719129|NCT00530842|12143076|FG001|Overall Study|Withdrawal by Subject|5
7719130|NCT00530842|12143075|FG000|Overall Study|Individual different reasons|4
7719131|NCT00530842|12143076|FG001|Overall Study|Individual different reasons|3
7719132|NCT00530842|12143075|FG000|Period 1|Adverse Event|7
7719133|NCT00530842|12143076|FG001|Period 1|Adverse Event|3
7719134|NCT00530842|12143075|FG000|Period 1|Lack of Efficacy|1
7719135|NCT00530842|12143076|FG001|Period 1|Lack of Efficacy|1
7719136|NCT00530842|12143075|FG000|Period 1|Protocol Violation|2
7719137|NCT00530842|12143076|FG001|Period 1|Protocol Violation|1
7719138|NCT00530842|12143075|FG000|Period 1|Withdrawal by Subject|2
7719139|NCT00530842|12143076|FG001|Period 1|Withdrawal by Subject|3
7719140|NCT00530842|12143075|FG000|Period 1|Individual different reasons|2
7719141|NCT00530842|12143076|FG001|Period 1|Individual different reasons|3
7719142|NCT00530842|12143075|FG000|Period 2|Adverse Event|3
7719143|NCT00530842|12143076|FG001|Period 2|Adverse Event|3
7719144|NCT00530842|12143075|FG000|Period 2|Lack of Efficacy|1
7719145|NCT00530842|12143076|FG001|Period 2|Lack of Efficacy|0
7719146|NCT00530842|12143075|FG000|Period 2|Lost to Follow-up|0
7719147|NCT00530842|12143076|FG001|Period 2|Lost to Follow-up|4
7719148|NCT00530842|12143075|FG000|Period 2|Protocol Violation|1
7719149|NCT00530842|12143076|FG001|Period 2|Protocol Violation|0
7719150|NCT00530842|12143075|FG000|Period 2|Withdrawal by Subject|1
7719151|NCT00530842|12143076|FG001|Period 2|Withdrawal by Subject|2
7719152|NCT00530842|12143075|FG000|Period 2|Individual different reasons|2
7719153|NCT00530842|12143076|FG001|Period 2|Individual different reasons|0
7719154|NCT00530855|12143084|FG000|Overall Study|Lack of Efficacy|20
7719155|NCT00530855|12143084|FG000|Overall Study|Withdrawal by Subject|30
7719156|NCT00530855|12143084|FG000|Overall Study|Fatal Serious AE|3
7719157|NCT00530855|12143084|FG000|Overall Study|Non Fatal Serious AE|7
7719158|NCT00530855|12143084|FG000|Overall Study|Non Fatal Non Serious AE|12
7719159|NCT00530855|12143084|FG000|Overall Study|Protocol Violation|3
7719160|NCT00530855|12143084|FG000|Overall Study|Unsatisfactory compliance of subject|11
7719161|NCT00530855|12143084|FG000|Overall Study|Lost to Follow-up|9
7719162|NCT00530855|12143084|FG000|Overall Study|Other reason for premature termination|17
7719163|NCT00530894|12143092|FG000|Overall Study|Death|84
7719164|NCT00530894|12143093|FG001|Overall Study|Death|89
7719165|NCT00530894|12143094|FG002|Overall Study|Death|55
7719166|NCT00530894|12143095|FG003|Overall Study|Death|89
7719167|NCT00530894|12143092|FG000|Overall Study|Lost to Follow-up|1
7719168|NCT00530894|12143093|FG001|Overall Study|Lost to Follow-up|3
7719169|NCT00530894|12143094|FG002|Overall Study|Lost to Follow-up|0
7719170|NCT00530894|12143095|FG003|Overall Study|Lost to Follow-up|0
7719171|NCT00530894|12143092|FG000|Overall Study|Withdrawal by Subject|1
7719172|NCT00530894|12143093|FG001|Overall Study|Withdrawal by Subject|23
7719173|NCT00530894|12143094|FG002|Overall Study|Withdrawal by Subject|0
7719174|NCT00530894|12143095|FG003|Overall Study|Withdrawal by Subject|5
7719175|NCT00530894|12143092|FG000|Overall Study|Alive and censored prior to 1 year|2
7719176|NCT00530894|12143093|FG001|Overall Study|Alive and censored prior to 1 year|0
7719177|NCT00530894|12143094|FG002|Overall Study|Alive and censored prior to 1 year|0
7719178|NCT00530894|12143095|FG003|Overall Study|Alive and censored prior to 1 year|0
7719179|NCT00530920|12143110|FG000|Overall Study|Randomized but not treated|0
7719180|NCT00530920|12143111|FG001|Overall Study|Randomized but not treated|2
7719181|NCT00530920|12143112|FG002|Overall Study|Randomized but not treated|0
7811708|NCT01185340|12275599|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7811709|NCT01185340|12275600|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7811710|NCT01185340|12275601|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7811711|NCT01185340|12275598|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
7811712|NCT01185340|12275599|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
7811713|NCT01185340|12275600|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
7811714|NCT01185340|12275601|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
7811715|NCT01185340|12275598|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
7811716|NCT01185340|12275599|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
7811717|NCT01185340|12275600|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
7811718|NCT01185340|12275601|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
7811719|NCT01185340|12275598|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
7811720|NCT01185340|12275599|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
7811721|NCT01185340|12275600|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
7811722|NCT01185340|12275601|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
7811723|NCT01185340|12275598|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7811724|NCT01185340|12275599|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
7811725|NCT01185340|12275600|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7811726|NCT01185340|12275601|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
7811727|NCT01185340|12275598|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
7811728|NCT01185340|12275599|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7811729|NCT01185340|12275600|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
7811730|NCT01185340|12275601|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7811731|NCT01185340|12275598|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
7811732|NCT01185340|12275599|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
7811733|NCT01185340|12275600|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
7811734|NCT01185340|12275601|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
7811735|NCT01185340|12275598|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7811736|NCT01185340|12275599|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7811737|NCT01185340|12275600|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
7811738|NCT01185340|12275601|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
7811739|NCT01185353|12275618|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1
7811740|NCT01185353|12275619|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1
7811741|NCT01185353|12275620|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1
7811742|NCT01185353|12275621|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1
7811743|NCT01185353|12275622|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5
7811744|NCT01185353|12275623|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0
7811745|NCT01185353|12275624|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0
7908251|NCT02031276|12423822|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0
7966874|NCT02757352|12523231|FG009|Follow-Up Period|Withdrawal by Subject|2
7966875|NCT02757430|12523262|FG000|Overall Study|Physician Decision|6
7966876|NCT02757430|12523262|FG000|Overall Study|Inclusion/Exclusion criteria not met|3
7966877|NCT02757430|12523262|FG000|Overall Study|No informed consent|1
7908252|NCT02031276|12423823|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2
7908253|NCT02031276|12423824|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0
7908254|NCT02031276|12423822|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2
7908255|NCT02031276|12423823|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0
7908256|NCT02031276|12423824|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0
7908257|NCT02031276|12423822|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
7908258|NCT02031276|12423823|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
7908259|NCT02031276|12423824|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
7908260|NCT02031276|12423822|FG000|Period 3 Open-label Risankizumab SC|Other|0
7908261|NCT02031276|12423823|FG001|Period 3 Open-label Risankizumab SC|Other|0
7908262|NCT02031276|12423824|FG002|Period 3 Open-label Risankizumab SC|Other|1
7908263|NCT02031302|12423838|FG000|Overall Study|Death|115
7908264|NCT02031302|12423839|FG001|Overall Study|Death|0
7908265|NCT02031302|12423838|FG000|Overall Study|Not treated with study valve system|18
7908266|NCT02031302|12423839|FG001|Overall Study|Not treated with study valve system|0
7908267|NCT02031302|12423838|FG000|Overall Study|Missed Follow Up|27
7908268|NCT02031302|12423839|FG001|Overall Study|Missed Follow Up|0
7908269|NCT02031302|12423838|FG000|Overall Study|Lost to Follow-up|4
7908270|NCT02031302|12423839|FG001|Overall Study|Lost to Follow-up|0
7908271|NCT02031432|12423846|FG000|Overall Study|Protocol Violation|1
7908272|NCT02031432|12423846|FG000|Overall Study|Lack of Efficacy|5
7908273|NCT02031432|12423846|FG000|Overall Study|Cancer Progression|2
7908274|NCT02031432|12423846|FG000|Overall Study|Withdrawn as forbidden meds required|1
7908275|NCT02031432|12423846|FG000|Overall Study|Adverse Event|8
7908276|NCT02031432|12423846|FG000|Overall Study|Withdrawal by Subject|5
7908277|NCT02031432|12423846|FG000|Overall Study|Lost to Follow-up|1
7908278|NCT02031432|12423846|FG000|Overall Study|Inclusion/Exclusion criteria not met|5
7908279|NCT02031432|12423846|FG000|Overall Study|Death|10
7908280|NCT02031458|12423853|FG000|May 8, 2015 to January 11, 2019|Death|89
7908281|NCT02031458|12423854|FG001|May 8, 2015 to January 11, 2019|Death|193
7908282|NCT02031458|12423855|FG002|May 8, 2015 to January 11, 2019|Death|198
7908283|NCT02031458|12423853|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2
7908284|NCT02031458|12423854|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5
7908285|NCT02031458|12423855|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8
7908286|NCT02031458|12423853|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1
7908287|NCT02031458|12423854|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
7908288|NCT02031458|12423855|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
7908289|NCT02031458|12423853|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2
7908290|NCT02031458|12423854|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3
7908291|NCT02031458|12423855|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3
7908292|NCT02031458|12423853|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7
7908293|NCT02031458|12423854|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4
7908294|NCT02031458|12423855|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0
7908295|NCT02031458|12423853|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24
7908296|NCT02031458|12423854|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42
7908297|NCT02031458|12423855|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23
7908298|NCT02031458|12423853|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13
7908299|NCT02031458|12423854|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16
7908300|NCT02031458|12423855|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14
7908301|NCT02031458|12423853|FG000|Baseline to May 8, 2015|Death|36
7908302|NCT02031458|12423854|FG001|Baseline to May 8, 2015|Death|87
7908303|NCT02031458|12423855|FG002|Baseline to May 8, 2015|Death|100
7908304|NCT02031458|12423853|FG000|Baseline to May 8, 2015|Protocol Violation|7
7908305|NCT02031458|12423854|FG001|Baseline to May 8, 2015|Protocol Violation|4
7908306|NCT02031458|12423855|FG002|Baseline to May 8, 2015|Protocol Violation|0
7908307|NCT02031458|12423853|FG000|Baseline to May 8, 2015|Physician Decision|0
7908308|NCT02031458|12423854|FG001|Baseline to May 8, 2015|Physician Decision|1
7908309|NCT02031458|12423855|FG002|Baseline to May 8, 2015|Physician Decision|0
7811746|NCT01185353|12275625|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0
7811747|NCT01185353|12275626|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0
7811748|NCT01185353|12275627|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0
7908310|NCT02031458|12423853|FG000|Baseline to May 8, 2015|Unknown Reason|0
7908311|NCT02031458|12423854|FG001|Baseline to May 8, 2015|Unknown Reason|1
7908312|NCT02031458|12423855|FG002|Baseline to May 8, 2015|Unknown Reason|2
7908313|NCT02031458|12423853|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6
7908314|NCT02031458|12423854|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9
7908315|NCT02031458|12423855|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3
7908316|NCT02031458|12423853|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46
7908317|NCT02031458|12423854|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83
7908318|NCT02031458|12423855|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73
7908319|NCT02031458|12423853|FG000|Baseline to May 8, 2015|On Treatment|43
7908320|NCT02031458|12423854|FG001|Baseline to May 8, 2015|On Treatment|81
7908321|NCT02031458|12423855|FG002|Baseline to May 8, 2015|On Treatment|73
7908322|NCT02031458|12423853|FG000|Baseline to May 8, 2015|Lost to Follow-up|1
7908323|NCT02031458|12423854|FG001|Baseline to May 8, 2015|Lost to Follow-up|1
7908324|NCT02031458|12423855|FG002|Baseline to May 8, 2015|Lost to Follow-up|2
7908325|NCT02031471|12423865|FG000|24 Week Treatment Period|Adverse Event|6
7908326|NCT02031471|12423865|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2
7908327|NCT02031471|12423865|FG000|24 Week Treatment Period|Protocol Violation|1
7908328|NCT02031471|12423865|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1
7908329|NCT02031471|12423865|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1
7811749|NCT01185353|12275618|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7811750|NCT01185353|12275619|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7811751|NCT01185353|12275620|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7811752|NCT01185353|12275621|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7811753|NCT01185353|12275622|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
7811754|NCT01185353|12275623|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7811755|NCT01185353|12275624|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7908330|NCT02031471|12423865|FG000|Long Term Extension (LTE) Period|Adverse Event|1
7908331|NCT02031471|12423865|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
7908332|NCT02031536|12423871|FG000|Overall Study|ineligible|1
7908333|NCT02031536|12423872|FG001|Overall Study|ineligible|0
7908334|NCT02031640|12423896|FG000|Screening Period|Adverse Event|1
7908335|NCT02031640|12423897|FG001|Screening Period|Adverse Event|0
7908336|NCT02031640|12423898|FG002|Screening Period|Adverse Event|0
7908337|NCT02031640|12423899|FG003|Screening Period|Adverse Event|0
7811756|NCT01185353|12275625|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7908338|NCT02031640|12423900|FG004|Screening Period|Adverse Event|0
7908339|NCT02031640|12423901|FG005|Screening Period|Adverse Event|0
7908340|NCT02031640|12423896|FG000|Screening Period|Withdrawal by Subject|29
7908341|NCT02031640|12423897|FG001|Screening Period|Withdrawal by Subject|0
7908342|NCT02031640|12423898|FG002|Screening Period|Withdrawal by Subject|0
7811757|NCT01185353|12275626|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7908343|NCT02031640|12423899|FG003|Screening Period|Withdrawal by Subject|0
7908344|NCT02031640|12423900|FG004|Screening Period|Withdrawal by Subject|0
7908345|NCT02031640|12423901|FG005|Screening Period|Withdrawal by Subject|0
7908346|NCT02031640|12423896|FG000|Screening Period|Inclusion criteria not met|312
7908347|NCT02031640|12423897|FG001|Screening Period|Inclusion criteria not met|0
7908348|NCT02031640|12423898|FG002|Screening Period|Inclusion criteria not met|0
7908349|NCT02031640|12423899|FG003|Screening Period|Inclusion criteria not met|0
7811758|NCT01185353|12275627|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7811759|NCT01185353|12275618|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
7811760|NCT01185353|12275619|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7811761|NCT01185353|12275620|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7811762|NCT01185353|12275621|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7811763|NCT01185353|12275622|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
7811764|NCT01185353|12275623|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7811765|NCT01185353|12275624|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7719182|NCT00530920|12143110|FG000|Overall Study|Adverse Event|0
7719183|NCT00530920|12143111|FG001|Overall Study|Adverse Event|0
7719184|NCT00530920|12143112|FG002|Overall Study|Adverse Event|3
7719185|NCT00530920|12143110|FG000|Overall Study|Withdrawal by Subject|0
7719186|NCT00530920|12143111|FG001|Overall Study|Withdrawal by Subject|0
7719187|NCT00530920|12143112|FG002|Overall Study|Withdrawal by Subject|1
7719188|NCT00530946|12143125|FG000|Overall Study|Adverse Event|1
7719189|NCT00530946|12143126|FG001|Overall Study|Adverse Event|2
7719190|NCT00530946|12143127|FG002|Overall Study|Adverse Event|1
7719191|NCT00530946|12143128|FG003|Overall Study|Adverse Event|1
7719192|NCT00530946|12143125|FG000|Overall Study|Protocol Violation|0
7719193|NCT00530946|12143126|FG001|Overall Study|Protocol Violation|0
7719194|NCT00530946|12143127|FG002|Overall Study|Protocol Violation|0
7719195|NCT00530946|12143128|FG003|Overall Study|Protocol Violation|1
7719196|NCT00530946|12143125|FG000|Overall Study|Noncompliance|1
7719197|NCT00530946|12143126|FG001|Overall Study|Noncompliance|0
7719198|NCT00530946|12143127|FG002|Overall Study|Noncompliance|0
7719199|NCT00530946|12143128|FG003|Overall Study|Noncompliance|0
7719200|NCT00531011|12143140|FG000|Overall Study|Withdrawal by Subject|2
7719201|NCT00531011|12143141|FG001|Overall Study|Withdrawal by Subject|4
7719202|NCT00531011|12143140|FG000|Overall Study|Death|1
7719203|NCT00531011|12143141|FG001|Overall Study|Death|0
7719204|NCT00531011|12143140|FG000|Overall Study|Lost to Follow-up|1
7719205|NCT00531011|12143141|FG001|Overall Study|Lost to Follow-up|0
7719206|NCT00531011|12143140|FG000|Overall Study|Physician Decision|0
7719207|NCT00531011|12143141|FG001|Overall Study|Physician Decision|3
7719208|NCT00531050|12143153|FG000|Part 1: Period 1|Adverse Event|0
7719209|NCT00531050|12143154|FG001|Part 1: Period 1|Adverse Event|1
7719210|NCT00531050|12143155|FG002|Part 1: Period 1|Adverse Event|0
7719211|NCT00531050|12143156|FG003|Part 1: Period 1|Adverse Event|0
7719212|NCT00531050|12143157|FG004|Part 1: Period 1|Adverse Event|0
7719213|NCT00531050|12143158|FG005|Part 1: Period 1|Adverse Event|0
7719214|NCT00531050|12143153|FG000|Part 1: Period 1|Protocol Deviation|0
7719215|NCT00531050|12143154|FG001|Part 1: Period 1|Protocol Deviation|0
7719216|NCT00531050|12143155|FG002|Part 1: Period 1|Protocol Deviation|0
7719217|NCT00531050|12143156|FG003|Part 1: Period 1|Protocol Deviation|1
7719218|NCT00531050|12143157|FG004|Part 1: Period 1|Protocol Deviation|0
7719219|NCT00531050|12143158|FG005|Part 1: Period 1|Protocol Deviation|0
7719220|NCT00531050|12143153|FG000|Part 1: Period 3|Adverse Event|1
7883603|NCT01783444|12383366|FG000|Treatment Phase|Withdrawal by Subject|6
7883604|NCT01783444|12383367|FG001|Treatment Phase|Withdrawal by Subject|8
7883605|NCT01783444|12383368|FG002|Treatment Phase|Withdrawal by Subject|9
7883606|NCT01783444|12383366|FG000|Treatment Phase|Administrative problems|2
7883607|NCT01783444|12383367|FG001|Treatment Phase|Administrative problems|0
7883608|NCT01783444|12383368|FG002|Treatment Phase|Administrative problems|1
7883609|NCT01783444|12383366|FG000|Treatment Phase|Physician Decision|8
7883610|NCT01783444|12383367|FG001|Treatment Phase|Physician Decision|6
7719221|NCT00531050|12143154|FG001|Part 1: Period 3|Adverse Event|0
7719222|NCT00531050|12143155|FG002|Part 1: Period 3|Adverse Event|0
7719223|NCT00531050|12143156|FG003|Part 1: Period 3|Adverse Event|0
7719224|NCT00531050|12143157|FG004|Part 1: Period 3|Adverse Event|0
7719225|NCT00531050|12143158|FG005|Part 1: Period 3|Adverse Event|0
7719226|NCT00531050|12143153|FG000|Part 2: Period 1|Adverse Event|0
7719227|NCT00531050|12143154|FG001|Part 2: Period 1|Adverse Event|0
7719228|NCT00531050|12143155|FG002|Part 2: Period 1|Adverse Event|0
7719229|NCT00531050|12143156|FG003|Part 2: Period 1|Adverse Event|0
7719230|NCT00531050|12143157|FG004|Part 2: Period 1|Adverse Event|0
7719231|NCT00531050|12143158|FG005|Part 2: Period 1|Adverse Event|1
7719232|NCT00531050|12143153|FG000|Part 2: Period 3|Abnormal test procedure|1
7908350|NCT02031640|12423900|FG004|Screening Period|Inclusion criteria not met|0
7719233|NCT00531050|12143154|FG001|Part 2: Period 3|Abnormal test procedure|0
7719234|NCT00531050|12143155|FG002|Part 2: Period 3|Abnormal test procedure|0
7719235|NCT00531050|12143156|FG003|Part 2: Period 3|Abnormal test procedure|0
7719236|NCT00531050|12143157|FG004|Part 2: Period 3|Abnormal test procedure|0
7719237|NCT00531050|12143158|FG005|Part 2: Period 3|Abnormal test procedure|1
7719238|NCT00531206|12143175|FG000|Overall Study|Adverse Event related|5
7719239|NCT00531206|12143175|FG000|Overall Study|Lack of Efficacy|2
7719240|NCT00531206|12143175|FG000|Overall Study|Lost to Follow-up|5
7719241|NCT00531206|12143175|FG000|Overall Study|including non-related adverse events|8
7719242|NCT00531284|12143196|FG000|Overall Study|Progressive Disease|1
7719243|NCT00531284|12143197|FG001|Overall Study|Progressive Disease|3
7908351|NCT02031640|12423901|FG005|Screening Period|Inclusion criteria not met|0
7908352|NCT02031640|12423896|FG000|Screening Period|Exclusion criteria met|30
7908353|NCT02031640|12423897|FG001|Screening Period|Exclusion criteria met|0
7908354|NCT02031640|12423898|FG002|Screening Period|Exclusion criteria met|0
7908355|NCT02031640|12423899|FG003|Screening Period|Exclusion criteria met|0
7908356|NCT02031640|12423900|FG004|Screening Period|Exclusion criteria met|0
7908357|NCT02031640|12423901|FG005|Screening Period|Exclusion criteria met|0
7908358|NCT02031640|12423896|FG000|Screening Period|Lost to Follow-up|14
7908359|NCT02031640|12423897|FG001|Screening Period|Lost to Follow-up|0
7908360|NCT02031640|12423898|FG002|Screening Period|Lost to Follow-up|0
7908361|NCT02031640|12423899|FG003|Screening Period|Lost to Follow-up|0
7908362|NCT02031640|12423900|FG004|Screening Period|Lost to Follow-up|0
7908363|NCT02031640|12423901|FG005|Screening Period|Lost to Follow-up|0
7908364|NCT02031640|12423896|FG000|Screening Period|Enrollment closed|26
7908365|NCT02031640|12423897|FG001|Screening Period|Enrollment closed|0
7811766|NCT01185353|12275625|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7811767|NCT01185353|12275626|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7811768|NCT01185353|12275627|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7811769|NCT01185353|12275618|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0
7811770|NCT01185353|12275619|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0
7811771|NCT01185353|12275620|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1
7811772|NCT01185353|12275621|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0
7811773|NCT01185353|12275622|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2
7811774|NCT01185353|12275623|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0
7811775|NCT01185353|12275624|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0
7811776|NCT01185353|12275625|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0
7811777|NCT01185353|12275626|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0
7811778|NCT01185353|12275627|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0
7811779|NCT01185353|12275618|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0
7811780|NCT01185353|12275619|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0
7811781|NCT01185353|12275620|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0
7811782|NCT01185353|12275621|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0
7811783|NCT01185353|12275622|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1
7811784|NCT01185353|12275623|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0
7811785|NCT01185353|12275624|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0
7811786|NCT01185353|12275625|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0
7811787|NCT01185353|12275626|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0
7811788|NCT01185353|12275627|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0
7811789|NCT01185353|12275618|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
7811790|NCT01185353|12275619|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7811791|NCT01185353|12275620|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7811792|NCT01185353|12275621|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7811793|NCT01185353|12275622|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
7811794|NCT01185353|12275623|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7811795|NCT01185353|12275624|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7811796|NCT01185353|12275625|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7811797|NCT01185353|12275626|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7811798|NCT01185353|12275627|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7811799|NCT01185353|12275618|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0
7811800|NCT01185353|12275619|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0
7811801|NCT01185353|12275620|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1
7811802|NCT01185353|12275621|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0
7811803|NCT01185353|12275622|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0
7811804|NCT01185353|12275623|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1
7811805|NCT01185353|12275624|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0
7908366|NCT02031640|12423898|FG002|Screening Period|Enrollment closed|0
7908367|NCT02031640|12423899|FG003|Screening Period|Enrollment closed|0
7908368|NCT02031640|12423900|FG004|Screening Period|Enrollment closed|0
7908369|NCT02031640|12423901|FG005|Screening Period|Enrollment closed|0
7908370|NCT02031640|12423896|FG000|Run-In Period|Adverse Event|4
7908371|NCT02031640|12423897|FG001|Run-In Period|Adverse Event|0
7908372|NCT02031640|12423898|FG002|Run-In Period|Adverse Event|0
7908373|NCT02031640|12423899|FG003|Run-In Period|Adverse Event|0
7908374|NCT02031640|12423900|FG004|Run-In Period|Adverse Event|0
7908375|NCT02031640|12423901|FG005|Run-In Period|Adverse Event|0
7908376|NCT02031640|12423896|FG000|Run-In Period|Withdrawal by Subject|17
7908377|NCT02031640|12423897|FG001|Run-In Period|Withdrawal by Subject|0
7908378|NCT02031640|12423898|FG002|Run-In Period|Withdrawal by Subject|0
7908379|NCT02031640|12423899|FG003|Run-In Period|Withdrawal by Subject|0
7908380|NCT02031640|12423900|FG004|Run-In Period|Withdrawal by Subject|0
7908381|NCT02031640|12423901|FG005|Run-In Period|Withdrawal by Subject|0
7908382|NCT02031640|12423896|FG000|Run-In Period|Inclusion criteria not met|38
7908383|NCT02031640|12423897|FG001|Run-In Period|Inclusion criteria not met|0
7908384|NCT02031640|12423898|FG002|Run-In Period|Inclusion criteria not met|0
7908385|NCT02031640|12423899|FG003|Run-In Period|Inclusion criteria not met|0
7908386|NCT02031640|12423900|FG004|Run-In Period|Inclusion criteria not met|0
7908387|NCT02031640|12423901|FG005|Run-In Period|Inclusion criteria not met|0
7908388|NCT02031640|12423896|FG000|Run-In Period|Exclusion criteria met|8
7908389|NCT02031640|12423897|FG001|Run-In Period|Exclusion criteria met|0
7908390|NCT02031640|12423898|FG002|Run-In Period|Exclusion criteria met|0
7908391|NCT02031640|12423899|FG003|Run-In Period|Exclusion criteria met|0
7908392|NCT02031640|12423900|FG004|Run-In Period|Exclusion criteria met|0
7908393|NCT02031640|12423901|FG005|Run-In Period|Exclusion criteria met|0
7908394|NCT02031640|12423896|FG000|Run-In Period|Randomization criteria not met|85
7908395|NCT02031640|12423897|FG001|Run-In Period|Randomization criteria not met|0
7908396|NCT02031640|12423898|FG002|Run-In Period|Randomization criteria not met|0
7908397|NCT02031640|12423899|FG003|Run-In Period|Randomization criteria not met|0
7908398|NCT02031640|12423900|FG004|Run-In Period|Randomization criteria not met|0
7908399|NCT02031640|12423901|FG005|Run-In Period|Randomization criteria not met|0
7908400|NCT02031640|12423896|FG000|Run-In Period|Various administrative reasons|17
7908401|NCT02031640|12423897|FG001|Run-In Period|Various administrative reasons|0
7908402|NCT02031640|12423898|FG002|Run-In Period|Various administrative reasons|0
7908403|NCT02031640|12423899|FG003|Run-In Period|Various administrative reasons|0
7908404|NCT02031640|12423900|FG004|Run-In Period|Various administrative reasons|0
7908405|NCT02031640|12423901|FG005|Run-In Period|Various administrative reasons|0
7908406|NCT02031640|12423896|FG000|Double-blind Treatment Period|Protocol deviation|0
7908407|NCT02031640|12423897|FG001|Double-blind Treatment Period|Protocol deviation|2
7908408|NCT02031640|12423898|FG002|Double-blind Treatment Period|Protocol deviation|0
7908409|NCT02031640|12423899|FG003|Double-blind Treatment Period|Protocol deviation|1
7908410|NCT02031640|12423900|FG004|Double-blind Treatment Period|Protocol deviation|3
7908411|NCT02031640|12423901|FG005|Double-blind Treatment Period|Protocol deviation|1
7908412|NCT02031640|12423896|FG000|Double-blind Treatment Period|Lack of Efficacy|0
7908413|NCT02031640|12423897|FG001|Double-blind Treatment Period|Lack of Efficacy|14
7908414|NCT02031640|12423898|FG002|Double-blind Treatment Period|Lack of Efficacy|3
7908415|NCT02031640|12423899|FG003|Double-blind Treatment Period|Lack of Efficacy|2
7908416|NCT02031640|12423900|FG004|Double-blind Treatment Period|Lack of Efficacy|5
7908417|NCT02031640|12423901|FG005|Double-blind Treatment Period|Lack of Efficacy|1
7908418|NCT02031640|12423896|FG000|Double-blind Treatment Period|Non-compliance|0
7908419|NCT02031640|12423897|FG001|Double-blind Treatment Period|Non-compliance|1
7908420|NCT02031640|12423898|FG002|Double-blind Treatment Period|Non-compliance|0
7908421|NCT02031640|12423899|FG003|Double-blind Treatment Period|Non-compliance|1
7908422|NCT02031640|12423900|FG004|Double-blind Treatment Period|Non-compliance|1
7908423|NCT02031640|12423901|FG005|Double-blind Treatment Period|Non-compliance|0
7908424|NCT02031640|12423896|FG000|Double-blind Treatment Period|Adverse Event|0
7908425|NCT02031640|12423897|FG001|Double-blind Treatment Period|Adverse Event|0
7908426|NCT02031640|12423898|FG002|Double-blind Treatment Period|Adverse Event|0
7908427|NCT02031640|12423899|FG003|Double-blind Treatment Period|Adverse Event|2
7908428|NCT02031640|12423900|FG004|Double-blind Treatment Period|Adverse Event|0
7908429|NCT02031640|12423901|FG005|Double-blind Treatment Period|Adverse Event|0
7908430|NCT02031640|12423896|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
7908431|NCT02031640|12423897|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
7908432|NCT02031640|12423898|FG002|Double-blind Treatment Period|Withdrawal by Subject|3
7908433|NCT02031640|12423899|FG003|Double-blind Treatment Period|Withdrawal by Subject|1
7908434|NCT02031640|12423900|FG004|Double-blind Treatment Period|Withdrawal by Subject|1
7908435|NCT02031640|12423901|FG005|Double-blind Treatment Period|Withdrawal by Subject|1
7908436|NCT02031640|12423896|FG000|Double-blind Treatment Period|Lost to Follow-up|0
7908437|NCT02031640|12423897|FG001|Double-blind Treatment Period|Lost to Follow-up|3
7908438|NCT02031640|12423898|FG002|Double-blind Treatment Period|Lost to Follow-up|0
7908439|NCT02031640|12423899|FG003|Double-blind Treatment Period|Lost to Follow-up|0
7908440|NCT02031640|12423900|FG004|Double-blind Treatment Period|Lost to Follow-up|1
7908441|NCT02031640|12423901|FG005|Double-blind Treatment Period|Lost to Follow-up|0
7908442|NCT02031679|12423922|FG000|Overall Study|Protocol Violation|0
7908443|NCT02031679|12423923|FG001|Overall Study|Protocol Violation|1
7908444|NCT02031679|12423922|FG000|Overall Study|Lack of Efficacy|0
7908445|NCT02031679|12423923|FG001|Overall Study|Lack of Efficacy|1
7908446|NCT02032173|12423936|FG000|Overall Study|Discontinuation due to sponsor decision|31
7908447|NCT02032238|12423959|FG000|Overall Study|Lost to Follow-up|2
7908448|NCT02032238|12423960|FG001|Overall Study|Lost to Follow-up|0
7908449|NCT02032407|12423966|FG000|Overall Study|Lost to Follow-up|2
7908450|NCT02032407|12423966|FG000|Overall Study|Pregnancy|1
7908451|NCT02032407|12423966|FG000|Overall Study|Other Miscellaneous Reasons|2
7719244|NCT00531284|12143198|FG002|Overall Study|Progressive Disease|5
7719245|NCT00531284|12143199|FG003|Overall Study|Progressive Disease|42
7719246|NCT00531284|12143200|FG004|Overall Study|Progressive Disease|4
7719247|NCT00531284|12143201|FG005|Overall Study|Progressive Disease|4
7719248|NCT00531284|12143202|FG006|Overall Study|Progressive Disease|3
7719249|NCT00531284|12143203|FG007|Overall Study|Progressive Disease|8
7719250|NCT00531284|12143204|FG008|Overall Study|Progressive Disease|6
7719251|NCT00531284|12143205|FG009|Overall Study|Progressive Disease|3
7719252|NCT00531284|12143206|FG010|Overall Study|Progressive Disease|3
7719253|NCT00531284|12143207|FG011|Overall Study|Progressive Disease|14
7719254|NCT00531284|12143208|FG012|Overall Study|Progressive Disease|2
7719255|NCT00531284|12143209|FG013|Overall Study|Progressive Disease|1
7719256|NCT00531284|12143210|FG014|Overall Study|Progressive Disease|2
7719257|NCT00531284|12143211|FG015|Overall Study|Progressive Disease|11
7719258|NCT00531284|12143212|FG016|Overall Study|Progressive Disease|5
7719259|NCT00531284|12143196|FG000|Overall Study|Adverse Event|0
7719260|NCT00531284|12143197|FG001|Overall Study|Adverse Event|1
7719261|NCT00531284|12143198|FG002|Overall Study|Adverse Event|1
7719262|NCT00531284|12143199|FG003|Overall Study|Adverse Event|7
7719263|NCT00531284|12143200|FG004|Overall Study|Adverse Event|0
7719264|NCT00531284|12143201|FG005|Overall Study|Adverse Event|2
7719265|NCT00531284|12143202|FG006|Overall Study|Adverse Event|3
7908452|NCT02032706|12424012|FG000|Overall Study|Did not qualify|5
7908453|NCT02032706|12424012|FG000|Overall Study|Protocol Violation|1
7908454|NCT02032875|12424027|FG000|Treatment Period|Adverse Event|1
7719266|NCT00531284|12143203|FG007|Overall Study|Adverse Event|2
7719267|NCT00531284|12143204|FG008|Overall Study|Adverse Event|3
7719268|NCT00531284|12143205|FG009|Overall Study|Adverse Event|0
7719269|NCT00531284|12143206|FG010|Overall Study|Adverse Event|0
7719270|NCT00531284|12143207|FG011|Overall Study|Adverse Event|5
7719271|NCT00531284|12143208|FG012|Overall Study|Adverse Event|0
7719272|NCT00531284|12143209|FG013|Overall Study|Adverse Event|1
7719273|NCT00531284|12143210|FG014|Overall Study|Adverse Event|1
7719274|NCT00531284|12143211|FG015|Overall Study|Adverse Event|0
7719275|NCT00531284|12143212|FG016|Overall Study|Adverse Event|2
7719276|NCT00531284|12143196|FG000|Overall Study|Withdrawal by Subject|1
7719277|NCT00531284|12143197|FG001|Overall Study|Withdrawal by Subject|0
7719278|NCT00531284|12143198|FG002|Overall Study|Withdrawal by Subject|0
7719279|NCT00531284|12143199|FG003|Overall Study|Withdrawal by Subject|4
7719280|NCT00531284|12143200|FG004|Overall Study|Withdrawal by Subject|0
7719281|NCT00531284|12143201|FG005|Overall Study|Withdrawal by Subject|0
7719282|NCT00531284|12143202|FG006|Overall Study|Withdrawal by Subject|0
7719283|NCT00531284|12143203|FG007|Overall Study|Withdrawal by Subject|0
7719284|NCT00531284|12143204|FG008|Overall Study|Withdrawal by Subject|0
7719285|NCT00531284|12143205|FG009|Overall Study|Withdrawal by Subject|0
7719286|NCT00531284|12143206|FG010|Overall Study|Withdrawal by Subject|0
7719287|NCT00531284|12143207|FG011|Overall Study|Withdrawal by Subject|3
7719288|NCT00531284|12143208|FG012|Overall Study|Withdrawal by Subject|0
7719289|NCT00531284|12143209|FG013|Overall Study|Withdrawal by Subject|1
7719290|NCT00531284|12143210|FG014|Overall Study|Withdrawal by Subject|0
7719291|NCT00531284|12143211|FG015|Overall Study|Withdrawal by Subject|1
7719292|NCT00531284|12143212|FG016|Overall Study|Withdrawal by Subject|1
7719293|NCT00531284|12143196|FG000|Overall Study|Other|1
7719294|NCT00531284|12143197|FG001|Overall Study|Other|0
7719295|NCT00531284|12143198|FG002|Overall Study|Other|0
7719296|NCT00531284|12143199|FG003|Overall Study|Other|10
7908455|NCT02032875|12424028|FG001|Treatment Period|Adverse Event|0
7719297|NCT00531284|12143200|FG004|Overall Study|Other|2
7719298|NCT00531284|12143201|FG005|Overall Study|Other|1
7719299|NCT00531284|12143202|FG006|Overall Study|Other|0
7908456|NCT02032875|12424027|FG000|Treatment Period|Liver transplant, No extension needed|0
7908457|NCT02032875|12424028|FG001|Treatment Period|Liver transplant, No extension needed|1
7908458|NCT02032875|12424027|FG000|Treatment Period|Liver transplant, Treatment extension|0
7908459|NCT02032875|12424028|FG001|Treatment Period|Liver transplant, Treatment extension|3
7908460|NCT02032875|12424027|FG000|Follow-up Period|Death|0
7908461|NCT02032875|12424028|FG001|Follow-up Period|Death|1
7908462|NCT02032875|12424027|FG000|Follow-up Period|Virologic Relapse|3
7908463|NCT02032875|12424028|FG001|Follow-up Period|Virologic Relapse|10
7908464|NCT02032888|12424038|FG000|Treatment Period|Poor compliance/noncompliance|1
7908465|NCT02032888|12424039|FG001|Treatment Period|Poor compliance/noncompliance|1
7908466|NCT02032888|12424040|FG002|Treatment Period|Poor compliance/noncompliance|0
7908467|NCT02032888|12424038|FG000|Treatment Period|Other|1
7908468|NCT02032888|12424039|FG001|Treatment Period|Other|1
7908469|NCT02032888|12424040|FG002|Treatment Period|Other|0
7908470|NCT02032888|12424038|FG000|Follow-up Period|Lost to Follow-up|1
7908471|NCT02032888|12424039|FG001|Follow-up Period|Lost to Follow-up|1
7908472|NCT02032888|12424040|FG002|Follow-up Period|Lost to Follow-up|0
7908473|NCT02032888|12424038|FG000|Follow-up Period|Death|1
7908474|NCT02032888|12424039|FG001|Follow-up Period|Death|1
7908475|NCT02032888|12424040|FG002|Follow-up Period|Death|0
7908476|NCT02032888|12424038|FG000|Follow-up Period|Other|1
7908477|NCT02032888|12424039|FG001|Follow-up Period|Other|0
7908478|NCT02032888|12424040|FG002|Follow-up Period|Other|0
7908479|NCT02032901|12424059|FG000|Treatment Period (12 Weeks)|Pregnancy|1
7908480|NCT02032901|12424060|FG001|Treatment Period (12 Weeks)|Pregnancy|0
7908481|NCT02032901|12424059|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
7908482|NCT02032901|12424060|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
7908483|NCT02033369|12424124|FG000|Overall Study|Physician Decision|1
7908484|NCT02033369|12424125|FG001|Overall Study|Physician Decision|2
7908485|NCT02033369|12424124|FG000|Overall Study|Not a good demographic match|0
7908486|NCT02033369|12424125|FG001|Overall Study|Not a good demographic match|2
7908487|NCT02033369|12424124|FG000|Overall Study|Withdrawal by Subject|1
7908488|NCT02033369|12424125|FG001|Overall Study|Withdrawal by Subject|1
7908489|NCT02033369|12424124|FG000|Overall Study|Lost to Follow-up|1
7908490|NCT02033369|12424125|FG001|Overall Study|Lost to Follow-up|0
7908491|NCT02033369|12424124|FG000|Overall Study|Protocol Violation|2
7908492|NCT02033369|12424125|FG001|Overall Study|Protocol Violation|0
7908493|NCT02033759|12424163|FG000|Overall Study|Withdrawal by Subject|2
7908494|NCT02033759|12424164|FG001|Overall Study|Withdrawal by Subject|1
7908495|NCT02033759|12424163|FG000|Overall Study|Protocol Violation|1
7908496|NCT02033759|12424164|FG001|Overall Study|Protocol Violation|1
7908497|NCT02033850|12424172|FG000|Overall Study|Death|1
7908498|NCT02033850|12424173|FG001|Overall Study|Death|0
7908499|NCT02033850|12424172|FG000|Overall Study|unrelated medical reason|1
7908500|NCT02033850|12424173|FG001|Overall Study|unrelated medical reason|1
7908501|NCT02033889|12424191|FG000|Overall Study|Adverse Event|3
7908502|NCT02033889|12424192|FG001|Overall Study|Adverse Event|1
7908503|NCT02033889|12424193|FG002|Overall Study|Adverse Event|3
7908504|NCT02033889|12424191|FG000|Overall Study|Death|3
7908505|NCT02033889|12424192|FG001|Overall Study|Death|1
7908506|NCT02033889|12424193|FG002|Overall Study|Death|2
7908507|NCT02033889|12424191|FG000|Overall Study|Excluded Medication|1
7908508|NCT02033889|12424192|FG001|Overall Study|Excluded Medication|1
7908509|NCT02033889|12424193|FG002|Overall Study|Excluded Medication|0
7908510|NCT02033889|12424191|FG000|Overall Study|Lost to Follow-up|8
7908511|NCT02033889|12424192|FG001|Overall Study|Lost to Follow-up|5
7908512|NCT02033889|12424193|FG002|Overall Study|Lost to Follow-up|6
7908513|NCT02033889|12424191|FG000|Overall Study|Non-Compliance With Study Drug|1
7908514|NCT02033889|12424192|FG001|Overall Study|Non-Compliance With Study Drug|0
7908515|NCT02033889|12424193|FG002|Overall Study|Non-Compliance With Study Drug|0
7908516|NCT02033889|12424191|FG000|Overall Study|Physician Decision|0
7908517|NCT02033889|12424192|FG001|Overall Study|Physician Decision|1
7908518|NCT02033889|12424193|FG002|Overall Study|Physician Decision|1
7908519|NCT02033889|12424191|FG000|Overall Study|Participant moved|0
7908520|NCT02033889|12424192|FG001|Overall Study|Participant moved|1
7908521|NCT02033889|12424193|FG002|Overall Study|Participant moved|0
7908522|NCT02033889|12424191|FG000|Overall Study|Withdrawal by Subject|18
7908523|NCT02033889|12424192|FG001|Overall Study|Withdrawal by Subject|10
7908524|NCT02033889|12424193|FG002|Overall Study|Withdrawal by Subject|13
7908525|NCT02034006|12424212|FG000|Overall Study|Withdrawal by Subject|7
7908526|NCT02034006|12424212|FG000|Overall Study|Lost to Follow-up|5
7908527|NCT02034006|12424212|FG000|Overall Study|Death|1
7908528|NCT02034006|12424212|FG000|Overall Study|Pregnancy|1
7908529|NCT02034058|12424228|FG000|Overall Study|Death|3
7908530|NCT02034162|12424234|FG000|Double-blind|Lost to Follow-up|3
7908531|NCT02034162|12424235|FG001|Double-blind|Lost to Follow-up|0
7908532|NCT02034162|12424236|FG002|Double-blind|Lost to Follow-up|0
7908533|NCT02034162|12424234|FG000|Double-blind|Physician Decision|1
7908534|NCT02034162|12424235|FG001|Double-blind|Physician Decision|0
7908535|NCT02034162|12424236|FG002|Double-blind|Physician Decision|0
7908536|NCT02034162|12424234|FG000|Double-blind|Protocol Violation|0
7908537|NCT02034162|12424235|FG001|Double-blind|Protocol Violation|1
7908538|NCT02034162|12424236|FG002|Double-blind|Protocol Violation|0
7908539|NCT02034162|12424234|FG000|Double-blind|Withdrawal by Subject|5
7908540|NCT02034162|12424235|FG001|Double-blind|Withdrawal by Subject|7
7908541|NCT02034162|12424236|FG002|Double-blind|Withdrawal by Subject|0
7908542|NCT02034409|12424253|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4
7908543|NCT02034409|12424254|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0
7908544|NCT02034409|12424253|FG000|Sham-Controlled Treatment Period|Adverse Event|1
7908545|NCT02034409|12424254|FG001|Sham-Controlled Treatment Period|Adverse Event|1
7908546|NCT02034409|12424253|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0
7908547|NCT02034409|12424254|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1
7908548|NCT02034409|12424253|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8
7908549|NCT02034409|12424254|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8
7908550|NCT02034409|12424253|FG000|Sham-Controlled Treatment Period|Physician Decision|1
7908551|NCT02034409|12424254|FG001|Sham-Controlled Treatment Period|Physician Decision|3
7908552|NCT02034409|12424253|FG000|Sham-Controlled Treatment Period|misrandomized|2
7908553|NCT02034409|12424254|FG001|Sham-Controlled Treatment Period|misrandomized|2
7908554|NCT02034435|12424262|FG000|Overall Study|Withdrawal by Subject|1
7908555|NCT02034435|12424263|FG001|Overall Study|Withdrawal by Subject|0
7908556|NCT02034435|12424264|FG002|Overall Study|Withdrawal by Subject|0
7908557|NCT02034435|12424265|FG003|Overall Study|Withdrawal by Subject|0
7908558|NCT02034435|12424262|FG000|Overall Study|Illness|0
7908559|NCT02034435|12424263|FG001|Overall Study|Illness|2
7908560|NCT02034435|12424264|FG002|Overall Study|Illness|0
7908561|NCT02034435|12424265|FG003|Overall Study|Illness|0
7908562|NCT02034435|12424262|FG000|Overall Study|Inadequate IV access|1
7908563|NCT02034435|12424263|FG001|Overall Study|Inadequate IV access|0
7908564|NCT02034435|12424264|FG002|Overall Study|Inadequate IV access|0
7908565|NCT02034435|12424265|FG003|Overall Study|Inadequate IV access|1
7908566|NCT02034474|12424277|FG000|Overall Study|Adverse Event|3
7908567|NCT02034474|12424278|FG001|Overall Study|Adverse Event|2
7908568|NCT02034474|12424277|FG000|Overall Study|Withdrawal by Subject|1
7908569|NCT02034474|12424278|FG001|Overall Study|Withdrawal by Subject|2
7908570|NCT02034513|12424288|FG000|Overall Study|Adverse Event|11
7908571|NCT02034513|12424289|FG001|Overall Study|Adverse Event|10
7908572|NCT02034513|12424288|FG000|Overall Study|Lack of Efficacy|0
7908573|NCT02034513|12424289|FG001|Overall Study|Lack of Efficacy|1
7908574|NCT02034513|12424288|FG000|Overall Study|Lost to Follow-up|6
7908575|NCT02034513|12424289|FG001|Overall Study|Lost to Follow-up|7
7908576|NCT02034513|12424288|FG000|Overall Study|Pregnancy|0
7908577|NCT02034513|12424289|FG001|Overall Study|Pregnancy|3
7908578|NCT02034513|12424288|FG000|Overall Study|Protocol Violation|7
7908579|NCT02034513|12424289|FG001|Overall Study|Protocol Violation|10
7908580|NCT02034513|12424288|FG000|Overall Study|Withdrawal by Subject|25
7908581|NCT02034513|12424289|FG001|Overall Study|Withdrawal by Subject|25
7908582|NCT02034513|12424288|FG000|Overall Study|Unclassified|0
7908583|NCT02034513|12424289|FG001|Overall Study|Unclassified|1
7908584|NCT02034552|12424300|FG000|Overall Study|Never treated|3
7908585|NCT02034552|12424301|FG001|Overall Study|Never treated|2
7908586|NCT02034552|12424302|FG002|Overall Study|Never treated|0
7908587|NCT02034552|12424300|FG000|Overall Study|Radiological progression|3
7908588|NCT02034552|12424301|FG001|Overall Study|Radiological progression|5
7908589|NCT02034552|12424302|FG002|Overall Study|Radiological progression|4
7908590|NCT02034552|12424300|FG000|Overall Study|AE not assoc. with disease progression|1
7908591|NCT02034552|12424301|FG001|Overall Study|AE not assoc. with disease progression|4
7908592|NCT02034552|12424302|FG002|Overall Study|AE not assoc. with disease progression|2
7908593|NCT02034552|12424300|FG000|Overall Study|AE associated with disease progression|0
7908594|NCT02034552|12424301|FG001|Overall Study|AE associated with disease progression|1
7908595|NCT02034552|12424302|FG002|Overall Study|AE associated with disease progression|0
7908596|NCT02034552|12424300|FG000|Overall Study|Withdrawal by Subject|2
7908597|NCT02034552|12424301|FG001|Overall Study|Withdrawal by Subject|1
7908598|NCT02034552|12424302|FG002|Overall Study|Withdrawal by Subject|1
7908599|NCT02034552|12424300|FG000|Overall Study|Non-compliance with study drug|0
7908600|NCT02034552|12424301|FG001|Overall Study|Non-compliance with study drug|0
7908601|NCT02034552|12424302|FG002|Overall Study|Non-compliance with study drug|1
7908602|NCT02034552|12424300|FG000|Overall Study|Clinical progression|5
7908603|NCT02034552|12424301|FG001|Overall Study|Clinical progression|7
7908604|NCT02034552|12424302|FG002|Overall Study|Clinical progression|9
7908605|NCT02034565|12424310|FG000|Overall Study|Adverse Event|1
7908606|NCT02034565|12424311|FG001|Overall Study|Adverse Event|0
7908607|NCT02034591|12424333|FG000|Overall Study|Withdrawal by Subject|0
7908608|NCT02034591|12424334|FG001|Overall Study|Withdrawal by Subject|0
7908609|NCT02034591|12424335|FG002|Overall Study|Withdrawal by Subject|0
7908610|NCT02034591|12424336|FG003|Overall Study|Withdrawal by Subject|0
7908611|NCT02034591|12424337|FG004|Overall Study|Withdrawal by Subject|1
7908612|NCT02034591|12424338|FG005|Overall Study|Withdrawal by Subject|0
7908613|NCT02034708|12424349|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
7908614|NCT02034708|12424350|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
7908615|NCT02034708|12424349|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
7908616|NCT02034708|12424350|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
7908617|NCT02034708|12424349|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
7908618|NCT02034708|12424350|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
7908619|NCT02034708|12424349|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3
7908620|NCT02034708|12424350|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2
7908621|NCT02034799|12424363|FG000|Overall Study|Withdrawal by Subject|0
7908622|NCT02034799|12424364|FG001|Overall Study|Withdrawal by Subject|2
7908623|NCT02034799|12424363|FG000|Overall Study|Lost to Follow-up|0
7908624|NCT02034799|12424364|FG001|Overall Study|Lost to Follow-up|1
7908625|NCT02034799|12424363|FG000|Overall Study|Death|2
7908626|NCT02034799|12424364|FG001|Overall Study|Death|1
7908627|NCT02034877|12424372|FG000|Overall Study|Lost to Follow-up|0
7908628|NCT02034877|12424373|FG001|Overall Study|Lost to Follow-up|3
7908629|NCT02034877|12424372|FG000|Overall Study|No Longer Willing to Participate|0
7908630|NCT02034877|12424373|FG001|Overall Study|No Longer Willing to Participate|3
7908631|NCT02034916|12424381|FG000|Overall Study|Death|39
7908632|NCT02034916|12424382|FG001|Overall Study|Death|28
7908633|NCT02034916|12424381|FG000|Overall Study|Withdrawal by Subject|2
7908634|NCT02034916|12424382|FG001|Overall Study|Withdrawal by Subject|1
7908635|NCT02034916|12424381|FG000|Overall Study|Lost to Follow-up|4
7908636|NCT02034916|12424382|FG001|Overall Study|Lost to Follow-up|1
7908637|NCT02034916|12424381|FG000|Overall Study|Study terminated by sponsor|4
7908638|NCT02034916|12424382|FG001|Overall Study|Study terminated by sponsor|5
7908639|NCT02035202|12424392|FG000|Overall Study|Lost to Follow-up|8
7908640|NCT02035202|12424393|FG001|Overall Study|Lost to Follow-up|16
7908641|NCT02035202|12424394|FG002|Overall Study|Lost to Follow-up|2
7719300|NCT00531284|12143203|FG007|Overall Study|Other|0
7719301|NCT00531284|12143204|FG008|Overall Study|Other|2
7719302|NCT00531284|12143205|FG009|Overall Study|Other|1
7719303|NCT00531284|12143206|FG010|Overall Study|Other|0
7719304|NCT00531284|12143207|FG011|Overall Study|Other|2
7719305|NCT00531284|12143208|FG012|Overall Study|Other|0
7719306|NCT00531284|12143209|FG013|Overall Study|Other|0
7719307|NCT00531284|12143210|FG014|Overall Study|Other|1
7719308|NCT00531284|12143211|FG015|Overall Study|Other|0
7719309|NCT00531284|12143212|FG016|Overall Study|Other|0
7719310|NCT00531427|12143270|FG000|Overall Study|Withdrawal by Subject|7
7811806|NCT01185353|12275625|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0
7811807|NCT01185353|12275626|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0
7811808|NCT01185353|12275627|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0
7908642|NCT02035267|12424406|FG000|Overall Study|Withdrawal consent-subject convenience|0
7908643|NCT02035267|12424407|FG001|Overall Study|Withdrawal consent-subject convenience|0
7811809|NCT01185353|12275618|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7811810|NCT01185353|12275619|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
7908644|NCT02035267|12424408|FG002|Overall Study|Withdrawal consent-subject convenience|1
7908645|NCT02035267|12424409|FG003|Overall Study|Withdrawal consent-subject convenience|0
7908646|NCT02035267|12424406|FG000|Overall Study|Adverse Event|0
7908647|NCT02035267|12424407|FG001|Overall Study|Adverse Event|0
7908648|NCT02035267|12424408|FG002|Overall Study|Adverse Event|1
7908649|NCT02035267|12424409|FG003|Overall Study|Adverse Event|0
7908650|NCT02035267|12424406|FG000|Overall Study|Lost to Follow-up|0
7908651|NCT02035267|12424407|FG001|Overall Study|Lost to Follow-up|0
7908652|NCT02035267|12424408|FG002|Overall Study|Lost to Follow-up|0
7811811|NCT01185353|12275620|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7811812|NCT01185353|12275621|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
7811813|NCT01185353|12275622|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7811814|NCT01185353|12275623|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7811815|NCT01185353|12275624|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7811816|NCT01185353|12275625|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7811817|NCT01185353|12275626|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7811818|NCT01185353|12275627|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7811819|NCT01185353|12275618|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7811820|NCT01185353|12275619|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7811821|NCT01185353|12275620|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7811822|NCT01185353|12275621|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
7811823|NCT01185353|12275622|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7811824|NCT01185353|12275623|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7811825|NCT01185353|12275624|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
7811826|NCT01185353|12275625|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7811827|NCT01185353|12275626|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7811828|NCT01185353|12275627|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7811829|NCT01185353|12275618|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7811830|NCT01185353|12275619|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7811831|NCT01185353|12275620|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
7811832|NCT01185353|12275621|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
7811833|NCT01185353|12275622|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7811834|NCT01185353|12275623|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
7811835|NCT01185353|12275624|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
7811836|NCT01185353|12275625|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7811837|NCT01185353|12275626|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7811838|NCT01185353|12275627|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7811839|NCT01185353|12275618|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7811840|NCT01185353|12275619|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7811841|NCT01185353|12275620|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7811842|NCT01185353|12275621|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7811843|NCT01185353|12275622|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7811844|NCT01185353|12275623|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7811845|NCT01185353|12275624|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
7811846|NCT01185353|12275625|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7908653|NCT02035267|12424409|FG003|Overall Study|Lost to Follow-up|1
7908654|NCT02035267|12424406|FG000|Overall Study|Other unspecified|0
7719311|NCT00531427|12143271|FG001|Overall Study|Withdrawal by Subject|13
7719312|NCT00531427|12143270|FG000|Overall Study|Adverse Event|44
7719313|NCT00531427|12143271|FG001|Overall Study|Adverse Event|30
7719314|NCT00531427|12143270|FG000|Overall Study|Lost to Follow-up|4
7719315|NCT00531427|12143271|FG001|Overall Study|Lost to Follow-up|3
7719316|NCT00531427|12143270|FG000|Overall Study|Lack of Efficacy|14
7908655|NCT02035267|12424407|FG001|Overall Study|Other unspecified|1
7908656|NCT02035267|12424408|FG002|Overall Study|Other unspecified|0
7908657|NCT02035267|12424409|FG003|Overall Study|Other unspecified|0
7908658|NCT02035332|12424421|FG000|Overall Study|Procedure Aborted due to Uterine Width|1
7908659|NCT02035475|12424430|FG000|Overall Study|Withdrawal by Subject|4
7908660|NCT02035475|12424430|FG000|Overall Study|Physician Decision|1
7908661|NCT02035475|12424430|FG000|Overall Study|Equipment Error|1
7908662|NCT02035553|12424438|FG000|Overall Study|Death (See All-Cause Mortality Table)|0
7908663|NCT02035553|12424439|FG001|Overall Study|Death (See All-Cause Mortality Table)|1
7908664|NCT02035553|12424438|FG000|Overall Study|Adverse Event|10
7908665|NCT02035553|12424439|FG001|Overall Study|Adverse Event|6
7908666|NCT02035553|12424438|FG000|Overall Study|Physician Decision|3
7908667|NCT02035553|12424439|FG001|Overall Study|Physician Decision|2
7908668|NCT02035553|12424438|FG000|Overall Study|Lack of Efficacy|1
7908669|NCT02035553|12424439|FG001|Overall Study|Lack of Efficacy|1
7908670|NCT02035553|12424438|FG000|Overall Study|Withdrawal by Subject|4
7908671|NCT02035553|12424439|FG001|Overall Study|Withdrawal by Subject|7
7908672|NCT02035553|12424438|FG000|Overall Study|Non-compliance with Study Drug|0
7908673|NCT02035553|12424439|FG001|Overall Study|Non-compliance with Study Drug|1
7908674|NCT02035553|12424438|FG000|Overall Study|Lost to Follow-up|0
7908675|NCT02035553|12424439|FG001|Overall Study|Lost to Follow-up|1
7908676|NCT02035553|12424438|FG000|Overall Study|Other Reason|0
7908677|NCT02035553|12424439|FG001|Overall Study|Other Reason|4
7908678|NCT02035696|12424449|FG000|Overall Study|Lost to Follow-up|0
7908679|NCT02035696|12424450|FG001|Overall Study|Lost to Follow-up|3
7908680|NCT02035696|12424451|FG002|Overall Study|Lost to Follow-up|1
7908681|NCT02035696|12424452|FG003|Overall Study|Lost to Follow-up|2
7908682|NCT02035696|12424449|FG000|Overall Study|Withdrawal by Subject|3
7908683|NCT02035696|12424450|FG001|Overall Study|Withdrawal by Subject|0
7908684|NCT02035696|12424451|FG002|Overall Study|Withdrawal by Subject|2
7908685|NCT02035696|12424452|FG003|Overall Study|Withdrawal by Subject|1
7908686|NCT02035748|12424466|FG000|Overall Study|Adverse Event|5
7908687|NCT02035748|12424466|FG000|Overall Study|Death|3
7908688|NCT02035748|12424466|FG000|Overall Study|Lost to Follow-up|2
7908689|NCT02035748|12424466|FG000|Overall Study|Physician Decision|3
7908690|NCT02035748|12424466|FG000|Overall Study|Withdrawal by Subject|6
7908691|NCT02035748|12424466|FG000|Overall Study|Progressive Disease|1
7908692|NCT02036294|12424473|FG000|Overall Study|Death|7
7908693|NCT02036294|12424474|FG001|Overall Study|Death|8
7908694|NCT02036294|12424473|FG000|Overall Study|Withdrawal by Subject|2
7908695|NCT02036294|12424474|FG001|Overall Study|Withdrawal by Subject|3
7908696|NCT02036502|12424504|FG000|Part 1:Dose Determination/Escalation|Death|3
7908697|NCT02036502|12424505|FG001|Part 1:Dose Determination/Escalation|Death|2
7908698|NCT02036502|12424506|FG002|Part 1:Dose Determination/Escalation|Death|0
7908699|NCT02036502|12424507|FG003|Part 1:Dose Determination/Escalation|Death|0
7908700|NCT02036502|12424508|FG004|Part 1:Dose Determination/Escalation|Death|0
7719317|NCT00531427|12143271|FG001|Overall Study|Lack of Efficacy|39
7719318|NCT00531427|12143270|FG000|Overall Study|Administrative|4
7719319|NCT00531427|12143271|FG001|Overall Study|Administrative|9
7719320|NCT00531479|12143289|FG000|Overall Study|Death|68
7719321|NCT00531479|12143290|FG001|Overall Study|Death|71
7719322|NCT00531479|12143289|FG000|Overall Study|Lost to Follow-up|0
7719323|NCT00531479|12143290|FG001|Overall Study|Lost to Follow-up|2
7719324|NCT00531479|12143289|FG000|Overall Study|Other|0
7719325|NCT00531479|12143290|FG001|Overall Study|Other|1
7719326|NCT00531479|12143289|FG000|Overall Study|Withdrawal by Subject|6
7908701|NCT02036502|12424509|FG005|Part 1:Dose Determination/Escalation|Death|0
7908702|NCT02036502|12424510|FG006|Part 1:Dose Determination/Escalation|Death|0
7908703|NCT02036502|12424511|FG007|Part 1:Dose Determination/Escalation|Death|0
7908704|NCT02036502|12424504|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3
7908705|NCT02036502|12424505|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7908706|NCT02036502|12424506|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7908707|NCT02036502|12424507|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7908708|NCT02036502|12424508|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7908709|NCT02036502|12424509|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7908710|NCT02036502|12424510|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7908711|NCT02036502|12424511|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7908712|NCT02036502|12424504|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0
7908713|NCT02036502|12424505|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1
7908714|NCT02036502|12424506|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0
7908715|NCT02036502|12424507|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0
7908716|NCT02036502|12424508|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0
7908717|NCT02036502|12424509|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0
7908718|NCT02036502|12424510|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0
7908719|NCT02036502|12424511|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0
7908720|NCT02036502|12424504|FG000|Part 1:Dose Determination/Escalation|Not treated|0
7908721|NCT02036502|12424505|FG001|Part 1:Dose Determination/Escalation|Not treated|1
7908722|NCT02036502|12424506|FG002|Part 1:Dose Determination/Escalation|Not treated|0
7908723|NCT02036502|12424507|FG003|Part 1:Dose Determination/Escalation|Not treated|0
7908724|NCT02036502|12424508|FG004|Part 1:Dose Determination/Escalation|Not treated|0
7908725|NCT02036502|12424509|FG005|Part 1:Dose Determination/Escalation|Not treated|0
7719327|NCT00531479|12143290|FG001|Overall Study|Withdrawal by Subject|6
7719328|NCT00531479|12143289|FG000|Overall Study|Did not receive treatment|2
7719329|NCT00531479|12143290|FG001|Overall Study|Did not receive treatment|3
7719330|NCT00531752|12143321|FG000|First Double-blind Intervention Period|Adverse Event|2
7719331|NCT00531752|12143322|FG001|First Double-blind Intervention Period|Adverse Event|0
7719332|NCT00531752|12143323|FG002|First Double-blind Intervention Period|Adverse Event|1
7908726|NCT02036502|12424510|FG006|Part 1:Dose Determination/Escalation|Not treated|0
7908727|NCT02036502|12424511|FG007|Part 1:Dose Determination/Escalation|Not treated|0
7908728|NCT02036502|12424504|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7908729|NCT02036502|12424505|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7719333|NCT00531752|12143324|FG003|First Double-blind Intervention Period|Adverse Event|1
7719334|NCT00531752|12143321|FG000|First Double-blind Intervention Period|Other|1
7719335|NCT00531752|12143322|FG001|First Double-blind Intervention Period|Other|4
7767837|NCT00856284|12210625|FG001|Overall Study|Lost to Follow-up|22
7811847|NCT01185353|12275626|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7811848|NCT01185353|12275627|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7811849|NCT01185353|12275618|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0
7811850|NCT01185353|12275619|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0
7811851|NCT01185353|12275620|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0
7811852|NCT01185353|12275621|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0
7811853|NCT01185353|12275622|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0
7811854|NCT01185353|12275623|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0
7811855|NCT01185353|12275624|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0
7811856|NCT01185353|12275625|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8
7811857|NCT01185353|12275626|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2
7811858|NCT01185353|12275627|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2
7811859|NCT01185353|12275618|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7908730|NCT02036502|12424506|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2
7908731|NCT02036502|12424507|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1
7908732|NCT02036502|12424508|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1
7908733|NCT02036502|12424509|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7908734|NCT02036502|12424510|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7908735|NCT02036502|12424511|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7908736|NCT02036502|12424504|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0
7908737|NCT02036502|12424505|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0
7908738|NCT02036502|12424506|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3
7908739|NCT02036502|12424507|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0
7908740|NCT02036502|12424508|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0
7908741|NCT02036502|12424509|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0
7908742|NCT02036502|12424510|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0
7908743|NCT02036502|12424511|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0
7908744|NCT02036502|12424504|FG000|Part 2:Dose Confirmation|Death|0
7908745|NCT02036502|12424505|FG001|Part 2:Dose Confirmation|Death|0
7908746|NCT02036502|12424506|FG002|Part 2:Dose Confirmation|Death|1
7908747|NCT02036502|12424507|FG003|Part 2:Dose Confirmation|Death|0
7908748|NCT02036502|12424508|FG004|Part 2:Dose Confirmation|Death|0
7908749|NCT02036502|12424509|FG005|Part 2:Dose Confirmation|Death|0
7908750|NCT02036502|12424510|FG006|Part 2:Dose Confirmation|Death|0
7908751|NCT02036502|12424511|FG007|Part 2:Dose Confirmation|Death|0
7908752|NCT02036502|12424504|FG000|Part 2:Dose Confirmation|Not treated|0
7908753|NCT02036502|12424505|FG001|Part 2:Dose Confirmation|Not treated|0
7908754|NCT02036502|12424506|FG002|Part 2:Dose Confirmation|Not treated|0
7908755|NCT02036502|12424507|FG003|Part 2:Dose Confirmation|Not treated|1
7908756|NCT02036502|12424508|FG004|Part 2:Dose Confirmation|Not treated|0
7908757|NCT02036502|12424509|FG005|Part 2:Dose Confirmation|Not treated|0
7908758|NCT02036502|12424510|FG006|Part 2:Dose Confirmation|Not treated|0
7908759|NCT02036502|12424511|FG007|Part 2:Dose Confirmation|Not treated|0
7908760|NCT02036502|12424504|FG000|Part 3:Dose Expansion|Adverse Event|0
7908761|NCT02036502|12424505|FG001|Part 3:Dose Expansion|Adverse Event|0
7908762|NCT02036502|12424506|FG002|Part 3:Dose Expansion|Adverse Event|0
7908763|NCT02036502|12424507|FG003|Part 3:Dose Expansion|Adverse Event|0
7908764|NCT02036502|12424508|FG004|Part 3:Dose Expansion|Adverse Event|0
7908765|NCT02036502|12424509|FG005|Part 3:Dose Expansion|Adverse Event|4
7908766|NCT02036502|12424510|FG006|Part 3:Dose Expansion|Adverse Event|0
7908767|NCT02036502|12424511|FG007|Part 3:Dose Expansion|Adverse Event|2
7908768|NCT02036502|12424504|FG000|Part 3:Dose Expansion|Death|0
7908769|NCT02036502|12424505|FG001|Part 3:Dose Expansion|Death|0
7908770|NCT02036502|12424506|FG002|Part 3:Dose Expansion|Death|0
7908771|NCT02036502|12424507|FG003|Part 3:Dose Expansion|Death|0
7908772|NCT02036502|12424508|FG004|Part 3:Dose Expansion|Death|0
7908773|NCT02036502|12424509|FG005|Part 3:Dose Expansion|Death|24
7908774|NCT02036502|12424510|FG006|Part 3:Dose Expansion|Death|0
7811860|NCT01185353|12275619|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7811861|NCT01185353|12275620|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7811862|NCT01185353|12275621|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7811863|NCT01185353|12275622|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7811864|NCT01185353|12275623|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7811865|NCT01185353|12275624|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7811866|NCT01185353|12275625|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
7811867|NCT01185353|12275626|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
7811868|NCT01185353|12275627|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
7811869|NCT01185353|12275618|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7811870|NCT01185353|12275619|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7811871|NCT01185353|12275620|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7811872|NCT01185353|12275621|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7811873|NCT01185353|12275622|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7811874|NCT01185353|12275623|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7811875|NCT01185353|12275624|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7811876|NCT01185353|12275625|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
7811877|NCT01185353|12275626|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
7811878|NCT01185353|12275627|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
7811879|NCT01185353|12275618|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7811880|NCT01185353|12275619|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7811881|NCT01185353|12275620|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7811882|NCT01185353|12275621|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7811883|NCT01185353|12275622|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7811884|NCT01185353|12275623|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7811885|NCT01185353|12275624|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7811886|NCT01185353|12275625|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7811887|NCT01185353|12275626|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
7811888|NCT01185353|12275627|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7811889|NCT01185353|12275618|FG000|Part C (Weeks 24 Through 76)|Death|0
7811890|NCT01185353|12275619|FG001|Part C (Weeks 24 Through 76)|Death|0
7811891|NCT01185353|12275620|FG002|Part C (Weeks 24 Through 76)|Death|0
7811892|NCT01185353|12275621|FG003|Part C (Weeks 24 Through 76)|Death|0
7811893|NCT01185353|12275622|FG004|Part C (Weeks 24 Through 76)|Death|0
7811894|NCT01185353|12275623|FG005|Part C (Weeks 24 Through 76)|Death|0
7811895|NCT01185353|12275624|FG006|Part C (Weeks 24 Through 76)|Death|0
7811896|NCT01185353|12275625|FG007|Part C (Weeks 24 Through 76)|Death|0
7811897|NCT01185353|12275626|FG008|Part C (Weeks 24 Through 76)|Death|0
7811898|NCT01185353|12275627|FG009|Part C (Weeks 24 Through 76)|Death|1
7811899|NCT01185353|12275618|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7811900|NCT01185353|12275619|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7811901|NCT01185353|12275620|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7811902|NCT01185353|12275621|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7811903|NCT01185353|12275622|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7811904|NCT01185353|12275623|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7811905|NCT01185353|12275624|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7811906|NCT01185353|12275625|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7811907|NCT01185353|12275626|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7811908|NCT01185353|12275627|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
7811909|NCT01185353|12275618|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0
7811910|NCT01185353|12275619|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0
7811911|NCT01185353|12275620|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0
7811912|NCT01185353|12275621|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0
7811913|NCT01185353|12275622|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0
7811914|NCT01185353|12275623|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0
7811915|NCT01185353|12275624|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0
7811916|NCT01185353|12275625|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0
7811917|NCT01185353|12275626|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0
7811918|NCT01185353|12275627|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1
7811919|NCT01185353|12275618|FG000|Part C (Weeks 24 Through 76)|Reason missing|0
7811920|NCT01185353|12275619|FG001|Part C (Weeks 24 Through 76)|Reason missing|0
7811921|NCT01185353|12275620|FG002|Part C (Weeks 24 Through 76)|Reason missing|0
7811922|NCT01185353|12275621|FG003|Part C (Weeks 24 Through 76)|Reason missing|0
7811923|NCT01185353|12275622|FG004|Part C (Weeks 24 Through 76)|Reason missing|0
7811924|NCT01185353|12275623|FG005|Part C (Weeks 24 Through 76)|Reason missing|0
7811925|NCT01185353|12275624|FG006|Part C (Weeks 24 Through 76)|Reason missing|0
7811926|NCT01185353|12275625|FG007|Part C (Weeks 24 Through 76)|Reason missing|0
7811927|NCT01185353|12275626|FG008|Part C (Weeks 24 Through 76)|Reason missing|1
7811928|NCT01185353|12275627|FG009|Part C (Weeks 24 Through 76)|Reason missing|0
7811929|NCT01185353|12275618|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7811930|NCT01185353|12275619|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7811931|NCT01185353|12275620|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7811932|NCT01185353|12275621|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7811933|NCT01185353|12275622|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7811934|NCT01185353|12275623|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7811935|NCT01185353|12275624|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7811936|NCT01185353|12275625|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
7811937|NCT01185353|12275626|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
7811938|NCT01185353|12275627|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7811939|NCT01185353|12275618|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7811940|NCT01185353|12275619|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7811941|NCT01185353|12275620|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7811942|NCT01185353|12275621|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7811943|NCT01185353|12275622|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7811944|NCT01185353|12275623|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7811945|NCT01185353|12275624|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7811946|NCT01185353|12275625|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
7811947|NCT01185353|12275626|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
7811948|NCT01185353|12275627|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
7811949|NCT01185353|12275618|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0
7811950|NCT01185353|12275619|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0
7811951|NCT01185353|12275620|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0
7811952|NCT01185353|12275621|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0
7811953|NCT01185353|12275622|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0
7811954|NCT01185353|12275623|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0
7811955|NCT01185353|12275624|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0
7811956|NCT01185353|12275625|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1
7811957|NCT01185353|12275626|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2
7811958|NCT01185353|12275627|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0
7811959|NCT01185366|12275668|FG000|First Line Therapy|Insurance Coverage Denied|1
7811960|NCT01185366|12275669|FG001|First Line Therapy|Insurance Coverage Denied|1
7811961|NCT01185366|12275668|FG000|First Line Therapy|Withdrawal by Subject|1
7908775|NCT02036502|12424511|FG007|Part 3:Dose Expansion|Death|3
7908776|NCT02036502|12424504|FG000|Part 3:Dose Expansion|Lost to Follow-up|0
7908777|NCT02036502|12424505|FG001|Part 3:Dose Expansion|Lost to Follow-up|0
7908778|NCT02036502|12424506|FG002|Part 3:Dose Expansion|Lost to Follow-up|0
7908779|NCT02036502|12424507|FG003|Part 3:Dose Expansion|Lost to Follow-up|0
7908780|NCT02036502|12424508|FG004|Part 3:Dose Expansion|Lost to Follow-up|0
7908781|NCT02036502|12424509|FG005|Part 3:Dose Expansion|Lost to Follow-up|0
7908782|NCT02036502|12424510|FG006|Part 3:Dose Expansion|Lost to Follow-up|0
7908783|NCT02036502|12424511|FG007|Part 3:Dose Expansion|Lost to Follow-up|1
7908784|NCT02036502|12424504|FG000|Part 3:Dose Expansion|Physician Decision|0
7908785|NCT02036502|12424505|FG001|Part 3:Dose Expansion|Physician Decision|0
7908786|NCT02036502|12424506|FG002|Part 3:Dose Expansion|Physician Decision|0
7908787|NCT02036502|12424507|FG003|Part 3:Dose Expansion|Physician Decision|0
7908788|NCT02036502|12424508|FG004|Part 3:Dose Expansion|Physician Decision|0
7908789|NCT02036502|12424509|FG005|Part 3:Dose Expansion|Physician Decision|1
7908790|NCT02036502|12424510|FG006|Part 3:Dose Expansion|Physician Decision|0
7908791|NCT02036502|12424511|FG007|Part 3:Dose Expansion|Physician Decision|0
7908792|NCT02036502|12424504|FG000|Part 3:Dose Expansion|Progressive Disease|0
7908793|NCT02036502|12424505|FG001|Part 3:Dose Expansion|Progressive Disease|0
7908794|NCT02036502|12424506|FG002|Part 3:Dose Expansion|Progressive Disease|0
7908795|NCT02036502|12424507|FG003|Part 3:Dose Expansion|Progressive Disease|0
7908796|NCT02036502|12424508|FG004|Part 3:Dose Expansion|Progressive Disease|0
7908797|NCT02036502|12424509|FG005|Part 3:Dose Expansion|Progressive Disease|1
7908798|NCT02036502|12424510|FG006|Part 3:Dose Expansion|Progressive Disease|0
7908799|NCT02036502|12424511|FG007|Part 3:Dose Expansion|Progressive Disease|0
7908800|NCT02036502|12424504|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7811962|NCT01185366|12275669|FG001|First Line Therapy|Withdrawal by Subject|0
7811963|NCT01185366|12275668|FG000|First Line Therapy|Lack of Metastatic Site|1
7811964|NCT01185366|12275669|FG001|First Line Therapy|Lack of Metastatic Site|0
7811965|NCT01185366|12275668|FG000|Crossover to Second Line Therapy|Adverse Event|3
7811966|NCT01185366|12275669|FG001|Crossover to Second Line Therapy|Adverse Event|6
7811967|NCT01185366|12275668|FG000|Crossover to Second Line Therapy|Physician Decision|5
7811968|NCT01185366|12275669|FG001|Crossover to Second Line Therapy|Physician Decision|1
7811969|NCT01185366|12275668|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1
7811970|NCT01185366|12275669|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0
7811971|NCT01185366|12275668|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5
7811972|NCT01185366|12275669|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3
7811973|NCT01185509|12275679|FG000|Overall Study|Progression/Relapse|9
7811974|NCT01185509|12275680|FG001|Overall Study|Progression/Relapse|15
7811975|NCT01185509|12275679|FG000|Overall Study|Physician Decision|2
7811976|NCT01185509|12275680|FG001|Overall Study|Physician Decision|2
7811977|NCT01185509|12275679|FG000|Overall Study|Withdrawal by Subject|0
7811978|NCT01185509|12275680|FG001|Overall Study|Withdrawal by Subject|1
7811979|NCT01185509|12275679|FG000|Overall Study|Death|0
7811980|NCT01185509|12275680|FG001|Overall Study|Death|1
7811981|NCT01185509|12275679|FG000|Overall Study|Intercurrent Illness|0
7811982|NCT01185509|12275680|FG001|Overall Study|Intercurrent Illness|1
7811983|NCT01185522|12275687|FG000|Overall Study|Lack of Efficacy|28
7811984|NCT01185522|12275687|FG000|Overall Study|Lost to Follow-up|19
7811985|NCT01185522|12275687|FG000|Overall Study|Withdrawal by Subject|10
7811986|NCT01185522|12275687|FG000|Overall Study|Poor tolerance|39
7811987|NCT01185522|12275687|FG000|Overall Study|Other reasons|12
7966878|NCT02757430|12523262|FG000|Overall Study|No procedure performed|2
7811988|NCT01185548|12275692|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
7811989|NCT01185561|12275707|FG000|Overall Study|Lost to Follow-up|0
7811990|NCT01185561|12275708|FG001|Overall Study|Lost to Follow-up|4
7811991|NCT01185561|12275707|FG000|Overall Study|Withdrawal by Subject|2
7811992|NCT01185561|12275708|FG001|Overall Study|Withdrawal by Subject|8
7811993|NCT01185600|12275716|FG000|Overall Study|Adverse Event|1
7811994|NCT01185600|12275717|FG001|Overall Study|Adverse Event|1
7811995|NCT01185600|12275716|FG000|Overall Study|Death|0
7811996|NCT01185600|12275717|FG001|Overall Study|Death|1
7811997|NCT01185600|12275716|FG000|Overall Study|Lost to Follow-up|0
7811998|NCT01185600|12275717|FG001|Overall Study|Lost to Follow-up|5
7811999|NCT01185600|12275716|FG000|Overall Study|Physician Decision|29
7812000|NCT01185600|12275717|FG001|Overall Study|Physician Decision|35
7812001|NCT01185600|12275716|FG000|Overall Study|Withdrawal by Subject|1
7812002|NCT01185600|12275717|FG001|Overall Study|Withdrawal by Subject|1
7908801|NCT02036502|12424505|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7908802|NCT02036502|12424506|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7908803|NCT02036502|12424507|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7908804|NCT02036502|12424508|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7908805|NCT02036502|12424509|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11
7908806|NCT02036502|12424510|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7908807|NCT02036502|12424511|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2
7908808|NCT02036502|12424504|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0
7908809|NCT02036502|12424505|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0
7908810|NCT02036502|12424506|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0
7908811|NCT02036502|12424507|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0
7908812|NCT02036502|12424508|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0
7908813|NCT02036502|12424509|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4
7908814|NCT02036502|12424510|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1
7908815|NCT02036502|12424511|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2
7908816|NCT02036502|12424504|FG000|Part 3:Dose Expansion|Not Treated|0
7908817|NCT02036502|12424505|FG001|Part 3:Dose Expansion|Not Treated|0
7908818|NCT02036502|12424506|FG002|Part 3:Dose Expansion|Not Treated|0
7908819|NCT02036502|12424507|FG003|Part 3:Dose Expansion|Not Treated|0
7908820|NCT02036502|12424508|FG004|Part 3:Dose Expansion|Not Treated|0
7908821|NCT02036502|12424509|FG005|Part 3:Dose Expansion|Not Treated|2
7908822|NCT02036502|12424510|FG006|Part 3:Dose Expansion|Not Treated|0
7908823|NCT02036502|12424511|FG007|Part 3:Dose Expansion|Not Treated|0
7908824|NCT02036515|12424534|FG000|Overall Study|Adverse Event|1
7908825|NCT02036515|12424535|FG001|Overall Study|Adverse Event|1
7908826|NCT02036515|12424536|FG002|Overall Study|Adverse Event|2
7908827|NCT02036515|12424534|FG000|Overall Study|Lost to Follow-up|0
7908828|NCT02036515|12424535|FG001|Overall Study|Lost to Follow-up|2
7908829|NCT02036515|12424536|FG002|Overall Study|Lost to Follow-up|0
7908830|NCT02036515|12424534|FG000|Overall Study|Non-compliance with study drug|0
7908831|NCT02036515|12424535|FG001|Overall Study|Non-compliance with study drug|0
7908832|NCT02036515|12424536|FG002|Overall Study|Non-compliance with study drug|2
7908833|NCT02036515|12424534|FG000|Overall Study|Screen failure|0
7908834|NCT02036515|12424535|FG001|Overall Study|Screen failure|2
7908835|NCT02036515|12424536|FG002|Overall Study|Screen failure|0
7908836|NCT02036515|12424534|FG000|Overall Study|Withdrawal by Subject|4
7908837|NCT02036515|12424535|FG001|Overall Study|Withdrawal by Subject|7
7908838|NCT02036515|12424536|FG002|Overall Study|Withdrawal by Subject|9
7908839|NCT02036515|12424534|FG000|Overall Study|Hyperglycemia|0
7908840|NCT02036515|12424535|FG001|Overall Study|Hyperglycemia|0
7908841|NCT02036515|12424536|FG002|Overall Study|Hyperglycemia|1
7908842|NCT02036580|12424551|FG000|Overall Study|Withdrawal by Subject|0
7908843|NCT02036580|12424552|FG001|Overall Study|Withdrawal by Subject|1
7908844|NCT02036580|12424553|FG002|Overall Study|Withdrawal by Subject|0
7908845|NCT02036580|12424551|FG000|Overall Study|Adverse Event|1
7908846|NCT02036580|12424552|FG001|Overall Study|Adverse Event|0
7908847|NCT02036580|12424553|FG002|Overall Study|Adverse Event|0
7908848|NCT02036645|12424573|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7908849|NCT02036645|12424574|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7908850|NCT02036645|12424575|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7908851|NCT02036645|12424576|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7908852|NCT02036645|12424577|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7908853|NCT02036645|12424578|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7908854|NCT02036645|12424579|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1
7908855|NCT02036645|12424580|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7908856|NCT02036645|12424581|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7908857|NCT02036645|12424582|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7908858|NCT02036645|12424583|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7908859|NCT02036645|12424584|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7908860|NCT02036645|12424573|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7908861|NCT02036645|12424574|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7908862|NCT02036645|12424575|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7812003|NCT01185600|12275716|FG000|Overall Study|Hold by DSMB|1
7812004|NCT01185600|12275717|FG001|Overall Study|Hold by DSMB|2
7812005|NCT01185639|12275726|FG000|Overall Study|Progressed and didn't receive therapy|2
7812006|NCT01185704|12275732|FG000|Overall Study|Randomized but not treated|3
7812007|NCT01185704|12275733|FG001|Overall Study|Randomized but not treated|3
7812008|NCT01185704|12275732|FG000|Overall Study|Lack of ovarian response|5
7812009|NCT01185704|12275733|FG001|Overall Study|Lack of ovarian response|1
7812010|NCT01185704|12275732|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5
7812011|NCT01185704|12275733|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3
7812012|NCT01185704|12275732|FG000|Overall Study|Ectopic pregnancy|0
7812013|NCT01185704|12275733|FG001|Overall Study|Ectopic pregnancy|1
7908863|NCT02036645|12424576|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1
7908864|NCT02036645|12424577|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7908865|NCT02036645|12424578|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7908866|NCT02036645|12424579|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7908867|NCT02036645|12424580|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7908868|NCT02036645|12424581|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7908869|NCT02036645|12424582|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7908870|NCT02036645|12424583|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7908871|NCT02036645|12424584|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7908872|NCT02036775|12424622|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7908873|NCT02036775|12424623|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7908874|NCT02036775|12424624|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7908875|NCT02036775|12424625|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7908876|NCT02036775|12424626|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7908877|NCT02036775|12424627|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
7908878|NCT02036853|12424641|FG000|Overall Study|Adverse Event|0
7908879|NCT02036853|12424642|FG001|Overall Study|Adverse Event|2
7908880|NCT02036853|12424641|FG000|Overall Study|Lack of Efficacy|0
7908881|NCT02036853|12424642|FG001|Overall Study|Lack of Efficacy|2
7908882|NCT02036853|12424641|FG000|Overall Study|Physician Decision|0
7908883|NCT02036853|12424642|FG001|Overall Study|Physician Decision|1
7908884|NCT02036853|12424641|FG000|Overall Study|Withdrawal by Subject|0
7908885|NCT02036853|12424642|FG001|Overall Study|Withdrawal by Subject|1
7964034|NCT02733627|12519002|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1
7964035|NCT02733627|12519003|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
7964036|NCT02733991|12519036|FG000|Overall Study|Adverse Event|1
7964037|NCT02733991|12519037|FG001|Overall Study|Adverse Event|0
7964038|NCT02733991|12519036|FG000|Overall Study|Withdrawal by Subject|0
7964039|NCT02733991|12519037|FG001|Overall Study|Withdrawal by Subject|5
7964040|NCT02734212|12519063|FG000|Overall Study|Lost to Follow-up|5
7964041|NCT02734212|12519064|FG001|Overall Study|Lost to Follow-up|10
7964042|NCT02734693|12519109|FG000|Overall Study|Adverse Event|1
7964043|NCT02734693|12519110|FG001|Overall Study|Adverse Event|3
7964044|NCT02734693|12519111|FG002|Overall Study|Adverse Event|3
7964045|NCT02734693|12519109|FG000|Overall Study|Lack of Efficacy|1
7964046|NCT02734693|12519110|FG001|Overall Study|Lack of Efficacy|0
7964047|NCT02734693|12519111|FG002|Overall Study|Lack of Efficacy|0
7812014|NCT01185782|12275741|FG000|Overall Study|Adverse Event|0
7908886|NCT02037165|12424664|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0
7908887|NCT02037165|12424665|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0
7908888|NCT02037165|12424666|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0
7908889|NCT02037165|12424667|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0
7908890|NCT02037165|12424668|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1
7908891|NCT02037256|12424709|FG000|Overall Study|Protocol Violation|0
7812015|NCT01185782|12275742|FG001|Overall Study|Adverse Event|1
7812016|NCT01185782|12275741|FG000|Overall Study|Protocol Violation|1
7812017|NCT01185782|12275742|FG001|Overall Study|Protocol Violation|0
7812018|NCT01185782|12275741|FG000|Overall Study|Poor Response to Treatment|3
7812019|NCT01185782|12275742|FG001|Overall Study|Poor Response to Treatment|1
7812020|NCT01185782|12275741|FG000|Overall Study|Other|2
7812021|NCT01185782|12275742|FG001|Overall Study|Other|5
7812022|NCT01185782|12275741|FG000|Overall Study|Randomized but not treated|0
7812023|NCT01185782|12275742|FG001|Overall Study|Randomized but not treated|4
7812024|NCT01185821|12275753|FG000|Overall Study|Abnormal laboratory value(s)|1
7812025|NCT01185821|12275754|FG001|Overall Study|Abnormal laboratory value(s)|2
7812026|NCT01185821|12275755|FG002|Overall Study|Abnormal laboratory value(s)|1
7812027|NCT01185821|12275756|FG003|Overall Study|Abnormal laboratory value(s)|0
7812028|NCT01185821|12275757|FG004|Overall Study|Abnormal laboratory value(s)|0
7812029|NCT01185821|12275753|FG000|Overall Study|Protocol Violation|0
7812030|NCT01185821|12275754|FG001|Overall Study|Protocol Violation|0
7812031|NCT01185821|12275755|FG002|Overall Study|Protocol Violation|0
7812032|NCT01185821|12275756|FG003|Overall Study|Protocol Violation|1
7812033|NCT01185821|12275757|FG004|Overall Study|Protocol Violation|1
7812034|NCT01185821|12275753|FG000|Overall Study|Abnormal test procedure result|0
7812035|NCT01185821|12275754|FG001|Overall Study|Abnormal test procedure result|0
7812036|NCT01185821|12275755|FG002|Overall Study|Abnormal test procedure result|0
7908892|NCT02037256|12424710|FG001|Overall Study|Protocol Violation|1
7908893|NCT02037256|12424709|FG000|Overall Study|Withdrawn prior to Velcade|0
7908894|NCT02037256|12424710|FG001|Overall Study|Withdrawn prior to Velcade|2
7908895|NCT02037295|12424722|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
7908896|NCT02037295|12424723|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
7908897|NCT02037295|12424724|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
7908898|NCT02037295|12424725|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
7908899|NCT02037477|12424760|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0
7908900|NCT02037477|12424761|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0
7908901|NCT02037477|12424762|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1
7908902|NCT02037477|12424763|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0
7908903|NCT02037568|12424784|FG000|Overall Study|Withdrawal by Subject|17
7908904|NCT02037568|12424785|FG001|Overall Study|Withdrawal by Subject|24
7908905|NCT02037568|12424784|FG000|Overall Study|Lost to Follow-up|16
7908906|NCT02037568|12424785|FG001|Overall Study|Lost to Follow-up|13
7908907|NCT02037568|12424784|FG000|Overall Study|Screen Failure|3
7908908|NCT02037568|12424785|FG001|Overall Study|Screen Failure|1
7908909|NCT02037568|12424784|FG000|Overall Study|Patient did not receive transplant|0
7908910|NCT02037568|12424785|FG001|Overall Study|Patient did not receive transplant|1
7812037|NCT01185821|12275756|FG003|Overall Study|Abnormal test procedure result|0
7812038|NCT01185821|12275757|FG004|Overall Study|Abnormal test procedure result|1
7812039|NCT01185821|12275753|FG000|Overall Study|Death|0
7812040|NCT01185821|12275754|FG001|Overall Study|Death|1
7812041|NCT01185821|12275755|FG002|Overall Study|Death|0
7812042|NCT01185821|12275756|FG003|Overall Study|Death|0
7812043|NCT01185821|12275757|FG004|Overall Study|Death|0
7812044|NCT01185821|12275753|FG000|Overall Study|Condition no longer required study drug|0
7812045|NCT01185821|12275754|FG001|Overall Study|Condition no longer required study drug|0
7812046|NCT01185821|12275755|FG002|Overall Study|Condition no longer required study drug|0
7812047|NCT01185821|12275756|FG003|Overall Study|Condition no longer required study drug|0
7812048|NCT01185821|12275757|FG004|Overall Study|Condition no longer required study drug|1
7812049|NCT01185821|12275753|FG000|Overall Study|Adverse Event|2
7812050|NCT01185821|12275754|FG001|Overall Study|Adverse Event|3
7812051|NCT01185821|12275755|FG002|Overall Study|Adverse Event|1
7812052|NCT01185821|12275756|FG003|Overall Study|Adverse Event|2
7812053|NCT01185821|12275757|FG004|Overall Study|Adverse Event|5
7812054|NCT01185821|12275753|FG000|Overall Study|Lack of Efficacy|0
7812055|NCT01185821|12275754|FG001|Overall Study|Lack of Efficacy|0
7812056|NCT01185821|12275755|FG002|Overall Study|Lack of Efficacy|3
7812057|NCT01185821|12275756|FG003|Overall Study|Lack of Efficacy|0
7812058|NCT01185821|12275757|FG004|Overall Study|Lack of Efficacy|9
7812059|NCT01185821|12275753|FG000|Overall Study|Withdrawal by Subject|3
7812060|NCT01185821|12275754|FG001|Overall Study|Withdrawal by Subject|2
7812061|NCT01185821|12275755|FG002|Overall Study|Withdrawal by Subject|2
7812062|NCT01185821|12275756|FG003|Overall Study|Withdrawal by Subject|1
7908911|NCT02037984|12424829|FG000|Overall Study|Lack of Efficacy|0
7908912|NCT02037984|12424830|FG001|Overall Study|Lack of Efficacy|0
7908913|NCT02037984|12424831|FG002|Overall Study|Lack of Efficacy|3
7908914|NCT02037984|12424832|FG003|Overall Study|Lack of Efficacy|10
7908915|NCT02037984|12424833|FG004|Overall Study|Lack of Efficacy|2
7908916|NCT02037984|12424834|FG005|Overall Study|Lack of Efficacy|2
7908917|NCT02037984|12424835|FG006|Overall Study|Lack of Efficacy|4
7908918|NCT02037984|12424836|FG007|Overall Study|Lack of Efficacy|3
7908919|NCT02037984|12424829|FG000|Overall Study|Lost to Follow-up|1
7908920|NCT02037984|12424830|FG001|Overall Study|Lost to Follow-up|0
7908921|NCT02037984|12424831|FG002|Overall Study|Lost to Follow-up|3
7908922|NCT02037984|12424832|FG003|Overall Study|Lost to Follow-up|5
7908923|NCT02037984|12424833|FG004|Overall Study|Lost to Follow-up|2
7908924|NCT02037984|12424834|FG005|Overall Study|Lost to Follow-up|2
7908925|NCT02037984|12424835|FG006|Overall Study|Lost to Follow-up|2
7908926|NCT02037984|12424836|FG007|Overall Study|Lost to Follow-up|4
7908927|NCT02037984|12424829|FG000|Overall Study|Physician Decision|0
7908928|NCT02037984|12424830|FG001|Overall Study|Physician Decision|0
7908929|NCT02037984|12424831|FG002|Overall Study|Physician Decision|0
7908930|NCT02037984|12424832|FG003|Overall Study|Physician Decision|0
7908931|NCT02037984|12424833|FG004|Overall Study|Physician Decision|0
7908932|NCT02037984|12424834|FG005|Overall Study|Physician Decision|0
7908933|NCT02037984|12424835|FG006|Overall Study|Physician Decision|1
7908934|NCT02037984|12424836|FG007|Overall Study|Physician Decision|0
7908935|NCT02037984|12424829|FG000|Overall Study|Protocol Violation|0
7908936|NCT02037984|12424830|FG001|Overall Study|Protocol Violation|0
7908937|NCT02037984|12424831|FG002|Overall Study|Protocol Violation|0
7908938|NCT02037984|12424832|FG003|Overall Study|Protocol Violation|0
7908939|NCT02037984|12424833|FG004|Overall Study|Protocol Violation|0
7908940|NCT02037984|12424834|FG005|Overall Study|Protocol Violation|1
7908941|NCT02037984|12424835|FG006|Overall Study|Protocol Violation|2
7908942|NCT02037984|12424836|FG007|Overall Study|Protocol Violation|0
7908943|NCT02037984|12424829|FG000|Overall Study|Technical Problems|0
7908944|NCT02037984|12424830|FG001|Overall Study|Technical Problems|0
7908945|NCT02037984|12424831|FG002|Overall Study|Technical Problems|3
7908946|NCT02037984|12424832|FG003|Overall Study|Technical Problems|3
7908947|NCT02037984|12424833|FG004|Overall Study|Technical Problems|2
7908948|NCT02037984|12424834|FG005|Overall Study|Technical Problems|3
7908949|NCT02037984|12424835|FG006|Overall Study|Technical Problems|4
7908950|NCT02037984|12424836|FG007|Overall Study|Technical Problems|2
7908951|NCT02037984|12424829|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7908952|NCT02037984|12424830|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7908953|NCT02037984|12424831|FG002|Overall Study|Withdrawal by Parent/Guardian|3
7908954|NCT02037984|12424832|FG003|Overall Study|Withdrawal by Parent/Guardian|2
7908955|NCT02037984|12424833|FG004|Overall Study|Withdrawal by Parent/Guardian|5
7908956|NCT02037984|12424834|FG005|Overall Study|Withdrawal by Parent/Guardian|1
7908957|NCT02037984|12424835|FG006|Overall Study|Withdrawal by Parent/Guardian|4
7908958|NCT02037984|12424836|FG007|Overall Study|Withdrawal by Parent/Guardian|2
7908959|NCT02037984|12424829|FG000|Overall Study|Withdrawal by Subject|0
7908960|NCT02037984|12424830|FG001|Overall Study|Withdrawal by Subject|0
7908961|NCT02037984|12424831|FG002|Overall Study|Withdrawal by Subject|0
7908962|NCT02037984|12424832|FG003|Overall Study|Withdrawal by Subject|1
7812063|NCT01185821|12275757|FG004|Overall Study|Withdrawal by Subject|3
7812064|NCT01185821|12275753|FG000|Overall Study|Lost to Follow-up|1
7812065|NCT01185821|12275754|FG001|Overall Study|Lost to Follow-up|1
7812066|NCT01185821|12275755|FG002|Overall Study|Lost to Follow-up|2
7812067|NCT01185821|12275756|FG003|Overall Study|Lost to Follow-up|1
7812068|NCT01185821|12275757|FG004|Overall Study|Lost to Follow-up|2
7812069|NCT01185821|12275753|FG000|Overall Study|Administrative problems|0
7812070|NCT01185821|12275754|FG001|Overall Study|Administrative problems|0
7812071|NCT01185821|12275755|FG002|Overall Study|Administrative problems|1
7812072|NCT01185821|12275756|FG003|Overall Study|Administrative problems|1
7812073|NCT01185821|12275757|FG004|Overall Study|Administrative problems|2
7812074|NCT01185834|12275771|FG000|Overall Study|Lost to Follow-up|2
7812075|NCT01185834|12275771|FG000|Overall Study|Discomfort|4
7812076|NCT01185834|12275771|FG000|Overall Study|Biomicroscopy|4
7812077|NCT01185834|12275771|FG000|Overall Study|Time/Job Conflict|2
7812078|NCT01185834|12275771|FG000|Overall Study|Early exit - Site error|2
7812079|NCT01185964|12275778|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1
7812080|NCT01185964|12275779|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6
7812081|NCT01185964|12275780|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2
7812082|NCT01185964|12275781|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0
7812083|NCT01185964|12275778|FG000|Phase 1b and Phase 2|Other Therapy Started|0
7812084|NCT01185964|12275779|FG001|Phase 1b and Phase 2|Other Therapy Started|3
7812085|NCT01185964|12275780|FG002|Phase 1b and Phase 2|Other Therapy Started|3
7812086|NCT01185964|12275781|FG003|Phase 1b and Phase 2|Other Therapy Started|0
7812087|NCT01185964|12275778|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0
7812088|NCT01185964|12275779|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0
7812089|NCT01185964|12275780|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1
7812090|NCT01185964|12275781|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0
7812091|NCT01185964|12275778|FG000|Phase 1b and Phase 2|Adverse Event|1
7812092|NCT01185964|12275779|FG001|Phase 1b and Phase 2|Adverse Event|0
7812093|NCT01185964|12275780|FG002|Phase 1b and Phase 2|Adverse Event|2
7812094|NCT01185964|12275781|FG003|Phase 1b and Phase 2|Adverse Event|0
7812095|NCT01185964|12275778|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0
7812096|NCT01185964|12275779|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1
7812097|NCT01185964|12275780|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1
7812098|NCT01185964|12275781|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0
7812099|NCT01185964|12275778|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
7812100|NCT01185964|12275779|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
7812101|NCT01185964|12275780|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
7812102|NCT01185964|12275781|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
7812103|NCT01185964|12275778|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
7812104|NCT01185964|12275779|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
7812105|NCT01185964|12275780|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
7812106|NCT01185964|12275781|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
7812107|NCT01185964|12275778|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
7812108|NCT01185964|12275779|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
7812109|NCT01185964|12275780|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
7812110|NCT01185964|12275781|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
7812111|NCT01186328|12275806|FG000|Overall Study|Death|1
7812112|NCT01186328|12275807|FG001|Overall Study|Death|0
7812113|NCT01186328|12275808|FG002|Overall Study|Death|0
7812114|NCT01186419|12275819|FG000|Overall Study|Withdrawal by Subject|5
7812115|NCT01186419|12275820|FG001|Overall Study|Withdrawal by Subject|3
7812116|NCT01186419|12275819|FG000|Overall Study|Adverse Event|1
7812117|NCT01186419|12275820|FG001|Overall Study|Adverse Event|2
7812118|NCT01186419|12275819|FG000|Overall Study|Physician Decision|0
7812119|NCT01186419|12275820|FG001|Overall Study|Physician Decision|3
7812120|NCT01186419|12275819|FG000|Overall Study|Other|1
7812121|NCT01186419|12275820|FG001|Overall Study|Other|1
7812122|NCT01186458|12275825|FG000|Overall Study|Adverse Event|1
7812123|NCT01186692|12275838|FG000|Overall Study|Not Catheterized|11
7812124|NCT01186692|12275838|FG000|Overall Study|Futher testing contraindicated implant|19
7812125|NCT01186692|12275838|FG000|Overall Study|Adverse Event|2
7812126|NCT01186744|12275856|FG000|Overall Study|Lack of Efficacy|156
7812127|NCT01186744|12275857|FG001|Overall Study|Lack of Efficacy|99
7812128|NCT01186744|12275858|FG002|Overall Study|Lack of Efficacy|0
7812129|NCT01186744|12275859|FG003|Overall Study|Lack of Efficacy|2
7812130|NCT01186744|12275860|FG004|Overall Study|Lack of Efficacy|2
7812131|NCT01186744|12275861|FG005|Overall Study|Lack of Efficacy|5
7812132|NCT01186744|12275856|FG000|Overall Study|Protocol Violation|1
7812133|NCT01186744|12275857|FG001|Overall Study|Protocol Violation|2
7812134|NCT01186744|12275858|FG002|Overall Study|Protocol Violation|0
7812135|NCT01186744|12275859|FG003|Overall Study|Protocol Violation|1
7812136|NCT01186744|12275860|FG004|Overall Study|Protocol Violation|1
7812137|NCT01186744|12275861|FG005|Overall Study|Protocol Violation|2
7812138|NCT01186744|12275856|FG000|Overall Study|Lost to Follow-up|15
7812139|NCT01186744|12275857|FG001|Overall Study|Lost to Follow-up|16
7812140|NCT01186744|12275858|FG002|Overall Study|Lost to Follow-up|2
7812141|NCT01186744|12275859|FG003|Overall Study|Lost to Follow-up|1
7812142|NCT01186744|12275860|FG004|Overall Study|Lost to Follow-up|1
7812143|NCT01186744|12275861|FG005|Overall Study|Lost to Follow-up|4
7812144|NCT01186744|12275856|FG000|Overall Study|Screen failure|1
7812145|NCT01186744|12275857|FG001|Overall Study|Screen failure|1
7812146|NCT01186744|12275858|FG002|Overall Study|Screen failure|0
7812147|NCT01186744|12275859|FG003|Overall Study|Screen failure|1
7812148|NCT01186744|12275860|FG004|Overall Study|Screen failure|0
7812149|NCT01186744|12275861|FG005|Overall Study|Screen failure|0
7812150|NCT01186744|12275856|FG000|Overall Study|Withdrawal by Subject|14
7812151|NCT01186744|12275857|FG001|Overall Study|Withdrawal by Subject|10
7812152|NCT01186744|12275858|FG002|Overall Study|Withdrawal by Subject|2
7812153|NCT01186744|12275859|FG003|Overall Study|Withdrawal by Subject|5
7812154|NCT01186744|12275860|FG004|Overall Study|Withdrawal by Subject|0
7812155|NCT01186744|12275861|FG005|Overall Study|Withdrawal by Subject|6
7812156|NCT01186744|12275856|FG000|Overall Study|Study terminated by Sponsor|1
7812157|NCT01186744|12275857|FG001|Overall Study|Study terminated by Sponsor|0
7812158|NCT01186744|12275858|FG002|Overall Study|Study terminated by Sponsor|0
7812159|NCT01186744|12275859|FG003|Overall Study|Study terminated by Sponsor|0
7812160|NCT01186744|12275860|FG004|Overall Study|Study terminated by Sponsor|0
7812161|NCT01186744|12275861|FG005|Overall Study|Study terminated by Sponsor|0
7812162|NCT01186744|12275856|FG000|Overall Study|Other|9
7812163|NCT01186744|12275857|FG001|Overall Study|Other|10
7812164|NCT01186744|12275858|FG002|Overall Study|Other|1
7812165|NCT01186744|12275859|FG003|Overall Study|Other|2
7812166|NCT01186744|12275860|FG004|Overall Study|Other|1
7812167|NCT01186744|12275861|FG005|Overall Study|Other|5
7812168|NCT01186744|12275856|FG000|Overall Study|Adverse Event|10
7812169|NCT01186744|12275857|FG001|Overall Study|Adverse Event|14
7812170|NCT01186744|12275858|FG002|Overall Study|Adverse Event|1
7812171|NCT01186744|12275859|FG003|Overall Study|Adverse Event|0
7812172|NCT01186744|12275860|FG004|Overall Study|Adverse Event|1
7812173|NCT01186744|12275861|FG005|Overall Study|Adverse Event|4
7812174|NCT01186744|12275856|FG000|Overall Study|Death|1
7812175|NCT01186744|12275857|FG001|Overall Study|Death|0
7812176|NCT01186744|12275858|FG002|Overall Study|Death|0
7812177|NCT01186744|12275859|FG003|Overall Study|Death|0
7812178|NCT01186744|12275860|FG004|Overall Study|Death|0
7812179|NCT01186744|12275861|FG005|Overall Study|Death|0
7812180|NCT01186770|12275900|FG000|Overall Study|Ineligibility|0
7812181|NCT01186770|12275901|FG001|Overall Study|Ineligibility|0
7812182|NCT01186770|12275902|FG002|Overall Study|Ineligibility|2
7812183|NCT01186770|12275903|FG003|Overall Study|Ineligibility|0
7812184|NCT01186770|12275900|FG000|Overall Study|Protocol Violation|7
7812185|NCT01186770|12275901|FG001|Overall Study|Protocol Violation|9
7812186|NCT01186770|12275902|FG002|Overall Study|Protocol Violation|12
7812187|NCT01186770|12275903|FG003|Overall Study|Protocol Violation|14
7812188|NCT01186770|12275900|FG000|Overall Study|Adverse Event|2
7812189|NCT01186770|12275901|FG001|Overall Study|Adverse Event|9
7812190|NCT01186770|12275902|FG002|Overall Study|Adverse Event|7
7812191|NCT01186770|12275903|FG003|Overall Study|Adverse Event|9
7812192|NCT01186770|12275900|FG000|Overall Study|Withdrawal by Subject|15
7812193|NCT01186770|12275901|FG001|Overall Study|Withdrawal by Subject|13
7812194|NCT01186770|12275902|FG002|Overall Study|Withdrawal by Subject|11
7908963|NCT02037984|12424833|FG004|Overall Study|Withdrawal by Subject|1
7908964|NCT02037984|12424834|FG005|Overall Study|Withdrawal by Subject|3
7908965|NCT02037984|12424835|FG006|Overall Study|Withdrawal by Subject|0
7908966|NCT02037984|12424836|FG007|Overall Study|Withdrawal by Subject|1
7908967|NCT02038010|12424864|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
7908968|NCT02038010|12424865|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1
7908969|NCT02038010|12424866|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
7908970|NCT02038010|12424867|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
7908971|NCT02038010|12424864|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1
7908972|NCT02038010|12424865|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
7908973|NCT02038010|12424866|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
7908974|NCT02038010|12424867|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
7908975|NCT02038010|12424864|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
7908976|NCT02038010|12424865|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1
7908977|NCT02038010|12424866|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
7908978|NCT02038010|12424867|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
7908979|NCT02038010|12424864|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
7908980|NCT02038010|12424865|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
7812195|NCT01186770|12275903|FG003|Overall Study|Withdrawal by Subject|17
7812196|NCT01186770|12275900|FG000|Overall Study|Lost to Follow-up|10
7812197|NCT01186770|12275901|FG001|Overall Study|Lost to Follow-up|6
7812198|NCT01186770|12275902|FG002|Overall Study|Lost to Follow-up|14
7812199|NCT01186770|12275903|FG003|Overall Study|Lost to Follow-up|9
7812200|NCT01186770|12275900|FG000|Overall Study|Insufficient response to treatment|7
7812201|NCT01186770|12275901|FG001|Overall Study|Insufficient response to treatment|8
7812202|NCT01186770|12275902|FG002|Overall Study|Insufficient response to treatment|5
7812203|NCT01186770|12275903|FG003|Overall Study|Insufficient response to treatment|7
7812204|NCT01186770|12275900|FG000|Overall Study|Other than specified|0
7812205|NCT01186770|12275901|FG001|Overall Study|Other than specified|1
7812206|NCT01186770|12275902|FG002|Overall Study|Other than specified|1
7812207|NCT01186770|12275903|FG003|Overall Study|Other than specified|2
7812208|NCT01186796|12275915|FG000|Overall Study|Adverse Event|3
7812209|NCT01186796|12275916|FG001|Overall Study|Adverse Event|0
7812210|NCT01186796|12275915|FG000|Overall Study|Withdrawal by Subject|1
7812211|NCT01186796|12275916|FG001|Overall Study|Withdrawal by Subject|1
7812212|NCT01186796|12275915|FG000|Overall Study|Protocol Violation|0
7812213|NCT01186796|12275916|FG001|Overall Study|Protocol Violation|1
7812214|NCT01186809|12275922|FG000|Overall Study|Death|30
7812215|NCT01186939|12275926|FG000|Overall Study|Death|7
7812216|NCT01186939|12275926|FG000|Overall Study|Withdrawal by Subject|2
7812217|NCT01186939|12275926|FG000|Overall Study|No longer receiving clinical benefit|17
7812218|NCT01186939|12275926|FG000|Overall Study|Program closed|5
7812219|NCT01186939|12275926|FG000|Overall Study|Sponsor decision|4
7812220|NCT01186939|12275926|FG000|Overall Study|Started additional treatment|1
7812221|NCT01186939|12275926|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
7812222|NCT01186939|12275926|FG000|Overall Study|Myocardial infarction|1
7812223|NCT01186939|12275926|FG000|Overall Study|Bone marrow transplant|1
7812224|NCT01186939|12275926|FG000|Overall Study|Transformation to AML|1
7812225|NCT01186978|12275930|FG000|Overall Study|Withdrawal by Subject|1
7812226|NCT01187043|12275955|FG000|Overall Study|Adverse Event|0
7812227|NCT01187043|12275956|FG001|Overall Study|Adverse Event|0
7812228|NCT01187043|12275957|FG002|Overall Study|Adverse Event|0
7812229|NCT01187043|12275958|FG003|Overall Study|Adverse Event|0
7812230|NCT01187043|12275959|FG004|Overall Study|Adverse Event|1
7812231|NCT01187043|12275955|FG000|Overall Study|Unable to make scheduled visits|1
7812232|NCT01187043|12275956|FG001|Overall Study|Unable to make scheduled visits|0
7812233|NCT01187043|12275957|FG002|Overall Study|Unable to make scheduled visits|4
7812234|NCT01187043|12275958|FG003|Overall Study|Unable to make scheduled visits|0
7812235|NCT01187043|12275959|FG004|Overall Study|Unable to make scheduled visits|1
7812236|NCT01187407|12276006|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
7812237|NCT01187407|12276007|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7812238|NCT01187407|12276008|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7812239|NCT01187407|12276009|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7812240|NCT01187407|12276010|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7812241|NCT01187407|12276006|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
7812242|NCT01187407|12276007|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7812243|NCT01187407|12276008|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7812244|NCT01187407|12276009|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7812245|NCT01187407|12276010|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7812246|NCT01187407|12276006|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
7812247|NCT01187407|12276007|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7812248|NCT01187407|12276008|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7812249|NCT01187407|12276009|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7812250|NCT01187407|12276010|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7812251|NCT01187407|12276006|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
7812252|NCT01187407|12276007|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7812253|NCT01187407|12276008|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7812254|NCT01187407|12276009|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7812255|NCT01187407|12276010|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7812256|NCT01187407|12276006|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
7812257|NCT01187407|12276007|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7812258|NCT01187407|12276008|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7812259|NCT01187407|12276009|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7812260|NCT01187407|12276010|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7812261|NCT01187407|12276006|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
7812262|NCT01187407|12276007|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7812263|NCT01187407|12276008|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7812264|NCT01187407|12276009|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7812265|NCT01187407|12276010|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7812266|NCT01187407|12276006|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
7812267|NCT01187407|12276007|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7908981|NCT02038010|12424866|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
7908982|NCT02038010|12424867|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
7908983|NCT02038010|12424864|FG000|Follow Up|Death|4
7908984|NCT02038010|12424865|FG001|Follow Up|Death|3
7908985|NCT02038010|12424866|FG002|Follow Up|Death|0
7908986|NCT02038010|12424867|FG003|Follow Up|Death|0
7908987|NCT02038010|12424864|FG000|Follow Up|Other|3
7908988|NCT02038010|12424865|FG001|Follow Up|Other|0
7812268|NCT01187407|12276008|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7812269|NCT01187407|12276009|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7812270|NCT01187407|12276010|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7908989|NCT02038010|12424866|FG002|Follow Up|Other|0
7812271|NCT01187407|12276006|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
7812272|NCT01187407|12276007|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
7812273|NCT01187407|12276008|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
7812274|NCT01187407|12276009|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
7812275|NCT01187407|12276010|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
7812276|NCT01187407|12276006|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
7812277|NCT01187407|12276007|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
7812278|NCT01187407|12276008|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
7908990|NCT02038010|12424867|FG003|Follow Up|Other|0
7812279|NCT01187407|12276009|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
7812280|NCT01187407|12276010|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
7812281|NCT01187407|12276006|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
7812282|NCT01187407|12276007|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
7812283|NCT01187407|12276008|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
7812284|NCT01187407|12276009|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
7812285|NCT01187407|12276010|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
7812286|NCT01187407|12276006|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7812287|NCT01187407|12276007|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7812288|NCT01187407|12276008|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7812289|NCT01187407|12276009|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
7812290|NCT01187407|12276010|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
7812291|NCT01187407|12276006|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
7812292|NCT01187407|12276007|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
7812293|NCT01187407|12276008|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7812294|NCT01187407|12276009|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
7812295|NCT01187407|12276010|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
7812296|NCT01187407|12276006|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
7812297|NCT01187407|12276007|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
7812298|NCT01187407|12276008|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
7812299|NCT01187407|12276009|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
7812300|NCT01187407|12276010|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
7812301|NCT01187407|12276006|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7812302|NCT01187407|12276007|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
7812303|NCT01187407|12276008|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
7812304|NCT01187407|12276009|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
7812305|NCT01187407|12276010|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
7812306|NCT01187446|12276029|FG000|Overall Study|Patient started non-protocol therapy|0
7812307|NCT01187446|12276030|FG001|Overall Study|Patient started non-protocol therapy|1
7861892|NCT01597245|12351192|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7861893|NCT01597245|12351193|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
7861894|NCT01597245|12351194|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7861895|NCT01597245|12351195|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7861896|NCT01597245|12351196|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
7861897|NCT01597245|12351197|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7861898|NCT01597245|12351198|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
7861899|NCT01597245|12351199|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
7861900|NCT01597245|12351200|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
7861901|NCT01597245|12351201|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7812308|NCT01187550|12276056|FG000|Overall Study|Protocol Violation|3
7812309|NCT01187550|12276057|FG001|Overall Study|Protocol Violation|1
7812310|NCT01187550|12276056|FG000|Overall Study|Other|3
7908991|NCT02038036|12424883|FG000|Core Study|Adverse Event|7
7812311|NCT01187550|12276057|FG001|Overall Study|Other|0
7812312|NCT01187550|12276056|FG000|Overall Study|Randomized but not treated|8
7812313|NCT01187550|12276057|FG001|Overall Study|Randomized but not treated|0
7812314|NCT01187901|12276076|FG000|Overall Study|Protocol Violation|1
7812315|NCT01187901|12276077|FG001|Overall Study|Protocol Violation|0
7812316|NCT01187901|12276076|FG000|Overall Study|Lost to Follow-up|1
7812317|NCT01187901|12276077|FG001|Overall Study|Lost to Follow-up|2
7812318|NCT01187901|12276076|FG000|Overall Study|Unrelated Health Reasons|1
7812319|NCT01187901|12276077|FG001|Overall Study|Unrelated Health Reasons|2
7812320|NCT01187901|12276076|FG000|Overall Study|Suspected Allergic Reaction|1
7812321|NCT01187901|12276077|FG001|Overall Study|Suspected Allergic Reaction|1
7812322|NCT01187901|12276076|FG000|Overall Study|Adverse Event|3
7812323|NCT01187901|12276077|FG001|Overall Study|Adverse Event|0
7812324|NCT01187901|12276076|FG000|Overall Study|No Endpoint due to Early Study Halt|2
7812325|NCT01187901|12276077|FG001|Overall Study|No Endpoint due to Early Study Halt|3
7812326|NCT01187901|12276076|FG000|Overall Study|Pregnancy|0
7812327|NCT01187901|12276077|FG001|Overall Study|Pregnancy|2
7812328|NCT01187953|12276089|FG000|Overall Study|Death|11
7908992|NCT02038036|12424884|FG001|Core Study|Adverse Event|7
7908993|NCT02038036|12424883|FG000|Core Study|Death|1
7908994|NCT02038036|12424884|FG001|Core Study|Death|1
7908995|NCT02038036|12424883|FG000|Core Study|Disease progression|2
7908996|NCT02038036|12424884|FG001|Core Study|Disease progression|2
7908997|NCT02038036|12424883|FG000|Core Study|Lost to Follow-up|0
7908998|NCT02038036|12424884|FG001|Core Study|Lost to Follow-up|1
7908999|NCT02038036|12424883|FG000|Core Study|Physician Decision|2
7909000|NCT02038036|12424884|FG001|Core Study|Physician Decision|1
7909001|NCT02038036|12424883|FG000|Core Study|Subject/guardian decision|0
7909002|NCT02038036|12424884|FG001|Core Study|Subject/guardian decision|1
7909003|NCT02038036|12424883|FG000|Core Study|Withdrawal by Subject|3
7909004|NCT02038036|12424884|FG001|Core Study|Withdrawal by Subject|1
7909005|NCT02038036|12424883|FG000|Crossover Period|Withdrawal by Subject|0
7909006|NCT02038036|12424884|FG001|Crossover Period|Withdrawal by Subject|3
7909007|NCT02038036|12424883|FG000|Crossover Period|Adverse Event|0
7909008|NCT02038036|12424884|FG001|Crossover Period|Adverse Event|9
7909009|NCT02038036|12424883|FG000|Crossover Period|Death|0
7909010|NCT02038036|12424884|FG001|Crossover Period|Death|2
7909011|NCT02038036|12424883|FG000|Crossover Period|Disease progression|0
7909012|NCT02038036|12424884|FG001|Crossover Period|Disease progression|3
7909013|NCT02038036|12424883|FG000|Crossover Period|Lost to Follow-up|0
7909014|NCT02038036|12424884|FG001|Crossover Period|Lost to Follow-up|1
7909015|NCT02038036|12424883|FG000|Crossover Period|Physician Decision|0
7909016|NCT02038036|12424884|FG001|Crossover Period|Physician Decision|2
7909017|NCT02038049|12424895|FG000|Overall Study|Lost to Follow-up|1
7909018|NCT02038049|12424896|FG001|Overall Study|Lost to Follow-up|0
7909019|NCT02038075|12424908|FG000|Overall Study|Withdrawal by Subject|3
7909020|NCT02038075|12424909|FG001|Overall Study|Withdrawal by Subject|0
7909021|NCT02038543|12424935|FG000|Overall Study|Screen Failure|0
7909022|NCT02038543|12424936|FG001|Overall Study|Screen Failure|0
7909023|NCT02038543|12424937|FG002|Overall Study|Screen Failure|0
7909024|NCT02038543|12424938|FG003|Overall Study|Screen Failure|1
7909025|NCT02038543|12424935|FG000|Overall Study|Withdrawal by Subject|0
7909026|NCT02038543|12424936|FG001|Overall Study|Withdrawal by Subject|0
7909027|NCT02038543|12424937|FG002|Overall Study|Withdrawal by Subject|0
7909028|NCT02038543|12424938|FG003|Overall Study|Withdrawal by Subject|1
7909029|NCT02038647|12424955|FG000|Overall Study|Progressive Disease|50
7909030|NCT02038647|12424956|FG001|Overall Study|Progressive Disease|59
7909031|NCT02038647|12424955|FG000|Overall Study|Adverse Event|18
7909032|NCT02038647|12424956|FG001|Overall Study|Adverse Event|10
7909033|NCT02038647|12424955|FG000|Overall Study|Symptomatic Deterioration|7
7909034|NCT02038647|12424956|FG001|Overall Study|Symptomatic Deterioration|7
7909035|NCT02038647|12424955|FG000|Overall Study|Withdrawal by Subject|5
7909036|NCT02038647|12424956|FG001|Overall Study|Withdrawal by Subject|2
7909037|NCT02038647|12424955|FG000|Overall Study|Not Reported|0
7909038|NCT02038647|12424956|FG001|Overall Study|Not Reported|1
7909039|NCT02038647|12424955|FG000|Overall Study|Ongoing at Datacut|9
7909040|NCT02038647|12424956|FG001|Overall Study|Ongoing at Datacut|10
7909041|NCT02038764|12424967|FG000|Overall Study|Adverse Event|0
7909042|NCT02038764|12424968|FG001|Overall Study|Adverse Event|0
7909043|NCT02038764|12424969|FG002|Overall Study|Adverse Event|1
7909044|NCT02038764|12424970|FG003|Overall Study|Adverse Event|0
7812329|NCT01187953|12276090|FG001|Overall Study|Death|13
7812330|NCT01187953|12276089|FG000|Overall Study|Adverse Event|1
7812331|NCT01187953|12276090|FG001|Overall Study|Adverse Event|2
7812332|NCT01187953|12276089|FG000|Overall Study|Lost to Follow-up|0
7812333|NCT01187953|12276090|FG001|Overall Study|Lost to Follow-up|3
7812334|NCT01187953|12276089|FG000|Overall Study|Withdrawal by Subject|3
7812335|NCT01187953|12276090|FG001|Overall Study|Withdrawal by Subject|3
7909045|NCT02038764|12424971|FG004|Overall Study|Adverse Event|0
7909046|NCT02038764|12424967|FG000|Overall Study|Lost to Follow-up|0
7909047|NCT02038764|12424968|FG001|Overall Study|Lost to Follow-up|1
7909048|NCT02038764|12424969|FG002|Overall Study|Lost to Follow-up|0
7909049|NCT02038764|12424970|FG003|Overall Study|Lost to Follow-up|0
7909050|NCT02038764|12424971|FG004|Overall Study|Lost to Follow-up|0
7909051|NCT02038764|12424967|FG000|Overall Study|Withdrawal by Subject|0
7909052|NCT02038764|12424968|FG001|Overall Study|Withdrawal by Subject|0
7812336|NCT01188226|12276100|FG000|Overall Study|Withdrawal by Subject|4
7812337|NCT01188343|12276117|FG000|Overall Study|Not vaccinated|0
7812338|NCT01188343|12276118|FG001|Overall Study|Not vaccinated|2
7812339|NCT01188343|12276119|FG002|Overall Study|Not vaccinated|1
7812340|NCT01188343|12276117|FG000|Overall Study|Withdrawal by Subject|1
7812341|NCT01188343|12276118|FG001|Overall Study|Withdrawal by Subject|24
7812342|NCT01188343|12276119|FG002|Overall Study|Withdrawal by Subject|0
7812343|NCT01188538|12276189|FG000|Overall Study|Lost to Follow-up|0
7812344|NCT01188538|12276190|FG001|Overall Study|Lost to Follow-up|1
7812345|NCT01188551|12276202|FG000|Overall Study|Pharmacy issues|1
7812346|NCT01188551|12276203|FG001|Overall Study|Pharmacy issues|0
7812347|NCT01188551|12276204|FG002|Overall Study|Pharmacy issues|0
7812348|NCT01188551|12276205|FG003|Overall Study|Pharmacy issues|0
7812349|NCT01188564|12276217|FG000|Double-blind Phase|randomized not treated|1
7812350|NCT01188564|12276218|FG001|Double-blind Phase|randomized not treated|0
7812351|NCT01188655|12276237|FG000|Overall Study|Lack of Efficacy|1
7812352|NCT01188655|12276237|FG000|Overall Study|Lost to Follow-up|1
7812353|NCT01188655|12276237|FG000|Overall Study|Other|11
7812354|NCT01188668|12276241|FG000|Period 1: ARIP Alone|Protocol Violation|2
7812355|NCT01188668|12276241|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
7812356|NCT01188668|12276241|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
7812357|NCT01188681|12276252|FG000|Overall Study|bladder cancer|0
7812358|NCT01188681|12276253|FG001|Overall Study|bladder cancer|0
7812359|NCT01188681|12276254|FG002|Overall Study|bladder cancer|1
7812360|NCT01188681|12276255|FG003|Overall Study|bladder cancer|0
7812361|NCT01188681|12276252|FG000|Overall Study|Withdrawal by Subject|0
7812362|NCT01188681|12276253|FG001|Overall Study|Withdrawal by Subject|0
7812363|NCT01188681|12276254|FG002|Overall Study|Withdrawal by Subject|0
7812364|NCT01188681|12276255|FG003|Overall Study|Withdrawal by Subject|1
7812365|NCT01188772|12276286|FG000|Overall Study|Randomized but Not Treated|0
7812366|NCT01188772|12276287|FG001|Overall Study|Randomized but Not Treated|1
7812367|NCT01188772|12276288|FG002|Overall Study|Randomized but Not Treated|0
7812368|NCT01188772|12276289|FG003|Overall Study|Randomized but Not Treated|0
7812369|NCT01188772|12276286|FG000|Overall Study|Adverse Event|0
7812370|NCT01188772|12276287|FG001|Overall Study|Adverse Event|1
7812371|NCT01188772|12276288|FG002|Overall Study|Adverse Event|2
7812372|NCT01188772|12276289|FG003|Overall Study|Adverse Event|0
7812373|NCT01188772|12276286|FG000|Overall Study|Lost to Follow-up|4
7812374|NCT01188772|12276287|FG001|Overall Study|Lost to Follow-up|1
7812375|NCT01188772|12276288|FG002|Overall Study|Lost to Follow-up|1
7812376|NCT01188772|12276289|FG003|Overall Study|Lost to Follow-up|1
7812377|NCT01188772|12276286|FG000|Overall Study|Non-responder|0
7812378|NCT01188772|12276287|FG001|Overall Study|Non-responder|0
7812379|NCT01188772|12276288|FG002|Overall Study|Non-responder|3
7812380|NCT01188772|12276289|FG003|Overall Study|Non-responder|0
7812381|NCT01188772|12276286|FG000|Overall Study|Physician Decision|0
7812382|NCT01188772|12276287|FG001|Overall Study|Physician Decision|0
7812383|NCT01188772|12276288|FG002|Overall Study|Physician Decision|1
7812384|NCT01188772|12276289|FG003|Overall Study|Physician Decision|0
7812385|NCT01188772|12276286|FG000|Overall Study|Terminated by Sponsor|0
7812386|NCT01188772|12276287|FG001|Overall Study|Terminated by Sponsor|0
7812387|NCT01188772|12276288|FG002|Overall Study|Terminated by Sponsor|1
7812388|NCT01188772|12276289|FG003|Overall Study|Terminated by Sponsor|0
7812389|NCT01188772|12276286|FG000|Overall Study|Treatment Failure|0
7812390|NCT01188772|12276287|FG001|Overall Study|Treatment Failure|0
7812391|NCT01188772|12276288|FG002|Overall Study|Treatment Failure|1
7812392|NCT01188772|12276289|FG003|Overall Study|Treatment Failure|0
7812393|NCT01188772|12276286|FG000|Overall Study|Virologic Failure|1
7812394|NCT01188772|12276287|FG001|Overall Study|Virologic Failure|0
7812395|NCT01188772|12276288|FG002|Overall Study|Virologic Failure|0
7812396|NCT01188772|12276289|FG003|Overall Study|Virologic Failure|0
7812397|NCT01188772|12276286|FG000|Overall Study|Withdrawal by Subject|0
7812398|NCT01188772|12276287|FG001|Overall Study|Withdrawal by Subject|0
7812399|NCT01188772|12276288|FG002|Overall Study|Withdrawal by Subject|2
7812400|NCT01188772|12276289|FG003|Overall Study|Withdrawal by Subject|0
7812401|NCT01188811|12276304|FG000|Overall Study|Withdrawal by Subject|0
7812402|NCT01188811|12276305|FG001|Overall Study|Withdrawal by Subject|2
7812403|NCT01188811|12276304|FG000|Overall Study|Adverse Event|6
7812404|NCT01188811|12276305|FG001|Overall Study|Adverse Event|0
7812405|NCT01188967|12276334|FG000|Overall Study|Withdrawal by Subject|1
7812406|NCT01188967|12276335|FG001|Overall Study|Withdrawal by Subject|1
7812407|NCT01188967|12276334|FG000|Overall Study|Physician Decision|1
7812408|NCT01188967|12276335|FG001|Overall Study|Physician Decision|1
7812409|NCT01188967|12276334|FG000|Overall Study|Lost to Follow-up|3
7812410|NCT01188967|12276335|FG001|Overall Study|Lost to Follow-up|2
7909053|NCT02038764|12424969|FG002|Overall Study|Withdrawal by Subject|0
7812411|NCT01189032|12276346|FG000|Overall Study|Adverse Event|1
7812412|NCT01189032|12276347|FG001|Overall Study|Adverse Event|3
7812413|NCT01189032|12276348|FG002|Overall Study|Adverse Event|4
7812414|NCT01189032|12276346|FG000|Overall Study|Lack of Efficacy|2
7812415|NCT01189032|12276347|FG001|Overall Study|Lack of Efficacy|3
7812416|NCT01189032|12276348|FG002|Overall Study|Lack of Efficacy|0
7812417|NCT01189032|12276346|FG000|Overall Study|Withdrawal by Subject|1
7812418|NCT01189032|12276347|FG001|Overall Study|Withdrawal by Subject|0
7812419|NCT01189032|12276348|FG002|Overall Study|Withdrawal by Subject|1
7812420|NCT01189032|12276346|FG000|Overall Study|Protocol Violation|1
7812421|NCT01189032|12276347|FG001|Overall Study|Protocol Violation|1
7812422|NCT01189032|12276348|FG002|Overall Study|Protocol Violation|1
7812423|NCT01189201|12276383|FG000|Overall Study|Adverse Event|1
7812424|NCT01189266|12276413|FG000|Overall Study|Adverse Event|1
7812425|NCT01189266|12276414|FG001|Overall Study|Adverse Event|0
7909054|NCT02038764|12424970|FG003|Overall Study|Withdrawal by Subject|0
7909055|NCT02038764|12424971|FG004|Overall Study|Withdrawal by Subject|1
7909056|NCT02038764|12424967|FG000|Overall Study|Other|1
7909057|NCT02038764|12424968|FG001|Overall Study|Other|0
7909058|NCT02038764|12424969|FG002|Overall Study|Other|1
7909059|NCT02038764|12424970|FG003|Overall Study|Other|0
7909060|NCT02038764|12424971|FG004|Overall Study|Other|0
7909061|NCT02038790|12424987|FG000|Day 0 - First Treatment|Withdrawal by Subject|1
7909062|NCT02038790|12424988|FG001|Day 0 - First Treatment|Withdrawal by Subject|1
7909063|NCT02038829|12424995|FG000|Washout Period 1|Death|0
7909064|NCT02038829|12424996|FG001|Washout Period 1|Death|0
7909065|NCT02038829|12424997|FG002|Washout Period 1|Death|0
7909066|NCT02038829|12424998|FG003|Washout Period 1|Death|0
7909067|NCT02038829|12424999|FG004|Washout Period 1|Death|1
7909068|NCT02038829|12425000|FG005|Washout Period 1|Death|0
7909069|NCT02038829|12425001|FG006|Washout Period 1|Death|0
7909070|NCT02038829|12425002|FG007|Washout Period 1|Death|0
7909071|NCT02038829|12425003|FG008|Washout Period 1|Death|0
7909072|NCT02038829|12425004|FG009|Washout Period 1|Death|0
7909073|NCT02038829|12425005|FG010|Washout Period 1|Death|0
7909074|NCT02038829|12425006|FG011|Washout Period 1|Death|0
7909075|NCT02038829|12424995|FG000|Treatment Period 2|Adverse Event|0
7909076|NCT02038829|12424996|FG001|Treatment Period 2|Adverse Event|0
7909077|NCT02038829|12424997|FG002|Treatment Period 2|Adverse Event|0
7909078|NCT02038829|12424998|FG003|Treatment Period 2|Adverse Event|0
7909079|NCT02038829|12424999|FG004|Treatment Period 2|Adverse Event|0
7909080|NCT02038829|12425000|FG005|Treatment Period 2|Adverse Event|0
7909081|NCT02038829|12425001|FG006|Treatment Period 2|Adverse Event|0
7909082|NCT02038829|12425002|FG007|Treatment Period 2|Adverse Event|0
7909083|NCT02038829|12425003|FG008|Treatment Period 2|Adverse Event|0
7909084|NCT02038829|12425004|FG009|Treatment Period 2|Adverse Event|0
7909085|NCT02038829|12425005|FG010|Treatment Period 2|Adverse Event|1
7909086|NCT02038829|12425006|FG011|Treatment Period 2|Adverse Event|0
7909087|NCT02038829|12424995|FG000|Treatment Period 2|Withdrawal by Subject|1
7909088|NCT02038829|12424996|FG001|Treatment Period 2|Withdrawal by Subject|0
7909089|NCT02038829|12424997|FG002|Treatment Period 2|Withdrawal by Subject|0
7909090|NCT02038829|12424998|FG003|Treatment Period 2|Withdrawal by Subject|0
7909091|NCT02038829|12424999|FG004|Treatment Period 2|Withdrawal by Subject|0
7909092|NCT02038829|12425000|FG005|Treatment Period 2|Withdrawal by Subject|0
7909093|NCT02038829|12425001|FG006|Treatment Period 2|Withdrawal by Subject|0
7909094|NCT02038829|12425002|FG007|Treatment Period 2|Withdrawal by Subject|0
7909095|NCT02038829|12425003|FG008|Treatment Period 2|Withdrawal by Subject|0
7909096|NCT02038829|12425004|FG009|Treatment Period 2|Withdrawal by Subject|0
7909097|NCT02038829|12425005|FG010|Treatment Period 2|Withdrawal by Subject|0
7909098|NCT02038829|12425006|FG011|Treatment Period 2|Withdrawal by Subject|0
7909099|NCT02038829|12424995|FG000|Washout Period 2|Adverse Event|0
7909100|NCT02038829|12424996|FG001|Washout Period 2|Adverse Event|0
7909101|NCT02038829|12424997|FG002|Washout Period 2|Adverse Event|0
7909102|NCT02038829|12424998|FG003|Washout Period 2|Adverse Event|0
7909103|NCT02038829|12424999|FG004|Washout Period 2|Adverse Event|0
7909104|NCT02038829|12425000|FG005|Washout Period 2|Adverse Event|0
7909105|NCT02038829|12425001|FG006|Washout Period 2|Adverse Event|0
7909106|NCT02038829|12425002|FG007|Washout Period 2|Adverse Event|0
7909107|NCT02038829|12425003|FG008|Washout Period 2|Adverse Event|1
7909108|NCT02038829|12425004|FG009|Washout Period 2|Adverse Event|0
7909109|NCT02038829|12425005|FG010|Washout Period 2|Adverse Event|0
7812426|NCT01189266|12276415|FG002|Overall Study|Adverse Event|5
7812427|NCT01189266|12276413|FG000|Overall Study|Death|0
7812428|NCT01189266|12276414|FG001|Overall Study|Death|0
7812429|NCT01189266|12276415|FG002|Overall Study|Death|5
7812430|NCT01189266|12276413|FG000|Overall Study|Lack of Efficacy|4
7909110|NCT02038829|12425006|FG011|Washout Period 2|Adverse Event|0
7909111|NCT02038829|12424995|FG000|Washout Period 2|Withdrawal by Subject|0
7909112|NCT02038829|12424996|FG001|Washout Period 2|Withdrawal by Subject|0
7909113|NCT02038829|12424997|FG002|Washout Period 2|Withdrawal by Subject|0
7909114|NCT02038829|12424998|FG003|Washout Period 2|Withdrawal by Subject|0
7909115|NCT02038829|12424999|FG004|Washout Period 2|Withdrawal by Subject|0
7909116|NCT02038829|12425000|FG005|Washout Period 2|Withdrawal by Subject|1
7909117|NCT02038829|12425001|FG006|Washout Period 2|Withdrawal by Subject|0
7909118|NCT02038829|12425002|FG007|Washout Period 2|Withdrawal by Subject|0
7909119|NCT02038829|12425003|FG008|Washout Period 2|Withdrawal by Subject|0
7909120|NCT02038829|12425004|FG009|Washout Period 2|Withdrawal by Subject|0
7909121|NCT02038829|12425005|FG010|Washout Period 2|Withdrawal by Subject|0
7909122|NCT02038829|12425006|FG011|Washout Period 2|Withdrawal by Subject|0
7909123|NCT02038829|12424995|FG000|Treatment Period 4|Adverse Event|0
7812431|NCT01189266|12276414|FG001|Overall Study|Lack of Efficacy|5
7812432|NCT01189266|12276415|FG002|Overall Study|Lack of Efficacy|44
7812433|NCT01189266|12276413|FG000|Overall Study|Physician Decision|0
7812434|NCT01189266|12276414|FG001|Overall Study|Physician Decision|0
7812435|NCT01189266|12276415|FG002|Overall Study|Physician Decision|1
7812436|NCT01189266|12276413|FG000|Overall Study|Protocol Violation|0
7812437|NCT01189266|12276414|FG001|Overall Study|Protocol Violation|1
7812438|NCT01189266|12276415|FG002|Overall Study|Protocol Violation|1
7812439|NCT01189266|12276413|FG000|Overall Study|Withdrawal by Subject|0
7812440|NCT01189266|12276414|FG001|Overall Study|Withdrawal by Subject|0
7812441|NCT01189266|12276415|FG002|Overall Study|Withdrawal by Subject|1
7909124|NCT02038829|12424996|FG001|Treatment Period 4|Adverse Event|1
7909125|NCT02038829|12424997|FG002|Treatment Period 4|Adverse Event|0
7909126|NCT02038829|12424998|FG003|Treatment Period 4|Adverse Event|0
7909127|NCT02038829|12424999|FG004|Treatment Period 4|Adverse Event|0
7909128|NCT02038829|12425000|FG005|Treatment Period 4|Adverse Event|0
7909129|NCT02038829|12425001|FG006|Treatment Period 4|Adverse Event|0
7909130|NCT02038829|12425002|FG007|Treatment Period 4|Adverse Event|0
7909131|NCT02038829|12425003|FG008|Treatment Period 4|Adverse Event|0
7909132|NCT02038829|12425004|FG009|Treatment Period 4|Adverse Event|0
7909133|NCT02038829|12425005|FG010|Treatment Period 4|Adverse Event|0
7909134|NCT02038829|12425006|FG011|Treatment Period 4|Adverse Event|0
7909135|NCT02038829|12424995|FG000|Washout Period 4|Adverse Event|0
7909136|NCT02038829|12424996|FG001|Washout Period 4|Adverse Event|0
7909137|NCT02038829|12424997|FG002|Washout Period 4|Adverse Event|0
7909138|NCT02038829|12424998|FG003|Washout Period 4|Adverse Event|0
7909139|NCT02038829|12424999|FG004|Washout Period 4|Adverse Event|0
7812442|NCT01189266|12276413|FG000|Overall Study|Patient refuses further therapy|1
7812443|NCT01189266|12276414|FG001|Overall Study|Patient refuses further therapy|0
7812444|NCT01189266|12276415|FG002|Overall Study|Patient refuses further therapy|7
7909140|NCT02038829|12425000|FG005|Washout Period 4|Adverse Event|0
7909141|NCT02038829|12425001|FG006|Washout Period 4|Adverse Event|1
7909142|NCT02038829|12425002|FG007|Washout Period 4|Adverse Event|0
7909143|NCT02038829|12425003|FG008|Washout Period 4|Adverse Event|0
7909144|NCT02038829|12425004|FG009|Washout Period 4|Adverse Event|0
7812445|NCT01189266|12276413|FG000|Overall Study|No treatment|0
7812446|NCT01189266|12276414|FG001|Overall Study|No treatment|0
7812447|NCT01189266|12276415|FG002|Overall Study|No treatment|1
7812448|NCT01189461|12276471|FG000|Overall Study|Lack of Efficacy|13
7812449|NCT01189461|12276471|FG000|Overall Study|Lost to Follow-up|1
7812450|NCT01189461|12276471|FG000|Overall Study|Withdrawal by Subject|6
7812451|NCT01189461|12276471|FG000|Overall Study|Protocol Violation|1
7812452|NCT01189461|12276471|FG000|Overall Study|Adverse Event|2
7812453|NCT01189461|12276471|FG000|Overall Study|Did not meet entrance criteria|3
7812454|NCT01189461|12276471|FG000|Overall Study|Other|8
7812455|NCT01189487|12276475|FG000|Overall Study|Lack of Efficacy|2
7812456|NCT01189487|12276475|FG000|Overall Study|Adverse Event|1
7812457|NCT01189500|12276479|FG000|Period 1: TAMOX Alone|Adverse Event|1
7812458|NCT01189500|12276479|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
7812459|NCT01189604|12276493|FG000|Overall Study|Impossible to visit|0
7812460|NCT01189604|12276494|FG001|Overall Study|Impossible to visit|0
7812461|NCT01189604|12276495|FG002|Overall Study|Impossible to visit|0
7812462|NCT01189604|12276496|FG003|Overall Study|Impossible to visit|0
7812463|NCT01189604|12276497|FG004|Overall Study|Impossible to visit|0
7812464|NCT01189604|12276498|FG005|Overall Study|Impossible to visit|1
7812465|NCT01189604|12276499|FG006|Overall Study|Impossible to visit|0
7812466|NCT01189604|12276493|FG000|Overall Study|Adverse Event|0
7812467|NCT01189604|12276494|FG001|Overall Study|Adverse Event|1
7812468|NCT01189604|12276495|FG002|Overall Study|Adverse Event|0
7812469|NCT01189604|12276496|FG003|Overall Study|Adverse Event|0
7812470|NCT01189604|12276497|FG004|Overall Study|Adverse Event|2
7812471|NCT01189604|12276498|FG005|Overall Study|Adverse Event|0
7812472|NCT01189604|12276499|FG006|Overall Study|Adverse Event|1
7812473|NCT01189604|12276493|FG000|Overall Study|Withdrawal by Subject|1
7812474|NCT01189604|12276494|FG001|Overall Study|Withdrawal by Subject|0
7812475|NCT01189604|12276495|FG002|Overall Study|Withdrawal by Subject|0
7812476|NCT01189604|12276496|FG003|Overall Study|Withdrawal by Subject|0
7812477|NCT01189604|12276497|FG004|Overall Study|Withdrawal by Subject|0
7909145|NCT02038829|12425005|FG010|Washout Period 4|Adverse Event|0
7909146|NCT02038829|12425006|FG011|Washout Period 4|Adverse Event|0
7909147|NCT02038829|12424995|FG000|Treatment Period 6|Adverse Event|0
7909148|NCT02038829|12424996|FG001|Treatment Period 6|Adverse Event|0
7909149|NCT02038829|12424997|FG002|Treatment Period 6|Adverse Event|1
7909150|NCT02038829|12424998|FG003|Treatment Period 6|Adverse Event|0
7909151|NCT02038829|12424999|FG004|Treatment Period 6|Adverse Event|0
7909152|NCT02038829|12425000|FG005|Treatment Period 6|Adverse Event|0
7909153|NCT02038829|12425001|FG006|Treatment Period 6|Adverse Event|0
7909154|NCT02038829|12425002|FG007|Treatment Period 6|Adverse Event|0
7909155|NCT02038829|12425003|FG008|Treatment Period 6|Adverse Event|0
7909156|NCT02038829|12425004|FG009|Treatment Period 6|Adverse Event|0
7909157|NCT02038829|12425005|FG010|Treatment Period 6|Adverse Event|0
7909158|NCT02038829|12425006|FG011|Treatment Period 6|Adverse Event|0
7909159|NCT02038881|12425024|FG000|Overall Study|Withdrawal by Subject|0
7909160|NCT02038881|12425025|FG001|Overall Study|Withdrawal by Subject|0
7909161|NCT02038881|12425026|FG002|Overall Study|Withdrawal by Subject|1
7909162|NCT02038881|12425024|FG000|Overall Study|Lost to Follow-up|2
7909163|NCT02038881|12425025|FG001|Overall Study|Lost to Follow-up|0
7909164|NCT02038881|12425026|FG002|Overall Study|Lost to Follow-up|0
7909165|NCT02038881|12425024|FG000|Overall Study|incarcerated|1
7909166|NCT02038881|12425025|FG001|Overall Study|incarcerated|0
7909167|NCT02038881|12425026|FG002|Overall Study|incarcerated|0
7909168|NCT02038907|12425067|FG000|Overall Study|Protocol Violation|0
7909169|NCT02038907|12425068|FG001|Overall Study|Protocol Violation|0
7909170|NCT02038907|12425069|FG002|Overall Study|Protocol Violation|0
7909171|NCT02038907|12425070|FG003|Overall Study|Protocol Violation|0
7909172|NCT02038907|12425071|FG004|Overall Study|Protocol Violation|0
7909173|NCT02038907|12425072|FG005|Overall Study|Protocol Violation|0
7909174|NCT02038907|12425073|FG006|Overall Study|Protocol Violation|0
7909175|NCT02038907|12425074|FG007|Overall Study|Protocol Violation|0
7909176|NCT02038907|12425075|FG008|Overall Study|Protocol Violation|0
7909177|NCT02038907|12425076|FG009|Overall Study|Protocol Violation|0
7909178|NCT02038907|12425077|FG010|Overall Study|Protocol Violation|1
7909179|NCT02038907|12425078|FG011|Overall Study|Protocol Violation|0
7909180|NCT02038907|12425079|FG012|Overall Study|Protocol Violation|0
7909181|NCT02038907|12425080|FG013|Overall Study|Protocol Violation|0
7909182|NCT02038907|12425067|FG000|Overall Study|Withdrawal by Subject|0
7812478|NCT01189604|12276498|FG005|Overall Study|Withdrawal by Subject|0
7812479|NCT01189604|12276499|FG006|Overall Study|Withdrawal by Subject|0
7812480|NCT01189812|12276548|FG000|Overall Study|Withdrawal by Subject|2
7812481|NCT01189812|12276549|FG001|Overall Study|Withdrawal by Subject|3
7812482|NCT01189812|12276548|FG000|Overall Study|Adverse Event|1
7812483|NCT01189812|12276549|FG001|Overall Study|Adverse Event|0
7812484|NCT01189812|12276548|FG000|Overall Study|Out of Window|4
7812485|NCT01189812|12276549|FG001|Overall Study|Out of Window|3
7909183|NCT02038907|12425068|FG001|Overall Study|Withdrawal by Subject|0
7909184|NCT02038907|12425069|FG002|Overall Study|Withdrawal by Subject|0
7909185|NCT02038907|12425070|FG003|Overall Study|Withdrawal by Subject|0
7909186|NCT02038907|12425071|FG004|Overall Study|Withdrawal by Subject|0
7909187|NCT02038907|12425072|FG005|Overall Study|Withdrawal by Subject|0
7909188|NCT02038907|12425073|FG006|Overall Study|Withdrawal by Subject|0
7812486|NCT01189812|12276548|FG000|Overall Study|Moved out of State|1
7812487|NCT01189812|12276549|FG001|Overall Study|Moved out of State|2
7812488|NCT01189890|12276557|FG000|Overall Study|Adverse Event|3
7812489|NCT01189890|12276558|FG001|Overall Study|Adverse Event|4
7812490|NCT01189890|12276557|FG000|Overall Study|Lack of Efficacy|7
7812491|NCT01189890|12276558|FG001|Overall Study|Lack of Efficacy|2
7812492|NCT01189890|12276557|FG000|Overall Study|Lost to Follow-up|1
7812493|NCT01189890|12276558|FG001|Overall Study|Lost to Follow-up|7
7812494|NCT01189890|12276557|FG000|Overall Study|Protocol Violation|1
7812495|NCT01189890|12276558|FG001|Overall Study|Protocol Violation|5
7812496|NCT01189890|12276557|FG000|Overall Study|Withdrawal by Subject|15
7812497|NCT01189890|12276558|FG001|Overall Study|Withdrawal by Subject|11
7812498|NCT01189890|12276557|FG000|Overall Study|Non Compliance|0
7812499|NCT01189890|12276558|FG001|Overall Study|Non Compliance|1
7812500|NCT01189890|12276557|FG000|Overall Study|Physician Decision|5
7812501|NCT01189890|12276558|FG001|Overall Study|Physician Decision|4
7812502|NCT01189890|12276557|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5
7812503|NCT01189890|12276558|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5
7812504|NCT01190007|12276564|FG000|Overall Study|Withdrawal by Subject|4
7812505|NCT01190007|12276564|FG000|Overall Study|Adverse Event|8
7812506|NCT01190007|12276564|FG000|Overall Study|Difficulty of visit for complications|1
7812507|NCT01190007|12276564|FG000|Overall Study|Participant was arrested|1
7812508|NCT01190020|12276570|FG000|Overall Study|Adverse Event|2
7812509|NCT01190020|12276571|FG001|Overall Study|Adverse Event|0
7812510|NCT01190020|12276570|FG000|Overall Study|Lost to Follow-up|2
7812511|NCT01190020|12276571|FG001|Overall Study|Lost to Follow-up|0
7812512|NCT01190020|12276570|FG000|Overall Study|Withdrawal by Subject|3
7812513|NCT01190020|12276571|FG001|Overall Study|Withdrawal by Subject|0
7812514|NCT01190098|12276592|FG000|Overall Study|Adverse Event|2
7812515|NCT01190098|12276593|FG001|Overall Study|Adverse Event|0
7812516|NCT01190098|12276592|FG000|Overall Study|Patient coomorbidity|0
7812517|NCT01190098|12276593|FG001|Overall Study|Patient coomorbidity|1
7812518|NCT01190098|12276592|FG000|Overall Study|Lack of transportation|1
7812519|NCT01190098|12276593|FG001|Overall Study|Lack of transportation|0
7812520|NCT01190098|12276592|FG000|Overall Study|Other|0
7812521|NCT01190098|12276593|FG001|Overall Study|Other|1
7812522|NCT01190124|12276602|FG000|Overall Study|Death|3
7812523|NCT01190124|12276603|FG001|Overall Study|Death|0
7812524|NCT01190124|12276604|FG002|Overall Study|Death|0
7812525|NCT01190124|12276602|FG000|Overall Study|Therapeutic Failure|12
7812526|NCT01190124|12276603|FG001|Overall Study|Therapeutic Failure|0
7812527|NCT01190124|12276604|FG002|Overall Study|Therapeutic Failure|1
7812528|NCT01190124|12276602|FG000|Overall Study|Lost to Follow-up|2
7812529|NCT01190124|12276603|FG001|Overall Study|Lost to Follow-up|0
7812530|NCT01190124|12276604|FG002|Overall Study|Lost to Follow-up|0
7812531|NCT01190150|12276617|FG000|First Treatment|Withdrawal by Subject|1
7812532|NCT01190150|12276618|FG001|First Treatment|Withdrawal by Subject|0
7812533|NCT01190150|12276617|FG000|Washout|Withdrawal by Subject|0
7812534|NCT01190150|12276618|FG001|Washout|Withdrawal by Subject|1
7812535|NCT01190150|12276617|FG000|Washout|Difficulty in adherence|0
7812536|NCT01190150|12276618|FG001|Washout|Difficulty in adherence|1
7812537|NCT01190176|12276624|FG000|Overall Study|Withdrawal by Subject|1
7812538|NCT01190176|12276624|FG000|Overall Study|Lost to Follow-up|1
7812539|NCT01190189|12276628|FG000|Overall Study|Lost to Follow-up|4
7812540|NCT01190189|12276628|FG000|Overall Study|Withdrawal by Subject|1
7812541|NCT01190189|12276628|FG000|Overall Study|Migrated/moved from study area|1
7812542|NCT01190215|12276634|FG000|Up to Month 6|Lost to Follow-up|2
7812543|NCT01190215|12276635|FG001|Up to Month 6|Lost to Follow-up|0
7812544|NCT01190410|12276643|FG000|Overall Study|Adverse Event|0
7812545|NCT01190410|12276644|FG001|Overall Study|Adverse Event|3
7812546|NCT01190410|12276643|FG000|Overall Study|Lack of Efficacy|0
7812547|NCT01190410|12276644|FG001|Overall Study|Lack of Efficacy|2
7812548|NCT01190410|12276643|FG000|Overall Study|Withdrawal by Subject|0
7812549|NCT01190410|12276644|FG001|Overall Study|Withdrawal by Subject|2
7812550|NCT01190410|12276643|FG000|Overall Study|Administrative decision|1
7812551|NCT01190410|12276644|FG001|Overall Study|Administrative decision|0
7812552|NCT01190410|12276643|FG000|Overall Study|PI discretion|0
7812553|NCT01190410|12276644|FG001|Overall Study|PI discretion|2
7812554|NCT01190436|12276656|FG000|Overall Study|Lost to Follow-up|35
7812555|NCT01190436|12276656|FG000|Overall Study|Other|4
7812556|NCT01190449|12276663|FG000|Overall Study|Ineligible|0
7812557|NCT01190449|12276664|FG001|Overall Study|Ineligible|4
7812558|NCT01190475|12276673|FG000|Overall Study|Withdrawal by Subject|0
7812559|NCT01190475|12276674|FG001|Overall Study|Withdrawal by Subject|0
7812560|NCT01190475|12276675|FG002|Overall Study|Withdrawal by Subject|1
7812561|NCT01190514|12276685|FG000|First Intervention (Period 1)|Adverse Event|1
7812562|NCT01190514|12276686|FG001|First Intervention (Period 1)|Adverse Event|0
7812563|NCT01190514|12276687|FG002|First Intervention (Period 1)|Adverse Event|0
7812564|NCT01190514|12276688|FG003|First Intervention (Period 1)|Adverse Event|0
7812565|NCT01190514|12276685|FG000|Third Intervention (Period 3)|Adverse Event|1
7812566|NCT01190514|12276686|FG001|Third Intervention (Period 3)|Adverse Event|0
7812567|NCT01190514|12276687|FG002|Third Intervention (Period 3)|Adverse Event|0
7812568|NCT01190514|12276688|FG003|Third Intervention (Period 3)|Adverse Event|0
7812569|NCT01190813|12276714|FG000|Overall Study|Lost to Follow-up|1
7812570|NCT01190813|12276715|FG001|Overall Study|Lost to Follow-up|2
7812571|NCT01190813|12276714|FG000|Overall Study|Withdrawal by Subject|2
7812572|NCT01190813|12276715|FG001|Overall Study|Withdrawal by Subject|1
7812573|NCT01190813|12276714|FG000|Overall Study|Refused study treatment after randomized|1
7812574|NCT01190813|12276715|FG001|Overall Study|Refused study treatment after randomized|0
7812575|NCT01190813|12276714|FG000|Overall Study|Adverse Event|0
7812576|NCT01190813|12276715|FG001|Overall Study|Adverse Event|1
7812577|NCT01190839|12276723|FG000|Overall Study|Adverse Event|32
7812578|NCT01190839|12276724|FG001|Overall Study|Adverse Event|41
7812579|NCT01190839|12276723|FG000|Overall Study|Protocol Violation|2
7812580|NCT01190839|12276724|FG001|Overall Study|Protocol Violation|2
7812581|NCT01190839|12276723|FG000|Overall Study|Lost to Follow-up|7
7812582|NCT01190839|12276724|FG001|Overall Study|Lost to Follow-up|1
7812583|NCT01190839|12276723|FG000|Overall Study|Death|1
7812584|NCT01190839|12276724|FG001|Overall Study|Death|0
7812585|NCT01190839|12276723|FG000|Overall Study|Trial stopped by Sponsor|71
7812586|NCT01190839|12276724|FG001|Overall Study|Trial stopped by Sponsor|68
7812587|NCT01190839|12276723|FG000|Overall Study|Undefined|35
7812588|NCT01190839|12276724|FG001|Overall Study|Undefined|31
7812589|NCT01190839|12276723|FG000|Overall Study|Randomized but not treated|2
7812590|NCT01190839|12276724|FG001|Overall Study|Randomized but not treated|4
7812591|NCT01190865|12276732|FG000|Overall Study|Withdrawal by Subject|1
7812592|NCT01190865|12276732|FG000|Overall Study|Non-compliance|2
7812593|NCT01190891|12276755|FG000|Overall Study|Protocol Violation|1
7812594|NCT01190891|12276756|FG001|Overall Study|Protocol Violation|0
7812595|NCT01190891|12276755|FG000|Overall Study|Withdrawal by Subject|5
7812596|NCT01190891|12276756|FG001|Overall Study|Withdrawal by Subject|0
7909189|NCT02038907|12425074|FG007|Overall Study|Withdrawal by Subject|0
7909190|NCT02038907|12425075|FG008|Overall Study|Withdrawal by Subject|0
7909191|NCT02038907|12425076|FG009|Overall Study|Withdrawal by Subject|0
7909192|NCT02038907|12425077|FG010|Overall Study|Withdrawal by Subject|1
7909193|NCT02038907|12425078|FG011|Overall Study|Withdrawal by Subject|0
7909194|NCT02038907|12425079|FG012|Overall Study|Withdrawal by Subject|0
7909195|NCT02038907|12425080|FG013|Overall Study|Withdrawal by Subject|0
7909196|NCT02038920|12425114|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3
7909197|NCT02038920|12425115|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11
7909198|NCT02038920|12425116|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7909199|NCT02038920|12425117|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7909200|NCT02038920|12425118|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7909201|NCT02038920|12425119|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7909202|NCT02038920|12425114|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2
7909203|NCT02038920|12425115|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7909204|NCT02038920|12425116|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7909205|NCT02038920|12425117|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7909206|NCT02038920|12425118|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7909207|NCT02038920|12425119|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7909208|NCT02038920|12425114|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
7909209|NCT02038920|12425115|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
7909210|NCT02038920|12425116|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7909211|NCT02038920|12425117|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7909212|NCT02038920|12425118|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7909213|NCT02038920|12425119|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7909214|NCT02038920|12425114|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
7909215|NCT02038920|12425115|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
7909216|NCT02038920|12425116|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
7909217|NCT02038920|12425117|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4
7812597|NCT01191008|12276762|FG000|Overall Study|Protocol Violation|7
7812598|NCT01191008|12276762|FG000|Overall Study|Lost to Follow-up|8
7812599|NCT01191086|12276766|FG000|Overall Study|Adverse Event|20
7812600|NCT01191086|12276766|FG000|Overall Study|Lack of Efficacy|10
7812601|NCT01191086|12276766|FG000|Overall Study|Lost to Follow-up|4
7812602|NCT01191086|12276766|FG000|Overall Study|Physician Decision|2
7812603|NCT01191086|12276766|FG000|Overall Study|Withdrawal by Subject|24
7812604|NCT01191086|12276766|FG000|Overall Study|Discontinuation criterion met|1
7812605|NCT01191086|12276766|FG000|Overall Study|Other|1
7812606|NCT01191190|12276770|FG000|Overall Study|Withdrawal by Subject|1
7812607|NCT01191268|12276798|FG000|Overall Study|Withdrawal by Subject|19
7812608|NCT01191268|12276799|FG001|Overall Study|Withdrawal by Subject|25
7812609|NCT01191268|12276800|FG002|Overall Study|Withdrawal by Subject|21
7812610|NCT01191268|12276798|FG000|Overall Study|Adverse Event|21
7812611|NCT01191268|12276799|FG001|Overall Study|Adverse Event|13
7812612|NCT01191268|12276800|FG002|Overall Study|Adverse Event|8
7812613|NCT01191268|12276798|FG000|Overall Study|Physician Decision|6
7812614|NCT01191268|12276799|FG001|Overall Study|Physician Decision|8
7812615|NCT01191268|12276800|FG002|Overall Study|Physician Decision|9
7812616|NCT01191268|12276798|FG000|Overall Study|Lost to Follow-up|8
7812617|NCT01191268|12276799|FG001|Overall Study|Lost to Follow-up|5
7812618|NCT01191268|12276800|FG002|Overall Study|Lost to Follow-up|9
7812619|NCT01191268|12276798|FG000|Overall Study|Entry Criteria Not Met|3
7812620|NCT01191268|12276799|FG001|Overall Study|Entry Criteria Not Met|1
7812621|NCT01191268|12276800|FG002|Overall Study|Entry Criteria Not Met|1
7812622|NCT01191268|12276798|FG000|Overall Study|Death|0
7812623|NCT01191268|12276799|FG001|Overall Study|Death|1
7812624|NCT01191268|12276800|FG002|Overall Study|Death|3
7812625|NCT01191268|12276798|FG000|Overall Study|Protocol Violation|1
7812626|NCT01191268|12276799|FG001|Overall Study|Protocol Violation|0
7812627|NCT01191268|12276800|FG002|Overall Study|Protocol Violation|1
7812628|NCT01191268|12276798|FG000|Overall Study|Sponsor Decision|0
7812629|NCT01191268|12276799|FG001|Overall Study|Sponsor Decision|2
7812630|NCT01191268|12276800|FG002|Overall Study|Sponsor Decision|0
7812631|NCT01191762|12276940|FG000|Overall Study|Adverse Event|1
7812632|NCT01191762|12276941|FG001|Overall Study|Adverse Event|0
7812633|NCT01191788|12276949|FG000|Overall Study|Lost to Follow-up|21
7812634|NCT01191788|12276950|FG001|Overall Study|Lost to Follow-up|22
7812635|NCT01191801|12276959|FG000|Overall Study|Death|36
7812636|NCT01191801|12276960|FG001|Overall Study|Death|12
7812637|NCT01191801|12276959|FG000|Overall Study|Lack of Efficacy|176
7812638|NCT01191801|12276960|FG001|Overall Study|Lack of Efficacy|258
7812639|NCT01191801|12276959|FG000|Overall Study|Adverse Event|9
7812640|NCT01191801|12276960|FG001|Overall Study|Adverse Event|8
7812641|NCT01191801|12276959|FG000|Overall Study|Protocol Violation|2
7812642|NCT01191801|12276960|FG001|Overall Study|Protocol Violation|4
7812643|NCT01191801|12276959|FG000|Overall Study|Physician Decision|47
7812644|NCT01191801|12276960|FG001|Overall Study|Physician Decision|24
7812645|NCT01191801|12276959|FG000|Overall Study|Withdrawal by Subject|1
7812646|NCT01191801|12276960|FG001|Overall Study|Withdrawal by Subject|4
7812647|NCT01191801|12276959|FG000|Overall Study|Not Provided|45
7812648|NCT01191801|12276960|FG001|Overall Study|Not Provided|27
7812649|NCT01191840|12276977|FG000|Overall Study|withdrew consent|2
7812650|NCT01191840|12276978|FG001|Overall Study|withdrew consent|1
7812651|NCT01191840|12276977|FG000|Overall Study|Subject discontinued treatment|1
7812652|NCT01191840|12276978|FG001|Overall Study|Subject discontinued treatment|2
7812653|NCT01191840|12276977|FG000|Overall Study|Lost to Follow-up|4
7812654|NCT01191840|12276978|FG001|Overall Study|Lost to Follow-up|6
7812655|NCT01191840|12276977|FG000|Overall Study|Non Staph Infection|4
7812656|NCT01191840|12276978|FG001|Overall Study|Non Staph Infection|3
7812657|NCT01191840|12276977|FG000|Overall Study|ineligible at enrollment|1
7812658|NCT01191840|12276978|FG001|Overall Study|ineligible at enrollment|0
7812659|NCT01191840|12276977|FG000|Overall Study|IRB approval lapse|0
7812660|NCT01191840|12276978|FG001|Overall Study|IRB approval lapse|2
7812661|NCT01191840|12276977|FG000|Overall Study|lab error speciation - non Staph infecti|0
7812662|NCT01191840|12276978|FG001|Overall Study|lab error speciation - non Staph infecti|1
7812663|NCT01191840|12276977|FG000|Overall Study|Withdrawal by Subject|2
7812664|NCT01191840|12276978|FG001|Overall Study|Withdrawal by Subject|0
7812665|NCT01191944|12276986|FG000|Overall Study|Adverse Event|11
7812666|NCT01191944|12276987|FG001|Overall Study|Adverse Event|12
7812667|NCT01191944|12276986|FG000|Overall Study|Protocol Violation|1
7812668|NCT01191944|12276987|FG001|Overall Study|Protocol Violation|2
7812669|NCT01191944|12276986|FG000|Overall Study|Withdrawal by Subject|4
7812670|NCT01191944|12276987|FG001|Overall Study|Withdrawal by Subject|2
7812671|NCT01191944|12276986|FG000|Overall Study|Other|1
7812672|NCT01191944|12276987|FG001|Overall Study|Other|3
7812673|NCT01192022|12276997|FG000|Overall Study|Withdrawal of Consent|3
7812674|NCT01192022|12276998|FG001|Overall Study|Withdrawal of Consent|1
7812675|NCT01192022|12276999|FG002|Overall Study|Withdrawal of Consent|0
7812676|NCT01192022|12277000|FG003|Overall Study|Withdrawal of Consent|0
7812677|NCT01192022|12277001|FG004|Overall Study|Withdrawal of Consent|0
7812678|NCT01192022|12276997|FG000|Overall Study|Lost to Follow-up|4
7812679|NCT01192022|12276998|FG001|Overall Study|Lost to Follow-up|2
7812680|NCT01192022|12276999|FG002|Overall Study|Lost to Follow-up|1
7812681|NCT01192022|12277000|FG003|Overall Study|Lost to Follow-up|1
7812682|NCT01192022|12277001|FG004|Overall Study|Lost to Follow-up|0
7812683|NCT01192022|12276997|FG000|Overall Study|Adverse Event|1
7812684|NCT01192022|12276998|FG001|Overall Study|Adverse Event|0
7812685|NCT01192022|12276999|FG002|Overall Study|Adverse Event|0
7812686|NCT01192022|12277000|FG003|Overall Study|Adverse Event|0
7812687|NCT01192022|12277001|FG004|Overall Study|Adverse Event|0
7812688|NCT01192022|12276997|FG000|Overall Study|Fatal Adverse Event|4
7812689|NCT01192022|12276998|FG001|Overall Study|Fatal Adverse Event|6
7812690|NCT01192022|12276999|FG002|Overall Study|Fatal Adverse Event|0
7812691|NCT01192022|12277000|FG003|Overall Study|Fatal Adverse Event|0
7812692|NCT01192022|12277001|FG004|Overall Study|Fatal Adverse Event|1
7812693|NCT01192022|12276997|FG000|Overall Study|Physician withdrew-patient hardship|1
7812694|NCT01192022|12276998|FG001|Overall Study|Physician withdrew-patient hardship|0
7812695|NCT01192022|12276999|FG002|Overall Study|Physician withdrew-patient hardship|0
7812696|NCT01192022|12277000|FG003|Overall Study|Physician withdrew-patient hardship|0
7812697|NCT01192022|12277001|FG004|Overall Study|Physician withdrew-patient hardship|0
7812698|NCT01192022|12276997|FG000|Overall Study|Patient too sick from chemotherapy|0
7812699|NCT01192022|12276998|FG001|Overall Study|Patient too sick from chemotherapy|1
7812700|NCT01192022|12276999|FG002|Overall Study|Patient too sick from chemotherapy|0
7812701|NCT01192022|12277000|FG003|Overall Study|Patient too sick from chemotherapy|0
7812702|NCT01192022|12277001|FG004|Overall Study|Patient too sick from chemotherapy|0
7812703|NCT01192022|12276997|FG000|Overall Study|Patient needed surgery|0
7812704|NCT01192022|12276998|FG001|Overall Study|Patient needed surgery|1
7812705|NCT01192022|12276999|FG002|Overall Study|Patient needed surgery|0
7812706|NCT01192022|12277000|FG003|Overall Study|Patient needed surgery|0
7812707|NCT01192022|12277001|FG004|Overall Study|Patient needed surgery|0
7812708|NCT01192022|12276997|FG000|Overall Study|Parents did not allow all follow up|0
7812709|NCT01192022|12276998|FG001|Overall Study|Parents did not allow all follow up|0
7812710|NCT01192022|12276999|FG002|Overall Study|Parents did not allow all follow up|0
7812711|NCT01192022|12277000|FG003|Overall Study|Parents did not allow all follow up|1
7812712|NCT01192022|12277001|FG004|Overall Study|Parents did not allow all follow up|0
7812713|NCT01192100|12277012|FG000|Overall Study|Withdrawal by Subject|0
7812714|NCT01192100|12277013|FG001|Overall Study|Withdrawal by Subject|0
7812715|NCT01192100|12277014|FG002|Overall Study|Withdrawal by Subject|0
7812716|NCT01192100|12277015|FG003|Overall Study|Withdrawal by Subject|0
7812717|NCT01192100|12277016|FG004|Overall Study|Withdrawal by Subject|1
7812718|NCT01192100|12277017|FG005|Overall Study|Withdrawal by Subject|0
7812719|NCT01192100|12277012|FG000|Overall Study|Protocol Violation|0
7812720|NCT01192100|12277013|FG001|Overall Study|Protocol Violation|0
7812721|NCT01192100|12277014|FG002|Overall Study|Protocol Violation|0
7812722|NCT01192100|12277015|FG003|Overall Study|Protocol Violation|1
7812723|NCT01192100|12277016|FG004|Overall Study|Protocol Violation|0
7812724|NCT01192100|12277017|FG005|Overall Study|Protocol Violation|0
7812725|NCT01192126|12277027|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
7812726|NCT01192126|12277028|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
7812727|NCT01192126|12277027|FG000|First Intervention (1 Week)|Lost to Follow-up|1
7812728|NCT01192126|12277028|FG001|First Intervention (1 Week)|Lost to Follow-up|1
7812729|NCT01192152|12277047|FG000|Period 1|left prematurely (while on treatment B)|0
7812730|NCT01192152|12277048|FG001|Period 1|left prematurely (while on treatment B)|1
7812731|NCT01192152|12277047|FG000|Period 3|family emergency|1
7812732|NCT01192152|12277048|FG001|Period 3|family emergency|0
7812733|NCT01192178|12277058|FG000|Overall Study|Withdrawal by Subject|6
7812734|NCT01192178|12277059|FG001|Overall Study|Withdrawal by Subject|10
7812735|NCT01192178|12277058|FG000|Overall Study|Protocol Violation|10
7812736|NCT01192178|12277059|FG001|Overall Study|Protocol Violation|3
7812737|NCT01192178|12277058|FG000|Overall Study|Physician Decision|2
7812738|NCT01192178|12277059|FG001|Overall Study|Physician Decision|4
7812739|NCT01192178|12277058|FG000|Overall Study|Lost to Follow-up|3
7812740|NCT01192178|12277059|FG001|Overall Study|Lost to Follow-up|3
7812741|NCT01192178|12277058|FG000|Overall Study|Adverse Event|2
7812742|NCT01192178|12277059|FG001|Overall Study|Adverse Event|1
7812743|NCT01192178|12277058|FG000|Overall Study|Lack of Efficacy|1
7812744|NCT01192178|12277059|FG001|Overall Study|Lack of Efficacy|2
7812745|NCT01192191|12277069|FG000|Overall Study|Adverse Event|7
7812746|NCT01192191|12277070|FG001|Overall Study|Adverse Event|12
7812747|NCT01192191|12277069|FG000|Overall Study|Participants Reached Stopping Criteria|3
7812748|NCT01192191|12277070|FG001|Overall Study|Participants Reached Stopping Criteria|2
7812749|NCT01192191|12277069|FG000|Overall Study|Lost to Follow-up|0
7812750|NCT01192191|12277070|FG001|Overall Study|Lost to Follow-up|1
7812751|NCT01192191|12277069|FG000|Overall Study|Withdrawal by Subject|1
7812752|NCT01192191|12277070|FG001|Overall Study|Withdrawal by Subject|6
7812753|NCT01192204|12277078|FG000|Overall Study|could not keep recall appointments|1
7812754|NCT01192204|12277079|FG001|Overall Study|could not keep recall appointments|0
7861902|NCT01597245|12351202|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7861903|NCT01597245|12351203|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7861904|NCT01597245|12351204|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7861905|NCT01597245|12351205|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7861906|NCT01597245|12351206|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7861907|NCT01597245|12351207|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7861908|NCT01597245|12351208|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7861909|NCT01597245|12351188|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7812755|NCT01192295|12277104|FG000|Overall Study|Adverse Event|3
7812756|NCT01192295|12277105|FG001|Overall Study|Adverse Event|7
7812757|NCT01192295|12277104|FG000|Overall Study|Withdrawal by Subject|3
7812758|NCT01192295|12277105|FG001|Overall Study|Withdrawal by Subject|4
7812759|NCT01192295|12277104|FG000|Overall Study|Lost to Follow-up|0
7812760|NCT01192295|12277105|FG001|Overall Study|Lost to Follow-up|1
7812761|NCT01192295|12277104|FG000|Overall Study|Lack of Efficacy|0
7812762|NCT01192295|12277105|FG001|Overall Study|Lack of Efficacy|5
7812763|NCT01192295|12277104|FG000|Overall Study|Administrative|4
7812764|NCT01192295|12277105|FG001|Overall Study|Administrative|6
7812765|NCT01192347|12277113|FG000|Overall Study|Death|3
7812766|NCT01192347|12277113|FG000|Overall Study|Lost to Follow-up|3
7812767|NCT01192347|12277113|FG000|Overall Study|Withdrawal by Subject|1
7812768|NCT01192347|12277113|FG000|Overall Study|Adverse Event|1
7812769|NCT01192347|12277113|FG000|Overall Study|Suspected serious adverse drug reaction|1
7812770|NCT01192347|12277113|FG000|Overall Study|Patient seen in different hospital|1
7812771|NCT01192347|12277113|FG000|Overall Study|Patient not visiting hospital regularly|1
7909218|NCT02038920|12425118|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
7909219|NCT02038920|12425119|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
7909220|NCT02038920|12425114|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7909221|NCT02038920|12425115|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7909222|NCT02038920|12425116|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1
7909223|NCT02038920|12425117|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7909224|NCT02038920|12425118|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7909225|NCT02038920|12425119|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7909226|NCT02038920|12425114|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
7909227|NCT02038920|12425115|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
7909228|NCT02038920|12425116|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2
7909229|NCT02038920|12425117|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4
7909230|NCT02038920|12425118|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10
7909231|NCT02038920|12425119|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
7909232|NCT02038920|12425114|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7909233|NCT02038920|12425115|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7909234|NCT02038920|12425116|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7909235|NCT02038920|12425117|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7909236|NCT02038920|12425118|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7909237|NCT02038920|12425119|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43
7909238|NCT02038920|12425114|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7909239|NCT02038920|12425115|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7909240|NCT02038920|12425116|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7909241|NCT02038920|12425117|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7909242|NCT02038920|12425118|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7909243|NCT02038920|12425119|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1
7909244|NCT02038920|12425114|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7909245|NCT02038920|12425115|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7909246|NCT02038920|12425116|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7909247|NCT02038920|12425117|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7909248|NCT02038920|12425118|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7909249|NCT02038920|12425119|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7
7909250|NCT02038920|12425114|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7909251|NCT02038920|12425115|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7909252|NCT02038920|12425116|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7909253|NCT02038920|12425117|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7909254|NCT02038920|12425118|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7909255|NCT02038920|12425119|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1
7909256|NCT02038920|12425114|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7909257|NCT02038920|12425115|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7909258|NCT02038920|12425116|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7909259|NCT02038920|12425117|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7909260|NCT02038920|12425118|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7909261|NCT02038920|12425119|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23
7812772|NCT01192347|12277113|FG000|Overall Study|Patient did not show up for visits|1
7909262|NCT02038920|12425114|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7812773|NCT01192399|12277117|FG000|Overall Study|Lack of Efficacy|2
7812774|NCT01192412|12277123|FG000|Overall Study|Lost to Follow-up|2
7812775|NCT01192412|12277124|FG001|Overall Study|Lost to Follow-up|1
7812776|NCT01192412|12277123|FG000|Overall Study|Withdrawal by Subject|2
7812777|NCT01192412|12277124|FG001|Overall Study|Withdrawal by Subject|1
7812778|NCT01192516|12277133|FG000|Overall Study|Lost to Follow-up|7
7812779|NCT01192516|12277134|FG001|Overall Study|Lost to Follow-up|10
7812780|NCT01192516|12277135|FG002|Overall Study|Lost to Follow-up|7
7812781|NCT01192516|12277133|FG000|Overall Study|Withdrawal by Subject|4
7812782|NCT01192516|12277134|FG001|Overall Study|Withdrawal by Subject|4
7812783|NCT01192516|12277135|FG002|Overall Study|Withdrawal by Subject|1
7812784|NCT01192516|12277133|FG000|Overall Study|started new treatment|5
7812785|NCT01192516|12277134|FG001|Overall Study|started new treatment|1
7812786|NCT01192516|12277135|FG002|Overall Study|started new treatment|0
7812787|NCT01192516|12277133|FG000|Overall Study|Unable to follow Actiwatch instructions|4
7812788|NCT01192516|12277134|FG001|Overall Study|Unable to follow Actiwatch instructions|2
7812789|NCT01192516|12277135|FG002|Overall Study|Unable to follow Actiwatch instructions|0
7812790|NCT01192815|12277156|FG000|Overall Study|Withdrawal by Subject|1
7812791|NCT01192815|12277156|FG000|Overall Study|Lack of Efficacy|1
7812792|NCT01193101|12277186|FG000|Overall Study|Adverse Event|0
7812793|NCT01193101|12277187|FG001|Overall Study|Adverse Event|1
7812794|NCT01193101|12277188|FG002|Overall Study|Adverse Event|1
7812795|NCT01193101|12277189|FG003|Overall Study|Adverse Event|3
7812796|NCT01193101|12277186|FG000|Overall Study|Lack of Efficacy|3
7812797|NCT01193101|12277187|FG001|Overall Study|Lack of Efficacy|1
7812798|NCT01193101|12277188|FG002|Overall Study|Lack of Efficacy|0
7812799|NCT01193101|12277189|FG003|Overall Study|Lack of Efficacy|8
7812800|NCT01193101|12277186|FG000|Overall Study|Withdrawal by Subject|2
7812801|NCT01193101|12277187|FG001|Overall Study|Withdrawal by Subject|4
7812802|NCT01193101|12277188|FG002|Overall Study|Withdrawal by Subject|1
7812803|NCT01193101|12277189|FG003|Overall Study|Withdrawal by Subject|1
7812804|NCT01193101|12277186|FG000|Overall Study|Administrative problems|0
7812805|NCT01193101|12277187|FG001|Overall Study|Administrative problems|0
7812806|NCT01193101|12277188|FG002|Overall Study|Administrative problems|1
7812807|NCT01193101|12277189|FG003|Overall Study|Administrative problems|0
7812808|NCT01193101|12277186|FG000|Overall Study|Abnormal test procedure results|0
7812809|NCT01193101|12277187|FG001|Overall Study|Abnormal test procedure results|1
7812810|NCT01193101|12277188|FG002|Overall Study|Abnormal test procedure results|0
7812811|NCT01193101|12277189|FG003|Overall Study|Abnormal test procedure results|0
7812812|NCT01193127|12277212|FG000|Randomized|Surgery Cancelled|0
7812813|NCT01193127|12277213|FG001|Randomized|Surgery Cancelled|0
7812814|NCT01193127|12277214|FG002|Randomized|Surgery Cancelled|0
7812815|NCT01193127|12277215|FG003|Randomized|Surgery Cancelled|1
7812816|NCT01193127|12277212|FG000|Treated|Withdrawal by Subject|0
7812817|NCT01193127|12277213|FG001|Treated|Withdrawal by Subject|0
7812818|NCT01193127|12277214|FG002|Treated|Withdrawal by Subject|0
7812819|NCT01193127|12277215|FG003|Treated|Withdrawal by Subject|1
7812820|NCT01193153|12277227|FG000|Open-label Lead in Period|Lost to Follow-up|32
7812821|NCT01193153|12277228|FG001|Open-label Lead in Period|Lost to Follow-up|0
7812822|NCT01193153|12277227|FG000|Open-label Lead in Period|Pregnancy|1
7812823|NCT01193153|12277228|FG001|Open-label Lead in Period|Pregnancy|0
7812824|NCT01193153|12277227|FG000|Open-label Lead in Period|Withdrawal by Subject|69
7812825|NCT01193153|12277228|FG001|Open-label Lead in Period|Withdrawal by Subject|0
7812826|NCT01193153|12277227|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
7812827|NCT01193153|12277228|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
7812828|NCT01193153|12277227|FG000|Open-label Lead in Period|Other|14
7812829|NCT01193153|12277228|FG001|Open-label Lead in Period|Other|0
7812830|NCT01193153|12277227|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
7812831|NCT01193153|12277228|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
7812832|NCT01193153|12277227|FG000|Open-label Lead in Period|Adverse Event|41
7812833|NCT01193153|12277228|FG001|Open-label Lead in Period|Adverse Event|0
7812834|NCT01193153|12277227|FG000|Open-label Lead in Period|Death|1
7812835|NCT01193153|12277228|FG001|Open-label Lead in Period|Death|0
7812836|NCT01193153|12277227|FG000|Open-label Lead in Period|Lack of Efficacy|26
7812837|NCT01193153|12277228|FG001|Open-label Lead in Period|Lack of Efficacy|0
7812838|NCT01193153|12277227|FG000|Open-label Stabilization Period|Adverse Event|9
7812839|NCT01193153|12277228|FG001|Open-label Stabilization Period|Adverse Event|0
7812840|NCT01193153|12277227|FG000|Open-label Stabilization Period|Death|2
7812841|NCT01193153|12277228|FG001|Open-label Stabilization Period|Death|0
7812842|NCT01193153|12277227|FG000|Open-label Stabilization Period|Lost to Follow-up|10
7812843|NCT01193153|12277228|FG001|Open-label Stabilization Period|Lost to Follow-up|0
7812844|NCT01193153|12277227|FG000|Open-label Stabilization Period|Lack of Efficacy|5
7812845|NCT01193153|12277228|FG001|Open-label Stabilization Period|Lack of Efficacy|0
7812846|NCT01193153|12277227|FG000|Open-label Stabilization Period|Withdrawal by Subject|29
7812847|NCT01193153|12277228|FG001|Open-label Stabilization Period|Withdrawal by Subject|0
7812848|NCT01193153|12277227|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
7812849|NCT01193153|12277228|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
7812850|NCT01193153|12277227|FG000|Open-label Stabilization Period|Other|8
7812851|NCT01193153|12277228|FG001|Open-label Stabilization Period|Other|0
7812852|NCT01193153|12277227|FG000|Double Blind Relapse Prevention Period|Other|2
7812853|NCT01193153|12277228|FG001|Double Blind Relapse Prevention Period|Other|3
7812854|NCT01193153|12277227|FG000|Double Blind Relapse Prevention Period|Adverse Event|12
7812855|NCT01193153|12277228|FG001|Double Blind Relapse Prevention Period|Adverse Event|3
7812856|NCT01193153|12277227|FG000|Double Blind Relapse Prevention Period|Death|2
7812857|NCT01193153|12277228|FG001|Double Blind Relapse Prevention Period|Death|0
7812858|NCT01193153|12277227|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2
7812859|NCT01193153|12277228|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9
7812860|NCT01193153|12277227|FG000|Double Blind Relapse Prevention Period|Pregnancy|1
7812861|NCT01193153|12277228|FG001|Double Blind Relapse Prevention Period|Pregnancy|0
7812862|NCT01193153|12277227|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
7812863|NCT01193153|12277228|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
7812864|NCT01193153|12277227|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25
7812865|NCT01193153|12277228|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57
7812866|NCT01193153|12277227|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
7719336|NCT00531752|12143323|FG002|First Double-blind Intervention Period|Other|4
7719337|NCT00531752|12143324|FG003|First Double-blind Intervention Period|Other|0
7719338|NCT00531752|12143321|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2
7719339|NCT00531752|12143322|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0
7719340|NCT00531752|12143323|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1
7812867|NCT01193153|12277228|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
7812868|NCT01193218|12277242|FG000|0-12 Weeks|Adverse Event|6
7812869|NCT01193218|12277243|FG001|0-12 Weeks|Adverse Event|0
7812870|NCT01193218|12277244|FG002|0-12 Weeks|Adverse Event|1
7812871|NCT01193218|12277245|FG003|0-12 Weeks|Adverse Event|0
7812872|NCT01193218|12277246|FG004|0-12 Weeks|Adverse Event|0
7812873|NCT01193218|12277247|FG005|0-12 Weeks|Adverse Event|2
7812874|NCT01193218|12277248|FG006|0-12 Weeks|Adverse Event|2
7812875|NCT01193218|12277249|FG007|0-12 Weeks|Adverse Event|0
7812876|NCT01193218|12277242|FG000|0-12 Weeks|Protocol Violation|0
7812877|NCT01193218|12277243|FG001|0-12 Weeks|Protocol Violation|0
7812878|NCT01193218|12277244|FG002|0-12 Weeks|Protocol Violation|0
7812879|NCT01193218|12277245|FG003|0-12 Weeks|Protocol Violation|0
7812880|NCT01193218|12277246|FG004|0-12 Weeks|Protocol Violation|1
7812881|NCT01193218|12277247|FG005|0-12 Weeks|Protocol Violation|1
7812882|NCT01193218|12277248|FG006|0-12 Weeks|Protocol Violation|0
7812883|NCT01193218|12277249|FG007|0-12 Weeks|Protocol Violation|0
7812884|NCT01193218|12277242|FG000|0-12 Weeks|Withdrawal by Subject|3
7812885|NCT01193218|12277243|FG001|0-12 Weeks|Withdrawal by Subject|0
7812886|NCT01193218|12277244|FG002|0-12 Weeks|Withdrawal by Subject|2
7812887|NCT01193218|12277245|FG003|0-12 Weeks|Withdrawal by Subject|0
7812888|NCT01193218|12277246|FG004|0-12 Weeks|Withdrawal by Subject|0
7812889|NCT01193218|12277247|FG005|0-12 Weeks|Withdrawal by Subject|0
7812890|NCT01193218|12277248|FG006|0-12 Weeks|Withdrawal by Subject|1
7812891|NCT01193218|12277249|FG007|0-12 Weeks|Withdrawal by Subject|0
7812892|NCT01193218|12277242|FG000|12-52 Weeks|Adverse Event|1
7812893|NCT01193218|12277243|FG001|12-52 Weeks|Adverse Event|0
7909263|NCT02038920|12425115|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7909264|NCT02038920|12425116|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7909265|NCT02038920|12425117|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7909266|NCT02038920|12425118|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7909267|NCT02038920|12425119|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2
7909268|NCT02038933|12425138|FG000|Overall Study|Disease progression|104
7812894|NCT01193218|12277244|FG002|12-52 Weeks|Adverse Event|1
7812895|NCT01193218|12277245|FG003|12-52 Weeks|Adverse Event|2
7812896|NCT01193218|12277246|FG004|12-52 Weeks|Adverse Event|3
7812897|NCT01193218|12277247|FG005|12-52 Weeks|Adverse Event|3
7812898|NCT01193218|12277248|FG006|12-52 Weeks|Adverse Event|1
7812899|NCT01193218|12277249|FG007|12-52 Weeks|Adverse Event|2
7812900|NCT01193218|12277242|FG000|12-52 Weeks|Lack of Efficacy|0
7812901|NCT01193218|12277243|FG001|12-52 Weeks|Lack of Efficacy|0
7909269|NCT02038933|12425138|FG000|Overall Study|Study drug toxicity|6
7812902|NCT01193218|12277244|FG002|12-52 Weeks|Lack of Efficacy|0
7909270|NCT02038933|12425138|FG000|Overall Study|Adverse event unrelated to study drug|6
7812903|NCT01193218|12277245|FG003|12-52 Weeks|Lack of Efficacy|0
7812904|NCT01193218|12277246|FG004|12-52 Weeks|Lack of Efficacy|0
7812905|NCT01193218|12277247|FG005|12-52 Weeks|Lack of Efficacy|0
7812906|NCT01193218|12277248|FG006|12-52 Weeks|Lack of Efficacy|1
7812907|NCT01193218|12277249|FG007|12-52 Weeks|Lack of Efficacy|0
7812908|NCT01193218|12277242|FG000|12-52 Weeks|Withdrawal by Subject|3
7812909|NCT01193218|12277243|FG001|12-52 Weeks|Withdrawal by Subject|0
7812910|NCT01193218|12277244|FG002|12-52 Weeks|Withdrawal by Subject|3
7812911|NCT01193218|12277245|FG003|12-52 Weeks|Withdrawal by Subject|0
7812912|NCT01193218|12277246|FG004|12-52 Weeks|Withdrawal by Subject|0
7812913|NCT01193218|12277247|FG005|12-52 Weeks|Withdrawal by Subject|2
7812914|NCT01193218|12277248|FG006|12-52 Weeks|Withdrawal by Subject|1
7812915|NCT01193218|12277249|FG007|12-52 Weeks|Withdrawal by Subject|2
7812916|NCT01193218|12277242|FG000|12-52 Weeks|Other reason than above|1
7812917|NCT01193218|12277243|FG001|12-52 Weeks|Other reason than above|0
7812918|NCT01193218|12277244|FG002|12-52 Weeks|Other reason than above|0
7812919|NCT01193218|12277245|FG003|12-52 Weeks|Other reason than above|1
7812920|NCT01193218|12277246|FG004|12-52 Weeks|Other reason than above|1
7812921|NCT01193218|12277247|FG005|12-52 Weeks|Other reason than above|0
7812922|NCT01193218|12277248|FG006|12-52 Weeks|Other reason than above|0
7812923|NCT01193218|12277249|FG007|12-52 Weeks|Other reason than above|0
7812924|NCT01193244|12277267|FG000|Overall Study|Withdrawal by Subject|79
7812925|NCT01193244|12277268|FG001|Overall Study|Withdrawal by Subject|97
7812926|NCT01193244|12277267|FG000|Overall Study|Other|303
7812927|NCT01193244|12277268|FG001|Overall Study|Other|278
7812928|NCT01193244|12277267|FG000|Overall Study|Lost to Follow-up|6
7812929|NCT01193244|12277268|FG001|Overall Study|Lost to Follow-up|15
7812930|NCT01193257|12277276|FG000|Overall Study|Death|202
7812931|NCT01193257|12277277|FG001|Overall Study|Death|391
7812932|NCT01193257|12277276|FG000|Overall Study|Study termination by sponsor|0
7812933|NCT01193257|12277277|FG001|Overall Study|Study termination by sponsor|3
7812934|NCT01193257|12277276|FG000|Overall Study|Withdrawal by Subject|26
7812935|NCT01193257|12277277|FG001|Overall Study|Withdrawal by Subject|86
7812936|NCT01193257|12277276|FG000|Overall Study|Lost to Follow-up|2
7812937|NCT01193257|12277277|FG001|Overall Study|Lost to Follow-up|3
7812938|NCT01193257|12277276|FG000|Overall Study|Unblinded due to futility|135
7812939|NCT01193257|12277277|FG001|Overall Study|Unblinded due to futility|251
7812940|NCT01193283|12277283|FG000|Overall Study|Death|1
7812941|NCT01193335|12277289|FG000|After Infant Series|Lost to Follow-up|1
7812942|NCT01193335|12277290|FG001|After Infant Series|Lost to Follow-up|2
7812943|NCT01193335|12277289|FG000|After Infant Series|No Longer Met Eligibility Criteria|0
7812944|NCT01193335|12277290|FG001|After Infant Series|No Longer Met Eligibility Criteria|1
7812945|NCT01193335|12277289|FG000|1-Year Follow-up|No Longer Willing to Participate|7
7812946|NCT01193335|12277290|FG001|1-Year Follow-up|No Longer Willing to Participate|9
7812947|NCT01193335|12277289|FG000|1-Year Follow-up|Lost to Follow-up|4
7812948|NCT01193335|12277290|FG001|1-Year Follow-up|Lost to Follow-up|0
7812949|NCT01193335|12277289|FG000|2-Year Follow-up|No Longer Willing to Participate|5
7812950|NCT01193335|12277290|FG001|2-Year Follow-up|No Longer Willing to Participate|6
7812951|NCT01193335|12277289|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2
7812952|NCT01193335|12277290|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2
7812953|NCT01193348|12277312|FG000|Screening Period|Screen Failure|5
7812954|NCT01193348|12277312|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
7812955|NCT01193348|12277312|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1
7812956|NCT01193348|12277312|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
7812957|NCT01193348|12277312|FG000|Extension Treatment Period|Physician Decision|1
7812958|NCT01193348|12277312|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
7812959|NCT01193517|12277324|FG000|Overall Study|Early Progression|1
7812960|NCT01193517|12277325|FG001|Overall Study|Early Progression|0
7812961|NCT01193517|12277326|FG002|Overall Study|Early Progression|0
7812962|NCT01193582|12277339|FG000|Vaccination Series|Withdrawal by Subject|11
7812963|NCT01193582|12277340|FG001|Vaccination Series|Withdrawal by Subject|13
7812964|NCT01193582|12277341|FG002|Vaccination Series|Withdrawal by Subject|8
7812965|NCT01193582|12277342|FG003|Vaccination Series|Withdrawal by Subject|3
7812966|NCT01193582|12277339|FG000|12 Month Follow-up|Death|0
7812967|NCT01193582|12277340|FG001|12 Month Follow-up|Death|0
7812968|NCT01193582|12277341|FG002|12 Month Follow-up|Death|1
7812969|NCT01193582|12277342|FG003|12 Month Follow-up|Death|0
7812970|NCT01193582|12277339|FG000|12 Month Follow-up|Withdrawal by Subject|6
7812971|NCT01193582|12277340|FG001|12 Month Follow-up|Withdrawal by Subject|0
7812972|NCT01193582|12277341|FG002|12 Month Follow-up|Withdrawal by Subject|3
7812973|NCT01193582|12277342|FG003|12 Month Follow-up|Withdrawal by Subject|11
7812974|NCT01193608|12277360|FG000|Overall Study|Other|0
7812975|NCT01193608|12277361|FG001|Overall Study|Other|1
7812976|NCT01193608|12277362|FG002|Overall Study|Other|0
7812977|NCT01193608|12277363|FG003|Overall Study|Other|0
7812978|NCT01193608|12277364|FG004|Overall Study|Other|0
7812979|NCT01193608|12277365|FG005|Overall Study|Other|0
7812980|NCT01193608|12277360|FG000|Overall Study|Withdrawal by Subject|0
7812981|NCT01193608|12277361|FG001|Overall Study|Withdrawal by Subject|1
7812982|NCT01193608|12277362|FG002|Overall Study|Withdrawal by Subject|2
7812983|NCT01193608|12277363|FG003|Overall Study|Withdrawal by Subject|3
7812984|NCT01193608|12277364|FG004|Overall Study|Withdrawal by Subject|3
7812985|NCT01193608|12277365|FG005|Overall Study|Withdrawal by Subject|0
7812986|NCT01193608|12277360|FG000|Overall Study|Lost to Follow-up|0
7812987|NCT01193608|12277361|FG001|Overall Study|Lost to Follow-up|0
7812988|NCT01193608|12277362|FG002|Overall Study|Lost to Follow-up|0
7812989|NCT01193608|12277363|FG003|Overall Study|Lost to Follow-up|0
7812990|NCT01193608|12277364|FG004|Overall Study|Lost to Follow-up|1
7812991|NCT01193608|12277365|FG005|Overall Study|Lost to Follow-up|2
7812992|NCT01193608|12277360|FG000|Overall Study|Adverse Event|0
7812993|NCT01193608|12277361|FG001|Overall Study|Adverse Event|0
7812994|NCT01193608|12277362|FG002|Overall Study|Adverse Event|0
7812995|NCT01193608|12277363|FG003|Overall Study|Adverse Event|0
7812996|NCT01193608|12277364|FG004|Overall Study|Adverse Event|1
7812997|NCT01193608|12277365|FG005|Overall Study|Adverse Event|0
7812998|NCT01193660|12277387|FG000|Overall Study|Withdrawal by Subject|2
7812999|NCT01193660|12277388|FG001|Overall Study|Withdrawal by Subject|3
7813000|NCT01193660|12277389|FG002|Overall Study|Withdrawal by Subject|1
7813001|NCT01193660|12277387|FG000|Overall Study|Death|1
7813002|NCT01193660|12277388|FG001|Overall Study|Death|0
7813003|NCT01193660|12277389|FG002|Overall Study|Death|0
7813004|NCT01193660|12277387|FG000|Overall Study|Physician Decision|1
7813005|NCT01193660|12277388|FG001|Overall Study|Physician Decision|0
7813006|NCT01193660|12277389|FG002|Overall Study|Physician Decision|1
7813007|NCT01193686|12277399|FG000|Overall Study|Withdrawal by Subject|4
7813008|NCT01193686|12277400|FG001|Overall Study|Withdrawal by Subject|1
7813009|NCT01193686|12277399|FG000|Overall Study|Removed by Investigators; unable to matc|3
7813010|NCT01193686|12277400|FG001|Overall Study|Removed by Investigators; unable to matc|0
7813011|NCT01193920|12277438|FG000|Overall Study|Withdrawal by Subject|1
7813012|NCT01193920|12277439|FG001|Overall Study|Withdrawal by Subject|0
7813013|NCT01193920|12277440|FG002|Overall Study|Withdrawal by Subject|5
7813014|NCT01193920|12277441|FG003|Overall Study|Withdrawal by Subject|1
7813015|NCT01193920|12277442|FG004|Overall Study|Withdrawal by Subject|3
7813016|NCT01193920|12277443|FG005|Overall Study|Withdrawal by Subject|1
7813017|NCT01193920|12277444|FG006|Overall Study|Withdrawal by Subject|3
7813018|NCT01193920|12277445|FG007|Overall Study|Withdrawal by Subject|0
7813019|NCT01193920|12277446|FG008|Overall Study|Withdrawal by Subject|1
7813020|NCT01193920|12277447|FG009|Overall Study|Withdrawal by Subject|0
7813021|NCT01193920|12277438|FG000|Overall Study|Lost to Follow-up|1
7813022|NCT01193920|12277439|FG001|Overall Study|Lost to Follow-up|0
7813023|NCT01193920|12277440|FG002|Overall Study|Lost to Follow-up|1
7813024|NCT01193920|12277441|FG003|Overall Study|Lost to Follow-up|1
7813025|NCT01193920|12277442|FG004|Overall Study|Lost to Follow-up|3
7813026|NCT01193920|12277443|FG005|Overall Study|Lost to Follow-up|3
7813027|NCT01193920|12277444|FG006|Overall Study|Lost to Follow-up|1
7813028|NCT01193920|12277445|FG007|Overall Study|Lost to Follow-up|0
7813029|NCT01193920|12277446|FG008|Overall Study|Lost to Follow-up|2
7813030|NCT01193920|12277447|FG009|Overall Study|Lost to Follow-up|3
7813031|NCT01193920|12277438|FG000|Overall Study|Protocol Violation|1
7813032|NCT01193920|12277439|FG001|Overall Study|Protocol Violation|0
7813033|NCT01193920|12277440|FG002|Overall Study|Protocol Violation|0
7813034|NCT01193920|12277441|FG003|Overall Study|Protocol Violation|0
7813035|NCT01193920|12277442|FG004|Overall Study|Protocol Violation|0
7813036|NCT01193920|12277443|FG005|Overall Study|Protocol Violation|0
7813037|NCT01193920|12277444|FG006|Overall Study|Protocol Violation|0
7813038|NCT01193920|12277445|FG007|Overall Study|Protocol Violation|0
7813039|NCT01193920|12277446|FG008|Overall Study|Protocol Violation|0
7813040|NCT01193920|12277447|FG009|Overall Study|Protocol Violation|0
7813041|NCT01193920|12277438|FG000|Overall Study|Death|0
7813042|NCT01193920|12277439|FG001|Overall Study|Death|0
7813043|NCT01193920|12277440|FG002|Overall Study|Death|0
7813044|NCT01193920|12277441|FG003|Overall Study|Death|1
7813045|NCT01193920|12277442|FG004|Overall Study|Death|0
7813046|NCT01193920|12277443|FG005|Overall Study|Death|0
7813047|NCT01193920|12277444|FG006|Overall Study|Death|2
7813048|NCT01193920|12277445|FG007|Overall Study|Death|3
7813049|NCT01193920|12277446|FG008|Overall Study|Death|2
7813050|NCT01193920|12277447|FG009|Overall Study|Death|4
7813051|NCT01193920|12277438|FG000|Overall Study|Unable to classify|0
7813052|NCT01193920|12277439|FG001|Overall Study|Unable to classify|0
7813053|NCT01193920|12277440|FG002|Overall Study|Unable to classify|0
7813054|NCT01193920|12277441|FG003|Overall Study|Unable to classify|1
7813055|NCT01193920|12277442|FG004|Overall Study|Unable to classify|0
7813056|NCT01193920|12277443|FG005|Overall Study|Unable to classify|0
7813057|NCT01193920|12277444|FG006|Overall Study|Unable to classify|0
7813058|NCT01193920|12277445|FG007|Overall Study|Unable to classify|1
7813059|NCT01193920|12277446|FG008|Overall Study|Unable to classify|0
7813060|NCT01193920|12277447|FG009|Overall Study|Unable to classify|0
7813061|NCT01194154|12277481|FG000|Overall Study|Adverse Event|12
7813062|NCT01194154|12277482|FG001|Overall Study|Adverse Event|7
7909271|NCT02038933|12425138|FG000|Overall Study|Participant request to discontinue treatment|2
7909272|NCT02038933|12425138|FG000|Overall Study|Lost to Follow-up|1
7909273|NCT02038933|12425138|FG000|Overall Study|Other reasons|2
7909274|NCT02038959|12425145|FG000|Overall Study|Withdrawal by Subject|6
7909275|NCT02038959|12425146|FG001|Overall Study|Withdrawal by Subject|8
7909276|NCT02039219|12425163|FG000|Treatment|Withdrawal by Subject|1
7909277|NCT02039219|12425164|FG001|Treatment|Withdrawal by Subject|0
7909278|NCT02039219|12425163|FG000|Treatment|Adverse Event|0
7909279|NCT02039219|12425164|FG001|Treatment|Adverse Event|1
7909280|NCT02039219|12425163|FG000|Treatment|Physician Decision|1
7909281|NCT02039219|12425164|FG001|Treatment|Physician Decision|0
7909282|NCT02039219|12425163|FG000|Treatment|Lost to Follow-up|0
7909283|NCT02039219|12425164|FG001|Treatment|Lost to Follow-up|1
7909284|NCT02039219|12425163|FG000|Treatment|Protocol Violation|1
7909285|NCT02039219|12425164|FG001|Treatment|Protocol Violation|0
7909286|NCT02039219|12425163|FG000|Treatment|Death|1
7909287|NCT02039219|12425164|FG001|Treatment|Death|0
7909288|NCT02039219|12425163|FG000|Follow up|Adverse Event|0
7909289|NCT02039219|12425164|FG001|Follow up|Adverse Event|1
7909290|NCT02039375|12425170|FG000|Overall Study|Lost to Follow-up|2
7909291|NCT02039414|12425176|FG000|Overall Study|Delivered|1
7909292|NCT02039414|12425177|FG001|Overall Study|Delivered|1
7909293|NCT02039414|12425176|FG000|Overall Study|Lost to Follow-up|2
7909294|NCT02039414|12425177|FG001|Overall Study|Lost to Follow-up|0
7909295|NCT02039414|12425176|FG000|Overall Study|Protocol Violation|3
7909296|NCT02039414|12425177|FG001|Overall Study|Protocol Violation|1
7909297|NCT02039427|12425187|FG000|Overall Study|Duration of surgery > 3h|1
7909298|NCT02039427|12425188|FG001|Overall Study|Duration of surgery > 3h|1
7909299|NCT02039427|12425189|FG002|Overall Study|Duration of surgery > 3h|0
7909300|NCT02039427|12425190|FG003|Overall Study|Duration of surgery > 3h|0
7909301|NCT02039427|12425187|FG000|Overall Study|Withdrawal on concent|0
7909302|NCT02039427|12425188|FG001|Overall Study|Withdrawal on concent|0
7909303|NCT02039427|12425189|FG002|Overall Study|Withdrawal on concent|0
7909304|NCT02039427|12425190|FG003|Overall Study|Withdrawal on concent|1
7909305|NCT02039427|12425187|FG000|Overall Study|Cancellation of surgery|0
7909306|NCT02039427|12425188|FG001|Overall Study|Cancellation of surgery|0
7909307|NCT02039427|12425189|FG002|Overall Study|Cancellation of surgery|1
7909308|NCT02039427|12425190|FG003|Overall Study|Cancellation of surgery|0
7909309|NCT02039427|12425187|FG000|Overall Study|Loss of follow - up|1
7909310|NCT02039427|12425188|FG001|Overall Study|Loss of follow - up|0
7909311|NCT02039427|12425189|FG002|Overall Study|Loss of follow - up|2
7909312|NCT02039427|12425190|FG003|Overall Study|Loss of follow - up|4
7909313|NCT02039427|12425187|FG000|Overall Study|Steroid Use|1
7909314|NCT02039427|12425188|FG001|Overall Study|Steroid Use|0
7909315|NCT02039427|12425189|FG002|Overall Study|Steroid Use|0
7909316|NCT02039427|12425190|FG003|Overall Study|Steroid Use|0
7909317|NCT02039505|12425207|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2
7909318|NCT02039505|12425208|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8
7909319|NCT02039505|12425209|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7
7909320|NCT02039505|12425210|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
7909321|NCT02039505|12425211|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
7909322|NCT02039505|12425212|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
7909323|NCT02039505|12425213|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
7909324|NCT02039505|12425207|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
7909325|NCT02039505|12425208|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
7909326|NCT02039505|12425209|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3
7909327|NCT02039505|12425210|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7909328|NCT02039505|12425211|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7909329|NCT02039505|12425212|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7909330|NCT02039505|12425213|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7909331|NCT02039505|12425207|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1
7909332|NCT02039505|12425208|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7909333|NCT02039505|12425209|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7909334|NCT02039505|12425210|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7909335|NCT02039505|12425211|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7909336|NCT02039505|12425212|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7909337|NCT02039505|12425213|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7909338|NCT02039505|12425207|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
7909339|NCT02039505|12425208|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
7909340|NCT02039505|12425209|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
7909341|NCT02039505|12425210|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13
7909342|NCT02039505|12425211|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8
7909343|NCT02039505|12425212|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12
7909344|NCT02039505|12425213|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
7909345|NCT02039505|12425207|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7909346|NCT02039505|12425208|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7964048|NCT02734693|12519109|FG000|Overall Study|Lost to Follow-up|2
7813063|NCT01194154|12277481|FG000|Overall Study|Lost to Follow-up|2
7813064|NCT01194154|12277482|FG001|Overall Study|Lost to Follow-up|3
7813065|NCT01194154|12277481|FG000|Overall Study|Protocol Violation|0
7813066|NCT01194154|12277482|FG001|Overall Study|Protocol Violation|1
7813067|NCT01194154|12277481|FG000|Overall Study|Withdrawal by Subject|5
7813068|NCT01194154|12277482|FG001|Overall Study|Withdrawal by Subject|6
7813069|NCT01194154|12277481|FG000|Overall Study|Blood pressure increase|5
7813070|NCT01194154|12277482|FG001|Overall Study|Blood pressure increase|3
7813071|NCT01194154|12277481|FG000|Overall Study|Hemoglobin decrease|0
7813072|NCT01194154|12277482|FG001|Overall Study|Hemoglobin decrease|1
7813073|NCT01194154|12277481|FG000|Overall Study|Hemoglobin increase|12
7813074|NCT01194154|12277482|FG001|Overall Study|Hemoglobin increase|3
7813075|NCT01194154|12277481|FG000|Overall Study|Skipping of CERA treatment at two visits|3
7813076|NCT01194154|12277482|FG001|Overall Study|Skipping of CERA treatment at two visits|0
7813077|NCT01194154|12277481|FG000|Overall Study|Treatment with prohibited medication|4
7813078|NCT01194154|12277482|FG001|Overall Study|Treatment with prohibited medication|5
7813079|NCT01194154|12277481|FG000|Overall Study|Other|4
7813080|NCT01194154|12277482|FG001|Overall Study|Other|0
7813081|NCT01194154|12277481|FG000|Overall Study|Did not receive study medication|2
7813082|NCT01194154|12277482|FG001|Overall Study|Did not receive study medication|4
7813083|NCT01194245|12277495|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
7813084|NCT01194245|12277496|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
7813085|NCT01194245|12277497|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
7813086|NCT01194245|12277498|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
7813087|NCT01194245|12277499|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
7813088|NCT01194245|12277495|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3
7813089|NCT01194245|12277496|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0
7813090|NCT01194245|12277497|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0
7813091|NCT01194245|12277498|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0
7813092|NCT01194245|12277499|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0
7813093|NCT01194245|12277495|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3
7813094|NCT01194245|12277496|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0
7813095|NCT01194245|12277497|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0
7813096|NCT01194245|12277498|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0
7813097|NCT01194245|12277499|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0
7813098|NCT01194245|12277495|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
7813099|NCT01194245|12277496|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
7813100|NCT01194245|12277497|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
7813101|NCT01194245|12277498|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
7813102|NCT01194245|12277499|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
7813103|NCT01194245|12277495|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7813104|NCT01194245|12277496|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7813105|NCT01194245|12277497|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7813106|NCT01194245|12277498|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7813107|NCT01194245|12277499|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
7813108|NCT01194245|12277495|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7813109|NCT01194245|12277496|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7813110|NCT01194245|12277497|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
7813111|NCT01194245|12277498|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
7813112|NCT01194245|12277499|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
7813113|NCT01194258|12277508|FG000|Titration Period|Withdrawal by Subject|6
7813114|NCT01194258|12277509|FG001|Titration Period|Withdrawal by Subject|0
7813115|NCT01194258|12277510|FG002|Titration Period|Withdrawal by Subject|0
7813116|NCT01194258|12277511|FG003|Titration Period|Withdrawal by Subject|0
7813117|NCT01194258|12277512|FG004|Titration Period|Withdrawal by Subject|0
7813118|NCT01194258|12277508|FG000|Titration Period|Lost to Follow-up|2
7813119|NCT01194258|12277509|FG001|Titration Period|Lost to Follow-up|0
7813120|NCT01194258|12277510|FG002|Titration Period|Lost to Follow-up|0
7813121|NCT01194258|12277511|FG003|Titration Period|Lost to Follow-up|0
7813122|NCT01194258|12277512|FG004|Titration Period|Lost to Follow-up|0
7813123|NCT01194258|12277508|FG000|Titration Period|Titration failure|3
7813124|NCT01194258|12277509|FG001|Titration Period|Titration failure|0
7813125|NCT01194258|12277510|FG002|Titration Period|Titration failure|0
7813126|NCT01194258|12277511|FG003|Titration Period|Titration failure|0
7813127|NCT01194258|12277512|FG004|Titration Period|Titration failure|0
7813128|NCT01194258|12277508|FG000|Period 1 (12 Weeks)|Death|0
7813129|NCT01194258|12277509|FG001|Period 1 (12 Weeks)|Death|0
7813130|NCT01194258|12277510|FG002|Period 1 (12 Weeks)|Death|0
7813131|NCT01194258|12277511|FG003|Period 1 (12 Weeks)|Death|0
7813132|NCT01194258|12277512|FG004|Period 1 (12 Weeks)|Death|1
7813133|NCT01194258|12277508|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0
7813134|NCT01194258|12277509|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0
7813135|NCT01194258|12277510|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0
7813136|NCT01194258|12277511|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0
7813137|NCT01194258|12277512|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2
7813138|NCT01194258|12277508|FG000|Period 2 (12 Weeks)|Adverse Event|0
7813139|NCT01194258|12277509|FG001|Period 2 (12 Weeks)|Adverse Event|1
7813140|NCT01194258|12277510|FG002|Period 2 (12 Weeks)|Adverse Event|0
7813141|NCT01194258|12277511|FG003|Period 2 (12 Weeks)|Adverse Event|0
7813142|NCT01194258|12277512|FG004|Period 2 (12 Weeks)|Adverse Event|0
7813143|NCT01194258|12277508|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0
7813144|NCT01194258|12277509|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1
7813145|NCT01194258|12277510|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1
7813146|NCT01194258|12277511|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0
7813147|NCT01194258|12277512|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0
7813148|NCT01194271|12277523|FG000|Overall Study|Withdrawal by Subject|1
7813149|NCT01194271|12277523|FG000|Overall Study|Ineligible, Screen Failure|1
7813150|NCT01194271|12277523|FG000|Overall Study|Death|1
7813151|NCT01194414|12277538|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
7813152|NCT01194414|12277539|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
7813153|NCT01194414|12277540|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
7813154|NCT01194414|12277541|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
7813155|NCT01194414|12277538|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
7813156|NCT01194414|12277539|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
7813157|NCT01194414|12277540|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
7813158|NCT01194414|12277541|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
7813159|NCT01194414|12277538|FG000|24 Weeks Double Blind Period|Protocol Violation|5
7813160|NCT01194414|12277539|FG001|24 Weeks Double Blind Period|Protocol Violation|3
7813161|NCT01194414|12277540|FG002|24 Weeks Double Blind Period|Protocol Violation|0
7813162|NCT01194414|12277541|FG003|24 Weeks Double Blind Period|Protocol Violation|0
7813163|NCT01194414|12277538|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
7813164|NCT01194414|12277539|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
7813165|NCT01194414|12277540|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
7813166|NCT01194414|12277541|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
7813167|NCT01194414|12277538|FG000|24 Weeks Double Blind Period|Pregnancy|2
7909347|NCT02039505|12425209|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7909348|NCT02039505|12425210|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6
7909349|NCT02039505|12425211|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
7909350|NCT02039505|12425212|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
7909351|NCT02039505|12425213|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7909352|NCT02039505|12425207|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7909353|NCT02039505|12425208|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7909354|NCT02039505|12425209|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7909355|NCT02039505|12425210|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3
7909356|NCT02039505|12425211|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2
7909357|NCT02039505|12425212|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1
7909358|NCT02039505|12425213|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7909359|NCT02039505|12425207|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7909360|NCT02039505|12425208|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7909361|NCT02039505|12425209|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7909362|NCT02039505|12425210|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2
7909363|NCT02039505|12425211|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7909364|NCT02039505|12425212|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7909365|NCT02039505|12425213|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7909366|NCT02039505|12425207|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7909367|NCT02039505|12425208|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7909368|NCT02039505|12425209|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7909369|NCT02039505|12425210|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7909370|NCT02039505|12425211|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7909371|NCT02039505|12425212|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7909372|NCT02039505|12425213|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44
7909373|NCT02039505|12425207|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7909374|NCT02039505|12425208|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7909375|NCT02039505|12425209|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7909376|NCT02039505|12425210|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7909377|NCT02039505|12425211|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7909378|NCT02039505|12425212|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7909379|NCT02039505|12425213|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19
7909380|NCT02039505|12425207|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7909381|NCT02039505|12425208|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7909382|NCT02039505|12425209|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7909383|NCT02039505|12425210|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7909384|NCT02039505|12425211|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7909385|NCT02039505|12425212|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7909386|NCT02039505|12425213|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7
7813168|NCT01194414|12277539|FG001|24 Weeks Double Blind Period|Pregnancy|2
7813169|NCT01194414|12277540|FG002|24 Weeks Double Blind Period|Pregnancy|0
7813170|NCT01194414|12277541|FG003|24 Weeks Double Blind Period|Pregnancy|0
7813171|NCT01194414|12277538|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2
7813172|NCT01194414|12277539|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1
7813173|NCT01194414|12277540|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0
7813174|NCT01194414|12277541|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0
7813175|NCT01194414|12277538|FG000|24 Weeks Double Blind Period|Other|0
7813176|NCT01194414|12277539|FG001|24 Weeks Double Blind Period|Other|1
7813177|NCT01194414|12277540|FG002|24 Weeks Double Blind Period|Other|0
7813178|NCT01194414|12277541|FG003|24 Weeks Double Blind Period|Other|0
7813179|NCT01194414|12277538|FG000|24 Weeks Double Blind Period|Adverse Event|28
7813180|NCT01194414|12277539|FG001|24 Weeks Double Blind Period|Adverse Event|40
7813181|NCT01194414|12277540|FG002|24 Weeks Double Blind Period|Adverse Event|0
7813182|NCT01194414|12277541|FG003|24 Weeks Double Blind Period|Adverse Event|0
7813183|NCT01194414|12277538|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
7813184|NCT01194414|12277539|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
7813185|NCT01194414|12277540|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
7813186|NCT01194414|12277541|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
7813187|NCT01194414|12277538|FG000|24 Weeks Double Blind Period|Death|0
7813188|NCT01194414|12277539|FG001|24 Weeks Double Blind Period|Death|1
7813189|NCT01194414|12277540|FG002|24 Weeks Double Blind Period|Death|0
7813190|NCT01194414|12277541|FG003|24 Weeks Double Blind Period|Death|0
7813191|NCT01194414|12277538|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3
7813192|NCT01194414|12277539|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5
7813193|NCT01194414|12277540|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0
7813194|NCT01194414|12277541|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0
7813195|NCT01194414|12277538|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
7813196|NCT01194414|12277539|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
7813197|NCT01194414|12277540|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
7813198|NCT01194414|12277541|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
7813199|NCT01194414|12277538|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
7813200|NCT01194414|12277539|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
7813201|NCT01194414|12277540|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
7813202|NCT01194414|12277541|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
7813203|NCT01194414|12277538|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4
7813204|NCT01194414|12277539|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3
7813205|NCT01194414|12277540|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2
7813206|NCT01194414|12277541|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1
7813207|NCT01194414|12277538|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
7813208|NCT01194414|12277539|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
7813209|NCT01194414|12277540|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
7813210|NCT01194414|12277541|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
7813211|NCT01194414|12277538|FG000|72 Weeks Open Label Extension|Pregnancy|1
7813212|NCT01194414|12277539|FG001|72 Weeks Open Label Extension|Pregnancy|3
7813213|NCT01194414|12277540|FG002|72 Weeks Open Label Extension|Pregnancy|1
7813214|NCT01194414|12277541|FG003|72 Weeks Open Label Extension|Pregnancy|1
7813215|NCT01194414|12277538|FG000|72 Weeks Open Label Extension|Other|2
7813216|NCT01194414|12277539|FG001|72 Weeks Open Label Extension|Other|1
7813217|NCT01194414|12277540|FG002|72 Weeks Open Label Extension|Other|0
7813218|NCT01194414|12277541|FG003|72 Weeks Open Label Extension|Other|0
7813219|NCT01194414|12277538|FG000|72 Weeks Open Label Extension|Protocol Violation|0
7813220|NCT01194414|12277539|FG001|72 Weeks Open Label Extension|Protocol Violation|0
7813221|NCT01194414|12277540|FG002|72 Weeks Open Label Extension|Protocol Violation|0
7813222|NCT01194414|12277541|FG003|72 Weeks Open Label Extension|Protocol Violation|1
7813223|NCT01194414|12277538|FG000|72 Weeks Open Label Extension|Adverse Event|35
7813224|NCT01194414|12277539|FG001|72 Weeks Open Label Extension|Adverse Event|21
7813225|NCT01194414|12277540|FG002|72 Weeks Open Label Extension|Adverse Event|2
7813226|NCT01194414|12277541|FG003|72 Weeks Open Label Extension|Adverse Event|12
7813227|NCT01194414|12277538|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
7813228|NCT01194414|12277539|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
7813229|NCT01194414|12277540|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
7909387|NCT02039505|12425207|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7909388|NCT02039505|12425208|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7909389|NCT02039505|12425209|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7909390|NCT02039505|12425210|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7813230|NCT01194414|12277541|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
7813231|NCT01194414|12277538|FG000|72 Weeks Open Label Extension|Death|1
7813232|NCT01194414|12277539|FG001|72 Weeks Open Label Extension|Death|2
7813233|NCT01194414|12277540|FG002|72 Weeks Open Label Extension|Death|0
7813234|NCT01194414|12277541|FG003|72 Weeks Open Label Extension|Death|2
7813235|NCT01194440|12277553|FG000|Baseline (First Dose)|Reason not specified|4
7964049|NCT02734693|12519110|FG001|Overall Study|Lost to Follow-up|0
7813236|NCT01194440|12277553|FG000|Baseline (First Dose)|Lack of Efficacy|1
7813237|NCT01194440|12277553|FG000|Baseline (First Dose)|Change in therapy|1
7813238|NCT01194440|12277553|FG000|Baseline (First Dose)|Adverse Event|1
7813239|NCT01194440|12277553|FG000|6-months (2nd Dose)|Change in therapy|4
7813240|NCT01194531|12277594|FG000|Overall Study|Withdrawal by Subject|1
7813241|NCT01194531|12277595|FG001|Overall Study|Withdrawal by Subject|0
7813242|NCT01194531|12277594|FG000|Overall Study|Protocol Violation|4
7813243|NCT01194531|12277595|FG001|Overall Study|Protocol Violation|1
7813244|NCT01194531|12277594|FG000|Overall Study|Physician Decision|0
7813245|NCT01194531|12277595|FG001|Overall Study|Physician Decision|2
7813246|NCT01194804|12277606|FG000|Overall Study|Withdrawal by Subject|1
7813247|NCT01194830|12277612|FG000|Overall Study|Adverse Event|3
7813248|NCT01194830|12277613|FG001|Overall Study|Adverse Event|2
7813249|NCT01194830|12277612|FG000|Overall Study|Protocol Violation|5
7813250|NCT01194830|12277613|FG001|Overall Study|Protocol Violation|4
7813251|NCT01194830|12277612|FG000|Overall Study|Lost to Follow-up|9
7813252|NCT01194830|12277613|FG001|Overall Study|Lost to Follow-up|7
7813253|NCT01194830|12277612|FG000|Overall Study|Withdrawal by Subject|2
7813254|NCT01194830|12277613|FG001|Overall Study|Withdrawal by Subject|1
7813255|NCT01194830|12277612|FG000|Overall Study|Lack of Efficacy|1
7813256|NCT01194830|12277613|FG001|Overall Study|Lack of Efficacy|1
7813257|NCT01194830|12277612|FG000|Overall Study|Non-compliance issues|4
7813258|NCT01194830|12277613|FG001|Overall Study|Non-compliance issues|4
7813259|NCT01194830|12277612|FG000|Overall Study|Other Reason|12
7813260|NCT01194830|12277613|FG001|Overall Study|Other Reason|8
7813261|NCT01194869|12277619|FG000|Overall Study|Disease Progression|2
7813262|NCT01194869|12277619|FG000|Overall Study|Toxicity|2
7813263|NCT01194973|12277623|FG000|Screening Period|Screen Failure|3
7813264|NCT01194973|12277623|FG000|26 Week Treatment Period|Adverse Event|1
7813265|NCT01194973|12277623|FG000|26 Week Treatment Period|Lack of Efficacy|1
7813266|NCT01194973|12277623|FG000|26 Week Treatment Period|Pregnancy|1
7813267|NCT01194999|12277627|FG000|Overall Study|Lost to Follow-up|17
7813268|NCT01195090|12277643|FG000|Overall Study|Adverse Event|1
7813269|NCT01195090|12277644|FG001|Overall Study|Adverse Event|2
7813270|NCT01195090|12277643|FG000|Overall Study|Lost to Follow-up|2
7813271|NCT01195090|12277644|FG001|Overall Study|Lost to Follow-up|2
7813272|NCT01195090|12277643|FG000|Overall Study|Protocol Violation|3
7813273|NCT01195090|12277644|FG001|Overall Study|Protocol Violation|4
7813274|NCT01195103|12277653|FG000|Overall Study|Withdrawal by Subject|1
7813275|NCT01195103|12277654|FG001|Overall Study|Withdrawal by Subject|0
7813276|NCT01195103|12277655|FG002|Overall Study|Withdrawal by Subject|0
7813277|NCT01195272|12277672|FG000|Overall Study|Adverse Event|1
7813278|NCT01195272|12277672|FG000|Overall Study|Lack of Efficacy|3
7813279|NCT01195363|12277678|FG000|Overall Study|Lost to Follow-up|7
7813280|NCT01195363|12277679|FG001|Overall Study|Lost to Follow-up|4
7813281|NCT01195363|12277678|FG000|Overall Study|Adverse Event|3
7813282|NCT01195363|12277679|FG001|Overall Study|Adverse Event|1
7813283|NCT01195363|12277678|FG000|Overall Study|Lack of Efficacy|0
7813284|NCT01195363|12277679|FG001|Overall Study|Lack of Efficacy|4
7813285|NCT01195363|12277678|FG000|Overall Study|incarceration|1
7813286|NCT01195363|12277679|FG001|Overall Study|incarceration|0
7813287|NCT01195415|12277685|FG000|Overall Study|No repeat biopsy due to progression|2
7813288|NCT01195545|12277693|FG000|Overall Study|Protocol Violation|4
7813289|NCT01195623|12277718|FG000|Overall Study|Lost to Follow-up|35
7813290|NCT01195623|12277719|FG001|Overall Study|Lost to Follow-up|37
7813291|NCT01195636|12277727|FG000|First Intervention (3 Weeks)|Adverse Event|2
7813292|NCT01195636|12277728|FG001|First Intervention (3 Weeks)|Adverse Event|3
7813293|NCT01195636|12277727|FG000|First Intervention (3 Weeks)|Protocol Violation|1
7813294|NCT01195636|12277728|FG001|First Intervention (3 Weeks)|Protocol Violation|0
7813295|NCT01195636|12277727|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
7813296|NCT01195636|12277728|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0
7813297|NCT01195636|12277727|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1
7813298|NCT01195636|12277728|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0
7813299|NCT01195636|12277727|FG000|Washout Period (2 Weeks)|Adverse Event|1
7813300|NCT01195636|12277728|FG001|Washout Period (2 Weeks)|Adverse Event|1
7813301|NCT01195636|12277727|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1
7813302|NCT01195636|12277728|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2
7813303|NCT01195636|12277727|FG000|Second Intervention (3 Weeks)|Adverse Event|1
7813304|NCT01195636|12277728|FG001|Second Intervention (3 Weeks)|Adverse Event|1
7813305|NCT01195636|12277727|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7813306|NCT01195636|12277728|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1
7813307|NCT01195662|12277737|FG000|Double Blind Treatment Period|Adverse Event|4
7813308|NCT01195662|12277738|FG001|Double Blind Treatment Period|Adverse Event|1
7813309|NCT01195662|12277739|FG002|Double Blind Treatment Period|Adverse Event|2
7813310|NCT01195662|12277737|FG000|Double Blind Treatment Period|Withdrawal by Subject|6
7813311|NCT01195662|12277738|FG001|Double Blind Treatment Period|Withdrawal by Subject|4
7813312|NCT01195662|12277739|FG002|Double Blind Treatment Period|Withdrawal by Subject|4
7813313|NCT01195662|12277737|FG000|Double Blind Treatment Period|Lost to Follow-up|3
7813314|NCT01195662|12277738|FG001|Double Blind Treatment Period|Lost to Follow-up|2
7813315|NCT01195662|12277739|FG002|Double Blind Treatment Period|Lost to Follow-up|3
7883611|NCT01783444|12383368|FG002|Treatment Phase|Physician Decision|5
7813316|NCT01195662|12277737|FG000|Double Blind Treatment Period|Administrative reason|2
7813317|NCT01195662|12277738|FG001|Double Blind Treatment Period|Administrative reason|1
7813318|NCT01195662|12277739|FG002|Double Blind Treatment Period|Administrative reason|1
7813319|NCT01195662|12277737|FG000|Double Blind Treatment Period|Requested discontinue treatment|1
7813320|NCT01195662|12277738|FG001|Double Blind Treatment Period|Requested discontinue treatment|0
7813321|NCT01195662|12277739|FG002|Double Blind Treatment Period|Requested discontinue treatment|1
7909391|NCT02039505|12425211|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7909392|NCT02039505|12425212|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7909393|NCT02039505|12425213|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1
7909394|NCT02039674|12425247|FG000|Overall Study|Adverse Event|0
7909395|NCT02039674|12425248|FG001|Overall Study|Adverse Event|0
7909396|NCT02039674|12425249|FG002|Overall Study|Adverse Event|1
7909397|NCT02039674|12425250|FG003|Overall Study|Adverse Event|1
7909398|NCT02039674|12425251|FG004|Overall Study|Adverse Event|0
7909399|NCT02039674|12425252|FG005|Overall Study|Adverse Event|0
7909400|NCT02039674|12425253|FG006|Overall Study|Adverse Event|0
7909401|NCT02039674|12425254|FG007|Overall Study|Adverse Event|0
7909402|NCT02039674|12425255|FG008|Overall Study|Adverse Event|2
7909403|NCT02039674|12425256|FG009|Overall Study|Adverse Event|0
7909404|NCT02039674|12425257|FG010|Overall Study|Adverse Event|0
7909405|NCT02039674|12425258|FG011|Overall Study|Adverse Event|2
7909406|NCT02039674|12425259|FG012|Overall Study|Adverse Event|2
7909407|NCT02039674|12425260|FG013|Overall Study|Adverse Event|1
7909408|NCT02039674|12425247|FG000|Overall Study|Death|0
7909409|NCT02039674|12425248|FG001|Overall Study|Death|0
7909410|NCT02039674|12425249|FG002|Overall Study|Death|1
7909411|NCT02039674|12425250|FG003|Overall Study|Death|2
7909412|NCT02039674|12425251|FG004|Overall Study|Death|0
7909413|NCT02039674|12425252|FG005|Overall Study|Death|0
7909414|NCT02039674|12425253|FG006|Overall Study|Death|0
7909415|NCT02039674|12425254|FG007|Overall Study|Death|0
7909416|NCT02039674|12425255|FG008|Overall Study|Death|0
7909417|NCT02039674|12425256|FG009|Overall Study|Death|0
7909418|NCT02039674|12425257|FG010|Overall Study|Death|1
7909419|NCT02039674|12425258|FG011|Overall Study|Death|1
7909420|NCT02039674|12425259|FG012|Overall Study|Death|0
7909421|NCT02039674|12425260|FG013|Overall Study|Death|8
7909422|NCT02039674|12425247|FG000|Overall Study|Excluded Medication|1
7909423|NCT02039674|12425248|FG001|Overall Study|Excluded Medication|1
7909424|NCT02039674|12425249|FG002|Overall Study|Excluded Medication|0
7909425|NCT02039674|12425250|FG003|Overall Study|Excluded Medication|1
7909426|NCT02039674|12425251|FG004|Overall Study|Excluded Medication|0
7909427|NCT02039674|12425252|FG005|Overall Study|Excluded Medication|1
7909428|NCT02039674|12425253|FG006|Overall Study|Excluded Medication|0
7909429|NCT02039674|12425254|FG007|Overall Study|Excluded Medication|0
7909430|NCT02039674|12425255|FG008|Overall Study|Excluded Medication|2
7909431|NCT02039674|12425256|FG009|Overall Study|Excluded Medication|2
7909432|NCT02039674|12425257|FG010|Overall Study|Excluded Medication|4
7909433|NCT02039674|12425258|FG011|Overall Study|Excluded Medication|2
7909434|NCT02039674|12425259|FG012|Overall Study|Excluded Medication|4
7909435|NCT02039674|12425260|FG013|Overall Study|Excluded Medication|3
7813322|NCT01195662|12277737|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1
7813323|NCT01195662|12277738|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5
7813324|NCT01195662|12277739|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2
7813325|NCT01195662|12277737|FG000|Double Blind Treatment Period|Lack of Efficacy|2
7813326|NCT01195662|12277738|FG001|Double Blind Treatment Period|Lack of Efficacy|0
7813327|NCT01195662|12277739|FG002|Double Blind Treatment Period|Lack of Efficacy|0
7813328|NCT01195662|12277737|FG000|Double Blind Treatment Period|Non-specified|3
7813329|NCT01195662|12277738|FG001|Double Blind Treatment Period|Non-specified|0
7813330|NCT01195662|12277739|FG002|Double Blind Treatment Period|Non-specified|0
7813331|NCT01195662|12277737|FG000|Double Blind Treatment Period|Missing disposition information|0
7813332|NCT01195662|12277738|FG001|Double Blind Treatment Period|Missing disposition information|1
7813333|NCT01195662|12277739|FG002|Double Blind Treatment Period|Missing disposition information|1
7813334|NCT01195662|12277737|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
7813335|NCT01195662|12277738|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
7813336|NCT01195662|12277739|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
7813337|NCT01195662|12277737|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
7813338|NCT01195662|12277738|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
7813339|NCT01195662|12277739|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
7813340|NCT01195675|12277748|FG000|Overall Study|Adverse Event|1
7813341|NCT01195675|12277748|FG000|Overall Study|Withdrawal by Subject|2
7813342|NCT01195831|12277831|FG000|Overall Study|Lost to Follow-up|2
7813343|NCT01195831|12277832|FG001|Overall Study|Lost to Follow-up|4
7813344|NCT01195831|12277831|FG000|Overall Study|Withdrawal by Subject|2
7813345|NCT01195831|12277832|FG001|Overall Study|Withdrawal by Subject|2
7813346|NCT01195831|12277831|FG000|Overall Study|Adverse Event|4
7813347|NCT01195831|12277832|FG001|Overall Study|Adverse Event|2
7909436|NCT02039674|12425247|FG000|Overall Study|Lost to Follow-up|0
7909437|NCT02039674|12425248|FG001|Overall Study|Lost to Follow-up|0
7909438|NCT02039674|12425249|FG002|Overall Study|Lost to Follow-up|0
7909439|NCT02039674|12425250|FG003|Overall Study|Lost to Follow-up|0
7813348|NCT01195831|12277831|FG000|Overall Study|Protocol Violation|0
7813349|NCT01195831|12277832|FG001|Overall Study|Protocol Violation|2
7813350|NCT01195844|12277838|FG000|Overall Study|Fecal sample not collected|40
7813351|NCT01195948|12277868|FG000|Overall Study|Lost to Follow-up|0
7813352|NCT01195948|12277869|FG001|Overall Study|Lost to Follow-up|1
7813353|NCT01195948|12277870|FG002|Overall Study|Lost to Follow-up|2
7813354|NCT01196026|12277887|FG000|Overall Study|Withdrawal by Subject|1
7813355|NCT01196026|12277888|FG001|Overall Study|Withdrawal by Subject|4
7813356|NCT01196026|12277889|FG002|Overall Study|Withdrawal by Subject|0
7813357|NCT01196026|12277890|FG003|Overall Study|Withdrawal by Subject|0
7813358|NCT01196026|12277891|FG004|Overall Study|Withdrawal by Subject|0
7813359|NCT01196026|12277892|FG005|Overall Study|Withdrawal by Subject|0
7813360|NCT01196026|12277887|FG000|Overall Study|Lost to Follow-up|0
7813361|NCT01196026|12277888|FG001|Overall Study|Lost to Follow-up|3
7813362|NCT01196026|12277889|FG002|Overall Study|Lost to Follow-up|0
7813363|NCT01196026|12277890|FG003|Overall Study|Lost to Follow-up|0
7813364|NCT01196026|12277891|FG004|Overall Study|Lost to Follow-up|1
7813365|NCT01196026|12277892|FG005|Overall Study|Lost to Follow-up|0
7813366|NCT01196026|12277887|FG000|Overall Study|Other|0
7813367|NCT01196026|12277888|FG001|Overall Study|Other|1
7813368|NCT01196026|12277889|FG002|Overall Study|Other|0
7813369|NCT01196026|12277890|FG003|Overall Study|Other|0
7813370|NCT01196026|12277891|FG004|Overall Study|Other|0
7813371|NCT01196026|12277892|FG005|Overall Study|Other|0
7813372|NCT01196052|12277908|FG000|Overall Study|Adverse Event|9
7813373|NCT01196052|12277908|FG000|Overall Study|Lost to Follow-up|1
7813374|NCT01196052|12277908|FG000|Overall Study|Noncompliance to Protocol Requirements|2
7813375|NCT01196052|12277908|FG000|Overall Study|Reason not Specified|5
7813376|NCT01196052|12277908|FG000|Overall Study|Withdrawal by Subject|6
7813377|NCT01196078|12277914|FG000|Overall Study|Withdrawal by Subject|3
7813378|NCT01196078|12277915|FG001|Overall Study|Withdrawal by Subject|5
7813379|NCT01196078|12277914|FG000|Overall Study|Adverse Event|4
7813380|NCT01196078|12277915|FG001|Overall Study|Adverse Event|4
7813381|NCT01196078|12277914|FG000|Overall Study|Protocol Violation|2
7813382|NCT01196078|12277915|FG001|Overall Study|Protocol Violation|1
7813383|NCT01196078|12277914|FG000|Overall Study|Lack of Efficacy|17
7813384|NCT01196078|12277915|FG001|Overall Study|Lack of Efficacy|23
7813385|NCT01196078|12277914|FG000|Overall Study|Lost to Follow-up|1
7813386|NCT01196078|12277915|FG001|Overall Study|Lost to Follow-up|0
7813387|NCT01196078|12277914|FG000|Overall Study|Death|6
7813388|NCT01196078|12277915|FG001|Overall Study|Death|4
7813389|NCT01196091|12277924|FG000|Overall Study|Adverse Event|22
7813390|NCT01196091|12277925|FG001|Overall Study|Adverse Event|27
7813391|NCT01196091|12277926|FG002|Overall Study|Adverse Event|26
7813392|NCT01196091|12277924|FG000|Overall Study|Death|3
7813393|NCT01196091|12277925|FG001|Overall Study|Death|2
7813394|NCT01196091|12277926|FG002|Overall Study|Death|2
7813395|NCT01196091|12277924|FG000|Overall Study|Entry Criteria Not Met|11
7813396|NCT01196091|12277925|FG001|Overall Study|Entry Criteria Not Met|11
7813397|NCT01196091|12277926|FG002|Overall Study|Entry Criteria Not Met|10
7813398|NCT01196091|12277924|FG000|Overall Study|Lack of Efficacy|15
7813399|NCT01196091|12277925|FG001|Overall Study|Lack of Efficacy|12
7813400|NCT01196091|12277926|FG002|Overall Study|Lack of Efficacy|17
7813401|NCT01196091|12277924|FG000|Overall Study|Lost to Follow-up|5
7813402|NCT01196091|12277925|FG001|Overall Study|Lost to Follow-up|5
7813403|NCT01196091|12277926|FG002|Overall Study|Lost to Follow-up|6
7813404|NCT01196091|12277924|FG000|Overall Study|Parent/Caregiver Decision|0
7813405|NCT01196091|12277925|FG001|Overall Study|Parent/Caregiver Decision|0
7813406|NCT01196091|12277926|FG002|Overall Study|Parent/Caregiver Decision|1
7813407|NCT01196091|12277924|FG000|Overall Study|Withdrawal by Subject|16
7813408|NCT01196091|12277925|FG001|Overall Study|Withdrawal by Subject|19
7813409|NCT01196091|12277926|FG002|Overall Study|Withdrawal by Subject|22
7813410|NCT01196091|12277924|FG000|Overall Study|Physician Decision|3
7813411|NCT01196091|12277925|FG001|Overall Study|Physician Decision|3
7813412|NCT01196091|12277926|FG002|Overall Study|Physician Decision|4
7813413|NCT01196091|12277924|FG000|Overall Study|Protocol Violation|1
7813414|NCT01196091|12277925|FG001|Overall Study|Protocol Violation|3
7813415|NCT01196091|12277926|FG002|Overall Study|Protocol Violation|3
7813416|NCT01196091|12277924|FG000|Overall Study|Sponsor Decision|6
7813417|NCT01196091|12277925|FG001|Overall Study|Sponsor Decision|5
7813418|NCT01196091|12277926|FG002|Overall Study|Sponsor Decision|4
7813419|NCT01196091|12277924|FG000|Overall Study|Excluded Site|5
7813420|NCT01196091|12277925|FG001|Overall Study|Excluded Site|11
7813421|NCT01196091|12277926|FG002|Overall Study|Excluded Site|8
7813422|NCT01196091|12277924|FG000|Overall Study|Randomized, No Study Drug Received|1
7813423|NCT01196091|12277925|FG001|Overall Study|Randomized, No Study Drug Received|0
7813424|NCT01196091|12277926|FG002|Overall Study|Randomized, No Study Drug Received|1
7813425|NCT01196104|12277941|FG000|Overall Study|Lost to Follow-up|1
7813426|NCT01196104|12277942|FG001|Overall Study|Lost to Follow-up|0
7813427|NCT01196104|12277941|FG000|Overall Study|Physician Decision|0
7813428|NCT01196104|12277942|FG001|Overall Study|Physician Decision|1
7813429|NCT01196104|12277941|FG000|Overall Study|Withdrawal by Subject|3
7909440|NCT02039674|12425251|FG004|Overall Study|Lost to Follow-up|0
7909441|NCT02039674|12425252|FG005|Overall Study|Lost to Follow-up|0
7909442|NCT02039674|12425253|FG006|Overall Study|Lost to Follow-up|0
7909443|NCT02039674|12425254|FG007|Overall Study|Lost to Follow-up|0
7909444|NCT02039674|12425255|FG008|Overall Study|Lost to Follow-up|0
7909445|NCT02039674|12425256|FG009|Overall Study|Lost to Follow-up|0
7909446|NCT02039674|12425257|FG010|Overall Study|Lost to Follow-up|0
7909447|NCT02039674|12425258|FG011|Overall Study|Lost to Follow-up|0
7909448|NCT02039674|12425259|FG012|Overall Study|Lost to Follow-up|1
7909449|NCT02039674|12425260|FG013|Overall Study|Lost to Follow-up|0
7909450|NCT02039674|12425247|FG000|Overall Study|Physician Decision|0
7909451|NCT02039674|12425248|FG001|Overall Study|Physician Decision|0
7909452|NCT02039674|12425249|FG002|Overall Study|Physician Decision|0
7909453|NCT02039674|12425250|FG003|Overall Study|Physician Decision|0
7909454|NCT02039674|12425251|FG004|Overall Study|Physician Decision|0
7909455|NCT02039674|12425252|FG005|Overall Study|Physician Decision|0
7909456|NCT02039674|12425253|FG006|Overall Study|Physician Decision|0
7909457|NCT02039674|12425254|FG007|Overall Study|Physician Decision|0
7909458|NCT02039674|12425255|FG008|Overall Study|Physician Decision|0
7909459|NCT02039674|12425256|FG009|Overall Study|Physician Decision|0
7909460|NCT02039674|12425257|FG010|Overall Study|Physician Decision|0
7909461|NCT02039674|12425258|FG011|Overall Study|Physician Decision|1
7909462|NCT02039674|12425259|FG012|Overall Study|Physician Decision|0
7909463|NCT02039674|12425260|FG013|Overall Study|Physician Decision|0
7909464|NCT02039674|12425247|FG000|Overall Study|Progressive Disease|6
7909465|NCT02039674|12425248|FG001|Overall Study|Progressive Disease|7
7909466|NCT02039674|12425249|FG002|Overall Study|Progressive Disease|6
7909467|NCT02039674|12425250|FG003|Overall Study|Progressive Disease|7
7909468|NCT02039674|12425251|FG004|Overall Study|Progressive Disease|8
7909469|NCT02039674|12425252|FG005|Overall Study|Progressive Disease|10
7909470|NCT02039674|12425253|FG006|Overall Study|Progressive Disease|1
7909471|NCT02039674|12425254|FG007|Overall Study|Progressive Disease|3
7909472|NCT02039674|12425255|FG008|Overall Study|Progressive Disease|7
7909473|NCT02039674|12425256|FG009|Overall Study|Progressive Disease|2
7909474|NCT02039674|12425257|FG010|Overall Study|Progressive Disease|0
7909475|NCT02039674|12425258|FG011|Overall Study|Progressive Disease|17
7909476|NCT02039674|12425259|FG012|Overall Study|Progressive Disease|18
7909477|NCT02039674|12425260|FG013|Overall Study|Progressive Disease|16
7909478|NCT02039674|12425247|FG000|Overall Study|Withdrawal by Subject|0
7909479|NCT02039674|12425248|FG001|Overall Study|Withdrawal by Subject|2
7909480|NCT02039674|12425249|FG002|Overall Study|Withdrawal by Subject|1
7909481|NCT02039674|12425250|FG003|Overall Study|Withdrawal by Subject|0
7909482|NCT02039674|12425251|FG004|Overall Study|Withdrawal by Subject|1
7909483|NCT02039674|12425252|FG005|Overall Study|Withdrawal by Subject|0
7909484|NCT02039674|12425253|FG006|Overall Study|Withdrawal by Subject|0
7909485|NCT02039674|12425254|FG007|Overall Study|Withdrawal by Subject|0
7909486|NCT02039674|12425255|FG008|Overall Study|Withdrawal by Subject|0
7909487|NCT02039674|12425256|FG009|Overall Study|Withdrawal by Subject|2
7909488|NCT02039674|12425257|FG010|Overall Study|Withdrawal by Subject|1
7909489|NCT02039674|12425258|FG011|Overall Study|Withdrawal by Subject|3
7909490|NCT02039674|12425259|FG012|Overall Study|Withdrawal by Subject|5
7909491|NCT02039674|12425260|FG013|Overall Study|Withdrawal by Subject|2
7909492|NCT02039674|12425247|FG000|Overall Study|Ongoing in Study|5
7909493|NCT02039674|12425248|FG001|Overall Study|Ongoing in Study|2
7909494|NCT02039674|12425249|FG002|Overall Study|Ongoing in Study|3
7909495|NCT02039674|12425250|FG003|Overall Study|Ongoing in Study|2
7909496|NCT02039674|12425251|FG004|Overall Study|Ongoing in Study|3
7909497|NCT02039674|12425252|FG005|Overall Study|Ongoing in Study|1
7909498|NCT02039674|12425253|FG006|Overall Study|Ongoing in Study|2
7909499|NCT02039674|12425254|FG007|Overall Study|Ongoing in Study|0
7909500|NCT02039674|12425255|FG008|Overall Study|Ongoing in Study|1
7909501|NCT02039674|12425256|FG009|Overall Study|Ongoing in Study|6
7909502|NCT02039674|12425257|FG010|Overall Study|Ongoing in Study|1
7909503|NCT02039674|12425258|FG011|Overall Study|Ongoing in Study|34
7909504|NCT02039674|12425259|FG012|Overall Study|Ongoing in Study|33
7909505|NCT02039674|12425260|FG013|Overall Study|Ongoing in Study|3
7909506|NCT02039687|12425297|FG000|Overall Study|Adverse Event|0
7909507|NCT02039687|12425298|FG001|Overall Study|Adverse Event|0
7909508|NCT02039687|12425299|FG002|Overall Study|Adverse Event|1
7909509|NCT02039687|12425300|FG003|Overall Study|Adverse Event|0
7909510|NCT02039687|12425297|FG000|Overall Study|Withdrawal by Subject|0
7909511|NCT02039687|12425298|FG001|Overall Study|Withdrawal by Subject|1
7909512|NCT02039687|12425299|FG002|Overall Study|Withdrawal by Subject|0
7909513|NCT02039687|12425300|FG003|Overall Study|Withdrawal by Subject|0
7909514|NCT02039687|12425297|FG000|Overall Study|treatment assignment could not be confir|0
7909515|NCT02039687|12425298|FG001|Overall Study|treatment assignment could not be confir|0
7909516|NCT02039687|12425299|FG002|Overall Study|treatment assignment could not be confir|2
7909517|NCT02039687|12425300|FG003|Overall Study|treatment assignment could not be confir|0
7909518|NCT02039778|12425319|FG000|Overall Study|Death|2
7909519|NCT02039778|12425319|FG000|Overall Study|Withdrawal by Subject|1
7909520|NCT02039778|12425319|FG000|Overall Study|Never started the protocol treatment|1
7909521|NCT02039856|12425333|FG000|Overall Study|Death|5
7909522|NCT02039856|12425334|FG001|Overall Study|Death|3
7909523|NCT02039856|12425333|FG000|Overall Study|Partial survey completion|61
7909524|NCT02039856|12425334|FG001|Overall Study|Partial survey completion|26
7909525|NCT02039856|12425333|FG000|Overall Study|Lost to Follow-up|388
7909526|NCT02039856|12425334|FG001|Overall Study|Lost to Follow-up|206
7909527|NCT02039856|12425333|FG000|Overall Study|Withdrawal by Subject|1573
7909528|NCT02039856|12425334|FG001|Overall Study|Withdrawal by Subject|618
7909529|NCT02039908|12425342|FG000|Phase 1-Summer|Withdrawal by Subject|7
7909530|NCT02039908|12425343|FG001|Phase 1-Summer|Withdrawal by Subject|6
7909531|NCT02039908|12425344|FG002|Phase 1-Summer|Withdrawal by Subject|0
7909532|NCT02039908|12425345|FG003|Phase 1-Summer|Withdrawal by Subject|0
7909533|NCT02039908|12425342|FG000|Phase 1-Summer|Protocol Violation|6
7909534|NCT02039908|12425343|FG001|Phase 1-Summer|Protocol Violation|0
7909535|NCT02039908|12425344|FG002|Phase 1-Summer|Protocol Violation|0
7909536|NCT02039908|12425345|FG003|Phase 1-Summer|Protocol Violation|0
7909537|NCT02039908|12425342|FG000|Phase 2-School Year|Lost to Follow-up|0
7909538|NCT02039908|12425343|FG001|Phase 2-School Year|Lost to Follow-up|0
7909539|NCT02039908|12425344|FG002|Phase 2-School Year|Lost to Follow-up|1
7909540|NCT02039908|12425345|FG003|Phase 2-School Year|Lost to Follow-up|3
7909541|NCT02039908|12425342|FG000|Phase 2-School Year|Protocol Violation|0
7909542|NCT02039908|12425343|FG001|Phase 2-School Year|Protocol Violation|0
7909543|NCT02039908|12425344|FG002|Phase 2-School Year|Protocol Violation|3
7909544|NCT02039908|12425345|FG003|Phase 2-School Year|Protocol Violation|0
7909545|NCT02039908|12425342|FG000|Phase 2-School Year|Withdrawal by Subject|0
7909546|NCT02039908|12425343|FG001|Phase 2-School Year|Withdrawal by Subject|0
7909547|NCT02039908|12425344|FG002|Phase 2-School Year|Withdrawal by Subject|8
7909548|NCT02039908|12425345|FG003|Phase 2-School Year|Withdrawal by Subject|5
7909549|NCT02040090|12425390|FG000|Overall Study|Adverse Event|2
7909550|NCT02040090|12425391|FG001|Overall Study|Adverse Event|0
7909551|NCT02040090|12425390|FG000|Overall Study|Physician Decision|1
7909552|NCT02040090|12425391|FG001|Overall Study|Physician Decision|0
7909553|NCT02040090|12425390|FG000|Overall Study|Withdrawal by Subject|0
7909554|NCT02040090|12425391|FG001|Overall Study|Withdrawal by Subject|1
7909555|NCT02040090|12425390|FG000|Overall Study|Lost to Follow-up|0
7909556|NCT02040090|12425391|FG001|Overall Study|Lost to Follow-up|1
7909557|NCT02040259|12425405|FG000|Overall Study|Death|280
7909558|NCT02040259|12425405|FG000|Overall Study|Lost to Follow-up|76
7909559|NCT02040259|12425405|FG000|Overall Study|Assessment not completed|3
7909560|NCT02040259|12425405|FG000|Overall Study|Withdrawal by Subject|4
7909561|NCT02040428|12425428|FG000|Overall Study|Death|4
7909562|NCT02040428|12425429|FG001|Overall Study|Death|3
7909563|NCT02040428|12425428|FG000|Overall Study|Withdrawal by Subject|1
7909564|NCT02040428|12425429|FG001|Overall Study|Withdrawal by Subject|1
7909565|NCT02040532|12425435|FG000|Overall Study|Lost to Follow-up|1
7909566|NCT02040532|12425435|FG000|Overall Study|Physician Decision|4
7909567|NCT02040532|12425435|FG000|Overall Study|Adverse Event|4
7909568|NCT02040532|12425435|FG000|Overall Study|Withdrawal by Subject|3
7909569|NCT02040766|12425457|FG000|Overall Study|Adverse Event|1
7909570|NCT02040766|12425458|FG001|Overall Study|Adverse Event|1
7909571|NCT02040766|12425459|FG002|Overall Study|Adverse Event|1
7909572|NCT02040766|12425460|FG003|Overall Study|Adverse Event|0
7909573|NCT02040766|12425461|FG004|Overall Study|Adverse Event|2
7909574|NCT02040766|12425457|FG000|Overall Study|Withdrawal by Subject|4
7909575|NCT02040766|12425458|FG001|Overall Study|Withdrawal by Subject|3
7813430|NCT01196104|12277942|FG001|Overall Study|Withdrawal by Subject|3
7813431|NCT01196104|12277941|FG000|Overall Study|Various|0
7813432|NCT01196104|12277942|FG001|Overall Study|Various|1
7813433|NCT01196416|12277978|FG000|Overall Study|Withdrawal by Subject|2
7813434|NCT01196429|12277984|FG000|Overall Study|Ineligible - inadequate pathology|1
7813435|NCT01196429|12277985|FG001|Overall Study|Ineligible - inadequate pathology|0
7813436|NCT01196429|12277984|FG000|Overall Study|Ineligible - wrong cell type|1
7813437|NCT01196429|12277985|FG001|Overall Study|Ineligible - wrong cell type|0
7813438|NCT01196429|12277984|FG000|Overall Study|Refused - Never Treated|1
7813439|NCT01196429|12277985|FG001|Overall Study|Refused - Never Treated|0
7813440|NCT01196741|12278004|FG000|Overall Study|Disease progression|34
7813441|NCT01196741|12278005|FG001|Overall Study|Disease progression|14
7813442|NCT01196741|12278004|FG000|Overall Study|Adverse Event|10
7813443|NCT01196741|12278005|FG001|Overall Study|Adverse Event|6
7813444|NCT01196741|12278004|FG000|Overall Study|Serious Adverse Event|3
7909576|NCT02040766|12425459|FG002|Overall Study|Withdrawal by Subject|2
7909577|NCT02040766|12425460|FG003|Overall Study|Withdrawal by Subject|3
7909578|NCT02040766|12425461|FG004|Overall Study|Withdrawal by Subject|2
7909579|NCT02040766|12425457|FG000|Overall Study|Non-compliance|0
7909580|NCT02040766|12425458|FG001|Overall Study|Non-compliance|1
7909581|NCT02040766|12425459|FG002|Overall Study|Non-compliance|0
7719341|NCT00531752|12143324|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1
7719342|NCT00531752|12143321|FG000|First Double-blind Intervention Period|Lost to Follow-up|0
7909582|NCT02040766|12425460|FG003|Overall Study|Non-compliance|0
7909583|NCT02040766|12425461|FG004|Overall Study|Non-compliance|0
7909584|NCT02040766|12425457|FG000|Overall Study|Protocol Violation|2
7909585|NCT02040766|12425458|FG001|Overall Study|Protocol Violation|1
7909586|NCT02040766|12425459|FG002|Overall Study|Protocol Violation|2
7909587|NCT02040766|12425460|FG003|Overall Study|Protocol Violation|3
7909588|NCT02040766|12425461|FG004|Overall Study|Protocol Violation|0
7909589|NCT02040766|12425457|FG000|Overall Study|Lost to Follow-up|4
7909590|NCT02040766|12425458|FG001|Overall Study|Lost to Follow-up|1
7909591|NCT02040766|12425459|FG002|Overall Study|Lost to Follow-up|3
7909592|NCT02040766|12425460|FG003|Overall Study|Lost to Follow-up|1
7909593|NCT02040766|12425461|FG004|Overall Study|Lost to Follow-up|4
7909594|NCT02040766|12425457|FG000|Overall Study|Not reported|1
7909595|NCT02040766|12425458|FG001|Overall Study|Not reported|0
7909596|NCT02040766|12425459|FG002|Overall Study|Not reported|0
7909597|NCT02040766|12425460|FG003|Overall Study|Not reported|0
7909598|NCT02040766|12425461|FG004|Overall Study|Not reported|0
7909599|NCT02040766|12425457|FG000|Overall Study|Lack of Efficacy|6
7909600|NCT02040766|12425458|FG001|Overall Study|Lack of Efficacy|3
7909601|NCT02040766|12425459|FG002|Overall Study|Lack of Efficacy|4
7909602|NCT02040766|12425460|FG003|Overall Study|Lack of Efficacy|6
7909603|NCT02040766|12425461|FG004|Overall Study|Lack of Efficacy|5
7909604|NCT02040779|12425477|FG000|Overall Study|Adverse Event|1
7909605|NCT02040779|12425478|FG001|Overall Study|Adverse Event|0
7909606|NCT02040779|12425479|FG002|Overall Study|Adverse Event|0
7909607|NCT02040779|12425477|FG000|Overall Study|Withdrawal by Subject|4
7909608|NCT02040779|12425478|FG001|Overall Study|Withdrawal by Subject|1
7909609|NCT02040779|12425479|FG002|Overall Study|Withdrawal by Subject|3
7909610|NCT02040779|12425477|FG000|Overall Study|Non-compliance|0
7909611|NCT02040779|12425478|FG001|Overall Study|Non-compliance|1
7909612|NCT02040779|12425479|FG002|Overall Study|Non-compliance|0
7909613|NCT02040779|12425477|FG000|Overall Study|Protocol Violation|2
7909614|NCT02040779|12425478|FG001|Overall Study|Protocol Violation|1
7909615|NCT02040779|12425479|FG002|Overall Study|Protocol Violation|0
7909616|NCT02040779|12425477|FG000|Overall Study|Lost to Follow-up|1
7909617|NCT02040779|12425478|FG001|Overall Study|Lost to Follow-up|2
7909618|NCT02040779|12425479|FG002|Overall Study|Lost to Follow-up|1
7909619|NCT02040779|12425477|FG000|Overall Study|Lack of Efficacy|4
7909620|NCT02040779|12425478|FG001|Overall Study|Lack of Efficacy|2
7909621|NCT02040779|12425479|FG002|Overall Study|Lack of Efficacy|0
7909622|NCT02040805|12425489|FG000|Overall Study|Lost to Follow-up|14
7909623|NCT02040805|12425490|FG001|Overall Study|Lost to Follow-up|9
7909624|NCT02040805|12425489|FG000|Overall Study|Withdrawal by Subject|28
7909625|NCT02040805|12425490|FG001|Overall Study|Withdrawal by Subject|41
7909626|NCT02040844|12425499|FG000|Overall Study|Adverse Event|0
7909627|NCT02040844|12425500|FG001|Overall Study|Adverse Event|0
7909628|NCT02040844|12425501|FG002|Overall Study|Adverse Event|1
7909629|NCT02040844|12425499|FG000|Overall Study|Withdrawal by Subject|16
7909630|NCT02040844|12425500|FG001|Overall Study|Withdrawal by Subject|22
7909631|NCT02040844|12425501|FG002|Overall Study|Withdrawal by Subject|25
7909632|NCT02040844|12425499|FG000|Overall Study|Lost to Follow-up|12
7909633|NCT02040844|12425500|FG001|Overall Study|Lost to Follow-up|9
7909634|NCT02040844|12425501|FG002|Overall Study|Lost to Follow-up|13
7909635|NCT02040844|12425499|FG000|Overall Study|Missing|13
7909636|NCT02040844|12425500|FG001|Overall Study|Missing|3
7909637|NCT02040844|12425501|FG002|Overall Study|Missing|2
7909638|NCT02040844|12425499|FG000|Overall Study|Non-specified|8
7909639|NCT02040844|12425500|FG001|Overall Study|Non-specified|2
7909640|NCT02040844|12425501|FG002|Overall Study|Non-specified|5
7909641|NCT02040844|12425499|FG000|Overall Study|Concomitant medication|1
7909642|NCT02040844|12425500|FG001|Overall Study|Concomitant medication|3
7909643|NCT02040844|12425501|FG002|Overall Study|Concomitant medication|1
7909644|NCT02040870|12425509|FG000|Overall Study|Completed treatment phase|6
7909645|NCT02040870|12425509|FG000|Overall Study|Adverse Event|7
7909646|NCT02040870|12425509|FG000|Overall Study|Progressive disease|58
7909647|NCT02040870|12425509|FG000|Overall Study|Physician Decision|6
7909648|NCT02040870|12425509|FG000|Overall Study|Subject/guardian decision|10
7909649|NCT02040870|12425509|FG000|Overall Study|Lost to Follow-up|3
7909650|NCT02040870|12425509|FG000|Overall Study|Death|13
7909651|NCT02041091|12425515|FG000|Treatment|Adverse Event|3
7909652|NCT02041091|12425516|FG001|Treatment|Adverse Event|3
7909653|NCT02041091|12425515|FG000|Treatment|Withdrawal by Subject|2
7813445|NCT01196741|12278005|FG001|Overall Study|Serious Adverse Event|1
7909654|NCT02041091|12425516|FG001|Treatment|Withdrawal by Subject|4
7909655|NCT02041091|12425515|FG000|Treatment|Physician Decision|1
7909656|NCT02041091|12425516|FG001|Treatment|Physician Decision|0
7909657|NCT02041091|12425515|FG000|Treatment|Sponsor Decision|15
7909658|NCT02041091|12425516|FG001|Treatment|Sponsor Decision|16
7909659|NCT02041091|12425515|FG000|Treatment|Lost to Follow-up|1
7909660|NCT02041091|12425516|FG001|Treatment|Lost to Follow-up|0
7909661|NCT02041091|12425515|FG000|Optional Safety Extension Period|Adverse Event|4
7909662|NCT02041091|12425516|FG001|Optional Safety Extension Period|Adverse Event|2
7909663|NCT02041091|12425515|FG000|Optional Safety Extension Period|Withdrawal by Subject|5
7719343|NCT00531752|12143322|FG001|First Double-blind Intervention Period|Lost to Follow-up|0
7719344|NCT00531752|12143323|FG002|First Double-blind Intervention Period|Lost to Follow-up|1
7719345|NCT00531752|12143324|FG003|First Double-blind Intervention Period|Lost to Follow-up|1
7719346|NCT00531752|12143321|FG000|First Double-blind Intervention Period|Randomized but not treated|1
7719347|NCT00531752|12143322|FG001|First Double-blind Intervention Period|Randomized but not treated|0
7719348|NCT00531752|12143323|FG002|First Double-blind Intervention Period|Randomized but not treated|0
7719349|NCT00531752|12143324|FG003|First Double-blind Intervention Period|Randomized but not treated|0
7719350|NCT00531752|12143321|FG000|Second Double-blind Intervention Period|Adverse Event|1
7719351|NCT00531752|12143322|FG001|Second Double-blind Intervention Period|Adverse Event|1
7719352|NCT00531752|12143323|FG002|Second Double-blind Intervention Period|Adverse Event|0
7719353|NCT00531752|12143324|FG003|Second Double-blind Intervention Period|Adverse Event|0
7719354|NCT00531752|12143321|FG000|Second Double-blind Intervention Period|Other|1
7719355|NCT00531752|12143322|FG001|Second Double-blind Intervention Period|Other|1
7813446|NCT01196741|12278004|FG000|Overall Study|Dose limiting Adverse Event|2
7813447|NCT01196741|12278005|FG001|Overall Study|Dose limiting Adverse Event|1
7813448|NCT01196741|12278004|FG000|Overall Study|Withdrawal by Subject|3
7813449|NCT01196741|12278005|FG001|Overall Study|Withdrawal by Subject|0
7813450|NCT01196741|12278004|FG000|Overall Study|Other reason|3
7813451|NCT01196741|12278005|FG001|Overall Study|Other reason|3
7813452|NCT01196741|12278004|FG000|Overall Study|Other|3
7813453|NCT01196741|12278005|FG001|Overall Study|Other|2
7813454|NCT01196741|12278004|FG000|Overall Study|Protocol Violation|2
7813455|NCT01196741|12278005|FG001|Overall Study|Protocol Violation|1
7813456|NCT01196975|12278067|FG000|Overall Study|Adverse Event|2
7813457|NCT01196975|12278068|FG001|Overall Study|Adverse Event|2
7813458|NCT01196975|12278069|FG002|Overall Study|Adverse Event|0
7813459|NCT01196975|12278070|FG003|Overall Study|Adverse Event|0
7813460|NCT01196975|12278071|FG004|Overall Study|Adverse Event|2
7813461|NCT01196975|12278067|FG000|Overall Study|Withdrawal by Subject|2
7813462|NCT01196975|12278068|FG001|Overall Study|Withdrawal by Subject|1
7813463|NCT01196975|12278069|FG002|Overall Study|Withdrawal by Subject|0
7909664|NCT02041091|12425516|FG001|Optional Safety Extension Period|Withdrawal by Subject|2
7909665|NCT02041091|12425515|FG000|Optional Safety Extension Period|Protocol Violation|2
7909666|NCT02041091|12425516|FG001|Optional Safety Extension Period|Protocol Violation|0
7909667|NCT02041091|12425515|FG000|Optional Safety Extension Period|Physician Decision|2
7909668|NCT02041091|12425516|FG001|Optional Safety Extension Period|Physician Decision|1
7909669|NCT02041091|12425515|FG000|Optional Safety Extension Period|Sponsor Decision|70
7909670|NCT02041091|12425516|FG001|Optional Safety Extension Period|Sponsor Decision|74
7909671|NCT02041091|12425515|FG000|Optional Safety Extension Period|Lost to Follow-up|2
7909672|NCT02041091|12425516|FG001|Optional Safety Extension Period|Lost to Follow-up|3
7909673|NCT02041104|12425530|FG000|Overall Study|Lost to Follow-up|1
7909674|NCT02041104|12425531|FG001|Overall Study|Lost to Follow-up|4
7909675|NCT02041104|12425530|FG000|Overall Study|discomfort during OGTT|0
7909676|NCT02041104|12425531|FG001|Overall Study|discomfort during OGTT|3
7909677|NCT02041286|12425564|FG000|Overall Study|Adverse Event|1
7909678|NCT02041299|12425572|FG000|Overall Study|Adverse Event|9
7909679|NCT02041299|12425573|FG001|Overall Study|Adverse Event|3
7909680|NCT02041299|12425572|FG000|Overall Study|Lost to Follow-up|4
7909681|NCT02041299|12425573|FG001|Overall Study|Lost to Follow-up|1
7909682|NCT02041299|12425572|FG000|Overall Study|Physician Decision|1
7909683|NCT02041299|12425573|FG001|Overall Study|Physician Decision|1
7909684|NCT02041299|12425572|FG000|Overall Study|Withdrawal by Subject|13
7909685|NCT02041299|12425573|FG001|Overall Study|Withdrawal by Subject|7
7909686|NCT02041299|12425572|FG000|Overall Study|Protocol Violation|11
7909687|NCT02041299|12425573|FG001|Overall Study|Protocol Violation|4
7909688|NCT02041299|12425572|FG000|Overall Study|Termination of the study|7
7909689|NCT02041299|12425573|FG001|Overall Study|Termination of the study|3
7909690|NCT02041299|12425572|FG000|Overall Study|Required bone marrow transplant|0
7909691|NCT02041299|12425573|FG001|Overall Study|Required bone marrow transplant|1
7909692|NCT02041299|12425572|FG000|Overall Study|Patient stopped dosing on unknown date|1
7909693|NCT02041299|12425573|FG001|Overall Study|Patient stopped dosing on unknown date|0
7909694|NCT02041429|12425604|FG000|Overall Study|Progressive Disease|2
7909695|NCT02041429|12425605|FG001|Overall Study|Progressive Disease|2
7909696|NCT02041429|12425606|FG002|Overall Study|Progressive Disease|3
7909697|NCT02041429|12425607|FG003|Overall Study|Progressive Disease|2
7909698|NCT02041429|12425604|FG000|Overall Study|Toxicity|0
7909699|NCT02041429|12425605|FG001|Overall Study|Toxicity|1
7909700|NCT02041429|12425606|FG002|Overall Study|Toxicity|4
7719356|NCT00531752|12143323|FG002|Second Double-blind Intervention Period|Other|0
7719357|NCT00531752|12143324|FG003|Second Double-blind Intervention Period|Other|0
7909701|NCT02041429|12425607|FG003|Overall Study|Toxicity|2
7909702|NCT02041429|12425604|FG000|Overall Study|Withdrawal by Subject|0
7909703|NCT02041429|12425605|FG001|Overall Study|Withdrawal by Subject|1
7909704|NCT02041429|12425606|FG002|Overall Study|Withdrawal by Subject|0
7909705|NCT02041429|12425607|FG003|Overall Study|Withdrawal by Subject|0
7909706|NCT02041429|12425604|FG000|Overall Study|On Maintenance Therapy|1
7909707|NCT02041429|12425605|FG001|Overall Study|On Maintenance Therapy|0
7909708|NCT02041429|12425606|FG002|Overall Study|On Maintenance Therapy|0
7909709|NCT02041429|12425607|FG003|Overall Study|On Maintenance Therapy|2
7909710|NCT02041494|12425624|FG000|Overall Study|Death|1
7813464|NCT01196975|12278070|FG003|Overall Study|Withdrawal by Subject|1
7813465|NCT01196975|12278071|FG004|Overall Study|Withdrawal by Subject|0
7813466|NCT01196975|12278067|FG000|Overall Study|Lost to Follow-up|11
7813467|NCT01196975|12278068|FG001|Overall Study|Lost to Follow-up|6
7813468|NCT01196975|12278069|FG002|Overall Study|Lost to Follow-up|5
7813469|NCT01196975|12278070|FG003|Overall Study|Lost to Follow-up|5
7813470|NCT01196975|12278071|FG004|Overall Study|Lost to Follow-up|11
7813471|NCT01196988|12278110|FG000|Overall Study|Adverse Event|1
7813472|NCT01196988|12278111|FG001|Overall Study|Adverse Event|2
7813473|NCT01196988|12278112|FG002|Overall Study|Adverse Event|0
7813474|NCT01196988|12278113|FG003|Overall Study|Adverse Event|0
7813475|NCT01196988|12278110|FG000|Overall Study|Withdrawal by Subject|5
7813476|NCT01196988|12278111|FG001|Overall Study|Withdrawal by Subject|1
7813477|NCT01196988|12278112|FG002|Overall Study|Withdrawal by Subject|4
7813478|NCT01196988|12278113|FG003|Overall Study|Withdrawal by Subject|0
7813479|NCT01196988|12278110|FG000|Overall Study|Lost to Follow-up|16
7813480|NCT01196988|12278111|FG001|Overall Study|Lost to Follow-up|29
7813481|NCT01196988|12278112|FG002|Overall Study|Lost to Follow-up|21
7813482|NCT01196988|12278113|FG003|Overall Study|Lost to Follow-up|1
7813483|NCT01196988|12278110|FG000|Overall Study|Other|2
7813484|NCT01196988|12278111|FG001|Overall Study|Other|0
7813485|NCT01196988|12278112|FG002|Overall Study|Other|0
7813486|NCT01196988|12278113|FG003|Overall Study|Other|0
7813487|NCT01197300|12278126|FG000|Overall Study|Lost to Follow-up|0
7813488|NCT01197300|12278127|FG001|Overall Study|Lost to Follow-up|1
7813489|NCT01197300|12278126|FG000|Overall Study|Protocol Violation|0
7813490|NCT01197300|12278127|FG001|Overall Study|Protocol Violation|1
7813491|NCT01197378|12278144|FG000|Overall Study|Adverse Event|3
7813492|NCT01197378|12278144|FG000|Overall Study|Withdrawal by Subject|1
7813493|NCT01197378|12278144|FG000|Overall Study|Physician Decision|1
7813494|NCT01197378|12278144|FG000|Overall Study|Other|2
7813495|NCT01197417|12278150|FG000|Overall Study|Physician Decision|3
7813496|NCT01197417|12278151|FG001|Overall Study|Physician Decision|2
7813497|NCT01197417|12278150|FG000|Overall Study|Withdrawal by Subject|2
7813498|NCT01197417|12278151|FG001|Overall Study|Withdrawal by Subject|4
7813499|NCT01197417|12278150|FG000|Overall Study|Site miscommunication|0
7813500|NCT01197417|12278151|FG001|Overall Study|Site miscommunication|1
7813501|NCT01197417|12278150|FG000|Overall Study|Subject transferred to intensive care|0
7813502|NCT01197417|12278151|FG001|Overall Study|Subject transferred to intensive care|1
7813503|NCT01197417|12278150|FG000|Overall Study|Not consented in time to receive drug|0
7813504|NCT01197417|12278151|FG001|Overall Study|Not consented in time to receive drug|1
7813505|NCT01197417|12278150|FG000|Overall Study|Hypotension|1
7813506|NCT01197417|12278151|FG001|Overall Study|Hypotension|2
7813507|NCT01197417|12278150|FG000|Overall Study|Found to be ineligible|2
7813508|NCT01197417|12278151|FG001|Overall Study|Found to be ineligible|5
7813509|NCT01197417|12278150|FG000|Overall Study|No 25-hour magnesium level|0
7813510|NCT01197417|12278151|FG001|Overall Study|No 25-hour magnesium level|2
7813511|NCT01197508|12278179|FG000|Overall Study|Withdrawal by Subject|8
7813512|NCT01197508|12278180|FG001|Overall Study|Withdrawal by Subject|7
7813513|NCT01197508|12278181|FG002|Overall Study|Withdrawal by Subject|15
7813514|NCT01197508|12278182|FG003|Overall Study|Withdrawal by Subject|4
7813515|NCT01197508|12278179|FG000|Overall Study|Eligiblity criteria not fulfilled|0
7813516|NCT01197508|12278180|FG001|Overall Study|Eligiblity criteria not fulfilled|0
7813517|NCT01197508|12278181|FG002|Overall Study|Eligiblity criteria not fulfilled|2
7813518|NCT01197508|12278182|FG003|Overall Study|Eligiblity criteria not fulfilled|0
7813519|NCT01197508|12278179|FG000|Overall Study|Adverse Event|10
7813520|NCT01197508|12278180|FG001|Overall Study|Adverse Event|13
7813521|NCT01197508|12278181|FG002|Overall Study|Adverse Event|23
7813522|NCT01197508|12278182|FG003|Overall Study|Adverse Event|3
7813523|NCT01197508|12278179|FG000|Overall Study|Severe non-compliance to protocol|0
7813524|NCT01197508|12278180|FG001|Overall Study|Severe non-compliance to protocol|3
7813525|NCT01197508|12278181|FG002|Overall Study|Severe non-compliance to protocol|1
7813526|NCT01197508|12278182|FG003|Overall Study|Severe non-compliance to protocol|3
7813527|NCT01197508|12278179|FG000|Overall Study|Condition under investigation worsened|1
7813528|NCT01197508|12278180|FG001|Overall Study|Condition under investigation worsened|1
7813529|NCT01197508|12278181|FG002|Overall Study|Condition under investigation worsened|1
7719358|NCT00531752|12143321|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0
7719359|NCT00531752|12143322|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0
7719360|NCT00531752|12143323|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0
7719361|NCT00531752|12143324|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1
7719362|NCT00531752|12143321|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0
7719363|NCT00531752|12143322|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0
7719364|NCT00531752|12143323|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0
7813530|NCT01197508|12278182|FG003|Overall Study|Condition under investigation worsened|1
7813531|NCT01197508|12278179|FG000|Overall Study|Lack of Efficacy|1
7813532|NCT01197508|12278180|FG001|Overall Study|Lack of Efficacy|2
7813533|NCT01197508|12278181|FG002|Overall Study|Lack of Efficacy|2
7813534|NCT01197508|12278182|FG003|Overall Study|Lack of Efficacy|1
7813535|NCT01197508|12278179|FG000|Overall Study|Study-specific withdrawal criteria|0
7813536|NCT01197508|12278180|FG001|Overall Study|Study-specific withdrawal criteria|0
7813537|NCT01197508|12278181|FG002|Overall Study|Study-specific withdrawal criteria|1
7813538|NCT01197508|12278182|FG003|Overall Study|Study-specific withdrawal criteria|2
7813539|NCT01197508|12278179|FG000|Overall Study|Lost to Follow-up|1
7813540|NCT01197508|12278180|FG001|Overall Study|Lost to Follow-up|1
7813541|NCT01197508|12278181|FG002|Overall Study|Lost to Follow-up|2
7813542|NCT01197508|12278182|FG003|Overall Study|Lost to Follow-up|0
7813543|NCT01197508|12278179|FG000|Overall Study|Other|2
7813544|NCT01197508|12278180|FG001|Overall Study|Other|3
7813545|NCT01197508|12278181|FG002|Overall Study|Other|2
7813546|NCT01197508|12278182|FG003|Overall Study|Other|2
7813547|NCT01197521|12278195|FG000|Overall Study|Not reported|24
7813548|NCT01197521|12278196|FG001|Overall Study|Not reported|25
7813549|NCT01197521|12278197|FG002|Overall Study|Not reported|21
7813550|NCT01197521|12278195|FG000|Overall Study|Enrolment in long term extension|42
7813551|NCT01197521|12278196|FG001|Overall Study|Enrolment in long term extension|36
7813552|NCT01197521|12278197|FG002|Overall Study|Enrolment in long term extension|87
7813553|NCT01197521|12278195|FG000|Overall Study|Severe non-compliance to protocol|1
7813554|NCT01197521|12278196|FG001|Overall Study|Severe non-compliance to protocol|3
7813555|NCT01197521|12278197|FG002|Overall Study|Severe non-compliance to protocol|3
7813556|NCT01197521|12278195|FG000|Overall Study|Lack of therapeutic response|2
7813557|NCT01197521|12278196|FG001|Overall Study|Lack of therapeutic response|3
7813558|NCT01197521|12278197|FG002|Overall Study|Lack of therapeutic response|4
7813559|NCT01197521|12278195|FG000|Overall Study|Dev. of study specific discont. criteria|6
7813560|NCT01197521|12278196|FG001|Overall Study|Dev. of study specific discont. criteria|16
7813561|NCT01197521|12278197|FG002|Overall Study|Dev. of study specific discont. criteria|2
7813562|NCT01197521|12278195|FG000|Overall Study|Lost to Follow-up|3
7813563|NCT01197521|12278196|FG001|Overall Study|Lost to Follow-up|2
7813564|NCT01197521|12278197|FG002|Overall Study|Lost to Follow-up|2
7813565|NCT01197521|12278195|FG000|Overall Study|Adverse Event|25
7813566|NCT01197521|12278196|FG001|Overall Study|Adverse Event|28
7813567|NCT01197521|12278197|FG002|Overall Study|Adverse Event|24
7813568|NCT01197534|12278211|FG000|Overall Study|Not reported|16
7813569|NCT01197534|12278212|FG001|Overall Study|Not reported|10
7813570|NCT01197534|12278213|FG002|Overall Study|Not reported|16
7813571|NCT01197534|12278211|FG000|Overall Study|Enrolment in long term extension|57
7813572|NCT01197534|12278212|FG001|Overall Study|Enrolment in long term extension|66
7813573|NCT01197534|12278213|FG002|Overall Study|Enrolment in long term extension|119
7813574|NCT01197534|12278211|FG000|Overall Study|Severe non-compliance to protocol|3
7813575|NCT01197534|12278212|FG001|Overall Study|Severe non-compliance to protocol|4
7813576|NCT01197534|12278213|FG002|Overall Study|Severe non-compliance to protocol|1
7813577|NCT01197534|12278211|FG000|Overall Study|Lack of therapeutic response|9
7813578|NCT01197534|12278212|FG001|Overall Study|Lack of therapeutic response|4
7813579|NCT01197534|12278213|FG002|Overall Study|Lack of therapeutic response|9
7813580|NCT01197534|12278211|FG000|Overall Study|Dev. of study specific discont. criteria|13
7813581|NCT01197534|12278212|FG001|Overall Study|Dev. of study specific discont. criteria|6
7813582|NCT01197534|12278213|FG002|Overall Study|Dev. of study specific discont. criteria|2
7813583|NCT01197534|12278211|FG000|Overall Study|Lost to Follow-up|1
7813584|NCT01197534|12278212|FG001|Overall Study|Lost to Follow-up|4
7813585|NCT01197534|12278213|FG002|Overall Study|Lost to Follow-up|2
7813586|NCT01197534|12278211|FG000|Overall Study|Adverse Event|35
7813587|NCT01197534|12278212|FG001|Overall Study|Adverse Event|36
7813588|NCT01197534|12278213|FG002|Overall Study|Adverse Event|24
7813589|NCT01197560|12278230|FG000|Overall Study|Adverse Event|6
7813590|NCT01197560|12278231|FG001|Overall Study|Adverse Event|8
7813591|NCT01197560|12278230|FG000|Overall Study|Death|3
7813592|NCT01197560|12278231|FG001|Overall Study|Death|5
7813593|NCT01197560|12278230|FG000|Overall Study|Withdrawal by Subject|1
7813594|NCT01197560|12278231|FG001|Overall Study|Withdrawal by Subject|1
7813595|NCT01197560|12278230|FG000|Overall Study|Disease progression|40
7813596|NCT01197560|12278231|FG001|Overall Study|Disease progression|35
7719365|NCT00531752|12143324|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1
7719366|NCT00531934|12143366|FG000|Overall Study|Adverse Event|4
7909711|NCT02041494|12425625|FG001|Overall Study|Death|3
7909712|NCT02041494|12425624|FG000|Overall Study|Lost to Follow-up|2
7909713|NCT02041494|12425625|FG001|Overall Study|Lost to Follow-up|6
7909714|NCT02041494|12425624|FG000|Overall Study|study terminated|16
7909715|NCT02041494|12425625|FG001|Overall Study|study terminated|11
7909716|NCT02041520|12425634|FG000|Overall Study|Adverse Event|2
7909717|NCT02041520|12425635|FG001|Overall Study|Adverse Event|1
7909718|NCT02041520|12425634|FG000|Overall Study|Withdrawal by Subject|3
7909719|NCT02041520|12425635|FG001|Overall Study|Withdrawal by Subject|4
7909720|NCT02041520|12425634|FG000|Overall Study|Protocol Violation|1
7909721|NCT02041520|12425635|FG001|Overall Study|Protocol Violation|0
7909722|NCT02041520|12425634|FG000|Overall Study|Lost to Follow-up|0
7909723|NCT02041520|12425635|FG001|Overall Study|Lost to Follow-up|1
7813597|NCT01197560|12278230|FG000|Overall Study|Miscellaneous|4
7813598|NCT01197560|12278231|FG001|Overall Study|Miscellaneous|3
7813599|NCT01197560|12278230|FG000|Overall Study|Missing|0
7813600|NCT01197560|12278231|FG001|Overall Study|Missing|1
7813601|NCT01197755|12278265|FG000|Overall Study|Adverse Event|8
7813602|NCT01197755|12278266|FG001|Overall Study|Adverse Event|10
7813603|NCT01197755|12278267|FG002|Overall Study|Adverse Event|10
7813604|NCT01197755|12278265|FG000|Overall Study|Study-specific discontinuation criteria|2
7813605|NCT01197755|12278266|FG001|Overall Study|Study-specific discontinuation criteria|1
7909724|NCT02041520|12425634|FG000|Overall Study|Hypothiroidism identified during follow-|0
7909725|NCT02041520|12425635|FG001|Overall Study|Hypothiroidism identified during follow-|1
7813606|NCT01197755|12278267|FG002|Overall Study|Study-specific discontinuation criteria|0
7813607|NCT01197755|12278265|FG000|Overall Study|Entered the long-term extension study|18
7813608|NCT01197755|12278266|FG001|Overall Study|Entered the long-term extension study|21
7813609|NCT01197755|12278267|FG002|Overall Study|Entered the long-term extension study|35
7813610|NCT01197755|12278265|FG000|Overall Study|Lack of therapeutic response|0
7813611|NCT01197755|12278266|FG001|Overall Study|Lack of therapeutic response|7
7813612|NCT01197755|12278267|FG002|Overall Study|Lack of therapeutic response|4
7813613|NCT01197755|12278265|FG000|Overall Study|Severe non-compliance to the protocol|2
7813614|NCT01197755|12278266|FG001|Overall Study|Severe non-compliance to the protocol|1
7813615|NCT01197755|12278267|FG002|Overall Study|Severe non-compliance to the protocol|2
7813616|NCT01197755|12278265|FG000|Overall Study|Withdrawal by Subject|1
7813617|NCT01197755|12278266|FG001|Overall Study|Withdrawal by Subject|0
7813618|NCT01197755|12278267|FG002|Overall Study|Withdrawal by Subject|0
7813619|NCT01197755|12278265|FG000|Overall Study|Lost to Follow-up|0
7813620|NCT01197755|12278266|FG001|Overall Study|Lost to Follow-up|0
7813621|NCT01197755|12278267|FG002|Overall Study|Lost to Follow-up|1
7813622|NCT01197755|12278265|FG000|Overall Study|eg, change in circumstances|7
7813623|NCT01197755|12278266|FG001|Overall Study|eg, change in circumstances|3
7813624|NCT01197755|12278267|FG002|Overall Study|eg, change in circumstances|2
7861910|NCT01597245|12351189|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7861911|NCT01597245|12351190|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7861912|NCT01597245|12351191|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7861913|NCT01597245|12351192|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
7861914|NCT01597245|12351193|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
7861915|NCT01597245|12351194|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
7861916|NCT01597245|12351195|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
7861917|NCT01597245|12351196|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
7861918|NCT01597245|12351197|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
7861919|NCT01597245|12351198|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
7861920|NCT01597245|12351199|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
7861921|NCT01597245|12351200|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
7861922|NCT01597245|12351201|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7861923|NCT01597245|12351202|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7861924|NCT01597245|12351203|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7861925|NCT01597245|12351204|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7861926|NCT01597245|12351205|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7861927|NCT01597245|12351206|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7861928|NCT01597245|12351207|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7861929|NCT01597245|12351208|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7861930|NCT01597245|12351188|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7861931|NCT01597245|12351189|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7861932|NCT01597245|12351190|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7861933|NCT01597245|12351191|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7861934|NCT01597245|12351192|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
7861935|NCT01597245|12351193|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
7861936|NCT01597245|12351194|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
7861937|NCT01597245|12351195|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7861938|NCT01597245|12351196|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
7861939|NCT01597245|12351197|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
7861940|NCT01597245|12351198|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
7861941|NCT01597245|12351199|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
7861942|NCT01597245|12351200|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
7861943|NCT01597245|12351201|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7861944|NCT01597245|12351202|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7861945|NCT01597245|12351203|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7861946|NCT01597245|12351204|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7861947|NCT01597245|12351205|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7861948|NCT01597245|12351206|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7861949|NCT01597245|12351207|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7861950|NCT01597245|12351208|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7861951|NCT01597245|12351188|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7861952|NCT01597245|12351189|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7861953|NCT01597245|12351190|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7861954|NCT01597245|12351191|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7861955|NCT01597245|12351192|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
7861956|NCT01597245|12351193|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7861957|NCT01597245|12351194|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7861958|NCT01597245|12351195|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7861959|NCT01597245|12351196|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
7813625|NCT01197794|12278284|FG000|Overall Study|Adverse Event|3
7813626|NCT01197794|12278285|FG001|Overall Study|Adverse Event|2
7813627|NCT01197794|12278286|FG002|Overall Study|Adverse Event|4
7813628|NCT01197794|12278287|FG003|Overall Study|Adverse Event|4
7813629|NCT01197794|12278288|FG004|Overall Study|Adverse Event|4
7813630|NCT01197794|12278289|FG005|Overall Study|Adverse Event|2
7813631|NCT01197794|12278290|FG006|Overall Study|Adverse Event|3
7813632|NCT01197794|12278284|FG000|Overall Study|Protocol Violation|0
7813633|NCT01197794|12278285|FG001|Overall Study|Protocol Violation|0
7813634|NCT01197794|12278286|FG002|Overall Study|Protocol Violation|0
7813635|NCT01197794|12278287|FG003|Overall Study|Protocol Violation|0
7813636|NCT01197794|12278288|FG004|Overall Study|Protocol Violation|2
7813637|NCT01197794|12278289|FG005|Overall Study|Protocol Violation|0
7813638|NCT01197794|12278290|FG006|Overall Study|Protocol Violation|1
7813639|NCT01197794|12278284|FG000|Overall Study|Development of study withdrawal criteria|3
7813640|NCT01197794|12278285|FG001|Overall Study|Development of study withdrawal criteria|0
7813641|NCT01197794|12278286|FG002|Overall Study|Development of study withdrawal criteria|0
7813642|NCT01197794|12278287|FG003|Overall Study|Development of study withdrawal criteria|1
7813643|NCT01197794|12278288|FG004|Overall Study|Development of study withdrawal criteria|0
7813644|NCT01197794|12278289|FG005|Overall Study|Development of study withdrawal criteria|0
7813645|NCT01197794|12278290|FG006|Overall Study|Development of study withdrawal criteria|1
7813646|NCT01197794|12278284|FG000|Overall Study|Eligibility criteria not fulfilled|5
7813647|NCT01197794|12278285|FG001|Overall Study|Eligibility criteria not fulfilled|8
7813648|NCT01197794|12278286|FG002|Overall Study|Eligibility criteria not fulfilled|2
7813649|NCT01197794|12278287|FG003|Overall Study|Eligibility criteria not fulfilled|5
7813650|NCT01197794|12278288|FG004|Overall Study|Eligibility criteria not fulfilled|5
7813651|NCT01197794|12278289|FG005|Overall Study|Eligibility criteria not fulfilled|9
7813652|NCT01197794|12278290|FG006|Overall Study|Eligibility criteria not fulfilled|6
7813653|NCT01197794|12278284|FG000|Overall Study|Withdrawal by Subject|3
7813654|NCT01197794|12278285|FG001|Overall Study|Withdrawal by Subject|3
7813655|NCT01197794|12278286|FG002|Overall Study|Withdrawal by Subject|4
7813656|NCT01197794|12278287|FG003|Overall Study|Withdrawal by Subject|1
7813657|NCT01197794|12278288|FG004|Overall Study|Withdrawal by Subject|1
7813658|NCT01197794|12278289|FG005|Overall Study|Withdrawal by Subject|5
7813659|NCT01197794|12278290|FG006|Overall Study|Withdrawal by Subject|6
7813660|NCT01197794|12278284|FG000|Overall Study|Lost to Follow-up|1
7813661|NCT01197794|12278285|FG001|Overall Study|Lost to Follow-up|1
7813662|NCT01197794|12278286|FG002|Overall Study|Lost to Follow-up|0
7813663|NCT01197794|12278287|FG003|Overall Study|Lost to Follow-up|1
7813664|NCT01197794|12278288|FG004|Overall Study|Lost to Follow-up|0
7813665|NCT01197794|12278289|FG005|Overall Study|Lost to Follow-up|1
7813666|NCT01197794|12278290|FG006|Overall Study|Lost to Follow-up|0
7909726|NCT02041702|12425645|FG000|Overall Study|Lost to Follow-up|1
7909727|NCT02041702|12425646|FG001|Overall Study|Lost to Follow-up|6
7909728|NCT02041702|12425645|FG000|Overall Study|Death|4
7909729|NCT02041702|12425646|FG001|Overall Study|Death|0
7909730|NCT02041702|12425645|FG000|Overall Study|Withdrawal by Subject|4
7909731|NCT02041702|12425646|FG001|Overall Study|Withdrawal by Subject|3
7909732|NCT02041702|12425645|FG000|Overall Study|Patient not confirmed as MRI compatible|1
7909733|NCT02041702|12425646|FG001|Overall Study|Patient not confirmed as MRI compatible|0
7909734|NCT02041702|12425645|FG000|Overall Study|Cardiac Resynchronization Therapy|1
7909735|NCT02041702|12425646|FG001|Overall Study|Cardiac Resynchronization Therapy|0
7909736|NCT02041923|12425654|FG000|Overall Study|Lost to Follow-up|26
7909737|NCT02041923|12425655|FG001|Overall Study|Lost to Follow-up|30
7909738|NCT02041962|12425665|FG000|Overall Study|Lost Aetna Coverage|43
7909739|NCT02041962|12425666|FG001|Overall Study|Lost Aetna Coverage|40
7909740|NCT02041962|12425665|FG000|Overall Study|Death|1
7909741|NCT02041962|12425666|FG001|Overall Study|Death|1
7813667|NCT01197794|12278284|FG000|Overall Study|Other|1
7813668|NCT01197794|12278285|FG001|Overall Study|Other|1
7813669|NCT01197794|12278286|FG002|Overall Study|Other|3
7813670|NCT01197794|12278287|FG003|Overall Study|Other|0
7813671|NCT01197794|12278288|FG004|Overall Study|Other|2
7813672|NCT01197794|12278289|FG005|Overall Study|Other|2
7813673|NCT01197794|12278290|FG006|Overall Study|Other|4
7813674|NCT01197911|12278332|FG000|Overall Study|Adverse Event|0
7813675|NCT01197911|12278333|FG001|Overall Study|Adverse Event|0
7813676|NCT01197911|12278334|FG002|Overall Study|Adverse Event|1
7813677|NCT01198002|12278346|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
7813678|NCT01198002|12278347|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
7813679|NCT01198002|12278348|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
7813680|NCT01198002|12278346|FG000|Treatment Period 1 (Weeks 0-52)|Death|2
7813681|NCT01198002|12278347|FG001|Treatment Period 1 (Weeks 0-52)|Death|0
7813682|NCT01198002|12278348|FG002|Treatment Period 1 (Weeks 0-52)|Death|1
7813683|NCT01198002|12278346|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
7813684|NCT01198002|12278347|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
7813685|NCT01198002|12278348|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
7813686|NCT01198002|12278346|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
7813687|NCT01198002|12278347|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
7813688|NCT01198002|12278348|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
7813689|NCT01198002|12278346|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
7813690|NCT01198002|12278347|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
7813691|NCT01198002|12278348|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
7813692|NCT01198002|12278346|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
7813693|NCT01198002|12278347|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
7813694|NCT01198002|12278348|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
7813695|NCT01198002|12278346|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
7813696|NCT01198002|12278347|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
7813697|NCT01198002|12278348|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
7813698|NCT01198002|12278346|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
7813699|NCT01198002|12278347|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
7813700|NCT01198002|12278348|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
7813701|NCT01198002|12278346|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
7813702|NCT01198002|12278347|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
7813703|NCT01198002|12278348|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
7813704|NCT01198002|12278346|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
7813705|NCT01198002|12278347|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
7813706|NCT01198002|12278348|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
7813707|NCT01198002|12278346|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
7813708|NCT01198002|12278347|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
7813709|NCT01198002|12278348|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
7813710|NCT01198002|12278346|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
7813711|NCT01198002|12278347|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
7813712|NCT01198002|12278348|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
7813713|NCT01198002|12278346|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
7813714|NCT01198002|12278347|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
7813715|NCT01198002|12278348|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
7813716|NCT01198002|12278346|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
7813717|NCT01198002|12278347|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
7813718|NCT01198002|12278348|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
7813719|NCT01198002|12278346|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
7813720|NCT01198002|12278347|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
7813721|NCT01198002|12278348|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
7813722|NCT01198028|12278378|FG000|Overall Study|Adverse Event|5
7813723|NCT01198028|12278378|FG000|Overall Study|Death|3
7813724|NCT01198028|12278378|FG000|Overall Study|Physician Decision|2
7813725|NCT01198132|12278384|FG000|Overall Study|Withdrawal by Subject|4
7813726|NCT01198132|12278385|FG001|Overall Study|Withdrawal by Subject|5
7813727|NCT01198132|12278384|FG000|Overall Study|Physician Decision|5
7813728|NCT01198132|12278385|FG001|Overall Study|Physician Decision|4
7813729|NCT01198132|12278384|FG000|Overall Study|Other Unspecified|3
7813730|NCT01198132|12278385|FG001|Overall Study|Other Unspecified|6
7813731|NCT01198132|12278384|FG000|Overall Study|Lack of Efficacy|2
7813732|NCT01198132|12278385|FG001|Overall Study|Lack of Efficacy|3
7813733|NCT01198132|12278384|FG000|Overall Study|Sign/symptoms of underlying disease|2
7813734|NCT01198132|12278385|FG001|Overall Study|Sign/symptoms of underlying disease|1
7813735|NCT01198132|12278384|FG000|Overall Study|Abnormal/clinically significant biologic|1
7813736|NCT01198132|12278385|FG001|Overall Study|Abnormal/clinically significant biologic|1
7813737|NCT01198132|12278384|FG000|Overall Study|Adverse Event|0
7813738|NCT01198132|12278385|FG001|Overall Study|Adverse Event|1
7813739|NCT01198132|12278384|FG000|Overall Study|Protocol Violation|1
7909742|NCT02041962|12425665|FG000|Overall Study|Lost to Follow-up|37
7813740|NCT01198132|12278385|FG001|Overall Study|Protocol Violation|0
7813741|NCT01198145|12278395|FG000|Overall Study|Withdrawal by Subject|1
7813742|NCT01198145|12278396|FG001|Overall Study|Withdrawal by Subject|1
7813743|NCT01198275|12278414|FG000|Overall Study|Adverse Event|2
7813744|NCT01198275|12278415|FG001|Overall Study|Adverse Event|3
7813745|NCT01198275|12278414|FG000|Overall Study|spontaneous return to sinus rhythm|4
7813746|NCT01198275|12278415|FG001|Overall Study|spontaneous return to sinus rhythm|2
7813747|NCT01198470|12278453|FG000|Overall Study|Adverse Event|2
7813748|NCT01198509|12278463|FG000|Overall Study|Withdrawal by Subject|1
7813749|NCT01198509|12278464|FG001|Overall Study|Withdrawal by Subject|0
7813750|NCT01198509|12278465|FG002|Overall Study|Withdrawal by Subject|0
7813751|NCT01198509|12278466|FG003|Overall Study|Withdrawal by Subject|0
7813752|NCT01198509|12278467|FG004|Overall Study|Withdrawal by Subject|0
7813753|NCT01198509|12278468|FG005|Overall Study|Withdrawal by Subject|0
7813754|NCT01198574|12278484|FG000|Overall Study|Resigned from schools|4
7813755|NCT01198574|12278485|FG001|Overall Study|Resigned from schools|1
7813756|NCT01198574|12278486|FG002|Overall Study|Resigned from schools|1
7813757|NCT01198574|12278487|FG003|Overall Study|Resigned from schools|4
7813758|NCT01198587|12278501|FG000|Overall Study|Lost to Follow-up|8
7813759|NCT01198587|12278502|FG001|Overall Study|Lost to Follow-up|0
7813760|NCT01198587|12278503|FG002|Overall Study|Lost to Follow-up|9
7813761|NCT01198587|12278504|FG003|Overall Study|Lost to Follow-up|0
7813762|NCT01198600|12278519|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
7813763|NCT01198600|12278520|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
7813764|NCT01198600|12278521|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
7813765|NCT01198600|12278522|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
7813766|NCT01198600|12278519|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
7813767|NCT01198600|12278520|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
7813768|NCT01198600|12278521|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
7813769|NCT01198600|12278522|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
7813770|NCT01198600|12278519|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
7909743|NCT02041962|12425666|FG001|Overall Study|Lost to Follow-up|32
7909744|NCT02041962|12425665|FG000|Overall Study|Withdrawal by Subject|0
7909745|NCT02041962|12425666|FG001|Overall Study|Withdrawal by Subject|11
7909746|NCT02042014|12425672|FG000|Overall Study|Adverse Event|1
7909747|NCT02042014|12425672|FG000|Overall Study|Physician Decision|7
7909748|NCT02042183|12425693|FG000|Overall Study|Physician Decision|7
7909749|NCT02042183|12425694|FG001|Overall Study|Physician Decision|2
7909750|NCT02042183|12425693|FG000|Overall Study|Lack of Efficacy|4
7909751|NCT02042183|12425694|FG001|Overall Study|Lack of Efficacy|3
7909752|NCT02042183|12425693|FG000|Overall Study|Non-compliance with Study Drug|2
7909753|NCT02042183|12425694|FG001|Overall Study|Non-compliance with Study Drug|3
7909754|NCT02042183|12425693|FG000|Overall Study|Adverse Event|17
7909755|NCT02042183|12425694|FG001|Overall Study|Adverse Event|6
7909756|NCT02042183|12425693|FG000|Overall Study|Other|3
7909757|NCT02042183|12425694|FG001|Overall Study|Other|3
7909758|NCT02042183|12425693|FG000|Overall Study|Withdrawal by Subject|21
7909759|NCT02042183|12425694|FG001|Overall Study|Withdrawal by Subject|16
7909760|NCT02042183|12425693|FG000|Overall Study|Site Terminated by Sponsor|2
7909761|NCT02042183|12425694|FG001|Overall Study|Site Terminated by Sponsor|1
7909762|NCT02042183|12425693|FG000|Overall Study|Lost to Follow-up|9
7909763|NCT02042183|12425694|FG001|Overall Study|Lost to Follow-up|2
7909764|NCT02042404|12425706|FG000|Overall Study|Death|1
7909765|NCT02042404|12425707|FG001|Overall Study|Death|0
7909766|NCT02042404|12425706|FG000|Overall Study|Unrelated Adverse Event|3
7909767|NCT02042404|12425707|FG001|Overall Study|Unrelated Adverse Event|0
7909768|NCT02042404|12425706|FG000|Overall Study|Inability to meet time requirements|1
7909769|NCT02042404|12425707|FG001|Overall Study|Inability to meet time requirements|0
7909770|NCT02042443|12425716|FG000|Overall Study|Adverse Event|2
7909771|NCT02042443|12425717|FG001|Overall Study|Adverse Event|1
7909772|NCT02042443|12425716|FG000|Overall Study|Withdrawal by Subject|0
7909773|NCT02042443|12425717|FG001|Overall Study|Withdrawal by Subject|1
7909774|NCT02042443|12425716|FG000|Overall Study|Progression|21
7909775|NCT02042443|12425717|FG001|Overall Study|Progression|17
7909776|NCT02042443|12425716|FG000|Overall Study|not protocol specified|1
7909777|NCT02042443|12425717|FG001|Overall Study|not protocol specified|1
7909778|NCT02042443|12425716|FG000|Overall Study|Not eligible/not analyzable|3
7909779|NCT02042443|12425717|FG001|Overall Study|Not eligible/not analyzable|6
7909780|NCT02043015|12425746|FG000|Overall Study|Lost to Follow-up|4
7909781|NCT02043015|12425746|FG000|Overall Study|Withdrawal by Subject|4
7909782|NCT02043015|12425746|FG000|Overall Study|Removed once target enrollment reached|15
7909783|NCT02043015|12425746|FG000|Overall Study|Participant moved away from study city|4
7909784|NCT02043015|12425746|FG000|Overall Study|Incarceration|1
7909785|NCT02043132|12425754|FG000|Overall Study|Lost to Follow-up|1
7909786|NCT02043132|12425755|FG001|Overall Study|Lost to Follow-up|1
7909787|NCT02043132|12425754|FG000|Overall Study|screen failures|4
7909788|NCT02043132|12425755|FG001|Overall Study|screen failures|8
7909789|NCT02043301|12425783|FG000|Overall Study|Discontinued|0
7909790|NCT02043301|12425784|FG001|Overall Study|Discontinued|1
7909791|NCT02043301|12425785|FG002|Overall Study|Discontinued|0
7909792|NCT02043366|12425799|FG000|Overall Study|Lost to Follow-up|2
7909793|NCT02043366|12425800|FG001|Overall Study|Lost to Follow-up|2
7909794|NCT02043366|12425801|FG002|Overall Study|Lost to Follow-up|2
7909795|NCT02043366|12425802|FG003|Overall Study|Lost to Follow-up|2
7909796|NCT02043366|12425803|FG004|Overall Study|Lost to Follow-up|2
7909797|NCT02043366|12425804|FG005|Overall Study|Lost to Follow-up|2
7909798|NCT02043509|12425831|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61
7909799|NCT02043509|12425832|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47
7909800|NCT02043509|12425831|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4
7909801|NCT02043509|12425832|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0
7813771|NCT01198600|12278520|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
7813772|NCT01198600|12278521|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
7813773|NCT01198600|12278522|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
7813774|NCT01198600|12278519|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
7813775|NCT01198600|12278520|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
7813776|NCT01198600|12278521|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
7813777|NCT01198600|12278522|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
7909802|NCT02043509|12425831|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67
7909803|NCT02043509|12425832|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67
7813778|NCT01198600|12278519|FG000|Phase 2: 56 Days of Wear|Inconvenience|0
7813779|NCT01198600|12278520|FG001|Phase 2: 56 Days of Wear|Inconvenience|0
7813780|NCT01198600|12278521|FG002|Phase 2: 56 Days of Wear|Inconvenience|2
7813781|NCT01198600|12278522|FG003|Phase 2: 56 Days of Wear|Inconvenience|0
7813782|NCT01198600|12278519|FG000|Phase 2: 56 Days of Wear|Relocation|0
7813783|NCT01198600|12278520|FG001|Phase 2: 56 Days of Wear|Relocation|0
7813784|NCT01198600|12278521|FG002|Phase 2: 56 Days of Wear|Relocation|2
7813785|NCT01198600|12278522|FG003|Phase 2: 56 Days of Wear|Relocation|0
7813786|NCT01198600|12278519|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
7813787|NCT01198600|12278520|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
7813788|NCT01198600|12278521|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
7813789|NCT01198600|12278522|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
7813790|NCT01198756|12278543|FG000|Overall Study|Adverse Event|0
7813791|NCT01198756|12278544|FG001|Overall Study|Adverse Event|0
7813792|NCT01198756|12278545|FG002|Overall Study|Adverse Event|0
7813793|NCT01198756|12278546|FG003|Overall Study|Adverse Event|1
7813794|NCT01198756|12278543|FG000|Overall Study|Protocol Violation|0
7813795|NCT01198756|12278544|FG001|Overall Study|Protocol Violation|0
7813796|NCT01198756|12278545|FG002|Overall Study|Protocol Violation|0
7813797|NCT01198756|12278546|FG003|Overall Study|Protocol Violation|2
7813798|NCT01198756|12278543|FG000|Overall Study|Withdrawal by Subject|9
7813799|NCT01198756|12278544|FG001|Overall Study|Withdrawal by Subject|4
7813800|NCT01198756|12278545|FG002|Overall Study|Withdrawal by Subject|7
7813801|NCT01198756|12278546|FG003|Overall Study|Withdrawal by Subject|5
7813802|NCT01198756|12278543|FG000|Overall Study|Lost to Follow-up|29
7813803|NCT01198756|12278544|FG001|Overall Study|Lost to Follow-up|36
7813804|NCT01198756|12278545|FG002|Overall Study|Lost to Follow-up|23
7813805|NCT01198756|12278546|FG003|Overall Study|Lost to Follow-up|18
7813806|NCT01198795|12278567|FG000|Overall Study|Did not meet InclusionExclusion criteria|30
7813807|NCT01198795|12278567|FG000|Overall Study|Withdrawal by Subject|17
7813808|NCT01198795|12278567|FG000|Overall Study|Lost to Follow-up|15
7813809|NCT01198795|12278567|FG000|Overall Study|Adverse Event|9
7813810|NCT01198795|12278567|FG000|Overall Study|Lack of Efficacy|5
7813811|NCT01198795|12278567|FG000|Overall Study|Protocol Violation|2
7813812|NCT01198795|12278567|FG000|Overall Study|Other Reason|4
7813813|NCT01198873|12278573|FG000|Overall Study|Adverse Event|4
7813814|NCT01198873|12278574|FG001|Overall Study|Adverse Event|7
7813815|NCT01198873|12278573|FG000|Overall Study|Study closure|29
7813816|NCT01198873|12278574|FG001|Overall Study|Study closure|23
7813817|NCT01198873|12278573|FG000|Overall Study|Other than above|4
7813818|NCT01198873|12278574|FG001|Overall Study|Other than above|2
7813819|NCT01198977|12278582|FG000|Overall Study|Lost to Follow-up|1
7813820|NCT01198977|12278583|FG001|Overall Study|Lost to Follow-up|0
7813821|NCT01199016|12278591|FG000|Overall Study|No longer meets eligibility criteria|4
7813822|NCT01199016|12278591|FG000|Overall Study|Entrance criteria|5
7813823|NCT01199016|12278591|FG000|Overall Study|Protocol Violation|9
7813824|NCT01199016|12278591|FG000|Overall Study|Other|13
7813825|NCT01199016|12278591|FG000|Overall Study|Withdrawal by Subject|21
7813826|NCT01199016|12278591|FG000|Overall Study|Lost to Follow-up|25
7813827|NCT01199042|12278595|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
7813828|NCT01199042|12278595|FG000|At Home (3 Months)|Lost to Follow-up|1
7813829|NCT01199055|12278607|FG000|Overall Study|Death|0
7813830|NCT01199055|12278608|FG001|Overall Study|Death|1
7813831|NCT01199055|12278609|FG002|Overall Study|Death|0
7813832|NCT01199055|12278607|FG000|Overall Study|Physician Decision|0
7813833|NCT01199055|12278608|FG001|Overall Study|Physician Decision|1
7813834|NCT01199055|12278609|FG002|Overall Study|Physician Decision|1
7813835|NCT01199055|12278607|FG000|Overall Study|Progressive disease|2
7813836|NCT01199055|12278608|FG001|Overall Study|Progressive disease|1
7813837|NCT01199055|12278609|FG002|Overall Study|Progressive disease|2
7813838|NCT01199055|12278607|FG000|Overall Study|Withdrawal by Subject|0
7813839|NCT01199055|12278608|FG001|Overall Study|Withdrawal by Subject|0
7813840|NCT01199055|12278609|FG002|Overall Study|Withdrawal by Subject|1
7813841|NCT01199068|12278622|FG000|Overall Study|Unacceptable toxicity|0
7813842|NCT01199068|12278623|FG001|Overall Study|Unacceptable toxicity|0
7813843|NCT01199068|12278624|FG002|Overall Study|Unacceptable toxicity|2
7813844|NCT01199068|12278622|FG000|Overall Study|Progressive disease|3
7813845|NCT01199068|12278623|FG001|Overall Study|Progressive disease|3
7813846|NCT01199068|12278624|FG002|Overall Study|Progressive disease|6
7813847|NCT01199068|12278622|FG000|Overall Study|Withdrawal by Subject|0
7813848|NCT01199068|12278623|FG001|Overall Study|Withdrawal by Subject|0
7813849|NCT01199068|12278624|FG002|Overall Study|Withdrawal by Subject|1
7813850|NCT01199198|12278645|FG000|Overall Study|Adverse Event|3
7813851|NCT01199198|12278646|FG001|Overall Study|Adverse Event|0
7813852|NCT01199198|12278645|FG000|Overall Study|Lost to Follow-up|1
7813853|NCT01199198|12278646|FG001|Overall Study|Lost to Follow-up|5
7813854|NCT01199198|12278645|FG000|Overall Study|Withdrawal by Subject|1
7813855|NCT01199198|12278646|FG001|Overall Study|Withdrawal by Subject|2
7813856|NCT01199198|12278645|FG000|Overall Study|ICU Transfer|1
7813857|NCT01199198|12278646|FG001|Overall Study|ICU Transfer|2
7813858|NCT01199198|12278645|FG000|Overall Study|Hospice-care transfer|1
7813859|NCT01199198|12278646|FG001|Overall Study|Hospice-care transfer|2
7813860|NCT01199263|12278665|FG000|Overall Study|Ineligible|0
7813861|NCT01199263|12278666|FG001|Overall Study|Ineligible|2
7813862|NCT01199263|12278665|FG000|Overall Study|Never Treated|6
7813863|NCT01199263|12278666|FG001|Overall Study|Never Treated|0
7813864|NCT01199289|12278678|FG000|Overall Study|Ineligibility determined|2
7813865|NCT01199289|12278679|FG001|Overall Study|Ineligibility determined|1
7813866|NCT01199289|12278680|FG002|Overall Study|Ineligibility determined|0
7813867|NCT01199289|12278681|FG003|Overall Study|Ineligibility determined|0
7813868|NCT01199289|12278678|FG000|Overall Study|Protocol Violation|1
7813869|NCT01199289|12278679|FG001|Overall Study|Protocol Violation|0
7813870|NCT01199289|12278680|FG002|Overall Study|Protocol Violation|0
7813871|NCT01199289|12278681|FG003|Overall Study|Protocol Violation|1
7813872|NCT01199289|12278678|FG000|Overall Study|Noncompliance|1
7813873|NCT01199289|12278679|FG001|Overall Study|Noncompliance|0
7813874|NCT01199289|12278680|FG002|Overall Study|Noncompliance|2
7813875|NCT01199289|12278681|FG003|Overall Study|Noncompliance|0
7909804|NCT02043509|12425831|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7
7909805|NCT02043509|12425832|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5
7909806|NCT02043548|12425840|FG000|Overall Study|Lack of Efficacy|1
7909807|NCT02043548|12425841|FG001|Overall Study|Lack of Efficacy|0
7909808|NCT02043548|12425840|FG000|Overall Study|Adverse Event|0
7909809|NCT02043548|12425841|FG001|Overall Study|Adverse Event|1
7909810|NCT02043782|12425870|FG000|Period 1|Adverse Event|0
7909811|NCT02043782|12425871|FG001|Period 1|Adverse Event|0
7909812|NCT02043782|12425872|FG002|Period 1|Adverse Event|1
7909813|NCT02043782|12425873|FG003|Period 1|Adverse Event|0
7909814|NCT02043782|12425874|FG004|Period 1|Adverse Event|0
7909815|NCT02043782|12425875|FG005|Period 1|Adverse Event|0
7909816|NCT02043899|12425892|FG000|Overall Study|Adverse Event|3
7909817|NCT02043899|12425892|FG000|Overall Study|Physician Decision|1
7909818|NCT02043899|12425892|FG000|Overall Study|Withdrawal by Subject|2
7909819|NCT02043899|12425892|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5
7909820|NCT02043899|12425892|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12
7909821|NCT02043899|12425892|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2
7909822|NCT02043899|12425892|FG000|Overall Study|Clinical progression necessitating urgent treatment|1
7909823|NCT02043899|12425892|FG000|Overall Study|Treatment delayed|1
7909824|NCT02043938|12425896|FG000|Overall Study|Withdrawal by Subject|7
7909825|NCT02043938|12425896|FG000|Overall Study|Unable to place EEG sensors on patient|1
7909826|NCT02043938|12425896|FG000|Overall Study|No show by subject|1
7909827|NCT02043938|12425896|FG000|Overall Study|Investigator decision|1
7909828|NCT02044094|12425903|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
7909829|NCT02044094|12425903|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
7909830|NCT02044094|12425903|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
7909831|NCT02044094|12425903|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
7909832|NCT02044094|12425903|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
7909833|NCT02044094|12425903|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
7909834|NCT02044094|12425903|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
7909835|NCT02044094|12425903|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
7964050|NCT02734693|12519111|FG002|Overall Study|Lost to Follow-up|0
7964051|NCT02734693|12519109|FG000|Overall Study|Protocol Violation|1
7964052|NCT02734693|12519110|FG001|Overall Study|Protocol Violation|0
7964053|NCT02734693|12519111|FG002|Overall Study|Protocol Violation|0
7964054|NCT02734693|12519109|FG000|Overall Study|Withdrawal by Subject|1
7964055|NCT02734693|12519110|FG001|Overall Study|Withdrawal by Subject|0
7964056|NCT02734693|12519111|FG002|Overall Study|Withdrawal by Subject|0
7964057|NCT02734810|12519121|FG000|Overall Study|Adverse Event|1
7964058|NCT02734810|12519122|FG001|Overall Study|Adverse Event|0
7964059|NCT02734810|12519121|FG000|Overall Study|Lack of Efficacy|1
7964060|NCT02734810|12519122|FG001|Overall Study|Lack of Efficacy|0
7813876|NCT01199289|12278678|FG000|Overall Study|Adverse Event|0
7964061|NCT02734862|12519144|FG000|Part A|Death|3
7964062|NCT02734862|12519145|FG001|Part A|Death|4
7964063|NCT02734862|12519146|FG002|Part A|Death|6
7964064|NCT02734862|12519144|FG000|Part A|Lost to Follow-up|2
7964065|NCT02734862|12519145|FG001|Part A|Lost to Follow-up|1
7964066|NCT02734862|12519146|FG002|Part A|Lost to Follow-up|1
7964067|NCT02734862|12519144|FG000|Part A|Withdrawal by Subject|1
7813877|NCT01199289|12278679|FG001|Overall Study|Adverse Event|3
7813878|NCT01199289|12278680|FG002|Overall Study|Adverse Event|1
7813879|NCT01199289|12278681|FG003|Overall Study|Adverse Event|4
7813880|NCT01199289|12278678|FG000|Overall Study|Full consent withdrawn|2
7813881|NCT01199289|12278679|FG001|Overall Study|Full consent withdrawn|2
7813882|NCT01199289|12278680|FG002|Overall Study|Full consent withdrawn|2
7813883|NCT01199289|12278681|FG003|Overall Study|Full consent withdrawn|3
7813884|NCT01199289|12278678|FG000|Overall Study|Administrative decision|0
7813885|NCT01199289|12278679|FG001|Overall Study|Administrative decision|0
7813886|NCT01199289|12278680|FG002|Overall Study|Administrative decision|0
7813887|NCT01199289|12278681|FG003|Overall Study|Administrative decision|1
7813888|NCT01199289|12278678|FG000|Overall Study|Lost to Follow-up|0
7813889|NCT01199289|12278679|FG001|Overall Study|Lost to Follow-up|0
7813890|NCT01199289|12278680|FG002|Overall Study|Lost to Follow-up|0
7813891|NCT01199289|12278681|FG003|Overall Study|Lost to Follow-up|1
7813892|NCT01199289|12278678|FG000|Overall Study|Protocol-specified criteria|3
7813893|NCT01199289|12278679|FG001|Overall Study|Protocol-specified criteria|0
7813894|NCT01199289|12278680|FG002|Overall Study|Protocol-specified criteria|0
7813895|NCT01199289|12278681|FG003|Overall Study|Protocol-specified criteria|1
7813896|NCT01199289|12278678|FG000|Overall Study|Pregnancy|0
7813897|NCT01199289|12278679|FG001|Overall Study|Pregnancy|1
7813898|NCT01199289|12278680|FG002|Overall Study|Pregnancy|0
7909836|NCT02044159|12425920|FG000|Overall Study|Consent declined (deferred consent)|2
7909837|NCT02044159|12425921|FG001|Overall Study|Consent declined (deferred consent)|4
7909838|NCT02044159|12425920|FG000|Overall Study|No longer eligible, drug not given|1
7909839|NCT02044159|12425921|FG001|Overall Study|No longer eligible, drug not given|0
7909840|NCT02044159|12425920|FG000|Overall Study|Nurse declined to give study drug|1
7909841|NCT02044159|12425921|FG001|Overall Study|Nurse declined to give study drug|0
7909842|NCT02044458|12425979|FG000|Overall Study|Protocol Violation|3
7909843|NCT02044458|12425980|FG001|Overall Study|Protocol Violation|8
7909844|NCT02044510|12425988|FG000|Overall Study|Adverse Event|1
7909845|NCT02044510|12425989|FG001|Overall Study|Adverse Event|2
7909846|NCT02044874|12426027|FG000|Overall Study|Adverse Event|5
7909847|NCT02044874|12426028|FG001|Overall Study|Adverse Event|6
7909848|NCT02044874|12426029|FG002|Overall Study|Adverse Event|6
7909849|NCT02044874|12426027|FG000|Overall Study|Withdrawal by Subject|8
7909850|NCT02044874|12426028|FG001|Overall Study|Withdrawal by Subject|16
7909851|NCT02044874|12426029|FG002|Overall Study|Withdrawal by Subject|23
7909852|NCT02044874|12426027|FG000|Overall Study|Physician Decision|0
7909853|NCT02044874|12426028|FG001|Overall Study|Physician Decision|2
7909854|NCT02044874|12426029|FG002|Overall Study|Physician Decision|1
7909855|NCT02044874|12426027|FG000|Overall Study|Lost to Follow-up|10
7909856|NCT02044874|12426028|FG001|Overall Study|Lost to Follow-up|27
7909857|NCT02044874|12426029|FG002|Overall Study|Lost to Follow-up|21
7909858|NCT02044874|12426027|FG000|Overall Study|Sponsor Decision|0
7909859|NCT02044874|12426028|FG001|Overall Study|Sponsor Decision|1
7909860|NCT02044874|12426029|FG002|Overall Study|Sponsor Decision|1
7909861|NCT02044874|12426027|FG000|Overall Study|Other|7
7909862|NCT02044874|12426028|FG001|Overall Study|Other|3
7909863|NCT02044874|12426029|FG002|Overall Study|Other|8
7909864|NCT02045095|12426048|FG000|Overall Study|Other|0
7909865|NCT02045095|12426049|FG001|Overall Study|Other|0
7909866|NCT02045095|12426050|FG002|Overall Study|Other|1
7909867|NCT02045095|12426051|FG003|Overall Study|Other|0
7909868|NCT02045095|12426052|FG004|Overall Study|Other|0
7909869|NCT02045095|12426053|FG005|Overall Study|Other|2
7909870|NCT02045095|12426054|FG006|Overall Study|Other|0
7909871|NCT02045095|12426048|FG000|Overall Study|Progressive Disease|3
7909872|NCT02045095|12426049|FG001|Overall Study|Progressive Disease|3
7909873|NCT02045095|12426050|FG002|Overall Study|Progressive Disease|2
7909874|NCT02045095|12426051|FG003|Overall Study|Progressive Disease|4
7909875|NCT02045095|12426052|FG004|Overall Study|Progressive Disease|2
7909876|NCT02045095|12426053|FG005|Overall Study|Progressive Disease|4
7909877|NCT02045095|12426054|FG006|Overall Study|Progressive Disease|1
7909878|NCT02045095|12426048|FG000|Overall Study|Withdrawal by Subject|0
7909879|NCT02045095|12426049|FG001|Overall Study|Withdrawal by Subject|0
7909880|NCT02045095|12426050|FG002|Overall Study|Withdrawal by Subject|0
7909881|NCT02045095|12426051|FG003|Overall Study|Withdrawal by Subject|0
7909882|NCT02045095|12426052|FG004|Overall Study|Withdrawal by Subject|3
7909883|NCT02045095|12426053|FG005|Overall Study|Withdrawal by Subject|0
7909884|NCT02045095|12426054|FG006|Overall Study|Withdrawal by Subject|0
7909885|NCT02045095|12426048|FG000|Overall Study|Adverse Event|0
7909886|NCT02045095|12426049|FG001|Overall Study|Adverse Event|1
7909887|NCT02045095|12426050|FG002|Overall Study|Adverse Event|1
7909888|NCT02045095|12426051|FG003|Overall Study|Adverse Event|0
7909889|NCT02045095|12426052|FG004|Overall Study|Adverse Event|0
7909890|NCT02045095|12426053|FG005|Overall Study|Adverse Event|2
7909891|NCT02045095|12426054|FG006|Overall Study|Adverse Event|0
7909892|NCT02045212|12426089|FG000|Overall Study|Adverse Event|0
7909893|NCT02045212|12426090|FG001|Overall Study|Adverse Event|1
7909894|NCT02045212|12426089|FG000|Overall Study|Withdrawal by Subject|1
7909895|NCT02045212|12426090|FG001|Overall Study|Withdrawal by Subject|0
7909896|NCT02045212|12426089|FG000|Overall Study|Finished 13 weeks, chose not to extend|1
7909897|NCT02045212|12426090|FG001|Overall Study|Finished 13 weeks, chose not to extend|0
7813899|NCT01199289|12278681|FG003|Overall Study|Pregnancy|1
7813900|NCT01199471|12278694|FG000|Overall Study|Protocol Violation|4
7813901|NCT01199471|12278694|FG000|Overall Study|Withdrawal by Subject|1
7813902|NCT01199471|12278694|FG000|Overall Study|Physician Decision|1
7813903|NCT01199575|12278699|FG000|Overall Study|Withdrawal by Subject|5
7813904|NCT01199601|12278706|FG000|Overall Study|Lost to Follow-up|47
7813905|NCT01199601|12278707|FG001|Overall Study|Lost to Follow-up|66
7813906|NCT01199601|12278706|FG000|Overall Study|Withdrawal by Subject|15
7813907|NCT01199601|12278707|FG001|Overall Study|Withdrawal by Subject|3
7813908|NCT01199601|12278706|FG000|Overall Study|Insecurity prevented staff interviewing.|7
7813909|NCT01199601|12278707|FG001|Overall Study|Insecurity prevented staff interviewing.|9
7813910|NCT01199705|12278713|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
7813911|NCT01199731|12278731|FG000|Overall Study|Adverse Event|0
7813912|NCT01199731|12278732|FG001|Overall Study|Adverse Event|1
7813913|NCT01199731|12278733|FG002|Overall Study|Adverse Event|0
7813914|NCT01199731|12278731|FG000|Overall Study|Study closed/terminated|7
7813915|NCT01199731|12278732|FG001|Overall Study|Study closed/terminated|9
7813916|NCT01199731|12278733|FG002|Overall Study|Study closed/terminated|7
7813917|NCT01199731|12278731|FG000|Overall Study|Lost to Follow-up|0
7813918|NCT01199731|12278732|FG001|Overall Study|Lost to Follow-up|0
7813919|NCT01199731|12278733|FG002|Overall Study|Lost to Follow-up|2
7813920|NCT01199731|12278731|FG000|Overall Study|Physician Decision|0
7813921|NCT01199731|12278732|FG001|Overall Study|Physician Decision|1
7813922|NCT01199731|12278733|FG002|Overall Study|Physician Decision|1
7813923|NCT01199731|12278731|FG000|Overall Study|Withdrawal by Subject|2
7813924|NCT01199731|12278732|FG001|Overall Study|Withdrawal by Subject|0
7813925|NCT01199731|12278733|FG002|Overall Study|Withdrawal by Subject|0
7813926|NCT01199822|12278748|FG000|Overall Study|Investigator discontinued therapy|0
7813927|NCT01199822|12278749|FG001|Overall Study|Investigator discontinued therapy|1
7813928|NCT01199822|12278750|FG002|Overall Study|Investigator discontinued therapy|0
7813929|NCT01199861|12278777|FG000|Overall Study|Administrative problems|1
7813930|NCT01199861|12278778|FG001|Overall Study|Administrative problems|0
7813931|NCT01199861|12278777|FG000|Overall Study|Adverse Event|1
7813932|NCT01199861|12278778|FG001|Overall Study|Adverse Event|0
7813933|NCT01199939|12278793|FG000|Overall Study|Adverse Event|4
7813934|NCT01199939|12278793|FG000|Overall Study|Protocol Violation|3
7813935|NCT01199939|12278793|FG000|Overall Study|Lost to Follow-up|2
7813936|NCT01199939|12278793|FG000|Overall Study|Reached a virologic endpoint|4
7813937|NCT01200069|12278839|FG000|Overall Study|Withdrawal by Subject|0
7813938|NCT01200069|12278840|FG001|Overall Study|Withdrawal by Subject|1
7813939|NCT01200238|12278895|FG000|Overall Study|Adverse Event|2
7813940|NCT01200238|12278896|FG001|Overall Study|Adverse Event|1
7813941|NCT01200238|12278895|FG000|Overall Study|Progressive Disease|5
7813942|NCT01200238|12278896|FG001|Overall Study|Progressive Disease|8
7813943|NCT01200238|12278895|FG000|Overall Study|Withdrawal by Subject|0
7813944|NCT01200238|12278896|FG001|Overall Study|Withdrawal by Subject|1
7813945|NCT01200290|12278902|FG000|Treatment Period|Adverse Event|1
7813946|NCT01200290|12278902|FG000|Post-Treatment Follow-Up Period|Death|2
7813947|NCT01200329|12278906|FG000|Overall Study|Lack of financial coverage|2
7813948|NCT01200329|12278906|FG000|Overall Study|Progressive disease|1
7813949|NCT01200342|12278910|FG000|Overall Study|Disease Progression|1
7813950|NCT01200355|12278916|FG000|Overall Study|Death|7
7813951|NCT01200355|12278917|FG001|Overall Study|Death|2
7813952|NCT01200368|12278926|FG000|Infant Series|Adverse Event|2
7813953|NCT01200368|12278927|FG001|Infant Series|Adverse Event|2
7813954|NCT01200368|12278928|FG002|Infant Series|Adverse Event|3
7813955|NCT01200368|12278926|FG000|Infant Series|Withdrawal by Subject|0
7813956|NCT01200368|12278927|FG001|Infant Series|Withdrawal by Subject|2
7813957|NCT01200368|12278928|FG002|Infant Series|Withdrawal by Subject|2
7813958|NCT01200368|12278926|FG000|Infant Series|Did not meet entrance criteria|0
7813959|NCT01200368|12278927|FG001|Infant Series|Did not meet entrance criteria|1
7813960|NCT01200368|12278928|FG002|Infant Series|Did not meet entrance criteria|0
7813961|NCT01200368|12278926|FG000|Infant Series|Randomized, not vaccinated|0
7813962|NCT01200368|12278927|FG001|Infant Series|Randomized, not vaccinated|1
7813963|NCT01200368|12278928|FG002|Infant Series|Randomized, not vaccinated|1
7813964|NCT01200368|12278926|FG000|Infant Series|Other|1
7813965|NCT01200368|12278927|FG001|Infant Series|Other|0
7813966|NCT01200368|12278928|FG002|Infant Series|Other|0
7813967|NCT01200368|12278926|FG000|After Infant Series|Adverse Event|6
7813968|NCT01200368|12278927|FG001|After Infant Series|Adverse Event|6
7813969|NCT01200368|12278928|FG002|After Infant Series|Adverse Event|3
7813970|NCT01200368|12278926|FG000|After Infant Series|Withdrawal by Subject|10
7813971|NCT01200368|12278927|FG001|After Infant Series|Withdrawal by Subject|8
7813972|NCT01200368|12278928|FG002|After Infant Series|Withdrawal by Subject|4
7813973|NCT01200368|12278926|FG000|After Infant Series|Lost to Follow-up|1
7813974|NCT01200368|12278927|FG001|After Infant Series|Lost to Follow-up|0
7813975|NCT01200368|12278928|FG002|After Infant Series|Lost to Follow-up|0
7813976|NCT01200368|12278926|FG000|After Infant Series|Other|1
7813977|NCT01200368|12278927|FG001|After Infant Series|Other|2
7813978|NCT01200368|12278928|FG002|After Infant Series|Other|2
7813979|NCT01200368|12278926|FG000|Toddler Dose|Adverse Event|0
7813980|NCT01200368|12278927|FG001|Toddler Dose|Adverse Event|3
7813981|NCT01200368|12278928|FG002|Toddler Dose|Adverse Event|1
7813982|NCT01200394|12278945|FG000|Overall Study|Adverse Event|0
7813983|NCT01200394|12278946|FG001|Overall Study|Adverse Event|14
7813984|NCT01200394|12278945|FG000|Overall Study|Death|1
7813985|NCT01200394|12278946|FG001|Overall Study|Death|0
7813986|NCT01200394|12278945|FG000|Overall Study|Lost to Follow-up|0
7813987|NCT01200394|12278946|FG001|Overall Study|Lost to Follow-up|1
7813988|NCT01200394|12278945|FG000|Overall Study|Did Not Meet Entrance Criteria|1
7813989|NCT01200394|12278946|FG001|Overall Study|Did Not Meet Entrance Criteria|4
7813990|NCT01200394|12278945|FG000|Overall Study|Protocol Violation|0
7813991|NCT01200394|12278946|FG001|Overall Study|Protocol Violation|3
7813992|NCT01200394|12278945|FG000|Overall Study|Withdrawal by Subject|0
7813993|NCT01200394|12278946|FG001|Overall Study|Withdrawal by Subject|5
7813994|NCT01200394|12278945|FG000|Overall Study|Other|0
7813995|NCT01200394|12278946|FG001|Overall Study|Other|1
7813996|NCT01200407|12278953|FG000|Overall Study|Lost to Follow-up|56
7813997|NCT01200407|12278953|FG000|Overall Study|Adverse Event|3
7813998|NCT01200407|12278953|FG000|Overall Study|Withdrawal by Subject|4
7813999|NCT01200407|12278953|FG000|Overall Study|Other|19
7814000|NCT01200485|12278966|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1
7814001|NCT01200485|12278967|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
7814002|NCT01200485|12278968|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
7814003|NCT01200485|12278966|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2
7814004|NCT01200485|12278967|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
7814005|NCT01200485|12278968|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
7814006|NCT01200511|12278979|FG000|Overall Study|Lost to Follow-up|3
7909898|NCT02045433|12426130|FG000|Overall Study|Withdrawal by Subject|1
7909899|NCT02045732|12426145|FG000|Overall Study|At the discretion of the investigator|1
7909900|NCT02045732|12426146|FG001|Overall Study|At the discretion of the investigator|1
7909901|NCT02045836|12426154|FG000|Overall Study|Adverse Event|4
7909902|NCT02045836|12426155|FG001|Overall Study|Adverse Event|4
7909903|NCT02045836|12426154|FG000|Overall Study|Withdrawal by Subject|1
7909904|NCT02045836|12426155|FG001|Overall Study|Withdrawal by Subject|1
7909905|NCT02045836|12426154|FG000|Overall Study|Lost to Follow-up|4
7909906|NCT02045836|12426155|FG001|Overall Study|Lost to Follow-up|7
7909907|NCT02045836|12426154|FG000|Overall Study|Migrated from study area|0
7909908|NCT02045836|12426155|FG001|Overall Study|Migrated from study area|2
7909909|NCT02045862|12426165|FG000|Overall Study|Death|0
7909910|NCT02045862|12426166|FG001|Overall Study|Death|0
7909911|NCT02045862|12426167|FG002|Overall Study|Death|1
7909912|NCT02045862|12426165|FG000|Overall Study|Miscellaneous|5
7909913|NCT02045862|12426166|FG001|Overall Study|Miscellaneous|0
7909914|NCT02045862|12426167|FG002|Overall Study|Miscellaneous|8
7909915|NCT02045862|12426165|FG000|Overall Study|Withdrawal by Patient|18
7909916|NCT02045862|12426166|FG001|Overall Study|Withdrawal by Patient|27
7909917|NCT02045862|12426167|FG002|Overall Study|Withdrawal by Patient|57
7909918|NCT02045862|12426165|FG000|Overall Study|Protocol Violation|0
7909919|NCT02045862|12426166|FG001|Overall Study|Protocol Violation|0
7909920|NCT02045862|12426167|FG002|Overall Study|Protocol Violation|6
7909921|NCT02045862|12426165|FG000|Overall Study|Lack of Efficacy|8
7909922|NCT02045862|12426166|FG001|Overall Study|Lack of Efficacy|4
7909923|NCT02045862|12426167|FG002|Overall Study|Lack of Efficacy|13
7909924|NCT02045862|12426165|FG000|Overall Study|Randomized but not Received Study Drug|0
7909925|NCT02045862|12426166|FG001|Overall Study|Randomized but not Received Study Drug|2
7909926|NCT02045862|12426167|FG002|Overall Study|Randomized but not Received Study Drug|8
7909927|NCT02045862|12426165|FG000|Overall Study|Adverse Event|7
7909928|NCT02045862|12426166|FG001|Overall Study|Adverse Event|5
7909929|NCT02045862|12426167|FG002|Overall Study|Adverse Event|27
7909930|NCT02045862|12426165|FG000|Overall Study|Lost to Follow-up|1
7909931|NCT02045862|12426166|FG001|Overall Study|Lost to Follow-up|2
7814007|NCT01200511|12278979|FG000|Overall Study|Withdrawal by Subject|1
7814008|NCT01200511|12278979|FG000|Overall Study|Adverse Event|1
7814009|NCT01200524|12278988|FG000|Overall Study|Withdrawal by Subject|1
7814010|NCT01200524|12278989|FG001|Overall Study|Withdrawal by Subject|1
7814011|NCT01200524|12278990|FG002|Overall Study|Withdrawal by Subject|3
7814012|NCT01200524|12278988|FG000|Overall Study|Adverse Event|1
7814013|NCT01200524|12278989|FG001|Overall Study|Adverse Event|0
7814014|NCT01200524|12278990|FG002|Overall Study|Adverse Event|0
7814015|NCT01200524|12278988|FG000|Overall Study|Non availability of study nurse|0
7909932|NCT02045862|12426167|FG002|Overall Study|Lost to Follow-up|6
7814016|NCT01200524|12278989|FG001|Overall Study|Non availability of study nurse|0
7814017|NCT01200524|12278990|FG002|Overall Study|Non availability of study nurse|1
7814018|NCT01200589|12279000|FG000|Overall Study|Withdrawal by Subject|13
7814019|NCT01200589|12279001|FG001|Overall Study|Withdrawal by Subject|11
7814020|NCT01200589|12279000|FG000|Overall Study|Physician Decision|2
7814021|NCT01200589|12279001|FG001|Overall Study|Physician Decision|2
7814022|NCT01200589|12279000|FG000|Overall Study|Lost to Follow-up|5
7814023|NCT01200589|12279001|FG001|Overall Study|Lost to Follow-up|4
7814024|NCT01200589|12279000|FG000|Overall Study|Study terminated|170
7909933|NCT02045875|12426177|FG000|Overall Study|Lost to Follow-up|3
7814025|NCT01200589|12279001|FG001|Overall Study|Study terminated|172
7814026|NCT01200758|12279009|FG000|Stage I|Death|0
7814027|NCT01200758|12279010|FG001|Stage I|Death|1
7814028|NCT01200758|12279011|FG002|Stage I|Death|0
7814029|NCT01200758|12279012|FG003|Stage I|Death|0
7814030|NCT01200758|12279009|FG000|Stage I|Physician Decision|1
7814031|NCT01200758|12279010|FG001|Stage I|Physician Decision|1
7814032|NCT01200758|12279011|FG002|Stage I|Physician Decision|0
7814033|NCT01200758|12279012|FG003|Stage I|Physician Decision|0
7814034|NCT01200758|12279009|FG000|Stage I|Lack of Efficacy|2
7814035|NCT01200758|12279010|FG001|Stage I|Lack of Efficacy|1
7814036|NCT01200758|12279011|FG002|Stage I|Lack of Efficacy|0
7814037|NCT01200758|12279012|FG003|Stage I|Lack of Efficacy|0
7814038|NCT01200758|12279009|FG000|Stage I|Adverse Event|5
7814039|NCT01200758|12279010|FG001|Stage I|Adverse Event|5
7814040|NCT01200758|12279011|FG002|Stage I|Adverse Event|0
7814041|NCT01200758|12279012|FG003|Stage I|Adverse Event|0
7814042|NCT01200758|12279009|FG000|Stage I|Withdrawal by Subject|1
7814043|NCT01200758|12279010|FG001|Stage I|Withdrawal by Subject|2
7814044|NCT01200758|12279011|FG002|Stage I|Withdrawal by Subject|0
7814045|NCT01200758|12279012|FG003|Stage I|Withdrawal by Subject|0
7814046|NCT01200758|12279009|FG000|Stage I|Disease Progression|9
7814047|NCT01200758|12279010|FG001|Stage I|Disease Progression|7
7814048|NCT01200758|12279011|FG002|Stage I|Disease Progression|0
7814049|NCT01200758|12279012|FG003|Stage I|Disease Progression|0
7814050|NCT01200758|12279009|FG000|Stage 2|Disease Progression|0
7814051|NCT01200758|12279010|FG001|Stage 2|Disease Progression|0
7814052|NCT01200758|12279011|FG002|Stage 2|Disease Progression|16
7814053|NCT01200758|12279012|FG003|Stage 2|Disease Progression|21
7814054|NCT01200758|12279009|FG000|Stage 2|Lack of Efficacy|0
7814055|NCT01200758|12279010|FG001|Stage 2|Lack of Efficacy|0
7814056|NCT01200758|12279011|FG002|Stage 2|Lack of Efficacy|4
7814057|NCT01200758|12279012|FG003|Stage 2|Lack of Efficacy|2
7814058|NCT01200758|12279009|FG000|Stage 2|Physician Decision|0
7814059|NCT01200758|12279010|FG001|Stage 2|Physician Decision|0
7814060|NCT01200758|12279011|FG002|Stage 2|Physician Decision|5
7814061|NCT01200758|12279012|FG003|Stage 2|Physician Decision|7
7814062|NCT01200758|12279009|FG000|Stage 2|Adverse Event|0
7814063|NCT01200758|12279010|FG001|Stage 2|Adverse Event|0
7814064|NCT01200758|12279011|FG002|Stage 2|Adverse Event|5
7814065|NCT01200758|12279012|FG003|Stage 2|Adverse Event|9
7814066|NCT01200758|12279009|FG000|Stage 2|Withdrawal by Subject|0
7814067|NCT01200758|12279010|FG001|Stage 2|Withdrawal by Subject|0
7814068|NCT01200758|12279011|FG002|Stage 2|Withdrawal by Subject|4
7814069|NCT01200758|12279012|FG003|Stage 2|Withdrawal by Subject|1
7814070|NCT01200758|12279009|FG000|Stage 2|Lost to Follow-up|0
7814071|NCT01200758|12279010|FG001|Stage 2|Lost to Follow-up|0
7814072|NCT01200758|12279011|FG002|Stage 2|Lost to Follow-up|3
7814073|NCT01200758|12279012|FG003|Stage 2|Lost to Follow-up|1
7814074|NCT01200758|12279009|FG000|Stage 2|Protocol Violation|0
7814075|NCT01200758|12279010|FG001|Stage 2|Protocol Violation|0
7814076|NCT01200758|12279011|FG002|Stage 2|Protocol Violation|1
7814077|NCT01200758|12279012|FG003|Stage 2|Protocol Violation|4
7814078|NCT01200758|12279009|FG000|Stage 2|Death|0
7814079|NCT01200758|12279010|FG001|Stage 2|Death|0
7814080|NCT01200758|12279011|FG002|Stage 2|Death|3
7814081|NCT01200758|12279012|FG003|Stage 2|Death|5
7814082|NCT01200797|12279024|FG000|Overall Study|symptomatic deterioration|2
7814083|NCT01200797|12279024|FG000|Overall Study|Adverse Event|4
7814084|NCT01200797|12279024|FG000|Overall Study|Disease Progression|13
7814085|NCT01200810|12279031|FG000|Overall Study|Physician Decision|1
7814086|NCT01200810|12279032|FG001|Overall Study|Physician Decision|0
7814087|NCT01200810|12279031|FG000|Overall Study|Withdrawal by Subject|1
7814088|NCT01200810|12279032|FG001|Overall Study|Withdrawal by Subject|2
7814089|NCT01200810|12279031|FG000|Overall Study|Sponsor stopped making study drug|3
7814090|NCT01200810|12279032|FG001|Overall Study|Sponsor stopped making study drug|3
7814091|NCT01200992|12279044|FG000|Overall Study|Study terminated early|35
7814092|NCT01200992|12279045|FG001|Overall Study|Study terminated early|41
7814093|NCT01200992|12279044|FG000|Overall Study|Randomized but not treated|2
7814094|NCT01200992|12279045|FG001|Overall Study|Randomized but not treated|0
7814095|NCT01201265|12279070|FG000|Overall Study|Death|14
7909934|NCT02045875|12426178|FG001|Overall Study|Lost to Follow-up|0
7909935|NCT02045875|12426177|FG000|Overall Study|Withdrawal by Subject|4
7909936|NCT02045875|12426178|FG001|Overall Study|Withdrawal by Subject|3
7909937|NCT02045979|12426187|FG000|Overall Study|Informed Consent Withdrawn|2
7909938|NCT02045979|12426188|FG001|Overall Study|Informed Consent Withdrawn|0
7909939|NCT02045979|12426189|FG002|Overall Study|Informed Consent Withdrawn|1
7909940|NCT02045979|12426187|FG000|Overall Study|not specified above|0
7909941|NCT02045979|12426188|FG001|Overall Study|not specified above|1
7909942|NCT02045979|12426189|FG002|Overall Study|not specified above|0
7909943|NCT02046070|12426213|FG000|Overall Study|Progressive Disease|18
7909944|NCT02046070|12426214|FG001|Overall Study|Progressive Disease|11
7909945|NCT02046070|12426215|FG002|Overall Study|Progressive Disease|40
7909946|NCT02046070|12426213|FG000|Overall Study|Adverse Event|8
7909947|NCT02046070|12426214|FG001|Overall Study|Adverse Event|10
7909948|NCT02046070|12426215|FG002|Overall Study|Adverse Event|17
7909949|NCT02046070|12426213|FG000|Overall Study|Withdrawal by Subject|1
7909950|NCT02046070|12426214|FG001|Overall Study|Withdrawal by Subject|2
7909951|NCT02046070|12426215|FG002|Overall Study|Withdrawal by Subject|6
7909952|NCT02046070|12426213|FG000|Overall Study|Study Terminated by Sponsor|1
7909953|NCT02046070|12426214|FG001|Overall Study|Study Terminated by Sponsor|1
7909954|NCT02046070|12426215|FG002|Overall Study|Study Terminated by Sponsor|1
7909955|NCT02046070|12426213|FG000|Overall Study|Reason not Specified|4
7909956|NCT02046070|12426214|FG001|Overall Study|Reason not Specified|4
7909957|NCT02046070|12426215|FG002|Overall Study|Reason not Specified|6
7909958|NCT02046122|12426223|FG000|Overall Study|Physician Decision|8
7909959|NCT02046122|12426223|FG000|Overall Study|Withdrawal by Subject|1
7909960|NCT02046148|12426238|FG000|Overall Study|Lost to Follow-up|1
7909961|NCT02046148|12426239|FG001|Overall Study|Lost to Follow-up|1
7909962|NCT02046148|12426238|FG000|Overall Study|Withdrawal by Subject|0
7909963|NCT02046148|12426239|FG001|Overall Study|Withdrawal by Subject|2
7909964|NCT02046174|12426245|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1
7909965|NCT02046174|12426246|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0
7909966|NCT02046369|12426374|FG000|Overall Study|Adverse Event|3
7909967|NCT02046369|12426375|FG001|Overall Study|Adverse Event|3
7909968|NCT02046369|12426374|FG000|Overall Study|Lack of Efficacy|3
7909969|NCT02046369|12426375|FG001|Overall Study|Lack of Efficacy|3
7909970|NCT02046369|12426374|FG000|Overall Study|Lost to Follow-up|3
7909971|NCT02046369|12426375|FG001|Overall Study|Lost to Follow-up|3
7909972|NCT02046369|12426374|FG000|Overall Study|Protocol Violation|1
7909973|NCT02046369|12426375|FG001|Overall Study|Protocol Violation|2
7909974|NCT02046369|12426374|FG000|Overall Study|Withdrawal by Subject|3
7909975|NCT02046369|12426375|FG001|Overall Study|Withdrawal by Subject|6
7909976|NCT02046369|12426374|FG000|Overall Study|never received study drug|0
7909977|NCT02046369|12426375|FG001|Overall Study|never received study drug|1
7909978|NCT02046369|12426374|FG000|Overall Study|non compliance|1
7909979|NCT02046369|12426375|FG001|Overall Study|non compliance|0
7814096|NCT01201265|12279070|FG000|Overall Study|Insufficient Therapeutic Response|3
7909980|NCT02046564|12426401|FG000|Overall Study|Adverse Event|6
7909981|NCT02046564|12426402|FG001|Overall Study|Adverse Event|3
7909982|NCT02046564|12426401|FG000|Overall Study|Physician Decision|0
7814097|NCT01201265|12279070|FG000|Overall Study|Lost to Follow-up|10
7814098|NCT01201265|12279070|FG000|Overall Study|Withdrawal by Subject|7
7814099|NCT01201265|12279070|FG000|Overall Study|Disease Progression|4
7814100|NCT01201317|12279077|FG000|Overall Study|Withdrawal by Subject|5
7814101|NCT01201317|12279078|FG001|Overall Study|Withdrawal by Subject|0
7814102|NCT01201317|12279079|FG002|Overall Study|Withdrawal by Subject|3
7814103|NCT01201317|12279077|FG000|Overall Study|Adverse Event|2
7814104|NCT01201317|12279078|FG001|Overall Study|Adverse Event|2
7814105|NCT01201317|12279079|FG002|Overall Study|Adverse Event|2
7814106|NCT01201317|12279077|FG000|Overall Study|Screen failure|1
7814107|NCT01201317|12279078|FG001|Overall Study|Screen failure|1
7814108|NCT01201317|12279079|FG002|Overall Study|Screen failure|0
7814109|NCT01201317|12279077|FG000|Overall Study|Protocol Violation|0
7814110|NCT01201317|12279078|FG001|Overall Study|Protocol Violation|1
7814111|NCT01201317|12279079|FG002|Overall Study|Protocol Violation|1
7814112|NCT01201317|12279077|FG000|Overall Study|Death|0
7814113|NCT01201317|12279078|FG001|Overall Study|Death|1
7909983|NCT02046564|12426402|FG001|Overall Study|Physician Decision|1
7909984|NCT02046564|12426401|FG000|Overall Study|Protocol Violation|3
7814114|NCT01201317|12279079|FG002|Overall Study|Death|0
7814115|NCT01201317|12279077|FG000|Overall Study|Study-specific withdrawal criteria|0
7814116|NCT01201317|12279078|FG001|Overall Study|Study-specific withdrawal criteria|0
7814117|NCT01201317|12279079|FG002|Overall Study|Study-specific withdrawal criteria|1
7814118|NCT01201317|12279077|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0
7814119|NCT01201317|12279078|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1
7814120|NCT01201317|12279079|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0
7814121|NCT01201317|12279077|FG000|Overall Study|Decrease in renal function|0
7814122|NCT01201317|12279078|FG001|Overall Study|Decrease in renal function|1
7814123|NCT01201317|12279079|FG002|Overall Study|Decrease in renal function|0
7814124|NCT01201317|12279077|FG000|Overall Study|Lack of Efficacy|1
7814125|NCT01201317|12279078|FG001|Overall Study|Lack of Efficacy|0
7814126|NCT01201317|12279079|FG002|Overall Study|Lack of Efficacy|0
7814127|NCT01201317|12279077|FG000|Overall Study|Safety, possible history of tuberculosis|0
7909985|NCT02046564|12426402|FG001|Overall Study|Protocol Violation|1
7909986|NCT02046564|12426401|FG000|Overall Study|Withdrawal by Subject|4
7909987|NCT02046564|12426402|FG001|Overall Study|Withdrawal by Subject|10
7909988|NCT02046564|12426401|FG000|Overall Study|Subject met withdrawal criteria|2
7909989|NCT02046564|12426402|FG001|Overall Study|Subject met withdrawal criteria|5
7909990|NCT02046603|12426410|FG000|Overall Study|Other|11
7909991|NCT02046603|12426411|FG001|Overall Study|Other|66
7909992|NCT02046603|12426410|FG000|Overall Study|Protocol Violation|0
7909993|NCT02046603|12426411|FG001|Overall Study|Protocol Violation|1
7909994|NCT02046603|12426410|FG000|Overall Study|Participant/legal guardian decision|1
7909995|NCT02046603|12426411|FG001|Overall Study|Participant/legal guardian decision|3
7909996|NCT02046603|12426410|FG000|Overall Study|Physician Decision|2
7909997|NCT02046603|12426411|FG001|Overall Study|Physician Decision|1
7909998|NCT02046603|12426410|FG000|Overall Study|Lost to Follow-up|1
7909999|NCT02046603|12426411|FG001|Overall Study|Lost to Follow-up|2
7910000|NCT02046603|12426410|FG000|Overall Study|Death|0
7910001|NCT02046603|12426411|FG001|Overall Study|Death|1
7910002|NCT02046603|12426410|FG000|Overall Study|Adverse Event|0
7910003|NCT02046603|12426411|FG001|Overall Study|Adverse Event|1
7910004|NCT02046616|12426418|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
7910005|NCT02046616|12426418|FG000|24-Week Treatment Period|Any Other Adverse Event|13
7910006|NCT02046616|12426418|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1
7910007|NCT02046616|12426418|FG000|24-Week Treatment Period|Physician Decision|3
7910008|NCT02046616|12426418|FG000|24-Week Treatment Period|Other|1
7910009|NCT02046616|12426418|FG000|8-Week FU Period|Lost to Follow-up|1
7910010|NCT02046993|12426467|FG000|Overall Study|Withdrawal by Subject|2
7910011|NCT02046993|12426468|FG001|Overall Study|Withdrawal by Subject|10
7910012|NCT02046993|12426467|FG000|Overall Study|Lost to Follow-up|1
7910013|NCT02046993|12426468|FG001|Overall Study|Lost to Follow-up|1
7910014|NCT02047045|12426489|FG000|Baseline|Withdrawal by Subject|3
7910015|NCT02047045|12426490|FG001|Baseline|Withdrawal by Subject|2
7910016|NCT02047045|12426489|FG000|Treatment Period (8 Weeks )|Adverse Event|3
7910017|NCT02047045|12426490|FG001|Treatment Period (8 Weeks )|Adverse Event|1
7910018|NCT02047045|12426489|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1
7910019|NCT02047045|12426490|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3
7910020|NCT02047045|12426489|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3
7910021|NCT02047045|12426490|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5
7910022|NCT02047045|12426489|FG000|Treatment Period (8 Weeks )|moved far away out of work|3
7910023|NCT02047045|12426490|FG001|Treatment Period (8 Weeks )|moved far away out of work|0
7910024|NCT02047045|12426489|FG000|Treatment Period (8 Weeks )|no reason was given|1
7910025|NCT02047045|12426490|FG001|Treatment Period (8 Weeks )|no reason was given|0
7910026|NCT02047045|12426489|FG000|Treatment Period (8 Weeks )|refused to take drugs|0
7910027|NCT02047045|12426490|FG001|Treatment Period (8 Weeks )|refused to take drugs|5
7910028|NCT02047045|12426489|FG000|Treatment Period (8 Weeks )|for safety considerations|0
7910029|NCT02047045|12426490|FG001|Treatment Period (8 Weeks )|for safety considerations|1
7910030|NCT02047045|12426489|FG000|Follow-up Period (24 Weeks)|Adverse Event|1
7910031|NCT02047045|12426490|FG001|Follow-up Period (24 Weeks)|Adverse Event|1
7910032|NCT02047110|12426500|FG000|DB Treatment Period up to Week 24|Adverse Event|1
7910033|NCT02047110|12426501|FG001|DB Treatment Period up to Week 24|Adverse Event|0
7910034|NCT02047110|12426502|FG002|DB Treatment Period up to Week 24|Adverse Event|0
7910035|NCT02047110|12426503|FG003|DB Treatment Period up to Week 24|Adverse Event|0
7814128|NCT01201317|12279078|FG001|Overall Study|Safety, possible history of tuberculosis|0
7814129|NCT01201317|12279079|FG002|Overall Study|Safety, possible history of tuberculosis|1
7814130|NCT01201343|12279087|FG000|Overall Study|Adverse Event|6
7814131|NCT01201343|12279087|FG000|Overall Study|Withdrawal by Subject|5
7814132|NCT01201343|12279087|FG000|Overall Study|Lost to Follow-up|2
7814133|NCT01201343|12279087|FG000|Overall Study|Lack of Efficacy|2
7814134|NCT01201343|12279087|FG000|Overall Study|Participant wrongly included in trial|1
7814135|NCT01201343|12279087|FG000|Overall Study|Randomized, not treated|3
7814136|NCT01201356|12279091|FG000|Overall Study|Adverse Event|170
7814137|NCT01201356|12279091|FG000|Overall Study|Abnormal laboratory value(s)|51
7814138|NCT01201356|12279091|FG000|Overall Study|Abnormal test procedure result(s)|3
7814139|NCT01201356|12279091|FG000|Overall Study|Unsatisfactory therapeutic effect|112
7814140|NCT01201356|12279091|FG000|Overall Study|Condition no longer requires study drug|12
7814141|NCT01201356|12279091|FG000|Overall Study|Withdrawal by Subject|144
7814142|NCT01201356|12279091|FG000|Overall Study|Lost to Follow-up|50
7814143|NCT01201356|12279091|FG000|Overall Study|administrative problems|74
7910036|NCT02047110|12426500|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1
7910037|NCT02047110|12426501|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0
7910038|NCT02047110|12426502|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0
7814144|NCT01201356|12279091|FG000|Overall Study|Death|16
7814145|NCT01201356|12279091|FG000|Overall Study|Protocol Violation|12
7814146|NCT01201759|12279110|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
7814147|NCT01201759|12279111|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
7814148|NCT01201759|12279110|FG000|Visit 3 - Washout|Adverse Event|0
7814149|NCT01201759|12279111|FG001|Visit 3 - Washout|Adverse Event|3
7910039|NCT02047110|12426503|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0
7910040|NCT02047110|12426500|FG000|DB Treatment Period up to Week 24|Protocol Violation|1
7910041|NCT02047110|12426501|FG001|DB Treatment Period up to Week 24|Protocol Violation|0
7910042|NCT02047110|12426502|FG002|DB Treatment Period up to Week 24|Protocol Violation|0
7910043|NCT02047110|12426503|FG003|DB Treatment Period up to Week 24|Protocol Violation|0
7910044|NCT02047110|12426500|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1
7910045|NCT02047110|12426501|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0
7910046|NCT02047110|12426502|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0
7910047|NCT02047110|12426503|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1
7910048|NCT02047110|12426500|FG000|DB Treatment Period up to Week 24|Other than specified|1
7910049|NCT02047110|12426501|FG001|DB Treatment Period up to Week 24|Other than specified|2
7910050|NCT02047110|12426502|FG002|DB Treatment Period up to Week 24|Other than specified|3
7910051|NCT02047110|12426503|FG003|DB Treatment Period up to Week 24|Other than specified|1
7910052|NCT02047110|12426500|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
7910053|NCT02047110|12426501|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1
7910054|NCT02047110|12426502|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
7910055|NCT02047110|12426503|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
7910056|NCT02047110|12426500|FG000|DB (Week 12 up to Week 24)|Other than specified|0
7814150|NCT01201759|12279110|FG000|Visit 3 - Washout|Lost to Follow-up|1
7814151|NCT01201759|12279111|FG001|Visit 3 - Washout|Lost to Follow-up|0
7814152|NCT01201759|12279110|FG000|Visit 4 Crossover|Lost to Follow-up|0
7814153|NCT01201759|12279111|FG001|Visit 4 Crossover|Lost to Follow-up|1
7814154|NCT01201785|12279130|FG000|Overall Study|Lost to Follow-up|16
7814155|NCT01201798|12279136|FG000|Overall Study|Adverse Event|2
7814156|NCT01201798|12279137|FG001|Overall Study|Adverse Event|0
7814157|NCT01201798|12279136|FG000|Overall Study|Lost to Follow-up|3
7814158|NCT01201798|12279137|FG001|Overall Study|Lost to Follow-up|5
7814159|NCT01201798|12279136|FG000|Overall Study|Decision Unrelated to an Adverse Event|1
7814160|NCT01201798|12279137|FG001|Overall Study|Decision Unrelated to an Adverse Event|1
7814161|NCT01201798|12279136|FG000|Overall Study|Noncompliance|1
7814162|NCT01201798|12279137|FG001|Overall Study|Noncompliance|0
7814163|NCT01201798|12279136|FG000|Overall Study|Protocol Violation|1
7814164|NCT01201798|12279137|FG001|Overall Study|Protocol Violation|1
7814165|NCT01201798|12279136|FG000|Overall Study|Treatment Failure|1
7814166|NCT01201798|12279137|FG001|Overall Study|Treatment Failure|8
7814167|NCT01201811|12279143|FG000|Overall Study|Adverse Event|6
7814168|NCT01201811|12279143|FG000|Overall Study|Disease progression|3
7814169|NCT01201811|12279143|FG000|Overall Study|Withdrawal by Subject|3
7814170|NCT01201811|12279143|FG000|Overall Study|Death|4
7814171|NCT01201811|12279143|FG000|Overall Study|Treatment Failure|2
7814172|NCT01201811|12279143|FG000|Overall Study|Physician Decision|1
7814173|NCT01201850|12279147|FG000|Overall Study|Tumor progression|4
7814174|NCT01201915|12279167|FG000|Overall Study|Adverse Event|2
7814175|NCT01201915|12279168|FG001|Overall Study|Adverse Event|1
7814176|NCT01201915|12279169|FG002|Overall Study|Adverse Event|1
7814177|NCT01201915|12279167|FG000|Overall Study|Lost to Follow-up|0
7814178|NCT01201915|12279168|FG001|Overall Study|Lost to Follow-up|4
7814179|NCT01201915|12279169|FG002|Overall Study|Lost to Follow-up|0
7814180|NCT01201915|12279167|FG000|Overall Study|Physician Decision|3
7814181|NCT01201915|12279168|FG001|Overall Study|Physician Decision|0
7814182|NCT01201915|12279169|FG002|Overall Study|Physician Decision|0
7814183|NCT01201915|12279167|FG000|Overall Study|Subject Decision|3
7814184|NCT01201915|12279168|FG001|Overall Study|Subject Decision|3
7814185|NCT01201915|12279169|FG002|Overall Study|Subject Decision|5
7814186|NCT01201915|12279167|FG000|Overall Study|Target Lesion Progression|0
7814187|NCT01201915|12279168|FG001|Overall Study|Target Lesion Progression|3
7814188|NCT01201915|12279169|FG002|Overall Study|Target Lesion Progression|0
7814189|NCT01201967|12279179|FG000|Overall Study|Lost to Follow-up|6
7814190|NCT01201967|12279180|FG001|Overall Study|Lost to Follow-up|5
7814191|NCT01202175|12279211|FG000|Overall Study|Lost to Follow-up|2
7814192|NCT01202175|12279211|FG000|Overall Study|Withdrawal by Subject|1
7814193|NCT01202175|12279211|FG000|Overall Study|Adverse Event|2
7814194|NCT01202188|12279221|FG000|Overall Study|Protocol deviation|14
7814195|NCT01202188|12279222|FG001|Overall Study|Protocol deviation|8
7814196|NCT01202188|12279223|FG002|Overall Study|Protocol deviation|12
7814197|NCT01202188|12279224|FG003|Overall Study|Protocol deviation|10
7814198|NCT01202188|12279225|FG004|Overall Study|Protocol deviation|11
7814199|NCT01202188|12279221|FG000|Overall Study|Subject withdrew consent|12
7814200|NCT01202188|12279222|FG001|Overall Study|Subject withdrew consent|13
7814201|NCT01202188|12279223|FG002|Overall Study|Subject withdrew consent|22
7814202|NCT01202188|12279224|FG003|Overall Study|Subject withdrew consent|11
7814203|NCT01202188|12279225|FG004|Overall Study|Subject withdrew consent|13
7814204|NCT01202188|12279221|FG000|Overall Study|Adverse Event|5
7814205|NCT01202188|12279222|FG001|Overall Study|Adverse Event|23
7814206|NCT01202188|12279223|FG002|Overall Study|Adverse Event|13
7814207|NCT01202188|12279224|FG003|Overall Study|Adverse Event|10
7814208|NCT01202188|12279225|FG004|Overall Study|Adverse Event|10
7814209|NCT01202188|12279221|FG000|Overall Study|Administrative problems|3
7814210|NCT01202188|12279222|FG001|Overall Study|Administrative problems|2
7814211|NCT01202188|12279223|FG002|Overall Study|Administrative problems|1
7814212|NCT01202188|12279224|FG003|Overall Study|Administrative problems|1
7814213|NCT01202188|12279225|FG004|Overall Study|Administrative problems|2
7814214|NCT01202188|12279221|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7814215|NCT01202188|12279222|FG001|Overall Study|Unsatisfactory therapeutic effect|8
7814216|NCT01202188|12279223|FG002|Overall Study|Unsatisfactory therapeutic effect|2
7814217|NCT01202188|12279224|FG003|Overall Study|Unsatisfactory therapeutic effect|5
7814218|NCT01202188|12279225|FG004|Overall Study|Unsatisfactory therapeutic effect|8
7814219|NCT01202188|12279221|FG000|Overall Study|Lost to Follow-up|1
7814220|NCT01202188|12279222|FG001|Overall Study|Lost to Follow-up|1
7814221|NCT01202188|12279223|FG002|Overall Study|Lost to Follow-up|0
7814222|NCT01202188|12279224|FG003|Overall Study|Lost to Follow-up|4
7814223|NCT01202188|12279225|FG004|Overall Study|Lost to Follow-up|1
7814224|NCT01202188|12279221|FG000|Overall Study|Death|1
7814225|NCT01202188|12279222|FG001|Overall Study|Death|1
7814226|NCT01202188|12279223|FG002|Overall Study|Death|1
7814227|NCT01202188|12279224|FG003|Overall Study|Death|1
7814228|NCT01202188|12279225|FG004|Overall Study|Death|0
7910057|NCT02047110|12426501|FG001|DB (Week 12 up to Week 24)|Other than specified|1
7910058|NCT02047110|12426502|FG002|DB (Week 12 up to Week 24)|Other than specified|1
7910059|NCT02047110|12426503|FG003|DB (Week 12 up to Week 24)|Other than specified|0
7910060|NCT02047110|12426500|FG000|Escape Treatment Period|Withdrawal by Subject|1
7910061|NCT02047110|12426501|FG001|Escape Treatment Period|Withdrawal by Subject|2
7910062|NCT02047110|12426502|FG002|Escape Treatment Period|Withdrawal by Subject|1
7910063|NCT02047110|12426503|FG003|Escape Treatment Period|Withdrawal by Subject|1
7910064|NCT02047110|12426500|FG000|Escape Treatment Period|Adverse Event|1
7910065|NCT02047110|12426501|FG001|Escape Treatment Period|Adverse Event|2
7910066|NCT02047110|12426502|FG002|Escape Treatment Period|Adverse Event|2
7910067|NCT02047110|12426503|FG003|Escape Treatment Period|Adverse Event|0
7910068|NCT02047110|12426500|FG000|Escape Treatment Period|Other than specified|1
7910069|NCT02047110|12426501|FG001|Escape Treatment Period|Other than specified|2
7910070|NCT02047110|12426502|FG002|Escape Treatment Period|Other than specified|0
7910071|NCT02047110|12426503|FG003|Escape Treatment Period|Other than specified|1
7910072|NCT02047110|12426500|FG000|OLE Treatment Period|Other than specified|0
7910073|NCT02047110|12426501|FG001|OLE Treatment Period|Other than specified|0
7910074|NCT02047110|12426502|FG002|OLE Treatment Period|Other than specified|1
7910075|NCT02047110|12426503|FG003|OLE Treatment Period|Other than specified|0
7910076|NCT02047227|12426522|FG000|Overall Study|Adverse Event|2
7910077|NCT02047227|12426523|FG001|Overall Study|Adverse Event|4
7910078|NCT02047227|12426522|FG000|Overall Study|Lost to Follow-up|0
7910079|NCT02047227|12426523|FG001|Overall Study|Lost to Follow-up|3
7910080|NCT02047227|12426522|FG000|Overall Study|Protocol Violation|1
7910081|NCT02047227|12426523|FG001|Overall Study|Protocol Violation|0
7910082|NCT02047227|12426522|FG000|Overall Study|Spontaneous pregnancy|1
7910083|NCT02047227|12426523|FG001|Overall Study|Spontaneous pregnancy|0
7910084|NCT02047227|12426522|FG000|Overall Study|Lack of ovarian response to stimulation|35
7910085|NCT02047227|12426523|FG001|Overall Study|Lack of ovarian response to stimulation|32
7910086|NCT02047227|12426522|FG000|Overall Study|No oocytes retrieved|21
7910087|NCT02047227|12426523|FG001|Overall Study|No oocytes retrieved|20
7814229|NCT01202188|12279221|FG000|Overall Study|Abnormal test procedure result (s)|0
7814230|NCT01202188|12279222|FG001|Overall Study|Abnormal test procedure result (s)|0
7814231|NCT01202188|12279223|FG002|Overall Study|Abnormal test procedure result (s)|2
7814232|NCT01202188|12279224|FG003|Overall Study|Abnormal test procedure result (s)|0
7814233|NCT01202188|12279225|FG004|Overall Study|Abnormal test procedure result (s)|0
7814234|NCT01202227|12279243|FG000|Overall Study|Adverse Event|16
7814235|NCT01202227|12279243|FG000|Overall Study|Withdrawal by Subject|2
7814236|NCT01202227|12279243|FG000|Overall Study|Lack of Efficacy|1
7814237|NCT01202279|12279253|FG000|Overall Study|Adverse Event|8
7814238|NCT01202279|12279254|FG001|Overall Study|Adverse Event|6
7814239|NCT01202279|12279253|FG000|Overall Study|Withdrawal by Subject|13
7814240|NCT01202279|12279254|FG001|Overall Study|Withdrawal by Subject|10
7814241|NCT01202279|12279253|FG000|Overall Study|Physician Decision|0
7814242|NCT01202279|12279254|FG001|Overall Study|Physician Decision|1
7814243|NCT01202279|12279253|FG000|Overall Study|Lost to Follow-up|10
7814244|NCT01202279|12279254|FG001|Overall Study|Lost to Follow-up|7
7814245|NCT01202279|12279253|FG000|Overall Study|Protocol Violation|1
7814246|NCT01202279|12279254|FG001|Overall Study|Protocol Violation|1
7814247|NCT01202279|12279253|FG000|Overall Study|study compliance|5
7814248|NCT01202279|12279254|FG001|Overall Study|study compliance|2
7814249|NCT01202409|12279260|FG000|Overall Study|Adverse Event|1
7814250|NCT01202409|12279260|FG000|Overall Study|Ineligible - KRAS mutants|7
7814251|NCT01202591|12279278|FG000|Overall Study|Adverse Event|2
7814252|NCT01202591|12279279|FG001|Overall Study|Adverse Event|1
7814253|NCT01202591|12279280|FG002|Overall Study|Adverse Event|4
7814254|NCT01202591|12279281|FG003|Overall Study|Adverse Event|4
7814255|NCT01202591|12279282|FG004|Overall Study|Adverse Event|0
7814256|NCT01202591|12279283|FG005|Overall Study|Adverse Event|0
7814257|NCT01202591|12279278|FG000|Overall Study|Other reason as per investigator|3
7814258|NCT01202591|12279279|FG001|Overall Study|Other reason as per investigator|4
7814259|NCT01202591|12279280|FG002|Overall Study|Other reason as per investigator|7
7814260|NCT01202591|12279281|FG003|Overall Study|Other reason as per investigator|3
7814261|NCT01202591|12279282|FG004|Overall Study|Other reason as per investigator|1
7814262|NCT01202591|12279283|FG005|Overall Study|Other reason as per investigator|3
7814263|NCT01202591|12279278|FG000|Overall Study|Withdrawal by Subject|0
7814264|NCT01202591|12279279|FG001|Overall Study|Withdrawal by Subject|0
7814265|NCT01202591|12279280|FG002|Overall Study|Withdrawal by Subject|0
7814266|NCT01202591|12279281|FG003|Overall Study|Withdrawal by Subject|0
7814267|NCT01202591|12279282|FG004|Overall Study|Withdrawal by Subject|2
7814268|NCT01202591|12279283|FG005|Overall Study|Withdrawal by Subject|1
7814269|NCT01202591|12279278|FG000|Overall Study|Objective Disease Progression|0
7814270|NCT01202591|12279279|FG001|Overall Study|Objective Disease Progression|0
7814271|NCT01202591|12279280|FG002|Overall Study|Objective Disease Progression|0
7814272|NCT01202591|12279281|FG003|Overall Study|Objective Disease Progression|0
7814273|NCT01202591|12279282|FG004|Overall Study|Objective Disease Progression|2
7814274|NCT01202591|12279283|FG005|Overall Study|Objective Disease Progression|0
7814275|NCT01202747|12279334|FG000|Overall Study|Withdrawal by Subject|1
7814276|NCT01202760|12279341|FG000|Overall Study|Entry Criteria Not Met|0
7814277|NCT01202760|12279342|FG001|Overall Study|Entry Criteria Not Met|3
7814278|NCT01202760|12279343|FG002|Overall Study|Entry Criteria Not Met|1
7814279|NCT01202760|12279341|FG000|Overall Study|Adverse Event|11
7814280|NCT01202760|12279342|FG001|Overall Study|Adverse Event|9
7814281|NCT01202760|12279343|FG002|Overall Study|Adverse Event|10
7814282|NCT01202760|12279341|FG000|Overall Study|Death|2
7814283|NCT01202760|12279342|FG001|Overall Study|Death|1
7814284|NCT01202760|12279343|FG002|Overall Study|Death|0
7814285|NCT01202760|12279341|FG000|Overall Study|Lack of Efficacy|6
7814286|NCT01202760|12279342|FG001|Overall Study|Lack of Efficacy|8
7814287|NCT01202760|12279343|FG002|Overall Study|Lack of Efficacy|7
7814288|NCT01202760|12279341|FG000|Overall Study|Lost to Follow-up|0
7814289|NCT01202760|12279342|FG001|Overall Study|Lost to Follow-up|2
7814290|NCT01202760|12279343|FG002|Overall Study|Lost to Follow-up|1
7814291|NCT01202760|12279341|FG000|Overall Study|Parent / Caregiver Decision|0
7814292|NCT01202760|12279342|FG001|Overall Study|Parent / Caregiver Decision|1
7814293|NCT01202760|12279343|FG002|Overall Study|Parent / Caregiver Decision|0
7814294|NCT01202760|12279341|FG000|Overall Study|Withdrawal by Subject|17
7814295|NCT01202760|12279342|FG001|Overall Study|Withdrawal by Subject|18
7814296|NCT01202760|12279343|FG002|Overall Study|Withdrawal by Subject|14
7814297|NCT01202760|12279341|FG000|Overall Study|Physician Decision|0
7814298|NCT01202760|12279342|FG001|Overall Study|Physician Decision|1
7910088|NCT02047227|12426522|FG000|Overall Study|No fertilization|61
7910089|NCT02047227|12426523|FG001|Overall Study|No fertilization|51
7910090|NCT02047227|12426522|FG000|Overall Study|Intention to freeze all embryos|1
7910091|NCT02047227|12426523|FG001|Overall Study|Intention to freeze all embryos|0
7910092|NCT02047227|12426522|FG000|Overall Study|All embryos discarded|12
7910093|NCT02047227|12426523|FG001|Overall Study|All embryos discarded|11
7910094|NCT02047227|12426522|FG000|Overall Study|Other|10
7910095|NCT02047227|12426523|FG001|Overall Study|Other|9
7910096|NCT02047253|12426529|FG000|Overall Study|Lost to Follow-up|8
7910097|NCT02047318|12426537|FG000|Core Study Period|Did not consent to 52-week follow- up|8
7910098|NCT02047318|12426537|FG000|Core Study Period|Adverse Event|1
7910099|NCT02047318|12426537|FG000|Core Study Period|Withdrawal by caregiver|3
7910100|NCT02047318|12426537|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1
7910101|NCT02047604|12426577|FG000|Overall Study|Withdrawal by Subject|0
7910102|NCT02047604|12426578|FG001|Overall Study|Withdrawal by Subject|0
7910103|NCT02047604|12426579|FG002|Overall Study|Withdrawal by Subject|0
7910104|NCT02047604|12426580|FG003|Overall Study|Withdrawal by Subject|0
7910105|NCT02047604|12426581|FG004|Overall Study|Withdrawal by Subject|1
7910106|NCT02047604|12426582|FG005|Overall Study|Withdrawal by Subject|1
7910107|NCT02047734|12426606|FG000|Overall Study|Adverse Event|18
7910108|NCT02047734|12426607|FG001|Overall Study|Adverse Event|13
7910109|NCT02047734|12426608|FG002|Overall Study|Adverse Event|13
7910110|NCT02047734|12426606|FG000|Overall Study|Lack of Efficacy|4
7910111|NCT02047734|12426607|FG001|Overall Study|Lack of Efficacy|5
7910112|NCT02047734|12426608|FG002|Overall Study|Lack of Efficacy|1
7814299|NCT01202760|12279343|FG002|Overall Study|Physician Decision|0
7814300|NCT01202760|12279341|FG000|Overall Study|Protocol Violation|7
7814301|NCT01202760|12279342|FG001|Overall Study|Protocol Violation|5
7814302|NCT01202760|12279343|FG002|Overall Study|Protocol Violation|2
7814303|NCT01202760|12279341|FG000|Overall Study|Sponsor Decision|4
7814304|NCT01202760|12279342|FG001|Overall Study|Sponsor Decision|4
7814305|NCT01202760|12279343|FG002|Overall Study|Sponsor Decision|0
7814306|NCT01202773|12279366|FG000|Overall Study|Adverse Event|4
7814307|NCT01202773|12279367|FG001|Overall Study|Adverse Event|5
7814308|NCT01202773|12279368|FG002|Overall Study|Adverse Event|5
7814309|NCT01202773|12279366|FG000|Overall Study|Lack of Efficacy|5
7814310|NCT01202773|12279367|FG001|Overall Study|Lack of Efficacy|4
7814311|NCT01202773|12279368|FG002|Overall Study|Lack of Efficacy|9
7814312|NCT01202773|12279366|FG000|Overall Study|Entry Criteria Not Met|2
7814313|NCT01202773|12279367|FG001|Overall Study|Entry Criteria Not Met|0
7814314|NCT01202773|12279368|FG002|Overall Study|Entry Criteria Not Met|1
7814315|NCT01202773|12279366|FG000|Overall Study|Lost to Follow-up|1
7814316|NCT01202773|12279367|FG001|Overall Study|Lost to Follow-up|2
7814317|NCT01202773|12279368|FG002|Overall Study|Lost to Follow-up|2
7814318|NCT01202773|12279366|FG000|Overall Study|Withdrawal by Subject|13
7814319|NCT01202773|12279367|FG001|Overall Study|Withdrawal by Subject|6
7814320|NCT01202773|12279368|FG002|Overall Study|Withdrawal by Subject|5
7814321|NCT01202773|12279366|FG000|Overall Study|Physician Decision|2
7814322|NCT01202773|12279367|FG001|Overall Study|Physician Decision|0
7814323|NCT01202773|12279368|FG002|Overall Study|Physician Decision|0
7814324|NCT01202773|12279366|FG000|Overall Study|Protocol Violation|11
7814325|NCT01202773|12279367|FG001|Overall Study|Protocol Violation|6
7814326|NCT01202773|12279368|FG002|Overall Study|Protocol Violation|10
7814327|NCT01202773|12279366|FG000|Overall Study|Sponsor Decision|19
7814328|NCT01202773|12279367|FG001|Overall Study|Sponsor Decision|20
7814329|NCT01202773|12279368|FG002|Overall Study|Sponsor Decision|23
7861960|NCT01597245|12351197|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
7861961|NCT01597245|12351198|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
7861962|NCT01597245|12351199|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7861963|NCT01597245|12351200|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
7861964|NCT01597245|12351201|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7861965|NCT01597245|12351202|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7861966|NCT01597245|12351203|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7861967|NCT01597245|12351204|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7861968|NCT01597245|12351205|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7861969|NCT01597245|12351206|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7861970|NCT01597245|12351207|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7814330|NCT01202877|12279389|FG000|Overall Study|Disease Progression|0
7814331|NCT01202877|12279390|FG001|Overall Study|Disease Progression|1
7814332|NCT01202877|12279391|FG002|Overall Study|Disease Progression|2
7814333|NCT01202877|12279389|FG000|Overall Study|Adverse Event|0
7814334|NCT01202877|12279390|FG001|Overall Study|Adverse Event|0
7814335|NCT01202877|12279391|FG002|Overall Study|Adverse Event|2
7814336|NCT01202877|12279389|FG000|Overall Study|Withdrawal by Subject|0
7814337|NCT01202877|12279390|FG001|Overall Study|Withdrawal by Subject|0
7814338|NCT01202877|12279391|FG002|Overall Study|Withdrawal by Subject|1
7814339|NCT01202877|12279389|FG000|Overall Study|Death|0
7814340|NCT01202877|12279390|FG001|Overall Study|Death|0
7814341|NCT01202877|12279391|FG002|Overall Study|Death|1
7814342|NCT01202903|12279401|FG000|Overall Study|Administrative Probelms|1
7814343|NCT01202903|12279402|FG001|Overall Study|Administrative Probelms|4
7814344|NCT01202903|12279401|FG000|Overall Study|Protocol Violation|0
7814345|NCT01202903|12279402|FG001|Overall Study|Protocol Violation|1
7814346|NCT01202903|12279401|FG000|Overall Study|Death|1
7814347|NCT01202903|12279402|FG001|Overall Study|Death|0
7814348|NCT01202903|12279401|FG000|Overall Study|Lost to Follow-up|1
7814349|NCT01202903|12279402|FG001|Overall Study|Lost to Follow-up|1
7814350|NCT01202903|12279401|FG000|Overall Study|Lack of Efficacy|1
7814351|NCT01202903|12279402|FG001|Overall Study|Lack of Efficacy|3
7814352|NCT01202903|12279401|FG000|Overall Study|Adverse Event|3
7814353|NCT01202903|12279402|FG001|Overall Study|Adverse Event|3
7814354|NCT01202903|12279401|FG000|Overall Study|Withdrawal by Subject|4
7814355|NCT01202903|12279402|FG001|Overall Study|Withdrawal by Subject|4
7814356|NCT01202955|12279410|FG000|Period 1: 10 Days|Withdrawal by Subject|0
7814357|NCT01202955|12279411|FG001|Period 1: 10 Days|Withdrawal by Subject|2
7814358|NCT01203072|12279438|FG000|Overall Study|Adverse Event|5
7814359|NCT01203072|12279439|FG001|Overall Study|Adverse Event|3
7814360|NCT01203072|12279440|FG002|Overall Study|Adverse Event|2
7814361|NCT01203072|12279441|FG003|Overall Study|Adverse Event|4
7814362|NCT01203072|12279442|FG004|Overall Study|Adverse Event|2
7814363|NCT01203072|12279438|FG000|Overall Study|Lack of Efficacy|1
7814364|NCT01203072|12279439|FG001|Overall Study|Lack of Efficacy|0
7814365|NCT01203072|12279440|FG002|Overall Study|Lack of Efficacy|0
7814366|NCT01203072|12279441|FG003|Overall Study|Lack of Efficacy|0
7814367|NCT01203072|12279442|FG004|Overall Study|Lack of Efficacy|0
7814368|NCT01203072|12279438|FG000|Overall Study|Lost to Follow-up|0
7814369|NCT01203072|12279439|FG001|Overall Study|Lost to Follow-up|1
7814370|NCT01203072|12279440|FG002|Overall Study|Lost to Follow-up|0
7814371|NCT01203072|12279441|FG003|Overall Study|Lost to Follow-up|0
7814372|NCT01203072|12279442|FG004|Overall Study|Lost to Follow-up|0
7814373|NCT01203072|12279438|FG000|Overall Study|Protocol Violation|2
7814374|NCT01203072|12279439|FG001|Overall Study|Protocol Violation|0
7814375|NCT01203072|12279440|FG002|Overall Study|Protocol Violation|0
7814376|NCT01203072|12279441|FG003|Overall Study|Protocol Violation|0
7814377|NCT01203072|12279442|FG004|Overall Study|Protocol Violation|1
7814378|NCT01203072|12279438|FG000|Overall Study|Withdrawal by Subject|2
7814379|NCT01203072|12279439|FG001|Overall Study|Withdrawal by Subject|2
7814380|NCT01203072|12279440|FG002|Overall Study|Withdrawal by Subject|1
7814381|NCT01203072|12279441|FG003|Overall Study|Withdrawal by Subject|2
7814382|NCT01203072|12279442|FG004|Overall Study|Withdrawal by Subject|3
7814383|NCT01203098|12279457|FG000|Overall Study|Adverse Event|3
7814384|NCT01203098|12279458|FG001|Overall Study|Adverse Event|1
7814385|NCT01203098|12279459|FG002|Overall Study|Adverse Event|7
7814386|NCT01203098|12279457|FG000|Overall Study|Lost to Follow-up|0
7814387|NCT01203098|12279458|FG001|Overall Study|Lost to Follow-up|0
7814388|NCT01203098|12279459|FG002|Overall Study|Lost to Follow-up|1
7814389|NCT01203098|12279457|FG000|Overall Study|Physician Decision|2
7814390|NCT01203098|12279458|FG001|Overall Study|Physician Decision|2
7814391|NCT01203098|12279459|FG002|Overall Study|Physician Decision|0
7814392|NCT01203098|12279457|FG000|Overall Study|Withdrawal by Subject|1
7814393|NCT01203098|12279458|FG001|Overall Study|Withdrawal by Subject|1
7814394|NCT01203098|12279459|FG002|Overall Study|Withdrawal by Subject|3
7814395|NCT01203787|12279514|FG000|Overall Study|Death|12
7814396|NCT01203787|12279515|FG001|Overall Study|Death|10
7814397|NCT01203787|12279514|FG000|Overall Study|Withdrawal by Subject|6
7814398|NCT01203787|12279515|FG001|Overall Study|Withdrawal by Subject|2
7814399|NCT01203787|12279514|FG000|Overall Study|Lost to Follow-up|2
7814400|NCT01203787|12279515|FG001|Overall Study|Lost to Follow-up|0
7814401|NCT01203787|12279514|FG000|Overall Study|Adverse Event|11
7814402|NCT01203787|12279515|FG001|Overall Study|Adverse Event|15
7814403|NCT01203852|12279532|FG000|Metoprolol 8 Weeks|Physician Decision|470
7814404|NCT01203852|12279532|FG000|Washout 2 Weeks|Physician Decision|46
7814405|NCT01203878|12279542|FG000|Overall Study|Withdrawal by Subject|0
7814406|NCT01203878|12279543|FG001|Overall Study|Withdrawal by Subject|0
7814407|NCT01203878|12279544|FG002|Overall Study|Withdrawal by Subject|1
7814408|NCT01203878|12279542|FG000|Overall Study|Adverse Event|0
7814409|NCT01203878|12279543|FG001|Overall Study|Adverse Event|0
7814410|NCT01203878|12279544|FG002|Overall Study|Adverse Event|2
7814411|NCT01203917|12279551|FG000|Overall Study|Death|29
7814412|NCT01203917|12279551|FG000|Overall Study|Lost to Follow-up|2
7814413|NCT01203917|12279551|FG000|Overall Study|Withdrawal by Subject|3
7814414|NCT01203917|12279551|FG000|Overall Study|Due to objective disease progression|1
7814415|NCT01203917|12279551|FG000|Overall Study|Due to EGFR M+I patient|1
7814416|NCT01203930|12279557|FG000|Overall Study|Disease Progression|0
7814417|NCT01203930|12279558|FG001|Overall Study|Disease Progression|4
7814418|NCT01203930|12279557|FG000|Overall Study|Death|3
7814419|NCT01203930|12279558|FG001|Overall Study|Death|1
7814420|NCT01203930|12279557|FG000|Overall Study|Withdrew Consent|1
7814421|NCT01203930|12279558|FG001|Overall Study|Withdrew Consent|10
7814422|NCT01203930|12279557|FG000|Overall Study|Investigator Request|0
7814423|NCT01203930|12279558|FG001|Overall Study|Investigator Request|8
7814424|NCT01203930|12279557|FG000|Overall Study|Study Terminated by Sponsor|0
7814425|NCT01203930|12279558|FG001|Overall Study|Study Terminated by Sponsor|12
7814426|NCT01203930|12279557|FG000|Overall Study|Poor tolerance of study drug|0
7814427|NCT01203930|12279558|FG001|Overall Study|Poor tolerance of study drug|1
7814428|NCT01203930|12279557|FG000|Overall Study|Adverse Event|17
7814429|NCT01203930|12279558|FG001|Overall Study|Adverse Event|5
7814430|NCT01203956|12279566|FG000|Second Two-week Period|Non-compliant: no evaluable results|5
7814431|NCT01203956|12279567|FG001|Second Two-week Period|Non-compliant: no evaluable results|6
7814432|NCT01204294|12279589|FG000|Overall Study|Adverse Event|2
7814433|NCT01204294|12279590|FG001|Overall Study|Adverse Event|6
7814434|NCT01204294|12279591|FG002|Overall Study|Adverse Event|0
7814435|NCT01204294|12279592|FG003|Overall Study|Adverse Event|7
7814436|NCT01204294|12279593|FG004|Overall Study|Adverse Event|1
7814437|NCT01204294|12279594|FG005|Overall Study|Adverse Event|4
7814438|NCT01204294|12279595|FG006|Overall Study|Adverse Event|0
7814439|NCT01204294|12279589|FG000|Overall Study|Protocol Violation|1
7814440|NCT01204294|12279590|FG001|Overall Study|Protocol Violation|0
7910113|NCT02047734|12426606|FG000|Overall Study|Protocol Violation|3
7910114|NCT02047734|12426607|FG001|Overall Study|Protocol Violation|1
7910115|NCT02047734|12426608|FG002|Overall Study|Protocol Violation|1
7910116|NCT02047734|12426606|FG000|Overall Study|Lost to Follow-up|1
7910117|NCT02047734|12426607|FG001|Overall Study|Lost to Follow-up|4
7910118|NCT02047734|12426608|FG002|Overall Study|Lost to Follow-up|0
7910119|NCT02047734|12426606|FG000|Overall Study|Death|0
7910120|NCT02047734|12426607|FG001|Overall Study|Death|1
7910121|NCT02047734|12426608|FG002|Overall Study|Death|0
7910122|NCT02047734|12426606|FG000|Overall Study|Withdrawal by Subject|30
7910123|NCT02047734|12426607|FG001|Overall Study|Withdrawal by Subject|31
7910124|NCT02047734|12426608|FG002|Overall Study|Withdrawal by Subject|19
7910125|NCT02047734|12426606|FG000|Overall Study|Physician Decision|7
7910126|NCT02047734|12426607|FG001|Overall Study|Physician Decision|6
7910127|NCT02047734|12426608|FG002|Overall Study|Physician Decision|5
7910128|NCT02047734|12426606|FG000|Overall Study|Miscellaneous|2
7910129|NCT02047734|12426607|FG001|Overall Study|Miscellaneous|4
7910130|NCT02047734|12426608|FG002|Overall Study|Miscellaneous|6
7910131|NCT02047734|12426606|FG000|Overall Study|Did Not Receive Study Drug|2
7910132|NCT02047734|12426607|FG001|Overall Study|Did Not Receive Study Drug|4
7910133|NCT02047734|12426608|FG002|Overall Study|Did Not Receive Study Drug|1
7910134|NCT02047903|12426616|FG000|Overall Study|Adverse Event|14
7910135|NCT02047903|12426616|FG000|Overall Study|Serious adverse event|10
7910136|NCT02047903|12426616|FG000|Overall Study|Withdrawal by Subject|16
7910137|NCT02047903|12426616|FG000|Overall Study|Lost to Follow-up|4
7910138|NCT02047903|12426616|FG000|Overall Study|Reason not listed|6
7910139|NCT02047903|12426616|FG000|Overall Study|Not Treated|9
7910140|NCT02048072|12426629|FG000|Overall Study|Adverse Event|3
7910141|NCT02048072|12426629|FG000|Overall Study|Lost to Follow-up|1
7814441|NCT01204294|12279591|FG002|Overall Study|Protocol Violation|2
7814442|NCT01204294|12279592|FG003|Overall Study|Protocol Violation|1
7814443|NCT01204294|12279593|FG004|Overall Study|Protocol Violation|0
7814444|NCT01204294|12279594|FG005|Overall Study|Protocol Violation|0
7910142|NCT02048241|12426635|FG000|Overall Study|Withdrawal by Subject|0
7910143|NCT02048241|12426636|FG001|Overall Study|Withdrawal by Subject|1
7814445|NCT01204294|12279595|FG006|Overall Study|Protocol Violation|0
7814446|NCT01204294|12279589|FG000|Overall Study|Withdrawal by Subject|0
7814447|NCT01204294|12279590|FG001|Overall Study|Withdrawal by Subject|2
7814448|NCT01204294|12279591|FG002|Overall Study|Withdrawal by Subject|2
7814449|NCT01204294|12279592|FG003|Overall Study|Withdrawal by Subject|1
7814450|NCT01204294|12279593|FG004|Overall Study|Withdrawal by Subject|1
7814451|NCT01204294|12279594|FG005|Overall Study|Withdrawal by Subject|1
7814452|NCT01204294|12279595|FG006|Overall Study|Withdrawal by Subject|2
7814453|NCT01204294|12279589|FG000|Overall Study|Lack of Efficacy|0
7814454|NCT01204294|12279590|FG001|Overall Study|Lack of Efficacy|0
7814455|NCT01204294|12279591|FG002|Overall Study|Lack of Efficacy|0
7814456|NCT01204294|12279592|FG003|Overall Study|Lack of Efficacy|2
7814457|NCT01204294|12279593|FG004|Overall Study|Lack of Efficacy|0
7814458|NCT01204294|12279594|FG005|Overall Study|Lack of Efficacy|0
7814459|NCT01204294|12279595|FG006|Overall Study|Lack of Efficacy|0
7814460|NCT01204294|12279589|FG000|Overall Study|Other (house moving)|0
7814461|NCT01204294|12279590|FG001|Overall Study|Other (house moving)|0
7814462|NCT01204294|12279591|FG002|Overall Study|Other (house moving)|1
7814463|NCT01204294|12279592|FG003|Overall Study|Other (house moving)|0
7814464|NCT01204294|12279593|FG004|Overall Study|Other (house moving)|0
7814465|NCT01204294|12279594|FG005|Overall Study|Other (house moving)|0
7814466|NCT01204294|12279595|FG006|Overall Study|Other (house moving)|0
7814467|NCT01204398|12279611|FG000|Overall Study|Adverse Event|1
7814468|NCT01204658|12279619|FG000|Primary Phase|Adverse Event|0
7814469|NCT01204658|12279620|FG001|Primary Phase|Adverse Event|0
7814470|NCT01204658|12279621|FG002|Primary Phase|Adverse Event|1
7814471|NCT01204658|12279622|FG003|Primary Phase|Adverse Event|0
7814472|NCT01204671|12279640|FG000|Overall Study|Adverse Event|4
7814473|NCT01204671|12279641|FG001|Overall Study|Adverse Event|3
7814474|NCT01204671|12279642|FG002|Overall Study|Adverse Event|3
7814475|NCT01204671|12279643|FG003|Overall Study|Adverse Event|3
7814476|NCT01204671|12279644|FG004|Overall Study|Adverse Event|1
7814477|NCT01204671|12279640|FG000|Overall Study|Withdrawal by Subject|2
7814478|NCT01204671|12279641|FG001|Overall Study|Withdrawal by Subject|3
7814479|NCT01204671|12279642|FG002|Overall Study|Withdrawal by Subject|4
7814480|NCT01204671|12279643|FG003|Overall Study|Withdrawal by Subject|5
7814481|NCT01204671|12279644|FG004|Overall Study|Withdrawal by Subject|3
7814482|NCT01204671|12279640|FG000|Overall Study|Lost to Follow-up|7
7814483|NCT01204671|12279641|FG001|Overall Study|Lost to Follow-up|8
7814484|NCT01204671|12279642|FG002|Overall Study|Lost to Follow-up|6
7814485|NCT01204671|12279643|FG003|Overall Study|Lost to Follow-up|4
7814486|NCT01204671|12279644|FG004|Overall Study|Lost to Follow-up|0
7814487|NCT01204671|12279640|FG000|Overall Study|Unknown Completion Status|1
7814488|NCT01204671|12279641|FG001|Overall Study|Unknown Completion Status|1
7814489|NCT01204671|12279642|FG002|Overall Study|Unknown Completion Status|0
7814490|NCT01204671|12279643|FG003|Overall Study|Unknown Completion Status|0
7814491|NCT01204671|12279644|FG004|Overall Study|Unknown Completion Status|0
7814492|NCT01204671|12279640|FG000|Overall Study|Physician Decision|0
7814493|NCT01204671|12279641|FG001|Overall Study|Physician Decision|0
7814494|NCT01204671|12279642|FG002|Overall Study|Physician Decision|0
7814495|NCT01204671|12279643|FG003|Overall Study|Physician Decision|1
7814496|NCT01204671|12279644|FG004|Overall Study|Physician Decision|0
7814497|NCT01204697|12279662|FG000|Overall Study|Death|26
7814498|NCT01204697|12279663|FG001|Overall Study|Death|27
7814499|NCT01204697|12279662|FG000|Overall Study|Lost to Follow-up|3
7814500|NCT01204697|12279663|FG001|Overall Study|Lost to Follow-up|4
7814501|NCT01204697|12279662|FG000|Overall Study|Withdrawal by Subject|2
7814502|NCT01204697|12279663|FG001|Overall Study|Withdrawal by Subject|4
7814503|NCT01204697|12279662|FG000|Overall Study|Randomized, but not treated|0
7814504|NCT01204697|12279663|FG001|Overall Study|Randomized, but not treated|1
7814505|NCT01204710|12279671|FG000|Randomization Treatment|Lost to Follow-up|1
7814506|NCT01204710|12279672|FG001|Randomization Treatment|Lost to Follow-up|0
7814507|NCT01204710|12279671|FG000|Randomization Treatment|Withdrawal by Subject|6
7814508|NCT01204710|12279672|FG001|Randomization Treatment|Withdrawal by Subject|5
7814509|NCT01204710|12279671|FG000|Randomization Treatment|Physician Decision|3
7814510|NCT01204710|12279672|FG001|Randomization Treatment|Physician Decision|2
7814511|NCT01204710|12279671|FG000|Randomization Treatment|Entry criteria not met|0
7814512|NCT01204710|12279672|FG001|Randomization Treatment|Entry criteria not met|1
7814513|NCT01204710|12279671|FG000|Randomization Treatment|Adverse Event|4
7814514|NCT01204710|12279672|FG001|Randomization Treatment|Adverse Event|2
7814515|NCT01204710|12279671|FG000|Randomization Treatment|Sponsor Decision|0
7814516|NCT01204710|12279672|FG001|Randomization Treatment|Sponsor Decision|1
7814517|NCT01204710|12279671|FG000|Randomization Treatment|Worsening of General condition|0
7814518|NCT01204710|12279672|FG001|Randomization Treatment|Worsening of General condition|1
7814519|NCT01204710|12279671|FG000|Randomization Treatment|Moved and Followed for Survival|0
7814520|NCT01204710|12279672|FG001|Randomization Treatment|Moved and Followed for Survival|1
7814521|NCT01204710|12279671|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
7814522|NCT01204710|12279672|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
7814523|NCT01204710|12279671|FG000|Optional Olaratumab Monotherapy|Physician Decision|0
7814524|NCT01204710|12279672|FG001|Optional Olaratumab Monotherapy|Physician Decision|1
7814525|NCT01204710|12279671|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
7814526|NCT01204710|12279672|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
7814527|NCT01204775|12279704|FG000|Overall Study|Poor/non-compliance|0
7814528|NCT01204775|12279705|FG001|Overall Study|Poor/non-compliance|1
7814529|NCT01204775|12279704|FG000|Overall Study|Withdrawal by Subject|1
7814530|NCT01204775|12279705|FG001|Overall Study|Withdrawal by Subject|0
7814531|NCT01204918|12279722|FG000|Overall Study|Withdrawal by Subject|4
7814532|NCT01204918|12279723|FG001|Overall Study|Withdrawal by Subject|10
7814533|NCT01204918|12279724|FG002|Overall Study|Withdrawal by Subject|5
7814534|NCT01205035|12279734|FG000|Overall Study|Withdrawal by Subject|1
7814535|NCT01205035|12279735|FG001|Overall Study|Withdrawal by Subject|0
7814536|NCT01205035|12279734|FG000|Overall Study|Physician Decision|1
7814537|NCT01205035|12279735|FG001|Overall Study|Physician Decision|0
7814538|NCT01205126|12279743|FG000|Titration Phase|Adverse Event|5
7814539|NCT01205126|12279744|FG001|Titration Phase|Adverse Event|3
7814540|NCT01205126|12279743|FG000|Titration Phase|Withdrawal by Subject|5
7814541|NCT01205126|12279744|FG001|Titration Phase|Withdrawal by Subject|5
7814542|NCT01205126|12279743|FG000|Titration Phase|Lost to Follow-up|2
7814543|NCT01205126|12279744|FG001|Titration Phase|Lost to Follow-up|2
7814544|NCT01205126|12279743|FG000|Titration Phase|No stable titration dose|1
7814545|NCT01205126|12279744|FG001|Titration Phase|No stable titration dose|0
7814546|NCT01205126|12279743|FG000|Titration Phase|More than maximum dosage required|2
7814547|NCT01205126|12279744|FG001|Titration Phase|More than maximum dosage required|3
7814548|NCT01205126|12279743|FG000|Titration Phase|Other|8
7814549|NCT01205126|12279744|FG001|Titration Phase|Other|6
7814550|NCT01205126|12279743|FG000|Between Titration & Maintenance Phase|Other|0
7814551|NCT01205126|12279744|FG001|Between Titration & Maintenance Phase|Other|4
7814552|NCT01205126|12279743|FG000|Maintenance Phase|Adverse Event|3
7814553|NCT01205126|12279744|FG001|Maintenance Phase|Adverse Event|7
7814554|NCT01205126|12279743|FG000|Maintenance Phase|Death|4
7814555|NCT01205126|12279744|FG001|Maintenance Phase|Death|4
7910144|NCT02048826|12426653|FG000|Overall Study|Withdrawal by Subject|1
7910145|NCT02048826|12426654|FG001|Overall Study|Withdrawal by Subject|0
7910146|NCT02049437|12426707|FG000|Period 1|Adverse Event|1
7910147|NCT02049437|12426708|FG001|Period 1|Adverse Event|1
7910148|NCT02049437|12426707|FG000|Period 1|Adverse Event|1
7910149|NCT02049437|12426708|FG001|Period 1|Adverse Event|0
7910150|NCT02049450|12426714|FG000|Overall Study|Adverse Event|2
7910151|NCT02049450|12426714|FG000|Overall Study|Withdrawal by Subject|1
7910152|NCT02049450|12426714|FG000|Overall Study|Patients/guardian decision|1
7910153|NCT02049814|12426745|FG000|Overall Study|Reason not Specified|4
7910154|NCT02049814|12426746|FG001|Overall Study|Reason not Specified|3
7910155|NCT02049814|12426745|FG000|Overall Study|Pregnancy|1
7910156|NCT02049814|12426746|FG001|Overall Study|Pregnancy|0
7910157|NCT02049814|12426745|FG000|Overall Study|Lost to Follow-up|2
7910158|NCT02049814|12426746|FG001|Overall Study|Lost to Follow-up|3
7910159|NCT02049814|12426745|FG000|Overall Study|Serious Protocol Violation|5
7910160|NCT02049814|12426746|FG001|Overall Study|Serious Protocol Violation|7
7910161|NCT02049814|12426745|FG000|Overall Study|Study Termination|0
7910162|NCT02049814|12426746|FG001|Overall Study|Study Termination|1
7910163|NCT02049814|12426745|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8
7910164|NCT02049814|12426746|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5
7910165|NCT02049814|12426745|FG000|Overall Study|Voluntary withdrawal|9
7910166|NCT02049814|12426746|FG001|Overall Study|Voluntary withdrawal|8
7910167|NCT02049866|12426752|FG000|Overall Study|Withdrawal by Subject|1
7910168|NCT02049944|12426769|FG000|Overall Study|Protocol Violation|2
7910169|NCT02049957|12426782|FG000|Overall Study|Progressive Disease|5
7910170|NCT02049957|12426783|FG001|Overall Study|Progressive Disease|4
7910171|NCT02049957|12426784|FG002|Overall Study|Progressive Disease|2
7910172|NCT02049957|12426785|FG003|Overall Study|Progressive Disease|2
7910173|NCT02049957|12426786|FG004|Overall Study|Progressive Disease|6
7910174|NCT02049957|12426787|FG005|Overall Study|Progressive Disease|35
7910175|NCT02049957|12426788|FG006|Overall Study|Progressive Disease|7
7910176|NCT02049957|12426789|FG007|Overall Study|Progressive Disease|26
7910177|NCT02049957|12426790|FG008|Overall Study|Progressive Disease|6
7910178|NCT02049957|12426782|FG000|Overall Study|Adverse Event|1
7910179|NCT02049957|12426783|FG001|Overall Study|Adverse Event|1
7910180|NCT02049957|12426784|FG002|Overall Study|Adverse Event|1
7910181|NCT02049957|12426785|FG003|Overall Study|Adverse Event|0
7910182|NCT02049957|12426786|FG004|Overall Study|Adverse Event|0
7910183|NCT02049957|12426787|FG005|Overall Study|Adverse Event|5
7910184|NCT02049957|12426788|FG006|Overall Study|Adverse Event|0
7910185|NCT02049957|12426789|FG007|Overall Study|Adverse Event|6
7910186|NCT02049957|12426790|FG008|Overall Study|Adverse Event|1
7814556|NCT01205126|12279743|FG000|Maintenance Phase|More than the maximum dosage required|5
7814557|NCT01205126|12279744|FG001|Maintenance Phase|More than the maximum dosage required|5
7814558|NCT01205126|12279743|FG000|Maintenance Phase|Prohibited drugs used|1
7814559|NCT01205126|12279744|FG001|Maintenance Phase|Prohibited drugs used|0
7814560|NCT01205126|12279743|FG000|Maintenance Phase|Other|11
7814561|NCT01205126|12279744|FG001|Maintenance Phase|Other|8
7814562|NCT01205126|12279743|FG000|Maintenance Phase|Lost to Follow-up|5
7814563|NCT01205126|12279744|FG001|Maintenance Phase|Lost to Follow-up|5
7814564|NCT01205126|12279743|FG000|Maintenance Phase|Withdrawal by Subject|8
7814565|NCT01205126|12279744|FG001|Maintenance Phase|Withdrawal by Subject|11
7814566|NCT01205152|12279750|FG000|Overall Study|Death|1
7814567|NCT01205165|12279756|FG000|Overall Study|Lost to Follow-up|2
7814568|NCT01205230|12279763|FG000|Overall Study|Adverse Event|4
7814569|NCT01205230|12279764|FG001|Overall Study|Adverse Event|0
7814570|NCT01205230|12279763|FG000|Overall Study|Physician Decision|1
7910187|NCT02049957|12426782|FG000|Overall Study|Study Terminated by Sponsor|0
7910188|NCT02049957|12426783|FG001|Overall Study|Study Terminated by Sponsor|1
7814571|NCT01205230|12279764|FG001|Overall Study|Physician Decision|0
7814572|NCT01205269|12279775|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0
7814573|NCT01205269|12279776|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0
7814574|NCT01205269|12279777|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0
7814575|NCT01205269|12279778|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1
7814576|NCT01205269|12279779|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0
7814577|NCT01205269|12279780|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0
7814578|NCT01205438|12279795|FG000|Overall Study|Adverse Event|19
7814579|NCT01205438|12279796|FG001|Overall Study|Adverse Event|17
7814580|NCT01205438|12279797|FG002|Overall Study|Adverse Event|24
7814581|NCT01205438|12279795|FG000|Overall Study|Death|1
7814582|NCT01205438|12279796|FG001|Overall Study|Death|1
7814583|NCT01205438|12279797|FG002|Overall Study|Death|3
7814584|NCT01205438|12279795|FG000|Overall Study|Entry Criteria Not Met|16
7814585|NCT01205438|12279796|FG001|Overall Study|Entry Criteria Not Met|15
7814586|NCT01205438|12279797|FG002|Overall Study|Entry Criteria Not Met|13
7814587|NCT01205438|12279795|FG000|Overall Study|Lack of Efficacy|14
7814588|NCT01205438|12279796|FG001|Overall Study|Lack of Efficacy|11
7814589|NCT01205438|12279797|FG002|Overall Study|Lack of Efficacy|14
7814590|NCT01205438|12279795|FG000|Overall Study|Lost to Follow-up|6
7814591|NCT01205438|12279796|FG001|Overall Study|Lost to Follow-up|7
7814592|NCT01205438|12279797|FG002|Overall Study|Lost to Follow-up|8
7814593|NCT01205438|12279795|FG000|Overall Study|Withdrawal by Subject|19
7814594|NCT01205438|12279796|FG001|Overall Study|Withdrawal by Subject|25
7814595|NCT01205438|12279797|FG002|Overall Study|Withdrawal by Subject|19
7814596|NCT01205438|12279795|FG000|Overall Study|Physician Decision|0
7814597|NCT01205438|12279796|FG001|Overall Study|Physician Decision|3
7814598|NCT01205438|12279797|FG002|Overall Study|Physician Decision|2
7814599|NCT01205438|12279795|FG000|Overall Study|Protocol Violation|2
7814600|NCT01205438|12279796|FG001|Overall Study|Protocol Violation|7
7814601|NCT01205438|12279797|FG002|Overall Study|Protocol Violation|4
7814602|NCT01205438|12279795|FG000|Overall Study|Sponsor Decision|0
7814603|NCT01205438|12279796|FG001|Overall Study|Sponsor Decision|1
7814604|NCT01205438|12279797|FG002|Overall Study|Sponsor Decision|1
7814605|NCT01205451|12279810|FG000|Overall Study|Lost to Follow-up|1
7814606|NCT01205451|12279811|FG001|Overall Study|Lost to Follow-up|1
7814607|NCT01205451|12279810|FG000|Overall Study|Withdrawal by Subject|5
7814608|NCT01205451|12279811|FG001|Overall Study|Withdrawal by Subject|9
7814609|NCT01205529|12279826|FG000|Overall Study|Procedure Cancelled|4
7814610|NCT01205529|12279826|FG000|Overall Study|Withdrawal by Subject|2
7814611|NCT01205529|12279826|FG000|Overall Study|Physician Decision|4
7814612|NCT01205529|12279826|FG000|Overall Study|Unstable post op|15
7814613|NCT01205529|12279826|FG000|Overall Study|No longer met criteria|30
7814614|NCT01205581|12279841|FG000|Overall Study|Withdrawal by Subject|1
7814615|NCT01205581|12279842|FG001|Overall Study|Withdrawal by Subject|0
7814616|NCT01205581|12279843|FG002|Overall Study|Withdrawal by Subject|0
7814617|NCT01205581|12279844|FG003|Overall Study|Withdrawal by Subject|0
7814618|NCT01205581|12279845|FG004|Overall Study|Withdrawal by Subject|0
7814619|NCT01205581|12279846|FG005|Overall Study|Withdrawal by Subject|0
7814620|NCT01205685|12279881|FG000|Overall Study|Disease Progression|10
7814621|NCT01205685|12279881|FG000|Overall Study|Withdrawal by Subject|1
7814622|NCT01205776|12279887|FG000|Overall Study|Lost to Follow-up|53
7814623|NCT01205776|12279888|FG001|Overall Study|Lost to Follow-up|61
7814624|NCT01205776|12279887|FG000|Overall Study|Withdrawal by Subject|11
7814625|NCT01205776|12279888|FG001|Overall Study|Withdrawal by Subject|34
7814626|NCT01206140|12279912|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1
7814627|NCT01206140|12279913|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0
7814628|NCT01206166|12279921|FG000|Overall Study|No evaluable data|2
7814629|NCT01206166|12279922|FG001|Overall Study|No evaluable data|3
7814630|NCT01206322|12279933|FG000|Overall Study|Adverse Event|0
7814631|NCT01206322|12279934|FG001|Overall Study|Adverse Event|0
7814632|NCT01206322|12279935|FG002|Overall Study|Adverse Event|0
7814633|NCT01206322|12279936|FG003|Overall Study|Adverse Event|1
7814634|NCT01206582|12279995|FG000|Overall Study|Withdrew prior to study|1
7814635|NCT01206582|12279996|FG001|Overall Study|Withdrew prior to study|0
7814636|NCT01206582|12279995|FG000|Overall Study|Discontinued intervention before week 8|1
7814637|NCT01206582|12279996|FG001|Overall Study|Discontinued intervention before week 8|2
7814638|NCT01206764|12280046|FG000|Overall Study|Adverse Event|20
7814639|NCT01206764|12280046|FG000|Overall Study|Abnormal laboratory value|2
7814640|NCT01206764|12280046|FG000|Overall Study|Abnormal test procedure result|1
7814641|NCT01206764|12280046|FG000|Overall Study|Patient withdrew consent|5
7814642|NCT01206764|12280046|FG000|Overall Study|Lost to Follow-up|6
7814643|NCT01206764|12280046|FG000|Overall Study|Death|11
7814644|NCT01206764|12280046|FG000|Overall Study|New cancer therapy|2
7814645|NCT01206764|12280046|FG000|Overall Study|Disease progression|88
7814646|NCT01206764|12280046|FG000|Overall Study|Protocol deviation|3
7814647|NCT01206777|12280050|FG000|Overall Study|Death|1
7814648|NCT01206777|12280050|FG000|Overall Study|Adverse Event|1
7814649|NCT01206816|12280061|FG000|Overall Study|Protocol Violation|0
7814650|NCT01206816|12280062|FG001|Overall Study|Protocol Violation|0
7814651|NCT01206816|12280063|FG002|Overall Study|Protocol Violation|1
7814652|NCT01206816|12280064|FG003|Overall Study|Protocol Violation|0
7814653|NCT01206816|12280065|FG004|Overall Study|Protocol Violation|0
7814654|NCT01206816|12280066|FG005|Overall Study|Protocol Violation|0
7814655|NCT01206816|12280067|FG006|Overall Study|Protocol Violation|0
7814656|NCT01206816|12280061|FG000|Overall Study|Withdrawal by Subject|0
7814657|NCT01206816|12280062|FG001|Overall Study|Withdrawal by Subject|0
7814658|NCT01206816|12280063|FG002|Overall Study|Withdrawal by Subject|1
7814659|NCT01206816|12280064|FG003|Overall Study|Withdrawal by Subject|0
7814660|NCT01206816|12280065|FG004|Overall Study|Withdrawal by Subject|0
7814661|NCT01206816|12280066|FG005|Overall Study|Withdrawal by Subject|0
7814662|NCT01206816|12280067|FG006|Overall Study|Withdrawal by Subject|0
7814663|NCT01206816|12280061|FG000|Overall Study|Progressive disease|3
7814664|NCT01206816|12280062|FG001|Overall Study|Progressive disease|3
7814665|NCT01206816|12280063|FG002|Overall Study|Progressive disease|13
7814666|NCT01206816|12280064|FG003|Overall Study|Progressive disease|3
7814667|NCT01206816|12280065|FG004|Overall Study|Progressive disease|3
7814668|NCT01206816|12280066|FG005|Overall Study|Progressive disease|16
7814669|NCT01206816|12280067|FG006|Overall Study|Progressive disease|3
7814670|NCT01206816|12280061|FG000|Overall Study|Other AE|0
7814671|NCT01206816|12280062|FG001|Overall Study|Other AE|0
7814672|NCT01206816|12280063|FG002|Overall Study|Other AE|4
7814673|NCT01206816|12280064|FG003|Overall Study|Other AE|0
7814674|NCT01206816|12280065|FG004|Overall Study|Other AE|0
7814675|NCT01206816|12280066|FG005|Overall Study|Other AE|3
7814676|NCT01206816|12280067|FG006|Overall Study|Other AE|2
7814677|NCT01206816|12280061|FG000|Overall Study|other than stated above|0
7814678|NCT01206816|12280062|FG001|Overall Study|other than stated above|0
7814679|NCT01206816|12280063|FG002|Overall Study|other than stated above|1
7814680|NCT01206816|12280064|FG003|Overall Study|other than stated above|0
7910189|NCT02049957|12426784|FG002|Overall Study|Study Terminated by Sponsor|0
7910190|NCT02049957|12426785|FG003|Overall Study|Study Terminated by Sponsor|0
7910191|NCT02049957|12426786|FG004|Overall Study|Study Terminated by Sponsor|0
7910192|NCT02049957|12426787|FG005|Overall Study|Study Terminated by Sponsor|0
7910193|NCT02049957|12426788|FG006|Overall Study|Study Terminated by Sponsor|1
7910194|NCT02049957|12426789|FG007|Overall Study|Study Terminated by Sponsor|0
7910195|NCT02049957|12426790|FG008|Overall Study|Study Terminated by Sponsor|0
7910196|NCT02049957|12426782|FG000|Overall Study|Withdrawal by Subject|0
7910197|NCT02049957|12426783|FG001|Overall Study|Withdrawal by Subject|0
7910198|NCT02049957|12426784|FG002|Overall Study|Withdrawal by Subject|0
7910199|NCT02049957|12426785|FG003|Overall Study|Withdrawal by Subject|1
7910200|NCT02049957|12426786|FG004|Overall Study|Withdrawal by Subject|0
7910201|NCT02049957|12426787|FG005|Overall Study|Withdrawal by Subject|2
7910202|NCT02049957|12426788|FG006|Overall Study|Withdrawal by Subject|0
7910203|NCT02049957|12426789|FG007|Overall Study|Withdrawal by Subject|3
7910204|NCT02049957|12426790|FG008|Overall Study|Withdrawal by Subject|1
7910205|NCT02049957|12426782|FG000|Overall Study|Physician Decision|0
7910206|NCT02049957|12426783|FG001|Overall Study|Physician Decision|0
7910207|NCT02049957|12426784|FG002|Overall Study|Physician Decision|0
7910208|NCT02049957|12426785|FG003|Overall Study|Physician Decision|0
7910209|NCT02049957|12426786|FG004|Overall Study|Physician Decision|0
7910210|NCT02049957|12426787|FG005|Overall Study|Physician Decision|1
7910211|NCT02049957|12426788|FG006|Overall Study|Physician Decision|0
7910212|NCT02049957|12426789|FG007|Overall Study|Physician Decision|0
7910213|NCT02049957|12426790|FG008|Overall Study|Physician Decision|0
7814681|NCT01206816|12280065|FG004|Overall Study|other than stated above|0
7814682|NCT01206816|12280066|FG005|Overall Study|other than stated above|0
7814683|NCT01206816|12280067|FG006|Overall Study|other than stated above|1
7814684|NCT01207219|12280090|FG000|Overall Study|changed diagnosis during study period|5
7814685|NCT01207219|12280091|FG001|Overall Study|changed diagnosis during study period|3
7814686|NCT01207219|12280092|FG002|Overall Study|changed diagnosis during study period|1
7814687|NCT01207219|12280090|FG000|Overall Study|Lost to Follow-up|6
7814688|NCT01207219|12280091|FG001|Overall Study|Lost to Follow-up|8
7814689|NCT01207219|12280092|FG002|Overall Study|Lost to Follow-up|6
7814690|NCT01207388|12280100|FG000|Overall Study|Death|67
7814691|NCT01207388|12280100|FG000|Overall Study|Withdrawal by Subject|1
7814692|NCT01207414|12280123|FG000|Overall Study|Adverse Event|25
7814693|NCT01207414|12280124|FG001|Overall Study|Adverse Event|39
7814694|NCT01207414|12280123|FG000|Overall Study|Abnormal test procedure results|0
7814695|NCT01207414|12280124|FG001|Overall Study|Abnormal test procedure results|1
7814696|NCT01207414|12280123|FG000|Overall Study|Unsatisfactory therapeutic effect|5
7814697|NCT01207414|12280124|FG001|Overall Study|Unsatisfactory therapeutic effect|4
7814698|NCT01207414|12280123|FG000|Overall Study|Patient withdrew consent|14
7814699|NCT01207414|12280124|FG001|Overall Study|Patient withdrew consent|11
7814700|NCT01207414|12280123|FG000|Overall Study|Lost to Follow-up|15
7814701|NCT01207414|12280124|FG001|Overall Study|Lost to Follow-up|17
7814702|NCT01207414|12280123|FG000|Overall Study|Administrative problems|1
7814703|NCT01207414|12280124|FG001|Overall Study|Administrative problems|1
7814704|NCT01207414|12280123|FG000|Overall Study|Protocol deviation|12
7814705|NCT01207414|12280124|FG001|Overall Study|Protocol deviation|9
7814706|NCT01207414|12280123|FG000|Overall Study|Randomized in error|1
7814707|NCT01207414|12280124|FG001|Overall Study|Randomized in error|0
7814708|NCT01207427|12280133|FG000|Double-blind Treatment Period|Adverse Event|0
7814709|NCT01207427|12280134|FG001|Double-blind Treatment Period|Adverse Event|1
7814710|NCT01207427|12280135|FG002|Double-blind Treatment Period|Adverse Event|0
7814711|NCT01207427|12280133|FG000|Double-blind Treatment Period|Lost to Follow-up|0
7814712|NCT01207427|12280134|FG001|Double-blind Treatment Period|Lost to Follow-up|0
7814713|NCT01207427|12280135|FG002|Double-blind Treatment Period|Lost to Follow-up|1
7814714|NCT01207427|12280133|FG000|Double-blind Treatment Period|Protocol Violation|2
7814715|NCT01207427|12280134|FG001|Double-blind Treatment Period|Protocol Violation|1
7814716|NCT01207427|12280135|FG002|Double-blind Treatment Period|Protocol Violation|1
7814717|NCT01207427|12280133|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
7814718|NCT01207427|12280134|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
7814719|NCT01207427|12280135|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7814720|NCT01207440|12280150|FG000|Overall Study|Adverse Event|46
7814721|NCT01207440|12280151|FG001|Overall Study|Adverse Event|11
7814722|NCT01207440|12280152|FG002|Overall Study|Adverse Event|7
7814723|NCT01207440|12280153|FG003|Overall Study|Adverse Event|2
7814724|NCT01207440|12280154|FG004|Overall Study|Adverse Event|6
7814725|NCT01207440|12280155|FG005|Overall Study|Adverse Event|6
7814726|NCT01207440|12280156|FG006|Overall Study|Adverse Event|2
7814727|NCT01207440|12280150|FG000|Overall Study|Death|6
7814728|NCT01207440|12280151|FG001|Overall Study|Death|3
7814729|NCT01207440|12280152|FG002|Overall Study|Death|2
7814730|NCT01207440|12280153|FG003|Overall Study|Death|2
7814731|NCT01207440|12280154|FG004|Overall Study|Death|7
7814732|NCT01207440|12280155|FG005|Overall Study|Death|5
7814733|NCT01207440|12280156|FG006|Overall Study|Death|1
7814734|NCT01207440|12280150|FG000|Overall Study|Lack of Efficacy|13
7814735|NCT01207440|12280151|FG001|Overall Study|Lack of Efficacy|2
7814736|NCT01207440|12280152|FG002|Overall Study|Lack of Efficacy|5
7814737|NCT01207440|12280153|FG003|Overall Study|Lack of Efficacy|1
7814738|NCT01207440|12280154|FG004|Overall Study|Lack of Efficacy|2
7814739|NCT01207440|12280155|FG005|Overall Study|Lack of Efficacy|3
7814740|NCT01207440|12280156|FG006|Overall Study|Lack of Efficacy|0
7814741|NCT01207440|12280150|FG000|Overall Study|Lost to Follow-up|0
7814742|NCT01207440|12280151|FG001|Overall Study|Lost to Follow-up|0
7814743|NCT01207440|12280152|FG002|Overall Study|Lost to Follow-up|2
7814744|NCT01207440|12280153|FG003|Overall Study|Lost to Follow-up|1
7814745|NCT01207440|12280154|FG004|Overall Study|Lost to Follow-up|0
7814746|NCT01207440|12280155|FG005|Overall Study|Lost to Follow-up|0
7910214|NCT02050048|12426812|FG000|Overall Study|Lost to Follow-up|0
7910215|NCT02050048|12426813|FG001|Overall Study|Lost to Follow-up|1
7910216|NCT02050048|12426812|FG000|Overall Study|Death|1
7910217|NCT02050048|12426813|FG001|Overall Study|Death|0
7910218|NCT02050048|12426812|FG000|Overall Study|Ineligible after ERCP|4
7910219|NCT02050048|12426813|FG001|Overall Study|Ineligible after ERCP|1
7910220|NCT02050321|12426819|FG000|Overall Study|Withdrawal by Subject|1
7910221|NCT02050321|12426819|FG000|Overall Study|Adverse Event|1
7910222|NCT02050373|12426835|FG000|Overall Study|Adverse Event|4
7910223|NCT02050373|12426836|FG001|Overall Study|Adverse Event|7
7910224|NCT02050373|12426835|FG000|Overall Study|Death|3
7910225|NCT02050373|12426836|FG001|Overall Study|Death|3
7910226|NCT02051296|12426855|FG000|Overall Study|Lost to Follow-up|1
7910227|NCT02051296|12426856|FG001|Overall Study|Lost to Follow-up|2
7910228|NCT02051296|12426855|FG000|Overall Study|withdraw prior to treatment|7
7910229|NCT02051296|12426856|FG001|Overall Study|withdraw prior to treatment|7
7910230|NCT02051764|12426912|FG000|Overall Study|Study terminated by sponsor|0
7910231|NCT02051764|12426913|FG001|Overall Study|Study terminated by sponsor|7
7814747|NCT01207440|12280156|FG006|Overall Study|Lost to Follow-up|0
7814748|NCT01207440|12280150|FG000|Overall Study|Non-compliance with Study Drug|3
7814749|NCT01207440|12280151|FG001|Overall Study|Non-compliance with Study Drug|0
7814750|NCT01207440|12280152|FG002|Overall Study|Non-compliance with Study Drug|1
7814751|NCT01207440|12280153|FG003|Overall Study|Non-compliance with Study Drug|0
7814752|NCT01207440|12280154|FG004|Overall Study|Non-compliance with Study Drug|0
7814753|NCT01207440|12280155|FG005|Overall Study|Non-compliance with Study Drug|0
7814754|NCT01207440|12280156|FG006|Overall Study|Non-compliance with Study Drug|0
7814755|NCT01207440|12280150|FG000|Overall Study|Physician Decision|6
7814756|NCT01207440|12280151|FG001|Overall Study|Physician Decision|5
7814757|NCT01207440|12280152|FG002|Overall Study|Physician Decision|5
7814758|NCT01207440|12280153|FG003|Overall Study|Physician Decision|0
7814759|NCT01207440|12280154|FG004|Overall Study|Physician Decision|1
7814760|NCT01207440|12280155|FG005|Overall Study|Physician Decision|0
7814761|NCT01207440|12280156|FG006|Overall Study|Physician Decision|0
7814762|NCT01207440|12280150|FG000|Overall Study|Progressive Disease|19
7814763|NCT01207440|12280151|FG001|Overall Study|Progressive Disease|10
7814764|NCT01207440|12280152|FG002|Overall Study|Progressive Disease|19
7814765|NCT01207440|12280153|FG003|Overall Study|Progressive Disease|7
7814766|NCT01207440|12280154|FG004|Overall Study|Progressive Disease|23
7814767|NCT01207440|12280155|FG005|Overall Study|Progressive Disease|27
7814768|NCT01207440|12280156|FG006|Overall Study|Progressive Disease|0
7814769|NCT01207440|12280150|FG000|Overall Study|Protocol Violation|2
7814770|NCT01207440|12280151|FG001|Overall Study|Protocol Violation|0
7814771|NCT01207440|12280152|FG002|Overall Study|Protocol Violation|0
7814772|NCT01207440|12280153|FG003|Overall Study|Protocol Violation|0
7910232|NCT02052011|12426946|FG000|Overall Study|Lost to Follow-up|3
7814773|NCT01207440|12280154|FG004|Overall Study|Protocol Violation|0
7814774|NCT01207440|12280155|FG005|Overall Study|Protocol Violation|0
7814775|NCT01207440|12280156|FG006|Overall Study|Protocol Violation|0
7814776|NCT01207440|12280150|FG000|Overall Study|Site Terminated by Sponsor|69
7814777|NCT01207440|12280151|FG001|Overall Study|Site Terminated by Sponsor|19
7814778|NCT01207440|12280152|FG002|Overall Study|Site Terminated by Sponsor|12
7814779|NCT01207440|12280153|FG003|Overall Study|Site Terminated by Sponsor|2
7814780|NCT01207440|12280154|FG004|Overall Study|Site Terminated by Sponsor|3
7814781|NCT01207440|12280155|FG005|Overall Study|Site Terminated by Sponsor|0
7814782|NCT01207440|12280156|FG006|Overall Study|Site Terminated by Sponsor|2
7814783|NCT01207440|12280150|FG000|Overall Study|Withdrawal by Subject|29
7814784|NCT01207440|12280151|FG001|Overall Study|Withdrawal by Subject|4
7814785|NCT01207440|12280152|FG002|Overall Study|Withdrawal by Subject|5
7814786|NCT01207440|12280153|FG003|Overall Study|Withdrawal by Subject|3
7814787|NCT01207440|12280154|FG004|Overall Study|Withdrawal by Subject|2
7814788|NCT01207440|12280155|FG005|Overall Study|Withdrawal by Subject|2
7814789|NCT01207440|12280156|FG006|Overall Study|Withdrawal by Subject|0
7814790|NCT01207440|12280150|FG000|Overall Study|Reason Not Specified|10
7814791|NCT01207440|12280151|FG001|Overall Study|Reason Not Specified|10
7814792|NCT01207440|12280152|FG002|Overall Study|Reason Not Specified|7
7814793|NCT01207440|12280153|FG003|Overall Study|Reason Not Specified|0
7814794|NCT01207440|12280154|FG004|Overall Study|Reason Not Specified|4
7814795|NCT01207440|12280155|FG005|Overall Study|Reason Not Specified|3
7814796|NCT01207440|12280156|FG006|Overall Study|Reason Not Specified|0
7814797|NCT01207453|12280180|FG000|First Intervention|Adverse Event|2
7814798|NCT01207453|12280181|FG001|First Intervention|Adverse Event|1
7814799|NCT01207453|12280180|FG000|Washout|Adverse Event|1
7814800|NCT01207453|12280181|FG001|Washout|Adverse Event|0
7814801|NCT01207453|12280180|FG000|Washout|Lost to Follow-up|1
7814802|NCT01207453|12280181|FG001|Washout|Lost to Follow-up|0
7814803|NCT01207453|12280180|FG000|2nd Intervention|Adverse Event|1
7814804|NCT01207453|12280181|FG001|2nd Intervention|Adverse Event|2
7814805|NCT01207453|12280180|FG000|2nd Intervention|Lost to Follow-up|1
7814806|NCT01207453|12280181|FG001|2nd Intervention|Lost to Follow-up|0
7814807|NCT01207583|12280211|FG000|Overall Study|Withdrawal by Subject|0
7814808|NCT01207583|12280212|FG001|Overall Study|Withdrawal by Subject|3
7814809|NCT01207583|12280213|FG002|Overall Study|Withdrawal by Subject|1
7814810|NCT01207583|12280211|FG000|Overall Study|Participant failed to return|1
7814811|NCT01207583|12280212|FG001|Overall Study|Participant failed to return|0
7814812|NCT01207583|12280213|FG002|Overall Study|Participant failed to return|0
7814813|NCT01207583|12280211|FG000|Overall Study|Lost to Follow-up|0
7814814|NCT01207583|12280212|FG001|Overall Study|Lost to Follow-up|2
7814815|NCT01207583|12280213|FG002|Overall Study|Lost to Follow-up|0
7814816|NCT01207596|12280234|FG000|Overall Study|Physician Decision|4
7814817|NCT01207596|12280234|FG000|Overall Study|Lack of Efficacy|1
7814818|NCT01207596|12280234|FG000|Overall Study|Adverse Event|3
7814819|NCT01207596|12280234|FG000|Overall Study|Withdrawal by Subject|1
7814820|NCT01207687|12280242|FG000|Overall Study|Adverse Event|1
7814821|NCT01207687|12280242|FG000|Overall Study|Withdrawal by Subject|1
7814822|NCT01208038|12280287|FG000|Overall Study|Withdrawal by Subject|1
7814823|NCT01208051|12280296|FG000|Total Enrollment|Withdrawal by Subject|0
7814824|NCT01208051|12280297|FG001|Total Enrollment|Withdrawal by Subject|1
7814825|NCT01208051|12280298|FG002|Total Enrollment|Withdrawal by Subject|0
7814826|NCT01208051|12280299|FG003|Total Enrollment|Withdrawal by Subject|0
7814827|NCT01208051|12280300|FG004|Total Enrollment|Withdrawal by Subject|2
7814828|NCT01208051|12280296|FG000|Total Enrollment|Brain metastases|0
7814829|NCT01208051|12280297|FG001|Total Enrollment|Brain metastases|0
7814830|NCT01208051|12280298|FG002|Total Enrollment|Brain metastases|1
7814831|NCT01208051|12280299|FG003|Total Enrollment|Brain metastases|0
7814832|NCT01208051|12280300|FG004|Total Enrollment|Brain metastases|0
7814833|NCT01208103|12280316|FG000|Overall Study|Adverse Event|1
7719367|NCT00531934|12143367|FG001|Overall Study|Adverse Event|8
7814834|NCT01208103|12280316|FG000|Overall Study|Withdrawal by Subject|1
7814835|NCT01208233|12280336|FG000|Overall Study|Adverse Event|0
7814836|NCT01208233|12280337|FG001|Overall Study|Adverse Event|1
7814837|NCT01208233|12280338|FG002|Overall Study|Adverse Event|2
7814838|NCT01208233|12280339|FG003|Overall Study|Adverse Event|0
7910233|NCT02052011|12426947|FG001|Overall Study|Lost to Follow-up|0
7910234|NCT02052011|12426946|FG000|Overall Study|Withdrawal by Subject|1
7910235|NCT02052011|12426947|FG001|Overall Study|Withdrawal by Subject|2
7910236|NCT02052310|12426964|FG000|Overall Study|Death|64
7910237|NCT02052310|12426965|FG001|Overall Study|Death|54
7910238|NCT02052310|12426964|FG000|Overall Study|Withdrawal by Subject|37
7910239|NCT02052310|12426965|FG001|Overall Study|Withdrawal by Subject|49
7910240|NCT02052310|12426964|FG000|Overall Study|Other than specified|32
7910241|NCT02052310|12426965|FG001|Overall Study|Other than specified|29
7910242|NCT02052310|12426964|FG000|Overall Study|Adverse Event|29
7910243|NCT02052310|12426965|FG001|Overall Study|Adverse Event|22
7910244|NCT02052310|12426964|FG000|Overall Study|Kidney Transplant|23
7814839|NCT01208233|12280340|FG004|Overall Study|Adverse Event|3
7814840|NCT01208233|12280341|FG005|Overall Study|Adverse Event|5
7814841|NCT01208233|12280336|FG000|Overall Study|Death|0
7814842|NCT01208233|12280337|FG001|Overall Study|Death|0
7814843|NCT01208233|12280338|FG002|Overall Study|Death|0
7814844|NCT01208233|12280339|FG003|Overall Study|Death|0
7910245|NCT02052310|12426965|FG001|Overall Study|Kidney Transplant|29
7910246|NCT02052310|12426964|FG000|Overall Study|Physician Decision|14
7910247|NCT02052310|12426965|FG001|Overall Study|Physician Decision|7
7910248|NCT02052310|12426964|FG000|Overall Study|Lack of Efficacy|6
7910249|NCT02052310|12426965|FG001|Overall Study|Lack of Efficacy|1
7910250|NCT02052310|12426964|FG000|Overall Study|Site Terminated by Sponsor|5
7910251|NCT02052310|12426965|FG001|Overall Study|Site Terminated by Sponsor|13
7910252|NCT02052310|12426964|FG000|Overall Study|Lost to Follow-up|4
7910253|NCT02052310|12426965|FG001|Overall Study|Lost to Follow-up|2
7910254|NCT02052310|12426964|FG000|Overall Study|Protocol Violation|1
7910255|NCT02052310|12426965|FG001|Overall Study|Protocol Violation|6
7910256|NCT02052414|12426971|FG000|Overall Study|Adverse Event|12
7910257|NCT02052414|12426971|FG000|Overall Study|Lack of Efficacy|2
7910258|NCT02052414|12426971|FG000|Overall Study|Withdrawal by Subject|3
7910259|NCT02052440|12426978|FG000|Overall Study|Withdrawal by Subject|0
7910260|NCT02052440|12426979|FG001|Overall Study|Withdrawal by Subject|1
7910261|NCT02052466|12426985|FG000|Overall Study|Withdrawal by Subject|1
7910262|NCT02052466|12426985|FG000|Overall Study|Acromial fracture|1
7910263|NCT02052596|12427007|FG000|Active Phase|Adverse Event|3
7910264|NCT02052596|12427008|FG001|Active Phase|Adverse Event|2
7910265|NCT02052596|12427007|FG000|Active Phase|Lost to Follow-up|8
7910266|NCT02052596|12427008|FG001|Active Phase|Lost to Follow-up|11
7910267|NCT02052596|12427007|FG000|Active Phase|Protocol Violation|1
7910268|NCT02052596|12427008|FG001|Active Phase|Protocol Violation|2
7910269|NCT02052596|12427007|FG000|Active Phase|Withdrawal by Subject|3
7910270|NCT02052596|12427008|FG001|Active Phase|Withdrawal by Subject|4
7910271|NCT02052596|12427007|FG000|Active Phase|Enrolled in error|1
7910272|NCT02052596|12427008|FG001|Active Phase|Enrolled in error|0
7910273|NCT02052596|12427007|FG000|Active Phase|Lost due to Crohn's disease|0
7910274|NCT02052596|12427008|FG001|Active Phase|Lost due to Crohn's disease|1
7910275|NCT02052596|12427007|FG000|Safety Phase|Adverse Event|6
7910276|NCT02052596|12427008|FG001|Safety Phase|Adverse Event|3
7910277|NCT02052596|12427007|FG000|Safety Phase|Lost to Follow-up|11
7910278|NCT02052596|12427008|FG001|Safety Phase|Lost to Follow-up|18
7910279|NCT02052596|12427007|FG000|Safety Phase|Protocol Violation|1
7910280|NCT02052596|12427008|FG001|Safety Phase|Protocol Violation|2
7910281|NCT02052596|12427007|FG000|Safety Phase|Withdrawal by Subject|8
7910282|NCT02052596|12427008|FG001|Safety Phase|Withdrawal by Subject|11
7910283|NCT02052596|12427007|FG000|Safety Phase|Enrolled in error|1
7814845|NCT01208233|12280340|FG004|Overall Study|Death|3
7814846|NCT01208233|12280341|FG005|Overall Study|Death|5
7814847|NCT01208233|12280336|FG000|Overall Study|Did not meet entrance criteria|2
7814848|NCT01208233|12280337|FG001|Overall Study|Did not meet entrance criteria|1
7814849|NCT01208233|12280338|FG002|Overall Study|Did not meet entrance criteria|1
7814850|NCT01208233|12280339|FG003|Overall Study|Did not meet entrance criteria|0
7814851|NCT01208233|12280340|FG004|Overall Study|Did not meet entrance criteria|1
7814852|NCT01208233|12280341|FG005|Overall Study|Did not meet entrance criteria|0
7814853|NCT01208233|12280336|FG000|Overall Study|Medication error without adverse event|0
7814854|NCT01208233|12280337|FG001|Overall Study|Medication error without adverse event|0
7814855|NCT01208233|12280338|FG002|Overall Study|Medication error without adverse event|0
7814856|NCT01208233|12280339|FG003|Overall Study|Medication error without adverse event|0
7814857|NCT01208233|12280340|FG004|Overall Study|Medication error without adverse event|0
7814858|NCT01208233|12280341|FG005|Overall Study|Medication error without adverse event|1
7814859|NCT01208233|12280336|FG000|Overall Study|Study terminated by sponsor|0
7814860|NCT01208233|12280337|FG001|Overall Study|Study terminated by sponsor|0
7814861|NCT01208233|12280338|FG002|Overall Study|Study terminated by sponsor|0
7814862|NCT01208233|12280339|FG003|Overall Study|Study terminated by sponsor|0
7814863|NCT01208233|12280340|FG004|Overall Study|Study terminated by sponsor|10
7814864|NCT01208233|12280341|FG005|Overall Study|Study terminated by sponsor|7
7814865|NCT01208233|12280336|FG000|Overall Study|Protocol Violation|0
7814866|NCT01208233|12280337|FG001|Overall Study|Protocol Violation|0
7814867|NCT01208233|12280338|FG002|Overall Study|Protocol Violation|0
7814868|NCT01208233|12280339|FG003|Overall Study|Protocol Violation|0
7814869|NCT01208233|12280340|FG004|Overall Study|Protocol Violation|3
7814870|NCT01208233|12280341|FG005|Overall Study|Protocol Violation|0
7814871|NCT01208233|12280336|FG000|Overall Study|Other|2
7814872|NCT01208233|12280337|FG001|Overall Study|Other|1
7814873|NCT01208233|12280338|FG002|Overall Study|Other|0
7814874|NCT01208233|12280339|FG003|Overall Study|Other|0
7814875|NCT01208233|12280340|FG004|Overall Study|Other|0
7814876|NCT01208233|12280341|FG005|Overall Study|Other|1
7814877|NCT01208233|12280336|FG000|Overall Study|Withdrawal by Subject|1
7814878|NCT01208233|12280337|FG001|Overall Study|Withdrawal by Subject|0
7814879|NCT01208233|12280338|FG002|Overall Study|Withdrawal by Subject|1
7814880|NCT01208233|12280339|FG003|Overall Study|Withdrawal by Subject|1
7814881|NCT01208233|12280340|FG004|Overall Study|Withdrawal by Subject|4
7814882|NCT01208233|12280341|FG005|Overall Study|Withdrawal by Subject|2
7814883|NCT01208324|12280365|FG000|Post-randomization of Patch|Withdrawal by Subject|1
7814884|NCT01208324|12280366|FG001|Post-randomization of Patch|Withdrawal by Subject|0
7814885|NCT01208324|12280367|FG002|Post-randomization of Patch|Withdrawal by Subject|0
7814886|NCT01208324|12280368|FG003|Post-randomization of Patch|Withdrawal by Subject|0
7814887|NCT01208337|12280378|FG000|Overall Study|Death|3
7814888|NCT01208402|12280384|FG000|Overall Study|Withdrawal by Subject|1
7910284|NCT02052596|12427008|FG001|Safety Phase|Enrolled in error|0
7814889|NCT01208402|12280385|FG001|Overall Study|Withdrawal by Subject|0
7814890|NCT01208415|12280391|FG000|Overall Study|Death|1
7814891|NCT01208415|12280391|FG000|Overall Study|Lost to Follow-up|2
7814892|NCT01208415|12280391|FG000|Overall Study|Withdrawal by Subject|3
7814893|NCT01208415|12280391|FG000|Overall Study|Device not placed|1
7814894|NCT01208415|12280391|FG000|Overall Study|Still be eligible for follow-up|33
7814895|NCT01208870|12280397|FG000|Overall Study|Lost to Follow-up|2
7814896|NCT01208870|12280398|FG001|Overall Study|Lost to Follow-up|8
7814897|NCT01208961|12280415|FG000|High-Fat Period III|Protocol Violation|1
7814898|NCT01208961|12280416|FG001|High-Fat Period III|Protocol Violation|0
7814899|NCT01209078|12280423|FG000|Overall Study|Adverse Event|5
7814900|NCT01209078|12280424|FG001|Overall Study|Adverse Event|0
7814901|NCT01209078|12280423|FG000|Overall Study|Lost to Follow-up|4
7814902|NCT01209078|12280424|FG001|Overall Study|Lost to Follow-up|0
7814903|NCT01209078|12280423|FG000|Overall Study|Physician Decision|5
7814904|NCT01209078|12280424|FG001|Overall Study|Physician Decision|2
7814905|NCT01209078|12280423|FG000|Overall Study|Withdrawal by Subject|2
7814906|NCT01209078|12280424|FG001|Overall Study|Withdrawal by Subject|1
7814907|NCT01209143|12280434|FG000|Overall Study|Adverse Event|2
7814908|NCT01209143|12280435|FG001|Overall Study|Adverse Event|1
7814909|NCT01209143|12280434|FG000|Overall Study|Death|0
7814910|NCT01209143|12280435|FG001|Overall Study|Death|1
7814911|NCT01209143|12280434|FG000|Overall Study|Physician Decision|3
7814912|NCT01209143|12280435|FG001|Overall Study|Physician Decision|1
7814913|NCT01209143|12280434|FG000|Overall Study|Lost to Follow-up|1
7814914|NCT01209143|12280435|FG001|Overall Study|Lost to Follow-up|0
7814915|NCT01209143|12280434|FG000|Overall Study|Withdrawal by Subject|2
7814916|NCT01209143|12280435|FG001|Overall Study|Withdrawal by Subject|1
7814917|NCT01209143|12280434|FG000|Overall Study|Disease progression|11
7814918|NCT01209143|12280435|FG001|Overall Study|Disease progression|16
7814919|NCT01209286|12280487|FG000|Overall Study|Adverse Event|4
7814920|NCT01209286|12280488|FG001|Overall Study|Adverse Event|3
7814921|NCT01209286|12280489|FG002|Overall Study|Adverse Event|1
7814922|NCT01209286|12280487|FG000|Overall Study|Hematological Relapse After Remission|0
7910285|NCT02052596|12427007|FG000|Safety Phase|Lost due to Crohn's disease|0
7910286|NCT02052596|12427008|FG001|Safety Phase|Lost due to Crohn's disease|1
7964068|NCT02734862|12519145|FG001|Part A|Withdrawal by Subject|1
7964069|NCT02734862|12519146|FG002|Part A|Withdrawal by Subject|2
7964070|NCT02734862|12519144|FG000|Part A|Physician Decision|2
7964071|NCT02734862|12519145|FG001|Part A|Physician Decision|0
7964072|NCT02734862|12519146|FG002|Part A|Physician Decision|1
7964073|NCT02734862|12519144|FG000|Part A|Adverse Event|2
7964074|NCT02734862|12519145|FG001|Part A|Adverse Event|0
7964075|NCT02734862|12519146|FG002|Part A|Adverse Event|1
7964076|NCT02734862|12519144|FG000|Part A|Noncompliance|1
7964077|NCT02734862|12519145|FG001|Part A|Noncompliance|1
7964078|NCT02734862|12519146|FG002|Part A|Noncompliance|0
7964079|NCT02734862|12519144|FG000|Part A|Other|1
7964080|NCT02734862|12519145|FG001|Part A|Other|1
7964081|NCT02734862|12519146|FG002|Part A|Other|3
7964082|NCT02734862|12519144|FG000|Part B|Death|8
7964083|NCT02734862|12519145|FG001|Part B|Death|3
7964084|NCT02734862|12519146|FG002|Part B|Death|5
7964085|NCT02734862|12519144|FG000|Part B|Lost to Follow-up|2
7814923|NCT01209286|12280488|FG001|Overall Study|Hematological Relapse After Remission|1
7814924|NCT01209286|12280489|FG002|Overall Study|Hematological Relapse After Remission|1
7814925|NCT01209286|12280487|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1
7814926|NCT01209286|12280488|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3
7814927|NCT01209286|12280489|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1
7814928|NCT01209286|12280487|FG000|Overall Study|Physician Decision|0
7814929|NCT01209286|12280488|FG001|Overall Study|Physician Decision|2
7814930|NCT01209286|12280489|FG002|Overall Study|Physician Decision|0
7814931|NCT01209286|12280487|FG000|Overall Study|Other|0
7814932|NCT01209286|12280488|FG001|Overall Study|Other|1
7814933|NCT01209286|12280489|FG002|Overall Study|Other|0
7814934|NCT01209325|12280506|FG000|Overall Study|Lost to Follow-up|24
7814935|NCT01209325|12280506|FG000|Overall Study|Adverse Event|1
7814936|NCT01209325|12280506|FG000|Overall Study|Relocated|3
7814937|NCT01209325|12280506|FG000|Overall Study|Refusal after starting therapy|8
7814938|NCT01209325|12280506|FG000|Overall Study|Protocol Violation|4
7814939|NCT01209325|12280506|FG000|Overall Study|Refusal prior to therapy|1
7814940|NCT01209325|12280506|FG000|Overall Study|Incarceration|2
7861971|NCT01597245|12351208|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7861972|NCT01597245|12351188|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7861973|NCT01597245|12351189|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7861974|NCT01597245|12351190|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7861975|NCT01597245|12351191|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7861976|NCT01597245|12351192|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
7861977|NCT01597245|12351193|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
7861978|NCT01597245|12351194|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
7861979|NCT01597245|12351195|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7861980|NCT01597245|12351196|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
7883650|NCT01783548|12383430|FG000|Overall Study|Adverse Event|8
7964086|NCT02734862|12519145|FG001|Part B|Lost to Follow-up|2
7964087|NCT02734862|12519146|FG002|Part B|Lost to Follow-up|0
7964088|NCT02734862|12519144|FG000|Part B|Withdrawal by Subject|3
7814941|NCT01209598|12280538|FG000|Overall Study|Withdrawal by Subject|1
7814942|NCT01209598|12280539|FG001|Overall Study|Withdrawal by Subject|0
7814943|NCT01209624|12280546|FG000|Overall Study|Death|2
7814944|NCT01209624|12280546|FG000|Overall Study|Adverse Event|13
7814945|NCT01209624|12280546|FG000|Overall Study|Lack of Efficacy|17
7910287|NCT02052960|12427055|FG000|Overall Study|Adverse Event|19
7910288|NCT02052960|12427056|FG001|Overall Study|Adverse Event|17
7910289|NCT02052960|12427055|FG000|Overall Study|Protocol Violation|4
7910290|NCT02052960|12427056|FG001|Overall Study|Protocol Violation|3
7910291|NCT02052960|12427055|FG000|Overall Study|Withdrawal by Subject|6
7910292|NCT02052960|12427056|FG001|Overall Study|Withdrawal by Subject|11
7910293|NCT02052960|12427055|FG000|Overall Study|Other|25
7910294|NCT02052960|12427056|FG001|Overall Study|Other|15
7910295|NCT02053168|12427069|FG000|Overall Study|Withdrawal by Subject|1
7910296|NCT02053168|12427069|FG000|Overall Study|Physician Decision|1
7910297|NCT02053168|12427069|FG000|Overall Study|Lost to Follow-up|1
7910298|NCT02053493|12427096|FG000|Overall Study|Withdrawal by Subject|1
7910299|NCT02053493|12427097|FG001|Overall Study|Withdrawal by Subject|1
7910300|NCT02053610|12427105|FG000|Overall Study|Adverse Event/Intercurrent Illness|25
7910301|NCT02053610|12427106|FG001|Overall Study|Adverse Event/Intercurrent Illness|43
7910302|NCT02053610|12427105|FG000|Overall Study|Withdrew Consent|2
7910303|NCT02053610|12427106|FG001|Overall Study|Withdrew Consent|9
7910304|NCT02053610|12427105|FG000|Overall Study|Death|5
7910305|NCT02053610|12427106|FG001|Overall Study|Death|5
7910306|NCT02053610|12427105|FG000|Overall Study|Administrative/Other|1
7910307|NCT02053610|12427106|FG001|Overall Study|Administrative/Other|1
7910308|NCT02053610|12427105|FG000|Overall Study|Disease Progression|2
7910309|NCT02053610|12427106|FG001|Overall Study|Disease Progression|3
7910310|NCT02053610|12427105|FG000|Overall Study|Refused treatment/Did not cooperate|1
7910311|NCT02053610|12427106|FG001|Overall Study|Refused treatment/Did not cooperate|3
7910312|NCT02053610|12427105|FG000|Overall Study|Did not Receive Treatment|4
7910313|NCT02053610|12427106|FG001|Overall Study|Did not Receive Treatment|2
7910314|NCT02053610|12427105|FG000|Overall Study|Insufficient Therapeutic Response|1
7910315|NCT02053610|12427106|FG001|Overall Study|Insufficient Therapeutic Response|1
7910316|NCT02053610|12427105|FG000|Overall Study|Violation of Selection Criteria|1
7910317|NCT02053610|12427106|FG001|Overall Study|Violation of Selection Criteria|0
7910318|NCT02053753|12427114|FG000|Overall Study|Withdrawal by Subject|2
7910319|NCT02053753|12427115|FG001|Overall Study|Withdrawal by Subject|4
7910320|NCT02053753|12427114|FG000|Overall Study|Decision by Sponsor|1
7910321|NCT02053753|12427115|FG001|Overall Study|Decision by Sponsor|1
7910322|NCT02053753|12427114|FG000|Overall Study|Lost to Follow-up|4
7910323|NCT02053753|12427115|FG001|Overall Study|Lost to Follow-up|3
7910324|NCT02054130|12427125|FG000|Overall Study|Withdrawal by Subject|4
7910325|NCT02054130|12427126|FG001|Overall Study|Withdrawal by Subject|4
7910326|NCT02054130|12427127|FG002|Overall Study|Withdrawal by Subject|7
7910327|NCT02054130|12427128|FG003|Overall Study|Withdrawal by Subject|10
7910328|NCT02054130|12427125|FG000|Overall Study|Death|0
7910329|NCT02054130|12427126|FG001|Overall Study|Death|1
7910330|NCT02054130|12427127|FG002|Overall Study|Death|0
7910331|NCT02054130|12427128|FG003|Overall Study|Death|0
7910332|NCT02054130|12427125|FG000|Overall Study|Lost to Follow-up|0
7910333|NCT02054130|12427126|FG001|Overall Study|Lost to Follow-up|0
7910334|NCT02054130|12427127|FG002|Overall Study|Lost to Follow-up|1
7910335|NCT02054130|12427128|FG003|Overall Study|Lost to Follow-up|2
7910336|NCT02054130|12427125|FG000|Overall Study|Missed dose|4
7910337|NCT02054130|12427126|FG001|Overall Study|Missed dose|6
7910338|NCT02054130|12427127|FG002|Overall Study|Missed dose|7
7910339|NCT02054130|12427128|FG003|Overall Study|Missed dose|10
7910340|NCT02054325|12427152|FG000|Overall Study|Lost to Follow-up|8
7910341|NCT02054325|12427153|FG001|Overall Study|Lost to Follow-up|5
7910342|NCT02054481|12427172|FG000|Overall Study|Adverse Event|1
7910343|NCT02054481|12427173|FG001|Overall Study|Adverse Event|1
7910344|NCT02054481|12427174|FG002|Overall Study|Adverse Event|0
7910345|NCT02054481|12427175|FG003|Overall Study|Adverse Event|1
7910346|NCT02054481|12427172|FG000|Overall Study|Lost to Follow-up|1
7910347|NCT02054481|12427173|FG001|Overall Study|Lost to Follow-up|0
7910348|NCT02054481|12427174|FG002|Overall Study|Lost to Follow-up|0
7814946|NCT01209624|12280546|FG000|Overall Study|Lost to Follow-up|290
7814947|NCT01209624|12280546|FG000|Overall Study|Other|4
7814948|NCT01209689|12280552|FG000|Overall Study|Insufficient Therapeutic Response|7
7814949|NCT01209689|12280553|FG001|Overall Study|Insufficient Therapeutic Response|2
7814950|NCT01209689|12280552|FG000|Overall Study|Refused Treatment|8
7814951|NCT01209689|12280553|FG001|Overall Study|Refused Treatment|3
7814952|NCT01209689|12280552|FG000|Overall Study|Adverse Event|4
7814953|NCT01209689|12280553|FG001|Overall Study|Adverse Event|0
7814954|NCT01209689|12280552|FG000|Overall Study|Violation of Selection Criteria at Entry|1
7814955|NCT01209689|12280553|FG001|Overall Study|Violation of Selection Criteria at Entry|0
7814956|NCT01209689|12280552|FG000|Overall Study|Failure to Return|3
7814957|NCT01209689|12280553|FG001|Overall Study|Failure to Return|0
7814958|NCT01209689|12280552|FG000|Overall Study|Sponsor's Decision to Stop the Study|68
7814959|NCT01209689|12280553|FG001|Overall Study|Sponsor's Decision to Stop the Study|17
7814960|NCT01209780|12280587|FG000|Overall Study|Adverse Event|0
7814961|NCT01209780|12280588|FG001|Overall Study|Adverse Event|1
7814962|NCT01209780|12280589|FG002|Overall Study|Adverse Event|0
7814963|NCT01209780|12280590|FG003|Overall Study|Adverse Event|0
7814964|NCT01209780|12280591|FG004|Overall Study|Adverse Event|0
7814965|NCT01209780|12280587|FG000|Overall Study|Withdrawal by Subject|9
7814966|NCT01209780|12280588|FG001|Overall Study|Withdrawal by Subject|2
7814967|NCT01209780|12280589|FG002|Overall Study|Withdrawal by Subject|1
7814968|NCT01209780|12280590|FG003|Overall Study|Withdrawal by Subject|1
7814969|NCT01209780|12280591|FG004|Overall Study|Withdrawal by Subject|0
7814970|NCT01209780|12280587|FG000|Overall Study|Lost to Follow-up|17
7814971|NCT01209780|12280588|FG001|Overall Study|Lost to Follow-up|12
7814972|NCT01209780|12280589|FG002|Overall Study|Lost to Follow-up|3
7814973|NCT01209780|12280590|FG003|Overall Study|Lost to Follow-up|9
7814974|NCT01209780|12280591|FG004|Overall Study|Lost to Follow-up|4
7814975|NCT01209780|12280587|FG000|Overall Study|Protocol Violation|0
7814976|NCT01209780|12280588|FG001|Overall Study|Protocol Violation|1
7814977|NCT01209780|12280589|FG002|Overall Study|Protocol Violation|0
7814978|NCT01209780|12280590|FG003|Overall Study|Protocol Violation|0
7814979|NCT01209780|12280591|FG004|Overall Study|Protocol Violation|0
7814980|NCT01209780|12280587|FG000|Overall Study|Inappropriate enrollment|0
7814981|NCT01209780|12280588|FG001|Overall Study|Inappropriate enrollment|2
7814982|NCT01209780|12280589|FG002|Overall Study|Inappropriate enrollment|0
7814983|NCT01209780|12280590|FG003|Overall Study|Inappropriate enrollment|0
7814984|NCT01209780|12280591|FG004|Overall Study|Inappropriate enrollment|1
7814985|NCT01209832|12280604|FG000|Period 1|Sponsor Decision and was not dosed|1
7814986|NCT01209832|12280604|FG000|Period 2|Sponsor Decision|1
7814987|NCT01210001|12280618|FG000|Overall Study|Not treated|1
7814988|NCT01210001|12280619|FG001|Overall Study|Not treated|0
7814989|NCT01210001|12280620|FG002|Overall Study|Not treated|0
7814990|NCT01210001|12280618|FG000|Overall Study|Adverse Event|4
7814991|NCT01210001|12280619|FG001|Overall Study|Adverse Event|2
7814992|NCT01210001|12280620|FG002|Overall Study|Adverse Event|5
7814993|NCT01210001|12280618|FG000|Overall Study|Non compliant with protocol|2
7814994|NCT01210001|12280619|FG001|Overall Study|Non compliant with protocol|2
7814995|NCT01210001|12280620|FG002|Overall Study|Non compliant with protocol|3
7814996|NCT01210001|12280618|FG000|Overall Study|Lost to Follow-up|4
7814997|NCT01210001|12280619|FG001|Overall Study|Lost to Follow-up|3
7814998|NCT01210001|12280620|FG002|Overall Study|Lost to Follow-up|2
7814999|NCT01210001|12280618|FG000|Overall Study|Patient refusal to continue,not due toAE|6
7815000|NCT01210001|12280619|FG001|Overall Study|Patient refusal to continue,not due toAE|2
7815001|NCT01210001|12280620|FG002|Overall Study|Patient refusal to continue,not due toAE|1
7815002|NCT01210001|12280618|FG000|Overall Study|Other reason not defined above|2
7815003|NCT01210001|12280619|FG001|Overall Study|Other reason not defined above|2
7815004|NCT01210001|12280620|FG002|Overall Study|Other reason not defined above|1
7815005|NCT01210118|12280639|FG000|Overall Study|Lost to Follow-up|1
7815006|NCT01210118|12280640|FG001|Overall Study|Lost to Follow-up|1
7815007|NCT01210118|12280639|FG000|Overall Study|Protocol Violation|1
7815008|NCT01210118|12280640|FG001|Overall Study|Protocol Violation|1
7815009|NCT01210118|12280639|FG000|Overall Study|Spontaneous abortion|1
7815010|NCT01210118|12280640|FG001|Overall Study|Spontaneous abortion|3
7815011|NCT01210144|12280651|FG000|Overall Study|Lack of ovarian response|1
7815012|NCT01210144|12280652|FG001|Overall Study|Lack of ovarian response|0
7815013|NCT01210144|12280651|FG000|Overall Study|No fertilization|1
7815014|NCT01210144|12280652|FG001|Overall Study|No fertilization|0
7815015|NCT01210144|12280651|FG000|Overall Study|No transfer|1
7815016|NCT01210144|12280652|FG001|Overall Study|No transfer|0
7815017|NCT01210222|12280680|FG000|Overall Study|Ineligible|2
7815018|NCT01210222|12280680|FG000|Overall Study|Never treated|1
7815019|NCT01210352|12280699|FG000|Overall Study|Adverse Event|0
7815020|NCT01210352|12280700|FG001|Overall Study|Adverse Event|0
7815021|NCT01210352|12280701|FG002|Overall Study|Adverse Event|0
7815022|NCT01210352|12280702|FG003|Overall Study|Adverse Event|0
7815023|NCT01210352|12280703|FG004|Overall Study|Adverse Event|0
7815024|NCT01210352|12280704|FG005|Overall Study|Adverse Event|0
7815025|NCT01210352|12280705|FG006|Overall Study|Adverse Event|0
7815026|NCT01210352|12280706|FG007|Overall Study|Adverse Event|2
7815027|NCT01210352|12280707|FG008|Overall Study|Adverse Event|1
7815028|NCT01210352|12280699|FG000|Overall Study|Lack of Efficacy|0
7815029|NCT01210352|12280700|FG001|Overall Study|Lack of Efficacy|0
7815030|NCT01210352|12280701|FG002|Overall Study|Lack of Efficacy|0
7815031|NCT01210352|12280702|FG003|Overall Study|Lack of Efficacy|0
7815032|NCT01210352|12280703|FG004|Overall Study|Lack of Efficacy|0
7815033|NCT01210352|12280704|FG005|Overall Study|Lack of Efficacy|0
7815034|NCT01210352|12280705|FG006|Overall Study|Lack of Efficacy|1
7815035|NCT01210352|12280706|FG007|Overall Study|Lack of Efficacy|0
7815036|NCT01210352|12280707|FG008|Overall Study|Lack of Efficacy|0
7815037|NCT01210352|12280699|FG000|Overall Study|Physician Decision|0
7815038|NCT01210352|12280700|FG001|Overall Study|Physician Decision|0
7815039|NCT01210352|12280701|FG002|Overall Study|Physician Decision|0
7815040|NCT01210352|12280702|FG003|Overall Study|Physician Decision|0
7815041|NCT01210352|12280703|FG004|Overall Study|Physician Decision|0
7815042|NCT01210352|12280704|FG005|Overall Study|Physician Decision|0
7815043|NCT01210352|12280705|FG006|Overall Study|Physician Decision|0
7815044|NCT01210352|12280706|FG007|Overall Study|Physician Decision|1
7815045|NCT01210352|12280707|FG008|Overall Study|Physician Decision|2
7815046|NCT01210352|12280699|FG000|Overall Study|Withdrawal by Subject|0
7815047|NCT01210352|12280700|FG001|Overall Study|Withdrawal by Subject|0
7815048|NCT01210352|12280701|FG002|Overall Study|Withdrawal by Subject|1
7815049|NCT01210352|12280702|FG003|Overall Study|Withdrawal by Subject|0
7815050|NCT01210352|12280703|FG004|Overall Study|Withdrawal by Subject|0
7815051|NCT01210352|12280704|FG005|Overall Study|Withdrawal by Subject|0
7815052|NCT01210352|12280705|FG006|Overall Study|Withdrawal by Subject|1
7815053|NCT01210352|12280706|FG007|Overall Study|Withdrawal by Subject|0
7815054|NCT01210352|12280707|FG008|Overall Study|Withdrawal by Subject|1
7815055|NCT01210352|12280699|FG000|Overall Study|Patient Discharged Early|0
7815056|NCT01210352|12280700|FG001|Overall Study|Patient Discharged Early|0
7815057|NCT01210352|12280701|FG002|Overall Study|Patient Discharged Early|1
7815058|NCT01210352|12280702|FG003|Overall Study|Patient Discharged Early|0
7815059|NCT01210352|12280703|FG004|Overall Study|Patient Discharged Early|0
7815060|NCT01210352|12280704|FG005|Overall Study|Patient Discharged Early|0
7815061|NCT01210352|12280705|FG006|Overall Study|Patient Discharged Early|0
7815062|NCT01210352|12280706|FG007|Overall Study|Patient Discharged Early|0
7815063|NCT01210352|12280707|FG008|Overall Study|Patient Discharged Early|0
7815064|NCT01210443|12280812|FG000|Overall Study|Study terminated by sponsor|2
7815065|NCT01210495|12280820|FG000|Overall Study|Participant Refused Further Follow-Up|1
7815066|NCT01210495|12280821|FG001|Overall Study|Participant Refused Further Follow-Up|0
7815067|NCT01210495|12280822|FG002|Overall Study|Participant Refused Further Follow-Up|11
7815068|NCT01210495|12280823|FG003|Overall Study|Participant Refused Further Follow-Up|2
7815069|NCT01210495|12280820|FG000|Overall Study|Death|14
7815070|NCT01210495|12280821|FG001|Overall Study|Death|7
7815071|NCT01210495|12280822|FG002|Overall Study|Death|112
7815072|NCT01210495|12280823|FG003|Overall Study|Death|54
7815073|NCT01210495|12280820|FG000|Overall Study|Study Terminated by Sponsor|0
7815074|NCT01210495|12280821|FG001|Overall Study|Study Terminated by Sponsor|0
7815075|NCT01210495|12280822|FG002|Overall Study|Study Terminated by Sponsor|4
7815076|NCT01210495|12280823|FG003|Overall Study|Study Terminated by Sponsor|11
7815077|NCT01210495|12280820|FG000|Overall Study|Lost to Follow-up|0
7815078|NCT01210495|12280821|FG001|Overall Study|Lost to Follow-up|0
7815079|NCT01210495|12280822|FG002|Overall Study|Lost to Follow-up|1
7815080|NCT01210495|12280823|FG003|Overall Study|Lost to Follow-up|1
7815081|NCT01210495|12280820|FG000|Overall Study|Other unspecified|0
7815082|NCT01210495|12280821|FG001|Overall Study|Other unspecified|0
7815083|NCT01210495|12280822|FG002|Overall Study|Other unspecified|6
7815084|NCT01210495|12280823|FG003|Overall Study|Other unspecified|0
7815085|NCT01210651|12280858|FG000|Overall Study|Lost to Follow-up|1
7815086|NCT01210651|12280859|FG001|Overall Study|Lost to Follow-up|1
7815087|NCT01210651|12280858|FG000|Overall Study|schedule conflicts|1
7815088|NCT01210651|12280859|FG001|Overall Study|schedule conflicts|5
7815089|NCT01210651|12280858|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0
7815090|NCT01210651|12280859|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1
7815091|NCT01210651|12280858|FG000|Overall Study|Withdrawal by Subject|1
7815092|NCT01210651|12280859|FG001|Overall Study|Withdrawal by Subject|1
7815093|NCT01210651|12280858|FG000|Overall Study|Injury outside study|2
7815094|NCT01210651|12280859|FG001|Overall Study|Injury outside study|0
7815095|NCT01210664|12280869|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
7815096|NCT01210664|12280870|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
7815097|NCT01210664|12280871|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
7815098|NCT01210664|12280872|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
7815099|NCT01210664|12280869|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
7815100|NCT01210664|12280870|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
7815101|NCT01210664|12280871|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
7815102|NCT01210664|12280872|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
7815103|NCT01210664|12280869|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
7815104|NCT01210664|12280870|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
7815105|NCT01210664|12280871|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
7815106|NCT01210664|12280872|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
7815107|NCT01210690|12280882|FG000|Overall Study|Adverse Event|7
7815108|NCT01210690|12280882|FG000|Overall Study|Lack of Efficacy|12
7815109|NCT01210690|12280882|FG000|Overall Study|Lost to Follow-up|3
7815110|NCT01210690|12280882|FG000|Overall Study|Disease Remission|1
7815111|NCT01210690|12280882|FG000|Overall Study|Withdrawal by Subject|1
7815112|NCT01210690|12280882|FG000|Overall Study|Patient refused to swallow|1
7815113|NCT01210690|12280882|FG000|Overall Study|Patient could not take glucose|1
7815114|NCT01210807|12280896|FG000|Overall Study|Lost to Follow-up|1
7815115|NCT01210807|12280897|FG001|Overall Study|Lost to Follow-up|2
7815116|NCT01210807|12280896|FG000|Overall Study|Not implanted bilaterally|2
7815117|NCT01210807|12280897|FG001|Overall Study|Not implanted bilaterally|1
7815118|NCT01211145|12280927|FG000|Overall Study|Reason not specified|3
7815119|NCT01211145|12280928|FG001|Overall Study|Reason not specified|2
7815120|NCT01211145|12280929|FG002|Overall Study|Reason not specified|2
7815121|NCT01211145|12280930|FG003|Overall Study|Reason not specified|1
7815122|NCT01211145|12280927|FG000|Overall Study|Lost to Follow-up|3
7815123|NCT01211145|12280928|FG001|Overall Study|Lost to Follow-up|2
7815124|NCT01211145|12280929|FG002|Overall Study|Lost to Follow-up|1
7815125|NCT01211145|12280930|FG003|Overall Study|Lost to Follow-up|2
7815126|NCT01211145|12280927|FG000|Overall Study|Study-specific withdrawal criteria|1
7815127|NCT01211145|12280928|FG001|Overall Study|Study-specific withdrawal criteria|0
7815128|NCT01211145|12280929|FG002|Overall Study|Study-specific withdrawal criteria|0
7815129|NCT01211145|12280930|FG003|Overall Study|Study-specific withdrawal criteria|0
7815130|NCT01211145|12280927|FG000|Overall Study|Severe noncompliance to protocol|1
7815131|NCT01211145|12280928|FG001|Overall Study|Severe noncompliance to protocol|0
7815132|NCT01211145|12280929|FG002|Overall Study|Severe noncompliance to protocol|0
7815133|NCT01211145|12280930|FG003|Overall Study|Severe noncompliance to protocol|0
7815134|NCT01211145|12280927|FG000|Overall Study|Eligibility criteria not fulfilled|16
7815135|NCT01211145|12280928|FG001|Overall Study|Eligibility criteria not fulfilled|12
7815136|NCT01211145|12280929|FG002|Overall Study|Eligibility criteria not fulfilled|10
7815137|NCT01211145|12280930|FG003|Overall Study|Eligibility criteria not fulfilled|15
7815138|NCT01211145|12280927|FG000|Overall Study|Patient decision|2
7815139|NCT01211145|12280928|FG001|Overall Study|Patient decision|1
7815140|NCT01211145|12280929|FG002|Overall Study|Patient decision|0
7815141|NCT01211145|12280930|FG003|Overall Study|Patient decision|2
7815142|NCT01211184|12280943|FG000|Overall Study|Withdrawal by Subject|0
7815143|NCT01211184|12280944|FG001|Overall Study|Withdrawal by Subject|2
7815144|NCT01211184|12280945|FG002|Overall Study|Withdrawal by Subject|1
7815145|NCT01211197|12280956|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7815146|NCT01211197|12280957|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7815147|NCT01211197|12280958|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7815148|NCT01211197|12280959|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7815149|NCT01211197|12280960|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7815150|NCT01211197|12280961|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7815151|NCT01211197|12280956|FG000|Washout Period 2 (7 Days)|Adverse Event|1
7815152|NCT01211197|12280957|FG001|Washout Period 2 (7 Days)|Adverse Event|0
7815153|NCT01211197|12280958|FG002|Washout Period 2 (7 Days)|Adverse Event|0
7815154|NCT01211197|12280959|FG003|Washout Period 2 (7 Days)|Adverse Event|0
7815155|NCT01211197|12280960|FG004|Washout Period 2 (7 Days)|Adverse Event|0
7815156|NCT01211197|12280961|FG005|Washout Period 2 (7 Days)|Adverse Event|0
7815157|NCT01211262|12280971|FG000|Overall Study|Progressive Disease|18
7815158|NCT01211262|12280972|FG001|Overall Study|Progressive Disease|9
7815159|NCT01211262|12280971|FG000|Overall Study|Adverse Event|4
7815160|NCT01211262|12280972|FG001|Overall Study|Adverse Event|0
7815161|NCT01211262|12280971|FG000|Overall Study|Withdrawal of Consent|1
7815162|NCT01211262|12280972|FG001|Overall Study|Withdrawal of Consent|0
7815163|NCT01211262|12280971|FG000|Overall Study|Other|0
7815164|NCT01211262|12280972|FG001|Overall Study|Other|1
7815165|NCT01211288|12280983|FG000|Overall Study|Lost to Follow-up|1
7815166|NCT01211288|12280984|FG001|Overall Study|Lost to Follow-up|1
7815167|NCT01211483|12281005|FG000|Phase 1b|Death|6
7815168|NCT01211483|12281006|FG001|Phase 1b|Death|0
7815169|NCT01211483|12281007|FG002|Phase 1b|Death|0
7815170|NCT01211483|12281008|FG003|Phase 1b|Death|0
7815171|NCT01211483|12281005|FG000|Phase 1b|Withdrawal by Subject|1
7815172|NCT01211483|12281006|FG001|Phase 1b|Withdrawal by Subject|0
7910349|NCT02054481|12427175|FG003|Overall Study|Lost to Follow-up|0
7910350|NCT02054481|12427172|FG000|Overall Study|Other reason|2
7910351|NCT02054481|12427173|FG001|Overall Study|Other reason|1
7910352|NCT02054481|12427174|FG002|Overall Study|Other reason|2
7910353|NCT02054481|12427175|FG003|Overall Study|Other reason|0
7910354|NCT02054520|12427192|FG000|Overall Study|Adverse Event|1
7910355|NCT02054520|12427193|FG001|Overall Study|Adverse Event|4
7910356|NCT02054520|12427194|FG002|Overall Study|Adverse Event|2
7910357|NCT02054520|12427195|FG003|Overall Study|Adverse Event|1
7910358|NCT02054520|12427196|FG004|Overall Study|Adverse Event|1
7910359|NCT02054520|12427197|FG005|Overall Study|Adverse Event|0
7910360|NCT02054520|12427192|FG000|Overall Study|Lack of Efficacy|7
7910361|NCT02054520|12427193|FG001|Overall Study|Lack of Efficacy|0
7910362|NCT02054520|12427194|FG002|Overall Study|Lack of Efficacy|2
7910363|NCT02054520|12427195|FG003|Overall Study|Lack of Efficacy|1
7910364|NCT02054520|12427196|FG004|Overall Study|Lack of Efficacy|3
7910365|NCT02054520|12427197|FG005|Overall Study|Lack of Efficacy|2
7910366|NCT02054520|12427192|FG000|Overall Study|Withdrawal by Subject|1
7910367|NCT02054520|12427193|FG001|Overall Study|Withdrawal by Subject|0
7910368|NCT02054520|12427194|FG002|Overall Study|Withdrawal by Subject|0
7910369|NCT02054520|12427195|FG003|Overall Study|Withdrawal by Subject|2
7910370|NCT02054520|12427196|FG004|Overall Study|Withdrawal by Subject|1
7910371|NCT02054520|12427197|FG005|Overall Study|Withdrawal by Subject|0
7910372|NCT02054520|12427192|FG000|Overall Study|Physician Decision|0
7910373|NCT02054520|12427193|FG001|Overall Study|Physician Decision|1
7910374|NCT02054520|12427194|FG002|Overall Study|Physician Decision|0
7910375|NCT02054520|12427195|FG003|Overall Study|Physician Decision|1
7910376|NCT02054520|12427196|FG004|Overall Study|Physician Decision|0
7910377|NCT02054520|12427197|FG005|Overall Study|Physician Decision|1
7910378|NCT02054520|12427192|FG000|Overall Study|Study terminated by Sponsor|0
7910379|NCT02054520|12427193|FG001|Overall Study|Study terminated by Sponsor|0
7815173|NCT01211483|12281007|FG002|Phase 1b|Withdrawal by Subject|0
7910380|NCT02054520|12427194|FG002|Overall Study|Study terminated by Sponsor|2
7815174|NCT01211483|12281008|FG003|Phase 1b|Withdrawal by Subject|0
7815175|NCT01211483|12281005|FG000|Phase 2|Lost to Follow-up|0
7815176|NCT01211483|12281006|FG001|Phase 2|Lost to Follow-up|1
7815177|NCT01211483|12281007|FG002|Phase 2|Lost to Follow-up|1
7815178|NCT01211483|12281008|FG003|Phase 2|Lost to Follow-up|2
7815179|NCT01211483|12281005|FG000|Phase 2|Death|0
7815180|NCT01211483|12281006|FG001|Phase 2|Death|64
7815181|NCT01211483|12281007|FG002|Phase 2|Death|53
7815182|NCT01211483|12281008|FG003|Phase 2|Death|53
7815183|NCT01211483|12281005|FG000|Phase 2|Withdrawal by Subject|0
7815184|NCT01211483|12281006|FG001|Phase 2|Withdrawal by Subject|1
7815185|NCT01211483|12281007|FG002|Phase 2|Withdrawal by Subject|10
7815186|NCT01211483|12281008|FG003|Phase 2|Withdrawal by Subject|5
7815187|NCT01211483|12281005|FG000|Phase 2|Study terminated by Sponsor|0
7815188|NCT01211483|12281006|FG001|Phase 2|Study terminated by Sponsor|6
7815189|NCT01211483|12281007|FG002|Phase 2|Study terminated by Sponsor|8
7815190|NCT01211483|12281008|FG003|Phase 2|Study terminated by Sponsor|11
7815191|NCT01211522|12281025|FG000|Overall Study|Withdrawal by Subject|3
7815192|NCT01211522|12281026|FG001|Overall Study|Withdrawal by Subject|7
7815193|NCT01211522|12281027|FG002|Overall Study|Withdrawal by Subject|5
7815194|NCT01211535|12281037|FG000|Overall Study|Adverse Event|0
7815195|NCT01211535|12281038|FG001|Overall Study|Adverse Event|1
7815196|NCT01211613|12281058|FG000|Overall Study|Lost to Follow-up|2
7815197|NCT01211613|12281059|FG001|Overall Study|Lost to Follow-up|2
7815198|NCT01211613|12281060|FG002|Overall Study|Lost to Follow-up|2
7815199|NCT01211613|12281058|FG000|Overall Study|Withdrawal by Subject|1
7815200|NCT01211613|12281059|FG001|Overall Study|Withdrawal by Subject|0
7815201|NCT01211613|12281060|FG002|Overall Study|Withdrawal by Subject|0
7815202|NCT01211665|12281070|FG000|Overall Study|Withdrawal by Subject|1
7815203|NCT01211665|12281071|FG001|Overall Study|Withdrawal by Subject|0
7815204|NCT01211665|12281070|FG000|Overall Study|Death|1
7815205|NCT01211665|12281071|FG001|Overall Study|Death|0
7815206|NCT01211769|12281090|FG000|Overall Study|Lost to Follow-up|7
7815207|NCT01211769|12281091|FG001|Overall Study|Lost to Follow-up|9
7815208|NCT01211769|12281092|FG002|Overall Study|Lost to Follow-up|5
7815209|NCT01211769|12281093|FG003|Overall Study|Lost to Follow-up|9
7815210|NCT01211769|12281090|FG000|Overall Study|Physician Decision|2
7815211|NCT01211769|12281091|FG001|Overall Study|Physician Decision|0
7815212|NCT01211769|12281092|FG002|Overall Study|Physician Decision|2
7910381|NCT02054520|12427195|FG003|Overall Study|Study terminated by Sponsor|1
7910382|NCT02054520|12427196|FG004|Overall Study|Study terminated by Sponsor|0
7910383|NCT02054520|12427197|FG005|Overall Study|Study terminated by Sponsor|0
7910384|NCT02054702|12427217|FG000|Overall Study|Lost to Follow-up|3
7910385|NCT02054702|12427218|FG001|Overall Study|Lost to Follow-up|5
7910386|NCT02054702|12427217|FG000|Overall Study|Adverse Event|3
7910387|NCT02054702|12427218|FG001|Overall Study|Adverse Event|1
7910388|NCT02054702|12427217|FG000|Overall Study|Met Withdrawal Criteria|4
7910389|NCT02054702|12427218|FG001|Overall Study|Met Withdrawal Criteria|1
7910390|NCT02054702|12427217|FG000|Overall Study|Physician Decision|0
7910391|NCT02054702|12427218|FG001|Overall Study|Physician Decision|1
7910392|NCT02054702|12427217|FG000|Overall Study|Withdrawal by Subject|14
7815213|NCT01211769|12281093|FG003|Overall Study|Physician Decision|1
7815214|NCT01211769|12281090|FG000|Overall Study|Adverse Event|0
7815215|NCT01211769|12281091|FG001|Overall Study|Adverse Event|1
7815216|NCT01211769|12281092|FG002|Overall Study|Adverse Event|1
7815217|NCT01211769|12281093|FG003|Overall Study|Adverse Event|1
7815218|NCT01212094|12281120|FG000|Year 1: Baseline Monitoring|Study terminated|7
7815219|NCT01212094|12281121|FG001|Year 1: Baseline Monitoring|Study terminated|0
7815220|NCT01212094|12281122|FG002|Year 1: Baseline Monitoring|Study terminated|0
7815221|NCT01212094|12281120|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7
7815222|NCT01212094|12281121|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0
7815223|NCT01212094|12281122|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0
7815224|NCT01212094|12281120|FG000|Year 1: Baseline Monitoring|Started on DMT|2
7815225|NCT01212094|12281121|FG001|Year 1: Baseline Monitoring|Started on DMT|0
7815226|NCT01212094|12281122|FG002|Year 1: Baseline Monitoring|Started on DMT|0
7815227|NCT01212094|12281120|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0
7815228|NCT01212094|12281121|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4
7815229|NCT01212094|12281122|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7
7815230|NCT01212094|12281120|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
7910393|NCT02054702|12427218|FG001|Overall Study|Withdrawal by Subject|4
7815231|NCT01212094|12281121|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
7815232|NCT01212094|12281122|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
7815233|NCT01212094|12281120|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0
7815234|NCT01212094|12281121|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0
7910394|NCT02054715|12427226|FG000|Baseline/Follow-up 1|Refused|1
7910395|NCT02054715|12427227|FG001|Baseline/Follow-up 1|Refused|3
7910396|NCT02054715|12427226|FG000|Baseline/Follow-up 1|Medical|0
7910397|NCT02054715|12427227|FG001|Baseline/Follow-up 1|Medical|1
7910398|NCT02054715|12427226|FG000|Baseline/Follow-up 1|Changed MD/Facility|0
7910399|NCT02054715|12427227|FG001|Baseline/Follow-up 1|Changed MD/Facility|1
7910400|NCT02054715|12427226|FG000|Baseline/Follow-up 1|Disliked Procedure|0
7910401|NCT02054715|12427227|FG001|Baseline/Follow-up 1|Disliked Procedure|1
7910402|NCT02054715|12427226|FG000|Baseline/Follow-up 1|No Reason|0
7910403|NCT02054715|12427227|FG001|Baseline/Follow-up 1|No Reason|1
7910404|NCT02054715|12427226|FG000|Baseline/Follow-up 1|Overwhelmed|2
7910405|NCT02054715|12427227|FG001|Baseline/Follow-up 1|Overwhelmed|0
7910406|NCT02054715|12427226|FG000|Baseline/Follow-up 1|Ineligible|3
7910407|NCT02054715|12427227|FG001|Baseline/Follow-up 1|Ineligible|0
7910408|NCT02054715|12427226|FG000|Baseline/Follow-up 1|Hospitalization|1
7910409|NCT02054715|12427227|FG001|Baseline/Follow-up 1|Hospitalization|0
7815235|NCT01212094|12281122|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1
7815236|NCT01212159|12281196|FG000|Overall Study|Withdrawal by Subject|12
7815237|NCT01212159|12281197|FG001|Overall Study|Withdrawal by Subject|12
7815238|NCT01212185|12281214|FG000|Overall Study|Protocol Violation|2
7815239|NCT01212185|12281215|FG001|Overall Study|Protocol Violation|1
7815240|NCT01212588|12281261|FG000|Overall Study|Physician Decision|0
7815241|NCT01212588|12281262|FG001|Overall Study|Physician Decision|1
7815242|NCT01212588|12281261|FG000|Overall Study|Protocol Violation|1
7815243|NCT01212588|12281262|FG001|Overall Study|Protocol Violation|1
7815244|NCT01212744|12281272|FG000|Overall Study|Withdrawal by Subject|1
7815245|NCT01212757|12281281|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
7910410|NCT02054715|12427226|FG000|Baseline/Follow-up 1|Changed Mind|1
7910411|NCT02054715|12427227|FG001|Baseline/Follow-up 1|Changed Mind|0
7910412|NCT02054715|12427226|FG000|Follow-up 2|Lost to Followup|3
7910413|NCT02054715|12427227|FG001|Follow-up 2|Lost to Followup|1
7815246|NCT01212757|12281282|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
7815247|NCT01212757|12281283|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
7815248|NCT01212757|12281284|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7815249|NCT01212757|12281285|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7815250|NCT01212757|12281286|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7815251|NCT01212757|12281287|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7815252|NCT01212757|12281288|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7815253|NCT01212757|12281289|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7815254|NCT01212757|12281281|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
7815255|NCT01212757|12281282|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
7815256|NCT01212757|12281283|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
7815257|NCT01212757|12281284|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7815258|NCT01212757|12281285|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7815259|NCT01212757|12281286|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7815260|NCT01212757|12281287|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7815261|NCT01212757|12281288|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7815262|NCT01212757|12281289|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7815263|NCT01212757|12281281|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
7815264|NCT01212757|12281282|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
7815265|NCT01212757|12281283|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
7815266|NCT01212757|12281284|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7815267|NCT01212757|12281285|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7815268|NCT01212757|12281286|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7815269|NCT01212757|12281287|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7815270|NCT01212757|12281288|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7815271|NCT01212757|12281289|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7815272|NCT01212757|12281281|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
7815273|NCT01212757|12281282|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7815274|NCT01212757|12281283|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
7815275|NCT01212757|12281284|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7815276|NCT01212757|12281285|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7815277|NCT01212757|12281286|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7815278|NCT01212757|12281287|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7815279|NCT01212757|12281288|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7815280|NCT01212757|12281289|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7815281|NCT01212757|12281281|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7815282|NCT01212757|12281282|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7815283|NCT01212757|12281283|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
7815284|NCT01212757|12281284|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7815285|NCT01212757|12281285|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7815286|NCT01212757|12281286|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7815287|NCT01212757|12281287|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7815288|NCT01212757|12281288|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7815289|NCT01212757|12281289|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7815290|NCT01212757|12281281|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7815291|NCT01212757|12281282|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7815292|NCT01212757|12281283|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7815293|NCT01212757|12281284|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7815294|NCT01212757|12281285|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7815295|NCT01212757|12281286|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7815296|NCT01212757|12281287|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7815297|NCT01212757|12281288|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7815298|NCT01212757|12281289|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7815299|NCT01212757|12281281|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1
7815300|NCT01212757|12281282|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2
7815301|NCT01212757|12281283|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0
7815302|NCT01212757|12281284|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0
7815303|NCT01212757|12281285|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0
7815304|NCT01212757|12281286|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0
7815305|NCT01212757|12281287|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0
7815306|NCT01212757|12281288|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0
7815307|NCT01212757|12281289|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0
7815308|NCT01212757|12281281|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
7815309|NCT01212757|12281282|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
7815310|NCT01212757|12281283|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
7815311|NCT01212757|12281284|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
7815312|NCT01212757|12281285|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
7815313|NCT01212757|12281286|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
7815314|NCT01212757|12281287|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
7815315|NCT01212757|12281288|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
7815316|NCT01212757|12281289|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
7815317|NCT01212757|12281281|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
7815318|NCT01212757|12281282|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
7815319|NCT01212757|12281283|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
7815320|NCT01212757|12281284|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
7815321|NCT01212757|12281285|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
7815322|NCT01212757|12281286|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
7815323|NCT01212757|12281287|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
7815324|NCT01212757|12281288|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
7815325|NCT01212757|12281289|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
7815326|NCT01212757|12281281|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7815327|NCT01212757|12281282|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7815328|NCT01212757|12281283|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
7815329|NCT01212757|12281284|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7815330|NCT01212757|12281285|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7815331|NCT01212757|12281286|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7815332|NCT01212757|12281287|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7815333|NCT01212757|12281288|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7815334|NCT01212757|12281289|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7815335|NCT01212757|12281281|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7815336|NCT01212757|12281282|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
7815337|NCT01212757|12281283|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
7815338|NCT01212757|12281284|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
7815339|NCT01212757|12281285|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
7815340|NCT01212757|12281286|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
7815341|NCT01212757|12281287|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7815342|NCT01212757|12281288|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7815343|NCT01212757|12281289|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7815344|NCT01212757|12281281|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7815345|NCT01212757|12281282|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
7815346|NCT01212757|12281283|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7815347|NCT01212757|12281284|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7815348|NCT01212757|12281285|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
7815349|NCT01212757|12281286|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7815350|NCT01212757|12281287|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7815351|NCT01212757|12281288|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7910414|NCT02054715|12427226|FG000|Follow-up 2|Refused|3
7815352|NCT01212757|12281289|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7815353|NCT01212757|12281281|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0
7815354|NCT01212757|12281282|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1
7815355|NCT01212757|12281283|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1
7815356|NCT01212757|12281284|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0
7815357|NCT01212757|12281285|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0
7815358|NCT01212757|12281286|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0
7815359|NCT01212757|12281287|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0
7815360|NCT01212757|12281288|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0
7883651|NCT01783548|12383431|FG001|Overall Study|Adverse Event|4
7910415|NCT02054715|12427227|FG001|Follow-up 2|Refused|2
7910416|NCT02054715|12427226|FG000|Follow-up 2|Followup Not Completed|3
7910417|NCT02054715|12427227|FG001|Follow-up 2|Followup Not Completed|4
7910418|NCT02054715|12427226|FG000|Follow-up 2|Ineligible|4
7910419|NCT02054715|12427227|FG001|Follow-up 2|Ineligible|5
7910420|NCT02054715|12427226|FG000|Follow-up 2|Death|3
7910421|NCT02054715|12427227|FG001|Follow-up 2|Death|3
7910422|NCT02054715|12427226|FG000|Follow-up 2|Hospitalization|0
7910423|NCT02054715|12427227|FG001|Follow-up 2|Hospitalization|2
7910424|NCT02054715|12427226|FG000|Follow-up 2|Changed MD/Facility|0
7910425|NCT02054715|12427227|FG001|Follow-up 2|Changed MD/Facility|1
7910426|NCT02054715|12427226|FG000|Follow-up 2|Changed Mind|0
7910427|NCT02054715|12427227|FG001|Follow-up 2|Changed Mind|1
7910428|NCT02054715|12427226|FG000|Follow-up 2|No Reason|2
7910429|NCT02054715|12427227|FG001|Follow-up 2|No Reason|0
7910430|NCT02054715|12427226|FG000|Follow-up 2|Treatment Change or Delay|1
7910431|NCT02054715|12427227|FG001|Follow-up 2|Treatment Change or Delay|0
7910432|NCT02054897|12427258|FG000|Overall Study|Withdrawal by Subject|2
7910433|NCT02054897|12427259|FG001|Overall Study|Withdrawal by Subject|0
7910434|NCT02054897|12427260|FG002|Overall Study|Withdrawal by Subject|2
7910435|NCT02054897|12427258|FG000|Overall Study|Missing follow-up information|3
7910436|NCT02054897|12427259|FG001|Overall Study|Missing follow-up information|5
7910437|NCT02054897|12427260|FG002|Overall Study|Missing follow-up information|3
7910438|NCT02054897|12427258|FG000|Overall Study|Lost to Follow-up|4
7910439|NCT02054897|12427259|FG001|Overall Study|Lost to Follow-up|2
7910440|NCT02054897|12427260|FG002|Overall Study|Lost to Follow-up|7
7910441|NCT02054897|12427258|FG000|Overall Study|Randomized but not exposed|1
7910442|NCT02054897|12427259|FG001|Overall Study|Randomized but not exposed|0
7910443|NCT02054897|12427260|FG002|Overall Study|Randomized but not exposed|0
7910444|NCT02055118|12427271|FG000|Overall Study|Withdrawal by Subject|0
7910445|NCT02055118|12427272|FG001|Overall Study|Withdrawal by Subject|2
7910446|NCT02055118|12427273|FG002|Overall Study|Withdrawal by Subject|0
7910447|NCT02055157|12427286|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
7910448|NCT02055157|12427287|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1
7910449|NCT02055157|12427288|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
7910450|NCT02055157|12427289|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
7910451|NCT02055157|12427286|FG000|Initial 6 Months|Adverse Event|0
7910452|NCT02055157|12427287|FG001|Initial 6 Months|Adverse Event|0
7910453|NCT02055157|12427288|FG002|Initial 6 Months|Adverse Event|0
7815361|NCT01212757|12281289|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0
7815362|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7815363|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7815364|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7815365|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7815366|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7815367|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7815368|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7815369|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7815370|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1
7815371|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0
7815372|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1
7815373|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1
7815374|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0
7815375|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0
7815376|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0
7815377|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0
7815378|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2
7815379|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2
7815380|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7815381|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
7815382|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
7815383|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7815384|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7815385|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7815386|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7815387|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
7815388|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7815389|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7815390|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
7815391|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
7815392|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7815393|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7815394|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7815395|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7815396|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
7815397|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
7815398|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7910454|NCT02055157|12427289|FG003|Initial 6 Months|Adverse Event|1
7910455|NCT02055157|12427286|FG000|Initial 6 Months|Consent withdrawn by subject|1
7910456|NCT02055157|12427287|FG001|Initial 6 Months|Consent withdrawn by subject|0
7910457|NCT02055157|12427288|FG002|Initial 6 Months|Consent withdrawn by subject|0
7910458|NCT02055157|12427289|FG003|Initial 6 Months|Consent withdrawn by subject|0
7910459|NCT02055157|12427286|FG000|18-month Extension|Investigator decision|0
7910460|NCT02055157|12427287|FG001|18-month Extension|Investigator decision|1
7910461|NCT02055157|12427288|FG002|18-month Extension|Investigator decision|0
7910462|NCT02055157|12427289|FG003|18-month Extension|Investigator decision|0
7910463|NCT02055157|12427286|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1
7910464|NCT02055157|12427287|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0
7910465|NCT02055157|12427288|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0
7910466|NCT02055157|12427289|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0
7910467|NCT02055352|12427312|FG000|Overall Study|Adverse Event|0
7910468|NCT02055352|12427313|FG001|Overall Study|Adverse Event|1
7910469|NCT02055352|12427312|FG000|Overall Study|Non-eligible|0
7910470|NCT02055352|12427313|FG001|Overall Study|Non-eligible|1
7910471|NCT02055352|12427312|FG000|Overall Study|Poor compliance|1
7910472|NCT02055352|12427313|FG001|Overall Study|Poor compliance|1
7910473|NCT02055352|12427312|FG000|Overall Study|Death|1
7910474|NCT02055352|12427313|FG001|Overall Study|Death|2
7815399|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7815400|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
7815401|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7815402|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7815403|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7815404|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7815405|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7815406|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7815407|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0
7815408|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4
7815409|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1
7815410|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0
7815411|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0
7815412|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0
7815413|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0
7815414|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2
7815415|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0
7815416|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
7815417|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
7815418|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
7815419|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
7815420|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
7815421|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
7815422|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
7815423|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
7815424|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
7815425|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7815426|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7815427|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
7815428|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7815429|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7815430|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7815431|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7815432|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7815433|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7815434|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
7815435|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
7815436|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
7815437|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
7815438|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
7815439|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
7815440|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
7815441|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
7815442|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
7815443|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7815444|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7815445|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7815446|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7815447|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7815448|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7815449|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7815450|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7815451|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
7815452|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7815453|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1
7815454|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7815455|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7815456|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7815457|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7910475|NCT02055352|12427312|FG000|Overall Study|Patient decision|1
7910476|NCT02055352|12427313|FG001|Overall Study|Patient decision|1
7815458|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7815459|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7815460|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7815461|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7815462|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7815463|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3
7815464|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7815465|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7815466|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7815467|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7815468|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7815469|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2
7815470|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7815471|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2
7815472|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7815473|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7815474|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7815475|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7815476|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7815477|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7815478|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1
7815479|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0
7815480|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1
7815481|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2
7815482|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0
7815483|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0
7815484|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0
7815485|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0
7815486|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1
7815487|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1
7815488|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
7815489|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
7815490|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
7815491|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
7815492|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
7815493|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
7815494|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
7815495|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
7815496|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
7815497|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
7815498|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
7815499|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
7815500|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
7815501|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
7815502|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
7883652|NCT01783548|12383430|FG000|Overall Study|Withdrawal by Subject|11
7815503|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
7815504|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
7910477|NCT02055352|12427312|FG000|Overall Study|Use of prohibited treatment|0
7910478|NCT02055352|12427313|FG001|Overall Study|Use of prohibited treatment|3
7910479|NCT02055352|12427312|FG000|Overall Study|AE, study drug would be detrimental|1
7910480|NCT02055352|12427313|FG001|Overall Study|AE, study drug would be detrimental|3
7910481|NCT02055352|12427312|FG000|Overall Study|Withdrawal of informed consent|1
7910482|NCT02055352|12427313|FG001|Overall Study|Withdrawal of informed consent|0
7910483|NCT02055352|12427312|FG000|Overall Study|Reason unknown|1
7910484|NCT02055352|12427313|FG001|Overall Study|Reason unknown|5
7910485|NCT02055365|12427319|FG000|Overall Study|Prematurely Withdrawn|1
7910486|NCT02055820|12427384|FG000|Phase I: Dose-Finding|Death|1
7910487|NCT02055820|12427385|FG001|Phase I: Dose-Finding|Death|0
7910488|NCT02055820|12427386|FG002|Phase I: Dose-Finding|Death|1
7910489|NCT02055820|12427387|FG003|Phase I: Dose-Finding|Death|2
7910490|NCT02055820|12427388|FG004|Phase I: Dose-Finding|Death|0
7910491|NCT02055820|12427389|FG005|Phase I: Dose-Finding|Death|1
7910492|NCT02055820|12427390|FG006|Phase I: Dose-Finding|Death|1
7910493|NCT02055820|12427391|FG007|Phase I: Dose-Finding|Death|0
7910494|NCT02055820|12427392|FG008|Phase I: Dose-Finding|Death|0
7910495|NCT02055820|12427393|FG009|Phase I: Dose-Finding|Death|0
7910496|NCT02055820|12427384|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0
7910497|NCT02055820|12427385|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0
7910498|NCT02055820|12427386|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0
7910499|NCT02055820|12427387|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0
7910500|NCT02055820|12427388|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0
7910501|NCT02055820|12427389|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1
7910502|NCT02055820|12427390|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0
7910503|NCT02055820|12427391|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0
7910504|NCT02055820|12427392|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0
7910505|NCT02055820|12427393|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0
7910506|NCT02055820|12427384|FG000|Phase I: Dose-Finding|Lost to Follow-up|0
7910507|NCT02055820|12427385|FG001|Phase I: Dose-Finding|Lost to Follow-up|0
7910508|NCT02055820|12427386|FG002|Phase I: Dose-Finding|Lost to Follow-up|0
7910509|NCT02055820|12427387|FG003|Phase I: Dose-Finding|Lost to Follow-up|1
7910510|NCT02055820|12427388|FG004|Phase I: Dose-Finding|Lost to Follow-up|0
7910511|NCT02055820|12427389|FG005|Phase I: Dose-Finding|Lost to Follow-up|0
7910512|NCT02055820|12427390|FG006|Phase I: Dose-Finding|Lost to Follow-up|1
7910513|NCT02055820|12427391|FG007|Phase I: Dose-Finding|Lost to Follow-up|0
7910514|NCT02055820|12427392|FG008|Phase I: Dose-Finding|Lost to Follow-up|0
7815505|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
7910515|NCT02055820|12427393|FG009|Phase I: Dose-Finding|Lost to Follow-up|0
7910516|NCT02055820|12427384|FG000|Phase II: Expansion|Death|0
7910517|NCT02055820|12427385|FG001|Phase II: Expansion|Death|0
7910518|NCT02055820|12427386|FG002|Phase II: Expansion|Death|0
7910519|NCT02055820|12427387|FG003|Phase II: Expansion|Death|0
7910520|NCT02055820|12427388|FG004|Phase II: Expansion|Death|33
7910521|NCT02055820|12427389|FG005|Phase II: Expansion|Death|0
7910522|NCT02055820|12427390|FG006|Phase II: Expansion|Death|0
7910523|NCT02055820|12427391|FG007|Phase II: Expansion|Death|0
7910524|NCT02055820|12427392|FG008|Phase II: Expansion|Death|0
7910525|NCT02055820|12427393|FG009|Phase II: Expansion|Death|0
7910526|NCT02055820|12427384|FG000|Phase II: Expansion|Lost to Follow-up|0
7910527|NCT02055820|12427385|FG001|Phase II: Expansion|Lost to Follow-up|0
7910528|NCT02055820|12427386|FG002|Phase II: Expansion|Lost to Follow-up|0
7910529|NCT02055820|12427387|FG003|Phase II: Expansion|Lost to Follow-up|0
7910530|NCT02055820|12427388|FG004|Phase II: Expansion|Lost to Follow-up|4
7910531|NCT02055820|12427389|FG005|Phase II: Expansion|Lost to Follow-up|0
7910532|NCT02055820|12427390|FG006|Phase II: Expansion|Lost to Follow-up|0
7910533|NCT02055820|12427391|FG007|Phase II: Expansion|Lost to Follow-up|0
7910534|NCT02055820|12427392|FG008|Phase II: Expansion|Lost to Follow-up|0
7910535|NCT02055820|12427393|FG009|Phase II: Expansion|Lost to Follow-up|0
7910536|NCT02055820|12427384|FG000|Phase II: Expansion|Withdrawal by Subject|0
7910537|NCT02055820|12427385|FG001|Phase II: Expansion|Withdrawal by Subject|0
7910538|NCT02055820|12427386|FG002|Phase II: Expansion|Withdrawal by Subject|0
7910539|NCT02055820|12427387|FG003|Phase II: Expansion|Withdrawal by Subject|0
7910540|NCT02055820|12427388|FG004|Phase II: Expansion|Withdrawal by Subject|12
7910541|NCT02055820|12427389|FG005|Phase II: Expansion|Withdrawal by Subject|0
7910542|NCT02055820|12427390|FG006|Phase II: Expansion|Withdrawal by Subject|0
7910543|NCT02055820|12427391|FG007|Phase II: Expansion|Withdrawal by Subject|0
7910544|NCT02055820|12427392|FG008|Phase II: Expansion|Withdrawal by Subject|0
7910545|NCT02055820|12427393|FG009|Phase II: Expansion|Withdrawal by Subject|0
7910546|NCT02055898|12427437|FG000|First Intervention (5 Days)|Physician Decision|2
7910547|NCT02055898|12427438|FG001|First Intervention (5 Days)|Physician Decision|0
7910548|NCT02055898|12427437|FG000|First Intervention (5 Days)|Withdrawal by Subject|0
7910549|NCT02055898|12427438|FG001|First Intervention (5 Days)|Withdrawal by Subject|1
7910550|NCT02055976|12427453|FG000|Overall Study|Other|0
7910551|NCT02055976|12427454|FG001|Overall Study|Other|0
7910552|NCT02055976|12427455|FG002|Overall Study|Other|1
7910553|NCT02055976|12427456|FG003|Overall Study|Other|0
7910554|NCT02055976|12427457|FG004|Overall Study|Other|0
7910555|NCT02055976|12427458|FG005|Overall Study|Other|0
7910556|NCT02055976|12427459|FG006|Overall Study|Other|0
7910557|NCT02055976|12427460|FG007|Overall Study|Other|0
7910558|NCT02055976|12427461|FG008|Overall Study|Other|0
7910559|NCT02055976|12427453|FG000|Overall Study|Adverse Event|0
7910560|NCT02055976|12427454|FG001|Overall Study|Adverse Event|0
7910561|NCT02055976|12427455|FG002|Overall Study|Adverse Event|0
7910562|NCT02055976|12427456|FG003|Overall Study|Adverse Event|0
7910563|NCT02055976|12427457|FG004|Overall Study|Adverse Event|0
7910564|NCT02055976|12427458|FG005|Overall Study|Adverse Event|1
7910565|NCT02055976|12427459|FG006|Overall Study|Adverse Event|1
7910566|NCT02055976|12427460|FG007|Overall Study|Adverse Event|0
7910567|NCT02055976|12427461|FG008|Overall Study|Adverse Event|0
7910568|NCT02055976|12427453|FG000|Overall Study|Does not meet entrance criteria|0
7910569|NCT02055976|12427454|FG001|Overall Study|Does not meet entrance criteria|0
7910570|NCT02055976|12427455|FG002|Overall Study|Does not meet entrance criteria|0
7910571|NCT02055976|12427456|FG003|Overall Study|Does not meet entrance criteria|0
7910572|NCT02055976|12427457|FG004|Overall Study|Does not meet entrance criteria|0
7910573|NCT02055976|12427458|FG005|Overall Study|Does not meet entrance criteria|0
7910574|NCT02055976|12427459|FG006|Overall Study|Does not meet entrance criteria|1
7910575|NCT02055976|12427460|FG007|Overall Study|Does not meet entrance criteria|0
7910576|NCT02055976|12427461|FG008|Overall Study|Does not meet entrance criteria|0
7910577|NCT02055976|12427453|FG000|Overall Study|Lost to Follow-up|0
7910578|NCT02055976|12427454|FG001|Overall Study|Lost to Follow-up|0
7910579|NCT02055976|12427455|FG002|Overall Study|Lost to Follow-up|0
7910580|NCT02055976|12427456|FG003|Overall Study|Lost to Follow-up|1
7910581|NCT02055976|12427457|FG004|Overall Study|Lost to Follow-up|0
7910582|NCT02055976|12427458|FG005|Overall Study|Lost to Follow-up|0
7910583|NCT02055976|12427459|FG006|Overall Study|Lost to Follow-up|0
7910584|NCT02055976|12427460|FG007|Overall Study|Lost to Follow-up|0
7910585|NCT02055976|12427461|FG008|Overall Study|Lost to Follow-up|0
7910586|NCT02056288|12427499|FG000|In-Hospital Data|Surgery cancelled|1
7910587|NCT02056288|12427500|FG001|In-Hospital Data|Surgery cancelled|0
7910588|NCT02056288|12427499|FG000|In-Hospital Data|Protocol Violation|3
7910589|NCT02056288|12427500|FG001|In-Hospital Data|Protocol Violation|0
7910590|NCT02056288|12427499|FG000|In-Hospital Data|Physician Decision|1
7910591|NCT02056288|12427500|FG001|In-Hospital Data|Physician Decision|0
7910592|NCT02056288|12427499|FG000|48-Hour Post-Discharge Data|Did not return diary|14
7910593|NCT02056288|12427500|FG001|48-Hour Post-Discharge Data|Did not return diary|20
7815506|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 4)|Death|0
7815507|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 4)|Death|0
7815508|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 4)|Death|1
7815509|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 4)|Death|0
7815510|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 4)|Death|0
7815511|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 4)|Death|0
7815512|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 4)|Death|0
7815513|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 4)|Death|0
7910594|NCT02056301|12427508|FG000|Overall Study|Protocol Violation|1
7910595|NCT02056301|12427509|FG001|Overall Study|Protocol Violation|2
7910596|NCT02056301|12427508|FG000|Overall Study|Surgical complications req. 2nd surgery|1
7910597|NCT02056301|12427509|FG001|Overall Study|Surgical complications req. 2nd surgery|0
7910598|NCT02056301|12427508|FG000|Overall Study|Withdrawal by Subject|0
7910599|NCT02056301|12427509|FG001|Overall Study|Withdrawal by Subject|1
7910600|NCT02056301|12427508|FG000|Overall Study|Issues with epidural|0
7910601|NCT02056301|12427509|FG001|Overall Study|Issues with epidural|3
7910602|NCT02056340|12427517|FG000|Overall Study|Lost to Follow-up|5
7910603|NCT02056340|12427518|FG001|Overall Study|Lost to Follow-up|5
7910604|NCT02056340|12427517|FG000|Overall Study|Withdrawal by Subject|2
7815514|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 4)|Death|1
7910605|NCT02056340|12427518|FG001|Overall Study|Withdrawal by Subject|6
7910606|NCT02056392|12427530|FG000|Overall Study|Lost to Follow-up|0
7910607|NCT02056392|12427531|FG001|Overall Study|Lost to Follow-up|1
7910608|NCT02056392|12427532|FG002|Overall Study|Lost to Follow-up|2
7910609|NCT02056392|12427533|FG003|Overall Study|Lost to Follow-up|0
7910610|NCT02056392|12427534|FG004|Overall Study|Lost to Follow-up|0
7910611|NCT02056392|12427535|FG005|Overall Study|Lost to Follow-up|0
7910612|NCT02056392|12427530|FG000|Overall Study|Protocol Violation|1
7910613|NCT02056392|12427531|FG001|Overall Study|Protocol Violation|0
7910614|NCT02056392|12427532|FG002|Overall Study|Protocol Violation|1
7910615|NCT02056392|12427533|FG003|Overall Study|Protocol Violation|0
7910616|NCT02056392|12427534|FG004|Overall Study|Protocol Violation|0
7910617|NCT02056392|12427535|FG005|Overall Study|Protocol Violation|0
7910618|NCT02056392|12427530|FG000|Overall Study|Withdrawal by Subject|1
7910619|NCT02056392|12427531|FG001|Overall Study|Withdrawal by Subject|0
7910620|NCT02056392|12427532|FG002|Overall Study|Withdrawal by Subject|0
7910621|NCT02056392|12427533|FG003|Overall Study|Withdrawal by Subject|0
7910622|NCT02056392|12427534|FG004|Overall Study|Withdrawal by Subject|1
7910623|NCT02056392|12427535|FG005|Overall Study|Withdrawal by Subject|0
7910624|NCT02056626|12427558|FG000|Overall Study|patient did not follow directions|3
7910625|NCT02056626|12427559|FG001|Overall Study|patient did not follow directions|1
7910626|NCT02056626|12427560|FG002|Overall Study|patient did not follow directions|0
7910627|NCT02056626|12427561|FG003|Overall Study|patient did not follow directions|0
7910628|NCT02056652|12427584|FG000|Overall Study|Withdrawal by Subject|1
7910629|NCT02056652|12427585|FG001|Overall Study|Withdrawal by Subject|0
7910630|NCT02056652|12427584|FG000|Overall Study|Lost to Follow-up|0
7910631|NCT02056652|12427585|FG001|Overall Study|Lost to Follow-up|3
7910632|NCT02056834|12427591|FG000|Overall Study|Lost to Follow-up|7
7910633|NCT02057068|12427607|FG000|Overall Study|Withdrawal by Subject|2
7910634|NCT02057068|12427608|FG001|Overall Study|Withdrawal by Subject|2
7910635|NCT02057068|12427607|FG000|Overall Study|Caregiver (CG) Health|0
7910636|NCT02057068|12427608|FG001|Overall Study|Caregiver (CG) Health|2
7910637|NCT02057068|12427607|FG000|Overall Study|Carepartner (CP) Health|4
7815515|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7815516|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7815517|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7815518|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7815519|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7815520|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7815521|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7815522|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
7815523|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7815524|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
7815525|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
7910638|NCT02057068|12427608|FG001|Overall Study|Carepartner (CP) Health|2
7910639|NCT02057068|12427607|FG000|Overall Study|Lost to Follow-up|2
7815526|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
7815527|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
7815528|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
7815529|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
7815530|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
7815531|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
7815532|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
7815533|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0
7815534|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2
7815535|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2
7815536|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0
7815537|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0
7815538|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0
7815539|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0
7815540|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2
7815541|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0
7815542|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
7815543|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
7815544|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
7815545|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
7815546|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
7815547|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
7815548|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
7910640|NCT02057068|12427608|FG001|Overall Study|Lost to Follow-up|2
7910641|NCT02057198|12427628|FG000|Overall Study|Death|0
7910642|NCT02057198|12427629|FG001|Overall Study|Death|0
7910643|NCT02057198|12427630|FG002|Overall Study|Death|1
7910644|NCT02057198|12427628|FG000|Overall Study|Discharged early; lost to followup|0
7910645|NCT02057198|12427629|FG001|Overall Study|Discharged early; lost to followup|1
7910646|NCT02057198|12427630|FG002|Overall Study|Discharged early; lost to followup|0
7910647|NCT02057250|12427642|FG000|AID Assessment Phase|Adverse Event|3
7910648|NCT02057250|12427643|FG001|AID Assessment Phase|Adverse Event|2
7910649|NCT02057250|12427644|FG002|AID Assessment Phase|Adverse Event|6
7910650|NCT02057250|12427645|FG003|AID Assessment Phase|Adverse Event|1
7910651|NCT02057250|12427646|FG004|AID Assessment Phase|Adverse Event|0
7910652|NCT02057250|12427642|FG000|AID Assessment Phase|Other than specified above|1
7910653|NCT02057250|12427643|FG001|AID Assessment Phase|Other than specified above|1
7910654|NCT02057250|12427644|FG002|AID Assessment Phase|Other than specified above|1
7910655|NCT02057250|12427645|FG003|AID Assessment Phase|Other than specified above|1
7910656|NCT02057250|12427646|FG004|AID Assessment Phase|Other than specified above|0
7910657|NCT02057250|12427642|FG000|Extension Phase|Adverse Event|0
7910658|NCT02057250|12427643|FG001|Extension Phase|Adverse Event|0
7910659|NCT02057250|12427644|FG002|Extension Phase|Adverse Event|0
7910660|NCT02057250|12427645|FG003|Extension Phase|Adverse Event|0
7910661|NCT02057250|12427646|FG004|Extension Phase|Adverse Event|15
7910662|NCT02057250|12427642|FG000|Extension Phase|Lack of Efficacy|0
7910663|NCT02057250|12427643|FG001|Extension Phase|Lack of Efficacy|0
7910664|NCT02057250|12427644|FG002|Extension Phase|Lack of Efficacy|0
7910665|NCT02057250|12427645|FG003|Extension Phase|Lack of Efficacy|0
7910666|NCT02057250|12427646|FG004|Extension Phase|Lack of Efficacy|10
7910667|NCT02057250|12427642|FG000|Extension Phase|Entered in this period but not treated|0
7910668|NCT02057250|12427643|FG001|Extension Phase|Entered in this period but not treated|0
7910669|NCT02057250|12427644|FG002|Extension Phase|Entered in this period but not treated|0
7910670|NCT02057250|12427645|FG003|Extension Phase|Entered in this period but not treated|0
7910671|NCT02057250|12427646|FG004|Extension Phase|Entered in this period but not treated|4
7910672|NCT02057250|12427642|FG000|Extension Phase|Other than specified above|0
7910673|NCT02057250|12427643|FG001|Extension Phase|Other than specified above|0
7910674|NCT02057250|12427644|FG002|Extension Phase|Other than specified above|0
7910675|NCT02057250|12427645|FG003|Extension Phase|Other than specified above|0
7910676|NCT02057250|12427646|FG004|Extension Phase|Other than specified above|7
7910677|NCT02057393|12427658|FG000|Overall Study|Withdrawal by Subject|1
7910678|NCT02057393|12427658|FG000|Overall Study|Patient did not meet criteria|1
7910679|NCT02057406|12427665|FG000|Overall Study|Physician Decision|0
7910680|NCT02057406|12427666|FG001|Overall Study|Physician Decision|0
7910681|NCT02057406|12427667|FG002|Overall Study|Physician Decision|2
7910682|NCT02057406|12427665|FG000|Overall Study|Withdrawal by Subject|0
7910683|NCT02057406|12427666|FG001|Overall Study|Withdrawal by Subject|2
7910684|NCT02057406|12427667|FG002|Overall Study|Withdrawal by Subject|0
7910685|NCT02057406|12427665|FG000|Overall Study|Lost to Follow-up|0
7910686|NCT02057406|12427666|FG001|Overall Study|Lost to Follow-up|0
7910687|NCT02057406|12427667|FG002|Overall Study|Lost to Follow-up|1
7910688|NCT02057406|12427665|FG000|Overall Study|Death|1
7910689|NCT02057406|12427666|FG001|Overall Study|Death|0
7910690|NCT02057406|12427667|FG002|Overall Study|Death|0
7910691|NCT02057406|12427665|FG000|Overall Study|Protocol Violation|0
7910692|NCT02057406|12427666|FG001|Overall Study|Protocol Violation|1
7910693|NCT02057406|12427667|FG002|Overall Study|Protocol Violation|0
7815549|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
7910694|NCT02057406|12427665|FG000|Overall Study|Patient transportation issues|0
7910695|NCT02057406|12427666|FG001|Overall Study|Patient transportation issues|0
7910696|NCT02057406|12427667|FG002|Overall Study|Patient transportation issues|1
7910697|NCT02057458|12427675|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0
7910698|NCT02057458|12427676|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1
7910699|NCT02057458|12427677|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0
7910700|NCT02057458|12427675|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2
7815550|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
7815551|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7815552|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
7815553|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7815554|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7815555|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7815556|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7815557|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7815558|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7815559|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7815560|NCT01212757|12281281|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7815561|NCT01212757|12281282|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1
7815562|NCT01212757|12281283|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1
7815563|NCT01212757|12281284|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7815564|NCT01212757|12281285|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7815565|NCT01212757|12281286|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7815566|NCT01212757|12281287|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7815567|NCT01212757|12281288|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7815568|NCT01212757|12281289|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7815569|NCT01212770|12281310|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
7815570|NCT01212770|12281311|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
7815571|NCT01212770|12281312|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
7815572|NCT01212770|12281313|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7815573|NCT01212770|12281314|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7815574|NCT01212770|12281315|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7815575|NCT01212770|12281316|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7815576|NCT01212770|12281317|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7815577|NCT01212770|12281318|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7815578|NCT01212770|12281310|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
7815579|NCT01212770|12281311|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
7815580|NCT01212770|12281312|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
7815581|NCT01212770|12281313|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7815582|NCT01212770|12281314|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7815583|NCT01212770|12281315|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7815584|NCT01212770|12281316|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7815585|NCT01212770|12281317|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7815586|NCT01212770|12281318|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7815587|NCT01212770|12281310|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
7815588|NCT01212770|12281311|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
7815589|NCT01212770|12281312|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
7910701|NCT02057458|12427676|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
7910702|NCT02057458|12427677|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
7910703|NCT02057458|12427675|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1
7910704|NCT02057458|12427676|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
7910705|NCT02057458|12427677|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
7910706|NCT02057523|12427707|FG000|Overall Study|Withdrawal by Subject|1
7910707|NCT02057523|12427707|FG000|Overall Study|Lack of Efficacy|1
7910708|NCT02057549|12427713|FG000|Overall Study|Lost to Follow-up|1
7910709|NCT02057549|12427714|FG001|Overall Study|Lost to Follow-up|0
7910710|NCT02057549|12427713|FG000|Overall Study|Physician Decision|1
7910711|NCT02057549|12427714|FG001|Overall Study|Physician Decision|0
7910712|NCT02057549|12427713|FG000|Overall Study|Withdrawal by Subject|1
7910713|NCT02057549|12427714|FG001|Overall Study|Withdrawal by Subject|0
7910714|NCT02057575|12427724|FG000|Overall Study|Adverse Event|0
7910715|NCT02057575|12427725|FG001|Overall Study|Adverse Event|2
7910716|NCT02057575|12427726|FG002|Overall Study|Adverse Event|0
7910717|NCT02057575|12427727|FG003|Overall Study|Adverse Event|1
7910718|NCT02057575|12427724|FG000|Overall Study|Withdrawal by Subject|1
7910719|NCT02057575|12427725|FG001|Overall Study|Withdrawal by Subject|0
7910720|NCT02057575|12427726|FG002|Overall Study|Withdrawal by Subject|0
7910721|NCT02057575|12427727|FG003|Overall Study|Withdrawal by Subject|0
7910722|NCT02057575|12427724|FG000|Overall Study|Dissallowed Concurrent Medication|0
7910723|NCT02057575|12427725|FG001|Overall Study|Dissallowed Concurrent Medication|1
7910724|NCT02057575|12427726|FG002|Overall Study|Dissallowed Concurrent Medication|0
7910725|NCT02057575|12427727|FG003|Overall Study|Dissallowed Concurrent Medication|0
7910726|NCT02057575|12427724|FG000|Overall Study|Protocol Violation|0
7910727|NCT02057575|12427725|FG001|Overall Study|Protocol Violation|1
7910728|NCT02057575|12427726|FG002|Overall Study|Protocol Violation|0
7910729|NCT02057575|12427727|FG003|Overall Study|Protocol Violation|0
7910730|NCT02057666|12427749|FG000|Double Blind Treatment Period|Withdrawal by Subject|8
7910731|NCT02057666|12427750|FG001|Double Blind Treatment Period|Withdrawal by Subject|5
7910732|NCT02057666|12427749|FG000|Double Blind Treatment Period|Poor tolerability|7
7910733|NCT02057666|12427750|FG001|Double Blind Treatment Period|Poor tolerability|2
7910734|NCT02057666|12427749|FG000|Double Blind Treatment Period|Symptomatic disease progression|8
7910735|NCT02057666|12427750|FG001|Double Blind Treatment Period|Symptomatic disease progression|3
7910736|NCT02057666|12427749|FG000|Double Blind Treatment Period|Physician Decision|1
7910737|NCT02057666|12427750|FG001|Double Blind Treatment Period|Physician Decision|0
7910738|NCT02057666|12427749|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1
7910739|NCT02057666|12427750|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0
7910740|NCT02057666|12427749|FG000|Double Blind Treatment Period|Subject planning to withdraw|1
7910741|NCT02057666|12427750|FG001|Double Blind Treatment Period|Subject planning to withdraw|0
7910742|NCT02057666|12427749|FG000|Double Blind Treatment Period|Sponsor's request|70
7910743|NCT02057666|12427750|FG001|Double Blind Treatment Period|Sponsor's request|34
7910744|NCT02057666|12427749|FG000|Open-Label Treatment Period|Poor tolerability|0
7910745|NCT02057666|12427750|FG001|Open-Label Treatment Period|Poor tolerability|1
7910746|NCT02057666|12427749|FG000|Open-Label Treatment Period|Symptomatic disease progression|0
7910747|NCT02057666|12427750|FG001|Open-Label Treatment Period|Symptomatic disease progression|1
7910748|NCT02057666|12427749|FG000|Open-Label Treatment Period|Sponsor's request|0
7910749|NCT02057666|12427750|FG001|Open-Label Treatment Period|Sponsor's request|4
7910750|NCT02057692|12427760|FG000|Overall Study|Adverse Event|1
7910751|NCT02057692|12427761|FG001|Overall Study|Adverse Event|0
7910752|NCT02057692|12427762|FG002|Overall Study|Adverse Event|0
7910753|NCT02057692|12427763|FG003|Overall Study|Adverse Event|0
7910754|NCT02057692|12427760|FG000|Overall Study|Lost to Follow-up|0
7910755|NCT02057692|12427761|FG001|Overall Study|Lost to Follow-up|0
7910756|NCT02057692|12427762|FG002|Overall Study|Lost to Follow-up|0
7910757|NCT02057692|12427763|FG003|Overall Study|Lost to Follow-up|1
7910758|NCT02057718|12427781|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0
7910759|NCT02057718|12427782|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2
7910760|NCT02057718|12427781|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1
7910761|NCT02057718|12427782|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0
7910762|NCT02057718|12427781|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0
7910763|NCT02057718|12427782|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1
7910764|NCT02057718|12427781|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0
7910765|NCT02057718|12427782|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3
7910766|NCT02057718|12427781|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1
7910767|NCT02057718|12427782|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1
7910768|NCT02057718|12427781|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0
7815590|NCT01212770|12281313|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7815591|NCT01212770|12281314|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7815592|NCT01212770|12281315|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7815593|NCT01212770|12281316|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7815594|NCT01212770|12281317|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7815595|NCT01212770|12281318|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7815596|NCT01212770|12281310|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7815597|NCT01212770|12281311|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7815598|NCT01212770|12281312|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
7815599|NCT01212770|12281313|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7815600|NCT01212770|12281314|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7815601|NCT01212770|12281315|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7815602|NCT01212770|12281316|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7815603|NCT01212770|12281317|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7815604|NCT01212770|12281318|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7815605|NCT01212770|12281310|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7964089|NCT02734862|12519145|FG001|Part B|Withdrawal by Subject|1
7964090|NCT02734862|12519146|FG002|Part B|Withdrawal by Subject|0
7815606|NCT01212770|12281311|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7815607|NCT01212770|12281312|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7815608|NCT01212770|12281313|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7815609|NCT01212770|12281314|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7815610|NCT01212770|12281315|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7815611|NCT01212770|12281316|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7815612|NCT01212770|12281317|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7815613|NCT01212770|12281318|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7815614|NCT01212770|12281310|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
7815615|NCT01212770|12281311|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
7815616|NCT01212770|12281312|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
7815617|NCT01212770|12281313|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7815618|NCT01212770|12281314|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7815619|NCT01212770|12281315|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7815620|NCT01212770|12281316|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7815621|NCT01212770|12281317|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7815622|NCT01212770|12281318|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7815623|NCT01212770|12281310|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
7815624|NCT01212770|12281311|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
7815625|NCT01212770|12281312|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
7815626|NCT01212770|12281313|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
7815627|NCT01212770|12281314|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
7815628|NCT01212770|12281315|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
7815629|NCT01212770|12281316|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
7815630|NCT01212770|12281317|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
7815631|NCT01212770|12281318|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
7815632|NCT01212770|12281310|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
7815633|NCT01212770|12281311|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
7815634|NCT01212770|12281312|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
7815635|NCT01212770|12281313|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
7815636|NCT01212770|12281314|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
7815637|NCT01212770|12281315|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
7815638|NCT01212770|12281316|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
7815639|NCT01212770|12281317|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
7815640|NCT01212770|12281318|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
7815641|NCT01212770|12281310|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
7815642|NCT01212770|12281311|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
7815643|NCT01212770|12281312|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
7815644|NCT01212770|12281313|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
7815645|NCT01212770|12281314|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
7815646|NCT01212770|12281315|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
7815647|NCT01212770|12281316|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
7910769|NCT02057718|12427782|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1
7910770|NCT02057718|12427781|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0
7910771|NCT02057718|12427782|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1
7910772|NCT02057718|12427781|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1
7910773|NCT02057718|12427782|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3
7910774|NCT02057718|12427781|FG000|Optional Follow-up Treatment Period|Progressive disease|0
7910775|NCT02057718|12427782|FG001|Optional Follow-up Treatment Period|Progressive disease|1
7910776|NCT02057718|12427781|FG000|Optional Follow-up Treatment Period|Adverse Event|1
7910777|NCT02057718|12427782|FG001|Optional Follow-up Treatment Period|Adverse Event|2
7910778|NCT02057718|12427781|FG000|Optional Follow-up Treatment Period|Liver Transplant|0
7910779|NCT02057718|12427782|FG001|Optional Follow-up Treatment Period|Liver Transplant|2
7910780|NCT02057757|12427790|FG000|Overall Study|Withdrawal by Subject|3
7910781|NCT02057757|12427791|FG001|Overall Study|Withdrawal by Subject|5
7910782|NCT02057757|12427790|FG000|Overall Study|Death|2
7910783|NCT02057757|12427791|FG001|Overall Study|Death|0
7910784|NCT02057757|12427790|FG000|Overall Study|Lost to Follow-up|8
7910785|NCT02057757|12427791|FG001|Overall Study|Lost to Follow-up|3
7910786|NCT02057757|12427790|FG000|Overall Study|Non-compliance|1
7815648|NCT01212770|12281317|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
7815649|NCT01212770|12281318|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
7815650|NCT01212770|12281310|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7815651|NCT01212770|12281311|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7815652|NCT01212770|12281312|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
7815653|NCT01212770|12281313|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7815654|NCT01212770|12281314|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7815655|NCT01212770|12281315|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7815656|NCT01212770|12281316|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7815657|NCT01212770|12281317|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7815658|NCT01212770|12281318|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7815659|NCT01212770|12281310|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7815660|NCT01212770|12281311|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7815661|NCT01212770|12281312|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7815662|NCT01212770|12281313|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
7815663|NCT01212770|12281314|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7815664|NCT01212770|12281315|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7815665|NCT01212770|12281316|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7815666|NCT01212770|12281317|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7910787|NCT02057757|12427791|FG001|Overall Study|Non-compliance|0
7910788|NCT02057835|12427811|FG000|Overall Study|Withdrawal by Subject|0
7815667|NCT01212770|12281318|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7815668|NCT01212770|12281310|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7815669|NCT01212770|12281311|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7815670|NCT01212770|12281312|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
7815671|NCT01212770|12281313|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
7815672|NCT01212770|12281314|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7815673|NCT01212770|12281315|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7815674|NCT01212770|12281316|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7815675|NCT01212770|12281317|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7815676|NCT01212770|12281318|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7815677|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0
7815678|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3
7815679|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3
7815680|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0
7815681|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0
7815682|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0
7815683|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0
7815684|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0
7815685|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2
7815686|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7815687|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
7815688|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
7815689|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7815690|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7815691|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7910789|NCT02057835|12427812|FG001|Overall Study|Withdrawal by Subject|2
7815692|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7815693|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
7815694|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
7815695|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7815696|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
7815697|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7815698|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7815699|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7815700|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7815701|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7815702|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7815703|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7815704|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7815705|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
7815706|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
7815707|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7815708|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7815709|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7815710|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7815711|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
7815712|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
7815713|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
7815714|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
7815715|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
7815716|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
7815717|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
7815718|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
7815719|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
7815720|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
7815721|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
7815722|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0
7815723|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2
7815724|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1
7815725|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0
7815726|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0
7815727|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0
7815728|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0
7815729|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0
7815730|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1
7815731|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0
7815732|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2
7815733|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2
7815734|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0
7815735|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0
7815736|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0
7815737|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0
7910790|NCT02057835|12427813|FG002|Overall Study|Withdrawal by Subject|0
7815738|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2
7815739|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1
7815740|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7815741|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
7815742|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
7815743|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7815744|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7815745|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7815746|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7815747|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
7815748|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
7815749|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7815750|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
7815751|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
7815752|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7815753|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7815754|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7815755|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7815756|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
7815757|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
7815758|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7815759|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
7815760|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7815761|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7815762|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7815763|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7815764|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7815765|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7815766|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7815767|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0
7815768|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0
7815769|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0
7815770|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0
7815771|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0
7815772|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0
7815773|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0
7815774|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1
7815775|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0
7815776|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0
7815777|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2
7815778|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1
7815779|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0
7815780|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0
7815781|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0
7815782|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0
7815783|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1
7815784|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1
7815785|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0
7815786|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1
7815787|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1
7815788|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0
7815789|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0
7815790|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0
7815791|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0
7815792|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0
7815793|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1
7815794|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7815795|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
7815796|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
7815797|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7815798|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7815799|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7815800|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7815801|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
7815802|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7815803|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7815804|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
7815805|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
7815806|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7815807|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7815808|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7815809|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7815810|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
7815811|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7815812|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7815813|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
7815814|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
7815815|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7815816|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7815817|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7815818|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7815819|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7815820|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7815821|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7815822|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7815823|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
7815824|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7815825|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7815826|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7815827|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7815828|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7815829|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7815830|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0
7815831|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1
7815832|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0
7815833|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0
7815834|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0
7815835|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0
7815836|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0
7815837|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0
7815838|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1
7815839|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 5)|Missing|0
7815840|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 5)|Missing|0
7815841|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 5)|Missing|1
7815842|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 5)|Missing|0
7815843|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 5)|Missing|0
7815844|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 5)|Missing|0
7815845|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 5)|Missing|0
7815846|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 5)|Missing|0
7815847|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 5)|Missing|0
7815848|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0
7815849|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0
7815850|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3
7815851|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0
7815852|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0
7815853|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0
7815854|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0
7815855|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0
7815856|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0
7815857|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0
7815858|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0
7815859|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2
7815860|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0
7815861|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0
7815862|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0
7815863|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0
7815864|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0
7719368|NCT00531934|12143366|FG000|Overall Study|Progression|52
7815865|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1
7815866|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7815867|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7815868|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
7815869|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7815870|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7815871|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7815872|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7815873|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7815874|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7815875|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7815876|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
7815877|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
7883653|NCT01783548|12383431|FG001|Overall Study|Withdrawal by Subject|8
7815878|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7815879|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7815880|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7815881|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7815882|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
7815883|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7815884|NCT01212770|12281310|FG000|Long-term Safety Phase (Year 5)|Death|0
7815885|NCT01212770|12281311|FG001|Long-term Safety Phase (Year 5)|Death|0
7815886|NCT01212770|12281312|FG002|Long-term Safety Phase (Year 5)|Death|0
7815887|NCT01212770|12281313|FG003|Long-term Safety Phase (Year 5)|Death|0
7815888|NCT01212770|12281314|FG004|Long-term Safety Phase (Year 5)|Death|0
7815889|NCT01212770|12281315|FG005|Long-term Safety Phase (Year 5)|Death|0
7815890|NCT01212770|12281316|FG006|Long-term Safety Phase (Year 5)|Death|0
7815891|NCT01212770|12281317|FG007|Long-term Safety Phase (Year 5)|Death|1
7815892|NCT01212770|12281318|FG008|Long-term Safety Phase (Year 5)|Death|0
7815893|NCT01212991|12281375|FG000|Double-blind|Lost to Follow-up|8
7815894|NCT01212991|12281376|FG001|Double-blind|Lost to Follow-up|4
7815895|NCT01212991|12281377|FG002|Double-blind|Lost to Follow-up|0
7815896|NCT01212991|12281375|FG000|Double-blind|Death|699
7815897|NCT01212991|12281376|FG001|Double-blind|Death|550
7815898|NCT01212991|12281377|FG002|Double-blind|Death|0
7815899|NCT01212991|12281375|FG000|Double-blind|Withdrawal by Subject|16
7815900|NCT01212991|12281376|FG001|Double-blind|Withdrawal by Subject|19
7815901|NCT01212991|12281377|FG002|Double-blind|Withdrawal by Subject|0
7815902|NCT01212991|12281375|FG000|Double-blind|Other|7
7815903|NCT01212991|12281376|FG001|Double-blind|Other|0
7815904|NCT01212991|12281377|FG002|Double-blind|Other|0
7815905|NCT01212991|12281375|FG000|Double-blind|Sponsor decision|142
7815906|NCT01212991|12281376|FG001|Double-blind|Sponsor decision|38
7815907|NCT01212991|12281377|FG002|Double-blind|Sponsor decision|0
7815908|NCT01212991|12281375|FG000|Open-label|Death|0
7815909|NCT01212991|12281376|FG001|Open-label|Death|0
7815910|NCT01212991|12281377|FG002|Open-label|Death|166
7815911|NCT01212991|12281375|FG000|Open-label|Lost to Follow-up|0
7815912|NCT01212991|12281376|FG001|Open-label|Lost to Follow-up|0
7815913|NCT01212991|12281377|FG002|Open-label|Lost to Follow-up|5
7815914|NCT01212991|12281375|FG000|Open-label|Withdrawal by Subject|0
7815915|NCT01212991|12281376|FG001|Open-label|Withdrawal by Subject|0
7910791|NCT02057835|12427814|FG003|Overall Study|Withdrawal by Subject|0
7910792|NCT02057835|12427815|FG004|Overall Study|Withdrawal by Subject|0
7910793|NCT02057835|12427816|FG005|Overall Study|Withdrawal by Subject|0
7910794|NCT02057835|12427817|FG006|Overall Study|Withdrawal by Subject|0
7910795|NCT02057835|12427818|FG007|Overall Study|Withdrawal by Subject|0
7910796|NCT02057835|12427819|FG008|Overall Study|Withdrawal by Subject|0
7910797|NCT02057835|12427820|FG009|Overall Study|Withdrawal by Subject|0
7910798|NCT02058069|12427866|FG000|Overall Study|Exclusion due to implant size|5
7910799|NCT02058069|12427866|FG000|Overall Study|Withdrawal by Subject|6
7910800|NCT02058095|12427872|FG000|Overall Study|Adverse Event|1
7910801|NCT02058095|12427873|FG001|Overall Study|Adverse Event|0
7910802|NCT02058108|12427881|FG000|Overall Study|Abnormal Laboratory Values|0
7910803|NCT02058108|12427882|FG001|Overall Study|Abnormal Laboratory Values|1
7910804|NCT02058108|12427881|FG000|Overall Study|Unsatisfactory therapeutic effect|37
7815916|NCT01212991|12281377|FG002|Open-label|Withdrawal by Subject|7
7815917|NCT01212991|12281375|FG000|Open-label|Sponsor decision|0
7815918|NCT01212991|12281376|FG001|Open-label|Sponsor decision|0
7815919|NCT01212991|12281377|FG002|Open-label|Sponsor decision|53
7815920|NCT01212991|12281375|FG000|Open-label|Other|0
7815921|NCT01212991|12281376|FG001|Open-label|Other|0
7815922|NCT01212991|12281377|FG002|Open-label|Other|3
7815923|NCT01213082|12281397|FG000|Overall Study|Lost to Follow-up|6
7815924|NCT01213082|12281398|FG001|Overall Study|Lost to Follow-up|7
7815925|NCT01213082|12281399|FG002|Overall Study|Lost to Follow-up|4
7815926|NCT01213082|12281397|FG000|Overall Study|Physician Decision|0
7815927|NCT01213082|12281398|FG001|Overall Study|Physician Decision|0
7815928|NCT01213082|12281399|FG002|Overall Study|Physician Decision|1
7815929|NCT01213173|12281409|FG000|Overall Study|Protocol Violation|2
7815930|NCT01213173|12281410|FG001|Overall Study|Protocol Violation|0
7815931|NCT01213173|12281409|FG000|Overall Study|Adverse Event|4
7815932|NCT01213173|12281410|FG001|Overall Study|Adverse Event|8
7815933|NCT01213173|12281409|FG000|Overall Study|Withdrawal by Subject|5
7815934|NCT01213173|12281410|FG001|Overall Study|Withdrawal by Subject|5
7815935|NCT01213173|12281409|FG000|Overall Study|Incorrect Enrollment|1
7815936|NCT01213173|12281410|FG001|Overall Study|Incorrect Enrollment|3
7815937|NCT01213251|12281423|FG000|Overall Study|Death|2
7815938|NCT01213251|12281424|FG001|Overall Study|Death|1
7815939|NCT01213251|12281425|FG002|Overall Study|Death|2
7815940|NCT01213251|12281423|FG000|Overall Study|Exit|3
7815941|NCT01213251|12281424|FG001|Overall Study|Exit|2
7815942|NCT01213251|12281425|FG002|Overall Study|Exit|8
7815943|NCT01213251|12281423|FG000|Overall Study|Protocol Violation|1
7815944|NCT01213251|12281424|FG001|Overall Study|Protocol Violation|1
7815945|NCT01213251|12281425|FG002|Overall Study|Protocol Violation|0
7815946|NCT01213251|12281423|FG000|Overall Study|Missed 18-Month Follow-up|0
7815947|NCT01213251|12281424|FG001|Overall Study|Missed 18-Month Follow-up|0
7815948|NCT01213251|12281425|FG002|Overall Study|Missed 18-Month Follow-up|1
7815949|NCT01213264|12281441|FG000|Overall Study|Adverse Event|1
7815950|NCT01213264|12281442|FG001|Overall Study|Adverse Event|0
7815951|NCT01213264|12281443|FG002|Overall Study|Adverse Event|0
7815952|NCT01213264|12281441|FG000|Overall Study|Lost to Follow-up|1
7815953|NCT01213264|12281442|FG001|Overall Study|Lost to Follow-up|2
7815954|NCT01213264|12281443|FG002|Overall Study|Lost to Follow-up|6
7815955|NCT01213472|12281462|FG000|Overall Study|Recurrence/Progressive disease|25
7815956|NCT01213472|12281462|FG000|Overall Study|Withdrawal by Subject|1
7815957|NCT01213472|12281462|FG000|Overall Study|Physician Decision|1
7815958|NCT01213524|12281468|FG000|Baseline|Withdrawal by Subject|5
7815959|NCT01213524|12281468|FG000|Baseline|high breath alcohol levels|1
7815960|NCT01213524|12281468|FG000|Baseline|Physician Decision|1
7815961|NCT01213524|12281468|FG000|Session 2|Withdrawal by Subject|5
7815962|NCT01213524|12281468|FG000|Session 3|Withdrawal by Subject|4
7815963|NCT01213524|12281468|FG000|Session 4|Physician Decision|1
7815964|NCT01213524|12281468|FG000|Session 4|Withdrawal by Subject|2
7815965|NCT01213836|12281526|FG000|Period 1, First Intervention|Adverse Event|2
7815966|NCT01213836|12281527|FG001|Period 1, First Intervention|Adverse Event|1
7815967|NCT01213836|12281526|FG000|Period 1, First Intervention|Protocol Violation|0
7815968|NCT01213836|12281527|FG001|Period 1, First Intervention|Protocol Violation|1
7815969|NCT01213836|12281526|FG000|Period 1, First Intervention|Withdrawal by Subject|1
7815970|NCT01213836|12281527|FG001|Period 1, First Intervention|Withdrawal by Subject|1
7815971|NCT01213966|12281549|FG000|Overall Study|Protocol Violation|1
7815972|NCT01213966|12281550|FG001|Overall Study|Protocol Violation|0
7815973|NCT01213966|12281551|FG002|Overall Study|Protocol Violation|3
7815974|NCT01213966|12281552|FG003|Overall Study|Protocol Violation|1
7815975|NCT01214044|12281562|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5
7815976|NCT01214044|12281562|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3
7815977|NCT01214044|12281562|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4
7815978|NCT01214044|12281562|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3
7815979|NCT01214044|12281562|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3
7815980|NCT01214044|12281562|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1
7815981|NCT01214174|12281622|FG000|Overall Study|Withdrawal by Subject|0
7815982|NCT01214174|12281623|FG001|Overall Study|Withdrawal by Subject|0
7815983|NCT01214174|12281624|FG002|Overall Study|Withdrawal by Subject|1
7815984|NCT01214187|12281634|FG000|Overall Study|Adverse Event|6
7815985|NCT01214187|12281635|FG001|Overall Study|Adverse Event|2
7815986|NCT01214187|12281634|FG000|Overall Study|Death|1
7815987|NCT01214187|12281635|FG001|Overall Study|Death|1
7815988|NCT01214187|12281634|FG000|Overall Study|Withdrawal by Subject|0
7815989|NCT01214187|12281635|FG001|Overall Study|Withdrawal by Subject|3
7815990|NCT01214200|12281641|FG000|Overall Study|Did not meet inclusion/exclusion|9
7815991|NCT01214200|12281641|FG000|Overall Study|Withdrawal by Subject|2
7815992|NCT01214239|12281649|FG000|Overall Study|Adverse Event|3
7815993|NCT01214239|12281650|FG001|Overall Study|Adverse Event|4
7815994|NCT01214239|12281649|FG000|Overall Study|Protocol Violation|2
7815995|NCT01214239|12281650|FG001|Overall Study|Protocol Violation|1
7815996|NCT01214239|12281649|FG000|Overall Study|Lost to Follow-up|1
7815997|NCT01214239|12281650|FG001|Overall Study|Lost to Follow-up|1
7815998|NCT01214239|12281649|FG000|Overall Study|Withdrawal by Subject|4
7815999|NCT01214239|12281650|FG001|Overall Study|Withdrawal by Subject|9
7816000|NCT01214239|12281649|FG000|Overall Study|Lack of Efficacy|1
7816001|NCT01214239|12281650|FG001|Overall Study|Lack of Efficacy|2
7816002|NCT01214239|12281649|FG000|Overall Study|patient's private reason|1
7816003|NCT01214239|12281650|FG001|Overall Study|patient's private reason|1
7816004|NCT01214252|12281656|FG000|Overall Study|Not eligible per protocol|82
7816005|NCT01214395|12281685|FG000|Overall Study|All patients had infection|5
7816006|NCT01214421|12281694|FG000|Overall Study|Lost to Follow-up|7
7816007|NCT01214421|12281695|FG001|Overall Study|Lost to Follow-up|3
7816008|NCT01214421|12281696|FG002|Overall Study|Lost to Follow-up|7
7816009|NCT01214421|12281697|FG003|Overall Study|Lost to Follow-up|3
7816010|NCT01214421|12281694|FG000|Overall Study|Adverse Event|16
7816011|NCT01214421|12281695|FG001|Overall Study|Adverse Event|35
7816012|NCT01214421|12281696|FG002|Overall Study|Adverse Event|14
7816013|NCT01214421|12281697|FG003|Overall Study|Adverse Event|3
7816014|NCT01214421|12281694|FG000|Overall Study|Sponsor Discontinued Site|1
7816015|NCT01214421|12281695|FG001|Overall Study|Sponsor Discontinued Site|2
7816016|NCT01214421|12281696|FG002|Overall Study|Sponsor Discontinued Site|0
7816017|NCT01214421|12281697|FG003|Overall Study|Sponsor Discontinued Site|0
7816018|NCT01214421|12281694|FG000|Overall Study|Withdrawal Criteria Met|3
7816019|NCT01214421|12281695|FG001|Overall Study|Withdrawal Criteria Met|0
7816020|NCT01214421|12281696|FG002|Overall Study|Withdrawal Criteria Met|2
7816021|NCT01214421|12281697|FG003|Overall Study|Withdrawal Criteria Met|1
7816022|NCT01214421|12281694|FG000|Overall Study|Physician Decision|2
7816023|NCT01214421|12281695|FG001|Overall Study|Physician Decision|0
7816024|NCT01214421|12281696|FG002|Overall Study|Physician Decision|4
7816025|NCT01214421|12281697|FG003|Overall Study|Physician Decision|0
7816026|NCT01214421|12281694|FG000|Overall Study|Withdrawal by Subject|21
7816027|NCT01214421|12281695|FG001|Overall Study|Withdrawal by Subject|18
7816028|NCT01214421|12281696|FG002|Overall Study|Withdrawal by Subject|11
7816029|NCT01214421|12281697|FG003|Overall Study|Withdrawal by Subject|2
7816030|NCT01214434|12281709|FG000|Overall Study|Withdrawal by Subject|1
7816031|NCT01214434|12281710|FG001|Overall Study|Withdrawal by Subject|0
7816032|NCT01214434|12281709|FG000|Overall Study|Lost to Follow-up|2
7816033|NCT01214434|12281710|FG001|Overall Study|Lost to Follow-up|2
7816034|NCT01214434|12281709|FG000|Overall Study|Site error|1
7816035|NCT01214434|12281710|FG001|Overall Study|Site error|0
7816036|NCT01214603|12281719|FG000|Overall Study|Adverse Event|0
7816037|NCT01214603|12281720|FG001|Overall Study|Adverse Event|0
7816038|NCT01214603|12281721|FG002|Overall Study|Adverse Event|1
7816039|NCT01214603|12281719|FG000|Overall Study|Death|1
7816040|NCT01214603|12281720|FG001|Overall Study|Death|0
7816041|NCT01214603|12281721|FG002|Overall Study|Death|0
7816042|NCT01214603|12281719|FG000|Overall Study|Progressive Disease|4
7816043|NCT01214603|12281720|FG001|Overall Study|Progressive Disease|1
7816044|NCT01214603|12281721|FG002|Overall Study|Progressive Disease|3
7816045|NCT01214616|12281734|FG000|Overall Study|Progressive disease|2
7816046|NCT01214616|12281735|FG001|Overall Study|Progressive disease|2
7816047|NCT01214616|12281736|FG002|Overall Study|Progressive disease|2
7816048|NCT01214616|12281737|FG003|Overall Study|Progressive disease|4
7816049|NCT01214616|12281734|FG000|Overall Study|Dose limiting toxicity|0
7816050|NCT01214616|12281735|FG001|Overall Study|Dose limiting toxicity|2
7816051|NCT01214616|12281736|FG002|Overall Study|Dose limiting toxicity|0
7816052|NCT01214616|12281737|FG003|Overall Study|Dose limiting toxicity|0
7816053|NCT01214616|12281734|FG000|Overall Study|Other adverse events|0
7816054|NCT01214616|12281735|FG001|Overall Study|Other adverse events|1
7816055|NCT01214616|12281736|FG002|Overall Study|Other adverse events|1
7816056|NCT01214616|12281737|FG003|Overall Study|Other adverse events|1
7816057|NCT01214616|12281734|FG000|Overall Study|Withdrawal by Subject|1
7816058|NCT01214616|12281735|FG001|Overall Study|Withdrawal by Subject|0
7816059|NCT01214616|12281736|FG002|Overall Study|Withdrawal by Subject|0
7816060|NCT01214616|12281737|FG003|Overall Study|Withdrawal by Subject|1
7816061|NCT01214629|12281766|FG000|Overall Study|Progressive Disease|1
7816062|NCT01214629|12281767|FG001|Overall Study|Progressive Disease|1
7816063|NCT01214629|12281768|FG002|Overall Study|Progressive Disease|0
7816064|NCT01214629|12281769|FG003|Overall Study|Progressive Disease|1
7816065|NCT01214629|12281770|FG004|Overall Study|Progressive Disease|2
7816066|NCT01214629|12281771|FG005|Overall Study|Progressive Disease|3
7816067|NCT01214629|12281772|FG006|Overall Study|Progressive Disease|1
7964091|NCT02734862|12519144|FG000|Part B|Other|0
7816068|NCT01214629|12281773|FG007|Overall Study|Progressive Disease|1
7816069|NCT01214629|12281774|FG008|Overall Study|Progressive Disease|1
7816070|NCT01214629|12281775|FG009|Overall Study|Progressive Disease|5
7816071|NCT01214629|12281776|FG010|Overall Study|Progressive Disease|1
7816072|NCT01214629|12281766|FG000|Overall Study|Adverse Event|0
7816073|NCT01214629|12281767|FG001|Overall Study|Adverse Event|0
7816074|NCT01214629|12281768|FG002|Overall Study|Adverse Event|0
7816075|NCT01214629|12281769|FG003|Overall Study|Adverse Event|1
7816076|NCT01214629|12281770|FG004|Overall Study|Adverse Event|0
7816077|NCT01214629|12281771|FG005|Overall Study|Adverse Event|1
7816078|NCT01214629|12281772|FG006|Overall Study|Adverse Event|0
7816079|NCT01214629|12281773|FG007|Overall Study|Adverse Event|0
7816080|NCT01214629|12281774|FG008|Overall Study|Adverse Event|0
7816081|NCT01214629|12281775|FG009|Overall Study|Adverse Event|1
7816082|NCT01214629|12281776|FG010|Overall Study|Adverse Event|0
7816083|NCT01214629|12281766|FG000|Overall Study|Physician Decision|0
7816084|NCT01214629|12281767|FG001|Overall Study|Physician Decision|0
7816085|NCT01214629|12281768|FG002|Overall Study|Physician Decision|0
7816086|NCT01214629|12281769|FG003|Overall Study|Physician Decision|0
7816087|NCT01214629|12281770|FG004|Overall Study|Physician Decision|0
7816088|NCT01214629|12281771|FG005|Overall Study|Physician Decision|0
7816089|NCT01214629|12281772|FG006|Overall Study|Physician Decision|0
7816090|NCT01214629|12281773|FG007|Overall Study|Physician Decision|0
7816091|NCT01214629|12281774|FG008|Overall Study|Physician Decision|0
7816092|NCT01214629|12281775|FG009|Overall Study|Physician Decision|0
7816093|NCT01214629|12281776|FG010|Overall Study|Physician Decision|1
7816094|NCT01214629|12281766|FG000|Overall Study|Withdrawal by Subject|0
7816095|NCT01214629|12281767|FG001|Overall Study|Withdrawal by Subject|0
7816096|NCT01214629|12281768|FG002|Overall Study|Withdrawal by Subject|0
7816097|NCT01214629|12281769|FG003|Overall Study|Withdrawal by Subject|0
7816098|NCT01214629|12281770|FG004|Overall Study|Withdrawal by Subject|0
7816099|NCT01214629|12281771|FG005|Overall Study|Withdrawal by Subject|0
7816100|NCT01214629|12281772|FG006|Overall Study|Withdrawal by Subject|0
7816101|NCT01214629|12281773|FG007|Overall Study|Withdrawal by Subject|0
7816102|NCT01214629|12281774|FG008|Overall Study|Withdrawal by Subject|0
7816103|NCT01214629|12281775|FG009|Overall Study|Withdrawal by Subject|1
7816104|NCT01214629|12281776|FG010|Overall Study|Withdrawal by Subject|0
7816105|NCT01214642|12281826|FG000|Overall Study|Progressive Disease|3
7816106|NCT01214642|12281827|FG001|Overall Study|Progressive Disease|2
7816107|NCT01214642|12281828|FG002|Overall Study|Progressive Disease|3
7816108|NCT01214642|12281829|FG003|Overall Study|Progressive Disease|5
7816109|NCT01214642|12281830|FG004|Overall Study|Progressive Disease|5
7816110|NCT01214642|12281831|FG005|Overall Study|Progressive Disease|3
7816111|NCT01214642|12281832|FG006|Overall Study|Progressive Disease|5
7816112|NCT01214642|12281833|FG007|Overall Study|Progressive Disease|3
7816113|NCT01214642|12281834|FG008|Overall Study|Progressive Disease|10
7816114|NCT01214642|12281835|FG009|Overall Study|Progressive Disease|2
7816115|NCT01214642|12281836|FG010|Overall Study|Progressive Disease|1
7816116|NCT01214642|12281837|FG011|Overall Study|Progressive Disease|4
7816117|NCT01214642|12281826|FG000|Overall Study|Adverse Event|0
7816118|NCT01214642|12281827|FG001|Overall Study|Adverse Event|1
7816119|NCT01214642|12281828|FG002|Overall Study|Adverse Event|0
7816120|NCT01214642|12281829|FG003|Overall Study|Adverse Event|0
7816121|NCT01214642|12281830|FG004|Overall Study|Adverse Event|0
7816122|NCT01214642|12281831|FG005|Overall Study|Adverse Event|0
7816123|NCT01214642|12281832|FG006|Overall Study|Adverse Event|1
7910805|NCT02058108|12427882|FG001|Overall Study|Unsatisfactory therapeutic effect|4
7910806|NCT02058108|12427881|FG000|Overall Study|No longer requires study drug|0
7910807|NCT02058108|12427882|FG001|Overall Study|No longer requires study drug|1
7910808|NCT02058108|12427881|FG000|Overall Study|Withdrawal by Subject|1
7910809|NCT02058108|12427882|FG001|Overall Study|Withdrawal by Subject|0
7910810|NCT02058108|12427881|FG000|Overall Study|Administrative problems|3
7910811|NCT02058108|12427882|FG001|Overall Study|Administrative problems|3
7910812|NCT02058108|12427881|FG000|Overall Study|Protocol Violation|0
7910813|NCT02058108|12427882|FG001|Overall Study|Protocol Violation|1
7816124|NCT01214642|12281833|FG007|Overall Study|Adverse Event|0
7816125|NCT01214642|12281834|FG008|Overall Study|Adverse Event|0
7910814|NCT02058147|12427893|FG000|Overall Study|Randomized but not treated|0
7910815|NCT02058147|12427894|FG001|Overall Study|Randomized but not treated|0
7910816|NCT02058147|12427895|FG002|Overall Study|Randomized but not treated|1
7910817|NCT02058147|12427893|FG000|Overall Study|Adverse Event|12
7910818|NCT02058147|12427894|FG001|Overall Study|Adverse Event|9
7910819|NCT02058147|12427895|FG002|Overall Study|Adverse Event|21
7910820|NCT02058147|12427893|FG000|Overall Study|Lack of Efficacy|1
7910821|NCT02058147|12427894|FG001|Overall Study|Lack of Efficacy|0
7910822|NCT02058147|12427895|FG002|Overall Study|Lack of Efficacy|3
7910823|NCT02058147|12427893|FG000|Overall Study|Poor compliance to protocol|8
7816126|NCT01214642|12281835|FG009|Overall Study|Adverse Event|1
7816127|NCT01214642|12281836|FG010|Overall Study|Adverse Event|1
7816128|NCT01214642|12281837|FG011|Overall Study|Adverse Event|0
7816129|NCT01214642|12281826|FG000|Overall Study|Death|0
7816130|NCT01214642|12281827|FG001|Overall Study|Death|0
7816131|NCT01214642|12281828|FG002|Overall Study|Death|1
7816132|NCT01214642|12281829|FG003|Overall Study|Death|0
7816133|NCT01214642|12281830|FG004|Overall Study|Death|0
7816134|NCT01214642|12281831|FG005|Overall Study|Death|0
7816135|NCT01214642|12281832|FG006|Overall Study|Death|0
7816136|NCT01214642|12281833|FG007|Overall Study|Death|0
7816137|NCT01214642|12281834|FG008|Overall Study|Death|0
7816138|NCT01214642|12281835|FG009|Overall Study|Death|0
7816139|NCT01214642|12281836|FG010|Overall Study|Death|1
7816140|NCT01214642|12281837|FG011|Overall Study|Death|0
7816141|NCT01214642|12281826|FG000|Overall Study|Withdrawal by Subject|0
7910824|NCT02058147|12427894|FG001|Overall Study|Poor compliance to protocol|9
7910825|NCT02058147|12427895|FG002|Overall Study|Poor compliance to protocol|4
7910826|NCT02058147|12427893|FG000|Overall Study|Other than specified|8
7910827|NCT02058147|12427894|FG001|Overall Study|Other than specified|9
7910828|NCT02058147|12427895|FG002|Overall Study|Other than specified|0
7910829|NCT02058160|12427905|FG000|Overall Study|Randomized but not treated|2
7816142|NCT01214642|12281827|FG001|Overall Study|Withdrawal by Subject|0
7816143|NCT01214642|12281828|FG002|Overall Study|Withdrawal by Subject|1
7910830|NCT02058160|12427906|FG001|Overall Study|Randomized but not treated|4
7816144|NCT01214642|12281829|FG003|Overall Study|Withdrawal by Subject|0
7816145|NCT01214642|12281830|FG004|Overall Study|Withdrawal by Subject|0
7910831|NCT02058160|12427905|FG000|Overall Study|Poor compliance to protocol|4
7910832|NCT02058160|12427906|FG001|Overall Study|Poor compliance to protocol|1
7816146|NCT01214642|12281831|FG005|Overall Study|Withdrawal by Subject|0
7816147|NCT01214642|12281832|FG006|Overall Study|Withdrawal by Subject|0
7910833|NCT02058160|12427905|FG000|Overall Study|Adverse Event|12
7910834|NCT02058160|12427906|FG001|Overall Study|Adverse Event|3
7910835|NCT02058160|12427905|FG000|Overall Study|Lost to Follow-up|1
7816148|NCT01214642|12281833|FG007|Overall Study|Withdrawal by Subject|0
7816149|NCT01214642|12281834|FG008|Overall Study|Withdrawal by Subject|3
7816150|NCT01214642|12281835|FG009|Overall Study|Withdrawal by Subject|1
7816151|NCT01214642|12281836|FG010|Overall Study|Withdrawal by Subject|1
7816152|NCT01214642|12281837|FG011|Overall Study|Withdrawal by Subject|0
7816153|NCT01214642|12281826|FG000|Overall Study|Physician Decision|0
7816154|NCT01214642|12281827|FG001|Overall Study|Physician Decision|0
7816155|NCT01214642|12281828|FG002|Overall Study|Physician Decision|1
7816156|NCT01214642|12281829|FG003|Overall Study|Physician Decision|1
7816157|NCT01214642|12281830|FG004|Overall Study|Physician Decision|1
7816158|NCT01214642|12281831|FG005|Overall Study|Physician Decision|0
7816159|NCT01214642|12281832|FG006|Overall Study|Physician Decision|0
7816160|NCT01214642|12281833|FG007|Overall Study|Physician Decision|0
7816161|NCT01214642|12281834|FG008|Overall Study|Physician Decision|0
7816162|NCT01214642|12281835|FG009|Overall Study|Physician Decision|0
7816163|NCT01214642|12281836|FG010|Overall Study|Physician Decision|0
7816164|NCT01214642|12281837|FG011|Overall Study|Physician Decision|2
7816165|NCT01214655|12281883|FG000|Part A|Progressive Disease|7
7816166|NCT01214655|12281884|FG001|Part A|Progressive Disease|0
7816167|NCT01214655|12281885|FG002|Part A|Progressive Disease|0
7816168|NCT01214655|12281883|FG000|Part A|Physician Decision|1
7910836|NCT02058160|12427906|FG001|Overall Study|Lost to Follow-up|0
7910837|NCT02058160|12427905|FG000|Overall Study|Other than specified above|12
7910838|NCT02058160|12427906|FG001|Overall Study|Other than specified above|6
7910839|NCT02058290|12427923|FG000|Overall Study|Protocol Violation|2
7816169|NCT01214655|12281884|FG001|Part A|Physician Decision|0
7816170|NCT01214655|12281885|FG002|Part A|Physician Decision|0
7816171|NCT01214655|12281883|FG000|Part B|Progressive disease|0
7816172|NCT01214655|12281884|FG001|Part B|Progressive disease|10
7816173|NCT01214655|12281885|FG002|Part B|Progressive disease|0
7910840|NCT02058290|12427924|FG001|Overall Study|Protocol Violation|1
7816174|NCT01214655|12281883|FG000|Part B|Death|0
7816175|NCT01214655|12281884|FG001|Part B|Death|1
7816176|NCT01214655|12281885|FG002|Part B|Death|0
7816177|NCT01214655|12281883|FG000|Part B|Withdrawal by Subject|0
7816178|NCT01214655|12281884|FG001|Part B|Withdrawal by Subject|2
7816179|NCT01214655|12281885|FG002|Part B|Withdrawal by Subject|0
7816180|NCT01214655|12281883|FG000|Part C|Progressive Disease|0
7816181|NCT01214655|12281884|FG001|Part C|Progressive Disease|0
7816182|NCT01214655|12281885|FG002|Part C|Progressive Disease|5
7816183|NCT01214655|12281883|FG000|Part C|Death|0
7816184|NCT01214655|12281884|FG001|Part C|Death|0
7816185|NCT01214655|12281885|FG002|Part C|Death|1
7816186|NCT01214655|12281883|FG000|Part C|Physician Decision|0
7816187|NCT01214655|12281884|FG001|Part C|Physician Decision|0
7816188|NCT01214655|12281885|FG002|Part C|Physician Decision|1
7816189|NCT01214668|12281937|FG000|Overall Study|Adverse Event|0
7816190|NCT01214668|12281938|FG001|Overall Study|Adverse Event|1
7816191|NCT01214668|12281939|FG002|Overall Study|Adverse Event|0
7816192|NCT01214668|12281940|FG003|Overall Study|Adverse Event|2
7816193|NCT01214668|12281941|FG004|Overall Study|Adverse Event|1
7816194|NCT01214668|12281942|FG005|Overall Study|Adverse Event|1
7816195|NCT01214668|12281937|FG000|Overall Study|Death|0
7816196|NCT01214668|12281938|FG001|Overall Study|Death|0
7816197|NCT01214668|12281939|FG002|Overall Study|Death|1
7816198|NCT01214668|12281940|FG003|Overall Study|Death|0
7816199|NCT01214668|12281941|FG004|Overall Study|Death|0
7816200|NCT01214668|12281942|FG005|Overall Study|Death|0
7816201|NCT01214668|12281937|FG000|Overall Study|Progressive Disease|4
7816202|NCT01214668|12281938|FG001|Overall Study|Progressive Disease|2
7816203|NCT01214668|12281939|FG002|Overall Study|Progressive Disease|5
7816204|NCT01214668|12281940|FG003|Overall Study|Progressive Disease|4
7816205|NCT01214668|12281941|FG004|Overall Study|Progressive Disease|4
7816206|NCT01214668|12281942|FG005|Overall Study|Progressive Disease|5
7816207|NCT01214668|12281937|FG000|Overall Study|Withdrawal by Subject|0
7816208|NCT01214668|12281938|FG001|Overall Study|Withdrawal by Subject|0
7910841|NCT02058290|12427923|FG000|Overall Study|Physician Decision|1
7816209|NCT01214668|12281939|FG002|Overall Study|Withdrawal by Subject|0
7816210|NCT01214668|12281940|FG003|Overall Study|Withdrawal by Subject|0
7816211|NCT01214668|12281941|FG004|Overall Study|Withdrawal by Subject|1
7816212|NCT01214668|12281942|FG005|Overall Study|Withdrawal by Subject|0
7816213|NCT01214720|12281959|FG000|Overall Study|Alive and still on treatment|34
7816214|NCT01214720|12281960|FG001|Overall Study|Alive and still on treatment|18
7816215|NCT01214720|12281959|FG000|Overall Study|Alive and in follow-up|45
7910842|NCT02058290|12427924|FG001|Overall Study|Physician Decision|0
7910843|NCT02058290|12427923|FG000|Overall Study|Didn't meet intraoperative criteria|8
7910844|NCT02058290|12427924|FG001|Overall Study|Didn't meet intraoperative criteria|7
7910845|NCT02058290|12427923|FG000|Overall Study|Withdrawal by Subject|0
7910846|NCT02058290|12427924|FG001|Overall Study|Withdrawal by Subject|1
7910847|NCT02058368|12427932|FG000|Overall Study|Adverse Event|15
7910848|NCT02058368|12427933|FG001|Overall Study|Adverse Event|20
7910849|NCT02058368|12427932|FG000|Overall Study|Lack of Efficacy|0
7910850|NCT02058368|12427933|FG001|Overall Study|Lack of Efficacy|1
7910851|NCT02058368|12427932|FG000|Overall Study|Protocol Violation|0
7910852|NCT02058368|12427933|FG001|Overall Study|Protocol Violation|4
7910853|NCT02058368|12427932|FG000|Overall Study|Lost to Follow-up|2
7910854|NCT02058368|12427933|FG001|Overall Study|Lost to Follow-up|0
7910855|NCT02058368|12427932|FG000|Overall Study|Physician Decision|2
7910856|NCT02058368|12427933|FG001|Overall Study|Physician Decision|3
7910857|NCT02058368|12427932|FG000|Overall Study|Withdrawal by Subject|22
7910858|NCT02058368|12427933|FG001|Overall Study|Withdrawal by Subject|26
7910859|NCT02058498|12427939|FG000|Overall Study|Withdrawal by Subject|4
7910860|NCT02058563|12427949|FG000|Overall Study|Lost to Follow-up|26
7910861|NCT02058563|12427950|FG001|Overall Study|Lost to Follow-up|22
7910862|NCT02058563|12427949|FG000|Overall Study|Other (vaccinated later as new subject)|1
7910863|NCT02058563|12427950|FG001|Overall Study|Other (vaccinated later as new subject)|0
7910864|NCT02058563|12427949|FG000|Overall Study|Consent Withdrawal|1
7910865|NCT02058563|12427950|FG001|Overall Study|Consent Withdrawal|1
7910866|NCT02058563|12427949|FG000|Overall Study|Other (patient incarcerated)|0
7910867|NCT02058563|12427950|FG001|Overall Study|Other (patient incarcerated)|1
7910868|NCT02058589|12427958|FG000|Overall Study|Serious Adverse Event|1
7910869|NCT02058589|12427959|FG001|Overall Study|Serious Adverse Event|1
7910870|NCT02058589|12427958|FG000|Overall Study|Non-Serious Adverse Event|1
7910871|NCT02058589|12427959|FG001|Overall Study|Non-Serious Adverse Event|0
7910872|NCT02058589|12427958|FG000|Overall Study|Withdrawal by Subject|0
7910873|NCT02058589|12427959|FG001|Overall Study|Withdrawal by Subject|1
7910874|NCT02058628|12427969|FG000|Overall Study|Adverse Event|1
7910875|NCT02058628|12427970|FG001|Overall Study|Adverse Event|0
7910876|NCT02058628|12427969|FG000|Overall Study|Withdrawal by Subject|2
7910877|NCT02058628|12427970|FG001|Overall Study|Withdrawal by Subject|2
7910878|NCT02058628|12427969|FG000|Overall Study|Lost to Follow-up|2
7910879|NCT02058628|12427970|FG001|Overall Study|Lost to Follow-up|4
7910880|NCT02058628|12427969|FG000|Overall Study|Not in time schedule|0
7910881|NCT02058628|12427970|FG001|Overall Study|Not in time schedule|1
7910882|NCT02058628|12427969|FG000|Overall Study|The visit date was not in timeline|0
7910883|NCT02058628|12427970|FG001|Overall Study|The visit date was not in timeline|1
7910884|NCT02058628|12427969|FG000|Overall Study|A lot of time for study for participant|1
7910885|NCT02058628|12427970|FG001|Overall Study|A lot of time for study for participant|0
7910886|NCT02058628|12427969|FG000|Overall Study|Non compliance|1
7910887|NCT02058628|12427970|FG001|Overall Study|Non compliance|0
7910888|NCT02058836|12427981|FG000|Overall Study|Withdrawal by Subject|1
7910889|NCT02058836|12427982|FG001|Overall Study|Withdrawal by Subject|1
7910890|NCT02058849|12427990|FG000|Overall Study|Hospitalization|1
7910891|NCT02058849|12427991|FG001|Overall Study|Hospitalization|1
7910892|NCT02058849|12427990|FG000|Overall Study|Death|1
7910893|NCT02058849|12427991|FG001|Overall Study|Death|0
7910894|NCT02058849|12427990|FG000|Overall Study|Lost to Follow-up|1
7910895|NCT02058849|12427991|FG001|Overall Study|Lost to Follow-up|0
7910896|NCT02058849|12427990|FG000|Overall Study|Withdrawal by Subject|4
7816216|NCT01214720|12281960|FG001|Overall Study|Alive and in follow-up|48
7910897|NCT02058849|12427991|FG001|Overall Study|Withdrawal by Subject|0
7910898|NCT02058940|12427997|FG000|Overall Study|Discharged from Critical Care Unit|1
7910899|NCT02058966|12428001|FG000|Open-Label Methamphetamine|Adverse Event|1
7910900|NCT02058966|12428001|FG000|First Intervention|Withdrawal by Subject|1
7910901|NCT02058992|12428013|FG000|Overall Study|Lost to Follow-up|4
7910902|NCT02058992|12428013|FG000|Overall Study|Protocol Violation|92
7910903|NCT02058992|12428013|FG000|Overall Study|CRF Uncollected|20
7816217|NCT01214720|12281959|FG000|Overall Study|Lost to Follow-up|6
7816218|NCT01214720|12281960|FG001|Overall Study|Lost to Follow-up|2
7816219|NCT01214837|12281982|FG000|Overall Study|Death|0
7816220|NCT01214837|12281983|FG001|Overall Study|Death|0
7816221|NCT01214837|12281984|FG002|Overall Study|Death|1
7816222|NCT01214837|12281982|FG000|Overall Study|Adverse Event|1
7816223|NCT01214837|12281983|FG001|Overall Study|Adverse Event|2
7816224|NCT01214837|12281984|FG002|Overall Study|Adverse Event|1
7816225|NCT01214837|12281982|FG000|Overall Study|Withdrawal by Subject|27
7816226|NCT01214837|12281983|FG001|Overall Study|Withdrawal by Subject|36
7816227|NCT01214837|12281984|FG002|Overall Study|Withdrawal by Subject|28
7816228|NCT01214837|12281982|FG000|Overall Study|Lost to Follow-up|20
7816229|NCT01214837|12281983|FG001|Overall Study|Lost to Follow-up|15
7816230|NCT01214837|12281984|FG002|Overall Study|Lost to Follow-up|21
7816231|NCT01214837|12281982|FG000|Overall Study|Inappropriate Enrolment|0
7816232|NCT01214837|12281983|FG001|Overall Study|Inappropriate Enrolment|1
7816233|NCT01214837|12281984|FG002|Overall Study|Inappropriate Enrolment|2
7816234|NCT01214837|12281982|FG000|Overall Study|Administrative Reason|2
7816235|NCT01214837|12281983|FG001|Overall Study|Administrative Reason|6
7816236|NCT01214837|12281984|FG002|Overall Study|Administrative Reason|4
7816237|NCT01214837|12281982|FG000|Overall Study|Protocol Violation|3
7816238|NCT01214837|12281983|FG001|Overall Study|Protocol Violation|1
7816239|NCT01214837|12281984|FG002|Overall Study|Protocol Violation|5
7816240|NCT01214837|12281982|FG000|Overall Study|Unable to Classify|1
7816241|NCT01214837|12281983|FG001|Overall Study|Unable to Classify|3
7816242|NCT01214837|12281984|FG002|Overall Study|Unable to Classify|0
7861981|NCT01597245|12351197|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
7861982|NCT01597245|12351198|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
7861983|NCT01597245|12351199|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
7861984|NCT01597245|12351200|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
7861985|NCT01597245|12351201|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7816243|NCT01214850|12281996|FG000|Overall Study|Withdrawal by Subject|38
7816244|NCT01214850|12281997|FG001|Overall Study|Withdrawal by Subject|31
7816245|NCT01214850|12281998|FG002|Overall Study|Withdrawal by Subject|28
7816246|NCT01214850|12281996|FG000|Overall Study|Lost to Follow-up|124
7816247|NCT01214850|12281997|FG001|Overall Study|Lost to Follow-up|98
7816248|NCT01214850|12281998|FG002|Overall Study|Lost to Follow-up|123
7816249|NCT01214850|12281996|FG000|Overall Study|Protocol Violation|5
7816250|NCT01214850|12281997|FG001|Overall Study|Protocol Violation|5
7816251|NCT01214850|12281998|FG002|Overall Study|Protocol Violation|6
7816252|NCT01214850|12281996|FG000|Overall Study|Adverse event or death|11
7816253|NCT01214850|12281997|FG001|Overall Study|Adverse event or death|8
7816254|NCT01214850|12281998|FG002|Overall Study|Adverse event or death|3
7816255|NCT01214850|12281996|FG000|Overall Study|Inappropriate enrollment|2
7816256|NCT01214850|12281997|FG001|Overall Study|Inappropriate enrollment|1
7816257|NCT01214850|12281998|FG002|Overall Study|Inappropriate enrollment|0
7816258|NCT01214850|12281996|FG000|Overall Study|Administrative reason|1
7816259|NCT01214850|12281997|FG001|Overall Study|Administrative reason|0
7816260|NCT01214850|12281998|FG002|Overall Study|Administrative reason|0
7816261|NCT01214850|12281996|FG000|Overall Study|Unable to classify|2
7816262|NCT01214850|12281997|FG001|Overall Study|Unable to classify|1
7816263|NCT01214850|12281998|FG002|Overall Study|Unable to classify|1
7816264|NCT01214915|12282009|FG000|Overall Study|Adverse Event|8
7816265|NCT01214915|12282009|FG000|Overall Study|Lack of Efficacy|3
7816266|NCT01215032|12282022|FG000|Overall Study|Adverse Event|3
7816267|NCT01215032|12282022|FG000|Overall Study|Lack of Efficacy|17
7816268|NCT01215097|12282030|FG000|Overall Study|Adverse Event|1
7816269|NCT01215097|12282031|FG001|Overall Study|Adverse Event|3
7816270|NCT01215097|12282030|FG000|Overall Study|Protocol Violation|0
7816271|NCT01215097|12282031|FG001|Overall Study|Protocol Violation|2
7816272|NCT01215097|12282030|FG000|Overall Study|Lost to Follow-up|2
7816273|NCT01215097|12282031|FG001|Overall Study|Lost to Follow-up|0
7816274|NCT01215097|12282030|FG000|Overall Study|Withdrawal by Subject|6
7816275|NCT01215097|12282031|FG001|Overall Study|Withdrawal by Subject|3
7816276|NCT01215097|12282030|FG000|Overall Study|Lack of Efficacy|0
7816277|NCT01215097|12282031|FG001|Overall Study|Lack of Efficacy|3
7816278|NCT01215097|12282030|FG000|Overall Study|patient's refusal to come|2
7816279|NCT01215097|12282031|FG001|Overall Study|patient's refusal to come|2
7816280|NCT01215097|12282030|FG000|Overall Study|patient's private reason|1
7816281|NCT01215097|12282031|FG001|Overall Study|patient's private reason|1
7816282|NCT01215175|12282071|FG000|Overall Study|Lost to Follow-up|0
7816283|NCT01215175|12282072|FG001|Overall Study|Lost to Follow-up|1
7816284|NCT01215175|12282073|FG002|Overall Study|Lost to Follow-up|0
7816285|NCT01215175|12282074|FG003|Overall Study|Lost to Follow-up|1
7816286|NCT01215175|12282075|FG004|Overall Study|Lost to Follow-up|0
7816287|NCT01215188|12282090|FG000|Overall Study|Lost to Follow-up|22
7816288|NCT01215188|12282091|FG001|Overall Study|Lost to Follow-up|22
7816289|NCT01215188|12282092|FG002|Overall Study|Lost to Follow-up|16
7816290|NCT01215188|12282090|FG000|Overall Study|Adverse Event|1
7816291|NCT01215188|12282091|FG001|Overall Study|Adverse Event|1
7816292|NCT01215188|12282092|FG002|Overall Study|Adverse Event|3
7816293|NCT01215188|12282090|FG000|Overall Study|Physician Decision|2
7816294|NCT01215188|12282091|FG001|Overall Study|Physician Decision|1
7816295|NCT01215188|12282092|FG002|Overall Study|Physician Decision|0
7816296|NCT01215188|12282090|FG000|Overall Study|Lack of Efficacy|0
7816297|NCT01215188|12282091|FG001|Overall Study|Lack of Efficacy|0
7816298|NCT01215188|12282092|FG002|Overall Study|Lack of Efficacy|1
7816299|NCT01215188|12282090|FG000|Overall Study|Protocol Violation|1
7816300|NCT01215188|12282091|FG001|Overall Study|Protocol Violation|1
7816301|NCT01215188|12282092|FG002|Overall Study|Protocol Violation|1
7816302|NCT01215188|12282090|FG000|Overall Study|Withdrawal by Subject|32
7816303|NCT01215188|12282091|FG001|Overall Study|Withdrawal by Subject|34
7816304|NCT01215188|12282092|FG002|Overall Study|Withdrawal by Subject|31
7816305|NCT01215227|12282106|FG000|Overall Study|Adverse Event|11
7816306|NCT01215227|12282107|FG001|Overall Study|Adverse Event|11
7816307|NCT01215227|12282108|FG002|Overall Study|Adverse Event|4
7816308|NCT01215227|12282109|FG003|Overall Study|Adverse Event|8
7816309|NCT01215227|12282110|FG004|Overall Study|Adverse Event|7
7816310|NCT01215227|12282111|FG005|Overall Study|Adverse Event|6
7816311|NCT01215227|12282106|FG000|Overall Study|Treatment Failure|8
7816312|NCT01215227|12282107|FG001|Overall Study|Treatment Failure|4
7816313|NCT01215227|12282108|FG002|Overall Study|Treatment Failure|1
7816314|NCT01215227|12282109|FG003|Overall Study|Treatment Failure|5
7816315|NCT01215227|12282110|FG004|Overall Study|Treatment Failure|1
7816316|NCT01215227|12282111|FG005|Overall Study|Treatment Failure|1
7816317|NCT01215227|12282106|FG000|Overall Study|Lost to Follow-up|1
7816318|NCT01215227|12282107|FG001|Overall Study|Lost to Follow-up|4
7816319|NCT01215227|12282108|FG002|Overall Study|Lost to Follow-up|1
7816320|NCT01215227|12282109|FG003|Overall Study|Lost to Follow-up|1
7816321|NCT01215227|12282110|FG004|Overall Study|Lost to Follow-up|1
7816322|NCT01215227|12282111|FG005|Overall Study|Lost to Follow-up|2
7816323|NCT01215227|12282106|FG000|Overall Study|Subject Withdrew Consent|16
7816324|NCT01215227|12282107|FG001|Overall Study|Subject Withdrew Consent|20
7816325|NCT01215227|12282108|FG002|Overall Study|Subject Withdrew Consent|7
7816326|NCT01215227|12282109|FG003|Overall Study|Subject Withdrew Consent|10
7816327|NCT01215227|12282110|FG004|Overall Study|Subject Withdrew Consent|11
7816328|NCT01215227|12282111|FG005|Overall Study|Subject Withdrew Consent|8
7816329|NCT01215227|12282106|FG000|Overall Study|Non-Compliance With Protocol|2
7816330|NCT01215227|12282107|FG001|Overall Study|Non-Compliance With Protocol|6
7816331|NCT01215227|12282108|FG002|Overall Study|Non-Compliance With Protocol|1
7816332|NCT01215227|12282109|FG003|Overall Study|Non-Compliance With Protocol|0
7816333|NCT01215227|12282110|FG004|Overall Study|Non-Compliance With Protocol|0
7816334|NCT01215227|12282111|FG005|Overall Study|Non-Compliance With Protocol|0
7816335|NCT01215227|12282106|FG000|Overall Study|Administrative|83
7816336|NCT01215227|12282107|FG001|Overall Study|Administrative|73
7816337|NCT01215227|12282108|FG002|Overall Study|Administrative|42
7816338|NCT01215227|12282109|FG003|Overall Study|Administrative|24
7816339|NCT01215227|12282110|FG004|Overall Study|Administrative|28
7816340|NCT01215227|12282111|FG005|Overall Study|Administrative|40
7816341|NCT01215227|12282106|FG000|Overall Study|Missing Status|0
7816342|NCT01215227|12282107|FG001|Overall Study|Missing Status|1
7816343|NCT01215227|12282108|FG002|Overall Study|Missing Status|0
7816344|NCT01215227|12282109|FG003|Overall Study|Missing Status|0
7816345|NCT01215227|12282110|FG004|Overall Study|Missing Status|0
7816346|NCT01215227|12282111|FG005|Overall Study|Missing Status|0
7816347|NCT01215227|12282106|FG000|Overall Study|Randomized but not treated|0
7816348|NCT01215227|12282107|FG001|Overall Study|Randomized but not treated|0
7816349|NCT01215227|12282108|FG002|Overall Study|Randomized but not treated|1
7816350|NCT01215227|12282109|FG003|Overall Study|Randomized but not treated|1
7816351|NCT01215227|12282110|FG004|Overall Study|Randomized but not treated|0
7816352|NCT01215227|12282111|FG005|Overall Study|Randomized but not treated|1
7816353|NCT01215253|12282136|FG000|Overall Study|Withdrawal by Subject|57
7816354|NCT01215253|12282137|FG001|Overall Study|Withdrawal by Subject|35
7816355|NCT01215253|12282136|FG000|Overall Study|Physician Decision|9
7816356|NCT01215253|12282137|FG001|Overall Study|Physician Decision|12
7816357|NCT01215253|12282136|FG000|Overall Study|Lost to Follow-up|6
7816358|NCT01215253|12282137|FG001|Overall Study|Lost to Follow-up|4
7816359|NCT01215253|12282136|FG000|Overall Study|Other|14
7816360|NCT01215253|12282137|FG001|Overall Study|Other|12
7816361|NCT01215357|12282204|FG000|Overall Study|Withdrawal by Subject|3
7816362|NCT01215357|12282204|FG000|Overall Study|Protocol Violation|9
7816363|NCT01215422|12282212|FG000|Overall Study|Relocation|1
7816364|NCT01215422|12282213|FG001|Overall Study|Relocation|0
7816365|NCT01215422|12282214|FG002|Overall Study|Relocation|0
7816366|NCT01215422|12282215|FG003|Overall Study|Relocation|0
7910904|NCT02059005|12428019|FG000|Overall Study|Death|1
7910905|NCT02059005|12428020|FG001|Overall Study|Death|3
7910906|NCT02059005|12428019|FG000|Overall Study|Lost to Follow-up|19
7910907|NCT02059005|12428020|FG001|Overall Study|Lost to Follow-up|19
7910908|NCT02059005|12428019|FG000|Overall Study|Incarceration|0
7910909|NCT02059005|12428020|FG001|Overall Study|Incarceration|1
7910910|NCT02059005|12428019|FG000|Overall Study|Inpatient|0
7910911|NCT02059005|12428020|FG001|Overall Study|Inpatient|1
7910912|NCT02059135|12428044|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
7910913|NCT02059135|12428045|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
7910914|NCT02059135|12428044|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
7910915|NCT02059135|12428045|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
7910916|NCT02059135|12428044|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0
7910917|NCT02059135|12428045|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1
7910918|NCT02059135|12428044|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
7910919|NCT02059135|12428045|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
7910920|NCT02059135|12428044|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
7910921|NCT02059135|12428045|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
7910922|NCT02059135|12428044|FG000|Neonatal Follow-up (Safety Population)|Death|3
7910923|NCT02059135|12428045|FG001|Neonatal Follow-up (Safety Population)|Death|2
7910924|NCT02059135|12428044|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
7910925|NCT02059135|12428045|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
7910926|NCT02059135|12428044|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
7910927|NCT02059135|12428045|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
7910928|NCT02059148|12428053|FG000|Treatment 1|Protocol Violation|0
7910929|NCT02059148|12428054|FG001|Treatment 1|Protocol Violation|0
7910930|NCT02059148|12428055|FG002|Treatment 1|Protocol Violation|0
7910931|NCT02059148|12428056|FG003|Treatment 1|Protocol Violation|0
7910932|NCT02059148|12428057|FG004|Treatment 1|Protocol Violation|0
7910933|NCT02059148|12428058|FG005|Treatment 1|Protocol Violation|1
7910934|NCT02059161|12428071|FG000|Overall Study|Pregnancy|0
7910935|NCT02059161|12428072|FG001|Overall Study|Pregnancy|2
7910936|NCT02059161|12428071|FG000|Overall Study|Adverse Event|2
7910937|NCT02059161|12428072|FG001|Overall Study|Adverse Event|6
7910938|NCT02059161|12428071|FG000|Overall Study|Lost to Follow-up|20
7910939|NCT02059161|12428072|FG001|Overall Study|Lost to Follow-up|12
7910940|NCT02059161|12428071|FG000|Overall Study|Physician Decision|4
7910941|NCT02059161|12428072|FG001|Overall Study|Physician Decision|4
7910942|NCT02059161|12428071|FG000|Overall Study|Protocol Violation|1
7910943|NCT02059161|12428072|FG001|Overall Study|Protocol Violation|1
7910944|NCT02059161|12428071|FG000|Overall Study|Withdrawal by Subject|16
7910945|NCT02059161|12428072|FG001|Overall Study|Withdrawal by Subject|13
7910946|NCT02059161|12428071|FG000|Overall Study|Randomized in error, no study drug|0
7910947|NCT02059161|12428072|FG001|Overall Study|Randomized in error, no study drug|1
7910948|NCT02059161|12428071|FG000|Overall Study|Non-compliance with study drug|6
7910949|NCT02059161|12428072|FG001|Overall Study|Non-compliance with study drug|2
7910950|NCT02059174|12428078|FG000|Period 1|Withdrawal by Subject|0
7910951|NCT02059174|12428079|FG001|Period 1|Withdrawal by Subject|2
7910952|NCT02059174|12428078|FG000|Period 2|Withdrawal by Subject|0
7910953|NCT02059174|12428079|FG001|Period 2|Withdrawal by Subject|2
7910954|NCT02059174|12428078|FG000|Period 2|Protocol Violation|1
7910955|NCT02059174|12428079|FG001|Period 2|Protocol Violation|0
7910956|NCT02059174|12428078|FG000|Period 3|Physician Decision|1
7910957|NCT02059174|12428079|FG001|Period 3|Physician Decision|0
7910958|NCT02059187|12428087|FG000|Overall Study|Adverse Event|0
7910959|NCT02059187|12428088|FG001|Overall Study|Adverse Event|3
7910960|NCT02059187|12428087|FG000|Overall Study|Death|1
7910961|NCT02059187|12428088|FG001|Overall Study|Death|1
7910962|NCT02059187|12428087|FG000|Overall Study|Lost to Follow-up|9
7910963|NCT02059187|12428088|FG001|Overall Study|Lost to Follow-up|8
7910964|NCT02059187|12428087|FG000|Overall Study|Non-compliance with study drug|1
7910965|NCT02059187|12428088|FG001|Overall Study|Non-compliance with study drug|0
7910966|NCT02059187|12428087|FG000|Overall Study|Physician Decision|1
7910967|NCT02059187|12428088|FG001|Overall Study|Physician Decision|2
7910968|NCT02059187|12428087|FG000|Overall Study|Protocol Violation|1
7816367|NCT01215422|12282212|FG000|Overall Study|Failed intubations|0
7910969|NCT02059187|12428088|FG001|Overall Study|Protocol Violation|0
7910970|NCT02059187|12428087|FG000|Overall Study|Withdrawal by Subject|12
7910971|NCT02059187|12428088|FG001|Overall Study|Withdrawal by Subject|8
7910972|NCT02059239|12428108|FG000|Overall Study|Progressive Disease after Bendamustine|1
7910973|NCT02059239|12428109|FG001|Overall Study|Progressive Disease after Bendamustine|3
7910974|NCT02059239|12428108|FG000|Overall Study|Physician Decision|1
7910975|NCT02059239|12428109|FG001|Overall Study|Physician Decision|0
7816368|NCT01215422|12282213|FG001|Overall Study|Failed intubations|0
7816369|NCT01215422|12282214|FG002|Overall Study|Failed intubations|3
7816370|NCT01215422|12282215|FG003|Overall Study|Failed intubations|8
7816371|NCT01215422|12282212|FG000|Overall Study|Did not complete all intubations|7
7910976|NCT02059278|12428118|FG000|Overall Study|Adverse Event|1
7910977|NCT02059278|12428119|FG001|Overall Study|Adverse Event|1
7910978|NCT02059278|12428118|FG000|Overall Study|Lost to Follow-up|1
7910979|NCT02059278|12428119|FG001|Overall Study|Lost to Follow-up|0
7910980|NCT02059278|12428118|FG000|Overall Study|Withdrawal by Subject|0
7910981|NCT02059278|12428119|FG001|Overall Study|Withdrawal by Subject|3
7910982|NCT02059278|12428118|FG000|Overall Study|Ran out of IP and decided to discontinue|1
7910983|NCT02059278|12428119|FG001|Overall Study|Ran out of IP and decided to discontinue|0
7910984|NCT02059291|12428134|FG000|Epoch 2|Lack of Efficacy|0
7910985|NCT02059291|12428135|FG001|Epoch 2|Lack of Efficacy|0
7910986|NCT02059291|12428136|FG002|Epoch 2|Lack of Efficacy|0
7910987|NCT02059291|12428137|FG003|Epoch 2|Lack of Efficacy|1
7910988|NCT02059291|12428138|FG004|Epoch 2|Lack of Efficacy|0
7910989|NCT02059291|12428139|FG005|Epoch 2|Lack of Efficacy|1
7910990|NCT02059291|12428140|FG006|Epoch 2|Lack of Efficacy|0
7910991|NCT02059291|12428141|FG007|Epoch 2|Lack of Efficacy|0
7910992|NCT02059291|12428142|FG008|Epoch 2|Lack of Efficacy|0
7910993|NCT02059291|12428143|FG009|Epoch 2|Lack of Efficacy|0
7910994|NCT02059291|12428144|FG010|Epoch 2|Lack of Efficacy|0
7910995|NCT02059291|12428145|FG011|Epoch 2|Lack of Efficacy|0
7910996|NCT02059291|12428146|FG012|Epoch 2|Lack of Efficacy|0
7910997|NCT02059291|12428147|FG013|Epoch 2|Lack of Efficacy|0
7910998|NCT02059291|12428148|FG014|Epoch 2|Lack of Efficacy|0
7910999|NCT02059291|12428149|FG015|Epoch 2|Lack of Efficacy|0
7911000|NCT02059291|12428150|FG016|Epoch 2|Lack of Efficacy|0
7911001|NCT02059291|12428151|FG017|Epoch 2|Lack of Efficacy|0
7911002|NCT02059291|12428152|FG018|Epoch 2|Lack of Efficacy|0
7911003|NCT02059291|12428153|FG019|Epoch 2|Lack of Efficacy|0
7911004|NCT02059291|12428154|FG020|Epoch 2|Lack of Efficacy|0
7911005|NCT02059291|12428155|FG021|Epoch 2|Lack of Efficacy|0
7911006|NCT02059291|12428156|FG022|Epoch 2|Lack of Efficacy|0
7911007|NCT02059291|12428157|FG023|Epoch 2|Lack of Efficacy|0
7911008|NCT02059291|12428158|FG024|Epoch 2|Lack of Efficacy|0
7911009|NCT02059291|12428134|FG000|Epoch 2|Adverse Event|0
7911010|NCT02059291|12428135|FG001|Epoch 2|Adverse Event|0
7911011|NCT02059291|12428136|FG002|Epoch 2|Adverse Event|1
7911012|NCT02059291|12428137|FG003|Epoch 2|Adverse Event|1
7911013|NCT02059291|12428138|FG004|Epoch 2|Adverse Event|0
7911014|NCT02059291|12428139|FG005|Epoch 2|Adverse Event|0
7911015|NCT02059291|12428140|FG006|Epoch 2|Adverse Event|0
7911016|NCT02059291|12428141|FG007|Epoch 2|Adverse Event|1
7911017|NCT02059291|12428142|FG008|Epoch 2|Adverse Event|1
7911018|NCT02059291|12428143|FG009|Epoch 2|Adverse Event|0
7911019|NCT02059291|12428144|FG010|Epoch 2|Adverse Event|0
7911020|NCT02059291|12428145|FG011|Epoch 2|Adverse Event|0
7911021|NCT02059291|12428146|FG012|Epoch 2|Adverse Event|0
7911022|NCT02059291|12428147|FG013|Epoch 2|Adverse Event|0
7911023|NCT02059291|12428148|FG014|Epoch 2|Adverse Event|0
7911024|NCT02059291|12428149|FG015|Epoch 2|Adverse Event|0
7911025|NCT02059291|12428150|FG016|Epoch 2|Adverse Event|0
7911026|NCT02059291|12428151|FG017|Epoch 2|Adverse Event|0
7911027|NCT02059291|12428152|FG018|Epoch 2|Adverse Event|0
7911028|NCT02059291|12428153|FG019|Epoch 2|Adverse Event|0
7911029|NCT02059291|12428154|FG020|Epoch 2|Adverse Event|0
7911030|NCT02059291|12428155|FG021|Epoch 2|Adverse Event|0
7911031|NCT02059291|12428156|FG022|Epoch 2|Adverse Event|0
7911032|NCT02059291|12428157|FG023|Epoch 2|Adverse Event|0
7911033|NCT02059291|12428158|FG024|Epoch 2|Adverse Event|0
7911034|NCT02059291|12428134|FG000|Epoch 2|Withdrawal by Subject|0
7911035|NCT02059291|12428135|FG001|Epoch 2|Withdrawal by Subject|1
7911036|NCT02059291|12428136|FG002|Epoch 2|Withdrawal by Subject|0
7816372|NCT01215422|12282213|FG001|Overall Study|Did not complete all intubations|0
7911037|NCT02059291|12428137|FG003|Epoch 2|Withdrawal by Subject|0
7911038|NCT02059291|12428138|FG004|Epoch 2|Withdrawal by Subject|0
7911039|NCT02059291|12428139|FG005|Epoch 2|Withdrawal by Subject|1
7911040|NCT02059291|12428140|FG006|Epoch 2|Withdrawal by Subject|0
7911041|NCT02059291|12428141|FG007|Epoch 2|Withdrawal by Subject|0
7911042|NCT02059291|12428142|FG008|Epoch 2|Withdrawal by Subject|1
7911043|NCT02059291|12428143|FG009|Epoch 2|Withdrawal by Subject|0
7911044|NCT02059291|12428144|FG010|Epoch 2|Withdrawal by Subject|0
7911045|NCT02059291|12428145|FG011|Epoch 2|Withdrawal by Subject|0
7816373|NCT01215422|12282214|FG002|Overall Study|Did not complete all intubations|0
7816374|NCT01215422|12282215|FG003|Overall Study|Did not complete all intubations|0
7816375|NCT01215435|12282239|FG000|Overall Study|Adverse Event|1
7816376|NCT01215435|12282240|FG001|Overall Study|Adverse Event|0
7816377|NCT01215435|12282239|FG000|Overall Study|Protocol Violation|2
7816378|NCT01215435|12282240|FG001|Overall Study|Protocol Violation|0
7816379|NCT01215435|12282239|FG000|Overall Study|Withdrawal Criteria|8
7816380|NCT01215435|12282240|FG001|Overall Study|Withdrawal Criteria|11
7816381|NCT01215435|12282239|FG000|Overall Study|Lost to Follow-up|3
7816382|NCT01215435|12282240|FG001|Overall Study|Lost to Follow-up|0
7816383|NCT01215435|12282239|FG000|Overall Study|Unclassified|5
7816384|NCT01215435|12282240|FG001|Overall Study|Unclassified|5
7816385|NCT01215513|12282246|FG000|Overall Study|Not completed CS42|9
7816386|NCT01215513|12282246|FG000|Overall Study|Not enrolled from CS42 to CS42A|21
7816387|NCT01215513|12282246|FG000|Overall Study|Adverse event (CS42A)|2
7816388|NCT01215513|12282246|FG000|Overall Study|Physician decision (CS42A)|6
7816389|NCT01215513|12282246|FG000|Overall Study|Withdrawal by subject (CS42A)|5
7816390|NCT01215513|12282246|FG000|Overall Study|Miscellaneous reasons (CS42A)|2
7816391|NCT01215721|12282286|FG000|Overall Study|Adverse Event|2
7816392|NCT01215734|12282292|FG000|Overall Study|Death|0
7816393|NCT01215734|12282293|FG001|Overall Study|Death|1
7816394|NCT01215851|12282318|FG000|Treatment Period|Adverse Event|1
7816395|NCT01215851|12282319|FG001|Treatment Period|Adverse Event|1
7911046|NCT02059291|12428146|FG012|Epoch 2|Withdrawal by Subject|0
7911047|NCT02059291|12428147|FG013|Epoch 2|Withdrawal by Subject|0
7911048|NCT02059291|12428148|FG014|Epoch 2|Withdrawal by Subject|0
7816396|NCT01215851|12282320|FG002|Treatment Period|Adverse Event|1
7816397|NCT01215851|12282321|FG003|Treatment Period|Adverse Event|3
7816398|NCT01215851|12282322|FG004|Treatment Period|Adverse Event|0
7816399|NCT01215851|12282323|FG005|Treatment Period|Adverse Event|1
7816400|NCT01215851|12282318|FG000|Follow up Period|Lost to Follow-up|0
7816401|NCT01215851|12282319|FG001|Follow up Period|Lost to Follow-up|0
7816402|NCT01215851|12282320|FG002|Follow up Period|Lost to Follow-up|0
7816403|NCT01215851|12282321|FG003|Follow up Period|Lost to Follow-up|0
7816404|NCT01215851|12282322|FG004|Follow up Period|Lost to Follow-up|0
7816405|NCT01215851|12282323|FG005|Follow up Period|Lost to Follow-up|1
7816406|NCT01215916|12282347|FG000|Overall Study|Progressive Disease|0
7816407|NCT01215916|12282348|FG001|Overall Study|Progressive Disease|2
7816408|NCT01215916|12282349|FG002|Overall Study|Progressive Disease|1
7816409|NCT01215916|12282350|FG003|Overall Study|Progressive Disease|2
7816410|NCT01215916|12282351|FG004|Overall Study|Progressive Disease|5
7816411|NCT01215916|12282352|FG005|Overall Study|Progressive Disease|4
7816412|NCT01215916|12282353|FG006|Overall Study|Progressive Disease|5
7816413|NCT01215916|12282354|FG007|Overall Study|Progressive Disease|3
7816414|NCT01215916|12282355|FG008|Overall Study|Progressive Disease|1
7816415|NCT01215916|12282347|FG000|Overall Study|Adverse Event|1
7816416|NCT01215916|12282348|FG001|Overall Study|Adverse Event|1
7816417|NCT01215916|12282349|FG002|Overall Study|Adverse Event|0
7816418|NCT01215916|12282350|FG003|Overall Study|Adverse Event|1
7816419|NCT01215916|12282351|FG004|Overall Study|Adverse Event|0
7816420|NCT01215916|12282352|FG005|Overall Study|Adverse Event|0
7816421|NCT01215916|12282353|FG006|Overall Study|Adverse Event|3
7816422|NCT01215916|12282354|FG007|Overall Study|Adverse Event|0
7816423|NCT01215916|12282355|FG008|Overall Study|Adverse Event|0
7816424|NCT01215916|12282347|FG000|Overall Study|Withdrawal by Subject|0
7816425|NCT01215916|12282348|FG001|Overall Study|Withdrawal by Subject|1
7816426|NCT01215916|12282349|FG002|Overall Study|Withdrawal by Subject|1
7816427|NCT01215916|12282350|FG003|Overall Study|Withdrawal by Subject|2
7816428|NCT01215916|12282351|FG004|Overall Study|Withdrawal by Subject|0
7816429|NCT01215916|12282352|FG005|Overall Study|Withdrawal by Subject|0
7816430|NCT01215916|12282353|FG006|Overall Study|Withdrawal by Subject|1
7816431|NCT01215916|12282354|FG007|Overall Study|Withdrawal by Subject|0
7816432|NCT01215916|12282355|FG008|Overall Study|Withdrawal by Subject|0
7816433|NCT01215916|12282347|FG000|Overall Study|Death|0
7816434|NCT01215916|12282348|FG001|Overall Study|Death|1
7816435|NCT01215916|12282349|FG002|Overall Study|Death|0
7816436|NCT01215916|12282350|FG003|Overall Study|Death|0
7816437|NCT01215916|12282351|FG004|Overall Study|Death|1
7816438|NCT01215916|12282352|FG005|Overall Study|Death|0
7816439|NCT01215916|12282353|FG006|Overall Study|Death|0
7816440|NCT01215916|12282354|FG007|Overall Study|Death|0
7816441|NCT01215916|12282355|FG008|Overall Study|Death|1
7816442|NCT01215916|12282347|FG000|Overall Study|Physician Decision|0
7816443|NCT01215916|12282348|FG001|Overall Study|Physician Decision|0
7816444|NCT01215916|12282349|FG002|Overall Study|Physician Decision|1
7816445|NCT01215916|12282350|FG003|Overall Study|Physician Decision|1
7816446|NCT01215916|12282351|FG004|Overall Study|Physician Decision|0
7816447|NCT01215916|12282352|FG005|Overall Study|Physician Decision|0
7816448|NCT01215916|12282353|FG006|Overall Study|Physician Decision|0
7816449|NCT01215916|12282354|FG007|Overall Study|Physician Decision|0
7816450|NCT01215916|12282355|FG008|Overall Study|Physician Decision|0
7816451|NCT01215942|12282390|FG000|Treatment Period|Adverse Event|15
7816452|NCT01215942|12282391|FG001|Treatment Period|Adverse Event|26
7816453|NCT01215942|12282390|FG000|Treatment Period|Death|2
7816454|NCT01215942|12282391|FG001|Treatment Period|Death|4
7816455|NCT01215942|12282390|FG000|Treatment Period|Lack of Efficacy|23
7816456|NCT01215942|12282391|FG001|Treatment Period|Lack of Efficacy|62
7816457|NCT01215942|12282390|FG000|Treatment Period|Lost to Follow-up|3
7816458|NCT01215942|12282391|FG001|Treatment Period|Lost to Follow-up|4
7816459|NCT01215942|12282390|FG000|Treatment Period|Withdrawal by Subject|17
7816460|NCT01215942|12282391|FG001|Treatment Period|Withdrawal by Subject|40
7816461|NCT01215942|12282390|FG000|Treatment Period|Physician Decision|5
7816462|NCT01215942|12282391|FG001|Treatment Period|Physician Decision|5
7816463|NCT01215942|12282390|FG000|Treatment Period|Protocol Violation|0
7816464|NCT01215942|12282391|FG001|Treatment Period|Protocol Violation|1
7816465|NCT01215942|12282390|FG000|Treatment Period|Sponsor Decision|349
7816466|NCT01215942|12282391|FG001|Treatment Period|Sponsor Decision|530
7816467|NCT01215942|12282390|FG000|Post-Treatment Follow-Up Period|Death|0
7816468|NCT01215942|12282391|FG001|Post-Treatment Follow-Up Period|Death|1
7816469|NCT01215942|12282390|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13
7816470|NCT01215942|12282391|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13
7816471|NCT01215942|12282390|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
7816472|NCT01215942|12282391|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
7816473|NCT01215942|12282390|FG000|Post-Treatment Follow-Up Period|Physician Decision|1
7816474|NCT01215942|12282391|FG001|Post-Treatment Follow-Up Period|Physician Decision|2
7816475|NCT01215942|12282390|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28
7816476|NCT01215942|12282391|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61
7816477|NCT01215955|12282412|FG000|Overall Study|Adverse Event|1
7816478|NCT01215955|12282413|FG001|Overall Study|Adverse Event|4
7816479|NCT01215955|12282414|FG002|Overall Study|Adverse Event|2
7816480|NCT01215955|12282415|FG003|Overall Study|Adverse Event|3
7816481|NCT01215955|12282412|FG000|Overall Study|Death|2
7816482|NCT01215955|12282413|FG001|Overall Study|Death|0
7816483|NCT01215955|12282414|FG002|Overall Study|Death|1
7816484|NCT01215955|12282415|FG003|Overall Study|Death|3
7816485|NCT01215955|12282412|FG000|Overall Study|Entry Criteria Not Met|1
7816486|NCT01215955|12282413|FG001|Overall Study|Entry Criteria Not Met|3
7816487|NCT01215955|12282414|FG002|Overall Study|Entry Criteria Not Met|4
7816488|NCT01215955|12282415|FG003|Overall Study|Entry Criteria Not Met|7
7816489|NCT01215955|12282412|FG000|Overall Study|Lack of Efficacy|1
7816490|NCT01215955|12282413|FG001|Overall Study|Lack of Efficacy|2
7816491|NCT01215955|12282414|FG002|Overall Study|Lack of Efficacy|1
7816492|NCT01215955|12282415|FG003|Overall Study|Lack of Efficacy|0
7816493|NCT01215955|12282412|FG000|Overall Study|Lost to Follow-up|4
7816494|NCT01215955|12282413|FG001|Overall Study|Lost to Follow-up|4
7816495|NCT01215955|12282414|FG002|Overall Study|Lost to Follow-up|8
7816496|NCT01215955|12282415|FG003|Overall Study|Lost to Follow-up|9
7816497|NCT01215955|12282412|FG000|Overall Study|Physician Decision|4
7816498|NCT01215955|12282413|FG001|Overall Study|Physician Decision|10
7816499|NCT01215955|12282414|FG002|Overall Study|Physician Decision|8
7816500|NCT01215955|12282415|FG003|Overall Study|Physician Decision|11
7816501|NCT01215955|12282412|FG000|Overall Study|Protocol Violation|17
7816502|NCT01215955|12282413|FG001|Overall Study|Protocol Violation|13
7816503|NCT01215955|12282414|FG002|Overall Study|Protocol Violation|8
7816504|NCT01215955|12282415|FG003|Overall Study|Protocol Violation|8
7816505|NCT01215955|12282412|FG000|Overall Study|Sponsor Decision|1
7816506|NCT01215955|12282413|FG001|Overall Study|Sponsor Decision|2
7816507|NCT01215955|12282414|FG002|Overall Study|Sponsor Decision|0
7816508|NCT01215955|12282415|FG003|Overall Study|Sponsor Decision|1
7816509|NCT01215955|12282412|FG000|Overall Study|Withdrawal by Subject|14
7816510|NCT01215955|12282413|FG001|Overall Study|Withdrawal by Subject|15
7816511|NCT01215955|12282414|FG002|Overall Study|Withdrawal by Subject|13
7816512|NCT01215955|12282415|FG003|Overall Study|Withdrawal by Subject|9
7816513|NCT01215955|12282412|FG000|Overall Study|Quality Issues|0
7816514|NCT01215955|12282413|FG001|Overall Study|Quality Issues|0
7816515|NCT01215955|12282414|FG002|Overall Study|Quality Issues|3
7816516|NCT01215955|12282415|FG003|Overall Study|Quality Issues|2
7816517|NCT01215968|12282430|FG000|Overall Study|Adverse Event|0
7816518|NCT01215968|12282431|FG001|Overall Study|Adverse Event|2
7816519|NCT01215968|12282430|FG000|Overall Study|Protocol Violation|2
7816520|NCT01215968|12282431|FG001|Overall Study|Protocol Violation|4
7816521|NCT01215968|12282430|FG000|Overall Study|Not received study drug|0
7816522|NCT01215968|12282431|FG001|Overall Study|Not received study drug|1
7816523|NCT01215981|12282442|FG000|Overall Study|Physician Decision|0
7816524|NCT01215981|12282443|FG001|Overall Study|Physician Decision|1
7816525|NCT01215981|12282442|FG000|Overall Study|Protocol Violation|1
7816526|NCT01215981|12282443|FG001|Overall Study|Protocol Violation|0
7816527|NCT01215981|12282442|FG000|Overall Study|Withdrawal by Subject|1
7816528|NCT01215981|12282443|FG001|Overall Study|Withdrawal by Subject|0
7816529|NCT01216072|12282451|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40
7816530|NCT01216072|12282452|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4
7816531|NCT01216072|12282451|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
7816532|NCT01216072|12282452|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
7816533|NCT01216072|12282451|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
7911049|NCT02059291|12428149|FG015|Epoch 2|Withdrawal by Subject|0
7911050|NCT02059291|12428150|FG016|Epoch 2|Withdrawal by Subject|0
7911051|NCT02059291|12428151|FG017|Epoch 2|Withdrawal by Subject|0
7911052|NCT02059291|12428152|FG018|Epoch 2|Withdrawal by Subject|0
7911053|NCT02059291|12428153|FG019|Epoch 2|Withdrawal by Subject|0
7911054|NCT02059291|12428154|FG020|Epoch 2|Withdrawal by Subject|0
7911055|NCT02059291|12428155|FG021|Epoch 2|Withdrawal by Subject|0
7911056|NCT02059291|12428156|FG022|Epoch 2|Withdrawal by Subject|0
7911057|NCT02059291|12428157|FG023|Epoch 2|Withdrawal by Subject|0
7911058|NCT02059291|12428158|FG024|Epoch 2|Withdrawal by Subject|0
7911059|NCT02059291|12428134|FG000|Epoch 3|Physician Decision|0
7911060|NCT02059291|12428135|FG001|Epoch 3|Physician Decision|0
7911061|NCT02059291|12428136|FG002|Epoch 3|Physician Decision|0
7911062|NCT02059291|12428137|FG003|Epoch 3|Physician Decision|0
7911063|NCT02059291|12428138|FG004|Epoch 3|Physician Decision|0
7911064|NCT02059291|12428139|FG005|Epoch 3|Physician Decision|0
7911065|NCT02059291|12428140|FG006|Epoch 3|Physician Decision|0
7911066|NCT02059291|12428141|FG007|Epoch 3|Physician Decision|0
7911067|NCT02059291|12428142|FG008|Epoch 3|Physician Decision|0
7911068|NCT02059291|12428143|FG009|Epoch 3|Physician Decision|0
7911069|NCT02059291|12428144|FG010|Epoch 3|Physician Decision|0
7911070|NCT02059291|12428145|FG011|Epoch 3|Physician Decision|0
7911071|NCT02059291|12428146|FG012|Epoch 3|Physician Decision|0
7911072|NCT02059291|12428147|FG013|Epoch 3|Physician Decision|1
7911073|NCT02059291|12428148|FG014|Epoch 3|Physician Decision|0
7911074|NCT02059291|12428149|FG015|Epoch 3|Physician Decision|1
7911075|NCT02059291|12428150|FG016|Epoch 3|Physician Decision|0
7911076|NCT02059291|12428151|FG017|Epoch 3|Physician Decision|0
7911077|NCT02059291|12428152|FG018|Epoch 3|Physician Decision|0
7911078|NCT02059291|12428153|FG019|Epoch 3|Physician Decision|0
7911079|NCT02059291|12428154|FG020|Epoch 3|Physician Decision|0
7911080|NCT02059291|12428155|FG021|Epoch 3|Physician Decision|0
7911081|NCT02059291|12428156|FG022|Epoch 3|Physician Decision|0
7911082|NCT02059291|12428157|FG023|Epoch 3|Physician Decision|0
7911083|NCT02059291|12428158|FG024|Epoch 3|Physician Decision|0
7911084|NCT02059291|12428134|FG000|Epoch 3|Adverse Event|0
7911085|NCT02059291|12428135|FG001|Epoch 3|Adverse Event|0
7911086|NCT02059291|12428136|FG002|Epoch 3|Adverse Event|0
7911087|NCT02059291|12428137|FG003|Epoch 3|Adverse Event|0
7911088|NCT02059291|12428138|FG004|Epoch 3|Adverse Event|0
7911089|NCT02059291|12428139|FG005|Epoch 3|Adverse Event|0
7911090|NCT02059291|12428140|FG006|Epoch 3|Adverse Event|0
7911091|NCT02059291|12428141|FG007|Epoch 3|Adverse Event|0
7911092|NCT02059291|12428142|FG008|Epoch 3|Adverse Event|0
7911093|NCT02059291|12428143|FG009|Epoch 3|Adverse Event|0
7911094|NCT02059291|12428144|FG010|Epoch 3|Adverse Event|0
7816534|NCT01216072|12282452|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
7816535|NCT01216072|12282451|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
7816536|NCT01216072|12282452|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
7816537|NCT01216072|12282451|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
7816538|NCT01216072|12282452|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
7816539|NCT01216072|12282451|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
7911095|NCT02059291|12428145|FG011|Epoch 3|Adverse Event|0
7816540|NCT01216072|12282452|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
7816541|NCT01216072|12282451|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
7816542|NCT01216072|12282452|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
7816543|NCT01216072|12282451|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0
7816544|NCT01216072|12282452|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10
7816545|NCT01216072|12282451|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
7816546|NCT01216072|12282452|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
7816547|NCT01216072|12282451|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
7816548|NCT01216072|12282452|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
7816549|NCT01216163|12282464|FG000|Overall Study|Withdrawal by Subject|1
7816550|NCT01216163|12282465|FG001|Overall Study|Withdrawal by Subject|1
7816551|NCT01216163|12282466|FG002|Overall Study|Withdrawal by Subject|0
7816552|NCT01216176|12282477|FG000|Overall Study|Adverse Event|0
7816553|NCT01216176|12282478|FG001|Overall Study|Adverse Event|8
7816554|NCT01216176|12282479|FG002|Overall Study|Adverse Event|0
7816555|NCT01216176|12282477|FG000|Overall Study|Physician Decision|0
7816556|NCT01216176|12282478|FG001|Overall Study|Physician Decision|0
7816557|NCT01216176|12282479|FG002|Overall Study|Physician Decision|1
7816558|NCT01216189|12282490|FG000|Overall Study|Lost to Follow-up|21
7816559|NCT01216189|12282491|FG001|Overall Study|Lost to Follow-up|3
7816560|NCT01216189|12282490|FG000|Overall Study|Death|4
7816561|NCT01216189|12282491|FG001|Overall Study|Death|2
7816562|NCT01216202|12282499|FG000|Overall Study|Withdrawal by Subject|8
7816563|NCT01216202|12282500|FG001|Overall Study|Withdrawal by Subject|0
7816564|NCT01216202|12282499|FG000|Overall Study|Death|0
7816565|NCT01216202|12282500|FG001|Overall Study|Death|2
7816566|NCT01216202|12282499|FG000|Overall Study|Lost to Follow-up|14
7816567|NCT01216202|12282500|FG001|Overall Study|Lost to Follow-up|0
7816568|NCT01216319|12282517|FG000|Overall Study|Lost to Follow-up|2
7816569|NCT01216319|12282517|FG000|Overall Study|Unanticipated chemo for breast cancer|2
7816570|NCT01216332|12282523|FG000|Overall Study|Withdrawal by Subject|4
7816571|NCT01216332|12282524|FG001|Overall Study|Withdrawal by Subject|0
7816572|NCT01217073|12282583|FG000|Base Period|Adverse Event|1
7816573|NCT01217073|12282584|FG001|Base Period|Adverse Event|0
7816574|NCT01217073|12282585|FG002|Base Period|Adverse Event|1
7816575|NCT01217073|12282586|FG003|Base Period|Adverse Event|0
7816576|NCT01217073|12282587|FG004|Base Period|Adverse Event|4
7816577|NCT01217073|12282588|FG005|Base Period|Adverse Event|1
7816578|NCT01217073|12282589|FG006|Base Period|Adverse Event|0
7816579|NCT01217073|12282590|FG007|Base Period|Adverse Event|0
7816580|NCT01217073|12282583|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1
7816581|NCT01217073|12282584|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0
7816582|NCT01217073|12282585|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0
7816583|NCT01217073|12282586|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0
7883654|NCT01783548|12383430|FG000|Overall Study|Non-compliance|4
7883655|NCT01783548|12383431|FG001|Overall Study|Non-compliance|0
7883656|NCT01783548|12383430|FG000|Overall Study|Protocol Violation|2
7883657|NCT01783548|12383431|FG001|Overall Study|Protocol Violation|2
7883658|NCT01783548|12383430|FG000|Overall Study|Lost to Follow-up|8
7883659|NCT01783548|12383431|FG001|Overall Study|Lost to Follow-up|3
7883660|NCT01783548|12383430|FG000|Overall Study|Lack of Efficacy|1
7883661|NCT01783548|12383431|FG001|Overall Study|Lack of Efficacy|1
7883662|NCT01783678|12383465|FG000|Overall Study|Randomized but Not Treated|0
7816584|NCT01217073|12282587|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0
7816585|NCT01217073|12282588|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0
7816586|NCT01217073|12282589|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0
7816587|NCT01217073|12282590|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0
7816588|NCT01217073|12282583|FG000|Base Period|Excluded medication|0
7816589|NCT01217073|12282584|FG001|Base Period|Excluded medication|0
7816590|NCT01217073|12282585|FG002|Base Period|Excluded medication|0
7816591|NCT01217073|12282586|FG003|Base Period|Excluded medication|0
7816592|NCT01217073|12282587|FG004|Base Period|Excluded medication|1
7816593|NCT01217073|12282588|FG005|Base Period|Excluded medication|0
7816594|NCT01217073|12282589|FG006|Base Period|Excluded medication|0
7816595|NCT01217073|12282590|FG007|Base Period|Excluded medication|0
7816596|NCT01217073|12282583|FG000|Base Period|Lack of Efficacy|0
7816597|NCT01217073|12282584|FG001|Base Period|Lack of Efficacy|0
7816598|NCT01217073|12282585|FG002|Base Period|Lack of Efficacy|0
7816599|NCT01217073|12282586|FG003|Base Period|Lack of Efficacy|0
7816600|NCT01217073|12282587|FG004|Base Period|Lack of Efficacy|0
7816601|NCT01217073|12282588|FG005|Base Period|Lack of Efficacy|1
7816602|NCT01217073|12282589|FG006|Base Period|Lack of Efficacy|0
7816603|NCT01217073|12282590|FG007|Base Period|Lack of Efficacy|0
7816604|NCT01217073|12282583|FG000|Base Period|Lost to Follow-up|0
7816605|NCT01217073|12282584|FG001|Base Period|Lost to Follow-up|0
7816606|NCT01217073|12282585|FG002|Base Period|Lost to Follow-up|1
7816607|NCT01217073|12282586|FG003|Base Period|Lost to Follow-up|1
7816608|NCT01217073|12282587|FG004|Base Period|Lost to Follow-up|3
7816609|NCT01217073|12282588|FG005|Base Period|Lost to Follow-up|0
7816610|NCT01217073|12282589|FG006|Base Period|Lost to Follow-up|0
7816611|NCT01217073|12282590|FG007|Base Period|Lost to Follow-up|0
7816612|NCT01217073|12282583|FG000|Base Period|Physician Decision|0
7816613|NCT01217073|12282584|FG001|Base Period|Physician Decision|0
7816614|NCT01217073|12282585|FG002|Base Period|Physician Decision|0
7816615|NCT01217073|12282586|FG003|Base Period|Physician Decision|0
7816616|NCT01217073|12282587|FG004|Base Period|Physician Decision|1
7816617|NCT01217073|12282588|FG005|Base Period|Physician Decision|0
7816618|NCT01217073|12282589|FG006|Base Period|Physician Decision|0
7816619|NCT01217073|12282590|FG007|Base Period|Physician Decision|0
7816620|NCT01217073|12282583|FG000|Base Period|Protocol Violation|1
7816621|NCT01217073|12282584|FG001|Base Period|Protocol Violation|0
7816622|NCT01217073|12282585|FG002|Base Period|Protocol Violation|0
7816623|NCT01217073|12282586|FG003|Base Period|Protocol Violation|0
7816624|NCT01217073|12282587|FG004|Base Period|Protocol Violation|1
7816625|NCT01217073|12282588|FG005|Base Period|Protocol Violation|2
7816626|NCT01217073|12282589|FG006|Base Period|Protocol Violation|0
7816627|NCT01217073|12282590|FG007|Base Period|Protocol Violation|0
7816628|NCT01217073|12282583|FG000|Base Period|Withdrawal by Subject|4
7816629|NCT01217073|12282584|FG001|Base Period|Withdrawal by Subject|5
7816630|NCT01217073|12282585|FG002|Base Period|Withdrawal by Subject|5
7816631|NCT01217073|12282586|FG003|Base Period|Withdrawal by Subject|1
7816632|NCT01217073|12282587|FG004|Base Period|Withdrawal by Subject|5
7816633|NCT01217073|12282588|FG005|Base Period|Withdrawal by Subject|5
7816634|NCT01217073|12282589|FG006|Base Period|Withdrawal by Subject|0
7816635|NCT01217073|12282590|FG007|Base Period|Withdrawal by Subject|0
7816636|NCT01217073|12282583|FG000|Extension Period|Adverse Event|0
7816637|NCT01217073|12282584|FG001|Extension Period|Adverse Event|0
7816638|NCT01217073|12282585|FG002|Extension Period|Adverse Event|0
7816639|NCT01217073|12282586|FG003|Extension Period|Adverse Event|0
7816640|NCT01217073|12282587|FG004|Extension Period|Adverse Event|0
7816641|NCT01217073|12282588|FG005|Extension Period|Adverse Event|0
7816642|NCT01217073|12282589|FG006|Extension Period|Adverse Event|19
7816643|NCT01217073|12282590|FG007|Extension Period|Adverse Event|5
7816644|NCT01217073|12282583|FG000|Extension Period|ALT/AST|0
7816645|NCT01217073|12282584|FG001|Extension Period|ALT/AST|0
7816646|NCT01217073|12282585|FG002|Extension Period|ALT/AST|0
7816647|NCT01217073|12282586|FG003|Extension Period|ALT/AST|0
7816648|NCT01217073|12282587|FG004|Extension Period|ALT/AST|0
7816649|NCT01217073|12282588|FG005|Extension Period|ALT/AST|0
7816650|NCT01217073|12282589|FG006|Extension Period|ALT/AST|2
7816651|NCT01217073|12282590|FG007|Extension Period|ALT/AST|0
7816652|NCT01217073|12282583|FG000|Extension Period|Contraindication to study medication|0
7816653|NCT01217073|12282584|FG001|Extension Period|Contraindication to study medication|0
7816654|NCT01217073|12282585|FG002|Extension Period|Contraindication to study medication|0
7816655|NCT01217073|12282586|FG003|Extension Period|Contraindication to study medication|0
7816656|NCT01217073|12282587|FG004|Extension Period|Contraindication to study medication|0
7816657|NCT01217073|12282588|FG005|Extension Period|Contraindication to study medication|0
7816658|NCT01217073|12282589|FG006|Extension Period|Contraindication to study medication|1
7816659|NCT01217073|12282590|FG007|Extension Period|Contraindication to study medication|0
7816660|NCT01217073|12282583|FG000|Extension Period|Creatinine/eGFR|0
7816661|NCT01217073|12282584|FG001|Extension Period|Creatinine/eGFR|0
7816662|NCT01217073|12282585|FG002|Extension Period|Creatinine/eGFR|0
7816663|NCT01217073|12282586|FG003|Extension Period|Creatinine/eGFR|0
7816664|NCT01217073|12282587|FG004|Extension Period|Creatinine/eGFR|0
7816665|NCT01217073|12282588|FG005|Extension Period|Creatinine/eGFR|0
7816666|NCT01217073|12282589|FG006|Extension Period|Creatinine/eGFR|11
7816667|NCT01217073|12282590|FG007|Extension Period|Creatinine/eGFR|1
7816668|NCT01217073|12282583|FG000|Extension Period|Death|0
7816669|NCT01217073|12282584|FG001|Extension Period|Death|0
7816670|NCT01217073|12282585|FG002|Extension Period|Death|0
7816671|NCT01217073|12282586|FG003|Extension Period|Death|0
7816672|NCT01217073|12282587|FG004|Extension Period|Death|0
7816673|NCT01217073|12282588|FG005|Extension Period|Death|0
7816674|NCT01217073|12282589|FG006|Extension Period|Death|1
7816675|NCT01217073|12282590|FG007|Extension Period|Death|0
7816676|NCT01217073|12282583|FG000|Extension Period|Excluded medication|0
7816677|NCT01217073|12282584|FG001|Extension Period|Excluded medication|0
7816678|NCT01217073|12282585|FG002|Extension Period|Excluded medication|0
7816679|NCT01217073|12282586|FG003|Extension Period|Excluded medication|0
7816680|NCT01217073|12282587|FG004|Extension Period|Excluded medication|0
7816681|NCT01217073|12282588|FG005|Extension Period|Excluded medication|0
7816682|NCT01217073|12282589|FG006|Extension Period|Excluded medication|2
7816683|NCT01217073|12282590|FG007|Extension Period|Excluded medication|0
7816684|NCT01217073|12282583|FG000|Extension Period|Lack of Efficacy|0
7816685|NCT01217073|12282584|FG001|Extension Period|Lack of Efficacy|0
7816686|NCT01217073|12282585|FG002|Extension Period|Lack of Efficacy|0
7816687|NCT01217073|12282586|FG003|Extension Period|Lack of Efficacy|0
7816688|NCT01217073|12282587|FG004|Extension Period|Lack of Efficacy|0
7816689|NCT01217073|12282588|FG005|Extension Period|Lack of Efficacy|0
7816690|NCT01217073|12282589|FG006|Extension Period|Lack of Efficacy|3
7816691|NCT01217073|12282590|FG007|Extension Period|Lack of Efficacy|0
7816692|NCT01217073|12282583|FG000|Extension Period|Lost to Follow-up|0
7816693|NCT01217073|12282584|FG001|Extension Period|Lost to Follow-up|0
7816694|NCT01217073|12282585|FG002|Extension Period|Lost to Follow-up|0
7816695|NCT01217073|12282586|FG003|Extension Period|Lost to Follow-up|0
7816696|NCT01217073|12282587|FG004|Extension Period|Lost to Follow-up|0
7816697|NCT01217073|12282588|FG005|Extension Period|Lost to Follow-up|0
7816698|NCT01217073|12282589|FG006|Extension Period|Lost to Follow-up|9
7816699|NCT01217073|12282590|FG007|Extension Period|Lost to Follow-up|1
7883663|NCT01783678|12383466|FG001|Overall Study|Randomized but Not Treated|0
7883664|NCT01783678|12383467|FG002|Overall Study|Randomized but Not Treated|0
7883665|NCT01783678|12383468|FG003|Overall Study|Randomized but Not Treated|1
7883666|NCT01783678|12383469|FG004|Overall Study|Randomized but Not Treated|0
7883667|NCT01783678|12383470|FG005|Overall Study|Randomized but Not Treated|0
7883668|NCT01783678|12383465|FG000|Overall Study|Lack of Efficacy|1
7883669|NCT01783678|12383466|FG001|Overall Study|Lack of Efficacy|13
7883670|NCT01783678|12383467|FG002|Overall Study|Lack of Efficacy|1
7883671|NCT01783678|12383468|FG003|Overall Study|Lack of Efficacy|3
7883672|NCT01783678|12383469|FG004|Overall Study|Lack of Efficacy|6
7883673|NCT01783678|12383470|FG005|Overall Study|Lack of Efficacy|5
7883674|NCT01783678|12383465|FG000|Overall Study|Lost to Follow-up|0
7883675|NCT01783678|12383466|FG001|Overall Study|Lost to Follow-up|4
7883676|NCT01783678|12383467|FG002|Overall Study|Lost to Follow-up|0
7883677|NCT01783678|12383468|FG003|Overall Study|Lost to Follow-up|2
7883678|NCT01783678|12383469|FG004|Overall Study|Lost to Follow-up|1
7883679|NCT01783678|12383470|FG005|Overall Study|Lost to Follow-up|0
7883680|NCT01783678|12383465|FG000|Overall Study|Withdrew Consent|1
7883681|NCT01783678|12383466|FG001|Overall Study|Withdrew Consent|1
7883682|NCT01783678|12383467|FG002|Overall Study|Withdrew Consent|0
7883683|NCT01783678|12383468|FG003|Overall Study|Withdrew Consent|2
7883684|NCT01783678|12383469|FG004|Overall Study|Withdrew Consent|0
7883685|NCT01783678|12383470|FG005|Overall Study|Withdrew Consent|0
7883686|NCT01783730|12383485|FG000|Overall Study|Failed to meet inclusion criteria|6
7883687|NCT01783743|12383491|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427
7883688|NCT01783743|12383492|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439
7883689|NCT01783743|12383491|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
7883690|NCT01783743|12383492|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
7883691|NCT01783743|12383491|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
7883692|NCT01783743|12383492|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
7883693|NCT01783821|12383500|FG000|Overall Study|Screen Failure|1
7883694|NCT01783821|12383501|FG001|Overall Study|Screen Failure|1
7883695|NCT01783886|12383535|FG000|Overall Study|Lost to Follow-up|0
7883696|NCT01783886|12383536|FG001|Overall Study|Lost to Follow-up|3
7883697|NCT01783886|12383537|FG002|Overall Study|Lost to Follow-up|0
7883698|NCT01783886|12383535|FG000|Overall Study|Protocol deviation|0
7883699|NCT01783886|12383536|FG001|Overall Study|Protocol deviation|0
7883700|NCT01783886|12383537|FG002|Overall Study|Protocol deviation|2
7883701|NCT01783886|12383535|FG000|Overall Study|Withdrawal of consent by participant|1
7883702|NCT01783886|12383536|FG001|Overall Study|Withdrawal of consent by participant|3
7883703|NCT01783886|12383537|FG002|Overall Study|Withdrawal of consent by participant|4
7911096|NCT02059291|12428146|FG012|Epoch 3|Adverse Event|0
7911097|NCT02059291|12428147|FG013|Epoch 3|Adverse Event|0
7911098|NCT02059291|12428148|FG014|Epoch 3|Adverse Event|0
7911099|NCT02059291|12428149|FG015|Epoch 3|Adverse Event|1
7911100|NCT02059291|12428150|FG016|Epoch 3|Adverse Event|0
7911101|NCT02059291|12428151|FG017|Epoch 3|Adverse Event|0
7911102|NCT02059291|12428152|FG018|Epoch 3|Adverse Event|0
7911103|NCT02059291|12428153|FG019|Epoch 3|Adverse Event|0
7911104|NCT02059291|12428154|FG020|Epoch 3|Adverse Event|0
7911105|NCT02059291|12428155|FG021|Epoch 3|Adverse Event|0
7911106|NCT02059291|12428156|FG022|Epoch 3|Adverse Event|0
7911107|NCT02059291|12428157|FG023|Epoch 3|Adverse Event|0
7911108|NCT02059291|12428158|FG024|Epoch 3|Adverse Event|0
7911109|NCT02059291|12428134|FG000|Epoch 3|Lack of Efficacy|0
7911110|NCT02059291|12428135|FG001|Epoch 3|Lack of Efficacy|0
7911111|NCT02059291|12428136|FG002|Epoch 3|Lack of Efficacy|0
7911112|NCT02059291|12428137|FG003|Epoch 3|Lack of Efficacy|0
7911113|NCT02059291|12428138|FG004|Epoch 3|Lack of Efficacy|0
7911114|NCT02059291|12428139|FG005|Epoch 3|Lack of Efficacy|0
7719369|NCT00531934|12143367|FG001|Overall Study|Progression|42
7719370|NCT00531934|12143366|FG000|Overall Study|Death|7
7719371|NCT00531934|12143367|FG001|Overall Study|Death|10
7719372|NCT00531934|12143366|FG000|Overall Study|Withdrawal by Subject|1
7911115|NCT02059291|12428140|FG006|Epoch 3|Lack of Efficacy|0
7911116|NCT02059291|12428141|FG007|Epoch 3|Lack of Efficacy|0
7911117|NCT02059291|12428142|FG008|Epoch 3|Lack of Efficacy|0
7911118|NCT02059291|12428143|FG009|Epoch 3|Lack of Efficacy|0
7911119|NCT02059291|12428144|FG010|Epoch 3|Lack of Efficacy|0
7911120|NCT02059291|12428145|FG011|Epoch 3|Lack of Efficacy|0
7911121|NCT02059291|12428146|FG012|Epoch 3|Lack of Efficacy|0
7911122|NCT02059291|12428147|FG013|Epoch 3|Lack of Efficacy|0
7911123|NCT02059291|12428148|FG014|Epoch 3|Lack of Efficacy|0
7911124|NCT02059291|12428149|FG015|Epoch 3|Lack of Efficacy|3
7911125|NCT02059291|12428150|FG016|Epoch 3|Lack of Efficacy|0
7911126|NCT02059291|12428151|FG017|Epoch 3|Lack of Efficacy|0
7911127|NCT02059291|12428152|FG018|Epoch 3|Lack of Efficacy|0
7911128|NCT02059291|12428153|FG019|Epoch 3|Lack of Efficacy|0
7816700|NCT01217073|12282583|FG000|Extension Period|Non-compliance with study drug|0
7816701|NCT01217073|12282584|FG001|Extension Period|Non-compliance with study drug|0
7816702|NCT01217073|12282585|FG002|Extension Period|Non-compliance with study drug|0
7816703|NCT01217073|12282586|FG003|Extension Period|Non-compliance with study drug|0
7816704|NCT01217073|12282587|FG004|Extension Period|Non-compliance with study drug|0
7816705|NCT01217073|12282588|FG005|Extension Period|Non-compliance with study drug|0
7816706|NCT01217073|12282589|FG006|Extension Period|Non-compliance with study drug|0
7816707|NCT01217073|12282590|FG007|Extension Period|Non-compliance with study drug|1
7816708|NCT01217073|12282583|FG000|Extension Period|Physician Decision|0
7816709|NCT01217073|12282584|FG001|Extension Period|Physician Decision|0
7816710|NCT01217073|12282585|FG002|Extension Period|Physician Decision|0
7816711|NCT01217073|12282586|FG003|Extension Period|Physician Decision|0
7816712|NCT01217073|12282587|FG004|Extension Period|Physician Decision|0
7816713|NCT01217073|12282588|FG005|Extension Period|Physician Decision|0
7816714|NCT01217073|12282589|FG006|Extension Period|Physician Decision|4
7816715|NCT01217073|12282590|FG007|Extension Period|Physician Decision|1
7816716|NCT01217073|12282583|FG000|Extension Period|Protocol Violation|0
7816717|NCT01217073|12282584|FG001|Extension Period|Protocol Violation|0
7816718|NCT01217073|12282585|FG002|Extension Period|Protocol Violation|0
7816719|NCT01217073|12282586|FG003|Extension Period|Protocol Violation|0
7816720|NCT01217073|12282587|FG004|Extension Period|Protocol Violation|0
7816721|NCT01217073|12282588|FG005|Extension Period|Protocol Violation|0
7816722|NCT01217073|12282589|FG006|Extension Period|Protocol Violation|2
7816723|NCT01217073|12282590|FG007|Extension Period|Protocol Violation|1
7816724|NCT01217073|12282583|FG000|Extension Period|Site discontinued study participation|0
7816725|NCT01217073|12282584|FG001|Extension Period|Site discontinued study participation|0
7816726|NCT01217073|12282585|FG002|Extension Period|Site discontinued study participation|0
7816727|NCT01217073|12282586|FG003|Extension Period|Site discontinued study participation|0
7816728|NCT01217073|12282587|FG004|Extension Period|Site discontinued study participation|0
7816729|NCT01217073|12282588|FG005|Extension Period|Site discontinued study participation|0
7816730|NCT01217073|12282589|FG006|Extension Period|Site discontinued study participation|7
7816731|NCT01217073|12282590|FG007|Extension Period|Site discontinued study participation|2
7816732|NCT01217073|12282583|FG000|Extension Period|Withdrawal by Subject|0
7816733|NCT01217073|12282584|FG001|Extension Period|Withdrawal by Subject|0
7816734|NCT01217073|12282585|FG002|Extension Period|Withdrawal by Subject|0
7816735|NCT01217073|12282586|FG003|Extension Period|Withdrawal by Subject|0
7816736|NCT01217073|12282587|FG004|Extension Period|Withdrawal by Subject|0
7816737|NCT01217073|12282588|FG005|Extension Period|Withdrawal by Subject|0
7816738|NCT01217073|12282589|FG006|Extension Period|Withdrawal by Subject|30
7816739|NCT01217073|12282590|FG007|Extension Period|Withdrawal by Subject|8
7816740|NCT01217112|12282619|FG000|Overall Study|Adverse Event|0
7816741|NCT01217112|12282620|FG001|Overall Study|Adverse Event|2
7911129|NCT02059291|12428154|FG020|Epoch 3|Lack of Efficacy|0
7911130|NCT02059291|12428155|FG021|Epoch 3|Lack of Efficacy|0
7911131|NCT02059291|12428156|FG022|Epoch 3|Lack of Efficacy|0
7911132|NCT02059291|12428157|FG023|Epoch 3|Lack of Efficacy|0
7911133|NCT02059291|12428158|FG024|Epoch 3|Lack of Efficacy|0
7719373|NCT00531934|12143367|FG001|Overall Study|Withdrawal by Subject|1
7816742|NCT01217112|12282621|FG002|Overall Study|Adverse Event|0
7816743|NCT01217112|12282622|FG003|Overall Study|Adverse Event|2
7816744|NCT01217112|12282623|FG004|Overall Study|Adverse Event|0
7816745|NCT01217112|12282619|FG000|Overall Study|Withdrawal by Subject|0
7816746|NCT01217112|12282620|FG001|Overall Study|Withdrawal by Subject|0
7816747|NCT01217112|12282621|FG002|Overall Study|Withdrawal by Subject|1
7816748|NCT01217112|12282622|FG003|Overall Study|Withdrawal by Subject|0
7816749|NCT01217112|12282623|FG004|Overall Study|Withdrawal by Subject|0
7816750|NCT01217112|12282619|FG000|Overall Study|Physician Decision|0
7816751|NCT01217112|12282620|FG001|Overall Study|Physician Decision|0
7816752|NCT01217112|12282621|FG002|Overall Study|Physician Decision|0
7816753|NCT01217112|12282622|FG003|Overall Study|Physician Decision|0
7816754|NCT01217112|12282623|FG004|Overall Study|Physician Decision|1
7816755|NCT01217190|12282637|FG000|Second Dosing|Withdrawal by Subject|0
7816756|NCT01217190|12282638|FG001|Second Dosing|Withdrawal by Subject|2
7816757|NCT01217229|12282647|FG000|Overall Study|Adverse Event|1
7816758|NCT01217229|12282647|FG000|Overall Study|Disease progression, deterioration|2
7816759|NCT01217229|12282647|FG000|Overall Study|Disease progression, Cheson criteria|14
7816760|NCT01217229|12282647|FG000|Overall Study|Protocol Violation|1
7816761|NCT01217229|12282647|FG000|Overall Study|Disease progression not confirmed|2
7816762|NCT01217307|12282653|FG000|Overall Study|Withdrawal by Subject|0
7816763|NCT01217307|12282654|FG001|Overall Study|Withdrawal by Subject|1
7816764|NCT01217385|12282660|FG000|Overall Study|Withdrawal by Subject|3
7816765|NCT01217385|12282660|FG000|Overall Study|DOSI not performed/not eval|12
7816766|NCT01217385|12282660|FG000|Overall Study|Central Path not Available|1
7816767|NCT01217385|12282660|FG000|Overall Study|Normal Breast TOI not available|10
7816768|NCT01217437|12282683|FG000|Overall Study|Adverse Event|0
7816769|NCT01217437|12282684|FG001|Overall Study|Adverse Event|8
7816770|NCT01217437|12282683|FG000|Overall Study|Death|5
7816771|NCT01217437|12282684|FG001|Overall Study|Death|0
7816772|NCT01217437|12282683|FG000|Overall Study|Lack of Efficacy|29
7911134|NCT02059291|12428134|FG000|Epoch 3|Withdrawal by Subject|0
7816773|NCT01217437|12282684|FG001|Overall Study|Lack of Efficacy|25
7816774|NCT01217437|12282683|FG000|Overall Study|Physician Decision|8
7816775|NCT01217437|12282684|FG001|Overall Study|Physician Decision|5
7816776|NCT01217437|12282683|FG000|Overall Study|Withdrawal by Subject|0
7816777|NCT01217437|12282684|FG001|Overall Study|Withdrawal by Subject|2
7816778|NCT01217437|12282683|FG000|Overall Study|Ineligible|1
7816779|NCT01217437|12282684|FG001|Overall Study|Ineligible|1
7816780|NCT01217463|12282692|FG000|Overall Study|Adverse Event|8
7816781|NCT01217463|12282693|FG001|Overall Study|Adverse Event|5
7816782|NCT01217463|12282692|FG000|Overall Study|Physician Decision|0
7816783|NCT01217463|12282693|FG001|Overall Study|Physician Decision|1
7816784|NCT01217463|12282692|FG000|Overall Study|Withdrawal by Subject|3
7816785|NCT01217463|12282693|FG001|Overall Study|Withdrawal by Subject|0
7816786|NCT01217463|12282692|FG000|Overall Study|Surgery on the Target Limb|0
7911135|NCT02059291|12428135|FG001|Epoch 3|Withdrawal by Subject|0
7911136|NCT02059291|12428136|FG002|Epoch 3|Withdrawal by Subject|0
7911137|NCT02059291|12428137|FG003|Epoch 3|Withdrawal by Subject|0
7911138|NCT02059291|12428138|FG004|Epoch 3|Withdrawal by Subject|0
7911139|NCT02059291|12428139|FG005|Epoch 3|Withdrawal by Subject|0
7911140|NCT02059291|12428140|FG006|Epoch 3|Withdrawal by Subject|0
7911141|NCT02059291|12428141|FG007|Epoch 3|Withdrawal by Subject|0
7911142|NCT02059291|12428142|FG008|Epoch 3|Withdrawal by Subject|0
7911143|NCT02059291|12428143|FG009|Epoch 3|Withdrawal by Subject|0
7911144|NCT02059291|12428144|FG010|Epoch 3|Withdrawal by Subject|0
7911145|NCT02059291|12428145|FG011|Epoch 3|Withdrawal by Subject|0
7911146|NCT02059291|12428146|FG012|Epoch 3|Withdrawal by Subject|0
7911147|NCT02059291|12428147|FG013|Epoch 3|Withdrawal by Subject|0
7911148|NCT02059291|12428148|FG014|Epoch 3|Withdrawal by Subject|0
7911149|NCT02059291|12428149|FG015|Epoch 3|Withdrawal by Subject|1
7911150|NCT02059291|12428150|FG016|Epoch 3|Withdrawal by Subject|0
7911151|NCT02059291|12428151|FG017|Epoch 3|Withdrawal by Subject|0
7816787|NCT01217463|12282693|FG001|Overall Study|Surgery on the Target Limb|1
7816788|NCT01217463|12282692|FG000|Overall Study|Patient Non-compliant|1
7816789|NCT01217463|12282693|FG001|Overall Study|Patient Non-compliant|0
7816790|NCT01217463|12282692|FG000|Overall Study|Other|1
7816791|NCT01217463|12282693|FG001|Overall Study|Other|1
7816792|NCT01217476|12282703|FG000|Overall Study|Adverse Event|6
7816793|NCT01217476|12282704|FG001|Overall Study|Adverse Event|1
7816794|NCT01217476|12282703|FG000|Overall Study|Physician Decision|0
7816795|NCT01217476|12282704|FG001|Overall Study|Physician Decision|1
7816796|NCT01217476|12282703|FG000|Overall Study|Withdrawal by Subject|3
7816797|NCT01217476|12282704|FG001|Overall Study|Withdrawal by Subject|3
7911152|NCT02059291|12428152|FG018|Epoch 3|Withdrawal by Subject|0
7911153|NCT02059291|12428153|FG019|Epoch 3|Withdrawal by Subject|0
7911154|NCT02059291|12428154|FG020|Epoch 3|Withdrawal by Subject|0
7911155|NCT02059291|12428155|FG021|Epoch 3|Withdrawal by Subject|0
7911156|NCT02059291|12428156|FG022|Epoch 3|Withdrawal by Subject|0
7911157|NCT02059291|12428157|FG023|Epoch 3|Withdrawal by Subject|0
7911158|NCT02059291|12428158|FG024|Epoch 3|Withdrawal by Subject|0
7911159|NCT02059291|12428134|FG000|Epoch 4|Adverse Event|0
7911160|NCT02059291|12428135|FG001|Epoch 4|Adverse Event|0
7911161|NCT02059291|12428136|FG002|Epoch 4|Adverse Event|0
7911162|NCT02059291|12428137|FG003|Epoch 4|Adverse Event|0
7911163|NCT02059291|12428138|FG004|Epoch 4|Adverse Event|0
7911164|NCT02059291|12428139|FG005|Epoch 4|Adverse Event|0
7911165|NCT02059291|12428140|FG006|Epoch 4|Adverse Event|0
7911166|NCT02059291|12428141|FG007|Epoch 4|Adverse Event|0
7911167|NCT02059291|12428142|FG008|Epoch 4|Adverse Event|0
7911168|NCT02059291|12428143|FG009|Epoch 4|Adverse Event|0
7911169|NCT02059291|12428144|FG010|Epoch 4|Adverse Event|0
7911170|NCT02059291|12428145|FG011|Epoch 4|Adverse Event|0
7911171|NCT02059291|12428146|FG012|Epoch 4|Adverse Event|0
7816798|NCT01217476|12282703|FG000|Overall Study|Surgery on the Target Limb|0
7816799|NCT01217476|12282704|FG001|Overall Study|Surgery on the Target Limb|2
7816800|NCT01217476|12282703|FG000|Overall Study|Protocol Deviation|1
7816801|NCT01217476|12282704|FG001|Overall Study|Protocol Deviation|0
7816802|NCT01217476|12282703|FG000|Overall Study|Other|2
7816803|NCT01217476|12282704|FG001|Overall Study|Other|0
7816804|NCT01217606|12282725|FG000|Initial Treatment Phase|Other Reasons|0
7816805|NCT01217606|12282726|FG001|Initial Treatment Phase|Other Reasons|2
7816806|NCT01217606|12282725|FG000|Initial Treatment Phase|Protocol Violation|3
7816807|NCT01217606|12282726|FG001|Initial Treatment Phase|Protocol Violation|2
7816808|NCT01217606|12282725|FG000|Initial Treatment Phase|Personal Reasons|0
7816809|NCT01217606|12282726|FG001|Initial Treatment Phase|Personal Reasons|2
7816810|NCT01217606|12282725|FG000|Initial Treatment Phase|Lack of Efficacy|1
7816811|NCT01217606|12282726|FG001|Initial Treatment Phase|Lack of Efficacy|0
7816812|NCT01217606|12282725|FG000|Initial Treatment Phase|Adverse Event|10
7911172|NCT02059291|12428147|FG013|Epoch 4|Adverse Event|0
7911173|NCT02059291|12428148|FG014|Epoch 4|Adverse Event|0
7911174|NCT02059291|12428149|FG015|Epoch 4|Adverse Event|0
7911175|NCT02059291|12428150|FG016|Epoch 4|Adverse Event|1
7911176|NCT02059291|12428151|FG017|Epoch 4|Adverse Event|0
7911177|NCT02059291|12428152|FG018|Epoch 4|Adverse Event|0
7911178|NCT02059291|12428153|FG019|Epoch 4|Adverse Event|0
7911179|NCT02059291|12428154|FG020|Epoch 4|Adverse Event|0
7911180|NCT02059291|12428155|FG021|Epoch 4|Adverse Event|0
7911181|NCT02059291|12428156|FG022|Epoch 4|Adverse Event|1
7911182|NCT02059291|12428157|FG023|Epoch 4|Adverse Event|0
7911183|NCT02059291|12428158|FG024|Epoch 4|Adverse Event|0
7911184|NCT02059291|12428134|FG000|Epoch 4|Pregnancy|0
7911185|NCT02059291|12428135|FG001|Epoch 4|Pregnancy|0
7911186|NCT02059291|12428136|FG002|Epoch 4|Pregnancy|0
7911187|NCT02059291|12428137|FG003|Epoch 4|Pregnancy|0
7911188|NCT02059291|12428138|FG004|Epoch 4|Pregnancy|0
7911189|NCT02059291|12428139|FG005|Epoch 4|Pregnancy|0
7911190|NCT02059291|12428140|FG006|Epoch 4|Pregnancy|0
7911191|NCT02059291|12428141|FG007|Epoch 4|Pregnancy|0
7911192|NCT02059291|12428142|FG008|Epoch 4|Pregnancy|0
7911193|NCT02059291|12428143|FG009|Epoch 4|Pregnancy|0
7911194|NCT02059291|12428144|FG010|Epoch 4|Pregnancy|0
7911195|NCT02059291|12428145|FG011|Epoch 4|Pregnancy|0
7911196|NCT02059291|12428146|FG012|Epoch 4|Pregnancy|0
7911197|NCT02059291|12428147|FG013|Epoch 4|Pregnancy|0
7911198|NCT02059291|12428148|FG014|Epoch 4|Pregnancy|0
7911199|NCT02059291|12428149|FG015|Epoch 4|Pregnancy|0
7911200|NCT02059291|12428150|FG016|Epoch 4|Pregnancy|1
7911201|NCT02059291|12428151|FG017|Epoch 4|Pregnancy|0
7911202|NCT02059291|12428152|FG018|Epoch 4|Pregnancy|0
7911203|NCT02059291|12428153|FG019|Epoch 4|Pregnancy|0
7911204|NCT02059291|12428154|FG020|Epoch 4|Pregnancy|0
7911205|NCT02059291|12428155|FG021|Epoch 4|Pregnancy|0
7911206|NCT02059291|12428156|FG022|Epoch 4|Pregnancy|0
7911207|NCT02059291|12428157|FG023|Epoch 4|Pregnancy|0
7911208|NCT02059291|12428158|FG024|Epoch 4|Pregnancy|0
7911209|NCT02059291|12428134|FG000|Epoch 4|Withdrawal by Subject|0
7911210|NCT02059291|12428135|FG001|Epoch 4|Withdrawal by Subject|0
7911211|NCT02059291|12428136|FG002|Epoch 4|Withdrawal by Subject|0
7911212|NCT02059291|12428137|FG003|Epoch 4|Withdrawal by Subject|0
7911213|NCT02059291|12428138|FG004|Epoch 4|Withdrawal by Subject|0
7911214|NCT02059291|12428139|FG005|Epoch 4|Withdrawal by Subject|0
7911215|NCT02059291|12428140|FG006|Epoch 4|Withdrawal by Subject|0
7911216|NCT02059291|12428141|FG007|Epoch 4|Withdrawal by Subject|0
7911217|NCT02059291|12428142|FG008|Epoch 4|Withdrawal by Subject|0
7911218|NCT02059291|12428143|FG009|Epoch 4|Withdrawal by Subject|0
7911219|NCT02059291|12428144|FG010|Epoch 4|Withdrawal by Subject|0
7911220|NCT02059291|12428145|FG011|Epoch 4|Withdrawal by Subject|0
7911221|NCT02059291|12428146|FG012|Epoch 4|Withdrawal by Subject|0
7911222|NCT02059291|12428147|FG013|Epoch 4|Withdrawal by Subject|0
7911223|NCT02059291|12428148|FG014|Epoch 4|Withdrawal by Subject|0
7911224|NCT02059291|12428149|FG015|Epoch 4|Withdrawal by Subject|0
7911225|NCT02059291|12428150|FG016|Epoch 4|Withdrawal by Subject|0
7911226|NCT02059291|12428151|FG017|Epoch 4|Withdrawal by Subject|0
7911227|NCT02059291|12428152|FG018|Epoch 4|Withdrawal by Subject|0
7911228|NCT02059291|12428153|FG019|Epoch 4|Withdrawal by Subject|0
7911229|NCT02059291|12428154|FG020|Epoch 4|Withdrawal by Subject|1
7911230|NCT02059291|12428155|FG021|Epoch 4|Withdrawal by Subject|0
7911231|NCT02059291|12428156|FG022|Epoch 4|Withdrawal by Subject|0
7911232|NCT02059291|12428157|FG023|Epoch 4|Withdrawal by Subject|0
7911233|NCT02059291|12428158|FG024|Epoch 4|Withdrawal by Subject|0
7911234|NCT02059291|12428134|FG000|Epoch 4|Lack of Efficacy|0
7911235|NCT02059291|12428135|FG001|Epoch 4|Lack of Efficacy|0
7911236|NCT02059291|12428136|FG002|Epoch 4|Lack of Efficacy|0
7911237|NCT02059291|12428137|FG003|Epoch 4|Lack of Efficacy|0
7911238|NCT02059291|12428138|FG004|Epoch 4|Lack of Efficacy|0
7911239|NCT02059291|12428139|FG005|Epoch 4|Lack of Efficacy|0
7911240|NCT02059291|12428140|FG006|Epoch 4|Lack of Efficacy|0
7816813|NCT01217606|12282726|FG001|Initial Treatment Phase|Adverse Event|6
7816814|NCT01217606|12282725|FG000|9-Month Masked Extension|Adverse Event|3
7816815|NCT01217606|12282726|FG001|9-Month Masked Extension|Adverse Event|6
7816816|NCT01217606|12282725|FG000|9-Month Masked Extension|Other Reasons|4
7816817|NCT01217606|12282726|FG001|9-Month Masked Extension|Other Reasons|4
7816818|NCT01217606|12282725|FG000|9-Month Masked Extension|Personal Reasons|2
7816819|NCT01217606|12282726|FG001|9-Month Masked Extension|Personal Reasons|1
7816820|NCT01217606|12282725|FG000|9-Month Masked Extension|Lost to Follow-up|1
7816821|NCT01217606|12282726|FG001|9-Month Masked Extension|Lost to Follow-up|0
7816822|NCT01217606|12282725|FG000|9-Month Masked Extension|Pregnancy|1
7816823|NCT01217606|12282726|FG001|9-Month Masked Extension|Pregnancy|0
7816824|NCT01217606|12282725|FG000|9-Month Masked Extension|Lack of Efficacy|2
7816825|NCT01217606|12282726|FG001|9-Month Masked Extension|Lack of Efficacy|0
7816826|NCT01217801|12282749|FG000|Period 1|Protocol Violation|1
7816827|NCT01217801|12282750|FG001|Period 1|Protocol Violation|1
7816828|NCT01217801|12282749|FG000|Period 1|Withdrawal by Subject|0
7816829|NCT01217801|12282750|FG001|Period 1|Withdrawal by Subject|1
7816830|NCT01217814|12282759|FG000|Overall Study|Adverse Event|1
7816831|NCT01217814|12282760|FG001|Overall Study|Adverse Event|1
7816832|NCT01217814|12282761|FG002|Overall Study|Adverse Event|0
7816833|NCT01217814|12282759|FG000|Overall Study|Lack of Efficacy|0
7816834|NCT01217814|12282760|FG001|Overall Study|Lack of Efficacy|0
7816835|NCT01217814|12282761|FG002|Overall Study|Lack of Efficacy|1
7816836|NCT01217892|12282793|FG000|Overall Study|Adverse Event|1
7816837|NCT01217892|12282794|FG001|Overall Study|Adverse Event|1
7816838|NCT01217892|12282795|FG002|Overall Study|Adverse Event|1
7816839|NCT01217892|12282796|FG003|Overall Study|Adverse Event|0
7816840|NCT01217892|12282793|FG000|Overall Study|Withdrawal by Subject|0
7816841|NCT01217892|12282794|FG001|Overall Study|Withdrawal by Subject|2
7816842|NCT01217892|12282795|FG002|Overall Study|Withdrawal by Subject|1
7816843|NCT01217892|12282796|FG003|Overall Study|Withdrawal by Subject|0
7816844|NCT01217892|12282793|FG000|Overall Study|Lab value|1
7816845|NCT01217892|12282794|FG001|Overall Study|Lab value|0
7816846|NCT01217892|12282795|FG002|Overall Study|Lab value|1
7816847|NCT01217892|12282796|FG003|Overall Study|Lab value|0
7816848|NCT01217892|12282793|FG000|Overall Study|Subject no longer meets study criteria|5
7816849|NCT01217892|12282794|FG001|Overall Study|Subject no longer meets study criteria|2
7816850|NCT01217892|12282795|FG002|Overall Study|Subject no longer meets study criteria|4
7816851|NCT01217892|12282796|FG003|Overall Study|Subject no longer meets study criteria|8
7816852|NCT01217892|12282793|FG000|Overall Study|Incorrect enrollment|0
7816853|NCT01217892|12282794|FG001|Overall Study|Incorrect enrollment|1
7816854|NCT01217892|12282795|FG002|Overall Study|Incorrect enrollment|1
7816855|NCT01217892|12282796|FG003|Overall Study|Incorrect enrollment|0
7816856|NCT01217892|12282793|FG000|Overall Study|Poor/Non-Compliance|0
7816857|NCT01217892|12282794|FG001|Overall Study|Poor/Non-Compliance|0
7816858|NCT01217892|12282795|FG002|Overall Study|Poor/Non-Compliance|1
7816859|NCT01217892|12282796|FG003|Overall Study|Poor/Non-Compliance|0
7816860|NCT01217944|12282809|FG000|Overall Study|Protocol Violation|1
7816861|NCT01217944|12282810|FG001|Overall Study|Protocol Violation|1
7816862|NCT01217944|12282811|FG002|Overall Study|Protocol Violation|0
7816863|NCT01217944|12282809|FG000|Overall Study|Lost to Follow-up|3
7816864|NCT01217944|12282810|FG001|Overall Study|Lost to Follow-up|1
7816865|NCT01217944|12282811|FG002|Overall Study|Lost to Follow-up|0
7816866|NCT01217944|12282809|FG000|Overall Study|Withdrawal by Subject|1
7816867|NCT01217944|12282810|FG001|Overall Study|Withdrawal by Subject|2
7816868|NCT01217944|12282811|FG002|Overall Study|Withdrawal by Subject|0
7816869|NCT01217944|12282809|FG000|Overall Study|Lack of Efficacy|1
7816870|NCT01217944|12282810|FG001|Overall Study|Lack of Efficacy|0
7911241|NCT02059291|12428141|FG007|Epoch 4|Lack of Efficacy|0
7911242|NCT02059291|12428142|FG008|Epoch 4|Lack of Efficacy|0
7816871|NCT01217944|12282811|FG002|Overall Study|Lack of Efficacy|0
7816872|NCT01217957|12282826|FG000|Phase 1|Withdrawal by Patient|1
7816873|NCT01217957|12282827|FG001|Phase 1|Withdrawal by Patient|0
7816874|NCT01217957|12282828|FG002|Phase 1|Withdrawal by Patient|1
7816875|NCT01217957|12282829|FG003|Phase 1|Withdrawal by Patient|1
7816876|NCT01217957|12282830|FG004|Phase 1|Withdrawal by Patient|0
7816877|NCT01217957|12282826|FG000|Phase 2|Withdrawal by Patient|0
7816878|NCT01217957|12282827|FG001|Phase 2|Withdrawal by Patient|0
7816879|NCT01217957|12282828|FG002|Phase 2|Withdrawal by Patient|0
7816880|NCT01217957|12282829|FG003|Phase 2|Withdrawal by Patient|0
7816881|NCT01217957|12282830|FG004|Phase 2|Withdrawal by Patient|1
7816882|NCT01218009|12282853|FG000|Overall Study|Protocol Violation|2
7816883|NCT01218009|12282854|FG001|Overall Study|Protocol Violation|1
7816884|NCT01218009|12282853|FG000|Overall Study|Withdrawal by Subject|3
7816885|NCT01218009|12282854|FG001|Overall Study|Withdrawal by Subject|1
7816886|NCT01218009|12282853|FG000|Overall Study|Sponsor terminated study|161
7816887|NCT01218009|12282854|FG001|Overall Study|Sponsor terminated study|163
7816888|NCT01218087|12282867|FG000|Overall Study|Death|2
7911243|NCT02059291|12428143|FG009|Epoch 4|Lack of Efficacy|0
7911244|NCT02059291|12428144|FG010|Epoch 4|Lack of Efficacy|0
7911245|NCT02059291|12428145|FG011|Epoch 4|Lack of Efficacy|0
7911246|NCT02059291|12428146|FG012|Epoch 4|Lack of Efficacy|0
7911247|NCT02059291|12428147|FG013|Epoch 4|Lack of Efficacy|0
7911248|NCT02059291|12428148|FG014|Epoch 4|Lack of Efficacy|0
7911249|NCT02059291|12428149|FG015|Epoch 4|Lack of Efficacy|0
7911250|NCT02059291|12428150|FG016|Epoch 4|Lack of Efficacy|0
7911251|NCT02059291|12428151|FG017|Epoch 4|Lack of Efficacy|0
7911252|NCT02059291|12428152|FG018|Epoch 4|Lack of Efficacy|0
7911253|NCT02059291|12428153|FG019|Epoch 4|Lack of Efficacy|0
7911254|NCT02059291|12428154|FG020|Epoch 4|Lack of Efficacy|0
7911255|NCT02059291|12428155|FG021|Epoch 4|Lack of Efficacy|0
7911256|NCT02059291|12428156|FG022|Epoch 4|Lack of Efficacy|0
7911257|NCT02059291|12428157|FG023|Epoch 4|Lack of Efficacy|1
7911258|NCT02059291|12428158|FG024|Epoch 4|Lack of Efficacy|0
7911259|NCT02059395|12428188|FG000|Overall Study|Lost to Follow-up|2
7816889|NCT01218087|12282868|FG001|Overall Study|Death|1
7816890|NCT01218087|12282867|FG000|Overall Study|Withdrawal by Subject|5
7816891|NCT01218087|12282868|FG001|Overall Study|Withdrawal by Subject|0
7911260|NCT02059395|12428189|FG001|Overall Study|Lost to Follow-up|4
7911261|NCT02059408|12428198|FG000|Overall Study|Did not get tested|0
7911262|NCT02059408|12428199|FG001|Overall Study|Did not get tested|330
7911263|NCT02059408|12428200|FG002|Overall Study|Did not get tested|358
7911264|NCT02059434|12428219|FG000|Washout Between Periods 1 and 2|Physician Decision|0
7911265|NCT02059434|12428220|FG001|Washout Between Periods 1 and 2|Physician Decision|0
7911266|NCT02059434|12428221|FG002|Washout Between Periods 1 and 2|Physician Decision|0
7911267|NCT02059434|12428222|FG003|Washout Between Periods 1 and 2|Physician Decision|0
7911268|NCT02059434|12428223|FG004|Washout Between Periods 1 and 2|Physician Decision|0
7911269|NCT02059434|12428224|FG005|Washout Between Periods 1 and 2|Physician Decision|0
7911270|NCT02059434|12428225|FG006|Washout Between Periods 1 and 2|Physician Decision|0
7911271|NCT02059434|12428226|FG007|Washout Between Periods 1 and 2|Physician Decision|1
7911272|NCT02059434|12428227|FG008|Washout Between Periods 1 and 2|Physician Decision|0
7911273|NCT02059434|12428219|FG000|Washout Between Periods 4 and 5|Adverse Event|0
7911274|NCT02059434|12428220|FG001|Washout Between Periods 4 and 5|Adverse Event|0
7911275|NCT02059434|12428221|FG002|Washout Between Periods 4 and 5|Adverse Event|0
7911276|NCT02059434|12428222|FG003|Washout Between Periods 4 and 5|Adverse Event|0
7911277|NCT02059434|12428223|FG004|Washout Between Periods 4 and 5|Adverse Event|0
7911278|NCT02059434|12428224|FG005|Washout Between Periods 4 and 5|Adverse Event|0
7911279|NCT02059434|12428225|FG006|Washout Between Periods 4 and 5|Adverse Event|0
7911280|NCT02059434|12428226|FG007|Washout Between Periods 4 and 5|Adverse Event|0
7911281|NCT02059434|12428227|FG008|Washout Between Periods 4 and 5|Adverse Event|1
7911282|NCT02059434|12428219|FG000|Washout Between Periods 6 and 7|Physician Decision|0
7911283|NCT02059434|12428220|FG001|Washout Between Periods 6 and 7|Physician Decision|0
7911284|NCT02059434|12428221|FG002|Washout Between Periods 6 and 7|Physician Decision|0
7911285|NCT02059434|12428222|FG003|Washout Between Periods 6 and 7|Physician Decision|0
7911286|NCT02059434|12428223|FG004|Washout Between Periods 6 and 7|Physician Decision|0
7911287|NCT02059434|12428224|FG005|Washout Between Periods 6 and 7|Physician Decision|0
7911288|NCT02059434|12428225|FG006|Washout Between Periods 6 and 7|Physician Decision|0
7911289|NCT02059434|12428226|FG007|Washout Between Periods 6 and 7|Physician Decision|0
7911290|NCT02059434|12428227|FG008|Washout Between Periods 6 and 7|Physician Decision|1
7911291|NCT02059434|12428219|FG000|Washout Between Periods 7 and 8|Adverse Event|0
7911292|NCT02059434|12428220|FG001|Washout Between Periods 7 and 8|Adverse Event|0
7911293|NCT02059434|12428221|FG002|Washout Between Periods 7 and 8|Adverse Event|0
7911294|NCT02059434|12428222|FG003|Washout Between Periods 7 and 8|Adverse Event|0
7911295|NCT02059434|12428223|FG004|Washout Between Periods 7 and 8|Adverse Event|0
7911296|NCT02059434|12428224|FG005|Washout Between Periods 7 and 8|Adverse Event|0
7911297|NCT02059434|12428225|FG006|Washout Between Periods 7 and 8|Adverse Event|0
7911298|NCT02059434|12428226|FG007|Washout Between Periods 7 and 8|Adverse Event|0
7816892|NCT01218087|12282867|FG000|Overall Study|Transferred|8
7911299|NCT02059434|12428227|FG008|Washout Between Periods 7 and 8|Adverse Event|1
7911300|NCT02059434|12428219|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7911301|NCT02059434|12428220|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7911302|NCT02059434|12428221|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7911303|NCT02059434|12428222|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7911304|NCT02059434|12428223|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7911305|NCT02059434|12428224|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7911306|NCT02059434|12428225|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7911307|NCT02059434|12428226|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7911308|NCT02059434|12428227|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1
7964092|NCT02734862|12519145|FG001|Part B|Other|1
7964093|NCT02734862|12519146|FG002|Part B|Other|0
7964094|NCT02735096|12519171|FG000|Overall Study|No symptoms in clinic/personal leave|1
7964095|NCT02735200|12519196|FG000|Overall Study|Lost to Follow-up|0
7964096|NCT02735200|12519197|FG001|Overall Study|Lost to Follow-up|5
7964097|NCT02735200|12519196|FG000|Overall Study|Withdrawal by Subject|8
7964098|NCT02735200|12519197|FG001|Overall Study|Withdrawal by Subject|0
7964099|NCT02735577|12519233|FG000|Disulfiram Treatment|Lost to Follow-up|1
7964100|NCT02735577|12519233|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2
7964101|NCT02735915|12519250|FG000|Overall Study|Not vaccinated but subject ID assigned|8
7964102|NCT02735915|12519250|FG000|Overall Study|Withdrawal following SAE|2
7964103|NCT02735915|12519250|FG000|Overall Study|Withdrawal by Subject|1
7964104|NCT02735980|12519259|FG000|Overall Study|Adverse Event|0
7964105|NCT02735980|12519260|FG001|Overall Study|Adverse Event|4
7816893|NCT01218087|12282868|FG001|Overall Study|Transferred|5
7816894|NCT01218100|12282878|FG000|Overall Study|Did not meet InclusionExclusion criteria|1
7816895|NCT01218100|12282879|FG001|Overall Study|Did not meet InclusionExclusion criteria|1
7816896|NCT01218100|12282880|FG002|Overall Study|Did not meet InclusionExclusion criteria|1
7816897|NCT01218100|12282881|FG003|Overall Study|Did not meet InclusionExclusion criteria|2
7816898|NCT01218100|12282878|FG000|Overall Study|Adverse Event|4
7816899|NCT01218100|12282879|FG001|Overall Study|Adverse Event|6
7816900|NCT01218100|12282880|FG002|Overall Study|Adverse Event|6
7816901|NCT01218100|12282881|FG003|Overall Study|Adverse Event|7
7816902|NCT01218100|12282878|FG000|Overall Study|Lack of Efficacy|9
7964106|NCT02735980|12519261|FG002|Overall Study|Adverse Event|1
7964107|NCT02735980|12519259|FG000|Overall Study|Death|5
7816903|NCT01218100|12282879|FG001|Overall Study|Lack of Efficacy|6
7816904|NCT01218100|12282880|FG002|Overall Study|Lack of Efficacy|5
7816905|NCT01218100|12282881|FG003|Overall Study|Lack of Efficacy|12
7816906|NCT01218100|12282878|FG000|Overall Study|Protocol Violation|0
7816907|NCT01218100|12282879|FG001|Overall Study|Protocol Violation|0
7816908|NCT01218100|12282880|FG002|Overall Study|Protocol Violation|1
7816909|NCT01218100|12282881|FG003|Overall Study|Protocol Violation|1
7816910|NCT01218100|12282878|FG000|Overall Study|Withdrawal by Subject|5
7816911|NCT01218100|12282879|FG001|Overall Study|Withdrawal by Subject|2
7816912|NCT01218100|12282880|FG002|Overall Study|Withdrawal by Subject|6
7816913|NCT01218100|12282881|FG003|Overall Study|Withdrawal by Subject|7
7964108|NCT02735980|12519260|FG001|Overall Study|Death|4
7964109|NCT02735980|12519261|FG002|Overall Study|Death|0
7964110|NCT02735980|12519259|FG000|Overall Study|Physician Decision|3
7964111|NCT02735980|12519260|FG001|Overall Study|Physician Decision|1
7964112|NCT02735980|12519261|FG002|Overall Study|Physician Decision|0
7964113|NCT02735980|12519259|FG000|Overall Study|Screen failure|1
7964114|NCT02735980|12519260|FG001|Overall Study|Screen failure|0
7964115|NCT02735980|12519261|FG002|Overall Study|Screen failure|0
7964116|NCT02735980|12519259|FG000|Overall Study|Withdrawal by Subject|1
7964117|NCT02735980|12519260|FG001|Overall Study|Withdrawal by Subject|2
7964118|NCT02735980|12519261|FG002|Overall Study|Withdrawal by Subject|0
7964119|NCT02736188|12519283|FG000|Overall Study|Discontinuation of Study by Sponsor|134
7964120|NCT02736188|12519283|FG000|Overall Study|Adverse Event|1
7964121|NCT02736188|12519283|FG000|Overall Study|Withdrawal by Subject|1
7964122|NCT02736188|12519283|FG000|Overall Study|Other|6
7964123|NCT02736409|12519293|FG000|Overall Study|Withdrawal by Subject|4
7964124|NCT02736409|12519294|FG001|Overall Study|Withdrawal by Subject|2
7964125|NCT02736409|12519295|FG002|Overall Study|Withdrawal by Subject|17
7964126|NCT02736409|12519296|FG003|Overall Study|Withdrawal by Subject|3
7964127|NCT02736409|12519293|FG000|Overall Study|Non-Compliance with Study Drug|0
7964128|NCT02736409|12519294|FG001|Overall Study|Non-Compliance with Study Drug|0
7964129|NCT02736409|12519295|FG002|Overall Study|Non-Compliance with Study Drug|0
7964130|NCT02736409|12519296|FG003|Overall Study|Non-Compliance with Study Drug|1
7964131|NCT02736409|12519293|FG000|Overall Study|Adverse Event|0
7964132|NCT02736409|12519294|FG001|Overall Study|Adverse Event|1
7964133|NCT02736409|12519295|FG002|Overall Study|Adverse Event|5
7964134|NCT02736409|12519296|FG003|Overall Study|Adverse Event|4
7964135|NCT02736409|12519293|FG000|Overall Study|Other|0
7964136|NCT02736409|12519294|FG001|Overall Study|Other|0
7964137|NCT02736409|12519295|FG002|Overall Study|Other|1
7964138|NCT02736409|12519296|FG003|Overall Study|Other|1
7964139|NCT02736409|12519293|FG000|Overall Study|Pregnancy|0
7964140|NCT02736409|12519294|FG001|Overall Study|Pregnancy|0
7964141|NCT02736409|12519295|FG002|Overall Study|Pregnancy|1
7964142|NCT02736409|12519296|FG003|Overall Study|Pregnancy|0
7964143|NCT02736409|12519293|FG000|Overall Study|Lost to Follow-up|0
7911309|NCT02059980|12428308|FG000|Overall Study|Lost to Follow-up|2
7911310|NCT02059980|12428309|FG001|Overall Study|Lost to Follow-up|1
7911311|NCT02060370|12428338|FG000|Overall Study|Physician Decision|1
7911312|NCT02060383|12428347|FG000|Core Phase|Unsatisfactory therapeutic effect|1
7911313|NCT02060383|12428348|FG001|Core Phase|Unsatisfactory therapeutic effect|5
7911314|NCT02060383|12428349|FG002|Core Phase|Unsatisfactory therapeutic effect|0
7911315|NCT02060383|12428350|FG003|Core Phase|Unsatisfactory therapeutic effect|0
7911316|NCT02060383|12428351|FG004|Core Phase|Unsatisfactory therapeutic effect|0
7911317|NCT02060383|12428347|FG000|Core Phase|Adverse Event|2
7911318|NCT02060383|12428348|FG001|Core Phase|Adverse Event|0
7911319|NCT02060383|12428349|FG002|Core Phase|Adverse Event|0
7911320|NCT02060383|12428350|FG003|Core Phase|Adverse Event|2
7911321|NCT02060383|12428351|FG004|Core Phase|Adverse Event|6
7911322|NCT02060383|12428347|FG000|Core Phase|Administrative problems|0
7911323|NCT02060383|12428348|FG001|Core Phase|Administrative problems|1
7911324|NCT02060383|12428349|FG002|Core Phase|Administrative problems|0
7911325|NCT02060383|12428350|FG003|Core Phase|Administrative problems|0
7816914|NCT01218100|12282878|FG000|Overall Study|Lost to Follow-up|3
7816915|NCT01218100|12282879|FG001|Overall Study|Lost to Follow-up|8
7816916|NCT01218100|12282880|FG002|Overall Study|Lost to Follow-up|2
7816917|NCT01218100|12282881|FG003|Overall Study|Lost to Follow-up|1
7911326|NCT02060383|12428351|FG004|Core Phase|Administrative problems|0
7911327|NCT02060383|12428347|FG000|Core Phase|Protocol Violation|0
7911328|NCT02060383|12428348|FG001|Core Phase|Protocol Violation|0
7911329|NCT02060383|12428349|FG002|Core Phase|Protocol Violation|0
7911330|NCT02060383|12428350|FG003|Core Phase|Protocol Violation|1
7911331|NCT02060383|12428351|FG004|Core Phase|Protocol Violation|0
7911332|NCT02060383|12428347|FG000|Core Phase|Withdrawal by Subject|0
7911333|NCT02060383|12428348|FG001|Core Phase|Withdrawal by Subject|0
7911334|NCT02060383|12428349|FG002|Core Phase|Withdrawal by Subject|0
7911335|NCT02060383|12428350|FG003|Core Phase|Withdrawal by Subject|4
7911336|NCT02060383|12428351|FG004|Core Phase|Withdrawal by Subject|2
7911337|NCT02060383|12428347|FG000|Extension Phase|Unsatisfactory therapeutic effect|1
7911338|NCT02060383|12428348|FG001|Extension Phase|Unsatisfactory therapeutic effect|1
7911339|NCT02060383|12428349|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
7816918|NCT01218100|12282878|FG000|Overall Study|Other Reason|2
7816919|NCT01218100|12282879|FG001|Overall Study|Other Reason|2
7816920|NCT01218100|12282880|FG002|Overall Study|Other Reason|6
7816921|NCT01218100|12282881|FG003|Overall Study|Other Reason|4
7816922|NCT01218113|12282894|FG000|Overall Study|Withdrawal by Subject|1
7816923|NCT01218113|12282895|FG001|Overall Study|Withdrawal by Subject|0
7816924|NCT01218113|12282896|FG002|Overall Study|Withdrawal by Subject|1
7816925|NCT01218113|12282894|FG000|Overall Study|Lost to Follow-up|4
7816926|NCT01218113|12282895|FG001|Overall Study|Lost to Follow-up|1
7816927|NCT01218113|12282896|FG002|Overall Study|Lost to Follow-up|4
7816928|NCT01218113|12282894|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0
7816929|NCT01218113|12282895|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0
7816930|NCT01218113|12282896|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1
7816931|NCT01218126|12282915|FG000|Overall Study|Adverse Event|8
7816932|NCT01218126|12282916|FG001|Overall Study|Adverse Event|10
7816933|NCT01218126|12282917|FG002|Overall Study|Adverse Event|12
7816934|NCT01218126|12282918|FG003|Overall Study|Adverse Event|16
7816935|NCT01218126|12282915|FG000|Overall Study|Lack of Efficacy|7
7816936|NCT01218126|12282916|FG001|Overall Study|Lack of Efficacy|2
7816937|NCT01218126|12282917|FG002|Overall Study|Lack of Efficacy|2
7816938|NCT01218126|12282918|FG003|Overall Study|Lack of Efficacy|6
7816939|NCT01218126|12282915|FG000|Overall Study|Protocol Violation|5
7816940|NCT01218126|12282916|FG001|Overall Study|Protocol Violation|2
7816941|NCT01218126|12282917|FG002|Overall Study|Protocol Violation|2
7816942|NCT01218126|12282918|FG003|Overall Study|Protocol Violation|3
7816943|NCT01218126|12282915|FG000|Overall Study|Protocol-defined stopping criteria|1
7816944|NCT01218126|12282916|FG001|Overall Study|Protocol-defined stopping criteria|1
7816945|NCT01218126|12282917|FG002|Overall Study|Protocol-defined stopping criteria|0
7816946|NCT01218126|12282918|FG003|Overall Study|Protocol-defined stopping criteria|0
7816947|NCT01218126|12282915|FG000|Overall Study|Lost to Follow-up|0
7816948|NCT01218126|12282916|FG001|Overall Study|Lost to Follow-up|0
7816949|NCT01218126|12282917|FG002|Overall Study|Lost to Follow-up|0
7816950|NCT01218126|12282918|FG003|Overall Study|Lost to Follow-up|2
7816951|NCT01218126|12282915|FG000|Overall Study|Physician Decision|1
7816952|NCT01218126|12282916|FG001|Overall Study|Physician Decision|2
7816953|NCT01218126|12282917|FG002|Overall Study|Physician Decision|4
7816954|NCT01218126|12282918|FG003|Overall Study|Physician Decision|2
7816955|NCT01218126|12282915|FG000|Overall Study|Withdrawal by Subject|2
7816956|NCT01218126|12282916|FG001|Overall Study|Withdrawal by Subject|5
7816957|NCT01218126|12282917|FG002|Overall Study|Withdrawal by Subject|4
7816958|NCT01218126|12282918|FG003|Overall Study|Withdrawal by Subject|6
7816959|NCT01218204|12282930|FG000|Part B Washout|Adverse Event|0
7816960|NCT01218204|12282931|FG001|Part B Washout|Adverse Event|1
7816961|NCT01218204|12282932|FG002|Part B Washout|Adverse Event|0
7816962|NCT01218204|12282933|FG003|Part B Washout|Adverse Event|0
7816963|NCT01218204|12282930|FG000|Part B Washout|Lost to Follow-up|0
7816964|NCT01218204|12282931|FG001|Part B Washout|Lost to Follow-up|2
7816965|NCT01218204|12282932|FG002|Part B Washout|Lost to Follow-up|0
7816966|NCT01218204|12282933|FG003|Part B Washout|Lost to Follow-up|0
7816967|NCT01218204|12282930|FG000|Part B Washout|Physician Decision|0
7816968|NCT01218204|12282931|FG001|Part B Washout|Physician Decision|14
7816969|NCT01218204|12282932|FG002|Part B Washout|Physician Decision|0
7816970|NCT01218204|12282933|FG003|Part B Washout|Physician Decision|0
7816971|NCT01218204|12282930|FG000|Part B Washout|Withdrawal by Subject|0
7816972|NCT01218204|12282931|FG001|Part B Washout|Withdrawal by Subject|14
7816973|NCT01218204|12282932|FG002|Part B Washout|Withdrawal by Subject|0
7816974|NCT01218204|12282933|FG003|Part B Washout|Withdrawal by Subject|0
7816975|NCT01218204|12282930|FG000|Part B Washout|Reached defined stopping criteria|0
7816976|NCT01218204|12282931|FG001|Part B Washout|Reached defined stopping criteria|2
7816977|NCT01218204|12282932|FG002|Part B Washout|Reached defined stopping criteria|0
7816978|NCT01218204|12282933|FG003|Part B Washout|Reached defined stopping criteria|0
7816979|NCT01218204|12282930|FG000|Part B Washout|Did not meet continuation criteria|0
7816980|NCT01218204|12282931|FG001|Part B Washout|Did not meet continuation criteria|112
7816981|NCT01218204|12282932|FG002|Part B Washout|Did not meet continuation criteria|0
7816982|NCT01218204|12282933|FG003|Part B Washout|Did not meet continuation criteria|0
7816983|NCT01218204|12282930|FG000|Part B Run-in|Adverse Event|0
7816984|NCT01218204|12282931|FG001|Part B Run-in|Adverse Event|0
7816985|NCT01218204|12282932|FG002|Part B Run-in|Adverse Event|1
7816986|NCT01218204|12282933|FG003|Part B Run-in|Adverse Event|0
7816987|NCT01218204|12282930|FG000|Part B Run-in|Protocol Violation|0
7816988|NCT01218204|12282931|FG001|Part B Run-in|Protocol Violation|0
7816989|NCT01218204|12282932|FG002|Part B Run-in|Protocol Violation|2
7816990|NCT01218204|12282933|FG003|Part B Run-in|Protocol Violation|0
7816991|NCT01218204|12282930|FG000|Part B Run-in|Withdrawal by Subject|0
7816992|NCT01218204|12282931|FG001|Part B Run-in|Withdrawal by Subject|0
7816993|NCT01218204|12282932|FG002|Part B Run-in|Withdrawal by Subject|3
7816994|NCT01218204|12282933|FG003|Part B Run-in|Withdrawal by Subject|0
7816995|NCT01218204|12282930|FG000|Part B Pooled Treatment Arm|Adverse Event|0
7816996|NCT01218204|12282931|FG001|Part B Pooled Treatment Arm|Adverse Event|0
7816997|NCT01218204|12282932|FG002|Part B Pooled Treatment Arm|Adverse Event|0
7816998|NCT01218204|12282933|FG003|Part B Pooled Treatment Arm|Adverse Event|2
7816999|NCT01218204|12282930|FG000|Part B Pooled Treatment Arm|Protocol Violation|0
7817000|NCT01218204|12282931|FG001|Part B Pooled Treatment Arm|Protocol Violation|0
7817001|NCT01218204|12282932|FG002|Part B Pooled Treatment Arm|Protocol Violation|0
7817002|NCT01218204|12282933|FG003|Part B Pooled Treatment Arm|Protocol Violation|1
7817003|NCT01218243|12282982|FG000|Overall Study|Lack of Efficacy|1
7817004|NCT01218243|12282983|FG001|Overall Study|Lack of Efficacy|1
7817005|NCT01218243|12282982|FG000|Overall Study|Lost to Follow-up|3
7817006|NCT01218243|12282983|FG001|Overall Study|Lost to Follow-up|3
7817007|NCT01218243|12282982|FG000|Overall Study|Protocol Violation|5
7817008|NCT01218243|12282983|FG001|Overall Study|Protocol Violation|10
7817009|NCT01218308|12282991|FG000|Overall Study|Adverse Event|1
7817010|NCT01218308|12282992|FG001|Overall Study|Adverse Event|2
7817011|NCT01218308|12282991|FG000|Overall Study|Protocol Violation|0
7817012|NCT01218308|12282992|FG001|Overall Study|Protocol Violation|2
7817013|NCT01218308|12282991|FG000|Overall Study|Withdrawal by Subject|61
7817014|NCT01218308|12282992|FG001|Overall Study|Withdrawal by Subject|64
7817015|NCT01218308|12282991|FG000|Overall Study|Lost to Follow-up|27
7817016|NCT01218308|12282992|FG001|Overall Study|Lost to Follow-up|31
7817017|NCT01218308|12282991|FG000|Overall Study|Other|14
7817018|NCT01218308|12282992|FG001|Overall Study|Other|21
7817019|NCT01218438|12283007|FG000|Epoch 1|Physician Decision|2
7817020|NCT01218438|12283007|FG000|Epoch 1|Adverse Event|1
7817021|NCT01218438|12283007|FG000|Epoch 3|Withdrawal by Subject|3
7817022|NCT01218438|12283007|FG000|Epoch 3|Adverse Event|1
7817023|NCT01218438|12283007|FG000|Epoch 4|Physician Decision|1
7817024|NCT01218438|12283007|FG000|Epoch 4|Withdrawal by Subject|2
7817025|NCT01218477|12283085|FG000|Overall Study|Disease progression|2
7817026|NCT01218477|12283086|FG001|Overall Study|Disease progression|3
7817027|NCT01218477|12283087|FG002|Overall Study|Disease progression|6
7817028|NCT01218477|12283088|FG003|Overall Study|Disease progression|2
7817029|NCT01218477|12283085|FG000|Overall Study|Study drug toxicity|0
7817030|NCT01218477|12283086|FG001|Overall Study|Study drug toxicity|2
7817031|NCT01218477|12283087|FG002|Overall Study|Study drug toxicity|5
7817032|NCT01218477|12283088|FG003|Overall Study|Study drug toxicity|0
7817033|NCT01218477|12283085|FG000|Overall Study|No longer meets study criteria|1
7817034|NCT01218477|12283086|FG001|Overall Study|No longer meets study criteria|0
7817035|NCT01218477|12283087|FG002|Overall Study|No longer meets study criteria|0
7817036|NCT01218477|12283088|FG003|Overall Study|No longer meets study criteria|0
7817037|NCT01218477|12283085|FG000|Overall Study|Withdrawal by Subject|0
7817038|NCT01218477|12283086|FG001|Overall Study|Withdrawal by Subject|0
7817039|NCT01218477|12283087|FG002|Overall Study|Withdrawal by Subject|1
7817040|NCT01218477|12283088|FG003|Overall Study|Withdrawal by Subject|0
7911340|NCT02060383|12428350|FG003|Extension Phase|Unsatisfactory therapeutic effect|2
7911341|NCT02060383|12428351|FG004|Extension Phase|Unsatisfactory therapeutic effect|2
7911342|NCT02060383|12428347|FG000|Extension Phase|Adverse Event|1
7911343|NCT02060383|12428348|FG001|Extension Phase|Adverse Event|1
7911344|NCT02060383|12428349|FG002|Extension Phase|Adverse Event|2
7911345|NCT02060383|12428350|FG003|Extension Phase|Adverse Event|0
7911346|NCT02060383|12428351|FG004|Extension Phase|Adverse Event|1
7911347|NCT02060383|12428347|FG000|Extension Phase|Withdrawal by Subject|0
7911348|NCT02060383|12428348|FG001|Extension Phase|Withdrawal by Subject|1
7911349|NCT02060383|12428349|FG002|Extension Phase|Withdrawal by Subject|0
7911350|NCT02060383|12428350|FG003|Extension Phase|Withdrawal by Subject|0
7911351|NCT02060383|12428351|FG004|Extension Phase|Withdrawal by Subject|2
7911352|NCT02060383|12428347|FG000|Extension Phase|Administrative problems|1
7911353|NCT02060383|12428348|FG001|Extension Phase|Administrative problems|0
7911354|NCT02060383|12428349|FG002|Extension Phase|Administrative problems|0
7911355|NCT02060383|12428350|FG003|Extension Phase|Administrative problems|0
7911356|NCT02060383|12428351|FG004|Extension Phase|Administrative problems|0
7911357|NCT02060383|12428347|FG000|Extension Phase|Death|0
7911358|NCT02060383|12428348|FG001|Extension Phase|Death|0
7911359|NCT02060383|12428349|FG002|Extension Phase|Death|1
7911360|NCT02060383|12428350|FG003|Extension Phase|Death|0
7911361|NCT02060383|12428351|FG004|Extension Phase|Death|1
7911362|NCT02060383|12428347|FG000|Extension Phase|Protocol Violation|0
7911363|NCT02060383|12428348|FG001|Extension Phase|Protocol Violation|0
7911364|NCT02060383|12428349|FG002|Extension Phase|Protocol Violation|0
7911365|NCT02060383|12428350|FG003|Extension Phase|Protocol Violation|0
7911366|NCT02060383|12428351|FG004|Extension Phase|Protocol Violation|1
7911367|NCT02060903|12428404|FG000|Overall Study|Lost to Follow-up|4
7817041|NCT01218477|12283085|FG000|Overall Study|Prepared for cell transplantation|0
7817042|NCT01218477|12283086|FG001|Overall Study|Prepared for cell transplantation|1
7817043|NCT01218477|12283087|FG002|Overall Study|Prepared for cell transplantation|1
7817044|NCT01218477|12283088|FG003|Overall Study|Prepared for cell transplantation|0
7817045|NCT01218477|12283085|FG000|Overall Study|Administrative reason by sponsor|0
7817046|NCT01218477|12283086|FG001|Overall Study|Administrative reason by sponsor|0
7817047|NCT01218477|12283087|FG002|Overall Study|Administrative reason by sponsor|1
7817048|NCT01218477|12283088|FG003|Overall Study|Administrative reason by sponsor|0
7817049|NCT01218477|12283085|FG000|Overall Study|Maximum clinical benefit|0
7817050|NCT01218477|12283086|FG001|Overall Study|Maximum clinical benefit|2
7911368|NCT02060903|12428405|FG001|Overall Study|Lost to Follow-up|0
7911369|NCT02060903|12428404|FG000|Overall Study|Withdrawal by Subject|0
7911370|NCT02060903|12428405|FG001|Overall Study|Withdrawal by Subject|7
7911371|NCT02061202|12428413|FG000|Overall Study|Lost to Follow-up|1
7911372|NCT02061202|12428414|FG001|Overall Study|Lost to Follow-up|1
7911373|NCT02061280|12428422|FG000|Overall Study|Protocol Violation|12
7817051|NCT01218477|12283087|FG002|Overall Study|Maximum clinical benefit|0
7817052|NCT01218477|12283088|FG003|Overall Study|Maximum clinical benefit|0
7817053|NCT01218516|12283104|FG000|Combination Therapy (up to 4.5 Months)|Death|2
7817054|NCT01218516|12283105|FG001|Combination Therapy (up to 4.5 Months)|Death|1
7817055|NCT01218516|12283106|FG002|Combination Therapy (up to 4.5 Months)|Death|0
7817056|NCT01218516|12283107|FG003|Combination Therapy (up to 4.5 Months)|Death|0
7817057|NCT01218516|12283104|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
7817058|NCT01218516|12283105|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3
7817059|NCT01218516|12283106|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
7817060|NCT01218516|12283107|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
7817061|NCT01218516|12283104|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2
7817062|NCT01218516|12283105|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2
7817063|NCT01218516|12283106|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0
7817064|NCT01218516|12283107|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0
7817065|NCT01218516|12283104|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2
7817066|NCT01218516|12283105|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
7817067|NCT01218516|12283106|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
7817068|NCT01218516|12283107|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
7817069|NCT01218516|12283104|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17
7817070|NCT01218516|12283105|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15
7817071|NCT01218516|12283106|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
7817072|NCT01218516|12283107|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
7817073|NCT01218516|12283104|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
7817074|NCT01218516|12283105|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1
7817075|NCT01218516|12283106|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
7817076|NCT01218516|12283107|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
7817077|NCT01218516|12283104|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
7817078|NCT01218516|12283105|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1
7817079|NCT01218516|12283106|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
7817080|NCT01218516|12283107|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
7817081|NCT01218516|12283104|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
7817082|NCT01218516|12283105|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3
7817083|NCT01218516|12283106|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
7817084|NCT01218516|12283107|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
7817085|NCT01218516|12283104|FG000|Combination Therapy (up to 4.5 Months)|Other|3
7817086|NCT01218516|12283105|FG001|Combination Therapy (up to 4.5 Months)|Other|4
7817087|NCT01218516|12283106|FG002|Combination Therapy (up to 4.5 Months)|Other|0
7817088|NCT01218516|12283107|FG003|Combination Therapy (up to 4.5 Months)|Other|0
7817089|NCT01218516|12283104|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
7911374|NCT02061280|12428423|FG001|Overall Study|Protocol Violation|8
7719374|NCT00531934|12143366|FG000|Overall Study|Other|2
7719375|NCT00531934|12143367|FG001|Overall Study|Other|2
7719376|NCT00531947|12143375|FG000|Overall Study|Adverse Event|5
7719377|NCT00531947|12143376|FG001|Overall Study|Adverse Event|10
7719378|NCT00531947|12143375|FG000|Overall Study|Lost to Follow-up|12
7719379|NCT00531947|12143376|FG001|Overall Study|Lost to Follow-up|9
7817090|NCT01218516|12283105|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1
7817091|NCT01218516|12283106|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
7817092|NCT01218516|12283107|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
7817093|NCT01218516|12283104|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2
7817094|NCT01218516|12283105|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3
7817095|NCT01218516|12283106|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
7817096|NCT01218516|12283107|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
7817097|NCT01218516|12283104|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
7817098|NCT01218516|12283105|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
7817099|NCT01218516|12283106|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
7817100|NCT01218516|12283107|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
7817101|NCT01218594|12283122|FG000|Overall Study|Death|1
7817102|NCT01218594|12283122|FG000|Overall Study|Withdrawal by Subject|3
7817103|NCT01218594|12283122|FG000|Overall Study|Adverse Event|2
7817104|NCT01218594|12283122|FG000|Overall Study|Physician Decision|6
7817105|NCT01218646|12283130|FG000|Overall Study|Adverse Event|0
7817106|NCT01218646|12283131|FG001|Overall Study|Adverse Event|0
7817107|NCT01218646|12283132|FG002|Overall Study|Adverse Event|1
7817108|NCT01218646|12283133|FG003|Overall Study|Adverse Event|0
7817109|NCT01218646|12283130|FG000|Overall Study|Lost to Follow-up|1
7817110|NCT01218646|12283131|FG001|Overall Study|Lost to Follow-up|0
7817111|NCT01218646|12283132|FG002|Overall Study|Lost to Follow-up|0
7817112|NCT01218646|12283133|FG003|Overall Study|Lost to Follow-up|0
7817113|NCT01218646|12283130|FG000|Overall Study|Protocol Violation|0
7817114|NCT01218646|12283131|FG001|Overall Study|Protocol Violation|0
7817115|NCT01218646|12283132|FG002|Overall Study|Protocol Violation|1
7817116|NCT01218646|12283133|FG003|Overall Study|Protocol Violation|1
7817117|NCT01218659|12283145|FG000|18-Month Randomized Period|Withdrawal by Subject|2
7817118|NCT01218659|12283146|FG001|18-Month Randomized Period|Withdrawal by Subject|3
7817119|NCT01218659|12283147|FG002|18-Month Randomized Period|Withdrawal by Subject|0
7817120|NCT01218659|12283145|FG000|18-Month Randomized Period|Did not receive study drug|0
7817121|NCT01218659|12283146|FG001|18-Month Randomized Period|Did not receive study drug|3
7817122|NCT01218659|12283147|FG002|18-Month Randomized Period|Did not receive study drug|0
7817123|NCT01218659|12283145|FG000|12-Month OLE|Withdrawal by Subject|0
7817124|NCT01218659|12283146|FG001|12-Month OLE|Withdrawal by Subject|0
7817125|NCT01218659|12283147|FG002|12-Month OLE|Withdrawal by Subject|2
7817126|NCT01218659|12283145|FG000|12-Month OLE|Physician Decision|0
7817127|NCT01218659|12283146|FG001|12-Month OLE|Physician Decision|0
7817128|NCT01218659|12283147|FG002|12-Month OLE|Physician Decision|1
7817129|NCT01218659|12283145|FG000|12-Month OLE|Lost to Follow-up|0
7817130|NCT01218659|12283146|FG001|12-Month OLE|Lost to Follow-up|0
7817131|NCT01218659|12283147|FG002|12-Month OLE|Lost to Follow-up|1
7817132|NCT01218659|12283145|FG000|12-Month OLE|Pregnancy|0
7817133|NCT01218659|12283146|FG001|12-Month OLE|Pregnancy|0
7817134|NCT01218659|12283147|FG002|12-Month OLE|Pregnancy|1
7817135|NCT01218659|12283145|FG000|12-Month OLE|Lack of Efficacy|0
7817136|NCT01218659|12283146|FG001|12-Month OLE|Lack of Efficacy|0
7817137|NCT01218659|12283147|FG002|12-Month OLE|Lack of Efficacy|1
7817138|NCT01218659|12283145|FG000|12-Month OLE|Declined to participate in the OLE|0
7817139|NCT01218659|12283146|FG001|12-Month OLE|Declined to participate in the OLE|0
7817140|NCT01218659|12283147|FG002|12-Month OLE|Declined to participate in the OLE|4
7817141|NCT01218802|12283167|FG000|Overall Study|Lost to Follow-up|5
7911375|NCT02061280|12428422|FG000|Overall Study|moved out of state|0
7911376|NCT02061280|12428423|FG001|Overall Study|moved out of state|1
7911377|NCT02061280|12428422|FG000|Overall Study|Withdrawal by Subject|1
7911378|NCT02061280|12428423|FG001|Overall Study|Withdrawal by Subject|2
7911379|NCT02061280|12428422|FG000|Overall Study|Lost to Follow-up|5
7911380|NCT02061280|12428423|FG001|Overall Study|Lost to Follow-up|1
7817142|NCT01218802|12283168|FG001|Overall Study|Lost to Follow-up|6
7911381|NCT02061540|12428445|FG000|Overall Study|Adverse Event|2
7911382|NCT02061540|12428445|FG000|Overall Study|Withdrawal by Subject|2
7911383|NCT02061592|12428456|FG000|Period 1|Withdrawal by Subject|1
7911384|NCT02061592|12428457|FG001|Period 1|Withdrawal by Subject|0
7911385|NCT02061592|12428456|FG000|Period 1|Protocol Violation|1
7911386|NCT02061592|12428457|FG001|Period 1|Protocol Violation|0
7911387|NCT02061592|12428456|FG000|Period 2|Lost to Follow-up|0
7911388|NCT02061592|12428457|FG001|Period 2|Lost to Follow-up|1
7911389|NCT02061813|12428496|FG000|Overall Study|Withdrawal by Subject|1
7911390|NCT02061813|12428496|FG000|Overall Study|Protocol Violation|2
7911391|NCT02062151|12428516|FG000|Overall Study|screen failure|1
7911392|NCT02062385|12428541|FG000|Overall Study|Adverse Event|19
7911393|NCT02062385|12428542|FG001|Overall Study|Adverse Event|13
7817143|NCT01218802|12283167|FG000|Overall Study|Withdrawal by Subject|3
7817144|NCT01218802|12283168|FG001|Overall Study|Withdrawal by Subject|10
7817145|NCT01218802|12283167|FG000|Overall Study|Adverse Event|0
7817146|NCT01218802|12283168|FG001|Overall Study|Adverse Event|2
7911394|NCT02062385|12428543|FG002|Overall Study|Adverse Event|1
7911395|NCT02062385|12428544|FG003|Overall Study|Adverse Event|0
7911396|NCT02062385|12428541|FG000|Overall Study|Protocol Violation|1
7911397|NCT02062385|12428542|FG001|Overall Study|Protocol Violation|0
7817147|NCT01218802|12283167|FG000|Overall Study|Incarcerated|2
7817148|NCT01218802|12283168|FG001|Overall Study|Incarcerated|0
7817149|NCT01218867|12283185|FG000|Overall Study|Death during treatment|0
7817150|NCT01218867|12283186|FG001|Overall Study|Death during treatment|0
7817151|NCT01218867|12283187|FG002|Overall Study|Death during treatment|0
7817152|NCT01218867|12283188|FG003|Overall Study|Death during treatment|0
7817153|NCT01218867|12283189|FG004|Overall Study|Death during treatment|0
7817154|NCT01218867|12283190|FG005|Overall Study|Death during treatment|0
7817155|NCT01218867|12283191|FG006|Overall Study|Death during treatment|1
7817156|NCT01218867|12283192|FG007|Overall Study|Death during treatment|0
7817157|NCT01218867|12283193|FG008|Overall Study|Death during treatment|0
7817158|NCT01218867|12283194|FG009|Overall Study|Death during treatment|0
7817159|NCT01218867|12283195|FG010|Overall Study|Death during treatment|0
7817160|NCT01219933|12283325|FG000|Overall Study|Adverse Event|8
7817161|NCT01219933|12283325|FG000|Overall Study|No LDA reached|5
7817162|NCT01219933|12283325|FG000|Overall Study|No LDA maintained|7
7817163|NCT01219933|12283325|FG000|Overall Study|Lost to Follow-up|3
7817164|NCT01219933|12283325|FG000|Overall Study|GC free|1
7817165|NCT01219933|12283325|FG000|Overall Study|Withdrawal by Subject|5
7817166|NCT01219933|12283325|FG000|Overall Study|Protocol Violation|8
7817167|NCT01219933|12283325|FG000|Overall Study|Lack of Efficacy|1
7817168|NCT01219959|12283332|FG000|Overall Study|Adverse Event|6
7817169|NCT01219959|12283333|FG001|Overall Study|Adverse Event|14
7817170|NCT01219959|12283332|FG000|Overall Study|Physician Decision|0
7817171|NCT01219959|12283333|FG001|Overall Study|Physician Decision|4
7817172|NCT01219959|12283332|FG000|Overall Study|Withdrawal by Subject|0
7817173|NCT01219959|12283333|FG001|Overall Study|Withdrawal by Subject|2
7817174|NCT01219959|12283332|FG000|Overall Study|Renal Transplantation|0
7817175|NCT01219959|12283333|FG001|Overall Study|Renal Transplantation|3
7817176|NCT01219959|12283332|FG000|Overall Study|Other|1
7817177|NCT01219959|12283333|FG001|Overall Study|Other|0
7817178|NCT01219985|12283339|FG000|Overall Study|Physician Decision|20
7817179|NCT01220024|12283347|FG000|Overall Study|Lost to Follow-up|1
7817180|NCT01220024|12283348|FG001|Overall Study|Lost to Follow-up|1
7817181|NCT01220128|12283361|FG000|Overall Study|Progressive disease|0
7817182|NCT01220128|12283362|FG001|Overall Study|Progressive disease|0
7817183|NCT01220128|12283363|FG002|Overall Study|Progressive disease|2
7817184|NCT01220128|12283364|FG003|Overall Study|Progressive disease|0
7817185|NCT01220128|12283365|FG004|Overall Study|Progressive disease|0
7817186|NCT01220128|12283366|FG005|Overall Study|Progressive disease|0
7817187|NCT01220128|12283367|FG006|Overall Study|Progressive disease|0
7817188|NCT01220128|12283361|FG000|Overall Study|Sponsor study termination|0
7817189|NCT01220128|12283362|FG001|Overall Study|Sponsor study termination|1
7817190|NCT01220128|12283363|FG002|Overall Study|Sponsor study termination|0
7817191|NCT01220128|12283364|FG003|Overall Study|Sponsor study termination|0
7817192|NCT01220128|12283365|FG004|Overall Study|Sponsor study termination|0
7817193|NCT01220128|12283366|FG005|Overall Study|Sponsor study termination|0
7817194|NCT01220128|12283367|FG006|Overall Study|Sponsor study termination|1
7817195|NCT01220128|12283361|FG000|Overall Study|Adverse event, serious fatal|2
7817196|NCT01220128|12283362|FG001|Overall Study|Adverse event, serious fatal|0
7817197|NCT01220128|12283363|FG002|Overall Study|Adverse event, serious fatal|0
7817198|NCT01220128|12283364|FG003|Overall Study|Adverse event, serious fatal|0
7817199|NCT01220128|12283365|FG004|Overall Study|Adverse event, serious fatal|0
7817200|NCT01220128|12283366|FG005|Overall Study|Adverse event, serious fatal|0
7817201|NCT01220128|12283367|FG006|Overall Study|Adverse event, serious fatal|1
7817202|NCT01220128|12283361|FG000|Overall Study|Adverse event, non-fatal|1
7817203|NCT01220128|12283362|FG001|Overall Study|Adverse event, non-fatal|0
7817204|NCT01220128|12283363|FG002|Overall Study|Adverse event, non-fatal|0
7817205|NCT01220128|12283364|FG003|Overall Study|Adverse event, non-fatal|0
7817206|NCT01220128|12283365|FG004|Overall Study|Adverse event, non-fatal|0
7817207|NCT01220128|12283366|FG005|Overall Study|Adverse event, non-fatal|0
7817208|NCT01220128|12283367|FG006|Overall Study|Adverse event, non-fatal|3
7817209|NCT01220128|12283361|FG000|Overall Study|Other|0
7817210|NCT01220128|12283362|FG001|Overall Study|Other|0
7817211|NCT01220128|12283363|FG002|Overall Study|Other|1
7817212|NCT01220128|12283364|FG003|Overall Study|Other|0
7817213|NCT01220128|12283365|FG004|Overall Study|Other|0
7817214|NCT01220128|12283366|FG005|Overall Study|Other|0
7817215|NCT01220128|12283367|FG006|Overall Study|Other|0
7817216|NCT01220128|12283361|FG000|Overall Study|Consent withdrawn by subject|1
7817217|NCT01220128|12283362|FG001|Overall Study|Consent withdrawn by subject|0
7817218|NCT01220128|12283363|FG002|Overall Study|Consent withdrawn by subject|0
7817219|NCT01220128|12283364|FG003|Overall Study|Consent withdrawn by subject|0
7817220|NCT01220128|12283365|FG004|Overall Study|Consent withdrawn by subject|0
7817221|NCT01220128|12283366|FG005|Overall Study|Consent withdrawn by subject|0
7817222|NCT01220128|12283367|FG006|Overall Study|Consent withdrawn by subject|0
7817223|NCT01220167|12283387|FG000|Period 3|Urine positive for substance abuse|0
7817224|NCT01220167|12283388|FG001|Period 3|Urine positive for substance abuse|1
7817225|NCT01220167|12283389|FG002|Period 3|Urine positive for substance abuse|0
7861986|NCT01597245|12351202|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7861987|NCT01597245|12351203|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7861988|NCT01597245|12351204|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7861989|NCT01597245|12351205|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7861990|NCT01597245|12351206|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7861991|NCT01597245|12351207|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7861992|NCT01597245|12351208|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7861993|NCT01597245|12351188|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7861994|NCT01597245|12351189|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7861995|NCT01597245|12351190|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7861996|NCT01597245|12351191|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7861997|NCT01597245|12351192|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7861998|NCT01597245|12351193|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7883704|NCT01783886|12383535|FG000|Overall Study|Adverse Event|4
7817226|NCT01220180|12283398|FG000|Overall Study|Lost to Follow-up|76
7817227|NCT01220180|12283398|FG000|Overall Study|Other|72
7817228|NCT01220180|12283398|FG000|Overall Study|Adverse Event|35
7817229|NCT01220180|12283398|FG000|Overall Study|Lack of Efficacy|22
7817230|NCT01220180|12283398|FG000|Overall Study|Death|1
7817231|NCT01220180|12283398|FG000|Overall Study|Randomized but not treated|1
7817232|NCT01220297|12283404|FG000|Overall Study|Death|2
7817233|NCT01220297|12283404|FG000|Overall Study|Lost to Follow-up|1
7817234|NCT01220401|12283410|FG000|Overall Study|Withdrawal by Subject|2
7817235|NCT01220401|12283410|FG000|Overall Study|Protocol Violation|1
7817236|NCT01220414|12283416|FG000|Overall Study|Withdrawal by Subject|1
7817237|NCT01220414|12283417|FG001|Overall Study|Withdrawal by Subject|0
7817238|NCT01220414|12283418|FG002|Overall Study|Withdrawal by Subject|0
7817239|NCT01220414|12283419|FG003|Overall Study|Withdrawal by Subject|1
7817240|NCT01220557|12283441|FG000|Overall Study|Lost to Follow-up|5
7817241|NCT01220557|12283442|FG001|Overall Study|Lost to Follow-up|3
7817242|NCT01220557|12283441|FG000|Overall Study|attended less than 6 lessons|1
7817243|NCT01220557|12283442|FG001|Overall Study|attended less than 6 lessons|2
7817244|NCT01220609|12283448|FG000|Overall Study|Ineligible-Wrong primary cancer site|1
7817245|NCT01220609|12283448|FG000|Overall Study|Ineligible- Wrong cell type|1
7817246|NCT01220609|12283448|FG000|Overall Study|Ineligible-Never treated|1
7911398|NCT02062385|12428543|FG002|Overall Study|Protocol Violation|0
7911399|NCT02062385|12428544|FG003|Overall Study|Protocol Violation|0
7911400|NCT02062385|12428541|FG000|Overall Study|Incomplete EPI by database lock|2
7911401|NCT02062385|12428542|FG001|Overall Study|Incomplete EPI by database lock|0
7911402|NCT02062385|12428543|FG002|Overall Study|Incomplete EPI by database lock|0
7817247|NCT01220856|12283487|FG000|Overall Study|graft loss|3
7817248|NCT01220856|12283488|FG001|Overall Study|graft loss|3
7817249|NCT01220856|12283487|FG000|Overall Study|Lost to Follow-up|1
7817250|NCT01220856|12283488|FG001|Overall Study|Lost to Follow-up|0
7817251|NCT01220999|12283510|FG000|Overall Study|Progressive disease|0
7817252|NCT01220999|12283511|FG001|Overall Study|Progressive disease|0
7817253|NCT01220999|12283512|FG002|Overall Study|Progressive disease|1
7817254|NCT01220999|12283513|FG003|Overall Study|Progressive disease|0
7817255|NCT01220999|12283514|FG004|Overall Study|Progressive disease|0
7817256|NCT01221090|12283530|FG000|Overall Study|Non-Compliant or Unable to Contact|15
7817257|NCT01221090|12283531|FG001|Overall Study|Non-Compliant or Unable to Contact|12
7817258|NCT01221090|12283532|FG002|Overall Study|Non-Compliant or Unable to Contact|15
7817259|NCT01221090|12283533|FG003|Overall Study|Non-Compliant or Unable to Contact|20
7817260|NCT01221090|12283530|FG000|Overall Study|Withdrawal by Subject|0
7817261|NCT01221090|12283531|FG001|Overall Study|Withdrawal by Subject|22
7817262|NCT01221090|12283532|FG002|Overall Study|Withdrawal by Subject|27
7817263|NCT01221090|12283533|FG003|Overall Study|Withdrawal by Subject|2
7817264|NCT01221181|12283543|FG000|Overall Study|Lost to Follow-up|1
7817265|NCT01221233|12283571|FG000|Overall Study|Withdrawal by Subject|3
7817266|NCT01221233|12283572|FG001|Overall Study|Withdrawal by Subject|1
7817267|NCT01221272|12283578|FG000|Period 1|Adverse Event|2
7817268|NCT01221272|12283579|FG001|Period 1|Adverse Event|0
7817269|NCT01221272|12283578|FG000|Period 1|Consent Withdrawal|0
7817270|NCT01221272|12283579|FG001|Period 1|Consent Withdrawal|1
7817271|NCT01221272|12283578|FG000|Period 1|Significant Dosing Noncompliance|0
7817272|NCT01221272|12283579|FG001|Period 1|Significant Dosing Noncompliance|1
7817273|NCT01221272|12283578|FG000|Period 2|Adverse Event|0
7817274|NCT01221272|12283579|FG001|Period 2|Adverse Event|2
7817275|NCT01221285|12283588|FG000|Overall Study|Withdrawal by Subject|1
7817276|NCT01221350|12283607|FG000|Overall Study|Discontinued intervention (GERD)|1
7817277|NCT01221350|12283608|FG001|Overall Study|Discontinued intervention (GERD)|0
7817278|NCT01221350|12283607|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0
7817279|NCT01221350|12283608|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1
7817280|NCT01221350|12283607|FG000|Overall Study|Withdrawal by Subject|4
7817281|NCT01221350|12283608|FG001|Overall Study|Withdrawal by Subject|2
7817282|NCT01221363|12283618|FG000|Overall Study|Pregnancy|1
7817283|NCT01221363|12283619|FG001|Overall Study|Pregnancy|0
7817284|NCT01221363|12283618|FG000|Overall Study|Withdrawal by Subject|11
7817285|NCT01221363|12283619|FG001|Overall Study|Withdrawal by Subject|5
7817286|NCT01221597|12283636|FG000|Overall Study|Adverse Event|4
7817287|NCT01221597|12283637|FG001|Overall Study|Adverse Event|1
7817288|NCT01221597|12283636|FG000|Overall Study|Withdrawal by Subject|20
7817289|NCT01221597|12283637|FG001|Overall Study|Withdrawal by Subject|6
7817290|NCT01221597|12283636|FG000|Overall Study|Lost to Follow-up|6
7817291|NCT01221597|12283637|FG001|Overall Study|Lost to Follow-up|5
7817292|NCT01221597|12283636|FG000|Overall Study|Protocol Violation|1
7817293|NCT01221597|12283637|FG001|Overall Study|Protocol Violation|0
7817294|NCT01221597|12283636|FG000|Overall Study|Other|3
7817295|NCT01221597|12283637|FG001|Overall Study|Other|4
7817296|NCT01221597|12283636|FG000|Overall Study|Death|2
7817297|NCT01221597|12283637|FG001|Overall Study|Death|0
7817298|NCT01221623|12283646|FG000|Overall Study|Withdrawal by Subject|19
7817299|NCT01221623|12283647|FG001|Overall Study|Withdrawal by Subject|8
7817300|NCT01221623|12283646|FG000|Overall Study|Lost to Follow-up|7
7817301|NCT01221623|12283647|FG001|Overall Study|Lost to Follow-up|1
7817302|NCT01221623|12283646|FG000|Overall Study|Adverse Event|6
7817303|NCT01221623|12283647|FG001|Overall Study|Adverse Event|3
7817304|NCT01221623|12283646|FG000|Overall Study|Death|1
7817305|NCT01221623|12283647|FG001|Overall Study|Death|0
7817306|NCT01221623|12283646|FG000|Overall Study|Other|5
7817307|NCT01221623|12283647|FG001|Overall Study|Other|2
7817308|NCT01221727|12283655|FG000|Overall Study|Physician Decision|2
7817309|NCT01221727|12283656|FG001|Overall Study|Physician Decision|0
7817310|NCT01221727|12283655|FG000|Overall Study|Withdrawal by Subject|1
7817311|NCT01221727|12283656|FG001|Overall Study|Withdrawal by Subject|1
7817312|NCT01221753|12283668|FG000|Overall Study|Adverse Event|1
7817313|NCT01221948|12283680|FG000|Overall Study|Physician Decision|5
7817314|NCT01221948|12283680|FG000|Overall Study|Withdrawal by Subject|2
7817315|NCT01221948|12283680|FG000|Overall Study|not disclosed|2
7817316|NCT01221948|12283680|FG000|Overall Study|Death|1
7817317|NCT01221948|12283680|FG000|Overall Study|Protocol Violation|4
7817318|NCT01222078|12283684|FG000|Overall Study|Early termination of the study|1
7817319|NCT01222104|12283696|FG000|Overall Study|Lost to Follow-up|37
7817320|NCT01222104|12283696|FG000|Overall Study|Death|10
7817321|NCT01222403|12283809|FG000|Overall Study|Inappropriate enrollment|0
7817322|NCT01222403|12283810|FG001|Overall Study|Inappropriate enrollment|2
7817323|NCT01222416|12283818|FG000|Overall Study|ineligible;metastasis|3
7817324|NCT01222416|12283819|FG001|Overall Study|ineligible;metastasis|0
7817325|NCT01222416|12283818|FG000|Overall Study|Adverse Event|4
7817326|NCT01222416|12283819|FG001|Overall Study|Adverse Event|0
7817327|NCT01222416|12283818|FG000|Overall Study|Withdrawal by Subject|5
7817328|NCT01222416|12283819|FG001|Overall Study|Withdrawal by Subject|0
7817329|NCT01222416|12283818|FG000|Overall Study|scheduling|6
7817330|NCT01222416|12283819|FG001|Overall Study|scheduling|0
7817331|NCT01222416|12283818|FG000|Overall Study|missed view/scan|1
7817332|NCT01222416|12283819|FG001|Overall Study|missed view/scan|0
7817333|NCT01222416|12283818|FG000|Overall Study|Death|1
7817334|NCT01222416|12283819|FG001|Overall Study|Death|0
7817335|NCT01222507|12283838|FG000|Overall Study|Physician Decision|1
7817336|NCT01222507|12283838|FG000|Overall Study|Withdrawal by Subject|1
7817337|NCT01222520|12283844|FG000|Open-label run-in Period|Withdrawal by Subject|0
7911403|NCT02062385|12428544|FG003|Overall Study|Incomplete EPI by database lock|0
7911404|NCT02062385|12428541|FG000|Overall Study|Moved|10
7911405|NCT02062385|12428542|FG001|Overall Study|Moved|11
7911406|NCT02062385|12428543|FG002|Overall Study|Moved|1
7911407|NCT02062385|12428544|FG003|Overall Study|Moved|0
7911408|NCT02062385|12428541|FG000|Overall Study|Withdrawn by parent/guardian|46
7911409|NCT02062385|12428542|FG001|Overall Study|Withdrawn by parent/guardian|41
7911410|NCT02062385|12428543|FG002|Overall Study|Withdrawn by parent/guardian|9
7911411|NCT02062385|12428544|FG003|Overall Study|Withdrawn by parent/guardian|8
7911412|NCT02062385|12428541|FG000|Overall Study|Death|0
7911413|NCT02062385|12428542|FG001|Overall Study|Death|0
7911414|NCT02062385|12428543|FG002|Overall Study|Death|0
7911415|NCT02062385|12428544|FG003|Overall Study|Death|1
7911416|NCT02062385|12428541|FG000|Overall Study|Lost to Follow-up|0
7911417|NCT02062385|12428542|FG001|Overall Study|Lost to Follow-up|0
7911418|NCT02062385|12428543|FG002|Overall Study|Lost to Follow-up|1
7911419|NCT02062385|12428544|FG003|Overall Study|Lost to Follow-up|0
7911420|NCT02062398|12428552|FG000|Overall Study|Implant removal|1
7911421|NCT02062437|12428556|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31
7911422|NCT02062437|12428556|FG000|Overall Study|Patient not available for the 2y visit|18
7911423|NCT02062437|12428556|FG000|Overall Study|Death|2
7911424|NCT02062437|12428556|FG000|Overall Study|Pt. couldn't come due to med. condition|1
7817338|NCT01222520|12283845|FG001|Open-label run-in Period|Withdrawal by Subject|2
7817339|NCT01222520|12283844|FG000|Open-label run-in Period|Blood pressure criteria not met|0
7817340|NCT01222520|12283845|FG001|Open-label run-in Period|Blood pressure criteria not met|18
7817341|NCT01222520|12283844|FG000|Open-label run-in Period|Number of patients fulfilled|0
7817342|NCT01222520|12283845|FG001|Open-label run-in Period|Number of patients fulfilled|3
7817343|NCT01222520|12283844|FG000|Double-blind Period|Adverse Event|0
7817344|NCT01222520|12283845|FG001|Double-blind Period|Adverse Event|1
7911425|NCT02062450|12428562|FG000|Overall Study|No follow-up visit|124
7817345|NCT01222520|12283844|FG000|Double-blind Period|Lack of Efficacy|0
7817346|NCT01222520|12283845|FG001|Double-blind Period|Lack of Efficacy|1
7817347|NCT01222520|12283844|FG000|Double-blind Period|Study medication stolen|1
7817348|NCT01222520|12283845|FG001|Double-blind Period|Study medication stolen|0
7817349|NCT01222533|12283851|FG000|Overall Study|Adverse Event|5
7817350|NCT01222533|12283851|FG000|Overall Study|Withdrawal by Subject|5
7817351|NCT01222533|12283851|FG000|Overall Study|Other|4
7817352|NCT01222715|12283879|FG000|Overall Study|Adverse Event|0
7817353|NCT01222715|12283880|FG001|Overall Study|Adverse Event|4
7817354|NCT01222715|12283879|FG000|Overall Study|Death|0
7817355|NCT01222715|12283880|FG001|Overall Study|Death|1
7817356|NCT01222715|12283879|FG000|Overall Study|Lack of Efficacy|22
7817357|NCT01222715|12283880|FG001|Overall Study|Lack of Efficacy|14
7911426|NCT02062632|12428630|FG000|Overall Study|No treatment data|1
7817358|NCT01222715|12283879|FG000|Overall Study|Physician Decision|12
7817359|NCT01222715|12283880|FG001|Overall Study|Physician Decision|2
7817360|NCT01222715|12283879|FG000|Overall Study|Refusal of further protocol therapy|0
7817361|NCT01222715|12283880|FG001|Overall Study|Refusal of further protocol therapy|4
7817362|NCT01222715|12283879|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1
7817363|NCT01222715|12283880|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1
7817364|NCT01222715|12283879|FG000|Overall Study|Ineligible|0
7817365|NCT01222715|12283880|FG001|Overall Study|Ineligible|1
7817366|NCT01222715|12283879|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
7817367|NCT01222715|12283880|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
7817368|NCT01222767|12283886|FG000|Overall Study|Progressive disease|13
7817369|NCT01222767|12283886|FG000|Overall Study|Adverse Event|2
7817370|NCT01222767|12283886|FG000|Overall Study|Surgical resection|1
7817371|NCT01222767|12283886|FG000|Overall Study|Never treated|1
7817372|NCT01223027|12283910|FG000|Overall Study|Adverse Event|20
7817373|NCT01223027|12283911|FG001|Overall Study|Adverse Event|10
7817374|NCT01223027|12283910|FG000|Overall Study|Death|42
7817375|NCT01223027|12283911|FG001|Overall Study|Death|42
7817376|NCT01223027|12283910|FG000|Overall Study|Lost to Follow-up|2
7817377|NCT01223027|12283911|FG001|Overall Study|Lost to Follow-up|1
7817378|NCT01223027|12283910|FG000|Overall Study|Physician Decision|4
7817379|NCT01223027|12283911|FG001|Overall Study|Physician Decision|8
7817380|NCT01223027|12283910|FG000|Overall Study|Progressive Disease|167
7817381|NCT01223027|12283911|FG001|Overall Study|Progressive Disease|183
7817382|NCT01223027|12283910|FG000|Overall Study|Protocol Violation|2
7817383|NCT01223027|12283911|FG001|Overall Study|Protocol Violation|1
7817384|NCT01223027|12283910|FG000|Overall Study|Subject/guardian decicion|18
7817385|NCT01223027|12283911|FG001|Overall Study|Subject/guardian decicion|16
7817386|NCT01223027|12283910|FG000|Overall Study|New therapy for study indication|17
7817387|NCT01223027|12283911|FG001|Overall Study|New therapy for study indication|8
7817388|NCT01223027|12283910|FG000|Overall Study|Study terminated by sponsor|2
7817389|NCT01223027|12283911|FG001|Overall Study|Study terminated by sponsor|8
7817390|NCT01223183|12283919|FG000|Imaging Day 1|Physician Decision|0
7817391|NCT01223183|12283920|FG001|Imaging Day 1|Physician Decision|1
7817392|NCT01223183|12283919|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1
7817393|NCT01223183|12283920|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0
7817394|NCT01223183|12283919|FG000|Washout Period (5-24 Days)|Physician Decision|1
7817395|NCT01223183|12283920|FG001|Washout Period (5-24 Days)|Physician Decision|0
7817396|NCT01223196|12283929|FG000|Overall Study|Lost to Follow-up|2
7817397|NCT01223196|12283930|FG001|Overall Study|Lost to Follow-up|0
7817398|NCT01223196|12283929|FG000|Overall Study|Physician Decision|1
7817399|NCT01223196|12283930|FG001|Overall Study|Physician Decision|0
7817400|NCT01223196|12283929|FG000|Overall Study|Withdrawal by Subject|1
7817401|NCT01223196|12283930|FG001|Overall Study|Withdrawal by Subject|0
7817402|NCT01223235|12283938|FG000|Overall Study|Withdrawal by Subject|1
7817403|NCT01223365|12283957|FG000|Open-label Titration Period|Enrolled but not treated|1
7817404|NCT01223365|12283957|FG000|Open-label Titration Period|Adverse Event|23
7817405|NCT01223365|12283957|FG000|Open-label Titration Period|Lack of Efficacy|3
7817406|NCT01223365|12283957|FG000|Open-label Titration Period|Withdrawal by Subject|5
7817407|NCT01223365|12283957|FG000|Open-label Titration Period|Protocol Violation|1
7817408|NCT01223365|12283957|FG000|Open-label Titration Period|Lost to Follow-up|2
7817409|NCT01223365|12283957|FG000|Open-label Titration Period|Noncompliance with study drug admin|1
7911427|NCT02062645|12428634|FG000|Overall Study|Adverse Event|2
7817410|NCT01223365|12283957|FG000|Open-label Titration Period|Noncompliance with study procedures|2
7817411|NCT01223365|12283957|FG000|Open-label Titration Period|Starting physical therapy|1
7817412|NCT01223365|12283957|FG000|Open-label Treatment Period|Adverse Event|39
7817413|NCT01223365|12283957|FG000|Open-label Treatment Period|Lack of Efficacy|2
7817414|NCT01223365|12283957|FG000|Open-label Treatment Period|Withdrawal by Subject|19
7817415|NCT01223365|12283957|FG000|Open-label Treatment Period|Protocol Violation|15
7817416|NCT01223365|12283957|FG000|Open-label Treatment Period|Lost to Follow-up|7
7817417|NCT01223365|12283957|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7
7817418|NCT01223365|12283957|FG000|Open-label Treatment Period|Noncompliance with study procedures|6
7817419|NCT01223365|12283957|FG000|Open-label Treatment Period|Moved out of area|2
7817420|NCT01223365|12283957|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1
7817421|NCT01223365|12283957|FG000|Open-label Treatment Period|"Out of window"|1
7817422|NCT01223365|12283957|FG000|Open-label Treatment Period|Starting physical therapy|1
7817423|NCT01223365|12283957|FG000|Open-label Treatment Period|Physician Decision|2
7817424|NCT01223404|12283987|FG000|First Intervention (1 Day)|Adverse Event|0
7817425|NCT01223404|12283988|FG001|First Intervention (1 Day)|Adverse Event|0
7817426|NCT01223404|12283989|FG002|First Intervention (1 Day)|Adverse Event|0
7817427|NCT01223404|12283990|FG003|First Intervention (1 Day)|Adverse Event|1
7817428|NCT01223404|12283991|FG004|First Intervention (1 Day)|Adverse Event|0
7817429|NCT01223404|12283992|FG005|First Intervention (1 Day)|Adverse Event|0
7817430|NCT01223404|12283987|FG000|Second Intervention (1 Day)|Adverse Event|1
7817431|NCT01223404|12283988|FG001|Second Intervention (1 Day)|Adverse Event|0
7817432|NCT01223404|12283989|FG002|Second Intervention (1 Day)|Adverse Event|0
7817433|NCT01223404|12283990|FG003|Second Intervention (1 Day)|Adverse Event|0
7817434|NCT01223404|12283991|FG004|Second Intervention (1 Day)|Adverse Event|0
7817435|NCT01223404|12283992|FG005|Second Intervention (1 Day)|Adverse Event|0
7817436|NCT01223404|12283987|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0
7817437|NCT01223404|12283988|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0
7817438|NCT01223404|12283989|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0
7817439|NCT01223404|12283990|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1
7817440|NCT01223404|12283991|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0
7817441|NCT01223404|12283992|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0
7817442|NCT01223937|12284028|FG000|Overall Study|Withdrawal by Subject|3
7817443|NCT01223937|12284029|FG001|Overall Study|Withdrawal by Subject|2
7817444|NCT01223937|12284028|FG000|Overall Study|Lost to Follow-up|1
7817445|NCT01223937|12284029|FG001|Overall Study|Lost to Follow-up|4
7817446|NCT01223937|12284028|FG000|Overall Study|Adverse Event|1
7817447|NCT01223937|12284029|FG001|Overall Study|Adverse Event|4
7817448|NCT01223937|12284028|FG000|Overall Study|Protocol Violation|8
7817449|NCT01223937|12284029|FG001|Overall Study|Protocol Violation|7
7817450|NCT01223937|12284028|FG000|Overall Study|Other|4
7817451|NCT01223937|12284029|FG001|Overall Study|Other|1
7817452|NCT01224158|12284055|FG000|Overall Study|Withdrawal by Subject|1
7817453|NCT01224158|12284056|FG001|Overall Study|Withdrawal by Subject|0
7817454|NCT01224171|12284064|FG000|Overall Study|Adverse Event|8
7817455|NCT01224171|12284065|FG001|Overall Study|Adverse Event|4
7817456|NCT01224171|12284064|FG000|Overall Study|Protocol Violation|0
7817457|NCT01224171|12284065|FG001|Overall Study|Protocol Violation|1
7817458|NCT01224171|12284064|FG000|Overall Study|Lack of Efficacy|5
7817459|NCT01224171|12284065|FG001|Overall Study|Lack of Efficacy|1
7817460|NCT01224171|12284064|FG000|Overall Study|Withdrawal of Consent|2
7817461|NCT01224171|12284065|FG001|Overall Study|Withdrawal of Consent|4
7817462|NCT01224171|12284064|FG000|Overall Study|Lost to Follow-up|0
7817463|NCT01224171|12284065|FG001|Overall Study|Lost to Follow-up|3
7817464|NCT01224431|12284087|FG000|Overall Study|not randomized|0
7817465|NCT01224431|12284088|FG001|Overall Study|not randomized|4
7817466|NCT01224431|12284087|FG000|Overall Study|no video record|0
7817467|NCT01224431|12284088|FG001|Overall Study|no video record|1
7817468|NCT01224639|12284112|FG000|Overall Study|Withdrawal by Subject|0
7817469|NCT01224639|12284113|FG001|Overall Study|Withdrawal by Subject|0
7817470|NCT01224639|12284114|FG002|Overall Study|Withdrawal by Subject|0
7817471|NCT01224639|12284115|FG003|Overall Study|Withdrawal by Subject|0
7817472|NCT01224639|12284116|FG004|Overall Study|Withdrawal by Subject|2
7817473|NCT01224639|12284117|FG005|Overall Study|Withdrawal by Subject|0
7817474|NCT01224639|12284118|FG006|Overall Study|Withdrawal by Subject|1
7817475|NCT01224639|12284119|FG007|Overall Study|Withdrawal by Subject|1
7817476|NCT01224639|12284112|FG000|Overall Study|Adverse Event|0
7817477|NCT01224639|12284113|FG001|Overall Study|Adverse Event|0
7817478|NCT01224639|12284114|FG002|Overall Study|Adverse Event|0
7817479|NCT01224639|12284115|FG003|Overall Study|Adverse Event|0
7817480|NCT01224639|12284116|FG004|Overall Study|Adverse Event|0
7817481|NCT01224639|12284117|FG005|Overall Study|Adverse Event|0
7817482|NCT01224639|12284118|FG006|Overall Study|Adverse Event|0
7817483|NCT01224639|12284119|FG007|Overall Study|Adverse Event|1
7817484|NCT01224782|12284146|FG000|Overall Study|Lost to Follow-up|177
7817485|NCT01224782|12284146|FG000|Overall Study|Withdrawal by Subject|16
7817486|NCT01224782|12284146|FG000|Overall Study|Death|14
7817487|NCT01224782|12284146|FG000|Overall Study|Improvement|13
7817488|NCT01224782|12284146|FG000|Overall Study|Adverse Event|12
7817489|NCT01224782|12284146|FG000|Overall Study|Adverse Reaction|11
7817490|NCT01224782|12284146|FG000|Overall Study|Noncompliance|10
7817491|NCT01224782|12284146|FG000|Overall Study|Other|4
7817492|NCT01224782|12284146|FG000|Overall Study|Start of Dialysis|3
7817493|NCT01224782|12284146|FG000|Overall Study|Change of Treatment|1
7817494|NCT01224782|12284146|FG000|Overall Study|Financial Reasons|1
7817495|NCT01224782|12284146|FG000|Overall Study|Deterioration|1
7817496|NCT01224782|12284146|FG000|Overall Study|Transplantation|1
7911428|NCT02062645|12428634|FG000|Overall Study|Protocol Violation|8
7911429|NCT02062645|12428634|FG000|Overall Study|Lost to Follow-up|5
7911430|NCT02062658|12428638|FG000|Overall Study|Withdrawal by Subject|1
7911431|NCT02062658|12428638|FG000|Overall Study|Lack of Efficacy|1
7911432|NCT02062879|12428666|FG000|Overall Study|Withdrawal by Subject|4
7911433|NCT02062879|12428667|FG001|Overall Study|Withdrawal by Subject|1
7817497|NCT01224821|12284150|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1
7817498|NCT01224821|12284150|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38
7817499|NCT01224821|12284150|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
7817500|NCT01224821|12284150|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
7817501|NCT01224821|12284150|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
7817502|NCT01224821|12284150|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
7817503|NCT01224821|12284150|FG000|Long-Term Follow-Up|Death|2
7817504|NCT01224821|12284150|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
7817505|NCT01224925|12284156|FG000|Overall Study|Lost to Follow-up|3
7817506|NCT01224925|12284157|FG001|Overall Study|Lost to Follow-up|2
7817507|NCT01225146|12284198|FG000|Overall Study|Sponsor discontinued making 2mg drug|0
7817508|NCT01225146|12284199|FG001|Overall Study|Sponsor discontinued making 2mg drug|2
7817509|NCT01225159|12284209|FG000|Overall Study|Change operation|1
7817510|NCT01225159|12284210|FG001|Overall Study|Change operation|0
7817511|NCT01225172|12284218|FG000|Overall Study|Subject decision to stop|1
7817512|NCT01225172|12284219|FG001|Overall Study|Subject decision to stop|0
7817513|NCT01225172|12284218|FG000|Overall Study|Subject request to discontinue treatment|3
7817514|NCT01225172|12284219|FG001|Overall Study|Subject request to discontinue treatment|1
7817515|NCT01225172|12284218|FG000|Overall Study|Subject no longer meets study criteria|1
7817516|NCT01225172|12284219|FG001|Overall Study|Subject no longer meets study criteria|0
7817517|NCT01225172|12284218|FG000|Overall Study|Withdrawal by Subject|1
7817518|NCT01225172|12284219|FG001|Overall Study|Withdrawal by Subject|0
7817519|NCT01225211|12284235|FG000|Overall Study|Adverse Event|0
7817520|NCT01225211|12284236|FG001|Overall Study|Adverse Event|0
7817521|NCT01225211|12284237|FG002|Overall Study|Adverse Event|1
7817522|NCT01225211|12284238|FG003|Overall Study|Adverse Event|0
7817523|NCT01225211|12284239|FG004|Overall Study|Adverse Event|0
7817524|NCT01225211|12284240|FG005|Overall Study|Adverse Event|0
7817525|NCT01225211|12284241|FG006|Overall Study|Adverse Event|0
7817526|NCT01225211|12284242|FG007|Overall Study|Adverse Event|0
7817527|NCT01225211|12284243|FG008|Overall Study|Adverse Event|0
7817528|NCT01225211|12284244|FG009|Overall Study|Adverse Event|1
7817529|NCT01225211|12284235|FG000|Overall Study|Withdrawal by Subject|0
7817530|NCT01225211|12284236|FG001|Overall Study|Withdrawal by Subject|0
7817531|NCT01225211|12284237|FG002|Overall Study|Withdrawal by Subject|0
7817532|NCT01225211|12284238|FG003|Overall Study|Withdrawal by Subject|0
7817533|NCT01225211|12284239|FG004|Overall Study|Withdrawal by Subject|0
7817534|NCT01225211|12284240|FG005|Overall Study|Withdrawal by Subject|0
7817535|NCT01225211|12284241|FG006|Overall Study|Withdrawal by Subject|1
7817536|NCT01225211|12284242|FG007|Overall Study|Withdrawal by Subject|0
7817537|NCT01225211|12284243|FG008|Overall Study|Withdrawal by Subject|1
7817538|NCT01225211|12284244|FG009|Overall Study|Withdrawal by Subject|3
7817539|NCT01225211|12284235|FG000|Overall Study|Other|0
7817540|NCT01225211|12284236|FG001|Overall Study|Other|0
7817541|NCT01225211|12284237|FG002|Overall Study|Other|0
7817542|NCT01225211|12284238|FG003|Overall Study|Other|0
7817543|NCT01225211|12284239|FG004|Overall Study|Other|0
7817544|NCT01225211|12284240|FG005|Overall Study|Other|0
7817545|NCT01225211|12284241|FG006|Overall Study|Other|0
7817546|NCT01225211|12284242|FG007|Overall Study|Other|0
7817547|NCT01225211|12284243|FG008|Overall Study|Other|0
7817548|NCT01225211|12284244|FG009|Overall Study|Other|1
7817549|NCT01225549|12284334|FG000|Period 4 - Washout|Disallowed medication|0
7817550|NCT01225549|12284335|FG001|Period 4 - Washout|Disallowed medication|1
7817551|NCT01225549|12284336|FG002|Period 4 - Washout|Disallowed medication|0
7817552|NCT01225549|12284337|FG003|Period 4 - Washout|Disallowed medication|0
7911434|NCT02063217|12428716|FG000|Overall Study|Withdrawal by Subject|1
7817553|NCT01225549|12284338|FG004|Period 4 - Washout|Disallowed medication|0
7817554|NCT01225549|12284339|FG005|Period 4 - Washout|Disallowed medication|0
7817555|NCT01225549|12284340|FG006|Period 4 - Washout|Disallowed medication|0
7817556|NCT01225549|12284341|FG007|Period 4 - Washout|Disallowed medication|0
7817557|NCT01225549|12284342|FG008|Period 4 - Washout|Disallowed medication|0
7817558|NCT01225549|12284343|FG009|Period 4 - Washout|Disallowed medication|0
7817559|NCT01225549|12284334|FG000|Period 6 - Washout|Disallowed medication|0
7817560|NCT01225549|12284335|FG001|Period 6 - Washout|Disallowed medication|0
7817561|NCT01225549|12284336|FG002|Period 6 - Washout|Disallowed medication|0
7817562|NCT01225549|12284337|FG003|Period 6 - Washout|Disallowed medication|1
7817563|NCT01225549|12284338|FG004|Period 6 - Washout|Disallowed medication|0
7817564|NCT01225549|12284339|FG005|Period 6 - Washout|Disallowed medication|0
7817565|NCT01225549|12284340|FG006|Period 6 - Washout|Disallowed medication|0
7817566|NCT01225549|12284341|FG007|Period 6 - Washout|Disallowed medication|0
7817567|NCT01225549|12284342|FG008|Period 6 - Washout|Disallowed medication|0
7817568|NCT01225549|12284343|FG009|Period 6 - Washout|Disallowed medication|0
7817569|NCT01225562|12284356|FG000|Overall Study|Withdrawal by Subject|52
7817570|NCT01225562|12284357|FG001|Overall Study|Withdrawal by Subject|50
7817571|NCT01225562|12284358|FG002|Overall Study|Withdrawal by Subject|52
7817572|NCT01225562|12284356|FG000|Overall Study|Lost to Follow-up|3
7817573|NCT01225562|12284357|FG001|Overall Study|Lost to Follow-up|6
7817574|NCT01225562|12284358|FG002|Overall Study|Lost to Follow-up|1
7817575|NCT01225731|12284371|FG000|Part 1|Did not meet eligibility criteria|1
7817576|NCT01225731|12284372|FG001|Part 1|Did not meet eligibility criteria|0
7817577|NCT01225731|12284373|FG002|Part 1|Did not meet eligibility criteria|0
7817578|NCT01225731|12284374|FG003|Part 1|Did not meet eligibility criteria|0
7817579|NCT01225731|12284375|FG004|Part 1|Did not meet eligibility criteria|1
7817580|NCT01225731|12284376|FG005|Part 1|Did not meet eligibility criteria|0
7817581|NCT01225731|12284377|FG006|Part 1|Did not meet eligibility criteria|0
7817582|NCT01225731|12284378|FG007|Part 1|Did not meet eligibility criteria|0
7817583|NCT01225731|12284379|FG008|Part 1|Did not meet eligibility criteria|0
7817584|NCT01225731|12284380|FG009|Part 1|Did not meet eligibility criteria|0
7817585|NCT01225731|12284381|FG010|Part 1|Did not meet eligibility criteria|0
7817586|NCT01225731|12284382|FG011|Part 1|Did not meet eligibility criteria|0
7817587|NCT01225731|12284383|FG012|Part 1|Did not meet eligibility criteria|0
7817588|NCT01225731|12284371|FG000|Part 1|Adverse Event|1
7817589|NCT01225731|12284372|FG001|Part 1|Adverse Event|2
7817590|NCT01225731|12284373|FG002|Part 1|Adverse Event|1
7817591|NCT01225731|12284374|FG003|Part 1|Adverse Event|1
7817592|NCT01225731|12284375|FG004|Part 1|Adverse Event|1
7817593|NCT01225731|12284376|FG005|Part 1|Adverse Event|0
7817594|NCT01225731|12284377|FG006|Part 1|Adverse Event|0
7817595|NCT01225731|12284378|FG007|Part 1|Adverse Event|0
7817596|NCT01225731|12284379|FG008|Part 1|Adverse Event|0
7817597|NCT01225731|12284380|FG009|Part 1|Adverse Event|0
7817598|NCT01225731|12284381|FG010|Part 1|Adverse Event|0
7817599|NCT01225731|12284382|FG011|Part 1|Adverse Event|0
7817600|NCT01225731|12284383|FG012|Part 1|Adverse Event|0
7817601|NCT01225731|12284371|FG000|Part 1|Withdrawal by Subject|0
7817602|NCT01225731|12284372|FG001|Part 1|Withdrawal by Subject|3
7817603|NCT01225731|12284373|FG002|Part 1|Withdrawal by Subject|0
7817604|NCT01225731|12284374|FG003|Part 1|Withdrawal by Subject|0
7817605|NCT01225731|12284375|FG004|Part 1|Withdrawal by Subject|4
7817606|NCT01225731|12284376|FG005|Part 1|Withdrawal by Subject|0
7817607|NCT01225731|12284377|FG006|Part 1|Withdrawal by Subject|0
7817608|NCT01225731|12284378|FG007|Part 1|Withdrawal by Subject|0
7817609|NCT01225731|12284379|FG008|Part 1|Withdrawal by Subject|0
7817610|NCT01225731|12284380|FG009|Part 1|Withdrawal by Subject|0
7817611|NCT01225731|12284381|FG010|Part 1|Withdrawal by Subject|0
7817612|NCT01225731|12284382|FG011|Part 1|Withdrawal by Subject|0
7817613|NCT01225731|12284383|FG012|Part 1|Withdrawal by Subject|0
7817614|NCT01225731|12284371|FG000|Part 1|Protocol Violation|0
7817615|NCT01225731|12284372|FG001|Part 1|Protocol Violation|0
7817616|NCT01225731|12284373|FG002|Part 1|Protocol Violation|0
7817617|NCT01225731|12284374|FG003|Part 1|Protocol Violation|1
7817618|NCT01225731|12284375|FG004|Part 1|Protocol Violation|0
7817619|NCT01225731|12284376|FG005|Part 1|Protocol Violation|0
7817620|NCT01225731|12284377|FG006|Part 1|Protocol Violation|0
7817621|NCT01225731|12284378|FG007|Part 1|Protocol Violation|0
7817622|NCT01225731|12284379|FG008|Part 1|Protocol Violation|0
7817623|NCT01225731|12284380|FG009|Part 1|Protocol Violation|0
7817624|NCT01225731|12284381|FG010|Part 1|Protocol Violation|0
7817625|NCT01225731|12284382|FG011|Part 1|Protocol Violation|0
7817626|NCT01225731|12284383|FG012|Part 1|Protocol Violation|0
7817627|NCT01225731|12284371|FG000|Part 2|Protocol Violation|0
7817628|NCT01225731|12284372|FG001|Part 2|Protocol Violation|0
7817629|NCT01225731|12284373|FG002|Part 2|Protocol Violation|0
7817630|NCT01225731|12284374|FG003|Part 2|Protocol Violation|0
7817631|NCT01225731|12284375|FG004|Part 2|Protocol Violation|0
7817632|NCT01225731|12284376|FG005|Part 2|Protocol Violation|1
7817633|NCT01225731|12284377|FG006|Part 2|Protocol Violation|0
7817634|NCT01225731|12284378|FG007|Part 2|Protocol Violation|0
7817635|NCT01225731|12284379|FG008|Part 2|Protocol Violation|1
7817636|NCT01225731|12284380|FG009|Part 2|Protocol Violation|0
7817637|NCT01225731|12284381|FG010|Part 2|Protocol Violation|0
7817638|NCT01225731|12284382|FG011|Part 2|Protocol Violation|0
7817639|NCT01225731|12284383|FG012|Part 2|Protocol Violation|0
7817640|NCT01225731|12284371|FG000|Part 2|Adverse Event|0
7817641|NCT01225731|12284372|FG001|Part 2|Adverse Event|0
7817642|NCT01225731|12284373|FG002|Part 2|Adverse Event|0
7817643|NCT01225731|12284374|FG003|Part 2|Adverse Event|0
7817644|NCT01225731|12284375|FG004|Part 2|Adverse Event|0
7817645|NCT01225731|12284376|FG005|Part 2|Adverse Event|0
7817646|NCT01225731|12284377|FG006|Part 2|Adverse Event|4
7911435|NCT02063217|12428717|FG001|Overall Study|Withdrawal by Subject|0
7911436|NCT02063217|12428718|FG002|Overall Study|Withdrawal by Subject|0
7911437|NCT02063659|12428755|FG000|Double-Blind Treatment Period|Adverse Event|1
7911438|NCT02063659|12428756|FG001|Double-Blind Treatment Period|Adverse Event|2
7911439|NCT02063659|12428757|FG002|Double-Blind Treatment Period|Adverse Event|0
7911440|NCT02063659|12428758|FG003|Double-Blind Treatment Period|Adverse Event|0
7911441|NCT02063659|12428755|FG000|Double-Blind Treatment Period|Physician Decision|1
7911442|NCT02063659|12428756|FG001|Double-Blind Treatment Period|Physician Decision|0
7911443|NCT02063659|12428757|FG002|Double-Blind Treatment Period|Physician Decision|0
7911444|NCT02063659|12428758|FG003|Double-Blind Treatment Period|Physician Decision|0
7911445|NCT02063659|12428755|FG000|Double-Blind Treatment Period|Withdrawal of consent|0
7911446|NCT02063659|12428756|FG001|Double-Blind Treatment Period|Withdrawal of consent|1
7817647|NCT01225731|12284378|FG007|Part 2|Adverse Event|4
7817648|NCT01225731|12284379|FG008|Part 2|Adverse Event|2
7817649|NCT01225731|12284380|FG009|Part 2|Adverse Event|0
7817650|NCT01225731|12284381|FG010|Part 2|Adverse Event|0
7817651|NCT01225731|12284382|FG011|Part 2|Adverse Event|0
7817652|NCT01225731|12284383|FG012|Part 2|Adverse Event|0
7817653|NCT01225731|12284371|FG000|Part 2|Lack of Efficacy|0
7911447|NCT02063659|12428757|FG002|Double-Blind Treatment Period|Withdrawal of consent|3
7911448|NCT02063659|12428758|FG003|Double-Blind Treatment Period|Withdrawal of consent|0
7911449|NCT02063659|12428755|FG000|Open-Label Extension Period (OLE)|Physician Decision|0
7911450|NCT02063659|12428756|FG001|Open-Label Extension Period (OLE)|Physician Decision|0
7911451|NCT02063659|12428757|FG002|Open-Label Extension Period (OLE)|Physician Decision|0
7911452|NCT02063659|12428758|FG003|Open-Label Extension Period (OLE)|Physician Decision|1
7911453|NCT02063659|12428755|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7911454|NCT02063659|12428756|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7911455|NCT02063659|12428757|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7911456|NCT02063659|12428758|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
7719380|NCT00531947|12143375|FG000|Overall Study|Withdrawal by Subject|14
7719381|NCT00531947|12143376|FG001|Overall Study|Withdrawal by Subject|19
7719382|NCT00531947|12143375|FG000|Overall Study|Protocol Violation|2
7719383|NCT00531947|12143376|FG001|Overall Study|Protocol Violation|1
7719384|NCT00531947|12143375|FG000|Overall Study|Non-Compliance|4
7719385|NCT00531947|12143376|FG001|Overall Study|Non-Compliance|7
7719386|NCT00531947|12143375|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5
7719387|NCT00531947|12143376|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5
7719388|NCT00531960|12143384|FG000|Overall Study|Adverse Event|5
7719389|NCT00531960|12143385|FG001|Overall Study|Adverse Event|4
7719390|NCT00531960|12143384|FG000|Overall Study|Death|3
7719391|NCT00531960|12143385|FG001|Overall Study|Death|2
7719392|NCT00531960|12143384|FG000|Overall Study|Lack of Efficacy|42
7719393|NCT00531960|12143385|FG001|Overall Study|Lack of Efficacy|41
7719394|NCT00531960|12143384|FG000|Overall Study|Violation of Selection Criteria|2
7719395|NCT00531960|12143385|FG001|Overall Study|Violation of Selection Criteria|0
7719396|NCT00531960|12143384|FG000|Overall Study|Refused Treatment|5
7719397|NCT00531960|12143385|FG001|Overall Study|Refused Treatment|6
7719398|NCT00531960|12143384|FG000|Overall Study|Other|4
7719399|NCT00531960|12143385|FG001|Overall Study|Other|10
7719400|NCT00532129|12143391|FG000|Treatment Period|Adverse event/Serious adverse event|25
7719401|NCT00532129|12143391|FG000|Treatment Period|Physician Decision|15
7817654|NCT01225731|12284372|FG001|Part 2|Lack of Efficacy|0
7817655|NCT01225731|12284373|FG002|Part 2|Lack of Efficacy|0
7817656|NCT01225731|12284374|FG003|Part 2|Lack of Efficacy|0
7719402|NCT00532129|12143391|FG000|Treatment Period|Disease progression|3
7719403|NCT00532129|12143391|FG000|Treatment Period|Protocol Violation|1
7719404|NCT00532129|12143391|FG000|Treatment Period|Other|5
7817657|NCT01225731|12284375|FG004|Part 2|Lack of Efficacy|0
7817658|NCT01225731|12284376|FG005|Part 2|Lack of Efficacy|1
7817659|NCT01225731|12284377|FG006|Part 2|Lack of Efficacy|0
7817660|NCT01225731|12284378|FG007|Part 2|Lack of Efficacy|12
7817661|NCT01225731|12284379|FG008|Part 2|Lack of Efficacy|3
7817662|NCT01225731|12284380|FG009|Part 2|Lack of Efficacy|0
7817663|NCT01225731|12284381|FG010|Part 2|Lack of Efficacy|0
7817664|NCT01225731|12284382|FG011|Part 2|Lack of Efficacy|0
7817665|NCT01225731|12284383|FG012|Part 2|Lack of Efficacy|0
7817666|NCT01225731|12284371|FG000|Part 2|Pregnancy|0
7817667|NCT01225731|12284372|FG001|Part 2|Pregnancy|0
7817668|NCT01225731|12284373|FG002|Part 2|Pregnancy|0
7817669|NCT01225731|12284374|FG003|Part 2|Pregnancy|0
7817670|NCT01225731|12284375|FG004|Part 2|Pregnancy|0
7817671|NCT01225731|12284376|FG005|Part 2|Pregnancy|0
7817672|NCT01225731|12284377|FG006|Part 2|Pregnancy|1
7817673|NCT01225731|12284378|FG007|Part 2|Pregnancy|0
7817674|NCT01225731|12284379|FG008|Part 2|Pregnancy|1
7817675|NCT01225731|12284380|FG009|Part 2|Pregnancy|0
7817676|NCT01225731|12284381|FG010|Part 2|Pregnancy|0
7817677|NCT01225731|12284382|FG011|Part 2|Pregnancy|0
7817678|NCT01225731|12284383|FG012|Part 2|Pregnancy|0
7817679|NCT01225731|12284371|FG000|Part 2|Lost to Follow-up|0
7817680|NCT01225731|12284372|FG001|Part 2|Lost to Follow-up|0
7817681|NCT01225731|12284373|FG002|Part 2|Lost to Follow-up|0
7817682|NCT01225731|12284374|FG003|Part 2|Lost to Follow-up|0
7817683|NCT01225731|12284375|FG004|Part 2|Lost to Follow-up|0
7817684|NCT01225731|12284376|FG005|Part 2|Lost to Follow-up|0
7817685|NCT01225731|12284377|FG006|Part 2|Lost to Follow-up|0
7817686|NCT01225731|12284378|FG007|Part 2|Lost to Follow-up|3
7817687|NCT01225731|12284379|FG008|Part 2|Lost to Follow-up|1
7817688|NCT01225731|12284380|FG009|Part 2|Lost to Follow-up|0
7817689|NCT01225731|12284381|FG010|Part 2|Lost to Follow-up|0
7817690|NCT01225731|12284382|FG011|Part 2|Lost to Follow-up|0
7817691|NCT01225731|12284383|FG012|Part 2|Lost to Follow-up|0
7817692|NCT01225731|12284371|FG000|Part 2|Physician Decision|0
7817693|NCT01225731|12284372|FG001|Part 2|Physician Decision|0
7817694|NCT01225731|12284373|FG002|Part 2|Physician Decision|0
7817695|NCT01225731|12284374|FG003|Part 2|Physician Decision|0
7817696|NCT01225731|12284375|FG004|Part 2|Physician Decision|0
7817697|NCT01225731|12284376|FG005|Part 2|Physician Decision|0
7817698|NCT01225731|12284377|FG006|Part 2|Physician Decision|0
7817699|NCT01225731|12284378|FG007|Part 2|Physician Decision|2
7817700|NCT01225731|12284379|FG008|Part 2|Physician Decision|2
7817701|NCT01225731|12284380|FG009|Part 2|Physician Decision|0
7817702|NCT01225731|12284381|FG010|Part 2|Physician Decision|0
7817703|NCT01225731|12284382|FG011|Part 2|Physician Decision|0
7817704|NCT01225731|12284383|FG012|Part 2|Physician Decision|0
7817705|NCT01225731|12284371|FG000|Part 2|Withdrawal by Subject|0
7817706|NCT01225731|12284372|FG001|Part 2|Withdrawal by Subject|0
7817707|NCT01225731|12284373|FG002|Part 2|Withdrawal by Subject|0
7817708|NCT01225731|12284374|FG003|Part 2|Withdrawal by Subject|0
7817709|NCT01225731|12284375|FG004|Part 2|Withdrawal by Subject|0
7817710|NCT01225731|12284376|FG005|Part 2|Withdrawal by Subject|1
7817711|NCT01225731|12284377|FG006|Part 2|Withdrawal by Subject|3
7817712|NCT01225731|12284378|FG007|Part 2|Withdrawal by Subject|4
7817713|NCT01225731|12284379|FG008|Part 2|Withdrawal by Subject|1
7817714|NCT01225731|12284380|FG009|Part 2|Withdrawal by Subject|0
7817715|NCT01225731|12284381|FG010|Part 2|Withdrawal by Subject|0
7817716|NCT01225731|12284382|FG011|Part 2|Withdrawal by Subject|0
7817717|NCT01225731|12284383|FG012|Part 2|Withdrawal by Subject|0
7817718|NCT01225731|12284371|FG000|Part 3|Adverse Event|0
7817719|NCT01225731|12284372|FG001|Part 3|Adverse Event|0
7817720|NCT01225731|12284373|FG002|Part 3|Adverse Event|0
7817721|NCT01225731|12284374|FG003|Part 3|Adverse Event|0
7817722|NCT01225731|12284375|FG004|Part 3|Adverse Event|0
7817723|NCT01225731|12284376|FG005|Part 3|Adverse Event|0
7817724|NCT01225731|12284377|FG006|Part 3|Adverse Event|0
7817725|NCT01225731|12284378|FG007|Part 3|Adverse Event|0
7817726|NCT01225731|12284379|FG008|Part 3|Adverse Event|0
7817727|NCT01225731|12284380|FG009|Part 3|Adverse Event|0
7817728|NCT01225731|12284381|FG010|Part 3|Adverse Event|1
7817729|NCT01225731|12284382|FG011|Part 3|Adverse Event|1
7817730|NCT01225731|12284383|FG012|Part 3|Adverse Event|0
7817731|NCT01225731|12284371|FG000|Part 3|Lost to Follow-up|0
7817732|NCT01225731|12284372|FG001|Part 3|Lost to Follow-up|0
7817733|NCT01225731|12284373|FG002|Part 3|Lost to Follow-up|0
7817734|NCT01225731|12284374|FG003|Part 3|Lost to Follow-up|0
7817735|NCT01225731|12284375|FG004|Part 3|Lost to Follow-up|0
7817736|NCT01225731|12284376|FG005|Part 3|Lost to Follow-up|0
7817737|NCT01225731|12284377|FG006|Part 3|Lost to Follow-up|0
7817738|NCT01225731|12284378|FG007|Part 3|Lost to Follow-up|0
7817739|NCT01225731|12284379|FG008|Part 3|Lost to Follow-up|0
7817740|NCT01225731|12284380|FG009|Part 3|Lost to Follow-up|0
7817741|NCT01225731|12284381|FG010|Part 3|Lost to Follow-up|1
7817742|NCT01225731|12284382|FG011|Part 3|Lost to Follow-up|2
7817743|NCT01225731|12284383|FG012|Part 3|Lost to Follow-up|1
7817744|NCT01225731|12284371|FG000|Part 3|Physician Decision|0
7817745|NCT01225731|12284372|FG001|Part 3|Physician Decision|0
7817746|NCT01225731|12284373|FG002|Part 3|Physician Decision|0
7817747|NCT01225731|12284374|FG003|Part 3|Physician Decision|0
7817748|NCT01225731|12284375|FG004|Part 3|Physician Decision|0
7817749|NCT01225731|12284376|FG005|Part 3|Physician Decision|0
7817750|NCT01225731|12284377|FG006|Part 3|Physician Decision|0
7817751|NCT01225731|12284378|FG007|Part 3|Physician Decision|0
7817752|NCT01225731|12284379|FG008|Part 3|Physician Decision|0
7817753|NCT01225731|12284380|FG009|Part 3|Physician Decision|0
7817754|NCT01225731|12284381|FG010|Part 3|Physician Decision|0
7817755|NCT01225731|12284382|FG011|Part 3|Physician Decision|1
7817756|NCT01225731|12284383|FG012|Part 3|Physician Decision|2
7817757|NCT01225731|12284371|FG000|Part 3|Withdrawal by Subject|0
7817758|NCT01225731|12284372|FG001|Part 3|Withdrawal by Subject|0
7817759|NCT01225731|12284373|FG002|Part 3|Withdrawal by Subject|0
7817760|NCT01225731|12284374|FG003|Part 3|Withdrawal by Subject|0
7817761|NCT01225731|12284375|FG004|Part 3|Withdrawal by Subject|0
7817762|NCT01225731|12284376|FG005|Part 3|Withdrawal by Subject|0
7817763|NCT01225731|12284377|FG006|Part 3|Withdrawal by Subject|0
7817764|NCT01225731|12284378|FG007|Part 3|Withdrawal by Subject|0
7817765|NCT01225731|12284379|FG008|Part 3|Withdrawal by Subject|0
7817766|NCT01225731|12284380|FG009|Part 3|Withdrawal by Subject|0
7817767|NCT01225731|12284381|FG010|Part 3|Withdrawal by Subject|4
7817768|NCT01225731|12284382|FG011|Part 3|Withdrawal by Subject|6
7817769|NCT01225731|12284383|FG012|Part 3|Withdrawal by Subject|4
7817770|NCT01225822|12284417|FG000|Overall Study|Adverse Event|13
7817771|NCT01225822|12284418|FG001|Overall Study|Adverse Event|31
7817772|NCT01225822|12284419|FG002|Overall Study|Adverse Event|18
7817773|NCT01225822|12284420|FG003|Overall Study|Adverse Event|23
7817774|NCT01225822|12284421|FG004|Overall Study|Adverse Event|14
7817775|NCT01225822|12284417|FG000|Overall Study|Protocol Violation|6
7817776|NCT01225822|12284418|FG001|Overall Study|Protocol Violation|8
7817777|NCT01225822|12284419|FG002|Overall Study|Protocol Violation|6
7817778|NCT01225822|12284420|FG003|Overall Study|Protocol Violation|7
7817779|NCT01225822|12284421|FG004|Overall Study|Protocol Violation|4
7817780|NCT01225822|12284417|FG000|Overall Study|Lost to Follow-up|0
7817781|NCT01225822|12284418|FG001|Overall Study|Lost to Follow-up|0
7817782|NCT01225822|12284419|FG002|Overall Study|Lost to Follow-up|0
7817783|NCT01225822|12284420|FG003|Overall Study|Lost to Follow-up|1
7817784|NCT01225822|12284421|FG004|Overall Study|Lost to Follow-up|0
7817785|NCT01225822|12284417|FG000|Overall Study|Withdrawal by Subject|6
7817786|NCT01225822|12284418|FG001|Overall Study|Withdrawal by Subject|7
7817787|NCT01225822|12284419|FG002|Overall Study|Withdrawal by Subject|7
7817788|NCT01225822|12284420|FG003|Overall Study|Withdrawal by Subject|11
7817789|NCT01225822|12284421|FG004|Overall Study|Withdrawal by Subject|6
7817790|NCT01225822|12284417|FG000|Overall Study|Other|13
7817791|NCT01225822|12284418|FG001|Overall Study|Other|10
7817792|NCT01225822|12284419|FG002|Overall Study|Other|7
7817793|NCT01225822|12284420|FG003|Overall Study|Other|10
7817794|NCT01225822|12284421|FG004|Overall Study|Other|7
7719405|NCT00532129|12143391|FG000|Follow-up Period|Adverse event/Serious adverse event|1
7719406|NCT00532129|12143391|FG000|Follow-up Period|Disease progression|57
7719407|NCT00532129|12143391|FG000|Follow-up Period|Lost to Follow-up|1
7719408|NCT00532129|12143391|FG000|Follow-up Period|Other|6
7719409|NCT00532155|12143397|FG000|Overall Study|Adverse Event|66
7719410|NCT00532155|12143398|FG001|Overall Study|Adverse Event|123
7719411|NCT00532155|12143397|FG000|Overall Study|Lack of Efficacy|332
7719412|NCT00532155|12143398|FG001|Overall Study|Lack of Efficacy|255
7719413|NCT00532155|12143397|FG000|Overall Study|Protocol Violation|1
7719414|NCT00532155|12143398|FG001|Overall Study|Protocol Violation|3
7911457|NCT02063659|12428755|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7911458|NCT02063659|12428756|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7911459|NCT02063659|12428757|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7911460|NCT02063659|12428758|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1
7911461|NCT02063659|12428755|FG000|Open-Label Extension Period (OLE)|Adverse Event|0
7911462|NCT02063659|12428756|FG001|Open-Label Extension Period (OLE)|Adverse Event|0
7911463|NCT02063659|12428757|FG002|Open-Label Extension Period (OLE)|Adverse Event|0
7911464|NCT02063659|12428758|FG003|Open-Label Extension Period (OLE)|Adverse Event|7
7911465|NCT02063659|12428755|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0
7911466|NCT02063659|12428756|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0
7911467|NCT02063659|12428757|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0
7911468|NCT02063659|12428758|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2
7911469|NCT02063672|12428774|FG000|Overall Study|Ongoing Follow-up|27
7911470|NCT02063672|12428775|FG001|Overall Study|Ongoing Follow-up|14
7911471|NCT02063672|12428774|FG000|Overall Study|Death|5
7911472|NCT02063672|12428775|FG001|Overall Study|Death|3
7911473|NCT02063672|12428774|FG000|Overall Study|Lost to Follow-up|1
7911474|NCT02063672|12428775|FG001|Overall Study|Lost to Follow-up|3
7911475|NCT02063672|12428774|FG000|Overall Study|Withdrawal by Subject|2
7911476|NCT02063672|12428775|FG001|Overall Study|Withdrawal by Subject|2
7911477|NCT02063698|12428783|FG000|Overall Study|did not complete booklet for days 2-8|1
7911478|NCT02063698|12428784|FG001|Overall Study|did not complete booklet for days 2-8|2
7719415|NCT00532155|12143397|FG000|Overall Study|Lost to Follow-up|2
7817795|NCT01225835|12284438|FG000|Overall Study|Completed protocol|2
7817796|NCT01225835|12284439|FG001|Overall Study|Completed protocol|1
7817797|NCT01225835|12284438|FG000|Overall Study|Did not meet hCG criterion|2
7817798|NCT01225835|12284439|FG001|Overall Study|Did not meet hCG criterion|0
7817799|NCT01225835|12284438|FG000|Overall Study|Adverse Event|2
7817800|NCT01225835|12284439|FG001|Overall Study|Adverse Event|1
7817801|NCT01225835|12284438|FG000|Overall Study|Other|1
7817802|NCT01225835|12284439|FG001|Overall Study|Other|1
7817803|NCT01225887|12284451|FG000|Overall Study|Ineligible:required test not done|2
7817804|NCT01225887|12284451|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1
7817805|NCT01225887|12284451|FG000|Overall Study|Ineligible:inadequate pathology|2
7817806|NCT01225952|12284467|FG000|Overall Study|Lost to Follow-up|1
7817807|NCT01225952|12284468|FG001|Overall Study|Lost to Follow-up|0
7817808|NCT01225952|12284469|FG002|Overall Study|Lost to Follow-up|0
7817809|NCT01225952|12284467|FG000|Overall Study|Study Eye Explanted|0
7817810|NCT01225952|12284468|FG001|Overall Study|Study Eye Explanted|0
7817811|NCT01225952|12284469|FG002|Overall Study|Study Eye Explanted|1
7817812|NCT01225952|12284467|FG000|Overall Study|Withdrawal by Subject|4
7817813|NCT01225952|12284468|FG001|Overall Study|Withdrawal by Subject|4
7817814|NCT01225952|12284469|FG002|Overall Study|Withdrawal by Subject|5
7817815|NCT01225952|12284467|FG000|Overall Study|Surgical complications|1
7817816|NCT01225952|12284468|FG001|Overall Study|Surgical complications|0
7817817|NCT01225952|12284469|FG002|Overall Study|Surgical complications|0
7861999|NCT01597245|12351194|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7862000|NCT01597245|12351195|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7862001|NCT01597245|12351196|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7862002|NCT01597245|12351197|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7862003|NCT01597245|12351198|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7862004|NCT01597245|12351199|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7862005|NCT01597245|12351200|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7862006|NCT01597245|12351201|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7862007|NCT01597245|12351202|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7862008|NCT01597245|12351203|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7862009|NCT01597245|12351204|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7862010|NCT01597245|12351205|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7862011|NCT01597245|12351206|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7862012|NCT01597245|12351207|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7862013|NCT01597245|12351208|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7862014|NCT01597245|12351188|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862015|NCT01597245|12351189|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862016|NCT01597245|12351190|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862017|NCT01597245|12351191|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862018|NCT01597245|12351192|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862019|NCT01597245|12351193|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862020|NCT01597245|12351194|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862021|NCT01597245|12351195|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862022|NCT01597245|12351196|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7883705|NCT01783886|12383536|FG001|Overall Study|Adverse Event|5
7883706|NCT01783886|12383537|FG002|Overall Study|Adverse Event|4
7883707|NCT01783938|12383560|FG000|Overall Study|Disease Progression|18
7883708|NCT01783938|12383561|FG001|Overall Study|Disease Progression|41
7883709|NCT01783938|12383560|FG000|Overall Study|Study Drug Toxicity|27
7883710|NCT01783938|12383561|FG001|Overall Study|Study Drug Toxicity|14
7883711|NCT01783938|12383560|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4
7883712|NCT01783938|12383561|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2
7883713|NCT01783938|12383560|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2
7883714|NCT01783938|12383561|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3
7883715|NCT01783938|12383560|FG000|Overall Study|Participant Withdrew Consent|2
7883716|NCT01783938|12383561|FG001|Overall Study|Participant Withdrew Consent|0
7883717|NCT01783938|12383560|FG000|Overall Study|Maximum Clinical Benefit|1
7883718|NCT01783938|12383561|FG001|Overall Study|Maximum Clinical Benefit|0
7883719|NCT01783938|12383560|FG000|Overall Study|Other Reasons|3
7883720|NCT01783938|12383561|FG001|Overall Study|Other Reasons|1
7883721|NCT01784029|12383581|FG000|Overall Study|Lost to Follow-up|19
7883722|NCT01784029|12383582|FG001|Overall Study|Lost to Follow-up|20
7883723|NCT01784029|12383583|FG002|Overall Study|Lost to Follow-up|22
7883724|NCT01784068|12383595|FG000|NTCS Phase|Adverse Event|5
7883725|NCT01784068|12383596|FG001|NTCS Phase|Adverse Event|0
7883726|NCT01784068|12383595|FG000|NTCS Phase|Physician Decision|2
7883727|NCT01784068|12383596|FG001|NTCS Phase|Physician Decision|0
7883728|NCT01784068|12383595|FG000|NTCS Phase|Patient/guardian decision|3
7883729|NCT01784068|12383596|FG001|NTCS Phase|Patient/guardian decision|0
7883730|NCT01784068|12383595|FG000|NTCS Phase|Death|2
7883731|NCT01784068|12383596|FG001|NTCS Phase|Death|0
7883732|NCT01784068|12383595|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203
7883733|NCT01784068|12383596|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0
7883734|NCT01784068|12383595|FG000|TFR Phase|Physician Decision|0
7883735|NCT01784068|12383596|FG001|TFR Phase|Physician Decision|1
7883736|NCT01784068|12383595|FG000|TFR Phase|Patient/guardian decision|0
7911479|NCT02063737|12428792|FG000|Overall Study|Lost to Follow-up|11
7911480|NCT02063737|12428793|FG001|Overall Study|Lost to Follow-up|4
7911481|NCT02063828|12428802|FG000|Overall Study|Withdrawal by Subject|4
7911482|NCT02063828|12428803|FG001|Overall Study|Withdrawal by Subject|6
7911483|NCT02063828|12428804|FG002|Overall Study|Withdrawal by Subject|3
7911484|NCT02063828|12428802|FG000|Overall Study|Death|0
7911485|NCT02063828|12428803|FG001|Overall Study|Death|0
7911486|NCT02063828|12428804|FG002|Overall Study|Death|1
7911487|NCT02063854|12428819|FG000|Overall Study|Pretreatment Event/Adverse Event|13
7911488|NCT02063854|12428820|FG001|Overall Study|Pretreatment Event/Adverse Event|10
7911489|NCT02063854|12428821|FG002|Overall Study|Pretreatment Event/Adverse Event|13
7911490|NCT02063854|12428822|FG003|Overall Study|Pretreatment Event/Adverse Event|8
7911491|NCT02063854|12428823|FG004|Overall Study|Pretreatment Event/Adverse Event|7
7911492|NCT02063854|12428824|FG005|Overall Study|Pretreatment Event/Adverse Event|18
7911493|NCT02063854|12428825|FG006|Overall Study|Pretreatment Event/Adverse Event|4
7911494|NCT02063854|12428819|FG000|Overall Study|Major Protocol Deviation|0
7911495|NCT02063854|12428820|FG001|Overall Study|Major Protocol Deviation|0
7911496|NCT02063854|12428821|FG002|Overall Study|Major Protocol Deviation|3
7911497|NCT02063854|12428822|FG003|Overall Study|Major Protocol Deviation|0
7911498|NCT02063854|12428823|FG004|Overall Study|Major Protocol Deviation|0
7911499|NCT02063854|12428824|FG005|Overall Study|Major Protocol Deviation|0
7911500|NCT02063854|12428825|FG006|Overall Study|Major Protocol Deviation|0
7911501|NCT02063854|12428819|FG000|Overall Study|Voluntary Withdrawal|2
7911502|NCT02063854|12428820|FG001|Overall Study|Voluntary Withdrawal|0
7817818|NCT01225991|12284477|FG000|Overall Study|Withdrawal by Subject|6
7817819|NCT01226043|12284483|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1
7817820|NCT01226043|12284484|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2
7911503|NCT02063854|12428821|FG002|Overall Study|Voluntary Withdrawal|8
7817821|NCT01226043|12284485|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0
7817822|NCT01226043|12284486|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0
7817823|NCT01226043|12284483|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0
7817824|NCT01226043|12284484|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1
7817825|NCT01226043|12284485|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0
7817826|NCT01226043|12284486|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0
7817827|NCT01226043|12284483|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
7817828|NCT01226043|12284484|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
7817829|NCT01226043|12284485|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
7817830|NCT01226043|12284486|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
7817831|NCT01226043|12284483|FG000|4-week Crossover Phase - Period 1|Physician Decision|0
7817832|NCT01226043|12284484|FG001|4-week Crossover Phase - Period 1|Physician Decision|6
7817833|NCT01226043|12284485|FG002|4-week Crossover Phase - Period 1|Physician Decision|0
7817834|NCT01226043|12284486|FG003|4-week Crossover Phase - Period 1|Physician Decision|0
7817835|NCT01226043|12284483|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
7817836|NCT01226043|12284484|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
7817837|NCT01226043|12284485|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
7817838|NCT01226043|12284486|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
7817839|NCT01226043|12284483|FG000|4-week Crossover Phase - Period 2|Physician Decision|4
7817840|NCT01226043|12284484|FG001|4-week Crossover Phase - Period 2|Physician Decision|5
7817841|NCT01226043|12284485|FG002|4-week Crossover Phase - Period 2|Physician Decision|0
7817842|NCT01226043|12284486|FG003|4-week Crossover Phase - Period 2|Physician Decision|0
7817843|NCT01226043|12284483|FG000|6-week Re-randomization Phase|Adverse Event|0
7817844|NCT01226043|12284484|FG001|6-week Re-randomization Phase|Adverse Event|0
7817845|NCT01226043|12284485|FG002|6-week Re-randomization Phase|Adverse Event|1
7817846|NCT01226043|12284486|FG003|6-week Re-randomization Phase|Adverse Event|1
7817847|NCT01226043|12284483|FG000|6-week Re-randomization Phase|Protocol Violation|0
7817848|NCT01226043|12284484|FG001|6-week Re-randomization Phase|Protocol Violation|0
7817849|NCT01226043|12284485|FG002|6-week Re-randomization Phase|Protocol Violation|1
7817850|NCT01226043|12284486|FG003|6-week Re-randomization Phase|Protocol Violation|1
7817851|NCT01226043|12284483|FG000|6-week Re-randomization Phase|Lost to Follow-up|0
7817852|NCT01226043|12284484|FG001|6-week Re-randomization Phase|Lost to Follow-up|0
7817853|NCT01226043|12284485|FG002|6-week Re-randomization Phase|Lost to Follow-up|1
7817854|NCT01226043|12284486|FG003|6-week Re-randomization Phase|Lost to Follow-up|3
7817855|NCT01226043|12284483|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0
7817856|NCT01226043|12284484|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0
7817857|NCT01226043|12284485|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1
7817858|NCT01226043|12284486|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3
7817859|NCT01226043|12284483|FG000|6-week Re-randomization Phase|Physician Decision|0
7817860|NCT01226043|12284484|FG001|6-week Re-randomization Phase|Physician Decision|0
7817861|NCT01226043|12284485|FG002|6-week Re-randomization Phase|Physician Decision|3
7817862|NCT01226043|12284486|FG003|6-week Re-randomization Phase|Physician Decision|2
7817863|NCT01226043|12284483|FG000|6-week Re-randomization Phase|completed in error|0
7817864|NCT01226043|12284484|FG001|6-week Re-randomization Phase|completed in error|0
7817865|NCT01226043|12284485|FG002|6-week Re-randomization Phase|completed in error|0
7817866|NCT01226043|12284486|FG003|6-week Re-randomization Phase|completed in error|1
7817867|NCT01226043|12284483|FG000|30-week Observational Phase|Adverse Event|0
7817868|NCT01226043|12284484|FG001|30-week Observational Phase|Adverse Event|0
7817869|NCT01226043|12284485|FG002|30-week Observational Phase|Adverse Event|1
7817870|NCT01226043|12284486|FG003|30-week Observational Phase|Adverse Event|1
7817871|NCT01226043|12284483|FG000|30-week Observational Phase|Protocol Violation|0
7817872|NCT01226043|12284484|FG001|30-week Observational Phase|Protocol Violation|0
7817873|NCT01226043|12284485|FG002|30-week Observational Phase|Protocol Violation|0
7817874|NCT01226043|12284486|FG003|30-week Observational Phase|Protocol Violation|1
7817875|NCT01226043|12284483|FG000|30-week Observational Phase|Lost to Follow-up|0
7817876|NCT01226043|12284484|FG001|30-week Observational Phase|Lost to Follow-up|0
7817877|NCT01226043|12284485|FG002|30-week Observational Phase|Lost to Follow-up|2
7817878|NCT01226043|12284486|FG003|30-week Observational Phase|Lost to Follow-up|2
7817879|NCT01226043|12284483|FG000|30-week Observational Phase|Withdrawal by Subject|0
7817880|NCT01226043|12284484|FG001|30-week Observational Phase|Withdrawal by Subject|0
7817881|NCT01226043|12284485|FG002|30-week Observational Phase|Withdrawal by Subject|1
7817882|NCT01226043|12284486|FG003|30-week Observational Phase|Withdrawal by Subject|7
7817883|NCT01226043|12284483|FG000|30-week Observational Phase|Physician Decision|0
7817884|NCT01226043|12284484|FG001|30-week Observational Phase|Physician Decision|0
7817885|NCT01226043|12284485|FG002|30-week Observational Phase|Physician Decision|2
7817886|NCT01226043|12284486|FG003|30-week Observational Phase|Physician Decision|2
7817887|NCT01226095|12284516|FG000|Overall Study|Poor compliance|1
7817888|NCT01226121|12284530|FG000|Overall Study|Lost to Follow-up|2
7817889|NCT01226121|12284531|FG001|Overall Study|Lost to Follow-up|0
7817890|NCT01226121|12284532|FG002|Overall Study|Lost to Follow-up|1
7817891|NCT01226459|12284546|FG000|Overall Study|Adverse Event|2
7817892|NCT01226459|12284547|FG001|Overall Study|Adverse Event|8
7817893|NCT01226459|12284546|FG000|Overall Study|Protocol Violation|4
7817894|NCT01226459|12284547|FG001|Overall Study|Protocol Violation|3
7817895|NCT01226459|12284546|FG000|Overall Study|Withdrawal by Subject|10
7817896|NCT01226459|12284547|FG001|Overall Study|Withdrawal by Subject|13
7817897|NCT01226459|12284546|FG000|Overall Study|Lost to Follow-up|4
7817898|NCT01226459|12284547|FG001|Overall Study|Lost to Follow-up|8
7817899|NCT01226459|12284546|FG000|Overall Study|Pregnancy|1
7817900|NCT01226459|12284547|FG001|Overall Study|Pregnancy|0
7817901|NCT01226472|12284553|FG000|Overall Study|Progressive Disease|1
7817902|NCT01226511|12284596|FG000|Acute Treatment Period|Adverse Event|7
7817903|NCT01226511|12284597|FG001|Acute Treatment Period|Adverse Event|6
7817904|NCT01226511|12284596|FG000|Acute Treatment Period|Lack of Efficacy|2
7817905|NCT01226511|12284597|FG001|Acute Treatment Period|Lack of Efficacy|1
7817906|NCT01226511|12284596|FG000|Acute Treatment Period|Lost to Follow-up|3
7817907|NCT01226511|12284597|FG001|Acute Treatment Period|Lost to Follow-up|6
7817908|NCT01226511|12284596|FG000|Acute Treatment Period|Parent/caregiver decision|5
7817909|NCT01226511|12284597|FG001|Acute Treatment Period|Parent/caregiver decision|7
7817910|NCT01226511|12284596|FG000|Acute Treatment Period|Protocol Violation|5
7817911|NCT01226511|12284597|FG001|Acute Treatment Period|Protocol Violation|5
7817912|NCT01226511|12284596|FG000|Acute Treatment Period|Withdrawal by Subject|10
7817913|NCT01226511|12284597|FG001|Acute Treatment Period|Withdrawal by Subject|6
7817914|NCT01226511|12284596|FG000|Extension Treatment Period|Adverse Event|8
7817915|NCT01226511|12284597|FG001|Extension Treatment Period|Adverse Event|8
7817916|NCT01226511|12284596|FG000|Extension Treatment Period|Lack of Efficacy|3
7817917|NCT01226511|12284597|FG001|Extension Treatment Period|Lack of Efficacy|2
7817918|NCT01226511|12284596|FG000|Extension Treatment Period|Lost to Follow-up|4
7817919|NCT01226511|12284597|FG001|Extension Treatment Period|Lost to Follow-up|3
7817920|NCT01226511|12284596|FG000|Extension Treatment Period|Protocol Violation|2
7817921|NCT01226511|12284597|FG001|Extension Treatment Period|Protocol Violation|2
7817922|NCT01226511|12284596|FG000|Extension Treatment Period|Withdrawal by Subject|1
7817923|NCT01226511|12284597|FG001|Extension Treatment Period|Withdrawal by Subject|3
7817924|NCT01226511|12284596|FG000|Extension Treatment Period|Parent/Caregiver Decision|8
7817925|NCT01226511|12284597|FG001|Extension Treatment Period|Parent/Caregiver Decision|8
7817926|NCT01226511|12284596|FG000|Extension Treatment Period|Sponsor Decision|1
7817927|NCT01226511|12284597|FG001|Extension Treatment Period|Sponsor Decision|1
7817928|NCT01226511|12284596|FG000|Taper Period|Adverse Event|1
7817929|NCT01226511|12284597|FG001|Taper Period|Adverse Event|0
7817930|NCT01226511|12284596|FG000|Taper Period|Lost to Follow-up|2
7817931|NCT01226511|12284597|FG001|Taper Period|Lost to Follow-up|2
7817932|NCT01226511|12284596|FG000|Taper Period|Protocol Violation|1
7911504|NCT02063854|12428822|FG003|Overall Study|Voluntary Withdrawal|1
7911505|NCT02063854|12428823|FG004|Overall Study|Voluntary Withdrawal|3
7911506|NCT02063854|12428824|FG005|Overall Study|Voluntary Withdrawal|6
7911507|NCT02063854|12428825|FG006|Overall Study|Voluntary Withdrawal|1
7911508|NCT02063854|12428819|FG000|Overall Study|Surgical Dental Work Performed/Planned|5
7911509|NCT02063854|12428820|FG001|Overall Study|Surgical Dental Work Performed/Planned|2
7911510|NCT02063854|12428821|FG002|Overall Study|Surgical Dental Work Performed/Planned|6
7911511|NCT02063854|12428822|FG003|Overall Study|Surgical Dental Work Performed/Planned|1
7911512|NCT02063854|12428823|FG004|Overall Study|Surgical Dental Work Performed/Planned|1
7911513|NCT02063854|12428824|FG005|Overall Study|Surgical Dental Work Performed/Planned|6
7911514|NCT02063854|12428825|FG006|Overall Study|Surgical Dental Work Performed/Planned|1
7911515|NCT02063854|12428819|FG000|Overall Study|Reason Not Specified|1
7911516|NCT02063854|12428820|FG001|Overall Study|Reason Not Specified|0
7911517|NCT02063854|12428821|FG002|Overall Study|Reason Not Specified|0
7911518|NCT02063854|12428822|FG003|Overall Study|Reason Not Specified|0
7911519|NCT02063854|12428823|FG004|Overall Study|Reason Not Specified|0
7911520|NCT02063854|12428824|FG005|Overall Study|Reason Not Specified|0
7911521|NCT02063854|12428825|FG006|Overall Study|Reason Not Specified|0
7911522|NCT02063854|12428819|FG000|Overall Study|Did Not Receive Study Drug|0
7911523|NCT02063854|12428820|FG001|Overall Study|Did Not Receive Study Drug|0
7911524|NCT02063854|12428821|FG002|Overall Study|Did Not Receive Study Drug|0
7911525|NCT02063854|12428822|FG003|Overall Study|Did Not Receive Study Drug|0
7911526|NCT02063854|12428823|FG004|Overall Study|Did Not Receive Study Drug|0
7911527|NCT02063854|12428824|FG005|Overall Study|Did Not Receive Study Drug|1
7911528|NCT02063854|12428825|FG006|Overall Study|Did Not Receive Study Drug|0
7911529|NCT02063880|12428854|FG000|Overall Study|Death|21
7911530|NCT02063880|12428855|FG001|Overall Study|Death|18
7911531|NCT02063880|12428854|FG000|Overall Study|Lost to Follow-up|7
7911532|NCT02063880|12428855|FG001|Overall Study|Lost to Follow-up|7
7911533|NCT02063880|12428854|FG000|Overall Study|Ineligible|0
7911534|NCT02063880|12428855|FG001|Overall Study|Ineligible|2
7911535|NCT02063984|12428863|FG000|Overall Study|Lost to Follow-up|6
7911536|NCT02063984|12428864|FG001|Overall Study|Lost to Follow-up|5
7817933|NCT01226511|12284597|FG001|Taper Period|Protocol Violation|0
7911537|NCT02064166|12428876|FG000|Overall Study|Adverse Event|1
7911538|NCT02064166|12428877|FG001|Overall Study|Adverse Event|0
7817934|NCT01226511|12284596|FG000|Taper Period|Parent/Caregiver Decision|1
7817935|NCT01226511|12284597|FG001|Taper Period|Parent/Caregiver Decision|1
7817936|NCT01226745|12284630|FG000|Overall Study|Did not complete schedule of assessments|8
7911539|NCT02064205|12428905|FG000|Overall Study|Withdrawal by Subject|1
7817937|NCT01226745|12284631|FG001|Overall Study|Did not complete schedule of assessments|3
7817938|NCT01226745|12284632|FG002|Overall Study|Did not complete schedule of assessments|6
7817939|NCT01226745|12284633|FG003|Overall Study|Did not complete schedule of assessments|0
7817940|NCT01226745|12284634|FG004|Overall Study|Did not complete schedule of assessments|0
7817941|NCT01226745|12284635|FG005|Overall Study|Did not complete schedule of assessments|1
7817942|NCT01226745|12284630|FG000|Overall Study|Lost to Follow-up|2
7817943|NCT01226745|12284631|FG001|Overall Study|Lost to Follow-up|6
7817944|NCT01226745|12284632|FG002|Overall Study|Lost to Follow-up|6
7817945|NCT01226745|12284633|FG003|Overall Study|Lost to Follow-up|1
7817946|NCT01226745|12284634|FG004|Overall Study|Lost to Follow-up|1
7817947|NCT01226745|12284635|FG005|Overall Study|Lost to Follow-up|2
7817948|NCT01226745|12284630|FG000|Overall Study|Death|1
7817949|NCT01226745|12284631|FG001|Overall Study|Death|0
7817950|NCT01226745|12284632|FG002|Overall Study|Death|0
7817951|NCT01226745|12284633|FG003|Overall Study|Death|0
7817952|NCT01226745|12284634|FG004|Overall Study|Death|0
7817953|NCT01226745|12284635|FG005|Overall Study|Death|1
7817954|NCT01226745|12284630|FG000|Overall Study|Other|6
7817955|NCT01226745|12284631|FG001|Overall Study|Other|7
7817956|NCT01226745|12284632|FG002|Overall Study|Other|8
7817957|NCT01226745|12284633|FG003|Overall Study|Other|4
7817958|NCT01226745|12284634|FG004|Overall Study|Other|3
7817959|NCT01226745|12284635|FG005|Overall Study|Other|1
7817960|NCT01227018|12284673|FG000|Overall Study|Disease progression|9
7817961|NCT01227018|12284673|FG000|Overall Study|Toxicity|2
7817962|NCT01227018|12284673|FG000|Overall Study|Withdrew after beginning treatment|4
7817963|NCT01227044|12284679|FG000|Overall Study|Lost to Follow-up|5
7817964|NCT01227044|12284680|FG001|Overall Study|Lost to Follow-up|7
7817965|NCT01227044|12284679|FG000|Overall Study|Discontinued Intervention|1
7817966|NCT01227044|12284680|FG001|Overall Study|Discontinued Intervention|2
7817967|NCT01227252|12284700|FG000|Overall Study|Sponsor Decision|0
7817968|NCT01227252|12284701|FG001|Overall Study|Sponsor Decision|1
7817969|NCT01227252|12284702|FG002|Overall Study|Sponsor Decision|0
7817970|NCT01227252|12284703|FG003|Overall Study|Sponsor Decision|0
7817971|NCT01227252|12284700|FG000|Overall Study|Lost to Follow-up|0
7817972|NCT01227252|12284701|FG001|Overall Study|Lost to Follow-up|1
7817973|NCT01227252|12284702|FG002|Overall Study|Lost to Follow-up|0
7817974|NCT01227252|12284703|FG003|Overall Study|Lost to Follow-up|0
7817975|NCT01227252|12284700|FG000|Overall Study|Withdrawal by Subject|0
7817976|NCT01227252|12284701|FG001|Overall Study|Withdrawal by Subject|1
7817977|NCT01227252|12284702|FG002|Overall Study|Withdrawal by Subject|0
7817978|NCT01227252|12284703|FG003|Overall Study|Withdrawal by Subject|0
7817979|NCT01227265|12284719|FG000|Overall Study|Did Not Receive Treatment|1
7817980|NCT01227265|12284720|FG001|Overall Study|Did Not Receive Treatment|2
7817981|NCT01227265|12284721|FG002|Overall Study|Did Not Receive Treatment|0
7817982|NCT01227265|12284719|FG000|Overall Study|Administrative|1
7817983|NCT01227265|12284720|FG001|Overall Study|Administrative|0
7817984|NCT01227265|12284721|FG002|Overall Study|Administrative|2
7817985|NCT01227265|12284719|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
7817986|NCT01227265|12284720|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
7817987|NCT01227265|12284721|FG002|Overall Study|Did Not Meet Protocol Eligibility|1
7817988|NCT01227265|12284719|FG000|Overall Study|Protocol Violation|2
7817989|NCT01227265|12284720|FG001|Overall Study|Protocol Violation|1
7817990|NCT01227265|12284721|FG002|Overall Study|Protocol Violation|0
7817991|NCT01227265|12284719|FG000|Overall Study|Withdrawal by Subject|7
7817992|NCT01227265|12284720|FG001|Overall Study|Withdrawal by Subject|7
7817993|NCT01227265|12284721|FG002|Overall Study|Withdrawal by Subject|3
7817994|NCT01227265|12284719|FG000|Overall Study|Lost to Follow-up|2
7817995|NCT01227265|12284720|FG001|Overall Study|Lost to Follow-up|0
7817996|NCT01227265|12284721|FG002|Overall Study|Lost to Follow-up|3
7817997|NCT01227265|12284719|FG000|Overall Study|Adverse Event|6
7817998|NCT01227265|12284720|FG001|Overall Study|Adverse Event|10
7817999|NCT01227265|12284721|FG002|Overall Study|Adverse Event|5
7818000|NCT01227278|12284731|FG000|Overall Study|Withdrawal by Subject|4
7818001|NCT01227278|12284732|FG001|Overall Study|Withdrawal by Subject|4
7818002|NCT01227278|12284731|FG000|Overall Study|Death|0
7818003|NCT01227278|12284732|FG001|Overall Study|Death|2
7818004|NCT01227278|12284731|FG000|Overall Study|Other|1
7818005|NCT01227278|12284732|FG001|Overall Study|Other|2
7818006|NCT01227395|12284746|FG000|Overall Study|Protocol Violation|0
7818007|NCT01227395|12284747|FG001|Overall Study|Protocol Violation|1
7818008|NCT01227421|12284775|FG000|Overall Study|Lost to Follow-up|6
7818009|NCT01227421|12284776|FG001|Overall Study|Lost to Follow-up|7
7818010|NCT01227421|12284777|FG002|Overall Study|Lost to Follow-up|5
7818011|NCT01227421|12284775|FG000|Overall Study|Adverse Event|2
7818012|NCT01227421|12284776|FG001|Overall Study|Adverse Event|7
7818013|NCT01227421|12284777|FG002|Overall Study|Adverse Event|2
7818014|NCT01227421|12284775|FG000|Overall Study|Withdrawal by Subject|1
7818015|NCT01227421|12284776|FG001|Overall Study|Withdrawal by Subject|2
7818016|NCT01227421|12284777|FG002|Overall Study|Withdrawal by Subject|1
7818017|NCT01227421|12284775|FG000|Overall Study|Protocol Violation|1
7818018|NCT01227421|12284776|FG001|Overall Study|Protocol Violation|1
7818019|NCT01227421|12284777|FG002|Overall Study|Protocol Violation|2
7818020|NCT01227421|12284775|FG000|Overall Study|Randomized in error|1
7818021|NCT01227421|12284776|FG001|Overall Study|Randomized in error|1
7818022|NCT01227421|12284777|FG002|Overall Study|Randomized in error|0
7818023|NCT01227512|12284797|FG000|Overall Study|Physician Decision|6
7818024|NCT01227512|12284798|FG001|Overall Study|Physician Decision|6
7818025|NCT01227512|12284797|FG000|Overall Study|Adverse Event|4
7818026|NCT01227512|12284798|FG001|Overall Study|Adverse Event|3
7818027|NCT01227512|12284797|FG000|Overall Study|Withdrawal by Subject|3
7818028|NCT01227512|12284798|FG001|Overall Study|Withdrawal by Subject|0
7818029|NCT01227512|12284797|FG000|Overall Study|Participant met withdrawal criteria|0
7818030|NCT01227512|12284798|FG001|Overall Study|Participant met withdrawal criteria|1
7818031|NCT01227564|12284813|FG000|Overall Study|No Longer Willing to Participate|4
7818032|NCT01227564|12284814|FG001|Overall Study|No Longer Willing to Participate|2
7818033|NCT01227564|12284815|FG002|Overall Study|No Longer Willing to Participate|5
7818034|NCT01227564|12284813|FG000|Overall Study|Participant moved to another town|0
7818035|NCT01227564|12284814|FG001|Overall Study|Participant moved to another town|0
7818036|NCT01227564|12284815|FG002|Overall Study|Participant moved to another town|1
7818037|NCT01227577|12284825|FG000|Overall Study|Protocol deviation|3
7818038|NCT01227577|12284825|FG000|Overall Study|Death|3
7818039|NCT01227577|12284825|FG000|Overall Study|Administrative problems|2
7818040|NCT01227577|12284825|FG000|Overall Study|Lost to Follow-up|1
7818041|NCT01227577|12284825|FG000|Overall Study|Withdrawal by Subject|4
7818042|NCT01227577|12284825|FG000|Overall Study|Lack of Efficacy|5
7818043|NCT01227577|12284825|FG000|Overall Study|Adverse Event|17
7818044|NCT01227629|12284839|FG000|Overall Study|Adverse Event|2
7818045|NCT01227629|12284840|FG001|Overall Study|Adverse Event|2
7818046|NCT01227629|12284841|FG002|Overall Study|Adverse Event|1
7818047|NCT01227629|12284842|FG003|Overall Study|Adverse Event|6
7818048|NCT01227629|12284843|FG004|Overall Study|Adverse Event|1
7818049|NCT01227629|12284844|FG005|Overall Study|Adverse Event|1
7818050|NCT01227629|12284845|FG006|Overall Study|Adverse Event|6
7818051|NCT01227629|12284846|FG007|Overall Study|Adverse Event|6
7818052|NCT01227629|12284847|FG008|Overall Study|Adverse Event|4
7818053|NCT01227629|12284848|FG009|Overall Study|Adverse Event|0
7818054|NCT01227629|12284839|FG000|Overall Study|Protocol Violation|0
7818055|NCT01227629|12284840|FG001|Overall Study|Protocol Violation|0
7818056|NCT01227629|12284841|FG002|Overall Study|Protocol Violation|0
7818057|NCT01227629|12284842|FG003|Overall Study|Protocol Violation|1
7818058|NCT01227629|12284843|FG004|Overall Study|Protocol Violation|0
7818059|NCT01227629|12284844|FG005|Overall Study|Protocol Violation|0
7818060|NCT01227629|12284845|FG006|Overall Study|Protocol Violation|0
7818061|NCT01227629|12284846|FG007|Overall Study|Protocol Violation|0
7818062|NCT01227629|12284847|FG008|Overall Study|Protocol Violation|0
7818063|NCT01227629|12284848|FG009|Overall Study|Protocol Violation|0
7818064|NCT01227629|12284839|FG000|Overall Study|Lost to Follow-up|0
7818065|NCT01227629|12284840|FG001|Overall Study|Lost to Follow-up|0
7818066|NCT01227629|12284841|FG002|Overall Study|Lost to Follow-up|0
7818067|NCT01227629|12284842|FG003|Overall Study|Lost to Follow-up|0
7818068|NCT01227629|12284843|FG004|Overall Study|Lost to Follow-up|1
7818069|NCT01227629|12284844|FG005|Overall Study|Lost to Follow-up|0
7818070|NCT01227629|12284845|FG006|Overall Study|Lost to Follow-up|0
7818071|NCT01227629|12284846|FG007|Overall Study|Lost to Follow-up|0
7818072|NCT01227629|12284847|FG008|Overall Study|Lost to Follow-up|0
7818073|NCT01227629|12284848|FG009|Overall Study|Lost to Follow-up|0
7818074|NCT01227629|12284839|FG000|Overall Study|Withdrawal by Subject|0
7818075|NCT01227629|12284840|FG001|Overall Study|Withdrawal by Subject|0
7818076|NCT01227629|12284841|FG002|Overall Study|Withdrawal by Subject|0
7818077|NCT01227629|12284842|FG003|Overall Study|Withdrawal by Subject|0
7818078|NCT01227629|12284843|FG004|Overall Study|Withdrawal by Subject|0
7818079|NCT01227629|12284844|FG005|Overall Study|Withdrawal by Subject|0
7818080|NCT01227629|12284845|FG006|Overall Study|Withdrawal by Subject|2
7818081|NCT01227629|12284846|FG007|Overall Study|Withdrawal by Subject|0
7818082|NCT01227629|12284847|FG008|Overall Study|Withdrawal by Subject|0
7818083|NCT01227629|12284848|FG009|Overall Study|Withdrawal by Subject|1
7818084|NCT01227629|12284839|FG000|Overall Study|Other|0
7818085|NCT01227629|12284840|FG001|Overall Study|Other|0
7818086|NCT01227629|12284841|FG002|Overall Study|Other|0
7818087|NCT01227629|12284842|FG003|Overall Study|Other|1
7818088|NCT01227629|12284843|FG004|Overall Study|Other|0
7818089|NCT01227629|12284844|FG005|Overall Study|Other|0
7818090|NCT01227629|12284845|FG006|Overall Study|Other|0
7818091|NCT01227629|12284846|FG007|Overall Study|Other|0
7818092|NCT01227629|12284847|FG008|Overall Study|Other|2
7818093|NCT01227629|12284848|FG009|Overall Study|Other|1
7818094|NCT01227668|12284909|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12
7818095|NCT01227668|12284910|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0
7818096|NCT01227668|12284909|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
7818097|NCT01227668|12284910|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
7818098|NCT01227668|12284909|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
7818099|NCT01227668|12284910|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
7818100|NCT01227668|12284909|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
7818101|NCT01227668|12284910|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
7818102|NCT01227668|12284909|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
7818103|NCT01227668|12284910|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
7818104|NCT01227668|12284909|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
7818105|NCT01227668|12284910|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
7818106|NCT01227668|12284909|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
7818107|NCT01227668|12284910|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
7818108|NCT01227668|12284909|FG000|Phase 2 (Randomization Phase)|Adverse Event|0
7818109|NCT01227668|12284910|FG001|Phase 2 (Randomization Phase)|Adverse Event|1
7818110|NCT01227668|12284909|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
7818111|NCT01227668|12284910|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
7818112|NCT01227668|12284909|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1
7818113|NCT01227668|12284910|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0
7818114|NCT01227668|12284909|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13
7818115|NCT01227668|12284910|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23
7818116|NCT01227668|12284909|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
7818117|NCT01227668|12284910|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
7818118|NCT01227707|12284929|FG000|Overall Study|Adverse Event|10
7818119|NCT01227707|12284929|FG000|Overall Study|Progression of disease|3
7818120|NCT01227707|12284929|FG000|Overall Study|Withdrawal by Subject|1
7818121|NCT01227707|12284929|FG000|Overall Study|Patient non-compliance|3
7818122|NCT01227707|12284929|FG000|Overall Study|Medical decision|6
7818123|NCT01227707|12284929|FG000|Overall Study|Death|1
7818124|NCT01227824|12284946|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
7818125|NCT01227824|12284947|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
7818126|NCT01227824|12284948|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
7818127|NCT01227824|12284946|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
7818128|NCT01227824|12284947|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
7818129|NCT01227824|12284948|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
7818130|NCT01227824|12284946|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
7818131|NCT01227824|12284947|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
7818132|NCT01227824|12284948|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
7818133|NCT01227824|12284946|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
7818134|NCT01227824|12284947|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
7818135|NCT01227824|12284948|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
7818136|NCT01227824|12284946|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
7818137|NCT01227824|12284947|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
7818138|NCT01227824|12284948|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
7818139|NCT01227824|12284946|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
7818140|NCT01227824|12284947|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
7818141|NCT01227824|12284948|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
7818142|NCT01227824|12284946|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
7818143|NCT01227824|12284947|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
7818144|NCT01227824|12284948|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
7818145|NCT01227824|12284946|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
7818146|NCT01227824|12284947|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
7818147|NCT01227824|12284948|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
7818148|NCT01227824|12284946|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0
7818149|NCT01227824|12284947|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0
7818150|NCT01227824|12284948|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4
7818151|NCT01227824|12284946|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
7818152|NCT01227824|12284947|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
7818153|NCT01227824|12284948|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
7818154|NCT01227824|12284946|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0
7818155|NCT01227824|12284947|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0
7818156|NCT01227824|12284948|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5
7818157|NCT01227824|12284946|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
7818158|NCT01227824|12284947|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
7818159|NCT01227824|12284948|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
7818160|NCT01227824|12284946|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
7818161|NCT01227824|12284947|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
7818162|NCT01227824|12284948|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
7818163|NCT01227824|12284946|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
7818164|NCT01227824|12284947|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
7818165|NCT01227824|12284948|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
7818166|NCT01227824|12284946|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0
7818167|NCT01227824|12284947|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0
7818168|NCT01227824|12284948|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3
7818169|NCT01227889|12284957|FG000|Randomized Phase (RP)|Adverse Event|13
7818170|NCT01227889|12284958|FG001|Randomized Phase (RP)|Adverse Event|0
7818171|NCT01227889|12284957|FG000|Randomized Phase (RP)|Physician Decision|13
7818172|NCT01227889|12284958|FG001|Randomized Phase (RP)|Physician Decision|5
7818173|NCT01227889|12284957|FG000|Randomized Phase (RP)|Progressive Disease|135
7818174|NCT01227889|12284958|FG001|Randomized Phase (RP)|Progressive Disease|52
7818175|NCT01227889|12284957|FG000|Randomized Phase (RP)|Study terminated by sponsor|10
7818176|NCT01227889|12284958|FG001|Randomized Phase (RP)|Study terminated by sponsor|0
7818177|NCT01227889|12284957|FG000|Randomized Phase (RP)|Missing|1
7818178|NCT01227889|12284958|FG001|Randomized Phase (RP)|Missing|3
7818179|NCT01227889|12284957|FG000|Randomized Phase (RP)|Withdrawal by Subject|15
7818180|NCT01227889|12284958|FG001|Randomized Phase (RP)|Withdrawal by Subject|3
7818181|NCT01227889|12284957|FG000|Crossover Phase|Adverse Event|0
7818182|NCT01227889|12284958|FG001|Crossover Phase|Adverse Event|1
7818183|NCT01227889|12284957|FG000|Crossover Phase|Physician Decision|0
7818184|NCT01227889|12284958|FG001|Crossover Phase|Physician Decision|3
7818185|NCT01227889|12284957|FG000|Crossover Phase|Progressive Disease|0
7818186|NCT01227889|12284958|FG001|Crossover Phase|Progressive Disease|31
7818187|NCT01227889|12284957|FG000|Crossover Phase|Study Terminated By Sponsor|0
7818188|NCT01227889|12284958|FG001|Crossover Phase|Study Terminated By Sponsor|1
7818189|NCT01227889|12284957|FG000|Crossover Phase|Withdrawal by Subject|0
7818190|NCT01227889|12284958|FG001|Crossover Phase|Withdrawal by Subject|1
7818191|NCT01227902|12284976|FG000|Overall Study|Adverse Event|12
7818192|NCT01227902|12284977|FG001|Overall Study|Adverse Event|8
7818193|NCT01227902|12284978|FG002|Overall Study|Adverse Event|11
7818194|NCT01227902|12284979|FG003|Overall Study|Adverse Event|4
7818195|NCT01227902|12284976|FG000|Overall Study|Lack of Efficacy|1
7818196|NCT01227902|12284977|FG001|Overall Study|Lack of Efficacy|2
7818197|NCT01227902|12284978|FG002|Overall Study|Lack of Efficacy|2
7818198|NCT01227902|12284979|FG003|Overall Study|Lack of Efficacy|1
7818199|NCT01227902|12284976|FG000|Overall Study|Protocol Violation|1
7818200|NCT01227902|12284977|FG001|Overall Study|Protocol Violation|0
7818201|NCT01227902|12284978|FG002|Overall Study|Protocol Violation|0
7818202|NCT01227902|12284979|FG003|Overall Study|Protocol Violation|0
7818203|NCT01227902|12284976|FG000|Overall Study|Lost to Follow-up|0
7818204|NCT01227902|12284977|FG001|Overall Study|Lost to Follow-up|0
7818205|NCT01227902|12284978|FG002|Overall Study|Lost to Follow-up|1
7818206|NCT01227902|12284979|FG003|Overall Study|Lost to Follow-up|2
7818207|NCT01227902|12284976|FG000|Overall Study|Physician Decision|0
7818208|NCT01227902|12284977|FG001|Overall Study|Physician Decision|1
7818209|NCT01227902|12284978|FG002|Overall Study|Physician Decision|1
7818210|NCT01227902|12284979|FG003|Overall Study|Physician Decision|0
7818211|NCT01227902|12284976|FG000|Overall Study|Withdrawal by Subject|4
7818212|NCT01227902|12284977|FG001|Overall Study|Withdrawal by Subject|2
7818213|NCT01227902|12284978|FG002|Overall Study|Withdrawal by Subject|4
7818214|NCT01227902|12284979|FG003|Overall Study|Withdrawal by Subject|3
7818215|NCT01227928|12284992|FG000|Overall Study|Lost to Follow-up|4
7818216|NCT01227928|12284993|FG001|Overall Study|Lost to Follow-up|2
7818217|NCT01227928|12284992|FG000|Overall Study|Withdrawal by Subject|4
7818218|NCT01227928|12284993|FG001|Overall Study|Withdrawal by Subject|3
7818219|NCT01227928|12284992|FG000|Overall Study|Death|14
7818220|NCT01227928|12284993|FG001|Overall Study|Death|12
7818221|NCT01227954|12284999|FG000|Overall Study|Protocol Violation|6
7818222|NCT01227954|12284999|FG000|Overall Study|No protocol treatment|7
7818223|NCT01227967|12285005|FG000|Overall Study|Protocol Violation|3
7818224|NCT01227967|12285006|FG001|Overall Study|Protocol Violation|1
7818225|NCT01227967|12285005|FG000|Overall Study|Death|0
7818226|NCT01227967|12285006|FG001|Overall Study|Death|1
7818227|NCT01227967|12285005|FG000|Overall Study|Lost to Follow-up|8
7818228|NCT01227967|12285006|FG001|Overall Study|Lost to Follow-up|3
7818229|NCT01227967|12285005|FG000|Overall Study|Withdrawal by Subject|4
7818230|NCT01227967|12285006|FG001|Overall Study|Withdrawal by Subject|3
7818231|NCT01227967|12285005|FG000|Overall Study|Physician Decision|0
7818232|NCT01227967|12285006|FG001|Overall Study|Physician Decision|1
7818233|NCT01227967|12285005|FG000|Overall Study|Never Started Treatment|0
7818234|NCT01227967|12285006|FG001|Overall Study|Never Started Treatment|4
7818235|NCT01227967|12285005|FG000|Overall Study|Taking Additional Antiviral Drug|1
7818236|NCT01227967|12285006|FG001|Overall Study|Taking Additional Antiviral Drug|0
7818237|NCT01228019|12285025|FG000|Overall Study|Dose Violation|70
7818238|NCT01228019|12285025|FG000|Overall Study|Duplicate enrollment|1
7818239|NCT01228019|12285025|FG000|Overall Study|Missing pre-treatment data|72
7818240|NCT01228019|12285025|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152
7818241|NCT01228019|12285025|FG000|Overall Study|Violation of Entry Criterion|9
7818242|NCT01228071|12285029|FG000|Overall Study|Protocol Violation|1
7818243|NCT01228071|12285029|FG000|Overall Study|Withdrawal by Subject|1
7818244|NCT01228175|12285051|FG000|Overall Study|Lost to Follow-up|64
7818245|NCT01228175|12285052|FG001|Overall Study|Lost to Follow-up|50
7818246|NCT01228175|12285051|FG000|Overall Study|Withdrawal by Subject|1
7818247|NCT01228175|12285052|FG001|Overall Study|Withdrawal by Subject|2
7818248|NCT01228175|12285051|FG000|Overall Study|Physician Decision|1
7818249|NCT01228175|12285052|FG001|Overall Study|Physician Decision|1
7818250|NCT01228318|12285060|FG000|Overall Study|Clinic no show to receive intervention|1
7818251|NCT01228318|12285061|FG001|Overall Study|Clinic no show to receive intervention|0
7818252|NCT01228318|12285060|FG000|Overall Study|Unable to contact|2
7818253|NCT01228318|12285061|FG001|Overall Study|Unable to contact|5
7818254|NCT01228318|12285060|FG000|Overall Study|Moved|0
7818255|NCT01228318|12285061|FG001|Overall Study|Moved|2
7818256|NCT01228318|12285060|FG000|Overall Study|Incarcerated|1
7818257|NCT01228318|12285061|FG001|Overall Study|Incarcerated|0
7818258|NCT01228591|12285076|FG000|Baseline|Lack of Efficacy|1
7818259|NCT01228591|12285077|FG001|Baseline|Lack of Efficacy|2
7818260|NCT01228734|12285089|FG000|Overall Study|Randomized, but not treated|0
7818261|NCT01228734|12285090|FG001|Overall Study|Randomized, but not treated|4
7818262|NCT01228747|12285098|FG000|Overall Study|Adverse Event|8
7818263|NCT01228747|12285099|FG001|Overall Study|Adverse Event|4
7818264|NCT01228747|12285098|FG000|Overall Study|Lack of Efficacy|40
7818265|NCT01228747|12285099|FG001|Overall Study|Lack of Efficacy|27
7818266|NCT01228747|12285098|FG000|Overall Study|Protocol Violation|6
7818267|NCT01228747|12285099|FG001|Overall Study|Protocol Violation|5
7818268|NCT01228747|12285098|FG000|Overall Study|Lost to Follow-up|4
7818269|NCT01228747|12285099|FG001|Overall Study|Lost to Follow-up|3
7818270|NCT01228747|12285098|FG000|Overall Study|Withdrawal by Subject|5
7818271|NCT01228747|12285099|FG001|Overall Study|Withdrawal by Subject|1
7818272|NCT01228747|12285098|FG000|Overall Study|Other Reason|2
7818273|NCT01228747|12285099|FG001|Overall Study|Other Reason|5
7818274|NCT01229111|12285131|FG000|Overall Study|Death|1
7818275|NCT01229150|12285139|FG000|Overall Study|Toxicity|2
7818276|NCT01229150|12285140|FG001|Overall Study|Toxicity|2
7818277|NCT01229150|12285141|FG002|Overall Study|Toxicity|0
7818278|NCT01229150|12285142|FG003|Overall Study|Toxicity|0
7818279|NCT01229176|12285164|FG000|Overall Study|Withdrawal by Subject|0
7818280|NCT01229176|12285165|FG001|Overall Study|Withdrawal by Subject|0
7818281|NCT01229176|12285166|FG002|Overall Study|Withdrawal by Subject|0
7818282|NCT01229176|12285167|FG003|Overall Study|Withdrawal by Subject|1
7818283|NCT01229176|12285168|FG004|Overall Study|Withdrawal by Subject|1
7818284|NCT01229176|12285169|FG005|Overall Study|Withdrawal by Subject|1
7818285|NCT01229176|12285170|FG006|Overall Study|Withdrawal by Subject|0
7818286|NCT01229176|12285171|FG007|Overall Study|Withdrawal by Subject|1
7818287|NCT01229176|12285164|FG000|Overall Study|Lost to Follow-up|0
7818288|NCT01229176|12285165|FG001|Overall Study|Lost to Follow-up|3
7818289|NCT01229176|12285166|FG002|Overall Study|Lost to Follow-up|0
7818290|NCT01229176|12285167|FG003|Overall Study|Lost to Follow-up|0
7818291|NCT01229176|12285168|FG004|Overall Study|Lost to Follow-up|1
7818292|NCT01229176|12285169|FG005|Overall Study|Lost to Follow-up|1
7818293|NCT01229176|12285170|FG006|Overall Study|Lost to Follow-up|0
7818294|NCT01229176|12285171|FG007|Overall Study|Lost to Follow-up|2
7883737|NCT01784068|12383596|FG001|TFR Phase|Patient/guardian decision|3
7883738|NCT01784068|12383595|FG000|TFR Phase|Death|0
7883739|NCT01784068|12383596|FG001|TFR Phase|Death|1
7883740|NCT01784068|12383595|FG000|TFR Phase|Lack of Efficacy|0
7883741|NCT01784068|12383596|FG001|TFR Phase|Lack of Efficacy|88
7883742|NCT01784211|12383609|FG000|Part A (Days 1-15)|Adverse Event|1
7883743|NCT01784211|12383610|FG001|Part A (Days 1-15)|Adverse Event|1
7883744|NCT01784211|12383611|FG002|Part A (Days 1-15)|Adverse Event|0
7883745|NCT01784211|12383612|FG003|Part A (Days 1-15)|Adverse Event|0
7883746|NCT01784211|12383613|FG004|Part A (Days 1-15)|Adverse Event|0
7883747|NCT01784211|12383614|FG005|Part A (Days 1-15)|Adverse Event|0
7883748|NCT01784211|12383609|FG000|Part A (Days 1-15)|Withdrawal by Subject|2
7883749|NCT01784211|12383610|FG001|Part A (Days 1-15)|Withdrawal by Subject|1
7883750|NCT01784211|12383611|FG002|Part A (Days 1-15)|Withdrawal by Subject|0
7883751|NCT01784211|12383612|FG003|Part A (Days 1-15)|Withdrawal by Subject|0
7883752|NCT01784211|12383613|FG004|Part A (Days 1-15)|Withdrawal by Subject|0
7883753|NCT01784211|12383614|FG005|Part A (Days 1-15)|Withdrawal by Subject|0
7911540|NCT02064231|12428921|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5
7911541|NCT02064231|12428922|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3
7911542|NCT02064231|12428923|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0
7911543|NCT02064231|12428924|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0
7911544|NCT02064231|12428921|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1
7911545|NCT02064231|12428922|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1
7911546|NCT02064231|12428923|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0
7911547|NCT02064231|12428924|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0
7911548|NCT02064231|12428921|FG000|First Test Period (Test A or Test C)|Adverse Event|1
7911549|NCT02064231|12428922|FG001|First Test Period (Test A or Test C)|Adverse Event|0
7911550|NCT02064231|12428923|FG002|First Test Period (Test A or Test C)|Adverse Event|1
7911551|NCT02064231|12428924|FG003|First Test Period (Test A or Test C)|Adverse Event|0
7911552|NCT02064231|12428921|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1
7911553|NCT02064231|12428922|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1
7911554|NCT02064231|12428923|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0
7911555|NCT02064231|12428924|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0
7911556|NCT02064439|12428948|FG000|Overall Study|Adverse Event|51
7911557|NCT02064439|12428949|FG001|Overall Study|Adverse Event|47
7911558|NCT02064439|12428950|FG002|Overall Study|Adverse Event|46
7911559|NCT02064439|12428948|FG000|Overall Study|Death|0
7911560|NCT02064439|12428949|FG001|Overall Study|Death|2
7911561|NCT02064439|12428950|FG002|Overall Study|Death|3
7911562|NCT02064439|12428948|FG000|Overall Study|Withdrawal by Subject|29
7911563|NCT02064439|12428949|FG001|Overall Study|Withdrawal by Subject|18
7911564|NCT02064439|12428950|FG002|Overall Study|Withdrawal by Subject|26
7911565|NCT02064439|12428948|FG000|Overall Study|Protocol Violation|3
7911566|NCT02064439|12428949|FG001|Overall Study|Protocol Violation|5
7911567|NCT02064439|12428950|FG002|Overall Study|Protocol Violation|3
7911568|NCT02064439|12428948|FG000|Overall Study|Lost to Follow-up|1
7818295|NCT01229254|12285213|FG000|Overall Study|Not Continuing Into Safety Extension|3
7818296|NCT01229254|12285214|FG001|Overall Study|Not Continuing Into Safety Extension|1
7818297|NCT01229254|12285215|FG002|Overall Study|Not Continuing Into Safety Extension|1
7818298|NCT01229254|12285213|FG000|Overall Study|Adverse Event|4
7818299|NCT01229254|12285214|FG001|Overall Study|Adverse Event|5
7818300|NCT01229254|12285215|FG002|Overall Study|Adverse Event|3
7818301|NCT01229254|12285213|FG000|Overall Study|Lost to Follow-up|3
7818302|NCT01229254|12285214|FG001|Overall Study|Lost to Follow-up|0
7818303|NCT01229254|12285215|FG002|Overall Study|Lost to Follow-up|1
7911569|NCT02064439|12428949|FG001|Overall Study|Lost to Follow-up|3
7911570|NCT02064439|12428950|FG002|Overall Study|Lost to Follow-up|4
7911571|NCT02064439|12428948|FG000|Overall Study|Non-compliance with study medication|21
7911572|NCT02064439|12428949|FG001|Overall Study|Non-compliance with study medication|19
7911573|NCT02064439|12428950|FG002|Overall Study|Non-compliance with study medication|23
7911574|NCT02064439|12428948|FG000|Overall Study|Physician Decision|0
7911575|NCT02064439|12428949|FG001|Overall Study|Physician Decision|1
7911576|NCT02064439|12428950|FG002|Overall Study|Physician Decision|1
7911577|NCT02064439|12428948|FG000|Overall Study|Logistical difficulties|6
7911578|NCT02064439|12428949|FG001|Overall Study|Logistical difficulties|5
7911579|NCT02064439|12428950|FG002|Overall Study|Logistical difficulties|2
7911580|NCT02064439|12428948|FG000|Overall Study|Efficacy outcome reached|18
7911581|NCT02064439|12428949|FG001|Overall Study|Efficacy outcome reached|16
7911582|NCT02064439|12428950|FG002|Overall Study|Efficacy outcome reached|57
7911583|NCT02064439|12428948|FG000|Overall Study|Safety outcome reached|12
7911584|NCT02064439|12428949|FG001|Overall Study|Safety outcome reached|20
7911585|NCT02064439|12428950|FG002|Overall Study|Safety outcome reached|10
7911586|NCT02064439|12428948|FG000|Overall Study|Other|2
7911587|NCT02064439|12428949|FG001|Overall Study|Other|2
7911588|NCT02064439|12428950|FG002|Overall Study|Other|7
7911589|NCT02064816|12428964|FG000|Overall Study|Adverse Event|3
7911590|NCT02064816|12428965|FG001|Overall Study|Adverse Event|2
7911591|NCT02064816|12428964|FG000|Overall Study|Withdrawal by Subject|2
7911592|NCT02064816|12428965|FG001|Overall Study|Withdrawal by Subject|1
7911593|NCT02064816|12428964|FG000|Overall Study|Lost to Follow-up|2
7911594|NCT02064816|12428965|FG001|Overall Study|Lost to Follow-up|1
7911595|NCT02064816|12428964|FG000|Overall Study|Therapeutic failure|0
7911596|NCT02064816|12428965|FG001|Overall Study|Therapeutic failure|1
7911597|NCT02064816|12428964|FG000|Overall Study|Other|1
7911598|NCT02064816|12428965|FG001|Overall Study|Other|3
7911599|NCT02064868|12429020|FG000|Overall Study|Lost to Follow-up|14
7911600|NCT02064868|12429021|FG001|Overall Study|Lost to Follow-up|8
7911601|NCT02064868|12429020|FG000|Overall Study|Physician Decision|1
7911602|NCT02064868|12429021|FG001|Overall Study|Physician Decision|0
7911603|NCT02064868|12429020|FG000|Overall Study|Withdrawal by Subject|14
7911604|NCT02064868|12429021|FG001|Overall Study|Withdrawal by Subject|3
7911605|NCT02064868|12429020|FG000|Overall Study|Technical Problems or Missing|5
7911606|NCT02064868|12429021|FG001|Overall Study|Technical Problems or Missing|2
7911607|NCT02064894|12429030|FG000|Overall Study|Withdrawal by Subject|43
7911608|NCT02064894|12429031|FG001|Overall Study|Withdrawal by Subject|102
7911609|NCT02064894|12429032|FG002|Overall Study|Withdrawal by Subject|115
7911610|NCT02064920|12429051|FG000|Overall Study|Adverse Event|0
7911611|NCT02064920|12429052|FG001|Overall Study|Adverse Event|4
7911612|NCT02064920|12429051|FG000|Overall Study|Physician Decision|0
7911613|NCT02064920|12429052|FG001|Overall Study|Physician Decision|1
7911614|NCT02064920|12429051|FG000|Overall Study|Technical Problems|0
7911615|NCT02064920|12429052|FG001|Overall Study|Technical Problems|1
7911616|NCT02064920|12429051|FG000|Overall Study|Withdrawal by Subject|1
7911617|NCT02064920|12429052|FG001|Overall Study|Withdrawal by Subject|3
7911618|NCT02065245|12429087|FG000|Infusion 1|Lost to Follow-up|0
7911619|NCT02065245|12429088|FG001|Infusion 1|Lost to Follow-up|0
7911620|NCT02065245|12429089|FG002|Infusion 1|Lost to Follow-up|0
7911621|NCT02065245|12429090|FG003|Infusion 1|Lost to Follow-up|0
7911622|NCT02065245|12429091|FG004|Infusion 1|Lost to Follow-up|0
7911623|NCT02065245|12429092|FG005|Infusion 1|Lost to Follow-up|0
7911624|NCT02065245|12429093|FG006|Infusion 1|Lost to Follow-up|1
7911625|NCT02065245|12429087|FG000|Infusion 1|Death|0
7911626|NCT02065245|12429088|FG001|Infusion 1|Death|0
7911627|NCT02065245|12429089|FG002|Infusion 1|Death|1
7911628|NCT02065245|12429090|FG003|Infusion 1|Death|0
7911629|NCT02065245|12429091|FG004|Infusion 1|Death|1
7911630|NCT02065245|12429092|FG005|Infusion 1|Death|0
7911631|NCT02065245|12429093|FG006|Infusion 1|Death|0
7911632|NCT02065245|12429087|FG000|Infusion 2|Death|0
7911633|NCT02065245|12429088|FG001|Infusion 2|Death|0
7911634|NCT02065245|12429089|FG002|Infusion 2|Death|0
7911635|NCT02065245|12429090|FG003|Infusion 2|Death|0
7911636|NCT02065245|12429091|FG004|Infusion 2|Death|0
7818304|NCT01229254|12285213|FG000|Overall Study|Physician Decision|0
7818305|NCT01229254|12285214|FG001|Overall Study|Physician Decision|3
7818306|NCT01229254|12285215|FG002|Overall Study|Physician Decision|0
7818307|NCT01229254|12285213|FG000|Overall Study|Protocol Violation|4
7818308|NCT01229254|12285214|FG001|Overall Study|Protocol Violation|6
7818309|NCT01229254|12285215|FG002|Overall Study|Protocol Violation|5
7818310|NCT01229254|12285213|FG000|Overall Study|Withdrawal by Subject|1
7818311|NCT01229254|12285214|FG001|Overall Study|Withdrawal by Subject|0
7818312|NCT01229254|12285215|FG002|Overall Study|Withdrawal by Subject|1
7818313|NCT01229254|12285213|FG000|Overall Study|Non-compliance with Study Drug|0
7818314|NCT01229254|12285214|FG001|Overall Study|Non-compliance with Study Drug|1
7818315|NCT01229254|12285215|FG002|Overall Study|Non-compliance with Study Drug|1
7818316|NCT01229267|12285229|FG000|Overall Study|Adverse Event|4
7818317|NCT01229267|12285230|FG001|Overall Study|Adverse Event|6
7818318|NCT01229267|12285231|FG002|Overall Study|Adverse Event|3
7818319|NCT01229267|12285232|FG003|Overall Study|Adverse Event|2
7818320|NCT01229267|12285233|FG004|Overall Study|Adverse Event|10
7818321|NCT01229267|12285229|FG000|Overall Study|Death|40
7818322|NCT01229267|12285230|FG001|Overall Study|Death|37
7818323|NCT01229267|12285231|FG002|Overall Study|Death|35
7818324|NCT01229267|12285232|FG003|Overall Study|Death|13
7818325|NCT01229267|12285233|FG004|Overall Study|Death|103
7818326|NCT01229267|12285229|FG000|Overall Study|Withdrawal by Subject|23
7818327|NCT01229267|12285230|FG001|Overall Study|Withdrawal by Subject|22
7818328|NCT01229267|12285231|FG002|Overall Study|Withdrawal by Subject|32
7818329|NCT01229267|12285232|FG003|Overall Study|Withdrawal by Subject|14
7818330|NCT01229267|12285233|FG004|Overall Study|Withdrawal by Subject|59
7818331|NCT01229267|12285229|FG000|Overall Study|Protocol Violation|0
7818332|NCT01229267|12285230|FG001|Overall Study|Protocol Violation|1
7818333|NCT01229267|12285231|FG002|Overall Study|Protocol Violation|0
7818334|NCT01229267|12285232|FG003|Overall Study|Protocol Violation|0
7818335|NCT01229267|12285233|FG004|Overall Study|Protocol Violation|0
7818336|NCT01229267|12285229|FG000|Overall Study|Progressive disease|0
7818337|NCT01229267|12285230|FG001|Overall Study|Progressive disease|0
7818338|NCT01229267|12285231|FG002|Overall Study|Progressive disease|0
7818339|NCT01229267|12285232|FG003|Overall Study|Progressive disease|0
7818340|NCT01229267|12285233|FG004|Overall Study|Progressive disease|1
7818341|NCT01229267|12285229|FG000|Overall Study|Physician Decision|8
7818342|NCT01229267|12285230|FG001|Overall Study|Physician Decision|11
7818343|NCT01229267|12285231|FG002|Overall Study|Physician Decision|8
7818344|NCT01229267|12285232|FG003|Overall Study|Physician Decision|3
7818345|NCT01229267|12285233|FG004|Overall Study|Physician Decision|25
7818346|NCT01229267|12285229|FG000|Overall Study|Lost to Follow-up|6
7818347|NCT01229267|12285230|FG001|Overall Study|Lost to Follow-up|5
7818348|NCT01229267|12285231|FG002|Overall Study|Lost to Follow-up|8
7818349|NCT01229267|12285232|FG003|Overall Study|Lost to Follow-up|3
7818350|NCT01229267|12285233|FG004|Overall Study|Lost to Follow-up|22
7818351|NCT01229371|12285244|FG000|Overall Study|Withdrawal by Subject|0
7818352|NCT01229371|12285245|FG001|Overall Study|Withdrawal by Subject|1
7818353|NCT01229371|12285246|FG002|Overall Study|Withdrawal by Subject|0
7818354|NCT01229371|12285247|FG003|Overall Study|Withdrawal by Subject|0
7818355|NCT01229397|12285259|FG000|Overall Study|Withdrawal by Subject|3
7818356|NCT01229397|12285260|FG001|Overall Study|Withdrawal by Subject|3
7818357|NCT01229397|12285259|FG000|Overall Study|Lost to Follow-up|7
7818358|NCT01229397|12285260|FG001|Overall Study|Lost to Follow-up|6
7818359|NCT01229397|12285259|FG000|Overall Study|Migrated/moved from study area|1
7818360|NCT01229397|12285260|FG001|Overall Study|Migrated/moved from study area|0
7911637|NCT02065245|12429092|FG005|Infusion 2|Death|0
7911638|NCT02065245|12429093|FG006|Infusion 2|Death|1
7911639|NCT02065245|12429087|FG000|Infusion 3|Lost to Follow-up|1
7911640|NCT02065245|12429088|FG001|Infusion 3|Lost to Follow-up|1
7818361|NCT01229436|12285283|FG000|Overall Study|Withdrawal by Subject|2
7818362|NCT01229436|12285283|FG000|Overall Study|Lost to Follow-up|3
7818363|NCT01229449|12285292|FG000|Overall Study|Withdrawal by Subject|0
7818364|NCT01229449|12285293|FG001|Overall Study|Withdrawal by Subject|3
7818365|NCT01229449|12285294|FG002|Overall Study|Withdrawal by Subject|0
7818366|NCT01229449|12285295|FG003|Overall Study|Withdrawal by Subject|1
7818367|NCT01229449|12285296|FG004|Overall Study|Withdrawal by Subject|1
7818368|NCT01229449|12285292|FG000|Overall Study|Lost to Follow-up|1
7818369|NCT01229449|12285293|FG001|Overall Study|Lost to Follow-up|1
7818370|NCT01229449|12285294|FG002|Overall Study|Lost to Follow-up|1
7818371|NCT01229449|12285295|FG003|Overall Study|Lost to Follow-up|0
7818372|NCT01229449|12285296|FG004|Overall Study|Lost to Follow-up|0
7818373|NCT01229449|12285292|FG000|Overall Study|Physician Decision|0
7818374|NCT01229449|12285293|FG001|Overall Study|Physician Decision|0
7818375|NCT01229449|12285294|FG002|Overall Study|Physician Decision|1
7818376|NCT01229449|12285295|FG003|Overall Study|Physician Decision|0
7818377|NCT01229449|12285296|FG004|Overall Study|Physician Decision|0
7818378|NCT01229735|12285345|FG000|Overall Study|Lack of Efficacy|8
7818379|NCT01229735|12285346|FG001|Overall Study|Lack of Efficacy|8
7818380|NCT01229735|12285345|FG000|Overall Study|Protocol Violation|13
7818381|NCT01229735|12285346|FG001|Overall Study|Protocol Violation|8
7818382|NCT01229735|12285345|FG000|Overall Study|Lost to Follow-up|0
7818383|NCT01229735|12285346|FG001|Overall Study|Lost to Follow-up|2
7818384|NCT01229735|12285345|FG000|Overall Study|Withdrawal by Subject|18
7818385|NCT01229735|12285346|FG001|Overall Study|Withdrawal by Subject|17
7818386|NCT01229735|12285345|FG000|Overall Study|Other Reason|13
7818387|NCT01229735|12285346|FG001|Overall Study|Other Reason|10
7818388|NCT01229735|12285345|FG000|Overall Study|SAE, non-fatal|0
7818389|NCT01229735|12285346|FG001|Overall Study|SAE, non-fatal|4
7818390|NCT01229735|12285345|FG000|Overall Study|AE, non-serious non-fatal|13
7818391|NCT01229735|12285346|FG001|Overall Study|AE, non-serious non-fatal|17
7818392|NCT01229735|12285345|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7818393|NCT01229735|12285346|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7818394|NCT01230060|12285371|FG000|Overall Study|Withdrawal by Subject|1
7818395|NCT01230554|12285416|FG000|Overall Study|Lost to Follow-up|2
7818396|NCT01230554|12285416|FG000|Overall Study|Inability to maintain visit schedule|1
7818397|NCT01230710|12285433|FG000|Overall Study|Disease Progression|41
7818398|NCT01230710|12285433|FG000|Overall Study|Lost to Follow-up|3
7818399|NCT01230710|12285433|FG000|Overall Study|Death|4
7818400|NCT01230710|12285433|FG000|Overall Study|Withdrawal of Consent|1
7818401|NCT01230749|12285441|FG000|Overall Study|Adverse Event|0
7818402|NCT01230749|12285442|FG001|Overall Study|Adverse Event|0
7818403|NCT01230749|12285443|FG002|Overall Study|Adverse Event|0
7818404|NCT01230749|12285444|FG003|Overall Study|Adverse Event|1
7818405|NCT01230749|12285441|FG000|Overall Study|Physician Decision|0
7818406|NCT01230749|12285442|FG001|Overall Study|Physician Decision|0
7818407|NCT01230749|12285443|FG002|Overall Study|Physician Decision|1
7818408|NCT01230749|12285444|FG003|Overall Study|Physician Decision|0
7818409|NCT01230749|12285441|FG000|Overall Study|Withdrawal by Subject|0
7818410|NCT01230749|12285442|FG001|Overall Study|Withdrawal by Subject|1
7818411|NCT01230749|12285443|FG002|Overall Study|Withdrawal by Subject|0
7818412|NCT01230749|12285444|FG003|Overall Study|Withdrawal by Subject|0
7818413|NCT01230749|12285441|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0
7818414|NCT01230749|12285442|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1
7818415|NCT01230749|12285443|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1
7818416|NCT01230749|12285444|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1
7818417|NCT01230814|12285475|FG000|Overall Study|Lost to Follow-up|11
7818418|NCT01230814|12285476|FG001|Overall Study|Lost to Follow-up|3
7818419|NCT01230814|12285475|FG000|Overall Study|Discontinued (not due to adverse event)|2
7818420|NCT01230814|12285476|FG001|Overall Study|Discontinued (not due to adverse event)|1
7818421|NCT01230827|12285486|FG000|Overall Study|Lost to Follow-up|0
7818422|NCT01230827|12285487|FG001|Overall Study|Lost to Follow-up|0
7818423|NCT01230827|12285488|FG002|Overall Study|Lost to Follow-up|1
7818424|NCT01230827|12285489|FG003|Overall Study|Lost to Follow-up|3
7818425|NCT01230827|12285486|FG000|Overall Study|Withdrawal by Subject|1
7818426|NCT01230827|12285487|FG001|Overall Study|Withdrawal by Subject|0
7818427|NCT01230827|12285488|FG002|Overall Study|Withdrawal by Subject|3
7818428|NCT01230827|12285489|FG003|Overall Study|Withdrawal by Subject|2
7818429|NCT01230827|12285486|FG000|Overall Study|Lack of Efficacy|14
7818430|NCT01230827|12285487|FG001|Overall Study|Lack of Efficacy|1
7818431|NCT01230827|12285488|FG002|Overall Study|Lack of Efficacy|2
7818432|NCT01230827|12285489|FG003|Overall Study|Lack of Efficacy|3
7818433|NCT01230827|12285486|FG000|Overall Study|Adverse Event|4
7818434|NCT01230827|12285487|FG001|Overall Study|Adverse Event|2
7818435|NCT01230827|12285488|FG002|Overall Study|Adverse Event|3
7818436|NCT01230827|12285489|FG003|Overall Study|Adverse Event|7
7818437|NCT01230827|12285486|FG000|Overall Study|Recovery|0
7818438|NCT01230827|12285487|FG001|Overall Study|Recovery|6
7818439|NCT01230827|12285488|FG002|Overall Study|Recovery|0
7818440|NCT01230827|12285489|FG003|Overall Study|Recovery|0
7818441|NCT01230827|12285486|FG000|Overall Study|Study terminated by Sponsor|0
7818442|NCT01230827|12285487|FG001|Overall Study|Study terminated by Sponsor|2
7818443|NCT01230827|12285488|FG002|Overall Study|Study terminated by Sponsor|56
7818444|NCT01230827|12285489|FG003|Overall Study|Study terminated by Sponsor|63
7818445|NCT01230892|12285499|FG000|Overall Study|Withdrawal by Subject|1
7818446|NCT01230892|12285500|FG001|Overall Study|Withdrawal by Subject|1
7818447|NCT01230892|12285499|FG000|Overall Study|Lost to Follow-up|2
7818448|NCT01230892|12285500|FG001|Overall Study|Lost to Follow-up|0
7818449|NCT01231321|12285526|FG000|Overall Study|Adverse Event|3
7818450|NCT01231321|12285526|FG000|Overall Study|Lack of Efficacy|2
7818451|NCT01231373|12285549|FG000|Overall Study|Withdrew consent prior to randomization|2
7818452|NCT01231373|12285550|FG001|Overall Study|Withdrew consent prior to randomization|1
7818453|NCT01231373|12285551|FG002|Overall Study|Withdrew consent prior to randomization|0
7818454|NCT01231373|12285552|FG003|Overall Study|Withdrew consent prior to randomization|0
7818455|NCT01231373|12285549|FG000|Overall Study|Lost to Follow-up|0
7818456|NCT01231373|12285550|FG001|Overall Study|Lost to Follow-up|0
7818457|NCT01231373|12285551|FG002|Overall Study|Lost to Follow-up|0
7818458|NCT01231373|12285552|FG003|Overall Study|Lost to Follow-up|1
7818459|NCT01231373|12285549|FG000|Overall Study|Withdrew Consent|1
7818460|NCT01231373|12285550|FG001|Overall Study|Withdrew Consent|0
7818461|NCT01231373|12285551|FG002|Overall Study|Withdrew Consent|0
7818462|NCT01231373|12285552|FG003|Overall Study|Withdrew Consent|0
7818463|NCT01231464|12285584|FG000|Overall Study|Adverse Event|0
7818464|NCT01231464|12285585|FG001|Overall Study|Adverse Event|1
7818465|NCT01231464|12285584|FG000|Overall Study|Protocol Violation|1
7818466|NCT01231464|12285585|FG001|Overall Study|Protocol Violation|2
7818467|NCT01231464|12285584|FG000|Overall Study|Lost to Follow-up|1
7818468|NCT01231464|12285585|FG001|Overall Study|Lost to Follow-up|2
7818469|NCT01231464|12285584|FG000|Overall Study|Withdrawal by Subject|3
7818470|NCT01231464|12285585|FG001|Overall Study|Withdrawal by Subject|2
7818471|NCT01231503|12285601|FG000|Overall Study|Adverse Event|0
7818472|NCT01231503|12285602|FG001|Overall Study|Adverse Event|0
7818473|NCT01231503|12285603|FG002|Overall Study|Adverse Event|0
7818474|NCT01231503|12285604|FG003|Overall Study|Adverse Event|0
7818475|NCT01231503|12285605|FG004|Overall Study|Adverse Event|0
7818476|NCT01231503|12285606|FG005|Overall Study|Adverse Event|1
7818477|NCT01231503|12285607|FG006|Overall Study|Adverse Event|0
7818478|NCT01231503|12285608|FG007|Overall Study|Adverse Event|0
7818479|NCT01231503|12285601|FG000|Overall Study|Adverse event, serious fatal|0
7818480|NCT01231503|12285602|FG001|Overall Study|Adverse event, serious fatal|0
7818481|NCT01231503|12285603|FG002|Overall Study|Adverse event, serious fatal|1
7818482|NCT01231503|12285604|FG003|Overall Study|Adverse event, serious fatal|1
7818483|NCT01231503|12285605|FG004|Overall Study|Adverse event, serious fatal|0
7818484|NCT01231503|12285606|FG005|Overall Study|Adverse event, serious fatal|1
7818485|NCT01231503|12285607|FG006|Overall Study|Adverse event, serious fatal|0
7818486|NCT01231503|12285608|FG007|Overall Study|Adverse event, serious fatal|0
7818487|NCT01231503|12285601|FG000|Overall Study|Withdrawal by Subject|6
7818488|NCT01231503|12285602|FG001|Overall Study|Withdrawal by Subject|3
7818489|NCT01231503|12285603|FG002|Overall Study|Withdrawal by Subject|3
7818490|NCT01231503|12285604|FG003|Overall Study|Withdrawal by Subject|1
7818491|NCT01231503|12285605|FG004|Overall Study|Withdrawal by Subject|3
7818492|NCT01231503|12285606|FG005|Overall Study|Withdrawal by Subject|5
7818493|NCT01231503|12285607|FG006|Overall Study|Withdrawal by Subject|1
7818494|NCT01231503|12285608|FG007|Overall Study|Withdrawal by Subject|2
7818495|NCT01231503|12285601|FG000|Overall Study|Lost to Follow-up|8
7818496|NCT01231503|12285602|FG001|Overall Study|Lost to Follow-up|10
7818497|NCT01231503|12285603|FG002|Overall Study|Lost to Follow-up|8
7818498|NCT01231503|12285604|FG003|Overall Study|Lost to Follow-up|5
7818499|NCT01231503|12285605|FG004|Overall Study|Lost to Follow-up|7
7818500|NCT01231503|12285606|FG005|Overall Study|Lost to Follow-up|9
7911641|NCT02065245|12429089|FG002|Infusion 3|Lost to Follow-up|0
7911642|NCT02065245|12429090|FG003|Infusion 3|Lost to Follow-up|0
7911643|NCT02065245|12429091|FG004|Infusion 3|Lost to Follow-up|0
7911644|NCT02065245|12429092|FG005|Infusion 3|Lost to Follow-up|0
7911645|NCT02065245|12429093|FG006|Infusion 3|Lost to Follow-up|0
7911646|NCT02065336|12429117|FG000|Extension Phase|Study Terminated by Sponsor|0
7911647|NCT02065336|12429118|FG001|Extension Phase|Study Terminated by Sponsor|0
7911648|NCT02065336|12429119|FG002|Extension Phase|Study Terminated by Sponsor|0
7911649|NCT02065336|12429120|FG003|Extension Phase|Study Terminated by Sponsor|0
7911650|NCT02065336|12429121|FG004|Extension Phase|Study Terminated by Sponsor|0
7911651|NCT02065336|12429122|FG005|Extension Phase|Study Terminated by Sponsor|0
7911652|NCT02065336|12429123|FG006|Extension Phase|Study Terminated by Sponsor|0
7911653|NCT02065336|12429124|FG007|Extension Phase|Study Terminated by Sponsor|0
7911654|NCT02065336|12429125|FG008|Extension Phase|Study Terminated by Sponsor|2
7911655|NCT02065336|12429126|FG009|Extension Phase|Study Terminated by Sponsor|8
7911656|NCT02065518|12429178|FG000|Overall Study|Lost to Follow-up|3
7911657|NCT02065518|12429179|FG001|Overall Study|Lost to Follow-up|4
7911658|NCT02065518|12429180|FG002|Overall Study|Lost to Follow-up|0
7911659|NCT02065518|12429181|FG003|Overall Study|Lost to Follow-up|3
7911660|NCT02065518|12429178|FG000|Overall Study|Withdrawal by Subject|3
7911661|NCT02065518|12429179|FG001|Overall Study|Withdrawal by Subject|4
7911662|NCT02065518|12429180|FG002|Overall Study|Withdrawal by Subject|9
7911663|NCT02065518|12429181|FG003|Overall Study|Withdrawal by Subject|2
7818501|NCT01231503|12285607|FG006|Overall Study|Lost to Follow-up|6
7818502|NCT01231503|12285608|FG007|Overall Study|Lost to Follow-up|6
7818503|NCT01231503|12285601|FG000|Overall Study|Protocol Violation|0
7818504|NCT01231503|12285602|FG001|Overall Study|Protocol Violation|0
7911664|NCT02065557|12429194|FG000|Induction Period|Withdrawal by Subject|2
7911665|NCT02065557|12429195|FG001|Induction Period|Withdrawal by Subject|1
7911666|NCT02065557|12429196|FG002|Induction Period|Withdrawal by Subject|0
7818505|NCT01231503|12285603|FG002|Overall Study|Protocol Violation|0
7818506|NCT01231503|12285604|FG003|Overall Study|Protocol Violation|1
7818507|NCT01231503|12285605|FG004|Overall Study|Protocol Violation|0
7818508|NCT01231503|12285606|FG005|Overall Study|Protocol Violation|0
7818509|NCT01231503|12285607|FG006|Overall Study|Protocol Violation|0
7818510|NCT01231503|12285608|FG007|Overall Study|Protocol Violation|0
7818511|NCT01231555|12285639|FG000|Overall Study|Study terminated|8
7818512|NCT01231555|12285640|FG001|Overall Study|Study terminated|5
7818513|NCT01231555|12285641|FG002|Overall Study|Study terminated|8
7818514|NCT01231555|12285639|FG000|Overall Study|Withdrawal by Subject|0
7818515|NCT01231555|12285640|FG001|Overall Study|Withdrawal by Subject|2
7818516|NCT01231555|12285641|FG002|Overall Study|Withdrawal by Subject|0
7818517|NCT01231581|12285651|FG000|Overall Study|Lost to Follow-up|2
7818518|NCT01231581|12285652|FG001|Overall Study|Lost to Follow-up|2
7818519|NCT01231581|12285651|FG000|Overall Study|Withdrawal by Subject|6
7818520|NCT01231581|12285652|FG001|Overall Study|Withdrawal by Subject|9
7818521|NCT01231581|12285651|FG000|Overall Study|Study Closed/Terminated|6
7818522|NCT01231581|12285652|FG001|Overall Study|Study Closed/Terminated|5
7818523|NCT01231581|12285651|FG000|Overall Study|Death|65
7818524|NCT01231581|12285652|FG001|Overall Study|Death|64
7818525|NCT01231581|12285651|FG000|Overall Study|Ongoing|1
7818526|NCT01231581|12285652|FG001|Overall Study|Ongoing|0
7818527|NCT01231607|12285663|FG000|Overall Study|Adverse Event|0
7818528|NCT01231607|12285664|FG001|Overall Study|Adverse Event|8
7818529|NCT01231607|12285665|FG002|Overall Study|Adverse Event|4
7818530|NCT01231607|12285666|FG003|Overall Study|Adverse Event|4
7818531|NCT01231607|12285667|FG004|Overall Study|Adverse Event|5
7818532|NCT01231607|12285663|FG000|Overall Study|Lost to Follow-up|13
7818533|NCT01231607|12285664|FG001|Overall Study|Lost to Follow-up|11
7818534|NCT01231607|12285665|FG002|Overall Study|Lost to Follow-up|10
7818535|NCT01231607|12285666|FG003|Overall Study|Lost to Follow-up|10
7818536|NCT01231607|12285667|FG004|Overall Study|Lost to Follow-up|4
7818537|NCT01231607|12285663|FG000|Overall Study|Physician Decision|4
7818538|NCT01231607|12285664|FG001|Overall Study|Physician Decision|4
7818539|NCT01231607|12285665|FG002|Overall Study|Physician Decision|3
7818540|NCT01231607|12285666|FG003|Overall Study|Physician Decision|5
7818541|NCT01231607|12285667|FG004|Overall Study|Physician Decision|4
7818542|NCT01231607|12285663|FG000|Overall Study|Protocol Violation|3
7818543|NCT01231607|12285664|FG001|Overall Study|Protocol Violation|2
7818544|NCT01231607|12285665|FG002|Overall Study|Protocol Violation|0
7818545|NCT01231607|12285666|FG003|Overall Study|Protocol Violation|2
7818546|NCT01231607|12285667|FG004|Overall Study|Protocol Violation|2
7818547|NCT01231607|12285663|FG000|Overall Study|Withdrawal by Subject|9
7818548|NCT01231607|12285664|FG001|Overall Study|Withdrawal by Subject|9
7818549|NCT01231607|12285665|FG002|Overall Study|Withdrawal by Subject|14
7818550|NCT01231607|12285666|FG003|Overall Study|Withdrawal by Subject|17
7818551|NCT01231607|12285667|FG004|Overall Study|Withdrawal by Subject|9
7818552|NCT01231620|12285685|FG000|Overall Study|Physician Decision|3
7818553|NCT01231620|12285686|FG001|Overall Study|Physician Decision|5
7818554|NCT01231620|12285687|FG002|Overall Study|Physician Decision|10
7818555|NCT01231620|12285685|FG000|Overall Study|Death|12
7818556|NCT01231620|12285686|FG001|Overall Study|Death|14
7818557|NCT01231620|12285687|FG002|Overall Study|Death|11
7818558|NCT01231620|12285685|FG000|Overall Study|Adverse Event|2
7818559|NCT01231620|12285686|FG001|Overall Study|Adverse Event|2
7818560|NCT01231620|12285687|FG002|Overall Study|Adverse Event|1
7818561|NCT01231620|12285685|FG000|Overall Study|Withdrawal by Subject|6
7818562|NCT01231620|12285686|FG001|Overall Study|Withdrawal by Subject|6
7818563|NCT01231620|12285687|FG002|Overall Study|Withdrawal by Subject|8
7818564|NCT01231620|12285685|FG000|Overall Study|Lost to Follow-up|3
7818565|NCT01231620|12285686|FG001|Overall Study|Lost to Follow-up|4
7818566|NCT01231620|12285687|FG002|Overall Study|Lost to Follow-up|9
7862023|NCT01597245|12351197|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862024|NCT01597245|12351198|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
7862025|NCT01597245|12351199|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862026|NCT01597245|12351200|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862027|NCT01597245|12351201|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862028|NCT01597245|12351202|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862029|NCT01597245|12351203|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862030|NCT01597245|12351204|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862031|NCT01597245|12351205|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862032|NCT01597245|12351206|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862033|NCT01597245|12351207|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862034|NCT01597245|12351208|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7862035|NCT01597245|12351188|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7862036|NCT01597245|12351189|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7862037|NCT01597245|12351190|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7862038|NCT01597245|12351191|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7818567|NCT01231659|12285715|FG000|Overall Study|Adverse Event|9
7818568|NCT01231659|12285715|FG000|Overall Study|Disease Progression|48
7818569|NCT01231659|12285715|FG000|Overall Study|Death|2
7818570|NCT01231659|12285715|FG000|Overall Study|Patient refused to complete study visit|1
7818571|NCT01231659|12285715|FG000|Overall Study|Other protocol defined criteria|12
7818572|NCT01231984|12285725|FG000|Study Period 1|Withdrawal by Subject|0
7818573|NCT01231984|12285726|FG001|Study Period 1|Withdrawal by Subject|0
7818574|NCT01231984|12285727|FG002|Study Period 1|Withdrawal by Subject|0
7818575|NCT01231984|12285728|FG003|Study Period 1|Withdrawal by Subject|1
7818576|NCT01231984|12285725|FG000|Study Period 1|Lost to Follow-up|1
7818577|NCT01231984|12285726|FG001|Study Period 1|Lost to Follow-up|1
7818578|NCT01231984|12285727|FG002|Study Period 1|Lost to Follow-up|1
7818579|NCT01231984|12285728|FG003|Study Period 1|Lost to Follow-up|0
7818580|NCT01231984|12285725|FG000|Study Period 1|Did not continue to meet I/E Criteria|2
7818581|NCT01231984|12285726|FG001|Study Period 1|Did not continue to meet I/E Criteria|2
7818582|NCT01231984|12285727|FG002|Study Period 1|Did not continue to meet I/E Criteria|2
7818583|NCT01231984|12285728|FG003|Study Period 1|Did not continue to meet I/E Criteria|2
7818584|NCT01231984|12285725|FG000|Study Period 1|Screen Failure|0
7818585|NCT01231984|12285726|FG001|Study Period 1|Screen Failure|0
7818586|NCT01231984|12285727|FG002|Study Period 1|Screen Failure|0
7818587|NCT01231984|12285728|FG003|Study Period 1|Screen Failure|1
7818588|NCT01231984|12285725|FG000|Study Period 1|Non-compliance with study requirements|5
7818589|NCT01231984|12285726|FG001|Study Period 1|Non-compliance with study requirements|0
7818590|NCT01231984|12285727|FG002|Study Period 1|Non-compliance with study requirements|2
7818591|NCT01231984|12285728|FG003|Study Period 1|Non-compliance with study requirements|1
7818592|NCT01231984|12285725|FG000|Study Period 1|Protocol Violation|3
7818593|NCT01231984|12285726|FG001|Study Period 1|Protocol Violation|4
7818594|NCT01231984|12285727|FG002|Study Period 1|Protocol Violation|2
7818595|NCT01231984|12285728|FG003|Study Period 1|Protocol Violation|3
7818596|NCT01231984|12285725|FG000|Study Period 1|Adverse Event|1
7818597|NCT01231984|12285726|FG001|Study Period 1|Adverse Event|0
7818598|NCT01231984|12285727|FG002|Study Period 1|Adverse Event|0
7818599|NCT01231984|12285728|FG003|Study Period 1|Adverse Event|0
7818600|NCT01231984|12285725|FG000|Study Period 1|Other|0
7818601|NCT01231984|12285726|FG001|Study Period 1|Other|0
7818602|NCT01231984|12285727|FG002|Study Period 1|Other|0
7818603|NCT01231984|12285728|FG003|Study Period 1|Other|1
7818604|NCT01231984|12285725|FG000|Study Period 2|Withdrawal by Subject|1
7818605|NCT01231984|12285726|FG001|Study Period 2|Withdrawal by Subject|1
7818606|NCT01231984|12285727|FG002|Study Period 2|Withdrawal by Subject|0
7818607|NCT01231984|12285728|FG003|Study Period 2|Withdrawal by Subject|0
7818608|NCT01231984|12285725|FG000|Study Period 2|Lost to Follow-up|1
7818609|NCT01231984|12285726|FG001|Study Period 2|Lost to Follow-up|0
7818610|NCT01231984|12285727|FG002|Study Period 2|Lost to Follow-up|0
7818611|NCT01231984|12285728|FG003|Study Period 2|Lost to Follow-up|3
7818612|NCT01231984|12285725|FG000|Study Period 2|Did not continue to meet I/E Criteria|1
7818613|NCT01231984|12285726|FG001|Study Period 2|Did not continue to meet I/E Criteria|1
7818614|NCT01231984|12285727|FG002|Study Period 2|Did not continue to meet I/E Criteria|0
7818615|NCT01231984|12285728|FG003|Study Period 2|Did not continue to meet I/E Criteria|1
7818616|NCT01232127|12285746|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1
7818617|NCT01232127|12285747|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0
7818618|NCT01232127|12285748|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0
7818619|NCT01232296|12285771|FG000|Overall Study|Adverse Event|24
7818620|NCT01232296|12285772|FG001|Overall Study|Adverse Event|12
7818621|NCT01232296|12285771|FG000|Overall Study|Physician Decision|1
7818622|NCT01232296|12285772|FG001|Overall Study|Physician Decision|1
7818623|NCT01232296|12285771|FG000|Overall Study|Progressive disease|43
7818624|NCT01232296|12285772|FG001|Overall Study|Progressive disease|61
7818625|NCT01232296|12285771|FG000|Overall Study|Study terminated by sponsor|0
7818626|NCT01232296|12285772|FG001|Overall Study|Study terminated by sponsor|1
7818627|NCT01232296|12285771|FG000|Overall Study|Technical problems|3
7818628|NCT01232296|12285772|FG001|Overall Study|Technical problems|0
7818629|NCT01232296|12285771|FG000|Overall Study|Subject/guardian decision|10
7818630|NCT01232296|12285772|FG001|Overall Study|Subject/guardian decision|2
7818631|NCT01232296|12285771|FG000|Overall Study|Death|1
7818632|NCT01232296|12285772|FG001|Overall Study|Death|6
7818633|NCT01232452|12285780|FG000|Overall Study|Adverse Event|17
7818634|NCT01232452|12285781|FG001|Overall Study|Adverse Event|15
7818635|NCT01232452|12285780|FG000|Overall Study|Withdrawal by Subject|11
7818636|NCT01232452|12285781|FG001|Overall Study|Withdrawal by Subject|8
7818637|NCT01232452|12285780|FG000|Overall Study|Physician Decision|8
7818638|NCT01232452|12285781|FG001|Overall Study|Physician Decision|12
7818639|NCT01232452|12285780|FG000|Overall Study|Protocol entry criterion not met|0
7818640|NCT01232452|12285781|FG001|Overall Study|Protocol entry criterion not met|2
7818641|NCT01232452|12285780|FG000|Overall Study|Sponsor Decision|3
7818642|NCT01232452|12285781|FG001|Overall Study|Sponsor Decision|1
7911667|NCT02065557|12429197|FG003|Induction Period|Withdrawal by Subject|0
7911668|NCT02065557|12429198|FG004|Induction Period|Withdrawal by Subject|0
7911669|NCT02065557|12429199|FG005|Induction Period|Withdrawal by Subject|0
7911670|NCT02065557|12429194|FG000|Induction Period|Lack of Efficacy|2
7911671|NCT02065557|12429195|FG001|Induction Period|Lack of Efficacy|1
7911672|NCT02065557|12429196|FG002|Induction Period|Lack of Efficacy|1
7911673|NCT02065557|12429197|FG003|Induction Period|Lack of Efficacy|0
7911674|NCT02065557|12429198|FG004|Induction Period|Lack of Efficacy|0
7818643|NCT01232452|12285780|FG000|Overall Study|Protocol Violation|0
7818644|NCT01232452|12285781|FG001|Overall Study|Protocol Violation|1
7818645|NCT01232491|12285798|FG000|Overall Study|Adverse Event|13
7818646|NCT01232491|12285799|FG001|Overall Study|Adverse Event|8
7818647|NCT01232491|12285798|FG000|Overall Study|Lack of Efficacy|1
7818648|NCT01232491|12285799|FG001|Overall Study|Lack of Efficacy|5
7818649|NCT01232491|12285798|FG000|Overall Study|Protocol Violation|13
7818650|NCT01232491|12285799|FG001|Overall Study|Protocol Violation|11
7818651|NCT01232491|12285798|FG000|Overall Study|Withdrawal Criteria|12
7818652|NCT01232491|12285799|FG001|Overall Study|Withdrawal Criteria|21
7818653|NCT01232491|12285798|FG000|Overall Study|Other|21
7818654|NCT01232491|12285799|FG001|Overall Study|Other|18
7818655|NCT01232556|12285828|FG000|Overall Study|Withdrawal by Subject|21
7818656|NCT01232556|12285829|FG001|Overall Study|Withdrawal by Subject|17
7818657|NCT01232556|12285828|FG000|Overall Study|Death|97
7818658|NCT01232556|12285829|FG001|Overall Study|Death|97
7818659|NCT01232556|12285828|FG000|Overall Study|Lost to Follow-up|0
7818660|NCT01232556|12285829|FG001|Overall Study|Lost to Follow-up|2
7818661|NCT01232556|12285828|FG000|Overall Study|Terminated by Sponsor|35
7818662|NCT01232556|12285829|FG001|Overall Study|Terminated by Sponsor|51
7818663|NCT01232556|12285828|FG000|Overall Study|Other|6
7818664|NCT01232556|12285829|FG001|Overall Study|Other|4
7818665|NCT01232569|12285837|FG000|Double-blind Treatment Period|Withdrawal by Subject|9
7818666|NCT01232569|12285838|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
7818667|NCT01232569|12285839|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7818668|NCT01232569|12285840|FG003|Double-blind Treatment Period|Withdrawal by Subject|0
7818669|NCT01232569|12285837|FG000|Double-blind Treatment Period|Escape|2
7911675|NCT02065557|12429199|FG005|Induction Period|Lack of Efficacy|0
7818670|NCT01232569|12285838|FG001|Double-blind Treatment Period|Escape|2
7818671|NCT01232569|12285839|FG002|Double-blind Treatment Period|Escape|0
7818672|NCT01232569|12285840|FG003|Double-blind Treatment Period|Escape|0
7818673|NCT01232569|12285837|FG000|Double-blind Treatment Period|Lost to Follow-up|4
7818674|NCT01232569|12285838|FG001|Double-blind Treatment Period|Lost to Follow-up|0
7818675|NCT01232569|12285839|FG002|Double-blind Treatment Period|Lost to Follow-up|0
7818676|NCT01232569|12285840|FG003|Double-blind Treatment Period|Lost to Follow-up|0
7818677|NCT01232569|12285837|FG000|Double-blind Treatment Period|Lack of Efficacy|1
7818678|NCT01232569|12285838|FG001|Double-blind Treatment Period|Lack of Efficacy|2
7818679|NCT01232569|12285839|FG002|Double-blind Treatment Period|Lack of Efficacy|0
7818680|NCT01232569|12285840|FG003|Double-blind Treatment Period|Lack of Efficacy|0
7818681|NCT01232569|12285837|FG000|Double-blind Treatment Period|Physician Decision|1
7818682|NCT01232569|12285838|FG001|Double-blind Treatment Period|Physician Decision|0
7818683|NCT01232569|12285839|FG002|Double-blind Treatment Period|Physician Decision|0
7818684|NCT01232569|12285840|FG003|Double-blind Treatment Period|Physician Decision|0
7818685|NCT01232569|12285837|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
7818686|NCT01232569|12285838|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
7818687|NCT01232569|12285839|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
7818688|NCT01232569|12285840|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
7818689|NCT01232569|12285837|FG000|Double-blind Treatment Period|Death|2
7818690|NCT01232569|12285838|FG001|Double-blind Treatment Period|Death|0
7911676|NCT02065557|12429194|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1
7911677|NCT02065557|12429195|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1
7911678|NCT02065557|12429196|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1
7911679|NCT02065557|12429197|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0
7911680|NCT02065557|12429198|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0
7911681|NCT02065557|12429199|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0
7911682|NCT02065557|12429194|FG000|Induction Period|Non-Responder at Week 8|4
7911683|NCT02065557|12429195|FG001|Induction Period|Non-Responder at Week 8|4
7911684|NCT02065557|12429196|FG002|Induction Period|Non-Responder at Week 8|0
7911685|NCT02065557|12429197|FG003|Induction Period|Non-Responder at Week 8|0
7911686|NCT02065557|12429198|FG004|Induction Period|Non-Responder at Week 8|0
7911687|NCT02065557|12429199|FG005|Induction Period|Non-Responder at Week 8|0
7911688|NCT02065557|12429194|FG000|Induction Period|Adverse Event|1
7911689|NCT02065557|12429195|FG001|Induction Period|Adverse Event|1
7911690|NCT02065557|12429196|FG002|Induction Period|Adverse Event|0
7911691|NCT02065557|12429197|FG003|Induction Period|Adverse Event|0
7911692|NCT02065557|12429198|FG004|Induction Period|Adverse Event|0
7911693|NCT02065557|12429199|FG005|Induction Period|Adverse Event|0
7911694|NCT02065557|12429194|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7911695|NCT02065557|12429195|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7911696|NCT02065557|12429196|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7911697|NCT02065557|12429197|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1
7911698|NCT02065557|12429198|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1
7911699|NCT02065557|12429199|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7911700|NCT02065557|12429194|FG000|Maintenance Period|Withdrawal by Subject|0
7911701|NCT02065557|12429195|FG001|Maintenance Period|Withdrawal by Subject|0
7911702|NCT02065557|12429196|FG002|Maintenance Period|Withdrawal by Subject|0
7911703|NCT02065557|12429197|FG003|Maintenance Period|Withdrawal by Subject|0
7911704|NCT02065557|12429198|FG004|Maintenance Period|Withdrawal by Subject|2
7911705|NCT02065557|12429199|FG005|Maintenance Period|Withdrawal by Subject|1
7911706|NCT02065557|12429194|FG000|Maintenance Period|Lack of Efficacy|0
7911707|NCT02065557|12429195|FG001|Maintenance Period|Lack of Efficacy|0
7911708|NCT02065557|12429196|FG002|Maintenance Period|Lack of Efficacy|0
7911709|NCT02065557|12429197|FG003|Maintenance Period|Lack of Efficacy|0
7911710|NCT02065557|12429198|FG004|Maintenance Period|Lack of Efficacy|5
7911711|NCT02065557|12429199|FG005|Maintenance Period|Lack of Efficacy|2
7911712|NCT02065557|12429194|FG000|Maintenance Period|Subject Non-Compliance|0
7911713|NCT02065557|12429195|FG001|Maintenance Period|Subject Non-Compliance|0
7911714|NCT02065557|12429196|FG002|Maintenance Period|Subject Non-Compliance|0
7911715|NCT02065557|12429197|FG003|Maintenance Period|Subject Non-Compliance|0
7911716|NCT02065557|12429198|FG004|Maintenance Period|Subject Non-Compliance|0
7911717|NCT02065557|12429199|FG005|Maintenance Period|Subject Non-Compliance|1
7911718|NCT02065570|12429226|FG000|Induction Study|Adverse Event|5
7911719|NCT02065570|12429227|FG001|Induction Study|Adverse Event|12
7911720|NCT02065570|12429228|FG002|Induction Study|Adverse Event|0
7911721|NCT02065570|12429229|FG003|Induction Study|Adverse Event|0
7911722|NCT02065570|12429226|FG000|Induction Study|Withdrawal by Subject|2
7818691|NCT01232569|12285839|FG002|Double-blind Treatment Period|Death|0
7818692|NCT01232569|12285840|FG003|Double-blind Treatment Period|Death|0
7818693|NCT01232738|12285849|FG000|Overall Study|Death|3
7818694|NCT01232738|12285849|FG000|Overall Study|Physician Decision|2
7911723|NCT02065570|12429227|FG001|Induction Study|Withdrawal by Subject|3
7911724|NCT02065570|12429228|FG002|Induction Study|Withdrawal by Subject|0
7911725|NCT02065570|12429229|FG003|Induction Study|Withdrawal by Subject|0
7911726|NCT02065570|12429226|FG000|Induction Study|Lost to Follow-up|1
7911727|NCT02065570|12429227|FG001|Induction Study|Lost to Follow-up|1
7911728|NCT02065570|12429228|FG002|Induction Study|Lost to Follow-up|0
7818695|NCT01232738|12285849|FG000|Overall Study|Lost to Follow-up|1
7818696|NCT01232738|12285849|FG000|Overall Study|Withdrawal by Subject|2
7818697|NCT01232738|12285849|FG000|Overall Study|Adverse Event|5
7818698|NCT01232790|12285857|FG000|Randomization|Withdrawal by Subject|2
7818699|NCT01232790|12285858|FG001|Randomization|Withdrawal by Subject|0
7818700|NCT01232790|12285857|FG000|Randomization|Protocol Violation|0
7818701|NCT01232790|12285858|FG001|Randomization|Protocol Violation|1
7818702|NCT01232790|12285857|FG000|Randomization|Physician Decision|0
7818703|NCT01232790|12285858|FG001|Randomization|Physician Decision|1
7818704|NCT01232790|12285857|FG000|Initial Assessment|Withdrawal by Subject|0
7818705|NCT01232790|12285858|FG001|Initial Assessment|Withdrawal by Subject|1
7818706|NCT01232790|12285857|FG000|First Crossover|Withdrawal by Subject|1
7818707|NCT01232790|12285858|FG001|First Crossover|Withdrawal by Subject|0
7818708|NCT01232790|12285857|FG000|Second Crossover|Withdrawal by Subject|1
7818709|NCT01232790|12285858|FG001|Second Crossover|Withdrawal by Subject|2
7818710|NCT01232868|12285880|FG000|Overall Study|Lost to Follow-up|2
7818711|NCT01232868|12285881|FG001|Overall Study|Lost to Follow-up|4
7818712|NCT01232894|12285889|FG000|Overall Study|Lost to Follow-up|0
7818713|NCT01232894|12285890|FG001|Overall Study|Lost to Follow-up|1
7818714|NCT01232894|12285889|FG000|Overall Study|Death|1
7818715|NCT01232894|12285890|FG001|Overall Study|Death|0
7818716|NCT01232894|12285889|FG000|Overall Study|Protocol Violation|1
7911729|NCT02065570|12429229|FG003|Induction Study|Lost to Follow-up|0
7911730|NCT02065570|12429226|FG000|Induction Study|Other, Not Specified|6
7911731|NCT02065570|12429227|FG001|Induction Study|Other, Not Specified|5
7911732|NCT02065570|12429228|FG002|Induction Study|Other, Not Specified|0
7911733|NCT02065570|12429229|FG003|Induction Study|Other, Not Specified|0
7911734|NCT02065570|12429226|FG000|Maintenance Study|Adverse Event|0
7911735|NCT02065570|12429227|FG001|Maintenance Study|Adverse Event|0
7911736|NCT02065570|12429228|FG002|Maintenance Study|Adverse Event|8
7911737|NCT02065570|12429229|FG003|Maintenance Study|Adverse Event|8
7911738|NCT02065570|12429226|FG000|Maintenance Study|Withdrawal by Subject|0
7911739|NCT02065570|12429227|FG001|Maintenance Study|Withdrawal by Subject|0
7911740|NCT02065570|12429228|FG002|Maintenance Study|Withdrawal by Subject|1
7911741|NCT02065570|12429229|FG003|Maintenance Study|Withdrawal by Subject|4
7911742|NCT02065570|12429226|FG000|Maintenance Study|Lost to Follow-up|0
7911743|NCT02065570|12429227|FG001|Maintenance Study|Lost to Follow-up|0
7911744|NCT02065570|12429228|FG002|Maintenance Study|Lost to Follow-up|2
7911745|NCT02065570|12429229|FG003|Maintenance Study|Lost to Follow-up|2
7911746|NCT02065570|12429226|FG000|Maintenance Study|Other, Not Specified|0
7911747|NCT02065570|12429227|FG001|Maintenance Study|Other, Not Specified|0
7911748|NCT02065570|12429228|FG002|Maintenance Study|Other, Not Specified|11
7911749|NCT02065570|12429229|FG003|Maintenance Study|Other, Not Specified|5
7911750|NCT02065622|12429242|FG000|Induction Study|Adverse Event|13
7911751|NCT02065622|12429243|FG001|Induction Study|Adverse Event|19
7911752|NCT02065622|12429244|FG002|Induction Study|Adverse Event|0
7911753|NCT02065622|12429245|FG003|Induction Study|Adverse Event|0
7911754|NCT02065622|12429246|FG004|Induction Study|Adverse Event|0
7911755|NCT02065622|12429242|FG000|Induction Study|Withdrawal by Subject|3
7911756|NCT02065622|12429243|FG001|Induction Study|Withdrawal by Subject|5
7911757|NCT02065622|12429244|FG002|Induction Study|Withdrawal by Subject|0
7911758|NCT02065622|12429245|FG003|Induction Study|Withdrawal by Subject|0
7911759|NCT02065622|12429246|FG004|Induction Study|Withdrawal by Subject|0
7911760|NCT02065622|12429242|FG000|Induction Study|Lost to Follow-up|1
7818717|NCT01232894|12285890|FG001|Overall Study|Protocol Violation|1
7818718|NCT01232894|12285889|FG000|Overall Study|Withdrawal by Subject|8
7911761|NCT02065622|12429243|FG001|Induction Study|Lost to Follow-up|0
7911762|NCT02065622|12429244|FG002|Induction Study|Lost to Follow-up|0
7911763|NCT02065622|12429245|FG003|Induction Study|Lost to Follow-up|0
7911764|NCT02065622|12429246|FG004|Induction Study|Lost to Follow-up|0
7911765|NCT02065622|12429242|FG000|Induction Study|Lack of Efficacy|22
7911766|NCT02065622|12429243|FG001|Induction Study|Lack of Efficacy|27
7911767|NCT02065622|12429244|FG002|Induction Study|Lack of Efficacy|0
7911768|NCT02065622|12429245|FG003|Induction Study|Lack of Efficacy|0
7911769|NCT02065622|12429246|FG004|Induction Study|Lack of Efficacy|0
7911770|NCT02065622|12429242|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4
7911771|NCT02065622|12429243|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5
7911772|NCT02065622|12429244|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0
7911773|NCT02065622|12429245|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0
7911774|NCT02065622|12429246|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0
7818719|NCT01232894|12285890|FG001|Overall Study|Withdrawal by Subject|5
7818720|NCT01232894|12285889|FG000|Overall Study|Physician Decision|2
7911775|NCT02065622|12429242|FG000|Induction Study|Subject Noncompliance|1
7911776|NCT02065622|12429243|FG001|Induction Study|Subject Noncompliance|1
7911777|NCT02065622|12429244|FG002|Induction Study|Subject Noncompliance|0
7911778|NCT02065622|12429245|FG003|Induction Study|Subject Noncompliance|0
7911779|NCT02065622|12429246|FG004|Induction Study|Subject Noncompliance|0
7911780|NCT02065622|12429242|FG000|Induction Study|Other, Not Specified|3
7911781|NCT02065622|12429243|FG001|Induction Study|Other, Not Specified|2
7911782|NCT02065622|12429244|FG002|Induction Study|Other, Not Specified|0
7911783|NCT02065622|12429245|FG003|Induction Study|Other, Not Specified|0
7911784|NCT02065622|12429246|FG004|Induction Study|Other, Not Specified|0
7818721|NCT01232894|12285890|FG001|Overall Study|Physician Decision|1
7818722|NCT01233050|12285920|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8
7818723|NCT01233050|12285921|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6
7818724|NCT01233076|12285927|FG000|Period 2, One Week|Lost to Follow-up|1
7818725|NCT01233076|12285928|FG001|Period 2, One Week|Lost to Follow-up|0
7818726|NCT01233232|12285937|FG000|Overall Study|Voluntary Discontinuation by Subject|1
7818727|NCT01233232|12285938|FG001|Overall Study|Voluntary Discontinuation by Subject|0
7818728|NCT01233232|12285939|FG002|Overall Study|Voluntary Discontinuation by Subject|0
7818729|NCT01233258|12285952|FG000|First Intervention (6 Months)|Withdrawal by Subject|0
7818730|NCT01233258|12285953|FG001|First Intervention (6 Months)|Withdrawal by Subject|0
7818731|NCT01233258|12285954|FG002|First Intervention (6 Months)|Withdrawal by Subject|0
7818732|NCT01233258|12285955|FG003|First Intervention (6 Months)|Withdrawal by Subject|1
7818733|NCT01233258|12285956|FG004|First Intervention (6 Months)|Withdrawal by Subject|0
7818734|NCT01233258|12285957|FG005|First Intervention (6 Months)|Withdrawal by Subject|1
7818735|NCT01233258|12285952|FG000|First Intervention (6 Months)|Protocol Violation|0
7818736|NCT01233258|12285953|FG001|First Intervention (6 Months)|Protocol Violation|0
7818737|NCT01233258|12285954|FG002|First Intervention (6 Months)|Protocol Violation|1
7818738|NCT01233258|12285955|FG003|First Intervention (6 Months)|Protocol Violation|0
7818739|NCT01233258|12285956|FG004|First Intervention (6 Months)|Protocol Violation|0
7818740|NCT01233258|12285957|FG005|First Intervention (6 Months)|Protocol Violation|0
7818741|NCT01233258|12285952|FG000|First Intervention (6 Months)|Non-compliance with study medication|1
7818742|NCT01233258|12285953|FG001|First Intervention (6 Months)|Non-compliance with study medication|0
7818743|NCT01233258|12285954|FG002|First Intervention (6 Months)|Non-compliance with study medication|0
7818744|NCT01233258|12285955|FG003|First Intervention (6 Months)|Non-compliance with study medication|0
7818745|NCT01233258|12285956|FG004|First Intervention (6 Months)|Non-compliance with study medication|0
7818746|NCT01233258|12285957|FG005|First Intervention (6 Months)|Non-compliance with study medication|0
7818747|NCT01233284|12285972|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1
7818748|NCT01233284|12285973|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0
7818749|NCT01233284|12285974|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0
7818750|NCT01233284|12285975|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0
7818751|NCT01233284|12285976|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0
7818752|NCT01233284|12285972|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0
7818753|NCT01233284|12285973|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1
7818754|NCT01233284|12285974|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0
7818755|NCT01233284|12285975|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0
7818756|NCT01233284|12285976|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0
7818757|NCT01233284|12285972|FG000|Period 1 (4 Weeks)|Other|0
7818758|NCT01233284|12285973|FG001|Period 1 (4 Weeks)|Other|0
7818759|NCT01233284|12285974|FG002|Period 1 (4 Weeks)|Other|1
7818760|NCT01233284|12285975|FG003|Period 1 (4 Weeks)|Other|0
7818761|NCT01233284|12285976|FG004|Period 1 (4 Weeks)|Other|0
7818762|NCT01233284|12285972|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0
7818763|NCT01233284|12285973|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0
7818764|NCT01233284|12285974|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1
7818765|NCT01233284|12285975|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0
7818766|NCT01233284|12285976|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0
7818767|NCT01233284|12285972|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0
7818768|NCT01233284|12285973|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0
7818769|NCT01233284|12285974|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1
7818770|NCT01233284|12285975|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0
7818771|NCT01233284|12285976|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0
7818772|NCT01233284|12285972|FG000|Period 3 (4 Weeks)|Other|0
7818773|NCT01233284|12285973|FG001|Period 3 (4 Weeks)|Other|0
7818774|NCT01233284|12285974|FG002|Period 3 (4 Weeks)|Other|0
7818775|NCT01233284|12285975|FG003|Period 3 (4 Weeks)|Other|1
7818776|NCT01233284|12285976|FG004|Period 3 (4 Weeks)|Other|0
7818777|NCT01233284|12285972|FG000|Period 4 (4 Weeks)|Adverse Event|0
7818778|NCT01233284|12285973|FG001|Period 4 (4 Weeks)|Adverse Event|1
7818779|NCT01233284|12285974|FG002|Period 4 (4 Weeks)|Adverse Event|0
7818780|NCT01233284|12285975|FG003|Period 4 (4 Weeks)|Adverse Event|0
7818781|NCT01233284|12285976|FG004|Period 4 (4 Weeks)|Adverse Event|0
7818782|NCT01233284|12285972|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0
7818783|NCT01233284|12285973|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0
7818784|NCT01233284|12285974|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0
7818785|NCT01233284|12285975|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1
7818786|NCT01233284|12285976|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0
7818787|NCT01233609|12285993|FG000|Overall Study|Death|1
7818788|NCT01233609|12285994|FG001|Overall Study|Death|0
7818789|NCT01233609|12285993|FG000|Overall Study|Lost to Follow-up|3
7818790|NCT01233609|12285994|FG001|Overall Study|Lost to Follow-up|1
7818791|NCT01233609|12285993|FG000|Overall Study|Adverse Event|2
7818792|NCT01233609|12285994|FG001|Overall Study|Adverse Event|1
7818793|NCT01233609|12285993|FG000|Overall Study|Withdrawal by Subject|3
7818794|NCT01233609|12285994|FG001|Overall Study|Withdrawal by Subject|0
7818795|NCT01233687|12286008|FG000|Phase II AMG 102 + Erlotinib|Death|1
7818796|NCT01233687|12286008|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2
7818797|NCT01233687|12286008|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
7818798|NCT01233817|12286028|FG000|Overall Study|Lost to Follow-up|1
7818799|NCT01233817|12286028|FG000|Overall Study|Withdrawal by Subject|2
7818800|NCT01233869|12286036|FG000|Initial Treatment Period (24 Months)|Death|1
7818801|NCT01233869|12286037|FG001|Initial Treatment Period (24 Months)|Death|0
7818802|NCT01233869|12286038|FG002|Initial Treatment Period (24 Months)|Death|0
7818803|NCT01233869|12286039|FG003|Initial Treatment Period (24 Months)|Death|0
7818804|NCT01233869|12286036|FG000|Initial Treatment Period (24 Months)|Adverse Event|9
7818805|NCT01233869|12286037|FG001|Initial Treatment Period (24 Months)|Adverse Event|17
7818806|NCT01233869|12286038|FG002|Initial Treatment Period (24 Months)|Adverse Event|0
7818807|NCT01233869|12286039|FG003|Initial Treatment Period (24 Months)|Adverse Event|3
7818808|NCT01233869|12286036|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
7818809|NCT01233869|12286037|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
7818810|NCT01233869|12286038|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
7818811|NCT01233869|12286039|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
7818812|NCT01233869|12286036|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0
7818813|NCT01233869|12286037|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0
7818814|NCT01233869|12286038|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0
7818815|NCT01233869|12286039|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1
7818816|NCT01233869|12286036|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
7818817|NCT01233869|12286037|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
7818818|NCT01233869|12286038|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
7818819|NCT01233869|12286039|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
7818820|NCT01233869|12286036|FG000|Extended Treatment Period (46 Months)|Other|3
7818821|NCT01233869|12286037|FG001|Extended Treatment Period (46 Months)|Other|0
7818822|NCT01233869|12286038|FG002|Extended Treatment Period (46 Months)|Other|0
7818823|NCT01233869|12286039|FG003|Extended Treatment Period (46 Months)|Other|3
7818824|NCT01233869|12286036|FG000|Extended Treatment Period (46 Months)|Adverse Event|1
7818825|NCT01233869|12286037|FG001|Extended Treatment Period (46 Months)|Adverse Event|0
7818826|NCT01233869|12286038|FG002|Extended Treatment Period (46 Months)|Adverse Event|0
7818827|NCT01233869|12286039|FG003|Extended Treatment Period (46 Months)|Adverse Event|1
7818828|NCT01233999|12286058|FG000|Overall Study|Withdrawal by Subject|1
7818829|NCT01233999|12286058|FG000|Overall Study|Lost to Follow-up|1
7818830|NCT01234337|12286073|FG000|Overall Study|Adverse Event|58
7818831|NCT01234337|12286074|FG001|Overall Study|Adverse Event|21
7818832|NCT01234337|12286073|FG000|Overall Study|Disease progression/recurrence/relapse|181
7818833|NCT01234337|12286074|FG001|Overall Study|Disease progression/recurrence/relapse|223
7818834|NCT01234337|12286073|FG000|Overall Study|Investi. decision not protocol driven|5
7818835|NCT01234337|12286074|FG001|Overall Study|Investi. decision not protocol driven|6
7818836|NCT01234337|12286073|FG000|Overall Study|Non-compliant with study medication|3
7818837|NCT01234337|12286074|FG001|Overall Study|Non-compliant with study medication|2
7818838|NCT01234337|12286073|FG000|Overall Study|Randomized but not treated|6
7818839|NCT01234337|12286074|FG001|Overall Study|Randomized but not treated|4
7818840|NCT01234337|12286073|FG000|Overall Study|Lost to Follow-up|0
7818841|NCT01234337|12286074|FG001|Overall Study|Lost to Follow-up|1
7818842|NCT01234337|12286073|FG000|Overall Study|Protocol Violation|2
7818843|NCT01234337|12286074|FG001|Overall Study|Protocol Violation|3
7818844|NCT01234337|12286073|FG000|Overall Study|Withdrawal by Subject|11
7818845|NCT01234337|12286074|FG001|Overall Study|Withdrawal by Subject|9
7818846|NCT01234337|12286073|FG000|Overall Study|Death|0
7818847|NCT01234337|12286074|FG001|Overall Study|Death|1
7818848|NCT01234337|12286073|FG000|Overall Study|Switch to commercial drug|0
7818849|NCT01234337|12286074|FG001|Overall Study|Switch to commercial drug|1
7818850|NCT01234350|12286082|FG000|Overall Study|Adverse Event|277
7818851|NCT01234350|12286083|FG001|Overall Study|Adverse Event|92
7818852|NCT01234350|12286082|FG000|Overall Study|Withdrawal by Subject|61
7818853|NCT01234350|12286083|FG001|Overall Study|Withdrawal by Subject|36
7818854|NCT01234350|12286082|FG000|Overall Study|Lost to Follow-up|115
7818855|NCT01234350|12286083|FG001|Overall Study|Lost to Follow-up|47
7818856|NCT01234350|12286082|FG000|Overall Study|Covers a diverse set of reasons|234
7818857|NCT01234350|12286083|FG001|Overall Study|Covers a diverse set of reasons|92
7818858|NCT01234402|12286094|FG000|Overall Study|Lost to Follow-up|0
7818859|NCT01234402|12286095|FG001|Overall Study|Lost to Follow-up|1
7818860|NCT01234402|12286096|FG002|Overall Study|Lost to Follow-up|3
7818861|NCT01234402|12286094|FG000|Overall Study|Withdrawal by Subject|1
7818862|NCT01234402|12286095|FG001|Overall Study|Withdrawal by Subject|3
7818863|NCT01234402|12286096|FG002|Overall Study|Withdrawal by Subject|4
7818864|NCT01234402|12286094|FG000|Overall Study|Never treated: Death|0
7818865|NCT01234402|12286095|FG001|Overall Study|Never treated: Death|0
7818866|NCT01234402|12286096|FG002|Overall Study|Never treated: Death|1
7818867|NCT01234402|12286094|FG000|Overall Study|Never treated: Withdrawal By Subject|0
7818868|NCT01234402|12286095|FG001|Overall Study|Never treated: Withdrawal By Subject|1
7818869|NCT01234402|12286096|FG002|Overall Study|Never treated: Withdrawal By Subject|0
7818870|NCT01234402|12286094|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0
7818871|NCT01234402|12286095|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1
7818872|NCT01234402|12286096|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0
7818873|NCT01234467|12286106|FG000|Overall Study|Adverse Event|3
7818874|NCT01234467|12286106|FG000|Overall Study|Death|2
7818875|NCT01234467|12286106|FG000|Overall Study|Withdrawal by Subject|2
7818876|NCT01234467|12286106|FG000|Overall Study|Disease Progression|2
7818877|NCT01234467|12286106|FG000|Overall Study|Clinical deterioration|1
7818878|NCT01234467|12286106|FG000|Overall Study|Physician Decision|1
7818879|NCT01234467|12286106|FG000|Overall Study|Other complicating disease (stroke)|1
7818880|NCT01234480|12286110|FG000|Overall Study|Pregnancy|88
7818881|NCT01234480|12286110|FG000|Overall Study|>36/Normal History|50
7818882|NCT01234480|12286110|FG000|Overall Study|Age|3
7818883|NCT01234480|12286110|FG000|Overall Study|HPV Vaccine History|28
7818884|NCT01234480|12286110|FG000|Overall Study|HPV Vaccine after Enrollment|17
7818885|NCT01234480|12286110|FG000|Overall Study|Hysterectomy|2
7818886|NCT01234480|12286110|FG000|Overall Study|Hysterectomy post enrollment|1
7818887|NCT01234480|12286110|FG000|Overall Study|Inclusion/Exclusion Violation|3
7818888|NCT01234480|12286110|FG000|Overall Study|Informed Consent Form Violation|30
7818889|NCT01234480|12286110|FG000|Overall Study|Incorrect Visit|3
7818890|NCT01234480|12286110|FG000|Overall Study|No Florida Lab License|20
7818891|NCT01234480|12286110|FG000|Overall Study|Out of Window|42
7818892|NCT01234480|12286110|FG000|Overall Study|Sample Processing/Storage|92
7818893|NCT01234480|12286110|FG000|Overall Study|Site Amendment prohibited colposcopy|11
7818894|NCT01234480|12286110|FG000|Overall Study|Site/Subject non-compliance|44
7818895|NCT01234480|12286110|FG000|Overall Study|Missing Sample|9
7818896|NCT01234649|12286119|FG000|Overall Study|Withdrawal by Subject|32
7818897|NCT01234649|12286120|FG001|Overall Study|Withdrawal by Subject|26
7818898|NCT01234649|12286119|FG000|Overall Study|Pregnancy|6
7818899|NCT01234649|12286120|FG001|Overall Study|Pregnancy|6
7818900|NCT01234649|12286119|FG000|Overall Study|intolerant to side effects|4
7818901|NCT01234649|12286120|FG001|Overall Study|intolerant to side effects|3
7818902|NCT01234649|12286119|FG000|Overall Study|Allergic reaction|1
7818903|NCT01234649|12286120|FG001|Overall Study|Allergic reaction|0
7818904|NCT01234649|12286119|FG000|Overall Study|Lack of Efficacy|0
7818905|NCT01234649|12286120|FG001|Overall Study|Lack of Efficacy|3
7818906|NCT01234675|12286126|FG000|First Intervention (6 Weeks)|Adverse Event|0
7818907|NCT01234675|12286127|FG001|First Intervention (6 Weeks)|Adverse Event|1
7818908|NCT01234675|12286126|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1
7818909|NCT01234675|12286127|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0
7818910|NCT01234883|12286161|FG000|Overall Study|Early treatment release|8
7818911|NCT01234883|12286162|FG001|Overall Study|Early treatment release|10
7818912|NCT01234883|12286161|FG000|Overall Study|Parent/guardian withdrew consent|1
7818913|NCT01234883|12286162|FG001|Overall Study|Parent/guardian withdrew consent|2
7818914|NCT01234883|12286161|FG000|Overall Study|Technical difficulties with IV infusion|0
7818915|NCT01234883|12286162|FG001|Overall Study|Technical difficulties with IV infusion|1
7818916|NCT01234883|12286161|FG000|Overall Study|Inclusion/exclusion failure|1
7818917|NCT01234883|12286162|FG001|Overall Study|Inclusion/exclusion failure|0
7818918|NCT01235338|12286194|FG000|Overall Study|Adverse Event|3
7818919|NCT01235338|12286195|FG001|Overall Study|Adverse Event|2
7818920|NCT01235338|12286194|FG000|Overall Study|Protocol Violation|1
7818921|NCT01235338|12286195|FG001|Overall Study|Protocol Violation|1
7818922|NCT01235338|12286194|FG000|Overall Study|Withdrawal by Subject|5
7818923|NCT01235338|12286195|FG001|Overall Study|Withdrawal by Subject|0
7818924|NCT01235338|12286194|FG000|Overall Study|Exclusion criteria violations|1
7818925|NCT01235338|12286195|FG001|Overall Study|Exclusion criteria violations|1
7818926|NCT01235338|12286194|FG000|Overall Study|Positive drug screen|0
7818927|NCT01235338|12286195|FG001|Overall Study|Positive drug screen|1
7818928|NCT01235338|12286194|FG000|Overall Study|Prohibited meds|1
7818929|NCT01235338|12286195|FG001|Overall Study|Prohibited meds|0
7818930|NCT01235351|12286205|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10
7818931|NCT01235351|12286206|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4
7818932|NCT01235403|12286225|FG000|Overall Study|Adverse Event|14
7818933|NCT01235403|12286225|FG000|Overall Study|Lost to Follow-up|2
7818934|NCT01235403|12286225|FG000|Overall Study|Withdrawal by Subject|4
7818935|NCT01235403|12286225|FG000|Overall Study|Lack of Efficacy|2
7818936|NCT01235403|12286225|FG000|Overall Study|Other reasons for premature termination|4
7818937|NCT01235442|12286231|FG000|Overall Study|Lost to Follow-up|12
7818938|NCT01235442|12286232|FG001|Overall Study|Lost to Follow-up|10
7818939|NCT01235442|12286231|FG000|Overall Study|Death|0
7818940|NCT01235442|12286232|FG001|Overall Study|Death|2
7818941|NCT01235442|12286231|FG000|Overall Study|Pregnancy|1
7818942|NCT01235442|12286232|FG001|Overall Study|Pregnancy|1
7818943|NCT01235442|12286231|FG000|Overall Study|Ineligibility determined|5
7818944|NCT01235442|12286232|FG001|Overall Study|Ineligibility determined|4
7818945|NCT01235442|12286231|FG000|Overall Study|Protocol Violation|3
7818946|NCT01235442|12286232|FG001|Overall Study|Protocol Violation|3
7818947|NCT01235442|12286231|FG000|Overall Study|Adverse Event|4
7818948|NCT01235442|12286232|FG001|Overall Study|Adverse Event|6
7818949|NCT01235442|12286231|FG000|Overall Study|Withdrawal by Subject|15
7818950|NCT01235442|12286232|FG001|Overall Study|Withdrawal by Subject|9
7818951|NCT01235442|12286231|FG000|Overall Study|Lack of Efficacy|1
7818952|NCT01235442|12286232|FG001|Overall Study|Lack of Efficacy|3
7818953|NCT01235442|12286231|FG000|Overall Study|Noncompliance|1
7818954|NCT01235442|12286232|FG001|Overall Study|Noncompliance|2
7818955|NCT01235442|12286231|FG000|Overall Study|Administrative decision|1
7818956|NCT01235442|12286232|FG001|Overall Study|Administrative decision|2
7818957|NCT01235442|12286231|FG000|Overall Study|Other unspecified|1
7818958|NCT01235442|12286232|FG001|Overall Study|Other unspecified|2
7818959|NCT01235507|12286238|FG000|Overall Study|Adverse Event|1
7818960|NCT01235507|12286238|FG000|Overall Study|Withdrawal by Subject|1
7818961|NCT01235546|12286244|FG000|Overall Study|Staff error, medication not administered|1
7818962|NCT01235546|12286245|FG001|Overall Study|Staff error, medication not administered|0
7818963|NCT01235546|12286244|FG000|Overall Study|Protocol Violation|1
7818964|NCT01235546|12286245|FG001|Overall Study|Protocol Violation|1
7818965|NCT01235598|12286262|FG000|Overall Study|Adverse Event|0
7818966|NCT01235598|12286263|FG001|Overall Study|Adverse Event|3
7818967|NCT01235598|12286262|FG000|Overall Study|Lack of Efficacy|0
7818968|NCT01235598|12286263|FG001|Overall Study|Lack of Efficacy|1
7911785|NCT02065622|12429242|FG000|Maintenance Study|Adverse Event|0
7818969|NCT01235598|12286262|FG000|Overall Study|Withdrawal by Subject|1
7818970|NCT01235598|12286263|FG001|Overall Study|Withdrawal by Subject|0
7818971|NCT01235689|12286272|FG000|Overall Study|Adverse Event|12
7911786|NCT02065622|12429243|FG001|Maintenance Study|Adverse Event|0
7911787|NCT02065622|12429244|FG002|Maintenance Study|Adverse Event|25
7911788|NCT02065622|12429245|FG003|Maintenance Study|Adverse Event|22
7911789|NCT02065622|12429246|FG004|Maintenance Study|Adverse Event|11
7911790|NCT02065622|12429242|FG000|Maintenance Study|Withdrawal by Subject|0
7911791|NCT02065622|12429243|FG001|Maintenance Study|Withdrawal by Subject|0
7911792|NCT02065622|12429244|FG002|Maintenance Study|Withdrawal by Subject|11
7911793|NCT02065622|12429245|FG003|Maintenance Study|Withdrawal by Subject|5
7911794|NCT02065622|12429246|FG004|Maintenance Study|Withdrawal by Subject|7
7911795|NCT02065622|12429242|FG000|Maintenance Study|Lost to Follow-up|0
7911796|NCT02065622|12429243|FG001|Maintenance Study|Lost to Follow-up|0
7818972|NCT01235689|12286273|FG001|Overall Study|Adverse Event|16
7818973|NCT01235689|12286272|FG000|Overall Study|Lack of Efficacy|12
7818974|NCT01235689|12286273|FG001|Overall Study|Lack of Efficacy|5
7818975|NCT01235689|12286272|FG000|Overall Study|Withdrawal by Subject|3
7818976|NCT01235689|12286273|FG001|Overall Study|Withdrawal by Subject|4
7818977|NCT01235689|12286272|FG000|Overall Study|Lost to Follow-up|1
7818978|NCT01235689|12286273|FG001|Overall Study|Lost to Follow-up|2
7818979|NCT01235689|12286272|FG000|Overall Study|Miscellaneous|1
7818980|NCT01235689|12286273|FG001|Overall Study|Miscellaneous|5
7818981|NCT01235715|12286281|FG000|Overall Study|Physician Decision|0
7818982|NCT01235715|12286282|FG001|Overall Study|Physician Decision|2
7818983|NCT01235728|12286289|FG000|Overall Study|Protocol Violation|0
7818984|NCT01235728|12286290|FG001|Overall Study|Protocol Violation|0
7818985|NCT01235728|12286291|FG002|Overall Study|Protocol Violation|0
7818986|NCT01235728|12286292|FG003|Overall Study|Protocol Violation|1
7818987|NCT01235728|12286293|FG004|Overall Study|Protocol Violation|0
7818988|NCT01235728|12286294|FG005|Overall Study|Protocol Violation|0
7818989|NCT01235728|12286295|FG006|Overall Study|Protocol Violation|0
7818990|NCT01235728|12286296|FG007|Overall Study|Protocol Violation|0
7818991|NCT01235741|12286307|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
7818992|NCT01235741|12286308|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
7818993|NCT01235741|12286309|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
7818994|NCT01235741|12286307|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
7818995|NCT01235741|12286308|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
7818996|NCT01235741|12286309|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
7818997|NCT01235741|12286307|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
7818998|NCT01235741|12286308|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
7818999|NCT01235741|12286309|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
7819000|NCT01235741|12286307|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
7819001|NCT01235741|12286308|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
7819002|NCT01235741|12286309|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
7819003|NCT01235741|12286307|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
7819004|NCT01235741|12286308|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
7819005|NCT01235741|12286309|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
7819006|NCT01235741|12286307|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
7819007|NCT01235741|12286308|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
7862039|NCT01597245|12351192|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7819008|NCT01235741|12286309|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
7819009|NCT01235741|12286307|FG000|Randomized to Treatment|Withdrawal by Subject|0
7819010|NCT01235741|12286308|FG001|Randomized to Treatment|Withdrawal by Subject|0
7819011|NCT01235741|12286309|FG002|Randomized to Treatment|Withdrawal by Subject|1
7819012|NCT01235741|12286307|FG000|Randomized to Treatment|Adverse Event|0
7819013|NCT01235741|12286308|FG001|Randomized to Treatment|Adverse Event|1
7819014|NCT01235741|12286309|FG002|Randomized to Treatment|Adverse Event|1
7819015|NCT01235741|12286307|FG000|Randomized to Treatment|Sponsor terminated study|0
7819016|NCT01235741|12286308|FG001|Randomized to Treatment|Sponsor terminated study|35
7819017|NCT01235741|12286309|FG002|Randomized to Treatment|Sponsor terminated study|34
7819018|NCT01235741|12286307|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
7819019|NCT01235741|12286308|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
7819020|NCT01235741|12286309|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
7819021|NCT01235741|12286307|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
7819022|NCT01235741|12286308|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
7819023|NCT01235741|12286309|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
7819024|NCT01235741|12286307|FG000|Follow-Up Post Treatment up to Month 6|Other|0
7819025|NCT01235741|12286308|FG001|Follow-Up Post Treatment up to Month 6|Other|1
7819026|NCT01235741|12286309|FG002|Follow-Up Post Treatment up to Month 6|Other|0
7819027|NCT01235793|12286321|FG000|Overall Study|Death|6
7819028|NCT01235949|12286353|FG000|Primary Phase|Migrated/moved from study area|1
7819029|NCT01235949|12286354|FG001|Primary Phase|Migrated/moved from study area|1
7819030|NCT01235949|12286355|FG002|Primary Phase|Migrated/moved from study area|0
7819031|NCT01235949|12286356|FG003|Primary Phase|Migrated/moved from study area|0
7819032|NCT01235949|12286357|FG004|Primary Phase|Migrated/moved from study area|1
7819033|NCT01235949|12286358|FG005|Primary Phase|Migrated/moved from study area|2
7819034|NCT01235949|12286359|FG006|Primary Phase|Migrated/moved from study area|0
7819035|NCT01235949|12286360|FG007|Primary Phase|Migrated/moved from study area|0
7819036|NCT01235949|12286361|FG008|Primary Phase|Migrated/moved from study area|0
7819037|NCT01235949|12286362|FG009|Primary Phase|Migrated/moved from study area|0
7819038|NCT01235949|12286363|FG010|Primary Phase|Migrated/moved from study area|0
7819039|NCT01235949|12286364|FG011|Primary Phase|Migrated/moved from study area|0
7819040|NCT01235949|12286365|FG012|Primary Phase|Migrated/moved from study area|0
7819041|NCT01235949|12286366|FG013|Primary Phase|Migrated/moved from study area|0
7819042|NCT01235949|12286367|FG014|Primary Phase|Migrated/moved from study area|0
7819043|NCT01235949|12286368|FG015|Primary Phase|Migrated/moved from study area|0
7819044|NCT01235949|12286369|FG016|Primary Phase|Migrated/moved from study area|0
7819045|NCT01235949|12286370|FG017|Primary Phase|Migrated/moved from study area|0
7819046|NCT01235949|12286353|FG000|Primary Phase|Adverse Event|0
7819047|NCT01235949|12286354|FG001|Primary Phase|Adverse Event|0
7819048|NCT01235949|12286355|FG002|Primary Phase|Adverse Event|0
7819049|NCT01235949|12286356|FG003|Primary Phase|Adverse Event|1
7819050|NCT01235949|12286357|FG004|Primary Phase|Adverse Event|0
7819051|NCT01235949|12286358|FG005|Primary Phase|Adverse Event|0
7819052|NCT01235949|12286359|FG006|Primary Phase|Adverse Event|0
7819053|NCT01235949|12286360|FG007|Primary Phase|Adverse Event|0
7819054|NCT01235949|12286361|FG008|Primary Phase|Adverse Event|0
7819055|NCT01235949|12286362|FG009|Primary Phase|Adverse Event|0
7819056|NCT01235949|12286363|FG010|Primary Phase|Adverse Event|0
7819057|NCT01235949|12286364|FG011|Primary Phase|Adverse Event|0
7819058|NCT01235949|12286365|FG012|Primary Phase|Adverse Event|0
7819059|NCT01235949|12286366|FG013|Primary Phase|Adverse Event|0
7819060|NCT01235949|12286367|FG014|Primary Phase|Adverse Event|0
7819061|NCT01235949|12286368|FG015|Primary Phase|Adverse Event|0
7819062|NCT01235949|12286369|FG016|Primary Phase|Adverse Event|0
7819063|NCT01235949|12286370|FG017|Primary Phase|Adverse Event|0
7819064|NCT01235949|12286353|FG000|Primary Phase|Withdrawal by Subject|3
7819065|NCT01235949|12286354|FG001|Primary Phase|Withdrawal by Subject|2
7819066|NCT01235949|12286355|FG002|Primary Phase|Withdrawal by Subject|2
7819067|NCT01235949|12286356|FG003|Primary Phase|Withdrawal by Subject|0
7819068|NCT01235949|12286357|FG004|Primary Phase|Withdrawal by Subject|0
7819069|NCT01235949|12286358|FG005|Primary Phase|Withdrawal by Subject|3
7819070|NCT01235949|12286359|FG006|Primary Phase|Withdrawal by Subject|0
7819071|NCT01235949|12286360|FG007|Primary Phase|Withdrawal by Subject|0
7819072|NCT01235949|12286361|FG008|Primary Phase|Withdrawal by Subject|0
7819073|NCT01235949|12286362|FG009|Primary Phase|Withdrawal by Subject|0
7819074|NCT01235949|12286363|FG010|Primary Phase|Withdrawal by Subject|0
7819075|NCT01235949|12286364|FG011|Primary Phase|Withdrawal by Subject|0
7819076|NCT01235949|12286365|FG012|Primary Phase|Withdrawal by Subject|0
7819077|NCT01235949|12286366|FG013|Primary Phase|Withdrawal by Subject|0
7819078|NCT01235949|12286367|FG014|Primary Phase|Withdrawal by Subject|0
7819079|NCT01235949|12286368|FG015|Primary Phase|Withdrawal by Subject|0
7819080|NCT01235949|12286369|FG016|Primary Phase|Withdrawal by Subject|0
7819081|NCT01235949|12286370|FG017|Primary Phase|Withdrawal by Subject|0
7819082|NCT01235949|12286353|FG000|Primary Phase|Lost to Follow-up|0
7819083|NCT01235949|12286354|FG001|Primary Phase|Lost to Follow-up|0
7819084|NCT01235949|12286355|FG002|Primary Phase|Lost to Follow-up|1
7819085|NCT01235949|12286356|FG003|Primary Phase|Lost to Follow-up|1
7819086|NCT01235949|12286357|FG004|Primary Phase|Lost to Follow-up|0
7819087|NCT01235949|12286358|FG005|Primary Phase|Lost to Follow-up|2
7819088|NCT01235949|12286359|FG006|Primary Phase|Lost to Follow-up|0
7819089|NCT01235949|12286360|FG007|Primary Phase|Lost to Follow-up|0
7819090|NCT01235949|12286361|FG008|Primary Phase|Lost to Follow-up|0
7819091|NCT01235949|12286362|FG009|Primary Phase|Lost to Follow-up|0
7819092|NCT01235949|12286363|FG010|Primary Phase|Lost to Follow-up|0
7819093|NCT01235949|12286364|FG011|Primary Phase|Lost to Follow-up|0
7819094|NCT01235949|12286365|FG012|Primary Phase|Lost to Follow-up|0
7819095|NCT01235949|12286366|FG013|Primary Phase|Lost to Follow-up|0
7819096|NCT01235949|12286367|FG014|Primary Phase|Lost to Follow-up|0
7819097|NCT01235949|12286368|FG015|Primary Phase|Lost to Follow-up|0
7819098|NCT01235949|12286369|FG016|Primary Phase|Lost to Follow-up|0
7819099|NCT01235949|12286370|FG017|Primary Phase|Lost to Follow-up|0
7819100|NCT01235949|12286353|FG000|Booster Phase|Migrated/moved from study area|0
7819101|NCT01235949|12286354|FG001|Booster Phase|Migrated/moved from study area|0
7819102|NCT01235949|12286355|FG002|Booster Phase|Migrated/moved from study area|0
7819103|NCT01235949|12286356|FG003|Booster Phase|Migrated/moved from study area|0
7819104|NCT01235949|12286357|FG004|Booster Phase|Migrated/moved from study area|0
7819105|NCT01235949|12286358|FG005|Booster Phase|Migrated/moved from study area|0
7819106|NCT01235949|12286359|FG006|Booster Phase|Migrated/moved from study area|0
7819107|NCT01235949|12286360|FG007|Booster Phase|Migrated/moved from study area|0
7819108|NCT01235949|12286361|FG008|Booster Phase|Migrated/moved from study area|0
7819109|NCT01235949|12286362|FG009|Booster Phase|Migrated/moved from study area|0
7819110|NCT01235949|12286363|FG010|Booster Phase|Migrated/moved from study area|0
7819111|NCT01235949|12286364|FG011|Booster Phase|Migrated/moved from study area|1
7819112|NCT01235949|12286365|FG012|Booster Phase|Migrated/moved from study area|1
7819113|NCT01235949|12286366|FG013|Booster Phase|Migrated/moved from study area|0
7819114|NCT01235949|12286367|FG014|Booster Phase|Migrated/moved from study area|0
7819115|NCT01235949|12286368|FG015|Booster Phase|Migrated/moved from study area|0
7819116|NCT01235949|12286369|FG016|Booster Phase|Migrated/moved from study area|0
7819117|NCT01235949|12286370|FG017|Booster Phase|Migrated/moved from study area|1
7819118|NCT01235949|12286353|FG000|Booster Phase|Adverse Event|0
7819119|NCT01235949|12286354|FG001|Booster Phase|Adverse Event|0
7819120|NCT01235949|12286355|FG002|Booster Phase|Adverse Event|0
7819121|NCT01235949|12286356|FG003|Booster Phase|Adverse Event|0
7819122|NCT01235949|12286357|FG004|Booster Phase|Adverse Event|0
7819123|NCT01235949|12286358|FG005|Booster Phase|Adverse Event|0
7819124|NCT01235949|12286359|FG006|Booster Phase|Adverse Event|0
7819125|NCT01235949|12286360|FG007|Booster Phase|Adverse Event|0
7819126|NCT01235949|12286361|FG008|Booster Phase|Adverse Event|0
7819127|NCT01235949|12286362|FG009|Booster Phase|Adverse Event|0
7819128|NCT01235949|12286363|FG010|Booster Phase|Adverse Event|0
7819129|NCT01235949|12286364|FG011|Booster Phase|Adverse Event|0
7819130|NCT01235949|12286365|FG012|Booster Phase|Adverse Event|0
7819131|NCT01235949|12286366|FG013|Booster Phase|Adverse Event|0
7819132|NCT01235949|12286367|FG014|Booster Phase|Adverse Event|0
7819133|NCT01235949|12286368|FG015|Booster Phase|Adverse Event|1
7819134|NCT01235949|12286369|FG016|Booster Phase|Adverse Event|0
7819135|NCT01235949|12286370|FG017|Booster Phase|Adverse Event|0
7819136|NCT01235949|12286353|FG000|Booster Phase|Withdrawal by Subject|0
7819137|NCT01235949|12286354|FG001|Booster Phase|Withdrawal by Subject|0
7819138|NCT01235949|12286355|FG002|Booster Phase|Withdrawal by Subject|0
7819139|NCT01235949|12286356|FG003|Booster Phase|Withdrawal by Subject|0
7819140|NCT01235949|12286357|FG004|Booster Phase|Withdrawal by Subject|0
7819141|NCT01235949|12286358|FG005|Booster Phase|Withdrawal by Subject|0
7819142|NCT01235949|12286359|FG006|Booster Phase|Withdrawal by Subject|0
7819143|NCT01235949|12286360|FG007|Booster Phase|Withdrawal by Subject|1
7911797|NCT02065622|12429244|FG002|Maintenance Study|Lost to Follow-up|4
7911798|NCT02065622|12429245|FG003|Maintenance Study|Lost to Follow-up|1
7911799|NCT02065622|12429246|FG004|Maintenance Study|Lost to Follow-up|1
7911800|NCT02065622|12429242|FG000|Maintenance Study|Lack of Efficacy|0
7911801|NCT02065622|12429243|FG001|Maintenance Study|Lack of Efficacy|0
7911802|NCT02065622|12429244|FG002|Maintenance Study|Lack of Efficacy|70
7911803|NCT02065622|12429245|FG003|Maintenance Study|Lack of Efficacy|55
7911804|NCT02065622|12429246|FG004|Maintenance Study|Lack of Efficacy|19
7911805|NCT02065622|12429242|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0
7911806|NCT02065622|12429243|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0
7911807|NCT02065622|12429244|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7
7911808|NCT02065622|12429245|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3
7911809|NCT02065622|12429246|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4
7911810|NCT02065622|12429242|FG000|Maintenance Study|Subject Non-Compliance|0
7911811|NCT02065622|12429243|FG001|Maintenance Study|Subject Non-Compliance|0
7911812|NCT02065622|12429244|FG002|Maintenance Study|Subject Non-Compliance|1
7911813|NCT02065622|12429245|FG003|Maintenance Study|Subject Non-Compliance|3
7911814|NCT02065622|12429246|FG004|Maintenance Study|Subject Non-Compliance|2
7911815|NCT02065622|12429242|FG000|Maintenance Study|Other, Not Specified|0
7911816|NCT02065622|12429243|FG001|Maintenance Study|Other, Not Specified|0
7911817|NCT02065622|12429244|FG002|Maintenance Study|Other, Not Specified|6
7911818|NCT02065622|12429245|FG003|Maintenance Study|Other, Not Specified|14
7911819|NCT02065622|12429246|FG004|Maintenance Study|Other, Not Specified|2
7911820|NCT02065622|12429242|FG000|Maintenance Study|Unknown Reason|0
7911821|NCT02065622|12429243|FG001|Maintenance Study|Unknown Reason|0
7911822|NCT02065622|12429244|FG002|Maintenance Study|Unknown Reason|0
7911823|NCT02065622|12429245|FG003|Maintenance Study|Unknown Reason|1
7911824|NCT02065622|12429246|FG004|Maintenance Study|Unknown Reason|0
7911825|NCT02065713|12429272|FG000|Overall Study|Adverse Event|0
7911826|NCT02065713|12429273|FG001|Overall Study|Adverse Event|1
7911827|NCT02065713|12429272|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7911828|NCT02065713|12429273|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7911829|NCT02065791|12429281|FG000|Overall Study|Closed Site|1
7911830|NCT02065791|12429282|FG001|Overall Study|Closed Site|1
7911831|NCT02065791|12429281|FG000|Overall Study|Withdrawal by Subject|11
7911832|NCT02065791|12429282|FG001|Overall Study|Withdrawal by Subject|5
7911833|NCT02065791|12429281|FG000|Overall Study|Lost to Follow-up|13
7911834|NCT02065791|12429282|FG001|Overall Study|Lost to Follow-up|9
7911835|NCT02065895|12429288|FG000|Overall Study|Protocol Violation|1
7911836|NCT02065895|12429289|FG001|Overall Study|Protocol Violation|0
7911837|NCT02065895|12429290|FG002|Overall Study|Protocol Violation|0
7911838|NCT02065895|12429291|FG003|Overall Study|Protocol Violation|1
7819144|NCT01235949|12286361|FG008|Booster Phase|Withdrawal by Subject|1
7819145|NCT01235949|12286362|FG009|Booster Phase|Withdrawal by Subject|0
7819146|NCT01235949|12286363|FG010|Booster Phase|Withdrawal by Subject|1
7911839|NCT02065895|12429292|FG004|Overall Study|Protocol Violation|0
7911840|NCT02065895|12429293|FG005|Overall Study|Protocol Violation|0
7911841|NCT02065895|12429288|FG000|Overall Study|Scheduling conflicts|0
7911842|NCT02065895|12429289|FG001|Overall Study|Scheduling conflicts|1
7911843|NCT02065895|12429290|FG002|Overall Study|Scheduling conflicts|0
7911844|NCT02065895|12429291|FG003|Overall Study|Scheduling conflicts|0
7911845|NCT02065895|12429292|FG004|Overall Study|Scheduling conflicts|0
7911846|NCT02065895|12429293|FG005|Overall Study|Scheduling conflicts|0
7819147|NCT01235949|12286364|FG011|Booster Phase|Withdrawal by Subject|1
7819148|NCT01235949|12286365|FG012|Booster Phase|Withdrawal by Subject|2
7819149|NCT01235949|12286366|FG013|Booster Phase|Withdrawal by Subject|0
7819150|NCT01235949|12286367|FG014|Booster Phase|Withdrawal by Subject|2
7819151|NCT01235949|12286368|FG015|Booster Phase|Withdrawal by Subject|0
7819152|NCT01235949|12286369|FG016|Booster Phase|Withdrawal by Subject|0
7819153|NCT01235949|12286370|FG017|Booster Phase|Withdrawal by Subject|0
7819154|NCT01235949|12286353|FG000|Booster Phase|Lost to Follow-up|0
7819155|NCT01235949|12286354|FG001|Booster Phase|Lost to Follow-up|0
7819156|NCT01235949|12286355|FG002|Booster Phase|Lost to Follow-up|0
7819157|NCT01235949|12286356|FG003|Booster Phase|Lost to Follow-up|0
7819158|NCT01235949|12286357|FG004|Booster Phase|Lost to Follow-up|0
7819159|NCT01235949|12286358|FG005|Booster Phase|Lost to Follow-up|0
7819160|NCT01235949|12286359|FG006|Booster Phase|Lost to Follow-up|0
7819161|NCT01235949|12286360|FG007|Booster Phase|Lost to Follow-up|0
7819162|NCT01235949|12286361|FG008|Booster Phase|Lost to Follow-up|1
7819163|NCT01235949|12286362|FG009|Booster Phase|Lost to Follow-up|1
7819164|NCT01235949|12286363|FG010|Booster Phase|Lost to Follow-up|1
7819165|NCT01235949|12286364|FG011|Booster Phase|Lost to Follow-up|1
7819166|NCT01235949|12286365|FG012|Booster Phase|Lost to Follow-up|0
7819167|NCT01235949|12286366|FG013|Booster Phase|Lost to Follow-up|0
7819168|NCT01235949|12286367|FG014|Booster Phase|Lost to Follow-up|0
7819169|NCT01235949|12286368|FG015|Booster Phase|Lost to Follow-up|0
7819170|NCT01235949|12286369|FG016|Booster Phase|Lost to Follow-up|0
7819171|NCT01235949|12286370|FG017|Booster Phase|Lost to Follow-up|1
7819172|NCT01235975|12286410|FG000|Overall Study|Serious Adverse Event|0
7819173|NCT01235975|12286411|FG001|Overall Study|Serious Adverse Event|1
7819174|NCT01235975|12286410|FG000|Overall Study|Withdrawal by Subject|8
7819175|NCT01235975|12286411|FG001|Overall Study|Withdrawal by Subject|2
7819176|NCT01235975|12286410|FG000|Overall Study|Migrated/moved from study area|2
7819177|NCT01235975|12286411|FG001|Overall Study|Migrated/moved from study area|1
7819178|NCT01235975|12286410|FG000|Overall Study|Lost to Follow-up|7
7819179|NCT01235975|12286411|FG001|Overall Study|Lost to Follow-up|3
7819180|NCT01236001|12286419|FG000|Overall Study|Adverse Event|5
7819181|NCT01236001|12286420|FG001|Overall Study|Adverse Event|14
7819182|NCT01236001|12286419|FG000|Overall Study|Lack of Efficacy|6
7819183|NCT01236001|12286420|FG001|Overall Study|Lack of Efficacy|6
7819184|NCT01236001|12286419|FG000|Overall Study|Lost to Follow-up|6
7819185|NCT01236001|12286420|FG001|Overall Study|Lost to Follow-up|1
7819186|NCT01236001|12286419|FG000|Overall Study|Incompliance|1
7819187|NCT01236001|12286420|FG001|Overall Study|Incompliance|0
7819188|NCT01236001|12286419|FG000|Overall Study|Planned Visit After End of Study|0
7819189|NCT01236001|12286420|FG001|Overall Study|Planned Visit After End of Study|1
7819190|NCT01236118|12286530|FG000|Overall Study|Adverse Event|2
7819191|NCT01236118|12286531|FG001|Overall Study|Adverse Event|0
7819192|NCT01236118|12286532|FG002|Overall Study|Adverse Event|2
7819193|NCT01236118|12286530|FG000|Overall Study|Physician Decision|0
7819194|NCT01236118|12286531|FG001|Overall Study|Physician Decision|1
7819195|NCT01236118|12286532|FG002|Overall Study|Physician Decision|0
7819196|NCT01236118|12286530|FG000|Overall Study|Withdrawal by Subject|0
7819197|NCT01236118|12286531|FG001|Overall Study|Withdrawal by Subject|0
7819198|NCT01236118|12286532|FG002|Overall Study|Withdrawal by Subject|1
7819199|NCT01236339|12286569|FG000|Overall Study|Termination of study by sponsor|11
7819200|NCT01236339|12286570|FG001|Overall Study|Termination of study by sponsor|13
7819201|NCT01236352|12286588|FG000|Overall Study|Death|0
7819202|NCT01236352|12286589|FG001|Overall Study|Death|0
7819203|NCT01236352|12286590|FG002|Overall Study|Death|0
7819204|NCT01236352|12286591|FG003|Overall Study|Death|0
7819205|NCT01236352|12286592|FG004|Overall Study|Death|0
7819206|NCT01236352|12286593|FG005|Overall Study|Death|0
7819207|NCT01236352|12286594|FG006|Overall Study|Death|0
7819208|NCT01236352|12286595|FG007|Overall Study|Death|1
7819209|NCT01236352|12286596|FG008|Overall Study|Death|0
7819210|NCT01236352|12286597|FG009|Overall Study|Death|0
7819211|NCT01236352|12286598|FG010|Overall Study|Death|0
7819212|NCT01236352|12286588|FG000|Overall Study|Withdrawal by Subject|0
7819213|NCT01236352|12286589|FG001|Overall Study|Withdrawal by Subject|0
7911847|NCT02066051|12429310|FG000|Overall Study|Subject developed active GVHD|1
7911848|NCT02066129|12429316|FG000|Overall Study|Lost to Follow-up|13
7911849|NCT02066129|12429317|FG001|Overall Study|Lost to Follow-up|12
7911850|NCT02066129|12429316|FG000|Overall Study|Withdrawal by Subject|7
7911851|NCT02066129|12429317|FG001|Overall Study|Withdrawal by Subject|10
7911852|NCT02066129|12429316|FG000|Overall Study|Lack of Efficacy|8
7911853|NCT02066129|12429317|FG001|Overall Study|Lack of Efficacy|10
7911854|NCT02066129|12429316|FG000|Overall Study|Physician Decision|1
7911855|NCT02066129|12429317|FG001|Overall Study|Physician Decision|1
7911856|NCT02066233|12429325|FG000|EG Scan II (Day 1)|difficulty intubating subject|6
7911857|NCT02066233|12429326|FG001|EG Scan II (Day 1)|difficulty intubating subject|6
7911858|NCT02066298|12429338|FG000|Overall Study|Lost to Follow-up|3
7819214|NCT01236352|12286590|FG002|Overall Study|Withdrawal by Subject|0
7819215|NCT01236352|12286591|FG003|Overall Study|Withdrawal by Subject|0
7819216|NCT01236352|12286592|FG004|Overall Study|Withdrawal by Subject|0
7719416|NCT00532155|12143398|FG001|Overall Study|Lost to Follow-up|0
7819217|NCT01236352|12286593|FG005|Overall Study|Withdrawal by Subject|0
7819218|NCT01236352|12286594|FG006|Overall Study|Withdrawal by Subject|0
7819219|NCT01236352|12286595|FG007|Overall Study|Withdrawal by Subject|0
7819220|NCT01236352|12286596|FG008|Overall Study|Withdrawal by Subject|0
7819221|NCT01236352|12286597|FG009|Overall Study|Withdrawal by Subject|2
7819222|NCT01236352|12286598|FG010|Overall Study|Withdrawal by Subject|1
7819223|NCT01236352|12286588|FG000|Overall Study|Adverse Event|0
7819224|NCT01236352|12286589|FG001|Overall Study|Adverse Event|0
7819225|NCT01236352|12286590|FG002|Overall Study|Adverse Event|0
7819226|NCT01236352|12286591|FG003|Overall Study|Adverse Event|0
7819227|NCT01236352|12286592|FG004|Overall Study|Adverse Event|0
7819228|NCT01236352|12286593|FG005|Overall Study|Adverse Event|0
7819229|NCT01236352|12286594|FG006|Overall Study|Adverse Event|2
7819230|NCT01236352|12286595|FG007|Overall Study|Adverse Event|0
7819231|NCT01236352|12286596|FG008|Overall Study|Adverse Event|0
7819232|NCT01236352|12286597|FG009|Overall Study|Adverse Event|4
7819233|NCT01236352|12286598|FG010|Overall Study|Adverse Event|1
7819234|NCT01236352|12286588|FG000|Overall Study|Study drug toxicity|0
7819235|NCT01236352|12286589|FG001|Overall Study|Study drug toxicity|0
7819236|NCT01236352|12286590|FG002|Overall Study|Study drug toxicity|0
7819237|NCT01236352|12286591|FG003|Overall Study|Study drug toxicity|0
7819238|NCT01236352|12286592|FG004|Overall Study|Study drug toxicity|0
7819239|NCT01236352|12286593|FG005|Overall Study|Study drug toxicity|1
7911859|NCT02066298|12429339|FG001|Overall Study|Lost to Follow-up|2
7911860|NCT02066298|12429340|FG002|Overall Study|Lost to Follow-up|3
7911861|NCT02066298|12429341|FG003|Overall Study|Lost to Follow-up|2
7911862|NCT02066298|12429342|FG004|Overall Study|Lost to Follow-up|3
7911863|NCT02066298|12429343|FG005|Overall Study|Lost to Follow-up|4
7911864|NCT02066298|12429338|FG000|Overall Study|Withdrawal by Subject|6
7911865|NCT02066298|12429339|FG001|Overall Study|Withdrawal by Subject|6
7911866|NCT02066298|12429340|FG002|Overall Study|Withdrawal by Subject|6
7911867|NCT02066298|12429341|FG003|Overall Study|Withdrawal by Subject|4
7911868|NCT02066298|12429342|FG004|Overall Study|Withdrawal by Subject|5
7911869|NCT02066298|12429343|FG005|Overall Study|Withdrawal by Subject|8
7911870|NCT02066298|12429338|FG000|Overall Study|Physician Decision|0
7911871|NCT02066298|12429339|FG001|Overall Study|Physician Decision|0
7911872|NCT02066298|12429340|FG002|Overall Study|Physician Decision|1
7911873|NCT02066298|12429341|FG003|Overall Study|Physician Decision|0
7911874|NCT02066298|12429342|FG004|Overall Study|Physician Decision|1
7911875|NCT02066298|12429343|FG005|Overall Study|Physician Decision|0
7911876|NCT02066311|12429355|FG000|Overall Study|Adverse Event|4
7719417|NCT00532155|12143397|FG000|Overall Study|Physician Decision|16
7911877|NCT02066311|12429355|FG000|Overall Study|Withdrawal by Subject|1
7911878|NCT02066389|12429365|FG000|Overall Study|Adverse Event|1
7911879|NCT02066389|12429366|FG001|Overall Study|Adverse Event|1
7911880|NCT02066389|12429367|FG002|Overall Study|Adverse Event|1
7911881|NCT02066389|12429368|FG003|Overall Study|Adverse Event|1
7911882|NCT02066389|12429369|FG004|Overall Study|Adverse Event|5
7911883|NCT02066389|12429370|FG005|Overall Study|Adverse Event|1
7911884|NCT02066389|12429365|FG000|Overall Study|Withdrawal by Subject|4
7911885|NCT02066389|12429366|FG001|Overall Study|Withdrawal by Subject|0
7911886|NCT02066389|12429367|FG002|Overall Study|Withdrawal by Subject|5
7911887|NCT02066389|12429368|FG003|Overall Study|Withdrawal by Subject|1
7911888|NCT02066389|12429369|FG004|Overall Study|Withdrawal by Subject|1
7819240|NCT01236352|12286594|FG006|Overall Study|Study drug toxicity|1
7819241|NCT01236352|12286595|FG007|Overall Study|Study drug toxicity|0
7911889|NCT02066389|12429370|FG005|Overall Study|Withdrawal by Subject|2
7911890|NCT02066389|12429365|FG000|Overall Study|Lost to Follow-up|0
7911891|NCT02066389|12429366|FG001|Overall Study|Lost to Follow-up|0
7911892|NCT02066389|12429367|FG002|Overall Study|Lost to Follow-up|0
7911893|NCT02066389|12429368|FG003|Overall Study|Lost to Follow-up|1
7911894|NCT02066389|12429369|FG004|Overall Study|Lost to Follow-up|1
7911895|NCT02066389|12429370|FG005|Overall Study|Lost to Follow-up|1
7911896|NCT02066389|12429365|FG000|Overall Study|Randomized in Error|0
7911897|NCT02066389|12429366|FG001|Overall Study|Randomized in Error|0
7819242|NCT01236352|12286596|FG008|Overall Study|Study drug toxicity|0
7819243|NCT01236352|12286597|FG009|Overall Study|Study drug toxicity|2
7819244|NCT01236352|12286598|FG010|Overall Study|Study drug toxicity|2
7819245|NCT01236352|12286588|FG000|Overall Study|Disease progression|1
7819246|NCT01236352|12286589|FG001|Overall Study|Disease progression|2
7819247|NCT01236352|12286590|FG002|Overall Study|Disease progression|1
7819248|NCT01236352|12286591|FG003|Overall Study|Disease progression|2
7819249|NCT01236352|12286592|FG004|Overall Study|Disease progression|2
7819250|NCT01236352|12286593|FG005|Overall Study|Disease progression|2
7819251|NCT01236352|12286594|FG006|Overall Study|Disease progression|1
7911898|NCT02066389|12429367|FG002|Overall Study|Randomized in Error|0
7911899|NCT02066389|12429368|FG003|Overall Study|Randomized in Error|0
7911900|NCT02066389|12429369|FG004|Overall Study|Randomized in Error|0
7911901|NCT02066389|12429370|FG005|Overall Study|Randomized in Error|1
7719418|NCT00532155|12143398|FG001|Overall Study|Physician Decision|15
7719419|NCT00532155|12143397|FG000|Overall Study|Withdrawal by Subject|23
7911902|NCT02066402|12429386|FG000|Overall Study|Adverse Event|1
7819252|NCT01236352|12286595|FG007|Overall Study|Disease progression|3
7819253|NCT01236352|12286596|FG008|Overall Study|Disease progression|2
7911903|NCT02066402|12429387|FG001|Overall Study|Adverse Event|2
7819254|NCT01236352|12286597|FG009|Overall Study|Disease progression|2
7819255|NCT01236352|12286598|FG010|Overall Study|Disease progression|2
7819256|NCT01236352|12286588|FG000|Overall Study|Poor/Non-compliance|1
7819257|NCT01236352|12286589|FG001|Overall Study|Poor/Non-compliance|0
7819258|NCT01236352|12286590|FG002|Overall Study|Poor/Non-compliance|0
7819259|NCT01236352|12286591|FG003|Overall Study|Poor/Non-compliance|0
7819260|NCT01236352|12286592|FG004|Overall Study|Poor/Non-compliance|0
7819261|NCT01236352|12286593|FG005|Overall Study|Poor/Non-compliance|0
7819262|NCT01236352|12286594|FG006|Overall Study|Poor/Non-compliance|0
7819263|NCT01236352|12286595|FG007|Overall Study|Poor/Non-compliance|0
7819264|NCT01236352|12286596|FG008|Overall Study|Poor/Non-compliance|0
7819265|NCT01236352|12286597|FG009|Overall Study|Poor/Non-compliance|0
7819266|NCT01236352|12286598|FG010|Overall Study|Poor/Non-compliance|0
7819267|NCT01236352|12286588|FG000|Overall Study|Maximum clinical benefit|1
7819268|NCT01236352|12286589|FG001|Overall Study|Maximum clinical benefit|1
7819269|NCT01236352|12286590|FG002|Overall Study|Maximum clinical benefit|1
7819270|NCT01236352|12286591|FG003|Overall Study|Maximum clinical benefit|0
7819271|NCT01236352|12286592|FG004|Overall Study|Maximum clinical benefit|2
7819272|NCT01236352|12286593|FG005|Overall Study|Maximum clinical benefit|0
7819273|NCT01236352|12286594|FG006|Overall Study|Maximum clinical benefit|3
7819274|NCT01236352|12286595|FG007|Overall Study|Maximum clinical benefit|1
7819275|NCT01236352|12286596|FG008|Overall Study|Maximum clinical benefit|1
7819276|NCT01236352|12286597|FG009|Overall Study|Maximum clinical benefit|4
7819277|NCT01236352|12286598|FG010|Overall Study|Maximum clinical benefit|2
7819278|NCT01236352|12286588|FG000|Overall Study|Subject request to discontinue treatment|0
7819279|NCT01236352|12286589|FG001|Overall Study|Subject request to discontinue treatment|0
7819280|NCT01236352|12286590|FG002|Overall Study|Subject request to discontinue treatment|1
7819281|NCT01236352|12286591|FG003|Overall Study|Subject request to discontinue treatment|1
7819282|NCT01236352|12286592|FG004|Overall Study|Subject request to discontinue treatment|0
7819283|NCT01236352|12286593|FG005|Overall Study|Subject request to discontinue treatment|1
7819284|NCT01236352|12286594|FG006|Overall Study|Subject request to discontinue treatment|0
7819285|NCT01236352|12286595|FG007|Overall Study|Subject request to discontinue treatment|0
7819286|NCT01236352|12286596|FG008|Overall Study|Subject request to discontinue treatment|0
7819287|NCT01236352|12286597|FG009|Overall Study|Subject request to discontinue treatment|1
7819288|NCT01236352|12286598|FG010|Overall Study|Subject request to discontinue treatment|4
7819289|NCT01236352|12286588|FG000|Overall Study|Subject to receive drug via EAP|1
7819290|NCT01236352|12286589|FG001|Overall Study|Subject to receive drug via EAP|1
7819291|NCT01236352|12286590|FG002|Overall Study|Subject to receive drug via EAP|1
7819292|NCT01236352|12286591|FG003|Overall Study|Subject to receive drug via EAP|0
7819293|NCT01236352|12286592|FG004|Overall Study|Subject to receive drug via EAP|0
7819294|NCT01236352|12286593|FG005|Overall Study|Subject to receive drug via EAP|0
7819295|NCT01236352|12286594|FG006|Overall Study|Subject to receive drug via EAP|0
7819296|NCT01236352|12286595|FG007|Overall Study|Subject to receive drug via EAP|2
7819297|NCT01236352|12286596|FG008|Overall Study|Subject to receive drug via EAP|0
7819298|NCT01236352|12286597|FG009|Overall Study|Subject to receive drug via EAP|4
7819299|NCT01236352|12286598|FG010|Overall Study|Subject to receive drug via EAP|0
7819300|NCT01236352|12286588|FG000|Overall Study|Patient moving to allogeneic transplant|0
7819301|NCT01236352|12286589|FG001|Overall Study|Patient moving to allogeneic transplant|0
7819302|NCT01236352|12286590|FG002|Overall Study|Patient moving to allogeneic transplant|0
7819303|NCT01236352|12286591|FG003|Overall Study|Patient moving to allogeneic transplant|0
7819304|NCT01236352|12286592|FG004|Overall Study|Patient moving to allogeneic transplant|0
7819305|NCT01236352|12286593|FG005|Overall Study|Patient moving to allogeneic transplant|0
7819306|NCT01236352|12286594|FG006|Overall Study|Patient moving to allogeneic transplant|1
7819307|NCT01236352|12286595|FG007|Overall Study|Patient moving to allogeneic transplant|0
7819308|NCT01236352|12286596|FG008|Overall Study|Patient moving to allogeneic transplant|0
7819309|NCT01236352|12286597|FG009|Overall Study|Patient moving to allogeneic transplant|0
7819310|NCT01236352|12286598|FG010|Overall Study|Patient moving to allogeneic transplant|0
7819311|NCT01236352|12286588|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0
7819312|NCT01236352|12286589|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0
7819313|NCT01236352|12286590|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0
7819314|NCT01236352|12286591|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0
7819315|NCT01236352|12286592|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0
7819316|NCT01236352|12286593|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0
7819317|NCT01236352|12286594|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0
7819318|NCT01236352|12286595|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0
7819319|NCT01236352|12286596|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0
7819320|NCT01236352|12286597|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0
7819321|NCT01236352|12286598|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1
7819322|NCT01236352|12286588|FG000|Overall Study|Lack of response to drug|0
7819323|NCT01236352|12286589|FG001|Overall Study|Lack of response to drug|0
7819324|NCT01236352|12286590|FG002|Overall Study|Lack of response to drug|0
7819325|NCT01236352|12286591|FG003|Overall Study|Lack of response to drug|0
7819326|NCT01236352|12286592|FG004|Overall Study|Lack of response to drug|0
7819327|NCT01236352|12286593|FG005|Overall Study|Lack of response to drug|0
7819328|NCT01236352|12286594|FG006|Overall Study|Lack of response to drug|0
7819329|NCT01236352|12286595|FG007|Overall Study|Lack of response to drug|0
7819330|NCT01236352|12286596|FG008|Overall Study|Lack of response to drug|0
7819331|NCT01236352|12286597|FG009|Overall Study|Lack of response to drug|1
7819332|NCT01236352|12286598|FG010|Overall Study|Lack of response to drug|1
7819333|NCT01236352|12286588|FG000|Overall Study|Patient transferred to IST|0
7819334|NCT01236352|12286589|FG001|Overall Study|Patient transferred to IST|0
7819335|NCT01236352|12286590|FG002|Overall Study|Patient transferred to IST|0
7819336|NCT01236352|12286591|FG003|Overall Study|Patient transferred to IST|0
7819337|NCT01236352|12286592|FG004|Overall Study|Patient transferred to IST|0
7819338|NCT01236352|12286593|FG005|Overall Study|Patient transferred to IST|0
7819339|NCT01236352|12286594|FG006|Overall Study|Patient transferred to IST|0
7819340|NCT01236352|12286595|FG007|Overall Study|Patient transferred to IST|0
7819341|NCT01236352|12286596|FG008|Overall Study|Patient transferred to IST|0
7819342|NCT01236352|12286597|FG009|Overall Study|Patient transferred to IST|2
7819343|NCT01236352|12286598|FG010|Overall Study|Patient transferred to IST|6
7819344|NCT01236365|12286624|FG000|Overall Study|Lost to Follow-up|0
7819345|NCT01236365|12286625|FG001|Overall Study|Lost to Follow-up|2
7819346|NCT01236365|12286624|FG000|Overall Study|Moved Out of State|1
7819347|NCT01236365|12286625|FG001|Overall Study|Moved Out of State|0
7819348|NCT01236365|12286624|FG000|Overall Study|Dropped at Randomization due to high LFT|1
7819349|NCT01236365|12286625|FG001|Overall Study|Dropped at Randomization due to high LFT|0
7819350|NCT01236534|12286656|FG000|Overall Study|Adverse Event|3
7819351|NCT01236534|12286657|FG001|Overall Study|Adverse Event|0
7819352|NCT01236573|12286674|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7819353|NCT01236573|12286675|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7819354|NCT01236573|12286676|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7819355|NCT01236573|12286677|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7819356|NCT01236573|12286678|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7819357|NCT01236573|12286679|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7819358|NCT01236573|12286680|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
7819359|NCT01236573|12286681|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7819360|NCT01236573|12286682|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
7819361|NCT01236573|12286683|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
7819362|NCT01236573|12286684|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7819363|NCT01236573|12286674|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7819364|NCT01236573|12286675|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7819365|NCT01236573|12286676|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7819366|NCT01236573|12286677|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7819367|NCT01236573|12286678|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7819368|NCT01236573|12286679|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7819369|NCT01236573|12286680|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7819370|NCT01236573|12286681|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7819371|NCT01236573|12286682|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
7819372|NCT01236573|12286683|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7819373|NCT01236573|12286684|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7819374|NCT01236573|12286674|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7819375|NCT01236573|12286675|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7819376|NCT01236573|12286676|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7819377|NCT01236573|12286677|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7819378|NCT01236573|12286678|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7819379|NCT01236573|12286679|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7819380|NCT01236573|12286680|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7819381|NCT01236573|12286681|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7819382|NCT01236573|12286682|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7819383|NCT01236573|12286683|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7819384|NCT01236573|12286684|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
7819385|NCT01236755|12286722|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8
7819386|NCT01236755|12286722|FG000|Spectacles Wearing Phase|Lost to Follow-up|9
7819387|NCT01236755|12286722|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5
7819388|NCT01236755|12286722|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3
7819389|NCT01237054|12286756|FG000|Overall Study|imaging 10C0096|1
7819390|NCT01237223|12286787|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
7819391|NCT01237223|12286788|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
7819392|NCT01237223|12286789|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
7819393|NCT01237223|12286790|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
7819394|NCT01237223|12286791|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
7819395|NCT01237223|12286792|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
7819396|NCT01237223|12286787|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
7819397|NCT01237223|12286788|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
7819398|NCT01237223|12286789|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
7819399|NCT01237223|12286790|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
7819400|NCT01237223|12286791|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
7819401|NCT01237223|12286792|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
7819402|NCT01237223|12286787|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
7819403|NCT01237223|12286788|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
7819404|NCT01237223|12286789|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
7819405|NCT01237223|12286790|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
7819406|NCT01237223|12286791|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
7819407|NCT01237223|12286792|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
7819408|NCT01237223|12286787|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
7819409|NCT01237223|12286788|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
7819410|NCT01237223|12286789|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
7819411|NCT01237223|12286790|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
7819412|NCT01237223|12286791|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
7819413|NCT01237223|12286792|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
7819414|NCT01237223|12286787|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
7819415|NCT01237223|12286788|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
7819416|NCT01237223|12286789|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
7819417|NCT01237223|12286790|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
7819418|NCT01237223|12286791|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
7819419|NCT01237223|12286792|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
7819420|NCT01237223|12286787|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
7819421|NCT01237223|12286788|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
7819422|NCT01237223|12286789|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
7819423|NCT01237223|12286790|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
7819424|NCT01237223|12286791|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
7819425|NCT01237223|12286792|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
7819426|NCT01237223|12286787|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
7819427|NCT01237223|12286788|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
7819428|NCT01237223|12286789|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
7819429|NCT01237223|12286790|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
7819430|NCT01237223|12286791|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
7911904|NCT02066402|12429386|FG000|Overall Study|Lost to Follow-up|11
7819431|NCT01237223|12286792|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
7819432|NCT01237223|12286787|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
7819433|NCT01237223|12286788|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
7819434|NCT01237223|12286789|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
7819435|NCT01237223|12286790|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
7819436|NCT01237223|12286791|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
7819437|NCT01237223|12286792|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
7819438|NCT01237223|12286787|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
7819439|NCT01237223|12286788|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
7819440|NCT01237223|12286789|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
7819441|NCT01237223|12286790|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
7819442|NCT01237223|12286791|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
7819443|NCT01237223|12286792|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
7819444|NCT01237223|12286787|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
7819445|NCT01237223|12286788|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
7819446|NCT01237223|12286789|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
7819447|NCT01237223|12286790|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
7819448|NCT01237223|12286791|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
7819449|NCT01237223|12286792|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
7819450|NCT01237327|12286821|FG000|Overall Study|Protocol Violation: Core Study|1
7819451|NCT01237327|12286822|FG001|Overall Study|Protocol Violation: Core Study|0
7819452|NCT01237327|12286821|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3
7819453|NCT01237327|12286822|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2
7819454|NCT01237327|12286821|FG000|Overall Study|Progression of Disease: Core Study|18
7819455|NCT01237327|12286822|FG001|Overall Study|Progression of Disease: Core Study|22
7819456|NCT01237327|12286821|FG000|Overall Study|Progression of Disease: Extension Study|15
7819457|NCT01237327|12286822|FG001|Overall Study|Progression of Disease: Extension Study|13
7819458|NCT01237327|12286821|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1
7819459|NCT01237327|12286822|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0
7819460|NCT01237327|12286821|FG000|Overall Study|Withdrawal by Subject|1
7819461|NCT01237327|12286822|FG001|Overall Study|Withdrawal by Subject|3
7819462|NCT01237327|12286821|FG000|Overall Study|Lost to Follow-up|3
7819463|NCT01237327|12286822|FG001|Overall Study|Lost to Follow-up|0
7819464|NCT01237340|12286828|FG000|Overall Study|Adverse Event|3
7819465|NCT01237340|12286828|FG000|Overall Study|Withdrawal by Subject|1
7819466|NCT01237340|12286828|FG000|Overall Study|Early termination of the trial|36
7819467|NCT01237587|12286841|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5
7819468|NCT01237587|12286842|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1
7819469|NCT01237587|12286841|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
7819470|NCT01237587|12286842|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
7819471|NCT01237587|12286841|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
7819472|NCT01237587|12286842|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
7819473|NCT01237587|12286841|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
7819474|NCT01237587|12286842|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
7819475|NCT01237587|12286841|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4
7819476|NCT01237587|12286842|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3
7819477|NCT01237587|12286841|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
7819478|NCT01237587|12286842|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
7819479|NCT01237587|12286841|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
7819480|NCT01237587|12286842|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
7819481|NCT01237587|12286841|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5
7819482|NCT01237587|12286842|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5
7819483|NCT01237587|12286841|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
7819484|NCT01237587|12286842|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
7819485|NCT01237587|12286841|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
7819486|NCT01237587|12286842|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
7819487|NCT01237587|12286841|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
7819488|NCT01237587|12286842|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
7819489|NCT01237587|12286841|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1
7819490|NCT01237587|12286842|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0
7819491|NCT01237587|12286841|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4
7819492|NCT01237587|12286842|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4
7819493|NCT01237587|12286841|FG000|Taper Phase|Adverse Event|0
7819494|NCT01237587|12286842|FG001|Taper Phase|Adverse Event|2
7819495|NCT01237587|12286841|FG000|Taper Phase|Protocol Violation|2
7819496|NCT01237587|12286842|FG001|Taper Phase|Protocol Violation|0
7819497|NCT01237587|12286841|FG000|Taper Phase|Lack of Efficacy|2
7819498|NCT01237587|12286842|FG001|Taper Phase|Lack of Efficacy|5
7819499|NCT01237587|12286841|FG000|Taper Phase|Parent/Guardian Decision|0
7911905|NCT02066402|12429387|FG001|Overall Study|Lost to Follow-up|8
7819500|NCT01237587|12286842|FG001|Taper Phase|Parent/Guardian Decision|2
7819501|NCT01237587|12286841|FG000|Taper Phase|Sponsor Decision|1
7819502|NCT01237587|12286842|FG001|Taper Phase|Sponsor Decision|0
7819503|NCT01237587|12286841|FG000|Taper Phase|Withdrawal by Subject|0
7819504|NCT01237587|12286842|FG001|Taper Phase|Withdrawal by Subject|1
7819505|NCT01237678|12286858|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
7819506|NCT01237678|12286859|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
7819507|NCT01237678|12286860|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
7819508|NCT01237678|12286858|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
7819509|NCT01237678|12286859|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
7819510|NCT01237678|12286860|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
7819511|NCT01237678|12286858|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
7819512|NCT01237678|12286859|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
7819513|NCT01237678|12286860|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
7819514|NCT01237678|12286858|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
7911906|NCT02066402|12429386|FG000|Overall Study|Withdrawal by Subject|14
7911907|NCT02066402|12429387|FG001|Overall Study|Withdrawal by Subject|11
7911908|NCT02066402|12429386|FG000|Overall Study|Progressive disease-clinical progression|0
7911909|NCT02066402|12429387|FG001|Overall Study|Progressive disease-clinical progression|1
7911910|NCT02066402|12429386|FG000|Overall Study|Protocol driven decision point|0
7911911|NCT02066402|12429387|FG001|Overall Study|Protocol driven decision point|1
7911912|NCT02066467|12429393|FG000|Overall Study|Did not undergo implant procedure|24
7911913|NCT02066467|12429393|FG000|Overall Study|Attempted to implant withoput success|43
7911914|NCT02066467|12429393|FG000|Overall Study|Consent ineligible|1
7911915|NCT02066467|12429393|FG000|Overall Study|Death|54
7911916|NCT02066467|12429393|FG000|Overall Study|Lost to Follow-up|51
7911917|NCT02066467|12429393|FG000|Overall Study|Adverse Event|20
7911918|NCT02066467|12429393|FG000|Overall Study|Withdrawal by Subject|16
7911919|NCT02066467|12429393|FG000|Overall Study|Physician Decision|2
7911920|NCT02066467|12429393|FG000|Overall Study|Not defined|4
7911921|NCT02066922|12429446|FG000|Overall Study|Adverse Event|1
7964144|NCT02736409|12519294|FG001|Overall Study|Lost to Follow-up|0
7964145|NCT02736409|12519295|FG002|Overall Study|Lost to Follow-up|2
7964146|NCT02736409|12519296|FG003|Overall Study|Lost to Follow-up|1
7964147|NCT02736409|12519293|FG000|Overall Study|Physician Decision|0
7964148|NCT02736409|12519294|FG001|Overall Study|Physician Decision|0
7964149|NCT02736409|12519295|FG002|Overall Study|Physician Decision|0
7964150|NCT02736409|12519296|FG003|Overall Study|Physician Decision|2
7964151|NCT02736474|12519309|FG000|Overall Study|Lost to Follow-up|0
7964152|NCT02736474|12519310|FG001|Overall Study|Lost to Follow-up|1
7964153|NCT02736578|12519318|FG000|Overall Study|Adverse Event|1
7964154|NCT02736578|12519319|FG001|Overall Study|Adverse Event|0
7964155|NCT02736721|12519329|FG000|Overall Study|Adverse Event|8
7964156|NCT02736721|12519329|FG000|Overall Study|Lost to Follow-up|3
7964157|NCT02736721|12519329|FG000|Overall Study|Other|5
7964158|NCT02736825|12519335|FG000|Overall Study|Lost to Follow-up|10
7964159|NCT02736825|12519336|FG001|Overall Study|Lost to Follow-up|11
7964160|NCT02736825|12519335|FG000|Overall Study|Early Termination|0
7964161|NCT02736825|12519336|FG001|Overall Study|Early Termination|1
7964162|NCT02736890|12519345|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1
7964163|NCT02736890|12519346|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2
7883757|NCT01784861|12383708|FG000|Overall Study|Adverse Event|0
7883758|NCT01784861|12383709|FG001|Overall Study|Adverse Event|0
7883759|NCT01784861|12383710|FG002|Overall Study|Adverse Event|1
7883760|NCT01784861|12383711|FG003|Overall Study|Adverse Event|2
7883761|NCT01784861|12383712|FG004|Overall Study|Adverse Event|1
7883762|NCT01784861|12383713|FG005|Overall Study|Adverse Event|0
7883763|NCT01784861|12383708|FG000|Overall Study|Withdrawal by Subject|0
7883764|NCT01784861|12383709|FG001|Overall Study|Withdrawal by Subject|0
7883765|NCT01784861|12383710|FG002|Overall Study|Withdrawal by Subject|0
7883766|NCT01784861|12383711|FG003|Overall Study|Withdrawal by Subject|1
7819515|NCT01237678|12286859|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
7819516|NCT01237678|12286860|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
7819517|NCT01237678|12286858|FG000|Phase II|Adverse Event|0
7819518|NCT01237678|12286859|FG001|Phase II|Adverse Event|39
7819519|NCT01237678|12286860|FG002|Phase II|Adverse Event|9
7819520|NCT01237678|12286858|FG000|Phase II|Death|0
7819521|NCT01237678|12286859|FG001|Phase II|Death|0
7819522|NCT01237678|12286860|FG002|Phase II|Death|2
7819523|NCT01237678|12286858|FG000|Phase II|Lack of Efficacy|0
7819524|NCT01237678|12286859|FG001|Phase II|Lack of Efficacy|25
7819525|NCT01237678|12286860|FG002|Phase II|Lack of Efficacy|3
7819526|NCT01237678|12286858|FG000|Phase II|Withdrawal by Subject|0
7819527|NCT01237678|12286859|FG001|Phase II|Withdrawal by Subject|1
7819528|NCT01237678|12286860|FG002|Phase II|Withdrawal by Subject|5
7819529|NCT01237678|12286858|FG000|Phase II|Completed Cycles 4-6|0
7819530|NCT01237678|12286859|FG001|Phase II|Completed Cycles 4-6|11
7819531|NCT01237678|12286860|FG002|Phase II|Completed Cycles 4-6|21
7819532|NCT01237678|12286858|FG000|Phase II|Sponsor Decision/Study Closed|0
7819533|NCT01237678|12286859|FG001|Phase II|Sponsor Decision/Study Closed|18
7819534|NCT01237678|12286860|FG002|Phase II|Sponsor Decision/Study Closed|7
7819535|NCT01237678|12286858|FG000|Phase II|Randomized but were not treated|0
7819536|NCT01237678|12286859|FG001|Phase II|Randomized but were not treated|4
7819537|NCT01237678|12286860|FG002|Phase II|Randomized but were not treated|3
7819538|NCT01237899|12286895|FG000|Washout Period of at Least 7 Days|Adverse Event|0
7819539|NCT01237899|12286896|FG001|Washout Period of at Least 7 Days|Adverse Event|0
7819540|NCT01237899|12286897|FG002|Washout Period of at Least 7 Days|Adverse Event|1
7819541|NCT01237899|12286898|FG003|Washout Period of at Least 7 Days|Adverse Event|0
7819542|NCT01237899|12286899|FG004|Washout Period of at Least 7 Days|Adverse Event|0
7819543|NCT01237899|12286900|FG005|Washout Period of at Least 7 Days|Adverse Event|0
7819544|NCT01237899|12286901|FG006|Washout Period of at Least 7 Days|Adverse Event|0
7819545|NCT01237899|12286902|FG007|Washout Period of at Least 7 Days|Adverse Event|0
7819546|NCT01237899|12286903|FG008|Washout Period of at Least 7 Days|Adverse Event|0
7819547|NCT01237899|12286904|FG009|Washout Period of at Least 7 Days|Adverse Event|0
7819548|NCT01237899|12286905|FG010|Washout Period of at Least 7 Days|Adverse Event|0
7819549|NCT01237951|12286923|FG000|Overall Study|Death|1
7819550|NCT01238120|12286931|FG000|Overall Study|Withdrawal by Subject|4
7819551|NCT01238120|12286932|FG001|Overall Study|Withdrawal by Subject|1
7819552|NCT01238120|12286933|FG002|Overall Study|Withdrawal by Subject|2
7819553|NCT01238120|12286934|FG003|Overall Study|Withdrawal by Subject|5
7819554|NCT01238120|12286931|FG000|Overall Study|Lost to Follow-up|2
7819555|NCT01238120|12286932|FG001|Overall Study|Lost to Follow-up|0
7819556|NCT01238120|12286933|FG002|Overall Study|Lost to Follow-up|1
7819557|NCT01238120|12286934|FG003|Overall Study|Lost to Follow-up|1
7819558|NCT01238120|12286931|FG000|Overall Study|Withdrawn due to Medical Problem|2
7819559|NCT01238120|12286932|FG001|Overall Study|Withdrawn due to Medical Problem|0
7819560|NCT01238120|12286933|FG002|Overall Study|Withdrawn due to Medical Problem|1
7819561|NCT01238120|12286934|FG003|Overall Study|Withdrawn due to Medical Problem|0
7819562|NCT01238172|12286946|FG000|Overall Study|Ineligible: based on Eligibility Review|2
7819563|NCT01238172|12286947|FG001|Overall Study|Ineligible: based on Eligibility Review|5
7819564|NCT01238172|12286946|FG000|Overall Study|Ineligible: based on Central Path Review|9
7819565|NCT01238172|12286947|FG001|Overall Study|Ineligible: based on Central Path Review|19
7862040|NCT01597245|12351193|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7862041|NCT01597245|12351194|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7862042|NCT01597245|12351195|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7862043|NCT01597245|12351196|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7862044|NCT01597245|12351197|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7862045|NCT01597245|12351198|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7862046|NCT01597245|12351199|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7862047|NCT01597245|12351200|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7862048|NCT01597245|12351201|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1
7862049|NCT01597245|12351202|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69
7862050|NCT01597245|12351203|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70
7862051|NCT01597245|12351204|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7862052|NCT01597245|12351205|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7862053|NCT01597245|12351206|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7883754|NCT01784419|12383626|FG000|Overall Study|Adverse Event|3
7883755|NCT01784523|12383632|FG000|Overall Study|Study closed early|7
7883756|NCT01784523|12383633|FG001|Overall Study|Study closed early|4
7819566|NCT01238575|12286983|FG000|Overall Study|Lack of Efficacy|2
7819567|NCT01238575|12286984|FG001|Overall Study|Lack of Efficacy|4
7819568|NCT01238575|12286983|FG000|Overall Study|Adverse Event|2
7819569|NCT01238575|12286984|FG001|Overall Study|Adverse Event|0
7819570|NCT01238588|12286990|FG000|Overall Study|Withdrawal by Subject|1
7819571|NCT01238588|12286990|FG000|Overall Study|Physician Decision|2
7819572|NCT01238822|12287002|FG000|Overall Study|COULD NOT SWALLOW PILLS|3
7819573|NCT01238835|12287012|FG000|Overall Study|Death|124
7819574|NCT01238835|12287012|FG000|Overall Study|Withdrawal by Subject|9
7819575|NCT01238835|12287012|FG000|Overall Study|Lost to Follow-up|1
7819576|NCT01238835|12287012|FG000|Overall Study|Site early discontinuation|2
7819577|NCT01238848|12287018|FG000|Overall Study|Physician Decision|13
7819578|NCT01238848|12287019|FG001|Overall Study|Physician Decision|5
7819579|NCT01238861|12287031|FG000|Overall Study|Lost to Follow-up|4
7819580|NCT01238861|12287032|FG001|Overall Study|Lost to Follow-up|2
7819581|NCT01238861|12287033|FG002|Overall Study|Lost to Follow-up|3
7819582|NCT01238861|12287034|FG003|Overall Study|Lost to Follow-up|1
7819583|NCT01238861|12287035|FG004|Overall Study|Lost to Follow-up|1
7819584|NCT01238861|12287036|FG005|Overall Study|Lost to Follow-up|2
7819585|NCT01238861|12287031|FG000|Overall Study|Unplanned surgery|1
7819586|NCT01238861|12287032|FG001|Overall Study|Unplanned surgery|0
7819587|NCT01238861|12287033|FG002|Overall Study|Unplanned surgery|0
7819588|NCT01238861|12287034|FG003|Overall Study|Unplanned surgery|0
7819589|NCT01238861|12287035|FG004|Overall Study|Unplanned surgery|0
7819590|NCT01238861|12287036|FG005|Overall Study|Unplanned surgery|0
7819591|NCT01238861|12287031|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0
7819592|NCT01238861|12287032|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0
7819593|NCT01238861|12287033|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1
7819594|NCT01238861|12287034|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0
7819595|NCT01238861|12287035|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1
7819596|NCT01238861|12287036|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1
7819597|NCT01238861|12287031|FG000|Overall Study|Incorrect enrollment/randomization|0
7819598|NCT01238861|12287032|FG001|Overall Study|Incorrect enrollment/randomization|0
7819599|NCT01238861|12287033|FG002|Overall Study|Incorrect enrollment/randomization|1
7819600|NCT01238861|12287034|FG003|Overall Study|Incorrect enrollment/randomization|0
7819601|NCT01238861|12287035|FG004|Overall Study|Incorrect enrollment/randomization|1
7819602|NCT01238861|12287036|FG005|Overall Study|Incorrect enrollment/randomization|0
7819603|NCT01238861|12287031|FG000|Overall Study|Subject traveled to Argentina by 1 year|0
7819604|NCT01238861|12287032|FG001|Overall Study|Subject traveled to Argentina by 1 year|0
7819605|NCT01238861|12287033|FG002|Overall Study|Subject traveled to Argentina by 1 year|1
7819606|NCT01238861|12287034|FG003|Overall Study|Subject traveled to Argentina by 1 year|0
7819607|NCT01238861|12287035|FG004|Overall Study|Subject traveled to Argentina by 1 year|0
7819608|NCT01238861|12287036|FG005|Overall Study|Subject traveled to Argentina by 1 year|0
7819609|NCT01238861|12287031|FG000|Overall Study|Subject moved out of state/area|0
7819610|NCT01238861|12287032|FG001|Overall Study|Subject moved out of state/area|0
7819611|NCT01238861|12287033|FG002|Overall Study|Subject moved out of state/area|1
7819612|NCT01238861|12287034|FG003|Overall Study|Subject moved out of state/area|1
7819613|NCT01238861|12287035|FG004|Overall Study|Subject moved out of state/area|0
7819614|NCT01238861|12287036|FG005|Overall Study|Subject moved out of state/area|0
7819615|NCT01238861|12287031|FG000|Overall Study|Strongyloides stercoralis antibodies +|0
7819616|NCT01238861|12287032|FG001|Overall Study|Strongyloides stercoralis antibodies +|0
7819617|NCT01238861|12287033|FG002|Overall Study|Strongyloides stercoralis antibodies +|0
7819618|NCT01238861|12287034|FG003|Overall Study|Strongyloides stercoralis antibodies +|1
7819619|NCT01238861|12287035|FG004|Overall Study|Strongyloides stercoralis antibodies +|0
7819620|NCT01238861|12287036|FG005|Overall Study|Strongyloides stercoralis antibodies +|0
7819621|NCT01238861|12287031|FG000|Overall Study|Personal problems|0
7819622|NCT01238861|12287032|FG001|Overall Study|Personal problems|0
7819623|NCT01238861|12287033|FG002|Overall Study|Personal problems|0
7819624|NCT01238861|12287034|FG003|Overall Study|Personal problems|1
7819625|NCT01238861|12287035|FG004|Overall Study|Personal problems|0
7819626|NCT01238861|12287036|FG005|Overall Study|Personal problems|0
7819627|NCT01238861|12287031|FG000|Overall Study|Unable to continue visits|0
7819628|NCT01238861|12287032|FG001|Overall Study|Unable to continue visits|0
7819629|NCT01238861|12287033|FG002|Overall Study|Unable to continue visits|0
7819630|NCT01238861|12287034|FG003|Overall Study|Unable to continue visits|1
7819631|NCT01238861|12287035|FG004|Overall Study|Unable to continue visits|0
7819632|NCT01238861|12287036|FG005|Overall Study|Unable to continue visits|1
7819633|NCT01238861|12287031|FG000|Overall Study|Serious adverse event|0
7819634|NCT01238861|12287032|FG001|Overall Study|Serious adverse event|0
7819635|NCT01238861|12287033|FG002|Overall Study|Serious adverse event|0
7819636|NCT01238861|12287034|FG003|Overall Study|Serious adverse event|0
7819637|NCT01238861|12287035|FG004|Overall Study|Serious adverse event|0
7819638|NCT01238861|12287036|FG005|Overall Study|Serious adverse event|1
7819639|NCT01238861|12287031|FG000|Overall Study|Lack of compliance|0
7819640|NCT01238861|12287032|FG001|Overall Study|Lack of compliance|0
7819641|NCT01238861|12287033|FG002|Overall Study|Lack of compliance|0
7819642|NCT01238861|12287034|FG003|Overall Study|Lack of compliance|0
7819643|NCT01238861|12287035|FG004|Overall Study|Lack of compliance|0
7819644|NCT01238861|12287036|FG005|Overall Study|Lack of compliance|1
7819645|NCT01238861|12287031|FG000|Overall Study|Adverse Event|0
7819646|NCT01238861|12287032|FG001|Overall Study|Adverse Event|1
7819647|NCT01238861|12287033|FG002|Overall Study|Adverse Event|0
7819648|NCT01238861|12287034|FG003|Overall Study|Adverse Event|0
7819649|NCT01238861|12287035|FG004|Overall Study|Adverse Event|0
7819650|NCT01238861|12287036|FG005|Overall Study|Adverse Event|0
7819651|NCT01238861|12287031|FG000|Overall Study|Withdrawal by Subject|6
7819652|NCT01238861|12287032|FG001|Overall Study|Withdrawal by Subject|5
7819653|NCT01238861|12287033|FG002|Overall Study|Withdrawal by Subject|4
7819654|NCT01238861|12287034|FG003|Overall Study|Withdrawal by Subject|8
7819655|NCT01238861|12287035|FG004|Overall Study|Withdrawal by Subject|10
7819656|NCT01238861|12287036|FG005|Overall Study|Withdrawal by Subject|9
7819657|NCT01238900|12287057|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4
7819658|NCT01238900|12287057|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1
7819659|NCT01238991|12287072|FG000|Overall Study|Adverse Event|1
7819660|NCT01238991|12287073|FG001|Overall Study|Adverse Event|0
7819661|NCT01238991|12287074|FG002|Overall Study|Adverse Event|3
7819662|NCT01238991|12287075|FG003|Overall Study|Adverse Event|1
7819663|NCT01238991|12287076|FG004|Overall Study|Adverse Event|1
7819664|NCT01238991|12287077|FG005|Overall Study|Adverse Event|0
7883767|NCT01784861|12383712|FG004|Overall Study|Withdrawal by Subject|0
7883768|NCT01784861|12383713|FG005|Overall Study|Withdrawal by Subject|0
7883769|NCT01784861|12383708|FG000|Overall Study|Physician Decision|0
7883770|NCT01784861|12383709|FG001|Overall Study|Physician Decision|0
7883771|NCT01784861|12383710|FG002|Overall Study|Physician Decision|0
7883772|NCT01784861|12383711|FG003|Overall Study|Physician Decision|2
7819665|NCT01238991|12287078|FG006|Overall Study|Adverse Event|1
7819666|NCT01238991|12287079|FG007|Overall Study|Adverse Event|1
7819667|NCT01238991|12287080|FG008|Overall Study|Adverse Event|0
7819668|NCT01238991|12287081|FG009|Overall Study|Adverse Event|0
7819669|NCT01238991|12287072|FG000|Overall Study|Death|0
7819670|NCT01238991|12287073|FG001|Overall Study|Death|0
7819671|NCT01238991|12287074|FG002|Overall Study|Death|0
7819672|NCT01238991|12287075|FG003|Overall Study|Death|1
7819673|NCT01238991|12287076|FG004|Overall Study|Death|0
7819674|NCT01238991|12287077|FG005|Overall Study|Death|0
7819675|NCT01238991|12287078|FG006|Overall Study|Death|0
7819676|NCT01238991|12287079|FG007|Overall Study|Death|0
7819677|NCT01238991|12287080|FG008|Overall Study|Death|0
7819678|NCT01238991|12287081|FG009|Overall Study|Death|0
7819679|NCT01238991|12287072|FG000|Overall Study|Lack of Efficacy|0
7819680|NCT01238991|12287073|FG001|Overall Study|Lack of Efficacy|0
7819681|NCT01238991|12287074|FG002|Overall Study|Lack of Efficacy|1
7819682|NCT01238991|12287075|FG003|Overall Study|Lack of Efficacy|0
7819683|NCT01238991|12287076|FG004|Overall Study|Lack of Efficacy|0
7819684|NCT01238991|12287077|FG005|Overall Study|Lack of Efficacy|0
7819685|NCT01238991|12287078|FG006|Overall Study|Lack of Efficacy|0
7819686|NCT01238991|12287079|FG007|Overall Study|Lack of Efficacy|0
7819687|NCT01238991|12287080|FG008|Overall Study|Lack of Efficacy|1
7819688|NCT01238991|12287081|FG009|Overall Study|Lack of Efficacy|0
7819689|NCT01238991|12287072|FG000|Overall Study|Withdrawal by Subject|0
7883773|NCT01784861|12383712|FG004|Overall Study|Physician Decision|0
7883774|NCT01784861|12383713|FG005|Overall Study|Physician Decision|1
7883775|NCT01784965|12383740|FG000|Overall Study|Withdrawal by Subject|6
7883776|NCT01784965|12383741|FG001|Overall Study|Withdrawal by Subject|3
7883777|NCT01784965|12383740|FG000|Overall Study|Adverse Event|0
7883778|NCT01784965|12383741|FG001|Overall Study|Adverse Event|8
7911922|NCT02067533|12429492|FG000|Overall Study|Lost to Follow-up|4
7911923|NCT02067533|12429493|FG001|Overall Study|Lost to Follow-up|2
7911924|NCT02067663|12429514|FG000|Overall Study|Lost to Follow-up|13
7911925|NCT02067663|12429515|FG001|Overall Study|Lost to Follow-up|14
7911926|NCT02067676|12429527|FG000|Overall Study|Withdrawal by Subject|1
7911927|NCT02067676|12429528|FG001|Overall Study|Withdrawal by Subject|0
7911928|NCT02067676|12429529|FG002|Overall Study|Withdrawal by Subject|0
7911929|NCT02067676|12429530|FG003|Overall Study|Withdrawal by Subject|0
7911930|NCT02067676|12429531|FG004|Overall Study|Withdrawal by Subject|0
7911931|NCT02067676|12429532|FG005|Overall Study|Withdrawal by Subject|0
7911932|NCT02067728|12429553|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
7911933|NCT02067728|12429554|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
7911934|NCT02067728|12429553|FG000|6 Month Follow up Survey|Lost to Follow-up|48
7911935|NCT02067728|12429554|FG001|6 Month Follow up Survey|Lost to Follow-up|60
7911936|NCT02067728|12429553|FG000|6 Month Measurements|Unable to attend|114
7911937|NCT02067728|12429554|FG001|6 Month Measurements|Unable to attend|97
7911938|NCT02068118|12429580|FG000|18-month Comparative Study Period|Death|90
7911939|NCT02068118|12429581|FG001|18-month Comparative Study Period|Death|97
7911940|NCT02068118|12429580|FG000|18-month Comparative Study Period|Withdrawal by Subject|23
7911941|NCT02068118|12429581|FG001|18-month Comparative Study Period|Withdrawal by Subject|52
7911942|NCT02068118|12429580|FG000|18-month Comparative Study Period|Lost to Follow-up|6
7911943|NCT02068118|12429581|FG001|18-month Comparative Study Period|Lost to Follow-up|7
7911944|NCT02068118|12429580|FG000|18-month Comparative Study Period|Heart transplant|9
7911945|NCT02068118|12429581|FG001|18-month Comparative Study Period|Heart transplant|15
7911946|NCT02068118|12429580|FG000|18-month Comparative Study Period|Inclusion in another protocol|0
7911947|NCT02068118|12429581|FG001|18-month Comparative Study Period|Inclusion in another protocol|2
7911948|NCT02068118|12429580|FG000|18-month Comparative Study Period|Hemiplegia|0
7819690|NCT01238991|12287073|FG001|Overall Study|Withdrawal by Subject|0
7911949|NCT02068118|12429581|FG001|18-month Comparative Study Period|Hemiplegia|1
7819691|NCT01238991|12287074|FG002|Overall Study|Withdrawal by Subject|1
7819692|NCT01238991|12287075|FG003|Overall Study|Withdrawal by Subject|0
7819693|NCT01238991|12287076|FG004|Overall Study|Withdrawal by Subject|0
7819694|NCT01238991|12287077|FG005|Overall Study|Withdrawal by Subject|0
7819695|NCT01238991|12287078|FG006|Overall Study|Withdrawal by Subject|0
7819696|NCT01238991|12287079|FG007|Overall Study|Withdrawal by Subject|0
7819697|NCT01238991|12287080|FG008|Overall Study|Withdrawal by Subject|0
7819698|NCT01238991|12287081|FG009|Overall Study|Withdrawal by Subject|0
7819699|NCT01238991|12287072|FG000|Overall Study|Study Terminated by Sponsor|0
7819700|NCT01238991|12287073|FG001|Overall Study|Study Terminated by Sponsor|0
7819701|NCT01238991|12287074|FG002|Overall Study|Study Terminated by Sponsor|0
7911950|NCT02068118|12429580|FG000|18-month Comparative Study Period|Alzheimer's disease|0
7911951|NCT02068118|12429581|FG001|18-month Comparative Study Period|Alzheimer's disease|1
7911952|NCT02068118|12429580|FG000|18-month Comparative Study Period|Move|0
7911953|NCT02068118|12429581|FG001|18-month Comparative Study Period|Move|1
7911954|NCT02068118|12429580|FG000|18-month Comparative Study Period|Hearing loss|0
7911955|NCT02068118|12429581|FG001|18-month Comparative Study Period|Hearing loss|1
7911956|NCT02068118|12429580|FG000|Extension Period|Death|0
7911957|NCT02068118|12429581|FG001|Extension Period|Death|2
7911958|NCT02068118|12429580|FG000|Extension Period|Withdrawal by Subject|1
7911959|NCT02068118|12429581|FG001|Extension Period|Withdrawal by Subject|0
7911960|NCT02068118|12429580|FG000|Extension Period|Heart transplant|1
7911961|NCT02068118|12429581|FG001|Extension Period|Heart transplant|0
7911962|NCT02068118|12429580|FG000|Extension Period|Wrong device use|0
7911963|NCT02068118|12429581|FG001|Extension Period|Wrong device use|1
7819702|NCT01238991|12287075|FG003|Overall Study|Study Terminated by Sponsor|0
7819703|NCT01238991|12287076|FG004|Overall Study|Study Terminated by Sponsor|1
7819704|NCT01238991|12287077|FG005|Overall Study|Study Terminated by Sponsor|0
7819705|NCT01238991|12287078|FG006|Overall Study|Study Terminated by Sponsor|7
7819706|NCT01238991|12287079|FG007|Overall Study|Study Terminated by Sponsor|4
7819707|NCT01238991|12287080|FG008|Overall Study|Study Terminated by Sponsor|2
7819708|NCT01238991|12287081|FG009|Overall Study|Study Terminated by Sponsor|2
7819709|NCT01238991|12287072|FG000|Overall Study|Caregiver's request|0
7819710|NCT01238991|12287073|FG001|Overall Study|Caregiver's request|0
7819711|NCT01238991|12287074|FG002|Overall Study|Caregiver's request|0
7819712|NCT01238991|12287075|FG003|Overall Study|Caregiver's request|0
7819713|NCT01238991|12287076|FG004|Overall Study|Caregiver's request|0
7911964|NCT02068222|12429593|FG000|Overall Study|Lost to Follow-up|1
7911965|NCT02068352|12429600|FG000|Overall Study|Lost to Follow-up|0
7911966|NCT02068352|12429601|FG001|Overall Study|Lost to Follow-up|2
7911967|NCT02068352|12429602|FG002|Overall Study|Lost to Follow-up|0
7911968|NCT02068352|12429600|FG000|Overall Study|Adverse Event|4
7911969|NCT02068352|12429601|FG001|Overall Study|Adverse Event|2
7911970|NCT02068352|12429602|FG002|Overall Study|Adverse Event|7
7911971|NCT02068352|12429600|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0
7911972|NCT02068352|12429601|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1
7911973|NCT02068352|12429602|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0
7911974|NCT02068352|12429600|FG000|Overall Study|Participant Withdrew Consent to Participate|6
7911975|NCT02068352|12429601|FG001|Overall Study|Participant Withdrew Consent to Participate|3
7911976|NCT02068352|12429602|FG002|Overall Study|Participant Withdrew Consent to Participate|1
7911977|NCT02068352|12429600|FG000|Overall Study|Protocol Deviation|0
7911978|NCT02068352|12429601|FG001|Overall Study|Protocol Deviation|0
7911979|NCT02068352|12429602|FG002|Overall Study|Protocol Deviation|1
7911980|NCT02068443|12429613|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7911981|NCT02068443|12429614|FG001|Overall Study|Pretreatment Event/Adverse Event|5
7911982|NCT02068443|12429615|FG002|Overall Study|Pretreatment Event/Adverse Event|2
7911983|NCT02068443|12429613|FG000|Overall Study|Voluntary Withdrawal|4
7911984|NCT02068443|12429614|FG001|Overall Study|Voluntary Withdrawal|0
7911985|NCT02068443|12429615|FG002|Overall Study|Voluntary Withdrawal|1
7911986|NCT02068443|12429613|FG000|Overall Study|Lack of Efficacy|2
7911987|NCT02068443|12429614|FG001|Overall Study|Lack of Efficacy|1
7911988|NCT02068443|12429615|FG002|Overall Study|Lack of Efficacy|0
7911989|NCT02068443|12429613|FG000|Overall Study|Other Reason Not Specified|1
7911990|NCT02068443|12429614|FG001|Overall Study|Other Reason Not Specified|0
7911991|NCT02068443|12429615|FG002|Overall Study|Other Reason Not Specified|0
7911992|NCT02068495|12429623|FG000|Overall Study|Case Report Forms Uncollected|60
7911993|NCT02068495|12429623|FG000|Overall Study|Protocol Deviation|49
7911994|NCT02068508|12429627|FG000|Overall Study|Case report forms uncollected|27
7911995|NCT02068508|12429627|FG000|Overall Study|Patient did not visit the study site|1
7911996|NCT02068508|12429627|FG000|Overall Study|Protocol Violation|4
7911997|NCT02068599|12429634|FG000|Overall Study|Adverse Event|4
7911998|NCT02068599|12429635|FG001|Overall Study|Adverse Event|1
7911999|NCT02068599|12429636|FG002|Overall Study|Adverse Event|1
7912000|NCT02068599|12429634|FG000|Overall Study|Withdrawal by Subject|2
7912001|NCT02068599|12429635|FG001|Overall Study|Withdrawal by Subject|7
7912002|NCT02068599|12429636|FG002|Overall Study|Withdrawal by Subject|5
7912003|NCT02068599|12429634|FG000|Overall Study|Protocol Violation|4
7912004|NCT02068599|12429635|FG001|Overall Study|Protocol Violation|2
7912005|NCT02068599|12429636|FG002|Overall Study|Protocol Violation|3
7912006|NCT02068599|12429634|FG000|Overall Study|Lost to Follow-up|1
7912007|NCT02068599|12429635|FG001|Overall Study|Lost to Follow-up|0
7912008|NCT02068599|12429636|FG002|Overall Study|Lost to Follow-up|0
7912009|NCT02068599|12429634|FG000|Overall Study|Lack of Efficacy|0
7912010|NCT02068599|12429635|FG001|Overall Study|Lack of Efficacy|0
7912011|NCT02068599|12429636|FG002|Overall Study|Lack of Efficacy|3
7912012|NCT02068599|12429634|FG000|Overall Study|Noncompliance|0
7912013|NCT02068599|12429635|FG001|Overall Study|Noncompliance|0
7912014|NCT02068599|12429636|FG002|Overall Study|Noncompliance|1
7912015|NCT02068768|12429703|FG000|Overall Study|Lost to Follow-up|5
7912016|NCT02068768|12429703|FG000|Overall Study|Early Termination by Sponsor|2
7912017|NCT02069015|12429732|FG000|Overall Study|Lost to Follow-up|39
7912018|NCT02069015|12429733|FG001|Overall Study|Lost to Follow-up|32
7912019|NCT02069015|12429732|FG000|Overall Study|Withdrawal by Subject|1
7912020|NCT02069015|12429733|FG001|Overall Study|Withdrawal by Subject|1
7912021|NCT02069093|12429744|FG000|Overall Study|Disease progression|14
7912022|NCT02069093|12429744|FG000|Overall Study|New cancer therapy|1
7912023|NCT02069093|12429744|FG000|Overall Study|Death|1
7912024|NCT02069093|12429744|FG000|Overall Study|Administrative problems|1
7819714|NCT01238991|12287077|FG005|Overall Study|Caregiver's request|0
7912025|NCT02069093|12429744|FG000|Overall Study|Withdrawal by Subject|2
7912026|NCT02069093|12429744|FG000|Overall Study|Abnormal laboratory values|1
7819715|NCT01238991|12287078|FG006|Overall Study|Caregiver's request|0
7819716|NCT01238991|12287079|FG007|Overall Study|Caregiver's request|0
7819717|NCT01238991|12287080|FG008|Overall Study|Caregiver's request|1
7819718|NCT01238991|12287081|FG009|Overall Study|Caregiver's request|0
7819719|NCT01238991|12287072|FG000|Overall Study|Admission to a nursing home|1
7819720|NCT01238991|12287073|FG001|Overall Study|Admission to a nursing home|0
7819721|NCT01238991|12287074|FG002|Overall Study|Admission to a nursing home|1
7819722|NCT01238991|12287075|FG003|Overall Study|Admission to a nursing home|0
7819723|NCT01238991|12287076|FG004|Overall Study|Admission to a nursing home|0
7819724|NCT01238991|12287077|FG005|Overall Study|Admission to a nursing home|0
7819725|NCT01238991|12287078|FG006|Overall Study|Admission to a nursing home|0
7819726|NCT01238991|12287079|FG007|Overall Study|Admission to a nursing home|0
7819727|NCT01238991|12287080|FG008|Overall Study|Admission to a nursing home|0
7819728|NCT01238991|12287081|FG009|Overall Study|Admission to a nursing home|0
7819729|NCT01239043|12287108|FG000|Overall Study|Protocol Violation|2
7912027|NCT02069093|12429744|FG000|Overall Study|Adverse Event|10
7912028|NCT02069379|12429782|FG000|Baseline Measurements|Lost to Follow-up|1
7912029|NCT02069379|12429783|FG001|Baseline Measurements|Lost to Follow-up|0
7819730|NCT01239043|12287109|FG001|Overall Study|Protocol Violation|1
7819731|NCT01239121|12287123|FG000|Overall Study|Withdrawal by Subject|2
7819732|NCT01239121|12287124|FG001|Overall Study|Withdrawal by Subject|4
7819733|NCT01239121|12287125|FG002|Overall Study|Withdrawal by Subject|0
7819734|NCT01239160|12287135|FG000|Overall Study|Lost to Follow-up|3
7819735|NCT01239160|12287136|FG001|Overall Study|Lost to Follow-up|5
7819736|NCT01239160|12287137|FG002|Overall Study|Lost to Follow-up|0
7912030|NCT02069379|12429784|FG002|Baseline Measurements|Lost to Follow-up|0
7819737|NCT01239160|12287135|FG000|Overall Study|Withdrawal by Subject|17
7819738|NCT01239160|12287136|FG001|Overall Study|Withdrawal by Subject|6
7819739|NCT01239160|12287137|FG002|Overall Study|Withdrawal by Subject|2
7819740|NCT01239160|12287135|FG000|Overall Study|Physician Decision|5
7819741|NCT01239160|12287136|FG001|Overall Study|Physician Decision|7
7819742|NCT01239160|12287137|FG002|Overall Study|Physician Decision|2
7819743|NCT01239160|12287135|FG000|Overall Study|Early Termination Due to Study Closure|0
7819744|NCT01239160|12287136|FG001|Overall Study|Early Termination Due to Study Closure|1
7819745|NCT01239160|12287137|FG002|Overall Study|Early Termination Due to Study Closure|6
7819746|NCT01239316|12287147|FG000|Overall Study|Progression/Relapse|11
7819747|NCT01239316|12287147|FG000|Overall Study|Adverse Event|1
7819748|NCT01239342|12287153|FG000|Overall Study|Adverse Event|1
7819749|NCT01239342|12287154|FG001|Overall Study|Adverse Event|0
7819750|NCT01239342|12287153|FG000|Overall Study|Withdrawal by Subject|1
7819751|NCT01239342|12287154|FG001|Overall Study|Withdrawal by Subject|5
7819752|NCT01239342|12287153|FG000|Overall Study|Reason Unknown|1
7819753|NCT01239342|12287154|FG001|Overall Study|Reason Unknown|1
7819754|NCT01239381|12287164|FG000|Overall Study|Protocol Violation|1
7819755|NCT01239381|12287164|FG000|Overall Study|Withdrawal by Subject|1
7819756|NCT01239394|12287169|FG000|Overall Study|Adverse Event|1
7819757|NCT01239472|12287175|FG000|Overall Study|Withdrawal by Subject|5
7819758|NCT01239472|12287176|FG001|Overall Study|Withdrawal by Subject|1
7819759|NCT01239472|12287175|FG000|Overall Study|Adverse Event|0
7819760|NCT01239472|12287176|FG001|Overall Study|Adverse Event|1
7819761|NCT01239472|12287175|FG000|Overall Study|Lack of Efficacy|0
7819762|NCT01239472|12287176|FG001|Overall Study|Lack of Efficacy|1
7819763|NCT01239732|12287201|FG000|Overall Study|Termination of study per protocol|667
7819764|NCT01239732|12287201|FG000|Overall Study|Death|226
7819765|NCT01239732|12287201|FG000|Overall Study|Withdrawal by Subject|87
7819766|NCT01239732|12287201|FG000|Overall Study|Adverse Event|6
7819767|NCT01239732|12287201|FG000|Overall Study|Protocol Violation|3
7819768|NCT01239732|12287201|FG000|Overall Study|Participant non compliance|5
7819769|NCT01239732|12287201|FG000|Overall Study|Study termination by sponsor|2
7912031|NCT02069379|12429785|FG003|Baseline Measurements|Lost to Follow-up|0
7912032|NCT02069379|12429782|FG000|Baseline Measurements|Ineligible based on initial assessments|2
7912033|NCT02069379|12429783|FG001|Baseline Measurements|Ineligible based on initial assessments|0
7912034|NCT02069379|12429784|FG002|Baseline Measurements|Ineligible based on initial assessments|0
7912035|NCT02069379|12429785|FG003|Baseline Measurements|Ineligible based on initial assessments|2
7912036|NCT02069379|12429782|FG000|First Treatment Arm|Lost to Follow-up|0
7912037|NCT02069379|12429783|FG001|First Treatment Arm|Lost to Follow-up|1
7912038|NCT02069379|12429784|FG002|First Treatment Arm|Lost to Follow-up|1
7912039|NCT02069379|12429785|FG003|First Treatment Arm|Lost to Follow-up|0
7912040|NCT02069379|12429782|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0
7912041|NCT02069379|12429783|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1
7912042|NCT02069379|12429784|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0
7912043|NCT02069379|12429785|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0
7912044|NCT02069379|12429782|FG000|Washout Period (4 Weeks)|Unrelated event|0
7912045|NCT02069379|12429783|FG001|Washout Period (4 Weeks)|Unrelated event|1
7912046|NCT02069379|12429784|FG002|Washout Period (4 Weeks)|Unrelated event|0
7912047|NCT02069379|12429785|FG003|Washout Period (4 Weeks)|Unrelated event|0
7912048|NCT02069379|12429782|FG000|Second Treatment Arm|Lost to Follow-up|0
7912049|NCT02069379|12429783|FG001|Second Treatment Arm|Lost to Follow-up|0
7912050|NCT02069379|12429784|FG002|Second Treatment Arm|Lost to Follow-up|1
7912051|NCT02069379|12429785|FG003|Second Treatment Arm|Lost to Follow-up|0
7912052|NCT02069392|12429797|FG000|Overall Study|Withdrawal by Subject|4
7912053|NCT02069392|12429798|FG001|Overall Study|Withdrawal by Subject|2
7912054|NCT02070380|12429865|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
7912055|NCT02070380|12429866|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
7912056|NCT02070380|12429867|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
7912057|NCT02070380|12429868|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
7912058|NCT02070380|12429865|FG000|Second Injection|Image sets missing or technically inadeq|0
7912059|NCT02070380|12429866|FG001|Second Injection|Image sets missing or technically inadeq|1
7912060|NCT02070380|12429867|FG002|Second Injection|Image sets missing or technically inadeq|0
7819770|NCT01239732|12287201|FG000|Overall Study|Investigator's decision|4
7819771|NCT01239732|12287201|FG000|Overall Study|Treatment failure|2
7819772|NCT01239732|12287201|FG000|Overall Study|Other|19
7819773|NCT01239745|12287205|FG000|Overall Study|Study terminated by sponsor|45
7819774|NCT01239745|12287205|FG000|Overall Study|Adverse Event|1
7819775|NCT01239992|12287209|FG000|Overall Study|Withdrawal by Subject|2
7819776|NCT01240135|12287224|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1
7819777|NCT01240135|12287225|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1
7819778|NCT01240135|12287224|FG000|Period Two, 14 Days of Wear|Adverse Event|0
7819779|NCT01240135|12287225|FG001|Period Two, 14 Days of Wear|Adverse Event|1
7819780|NCT01240200|12287233|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
7819781|NCT01240200|12287234|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
7819782|NCT01240356|12287249|FG000|Overall Study|Withdrawal by Subject|2
7819783|NCT01240356|12287250|FG001|Overall Study|Withdrawal by Subject|0
7819784|NCT01240356|12287249|FG000|Overall Study|MRI contraindication|1
7819785|NCT01240356|12287250|FG001|Overall Study|MRI contraindication|0
7819786|NCT01240382|12287261|FG000|Overall Study|Adverse Event|2
7819787|NCT01240382|12287262|FG001|Overall Study|Adverse Event|1
7819788|NCT01240382|12287261|FG000|Overall Study|Lack of Efficacy|0
7819789|NCT01240382|12287262|FG001|Overall Study|Lack of Efficacy|2
7819790|NCT01240382|12287261|FG000|Overall Study|Fear of adverse events|0
7819791|NCT01240382|12287262|FG001|Overall Study|Fear of adverse events|1
7819792|NCT01240551|12287270|FG000|Overall Study|Refused further treatment|3
7819793|NCT01240551|12287271|FG001|Overall Study|Refused further treatment|2
7819794|NCT01240551|12287270|FG000|Overall Study|Lost to Follow-up|1
7819795|NCT01240551|12287271|FG001|Overall Study|Lost to Follow-up|1
7819796|NCT01240590|12287282|FG000|Phase I|Refused further treatment|0
7819797|NCT01240590|12287283|FG001|Phase I|Refused further treatment|0
7819798|NCT01240590|12287284|FG002|Phase I|Refused further treatment|3
7819799|NCT01240590|12287285|FG003|Phase I|Refused further treatment|0
7819800|NCT01240590|12287286|FG004|Phase I|Refused further treatment|0
7819801|NCT01240590|12287282|FG000|Phase II|Refused further treatment|0
7819802|NCT01240590|12287283|FG001|Phase II|Refused further treatment|0
7819803|NCT01240590|12287284|FG002|Phase II|Refused further treatment|0
7819804|NCT01240590|12287285|FG003|Phase II|Refused further treatment|2
7819805|NCT01240590|12287286|FG004|Phase II|Refused further treatment|1
7862054|NCT01597245|12351207|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7862055|NCT01597245|12351208|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7862056|NCT01597245|12351188|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862057|NCT01597245|12351189|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862058|NCT01597245|12351190|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862059|NCT01597245|12351191|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862060|NCT01597245|12351192|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862061|NCT01597245|12351193|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862062|NCT01597245|12351194|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862063|NCT01597245|12351195|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862064|NCT01597245|12351196|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862065|NCT01597245|12351197|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862066|NCT01597245|12351198|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862067|NCT01597245|12351199|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862068|NCT01597245|12351200|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862069|NCT01597245|12351201|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1
7862070|NCT01597245|12351202|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62
7862071|NCT01597245|12351203|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63
7862072|NCT01597245|12351204|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862073|NCT01597245|12351205|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7819806|NCT01240746|12287315|FG000|Overall Study|Adverse Event|2
7819807|NCT01240746|12287316|FG001|Overall Study|Adverse Event|0
7819808|NCT01240746|12287317|FG002|Overall Study|Adverse Event|10
7819809|NCT01240746|12287315|FG000|Overall Study|Lost to Follow-up|23
7819810|NCT01240746|12287316|FG001|Overall Study|Lost to Follow-up|20
7819811|NCT01240746|12287317|FG002|Overall Study|Lost to Follow-up|102
7819812|NCT01240746|12287315|FG000|Overall Study|Protocol Violation|24
7819813|NCT01240746|12287316|FG001|Overall Study|Protocol Violation|15
7819814|NCT01240746|12287317|FG002|Overall Study|Protocol Violation|72
7819815|NCT01240746|12287315|FG000|Overall Study|Withdrawal by Subject|10
7819816|NCT01240746|12287316|FG001|Overall Study|Withdrawal by Subject|13
7819817|NCT01240746|12287317|FG002|Overall Study|Withdrawal by Subject|59
7819818|NCT01240785|12287327|FG000|Overall Study|Lost to Follow-up|1
7819819|NCT01240785|12287328|FG001|Overall Study|Lost to Follow-up|0
7819820|NCT01240785|12287327|FG000|Overall Study|Protocol Violation|0
7819821|NCT01240785|12287328|FG001|Overall Study|Protocol Violation|3
7819822|NCT01240811|12287337|FG000|Overall Study|Physician Decision|0
7819823|NCT01240811|12287338|FG001|Overall Study|Physician Decision|1
7819824|NCT01240811|12287339|FG002|Overall Study|Physician Decision|0
7819825|NCT01240811|12287337|FG000|Overall Study|Withdrawal by Subject|0
7819826|NCT01240811|12287338|FG001|Overall Study|Withdrawal by Subject|0
7819827|NCT01240811|12287339|FG002|Overall Study|Withdrawal by Subject|1
7819828|NCT01240863|12287351|FG000|Open-label Titration Period|Adverse Event|47
7819829|NCT01240863|12287352|FG001|Open-label Titration Period|Adverse Event|0
7819830|NCT01240863|12287353|FG002|Open-label Titration Period|Adverse Event|0
7819831|NCT01240863|12287351|FG000|Open-label Titration Period|Lack of Efficacy|19
7819832|NCT01240863|12287352|FG001|Open-label Titration Period|Lack of Efficacy|0
7819833|NCT01240863|12287353|FG002|Open-label Titration Period|Lack of Efficacy|0
7819834|NCT01240863|12287351|FG000|Open-label Titration Period|Withdrawal by Subject|9
7819835|NCT01240863|12287352|FG001|Open-label Titration Period|Withdrawal by Subject|0
7819836|NCT01240863|12287353|FG002|Open-label Titration Period|Withdrawal by Subject|0
7819837|NCT01240863|12287351|FG000|Open-label Titration Period|Protocol Violation|7
7819838|NCT01240863|12287352|FG001|Open-label Titration Period|Protocol Violation|0
7819839|NCT01240863|12287353|FG002|Open-label Titration Period|Protocol Violation|0
7819840|NCT01240863|12287351|FG000|Open-label Titration Period|Noncompliance to study drug admin|3
7819841|NCT01240863|12287352|FG001|Open-label Titration Period|Noncompliance to study drug admin|0
7819842|NCT01240863|12287353|FG002|Open-label Titration Period|Noncompliance to study drug admin|0
7819843|NCT01240863|12287351|FG000|Open-label Titration Period|Noncompliance to study procedures|3
7819844|NCT01240863|12287352|FG001|Open-label Titration Period|Noncompliance to study procedures|0
7819845|NCT01240863|12287353|FG002|Open-label Titration Period|Noncompliance to study procedures|0
7819846|NCT01240863|12287351|FG000|Open-label Titration Period|Dropped out prior to dosing|2
7819847|NCT01240863|12287352|FG001|Open-label Titration Period|Dropped out prior to dosing|0
7819848|NCT01240863|12287353|FG002|Open-label Titration Period|Dropped out prior to dosing|0
7819849|NCT01240863|12287351|FG000|Open-label Titration Period|Other|7
7819850|NCT01240863|12287352|FG001|Open-label Titration Period|Other|0
7819851|NCT01240863|12287353|FG002|Open-label Titration Period|Other|0
7819852|NCT01240863|12287351|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
7819853|NCT01240863|12287352|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
7819854|NCT01240863|12287353|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
7819855|NCT01240863|12287351|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7819856|NCT01240863|12287352|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
7819857|NCT01240863|12287353|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
7819858|NCT01240863|12287351|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
7819859|NCT01240863|12287352|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
7819860|NCT01240863|12287353|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
7819861|NCT01240863|12287351|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
7819862|NCT01240863|12287352|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
7819863|NCT01240863|12287353|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
7819864|NCT01240863|12287351|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
7819865|NCT01240863|12287352|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
7819866|NCT01240863|12287353|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
7819867|NCT01240863|12287351|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
7819868|NCT01240863|12287352|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
7819869|NCT01240863|12287353|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
7819870|NCT01240863|12287351|FG000|Double-blind Treatment Period (12 Weeks)|Other|0
7819871|NCT01240863|12287352|FG001|Double-blind Treatment Period (12 Weeks)|Other|1
7819872|NCT01240863|12287353|FG002|Double-blind Treatment Period (12 Weeks)|Other|5
7819873|NCT01240863|12287351|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
7819874|NCT01240863|12287352|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
7819875|NCT01240863|12287353|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
7819876|NCT01240915|12287373|FG000|Overall Study|Adverse Event|0
7819877|NCT01240915|12287374|FG001|Overall Study|Adverse Event|0
7819878|NCT01240915|12287375|FG002|Overall Study|Adverse Event|0
7819879|NCT01240915|12287376|FG003|Overall Study|Adverse Event|1
7819880|NCT01240915|12287377|FG004|Overall Study|Adverse Event|0
7819881|NCT01240915|12287378|FG005|Overall Study|Adverse Event|2
7819882|NCT01240915|12287379|FG006|Overall Study|Adverse Event|0
7819883|NCT01240915|12287380|FG007|Overall Study|Adverse Event|0
7819884|NCT01240915|12287381|FG008|Overall Study|Adverse Event|1
7819885|NCT01240915|12287373|FG000|Overall Study|Lost to Follow-up|0
7819886|NCT01240915|12287374|FG001|Overall Study|Lost to Follow-up|0
7819887|NCT01240915|12287375|FG002|Overall Study|Lost to Follow-up|0
7819888|NCT01240915|12287376|FG003|Overall Study|Lost to Follow-up|0
7819889|NCT01240915|12287377|FG004|Overall Study|Lost to Follow-up|1
7819890|NCT01240915|12287378|FG005|Overall Study|Lost to Follow-up|1
7819891|NCT01240915|12287379|FG006|Overall Study|Lost to Follow-up|0
7819892|NCT01240915|12287380|FG007|Overall Study|Lost to Follow-up|1
7819893|NCT01240915|12287381|FG008|Overall Study|Lost to Follow-up|1
7819894|NCT01240915|12287373|FG000|Overall Study|Withdrawal by Subject|2
7819895|NCT01240915|12287374|FG001|Overall Study|Withdrawal by Subject|1
7819896|NCT01240915|12287375|FG002|Overall Study|Withdrawal by Subject|0
7819897|NCT01240915|12287376|FG003|Overall Study|Withdrawal by Subject|2
7819898|NCT01240915|12287377|FG004|Overall Study|Withdrawal by Subject|0
7819899|NCT01240915|12287378|FG005|Overall Study|Withdrawal by Subject|4
7819900|NCT01240915|12287379|FG006|Overall Study|Withdrawal by Subject|2
7819901|NCT01240915|12287380|FG007|Overall Study|Withdrawal by Subject|3
7819902|NCT01240915|12287381|FG008|Overall Study|Withdrawal by Subject|3
7819903|NCT01240915|12287373|FG000|Overall Study|Other|0
7819904|NCT01240915|12287374|FG001|Overall Study|Other|0
7819905|NCT01240915|12287375|FG002|Overall Study|Other|0
7819906|NCT01240915|12287376|FG003|Overall Study|Other|0
7819907|NCT01240915|12287377|FG004|Overall Study|Other|2
7819908|NCT01240915|12287378|FG005|Overall Study|Other|0
7819909|NCT01240915|12287379|FG006|Overall Study|Other|0
7819910|NCT01240915|12287380|FG007|Overall Study|Other|0
7819911|NCT01240915|12287381|FG008|Overall Study|Other|0
7819912|NCT01240915|12287373|FG000|Overall Study|Insufficient Clinical Response|0
7819913|NCT01240915|12287374|FG001|Overall Study|Insufficient Clinical Response|0
7819914|NCT01240915|12287375|FG002|Overall Study|Insufficient Clinical Response|0
7819915|NCT01240915|12287376|FG003|Overall Study|Insufficient Clinical Response|0
7819916|NCT01240915|12287377|FG004|Overall Study|Insufficient Clinical Response|1
7819917|NCT01240915|12287378|FG005|Overall Study|Insufficient Clinical Response|3
7819918|NCT01240915|12287379|FG006|Overall Study|Insufficient Clinical Response|6
7819919|NCT01240915|12287380|FG007|Overall Study|Insufficient Clinical Response|0
7819920|NCT01240915|12287381|FG008|Overall Study|Insufficient Clinical Response|3
7819921|NCT01241240|12287405|FG000|Overall Study|Adverse Event|5
7819922|NCT01241240|12287406|FG001|Overall Study|Adverse Event|4
7819923|NCT01241240|12287405|FG000|Overall Study|Lost to Follow-up|2
7819924|NCT01241240|12287406|FG001|Overall Study|Lost to Follow-up|4
7819925|NCT01241240|12287405|FG000|Overall Study|Personal Reasons|1
7819926|NCT01241240|12287406|FG001|Overall Study|Personal Reasons|1
7819927|NCT01241292|12287414|FG000|Overall Study|Administrative Reason by Sponsor|1
7819928|NCT01241292|12287415|FG001|Overall Study|Administrative Reason by Sponsor|0
7819929|NCT01241292|12287414|FG000|Overall Study|Disease Progression|2
7819930|NCT01241292|12287415|FG001|Overall Study|Disease Progression|0
7819931|NCT01241292|12287414|FG000|Overall Study|Study Drug Toxicity|0
7819932|NCT01241292|12287415|FG001|Overall Study|Study Drug Toxicity|1
7819933|NCT01241292|12287414|FG000|Overall Study|Participant Discontinued Treatment|0
7819934|NCT01241292|12287415|FG001|Overall Study|Participant Discontinued Treatment|2
7819935|NCT01241318|12287427|FG000|Overall Study|Woman: false pregnancies|27
7819936|NCT01241318|12287428|FG001|Overall Study|Woman: false pregnancies|15
7819937|NCT01241318|12287427|FG000|Overall Study|Woman: miscarriage/abortion|46
7819938|NCT01241318|12287428|FG001|Overall Study|Woman: miscarriage/abortion|38
7819939|NCT01241318|12287427|FG000|Overall Study|Withdrawal by Subject|175
7819940|NCT01241318|12287428|FG001|Overall Study|Withdrawal by Subject|46
7819941|NCT01241318|12287427|FG000|Overall Study|Lost to Follow-up|740
7819942|NCT01241318|12287428|FG001|Overall Study|Lost to Follow-up|455
7819943|NCT01241318|12287427|FG000|Overall Study|Death|2
7819944|NCT01241318|12287428|FG001|Overall Study|Death|4
7819945|NCT01241318|12287427|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60
7819946|NCT01241318|12287428|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38
7819947|NCT01241318|12287427|FG000|Overall Study|Woman: Stillborn infant|129
7819948|NCT01241318|12287428|FG001|Overall Study|Woman: Stillborn infant|146
7819949|NCT01241448|12287474|FG000|Overall Study|Adverse Event|1
7819950|NCT01241448|12287475|FG001|Overall Study|Adverse Event|0
7819951|NCT01241448|12287476|FG002|Overall Study|Adverse Event|2
7819952|NCT01241448|12287477|FG003|Overall Study|Adverse Event|2
7819953|NCT01241448|12287474|FG000|Overall Study|Lost to Follow-up|2
7819954|NCT01241448|12287475|FG001|Overall Study|Lost to Follow-up|1
7819955|NCT01241448|12287476|FG002|Overall Study|Lost to Follow-up|1
7819956|NCT01241448|12287477|FG003|Overall Study|Lost to Follow-up|1
7819957|NCT01241448|12287474|FG000|Overall Study|Physician Decision|0
7819958|NCT01241448|12287475|FG001|Overall Study|Physician Decision|2
7819959|NCT01241448|12287476|FG002|Overall Study|Physician Decision|0
7819960|NCT01241448|12287477|FG003|Overall Study|Physician Decision|0
7819961|NCT01241448|12287474|FG000|Overall Study|Protocol Violation|10
7819962|NCT01241448|12287475|FG001|Overall Study|Protocol Violation|5
7819963|NCT01241448|12287476|FG002|Overall Study|Protocol Violation|3
7819964|NCT01241448|12287477|FG003|Overall Study|Protocol Violation|6
7819965|NCT01241448|12287474|FG000|Overall Study|Sponsor Decision|17
7819966|NCT01241448|12287475|FG001|Overall Study|Sponsor Decision|14
7819967|NCT01241448|12287476|FG002|Overall Study|Sponsor Decision|12
7819968|NCT01241448|12287477|FG003|Overall Study|Sponsor Decision|6
7819969|NCT01241448|12287474|FG000|Overall Study|Withdrawal by Subject|4
7819970|NCT01241448|12287475|FG001|Overall Study|Withdrawal by Subject|5
7819971|NCT01241448|12287476|FG002|Overall Study|Withdrawal by Subject|3
7819972|NCT01241448|12287477|FG003|Overall Study|Withdrawal by Subject|6
7819973|NCT01241448|12287474|FG000|Overall Study|Excluded due to data integrity issues|3
7819974|NCT01241448|12287475|FG001|Overall Study|Excluded due to data integrity issues|2
7819975|NCT01241448|12287476|FG002|Overall Study|Excluded due to data integrity issues|2
7819976|NCT01241448|12287477|FG003|Overall Study|Excluded due to data integrity issues|2
7819977|NCT01241461|12287490|FG000|Overall Study|Progressive Disease|3
7819978|NCT01241461|12287491|FG001|Overall Study|Progressive Disease|6
7819979|NCT01241552|12287519|FG000|Overall Study|Lack of Efficacy|1
7819980|NCT01241552|12287520|FG001|Overall Study|Lack of Efficacy|0
7819981|NCT01241552|12287521|FG002|Overall Study|Lack of Efficacy|0
7819982|NCT01241552|12287522|FG003|Overall Study|Lack of Efficacy|0
7819983|NCT01241552|12287519|FG000|Overall Study|Death|26
7819984|NCT01241552|12287520|FG001|Overall Study|Death|30
7819985|NCT01241552|12287521|FG002|Overall Study|Death|20
7819986|NCT01241552|12287522|FG003|Overall Study|Death|25
7819987|NCT01241552|12287519|FG000|Overall Study|Adverse Event|1
7819988|NCT01241552|12287520|FG001|Overall Study|Adverse Event|1
7819989|NCT01241552|12287521|FG002|Overall Study|Adverse Event|0
7819990|NCT01241552|12287522|FG003|Overall Study|Adverse Event|0
7819991|NCT01241552|12287519|FG000|Overall Study|Technical Problems|2
7819992|NCT01241552|12287520|FG001|Overall Study|Technical Problems|0
7819993|NCT01241552|12287521|FG002|Overall Study|Technical Problems|2
7819994|NCT01241552|12287522|FG003|Overall Study|Technical Problems|2
7819995|NCT01241552|12287519|FG000|Overall Study|Progressive Disease|0
7819996|NCT01241552|12287520|FG001|Overall Study|Progressive Disease|0
7819997|NCT01241552|12287521|FG002|Overall Study|Progressive Disease|1
7819998|NCT01241552|12287522|FG003|Overall Study|Progressive Disease|2
7819999|NCT01241552|12287519|FG000|Overall Study|Protocol Violation|0
7820000|NCT01241552|12287520|FG001|Overall Study|Protocol Violation|2
7820001|NCT01241552|12287521|FG002|Overall Study|Protocol Violation|6
7820002|NCT01241552|12287522|FG003|Overall Study|Protocol Violation|1
7820003|NCT01241552|12287519|FG000|Overall Study|Withdrawal by Subject|7
7820004|NCT01241552|12287520|FG001|Overall Study|Withdrawal by Subject|15
7820005|NCT01241552|12287521|FG002|Overall Study|Withdrawal by Subject|14
7820006|NCT01241552|12287522|FG003|Overall Study|Withdrawal by Subject|15
7820007|NCT01241552|12287519|FG000|Overall Study|Physician Decision|2
7820008|NCT01241552|12287520|FG001|Overall Study|Physician Decision|4
7820009|NCT01241552|12287521|FG002|Overall Study|Physician Decision|2
7820010|NCT01241552|12287522|FG003|Overall Study|Physician Decision|3
7820011|NCT01241552|12287519|FG000|Overall Study|Lost to Follow-up|2
7820012|NCT01241552|12287520|FG001|Overall Study|Lost to Follow-up|11
7820013|NCT01241552|12287521|FG002|Overall Study|Lost to Follow-up|15
7820014|NCT01241552|12287522|FG003|Overall Study|Lost to Follow-up|16
7820015|NCT01241591|12287541|FG000|Overall Study|Lack of Efficacy|5
7820016|NCT01241591|12287542|FG001|Overall Study|Lack of Efficacy|2
7820017|NCT01241591|12287543|FG002|Overall Study|Lack of Efficacy|2
7820018|NCT01241591|12287544|FG003|Overall Study|Lack of Efficacy|3
7820019|NCT01241591|12287541|FG000|Overall Study|Protocol Violation|5
7820020|NCT01241591|12287542|FG001|Overall Study|Protocol Violation|2
7820021|NCT01241591|12287543|FG002|Overall Study|Protocol Violation|3
7820022|NCT01241591|12287544|FG003|Overall Study|Protocol Violation|0
7820023|NCT01241591|12287541|FG000|Overall Study|Lost to Follow-up|1
7820024|NCT01241591|12287542|FG001|Overall Study|Lost to Follow-up|2
7820025|NCT01241591|12287543|FG002|Overall Study|Lost to Follow-up|2
7820026|NCT01241591|12287544|FG003|Overall Study|Lost to Follow-up|2
7820027|NCT01241591|12287541|FG000|Overall Study|Screen Failure|3
7820028|NCT01241591|12287542|FG001|Overall Study|Screen Failure|2
7820029|NCT01241591|12287543|FG002|Overall Study|Screen Failure|1
7820030|NCT01241591|12287544|FG003|Overall Study|Screen Failure|0
7820031|NCT01241591|12287541|FG000|Overall Study|Withdrawal by Subject|6
7820032|NCT01241591|12287542|FG001|Overall Study|Withdrawal by Subject|4
7820033|NCT01241591|12287543|FG002|Overall Study|Withdrawal by Subject|2
7820034|NCT01241591|12287544|FG003|Overall Study|Withdrawal by Subject|2
7820035|NCT01241591|12287541|FG000|Overall Study|Other|0
7820036|NCT01241591|12287542|FG001|Overall Study|Other|1
7820037|NCT01241591|12287543|FG002|Overall Study|Other|0
7820038|NCT01241591|12287544|FG003|Overall Study|Other|1
7820039|NCT01241591|12287541|FG000|Overall Study|Adverse Event|3
7820040|NCT01241591|12287542|FG001|Overall Study|Adverse Event|11
7820041|NCT01241591|12287543|FG002|Overall Study|Adverse Event|12
7820042|NCT01241591|12287544|FG003|Overall Study|Adverse Event|4
7820043|NCT01241604|12287554|FG000|Screening Period|Screen Failure|3
7912061|NCT02070380|12429868|FG003|Second Injection|Image sets missing or technically inadeq|0
7912062|NCT02070380|12429865|FG000|Second Injection|Protocol Violation|0
7912063|NCT02070380|12429866|FG001|Second Injection|Protocol Violation|1
7912064|NCT02070380|12429867|FG002|Second Injection|Protocol Violation|1
7912065|NCT02070380|12429868|FG003|Second Injection|Protocol Violation|5
7912066|NCT02070484|12429882|FG000|Overall Study|Withdrawal by Subject|1
7912067|NCT02070484|12429883|FG001|Overall Study|Withdrawal by Subject|0
7912068|NCT02070588|12429892|FG000|Overall Study|Withdrawal by Subject|29
7912069|NCT02070588|12429893|FG001|Overall Study|Withdrawal by Subject|1
7912070|NCT02070588|12429894|FG002|Overall Study|Withdrawal by Subject|0
7912071|NCT02070588|12429892|FG000|Overall Study|Writhdrawal due to early termination|9
7912072|NCT02070588|12429893|FG001|Overall Study|Writhdrawal due to early termination|0
7912073|NCT02070588|12429894|FG002|Overall Study|Writhdrawal due to early termination|0
7912074|NCT02070588|12429892|FG000|Overall Study|Adverse Event|1
7912075|NCT02070588|12429893|FG001|Overall Study|Adverse Event|0
7912076|NCT02070588|12429894|FG002|Overall Study|Adverse Event|0
7912077|NCT02070744|12429925|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0
7912078|NCT02070744|12429926|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0
7912079|NCT02070744|12429927|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0
7820044|NCT01241604|12287555|FG001|Screening Period|Screen Failure|0
7820045|NCT01241604|12287556|FG002|Screening Period|Screen Failure|0
7820046|NCT01241760|12287565|FG000|Overall Study|Adverse Event|1
7820047|NCT01241760|12287566|FG001|Overall Study|Adverse Event|0
7820048|NCT01241760|12287565|FG000|Overall Study|Lost to Follow-up|18
7820049|NCT01241760|12287566|FG001|Overall Study|Lost to Follow-up|22
7820050|NCT01241760|12287565|FG000|Overall Study|Withdrawal by Subject|13
7820051|NCT01241760|12287566|FG001|Overall Study|Withdrawal by Subject|13
7820052|NCT01241760|12287565|FG000|Overall Study|Switch To Commercially Available Medicat|1
7820053|NCT01241760|12287566|FG001|Overall Study|Switch To Commercially Available Medicat|4
7820054|NCT01241760|12287565|FG000|Overall Study|Other|1
7820055|NCT01241760|12287566|FG001|Overall Study|Other|1
7820056|NCT01242085|12287594|FG000|Overall Study|Withdrawal by Subject|4
7820057|NCT01242085|12287595|FG001|Overall Study|Withdrawal by Subject|2
7820058|NCT01242085|12287596|FG002|Overall Study|Withdrawal by Subject|0
7820059|NCT01242085|12287594|FG000|Overall Study|medically unable to have surgery|4
7820060|NCT01242085|12287595|FG001|Overall Study|medically unable to have surgery|5
7820061|NCT01242085|12287596|FG002|Overall Study|medically unable to have surgery|0
7820062|NCT01242111|12287602|FG000|Overall Study|Adverse Event|1
7820063|NCT01242111|12287602|FG000|Overall Study|Withdrawal by Subject|1
7820064|NCT01242111|12287602|FG000|Overall Study|Did not consent to MOR-100 follow-up|1
7820065|NCT01242176|12287606|FG000|Washout Period of 7 Days|Adverse Event|0
7820066|NCT01242176|12287607|FG001|Washout Period of 7 Days|Adverse Event|2
7820067|NCT01242176|12287606|FG000|Washout Period of 7 Days|Non-compliant with protocol|1
7820068|NCT01242176|12287607|FG001|Washout Period of 7 Days|Non-compliant with protocol|0
7820069|NCT01242371|12287624|FG000|Overall Study|Withdrawal by Subject|2
7820070|NCT01242371|12287625|FG001|Overall Study|Withdrawal by Subject|2
7820071|NCT01242371|12287624|FG000|Overall Study|Protocol Violation|0
7820072|NCT01242371|12287625|FG001|Overall Study|Protocol Violation|3
7820073|NCT01242514|12287634|FG000|Overall Study|e.g., project closure|1042
7820074|NCT01242514|12287635|FG001|Overall Study|e.g., project closure|305
7820075|NCT01242514|12287636|FG002|Overall Study|e.g., project closure|171
7820076|NCT01242514|12287634|FG000|Overall Study|Subject decision|33
7820077|NCT01242514|12287635|FG001|Overall Study|Subject decision|8
7820078|NCT01242514|12287636|FG002|Overall Study|Subject decision|2
7820079|NCT01242514|12287634|FG000|Overall Study|Severe non-compliance to protocol|5
7820080|NCT01242514|12287635|FG001|Overall Study|Severe non-compliance to protocol|2
7820081|NCT01242514|12287636|FG002|Overall Study|Severe non-compliance to protocol|1
7820082|NCT01242514|12287634|FG000|Overall Study|Lack of therapeutic response|99
7820083|NCT01242514|12287635|FG001|Overall Study|Lack of therapeutic response|16
7820084|NCT01242514|12287636|FG002|Overall Study|Lack of therapeutic response|10
7820085|NCT01242514|12287634|FG000|Overall Study|Dev. of study specific discont. criteria|21
7820086|NCT01242514|12287635|FG001|Overall Study|Dev. of study specific discont. criteria|3
7820087|NCT01242514|12287636|FG002|Overall Study|Dev. of study specific discont. criteria|5
7820088|NCT01242514|12287634|FG000|Overall Study|Lost to Follow-up|14
7820089|NCT01242514|12287635|FG001|Overall Study|Lost to Follow-up|5
7820090|NCT01242514|12287636|FG002|Overall Study|Lost to Follow-up|4
7820091|NCT01242514|12287634|FG000|Overall Study|Adverse Event|129
7820092|NCT01242514|12287635|FG001|Overall Study|Adverse Event|18
7820093|NCT01242514|12287636|FG002|Overall Study|Adverse Event|19
7820094|NCT01242748|12287676|FG000|Overall Study|Adverse Event|10
7820095|NCT01242748|12287677|FG001|Overall Study|Adverse Event|5
7820096|NCT01242748|12287676|FG000|Overall Study|Lost to Follow-up|6
7820097|NCT01242748|12287677|FG001|Overall Study|Lost to Follow-up|2
7820098|NCT01242748|12287676|FG000|Overall Study|Physician Decision|3
7820099|NCT01242748|12287677|FG001|Overall Study|Physician Decision|2
7820100|NCT01242748|12287676|FG000|Overall Study|Protocol Violation|1
7820101|NCT01242748|12287677|FG001|Overall Study|Protocol Violation|0
7820102|NCT01242748|12287676|FG000|Overall Study|Withdrawal by Subject|10
7820103|NCT01242748|12287677|FG001|Overall Study|Withdrawal by Subject|2
7820104|NCT01242748|12287676|FG000|Overall Study|Miscellaneous reasons|8
7820105|NCT01242748|12287677|FG001|Overall Study|Miscellaneous reasons|3
7820106|NCT01242813|12287683|FG000|Overall Study|Lost to Follow-up|2
7820107|NCT01243151|12287696|FG000|Overall Study|Adverse Event|0
7820108|NCT01243151|12287697|FG001|Overall Study|Adverse Event|1
7820109|NCT01243151|12287698|FG002|Overall Study|Adverse Event|0
7820110|NCT01243151|12287699|FG003|Overall Study|Adverse Event|0
7820111|NCT01243151|12287700|FG004|Overall Study|Adverse Event|0
7912080|NCT02070744|12429928|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1
7820112|NCT01243151|12287696|FG000|Overall Study|Protocol Violation|0
7820113|NCT01243151|12287697|FG001|Overall Study|Protocol Violation|0
7820114|NCT01243151|12287698|FG002|Overall Study|Protocol Violation|1
7820115|NCT01243151|12287699|FG003|Overall Study|Protocol Violation|0
7820116|NCT01243151|12287700|FG004|Overall Study|Protocol Violation|0
7820117|NCT01243151|12287696|FG000|Overall Study|Other|0
7912081|NCT02070744|12429929|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0
7912082|NCT02070744|12429925|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7912083|NCT02070744|12429926|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7912084|NCT02070744|12429927|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7912085|NCT02070744|12429928|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7912086|NCT02070744|12429929|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2
7912087|NCT02070744|12429925|FG000|OLE Phase (48 Weeks)|Other|0
7912088|NCT02070744|12429926|FG001|OLE Phase (48 Weeks)|Other|0
7912089|NCT02070744|12429927|FG002|OLE Phase (48 Weeks)|Other|0
7820118|NCT01243151|12287697|FG001|Overall Study|Other|0
7820119|NCT01243151|12287698|FG002|Overall Study|Other|0
7820120|NCT01243151|12287699|FG003|Overall Study|Other|1
7820121|NCT01243151|12287700|FG004|Overall Study|Other|0
7820122|NCT01243151|12287696|FG000|Overall Study|Randomized but not treated|0
7820123|NCT01243151|12287697|FG001|Overall Study|Randomized but not treated|0
7820124|NCT01243151|12287698|FG002|Overall Study|Randomized but not treated|0
7820125|NCT01243151|12287699|FG003|Overall Study|Randomized but not treated|1
7820126|NCT01243151|12287700|FG004|Overall Study|Randomized but not treated|0
7820127|NCT01243177|12287718|FG000|Overall Study|Lack of Efficacy|47
7820128|NCT01243177|12287719|FG001|Overall Study|Lack of Efficacy|31
7820129|NCT01243177|12287718|FG000|Overall Study|Protocol Violation|11
7820130|NCT01243177|12287719|FG001|Overall Study|Protocol Violation|10
7820131|NCT01243177|12287718|FG000|Overall Study|Lost to Follow-up|15
7820132|NCT01243177|12287719|FG001|Overall Study|Lost to Follow-up|18
7820133|NCT01243177|12287718|FG000|Overall Study|Withdrawal by Subject|46
7820134|NCT01243177|12287719|FG001|Overall Study|Withdrawal by Subject|38
7820135|NCT01243177|12287718|FG000|Overall Study|AE, serious fatal|0
7820136|NCT01243177|12287719|FG001|Overall Study|AE, serious fatal|1
7820137|NCT01243177|12287718|FG000|Overall Study|SAE, non-fatal|7
7820138|NCT01243177|12287719|FG001|Overall Study|SAE, non-fatal|9
7820139|NCT01243177|12287718|FG000|Overall Study|AE, non-serious non-fatal|40
7820140|NCT01243177|12287719|FG001|Overall Study|AE, non-serious non-fatal|58
7820141|NCT01243177|12287718|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1
7820142|NCT01243177|12287719|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0
7820143|NCT01243177|12287718|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7820144|NCT01243177|12287719|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
7820145|NCT01243177|12287718|FG000|Overall Study|Other Reason|11
7820146|NCT01243177|12287719|FG001|Overall Study|Other Reason|12
7820147|NCT01243242|12287727|FG000|Overall Study|Adverse Event|1
7820148|NCT01243242|12287728|FG001|Overall Study|Adverse Event|1
7820149|NCT01243242|12287727|FG000|Overall Study|Withdrawal by Subject|1
7820150|NCT01243242|12287728|FG001|Overall Study|Withdrawal by Subject|1
7820151|NCT01243242|12287727|FG000|Overall Study|Physician Decision|0
7820152|NCT01243242|12287728|FG001|Overall Study|Physician Decision|1
7820153|NCT01243242|12287727|FG000|Overall Study|sponsor decision|0
7820154|NCT01243242|12287728|FG001|Overall Study|sponsor decision|1
7820155|NCT01243242|12287727|FG000|Overall Study|non compliance|1
7820156|NCT01243242|12287728|FG001|Overall Study|non compliance|0
7820157|NCT01243268|12287734|FG000|Overall Study|Lost to Follow-up|4
7820158|NCT01243268|12287734|FG000|Overall Study|Protocol Violation|51
7820159|NCT01243268|12287734|FG000|Overall Study|Deviation with contract date|7
7820160|NCT01243268|12287734|FG000|Overall Study|Duplicate subject|2
7820161|NCT01243411|12287755|FG000|Overall Study|Withdrawal by Subject|18
7820162|NCT01243411|12287755|FG000|Overall Study|Lost to Follow-up|10
7820163|NCT01243411|12287755|FG000|Overall Study|Adverse Event|5
7820164|NCT01243411|12287755|FG000|Overall Study|Other|8
7820165|NCT01243424|12287761|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49
7820166|NCT01243424|12287762|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37
7820167|NCT01243424|12287761|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14
7820168|NCT01243424|12287762|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12
7820169|NCT01243424|12287761|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15
7820170|NCT01243424|12287762|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22
7820171|NCT01243424|12287761|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0
7820172|NCT01243424|12287762|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1
7820173|NCT01243424|12287761|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38
7820174|NCT01243424|12287762|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35
7820175|NCT01243424|12287761|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
7820176|NCT01243424|12287762|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
7820177|NCT01243424|12287761|FG000|Discontinuation From Study (Treated Set)|Not treated|5
7820178|NCT01243424|12287762|FG001|Discontinuation From Study (Treated Set)|Not treated|4
7820179|NCT01243424|12287761|FG000|Discontinuation From Treatment|Not treated|5
7820180|NCT01243424|12287762|FG001|Discontinuation From Treatment|Not treated|4
7820181|NCT01243424|12287761|FG000|Discontinuation From Treatment|Adverse Event|457
7820182|NCT01243424|12287762|FG001|Discontinuation From Treatment|Adverse Event|523
7820183|NCT01243424|12287761|FG000|Discontinuation From Treatment|Lack of Efficacy|61
7820184|NCT01243424|12287762|FG001|Discontinuation From Treatment|Lack of Efficacy|41
7820185|NCT01243424|12287761|FG000|Discontinuation From Treatment|Protocol Violation|46
7820186|NCT01243424|12287762|FG001|Discontinuation From Treatment|Protocol Violation|47
7820187|NCT01243424|12287761|FG000|Discontinuation From Treatment|Lost to Follow-up|24
7820188|NCT01243424|12287762|FG001|Discontinuation From Treatment|Lost to Follow-up|28
7820189|NCT01243424|12287761|FG000|Discontinuation From Treatment|Withdrawal by Subject|309
7820190|NCT01243424|12287762|FG001|Discontinuation From Treatment|Withdrawal by Subject|328
7820191|NCT01243424|12287761|FG000|Discontinuation From Treatment|Other than listed above|230
7820192|NCT01243424|12287762|FG001|Discontinuation From Treatment|Other than listed above|211
7820193|NCT01243671|12287815|FG000|Overall Study|Adverse Event|3
7820194|NCT01243671|12287815|FG000|Overall Study|Anti-adalimumab antibody positive|1
7820195|NCT01243671|12287815|FG000|Overall Study|Other|1
7820196|NCT01243762|12287826|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0
7820197|NCT01243762|12287827|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2
7820198|NCT01243762|12287828|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0
7820199|NCT01243762|12287829|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0
7820200|NCT01243762|12287830|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1
7820201|NCT01243762|12287831|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1
7820202|NCT01243762|12287832|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0
7820203|NCT01243762|12287826|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0
7820204|NCT01243762|12287827|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1
7820205|NCT01243762|12287828|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0
7820206|NCT01243762|12287829|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1
7820207|NCT01243762|12287830|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0
7820208|NCT01243762|12287831|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0
7820209|NCT01243762|12287832|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0
7820210|NCT01243762|12287826|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
7820211|NCT01243762|12287827|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
7820212|NCT01243762|12287828|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
7820213|NCT01243762|12287829|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
7820214|NCT01243762|12287830|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
7820215|NCT01243762|12287831|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
7820216|NCT01243762|12287832|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
7820217|NCT01243762|12287826|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7820218|NCT01243762|12287827|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
7820219|NCT01243762|12287828|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7820220|NCT01243762|12287829|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7820221|NCT01243762|12287830|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7820222|NCT01243762|12287831|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7820223|NCT01243762|12287832|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7820224|NCT01243762|12287826|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
7820225|NCT01243762|12287827|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
7820226|NCT01243762|12287828|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
7820227|NCT01243762|12287829|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
7820228|NCT01243762|12287830|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
7820229|NCT01243762|12287831|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
7820230|NCT01243762|12287832|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
7820231|NCT01243762|12287826|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
7820232|NCT01243762|12287827|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
7820233|NCT01243762|12287828|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
7820234|NCT01243762|12287829|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
7820235|NCT01243762|12287830|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
7820236|NCT01243762|12287831|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
7820237|NCT01243762|12287832|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
7820238|NCT01243762|12287826|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
7820239|NCT01243762|12287827|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
7820240|NCT01243762|12287828|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
7820241|NCT01243762|12287829|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
7820242|NCT01243762|12287830|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
7820243|NCT01243762|12287831|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
7820244|NCT01243762|12287832|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
7820245|NCT01243762|12287826|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
7820246|NCT01243762|12287827|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
7820247|NCT01243762|12287828|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
7820248|NCT01243762|12287829|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
7820249|NCT01243762|12287830|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
7820250|NCT01243762|12287831|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
7820251|NCT01243762|12287832|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
7820252|NCT01243775|12287851|FG000|Overall Study|Withdrawal by Subject|2
7820253|NCT01243944|12287857|FG000|Overall Study|Adverse Event|15
7820254|NCT01243944|12287858|FG001|Overall Study|Adverse Event|13
7820255|NCT01243944|12287857|FG000|Overall Study|Lost to Follow-up|2
7820256|NCT01243944|12287858|FG001|Overall Study|Lost to Follow-up|1
7820257|NCT01243944|12287857|FG000|Overall Study|Physician Decision|2
7820258|NCT01243944|12287858|FG001|Overall Study|Physician Decision|7
7820259|NCT01243944|12287857|FG000|Overall Study|Disease progression|12
7820260|NCT01243944|12287858|FG001|Overall Study|Disease progression|11
7820261|NCT01243944|12287857|FG000|Overall Study|Protocol deviation|1
7820262|NCT01243944|12287858|FG001|Overall Study|Protocol deviation|1
7820263|NCT01243944|12287857|FG000|Overall Study|Participant decision|10
7820264|NCT01243944|12287858|FG001|Overall Study|Participant decision|15
7820265|NCT01243944|12287857|FG000|Overall Study|Death|2
7820266|NCT01243944|12287858|FG001|Overall Study|Death|3
7820267|NCT01243944|12287857|FG000|Overall Study|Non-compliance with study treatment|1
7820268|NCT01243944|12287858|FG001|Overall Study|Non-compliance with study treatment|0
7820269|NCT01244035|12287871|FG000|Part 1: Period 1|Adverse Event|0
7820270|NCT01244035|12287872|FG001|Part 1: Period 1|Adverse Event|0
7820271|NCT01244035|12287873|FG002|Part 1: Period 1|Adverse Event|0
7820272|NCT01244035|12287874|FG003|Part 1: Period 1|Adverse Event|0
7820273|NCT01244035|12287875|FG004|Part 1: Period 1|Adverse Event|0
7820274|NCT01244035|12287876|FG005|Part 1: Period 1|Adverse Event|1
7912090|NCT02070744|12429928|FG003|OLE Phase (48 Weeks)|Other|0
7912091|NCT02070744|12429929|FG004|OLE Phase (48 Weeks)|Other|1
7912092|NCT02070757|12429946|FG000|Overall Study|Adverse Event|107
7912093|NCT02070757|12429947|FG001|Overall Study|Adverse Event|99
7912094|NCT02070757|12429946|FG000|Overall Study|Lost to Follow-up|7
7912095|NCT02070757|12429947|FG001|Overall Study|Lost to Follow-up|4
7912096|NCT02070757|12429946|FG000|Overall Study|Protocol Violation|0
7912097|NCT02070757|12429947|FG001|Overall Study|Protocol Violation|4
7912098|NCT02070757|12429946|FG000|Overall Study|Withdrawal by Subject|1
7912099|NCT02070757|12429947|FG001|Overall Study|Withdrawal by Subject|3
7912100|NCT02070757|12429946|FG000|Overall Study|Investigator Decision|0
7912101|NCT02070757|12429947|FG001|Overall Study|Investigator Decision|2
7912102|NCT02070757|12429946|FG000|Overall Study|Discharged from Study Hospital|2
7912103|NCT02070757|12429947|FG001|Overall Study|Discharged from Study Hospital|2
7912104|NCT02070965|12429956|FG000|Overall Study|Lost to Follow-up|0
7912105|NCT02070965|12429957|FG001|Overall Study|Lost to Follow-up|1
7912106|NCT02070965|12429958|FG002|Overall Study|Lost to Follow-up|0
7912107|NCT02070965|12429956|FG000|Overall Study|Withdrawal by Subject|1
7912108|NCT02070965|12429957|FG001|Overall Study|Withdrawal by Subject|1
7912109|NCT02070965|12429958|FG002|Overall Study|Withdrawal by Subject|1
7912110|NCT02070965|12429956|FG000|Overall Study|Subject moved|1
7912111|NCT02070965|12429957|FG001|Overall Study|Subject moved|0
7912112|NCT02070965|12429958|FG002|Overall Study|Subject moved|0
7912113|NCT02070978|12429969|FG000|Overall Study|Adverse Event|6
7912114|NCT02070978|12429970|FG001|Overall Study|Adverse Event|2
7912115|NCT02070978|12429971|FG002|Overall Study|Adverse Event|0
7912116|NCT02070978|12429969|FG000|Overall Study|Lost to Follow-up|1
7912117|NCT02070978|12429970|FG001|Overall Study|Lost to Follow-up|3
7912118|NCT02070978|12429971|FG002|Overall Study|Lost to Follow-up|4
7912119|NCT02070978|12429969|FG000|Overall Study|Withdrawal by Subject|3
7912120|NCT02070978|12429970|FG001|Overall Study|Withdrawal by Subject|5
7912121|NCT02070978|12429971|FG002|Overall Study|Withdrawal by Subject|3
7912122|NCT02070978|12429969|FG000|Overall Study|Protocol Violation|1
7912123|NCT02070978|12429970|FG001|Overall Study|Protocol Violation|0
7912124|NCT02070978|12429971|FG002|Overall Study|Protocol Violation|3
7912125|NCT02070978|12429969|FG000|Overall Study|Lack of Efficacy|0
7912126|NCT02070978|12429970|FG001|Overall Study|Lack of Efficacy|1
7912127|NCT02070978|12429971|FG002|Overall Study|Lack of Efficacy|0
7912128|NCT02070978|12429969|FG000|Overall Study|Death|0
7912129|NCT02070978|12429970|FG001|Overall Study|Death|0
7912130|NCT02070978|12429971|FG002|Overall Study|Death|2
7912131|NCT02070978|12429969|FG000|Overall Study|Un-specified|3
7912132|NCT02070978|12429970|FG001|Overall Study|Un-specified|2
7912133|NCT02070978|12429971|FG002|Overall Study|Un-specified|2
7912134|NCT02070978|12429969|FG000|Overall Study|Terminated by Sponsor|33
7912135|NCT02070978|12429970|FG001|Overall Study|Terminated by Sponsor|40
7912136|NCT02070978|12429971|FG002|Overall Study|Terminated by Sponsor|39
7912137|NCT02070991|12429981|FG000|Overall Study|Death|2
7912138|NCT02070991|12429982|FG001|Overall Study|Death|0
7912139|NCT02070991|12429981|FG000|Overall Study|Withdrawal by Subject|1
7912140|NCT02070991|12429982|FG001|Overall Study|Withdrawal by Subject|0
7912141|NCT02071082|12429990|FG000|Overall Study|Enrolled and Never Treated|1
7820275|NCT01244035|12287871|FG000|Part 1: Period 1|Withdrawal by Subject|0
7820276|NCT01244035|12287872|FG001|Part 1: Period 1|Withdrawal by Subject|2
7820277|NCT01244035|12287873|FG002|Part 1: Period 1|Withdrawal by Subject|0
7820278|NCT01244035|12287874|FG003|Part 1: Period 1|Withdrawal by Subject|0
7820279|NCT01244035|12287875|FG004|Part 1: Period 1|Withdrawal by Subject|0
7719420|NCT00532155|12143398|FG001|Overall Study|Withdrawal by Subject|44
7719421|NCT00532155|12143397|FG000|Overall Study|Consent withdrawn|5
7719422|NCT00532155|12143398|FG001|Overall Study|Consent withdrawn|7
7719423|NCT00532155|12143397|FG000|Overall Study|Moved|1
7719424|NCT00532155|12143398|FG001|Overall Study|Moved|0
7719425|NCT00532155|12143397|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1
7719426|NCT00532155|12143398|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0
7719427|NCT00532155|12143397|FG000|Overall Study|Occurence of a second cancer|0
7820280|NCT01244035|12287876|FG005|Part 1: Period 1|Withdrawal by Subject|0
7820281|NCT01244035|12287871|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1
7820282|NCT01244035|12287872|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0
7820283|NCT01244035|12287873|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2
7820284|NCT01244035|12287874|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0
7820285|NCT01244035|12287875|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1
7820286|NCT01244035|12287876|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1
7820287|NCT01244035|12287871|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0
7820288|NCT01244035|12287872|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0
7820289|NCT01244035|12287873|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1
7820290|NCT01244035|12287874|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0
7820291|NCT01244035|12287875|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0
7820292|NCT01244035|12287876|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0
7820293|NCT01244035|12287871|FG000|Part 1: Period 3|Adverse Event|0
7820294|NCT01244035|12287872|FG001|Part 1: Period 3|Adverse Event|0
7820295|NCT01244035|12287873|FG002|Part 1: Period 3|Adverse Event|0
7820296|NCT01244035|12287874|FG003|Part 1: Period 3|Adverse Event|0
7820297|NCT01244035|12287875|FG004|Part 1: Period 3|Adverse Event|0
7820298|NCT01244035|12287876|FG005|Part 1: Period 3|Adverse Event|1
7719428|NCT00532155|12143398|FG001|Overall Study|Occurence of a second cancer|1
7820299|NCT01244035|12287871|FG000|Part 1: Period 3|Withdrawal by Subject|0
7820300|NCT01244035|12287872|FG001|Part 1: Period 3|Withdrawal by Subject|0
7820301|NCT01244035|12287873|FG002|Part 1: Period 3|Withdrawal by Subject|0
7820302|NCT01244035|12287874|FG003|Part 1: Period 3|Withdrawal by Subject|0
7820303|NCT01244035|12287875|FG004|Part 1: Period 3|Withdrawal by Subject|1
7719429|NCT00532155|12143397|FG000|Overall Study|Occurence of a secondary cancer|0
7719430|NCT00532155|12143398|FG001|Overall Study|Occurence of a secondary cancer|1
7912142|NCT02071082|12429991|FG001|Overall Study|Enrolled and Never Treated|1
7912143|NCT02071082|12429990|FG000|Overall Study|Adverse Event|0
7912144|NCT02071082|12429991|FG001|Overall Study|Adverse Event|1
7912145|NCT02071082|12429990|FG000|Overall Study|Withdrew Consent|0
7912146|NCT02071082|12429991|FG001|Overall Study|Withdrew Consent|4
7912147|NCT02071082|12429990|FG000|Overall Study|Lost to Follow-up|1
7912148|NCT02071082|12429991|FG001|Overall Study|Lost to Follow-up|1
7912149|NCT02071225|12430015|FG000|Overall Study|Withdrawal of Consent|2
7912150|NCT02071225|12430015|FG000|Overall Study|Protocol Deviation|1
7912151|NCT02071225|12430015|FG000|Overall Study|Lost to Follow-up|2
7912152|NCT02071225|12430015|FG000|Overall Study|Death|25
7912153|NCT02071290|12430021|FG000|Overall Study|Death|1
7912154|NCT02071290|12430022|FG001|Overall Study|Death|0
7912155|NCT02071290|12430021|FG000|Overall Study|Withdrawal by Subject|0
7912156|NCT02071290|12430022|FG001|Overall Study|Withdrawal by Subject|1
7912157|NCT02071290|12430021|FG000|Overall Study|Protocol Violation|3
7912158|NCT02071290|12430022|FG001|Overall Study|Protocol Violation|5
7912159|NCT02071290|12430021|FG000|Overall Study|Physician Decision|0
7912160|NCT02071290|12430022|FG001|Overall Study|Physician Decision|1
7912161|NCT02071706|12430037|FG000|Overall Study|Adverse Event|1
7912162|NCT02071706|12430037|FG000|Overall Study|Withdrawal by Subject|2
7912163|NCT02071771|12430041|FG000|Period 1: First 10 Days|Unacceptable lens fit|1
7912164|NCT02071771|12430042|FG001|Period 1: First 10 Days|Unacceptable lens fit|0
7912165|NCT02071771|12430041|FG000|Period 1: First 10 Days|Unavailable lens power|1
7912166|NCT02071771|12430042|FG001|Period 1: First 10 Days|Unavailable lens power|0
7912167|NCT02071849|12430080|FG000|6-month Primary Endpoint|Did not receive device|4
7912168|NCT02071849|12430080|FG000|6-month Primary Endpoint|Adverse Event|1
7912169|NCT02071849|12430080|FG000|2-year Extended Follow-up|Adverse Event|1
7912170|NCT02072096|12430099|FG000|Overall Study|Lack of Efficacy|18
7912171|NCT02072096|12430100|FG001|Overall Study|Lack of Efficacy|29
7912172|NCT02072096|12430099|FG000|Overall Study|Protocol Violation|7
7912173|NCT02072096|12430100|FG001|Overall Study|Protocol Violation|7
7912174|NCT02072096|12430099|FG000|Overall Study|Withdrawal by Subject|5
7912175|NCT02072096|12430100|FG001|Overall Study|Withdrawal by Subject|7
7912176|NCT02072096|12430099|FG000|Overall Study|Adverse Event|5
7912177|NCT02072096|12430100|FG001|Overall Study|Adverse Event|2
7912178|NCT02072096|12430099|FG000|Overall Study|No Reason Provided|4
7912179|NCT02072096|12430100|FG001|Overall Study|No Reason Provided|2
7912180|NCT02072096|12430099|FG000|Overall Study|Death|2
7912181|NCT02072096|12430100|FG001|Overall Study|Death|0
7912182|NCT02072096|12430099|FG000|Overall Study|Physician Decision|0
7912183|NCT02072096|12430100|FG001|Overall Study|Physician Decision|1
7912184|NCT02072096|12430099|FG000|Overall Study|Study Terminated by Sponsor|43
7912185|NCT02072096|12430100|FG001|Overall Study|Study Terminated by Sponsor|30
7912186|NCT02072096|12430099|FG000|Overall Study|Lost to Follow-up|1
7912187|NCT02072096|12430100|FG001|Overall Study|Lost to Follow-up|0
7912188|NCT02072174|12430109|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14
7912189|NCT02072174|12430110|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15
7912190|NCT02072174|12430109|FG000|Overall Study|Protocol Violation|16
7912191|NCT02072174|12430110|FG001|Overall Study|Protocol Violation|23
7912192|NCT02072174|12430109|FG000|Overall Study|Physician Decision|0
7820304|NCT01244035|12287876|FG005|Part 1: Period 3|Withdrawal by Subject|0
7820305|NCT01244035|12287871|FG000|Part 1: Period 3|Protocol Deviation|0
7820306|NCT01244035|12287872|FG001|Part 1: Period 3|Protocol Deviation|1
7820307|NCT01244035|12287873|FG002|Part 1: Period 3|Protocol Deviation|0
7820308|NCT01244035|12287874|FG003|Part 1: Period 3|Protocol Deviation|0
7820309|NCT01244035|12287875|FG004|Part 1: Period 3|Protocol Deviation|0
7820310|NCT01244035|12287876|FG005|Part 1: Period 3|Protocol Deviation|0
7820311|NCT01244061|12287898|FG000|Overall Study|Death|1
7820312|NCT01244061|12287899|FG001|Overall Study|Death|0
7820313|NCT01244061|12287898|FG000|Overall Study|Did not meet entrance criteria|1
7820314|NCT01244061|12287899|FG001|Overall Study|Did not meet entrance criteria|0
7820315|NCT01244061|12287898|FG000|Overall Study|Lack of Efficacy|1
7820316|NCT01244061|12287899|FG001|Overall Study|Lack of Efficacy|3
7820317|NCT01244061|12287898|FG000|Overall Study|Lost to Follow-up|34
7820318|NCT01244061|12287899|FG001|Overall Study|Lost to Follow-up|30
7820319|NCT01244061|12287898|FG000|Overall Study|Withdrawal by Subject|29
7820320|NCT01244061|12287899|FG001|Overall Study|Withdrawal by Subject|46
7820321|NCT01244061|12287898|FG000|Overall Study|Other|8
7912193|NCT02072174|12430110|FG001|Overall Study|Physician Decision|1
7912194|NCT02072174|12430109|FG000|Overall Study|Non-compliance with protocol requirement|2
7912195|NCT02072174|12430110|FG001|Overall Study|Non-compliance with protocol requirement|0
7912196|NCT02072226|12430124|FG000|Overall Study|Lost to Follow-up|11
7912197|NCT02072226|12430125|FG001|Overall Study|Lost to Follow-up|7
7912198|NCT02072226|12430124|FG000|Overall Study|Patient Non-compliance|2
7820322|NCT01244061|12287899|FG001|Overall Study|Other|19
7820323|NCT01244061|12287898|FG000|Overall Study|Protocol Violation|1
7820324|NCT01244061|12287899|FG001|Overall Study|Protocol Violation|1
7820325|NCT01244061|12287898|FG000|Overall Study|Adverse Event|5
7820326|NCT01244061|12287899|FG001|Overall Study|Adverse Event|2
7820327|NCT01244061|12287898|FG000|Overall Study|Randomized but not treated|2
7820328|NCT01244061|12287899|FG001|Overall Study|Randomized but not treated|2
7820329|NCT01244126|12287908|FG000|Overall Study|Protocol Violation|3
7820330|NCT01244126|12287909|FG001|Overall Study|Protocol Violation|3
7820331|NCT01244126|12287910|FG002|Overall Study|Protocol Violation|9
7820332|NCT01244191|12287920|FG000|Overall Study|Progressive disease|295
7820333|NCT01244191|12287921|FG001|Overall Study|Progressive disease|350
7820334|NCT01244191|12287920|FG000|Overall Study|Clinical disease progression|54
7820335|NCT01244191|12287921|FG001|Overall Study|Clinical disease progression|36
7820336|NCT01244191|12287920|FG000|Overall Study|Adverse Event|65
7820337|NCT01244191|12287921|FG001|Overall Study|Adverse Event|48
7820338|NCT01244191|12287920|FG000|Overall Study|Death|22
7820339|NCT01244191|12287921|FG001|Overall Study|Death|29
7820340|NCT01244191|12287920|FG000|Overall Study|Lost to Follow-up|0
7820341|NCT01244191|12287921|FG001|Overall Study|Lost to Follow-up|2
7820342|NCT01244191|12287920|FG000|Overall Study|Protocol Violation|1
7820343|NCT01244191|12287921|FG001|Overall Study|Protocol Violation|2
7820344|NCT01244191|12287920|FG000|Overall Study|Withdrawal by Subject|31
7820345|NCT01244191|12287921|FG001|Overall Study|Withdrawal by Subject|23
7820346|NCT01244191|12287920|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12
7820347|NCT01244191|12287921|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8
7820348|NCT01244425|12287937|FG000|Overall Study|Withdrawal by Subject|2
7820349|NCT01244425|12287938|FG001|Overall Study|Withdrawal by Subject|2
7820350|NCT01244425|12287937|FG000|Overall Study|Adverse Event|1
7820351|NCT01244425|12287938|FG001|Overall Study|Adverse Event|1
7820352|NCT01244490|12287971|FG000|Overall Study|Lack of Efficacy|14
7820353|NCT01244490|12287972|FG001|Overall Study|Lack of Efficacy|5
7820354|NCT01244490|12287973|FG002|Overall Study|Lack of Efficacy|5
7820355|NCT01244490|12287971|FG000|Overall Study|Withdrawal by Subject|4
7820356|NCT01244490|12287972|FG001|Overall Study|Withdrawal by Subject|4
7820357|NCT01244490|12287973|FG002|Overall Study|Withdrawal by Subject|9
7820358|NCT01244490|12287971|FG000|Overall Study|Adverse Event|1
7820359|NCT01244490|12287972|FG001|Overall Study|Adverse Event|9
7820360|NCT01244490|12287973|FG002|Overall Study|Adverse Event|5
7820361|NCT01244490|12287971|FG000|Overall Study|Lost to Follow-up|0
7820362|NCT01244490|12287972|FG001|Overall Study|Lost to Follow-up|6
7820363|NCT01244490|12287973|FG002|Overall Study|Lost to Follow-up|3
7820364|NCT01244490|12287971|FG000|Overall Study|Other|0
7820365|NCT01244490|12287972|FG001|Overall Study|Other|0
7820366|NCT01244490|12287973|FG002|Overall Study|Other|1
7820367|NCT01244516|12287988|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
7820368|NCT01244516|12287989|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
7820369|NCT01244516|12287990|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
7820370|NCT01244516|12287988|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
7820371|NCT01244516|12287989|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
7820372|NCT01244516|12287990|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
7820373|NCT01244516|12287988|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
7820374|NCT01244516|12287989|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
7820375|NCT01244516|12287990|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
7820376|NCT01244516|12287988|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2
7820377|NCT01244516|12287989|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0
7820378|NCT01244516|12287990|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0
7820379|NCT01244516|12287988|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
7820380|NCT01244516|12287989|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
7820381|NCT01244516|12287990|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
7820382|NCT01244516|12287988|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
7820383|NCT01244516|12287989|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
7820384|NCT01244516|12287990|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
7820385|NCT01244516|12287988|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
7820386|NCT01244516|12287989|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
7820387|NCT01244516|12287990|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
7862074|NCT01597245|12351206|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862075|NCT01597245|12351207|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862076|NCT01597245|12351208|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7862077|NCT01597245|12351188|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862078|NCT01597245|12351189|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862079|NCT01597245|12351190|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862080|NCT01597245|12351191|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862081|NCT01597245|12351192|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862082|NCT01597245|12351193|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862083|NCT01597245|12351194|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862084|NCT01597245|12351195|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862085|NCT01597245|12351196|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862086|NCT01597245|12351197|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862087|NCT01597245|12351198|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862088|NCT01597245|12351199|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862089|NCT01597245|12351200|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862090|NCT01597245|12351201|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862091|NCT01597245|12351202|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
7862092|NCT01597245|12351203|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
7862093|NCT01597245|12351204|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862094|NCT01597245|12351205|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862095|NCT01597245|12351206|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862096|NCT01597245|12351207|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862097|NCT01597245|12351208|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7862098|NCT01597245|12351188|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862099|NCT01597245|12351189|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862100|NCT01597245|12351190|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862101|NCT01597245|12351191|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862102|NCT01597245|12351192|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862103|NCT01597245|12351193|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862104|NCT01597245|12351194|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862105|NCT01597245|12351195|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862106|NCT01597245|12351196|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862107|NCT01597245|12351197|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862108|NCT01597245|12351198|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862109|NCT01597245|12351199|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862110|NCT01597245|12351200|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862111|NCT01597245|12351201|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862112|NCT01597245|12351202|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
7862113|NCT01597245|12351203|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
7820388|NCT01244893|12288027|FG000|Baseline|Protocol Violation|0
7820389|NCT01244893|12288028|FG001|Baseline|Protocol Violation|1
7820390|NCT01244893|12288027|FG000|1-Week Follow Up|Lost to Follow-up|1
7820391|NCT01244893|12288028|FG001|1-Week Follow Up|Lost to Follow-up|0
7820392|NCT01244906|12288039|FG000|Overall Study|Death|2
7820393|NCT01244906|12288039|FG000|Overall Study|Progression of disease post treatment|6
7820394|NCT01244984|12288046|FG000|Overall Study|Adverse Event|2
7820395|NCT01244984|12288047|FG001|Overall Study|Adverse Event|11
7820396|NCT01244984|12288048|FG002|Overall Study|Adverse Event|2
7820397|NCT01244984|12288046|FG000|Overall Study|Protocol Violation|1
7820398|NCT01244984|12288047|FG001|Overall Study|Protocol Violation|0
7820399|NCT01244984|12288048|FG002|Overall Study|Protocol Violation|0
7820400|NCT01244984|12288046|FG000|Overall Study|Protocol Defined Stopping Criteria|1
7820401|NCT01244984|12288047|FG001|Overall Study|Protocol Defined Stopping Criteria|1
7820402|NCT01244984|12288048|FG002|Overall Study|Protocol Defined Stopping Criteria|0
7820403|NCT01244984|12288046|FG000|Overall Study|Withdrawal by Subject|1
7820404|NCT01244984|12288047|FG001|Overall Study|Withdrawal by Subject|2
7820405|NCT01244984|12288048|FG002|Overall Study|Withdrawal by Subject|2
7820406|NCT01245049|12288059|FG000|Overall Study|Migrated/moved from study area|0
7820407|NCT01245049|12288060|FG001|Overall Study|Migrated/moved from study area|1
7820408|NCT01245049|12288059|FG000|Overall Study|Withdrawal by Subject|0
7820409|NCT01245049|12288060|FG001|Overall Study|Withdrawal by Subject|1
7820410|NCT01245049|12288059|FG000|Overall Study|Lost to Follow-up|1
7820411|NCT01245049|12288060|FG001|Overall Study|Lost to Follow-up|2
7820412|NCT01245062|12288068|FG000|Randomization and Crossover Phase|Lost to Follow-up|4
7820413|NCT01245062|12288069|FG001|Randomization and Crossover Phase|Lost to Follow-up|2
7820414|NCT01245062|12288070|FG002|Randomization and Crossover Phase|Lost to Follow-up|0
7820415|NCT01245062|12288068|FG000|Randomization and Crossover Phase|Physician Decision|2
7820416|NCT01245062|12288069|FG001|Randomization and Crossover Phase|Physician Decision|4
7820417|NCT01245062|12288070|FG002|Randomization and Crossover Phase|Physician Decision|0
7820418|NCT01245062|12288068|FG000|Randomization and Crossover Phase|Withdrew Consent|12
7820419|NCT01245062|12288069|FG001|Randomization and Crossover Phase|Withdrew Consent|11
7820420|NCT01245062|12288070|FG002|Randomization and Crossover Phase|Withdrew Consent|0
7820421|NCT01245062|12288068|FG000|Randomization and Crossover Phase|Study closed/ terminated|23
7820422|NCT01245062|12288069|FG001|Randomization and Crossover Phase|Study closed/ terminated|14
7820423|NCT01245062|12288070|FG002|Randomization and Crossover Phase|Study closed/ terminated|0
7820424|NCT01245062|12288068|FG000|Cross-over Phase|Lost to Follow-up|0
7820425|NCT01245062|12288069|FG001|Cross-over Phase|Lost to Follow-up|0
7820426|NCT01245062|12288070|FG002|Cross-over Phase|Lost to Follow-up|1
7820427|NCT01245062|12288068|FG000|Cross-over Phase|Physician Decision|0
7820428|NCT01245062|12288069|FG001|Cross-over Phase|Physician Decision|0
7820429|NCT01245062|12288070|FG002|Cross-over Phase|Physician Decision|1
7820430|NCT01245062|12288068|FG000|Cross-over Phase|Withdrew Consent|0
7820431|NCT01245062|12288069|FG001|Cross-over Phase|Withdrew Consent|0
7820432|NCT01245062|12288070|FG002|Cross-over Phase|Withdrew Consent|4
7820433|NCT01245062|12288068|FG000|Cross-over Phase|Study closed/ terminated|0
7820434|NCT01245062|12288069|FG001|Cross-over Phase|Study closed/ terminated|0
7820435|NCT01245062|12288070|FG002|Cross-over Phase|Study closed/ terminated|11
7820436|NCT01245101|12288080|FG000|Period 1 (Treatment)|Withdrawal by Subject|2
7820437|NCT01245101|12288081|FG001|Period 1 (Treatment)|Withdrawal by Subject|0
7820438|NCT01245101|12288080|FG000|Period 2 (Washout)|Withdrawal by Subject|1
7820439|NCT01245101|12288081|FG001|Period 2 (Washout)|Withdrawal by Subject|0
7912199|NCT02072226|12430125|FG001|Overall Study|Patient Non-compliance|3
7912200|NCT02072226|12430124|FG000|Overall Study|Death|1
7912201|NCT02072226|12430125|FG001|Overall Study|Death|0
7912202|NCT02072226|12430124|FG000|Overall Study|Patient Withdrawal of Consent|1
7912203|NCT02072226|12430125|FG001|Overall Study|Patient Withdrawal of Consent|0
7719431|NCT00532155|12143397|FG000|Overall Study|Promotor ended study|1
7912204|NCT02072434|12430138|FG000|Overall Study|Protocol Violation|10
7912205|NCT02072434|12430139|FG001|Overall Study|Protocol Violation|9
7912206|NCT02072434|12430138|FG000|Overall Study|Physician Decision|5
7912207|NCT02072434|12430139|FG001|Overall Study|Physician Decision|10
7719432|NCT00532155|12143398|FG001|Overall Study|Promotor ended study|0
7719433|NCT00532155|12143397|FG000|Overall Study|Progressive disease (by incorrect scan)|0
7820440|NCT01245101|12288080|FG000|Period 3 (Treatment)|Withdrawal by Subject|1
7820441|NCT01245101|12288081|FG001|Period 3 (Treatment)|Withdrawal by Subject|0
7820442|NCT01245140|12288089|FG000|Overall Study|Adverse Event|1
7820443|NCT01245140|12288090|FG001|Overall Study|Adverse Event|3
7820444|NCT01245140|12288089|FG000|Overall Study|Lack of Efficacy|2
7820445|NCT01245140|12288090|FG001|Overall Study|Lack of Efficacy|4
7820446|NCT01245140|12288089|FG000|Overall Study|Protocol Violation|0
7820447|NCT01245140|12288090|FG001|Overall Study|Protocol Violation|1
7820448|NCT01245140|12288089|FG000|Overall Study|Withdrawal by Subject|0
7820449|NCT01245140|12288090|FG001|Overall Study|Withdrawal by Subject|1
7820450|NCT01245140|12288089|FG000|Overall Study|Refused Treatment/Did Not Coopera|0
7820451|NCT01245140|12288090|FG001|Overall Study|Refused Treatment/Did Not Coopera|1
7820452|NCT01245283|12288110|FG000|Overall Study|Lost to Follow-up|14
7820453|NCT01245283|12288111|FG001|Overall Study|Lost to Follow-up|11
7820454|NCT01245283|12288112|FG002|Overall Study|Lost to Follow-up|11
7820455|NCT01245374|12288123|FG000|Overall Study|Protocol Violation|1
7820456|NCT01245374|12288123|FG000|Overall Study|Withdrawal by Subject|3
7820457|NCT01245387|12288128|FG000|Overall Study|Lost to Follow-up|106
7820458|NCT01245387|12288128|FG000|Overall Study|Lack of Efficacy|195
7820459|NCT01245387|12288128|FG000|Overall Study|Adverse Event|9
7820460|NCT01245387|12288128|FG000|Overall Study|Death|3
7820461|NCT01245387|12288128|FG000|Overall Study|Other|131
7820462|NCT01245387|12288128|FG000|Overall Study|Missing discontinuation status|369
7820463|NCT01245673|12288163|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1
7820464|NCT01245751|12288185|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2
7820465|NCT01245751|12288186|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1
7820466|NCT01245751|12288187|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0
7820467|NCT01245751|12288188|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0
7820468|NCT01245751|12288185|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
7820469|NCT01245751|12288186|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
7820470|NCT01245751|12288187|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
7820471|NCT01245751|12288188|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
7820472|NCT01245751|12288185|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
7820473|NCT01245751|12288186|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
7820474|NCT01245751|12288187|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
7820475|NCT01245751|12288188|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
7820476|NCT01245764|12288203|FG000|Study Phase A|Other|3
7820477|NCT01245764|12288204|FG001|Study Phase A|Other|2
7820478|NCT01245764|12288205|FG002|Study Phase A|Other|3
7820479|NCT01245764|12288206|FG003|Study Phase A|Other|1
7820480|NCT01245764|12288203|FG000|Study Phase A|Protocol Violation|6
7820481|NCT01245764|12288204|FG001|Study Phase A|Protocol Violation|3
7820482|NCT01245764|12288205|FG002|Study Phase A|Protocol Violation|2
7820483|NCT01245764|12288206|FG003|Study Phase A|Protocol Violation|2
7820484|NCT01245764|12288203|FG000|Study Phase A|Lost to Follow-up|0
7820485|NCT01245764|12288204|FG001|Study Phase A|Lost to Follow-up|0
7820486|NCT01245764|12288205|FG002|Study Phase A|Lost to Follow-up|5
7820487|NCT01245764|12288206|FG003|Study Phase A|Lost to Follow-up|0
7820488|NCT01246206|12288279|FG000|Overall Study|Patient did not receive study regiments.|1
7820489|NCT01246466|12288308|FG000|Overall Study|Death|1
7820490|NCT01246466|12288308|FG000|Overall Study|Withdrawal by Subject|1
7820491|NCT01246583|12288321|FG000|Overall Study|Lost to Follow-up|0
7820492|NCT01246583|12288322|FG001|Overall Study|Lost to Follow-up|0
7820493|NCT01246583|12288323|FG002|Overall Study|Lost to Follow-up|0
7820494|NCT01246583|12288324|FG003|Overall Study|Lost to Follow-up|1
7820495|NCT01246583|12288321|FG000|Overall Study|Protocol Violation|0
7820496|NCT01246583|12288322|FG001|Overall Study|Protocol Violation|0
7820497|NCT01246583|12288323|FG002|Overall Study|Protocol Violation|1
7820498|NCT01246583|12288324|FG003|Overall Study|Protocol Violation|0
7820499|NCT01246583|12288321|FG000|Overall Study|Withdrawal by Subject|1
7820500|NCT01246583|12288322|FG001|Overall Study|Withdrawal by Subject|0
7820501|NCT01246583|12288323|FG002|Overall Study|Withdrawal by Subject|0
7820502|NCT01246583|12288324|FG003|Overall Study|Withdrawal by Subject|0
7820503|NCT01246960|12288359|FG000|Overall Study|Lost to Follow-up|3
7820504|NCT01246960|12288360|FG001|Overall Study|Lost to Follow-up|1
7820505|NCT01246960|12288359|FG000|Overall Study|Withdrawal (by participant or physician)|3
7820506|NCT01246960|12288360|FG001|Overall Study|Withdrawal (by participant or physician)|3
7820507|NCT01246973|12288368|FG000|Overall Study|Other|38
7820508|NCT01246973|12288369|FG001|Overall Study|Other|25
7820509|NCT01246973|12288368|FG000|Overall Study|Adverse Event|16
7820510|NCT01246973|12288369|FG001|Overall Study|Adverse Event|9
7820511|NCT01246973|12288368|FG000|Overall Study|Withdrawal by Subject|7
7820512|NCT01246973|12288369|FG001|Overall Study|Withdrawal by Subject|13
7820513|NCT01246986|12288382|FG000|Overall Study|Lost to Follow-up|0
7820514|NCT01246986|12288383|FG001|Overall Study|Lost to Follow-up|1
7820515|NCT01246986|12288384|FG002|Overall Study|Lost to Follow-up|3
7820516|NCT01246986|12288385|FG003|Overall Study|Lost to Follow-up|0
7820517|NCT01246986|12288386|FG004|Overall Study|Lost to Follow-up|0
7820518|NCT01246986|12288387|FG005|Overall Study|Lost to Follow-up|1
7820519|NCT01246986|12288388|FG006|Overall Study|Lost to Follow-up|0
7820520|NCT01246986|12288382|FG000|Overall Study|Withdrawal by Subject|3
7820521|NCT01246986|12288383|FG001|Overall Study|Withdrawal by Subject|4
7820522|NCT01246986|12288384|FG002|Overall Study|Withdrawal by Subject|3
7820523|NCT01246986|12288385|FG003|Overall Study|Withdrawal by Subject|0
7820524|NCT01246986|12288386|FG004|Overall Study|Withdrawal by Subject|4
7820525|NCT01246986|12288387|FG005|Overall Study|Withdrawal by Subject|0
7820526|NCT01246986|12288388|FG006|Overall Study|Withdrawal by Subject|0
7820527|NCT01246999|12288423|FG000|Overall Study|Lost to Follow-up|0
7820528|NCT01246999|12288424|FG001|Overall Study|Lost to Follow-up|1
7820529|NCT01246999|12288425|FG002|Overall Study|Lost to Follow-up|0
7820530|NCT01246999|12288426|FG003|Overall Study|Lost to Follow-up|0
7820531|NCT01246999|12288423|FG000|Overall Study|Withdrawal by Subject|0
7820532|NCT01246999|12288424|FG001|Overall Study|Withdrawal by Subject|0
7820533|NCT01246999|12288425|FG002|Overall Study|Withdrawal by Subject|0
7820534|NCT01246999|12288426|FG003|Overall Study|Withdrawal by Subject|2
7820535|NCT01247090|12288451|FG000|Overall Study|Physician Decision|1
7820536|NCT01247090|12288452|FG001|Overall Study|Physician Decision|0
7820537|NCT01247090|12288453|FG002|Overall Study|Physician Decision|0
7820538|NCT01247090|12288451|FG000|Overall Study|Withdrawal by Subject|0
7820539|NCT01247090|12288452|FG001|Overall Study|Withdrawal by Subject|1
7820540|NCT01247090|12288453|FG002|Overall Study|Withdrawal by Subject|0
7820541|NCT01247350|12288498|FG000|Overall Study|Adverse Event|0
7820542|NCT01247350|12288499|FG001|Overall Study|Adverse Event|0
7820543|NCT01247350|12288500|FG002|Overall Study|Adverse Event|1
7820544|NCT01247350|12288501|FG003|Overall Study|Adverse Event|0
7820545|NCT01247350|12288502|FG004|Overall Study|Adverse Event|0
7820546|NCT01247350|12288498|FG000|Overall Study|Withdrawal by Subject|0
7820547|NCT01247350|12288499|FG001|Overall Study|Withdrawal by Subject|0
7820548|NCT01247350|12288500|FG002|Overall Study|Withdrawal by Subject|0
7820549|NCT01247350|12288501|FG003|Overall Study|Withdrawal by Subject|1
7820550|NCT01247350|12288502|FG004|Overall Study|Withdrawal by Subject|0
7820551|NCT01247350|12288498|FG000|Overall Study|Entry criteria not met|0
7820552|NCT01247350|12288499|FG001|Overall Study|Entry criteria not met|0
7820553|NCT01247350|12288500|FG002|Overall Study|Entry criteria not met|0
7820554|NCT01247350|12288501|FG003|Overall Study|Entry criteria not met|0
7820555|NCT01247350|12288502|FG004|Overall Study|Entry criteria not met|1
7820556|NCT01247922|12288570|FG000|Overall Study|Disease progression|4
7820557|NCT01248013|12288583|FG000|Overall Study|Withdrawal by Subject|14
7820558|NCT01248065|12288589|FG000|Overall Study|Lost to Follow-up|3
7912208|NCT02072434|12430138|FG000|Overall Study|Adverse event, serious fatal|1
7912209|NCT02072434|12430139|FG001|Overall Study|Adverse event, serious fatal|6
7912210|NCT02072434|12430138|FG000|Overall Study|Adverse Event|7
7912211|NCT02072434|12430139|FG001|Overall Study|Adverse Event|6
7912212|NCT02072434|12430138|FG000|Overall Study|Withdrawal by Subject|17
7912213|NCT02072434|12430139|FG001|Overall Study|Withdrawal by Subject|29
7912214|NCT02072434|12430138|FG000|Overall Study|Other|14
7912215|NCT02072434|12430139|FG001|Overall Study|Other|29
7912216|NCT02072434|12430138|FG000|Overall Study|Lost to Follow-up|0
7912217|NCT02072434|12430139|FG001|Overall Study|Lost to Follow-up|1
7912218|NCT02072668|12430145|FG000|Second Intervention|Lost to Follow-up|1
7912219|NCT02072668|12430146|FG001|Second Intervention|Lost to Follow-up|0
7912220|NCT02072824|12430157|FG000|Overall Study|Insufficient clinical response|1
7912221|NCT02072824|12430158|FG001|Overall Study|Insufficient clinical response|0
7912222|NCT02072824|12430159|FG002|Overall Study|Insufficient clinical response|1
7912223|NCT02072824|12430157|FG000|Overall Study|No longer willing to participate|1
7912224|NCT02072824|12430158|FG001|Overall Study|No longer willing to participate|0
7912225|NCT02072824|12430159|FG002|Overall Study|No longer willing to participate|1
7912226|NCT02072824|12430157|FG000|Overall Study|Medication error|0
7912227|NCT02072824|12430158|FG001|Overall Study|Medication error|1
7912228|NCT02072824|12430159|FG002|Overall Study|Medication error|0
7912229|NCT02072824|12430157|FG000|Overall Study|Adverse Event|0
7912230|NCT02072824|12430158|FG001|Overall Study|Adverse Event|0
7912231|NCT02072824|12430159|FG002|Overall Study|Adverse Event|1
7912232|NCT02072941|12430173|FG000|Overall Study|Withdrawal by Subject|29
7912233|NCT02072941|12430174|FG001|Overall Study|Withdrawal by Subject|21
7912234|NCT02072941|12430173|FG000|Overall Study|Lost to Follow-up|4
7912235|NCT02072941|12430174|FG001|Overall Study|Lost to Follow-up|4
7912236|NCT02072941|12430173|FG000|Overall Study|Death|3
7912237|NCT02072941|12430174|FG001|Overall Study|Death|2
7912238|NCT02072941|12430173|FG000|Overall Study|Removed by Study Staff|2
7912239|NCT02072941|12430174|FG001|Overall Study|Removed by Study Staff|2
7912240|NCT02072980|12430180|FG000|Period 2, Second Wear|Adverse Event|0
7912241|NCT02072980|12430181|FG001|Period 2, Second Wear|Adverse Event|1
7912242|NCT02073643|12430247|FG000|Overall Study|Lost to Follow-up|24
7912243|NCT02073656|12430251|FG000|Primary Study|Lost to Follow-up|6
7912244|NCT02073656|12430251|FG000|Primary Study|Death|1
7912245|NCT02073656|12430251|FG000|Primary Study|Withdrew Consent|1
7912246|NCT02073682|12430259|FG000|Overall Study|Low Creatinine Clearance|1
7912247|NCT02073682|12430260|FG001|Overall Study|Low Creatinine Clearance|2
7912248|NCT02073682|12430259|FG000|Overall Study|Death|86
7912249|NCT02073682|12430260|FG001|Overall Study|Death|100
7912250|NCT02073682|12430259|FG000|Overall Study|Cancer Cured|10
7820559|NCT01248065|12288590|FG001|Overall Study|Lost to Follow-up|5
7820560|NCT01248065|12288589|FG000|Overall Study|Withdrawal by Subject|14
7820561|NCT01248065|12288590|FG001|Overall Study|Withdrawal by Subject|11
7820562|NCT01248065|12288589|FG000|Overall Study|Adverse Event|3
7912251|NCT02073682|12430260|FG001|Overall Study|Cancer Cured|15
7912252|NCT02073682|12430259|FG000|Overall Study|ID: Patient Noncompliance|1
7820563|NCT01248065|12288590|FG001|Overall Study|Adverse Event|0
7820564|NCT01248065|12288589|FG000|Overall Study|Third treatment failure event|3
7820565|NCT01248065|12288590|FG001|Overall Study|Third treatment failure event|1
7820566|NCT01248065|12288589|FG000|Overall Study|Other|3
7820567|NCT01248065|12288590|FG001|Overall Study|Other|5
7820568|NCT01248364|12288620|FG000|Overall Study|Adverse Event|0
7820569|NCT01248364|12288621|FG001|Overall Study|Adverse Event|1
7820570|NCT01248364|12288622|FG002|Overall Study|Adverse Event|0
7820571|NCT01248364|12288623|FG003|Overall Study|Adverse Event|0
7820572|NCT01248455|12288648|FG000|Overall Study|switched to alternate treatment|1
7820573|NCT01248468|12288655|FG000|Overall Study|Administrative problem|1
7820574|NCT01248468|12288656|FG001|Overall Study|Administrative problem|0
7820575|NCT01248468|12288657|FG002|Overall Study|Administrative problem|0
7820576|NCT01248468|12288655|FG000|Overall Study|Lost to Follow-up|9
7820577|NCT01248468|12288656|FG001|Overall Study|Lost to Follow-up|12
7820578|NCT01248468|12288657|FG002|Overall Study|Lost to Follow-up|4
7820579|NCT01248468|12288655|FG000|Overall Study|Pregnancy|1
7820580|NCT01248468|12288656|FG001|Overall Study|Pregnancy|0
7820581|NCT01248468|12288657|FG002|Overall Study|Pregnancy|0
7820582|NCT01248468|12288655|FG000|Overall Study|Withdrawal by Subject|4
7820583|NCT01248468|12288656|FG001|Overall Study|Withdrawal by Subject|2
7820584|NCT01248468|12288657|FG002|Overall Study|Withdrawal by Subject|0
7820585|NCT01248715|12288676|FG000|Overall Study|Not influenza positive|501
7820586|NCT01248715|12288677|FG001|Overall Study|Not influenza positive|510
7820587|NCT01248728|12288685|FG000|Overall Study|Adverse Event|1
7820588|NCT01248728|12288686|FG001|Overall Study|Adverse Event|1
7820589|NCT01248728|12288685|FG000|Overall Study|Withdrawal by Subject|2
7912253|NCT02073682|12430260|FG001|Overall Study|ID: Patient Noncompliance|2
7820590|NCT01248728|12288686|FG001|Overall Study|Withdrawal by Subject|1
7820591|NCT01248728|12288685|FG000|Overall Study|Lack of Efficacy|1
7820592|NCT01248728|12288686|FG001|Overall Study|Lack of Efficacy|0
7719434|NCT00532155|12143398|FG001|Overall Study|Progressive disease (by incorrect scan)|1
7719435|NCT00532155|12143397|FG000|Overall Study|Had brain metastasis, was mis-randomized|1
7820593|NCT01248780|12288700|FG000|Overall Study|Lack of Efficacy|2
7820594|NCT01248780|12288701|FG001|Overall Study|Lack of Efficacy|0
7820595|NCT01248780|12288700|FG000|Overall Study|Lost to Follow-up|0
7820596|NCT01248780|12288701|FG001|Overall Study|Lost to Follow-up|1
7820597|NCT01248780|12288700|FG000|Overall Study|Death|0
7820598|NCT01248780|12288701|FG001|Overall Study|Death|1
7820599|NCT01248780|12288700|FG000|Overall Study|Adverse Event|2
7820600|NCT01248780|12288701|FG001|Overall Study|Adverse Event|7
7820601|NCT01248780|12288700|FG000|Overall Study|Protocol Violation|1
7820602|NCT01248780|12288701|FG001|Overall Study|Protocol Violation|1
7912254|NCT02073682|12430259|FG000|Overall Study|ID: Palliative Treatment Only|10
7912255|NCT02073682|12430260|FG001|Overall Study|ID: Palliative Treatment Only|7
7912256|NCT02073682|12430259|FG000|Overall Study|Prohibited Concomitant Medication Use|0
7912257|NCT02073682|12430260|FG001|Overall Study|Prohibited Concomitant Medication Use|1
7912258|NCT02073682|12430259|FG000|Overall Study|Platelet Count <50,000/mL|1
7912259|NCT02073682|12430260|FG001|Overall Study|Platelet Count <50,000/mL|2
7912260|NCT02073682|12430259|FG000|Overall Study|Surgery/Medical Procedure|3
7912261|NCT02073682|12430260|FG001|Overall Study|Surgery/Medical Procedure|1
7912262|NCT02073682|12430259|FG000|Overall Study|Withdrawal by Subject|6
7912263|NCT02073682|12430260|FG001|Overall Study|Withdrawal by Subject|8
7912264|NCT02073682|12430259|FG000|Overall Study|Start of New Chemotherapy Regimen|6
7912265|NCT02073682|12430260|FG001|Overall Study|Start of New Chemotherapy Regimen|3
7912266|NCT02073682|12430259|FG000|Overall Study|Cancer Progression|53
7912267|NCT02073682|12430260|FG001|Overall Study|Cancer Progression|33
7912268|NCT02073682|12430259|FG000|Overall Study|Protocol Violation|1
7912269|NCT02073682|12430260|FG001|Overall Study|Protocol Violation|0
7912270|NCT02073682|12430259|FG000|Overall Study|Adverse Event|79
7912271|NCT02073682|12430260|FG001|Overall Study|Adverse Event|62
7912272|NCT02073682|12430259|FG000|Overall Study|No reason provided|11
7912273|NCT02073682|12430260|FG001|Overall Study|No reason provided|9
7912274|NCT02073682|12430259|FG000|Overall Study|PD: Inconvenience of Dosing|21
7912275|NCT02073682|12430260|FG001|Overall Study|PD: Inconvenience of Dosing|78
7912276|NCT02073682|12430259|FG000|Overall Study|Lost to Follow-up|1
7912277|NCT02073682|12430260|FG001|Overall Study|Lost to Follow-up|1
7912278|NCT02073682|12430259|FG000|Overall Study|ID: Benefit/Risk Judgment|32
7912279|NCT02073682|12430260|FG001|Overall Study|ID: Benefit/Risk Judgment|46
7912280|NCT02073929|12430277|FG000|Overall Study|Lost to Follow-up|2
7912281|NCT02073929|12430278|FG001|Overall Study|Lost to Follow-up|1
7912282|NCT02073929|12430277|FG000|Overall Study|Adverse Event|2
7912283|NCT02073929|12430278|FG001|Overall Study|Adverse Event|1
7912284|NCT02073929|12430277|FG000|Overall Study|Withdrawal by Subject|0
7912285|NCT02073929|12430278|FG001|Overall Study|Withdrawal by Subject|1
7912286|NCT02074059|12430290|FG000|Overall Study|Death|0
7912287|NCT02074059|12430291|FG001|Overall Study|Death|0
7912288|NCT02074059|12430292|FG002|Overall Study|Death|0
7912289|NCT02074059|12430293|FG003|Overall Study|Death|0
7912290|NCT02074059|12430294|FG004|Overall Study|Death|1
7912291|NCT02074059|12430295|FG005|Overall Study|Death|1
7912292|NCT02074514|12430344|FG000|Overall Study|Lack of Efficacy|3
7912293|NCT02074514|12430345|FG001|Overall Study|Lack of Efficacy|2
7912294|NCT02074514|12430344|FG000|Overall Study|Lost to Follow-up|0
7912295|NCT02074514|12430345|FG001|Overall Study|Lost to Follow-up|1
7912296|NCT02074514|12430344|FG000|Overall Study|Withdrew Consent|0
7912297|NCT02074514|12430345|FG001|Overall Study|Withdrew Consent|1
7912298|NCT02074553|12430357|FG000|Intervention Period 1|Family Emergency|0
7912299|NCT02074553|12430358|FG001|Intervention Period 1|Family Emergency|0
7912300|NCT02074553|12430359|FG002|Intervention Period 1|Family Emergency|0
7912301|NCT02074553|12430360|FG003|Intervention Period 1|Family Emergency|1
7912302|NCT02074553|12430361|FG004|Intervention Period 1|Family Emergency|0
7912303|NCT02074553|12430362|FG005|Intervention Period 1|Family Emergency|0
7912304|NCT02074553|12430363|FG006|Intervention Period 1|Family Emergency|0
7912305|NCT02074553|12430364|FG007|Intervention Period 1|Family Emergency|0
7912306|NCT02074553|12430357|FG000|Washout Period 1|Adverse Event|1
7912307|NCT02074553|12430358|FG001|Washout Period 1|Adverse Event|0
7912308|NCT02074553|12430359|FG002|Washout Period 1|Adverse Event|0
7912309|NCT02074553|12430360|FG003|Washout Period 1|Adverse Event|0
7912310|NCT02074553|12430361|FG004|Washout Period 1|Adverse Event|0
7912311|NCT02074553|12430362|FG005|Washout Period 1|Adverse Event|0
7820603|NCT01248780|12288700|FG000|Overall Study|Withdrawal by Subject|4
7912312|NCT02074553|12430363|FG006|Washout Period 1|Adverse Event|0
7912313|NCT02074553|12430364|FG007|Washout Period 1|Adverse Event|0
7912314|NCT02074553|12430357|FG000|Washout Period 1|Physician Decision|0
7912315|NCT02074553|12430358|FG001|Washout Period 1|Physician Decision|0
7912316|NCT02074553|12430359|FG002|Washout Period 1|Physician Decision|0
7912317|NCT02074553|12430360|FG003|Washout Period 1|Physician Decision|1
7912318|NCT02074553|12430361|FG004|Washout Period 1|Physician Decision|0
7912319|NCT02074553|12430362|FG005|Washout Period 1|Physician Decision|0
7912320|NCT02074553|12430363|FG006|Washout Period 1|Physician Decision|0
7912321|NCT02074553|12430364|FG007|Washout Period 1|Physician Decision|0
7912322|NCT02074553|12430357|FG000|Washout Period 1|Other|0
7912323|NCT02074553|12430358|FG001|Washout Period 1|Other|0
7912324|NCT02074553|12430359|FG002|Washout Period 1|Other|0
7820604|NCT01248780|12288701|FG001|Overall Study|Withdrawal by Subject|4
7820605|NCT01248780|12288700|FG000|Overall Study|Not treated|0
7820606|NCT01248780|12288701|FG001|Overall Study|Not treated|1
7820607|NCT01248793|12288709|FG000|Overall Study|Lost to Follow-up|0
7820608|NCT01248793|12288710|FG001|Overall Study|Lost to Follow-up|1
7820609|NCT01248793|12288709|FG000|Overall Study|Adverse Event|1
7820610|NCT01248793|12288710|FG001|Overall Study|Adverse Event|1
7820611|NCT01248793|12288709|FG000|Overall Study|Protocol Violation|0
7820612|NCT01248793|12288710|FG001|Overall Study|Protocol Violation|1
7820613|NCT01248793|12288709|FG000|Overall Study|Withdrawal by Subject|3
7820614|NCT01248793|12288710|FG001|Overall Study|Withdrawal by Subject|3
7820615|NCT01248884|12288719|FG000|Overall Study|Withdrawal by Subject|1
7820616|NCT01248884|12288720|FG001|Overall Study|Withdrawal by Subject|3
7820617|NCT01248884|12288721|FG002|Overall Study|Withdrawal by Subject|1
7820618|NCT01248884|12288719|FG000|Overall Study|Adverse Event|1
7820619|NCT01248884|12288720|FG001|Overall Study|Adverse Event|0
7820620|NCT01248884|12288721|FG002|Overall Study|Adverse Event|0
7820621|NCT01248936|12288731|FG000|Overall Study|Sponsor Decision|259
7820622|NCT01248936|12288731|FG000|Overall Study|Progression of Disease|50
7820623|NCT01248936|12288731|FG000|Overall Study|Death|26
7820624|NCT01248936|12288731|FG000|Overall Study|Withdrawal of Consent|20
7820625|NCT01248936|12288731|FG000|Overall Study|Adverse Event|8
7820626|NCT01248936|12288731|FG000|Overall Study|Lost to Follow-up|7
7820627|NCT01248936|12288731|FG000|Overall Study|Refused Treatment|1
7820628|NCT01248936|12288731|FG000|Overall Study|Other reason|3
7820629|NCT01248949|12288741|FG000|Overall Study|Lost to Follow-up|2
7820630|NCT01248949|12288742|FG001|Overall Study|Lost to Follow-up|2
7820631|NCT01248949|12288743|FG002|Overall Study|Lost to Follow-up|2
7820632|NCT01248949|12288744|FG003|Overall Study|Lost to Follow-up|1
7820633|NCT01248949|12288745|FG004|Overall Study|Lost to Follow-up|0
7820634|NCT01248949|12288741|FG000|Overall Study|Withdrawal by Subject|5
7820635|NCT01248949|12288742|FG001|Overall Study|Withdrawal by Subject|3
7820636|NCT01248949|12288743|FG002|Overall Study|Withdrawal by Subject|11
7820637|NCT01248949|12288744|FG003|Overall Study|Withdrawal by Subject|3
7820638|NCT01248949|12288745|FG004|Overall Study|Withdrawal by Subject|1
7820639|NCT01248949|12288741|FG000|Overall Study|Death|22
7820640|NCT01248949|12288742|FG001|Overall Study|Death|7
7820641|NCT01248949|12288743|FG002|Overall Study|Death|21
7820642|NCT01248949|12288744|FG003|Overall Study|Death|6
7820643|NCT01248949|12288745|FG004|Overall Study|Death|2
7820644|NCT01248949|12288741|FG000|Overall Study|Alternative Therapy|1
7820645|NCT01248949|12288742|FG001|Overall Study|Alternative Therapy|0
7820646|NCT01248949|12288743|FG002|Overall Study|Alternative Therapy|0
7820647|NCT01248949|12288744|FG003|Overall Study|Alternative Therapy|0
7820648|NCT01248949|12288745|FG004|Overall Study|Alternative Therapy|0
7820649|NCT01248949|12288741|FG000|Overall Study|Alternative Therapy.|1
7820650|NCT01248949|12288742|FG001|Overall Study|Alternative Therapy.|0
7820651|NCT01248949|12288743|FG002|Overall Study|Alternative Therapy.|0
7820652|NCT01248949|12288744|FG003|Overall Study|Alternative Therapy.|0
7820653|NCT01248949|12288745|FG004|Overall Study|Alternative Therapy.|0
7820654|NCT01248949|12288741|FG000|Overall Study|Palliative Radiation To Brain Metastases|1
7820655|NCT01248949|12288742|FG001|Overall Study|Palliative Radiation To Brain Metastases|0
7820656|NCT01248949|12288743|FG002|Overall Study|Palliative Radiation To Brain Metastases|0
7820657|NCT01248949|12288744|FG003|Overall Study|Palliative Radiation To Brain Metastases|0
7820658|NCT01248949|12288745|FG004|Overall Study|Palliative Radiation To Brain Metastases|0
7820659|NCT01248949|12288741|FG000|Overall Study|Entered Hospice And Refused Follow Up|0
7820660|NCT01248949|12288742|FG001|Overall Study|Entered Hospice And Refused Follow Up|0
7820661|NCT01248949|12288743|FG002|Overall Study|Entered Hospice And Refused Follow Up|0
7820662|NCT01248949|12288744|FG003|Overall Study|Entered Hospice And Refused Follow Up|0
7820663|NCT01248949|12288745|FG004|Overall Study|Entered Hospice And Refused Follow Up|1
7820664|NCT01248949|12288741|FG000|Overall Study|Participant Went To Hospice|0
7820665|NCT01248949|12288742|FG001|Overall Study|Participant Went To Hospice|0
7820666|NCT01248949|12288743|FG002|Overall Study|Participant Went To Hospice|1
7820667|NCT01248949|12288744|FG003|Overall Study|Participant Went To Hospice|0
7820668|NCT01248949|12288745|FG004|Overall Study|Participant Went To Hospice|0
7820669|NCT01248949|12288741|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1
7820670|NCT01248949|12288742|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0
7820671|NCT01248949|12288743|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0
7820672|NCT01248949|12288744|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0
7820673|NCT01248949|12288745|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0
7912325|NCT02074553|12430360|FG003|Washout Period 1|Other|0
7912326|NCT02074553|12430361|FG004|Washout Period 1|Other|0
7912327|NCT02074553|12430362|FG005|Washout Period 1|Other|1
7820674|NCT01248949|12288741|FG000|Overall Study|Pi Decision Due To Declining Status|0
7820675|NCT01248949|12288742|FG001|Overall Study|Pi Decision Due To Declining Status|0
7820676|NCT01248949|12288743|FG002|Overall Study|Pi Decision Due To Declining Status|1
7820677|NCT01248949|12288744|FG003|Overall Study|Pi Decision Due To Declining Status|0
7820678|NCT01248949|12288745|FG004|Overall Study|Pi Decision Due To Declining Status|0
7820679|NCT01248949|12288741|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0
7820680|NCT01248949|12288742|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1
7820681|NCT01248949|12288743|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0
7820682|NCT01248949|12288744|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0
7820683|NCT01248949|12288745|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0
7820684|NCT01248949|12288741|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
7820685|NCT01248949|12288742|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
7820686|NCT01248949|12288743|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
7820687|NCT01248949|12288744|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
7820688|NCT01248949|12288745|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
7820689|NCT01248962|12288759|FG000|Overall Study|Withdrawal by Subject|1
7820690|NCT01248962|12288760|FG001|Overall Study|Withdrawal by Subject|1
7820691|NCT01248962|12288759|FG000|Overall Study|Adverse Event|2
7820692|NCT01248962|12288760|FG001|Overall Study|Adverse Event|1
7820693|NCT01248962|12288759|FG000|Overall Study|Complete Response after 4 Cycles|1
7820694|NCT01248962|12288760|FG001|Overall Study|Complete Response after 4 Cycles|0
7820695|NCT01248962|12288759|FG000|Overall Study|Complete Response after 3 Cycles|0
7820696|NCT01248962|12288760|FG001|Overall Study|Complete Response after 3 Cycles|1
7820697|NCT01248962|12288759|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12
7820698|NCT01248962|12288760|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13
7820699|NCT01249092|12288771|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1
7820700|NCT01249092|12288771|FG000|Overall Study|Unable to tolerate expected SE -nausea|1
7820701|NCT01249118|12288777|FG000|First Washout Period|Physician Decision|0
7820702|NCT01249118|12288778|FG001|First Washout Period|Physician Decision|1
7820703|NCT01249118|12288779|FG002|First Washout Period|Physician Decision|0
7820704|NCT01249131|12288786|FG000|Washout Period of 10 Days|Adverse Event|0
7820705|NCT01249131|12288787|FG001|Washout Period of 10 Days|Adverse Event|0
7820706|NCT01249131|12288788|FG002|Washout Period of 10 Days|Adverse Event|0
7820707|NCT01249131|12288789|FG003|Washout Period of 10 Days|Adverse Event|0
7820708|NCT01249131|12288790|FG004|Washout Period of 10 Days|Adverse Event|1
7820709|NCT01249131|12288791|FG005|Washout Period of 10 Days|Adverse Event|0
7820710|NCT01249261|12288801|FG000|Overall Study|Withdrawal by Subject|1
7820711|NCT01249261|12288802|FG001|Overall Study|Withdrawal by Subject|0
7820712|NCT01249274|12288810|FG000|Overall Study|Lost to Follow-up|3
7820713|NCT01249274|12288811|FG001|Overall Study|Lost to Follow-up|4
7912328|NCT02074553|12430363|FG006|Washout Period 1|Other|0
7912329|NCT02074553|12430364|FG007|Washout Period 1|Other|0
7912330|NCT02074553|12430357|FG000|Washout Period 2|Adverse Event|0
7912331|NCT02074553|12430358|FG001|Washout Period 2|Adverse Event|0
7912332|NCT02074553|12430359|FG002|Washout Period 2|Adverse Event|0
7912333|NCT02074553|12430360|FG003|Washout Period 2|Adverse Event|0
7912334|NCT02074553|12430361|FG004|Washout Period 2|Adverse Event|0
7912335|NCT02074553|12430362|FG005|Washout Period 2|Adverse Event|0
7912336|NCT02074553|12430363|FG006|Washout Period 2|Adverse Event|1
7912337|NCT02074553|12430364|FG007|Washout Period 2|Adverse Event|0
7912338|NCT02074553|12430357|FG000|Washout Period 2|Physician Decision|0
7912339|NCT02074553|12430358|FG001|Washout Period 2|Physician Decision|0
7912340|NCT02074553|12430359|FG002|Washout Period 2|Physician Decision|0
7912341|NCT02074553|12430360|FG003|Washout Period 2|Physician Decision|0
7912342|NCT02074553|12430361|FG004|Washout Period 2|Physician Decision|0
7912343|NCT02074553|12430362|FG005|Washout Period 2|Physician Decision|1
7912344|NCT02074553|12430363|FG006|Washout Period 2|Physician Decision|0
7912345|NCT02074553|12430364|FG007|Washout Period 2|Physician Decision|0
7912346|NCT02074553|12430357|FG000|Washout Period 2|Lost to Follow-up|0
7912347|NCT02074553|12430358|FG001|Washout Period 2|Lost to Follow-up|0
7912348|NCT02074553|12430359|FG002|Washout Period 2|Lost to Follow-up|1
7912349|NCT02074553|12430360|FG003|Washout Period 2|Lost to Follow-up|0
7912350|NCT02074553|12430361|FG004|Washout Period 2|Lost to Follow-up|0
7912351|NCT02074553|12430362|FG005|Washout Period 2|Lost to Follow-up|0
7912352|NCT02074553|12430363|FG006|Washout Period 2|Lost to Follow-up|0
7912353|NCT02074553|12430364|FG007|Washout Period 2|Lost to Follow-up|0
7912354|NCT02074553|12430357|FG000|Washout Period 3|Physician Decision|0
7912355|NCT02074553|12430358|FG001|Washout Period 3|Physician Decision|0
7912356|NCT02074553|12430359|FG002|Washout Period 3|Physician Decision|0
7912357|NCT02074553|12430360|FG003|Washout Period 3|Physician Decision|0
7912358|NCT02074553|12430361|FG004|Washout Period 3|Physician Decision|0
7912359|NCT02074553|12430362|FG005|Washout Period 3|Physician Decision|0
7912360|NCT02074553|12430363|FG006|Washout Period 3|Physician Decision|0
7912361|NCT02074553|12430364|FG007|Washout Period 3|Physician Decision|1
7912362|NCT02074982|12430402|FG000|Overall Study|Adverse Event|15
7912363|NCT02074982|12430403|FG001|Overall Study|Adverse Event|7
7912364|NCT02074982|12430402|FG000|Overall Study|Lack of Efficacy|6
7912365|NCT02074982|12430403|FG001|Overall Study|Lack of Efficacy|1
7912366|NCT02074982|12430402|FG000|Overall Study|Lost to Follow-up|9
7912367|NCT02074982|12430403|FG001|Overall Study|Lost to Follow-up|10
7912368|NCT02074982|12430402|FG000|Overall Study|Non-compliance with study treatment|0
7820714|NCT01249274|12288810|FG000|Overall Study|Received inpatient substance treatment|1
7820715|NCT01249274|12288811|FG001|Overall Study|Received inpatient substance treatment|2
7820716|NCT01249365|12288819|FG000|Overall Study|Lost to Follow-up|1
7912369|NCT02074982|12430403|FG001|Overall Study|Non-compliance with study treatment|2
7820717|NCT01249651|12288832|FG000|Overall Study|Withdrawal by Subject|4
7820718|NCT01249651|12288832|FG000|Overall Study|Adverse Event|1
7820719|NCT01249651|12288832|FG000|Overall Study|Protocol Violation|1
7820720|NCT01249651|12288832|FG000|Overall Study|Sponsor Decision|1
7820721|NCT01249664|12288838|FG000|Overall Study|Withdrawal by Subject|5
7820722|NCT01249664|12288839|FG001|Overall Study|Withdrawal by Subject|0
7820723|NCT01249664|12288838|FG000|Overall Study|Adverse Event|1
7820724|NCT01249664|12288839|FG001|Overall Study|Adverse Event|0
7820725|NCT01249833|12288849|FG000|Overall Study|Lost to Follow-up|0
7820726|NCT01249833|12288850|FG001|Overall Study|Lost to Follow-up|1
7820727|NCT01250002|12288891|FG000|Overall Study|Change to open surgical procedure|4
7820728|NCT01250002|12288892|FG001|Overall Study|Change to open surgical procedure|3
7820729|NCT01250054|12288898|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1
7820730|NCT01250054|12288899|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0
7820731|NCT01250119|12288905|FG000|Diagnostic Phase|Failed to Produce a Test Results|69
7820732|NCT01250119|12288906|FG001|Diagnostic Phase|Failed to Produce a Test Results|0
7820733|NCT01250119|12288905|FG000|Diagnostic Phase|Participants Not Tested|44
7820734|NCT01250119|12288906|FG001|Diagnostic Phase|Participants Not Tested|0
7820735|NCT01250119|12288905|FG000|Treatment Phase|Progressive Disease|0
7820736|NCT01250119|12288906|FG001|Treatment Phase|Progressive Disease|32
7820737|NCT01250119|12288905|FG000|Treatment Phase|Death|0
7820738|NCT01250119|12288906|FG001|Treatment Phase|Death|2
7820739|NCT01250119|12288905|FG000|Treatment Phase|Withdrawal by Subject|0
7820740|NCT01250119|12288906|FG001|Treatment Phase|Withdrawal by Subject|1
7820741|NCT01250119|12288905|FG000|Treatment Phase|Adverse Event|0
7820742|NCT01250119|12288906|FG001|Treatment Phase|Adverse Event|2
7820743|NCT01250119|12288905|FG000|Treatment Phase|Unknown reason|0
7820744|NCT01250119|12288906|FG001|Treatment Phase|Unknown reason|4
7820745|NCT01250145|12288915|FG000|Overall Study|Adverse Event|2
7820746|NCT01250145|12288916|FG001|Overall Study|Adverse Event|1
7820747|NCT01250145|12288915|FG000|Overall Study|Withdrawal by Subject|0
7820748|NCT01250145|12288916|FG001|Overall Study|Withdrawal by Subject|4
7820749|NCT01250171|12288939|FG000|Overall Study|Administrative reasons|1
7820750|NCT01250171|12288940|FG001|Overall Study|Administrative reasons|0
7820751|NCT01250171|12288941|FG002|Overall Study|Administrative reasons|0
7820752|NCT01250379|12288977|FG000|Overall Study|Death|141
7820753|NCT01250379|12288978|FG001|Overall Study|Death|148
7820754|NCT01250379|12288977|FG000|Overall Study|Withdrawal by Subject|32
7820755|NCT01250379|12288978|FG001|Overall Study|Withdrawal by Subject|20
7912370|NCT02074982|12430402|FG000|Overall Study|Physician Decision|1
7912371|NCT02074982|12430403|FG001|Overall Study|Physician Decision|1
7912372|NCT02074982|12430402|FG000|Overall Study|Pregnancy|1
7912373|NCT02074982|12430403|FG001|Overall Study|Pregnancy|2
7912374|NCT02074982|12430402|FG000|Overall Study|Protocol deviation|4
7912375|NCT02074982|12430403|FG001|Overall Study|Protocol deviation|3
7912376|NCT02074982|12430402|FG000|Overall Study|Technical problems|0
7912377|NCT02074982|12430403|FG001|Overall Study|Technical problems|2
7912378|NCT02074982|12430402|FG000|Overall Study|Subject/guardian decision|15
7912379|NCT02074982|12430403|FG001|Overall Study|Subject/guardian decision|24
7912380|NCT02074982|12430402|FG000|Overall Study|Death|0
7912381|NCT02074982|12430403|FG001|Overall Study|Death|2
7912382|NCT02075008|12430415|FG000|Overall Study|Technical problems|1
7912383|NCT02075008|12430415|FG000|Overall Study|Pregnancy|1
7912384|NCT02075008|12430415|FG000|Overall Study|Physician Decision|1
7912385|NCT02075008|12430415|FG000|Overall Study|Lost to Follow-up|1
7912386|NCT02075008|12430415|FG000|Overall Study|Lack of Efficacy|1
7912387|NCT02075008|12430415|FG000|Overall Study|Death|1
7912388|NCT02075008|12430415|FG000|Overall Study|Adverse Event|5
7912389|NCT02075008|12430415|FG000|Overall Study|Withdrawal by Subject|6
7912390|NCT02075008|12430415|FG000|Overall Study|Study terminated by Sponsor|159
7912391|NCT02075047|12430421|FG000|Treatment Phase (4 Weeks)|Adverse Event|14
7912392|NCT02075047|12430422|FG001|Treatment Phase (4 Weeks)|Adverse Event|4
7912393|NCT02075047|12430421|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2
7912394|NCT02075047|12430422|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2
7912395|NCT02075047|12430421|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0
7912396|NCT02075047|12430422|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1
7912397|NCT02075047|12430421|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1
7820756|NCT01250379|12288977|FG000|Overall Study|Physician Decision|11
7820757|NCT01250379|12288978|FG001|Overall Study|Physician Decision|3
7820758|NCT01250379|12288977|FG000|Overall Study|Protocol Violation|2
7820759|NCT01250379|12288978|FG001|Overall Study|Protocol Violation|8
7820760|NCT01250379|12288977|FG000|Overall Study|Lost to Follow-up|9
7912398|NCT02075047|12430422|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0
7912399|NCT02075047|12430421|FG000|Treatment Phase (4 Weeks)|Screen Failure|1
7912400|NCT02075047|12430422|FG001|Treatment Phase (4 Weeks)|Screen Failure|0
7912401|NCT02075047|12430421|FG000|Treatment Phase (4 Weeks)|Other|1
7912402|NCT02075047|12430422|FG001|Treatment Phase (4 Weeks)|Other|1
7912403|NCT02075047|12430421|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4
7912404|NCT02075047|12430422|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2
7912405|NCT02075047|12430421|FG000|Follow up Phase (5 Weeks)|Adverse Event|14
7912406|NCT02075047|12430422|FG001|Follow up Phase (5 Weeks)|Adverse Event|4
7912407|NCT02075047|12430421|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2
7912408|NCT02075047|12430422|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2
7912409|NCT02075047|12430421|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0
7820761|NCT01250379|12288978|FG001|Overall Study|Lost to Follow-up|6
7820762|NCT01250379|12288977|FG000|Overall Study|Adverse Event|5
7820763|NCT01250379|12288978|FG001|Overall Study|Adverse Event|4
7820764|NCT01250379|12288977|FG000|Overall Study|Other|0
7820765|NCT01250379|12288978|FG001|Overall Study|Other|4
7820766|NCT01250379|12288977|FG000|Overall Study|Participant noncompliance|2
7820767|NCT01250379|12288978|FG001|Overall Study|Participant noncompliance|0
7820768|NCT01250418|12288986|FG000|Overall Study|monitor data failure|1
7820769|NCT01250418|12288987|FG001|Overall Study|monitor data failure|1
7820770|NCT01250509|12288995|FG000|Overall Study|Lost to Follow-up|5
7820771|NCT01250509|12288996|FG001|Overall Study|Lost to Follow-up|2
7820772|NCT01250756|12289023|FG000|Infant Series|Withdrawal by Subject|4
7820773|NCT01250756|12289024|FG001|Infant Series|Withdrawal by Subject|5
7820774|NCT01250756|12289023|FG000|Infant Series|Randomized, Not Vaccinated|2
7820775|NCT01250756|12289024|FG001|Infant Series|Randomized, Not Vaccinated|2
7820776|NCT01250756|12289023|FG000|Infant Series|Other|22
7820777|NCT01250756|12289024|FG001|Infant Series|Other|0
7820778|NCT01250756|12289023|FG000|After Infant Series|Adverse Event|5
7820779|NCT01250756|12289024|FG001|After Infant Series|Adverse Event|2
7820780|NCT01250756|12289023|FG000|After Infant Series|Withdrawal by Subject|4
7820781|NCT01250756|12289024|FG001|After Infant Series|Withdrawal by Subject|1
7820782|NCT01250756|12289023|FG000|After Infant Series|Other|2
7820783|NCT01250756|12289024|FG001|After Infant Series|Other|1
7820784|NCT01250756|12289023|FG000|Toddler Dose|Adverse Event|0
7820785|NCT01250756|12289024|FG001|Toddler Dose|Adverse Event|1
7820786|NCT01250756|12289023|FG000|After Toddler Dose|Adverse Event|0
7820787|NCT01250756|12289024|FG001|After Toddler Dose|Adverse Event|1
7820788|NCT01250769|12289040|FG000|Overall Study|Withdrawal by Subject|0
7820789|NCT01250769|12289041|FG001|Overall Study|Withdrawal by Subject|1
7820790|NCT01250769|12289042|FG002|Overall Study|Withdrawal by Subject|1
7820791|NCT01250769|12289043|FG003|Overall Study|Withdrawal by Subject|0
7820792|NCT01250769|12289040|FG000|Overall Study|Adverse Event|0
7820793|NCT01250769|12289041|FG001|Overall Study|Adverse Event|0
7820794|NCT01250769|12289042|FG002|Overall Study|Adverse Event|1
7820795|NCT01250769|12289043|FG003|Overall Study|Adverse Event|0
7820796|NCT01250873|12289060|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2
7820797|NCT01250873|12289060|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1
7862114|NCT01597245|12351204|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862115|NCT01597245|12351205|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862116|NCT01597245|12351206|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862117|NCT01597245|12351207|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862118|NCT01597245|12351208|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7862119|NCT01597245|12351188|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862120|NCT01597245|12351189|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862121|NCT01597245|12351190|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862122|NCT01597245|12351191|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862123|NCT01597245|12351192|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862124|NCT01597245|12351193|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862125|NCT01597245|12351194|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862126|NCT01597245|12351195|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862127|NCT01597245|12351196|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862128|NCT01597245|12351197|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862129|NCT01597245|12351198|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862130|NCT01597245|12351199|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862131|NCT01597245|12351200|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862132|NCT01597245|12351201|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1
7820798|NCT01250925|12289076|FG000|Overall Study|Lost to Follow-up|1
7820799|NCT01250925|12289077|FG001|Overall Study|Lost to Follow-up|1
7820800|NCT01250925|12289078|FG002|Overall Study|Lost to Follow-up|0
7820801|NCT01250925|12289076|FG000|Overall Study|Withdrawal by Subject|2
7820802|NCT01250925|12289077|FG001|Overall Study|Withdrawal by Subject|0
7820803|NCT01250925|12289078|FG002|Overall Study|Withdrawal by Subject|0
7820804|NCT01250925|12289076|FG000|Overall Study|Protocol Violation|2
7820805|NCT01250925|12289077|FG001|Overall Study|Protocol Violation|0
7820806|NCT01250925|12289078|FG002|Overall Study|Protocol Violation|0
7912410|NCT02075047|12430422|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1
7912411|NCT02075047|12430421|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1
7820807|NCT01250925|12289076|FG000|Overall Study|Physician Decision|0
7820808|NCT01250925|12289077|FG001|Overall Study|Physician Decision|2
7820809|NCT01250925|12289078|FG002|Overall Study|Physician Decision|1
7820810|NCT01250925|12289076|FG000|Overall Study|Adverse Event|0
7820811|NCT01250925|12289077|FG001|Overall Study|Adverse Event|0
7820812|NCT01250925|12289078|FG002|Overall Study|Adverse Event|1
7820813|NCT01251146|12289115|FG000|Overall Study|Lost to Follow-up|3
7820814|NCT01251146|12289116|FG001|Overall Study|Lost to Follow-up|10
7820815|NCT01251354|12289151|FG000|Overall Study|Adverse Event|1
7820816|NCT01251354|12289151|FG000|Overall Study|Investigator's Decision|1
7820817|NCT01251354|12289151|FG000|Overall Study|Disease Progression|4
7820818|NCT01251614|12289199|FG000|Overall Study|Adverse Event|1
7820819|NCT01251614|12289200|FG001|Overall Study|Adverse Event|0
7820820|NCT01251614|12289201|FG002|Overall Study|Adverse Event|1
7820821|NCT01251614|12289199|FG000|Overall Study|Lack of Efficacy|1
7820822|NCT01251614|12289200|FG001|Overall Study|Lack of Efficacy|9
7820823|NCT01251614|12289201|FG002|Overall Study|Lack of Efficacy|4
7820824|NCT01251614|12289199|FG000|Overall Study|Clearing of Psoriatic Lesions|1
7820825|NCT01251614|12289200|FG001|Overall Study|Clearing of Psoriatic Lesions|0
7820826|NCT01251614|12289201|FG002|Overall Study|Clearing of Psoriatic Lesions|0
7820827|NCT01251614|12289199|FG000|Overall Study|Pregnancy|0
7820828|NCT01251614|12289200|FG001|Overall Study|Pregnancy|0
7820829|NCT01251614|12289201|FG002|Overall Study|Pregnancy|2
7820830|NCT01251614|12289199|FG000|Overall Study|Loss of Disease Control|0
7820831|NCT01251614|12289200|FG001|Overall Study|Loss of Disease Control|1
7820832|NCT01251614|12289201|FG002|Overall Study|Loss of Disease Control|0
7820833|NCT01251614|12289199|FG000|Overall Study|Withdrawal by Subject|0
7820834|NCT01251614|12289200|FG001|Overall Study|Withdrawal by Subject|2
7820835|NCT01251614|12289201|FG002|Overall Study|Withdrawal by Subject|1
7820836|NCT01251614|12289199|FG000|Overall Study|Lost to Follow-up|0
7820837|NCT01251614|12289200|FG001|Overall Study|Lost to Follow-up|1
7820838|NCT01251614|12289201|FG002|Overall Study|Lost to Follow-up|0
7820839|NCT01251653|12289228|FG000|Overall Study|Progressive Disease|1
7820840|NCT01251653|12289229|FG001|Overall Study|Progressive Disease|7
7820841|NCT01251653|12289230|FG002|Overall Study|Progressive Disease|16
7820842|NCT01251653|12289231|FG003|Overall Study|Progressive Disease|4
7820843|NCT01251653|12289232|FG004|Overall Study|Progressive Disease|0
7820844|NCT01251653|12289233|FG005|Overall Study|Progressive Disease|17
7820845|NCT01251653|12289234|FG006|Overall Study|Progressive Disease|14
7820846|NCT01251653|12289235|FG007|Overall Study|Progressive Disease|7
7820847|NCT01251653|12289236|FG008|Overall Study|Progressive Disease|5
7820848|NCT01251653|12289228|FG000|Overall Study|Dose-limiting toxicity|0
7820849|NCT01251653|12289229|FG001|Overall Study|Dose-limiting toxicity|1
7820850|NCT01251653|12289230|FG002|Overall Study|Dose-limiting toxicity|1
7820851|NCT01251653|12289231|FG003|Overall Study|Dose-limiting toxicity|1
7820852|NCT01251653|12289232|FG004|Overall Study|Dose-limiting toxicity|0
7820853|NCT01251653|12289233|FG005|Overall Study|Dose-limiting toxicity|0
7820854|NCT01251653|12289234|FG006|Overall Study|Dose-limiting toxicity|2
7820855|NCT01251653|12289235|FG007|Overall Study|Dose-limiting toxicity|0
7820856|NCT01251653|12289236|FG008|Overall Study|Dose-limiting toxicity|0
7820857|NCT01251653|12289228|FG000|Overall Study|Adverse Event|1
7820858|NCT01251653|12289229|FG001|Overall Study|Adverse Event|0
7820859|NCT01251653|12289230|FG002|Overall Study|Adverse Event|2
7820860|NCT01251653|12289231|FG003|Overall Study|Adverse Event|1
7820861|NCT01251653|12289232|FG004|Overall Study|Adverse Event|1
7820862|NCT01251653|12289233|FG005|Overall Study|Adverse Event|0
7820863|NCT01251653|12289234|FG006|Overall Study|Adverse Event|2
7820864|NCT01251653|12289235|FG007|Overall Study|Adverse Event|2
7820865|NCT01251653|12289236|FG008|Overall Study|Adverse Event|1
7820866|NCT01251653|12289228|FG000|Overall Study|Withdrawal by Subject|1
7820867|NCT01251653|12289229|FG001|Overall Study|Withdrawal by Subject|0
7820868|NCT01251653|12289230|FG002|Overall Study|Withdrawal by Subject|1
7820869|NCT01251653|12289231|FG003|Overall Study|Withdrawal by Subject|0
7820870|NCT01251653|12289232|FG004|Overall Study|Withdrawal by Subject|1
7820871|NCT01251653|12289233|FG005|Overall Study|Withdrawal by Subject|1
7912412|NCT02075047|12430422|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0
7912413|NCT02075047|12430421|FG000|Follow up Phase (5 Weeks)|Screen Failure|1
7820872|NCT01251653|12289234|FG006|Overall Study|Withdrawal by Subject|0
7820873|NCT01251653|12289235|FG007|Overall Study|Withdrawal by Subject|1
7820874|NCT01251653|12289236|FG008|Overall Study|Withdrawal by Subject|0
7820875|NCT01251653|12289228|FG000|Overall Study|Other reason not mentioned above|0
7820876|NCT01251653|12289229|FG001|Overall Study|Other reason not mentioned above|0
7820877|NCT01251653|12289230|FG002|Overall Study|Other reason not mentioned above|0
7820878|NCT01251653|12289231|FG003|Overall Study|Other reason not mentioned above|0
7820879|NCT01251653|12289232|FG004|Overall Study|Other reason not mentioned above|0
7820880|NCT01251653|12289233|FG005|Overall Study|Other reason not mentioned above|0
7820881|NCT01251653|12289234|FG006|Overall Study|Other reason not mentioned above|0
7820882|NCT01251653|12289235|FG007|Overall Study|Other reason not mentioned above|2
7820883|NCT01251653|12289236|FG008|Overall Study|Other reason not mentioned above|0
7820884|NCT01251744|12289274|FG000|Overall Study|Lost to Follow-up|1
7820885|NCT01251744|12289275|FG001|Overall Study|Lost to Follow-up|0
7820886|NCT01251770|12289307|FG000|Overall Study|Protocol Violation|13
7820887|NCT01251770|12289308|FG001|Overall Study|Protocol Violation|7
7820888|NCT01251887|12289317|FG000|Overall Study|Scheduling conflict|1
7820889|NCT01251887|12289318|FG001|Overall Study|Scheduling conflict|2
7820890|NCT01251887|12289319|FG002|Overall Study|Scheduling conflict|2
7820891|NCT01251887|12289317|FG000|Overall Study|Physician Decision|0
7820892|NCT01251887|12289318|FG001|Overall Study|Physician Decision|1
7820893|NCT01251887|12289319|FG002|Overall Study|Physician Decision|0
7820894|NCT01251965|12289330|FG000|Overall Study|Participant/physician decision|1
7820895|NCT01251965|12289331|FG001|Overall Study|Participant/physician decision|2
7820896|NCT01251965|12289332|FG002|Overall Study|Participant/physician decision|0
7820897|NCT01251965|12289330|FG000|Overall Study|Death|0
7820898|NCT01251965|12289331|FG001|Overall Study|Death|0
7820899|NCT01251965|12289332|FG002|Overall Study|Death|11
7820900|NCT01252095|12289352|FG000|Overall Study|Disease progression|1
7820901|NCT01252095|12289353|FG001|Overall Study|Disease progression|0
7820902|NCT01252134|12289359|FG000|Period 1, 8 Hours|Personal Reasons|0
7820903|NCT01252134|12289360|FG001|Period 1, 8 Hours|Personal Reasons|1
7820904|NCT01252134|12289361|FG002|Period 1, 8 Hours|Personal Reasons|1
7820905|NCT01252134|12289362|FG003|Period 1, 8 Hours|Personal Reasons|0
7820906|NCT01252134|12289363|FG004|Period 1, 8 Hours|Personal Reasons|0
7820907|NCT01252134|12289364|FG005|Period 1, 8 Hours|Personal Reasons|0
7820908|NCT01252186|12289379|FG000|Overall Study|Adverse Event|9
7820909|NCT01252186|12289380|FG001|Overall Study|Adverse Event|6
7820910|NCT01252186|12289381|FG002|Overall Study|Adverse Event|8
7820911|NCT01252186|12289379|FG000|Overall Study|Withdrawal by Subject|2
7820912|NCT01252186|12289380|FG001|Overall Study|Withdrawal by Subject|5
7820913|NCT01252186|12289381|FG002|Overall Study|Withdrawal by Subject|2
7820914|NCT01252186|12289379|FG000|Overall Study|Physician Decision|0
7820915|NCT01252186|12289380|FG001|Overall Study|Physician Decision|0
7820916|NCT01252186|12289381|FG002|Overall Study|Physician Decision|1
7820917|NCT01252186|12289379|FG000|Overall Study|Non-compliance|0
7820918|NCT01252186|12289380|FG001|Overall Study|Non-compliance|3
7820919|NCT01252186|12289381|FG002|Overall Study|Non-compliance|4
7820920|NCT01252186|12289379|FG000|Overall Study|Protocol Violation|0
7820921|NCT01252186|12289380|FG001|Overall Study|Protocol Violation|0
7820922|NCT01252186|12289381|FG002|Overall Study|Protocol Violation|1
7820923|NCT01252186|12289379|FG000|Overall Study|Pregnancy|2
7820924|NCT01252186|12289380|FG001|Overall Study|Pregnancy|2
7820925|NCT01252186|12289381|FG002|Overall Study|Pregnancy|0
7820926|NCT01252186|12289379|FG000|Overall Study|Sponsor Request|2
7820927|NCT01252186|12289380|FG001|Overall Study|Sponsor Request|1
7820928|NCT01252186|12289381|FG002|Overall Study|Sponsor Request|0
7820929|NCT01252186|12289379|FG000|Overall Study|Lost to Follow-up|10
7820930|NCT01252186|12289380|FG001|Overall Study|Lost to Follow-up|10
7820931|NCT01252186|12289381|FG002|Overall Study|Lost to Follow-up|11
7820932|NCT01252186|12289379|FG000|Overall Study|Other - Miscellaneous Reasons|5
7820933|NCT01252186|12289380|FG001|Overall Study|Other - Miscellaneous Reasons|5
7820934|NCT01252186|12289381|FG002|Overall Study|Other - Miscellaneous Reasons|7
7820935|NCT01252238|12289392|FG000|Overall Study|Sponsor terminated study|4
7820936|NCT01252238|12289393|FG001|Overall Study|Sponsor terminated study|4
7820937|NCT01252238|12289394|FG002|Overall Study|Sponsor terminated study|4
7820938|NCT01252251|12289405|FG000|Overall Study|Withdrawal by Subject|1
7820939|NCT01252290|12289414|FG000|Overall Study|Withdrawal by Subject|1
7820940|NCT01252355|12289421|FG000|Overall Study|Adverse Event|9
7820941|NCT01252355|12289422|FG001|Overall Study|Adverse Event|17
7820942|NCT01252355|12289423|FG002|Overall Study|Adverse Event|22
7820943|NCT01252355|12289421|FG000|Overall Study|Lack of Efficacy|6
7820944|NCT01252355|12289422|FG001|Overall Study|Lack of Efficacy|4
7820945|NCT01252355|12289423|FG002|Overall Study|Lack of Efficacy|2
7820946|NCT01252355|12289421|FG000|Overall Study|Lost to Follow-up|0
7820947|NCT01252355|12289422|FG001|Overall Study|Lost to Follow-up|0
7820948|NCT01252355|12289423|FG002|Overall Study|Lost to Follow-up|1
7820949|NCT01252355|12289421|FG000|Overall Study|Poor Compliance to Protocol|1
7820950|NCT01252355|12289422|FG001|Overall Study|Poor Compliance to Protocol|1
7820951|NCT01252355|12289423|FG002|Overall Study|Poor Compliance to Protocol|1
7820952|NCT01252355|12289421|FG000|Overall Study|Progressive Disease|2
7820953|NCT01252355|12289422|FG001|Overall Study|Progressive Disease|0
7820954|NCT01252355|12289423|FG002|Overall Study|Progressive Disease|0
7820955|NCT01252355|12289421|FG000|Overall Study|Sponsor Early Termination of Study|149
7820956|NCT01252355|12289422|FG001|Overall Study|Sponsor Early Termination of Study|149
7820957|NCT01252355|12289423|FG002|Overall Study|Sponsor Early Termination of Study|146
7820958|NCT01252355|12289421|FG000|Overall Study|Randomized but not Treated|2
7820959|NCT01252355|12289422|FG001|Overall Study|Randomized but not Treated|0
7820960|NCT01252355|12289423|FG002|Overall Study|Randomized but not Treated|0
7820961|NCT01252355|12289421|FG000|Overall Study|Other Than Above|8
7820962|NCT01252355|12289422|FG001|Overall Study|Other Than Above|7
7820963|NCT01252355|12289423|FG002|Overall Study|Other Than Above|7
7820964|NCT01252563|12289431|FG000|Overall Study|Contract Deviation|41
7820965|NCT01252563|12289431|FG000|Overall Study|Centralized Registration Deviation|30
7820966|NCT01252563|12289431|FG000|Overall Study|Lost to Follow-up|161
7820967|NCT01252563|12289431|FG000|Overall Study|No visit after first day of treatment|194
7820968|NCT01252563|12289431|FG000|Overall Study|No drug administration|6
7820969|NCT01252667|12289472|FG000|Overall Study|Transplant aborted post-conditioning|0
7820970|NCT01252667|12289473|FG001|Overall Study|Transplant aborted post-conditioning|0
7820971|NCT01252667|12289474|FG002|Overall Study|Transplant aborted post-conditioning|0
7820972|NCT01252667|12289475|FG003|Overall Study|Transplant aborted post-conditioning|0
7820973|NCT01252667|12289476|FG004|Overall Study|Transplant aborted post-conditioning|0
7820974|NCT01252667|12289477|FG005|Overall Study|Transplant aborted post-conditioning|1
7820975|NCT01252810|12289518|FG000|Overall Study|Withdrawal by Subject|4
7820976|NCT01252810|12289519|FG001|Overall Study|Withdrawal by Subject|1
7820977|NCT01252810|12289518|FG000|Overall Study|Lost to Follow-up|0
7820978|NCT01252810|12289519|FG001|Overall Study|Lost to Follow-up|1
7820979|NCT01252810|12289518|FG000|Overall Study|Physician Decision|2
7820980|NCT01252810|12289519|FG001|Overall Study|Physician Decision|1
7820981|NCT01252810|12289518|FG000|Overall Study|Various reasons|8
7820982|NCT01252810|12289519|FG001|Overall Study|Various reasons|0
7820983|NCT01252940|12289527|FG000|Main Study Phase|Randomized but not treated|4
7820984|NCT01252940|12289528|FG001|Main Study Phase|Randomized but not treated|2
7820985|NCT01252940|12289527|FG000|Main Study Phase|Adverse Event|3
7820986|NCT01252940|12289528|FG001|Main Study Phase|Adverse Event|1
7820987|NCT01252940|12289527|FG000|Main Study Phase|Lack of Efficacy|1
7820988|NCT01252940|12289528|FG001|Main Study Phase|Lack of Efficacy|0
7820989|NCT01252940|12289527|FG000|Main Study Phase|Lost to Follow-up|6
7820990|NCT01252940|12289528|FG001|Main Study Phase|Lost to Follow-up|1
7820991|NCT01252940|12289527|FG000|Main Study Phase|Physician Decision|1
7820992|NCT01252940|12289528|FG001|Main Study Phase|Physician Decision|0
7820993|NCT01252940|12289527|FG000|Main Study Phase|Protocol Violation|4
7820994|NCT01252940|12289528|FG001|Main Study Phase|Protocol Violation|2
7820995|NCT01252940|12289527|FG000|Main Study Phase|Withdrawal by Subject|6
7820996|NCT01252940|12289528|FG001|Main Study Phase|Withdrawal by Subject|5
7820997|NCT01252940|12289527|FG000|Main Study Phase|Subject Non-compliance|1
7820998|NCT01252940|12289528|FG001|Main Study Phase|Subject Non-compliance|1
7820999|NCT01252940|12289527|FG000|Extension Phase|Adverse Event|2
7821000|NCT01252940|12289528|FG001|Extension Phase|Adverse Event|1
7821001|NCT01252940|12289527|FG000|Extension Phase|Lack of Efficacy|1
7821002|NCT01252940|12289528|FG001|Extension Phase|Lack of Efficacy|0
7821003|NCT01252940|12289527|FG000|Extension Phase|Lost to Follow-up|5
7821004|NCT01252940|12289528|FG001|Extension Phase|Lost to Follow-up|0
7821005|NCT01252940|12289527|FG000|Extension Phase|Physician Decision|0
7821006|NCT01252940|12289528|FG001|Extension Phase|Physician Decision|1
7821007|NCT01252940|12289527|FG000|Extension Phase|Subject Non-compliance|1
7821008|NCT01252940|12289528|FG001|Extension Phase|Subject Non-compliance|0
7821009|NCT01252940|12289527|FG000|Extension Phase|Withdrawal by Subject|1
7821010|NCT01252940|12289528|FG001|Extension Phase|Withdrawal by Subject|1
7821011|NCT01252966|12289537|FG000|Overall Study|Lost to Follow-up|16
7821012|NCT01252966|12289538|FG001|Overall Study|Lost to Follow-up|10
7821013|NCT01252966|12289537|FG000|Overall Study|Withdrawal by Subject|7
7821014|NCT01252966|12289538|FG001|Overall Study|Withdrawal by Subject|3
7821015|NCT01253018|12289548|FG000|Overall Study|Lost to Follow-up|1
7912414|NCT02075047|12430422|FG001|Follow up Phase (5 Weeks)|Screen Failure|0
7912415|NCT02075047|12430421|FG000|Follow up Phase (5 Weeks)|Other|1
7912416|NCT02075047|12430422|FG001|Follow up Phase (5 Weeks)|Other|2
7912417|NCT02075047|12430421|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7
7912418|NCT02075047|12430422|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4
7912419|NCT02075073|12430431|FG000|Overall Study|Withdrawal by Subject|0
7912420|NCT02075073|12430432|FG001|Overall Study|Withdrawal by Subject|1
7912421|NCT02075073|12430433|FG002|Overall Study|Withdrawal by Subject|0
7912422|NCT02075203|12430453|FG000|Overall Study|Withdrawal by Subject|1
7912423|NCT02075203|12430454|FG001|Overall Study|Withdrawal by Subject|0
7821016|NCT01253018|12289549|FG001|Overall Study|Lost to Follow-up|1
7821017|NCT01253018|12289548|FG000|Overall Study|Robot Repair Issues|2
7821018|NCT01253018|12289549|FG001|Overall Study|Robot Repair Issues|0
7821019|NCT01253018|12289548|FG000|Overall Study|Withdrawal by Subject|1
7821020|NCT01253018|12289549|FG001|Overall Study|Withdrawal by Subject|1
7821021|NCT01253044|12289558|FG000|Overall Study|Lost to Follow-up|38
7821022|NCT01253044|12289559|FG001|Overall Study|Lost to Follow-up|29
7912424|NCT02075203|12430455|FG002|Overall Study|Withdrawal by Subject|1
7821023|NCT01253135|12289565|FG000|Original Protocol|Protocol Amendment|15
7821024|NCT01253135|12289565|FG000|Amended Protocol|Non-compliance|1
7821025|NCT01253174|12289577|FG000|Period 1|Randomized but not treated|0
7912425|NCT02075203|12430453|FG000|Overall Study|Adverse Event|1
7912426|NCT02075203|12430454|FG001|Overall Study|Adverse Event|0
7912427|NCT02075203|12430455|FG002|Overall Study|Adverse Event|0
7912428|NCT02075203|12430453|FG000|Overall Study|participant refused to use contraception|1
7912429|NCT02075203|12430454|FG001|Overall Study|participant refused to use contraception|0
7912430|NCT02075203|12430455|FG002|Overall Study|participant refused to use contraception|0
7912431|NCT02075255|12430466|FG000|Overall Study|Study specific withdrawal criteria|0
7912432|NCT02075255|12430467|FG001|Overall Study|Study specific withdrawal criteria|1
7912433|NCT02075255|12430468|FG002|Overall Study|Study specific withdrawal criteria|1
7912434|NCT02075255|12430466|FG000|Overall Study|Withdrawal by Subject|4
7912435|NCT02075255|12430467|FG001|Overall Study|Withdrawal by Subject|1
7912436|NCT02075255|12430468|FG002|Overall Study|Withdrawal by Subject|0
7912437|NCT02075255|12430466|FG000|Overall Study|Lost to Follow-up|0
7912438|NCT02075255|12430467|FG001|Overall Study|Lost to Follow-up|0
7912439|NCT02075255|12430468|FG002|Overall Study|Lost to Follow-up|1
7912440|NCT02075255|12430466|FG000|Overall Study|Adverse Event|0
7912441|NCT02075255|12430467|FG001|Overall Study|Adverse Event|0
7912442|NCT02075255|12430468|FG002|Overall Study|Adverse Event|1
7912443|NCT02075255|12430466|FG000|Overall Study|Death|0
7912444|NCT02075255|12430467|FG001|Overall Study|Death|2
7912445|NCT02075255|12430468|FG002|Overall Study|Death|0
7912446|NCT02075463|12430476|FG000|Overall Study|Adverse Event|3
7912447|NCT02075463|12430476|FG000|Overall Study|Par. reached stopping criteria|4
7912448|NCT02075463|12430476|FG000|Overall Study|Withdrawal by Subject|1
7912449|NCT02075476|12430483|FG000|Overall Study|Death|2
7912450|NCT02075476|12430484|FG001|Overall Study|Death|2
7912451|NCT02075476|12430483|FG000|Overall Study|Lost to Follow-up|1
7912452|NCT02075476|12430484|FG001|Overall Study|Lost to Follow-up|3
7912453|NCT02075515|12430493|FG000|Overall Study|Serious Adverse Event|1
7912454|NCT02075515|12430494|FG001|Overall Study|Serious Adverse Event|1
7912455|NCT02075515|12430495|FG002|Overall Study|Serious Adverse Event|1
7912456|NCT02075515|12430493|FG000|Overall Study|Non-Serious Adverse Event|0
7912457|NCT02075515|12430494|FG001|Overall Study|Non-Serious Adverse Event|1
7912458|NCT02075515|12430495|FG002|Overall Study|Non-Serious Adverse Event|0
7912459|NCT02075515|12430493|FG000|Overall Study|Withdrawal by Subject|2
7912460|NCT02075515|12430494|FG001|Overall Study|Withdrawal by Subject|0
7912461|NCT02075515|12430495|FG002|Overall Study|Withdrawal by Subject|1
7912462|NCT02075515|12430493|FG000|Overall Study|Lost to Follow-up|1
7912463|NCT02075515|12430494|FG001|Overall Study|Lost to Follow-up|3
7912464|NCT02075515|12430495|FG002|Overall Study|Lost to Follow-up|6
7912465|NCT02075541|12430506|FG000|Overall Study|Serious Adverse Event|1
7912466|NCT02075541|12430507|FG001|Overall Study|Serious Adverse Event|4
7912467|NCT02075541|12430506|FG000|Overall Study|Protocol Violation|1
7912468|NCT02075541|12430507|FG001|Overall Study|Protocol Violation|0
7912469|NCT02075541|12430506|FG000|Overall Study|Withdrawal by Subject|1
7912470|NCT02075541|12430507|FG001|Overall Study|Withdrawal by Subject|3
7912471|NCT02075541|12430506|FG000|Overall Study|Sponsor study termination|0
7912472|NCT02075541|12430507|FG001|Overall Study|Sponsor study termination|1
7912473|NCT02075541|12430506|FG000|Overall Study|Other- unable to perform study procedure|1
7912474|NCT02075541|12430507|FG001|Overall Study|Other- unable to perform study procedure|0
7964164|NCT02736890|12519345|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1
7964165|NCT02736890|12519346|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0
7964166|NCT02737358|12519400|FG000|Overall Study|Withdrawal by Subject|7
7964167|NCT02737358|12519401|FG001|Overall Study|Withdrawal by Subject|12
7964168|NCT02737358|12519400|FG000|Overall Study|Lost to Follow-up|2
7964169|NCT02737358|12519401|FG001|Overall Study|Lost to Follow-up|3
7964170|NCT02737501|12519419|FG000|Randomized Phase|Died|41
7964171|NCT02737501|12519420|FG001|Randomized Phase|Died|29
7964172|NCT02737501|12519421|FG002|Randomized Phase|Died|0
7964173|NCT02737501|12519419|FG000|Randomized Phase|Withdrawal by Subject|16
7964174|NCT02737501|12519420|FG001|Randomized Phase|Withdrawal by Subject|6
7964175|NCT02737501|12519421|FG002|Randomized Phase|Withdrawal by Subject|0
7964176|NCT02737501|12519419|FG000|Randomized Phase|Lost to Follow-up|0
7964177|NCT02737501|12519420|FG001|Randomized Phase|Lost to Follow-up|1
7964178|NCT02737501|12519421|FG002|Randomized Phase|Lost to Follow-up|0
7964179|NCT02737501|12519419|FG000|Randomized Phase|Site Terminated by Sponsor|58
7964180|NCT02737501|12519420|FG001|Randomized Phase|Site Terminated by Sponsor|16
7964181|NCT02737501|12519421|FG002|Randomized Phase|Site Terminated by Sponsor|0
7964182|NCT02737501|12519419|FG000|Randomized Phase|Reason not Specified|1
7964183|NCT02737501|12519420|FG001|Randomized Phase|Reason not Specified|1
7964184|NCT02737501|12519421|FG002|Randomized Phase|Reason not Specified|0
7964185|NCT02737501|12519419|FG000|Randomized Phase|Never Treated|1
7912475|NCT02075554|12430513|FG000|Overall Study|Lost to Follow-up|7
7912476|NCT02075554|12430513|FG000|Overall Study|Withdrawal by Subject|5
7912477|NCT02075554|12430513|FG000|Overall Study|Physician Decision|3
7912478|NCT02075606|12430517|FG000|Overall Study|Adverse Event|5
7912479|NCT02075606|12430517|FG000|Overall Study|Withdrawal by Subject|1
7912480|NCT02075606|12430517|FG000|Overall Study|Death|1
7912481|NCT02075606|12430517|FG000|Overall Study|Investigator's decision|1
7912482|NCT02075606|12430517|FG000|Overall Study|Symptom management|1
7912483|NCT02075606|12430517|FG000|Overall Study|Increasing Symptoms|1
7912484|NCT02075632|12430528|FG000|Overall Study|Adverse Event|1
7821026|NCT01253174|12289578|FG001|Period 1|Randomized but not treated|1
7821027|NCT01253174|12289579|FG002|Period 1|Randomized but not treated|1
7821028|NCT01253174|12289580|FG003|Period 1|Randomized but not treated|0
7821029|NCT01253174|12289581|FG004|Period 1|Randomized but not treated|1
7821030|NCT01253174|12289582|FG005|Period 1|Randomized but not treated|0
7821031|NCT01253174|12289577|FG000|Period 2|Adverse Event|0
7821032|NCT01253174|12289578|FG001|Period 2|Adverse Event|0
7821033|NCT01253174|12289579|FG002|Period 2|Adverse Event|1
7821034|NCT01253174|12289580|FG003|Period 2|Adverse Event|0
7821035|NCT01253174|12289581|FG004|Period 2|Adverse Event|0
7821036|NCT01253174|12289582|FG005|Period 2|Adverse Event|0
7821037|NCT01253174|12289577|FG000|Period 3|Withdrawal by Subject|0
7821038|NCT01253174|12289578|FG001|Period 3|Withdrawal by Subject|1
7821039|NCT01253174|12289579|FG002|Period 3|Withdrawal by Subject|0
7821040|NCT01253174|12289580|FG003|Period 3|Withdrawal by Subject|0
7821041|NCT01253174|12289581|FG004|Period 3|Withdrawal by Subject|1
7821042|NCT01253174|12289582|FG005|Period 3|Withdrawal by Subject|0
7821043|NCT01253174|12289577|FG000|Period 3|Pregnancy|0
7821044|NCT01253174|12289578|FG001|Period 3|Pregnancy|0
7821045|NCT01253174|12289579|FG002|Period 3|Pregnancy|1
7821046|NCT01253174|12289580|FG003|Period 3|Pregnancy|0
7821047|NCT01253174|12289581|FG004|Period 3|Pregnancy|0
7821048|NCT01253174|12289582|FG005|Period 3|Pregnancy|0
7821049|NCT01253187|12289591|FG000|Period 2|Withdrawal by Subject|0
7821050|NCT01253187|12289592|FG001|Period 2|Withdrawal by Subject|0
7821051|NCT01253187|12289593|FG002|Period 2|Withdrawal by Subject|0
7821052|NCT01253187|12289594|FG003|Period 2|Withdrawal by Subject|0
7821053|NCT01253187|12289595|FG004|Period 2|Withdrawal by Subject|1
7821054|NCT01253187|12289596|FG005|Period 2|Withdrawal by Subject|0
7821055|NCT01253187|12289591|FG000|Period 3|Pregnancy|1
7821056|NCT01253187|12289592|FG001|Period 3|Pregnancy|0
7821057|NCT01253187|12289593|FG002|Period 3|Pregnancy|0
7821058|NCT01253187|12289594|FG003|Period 3|Pregnancy|0
7821059|NCT01253187|12289595|FG004|Period 3|Pregnancy|0
7821060|NCT01253187|12289596|FG005|Period 3|Pregnancy|0
7821061|NCT01253187|12289591|FG000|Period 3|difficulty with blood sampling|0
7821062|NCT01253187|12289592|FG001|Period 3|difficulty with blood sampling|1
7821063|NCT01253187|12289593|FG002|Period 3|difficulty with blood sampling|0
7821064|NCT01253187|12289594|FG003|Period 3|difficulty with blood sampling|0
7912485|NCT02075632|12430529|FG001|Overall Study|Adverse Event|1
7912486|NCT02075632|12430528|FG000|Overall Study|Lost to Follow-up|0
7912487|NCT02075632|12430529|FG001|Overall Study|Lost to Follow-up|3
7912488|NCT02075632|12430528|FG000|Overall Study|Withdrawal by Subject|0
7912489|NCT02075632|12430529|FG001|Overall Study|Withdrawal by Subject|1
7912490|NCT02075658|12430537|FG000|Overall Study|Physician Decision|2
7912491|NCT02075658|12430538|FG001|Overall Study|Physician Decision|2
7912492|NCT02076022|12430546|FG000|Overall Study|Withdrawal by Subject|2
7912493|NCT02076022|12430547|FG001|Overall Study|Withdrawal by Subject|0
7912494|NCT02076165|12430596|FG000|Overall Study|Lost to Follow-up|7
7912495|NCT02076165|12430597|FG001|Overall Study|Lost to Follow-up|5
7912496|NCT02076165|12430596|FG000|Overall Study|Refused follow-up assessment|1
7912497|NCT02076165|12430597|FG001|Overall Study|Refused follow-up assessment|1
7912498|NCT02076334|12430620|FG000|Overall Study|Protocol Violation|1
7912499|NCT02076334|12430621|FG001|Overall Study|Protocol Violation|0
7912500|NCT02076334|12430622|FG002|Overall Study|Protocol Violation|0
7912501|NCT02076334|12430623|FG003|Overall Study|Protocol Violation|0
7912502|NCT02076334|12430620|FG000|Overall Study|Lost to Follow-up|0
7912503|NCT02076334|12430621|FG001|Overall Study|Lost to Follow-up|1
7912504|NCT02076334|12430622|FG002|Overall Study|Lost to Follow-up|1
7912505|NCT02076334|12430623|FG003|Overall Study|Lost to Follow-up|0
7912506|NCT02076334|12430620|FG000|Overall Study|muscle soreness|0
7912507|NCT02076334|12430621|FG001|Overall Study|muscle soreness|0
7912508|NCT02076334|12430622|FG002|Overall Study|muscle soreness|0
7912509|NCT02076334|12430623|FG003|Overall Study|muscle soreness|1
7912510|NCT02077140|12430724|FG000|Overall Study|Lost to Follow-up|4
7912511|NCT02077140|12430725|FG001|Overall Study|Lost to Follow-up|1
7912512|NCT02077140|12430726|FG002|Overall Study|Lost to Follow-up|2
7912513|NCT02077140|12430727|FG003|Overall Study|Lost to Follow-up|2
7912514|NCT02077140|12430728|FG004|Overall Study|Lost to Follow-up|3
7912515|NCT02077140|12430724|FG000|Overall Study|Withdrawal by Subject|0
7912516|NCT02077140|12430725|FG001|Overall Study|Withdrawal by Subject|1
7821065|NCT01253187|12289595|FG004|Period 3|difficulty with blood sampling|0
7821066|NCT01253187|12289596|FG005|Period 3|difficulty with blood sampling|0
7821067|NCT01253187|12289591|FG000|Period 3|non-compliance|0
7821068|NCT01253187|12289592|FG001|Period 3|non-compliance|0
7912517|NCT02077140|12430726|FG002|Overall Study|Withdrawal by Subject|0
7912518|NCT02077140|12430727|FG003|Overall Study|Withdrawal by Subject|2
7912519|NCT02077140|12430728|FG004|Overall Study|Withdrawal by Subject|2
7912520|NCT02077374|12430745|FG000|Overall Study|Withdrawal by Subject|0
7912521|NCT02077374|12430746|FG001|Overall Study|Withdrawal by Subject|1
7912522|NCT02077374|12430745|FG000|Overall Study|Protocol Violation|0
7912523|NCT02077374|12430746|FG001|Overall Study|Protocol Violation|1
7912524|NCT02077465|12430757|FG000|Overall Study|Withdrew Consent|0
7912525|NCT02077465|12430758|FG001|Overall Study|Withdrew Consent|1
7912526|NCT02077465|12430757|FG000|Overall Study|Lost to Follow-up|1
7912527|NCT02077465|12430758|FG001|Overall Study|Lost to Follow-up|0
7912528|NCT02078102|12430766|FG000|Overall Study|Adverse Event|1
7912529|NCT02078102|12430767|FG001|Overall Study|Adverse Event|0
7912530|NCT02078102|12430766|FG000|Overall Study|Withdrawal by Subject|1
7912531|NCT02078102|12430767|FG001|Overall Study|Withdrawal by Subject|0
7912532|NCT02078102|12430766|FG000|Overall Study|Physician Decision|0
7912533|NCT02078102|12430767|FG001|Overall Study|Physician Decision|1
7912534|NCT02078219|12430793|FG000|Overall Study|Other|2
7912535|NCT02078219|12430794|FG001|Overall Study|Other|2
7912536|NCT02078219|12430795|FG002|Overall Study|Other|3
7912537|NCT02078219|12430796|FG003|Overall Study|Other|0
7912538|NCT02078219|12430797|FG004|Overall Study|Other|1
7912539|NCT02078219|12430793|FG000|Overall Study|Withdrawal by Subject|0
7912540|NCT02078219|12430794|FG001|Overall Study|Withdrawal by Subject|1
7912541|NCT02078219|12430795|FG002|Overall Study|Withdrawal by Subject|0
7912542|NCT02078219|12430796|FG003|Overall Study|Withdrawal by Subject|1
7912543|NCT02078219|12430797|FG004|Overall Study|Withdrawal by Subject|1
7912544|NCT02078219|12430793|FG000|Overall Study|Protocol Violation|0
7912545|NCT02078219|12430794|FG001|Overall Study|Protocol Violation|0
7912546|NCT02078219|12430795|FG002|Overall Study|Protocol Violation|0
7912547|NCT02078219|12430796|FG003|Overall Study|Protocol Violation|1
7912548|NCT02078219|12430797|FG004|Overall Study|Protocol Violation|0
7912549|NCT02078219|12430793|FG000|Overall Study|Death|0
7912550|NCT02078219|12430794|FG001|Overall Study|Death|0
7912551|NCT02078219|12430795|FG002|Overall Study|Death|0
7912552|NCT02078219|12430796|FG003|Overall Study|Death|1
7912553|NCT02078219|12430797|FG004|Overall Study|Death|0
7912554|NCT02078219|12430793|FG000|Overall Study|Adverse Event|1
7912555|NCT02078219|12430794|FG001|Overall Study|Adverse Event|1
7912556|NCT02078219|12430795|FG002|Overall Study|Adverse Event|3
7912557|NCT02078219|12430796|FG003|Overall Study|Adverse Event|1
7912558|NCT02078219|12430797|FG004|Overall Study|Adverse Event|0
7912559|NCT02078713|12430851|FG000|Overall Study|Lost to Follow-up|49
7912560|NCT02078713|12430852|FG001|Overall Study|Lost to Follow-up|55
7912561|NCT02078713|12430853|FG002|Overall Study|Lost to Follow-up|0
7912562|NCT02078713|12430854|FG003|Overall Study|Lost to Follow-up|0
7912563|NCT02078713|12430851|FG000|Overall Study|Pregnant at baseline|3
7912564|NCT02078713|12430852|FG001|Overall Study|Pregnant at baseline|5
7912565|NCT02078713|12430853|FG002|Overall Study|Pregnant at baseline|0
7912566|NCT02078713|12430854|FG003|Overall Study|Pregnant at baseline|0
7912567|NCT02078713|12430851|FG000|Overall Study|Enrolled twice|0
7912568|NCT02078713|12430852|FG001|Overall Study|Enrolled twice|1
7912569|NCT02078713|12430853|FG002|Overall Study|Enrolled twice|0
7912570|NCT02078713|12430854|FG003|Overall Study|Enrolled twice|0
7912571|NCT02078752|12430885|FG000|Overall Study|Death|0
7912572|NCT02078752|12430886|FG001|Overall Study|Death|3
7912573|NCT02078752|12430887|FG002|Overall Study|Death|0
7912574|NCT02078752|12430888|FG003|Overall Study|Death|0
7912575|NCT02078752|12430889|FG004|Overall Study|Death|0
7912576|NCT02078752|12430890|FG005|Overall Study|Death|1
7912577|NCT02078752|12430891|FG006|Overall Study|Death|0
7912578|NCT02078752|12430892|FG007|Overall Study|Death|1
7912579|NCT02078752|12430893|FG008|Overall Study|Death|0
7912580|NCT02078752|12430894|FG009|Overall Study|Death|4
7912581|NCT02078752|12430885|FG000|Overall Study|Lost to Follow-up|1
7912582|NCT02078752|12430886|FG001|Overall Study|Lost to Follow-up|0
7912583|NCT02078752|12430887|FG002|Overall Study|Lost to Follow-up|0
7912584|NCT02078752|12430888|FG003|Overall Study|Lost to Follow-up|1
7912585|NCT02078752|12430889|FG004|Overall Study|Lost to Follow-up|0
7912586|NCT02078752|12430890|FG005|Overall Study|Lost to Follow-up|0
7912587|NCT02078752|12430891|FG006|Overall Study|Lost to Follow-up|0
7912588|NCT02078752|12430892|FG007|Overall Study|Lost to Follow-up|0
7912589|NCT02078752|12430893|FG008|Overall Study|Lost to Follow-up|0
7912590|NCT02078752|12430894|FG009|Overall Study|Lost to Follow-up|0
7912591|NCT02078752|12430885|FG000|Overall Study|Withdrawal by Subject|1
7912592|NCT02078752|12430886|FG001|Overall Study|Withdrawal by Subject|1
7912593|NCT02078752|12430887|FG002|Overall Study|Withdrawal by Subject|1
7912594|NCT02078752|12430888|FG003|Overall Study|Withdrawal by Subject|1
7912595|NCT02078752|12430889|FG004|Overall Study|Withdrawal by Subject|0
7912596|NCT02078752|12430890|FG005|Overall Study|Withdrawal by Subject|3
7912597|NCT02078752|12430891|FG006|Overall Study|Withdrawal by Subject|2
7912598|NCT02078752|12430892|FG007|Overall Study|Withdrawal by Subject|1
7912599|NCT02078752|12430893|FG008|Overall Study|Withdrawal by Subject|0
7912600|NCT02078752|12430894|FG009|Overall Study|Withdrawal by Subject|1
7912601|NCT02078752|12430885|FG000|Overall Study|Other|0
7912602|NCT02078752|12430886|FG001|Overall Study|Other|3
7912603|NCT02078752|12430887|FG002|Overall Study|Other|0
7912604|NCT02078752|12430888|FG003|Overall Study|Other|0
7912605|NCT02078752|12430889|FG004|Overall Study|Other|1
7912606|NCT02078752|12430890|FG005|Overall Study|Other|0
7912607|NCT02078752|12430891|FG006|Overall Study|Other|0
7912608|NCT02078752|12430892|FG007|Overall Study|Other|1
7912609|NCT02078752|12430893|FG008|Overall Study|Other|0
7912610|NCT02078752|12430894|FG009|Overall Study|Other|0
7912611|NCT02078752|12430885|FG000|Overall Study|Study terminated by sponsor|0
7912612|NCT02078752|12430886|FG001|Overall Study|Study terminated by sponsor|0
7912613|NCT02078752|12430887|FG002|Overall Study|Study terminated by sponsor|0
7912614|NCT02078752|12430888|FG003|Overall Study|Study terminated by sponsor|0
7912615|NCT02078752|12430889|FG004|Overall Study|Study terminated by sponsor|0
7912616|NCT02078752|12430890|FG005|Overall Study|Study terminated by sponsor|0
7912617|NCT02078752|12430891|FG006|Overall Study|Study terminated by sponsor|0
7912618|NCT02078752|12430892|FG007|Overall Study|Study terminated by sponsor|0
7912619|NCT02078752|12430893|FG008|Overall Study|Study terminated by sponsor|0
7912620|NCT02078752|12430894|FG009|Overall Study|Study terminated by sponsor|5
7912621|NCT02078817|12430925|FG000|Overall Study|Withdrawal by Subject|1
7912622|NCT02078960|12430936|FG000|Treatment Period|Other|0
7912623|NCT02078960|12430937|FG001|Treatment Period|Other|0
7912624|NCT02078960|12430938|FG002|Treatment Period|Other|1
7912625|NCT02078960|12430936|FG000|Treatment Period|Lack of Efficacy|0
7912626|NCT02078960|12430937|FG001|Treatment Period|Lack of Efficacy|1
7912627|NCT02078960|12430938|FG002|Treatment Period|Lack of Efficacy|0
7912628|NCT02078960|12430936|FG000|Treatment Period|Disease progression - accelerated phase|0
7912629|NCT02078960|12430937|FG001|Treatment Period|Disease progression - accelerated phase|1
7912630|NCT02078960|12430938|FG002|Treatment Period|Disease progression - accelerated phase|0
7912631|NCT02078960|12430936|FG000|Treatment Period|Disease progression - blast phase|1
7912632|NCT02078960|12430937|FG001|Treatment Period|Disease progression - blast phase|0
7912633|NCT02078960|12430938|FG002|Treatment Period|Disease progression - blast phase|0
7912634|NCT02078960|12430936|FG000|Treatment Period|Withdrawal by Subject|0
7912635|NCT02078960|12430937|FG001|Treatment Period|Withdrawal by Subject|1
7912636|NCT02078960|12430938|FG002|Treatment Period|Withdrawal by Subject|1
7912637|NCT02078960|12430936|FG000|Treatment Period|Adverse Event|1
7912638|NCT02078960|12430937|FG001|Treatment Period|Adverse Event|0
7912639|NCT02078960|12430938|FG002|Treatment Period|Adverse Event|0
7912640|NCT02078960|12430936|FG000|Treatment Period|Death|0
7912641|NCT02078960|12430937|FG001|Treatment Period|Death|0
7912642|NCT02078960|12430938|FG002|Treatment Period|Death|1
7912643|NCT02078960|12430936|FG000|Follow-up Period|Death|2
7912644|NCT02078960|12430937|FG001|Follow-up Period|Death|0
7912645|NCT02078960|12430938|FG002|Follow-up Period|Death|0
7912646|NCT02078960|12430936|FG000|Follow-up Period|Lost to Follow-up|0
7912647|NCT02078960|12430937|FG001|Follow-up Period|Lost to Follow-up|1
7912648|NCT02078960|12430938|FG002|Follow-up Period|Lost to Follow-up|0
7912649|NCT02079038|12430960|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6
7912650|NCT02079038|12430961|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5
7912651|NCT02079038|12430960|FG000|Modified Intent to Treat Population|Death|1
7912652|NCT02079038|12430961|FG001|Modified Intent to Treat Population|Death|0
7912653|NCT02079038|12430960|FG000|Completed 6 Months|Lost to Follow-up|2
7912654|NCT02079038|12430961|FG001|Completed 6 Months|Lost to Follow-up|1
7912655|NCT02079077|12430969|FG000|Overall Study|Lost to Follow-up|5
7912656|NCT02079077|12430970|FG001|Overall Study|Lost to Follow-up|7
7912657|NCT02079077|12430969|FG000|Overall Study|Became STIs Positive|1
7912658|NCT02079077|12430970|FG001|Overall Study|Became STIs Positive|2
7912659|NCT02079246|12430976|FG000|OLEX|Withdrawal before treatment|1
7912660|NCT02079246|12430977|FG001|OLEX|Withdrawal before treatment|0
7912661|NCT02079246|12430976|FG000|OLEX|Death|11
7912662|NCT02079246|12430977|FG001|OLEX|Death|0
7912663|NCT02079246|12430976|FG000|OLEX|Adverse Event|66
7912664|NCT02079246|12430977|FG001|OLEX|Adverse Event|0
7912665|NCT02079246|12430976|FG000|OLEX|Withdrawal by Subject|60
7912666|NCT02079246|12430977|FG001|OLEX|Withdrawal by Subject|0
7912667|NCT02079246|12430976|FG000|OLEX|Lost to Follow-up|6
7912668|NCT02079246|12430977|FG001|OLEX|Lost to Follow-up|0
7912669|NCT02079246|12430976|FG000|OLEX|Protocol Violation|6
7912670|NCT02079246|12430977|FG001|OLEX|Protocol Violation|0
7912671|NCT02079246|12430976|FG000|OLEX|Lack of Efficacy|3
7912672|NCT02079246|12430977|FG001|OLEX|Lack of Efficacy|0
7912673|NCT02079246|12430976|FG000|OLEX|Results of the lead-in studies|58
7912674|NCT02079246|12430977|FG001|OLEX|Results of the lead-in studies|0
7912675|NCT02079246|12430976|FG000|OLEX|Other: Disallowed medication|8
7912676|NCT02079246|12430977|FG001|OLEX|Other: Disallowed medication|0
7912677|NCT02079246|12430976|FG000|OLEX|Other: Insufficient compliance|2
7912678|NCT02079246|12430977|FG001|OLEX|Other: Insufficient compliance|0
7912679|NCT02079246|12430976|FG000|OLEX|Other: Caregiver unavailable|3
7912680|NCT02079246|12430977|FG001|OLEX|Other: Caregiver unavailable|0
7912681|NCT02079246|12430976|FG000|OLEX|Other: Coordinator decision|1
7912682|NCT02079246|12430977|FG001|OLEX|Other: Coordinator decision|0
7912683|NCT02079246|12430976|FG000|OLEX|Other: Worsening of condition|1
7912684|NCT02079246|12430977|FG001|OLEX|Other: Worsening of condition|0
7912685|NCT02079246|12430976|FG000|OLEX|Other: Moved to nursing home|1
7912686|NCT02079246|12430977|FG001|OLEX|Other: Moved to nursing home|0
7912687|NCT02079246|12430976|FG000|OLEX|Other: Withdrawal of caregiver consent|1
7912688|NCT02079246|12430977|FG001|OLEX|Other: Withdrawal of caregiver consent|0
7912689|NCT02079246|12430976|FG000|OLEX-MEM|Adverse Event|0
7912690|NCT02079246|12430977|FG001|OLEX-MEM|Adverse Event|6
7912691|NCT02079246|12430976|FG000|OLEX-MEM|Withdrawal by Subject|0
7912692|NCT02079246|12430977|FG001|OLEX-MEM|Withdrawal by Subject|7
7912693|NCT02079246|12430976|FG000|OLEX-MEM|Protocol Violation|0
7912694|NCT02079246|12430977|FG001|OLEX-MEM|Protocol Violation|2
7912695|NCT02079246|12430976|FG000|OLEX-MEM|Lost to Follow-up|0
7912696|NCT02079246|12430977|FG001|OLEX-MEM|Lost to Follow-up|1
7912697|NCT02079246|12430976|FG000|OLEX-MEM|Other: Moved to nursing home|0
7912698|NCT02079246|12430977|FG001|OLEX-MEM|Other: Moved to nursing home|3
7912699|NCT02079519|12430995|FG000|Overall Study|Disease Progression|9
7912700|NCT02079519|12430995|FG000|Overall Study|Adverse Event|1
7912701|NCT02079532|12430999|FG000|Overall Study|Adverse Event|7
7912702|NCT02079532|12430999|FG000|Overall Study|Additional or changed therapy|2
7912703|NCT02079532|12430999|FG000|Overall Study|Lack of Efficacy|9
7912704|NCT02079532|12430999|FG000|Overall Study|Protocol Violation|3
7912705|NCT02079532|12430999|FG000|Overall Study|Withdrawal by Subject|1
7912706|NCT02079532|12430999|FG000|Overall Study|Administrative problems|1
7912707|NCT02079532|12430999|FG000|Overall Study|Inclusion into ReFIRST|3
7912708|NCT02079532|12430999|FG000|Overall Study|Other|3
7912709|NCT02079610|12431005|FG000|Overall Study|Withdrawal by Subject|1
7912710|NCT02079610|12431006|FG001|Overall Study|Withdrawal by Subject|1
7912711|NCT02079636|12431027|FG000|Overall Study|Death|2
7912712|NCT02079636|12431028|FG001|Overall Study|Death|1
7912713|NCT02079636|12431029|FG002|Overall Study|Death|0
7912714|NCT02079636|12431030|FG003|Overall Study|Death|5
7912715|NCT02079636|12431031|FG004|Overall Study|Death|1
7912716|NCT02079636|12431032|FG005|Overall Study|Death|2
7912717|NCT02079636|12431033|FG006|Overall Study|Death|1
7912718|NCT02079636|12431034|FG007|Overall Study|Death|0
7912719|NCT02079636|12431035|FG008|Overall Study|Death|0
7912720|NCT02079636|12431036|FG009|Overall Study|Death|0
7912721|NCT02079636|12431037|FG010|Overall Study|Death|0
7912722|NCT02079636|12431038|FG011|Overall Study|Death|1
7912723|NCT02079636|12431039|FG012|Overall Study|Death|1
7912724|NCT02079636|12431040|FG013|Overall Study|Death|0
7912725|NCT02079636|12431041|FG014|Overall Study|Death|2
7912726|NCT02079636|12431027|FG000|Overall Study|Adverse Event|1
7912727|NCT02079636|12431028|FG001|Overall Study|Adverse Event|1
7912728|NCT02079636|12431029|FG002|Overall Study|Adverse Event|0
7912729|NCT02079636|12431030|FG003|Overall Study|Adverse Event|1
7912730|NCT02079636|12431031|FG004|Overall Study|Adverse Event|1
7912731|NCT02079636|12431032|FG005|Overall Study|Adverse Event|2
7912732|NCT02079636|12431033|FG006|Overall Study|Adverse Event|0
7912733|NCT02079636|12431034|FG007|Overall Study|Adverse Event|0
7912734|NCT02079636|12431035|FG008|Overall Study|Adverse Event|0
7912735|NCT02079636|12431036|FG009|Overall Study|Adverse Event|0
7912736|NCT02079636|12431037|FG010|Overall Study|Adverse Event|0
7912737|NCT02079636|12431038|FG011|Overall Study|Adverse Event|0
7912738|NCT02079636|12431039|FG012|Overall Study|Adverse Event|0
7912739|NCT02079636|12431040|FG013|Overall Study|Adverse Event|0
7912740|NCT02079636|12431041|FG014|Overall Study|Adverse Event|0
7912741|NCT02079636|12431027|FG000|Overall Study|Progressive disease|0
7912742|NCT02079636|12431028|FG001|Overall Study|Progressive disease|0
7912743|NCT02079636|12431029|FG002|Overall Study|Progressive disease|0
7912744|NCT02079636|12431030|FG003|Overall Study|Progressive disease|2
7912745|NCT02079636|12431031|FG004|Overall Study|Progressive disease|0
7912746|NCT02079636|12431032|FG005|Overall Study|Progressive disease|0
7912747|NCT02079636|12431033|FG006|Overall Study|Progressive disease|0
7912748|NCT02079636|12431034|FG007|Overall Study|Progressive disease|0
7912749|NCT02079636|12431035|FG008|Overall Study|Progressive disease|0
7912750|NCT02079636|12431036|FG009|Overall Study|Progressive disease|0
7912751|NCT02079636|12431037|FG010|Overall Study|Progressive disease|0
7912752|NCT02079636|12431038|FG011|Overall Study|Progressive disease|0
7912753|NCT02079636|12431039|FG012|Overall Study|Progressive disease|1
7912754|NCT02079636|12431040|FG013|Overall Study|Progressive disease|0
7912755|NCT02079636|12431041|FG014|Overall Study|Progressive disease|0
7912756|NCT02079636|12431027|FG000|Overall Study|Withdrawal by Subject|0
7912757|NCT02079636|12431028|FG001|Overall Study|Withdrawal by Subject|0
7912758|NCT02079636|12431029|FG002|Overall Study|Withdrawal by Subject|0
7912759|NCT02079636|12431030|FG003|Overall Study|Withdrawal by Subject|4
7912760|NCT02079636|12431031|FG004|Overall Study|Withdrawal by Subject|0
7912761|NCT02079636|12431032|FG005|Overall Study|Withdrawal by Subject|1
7912762|NCT02079636|12431033|FG006|Overall Study|Withdrawal by Subject|0
7912763|NCT02079636|12431034|FG007|Overall Study|Withdrawal by Subject|0
7912764|NCT02079636|12431035|FG008|Overall Study|Withdrawal by Subject|0
7912765|NCT02079636|12431036|FG009|Overall Study|Withdrawal by Subject|2
7912766|NCT02079636|12431037|FG010|Overall Study|Withdrawal by Subject|1
7912767|NCT02079636|12431038|FG011|Overall Study|Withdrawal by Subject|1
7912768|NCT02079636|12431039|FG012|Overall Study|Withdrawal by Subject|1
7912769|NCT02079636|12431040|FG013|Overall Study|Withdrawal by Subject|0
7912770|NCT02079636|12431041|FG014|Overall Study|Withdrawal by Subject|2
7912771|NCT02079636|12431027|FG000|Overall Study|Physician Decision|0
7912772|NCT02079636|12431028|FG001|Overall Study|Physician Decision|0
7912773|NCT02079636|12431029|FG002|Overall Study|Physician Decision|0
7912774|NCT02079636|12431030|FG003|Overall Study|Physician Decision|0
7912775|NCT02079636|12431031|FG004|Overall Study|Physician Decision|0
7912776|NCT02079636|12431032|FG005|Overall Study|Physician Decision|1
7912777|NCT02079636|12431033|FG006|Overall Study|Physician Decision|0
7912778|NCT02079636|12431034|FG007|Overall Study|Physician Decision|0
7912779|NCT02079636|12431035|FG008|Overall Study|Physician Decision|0
7912780|NCT02079636|12431036|FG009|Overall Study|Physician Decision|1
7912781|NCT02079636|12431037|FG010|Overall Study|Physician Decision|1
7912782|NCT02079636|12431038|FG011|Overall Study|Physician Decision|0
7912783|NCT02079636|12431039|FG012|Overall Study|Physician Decision|0
7912784|NCT02079636|12431040|FG013|Overall Study|Physician Decision|0
7912785|NCT02079636|12431041|FG014|Overall Study|Physician Decision|1
7912786|NCT02079636|12431027|FG000|Overall Study|Lost to Follow-up|0
7912787|NCT02079636|12431028|FG001|Overall Study|Lost to Follow-up|0
7912788|NCT02079636|12431029|FG002|Overall Study|Lost to Follow-up|0
7912789|NCT02079636|12431030|FG003|Overall Study|Lost to Follow-up|0
7912790|NCT02079636|12431031|FG004|Overall Study|Lost to Follow-up|0
7912791|NCT02079636|12431032|FG005|Overall Study|Lost to Follow-up|0
7912792|NCT02079636|12431033|FG006|Overall Study|Lost to Follow-up|0
7912793|NCT02079636|12431034|FG007|Overall Study|Lost to Follow-up|1
7912794|NCT02079636|12431035|FG008|Overall Study|Lost to Follow-up|0
7912795|NCT02079636|12431036|FG009|Overall Study|Lost to Follow-up|0
7912796|NCT02079636|12431037|FG010|Overall Study|Lost to Follow-up|0
7912797|NCT02079636|12431038|FG011|Overall Study|Lost to Follow-up|0
7912798|NCT02079636|12431039|FG012|Overall Study|Lost to Follow-up|0
7912799|NCT02079636|12431040|FG013|Overall Study|Lost to Follow-up|0
7912800|NCT02079636|12431041|FG014|Overall Study|Lost to Follow-up|0
7912801|NCT02079649|12431109|FG000|Overall Study|Lost to Follow-up|0
7912802|NCT02079649|12431110|FG001|Overall Study|Lost to Follow-up|0
7912803|NCT02079649|12431111|FG002|Overall Study|Lost to Follow-up|0
7912804|NCT02079649|12431112|FG003|Overall Study|Lost to Follow-up|1
7912805|NCT02079649|12431109|FG000|Overall Study|Withdrawal by Subject|0
7912806|NCT02079649|12431110|FG001|Overall Study|Withdrawal by Subject|0
7912807|NCT02079649|12431111|FG002|Overall Study|Withdrawal by Subject|0
7912808|NCT02079649|12431112|FG003|Overall Study|Withdrawal by Subject|1
7912809|NCT02079649|12431109|FG000|Overall Study|Randomization error (prior to treatment)|1
7912810|NCT02079649|12431110|FG001|Overall Study|Randomization error (prior to treatment)|0
7912811|NCT02079649|12431111|FG002|Overall Study|Randomization error (prior to treatment)|1
7912812|NCT02079649|12431112|FG003|Overall Study|Randomization error (prior to treatment)|0
7912813|NCT02079805|12431125|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7912814|NCT02079805|12431126|FG001|Overall Study|Pretreatment Event/Adverse Event|1
7912815|NCT02079805|12431125|FG000|Overall Study|Voluntary Withdrawal|0
7912816|NCT02079805|12431126|FG001|Overall Study|Voluntary Withdrawal|1
7912817|NCT02079844|12431135|FG000|Treatment Period 1|Voluntary Withdrawal|0
7912818|NCT02079844|12431136|FG001|Treatment Period 1|Voluntary Withdrawal|0
7912819|NCT02079844|12431137|FG002|Treatment Period 1|Voluntary Withdrawal|2
7912820|NCT02079844|12431135|FG000|Treatment Period 2|Voluntary Withdrawal|0
7912821|NCT02079844|12431136|FG001|Treatment Period 2|Voluntary Withdrawal|1
7912822|NCT02079844|12431137|FG002|Treatment Period 2|Voluntary Withdrawal|0
7912823|NCT02079909|12431151|FG000|Overall Study|Adverse Event|23
7912824|NCT02079909|12431152|FG001|Overall Study|Adverse Event|23
7912825|NCT02079909|12431153|FG002|Overall Study|Adverse Event|7
7912826|NCT02079909|12431151|FG000|Overall Study|Withdrawal by Subject|9
7912827|NCT02079909|12431152|FG001|Overall Study|Withdrawal by Subject|17
7912828|NCT02079909|12431153|FG002|Overall Study|Withdrawal by Subject|4
7912829|NCT02079909|12431151|FG000|Overall Study|Lost to Follow-up|2
7912830|NCT02079909|12431152|FG001|Overall Study|Lost to Follow-up|3
7912831|NCT02079909|12431153|FG002|Overall Study|Lost to Follow-up|1
7912832|NCT02079909|12431151|FG000|Overall Study|Death|2
7912833|NCT02079909|12431152|FG001|Overall Study|Death|2
7912834|NCT02079909|12431153|FG002|Overall Study|Death|0
7912835|NCT02079909|12431151|FG000|Overall Study|Lack of Efficacy|0
7912836|NCT02079909|12431152|FG001|Overall Study|Lack of Efficacy|0
7912837|NCT02079909|12431153|FG002|Overall Study|Lack of Efficacy|1
7912838|NCT02079909|12431151|FG000|Overall Study|Protocol Violation|0
7912839|NCT02079909|12431152|FG001|Overall Study|Protocol Violation|1
7912840|NCT02079909|12431153|FG002|Overall Study|Protocol Violation|1
7912841|NCT02079909|12431151|FG000|Overall Study|Physician Decision|0
7912842|NCT02079909|12431152|FG001|Overall Study|Physician Decision|1
7912843|NCT02079909|12431153|FG002|Overall Study|Physician Decision|1
7912844|NCT02079909|12431151|FG000|Overall Study|Relocation etc.|2
7912845|NCT02079909|12431152|FG001|Overall Study|Relocation etc.|2
7912846|NCT02079909|12431153|FG002|Overall Study|Relocation etc.|3
7912847|NCT02080091|12431171|FG000|Overall Study|Study Terminated|22
7912848|NCT02080091|12431171|FG000|Overall Study|Death|1
7912849|NCT02080091|12431171|FG000|Overall Study|Withdrawal by Subject|1
7912850|NCT02080091|12431171|FG000|Overall Study|Other|1
7912851|NCT02080364|12431201|FG000|Baseline Period|Protocol Violation|2
7912852|NCT02080364|12431202|FG001|Baseline Period|Protocol Violation|1
7912853|NCT02080364|12431203|FG002|Baseline Period|Protocol Violation|0
7912854|NCT02080364|12431204|FG003|Baseline Period|Protocol Violation|0
7912855|NCT02080364|12431201|FG000|Baseline Period|Other|0
7912856|NCT02080364|12431202|FG001|Baseline Period|Other|1
7912857|NCT02080364|12431203|FG002|Baseline Period|Other|1
7912858|NCT02080364|12431204|FG003|Baseline Period|Other|0
7912859|NCT02080364|12431201|FG000|Treatment Period|Adverse Event|10
7912860|NCT02080364|12431202|FG001|Treatment Period|Adverse Event|15
7912861|NCT02080364|12431203|FG002|Treatment Period|Adverse Event|11
7912862|NCT02080364|12431204|FG003|Treatment Period|Adverse Event|14
7912863|NCT02080364|12431201|FG000|Treatment Period|Lost to Follow-up|2
7912864|NCT02080364|12431202|FG001|Treatment Period|Lost to Follow-up|3
7912865|NCT02080364|12431203|FG002|Treatment Period|Lost to Follow-up|5
7912866|NCT02080364|12431204|FG003|Treatment Period|Lost to Follow-up|0
7912867|NCT02080364|12431201|FG000|Treatment Period|Protocol Violation|5
7912868|NCT02080364|12431202|FG001|Treatment Period|Protocol Violation|3
7912869|NCT02080364|12431203|FG002|Treatment Period|Protocol Violation|5
7912870|NCT02080364|12431204|FG003|Treatment Period|Protocol Violation|1
7912871|NCT02080364|12431201|FG000|Treatment Period|Withdrawal by Subject|16
7912872|NCT02080364|12431202|FG001|Treatment Period|Withdrawal by Subject|16
7912873|NCT02080364|12431203|FG002|Treatment Period|Withdrawal by Subject|15
7912874|NCT02080364|12431204|FG003|Treatment Period|Withdrawal by Subject|10
7912875|NCT02080364|12431201|FG000|Treatment Period|Study Terminated by Sponsor|0
7912876|NCT02080364|12431202|FG001|Treatment Period|Study Terminated by Sponsor|0
7912877|NCT02080364|12431203|FG002|Treatment Period|Study Terminated by Sponsor|180
7912878|NCT02080364|12431204|FG003|Treatment Period|Study Terminated by Sponsor|183
7912879|NCT02080364|12431201|FG000|Treatment Period|Other|14
7912880|NCT02080364|12431202|FG001|Treatment Period|Other|12
7912881|NCT02080364|12431203|FG002|Treatment Period|Other|21
7912882|NCT02080364|12431204|FG003|Treatment Period|Other|16
7912883|NCT02080481|12431249|FG000|Overall Study|Never received a block.|1
7912884|NCT02080481|12431250|FG001|Overall Study|Never received a block.|0
7912885|NCT02080832|12431306|FG000|Overall Study|Excluded from analysis by MRI|9
7912886|NCT02080832|12431307|FG001|Overall Study|Excluded from analysis by MRI|10
7912887|NCT02080832|12431308|FG002|Overall Study|Excluded from analysis by MRI|14
7912888|NCT02080832|12431306|FG000|Overall Study|Lost to Follow-up|0
7912889|NCT02080832|12431307|FG001|Overall Study|Lost to Follow-up|2
7912890|NCT02080832|12431308|FG002|Overall Study|Lost to Follow-up|2
7912891|NCT02080871|12431318|FG000|Overall Study|Death|1
7912892|NCT02080871|12431318|FG000|Overall Study|Lost to Follow-up|1
7912893|NCT02081001|12431324|FG000|Overall Study|Adverse Event|0
7912894|NCT02081001|12431325|FG001|Overall Study|Adverse Event|0
7912895|NCT02081001|12431326|FG002|Overall Study|Adverse Event|0
7912896|NCT02081001|12431327|FG003|Overall Study|Adverse Event|0
7912897|NCT02081001|12431328|FG004|Overall Study|Adverse Event|1
7912898|NCT02081001|12431329|FG005|Overall Study|Adverse Event|0
7912899|NCT02081001|12431330|FG006|Overall Study|Adverse Event|0
7912900|NCT02081001|12431331|FG007|Overall Study|Adverse Event|0
7912901|NCT02081001|12431332|FG008|Overall Study|Adverse Event|0
7912902|NCT02081001|12431333|FG009|Overall Study|Adverse Event|0
7912903|NCT02081001|12431334|FG010|Overall Study|Adverse Event|0
7912904|NCT02081001|12431335|FG011|Overall Study|Adverse Event|0
7912905|NCT02081079|12431372|FG000|Overall Study|Lack of Efficacy|3
7912906|NCT02081079|12431373|FG001|Overall Study|Lack of Efficacy|2
7912907|NCT02081079|12431372|FG000|Overall Study|Lost to Follow-up|1
7912908|NCT02081079|12431373|FG001|Overall Study|Lost to Follow-up|0
7912909|NCT02081196|12431383|FG000|Overall Study|Lost to Follow-up|1
7912910|NCT02081417|12431409|FG000|Overall Study|Lost to Follow-up|26
7912911|NCT02081417|12431410|FG001|Overall Study|Lost to Follow-up|23
7912912|NCT02081417|12431409|FG000|Overall Study|Moved Away|1
7912913|NCT02081417|12431410|FG001|Overall Study|Moved Away|2
7912914|NCT02081417|12431409|FG000|Overall Study|Incarcerated|2
7912915|NCT02081417|12431410|FG001|Overall Study|Incarcerated|2
7912916|NCT02081417|12431409|FG000|Overall Study|Death|4
7912917|NCT02081417|12431410|FG001|Overall Study|Death|3
7912918|NCT02081417|12431409|FG000|Overall Study|Withdrawal by Subject|4
7912919|NCT02081417|12431410|FG001|Overall Study|Withdrawal by Subject|0
7912920|NCT02081417|12431409|FG000|Overall Study|Admitted to Residential Treatment|2
7912921|NCT02081417|12431410|FG001|Overall Study|Admitted to Residential Treatment|0
7912922|NCT02081417|12431409|FG000|Overall Study|Did not start treatment|17
7912923|NCT02081417|12431410|FG001|Overall Study|Did not start treatment|21
7912924|NCT02081534|12431441|FG000|Overall Study|Adverse Event|5
7912925|NCT02081534|12431442|FG001|Overall Study|Adverse Event|4
7912926|NCT02081534|12431443|FG002|Overall Study|Adverse Event|3
7912927|NCT02081534|12431444|FG003|Overall Study|Adverse Event|10
7912928|NCT02081534|12431445|FG004|Overall Study|Adverse Event|2
7912929|NCT02081534|12431446|FG005|Overall Study|Adverse Event|8
7912930|NCT02081534|12431447|FG006|Overall Study|Adverse Event|2
7912931|NCT02081534|12431441|FG000|Overall Study|Withdrawal by Subject|0
7912932|NCT02081534|12431442|FG001|Overall Study|Withdrawal by Subject|1
7912933|NCT02081534|12431443|FG002|Overall Study|Withdrawal by Subject|1
7912934|NCT02081534|12431444|FG003|Overall Study|Withdrawal by Subject|1
7912935|NCT02081534|12431445|FG004|Overall Study|Withdrawal by Subject|1
7912936|NCT02081534|12431446|FG005|Overall Study|Withdrawal by Subject|0
7912937|NCT02081534|12431447|FG006|Overall Study|Withdrawal by Subject|1
7912938|NCT02081534|12431441|FG000|Overall Study|Protocol Violation|0
7912939|NCT02081534|12431442|FG001|Overall Study|Protocol Violation|3
7912940|NCT02081534|12431443|FG002|Overall Study|Protocol Violation|0
7912941|NCT02081534|12431444|FG003|Overall Study|Protocol Violation|0
7912942|NCT02081534|12431445|FG004|Overall Study|Protocol Violation|0
7912943|NCT02081534|12431446|FG005|Overall Study|Protocol Violation|0
7912944|NCT02081534|12431447|FG006|Overall Study|Protocol Violation|1
7912945|NCT02081534|12431441|FG000|Overall Study|Lost to Follow-up|0
7912946|NCT02081534|12431442|FG001|Overall Study|Lost to Follow-up|0
7912947|NCT02081534|12431443|FG002|Overall Study|Lost to Follow-up|0
7912948|NCT02081534|12431444|FG003|Overall Study|Lost to Follow-up|2
7912949|NCT02081534|12431445|FG004|Overall Study|Lost to Follow-up|1
7912950|NCT02081534|12431446|FG005|Overall Study|Lost to Follow-up|1
7912951|NCT02081534|12431447|FG006|Overall Study|Lost to Follow-up|0
7912952|NCT02081586|12431471|FG000|Overall Study|Lost to Follow-up|0
7912953|NCT02081586|12431472|FG001|Overall Study|Lost to Follow-up|1
7912954|NCT02081586|12431473|FG002|Overall Study|Lost to Follow-up|0
7912955|NCT02081586|12431474|FG003|Overall Study|Lost to Follow-up|1
7912956|NCT02081586|12431471|FG000|Overall Study|Head injury not related to study|0
7912957|NCT02081586|12431472|FG001|Overall Study|Head injury not related to study|0
7912958|NCT02081586|12431473|FG002|Overall Study|Head injury not related to study|1
7912959|NCT02081586|12431474|FG003|Overall Study|Head injury not related to study|0
7912960|NCT02081599|12431488|FG000|Period 1：Double-blind Period|Adverse Event|3
7912961|NCT02081599|12431489|FG001|Period 1：Double-blind Period|Adverse Event|0
7912962|NCT02081599|12431488|FG000|Period 1：Double-blind Period|Lack of Efficacy|2
7912963|NCT02081599|12431489|FG001|Period 1：Double-blind Period|Lack of Efficacy|1
7912964|NCT02081599|12431488|FG000|Period 1：Double-blind Period|Physician Decision|1
7912965|NCT02081599|12431489|FG001|Period 1：Double-blind Period|Physician Decision|0
7912966|NCT02081599|12431488|FG000|Period 1：Double-blind Period|Protocol Violation|0
7912967|NCT02081599|12431489|FG001|Period 1：Double-blind Period|Protocol Violation|1
7912968|NCT02081599|12431488|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1
7912969|NCT02081599|12431489|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0
7912970|NCT02081599|12431488|FG000|Period 1：Double-blind Period|stopping criteria|1
7912971|NCT02081599|12431489|FG001|Period 1：Double-blind Period|stopping criteria|0
7912972|NCT02081599|12431488|FG000|Period 2：Open-label Period|Adverse Event|1
7912973|NCT02081599|12431489|FG001|Period 2：Open-label Period|Adverse Event|0
7912974|NCT02081599|12431488|FG000|Period 2：Open-label Period|Lack of Efficacy|2
7912975|NCT02081599|12431489|FG001|Period 2：Open-label Period|Lack of Efficacy|4
7912976|NCT02081599|12431488|FG000|Period 2：Open-label Period|Physician Decision|1
7912977|NCT02081599|12431489|FG001|Period 2：Open-label Period|Physician Decision|0
7912978|NCT02081599|12431488|FG000|Period 2：Open-label Period|Withdrawal by Subject|2
7912979|NCT02081599|12431489|FG001|Period 2：Open-label Period|Withdrawal by Subject|0
7912980|NCT02081677|12431514|FG000|Overall Study|Adverse Event|0
7912981|NCT02081677|12431515|FG001|Overall Study|Adverse Event|0
7912982|NCT02081677|12431516|FG002|Overall Study|Adverse Event|1
7912983|NCT02081677|12431517|FG003|Overall Study|Adverse Event|0
7912984|NCT02081677|12431514|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7912985|NCT02081677|12431515|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7912986|NCT02081677|12431516|FG002|Overall Study|No Longer Meets Eligibility Criteria|1
7912987|NCT02081677|12431517|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
7912988|NCT02081677|12431514|FG000|Overall Study|Not comfortable with lens care system|1
7912989|NCT02081677|12431515|FG001|Overall Study|Not comfortable with lens care system|0
7912990|NCT02081677|12431516|FG002|Overall Study|Not comfortable with lens care system|0
7912991|NCT02081677|12431517|FG003|Overall Study|Not comfortable with lens care system|0
7912992|NCT02081677|12431514|FG000|Overall Study|Unsatisfactory Lens Fitting|0
7912993|NCT02081677|12431515|FG001|Overall Study|Unsatisfactory Lens Fitting|1
7912994|NCT02081677|12431516|FG002|Overall Study|Unsatisfactory Lens Fitting|0
7912995|NCT02081677|12431517|FG003|Overall Study|Unsatisfactory Lens Fitting|0
7912996|NCT02081690|12431527|FG000|Overall Study|Death|3
7912997|NCT02081690|12431527|FG000|Overall Study|Physician Decision|3
7912998|NCT02081690|12431527|FG000|Overall Study|Withdrawal by Subject|1
7912999|NCT02081846|12431576|FG000|Overall Study|Withdrawal by Subject|1
7913000|NCT02081846|12431577|FG001|Overall Study|Withdrawal by Subject|0
7913001|NCT02081846|12431576|FG000|Overall Study|invalid consent|1
7913002|NCT02081846|12431577|FG001|Overall Study|invalid consent|0
7913003|NCT02081859|12431585|FG000|Overall Study|No fertilization|2
7913004|NCT02081859|12431586|FG001|Overall Study|No fertilization|2
7913005|NCT02081859|12431585|FG000|Overall Study|No sperm|1
7913006|NCT02081859|12431586|FG001|Overall Study|No sperm|0
7913007|NCT02081859|12431585|FG000|Overall Study|Unanticipated freeze all cycle|2
7913008|NCT02081859|12431586|FG001|Overall Study|Unanticipated freeze all cycle|6
7913009|NCT02081859|12431585|FG000|Overall Study|< 4 embryos|27
7913010|NCT02081859|12431586|FG001|Overall Study|< 4 embryos|23
7913011|NCT02081859|12431585|FG000|Overall Study|Other reasons|2
7913012|NCT02081859|12431586|FG001|Overall Study|Other reasons|0
7913013|NCT02082158|12431628|FG000|Overall Study|Withdrawal by Subject|0
7913014|NCT02082158|12431629|FG001|Overall Study|Withdrawal by Subject|0
7913015|NCT02082158|12431630|FG002|Overall Study|Withdrawal by Subject|0
7913016|NCT02082158|12431631|FG003|Overall Study|Withdrawal by Subject|0
7913017|NCT02082158|12431632|FG004|Overall Study|Withdrawal by Subject|1
7913018|NCT02082158|12431633|FG005|Overall Study|Withdrawal by Subject|0
7913019|NCT02082158|12431628|FG000|Overall Study|Failed Fit-testing|8
7913020|NCT02082158|12431629|FG001|Overall Study|Failed Fit-testing|8
7913021|NCT02082158|12431630|FG002|Overall Study|Failed Fit-testing|14
7913022|NCT02082158|12431631|FG003|Overall Study|Failed Fit-testing|4
7913023|NCT02082158|12431632|FG004|Overall Study|Failed Fit-testing|3
7913024|NCT02082158|12431633|FG005|Overall Study|Failed Fit-testing|7
7913025|NCT02082184|12431655|FG000|Overall Study|Adverse Event|1
7913026|NCT02082184|12431656|FG001|Overall Study|Adverse Event|0
7913027|NCT02082184|12431655|FG000|Overall Study|Medical diagnosis|1
7913028|NCT02082184|12431656|FG001|Overall Study|Medical diagnosis|2
7913029|NCT02082184|12431655|FG000|Overall Study|Device associated symptoms|5
7913030|NCT02082184|12431656|FG001|Overall Study|Device associated symptoms|0
7913031|NCT02082184|12431655|FG000|Overall Study|Withdrawal by Subject|3
7913032|NCT02082184|12431656|FG001|Overall Study|Withdrawal by Subject|2
7913033|NCT02082184|12431655|FG000|Overall Study|Protocol Violation|0
7913034|NCT02082184|12431656|FG001|Overall Study|Protocol Violation|6
7913035|NCT02082184|12431655|FG000|Overall Study|Lost to Follow-up|0
7913036|NCT02082184|12431656|FG001|Overall Study|Lost to Follow-up|2
7913037|NCT02082184|12431655|FG000|Overall Study|Subject non-compliance|0
7913038|NCT02082184|12431656|FG001|Overall Study|Subject non-compliance|1
7913039|NCT02082210|12431668|FG000|Overall Study|Death|0
7913040|NCT02082210|12431669|FG001|Overall Study|Death|0
7913041|NCT02082210|12431670|FG002|Overall Study|Death|1
7913042|NCT02082210|12431671|FG003|Overall Study|Death|1
7913043|NCT02082210|12431672|FG004|Overall Study|Death|1
7913044|NCT02082210|12431673|FG005|Overall Study|Death|0
7913045|NCT02082210|12431668|FG000|Overall Study|Withdrawal by Subject|0
7913046|NCT02082210|12431669|FG001|Overall Study|Withdrawal by Subject|0
7913047|NCT02082210|12431670|FG002|Overall Study|Withdrawal by Subject|0
7913048|NCT02082210|12431671|FG003|Overall Study|Withdrawal by Subject|1
7913049|NCT02082210|12431672|FG004|Overall Study|Withdrawal by Subject|2
7913050|NCT02082210|12431673|FG005|Overall Study|Withdrawal by Subject|2
7913051|NCT02082210|12431668|FG000|Overall Study|Clinical Progression|0
7913052|NCT02082210|12431669|FG001|Overall Study|Clinical Progression|0
7913053|NCT02082210|12431670|FG002|Overall Study|Clinical Progression|0
7913054|NCT02082210|12431671|FG003|Overall Study|Clinical Progression|1
7913055|NCT02082210|12431672|FG004|Overall Study|Clinical Progression|0
7913056|NCT02082210|12431673|FG005|Overall Study|Clinical Progression|0
7913057|NCT02082210|12431668|FG000|Overall Study|No Post-Baseline Tumor Assesment|0
7913058|NCT02082210|12431669|FG001|Overall Study|No Post-Baseline Tumor Assesment|0
7913059|NCT02082210|12431670|FG002|Overall Study|No Post-Baseline Tumor Assesment|1
7913060|NCT02082210|12431671|FG003|Overall Study|No Post-Baseline Tumor Assesment|2
7913061|NCT02082210|12431672|FG004|Overall Study|No Post-Baseline Tumor Assesment|0
7719436|NCT00532155|12143398|FG001|Overall Study|Had brain metastasis, was mis-randomized|0
7719437|NCT00532155|12143397|FG000|Overall Study|Study stopped|1
7719438|NCT00532155|12143398|FG001|Overall Study|Study stopped|0
7913062|NCT02082210|12431673|FG005|Overall Study|No Post-Baseline Tumor Assesment|0
7913063|NCT02082210|12431668|FG000|Overall Study|Physician Decision|0
7913064|NCT02082210|12431669|FG001|Overall Study|Physician Decision|0
7913065|NCT02082210|12431670|FG002|Overall Study|Physician Decision|1
7913066|NCT02082210|12431671|FG003|Overall Study|Physician Decision|1
7913067|NCT02082210|12431672|FG004|Overall Study|Physician Decision|0
7913068|NCT02082210|12431673|FG005|Overall Study|Physician Decision|0
7913069|NCT02082262|12431699|FG000|Overall Study|Withdrawal by Subject|3
7913070|NCT02082262|12431699|FG000|Overall Study|Adverse Event|48
7913071|NCT02082340|12431709|FG000|Overall Study|Lost to Follow-up|1
7913072|NCT02082340|12431710|FG001|Overall Study|Lost to Follow-up|1
7913073|NCT02082483|12431727|FG000|Overall Study|Lost to Follow-up|1
7913074|NCT02082483|12431728|FG001|Overall Study|Lost to Follow-up|1
7913075|NCT02082483|12431727|FG000|Overall Study|Withdrawal by Subject|2
7913076|NCT02082483|12431728|FG001|Overall Study|Withdrawal by Subject|1
7913077|NCT02082483|12431727|FG000|Overall Study|Physician Decision|1
7913078|NCT02082483|12431728|FG001|Overall Study|Physician Decision|1
7913079|NCT02082483|12431727|FG000|Overall Study|Death|2
7913080|NCT02082483|12431728|FG001|Overall Study|Death|3
7913081|NCT02082522|12431737|FG000|Overall Study|Sponsor termination|5
7913082|NCT02082522|12431738|FG001|Overall Study|Sponsor termination|3
7913083|NCT02082522|12431737|FG000|Overall Study|Withdrawal by Subject|2
7913084|NCT02082522|12431738|FG001|Overall Study|Withdrawal by Subject|4
7913085|NCT02082522|12431737|FG000|Overall Study|Death|1
7913086|NCT02082522|12431738|FG001|Overall Study|Death|0
7913087|NCT02082522|12431737|FG000|Overall Study|Lost to Follow-up|1
7913088|NCT02082522|12431738|FG001|Overall Study|Lost to Follow-up|0
7913089|NCT02082522|12431737|FG000|Overall Study|Physician Decision|3
7913090|NCT02082522|12431738|FG001|Overall Study|Physician Decision|1
7913091|NCT02082522|12431737|FG000|Overall Study|Disease progression|2
7913092|NCT02082522|12431738|FG001|Overall Study|Disease progression|2
7913093|NCT02082522|12431737|FG000|Overall Study|Chemotherapy change|1
7913094|NCT02082522|12431738|FG001|Overall Study|Chemotherapy change|3
7913095|NCT02082912|12431781|FG000|Overall Study|Physician Decision|0
7913096|NCT02082912|12431782|FG001|Overall Study|Physician Decision|1
7913097|NCT02082977|12431798|FG000|Part 1 (Up to 3.2 Years)|Death|1
7913098|NCT02082977|12431799|FG001|Part 1 (Up to 3.2 Years)|Death|0
7913099|NCT02082977|12431800|FG002|Part 1 (Up to 3.2 Years)|Death|0
7913100|NCT02082977|12431801|FG003|Part 1 (Up to 3.2 Years)|Death|0
7913101|NCT02082977|12431802|FG004|Part 1 (Up to 3.2 Years)|Death|0
7913102|NCT02082977|12431803|FG005|Part 1 (Up to 3.2 Years)|Death|1
7913103|NCT02082977|12431804|FG006|Part 1 (Up to 3.2 Years)|Death|2
7913104|NCT02082977|12431805|FG007|Part 1 (Up to 3.2 Years)|Death|0
7913105|NCT02082977|12431806|FG008|Part 1 (Up to 3.2 Years)|Death|1
7913106|NCT02082977|12431807|FG009|Part 1 (Up to 3.2 Years)|Death|0
7913107|NCT02082977|12431798|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7913108|NCT02082977|12431799|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7913109|NCT02082977|12431800|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7913110|NCT02082977|12431801|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7913111|NCT02082977|12431802|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7913112|NCT02082977|12431803|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7913113|NCT02082977|12431804|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7913114|NCT02082977|12431805|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2
7913115|NCT02082977|12431806|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7913116|NCT02082977|12431807|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7913117|NCT02082977|12431798|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7913118|NCT02082977|12431799|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7913119|NCT02082977|12431800|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7913120|NCT02082977|12431801|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7913121|NCT02082977|12431802|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7913122|NCT02082977|12431803|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1
7913123|NCT02082977|12431804|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7913124|NCT02082977|12431805|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7913125|NCT02082977|12431806|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7913126|NCT02082977|12431807|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7913127|NCT02082977|12431798|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0
7913128|NCT02082977|12431799|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0
7913129|NCT02082977|12431800|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0
7913130|NCT02082977|12431801|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0
7913131|NCT02082977|12431802|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1
7913132|NCT02082977|12431803|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1
7913133|NCT02082977|12431804|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4
7913134|NCT02082977|12431805|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1
7913135|NCT02082977|12431806|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2
7913136|NCT02082977|12431807|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0
7913137|NCT02082977|12431798|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7913138|NCT02082977|12431799|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7913139|NCT02082977|12431800|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7913140|NCT02082977|12431801|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7913141|NCT02082977|12431802|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7913142|NCT02082977|12431803|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7913143|NCT02082977|12431804|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7913144|NCT02082977|12431805|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2
7913145|NCT02082977|12431806|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7913146|NCT02082977|12431807|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7964186|NCT02737501|12519420|FG001|Randomized Phase|Never Treated|1
7964187|NCT02737501|12519421|FG002|Randomized Phase|Never Treated|0
7964188|NCT02737501|12519419|FG000|Crossover Phase|Died|0
7964189|NCT02737501|12519420|FG001|Crossover Phase|Died|0
7964190|NCT02737501|12519421|FG002|Crossover Phase|Died|22
7964191|NCT02737501|12519419|FG000|Crossover Phase|Withdrew Consent|0
7964192|NCT02737501|12519420|FG001|Crossover Phase|Withdrew Consent|0
7964193|NCT02737501|12519421|FG002|Crossover Phase|Withdrew Consent|9
7964194|NCT02737501|12519419|FG000|Crossover Phase|Physician Decision|0
7964195|NCT02737501|12519420|FG001|Crossover Phase|Physician Decision|0
7964196|NCT02737501|12519421|FG002|Crossover Phase|Physician Decision|1
7913147|NCT02083185|12431855|FG000|Overall Study|Lost to Follow-up|0
7913148|NCT02083185|12431856|FG001|Overall Study|Lost to Follow-up|3
7913149|NCT02083185|12431857|FG002|Overall Study|Lost to Follow-up|0
7913150|NCT02083185|12431855|FG000|Overall Study|Withdrawal by Subject|9
7913151|NCT02083185|12431856|FG001|Overall Study|Withdrawal by Subject|15
7913152|NCT02083185|12431857|FG002|Overall Study|Withdrawal by Subject|1
7913153|NCT02083185|12431855|FG000|Overall Study|Death|2
7913154|NCT02083185|12431856|FG001|Overall Study|Death|2
7913155|NCT02083185|12431857|FG002|Overall Study|Death|1
7913156|NCT02083185|12431855|FG000|Overall Study|Reason not Specified|9
7913157|NCT02083185|12431856|FG001|Overall Study|Reason not Specified|6
7913158|NCT02083185|12431857|FG002|Overall Study|Reason not Specified|5
7913159|NCT02083185|12431855|FG000|Overall Study|Study Terminated by Sponsor|0
7913160|NCT02083185|12431856|FG001|Overall Study|Study Terminated by Sponsor|1
7913161|NCT02083185|12431857|FG002|Overall Study|Study Terminated by Sponsor|0
7913162|NCT02083185|12431855|FG000|Overall Study|Did not Receive Study Drug|0
7913163|NCT02083185|12431856|FG001|Overall Study|Did not Receive Study Drug|2
7913164|NCT02083185|12431857|FG002|Overall Study|Did not Receive Study Drug|0
7913165|NCT02083380|12431877|FG000|Overall Study|Lack of Efficacy|68
7913166|NCT02083380|12431878|FG001|Overall Study|Lack of Efficacy|79
7913167|NCT02083380|12431879|FG002|Overall Study|Lack of Efficacy|64
7913168|NCT02083380|12431877|FG000|Overall Study|Withdrawal by Subject|9
7913169|NCT02083380|12431878|FG001|Overall Study|Withdrawal by Subject|3
7913170|NCT02083380|12431879|FG002|Overall Study|Withdrawal by Subject|7
7913171|NCT02083380|12431877|FG000|Overall Study|Physician Decision|1
7913172|NCT02083380|12431878|FG001|Overall Study|Physician Decision|6
7913173|NCT02083380|12431879|FG002|Overall Study|Physician Decision|3
7913174|NCT02083380|12431877|FG000|Overall Study|Adverse Event|0
7913175|NCT02083380|12431878|FG001|Overall Study|Adverse Event|0
7913176|NCT02083380|12431879|FG002|Overall Study|Adverse Event|1
7913177|NCT02083380|12431877|FG000|Overall Study|Lost to Follow-up|5
7913178|NCT02083380|12431878|FG001|Overall Study|Lost to Follow-up|3
7913179|NCT02083380|12431879|FG002|Overall Study|Lost to Follow-up|3
7913180|NCT02083380|12431877|FG000|Overall Study|Other|8
7913181|NCT02083380|12431878|FG001|Overall Study|Other|4
7913182|NCT02083380|12431879|FG002|Overall Study|Other|6
7913183|NCT02083653|12431908|FG000|Overall Study|Randomized but not Treated|0
7913184|NCT02083653|12431909|FG001|Overall Study|Randomized but not Treated|2
7913185|NCT02083653|12431910|FG002|Overall Study|Randomized but not Treated|7
7913186|NCT02083653|12431908|FG000|Overall Study|Adverse Event|12
7913187|NCT02083653|12431909|FG001|Overall Study|Adverse Event|5
7913188|NCT02083653|12431910|FG002|Overall Study|Adverse Event|4
7913189|NCT02083653|12431908|FG000|Overall Study|Lost to Follow-up|1
7913190|NCT02083653|12431909|FG001|Overall Study|Lost to Follow-up|0
7913191|NCT02083653|12431910|FG002|Overall Study|Lost to Follow-up|0
7913192|NCT02083653|12431908|FG000|Overall Study|Death|2
7913193|NCT02083653|12431909|FG001|Overall Study|Death|2
7913194|NCT02083653|12431910|FG002|Overall Study|Death|2
7913195|NCT02083653|12431908|FG000|Overall Study|Progressive Disease|65
7913196|NCT02083653|12431909|FG001|Overall Study|Progressive Disease|73
7913197|NCT02083653|12431910|FG002|Overall Study|Progressive Disease|63
7913198|NCT02083653|12431908|FG000|Overall Study|Withdrawal by Subject|2
7913199|NCT02083653|12431909|FG001|Overall Study|Withdrawal by Subject|1
7913200|NCT02083653|12431910|FG002|Overall Study|Withdrawal by Subject|2
7913201|NCT02083653|12431908|FG000|Overall Study|Other Events|0
7913202|NCT02083653|12431909|FG001|Overall Study|Other Events|2
7913203|NCT02083653|12431910|FG002|Overall Study|Other Events|2
7913204|NCT02083653|12431908|FG000|Overall Study|Reason Missing|0
7913205|NCT02083653|12431909|FG001|Overall Study|Reason Missing|0
7913206|NCT02083653|12431910|FG002|Overall Study|Reason Missing|4
7913207|NCT02083783|12431937|FG000|Overall Study|Withdrawal by Subject|1
7913208|NCT02083783|12431938|FG001|Overall Study|Withdrawal by Subject|0
7913209|NCT02083926|12431968|FG000|Overall Study|Withdrawal by Subject|1
7913210|NCT02083926|12431969|FG001|Overall Study|Withdrawal by Subject|0
7913211|NCT02083965|12431978|FG000|Treatment Period|Other|1
7913212|NCT02083965|12431979|FG001|Treatment Period|Other|0
7913213|NCT02084056|12431989|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
7913214|NCT02084056|12431990|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7913215|NCT02084056|12431991|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7913216|NCT02084056|12431992|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7913217|NCT02084056|12431989|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1
7913218|NCT02084056|12431990|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7913219|NCT02084056|12431991|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7913220|NCT02084056|12431992|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7913221|NCT02084082|12432013|FG000|Washout Period 1 (35 Days)|Adverse Event|0
7913222|NCT02084082|12432014|FG001|Washout Period 1 (35 Days)|Adverse Event|0
7913223|NCT02084082|12432015|FG002|Washout Period 1 (35 Days)|Adverse Event|1
7913224|NCT02084082|12432016|FG003|Washout Period 1 (35 Days)|Adverse Event|1
7913225|NCT02084082|12432013|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7913226|NCT02084082|12432014|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7913227|NCT02084082|12432015|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7913228|NCT02084082|12432016|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1
7913229|NCT02084134|12432028|FG000|Overall Study|Protocol Violation|4
7913230|NCT02084134|12432029|FG001|Overall Study|Protocol Violation|2
7913231|NCT02084134|12432028|FG000|Overall Study|Death|0
7913232|NCT02084134|12432029|FG001|Overall Study|Death|1
7913233|NCT02084238|12432039|FG000|Overall Study|Lost to Follow-up|2
7913234|NCT02085135|12432095|FG000|Overall Study|Adverse Event|4
7913235|NCT02085135|12432096|FG001|Overall Study|Adverse Event|7
7913236|NCT02085135|12432095|FG000|Overall Study|Lost to Follow-up|2
7913237|NCT02085135|12432096|FG001|Overall Study|Lost to Follow-up|2
7913238|NCT02085135|12432095|FG000|Overall Study|Withdrawal by Subject|3
7913239|NCT02085135|12432096|FG001|Overall Study|Withdrawal by Subject|0
7913240|NCT02085135|12432095|FG000|Overall Study|Lack of Efficacy|2
7913241|NCT02085135|12432096|FG001|Overall Study|Lack of Efficacy|0
7913242|NCT02085161|12432106|FG000|Overall Study|Not Treated|1
7913243|NCT02085161|12432107|FG001|Overall Study|Not Treated|0
7913244|NCT02085161|12432108|FG002|Overall Study|Not Treated|0
7913245|NCT02085161|12432109|FG003|Overall Study|Not Treated|0
7913246|NCT02085161|12432106|FG000|Overall Study|Adverse Event|8
7913247|NCT02085161|12432107|FG001|Overall Study|Adverse Event|5
7913248|NCT02085161|12432108|FG002|Overall Study|Adverse Event|4
7913249|NCT02085161|12432109|FG003|Overall Study|Adverse Event|5
7913250|NCT02085161|12432106|FG000|Overall Study|Protocol Violation|0
7913251|NCT02085161|12432107|FG001|Overall Study|Protocol Violation|1
7913252|NCT02085161|12432108|FG002|Overall Study|Protocol Violation|0
7913253|NCT02085161|12432109|FG003|Overall Study|Protocol Violation|1
7913254|NCT02085161|12432106|FG000|Overall Study|Withdrawal by Subject|2
7913255|NCT02085161|12432107|FG001|Overall Study|Withdrawal by Subject|4
7913256|NCT02085161|12432108|FG002|Overall Study|Withdrawal by Subject|0
7913257|NCT02085161|12432109|FG003|Overall Study|Withdrawal by Subject|3
7913258|NCT02085161|12432106|FG000|Overall Study|Other Reason|1
7913259|NCT02085161|12432107|FG001|Overall Study|Other Reason|0
7913260|NCT02085161|12432108|FG002|Overall Study|Other Reason|1
7913261|NCT02085161|12432109|FG003|Overall Study|Other Reason|1
7913262|NCT02085252|12432122|FG000|Overall Study|Withdrawal of Consent|1
7913263|NCT02085252|12432123|FG001|Overall Study|Withdrawal of Consent|0
7913264|NCT02085252|12432122|FG000|Overall Study|Adverse Event|0
7913265|NCT02085252|12432123|FG001|Overall Study|Adverse Event|1
7913266|NCT02085252|12432122|FG000|Overall Study|Discontinuation Due to Patient Decision|0
7913267|NCT02085252|12432123|FG001|Overall Study|Discontinuation Due to Patient Decision|1
7913268|NCT02085252|12432122|FG000|Overall Study|Reason Not Specified|0
7913269|NCT02085252|12432123|FG001|Overall Study|Reason Not Specified|1
7913270|NCT02085252|12432122|FG000|Overall Study|Reason Unknown|0
7913271|NCT02085252|12432123|FG001|Overall Study|Reason Unknown|1
7913272|NCT02085460|12432154|FG000|Overall Study|Adverse Event|2
7913273|NCT02085460|12432155|FG001|Overall Study|Adverse Event|2
7913274|NCT02085460|12432156|FG002|Overall Study|Adverse Event|1
7913275|NCT02085460|12432154|FG000|Overall Study|Physician Decision|1
7913276|NCT02085460|12432155|FG001|Overall Study|Physician Decision|1
7913277|NCT02085460|12432156|FG002|Overall Study|Physician Decision|2
7913278|NCT02085460|12432154|FG000|Overall Study|Withdrawal by Subject|11
7913279|NCT02085460|12432155|FG001|Overall Study|Withdrawal by Subject|5
7913280|NCT02085460|12432156|FG002|Overall Study|Withdrawal by Subject|7
7913281|NCT02085785|12432195|FG000|Overall Study|Withdrawal by Subject|2
7913282|NCT02085785|12432196|FG001|Overall Study|Withdrawal by Subject|1
7913283|NCT02085785|12432195|FG000|Overall Study|Lost to Follow-up|0
7913284|NCT02085785|12432196|FG001|Overall Study|Lost to Follow-up|1
7913285|NCT02086110|12432210|FG000|Overall Study|Withdrawal by Subject|1
7913286|NCT02086110|12432211|FG001|Overall Study|Withdrawal by Subject|1
7913287|NCT02086162|12432220|FG000|Overall Study|Withdrawal by Subject|4
7913288|NCT02086162|12432221|FG001|Overall Study|Withdrawal by Subject|4
7913289|NCT02086162|12432220|FG000|Overall Study|moved|1
7913290|NCT02086162|12432221|FG001|Overall Study|moved|1
7913291|NCT02086162|12432220|FG000|Overall Study|Lost to Follow-up|4
7913292|NCT02086162|12432221|FG001|Overall Study|Lost to Follow-up|2
7913293|NCT02086162|12432220|FG000|Overall Study|Death|1
7913294|NCT02086162|12432221|FG001|Overall Study|Death|0
7913295|NCT02086565|12432255|FG000|Overall Study|Lost to Follow-up|9
7913296|NCT02086565|12432256|FG001|Overall Study|Lost to Follow-up|7
7913297|NCT02086565|12432255|FG000|Overall Study|Withdrawal by Subject|2
7913298|NCT02086565|12432256|FG001|Overall Study|Withdrawal by Subject|1
7913299|NCT02086565|12432255|FG000|Overall Study|Death|3
7913300|NCT02086565|12432256|FG001|Overall Study|Death|2
7913301|NCT02086565|12432255|FG000|Overall Study|withdrawn by research team|2
7913302|NCT02086565|12432256|FG001|Overall Study|withdrawn by research team|2
7913303|NCT02086591|12432262|FG000|Overall Study|Adverse Event|1
7913304|NCT02086591|12432262|FG000|Overall Study|Withdrawal by Subject|1
7913305|NCT02086591|12432262|FG000|Overall Study|protocol terminated|3
7913306|NCT02086968|12432300|FG000|Overall Study|Adverse Event|1
7913307|NCT02086968|12432301|FG001|Overall Study|Adverse Event|5
7913308|NCT02086968|12432300|FG000|Overall Study|Lost to Follow-up|2
7913309|NCT02086968|12432301|FG001|Overall Study|Lost to Follow-up|3
7913310|NCT02086968|12432300|FG000|Overall Study|Study drug received outside protocol|0
7913311|NCT02086968|12432301|FG001|Overall Study|Study drug received outside protocol|1
7913312|NCT02086968|12432300|FG000|Overall Study|Physician Decision|4
7913313|NCT02086968|12432301|FG001|Overall Study|Physician Decision|0
7913314|NCT02086968|12432300|FG000|Overall Study|Withdrawal by Subject|1
7913315|NCT02086968|12432301|FG001|Overall Study|Withdrawal by Subject|4
7913316|NCT02087046|12432307|FG000|Overall Study|Adverse Event|4
7913317|NCT02087046|12432307|FG000|Overall Study|Death|1
7913318|NCT02087046|12432307|FG000|Overall Study|Lost to Follow-up|3
7913319|NCT02087046|12432307|FG000|Overall Study|Withdrawal by Subject|2
7913320|NCT02087046|12432307|FG000|Overall Study|Physician Decision|1
7913321|NCT02087059|12432312|FG000|Overall Study|Disease Progression|1
7913322|NCT02087059|12432312|FG000|Overall Study|Adverse Event|5
7913323|NCT02087059|12432312|FG000|Overall Study|Lost to Follow-up|1
7913324|NCT02087085|12432318|FG000|Overall Study|Adverse Event|10
7913325|NCT02087085|12432319|FG001|Overall Study|Adverse Event|14
7913326|NCT02087085|12432318|FG000|Overall Study|Lack of Efficacy|4
7913327|NCT02087085|12432319|FG001|Overall Study|Lack of Efficacy|3
7913328|NCT02087085|12432318|FG000|Overall Study|Lost to Follow-up|6
7913329|NCT02087085|12432319|FG001|Overall Study|Lost to Follow-up|4
7913330|NCT02087085|12432318|FG000|Overall Study|Withdrawal by Subject|9
7913331|NCT02087085|12432319|FG001|Overall Study|Withdrawal by Subject|11
7913332|NCT02087085|12432318|FG000|Overall Study|Protocol Violation|1
7913333|NCT02087085|12432319|FG001|Overall Study|Protocol Violation|0
7913334|NCT02087085|12432318|FG000|Overall Study|Study Terminated by Sponsor|87
7913335|NCT02087085|12432319|FG001|Overall Study|Study Terminated by Sponsor|80
7913336|NCT02087085|12432318|FG000|Overall Study|Other Miscellaneous Reasons|3
7913337|NCT02087085|12432319|FG001|Overall Study|Other Miscellaneous Reasons|4
7913338|NCT02087150|12432328|FG000|Overall Study|Death|0
7913339|NCT02087150|12432329|FG001|Overall Study|Death|1
7913340|NCT02087150|12432330|FG002|Overall Study|Death|0
7913341|NCT02087150|12432328|FG000|Overall Study|Lost to Follow-up|6
7913342|NCT02087150|12432329|FG001|Overall Study|Lost to Follow-up|13
7913343|NCT02087150|12432330|FG002|Overall Study|Lost to Follow-up|7
7913344|NCT02087150|12432328|FG000|Overall Study|Withdrawal by Subject|2
7719439|NCT00532155|12143397|FG000|Overall Study|Study terminated by sponsor|1
7719440|NCT00532155|12143398|FG001|Overall Study|Study terminated by sponsor|0
7719441|NCT00532155|12143397|FG000|Overall Study|Study termination stop further treatment|4
7719442|NCT00532155|12143398|FG001|Overall Study|Study termination stop further treatment|0
7719443|NCT00532155|12143397|FG000|Overall Study|Did not receive study medication|2
7719444|NCT00532155|12143398|FG001|Overall Study|Did not receive study medication|6
7719445|NCT00532259|12143404|FG000|Overall Study|Withdrawal by Subject|2
7719446|NCT00532259|12143404|FG000|Overall Study|Adverse Event|1
7719447|NCT00532259|12143404|FG000|Overall Study|Death|1
7719448|NCT00532259|12143404|FG000|Overall Study|Lack of Efficacy|21
7719449|NCT00532259|12143404|FG000|Overall Study|Lost to Follow-up|3
7719450|NCT00532259|12143404|FG000|Overall Study|Physician Decision|3
7719451|NCT00532259|12143404|FG000|Overall Study|Protocol Violation|1
7719452|NCT00532298|12143415|FG000|Overall Study|Adverse Event|1
7719453|NCT00532298|12143416|FG001|Overall Study|Adverse Event|0
7719454|NCT00532298|12143417|FG002|Overall Study|Adverse Event|0
7913345|NCT02087150|12432329|FG001|Overall Study|Withdrawal by Subject|5
7913346|NCT02087150|12432330|FG002|Overall Study|Withdrawal by Subject|3
7913347|NCT02087150|12432328|FG000|Overall Study|Physician Decision|0
7913348|NCT02087150|12432329|FG001|Overall Study|Physician Decision|1
7913349|NCT02087150|12432330|FG002|Overall Study|Physician Decision|0
7913350|NCT02087150|12432328|FG000|Overall Study|Procedure not done|1
7913351|NCT02087150|12432329|FG001|Overall Study|Procedure not done|13
7913352|NCT02087150|12432330|FG002|Overall Study|Procedure not done|0
7913353|NCT02087150|12432328|FG000|Overall Study|F/U not completed w/in study window|0
7913354|NCT02087150|12432329|FG001|Overall Study|F/U not completed w/in study window|0
7913355|NCT02087150|12432330|FG002|Overall Study|F/U not completed w/in study window|1
7913356|NCT02087150|12432328|FG000|Overall Study|Other|1
7913357|NCT02087150|12432329|FG001|Overall Study|Other|0
7913358|NCT02087150|12432330|FG002|Overall Study|Other|0
7913359|NCT02087150|12432328|FG000|Overall Study|Pt moved out of town|0
7913360|NCT02087150|12432329|FG001|Overall Study|Pt moved out of town|1
7913361|NCT02087150|12432330|FG002|Overall Study|Pt moved out of town|0
7719455|NCT00532298|12143418|FG003|Overall Study|Adverse Event|0
7913362|NCT02087176|12432343|FG000|Overall Study|Withdrawal by Subject|1
7913363|NCT02087176|12432343|FG000|Overall Study|Death|10
7913364|NCT02087176|12432343|FG000|Overall Study|Censored|19
7913365|NCT02087176|12432343|FG000|Overall Study|Study Terminated by Sponsor|2
7913366|NCT02087241|12432351|FG000|Overall Study|Death|2
7913367|NCT02087241|12432352|FG001|Overall Study|Death|1
7913368|NCT02087241|12432353|FG002|Overall Study|Death|1
7913369|NCT02087241|12432354|FG003|Overall Study|Death|1
7913370|NCT02087241|12432351|FG000|Overall Study|Withdrawal by Subject|1
7913371|NCT02087241|12432352|FG001|Overall Study|Withdrawal by Subject|0
7913372|NCT02087241|12432353|FG002|Overall Study|Withdrawal by Subject|0
7913373|NCT02087241|12432354|FG003|Overall Study|Withdrawal by Subject|1
7913374|NCT02087241|12432351|FG000|Overall Study|Progressive Disease|0
7913375|NCT02087241|12432352|FG001|Overall Study|Progressive Disease|0
7913376|NCT02087241|12432353|FG002|Overall Study|Progressive Disease|0
7913377|NCT02087241|12432354|FG003|Overall Study|Progressive Disease|1
7913378|NCT02087241|12432351|FG000|Overall Study|Study Terminated by Sponsor|0
7913379|NCT02087241|12432352|FG001|Overall Study|Study Terminated by Sponsor|2
7913380|NCT02087241|12432353|FG002|Overall Study|Study Terminated by Sponsor|0
7913381|NCT02087241|12432354|FG003|Overall Study|Study Terminated by Sponsor|4
7913382|NCT02087670|12432407|FG000|Overall Study|Withdrawal by Subject|3
7913383|NCT02087670|12432408|FG001|Overall Study|Withdrawal by Subject|2
7913384|NCT02087774|12432424|FG000|Overall Study|Were absent day of data collection|8
7913385|NCT02087774|12432425|FG001|Overall Study|Were absent day of data collection|20
7913386|NCT02087904|12432435|FG000|Overall Study|Did Not Receive Study Drug|0
7913387|NCT02087904|12432436|FG001|Overall Study|Did Not Receive Study Drug|0
7913388|NCT02087904|12432437|FG002|Overall Study|Did Not Receive Study Drug|2
7913389|NCT02087904|12432438|FG003|Overall Study|Did Not Receive Study Drug|1
7913390|NCT02087904|12432435|FG000|Overall Study|Adverse Event|8
7913391|NCT02087904|12432436|FG001|Overall Study|Adverse Event|4
7913392|NCT02087904|12432437|FG002|Overall Study|Adverse Event|4
7913393|NCT02087904|12432438|FG003|Overall Study|Adverse Event|12
7913394|NCT02087904|12432435|FG000|Overall Study|Lack of Efficacy|3
7913395|NCT02087904|12432436|FG001|Overall Study|Lack of Efficacy|6
7913396|NCT02087904|12432437|FG002|Overall Study|Lack of Efficacy|3
7913397|NCT02087904|12432438|FG003|Overall Study|Lack of Efficacy|2
7913398|NCT02087904|12432435|FG000|Overall Study|Other|6
7913399|NCT02087904|12432436|FG001|Overall Study|Other|2
7913400|NCT02087904|12432437|FG002|Overall Study|Other|4
7913401|NCT02087904|12432438|FG003|Overall Study|Other|4
7913402|NCT02087904|12432435|FG000|Overall Study|Withdrawal by Subject|8
7913403|NCT02087904|12432436|FG001|Overall Study|Withdrawal by Subject|3
7913404|NCT02087904|12432437|FG002|Overall Study|Withdrawal by Subject|7
7913405|NCT02087904|12432438|FG003|Overall Study|Withdrawal by Subject|4
7913406|NCT02087904|12432435|FG000|Overall Study|Lost to Follow-up|0
7913407|NCT02087904|12432436|FG001|Overall Study|Lost to Follow-up|4
7913408|NCT02087904|12432437|FG002|Overall Study|Lost to Follow-up|2
7913409|NCT02087904|12432438|FG003|Overall Study|Lost to Follow-up|2
7913410|NCT02087943|12432451|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1
7913411|NCT02087943|12432452|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2
7913412|NCT02087943|12432453|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6
7913413|NCT02087943|12432454|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0
7913414|NCT02087943|12432455|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0
7913415|NCT02087943|12432451|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
7913416|NCT02087943|12432452|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
7913417|NCT02087943|12432453|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
7913418|NCT02087943|12432454|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
7913419|NCT02087943|12432455|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
7913420|NCT02087943|12432451|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
7913421|NCT02087943|12432452|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
7913422|NCT02087943|12432453|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
7913423|NCT02087943|12432454|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
7913424|NCT02087943|12432455|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
7913425|NCT02087943|12432451|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
7913426|NCT02087943|12432452|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
7913427|NCT02087943|12432453|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
7913428|NCT02087943|12432454|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
7913429|NCT02087943|12432455|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
7913430|NCT02087943|12432451|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7913431|NCT02087943|12432452|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
7913432|NCT02087943|12432453|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7913433|NCT02087943|12432454|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7913434|NCT02087943|12432455|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7913435|NCT02087943|12432451|FG000|Active Treatment Phase Week 12-24|Adverse Event|0
7913436|NCT02087943|12432452|FG001|Active Treatment Phase Week 12-24|Adverse Event|1
7913437|NCT02087943|12432453|FG002|Active Treatment Phase Week 12-24|Adverse Event|2
7913438|NCT02087943|12432454|FG003|Active Treatment Phase Week 12-24|Adverse Event|0
7913439|NCT02087943|12432455|FG004|Active Treatment Phase Week 12-24|Adverse Event|1
7913440|NCT02087943|12432451|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0
7913441|NCT02087943|12432452|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3
7913442|NCT02087943|12432453|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1
7913443|NCT02087943|12432454|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1
7913444|NCT02087943|12432455|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0
7913445|NCT02087943|12432451|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
7913446|NCT02087943|12432452|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
7913447|NCT02087943|12432453|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
7913448|NCT02087943|12432454|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
7913449|NCT02087943|12432455|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
7913450|NCT02087943|12432451|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7913451|NCT02087943|12432452|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7913452|NCT02087943|12432453|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7913453|NCT02087943|12432454|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7913454|NCT02087943|12432455|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1
7913455|NCT02087943|12432451|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0
7913456|NCT02087943|12432452|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0
7913457|NCT02087943|12432453|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1
7913458|NCT02087943|12432454|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1
7913459|NCT02087943|12432455|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0
7913460|NCT02088034|12432485|FG000|Overall Study|Lost to Follow-up|1
7913461|NCT02088034|12432486|FG001|Overall Study|Lost to Follow-up|1
7913462|NCT02088034|12432487|FG002|Overall Study|Lost to Follow-up|0
7913463|NCT02088034|12432485|FG000|Overall Study|Pregnancy|2
7913464|NCT02088034|12432486|FG001|Overall Study|Pregnancy|1
7913465|NCT02088034|12432487|FG002|Overall Study|Pregnancy|2
7913466|NCT02088047|12432497|FG000|Overall Study|Withdrawal by Subject|1
7913467|NCT02088047|12432498|FG001|Overall Study|Withdrawal by Subject|0
7913468|NCT02088073|12432509|FG000|Acute Phase|Withdrawal by Subject|5
7913469|NCT02088073|12432510|FG001|Acute Phase|Withdrawal by Subject|0
7913470|NCT02088073|12432511|FG002|Acute Phase|Withdrawal by Subject|0
7913471|NCT02088073|12432512|FG003|Acute Phase|Withdrawal by Subject|0
7913472|NCT02088073|12432513|FG004|Acute Phase|Withdrawal by Subject|0
7913473|NCT02088073|12432509|FG000|Acute Phase|Hyperkalemia|2
7913474|NCT02088073|12432510|FG001|Acute Phase|Hyperkalemia|0
7913475|NCT02088073|12432511|FG002|Acute Phase|Hyperkalemia|0
7913476|NCT02088073|12432512|FG003|Acute Phase|Hyperkalemia|0
7913477|NCT02088073|12432513|FG004|Acute Phase|Hyperkalemia|0
7913478|NCT02088073|12432509|FG000|Maintanance Phase|Withdrawal by Subject|0
7913479|NCT02088073|12432510|FG001|Maintanance Phase|Withdrawal by Subject|2
7913480|NCT02088073|12432511|FG002|Maintanance Phase|Withdrawal by Subject|0
7913481|NCT02088073|12432512|FG003|Maintanance Phase|Withdrawal by Subject|0
7913482|NCT02088073|12432513|FG004|Maintanance Phase|Withdrawal by Subject|0
7913483|NCT02088073|12432509|FG000|Maintanance Phase|Adverse Event|0
7913484|NCT02088073|12432510|FG001|Maintanance Phase|Adverse Event|0
7913485|NCT02088073|12432511|FG002|Maintanance Phase|Adverse Event|3
7913486|NCT02088073|12432512|FG003|Maintanance Phase|Adverse Event|0
7913487|NCT02088073|12432513|FG004|Maintanance Phase|Adverse Event|1
7913488|NCT02088073|12432509|FG000|Maintanance Phase|Physician Decision|0
7913489|NCT02088073|12432510|FG001|Maintanance Phase|Physician Decision|0
7913490|NCT02088073|12432511|FG002|Maintanance Phase|Physician Decision|0
7913491|NCT02088073|12432512|FG003|Maintanance Phase|Physician Decision|0
7913492|NCT02088073|12432513|FG004|Maintanance Phase|Physician Decision|1
7913493|NCT02088073|12432509|FG000|Maintanance Phase|Sponsor's decision|0
7913494|NCT02088073|12432510|FG001|Maintanance Phase|Sponsor's decision|2
7913495|NCT02088073|12432511|FG002|Maintanance Phase|Sponsor's decision|0
7913496|NCT02088073|12432512|FG003|Maintanance Phase|Sponsor's decision|2
7913497|NCT02088073|12432513|FG004|Maintanance Phase|Sponsor's decision|1
7913498|NCT02088073|12432509|FG000|Maintanance Phase|Hypo- or hyperkalemia|0
7913499|NCT02088073|12432510|FG001|Maintanance Phase|Hypo- or hyperkalemia|3
7913500|NCT02088073|12432511|FG002|Maintanance Phase|Hypo- or hyperkalemia|0
7913501|NCT02088073|12432512|FG003|Maintanance Phase|Hypo- or hyperkalemia|3
7913502|NCT02088073|12432513|FG004|Maintanance Phase|Hypo- or hyperkalemia|1
7913503|NCT02088073|12432509|FG000|Maintanance Phase|Miscellaneous|0
7913504|NCT02088073|12432510|FG001|Maintanance Phase|Miscellaneous|2
7913505|NCT02088073|12432511|FG002|Maintanance Phase|Miscellaneous|1
7913506|NCT02088073|12432512|FG003|Maintanance Phase|Miscellaneous|2
7913507|NCT02088073|12432513|FG004|Maintanance Phase|Miscellaneous|1
7913508|NCT02088073|12432509|FG000|Maintanance Phase|Met ECG withdrawal criteria|0
7913509|NCT02088073|12432510|FG001|Maintanance Phase|Met ECG withdrawal criteria|0
7913510|NCT02088073|12432511|FG002|Maintanance Phase|Met ECG withdrawal criteria|1
7913511|NCT02088073|12432512|FG003|Maintanance Phase|Met ECG withdrawal criteria|0
7913512|NCT02088073|12432513|FG004|Maintanance Phase|Met ECG withdrawal criteria|2
7913513|NCT02088073|12432509|FG000|Maintanance Phase|Subject compliance|0
7913514|NCT02088073|12432510|FG001|Maintanance Phase|Subject compliance|1
7913515|NCT02088073|12432511|FG002|Maintanance Phase|Subject compliance|0
7913516|NCT02088073|12432512|FG003|Maintanance Phase|Subject compliance|0
7913517|NCT02088073|12432513|FG004|Maintanance Phase|Subject compliance|0
7913518|NCT02088177|12432526|FG000|Overall Study|Lost to Follow-up|3
7913519|NCT02088541|12432553|FG000|Overall Study|Adverse Event|3
7913520|NCT02088541|12432554|FG001|Overall Study|Adverse Event|0
7913521|NCT02088541|12432555|FG002|Overall Study|Adverse Event|3
7913522|NCT02088541|12432556|FG003|Overall Study|Adverse Event|3
7913523|NCT02088541|12432557|FG004|Overall Study|Adverse Event|0
7913524|NCT02088541|12432553|FG000|Overall Study|Death|51
7913525|NCT02088541|12432554|FG001|Overall Study|Death|21
7913526|NCT02088541|12432555|FG002|Overall Study|Death|85
7913527|NCT02088541|12432556|FG003|Overall Study|Death|28
7913528|NCT02088541|12432557|FG004|Overall Study|Death|38
7913529|NCT02088541|12432553|FG000|Overall Study|Lost to Follow-up|2
7913530|NCT02088541|12432554|FG001|Overall Study|Lost to Follow-up|0
7913531|NCT02088541|12432555|FG002|Overall Study|Lost to Follow-up|1
7913532|NCT02088541|12432556|FG003|Overall Study|Lost to Follow-up|0
7913533|NCT02088541|12432557|FG004|Overall Study|Lost to Follow-up|0
7913534|NCT02088541|12432553|FG000|Overall Study|Physician Decision|2
7913535|NCT02088541|12432554|FG001|Overall Study|Physician Decision|1
7913536|NCT02088541|12432555|FG002|Overall Study|Physician Decision|2
7913537|NCT02088541|12432556|FG003|Overall Study|Physician Decision|0
7913538|NCT02088541|12432557|FG004|Overall Study|Physician Decision|2
7913539|NCT02088541|12432553|FG000|Overall Study|Disease progression|7
7913540|NCT02088541|12432554|FG001|Overall Study|Disease progression|1
7913541|NCT02088541|12432555|FG002|Overall Study|Disease progression|2
7913542|NCT02088541|12432556|FG003|Overall Study|Disease progression|3
7913543|NCT02088541|12432557|FG004|Overall Study|Disease progression|1
7913544|NCT02088541|12432553|FG000|Overall Study|Study terminated by sponsor|1
7913545|NCT02088541|12432554|FG001|Overall Study|Study terminated by sponsor|1
7913546|NCT02088541|12432555|FG002|Overall Study|Study terminated by sponsor|12
7913547|NCT02088541|12432556|FG003|Overall Study|Study terminated by sponsor|2
7913548|NCT02088541|12432557|FG004|Overall Study|Study terminated by sponsor|6
7913549|NCT02088541|12432553|FG000|Overall Study|Withdrawal by Subject|3
7913550|NCT02088541|12432554|FG001|Overall Study|Withdrawal by Subject|2
7913551|NCT02088541|12432555|FG002|Overall Study|Withdrawal by Subject|9
7913552|NCT02088541|12432556|FG003|Overall Study|Withdrawal by Subject|7
7913553|NCT02088541|12432557|FG004|Overall Study|Withdrawal by Subject|10
7913554|NCT02088541|12432553|FG000|Overall Study|Other|2
7913555|NCT02088541|12432554|FG001|Overall Study|Other|1
7913556|NCT02088541|12432555|FG002|Overall Study|Other|3
7913557|NCT02088541|12432556|FG003|Overall Study|Other|1
7913558|NCT02088541|12432557|FG004|Overall Study|Other|1
7913559|NCT02088697|12432569|FG000|Period I|Physician Decision|1
7913560|NCT02088697|12432570|FG001|Period I|Physician Decision|4
7913561|NCT02088697|12432569|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1
7913562|NCT02088697|12432570|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0
7913563|NCT02088905|12432587|FG000|Overall Study|Withdrawal by Subject|5
7913564|NCT02088905|12432588|FG001|Overall Study|Withdrawal by Subject|1
7913565|NCT02089230|12432613|FG000|Overall Study|Death|0
7913566|NCT02089230|12432614|FG001|Overall Study|Death|0
7913567|NCT02089230|12432615|FG002|Overall Study|Death|2
7913568|NCT02089230|12432613|FG000|Overall Study|Seeking Alternative Therapy|0
7913569|NCT02089230|12432614|FG001|Overall Study|Seeking Alternative Therapy|0
7913570|NCT02089230|12432615|FG002|Overall Study|Seeking Alternative Therapy|4
7913571|NCT02089334|12432627|FG000|Overall Study|Withdrawal by Subject|0
7913572|NCT02089334|12432628|FG001|Overall Study|Withdrawal by Subject|0
7913573|NCT02089334|12432629|FG002|Overall Study|Withdrawal by Subject|0
7913574|NCT02089334|12432630|FG003|Overall Study|Withdrawal by Subject|2
7913575|NCT02089334|12432627|FG000|Overall Study|Adverse Event|0
7913576|NCT02089334|12432628|FG001|Overall Study|Adverse Event|0
7913577|NCT02089334|12432629|FG002|Overall Study|Adverse Event|0
7913578|NCT02089334|12432630|FG003|Overall Study|Adverse Event|2
7913579|NCT02089334|12432627|FG000|Overall Study|Progressive disease|0
7913580|NCT02089334|12432628|FG001|Overall Study|Progressive disease|0
7913581|NCT02089334|12432629|FG002|Overall Study|Progressive disease|0
7913582|NCT02089334|12432630|FG003|Overall Study|Progressive disease|2
7913583|NCT02089334|12432627|FG000|Overall Study|Physician Decision|0
7913584|NCT02089334|12432628|FG001|Overall Study|Physician Decision|0
7913585|NCT02089334|12432629|FG002|Overall Study|Physician Decision|1
7913586|NCT02089334|12432630|FG003|Overall Study|Physician Decision|1
7913587|NCT02089347|12432645|FG000|Overall Study|Protocol Violation|1
7913588|NCT02089347|12432646|FG001|Overall Study|Protocol Violation|0
7913589|NCT02089737|12432671|FG000|Overall Study|Survey form not completed|5
7913590|NCT02089737|12432671|FG000|Overall Study|Not treated|1
7913591|NCT02089997|12432676|FG000|Overall Study|Case report forms uncollected|99
7913592|NCT02089997|12432676|FG000|Overall Study|Protocol Violation|147
7913593|NCT02090283|12432697|FG000|Overall Study|Withdrawal by Subject|6
7913594|NCT02090283|12432698|FG001|Overall Study|Withdrawal by Subject|6
7913595|NCT02090283|12432699|FG002|Overall Study|Withdrawal by Subject|6
7913596|NCT02090283|12432697|FG000|Overall Study|Sponsor Terminated Study|6
7913597|NCT02090283|12432698|FG001|Overall Study|Sponsor Terminated Study|6
7913598|NCT02090283|12432699|FG002|Overall Study|Sponsor Terminated Study|1
7913599|NCT02090283|12432697|FG000|Overall Study|Lost to Follow-up|2
7913600|NCT02090283|12432698|FG001|Overall Study|Lost to Follow-up|2
7913601|NCT02090283|12432699|FG002|Overall Study|Lost to Follow-up|3
7913602|NCT02090283|12432697|FG000|Overall Study|Adverse Event|1
7913603|NCT02090283|12432698|FG001|Overall Study|Adverse Event|1
7913604|NCT02090283|12432699|FG002|Overall Study|Adverse Event|0
7913605|NCT02090283|12432697|FG000|Overall Study|Protocol Violation|2
7913606|NCT02090283|12432698|FG001|Overall Study|Protocol Violation|0
7913607|NCT02090283|12432699|FG002|Overall Study|Protocol Violation|0
7913608|NCT02090413|12432743|FG000|Overall Study|Adverse Event|11
7913609|NCT02090413|12432744|FG001|Overall Study|Adverse Event|15
7913610|NCT02090413|12432745|FG002|Overall Study|Adverse Event|20
7913611|NCT02090413|12432743|FG000|Overall Study|Flushing event|2
7913612|NCT02090413|12432744|FG001|Overall Study|Flushing event|0
7913613|NCT02090413|12432745|FG002|Overall Study|Flushing event|1
7913614|NCT02090413|12432743|FG000|Overall Study|Withdrawal by Subject|2
7913615|NCT02090413|12432744|FG001|Overall Study|Withdrawal by Subject|2
7913616|NCT02090413|12432745|FG002|Overall Study|Withdrawal by Subject|2
7913617|NCT02090413|12432743|FG000|Overall Study|Investigator Decision|1
7913618|NCT02090413|12432744|FG001|Overall Study|Investigator Decision|1
7913619|NCT02090413|12432745|FG002|Overall Study|Investigator Decision|0
7913620|NCT02090413|12432743|FG000|Overall Study|Other|2
7913621|NCT02090413|12432744|FG001|Overall Study|Other|1
7913622|NCT02090413|12432745|FG002|Overall Study|Other|0
7913623|NCT02090413|12432743|FG000|Overall Study|Lost to Follow-up|1
7913624|NCT02090413|12432744|FG001|Overall Study|Lost to Follow-up|1
7913625|NCT02090413|12432745|FG002|Overall Study|Lost to Follow-up|0
7913626|NCT02090426|12432756|FG000|Overall Study|Lost to Follow-up|12
7913627|NCT02090426|12432757|FG001|Overall Study|Lost to Follow-up|6
7913628|NCT02090634|12432765|FG000|Overall Study|Lost to Follow-up|0
7913629|NCT02090634|12432766|FG001|Overall Study|Lost to Follow-up|1
7913630|NCT02090634|12432765|FG000|Overall Study|Death|0
7913631|NCT02090634|12432766|FG001|Overall Study|Death|1
7913632|NCT02090634|12432765|FG000|Overall Study|Protocol Violation|3
7913633|NCT02090634|12432766|FG001|Overall Study|Protocol Violation|1
7913634|NCT02090634|12432765|FG000|Overall Study|Adverse Event|2
7913635|NCT02090634|12432766|FG001|Overall Study|Adverse Event|0
7913636|NCT02090725|12432772|FG000|Overall Study|Withdrawal by Subject|1
7913637|NCT02090725|12432772|FG000|Overall Study|participants moved from area|3
7913638|NCT02090764|12432778|FG000|Overall Study|Adverse Event|1
7913639|NCT02090764|12432779|FG001|Overall Study|Adverse Event|3
7913640|NCT02090764|12432778|FG000|Overall Study|Lack of Efficacy|0
7913641|NCT02090764|12432779|FG001|Overall Study|Lack of Efficacy|13
7913642|NCT02090764|12432778|FG000|Overall Study|Withdrawal by Subject|2
7913643|NCT02090764|12432779|FG001|Overall Study|Withdrawal by Subject|1
7913644|NCT02090764|12432778|FG000|Overall Study|Intercurrent illness and other|1
7913645|NCT02090764|12432779|FG001|Overall Study|Intercurrent illness and other|1
7913646|NCT02090764|12432778|FG000|Overall Study|Lost to Follow-up|2
7913647|NCT02090764|12432779|FG001|Overall Study|Lost to Follow-up|2
7913648|NCT02090855|12432789|FG000|Overall Study|no evaluable Standard of Truth results|2
7913649|NCT02090959|12432800|FG000|Overall Study|Withdrawal by Subject|10
7913650|NCT02090959|12432800|FG000|Overall Study|Adverse Event|1
7913651|NCT02090959|12432800|FG000|Overall Study|Investigator decision|2
7913652|NCT02090959|12432800|FG000|Overall Study|Study termination|6
7913653|NCT02090959|12432800|FG000|Overall Study|Enrolled but not treated|1
7913654|NCT02090959|12432800|FG000|Overall Study|Transfer for compassionate use medicine|4
7913655|NCT02090959|12432800|FG000|Overall Study|Move to medical need program|3
7913656|NCT02090959|12432800|FG000|Overall Study|Entered in to other study|34
7913657|NCT02090959|12432800|FG000|Overall Study|Switched to commercial supply|88
7913658|NCT02090959|12432800|FG000|Overall Study|Other than specified|2
7913659|NCT02091089|12432804|FG000|Overall Study|Lost to Follow-up|2
7913660|NCT02091167|12432814|FG000|Overall Study|Lost to Follow-up|0
7913661|NCT02091167|12432815|FG001|Overall Study|Lost to Follow-up|2
7913662|NCT02091284|12432823|FG000|Overall Study|Withdrawal by Subject|2
7913663|NCT02091284|12432824|FG001|Overall Study|Withdrawal by Subject|1
7913664|NCT02091284|12432823|FG000|Overall Study|unreliable data|1
7913665|NCT02091284|12432824|FG001|Overall Study|unreliable data|0
7913666|NCT02091362|12432834|FG000|Period 1|Protocol Violation|1
7913667|NCT02091362|12432835|FG001|Period 1|Protocol Violation|0
7913668|NCT02091362|12432834|FG000|Period 1|Withdrawal by Subject|2
7913669|NCT02091362|12432835|FG001|Period 1|Withdrawal by Subject|3
7913670|NCT02091362|12432834|FG000|Period 1|Lost to Follow-up|0
7913671|NCT02091362|12432835|FG001|Period 1|Lost to Follow-up|1
7913672|NCT02091362|12432834|FG000|Period 1|Adverse Event|2
7913673|NCT02091362|12432835|FG001|Period 1|Adverse Event|0
7913674|NCT02091362|12432834|FG000|Wash-out|Lost to Follow-up|1
7913675|NCT02091362|12432835|FG001|Wash-out|Lost to Follow-up|1
7913676|NCT02091362|12432834|FG000|Wash-out|Withdrawal by Subject|0
7913677|NCT02091362|12432835|FG001|Wash-out|Withdrawal by Subject|2
7913678|NCT02091362|12432834|FG000|Period 2|Adverse Event|1
7913679|NCT02091362|12432835|FG001|Period 2|Adverse Event|0
7913680|NCT02091362|12432834|FG000|Period 2|Lost to Follow-up|0
7913681|NCT02091362|12432835|FG001|Period 2|Lost to Follow-up|1
7913682|NCT02091362|12432834|FG000|Period 2|Withdrawal by Subject|1
7913683|NCT02091362|12432835|FG001|Period 2|Withdrawal by Subject|1
7913684|NCT02091414|12432845|FG000|Overall Study|Withdrawal by Subject|2
7913685|NCT02091414|12432845|FG000|Overall Study|Death|2
7913686|NCT02091440|12432849|FG000|Overall Study|Death|2
7964197|NCT02737501|12519419|FG000|Crossover Phase|Site Terminated by Sponsor|0
7964198|NCT02737501|12519420|FG001|Crossover Phase|Site Terminated by Sponsor|0
7964199|NCT02737501|12519421|FG002|Crossover Phase|Site Terminated by Sponsor|23
7964200|NCT02737592|12519429|FG000|Overall Study|Withdrawal by Subject|1
7964201|NCT02737618|12519433|FG000|Overall Study|Withdrawal by Subject|9
7966879|NCT02757625|12523279|FG000|Overall Study|Investigator's discretion|0
7966880|NCT02757625|12523280|FG001|Overall Study|Investigator's discretion|0
7966881|NCT02757625|12523281|FG002|Overall Study|Investigator's discretion|1
7966882|NCT02757625|12523282|FG003|Overall Study|Investigator's discretion|0
7966883|NCT02757625|12523279|FG000|Overall Study|Adverse Event|0
7966884|NCT02757625|12523280|FG001|Overall Study|Adverse Event|0
7966885|NCT02757625|12523281|FG002|Overall Study|Adverse Event|1
7966886|NCT02757625|12523282|FG003|Overall Study|Adverse Event|0
7966887|NCT02757768|12523296|FG000|Overall Study|Randomized Never Received Study Drug|3
7913687|NCT02091726|12432866|FG000|Overall Study|Lost to Follow-up|6
7913688|NCT02091739|12432873|FG000|MP: 16 Weeks|Adverse Event|1
7913689|NCT02091739|12432874|FG001|MP: 16 Weeks|Adverse Event|1
7913690|NCT02091739|12432875|FG002|MP: 16 Weeks|Adverse Event|1
7913691|NCT02091739|12432876|FG003|MP: 16 Weeks|Adverse Event|0
7913692|NCT02091739|12432877|FG004|MP: 16 Weeks|Adverse Event|0
7913693|NCT02091739|12432873|FG000|MP: 16 Weeks|Withdrawal by Subject|3
7913694|NCT02091739|12432874|FG001|MP: 16 Weeks|Withdrawal by Subject|4
7913695|NCT02091739|12432875|FG002|MP: 16 Weeks|Withdrawal by Subject|0
7913696|NCT02091739|12432876|FG003|MP: 16 Weeks|Withdrawal by Subject|0
7913697|NCT02091739|12432877|FG004|MP: 16 Weeks|Withdrawal by Subject|0
7913698|NCT02091739|12432873|FG000|MP: 16 Weeks|Lost to Follow-up|0
7913699|NCT02091739|12432874|FG001|MP: 16 Weeks|Lost to Follow-up|0
7913700|NCT02091739|12432875|FG002|MP: 16 Weeks|Lost to Follow-up|1
7913701|NCT02091739|12432876|FG003|MP: 16 Weeks|Lost to Follow-up|0
7913702|NCT02091739|12432877|FG004|MP: 16 Weeks|Lost to Follow-up|0
7913703|NCT02091739|12432873|FG000|EP: 48 Weeks|Other|0
7913704|NCT02091739|12432874|FG001|EP: 48 Weeks|Other|0
7913705|NCT02091739|12432875|FG002|EP: 48 Weeks|Other|0
7913706|NCT02091739|12432876|FG003|EP: 48 Weeks|Other|1
7913707|NCT02091739|12432877|FG004|EP: 48 Weeks|Other|0
7913708|NCT02091739|12432873|FG000|EP: 48 Weeks|Death|0
7913709|NCT02091739|12432874|FG001|EP: 48 Weeks|Death|0
7913710|NCT02091739|12432875|FG002|EP: 48 Weeks|Death|0
7913711|NCT02091739|12432876|FG003|EP: 48 Weeks|Death|3
7913712|NCT02091739|12432877|FG004|EP: 48 Weeks|Death|2
7913713|NCT02091739|12432873|FG000|EP: 48 Weeks|Adverse Event|0
7913714|NCT02091739|12432874|FG001|EP: 48 Weeks|Adverse Event|0
7913715|NCT02091739|12432875|FG002|EP: 48 Weeks|Adverse Event|0
7913716|NCT02091739|12432876|FG003|EP: 48 Weeks|Adverse Event|2
7913717|NCT02091739|12432877|FG004|EP: 48 Weeks|Adverse Event|6
7913718|NCT02091739|12432873|FG000|EP: 48 Weeks|Withdrawal by Subject|0
7913719|NCT02091739|12432874|FG001|EP: 48 Weeks|Withdrawal by Subject|0
7913720|NCT02091739|12432875|FG002|EP: 48 Weeks|Withdrawal by Subject|0
7913721|NCT02091739|12432876|FG003|EP: 48 Weeks|Withdrawal by Subject|2
7913722|NCT02091739|12432877|FG004|EP: 48 Weeks|Withdrawal by Subject|6
7913723|NCT02091869|12432906|FG000|Overall Study|Withdrawal by Subject|0
7913724|NCT02091869|12432907|FG001|Overall Study|Withdrawal by Subject|3
7913725|NCT02091921|12432917|FG000|Overall Study|Adverse Event|3
7913726|NCT02091986|12432927|FG000|Overall Study|7 rand in error 1 patient decision|2
7913727|NCT02091986|12432928|FG001|Overall Study|7 rand in error 1 patient decision|3
7913728|NCT02091986|12432929|FG002|Overall Study|7 rand in error 1 patient decision|3
7913729|NCT02091986|12432927|FG000|Overall Study|Lost to Follow-up|1
7913730|NCT02091986|12432928|FG001|Overall Study|Lost to Follow-up|0
7913731|NCT02091986|12432929|FG002|Overall Study|Lost to Follow-up|0
7913732|NCT02091986|12432927|FG000|Overall Study|Withdrawal by Subject|4
7913733|NCT02091986|12432928|FG001|Overall Study|Withdrawal by Subject|8
7913734|NCT02091986|12432929|FG002|Overall Study|Withdrawal by Subject|3
7913735|NCT02091986|12432927|FG000|Overall Study|Adverse Event|0
7913736|NCT02091986|12432928|FG001|Overall Study|Adverse Event|0
7913737|NCT02091986|12432929|FG002|Overall Study|Adverse Event|2
7913738|NCT02092025|12432937|FG000|Overall Study|Case Report Forms Uncollected|44
7913739|NCT02092025|12432937|FG000|Overall Study|Protocol Deviation|24
7913740|NCT02092116|12432943|FG000|Overall Study|Withdrawal by Subject|0
7913741|NCT02092116|12432944|FG001|Overall Study|Withdrawal by Subject|3
7913742|NCT02092116|12432943|FG000|Overall Study|Adverse Event|0
7913743|NCT02092116|12432944|FG001|Overall Study|Adverse Event|1
7913744|NCT02092220|12432968|FG000|Period 1|Unrelated Illness|0
7913745|NCT02092220|12432969|FG001|Period 1|Unrelated Illness|2
7913746|NCT02092220|12432968|FG000|Period 2|Severe Hypoglycaemia|1
7913747|NCT02092220|12432969|FG001|Period 2|Severe Hypoglycaemia|0
7913748|NCT02092220|12432968|FG000|Period 2|Nausea, Anxiety, Inconvenience|0
7913749|NCT02092220|12432969|FG001|Period 2|Nausea, Anxiety, Inconvenience|1
7913750|NCT02092285|12432977|FG000|Induction Phase|Adverse Event|7
7913751|NCT02092285|12432977|FG000|Induction Phase|Physician Decision|4
7913752|NCT02092285|12432977|FG000|Induction Phase|Pregnancy|1
7913753|NCT02092285|12432977|FG000|Induction Phase|Relapse/Recurrence|7
7913754|NCT02092285|12432977|FG000|Induction Phase|Withdrawal by Subject|2
7913755|NCT02092285|12432977|FG000|Induction Phase|Lack of Efficacy|14
7913756|NCT02092285|12432977|FG000|Maintenance Phase & Follow-up|Adverse Event|22
7913757|NCT02092285|12432977|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1
7913758|NCT02092285|12432977|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2
7913759|NCT02092285|12432977|FG000|Maintenance Phase & Follow-up|Physician Decision|10
7913760|NCT02092285|12432977|FG000|Maintenance Phase & Follow-up|Pregnancy|1
7913761|NCT02092285|12432977|FG000|Maintenance Phase & Follow-up|Protocol Violation|11
7913762|NCT02092285|12432977|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29
7913763|NCT02092285|12432977|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11
7913764|NCT02092285|12432977|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23
7913765|NCT02092324|12432996|FG000|Overall Study|Adverse Event|1
7913766|NCT02092324|12432996|FG000|Overall Study|Lack of Efficacy|6
7913767|NCT02092324|12432996|FG000|Overall Study|Proceed to Transplant|3
7913768|NCT02092324|12432996|FG000|Overall Study|Physician Decision|7
7913769|NCT02092324|12432996|FG000|Overall Study|Misdiagnosis|2
7913770|NCT02092350|12433005|FG000|Overall Study|Adverse Event|0
7913771|NCT02092350|12433006|FG001|Overall Study|Adverse Event|3
7913772|NCT02092350|12433005|FG000|Overall Study|Death|2
7913773|NCT02092350|12433006|FG001|Overall Study|Death|5
7913774|NCT02092350|12433005|FG000|Overall Study|Lost to Follow-up|3
7913775|NCT02092350|12433006|FG001|Overall Study|Lost to Follow-up|1
7913776|NCT02092350|12433005|FG000|Overall Study|Protocol Violation|1
7913777|NCT02092350|12433006|FG001|Overall Study|Protocol Violation|0
7913778|NCT02092350|12433005|FG000|Overall Study|Physician Decision|1
7913779|NCT02092350|12433006|FG001|Overall Study|Physician Decision|1
7913780|NCT02092350|12433005|FG000|Overall Study|Screen Failure|1
7913781|NCT02092350|12433006|FG001|Overall Study|Screen Failure|0
7913782|NCT02092350|12433005|FG000|Overall Study|Withdrawal by Subject|2
7913783|NCT02092350|12433006|FG001|Overall Study|Withdrawal by Subject|2
7913784|NCT02092389|12433014|FG000|Overall Study|Adverse Event|1
7913785|NCT02092389|12433014|FG000|Overall Study|Other|5
7913786|NCT02092467|12433035|FG000|Overall Study|Death|49
7913787|NCT02092467|12433036|FG001|Overall Study|Death|66
7913788|NCT02092467|12433037|FG002|Overall Study|Death|38
7913789|NCT02092467|12433035|FG000|Overall Study|Lost to Follow-up|38
7913790|NCT02092467|12433036|FG001|Overall Study|Lost to Follow-up|35
7913791|NCT02092467|12433037|FG002|Overall Study|Lost to Follow-up|40
7913792|NCT02092467|12433035|FG000|Overall Study|Global Deterioration of Health Status|1
7913793|NCT02092467|12433036|FG001|Overall Study|Global Deterioration of Health Status|0
7913794|NCT02092467|12433037|FG002|Overall Study|Global Deterioration of Health Status|0
7913795|NCT02092467|12433035|FG000|Overall Study|Other|32
7913796|NCT02092467|12433036|FG001|Overall Study|Other|30
7913797|NCT02092467|12433037|FG002|Overall Study|Other|24
7913798|NCT02092467|12433035|FG000|Overall Study|Withdrawal by Subject|282
7913799|NCT02092467|12433036|FG001|Overall Study|Withdrawal by Subject|327
7913800|NCT02092467|12433037|FG002|Overall Study|Withdrawal by Subject|289
7913801|NCT02092467|12433035|FG000|Overall Study|Randomized but not treated|2
7913802|NCT02092467|12433036|FG001|Overall Study|Randomized but not treated|1
7913803|NCT02092467|12433037|FG002|Overall Study|Randomized but not treated|7
7913804|NCT02092662|12433067|FG000|Overall Study|Lost to Follow-up|13
7913805|NCT02092662|12433068|FG001|Overall Study|Lost to Follow-up|0
7913806|NCT02092909|12433092|FG000|Overall Study|Adverse Event|0
7913807|NCT02092909|12433093|FG001|Overall Study|Adverse Event|0
7913808|NCT02092909|12433094|FG002|Overall Study|Adverse Event|4
7913809|NCT02092909|12433095|FG003|Overall Study|Adverse Event|2
7913810|NCT02092909|12433092|FG000|Overall Study|Lack of Efficacy|0
7913811|NCT02092909|12433093|FG001|Overall Study|Lack of Efficacy|2
7913812|NCT02092909|12433094|FG002|Overall Study|Lack of Efficacy|1
7913813|NCT02092909|12433095|FG003|Overall Study|Lack of Efficacy|0
7913814|NCT02092909|12433092|FG000|Overall Study|Withdrawal by Subject|0
7913815|NCT02092909|12433093|FG001|Overall Study|Withdrawal by Subject|0
7913816|NCT02092909|12433094|FG002|Overall Study|Withdrawal by Subject|2
7913817|NCT02092909|12433095|FG003|Overall Study|Withdrawal by Subject|1
7913818|NCT02092909|12433092|FG000|Overall Study|Study terminated by Sponsor|0
7913819|NCT02092909|12433093|FG001|Overall Study|Study terminated by Sponsor|0
7913820|NCT02092909|12433094|FG002|Overall Study|Study terminated by Sponsor|0
7913821|NCT02092909|12433095|FG003|Overall Study|Study terminated by Sponsor|2
7913822|NCT02092909|12433092|FG000|Overall Study|Miscellaneous|1
7913823|NCT02092909|12433093|FG001|Overall Study|Miscellaneous|1
7913824|NCT02092909|12433094|FG002|Overall Study|Miscellaneous|2
7913825|NCT02092909|12433095|FG003|Overall Study|Miscellaneous|1
7913826|NCT02092961|12433108|FG000|Overall Study|Not reported|1
7913827|NCT02092961|12433109|FG001|Overall Study|Not reported|0
7913828|NCT02092961|12433110|FG002|Overall Study|Not reported|1
7913829|NCT02092961|12433108|FG000|Overall Study|Study stopped|13
7913830|NCT02092961|12433109|FG001|Overall Study|Study stopped|9
7913831|NCT02092961|12433110|FG002|Overall Study|Study stopped|12
7913832|NCT02092961|12433108|FG000|Overall Study|Lack of therapeutic response|2
7913833|NCT02092961|12433109|FG001|Overall Study|Lack of therapeutic response|1
7913834|NCT02092961|12433110|FG002|Overall Study|Lack of therapeutic response|3
7913835|NCT02092961|12433108|FG000|Overall Study|Dev. of study specific discont. criteria|3
7913836|NCT02092961|12433109|FG001|Overall Study|Dev. of study specific discont. criteria|0
7913837|NCT02092961|12433110|FG002|Overall Study|Dev. of study specific discont. criteria|0
7913838|NCT02092961|12433108|FG000|Overall Study|Adverse Event|2
7913839|NCT02092961|12433109|FG001|Overall Study|Adverse Event|4
7913840|NCT02092961|12433110|FG002|Overall Study|Adverse Event|0
7913841|NCT02093026|12433131|FG000|Overall Study|Adverse Event|26
7913842|NCT02093026|12433131|FG000|Overall Study|Death|10
7913843|NCT02093026|12433131|FG000|Overall Study|Other|157
7913844|NCT02093221|12433141|FG000|Overall Study|Adverse Event|1
7913845|NCT02093221|12433142|FG001|Overall Study|Adverse Event|0
7821069|NCT01253187|12289593|FG002|Period 3|non-compliance|0
7913846|NCT02093221|12433143|FG002|Overall Study|Adverse Event|0
7913847|NCT02093221|12433144|FG003|Overall Study|Adverse Event|0
7913848|NCT02093221|12433145|FG004|Overall Study|Adverse Event|0
7913849|NCT02093221|12433141|FG000|Overall Study|Withdrawal by Subject|1
7913850|NCT02093221|12433142|FG001|Overall Study|Withdrawal by Subject|1
7913851|NCT02093221|12433143|FG002|Overall Study|Withdrawal by Subject|4
7913852|NCT02093221|12433144|FG003|Overall Study|Withdrawal by Subject|1
7913853|NCT02093221|12433145|FG004|Overall Study|Withdrawal by Subject|1
7913854|NCT02093221|12433141|FG000|Overall Study|Lost to Follow-up|2
7913855|NCT02093221|12433142|FG001|Overall Study|Lost to Follow-up|0
7913856|NCT02093221|12433143|FG002|Overall Study|Lost to Follow-up|1
7913857|NCT02093221|12433144|FG003|Overall Study|Lost to Follow-up|1
7913858|NCT02093221|12433145|FG004|Overall Study|Lost to Follow-up|0
7913859|NCT02093221|12433141|FG000|Overall Study|Death|0
7913860|NCT02093221|12433142|FG001|Overall Study|Death|1
7913861|NCT02093221|12433143|FG002|Overall Study|Death|0
7821070|NCT01253187|12289594|FG003|Period 3|non-compliance|0
7821071|NCT01253187|12289595|FG004|Period 3|non-compliance|1
7821072|NCT01253187|12289596|FG005|Period 3|non-compliance|0
7821073|NCT01253200|12289612|FG000|Overall Study|Death|1
7821074|NCT01253200|12289613|FG001|Overall Study|Death|0
7821075|NCT01253200|12289614|FG002|Overall Study|Death|0
7821076|NCT01253200|12289615|FG003|Overall Study|Death|0
7821077|NCT01253200|12289616|FG004|Overall Study|Death|0
7821078|NCT01253200|12289612|FG000|Overall Study|Lost to Follow-up|1
7821079|NCT01253200|12289613|FG001|Overall Study|Lost to Follow-up|1
7821080|NCT01253200|12289614|FG002|Overall Study|Lost to Follow-up|0
7821081|NCT01253200|12289615|FG003|Overall Study|Lost to Follow-up|0
7821082|NCT01253200|12289616|FG004|Overall Study|Lost to Follow-up|0
7821083|NCT01253200|12289612|FG000|Overall Study|Withdrawal by Subject|2
7821084|NCT01253200|12289613|FG001|Overall Study|Withdrawal by Subject|0
7821085|NCT01253200|12289614|FG002|Overall Study|Withdrawal by Subject|0
7821086|NCT01253200|12289615|FG003|Overall Study|Withdrawal by Subject|0
7821087|NCT01253200|12289616|FG004|Overall Study|Withdrawal by Subject|0
7821088|NCT01253200|12289612|FG000|Overall Study|Protocol Violation|1
7821089|NCT01253200|12289613|FG001|Overall Study|Protocol Violation|4
7821090|NCT01253200|12289614|FG002|Overall Study|Protocol Violation|0
7821091|NCT01253200|12289615|FG003|Overall Study|Protocol Violation|0
7821092|NCT01253200|12289616|FG004|Overall Study|Protocol Violation|5
7821093|NCT01253200|12289612|FG000|Overall Study|intents|10
7821094|NCT01253200|12289613|FG001|Overall Study|intents|10
7821095|NCT01253200|12289614|FG002|Overall Study|intents|1
7821096|NCT01253200|12289615|FG003|Overall Study|intents|3
7821097|NCT01253200|12289616|FG004|Overall Study|intents|0
7821098|NCT01253200|12289612|FG000|Overall Study|Attempts|6
7821099|NCT01253200|12289613|FG001|Overall Study|Attempts|4
7821100|NCT01253200|12289614|FG002|Overall Study|Attempts|1
7821101|NCT01253200|12289615|FG003|Overall Study|Attempts|2
7821102|NCT01253200|12289616|FG004|Overall Study|Attempts|0
7821103|NCT01253226|12289630|FG000|Overall Study|Adverse Event|0
7821104|NCT01253226|12289631|FG001|Overall Study|Adverse Event|0
7821105|NCT01253226|12289632|FG002|Overall Study|Adverse Event|1
7821106|NCT01253226|12289633|FG003|Overall Study|Adverse Event|0
7821107|NCT01253226|12289634|FG004|Overall Study|Adverse Event|0
7821108|NCT01253226|12289630|FG000|Overall Study|Death|0
7821109|NCT01253226|12289631|FG001|Overall Study|Death|1
7821110|NCT01253226|12289632|FG002|Overall Study|Death|0
7821111|NCT01253226|12289633|FG003|Overall Study|Death|0
7821112|NCT01253226|12289634|FG004|Overall Study|Death|0
7821113|NCT01253226|12289630|FG000|Overall Study|Physician Decision|0
7821114|NCT01253226|12289631|FG001|Overall Study|Physician Decision|0
7821115|NCT01253226|12289632|FG002|Overall Study|Physician Decision|0
7821116|NCT01253226|12289633|FG003|Overall Study|Physician Decision|0
7821117|NCT01253226|12289634|FG004|Overall Study|Physician Decision|2
7821118|NCT01253226|12289630|FG000|Overall Study|Withdrawal by Subject|0
7821119|NCT01253226|12289631|FG001|Overall Study|Withdrawal by Subject|0
7821120|NCT01253226|12289632|FG002|Overall Study|Withdrawal by Subject|0
7821121|NCT01253226|12289633|FG003|Overall Study|Withdrawal by Subject|1
7821122|NCT01253226|12289634|FG004|Overall Study|Withdrawal by Subject|0
7913862|NCT02093221|12433144|FG003|Overall Study|Death|0
7821123|NCT01253265|12289651|FG000|Overall Study|Met Predefined Discontinuation Criteria|1
7821124|NCT01253265|12289652|FG001|Overall Study|Met Predefined Discontinuation Criteria|0
7821125|NCT01253265|12289653|FG002|Overall Study|Met Predefined Discontinuation Criteria|0
7821126|NCT01253265|12289654|FG003|Overall Study|Met Predefined Discontinuation Criteria|0
7821127|NCT01253265|12289655|FG004|Overall Study|Met Predefined Discontinuation Criteria|0
7913863|NCT02093221|12433145|FG004|Overall Study|Death|0
7913864|NCT02093221|12433141|FG000|Overall Study|Protocol Violation|0
7913865|NCT02093221|12433142|FG001|Overall Study|Protocol Violation|1
7913866|NCT02093221|12433143|FG002|Overall Study|Protocol Violation|0
7913867|NCT02093221|12433144|FG003|Overall Study|Protocol Violation|0
7913868|NCT02093221|12433145|FG004|Overall Study|Protocol Violation|0
7913869|NCT02093221|12433141|FG000|Overall Study|Study termination|6
7913870|NCT02093221|12433142|FG001|Overall Study|Study termination|5
7913871|NCT02093221|12433143|FG002|Overall Study|Study termination|4
7913872|NCT02093221|12433144|FG003|Overall Study|Study termination|6
7913873|NCT02093221|12433145|FG004|Overall Study|Study termination|7
7913874|NCT02093351|12433173|FG000|Part A|Adverse Event|0
7913875|NCT02093351|12433174|FG001|Part A|Adverse Event|1
7913876|NCT02093351|12433175|FG002|Part A|Adverse Event|1
7913877|NCT02093351|12433176|FG003|Part A|Adverse Event|0
7913878|NCT02093351|12433173|FG000|Part A|Condition under investigation worsened|2
7913879|NCT02093351|12433174|FG001|Part A|Condition under investigation worsened|0
7913880|NCT02093351|12433175|FG002|Part A|Condition under investigation worsened|2
7913881|NCT02093351|12433176|FG003|Part A|Condition under investigation worsened|0
7913882|NCT02093351|12433173|FG000|Part A|Death|0
7913883|NCT02093351|12433174|FG001|Part A|Death|1
7913884|NCT02093351|12433175|FG002|Part A|Death|0
7913885|NCT02093351|12433176|FG003|Part A|Death|0
7913886|NCT02093351|12433173|FG000|Part B|Patient decision|0
7913887|NCT02093351|12433174|FG001|Part B|Patient decision|0
7913888|NCT02093351|12433175|FG002|Part B|Patient decision|0
7913889|NCT02093351|12433176|FG003|Part B|Patient decision|3
7913890|NCT02093351|12433173|FG000|Part B|Disease progression|0
7913891|NCT02093351|12433174|FG001|Part B|Disease progression|0
7913892|NCT02093351|12433175|FG002|Part B|Disease progression|0
7913893|NCT02093351|12433176|FG003|Part B|Disease progression|4
7913894|NCT02093351|12433173|FG000|Part B|Complete response|0
7913895|NCT02093351|12433174|FG001|Part B|Complete response|0
7913896|NCT02093351|12433175|FG002|Part B|Complete response|0
7913897|NCT02093351|12433176|FG003|Part B|Complete response|1
7913898|NCT02093351|12433173|FG000|Part B|Adverse event + disease progression|0
7913899|NCT02093351|12433174|FG001|Part B|Adverse event + disease progression|0
7913900|NCT02093351|12433175|FG002|Part B|Adverse event + disease progression|0
7913901|NCT02093351|12433176|FG003|Part B|Adverse event + disease progression|1
7913902|NCT02093351|12433173|FG000|Part B|Lack of therapeutic response|0
7913903|NCT02093351|12433174|FG001|Part B|Lack of therapeutic response|0
7913904|NCT02093351|12433175|FG002|Part B|Lack of therapeutic response|0
7913905|NCT02093351|12433176|FG003|Part B|Lack of therapeutic response|12
7913906|NCT02093351|12433173|FG000|Part B|Condition under investigation worsened|0
7913907|NCT02093351|12433174|FG001|Part B|Condition under investigation worsened|0
7913908|NCT02093351|12433175|FG002|Part B|Condition under investigation worsened|0
7913909|NCT02093351|12433176|FG003|Part B|Condition under investigation worsened|39
7913910|NCT02093351|12433173|FG000|Part B|Adverse Event|0
7913911|NCT02093351|12433174|FG001|Part B|Adverse Event|0
7913912|NCT02093351|12433175|FG002|Part B|Adverse Event|0
7913913|NCT02093351|12433176|FG003|Part B|Adverse Event|2
7913914|NCT02093351|12433173|FG000|Part B|Death|0
7913915|NCT02093351|12433174|FG001|Part B|Death|0
7913916|NCT02093351|12433175|FG002|Part B|Death|0
7913917|NCT02093351|12433176|FG003|Part B|Death|1
7913918|NCT02093390|12433193|FG000|Overall Study|Withdrawal by Subject|0
7913919|NCT02093390|12433194|FG001|Overall Study|Withdrawal by Subject|1
7913920|NCT02093520|12433203|FG000|Overall Study|Not treated|6
7913921|NCT02093520|12433204|FG001|Overall Study|Not treated|22
7913922|NCT02093663|12433210|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1
7913923|NCT02093663|12433211|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7913924|NCT02093663|12433212|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7913925|NCT02093663|12433213|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7913926|NCT02093663|12433214|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7913927|NCT02093663|12433210|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5
7913928|NCT02093663|12433211|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7913929|NCT02093663|12433212|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7913930|NCT02093663|12433213|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7913931|NCT02093663|12433214|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7913932|NCT02093663|12433210|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2
7913933|NCT02093663|12433211|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4
7913934|NCT02093663|12433212|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
7913935|NCT02093663|12433213|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
7913936|NCT02093663|12433214|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
7913937|NCT02093663|12433210|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7913938|NCT02093663|12433211|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7913939|NCT02093663|12433212|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1
7913940|NCT02093663|12433213|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7913941|NCT02093663|12433214|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7913942|NCT02093663|12433210|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
7913943|NCT02093663|12433211|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
7913944|NCT02093663|12433212|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5
7913945|NCT02093663|12433213|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
7913946|NCT02093663|12433214|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
7913947|NCT02093663|12433210|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
7913948|NCT02093663|12433211|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
7913949|NCT02093663|12433212|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
7913950|NCT02093663|12433213|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3
7913951|NCT02093663|12433214|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2
7913952|NCT02093663|12433210|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
7913953|NCT02093663|12433211|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
7913954|NCT02093663|12433212|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
7913955|NCT02093663|12433213|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6
7913956|NCT02093663|12433214|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7
7913957|NCT02093663|12433210|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
7913958|NCT02093663|12433211|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
7913959|NCT02093663|12433212|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
7913960|NCT02093663|12433213|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
7913961|NCT02093663|12433214|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
7913962|NCT02093663|12433210|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7913963|NCT02093663|12433211|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7913964|NCT02093663|12433212|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7913965|NCT02093663|12433213|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7913966|NCT02093663|12433214|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1
7913967|NCT02093897|12433296|FG000|Overall Study|Physician Decision|1
7913968|NCT02093897|12433296|FG000|Overall Study|Planned age group closure - no's reached|17
7913969|NCT02093897|12433296|FG000|Overall Study|Adverse event, non-fatal|1
7913970|NCT02093923|12433312|FG000|Overall Study|Lost to Follow-up|0
7913971|NCT02093923|12433313|FG001|Overall Study|Lost to Follow-up|0
7913972|NCT02093923|12433314|FG002|Overall Study|Lost to Follow-up|0
7913973|NCT02093923|12433315|FG003|Overall Study|Lost to Follow-up|1
7913974|NCT02093923|12433316|FG004|Overall Study|Lost to Follow-up|0
7913975|NCT02093923|12433312|FG000|Overall Study|Screen failure after randomization|0
7913976|NCT02093923|12433313|FG001|Overall Study|Screen failure after randomization|0
7913977|NCT02093923|12433314|FG002|Overall Study|Screen failure after randomization|0
7913978|NCT02093923|12433315|FG003|Overall Study|Screen failure after randomization|1
7913979|NCT02093923|12433316|FG004|Overall Study|Screen failure after randomization|0
7913980|NCT02094300|12433371|FG000|Overall Study|Death|7
7913981|NCT02094300|12433371|FG000|Overall Study|Lost to Follow-up|10
7913982|NCT02094300|12433371|FG000|Overall Study|Still be eligible for follow-up|3
7913983|NCT02094417|12433384|FG000|Overall Study|Adverse Event|0
7913984|NCT02094417|12433385|FG001|Overall Study|Adverse Event|0
7913985|NCT02094417|12433386|FG002|Overall Study|Adverse Event|0
7913986|NCT02094417|12433387|FG003|Overall Study|Adverse Event|1
7913987|NCT02094417|12433384|FG000|Overall Study|Eligibility criteria|0
7913988|NCT02094417|12433385|FG001|Overall Study|Eligibility criteria|1
7913989|NCT02094417|12433386|FG002|Overall Study|Eligibility criteria|0
7913990|NCT02094417|12433387|FG003|Overall Study|Eligibility criteria|0
7913991|NCT02094417|12433384|FG000|Overall Study|No responder|4
7913992|NCT02094417|12433385|FG001|Overall Study|No responder|4
7913993|NCT02094417|12433386|FG002|Overall Study|No responder|4
7913994|NCT02094417|12433387|FG003|Overall Study|No responder|3
7913995|NCT02094417|12433384|FG000|Overall Study|Unable to conduct observations or assess|0
7913996|NCT02094417|12433385|FG001|Overall Study|Unable to conduct observations or assess|1
7719456|NCT00532298|12143419|FG004|Overall Study|Adverse Event|1
7719457|NCT00532298|12143420|FG005|Overall Study|Adverse Event|1
7719458|NCT00532298|12143415|FG000|Overall Study|Lost to Follow-up|1
7719459|NCT00532298|12143416|FG001|Overall Study|Lost to Follow-up|1
7913997|NCT02094417|12433386|FG002|Overall Study|Unable to conduct observations or assess|0
7913998|NCT02094417|12433387|FG003|Overall Study|Unable to conduct observations or assess|0
7913999|NCT02094417|12433384|FG000|Overall Study|Withdrawal by Subject|1
7914000|NCT02094417|12433385|FG001|Overall Study|Withdrawal by Subject|2
7914001|NCT02094417|12433386|FG002|Overall Study|Withdrawal by Subject|1
7914002|NCT02094417|12433387|FG003|Overall Study|Withdrawal by Subject|3
7914003|NCT02094573|12433417|FG000|Overall Study|Adverse Event|4
7914004|NCT02094573|12433418|FG001|Overall Study|Adverse Event|14
7821128|NCT01253265|12289651|FG000|Overall Study|Withdrawal by Subject|0
7821129|NCT01253265|12289652|FG001|Overall Study|Withdrawal by Subject|0
7821130|NCT01253265|12289653|FG002|Overall Study|Withdrawal by Subject|0
7821131|NCT01253265|12289654|FG003|Overall Study|Withdrawal by Subject|0
7821132|NCT01253265|12289655|FG004|Overall Study|Withdrawal by Subject|1
7821133|NCT01253291|12289672|FG000|Overall Study|Withdrawal by Subject|1
7821134|NCT01253291|12289673|FG001|Overall Study|Withdrawal by Subject|1
7821135|NCT01253291|12289674|FG002|Overall Study|Withdrawal by Subject|0
7821136|NCT01253291|12289675|FG003|Overall Study|Withdrawal by Subject|0
7821137|NCT01253291|12289676|FG004|Overall Study|Withdrawal by Subject|0
7821138|NCT01253291|12289672|FG000|Overall Study|Adverse Event|0
7821139|NCT01253291|12289673|FG001|Overall Study|Adverse Event|1
7821140|NCT01253291|12289674|FG002|Overall Study|Adverse Event|0
7821141|NCT01253291|12289675|FG003|Overall Study|Adverse Event|0
7821142|NCT01253291|12289676|FG004|Overall Study|Adverse Event|0
7821143|NCT01253291|12289672|FG000|Overall Study|Lack of Efficacy|1
7821144|NCT01253291|12289673|FG001|Overall Study|Lack of Efficacy|0
7821145|NCT01253291|12289674|FG002|Overall Study|Lack of Efficacy|0
7821146|NCT01253291|12289675|FG003|Overall Study|Lack of Efficacy|0
7821147|NCT01253291|12289676|FG004|Overall Study|Lack of Efficacy|0
7914005|NCT02094573|12433417|FG000|Overall Study|Clinical Progressive Disease|9
7914006|NCT02094573|12433418|FG001|Overall Study|Clinical Progressive Disease|13
7821148|NCT01253291|12289672|FG000|Overall Study|Physician Decision|2
7821149|NCT01253291|12289673|FG001|Overall Study|Physician Decision|0
7821150|NCT01253291|12289674|FG002|Overall Study|Physician Decision|0
7821151|NCT01253291|12289675|FG003|Overall Study|Physician Decision|0
7821152|NCT01253291|12289676|FG004|Overall Study|Physician Decision|2
7914007|NCT02094573|12433417|FG000|Overall Study|Death|11
7914008|NCT02094573|12433418|FG001|Overall Study|Death|3
7914009|NCT02094573|12433417|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63
7914010|NCT02094573|12433418|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50
7914011|NCT02094573|12433417|FG000|Overall Study|Non-compliance with Study Drug|1
7914012|NCT02094573|12433418|FG001|Overall Study|Non-compliance with Study Drug|1
7914013|NCT02094573|12433417|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1
7914014|NCT02094573|12433418|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0
7914015|NCT02094573|12433417|FG000|Overall Study|Physician Decision|4
7914016|NCT02094573|12433418|FG001|Overall Study|Physician Decision|4
7914017|NCT02094573|12433417|FG000|Overall Study|Site Terminated by Sponsor|10
7914018|NCT02094573|12433418|FG001|Overall Study|Site Terminated by Sponsor|17
7914019|NCT02094573|12433417|FG000|Overall Study|Withdrawal by Subject|6
7914020|NCT02094573|12433418|FG001|Overall Study|Withdrawal by Subject|8
7914021|NCT02094573|12433417|FG000|Overall Study|Randomized but not Treated|3
7914022|NCT02094573|12433418|FG001|Overall Study|Randomized but not Treated|0
7914023|NCT02094612|12433455|FG000|Overall Study|Lost to Follow-up|47
7914024|NCT02094612|12433456|FG001|Overall Study|Lost to Follow-up|47
7914025|NCT02094612|12433455|FG000|Overall Study|Never started ADHD medication|32
7914026|NCT02094612|12433456|FG001|Overall Study|Never started ADHD medication|23
7914027|NCT02094677|12433473|FG000|Overall Study|Screening|3
7914028|NCT02094677|12433474|FG001|Overall Study|Screening|1
7914029|NCT02094885|12433497|FG000|Overall Study|Death|1
7914030|NCT02094885|12433498|FG001|Overall Study|Death|5
7914031|NCT02094885|12433497|FG000|Overall Study|Withdrawn due to age|1
7914032|NCT02094885|12433498|FG001|Overall Study|Withdrawn due to age|0
7914033|NCT02094898|12433504|FG000|Overall Study|Clinical Worsening|2
7914034|NCT02094898|12433504|FG000|Overall Study|Adverse Event|2
7914035|NCT02094898|12433504|FG000|Overall Study|Lack of Efficacy|1
7914036|NCT02094937|12433510|FG000|8 Weeks in Period 1|Adverse Event|9
7914037|NCT02094937|12433511|FG001|8 Weeks in Period 1|Adverse Event|0
7914038|NCT02094937|12433512|FG002|8 Weeks in Period 1|Adverse Event|0
7914039|NCT02094937|12433513|FG003|8 Weeks in Period 1|Adverse Event|0
7914040|NCT02094937|12433510|FG000|8 Weeks in Period 1|Lack of Efficacy|3
7914041|NCT02094937|12433511|FG001|8 Weeks in Period 1|Lack of Efficacy|0
7914042|NCT02094937|12433512|FG002|8 Weeks in Period 1|Lack of Efficacy|0
7914043|NCT02094937|12433513|FG003|8 Weeks in Period 1|Lack of Efficacy|0
7914044|NCT02094937|12433510|FG000|8 Weeks in Period 1|Protocol Violation|2
7914045|NCT02094937|12433511|FG001|8 Weeks in Period 1|Protocol Violation|0
7914046|NCT02094937|12433512|FG002|8 Weeks in Period 1|Protocol Violation|0
7914047|NCT02094937|12433513|FG003|8 Weeks in Period 1|Protocol Violation|0
7914048|NCT02094937|12433510|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41
7914049|NCT02094937|12433511|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0
7914050|NCT02094937|12433512|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0
7914051|NCT02094937|12433513|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0
7914052|NCT02094937|12433510|FG000|8 Weeks in Period 1|Physician Decision|1
7914053|NCT02094937|12433511|FG001|8 Weeks in Period 1|Physician Decision|0
7914054|NCT02094937|12433512|FG002|8 Weeks in Period 1|Physician Decision|0
7914055|NCT02094937|12433513|FG003|8 Weeks in Period 1|Physician Decision|0
7914056|NCT02094937|12433510|FG000|8 Weeks in Period 1|Withdrawal by Subject|4
7914057|NCT02094937|12433511|FG001|8 Weeks in Period 1|Withdrawal by Subject|0
7914058|NCT02094937|12433512|FG002|8 Weeks in Period 1|Withdrawal by Subject|0
7914059|NCT02094937|12433513|FG003|8 Weeks in Period 1|Withdrawal by Subject|0
7914060|NCT02094937|12433510|FG000|12 Weeks in Period 2|Adverse Event|0
7914061|NCT02094937|12433511|FG001|12 Weeks in Period 2|Adverse Event|2
7914062|NCT02094937|12433512|FG002|12 Weeks in Period 2|Adverse Event|4
7914063|NCT02094937|12433513|FG003|12 Weeks in Period 2|Adverse Event|1
7914064|NCT02094937|12433510|FG000|12 Weeks in Period 2|Lack of Efficacy|0
7914065|NCT02094937|12433511|FG001|12 Weeks in Period 2|Lack of Efficacy|1
7914066|NCT02094937|12433512|FG002|12 Weeks in Period 2|Lack of Efficacy|0
7914067|NCT02094937|12433513|FG003|12 Weeks in Period 2|Lack of Efficacy|0
7914068|NCT02094937|12433510|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0
7914069|NCT02094937|12433511|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5
7914070|NCT02094937|12433512|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6
7914071|NCT02094937|12433513|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11
7914072|NCT02094937|12433510|FG000|12 Weeks in Period 2|Withdrawal by Subject|0
7914073|NCT02094937|12433511|FG001|12 Weeks in Period 2|Withdrawal by Subject|2
7914074|NCT02094937|12433512|FG002|12 Weeks in Period 2|Withdrawal by Subject|2
7914075|NCT02094937|12433513|FG003|12 Weeks in Period 2|Withdrawal by Subject|0
7914076|NCT02094937|12433510|FG000|12 Weeks in Period 2|Randomized incorrectly|0
7914077|NCT02094937|12433511|FG001|12 Weeks in Period 2|Randomized incorrectly|1
7914078|NCT02094937|12433512|FG002|12 Weeks in Period 2|Randomized incorrectly|0
7914079|NCT02094937|12433513|FG003|12 Weeks in Period 2|Randomized incorrectly|0
7914080|NCT02095106|12433524|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
7914081|NCT02095106|12433525|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
7914082|NCT02095145|12433537|FG000|Overall Study|Withdrawal by Subject|1
7914083|NCT02095145|12433538|FG001|Overall Study|Withdrawal by Subject|0
7914084|NCT02095158|12433546|FG000|Overall Study|Adverse Event|14
7914085|NCT02095158|12433546|FG000|Overall Study|Lack of Efficacy|3
7914086|NCT02095158|12433546|FG000|Overall Study|Pregnancy|1
7914087|NCT02095158|12433546|FG000|Overall Study|Lost to Follow-up|20
7914088|NCT02095158|12433546|FG000|Overall Study|Personal Reasons|35
7914089|NCT02095158|12433546|FG000|Overall Study|Protocol Violation|1
7719460|NCT00532298|12143417|FG002|Overall Study|Lost to Follow-up|1
7719461|NCT00532298|12143418|FG003|Overall Study|Lost to Follow-up|0
7914090|NCT02095158|12433546|FG000|Overall Study|Other Miscellaneous Reasons|1
7914091|NCT02095197|12433552|FG000|Overall Study|Lost to Follow-up|0
7914092|NCT02095197|12433553|FG001|Overall Study|Lost to Follow-up|3
7914093|NCT02095223|12433561|FG000|Overall Study|Withdrawal by Subject|1
7914094|NCT02095223|12433562|FG001|Overall Study|Withdrawal by Subject|0
7914095|NCT02095535|12433582|FG000|Recruitment|Protocol Violation|2
7914096|NCT02095691|12433595|FG000|Overall Study|Physician Decision|1
7914097|NCT02095873|12433613|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1
7914098|NCT02095873|12433614|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0
7914099|NCT02095873|12433613|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1
7914100|NCT02095873|12433614|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0
7914101|NCT02095873|12433613|FG000|Second Intervention (8 Weeks)|Protocol Violation|1
7914102|NCT02095873|12433614|FG001|Second Intervention (8 Weeks)|Protocol Violation|0
7914103|NCT02095951|12433624|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9
7914104|NCT02095951|12433625|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6
7914105|NCT02096003|12433637|FG000|Overall Study|Protocol Violation|0
7821153|NCT01253304|12289693|FG000|Overall Study|Adverse Event|0
7821154|NCT01253304|12289694|FG001|Overall Study|Adverse Event|0
7821155|NCT01253304|12289695|FG002|Overall Study|Adverse Event|0
7821156|NCT01253304|12289696|FG003|Overall Study|Adverse Event|1
7821157|NCT01253317|12289706|FG000|Overall Study|Adverse Event|2
7821158|NCT01253369|12289739|FG000|Overall Study|Adverse Event|4
7821159|NCT01253369|12289739|FG000|Overall Study|Withdrawal by Subject|2
7821160|NCT01253369|12289739|FG000|Overall Study|Death|1
7821161|NCT01253369|12289739|FG000|Overall Study|Progressive disease|23
7821162|NCT01253369|12289739|FG000|Overall Study|Not Evaluable|3
7914106|NCT02096003|12433638|FG001|Overall Study|Protocol Violation|2
7914107|NCT02096003|12433637|FG000|Overall Study|additional surgery|2
7914108|NCT02096003|12433638|FG001|Overall Study|additional surgery|1
7914109|NCT02096263|12433674|FG000|Overall Study|Adverse Event|1
7914110|NCT02096263|12433675|FG001|Overall Study|Adverse Event|0
7914111|NCT02096263|12433676|FG002|Overall Study|Adverse Event|1
7914112|NCT02096263|12433674|FG000|Overall Study|Lost to Follow-up|14
7914113|NCT02096263|12433675|FG001|Overall Study|Lost to Follow-up|18
7914114|NCT02096263|12433676|FG002|Overall Study|Lost to Follow-up|15
7914115|NCT02096263|12433674|FG000|Overall Study|Other|7
7914116|NCT02096263|12433675|FG001|Overall Study|Other|9
7914117|NCT02096263|12433676|FG002|Overall Study|Other|6
7914118|NCT02096263|12433674|FG000|Overall Study|Sponsor study termination|0
7914119|NCT02096263|12433675|FG001|Overall Study|Sponsor study termination|0
7821163|NCT01253408|12289746|FG000|Overall Study|Adverse Event|0
7914120|NCT02096263|12433676|FG002|Overall Study|Sponsor study termination|1
7914121|NCT02096263|12433674|FG000|Overall Study|Protocol Violation|7
7914122|NCT02096263|12433675|FG001|Overall Study|Protocol Violation|2
7821164|NCT01253408|12289747|FG001|Overall Study|Adverse Event|1
7821165|NCT01253408|12289748|FG002|Overall Study|Adverse Event|0
7821166|NCT01253421|12289760|FG000|Assessment and Scheduling|Found to be Ineligible|74
7821167|NCT01253421|12289761|FG001|Assessment and Scheduling|Found to be Ineligible|0
7821168|NCT01253421|12289762|FG002|Assessment and Scheduling|Found to be Ineligible|0
7821169|NCT01253421|12289763|FG003|Assessment and Scheduling|Found to be Ineligible|0
7821170|NCT01253421|12289764|FG004|Assessment and Scheduling|Found to be Ineligible|0
7821171|NCT01253421|12289760|FG000|Assessment and Scheduling|Lost to Follow-up|17
7821172|NCT01253421|12289761|FG001|Assessment and Scheduling|Lost to Follow-up|0
7914123|NCT02096263|12433676|FG002|Overall Study|Protocol Violation|8
7914124|NCT02096263|12433674|FG000|Overall Study|Withdrawal by Subject|5
7914125|NCT02096263|12433675|FG001|Overall Study|Withdrawal by Subject|7
7914126|NCT02096263|12433676|FG002|Overall Study|Withdrawal by Subject|8
7914127|NCT02096471|12433697|FG000|Overall Study|Adverse Event|1
7914128|NCT02096471|12433697|FG000|Overall Study|Lack of Efficacy|7
7914129|NCT02096471|12433697|FG000|Overall Study|Withdrawal by Subject|3
7914130|NCT02096471|12433697|FG000|Overall Study|Non-Compliant|2
7914131|NCT02096705|12433722|FG000|Treatment|Adverse Event|6
7914132|NCT02096705|12433723|FG001|Treatment|Adverse Event|3
7914133|NCT02096705|12433722|FG000|Treatment|Subject request to discontinue treatment|1
7719462|NCT00532298|12143419|FG004|Overall Study|Lost to Follow-up|0
7719463|NCT00532298|12143420|FG005|Overall Study|Lost to Follow-up|1
7719464|NCT00532441|12143434|FG000|Overall Study|Death|1
7719465|NCT00532441|12143435|FG001|Overall Study|Death|0
7719466|NCT00532493|12143450|FG000|Overall Study|Death|1
7719467|NCT00532493|12143451|FG001|Overall Study|Death|1
7719468|NCT00532493|12143450|FG000|Overall Study|Lost to Follow-up|10
7719469|NCT00532493|12143451|FG001|Overall Study|Lost to Follow-up|7
7719470|NCT00532493|12143450|FG000|Overall Study|Withdrawal by Subject|7
7719471|NCT00532493|12143451|FG001|Overall Study|Withdrawal by Subject|9
7719472|NCT00532493|12143450|FG000|Overall Study|Physician Decision|1
7719473|NCT00532493|12143451|FG001|Overall Study|Physician Decision|6
7719474|NCT00532493|12143450|FG000|Overall Study|Adverse Event|6
7719475|NCT00532493|12143451|FG001|Overall Study|Adverse Event|5
7719476|NCT00532493|12143450|FG000|Overall Study|Protocol Deviation|1
7719477|NCT00532493|12143451|FG001|Overall Study|Protocol Deviation|0
7719478|NCT00532493|12143450|FG000|Overall Study|Subject Moved Away|3
7719479|NCT00532493|12143451|FG001|Overall Study|Subject Moved Away|1
7719480|NCT00532493|12143450|FG000|Overall Study|Contraindicative Medication|1
7719481|NCT00532493|12143451|FG001|Overall Study|Contraindicative Medication|0
7719482|NCT00532779|12143462|FG000|Overall Study|Adverse Event|122
7719483|NCT00532779|12143463|FG001|Overall Study|Adverse Event|112
7719484|NCT00532779|12143464|FG002|Overall Study|Adverse Event|56
7719485|NCT00532779|12143462|FG000|Overall Study|Lost to Follow-up|76
7719486|NCT00532779|12143463|FG001|Overall Study|Lost to Follow-up|65
7719487|NCT00532779|12143464|FG002|Overall Study|Lost to Follow-up|66
7719488|NCT00532779|12143462|FG000|Overall Study|Withdrawal by Subject|63
7719489|NCT00532779|12143463|FG001|Overall Study|Withdrawal by Subject|60
7719490|NCT00532779|12143464|FG002|Overall Study|Withdrawal by Subject|90
7719491|NCT00532779|12143462|FG000|Overall Study|Lack of Efficacy|12
7719492|NCT00532779|12143463|FG001|Overall Study|Lack of Efficacy|12
7719493|NCT00532779|12143464|FG002|Overall Study|Lack of Efficacy|40
7719494|NCT00532779|12143462|FG000|Overall Study|Protocol Violation|5
7719495|NCT00532779|12143463|FG001|Overall Study|Protocol Violation|9
7719496|NCT00532779|12143464|FG002|Overall Study|Protocol Violation|7
7719497|NCT00532779|12143462|FG000|Overall Study|Pregnancy|2
7719498|NCT00532779|12143463|FG001|Overall Study|Pregnancy|5
7719499|NCT00532779|12143464|FG002|Overall Study|Pregnancy|3
7719500|NCT00532779|12143462|FG000|Overall Study|Death|0
7719501|NCT00532779|12143463|FG001|Overall Study|Death|1
7719502|NCT00532779|12143464|FG002|Overall Study|Death|0
7719503|NCT00532779|12143462|FG000|Overall Study|Drug noncompliance, moved, other|14
7914134|NCT02096705|12433723|FG001|Treatment|Subject request to discontinue treatment|1
7914135|NCT02096705|12433722|FG000|Treatment|Withdrawal by Subject|1
7914136|NCT02096705|12433723|FG001|Treatment|Withdrawal by Subject|0
7914137|NCT02096705|12433722|FG000|Treatment|Other|1
7914138|NCT02096705|12433723|FG001|Treatment|Other|1
7914139|NCT02096705|12433722|FG000|Follow-up|Withdrawal by Subject|1
7914140|NCT02096705|12433723|FG001|Follow-up|Withdrawal by Subject|0
7914141|NCT02096705|12433722|FG000|Follow-up|Adverse Event|2
7914142|NCT02096705|12433723|FG001|Follow-up|Adverse Event|2
7719504|NCT00532779|12143463|FG001|Overall Study|Drug noncompliance, moved, other|23
7914143|NCT02096705|12433722|FG000|Follow-up|Subjects not reporting status|1
7914144|NCT02096705|12433723|FG001|Follow-up|Subjects not reporting status|2
7914145|NCT02096744|12433755|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
7914146|NCT02096744|12433756|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
7914147|NCT02096744|12433755|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1
7914148|NCT02096744|12433756|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0
7914149|NCT02096744|12433755|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
7914150|NCT02096744|12433756|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
7914151|NCT02096835|12433767|FG000|Overall Study|Withdrawal by Subject|1
7914152|NCT02096835|12433768|FG001|Overall Study|Withdrawal by Subject|0
7914153|NCT02096835|12433769|FG002|Overall Study|Withdrawal by Subject|0
7914154|NCT02096835|12433767|FG000|Overall Study|converted to open procedures|1
7914155|NCT02096835|12433768|FG001|Overall Study|converted to open procedures|0
7914156|NCT02096835|12433769|FG002|Overall Study|converted to open procedures|0
7914157|NCT02096835|12433767|FG000|Overall Study|Lost to Follow-up|1
7914158|NCT02096835|12433768|FG001|Overall Study|Lost to Follow-up|0
7914159|NCT02096835|12433769|FG002|Overall Study|Lost to Follow-up|1
7914160|NCT02096900|12433798|FG000|Overall Study|Did not receive medication|3
7914161|NCT02096900|12433799|FG001|Overall Study|Did not receive medication|1
7914162|NCT02096900|12433798|FG000|Overall Study|Surgery cancelled- medication received|1
7914163|NCT02096900|12433799|FG001|Overall Study|Surgery cancelled- medication received|1
7914164|NCT02096952|12433805|FG000|Overall Study|Adverse Event|1
7914165|NCT02097030|12433811|FG000|First Intervention (3 Days)|Lost to Follow-up|1
7914166|NCT02097030|12433812|FG001|First Intervention (3 Days)|Lost to Follow-up|0
7914167|NCT02097030|12433811|FG000|First Intervention (3 Days)|Visual Acuity|0
7914168|NCT02097030|12433812|FG001|First Intervention (3 Days)|Visual Acuity|1
7914169|NCT02097056|12433822|FG000|Overall Study|Protocol Violation|2
7914170|NCT02097056|12433822|FG000|Overall Study|Withdrawal by Subject|15
7914171|NCT02097056|12433822|FG000|Overall Study|Lost to Follow-up|2
7914172|NCT02097056|12433822|FG000|Overall Study|Adverse Event|37
7914173|NCT02097056|12433822|FG000|Overall Study|Other|2
7914174|NCT02097108|12433826|FG000|Overall Study|Adverse Event|1
7914175|NCT02097108|12433826|FG000|Overall Study|patient was abroad for 6 months|1
7914176|NCT02097238|12433830|FG000|Overall Study|Death|1
7914177|NCT02097238|12433830|FG000|Overall Study|Physician Decision|1
7914178|NCT02097238|12433830|FG000|Overall Study|Progressive Disease|17
7914179|NCT02097277|12433840|FG000|Overall Study|Subject no longer meets study criteria|0
7914180|NCT02097277|12433841|FG001|Overall Study|Subject no longer meets study criteria|1
7914181|NCT02097277|12433842|FG002|Overall Study|Subject no longer meets study criteria|0
7914182|NCT02097277|12433843|FG003|Overall Study|Subject no longer meets study criteria|1
7914183|NCT02097277|12433844|FG004|Overall Study|Subject no longer meets study criteria|0
7914184|NCT02097277|12433840|FG000|Overall Study|Subject request to discontinue treatment|0
7914185|NCT02097277|12433841|FG001|Overall Study|Subject request to discontinue treatment|0
7914186|NCT02097277|12433842|FG002|Overall Study|Subject request to discontinue treatment|0
7914187|NCT02097277|12433843|FG003|Overall Study|Subject request to discontinue treatment|0
7914188|NCT02097277|12433844|FG004|Overall Study|Subject request to discontinue treatment|1
7914189|NCT02097277|12433840|FG000|Overall Study|Lost to Follow-up|0
7914190|NCT02097277|12433841|FG001|Overall Study|Lost to Follow-up|1
7914191|NCT02097277|12433842|FG002|Overall Study|Lost to Follow-up|1
7914192|NCT02097277|12433843|FG003|Overall Study|Lost to Follow-up|0
7914193|NCT02097277|12433844|FG004|Overall Study|Lost to Follow-up|0
7914194|NCT02097277|12433840|FG000|Overall Study|Withdrawal by Subject|2
7914195|NCT02097277|12433841|FG001|Overall Study|Withdrawal by Subject|1
7914196|NCT02097277|12433842|FG002|Overall Study|Withdrawal by Subject|0
7914197|NCT02097277|12433843|FG003|Overall Study|Withdrawal by Subject|1
7914198|NCT02097277|12433844|FG004|Overall Study|Withdrawal by Subject|0
7914199|NCT02097277|12433840|FG000|Overall Study|Adverse Event|0
7914200|NCT02097277|12433841|FG001|Overall Study|Adverse Event|0
7914201|NCT02097277|12433842|FG002|Overall Study|Adverse Event|1
7914202|NCT02097277|12433843|FG003|Overall Study|Adverse Event|2
7914203|NCT02097277|12433844|FG004|Overall Study|Adverse Event|0
7914204|NCT02097290|12433860|FG000|Overall Study|Death|6
7914205|NCT02097290|12433860|FG000|Overall Study|Total Withdrawals|3
7914206|NCT02097290|12433860|FG000|Overall Study|Attempt|8
7914207|NCT02097472|12433876|FG000|Received Vaccination 2|Adverse Event|0
7914208|NCT02097472|12433877|FG001|Received Vaccination 2|Adverse Event|0
7914209|NCT02097472|12433878|FG002|Received Vaccination 2|Adverse Event|0
7914210|NCT02097472|12433879|FG003|Received Vaccination 2|Adverse Event|0
7914211|NCT02097472|12433880|FG004|Received Vaccination 2|Adverse Event|0
7914212|NCT02097472|12433881|FG005|Received Vaccination 2|Adverse Event|0
7914213|NCT02097472|12433882|FG006|Received Vaccination 2|Adverse Event|1
7914214|NCT02097472|12433883|FG007|Received Vaccination 2|Adverse Event|0
7964202|NCT04865354|12519443|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1
7964203|NCT04865354|12519444|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0
7964204|NCT04865354|12519443|FG000|First Wear Period (8 Days)|Lost to Follow-up|0
7964205|NCT04865354|12519444|FG001|First Wear Period (8 Days)|Lost to Follow-up|1
7964206|NCT04865354|12519443|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1
7964207|NCT04865354|12519444|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0
7966888|NCT02757768|12523297|FG001|Overall Study|Randomized Never Received Study Drug|4
7966889|NCT02757768|12523296|FG000|Overall Study|Adverse Event|5
7966890|NCT02757768|12523297|FG001|Overall Study|Adverse Event|3
7966891|NCT02757768|12523296|FG000|Overall Study|Lack of Efficacy|2
7966892|NCT02757768|12523297|FG001|Overall Study|Lack of Efficacy|1
7966893|NCT02757768|12523296|FG000|Overall Study|Lost to Follow-up|1
7966894|NCT02757768|12523297|FG001|Overall Study|Lost to Follow-up|0
7966895|NCT02757768|12523296|FG000|Overall Study|Protocol Deviation|2
7966896|NCT02757768|12523297|FG001|Overall Study|Protocol Deviation|9
7966897|NCT02757768|12523296|FG000|Overall Study|Withdrawal by Subject|16
7966898|NCT02757768|12523297|FG001|Overall Study|Withdrawal by Subject|9
7966899|NCT02757768|12523296|FG000|Overall Study|Miscellaneous|4
7966900|NCT02757768|12523297|FG001|Overall Study|Miscellaneous|2
7966901|NCT02757963|12523315|FG000|Overall Study|Adverse Event|3
7966902|NCT02757963|12523315|FG000|Overall Study|Reached Stopping Criteria|1054
7966903|NCT02757963|12523315|FG000|Overall Study|Lost to Follow-up|5
7966904|NCT02757963|12523315|FG000|Overall Study|Physician Decision|1
7966905|NCT02757963|12523315|FG000|Overall Study|Withdrawal by Subject|34
7966906|NCT02758171|12523343|FG000|Wash-out|Withdrawal by Subject|1
7966907|NCT02758171|12523344|FG001|Wash-out|Withdrawal by Subject|0
7966908|NCT02758171|12523343|FG000|Wash-out|Other reason|1
7966909|NCT02758171|12523344|FG001|Wash-out|Other reason|0
7966910|NCT02758301|12523356|FG000|Overall Study|Death|12
7966911|NCT02758301|12523357|FG001|Overall Study|Death|0
7966912|NCT02758301|12523356|FG000|Overall Study|Physician Decision|10
7914215|NCT02097719|12433993|FG000|Overall Study|Subject Withdrew Consent|1
7914216|NCT02097719|12433994|FG001|Overall Study|Subject Withdrew Consent|0
7914217|NCT02097719|12433993|FG000|Overall Study|Lost to Follow-up|0
7914218|NCT02097719|12433994|FG001|Overall Study|Lost to Follow-up|1
7914219|NCT02097719|12433993|FG000|Overall Study|Adverse Event|2
7914220|NCT02097719|12433994|FG001|Overall Study|Adverse Event|0
7914221|NCT02097745|12434010|FG000|Overall Study|Adverse Event|25
7914222|NCT02097745|12434010|FG000|Overall Study|Death|16
7914223|NCT02097745|12434010|FG000|Overall Study|Failure to Return|14
7914224|NCT02097745|12434010|FG000|Overall Study|Administrative/Other|27
7914225|NCT02097745|12434010|FG000|Overall Study|Reason Not Specified|96
7914226|NCT02097823|12434019|FG000|Overall Study|Withdrawal by Subject|1
7914227|NCT02097823|12434020|FG001|Overall Study|Withdrawal by Subject|1
7914228|NCT02098109|12434053|FG000|Overall Study|Protocol Violation|3
7914229|NCT02098109|12434054|FG001|Overall Study|Protocol Violation|0
7914230|NCT02098369|12434069|FG000|Overall Study|Withdrawal by Subject|1
7914231|NCT02098369|12434070|FG001|Overall Study|Withdrawal by Subject|5
7914232|NCT02098369|12434071|FG002|Overall Study|Withdrawal by Subject|0
7914233|NCT02098369|12434069|FG000|Overall Study|Lost to Follow-up|5
7914234|NCT02098369|12434070|FG001|Overall Study|Lost to Follow-up|1
7914235|NCT02098369|12434071|FG002|Overall Study|Lost to Follow-up|3
7914236|NCT02098369|12434069|FG000|Overall Study|Death|1
7914237|NCT02098369|12434070|FG001|Overall Study|Death|1
7914238|NCT02098369|12434071|FG002|Overall Study|Death|1
7914239|NCT02098369|12434069|FG000|Overall Study|Other|0
7914240|NCT02098369|12434070|FG001|Overall Study|Other|2
7914241|NCT02098369|12434071|FG002|Overall Study|Other|1
7914242|NCT02098395|12434083|FG000|Overall Study|Protocol Violation|2
7914243|NCT02098395|12434084|FG001|Overall Study|Protocol Violation|2
7914244|NCT02098395|12434085|FG002|Overall Study|Protocol Violation|0
7914245|NCT02098395|12434086|FG003|Overall Study|Protocol Violation|7
7914246|NCT02098395|12434083|FG000|Overall Study|Withdrawal by Subject|10
7914247|NCT02098395|12434084|FG001|Overall Study|Withdrawal by Subject|10
7914248|NCT02098395|12434085|FG002|Overall Study|Withdrawal by Subject|5
7914249|NCT02098395|12434086|FG003|Overall Study|Withdrawal by Subject|13
7914250|NCT02098395|12434083|FG000|Overall Study|Adverse Event|12
7914251|NCT02098395|12434084|FG001|Overall Study|Adverse Event|19
7914252|NCT02098395|12434085|FG002|Overall Study|Adverse Event|34
7914253|NCT02098395|12434086|FG003|Overall Study|Adverse Event|2
7914254|NCT02098395|12434083|FG000|Overall Study|Lost to Follow-up|2
7914255|NCT02098395|12434084|FG001|Overall Study|Lost to Follow-up|1
7914256|NCT02098395|12434085|FG002|Overall Study|Lost to Follow-up|0
7914257|NCT02098395|12434086|FG003|Overall Study|Lost to Follow-up|3
7914258|NCT02098395|12434083|FG000|Overall Study|Unclassified|0
7914259|NCT02098395|12434084|FG001|Overall Study|Unclassified|0
7914260|NCT02098395|12434085|FG002|Overall Study|Unclassified|3
7914261|NCT02098395|12434086|FG003|Overall Study|Unclassified|2
7914262|NCT02098733|12434096|FG000|Overall Study|Data Not Available|5
7914263|NCT02098733|12434096|FG000|Overall Study|Lost to Follow-up|5
7914264|NCT02098746|12434100|FG000|Overall Study|Changes of Investigator|2
7914265|NCT02098746|12434100|FG000|Overall Study|Other Miscellaneous Reasons|1
7914266|NCT02098746|12434100|FG000|Overall Study|Enrolled 15 Days After the First Dose|1
7914267|NCT02098746|12434100|FG000|Overall Study|Data Not Available After Treatment|1
7914268|NCT02099110|12434131|FG000|Overall Study|Protocol Violation|2
7914269|NCT02099110|12434132|FG001|Overall Study|Protocol Violation|1
7914270|NCT02099110|12434133|FG002|Overall Study|Protocol Violation|0
7914271|NCT02099110|12434134|FG003|Overall Study|Protocol Violation|3
7914272|NCT02099110|12434135|FG004|Overall Study|Protocol Violation|1
7914273|NCT02099110|12434131|FG000|Overall Study|Participant moved|1
7914274|NCT02099110|12434132|FG001|Overall Study|Participant moved|1
7914275|NCT02099110|12434133|FG002|Overall Study|Participant moved|1
7914276|NCT02099110|12434134|FG003|Overall Study|Participant moved|0
7914277|NCT02099110|12434135|FG004|Overall Study|Participant moved|2
7914278|NCT02099110|12434131|FG000|Overall Study|Withdrawal by Subject|7
7914279|NCT02099110|12434132|FG001|Overall Study|Withdrawal by Subject|11
7914280|NCT02099110|12434133|FG002|Overall Study|Withdrawal by Subject|13
7914281|NCT02099110|12434134|FG003|Overall Study|Withdrawal by Subject|9
7914282|NCT02099110|12434135|FG004|Overall Study|Withdrawal by Subject|13
7914283|NCT02099110|12434131|FG000|Overall Study|Adverse Event|3
7914284|NCT02099110|12434132|FG001|Overall Study|Adverse Event|5
7914285|NCT02099110|12434133|FG002|Overall Study|Adverse Event|2
7914286|NCT02099110|12434134|FG003|Overall Study|Adverse Event|3
7914287|NCT02099110|12434135|FG004|Overall Study|Adverse Event|2
7914288|NCT02099110|12434131|FG000|Overall Study|Lost to Follow-up|6
7914289|NCT02099110|12434132|FG001|Overall Study|Lost to Follow-up|12
7914290|NCT02099110|12434133|FG002|Overall Study|Lost to Follow-up|11
7914291|NCT02099110|12434134|FG003|Overall Study|Lost to Follow-up|5
7914292|NCT02099110|12434135|FG004|Overall Study|Lost to Follow-up|6
7914293|NCT02099110|12434131|FG000|Overall Study|Death|0
7914294|NCT02099110|12434132|FG001|Overall Study|Death|1
7914295|NCT02099110|12434133|FG002|Overall Study|Death|0
7914296|NCT02099110|12434134|FG003|Overall Study|Death|0
7914297|NCT02099110|12434135|FG004|Overall Study|Death|0
7914298|NCT02099110|12434131|FG000|Overall Study|Screen failure|0
7914299|NCT02099110|12434132|FG001|Overall Study|Screen failure|0
7914300|NCT02099110|12434133|FG002|Overall Study|Screen failure|0
7914301|NCT02099110|12434134|FG003|Overall Study|Screen failure|0
7914302|NCT02099110|12434135|FG004|Overall Study|Screen failure|1
7914303|NCT02099110|12434131|FG000|Overall Study|Non-compliance with study drug|2
7914304|NCT02099110|12434132|FG001|Overall Study|Non-compliance with study drug|0
7914305|NCT02099110|12434133|FG002|Overall Study|Non-compliance with study drug|0
7914306|NCT02099110|12434134|FG003|Overall Study|Non-compliance with study drug|0
7914307|NCT02099110|12434135|FG004|Overall Study|Non-compliance with study drug|1
7914308|NCT02099110|12434131|FG000|Overall Study|Physician Decision|3
7914309|NCT02099110|12434132|FG001|Overall Study|Physician Decision|0
7914310|NCT02099110|12434133|FG002|Overall Study|Physician Decision|1
7914311|NCT02099110|12434134|FG003|Overall Study|Physician Decision|2
7914312|NCT02099110|12434135|FG004|Overall Study|Physician Decision|1
7914313|NCT02099682|12434167|FG000|Overall Study|Data Not Available|51
7914314|NCT02099682|12434167|FG000|Overall Study|Lost to Follow-up|31
7914315|NCT02099682|12434167|FG000|Overall Study|Other|29
7914316|NCT02099708|12434171|FG000|Overall Study|Data Not Available|30
7914317|NCT02099708|12434171|FG000|Overall Study|Lost to Follow-up|141
7914318|NCT02099708|12434171|FG000|Overall Study|Other|29
7914319|NCT02099838|12434221|FG000|Overall Study|Death|1
7914320|NCT02099838|12434222|FG001|Overall Study|Death|0
7914321|NCT02099838|12434221|FG000|Overall Study|Lost to Follow-up|3
7914322|NCT02099838|12434222|FG001|Overall Study|Lost to Follow-up|1
7914323|NCT02099838|12434221|FG000|Overall Study|Withdrawal by Subject|0
7914324|NCT02099838|12434222|FG001|Overall Study|Withdrawal by Subject|1
7914325|NCT02100124|12434240|FG000|Overall Study|Lost to Follow-up|5
7914326|NCT02100124|12434241|FG001|Overall Study|Lost to Follow-up|11
7914327|NCT02100124|12434242|FG002|Overall Study|Lost to Follow-up|3
7914328|NCT02100124|12434240|FG000|Overall Study|Withdrawal by Subject|1
7914329|NCT02100124|12434241|FG001|Overall Study|Withdrawal by Subject|0
7914330|NCT02100124|12434242|FG002|Overall Study|Withdrawal by Subject|0
7914331|NCT02100228|12434256|FG000|Overall Study|Other|19
7914332|NCT02100228|12434257|FG001|Overall Study|Other|19
7914333|NCT02100228|12434256|FG000|Overall Study|Administrative reason|0
7914334|NCT02100228|12434257|FG001|Overall Study|Administrative reason|1
7914335|NCT02100228|12434256|FG000|Overall Study|Inclusion/Exclusion criteria not met|12
7914336|NCT02100228|12434257|FG001|Overall Study|Inclusion/Exclusion criteria not met|16
7914337|NCT02100228|12434256|FG000|Overall Study|Non-compliance|0
7914338|NCT02100228|12434257|FG001|Overall Study|Non-compliance|3
7914339|NCT02100228|12434256|FG000|Overall Study|Lost to Follow-up|0
7914340|NCT02100228|12434257|FG001|Overall Study|Lost to Follow-up|1
7914341|NCT02100228|12434256|FG000|Overall Study|Withdrawal by Subject|27
7914342|NCT02100228|12434257|FG001|Overall Study|Withdrawal by Subject|37
7914343|NCT02100228|12434256|FG000|Overall Study|Adverse Event|16
7914344|NCT02100228|12434257|FG001|Overall Study|Adverse Event|12
7914345|NCT02100228|12434256|FG000|Overall Study|Death|1
7914346|NCT02100228|12434257|FG001|Overall Study|Death|1
7914347|NCT02100319|12434274|FG000|Overall Study|Case Report Forms Uncollected|11
7914348|NCT02100319|12434274|FG000|Overall Study|Protocol Deviation|5
7914349|NCT02100475|12434297|FG000|Overall Study|Unclassified|1
7914350|NCT02100475|12434298|FG001|Overall Study|Unclassified|2
7914351|NCT02100475|12434297|FG000|Overall Study|Withdrawal criteria|1
7914352|NCT02100475|12434298|FG001|Overall Study|Withdrawal criteria|0
7914353|NCT02100514|12434306|FG000|Treatment Period|Adverse Event|0
7914354|NCT02100514|12434307|FG001|Treatment Period|Adverse Event|5
7914355|NCT02100514|12434308|FG002|Treatment Period|Adverse Event|0
7914356|NCT02100514|12434309|FG003|Treatment Period|Adverse Event|0
7914357|NCT02100514|12434310|FG004|Treatment Period|Adverse Event|0
7914358|NCT02100514|12434306|FG000|Treatment Period|Death|2
7914359|NCT02100514|12434307|FG001|Treatment Period|Death|2
7914360|NCT02100514|12434308|FG002|Treatment Period|Death|0
7914361|NCT02100514|12434309|FG003|Treatment Period|Death|0
7914362|NCT02100514|12434310|FG004|Treatment Period|Death|0
7914363|NCT02100514|12434306|FG000|Treatment Period|Lost to Follow-up|5
7914364|NCT02100514|12434307|FG001|Treatment Period|Lost to Follow-up|17
7914365|NCT02100514|12434308|FG002|Treatment Period|Lost to Follow-up|0
7914366|NCT02100514|12434309|FG003|Treatment Period|Lost to Follow-up|0
7914367|NCT02100514|12434310|FG004|Treatment Period|Lost to Follow-up|0
7914368|NCT02100514|12434306|FG000|Treatment Period|Did Not Meet Entrance Criteria|0
7914369|NCT02100514|12434307|FG001|Treatment Period|Did Not Meet Entrance Criteria|1
7914370|NCT02100514|12434308|FG002|Treatment Period|Did Not Meet Entrance Criteria|0
7914371|NCT02100514|12434309|FG003|Treatment Period|Did Not Meet Entrance Criteria|0
7914372|NCT02100514|12434310|FG004|Treatment Period|Did Not Meet Entrance Criteria|0
7914373|NCT02100514|12434306|FG000|Treatment Period|Protocol Violation|1
7914374|NCT02100514|12434307|FG001|Treatment Period|Protocol Violation|1
7914375|NCT02100514|12434308|FG002|Treatment Period|Protocol Violation|0
7914376|NCT02100514|12434309|FG003|Treatment Period|Protocol Violation|0
7914377|NCT02100514|12434310|FG004|Treatment Period|Protocol Violation|0
7914378|NCT02100514|12434306|FG000|Treatment Period|Withdrawal by Subject|12
7914379|NCT02100514|12434307|FG001|Treatment Period|Withdrawal by Subject|37
7914380|NCT02100514|12434308|FG002|Treatment Period|Withdrawal by Subject|0
7914381|NCT02100514|12434309|FG003|Treatment Period|Withdrawal by Subject|0
7914382|NCT02100514|12434310|FG004|Treatment Period|Withdrawal by Subject|0
7914383|NCT02100514|12434306|FG000|Treatment Period|Other|9
7914384|NCT02100514|12434307|FG001|Treatment Period|Other|11
7914385|NCT02100514|12434308|FG002|Treatment Period|Other|0
7914386|NCT02100514|12434309|FG003|Treatment Period|Other|0
7914387|NCT02100514|12434310|FG004|Treatment Period|Other|0
7914388|NCT02100514|12434306|FG000|Extension Period|Withdrew consent|0
7914389|NCT02100514|12434307|FG001|Extension Period|Withdrew consent|0
7914390|NCT02100514|12434308|FG002|Extension Period|Withdrew consent|2
7914391|NCT02100514|12434309|FG003|Extension Period|Withdrew consent|0
7914392|NCT02100514|12434310|FG004|Extension Period|Withdrew consent|0
7914393|NCT02100631|12434336|FG000|Overall Study|Withdrawal by Subject|1
7914394|NCT02100631|12434337|FG001|Overall Study|Withdrawal by Subject|0
7914395|NCT02100631|12434338|FG002|Overall Study|Withdrawal by Subject|0
7914396|NCT02100631|12434336|FG000|Overall Study|Lost to Follow-up|3
7914397|NCT02100631|12434337|FG001|Overall Study|Lost to Follow-up|4
7914398|NCT02100631|12434338|FG002|Overall Study|Lost to Follow-up|0
7914399|NCT02100631|12434336|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3
7914400|NCT02100631|12434337|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0
7914401|NCT02100631|12434338|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0
7914402|NCT02100644|12434346|FG000|LTG Escalation Phase|Adverse Event|9
7914403|NCT02100644|12434347|FG001|LTG Escalation Phase|Adverse Event|0
7914404|NCT02100644|12434348|FG002|LTG Escalation Phase|Adverse Event|0
7914405|NCT02100644|12434346|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
7914406|NCT02100644|12434347|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
7914407|NCT02100644|12434348|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
7914408|NCT02100644|12434346|FG000|LTG Escalation Phase|Withdrawal by Subject|3
7914409|NCT02100644|12434347|FG001|LTG Escalation Phase|Withdrawal by Subject|0
7914410|NCT02100644|12434348|FG002|LTG Escalation Phase|Withdrawal by Subject|0
7914411|NCT02100657|12434355|FG000|Cohort 1: Dose Level 1|Progressive disease|6
7914412|NCT02100657|12434356|FG001|Cohort 1: Dose Level 1|Progressive disease|0
7914413|NCT02100657|12434357|FG002|Cohort 1: Dose Level 1|Progressive disease|0
7914414|NCT02100657|12434355|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1
7914415|NCT02100657|12434356|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0
7914416|NCT02100657|12434357|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0
7914417|NCT02100657|12434355|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1
7914418|NCT02100657|12434356|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0
7914419|NCT02100657|12434357|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0
7914420|NCT02100657|12434355|FG000|Cohort 2: Dose Level 2|Progressive disease|0
7914421|NCT02100657|12434356|FG001|Cohort 2: Dose Level 2|Progressive disease|2
7914422|NCT02100657|12434357|FG002|Cohort 2: Dose Level 2|Progressive disease|0
7914423|NCT02100657|12434355|FG000|Cohort 2: Dose Level 2|Physician Decision|0
7914424|NCT02100657|12434356|FG001|Cohort 2: Dose Level 2|Physician Decision|1
7914425|NCT02100657|12434357|FG002|Cohort 2: Dose Level 2|Physician Decision|0
7914426|NCT02100657|12434355|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0
7914427|NCT02100657|12434356|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1
7914428|NCT02100657|12434357|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0
7914429|NCT02100657|12434355|FG000|Cohort 3: Dose Level 3|Progressive disease|0
7914430|NCT02100657|12434356|FG001|Cohort 3: Dose Level 3|Progressive disease|0
7914431|NCT02100657|12434357|FG002|Cohort 3: Dose Level 3|Progressive disease|15
7914432|NCT02100657|12434355|FG000|Cohort 3: Dose Level 3|Death|0
7914433|NCT02100657|12434356|FG001|Cohort 3: Dose Level 3|Death|0
7914434|NCT02100657|12434357|FG002|Cohort 3: Dose Level 3|Death|1
7914435|NCT02100657|12434355|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
7914436|NCT02100657|12434356|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
7914437|NCT02100657|12434357|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1
7914438|NCT02100657|12434355|FG000|Cohort 3: Dose Level 3|Physician Decision|0
7914439|NCT02100657|12434356|FG001|Cohort 3: Dose Level 3|Physician Decision|0
7914440|NCT02100657|12434357|FG002|Cohort 3: Dose Level 3|Physician Decision|1
7914441|NCT02100657|12434355|FG000|Cohort 3: Dose Level 3|Never were treated|0
7914442|NCT02100657|12434356|FG001|Cohort 3: Dose Level 3|Never were treated|0
7914443|NCT02100657|12434357|FG002|Cohort 3: Dose Level 3|Never were treated|3
7914444|NCT02100657|12434355|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0
7914445|NCT02100657|12434356|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0
7914446|NCT02100657|12434357|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3
7914447|NCT02100657|12434355|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0
7914448|NCT02100657|12434356|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0
7914449|NCT02100657|12434357|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3
7914450|NCT02100670|12434370|FG000|Overall Study|Adverse Event|10
7914451|NCT02100670|12434371|FG001|Overall Study|Adverse Event|3
7914452|NCT02100670|12434372|FG002|Overall Study|Adverse Event|3
7914453|NCT02100670|12434373|FG003|Overall Study|Adverse Event|0
7914454|NCT02100670|12434370|FG000|Overall Study|Lost to Follow-up|1
7914455|NCT02100670|12434371|FG001|Overall Study|Lost to Follow-up|0
7914456|NCT02100670|12434372|FG002|Overall Study|Lost to Follow-up|0
7914457|NCT02100670|12434373|FG003|Overall Study|Lost to Follow-up|0
7914458|NCT02100670|12434370|FG000|Overall Study|Protocol Violation|0
7914459|NCT02100670|12434371|FG001|Overall Study|Protocol Violation|1
7914460|NCT02100670|12434372|FG002|Overall Study|Protocol Violation|0
7914461|NCT02100670|12434373|FG003|Overall Study|Protocol Violation|1
7914462|NCT02100670|12434370|FG000|Overall Study|Withdrawal of Consent|0
7914463|NCT02100670|12434371|FG001|Overall Study|Withdrawal of Consent|1
7914464|NCT02100670|12434372|FG002|Overall Study|Withdrawal of Consent|1
7914465|NCT02100670|12434373|FG003|Overall Study|Withdrawal of Consent|0
7914466|NCT02100670|12434370|FG000|Overall Study|No swelling no pain|1
7914467|NCT02100670|12434371|FG001|Overall Study|No swelling no pain|0
7914468|NCT02100670|12434372|FG002|Overall Study|No swelling no pain|0
7914469|NCT02100670|12434373|FG003|Overall Study|No swelling no pain|0
7914470|NCT02100670|12434370|FG000|Overall Study|Poor Efficacy|0
7914471|NCT02100670|12434371|FG001|Overall Study|Poor Efficacy|1
7914472|NCT02100670|12434372|FG002|Overall Study|Poor Efficacy|0
7914473|NCT02100670|12434373|FG003|Overall Study|Poor Efficacy|0
7914474|NCT02100670|12434370|FG000|Overall Study|Physician Decision|0
7914475|NCT02100670|12434371|FG001|Overall Study|Physician Decision|1
7914476|NCT02100670|12434372|FG002|Overall Study|Physician Decision|0
7914477|NCT02100670|12434373|FG003|Overall Study|Physician Decision|0
7914478|NCT02100670|12434370|FG000|Overall Study|Withdrawal by Subject|1
7914479|NCT02100670|12434371|FG001|Overall Study|Withdrawal by Subject|0
7914480|NCT02100670|12434372|FG002|Overall Study|Withdrawal by Subject|0
7914481|NCT02100670|12434373|FG003|Overall Study|Withdrawal by Subject|0
7914482|NCT02100696|12434396|FG000|Induction Phase|Adverse Event|0
7914483|NCT02100696|12434397|FG001|Induction Phase|Adverse Event|0
7914484|NCT02100696|12434398|FG002|Induction Phase|Adverse Event|1
7914485|NCT02100696|12434399|FG003|Induction Phase|Adverse Event|0
7914486|NCT02100696|12434400|FG004|Induction Phase|Adverse Event|0
7914487|NCT02100696|12434401|FG005|Induction Phase|Adverse Event|0
7914488|NCT02100696|12434396|FG000|Induction Phase|Lost to Follow-up|1
7914489|NCT02100696|12434397|FG001|Induction Phase|Lost to Follow-up|0
7914490|NCT02100696|12434398|FG002|Induction Phase|Lost to Follow-up|1
7914491|NCT02100696|12434399|FG003|Induction Phase|Lost to Follow-up|0
7914492|NCT02100696|12434400|FG004|Induction Phase|Lost to Follow-up|0
7914493|NCT02100696|12434401|FG005|Induction Phase|Lost to Follow-up|0
7914494|NCT02100696|12434396|FG000|Induction Phase|Protocol Violation|0
7914495|NCT02100696|12434397|FG001|Induction Phase|Protocol Violation|1
7914496|NCT02100696|12434398|FG002|Induction Phase|Protocol Violation|1
7914497|NCT02100696|12434399|FG003|Induction Phase|Protocol Violation|0
7914498|NCT02100696|12434400|FG004|Induction Phase|Protocol Violation|0
7914499|NCT02100696|12434401|FG005|Induction Phase|Protocol Violation|0
7914500|NCT02100696|12434396|FG000|Induction Phase|Withdrawal by Subject|8
7914501|NCT02100696|12434397|FG001|Induction Phase|Withdrawal by Subject|2
7914502|NCT02100696|12434398|FG002|Induction Phase|Withdrawal by Subject|13
7914503|NCT02100696|12434399|FG003|Induction Phase|Withdrawal by Subject|0
7914504|NCT02100696|12434400|FG004|Induction Phase|Withdrawal by Subject|0
7914505|NCT02100696|12434401|FG005|Induction Phase|Withdrawal by Subject|0
7914506|NCT02100696|12434396|FG000|Induction Phase|Physician Decision|1
7914507|NCT02100696|12434397|FG001|Induction Phase|Physician Decision|0
7914508|NCT02100696|12434398|FG002|Induction Phase|Physician Decision|2
7914509|NCT02100696|12434399|FG003|Induction Phase|Physician Decision|0
7914510|NCT02100696|12434400|FG004|Induction Phase|Physician Decision|0
7914511|NCT02100696|12434401|FG005|Induction Phase|Physician Decision|0
7914512|NCT02100696|12434396|FG000|Induction Phase|Multiple Reasons|5
7914513|NCT02100696|12434397|FG001|Induction Phase|Multiple Reasons|2
7914514|NCT02100696|12434398|FG002|Induction Phase|Multiple Reasons|8
7914515|NCT02100696|12434399|FG003|Induction Phase|Multiple Reasons|0
7914516|NCT02100696|12434400|FG004|Induction Phase|Multiple Reasons|0
7914517|NCT02100696|12434401|FG005|Induction Phase|Multiple Reasons|0
7914518|NCT02100696|12434396|FG000|Maintenance Phase|Adverse Event|0
7914519|NCT02100696|12434397|FG001|Maintenance Phase|Adverse Event|0
7914520|NCT02100696|12434398|FG002|Maintenance Phase|Adverse Event|0
7914521|NCT02100696|12434399|FG003|Maintenance Phase|Adverse Event|0
7914522|NCT02100696|12434400|FG004|Maintenance Phase|Adverse Event|0
7914523|NCT02100696|12434401|FG005|Maintenance Phase|Adverse Event|2
7914524|NCT02100696|12434396|FG000|Maintenance Phase|Lost to Follow-up|0
7914525|NCT02100696|12434397|FG001|Maintenance Phase|Lost to Follow-up|0
7914526|NCT02100696|12434398|FG002|Maintenance Phase|Lost to Follow-up|0
7914527|NCT02100696|12434399|FG003|Maintenance Phase|Lost to Follow-up|0
7914528|NCT02100696|12434400|FG004|Maintenance Phase|Lost to Follow-up|1
7914529|NCT02100696|12434401|FG005|Maintenance Phase|Lost to Follow-up|0
7914530|NCT02100696|12434396|FG000|Maintenance Phase|Protocol Violation|0
7914531|NCT02100696|12434397|FG001|Maintenance Phase|Protocol Violation|0
7914532|NCT02100696|12434398|FG002|Maintenance Phase|Protocol Violation|0
7914533|NCT02100696|12434399|FG003|Maintenance Phase|Protocol Violation|0
7914534|NCT02100696|12434400|FG004|Maintenance Phase|Protocol Violation|1
7914535|NCT02100696|12434401|FG005|Maintenance Phase|Protocol Violation|0
7914536|NCT02100696|12434396|FG000|Maintenance Phase|Withdrawal by Subject|0
7914537|NCT02100696|12434397|FG001|Maintenance Phase|Withdrawal by Subject|0
7914538|NCT02100696|12434398|FG002|Maintenance Phase|Withdrawal by Subject|0
7914539|NCT02100696|12434399|FG003|Maintenance Phase|Withdrawal by Subject|1
7914540|NCT02100696|12434400|FG004|Maintenance Phase|Withdrawal by Subject|4
7914541|NCT02100696|12434401|FG005|Maintenance Phase|Withdrawal by Subject|2
7914542|NCT02100696|12434396|FG000|Maintenance Phase|Physician Decision|0
7914543|NCT02100696|12434397|FG001|Maintenance Phase|Physician Decision|0
7914544|NCT02100696|12434398|FG002|Maintenance Phase|Physician Decision|0
7914545|NCT02100696|12434399|FG003|Maintenance Phase|Physician Decision|0
7914546|NCT02100696|12434400|FG004|Maintenance Phase|Physician Decision|1
7914547|NCT02100696|12434401|FG005|Maintenance Phase|Physician Decision|0
7914548|NCT02100696|12434396|FG000|Maintenance Phase|Multiple Reasons|0
7914549|NCT02100696|12434397|FG001|Maintenance Phase|Multiple Reasons|0
7914550|NCT02100696|12434398|FG002|Maintenance Phase|Multiple Reasons|0
7914551|NCT02100696|12434399|FG003|Maintenance Phase|Multiple Reasons|0
7914552|NCT02100696|12434400|FG004|Maintenance Phase|Multiple Reasons|2
7914553|NCT02100696|12434401|FG005|Maintenance Phase|Multiple Reasons|1
7914554|NCT02100813|12434479|FG000|Overall Study|Adverse Event|0
7914555|NCT02100813|12434480|FG001|Overall Study|Adverse Event|0
7914556|NCT02100813|12434481|FG002|Overall Study|Adverse Event|0
7914557|NCT02100813|12434482|FG003|Overall Study|Adverse Event|0
7914558|NCT02100813|12434483|FG004|Overall Study|Adverse Event|0
7914559|NCT02100813|12434484|FG005|Overall Study|Adverse Event|0
7914560|NCT02100813|12434485|FG006|Overall Study|Adverse Event|0
7914561|NCT02100813|12434486|FG007|Overall Study|Adverse Event|1
7914562|NCT02100839|12434513|FG000|Multiple Ascending Dose|Adverse Event|2
7914563|NCT02100839|12434514|FG001|Multiple Ascending Dose|Adverse Event|0
7914564|NCT02100839|12434513|FG000|Multiple Ascending Dose|Withdrawal by Subject|2
7914565|NCT02100839|12434514|FG001|Multiple Ascending Dose|Withdrawal by Subject|0
7914566|NCT02100969|12434524|FG000|Overall Study|Did not pass screening phase|1
7914567|NCT02101021|12434538|FG000|Overall Study|Death|4
7914568|NCT02101021|12434539|FG001|Overall Study|Death|3
7914569|NCT02101021|12434540|FG002|Overall Study|Death|6
7914570|NCT02101021|12434541|FG003|Overall Study|Death|0
7914571|NCT02101021|12434542|FG004|Overall Study|Death|3
7914572|NCT02101021|12434538|FG000|Overall Study|Withdrew Consent from study|1
7914573|NCT02101021|12434539|FG001|Overall Study|Withdrew Consent from study|1
7914574|NCT02101021|12434540|FG002|Overall Study|Withdrew Consent from study|0
7914575|NCT02101021|12434541|FG003|Overall Study|Withdrew Consent from study|2
7914576|NCT02101021|12434542|FG004|Overall Study|Withdrew Consent from study|0
7914577|NCT02101021|12434538|FG000|Overall Study|Lost to Follow-up|1
7914578|NCT02101021|12434539|FG001|Overall Study|Lost to Follow-up|0
7914579|NCT02101021|12434540|FG002|Overall Study|Lost to Follow-up|0
7914580|NCT02101021|12434541|FG003|Overall Study|Lost to Follow-up|0
7914581|NCT02101021|12434542|FG004|Overall Study|Lost to Follow-up|0
7914582|NCT02101021|12434538|FG000|Overall Study|Study Terminated by Sponsor|1
7914583|NCT02101021|12434539|FG001|Overall Study|Study Terminated by Sponsor|0
7914584|NCT02101021|12434540|FG002|Overall Study|Study Terminated by Sponsor|1
7914585|NCT02101021|12434541|FG003|Overall Study|Study Terminated by Sponsor|1
7914586|NCT02101021|12434542|FG004|Overall Study|Study Terminated by Sponsor|1
7914587|NCT02101060|12434556|FG000|Overall Study|Adverse Event|1
7914588|NCT02101060|12434557|FG001|Overall Study|Adverse Event|0
7914589|NCT02101060|12434556|FG000|Overall Study|Withdrawal by Subject|1
7914590|NCT02101060|12434557|FG001|Overall Study|Withdrawal by Subject|1
7914591|NCT02101060|12434556|FG000|Overall Study|Lost to Follow-up|3
7914592|NCT02101060|12434557|FG001|Overall Study|Lost to Follow-up|3
7914593|NCT02101112|12434563|FG000|Overall Study|Adverse Event|0
7914594|NCT02101112|12434564|FG001|Overall Study|Adverse Event|0
7914595|NCT02101112|12434565|FG002|Overall Study|Adverse Event|1
7914596|NCT02101112|12434566|FG003|Overall Study|Adverse Event|0
7914597|NCT02101112|12434567|FG004|Overall Study|Adverse Event|0
7914598|NCT02101112|12434568|FG005|Overall Study|Adverse Event|0
7914599|NCT02101112|12434563|FG000|Overall Study|Withdrawal by Subject|0
7914600|NCT02101112|12434564|FG001|Overall Study|Withdrawal by Subject|0
7914601|NCT02101112|12434565|FG002|Overall Study|Withdrawal by Subject|0
7914602|NCT02101112|12434566|FG003|Overall Study|Withdrawal by Subject|0
7914603|NCT02101112|12434567|FG004|Overall Study|Withdrawal by Subject|1
7914604|NCT02101112|12434568|FG005|Overall Study|Withdrawal by Subject|0
7914605|NCT02101281|12434589|FG000|Overall Study|Adverse Event|0
7914606|NCT02101281|12434590|FG001|Overall Study|Adverse Event|1
7914607|NCT02101294|12434602|FG000|Overall Study|Withdrawal by Subject|5
7914608|NCT02101294|12434602|FG000|Overall Study|Lost to Follow-up|6
7914609|NCT02101359|12434611|FG000|Overall Study|Not included|23
7914610|NCT02101359|12434612|FG001|Overall Study|Not included|13
7914611|NCT02101359|12434611|FG000|Overall Study|Withdrawal by Subject|5
7914612|NCT02101359|12434612|FG001|Overall Study|Withdrawal by Subject|4
7914613|NCT02101359|12434611|FG000|Overall Study|Lost to Follow-up|1
7914614|NCT02101359|12434612|FG001|Overall Study|Lost to Follow-up|0
7914615|NCT02101359|12434611|FG000|Overall Study|Protocol Violation|0
7914616|NCT02101359|12434612|FG001|Overall Study|Protocol Violation|2
7914617|NCT02101554|12434660|FG000|Overall Study|Protocol Violation|0
7914618|NCT02101554|12434661|FG001|Overall Study|Protocol Violation|1
7914619|NCT02101554|12434662|FG002|Overall Study|Protocol Violation|0
7914620|NCT02101554|12434660|FG000|Overall Study|Insufficient Clinical Response|0
7914621|NCT02101554|12434661|FG001|Overall Study|Insufficient Clinical Response|2
7914622|NCT02101554|12434662|FG002|Overall Study|Insufficient Clinical Response|0
7914623|NCT02101554|12434660|FG000|Overall Study|Adverse Event|2
7914624|NCT02101554|12434661|FG001|Overall Study|Adverse Event|1
7914625|NCT02101554|12434662|FG002|Overall Study|Adverse Event|1
7914626|NCT02101554|12434660|FG000|Overall Study|Lost to Follow-up|0
7914627|NCT02101554|12434661|FG001|Overall Study|Lost to Follow-up|1
7914628|NCT02101554|12434662|FG002|Overall Study|Lost to Follow-up|0
7914629|NCT02101554|12434660|FG000|Overall Study|Withdrawl by Parents/Guardians|1
7914630|NCT02101554|12434661|FG001|Overall Study|Withdrawl by Parents/Guardians|0
7914631|NCT02101554|12434662|FG002|Overall Study|Withdrawl by Parents/Guardians|0
7914632|NCT02101983|12434676|FG000|Overall Study|Physician Decision|1
7914633|NCT02101983|12434677|FG001|Overall Study|Physician Decision|0
7914634|NCT02102204|12434692|FG000|Overall Study|Withdrawal by Subject|137
7914635|NCT02102204|12434692|FG000|Overall Study|Death|92
7914636|NCT02102204|12434692|FG000|Overall Study|Lost to Follow-up|65
7914637|NCT02102204|12434692|FG000|Overall Study|Sponsor Decision|5
7914638|NCT02102204|12434692|FG000|Overall Study|Ongoing|5
7914639|NCT02102399|12434712|FG000|Overall Study|Withdrawal by Subject|6
7914640|NCT02102399|12434713|FG001|Overall Study|Withdrawal by Subject|4
7914641|NCT02102464|12434726|FG000|Randomized Study|Withdrawal by Subject|0
7914642|NCT02102464|12434727|FG001|Randomized Study|Withdrawal by Subject|1
7914643|NCT02102464|12434728|FG002|Randomized Study|Withdrawal by Subject|0
7914644|NCT02102490|12434737|FG000|Overall Study|Death|6
7914645|NCT02102490|12434737|FG000|Overall Study|Lost to Follow-up|1
7914646|NCT02102724|12434743|FG000|Overall Study|Lost to Follow-up|1
7914647|NCT02102724|12434744|FG001|Overall Study|Lost to Follow-up|0
7914648|NCT02102724|12434743|FG000|Overall Study|surgery for brain aneurysm|1
7914649|NCT02102724|12434744|FG001|Overall Study|surgery for brain aneurysm|1
7914650|NCT02103062|12434785|FG000|Overall Study|Adverse Event|1
7914651|NCT02103062|12434786|FG001|Overall Study|Adverse Event|2
7914652|NCT02103062|12434785|FG000|Overall Study|Progressive Disease|17
7914653|NCT02103062|12434786|FG001|Overall Study|Progressive Disease|20
7914654|NCT02103062|12434785|FG000|Overall Study|Death|0
7914655|NCT02103062|12434786|FG001|Overall Study|Death|1
7914656|NCT02103439|12434855|FG000|Overall Study|Adverse Event|0
7914657|NCT02103439|12434856|FG001|Overall Study|Adverse Event|2
7914658|NCT02103439|12434855|FG000|Overall Study|Withdrawal by Subject|3
7914659|NCT02103439|12434856|FG001|Overall Study|Withdrawal by Subject|1
7914660|NCT02103478|12434873|FG000|Overall Study|Adverse Event|0
7914661|NCT02103478|12434874|FG001|Overall Study|Adverse Event|0
7914662|NCT02103478|12434875|FG002|Overall Study|Adverse Event|1
7914663|NCT02103478|12434876|FG003|Overall Study|Adverse Event|1
7914664|NCT02103478|12434877|FG004|Overall Study|Adverse Event|2
7914665|NCT02103478|12434878|FG005|Overall Study|Adverse Event|1
7914666|NCT02103478|12434879|FG006|Overall Study|Adverse Event|0
7914667|NCT02103478|12434880|FG007|Overall Study|Adverse Event|0
7914668|NCT02103478|12434881|FG008|Overall Study|Adverse Event|0
7914669|NCT02103478|12434873|FG000|Overall Study|Death|2
7914670|NCT02103478|12434874|FG001|Overall Study|Death|2
7914671|NCT02103478|12434875|FG002|Overall Study|Death|1
7914672|NCT02103478|12434876|FG003|Overall Study|Death|1
7914673|NCT02103478|12434877|FG004|Overall Study|Death|5
7914674|NCT02103478|12434878|FG005|Overall Study|Death|15
7914675|NCT02103478|12434879|FG006|Overall Study|Death|14
7914676|NCT02103478|12434880|FG007|Overall Study|Death|10
7914677|NCT02103478|12434881|FG008|Overall Study|Death|11
7914678|NCT02103478|12434873|FG000|Overall Study|Progressive Disease|2
7914679|NCT02103478|12434874|FG001|Overall Study|Progressive Disease|1
7914680|NCT02103478|12434875|FG002|Overall Study|Progressive Disease|2
7914681|NCT02103478|12434876|FG003|Overall Study|Progressive Disease|0
7914682|NCT02103478|12434877|FG004|Overall Study|Progressive Disease|9
7914683|NCT02103478|12434878|FG005|Overall Study|Progressive Disease|1
7914684|NCT02103478|12434879|FG006|Overall Study|Progressive Disease|2
7914685|NCT02103478|12434880|FG007|Overall Study|Progressive Disease|0
7914686|NCT02103478|12434881|FG008|Overall Study|Progressive Disease|1
7914687|NCT02103478|12434873|FG000|Overall Study|Withdrawal by Subject|2
7914688|NCT02103478|12434874|FG001|Overall Study|Withdrawal by Subject|0
7914689|NCT02103478|12434875|FG002|Overall Study|Withdrawal by Subject|0
7914690|NCT02103478|12434876|FG003|Overall Study|Withdrawal by Subject|4
7914691|NCT02103478|12434877|FG004|Overall Study|Withdrawal by Subject|0
7914692|NCT02103478|12434878|FG005|Overall Study|Withdrawal by Subject|0
7914693|NCT02103478|12434879|FG006|Overall Study|Withdrawal by Subject|1
7914694|NCT02103478|12434880|FG007|Overall Study|Withdrawal by Subject|1
7914695|NCT02103478|12434881|FG008|Overall Study|Withdrawal by Subject|0
7914696|NCT02103478|12434873|FG000|Overall Study|Lost to Follow-up|0
7914697|NCT02103478|12434874|FG001|Overall Study|Lost to Follow-up|0
7914698|NCT02103478|12434875|FG002|Overall Study|Lost to Follow-up|0
7914699|NCT02103478|12434876|FG003|Overall Study|Lost to Follow-up|0
7914700|NCT02103478|12434877|FG004|Overall Study|Lost to Follow-up|0
7914701|NCT02103478|12434878|FG005|Overall Study|Lost to Follow-up|0
7914702|NCT02103478|12434879|FG006|Overall Study|Lost to Follow-up|0
7914703|NCT02103478|12434880|FG007|Overall Study|Lost to Follow-up|1
7914704|NCT02103478|12434881|FG008|Overall Study|Lost to Follow-up|0
7914705|NCT02103478|12434873|FG000|Overall Study|Other|1
7914706|NCT02103478|12434874|FG001|Overall Study|Other|3
7914707|NCT02103478|12434875|FG002|Overall Study|Other|2
7914708|NCT02103478|12434876|FG003|Overall Study|Other|0
7914709|NCT02103478|12434877|FG004|Overall Study|Other|3
7914710|NCT02103478|12434878|FG005|Overall Study|Other|8
7914711|NCT02103478|12434879|FG006|Overall Study|Other|8
7914712|NCT02103478|12434880|FG007|Overall Study|Other|4
7914713|NCT02103478|12434881|FG008|Overall Study|Other|2
7914714|NCT02104505|12434972|FG000|First Intervention (14 Days)|Adverse Event|2
7914715|NCT02104505|12434973|FG001|First Intervention (14 Days)|Adverse Event|0
7914716|NCT02104505|12434972|FG000|First Intervention (14 Days)|Withdrawal by Subject|0
7914717|NCT02104505|12434973|FG001|First Intervention (14 Days)|Withdrawal by Subject|1
7914718|NCT02104505|12434972|FG000|First Intervention (14 Days)|Lost to Follow-up|0
7914719|NCT02104505|12434973|FG001|First Intervention (14 Days)|Lost to Follow-up|1
7914720|NCT02104505|12434972|FG000|First Intervention (14 Days)|exclusionary condition|0
7914721|NCT02104505|12434973|FG001|First Intervention (14 Days)|exclusionary condition|1
7914722|NCT02104505|12434972|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
7914723|NCT02104505|12434973|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
7914724|NCT02104505|12434972|FG000|Second Intervention (14 Days)|Adverse Event|2
7914725|NCT02104505|12434973|FG001|Second Intervention (14 Days)|Adverse Event|0
7914726|NCT02104557|12434980|FG000|Overall Study|Adverse Event|24
7914727|NCT02104557|12434980|FG000|Overall Study|Lost to Follow-up|34
7914728|NCT02104557|12434980|FG000|Overall Study|Violated the usage and dosage|14
7914729|NCT02104557|12434980|FG000|Overall Study|No longer met inclusion/exclusion criteria|1
7914730|NCT02104557|12434980|FG000|Overall Study|Administered Sayana prior to the contract|1
7914731|NCT02104557|12434980|FG000|Overall Study|Other|17
7914732|NCT02104557|12434980|FG000|Overall Study|Change to other contraception methods|5
7914733|NCT02104557|12434980|FG000|Overall Study|Discontinuation due to no pain|1
7914734|NCT02104557|12434980|FG000|Overall Study|Withdrawal consent|2
7914735|NCT02104557|12434980|FG000|Overall Study|Refusal of administration due to unknown reasons|69
7914736|NCT02104557|12434980|FG000|Overall Study|Discontinuation of contraception|9
7914737|NCT02104583|12434989|FG000|Overall Study|New ICD or CRT-D implanted|2
7914738|NCT02104583|12434990|FG001|Overall Study|New ICD or CRT-D implanted|0
7914739|NCT02104583|12434991|FG002|Overall Study|New ICD or CRT-D implanted|1
7914740|NCT02104583|12434992|FG003|Overall Study|New ICD or CRT-D implanted|0
7914741|NCT02104583|12434993|FG004|Overall Study|New ICD or CRT-D implanted|0
7914742|NCT02104583|12434989|FG000|Overall Study|Death|2
7914743|NCT02104583|12434990|FG001|Overall Study|Death|1
7914744|NCT02104583|12434991|FG002|Overall Study|Death|3
7914745|NCT02104583|12434992|FG003|Overall Study|Death|3
7914746|NCT02104583|12434993|FG004|Overall Study|Death|5
7914747|NCT02104583|12434989|FG000|Overall Study|Subject required cardiac ablation|6
7914748|NCT02104583|12434990|FG001|Overall Study|Subject required cardiac ablation|4
7914749|NCT02104583|12434991|FG002|Overall Study|Subject required cardiac ablation|4
7914750|NCT02104583|12434992|FG003|Overall Study|Subject required cardiac ablation|5
7914751|NCT02104583|12434993|FG004|Overall Study|Subject required cardiac ablation|4
7914752|NCT02104583|12434989|FG000|Overall Study|Subject required prohibited medication|0
7914753|NCT02104583|12434990|FG001|Overall Study|Subject required prohibited medication|1
7914754|NCT02104583|12434991|FG002|Overall Study|Subject required prohibited medication|1
7914755|NCT02104583|12434992|FG003|Overall Study|Subject required prohibited medication|0
7914756|NCT02104583|12434993|FG004|Overall Study|Subject required prohibited medication|1
7914757|NCT02104583|12434989|FG000|Overall Study|Withdrew Consent|3
7914758|NCT02104583|12434990|FG001|Overall Study|Withdrew Consent|2
7914759|NCT02104583|12434991|FG002|Overall Study|Withdrew Consent|0
7914760|NCT02104583|12434992|FG003|Overall Study|Withdrew Consent|2
7914761|NCT02104583|12434993|FG004|Overall Study|Withdrew Consent|1
7914762|NCT02104583|12434989|FG000|Overall Study|Investigator's Discretion|1
7914763|NCT02104583|12434990|FG001|Overall Study|Investigator's Discretion|0
7914764|NCT02104583|12434991|FG002|Overall Study|Investigator's Discretion|0
7914765|NCT02104583|12434992|FG003|Overall Study|Investigator's Discretion|0
7914766|NCT02104583|12434993|FG004|Overall Study|Investigator's Discretion|0
7914767|NCT02104583|12434989|FG000|Overall Study|Protocol Violation|0
7914768|NCT02104583|12434990|FG001|Overall Study|Protocol Violation|0
7914769|NCT02104583|12434991|FG002|Overall Study|Protocol Violation|1
7914770|NCT02104583|12434992|FG003|Overall Study|Protocol Violation|0
7914771|NCT02104583|12434993|FG004|Overall Study|Protocol Violation|0
7914772|NCT02104583|12434989|FG000|Overall Study|Adverse Event|3
7914773|NCT02104583|12434990|FG001|Overall Study|Adverse Event|3
7914774|NCT02104583|12434991|FG002|Overall Study|Adverse Event|6
7914775|NCT02104583|12434992|FG003|Overall Study|Adverse Event|6
7914776|NCT02104583|12434993|FG004|Overall Study|Adverse Event|1
7914777|NCT02104583|12434989|FG000|Overall Study|Lost to Follow-up|1
7914778|NCT02104583|12434990|FG001|Overall Study|Lost to Follow-up|0
7914779|NCT02104583|12434991|FG002|Overall Study|Lost to Follow-up|0
7914780|NCT02104583|12434992|FG003|Overall Study|Lost to Follow-up|0
7914781|NCT02104583|12434993|FG004|Overall Study|Lost to Follow-up|0
7914782|NCT02104583|12434989|FG000|Overall Study|Randomized but Never Treated|0
7914783|NCT02104583|12434990|FG001|Overall Study|Randomized but Never Treated|0
7914784|NCT02104583|12434991|FG002|Overall Study|Randomized but Never Treated|0
7914785|NCT02104583|12434992|FG003|Overall Study|Randomized but Never Treated|1
7914786|NCT02104583|12434993|FG004|Overall Study|Randomized but Never Treated|0
7914787|NCT02104752|12435032|FG000|Overall Study|Withdrawal by Subject|1
7914788|NCT02104752|12435033|FG001|Overall Study|Withdrawal by Subject|0
7914789|NCT02104752|12435032|FG000|Overall Study|Weight gain; unrelated anxiety|0
7914790|NCT02104752|12435033|FG001|Overall Study|Weight gain; unrelated anxiety|2
7914791|NCT02104765|12435046|FG000|Overall Study|Lost to Follow-up|0
7914792|NCT02104765|12435047|FG001|Overall Study|Lost to Follow-up|0
7914793|NCT02104765|12435048|FG002|Overall Study|Lost to Follow-up|1
7914794|NCT02104765|12435049|FG003|Overall Study|Lost to Follow-up|0
7914795|NCT02104765|12435050|FG004|Overall Study|Lost to Follow-up|0
7914796|NCT02104765|12435051|FG005|Overall Study|Lost to Follow-up|0
7914797|NCT02104765|12435052|FG006|Overall Study|Lost to Follow-up|0
7914798|NCT02104765|12435046|FG000|Overall Study|Withdrawal by Subject|0
7914799|NCT02104765|12435047|FG001|Overall Study|Withdrawal by Subject|0
7914800|NCT02104765|12435048|FG002|Overall Study|Withdrawal by Subject|0
7914801|NCT02104765|12435049|FG003|Overall Study|Withdrawal by Subject|1
7914802|NCT02104765|12435050|FG004|Overall Study|Withdrawal by Subject|1
7914803|NCT02104765|12435051|FG005|Overall Study|Withdrawal by Subject|0
7914804|NCT02104765|12435052|FG006|Overall Study|Withdrawal by Subject|1
7914805|NCT02104804|12435076|FG000|Overall Study|Did not take study medication|0
7914806|NCT02104804|12435077|FG001|Overall Study|Did not take study medication|1
7914807|NCT02104804|12435076|FG000|Overall Study|Study specific discontinuation criteria|6
7914808|NCT02104804|12435077|FG001|Overall Study|Study specific discontinuation criteria|1
7914809|NCT02104804|12435076|FG000|Overall Study|Other listed|2
7914810|NCT02104804|12435077|FG001|Overall Study|Other listed|1
7914811|NCT02104804|12435076|FG000|Overall Study|Protocol Violation|0
7914812|NCT02104804|12435077|FG001|Overall Study|Protocol Violation|1
7914813|NCT02104804|12435076|FG000|Overall Study|Adverse Event|4
7914814|NCT02104804|12435077|FG001|Overall Study|Adverse Event|3
7914815|NCT02104804|12435076|FG000|Overall Study|Withdrawal by Subject|4
7914816|NCT02104804|12435077|FG001|Overall Study|Withdrawal by Subject|12
7914817|NCT02104817|12435085|FG000|Overall Study|Death|363
7914818|NCT02104817|12435086|FG001|Overall Study|Death|330
7914819|NCT02104817|12435085|FG000|Overall Study|Lost to Follow-up|3
7914820|NCT02104817|12435086|FG001|Overall Study|Lost to Follow-up|2
7914821|NCT02104817|12435085|FG000|Overall Study|Protocol Violation|0
7914822|NCT02104817|12435086|FG001|Overall Study|Protocol Violation|1
7914823|NCT02104817|12435085|FG000|Overall Study|Study terminated by sponsor|5854
7914824|NCT02104817|12435086|FG001|Overall Study|Study terminated by sponsor|5901
7914825|NCT02104817|12435085|FG000|Overall Study|Withdrawal by Subject|111
7914826|NCT02104817|12435086|FG001|Overall Study|Withdrawal by Subject|78
7914827|NCT02104817|12435085|FG000|Overall Study|Other reasons|128
7914828|NCT02104817|12435086|FG001|Overall Study|Other reasons|135
7914829|NCT02104895|12435107|FG000|Overall Study|Withdrawal by Subject|0
7914830|NCT02104895|12435108|FG001|Overall Study|Withdrawal by Subject|14
7914831|NCT02104947|12435116|FG000|Overall Study|Withdrawal by Subject|10
7914832|NCT02104947|12435117|FG001|Overall Study|Withdrawal by Subject|3
7914833|NCT02104947|12435116|FG000|Overall Study|Lost to Follow-up|4
7914834|NCT02104947|12435117|FG001|Overall Study|Lost to Follow-up|4
7914835|NCT02104947|12435116|FG000|Overall Study|Protocol Violation|6
7914836|NCT02104947|12435117|FG001|Overall Study|Protocol Violation|8
7914837|NCT02104947|12435116|FG000|Overall Study|Adverse Event|57
7914838|NCT02104947|12435117|FG001|Overall Study|Adverse Event|38
7914839|NCT02104947|12435116|FG000|Overall Study|Other than stated above|2
7914840|NCT02104947|12435117|FG001|Overall Study|Other than stated above|3
7914841|NCT02105012|12435127|FG000|Overall Study|Withdrawal by Subject|11
7914842|NCT02105012|12435127|FG000|Overall Study|Protocol Specified Criteria|9
7914843|NCT02105012|12435127|FG000|Overall Study|Lost to Follow-up|4
7914844|NCT02105012|12435127|FG000|Overall Study|Protocol Violation|4
7914845|NCT02105012|12435127|FG000|Overall Study|Physician Decision|3
7914846|NCT02105012|12435127|FG000|Overall Study|Adverse Event|1
7914847|NCT02105012|12435127|FG000|Overall Study|Lack of Efficacy|1
7914848|NCT02105272|12435154|FG000|Overall Study|Adverse Event|1
7914849|NCT02105272|12435155|FG001|Overall Study|Adverse Event|2
7914850|NCT02105272|12435154|FG000|Overall Study|Physician Decision|0
7914851|NCT02105272|12435155|FG001|Overall Study|Physician Decision|1
7914852|NCT02105272|12435154|FG000|Overall Study|Protocol Violation|2
7914853|NCT02105272|12435155|FG001|Overall Study|Protocol Violation|0
7914854|NCT02105272|12435154|FG000|Overall Study|Withdrawal by Subject|2
7914855|NCT02105272|12435155|FG001|Overall Study|Withdrawal by Subject|0
7914856|NCT02105285|12435164|FG000|Overall Study|Adverse Event|1
7914857|NCT02105285|12435165|FG001|Overall Study|Adverse Event|1
7914858|NCT02105285|12435166|FG002|Overall Study|Adverse Event|0
7914859|NCT02105285|12435164|FG000|Overall Study|Protocol Violation|0
7914860|NCT02105285|12435165|FG001|Overall Study|Protocol Violation|1
7914861|NCT02105285|12435166|FG002|Overall Study|Protocol Violation|0
7914862|NCT02105285|12435164|FG000|Overall Study|Withdrawal by Subject|1
7914863|NCT02105285|12435165|FG001|Overall Study|Withdrawal by Subject|0
7914864|NCT02105285|12435166|FG002|Overall Study|Withdrawal by Subject|0
7964208|NCT04097925|12519464|FG000|Overall Study|Withdrawal by Subject|1
7964209|NCT03994120|12519488|FG000|Overall Study|Lost to Follow-up|3
7964210|NCT03994120|12519489|FG001|Overall Study|Lost to Follow-up|1
7964211|NCT03934216|12519497|FG000|Randomization|Randomized in Error|1
7964212|NCT03934216|12519498|FG001|Randomization|Randomized in Error|1
7964213|NCT03934216|12519497|FG000|Treatment Period|Adverse Event|10
7964214|NCT03934216|12519498|FG001|Treatment Period|Adverse Event|3
7964215|NCT03934216|12519497|FG000|Treatment Period|Withdrawal by Participant|6
7964216|NCT03934216|12519498|FG001|Treatment Period|Withdrawal by Participant|2
7964217|NCT03934216|12519497|FG000|Treatment Period|Other Reasons|2
7964218|NCT03934216|12519498|FG001|Treatment Period|Other Reasons|2
7966913|NCT02758301|12523357|FG001|Overall Study|Physician Decision|1
7966914|NCT02758301|12523356|FG000|Overall Study|Withdrawal by Subject|5
7966915|NCT02758301|12523357|FG001|Overall Study|Withdrawal by Subject|6
7966916|NCT02758301|12523356|FG000|Overall Study|Lost to Follow-up|7
7966917|NCT02758301|12523357|FG001|Overall Study|Lost to Follow-up|0
7966918|NCT02758301|12523356|FG000|Overall Study|Protocol Violation|0
7966919|NCT02758301|12523357|FG001|Overall Study|Protocol Violation|1
7966920|NCT02758613|12523367|FG000|Treatment|Physician and Sponsor Decision|1
7966921|NCT02758613|12523368|FG001|Treatment|Physician and Sponsor Decision|0
7966922|NCT02758613|12523369|FG002|Treatment|Physician and Sponsor Decision|0
7966923|NCT02758613|12523370|FG003|Treatment|Physician and Sponsor Decision|0
7966924|NCT02758613|12523367|FG000|Treatment|Withdrawal by Subject|1
7966925|NCT02758613|12523368|FG001|Treatment|Withdrawal by Subject|0
7966926|NCT02758613|12523369|FG002|Treatment|Withdrawal by Subject|1
7966927|NCT02758613|12523370|FG003|Treatment|Withdrawal by Subject|0
7914865|NCT02105454|12435197|FG000|Overall Study|Withdrawal by Subject|1
7914866|NCT02105467|12435203|FG000|Period 1|Lost to Follow-up|1
7914867|NCT02105467|12435204|FG001|Period 1|Lost to Follow-up|0
7914868|NCT02105467|12435203|FG000|Period 1|Death|1
7914869|NCT02105467|12435204|FG001|Period 1|Death|0
7914870|NCT02105467|12435203|FG000|Period 2|Lost to Follow-up|1
7914871|NCT02105467|12435204|FG001|Period 2|Lost to Follow-up|0
7914872|NCT02105467|12435203|FG000|Period 2|Death|1
7914873|NCT02105467|12435204|FG001|Period 2|Death|0
7914874|NCT02105467|12435203|FG000|Period 2|Withdrawal by Subject|0
7914875|NCT02105467|12435204|FG001|Period 2|Withdrawal by Subject|2
7914876|NCT02105467|12435203|FG000|Period 3|Lost to Follow-up|0
7914877|NCT02105467|12435204|FG001|Period 3|Lost to Follow-up|1
7914878|NCT02105662|12435220|FG000|Overall Study|Lost to Follow-up|5
7914879|NCT02105662|12435220|FG000|Overall Study|Withdrawal by Subject|1
7914880|NCT02105688|12435226|FG000|Part A: Double-Blind|Adverse Event|1
7914881|NCT02105688|12435227|FG001|Part A: Double-Blind|Adverse Event|0
7914882|NCT02105688|12435226|FG000|Part A: Double-Blind|Death|0
7914883|NCT02105688|12435227|FG001|Part A: Double-Blind|Death|1
7914884|NCT02105688|12435226|FG000|Part A: Double-Blind|Lost to Follow-up|15
7914885|NCT02105688|12435227|FG001|Part A: Double-Blind|Lost to Follow-up|11
7914886|NCT02105688|12435226|FG000|Part A: Double-Blind|Physician Decision|0
7914887|NCT02105688|12435227|FG001|Part A: Double-Blind|Physician Decision|1
7914888|NCT02105688|12435226|FG000|Part A: Double-Blind|Status Unknown|0
7914889|NCT02105688|12435227|FG001|Part A: Double-Blind|Status Unknown|2
7914890|NCT02105688|12435226|FG000|Part A: Double-Blind|Withdrawal by Subject|4
7914891|NCT02105688|12435227|FG001|Part A: Double-Blind|Withdrawal by Subject|2
7914892|NCT02105688|12435226|FG000|Part B: Observational Follow-up|Death|2
7914893|NCT02105688|12435227|FG001|Part B: Observational Follow-up|Death|1
7914894|NCT02105688|12435226|FG000|Part B: Observational Follow-up|Lost to Follow-up|23
7914895|NCT02105688|12435227|FG001|Part B: Observational Follow-up|Lost to Follow-up|15
7914896|NCT02105688|12435226|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9
7914897|NCT02105688|12435227|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3
7914898|NCT02105688|12435226|FG000|Part B: Observational Follow-up|Physician Decision|3
7914899|NCT02105688|12435227|FG001|Part B: Observational Follow-up|Physician Decision|1
7914900|NCT02105701|12435238|FG000|Overall Study|Lost to Follow-up|1
7914901|NCT02105701|12435239|FG001|Overall Study|Lost to Follow-up|0
7914902|NCT02105701|12435240|FG002|Overall Study|Lost to Follow-up|2
7914903|NCT02105701|12435241|FG003|Overall Study|Lost to Follow-up|1
7914904|NCT02105701|12435238|FG000|Overall Study|Protocol Violation|0
7914905|NCT02105701|12435239|FG001|Overall Study|Protocol Violation|0
7914906|NCT02105701|12435240|FG002|Overall Study|Protocol Violation|1
7914907|NCT02105701|12435241|FG003|Overall Study|Protocol Violation|0
7914908|NCT02105701|12435238|FG000|Overall Study|Withdrawal by Subject|2
7914909|NCT02105701|12435239|FG001|Overall Study|Withdrawal by Subject|1
7914910|NCT02105701|12435240|FG002|Overall Study|Withdrawal by Subject|0
7914911|NCT02105701|12435241|FG003|Overall Study|Withdrawal by Subject|1
7914912|NCT02105701|12435238|FG000|Overall Study|Death|1
7914913|NCT02105701|12435239|FG001|Overall Study|Death|0
7914914|NCT02105701|12435240|FG002|Overall Study|Death|0
7914915|NCT02105701|12435241|FG003|Overall Study|Death|0
7914916|NCT02105948|12435266|FG000|Overall Study|Adverse Event|10
7914917|NCT02105948|12435267|FG001|Overall Study|Adverse Event|7
7914918|NCT02105948|12435268|FG002|Overall Study|Adverse Event|11
7914919|NCT02105948|12435269|FG003|Overall Study|Adverse Event|11
7914920|NCT02105948|12435266|FG000|Overall Study|Lack of Efficacy|0
7914921|NCT02105948|12435267|FG001|Overall Study|Lack of Efficacy|1
7914922|NCT02105948|12435268|FG002|Overall Study|Lack of Efficacy|3
7914923|NCT02105948|12435269|FG003|Overall Study|Lack of Efficacy|2
7914924|NCT02105948|12435266|FG000|Overall Study|Lost to Follow-up|0
7914925|NCT02105948|12435267|FG001|Overall Study|Lost to Follow-up|0
7914926|NCT02105948|12435268|FG002|Overall Study|Lost to Follow-up|2
7914927|NCT02105948|12435269|FG003|Overall Study|Lost to Follow-up|1
7914928|NCT02105948|12435266|FG000|Overall Study|Physician Decision|2
7914929|NCT02105948|12435267|FG001|Overall Study|Physician Decision|2
7914930|NCT02105948|12435268|FG002|Overall Study|Physician Decision|2
7914931|NCT02105948|12435269|FG003|Overall Study|Physician Decision|2
7914932|NCT02105948|12435266|FG000|Overall Study|Withdrawal by Subject|15
7914933|NCT02105948|12435267|FG001|Overall Study|Withdrawal by Subject|10
7914934|NCT02105948|12435268|FG002|Overall Study|Withdrawal by Subject|10
7914935|NCT02105948|12435269|FG003|Overall Study|Withdrawal by Subject|11
7914936|NCT02105961|12435283|FG000|Overall Study|Adverse Event|18
7914937|NCT02105961|12435284|FG001|Overall Study|Adverse Event|7
7914938|NCT02105961|12435285|FG002|Overall Study|Adverse Event|13
7914939|NCT02105961|12435283|FG000|Overall Study|Lack of Efficacy|3
7914940|NCT02105961|12435284|FG001|Overall Study|Lack of Efficacy|0
7914941|NCT02105961|12435285|FG002|Overall Study|Lack of Efficacy|3
7914942|NCT02105961|12435283|FG000|Overall Study|Lost to Follow-up|2
7914943|NCT02105961|12435284|FG001|Overall Study|Lost to Follow-up|0
7914944|NCT02105961|12435285|FG002|Overall Study|Lost to Follow-up|1
7914945|NCT02105961|12435283|FG000|Overall Study|Physician Decision|3
7914946|NCT02105961|12435284|FG001|Overall Study|Physician Decision|3
7914947|NCT02105961|12435285|FG002|Overall Study|Physician Decision|2
7914948|NCT02105961|12435283|FG000|Overall Study|Withdrawal by Subject|15
7914949|NCT02105961|12435284|FG001|Overall Study|Withdrawal by Subject|7
7914950|NCT02105961|12435285|FG002|Overall Study|Withdrawal by Subject|11
7914951|NCT02105974|12435296|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158
7914952|NCT02105974|12435297|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0
7914953|NCT02105974|12435298|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0
7914954|NCT02105974|12435296|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
7914955|NCT02105974|12435297|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
7914956|NCT02105974|12435298|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
7914957|NCT02105974|12435296|FG000|2 Week Run-in Period|Adverse Event|6
7914958|NCT02105974|12435297|FG001|2 Week Run-in Period|Adverse Event|0
7914959|NCT02105974|12435298|FG002|2 Week Run-in Period|Adverse Event|0
7914960|NCT02105974|12435296|FG000|2 Week Run-in Period|Study closed/terminated|1
7914961|NCT02105974|12435297|FG001|2 Week Run-in Period|Study closed/terminated|0
7914962|NCT02105974|12435298|FG002|2 Week Run-in Period|Study closed/terminated|0
7914963|NCT02105974|12435296|FG000|2 Week Run-in Period|Lost to Follow-up|2
7914964|NCT02105974|12435297|FG001|2 Week Run-in Period|Lost to Follow-up|0
7914965|NCT02105974|12435298|FG002|2 Week Run-in Period|Lost to Follow-up|0
7914966|NCT02105974|12435296|FG000|2 Week Run-in Period|Withdrew consent|23
7914967|NCT02105974|12435297|FG001|2 Week Run-in Period|Withdrew consent|0
7914968|NCT02105974|12435298|FG002|2 Week Run-in Period|Withdrew consent|0
7914969|NCT02105974|12435296|FG000|2 Week Run-in Period|Investigator discretion|8
7914970|NCT02105974|12435297|FG001|2 Week Run-in Period|Investigator discretion|0
7914971|NCT02105974|12435298|FG002|2 Week Run-in Period|Investigator discretion|0
7914972|NCT02105974|12435296|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
7914973|NCT02105974|12435297|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
7914974|NCT02105974|12435298|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
7914975|NCT02105974|12435296|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
7914976|NCT02105974|12435297|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
7914977|NCT02105974|12435298|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
7914978|NCT02105974|12435296|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
7914979|NCT02105974|12435297|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
7914980|NCT02105974|12435298|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
7914981|NCT02105974|12435296|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
7914982|NCT02105974|12435297|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
7914983|NCT02105974|12435298|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
7914984|NCT02105974|12435296|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
7914985|NCT02105974|12435297|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
7914986|NCT02105974|12435298|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
7914987|NCT02105974|12435296|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
7914988|NCT02105974|12435297|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
7914989|NCT02105974|12435298|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
7914990|NCT02105974|12435296|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
7914991|NCT02105974|12435297|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
7914992|NCT02105974|12435298|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
7914993|NCT02105987|12435306|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10
7914994|NCT02105987|12435307|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0
7914995|NCT02105987|12435308|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0
7914996|NCT02105987|12435309|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0
7914997|NCT02105987|12435310|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0
7914998|NCT02105987|12435311|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0
7914999|NCT02105987|12435306|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15
7915000|NCT02105987|12435307|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17
7915001|NCT02105987|12435308|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0
7915002|NCT02105987|12435309|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0
7915003|NCT02105987|12435310|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0
7915004|NCT02105987|12435311|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0
7915005|NCT02105987|12435306|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
7915006|NCT02105987|12435307|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
7915007|NCT02105987|12435308|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7915008|NCT02105987|12435309|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7915009|NCT02105987|12435310|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7915010|NCT02105987|12435311|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7915011|NCT02105987|12435306|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
7915012|NCT02105987|12435307|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
7915013|NCT02105987|12435308|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7915014|NCT02105987|12435309|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7915015|NCT02105987|12435310|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7915016|NCT02105987|12435311|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7915017|NCT02105987|12435306|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4
7915018|NCT02105987|12435307|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3
7915019|NCT02105987|12435308|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0
7915020|NCT02105987|12435309|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0
7915021|NCT02105987|12435310|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0
7915022|NCT02105987|12435311|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0
7915023|NCT02105987|12435306|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7915024|NCT02105987|12435307|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
7915025|NCT02105987|12435308|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7915026|NCT02105987|12435309|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7915027|NCT02105987|12435310|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7915028|NCT02105987|12435311|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7915029|NCT02105987|12435306|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0
7915030|NCT02105987|12435307|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0
7915031|NCT02105987|12435308|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10
7915032|NCT02105987|12435309|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4
7915033|NCT02105987|12435310|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0
7915034|NCT02105987|12435311|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0
7915035|NCT02105987|12435306|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0
7915036|NCT02105987|12435307|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0
7915037|NCT02105987|12435308|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15
7915038|NCT02105987|12435309|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1
7915039|NCT02105987|12435310|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0
7915040|NCT02105987|12435311|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0
7915041|NCT02105987|12435306|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7915042|NCT02105987|12435307|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7915043|NCT02105987|12435308|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
7915044|NCT02105987|12435309|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
7915045|NCT02105987|12435310|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7915046|NCT02105987|12435311|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7915047|NCT02105987|12435306|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
7915048|NCT02105987|12435307|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
7915049|NCT02105987|12435308|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
7915050|NCT02105987|12435309|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
7915051|NCT02105987|12435310|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
7915052|NCT02105987|12435311|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
7915053|NCT02105987|12435306|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0
7915054|NCT02105987|12435307|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0
7915055|NCT02105987|12435308|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5
7915056|NCT02105987|12435309|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0
7915057|NCT02105987|12435310|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0
7915058|NCT02105987|12435311|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0
7915059|NCT02105987|12435306|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7915060|NCT02105987|12435307|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7915061|NCT02105987|12435308|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7915062|NCT02105987|12435309|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
7915063|NCT02105987|12435310|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7915064|NCT02105987|12435311|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7915065|NCT02105987|12435306|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0
7915066|NCT02105987|12435307|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0
7915067|NCT02105987|12435308|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1
7915068|NCT02105987|12435309|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0
7915069|NCT02105987|12435310|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0
7915070|NCT02105987|12435311|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0
7915071|NCT02105987|12435306|FG000|Continuation Phase|Protocol Violation|0
7915072|NCT02105987|12435307|FG001|Continuation Phase|Protocol Violation|0
7915073|NCT02105987|12435308|FG002|Continuation Phase|Protocol Violation|0
7915074|NCT02105987|12435309|FG003|Continuation Phase|Protocol Violation|0
7915075|NCT02105987|12435310|FG004|Continuation Phase|Protocol Violation|1
7915076|NCT02105987|12435311|FG005|Continuation Phase|Protocol Violation|0
7915077|NCT02106156|12435333|FG000|Overall Study|Patient Died|19
7915078|NCT02106156|12435334|FG001|Overall Study|Patient Died|0
7915079|NCT02106156|12435335|FG002|Overall Study|Patient Died|0
7915080|NCT02106156|12435333|FG000|Overall Study|Lack of Tolerability|305
7915081|NCT02106156|12435334|FG001|Overall Study|Lack of Tolerability|3
7915082|NCT02106156|12435335|FG002|Overall Study|Lack of Tolerability|0
7915083|NCT02106156|12435333|FG000|Overall Study|Lack of Virological Response|1044
7915084|NCT02106156|12435334|FG001|Overall Study|Lack of Virological Response|8
7915085|NCT02106156|12435335|FG002|Overall Study|Lack of Virological Response|0
7915086|NCT02106156|12435333|FG000|Overall Study|Concomitant Disease|74
7915087|NCT02106156|12435334|FG001|Overall Study|Concomitant Disease|2
7915088|NCT02106156|12435335|FG002|Overall Study|Concomitant Disease|0
7915089|NCT02106156|12435333|FG000|Overall Study|Lack of Compliance|211
7915090|NCT02106156|12435334|FG001|Overall Study|Lack of Compliance|7
7915091|NCT02106156|12435335|FG002|Overall Study|Lack of Compliance|0
7915092|NCT02106156|12435333|FG000|Overall Study|Patients Request|307
7915093|NCT02106156|12435334|FG001|Overall Study|Patients Request|9
7915094|NCT02106156|12435335|FG002|Overall Study|Patients Request|0
7915095|NCT02106156|12435333|FG000|Overall Study|Lost to Follow-up|451
7915096|NCT02106156|12435334|FG001|Overall Study|Lost to Follow-up|8
7915097|NCT02106156|12435335|FG002|Overall Study|Lost to Follow-up|0
7915098|NCT02106156|12435333|FG000|Overall Study|Unplanned Event|82
7915099|NCT02106156|12435334|FG001|Overall Study|Unplanned Event|2
7915100|NCT02106156|12435335|FG002|Overall Study|Unplanned Event|0
7915101|NCT02106156|12435333|FG000|Overall Study|Change of Laboratory Parameter|10
7915102|NCT02106156|12435334|FG001|Overall Study|Change of Laboratory Parameter|0
7915103|NCT02106156|12435335|FG002|Overall Study|Change of Laboratory Parameter|0
7915104|NCT02106156|12435333|FG000|Overall Study|Hospitalization/Surgical Intervention|6
7915105|NCT02106156|12435334|FG001|Overall Study|Hospitalization/Surgical Intervention|0
7915106|NCT02106156|12435335|FG002|Overall Study|Hospitalization/Surgical Intervention|0
7915107|NCT02106156|12435333|FG000|Overall Study|Relocation/Change of Physician|40
7915108|NCT02106156|12435334|FG001|Overall Study|Relocation/Change of Physician|1
7915109|NCT02106156|12435335|FG002|Overall Study|Relocation/Change of Physician|0
7915110|NCT02106325|12435344|FG000|Phase 1|Lost to Follow-up|2
7915111|NCT02106325|12435345|FG001|Phase 1|Lost to Follow-up|2
7915112|NCT02106325|12435344|FG000|Phase 2|Lost to Follow-up|2
7915113|NCT02106325|12435345|FG001|Phase 2|Lost to Follow-up|3
7915114|NCT02106325|12435344|FG000|Phase 3|Lost to Follow-up|2
7915115|NCT02106325|12435345|FG001|Phase 3|Lost to Follow-up|1
7915116|NCT02106390|12435354|FG000|Overall Study|Withdrawal by Subject|15
7915117|NCT02106390|12435355|FG001|Overall Study|Withdrawal by Subject|16
7915118|NCT02106390|12435356|FG002|Overall Study|Withdrawal by Subject|15
7915119|NCT02106390|12435354|FG000|Overall Study|Lost to Follow-up|25
7915120|NCT02106390|12435355|FG001|Overall Study|Lost to Follow-up|20
7915121|NCT02106390|12435356|FG002|Overall Study|Lost to Follow-up|13
7915122|NCT02106390|12435354|FG000|Overall Study|Other: Administrative Reason|8
7915123|NCT02106390|12435355|FG001|Overall Study|Other: Administrative Reason|5
7915124|NCT02106390|12435356|FG002|Overall Study|Other: Administrative Reason|12
7915125|NCT02106390|12435354|FG000|Overall Study|Other: Unspecified|1
7915126|NCT02106390|12435355|FG001|Overall Study|Other: Unspecified|4
7915127|NCT02106390|12435356|FG002|Overall Study|Other: Unspecified|2
7915128|NCT02106390|12435354|FG000|Overall Study|Adverse Event|0
7915129|NCT02106390|12435355|FG001|Overall Study|Adverse Event|2
7915130|NCT02106390|12435356|FG002|Overall Study|Adverse Event|1
7915131|NCT02106390|12435354|FG000|Overall Study|Protocol Violation|0
7915132|NCT02106390|12435355|FG001|Overall Study|Protocol Violation|1
7915133|NCT02106390|12435356|FG002|Overall Study|Protocol Violation|0
7915134|NCT02106403|12435367|FG000|Follow-Up Visit 3|Other Reason|0
7915135|NCT02106403|12435368|FG001|Follow-Up Visit 3|Other Reason|0
7915136|NCT02106403|12435369|FG002|Follow-Up Visit 3|Other Reason|0
7915137|NCT02106403|12435370|FG003|Follow-Up Visit 3|Other Reason|0
7915138|NCT02106403|12435371|FG004|Follow-Up Visit 3|Other Reason|0
7915139|NCT02106403|12435372|FG005|Follow-Up Visit 3|Other Reason|1
7915140|NCT02106442|12435382|FG000|Overall Study|Case Report Forms Uncollected|7
7915141|NCT02106442|12435382|FG000|Overall Study|Protocol Deviation|30
7915142|NCT02106455|12435386|FG000|Overall Study|Case Report Form Uncollected|6
7915143|NCT02106455|12435386|FG000|Overall Study|Protocol Deviation|2
7915144|NCT02106832|12435420|FG000|Overall Study|Adverse Event|1
7915145|NCT02106832|12435421|FG001|Overall Study|Adverse Event|2
7915146|NCT02106832|12435422|FG002|Overall Study|Adverse Event|3
7915147|NCT02106832|12435423|FG003|Overall Study|Adverse Event|0
7915148|NCT02106832|12435420|FG000|Overall Study|Death|4
7915149|NCT02106832|12435421|FG001|Overall Study|Death|4
7915150|NCT02106832|12435422|FG002|Overall Study|Death|1
7915151|NCT02106832|12435423|FG003|Overall Study|Death|4
7915152|NCT02106832|12435420|FG000|Overall Study|Deterioration of general conditions|0
7915153|NCT02106832|12435421|FG001|Overall Study|Deterioration of general conditions|0
7915154|NCT02106832|12435422|FG002|Overall Study|Deterioration of general conditions|1
7915155|NCT02106832|12435423|FG003|Overall Study|Deterioration of general conditions|0
7915156|NCT02106832|12435420|FG000|Overall Study|Lost to Follow-up|0
7915157|NCT02106832|12435421|FG001|Overall Study|Lost to Follow-up|1
7915158|NCT02106832|12435422|FG002|Overall Study|Lost to Follow-up|1
7915159|NCT02106832|12435423|FG003|Overall Study|Lost to Follow-up|3
7915160|NCT02106832|12435420|FG000|Overall Study|Physician Decision|1
7915161|NCT02106832|12435421|FG001|Overall Study|Physician Decision|0
7915162|NCT02106832|12435422|FG002|Overall Study|Physician Decision|0
7915163|NCT02106832|12435423|FG003|Overall Study|Physician Decision|0
7915164|NCT02106832|12435420|FG000|Overall Study|Protocol Violation|0
7915165|NCT02106832|12435421|FG001|Overall Study|Protocol Violation|0
7915166|NCT02106832|12435422|FG002|Overall Study|Protocol Violation|0
7915167|NCT02106832|12435423|FG003|Overall Study|Protocol Violation|1
7915168|NCT02106832|12435420|FG000|Overall Study|Withdrawal by Subject|17
7915169|NCT02106832|12435421|FG001|Overall Study|Withdrawal by Subject|17
7915170|NCT02106832|12435422|FG002|Overall Study|Withdrawal by Subject|10
7915171|NCT02106832|12435423|FG003|Overall Study|Withdrawal by Subject|7
7915172|NCT02106832|12435420|FG000|Overall Study|Technical problems|0
7915173|NCT02106832|12435421|FG001|Overall Study|Technical problems|1
7915174|NCT02106832|12435422|FG002|Overall Study|Technical problems|0
7915175|NCT02106832|12435423|FG003|Overall Study|Technical problems|0
7915176|NCT02106884|12435437|FG000|Overall Study|Change of diagnosis/exclusion|0
7915177|NCT02106884|12435438|FG001|Overall Study|Change of diagnosis/exclusion|1
7915178|NCT02106910|12435449|FG000|Overall Study|Lost to Follow-up|1
7915179|NCT02106910|12435450|FG001|Overall Study|Lost to Follow-up|1
7915180|NCT02106923|12435460|FG000|Overall Study|Protocol Violation|0
7915181|NCT02106923|12435461|FG001|Overall Study|Protocol Violation|0
7915182|NCT02106923|12435462|FG002|Overall Study|Protocol Violation|0
7915183|NCT02106923|12435463|FG003|Overall Study|Protocol Violation|0
7915184|NCT02106923|12435464|FG004|Overall Study|Protocol Violation|0
7915185|NCT02106923|12435465|FG005|Overall Study|Protocol Violation|1
7915186|NCT02106975|12435492|FG000|Overall Study|Death|25
7915187|NCT02106975|12435493|FG001|Overall Study|Death|39
7915188|NCT02107014|12435499|FG000|Overall Study|Withdrew before drug: moving interstate|1
7915189|NCT02107092|12435503|FG000|Overall Study|Miscellaneous|3
7915190|NCT02107092|12435503|FG000|Overall Study|Subject compliance|3
7915191|NCT02107092|12435503|FG000|Overall Study|Hypo-or hyperkalemia|2
7915192|NCT02107092|12435503|FG000|Overall Study|Met ECG withdrawal criteria|3
7915193|NCT02107092|12435503|FG000|Overall Study|Physician Decision|3
7915194|NCT02107092|12435503|FG000|Overall Study|Lost to Follow-up|2
7915195|NCT02107092|12435503|FG000|Overall Study|Withdrawal by Subject|9
7915196|NCT02107092|12435503|FG000|Overall Study|Adverse Event|7
7915197|NCT02107092|12435503|FG000|Overall Study|Expected progression of CKD|12
7915198|NCT02107131|12435509|FG000|Overall Study|Lost to Follow-up|4
7915199|NCT02107131|12435510|FG001|Overall Study|Lost to Follow-up|4
7915200|NCT02107131|12435509|FG000|Overall Study|Physician Decision|1
7915201|NCT02107131|12435510|FG001|Overall Study|Physician Decision|0
7915202|NCT02107131|12435509|FG000|Overall Study|Withdrawal by Subject|2
7915203|NCT02107131|12435510|FG001|Overall Study|Withdrawal by Subject|0
7915204|NCT02107131|12435509|FG000|Overall Study|mental instability|1
7915205|NCT02107131|12435510|FG001|Overall Study|mental instability|0
7915206|NCT02107131|12435509|FG000|Overall Study|Death|0
7915207|NCT02107131|12435510|FG001|Overall Study|Death|1
7915208|NCT02107131|12435509|FG000|Overall Study|Protocol Violation|0
7915209|NCT02107131|12435510|FG001|Overall Study|Protocol Violation|4
7915210|NCT02107196|12435533|FG000|12-week Treatment Period|Adverse Event|6
7915211|NCT02107196|12435534|FG001|12-week Treatment Period|Adverse Event|3
7915212|NCT02107196|12435533|FG000|12-week Treatment Period|Lack of Efficacy|2
7915213|NCT02107196|12435534|FG001|12-week Treatment Period|Lack of Efficacy|1
7915214|NCT02107196|12435533|FG000|12-week Treatment Period|Lost to Follow-up|3
7915215|NCT02107196|12435534|FG001|12-week Treatment Period|Lost to Follow-up|6
7915216|NCT02107196|12435533|FG000|12-week Treatment Period|Physician Decision|0
7915217|NCT02107196|12435534|FG001|12-week Treatment Period|Physician Decision|1
7915218|NCT02107196|12435533|FG000|12-week Treatment Period|Withdrawal by Subject|15
7915219|NCT02107196|12435534|FG001|12-week Treatment Period|Withdrawal by Subject|12
7915220|NCT02107196|12435533|FG000|12-week Treatment Period|Protocol Violation|7
7915221|NCT02107196|12435534|FG001|12-week Treatment Period|Protocol Violation|8
7915222|NCT02107196|12435533|FG000|12-week Treatment Period|Reason Missing|11
7915223|NCT02107196|12435534|FG001|12-week Treatment Period|Reason Missing|8
7915224|NCT02107196|12435533|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
7915225|NCT02107196|12435534|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
7915226|NCT02107196|12435533|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
7915227|NCT02107196|12435534|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
7915228|NCT02107196|12435533|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
7915229|NCT02107196|12435534|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
7915230|NCT02107196|12435533|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
7915231|NCT02107196|12435534|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
7915232|NCT02107274|12435542|FG000|Treatment vs. Placebo|Adverse Event|3
7915233|NCT02107274|12435543|FG001|Treatment vs. Placebo|Adverse Event|0
7915234|NCT02107274|12435542|FG000|Treatment vs. Placebo|Lost to Follow-up|0
7915235|NCT02107274|12435543|FG001|Treatment vs. Placebo|Lost to Follow-up|2
7915236|NCT02107274|12435542|FG000|Control Phase|Lost to Follow-up|1
7915237|NCT02107274|12435543|FG001|Control Phase|Lost to Follow-up|1
7915238|NCT02107274|12435542|FG000|Control Phase|Death|2
7915239|NCT02107274|12435543|FG001|Control Phase|Death|0
7915240|NCT02107274|12435542|FG000|Control Phase|Adverse Event|0
7915241|NCT02107274|12435543|FG001|Control Phase|Adverse Event|1
7915242|NCT02107313|12435558|FG000|Overall Study|One participant did not do the FED cohor|0
7915243|NCT02107313|12435559|FG001|Overall Study|One participant did not do the FED cohor|1
7915244|NCT02107443|12435576|FG000|Overall Study|Death|42
7915245|NCT02107443|12435577|FG001|Overall Study|Death|30
7915246|NCT02107443|12435576|FG000|Overall Study|Study Protocol Violation|3
7915247|NCT02107443|12435577|FG001|Overall Study|Study Protocol Violation|1
7915248|NCT02107443|12435576|FG000|Overall Study|Registered but Not Eligible|0
7915249|NCT02107443|12435577|FG001|Overall Study|Registered but Not Eligible|1
7915250|NCT02107443|12435576|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28
7915251|NCT02107443|12435577|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28
7915252|NCT02107443|12435576|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1
7915253|NCT02107443|12435577|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2
7915254|NCT02107443|12435576|FG000|Overall Study|Withdrawal: Changed Mind|2
7915255|NCT02107443|12435577|FG001|Overall Study|Withdrawal: Changed Mind|0
7915256|NCT02107443|12435576|FG000|Overall Study|Withdrawal: Changed MD/Facility|1
7915257|NCT02107443|12435577|FG001|Overall Study|Withdrawal: Changed MD/Facility|3
7915258|NCT02107443|12435576|FG000|Overall Study|Withdrawal: Too Many Forms|3
7915259|NCT02107443|12435577|FG001|Overall Study|Withdrawal: Too Many Forms|1
7915260|NCT02107443|12435576|FG000|Overall Study|Withdrawal: Too Time Consuming|3
7915261|NCT02107443|12435577|FG001|Overall Study|Withdrawal: Too Time Consuming|6
7915262|NCT02107443|12435576|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2
7915263|NCT02107443|12435577|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1
7915264|NCT02107443|12435576|FG000|Overall Study|Withdrawal: Other Medical|9
7915265|NCT02107443|12435577|FG001|Overall Study|Withdrawal: Other Medical|5
7915266|NCT02107443|12435576|FG000|Overall Study|Withdrawal: Disease Progression|4
7915267|NCT02107443|12435577|FG001|Overall Study|Withdrawal: Disease Progression|2
7915268|NCT02107443|12435576|FG000|Overall Study|Withdrawal: Personal Issues|0
7915269|NCT02107443|12435577|FG001|Overall Study|Withdrawal: Personal Issues|3
7915270|NCT02107482|12435584|FG000|Overall Study|inconveinence|2
7915271|NCT02107482|12435584|FG000|Overall Study|Lost to Follow-up|1
7915272|NCT02107482|12435584|FG000|Overall Study|Lack of Efficacy|1
7915273|NCT02107703|12435597|FG000|Overall Study|Withdrawal by Subject|36
7915274|NCT02107703|12435598|FG001|Overall Study|Withdrawal by Subject|19
7915275|NCT02107703|12435597|FG000|Overall Study|Lost to Follow-up|6
7915276|NCT02107703|12435598|FG001|Overall Study|Lost to Follow-up|4
7915277|NCT02107703|12435597|FG000|Overall Study|On study treatment/follow up|319
7915278|NCT02107703|12435598|FG001|Overall Study|On study treatment/follow up|152
7915279|NCT02107859|12435607|FG000|Overall Study|Withdrawal by Subject|14
7915280|NCT02107859|12435607|FG000|Overall Study|Adverse Event|3
7915281|NCT02107859|12435607|FG000|Overall Study|Study closure|41
7915282|NCT02107859|12435607|FG000|Overall Study|Other than specified|3
7915283|NCT02107898|12435613|FG000|Overall Study|Adverse Event|4
7915284|NCT02107898|12435614|FG001|Overall Study|Adverse Event|7
7915285|NCT02107898|12435613|FG000|Overall Study|Poor compliance to protocol|0
7915286|NCT02107898|12435614|FG001|Overall Study|Poor compliance to protocol|1
7915287|NCT02107898|12435613|FG000|Overall Study|Participant moved|0
7915288|NCT02107898|12435614|FG001|Overall Study|Participant moved|2
7915289|NCT02107898|12435613|FG000|Overall Study|Consent withdrawn by participant|2
7915290|NCT02107898|12435614|FG001|Overall Study|Consent withdrawn by participant|1
7915291|NCT02107898|12435613|FG000|Overall Study|Randomized but not treated|0
7915292|NCT02107898|12435614|FG001|Overall Study|Randomized but not treated|1
7915293|NCT02108262|12435650|FG000|Overall Study|Non-compliance|0
7915294|NCT02108262|12435651|FG001|Overall Study|Non-compliance|2
7915295|NCT02108262|12435652|FG002|Overall Study|Non-compliance|1
7915296|NCT02108262|12435653|FG003|Overall Study|Non-compliance|1
7915297|NCT02108262|12435650|FG000|Overall Study|Randomized by error/screen failure|0
7915298|NCT02108262|12435651|FG001|Overall Study|Randomized by error/screen failure|0
7915299|NCT02108262|12435652|FG002|Overall Study|Randomized by error/screen failure|1
7915300|NCT02108262|12435653|FG003|Overall Study|Randomized by error/screen failure|0
7915301|NCT02108262|12435650|FG000|Overall Study|Distance to center|0
7915302|NCT02108262|12435651|FG001|Overall Study|Distance to center|1
7915303|NCT02108262|12435652|FG002|Overall Study|Distance to center|1
7915304|NCT02108262|12435653|FG003|Overall Study|Distance to center|0
7915305|NCT02108262|12435650|FG000|Overall Study|Adverse Event|0
7915306|NCT02108262|12435651|FG001|Overall Study|Adverse Event|11
7915307|NCT02108262|12435652|FG002|Overall Study|Adverse Event|6
7915308|NCT02108262|12435653|FG003|Overall Study|Adverse Event|12
7915309|NCT02108262|12435650|FG000|Overall Study|Death|0
7915310|NCT02108262|12435651|FG001|Overall Study|Death|2
7915311|NCT02108262|12435652|FG002|Overall Study|Death|2
7915312|NCT02108262|12435653|FG003|Overall Study|Death|1
7915313|NCT02108262|12435650|FG000|Overall Study|Lost to Follow-up|0
7915314|NCT02108262|12435651|FG001|Overall Study|Lost to Follow-up|0
7915315|NCT02108262|12435652|FG002|Overall Study|Lost to Follow-up|1
7915316|NCT02108262|12435653|FG003|Overall Study|Lost to Follow-up|0
7915317|NCT02108262|12435650|FG000|Overall Study|Physician Decision|0
7915318|NCT02108262|12435651|FG001|Overall Study|Physician Decision|0
7915319|NCT02108262|12435652|FG002|Overall Study|Physician Decision|2
7915320|NCT02108262|12435653|FG003|Overall Study|Physician Decision|0
7915321|NCT02108262|12435650|FG000|Overall Study|Withdrawal by Subject|0
7915322|NCT02108262|12435651|FG001|Overall Study|Withdrawal by Subject|7
7915323|NCT02108262|12435652|FG002|Overall Study|Withdrawal by Subject|3
7915324|NCT02108262|12435653|FG003|Overall Study|Withdrawal by Subject|4
7915325|NCT02108262|12435650|FG000|Overall Study|Due to key hepatic values|0
7915326|NCT02108262|12435651|FG001|Overall Study|Due to key hepatic values|1
7915327|NCT02108262|12435652|FG002|Overall Study|Due to key hepatic values|0
7915328|NCT02108262|12435653|FG003|Overall Study|Due to key hepatic values|0
7915329|NCT02108262|12435650|FG000|Overall Study|Unable to contact patient|0
7915330|NCT02108262|12435651|FG001|Overall Study|Unable to contact patient|3
7915331|NCT02108262|12435652|FG002|Overall Study|Unable to contact patient|1
7915332|NCT02108262|12435653|FG003|Overall Study|Unable to contact patient|2
7915333|NCT02108262|12435650|FG000|Overall Study|Patient unable to come to site/attend visit|0
7915334|NCT02108262|12435651|FG001|Overall Study|Patient unable to come to site/attend visit|6
7915335|NCT02108262|12435652|FG002|Overall Study|Patient unable to come to site/attend visit|11
7915336|NCT02108262|12435653|FG003|Overall Study|Patient unable to come to site/attend visit|6
7915337|NCT02108262|12435650|FG000|Overall Study|Patient did not want another infusion|0
7915338|NCT02108262|12435651|FG001|Overall Study|Patient did not want another infusion|3
7915339|NCT02108262|12435652|FG002|Overall Study|Patient did not want another infusion|3
7915340|NCT02108262|12435653|FG003|Overall Study|Patient did not want another infusion|2
7915341|NCT02108262|12435650|FG000|Overall Study|Vacation|0
7915342|NCT02108262|12435651|FG001|Overall Study|Vacation|1
7915343|NCT02108262|12435652|FG002|Overall Study|Vacation|0
7915344|NCT02108262|12435653|FG003|Overall Study|Vacation|0
7915345|NCT02108262|12435650|FG000|Overall Study|Patient decision|0
7915346|NCT02108262|12435651|FG001|Overall Study|Patient decision|7
7915347|NCT02108262|12435652|FG002|Overall Study|Patient decision|9
7915348|NCT02108262|12435653|FG003|Overall Study|Patient decision|14
7915349|NCT02108262|12435650|FG000|Overall Study|Missed IV due to pharmacy error|0
7915350|NCT02108262|12435651|FG001|Overall Study|Missed IV due to pharmacy error|0
7915351|NCT02108262|12435652|FG002|Overall Study|Missed IV due to pharmacy error|1
7915352|NCT02108262|12435653|FG003|Overall Study|Missed IV due to pharmacy error|0
7915353|NCT02108600|12435690|FG000|Overall Study|Withdrawal by Subject|2
7915354|NCT02108600|12435691|FG001|Overall Study|Withdrawal by Subject|0
7915355|NCT02108600|12435690|FG000|Overall Study|Lost to Follow-up|1
7915356|NCT02108600|12435691|FG001|Overall Study|Lost to Follow-up|1
7915357|NCT02108912|12435714|FG000|Overall Study|Lost to Follow-up|1
7915358|NCT02108912|12435715|FG001|Overall Study|Lost to Follow-up|1
7915359|NCT02108912|12435714|FG000|Overall Study|lack of transportation|1
7915360|NCT02108912|12435715|FG001|Overall Study|lack of transportation|0
7915361|NCT02108912|12435714|FG000|Overall Study|high blood pressure|1
7915362|NCT02108912|12435715|FG001|Overall Study|high blood pressure|0
7915363|NCT02108951|12435721|FG000|Overall Study|Lost to Follow-up|1
7915364|NCT02108951|12435721|FG000|Overall Study|Patient's/guardian's decision|1
7915365|NCT02108951|12435721|FG000|Overall Study|Study Terminated by Sponsor|14
7915366|NCT02109029|12435739|FG000|Part B|Adverse Event|0
7915367|NCT02109029|12435740|FG001|Part B|Adverse Event|0
7915368|NCT02109029|12435741|FG002|Part B|Adverse Event|0
7915369|NCT02109029|12435742|FG003|Part B|Adverse Event|0
7915370|NCT02109029|12435743|FG004|Part B|Adverse Event|1
7915371|NCT02109029|12435744|FG005|Part B|Adverse Event|1
7915372|NCT02109042|12435755|FG000|Overall Study|Sponsor Decision|15
7915373|NCT02109107|12435760|FG000|Overall Study|Lost to Follow-up|2
7915374|NCT02109133|12435766|FG000|Overall Study|Lost to Follow-up|1
7915375|NCT02109133|12435767|FG001|Overall Study|Lost to Follow-up|0
7915376|NCT02109432|12435790|FG000|Overall Study|Withdrawal by Subject|1
7915377|NCT02109445|12435794|FG000|Overall Study|Symptomatic deterioration|2
7915378|NCT02109445|12435794|FG000|Overall Study|Adverse Event|1
7915379|NCT02109484|12435810|FG000|Overall Study|Lost to Follow-up|0
7915380|NCT02109484|12435811|FG001|Overall Study|Lost to Follow-up|0
7915381|NCT02109484|12435812|FG002|Overall Study|Lost to Follow-up|0
7915382|NCT02109484|12435813|FG003|Overall Study|Lost to Follow-up|1
7915383|NCT02109484|12435814|FG004|Overall Study|Lost to Follow-up|1
7915384|NCT02109484|12435815|FG005|Overall Study|Lost to Follow-up|0
7915385|NCT02109484|12435816|FG006|Overall Study|Lost to Follow-up|1
7915386|NCT02109484|12435817|FG007|Overall Study|Lost to Follow-up|0
7915387|NCT02109484|12435810|FG000|Overall Study|Withdrawal by Subject|0
7915388|NCT02109484|12435811|FG001|Overall Study|Withdrawal by Subject|0
7915389|NCT02109484|12435812|FG002|Overall Study|Withdrawal by Subject|0
7915390|NCT02109484|12435813|FG003|Overall Study|Withdrawal by Subject|0
7915391|NCT02109484|12435814|FG004|Overall Study|Withdrawal by Subject|1
7915392|NCT02109484|12435815|FG005|Overall Study|Withdrawal by Subject|1
7915393|NCT02109484|12435816|FG006|Overall Study|Withdrawal by Subject|1
7915394|NCT02109484|12435817|FG007|Overall Study|Withdrawal by Subject|0
7915395|NCT02109484|12435810|FG000|Overall Study|Physician Decision|0
7915396|NCT02109484|12435811|FG001|Overall Study|Physician Decision|0
7915397|NCT02109484|12435812|FG002|Overall Study|Physician Decision|0
7915398|NCT02109484|12435813|FG003|Overall Study|Physician Decision|0
7915399|NCT02109484|12435814|FG004|Overall Study|Physician Decision|2
7915400|NCT02109484|12435815|FG005|Overall Study|Physician Decision|0
7915401|NCT02109484|12435816|FG006|Overall Study|Physician Decision|0
7915402|NCT02109484|12435817|FG007|Overall Study|Physician Decision|0
7915403|NCT02109484|12435810|FG000|Overall Study|Death|0
7915404|NCT02109484|12435811|FG001|Overall Study|Death|0
7915405|NCT02109484|12435812|FG002|Overall Study|Death|0
7915406|NCT02109484|12435813|FG003|Overall Study|Death|0
7915407|NCT02109484|12435814|FG004|Overall Study|Death|0
7915408|NCT02109484|12435815|FG005|Overall Study|Death|0
7915409|NCT02109484|12435816|FG006|Overall Study|Death|0
7915410|NCT02109484|12435817|FG007|Overall Study|Death|2
7915411|NCT02109484|12435810|FG000|Overall Study|Moved away from study area|0
7915412|NCT02109484|12435811|FG001|Overall Study|Moved away from study area|0
7915413|NCT02109484|12435812|FG002|Overall Study|Moved away from study area|0
7915414|NCT02109484|12435813|FG003|Overall Study|Moved away from study area|0
7915415|NCT02109484|12435814|FG004|Overall Study|Moved away from study area|0
7915416|NCT02109484|12435815|FG005|Overall Study|Moved away from study area|0
7915417|NCT02109484|12435816|FG006|Overall Study|Moved away from study area|1
7915418|NCT02109484|12435817|FG007|Overall Study|Moved away from study area|1
7915419|NCT02109562|12435859|FG000|Overall Study|Insufficient clinical response|2
7915420|NCT02109562|12435860|FG001|Overall Study|Insufficient clinical response|0
7915421|NCT02109562|12435861|FG002|Overall Study|Insufficient clinical response|4
7915422|NCT02109562|12435859|FG000|Overall Study|Adverse Event|0
7915423|NCT02109562|12435860|FG001|Overall Study|Adverse Event|2
7915424|NCT02109562|12435861|FG002|Overall Study|Adverse Event|3
7915425|NCT02109562|12435859|FG000|Overall Study|Lost to Follow-up|1
7915426|NCT02109562|12435860|FG001|Overall Study|Lost to Follow-up|0
7915427|NCT02109562|12435861|FG002|Overall Study|Lost to Follow-up|1
7915428|NCT02109562|12435859|FG000|Overall Study|Protocol Violation|0
7915429|NCT02109562|12435860|FG001|Overall Study|Protocol Violation|3
7915430|NCT02109562|12435861|FG002|Overall Study|Protocol Violation|1
7915431|NCT02109562|12435859|FG000|Overall Study|Withdrawal by Subject|20
7915432|NCT02109562|12435860|FG001|Overall Study|Withdrawal by Subject|25
7915433|NCT02109562|12435861|FG002|Overall Study|Withdrawal by Subject|21
7915434|NCT02109562|12435859|FG000|Overall Study|Physician Decision|3
7915435|NCT02109562|12435860|FG001|Overall Study|Physician Decision|4
7915436|NCT02109562|12435861|FG002|Overall Study|Physician Decision|5
7915437|NCT02110225|12435923|FG000|Overall Study|Lost to Follow-up|0
7915438|NCT02110225|12435924|FG001|Overall Study|Lost to Follow-up|1
7915439|NCT02110225|12435925|FG002|Overall Study|Lost to Follow-up|0
7915440|NCT02110238|12435936|FG000|12 Week Pivotal Phase|Adverse Event|3
7915441|NCT02110238|12435937|FG001|12 Week Pivotal Phase|Adverse Event|0
7915442|NCT02110238|12435936|FG000|12 Week Pivotal Phase|Lack of Efficacy|2
7915443|NCT02110238|12435937|FG001|12 Week Pivotal Phase|Lack of Efficacy|3
7915444|NCT02110238|12435936|FG000|12 Week Pivotal Phase|Lost to Follow-up|2
7915445|NCT02110238|12435937|FG001|12 Week Pivotal Phase|Lost to Follow-up|0
7915446|NCT02110238|12435936|FG000|12 Week Pivotal Phase|Physician Decision|0
7915447|NCT02110238|12435937|FG001|12 Week Pivotal Phase|Physician Decision|2
7915448|NCT02110238|12435936|FG000|12 Week Pivotal Phase|Protocol Violation|0
7915449|NCT02110238|12435937|FG001|12 Week Pivotal Phase|Protocol Violation|1
7915450|NCT02110238|12435936|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3
7915451|NCT02110238|12435937|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3
7915452|NCT02110238|12435936|FG000|14 Week Blinded Extension Phase|Adverse Event|1
7915453|NCT02110238|12435937|FG001|14 Week Blinded Extension Phase|Adverse Event|1
7915454|NCT02110238|12435936|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2
7915455|NCT02110238|12435937|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4
7915456|NCT02110238|12435936|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3
7915457|NCT02110238|12435937|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1
7915458|NCT02110238|12435936|FG000|14 Week Blinded Extension Phase|Protocol Violation|2
7915459|NCT02110238|12435937|FG001|14 Week Blinded Extension Phase|Protocol Violation|3
7915460|NCT02110238|12435936|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4
7915461|NCT02110238|12435937|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3
7915462|NCT02110693|12435975|FG000|Overall Study|Withdrawal by Subject|6
7915463|NCT02110693|12435976|FG001|Overall Study|Withdrawal by Subject|7
7915464|NCT02110693|12435975|FG000|Overall Study|skipped assessment|15
7915465|NCT02110693|12435976|FG001|Overall Study|skipped assessment|18
7915466|NCT02110693|12435975|FG000|Overall Study|technical difficulties|6
7915467|NCT02110693|12435976|FG001|Overall Study|technical difficulties|4
7915468|NCT02110693|12435975|FG000|Overall Study|Other|1
7915469|NCT02110693|12435976|FG001|Overall Study|Other|0
7915470|NCT02110706|12435998|FG000|Overall Study|Adverse Event|2
7915471|NCT02110706|12435999|FG001|Overall Study|Adverse Event|3
7915472|NCT02110706|12435998|FG000|Overall Study|Patients who didn't receive 2nd infusion|3
7915473|NCT02110706|12435999|FG001|Overall Study|Patients who didn't receive 2nd infusion|1
7915474|NCT02110732|12436009|FG000|Overall Study|Physician Decision|5
7915475|NCT02110732|12436010|FG001|Overall Study|Physician Decision|2
7915476|NCT02110732|12436009|FG000|Overall Study|Lost to Follow-up|1
7915477|NCT02110732|12436010|FG001|Overall Study|Lost to Follow-up|1
7915478|NCT02110901|12436039|FG000|Overall Study|Death|6
7915479|NCT02110901|12436040|FG001|Overall Study|Death|3
7915480|NCT02110901|12436039|FG000|Overall Study|Lost to Follow-up|12
7915481|NCT02110901|12436040|FG001|Overall Study|Lost to Follow-up|8
7915482|NCT02110901|12436039|FG000|Overall Study|Withdrawal by Subject|7
7915483|NCT02110901|12436040|FG001|Overall Study|Withdrawal by Subject|3
7915484|NCT02110901|12436039|FG000|Overall Study|received a kidney transplant|5
7915485|NCT02110901|12436040|FG001|Overall Study|received a kidney transplant|0
7915486|NCT02111083|12436049|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1
7915487|NCT02111083|12436050|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1
7915488|NCT02111096|12436059|FG000|Overall Study|Adverse Event|4
7915489|NCT02111096|12436060|FG001|Overall Study|Adverse Event|1
7915490|NCT02111096|12436061|FG002|Overall Study|Adverse Event|2
7915491|NCT02111096|12436059|FG000|Overall Study|Non-Compliance with Study Drug|1
7915492|NCT02111096|12436060|FG001|Overall Study|Non-Compliance with Study Drug|1
7915493|NCT02111096|12436061|FG002|Overall Study|Non-Compliance with Study Drug|0
7915494|NCT02111096|12436059|FG000|Overall Study|Lost to Follow Up|1
7915495|NCT02111096|12436060|FG001|Overall Study|Lost to Follow Up|1
7915496|NCT02111096|12436061|FG002|Overall Study|Lost to Follow Up|1
7915497|NCT02111096|12436059|FG000|Overall Study|Physician Decision|0
7915498|NCT02111096|12436060|FG001|Overall Study|Physician Decision|1
7915499|NCT02111096|12436061|FG002|Overall Study|Physician Decision|0
7915500|NCT02111096|12436059|FG000|Overall Study|Protocol Violation|1
7915501|NCT02111096|12436060|FG001|Overall Study|Protocol Violation|0
7915502|NCT02111096|12436061|FG002|Overall Study|Protocol Violation|1
7915503|NCT02111096|12436059|FG000|Overall Study|Terminated by Sponsor|53
7915504|NCT02111096|12436060|FG001|Overall Study|Terminated by Sponsor|35
7915505|NCT02111096|12436061|FG002|Overall Study|Terminated by Sponsor|54
7915506|NCT02111096|12436059|FG000|Overall Study|Withdrawal by Subject|4
7915507|NCT02111096|12436060|FG001|Overall Study|Withdrawal by Subject|2
7915508|NCT02111096|12436061|FG002|Overall Study|Withdrawal by Subject|8
7915509|NCT02111174|12436074|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
7915510|NCT02111174|12436075|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
7915511|NCT02111174|12436074|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2
7915512|NCT02111174|12436075|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2
7915513|NCT02111174|12436074|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
7915514|NCT02111174|12436075|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
7915515|NCT02111174|12436074|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0
7915516|NCT02111174|12436075|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1
7915517|NCT02111213|12436107|FG000|Overall Study|Withdrawal by Subject|3
7915518|NCT02111213|12436108|FG001|Overall Study|Withdrawal by Subject|2
7915519|NCT02111213|12436107|FG000|Overall Study|Lost to Follow-up|3
7915520|NCT02111213|12436108|FG001|Overall Study|Lost to Follow-up|4
7915521|NCT02111369|12436118|FG000|Overall Study|Lost to Follow-up|2
7915522|NCT02111369|12436118|FG000|Overall Study|Withdrawal by Subject|1
7915523|NCT02111564|12436141|FG000|Overall Study|Death|109
7915524|NCT02111564|12436142|FG001|Overall Study|Death|120
7915525|NCT02111564|12436141|FG000|Overall Study|Lost to Follow-up|2
7915526|NCT02111564|12436142|FG001|Overall Study|Lost to Follow-up|3
7915527|NCT02111564|12436141|FG000|Overall Study|Withdrawal by Subject|20
7915528|NCT02111564|12436142|FG001|Overall Study|Withdrawal by Subject|20
7915529|NCT02111577|12436150|FG000|Overall Study|Protocol Violation|2
7915530|NCT02111577|12436151|FG001|Overall Study|Protocol Violation|0
7915531|NCT02111577|12436150|FG000|Overall Study|Unable to tolerate leukapheresis|1
7915532|NCT02111577|12436151|FG001|Overall Study|Unable to tolerate leukapheresis|0
7915533|NCT02111577|12436150|FG000|Overall Study|Failure to produce study treatment|6
7915534|NCT02111577|12436151|FG001|Overall Study|Failure to produce study treatment|0
7915535|NCT02111577|12436150|FG000|Overall Study|Death|518
7915536|NCT02111577|12436151|FG001|Overall Study|Death|254
7915537|NCT02111577|12436150|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1
7915538|NCT02111577|12436151|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0
7915539|NCT02111577|12436150|FG000|Overall Study|Adverse Event|1
7915540|NCT02111577|12436151|FG001|Overall Study|Adverse Event|1
7915541|NCT02111577|12436150|FG000|Overall Study|Withdrawal by Subject|51
7915542|NCT02111577|12436151|FG001|Overall Study|Withdrawal by Subject|23
7915543|NCT02111577|12436150|FG000|Overall Study|Disease progression|0
7915544|NCT02111577|12436151|FG001|Overall Study|Disease progression|1
7915545|NCT02111577|12436150|FG000|Overall Study|Lost to Follow-up|19
7915546|NCT02111577|12436151|FG001|Overall Study|Lost to Follow-up|10
7915547|NCT02111603|12436159|FG000|Overall Study|Withdrawal by Subject|1
7915548|NCT02111785|12436185|FG000|Overall Study|Death|0
7915549|NCT02111785|12436186|FG001|Overall Study|Death|1
7915550|NCT02111785|12436187|FG002|Overall Study|Death|0
7915551|NCT02111785|12436188|FG003|Overall Study|Death|0
7964219|NCT03907280|12519507|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0
7964220|NCT03907280|12519508|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1
7964221|NCT03907280|12519509|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0
7964222|NCT03745768|12519521|FG000|Overall Study|discontinued study|2
7964223|NCT03745768|12519522|FG001|Overall Study|discontinued study|0
7964224|NCT03694522|12519530|FG000|Overall Study|Ongoing|42
7964225|NCT03694522|12519531|FG001|Overall Study|Ongoing|27
7964226|NCT03694522|12519530|FG000|Overall Study|Withdrawal by Subject|6
7964227|NCT03694522|12519531|FG001|Overall Study|Withdrawal by Subject|10
7964228|NCT03694522|12519530|FG000|Overall Study|Death|28
7964229|NCT03694522|12519531|FG001|Overall Study|Death|40
7964230|NCT03694522|12519530|FG000|Overall Study|Other|1
7964231|NCT03694522|12519531|FG001|Overall Study|Other|1
7964232|NCT03689374|12519539|FG000|Run-in Period (12 Weeks)|Run-in failure|526
7964233|NCT03689374|12519540|FG001|Run-in Period (12 Weeks)|Run-in failure|0
7964234|NCT03689374|12519541|FG002|Run-in Period (12 Weeks)|Run-in failure|0
7964235|NCT03689374|12519539|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0
7964236|NCT03689374|12519540|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10
7964237|NCT03689374|12519541|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38
7964238|NCT03689374|12519539|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0
7964239|NCT03689374|12519540|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3
7964240|NCT03689374|12519541|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4
7964241|NCT03689374|12519539|FG000|Treatment Period (Week 0 to 52)|Death|0
7964242|NCT03689374|12519540|FG001|Treatment Period (Week 0 to 52)|Death|11
7964243|NCT03689374|12519541|FG002|Treatment Period (Week 0 to 52)|Death|1
7964244|NCT03639311|12519549|FG000|Overall Study|Ongoing at the time of analysis|88
7964245|NCT03639311|12519550|FG001|Overall Study|Ongoing at the time of analysis|0
7964246|NCT03639311|12519549|FG000|Overall Study|Lost to Follow-up|1
7964247|NCT03639311|12519550|FG001|Overall Study|Lost to Follow-up|0
7964248|NCT03639311|12519549|FG000|Overall Study|Adverse Event|1
7964249|NCT03639311|12519550|FG001|Overall Study|Adverse Event|0
7964250|NCT03591874|12519586|FG000|Overall Study|Adverse Event|4
7964251|NCT03591874|12519587|FG001|Overall Study|Adverse Event|0
7964252|NCT03591874|12519586|FG000|Overall Study|Withdrawal by Subject|2
7964253|NCT03591874|12519587|FG001|Overall Study|Withdrawal by Subject|1
7964254|NCT03591874|12519586|FG000|Overall Study|Investigator Withdrawal of Subject|1
7964255|NCT03591874|12519587|FG001|Overall Study|Investigator Withdrawal of Subject|0
7964256|NCT03591874|12519586|FG000|Overall Study|On Study at Time of Study Termination|12
7964257|NCT03591874|12519587|FG001|Overall Study|On Study at Time of Study Termination|6
7966928|NCT02759016|12523394|FG000|Overall Study|Not treated with BI 836826|1
7966929|NCT02759016|12523395|FG001|Overall Study|Not treated with BI 836826|0
7966930|NCT02759016|12523394|FG000|Overall Study|Progressive disease|1
7966931|NCT02759016|12523395|FG001|Overall Study|Progressive disease|0
7966932|NCT02759016|12523394|FG000|Overall Study|SD, PR-MRDpos or PR-L|0
7966933|NCT02759016|12523395|FG001|Overall Study|SD, PR-MRDpos or PR-L|2
7966934|NCT02759016|12523394|FG000|Overall Study|Other not defined above|2
7915552|NCT02111811|12436222|FG000|Treatment Phase|Lost to Follow-up|22
7915553|NCT02111811|12436223|FG001|Treatment Phase|Lost to Follow-up|18
7915554|NCT02111811|12436222|FG000|Treatment Phase|Death|2
7915555|NCT02111811|12436223|FG001|Treatment Phase|Death|0
7915556|NCT02111811|12436222|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26
7915557|NCT02111811|12436223|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17
7915558|NCT02111811|12436222|FG000|Follow up Period (Aim 2)|Death|2
7915559|NCT02111811|12436223|FG001|Follow up Period (Aim 2)|Death|0
7915560|NCT02111993|12436242|FG000|Overall Study|Physician Decision|5
7915561|NCT02111993|12436243|FG001|Overall Study|Physician Decision|4
7915562|NCT02112045|12436253|FG000|Overall Study|Withdrawal by Subject|1
7915563|NCT02112045|12436254|FG001|Overall Study|Withdrawal by Subject|0
7915564|NCT02112448|12436271|FG000|Overall Study|lab values precluding use of ketorolac|2
7915565|NCT02112448|12436272|FG001|Overall Study|lab values precluding use of ketorolac|2
7915566|NCT02112448|12436271|FG000|Overall Study|Protocol Violation|1
7915567|NCT02112448|12436272|FG001|Overall Study|Protocol Violation|2
7915568|NCT02112448|12436271|FG000|Overall Study|Physician Decision|4
7915569|NCT02112448|12436272|FG001|Overall Study|Physician Decision|6
7915570|NCT02112448|12436271|FG000|Overall Study|required heparin so could not use ketoro|1
7915571|NCT02112448|12436272|FG001|Overall Study|required heparin so could not use ketoro|0
7915572|NCT02112877|12436295|FG000|Overall Study|Withdrawal by Subject|1
7915573|NCT02112877|12436296|FG001|Overall Study|Withdrawal by Subject|7
7915574|NCT02112877|12436295|FG000|Overall Study|Visit Missed|1
7915575|NCT02112877|12436296|FG001|Overall Study|Visit Missed|6
7915576|NCT02112994|12436304|FG000|Overall Study|Progressive Disease|0
7915577|NCT02112994|12436305|FG001|Overall Study|Progressive Disease|0
7915578|NCT02112994|12436306|FG002|Overall Study|Progressive Disease|1
7915579|NCT02112994|12436304|FG000|Overall Study|Pregnancy|0
7915580|NCT02112994|12436305|FG001|Overall Study|Pregnancy|1
7915581|NCT02112994|12436306|FG002|Overall Study|Pregnancy|1
7915582|NCT02112994|12436304|FG000|Overall Study|Liver Transplant|0
7915583|NCT02112994|12436305|FG001|Overall Study|Liver Transplant|1
7915584|NCT02112994|12436306|FG002|Overall Study|Liver Transplant|0
7915585|NCT02112994|12436304|FG000|Overall Study|Withdrawal by Subject|0
7915586|NCT02112994|12436305|FG001|Overall Study|Withdrawal by Subject|0
7915587|NCT02112994|12436306|FG002|Overall Study|Withdrawal by Subject|1
7915588|NCT02113007|12436318|FG000|Overall Study|Progressive disease|2
7915589|NCT02113124|12436324|FG000|Overall Study|Unable to retrieve blood sample|1
7915590|NCT02113124|12436325|FG001|Overall Study|Unable to retrieve blood sample|1
7915591|NCT02113189|12436334|FG000|Overall Study|Lost to follow up|2
7915592|NCT02113189|12436335|FG001|Overall Study|Lost to follow up|1
7915593|NCT02113189|12436336|FG002|Overall Study|Lost to follow up|3
7915594|NCT02113436|12436369|FG000|Period 1: 8 Weeks|Adverse Event|1
7915595|NCT02113436|12436370|FG001|Period 1: 8 Weeks|Adverse Event|0
7915596|NCT02113436|12436371|FG002|Period 1: 8 Weeks|Adverse Event|0
7915597|NCT02113436|12436372|FG003|Period 1: 8 Weeks|Adverse Event|0
7915598|NCT02113436|12436369|FG000|Period 1: 8 Weeks|Protocol Violation|1
7915599|NCT02113436|12436370|FG001|Period 1: 8 Weeks|Protocol Violation|0
7915600|NCT02113436|12436371|FG002|Period 1: 8 Weeks|Protocol Violation|0
7915601|NCT02113436|12436372|FG003|Period 1: 8 Weeks|Protocol Violation|0
7915602|NCT02113436|12436369|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
7915603|NCT02113436|12436370|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
7915604|NCT02113436|12436371|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
7915605|NCT02113436|12436372|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
7915606|NCT02113436|12436369|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1
7915607|NCT02113436|12436370|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0
7915608|NCT02113436|12436371|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0
7915609|NCT02113436|12436372|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0
7915610|NCT02113436|12436369|FG000|Period 2: 16 Weeks|Adverse Event|0
7915611|NCT02113436|12436370|FG001|Period 2: 16 Weeks|Adverse Event|0
7915612|NCT02113436|12436371|FG002|Period 2: 16 Weeks|Adverse Event|4
7915613|NCT02113436|12436372|FG003|Period 2: 16 Weeks|Adverse Event|5
7915614|NCT02113436|12436369|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
7915615|NCT02113436|12436370|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
7915616|NCT02113436|12436371|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
7915617|NCT02113436|12436372|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
7915618|NCT02113436|12436369|FG000|Period 2: 16 Weeks|Physician Decision|0
7915619|NCT02113436|12436370|FG001|Period 2: 16 Weeks|Physician Decision|0
7915620|NCT02113436|12436371|FG002|Period 2: 16 Weeks|Physician Decision|2
7915621|NCT02113436|12436372|FG003|Period 2: 16 Weeks|Physician Decision|0
7915622|NCT02113436|12436369|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0
7915623|NCT02113436|12436370|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0
7915624|NCT02113436|12436371|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1
7915625|NCT02113436|12436372|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1
7915626|NCT02113449|12436381|FG000|Overall Study|Adverse Event|4
7915627|NCT02113579|12436391|FG000|Overall Study|Adverse Event|1
7915628|NCT02113579|12436392|FG001|Overall Study|Adverse Event|0
7915629|NCT02113579|12436391|FG000|Overall Study|Withdrawal by Subject|3
7915630|NCT02113579|12436392|FG001|Overall Study|Withdrawal by Subject|2
7915631|NCT02113579|12436391|FG000|Overall Study|Lost to Follow-up|6
7915632|NCT02113579|12436392|FG001|Overall Study|Lost to Follow-up|2
7915633|NCT02113956|12436400|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5
7915634|NCT02113956|12436401|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1
7915635|NCT02113956|12436400|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4
7915636|NCT02113956|12436401|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3
7915637|NCT02113956|12436400|FG000|3 Month Post-intervention|Lost to Follow-up|4
7915638|NCT02113956|12436401|FG001|3 Month Post-intervention|Lost to Follow-up|2
7915639|NCT02114151|12436407|FG000|Overall Study|Death|1
7915640|NCT02114151|12436407|FG000|Overall Study|Lost to Follow-up|1
7915641|NCT02114151|12436407|FG000|Overall Study|Withdrawal by Subject|5
7915642|NCT02114177|12436422|FG000|Overall Study|Lost to Follow-up|1
7915643|NCT02114177|12436423|FG001|Overall Study|Lost to Follow-up|2
7915644|NCT02114177|12436422|FG000|Overall Study|Withdrawal by Subject|6
7915645|NCT02114177|12436423|FG001|Overall Study|Withdrawal by Subject|1
7915646|NCT02114177|12436422|FG000|Overall Study|Other|2
7915647|NCT02114177|12436423|FG001|Overall Study|Other|1
7915648|NCT02114203|12436432|FG000|Overall Study|Adverse Event|0
7915649|NCT02114203|12436433|FG001|Overall Study|Adverse Event|1
7915650|NCT02114203|12436434|FG002|Overall Study|Adverse Event|0
7915651|NCT02114203|12436432|FG000|Overall Study|Withdrawal by Subject|0
7915652|NCT02114203|12436433|FG001|Overall Study|Withdrawal by Subject|1
7915653|NCT02114203|12436434|FG002|Overall Study|Withdrawal by Subject|0
7915654|NCT02114268|12436464|FG000|Overall Study|Lost to Follow-up|4
7915655|NCT02114268|12436465|FG001|Overall Study|Lost to Follow-up|1
7915656|NCT02114268|12436466|FG002|Overall Study|Lost to Follow-up|1
7915657|NCT02114268|12436467|FG003|Overall Study|Lost to Follow-up|0
7915658|NCT02114268|12436468|FG004|Overall Study|Lost to Follow-up|0
7915659|NCT02114268|12436469|FG005|Overall Study|Lost to Follow-up|2
7915660|NCT02114268|12436464|FG000|Overall Study|Withdrawal by Subject|1
7915661|NCT02114268|12436465|FG001|Overall Study|Withdrawal by Subject|0
7915662|NCT02114268|12436466|FG002|Overall Study|Withdrawal by Subject|0
7915663|NCT02114268|12436467|FG003|Overall Study|Withdrawal by Subject|0
7915664|NCT02114268|12436468|FG004|Overall Study|Withdrawal by Subject|0
7915665|NCT02114268|12436469|FG005|Overall Study|Withdrawal by Subject|1
7915666|NCT02114268|12436464|FG000|Overall Study|Withdrawn by site due to noncompliance|1
7915667|NCT02114268|12436465|FG001|Overall Study|Withdrawn by site due to noncompliance|0
7915668|NCT02114268|12436466|FG002|Overall Study|Withdrawn by site due to noncompliance|0
7915669|NCT02114268|12436467|FG003|Overall Study|Withdrawn by site due to noncompliance|0
7915670|NCT02114268|12436468|FG004|Overall Study|Withdrawn by site due to noncompliance|0
7915671|NCT02114268|12436469|FG005|Overall Study|Withdrawn by site due to noncompliance|0
7915672|NCT02114385|12436501|FG000|Overall Study|Withdrawal by Subject|3
7915673|NCT02114385|12436502|FG001|Overall Study|Withdrawal by Subject|2
7915674|NCT02114385|12436501|FG000|Overall Study|Lost to Follow-up|0
7915675|NCT02114385|12436502|FG001|Overall Study|Lost to Follow-up|6
7915676|NCT02114515|12436510|FG000|Overall Study|Lost to Follow-up|52
7915677|NCT02114515|12436511|FG001|Overall Study|Lost to Follow-up|55
7915678|NCT02114515|12436510|FG000|Overall Study|Death|12
7915679|NCT02114515|12436511|FG001|Overall Study|Death|12
7915680|NCT02114515|12436510|FG000|Overall Study|Withdrawal by Subject|4
7915681|NCT02114515|12436511|FG001|Overall Study|Withdrawal by Subject|22
7915682|NCT02114515|12436510|FG000|Overall Study|Other|65
7915683|NCT02114515|12436511|FG001|Overall Study|Other|61
7915684|NCT02114606|12436517|FG000|Overall Study|Unable to swallow Cytosponge|6
7915685|NCT02114684|12436523|FG000|Overall Study|Death|6
7915686|NCT02114684|12436524|FG001|Overall Study|Death|4
7915687|NCT02114684|12436523|FG000|Overall Study|Lost to Follow-up|1
7915688|NCT02114684|12436524|FG001|Overall Study|Lost to Follow-up|2
7915689|NCT02114684|12436523|FG000|Overall Study|Withdrawal by Subject|1
7915690|NCT02114684|12436524|FG001|Overall Study|Withdrawal by Subject|2
7915691|NCT02114684|12436523|FG000|Overall Study|Relocation|3
7915692|NCT02114684|12436524|FG001|Overall Study|Relocation|1
7915693|NCT02114684|12436523|FG000|Overall Study|Rifampicin resistant on culture|0
7915694|NCT02114684|12436524|FG001|Overall Study|Rifampicin resistant on culture|1
7915695|NCT02114684|12436523|FG000|Overall Study|Patient Incarcerated|1
7915696|NCT02114684|12436524|FG001|Overall Study|Patient Incarcerated|0
7915697|NCT02114879|12436536|FG000|Overall Study|Withdrawal by Subject|9
7915698|NCT02114879|12436537|FG001|Overall Study|Withdrawal by Subject|5
7915699|NCT02114879|12436536|FG000|Overall Study|Death|6
7915700|NCT02114879|12436537|FG001|Overall Study|Death|11
7915701|NCT02114879|12436536|FG000|Overall Study|Lost to Follow-up|4
7915702|NCT02114879|12436537|FG001|Overall Study|Lost to Follow-up|6
7915703|NCT02114879|12436536|FG000|Overall Study|Physician Decision|0
7915704|NCT02114879|12436537|FG001|Overall Study|Physician Decision|2
7915705|NCT02114892|12436545|FG000|Overall Study|Lost to Follow-up|1
7915706|NCT02114892|12436546|FG001|Overall Study|Lost to Follow-up|2
7915707|NCT02114931|12436554|FG000|Overall Study|Withdrawal by Subject|15
7915708|NCT02114931|12436555|FG001|Overall Study|Withdrawal by Subject|18
7915709|NCT02114931|12436554|FG000|Overall Study|Adverse Event|4
7915710|NCT02114931|12436555|FG001|Overall Study|Adverse Event|6
7915711|NCT02114931|12436554|FG000|Overall Study|Lost to Follow-up|3
7915712|NCT02114931|12436555|FG001|Overall Study|Lost to Follow-up|3
7915713|NCT02114931|12436554|FG000|Overall Study|Physician Decision|1
7915714|NCT02114931|12436555|FG001|Overall Study|Physician Decision|2
7915715|NCT02114931|12436554|FG000|Overall Study|Other|2
7915716|NCT02114931|12436555|FG001|Overall Study|Other|1
7915717|NCT02115113|12436570|FG000|Participants in Run-in Period|Death|0
7915718|NCT02115113|12436571|FG001|Participants in Run-in Period|Death|0
7915719|NCT02115113|12436572|FG002|Participants in Run-in Period|Death|1
7915720|NCT02115113|12436570|FG000|Participants in Run-in Period|Administrative problems|0
7915721|NCT02115113|12436571|FG001|Participants in Run-in Period|Administrative problems|0
7915722|NCT02115113|12436572|FG002|Participants in Run-in Period|Administrative problems|1
7915723|NCT02115113|12436570|FG000|Participants in Run-in Period|Lost to Follow-up|0
7915724|NCT02115113|12436571|FG001|Participants in Run-in Period|Lost to Follow-up|0
7915725|NCT02115113|12436572|FG002|Participants in Run-in Period|Lost to Follow-up|5
7915726|NCT02115113|12436570|FG000|Participants in Run-in Period|Withdrawal by Subject|0
7915727|NCT02115113|12436571|FG001|Participants in Run-in Period|Withdrawal by Subject|0
7915728|NCT02115113|12436572|FG002|Participants in Run-in Period|Withdrawal by Subject|3
7915729|NCT02115113|12436570|FG000|Participants Randomized|Lost to Follow-up|1
7915730|NCT02115113|12436571|FG001|Participants Randomized|Lost to Follow-up|0
7915731|NCT02115113|12436572|FG002|Participants Randomized|Lost to Follow-up|0
7915732|NCT02115113|12436570|FG000|Participants Randomized|Death|1
7915733|NCT02115113|12436571|FG001|Participants Randomized|Death|0
7915734|NCT02115113|12436572|FG002|Participants Randomized|Death|0
7915735|NCT02115139|12436581|FG000|Overall Study|Protocol Violation|1
7915736|NCT02115139|12436581|FG000|Overall Study|treatment discontinuation|6
7915737|NCT02115256|12436587|FG000|Overall Study|Withdrawal by Subject|0
7915738|NCT02115256|12436588|FG001|Overall Study|Withdrawal by Subject|1
7915739|NCT02115269|12436594|FG000|Overall Study|Lost to Follow-up|43
7915740|NCT02115269|12436594|FG000|Overall Study|Did not complete patient diary|3
7915741|NCT02115269|12436594|FG000|Overall Study|Moved to another city|7
7915742|NCT02115269|12436594|FG000|Overall Study|Withdrawal by Subject|2
7915743|NCT02115269|12436594|FG000|Overall Study|Didn't take study drug|2
7915744|NCT02115282|12436611|FG000|Overall Study|Disease progression during treatment|216
7915745|NCT02115282|12436612|FG001|Overall Study|Disease progression during treatment|229
7915746|NCT02115282|12436611|FG000|Overall Study|Adverse Event|49
7915747|NCT02115282|12436612|FG001|Overall Study|Adverse Event|23
7915748|NCT02115282|12436611|FG000|Overall Study|Death|1
7915749|NCT02115282|12436612|FG001|Overall Study|Death|3
7915750|NCT02115282|12436611|FG000|Overall Study|Alternative therapy|1
7915751|NCT02115282|12436612|FG001|Overall Study|Alternative therapy|1
7915752|NCT02115282|12436611|FG000|Overall Study|Complicating disease|0
7915753|NCT02115282|12436612|FG001|Overall Study|Complicating disease|3
7915754|NCT02115282|12436611|FG000|Overall Study|Withdrawal by Subject|12
7915755|NCT02115282|12436612|FG001|Overall Study|Withdrawal by Subject|10
7915756|NCT02115282|12436611|FG000|Overall Study|Symptomatic progression/deterioration|7
7915757|NCT02115282|12436612|FG001|Overall Study|Symptomatic progression/deterioration|18
7915758|NCT02115282|12436611|FG000|Overall Study|Non-compliance|5
7915759|NCT02115282|12436612|FG001|Overall Study|Non-compliance|1
7915760|NCT02115282|12436611|FG000|Overall Study|Protocol Violation|2
7915761|NCT02115282|12436612|FG001|Overall Study|Protocol Violation|2
7915762|NCT02115282|12436611|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3
7915763|NCT02115282|12436612|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3
7915764|NCT02115282|12436611|FG000|Overall Study|Not start protocol therapy|9
7915765|NCT02115282|12436612|FG001|Overall Study|Not start protocol therapy|10
7915766|NCT02115308|12436622|FG000|Overall Study|Safety Screening|2
7915767|NCT02115308|12436623|FG001|Overall Study|Safety Screening|2
7915768|NCT02115321|12436635|FG000|Overall Study|Death|1
7915769|NCT02115321|12436636|FG001|Overall Study|Death|0
7915770|NCT02115386|12436652|FG000|Overall Study|Protocol Violation|1
7915771|NCT02115386|12436652|FG000|Overall Study|Administrative - trial was terminated|6
7915772|NCT02115607|12436669|FG000|Overall Study|Withdrawal by Subject|1
7915773|NCT02115815|12436712|FG000|Overall Study|Withdrawal by Subject|2
7915774|NCT02115815|12436713|FG001|Overall Study|Withdrawal by Subject|0
7915775|NCT02115815|12436714|FG002|Overall Study|Withdrawal by Subject|0
7915776|NCT02115815|12436715|FG003|Overall Study|Withdrawal by Subject|0
7915777|NCT02115815|12436716|FG004|Overall Study|Withdrawal by Subject|0
7915778|NCT02115815|12436717|FG005|Overall Study|Withdrawal by Subject|0
7915779|NCT02115815|12436718|FG006|Overall Study|Withdrawal by Subject|0
7915780|NCT02115815|12436712|FG000|Overall Study|Not enough drug to dose participant|0
7915781|NCT02115815|12436713|FG001|Overall Study|Not enough drug to dose participant|0
7915782|NCT02115815|12436714|FG002|Overall Study|Not enough drug to dose participant|0
7915783|NCT02115815|12436715|FG003|Overall Study|Not enough drug to dose participant|0
7915784|NCT02115815|12436716|FG004|Overall Study|Not enough drug to dose participant|0
7915785|NCT02115815|12436717|FG005|Overall Study|Not enough drug to dose participant|1
7915786|NCT02115815|12436718|FG006|Overall Study|Not enough drug to dose participant|0
7915787|NCT02115815|12436712|FG000|Overall Study|Missed appointment, randomized in error|0
7915788|NCT02115815|12436713|FG001|Overall Study|Missed appointment, randomized in error|0
7915789|NCT02115815|12436714|FG002|Overall Study|Missed appointment, randomized in error|0
7915790|NCT02115815|12436715|FG003|Overall Study|Missed appointment, randomized in error|0
7915791|NCT02115815|12436716|FG004|Overall Study|Missed appointment, randomized in error|0
7915792|NCT02115815|12436717|FG005|Overall Study|Missed appointment, randomized in error|1
7915793|NCT02115815|12436718|FG006|Overall Study|Missed appointment, randomized in error|0
7915794|NCT02116205|12436751|FG000|Overall Study|Withdrawal by Subject|2
7915795|NCT02116205|12436752|FG001|Overall Study|Withdrawal by Subject|4
7915796|NCT02116205|12436753|FG002|Overall Study|Withdrawal by Subject|1
7915797|NCT02116205|12436754|FG003|Overall Study|Withdrawal by Subject|3
7915798|NCT02116205|12436751|FG000|Overall Study|Lost to Follow-up|0
7915799|NCT02116205|12436752|FG001|Overall Study|Lost to Follow-up|2
7915800|NCT02116205|12436753|FG002|Overall Study|Lost to Follow-up|1
7915801|NCT02116205|12436754|FG003|Overall Study|Lost to Follow-up|2
7915802|NCT02116205|12436751|FG000|Overall Study|Physician Decision|0
7915803|NCT02116205|12436752|FG001|Overall Study|Physician Decision|1
7915804|NCT02116205|12436753|FG002|Overall Study|Physician Decision|1
7915805|NCT02116205|12436754|FG003|Overall Study|Physician Decision|1
7915806|NCT02116205|12436751|FG000|Overall Study|Exclusion criteria|0
7915807|NCT02116205|12436752|FG001|Overall Study|Exclusion criteria|0
7915808|NCT02116205|12436753|FG002|Overall Study|Exclusion criteria|1
7915809|NCT02116205|12436754|FG003|Overall Study|Exclusion criteria|0
7915810|NCT02116309|12436766|FG000|Overall Study|Lost to Follow-up|0
7915811|NCT02116309|12436767|FG001|Overall Study|Lost to Follow-up|1
7915812|NCT02116361|12436781|FG000|Overall Study|Pregnancy|0
7915813|NCT02116361|12436782|FG001|Overall Study|Pregnancy|0
7915814|NCT02116361|12436783|FG002|Overall Study|Pregnancy|0
7915815|NCT02116361|12436784|FG003|Overall Study|Pregnancy|1
7915816|NCT02116361|12436781|FG000|Overall Study|Protocol Violation|1
7915817|NCT02116361|12436782|FG001|Overall Study|Protocol Violation|0
7915818|NCT02116361|12436783|FG002|Overall Study|Protocol Violation|0
7915819|NCT02116361|12436784|FG003|Overall Study|Protocol Violation|2
7915820|NCT02116361|12436781|FG000|Overall Study|Physician Decision|2
7915821|NCT02116361|12436782|FG001|Overall Study|Physician Decision|3
7915822|NCT02116361|12436783|FG002|Overall Study|Physician Decision|0
7915823|NCT02116361|12436784|FG003|Overall Study|Physician Decision|0
7915824|NCT02116361|12436781|FG000|Overall Study|Adverse Event|1
7915825|NCT02116361|12436782|FG001|Overall Study|Adverse Event|0
7915826|NCT02116361|12436783|FG002|Overall Study|Adverse Event|0
7915827|NCT02116361|12436784|FG003|Overall Study|Adverse Event|3
7915828|NCT02116361|12436781|FG000|Overall Study|Other Reasons|3
7915829|NCT02116361|12436782|FG001|Overall Study|Other Reasons|3
7915830|NCT02116361|12436783|FG002|Overall Study|Other Reasons|3
7915831|NCT02116361|12436784|FG003|Overall Study|Other Reasons|3
7915832|NCT02116361|12436781|FG000|Overall Study|Lack of Efficacy|5
7915833|NCT02116361|12436782|FG001|Overall Study|Lack of Efficacy|7
7915834|NCT02116361|12436783|FG002|Overall Study|Lack of Efficacy|4
7915835|NCT02116361|12436784|FG003|Overall Study|Lack of Efficacy|3
7915836|NCT02116361|12436781|FG000|Overall Study|Lost to Follow-up|4
7915837|NCT02116361|12436782|FG001|Overall Study|Lost to Follow-up|5
7915838|NCT02116361|12436783|FG002|Overall Study|Lost to Follow-up|7
7915839|NCT02116361|12436784|FG003|Overall Study|Lost to Follow-up|5
7915840|NCT02116361|12436781|FG000|Overall Study|Personal Reasons|6
7915841|NCT02116361|12436782|FG001|Overall Study|Personal Reasons|6
7915842|NCT02116361|12436783|FG002|Overall Study|Personal Reasons|4
7915843|NCT02116361|12436784|FG003|Overall Study|Personal Reasons|9
7915844|NCT02116361|12436781|FG000|Overall Study|Investigator Decision - Relapse|9
7915845|NCT02116361|12436782|FG001|Overall Study|Investigator Decision - Relapse|7
7915846|NCT02116361|12436783|FG002|Overall Study|Investigator Decision - Relapse|8
7915847|NCT02116361|12436784|FG003|Overall Study|Investigator Decision - Relapse|5
7915848|NCT02116530|12436796|FG000|Overall Study|Withdrawal by Subject|1
7915849|NCT02116530|12436797|FG001|Overall Study|Withdrawal by Subject|2
7915850|NCT02116530|12436796|FG000|Overall Study|Adverse Event|4
7915851|NCT02116530|12436797|FG001|Overall Study|Adverse Event|0
7915852|NCT02116530|12436796|FG000|Overall Study|Physician Decision|1
7915853|NCT02116530|12436797|FG001|Overall Study|Physician Decision|0
7915854|NCT02116530|12436796|FG000|Overall Study|Lost to Follow-up|1
7915855|NCT02116530|12436797|FG001|Overall Study|Lost to Follow-up|0
7915856|NCT02116530|12436796|FG000|Overall Study|Other Medical Problems|2
7915857|NCT02116530|12436797|FG001|Overall Study|Other Medical Problems|2
7915858|NCT02116582|12436803|FG000|Overall Study|Enrolled but Never Received Study Drug|1
7915859|NCT02116582|12436803|FG000|Overall Study|Adverse Event|22
7915860|NCT02116582|12436803|FG000|Overall Study|Death|9
7915861|NCT02116582|12436803|FG000|Overall Study|Progressive Disease|148
7915862|NCT02116582|12436803|FG000|Overall Study|Protocol Violation|3
7915863|NCT02116582|12436803|FG000|Overall Study|Withdrawal by Subject|8
7915864|NCT02116582|12436803|FG000|Overall Study|Other: Miscellaneous|11
7915865|NCT02116582|12436803|FG000|Overall Study|Lost to Follow-up|1
7915866|NCT02116582|12436803|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12
7915867|NCT02116608|12436810|FG000|Overall Study|Lost to Follow-up|0
7915868|NCT02116608|12436811|FG001|Overall Study|Lost to Follow-up|0
7915869|NCT02116608|12436812|FG002|Overall Study|Lost to Follow-up|1
7915870|NCT02116608|12436810|FG000|Overall Study|Physician Decision|0
7915871|NCT02116608|12436811|FG001|Overall Study|Physician Decision|1
7915872|NCT02116608|12436812|FG002|Overall Study|Physician Decision|0
7915873|NCT02116608|12436810|FG000|Overall Study|Death|0
7915874|NCT02116608|12436811|FG001|Overall Study|Death|1
7915875|NCT02116608|12436812|FG002|Overall Study|Death|0
7915876|NCT02116621|12436822|FG000|Baseline|Withdrawal by Subject|0
7915877|NCT02116621|12436823|FG001|Baseline|Withdrawal by Subject|4
7915878|NCT02116621|12436822|FG000|Three Month Follow-up|Death|1
7915879|NCT02116621|12436823|FG001|Three Month Follow-up|Death|1
7915880|NCT02116621|12436822|FG000|Three Month Follow-up|Withdrawal by Subject|4
7915881|NCT02116621|12436823|FG001|Three Month Follow-up|Withdrawal by Subject|1
7915882|NCT02116621|12436822|FG000|Three Month Follow-up|Lost to Follow-up|0
7915883|NCT02116621|12436823|FG001|Three Month Follow-up|Lost to Follow-up|1
7915884|NCT02116621|12436822|FG000|Three Month Follow-up|Did not complete follow-up survey|14
7915885|NCT02116621|12436823|FG001|Three Month Follow-up|Did not complete follow-up survey|4
7915886|NCT02116621|12436822|FG000|Six Month Follow-up|Withdrawal by Subject|1
7915887|NCT02116621|12436823|FG001|Six Month Follow-up|Withdrawal by Subject|1
7915888|NCT02116621|12436822|FG000|Six Month Follow-up|Lost to Follow-up|2
7915889|NCT02116621|12436823|FG001|Six Month Follow-up|Lost to Follow-up|1
7915890|NCT02116621|12436822|FG000|Six Month Follow-up|Did not complete follow-up survey|1
7915891|NCT02116621|12436823|FG001|Six Month Follow-up|Did not complete follow-up survey|1
7915892|NCT02116621|12436822|FG000|Twelve Month Follow-up|Withdrawal by Subject|1
7915893|NCT02116621|12436823|FG001|Twelve Month Follow-up|Withdrawal by Subject|0
7915894|NCT02116621|12436822|FG000|Twelve Month Follow-up|Lost to Follow-up|0
7915895|NCT02116621|12436823|FG001|Twelve Month Follow-up|Lost to Follow-up|1
7915896|NCT02116621|12436822|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1
7915897|NCT02116621|12436823|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3
7915898|NCT02116621|12436822|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14
7915899|NCT02116621|12436823|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8
7915900|NCT02116660|12436831|FG000|Overall Study|Deteriorating renal function|0
7915901|NCT02116660|12436832|FG001|Overall Study|Deteriorating renal function|1
7915902|NCT02116660|12436831|FG000|Overall Study|Adverse Event|1
7915903|NCT02116660|12436832|FG001|Overall Study|Adverse Event|1
7915904|NCT02116660|12436831|FG000|Overall Study|Withdrawal by Subject|0
7915905|NCT02116660|12436832|FG001|Overall Study|Withdrawal by Subject|2
7915906|NCT02116660|12436831|FG000|Overall Study|Organization reason|1
7915907|NCT02116660|12436832|FG001|Overall Study|Organization reason|0
7915908|NCT02116777|12436847|FG000|Overall Study|Adverse Event|0
7915909|NCT02116777|12436848|FG001|Overall Study|Adverse Event|0
7915910|NCT02116777|12436849|FG002|Overall Study|Adverse Event|0
7915911|NCT02116777|12436850|FG003|Overall Study|Adverse Event|0
7915912|NCT02116777|12436851|FG004|Overall Study|Adverse Event|2
7915913|NCT02116777|12436852|FG005|Overall Study|Adverse Event|2
7915914|NCT02116777|12436853|FG006|Overall Study|Adverse Event|0
7915915|NCT02116777|12436847|FG000|Overall Study|Death|0
7915916|NCT02116777|12436848|FG001|Overall Study|Death|0
7915917|NCT02116777|12436849|FG002|Overall Study|Death|0
7915918|NCT02116777|12436850|FG003|Overall Study|Death|1
7915919|NCT02116777|12436851|FG004|Overall Study|Death|0
7915920|NCT02116777|12436852|FG005|Overall Study|Death|0
7915921|NCT02116777|12436853|FG006|Overall Study|Death|0
7915922|NCT02116777|12436847|FG000|Overall Study|Lack of Efficacy|3
7915923|NCT02116777|12436848|FG001|Overall Study|Lack of Efficacy|3
7915924|NCT02116777|12436849|FG002|Overall Study|Lack of Efficacy|3
7915925|NCT02116777|12436850|FG003|Overall Study|Lack of Efficacy|8
7915926|NCT02116777|12436851|FG004|Overall Study|Lack of Efficacy|4
7915927|NCT02116777|12436852|FG005|Overall Study|Lack of Efficacy|1
7915928|NCT02116777|12436853|FG006|Overall Study|Lack of Efficacy|9
7915929|NCT02116777|12436847|FG000|Overall Study|Physician Decision|0
7915930|NCT02116777|12436848|FG001|Overall Study|Physician Decision|0
7915931|NCT02116777|12436849|FG002|Overall Study|Physician Decision|0
7915932|NCT02116777|12436850|FG003|Overall Study|Physician Decision|2
7915933|NCT02116777|12436851|FG004|Overall Study|Physician Decision|0
7915934|NCT02116777|12436852|FG005|Overall Study|Physician Decision|0
7915935|NCT02116777|12436853|FG006|Overall Study|Physician Decision|0
7915936|NCT02116777|12436847|FG000|Overall Study|Protocol Violation|0
7915937|NCT02116777|12436848|FG001|Overall Study|Protocol Violation|0
7915938|NCT02116777|12436849|FG002|Overall Study|Protocol Violation|0
7915939|NCT02116777|12436850|FG003|Overall Study|Protocol Violation|1
7915940|NCT02116777|12436851|FG004|Overall Study|Protocol Violation|0
7915941|NCT02116777|12436852|FG005|Overall Study|Protocol Violation|0
7915942|NCT02116777|12436853|FG006|Overall Study|Protocol Violation|0
7915943|NCT02116777|12436847|FG000|Overall Study|Withdrawal by Subject|0
7915944|NCT02116777|12436848|FG001|Overall Study|Withdrawal by Subject|0
7915945|NCT02116777|12436849|FG002|Overall Study|Withdrawal by Subject|0
7915946|NCT02116777|12436850|FG003|Overall Study|Withdrawal by Subject|1
7915947|NCT02116777|12436851|FG004|Overall Study|Withdrawal by Subject|0
7915948|NCT02116777|12436852|FG005|Overall Study|Withdrawal by Subject|0
7915949|NCT02116777|12436853|FG006|Overall Study|Withdrawal by Subject|0
7915950|NCT02116803|12436874|FG000|Overall Study|Adverse Event|2
7915951|NCT02116803|12436875|FG001|Overall Study|Adverse Event|1
7915952|NCT02116803|12436874|FG000|Overall Study|Physician Decision|1
7915953|NCT02116803|12436875|FG001|Overall Study|Physician Decision|0
7915954|NCT02116803|12436874|FG000|Overall Study|Progressive disease|4
7915955|NCT02116803|12436875|FG001|Overall Study|Progressive disease|0
7915956|NCT02116803|12436874|FG000|Overall Study|Study terminated by sponsor|2
7915957|NCT02116803|12436875|FG001|Overall Study|Study terminated by sponsor|1
7915958|NCT02116803|12436874|FG000|Overall Study|Death|1
7915959|NCT02116803|12436875|FG001|Overall Study|Death|0
7915960|NCT02116972|12436884|FG000|Overall Study|Adverse Event|4
7915961|NCT02116972|12436885|FG001|Overall Study|Adverse Event|4
7915962|NCT02116972|12436886|FG002|Overall Study|Adverse Event|1
7915963|NCT02116972|12436884|FG000|Overall Study|Withdrawal by Subject|1
7915964|NCT02116972|12436885|FG001|Overall Study|Withdrawal by Subject|1
7915965|NCT02116972|12436886|FG002|Overall Study|Withdrawal by Subject|5
7915966|NCT02116972|12436884|FG000|Overall Study|Protocol Violation|1
7915967|NCT02116972|12436885|FG001|Overall Study|Protocol Violation|0
7915968|NCT02116972|12436886|FG002|Overall Study|Protocol Violation|1
7915969|NCT02116972|12436884|FG000|Overall Study|Lost to Follow-up|4
7915970|NCT02116972|12436885|FG001|Overall Study|Lost to Follow-up|3
7915971|NCT02116972|12436886|FG002|Overall Study|Lost to Follow-up|1
7915972|NCT02116972|12436884|FG000|Overall Study|Lack of Efficacy|6
7915973|NCT02116972|12436885|FG001|Overall Study|Lack of Efficacy|6
7915974|NCT02116972|12436886|FG002|Overall Study|Lack of Efficacy|5
7915975|NCT02116972|12436884|FG000|Overall Study|scheduling conflicts and relocation|3
7915976|NCT02116972|12436885|FG001|Overall Study|scheduling conflicts and relocation|3
7915977|NCT02116972|12436886|FG002|Overall Study|scheduling conflicts and relocation|6
7915978|NCT02117024|12436898|FG000|Overall Study|Progressive Disease|26
7915979|NCT02117024|12436899|FG001|Overall Study|Progressive Disease|9
7915980|NCT02117024|12436898|FG000|Overall Study|Significant Clinical Progression|7
7915981|NCT02117024|12436899|FG001|Overall Study|Significant Clinical Progression|4
7915982|NCT02117024|12436898|FG000|Overall Study|Death|5
7915983|NCT02117024|12436899|FG001|Overall Study|Death|0
7915984|NCT02117024|12436898|FG000|Overall Study|Withdrawal by Subject|3
7915985|NCT02117024|12436899|FG001|Overall Study|Withdrawal by Subject|1
7915986|NCT02117024|12436898|FG000|Overall Study|Protocol Violation|1
7915987|NCT02117024|12436899|FG001|Overall Study|Protocol Violation|0
7915988|NCT02117024|12436898|FG000|Overall Study|Adverse Event|1
7915989|NCT02117024|12436899|FG001|Overall Study|Adverse Event|2
7915990|NCT02117024|12436898|FG000|Overall Study|Randomized in Error|1
7915991|NCT02117024|12436899|FG001|Overall Study|Randomized in Error|0
7915992|NCT02117024|12436898|FG000|Overall Study|Patient returned to primary oncologist|0
7915993|NCT02117024|12436899|FG001|Overall Study|Patient returned to primary oncologist|1
7915994|NCT02117024|12436898|FG000|Overall Study|Patient took treatment break|0
7915995|NCT02117024|12436899|FG001|Overall Study|Patient took treatment break|1
7915996|NCT02117024|12436898|FG000|Overall Study|Physician Decision|0
7915997|NCT02117024|12436899|FG001|Overall Study|Physician Decision|2
7915998|NCT02117349|12436930|FG000|Overall Study|Withdrawal by Subject|1
7915999|NCT02117349|12436931|FG001|Overall Study|Withdrawal by Subject|0
7916000|NCT02117349|12436930|FG000|Overall Study|Lost to Follow-up|1
7916001|NCT02117349|12436931|FG001|Overall Study|Lost to Follow-up|1
7916002|NCT02117349|12436930|FG000|Overall Study|Death|1
7916003|NCT02117349|12436931|FG001|Overall Study|Death|0
7916004|NCT02117414|12436939|FG000|Overall Study|Death|5
7916005|NCT02117414|12436940|FG001|Overall Study|Death|2
7916006|NCT02117414|12436939|FG000|Overall Study|Withdrawal by Subject|10
7916007|NCT02117414|12436940|FG001|Overall Study|Withdrawal by Subject|4
7916008|NCT02117427|12436951|FG000|Overall Study|Permanent need for exogenous EPO Tx|2
7916009|NCT02117427|12436952|FG001|Overall Study|Permanent need for exogenous EPO Tx|0
7916010|NCT02117427|12436953|FG002|Overall Study|Permanent need for exogenous EPO Tx|0
7916011|NCT02117427|12436951|FG000|Overall Study|Permanent need for exogenous ESA Tx|3
7916012|NCT02117427|12436952|FG001|Overall Study|Permanent need for exogenous ESA Tx|1
7916013|NCT02117427|12436953|FG002|Overall Study|Permanent need for exogenous ESA Tx|0
7916014|NCT02117427|12436951|FG000|Overall Study|Physician Decision|0
7916015|NCT02117427|12436952|FG001|Overall Study|Physician Decision|2
7916016|NCT02117427|12436953|FG002|Overall Study|Physician Decision|0
7916017|NCT02117427|12436951|FG000|Overall Study|No longer meets inclusion criteria|0
7916018|NCT02117427|12436952|FG001|Overall Study|No longer meets inclusion criteria|1
7916019|NCT02117427|12436953|FG002|Overall Study|No longer meets inclusion criteria|0
7916020|NCT02117427|12436951|FG000|Overall Study|Death|0
7916021|NCT02117427|12436952|FG001|Overall Study|Death|1
7916022|NCT02117427|12436953|FG002|Overall Study|Death|0
7916023|NCT02117479|12436961|FG000|Overall Study|Death|13
7916024|NCT02117479|12436962|FG001|Overall Study|Death|8
7916025|NCT02117479|12436961|FG000|Overall Study|Adverse Event|8
7916026|NCT02117479|12436962|FG001|Overall Study|Adverse Event|16
7916027|NCT02117479|12436961|FG000|Overall Study|Subject decision|8
7916028|NCT02117479|12436962|FG001|Overall Study|Subject decision|9
7916029|NCT02117479|12436961|FG000|Overall Study|Disease progression|104
7916030|NCT02117479|12436962|FG001|Overall Study|Disease progression|108
7916031|NCT02117479|12436961|FG000|Overall Study|Noncompliance with study treatment|1
7916032|NCT02117479|12436962|FG001|Overall Study|Noncompliance with study treatment|0
7916033|NCT02117479|12436961|FG000|Overall Study|Study terminated by the sponsor|4
7916034|NCT02117479|12436962|FG001|Overall Study|Study terminated by the sponsor|6
7916035|NCT02117479|12436961|FG000|Overall Study|Physician Decision|7
7916036|NCT02117479|12436962|FG001|Overall Study|Physician Decision|2
7916037|NCT02117479|12436961|FG000|Overall Study|Other unspecified|11
7916038|NCT02117479|12436962|FG001|Overall Study|Other unspecified|7
7916039|NCT02117544|12436968|FG000|Period 1|Lost to follow-up (prior to treatment)|2
7916040|NCT02117544|12436969|FG001|Period 1|Lost to follow-up (prior to treatment)|0
7916041|NCT02117570|12436979|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
7916042|NCT02117570|12436980|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
7916043|NCT02117570|12436981|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
7916044|NCT02117570|12436979|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
7916045|NCT02117570|12436980|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
7916046|NCT02117570|12436981|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
7916047|NCT02117570|12436979|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
7916048|NCT02117570|12436980|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
7916049|NCT02117570|12436981|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
7916050|NCT02117570|12436979|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0
7916051|NCT02117570|12436980|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0
7916052|NCT02117570|12436981|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1
7916053|NCT02117570|12436979|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
7916054|NCT02117570|12436980|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
7916055|NCT02117570|12436981|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
7916056|NCT02117570|12436979|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
7916057|NCT02117570|12436980|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
7916058|NCT02117570|12436981|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
7916059|NCT02117570|12436979|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
7916060|NCT02117570|12436980|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
7916061|NCT02117570|12436981|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
7916062|NCT02117648|12436992|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1
7916063|NCT02117648|12436992|FG000|Abemaciclib Alone Period 1|Adverse Event|1
7916064|NCT02117648|12436992|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
7916065|NCT02117648|12436992|FG000|Abemaciclib + Clarithromycin Period 2|Death|1
7916066|NCT02117648|12436992|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
7916067|NCT02117648|12436992|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
7916068|NCT02117648|12436992|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12
7916069|NCT02117648|12436992|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1
7916070|NCT02117648|12436992|FG000|Abemaciclib Safety-Extension Phase|Death|3
7916071|NCT02117648|12436992|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
7916072|NCT02117648|12436992|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2
7719505|NCT00532779|12143464|FG002|Overall Study|Drug noncompliance, moved, other|29
7916073|NCT02117687|12437002|FG000|Overall Study|Lost to Follow-up|0
7916074|NCT02117687|12437003|FG001|Overall Study|Lost to Follow-up|1
7916075|NCT02117687|12437002|FG000|Overall Study|Adverse Event|0
7916076|NCT02117687|12437003|FG001|Overall Study|Adverse Event|2
7916077|NCT02117687|12437002|FG000|Overall Study|Other Reasons|1
7916078|NCT02117687|12437003|FG001|Overall Study|Other Reasons|1
7916079|NCT02117713|12437009|FG000|Week 48|Adverse Event|4
7916080|NCT02117713|12437009|FG000|Week 48|Withdrawal by caregiver|2
7916081|NCT02117713|12437009|FG000|Week 48|Did not consent to Protocol Amendment 4|2
7916082|NCT02117713|12437009|FG000|Long Term Follow-up Treatment|Adverse Event|3
7916083|NCT02117713|12437009|FG000|Long Term Follow-up Treatment|Progressive Disease|2
7916084|NCT02117713|12437009|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1
7916085|NCT02118012|12437043|FG000|Overall Study|Adverse Event|0
7916086|NCT02118012|12437044|FG001|Overall Study|Adverse Event|1
7916087|NCT02118012|12437043|FG000|Overall Study|Physician Decision|0
7916088|NCT02118012|12437044|FG001|Overall Study|Physician Decision|1
7916089|NCT02118337|12437059|FG000|Overall Study|Other|1
7916090|NCT02118337|12437060|FG001|Overall Study|Other|0
7916091|NCT02118337|12437061|FG002|Overall Study|Other|0
7916092|NCT02118337|12437062|FG003|Overall Study|Other|0
7916093|NCT02118337|12437063|FG004|Overall Study|Other|2
7916094|NCT02118337|12437064|FG005|Overall Study|Other|3
7916095|NCT02118337|12437065|FG006|Overall Study|Other|1
7916096|NCT02118337|12437066|FG007|Overall Study|Other|28
7916097|NCT02118337|12437067|FG008|Overall Study|Other|15
7916098|NCT02118337|12437059|FG000|Overall Study|Lost to Follow-up|0
7916099|NCT02118337|12437060|FG001|Overall Study|Lost to Follow-up|0
7916100|NCT02118337|12437061|FG002|Overall Study|Lost to Follow-up|0
7916101|NCT02118337|12437062|FG003|Overall Study|Lost to Follow-up|0
7916102|NCT02118337|12437063|FG004|Overall Study|Lost to Follow-up|0
7916103|NCT02118337|12437064|FG005|Overall Study|Lost to Follow-up|0
7916104|NCT02118337|12437065|FG006|Overall Study|Lost to Follow-up|0
7916105|NCT02118337|12437066|FG007|Overall Study|Lost to Follow-up|1
7916106|NCT02118337|12437067|FG008|Overall Study|Lost to Follow-up|0
7916107|NCT02118337|12437059|FG000|Overall Study|Withdrawal by Subject|1
7916108|NCT02118337|12437060|FG001|Overall Study|Withdrawal by Subject|3
7916109|NCT02118337|12437061|FG002|Overall Study|Withdrawal by Subject|2
7916110|NCT02118337|12437062|FG003|Overall Study|Withdrawal by Subject|1
7916111|NCT02118337|12437063|FG004|Overall Study|Withdrawal by Subject|2
7916112|NCT02118337|12437064|FG005|Overall Study|Withdrawal by Subject|2
7916113|NCT02118337|12437065|FG006|Overall Study|Withdrawal by Subject|1
7916114|NCT02118337|12437066|FG007|Overall Study|Withdrawal by Subject|4
7916115|NCT02118337|12437067|FG008|Overall Study|Withdrawal by Subject|2
7916116|NCT02118337|12437059|FG000|Overall Study|Death|2
7916117|NCT02118337|12437060|FG001|Overall Study|Death|2
7916118|NCT02118337|12437061|FG002|Overall Study|Death|1
7916119|NCT02118337|12437062|FG003|Overall Study|Death|2
7916120|NCT02118337|12437063|FG004|Overall Study|Death|5
7916121|NCT02118337|12437064|FG005|Overall Study|Death|1
7916122|NCT02118337|12437065|FG006|Overall Study|Death|2
7916123|NCT02118337|12437066|FG007|Overall Study|Death|9
7916124|NCT02118337|12437067|FG008|Overall Study|Death|4
7916125|NCT02118428|12437093|FG000|Overall Study|Physician Decision|0
7916126|NCT02118428|12437094|FG001|Overall Study|Physician Decision|1
7916127|NCT02118428|12437095|FG002|Overall Study|Physician Decision|0
7916128|NCT02118428|12437093|FG000|Overall Study|Withdrawal by Subject|2
7916129|NCT02118428|12437094|FG001|Overall Study|Withdrawal by Subject|2
7916130|NCT02118428|12437095|FG002|Overall Study|Withdrawal by Subject|0
7916131|NCT02118428|12437093|FG000|Overall Study|Death|7
7916132|NCT02118428|12437094|FG001|Overall Study|Death|5
7916133|NCT02118428|12437095|FG002|Overall Study|Death|0
7916134|NCT02118428|12437093|FG000|Overall Study|Lost to Follow-up|3
7916135|NCT02118428|12437094|FG001|Overall Study|Lost to Follow-up|1
7916136|NCT02118428|12437095|FG002|Overall Study|Lost to Follow-up|0
7916137|NCT02118428|12437093|FG000|Overall Study|Screen Failure or Became Inelegible|1
7916138|NCT02118428|12437094|FG001|Overall Study|Screen Failure or Became Inelegible|0
7916139|NCT02118428|12437095|FG002|Overall Study|Screen Failure or Became Inelegible|1
7916140|NCT02118597|12437111|FG000|Overall Study|Sponsor terminated the study|14
7916141|NCT02118597|12437111|FG000|Overall Study|Serious Adverse Event|1
7916142|NCT02118597|12437111|FG000|Overall Study|Investigator's decision|1
7916143|NCT02118714|12437115|FG000|Overall Study|Lost to Follow-up|2
7916144|NCT02118714|12437115|FG000|Overall Study|Protocol Violation|1
7916145|NCT02118766|12437121|FG000|Overall Study|Adverse Event|7
7916146|NCT02118766|12437122|FG001|Overall Study|Adverse Event|2
7916147|NCT02118766|12437121|FG000|Overall Study|Withdrawal by Subject|3
7916148|NCT02118766|12437122|FG001|Overall Study|Withdrawal by Subject|6
7916149|NCT02118766|12437121|FG000|Overall Study|Lost to Follow-up|5
7916150|NCT02118766|12437122|FG001|Overall Study|Lost to Follow-up|4
7916151|NCT02118766|12437121|FG000|Overall Study|Withdrawal by parent/guardian|12
7916152|NCT02118766|12437122|FG001|Overall Study|Withdrawal by parent/guardian|18
7916153|NCT02118766|12437121|FG000|Overall Study|Other|3
7916154|NCT02118766|12437122|FG001|Overall Study|Other|1
7916155|NCT02118792|12437130|FG000|Overall Study|Withdrawal by Subject|6
7916156|NCT02118792|12437131|FG001|Overall Study|Withdrawal by Subject|3
7916157|NCT02118792|12437130|FG000|Overall Study|Lost to Follow-up|4
7916158|NCT02118792|12437131|FG001|Overall Study|Lost to Follow-up|4
7916159|NCT02118792|12437130|FG000|Overall Study|Adverse Event|5
7916160|NCT02118792|12437131|FG001|Overall Study|Adverse Event|4
7916161|NCT02118792|12437130|FG000|Overall Study|Withdrawal by parent/guardian|14
7916162|NCT02118792|12437131|FG001|Overall Study|Withdrawal by parent/guardian|20
7916163|NCT02118792|12437130|FG000|Overall Study|Other|1
7719506|NCT00532844|12143474|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0
7767838|NCT00856284|12210626|FG002|Overall Study|Lost to Follow-up|28
7916164|NCT02118792|12437131|FG001|Overall Study|Other|6
7916165|NCT02118792|12437130|FG000|Overall Study|Randomised but not treated|1
7916166|NCT02118792|12437131|FG001|Overall Study|Randomised but not treated|0
7916167|NCT02118896|12437162|FG000|Overall Study|Death|4
7916168|NCT02118896|12437163|FG001|Overall Study|Death|0
7916169|NCT02118896|12437164|FG002|Overall Study|Death|4
7916170|NCT02118896|12437165|FG003|Overall Study|Death|6
7916171|NCT02118896|12437166|FG004|Overall Study|Death|3
7916172|NCT02118896|12437167|FG005|Overall Study|Death|1
7916173|NCT02118896|12437168|FG006|Overall Study|Death|0
7916174|NCT02118896|12437169|FG007|Overall Study|Death|0
7916175|NCT02118896|12437170|FG008|Overall Study|Death|0
7916176|NCT02118896|12437171|FG009|Overall Study|Death|0
7916177|NCT02118896|12437162|FG000|Overall Study|Adverse Event|5
7916178|NCT02118896|12437163|FG001|Overall Study|Adverse Event|4
7916179|NCT02118896|12437164|FG002|Overall Study|Adverse Event|4
7916180|NCT02118896|12437165|FG003|Overall Study|Adverse Event|5
7916181|NCT02118896|12437166|FG004|Overall Study|Adverse Event|5
7916182|NCT02118896|12437167|FG005|Overall Study|Adverse Event|9
7916183|NCT02118896|12437168|FG006|Overall Study|Adverse Event|1
7916184|NCT02118896|12437169|FG007|Overall Study|Adverse Event|1
7916185|NCT02118896|12437170|FG008|Overall Study|Adverse Event|4
7916186|NCT02118896|12437171|FG009|Overall Study|Adverse Event|0
7916187|NCT02118896|12437162|FG000|Overall Study|Consent withdrawn|2
7916188|NCT02118896|12437163|FG001|Overall Study|Consent withdrawn|0
7916189|NCT02118896|12437164|FG002|Overall Study|Consent withdrawn|3
7916190|NCT02118896|12437165|FG003|Overall Study|Consent withdrawn|4
7916191|NCT02118896|12437166|FG004|Overall Study|Consent withdrawn|1
7916192|NCT02118896|12437167|FG005|Overall Study|Consent withdrawn|4
7916193|NCT02118896|12437168|FG006|Overall Study|Consent withdrawn|0
7916194|NCT02118896|12437169|FG007|Overall Study|Consent withdrawn|0
7916195|NCT02118896|12437170|FG008|Overall Study|Consent withdrawn|0
7916196|NCT02118896|12437171|FG009|Overall Study|Consent withdrawn|0
7916197|NCT02118896|12437162|FG000|Overall Study|Non-compliance|2
7916198|NCT02118896|12437163|FG001|Overall Study|Non-compliance|1
7916199|NCT02118896|12437164|FG002|Overall Study|Non-compliance|1
7916200|NCT02118896|12437165|FG003|Overall Study|Non-compliance|5
7916201|NCT02118896|12437166|FG004|Overall Study|Non-compliance|0
7916202|NCT02118896|12437167|FG005|Overall Study|Non-compliance|1
7916203|NCT02118896|12437168|FG006|Overall Study|Non-compliance|0
7916204|NCT02118896|12437169|FG007|Overall Study|Non-compliance|1
7916205|NCT02118896|12437170|FG008|Overall Study|Non-compliance|0
7916206|NCT02118896|12437171|FG009|Overall Study|Non-compliance|0
7916207|NCT02118896|12437162|FG000|Overall Study|Pregnancy|1
7916208|NCT02118896|12437163|FG001|Overall Study|Pregnancy|1
7916209|NCT02118896|12437164|FG002|Overall Study|Pregnancy|0
7916210|NCT02118896|12437165|FG003|Overall Study|Pregnancy|0
7916211|NCT02118896|12437166|FG004|Overall Study|Pregnancy|1
7916212|NCT02118896|12437167|FG005|Overall Study|Pregnancy|3
7916213|NCT02118896|12437168|FG006|Overall Study|Pregnancy|1
7916214|NCT02118896|12437169|FG007|Overall Study|Pregnancy|0
7916215|NCT02118896|12437170|FG008|Overall Study|Pregnancy|0
7916216|NCT02118896|12437171|FG009|Overall Study|Pregnancy|0
7916217|NCT02118896|12437162|FG000|Overall Study|Lost to Follow-up|1
7916218|NCT02118896|12437163|FG001|Overall Study|Lost to Follow-up|2
7916219|NCT02118896|12437164|FG002|Overall Study|Lost to Follow-up|1
7916220|NCT02118896|12437165|FG003|Overall Study|Lost to Follow-up|0
7916221|NCT02118896|12437166|FG004|Overall Study|Lost to Follow-up|2
7719507|NCT00532844|12143475|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1
7719508|NCT00532844|12143474|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1
7719509|NCT00532844|12143475|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0
7719510|NCT00532844|12143474|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1
7719511|NCT00532844|12143475|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0
7719512|NCT00532844|12143474|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1
7719513|NCT00532844|12143475|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0
7719514|NCT00532844|12143474|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1
7719515|NCT00532844|12143475|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0
7719516|NCT00532883|12143498|FG000|Overall Study|Adverse Event|1
7719517|NCT00532883|12143499|FG001|Overall Study|Adverse Event|0
7719518|NCT00532883|12143500|FG002|Overall Study|Adverse Event|0
7719519|NCT00532883|12143501|FG003|Overall Study|Adverse Event|1
7719520|NCT00532883|12143498|FG000|Overall Study|Lost to Follow-up|1
7719521|NCT00532883|12143499|FG001|Overall Study|Lost to Follow-up|1
7719522|NCT00532883|12143500|FG002|Overall Study|Lost to Follow-up|1
7719523|NCT00532883|12143501|FG003|Overall Study|Lost to Follow-up|0
7719524|NCT00532883|12143498|FG000|Overall Study|Withdrawal by Subject|0
7719525|NCT00532883|12143499|FG001|Overall Study|Withdrawal by Subject|1
7916222|NCT02118896|12437167|FG005|Overall Study|Lost to Follow-up|1
7916223|NCT02118896|12437168|FG006|Overall Study|Lost to Follow-up|0
7916224|NCT02118896|12437169|FG007|Overall Study|Lost to Follow-up|0
7916225|NCT02118896|12437170|FG008|Overall Study|Lost to Follow-up|0
7719526|NCT00532883|12143500|FG002|Overall Study|Withdrawal by Subject|1
7719527|NCT00532883|12143501|FG003|Overall Study|Withdrawal by Subject|0
7719528|NCT00532883|12143498|FG000|Overall Study|Subject was Nonadherent|0
7719529|NCT00532883|12143499|FG001|Overall Study|Subject was Nonadherent|1
7719530|NCT00532883|12143500|FG002|Overall Study|Subject was Nonadherent|1
7916226|NCT02118896|12437171|FG009|Overall Study|Lost to Follow-up|0
7916227|NCT02118896|12437162|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1
7916228|NCT02118896|12437163|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5
7916229|NCT02118896|12437164|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1
7916230|NCT02118896|12437165|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2
7916231|NCT02118896|12437166|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4
7916232|NCT02118896|12437167|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2
7916233|NCT02118896|12437168|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0
7916234|NCT02118896|12437169|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0
7916235|NCT02118896|12437170|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0
7916236|NCT02118896|12437171|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2
7916237|NCT02118896|12437162|FG000|Overall Study|Prohibited medication|0
7916238|NCT02118896|12437163|FG001|Overall Study|Prohibited medication|0
7916239|NCT02118896|12437164|FG002|Overall Study|Prohibited medication|0
7916240|NCT02118896|12437165|FG003|Overall Study|Prohibited medication|0
7916241|NCT02118896|12437166|FG004|Overall Study|Prohibited medication|1
7916242|NCT02118896|12437167|FG005|Overall Study|Prohibited medication|3
7916243|NCT02118896|12437168|FG006|Overall Study|Prohibited medication|0
7916244|NCT02118896|12437169|FG007|Overall Study|Prohibited medication|0
7916245|NCT02118896|12437170|FG008|Overall Study|Prohibited medication|0
7916246|NCT02118896|12437171|FG009|Overall Study|Prohibited medication|0
7916247|NCT02118896|12437162|FG000|Overall Study|Miscellaneous|1
7916248|NCT02118896|12437163|FG001|Overall Study|Miscellaneous|2
7916249|NCT02118896|12437164|FG002|Overall Study|Miscellaneous|0
7916250|NCT02118896|12437165|FG003|Overall Study|Miscellaneous|2
7916251|NCT02118896|12437166|FG004|Overall Study|Miscellaneous|0
7916252|NCT02118896|12437167|FG005|Overall Study|Miscellaneous|4
7916253|NCT02118896|12437168|FG006|Overall Study|Miscellaneous|0
7916254|NCT02118896|12437169|FG007|Overall Study|Miscellaneous|0
7916255|NCT02118896|12437170|FG008|Overall Study|Miscellaneous|0
7916256|NCT02118896|12437171|FG009|Overall Study|Miscellaneous|0
7916257|NCT02118961|12437196|FG000|Overall Study|Withdrawal by Subject|1
7916258|NCT02118961|12437197|FG001|Overall Study|Withdrawal by Subject|0
7916259|NCT02119026|12437205|FG000|1st-line Treatment|Adverse Event|9
7916260|NCT02119026|12437206|FG001|1st-line Treatment|Adverse Event|14
7916261|NCT02119026|12437205|FG000|1st-line Treatment|Physician Decision|3
7916262|NCT02119026|12437206|FG001|1st-line Treatment|Physician Decision|8
7916263|NCT02119026|12437205|FG000|1st-line Treatment|Withdrawal by Subject|4
7916264|NCT02119026|12437206|FG001|1st-line Treatment|Withdrawal by Subject|10
7916265|NCT02119026|12437205|FG000|1st-line Treatment|Patient condition or compliance|6
7916266|NCT02119026|12437206|FG001|1st-line Treatment|Patient condition or compliance|4
7916267|NCT02119026|12437205|FG000|1st-line Treatment|Surgery of metastases|2
7916268|NCT02119026|12437206|FG001|1st-line Treatment|Surgery of metastases|1
7916269|NCT02119026|12437205|FG000|1st-line Treatment|Death|2
7916270|NCT02119026|12437206|FG001|1st-line Treatment|Death|1
7916271|NCT02119026|12437205|FG000|2nd-line Treatment|Lost to Follow-up|2
7916272|NCT02119026|12437206|FG001|2nd-line Treatment|Lost to Follow-up|0
7916273|NCT02119026|12437205|FG000|2nd-line Treatment|Withdrawal by Subject|3
7916274|NCT02119026|12437206|FG001|2nd-line Treatment|Withdrawal by Subject|1
7916275|NCT02119026|12437205|FG000|2nd-line Treatment|Adverse Event|4
7916276|NCT02119026|12437206|FG001|2nd-line Treatment|Adverse Event|1
7916277|NCT02119104|12437212|FG000|Overall Study|Protocol Violation|16
7916278|NCT02119156|12437219|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
7916279|NCT02119156|12437220|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
7916280|NCT02119156|12437221|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1
7916281|NCT02119156|12437219|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4
7916282|NCT02119156|12437220|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
7916283|NCT02119156|12437221|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
7916284|NCT02119156|12437219|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1
7916285|NCT02119156|12437220|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2
7916286|NCT02119156|12437221|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0
7916287|NCT02119156|12437219|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1
7916288|NCT02119156|12437220|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
7916289|NCT02119156|12437221|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
7916290|NCT02119156|12437219|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0
7916291|NCT02119156|12437220|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10
7916292|NCT02119156|12437221|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7
7916293|NCT02119260|12437243|FG000|Overall Study|Adverse Event|1
7916294|NCT02119260|12437244|FG001|Overall Study|Adverse Event|0
7916295|NCT02119260|12437245|FG002|Overall Study|Adverse Event|0
7916296|NCT02119260|12437246|FG003|Overall Study|Adverse Event|0
7916297|NCT02119260|12437247|FG004|Overall Study|Adverse Event|0
7916298|NCT02119260|12437248|FG005|Overall Study|Adverse Event|0
7916299|NCT02119260|12437249|FG006|Overall Study|Adverse Event|0
7916300|NCT02119260|12437243|FG000|Overall Study|Withdrew consent|0
7916301|NCT02119260|12437244|FG001|Overall Study|Withdrew consent|1
7916302|NCT02119260|12437245|FG002|Overall Study|Withdrew consent|1
7916303|NCT02119260|12437246|FG003|Overall Study|Withdrew consent|0
7916304|NCT02119260|12437247|FG004|Overall Study|Withdrew consent|0
7916305|NCT02119260|12437248|FG005|Overall Study|Withdrew consent|0
7916306|NCT02119260|12437249|FG006|Overall Study|Withdrew consent|0
7916307|NCT02119286|12437277|FG000|Overall Study|Adverse Event|9
7916308|NCT02119286|12437278|FG001|Overall Study|Adverse Event|7
7916309|NCT02119286|12437279|FG002|Overall Study|Adverse Event|2
7916310|NCT02119286|12437277|FG000|Overall Study|Lack of Efficacy|11
7916311|NCT02119286|12437278|FG001|Overall Study|Lack of Efficacy|3
7916312|NCT02119286|12437279|FG002|Overall Study|Lack of Efficacy|4
7916313|NCT02119286|12437277|FG000|Overall Study|Lost to Follow-up|2
7916314|NCT02119286|12437278|FG001|Overall Study|Lost to Follow-up|0
7916315|NCT02119286|12437279|FG002|Overall Study|Lost to Follow-up|1
7916316|NCT02119286|12437277|FG000|Overall Study|Withdrawal by Subject|4
7916317|NCT02119286|12437278|FG001|Overall Study|Withdrawal by Subject|1
7916318|NCT02119286|12437279|FG002|Overall Study|Withdrawal by Subject|0
7916319|NCT02119299|12437287|FG000|Overall Study|Withdrawal by Subject|7
7916320|NCT02119299|12437287|FG000|Overall Study|Lack of Efficacy|1
7916321|NCT02119299|12437287|FG000|Overall Study|Pregnancy|1
7916322|NCT02119325|12437291|FG000|Washout Period 1|Adverse Event|0
7916323|NCT02119325|12437292|FG001|Washout Period 1|Adverse Event|1
7916324|NCT02119650|12437315|FG000|Overall Study|Adverse Event|3
7916325|NCT02119650|12437316|FG001|Overall Study|Adverse Event|4
7916326|NCT02119650|12437315|FG000|Overall Study|Subject decision|2
7916327|NCT02119650|12437316|FG001|Overall Study|Subject decision|3
7916328|NCT02119650|12437315|FG000|Overall Study|Disease progression|11
7916329|NCT02119650|12437316|FG001|Overall Study|Disease progression|14
7916330|NCT02119650|12437315|FG000|Overall Study|Death|5
7916331|NCT02119650|12437316|FG001|Overall Study|Death|1
7916332|NCT02119650|12437315|FG000|Overall Study|Noncompliance with study treatment|1
7916333|NCT02119650|12437316|FG001|Overall Study|Noncompliance with study treatment|1
7916334|NCT02119650|12437315|FG000|Overall Study|Study terminated by the sponsor|1
7916335|NCT02119650|12437316|FG001|Overall Study|Study terminated by the sponsor|0
7916336|NCT02119650|12437315|FG000|Overall Study|Physician Decision|0
7916337|NCT02119650|12437316|FG001|Overall Study|Physician Decision|2
7916338|NCT02119650|12437315|FG000|Overall Study|Multiple reasons for termination|2
7916339|NCT02119650|12437316|FG001|Overall Study|Multiple reasons for termination|1
7916340|NCT02119663|12437324|FG000|Overall Study|Disease progression|26
7916341|NCT02119663|12437325|FG001|Overall Study|Disease progression|27
7916342|NCT02119663|12437324|FG000|Overall Study|Adverse Event|5
7916343|NCT02119663|12437325|FG001|Overall Study|Adverse Event|5
7916344|NCT02119663|12437324|FG000|Overall Study|Death|3
7916345|NCT02119663|12437325|FG001|Overall Study|Death|2
7916346|NCT02119663|12437324|FG000|Overall Study|Physician Decision|1
7916347|NCT02119663|12437325|FG001|Overall Study|Physician Decision|2
7916348|NCT02119663|12437324|FG000|Overall Study|Other unspecified|2
7916349|NCT02119663|12437325|FG001|Overall Study|Other unspecified|0
7916350|NCT02119663|12437324|FG000|Overall Study|Subject decision|0
7916351|NCT02119663|12437325|FG001|Overall Study|Subject decision|1
7916352|NCT02119663|12437324|FG000|Overall Study|Study Terminated by the Sponsor|3
7916353|NCT02119663|12437325|FG001|Overall Study|Study Terminated by the Sponsor|4
7964258|NCT03418727|12519596|FG000|Overall Study|Adverse Event|1
7964259|NCT03418727|12519597|FG001|Overall Study|Adverse Event|2
7964260|NCT03418727|12519598|FG002|Overall Study|Adverse Event|0
7964261|NCT03418727|12519596|FG000|Overall Study|Withdrawal by Subject|0
7964262|NCT03418727|12519597|FG001|Overall Study|Withdrawal by Subject|0
7964263|NCT03418727|12519598|FG002|Overall Study|Withdrawal by Subject|2
7964264|NCT03410108|12519606|FG000|Overall Study|Ongoing|41
7964265|NCT03410108|12519606|FG000|Overall Study|Adverse Event|4
7964266|NCT03410108|12519606|FG000|Overall Study|Progressive Disease|58
7964267|NCT03410108|12519606|FG000|Overall Study|Withdrawal by Subject|1
7964268|NCT03123185|12519631|FG000|Overall Study|Withdrawal by Subject|0
7964269|NCT03123185|12519632|FG001|Overall Study|Withdrawal by Subject|0
7964270|NCT03123185|12519633|FG002|Overall Study|Withdrawal by Subject|0
7964271|NCT03123185|12519634|FG003|Overall Study|Withdrawal by Subject|0
7964272|NCT03123185|12519635|FG004|Overall Study|Withdrawal by Subject|0
7964273|NCT03123185|12519636|FG005|Overall Study|Withdrawal by Subject|0
7964274|NCT03123185|12519637|FG006|Overall Study|Withdrawal by Subject|0
7964275|NCT03123185|12519638|FG007|Overall Study|Withdrawal by Subject|0
7964276|NCT03123185|12519639|FG008|Overall Study|Withdrawal by Subject|0
7964277|NCT03123185|12519640|FG009|Overall Study|Withdrawal by Subject|0
7964278|NCT03123185|12519641|FG010|Overall Study|Withdrawal by Subject|0
7964279|NCT03123185|12519642|FG011|Overall Study|Withdrawal by Subject|0
7964280|NCT03123185|12519643|FG012|Overall Study|Withdrawal by Subject|1
7964281|NCT03123185|12519644|FG013|Overall Study|Withdrawal by Subject|0
7964282|NCT02949219|12519752|FG000|Overall Study|Withdrawal by Subject|1
7964283|NCT02921763|12519756|FG000|Overall Study|Adverse Event|4
7964284|NCT02921763|12519756|FG000|Overall Study|Lost to Follow-up|4
7964285|NCT02921763|12519756|FG000|Overall Study|Lack of Efficacy|3
7964286|NCT02921763|12519756|FG000|Overall Study|Protocol Violation|2
7916354|NCT02119676|12437335|FG000|Overall Study|Adverse Event|9
7916355|NCT02119676|12437336|FG001|Overall Study|Adverse Event|17
7916356|NCT02119676|12437337|FG002|Overall Study|Adverse Event|10
7916357|NCT02119676|12437338|FG003|Overall Study|Adverse Event|10
7916358|NCT02119676|12437335|FG000|Overall Study|Disease progression|53
7916359|NCT02119676|12437336|FG001|Overall Study|Disease progression|55
7916360|NCT02119676|12437337|FG002|Overall Study|Disease progression|68
7916361|NCT02119676|12437338|FG003|Overall Study|Disease progression|73
7916362|NCT02119676|12437335|FG000|Overall Study|Patient decision, inc. consent withdrawn|4
7916363|NCT02119676|12437336|FG001|Overall Study|Patient decision, inc. consent withdrawn|5
7916364|NCT02119676|12437337|FG002|Overall Study|Patient decision, inc. consent withdrawn|5
7916365|NCT02119676|12437338|FG003|Overall Study|Patient decision, inc. consent withdrawn|6
7916366|NCT02119676|12437335|FG000|Overall Study|Physician Decision|4
7916367|NCT02119676|12437336|FG001|Overall Study|Physician Decision|2
7916368|NCT02119676|12437337|FG002|Overall Study|Physician Decision|3
7916369|NCT02119676|12437338|FG003|Overall Study|Physician Decision|2
7916370|NCT02119676|12437335|FG000|Overall Study|Death|9
7916371|NCT02119676|12437336|FG001|Overall Study|Death|3
7916372|NCT02119676|12437337|FG002|Overall Study|Death|2
7916373|NCT02119676|12437338|FG003|Overall Study|Death|1
7916374|NCT02119676|12437335|FG000|Overall Study|Noncompliance|0
7916375|NCT02119676|12437336|FG001|Overall Study|Noncompliance|1
7916376|NCT02119676|12437337|FG002|Overall Study|Noncompliance|0
7916377|NCT02119676|12437338|FG003|Overall Study|Noncompliance|0
7916378|NCT02119676|12437335|FG000|Overall Study|Lost to Follow-up|0
7916379|NCT02119676|12437336|FG001|Overall Study|Lost to Follow-up|0
7916380|NCT02119676|12437337|FG002|Overall Study|Lost to Follow-up|1
7916381|NCT02119676|12437338|FG003|Overall Study|Lost to Follow-up|0
7916382|NCT02119676|12437335|FG000|Overall Study|Protocol deviation|0
7916383|NCT02119676|12437336|FG001|Overall Study|Protocol deviation|0
7916384|NCT02119676|12437337|FG002|Overall Study|Protocol deviation|1
7916385|NCT02119676|12437338|FG003|Overall Study|Protocol deviation|0
7916386|NCT02119676|12437335|FG000|Overall Study|Other, unspecified|2
7916387|NCT02119676|12437336|FG001|Overall Study|Other, unspecified|1
7916388|NCT02119676|12437337|FG002|Overall Study|Other, unspecified|3
7916389|NCT02119676|12437338|FG003|Overall Study|Other, unspecified|4
7916390|NCT02119676|12437335|FG000|Overall Study|Did not receive study med|2
7916391|NCT02119676|12437336|FG001|Overall Study|Did not receive study med|2
7916392|NCT02119676|12437337|FG002|Overall Study|Did not receive study med|4
7916393|NCT02119676|12437338|FG003|Overall Study|Did not receive study med|5
7916394|NCT02119819|12437354|FG000|Overall Study|Adverse Event|3
7916395|NCT02119819|12437355|FG001|Overall Study|Adverse Event|1
7916396|NCT02119819|12437356|FG002|Overall Study|Adverse Event|2
7916397|NCT02119819|12437357|FG003|Overall Study|Adverse Event|3
7916398|NCT02119819|12437358|FG004|Overall Study|Adverse Event|0
7916399|NCT02119819|12437359|FG005|Overall Study|Adverse Event|1
7916400|NCT02119819|12437354|FG000|Overall Study|Lack of Efficacy|0
7916401|NCT02119819|12437355|FG001|Overall Study|Lack of Efficacy|0
7916402|NCT02119819|12437356|FG002|Overall Study|Lack of Efficacy|0
7916403|NCT02119819|12437357|FG003|Overall Study|Lack of Efficacy|0
7916404|NCT02119819|12437358|FG004|Overall Study|Lack of Efficacy|0
7916405|NCT02119819|12437359|FG005|Overall Study|Lack of Efficacy|1
7916406|NCT02119819|12437354|FG000|Overall Study|Lost to Follow-up|0
7916407|NCT02119819|12437355|FG001|Overall Study|Lost to Follow-up|0
7916408|NCT02119819|12437356|FG002|Overall Study|Lost to Follow-up|1
7916409|NCT02119819|12437357|FG003|Overall Study|Lost to Follow-up|2
7916410|NCT02119819|12437358|FG004|Overall Study|Lost to Follow-up|1
7916411|NCT02119819|12437359|FG005|Overall Study|Lost to Follow-up|2
7916412|NCT02119819|12437354|FG000|Overall Study|Physician Decision|1
7916413|NCT02119819|12437355|FG001|Overall Study|Physician Decision|1
7916414|NCT02119819|12437356|FG002|Overall Study|Physician Decision|0
7916415|NCT02119819|12437357|FG003|Overall Study|Physician Decision|0
7916416|NCT02119819|12437358|FG004|Overall Study|Physician Decision|0
7916417|NCT02119819|12437359|FG005|Overall Study|Physician Decision|1
7916418|NCT02119819|12437354|FG000|Overall Study|Withdrawal by Subject|5
7916419|NCT02119819|12437355|FG001|Overall Study|Withdrawal by Subject|3
7916420|NCT02119819|12437356|FG002|Overall Study|Withdrawal by Subject|0
7916421|NCT02119819|12437357|FG003|Overall Study|Withdrawal by Subject|0
7916422|NCT02119819|12437358|FG004|Overall Study|Withdrawal by Subject|6
7916423|NCT02119819|12437359|FG005|Overall Study|Withdrawal by Subject|10
7916424|NCT02119819|12437354|FG000|Overall Study|Jury Duty|0
7916425|NCT02119819|12437355|FG001|Overall Study|Jury Duty|0
7916426|NCT02119819|12437356|FG002|Overall Study|Jury Duty|1
7916427|NCT02119819|12437357|FG003|Overall Study|Jury Duty|0
7916428|NCT02119819|12437358|FG004|Overall Study|Jury Duty|0
7916429|NCT02119819|12437359|FG005|Overall Study|Jury Duty|0
7916430|NCT02119819|12437354|FG000|Overall Study|Protocol Violation|0
7916431|NCT02119819|12437355|FG001|Overall Study|Protocol Violation|0
7916432|NCT02119819|12437356|FG002|Overall Study|Protocol Violation|0
7916433|NCT02119819|12437357|FG003|Overall Study|Protocol Violation|1
7916434|NCT02119819|12437358|FG004|Overall Study|Protocol Violation|0
7916435|NCT02119819|12437359|FG005|Overall Study|Protocol Violation|0
7916436|NCT02119819|12437354|FG000|Overall Study|Left the city to get a job|0
7916437|NCT02119819|12437355|FG001|Overall Study|Left the city to get a job|0
7916438|NCT02119819|12437356|FG002|Overall Study|Left the city to get a job|0
7916439|NCT02119819|12437357|FG003|Overall Study|Left the city to get a job|1
7916440|NCT02119819|12437358|FG004|Overall Study|Left the city to get a job|0
7916441|NCT02119819|12437359|FG005|Overall Study|Left the city to get a job|0
7916442|NCT02119936|12437382|FG000|Overall Study|Lost to Follow-up|10
7916443|NCT02120027|12437397|FG000|Overall Study|Adverse Event|4
7916444|NCT02120027|12437398|FG001|Overall Study|Adverse Event|5
7916445|NCT02120027|12437397|FG000|Overall Study|Lack of Efficacy|3
7916446|NCT02120027|12437398|FG001|Overall Study|Lack of Efficacy|5
7916447|NCT02120027|12437397|FG000|Overall Study|Lost to Follow-up|5
7916448|NCT02120027|12437398|FG001|Overall Study|Lost to Follow-up|13
7916449|NCT02120027|12437397|FG000|Overall Study|Other|4
7916450|NCT02120027|12437398|FG001|Overall Study|Other|0
7916451|NCT02120027|12437397|FG000|Overall Study|Physician Decision|4
7916452|NCT02120027|12437398|FG001|Overall Study|Physician Decision|3
7916453|NCT02120027|12437397|FG000|Overall Study|Protocol Violation|18
7916454|NCT02120027|12437398|FG001|Overall Study|Protocol Violation|21
7916455|NCT02120027|12437397|FG000|Overall Study|Study terminated by Sponsor|45
7916456|NCT02120027|12437398|FG001|Overall Study|Study terminated by Sponsor|47
7916457|NCT02120027|12437397|FG000|Overall Study|Withdrawal by Subject|33
7916458|NCT02120027|12437398|FG001|Overall Study|Withdrawal by Subject|25
7916459|NCT02120157|12437404|FG000|Overall Study|Death|8
7916460|NCT02120300|12437427|FG000|Overall Study|Enrolled but Never Treated|2
7916461|NCT02120300|12437428|FG001|Overall Study|Enrolled but Never Treated|0
7916462|NCT02120300|12437429|FG002|Overall Study|Enrolled but Never Treated|0
7916463|NCT02120300|12437430|FG003|Overall Study|Enrolled but Never Treated|0
7916464|NCT02120300|12437427|FG000|Overall Study|Lack of Efficacy|0
7916465|NCT02120300|12437428|FG001|Overall Study|Lack of Efficacy|0
7916466|NCT02120300|12437429|FG002|Overall Study|Lack of Efficacy|0
7916467|NCT02120300|12437430|FG003|Overall Study|Lack of Efficacy|1
7916468|NCT02120300|12437427|FG000|Overall Study|Lost to Follow-up|1
7916469|NCT02120300|12437428|FG001|Overall Study|Lost to Follow-up|0
7916470|NCT02120300|12437429|FG002|Overall Study|Lost to Follow-up|0
7916471|NCT02120300|12437430|FG003|Overall Study|Lost to Follow-up|0
7916472|NCT02120417|12437444|FG000|Overall Study|Death|5
7916473|NCT02120417|12437445|FG001|Overall Study|Death|1
7916474|NCT02120417|12437444|FG000|Overall Study|Adverse Event|3
7916475|NCT02120417|12437445|FG001|Overall Study|Adverse Event|9
7916476|NCT02120417|12437444|FG000|Overall Study|Participant decision|4
7916477|NCT02120417|12437445|FG001|Overall Study|Participant decision|4
7916478|NCT02120417|12437444|FG000|Overall Study|Disease progression|41
7916479|NCT02120417|12437445|FG001|Overall Study|Disease progression|45
7916480|NCT02120417|12437444|FG000|Overall Study|Noncompliance with study treatment|0
7916481|NCT02120417|12437445|FG001|Overall Study|Noncompliance with study treatment|2
7916482|NCT02120417|12437444|FG000|Overall Study|Physician Decision|2
7916483|NCT02120417|12437445|FG001|Overall Study|Physician Decision|3
7916484|NCT02120417|12437444|FG000|Overall Study|Other unspecified|5
7916485|NCT02120417|12437445|FG001|Overall Study|Other unspecified|4
7916486|NCT02120456|12437464|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0
7916487|NCT02120456|12437465|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0
7916488|NCT02120456|12437466|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0
7916489|NCT02120456|12437467|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0
7916490|NCT02120456|12437468|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0
7916491|NCT02120456|12437469|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0
7916492|NCT02120456|12437470|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1
7916493|NCT02120456|12437471|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0
7916494|NCT02120456|12437472|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0
7916495|NCT02120456|12437464|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0
7916496|NCT02120456|12437465|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0
7916497|NCT02120456|12437466|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0
7916498|NCT02120456|12437467|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0
7916499|NCT02120456|12437468|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0
7916500|NCT02120456|12437469|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0
7916501|NCT02120456|12437470|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1
7916502|NCT02120456|12437471|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0
7916503|NCT02120456|12437472|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0
7916504|NCT02120456|12437464|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7916505|NCT02120456|12437465|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7916506|NCT02120456|12437466|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7916507|NCT02120456|12437467|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7916508|NCT02120456|12437468|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7916509|NCT02120456|12437469|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7916510|NCT02120456|12437470|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7916511|NCT02120456|12437471|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7916512|NCT02120456|12437472|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1
7916513|NCT02120625|12437492|FG000|Overall Study|Physician Decision|2
7916514|NCT02120664|12437501|FG000|Overall Study|Withdrawal by Subject|0
7916515|NCT02120664|12437502|FG001|Overall Study|Withdrawal by Subject|0
7916516|NCT02120664|12437503|FG002|Overall Study|Withdrawal by Subject|0
7916517|NCT02120664|12437504|FG003|Overall Study|Withdrawal by Subject|1
7916518|NCT02120664|12437505|FG004|Overall Study|Withdrawal by Subject|0
7916519|NCT02120781|12437529|FG000|Overall Study|Physician Decision|2
7916520|NCT02120781|12437530|FG001|Overall Study|Physician Decision|0
7916521|NCT02120781|12437529|FG000|Overall Study|Completion not documented|2
7916522|NCT02120781|12437530|FG001|Overall Study|Completion not documented|1
7916523|NCT02120794|12437536|FG000|Overall Study|Withdrawal by Subject|43
7916524|NCT02120794|12437536|FG000|Overall Study|Adverse Event|10
7916525|NCT02120794|12437536|FG000|Overall Study|Physician Decision|4
7916526|NCT02120794|12437536|FG000|Overall Study|Due to insurance coverage|1
7916527|NCT02120833|12437542|FG000|Overall Study|Adverse Event|1
7916528|NCT02120833|12437543|FG001|Overall Study|Adverse Event|0
7916529|NCT02120833|12437542|FG000|Overall Study|Withdrawal by Subject|2
7916530|NCT02120833|12437543|FG001|Overall Study|Withdrawal by Subject|0
7916531|NCT02120833|12437542|FG000|Overall Study|Lost to Follow-up|1
7916532|NCT02120833|12437543|FG001|Overall Study|Lost to Follow-up|1
7916533|NCT02120898|12437552|FG000|Overall Study|Withdrawal by Subject|4
7916534|NCT02120898|12437553|FG001|Overall Study|Withdrawal by Subject|2
7916535|NCT02120898|12437554|FG002|Overall Study|Withdrawal by Subject|2
7916536|NCT02120898|12437552|FG000|Overall Study|Non-compliance with study drug|3
7916537|NCT02120898|12437553|FG001|Overall Study|Non-compliance with study drug|0
7916538|NCT02120898|12437554|FG002|Overall Study|Non-compliance with study drug|0
7916539|NCT02120898|12437552|FG000|Overall Study|Adverse Event|1
7916540|NCT02120898|12437553|FG001|Overall Study|Adverse Event|2
7916541|NCT02120898|12437554|FG002|Overall Study|Adverse Event|1
7916542|NCT02120898|12437552|FG000|Overall Study|Protocol Violation|1
7916543|NCT02120898|12437553|FG001|Overall Study|Protocol Violation|2
7916544|NCT02120898|12437554|FG002|Overall Study|Protocol Violation|0
7916545|NCT02120898|12437552|FG000|Overall Study|Lost to Follow-up|0
7916546|NCT02120898|12437553|FG001|Overall Study|Lost to Follow-up|0
7916547|NCT02120898|12437554|FG002|Overall Study|Lost to Follow-up|1
7916548|NCT02120924|12437565|FG000|Overall Study|Lack of Efficacy|1
7916549|NCT02120924|12437566|FG001|Overall Study|Lack of Efficacy|2
7916550|NCT02120924|12437567|FG002|Overall Study|Lack of Efficacy|3
7916551|NCT02120924|12437565|FG000|Overall Study|Adverse Event|0
7916552|NCT02120924|12437566|FG001|Overall Study|Adverse Event|1
7916553|NCT02120924|12437567|FG002|Overall Study|Adverse Event|3
7916554|NCT02120924|12437565|FG000|Overall Study|Withdrawal by Subject|16
7916555|NCT02120924|12437566|FG001|Overall Study|Withdrawal by Subject|20
7916556|NCT02120924|12437567|FG002|Overall Study|Withdrawal by Subject|8
7916557|NCT02120924|12437565|FG000|Overall Study|Lost to Follow-up|14
7916558|NCT02120924|12437566|FG001|Overall Study|Lost to Follow-up|14
7916559|NCT02120924|12437567|FG002|Overall Study|Lost to Follow-up|11
7916560|NCT02120924|12437565|FG000|Overall Study|Pregnancy|2
7916561|NCT02120924|12437566|FG001|Overall Study|Pregnancy|0
7916562|NCT02120924|12437567|FG002|Overall Study|Pregnancy|0
7916563|NCT02120924|12437565|FG000|Overall Study|Protocol Violation|3
7916564|NCT02120924|12437566|FG001|Overall Study|Protocol Violation|7
7916565|NCT02120924|12437567|FG002|Overall Study|Protocol Violation|2
7916566|NCT02120924|12437565|FG000|Overall Study|Physician Decision|0
7916567|NCT02120924|12437566|FG001|Overall Study|Physician Decision|1
7916568|NCT02120924|12437567|FG002|Overall Study|Physician Decision|1
7916569|NCT02120924|12437565|FG000|Overall Study|Death|1
7916570|NCT02120924|12437566|FG001|Overall Study|Death|0
7916571|NCT02120924|12437567|FG002|Overall Study|Death|0
7916572|NCT02120924|12437565|FG000|Overall Study|Compliance with IP|5
7916573|NCT02120924|12437566|FG001|Overall Study|Compliance with IP|1
7916574|NCT02120924|12437567|FG002|Overall Study|Compliance with IP|1
7916575|NCT02120950|12437578|FG000|Overall Study|Adverse Event|5
7916576|NCT02120950|12437579|FG001|Overall Study|Adverse Event|4
7916577|NCT02120950|12437580|FG002|Overall Study|Adverse Event|3
7916578|NCT02120950|12437578|FG000|Overall Study|Death|3
7916579|NCT02120950|12437579|FG001|Overall Study|Death|0
7916580|NCT02120950|12437580|FG002|Overall Study|Death|1
7916581|NCT02120950|12437578|FG000|Overall Study|Withdrawal by Subject|6
7916582|NCT02120950|12437579|FG001|Overall Study|Withdrawal by Subject|3
7916583|NCT02120950|12437580|FG002|Overall Study|Withdrawal by Subject|2
7916584|NCT02120950|12437578|FG000|Overall Study|Protocol Violation|1
7916585|NCT02120950|12437579|FG001|Overall Study|Protocol Violation|1
7916586|NCT02120950|12437580|FG002|Overall Study|Protocol Violation|7
7916587|NCT02120950|12437578|FG000|Overall Study|Other reasons|5
7916588|NCT02120950|12437579|FG001|Overall Study|Other reasons|4
7916589|NCT02120950|12437580|FG002|Overall Study|Other reasons|1
7916590|NCT02120950|12437578|FG000|Overall Study|Lost to Follow-up|0
7916591|NCT02120950|12437579|FG001|Overall Study|Lost to Follow-up|2
7916592|NCT02120950|12437580|FG002|Overall Study|Lost to Follow-up|1
7916593|NCT02121002|12437590|FG000|Overall Study|Physician Decision|2
7916594|NCT02121002|12437591|FG001|Overall Study|Physician Decision|0
7916595|NCT02121002|12437592|FG002|Overall Study|Physician Decision|0
7916596|NCT02121002|12437590|FG000|Overall Study|Withdrawal by Subject|3
7916597|NCT02121002|12437591|FG001|Overall Study|Withdrawal by Subject|1
7916598|NCT02121002|12437592|FG002|Overall Study|Withdrawal by Subject|4
7916599|NCT02121002|12437590|FG000|Overall Study|Protocol Violation|1
7916600|NCT02121002|12437591|FG001|Overall Study|Protocol Violation|2
7916601|NCT02121002|12437592|FG002|Overall Study|Protocol Violation|4
7916602|NCT02121002|12437590|FG000|Overall Study|Concomitant therapy|0
7916603|NCT02121002|12437591|FG001|Overall Study|Concomitant therapy|1
7916604|NCT02121002|12437592|FG002|Overall Study|Concomitant therapy|1
7916605|NCT02121002|12437590|FG000|Overall Study|Others|1
7916606|NCT02121002|12437591|FG001|Overall Study|Others|0
7916607|NCT02121002|12437592|FG002|Overall Study|Others|1
7916608|NCT02121210|12437616|FG000|Overall Study|Adverse Event|5
7916609|NCT02121210|12437617|FG001|Overall Study|Adverse Event|7
7916610|NCT02121210|12437616|FG000|Overall Study|Lack of Efficacy|2
7916611|NCT02121210|12437617|FG001|Overall Study|Lack of Efficacy|0
7916612|NCT02121210|12437616|FG000|Overall Study|Other than specified above|0
7916613|NCT02121210|12437617|FG001|Overall Study|Other than specified above|2
7916614|NCT02121262|12437625|FG000|Overall Study|Adverse Event|6
7916615|NCT02121262|12437626|FG001|Overall Study|Adverse Event|3
7916616|NCT02121262|12437625|FG000|Overall Study|Lack of Efficacy|3
7916617|NCT02121262|12437626|FG001|Overall Study|Lack of Efficacy|0
7916618|NCT02121262|12437625|FG000|Overall Study|Personal Reasons|19
7916619|NCT02121262|12437626|FG001|Overall Study|Personal Reasons|5
7916620|NCT02121262|12437625|FG000|Overall Study|Protocol Violation|1
7916621|NCT02121262|12437626|FG001|Overall Study|Protocol Violation|1
7916622|NCT02121262|12437625|FG000|Overall Study|Participant Dropped-out|0
7916623|NCT02121262|12437626|FG001|Overall Study|Participant Dropped-out|1
7916624|NCT02121262|12437625|FG000|Overall Study|Participant was Deemed Unsuitable|1
7916625|NCT02121262|12437626|FG001|Overall Study|Participant was Deemed Unsuitable|0
7916626|NCT02121262|12437625|FG000|Overall Study|Consent Withdrawn|1
7916627|NCT02121262|12437626|FG001|Overall Study|Consent Withdrawn|0
7916628|NCT02121301|12437635|FG000|Overall Study|Protocol Violation|1
7916629|NCT02121301|12437636|FG001|Overall Study|Protocol Violation|4
7916630|NCT02121301|12437637|FG002|Overall Study|Protocol Violation|1
7916631|NCT02121392|12437647|FG000|Prior to Intervention|Protocol Violation|40
7916632|NCT02121392|12437648|FG001|Prior to Intervention|Protocol Violation|35
7916633|NCT02121392|12437647|FG000|Prior to Intervention|Withdrawal by Subject|8
7916634|NCT02121392|12437648|FG001|Prior to Intervention|Withdrawal by Subject|6
7916635|NCT02121392|12437647|FG000|After Placement of AC Block vs Sham|Protocol Violation|3
7916636|NCT02121392|12437648|FG001|After Placement of AC Block vs Sham|Protocol Violation|2
7916637|NCT02121392|12437647|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0
7916638|NCT02121392|12437648|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1
7916639|NCT02121509|12437673|FG000|Washout Period (35 Days)|Adverse Event|1
7916640|NCT02121509|12437674|FG001|Washout Period (35 Days)|Adverse Event|1
7916641|NCT02121509|12437675|FG002|Washout Period (35 Days)|Adverse Event|0
7916642|NCT02121509|12437676|FG003|Washout Period (35 Days)|Adverse Event|0
7916643|NCT02121509|12437673|FG000|Washout Period (35 Days)|Withdrawal by Subject|0
7916644|NCT02121509|12437674|FG001|Washout Period (35 Days)|Withdrawal by Subject|3
7916645|NCT02121509|12437675|FG002|Washout Period (35 Days)|Withdrawal by Subject|0
7916646|NCT02121509|12437676|FG003|Washout Period (35 Days)|Withdrawal by Subject|0
7916647|NCT02121509|12437673|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1
7916648|NCT02121509|12437674|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0
7916649|NCT02121509|12437675|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0
7916650|NCT02121509|12437676|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0
7916651|NCT02121522|12437686|FG000|Overall Study|Adverse Event|1
7916652|NCT02121535|12437692|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0
7916653|NCT02121535|12437693|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1
7916654|NCT02121535|12437692|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1
7916655|NCT02121535|12437693|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0
7916656|NCT02121756|12437702|FG000|Overall Study|Adverse Event|3
7916657|NCT02121756|12437703|FG001|Overall Study|Adverse Event|0
7916658|NCT02121756|12437702|FG000|Overall Study|Protocol Violation|1
7916659|NCT02121756|12437703|FG001|Overall Study|Protocol Violation|1
7916660|NCT02121756|12437702|FG000|Overall Study|Physician Decision|2
7916661|NCT02121756|12437703|FG001|Overall Study|Physician Decision|1
7916662|NCT02121795|12437714|FG000|Double-Blind Phase|Randomized but Never Treated|1
7916663|NCT02121795|12437715|FG001|Double-Blind Phase|Randomized but Never Treated|4
7916664|NCT02121795|12437714|FG000|Double-Blind Phase|Withdrawal by Subject|19
7916665|NCT02121795|12437715|FG001|Double-Blind Phase|Withdrawal by Subject|16
7916666|NCT02121795|12437714|FG000|Double-Blind Phase|Lost to Follow-up|7
7916667|NCT02121795|12437715|FG001|Double-Blind Phase|Lost to Follow-up|4
7916668|NCT02121795|12437714|FG000|Double-Blind Phase|Physician Decision|2
7916669|NCT02121795|12437715|FG001|Double-Blind Phase|Physician Decision|5
7916670|NCT02121795|12437714|FG000|Double-Blind Phase|Adverse Event|5
7916671|NCT02121795|12437715|FG001|Double-Blind Phase|Adverse Event|0
7916672|NCT02121795|12437714|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3
7916673|NCT02121795|12437715|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
7916674|NCT02121795|12437714|FG000|Double-Blind Phase|Protocol Violation|0
7916675|NCT02121795|12437715|FG001|Double-Blind Phase|Protocol Violation|3
7916676|NCT02121795|12437714|FG000|Double-Blind Phase|Death|1
7916677|NCT02121795|12437715|FG001|Double-Blind Phase|Death|1
7916678|NCT02121795|12437714|FG000|Open-Label Phase|Physician Decision|8
7916679|NCT02121795|12437715|FG001|Open-Label Phase|Physician Decision|8
7916680|NCT02121795|12437714|FG000|Open-Label Phase|Withdrawal by Subject|3
7916681|NCT02121795|12437715|FG001|Open-Label Phase|Withdrawal by Subject|2
7916682|NCT02121795|12437714|FG000|Open-Label Phase|Lost to Follow-up|1
7916683|NCT02121795|12437715|FG001|Open-Label Phase|Lost to Follow-up|0
7916684|NCT02121808|12437723|FG000|Overall Study|Technical problem|3
7916685|NCT02121834|12437739|FG000|Overall Study|Protocol Violation|0
7916686|NCT02121834|12437740|FG001|Overall Study|Protocol Violation|1
7916687|NCT02121834|12437741|FG002|Overall Study|Protocol Violation|0
7916688|NCT02121834|12437742|FG003|Overall Study|Protocol Violation|0
7916689|NCT02121834|12437743|FG004|Overall Study|Protocol Violation|0
7916690|NCT02121834|12437744|FG005|Overall Study|Protocol Violation|0
7916691|NCT02121834|12437745|FG006|Overall Study|Protocol Violation|0
7916692|NCT02121834|12437739|FG000|Overall Study|Withdrawal by Subject|0
7916693|NCT02121834|12437740|FG001|Overall Study|Withdrawal by Subject|1
7916694|NCT02121834|12437741|FG002|Overall Study|Withdrawal by Subject|1
7916695|NCT02121834|12437742|FG003|Overall Study|Withdrawal by Subject|0
7916696|NCT02121834|12437743|FG004|Overall Study|Withdrawal by Subject|0
7916697|NCT02121834|12437744|FG005|Overall Study|Withdrawal by Subject|0
7916698|NCT02121834|12437745|FG006|Overall Study|Withdrawal by Subject|0
7916699|NCT02121834|12437739|FG000|Overall Study|Lost to Follow-up|0
7916700|NCT02121834|12437740|FG001|Overall Study|Lost to Follow-up|0
7916701|NCT02121834|12437741|FG002|Overall Study|Lost to Follow-up|1
7916702|NCT02121834|12437742|FG003|Overall Study|Lost to Follow-up|0
7916703|NCT02121834|12437743|FG004|Overall Study|Lost to Follow-up|0
7916704|NCT02121834|12437744|FG005|Overall Study|Lost to Follow-up|0
7916705|NCT02121834|12437745|FG006|Overall Study|Lost to Follow-up|0
7916706|NCT02121847|12437771|FG000|Overall Study|Administrative Reasons|1
7916707|NCT02121847|12437771|FG000|Overall Study|Adverse Event|2
7916708|NCT02122146|12437806|FG000|Part 1: Dose Escalation|Death|0
7916709|NCT02122146|12437807|FG001|Part 1: Dose Escalation|Death|1
7916710|NCT02122146|12437808|FG002|Part 1: Dose Escalation|Death|1
7916711|NCT02122146|12437809|FG003|Part 1: Dose Escalation|Death|0
7916712|NCT02122146|12437810|FG004|Part 1: Dose Escalation|Death|0
7916713|NCT02122146|12437811|FG005|Part 1: Dose Escalation|Death|0
7916714|NCT02122146|12437812|FG006|Part 1: Dose Escalation|Death|0
7916715|NCT02122146|12437813|FG007|Part 1: Dose Escalation|Death|0
7916716|NCT02122146|12437806|FG000|Part 1: Dose Escalation|Lost to Follow-up|0
7916717|NCT02122146|12437807|FG001|Part 1: Dose Escalation|Lost to Follow-up|0
7916718|NCT02122146|12437808|FG002|Part 1: Dose Escalation|Lost to Follow-up|1
7916719|NCT02122146|12437809|FG003|Part 1: Dose Escalation|Lost to Follow-up|0
7916720|NCT02122146|12437810|FG004|Part 1: Dose Escalation|Lost to Follow-up|1
7916721|NCT02122146|12437811|FG005|Part 1: Dose Escalation|Lost to Follow-up|0
7916722|NCT02122146|12437812|FG006|Part 1: Dose Escalation|Lost to Follow-up|0
7916723|NCT02122146|12437813|FG007|Part 1: Dose Escalation|Lost to Follow-up|0
7916724|NCT02122146|12437806|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0
7916725|NCT02122146|12437807|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0
7916726|NCT02122146|12437808|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0
7916727|NCT02122146|12437809|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1
7916728|NCT02122146|12437810|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0
7916729|NCT02122146|12437811|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0
7916730|NCT02122146|12437812|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0
7916731|NCT02122146|12437813|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0
7916732|NCT02122146|12437806|FG000|Part 1: Dose Escalation|Other|1
7916733|NCT02122146|12437807|FG001|Part 1: Dose Escalation|Other|0
7916734|NCT02122146|12437808|FG002|Part 1: Dose Escalation|Other|0
7916735|NCT02122146|12437809|FG003|Part 1: Dose Escalation|Other|0
7916736|NCT02122146|12437810|FG004|Part 1: Dose Escalation|Other|0
7916737|NCT02122146|12437811|FG005|Part 1: Dose Escalation|Other|1
7916738|NCT02122146|12437812|FG006|Part 1: Dose Escalation|Other|1
7916739|NCT02122146|12437813|FG007|Part 1: Dose Escalation|Other|2
7916740|NCT02122380|12437843|FG000|First Intervention (30 Days)|Adverse Event|1
7916741|NCT02122380|12437844|FG001|First Intervention (30 Days)|Adverse Event|0
7916742|NCT02122380|12437843|FG000|First Intervention (30 Days)|Physician Decision|0
7916743|NCT02122380|12437844|FG001|First Intervention (30 Days)|Physician Decision|1
7916744|NCT02122380|12437843|FG000|Washout (8 Weeks)|Lost to Follow-up|1
7916745|NCT02122380|12437844|FG001|Washout (8 Weeks)|Lost to Follow-up|0
7916746|NCT02122380|12437843|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0
7916747|NCT02122380|12437844|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2
7916748|NCT02122380|12437843|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0
7916749|NCT02122380|12437844|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2
7916750|NCT02122770|12437881|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3
7916751|NCT02122770|12437882|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0
7916752|NCT02122770|12437883|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1
7916753|NCT02122770|12437884|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2
7916754|NCT02122770|12437885|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0
7916755|NCT02122770|12437886|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0
7916756|NCT02122770|12437881|FG000|Part A: Drug-drug Interaction 2|Other|0
7916757|NCT02122770|12437882|FG001|Part A: Drug-drug Interaction 2|Other|0
7916758|NCT02122770|12437883|FG002|Part A: Drug-drug Interaction 2|Other|1
7916759|NCT02122770|12437884|FG003|Part A: Drug-drug Interaction 2|Other|0
7916760|NCT02122770|12437885|FG004|Part A: Drug-drug Interaction 2|Other|0
7916761|NCT02122770|12437886|FG005|Part A: Drug-drug Interaction 2|Other|0
7916762|NCT02122770|12437881|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7916763|NCT02122770|12437882|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1
7916764|NCT02122770|12437883|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7916765|NCT02122770|12437884|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7916766|NCT02122770|12437885|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7916767|NCT02122770|12437886|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7916768|NCT02122770|12437881|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
7916769|NCT02122770|12437882|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5
7916770|NCT02122770|12437883|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
7916771|NCT02122770|12437884|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
7916772|NCT02122770|12437885|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
7916773|NCT02122770|12437886|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
7916774|NCT02122770|12437881|FG000|Part B: Standard of Care|Adverse Event|0
7916775|NCT02122770|12437882|FG001|Part B: Standard of Care|Adverse Event|0
7916776|NCT02122770|12437883|FG002|Part B: Standard of Care|Adverse Event|0
7916777|NCT02122770|12437884|FG003|Part B: Standard of Care|Adverse Event|0
7916778|NCT02122770|12437885|FG004|Part B: Standard of Care|Adverse Event|4
7916779|NCT02122770|12437886|FG005|Part B: Standard of Care|Adverse Event|1
7916780|NCT02122770|12437881|FG000|Part B: Standard of Care|Other|0
7916781|NCT02122770|12437882|FG001|Part B: Standard of Care|Other|0
7916782|NCT02122770|12437883|FG002|Part B: Standard of Care|Other|0
7916783|NCT02122770|12437884|FG003|Part B: Standard of Care|Other|0
7916784|NCT02122770|12437885|FG004|Part B: Standard of Care|Other|0
7916785|NCT02122770|12437886|FG005|Part B: Standard of Care|Other|2
7916786|NCT02122770|12437881|FG000|Part B: Standard of Care|Withdrawal by Subject|0
7916787|NCT02122770|12437882|FG001|Part B: Standard of Care|Withdrawal by Subject|0
7916788|NCT02122770|12437883|FG002|Part B: Standard of Care|Withdrawal by Subject|0
7916789|NCT02122770|12437884|FG003|Part B: Standard of Care|Withdrawal by Subject|0
7916790|NCT02122770|12437885|FG004|Part B: Standard of Care|Withdrawal by Subject|4
7916791|NCT02122770|12437886|FG005|Part B: Standard of Care|Withdrawal by Subject|2
7916792|NCT02122770|12437881|FG000|Part B: Standard of Care|Symptomatic Deterioration|0
7916793|NCT02122770|12437882|FG001|Part B: Standard of Care|Symptomatic Deterioration|0
7916794|NCT02122770|12437883|FG002|Part B: Standard of Care|Symptomatic Deterioration|0
7916795|NCT02122770|12437884|FG003|Part B: Standard of Care|Symptomatic Deterioration|0
7916796|NCT02122770|12437885|FG004|Part B: Standard of Care|Symptomatic Deterioration|5
7916797|NCT02122770|12437886|FG005|Part B: Standard of Care|Symptomatic Deterioration|0
7916798|NCT02122770|12437881|FG000|Part B: Standard of Care|Progressive Disease|0
7916799|NCT02122770|12437882|FG001|Part B: Standard of Care|Progressive Disease|0
7916800|NCT02122770|12437883|FG002|Part B: Standard of Care|Progressive Disease|0
7916801|NCT02122770|12437884|FG003|Part B: Standard of Care|Progressive Disease|0
7916802|NCT02122770|12437885|FG004|Part B: Standard of Care|Progressive Disease|10
7916803|NCT02122770|12437886|FG005|Part B: Standard of Care|Progressive Disease|8
7916804|NCT02122783|12437911|FG000|Overall Study|Adverse Event|0
7916805|NCT02122783|12437912|FG001|Overall Study|Adverse Event|1
7916806|NCT02122887|12437933|FG000|Overall Study|Withdrawal by Subject|20
7916807|NCT02122887|12437934|FG001|Overall Study|Withdrawal by Subject|2
7916808|NCT02123134|12437955|FG000|Overall Study|Withdrawal of consent|3
7916809|NCT02123134|12437956|FG001|Overall Study|Withdrawal of consent|2
7916810|NCT02123134|12437955|FG000|Overall Study|Administrative decision|0
7916811|NCT02123134|12437956|FG001|Overall Study|Administrative decision|1
7916812|NCT02123251|12437964|FG000|Overall Study|Death|1
7916813|NCT02123251|12437965|FG001|Overall Study|Death|1
7916814|NCT02123251|12437964|FG000|Overall Study|Withdrawal by Subject|0
7916815|NCT02123251|12437965|FG001|Overall Study|Withdrawal by Subject|3
7916816|NCT02123251|12437964|FG000|Overall Study|Lost Medicaid eligibility|29
7916817|NCT02123251|12437965|FG001|Overall Study|Lost Medicaid eligibility|22
7916818|NCT02123251|12437964|FG000|Overall Study|Switched Managed Care Organization (MCO)|4
7916819|NCT02123251|12437965|FG001|Overall Study|Switched Managed Care Organization (MCO)|4
7916820|NCT02123446|12437981|FG000|Washout Period (1 Day)|Physician Decision|1
7916821|NCT02123446|12437982|FG001|Washout Period (1 Day)|Physician Decision|0
7916822|NCT02123459|12437988|FG000|Washout Period (1 Day)|Adverse Event|1
7916823|NCT02123459|12437989|FG001|Washout Period (1 Day)|Adverse Event|0
7916824|NCT02123472|12437995|FG000|Period 2 (7 Days)|Withdrawal by Subject|0
7916825|NCT02123472|12437996|FG001|Period 2 (7 Days)|Withdrawal by Subject|1
7916826|NCT02123511|12438013|FG000|Overall Study|Cancelled treatment|1
7916827|NCT02123511|12438014|FG001|Overall Study|Cancelled treatment|0
7916828|NCT02123511|12438013|FG000|Overall Study|Incomplete data|1
7916829|NCT02123511|12438014|FG001|Overall Study|Incomplete data|3
7916830|NCT02123511|12438013|FG000|Overall Study|Ineligible|0
7916831|NCT02123511|12438014|FG001|Overall Study|Ineligible|1
7916832|NCT02123576|12438022|FG000|Overall Study|Adverse Event|1
7916833|NCT02123576|12438023|FG001|Overall Study|Adverse Event|0
7916834|NCT02123797|12438035|FG000|Baseline Intervention|Death|9
7916835|NCT02123797|12438036|FG001|Baseline Intervention|Death|16
7916836|NCT02123797|12438037|FG002|Baseline Intervention|Death|0
7916837|NCT02123797|12438038|FG003|Baseline Intervention|Death|0
7916838|NCT02123797|12438039|FG004|Baseline Intervention|Death|0
7916839|NCT02123797|12438035|FG000|Baseline Intervention|Withdrawal by Subject|2
7916840|NCT02123797|12438036|FG001|Baseline Intervention|Withdrawal by Subject|8
7916841|NCT02123797|12438037|FG002|Baseline Intervention|Withdrawal by Subject|0
7916842|NCT02123797|12438038|FG003|Baseline Intervention|Withdrawal by Subject|0
7916843|NCT02123797|12438039|FG004|Baseline Intervention|Withdrawal by Subject|0
7916844|NCT02123797|12438035|FG000|Baseline Intervention|Relocation|2
7916845|NCT02123797|12438036|FG001|Baseline Intervention|Relocation|0
7916846|NCT02123797|12438037|FG002|Baseline Intervention|Relocation|0
7916847|NCT02123797|12438038|FG003|Baseline Intervention|Relocation|0
7916848|NCT02123797|12438039|FG004|Baseline Intervention|Relocation|0
7916849|NCT02123797|12438035|FG000|Baseline Intervention|Out of window for initial survey|6
7916850|NCT02123797|12438036|FG001|Baseline Intervention|Out of window for initial survey|13
7916851|NCT02123797|12438037|FG002|Baseline Intervention|Out of window for initial survey|0
7916852|NCT02123797|12438038|FG003|Baseline Intervention|Out of window for initial survey|0
7916853|NCT02123797|12438039|FG004|Baseline Intervention|Out of window for initial survey|0
7916854|NCT02123797|12438035|FG000|Baseline Intervention|Lost to Follow-up|0
7916855|NCT02123797|12438036|FG001|Baseline Intervention|Lost to Follow-up|5
7916856|NCT02123797|12438037|FG002|Baseline Intervention|Lost to Follow-up|0
7916857|NCT02123797|12438038|FG003|Baseline Intervention|Lost to Follow-up|0
7916858|NCT02123797|12438039|FG004|Baseline Intervention|Lost to Follow-up|0
7916859|NCT02123797|12438035|FG000|Baseline Intervention|Other Disease|3
7916860|NCT02123797|12438036|FG001|Baseline Intervention|Other Disease|0
7916861|NCT02123797|12438037|FG002|Baseline Intervention|Other Disease|0
7916862|NCT02123797|12438038|FG003|Baseline Intervention|Other Disease|0
7916863|NCT02123797|12438039|FG004|Baseline Intervention|Other Disease|0
7916864|NCT02123797|12438035|FG000|3-month Follow up (Cumulative Counts)|Death|33
7916865|NCT02123797|12438036|FG001|3-month Follow up (Cumulative Counts)|Death|57
7916866|NCT02123797|12438037|FG002|3-month Follow up (Cumulative Counts)|Death|0
7916867|NCT02123797|12438038|FG003|3-month Follow up (Cumulative Counts)|Death|0
7916868|NCT02123797|12438039|FG004|3-month Follow up (Cumulative Counts)|Death|0
7916869|NCT02123797|12438035|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2
7916870|NCT02123797|12438036|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7
7916871|NCT02123797|12438037|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50
7916872|NCT02123797|12438038|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82
7916873|NCT02123797|12438039|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3
7916874|NCT02123797|12438035|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6
7916875|NCT02123797|12438036|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16
7916876|NCT02123797|12438037|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7916877|NCT02123797|12438038|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7916878|NCT02123797|12438039|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7916879|NCT02123797|12438035|FG000|3-month Follow up (Cumulative Counts)|Relocation|0
7916880|NCT02123797|12438036|FG001|3-month Follow up (Cumulative Counts)|Relocation|1
7916881|NCT02123797|12438037|FG002|3-month Follow up (Cumulative Counts)|Relocation|0
7916882|NCT02123797|12438038|FG003|3-month Follow up (Cumulative Counts)|Relocation|0
7916883|NCT02123797|12438039|FG004|3-month Follow up (Cumulative Counts)|Relocation|0
7916884|NCT02123797|12438035|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16
7916885|NCT02123797|12438036|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36
7916886|NCT02123797|12438037|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
7916887|NCT02123797|12438038|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
7916888|NCT02123797|12438039|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
7916889|NCT02123797|12438035|FG000|6-month Follow up (Cumulative Counts)|Death|51
7916890|NCT02123797|12438036|FG001|6-month Follow up (Cumulative Counts)|Death|97
7916891|NCT02123797|12438037|FG002|6-month Follow up (Cumulative Counts)|Death|0
7916892|NCT02123797|12438038|FG003|6-month Follow up (Cumulative Counts)|Death|0
7916893|NCT02123797|12438039|FG004|6-month Follow up (Cumulative Counts)|Death|0
7916894|NCT02123797|12438035|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
7916895|NCT02123797|12438036|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20
7916896|NCT02123797|12438037|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66
7916897|NCT02123797|12438038|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113
7916898|NCT02123797|12438039|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
7916899|NCT02123797|12438035|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1
7916900|NCT02123797|12438036|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9
7916901|NCT02123797|12438037|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7916902|NCT02123797|12438038|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7916903|NCT02123797|12438039|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7916904|NCT02123797|12438035|FG000|6-month Follow up (Cumulative Counts)|Relocation|0
7916905|NCT02123797|12438036|FG001|6-month Follow up (Cumulative Counts)|Relocation|2
7916906|NCT02123797|12438037|FG002|6-month Follow up (Cumulative Counts)|Relocation|0
7916907|NCT02123797|12438038|FG003|6-month Follow up (Cumulative Counts)|Relocation|0
7916908|NCT02123797|12438039|FG004|6-month Follow up (Cumulative Counts)|Relocation|0
7916909|NCT02123966|12438070|FG000|Overall Study|Intercurrent Illness|1
7916910|NCT02124161|12438114|FG000|Overall Study|Other unspecified|0
7916911|NCT02124161|12438115|FG001|Overall Study|Other unspecified|1
7916912|NCT02124161|12438114|FG000|Overall Study|Death|1
7916913|NCT02124161|12438115|FG001|Overall Study|Death|0
7916914|NCT02124161|12438114|FG000|Overall Study|Protocol Violation|2
7916915|NCT02124161|12438115|FG001|Overall Study|Protocol Violation|1
7916916|NCT02124161|12438114|FG000|Overall Study|Withdrawal by Subject|1
7916917|NCT02124161|12438115|FG001|Overall Study|Withdrawal by Subject|2
7916918|NCT02124161|12438114|FG000|Overall Study|Adverse Event|2
7916919|NCT02124161|12438115|FG001|Overall Study|Adverse Event|0
7916920|NCT02124161|12438114|FG000|Overall Study|Does not meet entrance criteria|2
7916921|NCT02124161|12438115|FG001|Overall Study|Does not meet entrance criteria|3
7916922|NCT02124161|12438114|FG000|Overall Study|No longer meets eligibility criteria|5
7821173|NCT01253421|12289762|FG002|Assessment and Scheduling|Lost to Follow-up|0
7821174|NCT01253421|12289763|FG003|Assessment and Scheduling|Lost to Follow-up|0
7821175|NCT01253421|12289764|FG004|Assessment and Scheduling|Lost to Follow-up|0
7821176|NCT01253421|12289760|FG000|Assessment and Scheduling|Withdrawal by Subject|7
7821177|NCT01253421|12289761|FG001|Assessment and Scheduling|Withdrawal by Subject|0
7821178|NCT01253421|12289762|FG002|Assessment and Scheduling|Withdrawal by Subject|0
7821179|NCT01253421|12289763|FG003|Assessment and Scheduling|Withdrawal by Subject|0
7821180|NCT01253421|12289764|FG004|Assessment and Scheduling|Withdrawal by Subject|0
7821181|NCT01253421|12289760|FG000|Assessment and Scheduling|Physician Decision|1
7821182|NCT01253421|12289761|FG001|Assessment and Scheduling|Physician Decision|0
7821183|NCT01253421|12289762|FG002|Assessment and Scheduling|Physician Decision|0
7821184|NCT01253421|12289763|FG003|Assessment and Scheduling|Physician Decision|0
7821185|NCT01253421|12289764|FG004|Assessment and Scheduling|Physician Decision|0
7821186|NCT01253421|12289760|FG000|Drug+Scanning Visit|Physician Decision|0
7821187|NCT01253421|12289761|FG001|Drug+Scanning Visit|Physician Decision|0
7821188|NCT01253421|12289762|FG002|Drug+Scanning Visit|Physician Decision|0
7821189|NCT01253421|12289763|FG003|Drug+Scanning Visit|Physician Decision|0
7821190|NCT01253421|12289764|FG004|Drug+Scanning Visit|Physician Decision|1
7821191|NCT01253447|12289774|FG000|Overall Study|Adverse Event|2
7821192|NCT01253564|12289787|FG000|Overall Study|Disease Progression|22
7916923|NCT02124161|12438115|FG001|Overall Study|No longer meets eligibility criteria|4
7916924|NCT02124161|12438114|FG000|Overall Study|Lost to Follow-up|3
7916925|NCT02124161|12438115|FG001|Overall Study|Lost to Follow-up|4
7916926|NCT02124265|12438128|FG000|Overall Study|Adverse Event|1
7916927|NCT02124564|12438160|FG000|Treatment Period|Adverse Event|2
7821193|NCT01253564|12289787|FG000|Overall Study|Withdrawal by Subject|1
7821194|NCT01253564|12289787|FG000|Overall Study|Serious Adverse Event|1
7821195|NCT01253577|12289791|FG000|Overall Study|Lost to Follow-up|3
7821196|NCT01253811|12289802|FG000|Overall Study|Withdrawal criteria|1
7821197|NCT01254019|12289839|FG000|Overall Study|Adverse Event|0
7821198|NCT01254019|12289840|FG001|Overall Study|Adverse Event|2
7821199|NCT01254019|12289839|FG000|Overall Study|Protocol Violation|1
7821200|NCT01254019|12289840|FG001|Overall Study|Protocol Violation|0
7821201|NCT01254019|12289839|FG000|Overall Study|Withdrawal by Subject|0
7821202|NCT01254019|12289840|FG001|Overall Study|Withdrawal by Subject|2
7821203|NCT01254045|12289849|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
7821204|NCT01254045|12289850|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
7821205|NCT01254045|12289851|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
7821206|NCT01254045|12289852|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
7821207|NCT01254045|12289853|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
7916928|NCT02124564|12438160|FG000|Treatment Period|Lack of Efficacy|3
7916929|NCT02124564|12438160|FG000|Treatment Period|Withdrawal by Subject|2
7916930|NCT02124707|12438170|FG000|Overall Study|Adverse Event|5
7916931|NCT02124707|12438170|FG000|Overall Study|Physician Decision|1
7916932|NCT02124707|12438170|FG000|Overall Study|Death|1
7916933|NCT02124746|12438178|FG000|Overall Study|Adverse Event|2
7916934|NCT02124746|12438179|FG001|Overall Study|Adverse Event|1
7916935|NCT02124746|12438180|FG002|Overall Study|Adverse Event|2
7916936|NCT02124746|12438178|FG000|Overall Study|Death|2
7916937|NCT02124746|12438179|FG001|Overall Study|Death|1
7916938|NCT02124746|12438180|FG002|Overall Study|Death|3
7916939|NCT02124746|12438178|FG000|Overall Study|Lack of Efficacy|3
7916940|NCT02124746|12438179|FG001|Overall Study|Lack of Efficacy|2
7916941|NCT02124746|12438180|FG002|Overall Study|Lack of Efficacy|2
7916942|NCT02124746|12438178|FG000|Overall Study|Physician Decision|6
7916943|NCT02124746|12438179|FG001|Overall Study|Physician Decision|4
7916944|NCT02124746|12438180|FG002|Overall Study|Physician Decision|5
7916945|NCT02124746|12438178|FG000|Overall Study|Non-Compliance with Study Drug|0
7916946|NCT02124746|12438179|FG001|Overall Study|Non-Compliance with Study Drug|1
7916947|NCT02124746|12438180|FG002|Overall Study|Non-Compliance with Study Drug|0
7916948|NCT02124746|12438178|FG000|Overall Study|Withdrawal by Subject|3
7916949|NCT02124746|12438179|FG001|Overall Study|Withdrawal by Subject|3
7916950|NCT02124746|12438180|FG002|Overall Study|Withdrawal by Subject|0
7916951|NCT02124746|12438178|FG000|Overall Study|Study Terminated by Sponsor|0
7916952|NCT02124746|12438179|FG001|Overall Study|Study Terminated by Sponsor|0
7916953|NCT02124746|12438180|FG002|Overall Study|Study Terminated by Sponsor|6
7916954|NCT02124746|12438178|FG000|Overall Study|Disease Progression|3
7916955|NCT02124746|12438179|FG001|Overall Study|Disease Progression|6
7916956|NCT02124746|12438180|FG002|Overall Study|Disease Progression|4
7916957|NCT02124759|12438191|FG000|Overall Study|Withdrawal by Subject|3
7916958|NCT02124759|12438192|FG001|Overall Study|Withdrawal by Subject|1
7916959|NCT02124759|12438193|FG002|Overall Study|Withdrawal by Subject|1
7916960|NCT02124759|12438191|FG000|Overall Study|Screen Fail|2
7916961|NCT02124759|12438192|FG001|Overall Study|Screen Fail|2
7916962|NCT02124759|12438193|FG002|Overall Study|Screen Fail|3
7916963|NCT02124772|12438219|FG000|Overall Study|Lack of Efficacy|2
7916964|NCT02124772|12438220|FG001|Overall Study|Lack of Efficacy|0
7916965|NCT02124772|12438221|FG002|Overall Study|Lack of Efficacy|0
7916966|NCT02124772|12438222|FG003|Overall Study|Lack of Efficacy|1
7916967|NCT02124772|12438223|FG004|Overall Study|Lack of Efficacy|2
7916968|NCT02124772|12438224|FG005|Overall Study|Lack of Efficacy|3
7916969|NCT02124772|12438225|FG006|Overall Study|Lack of Efficacy|0
7916970|NCT02124772|12438226|FG007|Overall Study|Lack of Efficacy|2
7916971|NCT02124772|12438227|FG008|Overall Study|Lack of Efficacy|0
7916972|NCT02124772|12438228|FG009|Overall Study|Lack of Efficacy|1
7916973|NCT02124772|12438229|FG010|Overall Study|Lack of Efficacy|0
7916974|NCT02124772|12438230|FG011|Overall Study|Lack of Efficacy|0
7916975|NCT02124772|12438231|FG012|Overall Study|Lack of Efficacy|1
7916976|NCT02124772|12438219|FG000|Overall Study|Adverse Event|1
7916977|NCT02124772|12438220|FG001|Overall Study|Adverse Event|4
7916978|NCT02124772|12438221|FG002|Overall Study|Adverse Event|1
7916979|NCT02124772|12438222|FG003|Overall Study|Adverse Event|5
7916980|NCT02124772|12438223|FG004|Overall Study|Adverse Event|2
7916981|NCT02124772|12438224|FG005|Overall Study|Adverse Event|1
7916982|NCT02124772|12438225|FG006|Overall Study|Adverse Event|1
7916983|NCT02124772|12438226|FG007|Overall Study|Adverse Event|5
7916984|NCT02124772|12438227|FG008|Overall Study|Adverse Event|0
7916985|NCT02124772|12438228|FG009|Overall Study|Adverse Event|3
7916986|NCT02124772|12438229|FG010|Overall Study|Adverse Event|1
7916987|NCT02124772|12438230|FG011|Overall Study|Adverse Event|3
7916988|NCT02124772|12438231|FG012|Overall Study|Adverse Event|1
7916989|NCT02124772|12438219|FG000|Overall Study|Withdrawal consent|0
7916990|NCT02124772|12438220|FG001|Overall Study|Withdrawal consent|1
7916991|NCT02124772|12438221|FG002|Overall Study|Withdrawal consent|1
7916992|NCT02124772|12438222|FG003|Overall Study|Withdrawal consent|1
7916993|NCT02124772|12438223|FG004|Overall Study|Withdrawal consent|0
7916994|NCT02124772|12438224|FG005|Overall Study|Withdrawal consent|1
7916995|NCT02124772|12438225|FG006|Overall Study|Withdrawal consent|1
7916996|NCT02124772|12438226|FG007|Overall Study|Withdrawal consent|0
7916997|NCT02124772|12438227|FG008|Overall Study|Withdrawal consent|0
7916998|NCT02124772|12438228|FG009|Overall Study|Withdrawal consent|1
7916999|NCT02124772|12438229|FG010|Overall Study|Withdrawal consent|0
7917000|NCT02124772|12438230|FG011|Overall Study|Withdrawal consent|1
7917001|NCT02124772|12438231|FG012|Overall Study|Withdrawal consent|0
7917002|NCT02124772|12438219|FG000|Overall Study|Investigator discretion|0
7917003|NCT02124772|12438220|FG001|Overall Study|Investigator discretion|2
7917004|NCT02124772|12438221|FG002|Overall Study|Investigator discretion|2
7917005|NCT02124772|12438222|FG003|Overall Study|Investigator discretion|1
7917006|NCT02124772|12438223|FG004|Overall Study|Investigator discretion|1
7917007|NCT02124772|12438224|FG005|Overall Study|Investigator discretion|0
7917008|NCT02124772|12438225|FG006|Overall Study|Investigator discretion|1
7917009|NCT02124772|12438226|FG007|Overall Study|Investigator discretion|0
7917010|NCT02124772|12438227|FG008|Overall Study|Investigator discretion|0
7917011|NCT02124772|12438228|FG009|Overall Study|Investigator discretion|1
7917012|NCT02124772|12438229|FG010|Overall Study|Investigator discretion|0
7917013|NCT02124772|12438230|FG011|Overall Study|Investigator discretion|1
7917014|NCT02124772|12438231|FG012|Overall Study|Investigator discretion|0
7917015|NCT02124772|12438219|FG000|Overall Study|Progressive disease|0
7917016|NCT02124772|12438220|FG001|Overall Study|Progressive disease|0
7917017|NCT02124772|12438221|FG002|Overall Study|Progressive disease|0
7917018|NCT02124772|12438222|FG003|Overall Study|Progressive disease|0
7917019|NCT02124772|12438223|FG004|Overall Study|Progressive disease|0
7917020|NCT02124772|12438224|FG005|Overall Study|Progressive disease|0
7917021|NCT02124772|12438225|FG006|Overall Study|Progressive disease|1
7917022|NCT02124772|12438226|FG007|Overall Study|Progressive disease|1
7917023|NCT02124772|12438227|FG008|Overall Study|Progressive disease|0
7917024|NCT02124772|12438228|FG009|Overall Study|Progressive disease|0
7917025|NCT02124772|12438229|FG010|Overall Study|Progressive disease|0
7917026|NCT02124772|12438230|FG011|Overall Study|Progressive disease|0
7917027|NCT02124772|12438231|FG012|Overall Study|Progressive disease|0
7917028|NCT02124772|12438219|FG000|Overall Study|Other|0
7917029|NCT02124772|12438220|FG001|Overall Study|Other|7
7917030|NCT02124772|12438221|FG002|Overall Study|Other|2
7917031|NCT02124772|12438222|FG003|Overall Study|Other|5
7917032|NCT02124772|12438223|FG004|Overall Study|Other|4
7917033|NCT02124772|12438224|FG005|Overall Study|Other|3
7917034|NCT02124772|12438225|FG006|Overall Study|Other|4
7917035|NCT02124772|12438226|FG007|Overall Study|Other|1
7917036|NCT02124772|12438227|FG008|Overall Study|Other|1
7917037|NCT02124772|12438228|FG009|Overall Study|Other|1
7917038|NCT02124772|12438229|FG010|Overall Study|Other|1
7917039|NCT02124772|12438230|FG011|Overall Study|Other|1
7917040|NCT02124772|12438231|FG012|Overall Study|Other|0
7917041|NCT02124798|12438283|FG000|Overall Study|Adverse Event|3
7917042|NCT02124798|12438283|FG000|Overall Study|Lost to Follow-up|1
7917043|NCT02124811|12438289|FG000|Overall Study|Early termination|2
7917044|NCT02124811|12438290|FG001|Overall Study|Early termination|2
7917045|NCT02124811|12438289|FG000|Overall Study|Withdrawal by Subject|1
7917046|NCT02124811|12438290|FG001|Overall Study|Withdrawal by Subject|0
7917047|NCT02125279|12438311|FG000|Overall Study|Lack of Efficacy|2
7917048|NCT02125279|12438311|FG000|Overall Study|Withdrawal by Subject|6
7917049|NCT02125279|12438311|FG000|Overall Study|Protocol Violation|1
7917050|NCT02125279|12438311|FG000|Overall Study|Lost to Follow-up|4
7917051|NCT02125331|12438333|FG000|Overall Study|Protocol Violation|1
7917052|NCT02125331|12438334|FG001|Overall Study|Protocol Violation|0
7917053|NCT02125331|12438333|FG000|Overall Study|technical problem|2
7917054|NCT02125331|12438334|FG001|Overall Study|technical problem|0
7917055|NCT02125331|12438333|FG000|Overall Study|screen failure|2
7917056|NCT02125331|12438334|FG001|Overall Study|screen failure|0
7917057|NCT02125604|12438340|FG000|Overall Study|Other|4
7917058|NCT02125604|12438340|FG000|Overall Study|Investigator Decision|1
7917059|NCT02125604|12438340|FG000|Overall Study|Lost to Follow-up|2
7917060|NCT02125604|12438340|FG000|Overall Study|Consent Withdrawn|4
7917061|NCT02125604|12438340|FG000|Overall Study|Adverse Event|20
7917062|NCT02125734|12438350|FG000|Period 2|Adverse Event|0
7917063|NCT02125734|12438351|FG001|Period 2|Adverse Event|1
7917064|NCT02125838|12438359|FG000|Overall Study|Lost to Follow-up|4
7917065|NCT02125838|12438360|FG001|Overall Study|Lost to Follow-up|4
7917066|NCT02125877|12438368|FG000|Overall Study|Physician Decision|1
7917067|NCT02125877|12438369|FG001|Overall Study|Physician Decision|0
7917068|NCT02125877|12438368|FG000|Overall Study|Death|0
7917069|NCT02125877|12438369|FG001|Overall Study|Death|1
7917070|NCT02125877|12438368|FG000|Overall Study|Administrative problems|0
7917071|NCT02125877|12438369|FG001|Overall Study|Administrative problems|1
7917072|NCT02125877|12438368|FG000|Overall Study|Participant/guardian decision|0
7917073|NCT02125877|12438369|FG001|Overall Study|Participant/guardian decision|2
7917074|NCT02125877|12438368|FG000|Overall Study|Withdrawal by Subject|2
7917075|NCT02125877|12438369|FG001|Overall Study|Withdrawal by Subject|1
7917076|NCT02125877|12438368|FG000|Overall Study|Protocol deviation|4
7917077|NCT02125877|12438369|FG001|Overall Study|Protocol deviation|1
7917078|NCT02125877|12438368|FG000|Overall Study|Adverse Event|6
7917079|NCT02125877|12438369|FG001|Overall Study|Adverse Event|4
7917080|NCT02126670|12438399|FG000|Overall Study|Withdrawal by Subject|1
7917081|NCT02126670|12438400|FG001|Overall Study|Withdrawal by Subject|0
7917082|NCT02126670|12438401|FG002|Overall Study|Withdrawal by Subject|0
7917083|NCT02126670|12438402|FG003|Overall Study|Withdrawal by Subject|1
7917084|NCT02126826|12438432|FG000|Overall Study|Withdrawal by Subject|0
7917085|NCT02126826|12438433|FG001|Overall Study|Withdrawal by Subject|0
7917086|NCT02126826|12438434|FG002|Overall Study|Withdrawal by Subject|0
7917087|NCT02126826|12438435|FG003|Overall Study|Withdrawal by Subject|1
7917088|NCT02126826|12438436|FG004|Overall Study|Withdrawal by Subject|0
7917089|NCT02126826|12438437|FG005|Overall Study|Withdrawal by Subject|0
7917090|NCT02126826|12438438|FG006|Overall Study|Withdrawal by Subject|0
7917091|NCT02126839|12438461|FG000|Overall Study|Adverse Event|0
7917092|NCT02126839|12438462|FG001|Overall Study|Adverse Event|1
7917093|NCT02126839|12438461|FG000|Overall Study|Withdrawal by Subject|1
7917094|NCT02126839|12438462|FG001|Overall Study|Withdrawal by Subject|0
7917095|NCT02126839|12438461|FG000|Overall Study|Withdrawal by parent/guardian|1
7917096|NCT02126839|12438462|FG001|Overall Study|Withdrawal by parent/guardian|0
7917097|NCT02126839|12438461|FG000|Overall Study|Protocol Violation|2
7917098|NCT02126839|12438462|FG001|Overall Study|Protocol Violation|3
7917099|NCT02126839|12438461|FG000|Overall Study|Sponsor request|0
7917100|NCT02126839|12438462|FG001|Overall Study|Sponsor request|1
7917101|NCT02126839|12438461|FG000|Overall Study|Lost to Follow-up|1
7917102|NCT02126839|12438462|FG001|Overall Study|Lost to Follow-up|4
7917103|NCT02126839|12438461|FG000|Overall Study|Other|5
7917104|NCT02126839|12438462|FG001|Overall Study|Other|5
7917105|NCT02127125|12438477|FG000|Overall Study|Lost to Follow-up|0
7917106|NCT02127125|12438478|FG001|Overall Study|Lost to Follow-up|0
7917107|NCT02127125|12438479|FG002|Overall Study|Lost to Follow-up|0
7917108|NCT02127125|12438480|FG003|Overall Study|Lost to Follow-up|0
7917109|NCT02127125|12438481|FG004|Overall Study|Lost to Follow-up|2
7917110|NCT02127125|12438482|FG005|Overall Study|Lost to Follow-up|1
7917111|NCT02127125|12438483|FG006|Overall Study|Lost to Follow-up|0
7917112|NCT02127125|12438484|FG007|Overall Study|Lost to Follow-up|0
7917113|NCT02127125|12438485|FG008|Overall Study|Lost to Follow-up|0
7917114|NCT02127125|12438477|FG000|Overall Study|Withdrawal by Subject|0
7917115|NCT02127125|12438478|FG001|Overall Study|Withdrawal by Subject|0
7917116|NCT02127125|12438479|FG002|Overall Study|Withdrawal by Subject|0
7917117|NCT02127125|12438480|FG003|Overall Study|Withdrawal by Subject|1
7917118|NCT02127125|12438481|FG004|Overall Study|Withdrawal by Subject|0
7917119|NCT02127125|12438482|FG005|Overall Study|Withdrawal by Subject|0
7917120|NCT02127125|12438483|FG006|Overall Study|Withdrawal by Subject|0
7917121|NCT02127125|12438484|FG007|Overall Study|Withdrawal by Subject|0
7917122|NCT02127125|12438485|FG008|Overall Study|Withdrawal by Subject|0
7917123|NCT02127125|12438477|FG000|Overall Study|Physician Decision|0
7917124|NCT02127125|12438478|FG001|Overall Study|Physician Decision|0
7917125|NCT02127125|12438479|FG002|Overall Study|Physician Decision|1
7917126|NCT02127125|12438480|FG003|Overall Study|Physician Decision|0
7917127|NCT02127125|12438481|FG004|Overall Study|Physician Decision|1
7917128|NCT02127125|12438482|FG005|Overall Study|Physician Decision|2
7917129|NCT02127125|12438483|FG006|Overall Study|Physician Decision|0
7917130|NCT02127125|12438484|FG007|Overall Study|Physician Decision|0
7917131|NCT02127125|12438485|FG008|Overall Study|Physician Decision|0
7964287|NCT02921763|12519756|FG000|Overall Study|Withdrawal by Subject|2
7964288|NCT02921763|12519756|FG000|Overall Study|Physician Decision|1
7964289|NCT02921763|12519756|FG000|Overall Study|No data obtained|2
7964290|NCT02836236|12519786|FG000|Overall Study|Randomized but Never Treated|1
7964291|NCT02836236|12519787|FG001|Overall Study|Randomized but Never Treated|0
7964292|NCT02836236|12519786|FG000|Overall Study|Withdrew Consent|2
7964293|NCT02836236|12519787|FG001|Overall Study|Withdrew Consent|0
7964294|NCT02836236|12519786|FG000|Overall Study|Adverse Event|0
7964295|NCT02836236|12519787|FG001|Overall Study|Adverse Event|1
7964296|NCT02836236|12519786|FG000|Overall Study|Investigator's Discretion|1
7964297|NCT02836236|12519787|FG001|Overall Study|Investigator's Discretion|0
7964298|NCT02836236|12519786|FG000|Overall Study|Still on Study|101
7964299|NCT02836236|12519787|FG001|Overall Study|Still on Study|49
7964300|NCT02811861|12519796|FG000|Overall Study|Radiological Disease Progression|123
7964301|NCT02811861|12519797|FG001|Overall Study|Radiological Disease Progression|97
7917132|NCT02127281|12438507|FG000|Overall Study|Lost to Follow-up|1
7917133|NCT02127281|12438508|FG001|Overall Study|Lost to Follow-up|0
7917134|NCT02127307|12438514|FG000|Overall Study|Protocol Violation|36
7917135|NCT02127307|12438514|FG000|Overall Study|Lost to Follow-up|2
7917136|NCT02127307|12438514|FG000|Overall Study|Death|101
7917137|NCT02127307|12438514|FG000|Overall Study|Other than specified above|169
7917138|NCT02127372|12438520|FG000|Overall Study|Withdrawal by Subject|1
7917139|NCT02127372|12438521|FG001|Overall Study|Withdrawal by Subject|0
7917140|NCT02127931|12438578|FG000|Overall Study|Glitch in Game|1
7917141|NCT02127970|12438585|FG000|Overall Study|Adverse Event|2
7917142|NCT02127970|12438586|FG001|Overall Study|Adverse Event|1
7917143|NCT02127970|12438585|FG000|Overall Study|Death|1
7917144|NCT02127970|12438586|FG001|Overall Study|Death|1
7917145|NCT02127970|12438585|FG000|Overall Study|Lost to Follow-up|14
7917146|NCT02127970|12438586|FG001|Overall Study|Lost to Follow-up|14
7917147|NCT02127970|12438585|FG000|Overall Study|Reason not Specified|4
7917148|NCT02127970|12438586|FG001|Overall Study|Reason not Specified|7
7917149|NCT02127970|12438585|FG000|Overall Study|Pregnancy|0
7917150|NCT02127970|12438586|FG001|Overall Study|Pregnancy|1
7917151|NCT02127970|12438585|FG000|Overall Study|Subject Withdrew Consent|5
7917152|NCT02127970|12438586|FG001|Overall Study|Subject Withdrew Consent|3
7917153|NCT02128217|12438598|FG000|Overall Study|Lost to Follow-up|0
7917154|NCT02128217|12438599|FG001|Overall Study|Lost to Follow-up|1
7917155|NCT02128269|12438614|FG000|Treatment Period|Adverse Event|1
7917156|NCT02128269|12438614|FG000|Treatment Period|Physician Decision|1
7719531|NCT00532883|12143501|FG003|Overall Study|Subject was Nonadherent|0
7917157|NCT02128490|12438623|FG000|Overall Study|Pretreatment Event/Adverse Event|1
7917158|NCT02128490|12438624|FG001|Overall Study|Pretreatment Event/Adverse Event|0
7917159|NCT02128490|12438625|FG002|Overall Study|Pretreatment Event/Adverse Event|1
7917160|NCT02128490|12438626|FG003|Overall Study|Pretreatment Event/Adverse Event|1
7917161|NCT02128490|12438627|FG004|Overall Study|Pretreatment Event/Adverse Event|0
7917162|NCT02128490|12438623|FG000|Overall Study|Major Protocol Deviation|1
7917163|NCT02128490|12438624|FG001|Overall Study|Major Protocol Deviation|2
7917164|NCT02128490|12438625|FG002|Overall Study|Major Protocol Deviation|0
7917165|NCT02128490|12438626|FG003|Overall Study|Major Protocol Deviation|2
7917166|NCT02128490|12438627|FG004|Overall Study|Major Protocol Deviation|2
7917167|NCT02128490|12438623|FG000|Overall Study|Lost to Follow-up|0
7917168|NCT02128490|12438624|FG001|Overall Study|Lost to Follow-up|0
7917169|NCT02128490|12438625|FG002|Overall Study|Lost to Follow-up|1
7917170|NCT02128490|12438626|FG003|Overall Study|Lost to Follow-up|1
7917171|NCT02128490|12438627|FG004|Overall Study|Lost to Follow-up|1
7917172|NCT02128490|12438623|FG000|Overall Study|Voluntary Withdrawal|3
7917173|NCT02128490|12438624|FG001|Overall Study|Voluntary Withdrawal|3
7917174|NCT02128490|12438625|FG002|Overall Study|Voluntary Withdrawal|1
7917175|NCT02128490|12438626|FG003|Overall Study|Voluntary Withdrawal|1
7917176|NCT02128490|12438627|FG004|Overall Study|Voluntary Withdrawal|2
7917177|NCT02128490|12438623|FG000|Overall Study|Lack of Efficacy|0
7917178|NCT02128490|12438624|FG001|Overall Study|Lack of Efficacy|1
7917179|NCT02128490|12438625|FG002|Overall Study|Lack of Efficacy|0
7917180|NCT02128490|12438626|FG003|Overall Study|Lack of Efficacy|0
7917181|NCT02128490|12438627|FG004|Overall Study|Lack of Efficacy|0
7917182|NCT02128490|12438623|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0
7917183|NCT02128490|12438624|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0
7917184|NCT02128490|12438625|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0
7917185|NCT02128490|12438626|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0
7917186|NCT02128490|12438627|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1
7917187|NCT02128490|12438623|FG000|Overall Study|Other Miscellaneous Reasons|0
7917188|NCT02128490|12438624|FG001|Overall Study|Other Miscellaneous Reasons|0
7917189|NCT02128490|12438625|FG002|Overall Study|Other Miscellaneous Reasons|2
7917190|NCT02128490|12438626|FG003|Overall Study|Other Miscellaneous Reasons|1
7917191|NCT02128490|12438627|FG004|Overall Study|Other Miscellaneous Reasons|1
7917192|NCT02128542|12438641|FG000|Overall Study|Lost to Follow-up|3
7917193|NCT02128542|12438642|FG001|Overall Study|Lost to Follow-up|0
7917194|NCT02128542|12438641|FG000|Overall Study|Withdrew Consent|1
7917195|NCT02128542|12438642|FG001|Overall Study|Withdrew Consent|0
7917196|NCT02128724|12438654|FG000|Overall Study|Death|1
7917197|NCT02128724|12438655|FG001|Overall Study|Death|0
7917198|NCT02128724|12438656|FG002|Overall Study|Death|0
7917199|NCT02128724|12438657|FG003|Overall Study|Death|0
7917200|NCT02128724|12438654|FG000|Overall Study|Adverse Event|0
7917201|NCT02128724|12438655|FG001|Overall Study|Adverse Event|1
7917202|NCT02128724|12438656|FG002|Overall Study|Adverse Event|0
7917203|NCT02128724|12438657|FG003|Overall Study|Adverse Event|0
7917204|NCT02128724|12438654|FG000|Overall Study|Physician Decision|0
7917205|NCT02128724|12438655|FG001|Overall Study|Physician Decision|0
7917206|NCT02128724|12438656|FG002|Overall Study|Physician Decision|0
7917207|NCT02128724|12438657|FG003|Overall Study|Physician Decision|2
7917208|NCT02128724|12438654|FG000|Overall Study|Withdrawal by Subject|0
7917209|NCT02128724|12438655|FG001|Overall Study|Withdrawal by Subject|0
7917210|NCT02128724|12438656|FG002|Overall Study|Withdrawal by Subject|0
7917211|NCT02128724|12438657|FG003|Overall Study|Withdrawal by Subject|1
7917212|NCT02128932|12438696|FG000|Overall Study|Withdrawal by Subject|11
7917213|NCT02128932|12438697|FG001|Overall Study|Withdrawal by Subject|7
7917214|NCT02128932|12438698|FG002|Overall Study|Withdrawal by Subject|8
7917215|NCT02128932|12438696|FG000|Overall Study|Death|2
7917216|NCT02128932|12438697|FG001|Overall Study|Death|0
7917217|NCT02128932|12438698|FG002|Overall Study|Death|2
7917218|NCT02128932|12438696|FG000|Overall Study|Lost to Follow-up|2
7917219|NCT02128932|12438697|FG001|Overall Study|Lost to Follow-up|1
7917220|NCT02128932|12438698|FG002|Overall Study|Lost to Follow-up|1
7917221|NCT02128932|12438696|FG000|Overall Study|No reason for withdrawal|12
7917222|NCT02128932|12438697|FG001|Overall Study|No reason for withdrawal|11
7917223|NCT02128932|12438698|FG002|Overall Study|No reason for withdrawal|7
7917224|NCT02128997|12438708|FG000|Overall Study|Lost to Follow-up|6
7917225|NCT02128997|12438709|FG001|Overall Study|Lost to Follow-up|11
7917226|NCT02129062|12438715|FG000|Overall Study|Death|1
7917227|NCT02129062|12438715|FG000|Overall Study|Disease Progression|2
7917228|NCT02129192|12438732|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0
7917229|NCT02129192|12438733|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1
7917230|NCT02129205|12438752|FG000|Overall Study|Withdrawal by Subject|0
7917231|NCT02129205|12438753|FG001|Overall Study|Withdrawal by Subject|0
7917232|NCT02129205|12438754|FG002|Overall Study|Withdrawal by Subject|0
7917233|NCT02129205|12438755|FG003|Overall Study|Withdrawal by Subject|0
7917234|NCT02129205|12438756|FG004|Overall Study|Withdrawal by Subject|1
7917235|NCT02129205|12438757|FG005|Overall Study|Withdrawal by Subject|1
7917236|NCT02129205|12438758|FG006|Overall Study|Withdrawal by Subject|1
7917237|NCT02129205|12438759|FG007|Overall Study|Withdrawal by Subject|0
7917238|NCT02129205|12438760|FG008|Overall Study|Withdrawal by Subject|1
7917239|NCT02129205|12438761|FG009|Overall Study|Withdrawal by Subject|0
7917240|NCT02129205|12438752|FG000|Overall Study|Other|1
7917241|NCT02129205|12438753|FG001|Overall Study|Other|0
7917242|NCT02129205|12438754|FG002|Overall Study|Other|0
7917243|NCT02129205|12438755|FG003|Overall Study|Other|0
7917244|NCT02129205|12438756|FG004|Overall Study|Other|2
7917245|NCT02129205|12438757|FG005|Overall Study|Other|3
7917246|NCT02129205|12438758|FG006|Overall Study|Other|3
7917247|NCT02129205|12438759|FG007|Overall Study|Other|2
7917248|NCT02129205|12438760|FG008|Overall Study|Other|1
7917249|NCT02129205|12438761|FG009|Overall Study|Other|0
7917250|NCT02129608|12438816|FG000|Overall Study|Lost to Follow-up|0
7917251|NCT02129608|12438817|FG001|Overall Study|Lost to Follow-up|1
7917252|NCT02129608|12438818|FG002|Overall Study|Lost to Follow-up|1
7917253|NCT02129608|12438816|FG000|Overall Study|Withdrawal by Subject|0
7917254|NCT02129608|12438817|FG001|Overall Study|Withdrawal by Subject|0
7917255|NCT02129608|12438818|FG002|Overall Study|Withdrawal by Subject|2
7917256|NCT02129777|12438862|FG000|Double-Blind Period|Adverse Event|0
7917257|NCT02129777|12438863|FG001|Double-Blind Period|Adverse Event|0
7917258|NCT02129777|12438864|FG002|Double-Blind Period|Adverse Event|0
7917259|NCT02129777|12438865|FG003|Double-Blind Period|Adverse Event|0
7917260|NCT02129777|12438866|FG004|Double-Blind Period|Adverse Event|1
7917261|NCT02129777|12438867|FG005|Double-Blind Period|Adverse Event|0
7917262|NCT02129777|12438868|FG006|Double-Blind Period|Adverse Event|0
7917263|NCT02129777|12438862|FG000|Double-Blind Period|Lost to Follow-up|1
7917264|NCT02129777|12438863|FG001|Double-Blind Period|Lost to Follow-up|1
7917265|NCT02129777|12438864|FG002|Double-Blind Period|Lost to Follow-up|1
7917266|NCT02129777|12438865|FG003|Double-Blind Period|Lost to Follow-up|2
7917267|NCT02129777|12438866|FG004|Double-Blind Period|Lost to Follow-up|0
7917268|NCT02129777|12438867|FG005|Double-Blind Period|Lost to Follow-up|0
7917269|NCT02129777|12438868|FG006|Double-Blind Period|Lost to Follow-up|0
7917270|NCT02129777|12438862|FG000|Double-Blind Period|Withdrawal by Subject|2
7917271|NCT02129777|12438863|FG001|Double-Blind Period|Withdrawal by Subject|4
7917272|NCT02129777|12438864|FG002|Double-Blind Period|Withdrawal by Subject|3
7917273|NCT02129777|12438865|FG003|Double-Blind Period|Withdrawal by Subject|2
7917274|NCT02129777|12438866|FG004|Double-Blind Period|Withdrawal by Subject|3
7917275|NCT02129777|12438867|FG005|Double-Blind Period|Withdrawal by Subject|0
7917276|NCT02129777|12438868|FG006|Double-Blind Period|Withdrawal by Subject|0
7917277|NCT02129777|12438862|FG000|Double-Blind Period|Pregnancy|0
7917278|NCT02129777|12438863|FG001|Double-Blind Period|Pregnancy|0
7917279|NCT02129777|12438864|FG002|Double-Blind Period|Pregnancy|0
7917280|NCT02129777|12438865|FG003|Double-Blind Period|Pregnancy|0
7917281|NCT02129777|12438866|FG004|Double-Blind Period|Pregnancy|1
7917282|NCT02129777|12438867|FG005|Double-Blind Period|Pregnancy|0
7917283|NCT02129777|12438868|FG006|Double-Blind Period|Pregnancy|0
7917284|NCT02129777|12438862|FG000|Double-Blind Period|Lack of Efficacy|3
7917285|NCT02129777|12438863|FG001|Double-Blind Period|Lack of Efficacy|1
7917286|NCT02129777|12438864|FG002|Double-Blind Period|Lack of Efficacy|0
7917287|NCT02129777|12438865|FG003|Double-Blind Period|Lack of Efficacy|3
7917288|NCT02129777|12438866|FG004|Double-Blind Period|Lack of Efficacy|2
7917289|NCT02129777|12438867|FG005|Double-Blind Period|Lack of Efficacy|0
7917290|NCT02129777|12438868|FG006|Double-Blind Period|Lack of Efficacy|0
7917291|NCT02129777|12438862|FG000|Double-Blind Period|Other|1
7917292|NCT02129777|12438863|FG001|Double-Blind Period|Other|2
7917293|NCT02129777|12438864|FG002|Double-Blind Period|Other|0
7917294|NCT02129777|12438865|FG003|Double-Blind Period|Other|0
7917295|NCT02129777|12438866|FG004|Double-Blind Period|Other|0
7917296|NCT02129777|12438867|FG005|Double-Blind Period|Other|0
7917297|NCT02129777|12438868|FG006|Double-Blind Period|Other|0
7917298|NCT02129777|12438862|FG000|Open-Label Period|Lack of Efficacy|0
7917299|NCT02129777|12438863|FG001|Open-Label Period|Lack of Efficacy|0
7917300|NCT02129777|12438864|FG002|Open-Label Period|Lack of Efficacy|0
7917301|NCT02129777|12438865|FG003|Open-Label Period|Lack of Efficacy|0
7917302|NCT02129777|12438866|FG004|Open-Label Period|Lack of Efficacy|0
7917303|NCT02129777|12438867|FG005|Open-Label Period|Lack of Efficacy|0
7917304|NCT02129777|12438868|FG006|Open-Label Period|Lack of Efficacy|5
7917305|NCT02129777|12438862|FG000|Open-Label Period|Lost to Follow-up|0
7917306|NCT02129777|12438863|FG001|Open-Label Period|Lost to Follow-up|0
7917307|NCT02129777|12438864|FG002|Open-Label Period|Lost to Follow-up|0
7917308|NCT02129777|12438865|FG003|Open-Label Period|Lost to Follow-up|0
7917309|NCT02129777|12438866|FG004|Open-Label Period|Lost to Follow-up|0
7917310|NCT02129777|12438867|FG005|Open-Label Period|Lost to Follow-up|1
7917311|NCT02129777|12438868|FG006|Open-Label Period|Lost to Follow-up|1
7917312|NCT02129777|12438862|FG000|Open-Label Period|Withdrawal by Subject|0
7917313|NCT02129777|12438863|FG001|Open-Label Period|Withdrawal by Subject|0
7917314|NCT02129777|12438864|FG002|Open-Label Period|Withdrawal by Subject|0
7917315|NCT02129777|12438865|FG003|Open-Label Period|Withdrawal by Subject|0
7917316|NCT02129777|12438866|FG004|Open-Label Period|Withdrawal by Subject|0
7917317|NCT02129777|12438867|FG005|Open-Label Period|Withdrawal by Subject|1
7917318|NCT02129777|12438868|FG006|Open-Label Period|Withdrawal by Subject|3
7917319|NCT02129777|12438862|FG000|Open-Label Period|Study Termination|0
7917320|NCT02129777|12438863|FG001|Open-Label Period|Study Termination|0
7917321|NCT02129777|12438864|FG002|Open-Label Period|Study Termination|0
7917322|NCT02129777|12438865|FG003|Open-Label Period|Study Termination|0
7917323|NCT02129777|12438866|FG004|Open-Label Period|Study Termination|0
7917324|NCT02129777|12438867|FG005|Open-Label Period|Study Termination|10
7917325|NCT02129777|12438868|FG006|Open-Label Period|Study Termination|39
7917326|NCT02129803|12438889|FG000|Overall Study|Protocol Violation|4
7917327|NCT02129803|12438890|FG001|Overall Study|Protocol Violation|0
7917328|NCT02129803|12438889|FG000|Overall Study|Physician Decision|0
7917329|NCT02129803|12438890|FG001|Overall Study|Physician Decision|1
7917330|NCT02129803|12438889|FG000|Overall Study|Difficulty sleeping|1
7917331|NCT02129803|12438890|FG001|Overall Study|Difficulty sleeping|0
7917332|NCT02129803|12438889|FG000|Overall Study|Morning headache|0
7917333|NCT02129803|12438890|FG001|Overall Study|Morning headache|1
7917334|NCT02129803|12438889|FG000|Overall Study|Withdrawal by Subject|1
7917335|NCT02129803|12438890|FG001|Overall Study|Withdrawal by Subject|1
7917336|NCT02130024|12438898|FG000|Overall Study|Adverse Event|10
7917337|NCT02130024|12438899|FG001|Overall Study|Adverse Event|11
7917338|NCT02130024|12438898|FG000|Overall Study|Death|2
7917339|NCT02130024|12438899|FG001|Overall Study|Death|2
7917340|NCT02130024|12438898|FG000|Overall Study|Lost to Follow-up|1
7917341|NCT02130024|12438899|FG001|Overall Study|Lost to Follow-up|1
7917342|NCT02130024|12438898|FG000|Overall Study|Physician Decision|1
7917343|NCT02130024|12438899|FG001|Overall Study|Physician Decision|3
7917344|NCT02130024|12438898|FG000|Overall Study|Protocol Deviation|4
7917345|NCT02130024|12438899|FG001|Overall Study|Protocol Deviation|0
7917346|NCT02130024|12438898|FG000|Overall Study|Site Administration Problems|1
7917347|NCT02130024|12438899|FG001|Overall Study|Site Administration Problems|0
7917348|NCT02130024|12438898|FG000|Overall Study|Subject Withdrew Consent|6
7917349|NCT02130024|12438899|FG001|Overall Study|Subject Withdrew Consent|14
7917350|NCT02130193|12438916|FG000|Part B: 52-week Double-blind Period|Adverse Event|0
7917351|NCT02130193|12438917|FG001|Part B: 52-week Double-blind Period|Adverse Event|5
7917352|NCT02130193|12438918|FG002|Part B: 52-week Double-blind Period|Adverse Event|3
7917353|NCT02130193|12438916|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0
7917354|NCT02130193|12438917|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2
7917355|NCT02130193|12438918|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1
7917356|NCT02130193|12438916|FG000|Part B: 52-week Double-blind Period|Physician Decision|0
7917357|NCT02130193|12438917|FG001|Part B: 52-week Double-blind Period|Physician Decision|0
7917358|NCT02130193|12438918|FG002|Part B: 52-week Double-blind Period|Physician Decision|1
7917359|NCT02130193|12438916|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
7917360|NCT02130193|12438917|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
7917361|NCT02130193|12438918|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
7917362|NCT02130284|12438936|FG000|Overall Study|Withdrawal by Subject|3
7917363|NCT02130284|12438936|FG000|Overall Study|Subject Withdrew Consent|1
7917364|NCT02130284|12438936|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1
7917365|NCT02130284|12438936|FG000|Overall Study|Subject was screened as backup for study|3
7917366|NCT02130284|12438936|FG000|Overall Study|Screen Failure|1
7917367|NCT02130297|12438940|FG000|Overall Study|Lost to Follow-up|4
7917368|NCT02130557|12438946|FG000|Overall Study|Withdrawal by Subject|12
7917369|NCT02130557|12438947|FG001|Overall Study|Withdrawal by Subject|12
7917370|NCT02130557|12438946|FG000|Overall Study|Investigator Request|0
7917371|NCT02130557|12438947|FG001|Overall Study|Investigator Request|2
7917372|NCT02130557|12438946|FG000|Overall Study|Deceased|14
7917373|NCT02130557|12438947|FG001|Overall Study|Deceased|14
7917374|NCT02130557|12438946|FG000|Overall Study|Lost to Follow-up|6
7917375|NCT02130557|12438947|FG001|Overall Study|Lost to Follow-up|7
7917376|NCT02130557|12438946|FG000|Overall Study|Other|2
7917377|NCT02130557|12438947|FG001|Overall Study|Other|1
7917378|NCT02130557|12438946|FG000|Overall Study|Missing|2
7917379|NCT02130557|12438947|FG001|Overall Study|Missing|1
7917380|NCT02130570|12438955|FG000|Overall Study|Death|3
7917381|NCT02130570|12438956|FG001|Overall Study|Death|5
7917382|NCT02130570|12438955|FG000|Overall Study|Withdrawal by Subject|6
7917383|NCT02130570|12438956|FG001|Overall Study|Withdrawal by Subject|3
7917384|NCT02130570|12438955|FG000|Overall Study|Part of practice that discontinued study|0
7917385|NCT02130570|12438956|FG001|Overall Study|Part of practice that discontinued study|5
7917386|NCT02130765|12439020|FG000|Overall Study|Did not receive treatment|4
7917387|NCT02130765|12439021|FG001|Overall Study|Did not receive treatment|0
7917388|NCT02130765|12439022|FG002|Overall Study|Did not receive treatment|0
7917389|NCT02130765|12439023|FG003|Overall Study|Did not receive treatment|0
7917390|NCT02130986|12439037|FG000|Overall Study|Withdrawal by Subject|4
7917391|NCT02130986|12439038|FG001|Overall Study|Withdrawal by Subject|4
7917392|NCT02130986|12439037|FG000|Overall Study|Lost to Follow-up|151
7917393|NCT02130986|12439038|FG001|Overall Study|Lost to Follow-up|160
7917394|NCT02131064|12439060|FG000|Overall Study|Death|5
7917395|NCT02131064|12439061|FG001|Overall Study|Death|6
7917396|NCT02131064|12439060|FG000|Overall Study|Lost to Follow-up|4
7917397|NCT02131064|12439061|FG001|Overall Study|Lost to Follow-up|8
7917398|NCT02131064|12439060|FG000|Overall Study|Withdrawal by Subject|14
7917399|NCT02131064|12439061|FG001|Overall Study|Withdrawal by Subject|18
7917400|NCT02131064|12439060|FG000|Overall Study|Other|2
7917401|NCT02131064|12439061|FG001|Overall Study|Other|2
7917402|NCT02131129|12439070|FG000|Overall Study|Withdrawal by Subject|1
7917403|NCT02131129|12439071|FG001|Overall Study|Withdrawal by Subject|0
7917404|NCT02131233|12439079|FG000|Overall Study|Not Treated|2
7917405|NCT02131233|12439080|FG001|Overall Study|Not Treated|3
7917406|NCT02131233|12439079|FG000|Overall Study|Adverse Event|7
7917407|NCT02131233|12439080|FG001|Overall Study|Adverse Event|6
7917408|NCT02131233|12439079|FG000|Overall Study|Death|0
7917409|NCT02131233|12439080|FG001|Overall Study|Death|1
7917410|NCT02131233|12439079|FG000|Overall Study|Lack of Efficacy|6
7917411|NCT02131233|12439080|FG001|Overall Study|Lack of Efficacy|3
7917412|NCT02131233|12439079|FG000|Overall Study|Lost to Follow-up|14
7917413|NCT02131233|12439080|FG001|Overall Study|Lost to Follow-up|13
7917414|NCT02131233|12439079|FG000|Overall Study|Non-Compliance With Study Drug|8
7917415|NCT02131233|12439080|FG001|Overall Study|Non-Compliance With Study Drug|5
7917416|NCT02131233|12439079|FG000|Overall Study|Physician Decision|7
7917417|NCT02131233|12439080|FG001|Overall Study|Physician Decision|0
7917418|NCT02131233|12439079|FG000|Overall Study|Pregnancy|4
7917419|NCT02131233|12439080|FG001|Overall Study|Pregnancy|0
7917420|NCT02131233|12439079|FG000|Overall Study|Withdrawal by Subject|18
7917421|NCT02131233|12439080|FG001|Overall Study|Withdrawal by Subject|11
7917422|NCT02131259|12439086|FG000|Overall Study|Progressive disease|751
7917423|NCT02131259|12439086|FG000|Overall Study|Adverse Event|341
7917424|NCT02131259|12439086|FG000|Overall Study|Lost to Follow-up|7
7917425|NCT02131259|12439086|FG000|Overall Study|Relocation|32
7917426|NCT02131259|12439086|FG000|Overall Study|Other|63
7917427|NCT02131259|12439086|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22
7917428|NCT02131259|12439086|FG000|Overall Study|Progressive disease/relocation|1
7917429|NCT02131259|12439086|FG000|Overall Study|Progressive disease/other|2
7917430|NCT02131259|12439086|FG000|Overall Study|AE/lost to follow-up|1
7917431|NCT02131259|12439086|FG000|Overall Study|AE/other|1
7917432|NCT02131259|12439086|FG000|Overall Study|Progressive disease/AE/other|1
7917433|NCT02131259|12439086|FG000|Overall Study|Missing|3
7917434|NCT02131272|12439092|FG000|Overall Study|Withdrawal by parent|0
7917435|NCT02131272|12439093|FG001|Overall Study|Withdrawal by parent|1
7917436|NCT02131272|12439092|FG000|Overall Study|Withdrawal by Subject|0
7917437|NCT02131272|12439093|FG001|Overall Study|Withdrawal by Subject|1
7917438|NCT02131272|12439092|FG000|Overall Study|Withdrawal Criteria|1
7917439|NCT02131272|12439093|FG001|Overall Study|Withdrawal Criteria|0
7917440|NCT02131311|12439099|FG000|Overall Study|Adverse Event|2
7917441|NCT02131311|12439099|FG000|Overall Study|Protocol Violation|1
7917442|NCT02131311|12439099|FG000|Overall Study|Lost to Follow-up|1
7917443|NCT02131324|12439106|FG000|Overall Study|Withdrawal by Subject|1
7917444|NCT02131324|12439107|FG001|Overall Study|Withdrawal by Subject|2
7917445|NCT02131324|12439106|FG000|Overall Study|Lost to Follow-up|1
7917446|NCT02131324|12439107|FG001|Overall Study|Lost to Follow-up|1
7917447|NCT02131532|12439176|FG000|Overall Study|Withdrawal by Subject|1
7917448|NCT02131532|12439176|FG000|Overall Study|Physician Decision|1
7917449|NCT02131532|12439176|FG000|Overall Study|Other health conditions|2
7917450|NCT02131636|12439183|FG000|Overall Study|Personal Reasons|4
7917451|NCT02131636|12439184|FG001|Overall Study|Personal Reasons|4
7917452|NCT02131636|12439183|FG000|Overall Study|Lost to Follow-up|4
7917453|NCT02131636|12439184|FG001|Overall Study|Lost to Follow-up|0
7917454|NCT02131636|12439183|FG000|Overall Study|Adverse Event|4
7917455|NCT02131636|12439184|FG001|Overall Study|Adverse Event|1
7917456|NCT02131662|12439195|FG000|Overall Study|Protocol Violation|1
7917457|NCT02131662|12439196|FG001|Overall Study|Protocol Violation|0
7917458|NCT02131662|12439197|FG002|Overall Study|Protocol Violation|0
7917459|NCT02131662|12439198|FG003|Overall Study|Protocol Violation|0
7917460|NCT02131662|12439199|FG004|Overall Study|Protocol Violation|0
7917461|NCT02131662|12439195|FG000|Overall Study|Other|2
7917462|NCT02131662|12439196|FG001|Overall Study|Other|4
7917463|NCT02131662|12439197|FG002|Overall Study|Other|3
7917464|NCT02131662|12439198|FG003|Overall Study|Other|3
7917465|NCT02131662|12439199|FG004|Overall Study|Other|4
7917466|NCT02131662|12439195|FG000|Overall Study|Adverse Event|0
7917467|NCT02131662|12439196|FG001|Overall Study|Adverse Event|1
7917468|NCT02131662|12439197|FG002|Overall Study|Adverse Event|1
7917469|NCT02131662|12439198|FG003|Overall Study|Adverse Event|1
7917470|NCT02131662|12439199|FG004|Overall Study|Adverse Event|3
7917471|NCT02131662|12439195|FG000|Overall Study|Pregnancy|0
7917472|NCT02131662|12439196|FG001|Overall Study|Pregnancy|1
7917473|NCT02131662|12439197|FG002|Overall Study|Pregnancy|0
7917474|NCT02131662|12439198|FG003|Overall Study|Pregnancy|1
7917475|NCT02131662|12439199|FG004|Overall Study|Pregnancy|0
7917476|NCT02131662|12439195|FG000|Overall Study|Wish for pregnancy|0
7917477|NCT02131662|12439196|FG001|Overall Study|Wish for pregnancy|0
7917478|NCT02131662|12439197|FG002|Overall Study|Wish for pregnancy|0
7917479|NCT02131662|12439198|FG003|Overall Study|Wish for pregnancy|0
7917480|NCT02131662|12439199|FG004|Overall Study|Wish for pregnancy|1
7917481|NCT02131662|12439195|FG000|Overall Study|Lack of Efficacy|1
7917482|NCT02131662|12439196|FG001|Overall Study|Lack of Efficacy|0
7917483|NCT02131662|12439197|FG002|Overall Study|Lack of Efficacy|0
7917484|NCT02131662|12439198|FG003|Overall Study|Lack of Efficacy|0
7917485|NCT02131662|12439199|FG004|Overall Study|Lack of Efficacy|1
7917486|NCT02131662|12439195|FG000|Overall Study|Withdrawal by Subject|1
7917487|NCT02131662|12439196|FG001|Overall Study|Withdrawal by Subject|5
7917488|NCT02131662|12439197|FG002|Overall Study|Withdrawal by Subject|1
7917489|NCT02131662|12439198|FG003|Overall Study|Withdrawal by Subject|5
7917490|NCT02131662|12439199|FG004|Overall Study|Withdrawal by Subject|6
7917491|NCT02131662|12439195|FG000|Overall Study|Lost to Follow-up|1
7917492|NCT02131662|12439196|FG001|Overall Study|Lost to Follow-up|3
7917493|NCT02131662|12439197|FG002|Overall Study|Lost to Follow-up|0
7917494|NCT02131662|12439198|FG003|Overall Study|Lost to Follow-up|9
7917495|NCT02131662|12439199|FG004|Overall Study|Lost to Follow-up|0
7917496|NCT02131662|12439195|FG000|Overall Study|Not treated|2
7917497|NCT02131662|12439196|FG001|Overall Study|Not treated|0
7917498|NCT02131662|12439197|FG002|Overall Study|Not treated|2
7917499|NCT02131662|12439198|FG003|Overall Study|Not treated|2
7917500|NCT02131662|12439199|FG004|Overall Study|Not treated|3
7917501|NCT02131766|12439215|FG000|Overall Study|Withdrawal by Subject|4
7917502|NCT02132117|12439224|FG000|Overall Study|Adverse Event|6
7917503|NCT02132117|12439225|FG001|Overall Study|Adverse Event|1
7917504|NCT02132117|12439224|FG000|Overall Study|Lost to Follow-up|2
7917505|NCT02132117|12439225|FG001|Overall Study|Lost to Follow-up|2
7917506|NCT02132117|12439224|FG000|Overall Study|Personal Reasons|1
7917507|NCT02132117|12439225|FG001|Overall Study|Personal Reasons|2
7917508|NCT02132117|12439224|FG000|Overall Study|Other Miscellaneous Reasons|2
7917509|NCT02132117|12439225|FG001|Overall Study|Other Miscellaneous Reasons|0
7917510|NCT02132130|12439235|FG000|Overall Study|Lost to Follow-up|0
7917511|NCT02132130|12439236|FG001|Overall Study|Lost to Follow-up|2
7917512|NCT02132130|12439237|FG002|Overall Study|Lost to Follow-up|0
7917513|NCT02132130|12439238|FG003|Overall Study|Lost to Follow-up|0
7917514|NCT02132130|12439235|FG000|Overall Study|Withdrawal by Subject|0
7917515|NCT02132130|12439236|FG001|Overall Study|Withdrawal by Subject|0
7917516|NCT02132130|12439237|FG002|Overall Study|Withdrawal by Subject|0
7917517|NCT02132130|12439238|FG003|Overall Study|Withdrawal by Subject|1
7917518|NCT02132195|12439264|FG000|Initial Assignment|Relapsed|14
7917519|NCT02132195|12439265|FG001|Initial Assignment|Relapsed|0
7917520|NCT02132195|12439266|FG002|Initial Assignment|Relapsed|0
7917521|NCT02132195|12439264|FG000|Rescue Therapy|Relapsed|0
7917522|NCT02132195|12439265|FG001|Rescue Therapy|Relapsed|0
7917523|NCT02132195|12439266|FG002|Rescue Therapy|Relapsed|7
7821208|NCT01254045|12289854|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
7821209|NCT01254188|12289864|FG000|Overall Study|Disease Progression|6
7821210|NCT01254188|12289864|FG000|Overall Study|Protocol Violation|6
7821211|NCT01254188|12289864|FG000|Overall Study|Pregnancy|2
7917524|NCT02132195|12439264|FG000|Rescue Therapy|Physician Decision|0
7917525|NCT02132195|12439265|FG001|Rescue Therapy|Physician Decision|0
7917526|NCT02132195|12439266|FG002|Rescue Therapy|Physician Decision|1
7917527|NCT02132195|12439264|FG000|Rescue Therapy|Withdrawal by Subject|0
7917528|NCT02132195|12439265|FG001|Rescue Therapy|Withdrawal by Subject|0
7917529|NCT02132195|12439266|FG002|Rescue Therapy|Withdrawal by Subject|1
7917530|NCT02132195|12439264|FG000|Rescue Therapy|Adverse Event|0
7917531|NCT02132195|12439265|FG001|Rescue Therapy|Adverse Event|0
7917532|NCT02132195|12439266|FG002|Rescue Therapy|Adverse Event|2
7917533|NCT02132247|12439276|FG000|Overall Study|Protocol Violation|1
7917534|NCT02132247|12439277|FG001|Overall Study|Protocol Violation|0
7917535|NCT02132312|12439285|FG000|Overall Study|Adverse Event|2
7917536|NCT02132312|12439286|FG001|Overall Study|Adverse Event|0
7917537|NCT02132312|12439285|FG000|Overall Study|Physician Decision|1
7917538|NCT02132312|12439286|FG001|Overall Study|Physician Decision|1
7917539|NCT02132312|12439285|FG000|Overall Study|Protocol Violation|0
7917540|NCT02132312|12439286|FG001|Overall Study|Protocol Violation|1
7917541|NCT02132312|12439285|FG000|Overall Study|Withdrawal by Subject|1
7917542|NCT02132312|12439286|FG001|Overall Study|Withdrawal by Subject|0
7917543|NCT02132312|12439285|FG000|Overall Study|Lost to Follow-up|2
7917544|NCT02132312|12439286|FG001|Overall Study|Lost to Follow-up|1
7917545|NCT02132637|12439327|FG000|Study Period 1|Withdrawal by Subject|0
7917546|NCT02132637|12439328|FG001|Study Period 1|Withdrawal by Subject|4
7917547|NCT02132637|12439327|FG000|Study Period 1|Physician Decision|1
7917548|NCT02132637|12439328|FG001|Study Period 1|Physician Decision|0
7917549|NCT02132637|12439327|FG000|Study Period 2 (Crossover)|Adverse Event|0
7917550|NCT02132637|12439328|FG001|Study Period 2 (Crossover)|Adverse Event|1
7917551|NCT02132637|12439327|FG000|Study Period 2 (Crossover)|Physician Decision|2
7917552|NCT02132637|12439328|FG001|Study Period 2 (Crossover)|Physician Decision|0
7917553|NCT02132754|12439378|FG000|Overall Study|Adverse Event|0
7917554|NCT02132754|12439379|FG001|Overall Study|Adverse Event|0
7917555|NCT02132754|12439380|FG002|Overall Study|Adverse Event|0
7917556|NCT02132754|12439381|FG003|Overall Study|Adverse Event|0
7917557|NCT02132754|12439382|FG004|Overall Study|Adverse Event|0
7917558|NCT02132754|12439383|FG005|Overall Study|Adverse Event|0
7917559|NCT02132754|12439384|FG006|Overall Study|Adverse Event|0
7917560|NCT02132754|12439385|FG007|Overall Study|Adverse Event|0
7917561|NCT02132754|12439386|FG008|Overall Study|Adverse Event|0
7917562|NCT02132754|12439387|FG009|Overall Study|Adverse Event|0
7917563|NCT02132754|12439388|FG010|Overall Study|Adverse Event|0
7917564|NCT02132754|12439389|FG011|Overall Study|Adverse Event|0
7917565|NCT02132754|12439390|FG012|Overall Study|Adverse Event|0
7917566|NCT02132754|12439391|FG013|Overall Study|Adverse Event|0
7917567|NCT02132754|12439392|FG014|Overall Study|Adverse Event|0
7917568|NCT02132754|12439393|FG015|Overall Study|Adverse Event|0
7917569|NCT02132754|12439394|FG016|Overall Study|Adverse Event|0
7917570|NCT02132754|12439395|FG017|Overall Study|Adverse Event|1
7917571|NCT02132754|12439396|FG018|Overall Study|Adverse Event|0
7917572|NCT02132754|12439397|FG019|Overall Study|Adverse Event|0
7917573|NCT02132754|12439398|FG020|Overall Study|Adverse Event|0
7917574|NCT02132754|12439399|FG021|Overall Study|Adverse Event|0
7917575|NCT02132754|12439400|FG022|Overall Study|Adverse Event|0
7917576|NCT02132754|12439401|FG023|Overall Study|Adverse Event|0
7917577|NCT02132754|12439402|FG024|Overall Study|Adverse Event|0
7917578|NCT02132754|12439403|FG025|Overall Study|Adverse Event|1
7917579|NCT02132754|12439404|FG026|Overall Study|Adverse Event|1
7917580|NCT02132754|12439405|FG027|Overall Study|Adverse Event|0
7917581|NCT02132754|12439406|FG028|Overall Study|Adverse Event|0
7917582|NCT02132754|12439407|FG029|Overall Study|Adverse Event|0
7917583|NCT02132754|12439408|FG030|Overall Study|Adverse Event|1
7917584|NCT02132754|12439409|FG031|Overall Study|Adverse Event|0
7917585|NCT02132754|12439410|FG032|Overall Study|Adverse Event|1
7917586|NCT02132754|12439411|FG033|Overall Study|Adverse Event|1
7917587|NCT02132754|12439378|FG000|Overall Study|Clinical Progression|0
7917588|NCT02132754|12439379|FG001|Overall Study|Clinical Progression|0
7917589|NCT02132754|12439380|FG002|Overall Study|Clinical Progression|0
7917590|NCT02132754|12439381|FG003|Overall Study|Clinical Progression|0
7917591|NCT02132754|12439382|FG004|Overall Study|Clinical Progression|0
7917592|NCT02132754|12439383|FG005|Overall Study|Clinical Progression|0
7917593|NCT02132754|12439384|FG006|Overall Study|Clinical Progression|0
7917594|NCT02132754|12439385|FG007|Overall Study|Clinical Progression|0
7917595|NCT02132754|12439386|FG008|Overall Study|Clinical Progression|0
7917596|NCT02132754|12439387|FG009|Overall Study|Clinical Progression|1
7917597|NCT02132754|12439388|FG010|Overall Study|Clinical Progression|0
7917598|NCT02132754|12439389|FG011|Overall Study|Clinical Progression|0
7917599|NCT02132754|12439390|FG012|Overall Study|Clinical Progression|0
7917600|NCT02132754|12439391|FG013|Overall Study|Clinical Progression|0
7917601|NCT02132754|12439392|FG014|Overall Study|Clinical Progression|0
7917602|NCT02132754|12439393|FG015|Overall Study|Clinical Progression|0
7917603|NCT02132754|12439394|FG016|Overall Study|Clinical Progression|1
7917604|NCT02132754|12439395|FG017|Overall Study|Clinical Progression|1
7917605|NCT02132754|12439396|FG018|Overall Study|Clinical Progression|0
7917606|NCT02132754|12439397|FG019|Overall Study|Clinical Progression|1
7917607|NCT02132754|12439398|FG020|Overall Study|Clinical Progression|0
7917608|NCT02132754|12439399|FG021|Overall Study|Clinical Progression|0
7917609|NCT02132754|12439400|FG022|Overall Study|Clinical Progression|1
7917610|NCT02132754|12439401|FG023|Overall Study|Clinical Progression|0
7917611|NCT02132754|12439402|FG024|Overall Study|Clinical Progression|1
7917612|NCT02132754|12439403|FG025|Overall Study|Clinical Progression|1
7917613|NCT02132754|12439404|FG026|Overall Study|Clinical Progression|0
7917614|NCT02132754|12439405|FG027|Overall Study|Clinical Progression|1
7917615|NCT02132754|12439406|FG028|Overall Study|Clinical Progression|1
7917616|NCT02132754|12439407|FG029|Overall Study|Clinical Progression|0
7917617|NCT02132754|12439408|FG030|Overall Study|Clinical Progression|1
7917618|NCT02132754|12439409|FG031|Overall Study|Clinical Progression|0
7917619|NCT02132754|12439410|FG032|Overall Study|Clinical Progression|0
7917620|NCT02132754|12439411|FG033|Overall Study|Clinical Progression|2
7917621|NCT02132754|12439378|FG000|Overall Study|Death|0
7917622|NCT02132754|12439379|FG001|Overall Study|Death|0
7917623|NCT02132754|12439380|FG002|Overall Study|Death|0
7917624|NCT02132754|12439381|FG003|Overall Study|Death|0
7917625|NCT02132754|12439382|FG004|Overall Study|Death|0
7917626|NCT02132754|12439383|FG005|Overall Study|Death|0
7917627|NCT02132754|12439384|FG006|Overall Study|Death|0
7917628|NCT02132754|12439385|FG007|Overall Study|Death|0
7917629|NCT02132754|12439386|FG008|Overall Study|Death|0
7917630|NCT02132754|12439387|FG009|Overall Study|Death|0
7917631|NCT02132754|12439388|FG010|Overall Study|Death|0
7917632|NCT02132754|12439389|FG011|Overall Study|Death|0
7917633|NCT02132754|12439390|FG012|Overall Study|Death|0
7917634|NCT02132754|12439391|FG013|Overall Study|Death|0
7917635|NCT02132754|12439392|FG014|Overall Study|Death|0
7917636|NCT02132754|12439393|FG015|Overall Study|Death|1
7917637|NCT02132754|12439394|FG016|Overall Study|Death|0
7917638|NCT02132754|12439395|FG017|Overall Study|Death|0
7917639|NCT02132754|12439396|FG018|Overall Study|Death|0
7917640|NCT02132754|12439397|FG019|Overall Study|Death|1
7917641|NCT02132754|12439398|FG020|Overall Study|Death|0
7917642|NCT02132754|12439399|FG021|Overall Study|Death|1
7917643|NCT02132754|12439400|FG022|Overall Study|Death|0
7917644|NCT02132754|12439401|FG023|Overall Study|Death|0
7917645|NCT02132754|12439402|FG024|Overall Study|Death|0
7917646|NCT02132754|12439403|FG025|Overall Study|Death|0
7917647|NCT02132754|12439404|FG026|Overall Study|Death|1
7917648|NCT02132754|12439405|FG027|Overall Study|Death|0
7917649|NCT02132754|12439406|FG028|Overall Study|Death|0
7917650|NCT02132754|12439407|FG029|Overall Study|Death|0
7917651|NCT02132754|12439408|FG030|Overall Study|Death|0
7917652|NCT02132754|12439409|FG031|Overall Study|Death|0
7917653|NCT02132754|12439410|FG032|Overall Study|Death|0
7917654|NCT02132754|12439411|FG033|Overall Study|Death|2
7917655|NCT02132754|12439378|FG000|Overall Study|Excluded Medication|0
7917656|NCT02132754|12439379|FG001|Overall Study|Excluded Medication|0
7917657|NCT02132754|12439380|FG002|Overall Study|Excluded Medication|0
7917658|NCT02132754|12439381|FG003|Overall Study|Excluded Medication|0
7917659|NCT02132754|12439382|FG004|Overall Study|Excluded Medication|0
7917660|NCT02132754|12439383|FG005|Overall Study|Excluded Medication|0
7917661|NCT02132754|12439384|FG006|Overall Study|Excluded Medication|0
7917662|NCT02132754|12439385|FG007|Overall Study|Excluded Medication|0
7917663|NCT02132754|12439386|FG008|Overall Study|Excluded Medication|0
7917664|NCT02132754|12439387|FG009|Overall Study|Excluded Medication|0
7917665|NCT02132754|12439388|FG010|Overall Study|Excluded Medication|0
7917666|NCT02132754|12439389|FG011|Overall Study|Excluded Medication|0
7917667|NCT02132754|12439390|FG012|Overall Study|Excluded Medication|0
7917668|NCT02132754|12439391|FG013|Overall Study|Excluded Medication|0
7917669|NCT02132754|12439392|FG014|Overall Study|Excluded Medication|0
7821212|NCT01254188|12289864|FG000|Overall Study|Death|4
7821213|NCT01254188|12289864|FG000|Overall Study|Lost to Follow-up|5
7821214|NCT01254188|12289864|FG000|Overall Study|Withdrawal by Subject|7
7821215|NCT01254188|12289864|FG000|Overall Study|Adverse Event|43
7821216|NCT01254188|12289864|FG000|Overall Study|per investigator discretion|20
7821217|NCT01254227|12289877|FG000|Overall Study|Withdrawal by Subject|6
7821218|NCT01254227|12289877|FG000|Overall Study|Lost to Follow-up|6
7821219|NCT01254227|12289877|FG000|Overall Study|Adverse Event|5
7821220|NCT01254227|12289877|FG000|Overall Study|Abnormal test procedure result|5
7821221|NCT01254227|12289877|FG000|Overall Study|Administrative problems|2
7821222|NCT01254227|12289877|FG000|Overall Study|Death|1
7821223|NCT01254227|12289877|FG000|Overall Study|Protocol deviation|1
7821224|NCT01254292|12289883|FG000|Comparative Phase|Adverse Event|25
7821225|NCT01254292|12289884|FG001|Comparative Phase|Adverse Event|25
7821226|NCT01254292|12289883|FG000|Comparative Phase|Lost to Follow-up|3
7821227|NCT01254292|12289884|FG001|Comparative Phase|Lost to Follow-up|21
7821228|NCT01254292|12289883|FG000|Comparative Phase|Pregnancy|2
7821229|NCT01254292|12289884|FG001|Comparative Phase|Pregnancy|6
7821230|NCT01254292|12289883|FG000|Comparative Phase|Withdrawal by Subject|20
7821231|NCT01254292|12289884|FG001|Comparative Phase|Withdrawal by Subject|21
7821232|NCT01254292|12289883|FG000|Comparative Phase|Protocol Violation|1
7821233|NCT01254292|12289884|FG001|Comparative Phase|Protocol Violation|2
7821234|NCT01254292|12289883|FG000|Comparative Phase|Wish for pregnancy|4
7821235|NCT01254292|12289884|FG001|Comparative Phase|Wish for pregnancy|6
7821236|NCT01254292|12289883|FG000|LCS12 Extension Phase|Wish for pregnancy|14
7821237|NCT01254292|12289884|FG001|LCS12 Extension Phase|Wish for pregnancy|0
7821238|NCT01254292|12289883|FG000|LCS12 Extension Phase|Adverse Event|9
7821239|NCT01254292|12289884|FG001|LCS12 Extension Phase|Adverse Event|0
7821240|NCT01254292|12289883|FG000|LCS12 Extension Phase|Withdrawal by Subject|7
7821241|NCT01254292|12289884|FG001|LCS12 Extension Phase|Withdrawal by Subject|0
7821242|NCT01254292|12289883|FG000|LCS12 Extension Phase|Other unknown|4
7821243|NCT01254292|12289884|FG001|LCS12 Extension Phase|Other unknown|0
7821244|NCT01254292|12289883|FG000|LCS12 Extension Phase|Pregnancy|2
7821245|NCT01254292|12289884|FG001|LCS12 Extension Phase|Pregnancy|0
7821246|NCT01254292|12289883|FG000|LCS12 Extension Phase|Lost to Follow-up|1
7821247|NCT01254292|12289884|FG001|LCS12 Extension Phase|Lost to Follow-up|0
7821248|NCT01254305|12289894|FG000|Overall Study|Adverse Event|6
7821249|NCT01254305|12289895|FG001|Overall Study|Adverse Event|3
7821250|NCT01254305|12289896|FG002|Overall Study|Adverse Event|2
7821251|NCT01254305|12289894|FG000|Overall Study|Lack of Efficacy|1
7821252|NCT01254305|12289895|FG001|Overall Study|Lack of Efficacy|0
7821253|NCT01254305|12289896|FG002|Overall Study|Lack of Efficacy|1
7821254|NCT01254305|12289894|FG000|Overall Study|Protocol Violation|1
7821255|NCT01254305|12289895|FG001|Overall Study|Protocol Violation|7
7821256|NCT01254305|12289896|FG002|Overall Study|Protocol Violation|3
7821257|NCT01254305|12289894|FG000|Overall Study|Withdrawal by Subject|4
7821258|NCT01254305|12289895|FG001|Overall Study|Withdrawal by Subject|2
7917670|NCT02132754|12439393|FG015|Overall Study|Excluded Medication|0
7917671|NCT02132754|12439394|FG016|Overall Study|Excluded Medication|0
7821259|NCT01254305|12289896|FG002|Overall Study|Withdrawal by Subject|4
7821260|NCT01254305|12289894|FG000|Overall Study|Lost to Follow-up|10
7821261|NCT01254305|12289895|FG001|Overall Study|Lost to Follow-up|6
7821262|NCT01254305|12289896|FG002|Overall Study|Lost to Follow-up|5
7821263|NCT01254305|12289894|FG000|Overall Study|Other Reasons|0
7821264|NCT01254305|12289895|FG001|Overall Study|Other Reasons|0
7821265|NCT01254305|12289896|FG002|Overall Study|Other Reasons|2
7821266|NCT01254318|12289907|FG000|Overall Study|Lost to Follow-up|5
7821267|NCT01254318|12289907|FG000|Overall Study|Death|47
7821268|NCT01254331|12289911|FG000|Initial Phase|Adverse Event|3
7821269|NCT01254331|12289911|FG000|Initial Phase|Withdrawal by Subject|1
7821270|NCT01254331|12289911|FG000|Initial Phase|Pregnancy|1
7821271|NCT01254331|12289911|FG000|Extension Phase|Lack of Efficacy|1
7821272|NCT01254331|12289911|FG000|Extension Phase|Lost to Follow-up|3
7821273|NCT01254344|12289917|FG000|Overall Study|Adverse Event|2
7821274|NCT01254344|12289918|FG001|Overall Study|Adverse Event|5
7821275|NCT01254344|12289917|FG000|Overall Study|Physician Decision|7
7821276|NCT01254344|12289918|FG001|Overall Study|Physician Decision|4
7821277|NCT01254344|12289917|FG000|Overall Study|Protocol Violation|1
7821278|NCT01254344|12289918|FG001|Overall Study|Protocol Violation|4
7821279|NCT01254344|12289917|FG000|Overall Study|Withdrawal by Subject|3
7821280|NCT01254344|12289918|FG001|Overall Study|Withdrawal by Subject|6
7821281|NCT01254565|12289945|FG000|Overall Study|Non-compliance to Study Procedures|0
7821282|NCT01254565|12289946|FG001|Overall Study|Non-compliance to Study Procedures|0
7821283|NCT01254565|12289947|FG002|Overall Study|Non-compliance to Study Procedures|0
7821284|NCT01254565|12289948|FG003|Overall Study|Non-compliance to Study Procedures|0
7821285|NCT01254565|12289949|FG004|Overall Study|Non-compliance to Study Procedures|1
7821286|NCT01254565|12289950|FG005|Overall Study|Non-compliance to Study Procedures|0
7821287|NCT01254565|12289945|FG000|Overall Study|Did not Receive Treatment|1
7917672|NCT02132754|12439395|FG017|Overall Study|Excluded Medication|0
7917673|NCT02132754|12439396|FG018|Overall Study|Excluded Medication|0
7917674|NCT02132754|12439397|FG019|Overall Study|Excluded Medication|0
7917675|NCT02132754|12439398|FG020|Overall Study|Excluded Medication|1
7917676|NCT02132754|12439399|FG021|Overall Study|Excluded Medication|0
7917677|NCT02132754|12439400|FG022|Overall Study|Excluded Medication|0
7917678|NCT02132754|12439401|FG023|Overall Study|Excluded Medication|0
7917679|NCT02132754|12439402|FG024|Overall Study|Excluded Medication|0
7821288|NCT01254565|12289946|FG001|Overall Study|Did not Receive Treatment|1
7821289|NCT01254565|12289947|FG002|Overall Study|Did not Receive Treatment|0
7821290|NCT01254565|12289948|FG003|Overall Study|Did not Receive Treatment|0
7821291|NCT01254565|12289949|FG004|Overall Study|Did not Receive Treatment|3
7821292|NCT01254565|12289950|FG005|Overall Study|Did not Receive Treatment|4
7821293|NCT01254565|12289945|FG000|Overall Study|Other|0
7821294|NCT01254565|12289946|FG001|Overall Study|Other|0
7821295|NCT01254565|12289947|FG002|Overall Study|Other|0
7821296|NCT01254565|12289948|FG003|Overall Study|Other|1
7821297|NCT01254565|12289949|FG004|Overall Study|Other|0
7821298|NCT01254565|12289950|FG005|Overall Study|Other|0
7821299|NCT01254604|12289966|FG000|Overall Study|Lost to Follow-up|1
7821300|NCT01254604|12289967|FG001|Overall Study|Lost to Follow-up|1
7821301|NCT01254604|12289966|FG000|Overall Study|Protocol Violation|2
7821302|NCT01254604|12289967|FG001|Overall Study|Protocol Violation|2
7821303|NCT01254604|12289966|FG000|Overall Study|Withdrawal by Subject|2
7821304|NCT01254604|12289967|FG001|Overall Study|Withdrawal by Subject|4
7821305|NCT01254604|12289966|FG000|Overall Study|Adverse Event|3
7821306|NCT01254604|12289967|FG001|Overall Study|Adverse Event|2
7821307|NCT01254630|12289977|FG000|Overall Study|Adverse Event|36
7821308|NCT01254630|12289978|FG001|Overall Study|Adverse Event|15
7821309|NCT01254630|12289979|FG002|Overall Study|Adverse Event|40
7821310|NCT01254630|12289980|FG003|Overall Study|Adverse Event|8
7821311|NCT01254630|12289977|FG000|Overall Study|Death|461
7821312|NCT01254630|12289978|FG001|Overall Study|Death|151
7821313|NCT01254630|12289979|FG002|Overall Study|Death|478
7821314|NCT01254630|12289980|FG003|Overall Study|Death|139
7821315|NCT01254630|12289977|FG000|Overall Study|Lost to Follow-up|80
7821316|NCT01254630|12289978|FG001|Overall Study|Lost to Follow-up|26
7821317|NCT01254630|12289979|FG002|Overall Study|Lost to Follow-up|89
7821318|NCT01254630|12289980|FG003|Overall Study|Lost to Follow-up|32
7821319|NCT01254630|12289977|FG000|Overall Study|Physician Decision|24
7821320|NCT01254630|12289978|FG001|Overall Study|Physician Decision|8
7821321|NCT01254630|12289979|FG002|Overall Study|Physician Decision|16
7821322|NCT01254630|12289980|FG003|Overall Study|Physician Decision|7
7821323|NCT01254630|12289977|FG000|Overall Study|Withdrawal by Subject|201
7821324|NCT01254630|12289978|FG001|Overall Study|Withdrawal by Subject|94
7821325|NCT01254630|12289979|FG002|Overall Study|Withdrawal by Subject|188
7821326|NCT01254630|12289980|FG003|Overall Study|Withdrawal by Subject|89
7821327|NCT01254630|12289977|FG000|Overall Study|Study terminated by sponsor|0
7821328|NCT01254630|12289978|FG001|Overall Study|Study terminated by sponsor|994
7821329|NCT01254630|12289979|FG002|Overall Study|Study terminated by sponsor|0
7821330|NCT01254630|12289980|FG003|Overall Study|Study terminated by sponsor|1010
7821331|NCT01254630|12289977|FG000|Overall Study|Status not recorded|0
7821332|NCT01254630|12289978|FG001|Overall Study|Status not recorded|0
7821333|NCT01254630|12289979|FG002|Overall Study|Status not recorded|1
7821334|NCT01254630|12289980|FG003|Overall Study|Status not recorded|0
7821335|NCT01254643|12289988|FG000|Overall Study|Withdrawal by Subject|1
7821336|NCT01254656|12289995|FG000|Overall Study|Discontinued due to termination of study|40
7821337|NCT01254656|12289996|FG001|Overall Study|Discontinued due to termination of study|39
7821338|NCT01254656|12289997|FG002|Overall Study|Discontinued due to termination of study|13
7821339|NCT01254656|12289995|FG000|Overall Study|Lack of Efficacy|3
7821340|NCT01254656|12289996|FG001|Overall Study|Lack of Efficacy|0
7821341|NCT01254656|12289997|FG002|Overall Study|Lack of Efficacy|0
7821342|NCT01254656|12289995|FG000|Overall Study|Lost to Follow-up|1
7821343|NCT01254656|12289996|FG001|Overall Study|Lost to Follow-up|0
7821344|NCT01254656|12289997|FG002|Overall Study|Lost to Follow-up|2
7821345|NCT01254656|12289995|FG000|Overall Study|Withdrawal by Subject|2
7821346|NCT01254656|12289996|FG001|Overall Study|Withdrawal by Subject|2
7821347|NCT01254656|12289997|FG002|Overall Study|Withdrawal by Subject|1
7821348|NCT01254656|12289995|FG000|Overall Study|Pregnancy|0
7821349|NCT01254656|12289996|FG001|Overall Study|Pregnancy|0
7821350|NCT01254656|12289997|FG002|Overall Study|Pregnancy|2
7821351|NCT01254656|12289995|FG000|Overall Study|Adverse Event|1
7821352|NCT01254656|12289996|FG001|Overall Study|Adverse Event|1
7821353|NCT01254656|12289997|FG002|Overall Study|Adverse Event|0
7821354|NCT01254656|12289995|FG000|Overall Study|Death|0
7821355|NCT01254656|12289996|FG001|Overall Study|Death|1
7821356|NCT01254656|12289997|FG002|Overall Study|Death|0
7821357|NCT01254669|12290007|FG000|Overall Study|Withdrawal by Subject|0
7821358|NCT01254669|12290008|FG001|Overall Study|Withdrawal by Subject|1
7821359|NCT01254669|12290007|FG000|Overall Study|time constraint|2
7821360|NCT01254669|12290008|FG001|Overall Study|time constraint|2
7821361|NCT01254669|12290007|FG000|Overall Study|called to clinic during intervention|1
7821362|NCT01254669|12290008|FG001|Overall Study|called to clinic during intervention|1
7821363|NCT01254721|12290018|FG000|Overall Study|Lost to Follow-up|0
7821364|NCT01254721|12290019|FG001|Overall Study|Lost to Follow-up|4
7821365|NCT01254721|12290018|FG000|Overall Study|Lack of Efficacy|4
7821366|NCT01254721|12290019|FG001|Overall Study|Lack of Efficacy|2
7821367|NCT01254721|12290018|FG000|Overall Study|Death|0
7821368|NCT01254721|12290019|FG001|Overall Study|Death|1
7821369|NCT01254721|12290018|FG000|Overall Study|technical problum|1
7821370|NCT01254721|12290019|FG001|Overall Study|technical problum|0
7821371|NCT01254721|12290018|FG000|Overall Study|Adverse Event|2
7821372|NCT01254721|12290019|FG001|Overall Study|Adverse Event|3
7821373|NCT01254721|12290018|FG000|Overall Study|Withdrawal by Subject|8
7821374|NCT01254721|12290019|FG001|Overall Study|Withdrawal by Subject|11
7821375|NCT01254721|12290018|FG000|Overall Study|Wrongly randomization|0
7821376|NCT01254721|12290019|FG001|Overall Study|Wrongly randomization|1
7821377|NCT01254747|12290029|FG000|Overall Study|Unacceptable subjective vision|0
7821378|NCT01254747|12290030|FG001|Overall Study|Unacceptable subjective vision|0
7821379|NCT01254747|12290031|FG002|Overall Study|Unacceptable subjective vision|0
7821380|NCT01254747|12290032|FG003|Overall Study|Unacceptable subjective vision|2
7917680|NCT02132754|12439403|FG025|Overall Study|Excluded Medication|0
7917681|NCT02132754|12439404|FG026|Overall Study|Excluded Medication|0
7917682|NCT02132754|12439405|FG027|Overall Study|Excluded Medication|0
7917683|NCT02132754|12439406|FG028|Overall Study|Excluded Medication|0
7917684|NCT02132754|12439407|FG029|Overall Study|Excluded Medication|0
7917685|NCT02132754|12439408|FG030|Overall Study|Excluded Medication|0
7917686|NCT02132754|12439409|FG031|Overall Study|Excluded Medication|0
7917687|NCT02132754|12439410|FG032|Overall Study|Excluded Medication|0
7917688|NCT02132754|12439411|FG033|Overall Study|Excluded Medication|1
7917689|NCT02132754|12439378|FG000|Overall Study|Physician Decision|0
7917690|NCT02132754|12439379|FG001|Overall Study|Physician Decision|0
7917691|NCT02132754|12439380|FG002|Overall Study|Physician Decision|0
7917692|NCT02132754|12439381|FG003|Overall Study|Physician Decision|0
7917693|NCT02132754|12439382|FG004|Overall Study|Physician Decision|0
7917694|NCT02132754|12439383|FG005|Overall Study|Physician Decision|0
7917695|NCT02132754|12439384|FG006|Overall Study|Physician Decision|0
7917696|NCT02132754|12439385|FG007|Overall Study|Physician Decision|0
7917697|NCT02132754|12439386|FG008|Overall Study|Physician Decision|0
7917698|NCT02132754|12439387|FG009|Overall Study|Physician Decision|1
7917699|NCT02132754|12439388|FG010|Overall Study|Physician Decision|0
7917700|NCT02132754|12439389|FG011|Overall Study|Physician Decision|1
7917701|NCT02132754|12439390|FG012|Overall Study|Physician Decision|1
7917702|NCT02132754|12439391|FG013|Overall Study|Physician Decision|0
7917703|NCT02132754|12439392|FG014|Overall Study|Physician Decision|0
7917704|NCT02132754|12439393|FG015|Overall Study|Physician Decision|1
7917705|NCT02132754|12439394|FG016|Overall Study|Physician Decision|0
7917706|NCT02132754|12439395|FG017|Overall Study|Physician Decision|0
7917707|NCT02132754|12439396|FG018|Overall Study|Physician Decision|0
7917708|NCT02132754|12439397|FG019|Overall Study|Physician Decision|0
7917709|NCT02132754|12439398|FG020|Overall Study|Physician Decision|0
7917710|NCT02132754|12439399|FG021|Overall Study|Physician Decision|0
7821381|NCT01254747|12290029|FG000|Overall Study|Difficult removal handling|0
7917711|NCT02132754|12439400|FG022|Overall Study|Physician Decision|0
7917712|NCT02132754|12439401|FG023|Overall Study|Physician Decision|0
7917713|NCT02132754|12439402|FG024|Overall Study|Physician Decision|1
7917714|NCT02132754|12439403|FG025|Overall Study|Physician Decision|0
7917715|NCT02132754|12439404|FG026|Overall Study|Physician Decision|0
7917716|NCT02132754|12439405|FG027|Overall Study|Physician Decision|0
7917717|NCT02132754|12439406|FG028|Overall Study|Physician Decision|0
7917718|NCT02132754|12439407|FG029|Overall Study|Physician Decision|0
7917719|NCT02132754|12439408|FG030|Overall Study|Physician Decision|0
7917720|NCT02132754|12439409|FG031|Overall Study|Physician Decision|1
7917721|NCT02132754|12439410|FG032|Overall Study|Physician Decision|0
7917722|NCT02132754|12439411|FG033|Overall Study|Physician Decision|3
7917723|NCT02132754|12439378|FG000|Overall Study|Progressive Disease|1
7917724|NCT02132754|12439379|FG001|Overall Study|Progressive Disease|1
7917725|NCT02132754|12439380|FG002|Overall Study|Progressive Disease|1
7917726|NCT02132754|12439381|FG003|Overall Study|Progressive Disease|1
7917727|NCT02132754|12439382|FG004|Overall Study|Progressive Disease|1
7917728|NCT02132754|12439383|FG005|Overall Study|Progressive Disease|1
7917729|NCT02132754|12439384|FG006|Overall Study|Progressive Disease|1
7917730|NCT02132754|12439385|FG007|Overall Study|Progressive Disease|1
7917731|NCT02132754|12439386|FG008|Overall Study|Progressive Disease|1
7917732|NCT02132754|12439387|FG009|Overall Study|Progressive Disease|3
7917733|NCT02132754|12439388|FG010|Overall Study|Progressive Disease|3
7917734|NCT02132754|12439389|FG011|Overall Study|Progressive Disease|2
7917735|NCT02132754|12439390|FG012|Overall Study|Progressive Disease|2
7917736|NCT02132754|12439391|FG013|Overall Study|Progressive Disease|3
7917737|NCT02132754|12439392|FG014|Overall Study|Progressive Disease|2
7917738|NCT02132754|12439393|FG015|Overall Study|Progressive Disease|1
7821382|NCT01254747|12290030|FG001|Overall Study|Difficult removal handling|0
7821383|NCT01254747|12290031|FG002|Overall Study|Difficult removal handling|1
7821384|NCT01254747|12290032|FG003|Overall Study|Difficult removal handling|0
7821385|NCT01254747|12290029|FG000|Overall Study|Symptoms and problems|0
7917739|NCT02132754|12439394|FG016|Overall Study|Progressive Disease|2
7917740|NCT02132754|12439395|FG017|Overall Study|Progressive Disease|1
7917741|NCT02132754|12439396|FG018|Overall Study|Progressive Disease|3
7917742|NCT02132754|12439397|FG019|Overall Study|Progressive Disease|1
7917743|NCT02132754|12439398|FG020|Overall Study|Progressive Disease|1
7917744|NCT02132754|12439399|FG021|Overall Study|Progressive Disease|3
7917745|NCT02132754|12439400|FG022|Overall Study|Progressive Disease|2
7821386|NCT01254747|12290030|FG001|Overall Study|Symptoms and problems|2
7821387|NCT01254747|12290031|FG002|Overall Study|Symptoms and problems|1
7821388|NCT01254747|12290032|FG003|Overall Study|Symptoms and problems|0
7821389|NCT01254747|12290029|FG000|Overall Study|Lost to Follow-up|0
7821390|NCT01254747|12290030|FG001|Overall Study|Lost to Follow-up|0
7821391|NCT01254747|12290031|FG002|Overall Study|Lost to Follow-up|1
7821392|NCT01254747|12290032|FG003|Overall Study|Lost to Follow-up|0
7821393|NCT01254747|12290029|FG000|Overall Study|Biomicroscopy|0
7821394|NCT01254747|12290030|FG001|Overall Study|Biomicroscopy|0
7821395|NCT01254747|12290031|FG002|Overall Study|Biomicroscopy|1
7821396|NCT01254747|12290032|FG003|Overall Study|Biomicroscopy|0
7821397|NCT01254747|12290029|FG000|Overall Study|Discomfort|0
7821398|NCT01254747|12290030|FG001|Overall Study|Discomfort|4
7821399|NCT01254747|12290031|FG002|Overall Study|Discomfort|0
7821400|NCT01254747|12290032|FG003|Overall Study|Discomfort|0
7821401|NCT01254890|12290074|FG000|Overall Study|Ineligible|0
7821402|NCT01254890|12290075|FG001|Overall Study|Ineligible|3
7821403|NCT01254890|12290074|FG000|Overall Study|Withdrawal by Subject|1
7821404|NCT01254890|12290075|FG001|Overall Study|Withdrawal by Subject|2
7821405|NCT01254890|12290074|FG000|Overall Study|Disease Progression|0
7821406|NCT01254890|12290075|FG001|Overall Study|Disease Progression|5
7821407|NCT01255163|12290086|FG000|Overall Study|Withdrawal by Subject|1
7821408|NCT01255163|12290087|FG001|Overall Study|Withdrawal by Subject|0
7821409|NCT01255163|12290086|FG000|Overall Study|Lost to Follow-up|2
7821410|NCT01255163|12290087|FG001|Overall Study|Lost to Follow-up|0
7821411|NCT01255163|12290086|FG000|Overall Study|Adverse Event|0
7821412|NCT01255163|12290087|FG001|Overall Study|Adverse Event|2
7821413|NCT01255163|12290086|FG000|Overall Study|AstraZeneca stopped support of the study|1
7821414|NCT01255163|12290087|FG001|Overall Study|AstraZeneca stopped support of the study|3
7821415|NCT01255306|12290097|FG000|Overall Study|Physician Decision|1
7821416|NCT01255306|12290098|FG001|Overall Study|Physician Decision|1
7821417|NCT01255423|12290109|FG000|Overall Study|Abnormal Laboratory value|3
7821418|NCT01255423|12290110|FG001|Overall Study|Abnormal Laboratory value|2
7917746|NCT02132754|12439401|FG023|Overall Study|Progressive Disease|3
7917747|NCT02132754|12439402|FG024|Overall Study|Progressive Disease|0
7917748|NCT02132754|12439403|FG025|Overall Study|Progressive Disease|1
7917749|NCT02132754|12439404|FG026|Overall Study|Progressive Disease|2
7917750|NCT02132754|12439405|FG027|Overall Study|Progressive Disease|1
7917751|NCT02132754|12439406|FG028|Overall Study|Progressive Disease|2
7917752|NCT02132754|12439407|FG029|Overall Study|Progressive Disease|3
7917753|NCT02132754|12439408|FG030|Overall Study|Progressive Disease|1
7917754|NCT02132754|12439409|FG031|Overall Study|Progressive Disease|1
7917755|NCT02132754|12439410|FG032|Overall Study|Progressive Disease|3
7821419|NCT01255423|12290109|FG000|Overall Study|Use of prohibited medications|0
7917756|NCT02132754|12439411|FG033|Overall Study|Progressive Disease|6
7917757|NCT02132754|12439378|FG000|Overall Study|Screen Failure|0
7917758|NCT02132754|12439379|FG001|Overall Study|Screen Failure|0
7917759|NCT02132754|12439380|FG002|Overall Study|Screen Failure|0
7917760|NCT02132754|12439381|FG003|Overall Study|Screen Failure|0
7917761|NCT02132754|12439382|FG004|Overall Study|Screen Failure|0
7917762|NCT02132754|12439383|FG005|Overall Study|Screen Failure|0
7917763|NCT02132754|12439384|FG006|Overall Study|Screen Failure|0
7917764|NCT02132754|12439385|FG007|Overall Study|Screen Failure|0
7917765|NCT02132754|12439386|FG008|Overall Study|Screen Failure|0
7917766|NCT02132754|12439387|FG009|Overall Study|Screen Failure|0
7917767|NCT02132754|12439388|FG010|Overall Study|Screen Failure|0
7917768|NCT02132754|12439389|FG011|Overall Study|Screen Failure|0
7917769|NCT02132754|12439390|FG012|Overall Study|Screen Failure|0
7917770|NCT02132754|12439391|FG013|Overall Study|Screen Failure|0
7917771|NCT02132754|12439392|FG014|Overall Study|Screen Failure|0
7917772|NCT02132754|12439393|FG015|Overall Study|Screen Failure|0
7917773|NCT02132754|12439394|FG016|Overall Study|Screen Failure|0
7917774|NCT02132754|12439395|FG017|Overall Study|Screen Failure|0
7917775|NCT02132754|12439396|FG018|Overall Study|Screen Failure|0
7917776|NCT02132754|12439397|FG019|Overall Study|Screen Failure|1
7917777|NCT02132754|12439398|FG020|Overall Study|Screen Failure|0
7917778|NCT02132754|12439399|FG021|Overall Study|Screen Failure|1
7917779|NCT02132754|12439400|FG022|Overall Study|Screen Failure|0
7917780|NCT02132754|12439401|FG023|Overall Study|Screen Failure|0
7917781|NCT02132754|12439402|FG024|Overall Study|Screen Failure|0
7917782|NCT02132754|12439403|FG025|Overall Study|Screen Failure|0
7917783|NCT02132754|12439404|FG026|Overall Study|Screen Failure|0
7917784|NCT02132754|12439405|FG027|Overall Study|Screen Failure|0
7917785|NCT02132754|12439406|FG028|Overall Study|Screen Failure|0
7917786|NCT02132754|12439407|FG029|Overall Study|Screen Failure|0
7917787|NCT02132754|12439408|FG030|Overall Study|Screen Failure|0
7917788|NCT02132754|12439409|FG031|Overall Study|Screen Failure|0
7917789|NCT02132754|12439410|FG032|Overall Study|Screen Failure|0
7917790|NCT02132754|12439411|FG033|Overall Study|Screen Failure|0
7917791|NCT02132754|12439378|FG000|Overall Study|Transferred to Extension Study|0
7917792|NCT02132754|12439379|FG001|Overall Study|Transferred to Extension Study|0
7917793|NCT02132754|12439380|FG002|Overall Study|Transferred to Extension Study|0
7821420|NCT01255423|12290110|FG001|Overall Study|Use of prohibited medications|1
7821421|NCT01255436|12290118|FG000|Overall Study|Lost to Follow-up|178
7821422|NCT01255436|12290119|FG001|Overall Study|Lost to Follow-up|191
7821423|NCT01255436|12290118|FG000|Overall Study|Death, stroke, or MI|4
7821424|NCT01255436|12290119|FG001|Overall Study|Death, stroke, or MI|3
7821425|NCT01255592|12290132|FG000|Overall Study|Adverse Event|5
7821426|NCT01255592|12290133|FG001|Overall Study|Adverse Event|0
7821427|NCT01255592|12290132|FG000|Overall Study|Withdrawal by Subject|1
7917794|NCT02132754|12439381|FG003|Overall Study|Transferred to Extension Study|0
7917795|NCT02132754|12439382|FG004|Overall Study|Transferred to Extension Study|0
7917796|NCT02132754|12439383|FG005|Overall Study|Transferred to Extension Study|0
7917797|NCT02132754|12439384|FG006|Overall Study|Transferred to Extension Study|0
7917798|NCT02132754|12439385|FG007|Overall Study|Transferred to Extension Study|0
7917799|NCT02132754|12439386|FG008|Overall Study|Transferred to Extension Study|0
7917800|NCT02132754|12439387|FG009|Overall Study|Transferred to Extension Study|0
7917801|NCT02132754|12439388|FG010|Overall Study|Transferred to Extension Study|0
7917802|NCT02132754|12439389|FG011|Overall Study|Transferred to Extension Study|0
7917803|NCT02132754|12439390|FG012|Overall Study|Transferred to Extension Study|0
7917804|NCT02132754|12439391|FG013|Overall Study|Transferred to Extension Study|0
7917805|NCT02132754|12439392|FG014|Overall Study|Transferred to Extension Study|0
7917806|NCT02132754|12439393|FG015|Overall Study|Transferred to Extension Study|0
7917807|NCT02132754|12439394|FG016|Overall Study|Transferred to Extension Study|0
7917808|NCT02132754|12439395|FG017|Overall Study|Transferred to Extension Study|0
7917809|NCT02132754|12439396|FG018|Overall Study|Transferred to Extension Study|0
7917810|NCT02132754|12439397|FG019|Overall Study|Transferred to Extension Study|0
7917811|NCT02132754|12439398|FG020|Overall Study|Transferred to Extension Study|0
7917812|NCT02132754|12439399|FG021|Overall Study|Transferred to Extension Study|0
7917813|NCT02132754|12439400|FG022|Overall Study|Transferred to Extension Study|0
7917814|NCT02132754|12439401|FG023|Overall Study|Transferred to Extension Study|0
7917815|NCT02132754|12439402|FG024|Overall Study|Transferred to Extension Study|0
7917816|NCT02132754|12439403|FG025|Overall Study|Transferred to Extension Study|0
7917817|NCT02132754|12439404|FG026|Overall Study|Transferred to Extension Study|0
7917818|NCT02132754|12439405|FG027|Overall Study|Transferred to Extension Study|0
7917819|NCT02132754|12439406|FG028|Overall Study|Transferred to Extension Study|0
7917820|NCT02132754|12439407|FG029|Overall Study|Transferred to Extension Study|0
7917821|NCT02132754|12439408|FG030|Overall Study|Transferred to Extension Study|0
7917822|NCT02132754|12439409|FG031|Overall Study|Transferred to Extension Study|0
7917823|NCT02132754|12439410|FG032|Overall Study|Transferred to Extension Study|0
7917824|NCT02132754|12439411|FG033|Overall Study|Transferred to Extension Study|6
7917825|NCT02132754|12439378|FG000|Overall Study|Withdrawal by Subject|0
7917826|NCT02132754|12439379|FG001|Overall Study|Withdrawal by Subject|0
7917827|NCT02132754|12439380|FG002|Overall Study|Withdrawal by Subject|0
7917828|NCT02132754|12439381|FG003|Overall Study|Withdrawal by Subject|0
7917829|NCT02132754|12439382|FG004|Overall Study|Withdrawal by Subject|0
7917830|NCT02132754|12439383|FG005|Overall Study|Withdrawal by Subject|0
7917831|NCT02132754|12439384|FG006|Overall Study|Withdrawal by Subject|0
7917832|NCT02132754|12439385|FG007|Overall Study|Withdrawal by Subject|0
7917833|NCT02132754|12439386|FG008|Overall Study|Withdrawal by Subject|0
7917834|NCT02132754|12439387|FG009|Overall Study|Withdrawal by Subject|1
7917835|NCT02132754|12439388|FG010|Overall Study|Withdrawal by Subject|0
7917836|NCT02132754|12439389|FG011|Overall Study|Withdrawal by Subject|0
7917837|NCT02132754|12439390|FG012|Overall Study|Withdrawal by Subject|1
7917838|NCT02132754|12439391|FG013|Overall Study|Withdrawal by Subject|0
7917839|NCT02132754|12439392|FG014|Overall Study|Withdrawal by Subject|1
7917840|NCT02132754|12439393|FG015|Overall Study|Withdrawal by Subject|2
7917841|NCT02132754|12439394|FG016|Overall Study|Withdrawal by Subject|1
7917842|NCT02132754|12439395|FG017|Overall Study|Withdrawal by Subject|0
7917843|NCT02132754|12439396|FG018|Overall Study|Withdrawal by Subject|0
7917844|NCT02132754|12439397|FG019|Overall Study|Withdrawal by Subject|0
7917845|NCT02132754|12439398|FG020|Overall Study|Withdrawal by Subject|1
7917846|NCT02132754|12439399|FG021|Overall Study|Withdrawal by Subject|0
7917847|NCT02132754|12439400|FG022|Overall Study|Withdrawal by Subject|0
7917848|NCT02132754|12439401|FG023|Overall Study|Withdrawal by Subject|0
7719532|NCT00532883|12143498|FG000|Overall Study|Early Study Termination|4
7917849|NCT02132754|12439402|FG024|Overall Study|Withdrawal by Subject|1
7917850|NCT02132754|12439403|FG025|Overall Study|Withdrawal by Subject|0
7917851|NCT02132754|12439404|FG026|Overall Study|Withdrawal by Subject|0
7917852|NCT02132754|12439405|FG027|Overall Study|Withdrawal by Subject|1
7917853|NCT02132754|12439406|FG028|Overall Study|Withdrawal by Subject|0
7917854|NCT02132754|12439407|FG029|Overall Study|Withdrawal by Subject|0
7917855|NCT02132754|12439408|FG030|Overall Study|Withdrawal by Subject|0
7917856|NCT02132754|12439409|FG031|Overall Study|Withdrawal by Subject|1
7917857|NCT02132754|12439410|FG032|Overall Study|Withdrawal by Subject|0
7917858|NCT02132754|12439411|FG033|Overall Study|Withdrawal by Subject|2
7917859|NCT02132767|12439523|FG000|Overall Study|Death|3
7917860|NCT02132767|12439524|FG001|Overall Study|Death|2
7917861|NCT02132767|12439523|FG000|Overall Study|Withdrawal by Subject|10
7917862|NCT02132767|12439524|FG001|Overall Study|Withdrawal by Subject|9
7917863|NCT02132767|12439523|FG000|Overall Study|Lost to Follow-up|4
7917864|NCT02132767|12439524|FG001|Overall Study|Lost to Follow-up|4
7917865|NCT02132949|12439568|FG000|Overall Study|Death|7
7917866|NCT02132949|12439569|FG001|Overall Study|Death|13
7917867|NCT02132949|12439568|FG000|Overall Study|Lost to Follow-up|14
7917868|NCT02132949|12439569|FG001|Overall Study|Lost to Follow-up|4
7917869|NCT02132949|12439568|FG000|Overall Study|Withdrawal by Subject|6
7917870|NCT02132949|12439569|FG001|Overall Study|Withdrawal by Subject|5
7917871|NCT02132949|12439568|FG000|Overall Study|Noncompliance|5
7917872|NCT02132949|12439569|FG001|Overall Study|Noncompliance|1
7917873|NCT02132949|12439568|FG000|Overall Study|Physician Decision|3
7917874|NCT02132949|12439569|FG001|Overall Study|Physician Decision|1
7917875|NCT02132949|12439568|FG000|Overall Study|Disease Progression|3
7917876|NCT02132949|12439569|FG001|Overall Study|Disease Progression|0
7917877|NCT02132949|12439568|FG000|Overall Study|Adverse Event|2
7917878|NCT02132949|12439569|FG001|Overall Study|Adverse Event|1
7917879|NCT02132949|12439568|FG000|Overall Study|Withdrew Prior to Treatment|1
7917880|NCT02132949|12439569|FG001|Overall Study|Withdrew Prior to Treatment|2
7917881|NCT02132949|12439568|FG000|Overall Study|Reason Unspecified|0
7917882|NCT02132949|12439569|FG001|Overall Study|Reason Unspecified|1
7917883|NCT02133001|12439577|FG000|Double Blind (Day 1-25)|Adverse Event|1
7917884|NCT02133001|12439578|FG001|Double Blind (Day 1-25)|Adverse Event|5
7917885|NCT02133001|12439577|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4
7917886|NCT02133001|12439578|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1
7917887|NCT02133001|12439577|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2
7917888|NCT02133001|12439578|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0
7917889|NCT02133001|12439577|FG000|Double Blind (Day 1-25)|Other|2
7917890|NCT02133001|12439578|FG001|Double Blind (Day 1-25)|Other|2
7917891|NCT02133001|12439577|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1
7917892|NCT02133001|12439578|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1
7917893|NCT02133001|12439577|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
7917894|NCT02133001|12439578|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
7917895|NCT02133001|12439577|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
7917896|NCT02133001|12439578|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
7917897|NCT02133001|12439577|FG000|Follow-Up Phase (Day 26-81)|Other|0
7917898|NCT02133001|12439578|FG001|Follow-Up Phase (Day 26-81)|Other|1
7917899|NCT02133131|12439602|FG000|Overall Study|Adverse Event|0
7917900|NCT02133131|12439603|FG001|Overall Study|Adverse Event|0
7917901|NCT02133131|12439604|FG002|Overall Study|Adverse Event|0
7917902|NCT02133131|12439605|FG003|Overall Study|Adverse Event|1
7917903|NCT02133131|12439606|FG004|Overall Study|Adverse Event|0
7917904|NCT02133131|12439607|FG005|Overall Study|Adverse Event|0
7917905|NCT02133131|12439608|FG006|Overall Study|Adverse Event|0
7917906|NCT02133131|12439602|FG000|Overall Study|Lost to Follow-up|1
7917907|NCT02133131|12439603|FG001|Overall Study|Lost to Follow-up|0
7917908|NCT02133131|12439604|FG002|Overall Study|Lost to Follow-up|0
7917909|NCT02133131|12439605|FG003|Overall Study|Lost to Follow-up|1
7917910|NCT02133131|12439606|FG004|Overall Study|Lost to Follow-up|0
7917911|NCT02133131|12439607|FG005|Overall Study|Lost to Follow-up|0
7917912|NCT02133131|12439608|FG006|Overall Study|Lost to Follow-up|0
7917913|NCT02133131|12439602|FG000|Overall Study|Status not recorded|4
7917914|NCT02133131|12439603|FG001|Overall Study|Status not recorded|5
7917915|NCT02133131|12439604|FG002|Overall Study|Status not recorded|1
7917916|NCT02133131|12439605|FG003|Overall Study|Status not recorded|4
7917917|NCT02133131|12439606|FG004|Overall Study|Status not recorded|0
7917918|NCT02133131|12439607|FG005|Overall Study|Status not recorded|0
7917919|NCT02133131|12439608|FG006|Overall Study|Status not recorded|0
7917920|NCT02133131|12439602|FG000|Overall Study|Ongoing in study|0
7917921|NCT02133131|12439603|FG001|Overall Study|Ongoing in study|0
7917922|NCT02133131|12439604|FG002|Overall Study|Ongoing in study|0
7917923|NCT02133131|12439605|FG003|Overall Study|Ongoing in study|0
7917924|NCT02133131|12439606|FG004|Overall Study|Ongoing in study|15
7917925|NCT02133131|12439607|FG005|Overall Study|Ongoing in study|14
7917926|NCT02133131|12439608|FG006|Overall Study|Ongoing in study|11
7917927|NCT02133131|12439602|FG000|Overall Study|Protocol Violation|0
7917928|NCT02133131|12439603|FG001|Overall Study|Protocol Violation|0
7917929|NCT02133131|12439604|FG002|Overall Study|Protocol Violation|0
7917930|NCT02133131|12439605|FG003|Overall Study|Protocol Violation|0
7917931|NCT02133131|12439606|FG004|Overall Study|Protocol Violation|0
7917932|NCT02133131|12439607|FG005|Overall Study|Protocol Violation|0
7917933|NCT02133131|12439608|FG006|Overall Study|Protocol Violation|1
7917934|NCT02133352|12439639|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
7917935|NCT02133508|12439643|FG000|Overall Study|Decision of Investigator or Sponsor|1
7917936|NCT02133508|12439643|FG000|Overall Study|Death|12
7917937|NCT02133508|12439643|FG000|Overall Study|Lost to Follow-up|2
7917938|NCT02133664|12439649|FG000|Overall Study|Lost to Follow-up|2
7917939|NCT02133664|12439650|FG001|Overall Study|Lost to Follow-up|1
7917940|NCT02133664|12439649|FG000|Overall Study|Adverse Event|3
7917941|NCT02133664|12439650|FG001|Overall Study|Adverse Event|6
7917942|NCT02133742|12439656|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2
7917943|NCT02133742|12439656|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31
7917944|NCT02133742|12439656|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13
7917945|NCT02133742|12439656|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5
7917946|NCT02133742|12439656|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1
7917947|NCT02134015|12439677|FG000|Overall Study|Protocol Violation|0
7917948|NCT02134015|12439678|FG001|Overall Study|Protocol Violation|1
7917949|NCT02134015|12439677|FG000|Overall Study|Death|2
7917950|NCT02134015|12439678|FG001|Overall Study|Death|1
7917951|NCT02134015|12439677|FG000|Overall Study|Reason not provided|1
7917952|NCT02134015|12439678|FG001|Overall Study|Reason not provided|2
7917953|NCT02134015|12439677|FG000|Overall Study|Clinical progression|14
7917954|NCT02134015|12439678|FG001|Overall Study|Clinical progression|7
7917955|NCT02134015|12439677|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40
7917956|NCT02134015|12439678|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43
7917957|NCT02134015|12439677|FG000|Overall Study|Study terminated by sponsor|2
7917958|NCT02134015|12439678|FG001|Overall Study|Study terminated by sponsor|3
7917959|NCT02134015|12439677|FG000|Overall Study|Adverse Event|9
7917960|NCT02134015|12439678|FG001|Overall Study|Adverse Event|10
7917961|NCT02134015|12439677|FG000|Overall Study|Withdrawal by Subject|3
7917962|NCT02134015|12439678|FG001|Overall Study|Withdrawal by Subject|7
7917963|NCT02134353|12439727|FG000|Overall Study|Adverse Event|10
7917964|NCT02134353|12439728|FG001|Overall Study|Adverse Event|6
7917965|NCT02134353|12439727|FG000|Overall Study|Lost to Follow-up|1
7917966|NCT02134353|12439728|FG001|Overall Study|Lost to Follow-up|1
7917967|NCT02134353|12439727|FG000|Overall Study|Lack of Efficacy|2
7917968|NCT02134353|12439728|FG001|Overall Study|Lack of Efficacy|1
7917969|NCT02134353|12439727|FG000|Overall Study|Withdrawal by Subject|12
7917970|NCT02134353|12439728|FG001|Overall Study|Withdrawal by Subject|13
7917971|NCT02134353|12439727|FG000|Overall Study|Death|0
7917972|NCT02134353|12439728|FG001|Overall Study|Death|1
7917973|NCT02134353|12439727|FG000|Overall Study|Pregnancy|0
7917974|NCT02134353|12439728|FG001|Overall Study|Pregnancy|1
7917975|NCT02134353|12439727|FG000|Overall Study|Relocation|1
7917976|NCT02134353|12439728|FG001|Overall Study|Relocation|0
7917977|NCT02134353|12439727|FG000|Overall Study|Other - Patient's Choice|0
7917978|NCT02134353|12439728|FG001|Overall Study|Other - Patient's Choice|1
7917979|NCT02134587|12439738|FG000|Overall Study|Did not completed all meetings|30
7917980|NCT02134977|12439765|FG000|Overall Study|Protocol Deviation|102
7917981|NCT02135107|12439793|FG000|Treatment Period|Withdrawal by Subject|11
7917982|NCT02135107|12439794|FG001|Treatment Period|Withdrawal by Subject|0
7917983|NCT02135107|12439795|FG002|Treatment Period|Withdrawal by Subject|0
7917984|NCT02135107|12439796|FG003|Treatment Period|Withdrawal by Subject|0
7917985|NCT02135107|12439793|FG000|Treatment Period|Adverse Event|5
7917986|NCT02135107|12439794|FG001|Treatment Period|Adverse Event|2
7917987|NCT02135107|12439795|FG002|Treatment Period|Adverse Event|0
7917988|NCT02135107|12439796|FG003|Treatment Period|Adverse Event|0
7917989|NCT02135107|12439793|FG000|Treatment Period|Pregnancy|1
7917990|NCT02135107|12439794|FG001|Treatment Period|Pregnancy|0
7917991|NCT02135107|12439795|FG002|Treatment Period|Pregnancy|0
7917992|NCT02135107|12439796|FG003|Treatment Period|Pregnancy|0
7917993|NCT02135107|12439793|FG000|Treatment Period|Other|115
7917994|NCT02135107|12439794|FG001|Treatment Period|Other|24
7917995|NCT02135107|12439795|FG002|Treatment Period|Other|0
7917996|NCT02135107|12439796|FG003|Treatment Period|Other|0
7917997|NCT02135107|12439793|FG000|Maintenance Therapy Period|Adverse Event|0
7917998|NCT02135107|12439794|FG001|Maintenance Therapy Period|Adverse Event|0
7917999|NCT02135107|12439795|FG002|Maintenance Therapy Period|Adverse Event|3
7918000|NCT02135107|12439796|FG003|Maintenance Therapy Period|Adverse Event|7
7918001|NCT02135107|12439793|FG000|Maintenance Therapy Period|Withdrawal by Subject|0
7918002|NCT02135107|12439794|FG001|Maintenance Therapy Period|Withdrawal by Subject|0
7918003|NCT02135107|12439795|FG002|Maintenance Therapy Period|Withdrawal by Subject|5
7918004|NCT02135107|12439796|FG003|Maintenance Therapy Period|Withdrawal by Subject|4
7918005|NCT02135107|12439793|FG000|Maintenance Therapy Period|Pregnancy|0
7918006|NCT02135107|12439794|FG001|Maintenance Therapy Period|Pregnancy|0
7918007|NCT02135107|12439795|FG002|Maintenance Therapy Period|Pregnancy|0
7918008|NCT02135107|12439796|FG003|Maintenance Therapy Period|Pregnancy|1
7918009|NCT02135107|12439793|FG000|Maintenance Therapy Period|Other|0
7918010|NCT02135107|12439794|FG001|Maintenance Therapy Period|Other|0
7918011|NCT02135107|12439795|FG002|Maintenance Therapy Period|Other|7
7918012|NCT02135107|12439796|FG003|Maintenance Therapy Period|Other|8
7964302|NCT02811861|12519798|FG002|Overall Study|Radiological Disease Progression|174
7964303|NCT02811861|12519796|FG000|Overall Study|Clinical Disease Progression|20
7964304|NCT02811861|12519797|FG001|Overall Study|Clinical Disease Progression|19
7964305|NCT02811861|12519798|FG002|Overall Study|Clinical Disease Progression|22
7964306|NCT02811861|12519796|FG000|Overall Study|Adverse Event|63
7964307|NCT02811861|12519797|FG001|Overall Study|Adverse Event|60
7964308|NCT02811861|12519798|FG002|Overall Study|Adverse Event|41
7964309|NCT02811861|12519796|FG000|Overall Study|Lost to Follow-up|0
7964310|NCT02811861|12519797|FG001|Overall Study|Lost to Follow-up|0
7964311|NCT02811861|12519798|FG002|Overall Study|Lost to Follow-up|1
7964312|NCT02811861|12519796|FG000|Overall Study|Subject Choice|29
7964313|NCT02811861|12519797|FG001|Overall Study|Subject Choice|17
7964314|NCT02811861|12519798|FG002|Overall Study|Subject Choice|23
7964315|NCT02811861|12519796|FG000|Overall Study|Withdrawal by Subject|4
7964316|NCT02811861|12519797|FG001|Overall Study|Withdrawal by Subject|4
7964317|NCT02811861|12519798|FG002|Overall Study|Withdrawal by Subject|9
7964318|NCT02811861|12519796|FG000|Overall Study|Other|4
7964319|NCT02811861|12519797|FG001|Overall Study|Other|13
7964320|NCT02811861|12519798|FG002|Overall Study|Other|3
7964321|NCT02811861|12519796|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112
7964322|NCT02811861|12519797|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142
7964323|NCT02811861|12519798|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67
7964324|NCT02811861|12519796|FG000|Overall Study|Randomized but not treated|2
7964325|NCT02811861|12519797|FG001|Overall Study|Randomized but not treated|3
7964326|NCT02811861|12519798|FG002|Overall Study|Randomized but not treated|17
7964327|NCT02759185|12519810|FG000|Stage 1|Adverse Event|0
7964328|NCT02759185|12519811|FG001|Stage 1|Adverse Event|1
7964329|NCT02759185|12519812|FG002|Stage 1|Adverse Event|3
7964330|NCT02759185|12519813|FG003|Stage 1|Adverse Event|0
7964331|NCT02759185|12519814|FG004|Stage 1|Adverse Event|0
7964332|NCT02759185|12519815|FG005|Stage 1|Adverse Event|0
7964333|NCT02759185|12519816|FG006|Stage 1|Adverse Event|0
7964334|NCT02759185|12519810|FG000|Stage 1|Withdrawal by Subject|1
7964335|NCT02759185|12519811|FG001|Stage 1|Withdrawal by Subject|0
7964336|NCT02759185|12519812|FG002|Stage 1|Withdrawal by Subject|0
7964337|NCT02759185|12519813|FG003|Stage 1|Withdrawal by Subject|0
7964338|NCT02759185|12519814|FG004|Stage 1|Withdrawal by Subject|0
7964339|NCT02759185|12519815|FG005|Stage 1|Withdrawal by Subject|0
7964340|NCT02759185|12519816|FG006|Stage 1|Withdrawal by Subject|0
7964341|NCT02759185|12519810|FG000|Stage 2|Adverse Event|0
7964342|NCT02759185|12519811|FG001|Stage 2|Adverse Event|0
7964343|NCT02759185|12519812|FG002|Stage 2|Adverse Event|0
7964344|NCT02759185|12519813|FG003|Stage 2|Adverse Event|0
7918013|NCT02135445|12439829|FG000|Overall Study|Lost to Follow-up|1
7918014|NCT02135445|12439830|FG001|Overall Study|Lost to Follow-up|0
7918015|NCT02135445|12439829|FG000|Overall Study|Withdrawal by Subject|1
7918016|NCT02135445|12439830|FG001|Overall Study|Withdrawal by Subject|0
7918017|NCT02135614|12439838|FG000|Overall Study|Randomized but Not Treated|2
7918018|NCT02135614|12439839|FG001|Overall Study|Randomized but Not Treated|1
7918019|NCT02135614|12439838|FG000|Overall Study|Adverse Event|0
7918020|NCT02135614|12439839|FG001|Overall Study|Adverse Event|1
7918021|NCT02135614|12439838|FG000|Overall Study|Death|1
7918022|NCT02135614|12439839|FG001|Overall Study|Death|0
7918023|NCT02135614|12439838|FG000|Overall Study|Investigator's Discretion|0
7918024|NCT02135614|12439839|FG001|Overall Study|Investigator's Discretion|1
7918025|NCT02135614|12439838|FG000|Overall Study|Withdrew Consent|2
7918026|NCT02135614|12439839|FG001|Overall Study|Withdrew Consent|2
7918027|NCT02135614|12439838|FG000|Overall Study|Lost to Follow-up|3
7918028|NCT02135614|12439839|FG001|Overall Study|Lost to Follow-up|0
7918029|NCT02135692|12439856|FG000|Overall Study|Adverse Event|3
7918030|NCT02135692|12439856|FG000|Overall Study|Lack of Efficacy|2
7918031|NCT02135692|12439856|FG000|Overall Study|Protocol Violation|2
7918032|NCT02135692|12439856|FG000|Overall Study|Subject met Liver Stopping Criteria|1
7918033|NCT02135692|12439856|FG000|Overall Study|Product commercially available|159
7918034|NCT02135692|12439856|FG000|Overall Study|Study closed/terminated|153
7918035|NCT02135692|12439856|FG000|Overall Study|Lost to Follow-up|4
7918036|NCT02135692|12439856|FG000|Overall Study|Withdrawal by Subject|15
7918037|NCT02135848|12439862|FG000|Overall Study|Adverse Event|2
7918038|NCT02135848|12439863|FG001|Overall Study|Adverse Event|0
7918039|NCT02135848|12439862|FG000|Overall Study|Withdrawal by Subject|1
7918040|NCT02135848|12439863|FG001|Overall Study|Withdrawal by Subject|1
7918041|NCT02136576|12439956|FG000|Overall Study|Lost to Follow-up|2
7918042|NCT02136576|12439957|FG001|Overall Study|Lost to Follow-up|0
7918043|NCT02136576|12439958|FG002|Overall Study|Lost to Follow-up|0
7918044|NCT02136680|12439968|FG000|Overall Study|No Longer Interested|1
7918045|NCT02136680|12439969|FG001|Overall Study|No Longer Interested|1
7918046|NCT02136680|12439968|FG000|Overall Study|No longer receiving care at clinic|3
7918047|NCT02136680|12439969|FG001|Overall Study|No longer receiving care at clinic|5
7918048|NCT02136680|12439968|FG000|Overall Study|Moved away|5
7918049|NCT02136680|12439969|FG001|Overall Study|Moved away|4
7918050|NCT02136680|12439968|FG000|Overall Study|Unable to schedule|17
7918051|NCT02136680|12439969|FG001|Overall Study|Unable to schedule|16
7918052|NCT02136680|12439968|FG000|Overall Study|Study ended before interview due|6
7918053|NCT02136680|12439969|FG001|Overall Study|Study ended before interview due|3
7918054|NCT02136914|12439981|FG000|Overall Study|Sponsor's Decision to Stop the Study|7
7918055|NCT02136914|12439982|FG001|Overall Study|Sponsor's Decision to Stop the Study|7
7918056|NCT02136914|12439981|FG000|Overall Study|Withdrawal by Subject|3
7918057|NCT02136914|12439982|FG001|Overall Study|Withdrawal by Subject|10
7918058|NCT02136914|12439981|FG000|Overall Study|Subject Unwilling to Proceed|7
7918059|NCT02136914|12439982|FG001|Overall Study|Subject Unwilling to Proceed|2
7918060|NCT02136914|12439981|FG000|Overall Study|Lost to Follow-up|1
7918061|NCT02136914|12439982|FG001|Overall Study|Lost to Follow-up|1
7918062|NCT02136914|12439981|FG000|Overall Study|Did Not Receive Study Drug|2
7918063|NCT02136914|12439982|FG001|Overall Study|Did Not Receive Study Drug|0
7918064|NCT02136914|12439981|FG000|Overall Study|Lack of Efficacy|1
7918065|NCT02136914|12439982|FG001|Overall Study|Lack of Efficacy|0
7918066|NCT02136914|12439981|FG000|Overall Study|Death|0
7918067|NCT02136914|12439982|FG001|Overall Study|Death|1
7918068|NCT02137226|12439990|FG000|Period 1 (Initial Randomization)|Adverse Event|3
7918069|NCT02137226|12439991|FG001|Period 1 (Initial Randomization)|Adverse Event|3
7918070|NCT02137226|12439992|FG002|Period 1 (Initial Randomization)|Adverse Event|0
7918071|NCT02137226|12439993|FG003|Period 1 (Initial Randomization)|Adverse Event|0
7918072|NCT02137226|12439994|FG004|Period 1 (Initial Randomization)|Adverse Event|0
7918073|NCT02137226|12439990|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11
7918074|NCT02137226|12439991|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5
7918075|NCT02137226|12439992|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0
7918076|NCT02137226|12439993|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0
7918077|NCT02137226|12439994|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0
7918078|NCT02137226|12439990|FG000|Period 1 (Initial Randomization)|Physician Decision|1
7918079|NCT02137226|12439991|FG001|Period 1 (Initial Randomization)|Physician Decision|3
7918080|NCT02137226|12439992|FG002|Period 1 (Initial Randomization)|Physician Decision|0
7918081|NCT02137226|12439993|FG003|Period 1 (Initial Randomization)|Physician Decision|0
7918082|NCT02137226|12439994|FG004|Period 1 (Initial Randomization)|Physician Decision|0
7918083|NCT02137226|12439990|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3
7918084|NCT02137226|12439991|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2
7918085|NCT02137226|12439992|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0
7918086|NCT02137226|12439993|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0
7918087|NCT02137226|12439994|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0
7918088|NCT02137226|12439990|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1
7918089|NCT02137226|12439991|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0
7918090|NCT02137226|12439992|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0
7918091|NCT02137226|12439993|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0
7918092|NCT02137226|12439994|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0
7918093|NCT02137226|12439990|FG000|Period 1 (Initial Randomization)|Other Reason|1
7918094|NCT02137226|12439991|FG001|Period 1 (Initial Randomization)|Other Reason|3
7918095|NCT02137226|12439992|FG002|Period 1 (Initial Randomization)|Other Reason|0
7918096|NCT02137226|12439993|FG003|Period 1 (Initial Randomization)|Other Reason|0
7918097|NCT02137226|12439994|FG004|Period 1 (Initial Randomization)|Other Reason|0
7918098|NCT02137226|12439990|FG000|Period 2 (Re - Randomization)|Adverse Event|0
7918099|NCT02137226|12439991|FG001|Period 2 (Re - Randomization)|Adverse Event|0
7918100|NCT02137226|12439992|FG002|Period 2 (Re - Randomization)|Adverse Event|3
7918101|NCT02137226|12439993|FG003|Period 2 (Re - Randomization)|Adverse Event|1
7918102|NCT02137226|12439994|FG004|Period 2 (Re - Randomization)|Adverse Event|4
7918103|NCT02137226|12439990|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0
7918104|NCT02137226|12439991|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0
7918105|NCT02137226|12439992|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8
7918106|NCT02137226|12439993|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5
7918107|NCT02137226|12439994|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4
7918108|NCT02137226|12439990|FG000|Period 2 (Re - Randomization)|Physician Decision|0
7918109|NCT02137226|12439991|FG001|Period 2 (Re - Randomization)|Physician Decision|0
7918110|NCT02137226|12439992|FG002|Period 2 (Re - Randomization)|Physician Decision|0
7918111|NCT02137226|12439993|FG003|Period 2 (Re - Randomization)|Physician Decision|1
7918112|NCT02137226|12439994|FG004|Period 2 (Re - Randomization)|Physician Decision|0
7918113|NCT02137226|12439990|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0
7918114|NCT02137226|12439991|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0
7918115|NCT02137226|12439992|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3
7918116|NCT02137226|12439993|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0
7918117|NCT02137226|12439994|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0
7918118|NCT02137226|12439990|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0
7918119|NCT02137226|12439991|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0
7918120|NCT02137226|12439992|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2
7918121|NCT02137226|12439993|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0
7918122|NCT02137226|12439994|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0
7918123|NCT02137226|12439990|FG000|Period 2 (Re - Randomization)|Other Reason|0
7918124|NCT02137226|12439991|FG001|Period 2 (Re - Randomization)|Other Reason|0
7918125|NCT02137226|12439992|FG002|Period 2 (Re - Randomization)|Other Reason|1
7918126|NCT02137226|12439993|FG003|Period 2 (Re - Randomization)|Other Reason|1
7918127|NCT02137226|12439994|FG004|Period 2 (Re - Randomization)|Other Reason|1
7918128|NCT02137369|12440004|FG000|Overall Study|Withdrawal by Subject|3
7918129|NCT02137369|12440005|FG001|Overall Study|Withdrawal by Subject|2
7918130|NCT02137369|12440004|FG000|Overall Study|Adverse Event|2
7918131|NCT02137369|12440005|FG001|Overall Study|Adverse Event|0
7918132|NCT02137369|12440004|FG000|Overall Study|Lost to Follow-up|1
7918133|NCT02137369|12440005|FG001|Overall Study|Lost to Follow-up|0
7918134|NCT02137369|12440004|FG000|Overall Study|Moved away|2
7918135|NCT02137369|12440005|FG001|Overall Study|Moved away|0
7918136|NCT02137772|12440082|FG000|Overall Study|Adverse Event|6
7918137|NCT02137772|12440083|FG001|Overall Study|Adverse Event|3
7918138|NCT02137772|12440082|FG000|Overall Study|Death|71
7918139|NCT02137772|12440083|FG001|Overall Study|Death|44
7918140|NCT02137772|12440082|FG000|Overall Study|Lost to Follow-up|8
7918141|NCT02137772|12440083|FG001|Overall Study|Lost to Follow-up|4
7918142|NCT02137772|12440082|FG000|Overall Study|Physician Decision|15
7918143|NCT02137772|12440083|FG001|Overall Study|Physician Decision|5
7918144|NCT02137772|12440082|FG000|Overall Study|Withdrawal by Subject|28
7918145|NCT02137772|12440083|FG001|Overall Study|Withdrawal by Subject|17
7918146|NCT02137772|12440082|FG000|Overall Study|Non-compliance with study drug|1
7918147|NCT02137772|12440083|FG001|Overall Study|Non-compliance with study drug|0
7918148|NCT02137772|12440082|FG000|Overall Study|Not treated|3
7918149|NCT02137772|12440083|FG001|Overall Study|Not treated|2
7918150|NCT02137785|12440091|FG000|Overall Study|Lost to Follow-up|1
7918151|NCT02137785|12440092|FG001|Overall Study|Lost to Follow-up|0
7918152|NCT02137785|12440091|FG000|Overall Study|Withdrawal by Subject|1
7918153|NCT02137785|12440092|FG001|Overall Study|Withdrawal by Subject|4
7918154|NCT02137785|12440091|FG000|Overall Study|subject moved out of state|1
7918155|NCT02137785|12440092|FG001|Overall Study|subject moved out of state|0
7918156|NCT02137837|12440101|FG000|Overall Study|Adverse Event|0
7918157|NCT02137837|12440102|FG001|Overall Study|Adverse Event|2
7918158|NCT02137837|12440103|FG002|Overall Study|Adverse Event|1
7918159|NCT02137837|12440101|FG000|Overall Study|Refusal unrelated to adverse event|2
7918160|NCT02137837|12440102|FG001|Overall Study|Refusal unrelated to adverse event|2
7918161|NCT02137837|12440103|FG002|Overall Study|Refusal unrelated to adverse event|1
7918162|NCT02137837|12440101|FG000|Overall Study|Progression/relapse|9
7918163|NCT02137837|12440102|FG001|Overall Study|Progression/relapse|7
7918164|NCT02137837|12440103|FG002|Overall Study|Progression/relapse|7
7918165|NCT02137837|12440101|FG000|Overall Study|Not protocol specified|2
7918166|NCT02137837|12440102|FG001|Overall Study|Not protocol specified|1
7918167|NCT02137837|12440103|FG002|Overall Study|Not protocol specified|3
7918168|NCT02138110|12440168|FG000|Enrolled for Scaffold Implantation|Physician Decision|1
7918169|NCT02138110|12440168|FG000|Overall Scaffold Implantation|Death|3
7918170|NCT02138136|12440172|FG000|Overall Study|Protocol Violation|4
7918171|NCT02138136|12440172|FG000|Overall Study|Physician Decision|7
7918172|NCT02138136|12440172|FG000|Overall Study|Lack of Efficacy|35
7918173|NCT02138136|12440172|FG000|Overall Study|Pregnancy|2
7918174|NCT02138136|12440172|FG000|Overall Study|Adverse Event|18
7918175|NCT02138136|12440172|FG000|Overall Study|Withdrawal by Subject|36
7918176|NCT02138136|12440172|FG000|Overall Study|Lost to Follow-up|32
7918177|NCT02138136|12440172|FG000|Overall Study|Withdrawn by Sponsor|5
7918178|NCT02138214|12440180|FG000|Overall Study|Withdrawal by Subject|0
7918179|NCT02138214|12440181|FG001|Overall Study|Withdrawal by Subject|1
7918180|NCT02138214|12440182|FG002|Overall Study|Withdrawal by Subject|0
7918181|NCT02138214|12440180|FG000|Overall Study|Lost to Follow-up|0
7918182|NCT02138214|12440181|FG001|Overall Study|Lost to Follow-up|2
7918183|NCT02138214|12440182|FG002|Overall Study|Lost to Follow-up|4
7918184|NCT02138214|12440180|FG000|Overall Study|Screen Failure|0
7918185|NCT02138214|12440181|FG001|Overall Study|Screen Failure|1
7918186|NCT02138214|12440182|FG002|Overall Study|Screen Failure|0
7918187|NCT02138253|12440229|FG000|Overall Study|Adverse Event|3
7918188|NCT02138253|12440230|FG001|Overall Study|Adverse Event|3
7918189|NCT02138253|12440229|FG000|Overall Study|Lost to Follow-up|2
7918190|NCT02138253|12440230|FG001|Overall Study|Lost to Follow-up|1
7918191|NCT02138253|12440229|FG000|Overall Study|Physician Decision|2
7918192|NCT02138253|12440230|FG001|Overall Study|Physician Decision|0
7918193|NCT02138253|12440229|FG000|Overall Study|Non compliance|1
7918194|NCT02138253|12440230|FG001|Overall Study|Non compliance|0
7918195|NCT02138253|12440229|FG000|Overall Study|Withdrawal by Subject|1
7918196|NCT02138253|12440230|FG001|Overall Study|Withdrawal by Subject|0
7918197|NCT02138747|12440262|FG000|Treatment Period 1|Adverse Event|10
7918198|NCT02138747|12440263|FG001|Treatment Period 1|Adverse Event|14
7918199|NCT02138747|12440264|FG002|Treatment Period 1|Adverse Event|2
7918200|NCT02138747|12440265|FG003|Treatment Period 1|Adverse Event|1
7918201|NCT02138747|12440262|FG000|Treatment Period 1|Lost to Follow-up|0
7918202|NCT02138747|12440263|FG001|Treatment Period 1|Lost to Follow-up|1
7918203|NCT02138747|12440264|FG002|Treatment Period 1|Lost to Follow-up|1
7918204|NCT02138747|12440265|FG003|Treatment Period 1|Lost to Follow-up|0
7918205|NCT02138747|12440262|FG000|Treatment Period 1|Protocol Violation|0
7918206|NCT02138747|12440263|FG001|Treatment Period 1|Protocol Violation|2
7918207|NCT02138747|12440264|FG002|Treatment Period 1|Protocol Violation|0
7918208|NCT02138747|12440265|FG003|Treatment Period 1|Protocol Violation|0
7918209|NCT02138747|12440262|FG000|Treatment Period 1|Withdrawal by Subject|8
7918210|NCT02138747|12440263|FG001|Treatment Period 1|Withdrawal by Subject|4
7918211|NCT02138747|12440264|FG002|Treatment Period 1|Withdrawal by Subject|1
7918212|NCT02138747|12440265|FG003|Treatment Period 1|Withdrawal by Subject|3
7918213|NCT02138747|12440262|FG000|Treatment Period 1|Other - Miscellaneous|2
7918214|NCT02138747|12440263|FG001|Treatment Period 1|Other - Miscellaneous|4
7918215|NCT02138747|12440264|FG002|Treatment Period 1|Other - Miscellaneous|0
7918216|NCT02138747|12440265|FG003|Treatment Period 1|Other - Miscellaneous|0
7918217|NCT02138747|12440262|FG000|Treatment Period 2|Adverse Event|6
7918218|NCT02138747|12440263|FG001|Treatment Period 2|Adverse Event|3
7918219|NCT02138747|12440264|FG002|Treatment Period 2|Adverse Event|1
7918220|NCT02138747|12440265|FG003|Treatment Period 2|Adverse Event|1
7918221|NCT02138747|12440262|FG000|Treatment Period 2|Lost to Follow-up|2
7918222|NCT02138747|12440263|FG001|Treatment Period 2|Lost to Follow-up|0
7918223|NCT02138747|12440264|FG002|Treatment Period 2|Lost to Follow-up|0
7918224|NCT02138747|12440265|FG003|Treatment Period 2|Lost to Follow-up|0
7918225|NCT02138747|12440262|FG000|Treatment Period 2|Protocol Violation|1
7918226|NCT02138747|12440263|FG001|Treatment Period 2|Protocol Violation|0
7918227|NCT02138747|12440264|FG002|Treatment Period 2|Protocol Violation|0
7918228|NCT02138747|12440265|FG003|Treatment Period 2|Protocol Violation|0
7918229|NCT02138747|12440262|FG000|Treatment Period 2|Withdrawal by Subject|5
7918230|NCT02138747|12440263|FG001|Treatment Period 2|Withdrawal by Subject|4
7918231|NCT02138747|12440264|FG002|Treatment Period 2|Withdrawal by Subject|1
7918232|NCT02138747|12440265|FG003|Treatment Period 2|Withdrawal by Subject|2
7918233|NCT02138747|12440262|FG000|Treatment Period 2|Other - Miscellaneous|3
7918234|NCT02138747|12440263|FG001|Treatment Period 2|Other - Miscellaneous|0
7918235|NCT02138747|12440264|FG002|Treatment Period 2|Other - Miscellaneous|0
7918236|NCT02138747|12440265|FG003|Treatment Period 2|Other - Miscellaneous|0
7918237|NCT02138786|12440278|FG000|Overall Study|Adverse Event|0
7918238|NCT02138786|12440279|FG001|Overall Study|Adverse Event|2
7918239|NCT02138786|12440280|FG002|Overall Study|Adverse Event|1
7918240|NCT02138786|12440278|FG000|Overall Study|Death|1
7918241|NCT02138786|12440279|FG001|Overall Study|Death|7
7918242|NCT02138786|12440280|FG002|Overall Study|Death|2
7918243|NCT02138786|12440278|FG000|Overall Study|Disease Progression|1
7918244|NCT02138786|12440279|FG001|Overall Study|Disease Progression|1
7918245|NCT02138786|12440280|FG002|Overall Study|Disease Progression|3
7918246|NCT02138786|12440278|FG000|Overall Study|Withdrawal by Subject|1
7918247|NCT02138786|12440279|FG001|Overall Study|Withdrawal by Subject|2
7918248|NCT02138786|12440280|FG002|Overall Study|Withdrawal by Subject|0
7918249|NCT02138786|12440278|FG000|Overall Study|Patient's Wish|0
7918250|NCT02138786|12440279|FG001|Overall Study|Patient's Wish|2
7918251|NCT02138786|12440280|FG002|Overall Study|Patient's Wish|0
7918252|NCT02138786|12440278|FG000|Overall Study|Sponsor Terminated Study|0
7918253|NCT02138786|12440279|FG001|Overall Study|Sponsor Terminated Study|1
7918254|NCT02138786|12440280|FG002|Overall Study|Sponsor Terminated Study|1
7918255|NCT02138786|12440278|FG000|Overall Study|Non-Compliance|0
7918256|NCT02138786|12440279|FG001|Overall Study|Non-Compliance|0
7918257|NCT02138786|12440280|FG002|Overall Study|Non-Compliance|1
7918258|NCT02138825|12440288|FG000|Main Study Treatment|Adverse Event|11
7918259|NCT02138825|12440289|FG001|Main Study Treatment|Adverse Event|3
7918260|NCT02138825|12440288|FG000|Main Study Treatment|Death|1
7918261|NCT02138825|12440289|FG001|Main Study Treatment|Death|2
7918262|NCT02138825|12440288|FG000|Main Study Treatment|Protocol Violation|2
7918263|NCT02138825|12440289|FG001|Main Study Treatment|Protocol Violation|2
7918264|NCT02138825|12440288|FG000|Main Study Treatment|Sponsor decision|12
7918265|NCT02138825|12440289|FG001|Main Study Treatment|Sponsor decision|18
7918266|NCT02138825|12440288|FG000|Main Study Treatment|Study terminated by sponsor|10
7918267|NCT02138825|12440289|FG001|Main Study Treatment|Study terminated by sponsor|9
7918268|NCT02138825|12440288|FG000|Main Study Treatment|Withdrawal by Subject|3
7918269|NCT02138825|12440289|FG001|Main Study Treatment|Withdrawal by Subject|1
7918270|NCT02138825|12440288|FG000|Main Study Treatment|Medical decision|1
7918271|NCT02138825|12440289|FG001|Main Study Treatment|Medical decision|0
7918272|NCT02138825|12440288|FG000|Long-term Extension|Study termination by sponsor|32
7918273|NCT02138825|12440289|FG001|Long-term Extension|Study termination by sponsor|38
7918274|NCT02138825|12440288|FG000|Safety Follow-up|Adverse Event|4
7918275|NCT02138825|12440289|FG001|Safety Follow-up|Adverse Event|3
7918276|NCT02138825|12440288|FG000|Safety Follow-up|Death|11
7918277|NCT02138825|12440289|FG001|Safety Follow-up|Death|5
7918278|NCT02138825|12440288|FG000|Safety Follow-up|Withdrawal by Subject|5
7918279|NCT02138825|12440289|FG001|Safety Follow-up|Withdrawal by Subject|3
7918280|NCT02138825|12440288|FG000|Safety Follow-up|clinic worsening|1
7918281|NCT02138825|12440289|FG001|Safety Follow-up|clinic worsening|0
7918282|NCT02138825|12440288|FG000|Safety Follow-up|withdrawal by PI|1
7918283|NCT02138825|12440289|FG001|Safety Follow-up|withdrawal by PI|0
7918284|NCT02138825|12440288|FG000|Safety Follow-up|logistical difficulties|0
7918285|NCT02138825|12440289|FG001|Safety Follow-up|logistical difficulties|1
7918286|NCT02138825|12440288|FG000|Safety Follow-up|progressive disease|0
7918287|NCT02138825|12440289|FG001|Safety Follow-up|progressive disease|2
7719533|NCT00532883|12143499|FG001|Overall Study|Early Study Termination|4
7719534|NCT00532883|12143500|FG002|Overall Study|Early Study Termination|1
7719535|NCT00532883|12143501|FG003|Overall Study|Early Study Termination|4
7719536|NCT00532935|12143513|FG000|Overall Study|Adverse Event|11
7719537|NCT00532935|12143514|FG001|Overall Study|Adverse Event|12
7719538|NCT00532935|12143513|FG000|Overall Study|Lack of Efficacy|0
7719539|NCT00532935|12143514|FG001|Overall Study|Lack of Efficacy|3
7719540|NCT00532935|12143513|FG000|Overall Study|Lost to Follow-up|10
7719541|NCT00532935|12143514|FG001|Overall Study|Lost to Follow-up|6
7719542|NCT00532935|12143513|FG000|Overall Study|Physician Decision|4
7719543|NCT00532935|12143514|FG001|Overall Study|Physician Decision|5
7719544|NCT00532935|12143513|FG000|Overall Study|Pregnancy|1
7719545|NCT00532935|12143514|FG001|Overall Study|Pregnancy|0
7719546|NCT00532935|12143513|FG000|Overall Study|Protocol Violation|4
7719547|NCT00532935|12143514|FG001|Overall Study|Protocol Violation|2
7719548|NCT00532935|12143513|FG000|Overall Study|Withdrawal by Subject|10
7719549|NCT00532935|12143514|FG001|Overall Study|Withdrawal by Subject|9
7918288|NCT02138825|12440288|FG000|Safety Follow-up|too unwell to attend the visit|0
7719550|NCT00532935|12143513|FG000|Overall Study|Protocol Specific Criteria|11
7719551|NCT00532935|12143514|FG001|Overall Study|Protocol Specific Criteria|15
7719552|NCT00532948|12143523|FG000|Overall Study|Protocol Violation|1
7719553|NCT00532948|12143524|FG001|Overall Study|Protocol Violation|0
7918289|NCT02138825|12440289|FG001|Safety Follow-up|too unwell to attend the visit|1
7918290|NCT02138825|12440288|FG000|Safety Follow-up|treatment unblinded|0
7918291|NCT02138825|12440289|FG001|Safety Follow-up|treatment unblinded|1
7918292|NCT02138825|12440288|FG000|Safety Follow-up|withdrawn due to lung transplant|0
7918293|NCT02138825|12440289|FG001|Safety Follow-up|withdrawn due to lung transplant|1
7918294|NCT02138838|12440302|FG000|Overall Study|Study Closure|7
7918295|NCT02138838|12440303|FG001|Overall Study|Study Closure|6
7918296|NCT02138838|12440302|FG000|Overall Study|Withdrawal by Subject|1
7918297|NCT02138838|12440303|FG001|Overall Study|Withdrawal by Subject|5
7918298|NCT02138890|12440311|FG000|Overall Study|Adverse Event|1
7918299|NCT02138890|12440312|FG001|Overall Study|Adverse Event|0
7918300|NCT02138916|12440322|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6
7918301|NCT02138916|12440323|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9
7918302|NCT02138916|12440324|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7
7918303|NCT02138916|12440322|FG000|Overall Study|Death|14
7918304|NCT02138916|12440323|FG001|Overall Study|Death|11
7918305|NCT02138916|12440324|FG002|Overall Study|Death|12
7918306|NCT02138916|12440322|FG000|Overall Study|Withdrawal by Subject|27
7918307|NCT02138916|12440323|FG001|Overall Study|Withdrawal by Subject|31
7918308|NCT02138916|12440324|FG002|Overall Study|Withdrawal by Subject|32
7918309|NCT02138916|12440322|FG000|Overall Study|Study specific withdrawal criteria|0
7918310|NCT02138916|12440323|FG001|Overall Study|Study specific withdrawal criteria|0
7918311|NCT02138916|12440324|FG002|Overall Study|Study specific withdrawal criteria|1
7918312|NCT02138916|12440322|FG000|Overall Study|incorrect enrolment|1
7918313|NCT02138916|12440323|FG001|Overall Study|incorrect enrolment|1
7918314|NCT02138916|12440324|FG002|Overall Study|incorrect enrolment|0
7918315|NCT02138916|12440322|FG000|Overall Study|Severe non-compliance|1
7918316|NCT02138916|12440323|FG001|Overall Study|Severe non-compliance|2
7918317|NCT02138916|12440324|FG002|Overall Study|Severe non-compliance|1
7918318|NCT02138916|12440322|FG000|Overall Study|Lost to Follow-up|4
7918319|NCT02138916|12440323|FG001|Overall Study|Lost to Follow-up|2
7918320|NCT02138916|12440324|FG002|Overall Study|Lost to Follow-up|3
7918321|NCT02138916|12440322|FG000|Overall Study|Adverse Event|4
7918322|NCT02138916|12440323|FG001|Overall Study|Adverse Event|4
7918323|NCT02138916|12440324|FG002|Overall Study|Adverse Event|3
7918324|NCT02139046|12440349|FG000|Overall Study|Pretreatment Event/Adverse Event|9
7918325|NCT02139046|12440350|FG001|Overall Study|Pretreatment Event/Adverse Event|9
7918326|NCT02139046|12440351|FG002|Overall Study|Pretreatment Event/Adverse Event|10
7918327|NCT02139046|12440352|FG003|Overall Study|Pretreatment Event/Adverse Event|13
7918328|NCT02139046|12440353|FG004|Overall Study|Pretreatment Event/Adverse Event|7
7918329|NCT02139046|12440349|FG000|Overall Study|Major Protocol Deviation|9
7918330|NCT02139046|12440350|FG001|Overall Study|Major Protocol Deviation|10
7918331|NCT02139046|12440351|FG002|Overall Study|Major Protocol Deviation|16
7918332|NCT02139046|12440352|FG003|Overall Study|Major Protocol Deviation|12
7918333|NCT02139046|12440353|FG004|Overall Study|Major Protocol Deviation|6
7918334|NCT02139046|12440349|FG000|Overall Study|Lost to Follow-up|13
7918335|NCT02139046|12440350|FG001|Overall Study|Lost to Follow-up|16
7918336|NCT02139046|12440351|FG002|Overall Study|Lost to Follow-up|16
7918337|NCT02139046|12440352|FG003|Overall Study|Lost to Follow-up|18
7918338|NCT02139046|12440353|FG004|Overall Study|Lost to Follow-up|13
7918339|NCT02139046|12440349|FG000|Overall Study|Voluntary Withdrawal|20
7918340|NCT02139046|12440350|FG001|Overall Study|Voluntary Withdrawal|8
7918341|NCT02139046|12440351|FG002|Overall Study|Voluntary Withdrawal|10
7918342|NCT02139046|12440352|FG003|Overall Study|Voluntary Withdrawal|15
7918343|NCT02139046|12440353|FG004|Overall Study|Voluntary Withdrawal|16
7918344|NCT02139046|12440349|FG000|Overall Study|Lack of Efficacy|0
7918345|NCT02139046|12440350|FG001|Overall Study|Lack of Efficacy|1
7918346|NCT02139046|12440351|FG002|Overall Study|Lack of Efficacy|2
7918347|NCT02139046|12440352|FG003|Overall Study|Lack of Efficacy|1
7918348|NCT02139046|12440353|FG004|Overall Study|Lack of Efficacy|2
7918349|NCT02139046|12440349|FG000|Overall Study|Withdrawal due to a Gout Flare|1
7918350|NCT02139046|12440350|FG001|Overall Study|Withdrawal due to a Gout Flare|1
7918351|NCT02139046|12440351|FG002|Overall Study|Withdrawal due to a Gout Flare|1
7918352|NCT02139046|12440352|FG003|Overall Study|Withdrawal due to a Gout Flare|0
7918353|NCT02139046|12440353|FG004|Overall Study|Withdrawal due to a Gout Flare|1
7918354|NCT02139046|12440349|FG000|Overall Study|Other Miscellaneous Reasons|10
7918355|NCT02139046|12440350|FG001|Overall Study|Other Miscellaneous Reasons|9
7918356|NCT02139046|12440351|FG002|Overall Study|Other Miscellaneous Reasons|4
7918357|NCT02139046|12440352|FG003|Overall Study|Other Miscellaneous Reasons|9
7918358|NCT02139046|12440353|FG004|Overall Study|Other Miscellaneous Reasons|12
7918359|NCT02139124|12440370|FG000|Overall Study|Adverse Event|2
7918360|NCT02139124|12440371|FG001|Overall Study|Adverse Event|0
7918361|NCT02139124|12440372|FG002|Overall Study|Adverse Event|1
7918362|NCT02139124|12440373|FG003|Overall Study|Adverse Event|2
7918363|NCT02139124|12440374|FG004|Overall Study|Adverse Event|5
7918364|NCT02139124|12440370|FG000|Overall Study|Withdrawal by Subject|2
7918365|NCT02139124|12440371|FG001|Overall Study|Withdrawal by Subject|2
7918366|NCT02139124|12440372|FG002|Overall Study|Withdrawal by Subject|2
7918367|NCT02139124|12440373|FG003|Overall Study|Withdrawal by Subject|2
7918368|NCT02139124|12440374|FG004|Overall Study|Withdrawal by Subject|3
7918369|NCT02139124|12440370|FG000|Overall Study|Protocol Violation|0
7918370|NCT02139124|12440371|FG001|Overall Study|Protocol Violation|0
7918371|NCT02139124|12440372|FG002|Overall Study|Protocol Violation|0
7918372|NCT02139124|12440373|FG003|Overall Study|Protocol Violation|1
7918373|NCT02139124|12440374|FG004|Overall Study|Protocol Violation|1
7918374|NCT02139124|12440370|FG000|Overall Study|non-compliant|1
7918375|NCT02139124|12440371|FG001|Overall Study|non-compliant|0
7918376|NCT02139124|12440372|FG002|Overall Study|non-compliant|0
7918377|NCT02139124|12440373|FG003|Overall Study|non-compliant|2
7918378|NCT02139124|12440374|FG004|Overall Study|non-compliant|0
7918379|NCT02139124|12440370|FG000|Overall Study|incarceration|0
7918380|NCT02139124|12440371|FG001|Overall Study|incarceration|0
7918381|NCT02139124|12440372|FG002|Overall Study|incarceration|1
7918382|NCT02139124|12440373|FG003|Overall Study|incarceration|0
7918383|NCT02139124|12440374|FG004|Overall Study|incarceration|0
7918384|NCT02139124|12440370|FG000|Overall Study|subject moved|1
7918385|NCT02139124|12440371|FG001|Overall Study|subject moved|0
7918386|NCT02139124|12440372|FG002|Overall Study|subject moved|0
7918387|NCT02139124|12440373|FG003|Overall Study|subject moved|0
7918388|NCT02139124|12440374|FG004|Overall Study|subject moved|0
7918389|NCT02139124|12440370|FG000|Overall Study|Lost to Follow-up|3
7918390|NCT02139124|12440371|FG001|Overall Study|Lost to Follow-up|2
7918391|NCT02139124|12440372|FG002|Overall Study|Lost to Follow-up|0
7918392|NCT02139124|12440373|FG003|Overall Study|Lost to Follow-up|5
7918393|NCT02139124|12440374|FG004|Overall Study|Lost to Follow-up|4
7918394|NCT02139280|12440416|FG000|Overall Study|No longer eligible|2
7918395|NCT02139280|12440417|FG001|Overall Study|No longer eligible|0
7918396|NCT02139306|12440425|FG000|Overall Study|Withdrawal by Subject|4
7918397|NCT02139306|12440426|FG001|Overall Study|Withdrawal by Subject|6
7918398|NCT02139306|12440425|FG000|Overall Study|Adverse Event|3
7918399|NCT02139306|12440426|FG001|Overall Study|Adverse Event|4
7918400|NCT02139306|12440425|FG000|Overall Study|Physician Decision|0
7918401|NCT02139306|12440426|FG001|Overall Study|Physician Decision|1
7918402|NCT02139306|12440425|FG000|Overall Study|Other Unspecified|2
7918403|NCT02139306|12440426|FG001|Overall Study|Other Unspecified|3
7918404|NCT02139306|12440425|FG000|Overall Study|Protocol Violation|4
7918405|NCT02139306|12440426|FG001|Overall Study|Protocol Violation|0
7918406|NCT02139592|12440437|FG000|Overall Study|Case Report Forms Uncollected|8
7918407|NCT02139644|12440446|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70
7918408|NCT02139644|12440447|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7918409|NCT02139644|12440448|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7918410|NCT02139644|12440449|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7918411|NCT02139644|12440450|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7918412|NCT02139644|12440451|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7918413|NCT02139644|12440446|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
7918414|NCT02139644|12440447|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7918415|NCT02139644|12440448|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7918416|NCT02139644|12440449|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7918417|NCT02139644|12440450|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7918418|NCT02139644|12440451|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7918419|NCT02139644|12440446|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
7918420|NCT02139644|12440447|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7918421|NCT02139644|12440448|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7918422|NCT02139644|12440449|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7918423|NCT02139644|12440450|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7918424|NCT02139644|12440451|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7918425|NCT02139644|12440446|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11
7918426|NCT02139644|12440447|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7918427|NCT02139644|12440448|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7918428|NCT02139644|12440449|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7918429|NCT02139644|12440450|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7918430|NCT02139644|12440451|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7918431|NCT02139644|12440446|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8
7918432|NCT02139644|12440447|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7918433|NCT02139644|12440448|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7918434|NCT02139644|12440449|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7918435|NCT02139644|12440450|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7918436|NCT02139644|12440451|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7918437|NCT02139644|12440446|FG000|Run-In Period (Pre-assignment)|Adverse Event|3
7918438|NCT02139644|12440447|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
7918439|NCT02139644|12440448|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
7918440|NCT02139644|12440449|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
7918441|NCT02139644|12440450|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
7918442|NCT02139644|12440451|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
7918443|NCT02139644|12440446|FG000|Run-In Period (Pre-assignment)|Other|6
7918444|NCT02139644|12440447|FG001|Run-In Period (Pre-assignment)|Other|0
7918445|NCT02139644|12440448|FG002|Run-In Period (Pre-assignment)|Other|0
7918446|NCT02139644|12440449|FG003|Run-In Period (Pre-assignment)|Other|0
7918447|NCT02139644|12440450|FG004|Run-In Period (Pre-assignment)|Other|0
7918448|NCT02139644|12440451|FG005|Run-In Period (Pre-assignment)|Other|0
7918449|NCT02139644|12440446|FG000|Treatment Period|Adverse Event|0
7918450|NCT02139644|12440447|FG001|Treatment Period|Adverse Event|0
7918451|NCT02139644|12440448|FG002|Treatment Period|Adverse Event|3
7918452|NCT02139644|12440449|FG003|Treatment Period|Adverse Event|2
7918453|NCT02139644|12440450|FG004|Treatment Period|Adverse Event|1
7918454|NCT02139644|12440451|FG005|Treatment Period|Adverse Event|6
7918455|NCT02139644|12440446|FG000|Treatment Period|Withdrawal by Subject|0
7918456|NCT02139644|12440447|FG001|Treatment Period|Withdrawal by Subject|0
7918457|NCT02139644|12440448|FG002|Treatment Period|Withdrawal by Subject|2
7918458|NCT02139644|12440449|FG003|Treatment Period|Withdrawal by Subject|2
7918459|NCT02139644|12440450|FG004|Treatment Period|Withdrawal by Subject|3
7918460|NCT02139644|12440451|FG005|Treatment Period|Withdrawal by Subject|2
7918461|NCT02139644|12440446|FG000|Treatment Period|Non-compliance|0
7918462|NCT02139644|12440447|FG001|Treatment Period|Non-compliance|0
7918463|NCT02139644|12440448|FG002|Treatment Period|Non-compliance|0
7918464|NCT02139644|12440449|FG003|Treatment Period|Non-compliance|1
7918465|NCT02139644|12440450|FG004|Treatment Period|Non-compliance|0
7918466|NCT02139644|12440451|FG005|Treatment Period|Non-compliance|0
7918467|NCT02139644|12440446|FG000|Treatment Period|Protocol Violation|0
7918468|NCT02139644|12440447|FG001|Treatment Period|Protocol Violation|0
7918469|NCT02139644|12440448|FG002|Treatment Period|Protocol Violation|0
7918470|NCT02139644|12440449|FG003|Treatment Period|Protocol Violation|1
7918471|NCT02139644|12440450|FG004|Treatment Period|Protocol Violation|1
7918472|NCT02139644|12440451|FG005|Treatment Period|Protocol Violation|1
7918473|NCT02139644|12440446|FG000|Treatment Period|Disease progression|0
7918474|NCT02139644|12440447|FG001|Treatment Period|Disease progression|0
7918475|NCT02139644|12440448|FG002|Treatment Period|Disease progression|0
7918476|NCT02139644|12440449|FG003|Treatment Period|Disease progression|1
7918477|NCT02139644|12440450|FG004|Treatment Period|Disease progression|1
7918478|NCT02139644|12440451|FG005|Treatment Period|Disease progression|2
7918479|NCT02139644|12440446|FG000|Treatment Period|Lost to Follow-up|0
7918480|NCT02139644|12440447|FG001|Treatment Period|Lost to Follow-up|0
7918481|NCT02139644|12440448|FG002|Treatment Period|Lost to Follow-up|1
7918482|NCT02139644|12440449|FG003|Treatment Period|Lost to Follow-up|1
7918483|NCT02139644|12440450|FG004|Treatment Period|Lost to Follow-up|1
7918484|NCT02139644|12440451|FG005|Treatment Period|Lost to Follow-up|1
7918485|NCT02139644|12440446|FG000|Treatment Period|Lack of Efficacy|0
7918486|NCT02139644|12440447|FG001|Treatment Period|Lack of Efficacy|0
7918487|NCT02139644|12440448|FG002|Treatment Period|Lack of Efficacy|1
7918488|NCT02139644|12440449|FG003|Treatment Period|Lack of Efficacy|0
7918489|NCT02139644|12440450|FG004|Treatment Period|Lack of Efficacy|1
7918490|NCT02139644|12440451|FG005|Treatment Period|Lack of Efficacy|4
7918491|NCT02139644|12440446|FG000|Treatment Period|Other|0
7918492|NCT02139644|12440447|FG001|Treatment Period|Other|3
7918493|NCT02139644|12440448|FG002|Treatment Period|Other|1
7918494|NCT02139644|12440449|FG003|Treatment Period|Other|1
7918495|NCT02139644|12440450|FG004|Treatment Period|Other|0
7918496|NCT02139644|12440451|FG005|Treatment Period|Other|1
7918497|NCT02139826|12440472|FG000|Overall Study|Adverse Event|1
7918498|NCT02139943|12440492|FG000|Overall Study|Adverse Event|0
7918499|NCT02139943|12440493|FG001|Overall Study|Adverse Event|1
7918500|NCT02139943|12440494|FG002|Overall Study|Adverse Event|2
7918501|NCT02139943|12440492|FG000|Overall Study|Lost to Follow-up|3
7918502|NCT02139943|12440493|FG001|Overall Study|Lost to Follow-up|2
7918503|NCT02139943|12440494|FG002|Overall Study|Lost to Follow-up|2
7918504|NCT02139943|12440492|FG000|Overall Study|Withdrawal by Subject|4
7918505|NCT02139943|12440493|FG001|Overall Study|Withdrawal by Subject|3
7918506|NCT02139943|12440494|FG002|Overall Study|Withdrawal by Subject|0
7918507|NCT02139943|12440492|FG000|Overall Study|Other|0
7918508|NCT02139943|12440493|FG001|Overall Study|Other|0
7918509|NCT02139943|12440494|FG002|Overall Study|Other|1
7918510|NCT02139943|12440492|FG000|Overall Study|Participant wishes to discontinue|2
7918511|NCT02139943|12440493|FG001|Overall Study|Participant wishes to discontinue|0
7918512|NCT02139943|12440494|FG002|Overall Study|Participant wishes to discontinue|0
7918513|NCT02139943|12440492|FG000|Overall Study|Participant in Poor Compliance|1
7918514|NCT02139943|12440493|FG001|Overall Study|Participant in Poor Compliance|0
7918515|NCT02139943|12440494|FG002|Overall Study|Participant in Poor Compliance|1
7918516|NCT02139943|12440492|FG000|Overall Study|eGFR Withdrawal Criteria|0
7918517|NCT02139943|12440493|FG001|Overall Study|eGFR Withdrawal Criteria|0
7918518|NCT02139943|12440494|FG002|Overall Study|eGFR Withdrawal Criteria|1
7918519|NCT02139982|12440516|FG000|Overall Study|Lack of Efficacy|0
7918520|NCT02139982|12440517|FG001|Overall Study|Lack of Efficacy|1
7918521|NCT02139982|12440518|FG002|Overall Study|Lack of Efficacy|0
7918522|NCT02139982|12440519|FG003|Overall Study|Lack of Efficacy|1
7918523|NCT02139982|12440520|FG004|Overall Study|Lack of Efficacy|0
7918524|NCT02139982|12440521|FG005|Overall Study|Lack of Efficacy|0
7918525|NCT02139982|12440522|FG006|Overall Study|Lack of Efficacy|0
7918526|NCT02139982|12440523|FG007|Overall Study|Lack of Efficacy|0
7918527|NCT02139982|12440524|FG008|Overall Study|Lack of Efficacy|0
7918528|NCT02139982|12440525|FG009|Overall Study|Lack of Efficacy|0
7918529|NCT02140060|12440553|FG000|Overall Study|Adverse Event|0
7918530|NCT02140060|12440554|FG001|Overall Study|Adverse Event|0
7918531|NCT02140060|12440555|FG002|Overall Study|Adverse Event|0
7918532|NCT02140060|12440556|FG003|Overall Study|Adverse Event|1
7918533|NCT02140060|12440557|FG004|Overall Study|Adverse Event|1
7918534|NCT02140060|12440558|FG005|Overall Study|Adverse Event|1
7918535|NCT02140060|12440553|FG000|Overall Study|Lack of Efficacy|0
7918536|NCT02140060|12440554|FG001|Overall Study|Lack of Efficacy|0
7918537|NCT02140060|12440555|FG002|Overall Study|Lack of Efficacy|0
7918538|NCT02140060|12440556|FG003|Overall Study|Lack of Efficacy|1
7918539|NCT02140060|12440557|FG004|Overall Study|Lack of Efficacy|0
7918540|NCT02140060|12440558|FG005|Overall Study|Lack of Efficacy|0
7918541|NCT02140164|12440573|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2
7918542|NCT02140411|12440581|FG000|Overall Study|Adverse Event|1
7918543|NCT02140567|12440585|FG000|Overall Study|Problems with recording equipment|6
7918544|NCT02140645|12440605|FG000|Overall Study|Not linked|5489
7918545|NCT02140645|12440606|FG001|Overall Study|Not linked|61654
7918546|NCT02140645|12440607|FG002|Overall Study|Not linked|4236
7719554|NCT00532948|12143525|FG002|Overall Study|Protocol Violation|0
7719555|NCT00532948|12143523|FG000|Overall Study|Death|3
7918547|NCT02140645|12440608|FG003|Overall Study|Not linked|13833
7918548|NCT02140645|12440609|FG004|Overall Study|Not linked|3286
7918549|NCT02140645|12440610|FG005|Overall Study|Not linked|70896
7918550|NCT02140762|12440621|FG000|Overall Study|Adverse Event|1
7918551|NCT02140762|12440622|FG001|Overall Study|Adverse Event|1
7918552|NCT02140762|12440621|FG000|Overall Study|Lost to Follow-up|9
7918553|NCT02140762|12440622|FG001|Overall Study|Lost to Follow-up|5
7918554|NCT02140762|12440621|FG000|Overall Study|Protocol Violation|1
7918555|NCT02140762|12440622|FG001|Overall Study|Protocol Violation|1
7918556|NCT02140762|12440621|FG000|Overall Study|Withdrawal by Subject|6
7918557|NCT02140762|12440622|FG001|Overall Study|Withdrawal by Subject|4
7918558|NCT02140762|12440621|FG000|Overall Study|Other|0
7918559|NCT02140762|12440622|FG001|Overall Study|Other|1
7918560|NCT02140775|12440635|FG000|Overall Study|Withdrawal by Subject|30
7918561|NCT02140775|12440636|FG001|Overall Study|Withdrawal by Subject|7
7918562|NCT02140970|12440655|FG000|Overall Study|Lost to Follow-up|1
7918563|NCT02140970|12440656|FG001|Overall Study|Lost to Follow-up|2
7918564|NCT02140970|12440655|FG000|Overall Study|Misplaced consent, subject withdrawn|1
7918565|NCT02140970|12440656|FG001|Overall Study|Misplaced consent, subject withdrawn|0
7918566|NCT02140970|12440655|FG000|Overall Study|Did not meet inclusion criteria|0
7918567|NCT02140970|12440656|FG001|Overall Study|Did not meet inclusion criteria|1
7918568|NCT02141204|12440664|FG000|Overall Study|Lost to Follow-up|2
7918569|NCT02141204|12440665|FG001|Overall Study|Lost to Follow-up|1
7918570|NCT02141204|12440664|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1
7918571|NCT02141204|12440665|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2
7918572|NCT02141204|12440664|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
7918573|NCT02141204|12440665|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5
7918574|NCT02141204|12440664|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9
7918575|NCT02141204|12440665|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7
7918576|NCT02141217|12440673|FG000|Overall Study|Adverse Event|1
7918577|NCT02141217|12440674|FG001|Overall Study|Adverse Event|2
7918578|NCT02141217|12440673|FG000|Overall Study|Protocol Violation|1
7918579|NCT02141217|12440674|FG001|Overall Study|Protocol Violation|4
7918580|NCT02141217|12440673|FG000|Overall Study|Withdrawal by Subject|6
7918581|NCT02141217|12440674|FG001|Overall Study|Withdrawal by Subject|0
7918582|NCT02141217|12440673|FG000|Overall Study|Lost to Follow-up|1
7918583|NCT02141217|12440674|FG001|Overall Study|Lost to Follow-up|1
7918584|NCT02141217|12440673|FG000|Overall Study|Physician Decision|1
7918585|NCT02141217|12440674|FG001|Overall Study|Physician Decision|0
7918586|NCT02141217|12440673|FG000|Overall Study|Surgical Intervention|1
7918587|NCT02141217|12440674|FG001|Overall Study|Surgical Intervention|1
7918588|NCT02141295|12440686|FG000|Overall Study|Adverse Event|1
7918589|NCT02141295|12440687|FG001|Overall Study|Adverse Event|18
7918590|NCT02141295|12440688|FG002|Overall Study|Adverse Event|11
7918591|NCT02141295|12440686|FG000|Overall Study|Physician Decision|2
7918592|NCT02141295|12440687|FG001|Overall Study|Physician Decision|19
7918593|NCT02141295|12440688|FG002|Overall Study|Physician Decision|14
7918594|NCT02141295|12440686|FG000|Overall Study|Study terminated by sponsor|0
7918595|NCT02141295|12440687|FG001|Overall Study|Study terminated by sponsor|6
7918596|NCT02141295|12440688|FG002|Overall Study|Study terminated by sponsor|6
7918597|NCT02141295|12440686|FG000|Overall Study|Non-compliance|0
7918598|NCT02141295|12440687|FG001|Overall Study|Non-compliance|1
7918599|NCT02141295|12440688|FG002|Overall Study|Non-compliance|0
7918600|NCT02141295|12440686|FG000|Overall Study|Progressive disease|3
7918601|NCT02141295|12440687|FG001|Overall Study|Progressive disease|32
7918602|NCT02141295|12440688|FG002|Overall Study|Progressive disease|50
7918603|NCT02141295|12440686|FG000|Overall Study|Reason not specified|0
7918604|NCT02141295|12440687|FG001|Overall Study|Reason not specified|9
7918605|NCT02141295|12440688|FG002|Overall Study|Reason not specified|10
7918606|NCT02141295|12440686|FG000|Overall Study|Withdrawal by Subject|0
7918607|NCT02141295|12440687|FG001|Overall Study|Withdrawal by Subject|9
7918608|NCT02141295|12440688|FG002|Overall Study|Withdrawal by Subject|4
7918609|NCT02141360|12440700|FG000|Overall Study|Withdrawal by Subject|6
7918610|NCT02141360|12440701|FG001|Overall Study|Withdrawal by Subject|0
7918611|NCT02141360|12440702|FG002|Overall Study|Withdrawal by Subject|0
7719556|NCT00532948|12143524|FG001|Overall Study|Death|3
7918612|NCT02141360|12440700|FG000|Overall Study|Study Terminated before Visit|1
7918613|NCT02141360|12440701|FG001|Overall Study|Study Terminated before Visit|0
7918614|NCT02141360|12440702|FG002|Overall Study|Study Terminated before Visit|0
7918615|NCT02141399|12440710|FG000|Overall Study|Adverse Event|158
7918616|NCT02141399|12440710|FG000|Overall Study|Lack of Efficacy|62
7918617|NCT02141399|12440710|FG000|Overall Study|Lost to Follow-up|151
7918618|NCT02141399|12440710|FG000|Overall Study|Non-compliance with study drug|18
7918619|NCT02141399|12440710|FG000|Overall Study|Other|45
7918620|NCT02141399|12440710|FG000|Overall Study|Physician Decision|17
7918621|NCT02141399|12440710|FG000|Overall Study|Pregnancy|3
7918622|NCT02141399|12440710|FG000|Overall Study|Protocol Violation|38
7918623|NCT02141399|12440710|FG000|Overall Study|Withdrawal by Subject|238
7918624|NCT02141399|12440710|FG000|Overall Study|Failure to meet eligibility criteria|14
7918625|NCT02141490|12440737|FG000|Overall Study|Screening failures|4
7918626|NCT02141490|12440738|FG001|Overall Study|Screening failures|0
7918627|NCT02141490|12440739|FG002|Overall Study|Screening failures|0
7918628|NCT02141516|12440752|FG000|Overall Study|Adverse Event|0
7918629|NCT02141516|12440753|FG001|Overall Study|Adverse Event|1
7918630|NCT02141516|12440754|FG002|Overall Study|Adverse Event|0
7918631|NCT02141516|12440752|FG000|Overall Study|Lost to Follow-up|0
7918632|NCT02141516|12440753|FG001|Overall Study|Lost to Follow-up|1
7918633|NCT02141516|12440754|FG002|Overall Study|Lost to Follow-up|0
7918634|NCT02141516|12440752|FG000|Overall Study|Other|0
7918635|NCT02141516|12440753|FG001|Overall Study|Other|3
7918636|NCT02141516|12440754|FG002|Overall Study|Other|0
7918637|NCT02141620|12440788|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1
7918638|NCT02141620|12440789|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0
7918639|NCT02141633|12440797|FG000|Overall Study|Physician Decision|1
7918640|NCT02141633|12440798|FG001|Overall Study|Physician Decision|0
7918641|NCT02141659|12440810|FG000|Overall Study|Major Protocol Deviation|0
7918642|NCT02141659|12440811|FG001|Overall Study|Major Protocol Deviation|1
7918643|NCT02141659|12440812|FG002|Overall Study|Major Protocol Deviation|0
7918644|NCT02141659|12440813|FG003|Overall Study|Major Protocol Deviation|0
7918645|NCT02141659|12440814|FG004|Overall Study|Major Protocol Deviation|0
7918646|NCT02141659|12440815|FG005|Overall Study|Major Protocol Deviation|0
7918647|NCT02141659|12440810|FG000|Overall Study|Lack of Efficacy|0
7918648|NCT02141659|12440811|FG001|Overall Study|Lack of Efficacy|0
7918649|NCT02141659|12440812|FG002|Overall Study|Lack of Efficacy|0
7918650|NCT02141659|12440813|FG003|Overall Study|Lack of Efficacy|0
7918651|NCT02141659|12440814|FG004|Overall Study|Lack of Efficacy|0
7918652|NCT02141659|12440815|FG005|Overall Study|Lack of Efficacy|1
7918653|NCT02141659|12440810|FG000|Overall Study|Pretreatment Event/ Adverse Event|0
7918654|NCT02141659|12440811|FG001|Overall Study|Pretreatment Event/ Adverse Event|0
7918655|NCT02141659|12440812|FG002|Overall Study|Pretreatment Event/ Adverse Event|0
7918656|NCT02141659|12440813|FG003|Overall Study|Pretreatment Event/ Adverse Event|0
7918657|NCT02141659|12440814|FG004|Overall Study|Pretreatment Event/ Adverse Event|2
7918658|NCT02141659|12440815|FG005|Overall Study|Pretreatment Event/ Adverse Event|1
7918659|NCT02141672|12440832|FG000|Overall Study|Adverse Event|0
7918660|NCT02141672|12440833|FG001|Overall Study|Adverse Event|1
7918661|NCT02141672|12440834|FG002|Overall Study|Adverse Event|0
7918662|NCT02141672|12440832|FG000|Overall Study|Death|10
7918663|NCT02141672|12440833|FG001|Overall Study|Death|2
7918664|NCT02141672|12440834|FG002|Overall Study|Death|1
7918665|NCT02141672|12440832|FG000|Overall Study|Lack of Efficacy|0
7918666|NCT02141672|12440833|FG001|Overall Study|Lack of Efficacy|0
7918667|NCT02141672|12440834|FG002|Overall Study|Lack of Efficacy|2
7918668|NCT02141672|12440832|FG000|Overall Study|Lost to Follow-up|1
7918669|NCT02141672|12440833|FG001|Overall Study|Lost to Follow-up|1
7918670|NCT02141672|12440834|FG002|Overall Study|Lost to Follow-up|3
7918671|NCT02141672|12440832|FG000|Overall Study|Physician Decision|1
7918672|NCT02141672|12440833|FG001|Overall Study|Physician Decision|2
7918673|NCT02141672|12440834|FG002|Overall Study|Physician Decision|5
7918674|NCT02141672|12440832|FG000|Overall Study|Protocol Violation|0
7918675|NCT02141672|12440833|FG001|Overall Study|Protocol Violation|0
7918676|NCT02141672|12440834|FG002|Overall Study|Protocol Violation|1
7918677|NCT02141672|12440832|FG000|Overall Study|Withdrawal by Subject|3
7918678|NCT02141672|12440833|FG001|Overall Study|Withdrawal by Subject|2
7918679|NCT02141672|12440834|FG002|Overall Study|Withdrawal by Subject|5
7918680|NCT02141672|12440832|FG000|Overall Study|refused to follow-up|1
7918681|NCT02141672|12440833|FG001|Overall Study|refused to follow-up|0
7918682|NCT02141672|12440834|FG002|Overall Study|refused to follow-up|1
7918683|NCT02141854|12440847|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
7918684|NCT02141854|12440848|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7918685|NCT02141854|12440849|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7918686|NCT02141854|12440850|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7918687|NCT02141854|12440851|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7918688|NCT02141854|12440852|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7918689|NCT02141854|12440847|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76
7918690|NCT02141854|12440848|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7918691|NCT02141854|12440849|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7918692|NCT02141854|12440850|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7918693|NCT02141854|12440851|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7918694|NCT02141854|12440852|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7918695|NCT02141854|12440847|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14
7918696|NCT02141854|12440848|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7918697|NCT02141854|12440849|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7918698|NCT02141854|12440850|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7918699|NCT02141854|12440851|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7918700|NCT02141854|12440852|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7918701|NCT02141854|12440847|FG000|Run-In Period (Pre-assignment)|Other|14
7918702|NCT02141854|12440848|FG001|Run-In Period (Pre-assignment)|Other|0
7918703|NCT02141854|12440849|FG002|Run-In Period (Pre-assignment)|Other|0
7918704|NCT02141854|12440850|FG003|Run-In Period (Pre-assignment)|Other|0
7918705|NCT02141854|12440851|FG004|Run-In Period (Pre-assignment)|Other|0
7918706|NCT02141854|12440852|FG005|Run-In Period (Pre-assignment)|Other|0
7918707|NCT02141854|12440847|FG000|Run-In Period (Pre-assignment)|Adverse Event|10
7918708|NCT02141854|12440848|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
7918709|NCT02141854|12440849|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
7918710|NCT02141854|12440850|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
7918711|NCT02141854|12440851|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
7918712|NCT02141854|12440852|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
7918713|NCT02141854|12440847|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
7918714|NCT02141854|12440848|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7918715|NCT02141854|12440849|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7918716|NCT02141854|12440850|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7918717|NCT02141854|12440851|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7918718|NCT02141854|12440852|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7918719|NCT02141854|12440847|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6
7918720|NCT02141854|12440848|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7918721|NCT02141854|12440849|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7918722|NCT02141854|12440850|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7918723|NCT02141854|12440851|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7918724|NCT02141854|12440852|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7918725|NCT02141854|12440847|FG000|Treatment Period|Protocol Violation|0
7918726|NCT02141854|12440848|FG001|Treatment Period|Protocol Violation|1
7918727|NCT02141854|12440849|FG002|Treatment Period|Protocol Violation|0
7918728|NCT02141854|12440850|FG003|Treatment Period|Protocol Violation|2
7918729|NCT02141854|12440851|FG004|Treatment Period|Protocol Violation|2
7918730|NCT02141854|12440852|FG005|Treatment Period|Protocol Violation|1
7918731|NCT02141854|12440847|FG000|Treatment Period|Noncompliance|0
7918732|NCT02141854|12440848|FG001|Treatment Period|Noncompliance|0
7918733|NCT02141854|12440849|FG002|Treatment Period|Noncompliance|0
7918734|NCT02141854|12440850|FG003|Treatment Period|Noncompliance|1
7918735|NCT02141854|12440851|FG004|Treatment Period|Noncompliance|0
7918736|NCT02141854|12440852|FG005|Treatment Period|Noncompliance|0
7918737|NCT02141854|12440847|FG000|Treatment Period|Lack of Efficacy|0
7918738|NCT02141854|12440848|FG001|Treatment Period|Lack of Efficacy|0
7918739|NCT02141854|12440849|FG002|Treatment Period|Lack of Efficacy|0
7918740|NCT02141854|12440850|FG003|Treatment Period|Lack of Efficacy|1
7918741|NCT02141854|12440851|FG004|Treatment Period|Lack of Efficacy|1
7918742|NCT02141854|12440852|FG005|Treatment Period|Lack of Efficacy|7
7918743|NCT02141854|12440847|FG000|Treatment Period|Pregnancy|0
7918744|NCT02141854|12440848|FG001|Treatment Period|Pregnancy|1
7918745|NCT02141854|12440849|FG002|Treatment Period|Pregnancy|0
7918746|NCT02141854|12440850|FG003|Treatment Period|Pregnancy|0
7918747|NCT02141854|12440851|FG004|Treatment Period|Pregnancy|0
7918748|NCT02141854|12440852|FG005|Treatment Period|Pregnancy|0
7918749|NCT02141854|12440847|FG000|Treatment Period|Other|0
7918750|NCT02141854|12440848|FG001|Treatment Period|Other|1
7918751|NCT02141854|12440849|FG002|Treatment Period|Other|2
7918752|NCT02141854|12440850|FG003|Treatment Period|Other|0
7918753|NCT02141854|12440851|FG004|Treatment Period|Other|1
7918754|NCT02141854|12440852|FG005|Treatment Period|Other|2
7918755|NCT02141854|12440847|FG000|Treatment Period|Adverse Event|0
7918756|NCT02141854|12440848|FG001|Treatment Period|Adverse Event|2
7918757|NCT02141854|12440849|FG002|Treatment Period|Adverse Event|2
7918758|NCT02141854|12440850|FG003|Treatment Period|Adverse Event|0
7918759|NCT02141854|12440851|FG004|Treatment Period|Adverse Event|2
7918760|NCT02141854|12440852|FG005|Treatment Period|Adverse Event|2
7918761|NCT02141854|12440847|FG000|Treatment Period|Withdrawal by Subject|0
7918762|NCT02141854|12440848|FG001|Treatment Period|Withdrawal by Subject|2
7918763|NCT02141854|12440849|FG002|Treatment Period|Withdrawal by Subject|3
7918764|NCT02141854|12440850|FG003|Treatment Period|Withdrawal by Subject|3
7918765|NCT02141854|12440851|FG004|Treatment Period|Withdrawal by Subject|4
7918766|NCT02141854|12440852|FG005|Treatment Period|Withdrawal by Subject|7
7918767|NCT02141854|12440847|FG000|Treatment Period|Disease progression|0
7918768|NCT02141854|12440848|FG001|Treatment Period|Disease progression|2
7918769|NCT02141854|12440849|FG002|Treatment Period|Disease progression|1
7918770|NCT02141854|12440850|FG003|Treatment Period|Disease progression|3
7918771|NCT02141854|12440851|FG004|Treatment Period|Disease progression|0
7719557|NCT00532948|12143525|FG002|Overall Study|Death|4
7719558|NCT00532948|12143523|FG000|Overall Study|Violation of selection criteria at entry|0
7719559|NCT00532948|12143524|FG001|Overall Study|Violation of selection criteria at entry|1
7719560|NCT00532948|12143525|FG002|Overall Study|Violation of selection criteria at entry|0
7719561|NCT00532948|12143523|FG000|Overall Study|Failure to return|0
7918772|NCT02141854|12440852|FG005|Treatment Period|Disease progression|18
7918773|NCT02141854|12440847|FG000|Treatment Period|Lost to Follow-up|0
7918774|NCT02141854|12440848|FG001|Treatment Period|Lost to Follow-up|1
7918775|NCT02141854|12440849|FG002|Treatment Period|Lost to Follow-up|1
7918776|NCT02141854|12440850|FG003|Treatment Period|Lost to Follow-up|1
7918777|NCT02141854|12440851|FG004|Treatment Period|Lost to Follow-up|0
7918778|NCT02141854|12440852|FG005|Treatment Period|Lost to Follow-up|1
7918779|NCT02141984|12440868|FG000|Overall Study|Lack of Efficacy|2
7918780|NCT02141997|12440876|FG000|Overall Study|Adverse Event|0
7918781|NCT02141997|12440877|FG001|Overall Study|Adverse Event|2
7918782|NCT02141997|12440878|FG002|Overall Study|Adverse Event|0
7918783|NCT02141997|12440879|FG003|Overall Study|Adverse Event|1
7918784|NCT02141997|12440876|FG000|Overall Study|Participant noncompliance|1
7918785|NCT02141997|12440877|FG001|Overall Study|Participant noncompliance|0
7918786|NCT02141997|12440878|FG002|Overall Study|Participant noncompliance|0
7918787|NCT02141997|12440879|FG003|Overall Study|Participant noncompliance|0
7918788|NCT02141997|12440876|FG000|Overall Study|Withdrew consent|1
7918789|NCT02141997|12440877|FG001|Overall Study|Withdrew consent|0
7918790|NCT02141997|12440878|FG002|Overall Study|Withdrew consent|3
7918791|NCT02141997|12440879|FG003|Overall Study|Withdrew consent|0
7918792|NCT02141997|12440876|FG000|Overall Study|Other|1
7918793|NCT02141997|12440877|FG001|Overall Study|Other|4
7918794|NCT02141997|12440878|FG002|Overall Study|Other|0
7918795|NCT02141997|12440879|FG003|Overall Study|Other|0
7918796|NCT02142283|12440968|FG000|Overall Study|Death|20
7918797|NCT02142283|12440969|FG001|Overall Study|Death|18
7918798|NCT02142283|12440968|FG000|Overall Study|Withdrawal by Subject|1
7918799|NCT02142283|12440969|FG001|Overall Study|Withdrawal by Subject|3
7918800|NCT02142387|12440990|FG000|Overall Study|<19 years old|49
7918801|NCT02142387|12440991|FG001|Overall Study|<19 years old|326
7918802|NCT02142387|12440990|FG000|Overall Study|non-cardiac etiology|504
7918803|NCT02142387|12440991|FG001|Overall Study|non-cardiac etiology|3431
7918804|NCT02142387|12440990|FG000|Overall Study|CPR not performed|74
7719562|NCT00532948|12143524|FG001|Overall Study|Failure to return|1
7918805|NCT02142387|12440991|FG001|Overall Study|CPR not performed|473
7918806|NCT02142387|12440990|FG000|Overall Study|witnessed by paramedic|139
7918807|NCT02142387|12440991|FG001|Overall Study|witnessed by paramedic|917
7918808|NCT02142387|12440990|FG000|Overall Study|incomplete data|1
7918809|NCT02142387|12440991|FG001|Overall Study|incomplete data|9
7918810|NCT02142387|12440990|FG000|Overall Study|occurred not at home|298
7918811|NCT02142387|12440991|FG001|Overall Study|occurred not at home|2474
7918812|NCT02142504|12441000|FG000|Overall Study|Protocol Violation|2
7918813|NCT02142504|12441001|FG001|Overall Study|Protocol Violation|1
7918814|NCT02142504|12441002|FG002|Overall Study|Protocol Violation|2
7918815|NCT02142504|12441000|FG000|Overall Study|Adverse Event|2
7918816|NCT02142504|12441001|FG001|Overall Study|Adverse Event|3
7918817|NCT02142504|12441002|FG002|Overall Study|Adverse Event|4
7918818|NCT02142504|12441000|FG000|Overall Study|Lost to Follow-up|12
7918819|NCT02142504|12441001|FG001|Overall Study|Lost to Follow-up|19
7918820|NCT02142504|12441002|FG002|Overall Study|Lost to Follow-up|17
7918821|NCT02142504|12441000|FG000|Overall Study|Withdrawal by Subject|7
7918822|NCT02142504|12441001|FG001|Overall Study|Withdrawal by Subject|9
7918823|NCT02142504|12441002|FG002|Overall Study|Withdrawal by Subject|11
7918824|NCT02142504|12441000|FG000|Overall Study|Pregnancy|4
7918825|NCT02142504|12441001|FG001|Overall Study|Pregnancy|4
7918826|NCT02142504|12441002|FG002|Overall Study|Pregnancy|2
7918827|NCT02142504|12441000|FG000|Overall Study|Physician Decision|0
7918828|NCT02142504|12441001|FG001|Overall Study|Physician Decision|1
7918829|NCT02142504|12441002|FG002|Overall Study|Physician Decision|3
7918830|NCT02142504|12441000|FG000|Overall Study|Reason Not Specified|4
7918831|NCT02142504|12441001|FG001|Overall Study|Reason Not Specified|5
7918832|NCT02142504|12441002|FG002|Overall Study|Reason Not Specified|4
7918833|NCT02142712|12441018|FG000|Overall Study|Lost to Follow-up|1
7918834|NCT02142712|12441019|FG001|Overall Study|Lost to Follow-up|1
7918835|NCT02142712|12441020|FG002|Overall Study|Lost to Follow-up|1
7918836|NCT02142712|12441021|FG003|Overall Study|Lost to Follow-up|0
7918837|NCT02142894|12441030|FG000|Overall Study|Protocol Violation|8
7964345|NCT02759185|12519814|FG004|Stage 2|Adverse Event|1
7964346|NCT02759185|12519815|FG005|Stage 2|Adverse Event|2
7964347|NCT02759185|12519816|FG006|Stage 2|Adverse Event|0
7964348|NCT02759185|12519810|FG000|Stage 2|Withdrawal by Subject|0
7964349|NCT02759185|12519811|FG001|Stage 2|Withdrawal by Subject|0
7964350|NCT02759185|12519812|FG002|Stage 2|Withdrawal by Subject|0
7964351|NCT02759185|12519813|FG003|Stage 2|Withdrawal by Subject|0
7964352|NCT02759185|12519814|FG004|Stage 2|Withdrawal by Subject|1
7964353|NCT02759185|12519815|FG005|Stage 2|Withdrawal by Subject|1
7964354|NCT02759185|12519816|FG006|Stage 2|Withdrawal by Subject|1
7966935|NCT02759016|12523395|FG001|Overall Study|Other not defined above|1
7966936|NCT02759055|12523404|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927
7966937|NCT02759055|12523405|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508
7966938|NCT02759120|12523413|FG000|Overall Study|Death|34
7966939|NCT02759120|12523414|FG001|Overall Study|Death|36
7966940|NCT02759120|12523413|FG000|Overall Study|Lost to Follow-up|4
7966941|NCT02759120|12523414|FG001|Overall Study|Lost to Follow-up|7
7966942|NCT02759120|12523413|FG000|Overall Study|Physician Decision|3
7966943|NCT02759120|12523414|FG001|Overall Study|Physician Decision|0
7966944|NCT02759120|12523413|FG000|Overall Study|Withdrawal by Subject|28
7966945|NCT02759120|12523414|FG001|Overall Study|Withdrawal by Subject|15
7966946|NCT02759120|12523413|FG000|Overall Study|Moved out of area|3
7966947|NCT02759120|12523414|FG001|Overall Study|Moved out of area|4
7966948|NCT02759120|12523413|FG000|Overall Study|Lung transplant|3
7966949|NCT02759120|12523414|FG001|Overall Study|Lung transplant|5
7966950|NCT02759120|12523413|FG000|Overall Study|Other reason not completed|10
7966951|NCT02759120|12523414|FG001|Overall Study|Other reason not completed|12
7966952|NCT02759315|12523453|FG000|Overall Study|Adverse Event|0
7918838|NCT02143024|12441036|FG000|Overall Study|Lost to Follow-up|1
7918839|NCT02143024|12441037|FG001|Overall Study|Lost to Follow-up|1
7918840|NCT02143024|12441036|FG000|Overall Study|Withdrawal by Subject|1
7918841|NCT02143024|12441037|FG001|Overall Study|Withdrawal by Subject|0
7918842|NCT02143102|12441045|FG000|Overall Study|Lost to Follow-up|11
7918843|NCT02143102|12441046|FG001|Overall Study|Lost to Follow-up|0
7918844|NCT02143141|12441054|FG000|Overall Study|pain scores at 24 hours not collected|1
7918845|NCT02143141|12441055|FG001|Overall Study|pain scores at 24 hours not collected|0
7918846|NCT02143583|12441068|FG000|Overall Study|Withdrawal by Subject|1
7918847|NCT02143583|12441069|FG001|Overall Study|Withdrawal by Subject|0
7918848|NCT02143583|12441070|FG002|Overall Study|Withdrawal by Subject|1
7918849|NCT02143583|12441068|FG000|Overall Study|husband illness|0
7918850|NCT02143583|12441069|FG001|Overall Study|husband illness|0
7918851|NCT02143583|12441070|FG002|Overall Study|husband illness|1
7918852|NCT02143713|12441095|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1
7918853|NCT02143713|12441096|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2
7918854|NCT02143713|12441097|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5
7918855|NCT02143713|12441098|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4
7918856|NCT02143713|12441095|FG000|Treatment Period (6 Months)|Adverse Event|7
7918857|NCT02143713|12441096|FG001|Treatment Period (6 Months)|Adverse Event|8
7918858|NCT02143713|12441097|FG002|Treatment Period (6 Months)|Adverse Event|8
7918859|NCT02143713|12441098|FG003|Treatment Period (6 Months)|Adverse Event|9
7918860|NCT02143713|12441095|FG000|Treatment Period (6 Months)|Lost to Follow-up|3
7918861|NCT02143713|12441096|FG001|Treatment Period (6 Months)|Lost to Follow-up|0
7918862|NCT02143713|12441097|FG002|Treatment Period (6 Months)|Lost to Follow-up|4
7918863|NCT02143713|12441098|FG003|Treatment Period (6 Months)|Lost to Follow-up|3
7918864|NCT02143713|12441095|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
7918865|NCT02143713|12441096|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
7918866|NCT02143713|12441097|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
7918867|NCT02143713|12441098|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
7918868|NCT02143713|12441095|FG000|Treatment Period (6 Months)|Pregnancy|0
7918869|NCT02143713|12441096|FG001|Treatment Period (6 Months)|Pregnancy|2
7918870|NCT02143713|12441097|FG002|Treatment Period (6 Months)|Pregnancy|2
7918871|NCT02143713|12441098|FG003|Treatment Period (6 Months)|Pregnancy|0
7918872|NCT02143713|12441095|FG000|Treatment Period (6 Months)|Non-compliance|1
7918873|NCT02143713|12441096|FG001|Treatment Period (6 Months)|Non-compliance|0
7918874|NCT02143713|12441097|FG002|Treatment Period (6 Months)|Non-compliance|0
7918875|NCT02143713|12441098|FG003|Treatment Period (6 Months)|Non-compliance|3
7918876|NCT02143713|12441095|FG000|Treatment Period (6 Months)|Other|3
7918877|NCT02143713|12441096|FG001|Treatment Period (6 Months)|Other|0
7918878|NCT02143713|12441097|FG002|Treatment Period (6 Months)|Other|3
7918879|NCT02143713|12441098|FG003|Treatment Period (6 Months)|Other|2
7918880|NCT02143713|12441095|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
7918881|NCT02143713|12441096|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
7918882|NCT02143713|12441097|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
7918883|NCT02143713|12441098|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
7918884|NCT02143713|12441095|FG000|Treatment Period (6 Months)|Exclusionary Medication|2
7918885|NCT02143713|12441096|FG001|Treatment Period (6 Months)|Exclusionary Medication|0
7918886|NCT02143713|12441097|FG002|Treatment Period (6 Months)|Exclusionary Medication|0
7719563|NCT00532948|12143525|FG002|Overall Study|Failure to return|0
7719564|NCT00533273|12143556|FG000|Double-blind|Withdrew consent|0
7719565|NCT00533273|12143557|FG001|Double-blind|Withdrew consent|2
7719566|NCT00533273|12143556|FG000|Open-label|Withdrawal by Subject|6
7719567|NCT00533273|12143557|FG001|Open-label|Withdrawal by Subject|0
7719568|NCT00533429|12143565|FG000|Overall Study|Adverse Event|3
7719569|NCT00533429|12143566|FG001|Overall Study|Adverse Event|1
7719570|NCT00533429|12143565|FG000|Overall Study|Death|1
7719571|NCT00533429|12143566|FG001|Overall Study|Death|0
7719572|NCT00533429|12143565|FG000|Overall Study|Withdrawal by Subject|2
7719573|NCT00533429|12143566|FG001|Overall Study|Withdrawal by Subject|0
7918887|NCT02143713|12441098|FG003|Treatment Period (6 Months)|Exclusionary Medication|0
7918888|NCT02143713|12441095|FG000|Treatment Period (6 Months)|Lack of Efficacy|1
7918889|NCT02143713|12441096|FG001|Treatment Period (6 Months)|Lack of Efficacy|0
7918890|NCT02143713|12441097|FG002|Treatment Period (6 Months)|Lack of Efficacy|0
7918891|NCT02143713|12441098|FG003|Treatment Period (6 Months)|Lack of Efficacy|1
7918892|NCT02143713|12441095|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
7918893|NCT02143713|12441096|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
7918894|NCT02143713|12441097|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
7918895|NCT02143713|12441098|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
7918896|NCT02143713|12441095|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0
7918897|NCT02143713|12441096|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0
7918898|NCT02143713|12441097|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1
7918899|NCT02143713|12441098|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0
7918900|NCT02143713|12441095|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
7918901|NCT02143713|12441096|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
7918902|NCT02143713|12441097|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
7918903|NCT02143713|12441098|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
7918904|NCT02143713|12441095|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
7918905|NCT02143713|12441096|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
7918906|NCT02143713|12441097|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
7918907|NCT02143713|12441098|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
7918908|NCT02143713|12441095|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
7918909|NCT02143713|12441096|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
7918910|NCT02143713|12441097|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
7918911|NCT02143713|12441098|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
7918912|NCT02143713|12441095|FG000|Post-treatment Follow-up (12 Months)|Other|3
7918913|NCT02143713|12441096|FG001|Post-treatment Follow-up (12 Months)|Other|4
7918914|NCT02143713|12441097|FG002|Post-treatment Follow-up (12 Months)|Other|7
7918915|NCT02143713|12441098|FG003|Post-treatment Follow-up (12 Months)|Other|7
7918916|NCT02143778|12441109|FG000|Overall Study|Withdrawal by Subject|2
7918917|NCT02143778|12441109|FG000|Overall Study|Device malfunction|1
7918918|NCT02143843|12441114|FG000|Overall Study|Adverse Event|8
7918919|NCT02143843|12441114|FG000|Overall Study|Lack of Efficacy|2
7918920|NCT02143843|12441114|FG000|Overall Study|Withdrawal by Subject|2
7918921|NCT02143947|12441120|FG000|Overall Study|Lost to Follow-up|4
7918922|NCT02143947|12441121|FG001|Overall Study|Lost to Follow-up|2
7918923|NCT02144012|12441135|FG000|Overall Study|Adverse Event|1
7918924|NCT02144012|12441136|FG001|Overall Study|Adverse Event|0
7918925|NCT02144012|12441135|FG000|Overall Study|Death|1
7918926|NCT02144012|12441136|FG001|Overall Study|Death|0
7918927|NCT02144012|12441135|FG000|Overall Study|Withdrawal by Subject|11
7918928|NCT02144012|12441136|FG001|Overall Study|Withdrawal by Subject|3
7918929|NCT02144012|12441135|FG000|Overall Study|Study Terminated by Sponsor|18
7918930|NCT02144012|12441136|FG001|Overall Study|Study Terminated by Sponsor|12
7918931|NCT02144012|12441135|FG000|Overall Study|Other|3
7918932|NCT02144012|12441136|FG001|Overall Study|Other|0
7918933|NCT02144077|12441144|FG000|Overall Study|Withdrawal by Subject|3
7918934|NCT02144077|12441145|FG001|Overall Study|Withdrawal by Subject|3
7918935|NCT02144077|12441144|FG000|Overall Study|Adverse Event|2
7918936|NCT02144077|12441145|FG001|Overall Study|Adverse Event|3
7918937|NCT02144077|12441144|FG000|Overall Study|Lost to Follow-up|2
7918938|NCT02144077|12441145|FG001|Overall Study|Lost to Follow-up|2
7918939|NCT02144077|12441144|FG000|Overall Study|Protocol Violation|1
7918940|NCT02144077|12441145|FG001|Overall Study|Protocol Violation|2
7918941|NCT02144077|12441144|FG000|Overall Study|Death|0
7918942|NCT02144077|12441145|FG001|Overall Study|Death|1
7918943|NCT02144077|12441144|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2
7918944|NCT02144077|12441145|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0
7918945|NCT02144220|12441151|FG000|Overall Study|technology incompatibility|9
7918946|NCT02144220|12441151|FG000|Overall Study|Lack of Efficacy|4
7918947|NCT02144220|12441151|FG000|Overall Study|Physician Decision|3
7918948|NCT02144220|12441151|FG000|Overall Study|Withdrawal by Subject|2
7918949|NCT02144220|12441151|FG000|Overall Study|Protocol Violation|1
7918950|NCT02144285|12441187|FG000|Overall Study|Withdrawal by Subject|0
7918951|NCT02144285|12441188|FG001|Overall Study|Withdrawal by Subject|0
7918952|NCT02144285|12441189|FG002|Overall Study|Withdrawal by Subject|0
7918953|NCT02144285|12441190|FG003|Overall Study|Withdrawal by Subject|0
7918954|NCT02144285|12441191|FG004|Overall Study|Withdrawal by Subject|1
7918955|NCT02144285|12441192|FG005|Overall Study|Withdrawal by Subject|0
7918956|NCT02144285|12441193|FG006|Overall Study|Withdrawal by Subject|0
7918957|NCT02144285|12441194|FG007|Overall Study|Withdrawal by Subject|0
7918958|NCT02144285|12441195|FG008|Overall Study|Withdrawal by Subject|0
7918959|NCT02144285|12441196|FG009|Overall Study|Withdrawal by Subject|0
7918960|NCT02144337|12441234|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
7918961|NCT02144337|12441235|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
7918962|NCT02144337|12441234|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
7918963|NCT02144337|12441235|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
7918964|NCT02144337|12441234|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
7918965|NCT02144337|12441235|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
7918966|NCT02144337|12441234|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
7918967|NCT02144337|12441235|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
7918968|NCT02144337|12441234|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
7918969|NCT02144337|12441235|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
7918970|NCT02144610|12441275|FG000|Overall Study|Physician Decision|1
7918971|NCT02144610|12441276|FG001|Overall Study|Physician Decision|0
7918972|NCT02144610|12441275|FG000|Overall Study|Withdrawal by Subject|1
7918973|NCT02144610|12441276|FG001|Overall Study|Withdrawal by Subject|5
7918974|NCT02144610|12441275|FG000|Overall Study|Death|2
7918975|NCT02144610|12441276|FG001|Overall Study|Death|2
7918976|NCT02144610|12441275|FG000|Overall Study|Study Discontinuation by Sponsor|19
7918977|NCT02144610|12441276|FG001|Overall Study|Study Discontinuation by Sponsor|14
7918978|NCT02144610|12441275|FG000|Overall Study|Other|0
7918979|NCT02144610|12441276|FG001|Overall Study|Other|1
7918980|NCT02144701|12441293|FG000|Overall Study|development of relapse, GVHD or death|9
7918981|NCT02144701|12441294|FG001|Overall Study|development of relapse, GVHD or death|3
7918982|NCT02145026|12441313|FG000|Overall Study|Adverse Event|2
7918983|NCT02145026|12441313|FG000|Overall Study|Death|4
7918984|NCT02145026|12441313|FG000|Overall Study|Withdrawal by Subject|2
7918985|NCT02145026|12441313|FG000|Overall Study|Physician Decision|4
7918986|NCT02145078|12441321|FG000|Overall Study|Death|1
7918987|NCT02145078|12441321|FG000|Overall Study|Reason not given|3
7918988|NCT02145156|12441328|FG000|Overall Study|No match to vaccination records|60
7918989|NCT02145156|12441329|FG001|Overall Study|No match to vaccination records|52
7918990|NCT02145156|12441330|FG002|Overall Study|No match to vaccination records|41
7918991|NCT02145182|12441340|FG000|Overall Study|Adverse Event|4
7918992|NCT02145182|12441341|FG001|Overall Study|Adverse Event|1
7918993|NCT02145182|12441340|FG000|Overall Study|Death|7
7821428|NCT01255592|12290133|FG001|Overall Study|Withdrawal by Subject|0
7821429|NCT01255592|12290132|FG000|Overall Study|Other|0
7821430|NCT01255592|12290133|FG001|Overall Study|Other|1
7821431|NCT01255631|12290142|FG000|Overall Study|poor enrollment, no data analyzed|9
7821432|NCT01255631|12290143|FG001|Overall Study|poor enrollment, no data analyzed|6
7821433|NCT01255670|12290151|FG000|Overall Study|Adverse Event|10
7821434|NCT01255670|12290152|FG001|Overall Study|Adverse Event|10
7821435|NCT01255670|12290151|FG000|Overall Study|Lost to Follow-up|16
7821436|NCT01255670|12290152|FG001|Overall Study|Lost to Follow-up|10
7821437|NCT01255722|12290161|FG000|Overall Study|Adverse Event|0
7821438|NCT01255722|12290162|FG001|Overall Study|Adverse Event|1
7821439|NCT01255722|12290163|FG002|Overall Study|Adverse Event|1
7821440|NCT01255722|12290161|FG000|Overall Study|asymptomatic patient|1
7821441|NCT01255722|12290162|FG001|Overall Study|asymptomatic patient|0
7821442|NCT01255722|12290163|FG002|Overall Study|asymptomatic patient|0
7821443|NCT01255722|12290161|FG000|Overall Study|beta-blocker contraindicated|2
7821444|NCT01255722|12290162|FG001|Overall Study|beta-blocker contraindicated|0
7821445|NCT01255722|12290163|FG002|Overall Study|beta-blocker contraindicated|0
7821446|NCT01255761|12290174|FG000|Overall Study|Adverse Event|29
7821447|NCT01255761|12290175|FG001|Overall Study|Adverse Event|43
7821448|NCT01255761|12290174|FG000|Overall Study|Lack of Efficacy|86
7821449|NCT01255761|12290175|FG001|Overall Study|Lack of Efficacy|74
7821450|NCT01255761|12290174|FG000|Overall Study|Protocol Violation|9
7821451|NCT01255761|12290175|FG001|Overall Study|Protocol Violation|5
7821452|NCT01255761|12290174|FG000|Overall Study|Lost to Follow-up|10
7918994|NCT02145182|12441341|FG001|Overall Study|Death|7
7918995|NCT02145182|12441340|FG000|Overall Study|Lost to Follow-up|2
7918996|NCT02145182|12441341|FG001|Overall Study|Lost to Follow-up|2
7918997|NCT02145182|12441340|FG000|Overall Study|Pre-transplant Withdrawal|0
7918998|NCT02145182|12441341|FG001|Overall Study|Pre-transplant Withdrawal|2
7918999|NCT02145182|12441340|FG000|Overall Study|Withdrawal by Subject|5
7919000|NCT02145182|12441341|FG001|Overall Study|Withdrawal by Subject|4
7919001|NCT02145429|12441367|FG000|Overall Study|Death|4
7919002|NCT02145429|12441368|FG001|Overall Study|Death|5
7919003|NCT02145429|12441367|FG000|Overall Study|Lost to Follow-up|4
7919004|NCT02145429|12441368|FG001|Overall Study|Lost to Follow-up|3
7919005|NCT02145429|12441367|FG000|Overall Study|Withdrawal by Subject|8
7919006|NCT02145429|12441368|FG001|Overall Study|Withdrawal by Subject|3
7919007|NCT02145468|12441376|FG000|Overall Study|Withdrawal by Subject|5
7919008|NCT02145468|12441377|FG001|Overall Study|Withdrawal by Subject|8
7919009|NCT02146105|12441409|FG000|Overall Study|Adverse Event|1
7919010|NCT02146105|12441409|FG000|Overall Study|Withdrawal by Subject|5
7919011|NCT02146131|12441415|FG000|Overall Study|Physician Decision|61
7919012|NCT02146131|12441416|FG001|Overall Study|Physician Decision|56
7919013|NCT02146248|12441422|FG000|Overall Study|Withdrawal by Subject|2
7919014|NCT02146274|12441430|FG000|Overall Study|Protocol Violation|73
7919015|NCT02146326|12441441|FG000|Overall Study|Lost to Follow-up|3
7919016|NCT02146326|12441442|FG001|Overall Study|Lost to Follow-up|3
7919017|NCT02146326|12441443|FG002|Overall Study|Lost to Follow-up|11
7919018|NCT02146326|12441444|FG003|Overall Study|Lost to Follow-up|19
7919019|NCT02146326|12441441|FG000|Overall Study|Withdrawal by Subject|2
7919020|NCT02146326|12441442|FG001|Overall Study|Withdrawal by Subject|1
7919021|NCT02146326|12441443|FG002|Overall Study|Withdrawal by Subject|15
7919022|NCT02146326|12441444|FG003|Overall Study|Withdrawal by Subject|11
7919023|NCT02146326|12441441|FG000|Overall Study|Separated from mental health center|23
7919024|NCT02146326|12441442|FG001|Overall Study|Separated from mental health center|33
7919025|NCT02146326|12441443|FG002|Overall Study|Separated from mental health center|0
7919026|NCT02146326|12441444|FG003|Overall Study|Separated from mental health center|0
7919027|NCT02146326|12441441|FG000|Overall Study|Incarcerated|0
7919028|NCT02146326|12441442|FG001|Overall Study|Incarcerated|0
7919029|NCT02146326|12441443|FG002|Overall Study|Incarcerated|3
7919030|NCT02146326|12441444|FG003|Overall Study|Incarcerated|8
7919031|NCT02146326|12441441|FG000|Overall Study|Death|0
7919032|NCT02146326|12441442|FG001|Overall Study|Death|0
7821453|NCT01255761|12290175|FG001|Overall Study|Lost to Follow-up|8
7821454|NCT01255761|12290174|FG000|Overall Study|Withdrawal by Subject|11
7821455|NCT01255761|12290175|FG001|Overall Study|Withdrawal by Subject|27
7821456|NCT01255761|12290174|FG000|Overall Study|Other Reasons|37
7821457|NCT01255761|12290175|FG001|Overall Study|Other Reasons|18
7919033|NCT02146326|12441443|FG002|Overall Study|Death|4
7919034|NCT02146326|12441444|FG003|Overall Study|Death|4
7919035|NCT02146326|12441441|FG000|Overall Study|Unable to complete interview|0
7919036|NCT02146326|12441442|FG001|Overall Study|Unable to complete interview|0
7919037|NCT02146326|12441443|FG002|Overall Study|Unable to complete interview|10
7919038|NCT02146326|12441444|FG003|Overall Study|Unable to complete interview|6
7821458|NCT01255787|12290185|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6
7919039|NCT02146352|12441460|FG000|Overall Study|Death|1
7919040|NCT02146352|12441460|FG000|Overall Study|Patient entered hospice care|1
7919041|NCT02146365|12441470|FG000|Overall Study|Lost to Follow-up|2
7919042|NCT02146365|12441471|FG001|Overall Study|Lost to Follow-up|1
7821459|NCT01255787|12290186|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2
7821460|NCT01255787|12290187|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9
7919043|NCT02146365|12441472|FG002|Overall Study|Lost to Follow-up|3
7919044|NCT02146365|12441473|FG003|Overall Study|Lost to Follow-up|3
7919045|NCT02146365|12441474|FG004|Overall Study|Lost to Follow-up|1
7919046|NCT02146365|12441475|FG005|Overall Study|Lost to Follow-up|1
7919047|NCT02146365|12441476|FG006|Overall Study|Lost to Follow-up|0
7919048|NCT02146365|12441477|FG007|Overall Study|Lost to Follow-up|1
7919049|NCT02146365|12441470|FG000|Overall Study|Withdrawal by Subject|1
7919050|NCT02146365|12441471|FG001|Overall Study|Withdrawal by Subject|2
7919051|NCT02146365|12441472|FG002|Overall Study|Withdrawal by Subject|1
7919052|NCT02146365|12441473|FG003|Overall Study|Withdrawal by Subject|5
7919053|NCT02146365|12441474|FG004|Overall Study|Withdrawal by Subject|1
7919054|NCT02146365|12441475|FG005|Overall Study|Withdrawal by Subject|0
7919055|NCT02146365|12441476|FG006|Overall Study|Withdrawal by Subject|0
7919056|NCT02146365|12441477|FG007|Overall Study|Withdrawal by Subject|0
7919057|NCT02146365|12441470|FG000|Overall Study|Unable to Comply with Protocol|0
7919058|NCT02146365|12441471|FG001|Overall Study|Unable to Comply with Protocol|1
7919059|NCT02146365|12441472|FG002|Overall Study|Unable to Comply with Protocol|1
7919060|NCT02146365|12441473|FG003|Overall Study|Unable to Comply with Protocol|0
7919061|NCT02146365|12441474|FG004|Overall Study|Unable to Comply with Protocol|0
7919062|NCT02146365|12441475|FG005|Overall Study|Unable to Comply with Protocol|0
7919063|NCT02146365|12441476|FG006|Overall Study|Unable to Comply with Protocol|0
7919064|NCT02146365|12441477|FG007|Overall Study|Unable to Comply with Protocol|0
7919065|NCT02146365|12441470|FG000|Overall Study|Other|1
7919066|NCT02146365|12441471|FG001|Overall Study|Other|0
7919067|NCT02146365|12441472|FG002|Overall Study|Other|2
7919068|NCT02146365|12441473|FG003|Overall Study|Other|1
7919069|NCT02146365|12441474|FG004|Overall Study|Other|0
7919070|NCT02146365|12441475|FG005|Overall Study|Other|0
7919071|NCT02146365|12441476|FG006|Overall Study|Other|0
7919072|NCT02146365|12441477|FG007|Overall Study|Other|0
7919073|NCT02146430|12441499|FG000|Overall Study|Protocol Violation|5
7821461|NCT01255787|12290188|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9
7821462|NCT01255787|12290185|FG000|Overall Study|Major Protocol Deviation|1
7821463|NCT01255787|12290186|FG001|Overall Study|Major Protocol Deviation|1
7919074|NCT02146430|12441500|FG001|Overall Study|Protocol Violation|4
7919075|NCT02146430|12441501|FG002|Overall Study|Protocol Violation|8
7919076|NCT02146430|12441502|FG003|Overall Study|Protocol Violation|6
7919077|NCT02146430|12441499|FG000|Overall Study|Lack of Efficacy|13
7919078|NCT02146430|12441500|FG001|Overall Study|Lack of Efficacy|11
7919079|NCT02146430|12441501|FG002|Overall Study|Lack of Efficacy|8
7919080|NCT02146430|12441502|FG003|Overall Study|Lack of Efficacy|5
7919081|NCT02146430|12441499|FG000|Overall Study|Adverse Event|20
7919082|NCT02146430|12441500|FG001|Overall Study|Adverse Event|40
7919083|NCT02146430|12441501|FG002|Overall Study|Adverse Event|32
7919084|NCT02146430|12441502|FG003|Overall Study|Adverse Event|49
7919085|NCT02146430|12441499|FG000|Overall Study|Reason missing or not reported|2
7919086|NCT02146430|12441500|FG001|Overall Study|Reason missing or not reported|3
7919087|NCT02146430|12441501|FG002|Overall Study|Reason missing or not reported|4
7919088|NCT02146430|12441502|FG003|Overall Study|Reason missing or not reported|5
7919089|NCT02146430|12441499|FG000|Overall Study|Withdrawal by Subject|27
7919090|NCT02146430|12441500|FG001|Overall Study|Withdrawal by Subject|29
7919091|NCT02146430|12441501|FG002|Overall Study|Withdrawal by Subject|30
7919092|NCT02146430|12441502|FG003|Overall Study|Withdrawal by Subject|34
7919093|NCT02146599|12441525|FG000|Overall Study|Failed to meet inclusion criteria|5
7919094|NCT02146833|12441529|FG000|Overall Study|Death|10
7919095|NCT02146833|12441529|FG000|Overall Study|No longer consented to study treatment|1
7919096|NCT02147067|12441535|FG000|Overall Study|Withdrawal by Subject|2
7919097|NCT02147067|12441536|FG001|Overall Study|Withdrawal by Subject|2
7919098|NCT02147093|12441544|FG000|Period 1|Lost to Follow-up|0
7821464|NCT01255787|12290187|FG002|Overall Study|Major Protocol Deviation|0
7919099|NCT02147093|12441545|FG001|Period 1|Lost to Follow-up|1
7919100|NCT02147093|12441544|FG000|Period 2|Protocol Violation|2
7919101|NCT02147093|12441545|FG001|Period 2|Protocol Violation|0
7919102|NCT02147132|12441551|FG000|Overall Study|Lost to Follow-up|1
7919103|NCT02147132|12441552|FG001|Overall Study|Lost to Follow-up|0
7919104|NCT02147132|12441553|FG002|Overall Study|Lost to Follow-up|0
7919105|NCT02147132|12441554|FG003|Overall Study|Lost to Follow-up|0
7919106|NCT02147158|12441570|FG000|Treatment Course 1|Adverse Event|1
7919107|NCT02147158|12441571|FG001|Treatment Course 1|Adverse Event|4
7919108|NCT02147158|12441572|FG002|Treatment Course 1|Adverse Event|3
7919109|NCT02147158|12441573|FG003|Treatment Course 1|Adverse Event|4
7919110|NCT02147158|12441574|FG004|Treatment Course 1|Adverse Event|1
7919111|NCT02147158|12441575|FG005|Treatment Course 1|Adverse Event|2
7919112|NCT02147158|12441570|FG000|Treatment Course 1|Lost to Follow-up|2
7919113|NCT02147158|12441571|FG001|Treatment Course 1|Lost to Follow-up|4
7919114|NCT02147158|12441572|FG002|Treatment Course 1|Lost to Follow-up|3
7919115|NCT02147158|12441573|FG003|Treatment Course 1|Lost to Follow-up|3
7919116|NCT02147158|12441574|FG004|Treatment Course 1|Lost to Follow-up|2
7919117|NCT02147158|12441575|FG005|Treatment Course 1|Lost to Follow-up|4
7919118|NCT02147158|12441570|FG000|Treatment Course 1|Protocol Violation|0
7919119|NCT02147158|12441571|FG001|Treatment Course 1|Protocol Violation|0
7919120|NCT02147158|12441572|FG002|Treatment Course 1|Protocol Violation|1
7919121|NCT02147158|12441573|FG003|Treatment Course 1|Protocol Violation|1
7919122|NCT02147158|12441574|FG004|Treatment Course 1|Protocol Violation|0
7919123|NCT02147158|12441575|FG005|Treatment Course 1|Protocol Violation|0
7919124|NCT02147158|12441570|FG000|Treatment Course 1|Withdrawal of Consent|1
7919125|NCT02147158|12441571|FG001|Treatment Course 1|Withdrawal of Consent|1
7919126|NCT02147158|12441572|FG002|Treatment Course 1|Withdrawal of Consent|1
7919127|NCT02147158|12441573|FG003|Treatment Course 1|Withdrawal of Consent|5
7919128|NCT02147158|12441574|FG004|Treatment Course 1|Withdrawal of Consent|3
7919129|NCT02147158|12441575|FG005|Treatment Course 1|Withdrawal of Consent|2
7919130|NCT02147158|12441570|FG000|Off-Treatment Interval 1|Adverse Event|1
7919131|NCT02147158|12441571|FG001|Off-Treatment Interval 1|Adverse Event|0
7919132|NCT02147158|12441572|FG002|Off-Treatment Interval 1|Adverse Event|0
7919133|NCT02147158|12441573|FG003|Off-Treatment Interval 1|Adverse Event|1
7919134|NCT02147158|12441574|FG004|Off-Treatment Interval 1|Adverse Event|0
7919135|NCT02147158|12441575|FG005|Off-Treatment Interval 1|Adverse Event|0
7919136|NCT02147158|12441570|FG000|Off-Treatment Interval 1|Lost to Follow-up|2
7919137|NCT02147158|12441571|FG001|Off-Treatment Interval 1|Lost to Follow-up|1
7919138|NCT02147158|12441572|FG002|Off-Treatment Interval 1|Lost to Follow-up|3
7919139|NCT02147158|12441573|FG003|Off-Treatment Interval 1|Lost to Follow-up|2
7919140|NCT02147158|12441574|FG004|Off-Treatment Interval 1|Lost to Follow-up|4
7919141|NCT02147158|12441575|FG005|Off-Treatment Interval 1|Lost to Follow-up|2
7919142|NCT02147158|12441570|FG000|Off-Treatment Interval 1|Protocol Violation|1
7919143|NCT02147158|12441571|FG001|Off-Treatment Interval 1|Protocol Violation|0
7919144|NCT02147158|12441572|FG002|Off-Treatment Interval 1|Protocol Violation|2
7919145|NCT02147158|12441573|FG003|Off-Treatment Interval 1|Protocol Violation|0
7919146|NCT02147158|12441574|FG004|Off-Treatment Interval 1|Protocol Violation|1
7919147|NCT02147158|12441575|FG005|Off-Treatment Interval 1|Protocol Violation|0
7919148|NCT02147158|12441570|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4
7919149|NCT02147158|12441571|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3
7919150|NCT02147158|12441572|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5
7919151|NCT02147158|12441573|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10
7919152|NCT02147158|12441574|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2
7919153|NCT02147158|12441575|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3
7919154|NCT02147158|12441570|FG000|Off-Treatment Interval 1|Lack of Efficacy|0
7919155|NCT02147158|12441571|FG001|Off-Treatment Interval 1|Lack of Efficacy|0
7919156|NCT02147158|12441572|FG002|Off-Treatment Interval 1|Lack of Efficacy|2
7919157|NCT02147158|12441573|FG003|Off-Treatment Interval 1|Lack of Efficacy|0
7919158|NCT02147158|12441574|FG004|Off-Treatment Interval 1|Lack of Efficacy|1
7919159|NCT02147158|12441575|FG005|Off-Treatment Interval 1|Lack of Efficacy|0
7919160|NCT02147158|12441570|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
7919161|NCT02147158|12441571|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
7919162|NCT02147158|12441572|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3
7919163|NCT02147158|12441573|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
7919164|NCT02147158|12441574|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
7919165|NCT02147158|12441575|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
7919166|NCT02147158|12441570|FG000|Treatment Course 2|Adverse Event|0
7919167|NCT02147158|12441571|FG001|Treatment Course 2|Adverse Event|4
7919168|NCT02147158|12441572|FG002|Treatment Course 2|Adverse Event|2
7919169|NCT02147158|12441573|FG003|Treatment Course 2|Adverse Event|1
7919170|NCT02147158|12441574|FG004|Treatment Course 2|Adverse Event|0
7919171|NCT02147158|12441575|FG005|Treatment Course 2|Adverse Event|1
7919172|NCT02147158|12441570|FG000|Treatment Course 2|Withdrawal of Consent|0
7919173|NCT02147158|12441571|FG001|Treatment Course 2|Withdrawal of Consent|1
7919174|NCT02147158|12441572|FG002|Treatment Course 2|Withdrawal of Consent|2
7919175|NCT02147158|12441573|FG003|Treatment Course 2|Withdrawal of Consent|3
7919176|NCT02147158|12441574|FG004|Treatment Course 2|Withdrawal of Consent|0
7919177|NCT02147158|12441575|FG005|Treatment Course 2|Withdrawal of Consent|0
7919178|NCT02147158|12441570|FG000|Treatment Course 2|Lost to Follow-up|1
7919179|NCT02147158|12441571|FG001|Treatment Course 2|Lost to Follow-up|0
7919180|NCT02147158|12441572|FG002|Treatment Course 2|Lost to Follow-up|1
7919181|NCT02147158|12441573|FG003|Treatment Course 2|Lost to Follow-up|1
7919182|NCT02147158|12441574|FG004|Treatment Course 2|Lost to Follow-up|0
7919183|NCT02147158|12441575|FG005|Treatment Course 2|Lost to Follow-up|1
7919184|NCT02147158|12441570|FG000|Off-Treatment Interval 2|Lack of Efficacy|0
7919185|NCT02147158|12441571|FG001|Off-Treatment Interval 2|Lack of Efficacy|1
7919186|NCT02147158|12441572|FG002|Off-Treatment Interval 2|Lack of Efficacy|1
7919187|NCT02147158|12441573|FG003|Off-Treatment Interval 2|Lack of Efficacy|0
7919188|NCT02147158|12441574|FG004|Off-Treatment Interval 2|Lack of Efficacy|0
7919189|NCT02147158|12441575|FG005|Off-Treatment Interval 2|Lack of Efficacy|0
7919190|NCT02147158|12441570|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4
7919191|NCT02147158|12441571|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0
7919192|NCT02147158|12441572|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5
7919193|NCT02147158|12441573|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4
7919194|NCT02147158|12441574|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0
7919195|NCT02147158|12441575|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1
7919196|NCT02147158|12441570|FG000|Off-Treatment Interval 2|Lost to Follow-up|0
7919197|NCT02147158|12441571|FG001|Off-Treatment Interval 2|Lost to Follow-up|0
7919198|NCT02147158|12441572|FG002|Off-Treatment Interval 2|Lost to Follow-up|3
7919199|NCT02147158|12441573|FG003|Off-Treatment Interval 2|Lost to Follow-up|2
7919200|NCT02147158|12441574|FG004|Off-Treatment Interval 2|Lost to Follow-up|2
7919201|NCT02147158|12441575|FG005|Off-Treatment Interval 2|Lost to Follow-up|2
7919202|NCT02147158|12441570|FG000|Off-Treatment Interval 2|Protocol Violation|0
7919203|NCT02147158|12441571|FG001|Off-Treatment Interval 2|Protocol Violation|0
7919204|NCT02147158|12441572|FG002|Off-Treatment Interval 2|Protocol Violation|0
7719574|NCT00533429|12143565|FG000|Overall Study|Progressive Disease|12
7919205|NCT02147158|12441573|FG003|Off-Treatment Interval 2|Protocol Violation|1
7919206|NCT02147158|12441574|FG004|Off-Treatment Interval 2|Protocol Violation|0
7919207|NCT02147158|12441575|FG005|Off-Treatment Interval 2|Protocol Violation|0
7919208|NCT02147158|12441570|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
7919209|NCT02147158|12441571|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3
7919210|NCT02147158|12441572|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
7919211|NCT02147158|12441573|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4
7919212|NCT02147158|12441574|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
7919213|NCT02147158|12441575|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
7919214|NCT02147197|12441595|FG000|Overall Study|Adverse Event|1
7919215|NCT02147197|12441596|FG001|Overall Study|Adverse Event|0
7919216|NCT02147197|12441597|FG002|Overall Study|Adverse Event|0
7919217|NCT02147197|12441595|FG000|Overall Study|Withdrawal of Consent|4
7919218|NCT02147197|12441596|FG001|Overall Study|Withdrawal of Consent|3
7919219|NCT02147197|12441597|FG002|Overall Study|Withdrawal of Consent|2
7919220|NCT02147197|12441595|FG000|Overall Study|Lost to Follow-up|2
7919221|NCT02147197|12441596|FG001|Overall Study|Lost to Follow-up|3
7919222|NCT02147197|12441597|FG002|Overall Study|Lost to Follow-up|1
7919223|NCT02147197|12441595|FG000|Overall Study|Protocol Violation|1
7919224|NCT02147197|12441596|FG001|Overall Study|Protocol Violation|0
7919225|NCT02147197|12441597|FG002|Overall Study|Protocol Violation|3
7919226|NCT02147197|12441595|FG000|Overall Study|Other Miscellaneous Reasons|1
7919227|NCT02147197|12441596|FG001|Overall Study|Other Miscellaneous Reasons|0
7919228|NCT02147197|12441597|FG002|Overall Study|Other Miscellaneous Reasons|3
7919229|NCT02147288|12441607|FG000|Overall Study|post-operative hematoma|1
7919230|NCT02147288|12441608|FG001|Overall Study|post-operative hematoma|1
7919231|NCT02147288|12441609|FG002|Overall Study|post-operative hematoma|0
7919232|NCT02147288|12441610|FG003|Overall Study|post-operative hematoma|0
7919233|NCT02147288|12441611|FG004|Overall Study|post-operative hematoma|0
7919234|NCT02147288|12441612|FG005|Overall Study|post-operative hematoma|0
7919235|NCT02147288|12441613|FG006|Overall Study|post-operative hematoma|0
7919236|NCT02147288|12441614|FG007|Overall Study|post-operative hematoma|0
7919237|NCT02147288|12441615|FG008|Overall Study|post-operative hematoma|0
7919238|NCT02147288|12441616|FG009|Overall Study|post-operative hematoma|0
7919239|NCT02147288|12441607|FG000|Overall Study|complications from concurrent hernia rep|0
7919240|NCT02147288|12441608|FG001|Overall Study|complications from concurrent hernia rep|1
7919241|NCT02147288|12441609|FG002|Overall Study|complications from concurrent hernia rep|0
7919242|NCT02147288|12441610|FG003|Overall Study|complications from concurrent hernia rep|0
7919243|NCT02147288|12441611|FG004|Overall Study|complications from concurrent hernia rep|0
7919244|NCT02147288|12441612|FG005|Overall Study|complications from concurrent hernia rep|0
7919245|NCT02147288|12441613|FG006|Overall Study|complications from concurrent hernia rep|0
7919246|NCT02147288|12441614|FG007|Overall Study|complications from concurrent hernia rep|0
7919247|NCT02147288|12441615|FG008|Overall Study|complications from concurrent hernia rep|0
7919248|NCT02147288|12441616|FG009|Overall Study|complications from concurrent hernia rep|0
7919249|NCT02147353|12441628|FG000|Overall Study|Lost to Follow-up|2
7919250|NCT02147353|12441629|FG001|Overall Study|Lost to Follow-up|0
7919251|NCT02147353|12441628|FG000|Overall Study|unable to make visits|4
7919252|NCT02147353|12441629|FG001|Overall Study|unable to make visits|0
7919253|NCT02147353|12441628|FG000|Overall Study|medication noncompliance|3
7919254|NCT02147353|12441629|FG001|Overall Study|medication noncompliance|0
7919255|NCT02147561|12441644|FG000|Overall Study|Lost to Follow-up|3
7919256|NCT02147561|12441644|FG000|Overall Study|Subjects who didn't receive BOTOX|1
7919257|NCT02147587|12441650|FG000|Overall Study|Adverse Event|9
7919258|NCT02147587|12441651|FG001|Overall Study|Adverse Event|4
7919259|NCT02147587|12441650|FG000|Overall Study|Lack of Efficacy|2
7919260|NCT02147587|12441651|FG001|Overall Study|Lack of Efficacy|1
7919261|NCT02147626|12441668|FG000|Overall Study|Lost to Follow-up|4
7919262|NCT02147626|12441669|FG001|Overall Study|Lost to Follow-up|4
7919263|NCT02147626|12441668|FG000|Overall Study|Pregnancy|1
7919264|NCT02147626|12441669|FG001|Overall Study|Pregnancy|2
7919265|NCT02147626|12441668|FG000|Overall Study|Withdrawal by Subject|0
7919266|NCT02147626|12441669|FG001|Overall Study|Withdrawal by Subject|1
7919267|NCT02147691|12441677|FG000|Overall Study|Withdrawal by Subject|2
7919268|NCT02147691|12441678|FG001|Overall Study|Withdrawal by Subject|0
7919269|NCT02147691|12441677|FG000|Overall Study|Adverse Event|2
7919270|NCT02147691|12441678|FG001|Overall Study|Adverse Event|0
7919271|NCT02147691|12441677|FG000|Overall Study|Lost to Follow-up|0
7919272|NCT02147691|12441678|FG001|Overall Study|Lost to Follow-up|1
7919273|NCT02148211|12441728|FG000|Overall Study|Lost to Follow-up|352
7919274|NCT02148250|12441732|FG000|Screening|Withdrawal by Subject|5
7919275|NCT02148250|12441733|FG001|Screening|Withdrawal by Subject|0
7919276|NCT02148445|12441751|FG000|Overall Study|Death|1
7919277|NCT02148445|12441752|FG001|Overall Study|Death|3
7919278|NCT02148718|12441777|FG000|Overall Study|Protocol Violation|26
7919279|NCT02148718|12441777|FG000|Overall Study|Discontinued Study Prematurely|5
7919280|NCT02148952|12441806|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241
7919281|NCT02148952|12441807|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591
7919282|NCT02148952|12441806|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862
7919283|NCT02148952|12441807|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556
7919284|NCT02148952|12441806|FG000|Follow-Up|Lost to Follow-up|219
7919285|NCT02148952|12441807|FG001|Follow-Up|Lost to Follow-up|231
7919286|NCT02148952|12441806|FG000|Follow-Up|Withdrawal by Subject|46
7919287|NCT02148952|12441807|FG001|Follow-Up|Withdrawal by Subject|48
7919288|NCT02149108|12441823|FG000|Overall Study|Not treated|1
7919289|NCT02149108|12441824|FG001|Overall Study|Not treated|2
7919290|NCT02149108|12441823|FG000|Overall Study|Progressive Disease (PD)|324
7919291|NCT02149108|12441824|FG001|Overall Study|Progressive Disease (PD)|318
7919292|NCT02149108|12441823|FG000|Overall Study|Worsening/adverse event cancer disease|31
7919293|NCT02149108|12441824|FG001|Overall Study|Worsening/adverse event cancer disease|32
7919294|NCT02149108|12441823|FG000|Overall Study|Other Adverse Event (AE)|8
7919295|NCT02149108|12441824|FG001|Overall Study|Other Adverse Event (AE)|18
7919296|NCT02149108|12441823|FG000|Overall Study|Other not defined above|0
7919297|NCT02149108|12441824|FG001|Overall Study|Other not defined above|2
7919298|NCT02149108|12441823|FG000|Overall Study|Refusal to continue trial medication|15
7919299|NCT02149108|12441824|FG001|Overall Study|Refusal to continue trial medication|11
7919300|NCT02149108|12441823|FG000|Overall Study|Lost to Follow-up|1
7919301|NCT02149108|12441824|FG001|Overall Study|Lost to Follow-up|0
7919302|NCT02149199|12441843|FG000|Overall Study|Study specific withdrawal criteria|4
7919303|NCT02149199|12441844|FG001|Overall Study|Study specific withdrawal criteria|21
7919304|NCT02149199|12441845|FG002|Overall Study|Study specific withdrawal criteria|6
7919305|NCT02149199|12441843|FG000|Overall Study|Other|20
7919306|NCT02149199|12441844|FG001|Overall Study|Other|25
7919307|NCT02149199|12441845|FG002|Overall Study|Other|20
7919308|NCT02149199|12441843|FG000|Overall Study|Eligibility criteria not fulfilled|9
7919309|NCT02149199|12441844|FG001|Overall Study|Eligibility criteria not fulfilled|14
7919310|NCT02149199|12441845|FG002|Overall Study|Eligibility criteria not fulfilled|8
7919311|NCT02149199|12441843|FG000|Overall Study|Withdrawal by Subject|75
7919312|NCT02149199|12441844|FG001|Overall Study|Withdrawal by Subject|93
7919313|NCT02149199|12441845|FG002|Overall Study|Withdrawal by Subject|77
7919314|NCT02149199|12441843|FG000|Overall Study|Protocol Violation|16
7919315|NCT02149199|12441844|FG001|Overall Study|Protocol Violation|13
7919316|NCT02149199|12441845|FG002|Overall Study|Protocol Violation|15
7919317|NCT02149199|12441843|FG000|Overall Study|Lost to Follow-up|3
7919318|NCT02149199|12441844|FG001|Overall Study|Lost to Follow-up|12
7919319|NCT02149199|12441845|FG002|Overall Study|Lost to Follow-up|11
7919320|NCT02149199|12441843|FG000|Overall Study|Death|0
7919321|NCT02149199|12441844|FG001|Overall Study|Death|0
7919322|NCT02149199|12441845|FG002|Overall Study|Death|1
7919323|NCT02149199|12441843|FG000|Overall Study|Adverse Event|6
7919324|NCT02149199|12441844|FG001|Overall Study|Adverse Event|15
7919325|NCT02149199|12441845|FG002|Overall Study|Adverse Event|9
7919326|NCT02149264|12441853|FG000|Overall Study|Withdrawal by Subject|9
7919327|NCT02149264|12441853|FG000|Overall Study|Adverse Event|7
7919328|NCT02149264|12441853|FG000|Overall Study|Physician Decision|3
7919329|NCT02149264|12441853|FG000|Overall Study|Protocol Violation|1
7919330|NCT02149420|12441877|FG000|Core Study|Administrative problems|0
7919331|NCT02149420|12441878|FG001|Core Study|Administrative problems|1
7919332|NCT02149420|12441879|FG002|Core Study|Administrative problems|2
7919333|NCT02149420|12441877|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1
7919334|NCT02149420|12441878|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
7919335|NCT02149420|12441879|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
7919336|NCT02149810|12441903|FG000|Overall Study|Physician Decision|1
7919337|NCT02149810|12441904|FG001|Overall Study|Physician Decision|2
7919338|NCT02149810|12441903|FG000|Overall Study|Lost to Follow-up|2
7919339|NCT02149810|12441904|FG001|Overall Study|Lost to Follow-up|1
7919340|NCT02149810|12441903|FG000|Overall Study|Withdrawal by Subject|5
7919341|NCT02149810|12441904|FG001|Overall Study|Withdrawal by Subject|1
7919342|NCT02149836|12441910|FG000|Overall Study|Withdrawal by Subject|1
7919343|NCT02149875|12441917|FG000|Overall Study|Lost to Follow-up|3
7919344|NCT02149875|12441918|FG001|Overall Study|Lost to Follow-up|4
7919345|NCT02149875|12441919|FG002|Overall Study|Lost to Follow-up|5
7919346|NCT02149875|12441917|FG000|Overall Study|Withdrawal by Subject|3
7919347|NCT02149875|12441918|FG001|Overall Study|Withdrawal by Subject|2
7919348|NCT02149875|12441919|FG002|Overall Study|Withdrawal by Subject|2
7919349|NCT02149875|12441917|FG000|Overall Study|Physician Decision|1
7919350|NCT02149875|12441918|FG001|Overall Study|Physician Decision|2
7919351|NCT02149875|12441919|FG002|Overall Study|Physician Decision|2
7919352|NCT02150057|12441933|FG000|Overall Study|Lost to Follow-up|6
7919353|NCT02150057|12441934|FG001|Overall Study|Lost to Follow-up|4
7919354|NCT02150213|12441950|FG000|Overall Study|Lost to Follow-up|1
7919355|NCT02150213|12441950|FG000|Overall Study|Withdrawal by Subject|1
7919356|NCT02150343|12441958|FG000|Overall Study|Adverse Event|2
7919357|NCT02150343|12441959|FG001|Overall Study|Adverse Event|0
7919358|NCT02150343|12441960|FG002|Overall Study|Adverse Event|1
7919359|NCT02150343|12441961|FG003|Overall Study|Adverse Event|1
7919360|NCT02150343|12441958|FG000|Overall Study|Withdrawal by Subject|13
7919361|NCT02150343|12441959|FG001|Overall Study|Withdrawal by Subject|10
7919362|NCT02150343|12441960|FG002|Overall Study|Withdrawal by Subject|9
7919363|NCT02150343|12441961|FG003|Overall Study|Withdrawal by Subject|4
7919364|NCT02150343|12441958|FG000|Overall Study|Lost to Follow-up|4
7919365|NCT02150343|12441959|FG001|Overall Study|Lost to Follow-up|4
7919366|NCT02150343|12441960|FG002|Overall Study|Lost to Follow-up|2
7919367|NCT02150343|12441961|FG003|Overall Study|Lost to Follow-up|3
7919368|NCT02150343|12441958|FG000|Overall Study|Other|2
7919369|NCT02150343|12441959|FG001|Overall Study|Other|6
7919370|NCT02150343|12441960|FG002|Overall Study|Other|0
7919371|NCT02150343|12441961|FG003|Overall Study|Other|2
7919372|NCT02150954|12442009|FG000|Overall Study|Protocol Violation|1
7919373|NCT02150954|12442010|FG001|Overall Study|Protocol Violation|0
7919374|NCT02151058|12442019|FG000|Overall Study|Withdrawal by Subject|1
7919375|NCT02151058|12442020|FG001|Overall Study|Withdrawal by Subject|1
7919376|NCT02151058|12442021|FG002|Overall Study|Withdrawal by Subject|3
7919377|NCT02151058|12442019|FG000|Overall Study|Lost to Follow-up|1
7919378|NCT02151058|12442020|FG001|Overall Study|Lost to Follow-up|0
7919379|NCT02151058|12442021|FG002|Overall Study|Lost to Follow-up|2
7964355|NCT02629159|12519841|FG000|Overall Study|Adverse Event|17
7964356|NCT02629159|12519842|FG001|Overall Study|Adverse Event|20
7964357|NCT02629159|12519843|FG002|Overall Study|Adverse Event|22
7964358|NCT02629159|12519841|FG000|Overall Study|Withdrawal by Subject|22
7964359|NCT02629159|12519842|FG001|Overall Study|Withdrawal by Subject|11
7964360|NCT02629159|12519843|FG002|Overall Study|Withdrawal by Subject|15
7964361|NCT02629159|12519841|FG000|Overall Study|Lost to Follow-up|7
7964362|NCT02629159|12519842|FG001|Overall Study|Lost to Follow-up|4
7964363|NCT02629159|12519843|FG002|Overall Study|Lost to Follow-up|5
7964364|NCT02629159|12519841|FG000|Overall Study|Lack of Efficacy|4
7964365|NCT02629159|12519842|FG001|Overall Study|Lack of Efficacy|0
7964366|NCT02629159|12519843|FG002|Overall Study|Lack of Efficacy|1
7964367|NCT02629159|12519841|FG000|Overall Study|Other|6
7964368|NCT02629159|12519842|FG001|Overall Study|Other|4
7964369|NCT02629159|12519843|FG002|Overall Study|Other|8
7964370|NCT02586025|12519856|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1
7964371|NCT02586025|12519857|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0
7964372|NCT02586025|12519856|FG000|Neoadjuvant Treatment|Death|1
7964373|NCT02586025|12519857|FG001|Neoadjuvant Treatment|Death|0
7964374|NCT02586025|12519856|FG000|Neoadjuvant Treatment|Adverse Event|1
7919380|NCT02151110|12442037|FG000|Overall Study|Withdrawal by Subject|0
7919381|NCT02151110|12442038|FG001|Overall Study|Withdrawal by Subject|0
7919382|NCT02151110|12442039|FG002|Overall Study|Withdrawal by Subject|0
7919383|NCT02151110|12442040|FG003|Overall Study|Withdrawal by Subject|0
7919384|NCT02151110|12442041|FG004|Overall Study|Withdrawal by Subject|0
7919385|NCT02151110|12442042|FG005|Overall Study|Withdrawal by Subject|0
7919386|NCT02151110|12442043|FG006|Overall Study|Withdrawal by Subject|0
7919387|NCT02151110|12442044|FG007|Overall Study|Withdrawal by Subject|1
7919388|NCT02151110|12442037|FG000|Overall Study|Lost to Follow-up|0
7919389|NCT02151110|12442038|FG001|Overall Study|Lost to Follow-up|0
7919390|NCT02151110|12442039|FG002|Overall Study|Lost to Follow-up|0
7919391|NCT02151110|12442040|FG003|Overall Study|Lost to Follow-up|0
7919392|NCT02151110|12442041|FG004|Overall Study|Lost to Follow-up|0
7919393|NCT02151110|12442042|FG005|Overall Study|Lost to Follow-up|0
7919394|NCT02151110|12442043|FG006|Overall Study|Lost to Follow-up|0
7919395|NCT02151110|12442044|FG007|Overall Study|Lost to Follow-up|2
7919396|NCT02151149|12442071|FG000|Treatment Period|Death|2
7919397|NCT02151149|12442072|FG001|Treatment Period|Death|3
7919398|NCT02151149|12442071|FG000|Treatment Period|Adverse Event|17
7919399|NCT02151149|12442072|FG001|Treatment Period|Adverse Event|14
7919400|NCT02151149|12442071|FG000|Treatment Period|Progressive Disease|25
7919401|NCT02151149|12442072|FG001|Treatment Period|Progressive Disease|24
7919402|NCT02151149|12442071|FG000|Treatment Period|Symptomatic Deterioration|2
7919403|NCT02151149|12442072|FG001|Treatment Period|Symptomatic Deterioration|10
7919404|NCT02151149|12442071|FG000|Treatment Period|Withdrawal by Subject|13
7919405|NCT02151149|12442072|FG001|Treatment Period|Withdrawal by Subject|11
7919406|NCT02151149|12442071|FG000|Treatment Period|Miscellaneous|8
7919407|NCT02151149|12442072|FG001|Treatment Period|Miscellaneous|7
7919408|NCT02151149|12442071|FG000|Treatment Period|Participants randomized but not treated|3
7919409|NCT02151149|12442072|FG001|Treatment Period|Participants randomized but not treated|2
7919410|NCT02151149|12442071|FG000|Follow-Up Period|Lost to Follow-up|2
7919411|NCT02151149|12442072|FG001|Follow-Up Period|Lost to Follow-up|3
7919412|NCT02151149|12442071|FG000|Follow-Up Period|Death|37
7919413|NCT02151149|12442072|FG001|Follow-Up Period|Death|34
7919414|NCT02151266|12442088|FG000|Overall Study|Lost to Follow-up|1
7919415|NCT02151266|12442089|FG001|Overall Study|Lost to Follow-up|4
7919416|NCT02151266|12442090|FG002|Overall Study|Lost to Follow-up|1
7919417|NCT02151266|12442088|FG000|Overall Study|Did NOT receive intervention|3
7919418|NCT02151266|12442089|FG001|Overall Study|Did NOT receive intervention|6
7919419|NCT02151266|12442090|FG002|Overall Study|Did NOT receive intervention|2
7919420|NCT02151266|12442088|FG000|Overall Study|Not able to exercise|4
7919421|NCT02151266|12442089|FG001|Overall Study|Not able to exercise|5
7919422|NCT02151266|12442090|FG002|Overall Study|Not able to exercise|4
7919423|NCT02151461|12442119|FG000|Overall Study|Adverse Event|5
7919424|NCT02151461|12442120|FG001|Overall Study|Adverse Event|1
7919425|NCT02151461|12442121|FG002|Overall Study|Adverse Event|0
7919426|NCT02151461|12442122|FG003|Overall Study|Adverse Event|2
7919427|NCT02151461|12442119|FG000|Overall Study|Lost to Follow-up|0
7919428|NCT02151461|12442120|FG001|Overall Study|Lost to Follow-up|0
7919429|NCT02151461|12442121|FG002|Overall Study|Lost to Follow-up|1
7919430|NCT02151461|12442122|FG003|Overall Study|Lost to Follow-up|1
7919431|NCT02151461|12442119|FG000|Overall Study|Withdrawal by Subject|1
7919432|NCT02151461|12442120|FG001|Overall Study|Withdrawal by Subject|0
7919433|NCT02151461|12442121|FG002|Overall Study|Withdrawal by Subject|1
7919434|NCT02151461|12442122|FG003|Overall Study|Withdrawal by Subject|1
7919435|NCT02151461|12442119|FG000|Overall Study|Treatment discontinuation|0
7919436|NCT02151461|12442120|FG001|Overall Study|Treatment discontinuation|0
7919437|NCT02151461|12442121|FG002|Overall Study|Treatment discontinuation|1
7919438|NCT02151461|12442122|FG003|Overall Study|Treatment discontinuation|0
7919439|NCT02151591|12442151|FG000|Overall Study|Lost to Follow-up|6
7919440|NCT02151591|12442152|FG001|Overall Study|Lost to Follow-up|3
7919441|NCT02151643|12442163|FG000|Overall Study|Adverse Event|2
7919442|NCT02151643|12442164|FG001|Overall Study|Adverse Event|0
7919443|NCT02151643|12442165|FG002|Overall Study|Adverse Event|1
7919444|NCT02151643|12442166|FG003|Overall Study|Adverse Event|4
7919445|NCT02151643|12442167|FG004|Overall Study|Adverse Event|0
7919446|NCT02151643|12442163|FG000|Overall Study|Withdrawal by Subject|0
7919447|NCT02151643|12442164|FG001|Overall Study|Withdrawal by Subject|1
7919448|NCT02151643|12442165|FG002|Overall Study|Withdrawal by Subject|1
7919449|NCT02151643|12442166|FG003|Overall Study|Withdrawal by Subject|1
7919450|NCT02151643|12442167|FG004|Overall Study|Withdrawal by Subject|1
7919451|NCT02151643|12442163|FG000|Overall Study|Hyperphosphataemia|1
7919452|NCT02151643|12442164|FG001|Overall Study|Hyperphosphataemia|0
7919453|NCT02151643|12442165|FG002|Overall Study|Hyperphosphataemia|0
7919454|NCT02151643|12442166|FG003|Overall Study|Hyperphosphataemia|0
7919455|NCT02151643|12442167|FG004|Overall Study|Hyperphosphataemia|1
7919456|NCT02151643|12442163|FG000|Overall Study|High Ferritin levels|3
7919457|NCT02151643|12442164|FG001|Overall Study|High Ferritin levels|3
7919458|NCT02151643|12442165|FG002|Overall Study|High Ferritin levels|2
7919459|NCT02151643|12442166|FG003|Overall Study|High Ferritin levels|2
7919460|NCT02151643|12442167|FG004|Overall Study|High Ferritin levels|1
7919461|NCT02151682|12442181|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7919462|NCT02151682|12442182|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2
7964375|NCT02586025|12519857|FG001|Neoadjuvant Treatment|Adverse Event|0
7919463|NCT02151682|12442183|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7919464|NCT02151682|12442184|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7919465|NCT02151682|12442185|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7919466|NCT02151682|12442186|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7919467|NCT02151682|12442181|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7919468|NCT02151682|12442182|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1
7919469|NCT02151682|12442183|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7919470|NCT02151682|12442184|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7919471|NCT02151682|12442185|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7919472|NCT02151682|12442186|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7919473|NCT02151682|12442181|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7919474|NCT02151682|12442182|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1
7919475|NCT02151682|12442183|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7919476|NCT02151682|12442184|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7919477|NCT02151682|12442185|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7919478|NCT02151682|12442186|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7919479|NCT02151682|12442181|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
7919480|NCT02151682|12442182|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
7919481|NCT02151682|12442183|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7919482|NCT02151682|12442184|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7919483|NCT02151682|12442185|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7919484|NCT02151682|12442186|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7919485|NCT02151682|12442181|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1
7919486|NCT02151682|12442182|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7919487|NCT02151682|12442183|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7919488|NCT02151682|12442184|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7919489|NCT02151682|12442185|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7919490|NCT02151682|12442186|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7919491|NCT02151682|12442181|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0
7919492|NCT02151682|12442182|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0
7919493|NCT02151682|12442183|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3
7919494|NCT02151682|12442184|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0
7919495|NCT02151682|12442185|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0
7919496|NCT02151682|12442186|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0
7919497|NCT02151682|12442181|FG000|Part 2: Tapent. Extension or Observation|Death|0
7919498|NCT02151682|12442182|FG001|Part 2: Tapent. Extension or Observation|Death|0
7919499|NCT02151682|12442183|FG002|Part 2: Tapent. Extension or Observation|Death|0
7919500|NCT02151682|12442184|FG003|Part 2: Tapent. Extension or Observation|Death|2
7919501|NCT02151682|12442185|FG004|Part 2: Tapent. Extension or Observation|Death|0
7919502|NCT02151682|12442186|FG005|Part 2: Tapent. Extension or Observation|Death|0
7919503|NCT02151682|12442181|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7919504|NCT02151682|12442182|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7919505|NCT02151682|12442183|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
7919506|NCT02151682|12442184|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
7919507|NCT02151682|12442185|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7919508|NCT02151682|12442186|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7919509|NCT02151682|12442181|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7919510|NCT02151682|12442182|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7919511|NCT02151682|12442183|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3
7919512|NCT02151682|12442184|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7919513|NCT02151682|12442185|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7919514|NCT02151682|12442186|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7919515|NCT02151682|12442181|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7919516|NCT02151682|12442182|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7919517|NCT02151682|12442183|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1
7919518|NCT02151682|12442184|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7919519|NCT02151682|12442185|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7919520|NCT02151682|12442186|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7919521|NCT02151682|12442181|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0
7919522|NCT02151682|12442182|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0
7919523|NCT02151682|12442183|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13
7919524|NCT02151682|12442184|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0
7919525|NCT02151682|12442185|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0
7919526|NCT02151682|12442186|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0
7919527|NCT02151682|12442181|FG000|Part 2: Tapent. Extension or Observation|Missing|0
7919528|NCT02151682|12442182|FG001|Part 2: Tapent. Extension or Observation|Missing|0
7919529|NCT02151682|12442183|FG002|Part 2: Tapent. Extension or Observation|Missing|0
7919530|NCT02151682|12442184|FG003|Part 2: Tapent. Extension or Observation|Missing|1
7919531|NCT02151682|12442185|FG004|Part 2: Tapent. Extension or Observation|Missing|0
7919532|NCT02151682|12442186|FG005|Part 2: Tapent. Extension or Observation|Missing|0
7919533|NCT02151682|12442181|FG000|Part 2: Tapent. Extension or Observation|Various other|0
7919534|NCT02151682|12442182|FG001|Part 2: Tapent. Extension or Observation|Various other|0
7919535|NCT02151682|12442183|FG002|Part 2: Tapent. Extension or Observation|Various other|6
7919536|NCT02151682|12442184|FG003|Part 2: Tapent. Extension or Observation|Various other|0
7919537|NCT02151682|12442185|FG004|Part 2: Tapent. Extension or Observation|Various other|0
7919538|NCT02151682|12442186|FG005|Part 2: Tapent. Extension or Observation|Various other|0
7919539|NCT02151682|12442181|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7919540|NCT02151682|12442182|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7919541|NCT02151682|12442183|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1
7919542|NCT02151682|12442184|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7919543|NCT02151682|12442185|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7919544|NCT02151682|12442186|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7919545|NCT02151682|12442181|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7919546|NCT02151682|12442182|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7919547|NCT02151682|12442183|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7919548|NCT02151682|12442184|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7919549|NCT02151682|12442185|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7919550|NCT02151682|12442186|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1
7919551|NCT02151682|12442181|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0
7919552|NCT02151682|12442182|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0
7919553|NCT02151682|12442183|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0
7919554|NCT02151682|12442184|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0
7919555|NCT02151682|12442185|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0
7919556|NCT02151682|12442186|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1
7919557|NCT02151682|12442181|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7919558|NCT02151682|12442182|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7919559|NCT02151682|12442183|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7919560|NCT02151682|12442184|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7919561|NCT02151682|12442185|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7919562|NCT02151682|12442186|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3
7919563|NCT02151682|12442181|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7919564|NCT02151682|12442182|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7919565|NCT02151682|12442183|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7919566|NCT02151682|12442184|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7919567|NCT02151682|12442185|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7919568|NCT02151682|12442186|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2
7919569|NCT02151773|12442204|FG000|Overall Study|Protocol Deviation|64
7919570|NCT02151786|12442208|FG000|Overall Study|Unavailability of Case Report Form|26
7919571|NCT02151786|12442208|FG000|Overall Study|Outside the Contract Period|1
7919572|NCT02151786|12442208|FG000|Overall Study|Randomized, not Treated|1
7919573|NCT02151786|12442208|FG000|Overall Study|Unavailability of Information|8
7919574|NCT02151851|12442214|FG000|Overall Study|Lack of Efficacy|67
7919575|NCT02151851|12442215|FG001|Overall Study|Lack of Efficacy|94
7919576|NCT02151851|12442214|FG000|Overall Study|Protocol Violation|0
7919577|NCT02151851|12442215|FG001|Overall Study|Protocol Violation|1
7919578|NCT02151851|12442214|FG000|Overall Study|Withdrawal by Subject|2
7919579|NCT02151851|12442215|FG001|Overall Study|Withdrawal by Subject|5
7919580|NCT02151851|12442214|FG000|Overall Study|Medical impairment|1
7919581|NCT02151851|12442215|FG001|Overall Study|Medical impairment|0
7919582|NCT02151851|12442214|FG000|Overall Study|Low compliance to study visits|0
7919583|NCT02151851|12442215|FG001|Overall Study|Low compliance to study visits|1
7919584|NCT02151851|12442214|FG000|Overall Study|Subject entered into study in error|0
7919585|NCT02151851|12442215|FG001|Overall Study|Subject entered into study in error|1
7919586|NCT02151851|12442214|FG000|Overall Study|Adverse Event|6
7919587|NCT02151851|12442215|FG001|Overall Study|Adverse Event|28
7919588|NCT02151903|12442234|FG000|Overall Study|Withdrawal by Subject|1
7919589|NCT02151903|12442235|FG001|Overall Study|Withdrawal by Subject|0
7919590|NCT02151903|12442234|FG000|Overall Study|Progressive disease|2
7919591|NCT02151903|12442235|FG001|Overall Study|Progressive disease|1
7919592|NCT02152007|12442293|FG000|Overall Study|Withdrawal by Subject|1
7919593|NCT02152137|12442307|FG000|Overall Study|Withdrawal by Subject|1
7919594|NCT02152137|12442307|FG000|Overall Study|Originally assigned to Arm B|3
7919595|NCT02152163|12442313|FG000|Overall Study|Physician Decision|12
7919596|NCT02152163|12442314|FG001|Overall Study|Physician Decision|13
7919597|NCT02152345|12442322|FG000|Overall Study|Case Cancellations|2
7919598|NCT02152345|12442323|FG001|Overall Study|Case Cancellations|4
7919599|NCT02152345|12442322|FG000|Overall Study|Withdrawal by Subject|2
7919600|NCT02152345|12442323|FG001|Overall Study|Withdrawal by Subject|1
7919601|NCT02152371|12442331|FG000|Overall Study|Adverse Event|6
7919602|NCT02152371|12442332|FG001|Overall Study|Adverse Event|2
7919603|NCT02152371|12442331|FG000|Overall Study|Withdrawal by Subject|3
7919604|NCT02152371|12442332|FG001|Overall Study|Withdrawal by Subject|7
7919605|NCT02152371|12442331|FG000|Overall Study|Protocol Violation|2
7919606|NCT02152371|12442332|FG001|Overall Study|Protocol Violation|3
7919607|NCT02152371|12442331|FG000|Overall Study|Lost to Follow-up|1
7919608|NCT02152371|12442332|FG001|Overall Study|Lost to Follow-up|0
7919609|NCT02152371|12442331|FG000|Overall Study|Lack of Efficacy|0
7919610|NCT02152371|12442332|FG001|Overall Study|Lack of Efficacy|1
7919611|NCT02152371|12442331|FG000|Overall Study|Physician Decision|0
7919612|NCT02152371|12442332|FG001|Overall Study|Physician Decision|2
7919613|NCT02152371|12442331|FG000|Overall Study|Reason Not Given|0
7919614|NCT02152371|12442332|FG001|Overall Study|Reason Not Given|1
7919615|NCT02152384|12442338|FG000|Period 1|Withdrawal by Subject|0
7919616|NCT02152384|12442339|FG001|Period 1|Withdrawal by Subject|1
7919617|NCT02152384|12442338|FG000|Period 1|Adverse Event|1
7919618|NCT02152384|12442339|FG001|Period 1|Adverse Event|1
7919619|NCT02152605|12442367|FG000|Overall Study|Adverse Event|6
7919620|NCT02152605|12442368|FG001|Overall Study|Adverse Event|8
7919621|NCT02152605|12442367|FG000|Overall Study|Lack of Efficacy|7
7919622|NCT02152605|12442368|FG001|Overall Study|Lack of Efficacy|4
7919623|NCT02152605|12442367|FG000|Overall Study|Protocol deviation|1
7919624|NCT02152605|12442368|FG001|Overall Study|Protocol deviation|4
7919625|NCT02152605|12442367|FG000|Overall Study|Lost to Follow-up|1
7919626|NCT02152605|12442368|FG001|Overall Study|Lost to Follow-up|0
7919627|NCT02152605|12442367|FG000|Overall Study|Withdrew consent|4
7919628|NCT02152605|12442368|FG001|Overall Study|Withdrew consent|2
7919629|NCT02152761|12442392|FG000|Epoch: Treatment Epoch|Technical problems|0
7919630|NCT02152761|12442393|FG001|Epoch: Treatment Epoch|Technical problems|0
7919631|NCT02152761|12442394|FG002|Epoch: Treatment Epoch|Technical problems|0
7919632|NCT02152761|12442395|FG003|Epoch: Treatment Epoch|Technical problems|1
7919633|NCT02152761|12442392|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0
7919634|NCT02152761|12442393|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2
7919635|NCT02152761|12442394|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0
7919636|NCT02152761|12442395|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0
7919637|NCT02152761|12442392|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7
7919638|NCT02152761|12442393|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8
7919639|NCT02152761|12442394|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3
7919640|NCT02152761|12442395|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5
7919641|NCT02152761|12442392|FG000|Epoch: Treatment Epoch|Adverse Event|3
7919642|NCT02152761|12442393|FG001|Epoch: Treatment Epoch|Adverse Event|6
7919643|NCT02152761|12442394|FG002|Epoch: Treatment Epoch|Adverse Event|1
7919644|NCT02152761|12442395|FG003|Epoch: Treatment Epoch|Adverse Event|2
7919645|NCT02152761|12442392|FG000|Epoch: Treatment Epoch|Death|0
7919646|NCT02152761|12442393|FG001|Epoch: Treatment Epoch|Death|3
7919647|NCT02152761|12442394|FG002|Epoch: Treatment Epoch|Death|1
7919648|NCT02152761|12442395|FG003|Epoch: Treatment Epoch|Death|0
7919649|NCT02152761|12442392|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1
7919650|NCT02152761|12442393|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1
7919651|NCT02152761|12442394|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0
7919652|NCT02152761|12442395|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0
7919653|NCT02152761|12442392|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
7919654|NCT02152761|12442393|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3
7919655|NCT02152761|12442394|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0
7919656|NCT02152761|12442395|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
7919657|NCT02152761|12442392|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1
7919658|NCT02152761|12442393|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4
7919659|NCT02152761|12442394|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
7919660|NCT02152761|12442395|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
7919661|NCT02152761|12442392|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1
7919662|NCT02152761|12442393|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
7919663|NCT02152761|12442394|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
7919664|NCT02152761|12442395|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
7919665|NCT02152761|12442392|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1
7919666|NCT02152761|12442393|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0
7919667|NCT02152761|12442394|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0
7919668|NCT02152761|12442395|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1
7919669|NCT02153073|12442420|FG000|Overall Study|Case Report Forms Uncollected|230
7919670|NCT02153073|12442420|FG000|Overall Study|Protocol Deviation|68
7919671|NCT02153086|12442424|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2
7919672|NCT02153086|12442424|FG000|Overall Study|Other|2
7919673|NCT02153112|12442467|FG000|Overall Study|Adverse Event|0
7919674|NCT02153112|12442468|FG001|Overall Study|Adverse Event|0
7919675|NCT02153112|12442469|FG002|Overall Study|Adverse Event|1
7919676|NCT02153112|12442470|FG003|Overall Study|Adverse Event|0
7919677|NCT02153112|12442471|FG004|Overall Study|Adverse Event|0
7919678|NCT02153112|12442472|FG005|Overall Study|Adverse Event|0
7919679|NCT02153112|12442473|FG006|Overall Study|Adverse Event|0
7919680|NCT02153112|12442474|FG007|Overall Study|Adverse Event|0
7919681|NCT02153112|12442475|FG008|Overall Study|Adverse Event|0
7919682|NCT02153112|12442476|FG009|Overall Study|Adverse Event|0
7919683|NCT02153112|12442467|FG000|Overall Study|Lost to Follow-up|1
7919684|NCT02153112|12442468|FG001|Overall Study|Lost to Follow-up|1
7919685|NCT02153112|12442469|FG002|Overall Study|Lost to Follow-up|0
7919686|NCT02153112|12442470|FG003|Overall Study|Lost to Follow-up|0
7919687|NCT02153112|12442471|FG004|Overall Study|Lost to Follow-up|2
7919688|NCT02153112|12442472|FG005|Overall Study|Lost to Follow-up|1
7919689|NCT02153112|12442473|FG006|Overall Study|Lost to Follow-up|1
7919690|NCT02153112|12442474|FG007|Overall Study|Lost to Follow-up|0
7919691|NCT02153112|12442475|FG008|Overall Study|Lost to Follow-up|1
7919692|NCT02153112|12442476|FG009|Overall Study|Lost to Follow-up|1
7919693|NCT02153112|12442467|FG000|Overall Study|Withdrawal by Subject|3
7919694|NCT02153112|12442468|FG001|Overall Study|Withdrawal by Subject|1
7919695|NCT02153112|12442469|FG002|Overall Study|Withdrawal by Subject|2
7919696|NCT02153112|12442470|FG003|Overall Study|Withdrawal by Subject|2
7919697|NCT02153112|12442471|FG004|Overall Study|Withdrawal by Subject|1
7919698|NCT02153112|12442472|FG005|Overall Study|Withdrawal by Subject|1
7919699|NCT02153112|12442473|FG006|Overall Study|Withdrawal by Subject|7
7919700|NCT02153112|12442474|FG007|Overall Study|Withdrawal by Subject|2
7919701|NCT02153112|12442475|FG008|Overall Study|Withdrawal by Subject|13
7919702|NCT02153112|12442476|FG009|Overall Study|Withdrawal by Subject|12
7919703|NCT02153112|12442467|FG000|Overall Study|Reason not Specified|0
7919704|NCT02153112|12442468|FG001|Overall Study|Reason not Specified|0
7919705|NCT02153112|12442469|FG002|Overall Study|Reason not Specified|0
7919706|NCT02153112|12442470|FG003|Overall Study|Reason not Specified|0
7919707|NCT02153112|12442471|FG004|Overall Study|Reason not Specified|0
7919708|NCT02153112|12442472|FG005|Overall Study|Reason not Specified|0
7919709|NCT02153112|12442473|FG006|Overall Study|Reason not Specified|0
7919710|NCT02153112|12442474|FG007|Overall Study|Reason not Specified|0
7919711|NCT02153112|12442475|FG008|Overall Study|Reason not Specified|1
7919712|NCT02153112|12442476|FG009|Overall Study|Reason not Specified|1
7919713|NCT02153346|12442500|FG000|Overall Study|Lost to Follow-up|11
7919714|NCT02153359|12442505|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0
7919715|NCT02153359|12442506|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2
7919716|NCT02153398|12442520|FG000|Overall Study|Withdrawal by Subject|1
7919717|NCT02153398|12442521|FG001|Overall Study|Withdrawal by Subject|0
7919718|NCT02153398|12442522|FG002|Overall Study|Withdrawal by Subject|0
7919719|NCT02153398|12442523|FG003|Overall Study|Withdrawal by Subject|0
7919720|NCT02153398|12442524|FG004|Overall Study|Withdrawal by Subject|0
7919721|NCT02153398|12442520|FG000|Overall Study|Adverse Event|0
7919722|NCT02153398|12442521|FG001|Overall Study|Adverse Event|0
7919723|NCT02153398|12442522|FG002|Overall Study|Adverse Event|1
7919724|NCT02153398|12442523|FG003|Overall Study|Adverse Event|1
7919725|NCT02153398|12442524|FG004|Overall Study|Adverse Event|0
7919726|NCT02153736|12442587|FG000|Overall Study|Lost to Follow-up|1
7919727|NCT02153736|12442588|FG001|Overall Study|Lost to Follow-up|0
7919728|NCT02153736|12442587|FG000|Overall Study|Medical status change made ineligible|1
7919729|NCT02153736|12442588|FG001|Overall Study|Medical status change made ineligible|0
7919730|NCT02153736|12442587|FG000|Overall Study|Death|0
7919731|NCT02153736|12442588|FG001|Overall Study|Death|1
7919732|NCT02153736|12442587|FG000|Overall Study|Withdrawal by Subject|0
7919733|NCT02153736|12442588|FG001|Overall Study|Withdrawal by Subject|1
7919734|NCT02153788|12442596|FG000|Overall Study|Physician Decision|2
7919735|NCT02153788|12442597|FG001|Overall Study|Physician Decision|1
7919736|NCT02153827|12442605|FG000|Overall Study|Lost to Follow-up|3
7919737|NCT02153827|12442606|FG001|Overall Study|Lost to Follow-up|9
7919738|NCT02153905|12442614|FG000|Overall Study|Death|1
7919739|NCT02153905|12442615|FG001|Overall Study|Death|0
7919740|NCT02153918|12442621|FG000|Overall Study|Refused further treatment|1
7919741|NCT02154061|12442665|FG000|Overall Study|Pregnancy|1
7919742|NCT02154061|12442666|FG001|Overall Study|Pregnancy|0
7919743|NCT02154061|12442665|FG000|Overall Study|enrolled but not vaccinated|1
7919744|NCT02154061|12442666|FG001|Overall Study|enrolled but not vaccinated|0
7919745|NCT02154139|12442672|FG000|Overall Study|Injection not administered|2
7919746|NCT02154139|12442672|FG000|Overall Study|Other|2
7919747|NCT02154139|12442672|FG000|Overall Study|Investigator transferred|3
7919748|NCT02154347|12442691|FG000|Double-blind Period|Adverse Event|1
7919749|NCT02154347|12442692|FG001|Double-blind Period|Adverse Event|2
7919750|NCT02154347|12442691|FG000|Double-blind Period|Lack of Efficacy|1
7919751|NCT02154347|12442692|FG001|Double-blind Period|Lack of Efficacy|0
7919752|NCT02154347|12442691|FG000|Double-blind Period|Physician Decision|0
7919753|NCT02154347|12442692|FG001|Double-blind Period|Physician Decision|1
7919754|NCT02154347|12442691|FG000|Double-blind Period|Withdrawal by Subject|1
7919755|NCT02154347|12442692|FG001|Double-blind Period|Withdrawal by Subject|1
7919756|NCT02154347|12442691|FG000|Open-label Period|Adverse Event|3
7919757|NCT02154347|12442692|FG001|Open-label Period|Adverse Event|4
7919758|NCT02154347|12442691|FG000|Open-label Period|Lack of Efficacy|4
7919759|NCT02154347|12442692|FG001|Open-label Period|Lack of Efficacy|19
7919760|NCT02154347|12442691|FG000|Open-label Period|Protocol Violation|0
7919761|NCT02154347|12442692|FG001|Open-label Period|Protocol Violation|1
7919762|NCT02154347|12442691|FG000|Open-label Period|Withdrawal by Subject|0
7919763|NCT02154347|12442692|FG001|Open-label Period|Withdrawal by Subject|1
7919764|NCT02154425|12442708|FG000|Screening Period|Adverse Event|1
7919765|NCT02154581|12442727|FG000|Overall Study|Lost to Follow-up|7
7919766|NCT02154581|12442728|FG001|Overall Study|Lost to Follow-up|8
7919767|NCT02155283|12442791|FG000|Overall Study|Lost to Follow-up|3
7919768|NCT02155283|12442791|FG000|Overall Study|Withdrawal by Subject|1
7919769|NCT02155283|12442791|FG000|Overall Study|Protocol Violation|3
7919770|NCT02155309|12442797|FG000|Overall Study|Protocol Violation|0
7919771|NCT02155309|12442798|FG001|Overall Study|Protocol Violation|0
7919772|NCT02155309|12442799|FG002|Overall Study|Protocol Violation|1
7821465|NCT01255787|12290188|FG003|Overall Study|Major Protocol Deviation|4
7821466|NCT01255787|12290185|FG000|Overall Study|Lost to Follow-up|1
7821467|NCT01255787|12290186|FG001|Overall Study|Lost to Follow-up|2
7821468|NCT01255787|12290187|FG002|Overall Study|Lost to Follow-up|4
7821469|NCT01255787|12290188|FG003|Overall Study|Lost to Follow-up|2
7821470|NCT01255787|12290185|FG000|Overall Study|Withdrawal of Consent|3
7821471|NCT01255787|12290186|FG001|Overall Study|Withdrawal of Consent|9
7821472|NCT01255787|12290187|FG002|Overall Study|Withdrawal of Consent|3
7821473|NCT01255787|12290188|FG003|Overall Study|Withdrawal of Consent|4
7821474|NCT01255787|12290185|FG000|Overall Study|Pregnancy|0
7919773|NCT02155322|12442806|FG000|Overall Study|Adverse Event|1
7919774|NCT02155322|12442806|FG000|Overall Study|Physician Decision|1
7919775|NCT02155322|12442806|FG000|Overall Study|Relapse/Recurrence|8
7919776|NCT02155322|12442806|FG000|Overall Study|Withdrawal by Subject|4
7919777|NCT02155608|12442875|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0
7919778|NCT02155608|12442876|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1
7919779|NCT02155608|12442875|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
7919780|NCT02155608|12442876|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
7919781|NCT02155660|12442892|FG000|Overall Study|Other Reason|8
7919782|NCT02155660|12442893|FG001|Overall Study|Other Reason|6
7919783|NCT02155660|12442894|FG002|Overall Study|Other Reason|10
7919784|NCT02155660|12442895|FG003|Overall Study|Other Reason|10
7919785|NCT02155660|12442892|FG000|Overall Study|Study-specific withdrawal criteria|0
7919786|NCT02155660|12442893|FG001|Overall Study|Study-specific withdrawal criteria|1
7919787|NCT02155660|12442894|FG002|Overall Study|Study-specific withdrawal criteria|1
7919788|NCT02155660|12442895|FG003|Overall Study|Study-specific withdrawal criteria|1
7919789|NCT02155660|12442892|FG000|Overall Study|Severe non-compliance|0
7919790|NCT02155660|12442893|FG001|Overall Study|Severe non-compliance|4
7919791|NCT02155660|12442894|FG002|Overall Study|Severe non-compliance|0
7919792|NCT02155660|12442895|FG003|Overall Study|Severe non-compliance|1
7919793|NCT02155660|12442892|FG000|Overall Study|Adverse Event|2
7919794|NCT02155660|12442893|FG001|Overall Study|Adverse Event|6
7919795|NCT02155660|12442894|FG002|Overall Study|Adverse Event|3
7919796|NCT02155660|12442895|FG003|Overall Study|Adverse Event|1
7919797|NCT02155660|12442892|FG000|Overall Study|Lost to Follow-up|3
7919798|NCT02155660|12442893|FG001|Overall Study|Lost to Follow-up|6
7919799|NCT02155660|12442894|FG002|Overall Study|Lost to Follow-up|5
7919800|NCT02155660|12442895|FG003|Overall Study|Lost to Follow-up|8
7919801|NCT02155660|12442892|FG000|Overall Study|Death|17
7919802|NCT02155660|12442893|FG001|Overall Study|Death|19
7919803|NCT02155660|12442894|FG002|Overall Study|Death|17
7919804|NCT02155660|12442895|FG003|Overall Study|Death|19
7919805|NCT02155660|12442892|FG000|Overall Study|Withdrawal by Subject|28
7919806|NCT02155660|12442893|FG001|Overall Study|Withdrawal by Subject|31
7919807|NCT02155660|12442894|FG002|Overall Study|Withdrawal by Subject|24
7919808|NCT02155660|12442895|FG003|Overall Study|Withdrawal by Subject|21
7919809|NCT02155738|12442924|FG000|Overall Study|Missing critical information|1
7919810|NCT02155738|12442925|FG001|Overall Study|Missing critical information|0
7919811|NCT02155738|12442926|FG002|Overall Study|Missing critical information|0
7919812|NCT02155738|12442927|FG003|Overall Study|Missing critical information|1
7919813|NCT02155829|12442939|FG000|Overall Study|Adverse Event|1
7919814|NCT02155829|12442940|FG001|Overall Study|Adverse Event|0
7919815|NCT02155829|12442939|FG000|Overall Study|Withdrawal by Subject|3
7821475|NCT01255787|12290186|FG001|Overall Study|Pregnancy|0
7821476|NCT01255787|12290187|FG002|Overall Study|Pregnancy|0
7821477|NCT01255787|12290188|FG003|Overall Study|Pregnancy|1
7919816|NCT02155829|12442940|FG001|Overall Study|Withdrawal by Subject|3
7919817|NCT02155829|12442939|FG000|Overall Study|Protocol Violation|2
7919818|NCT02155829|12442940|FG001|Overall Study|Protocol Violation|0
7919819|NCT02155881|12442949|FG000|Overall Study|Withdrawal by Subject|0
7919820|NCT02155881|12442950|FG001|Overall Study|Withdrawal by Subject|2
7919821|NCT02155881|12442949|FG000|Overall Study|Inappropriately randomized|2
7919822|NCT02155881|12442950|FG001|Overall Study|Inappropriately randomized|2
7919823|NCT02155985|12442959|FG000|Overall Study|Withdrawal by Subject|0
7919824|NCT02155985|12442960|FG001|Overall Study|Withdrawal by Subject|0
7919825|NCT02155985|12442961|FG002|Overall Study|Withdrawal by Subject|1
7919826|NCT02155985|12442959|FG000|Overall Study|Lost to Follow-up|1
7919827|NCT02155985|12442960|FG001|Overall Study|Lost to Follow-up|0
7919828|NCT02155985|12442961|FG002|Overall Study|Lost to Follow-up|0
7919829|NCT02156076|12442973|FG000|Treatment Period|no longer meets study criteria|0
7919830|NCT02156076|12442974|FG001|Treatment Period|no longer meets study criteria|0
7919831|NCT02156076|12442975|FG002|Treatment Period|no longer meets study criteria|1
7919832|NCT02156076|12442976|FG003|Treatment Period|no longer meets study criteria|0
7919833|NCT02156076|12442973|FG000|Treatment Period|Poor/non-compliance|0
7919834|NCT02156076|12442974|FG001|Treatment Period|Poor/non-compliance|1
7919835|NCT02156076|12442975|FG002|Treatment Period|Poor/non-compliance|0
7919836|NCT02156076|12442976|FG003|Treatment Period|Poor/non-compliance|0
7919837|NCT02156076|12442973|FG000|Treatment Period|Lost to Follow-up|0
7821478|NCT01255787|12290185|FG000|Overall Study|Lack of Efficacy|2
7919838|NCT02156076|12442974|FG001|Treatment Period|Lost to Follow-up|0
7919839|NCT02156076|12442975|FG002|Treatment Period|Lost to Follow-up|0
7919840|NCT02156076|12442976|FG003|Treatment Period|Lost to Follow-up|1
7919841|NCT02156076|12442973|FG000|Treatment Period|Withdrawal by Subject|0
7919842|NCT02156076|12442974|FG001|Treatment Period|Withdrawal by Subject|0
7919843|NCT02156076|12442975|FG002|Treatment Period|Withdrawal by Subject|1
7919844|NCT02156076|12442976|FG003|Treatment Period|Withdrawal by Subject|0
7919845|NCT02156076|12442973|FG000|Treatment Period|Subject request to discontinue treatment|0
7919846|NCT02156076|12442974|FG001|Treatment Period|Subject request to discontinue treatment|1
7919847|NCT02156076|12442975|FG002|Treatment Period|Subject request to discontinue treatment|0
7919848|NCT02156076|12442976|FG003|Treatment Period|Subject request to discontinue treatment|0
7919849|NCT02156076|12442973|FG000|Treatment Period|Adverse Event|0
7919850|NCT02156076|12442974|FG001|Treatment Period|Adverse Event|0
7919851|NCT02156076|12442975|FG002|Treatment Period|Adverse Event|0
7919852|NCT02156076|12442976|FG003|Treatment Period|Adverse Event|1
7919853|NCT02156076|12442973|FG000|Follow-up Period|Withdrawal by Subject|1
7919854|NCT02156076|12442974|FG001|Follow-up Period|Withdrawal by Subject|0
7919855|NCT02156076|12442975|FG002|Follow-up Period|Withdrawal by Subject|0
7919856|NCT02156076|12442976|FG003|Follow-up Period|Withdrawal by Subject|0
7919857|NCT02156271|12443014|FG000|Overall Study|Physician Decision|4
7919858|NCT02156271|12443015|FG001|Overall Study|Physician Decision|3
7919859|NCT02156466|12443026|FG000|Overall Study|Adverse Event|0
7919860|NCT02156466|12443027|FG001|Overall Study|Adverse Event|0
7919861|NCT02156466|12443028|FG002|Overall Study|Adverse Event|1
7919862|NCT02156466|12443029|FG003|Overall Study|Adverse Event|1
7919863|NCT02156466|12443030|FG004|Overall Study|Adverse Event|0
7919864|NCT02156466|12443026|FG000|Overall Study|Quantiferon Positivity|0
7919865|NCT02156466|12443027|FG001|Overall Study|Quantiferon Positivity|0
7919866|NCT02156466|12443028|FG002|Overall Study|Quantiferon Positivity|0
7919867|NCT02156466|12443029|FG003|Overall Study|Quantiferon Positivity|1
7919868|NCT02156466|12443030|FG004|Overall Study|Quantiferon Positivity|0
7919869|NCT02156492|12443054|FG000|Period 1|No Reason Given|0
7919870|NCT02156492|12443055|FG001|Period 1|No Reason Given|1
7919871|NCT02156492|12443056|FG002|Period 1|No Reason Given|0
7919872|NCT02156492|12443054|FG000|Period 3|Adverse Event|0
7919873|NCT02156492|12443055|FG001|Period 3|Adverse Event|1
7919874|NCT02156492|12443056|FG002|Period 3|Adverse Event|0
7919875|NCT02156804|12443087|FG000|Overall Study|Withdrawal by Subject|1
7919876|NCT02157298|12443123|FG000|Overall Study|Adverse Event|1
7919877|NCT02157298|12443124|FG001|Overall Study|Adverse Event|0
7919878|NCT02157298|12443123|FG000|Overall Study|Subject no longer meets study criteria|1
7919879|NCT02157298|12443124|FG001|Overall Study|Subject no longer meets study criteria|2
7919880|NCT02157298|12443123|FG000|Overall Study|Poor/Non-compliance|1
7919881|NCT02157298|12443124|FG001|Overall Study|Poor/Non-compliance|0
7919882|NCT02157298|12443123|FG000|Overall Study|Withdrawal by Subject|1
7919883|NCT02157298|12443124|FG001|Overall Study|Withdrawal by Subject|0
7919884|NCT02157376|12443132|FG000|Overall Study|Death|10
7919885|NCT02157376|12443133|FG001|Overall Study|Death|4
7919886|NCT02157376|12443132|FG000|Overall Study|Eligibility criteria not fulfilled|0
7919887|NCT02157376|12443133|FG001|Overall Study|Eligibility criteria not fulfilled|1
7919888|NCT02157376|12443132|FG000|Overall Study|Withdrawal by Subject|3
7919889|NCT02157376|12443133|FG001|Overall Study|Withdrawal by Subject|8
7919890|NCT02157376|12443132|FG000|Overall Study|Not treated|8
7919891|NCT02157376|12443133|FG001|Overall Study|Not treated|3
7919892|NCT02157376|12443132|FG000|Overall Study|Investigator's misjudgement|1
7919893|NCT02157376|12443133|FG001|Overall Study|Investigator's misjudgement|2
7919894|NCT02157506|12443144|FG000|Overall Study|Adverse Event|0
7919895|NCT02157506|12443145|FG001|Overall Study|Adverse Event|1
7919896|NCT02157506|12443146|FG002|Overall Study|Adverse Event|0
7919897|NCT02157506|12443147|FG003|Overall Study|Adverse Event|0
7919898|NCT02157506|12443148|FG004|Overall Study|Adverse Event|0
7919899|NCT02157506|12443144|FG000|Overall Study|Lost to Follow-up|0
7919900|NCT02157506|12443145|FG001|Overall Study|Lost to Follow-up|0
7919901|NCT02157506|12443146|FG002|Overall Study|Lost to Follow-up|1
7919902|NCT02157506|12443147|FG003|Overall Study|Lost to Follow-up|0
7919903|NCT02157506|12443148|FG004|Overall Study|Lost to Follow-up|0
7919904|NCT02157519|12443162|FG000|Overall Study|Death|3
7919905|NCT02157519|12443163|FG001|Overall Study|Death|1
7919906|NCT02157519|12443162|FG000|Overall Study|Withdrawal by Subject|7
7919907|NCT02157519|12443163|FG001|Overall Study|Withdrawal by Subject|0
7919908|NCT02157519|12443162|FG000|Overall Study|Lost to Follow-up|1
7919909|NCT02157519|12443163|FG001|Overall Study|Lost to Follow-up|0
7919910|NCT02157779|12443181|FG000|Overall Study|Logistical|9
7919911|NCT02157779|12443182|FG001|Overall Study|Logistical|3
7919912|NCT02157779|12443181|FG000|Overall Study|Stopped attending, reason unknown|11
7919913|NCT02157779|12443182|FG001|Overall Study|Stopped attending, reason unknown|7
7919914|NCT02157779|12443181|FG000|Overall Study|No response to outreach after Baseline|1
7919915|NCT02157779|12443182|FG001|Overall Study|No response to outreach after Baseline|1
7919916|NCT02157779|12443181|FG000|Overall Study|Moved|1
7919917|NCT02157779|12443182|FG001|Overall Study|Moved|0
7919918|NCT02157779|12443181|FG000|Overall Study|Medical|1
7919919|NCT02157779|12443182|FG001|Overall Study|Medical|0
7919920|NCT02157779|12443181|FG000|Overall Study|Legal issue|1
7919921|NCT02157779|12443182|FG001|Overall Study|Legal issue|0
7919922|NCT02157935|12443203|FG000|Overall Study|Withdrawal by Subject|25
7919923|NCT02157935|12443204|FG001|Overall Study|Withdrawal by Subject|39
7919924|NCT02157935|12443203|FG000|Overall Study|Screen failure|1
7919925|NCT02157935|12443204|FG001|Overall Study|Screen failure|2
7919926|NCT02157935|12443203|FG000|Overall Study|Protocol Violation|1
7919927|NCT02157935|12443204|FG001|Overall Study|Protocol Violation|0
7919928|NCT02157935|12443203|FG000|Overall Study|Progressive disease|0
7919929|NCT02157935|12443204|FG001|Overall Study|Progressive disease|2
7919930|NCT02157935|12443203|FG000|Overall Study|Other|5
7919931|NCT02157935|12443204|FG001|Overall Study|Other|12
7919932|NCT02157935|12443203|FG000|Overall Study|Lack of Efficacy|0
7919933|NCT02157935|12443204|FG001|Overall Study|Lack of Efficacy|1
7919934|NCT02157935|12443203|FG000|Overall Study|Death|4
7919935|NCT02157935|12443204|FG001|Overall Study|Death|4
7919936|NCT02157935|12443203|FG000|Overall Study|Adverse Event|3
7919937|NCT02157935|12443204|FG001|Overall Study|Adverse Event|5
7919938|NCT02157948|12443212|FG000|Overall Study|Withdrawal by Subject|4
7919939|NCT02157948|12443213|FG001|Overall Study|Withdrawal by Subject|5
7919940|NCT02157948|12443212|FG000|Overall Study|Lost to Follow-up|3
7919941|NCT02157948|12443213|FG001|Overall Study|Lost to Follow-up|2
7919942|NCT02157948|12443212|FG000|Overall Study|Protocol Specified Criteria|2
7919943|NCT02157948|12443213|FG001|Overall Study|Protocol Specified Criteria|1
7919944|NCT02157948|12443212|FG000|Overall Study|Decision by Sponsor|0
7919945|NCT02157948|12443213|FG001|Overall Study|Decision by Sponsor|1
7919946|NCT02158039|12443219|FG000|Overall Study|Withdrawal by Subject|1
7821479|NCT01255787|12290186|FG001|Overall Study|Lack of Efficacy|2
7821480|NCT01255787|12290187|FG002|Overall Study|Lack of Efficacy|2
7821481|NCT01255787|12290188|FG003|Overall Study|Lack of Efficacy|2
7821482|NCT01255787|12290185|FG000|Overall Study|Noncompliance with Study Drug|3
7821483|NCT01255787|12290186|FG001|Overall Study|Noncompliance with Study Drug|1
7821484|NCT01255787|12290187|FG002|Overall Study|Noncompliance with Study Drug|0
7821485|NCT01255787|12290188|FG003|Overall Study|Noncompliance with Study Drug|0
7821486|NCT01255904|12290229|FG000|Overall Study|Physician Decision|1
7821487|NCT01255904|12290230|FG001|Overall Study|Physician Decision|4
7862133|NCT01597245|12351202|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11
7919947|NCT02158039|12443219|FG000|Overall Study|Screen Failure|9
7919948|NCT02158247|12443225|FG000|Overall Study|Invisible vocal cords|5
7964376|NCT02586025|12519856|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4
7964377|NCT02586025|12519857|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3
7964378|NCT02586025|12519856|FG000|Neoadjuvant Treatment|Physician Decision|2
7964379|NCT02586025|12519857|FG001|Neoadjuvant Treatment|Physician Decision|1
7964380|NCT02586025|12519856|FG000|Neoadjuvant Treatment|Progressive Disease|2
7964381|NCT02586025|12519857|FG001|Neoadjuvant Treatment|Progressive Disease|3
7964382|NCT02586025|12519856|FG000|Adjuvant Treatment|Remain in Adjuvant Treatment|133
7964383|NCT02586025|12519857|FG001|Adjuvant Treatment|Remain in Adjuvant Treatment|61
7964384|NCT02586025|12519856|FG000|Adjuvant Treatment|Withdrawal by Subject|5
7964385|NCT02586025|12519857|FG001|Adjuvant Treatment|Withdrawal by Subject|3
7964386|NCT02586025|12519856|FG000|Adjuvant Treatment|Physician Decision|0
7964387|NCT02586025|12519857|FG001|Adjuvant Treatment|Physician Decision|1
7964388|NCT02586025|12519856|FG000|Adjuvant Treatment|Recurrent Disease|1
7862134|NCT01597245|12351203|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12
7862135|NCT01597245|12351204|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862136|NCT01597245|12351205|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862137|NCT01597245|12351206|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862138|NCT01597245|12351207|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862139|NCT01597245|12351208|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7862140|NCT01597245|12351188|FG000|Long Term Extension (Week 60 - Week 264)|Death|0
7862141|NCT01597245|12351189|FG001|Long Term Extension (Week 60 - Week 264)|Death|0
7862142|NCT01597245|12351190|FG002|Long Term Extension (Week 60 - Week 264)|Death|0
7862143|NCT01597245|12351191|FG003|Long Term Extension (Week 60 - Week 264)|Death|0
7964389|NCT02586025|12519857|FG001|Adjuvant Treatment|Recurrent Disease|4
7964390|NCT02586025|12519856|FG000|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56
7964391|NCT02586025|12519857|FG001|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35
7964392|NCT02569242|12519865|FG000|Overall Study|Death|1
7964393|NCT02569242|12519866|FG001|Overall Study|Death|0
7964394|NCT02569242|12519865|FG000|Overall Study|Withdrawal by Subject|0
7964395|NCT02569242|12519866|FG001|Overall Study|Withdrawal by Subject|1
7964396|NCT02524379|12519872|FG000|Overall Study|Death|1
7964397|NCT02282345|12519904|FG000|Overall Study|Progression|0
7964398|NCT02282345|12519905|FG001|Overall Study|Progression|1
7964399|NCT02120469|12519917|FG000|Overall Study|HER-2/neu-amplified|1
7821488|NCT01256008|12290239|FG000|Overall Study|Lost to Follow-up|6
7821489|NCT01256008|12290240|FG001|Overall Study|Lost to Follow-up|4
7821490|NCT01256008|12290241|FG002|Overall Study|Lost to Follow-up|11
7821491|NCT01256008|12290239|FG000|Overall Study|Withdrawal by Subject|2
7821492|NCT01256008|12290240|FG001|Overall Study|Withdrawal by Subject|3
7821493|NCT01256008|12290241|FG002|Overall Study|Withdrawal by Subject|10
7821494|NCT01256060|12290260|FG000|Overall Study|Lost to Follow-up|0
7821495|NCT01256060|12290261|FG001|Overall Study|Lost to Follow-up|1
7821496|NCT01256060|12290262|FG002|Overall Study|Lost to Follow-up|0
7821497|NCT01256060|12290263|FG003|Overall Study|Lost to Follow-up|0
7821498|NCT01256177|12290280|FG000|Overall Study|Withdrawal by Subject|23
7821499|NCT01256177|12290281|FG001|Overall Study|Withdrawal by Subject|22
7821500|NCT01256177|12290280|FG000|Overall Study|Lost to Follow-up|2
7821501|NCT01256177|12290281|FG001|Overall Study|Lost to Follow-up|2
7821502|NCT01256177|12290280|FG000|Overall Study|Adverse Event|8
7821503|NCT01256177|12290281|FG001|Overall Study|Adverse Event|9
7821504|NCT01256177|12290280|FG000|Overall Study|Severe Non-Compliance to Protocol|4
7821505|NCT01256177|12290281|FG001|Overall Study|Severe Non-Compliance to Protocol|2
7821506|NCT01256177|12290280|FG000|Overall Study|Condition under Investigation Worsened|1
7821507|NCT01256177|12290281|FG001|Overall Study|Condition under Investigation Worsened|0
7821508|NCT01256177|12290280|FG000|Overall Study|Lack of Efficacy|11
7821509|NCT01256177|12290281|FG001|Overall Study|Lack of Efficacy|2
7821510|NCT01256177|12290280|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1
7821511|NCT01256177|12290281|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0
7821512|NCT01256190|12290289|FG000|Overall Study|Lost to Follow-up|2
7821513|NCT01256190|12290290|FG001|Overall Study|Lost to Follow-up|0
7821514|NCT01256294|12290296|FG000|Overall Study|Adverse Event|1
7821515|NCT01256294|12290297|FG001|Overall Study|Adverse Event|0
7821516|NCT01256294|12290296|FG000|Overall Study|Withdrawal by Subject|1
7821517|NCT01256294|12290297|FG001|Overall Study|Withdrawal by Subject|1
7821518|NCT01256294|12290296|FG000|Overall Study|Protocol deviation|2
7821519|NCT01256294|12290297|FG001|Overall Study|Protocol deviation|1
7821520|NCT01256385|12290305|FG000|Overall Study|Physician Decision|1
7821521|NCT01256385|12290306|FG001|Overall Study|Physician Decision|1
7821522|NCT01256385|12290305|FG000|Overall Study|Withdrawal by Subject|2
7821523|NCT01256385|12290306|FG001|Overall Study|Withdrawal by Subject|2
7821524|NCT01256411|12290316|FG000|Extension by Maximum Treatment|Protocol deviation|0
7821525|NCT01256411|12290317|FG001|Extension by Maximum Treatment|Protocol deviation|0
7821526|NCT01256411|12290318|FG002|Extension by Maximum Treatment|Protocol deviation|1
7821527|NCT01256411|12290319|FG003|Extension by Maximum Treatment|Protocol deviation|0
7821528|NCT01256411|12290320|FG004|Extension by Maximum Treatment|Protocol deviation|0
7821529|NCT01256411|12290321|FG005|Extension by Maximum Treatment|Protocol deviation|0
7821530|NCT01256411|12290316|FG000|Extension by Maximum Treatment|Lost to Follow-up|1
7821531|NCT01256411|12290317|FG001|Extension by Maximum Treatment|Lost to Follow-up|2
7821532|NCT01256411|12290318|FG002|Extension by Maximum Treatment|Lost to Follow-up|0
7821533|NCT01256411|12290319|FG003|Extension by Maximum Treatment|Lost to Follow-up|0
7821534|NCT01256411|12290320|FG004|Extension by Maximum Treatment|Lost to Follow-up|0
7821535|NCT01256411|12290321|FG005|Extension by Maximum Treatment|Lost to Follow-up|0
7821536|NCT01256411|12290316|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1
7821537|NCT01256411|12290317|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6
7821538|NCT01256411|12290318|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1
7821539|NCT01256411|12290319|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0
7821540|NCT01256411|12290320|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0
7821541|NCT01256411|12290321|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0
7919949|NCT02158364|12443250|FG000|Overall Study|Case report forms uncollected|10
7919950|NCT02158364|12443250|FG000|Overall Study|Protocol Deviation|50
7919951|NCT02158442|12443256|FG000|Overall Study|Withdrawal by Subject|1
7919952|NCT02158442|12443257|FG001|Overall Study|Withdrawal by Subject|0
7919953|NCT02158442|12443256|FG000|Overall Study|Perfusion staff not available|1
7919954|NCT02158442|12443257|FG001|Overall Study|Perfusion staff not available|0
7919955|NCT02158533|12443291|FG000|Stage 1|Adverse Event|6
7919956|NCT02158533|12443292|FG001|Stage 1|Adverse Event|4
7919957|NCT02158533|12443293|FG002|Stage 1|Adverse Event|7
7919958|NCT02158533|12443294|FG003|Stage 1|Adverse Event|0
7919959|NCT02158533|12443295|FG004|Stage 1|Adverse Event|0
7919960|NCT02158533|12443296|FG005|Stage 1|Adverse Event|0
7919961|NCT02158533|12443291|FG000|Stage 1|Withdrawal by Subject|3
7919962|NCT02158533|12443292|FG001|Stage 1|Withdrawal by Subject|2
7919963|NCT02158533|12443293|FG002|Stage 1|Withdrawal by Subject|1
7919964|NCT02158533|12443294|FG003|Stage 1|Withdrawal by Subject|0
7919965|NCT02158533|12443295|FG004|Stage 1|Withdrawal by Subject|0
7919966|NCT02158533|12443296|FG005|Stage 1|Withdrawal by Subject|0
7919967|NCT02158533|12443291|FG000|Stage 1|Lack of Efficacy|1
7919968|NCT02158533|12443292|FG001|Stage 1|Lack of Efficacy|0
7919969|NCT02158533|12443293|FG002|Stage 1|Lack of Efficacy|0
7919970|NCT02158533|12443294|FG003|Stage 1|Lack of Efficacy|0
7919971|NCT02158533|12443295|FG004|Stage 1|Lack of Efficacy|0
7919972|NCT02158533|12443296|FG005|Stage 1|Lack of Efficacy|0
7919973|NCT02158533|12443291|FG000|Stage 1|Lost to Follow-up|3
7919974|NCT02158533|12443292|FG001|Stage 1|Lost to Follow-up|1
7919975|NCT02158533|12443293|FG002|Stage 1|Lost to Follow-up|0
7919976|NCT02158533|12443294|FG003|Stage 1|Lost to Follow-up|0
7919977|NCT02158533|12443295|FG004|Stage 1|Lost to Follow-up|0
7919978|NCT02158533|12443296|FG005|Stage 1|Lost to Follow-up|0
7919979|NCT02158533|12443291|FG000|Stage 1|Failure to Meet Eligibility Criteria|0
7919980|NCT02158533|12443292|FG001|Stage 1|Failure to Meet Eligibility Criteria|1
7919981|NCT02158533|12443293|FG002|Stage 1|Failure to Meet Eligibility Criteria|0
7919982|NCT02158533|12443294|FG003|Stage 1|Failure to Meet Eligibility Criteria|0
7919983|NCT02158533|12443295|FG004|Stage 1|Failure to Meet Eligibility Criteria|0
7919984|NCT02158533|12443296|FG005|Stage 1|Failure to Meet Eligibility Criteria|0
7919985|NCT02158533|12443291|FG000|Stage 1|Non-compliance with study visits|1
7919986|NCT02158533|12443292|FG001|Stage 1|Non-compliance with study visits|0
7919987|NCT02158533|12443293|FG002|Stage 1|Non-compliance with study visits|0
7919988|NCT02158533|12443294|FG003|Stage 1|Non-compliance with study visits|0
7919989|NCT02158533|12443295|FG004|Stage 1|Non-compliance with study visits|0
7919990|NCT02158533|12443296|FG005|Stage 1|Non-compliance with study visits|0
7919991|NCT02158533|12443291|FG000|Stage 2|Adverse Event|0
7919992|NCT02158533|12443292|FG001|Stage 2|Adverse Event|0
7919993|NCT02158533|12443293|FG002|Stage 2|Adverse Event|0
7919994|NCT02158533|12443294|FG003|Stage 2|Adverse Event|0
7919995|NCT02158533|12443295|FG004|Stage 2|Adverse Event|0
7919996|NCT02158533|12443296|FG005|Stage 2|Adverse Event|1
7919997|NCT02158533|12443291|FG000|Stage 2|Lack of Efficacy|0
7919998|NCT02158533|12443292|FG001|Stage 2|Lack of Efficacy|0
7919999|NCT02158533|12443293|FG002|Stage 2|Lack of Efficacy|0
7920000|NCT02158533|12443294|FG003|Stage 2|Lack of Efficacy|0
7920001|NCT02158533|12443295|FG004|Stage 2|Lack of Efficacy|1
7920002|NCT02158533|12443296|FG005|Stage 2|Lack of Efficacy|0
7920003|NCT02158533|12443291|FG000|Stage 2|Lost to Follow-up|0
7920004|NCT02158533|12443292|FG001|Stage 2|Lost to Follow-up|0
7920005|NCT02158533|12443293|FG002|Stage 2|Lost to Follow-up|0
7920006|NCT02158533|12443294|FG003|Stage 2|Lost to Follow-up|1
7920007|NCT02158533|12443295|FG004|Stage 2|Lost to Follow-up|1
7920008|NCT02158533|12443296|FG005|Stage 2|Lost to Follow-up|2
7920009|NCT02158533|12443291|FG000|Stage 2|Withdrawal by Subject|0
7920010|NCT02158533|12443292|FG001|Stage 2|Withdrawal by Subject|0
7920011|NCT02158533|12443293|FG002|Stage 2|Withdrawal by Subject|0
7920012|NCT02158533|12443294|FG003|Stage 2|Withdrawal by Subject|0
7920013|NCT02158533|12443295|FG004|Stage 2|Withdrawal by Subject|1
7920014|NCT02158533|12443296|FG005|Stage 2|Withdrawal by Subject|2
7920015|NCT02158533|12443291|FG000|Stage 2|Physician Decision|0
7920016|NCT02158533|12443292|FG001|Stage 2|Physician Decision|0
7920017|NCT02158533|12443293|FG002|Stage 2|Physician Decision|0
7920018|NCT02158533|12443294|FG003|Stage 2|Physician Decision|0
7920019|NCT02158533|12443295|FG004|Stage 2|Physician Decision|1
7920020|NCT02158533|12443296|FG005|Stage 2|Physician Decision|0
7920021|NCT02158533|12443291|FG000|Stage 2|Pregnancy|0
7920022|NCT02158533|12443292|FG001|Stage 2|Pregnancy|0
7920023|NCT02158533|12443293|FG002|Stage 2|Pregnancy|0
7920024|NCT02158533|12443294|FG003|Stage 2|Pregnancy|1
7920025|NCT02158533|12443295|FG004|Stage 2|Pregnancy|0
7920026|NCT02158533|12443296|FG005|Stage 2|Pregnancy|0
7920027|NCT02158533|12443291|FG000|Stage 2|Psychiatrist decision to try new tx|0
7920028|NCT02158533|12443292|FG001|Stage 2|Psychiatrist decision to try new tx|0
7920029|NCT02158533|12443293|FG002|Stage 2|Psychiatrist decision to try new tx|0
7920030|NCT02158533|12443294|FG003|Stage 2|Psychiatrist decision to try new tx|1
7920031|NCT02158533|12443295|FG004|Stage 2|Psychiatrist decision to try new tx|0
7920032|NCT02158533|12443296|FG005|Stage 2|Psychiatrist decision to try new tx|0
7920033|NCT02158533|12443291|FG000|Stage 2|Non-adherence with study visits|0
7920034|NCT02158533|12443292|FG001|Stage 2|Non-adherence with study visits|0
7920035|NCT02158533|12443293|FG002|Stage 2|Non-adherence with study visits|0
7920036|NCT02158533|12443294|FG003|Stage 2|Non-adherence with study visits|0
7920037|NCT02158533|12443295|FG004|Stage 2|Non-adherence with study visits|0
7920038|NCT02158533|12443296|FG005|Stage 2|Non-adherence with study visits|1
7920039|NCT02158546|12443314|FG000|Overall Study|Physician Decision|0
7719575|NCT00533429|12143566|FG001|Overall Study|Progressive Disease|13
7719576|NCT00533429|12143565|FG000|Overall Study|Symptomatic deterioration|1
7719577|NCT00533429|12143566|FG001|Overall Study|Symptomatic deterioration|2
7719578|NCT00533507|12143585|FG000|Overall Study|Withdrawal by Subject|1
7719579|NCT00533702|12143596|FG000|Overall Study|Withdrawal by Subject|3
7920040|NCT02158546|12443315|FG001|Overall Study|Physician Decision|1
7920041|NCT02158546|12443316|FG002|Overall Study|Physician Decision|0
7920042|NCT02158546|12443317|FG003|Overall Study|Physician Decision|0
7920043|NCT02158546|12443314|FG000|Overall Study|Non-compliance|0
7920044|NCT02158546|12443315|FG001|Overall Study|Non-compliance|1
7920045|NCT02158546|12443316|FG002|Overall Study|Non-compliance|0
7920046|NCT02158546|12443317|FG003|Overall Study|Non-compliance|1
7920047|NCT02158546|12443314|FG000|Overall Study|Failure to meet eligibility criteria|0
7920048|NCT02158546|12443315|FG001|Overall Study|Failure to meet eligibility criteria|1
7920049|NCT02158546|12443316|FG002|Overall Study|Failure to meet eligibility criteria|0
7920050|NCT02158546|12443317|FG003|Overall Study|Failure to meet eligibility criteria|0
7920051|NCT02158546|12443314|FG000|Overall Study|Lack of Efficacy|1
7920052|NCT02158546|12443315|FG001|Overall Study|Lack of Efficacy|1
7920053|NCT02158546|12443316|FG002|Overall Study|Lack of Efficacy|0
7920054|NCT02158546|12443317|FG003|Overall Study|Lack of Efficacy|0
7920055|NCT02158546|12443314|FG000|Overall Study|Adverse Event|2
7920056|NCT02158546|12443315|FG001|Overall Study|Adverse Event|2
7920057|NCT02158546|12443316|FG002|Overall Study|Adverse Event|0
7920058|NCT02158546|12443317|FG003|Overall Study|Adverse Event|0
7920059|NCT02158546|12443314|FG000|Overall Study|Withdrawal by Subject|6
7920060|NCT02158546|12443315|FG001|Overall Study|Withdrawal by Subject|2
7920061|NCT02158546|12443316|FG002|Overall Study|Withdrawal by Subject|1
7920062|NCT02158546|12443317|FG003|Overall Study|Withdrawal by Subject|0
7920063|NCT02158546|12443314|FG000|Overall Study|Lost to Follow-up|5
7920064|NCT02158546|12443315|FG001|Overall Study|Lost to Follow-up|4
7920065|NCT02158546|12443316|FG002|Overall Study|Lost to Follow-up|0
7920066|NCT02158546|12443317|FG003|Overall Study|Lost to Follow-up|1
7920067|NCT02158546|12443314|FG000|Overall Study|Site Excluded|5
7920068|NCT02158546|12443315|FG001|Overall Study|Site Excluded|5
7920069|NCT02158546|12443316|FG002|Overall Study|Site Excluded|3
7920070|NCT02158546|12443317|FG003|Overall Study|Site Excluded|4
7920071|NCT02158663|12443333|FG000|Overall Study|Withdrawal by Subject|5
7920072|NCT02158663|12443334|FG001|Overall Study|Withdrawal by Subject|4
7920073|NCT02158728|12443342|FG000|Overall Study|no procedure according to CIP done|3
7920074|NCT02158728|12443342|FG000|Overall Study|no qualified dataset|24
7920075|NCT02158806|12443348|FG000|Overall Study|Death|2
7920076|NCT02158806|12443349|FG001|Overall Study|Death|0
7920077|NCT02158806|12443348|FG000|Overall Study|Withdrawal by Subject|2
7920078|NCT02158806|12443349|FG001|Overall Study|Withdrawal by Subject|0
7920079|NCT02158806|12443348|FG000|Overall Study|Lost to Follow-up|0
7920080|NCT02158806|12443349|FG001|Overall Study|Lost to Follow-up|3
7920081|NCT02158806|12443348|FG000|Overall Study|Moved out of area|0
7920082|NCT02158806|12443349|FG001|Overall Study|Moved out of area|1
7920083|NCT02158806|12443348|FG000|Overall Study|Transferred to palliative care|0
7920084|NCT02158806|12443349|FG001|Overall Study|Transferred to palliative care|1
7920085|NCT02158884|12443355|FG000|Baseline Assessment|Missed performance assessment|3
7920086|NCT02158884|12443355|FG000|Baseline Assessment|Missed SMFA|1
7920087|NCT02158884|12443355|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6
7920088|NCT02158884|12443355|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10
7719580|NCT00533702|12143597|FG001|Overall Study|Withdrawal by Subject|1
7719581|NCT00533702|12143596|FG000|Overall Study|Found ineligible after randomization|2
7719582|NCT00533702|12143597|FG001|Overall Study|Found ineligible after randomization|1
7920089|NCT02158884|12443355|FG000|6 Month Assessment|Missed SMFA|20
7920090|NCT02158884|12443355|FG000|12 Month Assessment|Missed SMFA|17
7920091|NCT02158936|12443362|FG000|Overall Study|Study closed/ terminated|57
7920092|NCT02158936|12443363|FG001|Overall Study|Study closed/ terminated|77
7920093|NCT02158936|12443362|FG000|Overall Study|Azacitidine tx discontinued|53
7920094|NCT02158936|12443363|FG001|Overall Study|Azacitidine tx discontinued|46
7920095|NCT02158936|12443362|FG000|Overall Study|Adverse Event|39
7920096|NCT02158936|12443363|FG001|Overall Study|Adverse Event|24
7920097|NCT02158936|12443362|FG000|Overall Study|Withdrawal by Subject|15
7920098|NCT02158936|12443363|FG001|Overall Study|Withdrawal by Subject|16
7920099|NCT02158936|12443362|FG000|Overall Study|Physician Decision|15
7920100|NCT02158936|12443363|FG001|Overall Study|Physician Decision|13
7920101|NCT02158936|12443362|FG000|Overall Study|Lost to Follow-up|0
7920102|NCT02158936|12443363|FG001|Overall Study|Lost to Follow-up|1
7719583|NCT00533845|12143605|FG000|Overall Study|Physician Decision|1
7719584|NCT00533845|12143606|FG001|Overall Study|Physician Decision|0
7719585|NCT00533897|12143615|FG000|Lead-in (LI) Period 1|Adverse Event|1
7719586|NCT00533897|12143616|FG001|Lead-in (LI) Period 1|Adverse Event|0
7920103|NCT02158949|12443371|FG000|Overall Study|Withdrawal by Subject|1
7920104|NCT02158949|12443372|FG001|Overall Study|Withdrawal by Subject|0
7920105|NCT02158949|12443371|FG000|Overall Study|Lost to Follow-up|5
7920106|NCT02158949|12443372|FG001|Overall Study|Lost to Follow-up|11
7920107|NCT02158975|12443378|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1
7920108|NCT02159053|12443386|FG000|Overall Study|Death|2
7920109|NCT02159053|12443387|FG001|Overall Study|Death|0
7920110|NCT02159053|12443388|FG002|Overall Study|Death|1
7920111|NCT02159053|12443386|FG000|Overall Study|Physician Decision|0
7920112|NCT02159053|12443387|FG001|Overall Study|Physician Decision|1
7920113|NCT02159053|12443388|FG002|Overall Study|Physician Decision|1
7920114|NCT02159053|12443386|FG000|Overall Study|Lack of Efficacy|3
7920115|NCT02159053|12443387|FG001|Overall Study|Lack of Efficacy|4
7920116|NCT02159053|12443388|FG002|Overall Study|Lack of Efficacy|7
7920117|NCT02159053|12443386|FG000|Overall Study|Adverse Event|7
7920118|NCT02159053|12443387|FG001|Overall Study|Adverse Event|6
7920119|NCT02159053|12443388|FG002|Overall Study|Adverse Event|5
7920120|NCT02159053|12443386|FG000|Overall Study|Participants/guardian decision|8
7920121|NCT02159053|12443387|FG001|Overall Study|Participants/guardian decision|10
7920122|NCT02159053|12443388|FG002|Overall Study|Participants/guardian decision|6
7920123|NCT02159183|12443418|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2
7920124|NCT02159183|12443419|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1
7920125|NCT02159183|12443418|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1
7920126|NCT02159183|12443419|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0
7920127|NCT02159183|12443418|FG000|Analysis After the 36 Months Follow-up|Death|0
7920128|NCT02159183|12443419|FG001|Analysis After the 36 Months Follow-up|Death|1
7920129|NCT02159183|12443418|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1
7920130|NCT02159183|12443419|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0
7920131|NCT02159183|12443418|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2
7920132|NCT02159183|12443419|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1
7920133|NCT02159352|12443427|FG000|Overall Study|Adverse Event|3
7920134|NCT02159352|12443428|FG001|Overall Study|Adverse Event|1
7920135|NCT02159352|12443427|FG000|Overall Study|Withdrawal by Subject|0
7920136|NCT02159352|12443428|FG001|Overall Study|Withdrawal by Subject|1
7920137|NCT02159365|12443453|FG000|Overall Study|Disease Progression|23
7920138|NCT02159365|12443453|FG000|Overall Study|Other reasons|11
7920139|NCT02159365|12443453|FG000|Overall Study|Administrative reason by Sponsor|9
7920140|NCT02159365|12443453|FG000|Overall Study|Adverse Event unrelated to study drug|9
7920141|NCT02159365|12443453|FG000|Overall Study|Study drug toxicity|7
7920142|NCT02159365|12443453|FG000|Overall Study|Maximum clinical benefit|3
7920143|NCT02159365|12443453|FG000|Overall Study|Subject request to discontinue treatment|3
7920144|NCT02159365|12443453|FG000|Overall Study|Subject withdrew consent|3
7920145|NCT02159365|12443453|FG000|Overall Study|Death|1
7920146|NCT02159365|12443453|FG000|Overall Study|Lost to Follow-up|1
7920147|NCT02159469|12443457|FG000|Overall Study|Missing Completion status|1
7821542|NCT01256411|12290316|FG000|Extension by Maximum Treatment|Lack of Efficacy|1
7821543|NCT01256411|12290317|FG001|Extension by Maximum Treatment|Lack of Efficacy|0
7821544|NCT01256411|12290318|FG002|Extension by Maximum Treatment|Lack of Efficacy|1
7821545|NCT01256411|12290319|FG003|Extension by Maximum Treatment|Lack of Efficacy|0
7821546|NCT01256411|12290320|FG004|Extension by Maximum Treatment|Lack of Efficacy|0
7821547|NCT01256411|12290321|FG005|Extension by Maximum Treatment|Lack of Efficacy|0
7821548|NCT01256411|12290316|FG000|Extension by Maximum Treatment|Adverse Event|4
7821549|NCT01256411|12290317|FG001|Extension by Maximum Treatment|Adverse Event|2
7821550|NCT01256411|12290318|FG002|Extension by Maximum Treatment|Adverse Event|1
7821551|NCT01256411|12290319|FG003|Extension by Maximum Treatment|Adverse Event|0
7821552|NCT01256411|12290320|FG004|Extension by Maximum Treatment|Adverse Event|0
7821553|NCT01256411|12290321|FG005|Extension by Maximum Treatment|Adverse Event|0
7821554|NCT01256411|12290316|FG000|Extension by Mono or Combination Therapy|Adverse Event|0
7821555|NCT01256411|12290317|FG001|Extension by Mono or Combination Therapy|Adverse Event|0
7821556|NCT01256411|12290318|FG002|Extension by Mono or Combination Therapy|Adverse Event|0
7821557|NCT01256411|12290319|FG003|Extension by Mono or Combination Therapy|Adverse Event|0
7920148|NCT02159469|12443457|FG000|Overall Study|Adverse Event|5
7920149|NCT02159469|12443457|FG000|Overall Study|Non-compliance|2
7920150|NCT02159469|12443457|FG000|Overall Study|Withdrawal by Subject|9
7920151|NCT02159469|12443457|FG000|Overall Study|Lost to Follow-up|1
7920152|NCT02159469|12443457|FG000|Overall Study|Sponsor's request|2
7920153|NCT02159469|12443457|FG000|Overall Study|Met Stopping Criteria|3
7920154|NCT02159469|12443457|FG000|Overall Study|Other|1
7920155|NCT02159469|12443457|FG000|Overall Study|Multiple|29
7920156|NCT02159482|12443462|FG000|Overall Study|Withdrawal by Subject|2
7821558|NCT01256411|12290320|FG004|Extension by Mono or Combination Therapy|Adverse Event|6
7821559|NCT01256411|12290321|FG005|Extension by Mono or Combination Therapy|Adverse Event|1
7821560|NCT01256411|12290316|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0
7821561|NCT01256411|12290317|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0
7920157|NCT02159482|12443462|FG000|Overall Study|Physician Decision|3
7821562|NCT01256411|12290318|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0
7821563|NCT01256411|12290319|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0
7821564|NCT01256411|12290320|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0
7821565|NCT01256411|12290321|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1
7821566|NCT01256411|12290316|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0
7821567|NCT01256411|12290317|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0
7821568|NCT01256411|12290318|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0
7821569|NCT01256411|12290319|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0
7821570|NCT01256411|12290320|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3
7821571|NCT01256411|12290321|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0
7821572|NCT01256411|12290316|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
7821573|NCT01256411|12290317|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
7821574|NCT01256411|12290318|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
7821575|NCT01256411|12290319|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
7821576|NCT01256411|12290320|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
7821577|NCT01256411|12290321|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
7821578|NCT01256411|12290316|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0
7821579|NCT01256411|12290317|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0
7821580|NCT01256411|12290318|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0
7821581|NCT01256411|12290319|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0
7821582|NCT01256411|12290320|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1
7821583|NCT01256411|12290321|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1
7821584|NCT01256450|12290355|FG000|Open-label Titration|Adverse Event|39
7821585|NCT01256450|12290356|FG001|Open-label Titration|Adverse Event|0
7821586|NCT01256450|12290357|FG002|Open-label Titration|Adverse Event|0
7920158|NCT02159521|12443466|FG000|Overall Study|Enrolled but not treated|3
7920159|NCT02159521|12443466|FG000|Overall Study|Withdrawal by Subject|7
7920160|NCT02159521|12443466|FG000|Overall Study|Lost to Follow-up|6
7920161|NCT02159521|12443466|FG000|Overall Study|Death|1
7920162|NCT02159521|12443466|FG000|Overall Study|Other than specified|1
7920163|NCT02159729|12443486|FG000|Overall Study|Adverse Event|0
7920164|NCT02159729|12443487|FG001|Overall Study|Adverse Event|1
7920165|NCT02159729|12443486|FG000|Overall Study|Subject's Request|13
7920166|NCT02159729|12443487|FG001|Overall Study|Subject's Request|10
7920167|NCT02159729|12443486|FG000|Overall Study|Lost to Follow-up|24
7920168|NCT02159729|12443487|FG001|Overall Study|Lost to Follow-up|9
7920169|NCT02159729|12443486|FG000|Overall Study|Non compliance|2
7920170|NCT02159729|12443487|FG001|Overall Study|Non compliance|0
7920171|NCT02159729|12443486|FG000|Overall Study|Other Unspecified|3
7920172|NCT02159729|12443487|FG001|Overall Study|Other Unspecified|1
7920173|NCT02159807|12443500|FG000|Overall Study|Adverse Event|0
7920174|NCT02159807|12443501|FG001|Overall Study|Adverse Event|0
7920175|NCT02159807|12443502|FG002|Overall Study|Adverse Event|1
7920176|NCT02159807|12443500|FG000|Overall Study|No CSF|1
7920177|NCT02159807|12443501|FG001|Overall Study|No CSF|1
7920178|NCT02159807|12443502|FG002|Overall Study|No CSF|1
7920179|NCT02159807|12443500|FG000|Overall Study|elevated blood pressure|0
7920180|NCT02159807|12443501|FG001|Overall Study|elevated blood pressure|0
7920181|NCT02159807|12443502|FG002|Overall Study|elevated blood pressure|1
7920182|NCT02159950|12443531|FG000|Overall Study|Adverse Event|0
7920183|NCT02159950|12443532|FG001|Overall Study|Adverse Event|1
7920184|NCT02159950|12443531|FG000|Overall Study|Progression|0
7920185|NCT02159950|12443532|FG001|Overall Study|Progression|1
7920186|NCT02160002|12443551|FG000|Overall Study|Withdrawal by Subject|2
7920187|NCT02160002|12443552|FG001|Overall Study|Withdrawal by Subject|1
7920188|NCT02160041|12443558|FG000|Overall Study|Adverse Event|11
7920189|NCT02160041|12443558|FG000|Overall Study|Death|2
7920190|NCT02160041|12443558|FG000|Overall Study|disease progression|57
7920191|NCT02160041|12443558|FG000|Overall Study|Protocol Violation|1
7920192|NCT02160041|12443558|FG000|Overall Study|non-compliance with study|1
7920193|NCT02160041|12443558|FG000|Overall Study|Physician Decision|3
7920194|NCT02160041|12443558|FG000|Overall Study|Withdrawal by Subject|8
7920195|NCT02160041|12443558|FG000|Overall Study|study terminated by by sponsor|1
7920196|NCT02160145|12443564|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23
7920197|NCT02160145|12443565|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0
7920198|NCT02160145|12443566|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0
7920199|NCT02160145|12443564|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
7920200|NCT02160145|12443565|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
7821587|NCT01256450|12290355|FG000|Open-label Titration|Lost to Follow-up|7
7920201|NCT02160145|12443566|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
7920202|NCT02160145|12443564|FG000|Randomized Double-blind Period|Subject decision|0
7920203|NCT02160145|12443565|FG001|Randomized Double-blind Period|Subject decision|21
7920204|NCT02160145|12443566|FG002|Randomized Double-blind Period|Subject decision|20
7920205|NCT02160145|12443564|FG000|Randomized Double-blind Period|Lost to Follow-up|0
7920206|NCT02160145|12443565|FG001|Randomized Double-blind Period|Lost to Follow-up|1
7920207|NCT02160145|12443566|FG002|Randomized Double-blind Period|Lost to Follow-up|3
7920208|NCT02160145|12443564|FG000|Randomized Double-blind Period|Physician Decision|0
7920209|NCT02160145|12443565|FG001|Randomized Double-blind Period|Physician Decision|7
7920210|NCT02160145|12443566|FG002|Randomized Double-blind Period|Physician Decision|5
7920211|NCT02160314|12443584|FG000|Overall Study|Adverse Event|0
7920212|NCT02160314|12443585|FG001|Overall Study|Adverse Event|6
7920213|NCT02160314|12443584|FG000|Overall Study|Protocol Violation|0
7920214|NCT02160314|12443585|FG001|Overall Study|Protocol Violation|4
7920215|NCT02160314|12443584|FG000|Overall Study|Withdrawal by Subject|1
7920216|NCT02160314|12443585|FG001|Overall Study|Withdrawal by Subject|2
7920217|NCT02160314|12443584|FG000|Overall Study|Lost to Follow-up|0
7920218|NCT02160314|12443585|FG001|Overall Study|Lost to Follow-up|1
7920219|NCT02160626|12443598|FG000|Overall Study|Adverse Event|1
7920220|NCT02160626|12443599|FG001|Overall Study|Adverse Event|0
7920221|NCT02160626|12443600|FG002|Overall Study|Adverse Event|0
7920222|NCT02160626|12443598|FG000|Overall Study|Schedule not conducive to study visits|0
7920223|NCT02160626|12443599|FG001|Overall Study|Schedule not conducive to study visits|0
7920224|NCT02160626|12443600|FG002|Overall Study|Schedule not conducive to study visits|1
7920225|NCT02160626|12443598|FG000|Overall Study|Withdrawal by Subject|0
7920226|NCT02160626|12443599|FG001|Overall Study|Withdrawal by Subject|1
7920227|NCT02160626|12443600|FG002|Overall Study|Withdrawal by Subject|0
7920228|NCT02160782|12443615|FG000|Open-label Period: Maralixibat|Adverse Event|2
7920229|NCT02160782|12443616|FG001|Open-label Period: Maralixibat|Adverse Event|0
7920230|NCT02160782|12443617|FG002|Open-label Period: Maralixibat|Adverse Event|0
7920231|NCT02160782|12443618|FG003|Open-label Period: Maralixibat|Adverse Event|0
7920232|NCT02160782|12443619|FG004|Open-label Period: Maralixibat|Adverse Event|0
7920233|NCT02160782|12443615|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7920234|NCT02160782|12443616|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7920235|NCT02160782|12443617|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7920236|NCT02160782|12443618|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1
7920237|NCT02160782|12443619|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7920238|NCT02160782|12443615|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7920239|NCT02160782|12443616|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7920240|NCT02160782|12443617|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7920241|NCT02160782|12443618|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5
7920242|NCT02160782|12443619|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7920243|NCT02160782|12443615|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7920244|NCT02160782|12443616|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7920245|NCT02160782|12443617|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7920246|NCT02160782|12443618|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7920247|NCT02160782|12443619|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4
7920248|NCT02160782|12443615|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0
7920249|NCT02160782|12443616|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0
7920250|NCT02160782|12443617|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0
7920251|NCT02160782|12443618|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0
7920252|NCT02160782|12443619|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1
7920253|NCT02160782|12443615|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0
7920254|NCT02160782|12443616|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0
7920255|NCT02160782|12443617|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0
7920256|NCT02160782|12443618|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0
7920257|NCT02160782|12443619|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3
7920258|NCT02160782|12443615|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7920259|NCT02160782|12443616|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7920260|NCT02160782|12443617|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7920261|NCT02160782|12443618|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7920262|NCT02160782|12443619|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1
7920263|NCT02160899|12443682|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
7920264|NCT02160899|12443683|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
7920265|NCT02160899|12443684|FG002|Overall Study|Adverse Event or Serious Adverse Event|0
7920266|NCT02160899|12443685|FG003|Overall Study|Adverse Event or Serious Adverse Event|1
7920267|NCT02160899|12443686|FG004|Overall Study|Adverse Event or Serious Adverse Event|2
7920268|NCT02160899|12443687|FG005|Overall Study|Adverse Event or Serious Adverse Event|0
7920269|NCT02160977|12443703|FG000|Six Weeks After Surgery|Lost to Follow-up|1
7920270|NCT02160977|12443704|FG001|Six Weeks After Surgery|Lost to Follow-up|0
7920271|NCT02160977|12443703|FG000|Three Months After Surgery|Lost to Follow-up|0
7920272|NCT02160977|12443704|FG001|Three Months After Surgery|Lost to Follow-up|2
7920273|NCT02160977|12443703|FG000|Six Months After Surgery|Lost to Follow-up|2
7920274|NCT02160977|12443704|FG001|Six Months After Surgery|Lost to Follow-up|1
7920275|NCT02161146|12443733|FG000|Overall Study|Adverse Event|1
7920276|NCT02161146|12443734|FG001|Overall Study|Adverse Event|1
7920277|NCT02161146|12443735|FG002|Overall Study|Adverse Event|0
7920278|NCT02161146|12443736|FG003|Overall Study|Adverse Event|1
7920279|NCT02161146|12443737|FG004|Overall Study|Adverse Event|0
7920280|NCT02161146|12443733|FG000|Overall Study|Lost to Follow-up|0
7920281|NCT02161146|12443734|FG001|Overall Study|Lost to Follow-up|1
7920282|NCT02161146|12443735|FG002|Overall Study|Lost to Follow-up|0
7920283|NCT02161146|12443736|FG003|Overall Study|Lost to Follow-up|0
7920284|NCT02161146|12443737|FG004|Overall Study|Lost to Follow-up|0
7920285|NCT02161146|12443733|FG000|Overall Study|Personal Reasons|0
7920286|NCT02161146|12443734|FG001|Overall Study|Personal Reasons|1
7920287|NCT02161146|12443735|FG002|Overall Study|Personal Reasons|0
7920288|NCT02161146|12443736|FG003|Overall Study|Personal Reasons|2
7920289|NCT02161146|12443737|FG004|Overall Study|Personal Reasons|1
7920290|NCT02161146|12443733|FG000|Overall Study|Other Miscellaneous Reasons|0
7920291|NCT02161146|12443734|FG001|Overall Study|Other Miscellaneous Reasons|1
7920292|NCT02161146|12443735|FG002|Overall Study|Other Miscellaneous Reasons|0
7920293|NCT02161146|12443736|FG003|Overall Study|Other Miscellaneous Reasons|0
7920294|NCT02161146|12443737|FG004|Overall Study|Other Miscellaneous Reasons|0
7920295|NCT02161185|12443747|FG000|Treatment Phase|Administrative/Other|7
7920296|NCT02161406|12443753|FG000|Overall Study|Death|2
7920297|NCT02161406|12443754|FG001|Overall Study|Death|1
7920298|NCT02161406|12443753|FG000|Overall Study|Lost to Follow-up|2
7920299|NCT02161406|12443754|FG001|Overall Study|Lost to Follow-up|1
7920300|NCT02161406|12443753|FG000|Overall Study|Withdrawal by Subject|2
7920301|NCT02161406|12443754|FG001|Overall Study|Withdrawal by Subject|4
7920302|NCT02161406|12443753|FG000|Overall Study|investigator withdrew subject|3
7920303|NCT02161406|12443754|FG001|Overall Study|investigator withdrew subject|1
7920304|NCT02161406|12443753|FG000|Overall Study|Lack of Efficacy|1
7920305|NCT02161406|12443754|FG001|Overall Study|Lack of Efficacy|1
7920306|NCT02161406|12443753|FG000|Overall Study|relocation|0
7920307|NCT02161406|12443754|FG001|Overall Study|relocation|1
7920308|NCT02161458|12443764|FG000|Overall Study|Withdrawal by Subject|0
7920309|NCT02161458|12443765|FG001|Overall Study|Withdrawal by Subject|4
7920310|NCT02161458|12443766|FG002|Overall Study|Withdrawal by Subject|4
7920311|NCT02161458|12443767|FG003|Overall Study|Withdrawal by Subject|0
7920312|NCT02161458|12443764|FG000|Overall Study|Lost to Follow-up|0
7920313|NCT02161458|12443765|FG001|Overall Study|Lost to Follow-up|2
7920314|NCT02161458|12443766|FG002|Overall Study|Lost to Follow-up|1
7920315|NCT02161458|12443767|FG003|Overall Study|Lost to Follow-up|0
7920316|NCT02161549|12443801|FG000|Overall Study|Physician Decision|6
7920317|NCT02161549|12443802|FG001|Overall Study|Physician Decision|2
7920318|NCT02161562|12443810|FG000|Overall Study|Withdrawal by Subject|5
7920319|NCT02161562|12443811|FG001|Overall Study|Withdrawal by Subject|8
7920320|NCT02161562|12443810|FG000|Overall Study|Protocol Violation|9
7920321|NCT02161562|12443811|FG001|Overall Study|Protocol Violation|4
7920322|NCT02161562|12443810|FG000|Overall Study|Pregnancy|1
7920323|NCT02161562|12443811|FG001|Overall Study|Pregnancy|2
7920324|NCT02161562|12443810|FG000|Overall Study|Lost to Follow-up|3
7920325|NCT02161562|12443811|FG001|Overall Study|Lost to Follow-up|1
7920326|NCT02161562|12443810|FG000|Overall Study|Lack of Efficacy|4
7920327|NCT02161562|12443811|FG001|Overall Study|Lack of Efficacy|1
7920328|NCT02161562|12443810|FG000|Overall Study|Adverse Event|1
7920329|NCT02161562|12443811|FG001|Overall Study|Adverse Event|1
7920330|NCT02161562|12443810|FG000|Overall Study|Participant moved back to home country|1
7920331|NCT02161562|12443811|FG001|Overall Study|Participant moved back to home country|0
7920332|NCT02161562|12443810|FG000|Overall Study|Withdrew due to being out of the country|1
7920333|NCT02161562|12443811|FG001|Overall Study|Withdrew due to being out of the country|0
7920334|NCT02161562|12443810|FG000|Overall Study|Participant moved out of province|1
7920335|NCT02161562|12443811|FG001|Overall Study|Participant moved out of province|0
7920336|NCT02161575|12443830|FG000|Overall Study|Protocol Violation|8
7920337|NCT02161575|12443830|FG000|Overall Study|Lack of Efficacy|1
7920338|NCT02161575|12443830|FG000|Overall Study|Adverse Event|2
7920339|NCT02161718|12443845|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2
7920340|NCT02161718|12443846|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0
7920341|NCT02161718|12443847|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0
7920342|NCT02161718|12443845|FG000|Open-Label ALKS 3831 Period|Physician Decision|1
7920343|NCT02161718|12443846|FG001|Open-Label ALKS 3831 Period|Physician Decision|0
7920344|NCT02161718|12443847|FG002|Open-Label ALKS 3831 Period|Physician Decision|0
7920345|NCT02161718|12443845|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1
7920346|NCT02161718|12443846|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0
7920347|NCT02161718|12443847|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0
7920348|NCT02161718|12443845|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1
7920349|NCT02161718|12443846|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0
7920350|NCT02161718|12443847|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0
7920351|NCT02161718|12443845|FG000|Open-Label ALKS 3831 Period|Adverse Event|3
7920352|NCT02161718|12443846|FG001|Open-Label ALKS 3831 Period|Adverse Event|0
7920353|NCT02161718|12443847|FG002|Open-Label ALKS 3831 Period|Adverse Event|0
7920354|NCT02161718|12443845|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4
7920355|NCT02161718|12443846|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0
7920356|NCT02161718|12443847|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0
7920357|NCT02161718|12443845|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3
7920358|NCT02161718|12443846|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0
7920359|NCT02161718|12443847|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0
7920360|NCT02161718|12443845|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6
7920361|NCT02161718|12443846|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0
7920362|NCT02161718|12443847|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0
7920363|NCT02161718|12443845|FG000|Post- Randomization Period|Withdrawal by Subject|0
7920364|NCT02161718|12443846|FG001|Post- Randomization Period|Withdrawal by Subject|23
7920365|NCT02161718|12443847|FG002|Post- Randomization Period|Withdrawal by Subject|18
7920366|NCT02161718|12443845|FG000|Post- Randomization Period|Lost to Follow-up|0
7920367|NCT02161718|12443846|FG001|Post- Randomization Period|Lost to Follow-up|9
7920368|NCT02161718|12443847|FG002|Post- Randomization Period|Lost to Follow-up|15
7920369|NCT02161718|12443845|FG000|Post- Randomization Period|Adverse Event|0
7920370|NCT02161718|12443846|FG001|Post- Randomization Period|Adverse Event|9
7920371|NCT02161718|12443847|FG002|Post- Randomization Period|Adverse Event|10
7920372|NCT02161718|12443845|FG000|Post- Randomization Period|Non- compliance with study drug|0
7920373|NCT02161718|12443846|FG001|Post- Randomization Period|Non- compliance with study drug|8
7920374|NCT02161718|12443847|FG002|Post- Randomization Period|Non- compliance with study drug|2
7920375|NCT02161718|12443845|FG000|Post- Randomization Period|Physician Decision|0
7920376|NCT02161718|12443846|FG001|Post- Randomization Period|Physician Decision|2
7920377|NCT02161718|12443847|FG002|Post- Randomization Period|Physician Decision|4
7964400|NCT02120469|12519918|FG001|Overall Study|HER-2/neu-amplified|0
7964401|NCT02120469|12519919|FG002|Overall Study|HER-2/neu-amplified|1
7964402|NCT02109744|12519932|FG000|Overall Study|Death|1
7964403|NCT02109744|12519933|FG001|Overall Study|Death|1
7964404|NCT02109744|12519932|FG000|Overall Study|no marrow exam|1
7964405|NCT02109744|12519933|FG001|Overall Study|no marrow exam|0
7964406|NCT02008396|12519941|FG000|Overall Study|Protocol Violation|0
7964407|NCT02008396|12519942|FG001|Overall Study|Protocol Violation|1
7964408|NCT02000622|12519951|FG000|Overall Study|Withdrawal by Subject|5
7964409|NCT02000622|12519952|FG001|Overall Study|Withdrawal by Subject|7
7920378|NCT02161718|12443845|FG000|Post- Randomization Period|Protocol Violation|0
7920379|NCT02161718|12443846|FG001|Post- Randomization Period|Protocol Violation|2
7920380|NCT02161718|12443847|FG002|Post- Randomization Period|Protocol Violation|3
7920381|NCT02161718|12443845|FG000|Post- Randomization Period|Lack of Efficacy|0
7920382|NCT02161718|12443846|FG001|Post- Randomization Period|Lack of Efficacy|0
7920383|NCT02161718|12443847|FG002|Post- Randomization Period|Lack of Efficacy|1
7920384|NCT02161718|12443845|FG000|Post- Randomization Period|Non-compliance with study procedures|0
7920385|NCT02161718|12443846|FG001|Post- Randomization Period|Non-compliance with study procedures|2
7920386|NCT02161718|12443847|FG002|Post- Randomization Period|Non-compliance with study procedures|4
7920387|NCT02161718|12443845|FG000|Post- Randomization Period|Received prohibitive treatment|0
7920388|NCT02161718|12443846|FG001|Post- Randomization Period|Received prohibitive treatment|1
7920389|NCT02161718|12443847|FG002|Post- Randomization Period|Received prohibitive treatment|2
7920390|NCT02161718|12443845|FG000|Post- Randomization Period|Relocation|0
7920391|NCT02161718|12443846|FG001|Post- Randomization Period|Relocation|3
7920392|NCT02161718|12443847|FG002|Post- Randomization Period|Relocation|0
7920393|NCT02161731|12443854|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
7920394|NCT02161731|12443855|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
7920395|NCT02161731|12443854|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
7920396|NCT02161731|12443855|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
7920397|NCT02161757|12443865|FG000|Randomised Through Start Treatment|Did not receive treatment|3
7920398|NCT02161757|12443866|FG001|Randomised Through Start Treatment|Did not receive treatment|2
7920399|NCT02161757|12443867|FG002|Randomised Through Start Treatment|Did not receive treatment|0
7920400|NCT02161757|12443865|FG000|Treatment Through Study Completion|Adverse Event|1
7920401|NCT02161757|12443866|FG001|Treatment Through Study Completion|Adverse Event|1
7920402|NCT02161757|12443867|FG002|Treatment Through Study Completion|Adverse Event|0
7920403|NCT02161757|12443865|FG000|Treatment Through Study Completion|Protocol Violation|0
7920404|NCT02161757|12443866|FG001|Treatment Through Study Completion|Protocol Violation|1
7920405|NCT02161757|12443867|FG002|Treatment Through Study Completion|Protocol Violation|2
7920406|NCT02161757|12443865|FG000|Treatment Through Study Completion|Withdrawal by Subject|27
7920407|NCT02161757|12443866|FG001|Treatment Through Study Completion|Withdrawal by Subject|19
7920408|NCT02161757|12443867|FG002|Treatment Through Study Completion|Withdrawal by Subject|20
7920409|NCT02161757|12443865|FG000|Treatment Through Study Completion|Lost to Follow-up|7
7920410|NCT02161757|12443866|FG001|Treatment Through Study Completion|Lost to Follow-up|2
7920411|NCT02161757|12443867|FG002|Treatment Through Study Completion|Lost to Follow-up|4
7920412|NCT02161757|12443865|FG000|Treatment Through Study Completion|Other|20
7920413|NCT02161757|12443866|FG001|Treatment Through Study Completion|Other|19
7920414|NCT02161757|12443867|FG002|Treatment Through Study Completion|Other|12
7920415|NCT02161757|12443865|FG000|Treatment Through Study Completion|Death|2
7920416|NCT02161757|12443866|FG001|Treatment Through Study Completion|Death|1
7920417|NCT02161757|12443867|FG002|Treatment Through Study Completion|Death|1
7920418|NCT02162719|12443921|FG000|Overall Study|Death|41
7920419|NCT02162719|12443922|FG001|Overall Study|Death|46
7920420|NCT02162719|12443921|FG000|Overall Study|Lost to Follow-up|1
7920421|NCT02162719|12443922|FG001|Overall Study|Lost to Follow-up|3
7920422|NCT02162719|12443921|FG000|Overall Study|Disease Progression|2
7920423|NCT02162719|12443922|FG001|Overall Study|Disease Progression|1
7920424|NCT02162719|12443921|FG000|Overall Study|Withdrawal by Subject|8
7920425|NCT02162719|12443922|FG001|Overall Study|Withdrawal by Subject|2
7920426|NCT02162719|12443921|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10
7920427|NCT02162719|12443922|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10
7920428|NCT02162758|12443930|FG000|Overall Study|Study termination|0
7920429|NCT02162758|12443931|FG001|Overall Study|Study termination|1
7920430|NCT02162771|12443939|FG000|Core Study Period (Part 2)|Progressive Disease|2
7920431|NCT02162771|12443940|FG001|Core Study Period (Part 2)|Progressive Disease|3
7920432|NCT02162771|12443939|FG000|Core Study Period (Part 2)|Adverse Event|4
7920433|NCT02162771|12443940|FG001|Core Study Period (Part 2)|Adverse Event|1
7920434|NCT02162771|12443939|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1
7920435|NCT02162771|12443940|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2
7920436|NCT02162771|12443939|FG000|Core Study Period (Part 2)|Physician Decision|0
7920437|NCT02162771|12443940|FG001|Core Study Period (Part 2)|Physician Decision|2
7920438|NCT02162771|12443939|FG000|Core Study Period (Part 2)|Death|1
7920439|NCT02162771|12443940|FG001|Core Study Period (Part 2)|Death|0
7920440|NCT02162771|12443939|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11
7920441|NCT02162771|12443940|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13
7920442|NCT02162771|12443939|FG000|Maintenance Study Period (Part 2)|Adverse Event|3
7920443|NCT02162771|12443940|FG001|Maintenance Study Period (Part 2)|Adverse Event|3
7920444|NCT02162771|12443939|FG000|Maintenance Study Period (Part 2)|Death|2
7920445|NCT02162771|12443940|FG001|Maintenance Study Period (Part 2)|Death|1
7920446|NCT02162771|12443939|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0
7920447|NCT02162771|12443940|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3
7920448|NCT02162771|12443939|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0
7920449|NCT02162771|12443940|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1
7920450|NCT02162771|12443939|FG000|Maintenance Study Period (Part 2)|Stable Disease|0
7920451|NCT02162771|12443940|FG001|Maintenance Study Period (Part 2)|Stable Disease|1
7920452|NCT02162862|12443949|FG000|Overall Study|Lost to Follow-up|0
7920453|NCT02162862|12443950|FG001|Overall Study|Lost to Follow-up|11
7920454|NCT02162862|12443951|FG002|Overall Study|Lost to Follow-up|0
7920455|NCT02162862|12443949|FG000|Overall Study|Subject did not feel the med was needed|0
7920456|NCT02162862|12443950|FG001|Overall Study|Subject did not feel the med was needed|0
7920457|NCT02162862|12443951|FG002|Overall Study|Subject did not feel the med was needed|4
7920458|NCT02163057|12443972|FG000|Overall Study|Participant Refusal to Continue|2
7920459|NCT02163057|12443973|FG001|Overall Study|Participant Refusal to Continue|2
7920460|NCT02163057|12443972|FG000|Overall Study|Participant Significant Noncompliance|0
7920461|NCT02163057|12443973|FG001|Overall Study|Participant Significant Noncompliance|1
7920462|NCT02163057|12443972|FG000|Overall Study|Progression of Disease|1
7920463|NCT02163057|12443973|FG001|Overall Study|Progression of Disease|2
7920464|NCT02163226|12443983|FG000|Overall Study|Death|2
7920465|NCT02163226|12443984|FG001|Overall Study|Death|1
7920466|NCT02163226|12443983|FG000|Overall Study|Withdrawal by Subject|5
7920467|NCT02163226|12443984|FG001|Overall Study|Withdrawal by Subject|2
7920468|NCT02163226|12443983|FG000|Overall Study|Returned home, local radiotherapy|3
7920469|NCT02163226|12443984|FG001|Overall Study|Returned home, local radiotherapy|0
7920470|NCT02163226|12443983|FG000|Overall Study|Repeat imaging showed no disease|2
7920471|NCT02163226|12443984|FG001|Overall Study|Repeat imaging showed no disease|0
7920472|NCT02163226|12443983|FG000|Overall Study|Incomplete radiotherapy|3
7920473|NCT02163226|12443984|FG001|Overall Study|Incomplete radiotherapy|0
7920474|NCT02163226|12443983|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1
7920475|NCT02163226|12443984|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0
7920476|NCT02163226|12443983|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0
7920477|NCT02163226|12443984|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5
7920478|NCT02163226|12443983|FG000|Overall Study|ineligible|0
7920479|NCT02163226|12443984|FG001|Overall Study|ineligible|3
7920480|NCT02163447|12444016|FG000|Overall Study|Withdrawal by Subject|2
7920481|NCT02163447|12444017|FG001|Overall Study|Withdrawal by Subject|0
7920482|NCT02163447|12444018|FG002|Overall Study|Withdrawal by Subject|1
7920483|NCT02163447|12444016|FG000|Overall Study|Lost to Follow-up|1
7920484|NCT02163447|12444017|FG001|Overall Study|Lost to Follow-up|3
7920485|NCT02163447|12444018|FG002|Overall Study|Lost to Follow-up|0
7920486|NCT02163447|12444016|FG000|Overall Study|Moved out of study area|2
7920487|NCT02163447|12444017|FG001|Overall Study|Moved out of study area|3
7920488|NCT02163447|12444018|FG002|Overall Study|Moved out of study area|2
7920489|NCT02163447|12444016|FG000|Overall Study|Became HIV infected at time of delivery|1
7920490|NCT02163447|12444017|FG001|Overall Study|Became HIV infected at time of delivery|0
7920491|NCT02163447|12444018|FG002|Overall Study|Became HIV infected at time of delivery|0
7920492|NCT02163499|12444045|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1
7920493|NCT02163499|12444045|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
7920494|NCT02163499|12444045|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1
7920495|NCT02163499|12444045|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1
7920496|NCT02163499|12444045|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
7920497|NCT02163499|12444045|FG000|Extended Dosing Phase: ZS|Adverse Event|51
7920498|NCT02163499|12444045|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40
7920499|NCT02163499|12444045|FG000|Extended Dosing Phase: ZS|Hypokalemia|9
7920500|NCT02163499|12444045|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5
7920501|NCT02163499|12444045|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
7920502|NCT02163499|12444045|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81
7920503|NCT02163499|12444045|FG000|Extended Dosing Phase: ZS|Physician Decision|8
7920504|NCT02163499|12444045|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31
7920505|NCT02163499|12444045|FG000|Extended Dosing Phase: ZS|Protocol Violation|2
7920506|NCT02163499|12444045|FG000|Extended Dosing Phase: ZS|Death|8
7920507|NCT02163499|12444045|FG000|Extended Dosing Phase: ZS|Subject Compliance|17
7920508|NCT02163499|12444045|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5
7920509|NCT02163499|12444045|FG000|Extended Dosing Phase: ZS|Various reasons|16
7920510|NCT02163538|12444055|FG000|Overall Study|Protocol Violation|1
7920511|NCT02163538|12444056|FG001|Overall Study|Protocol Violation|0
7920512|NCT02163538|12444055|FG000|Overall Study|Physician Decision|0
7920513|NCT02163538|12444056|FG001|Overall Study|Physician Decision|1
7920514|NCT02163759|12444074|FG000|Overall Study|Withdrawal by Subject|1
7920515|NCT02163759|12444075|FG001|Overall Study|Withdrawal by Subject|5
7920516|NCT02163759|12444076|FG002|Overall Study|Withdrawal by Subject|1
7920517|NCT02163759|12444074|FG000|Overall Study|Adverse Event|0
7920518|NCT02163759|12444075|FG001|Overall Study|Adverse Event|0
7920519|NCT02163759|12444076|FG002|Overall Study|Adverse Event|1
7920520|NCT02163759|12444074|FG000|Overall Study|Death|0
7920521|NCT02163759|12444075|FG001|Overall Study|Death|0
7920522|NCT02163759|12444076|FG002|Overall Study|Death|1
7920523|NCT02163902|12444115|FG000|Overall Study|Subject's Request|3
7920524|NCT02163902|12444116|FG001|Overall Study|Subject's Request|4
7920525|NCT02163902|12444115|FG000|Overall Study|Lost to Follow-up|6
7920526|NCT02163902|12444116|FG001|Overall Study|Lost to Follow-up|7
7920527|NCT02163902|12444115|FG000|Overall Study|Administrative Decision|2
7920528|NCT02163902|12444116|FG001|Overall Study|Administrative Decision|2
7920529|NCT02163915|12444127|FG000|Overall Study|Withdrawal by Subject|2
7920530|NCT02163915|12444128|FG001|Overall Study|Withdrawal by Subject|0
7920531|NCT02163915|12444129|FG002|Overall Study|Withdrawal by Subject|2
7920532|NCT02163915|12444130|FG003|Overall Study|Withdrawal by Subject|2
7920533|NCT02163915|12444131|FG004|Overall Study|Withdrawal by Subject|2
7920534|NCT02163915|12444127|FG000|Overall Study|Study termination|1
7920535|NCT02163915|12444128|FG001|Overall Study|Study termination|0
7920536|NCT02163915|12444129|FG002|Overall Study|Study termination|0
7920537|NCT02163915|12444130|FG003|Overall Study|Study termination|0
7920538|NCT02163915|12444131|FG004|Overall Study|Study termination|2
7920539|NCT02163915|12444127|FG000|Overall Study|Physician Decision|0
7920540|NCT02163915|12444128|FG001|Overall Study|Physician Decision|0
7920541|NCT02163915|12444129|FG002|Overall Study|Physician Decision|0
7821588|NCT01256450|12290356|FG001|Open-label Titration|Lost to Follow-up|0
7821589|NCT01256450|12290357|FG002|Open-label Titration|Lost to Follow-up|0
7821590|NCT01256450|12290355|FG000|Open-label Titration|Lack of analgesic effect|30
7821591|NCT01256450|12290356|FG001|Open-label Titration|Lack of analgesic effect|0
7821592|NCT01256450|12290357|FG002|Open-label Titration|Lack of analgesic effect|0
7821593|NCT01256450|12290355|FG000|Open-label Titration|Non-compliance|9
7821594|NCT01256450|12290356|FG001|Open-label Titration|Non-compliance|0
7821595|NCT01256450|12290357|FG002|Open-label Titration|Non-compliance|0
7821596|NCT01256450|12290355|FG000|Open-label Titration|Screen failure|1
7821597|NCT01256450|12290356|FG001|Open-label Titration|Screen failure|0
7821598|NCT01256450|12290357|FG002|Open-label Titration|Screen failure|0
7821599|NCT01256450|12290355|FG000|Open-label Titration|Other|13
7821600|NCT01256450|12290356|FG001|Open-label Titration|Other|0
7821601|NCT01256450|12290357|FG002|Open-label Titration|Other|0
7821602|NCT01256450|12290355|FG000|Double-blind Treatment|Adverse Event|0
7821603|NCT01256450|12290356|FG001|Double-blind Treatment|Adverse Event|8
7821604|NCT01256450|12290357|FG002|Double-blind Treatment|Adverse Event|6
7821605|NCT01256450|12290355|FG000|Double-blind Treatment|Lost to Follow-up|0
7821606|NCT01256450|12290356|FG001|Double-blind Treatment|Lost to Follow-up|1
7821607|NCT01256450|12290357|FG002|Double-blind Treatment|Lost to Follow-up|7
7821608|NCT01256450|12290355|FG000|Double-blind Treatment|Withdrawal by Subject|0
7821609|NCT01256450|12290356|FG001|Double-blind Treatment|Withdrawal by Subject|0
7821610|NCT01256450|12290357|FG002|Double-blind Treatment|Withdrawal by Subject|1
7821611|NCT01256450|12290355|FG000|Double-blind Treatment|Lack of analgesic effect|0
7821612|NCT01256450|12290356|FG001|Double-blind Treatment|Lack of analgesic effect|5
7821613|NCT01256450|12290357|FG002|Double-blind Treatment|Lack of analgesic effect|6
7821614|NCT01256450|12290355|FG000|Double-blind Treatment|Non-compliance|0
7821615|NCT01256450|12290356|FG001|Double-blind Treatment|Non-compliance|5
7821616|NCT01256450|12290357|FG002|Double-blind Treatment|Non-compliance|4
7821617|NCT01256450|12290355|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0
7821618|NCT01256450|12290356|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0
7821619|NCT01256450|12290357|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1
7821620|NCT01256450|12290355|FG000|Double-blind Treatment|Other|0
7821621|NCT01256450|12290356|FG001|Double-blind Treatment|Other|9
7821622|NCT01256450|12290357|FG002|Double-blind Treatment|Other|12
7821623|NCT01256476|12290366|FG000|Overall Study|Adverse Event|2
7821624|NCT01256476|12290367|FG001|Overall Study|Adverse Event|1
7821625|NCT01256476|12290366|FG000|Overall Study|Withdrawal by Subject|2
7821626|NCT01256476|12290367|FG001|Overall Study|Withdrawal by Subject|1
7821627|NCT01256476|12290366|FG000|Overall Study|Lost to Follow-up|1
7821628|NCT01256476|12290367|FG001|Overall Study|Lost to Follow-up|2
7821629|NCT01256476|12290366|FG000|Overall Study|Persistent ALT or AST elevation|1
7821630|NCT01256476|12290367|FG001|Overall Study|Persistent ALT or AST elevation|0
7821631|NCT01256476|12290366|FG000|Overall Study|Physician Decision|0
7821632|NCT01256476|12290367|FG001|Overall Study|Physician Decision|1
7821633|NCT01256476|12290366|FG000|Overall Study|Subject non-compliance|0
7821634|NCT01256476|12290367|FG001|Overall Study|Subject non-compliance|1
7821635|NCT01256476|12290366|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
7821636|NCT01256476|12290367|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
7821637|NCT01256502|12290373|FG000|Overall Study|Had scaffold removed|4
7821638|NCT01256502|12290373|FG000|Overall Study|Personal reasons|5
7821639|NCT01256502|12290373|FG000|Overall Study|Protocol deviation|1
7821640|NCT01256567|12290382|FG000|Overall Study|Withdrawal by Subject|1
7821641|NCT01256593|12290387|FG000|Overall Study|Protocol Violation|26
7821642|NCT01256593|12290387|FG000|Overall Study|No Drug Administration Information|2
7821643|NCT01256593|12290387|FG000|Overall Study|No Visit After Treatment|186
7821644|NCT01256658|12290393|FG000|Period 1|Lost to Follow-up|837
7821645|NCT01256658|12290394|FG001|Period 1|Lost to Follow-up|661
7821646|NCT01256658|12290393|FG000|Period 1|Withdrawal by Subject|35
7821647|NCT01256658|12290394|FG001|Period 1|Withdrawal by Subject|43
7821648|NCT01256658|12290393|FG000|Period 1|Death|48
7821649|NCT01256658|12290394|FG001|Period 1|Death|44
7920542|NCT02163915|12444130|FG003|Overall Study|Physician Decision|1
7920543|NCT02163915|12444131|FG004|Overall Study|Physician Decision|0
7821650|NCT01256671|12290403|FG000|Overall Study|Adverse Event|29
7821651|NCT01256671|12290403|FG000|Overall Study|Lost to Follow-up|16
7821652|NCT01256671|12290403|FG000|Overall Study|Withdrawal by Subject|31
7821653|NCT01256671|12290403|FG000|Overall Study|Physician Decision|3
7821654|NCT01256671|12290403|FG000|Overall Study|Lack of Efficacy|4
7821655|NCT01256671|12290403|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12
7821656|NCT01256684|12290410|FG000|Overall Study|Adverse Event|1
7821657|NCT01256684|12290411|FG001|Overall Study|Adverse Event|4
7821658|NCT01256684|12290412|FG002|Overall Study|Adverse Event|2
7920544|NCT02163993|12444168|FG000|Treatment Period|Adverse Event|0
7920545|NCT02163993|12444169|FG001|Treatment Period|Adverse Event|1
7920546|NCT02163993|12444170|FG002|Treatment Period|Adverse Event|0
7920547|NCT02163993|12444171|FG003|Treatment Period|Adverse Event|0
7920548|NCT02163993|12444172|FG004|Treatment Period|Adverse Event|1
7920549|NCT02163993|12444168|FG000|Treatment Period|Lost to Follow-up|2
7920550|NCT02163993|12444169|FG001|Treatment Period|Lost to Follow-up|3
7920551|NCT02163993|12444170|FG002|Treatment Period|Lost to Follow-up|1
7920552|NCT02163993|12444171|FG003|Treatment Period|Lost to Follow-up|3
7920553|NCT02163993|12444172|FG004|Treatment Period|Lost to Follow-up|1
7920554|NCT02163993|12444168|FG000|Treatment Period|Physician Decision|1
7920555|NCT02163993|12444169|FG001|Treatment Period|Physician Decision|0
7920556|NCT02163993|12444170|FG002|Treatment Period|Physician Decision|0
7920557|NCT02163993|12444171|FG003|Treatment Period|Physician Decision|0
7920558|NCT02163993|12444172|FG004|Treatment Period|Physician Decision|0
7920559|NCT02163993|12444168|FG000|Treatment Period|Protocol Violation|2
7920560|NCT02163993|12444169|FG001|Treatment Period|Protocol Violation|1
7920561|NCT02163993|12444170|FG002|Treatment Period|Protocol Violation|0
7920562|NCT02163993|12444171|FG003|Treatment Period|Protocol Violation|1
7920563|NCT02163993|12444172|FG004|Treatment Period|Protocol Violation|2
7821659|NCT01256684|12290410|FG000|Overall Study|Withdrawal by Subject|4
7821660|NCT01256684|12290411|FG001|Overall Study|Withdrawal by Subject|0
7920564|NCT02163993|12444168|FG000|Treatment Period|Withdrawal by Subject|6
7920565|NCT02163993|12444169|FG001|Treatment Period|Withdrawal by Subject|4
7920566|NCT02163993|12444170|FG002|Treatment Period|Withdrawal by Subject|1
7920567|NCT02163993|12444171|FG003|Treatment Period|Withdrawal by Subject|4
7920568|NCT02163993|12444172|FG004|Treatment Period|Withdrawal by Subject|1
7920569|NCT02163993|12444168|FG000|Treatment Period|Not treated|1
7920570|NCT02163993|12444169|FG001|Treatment Period|Not treated|0
7920571|NCT02163993|12444170|FG002|Treatment Period|Not treated|0
7920572|NCT02163993|12444171|FG003|Treatment Period|Not treated|1
7920573|NCT02163993|12444172|FG004|Treatment Period|Not treated|2
7920574|NCT02163993|12444168|FG000|Post-treatment Period|Adverse Event|0
7920575|NCT02163993|12444169|FG001|Post-treatment Period|Adverse Event|0
7920576|NCT02163993|12444170|FG002|Post-treatment Period|Adverse Event|1
7920577|NCT02163993|12444171|FG003|Post-treatment Period|Adverse Event|0
7920578|NCT02163993|12444172|FG004|Post-treatment Period|Adverse Event|0
7920579|NCT02163993|12444168|FG000|Post-treatment Period|Lost to Follow-up|2
7920580|NCT02163993|12444169|FG001|Post-treatment Period|Lost to Follow-up|2
7920581|NCT02163993|12444170|FG002|Post-treatment Period|Lost to Follow-up|3
7920582|NCT02163993|12444171|FG003|Post-treatment Period|Lost to Follow-up|1
7920583|NCT02163993|12444172|FG004|Post-treatment Period|Lost to Follow-up|0
7920584|NCT02163993|12444168|FG000|Post-treatment Period|Protocol Violation|0
7920585|NCT02163993|12444169|FG001|Post-treatment Period|Protocol Violation|0
7920586|NCT02163993|12444170|FG002|Post-treatment Period|Protocol Violation|0
7920587|NCT02163993|12444171|FG003|Post-treatment Period|Protocol Violation|0
7821661|NCT01256684|12290412|FG002|Overall Study|Withdrawal by Subject|2
7920588|NCT02163993|12444172|FG004|Post-treatment Period|Protocol Violation|1
7920589|NCT02163993|12444168|FG000|Post-treatment Period|Withdrawal by Subject|2
7920590|NCT02163993|12444169|FG001|Post-treatment Period|Withdrawal by Subject|4
7920591|NCT02163993|12444170|FG002|Post-treatment Period|Withdrawal by Subject|0
7821662|NCT01256684|12290410|FG000|Overall Study|Physician Decision|0
7821663|NCT01256684|12290411|FG001|Overall Study|Physician Decision|1
7920592|NCT02163993|12444171|FG003|Post-treatment Period|Withdrawal by Subject|1
7920593|NCT02163993|12444172|FG004|Post-treatment Period|Withdrawal by Subject|2
7920594|NCT02164318|12444208|FG000|Overall Study|Withdrawal by Subject|0
7920595|NCT02164318|12444209|FG001|Overall Study|Withdrawal by Subject|1
7920596|NCT02164318|12444210|FG002|Overall Study|Withdrawal by Subject|0
7920597|NCT02164318|12444211|FG003|Overall Study|Withdrawal by Subject|1
7920598|NCT02164383|12444223|FG000|Overall Study|Lost to Follow-up|1
7920599|NCT02164383|12444224|FG001|Overall Study|Lost to Follow-up|0
7920600|NCT02164513|12444259|FG000|Overall Study|Adverse Event|162
7920601|NCT02164513|12444260|FG001|Overall Study|Adverse Event|180
7920602|NCT02164513|12444261|FG002|Overall Study|Adverse Event|111
7920603|NCT02164513|12444259|FG000|Overall Study|Other: Study Closed or terminated|5
7920604|NCT02164513|12444260|FG001|Overall Study|Other: Study Closed or terminated|2
7920605|NCT02164513|12444261|FG002|Overall Study|Other: Study Closed or terminated|4
7920606|NCT02164513|12444259|FG000|Overall Study|Lost to Follow-up|30
7920607|NCT02164513|12444260|FG001|Overall Study|Lost to Follow-up|36
7920608|NCT02164513|12444261|FG002|Overall Study|Lost to Follow-up|22
7920609|NCT02164513|12444259|FG000|Overall Study|Physician Decision|47
7920610|NCT02164513|12444260|FG001|Overall Study|Physician Decision|57
7920611|NCT02164513|12444261|FG002|Overall Study|Physician Decision|28
7920612|NCT02164513|12444259|FG000|Overall Study|Withdrawal by Subject|192
7920613|NCT02164513|12444260|FG001|Overall Study|Withdrawal by Subject|261
7920614|NCT02164513|12444261|FG002|Overall Study|Withdrawal by Subject|130
7920615|NCT02164513|12444259|FG000|Overall Study|Other: Reason not provided by site|1
7920616|NCT02164513|12444260|FG001|Overall Study|Other: Reason not provided by site|0
7920617|NCT02164513|12444261|FG002|Overall Study|Other: Reason not provided by site|0
7920618|NCT02164539|12444276|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
7920619|NCT02164539|12444277|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
7920620|NCT02164539|12444278|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
7920621|NCT02164539|12444279|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
7920622|NCT02164539|12444280|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
7920623|NCT02164539|12444281|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
7964410|NCT02000622|12519951|FG000|Overall Study|Lost to Follow-up|4
7920624|NCT02164539|12444282|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
7920625|NCT02164539|12444276|FG000|Treatment Phase B (1 Week)|Adverse Event|0
7920626|NCT02164539|12444277|FG001|Treatment Phase B (1 Week)|Adverse Event|0
7920627|NCT02164539|12444278|FG002|Treatment Phase B (1 Week)|Adverse Event|0
7920628|NCT02164539|12444279|FG003|Treatment Phase B (1 Week)|Adverse Event|0
7920629|NCT02164539|12444280|FG004|Treatment Phase B (1 Week)|Adverse Event|2
7920630|NCT02164539|12444281|FG005|Treatment Phase B (1 Week)|Adverse Event|0
7920631|NCT02164539|12444282|FG006|Treatment Phase B (1 Week)|Adverse Event|0
7920632|NCT02164539|12444276|FG000|Treatment Phase B (1 Week)|Physician Decision|0
7920633|NCT02164539|12444277|FG001|Treatment Phase B (1 Week)|Physician Decision|0
7920634|NCT02164539|12444278|FG002|Treatment Phase B (1 Week)|Physician Decision|0
7920635|NCT02164539|12444279|FG003|Treatment Phase B (1 Week)|Physician Decision|0
7920636|NCT02164539|12444280|FG004|Treatment Phase B (1 Week)|Physician Decision|1
7920637|NCT02164539|12444281|FG005|Treatment Phase B (1 Week)|Physician Decision|0
7920638|NCT02164539|12444282|FG006|Treatment Phase B (1 Week)|Physician Decision|1
7920639|NCT02164539|12444276|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1
7920640|NCT02164539|12444277|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7920641|NCT02164539|12444278|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7920642|NCT02164539|12444279|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7920643|NCT02164539|12444280|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7920644|NCT02164539|12444281|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7920645|NCT02164539|12444282|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7920646|NCT02164539|12444276|FG000|Treatment Phase C (1 Week)|Adverse Event|0
7920647|NCT02164539|12444277|FG001|Treatment Phase C (1 Week)|Adverse Event|0
7920648|NCT02164539|12444278|FG002|Treatment Phase C (1 Week)|Adverse Event|0
7920649|NCT02164539|12444279|FG003|Treatment Phase C (1 Week)|Adverse Event|0
7920650|NCT02164539|12444280|FG004|Treatment Phase C (1 Week)|Adverse Event|0
7920651|NCT02164539|12444281|FG005|Treatment Phase C (1 Week)|Adverse Event|0
7920652|NCT02164539|12444282|FG006|Treatment Phase C (1 Week)|Adverse Event|1
7920653|NCT02164539|12444276|FG000|Treatment Phase C (1 Week)|Physician Decision|0
7920654|NCT02164539|12444277|FG001|Treatment Phase C (1 Week)|Physician Decision|0
7920655|NCT02164539|12444278|FG002|Treatment Phase C (1 Week)|Physician Decision|0
7920656|NCT02164539|12444279|FG003|Treatment Phase C (1 Week)|Physician Decision|0
7920657|NCT02164539|12444280|FG004|Treatment Phase C (1 Week)|Physician Decision|0
7920658|NCT02164539|12444281|FG005|Treatment Phase C (1 Week)|Physician Decision|0
7920659|NCT02164539|12444282|FG006|Treatment Phase C (1 Week)|Physician Decision|1
7920660|NCT02164864|12444305|FG000|Overall Study|Trial disease worsening|7
7920661|NCT02164864|12444306|FG001|Overall Study|Trial disease worsening|5
7920662|NCT02164864|12444307|FG002|Overall Study|Trial disease worsening|1
7920663|NCT02164864|12444305|FG000|Overall Study|Other pre-existing disease worsening|6
7920664|NCT02164864|12444306|FG001|Overall Study|Other pre-existing disease worsening|4
7920665|NCT02164864|12444307|FG002|Overall Study|Other pre-existing disease worsening|9
7920666|NCT02164864|12444305|FG000|Overall Study|Other Adverse Event (AE)|52
7920667|NCT02164864|12444306|FG001|Overall Study|Other Adverse Event (AE)|32
7920668|NCT02164864|12444307|FG002|Overall Study|Other Adverse Event (AE)|49
7920669|NCT02164864|12444305|FG000|Overall Study|Protocol Violation|2
7920670|NCT02164864|12444306|FG001|Overall Study|Protocol Violation|4
7920671|NCT02164864|12444307|FG002|Overall Study|Protocol Violation|1
7920672|NCT02164864|12444305|FG000|Overall Study|Lost to Follow-up|4
7821664|NCT01256684|12290412|FG002|Overall Study|Physician Decision|0
7821665|NCT01256684|12290410|FG000|Overall Study|Lack of Efficacy|0
7920673|NCT02164864|12444306|FG001|Overall Study|Lost to Follow-up|3
7821666|NCT01256684|12290411|FG001|Overall Study|Lack of Efficacy|1
7821667|NCT01256684|12290412|FG002|Overall Study|Lack of Efficacy|1
7821668|NCT01256684|12290410|FG000|Overall Study|Entry criteria not met/non-compliance|4
7821669|NCT01256684|12290411|FG001|Overall Study|Entry criteria not met/non-compliance|7
7821670|NCT01256684|12290412|FG002|Overall Study|Entry criteria not met/non-compliance|6
7821671|NCT01256788|12290423|FG000|Overall Study|Lost to Follow-up|5
7821672|NCT01256788|12290424|FG001|Overall Study|Lost to Follow-up|8
7821673|NCT01256788|12290425|FG002|Overall Study|Lost to Follow-up|3
7821674|NCT01256879|12290446|FG000|Overall Study|Withdrawal by Subject|1
7821675|NCT01257204|12290501|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0
7821676|NCT01257204|12290502|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1
7821677|NCT01257204|12290503|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3
7920674|NCT02164864|12444307|FG002|Overall Study|Lost to Follow-up|2
7920675|NCT02164864|12444305|FG000|Overall Study|Consent withdrawn, not due to AE|21
7920676|NCT02164864|12444306|FG001|Overall Study|Consent withdrawn, not due to AE|8
7920677|NCT02164864|12444307|FG002|Overall Study|Consent withdrawn, not due to AE|56
7920678|NCT02164864|12444305|FG000|Overall Study|Other than stated|3
7920679|NCT02164864|12444306|FG001|Overall Study|Other than stated|4
7920680|NCT02164864|12444307|FG002|Overall Study|Other than stated|14
7920681|NCT02164916|12444320|FG000|Overall Study|Adverse Event|3
7920682|NCT02164916|12444321|FG001|Overall Study|Adverse Event|8
7920683|NCT02164916|12444320|FG000|Overall Study|Death|1
7920684|NCT02164916|12444321|FG001|Overall Study|Death|1
7920685|NCT02164916|12444320|FG000|Overall Study|Refusal unrelated to adverse event|3
7920686|NCT02164916|12444321|FG001|Overall Study|Refusal unrelated to adverse event|7
7920687|NCT02164916|12444320|FG000|Overall Study|Progression|37
7920688|NCT02164916|12444321|FG001|Overall Study|Progression|26
7920689|NCT02164916|12444320|FG000|Overall Study|Not protocol specified|5
7920690|NCT02164916|12444321|FG001|Overall Study|Not protocol specified|1
7920691|NCT02164916|12444320|FG000|Overall Study|Reason under review|1
7920692|NCT02164916|12444321|FG001|Overall Study|Reason under review|6
7920693|NCT02164916|12444320|FG000|Overall Study|Not eligible|2
7920694|NCT02164916|12444321|FG001|Overall Study|Not eligible|5
7920695|NCT02164929|12444336|FG000|Overall Study|Converted to open procedure|1
7920696|NCT02164929|12444337|FG001|Overall Study|Converted to open procedure|0
7920697|NCT02164929|12444338|FG002|Overall Study|Converted to open procedure|0
7920698|NCT02164929|12444339|FG003|Overall Study|Converted to open procedure|2
7920699|NCT02164929|12444336|FG000|Overall Study|Failed regional block|0
7920700|NCT02164929|12444337|FG001|Overall Study|Failed regional block|0
7920701|NCT02164929|12444338|FG002|Overall Study|Failed regional block|1
7920702|NCT02164929|12444339|FG003|Overall Study|Failed regional block|0
7964411|NCT02000622|12519952|FG001|Overall Study|Lost to Follow-up|0
7964412|NCT02000622|12519951|FG000|Overall Study|Death|159
7964413|NCT02000622|12519952|FG001|Overall Study|Death|73
7964414|NCT02000622|12519951|FG000|Overall Study|Withdrawn due to site closure|1
7821678|NCT01257204|12290501|FG000|Treatment Period (up to Week 24)|Adverse Event|3
7821679|NCT01257204|12290502|FG001|Treatment Period (up to Week 24)|Adverse Event|1
7964415|NCT02000622|12519952|FG001|Overall Study|Withdrawn due to site closure|0
7964416|NCT01940341|12519969|FG000|Double-Blind Phase|Randomized but Never Treated|0
7964417|NCT01940341|12519970|FG001|Double-Blind Phase|Randomized but Never Treated|1
7964418|NCT01940341|12519969|FG000|Double-Blind Phase|Adverse Event|3
7964419|NCT01940341|12519970|FG001|Double-Blind Phase|Adverse Event|2
7964420|NCT01940341|12519969|FG000|Double-Blind Phase|Withdrew Consent|3
7964421|NCT01940341|12519970|FG001|Double-Blind Phase|Withdrew Consent|2
7964422|NCT01940341|12519969|FG000|Double-Blind Phase|Lost to Follow-up|4
7964423|NCT01940341|12519970|FG001|Double-Blind Phase|Lost to Follow-up|1
7964424|NCT01940341|12519969|FG000|Double-Blind Phase|Pregnancy|0
7964425|NCT01940341|12519970|FG001|Double-Blind Phase|Pregnancy|1
7964426|NCT01940341|12519969|FG000|Double-Blind Phase|Investigator's Discretion|1
7964427|NCT01940341|12519970|FG001|Double-Blind Phase|Investigator's Discretion|0
7964428|NCT01940341|12519969|FG000|Double-Blind Phase|Non-Compliance with Study Drug|0
7964429|NCT01940341|12519970|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
7821680|NCT01257204|12290503|FG002|Treatment Period (up to Week 24)|Adverse Event|2
7821681|NCT01257204|12290501|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1
7821682|NCT01257204|12290502|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0
7821683|NCT01257204|12290503|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1
7821684|NCT01257204|12290501|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0
7821685|NCT01257204|12290502|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2
7821686|NCT01257204|12290503|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0
7821687|NCT01257204|12290501|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
7821688|NCT01257204|12290502|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
7821689|NCT01257204|12290503|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
7821690|NCT01257204|12290501|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1
7821691|NCT01257204|12290502|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2
7920703|NCT02164981|12444352|FG000|Started|Withdrawal by Subject|2
7920704|NCT02164981|12444353|FG001|Started|Withdrawal by Subject|1
7920705|NCT02164981|12444354|FG002|Started|Withdrawal by Subject|0
7920706|NCT02164981|12444352|FG000|Started|Protocol Violation|2
7920707|NCT02164981|12444353|FG001|Started|Protocol Violation|0
7920708|NCT02164981|12444354|FG002|Started|Protocol Violation|0
7920709|NCT02164981|12444352|FG000|Started|Adverse Event|1
7821692|NCT01257204|12290503|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2
7821693|NCT01257204|12290501|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
7821694|NCT01257204|12290502|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
7821695|NCT01257204|12290503|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
7821696|NCT01257204|12290501|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1
7821697|NCT01257204|12290502|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4
7821698|NCT01257204|12290503|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4
7821699|NCT01257204|12290501|FG000|Follow-up Period (up to Week 48)|Other|0
7821700|NCT01257204|12290502|FG001|Follow-up Period (up to Week 48)|Other|0
7821701|NCT01257204|12290503|FG002|Follow-up Period (up to Week 48)|Other|5
7821702|NCT01257230|12290539|FG000|Overall Study|Not Treated|0
7821703|NCT01257230|12290540|FG001|Overall Study|Not Treated|0
7821704|NCT01257230|12290541|FG002|Overall Study|Not Treated|1
7821705|NCT01257230|12290539|FG000|Overall Study|Adverse Event|2
7821706|NCT01257230|12290540|FG001|Overall Study|Adverse Event|0
7821707|NCT01257230|12290541|FG002|Overall Study|Adverse Event|0
7821708|NCT01257230|12290539|FG000|Overall Study|Lack of Efficacy|0
7821709|NCT01257230|12290540|FG001|Overall Study|Lack of Efficacy|1
7821710|NCT01257230|12290541|FG002|Overall Study|Lack of Efficacy|0
7821711|NCT01257230|12290539|FG000|Overall Study|Protocol Violation|3
7920710|NCT02164981|12444353|FG001|Started|Adverse Event|2
7920711|NCT02164981|12444354|FG002|Started|Adverse Event|0
7920712|NCT02164981|12444352|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0
7920713|NCT02164981|12444353|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2
7920714|NCT02164981|12444354|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0
7920715|NCT02164981|12444352|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2
7920716|NCT02164981|12444353|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1
7920717|NCT02164981|12444354|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0
7920718|NCT02164981|12444352|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
7920719|NCT02164981|12444353|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
7920720|NCT02164981|12444354|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
7920721|NCT02165202|12444396|FG000|Oral Phase|Refused further participation|5
7920722|NCT02165202|12444397|FG001|Oral Phase|Refused further participation|1
7920723|NCT02165202|12444396|FG000|Oral Phase|Study product Related Toxicity|1
7920724|NCT02165202|12444397|FG001|Oral Phase|Study product Related Toxicity|0
7920725|NCT02165202|12444396|FG000|Oral Phase|Unable to contact Participant|1
7920726|NCT02165202|12444397|FG001|Oral Phase|Unable to contact Participant|1
7920727|NCT02165202|12444396|FG000|Oral Phase|Clinical reasons|1
7920728|NCT02165202|12444397|FG001|Oral Phase|Clinical reasons|0
7920729|NCT02165202|12444396|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1
7920730|NCT02165202|12444397|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0
7920731|NCT02165202|12444396|FG000|Oral Phase|CMC advised termination|1
7920732|NCT02165202|12444397|FG001|Oral Phase|CMC advised termination|0
7821712|NCT01257230|12290540|FG001|Overall Study|Protocol Violation|0
7920733|NCT02165202|12444396|FG000|Oral Phase|Relocated, no follow-up planned|1
7920734|NCT02165202|12444397|FG001|Oral Phase|Relocated, no follow-up planned|0
7920735|NCT02165202|12444396|FG000|Oral Phase|Abnormal EKG|0
7821713|NCT01257230|12290541|FG002|Overall Study|Protocol Violation|1
7821714|NCT01257230|12290539|FG000|Overall Study|Withdrawal by Subject|0
7821715|NCT01257230|12290540|FG001|Overall Study|Withdrawal by Subject|4
7821716|NCT01257230|12290541|FG002|Overall Study|Withdrawal by Subject|1
7821717|NCT01257230|12290539|FG000|Overall Study|Other reason not defined above|1
7821718|NCT01257230|12290540|FG001|Overall Study|Other reason not defined above|5
7821719|NCT01257230|12290541|FG002|Overall Study|Other reason not defined above|3
7821720|NCT01257425|12290572|FG000|Overall Study|Lack of Efficacy|3
7920736|NCT02165202|12444397|FG001|Oral Phase|Abnormal EKG|1
7920737|NCT02165202|12444396|FG000|Injection Phase|Abnormal Lab Value|5
7920738|NCT02165202|12444397|FG001|Injection Phase|Abnormal Lab Value|1
7920739|NCT02165202|12444396|FG000|Injection Phase|Reactive HIV or HIV Suspected|0
7920740|NCT02165202|12444397|FG001|Injection Phase|Reactive HIV or HIV Suspected|2
7920741|NCT02165202|12444396|FG000|Injection Phase|Unable to attend within Visit Window|1
7920742|NCT02165202|12444397|FG001|Injection Phase|Unable to attend within Visit Window|0
7920743|NCT02165202|12444396|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0
7920744|NCT02165202|12444397|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1
7920745|NCT02165202|12444396|FG000|Injection Phase|End of Study|2
7920746|NCT02165202|12444397|FG001|Injection Phase|End of Study|1
7920747|NCT02165202|12444396|FG000|Injection Phase|Study Product related Toxicity|1
7920748|NCT02165202|12444397|FG001|Injection Phase|Study Product related Toxicity|0
7920749|NCT02165202|12444396|FG000|Injection Phase|No longer interested|0
7920750|NCT02165202|12444397|FG001|Injection Phase|No longer interested|1
7920751|NCT02165202|12444396|FG000|Injection Phase|Participant unwilling to comply|1
7920752|NCT02165202|12444397|FG001|Injection Phase|Participant unwilling to comply|0
7920753|NCT02165397|12444410|FG000|Overall Study|Death|7
7920754|NCT02165397|12444411|FG001|Overall Study|Death|10
7920755|NCT02165397|12444412|FG002|Overall Study|Death|8
7920756|NCT02165397|12444410|FG000|Overall Study|Lost to Follow-up|1
7920757|NCT02165397|12444411|FG001|Overall Study|Lost to Follow-up|3
7920758|NCT02165397|12444412|FG002|Overall Study|Lost to Follow-up|0
7920759|NCT02165397|12444410|FG000|Overall Study|Withdrawal by Subject|6
7920760|NCT02165397|12444411|FG001|Overall Study|Withdrawal by Subject|6
7920761|NCT02165397|12444412|FG002|Overall Study|Withdrawal by Subject|1
7920762|NCT02165397|12444410|FG000|Overall Study|Other, Not Specified|0
7920763|NCT02165397|12444411|FG001|Overall Study|Other, Not Specified|0
7920764|NCT02165397|12444412|FG002|Overall Study|Other, Not Specified|1
7920765|NCT02165735|12444450|FG000|Overall Study|Lost to Follow-up|12
7920766|NCT02165735|12444451|FG001|Overall Study|Lost to Follow-up|10
7920767|NCT02165735|12444450|FG000|Overall Study|Withdrawal by Subject|3
7920768|NCT02165735|12444451|FG001|Overall Study|Withdrawal by Subject|0
7920769|NCT02165735|12444450|FG000|Overall Study|Participant indicated lack of time|1
7920770|NCT02165735|12444451|FG001|Overall Study|Participant indicated lack of time|3
7920771|NCT02165735|12444450|FG000|Overall Study|Protocol Violation|0
7920772|NCT02165735|12444451|FG001|Overall Study|Protocol Violation|1
7920773|NCT02165826|12444469|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44
7920774|NCT02165826|12444470|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57
7920775|NCT02165826|12444471|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68
7920776|NCT02165826|12444469|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0
7920777|NCT02165826|12444470|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1
7920778|NCT02165826|12444471|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3
7920779|NCT02165826|12444469|FG000|Main Treatment Period|Lost to Follow-up|4
7920780|NCT02165826|12444470|FG001|Main Treatment Period|Lost to Follow-up|2
7920781|NCT02165826|12444471|FG002|Main Treatment Period|Lost to Follow-up|1
7920782|NCT02165826|12444469|FG000|Main Treatment Period|Voluntary Withdrawal|23
7920783|NCT02165826|12444470|FG001|Main Treatment Period|Voluntary Withdrawal|23
7920784|NCT02165826|12444471|FG002|Main Treatment Period|Voluntary Withdrawal|21
7920785|NCT02165826|12444469|FG000|Main Treatment Period|Lack of Efficacy|2
7920786|NCT02165826|12444470|FG001|Main Treatment Period|Lack of Efficacy|0
7920787|NCT02165826|12444471|FG002|Main Treatment Period|Lack of Efficacy|0
7920788|NCT02165826|12444469|FG000|Main Treatment Period|Reason Not Specified|8
7920789|NCT02165826|12444470|FG001|Main Treatment Period|Reason Not Specified|5
7920790|NCT02165826|12444471|FG002|Main Treatment Period|Reason Not Specified|16
7920791|NCT02165826|12444469|FG000|Main Treatment Period|Did Not Receive Study Drug|0
7920792|NCT02165826|12444470|FG001|Main Treatment Period|Did Not Receive Study Drug|2
7920793|NCT02165826|12444471|FG002|Main Treatment Period|Did Not Receive Study Drug|0
7920794|NCT02165826|12444469|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4
7920795|NCT02165826|12444470|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10
7920796|NCT02165826|12444471|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3
7920797|NCT02165826|12444469|FG000|Down-Titration Period|Voluntary Withdrawal|2
7920798|NCT02165826|12444470|FG001|Down-Titration Period|Voluntary Withdrawal|1
7920799|NCT02165826|12444471|FG002|Down-Titration Period|Voluntary Withdrawal|2
7920800|NCT02165826|12444469|FG000|Down-Titration Period|Reason Not Specified|1
7920801|NCT02165826|12444470|FG001|Down-Titration Period|Reason Not Specified|0
7920802|NCT02165826|12444471|FG002|Down-Titration Period|Reason Not Specified|2
7920803|NCT02166047|12444522|FG000|Overall Study|Withdrawal by Participant|0
7920804|NCT02166047|12444523|FG001|Overall Study|Withdrawal by Participant|1
7920805|NCT02166047|12444524|FG002|Overall Study|Withdrawal by Participant|2
7920806|NCT02166047|12444525|FG003|Overall Study|Withdrawal by Participant|0
7920807|NCT02166047|12444526|FG004|Overall Study|Withdrawal by Participant|0
7920808|NCT02166047|12444527|FG005|Overall Study|Withdrawal by Participant|0
7920809|NCT02166047|12444528|FG006|Overall Study|Withdrawal by Participant|1
7920810|NCT02166047|12444529|FG007|Overall Study|Withdrawal by Participant|0
7920811|NCT02166047|12444530|FG008|Overall Study|Withdrawal by Participant|0
7920812|NCT02166047|12444531|FG009|Overall Study|Withdrawal by Participant|0
7920813|NCT02166047|12444532|FG010|Overall Study|Withdrawal by Participant|0
7920814|NCT02166047|12444533|FG011|Overall Study|Withdrawal by Participant|0
7920815|NCT02166047|12444522|FG000|Overall Study|Adverse Event|0
7920816|NCT02166047|12444523|FG001|Overall Study|Adverse Event|0
7920817|NCT02166047|12444524|FG002|Overall Study|Adverse Event|0
7920818|NCT02166047|12444525|FG003|Overall Study|Adverse Event|0
7920819|NCT02166047|12444526|FG004|Overall Study|Adverse Event|1
7920820|NCT02166047|12444527|FG005|Overall Study|Adverse Event|0
7920821|NCT02166047|12444528|FG006|Overall Study|Adverse Event|1
7920822|NCT02166047|12444529|FG007|Overall Study|Adverse Event|0
7920823|NCT02166047|12444530|FG008|Overall Study|Adverse Event|0
7920824|NCT02166047|12444531|FG009|Overall Study|Adverse Event|0
7920825|NCT02166047|12444532|FG010|Overall Study|Adverse Event|2
7920826|NCT02166047|12444533|FG011|Overall Study|Adverse Event|0
7920827|NCT02166333|12444563|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4
7920828|NCT02166333|12444564|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
7920829|NCT02166333|12444565|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
7920830|NCT02166333|12444566|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
7920831|NCT02166333|12444567|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3
7920832|NCT02166333|12444568|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1
7920833|NCT02166333|12444563|FG000|Stage 1|Death|4
7920834|NCT02166333|12444564|FG001|Stage 1|Death|0
7920835|NCT02166333|12444565|FG002|Stage 1|Death|2
7920836|NCT02166333|12444566|FG003|Stage 1|Death|0
7920837|NCT02166333|12444567|FG004|Stage 1|Death|3
7920838|NCT02166333|12444568|FG005|Stage 1|Death|2
7920839|NCT02166333|12444563|FG000|Stage 1|Lost to Follow-up|12
7920840|NCT02166333|12444564|FG001|Stage 1|Lost to Follow-up|0
7920841|NCT02166333|12444565|FG002|Stage 1|Lost to Follow-up|6
7920842|NCT02166333|12444566|FG003|Stage 1|Lost to Follow-up|0
7920843|NCT02166333|12444567|FG004|Stage 1|Lost to Follow-up|3
7920844|NCT02166333|12444568|FG005|Stage 1|Lost to Follow-up|3
7920845|NCT02166333|12444563|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180
7920846|NCT02166333|12444564|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0
7920847|NCT02166333|12444565|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63
7920848|NCT02166333|12444566|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0
7920849|NCT02166333|12444567|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54
7920850|NCT02166333|12444568|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52
7920851|NCT02166333|12444563|FG000|Stage 2|Death|4
7920852|NCT02166333|12444564|FG001|Stage 2|Death|2
7920853|NCT02166333|12444565|FG002|Stage 2|Death|1
7920854|NCT02166333|12444566|FG003|Stage 2|Death|0
7920855|NCT02166333|12444567|FG004|Stage 2|Death|0
7920856|NCT02166333|12444568|FG005|Stage 2|Death|1
7821721|NCT01257425|12290573|FG001|Overall Study|Lack of Efficacy|3
7821722|NCT01257425|12290572|FG000|Overall Study|Adverse Event|1
7821723|NCT01257425|12290573|FG001|Overall Study|Adverse Event|1
7821724|NCT01257425|12290572|FG000|Overall Study|Protocol Violation|1
7821725|NCT01257425|12290573|FG001|Overall Study|Protocol Violation|1
7821726|NCT01257425|12290572|FG000|Overall Study|Withdrawal by Subject|0
7821727|NCT01257425|12290573|FG001|Overall Study|Withdrawal by Subject|1
7821728|NCT01257425|12290572|FG000|Overall Study|Death|1
7920857|NCT02166333|12444563|FG000|Stage 2|Lost to Follow-up|23
7920858|NCT02166333|12444564|FG001|Stage 2|Lost to Follow-up|4
7920859|NCT02166333|12444565|FG002|Stage 2|Lost to Follow-up|11
7920860|NCT02166333|12444566|FG003|Stage 2|Lost to Follow-up|9
7920861|NCT02166333|12444567|FG004|Stage 2|Lost to Follow-up|3
7920862|NCT02166333|12444568|FG005|Stage 2|Lost to Follow-up|6
7920863|NCT02166476|12444589|FG000|Overall Study|Withdrawal by Subject|5
7920864|NCT02166476|12444590|FG001|Overall Study|Withdrawal by Subject|7
7920865|NCT02166476|12444589|FG000|Overall Study|Adverse Event|3
7920866|NCT02166476|12444590|FG001|Overall Study|Adverse Event|3
7920867|NCT02166476|12444589|FG000|Overall Study|Lost to Follow-up|5
7920868|NCT02166476|12444590|FG001|Overall Study|Lost to Follow-up|10
7920869|NCT02166476|12444589|FG000|Overall Study|Physician Decision|1
7920870|NCT02166476|12444590|FG001|Overall Study|Physician Decision|0
7920871|NCT02166476|12444589|FG000|Overall Study|Unable to Come for Visit|0
7920872|NCT02166476|12444590|FG001|Overall Study|Unable to Come for Visit|3
7920873|NCT02166606|12444599|FG000|Overall Study|Adverse Event|3
7920874|NCT02166606|12444599|FG000|Overall Study|Death|31
7920875|NCT02166606|12444599|FG000|Overall Study|Protocol Violation|7
7920876|NCT02166606|12444599|FG000|Overall Study|Lost to Follow-up|30
7920877|NCT02166606|12444599|FG000|Overall Study|Withdrawal by Subject|1
7920878|NCT02166606|12444599|FG000|Overall Study|Physician Decision|1
7920879|NCT02166606|12444599|FG000|Overall Study|Device upgrade|1
7920880|NCT02166606|12444599|FG000|Overall Study|Enrolled after End of Enrollment|4
7920881|NCT02166697|12444603|FG000|Overall Study|Protocol Violation|347
7920882|NCT02167035|12444609|FG000|Overall Study|Adverse Event|2
7920883|NCT02167035|12444610|FG001|Overall Study|Adverse Event|2
7920884|NCT02167035|12444609|FG000|Overall Study|Lost to Follow-up|3
7821729|NCT01257425|12290573|FG001|Overall Study|Death|0
7920885|NCT02167035|12444610|FG001|Overall Study|Lost to Follow-up|3
7920886|NCT02167035|12444609|FG000|Overall Study|Randomized to incorrect Study Medication|0
7821730|NCT01257503|12290590|FG000|Overall Study|Lost to Follow-up|7
7920887|NCT02167035|12444610|FG001|Overall Study|Randomized to incorrect Study Medication|1
7920888|NCT02167139|12444629|FG000|Randomised, Double-blind|Withdrawal by Subject|11
7920889|NCT02167139|12444630|FG001|Randomised, Double-blind|Withdrawal by Subject|8
7920890|NCT02167139|12444631|FG002|Randomised, Double-blind|Withdrawal by Subject|0
7920891|NCT02167139|12444632|FG003|Randomised, Double-blind|Withdrawal by Subject|0
7920892|NCT02167139|12444629|FG000|Randomised, Double-blind|Adverse Event|2
7920893|NCT02167139|12444630|FG001|Randomised, Double-blind|Adverse Event|9
7821731|NCT01257503|12290591|FG001|Overall Study|Lost to Follow-up|10
7821732|NCT01257503|12290590|FG000|Overall Study|Over 5 years old at enrollment|0
7821733|NCT01257503|12290591|FG001|Overall Study|Over 5 years old at enrollment|1
7821734|NCT01257503|12290590|FG000|Overall Study|strep culture positive at enrollment|1
7821735|NCT01257503|12290591|FG001|Overall Study|strep culture positive at enrollment|0
7821736|NCT01257542|12290599|FG000|Overall Study|Protocol Violation|3
7821737|NCT01257542|12290600|FG001|Overall Study|Protocol Violation|5
7821738|NCT01257542|12290599|FG000|Overall Study|Withdrawal by Subject|0
7821739|NCT01257542|12290600|FG001|Overall Study|Withdrawal by Subject|2
7821740|NCT01257581|12290609|FG000|Overall Study|Early Termination|3
7821741|NCT01257581|12290610|FG001|Overall Study|Early Termination|1
7821742|NCT01257581|12290611|FG002|Overall Study|Early Termination|2
7821743|NCT01257581|12290609|FG000|Overall Study|Death|2
7920894|NCT02167139|12444631|FG002|Randomised, Double-blind|Adverse Event|0
7920895|NCT02167139|12444632|FG003|Randomised, Double-blind|Adverse Event|0
7920896|NCT02167139|12444629|FG000|Randomised, Double-blind|Lack of Efficacy|1
7920897|NCT02167139|12444630|FG001|Randomised, Double-blind|Lack of Efficacy|2
7920898|NCT02167139|12444631|FG002|Randomised, Double-blind|Lack of Efficacy|0
7920899|NCT02167139|12444632|FG003|Randomised, Double-blind|Lack of Efficacy|0
7920900|NCT02167139|12444629|FG000|Randomised, Double-blind|Other|3
7920901|NCT02167139|12444630|FG001|Randomised, Double-blind|Other|0
7920902|NCT02167139|12444631|FG002|Randomised, Double-blind|Other|0
7920903|NCT02167139|12444632|FG003|Randomised, Double-blind|Other|0
7920904|NCT02167139|12444629|FG000|Transition-extension|Adverse Event|2
7920905|NCT02167139|12444630|FG001|Transition-extension|Adverse Event|0
7920906|NCT02167139|12444631|FG002|Transition-extension|Adverse Event|2
7920907|NCT02167139|12444632|FG003|Transition-extension|Adverse Event|3
7920908|NCT02167139|12444629|FG000|Transition-extension|Withdrawal by Subject|2
7920909|NCT02167139|12444630|FG001|Transition-extension|Withdrawal by Subject|0
7920910|NCT02167139|12444631|FG002|Transition-extension|Withdrawal by Subject|4
7920911|NCT02167139|12444632|FG003|Transition-extension|Withdrawal by Subject|1
7920912|NCT02167139|12444629|FG000|Transition-extension|Lack of Efficacy|0
7920913|NCT02167139|12444630|FG001|Transition-extension|Lack of Efficacy|0
7920914|NCT02167139|12444631|FG002|Transition-extension|Lack of Efficacy|1
7920915|NCT02167139|12444632|FG003|Transition-extension|Lack of Efficacy|1
7920916|NCT02167139|12444629|FG000|Transition-extension|Other|1
7920917|NCT02167139|12444630|FG001|Transition-extension|Other|0
7920918|NCT02167139|12444631|FG002|Transition-extension|Other|1
7920919|NCT02167139|12444632|FG003|Transition-extension|Other|0
7920920|NCT02167139|12444629|FG000|Transition-extension|Lost to Follow-up|1
7920921|NCT02167139|12444630|FG001|Transition-extension|Lost to Follow-up|0
7920922|NCT02167139|12444631|FG002|Transition-extension|Lost to Follow-up|0
7920923|NCT02167139|12444632|FG003|Transition-extension|Lost to Follow-up|0
7920924|NCT02167256|12444662|FG000|Overall Study|Adverse Event|13
7920925|NCT02167256|12444663|FG001|Overall Study|Adverse Event|6
7920926|NCT02167256|12444662|FG000|Overall Study|Withdrawal by Subject|4
7920927|NCT02167256|12444663|FG001|Overall Study|Withdrawal by Subject|4
7920928|NCT02167256|12444662|FG000|Overall Study|non-compliance|3
7920929|NCT02167256|12444663|FG001|Overall Study|non-compliance|0
7920930|NCT02167256|12444662|FG000|Overall Study|Study partner unable to participate|1
7920931|NCT02167256|12444663|FG001|Overall Study|Study partner unable to participate|0
7920932|NCT02167451|12444669|FG000|Overall Study|Withdrawal by Subject|1
7920933|NCT02167594|12444676|FG000|Overall Study|Withdrawal by Subject|2
7920934|NCT02167594|12444677|FG001|Overall Study|Withdrawal by Subject|0
7920935|NCT02167594|12444678|FG002|Overall Study|Withdrawal by Subject|0
7920936|NCT02167594|12444676|FG000|Overall Study|Death|0
7920937|NCT02167594|12444677|FG001|Overall Study|Death|1
7920938|NCT02167594|12444678|FG002|Overall Study|Death|0
7920939|NCT02167893|12444706|FG000|Overall Study|Investigator transferred|85
7920940|NCT02167893|12444706|FG000|Overall Study|Investigator health reasons|10
7920941|NCT02167893|12444706|FG000|Overall Study|Case report forms not collected|68
7920942|NCT02168101|12444728|FG000|Overall Study|Death|2
7920943|NCT02168101|12444729|FG001|Overall Study|Death|2
7920944|NCT02168101|12444730|FG002|Overall Study|Death|1
7920945|NCT02168387|12444768|FG000|Overall Study|Planned exubation|6
7920946|NCT02168387|12444769|FG001|Overall Study|Planned exubation|3
7920947|NCT02168387|12444768|FG000|Overall Study|Death|1
7920948|NCT02168387|12444769|FG001|Overall Study|Death|0
7920949|NCT02168439|12444777|FG000|Overall Study|Protocol Violation|0
7920950|NCT02168439|12444778|FG001|Overall Study|Protocol Violation|2
7920951|NCT02168478|12444784|FG000|Overall Study|Withdrawal by Subject|1
7920952|NCT02168478|12444784|FG000|Overall Study|Did Not Consent to Participation|2
7920953|NCT02168478|12444784|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1
7920954|NCT02168491|12444788|FG000|Overall Study|Withdrawal by Subject|1
7920955|NCT02168777|12444811|FG000|Overall Study|Withdrawal by Subject|1
7920956|NCT02168777|12444812|FG001|Overall Study|Withdrawal by Subject|0
7920957|NCT02168777|12444813|FG002|Overall Study|Withdrawal by Subject|2
7920958|NCT02168777|12444811|FG000|Overall Study|Adverse Event|1
7920959|NCT02168777|12444812|FG001|Overall Study|Adverse Event|0
7920960|NCT02168777|12444813|FG002|Overall Study|Adverse Event|1
7920961|NCT02168777|12444811|FG000|Overall Study|Disease recurrence|0
7920962|NCT02168777|12444812|FG001|Overall Study|Disease recurrence|0
7920963|NCT02168777|12444813|FG002|Overall Study|Disease recurrence|1
7920964|NCT02168777|12444811|FG000|Overall Study|Radiological disease progression|0
7920965|NCT02168777|12444812|FG001|Overall Study|Radiological disease progression|5
7920966|NCT02168777|12444813|FG002|Overall Study|Radiological disease progression|5
7920967|NCT02168777|12444811|FG000|Overall Study|Clinical disease progression|0
7920968|NCT02168777|12444812|FG001|Overall Study|Clinical disease progression|1
7920969|NCT02168777|12444813|FG002|Overall Study|Clinical disease progression|2
7920970|NCT02168777|12444811|FG000|Overall Study|Other reason|0
7920971|NCT02168777|12444812|FG001|Overall Study|Other reason|1
7920972|NCT02168777|12444813|FG002|Overall Study|Other reason|0
7920973|NCT02168803|12444827|FG000|Overall Study|Lost to Follow-up|1
7920974|NCT02168803|12444828|FG001|Overall Study|Lost to Follow-up|0
7920975|NCT02168803|12444829|FG002|Overall Study|Lost to Follow-up|1
7920976|NCT02168803|12444827|FG000|Overall Study|Withdrawal by Subject|1
7920977|NCT02168803|12444828|FG001|Overall Study|Withdrawal by Subject|1
7920978|NCT02168803|12444829|FG002|Overall Study|Withdrawal by Subject|2
7920979|NCT02168803|12444827|FG000|Overall Study|Physician Decision|0
7920980|NCT02168803|12444828|FG001|Overall Study|Physician Decision|1
7920981|NCT02168803|12444829|FG002|Overall Study|Physician Decision|0
7920982|NCT02168803|12444827|FG000|Overall Study|Adverse Event|0
7920983|NCT02168803|12444828|FG001|Overall Study|Adverse Event|1
7920984|NCT02168803|12444829|FG002|Overall Study|Adverse Event|1
7920985|NCT02168803|12444827|FG000|Overall Study|Death|0
7920986|NCT02168803|12444828|FG001|Overall Study|Death|0
7920987|NCT02168803|12444829|FG002|Overall Study|Death|1
7920988|NCT02168803|12444827|FG000|Overall Study|Sponsor Decision|0
7920989|NCT02168803|12444828|FG001|Overall Study|Sponsor Decision|0
7920990|NCT02168803|12444829|FG002|Overall Study|Sponsor Decision|1
7920991|NCT02168816|12444846|FG000|Overall Study|Lost to Follow-up|2
7920992|NCT02168816|12444847|FG001|Overall Study|Lost to Follow-up|2
7920993|NCT02168842|12444855|FG000|Overall Study|Withdrawal by Subject|5
7920994|NCT02168842|12444856|FG001|Overall Study|Withdrawal by Subject|3
7920995|NCT02168842|12444855|FG000|Overall Study|Lost to Follow-up|0
7920996|NCT02168842|12444856|FG001|Overall Study|Lost to Follow-up|2
7920997|NCT02168842|12444855|FG000|Overall Study|Death|2
7920998|NCT02168842|12444856|FG001|Overall Study|Death|1
7920999|NCT02168842|12444855|FG000|Overall Study|Physician Decision|1
7921000|NCT02168842|12444856|FG001|Overall Study|Physician Decision|2
7921001|NCT02168946|12444885|FG000|Overall Study|Adverse Event|8
7921002|NCT02168946|12444886|FG001|Overall Study|Adverse Event|5
7921003|NCT02168946|12444885|FG000|Overall Study|Lost to Follow-up|3
7921004|NCT02168946|12444886|FG001|Overall Study|Lost to Follow-up|0
7921005|NCT02168946|12444885|FG000|Overall Study|Subject unable to come back for visits|1
7921006|NCT02168946|12444886|FG001|Overall Study|Subject unable to come back for visits|0
7921007|NCT02169219|12444906|FG000|Overall Study|Lack of Efficacy|6
7921008|NCT02169271|12444917|FG000|Overall Study|Protocol Violation|1
7921009|NCT02169271|12444918|FG001|Overall Study|Protocol Violation|2
7921010|NCT02169284|12444926|FG000|Overall Study|Physician Decision|0
7921011|NCT02169284|12444927|FG001|Overall Study|Physician Decision|1
7921012|NCT02169336|12444938|FG000|Overall Study|Lack of Efficacy|1
7921013|NCT02169336|12444939|FG001|Overall Study|Lack of Efficacy|1
7921014|NCT02169336|12444940|FG002|Overall Study|Lack of Efficacy|0
7921015|NCT02169336|12444938|FG000|Overall Study|Adverse Event|2
7921016|NCT02169336|12444939|FG001|Overall Study|Adverse Event|3
7921017|NCT02169336|12444940|FG002|Overall Study|Adverse Event|1
7921018|NCT02169336|12444938|FG000|Overall Study|Withdrawal by Subject|1
7921019|NCT02169336|12444939|FG001|Overall Study|Withdrawal by Subject|0
7921020|NCT02169336|12444940|FG002|Overall Study|Withdrawal by Subject|0
7921021|NCT02169336|12444938|FG000|Overall Study|Physician Decision|0
7921022|NCT02169336|12444939|FG001|Overall Study|Physician Decision|0
7921023|NCT02169336|12444940|FG002|Overall Study|Physician Decision|1
7921024|NCT02169336|12444938|FG000|Overall Study|Subject declined to continue dosing|0
7921025|NCT02169336|12444939|FG001|Overall Study|Subject declined to continue dosing|0
7921026|NCT02169336|12444940|FG002|Overall Study|Subject declined to continue dosing|1
7921027|NCT02169414|12444952|FG000|Overall Study|Withdrawal by Subject|1
7921028|NCT02169414|12444953|FG001|Overall Study|Withdrawal by Subject|0
7921029|NCT02169414|12444954|FG002|Overall Study|Withdrawal by Subject|0
7921030|NCT02169414|12444955|FG003|Overall Study|Withdrawal by Subject|0
7921031|NCT02169414|12444952|FG000|Overall Study|Adverse Event|0
7921032|NCT02169414|12444953|FG001|Overall Study|Adverse Event|1
7921033|NCT02169414|12444954|FG002|Overall Study|Adverse Event|0
7921034|NCT02169414|12444955|FG003|Overall Study|Adverse Event|0
7921035|NCT02169505|12445038|FG000|Overall Study|Withdrawal by Subject|1
7921036|NCT02169674|12445044|FG000|Overall Study|Withdrawal by Subject|2
7921037|NCT02169674|12445045|FG001|Overall Study|Withdrawal by Subject|1
7921038|NCT02169674|12445044|FG000|Overall Study|Seroprotected|30
7921039|NCT02169674|12445045|FG001|Overall Study|Seroprotected|76
7921040|NCT02169674|12445044|FG000|Overall Study|Lost to Follow-up|0
7921041|NCT02169674|12445045|FG001|Overall Study|Lost to Follow-up|1
7821744|NCT01257581|12290610|FG001|Overall Study|Death|2
7821745|NCT01257581|12290611|FG002|Overall Study|Death|4
7821746|NCT01257698|12290621|FG000|Overall Study|Protocol Violation|4
7821747|NCT01257698|12290622|FG001|Overall Study|Protocol Violation|0
7821748|NCT01257737|12290630|FG000|Overall Study|Lost to Follow-up|1
7821749|NCT01257737|12290631|FG001|Overall Study|Lost to Follow-up|2
7821750|NCT01257737|12290630|FG000|Overall Study|Liver transplant|1
7821751|NCT01257737|12290631|FG001|Overall Study|Liver transplant|0
7821752|NCT01257737|12290630|FG000|Overall Study|Relocation out of the country|0
7821753|NCT01257737|12290631|FG001|Overall Study|Relocation out of the country|1
7821754|NCT01257737|12290630|FG000|Overall Study|Withdrew from study|0
7821755|NCT01257737|12290631|FG001|Overall Study|Withdrew from study|1
7821756|NCT01258075|12290673|FG000|Overall Study|Adverse Event|8
7921042|NCT02169739|12445053|FG000|Overall Study|Lost to Follow-up|0
7921043|NCT02169739|12445054|FG001|Overall Study|Lost to Follow-up|4
7921044|NCT02169791|12445061|FG000|Overall Study|Death|6
7921045|NCT02169791|12445061|FG000|Overall Study|patient withdrew consent|1
7921046|NCT02170025|12445093|FG000|Overall Study|Adverse Event|2
7921047|NCT02170025|12445094|FG001|Overall Study|Adverse Event|0
7921048|NCT02170051|12445102|FG000|Overall Study|Withdrawal by Subject|10
7921049|NCT02170051|12445103|FG001|Overall Study|Withdrawal by Subject|10
7921050|NCT02170051|12445102|FG000|Overall Study|Lost to Follow-up|1
7921051|NCT02170051|12445103|FG001|Overall Study|Lost to Follow-up|3
7921052|NCT02170064|12445112|FG000|Overall Study|Withdrawal by Subject|5
7921053|NCT02170064|12445113|FG001|Overall Study|Withdrawal by Subject|1
7921054|NCT02170064|12445114|FG002|Overall Study|Withdrawal by Subject|1
7921055|NCT02170064|12445112|FG000|Overall Study|Physician Decision|1
7921056|NCT02170064|12445113|FG001|Overall Study|Physician Decision|1
7921057|NCT02170064|12445114|FG002|Overall Study|Physician Decision|0
7921058|NCT02170077|12445125|FG000|Overall Study|Withdrawal by Subject|3
7921059|NCT02170077|12445126|FG001|Overall Study|Withdrawal by Subject|4
7921060|NCT02170077|12445127|FG002|Overall Study|Withdrawal by Subject|2
7921061|NCT02170077|12445125|FG000|Overall Study|Adverse Event|4
7821757|NCT01258075|12290674|FG001|Overall Study|Adverse Event|3
7921062|NCT02170077|12445126|FG001|Overall Study|Adverse Event|4
7921063|NCT02170077|12445127|FG002|Overall Study|Adverse Event|4
7921064|NCT02170077|12445125|FG000|Overall Study|Lost to Follow-up|0
7921065|NCT02170077|12445126|FG001|Overall Study|Lost to Follow-up|1
7821758|NCT01258075|12290673|FG000|Overall Study|Lost to Follow-up|11
7821759|NCT01258075|12290674|FG001|Overall Study|Lost to Follow-up|6
7921066|NCT02170077|12445127|FG002|Overall Study|Lost to Follow-up|0
7921067|NCT02170077|12445125|FG000|Overall Study|Exclusion criteria|2
7921068|NCT02170077|12445126|FG001|Overall Study|Exclusion criteria|2
7921069|NCT02170077|12445127|FG002|Overall Study|Exclusion criteria|5
7921070|NCT02170077|12445125|FG000|Overall Study|Exacerbation of seizures|0
7921071|NCT02170077|12445126|FG001|Overall Study|Exacerbation of seizures|2
7921072|NCT02170077|12445127|FG002|Overall Study|Exacerbation of seizures|1
7921073|NCT02170207|12445135|FG000|Overall Study|Case report forms unavailable|5
7921074|NCT02170389|12445169|FG000|Overall Study|Study terminated prior to start of treat|1
7921075|NCT02170688|12445212|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4
7921076|NCT02170688|12445213|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2
7921077|NCT02170688|12445214|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3
7921078|NCT02170688|12445215|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2
7921079|NCT02170688|12445216|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0
7921080|NCT02170688|12445212|FG000|Overall Study|Full dose not received|0
7921081|NCT02170688|12445213|FG001|Overall Study|Full dose not received|1
7921082|NCT02170688|12445214|FG002|Overall Study|Full dose not received|0
7921083|NCT02170688|12445215|FG003|Overall Study|Full dose not received|0
7921084|NCT02170688|12445216|FG004|Overall Study|Full dose not received|0
7921085|NCT02170688|12445212|FG000|Overall Study|Physician Decision|0
7921086|NCT02170688|12445213|FG001|Overall Study|Physician Decision|0
7921087|NCT02170688|12445214|FG002|Overall Study|Physician Decision|1
7921088|NCT02170688|12445215|FG003|Overall Study|Physician Decision|0
7921089|NCT02170688|12445216|FG004|Overall Study|Physician Decision|0
7921090|NCT02170727|12445230|FG000|Overall Study|Lost to Follow-up|1
7921091|NCT02170727|12445231|FG001|Overall Study|Lost to Follow-up|0
7921092|NCT02170727|12445230|FG000|Overall Study|Withdrawal by Subject|2
7921093|NCT02170727|12445231|FG001|Overall Study|Withdrawal by Subject|0
7921094|NCT02170779|12445242|FG000|Overall Study|Withdrawal by Subject|1
7921095|NCT02170779|12445243|FG001|Overall Study|Withdrawal by Subject|0
7921096|NCT02170779|12445242|FG000|Overall Study|Lost to Follow-up|0
7921097|NCT02170779|12445243|FG001|Overall Study|Lost to Follow-up|1
7921098|NCT02171065|12445280|FG000|Overall Study|Withdrawal by Subject|1
7921099|NCT02171065|12445281|FG001|Overall Study|Withdrawal by Subject|0
7921100|NCT02171065|12445282|FG002|Overall Study|Withdrawal by Subject|0
7921101|NCT02171065|12445280|FG000|Overall Study|Lost to Follow-up|0
7921102|NCT02171065|12445281|FG001|Overall Study|Lost to Follow-up|0
7921103|NCT02171065|12445282|FG002|Overall Study|Lost to Follow-up|1
7921104|NCT02171130|12445292|FG000|Overall Study|Death|1
7921105|NCT02171130|12445292|FG000|Overall Study|Discontinued; Clinical Material Issue|16
7921106|NCT02171130|12445292|FG000|Overall Study|Discontinued; Site Termination|5
7921107|NCT02171130|12445292|FG000|Overall Study|Withdrawal by Subject|3
7921108|NCT02171130|12445292|FG000|Overall Study|Physician Decision|1
7921109|NCT02171130|12445292|FG000|Overall Study|Lost to Follow-up|1
7921110|NCT02171130|12445292|FG000|Overall Study|Met Exclusion Criteria|1
7921111|NCT02171260|12445367|FG000|Overall Study|Death|0
7921112|NCT02171260|12445368|FG001|Overall Study|Death|0
7921113|NCT02171260|12445369|FG002|Overall Study|Death|0
7921114|NCT02171260|12445370|FG003|Overall Study|Death|1
7921115|NCT02171260|12445367|FG000|Overall Study|Physician Decision|1
7921116|NCT02171260|12445368|FG001|Overall Study|Physician Decision|0
7921117|NCT02171260|12445369|FG002|Overall Study|Physician Decision|1
7921118|NCT02171260|12445370|FG003|Overall Study|Physician Decision|0
7921119|NCT02171260|12445367|FG000|Overall Study|Withdrawal by Subject|1
7921120|NCT02171260|12445368|FG001|Overall Study|Withdrawal by Subject|0
7921121|NCT02171260|12445369|FG002|Overall Study|Withdrawal by Subject|0
7921122|NCT02171260|12445370|FG003|Overall Study|Withdrawal by Subject|0
7921123|NCT02171260|12445367|FG000|Overall Study|Evidence of progressive disease|4
7921124|NCT02171260|12445368|FG001|Overall Study|Evidence of progressive disease|6
7921125|NCT02171260|12445369|FG002|Overall Study|Evidence of progressive disease|4
7921126|NCT02171260|12445370|FG003|Overall Study|Evidence of progressive disease|4
7921127|NCT02171429|12445389|FG000|Overall Study|Other|0
7921128|NCT02171429|12445390|FG001|Overall Study|Other|1
7921129|NCT02171429|12445391|FG002|Overall Study|Other|1
7921130|NCT02171429|12445389|FG000|Overall Study|Non-Compliance|0
7921131|NCT02171429|12445390|FG001|Overall Study|Non-Compliance|0
7921132|NCT02171429|12445391|FG002|Overall Study|Non-Compliance|1
7921133|NCT02171429|12445389|FG000|Overall Study|Physician Decision|0
7921134|NCT02171429|12445390|FG001|Overall Study|Physician Decision|0
7921135|NCT02171429|12445391|FG002|Overall Study|Physician Decision|1
7921136|NCT02171429|12445389|FG000|Overall Study|Withdrawal by Subject|1
7921137|NCT02171429|12445390|FG001|Overall Study|Withdrawal by Subject|1
7921138|NCT02171429|12445391|FG002|Overall Study|Withdrawal by Subject|1
7921139|NCT02171429|12445389|FG000|Overall Study|Lost to Follow-up|0
7921140|NCT02171429|12445390|FG001|Overall Study|Lost to Follow-up|1
7921141|NCT02171429|12445391|FG002|Overall Study|Lost to Follow-up|0
7921142|NCT02171429|12445389|FG000|Overall Study|Death|0
7921143|NCT02171429|12445390|FG001|Overall Study|Death|0
7921144|NCT02171429|12445391|FG002|Overall Study|Death|1
7921145|NCT02172040|12445436|FG000|Overall Study|Adverse Event|0
7921146|NCT02172040|12445437|FG001|Overall Study|Adverse Event|2
7921147|NCT02172040|12445438|FG002|Overall Study|Adverse Event|0
7921148|NCT02172040|12445439|FG003|Overall Study|Adverse Event|0
7921149|NCT02172040|12445436|FG000|Overall Study|Protocol Violation|0
7921150|NCT02172040|12445437|FG001|Overall Study|Protocol Violation|1
7921151|NCT02172040|12445438|FG002|Overall Study|Protocol Violation|0
7921152|NCT02172040|12445439|FG003|Overall Study|Protocol Violation|0
7921153|NCT02172040|12445436|FG000|Overall Study|Withdrawal by Subject|0
7921154|NCT02172040|12445437|FG001|Overall Study|Withdrawal by Subject|0
7921155|NCT02172040|12445438|FG002|Overall Study|Withdrawal by Subject|1
7921156|NCT02172040|12445439|FG003|Overall Study|Withdrawal by Subject|0
7921157|NCT02172040|12445436|FG000|Overall Study|Not available for Day 13 & 14 visits|0
7921158|NCT02172040|12445437|FG001|Overall Study|Not available for Day 13 & 14 visits|0
7921159|NCT02172040|12445438|FG002|Overall Study|Not available for Day 13 & 14 visits|1
7921160|NCT02172040|12445439|FG003|Overall Study|Not available for Day 13 & 14 visits|0
7921161|NCT02172040|12445436|FG000|Overall Study|Family emergency abroad|0
7921162|NCT02172040|12445437|FG001|Overall Study|Family emergency abroad|0
7921163|NCT02172040|12445438|FG002|Overall Study|Family emergency abroad|0
7921164|NCT02172040|12445439|FG003|Overall Study|Family emergency abroad|1
7921165|NCT02172625|12445452|FG000|Overall Study|Adverse Event|0
7921166|NCT02172625|12445453|FG001|Overall Study|Adverse Event|1
7921167|NCT02172625|12445452|FG000|Overall Study|Pregnancy|0
7921168|NCT02172625|12445453|FG001|Overall Study|Pregnancy|1
7921169|NCT02172625|12445452|FG000|Overall Study|car accident|0
7921170|NCT02172625|12445453|FG001|Overall Study|car accident|1
7921171|NCT02172664|12445463|FG000|Overall Study|Lost to Follow-up|4
7921172|NCT02172664|12445464|FG001|Overall Study|Lost to Follow-up|4
7921173|NCT02172664|12445463|FG000|Overall Study|Death|1
7921174|NCT02172664|12445464|FG001|Overall Study|Death|1
7921175|NCT02172664|12445463|FG000|Overall Study|Moved out of area|1
7921176|NCT02172664|12445464|FG001|Overall Study|Moved out of area|1
7921177|NCT02172911|12445497|FG000|Overall Study|Serious Adverse Event|0
7921178|NCT02172911|12445498|FG001|Overall Study|Serious Adverse Event|1
7921179|NCT02172911|12445497|FG000|Overall Study|Progression of Disease|0
7921180|NCT02172911|12445498|FG001|Overall Study|Progression of Disease|1
7921181|NCT02172911|12445497|FG000|Overall Study|Loss of insurance coverage|1
7921182|NCT02172911|12445498|FG001|Overall Study|Loss of insurance coverage|0
7921183|NCT02172950|12445506|FG000|Overall Study|Physician Decision|3
7921184|NCT02172950|12445507|FG001|Overall Study|Physician Decision|3
7921185|NCT02172950|12445506|FG000|Overall Study|Lack of Efficacy|1
7921186|NCT02172950|12445507|FG001|Overall Study|Lack of Efficacy|0
7921187|NCT02172950|12445506|FG000|Overall Study|Adverse Event|4
7921188|NCT02172950|12445507|FG001|Overall Study|Adverse Event|1
7921189|NCT02172950|12445506|FG000|Overall Study|Withdrawal by Subject|10
7921190|NCT02172950|12445507|FG001|Overall Study|Withdrawal by Subject|0
7921191|NCT02172950|12445506|FG000|Overall Study|Protocol Violation|1
7921192|NCT02172950|12445507|FG001|Overall Study|Protocol Violation|0
7921193|NCT02172950|12445506|FG000|Overall Study|Lost to Follow-up|1
7921194|NCT02172950|12445507|FG001|Overall Study|Lost to Follow-up|0
7921195|NCT02172950|12445506|FG000|Overall Study|Death|1
7921196|NCT02172950|12445507|FG001|Overall Study|Death|0
7921197|NCT02172950|12445506|FG000|Overall Study|Patient traveling|1
7921198|NCT02172950|12445507|FG001|Overall Study|Patient traveling|0
7921199|NCT02172950|12445506|FG000|Overall Study|Patient went to other country|1
7921200|NCT02172950|12445507|FG001|Overall Study|Patient went to other country|0
7921201|NCT02172950|12445506|FG000|Overall Study|Patient relocated overseas|1
7921202|NCT02172950|12445507|FG001|Overall Study|Patient relocated overseas|1
7921203|NCT02172950|12445506|FG000|Overall Study|Patient moving|1
7921204|NCT02172950|12445507|FG001|Overall Study|Patient moving|0
7921205|NCT02173054|12445517|FG000|Overall Study|lack of compliance|1
7921206|NCT02173054|12445518|FG001|Overall Study|lack of compliance|0
7921207|NCT02173054|12445519|FG002|Overall Study|lack of compliance|0
7921208|NCT02173054|12445517|FG000|Overall Study|Withdrawal by Subject|0
7921209|NCT02173054|12445518|FG001|Overall Study|Withdrawal by Subject|0
7921210|NCT02173054|12445519|FG002|Overall Study|Withdrawal by Subject|1
7964430|NCT01940341|12519969|FG000|Double-Blind Phase|Protocol Specified Criteria|1
7964431|NCT01940341|12519970|FG001|Double-Blind Phase|Protocol Specified Criteria|0
7964432|NCT01940341|12519969|FG000|Double-Blind Phase|Still on Double-Blind Treatment|269
7964433|NCT01940341|12519970|FG001|Double-Blind Phase|Still on Double-Blind Treatment|132
7964434|NCT01940341|12519969|FG000|Open-label Extension Phase|Still on Study|4
7921211|NCT02173158|12445527|FG000|Efficacy Phase|Adverse Event|1
7921212|NCT02173548|12445618|FG000|Overall Study|Lost to Follow-up|0
7921213|NCT02173548|12445619|FG001|Overall Study|Lost to Follow-up|2
7921214|NCT02173548|12445618|FG000|Overall Study|Withdrawal by Subject|1
7921215|NCT02173548|12445619|FG001|Overall Study|Withdrawal by Subject|0
7921216|NCT02173704|12445627|FG000|Overall Study|Adverse Event|1
7921217|NCT02173704|12445628|FG001|Overall Study|Adverse Event|0
7921218|NCT02173704|12445627|FG000|Overall Study|Lost to Follow-up|1
7921219|NCT02173704|12445628|FG001|Overall Study|Lost to Follow-up|0
7921220|NCT02173704|12445627|FG000|Overall Study|Other|1
7921221|NCT02173704|12445628|FG001|Overall Study|Other|0
7921222|NCT02173704|12445627|FG000|Overall Study|Protocol Violation|1
7921223|NCT02173704|12445628|FG001|Overall Study|Protocol Violation|0
7921224|NCT02173704|12445627|FG000|Overall Study|Withdrawal by Subject|9
7921225|NCT02173704|12445628|FG001|Overall Study|Withdrawal by Subject|4
7921226|NCT02173769|12445634|FG000|Overall Study|Protocol Violation|4
7921227|NCT02174276|12445652|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1
7921228|NCT02174276|12445653|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
7921229|NCT02174276|12445654|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
7921230|NCT02174276|12445655|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
7921231|NCT02174276|12445652|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
7921232|NCT02174276|12445653|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
7921233|NCT02174276|12445654|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1
7921234|NCT02174276|12445655|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
7921235|NCT02174276|12445652|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
7921236|NCT02174276|12445653|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1
7921237|NCT02174276|12445654|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2
7921238|NCT02174276|12445655|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
7921239|NCT02174276|12445652|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
7921240|NCT02174276|12445653|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
7921241|NCT02174276|12445654|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1
7921242|NCT02174276|12445655|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
7921243|NCT02174276|12445652|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0
7921244|NCT02174276|12445653|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0
7921245|NCT02174276|12445654|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1
7921246|NCT02174276|12445655|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0
7921247|NCT02174276|12445652|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1
7921248|NCT02174276|12445653|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0
7921249|NCT02174276|12445654|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1
7921250|NCT02174276|12445655|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2
7921251|NCT02174523|12445700|FG000|Overall Study|Withdrawal by Subject|1
7921252|NCT02174523|12445701|FG001|Overall Study|Withdrawal by Subject|0
7921253|NCT02174562|12445708|FG000|Overall Study|Withdrawal by Subject|7
7921254|NCT02174562|12445709|FG001|Overall Study|Withdrawal by Subject|2
7921255|NCT02174562|12445708|FG000|Overall Study|Death|2
7921256|NCT02174562|12445709|FG001|Overall Study|Death|0
7921257|NCT02174562|12445708|FG000|Overall Study|Lost to Follow-up|0
7921258|NCT02174562|12445709|FG001|Overall Study|Lost to Follow-up|3
7921259|NCT02174627|12445717|FG000|Overall Study|Missing|0
7921260|NCT02174627|12445718|FG001|Overall Study|Missing|1
7921261|NCT02174627|12445717|FG000|Overall Study|Incorrect enrolment before randomization|0
7921262|NCT02174627|12445718|FG001|Overall Study|Incorrect enrolment before randomization|1
7921263|NCT02174627|12445717|FG000|Overall Study|Participant decision|84
7921264|NCT02174627|12445718|FG001|Overall Study|Participant decision|128
7921265|NCT02174731|12445726|FG000|Overall Study|Participant decision|67
7921266|NCT02174731|12445727|FG001|Overall Study|Participant decision|64
7921267|NCT02174731|12445726|FG000|Overall Study|Incorrect enrolment before randomization|0
7921268|NCT02174731|12445727|FG001|Overall Study|Incorrect enrolment before randomization|1
7921269|NCT02174731|12445726|FG000|Overall Study|Missing|2
7921270|NCT02174731|12445727|FG001|Overall Study|Missing|0
7921271|NCT02174848|12445735|FG000|Overall Study|Adverse Event|2
7921272|NCT02174848|12445736|FG001|Overall Study|Adverse Event|1
7921273|NCT02174848|12445735|FG000|Overall Study|Withdrawal by Subject|3
7921274|NCT02174848|12445736|FG001|Overall Study|Withdrawal by Subject|3
7921275|NCT02174848|12445735|FG000|Overall Study|Lost to Follow-up|0
7921276|NCT02174848|12445736|FG001|Overall Study|Lost to Follow-up|1
7921277|NCT02174848|12445735|FG000|Overall Study|Worsening of disease|1
7921278|NCT02174848|12445736|FG001|Overall Study|Worsening of disease|1
7921279|NCT02174848|12445735|FG000|Overall Study|Unable to comply with study requirements|1
7921280|NCT02174848|12445736|FG001|Overall Study|Unable to comply with study requirements|0
7921281|NCT02175121|12445761|FG000|Overall Study|Lack of Efficacy|1
7921282|NCT02175121|12445762|FG001|Overall Study|Lack of Efficacy|0
7921283|NCT02175121|12445763|FG002|Overall Study|Lack of Efficacy|0
7921284|NCT02175121|12445764|FG003|Overall Study|Lack of Efficacy|0
7921285|NCT02175121|12445765|FG004|Overall Study|Lack of Efficacy|0
7921286|NCT02175121|12445761|FG000|Overall Study|Lost to Follow-up|0
7921287|NCT02175121|12445762|FG001|Overall Study|Lost to Follow-up|1
7921288|NCT02175121|12445763|FG002|Overall Study|Lost to Follow-up|0
7921289|NCT02175121|12445764|FG003|Overall Study|Lost to Follow-up|1
7921290|NCT02175121|12445765|FG004|Overall Study|Lost to Follow-up|0
7921291|NCT02175121|12445761|FG000|Overall Study|Personal emergency|0
7921292|NCT02175121|12445762|FG001|Overall Study|Personal emergency|0
7921293|NCT02175121|12445763|FG002|Overall Study|Personal emergency|0
7921294|NCT02175121|12445764|FG003|Overall Study|Personal emergency|0
7921295|NCT02175121|12445765|FG004|Overall Study|Personal emergency|1
7921296|NCT02175121|12445761|FG000|Overall Study|Schedule conflict|0
7921297|NCT02175121|12445762|FG001|Overall Study|Schedule conflict|0
7921298|NCT02175121|12445763|FG002|Overall Study|Schedule conflict|1
7921299|NCT02175121|12445764|FG003|Overall Study|Schedule conflict|0
7921300|NCT02175121|12445765|FG004|Overall Study|Schedule conflict|0
7921301|NCT02175121|12445761|FG000|Overall Study|Time issues|0
7921302|NCT02175121|12445762|FG001|Overall Study|Time issues|0
7921303|NCT02175121|12445763|FG002|Overall Study|Time issues|1
7921304|NCT02175121|12445764|FG003|Overall Study|Time issues|0
7921305|NCT02175121|12445765|FG004|Overall Study|Time issues|0
7921306|NCT02175199|12445783|FG000|Overall Study|Withdrawal by Subject|1
7921307|NCT02175199|12445784|FG001|Overall Study|Withdrawal by Subject|5
7921308|NCT02175199|12445783|FG000|Overall Study|Randomized in Error|1
7921309|NCT02175199|12445784|FG001|Overall Study|Randomized in Error|0
7921310|NCT02175199|12445783|FG000|Overall Study|Sponsor Decision|1
7921311|NCT02175199|12445784|FG001|Overall Study|Sponsor Decision|0
7921312|NCT02175225|12445802|FG000|Overall Study|Withdrawal by Subject|1
7921313|NCT02175225|12445803|FG001|Overall Study|Withdrawal by Subject|2
7921314|NCT02175225|12445802|FG000|Overall Study|Lost to Follow-up|6
7921315|NCT02175225|12445803|FG001|Overall Study|Lost to Follow-up|7
7921316|NCT02175225|12445802|FG000|Overall Study|Study drug not administered|1
7921317|NCT02175225|12445803|FG001|Overall Study|Study drug not administered|2
7921318|NCT02175277|12445809|FG000|Overall Study|Protocol-specified Criteria|1
7921319|NCT02175368|12445813|FG000|Overall Study|Lost to Follow-up|1
7921320|NCT02175641|12445828|FG000|Overall Study|Death|3
7921321|NCT02175641|12445829|FG001|Overall Study|Death|4
7921322|NCT02175641|12445828|FG000|Overall Study|Lost to Follow-up|4
7921323|NCT02175641|12445829|FG001|Overall Study|Lost to Follow-up|4
7921324|NCT02175641|12445828|FG000|Overall Study|Withdrawal by Subject|7
7921325|NCT02175641|12445829|FG001|Overall Study|Withdrawal by Subject|4
7921326|NCT02175641|12445828|FG000|Overall Study|Discharged from Supportive Housing Agenc|13
7921327|NCT02175641|12445829|FG001|Overall Study|Discharged from Supportive Housing Agenc|15
7921328|NCT02175641|12445828|FG000|Overall Study|Developed Contraindicated Condition|8
7921329|NCT02175641|12445829|FG001|Overall Study|Developed Contraindicated Condition|0
7921330|NCT02175745|12445835|FG000|Overall Study|Not Eligible|1
7921331|NCT02175758|12445845|FG000|Treatment Phase|Lost to Follow-up|0
7921332|NCT02175758|12445846|FG001|Treatment Phase|Lost to Follow-up|1
7921333|NCT02175758|12445847|FG002|Treatment Phase|Lost to Follow-up|0
7921334|NCT02175758|12445848|FG003|Treatment Phase|Lost to Follow-up|0
7921335|NCT02175758|12445849|FG004|Treatment Phase|Lost to Follow-up|0
7921336|NCT02175758|12445850|FG005|Treatment Phase|Lost to Follow-up|0
7921337|NCT02175758|12445845|FG000|Treatment Phase|Adverse Event|0
7921338|NCT02175758|12445846|FG001|Treatment Phase|Adverse Event|0
7921339|NCT02175758|12445847|FG002|Treatment Phase|Adverse Event|0
7921340|NCT02175758|12445848|FG003|Treatment Phase|Adverse Event|0
7921341|NCT02175758|12445849|FG004|Treatment Phase|Adverse Event|1
7921342|NCT02175758|12445850|FG005|Treatment Phase|Adverse Event|0
7921343|NCT02175771|12445898|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23
7921344|NCT02175771|12445899|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7921345|NCT02175771|12445900|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7921346|NCT02175771|12445901|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7921347|NCT02175771|12445902|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7921348|NCT02175771|12445903|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7921349|NCT02175771|12445904|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7921350|NCT02175771|12445905|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7921351|NCT02175771|12445906|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7921352|NCT02175771|12445898|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20
7921353|NCT02175771|12445899|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7921354|NCT02175771|12445900|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7921355|NCT02175771|12445901|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7921356|NCT02175771|12445902|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7921357|NCT02175771|12445903|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7921358|NCT02175771|12445904|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7921359|NCT02175771|12445905|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7921360|NCT02175771|12445906|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7921361|NCT02175771|12445898|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
7921362|NCT02175771|12445899|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7921363|NCT02175771|12445900|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7921364|NCT02175771|12445901|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7921365|NCT02175771|12445902|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7921366|NCT02175771|12445903|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7921367|NCT02175771|12445904|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7921368|NCT02175771|12445905|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7921369|NCT02175771|12445906|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7921370|NCT02175771|12445898|FG000|Run-In Period (Pre-assignment)|Adverse Event|9
7921371|NCT02175771|12445899|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
7921372|NCT02175771|12445900|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
7921373|NCT02175771|12445901|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
7921374|NCT02175771|12445902|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
7921375|NCT02175771|12445903|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
7921376|NCT02175771|12445904|FG006|Run-In Period (Pre-assignment)|Adverse Event|0
7921377|NCT02175771|12445905|FG007|Run-In Period (Pre-assignment)|Adverse Event|0
7921378|NCT02175771|12445906|FG008|Run-In Period (Pre-assignment)|Adverse Event|0
7921379|NCT02175771|12445898|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
7921380|NCT02175771|12445899|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7921381|NCT02175771|12445900|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7921382|NCT02175771|12445901|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7921383|NCT02175771|12445902|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7921384|NCT02175771|12445903|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7921385|NCT02175771|12445904|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7921386|NCT02175771|12445905|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7921387|NCT02175771|12445906|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7921388|NCT02175771|12445898|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6
7921389|NCT02175771|12445899|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7921390|NCT02175771|12445900|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7921391|NCT02175771|12445901|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7921392|NCT02175771|12445902|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7921393|NCT02175771|12445903|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7921394|NCT02175771|12445904|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7921395|NCT02175771|12445905|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7921396|NCT02175771|12445906|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7921397|NCT02175771|12445898|FG000|Run-In Period (Pre-assignment)|Other|8
7921398|NCT02175771|12445899|FG001|Run-In Period (Pre-assignment)|Other|0
7921399|NCT02175771|12445900|FG002|Run-In Period (Pre-assignment)|Other|0
7921400|NCT02175771|12445901|FG003|Run-In Period (Pre-assignment)|Other|0
7921401|NCT02175771|12445902|FG004|Run-In Period (Pre-assignment)|Other|0
7921402|NCT02175771|12445903|FG005|Run-In Period (Pre-assignment)|Other|0
7921403|NCT02175771|12445904|FG006|Run-In Period (Pre-assignment)|Other|0
7921404|NCT02175771|12445905|FG007|Run-In Period (Pre-assignment)|Other|0
7921405|NCT02175771|12445906|FG008|Run-In Period (Pre-assignment)|Other|0
7921406|NCT02175771|12445898|FG000|Treatment Period|Adverse Event|0
7921407|NCT02175771|12445899|FG001|Treatment Period|Adverse Event|2
7921408|NCT02175771|12445900|FG002|Treatment Period|Adverse Event|1
7921409|NCT02175771|12445901|FG003|Treatment Period|Adverse Event|1
7921410|NCT02175771|12445902|FG004|Treatment Period|Adverse Event|1
7921411|NCT02175771|12445903|FG005|Treatment Period|Adverse Event|3
7719587|NCT00533897|12143617|FG002|Lead-in (LI) Period 1|Adverse Event|0
7719588|NCT00533897|12143618|FG003|Lead-in (LI) Period 1|Adverse Event|0
7921412|NCT02175771|12445904|FG006|Treatment Period|Adverse Event|2
7921413|NCT02175771|12445905|FG007|Treatment Period|Adverse Event|0
7921414|NCT02175771|12445906|FG008|Treatment Period|Adverse Event|1
7921415|NCT02175771|12445898|FG000|Treatment Period|Withdrawal by Subject|0
7921416|NCT02175771|12445899|FG001|Treatment Period|Withdrawal by Subject|9
7921417|NCT02175771|12445900|FG002|Treatment Period|Withdrawal by Subject|3
7921418|NCT02175771|12445901|FG003|Treatment Period|Withdrawal by Subject|6
7921419|NCT02175771|12445902|FG004|Treatment Period|Withdrawal by Subject|2
7921420|NCT02175771|12445903|FG005|Treatment Period|Withdrawal by Subject|4
7921421|NCT02175771|12445904|FG006|Treatment Period|Withdrawal by Subject|2
7921422|NCT02175771|12445905|FG007|Treatment Period|Withdrawal by Subject|9
7921423|NCT02175771|12445906|FG008|Treatment Period|Withdrawal by Subject|2
7921424|NCT02175771|12445898|FG000|Treatment Period|Noncompliance|0
7921425|NCT02175771|12445899|FG001|Treatment Period|Noncompliance|1
7921426|NCT02175771|12445900|FG002|Treatment Period|Noncompliance|2
7921427|NCT02175771|12445901|FG003|Treatment Period|Noncompliance|0
7921428|NCT02175771|12445902|FG004|Treatment Period|Noncompliance|0
7921429|NCT02175771|12445903|FG005|Treatment Period|Noncompliance|0
7921430|NCT02175771|12445904|FG006|Treatment Period|Noncompliance|0
7921431|NCT02175771|12445905|FG007|Treatment Period|Noncompliance|0
7921432|NCT02175771|12445906|FG008|Treatment Period|Noncompliance|1
7921433|NCT02175771|12445898|FG000|Treatment Period|Protocol Violation|0
7921434|NCT02175771|12445899|FG001|Treatment Period|Protocol Violation|0
7921435|NCT02175771|12445900|FG002|Treatment Period|Protocol Violation|0
7921436|NCT02175771|12445901|FG003|Treatment Period|Protocol Violation|0
7921437|NCT02175771|12445902|FG004|Treatment Period|Protocol Violation|0
7921438|NCT02175771|12445903|FG005|Treatment Period|Protocol Violation|0
7921439|NCT02175771|12445904|FG006|Treatment Period|Protocol Violation|0
7921440|NCT02175771|12445905|FG007|Treatment Period|Protocol Violation|1
7921441|NCT02175771|12445906|FG008|Treatment Period|Protocol Violation|0
7921442|NCT02175771|12445898|FG000|Treatment Period|Disease progression|0
7921443|NCT02175771|12445899|FG001|Treatment Period|Disease progression|0
7921444|NCT02175771|12445900|FG002|Treatment Period|Disease progression|0
7921445|NCT02175771|12445901|FG003|Treatment Period|Disease progression|0
7921446|NCT02175771|12445902|FG004|Treatment Period|Disease progression|0
7921447|NCT02175771|12445903|FG005|Treatment Period|Disease progression|0
7921448|NCT02175771|12445904|FG006|Treatment Period|Disease progression|0
7921449|NCT02175771|12445905|FG007|Treatment Period|Disease progression|2
7921450|NCT02175771|12445906|FG008|Treatment Period|Disease progression|0
7921451|NCT02175771|12445898|FG000|Treatment Period|Lost to Follow-up|0
7921452|NCT02175771|12445899|FG001|Treatment Period|Lost to Follow-up|3
7921453|NCT02175771|12445900|FG002|Treatment Period|Lost to Follow-up|1
7921454|NCT02175771|12445901|FG003|Treatment Period|Lost to Follow-up|3
7921455|NCT02175771|12445902|FG004|Treatment Period|Lost to Follow-up|1
7921456|NCT02175771|12445903|FG005|Treatment Period|Lost to Follow-up|2
7921457|NCT02175771|12445904|FG006|Treatment Period|Lost to Follow-up|1
7921458|NCT02175771|12445905|FG007|Treatment Period|Lost to Follow-up|2
7921459|NCT02175771|12445906|FG008|Treatment Period|Lost to Follow-up|2
7921460|NCT02175771|12445898|FG000|Treatment Period|Lack of Efficacy|0
7921461|NCT02175771|12445899|FG001|Treatment Period|Lack of Efficacy|0
7921462|NCT02175771|12445900|FG002|Treatment Period|Lack of Efficacy|0
7921463|NCT02175771|12445901|FG003|Treatment Period|Lack of Efficacy|0
7921464|NCT02175771|12445902|FG004|Treatment Period|Lack of Efficacy|0
7921465|NCT02175771|12445903|FG005|Treatment Period|Lack of Efficacy|1
7921466|NCT02175771|12445904|FG006|Treatment Period|Lack of Efficacy|0
7921467|NCT02175771|12445905|FG007|Treatment Period|Lack of Efficacy|1
7921468|NCT02175771|12445906|FG008|Treatment Period|Lack of Efficacy|0
7921469|NCT02175771|12445898|FG000|Treatment Period|Other|0
7921470|NCT02175771|12445899|FG001|Treatment Period|Other|1
7921471|NCT02175771|12445900|FG002|Treatment Period|Other|0
7921472|NCT02175771|12445901|FG003|Treatment Period|Other|3
7921473|NCT02175771|12445902|FG004|Treatment Period|Other|1
7921474|NCT02175771|12445903|FG005|Treatment Period|Other|0
7921475|NCT02175771|12445904|FG006|Treatment Period|Other|0
7921476|NCT02175771|12445905|FG007|Treatment Period|Other|2
7921477|NCT02175771|12445906|FG008|Treatment Period|Other|0
7921478|NCT02175966|12445926|FG000|Follow-up Period|Lack of Efficacy|10
7921479|NCT02175966|12445927|FG001|Follow-up Period|Lack of Efficacy|6
7921480|NCT02176018|12445961|FG000|Overall Study|Adverse Event|0
7921481|NCT02176018|12445962|FG001|Overall Study|Adverse Event|2
7921482|NCT02176018|12445961|FG000|Overall Study|Lost to Follow-up|3
7921483|NCT02176018|12445962|FG001|Overall Study|Lost to Follow-up|1
7921484|NCT02176018|12445961|FG000|Overall Study|Protocol Violation|1
7921485|NCT02176018|12445962|FG001|Overall Study|Protocol Violation|1
7921486|NCT02176018|12445961|FG000|Overall Study|Withdrawal by Subject|1
7921487|NCT02176018|12445962|FG001|Overall Study|Withdrawal by Subject|2
7921488|NCT02176226|12445982|FG000|Overall Study|Lost to Follow-up|3
7921489|NCT02176226|12445982|FG000|Overall Study|Withdrew prior to treatment|6
7921490|NCT02176291|12445988|FG000|Overall Study|Death|1
7921491|NCT02176291|12445989|FG001|Overall Study|Death|0
7921492|NCT02176291|12445988|FG000|Overall Study|non compliance with protocol|2
7921493|NCT02176291|12445989|FG001|Overall Study|non compliance with protocol|0
7921494|NCT02176291|12445988|FG000|Overall Study|Withdrawal by Subject|2
7921495|NCT02176291|12445989|FG001|Overall Study|Withdrawal by Subject|0
7921496|NCT02176356|12445999|FG000|Overall Study|Screen Failure|14
7921497|NCT02176356|12445999|FG000|Overall Study|Lost to Follow-up|4
7921498|NCT02176356|12445999|FG000|Overall Study|Personal Reasons|3
7921499|NCT02176356|12445999|FG000|Overall Study|Other Miscellaneous Reasons|2
7921500|NCT02176421|12446021|FG000|Overall Study|Lost to Follow-up|4
7921501|NCT02176421|12446021|FG000|Overall Study|Adverse Event|1
7921502|NCT02176525|12446048|FG000|Overall Study|Adverse Event|0
7921503|NCT02176525|12446049|FG001|Overall Study|Adverse Event|0
7921504|NCT02176525|12446050|FG002|Overall Study|Adverse Event|0
7921505|NCT02176525|12446051|FG003|Overall Study|Adverse Event|1
7921506|NCT02176525|12446052|FG004|Overall Study|Adverse Event|1
7921507|NCT02176525|12446053|FG005|Overall Study|Adverse Event|0
7921508|NCT02176525|12446054|FG006|Overall Study|Adverse Event|1
7921509|NCT02176525|12446055|FG007|Overall Study|Adverse Event|0
7921510|NCT02176525|12446048|FG000|Overall Study|not treated|1
7921511|NCT02176525|12446049|FG001|Overall Study|not treated|0
7921512|NCT02176525|12446050|FG002|Overall Study|not treated|0
7921513|NCT02176525|12446051|FG003|Overall Study|not treated|0
7921514|NCT02176525|12446052|FG004|Overall Study|not treated|0
7921515|NCT02176525|12446053|FG005|Overall Study|not treated|1
7921516|NCT02176525|12446054|FG006|Overall Study|not treated|0
7921517|NCT02176525|12446055|FG007|Overall Study|not treated|0
7921518|NCT02176642|12446083|FG000|Overall Study|Withdrawal by Subject|0
7921519|NCT02176642|12446084|FG001|Overall Study|Withdrawal by Subject|1
7921520|NCT02176655|12446090|FG000|Overall Study|Subjects did not treat|6
7921521|NCT02176928|12446101|FG000|Overall Study|Lost to Follow-up|2
7921522|NCT02176928|12446102|FG001|Overall Study|Lost to Follow-up|4
7921523|NCT02177032|12446112|FG000|Overall Study|ADMINISTRATIVE REASON|2
7921524|NCT02177032|12446113|FG001|Overall Study|ADMINISTRATIVE REASON|0
7921525|NCT02177032|12446114|FG002|Overall Study|ADMINISTRATIVE REASON|1
7921526|NCT02177032|12446115|FG003|Overall Study|ADMINISTRATIVE REASON|0
7921527|NCT02177032|12446112|FG000|Overall Study|Lost to Follow-up|0
7921528|NCT02177032|12446113|FG001|Overall Study|Lost to Follow-up|2
7921529|NCT02177032|12446114|FG002|Overall Study|Lost to Follow-up|0
7921530|NCT02177032|12446115|FG003|Overall Study|Lost to Follow-up|0
7921531|NCT02177032|12446112|FG000|Overall Study|OTHER|2
7921532|NCT02177032|12446113|FG001|Overall Study|OTHER|0
7921533|NCT02177032|12446114|FG002|Overall Study|OTHER|1
7921534|NCT02177032|12446115|FG003|Overall Study|OTHER|0
7921535|NCT02177032|12446112|FG000|Overall Study|Withdrawal by Subject|1
7921536|NCT02177032|12446113|FG001|Overall Study|Withdrawal by Subject|0
7921537|NCT02177032|12446114|FG002|Overall Study|Withdrawal by Subject|1
7921538|NCT02177032|12446115|FG003|Overall Study|Withdrawal by Subject|0
7921539|NCT02177123|12446136|FG000|Overall Study|Lost to Follow-up|6
7921540|NCT02177123|12446136|FG000|Overall Study|Withdrawal by Subject|4
7921541|NCT02177123|12446136|FG000|Overall Study|Adverse Event|4
7921542|NCT02177123|12446136|FG000|Overall Study|Physician Decision|3
7921543|NCT02177123|12446136|FG000|Overall Study|Excluded by Sponsor - other reason|2
7921544|NCT02177123|12446136|FG000|Overall Study|Excluded for medical reasons|2
7921545|NCT02177123|12446136|FG000|Overall Study|Death|1
7921546|NCT02177123|12446136|FG000|Overall Study|Other|1
7921547|NCT02177123|12446136|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1
7921548|NCT02177136|12446146|FG000|DB Phase|Withdrawal by Subject|2
7921549|NCT02177136|12446147|FG001|DB Phase|Withdrawal by Subject|0
7921550|NCT02177136|12446148|FG002|DB Phase|Withdrawal by Subject|0
7921551|NCT02177136|12446149|FG003|DB Phase|Withdrawal by Subject|0
7921552|NCT02177136|12446146|FG000|DB Phase|Discontinued Due to Pruritus|1
7921553|NCT02177136|12446147|FG001|DB Phase|Discontinued Due to Pruritus|3
7921554|NCT02177136|12446148|FG002|DB Phase|Discontinued Due to Pruritus|0
7921555|NCT02177136|12446149|FG003|DB Phase|Discontinued Due to Pruritus|0
7921556|NCT02177136|12446146|FG000|DB Phase|Adverse Event|3
7921557|NCT02177136|12446147|FG001|DB Phase|Adverse Event|2
7921558|NCT02177136|12446148|FG002|DB Phase|Adverse Event|3
7921559|NCT02177136|12446149|FG003|DB Phase|Adverse Event|0
7921560|NCT02177136|12446146|FG000|DB Phase|Protocol Violation|0
7921561|NCT02177136|12446147|FG001|DB Phase|Protocol Violation|0
7921562|NCT02177136|12446148|FG002|DB Phase|Protocol Violation|1
7921563|NCT02177136|12446149|FG003|DB Phase|Protocol Violation|0
7921564|NCT02177136|12446146|FG000|DB Phase|Withdrew Consent Prior to Dosing|1
7921565|NCT02177136|12446147|FG001|DB Phase|Withdrew Consent Prior to Dosing|0
7921566|NCT02177136|12446148|FG002|DB Phase|Withdrew Consent Prior to Dosing|0
7921567|NCT02177136|12446149|FG003|DB Phase|Withdrew Consent Prior to Dosing|0
7921568|NCT02177136|12446146|FG000|LTSE Phase|Withdrawal by Subject|0
7921569|NCT02177136|12446147|FG001|LTSE Phase|Withdrawal by Subject|0
7921570|NCT02177136|12446148|FG002|LTSE Phase|Withdrawal by Subject|0
7921571|NCT02177136|12446149|FG003|LTSE Phase|Withdrawal by Subject|6
7921572|NCT02177136|12446146|FG000|LTSE Phase|Adverse Event|0
7921573|NCT02177136|12446147|FG001|LTSE Phase|Adverse Event|0
7921574|NCT02177136|12446148|FG002|LTSE Phase|Adverse Event|0
7921575|NCT02177136|12446149|FG003|LTSE Phase|Adverse Event|10
7821760|NCT01258075|12290673|FG000|Overall Study|Withdrawal by Subject|10
7821761|NCT01258075|12290674|FG001|Overall Study|Withdrawal by Subject|7
7821762|NCT01258075|12290673|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1
7821763|NCT01258075|12290674|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2
7821764|NCT01258075|12290673|FG000|Overall Study|Other|12
7821765|NCT01258075|12290674|FG001|Overall Study|Other|5
7821766|NCT01258101|12290684|FG000|Overall Study|Adverse Event|5
7821767|NCT01258101|12290685|FG001|Overall Study|Adverse Event|6
7821768|NCT01258101|12290686|FG002|Overall Study|Adverse Event|0
7821769|NCT01258101|12290687|FG003|Overall Study|Adverse Event|0
7821770|NCT01258101|12290684|FG000|Overall Study|Extra exclusion criterion amended|2
7821771|NCT01258101|12290685|FG001|Overall Study|Extra exclusion criterion amended|1
7821772|NCT01258101|12290686|FG002|Overall Study|Extra exclusion criterion amended|1
7821773|NCT01258101|12290687|FG003|Overall Study|Extra exclusion criterion amended|1
7821774|NCT01258101|12290684|FG000|Overall Study|Informed consent has been withdrawn|2
7821775|NCT01258101|12290685|FG001|Overall Study|Informed consent has been withdrawn|2
7821776|NCT01258101|12290686|FG002|Overall Study|Informed consent has been withdrawn|1
7821777|NCT01258101|12290687|FG003|Overall Study|Informed consent has been withdrawn|1
7821778|NCT01258101|12290684|FG000|Overall Study|Patient is not able to attend visits|8
7821779|NCT01258101|12290685|FG001|Overall Study|Patient is not able to attend visits|9
7821780|NCT01258101|12290686|FG002|Overall Study|Patient is not able to attend visits|7
7821781|NCT01258101|12290687|FG003|Overall Study|Patient is not able to attend visits|6
7821782|NCT01258101|12290684|FG000|Overall Study|Patient´s compliance|4
7821783|NCT01258101|12290685|FG001|Overall Study|Patient´s compliance|3
7821784|NCT01258101|12290686|FG002|Overall Study|Patient´s compliance|1
7821785|NCT01258101|12290687|FG003|Overall Study|Patient´s compliance|2
7821786|NCT01258101|12290684|FG000|Overall Study|Lost to Follow-up|5
7821787|NCT01258101|12290685|FG001|Overall Study|Lost to Follow-up|5
7821788|NCT01258101|12290686|FG002|Overall Study|Lost to Follow-up|0
7821789|NCT01258101|12290687|FG003|Overall Study|Lost to Follow-up|6
7821790|NCT01258101|12290684|FG000|Overall Study|PCR positive at week 24|0
7821791|NCT01258101|12290685|FG001|Overall Study|PCR positive at week 24|0
7821792|NCT01258101|12290686|FG002|Overall Study|PCR positive at week 24|0
7821793|NCT01258101|12290687|FG003|Overall Study|PCR positive at week 24|1
7821794|NCT01258101|12290684|FG000|Overall Study|Other reason|7
7921576|NCT02177136|12446146|FG000|LTSE Phase|Discontinued Due to Pruritus|0
7921577|NCT02177136|12446147|FG001|LTSE Phase|Discontinued Due to Pruritus|0
7921578|NCT02177136|12446148|FG002|LTSE Phase|Discontinued Due to Pruritus|0
7921579|NCT02177136|12446149|FG003|LTSE Phase|Discontinued Due to Pruritus|4
7921580|NCT02177136|12446146|FG000|LTSE Phase|Physician Decision|0
7921581|NCT02177136|12446147|FG001|LTSE Phase|Physician Decision|0
7921582|NCT02177136|12446148|FG002|LTSE Phase|Physician Decision|0
7921583|NCT02177136|12446149|FG003|LTSE Phase|Physician Decision|2
7921584|NCT02177136|12446146|FG000|LTSE Phase|Lost to Follow-up|0
7921585|NCT02177136|12446147|FG001|LTSE Phase|Lost to Follow-up|0
7921586|NCT02177136|12446148|FG002|LTSE Phase|Lost to Follow-up|0
7921587|NCT02177136|12446149|FG003|LTSE Phase|Lost to Follow-up|1
7921588|NCT02177136|12446146|FG000|LTSE Phase|Participant Moved|0
7921589|NCT02177136|12446147|FG001|LTSE Phase|Participant Moved|0
7921590|NCT02177136|12446148|FG002|LTSE Phase|Participant Moved|0
7921591|NCT02177136|12446149|FG003|LTSE Phase|Participant Moved|1
7921592|NCT02177786|12446173|FG000|Overall Study|Withdrew Consent|2
7921593|NCT02177786|12446174|FG001|Overall Study|Withdrew Consent|6
7921594|NCT02177786|12446175|FG002|Overall Study|Withdrew Consent|9
7921595|NCT02177786|12446176|FG003|Overall Study|Withdrew Consent|5
7921596|NCT02177786|12446173|FG000|Overall Study|Progression to End Stage Renal Disease|2
7921597|NCT02177786|12446174|FG001|Overall Study|Progression to End Stage Renal Disease|3
7921598|NCT02177786|12446175|FG002|Overall Study|Progression to End Stage Renal Disease|2
7921599|NCT02177786|12446176|FG003|Overall Study|Progression to End Stage Renal Disease|1
7921600|NCT02177786|12446173|FG000|Overall Study|Adverse Event|1
7921601|NCT02177786|12446174|FG001|Overall Study|Adverse Event|1
7921602|NCT02177786|12446175|FG002|Overall Study|Adverse Event|2
7921603|NCT02177786|12446176|FG003|Overall Study|Adverse Event|3
7921604|NCT02177786|12446173|FG000|Overall Study|Death|1
7921605|NCT02177786|12446174|FG001|Overall Study|Death|1
7921606|NCT02177786|12446175|FG002|Overall Study|Death|1
7921607|NCT02177786|12446176|FG003|Overall Study|Death|1
7921608|NCT02177786|12446173|FG000|Overall Study|Lost to Follow-up|0
7921609|NCT02177786|12446174|FG001|Overall Study|Lost to Follow-up|0
7921610|NCT02177786|12446175|FG002|Overall Study|Lost to Follow-up|2
7921611|NCT02177786|12446176|FG003|Overall Study|Lost to Follow-up|2
7921612|NCT02177786|12446173|FG000|Overall Study|Non-Compliance with Study Drug|0
7921613|NCT02177786|12446174|FG001|Overall Study|Non-Compliance with Study Drug|1
7921614|NCT02177786|12446175|FG002|Overall Study|Non-Compliance with Study Drug|0
7921615|NCT02177786|12446176|FG003|Overall Study|Non-Compliance with Study Drug|1
7921616|NCT02177786|12446173|FG000|Overall Study|Protocol Violation|0
7921617|NCT02177786|12446174|FG001|Overall Study|Protocol Violation|0
7921618|NCT02177786|12446175|FG002|Overall Study|Protocol Violation|2
7921619|NCT02177786|12446176|FG003|Overall Study|Protocol Violation|0
7921620|NCT02177786|12446173|FG000|Overall Study|Progressive Disease|0
7921621|NCT02177786|12446174|FG001|Overall Study|Progressive Disease|1
7921622|NCT02177786|12446175|FG002|Overall Study|Progressive Disease|0
7921623|NCT02177786|12446176|FG003|Overall Study|Progressive Disease|0
7921624|NCT02177786|12446173|FG000|Overall Study|Missing study completion status|0
7921625|NCT02177786|12446174|FG001|Overall Study|Missing study completion status|1
7921626|NCT02177786|12446175|FG002|Overall Study|Missing study completion status|0
7921627|NCT02177786|12446176|FG003|Overall Study|Missing study completion status|0
7921628|NCT02177812|12446195|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7921629|NCT02177812|12446196|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7921630|NCT02177812|12446197|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7921631|NCT02177812|12446198|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7921632|NCT02177812|12446199|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7921633|NCT02177812|12446200|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
7921634|NCT02177812|12446201|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2
7921635|NCT02177812|12446202|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
7921636|NCT02177812|12446203|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7921637|NCT02177812|12446195|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0
7921638|NCT02177812|12446196|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0
7921639|NCT02177812|12446197|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0
7921640|NCT02177812|12446198|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0
7921641|NCT02177812|12446199|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0
7921642|NCT02177812|12446200|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1
7921643|NCT02177812|12446201|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1
7921644|NCT02177812|12446202|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0
7921645|NCT02177812|12446203|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0
7921646|NCT02177812|12446195|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0
7921647|NCT02177812|12446196|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0
7921648|NCT02177812|12446197|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0
7921649|NCT02177812|12446198|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1
7921650|NCT02177812|12446199|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1
7921651|NCT02177812|12446200|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1
7921652|NCT02177812|12446201|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6
7921653|NCT02177812|12446202|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1
7921654|NCT02177812|12446203|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0
7921655|NCT02177838|12446232|FG000|Overall Study|Withdrawal by Subject|1
7921656|NCT02177838|12446232|FG000|Overall Study|Physician Decision|1
7921657|NCT02177838|12446232|FG000|Overall Study|Death|1
7921658|NCT02177942|12446238|FG000|Overall Study|Adverse Event|1
7921659|NCT02177942|12446239|FG001|Overall Study|Adverse Event|0
7921660|NCT02177942|12446238|FG000|Overall Study|Lost to Follow-up|1
7921661|NCT02177942|12446239|FG001|Overall Study|Lost to Follow-up|1
7921662|NCT02177942|12446238|FG000|Overall Study|Protocol Violation|4
7921663|NCT02177942|12446239|FG001|Overall Study|Protocol Violation|6
7921664|NCT02177942|12446238|FG000|Overall Study|Withdrawal by Subject|71
7921665|NCT02177942|12446239|FG001|Overall Study|Withdrawal by Subject|81
7921666|NCT02178059|12446249|FG000|Washout|Physician Decision|1
7921667|NCT02178059|12446250|FG001|Washout|Physician Decision|0
7921668|NCT02178475|12446260|FG000|Overall Study|Withdrawal by Subject|7
7921669|NCT02178475|12446260|FG000|Overall Study|Lost to Follow-up|10
7921670|NCT02178475|12446260|FG000|Overall Study|Death|13
7921671|NCT02178475|12446260|FG000|Overall Study|Protocol-specified Criteria|99
7921672|NCT02178553|12446273|FG000|Overall Study|Did not proceed to open thoracotomy|7
7921673|NCT02178553|12446274|FG001|Overall Study|Did not proceed to open thoracotomy|3
7921674|NCT02178553|12446273|FG000|Overall Study|Physician Decision|0
7921675|NCT02178553|12446274|FG001|Overall Study|Physician Decision|4
7921676|NCT02178553|12446273|FG000|Overall Study|Technical problem with injection|1
7921677|NCT02178553|12446274|FG001|Overall Study|Technical problem with injection|3
7921678|NCT02178592|12446282|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0
7921679|NCT02178592|12446283|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2
7921680|NCT02178592|12446282|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
7921681|NCT02178592|12446283|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
7921682|NCT02178592|12446282|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3
7921683|NCT02178592|12446283|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2
7921684|NCT02178592|12446282|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3
7921685|NCT02178592|12446283|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1
7921686|NCT02178592|12446282|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11
7921687|NCT02178592|12446283|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3
7921688|NCT02178592|12446282|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1
7921689|NCT02178592|12446283|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0
7921690|NCT02178592|12446282|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1
7921691|NCT02178592|12446283|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0
7921692|NCT02178592|12446282|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0
7921693|NCT02178592|12446283|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1
7921694|NCT02178592|12446282|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2
7921695|NCT02178592|12446283|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0
7921696|NCT02178592|12446282|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4
7921697|NCT02178592|12446283|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1
7921698|NCT02178592|12446282|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2
7921699|NCT02178592|12446283|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0
7921700|NCT02178592|12446282|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3
7921701|NCT02178592|12446283|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1
7921702|NCT02178787|12446306|FG000|Overall Study|Lost to Follow-up|1
7921703|NCT02178787|12446307|FG001|Overall Study|Lost to Follow-up|0
7921704|NCT02178787|12446306|FG000|Overall Study|Withdrawal by Subject|0
7921705|NCT02178787|12446307|FG001|Overall Study|Withdrawal by Subject|2
7921706|NCT02178787|12446306|FG000|Overall Study|No TCD window|3
7921707|NCT02178787|12446307|FG001|Overall Study|No TCD window|7
7921708|NCT02178787|12446306|FG000|Overall Study|Physician Decision|1
7921709|NCT02178787|12446307|FG001|Overall Study|Physician Decision|0
7921710|NCT02178995|12446334|FG000|Double Blind|Adverse Event|0
7921711|NCT02178995|12446335|FG001|Double Blind|Adverse Event|0
7921712|NCT02178995|12446336|FG002|Double Blind|Adverse Event|0
7921713|NCT02178995|12446337|FG003|Double Blind|Adverse Event|0
7921714|NCT02178995|12446338|FG004|Double Blind|Adverse Event|0
7921715|NCT02178995|12446339|FG005|Double Blind|Adverse Event|1
7921716|NCT02178995|12446340|FG006|Double Blind|Adverse Event|0
7921717|NCT02178995|12446341|FG007|Double Blind|Adverse Event|1
7921718|NCT02178995|12446342|FG008|Double Blind|Adverse Event|1
7921719|NCT02178995|12446334|FG000|Double Blind|Lost to Follow-up|0
7921720|NCT02178995|12446335|FG001|Double Blind|Lost to Follow-up|1
7921721|NCT02178995|12446336|FG002|Double Blind|Lost to Follow-up|0
7921722|NCT02178995|12446337|FG003|Double Blind|Lost to Follow-up|0
7921723|NCT02178995|12446338|FG004|Double Blind|Lost to Follow-up|0
7921724|NCT02178995|12446339|FG005|Double Blind|Lost to Follow-up|0
7921725|NCT02178995|12446340|FG006|Double Blind|Lost to Follow-up|0
7921726|NCT02178995|12446341|FG007|Double Blind|Lost to Follow-up|1
7921727|NCT02178995|12446342|FG008|Double Blind|Lost to Follow-up|0
7921728|NCT02178995|12446334|FG000|Open Label|Adverse Event|2
7921729|NCT02178995|12446335|FG001|Open Label|Adverse Event|0
7921730|NCT02178995|12446336|FG002|Open Label|Adverse Event|0
7921731|NCT02178995|12446337|FG003|Open Label|Adverse Event|0
7921732|NCT02178995|12446338|FG004|Open Label|Adverse Event|0
7921733|NCT02178995|12446339|FG005|Open Label|Adverse Event|0
7921734|NCT02178995|12446340|FG006|Open Label|Adverse Event|0
7921735|NCT02178995|12446341|FG007|Open Label|Adverse Event|0
7921736|NCT02178995|12446342|FG008|Open Label|Adverse Event|0
7921737|NCT02179177|12446388|FG000|Overall Study|Lost to Follow-up|1
7921738|NCT02179177|12446389|FG001|Overall Study|Lost to Follow-up|1
7921739|NCT02179177|12446388|FG000|Overall Study|Withdrawal by Subject|1
7921740|NCT02179177|12446389|FG001|Overall Study|Withdrawal by Subject|1
7921741|NCT02179190|12446395|FG000|Enrollment|Exit Prior to Device Attempt|11
7921742|NCT02179190|12446395|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
7921743|NCT02179190|12446395|FG000|Follow-Up Post Barrel VRD Implanted|Death|3
7921744|NCT02179190|12446395|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
7921745|NCT02179190|12446395|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
7921746|NCT02179190|12446395|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
7921747|NCT02179398|12446401|FG000|Overall Study|Lack of obligatory data|3
7921748|NCT02179398|12446402|FG001|Overall Study|Lack of obligatory data|3
7921749|NCT02179398|12446401|FG000|Overall Study|Lost to Follow-up|0
7921750|NCT02179398|12446402|FG001|Overall Study|Lost to Follow-up|1
7921751|NCT02179515|12446433|FG000|Overall Study|switched to alternative treatment|0
7921752|NCT02179515|12446434|FG001|Overall Study|switched to alternative treatment|1
7921753|NCT02179515|12446435|FG002|Overall Study|switched to alternative treatment|1
7921754|NCT02179515|12446433|FG000|Overall Study|Death|0
7921755|NCT02179515|12446434|FG001|Overall Study|Death|1
7921756|NCT02179515|12446435|FG002|Overall Study|Death|1
7921757|NCT02179515|12446433|FG000|Overall Study|refused further treatment|0
7921758|NCT02179515|12446434|FG001|Overall Study|refused further treatment|3
7921759|NCT02179515|12446435|FG002|Overall Study|refused further treatment|4
7921760|NCT02179515|12446433|FG000|Overall Study|Disease progression on study|2
7921761|NCT02179515|12446434|FG001|Overall Study|Disease progression on study|11
7921762|NCT02179515|12446435|FG002|Overall Study|Disease progression on study|8
7921763|NCT02179918|12446491|FG000|Overall Study|Death|0
7921764|NCT02179918|12446492|FG001|Overall Study|Death|0
7921765|NCT02179918|12446493|FG002|Overall Study|Death|0
7921766|NCT02179918|12446494|FG003|Overall Study|Death|1
7921767|NCT02179918|12446495|FG004|Overall Study|Death|0
7921768|NCT02179918|12446491|FG000|Overall Study|Lost to Follow-up|0
7921769|NCT02179918|12446492|FG001|Overall Study|Lost to Follow-up|0
7921770|NCT02179918|12446493|FG002|Overall Study|Lost to Follow-up|1
7921771|NCT02179918|12446494|FG003|Overall Study|Lost to Follow-up|0
7921772|NCT02179918|12446495|FG004|Overall Study|Lost to Follow-up|0
7921773|NCT02179918|12446491|FG000|Overall Study|Progressive Disease|4
7921774|NCT02179918|12446492|FG001|Overall Study|Progressive Disease|1
7921775|NCT02179918|12446493|FG002|Overall Study|Progressive Disease|1
7921776|NCT02179918|12446494|FG003|Overall Study|Progressive Disease|2
7921777|NCT02179918|12446495|FG004|Overall Study|Progressive Disease|6
7921778|NCT02179918|12446491|FG000|Overall Study|Other|0
7921779|NCT02179918|12446492|FG001|Overall Study|Other|1
7921780|NCT02179918|12446493|FG002|Overall Study|Other|0
7921781|NCT02179918|12446494|FG003|Overall Study|Other|0
7921782|NCT02179918|12446495|FG004|Overall Study|Other|1
7921783|NCT02179918|12446491|FG000|Overall Study|Subject refused further follow-up|0
7921784|NCT02179918|12446492|FG001|Overall Study|Subject refused further follow-up|1
7921785|NCT02179918|12446493|FG002|Overall Study|Subject refused further follow-up|0
7921786|NCT02179918|12446494|FG003|Overall Study|Subject refused further follow-up|0
7921787|NCT02179918|12446495|FG004|Overall Study|Subject refused further follow-up|1
7921788|NCT02180061|12446510|FG000|Overall Study|Adverse Event|4
7921789|NCT02180061|12446511|FG001|Overall Study|Adverse Event|2
7921790|NCT02180061|12446510|FG000|Overall Study|Clinical Progression|5
7921791|NCT02180061|12446511|FG001|Overall Study|Clinical Progression|1
7921792|NCT02180061|12446510|FG000|Overall Study|Progressive Disease|15
7921793|NCT02180061|12446511|FG001|Overall Study|Progressive Disease|5
7921794|NCT02180061|12446510|FG000|Overall Study|Physician Decision|1
7921795|NCT02180061|12446511|FG001|Overall Study|Physician Decision|0
7921796|NCT02180165|12446530|FG000|Overall Study|Not Treated|0
7921797|NCT02180165|12446531|FG001|Overall Study|Not Treated|0
7921798|NCT02180165|12446532|FG002|Overall Study|Not Treated|1
7921799|NCT02180165|12446533|FG003|Overall Study|Not Treated|0
7921800|NCT02180165|12446530|FG000|Overall Study|Adverse Event|7
7921801|NCT02180165|12446531|FG001|Overall Study|Adverse Event|0
7921802|NCT02180165|12446532|FG002|Overall Study|Adverse Event|18
7921803|NCT02180165|12446533|FG003|Overall Study|Adverse Event|3
7921804|NCT02180165|12446530|FG000|Overall Study|Lack of Efficacy|0
7921805|NCT02180165|12446531|FG001|Overall Study|Lack of Efficacy|1
7921806|NCT02180165|12446532|FG002|Overall Study|Lack of Efficacy|3
7921807|NCT02180165|12446533|FG003|Overall Study|Lack of Efficacy|2
7921808|NCT02180165|12446530|FG000|Overall Study|Physician Decision|1
7921809|NCT02180165|12446531|FG001|Overall Study|Physician Decision|0
7921810|NCT02180165|12446532|FG002|Overall Study|Physician Decision|5
7921811|NCT02180165|12446533|FG003|Overall Study|Physician Decision|0
7921812|NCT02180165|12446530|FG000|Overall Study|Withdrawal by Subject|3
7921813|NCT02180165|12446531|FG001|Overall Study|Withdrawal by Subject|0
7921814|NCT02180165|12446532|FG002|Overall Study|Withdrawal by Subject|2
7921815|NCT02180165|12446533|FG003|Overall Study|Withdrawal by Subject|1
7921816|NCT02180438|12446549|FG000|Overall Study|Lost to Follow-up|1
7921817|NCT02180659|12446566|FG000|Overall Study|Adverse Event|1
7921818|NCT02180659|12446567|FG001|Overall Study|Adverse Event|0
7921819|NCT02180659|12446566|FG000|Overall Study|Lost to Follow-up|4
7921820|NCT02180659|12446567|FG001|Overall Study|Lost to Follow-up|2
7921821|NCT02180659|12446566|FG000|Overall Study|Subject incarcerated during conduct|1
7921822|NCT02180659|12446567|FG001|Overall Study|Subject incarcerated during conduct|0
7921823|NCT02180659|12446566|FG000|Overall Study|Withdrawal by Subject|0
7921824|NCT02180659|12446567|FG001|Overall Study|Withdrawal by Subject|2
7921825|NCT02180659|12446566|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0
7921826|NCT02180659|12446567|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1
7921827|NCT02180672|12446575|FG000|Overall Study|Lost to Follow-up|5
7921828|NCT02180672|12446576|FG001|Overall Study|Lost to Follow-up|7
7921829|NCT02181296|12446637|FG000|Overall Study|Lost to Follow-up|7
7921830|NCT02181296|12446638|FG001|Overall Study|Lost to Follow-up|6
7921831|NCT02181504|12446686|FG000|Overall Study|Adverse Event|1
7921832|NCT02181504|12446687|FG001|Overall Study|Adverse Event|1
7921833|NCT02181504|12446688|FG002|Overall Study|Adverse Event|1
7921834|NCT02181556|12446714|FG000|Overall Study|Withdrawal by Subject|1
7921835|NCT02181634|12446718|FG000|Overall Study|Lack of Efficacy|33
7921836|NCT02181634|12446718|FG000|Overall Study|Adverse Event|17
7921837|NCT02181634|12446718|FG000|Overall Study|Physician Decision|8
7921838|NCT02181634|12446718|FG000|Overall Study|Withdrawal by Subject|5
7921839|NCT02181634|12446718|FG000|Overall Study|Death|2
7921840|NCT02181634|12446718|FG000|Overall Study|Treatment delayed greater than 4 weeks|3
7921841|NCT02181634|12446718|FG000|Overall Study|Ineligible|1
7921842|NCT02181634|12446718|FG000|Overall Study|Max number of dose reduction|1
7921843|NCT02181634|12446718|FG000|Overall Study|Symptomatic progression|1
7921844|NCT02181634|12446718|FG000|Overall Study|Patient opted to proceed to surgery|1
7921845|NCT02181673|12446724|FG000|Up to Week 24|Adverse Event|2
7921846|NCT02181673|12446725|FG001|Up to Week 24|Adverse Event|0
7921847|NCT02181673|12446726|FG002|Up to Week 24|Adverse Event|3
7921848|NCT02181673|12446724|FG000|Up to Week 24|Death|1
7921849|NCT02181673|12446725|FG001|Up to Week 24|Death|0
7921850|NCT02181673|12446726|FG002|Up to Week 24|Death|0
7921851|NCT02181673|12446724|FG000|Up to Week 24|Lack of Efficacy|1
7921852|NCT02181673|12446725|FG001|Up to Week 24|Lack of Efficacy|0
7921853|NCT02181673|12446726|FG002|Up to Week 24|Lack of Efficacy|0
7921854|NCT02181673|12446724|FG000|Up to Week 24|Lost to Follow-up|1
7921855|NCT02181673|12446725|FG001|Up to Week 24|Lost to Follow-up|0
7921856|NCT02181673|12446726|FG002|Up to Week 24|Lost to Follow-up|0
7921857|NCT02181673|12446724|FG000|Up to Week 24|Physician Decision|0
7921858|NCT02181673|12446725|FG001|Up to Week 24|Physician Decision|0
7921859|NCT02181673|12446726|FG002|Up to Week 24|Physician Decision|3
7921860|NCT02181673|12446724|FG000|Up to Week 24|Withdrawal by Subject|10
7921861|NCT02181673|12446725|FG001|Up to Week 24|Withdrawal by Subject|0
7921862|NCT02181673|12446726|FG002|Up to Week 24|Withdrawal by Subject|1
7921863|NCT02181673|12446724|FG000|Up to Week 24|Other|2
7921864|NCT02181673|12446725|FG001|Up to Week 24|Other|0
7921865|NCT02181673|12446726|FG002|Up to Week 24|Other|3
7921866|NCT02181673|12446724|FG000|Up to Week 24|Randomized not Treated|0
7921867|NCT02181673|12446725|FG001|Up to Week 24|Randomized not Treated|0
7921868|NCT02181673|12446726|FG002|Up to Week 24|Randomized not Treated|1
7921869|NCT02181673|12446724|FG000|Week 24-Week 60|Adverse Event|0
7921870|NCT02181673|12446725|FG001|Week 24-Week 60|Adverse Event|4
7921871|NCT02181673|12446726|FG002|Week 24-Week 60|Adverse Event|10
7921872|NCT02181673|12446724|FG000|Week 24-Week 60|Other|0
7921873|NCT02181673|12446725|FG001|Week 24-Week 60|Other|2
7921874|NCT02181673|12446726|FG002|Week 24-Week 60|Other|1
7921875|NCT02181673|12446724|FG000|Week 24-Week 60|Withdrawal by Subject|0
7921876|NCT02181673|12446725|FG001|Week 24-Week 60|Withdrawal by Subject|2
7921877|NCT02181673|12446726|FG002|Week 24-Week 60|Withdrawal by Subject|2
7921878|NCT02181673|12446724|FG000|Week 24-Week 60|Pregnancy|0
7921879|NCT02181673|12446725|FG001|Week 24-Week 60|Pregnancy|0
7921880|NCT02181673|12446726|FG002|Week 24-Week 60|Pregnancy|1
7921881|NCT02181673|12446724|FG000|Week 24-Week 60|Lack of Efficacy|0
7921882|NCT02181673|12446725|FG001|Week 24-Week 60|Lack of Efficacy|0
7921883|NCT02181673|12446726|FG002|Week 24-Week 60|Lack of Efficacy|1
7921884|NCT02181673|12446724|FG000|Week 24-Week 60|Lost to Follow-up|0
7921885|NCT02181673|12446725|FG001|Week 24-Week 60|Lost to Follow-up|0
7921886|NCT02181673|12446726|FG002|Week 24-Week 60|Lost to Follow-up|1
7921887|NCT02181673|12446724|FG000|Week 24-Week 60|Physician Decision|0
7921888|NCT02181673|12446725|FG001|Week 24-Week 60|Physician Decision|0
7921889|NCT02181673|12446726|FG002|Week 24-Week 60|Physician Decision|1
7964435|NCT01940341|12519970|FG001|Open-label Extension Phase|Still on Study|1
7964436|NCT01866657|12519980|FG000|Overall Study|Surgery canceled|2
7964437|NCT01866657|12519981|FG001|Overall Study|Surgery canceled|0
7964438|NCT01705977|12519989|FG000|Overall Study|Withdrawal by Subject|128
7964439|NCT01705977|12519990|FG001|Overall Study|Withdrawal by Subject|128
7964440|NCT01705977|12519989|FG000|Overall Study|Adverse Event|57
7964441|NCT01705977|12519990|FG001|Overall Study|Adverse Event|49
7964442|NCT01705977|12519989|FG000|Overall Study|Protocol Violation|2
7964443|NCT01705977|12519990|FG001|Overall Study|Protocol Violation|4
7964444|NCT01705977|12519989|FG000|Overall Study|Site closure|3
7964445|NCT01705977|12519990|FG001|Overall Study|Site closure|2
7964446|NCT01705977|12519989|FG000|Overall Study|Lost to Follow-up|33
7964447|NCT01705977|12519990|FG001|Overall Study|Lost to Follow-up|37
7964448|NCT01705977|12519989|FG000|Overall Study|Physician Decision|48
7964449|NCT01705977|12519990|FG001|Overall Study|Physician Decision|38
7964450|NCT01705977|12519989|FG000|Overall Study|Missing study conclusion form|2
7964451|NCT01705977|12519990|FG001|Overall Study|Missing study conclusion form|2
7964452|NCT01366092|12520011|FG000|Overall Study|Progressive cGVHD|2
7964453|NCT01366092|12520011|FG000|Overall Study|Physician Decision|1
7964454|NCT01366092|12520011|FG000|Overall Study|Withdrawal by Subject|1
7964455|NCT01222247|12520017|FG000|Overall Study|Lost to Follow-up|2
7964456|NCT01222247|12520018|FG001|Overall Study|Lost to Follow-up|2
7964457|NCT01107626|12520028|FG000|Step 1: Induction Therapy|Lack of Efficacy|167
7964458|NCT01107626|12520029|FG001|Step 1: Induction Therapy|Lack of Efficacy|0
7964459|NCT01107626|12520030|FG002|Step 1: Induction Therapy|Lack of Efficacy|0
7964460|NCT01107626|12520031|FG003|Step 1: Induction Therapy|Lack of Efficacy|0
7964461|NCT01107626|12520028|FG000|Step 1: Induction Therapy|Adverse Event|198
7964462|NCT01107626|12520029|FG001|Step 1: Induction Therapy|Adverse Event|0
7964463|NCT01107626|12520030|FG002|Step 1: Induction Therapy|Adverse Event|0
7964464|NCT01107626|12520031|FG003|Step 1: Induction Therapy|Adverse Event|0
7964465|NCT01107626|12520028|FG000|Step 1: Induction Therapy|Death|62
7964466|NCT01107626|12520029|FG001|Step 1: Induction Therapy|Death|0
7964467|NCT01107626|12520030|FG002|Step 1: Induction Therapy|Death|0
7964468|NCT01107626|12520031|FG003|Step 1: Induction Therapy|Death|0
7921890|NCT02181738|12446737|FG000|Overall Study|Death|1
7921891|NCT02181738|12446738|FG001|Overall Study|Death|1
7921892|NCT02181738|12446739|FG002|Overall Study|Death|6
7921893|NCT02181738|12446740|FG003|Overall Study|Death|1
7921894|NCT02181738|12446737|FG000|Overall Study|Subject Withdrew Consent|1
7921895|NCT02181738|12446738|FG001|Overall Study|Subject Withdrew Consent|3
7921896|NCT02181738|12446739|FG002|Overall Study|Subject Withdrew Consent|2
7921897|NCT02181738|12446740|FG003|Overall Study|Subject Withdrew Consent|1
7921898|NCT02181738|12446737|FG000|Overall Study|Lost to Follow-up|0
7921899|NCT02181738|12446738|FG001|Overall Study|Lost to Follow-up|4
7921900|NCT02181738|12446739|FG002|Overall Study|Lost to Follow-up|2
7921901|NCT02181738|12446740|FG003|Overall Study|Lost to Follow-up|0
7921902|NCT02181738|12446737|FG000|Overall Study|Patient Return to Home Country|0
7921903|NCT02181738|12446738|FG001|Overall Study|Patient Return to Home Country|1
7921904|NCT02181738|12446739|FG002|Overall Study|Patient Return to Home Country|0
7921905|NCT02181738|12446740|FG003|Overall Study|Patient Return to Home Country|0
7921906|NCT02181803|12446759|FG000|Overall Study|Withdrawal by Subject|0
7921907|NCT02181803|12446760|FG001|Overall Study|Withdrawal by Subject|2
7921908|NCT02181803|12446761|FG002|Overall Study|Withdrawal by Subject|0
7921909|NCT02181803|12446762|FG003|Overall Study|Withdrawal by Subject|0
7921910|NCT02181803|12446763|FG004|Overall Study|Withdrawal by Subject|0
7921911|NCT02181803|12446764|FG005|Overall Study|Withdrawal by Subject|0
7921912|NCT02181803|12446765|FG006|Overall Study|Withdrawal by Subject|0
7921913|NCT02181803|12446766|FG007|Overall Study|Withdrawal by Subject|0
7921914|NCT02181803|12446767|FG008|Overall Study|Withdrawal by Subject|0
7921915|NCT02181803|12446759|FG000|Overall Study|Physician Decision|0
7921916|NCT02181803|12446760|FG001|Overall Study|Physician Decision|0
7921917|NCT02181803|12446761|FG002|Overall Study|Physician Decision|0
7921918|NCT02181803|12446762|FG003|Overall Study|Physician Decision|1
7921919|NCT02181803|12446763|FG004|Overall Study|Physician Decision|0
7921920|NCT02181803|12446764|FG005|Overall Study|Physician Decision|0
7921921|NCT02181803|12446765|FG006|Overall Study|Physician Decision|0
7921922|NCT02181803|12446766|FG007|Overall Study|Physician Decision|1
7921923|NCT02181803|12446767|FG008|Overall Study|Physician Decision|0
7921924|NCT02181803|12446759|FG000|Overall Study|Adverse Event|0
7921925|NCT02181803|12446760|FG001|Overall Study|Adverse Event|2
7921926|NCT02181803|12446761|FG002|Overall Study|Adverse Event|0
7921927|NCT02181803|12446762|FG003|Overall Study|Adverse Event|1
7921928|NCT02181803|12446763|FG004|Overall Study|Adverse Event|0
7921929|NCT02181803|12446764|FG005|Overall Study|Adverse Event|0
7921930|NCT02181803|12446765|FG006|Overall Study|Adverse Event|1
7921931|NCT02181803|12446766|FG007|Overall Study|Adverse Event|0
7921932|NCT02181803|12446767|FG008|Overall Study|Adverse Event|0
7921933|NCT02181816|12446812|FG000|Overall Study|Case Report Forms Uncollected|38
7921934|NCT02181816|12446812|FG000|Overall Study|Protocol Deviation|21
7921935|NCT02181842|12446820|FG000|Overall Study|Case Report Forms Uncollected|2
7921936|NCT02182440|12446837|FG000|Overall Study|Adverse Event|0
7921937|NCT02182440|12446838|FG001|Overall Study|Adverse Event|1
7921938|NCT02182440|12446839|FG002|Overall Study|Adverse Event|0
7921939|NCT02182440|12446840|FG003|Overall Study|Adverse Event|0
7921940|NCT02182440|12446837|FG000|Overall Study|Death|31
7921941|NCT02182440|12446838|FG001|Overall Study|Death|8
7921942|NCT02182440|12446839|FG002|Overall Study|Death|5
7921943|NCT02182440|12446840|FG003|Overall Study|Death|16
7921944|NCT02182440|12446837|FG000|Overall Study|Protocol Violation|0
7921945|NCT02182440|12446838|FG001|Overall Study|Protocol Violation|1
7921946|NCT02182440|12446839|FG002|Overall Study|Protocol Violation|0
7921947|NCT02182440|12446840|FG003|Overall Study|Protocol Violation|0
7921948|NCT02182440|12446837|FG000|Overall Study|Physician Decision|1
7921949|NCT02182440|12446838|FG001|Overall Study|Physician Decision|0
7921950|NCT02182440|12446839|FG002|Overall Study|Physician Decision|0
7921951|NCT02182440|12446840|FG003|Overall Study|Physician Decision|0
7921952|NCT02182440|12446837|FG000|Overall Study|Withdrawal by Subject|1
7921953|NCT02182440|12446838|FG001|Overall Study|Withdrawal by Subject|1
7921954|NCT02182440|12446839|FG002|Overall Study|Withdrawal by Subject|3
7921955|NCT02182440|12446840|FG003|Overall Study|Withdrawal by Subject|4
7921956|NCT02182440|12446837|FG000|Overall Study|different, e.g adm other hospital|12
7921957|NCT02182440|12446838|FG001|Overall Study|different, e.g adm other hospital|3
7921958|NCT02182440|12446839|FG002|Overall Study|different, e.g adm other hospital|3
7921959|NCT02182440|12446840|FG003|Overall Study|different, e.g adm other hospital|10
7921960|NCT02182830|12446867|FG000|Overall Study|Not Treated|1
7921961|NCT02182830|12446868|FG001|Overall Study|Not Treated|1
7921962|NCT02182830|12446867|FG000|Overall Study|Trial stopped, reason missing|3
7921963|NCT02182830|12446868|FG001|Overall Study|Trial stopped, reason missing|3
7921964|NCT02182830|12446867|FG000|Overall Study|Consent withdrawn|8
7921965|NCT02182830|12446868|FG001|Overall Study|Consent withdrawn|8
7921966|NCT02182830|12446867|FG000|Overall Study|Lost to Follow-up|3
7719589|NCT00533897|12143619|FG004|Lead-in (LI) Period 1|Adverse Event|0
7719590|NCT00533897|12143620|FG005|Lead-in (LI) Period 1|Adverse Event|0
7719591|NCT00533897|12143621|FG006|Lead-in (LI) Period 1|Adverse Event|0
7719592|NCT00533897|12143622|FG007|Lead-in (LI) Period 1|Adverse Event|0
7719593|NCT00533897|12143615|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2
7719594|NCT00533897|12143616|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7719595|NCT00533897|12143617|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7719596|NCT00533897|12143618|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7719597|NCT00533897|12143619|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7719598|NCT00533897|12143620|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7719599|NCT00533897|12143621|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7719600|NCT00533897|12143622|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7719601|NCT00533897|12143615|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1
7719602|NCT00533897|12143616|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0
7719603|NCT00533897|12143617|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0
7921967|NCT02182830|12446868|FG001|Overall Study|Lost to Follow-up|3
7921968|NCT02182843|12446874|FG000|Overall Study|Withdrawal by Subject|7
7921969|NCT02182843|12446874|FG000|Overall Study|Lost to Follow-up|2
7921970|NCT02182843|12446874|FG000|Overall Study|Adverse Event|1
7921971|NCT02182895|12446880|FG000|Overall Study|Discharged from hospital within 24 hours|2
7921972|NCT02182895|12446881|FG001|Overall Study|Discharged from hospital within 24 hours|4
7921973|NCT02182947|12446887|FG000|Overall Study|Withdrawal by Subject|7
7921974|NCT02182947|12446887|FG000|Overall Study|Lost to Follow-up|3
7921975|NCT02182947|12446887|FG000|Overall Study|Failed screening activities|8
7921976|NCT02182973|12446893|FG000|Overall Study|Withdrawal by Subject|3
7921977|NCT02182973|12446894|FG001|Overall Study|Withdrawal by Subject|0
7921978|NCT02182999|12446903|FG000|Overall Study|Adverse Event|4
7921979|NCT02182999|12446904|FG001|Overall Study|Adverse Event|3
7921980|NCT02182999|12446903|FG000|Overall Study|Physician Decision|1
7921981|NCT02182999|12446904|FG001|Overall Study|Physician Decision|0
7921982|NCT02183519|12446912|FG000|Overall Study|computer error|3
7921983|NCT02183519|12446913|FG001|Overall Study|computer error|0
7921984|NCT02183519|12446912|FG000|Overall Study|Did not respond to cough inducter|0
7921985|NCT02183519|12446913|FG001|Overall Study|Did not respond to cough inducter|3
7921986|NCT02183675|12446925|FG000|Treatment Period 2 (10 Days)|Adverse Event|0
7921987|NCT02183675|12446926|FG001|Treatment Period 2 (10 Days)|Adverse Event|0
7921988|NCT02183675|12446927|FG002|Treatment Period 2 (10 Days)|Adverse Event|0
7921989|NCT02183675|12446928|FG003|Treatment Period 2 (10 Days)|Adverse Event|0
7921990|NCT02183675|12446929|FG004|Treatment Period 2 (10 Days)|Adverse Event|0
7921991|NCT02183675|12446930|FG005|Treatment Period 2 (10 Days)|Adverse Event|2
7921992|NCT02184143|12446951|FG000|Overall Study|Withdrawal by Subject|4
7921993|NCT02184143|12446952|FG001|Overall Study|Withdrawal by Subject|4
7921994|NCT02184143|12446951|FG000|Overall Study|Lost to Follow-up|5
7921995|NCT02184143|12446952|FG001|Overall Study|Lost to Follow-up|3
7921996|NCT02184143|12446951|FG000|Overall Study|Death|1
7921997|NCT02184143|12446952|FG001|Overall Study|Death|0
7921998|NCT02184442|12446979|FG000|Overall Study|Death|61
7921999|NCT02184442|12446980|FG001|Overall Study|Death|65
7922000|NCT02184442|12446979|FG000|Overall Study|Withdrawal by Subject|3
7719604|NCT00533897|12143618|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0
7719605|NCT00533897|12143619|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0
7719606|NCT00533897|12143620|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0
7719607|NCT00533897|12143621|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0
7719608|NCT00533897|12143622|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0
7719609|NCT00533897|12143615|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
7719610|NCT00533897|12143616|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7719611|NCT00533897|12143617|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7719612|NCT00533897|12143618|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7719613|NCT00533897|12143619|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7719614|NCT00533897|12143620|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7719615|NCT00533897|12143621|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7719616|NCT00533897|12143622|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7719617|NCT00533897|12143615|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3
7719618|NCT00533897|12143616|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0
7719619|NCT00533897|12143617|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0
7719620|NCT00533897|12143618|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0
7719621|NCT00533897|12143619|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0
7719622|NCT00533897|12143620|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0
7719623|NCT00533897|12143621|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0
7719624|NCT00533897|12143622|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0
7719625|NCT00533897|12143615|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
7922001|NCT02184442|12446980|FG001|Overall Study|Withdrawal by Subject|11
7922002|NCT02184455|12446986|FG000|Overall Study|Lost to Follow-up|1
7922003|NCT02184572|12447005|FG000|Overall Study|Lost to Follow-up|29
7922004|NCT02184572|12447006|FG001|Overall Study|Lost to Follow-up|21
7922005|NCT02184572|12447005|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1
7922006|NCT02184572|12447006|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0
7922007|NCT02184572|12447005|FG000|Overall Study|Loss Of Kaiser Insurance|1
7922008|NCT02184572|12447006|FG001|Overall Study|Loss Of Kaiser Insurance|0
7922009|NCT02184572|12447005|FG000|Overall Study|2nd blooddraw & diary card incomplete|1
7922010|NCT02184572|12447006|FG001|Overall Study|2nd blooddraw & diary card incomplete|0
7922011|NCT02184572|12447005|FG000|Overall Study|Traveling Outside The Country|1
7922012|NCT02184572|12447006|FG001|Overall Study|Traveling Outside The Country|0
7922013|NCT02184572|12447005|FG000|Overall Study|Withdrawal by Subject|14
7922014|NCT02184572|12447006|FG001|Overall Study|Withdrawal by Subject|9
7922015|NCT02184611|12447016|FG000|Overall Study|Lack of Efficacy|11
7922016|NCT02184611|12447017|FG001|Overall Study|Lack of Efficacy|15
7922017|NCT02184611|12447016|FG000|Overall Study|Withdrawal by Subject|5
7922018|NCT02184611|12447017|FG001|Overall Study|Withdrawal by Subject|6
7922019|NCT02184611|12447016|FG000|Overall Study|Adverse Event|4
7922020|NCT02184611|12447017|FG001|Overall Study|Adverse Event|5
7922021|NCT02184611|12447016|FG000|Overall Study|Protocol Violation|1
7922022|NCT02184611|12447017|FG001|Overall Study|Protocol Violation|1
7922023|NCT02184611|12447016|FG000|Overall Study|Protocol defined stopping criteria|0
7922024|NCT02184611|12447017|FG001|Overall Study|Protocol defined stopping criteria|1
7922025|NCT02184988|12447044|FG000|Overall Study|Pregnancy|2
7922026|NCT02184988|12447044|FG000|Overall Study|Adverse Event|2
7922027|NCT02184988|12447044|FG000|Overall Study|moving away/travelling/unable to complet|6
7922028|NCT02184988|12447044|FG000|Overall Study|work scheduling issues|4
7922029|NCT02184988|12447044|FG000|Overall Study|various other reasons|9
7922030|NCT02184988|12447044|FG000|Overall Study|Lost to Follow-up|32
7922031|NCT02185014|12447048|FG000|Overall Study|Adverse Event|18
7922032|NCT02185014|12447048|FG000|Overall Study|Withdrew Consent|8
7922033|NCT02185014|12447048|FG000|Overall Study|Lost to Follow-up|4
7922034|NCT02185014|12447048|FG000|Overall Study|Lack of Efficacy|14
7922035|NCT02185014|12447048|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5
7922036|NCT02185014|12447048|FG000|Overall Study|Subject Noncompliance|1
7922037|NCT02185014|12447048|FG000|Overall Study|Other|4
7719626|NCT00533897|12143616|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7767839|NCT00856284|12210624|FG000|Overall Study|Voluntary withdrawal|48
7922038|NCT02185040|12447057|FG000|Part 1 Treatment Phase|Miscellaneous|0
7922039|NCT02185040|12447058|FG001|Part 1 Treatment Phase|Miscellaneous|0
7922040|NCT02185040|12447059|FG002|Part 1 Treatment Phase|Miscellaneous|1
7922041|NCT02185040|12447060|FG003|Part 1 Treatment Phase|Miscellaneous|0
7922042|NCT02185040|12447061|FG004|Part 1 Treatment Phase|Miscellaneous|0
7922043|NCT02185040|12447062|FG005|Part 1 Treatment Phase|Miscellaneous|0
7922044|NCT02185040|12447063|FG006|Part 1 Treatment Phase|Miscellaneous|0
7922045|NCT02185040|12447057|FG000|Part 1 Treatment Phase|Adverse Event|1
7922046|NCT02185040|12447058|FG001|Part 1 Treatment Phase|Adverse Event|0
7922047|NCT02185040|12447059|FG002|Part 1 Treatment Phase|Adverse Event|0
7922048|NCT02185040|12447060|FG003|Part 1 Treatment Phase|Adverse Event|2
7922049|NCT02185040|12447061|FG004|Part 1 Treatment Phase|Adverse Event|3
7922050|NCT02185040|12447062|FG005|Part 1 Treatment Phase|Adverse Event|0
7922051|NCT02185040|12447063|FG006|Part 1 Treatment Phase|Adverse Event|0
7922052|NCT02185040|12447057|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0
7922053|NCT02185040|12447058|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1
7922054|NCT02185040|12447059|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0
7922055|NCT02185040|12447060|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0
7922056|NCT02185040|12447061|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0
7922057|NCT02185040|12447062|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0
7922058|NCT02185040|12447063|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0
7922059|NCT02185040|12447057|FG000|Part 1 Treatment Phase|Lost to Follow-up|0
7922060|NCT02185040|12447058|FG001|Part 1 Treatment Phase|Lost to Follow-up|1
7922061|NCT02185040|12447059|FG002|Part 1 Treatment Phase|Lost to Follow-up|0
7922062|NCT02185040|12447060|FG003|Part 1 Treatment Phase|Lost to Follow-up|0
7922063|NCT02185040|12447061|FG004|Part 1 Treatment Phase|Lost to Follow-up|0
7719627|NCT00533897|12143617|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7922064|NCT02185040|12447062|FG005|Part 1 Treatment Phase|Lost to Follow-up|0
7922065|NCT02185040|12447063|FG006|Part 1 Treatment Phase|Lost to Follow-up|0
7922066|NCT02185040|12447057|FG000|Active Treatment Extension Phase|Miscellaneous|0
7922067|NCT02185040|12447058|FG001|Active Treatment Extension Phase|Miscellaneous|0
7922068|NCT02185040|12447059|FG002|Active Treatment Extension Phase|Miscellaneous|0
7922069|NCT02185040|12447060|FG003|Active Treatment Extension Phase|Miscellaneous|0
7922070|NCT02185040|12447061|FG004|Active Treatment Extension Phase|Miscellaneous|0
7922071|NCT02185040|12447062|FG005|Active Treatment Extension Phase|Miscellaneous|1
7922072|NCT02185040|12447063|FG006|Active Treatment Extension Phase|Miscellaneous|0
7922073|NCT02185040|12447057|FG000|Active Treatment Extension Phase|Adverse Event|0
7922074|NCT02185040|12447058|FG001|Active Treatment Extension Phase|Adverse Event|0
7922075|NCT02185040|12447059|FG002|Active Treatment Extension Phase|Adverse Event|0
7922076|NCT02185040|12447060|FG003|Active Treatment Extension Phase|Adverse Event|0
7922077|NCT02185040|12447061|FG004|Active Treatment Extension Phase|Adverse Event|0
7922078|NCT02185040|12447062|FG005|Active Treatment Extension Phase|Adverse Event|1
7922079|NCT02185040|12447063|FG006|Active Treatment Extension Phase|Adverse Event|4
7922080|NCT02185040|12447057|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0
7922081|NCT02185040|12447058|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0
7922082|NCT02185040|12447059|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0
7922083|NCT02185040|12447060|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0
7922084|NCT02185040|12447061|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0
7922085|NCT02185040|12447062|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1
7922086|NCT02185040|12447063|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1
7922087|NCT02185040|12447057|FG000|Active Treatment Extension Phase|Lost to Follow-up|0
7922088|NCT02185040|12447058|FG001|Active Treatment Extension Phase|Lost to Follow-up|0
7922089|NCT02185040|12447059|FG002|Active Treatment Extension Phase|Lost to Follow-up|0
7922090|NCT02185040|12447060|FG003|Active Treatment Extension Phase|Lost to Follow-up|0
7922091|NCT02185040|12447061|FG004|Active Treatment Extension Phase|Lost to Follow-up|0
7922092|NCT02185040|12447062|FG005|Active Treatment Extension Phase|Lost to Follow-up|0
7922093|NCT02185040|12447063|FG006|Active Treatment Extension Phase|Lost to Follow-up|2
7922094|NCT02185053|12447083|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1
7922095|NCT02185053|12447084|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
7922096|NCT02185053|12447085|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
7922097|NCT02185053|12447083|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2
7922098|NCT02185053|12447084|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
7922099|NCT02185053|12447085|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
7922100|NCT02185053|12447083|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0
7922101|NCT02185053|12447084|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1
7922102|NCT02185053|12447085|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0
7922103|NCT02185053|12447083|FG000|Donepezil Dose Escalation Phase|Adverse Event|0
7922104|NCT02185053|12447084|FG001|Donepezil Dose Escalation Phase|Adverse Event|1
7922105|NCT02185053|12447085|FG002|Donepezil Dose Escalation Phase|Adverse Event|0
7922106|NCT02185053|12447083|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
7922107|NCT02185053|12447084|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2
7922108|NCT02185053|12447085|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
7922109|NCT02185053|12447083|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
7922110|NCT02185053|12447084|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1
7922111|NCT02185053|12447085|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
7922112|NCT02185053|12447083|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
7922113|NCT02185053|12447084|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
7922114|NCT02185053|12447085|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1
7922115|NCT02185053|12447083|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
7922116|NCT02185053|12447084|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
7922117|NCT02185053|12447085|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2
7922118|NCT02185521|12447131|FG000|Overall Study|Withdrawal by Subject|1
7922119|NCT02185521|12447131|FG000|Overall Study|Protocol Violation|1
7922120|NCT02185534|12447142|FG000|First Period|Withdrawal by Subject|0
7922121|NCT02185534|12447143|FG001|First Period|Withdrawal by Subject|0
7922122|NCT02185534|12447144|FG002|First Period|Withdrawal by Subject|0
7922123|NCT02185534|12447145|FG003|First Period|Withdrawal by Subject|1
7922124|NCT02185534|12447146|FG004|First Period|Withdrawal by Subject|0
7922125|NCT02185534|12447147|FG005|First Period|Withdrawal by Subject|0
7922126|NCT02185534|12447142|FG000|First Washout Period|Withdrawal by Subject|1
7922127|NCT02185534|12447143|FG001|First Washout Period|Withdrawal by Subject|0
7922128|NCT02185534|12447144|FG002|First Washout Period|Withdrawal by Subject|0
7922129|NCT02185534|12447145|FG003|First Washout Period|Withdrawal by Subject|0
7922130|NCT02185534|12447146|FG004|First Washout Period|Withdrawal by Subject|1
7922131|NCT02185534|12447147|FG005|First Washout Period|Withdrawal by Subject|0
7922132|NCT02185534|12447142|FG000|First Washout Period|Protocol Violation|0
7922133|NCT02185534|12447143|FG001|First Washout Period|Protocol Violation|0
7922134|NCT02185534|12447144|FG002|First Washout Period|Protocol Violation|0
7922135|NCT02185534|12447145|FG003|First Washout Period|Protocol Violation|0
7922136|NCT02185534|12447146|FG004|First Washout Period|Protocol Violation|0
7922137|NCT02185534|12447147|FG005|First Washout Period|Protocol Violation|1
7922138|NCT02185794|12447169|FG000|Overall Study|Enrolled but Never Dosed|1
7922139|NCT02185794|12447170|FG001|Overall Study|Enrolled but Never Dosed|6
7922140|NCT02185794|12447171|FG002|Overall Study|Enrolled but Never Dosed|3
7922141|NCT02185794|12447172|FG003|Overall Study|Enrolled but Never Dosed|1
7922142|NCT02185794|12447173|FG004|Overall Study|Enrolled but Never Dosed|1
7922143|NCT02185794|12447174|FG005|Overall Study|Enrolled but Never Dosed|0
7922144|NCT02185794|12447169|FG000|Overall Study|Investigator's Discretion|1
7922145|NCT02185794|12447170|FG001|Overall Study|Investigator's Discretion|0
7922146|NCT02185794|12447171|FG002|Overall Study|Investigator's Discretion|1
7922147|NCT02185794|12447172|FG003|Overall Study|Investigator's Discretion|2
7922148|NCT02185794|12447173|FG004|Overall Study|Investigator's Discretion|2
7922149|NCT02185794|12447174|FG005|Overall Study|Investigator's Discretion|15
7922150|NCT02185794|12447169|FG000|Overall Study|Withdrew Consent|2
7922151|NCT02185794|12447170|FG001|Overall Study|Withdrew Consent|5
7922152|NCT02185794|12447171|FG002|Overall Study|Withdrew Consent|10
7922153|NCT02185794|12447172|FG003|Overall Study|Withdrew Consent|2
7922154|NCT02185794|12447173|FG004|Overall Study|Withdrew Consent|0
7922155|NCT02185794|12447174|FG005|Overall Study|Withdrew Consent|0
7922156|NCT02185794|12447169|FG000|Overall Study|Lost to Follow-up|1
7922157|NCT02185794|12447170|FG001|Overall Study|Lost to Follow-up|2
7922158|NCT02185794|12447171|FG002|Overall Study|Lost to Follow-up|2
7922159|NCT02185794|12447172|FG003|Overall Study|Lost to Follow-up|3
7922160|NCT02185794|12447173|FG004|Overall Study|Lost to Follow-up|0
7922161|NCT02185794|12447174|FG005|Overall Study|Lost to Follow-up|1
7922162|NCT02186015|12447204|FG000|Overall Study|Physician Decision|1
7922163|NCT02186015|12447205|FG001|Overall Study|Physician Decision|0
7922164|NCT02186171|12447214|FG000|Overall Study|Withdrawal by Subject|1
7922165|NCT02186171|12447215|FG001|Overall Study|Withdrawal by Subject|9
7922166|NCT02186171|12447214|FG000|Overall Study|Lost to Follow-up|2
7922167|NCT02186171|12447215|FG001|Overall Study|Lost to Follow-up|2
7922168|NCT02186171|12447214|FG000|Overall Study|Death|1
7922169|NCT02186171|12447215|FG001|Overall Study|Death|2
7922170|NCT02186171|12447214|FG000|Overall Study|Protocol-specified Criteria|0
7922171|NCT02186171|12447215|FG001|Overall Study|Protocol-specified Criteria|2
7922172|NCT02186223|12447232|FG000|Overall Study|Not eligible for device placement|6
7922173|NCT02186223|12447232|FG000|Overall Study|Unable to obtain femoral access|3
7922174|NCT02186223|12447232|FG000|Overall Study|Death|3
7922175|NCT02186223|12447232|FG000|Overall Study|Device in place less than 48 hours|9
7922176|NCT02186301|12447240|FG000|Overall Study|Progressive Disease|7
7922177|NCT02186301|12447241|FG001|Overall Study|Progressive Disease|22
7922178|NCT02186301|12447242|FG002|Overall Study|Progressive Disease|27
7922179|NCT02186301|12447240|FG000|Overall Study|Adverse Event|5
7922180|NCT02186301|12447241|FG001|Overall Study|Adverse Event|5
7922181|NCT02186301|12447242|FG002|Overall Study|Adverse Event|5
7922182|NCT02186301|12447240|FG000|Overall Study|Death|1
7922183|NCT02186301|12447241|FG001|Overall Study|Death|0
7922184|NCT02186301|12447242|FG002|Overall Study|Death|0
7922185|NCT02186301|12447240|FG000|Overall Study|Withdrawal by Subject|5
7922186|NCT02186301|12447241|FG001|Overall Study|Withdrawal by Subject|1
7922187|NCT02186301|12447242|FG002|Overall Study|Withdrawal by Subject|3
7922188|NCT02186301|12447240|FG000|Overall Study|Physician Decision|1
7922189|NCT02186301|12447241|FG001|Overall Study|Physician Decision|0
7922190|NCT02186301|12447242|FG002|Overall Study|Physician Decision|1
7922191|NCT02186301|12447240|FG000|Overall Study|Study Terminated by Sponsor|1
7922192|NCT02186301|12447241|FG001|Overall Study|Study Terminated by Sponsor|0
7922193|NCT02186301|12447242|FG002|Overall Study|Study Terminated by Sponsor|11
7922194|NCT02186301|12447240|FG000|Overall Study|Protocol Deviation|0
7922195|NCT02186301|12447241|FG001|Overall Study|Protocol Deviation|2
7922196|NCT02186301|12447242|FG002|Overall Study|Protocol Deviation|0
7922197|NCT02186301|12447240|FG000|Overall Study|Missing|0
7922198|NCT02186301|12447241|FG001|Overall Study|Missing|0
7922199|NCT02186301|12447242|FG002|Overall Study|Missing|2
7922200|NCT02186301|12447240|FG000|Overall Study|Other|0
7922201|NCT02186301|12447241|FG001|Overall Study|Other|0
7922202|NCT02186301|12447242|FG002|Overall Study|Other|1
7922203|NCT02186561|12447256|FG000|Enrollment|Did Not Meet Inclusion Criteria|46
7922204|NCT02186561|12447256|FG000|Enrollment|Enrollment Cap Reached|5
7922205|NCT02186561|12447256|FG000|Enrollment|Insurance Denial|2
7922206|NCT02186561|12447256|FG000|Enrollment|Withdrawal by Subject|2
7922207|NCT02186561|12447256|FG000|Enrollment|Investigator Withdrew Consent|1
7922208|NCT02186561|12447256|FG000|30-Day Post Index Procedure Visit|Death|1
7922209|NCT02186561|12447256|FG000|1- Year Post Index Procedure Visit|Death|1
7922210|NCT02186561|12447256|FG000|1- Year Post Index Procedure Visit|Missed|1
7922211|NCT02186652|12447272|FG000|Overall Study|Lost to Follow-up|2
7922212|NCT02186652|12447273|FG001|Overall Study|Lost to Follow-up|0
7922213|NCT02186821|12447308|FG000|Overall Study|Adverse Event|9
7922214|NCT02186821|12447308|FG000|Overall Study|Death|2
7922215|NCT02186821|12447308|FG000|Overall Study|Disease progression|32
7922216|NCT02186821|12447308|FG000|Overall Study|Protocol Violation|1
7922217|NCT02186821|12447308|FG000|Overall Study|Physician Decision|1
7922218|NCT02186821|12447308|FG000|Overall Study|Study terminated by sponsor|2
7922219|NCT02186873|12447314|FG000|Overall Study|Adverse Event|1
7922220|NCT02186873|12447315|FG001|Overall Study|Adverse Event|3
7922221|NCT02186873|12447314|FG000|Overall Study|Lack of Efficacy|0
7922222|NCT02186873|12447315|FG001|Overall Study|Lack of Efficacy|1
7922223|NCT02186873|12447314|FG000|Overall Study|Lost to Follow-up|1
7922224|NCT02186873|12447315|FG001|Overall Study|Lost to Follow-up|2
7922225|NCT02186873|12447314|FG000|Overall Study|Withdrawal by Subject|7
7922226|NCT02186873|12447315|FG001|Overall Study|Withdrawal by Subject|2
7922227|NCT02187029|12447352|FG000|Overall Study|Adverse Event|0
7922228|NCT02187029|12447353|FG001|Overall Study|Adverse Event|1
7922229|NCT02187029|12447354|FG002|Overall Study|Adverse Event|1
7922230|NCT02187029|12447355|FG003|Overall Study|Adverse Event|0
7922231|NCT02187029|12447352|FG000|Overall Study|Study Terminated by Sponsor|0
7922232|NCT02187029|12447353|FG001|Overall Study|Study Terminated by Sponsor|0
7922233|NCT02187029|12447354|FG002|Overall Study|Study Terminated by Sponsor|10
7922234|NCT02187029|12447355|FG003|Overall Study|Study Terminated by Sponsor|3
7922235|NCT02187029|12447352|FG000|Overall Study|Withdrawal by Subject|1
7922236|NCT02187029|12447353|FG001|Overall Study|Withdrawal by Subject|0
7922237|NCT02187029|12447354|FG002|Overall Study|Withdrawal by Subject|0
7922238|NCT02187029|12447355|FG003|Overall Study|Withdrawal by Subject|0
7922239|NCT02187042|12447367|FG000|Overall Study|Death|1
7922240|NCT02187042|12447368|FG001|Overall Study|Death|1
7922241|NCT02187042|12447367|FG000|Overall Study|Toxicity|6
7922242|NCT02187042|12447368|FG001|Overall Study|Toxicity|5
7922243|NCT02187042|12447367|FG000|Overall Study|Participant choice|1
7922244|NCT02187042|12447368|FG001|Overall Study|Participant choice|0
7922245|NCT02187042|12447367|FG000|Overall Study|Doctor choice|1
7922246|NCT02187042|12447368|FG001|Overall Study|Doctor choice|0
7922247|NCT02187042|12447367|FG000|Overall Study|Progressive disease|4
7922248|NCT02187042|12447368|FG001|Overall Study|Progressive disease|8
7922249|NCT02187055|12447378|FG000|Overall Study|Lack of Efficacy|10
7922250|NCT02187055|12447379|FG001|Overall Study|Lack of Efficacy|3
7922251|NCT02187055|12447380|FG002|Overall Study|Lack of Efficacy|7
7922252|NCT02187055|12447378|FG000|Overall Study|Lost to Follow-up|2
7922253|NCT02187055|12447379|FG001|Overall Study|Lost to Follow-up|7
7922254|NCT02187055|12447380|FG002|Overall Study|Lost to Follow-up|3
7922255|NCT02187055|12447378|FG000|Overall Study|No longer meets eligibility criteria|0
7922256|NCT02187055|12447379|FG001|Overall Study|No longer meets eligibility criteria|2
7922257|NCT02187055|12447380|FG002|Overall Study|No longer meets eligibility criteria|0
7922258|NCT02187055|12447378|FG000|Overall Study|No longer willing to participate|6
7922259|NCT02187055|12447379|FG001|Overall Study|No longer willing to participate|8
7922260|NCT02187055|12447380|FG002|Overall Study|No longer willing to participate|10
7821795|NCT01258101|12290685|FG001|Overall Study|Other reason|8
7821796|NCT01258101|12290686|FG002|Overall Study|Other reason|1
7821797|NCT01258101|12290687|FG003|Overall Study|Other reason|8
7821798|NCT01258348|12290712|FG000|Overall Study|Adverse Event|1
7821799|NCT01258348|12290713|FG001|Overall Study|Adverse Event|1
7821800|NCT01258348|12290714|FG002|Overall Study|Adverse Event|3
7821801|NCT01258348|12290715|FG003|Overall Study|Adverse Event|2
7821802|NCT01258348|12290716|FG004|Overall Study|Adverse Event|4
7821803|NCT01258348|12290712|FG000|Overall Study|Progressive Disease|0
7821804|NCT01258348|12290713|FG001|Overall Study|Progressive Disease|3
7821805|NCT01258348|12290714|FG002|Overall Study|Progressive Disease|0
7821806|NCT01258348|12290715|FG003|Overall Study|Progressive Disease|2
7821807|NCT01258348|12290716|FG004|Overall Study|Progressive Disease|2
7821808|NCT01258348|12290712|FG000|Overall Study|Physician Decision|0
7821809|NCT01258348|12290713|FG001|Overall Study|Physician Decision|0
7821810|NCT01258348|12290714|FG002|Overall Study|Physician Decision|0
7821811|NCT01258348|12290715|FG003|Overall Study|Physician Decision|2
7821812|NCT01258348|12290716|FG004|Overall Study|Physician Decision|0
7821813|NCT01258348|12290712|FG000|Overall Study|Withdrawal by Subject|0
7821814|NCT01258348|12290713|FG001|Overall Study|Withdrawal by Subject|1
7821815|NCT01258348|12290714|FG002|Overall Study|Withdrawal by Subject|0
7821816|NCT01258348|12290715|FG003|Overall Study|Withdrawal by Subject|0
7821817|NCT01258348|12290716|FG004|Overall Study|Withdrawal by Subject|0
7821818|NCT01258595|12290787|FG000|Overall Study|Lost to Follow-up|1
7821819|NCT01258595|12290788|FG001|Overall Study|Lost to Follow-up|0
7821820|NCT01258595|12290787|FG000|Overall Study|Withdrawal by Subject|0
7821821|NCT01258595|12290788|FG001|Overall Study|Withdrawal by Subject|1
7922261|NCT02187055|12447378|FG000|Overall Study|Other|5
7922262|NCT02187055|12447379|FG001|Overall Study|Other|6
7922263|NCT02187055|12447380|FG002|Overall Study|Other|3
7922264|NCT02187055|12447378|FG000|Overall Study|Protocol Violation|9
7922265|NCT02187055|12447379|FG001|Overall Study|Protocol Violation|9
7922266|NCT02187055|12447380|FG002|Overall Study|Protocol Violation|4
7922267|NCT02187055|12447378|FG000|Overall Study|Pregnancy|3
7922268|NCT02187055|12447379|FG001|Overall Study|Pregnancy|1
7922269|NCT02187055|12447380|FG002|Overall Study|Pregnancy|0
7922270|NCT02187055|12447378|FG000|Overall Study|Withdrawal by Subject|11
7922271|NCT02187055|12447379|FG001|Overall Study|Withdrawal by Subject|11
7922272|NCT02187055|12447380|FG002|Overall Study|Withdrawal by Subject|11
7922273|NCT02187055|12447378|FG000|Overall Study|Adverse Event|21
7922274|NCT02187055|12447379|FG001|Overall Study|Adverse Event|26
7922275|NCT02187055|12447380|FG002|Overall Study|Adverse Event|36
7922276|NCT02187055|12447378|FG000|Overall Study|Death|2
7922277|NCT02187055|12447379|FG001|Overall Study|Death|0
7922278|NCT02187055|12447380|FG002|Overall Study|Death|0
7922279|NCT02187159|12447392|FG000|Overall Study|Protocol Violation|4
7922280|NCT02187159|12447393|FG001|Overall Study|Protocol Violation|6
7922281|NCT02187159|12447394|FG002|Overall Study|Protocol Violation|3
7922282|NCT02187159|12447395|FG003|Overall Study|Protocol Violation|4
7922283|NCT02187159|12447392|FG000|Overall Study|Lack of Efficacy|10
7922284|NCT02187159|12447393|FG001|Overall Study|Lack of Efficacy|5
7922285|NCT02187159|12447394|FG002|Overall Study|Lack of Efficacy|4
7922286|NCT02187159|12447395|FG003|Overall Study|Lack of Efficacy|7
7922287|NCT02187159|12447392|FG000|Overall Study|Adverse Event|28
7922288|NCT02187159|12447393|FG001|Overall Study|Adverse Event|33
7922289|NCT02187159|12447394|FG002|Overall Study|Adverse Event|42
7922290|NCT02187159|12447395|FG003|Overall Study|Adverse Event|50
7922291|NCT02187159|12447392|FG000|Overall Study|Withdrawal by Subject|24
7922292|NCT02187159|12447393|FG001|Overall Study|Withdrawal by Subject|28
7922293|NCT02187159|12447394|FG002|Overall Study|Withdrawal by Subject|25
7922294|NCT02187159|12447395|FG003|Overall Study|Withdrawal by Subject|26
7922295|NCT02187159|12447392|FG000|Overall Study|Other|3
7922296|NCT02187159|12447393|FG001|Overall Study|Other|7
7922297|NCT02187159|12447394|FG002|Overall Study|Other|3
7922298|NCT02187159|12447395|FG003|Overall Study|Other|9
7922299|NCT02187172|12447407|FG000|Overall Study|Lost to Follow-up|1
7922300|NCT02187172|12447408|FG001|Overall Study|Lost to Follow-up|2
7922301|NCT02187172|12447407|FG000|Overall Study|Lack of Efficacy|1
7922302|NCT02187172|12447408|FG001|Overall Study|Lack of Efficacy|2
7922303|NCT02187172|12447407|FG000|Overall Study|Adverse Event|0
7922304|NCT02187172|12447408|FG001|Overall Study|Adverse Event|1
7922305|NCT02187172|12447407|FG000|Overall Study|Physician Decision|1
7922306|NCT02187172|12447408|FG001|Overall Study|Physician Decision|1
7922307|NCT02187471|12447420|FG000|Overall Study|Protocol Violation|4
7922308|NCT02187471|12447421|FG001|Overall Study|Protocol Violation|5
7922309|NCT02187471|12447422|FG002|Overall Study|Protocol Violation|4
7922310|NCT02187471|12447423|FG003|Overall Study|Protocol Violation|4
7922311|NCT02187471|12447420|FG000|Overall Study|Missing|0
7922312|NCT02187471|12447421|FG001|Overall Study|Missing|0
7922313|NCT02187471|12447422|FG002|Overall Study|Missing|0
7922314|NCT02187471|12447423|FG003|Overall Study|Missing|1
7922315|NCT02187471|12447420|FG000|Overall Study|Lack of Efficacy|18
7922316|NCT02187471|12447421|FG001|Overall Study|Lack of Efficacy|9
7922317|NCT02187471|12447422|FG002|Overall Study|Lack of Efficacy|13
7922318|NCT02187471|12447423|FG003|Overall Study|Lack of Efficacy|11
7922319|NCT02187471|12447420|FG000|Overall Study|Adverse Event|24
7922320|NCT02187471|12447421|FG001|Overall Study|Adverse Event|34
7922321|NCT02187471|12447422|FG002|Overall Study|Adverse Event|44
7922322|NCT02187471|12447423|FG003|Overall Study|Adverse Event|36
7922323|NCT02187471|12447420|FG000|Overall Study|Withdrawal by Subject|23
7922324|NCT02187471|12447421|FG001|Overall Study|Withdrawal by Subject|29
7922325|NCT02187471|12447422|FG002|Overall Study|Withdrawal by Subject|22
7922326|NCT02187471|12447423|FG003|Overall Study|Withdrawal by Subject|24
7922327|NCT02187471|12447420|FG000|Overall Study|Other|7
7922328|NCT02187471|12447421|FG001|Overall Study|Other|5
7922329|NCT02187471|12447422|FG002|Overall Study|Other|3
7922330|NCT02187471|12447423|FG003|Overall Study|Other|4
7922331|NCT02187744|12447436|FG000|Study|Participant refused further follow-up|1
7922332|NCT02187744|12447437|FG001|Study|Participant refused further follow-up|0
7922333|NCT02187744|12447436|FG000|Study|Other|2
7922334|NCT02187744|12447437|FG001|Study|Other|1
7922335|NCT02187744|12447436|FG000|Study|Lost to Follow-up|0
7922336|NCT02187744|12447437|FG001|Study|Lost to Follow-up|2
7922337|NCT02187744|12447436|FG000|Study|Related adverse event, not serious|0
7922338|NCT02187744|12447437|FG001|Study|Related adverse event, not serious|2
7922339|NCT02187744|12447436|FG000|Study|Death|1
7821822|NCT01258608|12290796|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1
7821823|NCT01258608|12290797|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0
7821824|NCT01258608|12290796|FG000|Overall Study|Clinical progression|1
7821825|NCT01258608|12290797|FG001|Overall Study|Clinical progression|0
7821826|NCT01258608|12290796|FG000|Overall Study|Sponsor decision|0
7821827|NCT01258608|12290797|FG001|Overall Study|Sponsor decision|1
7821828|NCT01258608|12290796|FG000|Overall Study|Physician Decision|6
7821829|NCT01258608|12290797|FG001|Overall Study|Physician Decision|1
7821830|NCT01258608|12290796|FG000|Overall Study|Lost to Follow-up|0
7821831|NCT01258608|12290797|FG001|Overall Study|Lost to Follow-up|1
7821832|NCT01258608|12290796|FG000|Overall Study|Lack of compliance|1
7922340|NCT02187744|12447437|FG001|Study|Death|0
7922341|NCT02187744|12447436|FG000|Study|Related adverse event, serious non-fatal|0
7922342|NCT02187744|12447437|FG001|Study|Related adverse event, serious non-fatal|1
7922343|NCT02187744|12447436|FG000|Treatment|Death|1
7922344|NCT02187744|12447437|FG001|Treatment|Death|0
7922345|NCT02187744|12447436|FG000|Treatment|Related adverse event, serious non-fatal|0
7922346|NCT02187744|12447437|FG001|Treatment|Related adverse event, serious non-fatal|1
7922347|NCT02187744|12447436|FG000|Treatment|Related adverse event, not serious|0
7922348|NCT02187744|12447437|FG001|Treatment|Related adverse event, not serious|2
7922349|NCT02187744|12447436|FG000|Treatment|Lost to Follow-up|0
7922350|NCT02187744|12447437|FG001|Treatment|Lost to Follow-up|1
7922351|NCT02187744|12447436|FG000|Treatment|Other|2
7922352|NCT02187744|12447437|FG001|Treatment|Other|0
7922353|NCT02187744|12447436|FG000|Treatment|Participant refused continued treatment|1
7922354|NCT02187744|12447437|FG001|Treatment|Participant refused continued treatment|1
7922355|NCT02187783|12447443|FG000|Overall Study|Adverse Event|8
7922356|NCT02187783|12447443|FG000|Overall Study|Death|3
7922357|NCT02187783|12447443|FG000|Overall Study|Progressive disease|80
7922358|NCT02187783|12447443|FG000|Overall Study|Protocol Violation|3
7922359|NCT02187783|12447443|FG000|Overall Study|Physician Decision|2
7922360|NCT02187783|12447443|FG000|Overall Study|Withdrawal by Subject|9
7922361|NCT02187783|12447443|FG000|Overall Study|Study terminated by sponsor|1
7922362|NCT02187809|12447447|FG000|Overall Study|The study was terminated|3
7922363|NCT02187861|12447455|FG000|Overall Study|Adverse Event|2
7922364|NCT02187861|12447456|FG001|Overall Study|Adverse Event|1
7922365|NCT02187861|12447457|FG002|Overall Study|Adverse Event|2
7922366|NCT02187861|12447458|FG003|Overall Study|Adverse Event|1
7922367|NCT02187861|12447455|FG000|Overall Study|Death|0
7922368|NCT02187861|12447456|FG001|Overall Study|Death|3
7922369|NCT02187861|12447457|FG002|Overall Study|Death|1
7922370|NCT02187861|12447458|FG003|Overall Study|Death|2
7922371|NCT02187861|12447455|FG000|Overall Study|Physician Decision|0
7922372|NCT02187861|12447456|FG001|Overall Study|Physician Decision|1
7922373|NCT02187861|12447457|FG002|Overall Study|Physician Decision|0
7922374|NCT02187861|12447458|FG003|Overall Study|Physician Decision|3
7922375|NCT02187861|12447455|FG000|Overall Study|Progressive Disease|4
7922376|NCT02187861|12447456|FG001|Overall Study|Progressive Disease|42
7922377|NCT02187861|12447457|FG002|Overall Study|Progressive Disease|19
7821833|NCT01258608|12290797|FG001|Overall Study|Lack of compliance|0
7922378|NCT02187861|12447458|FG003|Overall Study|Progressive Disease|22
7922379|NCT02187861|12447455|FG000|Overall Study|Withdrawal by Subject|0
7821834|NCT01258608|12290796|FG000|Overall Study|Lack of Efficacy|0
7821835|NCT01258608|12290797|FG001|Overall Study|Lack of Efficacy|1
7922380|NCT02187861|12447456|FG001|Overall Study|Withdrawal by Subject|0
7922381|NCT02187861|12447457|FG002|Overall Study|Withdrawal by Subject|3
7922382|NCT02187861|12447458|FG003|Overall Study|Withdrawal by Subject|3
7922383|NCT02187861|12447455|FG000|Overall Study|Other|0
7922384|NCT02187861|12447456|FG001|Overall Study|Other|1
7922385|NCT02187861|12447457|FG002|Overall Study|Other|7
7922386|NCT02187861|12447458|FG003|Overall Study|Other|1
7922387|NCT02188160|12447479|FG000|Overall Study|Adverse Event|1
7922388|NCT02188160|12447480|FG001|Overall Study|Adverse Event|0
7922389|NCT02188160|12447479|FG000|Overall Study|Use of an excluded medication|0
7922390|NCT02188160|12447480|FG001|Overall Study|Use of an excluded medication|1
7922391|NCT02188303|12447494|FG000|Overall Study|Adverse Event|0
7922392|NCT02188303|12447495|FG001|Overall Study|Adverse Event|0
7922393|NCT02188303|12447496|FG002|Overall Study|Adverse Event|0
7922394|NCT02188303|12447497|FG003|Overall Study|Adverse Event|0
7922395|NCT02188303|12447498|FG004|Overall Study|Adverse Event|0
7922396|NCT02188303|12447499|FG005|Overall Study|Adverse Event|2
7922397|NCT02188303|12447500|FG006|Overall Study|Adverse Event|0
7922398|NCT02188303|12447501|FG007|Overall Study|Adverse Event|2
7922399|NCT02188303|12447494|FG000|Overall Study|Dose Termination Criteria Met|0
7922400|NCT02188303|12447495|FG001|Overall Study|Dose Termination Criteria Met|0
7922401|NCT02188303|12447496|FG002|Overall Study|Dose Termination Criteria Met|0
7922402|NCT02188303|12447497|FG003|Overall Study|Dose Termination Criteria Met|0
7922403|NCT02188303|12447498|FG004|Overall Study|Dose Termination Criteria Met|0
7922404|NCT02188303|12447499|FG005|Overall Study|Dose Termination Criteria Met|0
7922405|NCT02188303|12447500|FG006|Overall Study|Dose Termination Criteria Met|2
7922406|NCT02188303|12447501|FG007|Overall Study|Dose Termination Criteria Met|4
7922407|NCT02188459|12447527|FG000|Overall Study|Lost to Follow-up|3
7922408|NCT02188459|12447528|FG001|Overall Study|Lost to Follow-up|4
7922409|NCT02188459|12447527|FG000|Overall Study|Early Termination|0
7922410|NCT02188459|12447528|FG001|Overall Study|Early Termination|3
7922411|NCT02188485|12447540|FG000|Overall Study|Withdrawal by Subject|2
7922412|NCT02188485|12447541|FG001|Overall Study|Withdrawal by Subject|1
7922413|NCT02188485|12447540|FG000|Overall Study|PI withdrew, lack of capacity|0
7922414|NCT02188485|12447541|FG001|Overall Study|PI withdrew, lack of capacity|2
7922415|NCT02188589|12447556|FG000|Overall Study|Withdrawal by Subject|5
7922416|NCT02188719|12447565|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
7922417|NCT02188719|12447566|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1
7922418|NCT02188719|12447567|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
7922419|NCT02188719|12447568|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
7922420|NCT02188784|12447578|FG000|Overall Study|Death|3
7922421|NCT02188784|12447579|FG001|Overall Study|Death|1
7922422|NCT02188784|12447578|FG000|Overall Study|Lost to Follow-up|1
7922423|NCT02188784|12447579|FG001|Overall Study|Lost to Follow-up|0
7922424|NCT02188784|12447578|FG000|Overall Study|Withdrawal by Subject|3
7922425|NCT02188784|12447579|FG001|Overall Study|Withdrawal by Subject|9
7922426|NCT02188784|12447578|FG000|Overall Study|Physician Decision|2
7922427|NCT02188784|12447579|FG001|Overall Study|Physician Decision|3
7922428|NCT02188849|12447587|FG000|Overall Study|Lost to Follow-up|3
7922429|NCT02188849|12447588|FG001|Overall Study|Lost to Follow-up|8
7922430|NCT02189252|12447622|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
7922431|NCT02189252|12447623|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
7922432|NCT02189252|12447624|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
7922433|NCT02189252|12447625|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
7922434|NCT02189252|12447622|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0
7922435|NCT02189252|12447623|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1
7922436|NCT02189252|12447624|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0
7922437|NCT02189252|12447625|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0
7922438|NCT02189473|12447656|FG000|Overall Study|Death|22
7922439|NCT02189473|12447657|FG001|Overall Study|Death|23
7922440|NCT02189473|12447656|FG000|Overall Study|Lost to Follow-up|1
7922441|NCT02189473|12447657|FG001|Overall Study|Lost to Follow-up|2
7922442|NCT02189759|12447680|FG000|Overall Study|Lost to Follow-up|0
7922443|NCT02189759|12447681|FG001|Overall Study|Lost to Follow-up|0
7922444|NCT02189759|12447682|FG002|Overall Study|Lost to Follow-up|2
7922445|NCT02189759|12447683|FG003|Overall Study|Lost to Follow-up|5
7922446|NCT02189837|12447699|FG000|Overall Study|Withdrawal by Subject|2
7922447|NCT02189837|12447700|FG001|Overall Study|Withdrawal by Subject|1
7922448|NCT02189837|12447701|FG002|Overall Study|Withdrawal by Subject|3
7922449|NCT02189837|12447702|FG003|Overall Study|Withdrawal by Subject|1
7922450|NCT02189837|12447699|FG000|Overall Study|Sponsor Decision|0
7922451|NCT02189837|12447700|FG001|Overall Study|Sponsor Decision|0
7922452|NCT02189837|12447701|FG002|Overall Study|Sponsor Decision|0
7922453|NCT02189837|12447702|FG003|Overall Study|Sponsor Decision|1
7922454|NCT02189863|12447721|FG000|First 2 Weeks|Motion Sickness|4
7922455|NCT02189863|12447722|FG001|First 2 Weeks|Motion Sickness|2
7922456|NCT02189941|12447744|FG000|Overall Study|Non-compliance|0
7922457|NCT02189941|12447745|FG001|Overall Study|Non-compliance|0
7922458|NCT02189941|12447746|FG002|Overall Study|Non-compliance|1
7922459|NCT02190279|12447775|FG000|Overall Study|Withdrawal consent|1
7922460|NCT02190279|12447776|FG001|Overall Study|Withdrawal consent|0
7922461|NCT02190279|12447777|FG002|Overall Study|Withdrawal consent|1
7922462|NCT02190279|12447775|FG000|Overall Study|Lost to Follow-up|2
7922463|NCT02190279|12447776|FG001|Overall Study|Lost to Follow-up|0
7922464|NCT02190279|12447777|FG002|Overall Study|Lost to Follow-up|0
7922465|NCT02190279|12447775|FG000|Overall Study|Refused further treatment|0
7922466|NCT02190279|12447776|FG001|Overall Study|Refused further treatment|0
7922467|NCT02190279|12447777|FG002|Overall Study|Refused further treatment|1
7922468|NCT02190279|12447775|FG000|Overall Study|Screening failure|0
7922469|NCT02190279|12447776|FG001|Overall Study|Screening failure|0
7922470|NCT02190279|12447777|FG002|Overall Study|Screening failure|1
7922471|NCT02190435|12447789|FG000|Overall Study|First 12 patients were lead-ins|12
7922472|NCT02190435|12447790|FG001|Overall Study|First 12 patients were lead-ins|0
7922473|NCT02190435|12447789|FG000|Overall Study|3 consented screen fails|3
7922474|NCT02190435|12447790|FG001|Overall Study|3 consented screen fails|0
7922475|NCT02190591|12447803|FG000|Overall Study|Withdrawal by Subject|1
7922476|NCT02190591|12447804|FG001|Overall Study|Withdrawal by Subject|8
7922477|NCT02190591|12447803|FG000|Overall Study|Protocol Violation|1
7922478|NCT02190591|12447804|FG001|Overall Study|Protocol Violation|0
7922479|NCT02190591|12447803|FG000|Overall Study|did not use peanut ball as instructed|0
7922480|NCT02190591|12447804|FG001|Overall Study|did not use peanut ball as instructed|2
7922481|NCT02190591|12447803|FG000|Overall Study|face presentation so she was ineligible|0
7922482|NCT02190591|12447804|FG001|Overall Study|face presentation so she was ineligible|1
7922483|NCT02190604|12447829|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922484|NCT02190604|12447830|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922485|NCT02190604|12447831|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922486|NCT02190604|12447832|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922487|NCT02190604|12447833|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922488|NCT02190604|12447834|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922489|NCT02190604|12447835|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922490|NCT02190604|12447836|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922491|NCT02190604|12447837|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922492|NCT02190604|12447838|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922493|NCT02190604|12447839|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922494|NCT02190604|12447840|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922495|NCT02190604|12447841|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922496|NCT02190604|12447842|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922497|NCT02190604|12447843|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
7922498|NCT02190604|12447844|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922499|NCT02190604|12447845|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922500|NCT02190604|12447846|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922501|NCT02190604|12447847|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7922502|NCT02190604|12447829|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922503|NCT02190604|12447830|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922504|NCT02190604|12447831|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922505|NCT02190604|12447832|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922506|NCT02190604|12447833|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922507|NCT02190604|12447834|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922508|NCT02190604|12447835|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922509|NCT02190604|12447836|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922510|NCT02190604|12447837|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922511|NCT02190604|12447838|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922512|NCT02190604|12447839|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922513|NCT02190604|12447840|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922514|NCT02190604|12447841|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922515|NCT02190604|12447842|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
7922516|NCT02190604|12447843|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922517|NCT02190604|12447844|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922518|NCT02190604|12447845|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922519|NCT02190604|12447846|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7922520|NCT02190604|12447847|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7964469|NCT01107626|12520028|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54
7964470|NCT01107626|12520029|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0
7964471|NCT01107626|12520030|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0
7964472|NCT01107626|12520031|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0
7964473|NCT01107626|12520028|FG000|Step 1: Induction Therapy|Complicating disease|13
7964474|NCT01107626|12520029|FG001|Step 1: Induction Therapy|Complicating disease|0
7964475|NCT01107626|12520030|FG002|Step 1: Induction Therapy|Complicating disease|0
7964476|NCT01107626|12520031|FG003|Step 1: Induction Therapy|Complicating disease|0
7964477|NCT01107626|12520028|FG000|Step 1: Induction Therapy|Alternative therapy|12
7964478|NCT01107626|12520029|FG001|Step 1: Induction Therapy|Alternative therapy|0
7964479|NCT01107626|12520030|FG002|Step 1: Induction Therapy|Alternative therapy|0
7964480|NCT01107626|12520031|FG003|Step 1: Induction Therapy|Alternative therapy|0
7964481|NCT01107626|12520028|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10
7964482|NCT01107626|12520029|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0
7964483|NCT01107626|12520030|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0
7964484|NCT01107626|12520031|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0
7964485|NCT01107626|12520028|FG000|Step 1: Induction Therapy|Non-compliance|4
7964486|NCT01107626|12520029|FG001|Step 1: Induction Therapy|Non-compliance|0
7964487|NCT01107626|12520030|FG002|Step 1: Induction Therapy|Non-compliance|0
7964488|NCT01107626|12520031|FG003|Step 1: Induction Therapy|Non-compliance|0
7964489|NCT01107626|12520028|FG000|Step 1: Induction Therapy|Pain|4
7964490|NCT01107626|12520029|FG001|Step 1: Induction Therapy|Pain|0
7964491|NCT01107626|12520030|FG002|Step 1: Induction Therapy|Pain|0
7964492|NCT01107626|12520031|FG003|Step 1: Induction Therapy|Pain|0
7964493|NCT01107626|12520028|FG000|Step 1: Induction Therapy|Protocol Violation|1
7964494|NCT01107626|12520029|FG001|Step 1: Induction Therapy|Protocol Violation|0
7964495|NCT01107626|12520030|FG002|Step 1: Induction Therapy|Protocol Violation|0
7964496|NCT01107626|12520031|FG003|Step 1: Induction Therapy|Protocol Violation|0
7964497|NCT01107626|12520028|FG000|Step 1: Induction Therapy|Hospice care|1
7964498|NCT01107626|12520029|FG001|Step 1: Induction Therapy|Hospice care|0
7964499|NCT01107626|12520030|FG002|Step 1: Induction Therapy|Hospice care|0
7964500|NCT01107626|12520031|FG003|Step 1: Induction Therapy|Hospice care|0
7964501|NCT01107626|12520028|FG000|Step 1: Induction Therapy|Physician Decision|1
7964502|NCT01107626|12520029|FG001|Step 1: Induction Therapy|Physician Decision|0
7964503|NCT01107626|12520030|FG002|Step 1: Induction Therapy|Physician Decision|0
7964504|NCT01107626|12520031|FG003|Step 1: Induction Therapy|Physician Decision|0
7964505|NCT01107626|12520028|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50
7964506|NCT01107626|12520029|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0
7964507|NCT01107626|12520030|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0
7964508|NCT01107626|12520031|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0
7964509|NCT01107626|12520028|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0
7964510|NCT01107626|12520029|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217
7964511|NCT01107626|12520030|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217
7964512|NCT01107626|12520031|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170
7964513|NCT01107626|12520028|FG000|Step 2: Maintenance Therapy|Adverse Event|0
7964514|NCT01107626|12520029|FG001|Step 2: Maintenance Therapy|Adverse Event|32
7964515|NCT01107626|12520030|FG002|Step 2: Maintenance Therapy|Adverse Event|29
7964516|NCT01107626|12520031|FG003|Step 2: Maintenance Therapy|Adverse Event|46
7964517|NCT01107626|12520028|FG000|Step 2: Maintenance Therapy|Death|0
7964518|NCT01107626|12520029|FG001|Step 2: Maintenance Therapy|Death|8
7964519|NCT01107626|12520030|FG002|Step 2: Maintenance Therapy|Death|2
7964520|NCT01107626|12520031|FG003|Step 2: Maintenance Therapy|Death|13
7964521|NCT01107626|12520028|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0
7922521|NCT02191046|12447937|FG000|Overall Study|low compliance|5
7922522|NCT02191046|12447938|FG001|Overall Study|low compliance|1
7922523|NCT02191137|12447944|FG000|Treatment|Death|4
7922524|NCT02191137|12447944|FG000|Treatment|Withdrawal by Subject|3
7922525|NCT02191137|12447944|FG000|Treatment|Adverse Event|2
7922526|NCT02191137|12447944|FG000|Treatment|Other|1
7922527|NCT02191137|12447944|FG000|Follow-up|Lost to Follow-up|2
7922528|NCT02191137|12447944|FG000|Follow-up|Ongoing/unknown|2
7922529|NCT02191137|12447944|FG000|Follow-up|Adverse Event|1
7922530|NCT02191267|12447951|FG000|Overall Study|Withdrawal by Subject|1
7922531|NCT02191267|12447952|FG001|Overall Study|Withdrawal by Subject|0
7922532|NCT02191267|12447953|FG002|Overall Study|Withdrawal by Subject|0
7922533|NCT02191397|12447963|FG000|Overall Study|Adverse Event|28
7922534|NCT02191397|12447964|FG001|Overall Study|Adverse Event|17
7922535|NCT02191397|12447963|FG000|Overall Study|Lack of Efficacy|10
7922536|NCT02191397|12447964|FG001|Overall Study|Lack of Efficacy|5
7922537|NCT02191397|12447963|FG000|Overall Study|Protocol Violation|0
7922538|NCT02191397|12447964|FG001|Overall Study|Protocol Violation|3
7922539|NCT02191397|12447963|FG000|Overall Study|Met protocol-defined stopping criteria|5
7922540|NCT02191397|12447964|FG001|Overall Study|Met protocol-defined stopping criteria|4
7922541|NCT02191397|12447963|FG000|Overall Study|Lost to Follow-up|10
7922542|NCT02191397|12447964|FG001|Overall Study|Lost to Follow-up|11
7922543|NCT02191397|12447963|FG000|Overall Study|Physician Decision|8
7922544|NCT02191397|12447964|FG001|Overall Study|Physician Decision|3
7922545|NCT02191397|12447963|FG000|Overall Study|Withdrawal by Subject|22
7922546|NCT02191397|12447964|FG001|Overall Study|Withdrawal by Subject|27
7922547|NCT02191579|12447972|FG000|Treatment 1|Multiple Reasons Specified|27
7922548|NCT02191579|12447973|FG001|Treatment 1|Multiple Reasons Specified|58
7922549|NCT02191579|12447972|FG000|Treatment 2|Multiple Reasons Specified|0
7922550|NCT02191579|12447973|FG001|Treatment 2|Multiple Reasons Specified|25
7922551|NCT02191605|12447984|FG000|Overall Study|Lost to Follow-up|9
7922552|NCT02191605|12447985|FG001|Overall Study|Lost to Follow-up|4
7922553|NCT02191605|12447986|FG002|Overall Study|Lost to Follow-up|7
7922554|NCT02191605|12447987|FG003|Overall Study|Lost to Follow-up|3
7922555|NCT02191605|12447988|FG004|Overall Study|Lost to Follow-up|4
7922556|NCT02191618|12448000|FG000|Overall Study|Withdrawal by Subject|3
7922557|NCT02191618|12448000|FG000|Overall Study|Missed Visit|4
7922558|NCT02192099|12448020|FG000|Overall Study|Adverse Event|1
7922559|NCT02192099|12448020|FG000|Overall Study|Lost to Follow-up|2
7922560|NCT02192099|12448020|FG000|Overall Study|Physician Decision|1
7922561|NCT02192099|12448020|FG000|Overall Study|Pregnancy|1
7922562|NCT02192099|12448020|FG000|Overall Study|Protocol Violation|8
7922563|NCT02192099|12448020|FG000|Overall Study|Study Terminated by Sponsor|32
7922564|NCT02192099|12448020|FG000|Overall Study|Withdrawal by Subject|11
7922565|NCT02192099|12448020|FG000|Overall Study|Miscellaneous Reasons|5
7922566|NCT02192164|12448024|FG000|Overall Study|Other|8
7922567|NCT02192164|12448024|FG000|Overall Study|Withdrawal by Subject|1
7922568|NCT02192164|12448024|FG000|Overall Study|Physician Decision|4
7922569|NCT02192164|12448024|FG000|Overall Study|Did not meet the exclusion criteria|1
7922570|NCT02192190|12448037|FG000|Overall Study|Adverse Event|1
7922571|NCT02192190|12448038|FG001|Overall Study|Adverse Event|1
7922572|NCT02192190|12448039|FG002|Overall Study|Adverse Event|0
7922573|NCT02192190|12448040|FG003|Overall Study|Adverse Event|0
7922574|NCT02192190|12448041|FG004|Overall Study|Adverse Event|0
7922575|NCT02192190|12448042|FG005|Overall Study|Adverse Event|0
7922576|NCT02192190|12448037|FG000|Overall Study|Lost to Follow-up|3
7922577|NCT02192190|12448038|FG001|Overall Study|Lost to Follow-up|3
7922578|NCT02192190|12448039|FG002|Overall Study|Lost to Follow-up|2
7922579|NCT02192190|12448040|FG003|Overall Study|Lost to Follow-up|1
7922580|NCT02192190|12448041|FG004|Overall Study|Lost to Follow-up|4
7922581|NCT02192190|12448042|FG005|Overall Study|Lost to Follow-up|3
7922582|NCT02192190|12448037|FG000|Overall Study|Physician Decision|2
7922583|NCT02192190|12448038|FG001|Overall Study|Physician Decision|0
7922584|NCT02192190|12448039|FG002|Overall Study|Physician Decision|0
7922585|NCT02192190|12448040|FG003|Overall Study|Physician Decision|0
7922586|NCT02192190|12448041|FG004|Overall Study|Physician Decision|0
7922587|NCT02192190|12448042|FG005|Overall Study|Physician Decision|0
7922588|NCT02192190|12448037|FG000|Overall Study|Terminated by Sponsor|43
7922589|NCT02192190|12448038|FG001|Overall Study|Terminated by Sponsor|23
7922590|NCT02192190|12448039|FG002|Overall Study|Terminated by Sponsor|20
7922591|NCT02192190|12448040|FG003|Overall Study|Terminated by Sponsor|23
7922592|NCT02192190|12448041|FG004|Overall Study|Terminated by Sponsor|21
7922593|NCT02192190|12448042|FG005|Overall Study|Terminated by Sponsor|23
7922594|NCT02192190|12448037|FG000|Overall Study|Withdrawal by Subject|4
7922595|NCT02192190|12448038|FG001|Overall Study|Withdrawal by Subject|1
7922596|NCT02192190|12448039|FG002|Overall Study|Withdrawal by Subject|2
7922597|NCT02192190|12448040|FG003|Overall Study|Withdrawal by Subject|1
7922598|NCT02192190|12448041|FG004|Overall Study|Withdrawal by Subject|5
7922599|NCT02192190|12448042|FG005|Overall Study|Withdrawal by Subject|3
7922600|NCT02192190|12448037|FG000|Overall Study|Could not Keep Visit Schedule|1
7922601|NCT02192190|12448038|FG001|Overall Study|Could not Keep Visit Schedule|0
7922602|NCT02192190|12448039|FG002|Overall Study|Could not Keep Visit Schedule|0
7922603|NCT02192190|12448040|FG003|Overall Study|Could not Keep Visit Schedule|0
7922604|NCT02192190|12448041|FG004|Overall Study|Could not Keep Visit Schedule|0
7922605|NCT02192190|12448042|FG005|Overall Study|Could not Keep Visit Schedule|0
7922606|NCT02192190|12448037|FG000|Overall Study|Positive Drug Screen|0
7922607|NCT02192190|12448038|FG001|Overall Study|Positive Drug Screen|0
7922608|NCT02192190|12448039|FG002|Overall Study|Positive Drug Screen|0
7922609|NCT02192190|12448040|FG003|Overall Study|Positive Drug Screen|1
7922610|NCT02192190|12448041|FG004|Overall Study|Positive Drug Screen|0
7922611|NCT02192190|12448042|FG005|Overall Study|Positive Drug Screen|0
7922612|NCT02192190|12448037|FG000|Overall Study|Inadequate Pain Relief|0
7922613|NCT02192190|12448038|FG001|Overall Study|Inadequate Pain Relief|1
7922614|NCT02192190|12448039|FG002|Overall Study|Inadequate Pain Relief|1
7922615|NCT02192190|12448040|FG003|Overall Study|Inadequate Pain Relief|0
7922616|NCT02192190|12448041|FG004|Overall Study|Inadequate Pain Relief|0
7922617|NCT02192190|12448042|FG005|Overall Study|Inadequate Pain Relief|0
7922618|NCT02192606|12448078|FG000|Overall Study|surgery type was changed|1
7922619|NCT02192606|12448079|FG001|Overall Study|surgery type was changed|1
7922620|NCT02192606|12448078|FG000|Overall Study|Physician Decision|1
7922621|NCT02192606|12448079|FG001|Overall Study|Physician Decision|2
7922622|NCT02192606|12448078|FG000|Overall Study|3D equipment rep unable to join|0
7922623|NCT02192606|12448079|FG001|Overall Study|3D equipment rep unable to join|1
7922624|NCT02192905|12448111|FG000|Overall Study|Lost to Follow-up|1
7922625|NCT02192970|12448118|FG000|Overall Study|Lost to Follow-up|6
7922626|NCT02192970|12448119|FG001|Overall Study|Lost to Follow-up|0
7922627|NCT02193074|12448127|FG000|Overall Study|Withdrawal by Subject|1
7922628|NCT02193074|12448128|FG001|Overall Study|Withdrawal by Subject|2
7922629|NCT02193074|12448127|FG000|Overall Study|Adverse Event|16
7922630|NCT02193074|12448128|FG001|Overall Study|Adverse Event|13
7922631|NCT02193087|12448138|FG000|Overall Study|Adverse Event|2
7922632|NCT02193087|12448139|FG001|Overall Study|Adverse Event|0
7922633|NCT02193087|12448140|FG002|Overall Study|Adverse Event|0
7922634|NCT02193087|12448141|FG003|Overall Study|Adverse Event|11
7922635|NCT02193087|12448138|FG000|Overall Study|Lost to Follow-up|14
7922636|NCT02193087|12448139|FG001|Overall Study|Lost to Follow-up|6
7922637|NCT02193087|12448140|FG002|Overall Study|Lost to Follow-up|4
7922638|NCT02193087|12448141|FG003|Overall Study|Lost to Follow-up|37
7922639|NCT02193087|12448138|FG000|Overall Study|Protocol Violation|2
7922640|NCT02193087|12448139|FG001|Overall Study|Protocol Violation|0
7922641|NCT02193087|12448140|FG002|Overall Study|Protocol Violation|1
7922642|NCT02193087|12448141|FG003|Overall Study|Protocol Violation|2
7922643|NCT02193087|12448138|FG000|Overall Study|Withdrawal by Subject|10
7922644|NCT02193087|12448139|FG001|Overall Study|Withdrawal by Subject|3
7922645|NCT02193087|12448140|FG002|Overall Study|Withdrawal by Subject|1
7922646|NCT02193087|12448141|FG003|Overall Study|Withdrawal by Subject|19
7922647|NCT02193087|12448138|FG000|Overall Study|Other Reason Not Specified|7
7922648|NCT02193087|12448139|FG001|Overall Study|Other Reason Not Specified|2
7922649|NCT02193087|12448140|FG002|Overall Study|Other Reason Not Specified|1
7922650|NCT02193087|12448141|FG003|Overall Study|Other Reason Not Specified|9
7922651|NCT02193087|12448138|FG000|Overall Study|Did Not Receive Any Vaccination|2
7922652|NCT02193087|12448139|FG001|Overall Study|Did Not Receive Any Vaccination|3
7922653|NCT02193087|12448140|FG002|Overall Study|Did Not Receive Any Vaccination|0
7922654|NCT02193087|12448141|FG003|Overall Study|Did Not Receive Any Vaccination|1
7922655|NCT02193165|12448165|FG000|4 Week Product Use|Lost to Follow-up|1
7922656|NCT02193165|12448166|FG001|4 Week Product Use|Lost to Follow-up|1
7922657|NCT02193165|12448167|FG002|4 Week Product Use|Lost to Follow-up|1
7922658|NCT02193165|12448165|FG000|6 Week Product Use|Lost to Follow-up|0
7922659|NCT02193165|12448166|FG001|6 Week Product Use|Lost to Follow-up|1
7922660|NCT02193165|12448167|FG002|6 Week Product Use|Lost to Follow-up|0
7922661|NCT02193178|12448175|FG000|Overall Study|Lost to Follow-up|1
7922662|NCT02193178|12448175|FG000|Overall Study|Dry eyes|1
7922663|NCT02193776|12448210|FG000|Overall Study|Consent withdrawn|1
7922664|NCT02193776|12448211|FG001|Overall Study|Consent withdrawn|0
7922665|NCT02193776|12448212|FG002|Overall Study|Consent withdrawn|0
7922666|NCT02193776|12448213|FG003|Overall Study|Consent withdrawn|0
7922667|NCT02193776|12448210|FG000|Overall Study|Failure to comply with protocol|0
7922668|NCT02193776|12448211|FG001|Overall Study|Failure to comply with protocol|1
7922669|NCT02193776|12448212|FG002|Overall Study|Failure to comply with protocol|0
7922670|NCT02193776|12448213|FG003|Overall Study|Failure to comply with protocol|0
7922671|NCT02193776|12448210|FG000|Overall Study|Investigator/Sponsor decision|1
7922672|NCT02193776|12448211|FG001|Overall Study|Investigator/Sponsor decision|1
7922673|NCT02193776|12448212|FG002|Overall Study|Investigator/Sponsor decision|0
7922674|NCT02193776|12448213|FG003|Overall Study|Investigator/Sponsor decision|0
7922675|NCT02193776|12448210|FG000|Overall Study|Death|1
7922676|NCT02193776|12448211|FG001|Overall Study|Death|0
7922677|NCT02193776|12448212|FG002|Overall Study|Death|0
7922678|NCT02193776|12448213|FG003|Overall Study|Death|0
7922679|NCT02193776|12448210|FG000|Overall Study|Adverse event/Specific toxicity|5
7922680|NCT02193776|12448211|FG001|Overall Study|Adverse event/Specific toxicity|5
7922681|NCT02193776|12448212|FG002|Overall Study|Adverse event/Specific toxicity|2
7922682|NCT02193776|12448213|FG003|Overall Study|Adverse event/Specific toxicity|2
7922683|NCT02193828|12448241|FG000|Overall Study|Withdrawal by Subject|0
7922684|NCT02193828|12448242|FG001|Overall Study|Withdrawal by Subject|0
7922685|NCT02193828|12448243|FG002|Overall Study|Withdrawal by Subject|1
7922686|NCT02193828|12448244|FG003|Overall Study|Withdrawal by Subject|1
7922687|NCT02193880|12448254|FG000|Overall Study|patients did not collect enough HPC|3
7922688|NCT02194062|12448261|FG000|Overall Study|Lost to Follow-up|2
7922689|NCT02194062|12448262|FG001|Overall Study|Lost to Follow-up|2
7922690|NCT02194062|12448263|FG002|Overall Study|Lost to Follow-up|5
7922691|NCT02194465|12448293|FG000|Overall Study|Adverse Event|6
7922692|NCT02194465|12448294|FG001|Overall Study|Adverse Event|1
7922693|NCT02194465|12448295|FG002|Overall Study|Adverse Event|4
7922694|NCT02194465|12448296|FG003|Overall Study|Adverse Event|4
7922695|NCT02194465|12448297|FG004|Overall Study|Adverse Event|4
7922696|NCT02194465|12448298|FG005|Overall Study|Adverse Event|2
7922697|NCT02194465|12448299|FG006|Overall Study|Adverse Event|0
7922698|NCT02194465|12448293|FG000|Overall Study|Lost to Follow-up|0
7922699|NCT02194465|12448294|FG001|Overall Study|Lost to Follow-up|0
7922700|NCT02194465|12448295|FG002|Overall Study|Lost to Follow-up|0
7922701|NCT02194465|12448296|FG003|Overall Study|Lost to Follow-up|1
7922702|NCT02194465|12448297|FG004|Overall Study|Lost to Follow-up|0
7922703|NCT02194465|12448298|FG005|Overall Study|Lost to Follow-up|1
7922704|NCT02194465|12448299|FG006|Overall Study|Lost to Follow-up|0
7922705|NCT02194465|12448293|FG000|Overall Study|Physician Decision|1
7922706|NCT02194465|12448294|FG001|Overall Study|Physician Decision|0
7922707|NCT02194465|12448295|FG002|Overall Study|Physician Decision|0
7922708|NCT02194465|12448296|FG003|Overall Study|Physician Decision|0
7922709|NCT02194465|12448297|FG004|Overall Study|Physician Decision|0
7922710|NCT02194465|12448298|FG005|Overall Study|Physician Decision|0
7922711|NCT02194465|12448299|FG006|Overall Study|Physician Decision|0
7922712|NCT02194465|12448293|FG000|Overall Study|Protocol Violation|1
7922713|NCT02194465|12448294|FG001|Overall Study|Protocol Violation|1
7922714|NCT02194465|12448295|FG002|Overall Study|Protocol Violation|2
7922715|NCT02194465|12448296|FG003|Overall Study|Protocol Violation|1
7922716|NCT02194465|12448297|FG004|Overall Study|Protocol Violation|1
7922717|NCT02194465|12448298|FG005|Overall Study|Protocol Violation|0
7922718|NCT02194465|12448299|FG006|Overall Study|Protocol Violation|0
7922719|NCT02194465|12448293|FG000|Overall Study|Withdrawal by Subject|1
7922720|NCT02194465|12448294|FG001|Overall Study|Withdrawal by Subject|3
7922721|NCT02194465|12448295|FG002|Overall Study|Withdrawal by Subject|1
7922722|NCT02194465|12448296|FG003|Overall Study|Withdrawal by Subject|2
7922723|NCT02194465|12448297|FG004|Overall Study|Withdrawal by Subject|2
7922724|NCT02194465|12448298|FG005|Overall Study|Withdrawal by Subject|1
7922725|NCT02194465|12448299|FG006|Overall Study|Withdrawal by Subject|2
7922726|NCT02194465|12448293|FG000|Overall Study|Discontinued follow-up period|0
7821836|NCT01258608|12290796|FG000|Overall Study|Adverse Event|6
7821837|NCT01258608|12290797|FG001|Overall Study|Adverse Event|10
7821838|NCT01258608|12290796|FG000|Overall Study|Withdrawal by Subject|6
7821839|NCT01258608|12290797|FG001|Overall Study|Withdrawal by Subject|5
7821840|NCT01258660|12290806|FG000|Overall Study|Adverse Event|2
7821841|NCT01258660|12290807|FG001|Overall Study|Adverse Event|4
7821842|NCT01258660|12290806|FG000|Overall Study|Withdrawal by Subject|3
7821843|NCT01258660|12290807|FG001|Overall Study|Withdrawal by Subject|0
7821844|NCT01258660|12290806|FG000|Overall Study|due to relocation|2
7821845|NCT01258660|12290807|FG001|Overall Study|due to relocation|0
7922727|NCT02194465|12448294|FG001|Overall Study|Discontinued follow-up period|2
7922728|NCT02194465|12448295|FG002|Overall Study|Discontinued follow-up period|1
7922729|NCT02194465|12448296|FG003|Overall Study|Discontinued follow-up period|0
7922730|NCT02194465|12448297|FG004|Overall Study|Discontinued follow-up period|2
7922731|NCT02194465|12448298|FG005|Overall Study|Discontinued follow-up period|0
7922732|NCT02194465|12448299|FG006|Overall Study|Discontinued follow-up period|0
7922733|NCT02194621|12448322|FG000|Overall Study|6 withdrew prior to randomization|2
7922734|NCT02194621|12448323|FG001|Overall Study|6 withdrew prior to randomization|2
7922735|NCT02194621|12448324|FG002|Overall Study|6 withdrew prior to randomization|2
7922736|NCT02194621|12448322|FG000|Overall Study|Withdrawal by Subject|4
7922737|NCT02194621|12448323|FG001|Overall Study|Withdrawal by Subject|4
7922738|NCT02194621|12448324|FG002|Overall Study|Withdrawal by Subject|7
7922739|NCT02194699|12448334|FG000|Randomised|Did not receive treatment|1
7922740|NCT02194699|12448335|FG001|Randomised|Did not receive treatment|5
7922741|NCT02194699|12448334|FG000|Randomised|Without potential for 52 weeks of IP|5
7922742|NCT02194699|12448335|FG001|Randomised|Without potential for 52 weeks of IP|5
7922743|NCT02194699|12448334|FG000|Randomised|Duplicate patient|2
7922744|NCT02194699|12448335|FG001|Randomised|Duplicate patient|1
7922745|NCT02194699|12448334|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4
7922746|NCT02194699|12448335|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3
7922747|NCT02194699|12448334|FG000|With Potential to Receive 52 Weeks of IP|Death|1
7922748|NCT02194699|12448335|FG001|With Potential to Receive 52 Weeks of IP|Death|3
7922749|NCT02194699|12448334|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
7922750|NCT02194699|12448335|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
7922751|NCT02194699|12448334|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
7922752|NCT02194699|12448335|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
7922753|NCT02194699|12448334|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
7922754|NCT02194699|12448335|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
7922755|NCT02194699|12448334|FG000|With Potential to Receive 52 Weeks of IP|Other|24
7922756|NCT02194699|12448335|FG001|With Potential to Receive 52 Weeks of IP|Other|16
7922757|NCT02194933|12448351|FG000|Overall Study|Lost to Follow-up|1
7821846|NCT01258660|12290806|FG000|Overall Study|Protocol Violation|0
7922758|NCT02194933|12448352|FG001|Overall Study|Lost to Follow-up|2
7922759|NCT02194933|12448351|FG000|Overall Study|Participant met withdrawal criteria|1
7922760|NCT02194933|12448352|FG001|Overall Study|Participant met withdrawal criteria|3
7922761|NCT02194933|12448351|FG000|Overall Study|Withdrawal by Subject|0
7922762|NCT02194933|12448352|FG001|Overall Study|Withdrawal by Subject|2
7922763|NCT02194933|12448351|FG000|Overall Study|Lack of Efficacy|1
7922764|NCT02194933|12448352|FG001|Overall Study|Lack of Efficacy|2
7922765|NCT02194985|12448360|FG000|Overall Study|Adverse Event|1
7922766|NCT02194985|12448360|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3
7922767|NCT02194985|12448360|FG000|Overall Study|Physician Decision|4
7922768|NCT02194985|12448360|FG000|Overall Study|Lost to Follow-up|1
7922769|NCT02194985|12448360|FG000|Overall Study|Withdrawal by Subject|2
7922770|NCT02194998|12448368|FG000|On-HCV Treatment|Did not pick up study medication|0
7922771|NCT02194998|12448369|FG001|On-HCV Treatment|Did not pick up study medication|1
7922772|NCT02194998|12448370|FG002|On-HCV Treatment|Did not pick up study medication|0
7922773|NCT02194998|12448371|FG003|On-HCV Treatment|Did not pick up study medication|0
7922774|NCT02194998|12448368|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
7922775|NCT02194998|12448369|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
7922776|NCT02194998|12448370|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
7922777|NCT02194998|12448371|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
7922778|NCT02195011|12448383|FG000|Overall Study|Adverse Event|4
7922779|NCT02195011|12448384|FG001|Overall Study|Adverse Event|0
7922780|NCT02195011|12448383|FG000|Overall Study|Progressive Disease|18
7922781|NCT02195011|12448384|FG001|Overall Study|Progressive Disease|1
7821847|NCT01258660|12290807|FG001|Overall Study|Protocol Violation|1
7922782|NCT02195011|12448383|FG000|Overall Study|Withdrawal by Subject|3
7922783|NCT02195011|12448384|FG001|Overall Study|Withdrawal by Subject|0
7922784|NCT02195427|12448479|FG000|Overall Study|Did not consent to study extension|13
7922785|NCT02195427|12448480|FG001|Overall Study|Did not consent to study extension|9
7922786|NCT02195427|12448479|FG000|Overall Study|Withdrawal by Subject|4
7922787|NCT02195427|12448480|FG001|Overall Study|Withdrawal by Subject|2
7922788|NCT02195427|12448479|FG000|Overall Study|Lost to Follow-up|0
7922789|NCT02195427|12448480|FG001|Overall Study|Lost to Follow-up|1
7922790|NCT02195427|12448479|FG000|Overall Study|Protocol Violation|7
7922791|NCT02195427|12448480|FG001|Overall Study|Protocol Violation|14
7922792|NCT02195427|12448479|FG000|Overall Study|Conditional re-treatment at W52|2
7922793|NCT02195427|12448480|FG001|Overall Study|Conditional re-treatment at W52|1
7922794|NCT02195518|12448490|FG000|Overall Study|Adverse Event|1
7922795|NCT02195518|12448490|FG000|Overall Study|Protocol Violation|4
7922796|NCT02195518|12448490|FG000|Overall Study|Pregnancy|2
7922797|NCT02195518|12448490|FG000|Overall Study|Withdrawal by Subject|1
7922798|NCT02195518|12448490|FG000|Overall Study|Lost to Follow-up|1
7922799|NCT02195531|12448497|FG000|Overall Study|Withdrawal by Subject|1
7922800|NCT02195531|12448498|FG001|Overall Study|Withdrawal by Subject|1
7922801|NCT02195531|12448499|FG002|Overall Study|Withdrawal by Subject|1
7922802|NCT02195583|12448507|FG000|Overall Study|Lost to Follow-up|1
7922803|NCT02195583|12448507|FG000|Overall Study|Withdrawal by Subject|4
7922804|NCT02195583|12448507|FG000|Overall Study|Adverse Event|2
7922805|NCT02195583|12448507|FG000|Overall Study|Other Reason|2
7922806|NCT02195687|12448533|FG000|Overall Study|Personal Reasons|1
7922807|NCT02195687|12448534|FG001|Overall Study|Personal Reasons|1
7821848|NCT01258660|12290806|FG000|Overall Study|Invalid for primary analysis data set|4
7922808|NCT02195687|12448533|FG000|Overall Study|Lost to Follow-up|4
7922809|NCT02195687|12448534|FG001|Overall Study|Lost to Follow-up|1
7922810|NCT02195700|12448542|FG000|Overall Study|Protocol Violation|0
7922811|NCT02195700|12448543|FG001|Overall Study|Protocol Violation|2
7922812|NCT02195700|12448542|FG000|Overall Study|Noncompliance|1
7922813|NCT02195700|12448543|FG001|Overall Study|Noncompliance|0
7922814|NCT02195700|12448542|FG000|Overall Study|Adverse Event|1
7922815|NCT02195700|12448543|FG001|Overall Study|Adverse Event|2
7922816|NCT02195700|12448542|FG000|Overall Study|Withdrawal by Subject|3
7922817|NCT02195700|12448543|FG001|Overall Study|Withdrawal by Subject|2
7922818|NCT02195700|12448542|FG000|Overall Study|Lost to Follow-up|1
7922819|NCT02195700|12448543|FG001|Overall Study|Lost to Follow-up|1
7922820|NCT02195869|12448558|FG000|Overall Study|cGVHD Progression|5
7922821|NCT02195869|12448558|FG000|Overall Study|Malignancy Progression/relapse|2
7922822|NCT02195869|12448558|FG000|Overall Study|Adverse Event|15
7922823|NCT02195869|12448558|FG000|Overall Study|Withdrawal by Subject|7
7922824|NCT02195869|12448558|FG000|Overall Study|Physician Decision|4
7922825|NCT02195869|12448558|FG000|Overall Study|Study Terminated by Sponsor|7
7922826|NCT02195869|12448558|FG000|Overall Study|Noncompliance with study drug|2
7922827|NCT02196038|12448593|FG000|Overall Study|Death|16
7922828|NCT02196038|12448594|FG001|Overall Study|Death|21
7922829|NCT02196038|12448593|FG000|Overall Study|Withdrawal by Subject|0
7922830|NCT02196038|12448594|FG001|Overall Study|Withdrawal by Subject|1
7922831|NCT02196038|12448593|FG000|Overall Study|Lost to Follow-up|1
7922832|NCT02196038|12448594|FG001|Overall Study|Lost to Follow-up|0
7922833|NCT02196077|12448600|FG000|Overall Study|Adverse Event|4
7922834|NCT02196077|12448600|FG000|Overall Study|Lack of Efficacy|1
7922835|NCT02196077|12448600|FG000|Overall Study|Withdrawal by Subject|14
7922836|NCT02196077|12448600|FG000|Overall Study|Physician Decision|1
7922837|NCT02196077|12448600|FG000|Overall Study|Lost to Follow-up|3
7922838|NCT02196077|12448600|FG000|Overall Study|Protocol Violation|24
7922839|NCT02196259|12448624|FG000|Overall Study|Researcher choice|0
7922840|NCT02196259|12448625|FG001|Overall Study|Researcher choice|0
7922841|NCT02196259|12448626|FG002|Overall Study|Researcher choice|1
7922842|NCT02196259|12448624|FG000|Overall Study|Partial data analysis|0
7922843|NCT02196259|12448625|FG001|Overall Study|Partial data analysis|3
7922844|NCT02196259|12448626|FG002|Overall Study|Partial data analysis|0
7922845|NCT02196324|12448635|FG000|Overall Study|Withdrawal by Subject|8
7922846|NCT02196324|12448636|FG001|Overall Study|Withdrawal by Subject|4
7922847|NCT02196324|12448635|FG000|Overall Study|Adverse Event or Serious Adverse Event|6
7922848|NCT02196324|12448636|FG001|Overall Study|Adverse Event or Serious Adverse Event|3
7922849|NCT02196324|12448635|FG000|Overall Study|Occurrence of an Exclusion Criterion|0
7922850|NCT02196324|12448636|FG001|Overall Study|Occurrence of an Exclusion Criterion|1
7922851|NCT02196324|12448635|FG000|Overall Study|Other|1
7922852|NCT02196324|12448636|FG001|Overall Study|Other|0
7922853|NCT02196506|12448644|FG000|Phase A|Participant Met Withdrawal Criteria|34
7922854|NCT02196506|12448645|FG001|Phase A|Participant Met Withdrawal Criteria|0
7922855|NCT02196506|12448646|FG002|Phase A|Participant Met Withdrawal Criteria|0
7922856|NCT02196506|12448647|FG003|Phase A|Participant Met Withdrawal Criteria|0
7922857|NCT02196506|12448644|FG000|Phase A|Withdrawal by Subject|34
7922858|NCT02196506|12448645|FG001|Phase A|Withdrawal by Subject|0
7922859|NCT02196506|12448646|FG002|Phase A|Withdrawal by Subject|0
7922860|NCT02196506|12448647|FG003|Phase A|Withdrawal by Subject|0
7922861|NCT02196506|12448644|FG000|Phase A|Adverse Event|22
7922862|NCT02196506|12448645|FG001|Phase A|Adverse Event|0
7922863|NCT02196506|12448646|FG002|Phase A|Adverse Event|0
7922864|NCT02196506|12448647|FG003|Phase A|Adverse Event|0
7922865|NCT02196506|12448644|FG000|Phase A|Lost to Follow-up|9
7922866|NCT02196506|12448645|FG001|Phase A|Lost to Follow-up|0
7922867|NCT02196506|12448646|FG002|Phase A|Lost to Follow-up|0
7922868|NCT02196506|12448647|FG003|Phase A|Lost to Follow-up|0
7922869|NCT02196506|12448644|FG000|Phase A|Protocol deviation|12
7922870|NCT02196506|12448645|FG001|Phase A|Protocol deviation|0
7922871|NCT02196506|12448646|FG002|Phase A|Protocol deviation|0
7922872|NCT02196506|12448647|FG003|Phase A|Protocol deviation|0
7922873|NCT02196506|12448644|FG000|Phase A|Participant withdrawn by investigator|10
7922874|NCT02196506|12448645|FG001|Phase A|Participant withdrawn by investigator|0
7922875|NCT02196506|12448646|FG002|Phase A|Participant withdrawn by investigator|0
7922876|NCT02196506|12448647|FG003|Phase A|Participant withdrawn by investigator|0
7922877|NCT02196506|12448644|FG000|Phase B|Participant Met Withdrawal Criteria|0
7922878|NCT02196506|12448645|FG001|Phase B|Participant Met Withdrawal Criteria|0
7922879|NCT02196506|12448646|FG002|Phase B|Participant Met Withdrawal Criteria|1
7922880|NCT02196506|12448647|FG003|Phase B|Participant Met Withdrawal Criteria|0
7922881|NCT02196506|12448644|FG000|Phase B|Lack of Efficacy|0
7922882|NCT02196506|12448645|FG001|Phase B|Lack of Efficacy|1
7922883|NCT02196506|12448646|FG002|Phase B|Lack of Efficacy|2
7922884|NCT02196506|12448647|FG003|Phase B|Lack of Efficacy|0
7922885|NCT02196506|12448644|FG000|Phase B|Withdrawal by Participant|0
7922886|NCT02196506|12448645|FG001|Phase B|Withdrawal by Participant|8
7922887|NCT02196506|12448646|FG002|Phase B|Withdrawal by Participant|1
7922888|NCT02196506|12448647|FG003|Phase B|Withdrawal by Participant|0
7922889|NCT02196506|12448644|FG000|Phase B|Adverse Event|0
7922890|NCT02196506|12448645|FG001|Phase B|Adverse Event|4
7922891|NCT02196506|12448646|FG002|Phase B|Adverse Event|1
7922892|NCT02196506|12448647|FG003|Phase B|Adverse Event|0
7922893|NCT02196506|12448644|FG000|Phase B|Lost to Follow-up|0
7922894|NCT02196506|12448645|FG001|Phase B|Lost to Follow-up|2
7922895|NCT02196506|12448646|FG002|Phase B|Lost to Follow-up|1
7922896|NCT02196506|12448647|FG003|Phase B|Lost to Follow-up|0
7922897|NCT02196506|12448644|FG000|Phase A+|Participant Met Withdrawal Criteria|0
7922898|NCT02196506|12448645|FG001|Phase A+|Participant Met Withdrawal Criteria|0
7922899|NCT02196506|12448646|FG002|Phase A+|Participant Met Withdrawal Criteria|0
7922900|NCT02196506|12448647|FG003|Phase A+|Participant Met Withdrawal Criteria|1
7922901|NCT02196506|12448644|FG000|Phase A+|Withdrawal by Participant|0
7922902|NCT02196506|12448645|FG001|Phase A+|Withdrawal by Participant|0
7922903|NCT02196506|12448646|FG002|Phase A+|Withdrawal by Participant|0
7922904|NCT02196506|12448647|FG003|Phase A+|Withdrawal by Participant|5
7922905|NCT02196506|12448644|FG000|Phase A+|Adverse Event|0
7922906|NCT02196506|12448645|FG001|Phase A+|Adverse Event|0
7922907|NCT02196506|12448646|FG002|Phase A+|Adverse Event|0
7922908|NCT02196506|12448647|FG003|Phase A+|Adverse Event|1
7922909|NCT02196506|12448644|FG000|Phase A+|Lost to Follow-up|0
7922910|NCT02196506|12448645|FG001|Phase A+|Lost to Follow-up|0
7922911|NCT02196506|12448646|FG002|Phase A+|Lost to Follow-up|0
7922912|NCT02196506|12448647|FG003|Phase A+|Lost to Follow-up|6
7922913|NCT02196506|12448644|FG000|Phase A+|Participant withdrawn by investigator|0
7922914|NCT02196506|12448645|FG001|Phase A+|Participant withdrawn by investigator|0
7922915|NCT02196506|12448646|FG002|Phase A+|Participant withdrawn by investigator|0
7922916|NCT02196506|12448647|FG003|Phase A+|Participant withdrawn by investigator|1
7922917|NCT02196558|12448656|FG000|Treatment Phase (12 Weeks)|Adverse Event|0
7922918|NCT02196558|12448657|FG001|Treatment Phase (12 Weeks)|Adverse Event|2
7922919|NCT02196558|12448658|FG002|Treatment Phase (12 Weeks)|Adverse Event|0
7922920|NCT02196558|12448656|FG000|Treatment Phase (12 Weeks)|Participant Choice|0
7922921|NCT02196558|12448657|FG001|Treatment Phase (12 Weeks)|Participant Choice|1
7922922|NCT02196558|12448658|FG002|Treatment Phase (12 Weeks)|Participant Choice|1
7922923|NCT02196558|12448656|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0
7922924|NCT02196558|12448657|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0
7922925|NCT02196558|12448658|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1
7922926|NCT02196558|12448656|FG000|Extension Phase (40 Weeks)|Adverse Event|1
7922927|NCT02196558|12448657|FG001|Extension Phase (40 Weeks)|Adverse Event|2
7922928|NCT02196558|12448658|FG002|Extension Phase (40 Weeks)|Adverse Event|0
7922929|NCT02196558|12448656|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
7922930|NCT02196558|12448657|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
7922931|NCT02196558|12448658|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
7922932|NCT02196675|12448669|FG000|Overall Study|Withdrawal by Subject|1
7922933|NCT02196675|12448670|FG001|Overall Study|Withdrawal by Subject|0
7922934|NCT02196675|12448671|FG002|Overall Study|Withdrawal by Subject|0
7922935|NCT02196675|12448669|FG000|Overall Study|Intra-operative surgical exclusion|1
7922936|NCT02196675|12448670|FG001|Overall Study|Intra-operative surgical exclusion|1
7922937|NCT02196675|12448671|FG002|Overall Study|Intra-operative surgical exclusion|0
7922938|NCT02196675|12448669|FG000|Overall Study|Protocol Violation|0
7922939|NCT02196675|12448670|FG001|Overall Study|Protocol Violation|1
7922940|NCT02196675|12448671|FG002|Overall Study|Protocol Violation|0
7922941|NCT02196675|12448669|FG000|Overall Study|Death|0
7922942|NCT02196675|12448670|FG001|Overall Study|Death|0
7922943|NCT02196675|12448671|FG002|Overall Study|Death|1
7922944|NCT02196701|12448690|FG000|Overall Study|Adverse Event|1
7922945|NCT02196701|12448690|FG000|Overall Study|Lost to Follow-up|1
7922946|NCT02196701|12448690|FG000|Overall Study|Non-adherence to Protocol|1
7922947|NCT02196714|12448697|FG000|Overall Study|Protocol Violation|0
7922948|NCT02196714|12448698|FG001|Overall Study|Protocol Violation|0
7922949|NCT02196714|12448699|FG002|Overall Study|Protocol Violation|1
7922950|NCT02196714|12448700|FG003|Overall Study|Protocol Violation|0
7922951|NCT02197130|12448808|FG000|Overall Study|Adverse Event|13
7922952|NCT02197130|12448809|FG001|Overall Study|Adverse Event|4
7922953|NCT02197130|12448810|FG002|Overall Study|Adverse Event|23
7922954|NCT02197130|12448808|FG000|Overall Study|Death|0
7922955|NCT02197130|12448809|FG001|Overall Study|Death|1
7922956|NCT02197130|12448810|FG002|Overall Study|Death|0
7922957|NCT02197130|12448808|FG000|Overall Study|Lost to Follow-up|2
7922958|NCT02197130|12448809|FG001|Overall Study|Lost to Follow-up|0
7922959|NCT02197130|12448810|FG002|Overall Study|Lost to Follow-up|1
7922960|NCT02197130|12448808|FG000|Overall Study|Does not meet entrance criteria|0
7922961|NCT02197130|12448809|FG001|Overall Study|Does not meet entrance criteria|0
7922962|NCT02197130|12448810|FG002|Overall Study|Does not meet entrance criteria|1
7922963|NCT02197130|12448808|FG000|Overall Study|Withdrawal by Subject|0
7922964|NCT02197130|12448809|FG001|Overall Study|Withdrawal by Subject|3
7922965|NCT02197130|12448810|FG002|Overall Study|Withdrawal by Subject|4
7922966|NCT02197130|12448808|FG000|Overall Study|Other|1
7922967|NCT02197130|12448809|FG001|Overall Study|Other|0
7922968|NCT02197130|12448810|FG002|Overall Study|Other|3
7922969|NCT02197247|12448818|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
7922970|NCT02197247|12448818|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
7922971|NCT02197247|12448818|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
7922972|NCT02197247|12448818|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
7922973|NCT02197247|12448818|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
7922974|NCT02197247|12448818|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
7922975|NCT02197247|12448818|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1
7922976|NCT02197247|12448818|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
7922977|NCT02197377|12448839|FG000|Overall Study|Insertion Failure|0
7922978|NCT02197377|12448840|FG001|Overall Study|Insertion Failure|3
7922979|NCT02197416|12448849|FG000|Overall Study|Other reasons|0
7922980|NCT02197416|12448850|FG001|Overall Study|Other reasons|2
7922981|NCT02197416|12448851|FG002|Overall Study|Other reasons|5
7922982|NCT02197416|12448849|FG000|Overall Study|Withdrawal by Subject|0
7922983|NCT02197416|12448850|FG001|Overall Study|Withdrawal by Subject|2
7922984|NCT02197416|12448851|FG002|Overall Study|Withdrawal by Subject|1
7922985|NCT02197416|12448849|FG000|Overall Study|Protocol Violation|1
7922986|NCT02197416|12448850|FG001|Overall Study|Protocol Violation|0
7922987|NCT02197416|12448851|FG002|Overall Study|Protocol Violation|1
7922988|NCT02197416|12448849|FG000|Overall Study|Adverse Event|0
7922989|NCT02197416|12448850|FG001|Overall Study|Adverse Event|0
7922990|NCT02197416|12448851|FG002|Overall Study|Adverse Event|1
7922991|NCT02197520|12448870|FG000|Period 1|Withdrawal by Subject|1
7922992|NCT02197520|12448871|FG001|Period 1|Withdrawal by Subject|0
7922993|NCT02197520|12448870|FG000|Period 2|Adverse Event|0
7922994|NCT02197520|12448871|FG001|Period 2|Adverse Event|2
7922995|NCT02197520|12448870|FG000|Period 2|Withdrawal by Subject|1
7922996|NCT02197520|12448871|FG001|Period 2|Withdrawal by Subject|0
7922997|NCT02197572|12448879|FG000|Overall Study|Progressive Disease|28
7922998|NCT02197572|12448879|FG000|Overall Study|Withdrawal by Subject|9
7922999|NCT02197572|12448879|FG000|Overall Study|Adverse Event|3
7923000|NCT02197572|12448879|FG000|Overall Study|Reason Not Specified|4
7923001|NCT02197806|12448891|FG000|Overall Study|Adverse Event|0
7923002|NCT02197806|12448892|FG001|Overall Study|Adverse Event|1
7923003|NCT02197806|12448893|FG002|Overall Study|Adverse Event|0
7923004|NCT02197806|12448894|FG003|Overall Study|Adverse Event|1
7923005|NCT02197897|12448904|FG000|Overall Study|not eligible|1
7923006|NCT02198040|12448911|FG000|Overall Study|Work reasons|0
7923007|NCT02198040|12448912|FG001|Overall Study|Work reasons|1
7923008|NCT02198040|12448913|FG002|Overall Study|Work reasons|0
7923009|NCT02198040|12448911|FG000|Overall Study|Withdrawal by Subject|0
7923010|NCT02198040|12448912|FG001|Overall Study|Withdrawal by Subject|0
7923011|NCT02198040|12448913|FG002|Overall Study|Withdrawal by Subject|1
7923012|NCT02198235|12448926|FG000|Overall Study|Lost to Follow-up|3
7923013|NCT02198235|12448927|FG001|Overall Study|Lost to Follow-up|2
7923014|NCT02198235|12448928|FG002|Overall Study|Lost to Follow-up|2
7923015|NCT02198651|12448945|FG000|Lead-in Period|Withdrew consent|13
7923016|NCT02198651|12448946|FG001|Lead-in Period|Withdrew consent|0
7923017|NCT02198651|12448947|FG002|Lead-in Period|Withdrew consent|0
7923018|NCT02198651|12448948|FG003|Lead-in Period|Withdrew consent|0
7923019|NCT02198651|12448949|FG004|Lead-in Period|Withdrew consent|0
7923020|NCT02198651|12448945|FG000|Lead-in Period|Adverse Event|2
7923021|NCT02198651|12448946|FG001|Lead-in Period|Adverse Event|0
7923022|NCT02198651|12448947|FG002|Lead-in Period|Adverse Event|0
7923023|NCT02198651|12448948|FG003|Lead-in Period|Adverse Event|0
7923024|NCT02198651|12448949|FG004|Lead-in Period|Adverse Event|0
7923025|NCT02198651|12448945|FG000|Lead-in Period|Other, not specified|22
7923026|NCT02198651|12448946|FG001|Lead-in Period|Other, not specified|0
7923027|NCT02198651|12448947|FG002|Lead-in Period|Other, not specified|0
7923028|NCT02198651|12448948|FG003|Lead-in Period|Other, not specified|0
7923029|NCT02198651|12448949|FG004|Lead-in Period|Other, not specified|0
7923030|NCT02198651|12448945|FG000|Double-blind Period|Withdrew consent|0
7923031|NCT02198651|12448946|FG001|Double-blind Period|Withdrew consent|4
7923032|NCT02198651|12448947|FG002|Double-blind Period|Withdrew consent|0
7923033|NCT02198651|12448948|FG003|Double-blind Period|Withdrew consent|0
7923034|NCT02198651|12448949|FG004|Double-blind Period|Withdrew consent|0
7923035|NCT02198651|12448945|FG000|Double-blind Period|Adverse Event|0
7923036|NCT02198651|12448946|FG001|Double-blind Period|Adverse Event|1
7923037|NCT02198651|12448947|FG002|Double-blind Period|Adverse Event|0
7923038|NCT02198651|12448948|FG003|Double-blind Period|Adverse Event|0
7923039|NCT02198651|12448949|FG004|Double-blind Period|Adverse Event|0
7923040|NCT02198651|12448945|FG000|Double-blind Period|Other, not specified|0
7923041|NCT02198651|12448946|FG001|Double-blind Period|Other, not specified|4
7923042|NCT02198651|12448947|FG002|Double-blind Period|Other, not specified|1
7923043|NCT02198651|12448948|FG003|Double-blind Period|Other, not specified|0
7923044|NCT02198651|12448949|FG004|Double-blind Period|Other, not specified|0
7923045|NCT02198651|12448945|FG000|Open-label Rescue Period|Withdrew consent|0
7923046|NCT02198651|12448946|FG001|Open-label Rescue Period|Withdrew consent|0
7923047|NCT02198651|12448947|FG002|Open-label Rescue Period|Withdrew consent|0
7923048|NCT02198651|12448948|FG003|Open-label Rescue Period|Withdrew consent|2
7923049|NCT02198651|12448949|FG004|Open-label Rescue Period|Withdrew consent|0
7923050|NCT02198651|12448945|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7923051|NCT02198651|12448946|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7923052|NCT02198651|12448947|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7923053|NCT02198651|12448948|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1
7923054|NCT02198651|12448949|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7923055|NCT02198664|12448964|FG000|Overall Study|Adverse Event|2
7923056|NCT02198664|12448965|FG001|Overall Study|Adverse Event|0
7923057|NCT02198664|12448964|FG000|Overall Study|Withdrawal by Subject|11
7923058|NCT02198664|12448965|FG001|Overall Study|Withdrawal by Subject|8
7923059|NCT02198664|12448964|FG000|Overall Study|Failure to tolerate|2
7923060|NCT02198664|12448965|FG001|Overall Study|Failure to tolerate|0
7923061|NCT02198664|12448964|FG000|Overall Study|Not stated|1
7923062|NCT02198664|12448965|FG001|Overall Study|Not stated|0
7923063|NCT02198963|12448973|FG000|Overall Study|Adverse Event|1
7923064|NCT02198963|12448973|FG000|Overall Study|Withdrawal by Subject|6
7923065|NCT02199028|12448984|FG000|Week 1|Adverse Event|1
7923066|NCT02199028|12448985|FG001|Week 1|Adverse Event|0
7923067|NCT02199028|12448984|FG000|Week 3|Adverse Event|1
7923068|NCT02199028|12448985|FG001|Week 3|Adverse Event|0
7923069|NCT02199080|12448997|FG000|Overall Study|Protocol Violation|12
7923070|NCT02199314|12449013|FG000|Overall Study|Withdrawal by Subject|6
7923071|NCT02199314|12449013|FG000|Overall Study|Physician Decision|10
7923072|NCT02199509|12449028|FG000|Overall Study|Suicidal Ideation|0
7923073|NCT02199509|12449029|FG001|Overall Study|Suicidal Ideation|1
7923074|NCT02199509|12449028|FG000|Overall Study|Misunderstood titration schedule|1
7923075|NCT02199509|12449029|FG001|Overall Study|Misunderstood titration schedule|0
7964522|NCT01107626|12520029|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11
7964523|NCT01107626|12520030|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21
7964524|NCT01107626|12520031|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27
7964525|NCT01107626|12520028|FG000|Step 2: Maintenance Therapy|Alternative therapy|0
7964526|NCT01107626|12520029|FG001|Step 2: Maintenance Therapy|Alternative therapy|2
7923076|NCT02199795|12449072|FG000|Overall Study|no longer met inclusion criteria|1
7923077|NCT02199795|12449073|FG001|Overall Study|no longer met inclusion criteria|0
7923078|NCT02199795|12449072|FG000|Overall Study|withdrew due to shoulder pain|1
7923079|NCT02199795|12449073|FG001|Overall Study|withdrew due to shoulder pain|0
7923080|NCT02200211|12449098|FG000|Overall Study|Lost to Follow-up|7
7923081|NCT02200211|12449099|FG001|Overall Study|Lost to Follow-up|7
7923082|NCT02200211|12449100|FG002|Overall Study|Lost to Follow-up|1
7923083|NCT02200211|12449101|FG003|Overall Study|Lost to Follow-up|2
7923084|NCT02200211|12449098|FG000|Overall Study|Withdrawal by Subject|1
7923085|NCT02200211|12449099|FG001|Overall Study|Withdrawal by Subject|0
7923086|NCT02200211|12449100|FG002|Overall Study|Withdrawal by Subject|0
7923087|NCT02200211|12449101|FG003|Overall Study|Withdrawal by Subject|0
7923088|NCT02200510|12449125|FG000|Overall Study|Death|1
7923089|NCT02200510|12449126|FG001|Overall Study|Death|1
7923090|NCT02200510|12449125|FG000|Overall Study|Protocol Violation|0
7923091|NCT02200510|12449126|FG001|Overall Study|Protocol Violation|1
7923092|NCT02200510|12449125|FG000|Overall Study|Lost to Follow-up|7
7923093|NCT02200510|12449126|FG001|Overall Study|Lost to Follow-up|1
7923094|NCT02200510|12449125|FG000|Overall Study|potential COI - joined study team|1
7923095|NCT02200510|12449126|FG001|Overall Study|potential COI - joined study team|0
7923096|NCT02201277|12449195|FG000|Overall Study|Death|3
7923097|NCT02201277|12449196|FG001|Overall Study|Death|4
7923098|NCT02201277|12449195|FG000|Overall Study|Lost to Follow-up|2
7923099|NCT02201277|12449196|FG001|Overall Study|Lost to Follow-up|1
7923100|NCT02201277|12449195|FG000|Overall Study|Failed retrieval|1
7923101|NCT02201277|12449196|FG001|Overall Study|Failed retrieval|0
7923102|NCT02201277|12449195|FG000|Overall Study|Physician Decision|1
7923103|NCT02201277|12449196|FG001|Overall Study|Physician Decision|0
7923104|NCT02201290|12449206|FG000|Overall Study|Withdrawal by Subject|2
7923105|NCT02201290|12449206|FG000|Overall Study|Lack of Efficacy|2
7923106|NCT02201290|12449206|FG000|Overall Study|Adverse Event|1
7923107|NCT02201329|12449210|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
7923108|NCT02201329|12449210|FG000|Overall Study|Withdrawal by Subject|2
7923109|NCT02201524|12449236|FG000|Overall Study|Adverse Event|0
7923110|NCT02201524|12449237|FG001|Overall Study|Adverse Event|2
7923111|NCT02201524|12449238|FG002|Overall Study|Adverse Event|1
7923112|NCT02201524|12449239|FG003|Overall Study|Adverse Event|0
7923113|NCT02201524|12449236|FG000|Overall Study|Insufficient clinical response|1
7923114|NCT02201524|12449237|FG001|Overall Study|Insufficient clinical response|0
7923115|NCT02201524|12449238|FG002|Overall Study|Insufficient clinical response|0
7923116|NCT02201524|12449239|FG003|Overall Study|Insufficient clinical response|0
7923117|NCT02201524|12449236|FG000|Overall Study|Lost to Follow-up|0
7923118|NCT02201524|12449237|FG001|Overall Study|Lost to Follow-up|0
7923119|NCT02201524|12449238|FG002|Overall Study|Lost to Follow-up|2
7923120|NCT02201524|12449239|FG003|Overall Study|Lost to Follow-up|0
7923121|NCT02201524|12449236|FG000|Overall Study|No longer meets eligibility criteria|0
7923122|NCT02201524|12449237|FG001|Overall Study|No longer meets eligibility criteria|0
7923123|NCT02201524|12449238|FG002|Overall Study|No longer meets eligibility criteria|0
7923124|NCT02201524|12449239|FG003|Overall Study|No longer meets eligibility criteria|2
7923125|NCT02201524|12449236|FG000|Overall Study|Protocol Violation|0
7923126|NCT02201524|12449237|FG001|Overall Study|Protocol Violation|0
7923127|NCT02201524|12449238|FG002|Overall Study|Protocol Violation|0
7923128|NCT02201524|12449239|FG003|Overall Study|Protocol Violation|1
7923129|NCT02201524|12449236|FG000|Overall Study|Withdrawal by Subject|0
7923130|NCT02201524|12449237|FG001|Overall Study|Withdrawal by Subject|0
7923131|NCT02201524|12449238|FG002|Overall Study|Withdrawal by Subject|1
7923132|NCT02201524|12449239|FG003|Overall Study|Withdrawal by Subject|1
7923133|NCT02201524|12449236|FG000|Overall Study|Other|1
7923134|NCT02201524|12449237|FG001|Overall Study|Other|1
7923135|NCT02201524|12449238|FG002|Overall Study|Other|0
7923136|NCT02201524|12449239|FG003|Overall Study|Other|0
7923137|NCT02201771|12449252|FG000|Overall Study|Death|3
7923138|NCT02201771|12449253|FG001|Overall Study|Death|2
7923139|NCT02201771|12449254|FG002|Overall Study|Death|0
7923140|NCT02201771|12449252|FG000|Overall Study|Protocol Violation|10
7923141|NCT02201771|12449253|FG001|Overall Study|Protocol Violation|8
7923142|NCT02201771|12449254|FG002|Overall Study|Protocol Violation|10
7923143|NCT02201784|12449264|FG000|Overall Study|Failure to achieve adequate block|2
7923144|NCT02201784|12449265|FG001|Overall Study|Failure to achieve adequate block|0
7923145|NCT02201901|12449274|FG000|Overall Study|Randomized but never treated|0
7923146|NCT02201901|12449275|FG001|Overall Study|Randomized but never treated|1
7923147|NCT02201901|12449276|FG002|Overall Study|Randomized but never treated|0
7923148|NCT02201901|12449274|FG000|Overall Study|Lack of Efficacy|7
7923149|NCT02201901|12449275|FG001|Overall Study|Lack of Efficacy|1
7923150|NCT02201901|12449276|FG002|Overall Study|Lack of Efficacy|6
7923151|NCT02201901|12449274|FG000|Overall Study|Death|3
7923152|NCT02201901|12449275|FG001|Overall Study|Death|3
7923153|NCT02201901|12449276|FG002|Overall Study|Death|3
7923154|NCT02201901|12449274|FG000|Overall Study|Lost to Follow-up|2
7923155|NCT02201901|12449275|FG001|Overall Study|Lost to Follow-up|3
7923156|NCT02201901|12449276|FG002|Overall Study|Lost to Follow-up|2
7923157|NCT02201901|12449274|FG000|Overall Study|Withdrew Consent|2
7923158|NCT02201901|12449275|FG001|Overall Study|Withdrew Consent|0
7923159|NCT02201901|12449276|FG002|Overall Study|Withdrew Consent|2
7923160|NCT02201901|12449274|FG000|Overall Study|Adverse Event|1
7923161|NCT02201901|12449275|FG001|Overall Study|Adverse Event|1
7923162|NCT02201901|12449276|FG002|Overall Study|Adverse Event|0
7923163|NCT02201940|12449287|FG000|Overall Study|Randomized/Enrolled but Never Treated|1
7923164|NCT02201940|12449288|FG001|Overall Study|Randomized/Enrolled but Never Treated|0
7923165|NCT02201940|12449287|FG000|Overall Study|Lack of Efficacy|2
7923166|NCT02201940|12449288|FG001|Overall Study|Lack of Efficacy|113
7923167|NCT02201940|12449287|FG000|Overall Study|Lost to Follow-up|5
7923168|NCT02201940|12449288|FG001|Overall Study|Lost to Follow-up|0
7923169|NCT02201940|12449287|FG000|Overall Study|Withdrew Consent|2
7923170|NCT02201940|12449288|FG001|Overall Study|Withdrew Consent|1
7923171|NCT02201940|12449287|FG000|Overall Study|Investigator's Discretion|1
7923172|NCT02201940|12449288|FG001|Overall Study|Investigator's Discretion|1
7923173|NCT02201940|12449287|FG000|Overall Study|Death|1
7923174|NCT02201940|12449288|FG001|Overall Study|Death|0
7923175|NCT02201940|12449287|FG000|Overall Study|Adverse Event|0
7923176|NCT02201940|12449288|FG001|Overall Study|Adverse Event|1
7923177|NCT02201953|12449296|FG000|Overall Study|Randomized but Never Treated|1
7923178|NCT02201953|12449297|FG001|Overall Study|Randomized but Never Treated|5
7923179|NCT02201953|12449296|FG000|Overall Study|Lack of Efficacy|9
7923180|NCT02201953|12449297|FG001|Overall Study|Lack of Efficacy|30
7923181|NCT02201953|12449296|FG000|Overall Study|Lost to Follow-up|8
7923182|NCT02201953|12449297|FG001|Overall Study|Lost to Follow-up|8
7923183|NCT02201953|12449296|FG000|Overall Study|Withdrew Consent|2
7923184|NCT02201953|12449297|FG001|Overall Study|Withdrew Consent|5
7923185|NCT02201953|12449296|FG000|Overall Study|Adverse Event|0
7923186|NCT02201953|12449297|FG001|Overall Study|Adverse Event|5
7923187|NCT02201953|12449296|FG000|Overall Study|Death|0
7923188|NCT02201953|12449297|FG001|Overall Study|Death|3
7923189|NCT02202031|12449305|FG000|Overall Study|Lost to Follow-up|1
7923190|NCT02202031|12449306|FG001|Overall Study|Lost to Follow-up|0
7923191|NCT02202031|12449305|FG000|Overall Study|Too Busy|1
7923192|NCT02202031|12449306|FG001|Overall Study|Too Busy|3
7923193|NCT02202031|12449305|FG000|Overall Study|Illness/Medical Reason|0
7923194|NCT02202031|12449306|FG001|Overall Study|Illness/Medical Reason|2
7923195|NCT02202031|12449305|FG000|Overall Study|Intolerance/Lack of Improvement|3
7923196|NCT02202031|12449306|FG001|Overall Study|Intolerance/Lack of Improvement|0
7923197|NCT02202109|12449314|FG000|Overall Study|Lost to Follow-up|88
7923198|NCT02202109|12449315|FG001|Overall Study|Lost to Follow-up|87
7923199|NCT02202109|12449314|FG000|Overall Study|Withdrawal by Subject|2
7923200|NCT02202109|12449315|FG001|Overall Study|Withdrawal by Subject|0
7923201|NCT02202161|12449333|FG000|Overall Study|Adverse Event|1
7923202|NCT02202161|12449334|FG001|Overall Study|Adverse Event|1
7923203|NCT02202161|12449335|FG002|Overall Study|Adverse Event|0
7923204|NCT02202161|12449336|FG003|Overall Study|Adverse Event|0
7923205|NCT02202161|12449337|FG004|Overall Study|Adverse Event|0
7923206|NCT02202161|12449338|FG005|Overall Study|Adverse Event|1
7923207|NCT02202161|12449339|FG006|Overall Study|Adverse Event|0
7923208|NCT02202161|12449340|FG007|Overall Study|Adverse Event|0
7923209|NCT02202161|12449333|FG000|Overall Study|Did not meet continuation criteria|0
7923210|NCT02202161|12449334|FG001|Overall Study|Did not meet continuation criteria|0
7923211|NCT02202161|12449335|FG002|Overall Study|Did not meet continuation criteria|0
7923212|NCT02202161|12449336|FG003|Overall Study|Did not meet continuation criteria|0
7923213|NCT02202161|12449337|FG004|Overall Study|Did not meet continuation criteria|0
7923214|NCT02202161|12449338|FG005|Overall Study|Did not meet continuation criteria|0
7923215|NCT02202161|12449339|FG006|Overall Study|Did not meet continuation criteria|0
7923216|NCT02202161|12449340|FG007|Overall Study|Did not meet continuation criteria|3
7923217|NCT02202161|12449333|FG000|Overall Study|Physician Decision|0
7923218|NCT02202161|12449334|FG001|Overall Study|Physician Decision|0
7923219|NCT02202161|12449335|FG002|Overall Study|Physician Decision|0
7923220|NCT02202161|12449336|FG003|Overall Study|Physician Decision|0
7923221|NCT02202161|12449337|FG004|Overall Study|Physician Decision|0
7923222|NCT02202161|12449338|FG005|Overall Study|Physician Decision|0
7923223|NCT02202161|12449339|FG006|Overall Study|Physician Decision|0
7923224|NCT02202161|12449340|FG007|Overall Study|Physician Decision|3
7923225|NCT02202161|12449333|FG000|Overall Study|Withdrawal by Subject|0
7923226|NCT02202161|12449334|FG001|Overall Study|Withdrawal by Subject|0
7923227|NCT02202161|12449335|FG002|Overall Study|Withdrawal by Subject|0
7923228|NCT02202161|12449336|FG003|Overall Study|Withdrawal by Subject|0
7923229|NCT02202161|12449337|FG004|Overall Study|Withdrawal by Subject|1
7923230|NCT02202161|12449338|FG005|Overall Study|Withdrawal by Subject|0
7923231|NCT02202161|12449339|FG006|Overall Study|Withdrawal by Subject|0
7923232|NCT02202161|12449340|FG007|Overall Study|Withdrawal by Subject|0
7923233|NCT02202317|12449368|FG000|Overall Study|Lost to Follow-up|1
7923234|NCT02202499|12449375|FG000|Overall Study|Cancer diagnosis|0
7923235|NCT02202499|12449376|FG001|Overall Study|Cancer diagnosis|0
7923236|NCT02202499|12449377|FG002|Overall Study|Cancer diagnosis|1
7923237|NCT02202499|12449375|FG000|Overall Study|Moved from area|0
7923238|NCT02202499|12449376|FG001|Overall Study|Moved from area|0
7923239|NCT02202499|12449377|FG002|Overall Study|Moved from area|1
7923240|NCT02202499|12449375|FG000|Overall Study|Declined before randomization|1
7923241|NCT02202499|12449376|FG001|Overall Study|Declined before randomization|0
7923242|NCT02202499|12449377|FG002|Overall Study|Declined before randomization|0
7923243|NCT02202499|12449375|FG000|Overall Study|Auto accident|1
7923244|NCT02202499|12449376|FG001|Overall Study|Auto accident|0
7923245|NCT02202499|12449377|FG002|Overall Study|Auto accident|0
7923246|NCT02202538|12449390|FG000|Overall Study|Withdrawal by Subject|5
7923247|NCT02202538|12449390|FG000|Overall Study|Did not meet all inclusion criteria|2
7923248|NCT02202538|12449390|FG000|Overall Study|Investigator Decision|1
7923249|NCT02202551|12449398|FG000|Overall Study|Adverse Event|8
7923250|NCT02202551|12449399|FG001|Overall Study|Adverse Event|19
7923251|NCT02202551|12449400|FG002|Overall Study|Adverse Event|5
7923252|NCT02202551|12449401|FG003|Overall Study|Adverse Event|9
7923253|NCT02202551|12449398|FG000|Overall Study|Death|3
7923254|NCT02202551|12449399|FG001|Overall Study|Death|2
7923255|NCT02202551|12449400|FG002|Overall Study|Death|1
7923256|NCT02202551|12449401|FG003|Overall Study|Death|1
7923257|NCT02202551|12449398|FG000|Overall Study|Lost to Follow-up|0
7923258|NCT02202551|12449399|FG001|Overall Study|Lost to Follow-up|1
7923259|NCT02202551|12449400|FG002|Overall Study|Lost to Follow-up|0
7923260|NCT02202551|12449401|FG003|Overall Study|Lost to Follow-up|1
7923261|NCT02202551|12449398|FG000|Overall Study|Needed to take excluded medication|0
7923262|NCT02202551|12449399|FG001|Overall Study|Needed to take excluded medication|2
7923263|NCT02202551|12449400|FG002|Overall Study|Needed to take excluded medication|0
7923264|NCT02202551|12449401|FG003|Overall Study|Needed to take excluded medication|1
7923265|NCT02202551|12449398|FG000|Overall Study|Subject moved away|0
7923266|NCT02202551|12449399|FG001|Overall Study|Subject moved away|1
7923267|NCT02202551|12449400|FG002|Overall Study|Subject moved away|0
7923268|NCT02202551|12449401|FG003|Overall Study|Subject moved away|0
7923269|NCT02202551|12449398|FG000|Overall Study|DBS surgery|3
7923270|NCT02202551|12449399|FG001|Overall Study|DBS surgery|0
7923271|NCT02202551|12449400|FG002|Overall Study|DBS surgery|0
7923272|NCT02202551|12449401|FG003|Overall Study|DBS surgery|0
7923273|NCT02202551|12449398|FG000|Overall Study|Dyskinesia upon taper|1
7923274|NCT02202551|12449399|FG001|Overall Study|Dyskinesia upon taper|0
7923275|NCT02202551|12449400|FG002|Overall Study|Dyskinesia upon taper|0
7923276|NCT02202551|12449401|FG003|Overall Study|Dyskinesia upon taper|0
7923277|NCT02202551|12449398|FG000|Overall Study|Lack of Efficacy|0
7923278|NCT02202551|12449399|FG001|Overall Study|Lack of Efficacy|1
7923279|NCT02202551|12449400|FG002|Overall Study|Lack of Efficacy|0
7923280|NCT02202551|12449401|FG003|Overall Study|Lack of Efficacy|0
7923281|NCT02202551|12449398|FG000|Overall Study|Physician Decision|1
7923282|NCT02202551|12449399|FG001|Overall Study|Physician Decision|0
7923283|NCT02202551|12449400|FG002|Overall Study|Physician Decision|0
7923284|NCT02202551|12449401|FG003|Overall Study|Physician Decision|0
7923285|NCT02202551|12449398|FG000|Overall Study|Site closure|3
7923286|NCT02202551|12449399|FG001|Overall Study|Site closure|0
7923287|NCT02202551|12449400|FG002|Overall Study|Site closure|0
7923288|NCT02202551|12449401|FG003|Overall Study|Site closure|1
7923289|NCT02202551|12449398|FG000|Overall Study|Unable to complete visits per protocol|1
7923290|NCT02202551|12449399|FG001|Overall Study|Unable to complete visits per protocol|0
7923291|NCT02202551|12449400|FG002|Overall Study|Unable to complete visits per protocol|0
7923292|NCT02202551|12449401|FG003|Overall Study|Unable to complete visits per protocol|0
7923293|NCT02202551|12449398|FG000|Overall Study|Worsening Dyskinesia|0
7923294|NCT02202551|12449399|FG001|Overall Study|Worsening Dyskinesia|0
7923295|NCT02202551|12449400|FG002|Overall Study|Worsening Dyskinesia|0
7923296|NCT02202551|12449401|FG003|Overall Study|Worsening Dyskinesia|1
7923297|NCT02202551|12449398|FG000|Overall Study|Protocol Violation|0
7923298|NCT02202551|12449399|FG001|Overall Study|Protocol Violation|1
7923299|NCT02202551|12449400|FG002|Overall Study|Protocol Violation|0
7923300|NCT02202551|12449401|FG003|Overall Study|Protocol Violation|0
7923301|NCT02202551|12449398|FG000|Overall Study|Sponsor's decision|2
7923302|NCT02202551|12449399|FG001|Overall Study|Sponsor's decision|0
7923303|NCT02202551|12449400|FG002|Overall Study|Sponsor's decision|0
7923304|NCT02202551|12449401|FG003|Overall Study|Sponsor's decision|0
7923305|NCT02202551|12449398|FG000|Overall Study|Subject unwilling to proceed|1
7923306|NCT02202551|12449399|FG001|Overall Study|Subject unwilling to proceed|5
7923307|NCT02202551|12449400|FG002|Overall Study|Subject unwilling to proceed|3
7923308|NCT02202551|12449401|FG003|Overall Study|Subject unwilling to proceed|5
7923309|NCT02202551|12449398|FG000|Overall Study|Subject consent withdrawn|0
7923310|NCT02202551|12449399|FG001|Overall Study|Subject consent withdrawn|3
7923311|NCT02202551|12449400|FG002|Overall Study|Subject consent withdrawn|1
7923312|NCT02202551|12449401|FG003|Overall Study|Subject consent withdrawn|2
7923313|NCT02202551|12449398|FG000|Overall Study|eGFR<50mL/min/m2|2
7923314|NCT02202551|12449399|FG001|Overall Study|eGFR<50mL/min/m2|2
7923315|NCT02202551|12449400|FG002|Overall Study|eGFR<50mL/min/m2|0
7923316|NCT02202551|12449401|FG003|Overall Study|eGFR<50mL/min/m2|1
7923317|NCT02202616|12449415|FG000|Overall Study|Screen failed|24
7923318|NCT02202616|12449415|FG000|Overall Study|Adverse Event|32
7923319|NCT02202616|12449415|FG000|Overall Study|Protocol deviation|18
7923320|NCT02202616|12449415|FG000|Overall Study|Patient withdrew consent|12
7923321|NCT02202616|12449415|FG000|Overall Study|Lost to Follow-up|6
7923322|NCT02202616|12449415|FG000|Overall Study|Administrative problems|6
7923323|NCT02202616|12449415|FG000|Overall Study|Abnormal test procedure result|1
7923324|NCT02202616|12449415|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7923325|NCT02202759|12449435|FG000|Overall Study|Study Terminated by Sponsor|3
7923326|NCT02202759|12449436|FG001|Overall Study|Study Terminated by Sponsor|3
7923327|NCT02202759|12449437|FG002|Overall Study|Study Terminated by Sponsor|3
7923328|NCT02202759|12449435|FG000|Overall Study|Withdrawal by Subject|2
7923329|NCT02202759|12449436|FG001|Overall Study|Withdrawal by Subject|1
7923330|NCT02202759|12449437|FG002|Overall Study|Withdrawal by Subject|1
7923331|NCT02202759|12449435|FG000|Overall Study|Reason not Specified|4
7923332|NCT02202759|12449436|FG001|Overall Study|Reason not Specified|11
7923333|NCT02202759|12449437|FG002|Overall Study|Reason not Specified|10
7923334|NCT02202785|12449447|FG000|Overall Study|Study Terminated by Sponsor|1
7923335|NCT02202785|12449448|FG001|Overall Study|Study Terminated by Sponsor|6
7923336|NCT02202785|12449449|FG002|Overall Study|Study Terminated by Sponsor|4
7923337|NCT02202785|12449447|FG000|Overall Study|Withdrawal by Subject|0
7923338|NCT02202785|12449448|FG001|Overall Study|Withdrawal by Subject|1
7923339|NCT02202785|12449449|FG002|Overall Study|Withdrawal by Subject|0
7923340|NCT02202785|12449447|FG000|Overall Study|Lost to Follow-up|0
7923341|NCT02202785|12449448|FG001|Overall Study|Lost to Follow-up|1
7923342|NCT02202785|12449449|FG002|Overall Study|Lost to Follow-up|0
7923343|NCT02202785|12449447|FG000|Overall Study|Reason not Specified|10
7923344|NCT02202785|12449448|FG001|Overall Study|Reason not Specified|7
7923345|NCT02202785|12449449|FG002|Overall Study|Reason not Specified|13
7923346|NCT02202837|12449459|FG000|Overall Study|Enbrel treatment discontinued|36
7923347|NCT02202837|12449460|FG001|Overall Study|Enbrel treatment discontinued|4
7923348|NCT02202837|12449459|FG000|Overall Study|Other|10
7923349|NCT02202837|12449460|FG001|Overall Study|Other|0
7923350|NCT02202837|12449459|FG000|Overall Study|Lost to Follow-up|7
7923351|NCT02202837|12449460|FG001|Overall Study|Lost to Follow-up|1
7923352|NCT02202850|12449468|FG000|Overall Study|Other|2
7923353|NCT02202850|12449469|FG001|Overall Study|Other|2
7923354|NCT02202850|12449468|FG000|Overall Study|Enbrel treatment discontinued|15
7923355|NCT02202850|12449469|FG001|Overall Study|Enbrel treatment discontinued|3
7923356|NCT02202850|12449468|FG000|Overall Study|Lost to Follow-up|7
7923357|NCT02202850|12449469|FG001|Overall Study|Lost to Follow-up|1
7923358|NCT02202980|12449489|FG000|Overall Study|Lack of Efficacy|1
7923359|NCT02202980|12449490|FG001|Overall Study|Lack of Efficacy|0
7923360|NCT02202980|12449491|FG002|Overall Study|Lack of Efficacy|7
7923361|NCT02202980|12449492|FG003|Overall Study|Lack of Efficacy|0
7923362|NCT02202980|12449493|FG004|Overall Study|Lack of Efficacy|3
7923363|NCT02202980|12449494|FG005|Overall Study|Lack of Efficacy|1
7923364|NCT02202980|12449495|FG006|Overall Study|Lack of Efficacy|11
7923365|NCT02202980|12449496|FG007|Overall Study|Lack of Efficacy|2
7923366|NCT02202980|12449497|FG008|Overall Study|Lack of Efficacy|2
7923367|NCT02202980|12449498|FG009|Overall Study|Lack of Efficacy|0
7923368|NCT02202980|12449499|FG010|Overall Study|Lack of Efficacy|0
7923369|NCT02202980|12449500|FG011|Overall Study|Lack of Efficacy|3
7923370|NCT02202980|12449501|FG012|Overall Study|Lack of Efficacy|10
7923371|NCT02202980|12449502|FG013|Overall Study|Lack of Efficacy|0
7923372|NCT02202980|12449489|FG000|Overall Study|Protocol Violation|0
7923373|NCT02202980|12449490|FG001|Overall Study|Protocol Violation|0
7923374|NCT02202980|12449491|FG002|Overall Study|Protocol Violation|0
7923375|NCT02202980|12449492|FG003|Overall Study|Protocol Violation|3
7923376|NCT02202980|12449493|FG004|Overall Study|Protocol Violation|3
7923377|NCT02202980|12449494|FG005|Overall Study|Protocol Violation|0
7923378|NCT02202980|12449495|FG006|Overall Study|Protocol Violation|0
7923379|NCT02202980|12449496|FG007|Overall Study|Protocol Violation|0
7923380|NCT02202980|12449497|FG008|Overall Study|Protocol Violation|0
7923381|NCT02202980|12449498|FG009|Overall Study|Protocol Violation|0
7923382|NCT02202980|12449499|FG010|Overall Study|Protocol Violation|0
7923383|NCT02202980|12449500|FG011|Overall Study|Protocol Violation|0
7923384|NCT02202980|12449501|FG012|Overall Study|Protocol Violation|0
7923385|NCT02202980|12449502|FG013|Overall Study|Protocol Violation|0
7923386|NCT02202980|12449489|FG000|Overall Study|Lost to Follow-up|0
7923387|NCT02202980|12449490|FG001|Overall Study|Lost to Follow-up|1
7923388|NCT02202980|12449491|FG002|Overall Study|Lost to Follow-up|1
7923389|NCT02202980|12449492|FG003|Overall Study|Lost to Follow-up|1
7923390|NCT02202980|12449493|FG004|Overall Study|Lost to Follow-up|0
7923391|NCT02202980|12449494|FG005|Overall Study|Lost to Follow-up|0
7923392|NCT02202980|12449495|FG006|Overall Study|Lost to Follow-up|0
7923393|NCT02202980|12449496|FG007|Overall Study|Lost to Follow-up|1
7923394|NCT02202980|12449497|FG008|Overall Study|Lost to Follow-up|1
7923395|NCT02202980|12449498|FG009|Overall Study|Lost to Follow-up|0
7923396|NCT02202980|12449499|FG010|Overall Study|Lost to Follow-up|0
7923397|NCT02202980|12449500|FG011|Overall Study|Lost to Follow-up|0
7923398|NCT02202980|12449501|FG012|Overall Study|Lost to Follow-up|1
7923399|NCT02202980|12449502|FG013|Overall Study|Lost to Follow-up|0
7923400|NCT02202980|12449489|FG000|Overall Study|Withdrew Consent|0
7923401|NCT02202980|12449490|FG001|Overall Study|Withdrew Consent|1
7923402|NCT02202980|12449491|FG002|Overall Study|Withdrew Consent|2
7923403|NCT02202980|12449492|FG003|Overall Study|Withdrew Consent|0
7923404|NCT02202980|12449493|FG004|Overall Study|Withdrew Consent|0
7923405|NCT02202980|12449494|FG005|Overall Study|Withdrew Consent|0
7923406|NCT02202980|12449495|FG006|Overall Study|Withdrew Consent|0
7923407|NCT02202980|12449496|FG007|Overall Study|Withdrew Consent|0
7923408|NCT02202980|12449497|FG008|Overall Study|Withdrew Consent|1
7923409|NCT02202980|12449498|FG009|Overall Study|Withdrew Consent|0
7923410|NCT02202980|12449499|FG010|Overall Study|Withdrew Consent|0
7923411|NCT02202980|12449500|FG011|Overall Study|Withdrew Consent|0
7923412|NCT02202980|12449501|FG012|Overall Study|Withdrew Consent|0
7923413|NCT02202980|12449502|FG013|Overall Study|Withdrew Consent|0
7923414|NCT02203032|12449541|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
7923415|NCT02203032|12449542|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
7923416|NCT02203032|12449543|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
7923417|NCT02203032|12449544|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
7923418|NCT02203032|12449541|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
7923419|NCT02203032|12449542|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
7923420|NCT02203032|12449543|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
7923421|NCT02203032|12449544|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
7923422|NCT02203032|12449541|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
7923423|NCT02203032|12449542|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
7923424|NCT02203032|12449543|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
7923425|NCT02203032|12449544|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
7923426|NCT02203032|12449541|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
7923427|NCT02203032|12449542|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
7923428|NCT02203032|12449543|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
7923429|NCT02203032|12449544|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
7923430|NCT02203032|12449541|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
7923431|NCT02203032|12449542|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
7923432|NCT02203032|12449543|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
7923433|NCT02203032|12449544|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
7923434|NCT02203032|12449541|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2
7923435|NCT02203032|12449542|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0
7923436|NCT02203032|12449543|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0
7923437|NCT02203032|12449544|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0
7923438|NCT02203032|12449541|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
7923439|NCT02203032|12449542|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
7923440|NCT02203032|12449543|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
7923441|NCT02203032|12449544|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
7923442|NCT02203032|12449541|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
7923443|NCT02203032|12449542|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
7923444|NCT02203032|12449543|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
7923445|NCT02203032|12449544|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
7923446|NCT02203032|12449541|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
7923447|NCT02203032|12449542|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
7923448|NCT02203032|12449543|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
7923449|NCT02203032|12449544|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
7923450|NCT02203032|12449541|FG000|Blinded Phase (Week 16 to Week 44)|Other|0
7923451|NCT02203032|12449542|FG001|Blinded Phase (Week 16 to Week 44)|Other|4
7923452|NCT02203032|12449543|FG002|Blinded Phase (Week 16 to Week 44)|Other|1
7923453|NCT02203032|12449544|FG003|Blinded Phase (Week 16 to Week 44)|Other|15
7923454|NCT02203032|12449541|FG000|Blinded Phase (Week 16 to Week 44)|Death|0
7923455|NCT02203032|12449542|FG001|Blinded Phase (Week 16 to Week 44)|Death|0
7923456|NCT02203032|12449543|FG002|Blinded Phase (Week 16 to Week 44)|Death|0
7923457|NCT02203032|12449544|FG003|Blinded Phase (Week 16 to Week 44)|Death|1
7923458|NCT02203032|12449541|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
7923459|NCT02203032|12449542|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
7923460|NCT02203032|12449543|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
7923461|NCT02203032|12449544|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
7923462|NCT02203071|12449554|FG000|Overall Study|Lost to Follow-up|3
7923463|NCT02203071|12449555|FG001|Overall Study|Lost to Follow-up|1
7923464|NCT02203149|12449566|FG000|Part 1|Adverse Event|0
7923465|NCT02203149|12449567|FG001|Part 1|Adverse Event|1
7923466|NCT02203149|12449568|FG002|Part 1|Adverse Event|0
7923467|NCT02203149|12449569|FG003|Part 1|Adverse Event|0
7923468|NCT02203149|12449570|FG004|Part 1|Adverse Event|0
7923469|NCT02203149|12449566|FG000|Part 2|Death|0
7923470|NCT02203149|12449567|FG001|Part 2|Death|0
7923471|NCT02203149|12449568|FG002|Part 2|Death|1
7923472|NCT02203149|12449569|FG003|Part 2|Death|1
7923473|NCT02203149|12449570|FG004|Part 2|Death|0
7923474|NCT02203149|12449566|FG000|Part 2|Withdrawal by Subject|0
7923475|NCT02203149|12449567|FG001|Part 2|Withdrawal by Subject|0
7923476|NCT02203149|12449568|FG002|Part 2|Withdrawal by Subject|0
7923477|NCT02203149|12449569|FG003|Part 2|Withdrawal by Subject|1
7923478|NCT02203149|12449570|FG004|Part 2|Withdrawal by Subject|0
7923479|NCT02203149|12449566|FG000|Part 2|Adverse Event|0
7923480|NCT02203149|12449567|FG001|Part 2|Adverse Event|0
7923481|NCT02203149|12449568|FG002|Part 2|Adverse Event|0
7923482|NCT02203149|12449569|FG003|Part 2|Adverse Event|1
7923483|NCT02203149|12449570|FG004|Part 2|Adverse Event|1
7923484|NCT02203331|12449602|FG000|Overall Study|Pregnancy|1
7923485|NCT02203331|12449603|FG001|Overall Study|Pregnancy|0
7923486|NCT02203331|12449604|FG002|Overall Study|Pregnancy|0
7923487|NCT02203331|12449605|FG003|Overall Study|Pregnancy|0
7923488|NCT02203331|12449606|FG004|Overall Study|Pregnancy|2
7923489|NCT02203331|12449607|FG005|Overall Study|Pregnancy|0
7923490|NCT02203331|12449602|FG000|Overall Study|Withdrawal by Subject|1
7923491|NCT02203331|12449603|FG001|Overall Study|Withdrawal by Subject|0
7923492|NCT02203331|12449604|FG002|Overall Study|Withdrawal by Subject|1
7923493|NCT02203331|12449605|FG003|Overall Study|Withdrawal by Subject|0
7923494|NCT02203331|12449606|FG004|Overall Study|Withdrawal by Subject|0
7923495|NCT02203331|12449607|FG005|Overall Study|Withdrawal by Subject|3
7923496|NCT02203331|12449602|FG000|Overall Study|Adverse Event|4
7923497|NCT02203331|12449603|FG001|Overall Study|Adverse Event|8
7923498|NCT02203331|12449604|FG002|Overall Study|Adverse Event|3
7923499|NCT02203331|12449605|FG003|Overall Study|Adverse Event|4
7923500|NCT02203331|12449606|FG004|Overall Study|Adverse Event|3
7923501|NCT02203331|12449607|FG005|Overall Study|Adverse Event|3
7923502|NCT02203331|12449602|FG000|Overall Study|Other Reasons|1
7923503|NCT02203331|12449603|FG001|Overall Study|Other Reasons|2
7923504|NCT02203331|12449604|FG002|Overall Study|Other Reasons|0
7923505|NCT02203331|12449605|FG003|Overall Study|Other Reasons|2
7923506|NCT02203331|12449606|FG004|Overall Study|Other Reasons|0
7923507|NCT02203331|12449607|FG005|Overall Study|Other Reasons|0
7923508|NCT02203331|12449602|FG000|Overall Study|Lack of Efficacy|0
7923509|NCT02203331|12449603|FG001|Overall Study|Lack of Efficacy|2
7923510|NCT02203331|12449604|FG002|Overall Study|Lack of Efficacy|1
7923511|NCT02203331|12449605|FG003|Overall Study|Lack of Efficacy|0
7923512|NCT02203331|12449606|FG004|Overall Study|Lack of Efficacy|0
7923513|NCT02203331|12449607|FG005|Overall Study|Lack of Efficacy|1
7923514|NCT02203331|12449602|FG000|Overall Study|Protocol Violation|0
7923515|NCT02203331|12449603|FG001|Overall Study|Protocol Violation|2
7923516|NCT02203331|12449604|FG002|Overall Study|Protocol Violation|0
7923517|NCT02203331|12449605|FG003|Overall Study|Protocol Violation|1
7923518|NCT02203331|12449606|FG004|Overall Study|Protocol Violation|1
7923519|NCT02203331|12449607|FG005|Overall Study|Protocol Violation|0
7923520|NCT02203331|12449602|FG000|Overall Study|Lost to Follow-up|0
7923521|NCT02203331|12449603|FG001|Overall Study|Lost to Follow-up|0
7923522|NCT02203331|12449604|FG002|Overall Study|Lost to Follow-up|0
7923523|NCT02203331|12449605|FG003|Overall Study|Lost to Follow-up|0
7923524|NCT02203331|12449606|FG004|Overall Study|Lost to Follow-up|1
7923525|NCT02203331|12449607|FG005|Overall Study|Lost to Follow-up|0
7923526|NCT02203357|12449624|FG000|Overall Study|Lost to Follow-up|58
7923527|NCT02203357|12449625|FG001|Overall Study|Lost to Follow-up|66
7923528|NCT02203357|12449626|FG002|Overall Study|Lost to Follow-up|70
7923529|NCT02203591|12449653|FG000|Overall Study|Did not meet treatment day baseline|147
7923530|NCT02203591|12449654|FG001|Overall Study|Did not meet treatment day baseline|141
7923531|NCT02203591|12449655|FG002|Overall Study|Did not meet treatment day baseline|150
7923532|NCT02203591|12449656|FG003|Overall Study|Did not meet treatment day baseline|45
7923533|NCT02203591|12449657|FG004|Overall Study|Did not meet treatment day baseline|33
7923534|NCT02203591|12449658|FG005|Overall Study|Did not meet treatment day baseline|35
7923535|NCT02203591|12449659|FG006|Overall Study|Did not meet treatment day baseline|29
7923536|NCT02203591|12449660|FG007|Overall Study|Did not meet treatment day baseline|12
7923537|NCT02203591|12449653|FG000|Overall Study|Discontinued early due to compromised test sites|0
7923538|NCT02203591|12449654|FG001|Overall Study|Discontinued early due to compromised test sites|1
7923539|NCT02203591|12449655|FG002|Overall Study|Discontinued early due to compromised test sites|1
7923540|NCT02203591|12449656|FG003|Overall Study|Discontinued early due to compromised test sites|0
7923541|NCT02203591|12449657|FG004|Overall Study|Discontinued early due to compromised test sites|1
7923542|NCT02203591|12449658|FG005|Overall Study|Discontinued early due to compromised test sites|0
7923543|NCT02203591|12449659|FG006|Overall Study|Discontinued early due to compromised test sites|0
7923544|NCT02203591|12449660|FG007|Overall Study|Discontinued early due to compromised test sites|1
7923545|NCT02203721|12449693|FG000|Overall Study|Lost to Follow-up|1
7923546|NCT02203721|12449694|FG001|Overall Study|Lost to Follow-up|0
7923547|NCT02203721|12449693|FG000|Overall Study|Death|0
7923548|NCT02203721|12449694|FG001|Overall Study|Death|2
7923549|NCT02203721|12449693|FG000|Overall Study|Illness|0
7923550|NCT02203721|12449694|FG001|Overall Study|Illness|1
7923551|NCT02203838|12449732|FG000|Overall Study|Lack of Efficacy|7
7923552|NCT02203838|12449733|FG001|Overall Study|Lack of Efficacy|0
7923553|NCT02203838|12449734|FG002|Overall Study|Lack of Efficacy|1
7923554|NCT02203838|12449735|FG003|Overall Study|Lack of Efficacy|1
7923555|NCT02203838|12449732|FG000|Overall Study|Adverse Event|46
7923556|NCT02203838|12449733|FG001|Overall Study|Adverse Event|6
7923557|NCT02203838|12449734|FG002|Overall Study|Adverse Event|3
7923558|NCT02203838|12449735|FG003|Overall Study|Adverse Event|2
7923559|NCT02203838|12449732|FG000|Overall Study|Lost to Follow-up|39
7923560|NCT02203838|12449733|FG001|Overall Study|Lost to Follow-up|3
7923561|NCT02203838|12449734|FG002|Overall Study|Lost to Follow-up|2
7923562|NCT02203838|12449735|FG003|Overall Study|Lost to Follow-up|1
7923563|NCT02203838|12449732|FG000|Overall Study|Protocol Violation|7
7923564|NCT02203838|12449733|FG001|Overall Study|Protocol Violation|3
7923565|NCT02203838|12449734|FG002|Overall Study|Protocol Violation|0
7923566|NCT02203838|12449735|FG003|Overall Study|Protocol Violation|0
7923567|NCT02203838|12449732|FG000|Overall Study|Withdrawal by Subject|83
7923568|NCT02203838|12449733|FG001|Overall Study|Withdrawal by Subject|10
7923569|NCT02203838|12449734|FG002|Overall Study|Withdrawal by Subject|8
7923570|NCT02203838|12449735|FG003|Overall Study|Withdrawal by Subject|11
7923571|NCT02203838|12449732|FG000|Overall Study|Physician Decision|27
7923572|NCT02203838|12449733|FG001|Overall Study|Physician Decision|0
7923573|NCT02203838|12449734|FG002|Overall Study|Physician Decision|2
7923574|NCT02203838|12449735|FG003|Overall Study|Physician Decision|3
7923575|NCT02203838|12449732|FG000|Overall Study|Other|1
7923576|NCT02203838|12449733|FG001|Overall Study|Other|0
7923577|NCT02203838|12449734|FG002|Overall Study|Other|0
7923578|NCT02203838|12449735|FG003|Overall Study|Other|0
7923579|NCT02203851|12449745|FG000|Overall Study|Lost to Follow-up|4
7923580|NCT02203851|12449745|FG000|Overall Study|Withdrawal by Subject|6
7923581|NCT02203851|12449745|FG000|Overall Study|Other|1
7923582|NCT02203916|12449759|FG000|Overall Study|Pretreatment Event/Adverse Event|1
7923583|NCT02203916|12449760|FG001|Overall Study|Pretreatment Event/Adverse Event|3
7923584|NCT02203916|12449761|FG002|Overall Study|Pretreatment Event/Adverse Event|2
7923585|NCT02203916|12449759|FG000|Overall Study|Major Protocol Deviation|1
7923586|NCT02203916|12449760|FG001|Overall Study|Major Protocol Deviation|1
7923587|NCT02203916|12449761|FG002|Overall Study|Major Protocol Deviation|0
7923588|NCT02203916|12449759|FG000|Overall Study|Lost to Follow-up|0
7923589|NCT02203916|12449760|FG001|Overall Study|Lost to Follow-up|1
7923590|NCT02203916|12449761|FG002|Overall Study|Lost to Follow-up|0
7923591|NCT02203916|12449759|FG000|Overall Study|Voluntary Withdrawal|3
7923592|NCT02203916|12449760|FG001|Overall Study|Voluntary Withdrawal|3
7923593|NCT02203916|12449761|FG002|Overall Study|Voluntary Withdrawal|8
7923594|NCT02203916|12449759|FG000|Overall Study|Lack of Efficacy|3
7923595|NCT02203916|12449760|FG001|Overall Study|Lack of Efficacy|0
7923596|NCT02203916|12449761|FG002|Overall Study|Lack of Efficacy|0
7923597|NCT02203916|12449759|FG000|Overall Study|Reason Not Specified|0
7923598|NCT02203916|12449760|FG001|Overall Study|Reason Not Specified|2
7923599|NCT02203916|12449761|FG002|Overall Study|Reason Not Specified|1
7923600|NCT02204007|12449771|FG000|Overall Study|Surgery Canceled|1
7923601|NCT02204007|12449772|FG001|Overall Study|Surgery Canceled|1
7923602|NCT02204293|12449806|FG000|Core Study Part I|Met one or more exclusion criteria|1
7923603|NCT02204293|12449807|FG001|Core Study Part I|Met one or more exclusion criteria|0
7923604|NCT02204293|12449808|FG002|Core Study Part I|Met one or more exclusion criteria|0
7923605|NCT02204293|12449809|FG003|Core Study Part I|Met one or more exclusion criteria|0
7923606|NCT02204293|12449810|FG004|Core Study Part I|Met one or more exclusion criteria|0
7923607|NCT02204293|12449811|FG005|Core Study Part I|Met one or more exclusion criteria|0
7923608|NCT02204293|12449806|FG000|Core Study Part I|Adverse Event|1
7923609|NCT02204293|12449807|FG001|Core Study Part I|Adverse Event|0
7923610|NCT02204293|12449808|FG002|Core Study Part I|Adverse Event|0
7923611|NCT02204293|12449809|FG003|Core Study Part I|Adverse Event|0
7923612|NCT02204293|12449810|FG004|Core Study Part I|Adverse Event|0
7923613|NCT02204293|12449811|FG005|Core Study Part I|Adverse Event|0
7923614|NCT02204293|12449806|FG000|Core Study Part I|Physician Decision|0
7923615|NCT02204293|12449807|FG001|Core Study Part I|Physician Decision|3
7923616|NCT02204293|12449808|FG002|Core Study Part I|Physician Decision|0
7923617|NCT02204293|12449809|FG003|Core Study Part I|Physician Decision|0
7923618|NCT02204293|12449810|FG004|Core Study Part I|Physician Decision|0
7923619|NCT02204293|12449811|FG005|Core Study Part I|Physician Decision|0
7923620|NCT02204293|12449806|FG000|LTE Phase|Study Suspended|0
7923621|NCT02204293|12449807|FG001|LTE Phase|Study Suspended|0
7923622|NCT02204293|12449808|FG002|LTE Phase|Study Suspended|0
7923623|NCT02204293|12449809|FG003|LTE Phase|Study Suspended|0
7923624|NCT02204293|12449810|FG004|LTE Phase|Study Suspended|0
7923625|NCT02204293|12449811|FG005|LTE Phase|Study Suspended|7
7923626|NCT02204319|12449825|FG000|Overall Study|Pregnancy|1
7923627|NCT02204319|12449825|FG000|Overall Study|Withdrawal by Subject|2
7923628|NCT02204371|12449830|FG000|Overall Study|Adverse Event|1
7923629|NCT02204410|12449834|FG000|Overall Study|Lost to Follow-up|5
7923630|NCT02204410|12449834|FG000|Overall Study|Physician Decision|2
7923631|NCT02204410|12449834|FG000|Overall Study|Protocol Violation|1
7923632|NCT02204410|12449834|FG000|Overall Study|Withdrawal by Subject|3
7923633|NCT02204449|12449840|FG000|Overall Study|Lost to Follow-up|7
7923634|NCT02204449|12449841|FG001|Overall Study|Lost to Follow-up|9
7923635|NCT02204449|12449840|FG000|Overall Study|Death|0
7923636|NCT02204449|12449841|FG001|Overall Study|Death|1
7923637|NCT02204449|12449840|FG000|Overall Study|Withdrawal by Subject|0
7923638|NCT02204449|12449841|FG001|Overall Study|Withdrawal by Subject|1
7923639|NCT02204579|12449851|FG000|Overall Study|Screen failures|2
7923640|NCT02204917|12449877|FG000|Overall Study|Protocol Violation|1
7923641|NCT02204982|12449886|FG000|Overall Study|Patient ineligible-medical monitor|1
7923642|NCT02204982|12449887|FG001|Overall Study|Patient ineligible-medical monitor|0
7923643|NCT02204982|12449886|FG000|Overall Study|Withdrawal by Subject|1
7923644|NCT02204982|12449887|FG001|Overall Study|Withdrawal by Subject|0
7923645|NCT02204982|12449886|FG000|Overall Study|Adverse Event|1
7923646|NCT02204982|12449887|FG001|Overall Study|Adverse Event|0
7923647|NCT02204982|12449886|FG000|Overall Study|Adverse Event and Investigator decision|1
7923648|NCT02204982|12449887|FG001|Overall Study|Adverse Event and Investigator decision|0
7923649|NCT02204982|12449886|FG000|Overall Study|Physician Decision|0
7923650|NCT02204982|12449887|FG001|Overall Study|Physician Decision|2
7923651|NCT02204982|12449886|FG000|Overall Study|Protocol-Specified Disease Progression|0
7923652|NCT02204982|12449887|FG001|Overall Study|Protocol-Specified Disease Progression|4
7923653|NCT02204982|12449886|FG000|Overall Study|Termination of Study bySponsor|0
7923654|NCT02204982|12449887|FG001|Overall Study|Termination of Study bySponsor|1
7923655|NCT02205333|12449921|FG000|Overall Study|Death|5
7923656|NCT02205333|12449922|FG001|Overall Study|Death|6
7923657|NCT02205333|12449923|FG002|Overall Study|Death|2
7923658|NCT02205333|12449924|FG003|Overall Study|Death|6
7923659|NCT02205333|12449925|FG004|Overall Study|Death|5
7923660|NCT02205333|12449926|FG005|Overall Study|Death|3
7923661|NCT02205333|12449927|FG006|Overall Study|Death|3
7923662|NCT02205333|12449928|FG007|Overall Study|Death|2
7923663|NCT02205333|12449929|FG008|Overall Study|Death|0
7923664|NCT02205333|12449921|FG000|Overall Study|Withdrawal by Subject|1
7923665|NCT02205333|12449922|FG001|Overall Study|Withdrawal by Subject|0
7923666|NCT02205333|12449923|FG002|Overall Study|Withdrawal by Subject|0
7923667|NCT02205333|12449924|FG003|Overall Study|Withdrawal by Subject|1
7923668|NCT02205333|12449925|FG004|Overall Study|Withdrawal by Subject|0
7923669|NCT02205333|12449926|FG005|Overall Study|Withdrawal by Subject|0
7923670|NCT02205333|12449927|FG006|Overall Study|Withdrawal by Subject|2
7923671|NCT02205333|12449928|FG007|Overall Study|Withdrawal by Subject|0
7923672|NCT02205333|12449929|FG008|Overall Study|Withdrawal by Subject|0
7923673|NCT02205476|12449951|FG000|Overall Study|Study termination by Sponsor|7
7923674|NCT02205476|12449952|FG001|Overall Study|Study termination by Sponsor|3
7821849|NCT01258660|12290807|FG001|Overall Study|Invalid for primary analysis data set|6
7821850|NCT01258738|12290816|FG000|Double-blind Period|Did not meet inclusion criteria|3
7923675|NCT02205814|12449985|FG000|Overall Study|Lost to Follow-up|0
7923676|NCT02205814|12449986|FG001|Overall Study|Lost to Follow-up|0
7923677|NCT02205814|12449987|FG002|Overall Study|Lost to Follow-up|0
7923678|NCT02205814|12449988|FG003|Overall Study|Lost to Follow-up|1
7923679|NCT02205814|12449985|FG000|Overall Study|Lack of Efficacy|1
7923680|NCT02205814|12449986|FG001|Overall Study|Lack of Efficacy|0
7923681|NCT02205814|12449987|FG002|Overall Study|Lack of Efficacy|1
7923682|NCT02205814|12449988|FG003|Overall Study|Lack of Efficacy|1
7923683|NCT02205814|12449985|FG000|Overall Study|Physician Decision|0
7923684|NCT02205814|12449986|FG001|Overall Study|Physician Decision|0
7923685|NCT02205814|12449987|FG002|Overall Study|Physician Decision|1
7923686|NCT02205814|12449988|FG003|Overall Study|Physician Decision|0
7821851|NCT01258738|12290817|FG001|Double-blind Period|Did not meet inclusion criteria|3
7821852|NCT01258738|12290816|FG000|Double-blind Period|Withdrawal by Subject|2
7821853|NCT01258738|12290817|FG001|Double-blind Period|Withdrawal by Subject|2
7821854|NCT01258738|12290816|FG000|Double-blind Period|Protocol Violation|1
7821855|NCT01258738|12290817|FG001|Double-blind Period|Protocol Violation|1
7821856|NCT01258738|12290816|FG000|Double-blind Period|Adverse Event|3
7821857|NCT01258738|12290817|FG001|Double-blind Period|Adverse Event|1
7821858|NCT01258738|12290816|FG000|Open-label Period|Did not meet inclusion criteria|0
7821859|NCT01258738|12290817|FG001|Open-label Period|Did not meet inclusion criteria|1
7821860|NCT01258738|12290816|FG000|Open-label Period|Insufficient clinical response|5
7821861|NCT01258738|12290817|FG001|Open-label Period|Insufficient clinical response|3
7821862|NCT01258738|12290816|FG000|Open-label Period|Lost to Follow-up|0
7821863|NCT01258738|12290817|FG001|Open-label Period|Lost to Follow-up|2
7821864|NCT01258738|12290816|FG000|Open-label Period|Withdrawal by Subject|5
7821865|NCT01258738|12290817|FG001|Open-label Period|Withdrawal by Subject|6
7821866|NCT01258738|12290816|FG000|Open-label Period|Protocol Violation|2
7821867|NCT01258738|12290817|FG001|Open-label Period|Protocol Violation|2
7821868|NCT01258738|12290816|FG000|Open-label Period|Adverse Event|4
7821869|NCT01258738|12290817|FG001|Open-label Period|Adverse Event|5
7821870|NCT01258738|12290816|FG000|Open-label Period|Other Reasons|0
7923687|NCT02205814|12449985|FG000|Overall Study|Protocol Violation|1
7923688|NCT02205814|12449986|FG001|Overall Study|Protocol Violation|0
7923689|NCT02205814|12449987|FG002|Overall Study|Protocol Violation|0
7923690|NCT02205814|12449988|FG003|Overall Study|Protocol Violation|1
7923691|NCT02205814|12449985|FG000|Overall Study|Withdrawal by Subject|0
7923692|NCT02205814|12449986|FG001|Overall Study|Withdrawal by Subject|1
7923693|NCT02205814|12449987|FG002|Overall Study|Withdrawal by Subject|2
7923694|NCT02205814|12449988|FG003|Overall Study|Withdrawal by Subject|1
7923695|NCT02205814|12449985|FG000|Overall Study|not compliant with study procedures|0
7923696|NCT02205814|12449986|FG001|Overall Study|not compliant with study procedures|0
7923697|NCT02205814|12449987|FG002|Overall Study|not compliant with study procedures|1
7923698|NCT02205814|12449988|FG003|Overall Study|not compliant with study procedures|0
7923699|NCT02206061|12450018|FG000|Overall Study|Withdrawal by Subject|4
7923700|NCT02206061|12450019|FG001|Overall Study|Withdrawal by Subject|7
7923701|NCT02206061|12450020|FG002|Overall Study|Withdrawal by Subject|1
7923702|NCT02206061|12450018|FG000|Overall Study|Lost to Follow-up|14
7923703|NCT02206061|12450019|FG001|Overall Study|Lost to Follow-up|7
7923704|NCT02206061|12450020|FG002|Overall Study|Lost to Follow-up|20
7923705|NCT02206152|12450028|FG000|Pre-Randomization|Withdrawal by Subject|2
7923706|NCT02206607|12450043|FG000|Open-Label Run-In|Withdrawal by Subject|3
7923707|NCT02206607|12450044|FG001|Open-Label Run-In|Withdrawal by Subject|0
7923708|NCT02206607|12450045|FG002|Open-Label Run-In|Withdrawal by Subject|0
7923709|NCT02206607|12450046|FG003|Open-Label Run-In|Withdrawal by Subject|0
7923710|NCT02206607|12450047|FG004|Open-Label Run-In|Withdrawal by Subject|0
7923711|NCT02206607|12450043|FG000|Second Intervention Period|Insufficient Clinical Response|0
7923712|NCT02206607|12450044|FG001|Second Intervention Period|Insufficient Clinical Response|0
7923713|NCT02206607|12450045|FG002|Second Intervention Period|Insufficient Clinical Response|0
7923714|NCT02206607|12450046|FG003|Second Intervention Period|Insufficient Clinical Response|1
7923715|NCT02206607|12450047|FG004|Second Intervention Period|Insufficient Clinical Response|0
7923716|NCT02206620|12450063|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
7923717|NCT02206620|12450064|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
7923718|NCT02206620|12450063|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0
7923719|NCT02206620|12450064|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2
7923720|NCT02206685|12450078|FG000|Overall Study|Surgery cancelled/changed|2
7923721|NCT02206685|12450079|FG001|Overall Study|Surgery cancelled/changed|3
7923722|NCT02206685|12450078|FG000|Overall Study|Withdrawal by Subject|1
7923723|NCT02206685|12450079|FG001|Overall Study|Withdrawal by Subject|2
7923724|NCT02206685|12450078|FG000|Overall Study|Protocol Violation|2
7923725|NCT02206685|12450079|FG001|Overall Study|Protocol Violation|2
7923726|NCT02206828|12450094|FG000|Overall Study|Lost to Follow-up|7
7923727|NCT02207088|12450121|FG000|Overall Study|Adverse Event|2
7923728|NCT02207231|12450128|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
7923729|NCT02207231|12450129|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
7923730|NCT02207231|12450130|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
7923731|NCT02207231|12450131|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
7923732|NCT02207231|12450128|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
7923733|NCT02207231|12450129|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
7923734|NCT02207231|12450130|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
7923735|NCT02207231|12450131|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
7923736|NCT02207231|12450128|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
7923737|NCT02207231|12450129|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
7923738|NCT02207231|12450130|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
7923739|NCT02207231|12450131|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
7923740|NCT02207231|12450128|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
7923741|NCT02207231|12450129|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
7923742|NCT02207231|12450130|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
7923743|NCT02207231|12450131|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
7923744|NCT02207231|12450128|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
7923745|NCT02207231|12450129|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
7923746|NCT02207231|12450130|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
7923747|NCT02207231|12450131|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
7923748|NCT02207231|12450128|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
7923749|NCT02207231|12450129|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
7923750|NCT02207231|12450130|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
7923751|NCT02207231|12450131|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
7923752|NCT02207231|12450128|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1
7923753|NCT02207231|12450129|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6
7923754|NCT02207231|12450130|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10
7923755|NCT02207231|12450131|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0
7923756|NCT02207231|12450128|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0
7923757|NCT02207231|12450129|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0
7923758|NCT02207231|12450130|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1
7923759|NCT02207231|12450131|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0
7923760|NCT02207231|12450128|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
7923761|NCT02207231|12450129|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
7923762|NCT02207231|12450130|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
7923763|NCT02207231|12450131|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
7923764|NCT02207231|12450128|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
7923765|NCT02207231|12450129|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
7923766|NCT02207231|12450130|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
7923767|NCT02207231|12450131|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0
7923768|NCT02207231|12450128|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
7923769|NCT02207231|12450129|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
7923770|NCT02207231|12450130|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
7923771|NCT02207231|12450131|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0
7923772|NCT02207231|12450128|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0
7923773|NCT02207231|12450129|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1
7923774|NCT02207231|12450130|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0
7923775|NCT02207231|12450131|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0
7923776|NCT02207231|12450128|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0
7923777|NCT02207231|12450129|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3
7923778|NCT02207231|12450130|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3
7923779|NCT02207231|12450131|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0
7923780|NCT02207231|12450128|FG000|Active Controlled Period: Week 16 - 48|Other|0
7923781|NCT02207231|12450129|FG001|Active Controlled Period: Week 16 - 48|Other|2
7923782|NCT02207231|12450130|FG002|Active Controlled Period: Week 16 - 48|Other|3
7923783|NCT02207231|12450131|FG003|Active Controlled Period: Week 16 - 48|Other|0
7923784|NCT02207231|12450128|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0
7923785|NCT02207231|12450129|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0
7923786|NCT02207231|12450130|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12
7923787|NCT02207231|12450131|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19
7923788|NCT02207231|12450128|FG000|Open-label Guselkumab: Week 48 - 264|Death|0
7923789|NCT02207231|12450129|FG001|Open-label Guselkumab: Week 48 - 264|Death|0
7923790|NCT02207231|12450130|FG002|Open-label Guselkumab: Week 48 - 264|Death|1
7923791|NCT02207231|12450131|FG003|Open-label Guselkumab: Week 48 - 264|Death|3
7923792|NCT02207231|12450128|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0
7923793|NCT02207231|12450129|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0
7923794|NCT02207231|12450130|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3
7923795|NCT02207231|12450131|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7
7923796|NCT02207231|12450128|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0
7923797|NCT02207231|12450129|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0
7923798|NCT02207231|12450130|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2
7923799|NCT02207231|12450131|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4
7923800|NCT02207231|12450128|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0
7923801|NCT02207231|12450129|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0
7923802|NCT02207231|12450130|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6
7923803|NCT02207231|12450131|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11
7923804|NCT02207231|12450128|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0
7923805|NCT02207231|12450129|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0
7923806|NCT02207231|12450130|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10
7923807|NCT02207231|12450131|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28
7923808|NCT02207231|12450128|FG000|Open-label Guselkumab: Week 48 - 264|Other|0
7923809|NCT02207231|12450129|FG001|Open-label Guselkumab: Week 48 - 264|Other|0
7923810|NCT02207231|12450130|FG002|Open-label Guselkumab: Week 48 - 264|Other|4
7923811|NCT02207231|12450131|FG003|Open-label Guselkumab: Week 48 - 264|Other|11
7923812|NCT02207244|12450152|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2
7923813|NCT02207244|12450153|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9
7923814|NCT02207244|12450154|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4
7923815|NCT02207244|12450155|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0
7923816|NCT02207244|12450156|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0
7923817|NCT02207244|12450157|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0
7923818|NCT02207244|12450158|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0
7923819|NCT02207244|12450159|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0
7923820|NCT02207244|12450160|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0
7923821|NCT02207244|12450161|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0
7923822|NCT02207244|12450162|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0
7923823|NCT02207244|12450152|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4
7923824|NCT02207244|12450153|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7719628|NCT00533897|12143618|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7719629|NCT00533897|12143619|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7719630|NCT00533897|12143620|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7923825|NCT02207244|12450154|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2
7923826|NCT02207244|12450155|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7923827|NCT02207244|12450156|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7923828|NCT02207244|12450157|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7923829|NCT02207244|12450158|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7923830|NCT02207244|12450159|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7923831|NCT02207244|12450160|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7923832|NCT02207244|12450161|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7923833|NCT02207244|12450162|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7923834|NCT02207244|12450152|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1
7923835|NCT02207244|12450153|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3
7923836|NCT02207244|12450154|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2
7923837|NCT02207244|12450155|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7923838|NCT02207244|12450156|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7923839|NCT02207244|12450157|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7923840|NCT02207244|12450158|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7923841|NCT02207244|12450159|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7923842|NCT02207244|12450160|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7923843|NCT02207244|12450161|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7923844|NCT02207244|12450162|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7923845|NCT02207244|12450152|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7
7923846|NCT02207244|12450153|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1
7923847|NCT02207244|12450154|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7923848|NCT02207244|12450155|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7923849|NCT02207244|12450156|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7923850|NCT02207244|12450157|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7923851|NCT02207244|12450158|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7923852|NCT02207244|12450159|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7923853|NCT02207244|12450160|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7923854|NCT02207244|12450161|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7923855|NCT02207244|12450162|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7923856|NCT02207244|12450152|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1
7923857|NCT02207244|12450153|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3
7923858|NCT02207244|12450154|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1
7923859|NCT02207244|12450155|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7923860|NCT02207244|12450156|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7923861|NCT02207244|12450157|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7923862|NCT02207244|12450158|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7923863|NCT02207244|12450159|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7923864|NCT02207244|12450160|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7923865|NCT02207244|12450161|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7923866|NCT02207244|12450162|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7923867|NCT02207244|12450152|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0
7923868|NCT02207244|12450153|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1
7923869|NCT02207244|12450154|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2
7923870|NCT02207244|12450155|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0
7923871|NCT02207244|12450156|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0
7923872|NCT02207244|12450157|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0
7923873|NCT02207244|12450158|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0
7923874|NCT02207244|12450159|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0
7923875|NCT02207244|12450160|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0
7923876|NCT02207244|12450161|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0
7923877|NCT02207244|12450162|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0
7923878|NCT02207244|12450152|FG000|Placebo Controlled Period: Week 0-16|OTHER|0
7923879|NCT02207244|12450153|FG001|Placebo Controlled Period: Week 0-16|OTHER|1
7923880|NCT02207244|12450154|FG002|Placebo Controlled Period: Week 0-16|OTHER|0
7923881|NCT02207244|12450155|FG003|Placebo Controlled Period: Week 0-16|OTHER|0
7923882|NCT02207244|12450156|FG004|Placebo Controlled Period: Week 0-16|OTHER|0
7923883|NCT02207244|12450157|FG005|Placebo Controlled Period: Week 0-16|OTHER|0
7923884|NCT02207244|12450158|FG006|Placebo Controlled Period: Week 0-16|OTHER|0
7923885|NCT02207244|12450159|FG007|Placebo Controlled Period: Week 0-16|OTHER|0
7923886|NCT02207244|12450160|FG008|Placebo Controlled Period: Week 0-16|OTHER|0
7923887|NCT02207244|12450161|FG009|Placebo Controlled Period: Week 0-16|OTHER|0
7923888|NCT02207244|12450162|FG010|Placebo Controlled Period: Week 0-16|OTHER|0
7923889|NCT02207244|12450152|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7923890|NCT02207244|12450153|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7923891|NCT02207244|12450154|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7923892|NCT02207244|12450155|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7923893|NCT02207244|12450156|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3
7923894|NCT02207244|12450157|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2
7923895|NCT02207244|12450158|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7923896|NCT02207244|12450159|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7923897|NCT02207244|12450160|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7923898|NCT02207244|12450161|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7923899|NCT02207244|12450162|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7923900|NCT02207244|12450152|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7923901|NCT02207244|12450153|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7923902|NCT02207244|12450154|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7923903|NCT02207244|12450155|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7923904|NCT02207244|12450156|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7923905|NCT02207244|12450157|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2
7923906|NCT02207244|12450158|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7923907|NCT02207244|12450159|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7923908|NCT02207244|12450160|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7923909|NCT02207244|12450161|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7923910|NCT02207244|12450162|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7923911|NCT02207244|12450152|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7923912|NCT02207244|12450153|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7923913|NCT02207244|12450154|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7923914|NCT02207244|12450155|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1
7923915|NCT02207244|12450156|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2
7923916|NCT02207244|12450157|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2
7923917|NCT02207244|12450158|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7923918|NCT02207244|12450159|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7923919|NCT02207244|12450160|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7923920|NCT02207244|12450161|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7923921|NCT02207244|12450162|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7923922|NCT02207244|12450152|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7923923|NCT02207244|12450153|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7923924|NCT02207244|12450154|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7923925|NCT02207244|12450155|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3
7923926|NCT02207244|12450156|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3
7923927|NCT02207244|12450157|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2
7923928|NCT02207244|12450158|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7923929|NCT02207244|12450159|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7923930|NCT02207244|12450160|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7923931|NCT02207244|12450161|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7923932|NCT02207244|12450162|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7923933|NCT02207244|12450152|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7923934|NCT02207244|12450153|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7923935|NCT02207244|12450154|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7923936|NCT02207244|12450155|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1
7923937|NCT02207244|12450156|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7923938|NCT02207244|12450157|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1
7923939|NCT02207244|12450158|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7923940|NCT02207244|12450159|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7923941|NCT02207244|12450160|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7923942|NCT02207244|12450161|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7923943|NCT02207244|12450162|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7923944|NCT02207244|12450152|FG000|Placebo Crossover and ACP: Week 16-28|Other|0
7923945|NCT02207244|12450153|FG001|Placebo Crossover and ACP: Week 16-28|Other|0
7923946|NCT02207244|12450154|FG002|Placebo Crossover and ACP: Week 16-28|Other|0
7923947|NCT02207244|12450155|FG003|Placebo Crossover and ACP: Week 16-28|Other|1
7923948|NCT02207244|12450156|FG004|Placebo Crossover and ACP: Week 16-28|Other|0
7923949|NCT02207244|12450157|FG005|Placebo Crossover and ACP: Week 16-28|Other|0
7923950|NCT02207244|12450158|FG006|Placebo Crossover and ACP: Week 16-28|Other|0
7923951|NCT02207244|12450159|FG007|Placebo Crossover and ACP: Week 16-28|Other|0
7923952|NCT02207244|12450160|FG008|Placebo Crossover and ACP: Week 16-28|Other|0
7923953|NCT02207244|12450161|FG009|Placebo Crossover and ACP: Week 16-28|Other|0
7923954|NCT02207244|12450162|FG010|Placebo Crossover and ACP: Week 16-28|Other|0
7923955|NCT02207244|12450152|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7923956|NCT02207244|12450153|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7923957|NCT02207244|12450154|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7923958|NCT02207244|12450155|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7923959|NCT02207244|12450156|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7923960|NCT02207244|12450157|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7923961|NCT02207244|12450158|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1
7923962|NCT02207244|12450159|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5
7923963|NCT02207244|12450160|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3
7923964|NCT02207244|12450161|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2
7923965|NCT02207244|12450162|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7923966|NCT02207244|12450152|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7923967|NCT02207244|12450153|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7923968|NCT02207244|12450154|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7923969|NCT02207244|12450155|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7923970|NCT02207244|12450156|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7923971|NCT02207244|12450157|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7923972|NCT02207244|12450158|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7923973|NCT02207244|12450159|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2
7923974|NCT02207244|12450160|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7923975|NCT02207244|12450161|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7923976|NCT02207244|12450162|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7923977|NCT02207244|12450152|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7923978|NCT02207244|12450153|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7923979|NCT02207244|12450154|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7923980|NCT02207244|12450155|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7923981|NCT02207244|12450156|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7923982|NCT02207244|12450157|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7923983|NCT02207244|12450158|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1
7923984|NCT02207244|12450159|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3
7923985|NCT02207244|12450160|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2
7923986|NCT02207244|12450161|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2
7923987|NCT02207244|12450162|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7923988|NCT02207244|12450152|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7923989|NCT02207244|12450153|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7821871|NCT01258738|12290817|FG001|Open-label Period|Other Reasons|1
7821872|NCT01258738|12290816|FG000|Open-label Period|Withdrawn due to pregnancy|1
7821873|NCT01258738|12290817|FG001|Open-label Period|Withdrawn due to pregnancy|1
7821874|NCT01258998|12290850|FG000|Overall Study|Ineligible|1
7821875|NCT01259089|12290869|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0
7821876|NCT01259089|12290870|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0
7821877|NCT01259089|12290871|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0
7821878|NCT01259089|12290872|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0
7821879|NCT01259089|12290873|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0
7821880|NCT01259089|12290874|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1
7821881|NCT01259089|12290869|FG000|Reached First Response at 4 Weeks|Adverse Event|0
7923990|NCT02207244|12450154|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7923991|NCT02207244|12450155|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7923992|NCT02207244|12450156|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7923993|NCT02207244|12450157|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7923994|NCT02207244|12450158|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2
7923995|NCT02207244|12450159|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7
7923996|NCT02207244|12450160|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7923997|NCT02207244|12450161|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2
7923998|NCT02207244|12450162|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7923999|NCT02207244|12450152|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7821882|NCT01259089|12290870|FG001|Reached First Response at 4 Weeks|Adverse Event|0
7821883|NCT01259089|12290871|FG002|Reached First Response at 4 Weeks|Adverse Event|0
7821884|NCT01259089|12290872|FG003|Reached First Response at 4 Weeks|Adverse Event|0
7821885|NCT01259089|12290873|FG004|Reached First Response at 4 Weeks|Adverse Event|0
7924000|NCT02207244|12450153|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7924001|NCT02207244|12450154|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7924002|NCT02207244|12450155|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7924003|NCT02207244|12450156|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7924004|NCT02207244|12450157|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7924005|NCT02207244|12450158|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
7924006|NCT02207244|12450159|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7
7924007|NCT02207244|12450160|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
7924008|NCT02207244|12450161|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
7924009|NCT02207244|12450162|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7924010|NCT02207244|12450152|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7924011|NCT02207244|12450153|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7924012|NCT02207244|12450154|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7924013|NCT02207244|12450155|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7924014|NCT02207244|12450156|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7924015|NCT02207244|12450157|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7924016|NCT02207244|12450158|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7924017|NCT02207244|12450159|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1
7924018|NCT02207244|12450160|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1
7924019|NCT02207244|12450161|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7924020|NCT02207244|12450162|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7924021|NCT02207244|12450152|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7924022|NCT02207244|12450153|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7924023|NCT02207244|12450154|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7924024|NCT02207244|12450155|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7924025|NCT02207244|12450156|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7924026|NCT02207244|12450157|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7924027|NCT02207244|12450158|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7924028|NCT02207244|12450159|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7924029|NCT02207244|12450160|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1
7924030|NCT02207244|12450161|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7924031|NCT02207244|12450162|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7924032|NCT02207244|12450152|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0
7924033|NCT02207244|12450153|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0
7924034|NCT02207244|12450154|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0
7924035|NCT02207244|12450155|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0
7924036|NCT02207244|12450156|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0
7924037|NCT02207244|12450157|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0
7924038|NCT02207244|12450158|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0
7924039|NCT02207244|12450159|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2
7924040|NCT02207244|12450160|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0
7924041|NCT02207244|12450161|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0
7924042|NCT02207244|12450162|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0
7924043|NCT02207244|12450152|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7924044|NCT02207244|12450153|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7924045|NCT02207244|12450154|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7924046|NCT02207244|12450155|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7924047|NCT02207244|12450156|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7924048|NCT02207244|12450157|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7924049|NCT02207244|12450158|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8
7924050|NCT02207244|12450159|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7924051|NCT02207244|12450160|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7924052|NCT02207244|12450161|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7924053|NCT02207244|12450162|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7924054|NCT02207244|12450152|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7924055|NCT02207244|12450153|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7924056|NCT02207244|12450154|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7924057|NCT02207244|12450155|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7924058|NCT02207244|12450156|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7924059|NCT02207244|12450157|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7924060|NCT02207244|12450158|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7924061|NCT02207244|12450159|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7924062|NCT02207244|12450160|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10
7924063|NCT02207244|12450161|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7924064|NCT02207244|12450162|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30
7924065|NCT02207244|12450152|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7924066|NCT02207244|12450153|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7924067|NCT02207244|12450154|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7924068|NCT02207244|12450155|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7924069|NCT02207244|12450156|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7924070|NCT02207244|12450157|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7924071|NCT02207244|12450158|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7924072|NCT02207244|12450159|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7924073|NCT02207244|12450160|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2
7924074|NCT02207244|12450161|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7924075|NCT02207244|12450162|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3
7924076|NCT02207244|12450152|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7924077|NCT02207244|12450153|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7924078|NCT02207244|12450154|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7924079|NCT02207244|12450155|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7924080|NCT02207244|12450156|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7924081|NCT02207244|12450157|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7924082|NCT02207244|12450158|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7924083|NCT02207244|12450159|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7924084|NCT02207244|12450160|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5
7924085|NCT02207244|12450161|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7924086|NCT02207244|12450162|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26
7924087|NCT02207244|12450152|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0
7924088|NCT02207244|12450153|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0
7924089|NCT02207244|12450154|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0
7924090|NCT02207244|12450155|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0
7924091|NCT02207244|12450156|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0
7924092|NCT02207244|12450157|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0
7924093|NCT02207244|12450158|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0
7924094|NCT02207244|12450159|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0
7924095|NCT02207244|12450160|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12
7924096|NCT02207244|12450161|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0
7924097|NCT02207244|12450162|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21
7924098|NCT02207244|12450152|FG000|Open-label Guselkumab: Week 72-264|Death|0
7924099|NCT02207244|12450153|FG001|Open-label Guselkumab: Week 72-264|Death|0
7924100|NCT02207244|12450154|FG002|Open-label Guselkumab: Week 72-264|Death|0
7924101|NCT02207244|12450155|FG003|Open-label Guselkumab: Week 72-264|Death|0
7924102|NCT02207244|12450156|FG004|Open-label Guselkumab: Week 72-264|Death|0
7924103|NCT02207244|12450157|FG005|Open-label Guselkumab: Week 72-264|Death|0
7924104|NCT02207244|12450158|FG006|Open-label Guselkumab: Week 72-264|Death|0
7924105|NCT02207244|12450159|FG007|Open-label Guselkumab: Week 72-264|Death|0
7924106|NCT02207244|12450160|FG008|Open-label Guselkumab: Week 72-264|Death|1
7924107|NCT02207244|12450161|FG009|Open-label Guselkumab: Week 72-264|Death|0
7924108|NCT02207244|12450162|FG010|Open-label Guselkumab: Week 72-264|Death|1
7924109|NCT02207244|12450152|FG000|Open-label Guselkumab: Week 72-264|Other|0
7924110|NCT02207244|12450153|FG001|Open-label Guselkumab: Week 72-264|Other|0
7924111|NCT02207244|12450154|FG002|Open-label Guselkumab: Week 72-264|Other|0
7924112|NCT02207244|12450155|FG003|Open-label Guselkumab: Week 72-264|Other|0
7924113|NCT02207244|12450156|FG004|Open-label Guselkumab: Week 72-264|Other|0
7924114|NCT02207244|12450157|FG005|Open-label Guselkumab: Week 72-264|Other|0
7924115|NCT02207244|12450158|FG006|Open-label Guselkumab: Week 72-264|Other|0
7924116|NCT02207244|12450159|FG007|Open-label Guselkumab: Week 72-264|Other|0
7924117|NCT02207244|12450160|FG008|Open-label Guselkumab: Week 72-264|Other|8
7924118|NCT02207244|12450161|FG009|Open-label Guselkumab: Week 72-264|Other|0
7924119|NCT02207244|12450162|FG010|Open-label Guselkumab: Week 72-264|Other|19
7924120|NCT02207244|12450152|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0
7924121|NCT02207244|12450153|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0
7924122|NCT02207244|12450154|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0
7924123|NCT02207244|12450155|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0
7924124|NCT02207244|12450156|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0
7924125|NCT02207244|12450157|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0
7924126|NCT02207244|12450158|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0
7924127|NCT02207244|12450159|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0
7924128|NCT02207244|12450160|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0
7924129|NCT02207244|12450161|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0
7924130|NCT02207244|12450162|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2
7924131|NCT02207374|12450203|FG000|Overall Study|Withdrawal by Subject|5
7924132|NCT02207374|12450204|FG001|Overall Study|Withdrawal by Subject|9
7924133|NCT02207374|12450205|FG002|Overall Study|Withdrawal by Subject|4
7924134|NCT02207374|12450203|FG000|Overall Study|Death|1
7924135|NCT02207374|12450204|FG001|Overall Study|Death|0
7924136|NCT02207374|12450205|FG002|Overall Study|Death|1
7924137|NCT02207374|12450203|FG000|Overall Study|Missing follow-up information|0
7924138|NCT02207374|12450204|FG001|Overall Study|Missing follow-up information|1
7924139|NCT02207374|12450205|FG002|Overall Study|Missing follow-up information|1
7924140|NCT02207400|12450215|FG000|Overall Study|Adverse Event|1
7924141|NCT02207400|12450216|FG001|Overall Study|Adverse Event|1
7924142|NCT02207400|12450215|FG000|Overall Study|Lost to Follow-up|6
7924143|NCT02207400|12450216|FG001|Overall Study|Lost to Follow-up|7
7924144|NCT02207400|12450215|FG000|Overall Study|Protocol Violation|1
7924145|NCT02207400|12450216|FG001|Overall Study|Protocol Violation|1
7924146|NCT02207400|12450215|FG000|Overall Study|Withdrawal by Subject|8
7924147|NCT02207400|12450216|FG001|Overall Study|Withdrawal by Subject|4
7924148|NCT02207400|12450215|FG000|Overall Study|Positive Urine Pregnancy Test|0
7924149|NCT02207400|12450216|FG001|Overall Study|Positive Urine Pregnancy Test|1
7924150|NCT02207413|12450231|FG000|Overall Study|Withdrawal by Subject|1
7924151|NCT02207413|12450232|FG001|Overall Study|Withdrawal by Subject|0
7924152|NCT02207413|12450233|FG002|Overall Study|Withdrawal by Subject|0
7924153|NCT02207413|12450234|FG003|Overall Study|Withdrawal by Subject|0
7924154|NCT02207413|12450235|FG004|Overall Study|Withdrawal by Subject|3
7924155|NCT02207413|12450236|FG005|Overall Study|Withdrawal by Subject|7
7924156|NCT02207413|12450231|FG000|Overall Study|Lost to Follow-up|0
7924157|NCT02207413|12450232|FG001|Overall Study|Lost to Follow-up|0
7924158|NCT02207413|12450233|FG002|Overall Study|Lost to Follow-up|0
7924159|NCT02207413|12450234|FG003|Overall Study|Lost to Follow-up|1
7924160|NCT02207413|12450235|FG004|Overall Study|Lost to Follow-up|1
7924161|NCT02207413|12450236|FG005|Overall Study|Lost to Follow-up|5
7924162|NCT02207413|12450231|FG000|Overall Study|Adverse Event|0
7924163|NCT02207413|12450232|FG001|Overall Study|Adverse Event|0
7924164|NCT02207413|12450233|FG002|Overall Study|Adverse Event|0
7924165|NCT02207413|12450234|FG003|Overall Study|Adverse Event|0
7924166|NCT02207413|12450235|FG004|Overall Study|Adverse Event|2
7924167|NCT02207413|12450236|FG005|Overall Study|Adverse Event|1
7924168|NCT02207413|12450231|FG000|Overall Study|Migrated/moved from study area|0
7924169|NCT02207413|12450232|FG001|Overall Study|Migrated/moved from study area|0
7924170|NCT02207413|12450233|FG002|Overall Study|Migrated/moved from study area|0
7924171|NCT02207413|12450234|FG003|Overall Study|Migrated/moved from study area|0
7924172|NCT02207413|12450235|FG004|Overall Study|Migrated/moved from study area|1
7924173|NCT02207413|12450236|FG005|Overall Study|Migrated/moved from study area|0
7924174|NCT02207491|12450267|FG000|Overall Study|Adverse Event|20
7924175|NCT02207491|12450268|FG001|Overall Study|Adverse Event|4
7924176|NCT02207491|12450267|FG000|Overall Study|Withdrawal by Subject|3
7924177|NCT02207491|12450268|FG001|Overall Study|Withdrawal by Subject|2
7924178|NCT02207491|12450267|FG000|Overall Study|Non-compliant|0
7924179|NCT02207491|12450268|FG001|Overall Study|Non-compliant|1
7924180|NCT02207491|12450267|FG000|Overall Study|Lost to Follow-up|0
7924181|NCT02207491|12450268|FG001|Overall Study|Lost to Follow-up|1
7924182|NCT02207491|12450267|FG000|Overall Study|Lack of Efficacy|3
7924183|NCT02207491|12450268|FG001|Overall Study|Lack of Efficacy|0
7924184|NCT02207491|12450267|FG000|Overall Study|Physician Decision|2
7924185|NCT02207491|12450268|FG001|Overall Study|Physician Decision|0
7924186|NCT02207491|12450267|FG000|Overall Study|Protocol Violation|3
7924187|NCT02207491|12450268|FG001|Overall Study|Protocol Violation|5
7924188|NCT02207530|12450274|FG000|Overall Study|Worsening condition under investigation|78
7924189|NCT02207530|12450274|FG000|Overall Study|Patient decision to stop study treatment|5
7924190|NCT02207530|12450274|FG000|Overall Study|Adverse Event|8
7924191|NCT02207556|12450280|FG000|Overall Study|Physician Decision|1
7924192|NCT02207556|12450281|FG001|Overall Study|Physician Decision|0
7719631|NCT00533897|12143621|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7719632|NCT00533897|12143622|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7719633|NCT00533897|12143615|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7924193|NCT02207556|12450280|FG000|Overall Study|Withdrawal by Subject|1
7924194|NCT02207556|12450281|FG001|Overall Study|Withdrawal by Subject|0
7924195|NCT02207556|12450280|FG000|Overall Study|Death|0
7924196|NCT02207556|12450281|FG001|Overall Study|Death|5
7964527|NCT01107626|12520030|FG002|Step 2: Maintenance Therapy|Alternative therapy|4
7964528|NCT01107626|12520031|FG003|Step 2: Maintenance Therapy|Alternative therapy|5
7964529|NCT01107626|12520028|FG000|Step 2: Maintenance Therapy|Other complicating disease|0
7964530|NCT01107626|12520029|FG001|Step 2: Maintenance Therapy|Other complicating disease|2
7964531|NCT01107626|12520030|FG002|Step 2: Maintenance Therapy|Other complicating disease|5
7964532|NCT01107626|12520031|FG003|Step 2: Maintenance Therapy|Other complicating disease|9
7964533|NCT01107626|12520028|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0
7964534|NCT01107626|12520029|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2
7964535|NCT01107626|12520030|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4
7964536|NCT01107626|12520031|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3
7964537|NCT01107626|12520028|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0
7964538|NCT01107626|12520029|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
7964539|NCT01107626|12520030|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
7964540|NCT01107626|12520031|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3
7964541|NCT01107626|12520028|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
7964542|NCT01107626|12520029|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
7964543|NCT01107626|12520030|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
7964544|NCT01107626|12520031|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
7964545|NCT01107626|12520028|FG000|Step 2: Maintenance Therapy|Financial reason|0
7964546|NCT01107626|12520029|FG001|Step 2: Maintenance Therapy|Financial reason|2
7964547|NCT01107626|12520030|FG002|Step 2: Maintenance Therapy|Financial reason|0
7964548|NCT01107626|12520031|FG003|Step 2: Maintenance Therapy|Financial reason|0
7964549|NCT01107626|12520028|FG000|Step 2: Maintenance Therapy|Physician Decision|0
7964550|NCT01107626|12520029|FG001|Step 2: Maintenance Therapy|Physician Decision|2
7964551|NCT01107626|12520030|FG002|Step 2: Maintenance Therapy|Physician Decision|3
7964552|NCT01107626|12520031|FG003|Step 2: Maintenance Therapy|Physician Decision|3
7964553|NCT01107626|12520028|FG000|Step 2: Maintenance Therapy|Hospice care|0
7964554|NCT01107626|12520029|FG001|Step 2: Maintenance Therapy|Hospice care|1
7964555|NCT01107626|12520030|FG002|Step 2: Maintenance Therapy|Hospice care|2
7964556|NCT01107626|12520031|FG003|Step 2: Maintenance Therapy|Hospice care|0
7964557|NCT01107626|12520028|FG000|Step 2: Maintenance Therapy|Non-compliance|0
7964558|NCT01107626|12520029|FG001|Step 2: Maintenance Therapy|Non-compliance|0
7964559|NCT01107626|12520030|FG002|Step 2: Maintenance Therapy|Non-compliance|0
7964560|NCT01107626|12520031|FG003|Step 2: Maintenance Therapy|Non-compliance|2
7964561|NCT01107626|12520028|FG000|Step 2: Maintenance Therapy|Pain|0
7964562|NCT01107626|12520029|FG001|Step 2: Maintenance Therapy|Pain|0
7924197|NCT02207608|12450292|FG000|Overall Study|Adverse Event|1
7924198|NCT02207608|12450293|FG001|Overall Study|Adverse Event|0
7924199|NCT02207621|12450302|FG000|Overall Study|Adverse Event|71
7924200|NCT02207621|12450303|FG001|Overall Study|Adverse Event|15
7924201|NCT02207621|12450304|FG002|Overall Study|Adverse Event|132
7924202|NCT02207621|12450302|FG000|Overall Study|Withdrawal by Subject|9
7924203|NCT02207621|12450303|FG001|Overall Study|Withdrawal by Subject|9
7924204|NCT02207621|12450304|FG002|Overall Study|Withdrawal by Subject|13
7924205|NCT02207621|12450302|FG000|Overall Study|Non-Compliant|3
7924206|NCT02207621|12450303|FG001|Overall Study|Non-Compliant|3
7924207|NCT02207621|12450304|FG002|Overall Study|Non-Compliant|1
7924208|NCT02207621|12450302|FG000|Overall Study|Lost to Follow-up|1
7924209|NCT02207621|12450303|FG001|Overall Study|Lost to Follow-up|0
7924210|NCT02207621|12450304|FG002|Overall Study|Lost to Follow-up|3
7924211|NCT02207621|12450302|FG000|Overall Study|Lack of Efficacy|10
7924212|NCT02207621|12450303|FG001|Overall Study|Lack of Efficacy|2
7924213|NCT02207621|12450304|FG002|Overall Study|Lack of Efficacy|4
7924214|NCT02207621|12450302|FG000|Overall Study|Disallowed Concurrent Medication|2
7924215|NCT02207621|12450303|FG001|Overall Study|Disallowed Concurrent Medication|5
7924216|NCT02207621|12450304|FG002|Overall Study|Disallowed Concurrent Medication|2
7924217|NCT02207621|12450302|FG000|Overall Study|Physician Decision|1
7924218|NCT02207621|12450303|FG001|Overall Study|Physician Decision|2
7924219|NCT02207621|12450304|FG002|Overall Study|Physician Decision|2
7924220|NCT02207621|12450302|FG000|Overall Study|Protocol Violation|4
7924221|NCT02207621|12450303|FG001|Overall Study|Protocol Violation|10
7924222|NCT02207621|12450304|FG002|Overall Study|Protocol Violation|6
7924223|NCT02207621|12450302|FG000|Overall Study|Death|2
7924224|NCT02207621|12450303|FG001|Overall Study|Death|0
7924225|NCT02207621|12450304|FG002|Overall Study|Death|0
7924226|NCT02207621|12450302|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2
7924227|NCT02207621|12450303|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1
7924228|NCT02207621|12450304|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5
7924229|NCT02207634|12450315|FG000|Overall Study|Withdrawal by Subject|21
7924230|NCT02207634|12450316|FG001|Overall Study|Withdrawal by Subject|31
7924231|NCT02207634|12450315|FG000|Overall Study|Lost to Follow-up|1
7924232|NCT02207634|12450316|FG001|Overall Study|Lost to Follow-up|0
7924233|NCT02207725|12450326|FG000|Overall Study|Did Not Receive Treatment|0
7924234|NCT02207725|12450327|FG001|Overall Study|Did Not Receive Treatment|1
7924235|NCT02207725|12450328|FG002|Overall Study|Did Not Receive Treatment|1
7924236|NCT02207725|12450329|FG003|Overall Study|Did Not Receive Treatment|1
7924237|NCT02207816|12450353|FG000|Overall Study|Serious Adverse Event|0
7924238|NCT02207816|12450354|FG001|Overall Study|Serious Adverse Event|5
7924239|NCT02207816|12450355|FG002|Overall Study|Serious Adverse Event|2
7924240|NCT02207816|12450353|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2
7924241|NCT02207816|12450354|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1
7924242|NCT02207816|12450355|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2
7924243|NCT02207816|12450353|FG000|Overall Study|Withdrawal by Subject|4
7924244|NCT02207816|12450354|FG001|Overall Study|Withdrawal by Subject|9
7924245|NCT02207816|12450355|FG002|Overall Study|Withdrawal by Subject|7
7924246|NCT02207816|12450353|FG000|Overall Study|Migrated/Moved From Study Area|41
7924247|NCT02207816|12450354|FG001|Overall Study|Migrated/Moved From Study Area|60
7924248|NCT02207816|12450355|FG002|Overall Study|Migrated/Moved From Study Area|51
7924249|NCT02207816|12450353|FG000|Overall Study|Lost to Follow-up|3
7924250|NCT02207816|12450354|FG001|Overall Study|Lost to Follow-up|9
7924251|NCT02207816|12450355|FG002|Overall Study|Lost to Follow-up|1
7924252|NCT02207816|12450353|FG000|Overall Study|Other|1
7924253|NCT02207816|12450354|FG001|Overall Study|Other|2
7924254|NCT02207816|12450355|FG002|Overall Study|Other|4
7924255|NCT02207829|12450368|FG000|Overall Study|Adverse Event|10
7924256|NCT02207829|12450369|FG001|Overall Study|Adverse Event|9
7924257|NCT02207829|12450368|FG000|Overall Study|Lack of Efficacy|7
7924258|NCT02207829|12450369|FG001|Overall Study|Lack of Efficacy|5
7924259|NCT02207829|12450368|FG000|Overall Study|Lost to Follow-up|2
7924260|NCT02207829|12450369|FG001|Overall Study|Lost to Follow-up|2
7924261|NCT02207829|12450368|FG000|Overall Study|Protocol deviation|5
7924262|NCT02207829|12450369|FG001|Overall Study|Protocol deviation|4
7924263|NCT02207829|12450368|FG000|Overall Study|Withdrew consent|18
7924264|NCT02207829|12450369|FG001|Overall Study|Withdrew consent|14
7924265|NCT02207907|12450377|FG000|Overall Study|Lost to Follow-up|3
7924266|NCT02207907|12450378|FG001|Overall Study|Lost to Follow-up|1
7924267|NCT02207907|12450377|FG000|Overall Study|Withdrawal by Subject|5
7924268|NCT02207907|12450378|FG001|Overall Study|Withdrawal by Subject|6
7924269|NCT02207907|12450377|FG000|Overall Study|Did not meet study criteria|3
7924270|NCT02207907|12450378|FG001|Overall Study|Did not meet study criteria|0
7924271|NCT02207907|12450377|FG000|Overall Study|Pregnancy|0
7924272|NCT02207907|12450378|FG001|Overall Study|Pregnancy|1
7924273|NCT02207946|12450387|FG000|Overall Study|Lost to Follow-up|1
7924274|NCT02207946|12450388|FG001|Overall Study|Lost to Follow-up|0
7924275|NCT02207946|12450387|FG000|Overall Study|Adverse Event|0
7924276|NCT02207946|12450388|FG001|Overall Study|Adverse Event|1
7924277|NCT02208050|12450420|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1
7924278|NCT02208050|12450421|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0
7924279|NCT02208063|12450443|FG000|Overall Study|Death|3
7924280|NCT02208063|12450444|FG001|Overall Study|Death|5
7924281|NCT02208063|12450443|FG000|Overall Study|Not Specified in report|3
7924282|NCT02208063|12450444|FG001|Overall Study|Not Specified in report|4
7924283|NCT02208063|12450443|FG000|Overall Study|Withdrawal by Subject|5
7821886|NCT01259089|12290874|FG005|Reached First Response at 4 Weeks|Adverse Event|1
7821887|NCT01259089|12290869|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
7821888|NCT01259089|12290870|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
7821889|NCT01259089|12290871|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
7821890|NCT01259089|12290872|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
7821891|NCT01259089|12290873|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
7821892|NCT01259089|12290874|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
7821893|NCT01259089|12290869|FG000|Confirmed Response at 8 Weeks|Adverse Event|0
7821894|NCT01259089|12290870|FG001|Confirmed Response at 8 Weeks|Adverse Event|0
7821895|NCT01259089|12290871|FG002|Confirmed Response at 8 Weeks|Adverse Event|0
7924284|NCT02208063|12450444|FG001|Overall Study|Withdrawal by Subject|2
7924285|NCT02208063|12450443|FG000|Overall Study|Lost to Follow-up|1
7924286|NCT02208063|12450444|FG001|Overall Study|Lost to Follow-up|0
7924287|NCT02208089|12450452|FG000|Overall Study|Withdrawal by Subject|1
7924288|NCT02208089|12450453|FG001|Overall Study|Withdrawal by Subject|0
7924289|NCT02208089|12450452|FG000|Overall Study|Lost to Follow-up|6
7924290|NCT02208089|12450453|FG001|Overall Study|Lost to Follow-up|0
7924291|NCT02208843|12450502|FG000|Overall Study|Clinical symptoms of progression|2
7924292|NCT02208843|12450502|FG000|Overall Study|Progression disease according to RECIST|24
7924293|NCT02208843|12450502|FG000|Overall Study|Adverse Event|12
7924294|NCT02208843|12450502|FG000|Overall Study|Protocol Violation|1
7924295|NCT02208843|12450502|FG000|Overall Study|Withdrawal by Subject|1
7924296|NCT02208843|12450502|FG000|Overall Study|Switched to commercial afatinib|20
7924297|NCT02208999|12450508|FG000|Overall Study|Lost to Follow-up|1
7924298|NCT02209181|12450536|FG000|Overall Study|Adverse Event|1
7924299|NCT02209181|12450537|FG001|Overall Study|Adverse Event|0
7924300|NCT02209181|12450538|FG002|Overall Study|Adverse Event|1
7924301|NCT02209181|12450539|FG003|Overall Study|Adverse Event|0
7924302|NCT02209181|12450536|FG000|Overall Study|Withdrawal by Subject|0
7924303|NCT02209181|12450537|FG001|Overall Study|Withdrawal by Subject|1
7924304|NCT02209181|12450538|FG002|Overall Study|Withdrawal by Subject|0
7924305|NCT02209181|12450539|FG003|Overall Study|Withdrawal by Subject|0
7924306|NCT02209454|12450571|FG000|Second Period|Adverse Event|1
7924307|NCT02209454|12450572|FG001|Second Period|Adverse Event|0
7924308|NCT02209506|12450583|FG000|Overall Study|Withdrawal by Subject|0
7924309|NCT02209506|12450584|FG001|Overall Study|Withdrawal by Subject|0
7924310|NCT02209506|12450585|FG002|Overall Study|Withdrawal by Subject|0
7924311|NCT02209506|12450586|FG003|Overall Study|Withdrawal by Subject|0
7924312|NCT02209506|12450587|FG004|Overall Study|Withdrawal by Subject|1
7924313|NCT02209597|12450622|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2
7924314|NCT02209597|12450622|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1
7924315|NCT02209597|12450622|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3
7924316|NCT02209597|12450622|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1
7924317|NCT02209766|12450646|FG000|Overall Study|Withdrawal by Subject|0
7924318|NCT02209766|12450647|FG001|Overall Study|Withdrawal by Subject|0
7924319|NCT02209766|12450648|FG002|Overall Study|Withdrawal by Subject|0
7924320|NCT02209766|12450649|FG003|Overall Study|Withdrawal by Subject|1
7924321|NCT02209766|12450650|FG004|Overall Study|Withdrawal by Subject|0
7924322|NCT02210000|12450671|FG000|Overall Study|Study Terminated|11
7924323|NCT02210000|12450672|FG001|Overall Study|Study Terminated|12
7924324|NCT02210000|12450671|FG000|Overall Study|Withdrawal by Subject|7
7924325|NCT02210000|12450672|FG001|Overall Study|Withdrawal by Subject|1
7924326|NCT02210000|12450671|FG000|Overall Study|Adverse Event|1
7924327|NCT02210000|12450672|FG001|Overall Study|Adverse Event|5
7924328|NCT02210000|12450671|FG000|Overall Study|Lost to Follow-up|0
7924329|NCT02210000|12450672|FG001|Overall Study|Lost to Follow-up|2
7924330|NCT02210000|12450671|FG000|Overall Study|Physician Decision|0
7924331|NCT02210000|12450672|FG001|Overall Study|Physician Decision|1
7924332|NCT02210091|12450692|FG000|Overall Study|Physician Decision|0
7924333|NCT02210091|12450693|FG001|Overall Study|Physician Decision|1
7924334|NCT02210091|12450692|FG000|Overall Study|Withdrawal by Sponsor|0
7924335|NCT02210091|12450693|FG001|Overall Study|Withdrawal by Sponsor|1
7924336|NCT02210208|12450724|FG000|Period A (Graft Site)|Withdrawal by Subject|1
7924337|NCT02210208|12450724|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1
7924338|NCT02210208|12450724|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7
7924339|NCT02210221|12450730|FG000|Overall Study|Lack of Efficacy|7
7924340|NCT02210221|12450730|FG000|Overall Study|Withdrawal by Subject|43
7924341|NCT02210689|12450776|FG000|Overall Study|Withdrawal by Subject|7
7924342|NCT02210689|12450777|FG001|Overall Study|Withdrawal by Subject|4
7924343|NCT02210689|12450778|FG002|Overall Study|Withdrawal by Subject|2
7924344|NCT02210689|12450776|FG000|Overall Study|Adverse Event|0
7924345|NCT02210689|12450777|FG001|Overall Study|Adverse Event|1
7924346|NCT02210689|12450778|FG002|Overall Study|Adverse Event|0
7924347|NCT02210689|12450776|FG000|Overall Study|Protocol Violation|1
7924348|NCT02210689|12450777|FG001|Overall Study|Protocol Violation|0
7924349|NCT02210689|12450778|FG002|Overall Study|Protocol Violation|0
7924350|NCT02210689|12450776|FG000|Overall Study|Lost to Follow-up|11
7924351|NCT02210689|12450777|FG001|Overall Study|Lost to Follow-up|9
7924352|NCT02210689|12450778|FG002|Overall Study|Lost to Follow-up|5
7924353|NCT02210689|12450776|FG000|Overall Study|Pregnancy|0
7924354|NCT02210689|12450777|FG001|Overall Study|Pregnancy|1
7924355|NCT02210689|12450778|FG002|Overall Study|Pregnancy|0
7924356|NCT02210689|12450776|FG000|Overall Study|Lack of Efficacy|0
7924357|NCT02210689|12450777|FG001|Overall Study|Lack of Efficacy|1
7924358|NCT02210689|12450778|FG002|Overall Study|Lack of Efficacy|5
7924359|NCT02210689|12450776|FG000|Overall Study|Prohibited medication|2
7924360|NCT02210689|12450777|FG001|Overall Study|Prohibited medication|8
7924361|NCT02210689|12450778|FG002|Overall Study|Prohibited medication|1
7924362|NCT02210689|12450776|FG000|Overall Study|Negative Nugent score at baseline|6
7924363|NCT02210689|12450777|FG001|Overall Study|Negative Nugent score at baseline|2
7924364|NCT02210689|12450778|FG002|Overall Study|Negative Nugent score at baseline|2
7924365|NCT02210689|12450776|FG000|Overall Study|Other|25
7924366|NCT02210689|12450777|FG001|Overall Study|Other|21
7924367|NCT02210689|12450778|FG002|Overall Study|Other|8
7924368|NCT02210780|12450788|FG000|Overall Study|Adverse Event|0
7924369|NCT02210780|12450789|FG001|Overall Study|Adverse Event|5
7924370|NCT02210780|12450788|FG000|Overall Study|Lost to Follow-up|2
7924371|NCT02210780|12450789|FG001|Overall Study|Lost to Follow-up|1
7924372|NCT02210780|12450788|FG000|Overall Study|Withdrawal by Subject|1
7924373|NCT02210780|12450789|FG001|Overall Study|Withdrawal by Subject|1
7924374|NCT02210780|12450788|FG000|Overall Study|Physician Decision|1
7924375|NCT02210780|12450789|FG001|Overall Study|Physician Decision|0
7924376|NCT02210780|12450788|FG000|Overall Study|Protocol Violation|1
7924377|NCT02210780|12450789|FG001|Overall Study|Protocol Violation|0
7924378|NCT02210780|12450788|FG000|Overall Study|Other than specified above|0
7924379|NCT02210780|12450789|FG001|Overall Study|Other than specified above|1
7924380|NCT02211014|12450797|FG000|Overall Study|Adverse Event|0
7924381|NCT02211014|12450798|FG001|Overall Study|Adverse Event|2
7924382|NCT02211014|12450797|FG000|Overall Study|Physician Decision|1
7924383|NCT02211014|12450798|FG001|Overall Study|Physician Decision|2
7924384|NCT02211014|12450797|FG000|Overall Study|Started another cancer therapy|1
7924385|NCT02211014|12450798|FG001|Overall Study|Started another cancer therapy|0
7924386|NCT02211014|12450797|FG000|Overall Study|Withdrawal by Subject|0
7924387|NCT02211014|12450798|FG001|Overall Study|Withdrawal by Subject|1
7924388|NCT02211014|12450797|FG000|Overall Study|In agreement with patient, no benefit|0
7924389|NCT02211014|12450798|FG001|Overall Study|In agreement with patient, no benefit|1
7924390|NCT02211261|12450831|FG000|Overall Study|Withdrawal by Subject|0
7924391|NCT02211261|12450832|FG001|Overall Study|Withdrawal by Subject|0
7924392|NCT02211261|12450833|FG002|Overall Study|Withdrawal by Subject|1
7924393|NCT02211261|12450834|FG003|Overall Study|Withdrawal by Subject|0
7924394|NCT02211261|12450835|FG004|Overall Study|Withdrawal by Subject|2
7924395|NCT02211261|12450836|FG005|Overall Study|Withdrawal by Subject|0
7924396|NCT02211261|12450837|FG006|Overall Study|Withdrawal by Subject|0
7924397|NCT02211261|12450838|FG007|Overall Study|Withdrawal by Subject|0
7924398|NCT02211261|12450839|FG008|Overall Study|Withdrawal by Subject|0
7924399|NCT02211261|12450840|FG009|Overall Study|Withdrawal by Subject|0
7924400|NCT02211261|12450841|FG010|Overall Study|Withdrawal by Subject|0
7924401|NCT02211261|12450831|FG000|Overall Study|Other|0
7924402|NCT02211261|12450832|FG001|Overall Study|Other|0
7924403|NCT02211261|12450833|FG002|Overall Study|Other|0
7924404|NCT02211261|12450834|FG003|Overall Study|Other|0
7924405|NCT02211261|12450835|FG004|Overall Study|Other|0
7924406|NCT02211261|12450836|FG005|Overall Study|Other|1
7924407|NCT02211261|12450837|FG006|Overall Study|Other|0
7924408|NCT02211261|12450838|FG007|Overall Study|Other|0
7924409|NCT02211261|12450839|FG008|Overall Study|Other|0
7924410|NCT02211261|12450840|FG009|Overall Study|Other|2
7924411|NCT02211261|12450841|FG010|Overall Study|Other|0
7924412|NCT02211261|12450831|FG000|Overall Study|Lost to Follow-up|0
7924413|NCT02211261|12450832|FG001|Overall Study|Lost to Follow-up|0
7924414|NCT02211261|12450833|FG002|Overall Study|Lost to Follow-up|0
7924415|NCT02211261|12450834|FG003|Overall Study|Lost to Follow-up|0
7924416|NCT02211261|12450835|FG004|Overall Study|Lost to Follow-up|0
7924417|NCT02211261|12450836|FG005|Overall Study|Lost to Follow-up|0
7924418|NCT02211261|12450837|FG006|Overall Study|Lost to Follow-up|0
7924419|NCT02211261|12450838|FG007|Overall Study|Lost to Follow-up|1
7924420|NCT02211261|12450839|FG008|Overall Study|Lost to Follow-up|0
7924421|NCT02211261|12450840|FG009|Overall Study|Lost to Follow-up|0
7924422|NCT02211261|12450841|FG010|Overall Study|Lost to Follow-up|0
7924423|NCT02211313|12450876|FG000|Overall Study|Treatment Failure|5
7924424|NCT02211313|12450877|FG001|Overall Study|Treatment Failure|2
7924425|NCT02211313|12450876|FG000|Overall Study|No Follow up Questionnaires|1
7924426|NCT02211313|12450877|FG001|Overall Study|No Follow up Questionnaires|1
7924427|NCT02211638|12450909|FG000|Overall Study|Case Report Forms Uncollected|291
7924428|NCT02211638|12450909|FG000|Overall Study|Protocol Violation|692
7924429|NCT02212197|12450935|FG000|Overall Study|Need for radiotherapy|1
7924430|NCT02212197|12450936|FG001|Overall Study|Need for radiotherapy|0
7924431|NCT02212197|12450937|FG002|Overall Study|Need for radiotherapy|0
7924432|NCT02212301|12450945|FG000|Period 1|Lost to Follow-up|0
7924433|NCT02212301|12450946|FG001|Period 1|Lost to Follow-up|1
7924434|NCT02212379|12450953|FG000|From Baseline to Week 48|Lack of Efficacy|1
7924435|NCT02212379|12450953|FG000|From Baseline to Week 48|Adverse Event|7
7924436|NCT02212379|12450953|FG000|From Baseline to Week 48|Withdrawal by Subject|1
7924437|NCT02212379|12450953|FG000|From Week 48 to Week 96|Lack of Efficacy|1
7924438|NCT02212379|12450953|FG000|From Week 48 to Week 96|Adverse Event|1
7924439|NCT02212379|12450953|FG000|From Week 48 to Week 96|Withdrawal by Subject|2
7924440|NCT02212457|12450966|FG000|Overall Study|Adverse Event|1
7924441|NCT02212457|12450967|FG001|Overall Study|Adverse Event|2
7924442|NCT02212457|12450968|FG002|Overall Study|Adverse Event|2
7924443|NCT02212457|12450969|FG003|Overall Study|Adverse Event|2
7924444|NCT02212457|12450970|FG004|Overall Study|Adverse Event|0
7924445|NCT02212457|12450971|FG005|Overall Study|Adverse Event|1
7924446|NCT02212457|12450966|FG000|Overall Study|Withdrawal by Subject|8
7924447|NCT02212457|12450967|FG001|Overall Study|Withdrawal by Subject|10
7924448|NCT02212457|12450968|FG002|Overall Study|Withdrawal by Subject|8
7924449|NCT02212457|12450969|FG003|Overall Study|Withdrawal by Subject|6
7924450|NCT02212457|12450970|FG004|Overall Study|Withdrawal by Subject|5
7924451|NCT02212457|12450971|FG005|Overall Study|Withdrawal by Subject|4
7924452|NCT02212457|12450966|FG000|Overall Study|Lost to Follow-up|6
7924453|NCT02212457|12450967|FG001|Overall Study|Lost to Follow-up|7
7924454|NCT02212457|12450968|FG002|Overall Study|Lost to Follow-up|4
7924455|NCT02212457|12450969|FG003|Overall Study|Lost to Follow-up|1
7924456|NCT02212457|12450970|FG004|Overall Study|Lost to Follow-up|8
7924457|NCT02212457|12450971|FG005|Overall Study|Lost to Follow-up|4
7924458|NCT02212457|12450966|FG000|Overall Study|Protocol Violation|2
7924459|NCT02212457|12450967|FG001|Overall Study|Protocol Violation|1
7924460|NCT02212457|12450968|FG002|Overall Study|Protocol Violation|0
7924461|NCT02212457|12450969|FG003|Overall Study|Protocol Violation|1
7924462|NCT02212457|12450970|FG004|Overall Study|Protocol Violation|2
7924463|NCT02212457|12450971|FG005|Overall Study|Protocol Violation|3
7924464|NCT02212457|12450966|FG000|Overall Study|Other|2
7924465|NCT02212457|12450967|FG001|Overall Study|Other|1
7924466|NCT02212457|12450968|FG002|Overall Study|Other|2
7924467|NCT02212457|12450969|FG003|Overall Study|Other|1
7924468|NCT02212457|12450970|FG004|Overall Study|Other|0
7924469|NCT02212457|12450971|FG005|Overall Study|Other|1
7924470|NCT02212678|12450996|FG000|Overall Study|Adverse Event|1
7924471|NCT02212730|12451002|FG000|Overall Study|Tumor not of the required cell histology|1
7924472|NCT02212730|12451003|FG001|Overall Study|Tumor not of the required cell histology|0
7924473|NCT02212730|12451002|FG000|Overall Study|Withdrawal by Subject|1
7924474|NCT02212730|12451003|FG001|Overall Study|Withdrawal by Subject|0
7924475|NCT02212730|12451002|FG000|Overall Study|Disease progression prior to RCC surgery|0
7924476|NCT02212730|12451003|FG001|Overall Study|Disease progression prior to RCC surgery|1
7924477|NCT02213042|12451032|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14
7924478|NCT02213042|12451033|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13
7924479|NCT02213042|12451034|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8
7924480|NCT02213042|12451032|FG000|Overall Study|Adverse Event|2
7924481|NCT02213042|12451033|FG001|Overall Study|Adverse Event|1
7924482|NCT02213042|12451034|FG002|Overall Study|Adverse Event|0
7924483|NCT02213042|12451032|FG000|Overall Study|Withdrawal by Subject|0
7924484|NCT02213042|12451033|FG001|Overall Study|Withdrawal by Subject|1
7924485|NCT02213042|12451034|FG002|Overall Study|Withdrawal by Subject|1
7924486|NCT02213042|12451032|FG000|Overall Study|Protocol Violation|1
7924487|NCT02213042|12451033|FG001|Overall Study|Protocol Violation|0
7924488|NCT02213042|12451034|FG002|Overall Study|Protocol Violation|0
7924489|NCT02213042|12451032|FG000|Overall Study|Investigator discretion|0
7924490|NCT02213042|12451033|FG001|Overall Study|Investigator discretion|0
7924491|NCT02213042|12451034|FG002|Overall Study|Investigator discretion|1
7924492|NCT02213055|12451046|FG000|Overall Study|Protocol was not Followed at Enrollment|5
7924493|NCT02213055|12451047|FG001|Overall Study|Protocol was not Followed at Enrollment|0
7924494|NCT02213055|12451046|FG000|Overall Study|Protocol was not Followed during Study|1
7924495|NCT02213055|12451047|FG001|Overall Study|Protocol was not Followed during Study|0
7924496|NCT02213055|12451046|FG000|Overall Study|Documentation Issue at Enrollment|1
7719634|NCT00533897|12143616|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
7719635|NCT00533897|12143617|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
7719636|NCT00533897|12143618|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7719637|NCT00533897|12143619|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7719638|NCT00533897|12143620|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7719639|NCT00533897|12143621|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7719640|NCT00533897|12143622|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7719641|NCT00533897|12143615|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7719642|NCT00533897|12143616|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7719643|NCT00533897|12143617|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
7719644|NCT00533897|12143618|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7719645|NCT00533897|12143619|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7719646|NCT00533897|12143620|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7719647|NCT00533897|12143621|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7924497|NCT02213055|12451047|FG001|Overall Study|Documentation Issue at Enrollment|0
7924498|NCT02213055|12451046|FG000|Overall Study|Documentation Issue during Study|10
7924499|NCT02213055|12451047|FG001|Overall Study|Documentation Issue during Study|0
7924500|NCT02213055|12451046|FG000|Overall Study|Did not have Live Lice|8
7924501|NCT02213055|12451047|FG001|Overall Study|Did not have Live Lice|0
7924502|NCT02213055|12451046|FG000|Overall Study|Had another Treatment during the Study|3
7924503|NCT02213055|12451047|FG001|Overall Study|Had another Treatment during the Study|0
7924504|NCT02213055|12451046|FG000|Overall Study|Did not meet Inclusion Criteria|6
7924505|NCT02213055|12451047|FG001|Overall Study|Did not meet Inclusion Criteria|0
7924506|NCT02213055|12451046|FG000|Overall Study|Did not Return to School|5
7924507|NCT02213055|12451047|FG001|Overall Study|Did not Return to School|0
7924508|NCT02213094|12451055|FG000|Overall Study|Adverse Event|1
7924509|NCT02213094|12451056|FG001|Overall Study|Adverse Event|0
7924510|NCT02213133|12451065|FG000|Overall Study|Participant discontinued study therapy|2
7924511|NCT02213133|12451066|FG001|Overall Study|Participant discontinued study therapy|0
7924512|NCT02213133|12451067|FG002|Overall Study|Participant discontinued study therapy|0
7924513|NCT02213133|12451065|FG000|Overall Study|Participant withdrew informed consent|2
7924514|NCT02213133|12451066|FG001|Overall Study|Participant withdrew informed consent|1
7924515|NCT02213133|12451067|FG002|Overall Study|Participant withdrew informed consent|2
7924516|NCT02213133|12451065|FG000|Overall Study|Disease progression|11
7924517|NCT02213133|12451066|FG001|Overall Study|Disease progression|2
7924518|NCT02213133|12451067|FG002|Overall Study|Disease progression|0
7924519|NCT02213133|12451065|FG000|Overall Study|Adverse Event (AE)|1
7924520|NCT02213133|12451066|FG001|Overall Study|Adverse Event (AE)|0
7924521|NCT02213133|12451067|FG002|Overall Study|Adverse Event (AE)|0
7924522|NCT02213133|12451065|FG000|Overall Study|Death|16
7924523|NCT02213133|12451066|FG001|Overall Study|Death|2
7924524|NCT02213133|12451067|FG002|Overall Study|Death|1
7924525|NCT02213133|12451065|FG000|Overall Study|Other|5
7924526|NCT02213133|12451066|FG001|Overall Study|Other|0
7924527|NCT02213133|12451067|FG002|Overall Study|Other|0
7924528|NCT02213198|12451078|FG000|Baseline|No show for intake|7
7924529|NCT02213198|12451079|FG001|Baseline|No show for intake|9
7924530|NCT02213198|12451078|FG000|Baseline|Withdrawal by Subject|34
7924531|NCT02213198|12451079|FG001|Baseline|Withdrawal by Subject|11
7924532|NCT02213198|12451078|FG000|Baseline|transferred out of clinic|7
7924533|NCT02213198|12451079|FG001|Baseline|transferred out of clinic|9
7924534|NCT02213198|12451078|FG000|Baseline|Lost to Follow-up|40
7924535|NCT02213198|12451079|FG001|Baseline|Lost to Follow-up|21
7924536|NCT02213198|12451078|FG000|Baseline|incarcerated,violent|0
7924537|NCT02213198|12451079|FG001|Baseline|incarcerated,violent|1
7924538|NCT02213198|12451078|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
7924539|NCT02213198|12451079|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
7924540|NCT02213198|12451078|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
7924541|NCT02213198|12451079|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
7924542|NCT02213198|12451078|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
7924543|NCT02213198|12451079|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
7924544|NCT02213198|12451078|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
7924545|NCT02213198|12451079|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
7924546|NCT02213198|12451078|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
7924547|NCT02213198|12451079|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
7924548|NCT02213198|12451078|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
7924549|NCT02213198|12451079|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
7924550|NCT02213263|12451095|FG000|Overall Study|Insufficient clinical response|4
7924551|NCT02213263|12451096|FG001|Overall Study|Insufficient clinical response|3
7924552|NCT02213263|12451095|FG000|Overall Study|Lost to Follow-up|0
7924553|NCT02213263|12451096|FG001|Overall Study|Lost to Follow-up|1
7924554|NCT02213263|12451095|FG000|Overall Study|No longer willing to participate|3
7924555|NCT02213263|12451096|FG001|Overall Study|No longer willing to participate|4
7924556|NCT02213263|12451095|FG000|Overall Study|Progressive disease|20
7924557|NCT02213263|12451096|FG001|Overall Study|Progressive disease|14
7924558|NCT02213263|12451095|FG000|Overall Study|Protocol Violation|0
7924559|NCT02213263|12451096|FG001|Overall Study|Protocol Violation|1
7924560|NCT02213263|12451095|FG000|Overall Study|Adverse Event|1
7924561|NCT02213263|12451096|FG001|Overall Study|Adverse Event|3
7924562|NCT02213458|12451117|FG000|Overall Study|No longer meets criteria: caregiver deceased|4
7924563|NCT02213458|12451118|FG001|Overall Study|No longer meets criteria: caregiver deceased|0
7924564|NCT02213458|12451117|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4
7924565|NCT02213458|12451118|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0
7924566|NCT02213458|12451117|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2
7924567|NCT02213458|12451118|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0
7924568|NCT02213458|12451117|FG000|Overall Study|No longer meets criteria: patient moved out of state|10
7924569|NCT02213458|12451118|FG001|Overall Study|No longer meets criteria: patient moved out of state|0
7924570|NCT02213458|12451117|FG000|Overall Study|Refused re-consent|6
7924571|NCT02213458|12451118|FG001|Overall Study|Refused re-consent|0
7924572|NCT02213458|12451117|FG000|Overall Study|Lost to Follow-up|2
7924573|NCT02213458|12451118|FG001|Overall Study|Lost to Follow-up|2
7924574|NCT02213458|12451117|FG000|Overall Study|Withdrawal by Subject|26
7924575|NCT02213458|12451118|FG001|Overall Study|Withdrawal by Subject|8
7924576|NCT02213510|12451126|FG000|Overall Study|Death|0
7924577|NCT02213510|12451127|FG001|Overall Study|Death|1
7924578|NCT02213510|12451126|FG000|Overall Study|Lost to Follow-up|1
7924579|NCT02213510|12451127|FG001|Overall Study|Lost to Follow-up|0
7924580|NCT02213666|12451133|FG000|Overall Study|Withdrawal by Subject|1
7924581|NCT02214121|12451158|FG000|Part A|Patient decision|2
7924582|NCT02214121|12451159|FG001|Part A|Patient decision|0
7924583|NCT02214121|12451160|FG002|Part A|Patient decision|0
7924584|NCT02214121|12451158|FG000|Part A|Dev. of study-specific withdrawal crit.|4
7924585|NCT02214121|12451159|FG001|Part A|Dev. of study-specific withdrawal crit.|0
7924586|NCT02214121|12451160|FG002|Part A|Dev. of study-specific withdrawal crit.|0
7924587|NCT02214121|12451158|FG000|Part A|Other|1
7924588|NCT02214121|12451159|FG001|Part A|Other|0
7924589|NCT02214121|12451160|FG002|Part A|Other|0
7924590|NCT02214121|12451158|FG000|Part B|Patient decision|0
7924591|NCT02214121|12451159|FG001|Part B|Patient decision|1
7924592|NCT02214121|12451160|FG002|Part B|Patient decision|0
7924593|NCT02214121|12451158|FG000|Part B|Dev. of study-specific withdrawal crit.|0
7924594|NCT02214121|12451159|FG001|Part B|Dev. of study-specific withdrawal crit.|2
7924595|NCT02214121|12451160|FG002|Part B|Dev. of study-specific withdrawal crit.|0
7924596|NCT02214121|12451158|FG000|Part B|Lost to Follow-up|0
7924597|NCT02214121|12451159|FG001|Part B|Lost to Follow-up|0
7924598|NCT02214121|12451160|FG002|Part B|Lost to Follow-up|1
7924599|NCT02214186|12451195|FG000|Overall Study|Lost to Follow-up|1
7924600|NCT02214186|12451196|FG001|Overall Study|Lost to Follow-up|1
7924601|NCT02214186|12451195|FG000|Overall Study|Protocol Violation|1
7924602|NCT02214186|12451196|FG001|Overall Study|Protocol Violation|1
7924603|NCT02214225|12451219|FG000|Overall Study|Lost to Follow-up|46
7924604|NCT02214225|12451220|FG001|Overall Study|Lost to Follow-up|18
7924605|NCT02214225|12451221|FG002|Overall Study|Lost to Follow-up|18
7924606|NCT02214225|12451219|FG000|Overall Study|Withdrawal by Subject|2
7924607|NCT02214225|12451220|FG001|Overall Study|Withdrawal by Subject|0
7924608|NCT02214225|12451221|FG002|Overall Study|Withdrawal by Subject|2
7924609|NCT02214225|12451219|FG000|Overall Study|Death|5
7924610|NCT02214225|12451220|FG001|Overall Study|Death|0
7924611|NCT02214225|12451221|FG002|Overall Study|Death|1
7924612|NCT02214225|12451219|FG000|Overall Study|randomized in error, not vaccinated|2
7924613|NCT02214225|12451220|FG001|Overall Study|randomized in error, not vaccinated|1
7924614|NCT02214225|12451221|FG002|Overall Study|randomized in error, not vaccinated|1
7924615|NCT02215252|12451349|FG000|Overall Study|Adverse Event|1
7924616|NCT02215252|12451350|FG001|Overall Study|Adverse Event|5
7924617|NCT02215252|12451351|FG002|Overall Study|Adverse Event|2
7924618|NCT02215252|12451349|FG000|Overall Study|Lost to Follow-up|0
7924619|NCT02215252|12451350|FG001|Overall Study|Lost to Follow-up|0
7924620|NCT02215252|12451351|FG002|Overall Study|Lost to Follow-up|1
7924621|NCT02215252|12451349|FG000|Overall Study|Does not Meet Entrance Criteria|0
7924622|NCT02215252|12451350|FG001|Overall Study|Does not Meet Entrance Criteria|1
7924623|NCT02215252|12451351|FG002|Overall Study|Does not Meet Entrance Criteria|0
7924624|NCT02215252|12451349|FG000|Overall Study|Protocol Violation|0
7924625|NCT02215252|12451350|FG001|Overall Study|Protocol Violation|1
7924626|NCT02215252|12451351|FG002|Overall Study|Protocol Violation|0
7924627|NCT02215252|12451349|FG000|Overall Study|Withdrawal by Subject|1
7924628|NCT02215252|12451350|FG001|Overall Study|Withdrawal by Subject|0
7924629|NCT02215252|12451351|FG002|Overall Study|Withdrawal by Subject|0
7924630|NCT02215252|12451349|FG000|Overall Study|Other|0
7924631|NCT02215252|12451350|FG001|Overall Study|Other|1
7924632|NCT02215252|12451351|FG002|Overall Study|Other|1
7924633|NCT02215616|12451367|FG000|Overall Study|Sponsor requested to stop study drug|0
7924634|NCT02215616|12451368|FG001|Overall Study|Sponsor requested to stop study drug|0
7924635|NCT02215616|12451369|FG002|Overall Study|Sponsor requested to stop study drug|1
7924636|NCT02215616|12451370|FG003|Overall Study|Sponsor requested to stop study drug|4
7924637|NCT02215616|12451367|FG000|Overall Study|Death|1
7924638|NCT02215616|12451368|FG001|Overall Study|Death|0
7924639|NCT02215616|12451369|FG002|Overall Study|Death|0
7924640|NCT02215616|12451370|FG003|Overall Study|Death|0
7924641|NCT02215616|12451367|FG000|Overall Study|Adverse Event|7
7924642|NCT02215616|12451368|FG001|Overall Study|Adverse Event|4
7924643|NCT02215616|12451369|FG002|Overall Study|Adverse Event|9
7924644|NCT02215616|12451370|FG003|Overall Study|Adverse Event|2
7821896|NCT01259089|12290872|FG003|Confirmed Response at 8 Weeks|Adverse Event|0
7821897|NCT01259089|12290873|FG004|Confirmed Response at 8 Weeks|Adverse Event|1
7821898|NCT01259089|12290874|FG005|Confirmed Response at 8 Weeks|Adverse Event|2
7821899|NCT01259089|12290869|FG000|Confirmed Response at 8 Weeks|Progressive disease|0
7821900|NCT01259089|12290870|FG001|Confirmed Response at 8 Weeks|Progressive disease|0
7821901|NCT01259089|12290871|FG002|Confirmed Response at 8 Weeks|Progressive disease|1
7821902|NCT01259089|12290872|FG003|Confirmed Response at 8 Weeks|Progressive disease|1
7821903|NCT01259089|12290873|FG004|Confirmed Response at 8 Weeks|Progressive disease|3
7821904|NCT01259089|12290874|FG005|Confirmed Response at 8 Weeks|Progressive disease|7
7821905|NCT01259089|12290869|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
7821906|NCT01259089|12290870|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
7821907|NCT01259089|12290871|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
7821908|NCT01259089|12290872|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
7821909|NCT01259089|12290873|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
7821910|NCT01259089|12290874|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
7821911|NCT01259089|12290869|FG000|Continued Treatment After 8 Weeks|Adverse Event|0
7821912|NCT01259089|12290870|FG001|Continued Treatment After 8 Weeks|Adverse Event|0
7924645|NCT02215616|12451367|FG000|Overall Study|Withdrawal by Subject|1
7924646|NCT02215616|12451368|FG001|Overall Study|Withdrawal by Subject|8
7821913|NCT01259089|12290871|FG002|Continued Treatment After 8 Weeks|Adverse Event|0
7821914|NCT01259089|12290872|FG003|Continued Treatment After 8 Weeks|Adverse Event|0
7821915|NCT01259089|12290873|FG004|Continued Treatment After 8 Weeks|Adverse Event|2
7821916|NCT01259089|12290874|FG005|Continued Treatment After 8 Weeks|Adverse Event|1
7821917|NCT01259089|12290869|FG000|Continued Treatment After 8 Weeks|Progressive disease|1
7821918|NCT01259089|12290870|FG001|Continued Treatment After 8 Weeks|Progressive disease|1
7821919|NCT01259089|12290871|FG002|Continued Treatment After 8 Weeks|Progressive disease|1
7821920|NCT01259089|12290872|FG003|Continued Treatment After 8 Weeks|Progressive disease|1
7821921|NCT01259089|12290873|FG004|Continued Treatment After 8 Weeks|Progressive disease|0
7821922|NCT01259089|12290874|FG005|Continued Treatment After 8 Weeks|Progressive disease|0
7821923|NCT01259089|12290869|FG000|Survival Follow up for Two Years|Death|3
7924647|NCT02215616|12451369|FG002|Overall Study|Withdrawal by Subject|2
7924648|NCT02215616|12451370|FG003|Overall Study|Withdrawal by Subject|5
7924649|NCT02215616|12451367|FG000|Overall Study|Non-compliance|0
7924650|NCT02215616|12451368|FG001|Overall Study|Non-compliance|2
7924651|NCT02215616|12451369|FG002|Overall Study|Non-compliance|1
7924652|NCT02215616|12451370|FG003|Overall Study|Non-compliance|0
7924653|NCT02215616|12451367|FG000|Overall Study|Protocol Violation|0
7924654|NCT02215616|12451368|FG001|Overall Study|Protocol Violation|2
7821924|NCT01259089|12290870|FG001|Survival Follow up for Two Years|Death|2
7821925|NCT01259089|12290871|FG002|Survival Follow up for Two Years|Death|2
7821926|NCT01259089|12290872|FG003|Survival Follow up for Two Years|Death|3
7821927|NCT01259089|12290873|FG004|Survival Follow up for Two Years|Death|6
7821928|NCT01259089|12290874|FG005|Survival Follow up for Two Years|Death|13
7924655|NCT02215616|12451369|FG002|Overall Study|Protocol Violation|0
7924656|NCT02215616|12451370|FG003|Overall Study|Protocol Violation|0
7924657|NCT02215616|12451367|FG000|Overall Study|Lost to Follow-up|1
7924658|NCT02215616|12451368|FG001|Overall Study|Lost to Follow-up|1
7924659|NCT02215616|12451369|FG002|Overall Study|Lost to Follow-up|0
7924660|NCT02215616|12451370|FG003|Overall Study|Lost to Follow-up|1
7924661|NCT02215616|12451367|FG000|Overall Study|Other than specified|1
7924662|NCT02215616|12451368|FG001|Overall Study|Other than specified|0
7924663|NCT02215616|12451369|FG002|Overall Study|Other than specified|1
7924664|NCT02215616|12451370|FG003|Overall Study|Other than specified|1
7924665|NCT02215954|12451383|FG000|Overall Study|Adverse Event|0
7924666|NCT02215954|12451384|FG001|Overall Study|Adverse Event|0
7924667|NCT02215954|12451385|FG002|Overall Study|Adverse Event|1
7924668|NCT02215954|12451383|FG000|Overall Study|Withdrawal by Subject|0
7924669|NCT02215954|12451384|FG001|Overall Study|Withdrawal by Subject|0
7924670|NCT02215954|12451385|FG002|Overall Study|Withdrawal by Subject|2
7924671|NCT02215954|12451383|FG000|Overall Study|Not exposed|1
7924672|NCT02215954|12451384|FG001|Overall Study|Not exposed|1
7924673|NCT02215954|12451385|FG002|Overall Study|Not exposed|3
7924674|NCT02215967|12451398|FG000|Overall Study|Patient became ineligible for treatment|0
7924675|NCT02215967|12451399|FG001|Overall Study|Patient became ineligible for treatment|0
7924676|NCT02215967|12451400|FG002|Overall Study|Patient became ineligible for treatment|0
7924677|NCT02215967|12451401|FG003|Overall Study|Patient became ineligible for treatment|3
7924678|NCT02215967|12451398|FG000|Overall Study|Patient did not get CAR T-Cells|0
7924679|NCT02215967|12451399|FG001|Overall Study|Patient did not get CAR T-Cells|0
7924680|NCT02215967|12451400|FG002|Overall Study|Patient did not get CAR T-Cells|1
7924681|NCT02215967|12451401|FG003|Overall Study|Patient did not get CAR T-Cells|0
7924682|NCT02216071|12451413|FG000|Overall Study|Withdrawal by Subject|7
7924683|NCT02216071|12451414|FG001|Overall Study|Withdrawal by Subject|2
7924684|NCT02216071|12451413|FG000|Overall Study|Lost to Follow-up|3
7924685|NCT02216071|12451414|FG001|Overall Study|Lost to Follow-up|3
7924686|NCT02216071|12451413|FG000|Overall Study|Protocol Violation|3
7924687|NCT02216071|12451414|FG001|Overall Study|Protocol Violation|5
7924688|NCT02216071|12451413|FG000|Overall Study|Other|2
7924689|NCT02216071|12451414|FG001|Overall Study|Other|2
7924690|NCT02216123|12451431|FG000|Overall Study|Lost to Follow-up|4
7924691|NCT02216123|12451432|FG001|Overall Study|Lost to Follow-up|2
7924692|NCT02216123|12451431|FG000|Overall Study|Withdrawal by Subject|2
7924693|NCT02216123|12451432|FG001|Overall Study|Withdrawal by Subject|0
7924694|NCT02216214|12451457|FG000|Overall Study|Randomized Never Received Study Drug|1
7924695|NCT02216214|12451458|FG001|Overall Study|Randomized Never Received Study Drug|0
7924696|NCT02216214|12451457|FG000|Overall Study|Adverse Event|10
7924697|NCT02216214|12451458|FG001|Overall Study|Adverse Event|8
7924698|NCT02216214|12451457|FG000|Overall Study|Lack of Efficacy|2
7924699|NCT02216214|12451458|FG001|Overall Study|Lack of Efficacy|2
7924700|NCT02216214|12451457|FG000|Overall Study|Lost to Follow-up|3
7924701|NCT02216214|12451458|FG001|Overall Study|Lost to Follow-up|2
7924702|NCT02216214|12451457|FG000|Overall Study|Protocol Violation|4
7924703|NCT02216214|12451458|FG001|Overall Study|Protocol Violation|2
7924704|NCT02216214|12451457|FG000|Overall Study|Withdrawal by Subject|22
7924705|NCT02216214|12451458|FG001|Overall Study|Withdrawal by Subject|20
7924706|NCT02216214|12451457|FG000|Overall Study|Study Terminated By Sponsor|0
7924707|NCT02216214|12451458|FG001|Overall Study|Study Terminated By Sponsor|1
7924708|NCT02216214|12451457|FG000|Overall Study|Miscellaneous|1
7924709|NCT02216214|12451458|FG001|Overall Study|Miscellaneous|1
7924710|NCT02216357|12451466|FG000|Overall Study|Inclusion or exclusion criteria not met|2
7924711|NCT02216357|12451467|FG001|Overall Study|Inclusion or exclusion criteria not met|1
7964563|NCT01107626|12520030|FG002|Step 2: Maintenance Therapy|Pain|0
7821929|NCT01259089|12290869|FG000|Survival Follow up for Two Years|Lost to Follow-up|0
7821930|NCT01259089|12290870|FG001|Survival Follow up for Two Years|Lost to Follow-up|0
7821931|NCT01259089|12290871|FG002|Survival Follow up for Two Years|Lost to Follow-up|0
7821932|NCT01259089|12290872|FG003|Survival Follow up for Two Years|Lost to Follow-up|0
7821933|NCT01259089|12290873|FG004|Survival Follow up for Two Years|Lost to Follow-up|0
7821934|NCT01259089|12290874|FG005|Survival Follow up for Two Years|Lost to Follow-up|2
7821935|NCT01259089|12290869|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0
7821936|NCT01259089|12290870|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0
7924712|NCT02216526|12451480|FG000|Overall Study|Adverse Event|1
7924713|NCT02216526|12451481|FG001|Overall Study|Adverse Event|1
7924714|NCT02216526|12451482|FG002|Overall Study|Adverse Event|0
7924715|NCT02216526|12451480|FG000|Overall Study|Death|0
7924716|NCT02216526|12451481|FG001|Overall Study|Death|1
7924717|NCT02216526|12451482|FG002|Overall Study|Death|3
7924718|NCT02216526|12451480|FG000|Overall Study|Protocol Violation|2
7924719|NCT02216526|12451481|FG001|Overall Study|Protocol Violation|0
7924720|NCT02216526|12451482|FG002|Overall Study|Protocol Violation|2
7924721|NCT02216526|12451480|FG000|Overall Study|Hospitalization|2
7821937|NCT01259089|12290871|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0
7924722|NCT02216526|12451481|FG001|Overall Study|Hospitalization|1
7924723|NCT02216526|12451482|FG002|Overall Study|Hospitalization|3
7821938|NCT01259089|12290872|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0
7821939|NCT01259089|12290873|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0
7821940|NCT01259089|12290874|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4
7924724|NCT02216591|12451492|FG000|Overall Study|Lost to Follow-up|0
7924725|NCT02216591|12451493|FG001|Overall Study|Lost to Follow-up|1
7924726|NCT02216773|12451510|FG000|Overall Study|Disease progression|4
7924727|NCT02216773|12451511|FG001|Overall Study|Disease progression|2
7924728|NCT02216773|12451510|FG000|Overall Study|Insufficient FLRV|4
7924729|NCT02216773|12451511|FG001|Overall Study|Insufficient FLRV|0
7924730|NCT02216773|12451510|FG000|Overall Study|Abandoned|4
7924731|NCT02216773|12451511|FG001|Overall Study|Abandoned|3
7924732|NCT02216812|12451519|FG000|Overall Study|Lost to Follow-up|10
7821941|NCT01259102|12290893|FG000|Overall Study|Adverse Event|1
7821942|NCT01259102|12290894|FG001|Overall Study|Adverse Event|0
7924733|NCT02216812|12451520|FG001|Overall Study|Lost to Follow-up|5
7924734|NCT02217280|12451526|FG000|Overall Study|Withdrawal by Subject|2
7924735|NCT02217280|12451526|FG000|Overall Study|Post-consent sceen fail|2
7924736|NCT02217332|12451531|FG000|Overall Study|Adverse Event|3
7924737|NCT02217332|12451531|FG000|Overall Study|Dose interruption >1 month|1
7924738|NCT02217332|12451531|FG000|Overall Study|Protocol Violation (eligibility)|1
7924739|NCT02217332|12451531|FG000|Overall Study|Withdrawal by Subject|1
7924740|NCT02217332|12451531|FG000|Overall Study|Lost to Follow-up|1
7924741|NCT02217410|12451538|FG000|Overall Study|Graft Loss|0
7924742|NCT02217410|12451539|FG001|Overall Study|Graft Loss|0
7924743|NCT02217410|12451540|FG002|Overall Study|Graft Loss|2
7924744|NCT02217410|12451538|FG000|Overall Study|Withdrawal by Subject|0
7924745|NCT02217410|12451539|FG001|Overall Study|Withdrawal by Subject|0
7924746|NCT02217410|12451540|FG002|Overall Study|Withdrawal by Subject|2
7924747|NCT02217410|12451538|FG000|Overall Study|Lost to Follow-up|0
7924748|NCT02217410|12451539|FG001|Overall Study|Lost to Follow-up|0
7924749|NCT02217410|12451540|FG002|Overall Study|Lost to Follow-up|1
7821943|NCT01259102|12290895|FG002|Overall Study|Adverse Event|1
7821944|NCT01259102|12290896|FG003|Overall Study|Adverse Event|1
7821945|NCT01259102|12290897|FG004|Overall Study|Adverse Event|0
7821946|NCT01259102|12290893|FG000|Overall Study|Other|0
7821947|NCT01259102|12290894|FG001|Overall Study|Other|0
7821948|NCT01259102|12290895|FG002|Overall Study|Other|1
7821949|NCT01259102|12290896|FG003|Overall Study|Other|1
7821950|NCT01259102|12290897|FG004|Overall Study|Other|1
7924750|NCT02217410|12451538|FG000|Overall Study|Lack of Efficacy|0
7924751|NCT02217410|12451539|FG001|Overall Study|Lack of Efficacy|1
7924752|NCT02217410|12451540|FG002|Overall Study|Lack of Efficacy|0
7924753|NCT02217410|12451538|FG000|Overall Study|Physician Decision|1
7821951|NCT01259115|12290909|FG000|Period 1|Adverse Event|1
7821952|NCT01259115|12290910|FG001|Period 1|Adverse Event|0
7821953|NCT01259115|12290909|FG000|Period 1|Protocol Violation|2
7821954|NCT01259115|12290910|FG001|Period 1|Protocol Violation|0
7821955|NCT01259115|12290909|FG000|Period 1|Lost to Follow-up|0
7821956|NCT01259115|12290910|FG001|Period 1|Lost to Follow-up|1
7821957|NCT01259115|12290909|FG000|Period 2|Adverse Event|1
7821958|NCT01259115|12290910|FG001|Period 2|Adverse Event|0
7821959|NCT01259245|12290932|FG000|Overall Study|Withdrawal by Subject|27
7821960|NCT01259245|12290933|FG001|Overall Study|Withdrawal by Subject|24
7821961|NCT01259245|12290932|FG000|Overall Study|Death|1
7821962|NCT01259245|12290933|FG001|Overall Study|Death|2
7821963|NCT01259297|12290949|FG000|Double Blind Randomized Period|Death|1
7821964|NCT01259297|12290950|FG001|Double Blind Randomized Period|Death|1
7821965|NCT01259297|12290951|FG002|Double Blind Randomized Period|Death|1
7821966|NCT01259297|12290952|FG003|Double Blind Randomized Period|Death|2
7821967|NCT01259297|12290953|FG004|Double Blind Randomized Period|Death|1
7821968|NCT01259297|12290954|FG005|Double Blind Randomized Period|Death|5
7924754|NCT02217410|12451539|FG001|Overall Study|Physician Decision|3
7924755|NCT02217410|12451540|FG002|Overall Study|Physician Decision|0
7924756|NCT02217436|12451555|FG000|Overall Study|Protocol Violation|1
7924757|NCT02217436|12451556|FG001|Overall Study|Protocol Violation|1
7924758|NCT02217436|12451555|FG000|Overall Study|Incomplete data|0
7924759|NCT02217436|12451556|FG001|Overall Study|Incomplete data|1
7924760|NCT02217475|12451565|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
7924761|NCT02217475|12451566|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1
7924762|NCT02217475|12451567|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
7924763|NCT02217475|12451565|FG000|Treatment Period 1 (Year 1)|Adverse Event|4
7924764|NCT02217475|12451566|FG001|Treatment Period 1 (Year 1)|Adverse Event|5
7924765|NCT02217475|12451567|FG002|Treatment Period 1 (Year 1)|Adverse Event|9
7924766|NCT02217475|12451565|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1
7924767|NCT02217475|12451566|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0
7924768|NCT02217475|12451567|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0
7924769|NCT02217475|12451565|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5
7924770|NCT02217475|12451566|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2
7924771|NCT02217475|12451567|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11
7924772|NCT02217475|12451565|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
7924773|NCT02217475|12451566|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
7924774|NCT02217475|12451567|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1
7924775|NCT02217475|12451565|FG000|Discontinued After Period 1|Adverse Event|1
7924776|NCT02217475|12451566|FG001|Discontinued After Period 1|Adverse Event|2
7924777|NCT02217475|12451567|FG002|Discontinued After Period 1|Adverse Event|0
7924778|NCT02217475|12451565|FG000|Discontinued After Period 1|Participant Withdrew Consent|1
7924779|NCT02217475|12451566|FG001|Discontinued After Period 1|Participant Withdrew Consent|1
7924780|NCT02217475|12451567|FG002|Discontinued After Period 1|Participant Withdrew Consent|2
7924781|NCT02217475|12451565|FG000|Discontinued After Period 1|Physician Decision|0
7924782|NCT02217475|12451566|FG001|Discontinued After Period 1|Physician Decision|0
7924783|NCT02217475|12451567|FG002|Discontinued After Period 1|Physician Decision|1
7924784|NCT02217475|12451565|FG000|Treatment Period 2 (Year 2)|Adverse Event|0
7924785|NCT02217475|12451566|FG001|Treatment Period 2 (Year 2)|Adverse Event|1
7924786|NCT02217475|12451567|FG002|Treatment Period 2 (Year 2)|Adverse Event|5
7924787|NCT02217475|12451565|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0
7924788|NCT02217475|12451566|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1
7924789|NCT02217475|12451567|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2
7924790|NCT02217475|12451565|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
7924791|NCT02217475|12451566|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0
7924792|NCT02217475|12451567|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
7924793|NCT02217475|12451565|FG000|Treatment Period 2 (Year 2)|Physician Decision|0
7924794|NCT02217475|12451566|FG001|Treatment Period 2 (Year 2)|Physician Decision|0
7924795|NCT02217475|12451567|FG002|Treatment Period 2 (Year 2)|Physician Decision|2
7924796|NCT02217475|12451565|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
7924797|NCT02217475|12451566|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
7924798|NCT02217475|12451567|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1
7924799|NCT02217501|12451586|FG000|Overall Study|Death|3
7924800|NCT02217501|12451587|FG001|Overall Study|Death|4
7924801|NCT02217527|12451595|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
7924802|NCT02217527|12451596|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
7924803|NCT02217527|12451595|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
7924804|NCT02217527|12451596|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
7924805|NCT02217566|12451602|FG000|Overall Study|Lost to Follow-up|2
7924806|NCT02217566|12451602|FG000|Overall Study|Death|3
7924807|NCT02217566|12451602|FG000|Overall Study|Early study termination|6
7924808|NCT02217878|12451624|FG000|Overall Study|required morphine due to chest pain|1
7924809|NCT02217878|12451625|FG001|Overall Study|required morphine due to chest pain|2
7924810|NCT02217878|12451624|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1
7924811|NCT02217878|12451625|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0
7924812|NCT02217982|12451656|FG000|Overall Study|Trial discontinued|1
7924813|NCT02217982|12451657|FG001|Overall Study|Trial discontinued|0
7924814|NCT02217982|12451656|FG000|Overall Study|Adverse Event|0
7924815|NCT02217982|12451657|FG001|Overall Study|Adverse Event|1
7924816|NCT02218008|12451666|FG000|Stage 1 (S1)|Adverse Event|6
7924817|NCT02218008|12451667|FG001|Stage 1 (S1)|Adverse Event|5
7924818|NCT02218008|12451668|FG002|Stage 1 (S1)|Adverse Event|11
7924819|NCT02218008|12451669|FG003|Stage 1 (S1)|Adverse Event|0
7924820|NCT02218008|12451670|FG004|Stage 1 (S1)|Adverse Event|0
7924821|NCT02218008|12451671|FG005|Stage 1 (S1)|Adverse Event|0
7924822|NCT02218008|12451666|FG000|Stage 1 (S1)|Withdrawal by Subject|6
7924823|NCT02218008|12451667|FG001|Stage 1 (S1)|Withdrawal by Subject|1
7924824|NCT02218008|12451668|FG002|Stage 1 (S1)|Withdrawal by Subject|1
7924825|NCT02218008|12451669|FG003|Stage 1 (S1)|Withdrawal by Subject|0
7924826|NCT02218008|12451670|FG004|Stage 1 (S1)|Withdrawal by Subject|0
7924827|NCT02218008|12451671|FG005|Stage 1 (S1)|Withdrawal by Subject|0
7924828|NCT02218008|12451666|FG000|Stage 1 (S1)|Lack of Efficacy|3
7924829|NCT02218008|12451667|FG001|Stage 1 (S1)|Lack of Efficacy|0
7924830|NCT02218008|12451668|FG002|Stage 1 (S1)|Lack of Efficacy|0
7924831|NCT02218008|12451669|FG003|Stage 1 (S1)|Lack of Efficacy|0
7924832|NCT02218008|12451670|FG004|Stage 1 (S1)|Lack of Efficacy|0
7924833|NCT02218008|12451671|FG005|Stage 1 (S1)|Lack of Efficacy|0
7924834|NCT02218008|12451666|FG000|Stage 1 (S1)|Lost to Follow-up|3
7924835|NCT02218008|12451667|FG001|Stage 1 (S1)|Lost to Follow-up|0
7924836|NCT02218008|12451668|FG002|Stage 1 (S1)|Lost to Follow-up|1
7924837|NCT02218008|12451669|FG003|Stage 1 (S1)|Lost to Follow-up|0
7924838|NCT02218008|12451670|FG004|Stage 1 (S1)|Lost to Follow-up|0
7924839|NCT02218008|12451671|FG005|Stage 1 (S1)|Lost to Follow-up|0
7924840|NCT02218008|12451666|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2
7924841|NCT02218008|12451667|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1
7924842|NCT02218008|12451668|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0
7924843|NCT02218008|12451669|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0
7924844|NCT02218008|12451670|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0
7924845|NCT02218008|12451671|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0
7924846|NCT02218008|12451666|FG000|Stage 1 (S1)|Non-compliance; drug use|1
7924847|NCT02218008|12451667|FG001|Stage 1 (S1)|Non-compliance; drug use|0
7924848|NCT02218008|12451668|FG002|Stage 1 (S1)|Non-compliance; drug use|0
7924849|NCT02218008|12451669|FG003|Stage 1 (S1)|Non-compliance; drug use|0
7924850|NCT02218008|12451670|FG004|Stage 1 (S1)|Non-compliance; drug use|0
7924851|NCT02218008|12451671|FG005|Stage 1 (S1)|Non-compliance; drug use|0
7924852|NCT02218008|12451666|FG000|Stage 1 (S1)|Pregnancy|0
7924853|NCT02218008|12451667|FG001|Stage 1 (S1)|Pregnancy|0
7924854|NCT02218008|12451668|FG002|Stage 1 (S1)|Pregnancy|1
7924855|NCT02218008|12451669|FG003|Stage 1 (S1)|Pregnancy|0
7924856|NCT02218008|12451670|FG004|Stage 1 (S1)|Pregnancy|0
7924857|NCT02218008|12451671|FG005|Stage 1 (S1)|Pregnancy|0
7924858|NCT02218008|12451666|FG000|Stage 1 (S1)|Protocol Violation|0
7924859|NCT02218008|12451667|FG001|Stage 1 (S1)|Protocol Violation|0
7924860|NCT02218008|12451668|FG002|Stage 1 (S1)|Protocol Violation|1
7924861|NCT02218008|12451669|FG003|Stage 1 (S1)|Protocol Violation|0
7924862|NCT02218008|12451670|FG004|Stage 1 (S1)|Protocol Violation|0
7924863|NCT02218008|12451671|FG005|Stage 1 (S1)|Protocol Violation|0
7924864|NCT02218008|12451666|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1
7924865|NCT02218008|12451667|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7924866|NCT02218008|12451668|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7924867|NCT02218008|12451669|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7924868|NCT02218008|12451670|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7924869|NCT02218008|12451671|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7924870|NCT02218008|12451666|FG000|Stage 2 (S2)|Adverse Event|0
7924871|NCT02218008|12451667|FG001|Stage 2 (S2)|Adverse Event|0
7924872|NCT02218008|12451668|FG002|Stage 2 (S2)|Adverse Event|0
7924873|NCT02218008|12451669|FG003|Stage 2 (S2)|Adverse Event|2
7924874|NCT02218008|12451670|FG004|Stage 2 (S2)|Adverse Event|3
7924875|NCT02218008|12451671|FG005|Stage 2 (S2)|Adverse Event|3
7924876|NCT02218008|12451666|FG000|Stage 2 (S2)|Withdrawal by Subject|0
7924877|NCT02218008|12451667|FG001|Stage 2 (S2)|Withdrawal by Subject|0
7924878|NCT02218008|12451668|FG002|Stage 2 (S2)|Withdrawal by Subject|0
7924879|NCT02218008|12451669|FG003|Stage 2 (S2)|Withdrawal by Subject|1
7924880|NCT02218008|12451670|FG004|Stage 2 (S2)|Withdrawal by Subject|1
7924881|NCT02218008|12451671|FG005|Stage 2 (S2)|Withdrawal by Subject|0
7924882|NCT02218008|12451666|FG000|Stage 2 (S2)|Lack of Efficacy|0
7924883|NCT02218008|12451667|FG001|Stage 2 (S2)|Lack of Efficacy|0
7924884|NCT02218008|12451668|FG002|Stage 2 (S2)|Lack of Efficacy|0
7924885|NCT02218008|12451669|FG003|Stage 2 (S2)|Lack of Efficacy|0
7924886|NCT02218008|12451670|FG004|Stage 2 (S2)|Lack of Efficacy|0
7924887|NCT02218008|12451671|FG005|Stage 2 (S2)|Lack of Efficacy|2
7924888|NCT02218008|12451666|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7924889|NCT02218008|12451667|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7924890|NCT02218008|12451668|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7924891|NCT02218008|12451669|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1
7924892|NCT02218008|12451670|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7924893|NCT02218008|12451671|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7924894|NCT02218008|12451666|FG000|Stage 2 (S2)|Lost to Follow-up|0
7924895|NCT02218008|12451667|FG001|Stage 2 (S2)|Lost to Follow-up|0
7924896|NCT02218008|12451668|FG002|Stage 2 (S2)|Lost to Follow-up|0
7924897|NCT02218008|12451669|FG003|Stage 2 (S2)|Lost to Follow-up|0
7924898|NCT02218008|12451670|FG004|Stage 2 (S2)|Lost to Follow-up|0
7924899|NCT02218008|12451671|FG005|Stage 2 (S2)|Lost to Follow-up|1
7924900|NCT02218216|12451718|FG000|Overall Study|Study terminated before completed|6
7924901|NCT02218216|12451719|FG001|Overall Study|Study terminated before completed|0
7924902|NCT02218216|12451720|FG002|Overall Study|Study terminated before completed|0
7924903|NCT02218268|12451732|FG000|24 Hour Washout|Physician Decision|11
7924904|NCT02218268|12451733|FG001|24 Hour Washout|Physician Decision|9
7924905|NCT02218372|12451759|FG000|Overall Study|Adverse Event|1
7924906|NCT02218372|12451760|FG001|Overall Study|Adverse Event|1
7924907|NCT02218372|12451759|FG000|Overall Study|Miscellaneous|2
7924908|NCT02218372|12451760|FG001|Overall Study|Miscellaneous|1
7924909|NCT02218372|12451759|FG000|Overall Study|Randomized but did not receive treatment|2
7924910|NCT02218372|12451760|FG001|Overall Study|Randomized but did not receive treatment|3
7924911|NCT02218372|12451759|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7924912|NCT02218372|12451760|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7924913|NCT02218489|12451791|FG000|Overall Study|Withdrawal by Subject|4
7924914|NCT02218489|12451792|FG001|Overall Study|Withdrawal by Subject|3
7924915|NCT02218489|12451791|FG000|Overall Study|Lost to Follow-up|1
7924916|NCT02218489|12451792|FG001|Overall Study|Lost to Follow-up|0
7924917|NCT02218541|12451801|FG000|Overall Study|Lost to Follow-up|2
7924918|NCT02218541|12451802|FG001|Overall Study|Lost to Follow-up|1
7924919|NCT02218541|12451801|FG000|Overall Study|Implant Failure|4
7924920|NCT02218541|12451802|FG001|Overall Study|Implant Failure|1
7924921|NCT02218736|12451811|FG000|Overall Study|Withdrawal by Subject|10
7924922|NCT02218736|12451812|FG001|Overall Study|Withdrawal by Subject|9
7924923|NCT02218736|12451811|FG000|Overall Study|Protocol Violation|2
7924924|NCT02218736|12451812|FG001|Overall Study|Protocol Violation|0
7924925|NCT02219009|12451820|FG000|Overall Study|Withdrawal by Subject|5
7924926|NCT02219009|12451821|FG001|Overall Study|Withdrawal by Subject|1
7924927|NCT02219009|12451820|FG000|Overall Study|Adverse Event|2
7924928|NCT02219009|12451821|FG001|Overall Study|Adverse Event|4
7924929|NCT02219009|12451820|FG000|Overall Study|Lost to Follow-up|2
7924930|NCT02219009|12451821|FG001|Overall Study|Lost to Follow-up|2
7924931|NCT02219009|12451820|FG000|Overall Study|Protocol deviation|1
7924932|NCT02219009|12451821|FG001|Overall Study|Protocol deviation|0
7924933|NCT02219009|12451820|FG000|Overall Study|Physician Decision|0
7924934|NCT02219009|12451821|FG001|Overall Study|Physician Decision|1
7924935|NCT02219048|12451829|FG000|Overall Study|Adverse Event|2
7924936|NCT02219048|12451830|FG001|Overall Study|Adverse Event|5
7924937|NCT02219048|12451829|FG000|Overall Study|No longer meets eligibility criteria|1
7924938|NCT02219048|12451830|FG001|Overall Study|No longer meets eligibility criteria|0
7924939|NCT02219048|12451829|FG000|Overall Study|Study terminated by sponsor|16
7924940|NCT02219048|12451830|FG001|Overall Study|Study terminated by sponsor|15
7924941|NCT02219048|12451829|FG000|Overall Study|Withdrawal by Subject|2
7924942|NCT02219048|12451830|FG001|Overall Study|Withdrawal by Subject|0
7924943|NCT02219048|12451829|FG000|Overall Study|Other|0
7924944|NCT02219048|12451830|FG001|Overall Study|Other|1
7924945|NCT02219087|12451838|FG000|Overall Study|Randomization envelope pulled out of seq|0
7924946|NCT02219087|12451839|FG001|Overall Study|Randomization envelope pulled out of seq|1
7924947|NCT02219308|12451909|FG000|Overall Study|Withdrawal by Subject|1
7924948|NCT02219308|12451910|FG001|Overall Study|Withdrawal by Subject|2
7924949|NCT02219334|12451927|FG000|Overall Study|Withdrawal by Subject|1
7924950|NCT02219334|12451928|FG001|Overall Study|Withdrawal by Subject|0
7924951|NCT02219334|12451927|FG000|Overall Study|Protocol Violation|7
7924952|NCT02219334|12451928|FG001|Overall Study|Protocol Violation|3
7924953|NCT02219464|12451947|FG000|Overall Study|Withdrawal by Subject|1
7924954|NCT02219464|12451948|FG001|Overall Study|Withdrawal by Subject|0
7924955|NCT02219464|12451947|FG000|Overall Study|case cancelled|1
7924956|NCT02219464|12451948|FG001|Overall Study|case cancelled|0
7924957|NCT02219464|12451947|FG000|Overall Study|catheter malfunction|1
7924958|NCT02219464|12451948|FG001|Overall Study|catheter malfunction|0
7924959|NCT02219477|12451957|FG000|Overall Study|Adverse Event|0
7924960|NCT02219477|12451958|FG001|Overall Study|Adverse Event|1
7924961|NCT02219477|12451959|FG002|Overall Study|Adverse Event|1
7924962|NCT02219477|12451957|FG000|Overall Study|Withdrawal by Subject|0
7924963|NCT02219477|12451958|FG001|Overall Study|Withdrawal by Subject|1
7924964|NCT02219477|12451959|FG002|Overall Study|Withdrawal by Subject|0
7924965|NCT02219685|12451991|FG000|Blinded Treatment Phase|Lost to Follow-up|1
7924966|NCT02219685|12451992|FG001|Blinded Treatment Phase|Lost to Follow-up|0
7924967|NCT02219685|12451991|FG000|Blinded Treatment Phase|Withdrew Consent|1
7924968|NCT02219685|12451992|FG001|Blinded Treatment Phase|Withdrew Consent|0
7924969|NCT02219932|12452011|FG000|Overall Study|Other|5
7924970|NCT02219932|12452012|FG001|Overall Study|Other|11
7924971|NCT02219932|12452011|FG000|Overall Study|Death|1
7924972|NCT02219932|12452012|FG001|Overall Study|Death|1
7924973|NCT02219932|12452011|FG000|Overall Study|Investigator Decision|0
7924974|NCT02219932|12452012|FG001|Overall Study|Investigator Decision|1
7924975|NCT02219932|12452011|FG000|Overall Study|Consent Withdrawn|11
7924976|NCT02219932|12452012|FG001|Overall Study|Consent Withdrawn|7
7924977|NCT02219932|12452011|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10
7924978|NCT02219932|12452012|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2
7924979|NCT02219932|12452011|FG000|Overall Study|Protocol Violation|10
7924980|NCT02219932|12452012|FG001|Overall Study|Protocol Violation|6
7924981|NCT02219932|12452011|FG000|Overall Study|Pregnancy|1
7924982|NCT02219932|12452012|FG001|Overall Study|Pregnancy|0
7924983|NCT02219932|12452011|FG000|Overall Study|Lost to Follow-up|4
7924984|NCT02219932|12452012|FG001|Overall Study|Lost to Follow-up|2
7924985|NCT02219932|12452011|FG000|Overall Study|Adverse Event|23
7924986|NCT02219932|12452012|FG001|Overall Study|Adverse Event|21
7924987|NCT02220205|12452035|FG000|Overall Study|Withdrawal by Subject|1
7924988|NCT02220205|12452036|FG001|Overall Study|Withdrawal by Subject|0
7924989|NCT02220712|12452042|FG000|Overall Study|Adverse Event|1
7924990|NCT02220712|12452042|FG000|Overall Study|Withdrawal by Subject|2
7924991|NCT02220712|12452042|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1
7924992|NCT02220725|12452054|FG000|Overall Study|Lost to Follow-up|0
7924993|NCT02220725|12452055|FG001|Overall Study|Lost to Follow-up|0
7924994|NCT02220725|12452056|FG002|Overall Study|Lost to Follow-up|0
7924995|NCT02220725|12452057|FG003|Overall Study|Lost to Follow-up|1
7924996|NCT02220725|12452054|FG000|Overall Study|Withdrawal by Subject|0
7924997|NCT02220725|12452055|FG001|Overall Study|Withdrawal by Subject|0
7924998|NCT02220725|12452056|FG002|Overall Study|Withdrawal by Subject|0
7924999|NCT02220725|12452057|FG003|Overall Study|Withdrawal by Subject|1
7925000|NCT02220764|12452072|FG000|Overall Study|Lost to Follow-up|3
7925001|NCT02220764|12452073|FG001|Overall Study|Lost to Follow-up|1
7925002|NCT02220764|12452072|FG000|Overall Study|Death|1
7925003|NCT02220764|12452073|FG001|Overall Study|Death|0
7925004|NCT02220907|12452079|FG000|Overall Study|Adverse Event|7
7925005|NCT02220907|12452079|FG000|Overall Study|Physician Decision|1
7925006|NCT02220907|12452079|FG000|Overall Study|Withdrawal by Subject|2
7925007|NCT02220907|12452079|FG000|Overall Study|Conflict with the stopping criteria|1
7925008|NCT02220920|12452085|FG000|Overall Study|Adverse Event|1
7925009|NCT02220920|12452086|FG001|Overall Study|Adverse Event|0
7925010|NCT02220920|12452085|FG000|Overall Study|Lack of Efficacy|0
7925011|NCT02220920|12452086|FG001|Overall Study|Lack of Efficacy|1
7925012|NCT02220920|12452085|FG000|Overall Study|Withdrawal by Subject|1
7925013|NCT02220920|12452086|FG001|Overall Study|Withdrawal by Subject|0
7925014|NCT02220920|12452085|FG000|Overall Study|Conflict with the stopping criteria|1
7925015|NCT02220920|12452086|FG001|Overall Study|Conflict with the stopping criteria|2
7925016|NCT02220998|12452094|FG000|Overall Study|Randomized but Never Treated|1
7925017|NCT02220998|12452095|FG001|Overall Study|Randomized but Never Treated|2
7925018|NCT02220998|12452094|FG000|Overall Study|Death|2
7925019|NCT02220998|12452095|FG001|Overall Study|Death|0
7925020|NCT02220998|12452094|FG000|Overall Study|Lack of Efficacy|0
7925021|NCT02220998|12452095|FG001|Overall Study|Lack of Efficacy|5
7925022|NCT02220998|12452094|FG000|Overall Study|Lost to Follow-up|4
7925023|NCT02220998|12452095|FG001|Overall Study|Lost to Follow-up|4
7925024|NCT02221284|12452122|FG000|Overall Study|Case Report Forms Uncollected|56
7925025|NCT02221284|12452122|FG000|Overall Study|Protocol Deviation|5
7925026|NCT02221648|12452147|FG000|Overall Study|Withdrawal by Subject|3
7925027|NCT02221648|12452148|FG001|Overall Study|Withdrawal by Subject|3
7925028|NCT02221674|12452161|FG000|Overall Study|Lost to Follow-up|1
7925029|NCT02221674|12452162|FG001|Overall Study|Lost to Follow-up|0
7821969|NCT01259297|12290955|FG006|Double Blind Randomized Period|Death|2
7821970|NCT01259297|12290956|FG007|Double Blind Randomized Period|Death|1
7821971|NCT01259297|12290949|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
7821972|NCT01259297|12290950|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
7821973|NCT01259297|12290951|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
7925030|NCT02221674|12452163|FG002|Overall Study|Lost to Follow-up|0
7925031|NCT02221882|12452195|FG000|Overall Study|Withdrawal by Subject|0
7925032|NCT02221882|12452196|FG001|Overall Study|Withdrawal by Subject|0
7925033|NCT02221882|12452197|FG002|Overall Study|Withdrawal by Subject|4
7925034|NCT02221882|12452198|FG003|Overall Study|Withdrawal by Subject|2
7925035|NCT02221882|12452199|FG004|Overall Study|Withdrawal by Subject|2
7925036|NCT02221882|12452200|FG005|Overall Study|Withdrawal by Subject|2
7925037|NCT02221882|12452195|FG000|Overall Study|Death|0
7925038|NCT02221882|12452196|FG001|Overall Study|Death|1
7925039|NCT02221882|12452197|FG002|Overall Study|Death|0
7925040|NCT02221882|12452198|FG003|Overall Study|Death|0
7925041|NCT02221882|12452199|FG004|Overall Study|Death|0
7925042|NCT02221882|12452200|FG005|Overall Study|Death|0
7925043|NCT02222207|12452244|FG000|Overall Study|Death|1
7925044|NCT02222207|12452244|FG000|Overall Study|Other reasons|2
7925045|NCT02222207|12452244|FG000|Overall Study|Adverse Event|1
7925046|NCT02222246|12452250|FG000|Overall Study|No Emergency Department Visits|27
7925047|NCT02222246|12452251|FG001|Overall Study|No Emergency Department Visits|26
7925048|NCT02222246|12452250|FG000|Overall Study|Physician Decision|0
7925049|NCT02222246|12452251|FG001|Overall Study|Physician Decision|1
7925050|NCT02222493|12452274|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
7925051|NCT02222493|12452275|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
7925052|NCT02222493|12452274|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
7925053|NCT02222493|12452275|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
7925054|NCT02222493|12452274|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
7925055|NCT02222493|12452275|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
7925056|NCT02222493|12452274|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
7925057|NCT02222493|12452275|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
7925058|NCT02222493|12452274|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
7925059|NCT02222493|12452275|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
7925060|NCT02222493|12452274|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
7925061|NCT02222493|12452275|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
7925062|NCT02222493|12452274|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
7925063|NCT02222493|12452275|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
7925064|NCT02222493|12452274|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
7925065|NCT02222493|12452275|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
7925066|NCT02222493|12452274|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
7925067|NCT02222493|12452275|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
7925068|NCT02222493|12452274|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
7925069|NCT02222493|12452275|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
7925070|NCT02222493|12452274|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
7925071|NCT02222493|12452275|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
7925072|NCT02222493|12452274|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
7925073|NCT02222493|12452275|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
7925074|NCT02222493|12452274|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
7925075|NCT02222493|12452275|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
7925076|NCT02222493|12452274|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
7925077|NCT02222493|12452275|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
7925078|NCT02222493|12452274|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
7925079|NCT02222493|12452275|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
7925080|NCT02222493|12452274|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
7925081|NCT02222493|12452275|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
7925082|NCT02222493|12452274|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
7925083|NCT02222493|12452275|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
7925084|NCT02222493|12452274|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
7925085|NCT02222493|12452275|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
7925086|NCT02222493|12452274|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
7925087|NCT02222493|12452275|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
7925088|NCT02222493|12452274|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
7925089|NCT02222493|12452275|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
7925090|NCT02222493|12452274|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
7925091|NCT02222493|12452275|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
7925092|NCT02222493|12452274|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
7925093|NCT02222493|12452275|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
7925094|NCT02222558|12452294|FG000|Period 1: Single Dose|Withdrawal by Subject|4
7925095|NCT02222558|12452295|FG001|Period 1: Single Dose|Withdrawal by Subject|0
7925096|NCT02222558|12452296|FG002|Period 1: Single Dose|Withdrawal by Subject|0
7925097|NCT02222558|12452297|FG003|Period 1: Single Dose|Withdrawal by Subject|0
7925098|NCT02222558|12452298|FG004|Period 1: Single Dose|Withdrawal by Subject|0
7925099|NCT02222558|12452299|FG005|Period 1: Single Dose|Withdrawal by Subject|0
7925100|NCT02222558|12452294|FG000|Period 3|Withdrawal by Subject|0
7925101|NCT02222558|12452295|FG001|Period 3|Withdrawal by Subject|0
7925102|NCT02222558|12452296|FG002|Period 3|Withdrawal by Subject|0
7925103|NCT02222558|12452297|FG003|Period 3|Withdrawal by Subject|0
7925104|NCT02222558|12452298|FG004|Period 3|Withdrawal by Subject|0
7925105|NCT02222558|12452299|FG005|Period 3|Withdrawal by Subject|1
7925106|NCT02222688|12452333|FG000|Overall Study|Withdrawal by Subject|0
7925107|NCT02222688|12452334|FG001|Overall Study|Withdrawal by Subject|0
7925108|NCT02222688|12452335|FG002|Overall Study|Withdrawal by Subject|0
7925109|NCT02222688|12452336|FG003|Overall Study|Withdrawal by Subject|2
7925110|NCT02222688|12452337|FG004|Overall Study|Withdrawal by Subject|1
7925111|NCT02222688|12452338|FG005|Overall Study|Withdrawal by Subject|0
7925112|NCT02222688|12452339|FG006|Overall Study|Withdrawal by Subject|1
7925113|NCT02222688|12452333|FG000|Overall Study|Disease progression|1
7925114|NCT02222688|12452334|FG001|Overall Study|Disease progression|0
7925115|NCT02222688|12452335|FG002|Overall Study|Disease progression|0
7925116|NCT02222688|12452336|FG003|Overall Study|Disease progression|0
7925117|NCT02222688|12452337|FG004|Overall Study|Disease progression|0
7925118|NCT02222688|12452338|FG005|Overall Study|Disease progression|0
7925119|NCT02222688|12452339|FG006|Overall Study|Disease progression|0
7925120|NCT02222714|12452362|FG000|Overall Study|Death|0
7925121|NCT02222714|12452363|FG001|Overall Study|Death|2
7925122|NCT02222714|12452364|FG002|Overall Study|Death|3
7925123|NCT02222714|12452365|FG003|Overall Study|Death|4
7925124|NCT02222714|12452366|FG004|Overall Study|Death|6
7925125|NCT02222714|12452362|FG000|Overall Study|Withdrawal by Subject|0
7925126|NCT02222714|12452363|FG001|Overall Study|Withdrawal by Subject|0
7925127|NCT02222714|12452364|FG002|Overall Study|Withdrawal by Subject|1
7925128|NCT02222714|12452365|FG003|Overall Study|Withdrawal by Subject|0
7925129|NCT02222714|12452366|FG004|Overall Study|Withdrawal by Subject|1
7925130|NCT02222818|12452383|FG000|Period 1|Eligibility criteria not met|0
7925131|NCT02222818|12452384|FG001|Period 1|Eligibility criteria not met|3
7925132|NCT02222896|12452398|FG000|Abdomen|Did not qualify|34
7925133|NCT02222896|12452399|FG001|Abdomen|Did not qualify|10
7925134|NCT02222896|12452400|FG002|Abdomen|Did not qualify|32
7925135|NCT02222896|12452398|FG000|Groin|Did not qualify|43
7925136|NCT02222896|12452399|FG001|Groin|Did not qualify|9
7925137|NCT02222896|12452400|FG002|Groin|Did not qualify|40
7925138|NCT02222922|12452420|FG000|Overall Study|Death|0
7925139|NCT02222922|12452421|FG001|Overall Study|Death|0
7925140|NCT02222922|12452422|FG002|Overall Study|Death|0
7925141|NCT02222922|12452423|FG003|Overall Study|Death|0
7925142|NCT02222922|12452424|FG004|Overall Study|Death|13
7925143|NCT02222922|12452425|FG005|Overall Study|Death|0
7925144|NCT02222922|12452426|FG006|Overall Study|Death|0
7925145|NCT02222922|12452427|FG007|Overall Study|Death|0
7925146|NCT02222922|12452428|FG008|Overall Study|Death|2
7925147|NCT02222922|12452420|FG000|Overall Study|Lost to Follow-up|0
7925148|NCT02222922|12452421|FG001|Overall Study|Lost to Follow-up|0
7925149|NCT02222922|12452422|FG002|Overall Study|Lost to Follow-up|1
7925150|NCT02222922|12452423|FG003|Overall Study|Lost to Follow-up|0
7925151|NCT02222922|12452424|FG004|Overall Study|Lost to Follow-up|9
7925152|NCT02222922|12452425|FG005|Overall Study|Lost to Follow-up|1
7925153|NCT02222922|12452426|FG006|Overall Study|Lost to Follow-up|0
7925154|NCT02222922|12452427|FG007|Overall Study|Lost to Follow-up|0
7925155|NCT02222922|12452428|FG008|Overall Study|Lost to Follow-up|0
7925156|NCT02222922|12452420|FG000|Overall Study|Other|0
7925157|NCT02222922|12452421|FG001|Overall Study|Other|0
7925158|NCT02222922|12452422|FG002|Overall Study|Other|0
7925159|NCT02222922|12452423|FG003|Overall Study|Other|2
7925160|NCT02222922|12452424|FG004|Overall Study|Other|10
7925161|NCT02222922|12452425|FG005|Overall Study|Other|2
7925162|NCT02222922|12452426|FG006|Overall Study|Other|2
7925163|NCT02222922|12452427|FG007|Overall Study|Other|4
7925164|NCT02222922|12452428|FG008|Overall Study|Other|1
7925165|NCT02222922|12452420|FG000|Overall Study|Participant refused further follow-up|1
7925166|NCT02222922|12452421|FG001|Overall Study|Participant refused further follow-up|0
7925167|NCT02222922|12452422|FG002|Overall Study|Participant refused further follow-up|0
7925168|NCT02222922|12452423|FG003|Overall Study|Participant refused further follow-up|1
7925169|NCT02222922|12452424|FG004|Overall Study|Participant refused further follow-up|6
7925170|NCT02222922|12452425|FG005|Overall Study|Participant refused further follow-up|0
7925171|NCT02222922|12452426|FG006|Overall Study|Participant refused further follow-up|0
7925172|NCT02222922|12452427|FG007|Overall Study|Participant refused further follow-up|0
7925173|NCT02222922|12452428|FG008|Overall Study|Participant refused further follow-up|3
7925174|NCT02223364|12452504|FG000|Overall Study|Protocol Violation|3
7925175|NCT02223364|12452505|FG001|Overall Study|Protocol Violation|0
7925176|NCT02223364|12452506|FG002|Overall Study|Protocol Violation|3
7925177|NCT02223364|12452504|FG000|Overall Study|subject expired before surgery|1
7925178|NCT02223364|12452505|FG001|Overall Study|subject expired before surgery|0
7925179|NCT02223364|12452506|FG002|Overall Study|subject expired before surgery|0
7925180|NCT02223364|12452504|FG000|Overall Study|Physician Decision|1
7925181|NCT02223364|12452505|FG001|Overall Study|Physician Decision|0
7925182|NCT02223364|12452506|FG002|Overall Study|Physician Decision|0
7925183|NCT02223390|12452516|FG000|Overall Study|Lost to Follow-up|9
7925184|NCT02223390|12452517|FG001|Overall Study|Lost to Follow-up|4
7925185|NCT02223715|12452592|FG000|Overall Study|Death|31
7925186|NCT02223715|12452592|FG000|Overall Study|Lost to Follow-up|73
7925187|NCT02223754|12452601|FG000|Period 1|Adverse Event|1
7925188|NCT02223754|12452602|FG001|Period 1|Adverse Event|0
7925189|NCT02223754|12452601|FG000|Period 1|Lost to Follow-up|0
7925190|NCT02223754|12452602|FG001|Period 1|Lost to Follow-up|1
7925191|NCT02223754|12452601|FG000|Period 1|Protocol Violation|2
7925192|NCT02223754|12452602|FG001|Period 1|Protocol Violation|4
7925193|NCT02223754|12452601|FG000|Period 1|Withdrawal by Subject|0
7925194|NCT02223754|12452602|FG001|Period 1|Withdrawal by Subject|4
7925195|NCT02223754|12452601|FG000|Period 1|Test Article No Longer Available|1
7925196|NCT02223754|12452602|FG001|Period 1|Test Article No Longer Available|5
7925197|NCT02223754|12452601|FG000|Period 1|Unsatisfactory Visual Response|0
7925198|NCT02223754|12452602|FG001|Period 1|Unsatisfactory Visual Response|1
7925199|NCT02223754|12452601|FG000|Period 2|Adverse Event|0
7925200|NCT02223754|12452602|FG001|Period 2|Adverse Event|1
7925201|NCT02223754|12452601|FG000|Period 2|Protocol Violation|1
7925202|NCT02223754|12452602|FG001|Period 2|Protocol Violation|0
7925203|NCT02223754|12452601|FG000|Period 2|Lens Discomfort|1
7925204|NCT02223754|12452602|FG001|Period 2|Lens Discomfort|1
7925205|NCT02223754|12452601|FG000|Period 2|Lost to Follow-up|1
7925206|NCT02223754|12452602|FG001|Period 2|Lost to Follow-up|0
7925207|NCT02223754|12452601|FG000|Period 2|Test Article No Longer Available|0
7925208|NCT02223754|12452602|FG001|Period 2|Test Article No Longer Available|1
7925209|NCT02223793|12452612|FG000|Overall Study|Lost to Follow-up|10
7925210|NCT02223793|12452613|FG001|Overall Study|Lost to Follow-up|1
7925211|NCT02223793|12452614|FG002|Overall Study|Lost to Follow-up|2
7925212|NCT02223793|12452612|FG000|Overall Study|Withdrawal by Subject|3
7925213|NCT02223793|12452613|FG001|Overall Study|Withdrawal by Subject|2
7925214|NCT02223793|12452614|FG002|Overall Study|Withdrawal by Subject|3
7925215|NCT02223793|12452612|FG000|Overall Study|Moved/studycenter unable to participate|4
7925216|NCT02223793|12452613|FG001|Overall Study|Moved/studycenter unable to participate|6
7925217|NCT02223793|12452614|FG002|Overall Study|Moved/studycenter unable to participate|8
7925218|NCT02223858|12452624|FG000|Overall Study|Death|1
7925219|NCT02223858|12452625|FG001|Overall Study|Death|1
7925220|NCT02223858|12452624|FG000|Overall Study|Lost to Follow-up|6
7925221|NCT02223858|12452625|FG001|Overall Study|Lost to Follow-up|11
7925222|NCT02223858|12452624|FG000|Overall Study|Withdrawal by Subject|8
7925223|NCT02223858|12452625|FG001|Overall Study|Withdrawal by Subject|5
7925224|NCT02223858|12452624|FG000|Overall Study|Refused|9
7925225|NCT02223858|12452625|FG001|Overall Study|Refused|9
7925226|NCT02224053|12452635|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
7925227|NCT02224053|12452635|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
7925228|NCT02224053|12452635|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3
7925229|NCT02224053|12452635|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
7925230|NCT02224053|12452635|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
7964564|NCT01107626|12520031|FG003|Step 2: Maintenance Therapy|Pain|1
7964565|NCT01107626|12520028|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0
7964566|NCT01107626|12520029|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4
7964567|NCT01107626|12520030|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4
7964568|NCT01107626|12520031|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10
7964569|NCT00920387|12520042|FG000|Stage 1|Adverse Event|1
7964570|NCT00920387|12520043|FG001|Stage 1|Adverse Event|0
7964571|NCT00920387|12520044|FG002|Stage 1|Adverse Event|0
7966953|NCT02759315|12523454|FG001|Overall Study|Adverse Event|0
7966954|NCT02759315|12523455|FG002|Overall Study|Adverse Event|0
7966955|NCT02759315|12523456|FG003|Overall Study|Adverse Event|1
7966956|NCT02759315|12523457|FG004|Overall Study|Adverse Event|0
7966957|NCT02759315|12523453|FG000|Overall Study|Death|0
7966958|NCT02759315|12523454|FG001|Overall Study|Death|0
7966959|NCT02759315|12523455|FG002|Overall Study|Death|1
7966960|NCT02759315|12523456|FG003|Overall Study|Death|0
7966961|NCT02759315|12523457|FG004|Overall Study|Death|0
7966962|NCT02759315|12523453|FG000|Overall Study|Lost to Follow-up|2
7966963|NCT02759315|12523454|FG001|Overall Study|Lost to Follow-up|0
7966964|NCT02759315|12523455|FG002|Overall Study|Lost to Follow-up|4
7966965|NCT02759315|12523456|FG003|Overall Study|Lost to Follow-up|0
7966966|NCT02759315|12523457|FG004|Overall Study|Lost to Follow-up|0
7966967|NCT02759315|12523453|FG000|Overall Study|Protocol Violation|0
7966968|NCT02759315|12523454|FG001|Overall Study|Protocol Violation|1
7966969|NCT02759315|12523455|FG002|Overall Study|Protocol Violation|0
7966970|NCT02759315|12523456|FG003|Overall Study|Protocol Violation|0
7966971|NCT02759315|12523457|FG004|Overall Study|Protocol Violation|0
7966972|NCT02759315|12523453|FG000|Overall Study|Study terminated prior to completion|2
7966973|NCT02759315|12523454|FG001|Overall Study|Study terminated prior to completion|0
7966974|NCT02759315|12523455|FG002|Overall Study|Study terminated prior to completion|5
7966975|NCT02759315|12523456|FG003|Overall Study|Study terminated prior to completion|0
7966976|NCT02759315|12523457|FG004|Overall Study|Study terminated prior to completion|1
7966977|NCT02759471|12523490|FG000|Overall Study|discomfort|2
7966978|NCT02759562|12523498|FG000|Open-Label Treatment Period|Withdrew Consent|1
7966979|NCT02759562|12523499|FG001|Open-Label Treatment Period|Withdrew Consent|0
7966980|NCT02759562|12523498|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1
7966981|NCT02759562|12523499|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2
7966982|NCT02759692|12523510|FG000|Period 1|Test article no longer available|1
7966983|NCT02759692|12523511|FG001|Period 1|Test article no longer available|1
7966984|NCT02759692|12523510|FG000|Period 1|No longer meets eligibility criteria.|1
7966985|NCT02759692|12523511|FG001|Period 1|No longer meets eligibility criteria.|0
7966986|NCT02759692|12523510|FG000|Period 1|Miss-Randomized|1
7966987|NCT02759692|12523511|FG001|Period 1|Miss-Randomized|1
7925231|NCT02224157|12452643|FG000|Overall Study|Severe non-compliance to protocol|2
7925232|NCT02224157|12452644|FG001|Overall Study|Severe non-compliance to protocol|2
7925233|NCT02224157|12452643|FG000|Overall Study|Other|13
7925234|NCT02224157|12452644|FG001|Overall Study|Other|10
7925235|NCT02224157|12452643|FG000|Overall Study|Subject decision|58
7925236|NCT02224157|12452644|FG001|Overall Study|Subject decision|50
7925237|NCT02224157|12452643|FG000|Overall Study|Prematurely closed site|4
7925238|NCT02224157|12452644|FG001|Overall Study|Prematurely closed site|2
7925239|NCT02224157|12452643|FG000|Overall Study|Eligibility criteria not fulfilled|4
7925240|NCT02224157|12452644|FG001|Overall Study|Eligibility criteria not fulfilled|8
7925241|NCT02224157|12452643|FG000|Overall Study|Lost to Follow-up|27
7925242|NCT02224157|12452644|FG001|Overall Study|Lost to Follow-up|35
7925243|NCT02224157|12452643|FG000|Overall Study|Death|1
7925244|NCT02224157|12452644|FG001|Overall Study|Death|1
7925245|NCT02224157|12452643|FG000|Overall Study|Adverse Event|1
7925246|NCT02224157|12452644|FG001|Overall Study|Adverse Event|3
7925247|NCT02224274|12452652|FG000|Overall Study|Death|1
7925248|NCT02224274|12452653|FG001|Overall Study|Death|0
7925249|NCT02224625|12452700|FG000|Irritation|Adverse Event|6
7925250|NCT02224625|12452700|FG000|Sensitization|Adverse Event|55
7925251|NCT02224638|12452714|FG000|Overall Study|Adverse Event|1
7925252|NCT02224638|12452715|FG001|Overall Study|Adverse Event|1
7925253|NCT02224664|12452723|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5
7925254|NCT02224664|12452724|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7925255|NCT02224664|12452725|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7925256|NCT02224664|12452726|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7925257|NCT02224664|12452727|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7925258|NCT02224664|12452723|FG000|Dose Escalation Period (21 Days)|Adverse Event|0
7925259|NCT02224664|12452724|FG001|Dose Escalation Period (21 Days)|Adverse Event|0
7925260|NCT02224664|12452725|FG002|Dose Escalation Period (21 Days)|Adverse Event|2
7925261|NCT02224664|12452726|FG003|Dose Escalation Period (21 Days)|Adverse Event|2
7925262|NCT02224664|12452727|FG004|Dose Escalation Period (21 Days)|Adverse Event|7
7925263|NCT02224664|12452723|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
7925264|NCT02224664|12452724|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
7925265|NCT02224664|12452725|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
7925266|NCT02224664|12452726|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
7925267|NCT02224664|12452727|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
7925268|NCT02224846|12452753|FG000|Period 1 (Month 3)|Adverse Event|2
7925269|NCT02224846|12452754|FG001|Period 1 (Month 3)|Adverse Event|1
7925270|NCT02224846|12452753|FG000|Period 1 (Month 3)|Lost to Follow-up|3
7925271|NCT02224846|12452754|FG001|Period 1 (Month 3)|Lost to Follow-up|8
7925272|NCT02224846|12452753|FG000|Period 1 (Month 3)|Protocol Violation|4
7925273|NCT02224846|12452754|FG001|Period 1 (Month 3)|Protocol Violation|8
7925274|NCT02224846|12452753|FG000|Period 1 (Month 3)|Withdrawal by Subject|8
7925275|NCT02224846|12452754|FG001|Period 1 (Month 3)|Withdrawal by Subject|18
7925276|NCT02224846|12452753|FG000|Period 1 (Month 3)|Sponsor Decision|2
7925277|NCT02224846|12452754|FG001|Period 1 (Month 3)|Sponsor Decision|1
7925278|NCT02224846|12452753|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1
7925279|NCT02224846|12452754|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2
7925280|NCT02224846|12452753|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
7925281|NCT02224846|12452754|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
7925282|NCT02224846|12452753|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0
7925283|NCT02224846|12452754|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3
7925284|NCT02224846|12452753|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
7925285|NCT02224846|12452754|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
7925286|NCT02224846|12452753|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0
7925287|NCT02224846|12452754|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2
7925288|NCT02224846|12452753|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3
7925289|NCT02224846|12452754|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4
7925290|NCT02224846|12452753|FG000|Period 2 (Month 12 to Month 24)|Death|1
7925291|NCT02224846|12452754|FG001|Period 2 (Month 12 to Month 24)|Death|0
7925292|NCT02224846|12452753|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
7925293|NCT02224846|12452754|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
7925294|NCT02224846|12452753|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4
7925295|NCT02224846|12452754|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11
7925296|NCT02224846|12452753|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
7925297|NCT02224846|12452754|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
7925298|NCT02224846|12452753|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0
7925299|NCT02224846|12452754|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2
7925300|NCT02224846|12452753|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
7925301|NCT02224846|12452754|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
7925302|NCT02225223|12452774|FG000|Overall Study|Death|10
7925303|NCT02225223|12452775|FG001|Overall Study|Death|1
7925304|NCT02225223|12452774|FG000|Overall Study|Lost to Follow-up|5
7925305|NCT02225223|12452775|FG001|Overall Study|Lost to Follow-up|0
7925306|NCT02225223|12452774|FG000|Overall Study|Other|1
7925307|NCT02225223|12452775|FG001|Overall Study|Other|2
7925308|NCT02225223|12452774|FG000|Overall Study|Physician Decision|1
7925309|NCT02225223|12452775|FG001|Overall Study|Physician Decision|0
7925310|NCT02225223|12452774|FG000|Overall Study|Withdrawal by Subject|2
7925311|NCT02225223|12452775|FG001|Overall Study|Withdrawal by Subject|2
7925312|NCT02225353|12452784|FG000|Overall Study|Lost to Follow-up|0
7925313|NCT02225353|12452785|FG001|Overall Study|Lost to Follow-up|1
7925314|NCT02225353|12452786|FG002|Overall Study|Lost to Follow-up|3
7925315|NCT02225353|12452784|FG000|Overall Study|Protocol Violation|4
7925316|NCT02225353|12452785|FG001|Overall Study|Protocol Violation|5
7925317|NCT02225353|12452786|FG002|Overall Study|Protocol Violation|12
7925318|NCT02225587|12452799|FG000|Overall Study|Adverse Event|5
7925319|NCT02225587|12452800|FG001|Overall Study|Adverse Event|5
7925320|NCT02225587|12452799|FG000|Overall Study|Lost to Follow-up|5
7925321|NCT02225587|12452800|FG001|Overall Study|Lost to Follow-up|5
7925322|NCT02225587|12452799|FG000|Overall Study|Non-Compliance With Study Drug|1
7925323|NCT02225587|12452800|FG001|Overall Study|Non-Compliance With Study Drug|0
7719648|NCT00533897|12143622|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7719649|NCT00533897|12143615|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7719650|NCT00533897|12143616|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7719651|NCT00533897|12143617|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7821974|NCT01259297|12290952|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
7821975|NCT01259297|12290953|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
7821976|NCT01259297|12290954|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
7821977|NCT01259297|12290955|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
7821978|NCT01259297|12290956|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
7821979|NCT01259297|12290949|FG000|Double Blind Randomized Period|Other reasons|0
7719652|NCT00533897|12143618|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7719653|NCT00533897|12143619|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7719654|NCT00533897|12143620|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
7719655|NCT00533897|12143621|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7719656|NCT00533897|12143622|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7719657|NCT00533897|12143615|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7821980|NCT01259297|12290950|FG001|Double Blind Randomized Period|Other reasons|1
7719658|NCT00533897|12143616|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7719659|NCT00533897|12143617|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7719660|NCT00533897|12143618|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7719661|NCT00533897|12143619|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7719662|NCT00533897|12143620|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
7821981|NCT01259297|12290951|FG002|Double Blind Randomized Period|Other reasons|0
7925324|NCT02225587|12452799|FG000|Overall Study|Physician Decision|2
7925325|NCT02225587|12452800|FG001|Overall Study|Physician Decision|0
7925326|NCT02225587|12452799|FG000|Overall Study|Protocol Violation|1
7925327|NCT02225587|12452800|FG001|Overall Study|Protocol Violation|0
7925328|NCT02225587|12452799|FG000|Overall Study|Participant Moved|1
7925329|NCT02225587|12452800|FG001|Overall Study|Participant Moved|0
7925330|NCT02225587|12452799|FG000|Overall Study|Withdrawal by Subject|13
7925331|NCT02225587|12452800|FG001|Overall Study|Withdrawal by Subject|28
7925332|NCT02225665|12452808|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1
7925333|NCT02225665|12452809|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0
7925334|NCT02225665|12452808|FG000|Overall Study|Subject restarted HAART prior to month 18.|0
7925335|NCT02225665|12452809|FG001|Overall Study|Subject restarted HAART prior to month 18.|1
7925336|NCT02225743|12452815|FG000|Overall Study|Withdrawal by Subject|18
7925337|NCT02226003|12452832|FG000|Overall Study|Lost to Follow-up|2
7925338|NCT02226003|12452833|FG001|Overall Study|Lost to Follow-up|1
7925339|NCT02226003|12452834|FG002|Overall Study|Lost to Follow-up|3
7925340|NCT02226003|12452832|FG000|Overall Study|Withdrawal by Subject|0
7925341|NCT02226003|12452833|FG001|Overall Study|Withdrawal by Subject|0
7925342|NCT02226003|12452834|FG002|Overall Study|Withdrawal by Subject|3
7925343|NCT02226120|12452842|FG000|Overall Study|Adverse Event|60
7925344|NCT02226120|12452842|FG000|Overall Study|Death|172
7925345|NCT02226120|12452842|FG000|Overall Study|Study terminated by sponsor|1
7925346|NCT02226120|12452842|FG000|Overall Study|Technical problems|4
7925347|NCT02226120|12452842|FG000|Overall Study|Lost to Follow-up|13
7925348|NCT02226120|12452842|FG000|Overall Study|Physician Decision|21
7925349|NCT02226120|12452842|FG000|Overall Study|Withdrawal by parent/guardian|36
7925350|NCT02226120|12452842|FG000|Overall Study|Non-compliance with study drug|10
7925351|NCT02226120|12452842|FG000|Overall Study|Protocol deviation|1
7925352|NCT02226120|12452842|FG000|Overall Study|missing treatment disposition pages|2
7925353|NCT02226172|12452846|FG000|Overall Study|Participant refused further follow-up|4
7925354|NCT02226172|12452846|FG000|Overall Study|Other|5
7925355|NCT02226172|12452846|FG000|Overall Study|Death|1
7821982|NCT01259297|12290952|FG003|Double Blind Randomized Period|Other reasons|0
7821983|NCT01259297|12290953|FG004|Double Blind Randomized Period|Other reasons|1
7821984|NCT01259297|12290954|FG005|Double Blind Randomized Period|Other reasons|2
7821985|NCT01259297|12290955|FG006|Double Blind Randomized Period|Other reasons|3
7821986|NCT01259297|12290956|FG007|Double Blind Randomized Period|Other reasons|1
7821987|NCT01259375|12290973|FG000|Overall Study|Adverse Event|1
7925356|NCT02226172|12452846|FG000|Overall Study|Study terminated by sponsor|1
7925357|NCT02226172|12452846|FG000|Overall Study|Adverse Event|6
7925358|NCT02226198|12452850|FG000|Lead-in Phase|Protocol Violation|1
7925359|NCT02226198|12452851|FG001|Lead-in Phase|Protocol Violation|0
7925360|NCT02226198|12452852|FG002|Lead-in Phase|Protocol Violation|0
7925361|NCT02226198|12452850|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
7925362|NCT02226198|12452851|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
7925363|NCT02226198|12452852|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
7925364|NCT02226549|12452880|FG000|Overall Study|Randomized but Never Treated|1
7925365|NCT02226549|12452881|FG001|Overall Study|Randomized but Never Treated|0
7925366|NCT02226549|12452880|FG000|Overall Study|Lost to Follow-up|0
7925367|NCT02226549|12452881|FG001|Overall Study|Lost to Follow-up|1
7925368|NCT02226562|12452889|FG000|Overall Study|Lost to Follow-up|0
7925369|NCT02226562|12452890|FG001|Overall Study|Lost to Follow-up|1
7925370|NCT02226653|12452898|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1
7925371|NCT02226653|12452899|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0
7925372|NCT02226653|12452898|FG000|Treatment Period 5 Fed State|Adverse Event|0
7925373|NCT02226653|12452899|FG001|Treatment Period 5 Fed State|Adverse Event|1
7925374|NCT02227108|12452923|FG000|Overall Study|Did not receive treatment|2
7925375|NCT02227108|12452923|FG000|Overall Study|Other|3
7925376|NCT02227108|12452923|FG000|Overall Study|Progressive disease|17
7925377|NCT02227108|12452923|FG000|Overall Study|Initiation of alternative therapy|2
7925378|NCT02227108|12452923|FG000|Overall Study|Investigator discretion|1
7925379|NCT02227108|12452923|FG000|Overall Study|Adverse Event|6
7925380|NCT02227368|12452959|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
7925381|NCT02227368|12452960|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
7925382|NCT02227368|12452959|FG000|Overall Study|Lost to Follow-up|1
7925383|NCT02227368|12452960|FG001|Overall Study|Lost to Follow-up|0
7925384|NCT02227368|12452959|FG000|Overall Study|Adverse Event|1
7925385|NCT02227368|12452960|FG001|Overall Study|Adverse Event|0
7925386|NCT02227446|12452968|FG000|Overall Study|not eligible post randomization|18
7925387|NCT02227446|12452969|FG001|Overall Study|not eligible post randomization|29
7925388|NCT02227446|12452968|FG000|Overall Study|Withdrawal by Subject|4
7925389|NCT02227446|12452969|FG001|Overall Study|Withdrawal by Subject|5
7925390|NCT02227784|12453029|FG000|Double-Blind Phase|Adverse Event|3
7925391|NCT02227784|12453030|FG001|Double-Blind Phase|Adverse Event|2
7925392|NCT02227784|12453031|FG002|Double-Blind Phase|Adverse Event|1
7925393|NCT02227784|12453032|FG003|Double-Blind Phase|Adverse Event|3
7925394|NCT02227784|12453033|FG004|Double-Blind Phase|Adverse Event|0
7925395|NCT02227784|12453029|FG000|Double-Blind Phase|Physician Decision|1
7925396|NCT02227784|12453030|FG001|Double-Blind Phase|Physician Decision|0
7925397|NCT02227784|12453031|FG002|Double-Blind Phase|Physician Decision|0
7925398|NCT02227784|12453032|FG003|Double-Blind Phase|Physician Decision|1
7925399|NCT02227784|12453033|FG004|Double-Blind Phase|Physician Decision|0
7925400|NCT02227784|12453029|FG000|Double-Blind Phase|Protocol Violation|0
7925401|NCT02227784|12453030|FG001|Double-Blind Phase|Protocol Violation|0
7925402|NCT02227784|12453031|FG002|Double-Blind Phase|Protocol Violation|1
7925403|NCT02227784|12453032|FG003|Double-Blind Phase|Protocol Violation|1
7925404|NCT02227784|12453033|FG004|Double-Blind Phase|Protocol Violation|0
7925405|NCT02227784|12453029|FG000|Double-Blind Phase|Sponsor Decision|34
7925406|NCT02227784|12453030|FG001|Double-Blind Phase|Sponsor Decision|15
7925407|NCT02227784|12453031|FG002|Double-Blind Phase|Sponsor Decision|14
7925408|NCT02227784|12453032|FG003|Double-Blind Phase|Sponsor Decision|32
7925409|NCT02227784|12453033|FG004|Double-Blind Phase|Sponsor Decision|0
7925410|NCT02227784|12453029|FG000|Double-Blind Phase|Withdrawal by Subject|2
7925411|NCT02227784|12453030|FG001|Double-Blind Phase|Withdrawal by Subject|1
7925412|NCT02227784|12453031|FG002|Double-Blind Phase|Withdrawal by Subject|5
7925413|NCT02227784|12453032|FG003|Double-Blind Phase|Withdrawal by Subject|2
7925414|NCT02227784|12453033|FG004|Double-Blind Phase|Withdrawal by Subject|0
7925415|NCT02227784|12453029|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0
7925416|NCT02227784|12453030|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0
7925417|NCT02227784|12453031|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0
7925418|NCT02227784|12453032|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0
7925419|NCT02227784|12453033|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1
7925420|NCT02227784|12453029|FG000|Open-Label Extension Phase (OLE)|Death|0
7925421|NCT02227784|12453030|FG001|Open-Label Extension Phase (OLE)|Death|0
7925422|NCT02227784|12453031|FG002|Open-Label Extension Phase (OLE)|Death|0
7925423|NCT02227784|12453032|FG003|Open-Label Extension Phase (OLE)|Death|0
7925424|NCT02227784|12453033|FG004|Open-Label Extension Phase (OLE)|Death|1
7925425|NCT02227784|12453029|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7925426|NCT02227784|12453030|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7925427|NCT02227784|12453031|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7925428|NCT02227784|12453032|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7925429|NCT02227784|12453033|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243
7925430|NCT02227784|12453029|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7925431|NCT02227784|12453030|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7925432|NCT02227784|12453031|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7925433|NCT02227784|12453032|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7925434|NCT02227784|12453033|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
7925435|NCT02227849|12453061|FG000|Overall Study|Adverse Event|4
7925436|NCT02227849|12453061|FG000|Overall Study|Physician Decision|1
7925437|NCT02227849|12453061|FG000|Overall Study|Withdrawal by Subject|3
7925438|NCT02228096|12453067|FG000|Overall Study|Study terminated by Sponsor|24
7925439|NCT02228096|12453067|FG000|Overall Study|Lack of Efficacy|18
7925440|NCT02228096|12453067|FG000|Overall Study|Death|12
7925441|NCT02228096|12453067|FG000|Overall Study|Physician Decision|3
7925442|NCT02228096|12453067|FG000|Overall Study|Subject/guardian decision|2
7925443|NCT02228096|12453067|FG000|Overall Study|New therapy for study indication|1
7925444|NCT02228096|12453067|FG000|Overall Study|Enrolled, not infused|11
7925445|NCT02228395|12453089|FG000|First Intervention Period|No longer willing to participate|1
7925446|NCT02228395|12453090|FG001|First Intervention Period|No longer willing to participate|0
7925447|NCT02228395|12453091|FG002|First Intervention Period|No longer willing to participate|0
7925448|NCT02228395|12453089|FG000|First Intervention Period|Unable to comply with study dates|0
7925449|NCT02228395|12453090|FG001|First Intervention Period|Unable to comply with study dates|1
7925450|NCT02228395|12453091|FG002|First Intervention Period|Unable to comply with study dates|1
7925451|NCT02228460|12453110|FG000|Overall Study|Adverse Event|1
7925452|NCT02228460|12453110|FG000|Overall Study|Lost to Follow-up|1
7925453|NCT02228564|12453124|FG000|Overall Study|Withdrawal by Subject|10
7925454|NCT02228564|12453124|FG000|Overall Study|Death|11
7925455|NCT02228564|12453124|FG000|Overall Study|Physician Decision|5
7925456|NCT02228564|12453124|FG000|Overall Study|Lost to Follow-up|17
7925457|NCT02228564|12453124|FG000|Overall Study|Other|6
7925458|NCT02228590|12453128|FG000|Overall Study|Withdrawal by Subject|1
7925459|NCT02228720|12453142|FG000|Open Label - Day 30|Lost to Follow-up|1
7925460|NCT02228967|12453157|FG000|Overall Study|Lost to Follow-up|146
7925461|NCT02228967|12453158|FG001|Overall Study|Lost to Follow-up|142
7925462|NCT02228967|12453157|FG000|Overall Study|Withdrawal by Subject|13
7925463|NCT02228967|12453158|FG001|Overall Study|Withdrawal by Subject|18
7925464|NCT02228980|12453168|FG000|Overall Study|Adverse Event|14
7925465|NCT02228980|12453169|FG001|Overall Study|Adverse Event|0
7925466|NCT02228980|12453170|FG002|Overall Study|Adverse Event|0
7925467|NCT02228980|12453171|FG003|Overall Study|Adverse Event|0
7925468|NCT02228980|12453168|FG000|Overall Study|Protocol Violation|7
7925469|NCT02228980|12453169|FG001|Overall Study|Protocol Violation|0
7925470|NCT02228980|12453170|FG002|Overall Study|Protocol Violation|0
7925471|NCT02228980|12453171|FG003|Overall Study|Protocol Violation|0
7925472|NCT02228980|12453168|FG000|Overall Study|Withdrawal by Subject|3
7925473|NCT02228980|12453169|FG001|Overall Study|Withdrawal by Subject|3
7925474|NCT02228980|12453170|FG002|Overall Study|Withdrawal by Subject|2
7925475|NCT02228980|12453171|FG003|Overall Study|Withdrawal by Subject|3
7925476|NCT02229214|12453187|FG000|Overall Study|Adverse Event|2
7925477|NCT02229214|12453188|FG001|Overall Study|Adverse Event|0
7925478|NCT02229214|12453187|FG000|Overall Study|Withdrawal by Subject|4
7925479|NCT02229214|12453188|FG001|Overall Study|Withdrawal by Subject|0
7925480|NCT02229227|12453198|FG000|Overall Study|Adverse Event|14
7925481|NCT02229227|12453199|FG001|Overall Study|Adverse Event|9
7925482|NCT02229227|12453198|FG000|Overall Study|Lack of Efficacy|3
7925483|NCT02229227|12453199|FG001|Overall Study|Lack of Efficacy|3
7925484|NCT02229227|12453198|FG000|Overall Study|Protocol Violation|6
7925485|NCT02229227|12453199|FG001|Overall Study|Protocol Violation|8
7925486|NCT02229227|12453198|FG000|Overall Study|Protocol defined stopping criteria|1
7925487|NCT02229227|12453199|FG001|Overall Study|Protocol defined stopping criteria|3
7925488|NCT02229227|12453198|FG000|Overall Study|Lost to Follow-up|3
7925489|NCT02229227|12453199|FG001|Overall Study|Lost to Follow-up|3
7925490|NCT02229227|12453198|FG000|Overall Study|Study terminated by sponsor|11
7925491|NCT02229227|12453199|FG001|Overall Study|Study terminated by sponsor|11
7925492|NCT02229227|12453198|FG000|Overall Study|Withdrawal by Subject|8
7925493|NCT02229227|12453199|FG001|Overall Study|Withdrawal by Subject|12
7925494|NCT02229227|12453198|FG000|Overall Study|Other|0
7925495|NCT02229227|12453199|FG001|Overall Study|Other|1
7925496|NCT02229227|12453198|FG000|Overall Study|Physician Decision|5
7925497|NCT02229227|12453199|FG001|Overall Study|Physician Decision|12
7925498|NCT02229383|12453212|FG000|Overall Study|Adverse Event|7
7925499|NCT02229383|12453213|FG001|Overall Study|Adverse Event|4
7925500|NCT02229383|12453212|FG000|Overall Study|Death|0
7925501|NCT02229383|12453213|FG001|Overall Study|Death|1
7925502|NCT02229383|12453212|FG000|Overall Study|Lost to Follow-up|5
7925503|NCT02229383|12453213|FG001|Overall Study|Lost to Follow-up|3
7925504|NCT02229383|12453212|FG000|Overall Study|Withdrawal by Subject|4
7925505|NCT02229383|12453213|FG001|Overall Study|Withdrawal by Subject|6
7925506|NCT02229383|12453212|FG000|Overall Study|Did not receive treatment|1
7925507|NCT02229383|12453213|FG001|Overall Study|Did not receive treatment|0
7925508|NCT02229383|12453212|FG000|Overall Study|Other|3
7925509|NCT02229383|12453213|FG001|Overall Study|Other|8
7925510|NCT02229396|12453222|FG000|Overall Study|Adverse Event|6
7925511|NCT02229396|12453223|FG001|Overall Study|Adverse Event|12
7925512|NCT02229396|12453224|FG002|Overall Study|Adverse Event|12
7925513|NCT02229396|12453222|FG000|Overall Study|Death|2
7925514|NCT02229396|12453223|FG001|Overall Study|Death|3
7925515|NCT02229396|12453224|FG002|Overall Study|Death|1
7925516|NCT02229396|12453222|FG000|Overall Study|Lost to Follow-up|14
7925517|NCT02229396|12453223|FG001|Overall Study|Lost to Follow-up|14
7925518|NCT02229396|12453224|FG002|Overall Study|Lost to Follow-up|21
7925519|NCT02229396|12453222|FG000|Overall Study|Protocol Violation|2
7925520|NCT02229396|12453223|FG001|Overall Study|Protocol Violation|1
7925521|NCT02229396|12453224|FG002|Overall Study|Protocol Violation|0
7925522|NCT02229396|12453222|FG000|Overall Study|Patient Incorrectly Randomized|0
7925523|NCT02229396|12453223|FG001|Overall Study|Patient Incorrectly Randomized|0
7925524|NCT02229396|12453224|FG002|Overall Study|Patient Incorrectly Randomized|1
7925525|NCT02229396|12453222|FG000|Overall Study|Other|10
7925526|NCT02229396|12453223|FG001|Overall Study|Other|18
7925527|NCT02229396|12453224|FG002|Overall Study|Other|15
7925528|NCT02229396|12453222|FG000|Overall Study|Withdrawal by Subject|42
7925529|NCT02229396|12453223|FG001|Overall Study|Withdrawal by Subject|28
7925530|NCT02229396|12453224|FG002|Overall Study|Withdrawal by Subject|41
7925531|NCT02229396|12453222|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
7925532|NCT02229396|12453223|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
7925533|NCT02229396|12453224|FG002|Overall Study|Study-Specific Withdrawal Criteria|3
7925534|NCT02229396|12453222|FG000|Overall Study|Withdrew; No Record on Termination Page|2
7925535|NCT02229396|12453223|FG001|Overall Study|Withdrew; No Record on Termination Page|0
7925536|NCT02229396|12453224|FG002|Overall Study|Withdrew; No Record on Termination Page|1
7925537|NCT02229539|12453290|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
7925538|NCT02229539|12453291|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
7925539|NCT02229539|12453292|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
7925540|NCT02229539|12453290|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
7925541|NCT02229539|12453291|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
7925542|NCT02229539|12453292|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
7925543|NCT02229539|12453290|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
7925544|NCT02229539|12453291|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
7925545|NCT02229539|12453292|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
7925546|NCT02229539|12453290|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
7925547|NCT02229539|12453291|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
7925548|NCT02229539|12453292|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
7925549|NCT02229539|12453290|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
7925550|NCT02229539|12453291|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
7925551|NCT02229539|12453292|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
7925552|NCT02229539|12453290|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
7925553|NCT02229539|12453291|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
7925554|NCT02229539|12453292|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
7925555|NCT02229539|12453290|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
7925556|NCT02229539|12453291|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
7925557|NCT02229539|12453292|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
7925558|NCT02229539|12453290|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
7925559|NCT02229539|12453291|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
7925560|NCT02229539|12453292|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
7925561|NCT02229539|12453290|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
7925562|NCT02229539|12453291|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
7925563|NCT02229539|12453292|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
7925564|NCT02229552|12453300|FG000|Baseline|Withdrawal by Subject|6
7925565|NCT02229552|12453300|FG000|1-year Follow up|Withdrawal by Subject|7
7925566|NCT02229552|12453300|FG000|1-year Follow up|Lost to Follow-up|18
7925567|NCT02229552|12453300|FG000|2-Year Follow up|Withdrawal by Subject|9
7925568|NCT02229552|12453300|FG000|2-Year Follow up|Lost to Follow-up|17
7925569|NCT02229851|12453307|FG000|Main Phase (Double-blind Phase)|Unclassified|1
7925570|NCT02229851|12453308|FG001|Main Phase (Double-blind Phase)|Unclassified|2
7925571|NCT02229851|12453309|FG002|Main Phase (Double-blind Phase)|Unclassified|0
7925572|NCT02229851|12453310|FG003|Main Phase (Double-blind Phase)|Unclassified|0
7925573|NCT02229851|12453311|FG004|Main Phase (Double-blind Phase)|Unclassified|0
7925574|NCT02229851|12453312|FG005|Main Phase (Double-blind Phase)|Unclassified|0
7925575|NCT02229851|12453313|FG006|Main Phase (Double-blind Phase)|Unclassified|0
7925576|NCT02229851|12453307|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7925577|NCT02229851|12453308|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1
7925578|NCT02229851|12453309|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7925579|NCT02229851|12453310|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7925580|NCT02229851|12453311|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7925581|NCT02229851|12453312|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7925582|NCT02229851|12453313|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7925583|NCT02229851|12453307|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
7925584|NCT02229851|12453308|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12
7925585|NCT02229851|12453309|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
7925586|NCT02229851|12453310|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7925587|NCT02229851|12453311|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7925588|NCT02229851|12453312|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7925589|NCT02229851|12453313|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7925590|NCT02229851|12453307|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0
7925591|NCT02229851|12453308|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0
7925592|NCT02229851|12453309|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2
7925593|NCT02229851|12453310|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0
7925594|NCT02229851|12453311|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0
7925595|NCT02229851|12453312|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0
7925596|NCT02229851|12453313|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0
7925597|NCT02229851|12453307|FG000|Main Phase (Double-blind Phase)|Death|1
7925598|NCT02229851|12453308|FG001|Main Phase (Double-blind Phase)|Death|1
7925599|NCT02229851|12453309|FG002|Main Phase (Double-blind Phase)|Death|0
7925600|NCT02229851|12453310|FG003|Main Phase (Double-blind Phase)|Death|0
7925601|NCT02229851|12453311|FG004|Main Phase (Double-blind Phase)|Death|0
7925602|NCT02229851|12453312|FG005|Main Phase (Double-blind Phase)|Death|0
7925603|NCT02229851|12453313|FG006|Main Phase (Double-blind Phase)|Death|0
7925604|NCT02229851|12453307|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7925605|NCT02229851|12453308|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7925606|NCT02229851|12453309|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7925607|NCT02229851|12453310|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7925608|NCT02229851|12453311|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1
7925609|NCT02229851|12453312|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1
7925610|NCT02229851|12453313|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1
7925611|NCT02229851|12453307|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
7925612|NCT02229851|12453308|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
7925613|NCT02229851|12453309|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
7925614|NCT02229851|12453310|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
7925615|NCT02229851|12453311|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4
7925616|NCT02229851|12453312|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3
7925617|NCT02229851|12453313|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
7925618|NCT02229851|12453307|FG000|Extension Phase (Open-label Phase)|Death|0
7925619|NCT02229851|12453308|FG001|Extension Phase (Open-label Phase)|Death|0
7925620|NCT02229851|12453309|FG002|Extension Phase (Open-label Phase)|Death|0
7925621|NCT02229851|12453310|FG003|Extension Phase (Open-label Phase)|Death|1
7925622|NCT02229851|12453311|FG004|Extension Phase (Open-label Phase)|Death|0
7925623|NCT02229851|12453312|FG005|Extension Phase (Open-label Phase)|Death|1
7925624|NCT02229851|12453313|FG006|Extension Phase (Open-label Phase)|Death|1
7925625|NCT02229864|12453328|FG000|Overall Study|Death|2
7925626|NCT02229864|12453328|FG000|Overall Study|Lost to Follow-up|1
7925627|NCT02230085|12453332|FG000|Overall Study|Physician Decision|1
7925628|NCT02230085|12453332|FG000|Overall Study|Withdrawal by Subject|3
7925629|NCT02230306|12453336|FG000|Overall Study|Did not receive study treatment|1
7925630|NCT02230332|12453342|FG000|Overall Study|Adverse Event|2
7925631|NCT02230332|12453343|FG001|Overall Study|Adverse Event|1
7925632|NCT02230332|12453342|FG000|Overall Study|Lost to Follow-up|1
7925633|NCT02230332|12453343|FG001|Overall Study|Lost to Follow-up|0
7925634|NCT02230332|12453342|FG000|Overall Study|Protocol Violation|1
7925635|NCT02230332|12453343|FG001|Overall Study|Protocol Violation|0
7925636|NCT02230384|12453351|FG000|Phase 1|Lost to Follow-up|1
7925637|NCT02230384|12453352|FG001|Phase 1|Lost to Follow-up|0
7925638|NCT02230384|12453351|FG000|Phase 1|Physician Decision|0
7925639|NCT02230384|12453352|FG001|Phase 1|Physician Decision|1
7925640|NCT02230384|12453351|FG000|Phase 2 - Switch|Withdrawal by Subject|0
7925641|NCT02230384|12453352|FG001|Phase 2 - Switch|Withdrawal by Subject|1
7925642|NCT02230384|12453351|FG000|Phase 2 - Switch|Lost to Follow-up|1
7925643|NCT02230384|12453352|FG001|Phase 2 - Switch|Lost to Follow-up|0
7925644|NCT02230384|12453351|FG000|Phase 2 - Switch|Adverse Event|2
7925645|NCT02230384|12453352|FG001|Phase 2 - Switch|Adverse Event|0
7925646|NCT02230527|12453368|FG000|Overall Study|Withdrawal by Subject|1
7925647|NCT02230527|12453369|FG001|Overall Study|Withdrawal by Subject|1
7925648|NCT02230527|12453368|FG000|Overall Study|Death|1
7925649|NCT02230527|12453369|FG001|Overall Study|Death|0
7925650|NCT02230527|12453368|FG000|Overall Study|Lost to Follow-up|2
7925651|NCT02230527|12453369|FG001|Overall Study|Lost to Follow-up|1
7925652|NCT02230527|12453368|FG000|Overall Study|Other|1
7925653|NCT02230527|12453369|FG001|Overall Study|Other|0
7925654|NCT02230670|12453423|FG000|Overall Study|Adverse Event|1
7925655|NCT02230670|12453424|FG001|Overall Study|Adverse Event|2
7925656|NCT02230670|12453423|FG000|Overall Study|Withdrawal by Subject|2
7925657|NCT02230670|12453424|FG001|Overall Study|Withdrawal by Subject|2
7925658|NCT02230670|12453423|FG000|Overall Study|Physician Decision|0
7925659|NCT02230670|12453424|FG001|Overall Study|Physician Decision|1
7925660|NCT02230670|12453423|FG000|Overall Study|Protocol Violation|0
7925661|NCT02230670|12453424|FG001|Overall Study|Protocol Violation|1
7925662|NCT02230670|12453423|FG000|Overall Study|Progression to Child-Pugh C|1
7925663|NCT02230670|12453424|FG001|Overall Study|Progression to Child-Pugh C|2
7925664|NCT02230683|12453430|FG000|Overall Study|Adverse Event|1
7925665|NCT02230904|12453464|FG000|Overall Study|Safety follow up could not take place|0
7925666|NCT02230904|12453465|FG001|Overall Study|Safety follow up could not take place|1
7925667|NCT02230956|12453476|FG000|Overall Study|Adverse Event|1
7925668|NCT02230956|12453477|FG001|Overall Study|Adverse Event|1
7925669|NCT02230956|12453478|FG002|Overall Study|Adverse Event|0
7925670|NCT02230956|12453476|FG000|Overall Study|Lack of Efficacy|1
7925671|NCT02230956|12453477|FG001|Overall Study|Lack of Efficacy|1
7925672|NCT02230956|12453478|FG002|Overall Study|Lack of Efficacy|1
7925673|NCT02230956|12453476|FG000|Overall Study|Lost to Follow-up|1
7925674|NCT02230956|12453477|FG001|Overall Study|Lost to Follow-up|1
7925675|NCT02230956|12453478|FG002|Overall Study|Lost to Follow-up|2
7925676|NCT02230956|12453476|FG000|Overall Study|Personal Reasons|2
7925677|NCT02230956|12453477|FG001|Overall Study|Personal Reasons|1
7925678|NCT02230956|12453478|FG002|Overall Study|Personal Reasons|1
7925679|NCT02230956|12453476|FG000|Overall Study|Protocol Violation|0
7925680|NCT02230956|12453477|FG001|Overall Study|Protocol Violation|1
7925681|NCT02230956|12453478|FG002|Overall Study|Protocol Violation|1
7925682|NCT02230956|12453476|FG000|Overall Study|Other Miscellaneous Reason|0
7925683|NCT02230956|12453477|FG001|Overall Study|Other Miscellaneous Reason|1
7925684|NCT02230956|12453478|FG002|Overall Study|Other Miscellaneous Reason|2
7925685|NCT02231164|12453506|FG000|Overall Study|Adverse Event|1
7925686|NCT02231164|12453507|FG001|Overall Study|Adverse Event|1
7925687|NCT02231164|12453506|FG000|Overall Study|Lack of Efficacy|4
7925688|NCT02231164|12453507|FG001|Overall Study|Lack of Efficacy|3
7925689|NCT02231164|12453506|FG000|Overall Study|Withdrawal by Subject|1
7925690|NCT02231164|12453507|FG001|Overall Study|Withdrawal by Subject|2
7925691|NCT02231580|12453529|FG000|Overall Study|Adverse Event|5
7925692|NCT02231580|12453530|FG001|Overall Study|Adverse Event|0
7925693|NCT02231918|12453541|FG000|Overall Study|Withdrawal by Subject|0
7925694|NCT02231918|12453542|FG001|Overall Study|Withdrawal by Subject|1
7925695|NCT02231918|12453543|FG002|Overall Study|Withdrawal by Subject|0
7925696|NCT02231918|12453541|FG000|Overall Study|Adverse Event|0
7925697|NCT02231918|12453542|FG001|Overall Study|Adverse Event|0
7925698|NCT02231918|12453543|FG002|Overall Study|Adverse Event|1
7964572|NCT04526574|12520091|FG000|Overall Study|Protocol Violation|3
7964573|NCT04526574|12520092|FG001|Overall Study|Protocol Violation|1
7964574|NCT04526574|12520091|FG000|Overall Study|Withdrawal by Subject|12
7964575|NCT04526574|12520092|FG001|Overall Study|Withdrawal by Subject|9
7964576|NCT04526574|12520091|FG000|Overall Study|Other|1
7964577|NCT04526574|12520092|FG001|Overall Study|Other|2
7964578|NCT04526574|12520091|FG000|Overall Study|Adverse Event|1
7964579|NCT04526574|12520092|FG001|Overall Study|Adverse Event|1
7964580|NCT04526574|12520091|FG000|Overall Study|Death|2
7964581|NCT04526574|12520092|FG001|Overall Study|Death|3
7964582|NCT04526574|12520091|FG000|Overall Study|Lost to Follow-up|9
7964583|NCT04526574|12520092|FG001|Overall Study|Lost to Follow-up|9
7964584|NCT04526574|12520091|FG000|Overall Study|No longer meets eligibility criteria|8
7964585|NCT04526574|12520092|FG001|Overall Study|No longer meets eligibility criteria|8
7966988|NCT02759692|12523510|FG000|Period 2|Lost to Follow-up|1
7966989|NCT02759692|12523511|FG001|Period 2|Lost to Follow-up|0
7966990|NCT02759692|12523510|FG000|Period 2|Test article no longer available|0
7966991|NCT02759692|12523511|FG001|Period 2|Test article no longer available|1
7966992|NCT02759939|12523521|FG000|Overall Study|Missing data on first outcome assessed|11
7966993|NCT02759939|12523522|FG001|Overall Study|Missing data on first outcome assessed|2
7966994|NCT02759939|12523523|FG002|Overall Study|Missing data on first outcome assessed|5
7966995|NCT02759939|12523524|FG003|Overall Study|Missing data on first outcome assessed|2
7966996|NCT02759939|12523521|FG000|Overall Study|Ineligible for T2 and T3|310
7966997|NCT02759939|12523522|FG001|Overall Study|Ineligible for T2 and T3|179
7966998|NCT02759939|12523523|FG002|Overall Study|Ineligible for T2 and T3|366
7966999|NCT02759939|12523524|FG003|Overall Study|Ineligible for T2 and T3|391
7967000|NCT02759939|12523521|FG000|Overall Study|Lost to Follow-up|735
7967001|NCT02759939|12523522|FG001|Overall Study|Lost to Follow-up|791
7967002|NCT02759939|12523523|FG002|Overall Study|Lost to Follow-up|783
7967003|NCT02759939|12523524|FG003|Overall Study|Lost to Follow-up|650
7967004|NCT02760069|12523547|FG000|Overall Study|Withdrawal by Subject|0
7967005|NCT02760069|12523548|FG001|Overall Study|Withdrawal by Subject|1
7967006|NCT02760069|12523549|FG002|Overall Study|Withdrawal by Subject|1
7967007|NCT02760368|12523595|FG000|Overall Study|Withdrawal by Subject|12
7967008|NCT02760368|12523596|FG001|Overall Study|Withdrawal by Subject|8
7967009|NCT02760368|12523597|FG002|Overall Study|Withdrawal by Subject|9
7967010|NCT02760368|12523595|FG000|Overall Study|Screen Failure|0
7967011|NCT02760368|12523596|FG001|Overall Study|Screen Failure|0
7967012|NCT02760368|12523597|FG002|Overall Study|Screen Failure|1
7967013|NCT02760368|12523595|FG000|Overall Study|Death|1
7967014|NCT02760368|12523596|FG001|Overall Study|Death|0
7967015|NCT02760368|12523597|FG002|Overall Study|Death|0
7967016|NCT02760368|12523595|FG000|Overall Study|Withdrawal by Sponsor|0
7967017|NCT02760368|12523596|FG001|Overall Study|Withdrawal by Sponsor|0
7967018|NCT02760368|12523597|FG002|Overall Study|Withdrawal by Sponsor|1
7967019|NCT02760407|12523609|FG000|Overall Study|Death|2
7967020|NCT02760407|12523610|FG001|Overall Study|Death|3
7967021|NCT02760407|12523611|FG002|Overall Study|Death|1
7967022|NCT02760407|12523612|FG003|Overall Study|Death|1
7967023|NCT02760407|12523609|FG000|Overall Study|Lost to Follow-up|1
7967024|NCT02760407|12523610|FG001|Overall Study|Lost to Follow-up|7
7967025|NCT02760407|12523611|FG002|Overall Study|Lost to Follow-up|4
7967026|NCT02760407|12523612|FG003|Overall Study|Lost to Follow-up|6
7967027|NCT02760407|12523609|FG000|Overall Study|Withdrawal by Subject|25
7967028|NCT02760407|12523610|FG001|Overall Study|Withdrawal by Subject|31
7967029|NCT02760407|12523611|FG002|Overall Study|Withdrawal by Subject|37
7967030|NCT02760407|12523612|FG003|Overall Study|Withdrawal by Subject|25
7967031|NCT02760407|12523609|FG000|Overall Study|Violation of Eligibility criteria|0
7967032|NCT02760407|12523610|FG001|Overall Study|Violation of Eligibility criteria|0
7967033|NCT02760407|12523611|FG002|Overall Study|Violation of Eligibility criteria|1
7967034|NCT02760407|12523612|FG003|Overall Study|Violation of Eligibility criteria|1
7967035|NCT02760407|12523609|FG000|Overall Study|Personal reasons|0
7967036|NCT02760407|12523610|FG001|Overall Study|Personal reasons|0
7967037|NCT02760407|12523611|FG002|Overall Study|Personal reasons|0
7925699|NCT02232061|12453561|FG000|Overall Study|Administrative problems|1
7925700|NCT02232061|12453561|FG000|Overall Study|Withdrawal by Subject|1
7925701|NCT02232074|12453567|FG000|Overall Study|Withdrawal by Subject|5
7925702|NCT02232074|12453568|FG001|Overall Study|Withdrawal by Subject|3
7925703|NCT02232074|12453567|FG000|Overall Study|No legal concerns at baseline|36
7925704|NCT02232074|12453568|FG001|Overall Study|No legal concerns at baseline|41
7925705|NCT02232074|12453567|FG000|Overall Study|deemed ineligible|0
7925706|NCT02232074|12453568|FG001|Overall Study|deemed ineligible|1
7925707|NCT02232178|12453594|FG000|Overall Study|Lost to Follow-up|0
7925708|NCT02232178|12453595|FG001|Overall Study|Lost to Follow-up|1
7925709|NCT02232178|12453596|FG002|Overall Study|Lost to Follow-up|0
7925710|NCT02232178|12453594|FG000|Overall Study|ineligibility|0
7925711|NCT02232178|12453595|FG001|Overall Study|ineligibility|0
7925712|NCT02232178|12453596|FG002|Overall Study|ineligibility|1
7925713|NCT02232178|12453594|FG000|Overall Study|surgical complication|1
7925714|NCT02232178|12453595|FG001|Overall Study|surgical complication|0
7925715|NCT02232178|12453596|FG002|Overall Study|surgical complication|0
7925716|NCT02232243|12453607|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
7925717|NCT02232243|12453608|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1
7925718|NCT02232243|12453609|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
7925719|NCT02232425|12453620|FG000|Overall Study|Lost to Follow-up|6
7925720|NCT02232425|12453621|FG001|Overall Study|Lost to Follow-up|2
7925721|NCT02232425|12453620|FG000|Overall Study|Adverse Event|2
7925722|NCT02232425|12453621|FG001|Overall Study|Adverse Event|0
7925723|NCT02232425|12453620|FG000|Overall Study|Withdrawal by Subject|5
7925724|NCT02232425|12453621|FG001|Overall Study|Withdrawal by Subject|6
7925725|NCT02232425|12453620|FG000|Overall Study|Lack of Efficacy|1
7925726|NCT02232425|12453621|FG001|Overall Study|Lack of Efficacy|0
7964586|NCT04345367|12520108|FG000|Overall Study|Other|3
7964587|NCT04345367|12520109|FG001|Overall Study|Other|4
7964588|NCT04345367|12520108|FG000|Overall Study|Medication Error Without Associated Adverse Event|1
7964589|NCT04345367|12520109|FG001|Overall Study|Medication Error Without Associated Adverse Event|0
7964590|NCT04345367|12520108|FG000|Overall Study|Withdrawal by Subject|11
7964591|NCT04345367|12520109|FG001|Overall Study|Withdrawal by Subject|11
7964592|NCT04345367|12520108|FG000|Overall Study|Protocol Violation|4
7964593|NCT04345367|12520109|FG001|Overall Study|Protocol Violation|3
7964594|NCT04345367|12520108|FG000|Overall Study|Lost to Follow-up|2
7964595|NCT04345367|12520109|FG001|Overall Study|Lost to Follow-up|4
7964596|NCT04345367|12520108|FG000|Overall Study|Lack of Efficacy|2
7964597|NCT04345367|12520109|FG001|Overall Study|Lack of Efficacy|0
7964598|NCT04345367|12520108|FG000|Overall Study|Death|2
7964599|NCT04345367|12520109|FG001|Overall Study|Death|0
7964600|NCT04345367|12520108|FG000|Overall Study|Adverse Event|10
7964601|NCT04345367|12520109|FG001|Overall Study|Adverse Event|9
7967038|NCT02760407|12523612|FG003|Overall Study|Personal reasons|1
7967039|NCT02760407|12523609|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1
7967040|NCT02760407|12523610|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
7967041|NCT02760407|12523611|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
7967042|NCT02760407|12523612|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
7967043|NCT02760407|12523609|FG000|Overall Study|Use of prohibited Medication|0
7967044|NCT02760407|12523610|FG001|Overall Study|Use of prohibited Medication|0
7967045|NCT02760407|12523611|FG002|Overall Study|Use of prohibited Medication|1
7967046|NCT02760407|12523612|FG003|Overall Study|Use of prohibited Medication|0
7967047|NCT02760407|12523609|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
7925727|NCT02232698|12453629|FG000|Overall Study|Pregnancy|1
7925728|NCT02232698|12453630|FG001|Overall Study|Pregnancy|1
7925729|NCT02232698|12453629|FG000|Overall Study|Met exclusion criteria|1
7925730|NCT02232698|12453630|FG001|Overall Study|Met exclusion criteria|1
7925731|NCT02232698|12453629|FG000|Overall Study|Had device-associated symptoms|7
7925732|NCT02232698|12453630|FG001|Overall Study|Had device-associated symptoms|0
7925733|NCT02232698|12453629|FG000|Overall Study|Non-compliance with study device|1
7925734|NCT02232698|12453630|FG001|Overall Study|Non-compliance with study device|4
7719663|NCT00533897|12143621|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7719664|NCT00533897|12143622|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7925735|NCT02232698|12453629|FG000|Overall Study|Allocated to control group|0
7925736|NCT02232698|12453630|FG001|Overall Study|Allocated to control group|3
7925737|NCT02232698|12453629|FG000|Overall Study|Withdrawal by Subject|0
7925738|NCT02232698|12453630|FG001|Overall Study|Withdrawal by Subject|11
7925739|NCT02232802|12453638|FG000|Period 1|Sponsor request|1
7925740|NCT02232802|12453639|FG001|Period 1|Sponsor request|0
7925741|NCT02232802|12453638|FG000|Period 1|Adverse Event|1
7925742|NCT02232802|12453639|FG001|Period 1|Adverse Event|1
7925743|NCT02232893|12453647|FG000|Overall Study|Withdrawal by Subject|4
7925744|NCT02232893|12453648|FG001|Overall Study|Withdrawal by Subject|1
7925745|NCT02232893|12453647|FG000|Overall Study|Adverse Event|0
7925746|NCT02232893|12453648|FG001|Overall Study|Adverse Event|1
7925747|NCT02232893|12453647|FG000|Overall Study|Sponsor request early termination|0
7925748|NCT02232893|12453648|FG001|Overall Study|Sponsor request early termination|1
7925749|NCT02232893|12453647|FG000|Overall Study|Developed exclusion criteria|0
7925750|NCT02232893|12453648|FG001|Overall Study|Developed exclusion criteria|1
7925751|NCT02232893|12453647|FG000|Overall Study|Other|0
7925752|NCT02232893|12453648|FG001|Overall Study|Other|3
7925753|NCT02232984|12453654|FG000|Overall Study|Withdrawal by Subject|5
7925754|NCT02232984|12453654|FG000|Overall Study|Death|1
7925755|NCT02232984|12453654|FG000|Overall Study|Investigator withdrawal|10
7925756|NCT02232984|12453654|FG000|Overall Study|Device implant unsuccessful|53
7925757|NCT02232984|12453654|FG000|Overall Study|not disclosed by site|7
7925758|NCT02232984|12453654|FG000|Overall Study|Protocol Violation|1
7925759|NCT02233309|12453683|FG000|Overall Study|Physician Decision|5
7925760|NCT02233413|12453689|FG000|Overall Study|Lost to Follow-up|7
7925761|NCT02233413|12453690|FG001|Overall Study|Lost to Follow-up|9
7925762|NCT02233413|12453689|FG000|Overall Study|Withdrawal by Subject|4
7925763|NCT02233413|12453690|FG001|Overall Study|Withdrawal by Subject|5
7925764|NCT02233543|12453722|FG000|Period 1|Withdrawal by Subject|1
7925765|NCT02233543|12453723|FG001|Period 1|Withdrawal by Subject|0
7925766|NCT02233543|12453722|FG000|Period 1|Participants required other treatment.|2
7925767|NCT02233543|12453723|FG001|Period 1|Participants required other treatment.|3
7925768|NCT02233543|12453722|FG000|Period 2|Adverse Event|1
7925769|NCT02233543|12453723|FG001|Period 2|Adverse Event|0
7925770|NCT02233543|12453722|FG000|Period 2|Participant required other treatment.|0
7925771|NCT02233543|12453723|FG001|Period 2|Participant required other treatment.|1
7925772|NCT02233543|12453722|FG000|Period 2|COPD exacerbation|1
7925773|NCT02233543|12453723|FG001|Period 2|COPD exacerbation|0
7925774|NCT02233647|12453729|FG000|Overall Study|Adverse Event|1
7925775|NCT02233738|12453735|FG000|Overall Study|Lost to Follow-up|5
7925776|NCT02233738|12453736|FG001|Overall Study|Lost to Follow-up|12
7925777|NCT02233738|12453735|FG000|Overall Study|Death|0
7925778|NCT02233738|12453736|FG001|Overall Study|Death|1
7925779|NCT02233738|12453735|FG000|Overall Study|Withdrawal by Subject|0
7925780|NCT02233738|12453736|FG001|Overall Study|Withdrawal by Subject|1
7925781|NCT02233738|12453735|FG000|Overall Study|Did not return after Baseline|3
7925782|NCT02233738|12453736|FG001|Overall Study|Did not return after Baseline|2
7925783|NCT02233803|12453913|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
7925784|NCT02233803|12453914|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
7925785|NCT02233803|12453913|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0
7925786|NCT02233803|12453914|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1
7925787|NCT02233803|12453913|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2
7925788|NCT02233803|12453914|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2
7925789|NCT02233803|12453913|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
7925790|NCT02233803|12453914|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
7925791|NCT02233803|12453913|FG000|Washout Period (4-Wks)|Lost to Follow-up|0
7925792|NCT02233803|12453914|FG001|Washout Period (4-Wks)|Lost to Follow-up|1
7925793|NCT02233803|12453913|FG000|Washout Period (4-Wks)|Physician Decision|1
7925794|NCT02233803|12453914|FG001|Washout Period (4-Wks)|Physician Decision|0
7719665|NCT00533897|12143615|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0
7719666|NCT00533897|12143616|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0
7925795|NCT02233803|12453913|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1
7925796|NCT02233803|12453914|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1
7925797|NCT02233803|12453913|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
7925798|NCT02233803|12453914|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
7925799|NCT02233803|12453913|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
7925800|NCT02233803|12453914|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
7925801|NCT02233946|12453929|FG000|Baseline|Withdrawal by Subject|2
7925802|NCT02233946|12453930|FG001|Baseline|Withdrawal by Subject|0
7925803|NCT02233946|12453929|FG000|3-months Follow-up|Lost to Follow-up|53
7925804|NCT02233946|12453930|FG001|3-months Follow-up|Lost to Follow-up|29
7925805|NCT02233946|12453929|FG000|6-months Follow-up|Lost to Follow-up|21
7925806|NCT02233946|12453930|FG001|6-months Follow-up|Lost to Follow-up|2
7925807|NCT02233946|12453929|FG000|9-month Follow-up|Lost to Follow-up|20
7925808|NCT02233946|12453930|FG001|9-month Follow-up|Lost to Follow-up|11
7925809|NCT02233946|12453929|FG000|12-month Follow-up|Lost to Follow-up|28
7925810|NCT02233946|12453930|FG001|12-month Follow-up|Lost to Follow-up|11
7925811|NCT02234063|12453962|FG000|Overall Study|Lost to Follow-up|235
7925812|NCT02234063|12453963|FG001|Overall Study|Lost to Follow-up|42
7925813|NCT02234063|12453962|FG000|Overall Study|Withdrawal by Subject|20
7925814|NCT02234063|12453963|FG001|Overall Study|Withdrawal by Subject|1
7925815|NCT02234141|12453995|FG000|Treatment Period (24 Weeks)|Protocol Violation|0
7925816|NCT02234141|12453996|FG001|Treatment Period (24 Weeks)|Protocol Violation|0
7925817|NCT02234141|12453997|FG002|Treatment Period (24 Weeks)|Protocol Violation|0
7925818|NCT02234141|12453998|FG003|Treatment Period (24 Weeks)|Protocol Violation|1
7925819|NCT02234141|12453999|FG004|Treatment Period (24 Weeks)|Protocol Violation|0
7925820|NCT02234141|12454000|FG005|Treatment Period (24 Weeks)|Protocol Violation|0
7925821|NCT02234141|12454001|FG006|Treatment Period (24 Weeks)|Protocol Violation|0
7925822|NCT02234141|12453995|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0
7925823|NCT02234141|12453996|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2
7925824|NCT02234141|12453997|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0
7925825|NCT02234141|12453998|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0
7925826|NCT02234141|12453999|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0
7925827|NCT02234141|12454000|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0
7925828|NCT02234141|12454001|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0
7925829|NCT02234141|12453995|FG000|Treatment Period (24 Weeks)|Death|1
7925830|NCT02234141|12453996|FG001|Treatment Period (24 Weeks)|Death|2
7925831|NCT02234141|12453997|FG002|Treatment Period (24 Weeks)|Death|0
7925832|NCT02234141|12453998|FG003|Treatment Period (24 Weeks)|Death|1
7925833|NCT02234141|12453999|FG004|Treatment Period (24 Weeks)|Death|0
7925834|NCT02234141|12454000|FG005|Treatment Period (24 Weeks)|Death|0
7925835|NCT02234141|12454001|FG006|Treatment Period (24 Weeks)|Death|0
7925836|NCT02234141|12453995|FG000|Treatment Period (24 Weeks)|Adverse Event|3
7925837|NCT02234141|12453996|FG001|Treatment Period (24 Weeks)|Adverse Event|1
7925838|NCT02234141|12453997|FG002|Treatment Period (24 Weeks)|Adverse Event|2
7925839|NCT02234141|12453998|FG003|Treatment Period (24 Weeks)|Adverse Event|3
7925840|NCT02234141|12453999|FG004|Treatment Period (24 Weeks)|Adverse Event|0
7925841|NCT02234141|12454000|FG005|Treatment Period (24 Weeks)|Adverse Event|0
7925842|NCT02234141|12454001|FG006|Treatment Period (24 Weeks)|Adverse Event|0
7925843|NCT02234141|12453995|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0
7925844|NCT02234141|12453996|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1
7925845|NCT02234141|12453997|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0
7925846|NCT02234141|12453998|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0
7925847|NCT02234141|12453999|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0
7925848|NCT02234141|12454000|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0
7925849|NCT02234141|12454001|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0
7925850|NCT02234141|12453995|FG000|Long-Term Treatment Period|Death|0
7925851|NCT02234141|12453996|FG001|Long-Term Treatment Period|Death|0
7925852|NCT02234141|12453997|FG002|Long-Term Treatment Period|Death|0
7925853|NCT02234141|12453998|FG003|Long-Term Treatment Period|Death|0
7925854|NCT02234141|12453999|FG004|Long-Term Treatment Period|Death|0
7925855|NCT02234141|12454000|FG005|Long-Term Treatment Period|Death|1
7925856|NCT02234141|12454001|FG006|Long-Term Treatment Period|Death|0
7925857|NCT02234141|12453995|FG000|Long-Term Treatment Period|Investigator's discretion|1
7925858|NCT02234141|12453996|FG001|Long-Term Treatment Period|Investigator's discretion|3
7925859|NCT02234141|12453997|FG002|Long-Term Treatment Period|Investigator's discretion|2
7925860|NCT02234141|12453998|FG003|Long-Term Treatment Period|Investigator's discretion|0
7925861|NCT02234141|12453999|FG004|Long-Term Treatment Period|Investigator's discretion|0
7925862|NCT02234141|12454000|FG005|Long-Term Treatment Period|Investigator's discretion|0
7925863|NCT02234141|12454001|FG006|Long-Term Treatment Period|Investigator's discretion|1
7925864|NCT02234141|12453995|FG000|Long-Term Treatment Period|Adverse Event|4
7925865|NCT02234141|12453996|FG001|Long-Term Treatment Period|Adverse Event|0
7925866|NCT02234141|12453997|FG002|Long-Term Treatment Period|Adverse Event|5
7925867|NCT02234141|12453998|FG003|Long-Term Treatment Period|Adverse Event|0
7925868|NCT02234141|12453999|FG004|Long-Term Treatment Period|Adverse Event|1
7925869|NCT02234141|12454000|FG005|Long-Term Treatment Period|Adverse Event|1
7925870|NCT02234141|12454001|FG006|Long-Term Treatment Period|Adverse Event|1
7925871|NCT02234141|12453995|FG000|Long-Term Treatment Period|Withdrew Consent|0
7925872|NCT02234141|12453996|FG001|Long-Term Treatment Period|Withdrew Consent|1
7925873|NCT02234141|12453997|FG002|Long-Term Treatment Period|Withdrew Consent|1
7925874|NCT02234141|12453998|FG003|Long-Term Treatment Period|Withdrew Consent|0
7925875|NCT02234141|12453999|FG004|Long-Term Treatment Period|Withdrew Consent|0
7925876|NCT02234141|12454000|FG005|Long-Term Treatment Period|Withdrew Consent|0
7925877|NCT02234141|12454001|FG006|Long-Term Treatment Period|Withdrew Consent|0
7925878|NCT02234141|12453995|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28
7925879|NCT02234141|12453996|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27
7925880|NCT02234141|12453997|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25
7925881|NCT02234141|12453998|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0
7925882|NCT02234141|12453999|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9
7925883|NCT02234141|12454000|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10
7925884|NCT02234141|12454001|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8
7925885|NCT02234284|12454019|FG000|Overall Study|Death|4
7925886|NCT02234284|12454020|FG001|Overall Study|Death|2
7925887|NCT02234284|12454019|FG000|Overall Study|Withdrawal by Subject|1
7925888|NCT02234284|12454020|FG001|Overall Study|Withdrawal by Subject|0
7925889|NCT02234284|12454019|FG000|Overall Study|Lost to Follow-up|20
7925890|NCT02234284|12454020|FG001|Overall Study|Lost to Follow-up|7
7925891|NCT02234362|12454030|FG000|Overall Study|Not eligible after first screening visit|17
7925892|NCT02234362|12454030|FG000|Overall Study|Lost to Follow-up|6
7925893|NCT02234362|12454030|FG000|Overall Study|Withdrawal by Subject|3
7925894|NCT02234479|12454040|FG000|Overall Study|Withdrawal by Subject|1
7925895|NCT02234479|12454041|FG001|Overall Study|Withdrawal by Subject|3
7925896|NCT02234583|12454082|FG000|Overall Study|Adverse Event|172
7925897|NCT02234583|12454083|FG001|Overall Study|Adverse Event|156
7925898|NCT02234583|12454082|FG000|Overall Study|Withdrawal by Subject|109
7925899|NCT02234583|12454083|FG001|Overall Study|Withdrawal by Subject|157
7925900|NCT02234583|12454082|FG000|Overall Study|Lost to Follow-up|0
7925901|NCT02234583|12454083|FG001|Overall Study|Lost to Follow-up|1
7925902|NCT02234583|12454082|FG000|Overall Study|Lack of Efficacy|58
7925903|NCT02234583|12454083|FG001|Overall Study|Lack of Efficacy|103
7925904|NCT02234583|12454082|FG000|Overall Study|Protocol Violation|35
7925905|NCT02234583|12454083|FG001|Overall Study|Protocol Violation|42
7925906|NCT02234583|12454082|FG000|Overall Study|Other|39
7925907|NCT02234583|12454083|FG001|Overall Study|Other|97
7925908|NCT02234596|12454095|FG000|Overall Study|Participant not treated|2
7925909|NCT02234622|12454101|FG000|Overall Study|Withdrawal by Subject|16
7925910|NCT02234622|12454102|FG001|Overall Study|Withdrawal by Subject|22
7925911|NCT02234622|12454101|FG000|Overall Study|Lost to Follow-up|27
7925912|NCT02234622|12454102|FG001|Overall Study|Lost to Follow-up|14
7925913|NCT02235077|12454138|FG000|Overall Study|Death|5
7925914|NCT02235077|12454139|FG001|Overall Study|Death|7
7925915|NCT02235077|12454138|FG000|Overall Study|Lost to Follow-up|5
7925916|NCT02235077|12454139|FG001|Overall Study|Lost to Follow-up|6
7925917|NCT02235077|12454138|FG000|Overall Study|Withdrawal by Subject|8
7925918|NCT02235077|12454139|FG001|Overall Study|Withdrawal by Subject|5
7925919|NCT02235077|12454138|FG000|Overall Study|Physician Decision|0
7925920|NCT02235077|12454139|FG001|Overall Study|Physician Decision|1
7925921|NCT02235298|12454151|FG000|Overall Study|Lost to Follow-up|6
7925922|NCT02235298|12454152|FG001|Overall Study|Lost to Follow-up|5
7925923|NCT02235298|12454151|FG000|Overall Study|Adverse Event|2
7925924|NCT02235298|12454152|FG001|Overall Study|Adverse Event|2
7925925|NCT02235298|12454151|FG000|Overall Study|Withdrawal by Subject|0
7925926|NCT02235298|12454152|FG001|Overall Study|Withdrawal by Subject|1
7925927|NCT02235311|12454160|FG000|Overall Study|Lost to Follow-up|0
7925928|NCT02235311|12454161|FG001|Overall Study|Lost to Follow-up|1
7925929|NCT02235311|12454160|FG000|Overall Study|Protocol Violation|0
7925930|NCT02235311|12454161|FG001|Overall Study|Protocol Violation|1
7925931|NCT02235454|12454167|FG000|Overall Study|Withdrawal by Subject|2
7925932|NCT02236130|12454212|FG000|Overall Study|Lost to Follow-up|7
7925933|NCT02236130|12454213|FG001|Overall Study|Lost to Follow-up|12
7925934|NCT02236520|12454232|FG000|Overall Study|Physician Decision|0
7925935|NCT02236520|12454233|FG001|Overall Study|Physician Decision|5
7925936|NCT02236520|12454234|FG002|Overall Study|Physician Decision|0
7925937|NCT02236520|12454235|FG003|Overall Study|Physician Decision|0
7925938|NCT02236520|12454232|FG000|Overall Study|Withdrawal by Subject|1
7925939|NCT02236520|12454233|FG001|Overall Study|Withdrawal by Subject|0
7925940|NCT02236520|12454234|FG002|Overall Study|Withdrawal by Subject|0
7925941|NCT02236520|12454235|FG003|Overall Study|Withdrawal by Subject|1
7925942|NCT02236520|12454232|FG000|Overall Study|Pregnancy|1
7925943|NCT02236520|12454233|FG001|Overall Study|Pregnancy|0
7925944|NCT02236520|12454234|FG002|Overall Study|Pregnancy|0
7925945|NCT02236520|12454235|FG003|Overall Study|Pregnancy|0
7925946|NCT02236559|12454247|FG000|Overall Study|Met Exclusion|3
7925947|NCT02236559|12454248|FG001|Overall Study|Met Exclusion|6
7925948|NCT02236559|12454247|FG000|Overall Study|Did not Meet Inclusion|3
7925949|NCT02236559|12454248|FG001|Overall Study|Did not Meet Inclusion|3
7925950|NCT02236559|12454247|FG000|Overall Study|Subject Did Not Consent|4
7925951|NCT02236559|12454248|FG001|Overall Study|Subject Did Not Consent|2
7925952|NCT02236559|12454247|FG000|Overall Study|Physician Decision|1
7925953|NCT02236559|12454248|FG001|Overall Study|Physician Decision|1
7925954|NCT02236559|12454247|FG000|Overall Study|Withdrawal by Subject|1
7925955|NCT02236559|12454248|FG001|Overall Study|Withdrawal by Subject|0
7925956|NCT02236598|12454256|FG000|Overall Study|Adverse Event|0
7925957|NCT02236598|12454257|FG001|Overall Study|Adverse Event|1
7925958|NCT02236598|12454256|FG000|Overall Study|Withdrawal by Subject|0
7925959|NCT02236598|12454257|FG001|Overall Study|Withdrawal by Subject|1
7925960|NCT02236611|12454265|FG000|Overall Study|Adverse Event|10
7925961|NCT02236611|12454266|FG001|Overall Study|Adverse Event|16
7925962|NCT02236611|12454265|FG000|Overall Study|Lack of Efficacy|4
7925963|NCT02236611|12454266|FG001|Overall Study|Lack of Efficacy|7
7925964|NCT02236611|12454265|FG000|Overall Study|Lost to Follow-up|0
7925965|NCT02236611|12454266|FG001|Overall Study|Lost to Follow-up|2
7925966|NCT02236611|12454265|FG000|Overall Study|Protocol deviation|3
7925967|NCT02236611|12454266|FG001|Overall Study|Protocol deviation|5
7925968|NCT02236611|12454265|FG000|Overall Study|Withdrew consent|9
7925969|NCT02236611|12454266|FG001|Overall Study|Withdrew consent|4
7925970|NCT02236988|12454280|FG000|Overall Study|Lost to Follow-up|0
7925971|NCT02236988|12454281|FG001|Overall Study|Lost to Follow-up|0
7925972|NCT02236988|12454282|FG002|Overall Study|Lost to Follow-up|0
7925973|NCT02236988|12454283|FG003|Overall Study|Lost to Follow-up|1
7925974|NCT02236988|12454280|FG000|Overall Study|Unable to Comply with Study Visits|0
7925975|NCT02236988|12454281|FG001|Overall Study|Unable to Comply with Study Visits|0
7925976|NCT02236988|12454282|FG002|Overall Study|Unable to Comply with Study Visits|0
7925977|NCT02236988|12454283|FG003|Overall Study|Unable to Comply with Study Visits|2
7925978|NCT02237001|12454334|FG000|Overall Study|Lost to Follow-up|2
7925979|NCT02237001|12454334|FG000|Overall Study|Withdrawal by Subject|1
7925980|NCT02237001|12454334|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3
7925981|NCT02237001|12454334|FG000|Overall Study|Re-operation|4
7925982|NCT02237001|12454334|FG000|Overall Study|Incarceration|1
7925983|NCT02237118|12454355|FG000|Overall Study|Protocol Violation|0
7925984|NCT02237118|12454356|FG001|Overall Study|Protocol Violation|1
7925985|NCT02237118|12454355|FG000|Overall Study|consent withdrawn|1
7925986|NCT02237118|12454356|FG001|Overall Study|consent withdrawn|0
7925987|NCT02237157|12454370|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3
7925988|NCT02237157|12454371|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
7925989|NCT02237157|12454372|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
7925990|NCT02237157|12454373|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
7925991|NCT02237157|12454370|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1
7925992|NCT02237157|12454371|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
7925993|NCT02237157|12454372|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
7925994|NCT02237157|12454373|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
7925995|NCT02237196|12454384|FG000|Overall Study|Adverse Event|0
7925996|NCT02237196|12454385|FG001|Overall Study|Adverse Event|1
7925997|NCT02237196|12454386|FG002|Overall Study|Adverse Event|1
7925998|NCT02237196|12454387|FG003|Overall Study|Adverse Event|0
7925999|NCT02237196|12454384|FG000|Overall Study|Lost to Follow-up|4
7926000|NCT02237196|12454385|FG001|Overall Study|Lost to Follow-up|2
7926001|NCT02237196|12454386|FG002|Overall Study|Lost to Follow-up|4
7926002|NCT02237196|12454387|FG003|Overall Study|Lost to Follow-up|6
7926003|NCT02237196|12454384|FG000|Overall Study|Physician Decision|2
7926004|NCT02237196|12454385|FG001|Overall Study|Physician Decision|0
7926005|NCT02237196|12454386|FG002|Overall Study|Physician Decision|0
7926006|NCT02237196|12454387|FG003|Overall Study|Physician Decision|1
7926007|NCT02237196|12454384|FG000|Overall Study|Pregnancy|0
7926008|NCT02237196|12454385|FG001|Overall Study|Pregnancy|0
7926009|NCT02237196|12454386|FG002|Overall Study|Pregnancy|1
7926010|NCT02237196|12454387|FG003|Overall Study|Pregnancy|1
7926011|NCT02237196|12454384|FG000|Overall Study|Withdrawal by Subject|1
7926012|NCT02237196|12454385|FG001|Overall Study|Withdrawal by Subject|1
7926013|NCT02237196|12454386|FG002|Overall Study|Withdrawal by Subject|4
7926014|NCT02237196|12454387|FG003|Overall Study|Withdrawal by Subject|1
7926015|NCT02237196|12454384|FG000|Overall Study|Site Error|1
7926016|NCT02237196|12454385|FG001|Overall Study|Site Error|2
7926017|NCT02237196|12454386|FG002|Overall Study|Site Error|0
7926018|NCT02237196|12454387|FG003|Overall Study|Site Error|2
7926019|NCT02237911|12454424|FG000|Overall Study|Withdrawal by Subject|4
7926020|NCT02237911|12454425|FG001|Overall Study|Withdrawal by Subject|7
7926021|NCT02237911|12454426|FG002|Overall Study|Withdrawal by Subject|2
7926022|NCT02237911|12454424|FG000|Overall Study|Lost to Follow-up|3
7926023|NCT02237911|12454425|FG001|Overall Study|Lost to Follow-up|1
7926024|NCT02237911|12454426|FG002|Overall Study|Lost to Follow-up|1
7926025|NCT02238067|12454464|FG000|Overall Study|Not completed survey at Month 6|45
7926026|NCT02238080|12454468|FG000|Overall Study|Death|13
7926027|NCT02238080|12454468|FG000|Overall Study|Treatment interrupted|6
7926028|NCT02238080|12454468|FG000|Overall Study|Withdrawal by Subject|2
7926029|NCT02238080|12454468|FG000|Overall Study|Other|4
7926030|NCT02238379|12454474|FG000|Overall Study|Lost to Follow-up|1
7926031|NCT02238379|12454475|FG001|Overall Study|Lost to Follow-up|0
7926032|NCT02238483|12454483|FG000|Overall Study|Withdrawal by Subject|2
7926033|NCT02238483|12454484|FG001|Overall Study|Withdrawal by Subject|7
7926034|NCT02238483|12454483|FG000|Overall Study|Lost to Follow-up|1
7926035|NCT02238483|12454484|FG001|Overall Study|Lost to Follow-up|1
7926036|NCT02238483|12454483|FG000|Overall Study|Protocol Violation|1
7926037|NCT02238483|12454484|FG001|Overall Study|Protocol Violation|2
7926038|NCT02238483|12454483|FG000|Overall Study|Death|1
7926039|NCT02238483|12454484|FG001|Overall Study|Death|0
7926040|NCT02238483|12454483|FG000|Overall Study|Adverse Event|7
7926041|NCT02238483|12454484|FG001|Overall Study|Adverse Event|3
7926042|NCT02238483|12454483|FG000|Overall Study|Withdrawn due to physician decision|1
7926043|NCT02238483|12454484|FG001|Overall Study|Withdrawn due to physician decision|0
7926044|NCT02238483|12454483|FG000|Overall Study|Completion status not recorded|1
7926045|NCT02238483|12454484|FG001|Overall Study|Completion status not recorded|1
7926046|NCT02238483|12454483|FG000|Overall Study|Illness in family member|1
7926047|NCT02238483|12454484|FG001|Overall Study|Illness in family member|0
7926048|NCT02238626|12454494|FG000|Overall Study|Adverse Event|3
7926049|NCT02238626|12454495|FG001|Overall Study|Adverse Event|5
7926050|NCT02238626|12454496|FG002|Overall Study|Adverse Event|0
7926051|NCT02238626|12454497|FG003|Overall Study|Adverse Event|3
7926052|NCT02238626|12454494|FG000|Overall Study|Lost to Follow-up|2
7926053|NCT02238626|12454495|FG001|Overall Study|Lost to Follow-up|4
7926054|NCT02238626|12454496|FG002|Overall Study|Lost to Follow-up|2
7926055|NCT02238626|12454497|FG003|Overall Study|Lost to Follow-up|2
7926056|NCT02238626|12454494|FG000|Overall Study|Withdrawal by Subject|0
7926057|NCT02238626|12454495|FG001|Overall Study|Withdrawal by Subject|3
7926058|NCT02238626|12454496|FG002|Overall Study|Withdrawal by Subject|0
7926059|NCT02238626|12454497|FG003|Overall Study|Withdrawal by Subject|1
7926060|NCT02238626|12454494|FG000|Overall Study|Death|0
7926061|NCT02238626|12454495|FG001|Overall Study|Death|0
7926062|NCT02238626|12454496|FG002|Overall Study|Death|1
7926063|NCT02238626|12454497|FG003|Overall Study|Death|1
7926064|NCT02238626|12454494|FG000|Overall Study|Other|0
7926065|NCT02238626|12454495|FG001|Overall Study|Other|2
7926066|NCT02238626|12454496|FG002|Overall Study|Other|0
7926067|NCT02238626|12454497|FG003|Overall Study|Other|0
7926068|NCT02239094|12454544|FG000|Overall Study|Withdrawal by Subject|1
7926069|NCT02239094|12454544|FG000|Overall Study|Remitted before started|1
7926070|NCT02239120|12454550|FG000|Overall Study|Death|56
7926071|NCT02239120|12454551|FG001|Overall Study|Death|58
7926072|NCT02239120|12454550|FG000|Overall Study|Lost to Follow-up|19
7926073|NCT02239120|12454551|FG001|Overall Study|Lost to Follow-up|14
7926074|NCT02239224|12454561|FG000|Overall Study|Administrative|0
7926075|NCT02239224|12454562|FG001|Overall Study|Administrative|0
7926076|NCT02239224|12454563|FG002|Overall Study|Administrative|3
7926077|NCT02239224|12454564|FG003|Overall Study|Administrative|1
7926078|NCT02239263|12454574|FG000|Overall Study|Protocol Violation|6
7926079|NCT02239328|12454584|FG000|Overall Study|Benign disease noted at time of surgery|6
7926080|NCT02239328|12454584|FG000|Overall Study|Equipment or website malfunction|2
7926081|NCT02239510|12454594|FG000|Overall Study|Lost to Follow-up|2
7926082|NCT02239510|12454595|FG001|Overall Study|Lost to Follow-up|1
7926083|NCT02239536|12454603|FG000|Overall Study|Non-neoplastic polyp|23
7926084|NCT02239536|12454604|FG001|Overall Study|Non-neoplastic polyp|17
7926085|NCT02239601|12454639|FG000|Overall Study|Withdrawal by Subject|3
7926086|NCT02239601|12454640|FG001|Overall Study|Withdrawal by Subject|4
7926087|NCT02239601|12454639|FG000|Overall Study|Protocol Violation|4
7926088|NCT02239601|12454640|FG001|Overall Study|Protocol Violation|2
7926089|NCT02239640|12454651|FG000|Overall Study|Withdrawal by Subject|3
7926090|NCT02239640|12454651|FG000|Overall Study|Lost to Follow-up|72
7926091|NCT02239640|12454651|FG000|Overall Study|Death|142
7926092|NCT02239679|12454664|FG000|Overall Study|Lost to Follow-up|1
7926093|NCT02239679|12454665|FG001|Overall Study|Lost to Follow-up|0
7926094|NCT02239679|12454666|FG002|Overall Study|Lost to Follow-up|0
7926095|NCT02239679|12454664|FG000|Overall Study|Withdrawal by Subject|2
7926096|NCT02239679|12454665|FG001|Overall Study|Withdrawal by Subject|3
7926097|NCT02239679|12454666|FG002|Overall Study|Withdrawal by Subject|1
7926098|NCT02239692|12454676|FG000|Overall Study|Incomplete colonoscopy|1
7926099|NCT02239692|12454677|FG001|Overall Study|Incomplete colonoscopy|2
7926100|NCT02239692|12454676|FG000|Overall Study|Adverse Event|0
7926101|NCT02239692|12454677|FG001|Overall Study|Adverse Event|1
7926102|NCT02239692|12454676|FG000|Overall Study|Physician Decision|0
7926103|NCT02239692|12454677|FG001|Overall Study|Physician Decision|1
7926104|NCT02239692|12454676|FG000|Overall Study|Lost to Follow-up|1
7926105|NCT02239692|12454677|FG001|Overall Study|Lost to Follow-up|4
7926106|NCT02239692|12454676|FG000|Overall Study|Withdrawal by Subject|3
7926107|NCT02239692|12454677|FG001|Overall Study|Withdrawal by Subject|5
7926108|NCT02239692|12454676|FG000|Overall Study|Other reason|1
7926109|NCT02239692|12454677|FG001|Overall Study|Other reason|0
7926110|NCT02239939|12454728|FG000|Overall Study|Adverse Event|1
7926111|NCT02239939|12454729|FG001|Overall Study|Adverse Event|0
7926112|NCT02239939|12454728|FG000|Overall Study|Withdrawal by Subject|1
7926113|NCT02239939|12454729|FG001|Overall Study|Withdrawal by Subject|1
7926114|NCT02239939|12454728|FG000|Overall Study|Lost to Follow-up|0
7926115|NCT02239939|12454729|FG001|Overall Study|Lost to Follow-up|1
7926116|NCT02239978|12454739|FG000|Overall Study|Withdrawal by Subject|2
7926117|NCT02239978|12454740|FG001|Overall Study|Withdrawal by Subject|0
7926118|NCT02240108|12454765|FG000|Overall Study|Other than specified|8
7926119|NCT02240108|12454766|FG001|Overall Study|Other than specified|6
7926120|NCT02240108|12454765|FG000|Overall Study|Adverse Event|1
7926121|NCT02240108|12454766|FG001|Overall Study|Adverse Event|9
7926122|NCT02240108|12454765|FG000|Overall Study|Pregnancy|1
7926123|NCT02240108|12454766|FG001|Overall Study|Pregnancy|0
7926124|NCT02240108|12454765|FG000|Overall Study|Withdrawal by Subject|4
7926125|NCT02240108|12454766|FG001|Overall Study|Withdrawal by Subject|9
7926126|NCT02240108|12454765|FG000|Overall Study|StudyTerminated by Sponsor|0
7926127|NCT02240108|12454766|FG001|Overall Study|StudyTerminated by Sponsor|1
7926128|NCT02240121|12454774|FG000|Overall Study|Protocol Violation|1
7926129|NCT02240121|12454775|FG001|Overall Study|Protocol Violation|2
7926130|NCT02240121|12454774|FG000|Overall Study|Physician Decision|0
7926131|NCT02240121|12454775|FG001|Overall Study|Physician Decision|1
7926132|NCT02240121|12454774|FG000|Overall Study|Change in protocol interpretation|1
7926133|NCT02240121|12454775|FG001|Overall Study|Change in protocol interpretation|0
7926134|NCT02240121|12454774|FG000|Overall Study|Lack of Efficacy|2
7926135|NCT02240121|12454775|FG001|Overall Study|Lack of Efficacy|3
7926136|NCT02240121|12454774|FG000|Overall Study|Site closed|1
7926137|NCT02240121|12454775|FG001|Overall Study|Site closed|1
7926138|NCT02240121|12454774|FG000|Overall Study|Pregnancy|1
7926139|NCT02240121|12454775|FG001|Overall Study|Pregnancy|0
7926140|NCT02240121|12454774|FG000|Overall Study|Adverse Event|2
7926141|NCT02240121|12454775|FG001|Overall Study|Adverse Event|4
7926142|NCT02240121|12454774|FG000|Overall Study|Withdrawal by Subject|6
7926143|NCT02240121|12454775|FG001|Overall Study|Withdrawal by Subject|2
7926144|NCT02240121|12454774|FG000|Overall Study|Lost to Follow-up|3
7926145|NCT02240121|12454775|FG001|Overall Study|Lost to Follow-up|4
7926146|NCT02240121|12454774|FG000|Overall Study|Other than specified|1
7926147|NCT02240121|12454775|FG001|Overall Study|Other than specified|3
7926148|NCT02240368|12454795|FG000|Overall Study|Surgery lasted less then 20 minutes|1
7926149|NCT02240368|12454796|FG001|Overall Study|Surgery lasted less then 20 minutes|0
7926150|NCT02240368|12454797|FG002|Overall Study|Surgery lasted less then 20 minutes|0
7926151|NCT02240368|12454795|FG000|Overall Study|Entropy failed to detect more than 50%|0
7926152|NCT02240368|12454796|FG001|Overall Study|Entropy failed to detect more than 50%|0
7926153|NCT02240368|12454797|FG002|Overall Study|Entropy failed to detect more than 50%|1
7926154|NCT02240628|12454816|FG000|Overall Study|Physician Decision|6
7926155|NCT02240628|12454817|FG001|Overall Study|Physician Decision|5
7964602|NCT04048382|12520154|FG000|3-Month Follow Up|Enrolled but did not complete survey|2
7964603|NCT04048382|12520155|FG001|3-Month Follow Up|Enrolled but did not complete survey|0
7964604|NCT04048382|12520154|FG000|3-Month Follow Up|Withdrawal by Subject|0
7964605|NCT04048382|12520155|FG001|3-Month Follow Up|Withdrawal by Subject|1
7964606|NCT04048382|12520154|FG000|6-Month Follow up|Enrolled but did not complete survey|2
7964607|NCT04048382|12520155|FG001|6-Month Follow up|Enrolled but did not complete survey|0
7964608|NCT03928821|12520165|FG000|Overall Study|Death|0
7964609|NCT03928821|12520166|FG001|Overall Study|Death|1
7964610|NCT03928821|12520167|FG002|Overall Study|Death|0
7964611|NCT03928821|12520168|FG003|Overall Study|Death|0
7964612|NCT03928821|12520165|FG000|Overall Study|Lost to Follow-up|0
7964613|NCT03928821|12520166|FG001|Overall Study|Lost to Follow-up|2
7964614|NCT03928821|12520167|FG002|Overall Study|Lost to Follow-up|3
7964615|NCT03928821|12520168|FG003|Overall Study|Lost to Follow-up|0
7964616|NCT03928821|12520165|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0
7964617|NCT03928821|12520166|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0
7964618|NCT03928821|12520167|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0
7964619|NCT03928821|12520168|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1
7967048|NCT02760407|12523610|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
7967049|NCT02760407|12523611|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1
7967050|NCT02760407|12523612|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
7967051|NCT02760407|12523609|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1
7967052|NCT02760407|12523610|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
7967053|NCT02760407|12523611|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
7967054|NCT02760407|12523612|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
7967055|NCT02760407|12523609|FG000|Overall Study|Investigator's Decision (Adverse Event)|0
7967056|NCT02760407|12523610|FG001|Overall Study|Investigator's Decision (Adverse Event)|1
7967057|NCT02760407|12523611|FG002|Overall Study|Investigator's Decision (Adverse Event)|0
7967058|NCT02760407|12523612|FG003|Overall Study|Investigator's Decision (Adverse Event)|0
7967059|NCT02760407|12523609|FG000|Overall Study|Inadequately Enrolled|0
7967060|NCT02760407|12523610|FG001|Overall Study|Inadequately Enrolled|0
7967061|NCT02760407|12523611|FG002|Overall Study|Inadequately Enrolled|0
7967062|NCT02760407|12523612|FG003|Overall Study|Inadequately Enrolled|1
7967063|NCT02760407|12523609|FG000|Overall Study|Withdrawal By PI's Decision|0
7967064|NCT02760407|12523610|FG001|Overall Study|Withdrawal By PI's Decision|1
7967065|NCT02760407|12523611|FG002|Overall Study|Withdrawal By PI's Decision|0
7967066|NCT02760407|12523612|FG003|Overall Study|Withdrawal By PI's Decision|0
7967067|NCT02760407|12523609|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1
7967068|NCT02760407|12523610|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0
7967069|NCT02760407|12523611|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1
7967070|NCT02760407|12523612|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0
7967071|NCT02760407|12523609|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
7926156|NCT02240680|12454855|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6
7926157|NCT02240680|12454856|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6
7926158|NCT02240680|12454857|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0
7926159|NCT02240680|12454858|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0
7926160|NCT02240680|12454855|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4
7926161|NCT02240680|12454856|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1
7926162|NCT02240680|12454857|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0
7926163|NCT02240680|12454858|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0
7926164|NCT02240680|12454855|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
7926165|NCT02240680|12454856|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
7964620|NCT03856996|12520180|FG000|Overall Study|Withdrawal by Subject|1
7821988|NCT01259388|12290981|FG000|Overall Study|Adverse Event|3
7821989|NCT01259388|12290982|FG001|Overall Study|Adverse Event|0
7821990|NCT01259388|12290981|FG000|Overall Study|Withdrawal by Subject|1
7821991|NCT01259388|12290982|FG001|Overall Study|Withdrawal by Subject|1
7821992|NCT01259388|12290981|FG000|Overall Study|Physician Decision|1
7821993|NCT01259388|12290982|FG001|Overall Study|Physician Decision|0
7821994|NCT01259401|12290990|FG000|4-month Follow-up|Death|0
7821995|NCT01259401|12290991|FG001|4-month Follow-up|Death|1
7821996|NCT01259401|12290990|FG000|4-month Follow-up|Lost to Follow-up|0
7821997|NCT01259401|12290991|FG001|4-month Follow-up|Lost to Follow-up|1
7821998|NCT01259466|12291018|FG000|Overall Study|Withdrawal by Subject|1
7821999|NCT01259466|12291019|FG001|Overall Study|Withdrawal by Subject|9
7822000|NCT01259492|12291029|FG000|Period 1 (9 Weeks)|Adverse Event|13
7822001|NCT01259492|12291030|FG001|Period 1 (9 Weeks)|Adverse Event|18
7822002|NCT01259492|12291031|FG002|Period 1 (9 Weeks)|Adverse Event|26
7822003|NCT01259492|12291032|FG003|Period 1 (9 Weeks)|Adverse Event|3
7822004|NCT01259492|12291029|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2
7822005|NCT01259492|12291030|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2
7822006|NCT01259492|12291031|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4
7822007|NCT01259492|12291032|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11
7822008|NCT01259492|12291029|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5
7822009|NCT01259492|12291030|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8
7822010|NCT01259492|12291031|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6
7822011|NCT01259492|12291032|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7
7822012|NCT01259492|12291029|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4
7822013|NCT01259492|12291030|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6
7822014|NCT01259492|12291031|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3
7822015|NCT01259492|12291032|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4
7822016|NCT01259492|12291029|FG000|Period 1 (9 Weeks)|Administrative Problems|0
7822017|NCT01259492|12291030|FG001|Period 1 (9 Weeks)|Administrative Problems|1
7822018|NCT01259492|12291031|FG002|Period 1 (9 Weeks)|Administrative Problems|1
7822019|NCT01259492|12291032|FG003|Period 1 (9 Weeks)|Administrative Problems|2
7822020|NCT01259492|12291029|FG000|Period 1 (9 Weeks)|Protocol Violation|5
7822021|NCT01259492|12291030|FG001|Period 1 (9 Weeks)|Protocol Violation|6
7822022|NCT01259492|12291031|FG002|Period 1 (9 Weeks)|Protocol Violation|3
7822023|NCT01259492|12291032|FG003|Period 1 (9 Weeks)|Protocol Violation|1
7822024|NCT01259492|12291029|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3
7822025|NCT01259492|12291030|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4
7822026|NCT01259492|12291031|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7
7822027|NCT01259492|12291032|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8
7822028|NCT01259492|12291029|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
7822029|NCT01259492|12291030|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
7822030|NCT01259492|12291031|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
7822031|NCT01259492|12291032|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
7822032|NCT01259492|12291029|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
7822033|NCT01259492|12291030|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
7822034|NCT01259492|12291031|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
7822035|NCT01259492|12291032|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
7822036|NCT01259492|12291029|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
7822037|NCT01259492|12291030|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
7822038|NCT01259492|12291031|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
7822039|NCT01259492|12291032|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
7822040|NCT01259492|12291029|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0
7822041|NCT01259492|12291030|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2
7822042|NCT01259492|12291031|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1
7822043|NCT01259492|12291032|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0
7822044|NCT01259492|12291029|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
7822045|NCT01259492|12291030|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
7822046|NCT01259492|12291031|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
7822047|NCT01259492|12291032|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
7822048|NCT01259492|12291029|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
7822049|NCT01259492|12291030|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
7822050|NCT01259492|12291031|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
7822051|NCT01259492|12291032|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
7822052|NCT01259492|12291029|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
7822053|NCT01259492|12291030|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
7822054|NCT01259492|12291031|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
7822055|NCT01259492|12291032|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
7822056|NCT01259492|12291029|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
7822057|NCT01259492|12291030|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
7822058|NCT01259492|12291031|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
7822059|NCT01259492|12291032|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
7926166|NCT02240680|12454857|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
7926167|NCT02240680|12454858|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
7926168|NCT02240680|12454855|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
7926169|NCT02240680|12454856|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
7926170|NCT02240680|12454857|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
7926171|NCT02240680|12454858|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
7926172|NCT02240680|12454855|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1
7926173|NCT02240680|12454856|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0
7926174|NCT02240680|12454857|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0
7926175|NCT02240680|12454858|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0
7926176|NCT02240680|12454855|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
7926177|NCT02240680|12454856|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
7926178|NCT02240680|12454857|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
7926179|NCT02240680|12454858|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
7926180|NCT02240680|12454855|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
7926181|NCT02240680|12454856|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
7926182|NCT02240680|12454857|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
7926183|NCT02240680|12454858|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
7926184|NCT02240680|12454855|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
7926185|NCT02240680|12454856|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
7926186|NCT02240680|12454857|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
7926187|NCT02240680|12454858|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
7926188|NCT02240693|12454871|FG000|Overall Study|Adverse Event|0
7926189|NCT02240693|12454872|FG001|Overall Study|Adverse Event|0
7926190|NCT02240693|12454873|FG002|Overall Study|Adverse Event|0
7926191|NCT02240693|12454874|FG003|Overall Study|Adverse Event|0
7926192|NCT02240693|12454875|FG004|Overall Study|Adverse Event|1
7926193|NCT02240693|12454871|FG000|Overall Study|Withdrawal by Subject|0
7926194|NCT02240693|12454872|FG001|Overall Study|Withdrawal by Subject|0
7926195|NCT02240693|12454873|FG002|Overall Study|Withdrawal by Subject|2
7926196|NCT02240693|12454874|FG003|Overall Study|Withdrawal by Subject|1
7926197|NCT02240693|12454875|FG004|Overall Study|Withdrawal by Subject|0
7926198|NCT02240693|12454871|FG000|Overall Study|Other than specified|0
7926199|NCT02240693|12454872|FG001|Overall Study|Other than specified|0
7926200|NCT02240693|12454873|FG002|Overall Study|Other than specified|2
7926201|NCT02240693|12454874|FG003|Overall Study|Other than specified|0
7926202|NCT02240693|12454875|FG004|Overall Study|Other than specified|0
7926203|NCT02240706|12454894|FG000|Overall Study|Lack of Efficacy|2
7926204|NCT02240706|12454895|FG001|Overall Study|Lack of Efficacy|2
7926205|NCT02240706|12454896|FG002|Overall Study|Lack of Efficacy|2
7926206|NCT02240706|12454897|FG003|Overall Study|Lack of Efficacy|2
7926207|NCT02240706|12454898|FG004|Overall Study|Lack of Efficacy|5
7926208|NCT02240706|12454899|FG005|Overall Study|Lack of Efficacy|0
7926209|NCT02240706|12454900|FG006|Overall Study|Lack of Efficacy|0
7926210|NCT02240706|12454894|FG000|Overall Study|Adverse Event|1
7926211|NCT02240706|12454895|FG001|Overall Study|Adverse Event|0
7926212|NCT02240706|12454896|FG002|Overall Study|Adverse Event|1
7926213|NCT02240706|12454897|FG003|Overall Study|Adverse Event|0
7926214|NCT02240706|12454898|FG004|Overall Study|Adverse Event|2
7926215|NCT02240706|12454899|FG005|Overall Study|Adverse Event|0
7926216|NCT02240706|12454900|FG006|Overall Study|Adverse Event|0
7926217|NCT02240706|12454894|FG000|Overall Study|Progressive disease|0
7926218|NCT02240706|12454895|FG001|Overall Study|Progressive disease|0
7926219|NCT02240706|12454896|FG002|Overall Study|Progressive disease|0
7926220|NCT02240706|12454897|FG003|Overall Study|Progressive disease|0
7926221|NCT02240706|12454898|FG004|Overall Study|Progressive disease|1
7926222|NCT02240706|12454899|FG005|Overall Study|Progressive disease|0
7926223|NCT02240706|12454900|FG006|Overall Study|Progressive disease|0
7926224|NCT02240706|12454894|FG000|Overall Study|Dose limiting toxicity|0
7926225|NCT02240706|12454895|FG001|Overall Study|Dose limiting toxicity|0
7926226|NCT02240706|12454896|FG002|Overall Study|Dose limiting toxicity|0
7926227|NCT02240706|12454897|FG003|Overall Study|Dose limiting toxicity|0
7926228|NCT02240706|12454898|FG004|Overall Study|Dose limiting toxicity|1
7926229|NCT02240706|12454899|FG005|Overall Study|Dose limiting toxicity|0
7926230|NCT02240706|12454900|FG006|Overall Study|Dose limiting toxicity|0
7926231|NCT02240706|12454894|FG000|Overall Study|Refused to continue taking medication|0
7926232|NCT02240706|12454895|FG001|Overall Study|Refused to continue taking medication|1
7926233|NCT02240706|12454896|FG002|Overall Study|Refused to continue taking medication|3
7926234|NCT02240706|12454897|FG003|Overall Study|Refused to continue taking medication|1
7926235|NCT02240706|12454898|FG004|Overall Study|Refused to continue taking medication|2
7926236|NCT02240706|12454899|FG005|Overall Study|Refused to continue taking medication|0
7926237|NCT02240706|12454900|FG006|Overall Study|Refused to continue taking medication|0
7926238|NCT02240706|12454894|FG000|Overall Study|Insurance billing concerns|0
7926239|NCT02240706|12454895|FG001|Overall Study|Insurance billing concerns|0
7926240|NCT02240706|12454896|FG002|Overall Study|Insurance billing concerns|0
7926241|NCT02240706|12454897|FG003|Overall Study|Insurance billing concerns|1
7926242|NCT02240706|12454898|FG004|Overall Study|Insurance billing concerns|0
7926243|NCT02240706|12454899|FG005|Overall Study|Insurance billing concerns|0
7926244|NCT02240706|12454900|FG006|Overall Study|Insurance billing concerns|0
7926245|NCT02241512|12454931|FG000|Overall Study|Pump malfunction, drug not delivered|1
7926246|NCT02241512|12454932|FG001|Overall Study|Pump malfunction, drug not delivered|0
7926247|NCT02241733|12454958|FG000|Overall Study|Lost to Follow-up|9
7926248|NCT02241733|12454959|FG001|Overall Study|Lost to Follow-up|4
7926249|NCT02241733|12454958|FG000|Overall Study|Physician Decision|6
7926250|NCT02241733|12454959|FG001|Overall Study|Physician Decision|2
7926251|NCT02241733|12454958|FG000|Overall Study|Withdrawal by Subject|0
7926252|NCT02241733|12454959|FG001|Overall Study|Withdrawal by Subject|2
7926253|NCT02241733|12454958|FG000|Overall Study|Death|0
7926254|NCT02241733|12454959|FG001|Overall Study|Death|2
7926255|NCT02241785|12454965|FG000|Overall Study|Sponsor Termination|43
7926256|NCT02241785|12454965|FG000|Overall Study|Withdrawal by Subject|1
7926257|NCT02241785|12454965|FG000|Overall Study|Lost to Follow-up|2
7926258|NCT02241785|12454965|FG000|Overall Study|Adverse Event|1
7926259|NCT02241889|12454969|FG000|Overall Study|device issues|0
7926260|NCT02241889|12454970|FG001|Overall Study|device issues|0
7926261|NCT02241889|12454971|FG002|Overall Study|device issues|1
7926262|NCT02241889|12454972|FG003|Overall Study|device issues|0
7926263|NCT02241889|12454973|FG004|Overall Study|device issues|0
7926264|NCT02241889|12454974|FG005|Overall Study|device issues|0
7926265|NCT02241889|12454969|FG000|Overall Study|Withdrawal by Subject|0
7926266|NCT02241889|12454970|FG001|Overall Study|Withdrawal by Subject|0
7926267|NCT02241889|12454971|FG002|Overall Study|Withdrawal by Subject|0
7926268|NCT02241889|12454972|FG003|Overall Study|Withdrawal by Subject|0
7926269|NCT02241889|12454973|FG004|Overall Study|Withdrawal by Subject|0
7926270|NCT02241889|12454974|FG005|Overall Study|Withdrawal by Subject|1
7926271|NCT02242045|12454986|FG000|Overall Study|Investigator's Discretion|1
7926272|NCT02242045|12454986|FG000|Overall Study|Progressive Disease|2
7926273|NCT02242045|12454986|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1
7926274|NCT02242045|12454986|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2
7926275|NCT02242201|12454993|FG000|Overall Study|preoperative identified neuropathy|2
7926276|NCT02242201|12454994|FG001|Overall Study|preoperative identified neuropathy|0
7926277|NCT02242201|12454995|FG002|Overall Study|preoperative identified neuropathy|0
7926278|NCT02242201|12454993|FG000|Overall Study|planned post-op anticoagulation|1
7926279|NCT02242201|12454994|FG001|Overall Study|planned post-op anticoagulation|0
7926280|NCT02242201|12454995|FG002|Overall Study|planned post-op anticoagulation|0
7926281|NCT02242201|12454993|FG000|Overall Study|changed surgical procedure|1
7926282|NCT02242201|12454994|FG001|Overall Study|changed surgical procedure|0
7926283|NCT02242201|12454995|FG002|Overall Study|changed surgical procedure|0
7926284|NCT02242201|12454993|FG000|Overall Study|postponed surgery|0
7926285|NCT02242201|12454994|FG001|Overall Study|postponed surgery|0
7926286|NCT02242201|12454995|FG002|Overall Study|postponed surgery|1
7926287|NCT02242201|12454993|FG000|Overall Study|preoperative opioid consumption|0
7926288|NCT02242201|12454994|FG001|Overall Study|preoperative opioid consumption|1
7926289|NCT02242201|12454995|FG002|Overall Study|preoperative opioid consumption|0
7926290|NCT02242305|12455005|FG000|Overall Study|Without spasm-like pain during 3 weeks|1
7926291|NCT02242305|12455006|FG001|Overall Study|Without spasm-like pain during 3 weeks|4
7926292|NCT02242305|12455005|FG000|Overall Study|Adverse Event|1
7926293|NCT02242305|12455006|FG001|Overall Study|Adverse Event|0
7926294|NCT02242305|12455005|FG000|Overall Study|Non-compliance dosing regimen or visit|2
7926295|NCT02242305|12455006|FG001|Overall Study|Non-compliance dosing regimen or visit|2
7926296|NCT02242305|12455005|FG000|Overall Study|Subject withdraws inform consent|0
7926297|NCT02242305|12455006|FG001|Overall Study|Subject withdraws inform consent|4
7926298|NCT02242305|12455005|FG000|Overall Study|Lost to Follow-up|2
7926299|NCT02242305|12455006|FG001|Overall Study|Lost to Follow-up|0
7926300|NCT02242487|12455014|FG000|Overall Study|Adverse Event|13
7926301|NCT02242487|12455015|FG001|Overall Study|Adverse Event|15
7926302|NCT02242487|12455014|FG000|Overall Study|Lack of Efficacy|4
7926303|NCT02242487|12455015|FG001|Overall Study|Lack of Efficacy|6
7926304|NCT02242487|12455014|FG000|Overall Study|Protocol Violation|2
7926305|NCT02242487|12455015|FG001|Overall Study|Protocol Violation|0
7926306|NCT02242487|12455014|FG000|Overall Study|Lost to Follow-up|2
7926307|NCT02242487|12455015|FG001|Overall Study|Lost to Follow-up|1
7926308|NCT02242487|12455014|FG000|Overall Study|Other - Miscellaneous|4
7926309|NCT02242487|12455015|FG001|Overall Study|Other - Miscellaneous|6
7926310|NCT02242487|12455014|FG000|Overall Study|Withdrawal by Subject|37
7926311|NCT02242487|12455015|FG001|Overall Study|Withdrawal by Subject|19
7926312|NCT02242643|12455042|FG000|Overall Study|Protocol Violation|1
7926313|NCT02242643|12455043|FG001|Overall Study|Protocol Violation|2
7926314|NCT02242643|12455042|FG000|Overall Study|Withdrawal by Subject|15
7926315|NCT02242643|12455043|FG001|Overall Study|Withdrawal by Subject|10
7926316|NCT02242643|12455042|FG000|Overall Study|Migrated/moved from study area|1
7926317|NCT02242643|12455043|FG001|Overall Study|Migrated/moved from study area|3
7926318|NCT02242643|12455042|FG000|Overall Study|Lost to Follow-up|54
7926319|NCT02242643|12455043|FG001|Overall Study|Lost to Follow-up|61
7926320|NCT02242643|12455042|FG000|Overall Study|Child placed in foster care by family|0
7926321|NCT02242643|12455043|FG001|Overall Study|Child placed in foster care by family|1
7926322|NCT02242643|12455042|FG000|Overall Study|Non-compliance|1
7926323|NCT02242643|12455043|FG001|Overall Study|Non-compliance|0
7926324|NCT02242643|12455042|FG000|Overall Study|Consent withdrawal by parent|1
7926325|NCT02242643|12455043|FG001|Overall Study|Consent withdrawal by parent|0
7926326|NCT02242643|12455042|FG000|Overall Study|Protocol requirements not followed|1
7926327|NCT02242643|12455043|FG001|Overall Study|Protocol requirements not followed|0
7926328|NCT02242643|12455042|FG000|Overall Study|Language barrier|1
7926329|NCT02242643|12455043|FG001|Overall Study|Language barrier|0
7926330|NCT02242643|12455042|FG000|Overall Study|Withdrawal by subject at Visit 2|0
7926331|NCT02242643|12455043|FG001|Overall Study|Withdrawal by subject at Visit 2|1
7926332|NCT02242903|12455058|FG000|Overall Study|Withdrawal by Subject|1
7926333|NCT02242903|12455059|FG001|Overall Study|Withdrawal by Subject|0
7926334|NCT02242903|12455060|FG002|Overall Study|Withdrawal by Subject|0
7926335|NCT02242903|12455061|FG003|Overall Study|Withdrawal by Subject|0
7926336|NCT02242903|12455062|FG004|Overall Study|Withdrawal by Subject|0
7926337|NCT02242903|12455063|FG005|Overall Study|Withdrawal by Subject|0
7926338|NCT02242903|12455064|FG006|Overall Study|Withdrawal by Subject|0
7926339|NCT02242981|12455086|FG000|Overall Study|Withdrawal by Subject|1
7926340|NCT02243046|12455106|FG000|Overall Study|Lost to Follow-up|1
7926341|NCT02243046|12455107|FG001|Overall Study|Lost to Follow-up|1
7926342|NCT02243046|12455108|FG002|Overall Study|Lost to Follow-up|4
7926343|NCT02243176|12455118|FG000|Overall Study|Other reason|1
7926344|NCT02243176|12455119|FG001|Overall Study|Other reason|2
7926345|NCT02243176|12455118|FG000|Overall Study|protocol specified withdrawal critera|1
7926346|NCT02243176|12455119|FG001|Overall Study|protocol specified withdrawal critera|3
7926347|NCT02243176|12455118|FG000|Overall Study|Protocol Violation|2
7926348|NCT02243176|12455119|FG001|Overall Study|Protocol Violation|1
7926349|NCT02243176|12455118|FG000|Overall Study|Withdrawal by Subject|8
7926350|NCT02243176|12455119|FG001|Overall Study|Withdrawal by Subject|7
7926351|NCT02243176|12455118|FG000|Overall Study|Adverse Event|2
7926352|NCT02243176|12455119|FG001|Overall Study|Adverse Event|2
7926353|NCT02243202|12455129|FG000|Overall Study|Adverse Event|5
7926354|NCT02243202|12455130|FG001|Overall Study|Adverse Event|6
7926355|NCT02243202|12455131|FG002|Overall Study|Adverse Event|10
7926356|NCT02243202|12455132|FG003|Overall Study|Adverse Event|4
7926357|NCT02243202|12455129|FG000|Overall Study|Lost to Follow-up|9
7926358|NCT02243202|12455130|FG001|Overall Study|Lost to Follow-up|9
7926359|NCT02243202|12455131|FG002|Overall Study|Lost to Follow-up|14
7926360|NCT02243202|12455132|FG003|Overall Study|Lost to Follow-up|11
7926361|NCT02243202|12455129|FG000|Overall Study|Protocol Violation|3
7926362|NCT02243202|12455130|FG001|Overall Study|Protocol Violation|1
7926363|NCT02243202|12455131|FG002|Overall Study|Protocol Violation|2
7926364|NCT02243202|12455132|FG003|Overall Study|Protocol Violation|1
7926365|NCT02243202|12455129|FG000|Overall Study|Withdrawal by Subject|7
7926366|NCT02243202|12455130|FG001|Overall Study|Withdrawal by Subject|6
7926367|NCT02243202|12455131|FG002|Overall Study|Withdrawal by Subject|4
7926368|NCT02243202|12455132|FG003|Overall Study|Withdrawal by Subject|4
7926369|NCT02243202|12455129|FG000|Overall Study|Other|1
7926370|NCT02243202|12455130|FG001|Overall Study|Other|3
7926371|NCT02243202|12455131|FG002|Overall Study|Other|1
7926372|NCT02243202|12455132|FG003|Overall Study|Other|2
7926373|NCT02243202|12455129|FG000|Overall Study|Randomized but not received treatment|0
7926374|NCT02243202|12455130|FG001|Overall Study|Randomized but not received treatment|0
7926375|NCT02243202|12455131|FG002|Overall Study|Randomized but not received treatment|0
7926376|NCT02243202|12455132|FG003|Overall Study|Randomized but not received treatment|1
7926377|NCT02243280|12455153|FG000|Treated|Adverse Event|1
7926378|NCT02243280|12455154|FG001|Treated|Adverse Event|0
7926379|NCT02243280|12455155|FG002|Treated|Adverse Event|0
7926380|NCT02243280|12455156|FG003|Treated|Adverse Event|0
7926381|NCT02243280|12455157|FG004|Treated|Adverse Event|0
7926382|NCT02243280|12455158|FG005|Treated|Adverse Event|0
7926383|NCT02243280|12455159|FG006|Treated|Adverse Event|0
7926384|NCT02243280|12455160|FG007|Treated|Adverse Event|0
7926385|NCT02243280|12455161|FG008|Treated|Adverse Event|0
7926386|NCT02243280|12455162|FG009|Treated|Adverse Event|0
7926387|NCT02243280|12455163|FG010|Treated|Adverse Event|1
7926388|NCT02243280|12455153|FG000|Treated|Lost to Follow-up|0
7926389|NCT02243280|12455154|FG001|Treated|Lost to Follow-up|0
7926390|NCT02243280|12455155|FG002|Treated|Lost to Follow-up|0
7926391|NCT02243280|12455156|FG003|Treated|Lost to Follow-up|0
7926392|NCT02243280|12455157|FG004|Treated|Lost to Follow-up|0
7926393|NCT02243280|12455158|FG005|Treated|Lost to Follow-up|0
7926394|NCT02243280|12455159|FG006|Treated|Lost to Follow-up|0
7926395|NCT02243280|12455160|FG007|Treated|Lost to Follow-up|0
7926396|NCT02243280|12455161|FG008|Treated|Lost to Follow-up|1
7926397|NCT02243280|12455162|FG009|Treated|Lost to Follow-up|0
7926398|NCT02243280|12455163|FG010|Treated|Lost to Follow-up|2
7926399|NCT02243293|12455198|FG000|Overall Study|Adverse Event|1
7926400|NCT02243293|12455199|FG001|Overall Study|Adverse Event|0
7926401|NCT02243293|12455200|FG002|Overall Study|Adverse Event|0
7926402|NCT02243293|12455201|FG003|Overall Study|Adverse Event|0
7926403|NCT02243293|12455202|FG004|Overall Study|Adverse Event|0
7926404|NCT02243293|12455203|FG005|Overall Study|Adverse Event|0
7926405|NCT02243293|12455204|FG006|Overall Study|Adverse Event|0
7926406|NCT02243293|12455205|FG007|Overall Study|Adverse Event|0
7926407|NCT02243293|12455206|FG008|Overall Study|Adverse Event|0
7926408|NCT02243293|12455207|FG009|Overall Study|Adverse Event|0
7926409|NCT02243293|12455208|FG010|Overall Study|Adverse Event|0
7926410|NCT02243293|12455209|FG011|Overall Study|Adverse Event|0
7926411|NCT02243293|12455210|FG012|Overall Study|Adverse Event|0
7926412|NCT02243293|12455211|FG013|Overall Study|Adverse Event|0
7926413|NCT02243293|12455212|FG014|Overall Study|Adverse Event|0
7926414|NCT02243293|12455213|FG015|Overall Study|Adverse Event|1
7926415|NCT02243293|12455214|FG016|Overall Study|Adverse Event|0
7926416|NCT02243293|12455215|FG017|Overall Study|Adverse Event|0
7926417|NCT02243293|12455216|FG018|Overall Study|Adverse Event|0
7926418|NCT02243293|12455217|FG019|Overall Study|Adverse Event|0
7926419|NCT02243293|12455218|FG020|Overall Study|Adverse Event|1
7926420|NCT02243293|12455219|FG021|Overall Study|Adverse Event|0
7926421|NCT02243293|12455198|FG000|Overall Study|Withdrawal by Subject|1
7926422|NCT02243293|12455199|FG001|Overall Study|Withdrawal by Subject|0
7926423|NCT02243293|12455200|FG002|Overall Study|Withdrawal by Subject|0
7926424|NCT02243293|12455201|FG003|Overall Study|Withdrawal by Subject|0
7926425|NCT02243293|12455202|FG004|Overall Study|Withdrawal by Subject|0
7926426|NCT02243293|12455203|FG005|Overall Study|Withdrawal by Subject|0
7926427|NCT02243293|12455204|FG006|Overall Study|Withdrawal by Subject|0
7926428|NCT02243293|12455205|FG007|Overall Study|Withdrawal by Subject|0
7926429|NCT02243293|12455206|FG008|Overall Study|Withdrawal by Subject|0
7926430|NCT02243293|12455207|FG009|Overall Study|Withdrawal by Subject|1
7926431|NCT02243293|12455208|FG010|Overall Study|Withdrawal by Subject|0
7926432|NCT02243293|12455209|FG011|Overall Study|Withdrawal by Subject|1
7926433|NCT02243293|12455210|FG012|Overall Study|Withdrawal by Subject|0
7926434|NCT02243293|12455211|FG013|Overall Study|Withdrawal by Subject|0
7926435|NCT02243293|12455212|FG014|Overall Study|Withdrawal by Subject|0
7926436|NCT02243293|12455213|FG015|Overall Study|Withdrawal by Subject|0
7926437|NCT02243293|12455214|FG016|Overall Study|Withdrawal by Subject|0
7926438|NCT02243293|12455215|FG017|Overall Study|Withdrawal by Subject|0
7926439|NCT02243293|12455216|FG018|Overall Study|Withdrawal by Subject|0
7926440|NCT02243293|12455217|FG019|Overall Study|Withdrawal by Subject|0
7926441|NCT02243293|12455218|FG020|Overall Study|Withdrawal by Subject|0
7926442|NCT02243293|12455219|FG021|Overall Study|Withdrawal by Subject|1
7926443|NCT02243293|12455198|FG000|Overall Study|Lost to Follow-up|0
7926444|NCT02243293|12455199|FG001|Overall Study|Lost to Follow-up|1
7926445|NCT02243293|12455200|FG002|Overall Study|Lost to Follow-up|1
7926446|NCT02243293|12455201|FG003|Overall Study|Lost to Follow-up|1
7926447|NCT02243293|12455202|FG004|Overall Study|Lost to Follow-up|0
7926448|NCT02243293|12455203|FG005|Overall Study|Lost to Follow-up|0
7926449|NCT02243293|12455204|FG006|Overall Study|Lost to Follow-up|3
7926450|NCT02243293|12455205|FG007|Overall Study|Lost to Follow-up|0
7926451|NCT02243293|12455206|FG008|Overall Study|Lost to Follow-up|0
7926452|NCT02243293|12455207|FG009|Overall Study|Lost to Follow-up|0
7926453|NCT02243293|12455208|FG010|Overall Study|Lost to Follow-up|0
7926454|NCT02243293|12455209|FG011|Overall Study|Lost to Follow-up|2
7926455|NCT02243293|12455210|FG012|Overall Study|Lost to Follow-up|0
7926456|NCT02243293|12455211|FG013|Overall Study|Lost to Follow-up|0
7926457|NCT02243293|12455212|FG014|Overall Study|Lost to Follow-up|0
7926458|NCT02243293|12455213|FG015|Overall Study|Lost to Follow-up|0
7926459|NCT02243293|12455214|FG016|Overall Study|Lost to Follow-up|3
7926460|NCT02243293|12455215|FG017|Overall Study|Lost to Follow-up|1
7926461|NCT02243293|12455216|FG018|Overall Study|Lost to Follow-up|0
7926462|NCT02243293|12455217|FG019|Overall Study|Lost to Follow-up|0
7926463|NCT02243293|12455218|FG020|Overall Study|Lost to Follow-up|1
7926464|NCT02243293|12455219|FG021|Overall Study|Lost to Follow-up|2
7926465|NCT02243293|12455198|FG000|Overall Study|Enrolled into a Re-treatment Study|0
7926466|NCT02243293|12455199|FG001|Overall Study|Enrolled into a Re-treatment Study|0
7926467|NCT02243293|12455200|FG002|Overall Study|Enrolled into a Re-treatment Study|0
7926468|NCT02243293|12455201|FG003|Overall Study|Enrolled into a Re-treatment Study|0
7926469|NCT02243293|12455202|FG004|Overall Study|Enrolled into a Re-treatment Study|0
7926470|NCT02243293|12455203|FG005|Overall Study|Enrolled into a Re-treatment Study|0
7926471|NCT02243293|12455204|FG006|Overall Study|Enrolled into a Re-treatment Study|0
7926472|NCT02243293|12455205|FG007|Overall Study|Enrolled into a Re-treatment Study|0
7926473|NCT02243293|12455206|FG008|Overall Study|Enrolled into a Re-treatment Study|0
7926474|NCT02243293|12455207|FG009|Overall Study|Enrolled into a Re-treatment Study|0
7926475|NCT02243293|12455208|FG010|Overall Study|Enrolled into a Re-treatment Study|0
7926476|NCT02243293|12455209|FG011|Overall Study|Enrolled into a Re-treatment Study|0
7926477|NCT02243293|12455210|FG012|Overall Study|Enrolled into a Re-treatment Study|0
7926478|NCT02243293|12455211|FG013|Overall Study|Enrolled into a Re-treatment Study|0
7926479|NCT02243293|12455212|FG014|Overall Study|Enrolled into a Re-treatment Study|1
7926480|NCT02243293|12455213|FG015|Overall Study|Enrolled into a Re-treatment Study|0
7926481|NCT02243293|12455214|FG016|Overall Study|Enrolled into a Re-treatment Study|0
7926482|NCT02243293|12455215|FG017|Overall Study|Enrolled into a Re-treatment Study|0
7926483|NCT02243293|12455216|FG018|Overall Study|Enrolled into a Re-treatment Study|0
7926484|NCT02243293|12455217|FG019|Overall Study|Enrolled into a Re-treatment Study|0
7926485|NCT02243293|12455218|FG020|Overall Study|Enrolled into a Re-treatment Study|0
7926486|NCT02243293|12455219|FG021|Overall Study|Enrolled into a Re-treatment Study|0
7926487|NCT02243293|12455198|FG000|Overall Study|Randomized but did'nt receive study drug|0
7926488|NCT02243293|12455199|FG001|Overall Study|Randomized but did'nt receive study drug|0
7926489|NCT02243293|12455200|FG002|Overall Study|Randomized but did'nt receive study drug|0
7926490|NCT02243293|12455201|FG003|Overall Study|Randomized but did'nt receive study drug|0
7926491|NCT02243293|12455202|FG004|Overall Study|Randomized but did'nt receive study drug|1
7926492|NCT02243293|12455203|FG005|Overall Study|Randomized but did'nt receive study drug|0
7926493|NCT02243293|12455204|FG006|Overall Study|Randomized but did'nt receive study drug|0
7926494|NCT02243293|12455205|FG007|Overall Study|Randomized but did'nt receive study drug|0
7926495|NCT02243293|12455206|FG008|Overall Study|Randomized but did'nt receive study drug|0
7926496|NCT02243293|12455207|FG009|Overall Study|Randomized but did'nt receive study drug|1
7926497|NCT02243293|12455208|FG010|Overall Study|Randomized but did'nt receive study drug|0
7926498|NCT02243293|12455209|FG011|Overall Study|Randomized but did'nt receive study drug|0
7926499|NCT02243293|12455210|FG012|Overall Study|Randomized but did'nt receive study drug|0
7926500|NCT02243293|12455211|FG013|Overall Study|Randomized but did'nt receive study drug|0
7926501|NCT02243293|12455212|FG014|Overall Study|Randomized but did'nt receive study drug|0
7926502|NCT02243293|12455213|FG015|Overall Study|Randomized but did'nt receive study drug|0
7926503|NCT02243293|12455214|FG016|Overall Study|Randomized but did'nt receive study drug|0
7926504|NCT02243293|12455215|FG017|Overall Study|Randomized but did'nt receive study drug|0
7926505|NCT02243293|12455216|FG018|Overall Study|Randomized but did'nt receive study drug|0
7926506|NCT02243293|12455217|FG019|Overall Study|Randomized but did'nt receive study drug|1
7926507|NCT02243293|12455218|FG020|Overall Study|Randomized but did'nt receive study drug|0
7926508|NCT02243293|12455219|FG021|Overall Study|Randomized but did'nt receive study drug|0
7926509|NCT02243371|12455258|FG000|Overall Study|Progressive Disease (clinic & radio)|35
7926510|NCT02243371|12455259|FG001|Overall Study|Progressive Disease (clinic & radio)|24
7926511|NCT02243371|12455258|FG000|Overall Study|Death (unrelated)|2
7926512|NCT02243371|12455259|FG001|Overall Study|Death (unrelated)|4
7926513|NCT02243371|12455258|FG000|Overall Study|Adverse Event (unrelated)|0
7926514|NCT02243371|12455259|FG001|Overall Study|Adverse Event (unrelated)|1
7926515|NCT02243371|12455258|FG000|Overall Study|Lack of Clinical Benefit|0
7926516|NCT02243371|12455259|FG001|Overall Study|Lack of Clinical Benefit|1
7926517|NCT02243371|12455258|FG000|Overall Study|Withdrawal by Subject|0
7926518|NCT02243371|12455259|FG001|Overall Study|Withdrawal by Subject|2
7926519|NCT02243696|12455278|FG000|Overall Study|Death|282
7926520|NCT02243696|12455278|FG000|Overall Study|Withdrawal by Subject|79
7926521|NCT02243696|12455278|FG000|Overall Study|Lost to Follow-up|57
7926522|NCT02243696|12455278|FG000|Overall Study|Subject No Longer has Study System|42
7926523|NCT02243696|12455278|FG000|Overall Study|Subject Withdrawn by Investigator|273
7926524|NCT02243696|12455278|FG000|Overall Study|Study Terminated for EP PASSION|961
7926525|NCT02243865|12455284|FG000|Overall Study|Protocol Violation|1
7926526|NCT02243865|12455285|FG001|Overall Study|Protocol Violation|3
7926527|NCT02243865|12455284|FG000|Overall Study|Lost to Follow-up|1
7926528|NCT02243865|12455285|FG001|Overall Study|Lost to Follow-up|1
7926529|NCT02243865|12455284|FG000|Overall Study|Withdrawal by Subject|1
7926530|NCT02243865|12455285|FG001|Overall Study|Withdrawal by Subject|0
7926531|NCT02243865|12455284|FG000|Overall Study|Adverse Event|1
7926532|NCT02243865|12455285|FG001|Overall Study|Adverse Event|1
7926533|NCT02244424|12455304|FG000|Overall Study|Lost to Follow-up|20
7926534|NCT02244424|12455305|FG001|Overall Study|Lost to Follow-up|10
7926535|NCT02244580|12455311|FG000|Overall Study|No cancer tissues available|241
7926536|NCT02244619|12455321|FG000|Overall Study|Did not receive study intervention|8
7926537|NCT02244619|12455322|FG001|Overall Study|Did not receive study intervention|21
7926538|NCT02244957|12455344|FG000|Overall Study|Lack of Efficacy|1
7926539|NCT02244957|12455345|FG001|Overall Study|Lack of Efficacy|0
7926540|NCT02244996|12455355|FG000|Overall Study|Lack of Efficacy|2
7926541|NCT02244996|12455356|FG001|Overall Study|Lack of Efficacy|6
7926542|NCT02245412|12455378|FG000|Treatment Period|Death|1
7926543|NCT02245412|12455379|FG001|Treatment Period|Death|1
7926544|NCT02245412|12455380|FG002|Treatment Period|Death|0
7926545|NCT02245412|12455378|FG000|Treatment Period|Physician Decision|1
7926546|NCT02245412|12455379|FG001|Treatment Period|Physician Decision|1
7926547|NCT02245412|12455380|FG002|Treatment Period|Physician Decision|0
7926548|NCT02245412|12455378|FG000|Treatment Period|Withdrawal by Subject|2
7926549|NCT02245412|12455379|FG001|Treatment Period|Withdrawal by Subject|1
7926550|NCT02245412|12455380|FG002|Treatment Period|Withdrawal by Subject|0
7926551|NCT02245412|12455378|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1
7926552|NCT02245412|12455379|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0
7926553|NCT02245412|12455380|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0
7926554|NCT02245412|12455378|FG000|Follow-Up Period|Death|4
7926555|NCT02245412|12455379|FG001|Follow-Up Period|Death|2
7926556|NCT02245412|12455380|FG002|Follow-Up Period|Death|1
7926557|NCT02245412|12455378|FG000|Follow-Up Period|Physician Decision|1
7926558|NCT02245412|12455379|FG001|Follow-Up Period|Physician Decision|0
7926559|NCT02245412|12455380|FG002|Follow-Up Period|Physician Decision|0
7926560|NCT02245412|12455378|FG000|Follow-Up Period|Other - Terminated by Sponsor|0
7926561|NCT02245412|12455379|FG001|Follow-Up Period|Other - Terminated by Sponsor|0
7926562|NCT02245412|12455380|FG002|Follow-Up Period|Other - Terminated by Sponsor|1
7926563|NCT02245568|12455397|FG000|Overall Study|Study terminated by Sponsor|346
7926564|NCT02245568|12455397|FG000|Overall Study|Adverse Event|144
7926565|NCT02245568|12455397|FG000|Overall Study|Lack of Efficacy|98
7926566|NCT02245568|12455397|FG000|Overall Study|Withdrawal by Caregiver|85
7926567|NCT02245568|12455397|FG000|Overall Study|Withdrawal by Subject|77
7926568|NCT02245568|12455397|FG000|Overall Study|Withdrawal by Legal Representative|31
7926569|NCT02245568|12455397|FG000|Overall Study|Missing (Site closure)|16
7926570|NCT02245568|12455397|FG000|Overall Study|Physician Decision|14
7926571|NCT02245568|12455397|FG000|Overall Study|Non-compliance with study drug|11
7926572|NCT02245568|12455397|FG000|Overall Study|Death|9
7926573|NCT02245568|12455397|FG000|Overall Study|Blue staining|6
7926574|NCT02245568|12455397|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6
7926575|NCT02245568|12455397|FG000|Overall Study|Intolerance/dosing issues/interruption|5
7926576|NCT02245568|12455397|FG000|Overall Study|Lost to Follow-up|5
7926577|NCT02245620|12455403|FG000|Overall Study|Physician Decision|1
7926578|NCT02245620|12455404|FG001|Overall Study|Physician Decision|1
7926579|NCT02245737|12455413|FG000|Overall Study|Adverse Event|23
7926580|NCT02245737|12455414|FG001|Overall Study|Adverse Event|26
7926581|NCT02245737|12455415|FG002|Overall Study|Adverse Event|33
7926582|NCT02245737|12455413|FG000|Overall Study|Condition Worsened|9
7926583|NCT02245737|12455414|FG001|Overall Study|Condition Worsened|10
7926584|NCT02245737|12455415|FG002|Overall Study|Condition Worsened|9
7926585|NCT02245737|12455413|FG000|Overall Study|Death|2
7926586|NCT02245737|12455414|FG001|Overall Study|Death|4
7926587|NCT02245737|12455415|FG002|Overall Study|Death|4
7926588|NCT02245737|12455413|FG000|Overall Study|Eligibility Criteria No Longer Met|2
7926589|NCT02245737|12455414|FG001|Overall Study|Eligibility Criteria No Longer Met|4
7926590|NCT02245737|12455415|FG002|Overall Study|Eligibility Criteria No Longer Met|4
7926591|NCT02245737|12455413|FG000|Overall Study|Initiation of Symptomatic AD medication|2
7926592|NCT02245737|12455414|FG001|Overall Study|Initiation of Symptomatic AD medication|0
7926593|NCT02245737|12455415|FG002|Overall Study|Initiation of Symptomatic AD medication|0
7926594|NCT02245737|12455413|FG000|Overall Study|Lost to Follow-up|2
7926595|NCT02245737|12455414|FG001|Overall Study|Lost to Follow-up|5
7926596|NCT02245737|12455415|FG002|Overall Study|Lost to Follow-up|4
7926597|NCT02245737|12455413|FG000|Overall Study|Other-determined by Investigator|9
7926598|NCT02245737|12455414|FG001|Overall Study|Other-determined by Investigator|10
7926599|NCT02245737|12455415|FG002|Overall Study|Other-determined by Investigator|10
7926600|NCT02245737|12455413|FG000|Overall Study|Physician Decision|6
7926601|NCT02245737|12455414|FG001|Overall Study|Physician Decision|3
7926602|NCT02245737|12455415|FG002|Overall Study|Physician Decision|6
7926603|NCT02245737|12455413|FG000|Overall Study|Protocol Violation|3
7926604|NCT02245737|12455414|FG001|Overall Study|Protocol Violation|2
7926605|NCT02245737|12455415|FG002|Overall Study|Protocol Violation|3
7926606|NCT02245737|12455413|FG000|Overall Study|Withdrawal by Subject|40
7926607|NCT02245737|12455414|FG001|Overall Study|Withdrawal by Subject|41
7926608|NCT02245737|12455415|FG002|Overall Study|Withdrawal by Subject|44
7926609|NCT02245737|12455413|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10
7926610|NCT02245737|12455414|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20
7926611|NCT02245737|12455415|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22
7926612|NCT02245737|12455413|FG000|Overall Study|Sponsor Decision|445
7926613|NCT02245737|12455414|FG001|Overall Study|Sponsor Decision|430
7926614|NCT02245737|12455415|FG002|Overall Study|Sponsor Decision|432
7926615|NCT02246166|12455464|FG000|Overall Study|Protocol Violation|1
7926616|NCT02246166|12455465|FG001|Overall Study|Protocol Violation|0
7926617|NCT02246218|12455473|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7926618|NCT02246218|12455474|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7926619|NCT02246218|12455473|FG000|Overall Study|Stopping Rule: Liver Transplant|2
7926620|NCT02246218|12455474|FG001|Overall Study|Stopping Rule: Liver Transplant|4
7926621|NCT02246218|12455473|FG000|Overall Study|Adverse Event|1
7926622|NCT02246218|12455474|FG001|Overall Study|Adverse Event|1
7926623|NCT02246218|12455473|FG000|Overall Study|Lost to Follow-up|1
7926624|NCT02246218|12455474|FG001|Overall Study|Lost to Follow-up|0
7926625|NCT02246439|12455500|FG000|Overall Study|Adverse Event|3
7926626|NCT02246439|12455501|FG001|Overall Study|Adverse Event|0
7926627|NCT02246439|12455500|FG000|Overall Study|Lost to Follow-up|7
7926628|NCT02246439|12455501|FG001|Overall Study|Lost to Follow-up|5
7926629|NCT02246439|12455500|FG000|Overall Study|Protocol Violation|0
7926630|NCT02246439|12455501|FG001|Overall Study|Protocol Violation|2
7926631|NCT02246439|12455500|FG000|Overall Study|Physician Decision|0
7926632|NCT02246439|12455501|FG001|Overall Study|Physician Decision|1
7926633|NCT02246439|12455500|FG000|Overall Study|Unkonwn|1
7926634|NCT02246439|12455501|FG001|Overall Study|Unkonwn|3
7926635|NCT02246439|12455500|FG000|Overall Study|Withdrawal by Subject|1
7926636|NCT02246439|12455501|FG001|Overall Study|Withdrawal by Subject|0
7926637|NCT02246478|12455511|FG000|Multiple-dose Phase|Protocol Violation|1
7926638|NCT02246478|12455512|FG001|Multiple-dose Phase|Protocol Violation|0
7926639|NCT02246478|12455513|FG002|Multiple-dose Phase|Protocol Violation|0
7926640|NCT02246478|12455514|FG003|Multiple-dose Phase|Protocol Violation|1
7926641|NCT02246582|12455531|FG000|Overall Study|Withdrawal by Subject|3
7926642|NCT02246582|12455532|FG001|Overall Study|Withdrawal by Subject|4
7926643|NCT02246647|12455547|FG000|Overall Study|Withdrawal by Subject|1
7926644|NCT02246647|12455548|FG001|Overall Study|Withdrawal by Subject|1
7926645|NCT02246660|12455571|FG000|Overall Study|Withdrawal by Subject|0
7926646|NCT02246660|12455572|FG001|Overall Study|Withdrawal by Subject|1
7926647|NCT02246660|12455573|FG002|Overall Study|Withdrawal by Subject|0
7926648|NCT02246660|12455571|FG000|Overall Study|Death|0
7926649|NCT02246660|12455572|FG001|Overall Study|Death|0
7926650|NCT02246660|12455573|FG002|Overall Study|Death|1
7926651|NCT02246673|12455586|FG000|Overall Study|Sponsor Decision|1
7926652|NCT02246673|12455587|FG001|Overall Study|Sponsor Decision|0
7926653|NCT02246673|12455588|FG002|Overall Study|Sponsor Decision|0
7926654|NCT02246673|12455589|FG003|Overall Study|Sponsor Decision|0
7926655|NCT02246673|12455590|FG004|Overall Study|Sponsor Decision|0
7926656|NCT02246673|12455586|FG000|Overall Study|Withdrawal by Subject|0
7926657|NCT02246673|12455587|FG001|Overall Study|Withdrawal by Subject|0
7926658|NCT02246673|12455588|FG002|Overall Study|Withdrawal by Subject|0
7926659|NCT02246673|12455589|FG003|Overall Study|Withdrawal by Subject|0
7926660|NCT02246673|12455590|FG004|Overall Study|Withdrawal by Subject|1
7926661|NCT02246673|12455586|FG000|Overall Study|Lost to Follow-up|0
7926662|NCT02246673|12455587|FG001|Overall Study|Lost to Follow-up|0
7926663|NCT02246673|12455588|FG002|Overall Study|Lost to Follow-up|0
7926664|NCT02246673|12455589|FG003|Overall Study|Lost to Follow-up|1
7926665|NCT02246673|12455590|FG004|Overall Study|Lost to Follow-up|0
7926666|NCT02246673|12455586|FG000|Overall Study|Protocol Violation|0
7926667|NCT02246673|12455587|FG001|Overall Study|Protocol Violation|0
7926668|NCT02246673|12455588|FG002|Overall Study|Protocol Violation|0
7926669|NCT02246673|12455589|FG003|Overall Study|Protocol Violation|1
7926670|NCT02246673|12455590|FG004|Overall Study|Protocol Violation|0
7926671|NCT02246764|12455635|FG000|Overall Study|Adverse Event|15
7926672|NCT02246764|12455636|FG001|Overall Study|Adverse Event|29
7926673|NCT02246764|12455637|FG002|Overall Study|Adverse Event|1
7926674|NCT02246764|12455635|FG000|Overall Study|Withdrawal by Subject|0
7926675|NCT02246764|12455636|FG001|Overall Study|Withdrawal by Subject|0
7926676|NCT02246764|12455637|FG002|Overall Study|Withdrawal by Subject|1
7926677|NCT02246764|12455635|FG000|Overall Study|Disallowed Concomitant Medication|1
7926678|NCT02246764|12455636|FG001|Overall Study|Disallowed Concomitant Medication|0
7926679|NCT02246764|12455637|FG002|Overall Study|Disallowed Concomitant Medication|0
7926680|NCT02246764|12455635|FG000|Overall Study|Physician Decision|0
7926681|NCT02246764|12455636|FG001|Overall Study|Physician Decision|2
7926682|NCT02246764|12455637|FG002|Overall Study|Physician Decision|1
7926683|NCT02246764|12455635|FG000|Overall Study|Protocol Violation|2
7926684|NCT02246764|12455636|FG001|Overall Study|Protocol Violation|1
7926685|NCT02246764|12455637|FG002|Overall Study|Protocol Violation|1
7926686|NCT02246777|12455645|FG000|Overall Study|Adverse Event|2
7926687|NCT02246777|12455645|FG000|Overall Study|Change of residence|1
7926688|NCT02246998|12455658|FG000|Overall Study|Adverse Event|0
7926689|NCT02246998|12455659|FG001|Overall Study|Adverse Event|1
7926690|NCT02246998|12455660|FG002|Overall Study|Adverse Event|1
7926691|NCT02246998|12455661|FG003|Overall Study|Adverse Event|0
7926692|NCT02246998|12455658|FG000|Overall Study|Lost to Follow-up|1
7926693|NCT02246998|12455659|FG001|Overall Study|Lost to Follow-up|0
7926694|NCT02246998|12455660|FG002|Overall Study|Lost to Follow-up|0
7926695|NCT02246998|12455661|FG003|Overall Study|Lost to Follow-up|1
7926696|NCT02246998|12455658|FG000|Overall Study|Randomized but Never Dosed|1
7926697|NCT02246998|12455659|FG001|Overall Study|Randomized but Never Dosed|2
7926698|NCT02246998|12455660|FG002|Overall Study|Randomized but Never Dosed|2
7926699|NCT02246998|12455661|FG003|Overall Study|Randomized but Never Dosed|1
7926700|NCT02247011|12455676|FG000|Overall Study|Poor quality of radiological results|125
7926701|NCT02247401|12455730|FG000|Overall Study|Adverse Event|1
7926702|NCT02247401|12455731|FG001|Overall Study|Adverse Event|0
7926703|NCT02247401|12455732|FG002|Overall Study|Adverse Event|0
7926704|NCT02247401|12455730|FG000|Overall Study|Withdrawal by Subject|4
7926705|NCT02247401|12455731|FG001|Overall Study|Withdrawal by Subject|1
7926706|NCT02247401|12455732|FG002|Overall Study|Withdrawal by Subject|1
7926707|NCT02247401|12455730|FG000|Overall Study|Lost to Follow-up|1
7926708|NCT02247401|12455731|FG001|Overall Study|Lost to Follow-up|1
7926709|NCT02247401|12455732|FG002|Overall Study|Lost to Follow-up|1
7926710|NCT02247440|12455741|FG000|Overall Study|Withdrawal by Subject|1
7926711|NCT02247440|12455741|FG000|Overall Study|Lack of Efficacy|3
7926712|NCT02247466|12455747|FG000|Overall Study|Procedure changed to open surgery|0
7926713|NCT02247466|12455748|FG001|Overall Study|Procedure changed to open surgery|3
7926714|NCT02247479|12455757|FG000|Overall Study|Adverse Event|8
7926715|NCT02247479|12455758|FG001|Overall Study|Adverse Event|9
7926716|NCT02247479|12455759|FG002|Overall Study|Adverse Event|8
7926717|NCT02247479|12455757|FG000|Overall Study|Death|5
7926718|NCT02247479|12455758|FG001|Overall Study|Death|4
7926719|NCT02247479|12455759|FG002|Overall Study|Death|6
7926720|NCT02247479|12455757|FG000|Overall Study|Lost to Follow-up|3
7926721|NCT02247479|12455758|FG001|Overall Study|Lost to Follow-up|3
7926722|NCT02247479|12455759|FG002|Overall Study|Lost to Follow-up|1
7926723|NCT02247479|12455757|FG000|Overall Study|Non-compliance|0
7926724|NCT02247479|12455758|FG001|Overall Study|Non-compliance|0
7926725|NCT02247479|12455759|FG002|Overall Study|Non-compliance|1
7926726|NCT02247479|12455757|FG000|Overall Study|Withdrawal by Subject|25
7926727|NCT02247479|12455758|FG001|Overall Study|Withdrawal by Subject|29
7926728|NCT02247479|12455759|FG002|Overall Study|Withdrawal by Subject|24
7926729|NCT02247479|12455757|FG000|Overall Study|Study Terminated by Sponsor|98
7926730|NCT02247479|12455758|FG001|Overall Study|Study Terminated by Sponsor|88
7926731|NCT02247479|12455759|FG002|Overall Study|Study Terminated by Sponsor|94
7926732|NCT02247479|12455757|FG000|Overall Study|Physician Decision|1
7926733|NCT02247479|12455758|FG001|Overall Study|Physician Decision|0
7926734|NCT02247479|12455759|FG002|Overall Study|Physician Decision|2
7926735|NCT02247479|12455757|FG000|Overall Study|Unspecified Reason|2
7926736|NCT02247479|12455758|FG001|Overall Study|Unspecified Reason|5
7926737|NCT02247479|12455759|FG002|Overall Study|Unspecified Reason|2
7926738|NCT02247531|12455770|FG000|Overall Study|Adverse Event|3
7926739|NCT02247531|12455771|FG001|Overall Study|Adverse Event|4
7926740|NCT02247531|12455772|FG002|Overall Study|Adverse Event|9
7926741|NCT02247531|12455770|FG000|Overall Study|Death|8
7926742|NCT02247531|12455771|FG001|Overall Study|Death|9
7926743|NCT02247531|12455772|FG002|Overall Study|Death|5
7926744|NCT02247531|12455770|FG000|Overall Study|Lost to Follow-up|1
7926745|NCT02247531|12455771|FG001|Overall Study|Lost to Follow-up|8
7926746|NCT02247531|12455772|FG002|Overall Study|Lost to Follow-up|3
7926747|NCT02247531|12455770|FG000|Overall Study|Non-compliance|2
7926748|NCT02247531|12455771|FG001|Overall Study|Non-compliance|2
7926749|NCT02247531|12455772|FG002|Overall Study|Non-compliance|0
7926750|NCT02247531|12455770|FG000|Overall Study|Withdrawal by Subject|26
7926751|NCT02247531|12455771|FG001|Overall Study|Withdrawal by Subject|31
7926752|NCT02247531|12455772|FG002|Overall Study|Withdrawal by Subject|25
7926753|NCT02247531|12455770|FG000|Overall Study|Study Terminated by Sponsor|64
7926754|NCT02247531|12455771|FG001|Overall Study|Study Terminated by Sponsor|66
7926755|NCT02247531|12455772|FG002|Overall Study|Study Terminated by Sponsor|62
7926756|NCT02247531|12455770|FG000|Overall Study|Physician Decision|0
7926757|NCT02247531|12455771|FG001|Overall Study|Physician Decision|2
7926758|NCT02247531|12455772|FG002|Overall Study|Physician Decision|2
7926759|NCT02247531|12455770|FG000|Overall Study|Unspecified Reason|2
7926760|NCT02247531|12455771|FG001|Overall Study|Unspecified Reason|3
7926761|NCT02247531|12455772|FG002|Overall Study|Unspecified Reason|4
7926762|NCT02247804|12455802|FG000|Treatment Period 1|Adverse Event|9
7926763|NCT02247804|12455803|FG001|Treatment Period 1|Adverse Event|2
7926764|NCT02247804|12455804|FG002|Treatment Period 1|Adverse Event|0
7926765|NCT02247804|12455802|FG000|Treatment Period 1|Lack of Efficacy|0
7926766|NCT02247804|12455803|FG001|Treatment Period 1|Lack of Efficacy|0
7926767|NCT02247804|12455804|FG002|Treatment Period 1|Lack of Efficacy|2
7926768|NCT02247804|12455802|FG000|Treatment Period 1|Lost to Follow-up|1
7926769|NCT02247804|12455803|FG001|Treatment Period 1|Lost to Follow-up|0
7926770|NCT02247804|12455804|FG002|Treatment Period 1|Lost to Follow-up|2
7926771|NCT02247804|12455802|FG000|Treatment Period 1|Personal Reasons|7
7926772|NCT02247804|12455803|FG001|Treatment Period 1|Personal Reasons|1
7926773|NCT02247804|12455804|FG002|Treatment Period 1|Personal Reasons|2
7926774|NCT02247804|12455802|FG000|Treatment Period 1|Protocol Deviation|0
7926775|NCT02247804|12455803|FG001|Treatment Period 1|Protocol Deviation|0
7926776|NCT02247804|12455804|FG002|Treatment Period 1|Protocol Deviation|1
7926777|NCT02247804|12455802|FG000|Treatment Period 1|Randomized but not Treated|5
7926778|NCT02247804|12455803|FG001|Treatment Period 1|Randomized but not Treated|1
7926779|NCT02247804|12455804|FG002|Treatment Period 1|Randomized but not Treated|1
7926780|NCT02247804|12455802|FG000|Treatment Period 2|Adverse Event|6
7926781|NCT02247804|12455803|FG001|Treatment Period 2|Adverse Event|3
7926782|NCT02247804|12455804|FG002|Treatment Period 2|Adverse Event|3
7926783|NCT02247804|12455802|FG000|Treatment Period 2|Lack of Efficacy|0
7926784|NCT02247804|12455803|FG001|Treatment Period 2|Lack of Efficacy|0
7926785|NCT02247804|12455804|FG002|Treatment Period 2|Lack of Efficacy|1
7926786|NCT02247804|12455802|FG000|Treatment Period 2|Lost to Follow-up|0
7926787|NCT02247804|12455803|FG001|Treatment Period 2|Lost to Follow-up|1
7926788|NCT02247804|12455804|FG002|Treatment Period 2|Lost to Follow-up|1
7926789|NCT02247804|12455802|FG000|Treatment Period 2|Personal Reasons|2
7926790|NCT02247804|12455803|FG001|Treatment Period 2|Personal Reasons|1
7926791|NCT02247804|12455804|FG002|Treatment Period 2|Personal Reasons|1
7926792|NCT02247804|12455802|FG000|Treatment Period 2|Reason not Specified|0
7926793|NCT02247804|12455803|FG001|Treatment Period 2|Reason not Specified|0
7926794|NCT02247804|12455804|FG002|Treatment Period 2|Reason not Specified|2
7926795|NCT02247804|12455802|FG000|Treatment Period 3|Adverse Event|4
7926796|NCT02247804|12455803|FG001|Treatment Period 3|Adverse Event|3
7926797|NCT02247804|12455804|FG002|Treatment Period 3|Adverse Event|3
7926798|NCT02247804|12455802|FG000|Treatment Period 3|Lack of Efficacy|0
7926799|NCT02247804|12455803|FG001|Treatment Period 3|Lack of Efficacy|1
7926800|NCT02247804|12455804|FG002|Treatment Period 3|Lack of Efficacy|0
7926801|NCT02247804|12455802|FG000|Treatment Period 3|Lost to Follow-up|1
7926802|NCT02247804|12455803|FG001|Treatment Period 3|Lost to Follow-up|2
7926803|NCT02247804|12455804|FG002|Treatment Period 3|Lost to Follow-up|2
7926804|NCT02247804|12455802|FG000|Treatment Period 3|Personal Reasons|4
7926805|NCT02247804|12455803|FG001|Treatment Period 3|Personal Reasons|3
7926806|NCT02247804|12455804|FG002|Treatment Period 3|Personal Reasons|2
7926807|NCT02247804|12455802|FG000|Treatment Period 3|Reason not Specified|2
7926808|NCT02247804|12455803|FG001|Treatment Period 3|Reason not Specified|1
7926809|NCT02247804|12455804|FG002|Treatment Period 3|Reason not Specified|3
7926810|NCT02247960|12455814|FG000|Patient Consent and Randomization|Physician Decision|2
7926811|NCT02247960|12455815|FG001|Patient Consent and Randomization|Physician Decision|2
7926812|NCT02247960|12455814|FG000|Patient Consent and Randomization|Withdrawal by Subject|0
7926813|NCT02247960|12455815|FG001|Patient Consent and Randomization|Withdrawal by Subject|4
7926814|NCT02247960|12455814|FG000|Catheter Removed|Lost to Follow-up|7
7926815|NCT02247960|12455815|FG001|Catheter Removed|Lost to Follow-up|10
7926816|NCT02248480|12455845|FG000|Overall Study|Lack of Efficacy|4
7926817|NCT02248480|12455846|FG001|Overall Study|Lack of Efficacy|6
7926818|NCT02248480|12455845|FG000|Overall Study|Adverse Event|11
7926819|NCT02248480|12455846|FG001|Overall Study|Adverse Event|2
7926820|NCT02248480|12455845|FG000|Overall Study|Withdrawal by Subject|2
7926821|NCT02248480|12455846|FG001|Overall Study|Withdrawal by Subject|4
7926822|NCT02248480|12455845|FG000|Overall Study|Entry Criteria Not Met|0
7926823|NCT02248480|12455846|FG001|Overall Study|Entry Criteria Not Met|1
7926824|NCT02248480|12455845|FG000|Overall Study|Other:Physician Decision|0
7926825|NCT02248480|12455846|FG001|Overall Study|Other:Physician Decision|1
7926826|NCT02248649|12455875|FG000|Overall Study|Death|7
7926827|NCT02248649|12455876|FG001|Overall Study|Death|11
7926828|NCT02248649|12455875|FG000|Overall Study|Lost to Follow-up|14
7926829|NCT02248649|12455876|FG001|Overall Study|Lost to Follow-up|10
7926830|NCT02248675|12455897|FG000|Overall Study|Lost to Follow-up|3
7926831|NCT02248675|12455898|FG001|Overall Study|Lost to Follow-up|1
7926832|NCT02248818|12455936|FG000|Screening|Protocol Violation|0
7926833|NCT02248818|12455937|FG001|Screening|Protocol Violation|0
7926834|NCT02248818|12455938|FG002|Screening|Protocol Violation|0
7926835|NCT02248818|12455939|FG003|Screening|Protocol Violation|0
7926836|NCT02248818|12455940|FG004|Screening|Protocol Violation|0
7926837|NCT02248818|12455941|FG005|Screening|Protocol Violation|0
7926838|NCT02248818|12455942|FG006|Screening|Protocol Violation|0
7926839|NCT02248818|12455943|FG007|Screening|Protocol Violation|0
7926840|NCT02248818|12455944|FG008|Screening|Protocol Violation|7
7926841|NCT02248818|12455936|FG000|Screening|Study fully enrolled|0
7926842|NCT02248818|12455937|FG001|Screening|Study fully enrolled|0
7926843|NCT02248818|12455938|FG002|Screening|Study fully enrolled|0
7926844|NCT02248818|12455939|FG003|Screening|Study fully enrolled|0
7926845|NCT02248818|12455940|FG004|Screening|Study fully enrolled|0
7926846|NCT02248818|12455941|FG005|Screening|Study fully enrolled|0
7926847|NCT02248818|12455942|FG006|Screening|Study fully enrolled|0
7926848|NCT02248818|12455943|FG007|Screening|Study fully enrolled|0
7926849|NCT02248818|12455944|FG008|Screening|Study fully enrolled|14
7926850|NCT02248818|12455936|FG000|Screening|Physician Decision|0
7926851|NCT02248818|12455937|FG001|Screening|Physician Decision|0
7926852|NCT02248818|12455938|FG002|Screening|Physician Decision|0
7926853|NCT02248818|12455939|FG003|Screening|Physician Decision|0
7926854|NCT02248818|12455940|FG004|Screening|Physician Decision|0
7926855|NCT02248818|12455941|FG005|Screening|Physician Decision|0
7926856|NCT02248818|12455942|FG006|Screening|Physician Decision|0
7926857|NCT02248818|12455943|FG007|Screening|Physician Decision|0
7926858|NCT02248818|12455944|FG008|Screening|Physician Decision|73
7926859|NCT02248818|12455936|FG000|Screening|Withdrawal by Subject|0
7926860|NCT02248818|12455937|FG001|Screening|Withdrawal by Subject|0
7926861|NCT02248818|12455938|FG002|Screening|Withdrawal by Subject|0
7926862|NCT02248818|12455939|FG003|Screening|Withdrawal by Subject|0
7926863|NCT02248818|12455940|FG004|Screening|Withdrawal by Subject|0
7926864|NCT02248818|12455941|FG005|Screening|Withdrawal by Subject|0
7926865|NCT02248818|12455942|FG006|Screening|Withdrawal by Subject|0
7926866|NCT02248818|12455943|FG007|Screening|Withdrawal by Subject|0
7926867|NCT02248818|12455944|FG008|Screening|Withdrawal by Subject|6
7926868|NCT02248818|12455936|FG000|Screening|Lost to Follow-up|0
7926869|NCT02248818|12455937|FG001|Screening|Lost to Follow-up|0
7926870|NCT02248818|12455938|FG002|Screening|Lost to Follow-up|0
7926871|NCT02248818|12455939|FG003|Screening|Lost to Follow-up|0
7926872|NCT02248818|12455940|FG004|Screening|Lost to Follow-up|0
7926873|NCT02248818|12455941|FG005|Screening|Lost to Follow-up|0
7926874|NCT02248818|12455942|FG006|Screening|Lost to Follow-up|0
7926875|NCT02248818|12455943|FG007|Screening|Lost to Follow-up|0
7926876|NCT02248818|12455944|FG008|Screening|Lost to Follow-up|7
7926877|NCT02248818|12455936|FG000|Randomised Study|Administrative - randomization error|0
7926878|NCT02248818|12455937|FG001|Randomised Study|Administrative - randomization error|0
7926879|NCT02248818|12455938|FG002|Randomised Study|Administrative - randomization error|0
7926880|NCT02248818|12455939|FG003|Randomised Study|Administrative - randomization error|0
7926881|NCT02248818|12455940|FG004|Randomised Study|Administrative - randomization error|0
7926882|NCT02248818|12455941|FG005|Randomised Study|Administrative - randomization error|8
7926883|NCT02248818|12455942|FG006|Randomised Study|Administrative - randomization error|0
7926884|NCT02248818|12455943|FG007|Randomised Study|Administrative - randomization error|0
7926885|NCT02248818|12455944|FG008|Randomised Study|Administrative - randomization error|0
7926886|NCT02248857|12455965|FG000|3 Month|Withdrawal by Subject|9
7926887|NCT02248857|12455966|FG001|3 Month|Withdrawal by Subject|3
7926888|NCT02248857|12455967|FG002|3 Month|Withdrawal by Subject|4
7926889|NCT02248857|12455965|FG000|3 Month|Unable to reach for 3 month|35
7926890|NCT02248857|12455966|FG001|3 Month|Unable to reach for 3 month|29
7926891|NCT02248857|12455967|FG002|3 Month|Unable to reach for 3 month|26
7926892|NCT02248857|12455965|FG000|3 Month|Partially completed, unable to finish|2
7926893|NCT02248857|12455966|FG001|3 Month|Partially completed, unable to finish|2
7926894|NCT02248857|12455967|FG002|3 Month|Partially completed, unable to finish|1
7926895|NCT02248857|12455965|FG000|6 Month|Lost to Follow-up|27
7926896|NCT02248857|12455966|FG001|6 Month|Lost to Follow-up|26
7926897|NCT02248857|12455967|FG002|6 Month|Lost to Follow-up|15
7926898|NCT02248857|12455965|FG000|6 Month|Partially completed, unable to finish|0
7926899|NCT02248857|12455966|FG001|6 Month|Partially completed, unable to finish|1
7926900|NCT02248857|12455967|FG002|6 Month|Partially completed, unable to finish|0
7926901|NCT02248857|12455965|FG000|6 Month|Withdrawal by Subject|0
7926902|NCT02248857|12455966|FG001|6 Month|Withdrawal by Subject|2
7926903|NCT02248857|12455967|FG002|6 Month|Withdrawal by Subject|2
7926904|NCT02248857|12455965|FG000|6 Month|Death|1
7926905|NCT02248857|12455966|FG001|6 Month|Death|0
7926906|NCT02248857|12455967|FG002|6 Month|Death|0
7926907|NCT02248961|12455985|FG000|Overall Study|Adverse Event|1
7926908|NCT02248961|12455986|FG001|Overall Study|Adverse Event|0
7926909|NCT02248961|12455985|FG000|Overall Study|Withdrawal by Subject|1
7926910|NCT02248961|12455986|FG001|Overall Study|Withdrawal by Subject|2
7926911|NCT02248961|12455985|FG000|Overall Study|Unmet inclusion/exclusion criteria|1
7926912|NCT02248961|12455986|FG001|Overall Study|Unmet inclusion/exclusion criteria|0
7926913|NCT02248974|12455994|FG000|1-Day Follow-Up|Lost to Follow-up|4
7926914|NCT02248974|12455995|FG001|1-Day Follow-Up|Lost to Follow-up|0
7926915|NCT02248974|12455994|FG000|1-Day Follow-Up|Withdrawal by Subject|5
7926916|NCT02248974|12455995|FG001|1-Day Follow-Up|Withdrawal by Subject|0
7926917|NCT02248974|12455994|FG000|1-Day Follow-Up|Enrolled in another study|1
7926918|NCT02248974|12455995|FG001|1-Day Follow-Up|Enrolled in another study|0
7926919|NCT02248974|12455994|FG000|1-Week Follow-Up|Became ineligible for LVAD|4
7926920|NCT02248974|12455995|FG001|1-Week Follow-Up|Became ineligible for LVAD|1
7926921|NCT02248974|12455994|FG000|1-Week Follow-Up|Enrolled in another study|1
7926922|NCT02248974|12455995|FG001|1-Week Follow-Up|Enrolled in another study|1
7926923|NCT02248974|12455994|FG000|1-Week Follow-Up|Transferred to another facility|1
7926924|NCT02248974|12455995|FG001|1-Week Follow-Up|Transferred to another facility|0
7926925|NCT02248974|12455994|FG000|1-Week Follow-Up|Cognitive Difficulty|1
7926926|NCT02248974|12455995|FG001|1-Week Follow-Up|Cognitive Difficulty|0
7926927|NCT02248974|12455994|FG000|1-Week Follow-Up|Death|1
7926928|NCT02248974|12455995|FG001|1-Week Follow-Up|Death|1
7926929|NCT02248974|12455994|FG000|1-Week Follow-Up|Excluded because of age|0
7926930|NCT02248974|12455995|FG001|1-Week Follow-Up|Excluded because of age|1
7926931|NCT02248974|12455994|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0
7926932|NCT02248974|12455995|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1
7926933|NCT02248974|12455994|FG000|1-Week Follow-Up|Timing: implanted before survey|0
7926934|NCT02248974|12455995|FG001|1-Week Follow-Up|Timing: implanted before survey|2
7926935|NCT02248974|12455994|FG000|1-Week Follow-Up|Withdrawal by Subject|0
7926936|NCT02248974|12455995|FG001|1-Week Follow-Up|Withdrawal by Subject|2
7926937|NCT02248974|12455994|FG000|1-Week Follow-Up|Lost to Follow-up|0
7926938|NCT02248974|12455995|FG001|1-Week Follow-Up|Lost to Follow-up|8
7926939|NCT02248974|12455994|FG000|1-Month Follow-Up|Lost to Follow-up|2
7926940|NCT02248974|12455995|FG001|1-Month Follow-Up|Lost to Follow-up|3
7926941|NCT02249091|12456011|FG000|Overall Study|Lack of Efficacy|8
7926942|NCT02249091|12456012|FG001|Overall Study|Lack of Efficacy|3
7926943|NCT02249091|12456011|FG000|Overall Study|Physician Decision|4
7926944|NCT02249091|12456012|FG001|Overall Study|Physician Decision|1
7926945|NCT02249091|12456011|FG000|Overall Study|Withdrawal by Subject|2
7926946|NCT02249091|12456012|FG001|Overall Study|Withdrawal by Subject|2
7926947|NCT02249091|12456011|FG000|Overall Study|Death|3
7926948|NCT02249091|12456012|FG001|Overall Study|Death|4
7926949|NCT02249091|12456011|FG000|Overall Study|Adverse Event|1
7926950|NCT02249091|12456012|FG001|Overall Study|Adverse Event|0
7926951|NCT02249091|12456011|FG000|Overall Study|Stable disease with following SCT|0
7926952|NCT02249091|12456012|FG001|Overall Study|Stable disease with following SCT|1
7926953|NCT02249091|12456011|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0
7926954|NCT02249091|12456012|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1
7926955|NCT02249091|12456011|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1
7926956|NCT02249091|12456012|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0
7926957|NCT02249091|12456011|FG000|Overall Study|Refractory AML|1
7926958|NCT02249091|12456012|FG001|Overall Study|Refractory AML|1
7926959|NCT02249182|12456032|FG000|Treatment Phase|Lost to Follow-up|4
7926960|NCT02249182|12456033|FG001|Treatment Phase|Lost to Follow-up|0
7926961|NCT02249182|12456034|FG002|Treatment Phase|Lost to Follow-up|0
7926962|NCT02249182|12456035|FG003|Treatment Phase|Lost to Follow-up|0
7926963|NCT02249182|12456036|FG004|Treatment Phase|Lost to Follow-up|0
7964621|NCT03856996|12520181|FG001|Overall Study|Withdrawal by Subject|0
7964622|NCT03856996|12520180|FG000|Overall Study|Lost to Follow-up|0
7964623|NCT03856996|12520181|FG001|Overall Study|Lost to Follow-up|1
7964624|NCT03856996|12520180|FG000|Overall Study|Adverse Event|1
7964625|NCT03856996|12520181|FG001|Overall Study|Adverse Event|1
7767840|NCT00856284|12210625|FG001|Overall Study|Voluntary withdrawal|52
7964626|NCT03856996|12520180|FG000|Overall Study|Other|1
7964627|NCT03856996|12520181|FG001|Overall Study|Other|0
7719667|NCT00533897|12143617|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0
7719668|NCT00533897|12143618|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0
7926964|NCT02249767|12456084|FG000|Overall Study|Did not use medication|8
7926965|NCT02249767|12456085|FG001|Overall Study|Did not use medication|9
7926966|NCT02249767|12456086|FG002|Overall Study|Did not use medication|8
7926967|NCT02249832|12456106|FG000|Overall Study|Withdrawal by Subject|3
7926968|NCT02249832|12456106|FG000|Overall Study|Lost to Follow-up|10
7926969|NCT02249949|12456115|FG000|Overall Study|Cancelled prior to treatment|2
7926970|NCT02250183|12456128|FG000|Overall Study|Withdrawal by Subject|2
7926971|NCT02250183|12456128|FG000|Overall Study|Adverse Event|5
7926972|NCT02250183|12456128|FG000|Overall Study|Lost to Follow-up|1
7926973|NCT02250274|12456137|FG000|Overall Study|Insufficient blood draw amount|7
7926974|NCT02250274|12456138|FG001|Overall Study|Insufficient blood draw amount|6
7926975|NCT02250443|12456160|FG000|Overall Study|Administrative problems|7
7926976|NCT02250443|12456160|FG000|Overall Study|Adverse Event|3
7926977|NCT02250651|12456199|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0
7926978|NCT02250651|12456200|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2
7926979|NCT02250651|12456201|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2
7926980|NCT02250651|12456199|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1
7926981|NCT02250651|12456200|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0
7926982|NCT02250651|12456201|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0
7926983|NCT02250651|12456199|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2
7926984|NCT02250651|12456200|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3
7926985|NCT02250651|12456201|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5
7926986|NCT02250651|12456199|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1
7926987|NCT02250651|12456200|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0
7926988|NCT02250651|12456201|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0
7926989|NCT02250651|12456199|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0
7926990|NCT02250651|12456200|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0
7926991|NCT02250651|12456201|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1
7926992|NCT02250651|12456199|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0
7926993|NCT02250651|12456200|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1
7926994|NCT02250651|12456201|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3
7926995|NCT02250651|12456199|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4
7926996|NCT02250651|12456200|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1
7926997|NCT02250651|12456201|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0
7926998|NCT02250651|12456199|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0
7926999|NCT02250651|12456200|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0
7927000|NCT02250651|12456201|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3
7927001|NCT02250651|12456199|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2
7927002|NCT02250651|12456200|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3
7927003|NCT02250651|12456201|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2
7927004|NCT02250651|12456199|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0
7927005|NCT02250651|12456200|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1
7927006|NCT02250651|12456201|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0
7927007|NCT02250651|12456199|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0
7927008|NCT02250651|12456200|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1
7927009|NCT02250651|12456201|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0
7927010|NCT02250651|12456199|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4
7927011|NCT02250651|12456200|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1
7927012|NCT02250651|12456201|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1
7927013|NCT02250651|12456199|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1
7927014|NCT02250651|12456200|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2
7927015|NCT02250651|12456201|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1
7927016|NCT02250651|12456199|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2
7927017|NCT02250651|12456200|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0
7927018|NCT02250651|12456201|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2
7927019|NCT02250651|12456199|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2
7927020|NCT02250651|12456200|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1
7927021|NCT02250651|12456201|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1
7927022|NCT02251275|12456240|FG000|Overall Study|Adverse Event|23
7927023|NCT02251275|12456241|FG001|Overall Study|Adverse Event|60
7927024|NCT02251275|12456242|FG002|Overall Study|Adverse Event|28
7927025|NCT02251275|12456243|FG003|Overall Study|Adverse Event|0
7927026|NCT02251275|12456244|FG004|Overall Study|Adverse Event|0
7927027|NCT02251275|12456240|FG000|Overall Study|Lost to Follow-up|5
7927028|NCT02251275|12456241|FG001|Overall Study|Lost to Follow-up|6
7927029|NCT02251275|12456242|FG002|Overall Study|Lost to Follow-up|4
7927030|NCT02251275|12456243|FG003|Overall Study|Lost to Follow-up|0
7927031|NCT02251275|12456244|FG004|Overall Study|Lost to Follow-up|0
7927032|NCT02251275|12456240|FG000|Overall Study|Physician Decision|19
7927033|NCT02251275|12456241|FG001|Overall Study|Physician Decision|30
7927034|NCT02251275|12456242|FG002|Overall Study|Physician Decision|26
7927035|NCT02251275|12456243|FG003|Overall Study|Physician Decision|0
7927036|NCT02251275|12456244|FG004|Overall Study|Physician Decision|1
7927037|NCT02251275|12456240|FG000|Overall Study|Protocol Deviation|0
7927038|NCT02251275|12456241|FG001|Overall Study|Protocol Deviation|0
7927039|NCT02251275|12456242|FG002|Overall Study|Protocol Deviation|1
7927040|NCT02251275|12456243|FG003|Overall Study|Protocol Deviation|0
7927041|NCT02251275|12456244|FG004|Overall Study|Protocol Deviation|0
7927042|NCT02251275|12456240|FG000|Overall Study|Withdrawal by Subject|25
7927043|NCT02251275|12456241|FG001|Overall Study|Withdrawal by Subject|51
7927044|NCT02251275|12456242|FG002|Overall Study|Withdrawal by Subject|35
7927045|NCT02251275|12456243|FG003|Overall Study|Withdrawal by Subject|1
7927046|NCT02251275|12456244|FG004|Overall Study|Withdrawal by Subject|0
7927047|NCT02251652|12456286|FG000|Overall Study|Withdrawal by Subject|1
7927048|NCT02251717|12456294|FG000|Overall Study|Adverse Event|0
7927049|NCT02251717|12456295|FG001|Overall Study|Adverse Event|1
7927050|NCT02251717|12456294|FG000|Overall Study|Withdrew Consent|1
7927051|NCT02251717|12456295|FG001|Overall Study|Withdrew Consent|0
7927052|NCT02251743|12456303|FG000|Overall Study|Withdrawal by Subject|1
7927053|NCT02251743|12456304|FG001|Overall Study|Withdrawal by Subject|1
7927054|NCT02251912|12456329|FG000|Overall Study|Withdrawal by Subject|2
7927055|NCT02251912|12456330|FG001|Overall Study|Withdrawal by Subject|3
7927056|NCT02251912|12456329|FG000|Overall Study|Adverse Event|0
7927057|NCT02251912|12456330|FG001|Overall Study|Adverse Event|2
7927058|NCT02251990|12456342|FG000|Period 1 (Double-blind [DB])|Adverse Event|1
7927059|NCT02251990|12456343|FG001|Period 1 (Double-blind [DB])|Adverse Event|1
7927060|NCT02251990|12456342|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5
7927061|NCT02251990|12456343|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0
7927062|NCT02251990|12456342|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
7927063|NCT02251990|12456343|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
7927064|NCT02251990|12456342|FG000|Period 1 (Double-blind [DB])|Not Treated|1
7927065|NCT02251990|12456343|FG001|Period 1 (Double-blind [DB])|Not Treated|0
7927066|NCT02251990|12456342|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
7927067|NCT02251990|12456343|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
7927068|NCT02251990|12456342|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
7927069|NCT02251990|12456343|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
7927070|NCT02252016|12456352|FG000|Overall Study|Lost to Follow-up|2
7927071|NCT02252016|12456353|FG001|Overall Study|Lost to Follow-up|1
7927072|NCT02252016|12456352|FG000|Overall Study|Physician Decision|1
7927073|NCT02252016|12456353|FG001|Overall Study|Physician Decision|0
7927074|NCT02252016|12456352|FG000|Overall Study|Withdrawal by Subject|0
7927075|NCT02252016|12456353|FG001|Overall Study|Withdrawal by Subject|2
7927076|NCT02252081|12456374|FG000|Overall Study|Withdrawal by Subject|2
7927077|NCT02252081|12456375|FG001|Overall Study|Withdrawal by Subject|1
7927078|NCT02252081|12456374|FG000|Overall Study|Adverse Event|4
7927079|NCT02252081|12456375|FG001|Overall Study|Adverse Event|1
7927080|NCT02252081|12456374|FG000|Overall Study|non compliance & others|0
7927081|NCT02252081|12456375|FG001|Overall Study|non compliance & others|2
7927082|NCT02252146|12456393|FG000|Overall Study|Lack of Efficacy|4
7927083|NCT02252146|12456393|FG000|Overall Study|Entered hospice care|1
7927084|NCT02252146|12456393|FG000|Overall Study|Inability to travel to study site|1
7927085|NCT02252211|12456399|FG000|Overall Study|Adverse Event|0
7927086|NCT02252211|12456400|FG001|Overall Study|Adverse Event|1
7927087|NCT02252211|12456401|FG002|Overall Study|Adverse Event|0
7927088|NCT02252211|12456399|FG000|Overall Study|Progressive disease|3
7927089|NCT02252211|12456400|FG001|Overall Study|Progressive disease|2
7927090|NCT02252211|12456401|FG002|Overall Study|Progressive disease|0
7927091|NCT02252211|12456399|FG000|Overall Study|Withdrawal by Subject|1
7927092|NCT02252211|12456400|FG001|Overall Study|Withdrawal by Subject|0
7927093|NCT02252211|12456401|FG002|Overall Study|Withdrawal by Subject|0
7927094|NCT02252211|12456399|FG000|Overall Study|Serious Adverse Event During Screening|1
7927095|NCT02252211|12456400|FG001|Overall Study|Serious Adverse Event During Screening|0
7927096|NCT02252211|12456401|FG002|Overall Study|Serious Adverse Event During Screening|1
7927097|NCT02252406|12456419|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2
7927098|NCT02252406|12456420|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3
7927099|NCT02252406|12456419|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1
7927100|NCT02252406|12456420|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0
7927101|NCT02252406|12456419|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1
7927102|NCT02252406|12456420|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0
7927103|NCT02252406|12456419|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
7927104|NCT02252406|12456420|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
7927105|NCT02252406|12456419|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2
7927106|NCT02252406|12456420|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0
7927107|NCT02252536|12456437|FG000|Overall Study|Lost to Follow-up|5
7927108|NCT02252536|12456438|FG001|Overall Study|Lost to Follow-up|3
7927109|NCT02252588|12456456|FG000|Overall Study|Withdrawal by Subject|4
7927110|NCT02252588|12456457|FG001|Overall Study|Withdrawal by Subject|0
7927111|NCT02252939|12456475|FG000|Overall Study|Lost to Follow-up|3
7927112|NCT02252965|12456486|FG000|Overall Study|Adverse Event|9
7927113|NCT02252965|12456487|FG001|Overall Study|Adverse Event|14
7927114|NCT02252965|12456486|FG000|Overall Study|Lost to Follow-up|16
7927115|NCT02252965|12456487|FG001|Overall Study|Lost to Follow-up|8
7927116|NCT02252965|12456486|FG000|Overall Study|Protocol Violation|4
7927117|NCT02252965|12456487|FG001|Overall Study|Protocol Violation|5
7927118|NCT02252965|12456486|FG000|Overall Study|Lack of Efficacy|0
7927119|NCT02252965|12456487|FG001|Overall Study|Lack of Efficacy|2
7927120|NCT02252965|12456486|FG000|Overall Study|Withdrawal by Subject|7
7927121|NCT02252965|12456487|FG001|Overall Study|Withdrawal by Subject|9
7927122|NCT02252965|12456486|FG000|Overall Study|Other|4
7927123|NCT02252965|12456487|FG001|Overall Study|Other|5
7927124|NCT02253147|12456495|FG000|Overall Study|Protocol Violation|30
7927125|NCT02253147|12456495|FG000|Overall Study|Did not consent to study extension|9
7927126|NCT02253147|12456495|FG000|Overall Study|Conditional re-treatment at W52|5
7927127|NCT02253147|12456495|FG000|Overall Study|Lost to Follow-up|2
7927128|NCT02253147|12456495|FG000|Overall Study|Withdrawal by Subject|1
7927129|NCT02253433|12456539|FG000|Overall Study|Unable to Contact|9
7927130|NCT02253433|12456540|FG001|Overall Study|Unable to Contact|16
7927131|NCT02253433|12456539|FG000|Overall Study|Death|1
7927132|NCT02253433|12456540|FG001|Overall Study|Death|1
7927133|NCT02253433|12456539|FG000|Overall Study|No Longer Interested|3
7927134|NCT02253433|12456540|FG001|Overall Study|No Longer Interested|15
7927135|NCT02253433|12456539|FG000|Overall Study|Out of Study Area|2
7927136|NCT02253433|12456540|FG001|Overall Study|Out of Study Area|7
7927137|NCT02253433|12456539|FG000|Overall Study|Uncomfortable with home visitors|0
7927138|NCT02253433|12456540|FG001|Overall Study|Uncomfortable with home visitors|3
7927139|NCT02253433|12456539|FG000|Overall Study|Unstable Housing/Homeless|0
7927140|NCT02253433|12456540|FG001|Overall Study|Unstable Housing/Homeless|7
7927141|NCT02253433|12456539|FG000|Overall Study|Too Busy|0
7927142|NCT02253433|12456540|FG001|Overall Study|Too Busy|4
7927143|NCT02253433|12456539|FG000|Overall Study|Medical or Other Concerns|1
7927144|NCT02253433|12456540|FG001|Overall Study|Medical or Other Concerns|2
7927145|NCT02253654|12456553|FG000|Overall Study|Withdrawal by Subject|12
7927146|NCT02253654|12456554|FG001|Overall Study|Withdrawal by Subject|4
7927147|NCT02253654|12456553|FG000|Overall Study|Decision by Sponsor|1
7927148|NCT02253654|12456554|FG001|Overall Study|Decision by Sponsor|1
7927149|NCT02253654|12456553|FG000|Overall Study|Lost to Follow-up|2
7927150|NCT02253654|12456554|FG001|Overall Study|Lost to Follow-up|5
7927151|NCT02253654|12456553|FG000|Overall Study|Death|4
7927152|NCT02253654|12456554|FG001|Overall Study|Death|7
7927153|NCT02253654|12456553|FG000|Overall Study|Did Not Receive Study Treatment|4
7927154|NCT02253654|12456554|FG001|Overall Study|Did Not Receive Study Treatment|1
7927155|NCT02253992|12456563|FG000|Overall Study|Study drug toxicity|1
7927156|NCT02253992|12456564|FG001|Overall Study|Study drug toxicity|0
7927157|NCT02253992|12456565|FG002|Overall Study|Study drug toxicity|10
7927158|NCT02253992|12456563|FG000|Overall Study|Disease progression|4
7927159|NCT02253992|12456564|FG001|Overall Study|Disease progression|3
7927160|NCT02253992|12456565|FG002|Overall Study|Disease progression|98
7927161|NCT02253992|12456563|FG000|Overall Study|Withdrawal by Subject|0
7927162|NCT02253992|12456564|FG001|Overall Study|Withdrawal by Subject|0
7927163|NCT02253992|12456565|FG002|Overall Study|Withdrawal by Subject|3
7927164|NCT02253992|12456563|FG000|Overall Study|Adverse Event|0
7927165|NCT02253992|12456564|FG001|Overall Study|Adverse Event|0
7927166|NCT02253992|12456565|FG002|Overall Study|Adverse Event|8
7927167|NCT02253992|12456563|FG000|Overall Study|Death|0
7927168|NCT02253992|12456564|FG001|Overall Study|Death|0
7927169|NCT02253992|12456565|FG002|Overall Study|Death|1
7927170|NCT02253992|12456563|FG000|Overall Study|Subject discontinued study drug|1
7927171|NCT02253992|12456564|FG001|Overall Study|Subject discontinued study drug|0
7927172|NCT02253992|12456565|FG002|Overall Study|Subject discontinued study drug|1
7927173|NCT02253992|12456563|FG000|Overall Study|Completed treatment as per protocol|0
7927174|NCT02253992|12456564|FG001|Overall Study|Completed treatment as per protocol|1
7927175|NCT02253992|12456565|FG002|Overall Study|Completed treatment as per protocol|22
7927176|NCT02253992|12456563|FG000|Overall Study|Other|0
7927177|NCT02253992|12456564|FG001|Overall Study|Other|0
7927178|NCT02253992|12456565|FG002|Overall Study|Other|1
7927179|NCT02254291|12456599|FG000|Overall Study|Withdrawal by Subject|0
7927180|NCT02254291|12456600|FG001|Overall Study|Withdrawal by Subject|3
7927181|NCT02254291|12456601|FG002|Overall Study|Withdrawal by Subject|1
7927182|NCT02254291|12456599|FG000|Overall Study|Missing follow-up information|0
7927183|NCT02254291|12456600|FG001|Overall Study|Missing follow-up information|0
7927184|NCT02254291|12456601|FG002|Overall Study|Missing follow-up information|1
7927185|NCT02254304|12456611|FG000|Overall Study|Adverse Event|2
7927186|NCT02254304|12456612|FG001|Overall Study|Adverse Event|1
7927187|NCT02254304|12456611|FG000|Overall Study|Lost to Follow-up|2
7927188|NCT02254304|12456612|FG001|Overall Study|Lost to Follow-up|2
7927189|NCT02254304|12456611|FG000|Overall Study|Protocol Violation|1
7927190|NCT02254304|12456612|FG001|Overall Study|Protocol Violation|0
7927191|NCT02254304|12456611|FG000|Overall Study|Withdrawal by Subject|3
7927192|NCT02254304|12456612|FG001|Overall Study|Withdrawal by Subject|0
7927193|NCT02254304|12456611|FG000|Overall Study|Injection site pain and Injection fear|1
7927194|NCT02254304|12456612|FG001|Overall Study|Injection site pain and Injection fear|0
7927195|NCT02254304|12456611|FG000|Overall Study|Personal causes|4
7927196|NCT02254304|12456612|FG001|Overall Study|Personal causes|1
7927197|NCT02254304|12456611|FG000|Overall Study|Personal decision|1
7927198|NCT02254304|12456612|FG001|Overall Study|Personal decision|0
7927199|NCT02254408|12456622|FG000|Overall Study|Randomized But Not Treated|1
7927200|NCT02254408|12456623|FG001|Overall Study|Randomized But Not Treated|3
7927201|NCT02254408|12456622|FG000|Overall Study|Adverse Event|1
7927202|NCT02254408|12456623|FG001|Overall Study|Adverse Event|0
7927203|NCT02254408|12456622|FG000|Overall Study|Death|2
7927204|NCT02254408|12456623|FG001|Overall Study|Death|3
7927205|NCT02254408|12456622|FG000|Overall Study|Investigator's Discretion|0
7927206|NCT02254408|12456623|FG001|Overall Study|Investigator's Discretion|1
7927207|NCT02254408|12456622|FG000|Overall Study|Withdrawal by Subject|3
7927208|NCT02254408|12456623|FG001|Overall Study|Withdrawal by Subject|3
7927209|NCT02254408|12456622|FG000|Overall Study|Lost to Follow-up|1
7927210|NCT02254408|12456623|FG001|Overall Study|Lost to Follow-up|0
7927211|NCT02254421|12456631|FG000|Overall Study|Randomized but Not Treated|1
7927212|NCT02254421|12456632|FG001|Overall Study|Randomized but Not Treated|0
7927213|NCT02254421|12456631|FG000|Overall Study|Death|0
7927214|NCT02254421|12456632|FG001|Overall Study|Death|2
7927215|NCT02254421|12456631|FG000|Overall Study|Withdrew Consent|1
7927216|NCT02254421|12456632|FG001|Overall Study|Withdrew Consent|1
7927217|NCT02254460|12456638|FG000|Overall Study|Adverse Event|1
7927218|NCT02254460|12456639|FG001|Overall Study|Adverse Event|0
7927219|NCT02254486|12456656|FG000|Overall Study|Adverse Event|1
7927220|NCT02254486|12456657|FG001|Overall Study|Adverse Event|1
7927221|NCT02254486|12456656|FG000|Overall Study|Lack of Efficacy|1
7927222|NCT02254486|12456657|FG001|Overall Study|Lack of Efficacy|0
7927223|NCT02254486|12456656|FG000|Overall Study|Lost to Follow-up|2
7927224|NCT02254486|12456657|FG001|Overall Study|Lost to Follow-up|4
7927225|NCT02254486|12456656|FG000|Overall Study|Protocol Violation|1
7927226|NCT02254486|12456657|FG001|Overall Study|Protocol Violation|2
7927227|NCT02254486|12456656|FG000|Overall Study|Withdrawal by Subject|17
7927228|NCT02254486|12456657|FG001|Overall Study|Withdrawal by Subject|15
7927229|NCT02254486|12456656|FG000|Overall Study|GFR<60mL/min|16
7927230|NCT02254486|12456657|FG001|Overall Study|GFR<60mL/min|21
7927231|NCT02254486|12456656|FG000|Overall Study|Various|12
7927232|NCT02254486|12456657|FG001|Overall Study|Various|12
7927233|NCT02254551|12456663|FG000|Dose Escalation|Physician Decision|1
7927234|NCT02254551|12456663|FG000|Dose Escalation|Dose-limiting toxicity|2
7927235|NCT02254681|12456670|FG000|Overall Study|Lack of Efficacy|6
7927236|NCT02254772|12456675|FG000|Overall Study|Ineligible|1
7927237|NCT02254772|12456675|FG000|Overall Study|Withdrawal by Subject|1
7927238|NCT02255149|12456692|FG000|Overall Study|Lost to Follow-up|2
7927239|NCT02255149|12456692|FG000|Overall Study|Withdrawal by Subject|1
7927240|NCT02255149|12456692|FG000|Overall Study|Withdrawal by PI|1
7927241|NCT02255149|12456692|FG000|Overall Study|Implant Failure|1
7927242|NCT02255279|12456711|FG000|Overall Study|Lost to Follow-up|2
7927243|NCT02255279|12456712|FG001|Overall Study|Lost to Follow-up|2
7927244|NCT02255279|12456711|FG000|Overall Study|Protocol Violation|0
7927245|NCT02255279|12456712|FG001|Overall Study|Protocol Violation|1
7927246|NCT02255279|12456711|FG000|Overall Study|Withdrawal by Subject|3
7927247|NCT02255279|12456712|FG001|Overall Study|Withdrawal by Subject|6
7927248|NCT02255422|12456748|FG000|Overall Study|Withdrawal by Subject|0
7927249|NCT02255422|12456749|FG001|Overall Study|Withdrawal by Subject|0
7927250|NCT02255422|12456750|FG002|Overall Study|Withdrawal by Subject|0
7927251|NCT02255422|12456751|FG003|Overall Study|Withdrawal by Subject|0
7927252|NCT02255422|12456752|FG004|Overall Study|Withdrawal by Subject|0
7927253|NCT02255422|12456753|FG005|Overall Study|Withdrawal by Subject|0
7927254|NCT02255422|12456754|FG006|Overall Study|Withdrawal by Subject|2
7927255|NCT02255422|12456748|FG000|Overall Study|Lost to Follow-up|0
7927256|NCT02255422|12456749|FG001|Overall Study|Lost to Follow-up|0
7927257|NCT02255422|12456750|FG002|Overall Study|Lost to Follow-up|1
7927258|NCT02255422|12456751|FG003|Overall Study|Lost to Follow-up|0
7927259|NCT02255422|12456752|FG004|Overall Study|Lost to Follow-up|0
7927260|NCT02255422|12456753|FG005|Overall Study|Lost to Follow-up|0
7927261|NCT02255422|12456754|FG006|Overall Study|Lost to Follow-up|0
7927262|NCT02255461|12456775|FG000|Overall Study|Adverse Event|0
7927263|NCT02255461|12456776|FG001|Overall Study|Adverse Event|1
7927264|NCT02255461|12456777|FG002|Overall Study|Adverse Event|0
7927265|NCT02255461|12456778|FG003|Overall Study|Adverse Event|0
7927266|NCT02255461|12456779|FG004|Overall Study|Adverse Event|1
7927267|NCT02255461|12456775|FG000|Overall Study|Withdrawal by Subject|0
7927268|NCT02255461|12456776|FG001|Overall Study|Withdrawal by Subject|0
7927269|NCT02255461|12456777|FG002|Overall Study|Withdrawal by Subject|1
7927270|NCT02255461|12456778|FG003|Overall Study|Withdrawal by Subject|0
7927271|NCT02255461|12456779|FG004|Overall Study|Withdrawal by Subject|1
7927272|NCT02255461|12456775|FG000|Overall Study|Not meet dose reduction BSA requirement|0
7927273|NCT02255461|12456776|FG001|Overall Study|Not meet dose reduction BSA requirement|1
7927274|NCT02255461|12456777|FG002|Overall Study|Not meet dose reduction BSA requirement|0
7927275|NCT02255461|12456778|FG003|Overall Study|Not meet dose reduction BSA requirement|0
7927276|NCT02255461|12456779|FG004|Overall Study|Not meet dose reduction BSA requirement|0
7927277|NCT02255474|12456799|FG000|Overall Study|Lost to Follow-up|1
7927278|NCT02255474|12456800|FG001|Overall Study|Lost to Follow-up|1
7927279|NCT02255474|12456801|FG002|Overall Study|Lost to Follow-up|3
7927280|NCT02255474|12456799|FG000|Overall Study|Withdrawal by Subject|1
7927281|NCT02255474|12456800|FG001|Overall Study|Withdrawal by Subject|1
7927282|NCT02255474|12456801|FG002|Overall Study|Withdrawal by Subject|0
7927283|NCT02255500|12456812|FG000|Overall Study|Withdrawal by Subject|1
7927284|NCT02255500|12456813|FG001|Overall Study|Withdrawal by Subject|0
7927285|NCT02255552|12456830|FG000|Overall Study|Participants enrolled into another study|0
7927286|NCT02255552|12456831|FG001|Overall Study|Participants enrolled into another study|11
7927287|NCT02255552|12456830|FG000|Overall Study|Withdrawal by Subject|1
7927288|NCT02255552|12456831|FG001|Overall Study|Withdrawal by Subject|4
7927289|NCT02255565|12456840|FG000|Overall Study|Withdrawal by Subject|0
7927290|NCT02255565|12456841|FG001|Overall Study|Withdrawal by Subject|1
7927291|NCT02255565|12456842|FG002|Overall Study|Withdrawal by Subject|0
7927292|NCT02255760|12456901|FG000|Overall Study|Lost to Follow-up|0
7927293|NCT02255760|12456902|FG001|Overall Study|Lost to Follow-up|1
7927294|NCT02255760|12456903|FG002|Overall Study|Lost to Follow-up|0
7927295|NCT02255760|12456904|FG003|Overall Study|Lost to Follow-up|0
7927296|NCT02255760|12456905|FG004|Overall Study|Lost to Follow-up|0
7927297|NCT02255981|12456921|FG000|Overall Study|Lost to Follow-up|3
7927298|NCT02255981|12456921|FG000|Overall Study|Withdrawal by Subject|1
7927299|NCT02256267|12456962|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
7927300|NCT02256267|12456962|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1
7927301|NCT02256384|12456987|FG000|Overall Study|Withdrawal by Subject|12
7927302|NCT02256384|12456987|FG000|Overall Study|Equipment not capturing data|2
7927303|NCT02256436|12456997|FG000|Overall Study|Adverse Event|9
7927304|NCT02256436|12456998|FG001|Overall Study|Adverse Event|14
7927305|NCT02256436|12456997|FG000|Overall Study|Death|216
7927306|NCT02256436|12456998|FG001|Overall Study|Death|208
7927307|NCT02256436|12456997|FG000|Overall Study|Lost to Follow-up|1
7927308|NCT02256436|12456998|FG001|Overall Study|Lost to Follow-up|2
7927309|NCT02256436|12456997|FG000|Overall Study|Physician Decision|1
7927310|NCT02256436|12456998|FG001|Overall Study|Physician Decision|0
7927311|NCT02256436|12456997|FG000|Overall Study|Protocol Violation|0
7927312|NCT02256436|12456998|FG001|Overall Study|Protocol Violation|1
7927313|NCT02256436|12456997|FG000|Overall Study|Withdrawal by Subject|26
7927314|NCT02256436|12456998|FG001|Overall Study|Withdrawal by Subject|10
7927315|NCT02256436|12456997|FG000|Overall Study|Transferred to Extension Study|11
7927316|NCT02256436|12456998|FG001|Overall Study|Transferred to Extension Study|23
7927317|NCT02256436|12456997|FG000|Overall Study|Did Not Continue on Extension Study|8
7927318|NCT02256436|12456998|FG001|Overall Study|Did Not Continue on Extension Study|12
7927319|NCT02256488|12457009|FG000|Overall Study|Lost to Follow-up|6
7927320|NCT02256488|12457010|FG001|Overall Study|Lost to Follow-up|6
7927321|NCT02256488|12457011|FG002|Overall Study|Lost to Follow-up|9
7927322|NCT02256488|12457012|FG003|Overall Study|Lost to Follow-up|3
7927323|NCT02256488|12457009|FG000|Overall Study|OTHER|1
7927324|NCT02256488|12457010|FG001|Overall Study|OTHER|0
7927325|NCT02256488|12457011|FG002|Overall Study|OTHER|1
7927326|NCT02256488|12457012|FG003|Overall Study|OTHER|1
7927327|NCT02256488|12457009|FG000|Overall Study|Withdrawal by Subject|1
7927328|NCT02256488|12457010|FG001|Overall Study|Withdrawal by Subject|0
7927329|NCT02256488|12457011|FG002|Overall Study|Withdrawal by Subject|0
7927330|NCT02256488|12457012|FG003|Overall Study|Withdrawal by Subject|2
7927331|NCT02256540|12457023|FG000|Overall Study|Withdrawal by Subject|0
7927332|NCT02256540|12457024|FG001|Overall Study|Withdrawal by Subject|1
7927333|NCT02256540|12457025|FG002|Overall Study|Withdrawal by Subject|1
7927334|NCT02256540|12457023|FG000|Overall Study|Back pain preventing exercise|0
7927335|NCT02256540|12457024|FG001|Overall Study|Back pain preventing exercise|0
7927336|NCT02256540|12457025|FG002|Overall Study|Back pain preventing exercise|1
7927337|NCT02256553|12457033|FG000|Period I|Adverse Event|5
7927338|NCT02256553|12457033|FG000|Period I|Protocol Violation|1
7927339|NCT02256553|12457033|FG000|Period II|Adverse Event|1
7927340|NCT02256553|12457033|FG000|Period II|Subject Moved|1
7927341|NCT02256553|12457033|FG000|Period III|Adverse Event|3
7927342|NCT02256839|12457041|FG000|Overall Study|Did not meet Eligibility Criteria|2
7927343|NCT02256839|12457042|FG001|Overall Study|Did not meet Eligibility Criteria|3
7927344|NCT02256891|12457050|FG000|Overall Study|Death|0
7927345|NCT02256891|12457051|FG001|Overall Study|Death|2
7927346|NCT02256891|12457050|FG000|Overall Study|Lost to Follow-up|0
7927347|NCT02256891|12457051|FG001|Overall Study|Lost to Follow-up|3
7927348|NCT02256891|12457050|FG000|Overall Study|Physician Decision|7
7927349|NCT02256891|12457051|FG001|Overall Study|Physician Decision|3
7927350|NCT02256891|12457050|FG000|Overall Study|Screen Fail|5
7927351|NCT02256891|12457051|FG001|Overall Study|Screen Fail|4
7927352|NCT02256891|12457050|FG000|Overall Study|Equipment Malfunction|0
7927353|NCT02256891|12457051|FG001|Overall Study|Equipment Malfunction|1
7927354|NCT02256917|12457059|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1
7927355|NCT02256917|12457059|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1
7927356|NCT02256917|12457059|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1
7927357|NCT02256917|12457059|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1
7927358|NCT02256917|12457059|FG000|Prophylactic Treatment Phase II|Discontinued medication|1
7927359|NCT02256969|12457073|FG000|Overall Study|Screenfailed or withdrew|2
7927360|NCT02256969|12457074|FG001|Overall Study|Screenfailed or withdrew|1
7927361|NCT02256969|12457075|FG002|Overall Study|Screenfailed or withdrew|1
7927362|NCT02256982|12457085|FG000|Overall Study|Disease Progression|0
7927363|NCT02256982|12457086|FG001|Overall Study|Disease Progression|1
7927364|NCT02257372|12457145|FG000|Overall Study|Adverse Event|3
7927365|NCT02257372|12457146|FG001|Overall Study|Adverse Event|7
7927366|NCT02257372|12457145|FG000|Overall Study|Lack of Efficacy|2
7927367|NCT02257372|12457146|FG001|Overall Study|Lack of Efficacy|1
7927368|NCT02257372|12457145|FG000|Overall Study|Protocol Violation|1
7927369|NCT02257372|12457146|FG001|Overall Study|Protocol Violation|1
7927370|NCT02257372|12457145|FG000|Overall Study|Lost to Follow-up|0
7927371|NCT02257372|12457146|FG001|Overall Study|Lost to Follow-up|1
7927372|NCT02257372|12457145|FG000|Overall Study|Withdrew consent|1
7927373|NCT02257372|12457146|FG001|Overall Study|Withdrew consent|0
7964628|NCT03282123|12520224|FG000|Overall Study|Withdrawal by Subject|5
7967072|NCT02760407|12523610|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
7967073|NCT02760407|12523611|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1
7967074|NCT02760407|12523612|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
7967075|NCT02760407|12523609|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1
7967076|NCT02760407|12523610|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
7967077|NCT02760407|12523611|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
7967078|NCT02760407|12523612|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
7967079|NCT02760407|12523609|FG000|Overall Study|Study Treatment Was Terminated At The Site|0
7967080|NCT02760407|12523610|FG001|Overall Study|Study Treatment Was Terminated At The Site|0
7967081|NCT02760407|12523611|FG002|Overall Study|Study Treatment Was Terminated At The Site|1
7967082|NCT02760407|12523612|FG003|Overall Study|Study Treatment Was Terminated At The Site|0
7967083|NCT02760407|12523609|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1
7967084|NCT02760407|12523610|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
7967085|NCT02760407|12523611|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
7967086|NCT02760407|12523612|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
7967087|NCT02760407|12523609|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1
7967088|NCT02760407|12523610|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
7967089|NCT02760407|12523611|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
7967090|NCT02760407|12523612|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
7967091|NCT02760407|12523609|FG000|Overall Study|Lack Of Efficacy Per PI|0
7967092|NCT02760407|12523610|FG001|Overall Study|Lack Of Efficacy Per PI|0
7967093|NCT02760407|12523611|FG002|Overall Study|Lack Of Efficacy Per PI|0
7967094|NCT02760407|12523612|FG003|Overall Study|Lack Of Efficacy Per PI|1
7967095|NCT02760407|12523609|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1
7967096|NCT02760407|12523610|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
7967097|NCT02760407|12523611|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
7967098|NCT02760407|12523612|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
7967099|NCT02760407|12523609|FG000|Overall Study|Investigator recorded as Adverse Event|1
7967100|NCT02760407|12523610|FG001|Overall Study|Investigator recorded as Adverse Event|0
7967101|NCT02760407|12523611|FG002|Overall Study|Investigator recorded as Adverse Event|2
7967102|NCT02760407|12523612|FG003|Overall Study|Investigator recorded as Adverse Event|0
7967103|NCT02760433|12523628|FG000|Overall Study|Lost to Follow-up|1
7967104|NCT02760433|12523629|FG001|Overall Study|Lost to Follow-up|0
7967105|NCT02760433|12523630|FG002|Overall Study|Lost to Follow-up|1
7967106|NCT02760433|12523631|FG003|Overall Study|Lost to Follow-up|0
7967107|NCT02760433|12523632|FG004|Overall Study|Lost to Follow-up|0
7967108|NCT02760433|12523628|FG000|Overall Study|Withdrawal by Subject|23
7967109|NCT02760433|12523629|FG001|Overall Study|Withdrawal by Subject|9
7967110|NCT02760433|12523630|FG002|Overall Study|Withdrawal by Subject|0
7967111|NCT02760433|12523631|FG003|Overall Study|Withdrawal by Subject|2
7967112|NCT02760433|12523632|FG004|Overall Study|Withdrawal by Subject|9
7967113|NCT02760433|12523628|FG000|Overall Study|Lack of Response At Week 14|0
7927374|NCT02257385|12457154|FG000|Overall Study|Adverse Event|12
7927375|NCT02257385|12457155|FG001|Overall Study|Adverse Event|8
7927376|NCT02257385|12457154|FG000|Overall Study|Lack of Efficacy|1
7927377|NCT02257385|12457155|FG001|Overall Study|Lack of Efficacy|2
7927378|NCT02257385|12457154|FG000|Overall Study|Protocol Violation|5
7927379|NCT02257385|12457155|FG001|Overall Study|Protocol Violation|7
7927380|NCT02257385|12457154|FG000|Overall Study|Lost to Follow-up|0
7927381|NCT02257385|12457155|FG001|Overall Study|Lost to Follow-up|1
7927382|NCT02257385|12457154|FG000|Overall Study|Withdrawal by Subject|4
7927383|NCT02257385|12457155|FG001|Overall Study|Withdrawal by Subject|4
7927384|NCT02257632|12457183|FG000|Overall Study|Withdrawal by Subject|0
7927385|NCT02257632|12457184|FG001|Overall Study|Withdrawal by Subject|1
7927386|NCT02257632|12457183|FG000|Overall Study|Adverse Event|1
7927387|NCT02257632|12457184|FG001|Overall Study|Adverse Event|2
7927388|NCT02257684|12457192|FG000|Overall Study|Adverse Event|2
7927389|NCT02257684|12457192|FG000|Overall Study|Lack of Efficacy|1
7927390|NCT02257684|12457192|FG000|Overall Study|Sponsor's Decision|1
7927391|NCT02258074|12457235|FG000|Overall Study|Withdrawal by Subject|1
7927392|NCT02258074|12457236|FG001|Overall Study|Withdrawal by Subject|0
7927393|NCT02258074|12457237|FG002|Overall Study|Withdrawal by Subject|0
7927394|NCT02258074|12457238|FG003|Overall Study|Withdrawal by Subject|0
7927395|NCT02258334|12457275|FG000|Overall Study|Adverse Event|1
7927396|NCT02258334|12457276|FG001|Overall Study|Adverse Event|0
7927397|NCT02258334|12457277|FG002|Overall Study|Adverse Event|0
7927398|NCT02258334|12457278|FG003|Overall Study|Adverse Event|0
7927399|NCT02258464|12457313|FG000|Overall Study|Progressive disease (PD)|9
7927400|NCT02258464|12457314|FG001|Overall Study|Progressive disease (PD)|17
7927401|NCT02258464|12457313|FG000|Overall Study|Study drug never administered|1
7927402|NCT02258464|12457314|FG001|Overall Study|Study drug never administered|1
7927403|NCT02258464|12457313|FG000|Overall Study|AE not related to clinical PD|1
7927404|NCT02258464|12457314|FG001|Overall Study|AE not related to clinical PD|3
7927405|NCT02258464|12457313|FG000|Overall Study|Withdrawal by Subject|5
7927406|NCT02258464|12457314|FG001|Overall Study|Withdrawal by Subject|4
7927407|NCT02258464|12457313|FG000|Overall Study|AE related to clinical PD|1
7927408|NCT02258464|12457314|FG001|Overall Study|AE related to clinical PD|0
7927409|NCT02258529|12457332|FG000|Overall Study|Study Terminated by Sponsor|9
7927410|NCT02258529|12457332|FG000|Overall Study|Adverse Event|1
7927411|NCT02259010|12457336|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5
7927412|NCT02259088|12457344|FG000|Overall Study|Adverse Event|6
7927413|NCT02259088|12457345|FG001|Overall Study|Adverse Event|4
7927414|NCT02259088|12457344|FG000|Overall Study|Lost to Follow-up|2
7927415|NCT02259088|12457345|FG001|Overall Study|Lost to Follow-up|0
7927416|NCT02259088|12457344|FG000|Overall Study|Death|2
7927417|NCT02259088|12457345|FG001|Overall Study|Death|0
7927418|NCT02259088|12457344|FG000|Overall Study|Physician Decision|5
7927419|NCT02259088|12457345|FG001|Overall Study|Physician Decision|2
7927420|NCT02259088|12457344|FG000|Overall Study|Protocol deviation|5
7927421|NCT02259088|12457345|FG001|Overall Study|Protocol deviation|0
7927422|NCT02259088|12457344|FG000|Overall Study|Subject/guardian decision|8
7927423|NCT02259088|12457345|FG001|Overall Study|Subject/guardian decision|8
7927424|NCT02259114|12457356|FG000|Overall Study|Progressive Disease|14
7927425|NCT02259114|12457357|FG001|Overall Study|Progressive Disease|2
7927426|NCT02259114|12457358|FG002|Overall Study|Progressive Disease|10
7927427|NCT02259114|12457359|FG003|Overall Study|Progressive Disease|2
7927428|NCT02259114|12457360|FG004|Overall Study|Progressive Disease|5
7927429|NCT02259114|12457356|FG000|Overall Study|Adverse Event|2
7927430|NCT02259114|12457357|FG001|Overall Study|Adverse Event|1
7927431|NCT02259114|12457358|FG002|Overall Study|Adverse Event|0
7927432|NCT02259114|12457359|FG003|Overall Study|Adverse Event|0
7927433|NCT02259114|12457360|FG004|Overall Study|Adverse Event|1
7927434|NCT02259114|12457356|FG000|Overall Study|Death|3
7927435|NCT02259114|12457357|FG001|Overall Study|Death|0
7927436|NCT02259114|12457358|FG002|Overall Study|Death|1
7927437|NCT02259114|12457359|FG003|Overall Study|Death|0
7927438|NCT02259114|12457360|FG004|Overall Study|Death|0
7927439|NCT02259114|12457356|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7927440|NCT02259114|12457357|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7927441|NCT02259114|12457358|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1
7927442|NCT02259114|12457359|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7927443|NCT02259114|12457360|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7927444|NCT02259114|12457356|FG000|Overall Study|Withdrawal by Subject|0
7927445|NCT02259114|12457357|FG001|Overall Study|Withdrawal by Subject|0
7927446|NCT02259114|12457358|FG002|Overall Study|Withdrawal by Subject|1
7927447|NCT02259114|12457359|FG003|Overall Study|Withdrawal by Subject|1
7927448|NCT02259114|12457360|FG004|Overall Study|Withdrawal by Subject|0
7927449|NCT02259114|12457356|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1
7927450|NCT02259114|12457357|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1
7927451|NCT02259114|12457358|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0
7927452|NCT02259114|12457359|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0
7927453|NCT02259114|12457360|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0
7927454|NCT02259114|12457356|FG000|Overall Study|Not Treated|1
7927455|NCT02259114|12457357|FG001|Overall Study|Not Treated|0
7927456|NCT02259114|12457358|FG002|Overall Study|Not Treated|0
7927457|NCT02259114|12457359|FG003|Overall Study|Not Treated|0
7927458|NCT02259114|12457360|FG004|Overall Study|Not Treated|0
7927459|NCT02259231|12457379|FG000|Overall Study|Adverse Event|1
7927460|NCT02259231|12457380|FG001|Overall Study|Adverse Event|1
7927461|NCT02259231|12457381|FG002|Overall Study|Adverse Event|2
7927462|NCT02259231|12457382|FG003|Overall Study|Adverse Event|0
7927463|NCT02259231|12457383|FG004|Overall Study|Adverse Event|0
7927464|NCT02259231|12457384|FG005|Overall Study|Adverse Event|0
7927465|NCT02259231|12457385|FG006|Overall Study|Adverse Event|0
7927466|NCT02259231|12457379|FG000|Overall Study|Progressive Disease|4
7927467|NCT02259231|12457380|FG001|Overall Study|Progressive Disease|5
7927468|NCT02259231|12457381|FG002|Overall Study|Progressive Disease|4
7927469|NCT02259231|12457382|FG003|Overall Study|Progressive Disease|5
7927470|NCT02259231|12457383|FG004|Overall Study|Progressive Disease|4
7927471|NCT02259231|12457384|FG005|Overall Study|Progressive Disease|5
7927472|NCT02259231|12457385|FG006|Overall Study|Progressive Disease|4
7927473|NCT02259231|12457379|FG000|Overall Study|Sponsor termination of study|1
7927474|NCT02259231|12457380|FG001|Overall Study|Sponsor termination of study|0
7927475|NCT02259231|12457381|FG002|Overall Study|Sponsor termination of study|0
7927476|NCT02259231|12457382|FG003|Overall Study|Sponsor termination of study|1
7927477|NCT02259231|12457383|FG004|Overall Study|Sponsor termination of study|2
7927478|NCT02259231|12457384|FG005|Overall Study|Sponsor termination of study|1
7927479|NCT02259231|12457385|FG006|Overall Study|Sponsor termination of study|1
7927480|NCT02259348|12457401|FG000|Overall Study|Donors|6
7927481|NCT02259348|12457401|FG000|Overall Study|Death|4
7927482|NCT02259400|12457407|FG000|Overall Study|Death|0
7927483|NCT02259400|12457408|FG001|Overall Study|Death|2
7927484|NCT02259582|12457417|FG000|Overall Study|Physician Decision|0
7927485|NCT02259582|12457418|FG001|Overall Study|Physician Decision|1
7927486|NCT02259582|12457419|FG002|Overall Study|Physician Decision|0
7927487|NCT02259582|12457417|FG000|Overall Study|Death|0
7927488|NCT02259582|12457418|FG001|Overall Study|Death|0
7927489|NCT02259582|12457419|FG002|Overall Study|Death|1
7927490|NCT02259582|12457417|FG000|Overall Study|Adverse Event|1
7927491|NCT02259582|12457418|FG001|Overall Study|Adverse Event|0
7927492|NCT02259582|12457419|FG002|Overall Study|Adverse Event|1
7927493|NCT02259582|12457417|FG000|Overall Study|Withdrawal by Subject|0
7927494|NCT02259582|12457418|FG001|Overall Study|Withdrawal by Subject|0
7927495|NCT02259582|12457419|FG002|Overall Study|Withdrawal by Subject|1
7927496|NCT02259582|12457417|FG000|Overall Study|Disease progression|14
7927497|NCT02259582|12457418|FG001|Overall Study|Disease progression|15
7927498|NCT02259582|12457419|FG002|Overall Study|Disease progression|17
7927499|NCT02259582|12457417|FG000|Overall Study|Lack of Subject Adherence to Protocol|1
7927500|NCT02259582|12457418|FG001|Overall Study|Lack of Subject Adherence to Protocol|1
7927501|NCT02259582|12457419|FG002|Overall Study|Lack of Subject Adherence to Protocol|1
7927502|NCT02260154|12457440|FG000|Overall Study|Screening failure|2
7927503|NCT02260180|12457448|FG000|Overall Study|Adverse Event|2
7927504|NCT02260180|12457449|FG001|Overall Study|Adverse Event|0
7927505|NCT02260180|12457450|FG002|Overall Study|Adverse Event|1
7927506|NCT02260258|12457460|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2
7927507|NCT02260258|12457461|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1
7927508|NCT02260388|12457472|FG000|Overall Study|Lost to Follow-up|2
7927509|NCT02260388|12457473|FG001|Overall Study|Lost to Follow-up|8
7927510|NCT02260388|12457474|FG002|Overall Study|Lost to Follow-up|3
7927511|NCT02260388|12457475|FG003|Overall Study|Lost to Follow-up|4
7927512|NCT02260492|12457501|FG000|Overall Study|Adverse Event|6
7927513|NCT02260492|12457502|FG001|Overall Study|Adverse Event|1
7927514|NCT02260492|12457503|FG002|Overall Study|Adverse Event|2
7927515|NCT02260492|12457501|FG000|Overall Study|Death|0
7927516|NCT02260492|12457502|FG001|Overall Study|Death|1
7927517|NCT02260492|12457503|FG002|Overall Study|Death|0
7927518|NCT02260492|12457501|FG000|Overall Study|Lost to Follow-up|12
7927519|NCT02260492|12457502|FG001|Overall Study|Lost to Follow-up|9
7927520|NCT02260492|12457503|FG002|Overall Study|Lost to Follow-up|0
7927521|NCT02260492|12457501|FG000|Overall Study|Physician Decision|2
7927522|NCT02260492|12457502|FG001|Overall Study|Physician Decision|0
7927523|NCT02260492|12457503|FG002|Overall Study|Physician Decision|1
7927524|NCT02260492|12457501|FG000|Overall Study|Withdrawal by Subject|3
7927525|NCT02260492|12457502|FG001|Overall Study|Withdrawal by Subject|2
7927526|NCT02260492|12457503|FG002|Overall Study|Withdrawal by Subject|2
7927527|NCT02260635|12457542|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
7927528|NCT02260635|12457543|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
7927529|NCT02260635|12457542|FG000|Open-Label Extension|Study Termination|25
7927530|NCT02260635|12457543|FG001|Open-Label Extension|Study Termination|25
7927531|NCT02260635|12457542|FG000|Open-Label Extension|Withdrawal by Subject|1
7927532|NCT02260635|12457543|FG001|Open-Label Extension|Withdrawal by Subject|0
7927533|NCT02260648|12457554|FG000|Overall Study|Adverse Event|3
7927534|NCT02260648|12457555|FG001|Overall Study|Adverse Event|0
7927535|NCT02260648|12457556|FG002|Overall Study|Adverse Event|1
7927536|NCT02260648|12457554|FG000|Overall Study|Withdrawal by Subject|1
7927537|NCT02260648|12457555|FG001|Overall Study|Withdrawal by Subject|1
7927538|NCT02260648|12457556|FG002|Overall Study|Withdrawal by Subject|0
7927539|NCT02260648|12457554|FG000|Overall Study|Protocol Violation|1
7927540|NCT02260648|12457555|FG001|Overall Study|Protocol Violation|0
7927541|NCT02260648|12457556|FG002|Overall Study|Protocol Violation|0
7927542|NCT02260648|12457554|FG000|Overall Study|Discontinue Due to Study Termination|13
7927543|NCT02260648|12457555|FG001|Overall Study|Discontinue Due to Study Termination|12
7927544|NCT02260648|12457556|FG002|Overall Study|Discontinue Due to Study Termination|7
7927545|NCT02260791|12457566|FG000|Overall Study|Lost to Follow-up|4
7927546|NCT02260791|12457567|FG001|Overall Study|Lost to Follow-up|4
7927547|NCT02260791|12457566|FG000|Overall Study|Lack of Efficacy|2
7927548|NCT02260791|12457567|FG001|Overall Study|Lack of Efficacy|1
7927549|NCT02260791|12457566|FG000|Overall Study|Adverse Event|13
7927550|NCT02260791|12457567|FG001|Overall Study|Adverse Event|9
7927551|NCT02260791|12457566|FG000|Overall Study|Death|1
7927552|NCT02260791|12457567|FG001|Overall Study|Death|0
7927553|NCT02260791|12457566|FG000|Overall Study|Withdrawal by Subject|11
7927554|NCT02260791|12457567|FG001|Overall Study|Withdrawal by Subject|16
7927555|NCT02260791|12457566|FG000|Overall Study|Screen failure|0
7927556|NCT02260791|12457567|FG001|Overall Study|Screen failure|1
7927557|NCT02260791|12457566|FG000|Overall Study|Protocol deviation|2
7927558|NCT02260791|12457567|FG001|Overall Study|Protocol deviation|3
7927559|NCT02260804|12457575|FG000|Induction Study Period|Protocol Violation|2
7927560|NCT02260804|12457576|FG001|Induction Study Period|Protocol Violation|0
7927561|NCT02260804|12457575|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6
7927562|NCT02260804|12457576|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9
7927563|NCT02260804|12457575|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3
7927564|NCT02260804|12457576|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1
7927565|NCT02260804|12457575|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1
7927566|NCT02260804|12457576|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3
7927567|NCT02260804|12457575|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1
7927568|NCT02260804|12457576|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0
7927569|NCT02260804|12457575|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1
7927570|NCT02260804|12457576|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0
7927571|NCT02260804|12457575|FG000|1st Year of the Maintenance Period (MP1)|Death|0
7927572|NCT02260804|12457576|FG001|1st Year of the Maintenance Period (MP1)|Death|1
7927573|NCT02260804|12457575|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0
7927574|NCT02260804|12457576|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1
7927575|NCT02260804|12457575|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6
7927576|NCT02260804|12457576|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5
7927577|NCT02260804|12457575|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3
7927578|NCT02260804|12457576|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0
7927579|NCT02260804|12457575|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0
7927580|NCT02260804|12457576|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1
7927581|NCT02260817|12457584|FG000|Overall Study|Lost to Follow-up|0
7927582|NCT02260817|12457585|FG001|Overall Study|Lost to Follow-up|14
7927583|NCT02260817|12457584|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0
7927584|NCT02260817|12457585|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7
7927585|NCT02260817|12457584|FG000|Overall Study|Observation, no biopsy|0
7927586|NCT02260817|12457585|FG001|Overall Study|Observation, no biopsy|1
7927587|NCT02260817|12457584|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0
7927588|NCT02260817|12457585|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1
7927589|NCT02260817|12457584|FG000|Overall Study|Protocol Violation|0
7927590|NCT02260817|12457585|FG001|Overall Study|Protocol Violation|14
7927591|NCT02260882|12457593|FG000|Overall Study|Protocol Violation|0
7927592|NCT02260882|12457594|FG001|Overall Study|Protocol Violation|1
7927593|NCT02260921|12457603|FG000|Overall Study|Adverse Event|1
7927594|NCT02260921|12457604|FG001|Overall Study|Adverse Event|0
7927595|NCT02260921|12457603|FG000|Overall Study|Lost to Follow-up|4
7927596|NCT02260921|12457604|FG001|Overall Study|Lost to Follow-up|3
7927597|NCT02260921|12457603|FG000|Overall Study|Withdraw Consent|4
7927598|NCT02260921|12457604|FG001|Overall Study|Withdraw Consent|1
7927599|NCT02260921|12457603|FG000|Overall Study|Death|1
7927600|NCT02260921|12457604|FG001|Overall Study|Death|0
7927601|NCT02260921|12457603|FG000|Overall Study|Prohibited Treatment for Knee Pain|4
7927602|NCT02260921|12457604|FG001|Overall Study|Prohibited Treatment for Knee Pain|0
7927603|NCT02260934|12457612|FG000|Overall Study|Lost to Follow-up|2
7927604|NCT02260934|12457613|FG001|Overall Study|Lost to Follow-up|1
7927605|NCT02260934|12457612|FG000|Overall Study|Withdrawal by Subject|0
7927606|NCT02260934|12457613|FG001|Overall Study|Withdrawal by Subject|2
7927607|NCT02260934|12457612|FG000|Overall Study|Participant Relocated|1
7927608|NCT02260934|12457613|FG001|Overall Study|Participant Relocated|0
7927609|NCT02260934|12457612|FG000|Overall Study|Site error|0
7927610|NCT02260934|12457613|FG001|Overall Study|Site error|1
7927611|NCT02260986|12457629|FG000|Overall Study|Adverse Event|24
7927612|NCT02260986|12457630|FG001|Overall Study|Adverse Event|0
7927613|NCT02260986|12457631|FG002|Overall Study|Adverse Event|11
7927614|NCT02260986|12457629|FG000|Overall Study|Lack of Efficacy|27
7927615|NCT02260986|12457630|FG001|Overall Study|Lack of Efficacy|3
7927616|NCT02260986|12457631|FG002|Overall Study|Lack of Efficacy|0
7927617|NCT02260986|12457629|FG000|Overall Study|Protocol Violation|14
7927618|NCT02260986|12457630|FG001|Overall Study|Protocol Violation|5
7927619|NCT02260986|12457631|FG002|Overall Study|Protocol Violation|16
7927620|NCT02260986|12457629|FG000|Overall Study|Car accident|0
7927621|NCT02260986|12457630|FG001|Overall Study|Car accident|0
7927622|NCT02260986|12457631|FG002|Overall Study|Car accident|1
7927623|NCT02260986|12457629|FG000|Overall Study|Withdrawal by Subject|17
7927624|NCT02260986|12457630|FG001|Overall Study|Withdrawal by Subject|4
7927625|NCT02260986|12457631|FG002|Overall Study|Withdrawal by Subject|9
7927626|NCT02260986|12457629|FG000|Overall Study|Incorrect randomization|0
7927627|NCT02260986|12457630|FG001|Overall Study|Incorrect randomization|1
7927628|NCT02260986|12457631|FG002|Overall Study|Incorrect randomization|0
7927629|NCT02260986|12457629|FG000|Overall Study|Lack of investigation product supply|2
7927630|NCT02260986|12457630|FG001|Overall Study|Lack of investigation product supply|0
7927631|NCT02260986|12457631|FG002|Overall Study|Lack of investigation product supply|1
7927632|NCT02260986|12457629|FG000|Overall Study|Lost to Follow-up|4
7927633|NCT02260986|12457630|FG001|Overall Study|Lost to Follow-up|0
7927634|NCT02260986|12457631|FG002|Overall Study|Lost to Follow-up|3
7927635|NCT02260986|12457629|FG000|Overall Study|Pregnancy|2
7927636|NCT02260986|12457630|FG001|Overall Study|Pregnancy|0
7927637|NCT02260986|12457631|FG002|Overall Study|Pregnancy|0
7927638|NCT02261467|12457667|FG000|Overall Study|Enrolled in Error|1
7927639|NCT02261467|12457668|FG001|Overall Study|Enrolled in Error|0
7927640|NCT02261467|12457667|FG000|Overall Study|Protocol Violation|0
7927641|NCT02261467|12457668|FG001|Overall Study|Protocol Violation|1
7927642|NCT02261467|12457667|FG000|Overall Study|Personal Reasons|17
7927643|NCT02261467|12457668|FG001|Overall Study|Personal Reasons|22
7927644|NCT02261467|12457667|FG000|Overall Study|Lost to Follow-up|2
7927645|NCT02261467|12457668|FG001|Overall Study|Lost to Follow-up|13
7927646|NCT02261467|12457667|FG000|Overall Study|Adverse Event|1
7927647|NCT02261467|12457668|FG001|Overall Study|Adverse Event|1
7927648|NCT02261493|12457677|FG000|Overall Study|Noncompliance|0
7927649|NCT02261493|12457678|FG001|Overall Study|Noncompliance|0
7927650|NCT02261493|12457679|FG002|Overall Study|Noncompliance|2
7927651|NCT02261493|12457677|FG000|Overall Study|Physician Decision|0
7927652|NCT02261493|12457678|FG001|Overall Study|Physician Decision|1
7927653|NCT02261493|12457679|FG002|Overall Study|Physician Decision|0
7927654|NCT02261493|12457677|FG000|Overall Study|Undisclosed alcohol abuse|0
7927655|NCT02261493|12457678|FG001|Overall Study|Undisclosed alcohol abuse|1
7927656|NCT02261493|12457679|FG002|Overall Study|Undisclosed alcohol abuse|0
7927657|NCT02261493|12457677|FG000|Overall Study|Protocol Violation|1
7927658|NCT02261493|12457678|FG001|Overall Study|Protocol Violation|0
7927659|NCT02261493|12457679|FG002|Overall Study|Protocol Violation|0
7927660|NCT02261493|12457677|FG000|Overall Study|Personal Reasons|14
7927661|NCT02261493|12457678|FG001|Overall Study|Personal Reasons|14
7927662|NCT02261493|12457679|FG002|Overall Study|Personal Reasons|16
7927663|NCT02261493|12457677|FG000|Overall Study|Lost to Follow-up|14
7927664|NCT02261493|12457678|FG001|Overall Study|Lost to Follow-up|27
7927665|NCT02261493|12457679|FG002|Overall Study|Lost to Follow-up|8
7927666|NCT02261493|12457677|FG000|Overall Study|Pregnancy|1
7927667|NCT02261493|12457678|FG001|Overall Study|Pregnancy|2
7927668|NCT02261493|12457679|FG002|Overall Study|Pregnancy|0
7927669|NCT02261493|12457677|FG000|Overall Study|Lack of Efficacy|0
7927670|NCT02261493|12457678|FG001|Overall Study|Lack of Efficacy|1
7927671|NCT02261493|12457679|FG002|Overall Study|Lack of Efficacy|0
7927672|NCT02261493|12457677|FG000|Overall Study|Adverse Event|0
7927673|NCT02261493|12457678|FG001|Overall Study|Adverse Event|1
7927674|NCT02261493|12457679|FG002|Overall Study|Adverse Event|0
7927675|NCT02261974|12457757|FG000|Overall Study|Withdrawal by Subject|3
7927676|NCT02261974|12457758|FG001|Overall Study|Withdrawal by Subject|2
7927677|NCT02261974|12457757|FG000|Overall Study|Pregnancy|0
7927678|NCT02261974|12457758|FG001|Overall Study|Pregnancy|1
7927679|NCT02261974|12457757|FG000|Overall Study|Missed treatment cut-off date|6
7927680|NCT02261974|12457758|FG001|Overall Study|Missed treatment cut-off date|3
7927681|NCT02261974|12457757|FG000|Overall Study|Received partial treatment; FU to 1 mo|3
7927682|NCT02261974|12457758|FG001|Overall Study|Received partial treatment; FU to 1 mo|1
7927683|NCT02261974|12457757|FG000|Overall Study|Lost to Follow-up|2
7927684|NCT02261974|12457758|FG001|Overall Study|Lost to Follow-up|0
7927685|NCT02261974|12457757|FG000|Overall Study|Adverse Event|1
7927686|NCT02261974|12457758|FG001|Overall Study|Adverse Event|0
7927687|NCT02262260|12457788|FG000|Overall Study|Adverse Event|4
7927688|NCT02262260|12457789|FG001|Overall Study|Adverse Event|1
7927689|NCT02262260|12457788|FG000|Overall Study|Withdrawal of consent|4
7927690|NCT02262260|12457789|FG001|Overall Study|Withdrawal of consent|2
7927691|NCT02262260|12457788|FG000|Overall Study|Lost to Follow-up|1
7927692|NCT02262260|12457789|FG001|Overall Study|Lost to Follow-up|2
7927693|NCT02262260|12457788|FG000|Overall Study|Protocol deviation|2
7927694|NCT02262260|12457789|FG001|Overall Study|Protocol deviation|5
7927695|NCT02262364|12457795|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1
7927696|NCT02262377|12457801|FG000|Overall Study|Lost to Follow-up|5
7927697|NCT02262377|12457802|FG001|Overall Study|Lost to Follow-up|6
7927698|NCT02262377|12457801|FG000|Overall Study|Found ineligible after enrollment|3
7927699|NCT02262377|12457802|FG001|Overall Study|Found ineligible after enrollment|0
7927700|NCT02262377|12457801|FG000|Overall Study|Withdrawal by Subject|4
7927701|NCT02262377|12457802|FG001|Overall Study|Withdrawal by Subject|0
7927702|NCT02262728|12457816|FG000|Follow-up Phase (3 Years)|Death|0
7927703|NCT02262728|12457817|FG001|Follow-up Phase (3 Years)|Death|1
7927704|NCT02262728|12457816|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4
7927705|NCT02262728|12457817|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1
7927706|NCT02262728|12457816|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0
7927707|NCT02262728|12457817|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1
7927708|NCT02262754|12457826|FG000|Overall Study|Adverse Event|3
7927709|NCT02262754|12457827|FG001|Overall Study|Adverse Event|4
7927710|NCT02262754|12457828|FG002|Overall Study|Adverse Event|0
7927711|NCT02262754|12457826|FG000|Overall Study|Lack of Efficacy|2
7927712|NCT02262754|12457827|FG001|Overall Study|Lack of Efficacy|0
7927713|NCT02262754|12457828|FG002|Overall Study|Lack of Efficacy|1
7927714|NCT02262754|12457826|FG000|Overall Study|Lost to Follow-up|0
7927715|NCT02262754|12457827|FG001|Overall Study|Lost to Follow-up|0
7927716|NCT02262754|12457828|FG002|Overall Study|Lost to Follow-up|1
7927717|NCT02262754|12457826|FG000|Overall Study|No longer meets eligibility criteria|0
7927718|NCT02262754|12457827|FG001|Overall Study|No longer meets eligibility criteria|1
7927719|NCT02262754|12457828|FG002|Overall Study|No longer meets eligibility criteria|0
7927720|NCT02262754|12457826|FG000|Overall Study|Study terminated by sponsor|5
7927721|NCT02262754|12457827|FG001|Overall Study|Study terminated by sponsor|4
7927722|NCT02262754|12457828|FG002|Overall Study|Study terminated by sponsor|4
7927723|NCT02262754|12457826|FG000|Overall Study|Protocol Violation|1
7927724|NCT02262754|12457827|FG001|Overall Study|Protocol Violation|0
7927725|NCT02262754|12457828|FG002|Overall Study|Protocol Violation|0
7927726|NCT02262754|12457826|FG000|Overall Study|Withdrawal by Subject|1
7927727|NCT02262754|12457827|FG001|Overall Study|Withdrawal by Subject|0
7927728|NCT02262754|12457828|FG002|Overall Study|Withdrawal by Subject|1
7927729|NCT02262754|12457826|FG000|Overall Study|Other|4
7927730|NCT02262754|12457827|FG001|Overall Study|Other|0
7927731|NCT02262754|12457828|FG002|Overall Study|Other|2
7927732|NCT02263079|12457854|FG000|Overall Study|Physician Decision|1
7927733|NCT02263079|12457855|FG001|Overall Study|Physician Decision|0
7927734|NCT02263079|12457856|FG002|Overall Study|Physician Decision|0
7927735|NCT02263079|12457854|FG000|Overall Study|Withdrawal by Subject|2
7927736|NCT02263079|12457855|FG001|Overall Study|Withdrawal by Subject|8
7927737|NCT02263079|12457856|FG002|Overall Study|Withdrawal by Subject|0
7927738|NCT02263326|12457894|FG000|Overall Study|Lost to Follow-up|1
7927739|NCT02263326|12457895|FG001|Overall Study|Lost to Follow-up|1
7927740|NCT02263547|12457901|FG000|Overall Study|Adverse Event|1
7927741|NCT02263547|12457901|FG000|Overall Study|Lost to Follow-up|2
7927742|NCT02264574|12457948|FG000|Overall Study|Death|21
7927743|NCT02264574|12457949|FG001|Overall Study|Death|21
7927744|NCT02264574|12457948|FG000|Overall Study|Withdrawal by Subject|8
7927745|NCT02264574|12457949|FG001|Overall Study|Withdrawal by Subject|6
7927746|NCT02264574|12457948|FG000|Overall Study|Other, Not Specified|0
7927747|NCT02264574|12457949|FG001|Overall Study|Other, Not Specified|3
7927748|NCT02264639|12457960|FG000|Overall Study|Death (after completing single-dose phase)|1
7927749|NCT02264639|12457961|FG001|Overall Study|Death (after completing single-dose phase)|0
7927750|NCT02264639|12457962|FG002|Overall Study|Death (after completing single-dose phase)|0
7927751|NCT02264639|12457963|FG003|Overall Study|Death (after completing single-dose phase)|0
7927752|NCT02264639|12457964|FG004|Overall Study|Death (after completing single-dose phase)|0
7927753|NCT02264639|12457960|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1
7927754|NCT02264639|12457961|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7927755|NCT02264639|12457962|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7927756|NCT02264639|12457963|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7927757|NCT02264639|12457964|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7927758|NCT02264639|12457960|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0
7927759|NCT02264639|12457961|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0
7927760|NCT02264639|12457962|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1
7927761|NCT02264639|12457963|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0
7927762|NCT02264639|12457964|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0
7927763|NCT02264639|12457960|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7927764|NCT02264639|12457961|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7927765|NCT02264639|12457962|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7927766|NCT02264639|12457963|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7927767|NCT02264639|12457964|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1
7927768|NCT02264821|12457982|FG000|Overall Study|Protocol Violation|1
7927769|NCT02264821|12457983|FG001|Overall Study|Protocol Violation|3
7927770|NCT02264821|12457984|FG002|Overall Study|Protocol Violation|6
7927771|NCT02264990|12457994|FG000|Overall Study|Death|255
7927772|NCT02264990|12457995|FG001|Overall Study|Death|250
7927773|NCT02264990|12457994|FG000|Overall Study|Withdrawal by Subject|4
7927774|NCT02264990|12457995|FG001|Overall Study|Withdrawal by Subject|5
7927775|NCT02264990|12457994|FG000|Overall Study|Lost to Follow-up|1
7927776|NCT02264990|12457995|FG001|Overall Study|Lost to Follow-up|3
7927777|NCT02264990|12457994|FG000|Overall Study|Other|0
7927778|NCT02264990|12457995|FG001|Overall Study|Other|1
7927779|NCT02265237|12458013|FG000|As Treated (Overall Study)|Adverse Event|1
7927780|NCT02265237|12458014|FG001|As Treated (Overall Study)|Adverse Event|1
7927781|NCT02265237|12458015|FG002|As Treated (Overall Study)|Adverse Event|0
7927782|NCT02265237|12458016|FG003|As Treated (Overall Study)|Adverse Event|0
7927783|NCT02265237|12458013|FG000|As Treated (Overall Study)|Withdrawal by Subject|1
7927784|NCT02265237|12458014|FG001|As Treated (Overall Study)|Withdrawal by Subject|0
7927785|NCT02265237|12458015|FG002|As Treated (Overall Study)|Withdrawal by Subject|1
7927786|NCT02265237|12458016|FG003|As Treated (Overall Study)|Withdrawal by Subject|0
7927787|NCT02265237|12458013|FG000|As Treated (Overall Study)|Lost to Follow-up|1
7927788|NCT02265237|12458014|FG001|As Treated (Overall Study)|Lost to Follow-up|2
7927789|NCT02265237|12458015|FG002|As Treated (Overall Study)|Lost to Follow-up|6
7927790|NCT02265237|12458016|FG003|As Treated (Overall Study)|Lost to Follow-up|0
7927791|NCT02265237|12458013|FG000|As Treated (Overall Study)|Other|2
7927792|NCT02265237|12458014|FG001|As Treated (Overall Study)|Other|0
7927793|NCT02265237|12458015|FG002|As Treated (Overall Study)|Other|3
7927794|NCT02265237|12458016|FG003|As Treated (Overall Study)|Other|1
7927795|NCT02265510|12458045|FG000|Overall Study|Withdrawal by Subject|1
7927796|NCT02265510|12458046|FG001|Overall Study|Withdrawal by Subject|1
7927797|NCT02265510|12458047|FG002|Overall Study|Withdrawal by Subject|2
7927798|NCT02265510|12458048|FG003|Overall Study|Withdrawal by Subject|1
7927799|NCT02265510|12458049|FG004|Overall Study|Withdrawal by Subject|0
7927800|NCT02265510|12458050|FG005|Overall Study|Withdrawal by Subject|2
7927801|NCT02265510|12458051|FG006|Overall Study|Withdrawal by Subject|0
7927802|NCT02265510|12458052|FG007|Overall Study|Withdrawal by Subject|2
7927803|NCT02265510|12458053|FG008|Overall Study|Withdrawal by Subject|0
7927804|NCT02265510|12458054|FG009|Overall Study|Withdrawal by Subject|0
7927805|NCT02265510|12458055|FG010|Overall Study|Withdrawal by Subject|0
7927806|NCT02265510|12458056|FG011|Overall Study|Withdrawal by Subject|0
7927807|NCT02265510|12458057|FG012|Overall Study|Withdrawal by Subject|1
7927808|NCT02265510|12458058|FG013|Overall Study|Withdrawal by Subject|0
7927809|NCT02265510|12458045|FG000|Overall Study|Disease Progression|0
7927810|NCT02265510|12458046|FG001|Overall Study|Disease Progression|1
7927811|NCT02265510|12458047|FG002|Overall Study|Disease Progression|2
7927812|NCT02265510|12458048|FG003|Overall Study|Disease Progression|1
7927813|NCT02265510|12458049|FG004|Overall Study|Disease Progression|1
7927814|NCT02265510|12458050|FG005|Overall Study|Disease Progression|0
7927815|NCT02265510|12458051|FG006|Overall Study|Disease Progression|0
7927816|NCT02265510|12458052|FG007|Overall Study|Disease Progression|0
7927817|NCT02265510|12458053|FG008|Overall Study|Disease Progression|0
7927818|NCT02265510|12458054|FG009|Overall Study|Disease Progression|0
7927819|NCT02265510|12458055|FG010|Overall Study|Disease Progression|0
7927820|NCT02265510|12458056|FG011|Overall Study|Disease Progression|0
7927821|NCT02265510|12458057|FG012|Overall Study|Disease Progression|0
7927822|NCT02265510|12458058|FG013|Overall Study|Disease Progression|0
7927823|NCT02265510|12458045|FG000|Overall Study|Death|2
7927824|NCT02265510|12458046|FG001|Overall Study|Death|0
7927825|NCT02265510|12458047|FG002|Overall Study|Death|2
7927826|NCT02265510|12458048|FG003|Overall Study|Death|2
7927827|NCT02265510|12458049|FG004|Overall Study|Death|1
7927828|NCT02265510|12458050|FG005|Overall Study|Death|3
7927829|NCT02265510|12458051|FG006|Overall Study|Death|2
7927830|NCT02265510|12458052|FG007|Overall Study|Death|1
7927831|NCT02265510|12458053|FG008|Overall Study|Death|3
7927832|NCT02265510|12458054|FG009|Overall Study|Death|3
7927833|NCT02265510|12458055|FG010|Overall Study|Death|4
7927834|NCT02265510|12458056|FG011|Overall Study|Death|12
7927835|NCT02265510|12458057|FG012|Overall Study|Death|7
7927836|NCT02265510|12458058|FG013|Overall Study|Death|6
7927837|NCT02265510|12458045|FG000|Overall Study|Lost to Follow-up|0
7927838|NCT02265510|12458046|FG001|Overall Study|Lost to Follow-up|0
7927839|NCT02265510|12458047|FG002|Overall Study|Lost to Follow-up|0
7927840|NCT02265510|12458048|FG003|Overall Study|Lost to Follow-up|0
7927841|NCT02265510|12458049|FG004|Overall Study|Lost to Follow-up|1
7927842|NCT02265510|12458050|FG005|Overall Study|Lost to Follow-up|0
7927843|NCT02265510|12458051|FG006|Overall Study|Lost to Follow-up|0
7927844|NCT02265510|12458052|FG007|Overall Study|Lost to Follow-up|0
7927845|NCT02265510|12458053|FG008|Overall Study|Lost to Follow-up|0
7927846|NCT02265510|12458054|FG009|Overall Study|Lost to Follow-up|2
7927847|NCT02265510|12458055|FG010|Overall Study|Lost to Follow-up|0
7927848|NCT02265510|12458056|FG011|Overall Study|Lost to Follow-up|0
7927849|NCT02265510|12458057|FG012|Overall Study|Lost to Follow-up|0
7927850|NCT02265510|12458058|FG013|Overall Study|Lost to Follow-up|2
7927851|NCT02265510|12458045|FG000|Overall Study|Other|0
7927852|NCT02265510|12458046|FG001|Overall Study|Other|1
7927853|NCT02265510|12458047|FG002|Overall Study|Other|0
7927854|NCT02265510|12458048|FG003|Overall Study|Other|0
7927855|NCT02265510|12458049|FG004|Overall Study|Other|0
7927856|NCT02265510|12458050|FG005|Overall Study|Other|0
7927857|NCT02265510|12458051|FG006|Overall Study|Other|0
7927858|NCT02265510|12458052|FG007|Overall Study|Other|0
7927859|NCT02265510|12458053|FG008|Overall Study|Other|0
7927860|NCT02265510|12458054|FG009|Overall Study|Other|0
7927861|NCT02265510|12458055|FG010|Overall Study|Other|0
7927862|NCT02265510|12458056|FG011|Overall Study|Other|0
7927863|NCT02265510|12458057|FG012|Overall Study|Other|0
7927864|NCT02265510|12458058|FG013|Overall Study|Other|0
7927865|NCT02265510|12458045|FG000|Overall Study|Study Terminated by Sponsor|0
7927866|NCT02265510|12458046|FG001|Overall Study|Study Terminated by Sponsor|0
7927867|NCT02265510|12458047|FG002|Overall Study|Study Terminated by Sponsor|0
7927868|NCT02265510|12458048|FG003|Overall Study|Study Terminated by Sponsor|0
7927869|NCT02265510|12458049|FG004|Overall Study|Study Terminated by Sponsor|0
7927870|NCT02265510|12458050|FG005|Overall Study|Study Terminated by Sponsor|1
7927871|NCT02265510|12458051|FG006|Overall Study|Study Terminated by Sponsor|1
7927872|NCT02265510|12458052|FG007|Overall Study|Study Terminated by Sponsor|1
7927873|NCT02265510|12458053|FG008|Overall Study|Study Terminated by Sponsor|1
7927874|NCT02265510|12458054|FG009|Overall Study|Study Terminated by Sponsor|2
7927875|NCT02265510|12458055|FG010|Overall Study|Study Terminated by Sponsor|1
7927876|NCT02265510|12458056|FG011|Overall Study|Study Terminated by Sponsor|4
7927877|NCT02265510|12458057|FG012|Overall Study|Study Terminated by Sponsor|1
7927878|NCT02265510|12458058|FG013|Overall Study|Study Terminated by Sponsor|2
7927879|NCT02265705|12458116|FG000|Treatment Period Week 0-24|Adverse Event|3
7927880|NCT02265705|12458117|FG001|Treatment Period Week 0-24|Adverse Event|2
7927881|NCT02265705|12458118|FG002|Treatment Period Week 0-24|Adverse Event|0
7927882|NCT02265705|12458119|FG003|Treatment Period Week 0-24|Adverse Event|0
7927883|NCT02265705|12458120|FG004|Treatment Period Week 0-24|Adverse Event|0
7927884|NCT02265705|12458121|FG005|Treatment Period Week 0-24|Adverse Event|0
7927885|NCT02265705|12458122|FG006|Treatment Period Week 0-24|Adverse Event|0
7927886|NCT02265705|12458116|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1
7927887|NCT02265705|12458117|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1
7927888|NCT02265705|12458118|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0
7927889|NCT02265705|12458119|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0
7927890|NCT02265705|12458120|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0
7927891|NCT02265705|12458121|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0
7927892|NCT02265705|12458122|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0
7927893|NCT02265705|12458116|FG000|Treatment Period Week 0-24|Physician Decision|1
7927894|NCT02265705|12458117|FG001|Treatment Period Week 0-24|Physician Decision|0
7927895|NCT02265705|12458118|FG002|Treatment Period Week 0-24|Physician Decision|0
7927896|NCT02265705|12458119|FG003|Treatment Period Week 0-24|Physician Decision|0
7927897|NCT02265705|12458120|FG004|Treatment Period Week 0-24|Physician Decision|0
7927898|NCT02265705|12458121|FG005|Treatment Period Week 0-24|Physician Decision|0
7927899|NCT02265705|12458122|FG006|Treatment Period Week 0-24|Physician Decision|0
7927900|NCT02265705|12458116|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7
7927901|NCT02265705|12458117|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5
7927902|NCT02265705|12458118|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0
7927903|NCT02265705|12458119|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0
7927904|NCT02265705|12458120|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0
7927905|NCT02265705|12458121|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0
7927906|NCT02265705|12458122|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0
7927907|NCT02265705|12458116|FG000|Treatment Period Week 0-24|Lack of Efficacy|0
7927908|NCT02265705|12458117|FG001|Treatment Period Week 0-24|Lack of Efficacy|1
7927909|NCT02265705|12458118|FG002|Treatment Period Week 0-24|Lack of Efficacy|0
7927910|NCT02265705|12458119|FG003|Treatment Period Week 0-24|Lack of Efficacy|0
7927911|NCT02265705|12458120|FG004|Treatment Period Week 0-24|Lack of Efficacy|0
7927912|NCT02265705|12458121|FG005|Treatment Period Week 0-24|Lack of Efficacy|0
7927913|NCT02265705|12458122|FG006|Treatment Period Week 0-24|Lack of Efficacy|0
7927914|NCT02265705|12458116|FG000|Rescue Period|Withdrawal by Subject|0
7927915|NCT02265705|12458117|FG001|Rescue Period|Withdrawal by Subject|0
7927916|NCT02265705|12458118|FG002|Rescue Period|Withdrawal by Subject|1
7927917|NCT02265705|12458119|FG003|Rescue Period|Withdrawal by Subject|0
7927918|NCT02265705|12458120|FG004|Rescue Period|Withdrawal by Subject|0
7927919|NCT02265705|12458121|FG005|Rescue Period|Withdrawal by Subject|0
7927920|NCT02265705|12458122|FG006|Rescue Period|Withdrawal by Subject|0
7927921|NCT02265705|12458116|FG000|Rescue Period|Death|0
7927922|NCT02265705|12458117|FG001|Rescue Period|Death|0
7927923|NCT02265705|12458118|FG002|Rescue Period|Death|1
7927924|NCT02265705|12458119|FG003|Rescue Period|Death|0
7927925|NCT02265705|12458120|FG004|Rescue Period|Death|0
7927926|NCT02265705|12458121|FG005|Rescue Period|Death|0
7927927|NCT02265705|12458122|FG006|Rescue Period|Death|0
7927928|NCT02265705|12458116|FG000|Rescue Period|Lack of Efficacy|0
7927929|NCT02265705|12458117|FG001|Rescue Period|Lack of Efficacy|0
7927930|NCT02265705|12458118|FG002|Rescue Period|Lack of Efficacy|1
7927931|NCT02265705|12458119|FG003|Rescue Period|Lack of Efficacy|0
7927932|NCT02265705|12458120|FG004|Rescue Period|Lack of Efficacy|0
7927933|NCT02265705|12458121|FG005|Rescue Period|Lack of Efficacy|0
7927934|NCT02265705|12458122|FG006|Rescue Period|Lack of Efficacy|0
7927935|NCT02265705|12458116|FG000|Open Label Period|Adverse Event|0
7927936|NCT02265705|12458117|FG001|Open Label Period|Adverse Event|0
7927937|NCT02265705|12458118|FG002|Open Label Period|Adverse Event|0
7927938|NCT02265705|12458119|FG003|Open Label Period|Adverse Event|2
7927939|NCT02265705|12458120|FG004|Open Label Period|Adverse Event|2
7927940|NCT02265705|12458121|FG005|Open Label Period|Adverse Event|0
7927941|NCT02265705|12458122|FG006|Open Label Period|Adverse Event|0
7927942|NCT02265705|12458116|FG000|Open Label Period|Physician Decision|0
7927943|NCT02265705|12458117|FG001|Open Label Period|Physician Decision|0
7927944|NCT02265705|12458118|FG002|Open Label Period|Physician Decision|0
7927945|NCT02265705|12458119|FG003|Open Label Period|Physician Decision|0
7927946|NCT02265705|12458120|FG004|Open Label Period|Physician Decision|1
7927947|NCT02265705|12458121|FG005|Open Label Period|Physician Decision|0
7927948|NCT02265705|12458122|FG006|Open Label Period|Physician Decision|0
7927949|NCT02265705|12458116|FG000|Open Label Period|Withdrawal by Subject|0
7927950|NCT02265705|12458117|FG001|Open Label Period|Withdrawal by Subject|0
7927951|NCT02265705|12458118|FG002|Open Label Period|Withdrawal by Subject|0
7927952|NCT02265705|12458119|FG003|Open Label Period|Withdrawal by Subject|0
7927953|NCT02265705|12458120|FG004|Open Label Period|Withdrawal by Subject|2
7927954|NCT02265705|12458121|FG005|Open Label Period|Withdrawal by Subject|0
7927955|NCT02265705|12458122|FG006|Open Label Period|Withdrawal by Subject|0
7927956|NCT02265705|12458116|FG000|Follow-up Period|Sponsor Decision|0
7927957|NCT02265705|12458117|FG001|Follow-up Period|Sponsor Decision|0
7927958|NCT02265705|12458118|FG002|Follow-up Period|Sponsor Decision|0
7927959|NCT02265705|12458119|FG003|Follow-up Period|Sponsor Decision|0
7927960|NCT02265705|12458120|FG004|Follow-up Period|Sponsor Decision|0
7927961|NCT02265705|12458121|FG005|Follow-up Period|Sponsor Decision|1
7927962|NCT02265705|12458122|FG006|Follow-up Period|Sponsor Decision|6
7927963|NCT02265705|12458116|FG000|Follow-up Period|Adverse Event|0
7927964|NCT02265705|12458117|FG001|Follow-up Period|Adverse Event|0
7927965|NCT02265705|12458118|FG002|Follow-up Period|Adverse Event|0
7927966|NCT02265705|12458119|FG003|Follow-up Period|Adverse Event|0
7927967|NCT02265705|12458120|FG004|Follow-up Period|Adverse Event|0
7927968|NCT02265705|12458121|FG005|Follow-up Period|Adverse Event|0
7927969|NCT02265705|12458122|FG006|Follow-up Period|Adverse Event|3
7927970|NCT02265705|12458116|FG000|Follow-up Period|Physician Decision|0
7927971|NCT02265705|12458117|FG001|Follow-up Period|Physician Decision|0
7927972|NCT02265705|12458118|FG002|Follow-up Period|Physician Decision|0
7927973|NCT02265705|12458119|FG003|Follow-up Period|Physician Decision|0
7927974|NCT02265705|12458120|FG004|Follow-up Period|Physician Decision|0
7927975|NCT02265705|12458121|FG005|Follow-up Period|Physician Decision|0
7927976|NCT02265705|12458122|FG006|Follow-up Period|Physician Decision|1
7927977|NCT02265705|12458116|FG000|Follow-up Period|Withdrawal by Subject|0
7927978|NCT02265705|12458117|FG001|Follow-up Period|Withdrawal by Subject|0
7927979|NCT02265705|12458118|FG002|Follow-up Period|Withdrawal by Subject|0
7927980|NCT02265705|12458119|FG003|Follow-up Period|Withdrawal by Subject|0
7927981|NCT02265705|12458120|FG004|Follow-up Period|Withdrawal by Subject|0
7927982|NCT02265705|12458121|FG005|Follow-up Period|Withdrawal by Subject|0
7927983|NCT02265705|12458122|FG006|Follow-up Period|Withdrawal by Subject|1
7927984|NCT02265744|12458138|FG000|Overall Study|Poor/Non-compliance|1
7927985|NCT02265744|12458139|FG001|Overall Study|Poor/Non-compliance|1
7927986|NCT02265744|12458140|FG002|Overall Study|Poor/Non-compliance|0
7927987|NCT02265744|12458141|FG003|Overall Study|Poor/Non-compliance|0
7927988|NCT02265744|12458142|FG004|Overall Study|Poor/Non-compliance|2
7927989|NCT02265744|12458138|FG000|Overall Study|Lost to Follow-up|0
7927990|NCT02265744|12458139|FG001|Overall Study|Lost to Follow-up|0
7927991|NCT02265744|12458140|FG002|Overall Study|Lost to Follow-up|0
7927992|NCT02265744|12458141|FG003|Overall Study|Lost to Follow-up|1
7927993|NCT02265744|12458142|FG004|Overall Study|Lost to Follow-up|0
7927994|NCT02265744|12458138|FG000|Overall Study|Death|0
7927995|NCT02265744|12458139|FG001|Overall Study|Death|0
7927996|NCT02265744|12458140|FG002|Overall Study|Death|0
7927997|NCT02265744|12458141|FG003|Overall Study|Death|2
7927998|NCT02265744|12458142|FG004|Overall Study|Death|0
7927999|NCT02265744|12458138|FG000|Overall Study|Withdrawal by Subject|2
7928000|NCT02265744|12458139|FG001|Overall Study|Withdrawal by Subject|0
7928001|NCT02265744|12458140|FG002|Overall Study|Withdrawal by Subject|0
7928002|NCT02265744|12458141|FG003|Overall Study|Withdrawal by Subject|2
7928003|NCT02265744|12458142|FG004|Overall Study|Withdrawal by Subject|0
7928004|NCT02265744|12458138|FG000|Overall Study|Participant request to discontinue|2
7928005|NCT02265744|12458139|FG001|Overall Study|Participant request to discontinue|2
7928006|NCT02265744|12458140|FG002|Overall Study|Participant request to discontinue|2
7928007|NCT02265744|12458141|FG003|Overall Study|Participant request to discontinue|0
7928008|NCT02265744|12458142|FG004|Overall Study|Participant request to discontinue|0
7928009|NCT02265744|12458138|FG000|Overall Study|Adverse Event|8
7928010|NCT02265744|12458139|FG001|Overall Study|Adverse Event|4
7928011|NCT02265744|12458140|FG002|Overall Study|Adverse Event|9
7928012|NCT02265744|12458141|FG003|Overall Study|Adverse Event|8
7928013|NCT02265744|12458142|FG004|Overall Study|Adverse Event|2
7928014|NCT02265744|12458138|FG000|Overall Study|Lack of Efficacy|2
7928015|NCT02265744|12458139|FG001|Overall Study|Lack of Efficacy|4
7928016|NCT02265744|12458140|FG002|Overall Study|Lack of Efficacy|3
7928017|NCT02265744|12458141|FG003|Overall Study|Lack of Efficacy|4
7928018|NCT02265744|12458142|FG004|Overall Study|Lack of Efficacy|5
7928019|NCT02265744|12458138|FG000|Overall Study|Reason not provided by Investigator|1
7928020|NCT02265744|12458139|FG001|Overall Study|Reason not provided by Investigator|0
7928021|NCT02265744|12458140|FG002|Overall Study|Reason not provided by Investigator|0
7928022|NCT02265744|12458141|FG003|Overall Study|Reason not provided by Investigator|2
7928023|NCT02265744|12458142|FG004|Overall Study|Reason not provided by Investigator|0
7928024|NCT02265744|12458138|FG000|Overall Study|Administrative reason by sponsor|3
7928025|NCT02265744|12458139|FG001|Overall Study|Administrative reason by sponsor|2
7928026|NCT02265744|12458140|FG002|Overall Study|Administrative reason by sponsor|2
7928027|NCT02265744|12458141|FG003|Overall Study|Administrative reason by sponsor|3
7928028|NCT02265744|12458142|FG004|Overall Study|Administrative reason by sponsor|3
7928029|NCT02265744|12458138|FG000|Overall Study|Subject no longer meets study criteria|0
7928030|NCT02265744|12458139|FG001|Overall Study|Subject no longer meets study criteria|0
7928031|NCT02265744|12458140|FG002|Overall Study|Subject no longer meets study criteria|0
7928032|NCT02265744|12458141|FG003|Overall Study|Subject no longer meets study criteria|0
7928033|NCT02265744|12458142|FG004|Overall Study|Subject no longer meets study criteria|1
7928034|NCT02265744|12458138|FG000|Overall Study|Pregnancy|1
7928035|NCT02265744|12458139|FG001|Overall Study|Pregnancy|2
7928036|NCT02265744|12458140|FG002|Overall Study|Pregnancy|1
7928037|NCT02265744|12458141|FG003|Overall Study|Pregnancy|1
7928038|NCT02265744|12458142|FG004|Overall Study|Pregnancy|0
7928039|NCT02265796|12458160|FG000|Overall Study|Death|1
7928040|NCT02265796|12458161|FG001|Overall Study|Death|0
7928041|NCT02265796|12458160|FG000|Overall Study|started on excluded medication|1
7928042|NCT02265796|12458161|FG001|Overall Study|started on excluded medication|0
7928043|NCT02265796|12458160|FG000|Overall Study|Withdrawal by Subject|1
7928044|NCT02265796|12458161|FG001|Overall Study|Withdrawal by Subject|1
7928045|NCT02265952|12458189|FG000|Open Label Extension (OLE) Period|Physician Decision|0
7928046|NCT02265952|12458190|FG001|Open Label Extension (OLE) Period|Physician Decision|7
7928047|NCT02265952|12458189|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0
7928048|NCT02265952|12458190|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1
7928049|NCT02266004|12458205|FG000|Overall Study|unrelated adverse event|1
7928050|NCT02266004|12458205|FG000|Overall Study|Physician Decision|1
7928051|NCT02266147|12458222|FG000|PART 1: Dose Escalation|Physician Decision|0
7928052|NCT02266147|12458223|FG001|PART 1: Dose Escalation|Physician Decision|0
7928053|NCT02266147|12458224|FG002|PART 1: Dose Escalation|Physician Decision|1
7928054|NCT02266147|12458225|FG003|PART 1: Dose Escalation|Physician Decision|0
7928055|NCT02266147|12458222|FG000|PART 1: Dose Escalation|Lack of Efficacy|0
7928056|NCT02266147|12458223|FG001|PART 1: Dose Escalation|Lack of Efficacy|2
7928057|NCT02266147|12458224|FG002|PART 1: Dose Escalation|Lack of Efficacy|1
7928058|NCT02266147|12458225|FG003|PART 1: Dose Escalation|Lack of Efficacy|1
7928059|NCT02266147|12458222|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0
7928060|NCT02266147|12458223|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0
7928061|NCT02266147|12458224|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1
7928062|NCT02266147|12458225|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3
7928063|NCT02266147|12458222|FG000|PART 1: Dose Escalation|Other|1
7928064|NCT02266147|12458223|FG001|PART 1: Dose Escalation|Other|1
7928065|NCT02266147|12458224|FG002|PART 1: Dose Escalation|Other|0
7928066|NCT02266147|12458225|FG003|PART 1: Dose Escalation|Other|0
7928067|NCT02266147|12458222|FG000|PART 2: Dose Expansion|Lack of Efficacy|1
7928068|NCT02266147|12458223|FG001|PART 2: Dose Expansion|Lack of Efficacy|0
7928069|NCT02266147|12458224|FG002|PART 2: Dose Expansion|Lack of Efficacy|0
7928070|NCT02266147|12458225|FG003|PART 2: Dose Expansion|Lack of Efficacy|1
7928071|NCT02266147|12458222|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6
7928072|NCT02266147|12458223|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0
7928073|NCT02266147|12458224|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0
7928074|NCT02266147|12458225|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8
7928075|NCT02266225|12458237|FG000|Overall Study|Lost to Follow-up|2
7928076|NCT02266225|12458237|FG000|Overall Study|Death|1
7928077|NCT02266225|12458237|FG000|Overall Study|Withdrawal by Subject|13
7928078|NCT02266381|12458272|FG000|Overall Study|Physician Decision|3
7928079|NCT02266381|12458273|FG001|Overall Study|Physician Decision|5
7928080|NCT02266381|12458274|FG002|Overall Study|Physician Decision|4
7928081|NCT02266433|12458286|FG000|Overall Study|Lost to Follow-up|54
7928082|NCT02266433|12458287|FG001|Overall Study|Lost to Follow-up|46
7928083|NCT02266433|12458286|FG000|Overall Study|Withdrawal by Subject|5
7928084|NCT02266433|12458287|FG001|Overall Study|Withdrawal by Subject|7
7928085|NCT02266706|12458321|FG000|Overall Study|Withdrawal by Subject|0
7928086|NCT02266706|12458322|FG001|Overall Study|Withdrawal by Subject|1
7928087|NCT02266706|12458323|FG002|Overall Study|Withdrawal by Subject|1
7928088|NCT02266706|12458324|FG003|Overall Study|Withdrawal by Subject|0
7928089|NCT02266706|12458325|FG004|Overall Study|Withdrawal by Subject|0
7928090|NCT02266706|12458326|FG005|Overall Study|Withdrawal by Subject|1
7928091|NCT02266706|12458327|FG006|Overall Study|Withdrawal by Subject|0
7928092|NCT02266706|12458328|FG007|Overall Study|Withdrawal by Subject|0
7928093|NCT02266706|12458329|FG008|Overall Study|Withdrawal by Subject|0
7928094|NCT02266706|12458321|FG000|Overall Study|Screen failure|0
7928095|NCT02266706|12458322|FG001|Overall Study|Screen failure|0
7928096|NCT02266706|12458323|FG002|Overall Study|Screen failure|0
7928097|NCT02266706|12458324|FG003|Overall Study|Screen failure|0
7928098|NCT02266706|12458325|FG004|Overall Study|Screen failure|0
7928099|NCT02266706|12458326|FG005|Overall Study|Screen failure|1
7928100|NCT02266706|12458327|FG006|Overall Study|Screen failure|1
7928101|NCT02266706|12458328|FG007|Overall Study|Screen failure|0
7928102|NCT02266706|12458329|FG008|Overall Study|Screen failure|0
7928103|NCT02266706|12458321|FG000|Overall Study|Enrollment in another study|0
7928104|NCT02266706|12458322|FG001|Overall Study|Enrollment in another study|0
7928105|NCT02266706|12458323|FG002|Overall Study|Enrollment in another study|0
7928106|NCT02266706|12458324|FG003|Overall Study|Enrollment in another study|1
7928107|NCT02266706|12458325|FG004|Overall Study|Enrollment in another study|0
7928108|NCT02266706|12458326|FG005|Overall Study|Enrollment in another study|0
7928109|NCT02266706|12458327|FG006|Overall Study|Enrollment in another study|0
7928110|NCT02266706|12458328|FG007|Overall Study|Enrollment in another study|0
7928111|NCT02266706|12458329|FG008|Overall Study|Enrollment in another study|0
7964629|NCT03199391|12520229|FG000|Overall Study|Death|1
7964630|NCT03199391|12520229|FG000|Overall Study|Lost to Follow-up|3
7964631|NCT03199391|12520229|FG000|Overall Study|Adverse Event|2
7964632|NCT03199391|12520229|FG000|Overall Study|Withdrawal by Subject|10
7964633|NCT03122886|12520235|FG000|Overall Study|Withdrawal by Subject|1
7964634|NCT03122886|12520236|FG001|Overall Study|Withdrawal by Subject|2
7964635|NCT03042611|12520244|FG000|Core Phase|Withdrawal by Subject|13
7964636|NCT03042611|12520245|FG001|Core Phase|Withdrawal by Subject|4
7964637|NCT03042611|12520246|FG002|Core Phase|Withdrawal by Subject|0
7964638|NCT03042611|12520247|FG003|Core Phase|Withdrawal by Subject|0
7964639|NCT03042611|12520244|FG000|Core Phase|Death|232
7964640|NCT03042611|12520245|FG001|Core Phase|Death|110
7964641|NCT03042611|12520246|FG002|Core Phase|Death|0
7964642|NCT03042611|12520247|FG003|Core Phase|Death|0
7964643|NCT03042611|12520244|FG000|Core Phase|Lost to Follow-up|4
7964644|NCT03042611|12520245|FG001|Core Phase|Lost to Follow-up|7
7964645|NCT03042611|12520246|FG002|Core Phase|Lost to Follow-up|0
7964646|NCT03042611|12520247|FG003|Core Phase|Lost to Follow-up|0
7964647|NCT03042611|12520244|FG000|Core Phase|Physician Decision|7
7964648|NCT03042611|12520245|FG001|Core Phase|Physician Decision|2
7964649|NCT03042611|12520246|FG002|Core Phase|Physician Decision|0
7964650|NCT03042611|12520247|FG003|Core Phase|Physician Decision|0
7964651|NCT03042611|12520244|FG000|Core Phase|Study Closed|0
7964652|NCT03042611|12520245|FG001|Core Phase|Study Closed|1
7964653|NCT03042611|12520246|FG002|Core Phase|Study Closed|0
7964654|NCT03042611|12520247|FG003|Core Phase|Study Closed|0
7964655|NCT03042611|12520244|FG000|Extension Phase|Death|0
7964656|NCT03042611|12520245|FG001|Extension Phase|Death|0
7964657|NCT03042611|12520246|FG002|Extension Phase|Death|34
7964658|NCT03042611|12520247|FG003|Extension Phase|Death|16
7964659|NCT03042611|12520244|FG000|Extension Phase|Lost to Follow-up|0
7964660|NCT03042611|12520245|FG001|Extension Phase|Lost to Follow-up|0
7964661|NCT03042611|12520246|FG002|Extension Phase|Lost to Follow-up|1
7964662|NCT03042611|12520247|FG003|Extension Phase|Lost to Follow-up|1
7964663|NCT03042611|12520244|FG000|Extension Phase|Study Closed|0
7964664|NCT03042611|12520245|FG001|Extension Phase|Study Closed|0
7964665|NCT03042611|12520246|FG002|Extension Phase|Study Closed|17
7964666|NCT03042611|12520247|FG003|Extension Phase|Study Closed|11
7964667|NCT03041181|12520255|FG000|Overall Study|Disease Progression|1
7964668|NCT03041181|12520256|FG001|Overall Study|Disease Progression|2
7964669|NCT03017742|12520262|FG000|Overall Study|Protocol Violation|36
7964670|NCT03017742|12520262|FG000|Overall Study|Withdrawal by Subject|37
7964671|NCT02941926|12520266|FG000|Overall Study|Progressive disease|1109
7964672|NCT02941926|12520266|FG000|Overall Study|Adverse Event|504
7964673|NCT02941926|12520266|FG000|Overall Study|Subject/guardian decision|127
7964674|NCT02941926|12520266|FG000|Overall Study|Physician Decision|112
7964675|NCT02941926|12520266|FG000|Overall Study|Death|46
7964676|NCT02941926|12520266|FG000|Overall Study|Protocol deviation|34
7964677|NCT02941926|12520266|FG000|Overall Study|Lost to Follow-up|8
7964678|NCT02941926|12520266|FG000|Overall Study|Technical problems|5
7964679|NCT02879448|12520274|FG000|Overall Study|No implant attempt|17
7964680|NCT02879448|12520275|FG001|Overall Study|No implant attempt|28
7964681|NCT02879448|12520274|FG000|Overall Study|Withdrawal by Subject|20
7964682|NCT02879448|12520275|FG001|Overall Study|Withdrawal by Subject|46
7964683|NCT02879448|12520274|FG000|Overall Study|Death|63
7964684|NCT02879448|12520275|FG001|Overall Study|Death|85
7964685|NCT02879448|12520274|FG000|Overall Study|Lost to Follow-up|3
7964686|NCT02879448|12520275|FG001|Overall Study|Lost to Follow-up|4
7964687|NCT02879448|12520274|FG000|Overall Study|Missing visit|34
7964688|NCT02879448|12520275|FG001|Overall Study|Missing visit|39
7964689|NCT02879448|12520274|FG000|Overall Study|Pending evaluation|1
7964690|NCT02879448|12520275|FG001|Overall Study|Pending evaluation|0
7964691|NCT02739347|12520283|FG000|Overall Study|Adverse Event|3
7964692|NCT02739347|12520284|FG001|Overall Study|Adverse Event|0
7964693|NCT02739347|12520283|FG000|Overall Study|Protocol Violation|0
7964694|NCT02739347|12520284|FG001|Overall Study|Protocol Violation|1
7964695|NCT02739347|12520283|FG000|Overall Study|Lost to Follow-up|0
7964696|NCT02739347|12520284|FG001|Overall Study|Lost to Follow-up|2
7967114|NCT02760433|12523629|FG001|Overall Study|Lack of Response At Week 14|0
7967115|NCT02760433|12523630|FG002|Overall Study|Lack of Response At Week 14|0
7967116|NCT02760433|12523631|FG003|Overall Study|Lack of Response At Week 14|0
7928112|NCT02266875|12458369|FG000|Overall Study|Withdrawal by Subject|9
7928113|NCT02266875|12458370|FG001|Overall Study|Withdrawal by Subject|0
7928114|NCT02266875|12458369|FG000|Overall Study|Lost to Follow-up|2
7928115|NCT02266875|12458370|FG001|Overall Study|Lost to Follow-up|0
7928116|NCT02266888|12458378|FG000|Overall Study|Death|2
7928117|NCT02266888|12458379|FG001|Overall Study|Death|2
7928118|NCT02266888|12458380|FG002|Overall Study|Death|4
7928119|NCT02266888|12458381|FG003|Overall Study|Death|2
7928120|NCT02266888|12458378|FG000|Overall Study|Physician Decision|0
7928121|NCT02266888|12458379|FG001|Overall Study|Physician Decision|1
7928122|NCT02266888|12458380|FG002|Overall Study|Physician Decision|2
7928123|NCT02266888|12458381|FG003|Overall Study|Physician Decision|2
7928124|NCT02266888|12458378|FG000|Overall Study|Study Terminated|5
7928125|NCT02266888|12458379|FG001|Overall Study|Study Terminated|1
7928126|NCT02266888|12458380|FG002|Overall Study|Study Terminated|0
7928127|NCT02266888|12458381|FG003|Overall Study|Study Terminated|0
7928128|NCT02266888|12458378|FG000|Overall Study|No Longer Eligible|0
7928129|NCT02266888|12458379|FG001|Overall Study|No Longer Eligible|0
7928130|NCT02266888|12458380|FG002|Overall Study|No Longer Eligible|0
7928131|NCT02266888|12458381|FG003|Overall Study|No Longer Eligible|2
7928132|NCT02266888|12458378|FG000|Overall Study|Randomization Closed|0
7928133|NCT02266888|12458379|FG001|Overall Study|Randomization Closed|0
7928134|NCT02266888|12458380|FG002|Overall Study|Randomization Closed|4
7928135|NCT02266888|12458381|FG003|Overall Study|Randomization Closed|0
7928136|NCT02266888|12458378|FG000|Overall Study|Personnel unavailable at transplant|0
7928137|NCT02266888|12458379|FG001|Overall Study|Personnel unavailable at transplant|0
7928138|NCT02266888|12458380|FG002|Overall Study|Personnel unavailable at transplant|0
7928139|NCT02266888|12458381|FG003|Overall Study|Personnel unavailable at transplant|1
7928140|NCT02266888|12458378|FG000|Overall Study|Transfer of care|0
7928141|NCT02266888|12458379|FG001|Overall Study|Transfer of care|0
7928142|NCT02266888|12458380|FG002|Overall Study|Transfer of care|1
7928143|NCT02266888|12458381|FG003|Overall Study|Transfer of care|0
7928144|NCT02267135|12458395|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1
7928145|NCT02267135|12458396|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3
7928146|NCT02267135|12458395|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0
7928147|NCT02267135|12458396|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1
7928148|NCT02267135|12458395|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1
7928149|NCT02267135|12458396|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1
7928150|NCT02267135|12458395|FG000|Period 2 (Randomized Set)|Adverse Event|2
7928151|NCT02267135|12458396|FG001|Period 2 (Randomized Set)|Adverse Event|0
7928152|NCT02267135|12458395|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1
7928153|NCT02267135|12458396|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0
7928154|NCT02267187|12458405|FG000|Overall Study|Physician Decision|2
7928155|NCT02267187|12458405|FG000|Overall Study|Screen fail|3
7928156|NCT02267278|12458428|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1
7928157|NCT02267278|12458428|FG000|Overall Study|transformation to acute leukemia (AML)|1
7928158|NCT02267278|12458428|FG000|Overall Study|Developed new cancer diagnoses|2
7928159|NCT02267278|12458428|FG000|Overall Study|prescribed prohibited medication|1
7928160|NCT02267317|12458435|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1
7928161|NCT02267317|12458436|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7928162|NCT02267317|12458437|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7928163|NCT02267317|12458438|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7928164|NCT02267317|12458439|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7928165|NCT02267317|12458440|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7928166|NCT02267317|12458435|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1
7928167|NCT02267317|12458436|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7928168|NCT02267317|12458437|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7928169|NCT02267317|12458438|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7928170|NCT02267317|12458439|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7928171|NCT02267317|12458440|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7928172|NCT02267746|12458527|FG000|Overall Study|Adverse Event|0
7928173|NCT02267746|12458528|FG001|Overall Study|Adverse Event|2
7928174|NCT02267746|12458529|FG002|Overall Study|Adverse Event|1
7928175|NCT02267746|12458527|FG000|Overall Study|Protocol Violation|8
7928176|NCT02267746|12458528|FG001|Overall Study|Protocol Violation|7
7928177|NCT02267746|12458529|FG002|Overall Study|Protocol Violation|3
7928178|NCT02267746|12458527|FG000|Overall Study|Lack of Efficacy|11
7928179|NCT02267746|12458528|FG001|Overall Study|Lack of Efficacy|11
7928180|NCT02267746|12458529|FG002|Overall Study|Lack of Efficacy|15
7928181|NCT02267746|12458527|FG000|Overall Study|Protocol Violation|1
7928182|NCT02267746|12458528|FG001|Overall Study|Protocol Violation|2
7928183|NCT02267746|12458529|FG002|Overall Study|Protocol Violation|1
7928184|NCT02267746|12458527|FG000|Overall Study|Miscellaneous|1
7928185|NCT02267746|12458528|FG001|Overall Study|Miscellaneous|0
7928186|NCT02267746|12458529|FG002|Overall Study|Miscellaneous|1
7928187|NCT02267824|12458561|FG000|Overall Study|Pregnancy|1
7928188|NCT02267824|12458562|FG001|Overall Study|Pregnancy|1
7928189|NCT02267824|12458561|FG000|Overall Study|Lost to Follow-up|4
7928190|NCT02267824|12458562|FG001|Overall Study|Lost to Follow-up|0
7928191|NCT02267824|12458561|FG000|Overall Study|Protocol Violation|3
7928192|NCT02267824|12458562|FG001|Overall Study|Protocol Violation|0
7964697|NCT02582749|12520292|FG000|Overall Study|Study terminated by funder|5
7928193|NCT02267824|12458561|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2
7928194|NCT02267824|12458562|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0
7928195|NCT02268045|12458588|FG000|Overall Study|Death|4
7928196|NCT02268045|12458589|FG001|Overall Study|Death|4
7928197|NCT02268045|12458588|FG000|Overall Study|Disease Progression|2
7928198|NCT02268045|12458589|FG001|Overall Study|Disease Progression|1
7928199|NCT02268045|12458588|FG000|Overall Study|Adverse Event|7
7928200|NCT02268045|12458589|FG001|Overall Study|Adverse Event|7
7928201|NCT02268045|12458588|FG000|Overall Study|Withdrawal by Subject|2
7928202|NCT02268045|12458589|FG001|Overall Study|Withdrawal by Subject|6
7928203|NCT02268045|12458588|FG000|Overall Study|Physician Decision|0
7928204|NCT02268045|12458589|FG001|Overall Study|Physician Decision|1
7928205|NCT02268045|12458588|FG000|Overall Study|Protocol Violation|1
7928206|NCT02268045|12458589|FG001|Overall Study|Protocol Violation|1
7928207|NCT02268058|12458601|FG000|Overall Study|Protocol Violation|1
7928208|NCT02268058|12458602|FG001|Overall Study|Protocol Violation|0
7928209|NCT02268058|12458603|FG002|Overall Study|Protocol Violation|0
7928210|NCT02268058|12458604|FG003|Overall Study|Protocol Violation|0
7928211|NCT02268084|12458616|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0
7928212|NCT02268084|12458617|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3
7928213|NCT02268084|12458616|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9
7928214|NCT02268084|12458617|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4
7928215|NCT02268214|12458632|FG000|Overall Study|Subject no longer meets study criteria|0
7928216|NCT02268214|12458633|FG001|Overall Study|Subject no longer meets study criteria|2
7928217|NCT02268214|12458634|FG002|Overall Study|Subject no longer meets study criteria|0
7928218|NCT02268214|12458632|FG000|Overall Study|Pregnancy|2
7928219|NCT02268214|12458633|FG001|Overall Study|Pregnancy|2
7928220|NCT02268214|12458634|FG002|Overall Study|Pregnancy|1
7928221|NCT02268214|12458632|FG000|Overall Study|Lost to Follow-up|3
7928222|NCT02268214|12458633|FG001|Overall Study|Lost to Follow-up|3
7928223|NCT02268214|12458634|FG002|Overall Study|Lost to Follow-up|4
7928224|NCT02268214|12458632|FG000|Overall Study|Lack of Efficacy|1
7928225|NCT02268214|12458633|FG001|Overall Study|Lack of Efficacy|0
7928226|NCT02268214|12458634|FG002|Overall Study|Lack of Efficacy|2
7928227|NCT02268214|12458632|FG000|Overall Study|Adverse Event|11
7928228|NCT02268214|12458633|FG001|Overall Study|Adverse Event|14
7928229|NCT02268214|12458634|FG002|Overall Study|Adverse Event|9
7928230|NCT02268214|12458632|FG000|Overall Study|Withdrawal by Subject|4
7928231|NCT02268214|12458633|FG001|Overall Study|Withdrawal by Subject|5
7928232|NCT02268214|12458634|FG002|Overall Study|Withdrawal by Subject|10
7928233|NCT02268214|12458632|FG000|Overall Study|Subject request to discontinue treatment|10
7928234|NCT02268214|12458633|FG001|Overall Study|Subject request to discontinue treatment|8
7928235|NCT02268214|12458634|FG002|Overall Study|Subject request to discontinue treatment|6
7928236|NCT02268214|12458632|FG000|Overall Study|Poor/non-compliance|2
7928237|NCT02268214|12458633|FG001|Overall Study|Poor/non-compliance|1
7928238|NCT02268214|12458634|FG002|Overall Study|Poor/non-compliance|2
7928239|NCT02268214|12458632|FG000|Overall Study|Other reasons|7
7928240|NCT02268214|12458633|FG001|Overall Study|Other reasons|3
7928241|NCT02268214|12458634|FG002|Overall Study|Other reasons|3
7928242|NCT02268214|12458632|FG000|Overall Study|Not entering long-term period|2
7928243|NCT02268214|12458633|FG001|Overall Study|Not entering long-term period|3
7928244|NCT02268214|12458634|FG002|Overall Study|Not entering long-term period|5
7928245|NCT02268396|12458642|FG000|Overall Study|Adverse Event|3
7928246|NCT02268396|12458642|FG000|Overall Study|Administrative|2
7928247|NCT02268396|12458642|FG000|Overall Study|Withdrawal by Subject|1
7928248|NCT02268396|12458642|FG000|Overall Study|Lost to Follow-up|2
7928249|NCT02268396|12458642|FG000|Overall Study|Protocol-Specified Criteria|2
7928250|NCT02268396|12458642|FG000|Overall Study|2 Subjects no Day 29 Assessment|2
7928251|NCT02268526|12458658|FG000|Overall Study|Adverse Event|0
7928252|NCT02268526|12458659|FG001|Overall Study|Adverse Event|2
7928253|NCT02268526|12458660|FG002|Overall Study|Adverse Event|1
7928254|NCT02268526|12458658|FG000|Overall Study|Death|1
7928255|NCT02268526|12458659|FG001|Overall Study|Death|11
7928256|NCT02268526|12458660|FG002|Overall Study|Death|0
7928257|NCT02268526|12458658|FG000|Overall Study|protocol deviation|0
7928258|NCT02268526|12458659|FG001|Overall Study|protocol deviation|1
7928259|NCT02268526|12458660|FG002|Overall Study|protocol deviation|0
7928260|NCT02268526|12458658|FG000|Overall Study|Physician Decision|0
7928261|NCT02268526|12458659|FG001|Overall Study|Physician Decision|0
7928262|NCT02268526|12458660|FG002|Overall Study|Physician Decision|1
7928263|NCT02268526|12458658|FG000|Overall Study|Subject/guardian decision|0
7928264|NCT02268526|12458659|FG001|Overall Study|Subject/guardian decision|7
7928265|NCT02268526|12458660|FG002|Overall Study|Subject/guardian decision|3
7928266|NCT02268786|12458672|FG000|Overall Study|No Euploid Embryos available|42
7928267|NCT02268786|12458673|FG001|Overall Study|No Euploid Embryos available|0
7928268|NCT02268786|12458672|FG000|Overall Study|Withdrawal by Subject|7
7928269|NCT02268786|12458673|FG001|Overall Study|Withdrawal by Subject|14
7928270|NCT02268786|12458672|FG000|Overall Study|Thaw Failure|6
7928271|NCT02268786|12458673|FG001|Overall Study|Thaw Failure|4
7928272|NCT02268786|12458672|FG000|Overall Study|Protocol Violation|1
7928273|NCT02268786|12458673|FG001|Overall Study|Protocol Violation|0
7928274|NCT02268812|12458683|FG000|Overall Study|Adverse Event|8
7928275|NCT02268812|12458684|FG001|Overall Study|Adverse Event|26
7928276|NCT02268812|12458685|FG002|Overall Study|Adverse Event|7
7928277|NCT02268812|12458686|FG003|Overall Study|Adverse Event|10
7928278|NCT02268812|12458683|FG000|Overall Study|Protocol deviation|0
7928279|NCT02268812|12458684|FG001|Overall Study|Protocol deviation|0
7928280|NCT02268812|12458685|FG002|Overall Study|Protocol deviation|1
7928281|NCT02268812|12458686|FG003|Overall Study|Protocol deviation|0
7928282|NCT02268812|12458683|FG000|Overall Study|Withdrawal by Subject|0
7928283|NCT02268812|12458684|FG001|Overall Study|Withdrawal by Subject|1
7928284|NCT02268812|12458685|FG002|Overall Study|Withdrawal by Subject|0
7928285|NCT02268812|12458686|FG003|Overall Study|Withdrawal by Subject|0
7928286|NCT02268812|12458683|FG000|Overall Study|Physician Decision|3
7928287|NCT02268812|12458684|FG001|Overall Study|Physician Decision|1
7928288|NCT02268812|12458685|FG002|Overall Study|Physician Decision|0
7928289|NCT02268812|12458686|FG003|Overall Study|Physician Decision|1
7928290|NCT02268812|12458683|FG000|Overall Study|Other|5
7928291|NCT02268812|12458684|FG001|Overall Study|Other|4
7928292|NCT02268812|12458685|FG002|Overall Study|Other|1
7928293|NCT02268812|12458686|FG003|Overall Study|Other|3
7928294|NCT02268864|12458699|FG000|Overall Study|Withdrawal by Subject|2
7928295|NCT02268864|12458700|FG001|Overall Study|Withdrawal by Subject|0
7928296|NCT02268864|12458701|FG002|Overall Study|Withdrawal by Subject|0
7928297|NCT02268864|12458699|FG000|Overall Study|Death|0
7928298|NCT02268864|12458700|FG001|Overall Study|Death|1
7928299|NCT02268864|12458701|FG002|Overall Study|Death|0
7719669|NCT00533897|12143619|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0
7719670|NCT00533897|12143620|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0
7719671|NCT00533897|12143621|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2
7719672|NCT00533897|12143622|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5
7719673|NCT00533897|12143615|FG000|Long Term Extension (LTE)|Death|0
7719674|NCT00533897|12143616|FG001|Long Term Extension (LTE)|Death|0
7719675|NCT00533897|12143617|FG002|Long Term Extension (LTE)|Death|0
7719676|NCT00533897|12143618|FG003|Long Term Extension (LTE)|Death|0
7719677|NCT00533897|12143619|FG004|Long Term Extension (LTE)|Death|0
7719678|NCT00533897|12143620|FG005|Long Term Extension (LTE)|Death|0
7719679|NCT00533897|12143621|FG006|Long Term Extension (LTE)|Death|1
7719680|NCT00533897|12143622|FG007|Long Term Extension (LTE)|Death|3
7719681|NCT00533897|12143615|FG000|Long Term Extension (LTE)|Lack of Efficacy|0
7719682|NCT00533897|12143616|FG001|Long Term Extension (LTE)|Lack of Efficacy|0
7719683|NCT00533897|12143617|FG002|Long Term Extension (LTE)|Lack of Efficacy|0
7928300|NCT02269098|12458747|FG000|Overall Study|Lost to Follow-up|14
7928301|NCT02269098|12458748|FG001|Overall Study|Lost to Follow-up|9
7928302|NCT02269124|12458757|FG000|Overall Study|Lost to Follow-up|1
7928303|NCT02269124|12458758|FG001|Overall Study|Lost to Follow-up|0
7928304|NCT02269124|12458757|FG000|Overall Study|Withdrawal by Subject|0
7928305|NCT02269124|12458758|FG001|Overall Study|Withdrawal by Subject|2
7928306|NCT02269163|12458767|FG000|Overall Study|Lost to Follow-up|1
7928307|NCT02269163|12458768|FG001|Overall Study|Lost to Follow-up|0
7928308|NCT02269163|12458767|FG000|Overall Study|Major protocol violation|0
7928309|NCT02269163|12458768|FG001|Overall Study|Major protocol violation|1
7928310|NCT02269163|12458767|FG000|Overall Study|Other|2
7928311|NCT02269163|12458768|FG001|Overall Study|Other|2
7928312|NCT02269163|12458767|FG000|Overall Study|Withdrawal by Subject|0
7928313|NCT02269163|12458768|FG001|Overall Study|Withdrawal by Subject|3
7928314|NCT02269163|12458767|FG000|Overall Study|Physician Decision|0
7928315|NCT02269163|12458768|FG001|Overall Study|Physician Decision|1
7928316|NCT02269241|12458776|FG000|Overall Study|Lost to Follow-up|269
7928317|NCT02269241|12458776|FG000|Overall Study|Withdrawal by Subject|155
7928318|NCT02269241|12458776|FG000|Overall Study|Protocol Violation|1
7928319|NCT02269241|12458776|FG000|Overall Study|Physician Decision|7
7928320|NCT02269241|12458776|FG000|Overall Study|Pregnancy|15
7928321|NCT02269241|12458776|FG000|Overall Study|Wish for pregnancy|5
7928322|NCT02269241|12458776|FG000|Overall Study|Development of an exclusion criteria|16
7928323|NCT02269241|12458776|FG000|Overall Study|Adverse Event|113
7928324|NCT02269241|12458776|FG000|Overall Study|At the specific request of the sponsor|20
7928325|NCT02269241|12458776|FG000|Overall Study|Several reasons not classified|53
7928326|NCT02269241|12458776|FG000|Overall Study|Screening failures|546
7928327|NCT02269423|12458785|FG000|Overall Study|Discontinued due to change in residence|0
7928328|NCT02269423|12458786|FG001|Overall Study|Discontinued due to change in residence|1
7928329|NCT02269423|12458787|FG002|Overall Study|Discontinued due to change in residence|0
7928330|NCT02269423|12458788|FG003|Overall Study|Discontinued due to change in residence|1
7928331|NCT02269475|12458800|FG000|Overall Study|Meet Exclusion Criteria No. 17|3
7928332|NCT02269475|12458801|FG001|Overall Study|Meet Exclusion Criteria No. 17|0
7928333|NCT02269475|12458800|FG000|Overall Study|Withdrawal by Subject|0
7928334|NCT02269475|12458801|FG001|Overall Study|Withdrawal by Subject|1
7928335|NCT02269657|12458821|FG000|Overall Study|Protocol Violation|3
7928336|NCT02269709|12458827|FG000|Time of Enrollment|Withdrawal by Subject|3
7928337|NCT02269709|12458827|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
7928338|NCT02269709|12458827|FG000|Six Month Follow-up|Lost to Follow-up|12
7928339|NCT02269787|12458834|FG000|Overall Study|Lost to Follow-up|20
7928340|NCT02269787|12458835|FG001|Overall Study|Lost to Follow-up|6
7928341|NCT02269787|12458834|FG000|Overall Study|Death|2
7928342|NCT02269787|12458835|FG001|Overall Study|Death|3
7928343|NCT02269787|12458834|FG000|Overall Study|Incapacitated|0
7928344|NCT02269787|12458835|FG001|Overall Study|Incapacitated|1
7928345|NCT02269943|12458843|FG000|Treatment Period|Death|0
7928346|NCT02269943|12458844|FG001|Treatment Period|Death|1
7928347|NCT02269943|12458843|FG000|Treatment Period|Adverse Event|1
7928348|NCT02269943|12458844|FG001|Treatment Period|Adverse Event|10
7928349|NCT02269943|12458843|FG000|Treatment Period|Progressive Disease|5
7928350|NCT02269943|12458844|FG001|Treatment Period|Progressive Disease|17
7928351|NCT02269943|12458843|FG000|Treatment Period|Symptomatic Deterioration|0
7928352|NCT02269943|12458844|FG001|Treatment Period|Symptomatic Deterioration|2
7928353|NCT02269943|12458843|FG000|Follow-Up Survival Period|Death|3
7928354|NCT02269943|12458844|FG001|Follow-Up Survival Period|Death|16
7928355|NCT02269943|12458843|FG000|Follow-Up Survival Period|Lost to Follow-up|0
7928356|NCT02269943|12458844|FG001|Follow-Up Survival Period|Lost to Follow-up|2
7928357|NCT02269943|12458843|FG000|Follow-Up Survival Period|Alive|2
7928358|NCT02269943|12458844|FG001|Follow-Up Survival Period|Alive|8
7928359|NCT02270242|12458865|FG000|Overall Study|Withdrawal by Subject|18
7928360|NCT02270242|12458866|FG001|Overall Study|Withdrawal by Subject|25
7928361|NCT02270242|12458865|FG000|Overall Study|Lost to Follow-up|41
7928362|NCT02270242|12458866|FG001|Overall Study|Lost to Follow-up|27
7928363|NCT02270242|12458865|FG000|Overall Study|Physician Decision|0
7928364|NCT02270242|12458866|FG001|Overall Study|Physician Decision|1
7928365|NCT02270515|12458881|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
7928366|NCT02270515|12458881|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5
7928367|NCT02270515|12458881|FG000|Intervention Period 1: 0-6 Months|Received transplant|3
7928368|NCT02270515|12458881|FG000|Intervention Period 1: 0-6 Months|Death|7
7928369|NCT02270515|12458881|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
7928370|NCT02270515|12458881|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7
7928371|NCT02270515|12458881|FG000|Intervention Period 2: 6-12 Months|Received transplant|1
7928372|NCT02270515|12458881|FG000|Intervention Period 2: 6-12 Months|Death|5
7928373|NCT02270515|12458881|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
7928374|NCT02270515|12458881|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
7928375|NCT02270515|12458881|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2
7928376|NCT02270515|12458881|FG000|Intervention Period 3: 12-18 Months|Received transplant|2
7928377|NCT02270515|12458881|FG000|Intervention Period 3: 12-18 Months|Death|3
7928378|NCT02270515|12458881|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
7928379|NCT02270671|12458903|FG000|Overall Study|Withdrawal by Subject|1
7928380|NCT02270671|12458904|FG001|Overall Study|Withdrawal by Subject|1
7928381|NCT02270671|12458903|FG000|Overall Study|Protocol Violation|0
7928382|NCT02270671|12458904|FG001|Overall Study|Protocol Violation|1
7928383|NCT02270671|12458903|FG000|Overall Study|Missed Post-intervention Data Collection|2
7928384|NCT02270671|12458904|FG001|Overall Study|Missed Post-intervention Data Collection|2
7928385|NCT02270671|12458903|FG000|Overall Study|Lost to Follow-up|2
7928386|NCT02270671|12458904|FG001|Overall Study|Lost to Follow-up|1
7928387|NCT02270736|12458913|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7928388|NCT02270736|12458914|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1
7928389|NCT02270736|12458915|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7928390|NCT02270736|12458916|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7928391|NCT02270736|12458917|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7928392|NCT02270736|12458913|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2
7928393|NCT02270736|12458914|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
7928394|NCT02270736|12458915|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1
7928395|NCT02270736|12458916|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
7928396|NCT02270736|12458917|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
7928397|NCT02270736|12458913|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7928398|NCT02270736|12458914|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1
7928399|NCT02270736|12458915|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7928400|NCT02270736|12458916|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7928401|NCT02270736|12458917|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7928402|NCT02270736|12458913|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7928403|NCT02270736|12458914|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7928404|NCT02270736|12458915|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1
7928405|NCT02270736|12458916|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7928406|NCT02270736|12458917|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7928407|NCT02270736|12458913|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0
7928408|NCT02270736|12458914|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0
7928409|NCT02270736|12458915|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0
7928410|NCT02270736|12458916|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1
7928411|NCT02270736|12458917|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0
7928412|NCT02270736|12458913|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7928413|NCT02270736|12458914|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7928414|NCT02270736|12458915|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7928415|NCT02270736|12458916|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2
7928416|NCT02270736|12458917|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7928417|NCT02270736|12458913|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0
7928418|NCT02270736|12458914|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0
7928419|NCT02270736|12458915|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0
7928420|NCT02270736|12458916|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4
7928421|NCT02270736|12458917|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0
7928422|NCT02270736|12458913|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7928423|NCT02270736|12458914|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7928424|NCT02270736|12458915|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7928425|NCT02270736|12458916|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16
7928426|NCT02270736|12458917|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7928427|NCT02270736|12458913|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7928428|NCT02270736|12458914|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7928429|NCT02270736|12458915|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7928430|NCT02270736|12458916|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2
7928431|NCT02270736|12458917|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7928432|NCT02270944|12458932|FG000|Overall Study|Lost to Follow-up|9
7928433|NCT02270944|12458933|FG001|Overall Study|Lost to Follow-up|4
7928434|NCT02270944|12458932|FG000|Overall Study|Withdrawal by Subject|2
7928435|NCT02270944|12458933|FG001|Overall Study|Withdrawal by Subject|1
7928436|NCT02270983|12458943|FG000|Overall Study|Adverse Event|3
7928437|NCT02270983|12458944|FG001|Overall Study|Adverse Event|2
7928438|NCT02270983|12458945|FG002|Overall Study|Adverse Event|6
7928439|NCT02270983|12458943|FG000|Overall Study|Lack of Efficacy|2
7928440|NCT02270983|12458944|FG001|Overall Study|Lack of Efficacy|1
7928441|NCT02270983|12458945|FG002|Overall Study|Lack of Efficacy|1
7928442|NCT02270983|12458943|FG000|Overall Study|Withdrawal by Subject|1
7928443|NCT02270983|12458944|FG001|Overall Study|Withdrawal by Subject|0
7928444|NCT02270983|12458945|FG002|Overall Study|Withdrawal by Subject|2
7928445|NCT02270983|12458943|FG000|Overall Study|Lost to Follow-up|1
7928446|NCT02270983|12458944|FG001|Overall Study|Lost to Follow-up|1
7928447|NCT02270983|12458945|FG002|Overall Study|Lost to Follow-up|2
7928448|NCT02270983|12458943|FG000|Overall Study|Protocol Violation|1
7928449|NCT02270983|12458944|FG001|Overall Study|Protocol Violation|1
7928450|NCT02270983|12458945|FG002|Overall Study|Protocol Violation|1
7928451|NCT02270983|12458943|FG000|Overall Study|family emergency|0
7928452|NCT02270983|12458944|FG001|Overall Study|family emergency|1
7928453|NCT02270983|12458945|FG002|Overall Study|family emergency|0
7928454|NCT02270983|12458943|FG000|Overall Study|study procedure non-compliance|1
7928455|NCT02270983|12458944|FG001|Overall Study|study procedure non-compliance|0
7928456|NCT02270983|12458945|FG002|Overall Study|study procedure non-compliance|0
7928457|NCT02270983|12458943|FG000|Overall Study|moved away from study site|0
7928458|NCT02270983|12458944|FG001|Overall Study|moved away from study site|1
7928459|NCT02270983|12458945|FG002|Overall Study|moved away from study site|0
7928460|NCT02271529|12459011|FG000|Overall Study|Withdrawal by Subject|1
7928461|NCT02271854|12459032|FG000|Overall Study|Withdrawal by Subject|2
7928462|NCT02271854|12459032|FG000|Overall Study|Unable or unwilling to cooperate with st|1
7928463|NCT02271854|12459032|FG000|Overall Study|Lost to Follow-up|1
7928464|NCT02271880|12459039|FG000|Overall Study|Premature discontinuation of study|3
7928465|NCT02271880|12459040|FG001|Overall Study|Premature discontinuation of study|4
7928466|NCT02271945|12459054|FG000|Overall Study|Death|3
7928467|NCT02271945|12459055|FG001|Overall Study|Death|3
7928468|NCT02271945|12459054|FG000|Overall Study|Withdrawal by Subject|1
7928469|NCT02271945|12459055|FG001|Overall Study|Withdrawal by Subject|1
7928470|NCT02271945|12459054|FG000|Overall Study|Other|1
7928471|NCT02271945|12459055|FG001|Overall Study|Other|1
7928472|NCT02271984|12459061|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7928473|NCT02271984|12459062|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7928474|NCT02271984|12459063|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7928475|NCT02271984|12459064|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7928476|NCT02271984|12459065|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7928477|NCT02271984|12459066|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1
7928478|NCT02271984|12459067|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7928479|NCT02271984|12459068|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1
7928480|NCT02271984|12459069|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7928481|NCT02271984|12459070|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7928482|NCT02271984|12459071|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7928483|NCT02271984|12459072|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7928484|NCT02272413|12459098|FG000|Randomized Through Treatment Start|Not treated|3
7928485|NCT02272413|12459099|FG001|Randomized Through Treatment Start|Not treated|5
7928486|NCT02272413|12459098|FG000|Pre-switch Period|Adverse Event|38
7928487|NCT02272413|12459099|FG001|Pre-switch Period|Adverse Event|37
7928488|NCT02272413|12459098|FG000|Pre-switch Period|Death|26
7928489|NCT02272413|12459099|FG001|Pre-switch Period|Death|26
7928490|NCT02272413|12459098|FG000|Pre-switch Period|Withdrawal by Subject|27
7928491|NCT02272413|12459099|FG001|Pre-switch Period|Withdrawal by Subject|15
7928492|NCT02272413|12459098|FG000|Pre-switch Period|Physician Decision|6
7928493|NCT02272413|12459099|FG001|Pre-switch Period|Physician Decision|18
7928494|NCT02272413|12459098|FG000|Pre-switch Period|Progressive disease|185
7928495|NCT02272413|12459099|FG001|Pre-switch Period|Progressive disease|173
7928496|NCT02272413|12459098|FG000|Pre-switch Period|Lost to Follow-up|0
7928497|NCT02272413|12459099|FG001|Pre-switch Period|Lost to Follow-up|2
7928498|NCT02272413|12459098|FG000|Pre-switch Period|Protocol Violation|1
7928499|NCT02272413|12459099|FG001|Pre-switch Period|Protocol Violation|0
7928500|NCT02272413|12459098|FG000|Pre-switch Period|Other than listed|10
7928501|NCT02272413|12459099|FG001|Pre-switch Period|Other than listed|11
7928502|NCT02272413|12459098|FG000|Post-switch Period|Adverse Event|4
7928503|NCT02272413|12459099|FG001|Post-switch Period|Adverse Event|4
7928504|NCT02272413|12459098|FG000|Post-switch Period|Death|3
7928505|NCT02272413|12459099|FG001|Post-switch Period|Death|2
7928506|NCT02272413|12459098|FG000|Post-switch Period|Withdrawal by Subject|1
7928507|NCT02272413|12459099|FG001|Post-switch Period|Withdrawal by Subject|2
7928508|NCT02272413|12459098|FG000|Post-switch Period|Physician Decision|1
7928509|NCT02272413|12459099|FG001|Post-switch Period|Physician Decision|1
7928510|NCT02272413|12459098|FG000|Post-switch Period|Progressive disease|21
7928511|NCT02272413|12459099|FG001|Post-switch Period|Progressive disease|21
7928512|NCT02272413|12459098|FG000|Post-switch Period|Study terminated by sponsor|8
7928513|NCT02272413|12459099|FG001|Post-switch Period|Study terminated by sponsor|11
7928514|NCT02272413|12459098|FG000|Post-switch Period|Other than listed|4
7928515|NCT02272413|12459099|FG001|Post-switch Period|Other than listed|5
7928516|NCT02272634|12459110|FG000|Overall Study|Adverse Event|1
7928517|NCT02272634|12459111|FG001|Overall Study|Adverse Event|0
7928518|NCT02272634|12459112|FG002|Overall Study|Adverse Event|0
7928519|NCT02272634|12459110|FG000|Overall Study|Protocol Violation|0
7928520|NCT02272634|12459111|FG001|Overall Study|Protocol Violation|0
7928521|NCT02272634|12459112|FG002|Overall Study|Protocol Violation|1
7928522|NCT02272634|12459110|FG000|Overall Study|Withdrawal by Subject|0
7928523|NCT02272634|12459111|FG001|Overall Study|Withdrawal by Subject|1
7928524|NCT02272634|12459112|FG002|Overall Study|Withdrawal by Subject|0
7928525|NCT02272725|12459129|FG000|Overall Study|equipment malfunction|2
7928526|NCT02272725|12459130|FG001|Overall Study|equipment malfunction|0
7928527|NCT02272777|12459138|FG000|Overall Study|Adverse Event|0
7928528|NCT02272777|12459139|FG001|Overall Study|Adverse Event|1
7928529|NCT02272777|12459138|FG000|Overall Study|Withdrawal by Subject|0
7928530|NCT02272777|12459139|FG001|Overall Study|Withdrawal by Subject|3
7928531|NCT02272777|12459138|FG000|Overall Study|Lost to Follow-up|2
7928532|NCT02272777|12459139|FG001|Overall Study|Lost to Follow-up|0
7928533|NCT02272777|12459138|FG000|Overall Study|Other|2
7928534|NCT02272777|12459139|FG001|Overall Study|Other|0
7928535|NCT02272816|12459145|FG000|Overall Study|Adverse Event|1
7928536|NCT02272842|12459151|FG000|Overall Study|Lost to Follow-up|8
7928537|NCT02272842|12459152|FG001|Overall Study|Lost to Follow-up|8
7928538|NCT02272842|12459151|FG000|Overall Study|Withdrawal by Subject|8
7928539|NCT02272842|12459152|FG001|Overall Study|Withdrawal by Subject|2
7928540|NCT02272985|12459159|FG000|Overall Study|Withdrawal by Subject|1
7928541|NCT02272985|12459159|FG000|Overall Study|hip fracture|1
7928542|NCT02272985|12459159|FG000|Overall Study|kidney transplantation|1
7928543|NCT02273037|12459166|FG000|Overall Study|Lost to Follow-up|1
7928544|NCT02273037|12459167|FG001|Overall Study|Lost to Follow-up|0
7928545|NCT02273037|12459166|FG000|Overall Study|Delivered before monitoring initiated|1
7928546|NCT02273037|12459167|FG001|Overall Study|Delivered before monitoring initiated|3
7928547|NCT02273037|12459166|FG000|Overall Study|Breech delivery|2
7928548|NCT02273037|12459167|FG001|Overall Study|Breech delivery|3
7928549|NCT02273037|12459166|FG000|Overall Study|Multiple delivery|2
7928550|NCT02273037|12459167|FG001|Overall Study|Multiple delivery|2
7928551|NCT02273037|12459166|FG000|Overall Study|Other complication|2
7928552|NCT02273037|12459167|FG001|Overall Study|Other complication|0
7928553|NCT02273050|12459178|FG000|Overall Study|Adverse Event|4
7928554|NCT02273050|12459179|FG001|Overall Study|Adverse Event|3
7928555|NCT02273050|12459180|FG002|Overall Study|Adverse Event|3
7928556|NCT02273050|12459178|FG000|Overall Study|Death|0
7928557|NCT02273050|12459179|FG001|Overall Study|Death|0
7928558|NCT02273050|12459180|FG002|Overall Study|Death|1
7928559|NCT02273050|12459178|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0
7928560|NCT02273050|12459179|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1
7928561|NCT02273050|12459180|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1
7928562|NCT02273050|12459178|FG000|Overall Study|Lack of Efficacy|0
7928563|NCT02273050|12459179|FG001|Overall Study|Lack of Efficacy|1
7928564|NCT02273050|12459180|FG002|Overall Study|Lack of Efficacy|1
7928565|NCT02273050|12459178|FG000|Overall Study|Withdrawal by Subject|17
7928566|NCT02273050|12459179|FG001|Overall Study|Withdrawal by Subject|14
7928567|NCT02273050|12459180|FG002|Overall Study|Withdrawal by Subject|16
7928568|NCT02273050|12459178|FG000|Overall Study|Lost to Follow-up|0
7928569|NCT02273050|12459179|FG001|Overall Study|Lost to Follow-up|2
7928570|NCT02273050|12459180|FG002|Overall Study|Lost to Follow-up|3
7928571|NCT02273050|12459178|FG000|Overall Study|Protocol Violation|3
7928572|NCT02273050|12459179|FG001|Overall Study|Protocol Violation|1
7928573|NCT02273050|12459180|FG002|Overall Study|Protocol Violation|4
7928574|NCT02273141|12459212|FG000|Overall Study|Adverse Event|0
7928575|NCT02273141|12459213|FG001|Overall Study|Adverse Event|1
7928576|NCT02273141|12459212|FG000|Overall Study|Lost to Follow-up|1
7928577|NCT02273141|12459213|FG001|Overall Study|Lost to Follow-up|3
7928578|NCT02273141|12459212|FG000|Overall Study|Withdrawal by Subject|10
7928579|NCT02273141|12459213|FG001|Overall Study|Withdrawal by Subject|15
7928580|NCT02273141|12459212|FG000|Overall Study|Various|6
7928581|NCT02273141|12459213|FG001|Overall Study|Various|6
7928582|NCT02273167|12459222|FG000|Overall Study|Adverse Event|1
7928583|NCT02273167|12459223|FG001|Overall Study|Adverse Event|0
7928584|NCT02273167|12459224|FG002|Overall Study|Adverse Event|0
7928585|NCT02273167|12459222|FG000|Overall Study|Protocol Violation|3
7928586|NCT02273167|12459223|FG001|Overall Study|Protocol Violation|1
7928587|NCT02273167|12459224|FG002|Overall Study|Protocol Violation|1
7928588|NCT02273167|12459222|FG000|Overall Study|Lost to Follow-up|0
7928589|NCT02273167|12459223|FG001|Overall Study|Lost to Follow-up|1
7928590|NCT02273167|12459224|FG002|Overall Study|Lost to Follow-up|1
7928591|NCT02273167|12459222|FG000|Overall Study|Withdrawal by Subject|10
7928592|NCT02273167|12459223|FG001|Overall Study|Withdrawal by Subject|12
7928593|NCT02273167|12459224|FG002|Overall Study|Withdrawal by Subject|11
7928594|NCT02273167|12459222|FG000|Overall Study|Various|10
7928595|NCT02273167|12459223|FG001|Overall Study|Various|9
7928596|NCT02273167|12459224|FG002|Overall Study|Various|8
7928597|NCT02273180|12459235|FG000|Overall Study|Adverse Event|2
7928598|NCT02273180|12459236|FG001|Overall Study|Adverse Event|2
7928599|NCT02273180|12459235|FG000|Overall Study|Lack of Efficacy|1
7928600|NCT02273180|12459236|FG001|Overall Study|Lack of Efficacy|0
7928601|NCT02273180|12459235|FG000|Overall Study|Protocol Violation|1
7928602|NCT02273180|12459236|FG001|Overall Study|Protocol Violation|7
7928603|NCT02273180|12459235|FG000|Overall Study|Randomized but not treated|1
7928604|NCT02273180|12459236|FG001|Overall Study|Randomized but not treated|0
7928605|NCT02273180|12459235|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1
7928606|NCT02273180|12459236|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0
7928607|NCT02273180|12459235|FG000|Overall Study|Other than specified above|21
7928608|NCT02273180|12459236|FG001|Overall Study|Other than specified above|10
7928609|NCT02273596|12459268|FG000|24-Week Treatment Period|Adverse Event|3
7928610|NCT02273596|12459268|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1
7928611|NCT02273596|12459268|FG000|24-Week Treatment Period|Participant was unable to Come|1
7928612|NCT02273596|12459268|FG000|24-Week Treatment Period|Physician Decision|1
7928613|NCT02273596|12459268|FG000|24-Week Treatment Period|Protocol Deviation|1
7928614|NCT02273596|12459268|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19
7928615|NCT02273596|12459268|FG000|Extension Period|Participant Withdrew for Personal Reasons|1
7928616|NCT02273596|12459268|FG000|Extension Period|Lost to Follow-up|1
7928617|NCT02273596|12459268|FG000|Extension Period|Protocol Deviation|1
7928618|NCT02273726|12459280|FG000|Overall Study|Death|70
7928619|NCT02273726|12459281|FG001|Overall Study|Death|62
7928620|NCT02273726|12459280|FG000|Overall Study|Withdrawal by Subject|41
7928621|NCT02273726|12459281|FG001|Overall Study|Withdrawal by Subject|29
7928622|NCT02273726|12459280|FG000|Overall Study|Kidney transplant|31
7928623|NCT02273726|12459281|FG001|Overall Study|Kidney transplant|39
7928624|NCT02273726|12459280|FG000|Overall Study|Physician Decision|30
7928625|NCT02273726|12459281|FG001|Overall Study|Physician Decision|15
7928626|NCT02273726|12459280|FG000|Overall Study|Adverse Event|27
7928627|NCT02273726|12459281|FG001|Overall Study|Adverse Event|9
7928628|NCT02273726|12459280|FG000|Overall Study|Lost to Follow-up|6
7928629|NCT02273726|12459281|FG001|Overall Study|Lost to Follow-up|3
7928630|NCT02273726|12459280|FG000|Overall Study|Lack of Efficacy|6
7928631|NCT02273726|12459281|FG001|Overall Study|Lack of Efficacy|1
7928632|NCT02273726|12459280|FG000|Overall Study|Protocol Violation|4
7928633|NCT02273726|12459281|FG001|Overall Study|Protocol Violation|0
7928634|NCT02273726|12459280|FG000|Overall Study|Other than specified|28
7928635|NCT02273726|12459281|FG001|Overall Study|Other than specified|30
7928636|NCT02273739|12459291|FG000|Overall Study|Progression of Disease|3
7928637|NCT02273739|12459292|FG001|Overall Study|Progression of Disease|4
7928638|NCT02273739|12459293|FG002|Overall Study|Progression of Disease|5
7928639|NCT02273739|12459294|FG003|Overall Study|Progression of Disease|2
7928640|NCT02273739|12459291|FG000|Overall Study|Death|0
7928641|NCT02273739|12459292|FG001|Overall Study|Death|0
7928642|NCT02273739|12459293|FG002|Overall Study|Death|0
7928643|NCT02273739|12459294|FG003|Overall Study|Death|2
7928644|NCT02273739|12459291|FG000|Overall Study|Adverse Event|0
7928645|NCT02273739|12459292|FG001|Overall Study|Adverse Event|0
7928646|NCT02273739|12459293|FG002|Overall Study|Adverse Event|0
7928647|NCT02273739|12459294|FG003|Overall Study|Adverse Event|1
7928648|NCT02273739|12459291|FG000|Overall Study|Withdrawal by Subject|0
7928649|NCT02273739|12459292|FG001|Overall Study|Withdrawal by Subject|0
7928650|NCT02273739|12459293|FG002|Overall Study|Withdrawal by Subject|2
7928651|NCT02273739|12459294|FG003|Overall Study|Withdrawal by Subject|1
7928652|NCT02273739|12459291|FG000|Overall Study|Physician Decision|0
7928653|NCT02273739|12459292|FG001|Overall Study|Physician Decision|0
7928654|NCT02273739|12459293|FG002|Overall Study|Physician Decision|0
7928655|NCT02273739|12459294|FG003|Overall Study|Physician Decision|1
7928656|NCT02273908|12459311|FG000|Overall Study|Adverse Event|16
7928657|NCT02273908|12459312|FG001|Overall Study|Adverse Event|0
7928658|NCT02273908|12459311|FG000|Overall Study|Lost to Follow-up|10
7928659|NCT02273908|12459312|FG001|Overall Study|Lost to Follow-up|1
7928660|NCT02273908|12459311|FG000|Overall Study|Did not meet entrance criteria|3
7928661|NCT02273908|12459312|FG001|Overall Study|Did not meet entrance criteria|2
7928662|NCT02273908|12459311|FG000|Overall Study|Withdrawal by Subject|4
7928663|NCT02273908|12459312|FG001|Overall Study|Withdrawal by Subject|2
7928664|NCT02273960|12459326|FG000|Short Term Period|Lost to Follow-up|1
7928665|NCT02273960|12459327|FG001|Short Term Period|Lost to Follow-up|0
7928666|NCT02273960|12459328|FG002|Short Term Period|Lost to Follow-up|0
7928667|NCT02273960|12459329|FG003|Short Term Period|Lost to Follow-up|0
7928668|NCT02273960|12459326|FG000|Short Term Period|Lack of Efficacy|0
7928669|NCT02273960|12459327|FG001|Short Term Period|Lack of Efficacy|0
7928670|NCT02273960|12459328|FG002|Short Term Period|Lack of Efficacy|0
7928671|NCT02273960|12459329|FG003|Short Term Period|Lack of Efficacy|1
7928672|NCT02273960|12459326|FG000|Short Term Period|ST complete, not entering LTE|4
7928673|NCT02273960|12459327|FG001|Short Term Period|ST complete, not entering LTE|6
7928674|NCT02273960|12459328|FG002|Short Term Period|ST complete, not entering LTE|4
7928675|NCT02273960|12459329|FG003|Short Term Period|ST complete, not entering LTE|5
7928676|NCT02273960|12459326|FG000|Long Term Extension|Death|0
7928677|NCT02273960|12459327|FG001|Long Term Extension|Death|0
7928678|NCT02273960|12459328|FG002|Long Term Extension|Death|0
7928679|NCT02273960|12459329|FG003|Long Term Extension|Death|1
7928680|NCT02273973|12459341|FG000|Overall Study|Adverse Event|4
7928681|NCT02273973|12459342|FG001|Overall Study|Adverse Event|0
7928682|NCT02273973|12459341|FG000|Overall Study|Withdrawal by Subject|2
7928683|NCT02273973|12459342|FG001|Overall Study|Withdrawal by Subject|3
7928684|NCT02273973|12459341|FG000|Overall Study|Death|1
7928685|NCT02273973|12459342|FG001|Overall Study|Death|0
7928686|NCT02273973|12459341|FG000|Overall Study|Non-compliance|1
7928687|NCT02273973|12459342|FG001|Overall Study|Non-compliance|0
7928688|NCT02273973|12459341|FG000|Overall Study|Protocol Violation|1
7928689|NCT02273973|12459342|FG001|Overall Study|Protocol Violation|0
7928690|NCT02273973|12459341|FG000|Overall Study|Progression of disease|0
7928691|NCT02273973|12459342|FG001|Overall Study|Progression of disease|2
7928692|NCT02273973|12459341|FG000|Overall Study|Lost to Follow-up|0
7928693|NCT02273973|12459342|FG001|Overall Study|Lost to Follow-up|1
7928694|NCT02273973|12459341|FG000|Overall Study|Physician Decision|0
7928695|NCT02273973|12459342|FG001|Overall Study|Physician Decision|1
7928696|NCT02273973|12459341|FG000|Overall Study|Reason not specified|0
7928697|NCT02273973|12459342|FG001|Overall Study|Reason not specified|1
7928698|NCT02274038|12459348|FG000|Overall Study|Death|1
7928699|NCT02274311|12459354|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1
7928700|NCT02274493|12459360|FG000|Overall Study|Withdrawal by Subject|1
7928701|NCT02274558|12459367|FG000|Overall Study|Adverse Event|2
7928702|NCT02274558|12459368|FG001|Overall Study|Adverse Event|4
7928703|NCT02274558|12459369|FG002|Overall Study|Adverse Event|2
7928704|NCT02274558|12459367|FG000|Overall Study|Non-compliance|2
7928705|NCT02274558|12459368|FG001|Overall Study|Non-compliance|1
7928706|NCT02274558|12459369|FG002|Overall Study|Non-compliance|0
7928707|NCT02274558|12459367|FG000|Overall Study|Withdrawal by Subject|1
7928708|NCT02274558|12459368|FG001|Overall Study|Withdrawal by Subject|5
7928709|NCT02274558|12459369|FG002|Overall Study|Withdrawal by Subject|4
7928710|NCT02274558|12459367|FG000|Overall Study|Death|0
7928711|NCT02274558|12459368|FG001|Overall Study|Death|0
7928712|NCT02274558|12459369|FG002|Overall Study|Death|1
7928713|NCT02274558|12459367|FG000|Overall Study|Lost to Follow-up|2
7928714|NCT02274558|12459368|FG001|Overall Study|Lost to Follow-up|1
7928715|NCT02274558|12459369|FG002|Overall Study|Lost to Follow-up|1
7928716|NCT02274558|12459367|FG000|Overall Study|Physician Decision|0
7928717|NCT02274558|12459368|FG001|Overall Study|Physician Decision|2
7928718|NCT02274558|12459369|FG002|Overall Study|Physician Decision|1
7964698|NCT02582749|12520293|FG001|Overall Study|Study terminated by funder|10
7964699|NCT02582749|12520292|FG000|Overall Study|Withdrawal by Subject|0
7964700|NCT02582749|12520293|FG001|Overall Study|Withdrawal by Subject|1
7964701|NCT02499952|12520308|FG000|Overall Study|Lost to Follow-up|1
7964702|NCT02499952|12520308|FG000|Overall Study|Death|9
7964703|NCT02450331|12520314|FG000|Overall Study|Death|120
7964704|NCT02450331|12520315|FG001|Overall Study|Death|114
7928719|NCT02274766|12459404|FG000|Overall Study|Withdrawal by Subject|3
7928720|NCT02274766|12459405|FG001|Overall Study|Withdrawal by Subject|6
7928721|NCT02274766|12459404|FG000|Overall Study|Did Not Receive Study Drug|1
7928722|NCT02274766|12459405|FG001|Overall Study|Did Not Receive Study Drug|1
7928723|NCT02274766|12459404|FG000|Overall Study|Subject Unwilling to Proceed|0
7928724|NCT02274766|12459405|FG001|Overall Study|Subject Unwilling to Proceed|1
7928725|NCT02274766|12459404|FG000|Overall Study|Adverse Event|0
7928726|NCT02274766|12459405|FG001|Overall Study|Adverse Event|1
7928727|NCT02274792|12459411|FG000|Overall Study|Withdrawal by Subject|13
7928728|NCT02274792|12459411|FG000|Overall Study|Lost to Follow-up|8
7928729|NCT02274792|12459411|FG000|Overall Study|Protocol Specified Criteria|2
7928730|NCT02274792|12459411|FG000|Overall Study|Sponsor Decision|2
7928731|NCT02274857|12459426|FG000|Overall Study|Adverse Event|1
7928732|NCT02274857|12459427|FG001|Overall Study|Adverse Event|0
7928733|NCT02274857|12459426|FG000|Overall Study|Death|1
7928734|NCT02274857|12459427|FG001|Overall Study|Death|2
7928735|NCT02274857|12459426|FG000|Overall Study|Lost to Follow-up|3
7928736|NCT02274857|12459427|FG001|Overall Study|Lost to Follow-up|0
7928737|NCT02274857|12459426|FG000|Overall Study|Physician Decision|2
7928738|NCT02274857|12459427|FG001|Overall Study|Physician Decision|0
7928739|NCT02274857|12459426|FG000|Overall Study|Trial screen failure|0
7928740|NCT02274857|12459427|FG001|Overall Study|Trial screen failure|2
7928741|NCT02274857|12459426|FG000|Overall Study|Withdrawal by Subject|11
7928742|NCT02274857|12459427|FG001|Overall Study|Withdrawal by Subject|2
7928743|NCT02274857|12459426|FG000|Overall Study|Other|2
7928744|NCT02274857|12459427|FG001|Overall Study|Other|0
7928745|NCT02274948|12459448|FG000|Overall Study|Lost to Follow-up|28
7928746|NCT02274948|12459449|FG001|Overall Study|Lost to Follow-up|25
7928747|NCT02274948|12459448|FG000|Overall Study|Withdrawal by Subject|64
7928748|NCT02274948|12459449|FG001|Overall Study|Withdrawal by Subject|58
7928749|NCT02274948|12459448|FG000|Overall Study|Stopped on family Practitioner advice|2
7928750|NCT02274948|12459449|FG001|Overall Study|Stopped on family Practitioner advice|5
7928751|NCT02274948|12459448|FG000|Overall Study|Left the area|4
7928752|NCT02274948|12459449|FG001|Overall Study|Left the area|3
7928753|NCT02275026|12459456|FG000|Overall Study|Ineligible after cognitive baseline testing|11
7928754|NCT02275026|12459456|FG000|Overall Study|Withdrawal by Subject|4
7928755|NCT02275026|12459456|FG000|Overall Study|Ineligible due to medical history|13
7928756|NCT02275026|12459456|FG000|Overall Study|MRI malfunction precluded testing|1
7928757|NCT02275026|12459456|FG000|Overall Study|Ineligible after MRI findings|1
7928758|NCT02275026|12459456|FG000|Overall Study|Lost to Follow-up|2
7928759|NCT02275026|12459456|FG000|Overall Study|Scanner failure|1
7928760|NCT02275052|12459463|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7928761|NCT02275052|12459464|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7928762|NCT02275052|12459465|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7928763|NCT02275052|12459466|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7928764|NCT02275052|12459463|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
7928765|NCT02275052|12459464|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
7928766|NCT02275052|12459465|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
7928767|NCT02275052|12459466|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
7928768|NCT02275052|12459463|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
7928769|NCT02275052|12459464|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
7928770|NCT02275052|12459465|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7928771|NCT02275052|12459466|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7928772|NCT02275052|12459463|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
7928773|NCT02275052|12459464|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
7928774|NCT02275052|12459465|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
7928775|NCT02275052|12459466|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
7928776|NCT02275052|12459463|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
7928777|NCT02275052|12459464|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
7928778|NCT02275052|12459465|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
7928779|NCT02275052|12459466|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
7928780|NCT02275052|12459463|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3
7928781|NCT02275052|12459464|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0
7928782|NCT02275052|12459465|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0
7928783|NCT02275052|12459466|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0
7928784|NCT02275052|12459463|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1
7928785|NCT02275052|12459464|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0
7928786|NCT02275052|12459465|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0
7928787|NCT02275052|12459466|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0
7928788|NCT02275052|12459463|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
7928789|NCT02275052|12459464|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
7928790|NCT02275052|12459465|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
7928791|NCT02275052|12459466|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
7928792|NCT02275052|12459463|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7928793|NCT02275052|12459464|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7928794|NCT02275052|12459465|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7928795|NCT02275052|12459466|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
7928796|NCT02275052|12459463|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
7928797|NCT02275052|12459464|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
7928798|NCT02275052|12459465|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
7928799|NCT02275052|12459466|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
7928800|NCT02275052|12459463|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7928801|NCT02275052|12459464|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7928802|NCT02275052|12459465|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7928803|NCT02275052|12459466|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
7928804|NCT02275065|12459477|FG000|Overall Study|Randomized but not treated|1
7928805|NCT02275065|12459478|FG001|Overall Study|Randomized but not treated|0
7928806|NCT02275065|12459479|FG002|Overall Study|Randomized but not treated|1
7928807|NCT02275065|12459480|FG003|Overall Study|Randomized but not treated|1
7928808|NCT02275065|12459481|FG004|Overall Study|Randomized but not treated|0
7928809|NCT02275117|12459498|FG000|Overall Study|Adverse Event|0
7928810|NCT02275117|12459499|FG001|Overall Study|Adverse Event|0
7928811|NCT02275117|12459500|FG002|Overall Study|Adverse Event|0
7928812|NCT02275117|12459501|FG003|Overall Study|Adverse Event|0
7928813|NCT02275117|12459502|FG004|Overall Study|Adverse Event|1
7928814|NCT02275117|12459498|FG000|Overall Study|Lack of Efficacy|6
7928815|NCT02275117|12459499|FG001|Overall Study|Lack of Efficacy|7
7928816|NCT02275117|12459500|FG002|Overall Study|Lack of Efficacy|5
7928817|NCT02275117|12459501|FG003|Overall Study|Lack of Efficacy|2
7928818|NCT02275117|12459502|FG004|Overall Study|Lack of Efficacy|10
7928819|NCT02275117|12459498|FG000|Overall Study|Lost to Follow-up|11
7928820|NCT02275117|12459499|FG001|Overall Study|Lost to Follow-up|16
7928821|NCT02275117|12459500|FG002|Overall Study|Lost to Follow-up|15
7928822|NCT02275117|12459501|FG003|Overall Study|Lost to Follow-up|16
7928823|NCT02275117|12459502|FG004|Overall Study|Lost to Follow-up|8
7928824|NCT02275117|12459498|FG000|Overall Study|Physician Decision|0
7928825|NCT02275117|12459499|FG001|Overall Study|Physician Decision|1
7928826|NCT02275117|12459500|FG002|Overall Study|Physician Decision|1
7928827|NCT02275117|12459501|FG003|Overall Study|Physician Decision|0
7928828|NCT02275117|12459502|FG004|Overall Study|Physician Decision|1
7928829|NCT02275117|12459498|FG000|Overall Study|Protocol Violation|1
7928830|NCT02275117|12459499|FG001|Overall Study|Protocol Violation|0
7928831|NCT02275117|12459500|FG002|Overall Study|Protocol Violation|1
7928832|NCT02275117|12459501|FG003|Overall Study|Protocol Violation|1
7928833|NCT02275117|12459502|FG004|Overall Study|Protocol Violation|0
7928834|NCT02275117|12459498|FG000|Overall Study|Withdrawal by Subject|6
7928835|NCT02275117|12459499|FG001|Overall Study|Withdrawal by Subject|4
7928836|NCT02275117|12459500|FG002|Overall Study|Withdrawal by Subject|7
7928837|NCT02275117|12459501|FG003|Overall Study|Withdrawal by Subject|3
7928838|NCT02275117|12459502|FG004|Overall Study|Withdrawal by Subject|3
7928839|NCT02275117|12459498|FG000|Overall Study|Terminated by Sponsor|4
7928840|NCT02275117|12459499|FG001|Overall Study|Terminated by Sponsor|4
7928841|NCT02275117|12459500|FG002|Overall Study|Terminated by Sponsor|4
7928842|NCT02275117|12459501|FG003|Overall Study|Terminated by Sponsor|6
7928843|NCT02275117|12459502|FG004|Overall Study|Terminated by Sponsor|4
7928844|NCT02275117|12459498|FG000|Overall Study|Worsening of Study Indication|0
7928845|NCT02275117|12459499|FG001|Overall Study|Worsening of Study Indication|1
7928846|NCT02275117|12459500|FG002|Overall Study|Worsening of Study Indication|2
7928847|NCT02275117|12459501|FG003|Overall Study|Worsening of Study Indication|0
7928848|NCT02275117|12459502|FG004|Overall Study|Worsening of Study Indication|0
7928849|NCT02275117|12459498|FG000|Overall Study|Study Burden|5
7928850|NCT02275117|12459499|FG001|Overall Study|Study Burden|4
7928851|NCT02275117|12459500|FG002|Overall Study|Study Burden|7
7928852|NCT02275117|12459501|FG003|Overall Study|Study Burden|5
7928853|NCT02275117|12459502|FG004|Overall Study|Study Burden|7
7928854|NCT02275117|12459498|FG000|Overall Study|Other|1
7928855|NCT02275117|12459499|FG001|Overall Study|Other|0
7928856|NCT02275117|12459500|FG002|Overall Study|Other|0
7928857|NCT02275117|12459501|FG003|Overall Study|Other|0
7928858|NCT02275117|12459502|FG004|Overall Study|Other|2
7928859|NCT02275338|12459528|FG000|Overall Study|Adverse Event|15
7928860|NCT02275338|12459528|FG000|Overall Study|Lack of Efficacy|3
7928861|NCT02275338|12459528|FG000|Overall Study|Withdrawal by Subject|4
7928862|NCT02275338|12459528|FG000|Overall Study|Disease progression (death)|1
7928863|NCT02275338|12459528|FG000|Overall Study|Ineligible to start Phase 2|4
7928864|NCT02275338|12459528|FG000|Overall Study|Reason not specified|5
7928865|NCT02275338|12459528|FG000|Overall Study|Does not meet entry criteria|1
7928866|NCT02275364|12459533|FG000|Period 1|Withdrawal by Subject|1
7928867|NCT02275364|12459534|FG001|Period 1|Withdrawal by Subject|0
7928868|NCT02275364|12459533|FG000|Period 1|Other reason|1
7928869|NCT02275364|12459534|FG001|Period 1|Other reason|0
7928870|NCT02275611|12459555|FG000|Inpatient Withdrawal|Withdrawal by Subject|1
7928871|NCT02275611|12459556|FG001|Inpatient Withdrawal|Withdrawal by Subject|0
7928872|NCT02275611|12459557|FG002|Inpatient Withdrawal|Withdrawal by Subject|0
7928873|NCT02275611|12459558|FG003|Inpatient Withdrawal|Withdrawal by Subject|0
7928874|NCT02275819|12459585|FG000|Overall Study|Adverse Event|0
7928875|NCT02275819|12459586|FG001|Overall Study|Adverse Event|1
7928876|NCT02276027|12459600|FG000|Overall Study|Death|1
7928877|NCT02276027|12459601|FG001|Overall Study|Death|0
7928878|NCT02276027|12459602|FG002|Overall Study|Death|0
7928879|NCT02276027|12459603|FG003|Overall Study|Death|2
7928880|NCT02276027|12459600|FG000|Overall Study|Physician Decision|0
7928881|NCT02276027|12459601|FG001|Overall Study|Physician Decision|0
7928882|NCT02276027|12459602|FG002|Overall Study|Physician Decision|0
7928883|NCT02276027|12459603|FG003|Overall Study|Physician Decision|1
7928884|NCT02276027|12459600|FG000|Overall Study|Progressive disease|1
7928885|NCT02276027|12459601|FG001|Overall Study|Progressive disease|13
7928886|NCT02276027|12459602|FG002|Overall Study|Progressive disease|12
7928887|NCT02276027|12459603|FG003|Overall Study|Progressive disease|14
7928888|NCT02276027|12459600|FG000|Overall Study|Subject/guardian decision|0
7928889|NCT02276027|12459601|FG001|Overall Study|Subject/guardian decision|1
7928890|NCT02276027|12459602|FG002|Overall Study|Subject/guardian decision|0
7928891|NCT02276027|12459603|FG003|Overall Study|Subject/guardian decision|3
7928892|NCT02276027|12459600|FG000|Overall Study|Adverse Event|0
7928893|NCT02276027|12459601|FG001|Overall Study|Adverse Event|2
7928894|NCT02276027|12459602|FG002|Overall Study|Adverse Event|8
7928895|NCT02276027|12459603|FG003|Overall Study|Adverse Event|2
7928896|NCT02276040|12459613|FG000|Overall Study|Physician Decision|15
7928897|NCT02276053|12459617|FG000|Overall Study|Death|2
7928898|NCT02276053|12459617|FG000|Overall Study|Adverse Event|5
7928899|NCT02276053|12459617|FG000|Overall Study|Lack of Efficacy|2
7928900|NCT02276053|12459617|FG000|Overall Study|Withdrawal by Subject|1
7928901|NCT02276053|12459617|FG000|Overall Study|Patient does not meet selection criteria|3
7928902|NCT02276053|12459617|FG000|Overall Study|Patient needs to increase baseline AED|1
7928903|NCT02276222|12459624|FG000|Overall Study|Adverse Event|62
7928904|NCT02276222|12459625|FG001|Overall Study|Adverse Event|11
7928905|NCT02276222|12459624|FG000|Overall Study|Death|3
7928906|NCT02276222|12459625|FG001|Overall Study|Death|4
7928907|NCT02276222|12459624|FG000|Overall Study|Lack of Efficacy|13
7928908|NCT02276222|12459625|FG001|Overall Study|Lack of Efficacy|3
7928909|NCT02276222|12459624|FG000|Overall Study|Protocol Violation|3
7928910|NCT02276222|12459625|FG001|Overall Study|Protocol Violation|2
7928911|NCT02276222|12459624|FG000|Overall Study|Withdrawal by Subject|79
7928912|NCT02276222|12459625|FG001|Overall Study|Withdrawal by Subject|33
7928913|NCT02276222|12459624|FG000|Overall Study|non compliance with study medication|6
7928914|NCT02276222|12459625|FG001|Overall Study|non compliance with study medication|2
7928915|NCT02276222|12459624|FG000|Overall Study|sponsor decision|0
7928916|NCT02276222|12459625|FG001|Overall Study|sponsor decision|3
7928917|NCT02276222|12459624|FG000|Overall Study|Lost to Follow-up|15
7928918|NCT02276222|12459625|FG001|Overall Study|Lost to Follow-up|5
7928919|NCT02276222|12459624|FG000|Overall Study|Physician Decision|2
7928920|NCT02276222|12459625|FG001|Overall Study|Physician Decision|1
7928921|NCT02276222|12459624|FG000|Overall Study|sheduling conflict|1
7928922|NCT02276222|12459625|FG001|Overall Study|sheduling conflict|0
7928923|NCT02276222|12459624|FG000|Overall Study|subject withdrew after randomization|1
7928924|NCT02276222|12459625|FG001|Overall Study|subject withdrew after randomization|0
7928925|NCT02276482|12459642|FG000|Overall Study|Adverse Event|1
7928926|NCT02276482|12459643|FG001|Overall Study|Adverse Event|0
7928927|NCT02276482|12459642|FG000|Overall Study|Withdrawal by Subject|1
7928928|NCT02276482|12459643|FG001|Overall Study|Withdrawal by Subject|0
7928929|NCT02276482|12459642|FG000|Overall Study|Gram-negative infection|1
7928930|NCT02276482|12459643|FG001|Overall Study|Gram-negative infection|0
7928931|NCT02276482|12459642|FG000|Overall Study|Reason not specified|0
7928932|NCT02276482|12459643|FG001|Overall Study|Reason not specified|1
7928933|NCT02276612|12459651|FG000|Overall Study|Death|1
7928934|NCT02276612|12459652|FG001|Overall Study|Death|0
7928935|NCT02276612|12459651|FG000|Overall Study|Pregnancy|1
7928936|NCT02276612|12459652|FG001|Overall Study|Pregnancy|0
7928937|NCT02276612|12459651|FG000|Overall Study|Withdrew Consent|1
7928938|NCT02276612|12459652|FG001|Overall Study|Withdrew Consent|0
7928939|NCT02276612|12459651|FG000|Overall Study|Lost to Follow-up|1
7928940|NCT02276612|12459652|FG001|Overall Study|Lost to Follow-up|0
7928941|NCT02276807|12459673|FG000|Overall Study|Withdrawal by Subject|8
7928942|NCT02276807|12459674|FG001|Overall Study|Withdrawal by Subject|7
7928943|NCT02276807|12459673|FG000|Overall Study|Lost to Follow-up|10
7928944|NCT02276807|12459674|FG001|Overall Study|Lost to Follow-up|10
7928945|NCT02276872|12459683|FG000|Overall Study|Adverse Event|1
7928946|NCT02276872|12459684|FG001|Overall Study|Adverse Event|0
7928947|NCT02276872|12459685|FG002|Overall Study|Adverse Event|0
7928948|NCT02277691|12459761|FG000|Overall Study|Pretreatment Event/Adverse Event|33
7928949|NCT02277691|12459761|FG000|Overall Study|Voluntary Withdrawal|7
7928950|NCT02277691|12459761|FG000|Overall Study|Lack of Efficacy|5
7928951|NCT02277691|12459761|FG000|Overall Study|Used Other Antihypertensive Drug|1
7928952|NCT02277743|12459768|FG000|Overall Study|Protocol Violation|1
7928953|NCT02277743|12459769|FG001|Overall Study|Protocol Violation|1
7928954|NCT02277743|12459770|FG002|Overall Study|Protocol Violation|1
7928955|NCT02277743|12459768|FG000|Overall Study|Adverse Event|10
7928956|NCT02277743|12459769|FG001|Overall Study|Adverse Event|6
7928957|NCT02277743|12459770|FG002|Overall Study|Adverse Event|6
7928958|NCT02277743|12459768|FG000|Overall Study|Lack of Efficacy|11
7928959|NCT02277743|12459769|FG001|Overall Study|Lack of Efficacy|4
7928960|NCT02277743|12459770|FG002|Overall Study|Lack of Efficacy|3
7928961|NCT02277743|12459768|FG000|Overall Study|Other than specified above|18
7928962|NCT02277743|12459769|FG001|Overall Study|Other than specified above|5
7928963|NCT02277743|12459770|FG002|Overall Study|Other than specified above|16
7928964|NCT02277769|12459781|FG000|Overall Study|Protocol Violation|3
7928965|NCT02277769|12459782|FG001|Overall Study|Protocol Violation|3
7928966|NCT02277769|12459783|FG002|Overall Study|Protocol Violation|5
7928967|NCT02277769|12459781|FG000|Overall Study|Lack of Efficacy|17
7928968|NCT02277769|12459782|FG001|Overall Study|Lack of Efficacy|0
7928969|NCT02277769|12459783|FG002|Overall Study|Lack of Efficacy|4
7928970|NCT02277769|12459781|FG000|Overall Study|Adverse Event|14
7928971|NCT02277769|12459782|FG001|Overall Study|Adverse Event|2
7928972|NCT02277769|12459783|FG002|Overall Study|Adverse Event|4
7928973|NCT02277769|12459781|FG000|Overall Study|Other than specified above|12
7928974|NCT02277769|12459782|FG001|Overall Study|Other than specified above|8
7928975|NCT02277769|12459783|FG002|Overall Study|Other than specified above|5
7928976|NCT02277990|12459804|FG000|Overall Study|Death|170
7928977|NCT02277990|12459805|FG001|Overall Study|Death|188
7928978|NCT02277990|12459804|FG000|Overall Study|Withdrawal by Subject|64
7928979|NCT02277990|12459805|FG001|Overall Study|Withdrawal by Subject|53
7928980|NCT02277990|12459804|FG000|Overall Study|Physician Decision|40
7928981|NCT02277990|12459805|FG001|Overall Study|Physician Decision|34
7928982|NCT02277990|12459804|FG000|Overall Study|Lost to Follow-up|66
7928983|NCT02277990|12459805|FG001|Overall Study|Lost to Follow-up|69
7928984|NCT02277990|12459804|FG000|Overall Study|Had other reason|26
7928985|NCT02277990|12459805|FG001|Overall Study|Had other reason|32
7928986|NCT02278003|12459813|FG000|Overall Study|Withdrawal by Subject|11
7928987|NCT02278003|12459814|FG001|Overall Study|Withdrawal by Subject|0
7928988|NCT02278003|12459813|FG000|Overall Study|Not Treated|1
7928989|NCT02278003|12459814|FG001|Overall Study|Not Treated|0
7928990|NCT02278003|12459813|FG000|Overall Study|Recognition task improperly completed|7
7928991|NCT02278003|12459814|FG001|Overall Study|Recognition task improperly completed|0
7928992|NCT02278263|12459836|FG000|Overall Study|Protocol Violation|7
7928993|NCT02278263|12459837|FG001|Overall Study|Protocol Violation|0
7928994|NCT02278263|12459838|FG002|Overall Study|Protocol Violation|9
7928995|NCT02278328|12459858|FG000|Neuropsych Screening|found ineligible on neuropsych|1
7928996|NCT02278328|12459859|FG001|Neuropsych Screening|found ineligible on neuropsych|0
7928997|NCT02278328|12459860|FG002|Neuropsych Screening|found ineligible on neuropsych|0
7928998|NCT02278328|12459858|FG000|Neuropsych Screening|Withdrawal by Subject|0
7928999|NCT02278328|12459859|FG001|Neuropsych Screening|Withdrawal by Subject|1
7929000|NCT02278328|12459860|FG002|Neuropsych Screening|Withdrawal by Subject|0
7929001|NCT02278328|12459858|FG000|Neuropsych Screening|incomplete consent|0
7929002|NCT02278328|12459859|FG001|Neuropsych Screening|incomplete consent|0
7929003|NCT02278328|12459860|FG002|Neuropsych Screening|incomplete consent|2
7929004|NCT02278341|12459868|FG000|Overall Study|Randomized but never received study drug|1
7929005|NCT02278341|12459869|FG001|Overall Study|Randomized but never received study drug|1
7929006|NCT02278341|12459868|FG000|Overall Study|Adverse Event|3
7929007|NCT02278341|12459869|FG001|Overall Study|Adverse Event|0
7929008|NCT02278341|12459868|FG000|Overall Study|Death|68
7929009|NCT02278341|12459869|FG001|Overall Study|Death|56
7929010|NCT02278341|12459868|FG000|Overall Study|Withdrawal by Subject|30
7929011|NCT02278341|12459869|FG001|Overall Study|Withdrawal by Subject|19
7929012|NCT02278341|12459868|FG000|Overall Study|Lost to Follow-up|0
7929013|NCT02278341|12459869|FG001|Overall Study|Lost to Follow-up|1
7929014|NCT02278341|12459868|FG000|Overall Study|Physician Decision|1
7929015|NCT02278341|12459869|FG001|Overall Study|Physician Decision|1
7929016|NCT02278341|12459868|FG000|Overall Study|Miscellaneous|15
7929017|NCT02278341|12459869|FG001|Overall Study|Miscellaneous|14
7929018|NCT02278354|12459878|FG000|Overall Study|Lost to Follow-up|2
7929019|NCT02278354|12459879|FG001|Overall Study|Lost to Follow-up|2
7929020|NCT02278354|12459878|FG000|Overall Study|Withdrawal by Subject|0
7929021|NCT02278354|12459879|FG001|Overall Study|Withdrawal by Subject|1
7929022|NCT02278354|12459878|FG000|Overall Study|<10 professional fights|2
7929023|NCT02278354|12459879|FG001|Overall Study|<10 professional fights|0
7929024|NCT02278367|12459889|FG000|Overall Study|Physician Decision|5
7929025|NCT02278367|12459890|FG001|Overall Study|Physician Decision|0
7929026|NCT02278367|12459889|FG000|Overall Study|Withdrawal by Subject|5
7929027|NCT02278367|12459890|FG001|Overall Study|Withdrawal by Subject|0
7929028|NCT02278471|12459898|FG000|Overall Study|Lost to Follow-up|6
7929029|NCT02278471|12459899|FG001|Overall Study|Lost to Follow-up|15
7929030|NCT02278471|12459898|FG000|Overall Study|Death|2
7929031|NCT02278471|12459899|FG001|Overall Study|Death|2
7929032|NCT02278471|12459898|FG000|Overall Study|Withdrawal by Subject|0
7929033|NCT02278471|12459899|FG001|Overall Study|Withdrawal by Subject|3
7929034|NCT02278614|12459926|FG000|Overall Study|Withdrawal by Subject|3
7929035|NCT02278614|12459927|FG001|Overall Study|Withdrawal by Subject|5
7929036|NCT02278614|12459926|FG000|Overall Study|Adverse Event|1
7929037|NCT02278614|12459927|FG001|Overall Study|Adverse Event|0
7929038|NCT02278614|12459926|FG000|Overall Study|left eye was not eligible|1
7929039|NCT02278614|12459927|FG001|Overall Study|left eye was not eligible|0
7929040|NCT02278939|12459943|FG000|Overall Study|lack of time|1
7929041|NCT02278939|12459944|FG001|Overall Study|lack of time|0
7929042|NCT02278939|12459943|FG000|Overall Study|Lost to Follow-up|1
7929043|NCT02278939|12459944|FG001|Overall Study|Lost to Follow-up|1
7929044|NCT02278939|12459943|FG000|Overall Study|death in family|1
7929045|NCT02278939|12459944|FG001|Overall Study|death in family|0
7929046|NCT02278939|12459943|FG000|Overall Study|family emergency unable to commit|2
7929047|NCT02278939|12459944|FG001|Overall Study|family emergency unable to commit|0
7929048|NCT02278952|12459950|FG000|Overall Study|Insufficient Sample|6
7929049|NCT02279043|12459963|FG000|Overall Study|Post-rand. exclusion - not eligible|1
7929050|NCT02279043|12459964|FG001|Overall Study|Post-rand. exclusion - not eligible|1
7929051|NCT02279043|12459965|FG002|Overall Study|Post-rand. exclusion - not eligible|0
7929052|NCT02279043|12459963|FG000|Overall Study|Lost to Follow-up|46
7929053|NCT02279043|12459964|FG001|Overall Study|Lost to Follow-up|88
7929054|NCT02279043|12459965|FG002|Overall Study|Lost to Follow-up|0
7929055|NCT02279407|12459997|FG000|Overall Study|Couldn't swallow IP; noncompliance|0
7929056|NCT02279407|12459998|FG001|Overall Study|Couldn't swallow IP; noncompliance|0
7929057|NCT02279407|12459999|FG002|Overall Study|Couldn't swallow IP; noncompliance|2
7929058|NCT02279407|12460000|FG003|Overall Study|Couldn't swallow IP; noncompliance|0
7929059|NCT02279407|12459997|FG000|Overall Study|Withdrawal by Subject|1
7929060|NCT02279407|12459998|FG001|Overall Study|Withdrawal by Subject|0
7929061|NCT02279407|12459999|FG002|Overall Study|Withdrawal by Subject|1
7929062|NCT02279407|12460000|FG003|Overall Study|Withdrawal by Subject|1
7929063|NCT02279407|12459997|FG000|Overall Study|Adverse Event|1
7929064|NCT02279407|12459998|FG001|Overall Study|Adverse Event|1
7929065|NCT02279407|12459999|FG002|Overall Study|Adverse Event|2
7929066|NCT02279407|12460000|FG003|Overall Study|Adverse Event|0
7929067|NCT02279420|12460010|FG000|Overall Study|Lost to Follow-up|23
7929068|NCT02279498|12460016|FG000|Overall Study|Adverse Event|3
7929069|NCT02279498|12460017|FG001|Overall Study|Adverse Event|0
7929070|NCT02279498|12460016|FG000|Overall Study|Lack of Efficacy|4
7929071|NCT02279498|12460017|FG001|Overall Study|Lack of Efficacy|0
7929072|NCT02279498|12460016|FG000|Overall Study|Lost to Follow-up|0
7929073|NCT02279498|12460017|FG001|Overall Study|Lost to Follow-up|1
7929074|NCT02279498|12460016|FG000|Overall Study|Withdrawal by Subject|9
7929075|NCT02279498|12460017|FG001|Overall Study|Withdrawal by Subject|2
7929076|NCT02279498|12460016|FG000|Overall Study|Undefined|2
7929077|NCT02279498|12460017|FG001|Overall Study|Undefined|1
7929078|NCT02279524|12460027|FG000|Overall Study|Withdrawal by Subject|3
7929079|NCT02279524|12460028|FG001|Overall Study|Withdrawal by Subject|6
7929080|NCT02279524|12460029|FG002|Overall Study|Withdrawal by Subject|3
7929081|NCT02279524|12460027|FG000|Overall Study|Adverse Event|4
7929082|NCT02279524|12460028|FG001|Overall Study|Adverse Event|3
7929083|NCT02279524|12460029|FG002|Overall Study|Adverse Event|2
7929084|NCT02279524|12460027|FG000|Overall Study|Lost to Follow-up|1
7929085|NCT02279524|12460028|FG001|Overall Study|Lost to Follow-up|1
7929086|NCT02279524|12460029|FG002|Overall Study|Lost to Follow-up|0
7929087|NCT02279524|12460027|FG000|Overall Study|Disallowed medication|1
7929088|NCT02279524|12460028|FG001|Overall Study|Disallowed medication|1
7929089|NCT02279524|12460029|FG002|Overall Study|Disallowed medication|2
7929090|NCT02279524|12460027|FG000|Overall Study|Bariatric surgery|1
7929091|NCT02279524|12460028|FG001|Overall Study|Bariatric surgery|0
7929092|NCT02279524|12460029|FG002|Overall Study|Bariatric surgery|0
7929093|NCT02279732|12460072|FG000|Overall Study|Death|23
7929094|NCT02279732|12460073|FG001|Overall Study|Death|20
7929095|NCT02279732|12460072|FG000|Overall Study|Disease Progression|13
7929096|NCT02279732|12460073|FG001|Overall Study|Disease Progression|3
7929097|NCT02279732|12460072|FG000|Overall Study|Withdrawal by Subject|2
7929098|NCT02279732|12460073|FG001|Overall Study|Withdrawal by Subject|7
7929099|NCT02279732|12460072|FG000|Overall Study|Adverse Event|1
7929100|NCT02279732|12460073|FG001|Overall Study|Adverse Event|2
7929101|NCT02279732|12460072|FG000|Overall Study|Administrative Reason By Sponsor|0
7929102|NCT02279732|12460073|FG001|Overall Study|Administrative Reason By Sponsor|2
7929103|NCT02279732|12460072|FG000|Overall Study|Study Drug Toxicity|2
7929104|NCT02279732|12460073|FG001|Overall Study|Study Drug Toxicity|0
7929105|NCT02279732|12460072|FG000|Overall Study|Lost to Follow-up|0
7929106|NCT02279732|12460073|FG001|Overall Study|Lost to Follow-up|1
7929107|NCT02279732|12460072|FG000|Overall Study|Maximum Clinical Benefit|1
7929108|NCT02279732|12460073|FG001|Overall Study|Maximum Clinical Benefit|0
7929109|NCT02279732|12460072|FG000|Overall Study|Subject Requested to Discontinue|0
7929110|NCT02279732|12460073|FG001|Overall Study|Subject Requested to Discontinue|1
7929111|NCT02279732|12460072|FG000|Overall Study|Other|53
7929112|NCT02279732|12460073|FG001|Overall Study|Other|67
7929113|NCT02279732|12460072|FG000|Overall Study|Other|3
7929114|NCT02279732|12460073|FG001|Overall Study|Other|3
7929115|NCT02279862|12460081|FG000|Overall Study|Study drug toxicity|3
7929116|NCT02279862|12460082|FG001|Overall Study|Study drug toxicity|6
7929117|NCT02279862|12460081|FG000|Overall Study|No longer meets criteria|0
7929118|NCT02279862|12460082|FG001|Overall Study|No longer meets criteria|1
7929119|NCT02279862|12460081|FG000|Overall Study|Administrative reason by sponsor|0
7929120|NCT02279862|12460082|FG001|Overall Study|Administrative reason by sponsor|1
7929121|NCT02279862|12460081|FG000|Overall Study|Disease progression|5
7929122|NCT02279862|12460082|FG001|Overall Study|Disease progression|2
7929123|NCT02279862|12460081|FG000|Overall Study|Study closed by sponsor|16
7929124|NCT02279862|12460082|FG001|Overall Study|Study closed by sponsor|13
7929125|NCT02279862|12460081|FG000|Overall Study|Other|1
7929126|NCT02279862|12460082|FG001|Overall Study|Other|2
7822060|NCT01259492|12291029|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
7822061|NCT01259492|12291030|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
7822062|NCT01259492|12291031|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
7822063|NCT01259492|12291032|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
7822064|NCT01259492|12291029|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
7822065|NCT01259492|12291030|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
7822066|NCT01259492|12291031|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
7929127|NCT02279862|12460081|FG000|Overall Study|Withdrawal by Subject|1
7822067|NCT01259492|12291032|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
7822068|NCT01259492|12291029|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
7822069|NCT01259492|12291030|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
7822070|NCT01259492|12291031|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
7822071|NCT01259492|12291032|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
7822072|NCT01259492|12291029|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
7822073|NCT01259492|12291030|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
7822074|NCT01259492|12291031|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
7822075|NCT01259492|12291032|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
7822076|NCT01259492|12291029|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
7822077|NCT01259492|12291030|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
7822078|NCT01259492|12291031|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
7822079|NCT01259492|12291032|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
7822080|NCT01259713|12291054|FG000|Overall Study|Adverse Event|54
7822081|NCT01259713|12291055|FG001|Overall Study|Adverse Event|23
7822082|NCT01259713|12291054|FG000|Overall Study|Death Not Related to IFI|8
7822083|NCT01259713|12291055|FG001|Overall Study|Death Not Related to IFI|1
7822084|NCT01259713|12291054|FG000|Overall Study|Investigators Discretion|14
7822085|NCT01259713|12291055|FG001|Overall Study|Investigators Discretion|6
7822086|NCT01259713|12291054|FG000|Overall Study|Lack of Efficacy|2
7929128|NCT02279862|12460082|FG001|Overall Study|Withdrawal by Subject|0
7929129|NCT02280044|12460090|FG000|Overall Study|Planned alternate|0
7929130|NCT02280044|12460091|FG001|Overall Study|Planned alternate|2
7929131|NCT02280096|12460099|FG000|Overall Study|Pregnancy|1
7822087|NCT01259713|12291055|FG001|Overall Study|Lack of Efficacy|0
7822088|NCT01259713|12291054|FG000|Overall Study|Protocol Violation|5
7822089|NCT01259713|12291055|FG001|Overall Study|Protocol Violation|4
7929132|NCT02280096|12460100|FG001|Overall Study|Pregnancy|0
7929133|NCT02280096|12460099|FG000|Overall Study|Functional neurological disorder|1
7822090|NCT01259713|12291054|FG000|Overall Study|Subject Withdrew Consent|12
7822091|NCT01259713|12291055|FG001|Overall Study|Subject Withdrew Consent|7
7929134|NCT02280096|12460100|FG001|Overall Study|Functional neurological disorder|0
7929135|NCT02280096|12460099|FG000|Overall Study|Lack of attachment|0
7929136|NCT02280096|12460100|FG001|Overall Study|Lack of attachment|1
7929137|NCT02280187|12460125|FG000|Overall Study|Lost to Follow-up|218
7929138|NCT02280291|12460146|FG000|Overall Study|Lost to Follow-up|2
7929139|NCT02280291|12460147|FG001|Overall Study|Lost to Follow-up|1
7929140|NCT02280291|12460148|FG002|Overall Study|Lost to Follow-up|3
7929141|NCT02280291|12460149|FG003|Overall Study|Lost to Follow-up|8
7929142|NCT02280291|12460146|FG000|Overall Study|Protocol Violation|1
7929143|NCT02280291|12460147|FG001|Overall Study|Protocol Violation|0
7929144|NCT02280291|12460148|FG002|Overall Study|Protocol Violation|0
7929145|NCT02280291|12460149|FG003|Overall Study|Protocol Violation|0
7929146|NCT02280291|12460146|FG000|Overall Study|Other|1
7929147|NCT02280291|12460147|FG001|Overall Study|Other|1
7929148|NCT02280291|12460148|FG002|Overall Study|Other|0
7929149|NCT02280291|12460149|FG003|Overall Study|Other|0
7929150|NCT02280304|12460163|FG000|Overall Study|Lost to Follow-up|7
7929151|NCT02280304|12460164|FG001|Overall Study|Lost to Follow-up|8
7929152|NCT02280408|12460213|FG000|Overall Study|Lost to Follow-up|0
7929153|NCT02280408|12460214|FG001|Overall Study|Lost to Follow-up|2
7929154|NCT02280408|12460215|FG002|Overall Study|Lost to Follow-up|0
7929155|NCT02280408|12460216|FG003|Overall Study|Lost to Follow-up|0
7929156|NCT02280421|12460228|FG000|Washout (2 Weeks)|Adverse Event|0
7929157|NCT02280421|12460229|FG001|Washout (2 Weeks)|Adverse Event|1
7929158|NCT02280421|12460228|FG000|Washout (2 Weeks)|Withdrawal by Subject|1
7929159|NCT02280421|12460229|FG001|Washout (2 Weeks)|Withdrawal by Subject|0
7929160|NCT02280473|12460249|FG000|Overall Study|Adverse Event|1
7929161|NCT02280473|12460250|FG001|Overall Study|Adverse Event|1
7929162|NCT02280473|12460249|FG000|Overall Study|Lack of Efficacy|0
7929163|NCT02280473|12460250|FG001|Overall Study|Lack of Efficacy|1
7929164|NCT02280473|12460249|FG000|Overall Study|Lost to Follow-up|0
7929165|NCT02280473|12460250|FG001|Overall Study|Lost to Follow-up|1
7929166|NCT02280499|12460256|FG000|Overall Study|Death|14
7929167|NCT02280499|12460256|FG000|Overall Study|Lost to Follow-up|42
7929168|NCT02280499|12460256|FG000|Overall Study|Adverse Event|5
7929169|NCT02280863|12460294|FG000|Integrated Platform|Met stopping criteria|0
7929170|NCT02280863|12460295|FG001|Integrated Platform|Met stopping criteria|1
7929171|NCT02281318|12460311|FG000|Overall Study|Adverse Event|2
7929172|NCT02281318|12460312|FG001|Overall Study|Adverse Event|2
7929173|NCT02281318|12460311|FG000|Overall Study|Lack of Efficacy|2
7929174|NCT02281318|12460312|FG001|Overall Study|Lack of Efficacy|0
7929175|NCT02281318|12460311|FG000|Overall Study|Lost to Follow-up|2
7929176|NCT02281318|12460312|FG001|Overall Study|Lost to Follow-up|1
7929177|NCT02281318|12460311|FG000|Overall Study|Physician Decision|2
7929178|NCT02281318|12460312|FG001|Overall Study|Physician Decision|0
7929179|NCT02281318|12460311|FG000|Overall Study|Withdrawal by Subject|6
7929180|NCT02281318|12460312|FG001|Overall Study|Withdrawal by Subject|2
7929181|NCT02281357|12460324|FG000|Overall Study|Adverse Event|2
7929182|NCT02281357|12460325|FG001|Overall Study|Adverse Event|1
7929183|NCT02281357|12460324|FG000|Overall Study|Lost to Follow-up|1
7929184|NCT02281357|12460325|FG001|Overall Study|Lost to Follow-up|0
7929185|NCT02281357|12460324|FG000|Overall Study|Withdrawal by Subject|4
7929186|NCT02281357|12460325|FG001|Overall Study|Withdrawal by Subject|3
7929187|NCT02281552|12460390|FG000|Overall Study|Medication error|1
7929188|NCT02281552|12460391|FG001|Overall Study|Medication error|0
7929189|NCT02281552|12460390|FG000|Overall Study|Insufficient clinical response|0
7929190|NCT02281552|12460391|FG001|Overall Study|Insufficient clinical response|1
7929191|NCT02281552|12460390|FG000|Overall Study|Adverse Event|3
7929192|NCT02281552|12460391|FG001|Overall Study|Adverse Event|9
7929193|NCT02281760|12460414|FG000|Overall Study|Withdrawal by Subject|1
7929194|NCT02281773|12460423|FG000|Overall Study|Adverse Event|6
7929195|NCT02281773|12460424|FG001|Overall Study|Adverse Event|1
7929196|NCT02281773|12460425|FG002|Overall Study|Adverse Event|4
7929197|NCT02281773|12460426|FG003|Overall Study|Adverse Event|8
7929198|NCT02281773|12460427|FG004|Overall Study|Adverse Event|9
7929199|NCT02281773|12460423|FG000|Overall Study|Protocol Violation|1
7929200|NCT02281773|12460424|FG001|Overall Study|Protocol Violation|0
7929201|NCT02281773|12460425|FG002|Overall Study|Protocol Violation|0
7929202|NCT02281773|12460426|FG003|Overall Study|Protocol Violation|2
7929203|NCT02281773|12460427|FG004|Overall Study|Protocol Violation|2
7929204|NCT02281773|12460423|FG000|Overall Study|Lost to Follow-up|2
7929205|NCT02281773|12460424|FG001|Overall Study|Lost to Follow-up|2
7929206|NCT02281773|12460425|FG002|Overall Study|Lost to Follow-up|6
7929207|NCT02281773|12460426|FG003|Overall Study|Lost to Follow-up|2
7929208|NCT02281773|12460427|FG004|Overall Study|Lost to Follow-up|10
7929209|NCT02281773|12460423|FG000|Overall Study|Withdrawal by Subject|2
7929210|NCT02281773|12460424|FG001|Overall Study|Withdrawal by Subject|8
7929211|NCT02281773|12460425|FG002|Overall Study|Withdrawal by Subject|6
7929212|NCT02281773|12460426|FG003|Overall Study|Withdrawal by Subject|6
7929213|NCT02281773|12460427|FG004|Overall Study|Withdrawal by Subject|8
7929214|NCT02281773|12460423|FG000|Overall Study|Other Reason|0
7929215|NCT02281773|12460424|FG001|Overall Study|Other Reason|4
7929216|NCT02281773|12460425|FG002|Overall Study|Other Reason|2
7929217|NCT02281773|12460426|FG003|Overall Study|Other Reason|3
7929218|NCT02281773|12460427|FG004|Overall Study|Other Reason|1
7929219|NCT02282163|12460457|FG000|Overall Study|Protocol Violation|1
7964705|NCT02450331|12520314|FG000|Overall Study|Lost to Follow-up|9
7964706|NCT02450331|12520315|FG001|Overall Study|Lost to Follow-up|7
7964707|NCT02450331|12520314|FG000|Overall Study|Withdrawal by Subject|50
7964708|NCT02450331|12520315|FG001|Overall Study|Withdrawal by Subject|39
7964709|NCT02450331|12520314|FG000|Overall Study|On-Study Status: In Disease recurrence follow-up|179
7964710|NCT02450331|12520315|FG001|Overall Study|On-Study Status: In Disease recurrence follow-up|208
7964711|NCT02450331|12520314|FG000|Overall Study|On-Study Status: In Survival follow-up|45
7964712|NCT02450331|12520315|FG001|Overall Study|On-Study Status: In Survival follow-up|38
7964713|NCT01984346|12520333|FG000|Overall Study|Physician Decision|4
7964714|NCT01984346|12520334|FG001|Overall Study|Physician Decision|2
7964715|NCT01984346|12520333|FG000|Overall Study|Withdrawal by Subject|2
7964716|NCT01984346|12520334|FG001|Overall Study|Withdrawal by Subject|2
7964717|NCT01984346|12520333|FG000|Overall Study|Enrollment Closed|8
7964718|NCT01984346|12520334|FG001|Overall Study|Enrollment Closed|1
7964719|NCT01984346|12520333|FG000|Overall Study|Insurance Coverage|1
7964720|NCT01984346|12520334|FG001|Overall Study|Insurance Coverage|0
7964721|NCT01984346|12520333|FG000|Overall Study|Intra-operative Exclusion|2
7964722|NCT01984346|12520334|FG001|Overall Study|Intra-operative Exclusion|0
7964723|NCT01963780|12520340|FG000|Overall Study|Death|7
7964724|NCT01793610|12520357|FG000|Overall Study|Withdrawal by Subject|1
7964725|NCT01793610|12520358|FG001|Overall Study|Withdrawal by Subject|0
7964726|NCT01793610|12520359|FG002|Overall Study|Withdrawal by Subject|1
7964727|NCT01780545|12520373|FG000|Overall Study|Withdrawal by Subject|3
7929220|NCT02282293|12460472|FG000|Overall Study|Lost to Follow-up|2
7929221|NCT02282293|12460473|FG001|Overall Study|Lost to Follow-up|2
7929222|NCT02282293|12460472|FG000|Overall Study|Unable to comply with study procedures|1
7929223|NCT02282293|12460473|FG001|Overall Study|Unable to comply with study procedures|0
7929224|NCT02282293|12460472|FG000|Overall Study|Moved out of study area|0
7929225|NCT02282293|12460473|FG001|Overall Study|Moved out of study area|1
7929226|NCT02282527|12460485|FG000|Overall Study|Lost to Follow-up|0
7929227|NCT02282527|12460486|FG001|Overall Study|Lost to Follow-up|1
7929228|NCT02282527|12460485|FG000|Overall Study|Lack of home health aid|1
7929229|NCT02282527|12460486|FG001|Overall Study|Lack of home health aid|0
7929230|NCT02282605|12460498|FG000|Overall Study|negative SA result on Day -1|3
7929231|NCT02282605|12460499|FG001|Overall Study|negative SA result on Day -1|0
7929232|NCT02282605|12460500|FG002|Overall Study|negative SA result on Day -1|0
7929233|NCT02282631|12460510|FG000|Overall Study|Lost to Follow-up|2
7929234|NCT02282631|12460511|FG001|Overall Study|Lost to Follow-up|0
7929235|NCT02282813|12460535|FG000|Overall Study|Withdrawal by Subject|4
7929236|NCT02282813|12460536|FG001|Overall Study|Withdrawal by Subject|5
7929237|NCT02282813|12460537|FG002|Overall Study|Withdrawal by Subject|0
7929238|NCT02282813|12460535|FG000|Overall Study|Adverse Event|3
7929239|NCT02282813|12460536|FG001|Overall Study|Adverse Event|10
7929240|NCT02282813|12460537|FG002|Overall Study|Adverse Event|1
7929241|NCT02282813|12460535|FG000|Overall Study|Subject non-compliance|1
7929242|NCT02282813|12460536|FG001|Overall Study|Subject non-compliance|4
7929243|NCT02282813|12460537|FG002|Overall Study|Subject non-compliance|0
7929244|NCT02282813|12460535|FG000|Overall Study|Physician Decision|0
7929245|NCT02282813|12460536|FG001|Overall Study|Physician Decision|3
7929246|NCT02282813|12460537|FG002|Overall Study|Physician Decision|1
7929247|NCT02282813|12460535|FG000|Overall Study|Lost to Follow-up|2
7929248|NCT02282813|12460536|FG001|Overall Study|Lost to Follow-up|0
7929249|NCT02282813|12460537|FG002|Overall Study|Lost to Follow-up|1
7929250|NCT02282813|12460535|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1
7929251|NCT02282813|12460536|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0
7929252|NCT02282813|12460537|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0
7929253|NCT02282813|12460535|FG000|Overall Study|Lack of Efficacy|1
7929254|NCT02282813|12460536|FG001|Overall Study|Lack of Efficacy|0
7929255|NCT02282813|12460537|FG002|Overall Study|Lack of Efficacy|0
7929256|NCT02282813|12460535|FG000|Overall Study|Administrative reasons|0
7929257|NCT02282813|12460536|FG001|Overall Study|Administrative reasons|1
7929258|NCT02282813|12460537|FG002|Overall Study|Administrative reasons|0
7929259|NCT02282982|12460555|FG000|Overall Study|Lost to Follow-up|15
7929260|NCT02282982|12460555|FG000|Overall Study|Withdrew consent|2
7929261|NCT02282982|12460555|FG000|Overall Study|Death|4
7929262|NCT02282982|12460555|FG000|Overall Study|Lack of product|156
7929263|NCT02282982|12460555|FG000|Overall Study|Palivizumab is ended|11
7929264|NCT02282982|12460555|FG000|Overall Study|Other, not specified|18
7929265|NCT02283268|12460559|FG000|Overall Study|Withdrawal by Subject|1
7929266|NCT02283294|12460573|FG000|Overall Study|Lost to Follow-up|1
7929267|NCT02283294|12460574|FG001|Overall Study|Lost to Follow-up|1
7929268|NCT02283294|12460573|FG000|Overall Study|Withdrawal by Subject|1
7929269|NCT02283294|12460574|FG001|Overall Study|Withdrawal by Subject|6
7929270|NCT02283294|12460573|FG000|Overall Study|Protocol Violation|1
7929271|NCT02283294|12460574|FG001|Overall Study|Protocol Violation|0
7929272|NCT02283294|12460573|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0
7929273|NCT02283294|12460574|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1
7929274|NCT02283411|12460590|FG000|Overall Study|Withdrawal by Subject|3
7929275|NCT02283411|12460590|FG000|Overall Study|Screen Failed|28
7929276|NCT02283658|12460603|FG000|Overall Study|Withdrawal by Subject|1
7929277|NCT02283762|12460613|FG000|Main Treatment Phase (MT)|Adverse Event|9
7929278|NCT02283762|12460614|FG001|Main Treatment Phase (MT)|Adverse Event|9
7929279|NCT02283762|12460613|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1
7929280|NCT02283762|12460614|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0
7929281|NCT02283762|12460613|FG000|Main Treatment Phase (MT)|Physician Decision|1
7929282|NCT02283762|12460614|FG001|Main Treatment Phase (MT)|Physician Decision|1
7929283|NCT02283762|12460613|FG000|Main Treatment Phase (MT)|Pregnancy|0
7929284|NCT02283762|12460614|FG001|Main Treatment Phase (MT)|Pregnancy|1
7929285|NCT02283762|12460613|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7
7929286|NCT02283762|12460614|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4
7929287|NCT02283762|12460613|FG000|Long-term Extension Phase (LTE)|Adverse Event|2
7929288|NCT02283762|12460614|FG001|Long-term Extension Phase (LTE)|Adverse Event|6
7929289|NCT02283762|12460613|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1
7929290|NCT02283762|12460614|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1
7929291|NCT02283762|12460613|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1
7929292|NCT02283762|12460614|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0
7929293|NCT02283762|12460613|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4
7929294|NCT02283762|12460614|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3
7929295|NCT02283762|12460613|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1
7929296|NCT02283762|12460614|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1
7929297|NCT02283762|12460613|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0
7929298|NCT02283762|12460614|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1
7929299|NCT02283762|12460613|FG000|Long-term Extension Phase (LTE)|Physician Decision|1
7929300|NCT02283762|12460614|FG001|Long-term Extension Phase (LTE)|Physician Decision|2
7929301|NCT02283788|12460626|FG000|Overall Study|Adverse Event|1
7929302|NCT02283788|12460627|FG001|Overall Study|Adverse Event|3
7929303|NCT02283788|12460628|FG002|Overall Study|Adverse Event|5
7929304|NCT02283788|12460629|FG003|Overall Study|Adverse Event|1
7929305|NCT02283788|12460626|FG000|Overall Study|Withdrawal by Subject|0
7929306|NCT02283788|12460627|FG001|Overall Study|Withdrawal by Subject|1
7929307|NCT02283788|12460628|FG002|Overall Study|Withdrawal by Subject|0
7929308|NCT02283788|12460629|FG003|Overall Study|Withdrawal by Subject|1
7929309|NCT02284009|12460681|FG000|Overall Study|Adverse Event|3
7929310|NCT02284009|12460682|FG001|Overall Study|Adverse Event|0
7929311|NCT02284009|12460681|FG000|Overall Study|Lost to Follow-up|1
7929312|NCT02284009|12460682|FG001|Overall Study|Lost to Follow-up|3
7929313|NCT02284009|12460681|FG000|Overall Study|Physician Decision|0
7929314|NCT02284009|12460682|FG001|Overall Study|Physician Decision|2
7929315|NCT02284009|12460681|FG000|Overall Study|Withdrawal by Subject|2
7929316|NCT02284009|12460682|FG001|Overall Study|Withdrawal by Subject|5
7929317|NCT02284178|12460712|FG000|Overall Study|Met exclusion criteria|49
7929318|NCT02284178|12460713|FG001|Overall Study|Met exclusion criteria|54
7929319|NCT02284243|12460721|FG000|Overall Study|Lack of Efficacy|3
7929320|NCT02284243|12460722|FG001|Overall Study|Lack of Efficacy|3
7929321|NCT02284243|12460721|FG000|Overall Study|Adverse Event|1
7929322|NCT02284243|12460722|FG001|Overall Study|Adverse Event|0
7929323|NCT02284347|12460728|FG000|Overall Study|Lost to Follow-up|2
7929324|NCT02284347|12460728|FG000|Overall Study|Withdrawn prior to treatment|1
7929325|NCT02284893|12460818|FG000|26 Week (Short Term)|Adverse Event|1
7929326|NCT02284893|12460819|FG001|26 Week (Short Term)|Adverse Event|9
7929327|NCT02284893|12460818|FG000|26 Week (Short Term)|Discontinuation by the subject|2
7929328|NCT02284893|12460819|FG001|26 Week (Short Term)|Discontinuation by the subject|2
7929329|NCT02284893|12460818|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7
7929330|NCT02284893|12460819|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10
7929331|NCT02284893|12460818|FG000|26 Week (Short Term)|Lost to Follow-up|3
7929332|NCT02284893|12460819|FG001|26 Week (Short Term)|Lost to Follow-up|1
7929333|NCT02284893|12460818|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5
7929334|NCT02284893|12460819|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8
7929335|NCT02284893|12460818|FG000|26 Week (Short Term)|Other|1
7929336|NCT02284893|12460819|FG001|26 Week (Short Term)|Other|1
7929337|NCT02284893|12460818|FG000|52 Week (Long Term)|Adverse Event|3
7929338|NCT02284893|12460819|FG001|52 Week (Long Term)|Adverse Event|1
7929339|NCT02284893|12460818|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0
7929340|NCT02284893|12460819|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1
7929341|NCT02284893|12460818|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4
7929342|NCT02284893|12460819|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6
7929343|NCT02284893|12460818|FG000|52 Week (Long Term)|Lost to Follow-up|2
7929344|NCT02284893|12460819|FG001|52 Week (Long Term)|Lost to Follow-up|2
7929345|NCT02284893|12460818|FG000|52 Week (Long Term)|Non-Compliance|2
7929346|NCT02284893|12460819|FG001|52 Week (Long Term)|Non-Compliance|3
7929347|NCT02285010|12460827|FG000|Overall Study|not abdominal hysterectomy|2
7929348|NCT02285010|12460828|FG001|Overall Study|not abdominal hysterectomy|0
7929349|NCT02285010|12460827|FG000|Overall Study|Not spinal anesthesia|3
7929350|NCT02285010|12460828|FG001|Overall Study|Not spinal anesthesia|1
7929351|NCT02285153|12460846|FG000|Overall Study|Adverse Event|1
7929352|NCT02285153|12460847|FG001|Overall Study|Adverse Event|0
7929353|NCT02285361|12460862|FG000|Overall Study|Protocol Violation|43
7929354|NCT02285361|12460862|FG000|Overall Study|Lost to Follow-up|5
7929355|NCT02285361|12460862|FG000|Overall Study|Not taken GIOTRIF|2
7929356|NCT02285361|12460862|FG000|Overall Study|Consented prior to the contract date|1
7929357|NCT02285777|12460886|FG000|Overall Study|Withdrawal by Subject|1
7929358|NCT02285777|12460887|FG001|Overall Study|Withdrawal by Subject|1
7929359|NCT02285777|12460886|FG000|Overall Study|Lost to Follow-up|4
7929360|NCT02285777|12460887|FG001|Overall Study|Lost to Follow-up|2
7929361|NCT02285855|12460895|FG000|Overall Study|Withdrawal by Subject|2
7929362|NCT02285855|12460896|FG001|Overall Study|Withdrawal by Subject|1
7929363|NCT02285920|12460919|FG000|Overall Study|Kidney transplantation|2
7929364|NCT02285920|12460920|FG001|Overall Study|Kidney transplantation|2
7929365|NCT02285920|12460921|FG002|Overall Study|Kidney transplantation|2
7929366|NCT02285920|12460922|FG003|Overall Study|Kidney transplantation|0
7929367|NCT02285920|12460919|FG000|Overall Study|Change to peritoneal dialysis|0
7929368|NCT02285920|12460920|FG001|Overall Study|Change to peritoneal dialysis|0
7929369|NCT02285920|12460921|FG002|Overall Study|Change to peritoneal dialysis|1
7929370|NCT02285920|12460922|FG003|Overall Study|Change to peritoneal dialysis|0
7929371|NCT02285920|12460919|FG000|Overall Study|Transfer to non-participating unit|0
7929372|NCT02285920|12460920|FG001|Overall Study|Transfer to non-participating unit|1
7929373|NCT02285920|12460921|FG002|Overall Study|Transfer to non-participating unit|0
7929374|NCT02285920|12460922|FG003|Overall Study|Transfer to non-participating unit|0
7929375|NCT02285920|12460919|FG000|Overall Study|Dialysis discontinuation|0
7929376|NCT02285920|12460920|FG001|Overall Study|Dialysis discontinuation|1
7929377|NCT02285920|12460921|FG002|Overall Study|Dialysis discontinuation|0
7929378|NCT02285920|12460922|FG003|Overall Study|Dialysis discontinuation|0
7929379|NCT02285920|12460919|FG000|Overall Study|Death|2
7929380|NCT02285920|12460920|FG001|Overall Study|Death|0
7929381|NCT02285920|12460921|FG002|Overall Study|Death|2
7929382|NCT02285920|12460922|FG003|Overall Study|Death|1
7929383|NCT02285998|12460934|FG000|Overall Study|Adverse Event|9
7929384|NCT02285998|12460935|FG001|Overall Study|Adverse Event|8
7929385|NCT02285998|12460934|FG000|Overall Study|Physician Decision|1
7929386|NCT02285998|12460935|FG001|Overall Study|Physician Decision|2
7929387|NCT02285998|12460934|FG000|Overall Study|Lost to Follow-up|176
7929388|NCT02285998|12460935|FG001|Overall Study|Lost to Follow-up|172
7929389|NCT02285998|12460934|FG000|Overall Study|Withdrawal by Subject|53
7929390|NCT02285998|12460935|FG001|Overall Study|Withdrawal by Subject|61
7929391|NCT02285998|12460934|FG000|Overall Study|Other Reasons|7
7929392|NCT02285998|12460935|FG001|Overall Study|Other Reasons|10
7929393|NCT02286102|12460943|FG000|Overall Study|Screen Failure|1
7929394|NCT02286102|12460944|FG001|Overall Study|Screen Failure|1
7929395|NCT02286193|12460950|FG000|Overall Study|Referred: CRS unable to make contact|62
7929396|NCT02286193|12460950|FG000|Overall Study|Referred: unable to reach/resource sent|104
7929397|NCT02286193|12460950|FG000|Overall Study|Referred: Declined service|38
7929398|NCT02286466|12460957|FG000|Overall Study|Death|1
7929399|NCT02286466|12460958|FG001|Overall Study|Death|3
7929400|NCT02286466|12460957|FG000|Overall Study|Withdrawal by Subject|5
7929401|NCT02286466|12460958|FG001|Overall Study|Withdrawal by Subject|2
7929402|NCT02286466|12460957|FG000|Overall Study|Lost to Follow-up|1
7929403|NCT02286466|12460958|FG001|Overall Study|Lost to Follow-up|4
7929404|NCT02286466|12460957|FG000|Overall Study|Declined Clinician Assessment|0
7929405|NCT02286466|12460958|FG001|Overall Study|Declined Clinician Assessment|1
7929406|NCT02286713|12461039|FG000|One Week Follow-Up|Death|1
7929407|NCT02286713|12461040|FG001|One Week Follow-Up|Death|0
7929408|NCT02286713|12461039|FG000|One Week Follow-Up|Lost to Follow-up|17
7929409|NCT02286713|12461040|FG001|One Week Follow-Up|Lost to Follow-up|21
7929410|NCT02286713|12461039|FG000|One Week Follow-Up|Withdrawal by Subject|6
7929411|NCT02286713|12461040|FG001|One Week Follow-Up|Withdrawal by Subject|3
7929412|NCT02286713|12461039|FG000|Three Month Follow-Up|Death|1
7929413|NCT02286713|12461040|FG001|Three Month Follow-Up|Death|1
7929414|NCT02286713|12461039|FG000|Three Month Follow-Up|Lost to Follow-up|26
7929415|NCT02286713|12461040|FG001|Three Month Follow-Up|Lost to Follow-up|24
7929416|NCT02286713|12461039|FG000|Three Month Follow-Up|Withdrawal by Subject|1
7929417|NCT02286713|12461040|FG001|Three Month Follow-Up|Withdrawal by Subject|1
7929418|NCT02286713|12461039|FG000|Six Month Follow-Up|Death|2
7929419|NCT02286713|12461040|FG001|Six Month Follow-Up|Death|0
7929420|NCT02286713|12461039|FG000|Six Month Follow-Up|Lost to Follow-up|30
7929421|NCT02286713|12461040|FG001|Six Month Follow-Up|Lost to Follow-up|27
7929422|NCT02286843|12461059|FG000|Overall Study|Not Treated|4
7929423|NCT02286843|12461059|FG000|Overall Study|Protocol Violation|1
7929424|NCT02286843|12461059|FG000|Overall Study|Withdrawal by Subject|1
7929425|NCT02286895|12461065|FG000|Assessed for Measles Seroconversion|Protocol Violation|1
7929426|NCT02286895|12461066|FG001|Assessed for Measles Seroconversion|Protocol Violation|4
7929427|NCT02286895|12461065|FG000|Assessed for Measles Seroconversion|Missing measurement|6
7929428|NCT02286895|12461066|FG001|Assessed for Measles Seroconversion|Missing measurement|3
7929429|NCT02286895|12461065|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41
7929430|NCT02286895|12461066|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32
7929431|NCT02286947|12461081|FG000|Overall Study|Withdrawal by Subject|2
7929432|NCT02286960|12461089|FG000|Overall Study|Lost to Follow-up|3
7929433|NCT02286960|12461090|FG001|Overall Study|Lost to Follow-up|3
7929434|NCT02287038|12461098|FG000|Overall Study|Stopped attending appointments|3
7929435|NCT02287038|12461099|FG001|Overall Study|Stopped attending appointments|2
7929436|NCT02287038|12461098|FG000|Overall Study|Anxiety after starting medication|0
7929437|NCT02287038|12461099|FG001|Overall Study|Anxiety after starting medication|1
7929438|NCT02287038|12461098|FG000|Overall Study|Nausea after starting medication|1
7929439|NCT02287038|12461099|FG001|Overall Study|Nausea after starting medication|0
7929440|NCT02287038|12461098|FG000|Overall Study|Abnormal ECG after starting medication|1
7929441|NCT02287038|12461099|FG001|Overall Study|Abnormal ECG after starting medication|0
7929442|NCT02287402|12461115|FG000|Treatment Period|Adverse Event|17
7929443|NCT02287402|12461115|FG000|Treatment Period|Voluntary Withdrawal|10
7929444|NCT02287402|12461115|FG000|Follow-up|Lost to Follow-up|1
7929445|NCT02287402|12461115|FG000|Follow-up|Voluntary Withdrawal|2
7929446|NCT02287467|12461125|FG000|Overall Study|Protocol Violation|12
7929447|NCT02287467|12461126|FG001|Overall Study|Protocol Violation|9
7929448|NCT02287610|12461135|FG000|Overall Study|Lost to Follow-up|3
7929449|NCT02287610|12461135|FG000|Overall Study|Withdrawal by Subject|8
7929450|NCT02287610|12461135|FG000|Overall Study|Excluded-investigator non-responsiveness|5
7929451|NCT02287623|12461141|FG000|Overall Study|Protocol Violation|0
7929452|NCT02287623|12461142|FG001|Overall Study|Protocol Violation|1
7929453|NCT02287883|12461200|FG000|Overall Study|Death|8
7929454|NCT02287883|12461201|FG001|Overall Study|Death|7
7929455|NCT02287883|12461200|FG000|Overall Study|No longer eligible|222
7929456|NCT02287883|12461201|FG001|Overall Study|No longer eligible|182
7929457|NCT02287883|12461200|FG000|Overall Study|Non-response to survey|229
7929458|NCT02287883|12461201|FG001|Overall Study|Non-response to survey|237
7929459|NCT02287896|12461209|FG000|Second Injection Visit|Withdrawal by Subject|0
7929460|NCT02287896|12461210|FG001|Second Injection Visit|Withdrawal by Subject|1
7929461|NCT02287922|12461243|FG000|Overall Study|Adverse Event|1
7929462|NCT02287922|12461244|FG001|Overall Study|Adverse Event|1
7929463|NCT02287922|12461245|FG002|Overall Study|Adverse Event|3
7929464|NCT02287922|12461246|FG003|Overall Study|Adverse Event|4
7929465|NCT02287922|12461243|FG000|Overall Study|Withdrawal by Subject|1
7929466|NCT02287922|12461244|FG001|Overall Study|Withdrawal by Subject|1
7929467|NCT02287922|12461245|FG002|Overall Study|Withdrawal by Subject|1
7929468|NCT02287922|12461246|FG003|Overall Study|Withdrawal by Subject|2
7929469|NCT02287922|12461243|FG000|Overall Study|Lost to Follow-up|0
7929470|NCT02287922|12461244|FG001|Overall Study|Lost to Follow-up|0
7929471|NCT02287922|12461245|FG002|Overall Study|Lost to Follow-up|1
7929472|NCT02287922|12461246|FG003|Overall Study|Lost to Follow-up|0
7929473|NCT02287922|12461243|FG000|Overall Study|Sponsor's decision|0
7929474|NCT02287922|12461244|FG001|Overall Study|Sponsor's decision|0
7929475|NCT02287922|12461245|FG002|Overall Study|Sponsor's decision|0
7929476|NCT02287922|12461246|FG003|Overall Study|Sponsor's decision|1
7929477|NCT02287922|12461243|FG000|Overall Study|Other|1
7929478|NCT02287922|12461244|FG001|Overall Study|Other|0
7929479|NCT02287922|12461245|FG002|Overall Study|Other|2
7929480|NCT02287922|12461246|FG003|Overall Study|Other|0
7929481|NCT02288091|12461257|FG000|Overall Study|Lost to Follow-up|1
7929482|NCT02288091|12461257|FG000|Overall Study|Screen fail|7
7929483|NCT02288182|12461282|FG000|Overall Study|Adverse Event|0
7929484|NCT02288182|12461283|FG001|Overall Study|Adverse Event|1
7929485|NCT02288182|12461282|FG000|Overall Study|Lost to Follow-up|0
7929486|NCT02288182|12461283|FG001|Overall Study|Lost to Follow-up|1
7929487|NCT02288312|12461303|FG000|Overall Study|Pregnancy|1
7929488|NCT02288312|12461304|FG001|Overall Study|Pregnancy|0
7929489|NCT02288312|12461305|FG002|Overall Study|Pregnancy|0
7929490|NCT02288325|12461313|FG000|Run-in Period|Adverse Event|48
7929491|NCT02288325|12461314|FG001|Run-in Period|Adverse Event|0
7929492|NCT02288325|12461315|FG002|Run-in Period|Adverse Event|0
7929493|NCT02288325|12461313|FG000|Run-in Period|Lack of Efficacy|16
7929494|NCT02288325|12461314|FG001|Run-in Period|Lack of Efficacy|0
7929495|NCT02288325|12461315|FG002|Run-in Period|Lack of Efficacy|0
7929496|NCT02288325|12461313|FG000|Run-in Period|Withdrawal of Consent|28
7929497|NCT02288325|12461314|FG001|Run-in Period|Withdrawal of Consent|0
7929498|NCT02288325|12461315|FG002|Run-in Period|Withdrawal of Consent|0
7929499|NCT02288325|12461313|FG000|Run-in Period|Lost to Follow-up|25
7929500|NCT02288325|12461314|FG001|Run-in Period|Lost to Follow-up|0
7929501|NCT02288325|12461315|FG002|Run-in Period|Lost to Follow-up|0
7929502|NCT02288325|12461313|FG000|Run-in Period|Protocol Violation|17
7929503|NCT02288325|12461314|FG001|Run-in Period|Protocol Violation|0
7929504|NCT02288325|12461315|FG002|Run-in Period|Protocol Violation|0
7929505|NCT02288325|12461313|FG000|Run-in Period|Non-Compliance With Study Drug|3
7929506|NCT02288325|12461314|FG001|Run-in Period|Non-Compliance With Study Drug|0
7929507|NCT02288325|12461315|FG002|Run-in Period|Non-Compliance With Study Drug|0
7929508|NCT02288325|12461313|FG000|Run-in Period|Reason not Specified|8
7929509|NCT02288325|12461314|FG001|Run-in Period|Reason not Specified|0
7929510|NCT02288325|12461315|FG002|Run-in Period|Reason not Specified|0
7929511|NCT02288325|12461313|FG000|Stabilization Period|Adverse Event|13
7929512|NCT02288325|12461314|FG001|Stabilization Period|Adverse Event|0
7929513|NCT02288325|12461315|FG002|Stabilization Period|Adverse Event|0
7929514|NCT02288325|12461313|FG000|Stabilization Period|Lack of Efficacy|22
7929515|NCT02288325|12461314|FG001|Stabilization Period|Lack of Efficacy|0
7929516|NCT02288325|12461315|FG002|Stabilization Period|Lack of Efficacy|0
7929517|NCT02288325|12461313|FG000|Stabilization Period|Withdrawal of Consent|23
7929518|NCT02288325|12461314|FG001|Stabilization Period|Withdrawal of Consent|0
7929519|NCT02288325|12461315|FG002|Stabilization Period|Withdrawal of Consent|0
7929520|NCT02288325|12461313|FG000|Stabilization Period|Lost to Follow-up|12
7929521|NCT02288325|12461314|FG001|Stabilization Period|Lost to Follow-up|0
7929522|NCT02288325|12461315|FG002|Stabilization Period|Lost to Follow-up|0
7929523|NCT02288325|12461313|FG000|Stabilization Period|Protocol Violation|8
7929524|NCT02288325|12461314|FG001|Stabilization Period|Protocol Violation|0
7929525|NCT02288325|12461315|FG002|Stabilization Period|Protocol Violation|0
7929526|NCT02288325|12461313|FG000|Stabilization Period|Non-Compliance With Study Drug|5
7929527|NCT02288325|12461314|FG001|Stabilization Period|Non-Compliance With Study Drug|0
7929528|NCT02288325|12461315|FG002|Stabilization Period|Non-Compliance With Study Drug|0
7929529|NCT02288325|12461313|FG000|Stabilization Period|Reason not Specified|15
7929530|NCT02288325|12461314|FG001|Stabilization Period|Reason not Specified|0
7929531|NCT02288325|12461315|FG002|Stabilization Period|Reason not Specified|0
7929532|NCT02288325|12461313|FG000|Double-blind Treatment Period|Adverse Event|0
7929533|NCT02288325|12461314|FG001|Double-blind Treatment Period|Adverse Event|2
7929534|NCT02288325|12461315|FG002|Double-blind Treatment Period|Adverse Event|5
7929535|NCT02288325|12461313|FG000|Double-blind Treatment Period|Withdrawal of Consent|0
7929536|NCT02288325|12461314|FG001|Double-blind Treatment Period|Withdrawal of Consent|8
7929537|NCT02288325|12461315|FG002|Double-blind Treatment Period|Withdrawal of Consent|8
7929538|NCT02288325|12461313|FG000|Double-blind Treatment Period|Lost to Follow-up|0
7929539|NCT02288325|12461314|FG001|Double-blind Treatment Period|Lost to Follow-up|4
7929540|NCT02288325|12461315|FG002|Double-blind Treatment Period|Lost to Follow-up|5
7929541|NCT02288325|12461313|FG000|Double-blind Treatment Period|Protocol Violation|0
7929542|NCT02288325|12461314|FG001|Double-blind Treatment Period|Protocol Violation|1
7929543|NCT02288325|12461315|FG002|Double-blind Treatment Period|Protocol Violation|2
7929544|NCT02288325|12461313|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0
7929545|NCT02288325|12461314|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1
7929546|NCT02288325|12461315|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4
7929547|NCT02288325|12461313|FG000|Double-blind Treatment Period|Multiple Reasons|0
7929548|NCT02288325|12461314|FG001|Double-blind Treatment Period|Multiple Reasons|8
7929549|NCT02288325|12461315|FG002|Double-blind Treatment Period|Multiple Reasons|2
7929550|NCT02288559|12461344|FG000|Overall Study|Adverse Event|1
7929551|NCT02288559|12461345|FG001|Overall Study|Adverse Event|1
7929552|NCT02288559|12461346|FG002|Overall Study|Adverse Event|5
7929553|NCT02288559|12461347|FG003|Overall Study|Adverse Event|0
7929554|NCT02288559|12461344|FG000|Overall Study|Death|0
7929555|NCT02288559|12461345|FG001|Overall Study|Death|0
7929556|NCT02288559|12461346|FG002|Overall Study|Death|1
7929557|NCT02288559|12461347|FG003|Overall Study|Death|0
7929558|NCT02288559|12461344|FG000|Overall Study|Lost to Follow-up|0
7929559|NCT02288559|12461345|FG001|Overall Study|Lost to Follow-up|0
7929560|NCT02288559|12461346|FG002|Overall Study|Lost to Follow-up|0
7929561|NCT02288559|12461347|FG003|Overall Study|Lost to Follow-up|1
7929562|NCT02288559|12461344|FG000|Overall Study|Withdrawal by Subject|0
7929563|NCT02288559|12461345|FG001|Overall Study|Withdrawal by Subject|0
7929564|NCT02288559|12461346|FG002|Overall Study|Withdrawal by Subject|2
7929565|NCT02288559|12461347|FG003|Overall Study|Withdrawal by Subject|1
7929566|NCT02288559|12461344|FG000|Overall Study|Reason Not Specified|0
7929567|NCT02288559|12461345|FG001|Overall Study|Reason Not Specified|0
7929568|NCT02288559|12461346|FG002|Overall Study|Reason Not Specified|3
7929569|NCT02288559|12461347|FG003|Overall Study|Reason Not Specified|0
7929570|NCT02289079|12461365|FG000|Overall Study|Physician Decision|2
7929571|NCT02289079|12461366|FG001|Overall Study|Physician Decision|0
7929572|NCT02289079|12461365|FG000|Overall Study|Lost to Follow-up|0
7929573|NCT02289079|12461366|FG001|Overall Study|Lost to Follow-up|1
7929574|NCT02289352|12461397|FG000|Overall Study|Withdrawal by Subject|1
7929575|NCT02289352|12461398|FG001|Overall Study|Withdrawal by Subject|1
7929576|NCT02289352|12461399|FG002|Overall Study|Withdrawal by Subject|0
7929577|NCT02289417|12461411|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3
7929578|NCT02289417|12461412|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7929579|NCT02289417|12461413|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1
7929580|NCT02289417|12461414|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7929581|NCT02289417|12461415|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7929582|NCT02289417|12461416|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7929583|NCT02289417|12461417|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7929584|NCT02289417|12461418|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7929585|NCT02289417|12461419|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7929586|NCT02289417|12461411|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1
7929587|NCT02289417|12461412|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3
7929588|NCT02289417|12461413|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2
7929589|NCT02289417|12461414|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7929590|NCT02289417|12461415|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7929591|NCT02289417|12461416|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7929592|NCT02289417|12461417|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7929593|NCT02289417|12461418|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7929594|NCT02289417|12461419|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7929595|NCT02289417|12461411|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7929596|NCT02289417|12461412|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1
7929597|NCT02289417|12461413|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7929598|NCT02289417|12461414|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7929599|NCT02289417|12461415|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7929600|NCT02289417|12461416|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7929601|NCT02289417|12461417|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7929602|NCT02289417|12461418|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7929603|NCT02289417|12461419|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7719684|NCT00533897|12143618|FG003|Long Term Extension (LTE)|Lack of Efficacy|0
7719685|NCT00533897|12143619|FG004|Long Term Extension (LTE)|Lack of Efficacy|0
7719686|NCT00533897|12143620|FG005|Long Term Extension (LTE)|Lack of Efficacy|0
7719687|NCT00533897|12143621|FG006|Long Term Extension (LTE)|Lack of Efficacy|5
7719688|NCT00533897|12143622|FG007|Long Term Extension (LTE)|Lack of Efficacy|3
7719689|NCT00533897|12143615|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0
7719690|NCT00533897|12143616|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0
7719691|NCT00533897|12143617|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0
7719692|NCT00533897|12143618|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0
7719693|NCT00533897|12143619|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0
7719694|NCT00533897|12143620|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0
7719695|NCT00533897|12143621|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1
7719696|NCT00533897|12143622|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0
7719697|NCT00533897|12143615|FG000|Long Term Extension (LTE)|Adverse Event|0
7719698|NCT00533897|12143616|FG001|Long Term Extension (LTE)|Adverse Event|0
7719699|NCT00533897|12143617|FG002|Long Term Extension (LTE)|Adverse Event|0
7719700|NCT00533897|12143618|FG003|Long Term Extension (LTE)|Adverse Event|0
7719701|NCT00533897|12143619|FG004|Long Term Extension (LTE)|Adverse Event|0
7719702|NCT00533897|12143620|FG005|Long Term Extension (LTE)|Adverse Event|0
7719703|NCT00533897|12143621|FG006|Long Term Extension (LTE)|Adverse Event|2
7719704|NCT00533897|12143622|FG007|Long Term Extension (LTE)|Adverse Event|5
7929604|NCT02289417|12461411|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3
7929605|NCT02289417|12461412|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7929606|NCT02289417|12461413|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7929607|NCT02289417|12461414|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7929608|NCT02289417|12461415|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7929609|NCT02289417|12461416|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7929610|NCT02289417|12461417|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7929611|NCT02289417|12461418|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7929612|NCT02289417|12461419|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7929613|NCT02289417|12461411|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0
7929614|NCT02289417|12461412|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1
7929615|NCT02289417|12461413|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4
7929616|NCT02289417|12461414|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2
7929617|NCT02289417|12461415|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2
7929618|NCT02289417|12461416|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1
7929619|NCT02289417|12461417|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0
7929620|NCT02289417|12461418|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0
7929621|NCT02289417|12461419|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0
7929622|NCT02289417|12461411|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0
7929623|NCT02289417|12461412|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0
7929624|NCT02289417|12461413|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1
7929625|NCT02289417|12461414|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0
7929626|NCT02289417|12461415|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0
7929627|NCT02289417|12461416|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0
7929628|NCT02289417|12461417|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0
7929629|NCT02289417|12461418|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0
7929630|NCT02289417|12461419|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0
7929631|NCT02289417|12461411|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7929632|NCT02289417|12461412|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1
7929633|NCT02289417|12461413|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4
7929634|NCT02289417|12461414|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6
7929635|NCT02289417|12461415|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2
7929636|NCT02289417|12461416|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3
7929637|NCT02289417|12461417|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7929638|NCT02289417|12461418|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7929639|NCT02289417|12461419|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7929640|NCT02289417|12461411|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7929641|NCT02289417|12461412|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7929642|NCT02289417|12461413|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
7929643|NCT02289417|12461414|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7929644|NCT02289417|12461415|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
7929645|NCT02289417|12461416|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
7929646|NCT02289417|12461417|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7929647|NCT02289417|12461418|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7929648|NCT02289417|12461419|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7929649|NCT02289417|12461411|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7929650|NCT02289417|12461412|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7929651|NCT02289417|12461413|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7929652|NCT02289417|12461414|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7929653|NCT02289417|12461415|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7929654|NCT02289417|12461416|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7929655|NCT02289417|12461417|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1
7929656|NCT02289417|12461418|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7929657|NCT02289417|12461419|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7929658|NCT02289417|12461411|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7929659|NCT02289417|12461412|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7929660|NCT02289417|12461413|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7929661|NCT02289417|12461414|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1
7929662|NCT02289417|12461415|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7929663|NCT02289417|12461416|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7929664|NCT02289417|12461417|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1
7929665|NCT02289417|12461418|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7929666|NCT02289417|12461419|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7929667|NCT02289417|12461411|FG000|Extension Phase Weeks 52-104|Adverse Event|0
7929668|NCT02289417|12461412|FG001|Extension Phase Weeks 52-104|Adverse Event|0
7929669|NCT02289417|12461413|FG002|Extension Phase Weeks 52-104|Adverse Event|0
7929670|NCT02289417|12461414|FG003|Extension Phase Weeks 52-104|Adverse Event|0
7929671|NCT02289417|12461415|FG004|Extension Phase Weeks 52-104|Adverse Event|0
7929672|NCT02289417|12461416|FG005|Extension Phase Weeks 52-104|Adverse Event|0
7929673|NCT02289417|12461417|FG006|Extension Phase Weeks 52-104|Adverse Event|0
7929674|NCT02289417|12461418|FG007|Extension Phase Weeks 52-104|Adverse Event|2
7929675|NCT02289417|12461419|FG008|Extension Phase Weeks 52-104|Adverse Event|3
7929676|NCT02289417|12461411|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0
7929677|NCT02289417|12461412|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0
7929678|NCT02289417|12461413|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0
7929679|NCT02289417|12461414|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0
7929680|NCT02289417|12461415|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0
7929681|NCT02289417|12461416|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0
7929682|NCT02289417|12461417|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0
7929683|NCT02289417|12461418|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2
7929684|NCT02289417|12461419|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2
7929685|NCT02289417|12461411|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7929686|NCT02289417|12461412|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7929687|NCT02289417|12461413|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7929688|NCT02289417|12461414|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7929689|NCT02289417|12461415|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7929690|NCT02289417|12461416|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7929691|NCT02289417|12461417|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7929692|NCT02289417|12461418|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2
7929693|NCT02289417|12461419|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1
7929694|NCT02289417|12461411|FG000|Extension Phase Weeks 52-104|Miscellaneous|0
7929695|NCT02289417|12461412|FG001|Extension Phase Weeks 52-104|Miscellaneous|0
7929696|NCT02289417|12461413|FG002|Extension Phase Weeks 52-104|Miscellaneous|0
7929697|NCT02289417|12461414|FG003|Extension Phase Weeks 52-104|Miscellaneous|0
7929698|NCT02289417|12461415|FG004|Extension Phase Weeks 52-104|Miscellaneous|0
7929699|NCT02289417|12461416|FG005|Extension Phase Weeks 52-104|Miscellaneous|0
7929700|NCT02289417|12461417|FG006|Extension Phase Weeks 52-104|Miscellaneous|0
7929701|NCT02289417|12461418|FG007|Extension Phase Weeks 52-104|Miscellaneous|1
7929702|NCT02289417|12461419|FG008|Extension Phase Weeks 52-104|Miscellaneous|0
7929703|NCT02289456|12461435|FG000|Induction Period|Death|2
7929704|NCT02289456|12461435|FG000|Induction Period|Adverse Event|11
7929705|NCT02289456|12461435|FG000|Induction Period|Progressive Disease (PD)|4
7929706|NCT02289456|12461435|FG000|Induction Period|Symptomatic Deterioration|4
7929707|NCT02289456|12461435|FG000|Induction Period|Withdrawal by Subject|2
7929708|NCT02289456|12461435|FG000|Induction Period|Miscellaneous|1
7929709|NCT02289456|12461435|FG000|Monotherapy Period|Death|1
7929710|NCT02289456|12461435|FG000|Monotherapy Period|Adverse Event|1
7929711|NCT02289456|12461435|FG000|Monotherapy Period|Progressive Disease (PD)|8
7929712|NCT02289456|12461435|FG000|Monotherapy Period|Symptomatic Deterioration|1
7929713|NCT02289456|12461435|FG000|Monotherapy Period|Withdrawal by Subject|2
7929714|NCT02289456|12461435|FG000|Monotherapy Period|Study Terminated by Sponsor|2
7929715|NCT02289456|12461435|FG000|Monotherapy Period|Miscellaneous|1
7929716|NCT02289469|12461446|FG000|Overall Study|Unable to match a control|6
7929717|NCT02289469|12461447|FG001|Overall Study|Unable to match a control|0
7929718|NCT02289690|12461463|FG000|Overall Study|Adverse Event Related to Progression|0
7929719|NCT02289690|12461464|FG001|Overall Study|Adverse Event Related to Progression|1
7929720|NCT02289690|12461465|FG002|Overall Study|Adverse Event Related to Progression|1
7929721|NCT02289690|12461466|FG003|Overall Study|Adverse Event Related to Progression|0
7929722|NCT02289690|12461467|FG004|Overall Study|Adverse Event Related to Progression|1
7929723|NCT02289690|12461468|FG005|Overall Study|Adverse Event Related to Progression|0
7929724|NCT02289690|12461469|FG006|Overall Study|Adverse Event Related to Progression|1
7929725|NCT02289690|12461470|FG007|Overall Study|Adverse Event Related to Progression|0
7929726|NCT02289690|12461471|FG008|Overall Study|Adverse Event Related to Progression|0
7929727|NCT02289690|12461472|FG009|Overall Study|Adverse Event Related to Progression|0
7929728|NCT02289690|12461463|FG000|Overall Study|Withdrawal by Subject|1
7929729|NCT02289690|12461464|FG001|Overall Study|Withdrawal by Subject|0
7929730|NCT02289690|12461465|FG002|Overall Study|Withdrawal by Subject|0
7929731|NCT02289690|12461466|FG003|Overall Study|Withdrawal by Subject|0
7929732|NCT02289690|12461467|FG004|Overall Study|Withdrawal by Subject|1
7929733|NCT02289690|12461468|FG005|Overall Study|Withdrawal by Subject|1
7929734|NCT02289690|12461469|FG006|Overall Study|Withdrawal by Subject|0
7929735|NCT02289690|12461470|FG007|Overall Study|Withdrawal by Subject|0
7929736|NCT02289690|12461471|FG008|Overall Study|Withdrawal by Subject|4
7929737|NCT02289690|12461472|FG009|Overall Study|Withdrawal by Subject|2
7929738|NCT02289690|12461463|FG000|Overall Study|Progressive Disease, Per Protocol|3
7929739|NCT02289690|12461464|FG001|Overall Study|Progressive Disease, Per Protocol|2
7929740|NCT02289690|12461465|FG002|Overall Study|Progressive Disease, Per Protocol|3
7929741|NCT02289690|12461466|FG003|Overall Study|Progressive Disease, Per Protocol|2
7929742|NCT02289690|12461467|FG004|Overall Study|Progressive Disease, Per Protocol|5
7929743|NCT02289690|12461468|FG005|Overall Study|Progressive Disease, Per Protocol|13
7929744|NCT02289690|12461469|FG006|Overall Study|Progressive Disease, Per Protocol|2
7929745|NCT02289690|12461470|FG007|Overall Study|Progressive Disease, Per Protocol|0
7929746|NCT02289690|12461471|FG008|Overall Study|Progressive Disease, Per Protocol|0
7929747|NCT02289690|12461472|FG009|Overall Study|Progressive Disease, Per Protocol|0
7929748|NCT02289690|12461463|FG000|Overall Study|Lost to Follow-up|0
7929749|NCT02289690|12461464|FG001|Overall Study|Lost to Follow-up|0
7929750|NCT02289690|12461465|FG002|Overall Study|Lost to Follow-up|0
7929751|NCT02289690|12461466|FG003|Overall Study|Lost to Follow-up|0
7929752|NCT02289690|12461467|FG004|Overall Study|Lost to Follow-up|0
7929753|NCT02289690|12461468|FG005|Overall Study|Lost to Follow-up|0
7929754|NCT02289690|12461469|FG006|Overall Study|Lost to Follow-up|0
7929755|NCT02289690|12461470|FG007|Overall Study|Lost to Follow-up|1
7929756|NCT02289690|12461471|FG008|Overall Study|Lost to Follow-up|0
7929757|NCT02289690|12461472|FG009|Overall Study|Lost to Follow-up|2
7929758|NCT02289690|12461463|FG000|Overall Study|Death|0
7929759|NCT02289690|12461464|FG001|Overall Study|Death|0
7929760|NCT02289690|12461465|FG002|Overall Study|Death|0
7929761|NCT02289690|12461466|FG003|Overall Study|Death|0
7929762|NCT02289690|12461467|FG004|Overall Study|Death|0
7929763|NCT02289690|12461468|FG005|Overall Study|Death|0
7929764|NCT02289690|12461469|FG006|Overall Study|Death|0
7929765|NCT02289690|12461470|FG007|Overall Study|Death|49
7929766|NCT02289690|12461471|FG008|Overall Study|Death|45
7929767|NCT02289690|12461472|FG009|Overall Study|Death|41
7929768|NCT02289690|12461463|FG000|Overall Study|Sponsor Discontinued Study|0
7929769|NCT02289690|12461464|FG001|Overall Study|Sponsor Discontinued Study|0
7929770|NCT02289690|12461465|FG002|Overall Study|Sponsor Discontinued Study|0
7929771|NCT02289690|12461466|FG003|Overall Study|Sponsor Discontinued Study|0
7929772|NCT02289690|12461467|FG004|Overall Study|Sponsor Discontinued Study|0
7929773|NCT02289690|12461468|FG005|Overall Study|Sponsor Discontinued Study|0
7929774|NCT02289690|12461469|FG006|Overall Study|Sponsor Discontinued Study|0
7929775|NCT02289690|12461470|FG007|Overall Study|Sponsor Discontinued Study|9
7929776|NCT02289690|12461471|FG008|Overall Study|Sponsor Discontinued Study|7
7929777|NCT02289690|12461472|FG009|Overall Study|Sponsor Discontinued Study|15
7929778|NCT02289690|12461463|FG000|Overall Study|Other|0
7929779|NCT02289690|12461464|FG001|Overall Study|Other|0
7929780|NCT02289690|12461465|FG002|Overall Study|Other|0
7929781|NCT02289690|12461466|FG003|Overall Study|Other|1
7929782|NCT02289690|12461467|FG004|Overall Study|Other|1
7929783|NCT02289690|12461468|FG005|Overall Study|Other|0
7929784|NCT02289690|12461469|FG006|Overall Study|Other|1
7929785|NCT02289690|12461470|FG007|Overall Study|Other|2
7929786|NCT02289690|12461471|FG008|Overall Study|Other|3
7929787|NCT02289690|12461472|FG009|Overall Study|Other|1
7929788|NCT02289729|12461508|FG000|Overall Study|Lack of Efficacy|3
7929789|NCT02289729|12461508|FG000|Overall Study|Very Narrow Therapeutic Margin|1
7929790|NCT02289729|12461508|FG000|Overall Study|Withdrawal by Subject|1
7929791|NCT02289729|12461508|FG000|Overall Study|Death|1
7929792|NCT02289742|12461514|FG000|First Wear Period|Adverse event prior to treatment|0
7929793|NCT02289742|12461515|FG001|First Wear Period|Adverse event prior to treatment|1
7929794|NCT02289742|12461516|FG002|First Wear Period|Adverse event prior to treatment|0
7929795|NCT02289742|12461517|FG003|First Wear Period|Adverse event prior to treatment|0
7929796|NCT02289742|12461514|FG000|First Wear Period|Adverse Event|0
7929797|NCT02289742|12461515|FG001|First Wear Period|Adverse Event|0
7929798|NCT02289742|12461516|FG002|First Wear Period|Adverse Event|1
7929799|NCT02289742|12461517|FG003|First Wear Period|Adverse Event|0
7929800|NCT02289742|12461514|FG000|First Wear Period|Other prior to treatment|0
7929801|NCT02289742|12461515|FG001|First Wear Period|Other prior to treatment|0
7929802|NCT02289742|12461516|FG002|First Wear Period|Other prior to treatment|0
7929803|NCT02289742|12461517|FG003|First Wear Period|Other prior to treatment|1
7929804|NCT02289742|12461514|FG000|Third Wear Period|Adverse Event|0
7929805|NCT02289742|12461515|FG001|Third Wear Period|Adverse Event|1
7929806|NCT02289742|12461516|FG002|Third Wear Period|Adverse Event|0
7929807|NCT02289742|12461517|FG003|Third Wear Period|Adverse Event|0
7929808|NCT02289742|12461514|FG000|Third Wear Period|Reason not given|0
7929809|NCT02289742|12461515|FG001|Third Wear Period|Reason not given|0
7929810|NCT02289742|12461516|FG002|Third Wear Period|Reason not given|0
7929811|NCT02289742|12461517|FG003|Third Wear Period|Reason not given|1
7929812|NCT02289820|12461542|FG000|Overall Study|Withdrawal by Subject|2
7929813|NCT02289820|12461543|FG001|Overall Study|Withdrawal by Subject|1
7929814|NCT02289820|12461544|FG002|Overall Study|Withdrawal by Subject|2
7929815|NCT02289820|12461545|FG003|Overall Study|Withdrawal by Subject|1
7929816|NCT02289820|12461546|FG004|Overall Study|Withdrawal by Subject|0
7929817|NCT02289820|12461547|FG005|Overall Study|Withdrawal by Subject|0
7929818|NCT02289820|12461548|FG006|Overall Study|Withdrawal by Subject|1
7929819|NCT02289820|12461542|FG000|Overall Study|Death|0
7929820|NCT02289820|12461543|FG001|Overall Study|Death|0
7929821|NCT02289820|12461544|FG002|Overall Study|Death|1
7929822|NCT02289820|12461545|FG003|Overall Study|Death|0
7929823|NCT02289820|12461546|FG004|Overall Study|Death|0
7929824|NCT02289820|12461547|FG005|Overall Study|Death|0
7929825|NCT02289820|12461548|FG006|Overall Study|Death|0
7929826|NCT02289820|12461542|FG000|Overall Study|Lost to Follow-up|0
7929827|NCT02289820|12461543|FG001|Overall Study|Lost to Follow-up|0
7929828|NCT02289820|12461544|FG002|Overall Study|Lost to Follow-up|3
7929829|NCT02289820|12461545|FG003|Overall Study|Lost to Follow-up|1
7929830|NCT02289820|12461546|FG004|Overall Study|Lost to Follow-up|0
7929831|NCT02289820|12461547|FG005|Overall Study|Lost to Follow-up|1
7929832|NCT02289820|12461548|FG006|Overall Study|Lost to Follow-up|1
7929833|NCT02289820|12461542|FG000|Overall Study|withdrawal of consent|0
7929834|NCT02289820|12461543|FG001|Overall Study|withdrawal of consent|1
7929835|NCT02289820|12461544|FG002|Overall Study|withdrawal of consent|0
7929836|NCT02289820|12461545|FG003|Overall Study|withdrawal of consent|0
7929837|NCT02289820|12461546|FG004|Overall Study|withdrawal of consent|0
7929838|NCT02289820|12461547|FG005|Overall Study|withdrawal of consent|0
7929839|NCT02289820|12461548|FG006|Overall Study|withdrawal of consent|0
7929840|NCT02289833|12461570|FG000|Overall Study|Study discontinuation|0
7929841|NCT02289833|12461571|FG001|Overall Study|Study discontinuation|1
7929842|NCT02289833|12461570|FG000|Overall Study|Lost to Follow-up|4
7929843|NCT02289833|12461571|FG001|Overall Study|Lost to Follow-up|0
7929844|NCT02289833|12461570|FG000|Overall Study|Death|23
7929845|NCT02289833|12461571|FG001|Overall Study|Death|16
7929846|NCT02289898|12461582|FG000|Overall Study|Death|5
7929847|NCT02289898|12461583|FG001|Overall Study|Death|4
7929848|NCT02289898|12461584|FG002|Overall Study|Death|3
7929849|NCT02289898|12461582|FG000|Overall Study|Physician Decision|2
7929850|NCT02289898|12461583|FG001|Overall Study|Physician Decision|5
7929851|NCT02289898|12461584|FG002|Overall Study|Physician Decision|2
7929852|NCT02289898|12461582|FG000|Overall Study|Withdrawal by Subject|0
7929853|NCT02289898|12461583|FG001|Overall Study|Withdrawal by Subject|4
7929854|NCT02289898|12461584|FG002|Overall Study|Withdrawal by Subject|1
7929855|NCT02289898|12461582|FG000|Overall Study|Adverse Event|3
7929856|NCT02289898|12461583|FG001|Overall Study|Adverse Event|5
7929857|NCT02289898|12461584|FG002|Overall Study|Adverse Event|5
7929858|NCT02289898|12461582|FG000|Overall Study|Disease progression|34
7929859|NCT02289898|12461583|FG001|Overall Study|Disease progression|28
7929860|NCT02289898|12461584|FG002|Overall Study|Disease progression|34
7929861|NCT02289898|12461582|FG000|Overall Study|Use of another anticancer therapy|0
7929862|NCT02289898|12461583|FG001|Overall Study|Use of another anticancer therapy|0
7929863|NCT02289898|12461584|FG002|Overall Study|Use of another anticancer therapy|1
7929864|NCT02289898|12461582|FG000|Overall Study|Other|8
7929865|NCT02289898|12461583|FG001|Overall Study|Other|7
7929866|NCT02289898|12461584|FG002|Overall Study|Other|10
7964728|NCT01780545|12520374|FG001|Overall Study|Withdrawal by Subject|1
7964729|NCT01780545|12520373|FG000|Overall Study|Lost to Follow-up|1
7964730|NCT01780545|12520374|FG001|Overall Study|Lost to Follow-up|1
7964731|NCT01732107|12520383|FG000|Overall Study|Adverse Event|2
7964732|NCT01732107|12520383|FG000|Overall Study|Disease Progression|8
7964733|NCT01732107|12520383|FG000|Overall Study|Physician Decision|1
7964734|NCT01732107|12520383|FG000|Overall Study|Withdrawal by Subject|2
7964735|NCT01681433|12520389|FG000|Overall Study|Lack of Efficacy|23
7964736|NCT01681433|12520390|FG001|Overall Study|Lack of Efficacy|23
7964737|NCT01681433|12520389|FG000|Overall Study|Withdrawal by Subject|5
7964738|NCT01681433|12520390|FG001|Overall Study|Withdrawal by Subject|5
7964739|NCT01681433|12520389|FG000|Overall Study|Protocol Violation|2
7964740|NCT01681433|12520390|FG001|Overall Study|Protocol Violation|0
7964741|NCT01681433|12520389|FG000|Overall Study|Adverse Event|2
7964742|NCT01681433|12520390|FG001|Overall Study|Adverse Event|4
7964743|NCT01681433|12520389|FG000|Overall Study|Lost to Follow-up|0
7964744|NCT01681433|12520390|FG001|Overall Study|Lost to Follow-up|1
7964745|NCT01630434|12520398|FG000|Overall Study|Donor lungs turned down|1
7964746|NCT01630434|12520399|FG001|Overall Study|Donor lungs turned down|0
7964747|NCT01630434|12520398|FG000|Overall Study|Protocol Violation|9
7964748|NCT01630434|12520399|FG001|Overall Study|Protocol Violation|4
7964749|NCT01630434|12520398|FG000|Overall Study|Death|20
7964750|NCT01630434|12520399|FG001|Overall Study|Death|26
7967117|NCT02760433|12523632|FG004|Overall Study|Lack of Response At Week 14|1
7967118|NCT02760433|12523628|FG000|Overall Study|Subject refused to continue the study|1
7967119|NCT02760433|12523629|FG001|Overall Study|Subject refused to continue the study|0
7967120|NCT02760433|12523630|FG002|Overall Study|Subject refused to continue the study|0
7967121|NCT02760433|12523631|FG003|Overall Study|Subject refused to continue the study|0
7967122|NCT02760433|12523632|FG004|Overall Study|Subject refused to continue the study|0
7967123|NCT02760433|12523628|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2
7967124|NCT02760433|12523629|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7967125|NCT02760433|12523630|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7967126|NCT02760433|12523631|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7967127|NCT02760433|12523632|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7967128|NCT02760433|12523628|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7967129|NCT02760433|12523629|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1
7967130|NCT02760433|12523630|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7967131|NCT02760433|12523631|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7967132|NCT02760433|12523632|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7967133|NCT02760654|12523651|FG000|Overall Study|Lost to Follow-up|3
7967134|NCT02760654|12523652|FG001|Overall Study|Lost to Follow-up|3
7967135|NCT02760654|12523651|FG000|Overall Study|Withdrawal by Subject|4
7929867|NCT02289950|12461593|FG000|Overall Study|Progressive disease by RECIST 1.1|99
7929868|NCT02289950|12461594|FG001|Overall Study|Progressive disease by RECIST 1.1|52
7929869|NCT02289950|12461593|FG000|Overall Study|Progressive disease by Clinical Assessment|4
7929870|NCT02289950|12461594|FG001|Overall Study|Progressive disease by Clinical Assessment|4
7929871|NCT02289950|12461593|FG000|Overall Study|Lost to Follow-up|1
7929872|NCT02289950|12461594|FG001|Overall Study|Lost to Follow-up|0
7929873|NCT02289950|12461593|FG000|Overall Study|Physician Decision|9
7929874|NCT02289950|12461594|FG001|Overall Study|Physician Decision|3
7929875|NCT02289950|12461593|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9
7929876|NCT02289950|12461594|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2
7929877|NCT02289950|12461593|FG000|Overall Study|Withdrawal by Subject|1
7929878|NCT02289950|12461594|FG001|Overall Study|Withdrawal by Subject|3
7929879|NCT02289950|12461593|FG000|Overall Study|Test article held for greater than 28 days|0
7929880|NCT02289950|12461594|FG001|Overall Study|Test article held for greater than 28 days|1
7929881|NCT02289950|12461593|FG000|Overall Study|Adverse Event|11
7929882|NCT02289950|12461594|FG001|Overall Study|Adverse Event|3
7929883|NCT02289950|12461593|FG000|Overall Study|Death|1
7929884|NCT02289950|12461594|FG001|Overall Study|Death|1
7929885|NCT02289950|12461593|FG000|Overall Study|Other|5
7929886|NCT02289950|12461594|FG001|Overall Study|Other|2
7929887|NCT02289950|12461593|FG000|Overall Study|Not Treated|2
7929888|NCT02289950|12461594|FG001|Overall Study|Not Treated|1
7929889|NCT02289963|12461602|FG000|Overall Study|Adverse Event|1
7929890|NCT02289963|12461603|FG001|Overall Study|Adverse Event|2
7929891|NCT02289963|12461602|FG000|Overall Study|Poor compliance to protocol|1
7929892|NCT02289963|12461603|FG001|Overall Study|Poor compliance to protocol|0
7929893|NCT02289963|12461602|FG000|Overall Study|Withdrawal by Subject|1
7929894|NCT02289963|12461603|FG001|Overall Study|Withdrawal by Subject|0
7929895|NCT02289963|12461602|FG000|Overall Study|Last injection missed|2
7929896|NCT02289963|12461603|FG001|Overall Study|Last injection missed|2
7929897|NCT02289963|12461602|FG000|Overall Study|End treatment visit outside visit window|0
7929898|NCT02289963|12461603|FG001|Overall Study|End treatment visit outside visit window|4
7929899|NCT02289963|12461602|FG000|Overall Study|Other than specified above|0
7929900|NCT02289963|12461603|FG001|Overall Study|Other than specified above|2
7929901|NCT02290028|12461618|FG000|Overall Study|Death|217
7929902|NCT02290028|12461618|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186
7929903|NCT02290028|12461618|FG000|Overall Study|No longer under care of study physician|76
7929904|NCT02290028|12461618|FG000|Overall Study|Sentus lead or required CRT-D explanted|55
7929905|NCT02290028|12461618|FG000|Overall Study|Withdrawal by Subject|52
7929906|NCT02290028|12461618|FG000|Overall Study|Study site closure|44
7929907|NCT02290028|12461618|FG000|Overall Study|Lost to Follow-up|34
7929908|NCT02290028|12461618|FG000|Overall Study|Miscellaneous|10
7929909|NCT02290028|12461618|FG000|Overall Study|Transition to EP PASSION|1295
7929910|NCT02290028|12461618|FG000|Overall Study|Planned study completion at 12 months|257
7929911|NCT02290223|12461651|FG000|6 Months|Lost to Follow-up|9
7929912|NCT02290223|12461652|FG001|6 Months|Lost to Follow-up|6
7929913|NCT02290223|12461651|FG000|6 Months|Withdrawal by Subject|5
7929914|NCT02290223|12461652|FG001|6 Months|Withdrawal by Subject|0
7929915|NCT02290223|12461651|FG000|6 Months|deceased (not related to study)|2
7929916|NCT02290223|12461652|FG001|6 Months|deceased (not related to study)|0
7929917|NCT02290223|12461651|FG000|12 Months|Lost to Follow-up|16
7929918|NCT02290223|12461652|FG001|12 Months|Lost to Follow-up|10
7929919|NCT02290223|12461651|FG000|12 Months|Refusal|0
7929920|NCT02290223|12461652|FG001|12 Months|Refusal|1
7929921|NCT02290340|12461662|FG000|Overall Study|Lost to Follow-up|0
7929922|NCT02290340|12461663|FG001|Overall Study|Lost to Follow-up|0
7929923|NCT02290340|12461664|FG002|Overall Study|Lost to Follow-up|0
7929924|NCT02290340|12461665|FG003|Overall Study|Lost to Follow-up|1
7929925|NCT02290340|12461662|FG000|Overall Study|Withdrawal by Subject|1
7929926|NCT02290340|12461663|FG001|Overall Study|Withdrawal by Subject|0
7929927|NCT02290340|12461664|FG002|Overall Study|Withdrawal by Subject|0
7929928|NCT02290340|12461665|FG003|Overall Study|Withdrawal by Subject|0
7929929|NCT02290340|12461662|FG000|Overall Study|Other|1
7929930|NCT02290340|12461663|FG001|Overall Study|Other|0
7929931|NCT02290340|12461664|FG002|Overall Study|Other|0
7929932|NCT02290340|12461665|FG003|Overall Study|Other|1
7929933|NCT02290405|12461680|FG000|Overall Study|Withdrawal by Subject|1
7929934|NCT02290405|12461681|FG001|Overall Study|Withdrawal by Subject|0
7929935|NCT02290691|12461721|FG000|Overall Study|Noncompliance|0
7929936|NCT02290691|12461722|FG001|Overall Study|Noncompliance|1
7929937|NCT02290691|12461721|FG000|Overall Study|Withdrawal by Subject|1
7929938|NCT02290691|12461722|FG001|Overall Study|Withdrawal by Subject|1
7929939|NCT02290691|12461721|FG000|Overall Study|Lost to Follow-up|7
7929940|NCT02290691|12461722|FG001|Overall Study|Lost to Follow-up|7
7929941|NCT02290821|12461730|FG000|Overall Study|Withdrawal by Subject|1
7929942|NCT02290821|12461731|FG001|Overall Study|Withdrawal by Subject|1
7929943|NCT02290821|12461730|FG000|Overall Study|Unable or unwilling to cooperate with|2
7929944|NCT02290821|12461731|FG001|Overall Study|Unable or unwilling to cooperate with|0
7929945|NCT02290821|12461730|FG000|Overall Study|Lost to Follow-up|3
7929946|NCT02290821|12461731|FG001|Overall Study|Lost to Follow-up|2
7929947|NCT02290873|12461740|FG000|Overall Study|Withdrawal by Subject|0
7929948|NCT02290873|12461741|FG001|Overall Study|Withdrawal by Subject|1
7929949|NCT02290873|12461742|FG002|Overall Study|Withdrawal by Subject|1
7929950|NCT02290873|12461740|FG000|Overall Study|Nellcor device error|1
7929951|NCT02290873|12461741|FG001|Overall Study|Nellcor device error|0
7929952|NCT02290873|12461742|FG002|Overall Study|Nellcor device error|0
7929953|NCT02290873|12461740|FG000|Overall Study|Esophagogastroduodenoscopy was added|1
7929954|NCT02290873|12461741|FG001|Overall Study|Esophagogastroduodenoscopy was added|0
7929955|NCT02290873|12461742|FG002|Overall Study|Esophagogastroduodenoscopy was added|0
7929956|NCT02290873|12461740|FG000|Overall Study|Protocol Violation|0
7929957|NCT02290873|12461741|FG001|Overall Study|Protocol Violation|0
7929958|NCT02290873|12461742|FG002|Overall Study|Protocol Violation|1
7929959|NCT02290925|12461753|FG000|First Period of Three Months|Lost to Follow-up|2
7929960|NCT02290925|12461754|FG001|First Period of Three Months|Lost to Follow-up|1
7929961|NCT02290925|12461753|FG000|First Period of Three Months|Death|1
7929962|NCT02290925|12461754|FG001|First Period of Three Months|Death|0
7929963|NCT02290925|12461753|FG000|First Period of Three Months|Insulin Started|1
7929964|NCT02290925|12461754|FG001|First Period of Three Months|Insulin Started|1
7929965|NCT02290925|12461753|FG000|Second Period of 3 Months|Lost to Follow-up|1
7929966|NCT02290925|12461754|FG001|Second Period of 3 Months|Lost to Follow-up|3
7929967|NCT02290925|12461753|FG000|Second Period of 3 Months|insulin started|0
7929968|NCT02290925|12461754|FG001|Second Period of 3 Months|insulin started|1
7929969|NCT02291029|12461778|FG000|Overall Study|Withdrawal by Subject|0
7929970|NCT02291029|12461779|FG001|Overall Study|Withdrawal by Subject|0
7929971|NCT02291029|12461780|FG002|Overall Study|Withdrawal by Subject|1
7929972|NCT02291029|12461781|FG003|Overall Study|Withdrawal by Subject|0
7929973|NCT02291029|12461782|FG004|Overall Study|Withdrawal by Subject|0
7929974|NCT02291029|12461783|FG005|Overall Study|Withdrawal by Subject|0
7929975|NCT02291029|12461778|FG000|Overall Study|Adverse Event|0
7929976|NCT02291029|12461779|FG001|Overall Study|Adverse Event|1
7929977|NCT02291029|12461780|FG002|Overall Study|Adverse Event|0
7929978|NCT02291029|12461781|FG003|Overall Study|Adverse Event|0
7929979|NCT02291029|12461782|FG004|Overall Study|Adverse Event|0
7929980|NCT02291029|12461783|FG005|Overall Study|Adverse Event|0
7929981|NCT02291237|12461803|FG000|Overall Study|Study Terminated by Sponsor|72
7929982|NCT02291237|12461804|FG001|Overall Study|Study Terminated by Sponsor|67
7929983|NCT02291237|12461803|FG000|Overall Study|Adverse Event|1
7929984|NCT02291237|12461804|FG001|Overall Study|Adverse Event|3
7929985|NCT02291237|12461803|FG000|Overall Study|Investigator's Discretion|0
7929986|NCT02291237|12461804|FG001|Overall Study|Investigator's Discretion|3
7929987|NCT02291237|12461803|FG000|Overall Study|Withdrew Consent|11
7929988|NCT02291237|12461804|FG001|Overall Study|Withdrew Consent|11
7929989|NCT02291237|12461803|FG000|Overall Study|Lost to Follow-up|0
7929990|NCT02291237|12461804|FG001|Overall Study|Lost to Follow-up|2
7929991|NCT02291237|12461803|FG000|Overall Study|Subject Required Prohibited Medication|2
7929992|NCT02291237|12461804|FG001|Overall Study|Subject Required Prohibited Medication|0
7929993|NCT02291289|12461814|FG000|Induction Treatment|Not Dosed|2
7929994|NCT02291289|12461815|FG001|Induction Treatment|Not Dosed|0
7929995|NCT02291289|12461816|FG002|Induction Treatment|Not Dosed|0
7929996|NCT02291289|12461817|FG003|Induction Treatment|Not Dosed|9
7929997|NCT02291289|12461818|FG004|Induction Treatment|Not Dosed|0
7929998|NCT02291289|12461819|FG005|Induction Treatment|Not Dosed|0
7929999|NCT02291289|12461820|FG006|Induction Treatment|Not Dosed|0
7930000|NCT02291289|12461821|FG007|Induction Treatment|Not Dosed|0
7930001|NCT02291289|12461822|FG008|Induction Treatment|Not Dosed|0
7930002|NCT02291289|12461823|FG009|Induction Treatment|Not Dosed|1
7930003|NCT02291289|12461824|FG010|Induction Treatment|Not Dosed|0
7930004|NCT02291289|12461825|FG011|Induction Treatment|Not Dosed|0
7930005|NCT02291289|12461814|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
7930006|NCT02291289|12461815|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0
7930007|NCT02291289|12461816|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0
7930008|NCT02291289|12461817|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0
7930009|NCT02291289|12461818|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13
7930010|NCT02291289|12461819|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11
7930011|NCT02291289|12461820|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0
7930012|NCT02291289|12461821|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0
7930013|NCT02291289|12461822|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0
7930014|NCT02291289|12461823|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0
7930015|NCT02291289|12461824|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2
7930016|NCT02291289|12461825|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3
7930017|NCT02291289|12461814|FG000|Maintenance Treatment Phase|Protocol Violation|0
7930018|NCT02291289|12461815|FG001|Maintenance Treatment Phase|Protocol Violation|1
7930019|NCT02291289|12461816|FG002|Maintenance Treatment Phase|Protocol Violation|0
7930020|NCT02291289|12461817|FG003|Maintenance Treatment Phase|Protocol Violation|0
7930021|NCT02291289|12461818|FG004|Maintenance Treatment Phase|Protocol Violation|2
7930022|NCT02291289|12461819|FG005|Maintenance Treatment Phase|Protocol Violation|1
7930023|NCT02291289|12461820|FG006|Maintenance Treatment Phase|Protocol Violation|0
7930024|NCT02291289|12461821|FG007|Maintenance Treatment Phase|Protocol Violation|0
7930025|NCT02291289|12461822|FG008|Maintenance Treatment Phase|Protocol Violation|0
7930026|NCT02291289|12461823|FG009|Maintenance Treatment Phase|Protocol Violation|0
7930027|NCT02291289|12461824|FG010|Maintenance Treatment Phase|Protocol Violation|0
7930028|NCT02291289|12461825|FG011|Maintenance Treatment Phase|Protocol Violation|0
7930029|NCT02291289|12461814|FG000|Maintenance Treatment Phase|Death|0
7930030|NCT02291289|12461815|FG001|Maintenance Treatment Phase|Death|23
7822092|NCT01259726|12291065|FG000|Overall Study|Death|1
7822093|NCT01259726|12291066|FG001|Overall Study|Death|0
7822094|NCT01259726|12291067|FG002|Overall Study|Death|0
7822095|NCT01259726|12291068|FG003|Overall Study|Death|0
7822096|NCT01259726|12291065|FG000|Overall Study|Physician Decision|2
7930031|NCT02291289|12461816|FG002|Maintenance Treatment Phase|Death|13
7930032|NCT02291289|12461817|FG003|Maintenance Treatment Phase|Death|0
7930033|NCT02291289|12461818|FG004|Maintenance Treatment Phase|Death|185
7930034|NCT02291289|12461819|FG005|Maintenance Treatment Phase|Death|100
7930035|NCT02291289|12461820|FG006|Maintenance Treatment Phase|Death|0
7930036|NCT02291289|12461821|FG007|Maintenance Treatment Phase|Death|1
7930037|NCT02291289|12461822|FG008|Maintenance Treatment Phase|Death|1
7930038|NCT02291289|12461823|FG009|Maintenance Treatment Phase|Death|0
7930039|NCT02291289|12461824|FG010|Maintenance Treatment Phase|Death|26
7930040|NCT02291289|12461825|FG011|Maintenance Treatment Phase|Death|11
7930041|NCT02291289|12461814|FG000|Maintenance Treatment Phase|Adverse Event|0
7930042|NCT02291289|12461815|FG001|Maintenance Treatment Phase|Adverse Event|0
7930043|NCT02291289|12461816|FG002|Maintenance Treatment Phase|Adverse Event|0
7930044|NCT02291289|12461817|FG003|Maintenance Treatment Phase|Adverse Event|0
7930045|NCT02291289|12461818|FG004|Maintenance Treatment Phase|Adverse Event|1
7930046|NCT02291289|12461819|FG005|Maintenance Treatment Phase|Adverse Event|0
7930047|NCT02291289|12461820|FG006|Maintenance Treatment Phase|Adverse Event|0
7930048|NCT02291289|12461821|FG007|Maintenance Treatment Phase|Adverse Event|0
7930049|NCT02291289|12461822|FG008|Maintenance Treatment Phase|Adverse Event|0
7930050|NCT02291289|12461823|FG009|Maintenance Treatment Phase|Adverse Event|0
7930051|NCT02291289|12461824|FG010|Maintenance Treatment Phase|Adverse Event|0
7930052|NCT02291289|12461825|FG011|Maintenance Treatment Phase|Adverse Event|0
7930053|NCT02291289|12461814|FG000|Maintenance Treatment Phase|Lost to Follow-up|0
7930054|NCT02291289|12461815|FG001|Maintenance Treatment Phase|Lost to Follow-up|0
7930055|NCT02291289|12461816|FG002|Maintenance Treatment Phase|Lost to Follow-up|0
7930056|NCT02291289|12461817|FG003|Maintenance Treatment Phase|Lost to Follow-up|0
7930057|NCT02291289|12461818|FG004|Maintenance Treatment Phase|Lost to Follow-up|12
7930058|NCT02291289|12461819|FG005|Maintenance Treatment Phase|Lost to Follow-up|3
7930059|NCT02291289|12461820|FG006|Maintenance Treatment Phase|Lost to Follow-up|0
7930060|NCT02291289|12461821|FG007|Maintenance Treatment Phase|Lost to Follow-up|1
7930061|NCT02291289|12461822|FG008|Maintenance Treatment Phase|Lost to Follow-up|0
7930062|NCT02291289|12461823|FG009|Maintenance Treatment Phase|Lost to Follow-up|0
7930063|NCT02291289|12461824|FG010|Maintenance Treatment Phase|Lost to Follow-up|2
7930064|NCT02291289|12461825|FG011|Maintenance Treatment Phase|Lost to Follow-up|1
7930065|NCT02291289|12461814|FG000|Maintenance Treatment Phase|Other|0
7930066|NCT02291289|12461815|FG001|Maintenance Treatment Phase|Other|0
7930067|NCT02291289|12461816|FG002|Maintenance Treatment Phase|Other|1
7930068|NCT02291289|12461817|FG003|Maintenance Treatment Phase|Other|0
7930069|NCT02291289|12461818|FG004|Maintenance Treatment Phase|Other|29
7930070|NCT02291289|12461819|FG005|Maintenance Treatment Phase|Other|8
7930071|NCT02291289|12461820|FG006|Maintenance Treatment Phase|Other|0
7930072|NCT02291289|12461821|FG007|Maintenance Treatment Phase|Other|0
7930073|NCT02291289|12461822|FG008|Maintenance Treatment Phase|Other|1
7930074|NCT02291289|12461823|FG009|Maintenance Treatment Phase|Other|0
7930075|NCT02291289|12461824|FG010|Maintenance Treatment Phase|Other|0
7930076|NCT02291289|12461825|FG011|Maintenance Treatment Phase|Other|0
7930077|NCT02291289|12461814|FG000|Maintenance Treatment Phase|Physician Decision|0
7930078|NCT02291289|12461815|FG001|Maintenance Treatment Phase|Physician Decision|0
7930079|NCT02291289|12461816|FG002|Maintenance Treatment Phase|Physician Decision|0
7930080|NCT02291289|12461817|FG003|Maintenance Treatment Phase|Physician Decision|0
7930081|NCT02291289|12461818|FG004|Maintenance Treatment Phase|Physician Decision|2
7930082|NCT02291289|12461819|FG005|Maintenance Treatment Phase|Physician Decision|0
7930083|NCT02291289|12461820|FG006|Maintenance Treatment Phase|Physician Decision|0
7930084|NCT02291289|12461821|FG007|Maintenance Treatment Phase|Physician Decision|0
7930085|NCT02291289|12461822|FG008|Maintenance Treatment Phase|Physician Decision|0
7930086|NCT02291289|12461823|FG009|Maintenance Treatment Phase|Physician Decision|0
7930087|NCT02291289|12461824|FG010|Maintenance Treatment Phase|Physician Decision|0
7930088|NCT02291289|12461825|FG011|Maintenance Treatment Phase|Physician Decision|1
7930089|NCT02291289|12461814|FG000|Maintenance Treatment Phase|Multiple Reasons|0
7930090|NCT02291289|12461815|FG001|Maintenance Treatment Phase|Multiple Reasons|0
7930091|NCT02291289|12461816|FG002|Maintenance Treatment Phase|Multiple Reasons|0
7930092|NCT02291289|12461817|FG003|Maintenance Treatment Phase|Multiple Reasons|0
7930093|NCT02291289|12461818|FG004|Maintenance Treatment Phase|Multiple Reasons|4
7930094|NCT02291289|12461819|FG005|Maintenance Treatment Phase|Multiple Reasons|1
7930095|NCT02291289|12461820|FG006|Maintenance Treatment Phase|Multiple Reasons|0
7930096|NCT02291289|12461821|FG007|Maintenance Treatment Phase|Multiple Reasons|0
7930097|NCT02291289|12461822|FG008|Maintenance Treatment Phase|Multiple Reasons|0
7930098|NCT02291289|12461823|FG009|Maintenance Treatment Phase|Multiple Reasons|0
7930099|NCT02291289|12461824|FG010|Maintenance Treatment Phase|Multiple Reasons|0
7930100|NCT02291289|12461825|FG011|Maintenance Treatment Phase|Multiple Reasons|0
7930101|NCT02291289|12461814|FG000|Maintenance Treatment Phase|No Treatment Received|0
7930102|NCT02291289|12461815|FG001|Maintenance Treatment Phase|No Treatment Received|0
7930103|NCT02291289|12461816|FG002|Maintenance Treatment Phase|No Treatment Received|2
7930104|NCT02291289|12461817|FG003|Maintenance Treatment Phase|No Treatment Received|0
7930105|NCT02291289|12461818|FG004|Maintenance Treatment Phase|No Treatment Received|4
7930106|NCT02291289|12461819|FG005|Maintenance Treatment Phase|No Treatment Received|5
7930107|NCT02291289|12461820|FG006|Maintenance Treatment Phase|No Treatment Received|0
7930108|NCT02291289|12461821|FG007|Maintenance Treatment Phase|No Treatment Received|0
7930109|NCT02291289|12461822|FG008|Maintenance Treatment Phase|No Treatment Received|0
7930110|NCT02291289|12461823|FG009|Maintenance Treatment Phase|No Treatment Received|0
7930111|NCT02291289|12461824|FG010|Maintenance Treatment Phase|No Treatment Received|1
7930112|NCT02291289|12461825|FG011|Maintenance Treatment Phase|No Treatment Received|0
7930113|NCT02291419|12461869|FG000|Overall Study|Early study termination|1
7930114|NCT02291419|12461870|FG001|Overall Study|Early study termination|5
7930115|NCT02291432|12461876|FG000|Overall Study|Withdrawal by Subject|2
7930116|NCT02291510|12461884|FG000|Overall Study|Adverse Event|0
7930117|NCT02291510|12461885|FG001|Overall Study|Adverse Event|0
7930118|NCT02291510|12461886|FG002|Overall Study|Adverse Event|0
7930119|NCT02291510|12461887|FG003|Overall Study|Adverse Event|1
7930120|NCT02291549|12461899|FG000|Overall Study|Lost to Follow-up|1
7930121|NCT02291549|12461900|FG001|Overall Study|Lost to Follow-up|0
7930122|NCT02291549|12461899|FG000|Overall Study|Withdrawal by Subject|0
7930123|NCT02291549|12461900|FG001|Overall Study|Withdrawal by Subject|1
7930124|NCT02291601|12461908|FG000|Abdomen|Did not qualify|333
7930125|NCT02291601|12461909|FG001|Abdomen|Did not qualify|54
7930126|NCT02291601|12461910|FG002|Abdomen|Did not qualify|339
7930127|NCT02291601|12461908|FG000|Groin|Did not qualify|183
7930128|NCT02291601|12461909|FG001|Groin|Did not qualify|30
7930129|NCT02291601|12461910|FG002|Groin|Did not qualify|177
7930130|NCT02291614|12461932|FG000|Overall Study|Lost to Follow-up|0
7930131|NCT02291614|12461933|FG001|Overall Study|Lost to Follow-up|0
7930132|NCT02291614|12461934|FG002|Overall Study|Lost to Follow-up|0
7930133|NCT02291614|12461935|FG003|Overall Study|Lost to Follow-up|0
7930134|NCT02291614|12461936|FG004|Overall Study|Lost to Follow-up|0
7930135|NCT02291614|12461937|FG005|Overall Study|Lost to Follow-up|0
7930136|NCT02291614|12461938|FG006|Overall Study|Lost to Follow-up|0
7930137|NCT02291614|12461939|FG007|Overall Study|Lost to Follow-up|1
7930138|NCT02291614|12461940|FG008|Overall Study|Lost to Follow-up|0
7930139|NCT02291614|12461941|FG009|Overall Study|Lost to Follow-up|0
7930140|NCT02291614|12461942|FG010|Overall Study|Lost to Follow-up|0
7930141|NCT02291614|12461932|FG000|Overall Study|Withdrawal by Subject|0
7930142|NCT02291614|12461933|FG001|Overall Study|Withdrawal by Subject|1
7930143|NCT02291614|12461934|FG002|Overall Study|Withdrawal by Subject|0
7930144|NCT02291614|12461935|FG003|Overall Study|Withdrawal by Subject|0
7930145|NCT02291614|12461936|FG004|Overall Study|Withdrawal by Subject|0
7930146|NCT02291614|12461937|FG005|Overall Study|Withdrawal by Subject|0
7930147|NCT02291614|12461938|FG006|Overall Study|Withdrawal by Subject|0
7930148|NCT02291614|12461939|FG007|Overall Study|Withdrawal by Subject|0
7930149|NCT02291614|12461940|FG008|Overall Study|Withdrawal by Subject|0
7930150|NCT02291614|12461941|FG009|Overall Study|Withdrawal by Subject|2
7930151|NCT02291614|12461942|FG010|Overall Study|Withdrawal by Subject|2
7930152|NCT02291614|12461932|FG000|Overall Study|Decision by sponsor|0
7930153|NCT02291614|12461933|FG001|Overall Study|Decision by sponsor|0
7930154|NCT02291614|12461934|FG002|Overall Study|Decision by sponsor|0
7930155|NCT02291614|12461935|FG003|Overall Study|Decision by sponsor|1
7930156|NCT02291614|12461936|FG004|Overall Study|Decision by sponsor|0
7930157|NCT02291614|12461937|FG005|Overall Study|Decision by sponsor|0
7930158|NCT02291614|12461938|FG006|Overall Study|Decision by sponsor|0
7930159|NCT02291614|12461939|FG007|Overall Study|Decision by sponsor|0
7930160|NCT02291614|12461940|FG008|Overall Study|Decision by sponsor|0
7930161|NCT02291614|12461941|FG009|Overall Study|Decision by sponsor|0
7930162|NCT02291614|12461942|FG010|Overall Study|Decision by sponsor|0
7930163|NCT02291614|12461932|FG000|Overall Study|Death|0
7930164|NCT02291614|12461933|FG001|Overall Study|Death|0
7930165|NCT02291614|12461934|FG002|Overall Study|Death|1
7930166|NCT02291614|12461935|FG003|Overall Study|Death|0
7930167|NCT02291614|12461936|FG004|Overall Study|Death|1
7930168|NCT02291614|12461937|FG005|Overall Study|Death|1
7930169|NCT02291614|12461938|FG006|Overall Study|Death|1
7930170|NCT02291614|12461939|FG007|Overall Study|Death|0
7930171|NCT02291614|12461940|FG008|Overall Study|Death|0
7930172|NCT02291614|12461941|FG009|Overall Study|Death|0
7930173|NCT02291614|12461942|FG010|Overall Study|Death|0
7930174|NCT02291679|12461975|FG000|Overall Study|Adverse Event|2
7930175|NCT02291679|12461976|FG001|Overall Study|Adverse Event|12
7930176|NCT02291679|12461977|FG002|Overall Study|Adverse Event|19
7930177|NCT02291679|12461975|FG000|Overall Study|Protocol Violation|5
7930178|NCT02291679|12461976|FG001|Overall Study|Protocol Violation|1
7930179|NCT02291679|12461977|FG002|Overall Study|Protocol Violation|7
7930180|NCT02291679|12461975|FG000|Overall Study|Withdrew Consent|18
7930181|NCT02291679|12461976|FG001|Overall Study|Withdrew Consent|10
7930182|NCT02291679|12461977|FG002|Overall Study|Withdrew Consent|15
7930183|NCT02291679|12461975|FG000|Overall Study|Lost to Follow-up|12
7930184|NCT02291679|12461976|FG001|Overall Study|Lost to Follow-up|10
7930185|NCT02291679|12461977|FG002|Overall Study|Lost to Follow-up|9
7930186|NCT02291679|12461975|FG000|Overall Study|Insufficient Therapeutic Response|5
7930187|NCT02291679|12461976|FG001|Overall Study|Insufficient Therapeutic Response|5
7930188|NCT02291679|12461977|FG002|Overall Study|Insufficient Therapeutic Response|7
7930189|NCT02291679|12461975|FG000|Overall Study|Other|2
7930190|NCT02291679|12461976|FG001|Overall Study|Other|4
7930191|NCT02291679|12461977|FG002|Overall Study|Other|2
7930192|NCT02291861|12462001|FG000|Overall Study|Adverse Event|2
7930193|NCT02291861|12462002|FG001|Overall Study|Adverse Event|4
7930194|NCT02291861|12462003|FG002|Overall Study|Adverse Event|1
7930195|NCT02291861|12462004|FG003|Overall Study|Adverse Event|2
7930196|NCT02291861|12462001|FG000|Overall Study|Death|0
7930197|NCT02291861|12462002|FG001|Overall Study|Death|0
7930198|NCT02291861|12462003|FG002|Overall Study|Death|1
7930199|NCT02291861|12462004|FG003|Overall Study|Death|1
7930200|NCT02291861|12462001|FG000|Overall Study|Protocol Violation|1
7930201|NCT02291861|12462002|FG001|Overall Study|Protocol Violation|0
7930202|NCT02291861|12462003|FG002|Overall Study|Protocol Violation|0
7930203|NCT02291861|12462004|FG003|Overall Study|Protocol Violation|1
7930204|NCT02291861|12462001|FG000|Overall Study|Withdrawal by Subject|1
7930205|NCT02291861|12462002|FG001|Overall Study|Withdrawal by Subject|2
7930206|NCT02291861|12462003|FG002|Overall Study|Withdrawal by Subject|1
7930207|NCT02291861|12462004|FG003|Overall Study|Withdrawal by Subject|4
7930208|NCT02291861|12462001|FG000|Overall Study|Noncompliance|1
7930209|NCT02291861|12462002|FG001|Overall Study|Noncompliance|1
7930210|NCT02291861|12462003|FG002|Overall Study|Noncompliance|2
7930211|NCT02291861|12462004|FG003|Overall Study|Noncompliance|1
7930212|NCT02291861|12462001|FG000|Overall Study|Lost to Follow-up|2
7930213|NCT02291861|12462002|FG001|Overall Study|Lost to Follow-up|1
7930214|NCT02291861|12462003|FG002|Overall Study|Lost to Follow-up|4
7930215|NCT02291861|12462004|FG003|Overall Study|Lost to Follow-up|0
7930216|NCT02291861|12462001|FG000|Overall Study|Other|0
7930217|NCT02291861|12462002|FG001|Overall Study|Other|0
7930218|NCT02291861|12462003|FG002|Overall Study|Other|0
7930219|NCT02291861|12462004|FG003|Overall Study|Other|1
7930220|NCT02291913|12462014|FG000|Overall Study|Progressive Disease|32
7930221|NCT02291913|12462014|FG000|Overall Study|Adverse Event|11
7930222|NCT02291913|12462014|FG000|Overall Study|Death|2
7930223|NCT02291913|12462014|FG000|Overall Study|Physician Decision|1
7930224|NCT02291913|12462014|FG000|Overall Study|Withdrawal by Subject|1
7930225|NCT02291913|12462014|FG000|Overall Study|Protocol Violation|1
7930226|NCT02292212|12462031|FG000|ViE Phase|Withdrawal by Subject|1
7930227|NCT02292212|12462031|FG000|ViE Phase|Protocol Violation|2
7930228|NCT02292446|12462055|FG000|Overall Study|Adverse Event|12
7930229|NCT02292446|12462055|FG000|Overall Study|Death|1
7930230|NCT02292446|12462055|FG000|Overall Study|Disease progression|2
7930231|NCT02292446|12462055|FG000|Overall Study|Subject/guardian decision|2
7930232|NCT02292446|12462055|FG000|Overall Study|Withdrawal by Subject|3
7930233|NCT02292719|12462077|FG000|Overall Study|Withdrawal by Subject|0
7930234|NCT02292719|12462078|FG001|Overall Study|Withdrawal by Subject|0
7930235|NCT02292719|12462079|FG002|Overall Study|Withdrawal by Subject|0
7930236|NCT02292719|12462080|FG003|Overall Study|Withdrawal by Subject|1
7930237|NCT02292719|12462081|FG004|Overall Study|Withdrawal by Subject|1
7930238|NCT02292719|12462082|FG005|Overall Study|Withdrawal by Subject|0
7930239|NCT02292719|12462077|FG000|Overall Study|Subject enrolled in new study.|0
7930240|NCT02292719|12462078|FG001|Overall Study|Subject enrolled in new study.|0
7930241|NCT02292719|12462079|FG002|Overall Study|Subject enrolled in new study.|1
7930242|NCT02292719|12462080|FG003|Overall Study|Subject enrolled in new study.|0
7930243|NCT02292719|12462081|FG004|Overall Study|Subject enrolled in new study.|0
7930244|NCT02292719|12462082|FG005|Overall Study|Subject enrolled in new study.|0
7930245|NCT02292771|12462098|FG000|Overall Study|Withdrawal by Subject|2
7930246|NCT02292771|12462099|FG001|Overall Study|Withdrawal by Subject|1
7930247|NCT02292771|12462098|FG000|Overall Study|Lost to Follow-up|2
7930248|NCT02292771|12462099|FG001|Overall Study|Lost to Follow-up|1
7930249|NCT02292784|12462112|FG000|Overall Study|Lost to Follow-up|1
7930250|NCT02292784|12462113|FG001|Overall Study|Lost to Follow-up|17
7930251|NCT02292784|12462114|FG002|Overall Study|Lost to Follow-up|18
7930252|NCT02292784|12462112|FG000|Overall Study|Withdrawal by Subject|0
7930253|NCT02292784|12462113|FG001|Overall Study|Withdrawal by Subject|3
7930254|NCT02292784|12462114|FG002|Overall Study|Withdrawal by Subject|3
7930255|NCT02292849|12462125|FG000|Overall Study|Lost to Follow-up|0
7930256|NCT02292849|12462126|FG001|Overall Study|Lost to Follow-up|2
7930257|NCT02292849|12462127|FG002|Overall Study|Lost to Follow-up|2
7930258|NCT02292849|12462125|FG000|Overall Study|Physician Decision|4
7930259|NCT02292849|12462126|FG001|Overall Study|Physician Decision|0
7930260|NCT02292849|12462127|FG002|Overall Study|Physician Decision|0
7930261|NCT02292927|12462137|FG000|Overall Study|Protocol Violation|13
7930262|NCT02292927|12462138|FG001|Overall Study|Protocol Violation|7
7930263|NCT02293395|12462167|FG000|Overall Study|Lost to Follow-up|1
7930264|NCT02293395|12462168|FG001|Overall Study|Lost to Follow-up|0
7930265|NCT02293395|12462167|FG000|Overall Study|Withdrawal by Subject|8
7930266|NCT02293395|12462168|FG001|Overall Study|Withdrawal by Subject|7
7930267|NCT02293460|12462174|FG000|Overall Study|Protocol Violation|1
7930268|NCT02293460|12462174|FG000|Overall Study|Lack of Efficacy|2
7930269|NCT02293460|12462174|FG000|Overall Study|Adverse Event|2
7930270|NCT02293460|12462174|FG000|Overall Study|Withdrawal by Subject|1
7930271|NCT02293499|12462181|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0
7930272|NCT02293499|12462182|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0
7930273|NCT02293499|12462183|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10
7930274|NCT02293499|12462181|FG000|Intervention - Camp|Withdrawal by Subject|3
7930275|NCT02293499|12462182|FG001|Intervention - Camp|Withdrawal by Subject|6
7930276|NCT02293499|12462183|FG002|Intervention - Camp|Withdrawal by Subject|2
7930277|NCT02293499|12462181|FG000|Intervention - Camp|these are those not showing up at camp|24
7930278|NCT02293499|12462182|FG001|Intervention - Camp|these are those not showing up at camp|28
7930279|NCT02293499|12462183|FG002|Intervention - Camp|these are those not showing up at camp|4
7930280|NCT02293499|12462181|FG000|3 Month Follow Up|Withdrawal by Subject|1
7930281|NCT02293499|12462182|FG001|3 Month Follow Up|Withdrawal by Subject|0
7930282|NCT02293499|12462183|FG002|3 Month Follow Up|Withdrawal by Subject|4
7930283|NCT02293499|12462181|FG000|3 Month Follow Up|Lost to Follow-up|14
7930284|NCT02293499|12462182|FG001|3 Month Follow Up|Lost to Follow-up|15
7930285|NCT02293499|12462183|FG002|3 Month Follow Up|Lost to Follow-up|6
7930286|NCT02293499|12462181|FG000|6 Month Follow Up|Lost to Follow-up|17
7930287|NCT02293499|12462182|FG001|6 Month Follow Up|Lost to Follow-up|27
7930288|NCT02293499|12462183|FG002|6 Month Follow Up|Lost to Follow-up|6
7930289|NCT02293499|12462181|FG000|6 Month Follow Up|Withdrawal by Subject|0
7930290|NCT02293499|12462182|FG001|6 Month Follow Up|Withdrawal by Subject|0
7930291|NCT02293499|12462183|FG002|6 Month Follow Up|Withdrawal by Subject|1
7930292|NCT02293499|12462181|FG000|9 Month Follow Up|Withdrawal by Subject|2
7930293|NCT02293499|12462182|FG001|9 Month Follow Up|Withdrawal by Subject|0
7930294|NCT02293499|12462183|FG002|9 Month Follow Up|Withdrawal by Subject|0
7930295|NCT02293499|12462181|FG000|9 Month Follow Up|Lost to Follow-up|24
7930296|NCT02293499|12462182|FG001|9 Month Follow Up|Lost to Follow-up|28
7930297|NCT02293499|12462183|FG002|9 Month Follow Up|Lost to Follow-up|4
7930298|NCT02293499|12462181|FG000|12 Month Follow Up|Lost to Follow-up|26
7930299|NCT02293499|12462182|FG001|12 Month Follow Up|Lost to Follow-up|25
7930300|NCT02293499|12462183|FG002|12 Month Follow Up|Lost to Follow-up|6
7930301|NCT02293499|12462181|FG000|12 Month Follow Up|Withdrawal by Subject|0
7930302|NCT02293499|12462182|FG001|12 Month Follow Up|Withdrawal by Subject|1
7930303|NCT02293499|12462183|FG002|12 Month Follow Up|Withdrawal by Subject|0
7930304|NCT02293499|12462181|FG000|15 Month Follow Up|Lost to Follow-up|22
7930305|NCT02293499|12462182|FG001|15 Month Follow Up|Lost to Follow-up|22
7930306|NCT02293499|12462183|FG002|15 Month Follow Up|Lost to Follow-up|7
7930307|NCT02293538|12462211|FG000|Overall Study|Adverse Event|0
7930308|NCT02293538|12462212|FG001|Overall Study|Adverse Event|1
7930309|NCT02293538|12462211|FG000|Overall Study|Lost to Follow-up|1
7930310|NCT02293538|12462212|FG001|Overall Study|Lost to Follow-up|0
7930311|NCT02293538|12462211|FG000|Overall Study|Withdrawal by Subject|0
7930312|NCT02293538|12462212|FG001|Overall Study|Withdrawal by Subject|1
7930313|NCT02293837|12462227|FG000|Overall Study|Lost to Follow-up|0
7930314|NCT02293837|12462228|FG001|Overall Study|Lost to Follow-up|2
7930315|NCT02293837|12462229|FG002|Overall Study|Lost to Follow-up|1
7930316|NCT02293837|12462230|FG003|Overall Study|Lost to Follow-up|0
7930317|NCT02293837|12462227|FG000|Overall Study|Withdrawal by Subject|2
7930318|NCT02293837|12462228|FG001|Overall Study|Withdrawal by Subject|1
7930319|NCT02293837|12462229|FG002|Overall Study|Withdrawal by Subject|2
7930320|NCT02293837|12462230|FG003|Overall Study|Withdrawal by Subject|1
7930321|NCT02293837|12462227|FG000|Overall Study|COVID-19 Related|1
7930322|NCT02293837|12462228|FG001|Overall Study|COVID-19 Related|1
7930323|NCT02293837|12462229|FG002|Overall Study|COVID-19 Related|0
7930324|NCT02293837|12462230|FG003|Overall Study|COVID-19 Related|0
7930325|NCT02293837|12462227|FG000|Overall Study|Participant ill and could not be infused|0
7930326|NCT02293837|12462228|FG001|Overall Study|Participant ill and could not be infused|0
7930327|NCT02293837|12462229|FG002|Overall Study|Participant ill and could not be infused|1
7930328|NCT02293837|12462230|FG003|Overall Study|Participant ill and could not be infused|0
7930329|NCT02293863|12462247|FG000|Overall Study|Death|4
7930330|NCT02293863|12462248|FG001|Overall Study|Death|6
7930331|NCT02293863|12462249|FG002|Overall Study|Death|4
7930332|NCT02293863|12462247|FG000|Overall Study|Lost to Follow-up|2
7930333|NCT02293863|12462248|FG001|Overall Study|Lost to Follow-up|2
7930334|NCT02293863|12462249|FG002|Overall Study|Lost to Follow-up|2
7930335|NCT02293863|12462247|FG000|Overall Study|Withdrawal by Subject|3
7930336|NCT02293863|12462248|FG001|Overall Study|Withdrawal by Subject|3
7930337|NCT02293863|12462249|FG002|Overall Study|Withdrawal by Subject|1
7930338|NCT02293863|12462247|FG000|Overall Study|Reason Not Specified|0
7930339|NCT02293863|12462248|FG001|Overall Study|Reason Not Specified|2
7930340|NCT02293863|12462249|FG002|Overall Study|Reason Not Specified|2
7930341|NCT02293902|12462262|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5
7930342|NCT02293902|12462263|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6
7930343|NCT02293902|12462264|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8
7930344|NCT02293902|12462265|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0
7930345|NCT02293902|12462266|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0
7930346|NCT02293902|12462262|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
7930347|NCT02293902|12462263|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
7930348|NCT02293902|12462264|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
7930349|NCT02293902|12462265|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
7930350|NCT02293902|12462266|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
7930351|NCT02293902|12462262|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
7930352|NCT02293902|12462263|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7930353|NCT02293902|12462264|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7930354|NCT02293902|12462265|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7930355|NCT02293902|12462266|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7930356|NCT02293902|12462262|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
7930357|NCT02293902|12462263|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
7930358|NCT02293902|12462264|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
7930359|NCT02293902|12462265|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
7930360|NCT02293902|12462266|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
7930361|NCT02293902|12462262|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
7930362|NCT02293902|12462263|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
7930363|NCT02293902|12462264|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
7930364|NCT02293902|12462265|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
7930365|NCT02293902|12462266|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
7930366|NCT02293993|12462288|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1
7930367|NCT02293993|12462289|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0
7930368|NCT02293993|12462290|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0
7930369|NCT02293993|12462291|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1
7930370|NCT02293993|12462288|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0
7930371|NCT02293993|12462289|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2
7930372|NCT02293993|12462290|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1
7930373|NCT02293993|12462291|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0
7930374|NCT02293993|12462288|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
7930375|NCT02293993|12462289|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
7930376|NCT02293993|12462290|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1
7930377|NCT02293993|12462291|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
7930378|NCT02293993|12462288|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2
7930379|NCT02293993|12462289|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2
7930380|NCT02293993|12462290|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3
7930381|NCT02293993|12462291|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1
7930382|NCT02293993|12462288|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
7930383|NCT02293993|12462289|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1
7930384|NCT02293993|12462290|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
7930385|NCT02293993|12462291|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
7930386|NCT02294019|12462309|FG000|Overall Study|Adverse Event|2
7930387|NCT02294019|12462309|FG000|Overall Study|Protocol Violation|68
7930388|NCT02294019|12462309|FG000|Overall Study|Lost to Follow-up|31
7930389|NCT02294019|12462309|FG000|Overall Study|Other|1
7930390|NCT02294019|12462309|FG000|Overall Study|Withdrawal by Subject|1
7930391|NCT02294058|12462316|FG000|Overall Study|Adverse Event|16
7930392|NCT02294058|12462317|FG001|Overall Study|Adverse Event|7
7930393|NCT02294058|12462318|FG002|Overall Study|Adverse Event|13
7930394|NCT02294058|12462316|FG000|Overall Study|Lack of Efficacy|3
7930395|NCT02294058|12462317|FG001|Overall Study|Lack of Efficacy|3
7930396|NCT02294058|12462318|FG002|Overall Study|Lack of Efficacy|0
7930397|NCT02294058|12462316|FG000|Overall Study|Lost to Follow-up|1
7930398|NCT02294058|12462317|FG001|Overall Study|Lost to Follow-up|0
7930399|NCT02294058|12462318|FG002|Overall Study|Lost to Follow-up|2
7930400|NCT02294058|12462316|FG000|Overall Study|Withdrawal by Subject|10
7930401|NCT02294058|12462317|FG001|Overall Study|Withdrawal by Subject|14
7930402|NCT02294058|12462318|FG002|Overall Study|Withdrawal by Subject|13
7930403|NCT02294058|12462316|FG000|Overall Study|Physician Decision|2
7930404|NCT02294058|12462317|FG001|Overall Study|Physician Decision|1
7930405|NCT02294058|12462318|FG002|Overall Study|Physician Decision|0
7930406|NCT02294058|12462316|FG000|Overall Study|Miscellaneous|4
7930407|NCT02294058|12462317|FG001|Overall Study|Miscellaneous|1
7930408|NCT02294058|12462318|FG002|Overall Study|Miscellaneous|1
7930409|NCT02294175|12462329|FG000|Overall Study|Withdrawal by Subject|1
7930410|NCT02294175|12462330|FG001|Overall Study|Withdrawal by Subject|2
7930411|NCT02294175|12462329|FG000|Overall Study|pt taking excluded medication|3
7930412|NCT02294175|12462330|FG001|Overall Study|pt taking excluded medication|1
7930413|NCT02294175|12462329|FG000|Overall Study|Protocol Violation|1
7930414|NCT02294175|12462330|FG001|Overall Study|Protocol Violation|0
7930415|NCT02294175|12462329|FG000|Overall Study|Lost to Follow-up|0
7930416|NCT02294175|12462330|FG001|Overall Study|Lost to Follow-up|1
7930417|NCT02294175|12462329|FG000|Overall Study|wound healed|0
7930418|NCT02294175|12462330|FG001|Overall Study|wound healed|2
7930419|NCT02294227|12462339|FG000|Overall Study|Death|0
7930420|NCT02294227|12462340|FG001|Overall Study|Death|0
7930421|NCT02294227|12462341|FG002|Overall Study|Death|1
7930422|NCT02294227|12462339|FG000|Overall Study|Subject/Guardian Decision|6
7930423|NCT02294227|12462340|FG001|Overall Study|Subject/Guardian Decision|3
7930424|NCT02294227|12462341|FG002|Overall Study|Subject/Guardian Decision|7
7930425|NCT02294227|12462339|FG000|Overall Study|Physician Decision|1
7930426|NCT02294227|12462340|FG001|Overall Study|Physician Decision|2
7930427|NCT02294227|12462341|FG002|Overall Study|Physician Decision|1
7930428|NCT02294227|12462339|FG000|Overall Study|Lost to Follow-up|1
7930429|NCT02294227|12462340|FG001|Overall Study|Lost to Follow-up|0
7930430|NCT02294227|12462341|FG002|Overall Study|Lost to Follow-up|0
7930431|NCT02294227|12462339|FG000|Overall Study|Lack of Efficacy|11
7930432|NCT02294227|12462340|FG001|Overall Study|Lack of Efficacy|12
7930433|NCT02294227|12462341|FG002|Overall Study|Lack of Efficacy|8
7930434|NCT02294227|12462339|FG000|Overall Study|Adverse Event|6
7930435|NCT02294227|12462340|FG001|Overall Study|Adverse Event|8
7930436|NCT02294227|12462341|FG002|Overall Study|Adverse Event|2
7930437|NCT02294318|12462357|FG000|Overall Study|Worsening of drinking|3
7930438|NCT02294318|12462358|FG001|Overall Study|Worsening of drinking|0
7930439|NCT02294318|12462357|FG000|Overall Study|Not exposed to intervention|0
7930440|NCT02294318|12462358|FG001|Overall Study|Not exposed to intervention|2
7930441|NCT02294396|12462368|FG000|Overall Study|Adverse Event|26
7930442|NCT02294396|12462369|FG001|Overall Study|Adverse Event|25
7930443|NCT02294396|12462370|FG002|Overall Study|Adverse Event|21
7930444|NCT02294396|12462371|FG003|Overall Study|Adverse Event|24
7930445|NCT02294396|12462368|FG000|Overall Study|Electrocardiogram adviser's judgment|1
7930446|NCT02294396|12462369|FG001|Overall Study|Electrocardiogram adviser's judgment|0
7930447|NCT02294396|12462370|FG002|Overall Study|Electrocardiogram adviser's judgment|0
7930448|NCT02294396|12462371|FG003|Overall Study|Electrocardiogram adviser's judgment|1
7930449|NCT02294396|12462368|FG000|Overall Study|Withdrawal by Subject|8
7930450|NCT02294396|12462369|FG001|Overall Study|Withdrawal by Subject|6
7930451|NCT02294396|12462370|FG002|Overall Study|Withdrawal by Subject|6
7930452|NCT02294396|12462371|FG003|Overall Study|Withdrawal by Subject|8
7930453|NCT02294396|12462368|FG000|Overall Study|Lost to Follow-up|0
7930454|NCT02294396|12462369|FG001|Overall Study|Lost to Follow-up|0
7930455|NCT02294396|12462370|FG002|Overall Study|Lost to Follow-up|1
7930456|NCT02294396|12462371|FG003|Overall Study|Lost to Follow-up|1
7930457|NCT02294396|12462368|FG000|Overall Study|Protocol Deviation|3
7930458|NCT02294396|12462369|FG001|Overall Study|Protocol Deviation|2
7930459|NCT02294396|12462370|FG002|Overall Study|Protocol Deviation|2
7930460|NCT02294396|12462371|FG003|Overall Study|Protocol Deviation|1
7930461|NCT02294396|12462368|FG000|Overall Study|Miscellaneous|2
7930462|NCT02294396|12462369|FG001|Overall Study|Miscellaneous|0
7930463|NCT02294396|12462370|FG002|Overall Study|Miscellaneous|5
7930464|NCT02294396|12462371|FG003|Overall Study|Miscellaneous|2
7930465|NCT02294474|12462383|FG000|Overall Study|Adverse Event|7
7930466|NCT02294474|12462384|FG001|Overall Study|Adverse Event|7
7930467|NCT02294474|12462383|FG000|Overall Study|Lack of Efficacy|2
7930468|NCT02294474|12462384|FG001|Overall Study|Lack of Efficacy|1
7930469|NCT02294474|12462383|FG000|Overall Study|Protocol Violation|4
7930470|NCT02294474|12462384|FG001|Overall Study|Protocol Violation|2
7930471|NCT02294474|12462383|FG000|Overall Study|Other than specified above|12
7930472|NCT02294474|12462384|FG001|Overall Study|Other than specified above|12
7930473|NCT02294604|12462394|FG000|Overall Study|Did not provide samples for culture|0
7930474|NCT02294604|12462395|FG001|Overall Study|Did not provide samples for culture|1
7930475|NCT02294604|12462396|FG002|Overall Study|Did not provide samples for culture|0
7930476|NCT02294604|12462394|FG000|Overall Study|Culture contamination|1
7930477|NCT02294604|12462395|FG001|Overall Study|Culture contamination|2
7930478|NCT02294604|12462396|FG002|Overall Study|Culture contamination|0
7930479|NCT02294682|12462423|FG000|Overall Study|Could not swallow pills|1
7930480|NCT02294682|12462424|FG001|Overall Study|Could not swallow pills|0
7719705|NCT00533897|12143615|FG000|Long Term Extension (LTE)|Pregnancy|0
7930481|NCT02294734|12462432|FG000|Overall Study|Adverse Event|5
7930482|NCT02294734|12462433|FG001|Overall Study|Adverse Event|5
7930483|NCT02294734|12462432|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1
7930484|NCT02294734|12462433|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0
7930485|NCT02294734|12462432|FG000|Overall Study|Lost to Follow-up|2
7930486|NCT02294734|12462433|FG001|Overall Study|Lost to Follow-up|0
7930487|NCT02294734|12462432|FG000|Overall Study|Physician Decision|2
7930488|NCT02294734|12462433|FG001|Overall Study|Physician Decision|1
7930489|NCT02294734|12462432|FG000|Overall Study|Withdrawal by Subject|4
7930490|NCT02294734|12462433|FG001|Overall Study|Withdrawal by Subject|2
7930491|NCT02294773|12462443|FG000|Overall Study|Withdrawal by Subject|0
7930492|NCT02294773|12462444|FG001|Overall Study|Withdrawal by Subject|2
7930493|NCT02294786|12462452|FG000|Overall Study|Withdrawal by Subject|0
7930494|NCT02294786|12462453|FG001|Overall Study|Withdrawal by Subject|1
7930495|NCT02294786|12462452|FG000|Overall Study|Physician Decision|6
7930496|NCT02294786|12462453|FG001|Overall Study|Physician Decision|7
7930497|NCT02294786|12462452|FG000|Overall Study|Lost to Follow-up|1
7930498|NCT02294786|12462453|FG001|Overall Study|Lost to Follow-up|2
7930499|NCT02294786|12462452|FG000|Overall Study|Protocol Violation|1
7930500|NCT02294786|12462453|FG001|Overall Study|Protocol Violation|0
7930501|NCT02294786|12462452|FG000|Overall Study|Adverse Event|1
7930502|NCT02294786|12462453|FG001|Overall Study|Adverse Event|1
7930503|NCT02294786|12462452|FG000|Overall Study|Death|2
7930504|NCT02294786|12462453|FG001|Overall Study|Death|3
7930505|NCT02295020|12462462|FG000|Overall Study|Adverse Event|0
7930506|NCT02295020|12462463|FG001|Overall Study|Adverse Event|1
7930507|NCT02295020|12462462|FG000|Overall Study|Withdrawal by Subject|3
7930508|NCT02295020|12462463|FG001|Overall Study|Withdrawal by Subject|2
7930509|NCT02295280|12462477|FG000|Overall Study|Adverse Event|0
7930510|NCT02295280|12462478|FG001|Overall Study|Adverse Event|1
7930511|NCT02295644|12462505|FG000|Overall Study|Did not meet inclusion criterion|0
7930512|NCT02295644|12462506|FG001|Overall Study|Did not meet inclusion criterion|0
7930513|NCT02295644|12462507|FG002|Overall Study|Did not meet inclusion criterion|1
7930514|NCT02295644|12462508|FG003|Overall Study|Did not meet inclusion criterion|2
7930515|NCT02295774|12462527|FG000|Overall Study|Physician Decision|1
7930516|NCT02295774|12462527|FG000|Overall Study|Withdrawal by Subject|2
7930517|NCT02295995|12462534|FG000|Overall Study|Lost to Follow-up|5
7930518|NCT02295995|12462535|FG001|Overall Study|Lost to Follow-up|1
7930519|NCT02296112|12462551|FG000|Overall Study|Disease progression|7
7930520|NCT02296112|12462551|FG000|Overall Study|Toxicity|1
7930521|NCT02296112|12462551|FG000|Overall Study|Began an alternate therapy|1
7930522|NCT02296138|12462562|FG000|Overall Study|Adverse Event|348
7930523|NCT02296138|12462563|FG001|Overall Study|Adverse Event|259
7930524|NCT02296138|12462562|FG000|Overall Study|Lack of Efficacy|59
7930525|NCT02296138|12462563|FG001|Overall Study|Lack of Efficacy|37
7930526|NCT02296138|12462562|FG000|Overall Study|Protocol Violation|35
7930527|NCT02296138|12462563|FG001|Overall Study|Protocol Violation|36
7930528|NCT02296138|12462562|FG000|Overall Study|Lost to Follow-up|9
7930529|NCT02296138|12462563|FG001|Overall Study|Lost to Follow-up|12
7930530|NCT02296138|12462562|FG000|Overall Study|Withdrawal by Subject|184
7930531|NCT02296138|12462563|FG001|Overall Study|Withdrawal by Subject|131
7930532|NCT02296138|12462562|FG000|Overall Study|Not Treated|1
7930533|NCT02296138|12462563|FG001|Overall Study|Not Treated|1
7930534|NCT02296138|12462562|FG000|Overall Study|Patients with data irregularities|10
7930535|NCT02296138|12462563|FG001|Overall Study|Patients with data irregularities|11
7930536|NCT02296138|12462562|FG000|Overall Study|Other than specified|15
7930537|NCT02296138|12462563|FG001|Overall Study|Other than specified|13
7930538|NCT02296190|12462579|FG000|Overall Study|Lost to Follow-up|0
7930539|NCT02296190|12462580|FG001|Overall Study|Lost to Follow-up|0
7930540|NCT02296190|12462581|FG002|Overall Study|Lost to Follow-up|0
7930541|NCT02296190|12462582|FG003|Overall Study|Lost to Follow-up|0
7930542|NCT02296190|12462583|FG004|Overall Study|Lost to Follow-up|1
7930543|NCT02296190|12462584|FG005|Overall Study|Lost to Follow-up|0
7930544|NCT02296190|12462579|FG000|Overall Study|Failure to induce PSVT|6
7930545|NCT02296190|12462580|FG001|Overall Study|Failure to induce PSVT|10
7930546|NCT02296190|12462581|FG002|Overall Study|Failure to induce PSVT|5
7930547|NCT02296190|12462582|FG003|Overall Study|Failure to induce PSVT|13
7930548|NCT02296190|12462583|FG004|Overall Study|Failure to induce PSVT|8
7930549|NCT02296190|12462584|FG005|Overall Study|Failure to induce PSVT|0
7930550|NCT02296190|12462579|FG000|Overall Study|Physician Decision|1
7930551|NCT02296190|12462580|FG001|Overall Study|Physician Decision|1
7930552|NCT02296190|12462581|FG002|Overall Study|Physician Decision|0
7930553|NCT02296190|12462582|FG003|Overall Study|Physician Decision|1
7930554|NCT02296190|12462583|FG004|Overall Study|Physician Decision|2
7930555|NCT02296190|12462584|FG005|Overall Study|Physician Decision|0
7930556|NCT02296190|12462579|FG000|Overall Study|Withdrawal by Subject|0
7930557|NCT02296190|12462580|FG001|Overall Study|Withdrawal by Subject|1
7930558|NCT02296190|12462581|FG002|Overall Study|Withdrawal by Subject|0
7930559|NCT02296190|12462582|FG003|Overall Study|Withdrawal by Subject|0
7930560|NCT02296190|12462583|FG004|Overall Study|Withdrawal by Subject|0
7930561|NCT02296190|12462584|FG005|Overall Study|Withdrawal by Subject|0
7930562|NCT02296190|12462579|FG000|Overall Study|PSVT < 5 minutes|5
7930563|NCT02296190|12462580|FG001|Overall Study|PSVT < 5 minutes|6
7930564|NCT02296190|12462581|FG002|Overall Study|PSVT < 5 minutes|6
7930565|NCT02296190|12462582|FG003|Overall Study|PSVT < 5 minutes|6
7930566|NCT02296190|12462583|FG004|Overall Study|PSVT < 5 minutes|5
7930567|NCT02296190|12462584|FG005|Overall Study|PSVT < 5 minutes|0
7930568|NCT02296190|12462579|FG000|Overall Study|Patient was given Propofol|0
7930569|NCT02296190|12462580|FG001|Overall Study|Patient was given Propofol|1
7930570|NCT02296190|12462581|FG002|Overall Study|Patient was given Propofol|0
7930571|NCT02296190|12462582|FG003|Overall Study|Patient was given Propofol|1
7930572|NCT02296190|12462583|FG004|Overall Study|Patient was given Propofol|0
7930573|NCT02296190|12462584|FG005|Overall Study|Patient was given Propofol|0
7930574|NCT02296190|12462579|FG000|Overall Study|Patient with Atrial Tachycardia|0
7930575|NCT02296190|12462580|FG001|Overall Study|Patient with Atrial Tachycardia|0
7930576|NCT02296190|12462581|FG002|Overall Study|Patient with Atrial Tachycardia|0
7930577|NCT02296190|12462582|FG003|Overall Study|Patient with Atrial Tachycardia|1
7930578|NCT02296190|12462583|FG004|Overall Study|Patient with Atrial Tachycardia|0
7930579|NCT02296190|12462584|FG005|Overall Study|Patient with Atrial Tachycardia|0
7930580|NCT02296190|12462579|FG000|Overall Study|Blood pressure <100 after sedation|0
7930581|NCT02296190|12462580|FG001|Overall Study|Blood pressure <100 after sedation|0
7930582|NCT02296190|12462581|FG002|Overall Study|Blood pressure <100 after sedation|0
7930583|NCT02296190|12462582|FG003|Overall Study|Blood pressure <100 after sedation|1
7930584|NCT02296190|12462583|FG004|Overall Study|Blood pressure <100 after sedation|0
7930585|NCT02296190|12462584|FG005|Overall Study|Blood pressure <100 after sedation|0
7930586|NCT02296190|12462579|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0
7930587|NCT02296190|12462580|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1
7930588|NCT02296190|12462581|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1
7930589|NCT02296190|12462582|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0
7930590|NCT02296190|12462583|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0
7930591|NCT02296190|12462584|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0
7930592|NCT02296190|12462579|FG000|Overall Study|Patient on antiarrhythmic medication|1
7930593|NCT02296190|12462580|FG001|Overall Study|Patient on antiarrhythmic medication|0
7930594|NCT02296190|12462581|FG002|Overall Study|Patient on antiarrhythmic medication|0
7930595|NCT02296190|12462582|FG003|Overall Study|Patient on antiarrhythmic medication|0
7930596|NCT02296190|12462583|FG004|Overall Study|Patient on antiarrhythmic medication|0
7930597|NCT02296190|12462584|FG005|Overall Study|Patient on antiarrhythmic medication|0
7930598|NCT02296190|12462579|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0
7930599|NCT02296190|12462580|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1
7930600|NCT02296190|12462581|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0
7930601|NCT02296190|12462582|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0
7930602|NCT02296190|12462583|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0
7930603|NCT02296190|12462584|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0
7930604|NCT02296190|12462579|FG000|Overall Study|Lab result not available in time|1
7930605|NCT02296190|12462580|FG001|Overall Study|Lab result not available in time|0
7930606|NCT02296190|12462581|FG002|Overall Study|Lab result not available in time|0
7930607|NCT02296190|12462582|FG003|Overall Study|Lab result not available in time|0
7930608|NCT02296190|12462583|FG004|Overall Study|Lab result not available in time|0
7930609|NCT02296190|12462584|FG005|Overall Study|Lab result not available in time|0
7930610|NCT02296242|12462602|FG000|Overall Study|Death|1
7930611|NCT02296242|12462603|FG001|Overall Study|Death|1
7930612|NCT02296242|12462604|FG002|Overall Study|Death|1
7930613|NCT02296242|12462605|FG003|Overall Study|Death|1
7930614|NCT02296242|12462606|FG004|Overall Study|Death|1
7930615|NCT02296242|12462602|FG000|Overall Study|Withdrawal by Subject|0
7930616|NCT02296242|12462603|FG001|Overall Study|Withdrawal by Subject|0
7930617|NCT02296242|12462604|FG002|Overall Study|Withdrawal by Subject|1
7930618|NCT02296242|12462605|FG003|Overall Study|Withdrawal by Subject|1
7930619|NCT02296242|12462606|FG004|Overall Study|Withdrawal by Subject|3
7930620|NCT02296242|12462602|FG000|Overall Study|Disease Progression|1
7930621|NCT02296242|12462603|FG001|Overall Study|Disease Progression|3
7930622|NCT02296242|12462604|FG002|Overall Study|Disease Progression|2
7930623|NCT02296242|12462605|FG003|Overall Study|Disease Progression|8
7930624|NCT02296242|12462606|FG004|Overall Study|Disease Progression|11
7930625|NCT02296242|12462602|FG000|Overall Study|Unacceptable Toxicity|0
7930626|NCT02296242|12462603|FG001|Overall Study|Unacceptable Toxicity|0
7930627|NCT02296242|12462604|FG002|Overall Study|Unacceptable Toxicity|0
7930628|NCT02296242|12462605|FG003|Overall Study|Unacceptable Toxicity|0
7930629|NCT02296242|12462606|FG004|Overall Study|Unacceptable Toxicity|1
7930630|NCT02296242|12462602|FG000|Overall Study|Patient Condition Changed|0
7930631|NCT02296242|12462603|FG001|Overall Study|Patient Condition Changed|0
7930632|NCT02296242|12462604|FG002|Overall Study|Patient Condition Changed|2
7930633|NCT02296242|12462605|FG003|Overall Study|Patient Condition Changed|0
7930634|NCT02296242|12462606|FG004|Overall Study|Patient Condition Changed|1
7930635|NCT02296242|12462602|FG000|Overall Study|At Least 3 Drug Interruptions|0
7930636|NCT02296242|12462603|FG001|Overall Study|At Least 3 Drug Interruptions|0
7930637|NCT02296242|12462604|FG002|Overall Study|At Least 3 Drug Interruptions|1
7930638|NCT02296242|12462605|FG003|Overall Study|At Least 3 Drug Interruptions|1
7930639|NCT02296242|12462606|FG004|Overall Study|At Least 3 Drug Interruptions|1
7930640|NCT02296242|12462602|FG000|Overall Study|Lost to Follow-up|1
7930641|NCT02296242|12462603|FG001|Overall Study|Lost to Follow-up|0
7930642|NCT02296242|12462604|FG002|Overall Study|Lost to Follow-up|0
7930643|NCT02296242|12462605|FG003|Overall Study|Lost to Follow-up|0
7930644|NCT02296242|12462606|FG004|Overall Study|Lost to Follow-up|0
7930645|NCT02296242|12462602|FG000|Overall Study|Need for Hydroxyurea|2
7930646|NCT02296242|12462603|FG001|Overall Study|Need for Hydroxyurea|0
7930647|NCT02296242|12462604|FG002|Overall Study|Need for Hydroxyurea|0
7930648|NCT02296242|12462605|FG003|Overall Study|Need for Hydroxyurea|0
7930649|NCT02296242|12462606|FG004|Overall Study|Need for Hydroxyurea|0
7930650|NCT02296242|12462602|FG000|Overall Study|Screened for Other Protocol|0
7930651|NCT02296242|12462603|FG001|Overall Study|Screened for Other Protocol|1
7930652|NCT02296242|12462604|FG002|Overall Study|Screened for Other Protocol|0
7930653|NCT02296242|12462605|FG003|Overall Study|Screened for Other Protocol|0
7930654|NCT02296242|12462606|FG004|Overall Study|Screened for Other Protocol|0
7930655|NCT02296242|12462602|FG000|Overall Study|Physician Decision|0
7930656|NCT02296242|12462603|FG001|Overall Study|Physician Decision|1
7930657|NCT02296242|12462604|FG002|Overall Study|Physician Decision|0
7930658|NCT02296242|12462605|FG003|Overall Study|Physician Decision|1
7930659|NCT02296242|12462606|FG004|Overall Study|Physician Decision|0
7930660|NCT02296242|12462602|FG000|Overall Study|Alternative Treatment|0
7930661|NCT02296242|12462603|FG001|Overall Study|Alternative Treatment|0
7930662|NCT02296242|12462604|FG002|Overall Study|Alternative Treatment|0
7930663|NCT02296242|12462605|FG003|Overall Study|Alternative Treatment|1
7930664|NCT02296242|12462606|FG004|Overall Study|Alternative Treatment|0
7930665|NCT02296242|12462602|FG000|Overall Study|Adverse Event|0
7930666|NCT02296242|12462603|FG001|Overall Study|Adverse Event|0
7930667|NCT02296242|12462604|FG002|Overall Study|Adverse Event|0
7930668|NCT02296242|12462605|FG003|Overall Study|Adverse Event|1
7930669|NCT02296242|12462606|FG004|Overall Study|Adverse Event|0
7930670|NCT02296242|12462602|FG000|Overall Study|Lack of Efficacy|0
7930671|NCT02296242|12462603|FG001|Overall Study|Lack of Efficacy|0
7930672|NCT02296242|12462604|FG002|Overall Study|Lack of Efficacy|0
7930673|NCT02296242|12462605|FG003|Overall Study|Lack of Efficacy|0
7930674|NCT02296242|12462606|FG004|Overall Study|Lack of Efficacy|3
7930675|NCT02296320|12462629|FG000|Overall Study|Withdrawal by Subject|4
7930676|NCT02296320|12462630|FG001|Overall Study|Withdrawal by Subject|0
7930677|NCT02296320|12462631|FG002|Overall Study|Withdrawal by Subject|2
7930678|NCT02296320|12462629|FG000|Overall Study|Death|24
7930679|NCT02296320|12462630|FG001|Overall Study|Death|3
7930680|NCT02296320|12462631|FG002|Overall Study|Death|27
7930681|NCT02296320|12462629|FG000|Overall Study|Lost to Follow-up|5
7930682|NCT02296320|12462630|FG001|Overall Study|Lost to Follow-up|2
7930683|NCT02296320|12462631|FG002|Overall Study|Lost to Follow-up|7
7930684|NCT02296320|12462629|FG000|Overall Study|Not treated|2
7930685|NCT02296320|12462630|FG001|Overall Study|Not treated|0
7930686|NCT02296320|12462631|FG002|Overall Study|Not treated|0
7930687|NCT02296320|12462629|FG000|Overall Study|Not - specified|0
7930688|NCT02296320|12462630|FG001|Overall Study|Not - specified|0
7930689|NCT02296320|12462631|FG002|Overall Study|Not - specified|1
7930690|NCT02296424|12462654|FG000|Part 1|New therapy for study indication|0
7930691|NCT02296424|12462655|FG001|Part 1|New therapy for study indication|1
7930692|NCT02296424|12462656|FG002|Part 1|New therapy for study indication|0
7930693|NCT02296424|12462657|FG003|Part 1|New therapy for study indication|0
7930694|NCT02296424|12462654|FG000|Part 1|Protocol Violation|0
7930695|NCT02296424|12462655|FG001|Part 1|Protocol Violation|1
7930696|NCT02296424|12462656|FG002|Part 1|Protocol Violation|0
7930697|NCT02296424|12462657|FG003|Part 1|Protocol Violation|0
7930698|NCT02296424|12462654|FG000|Part 1|Withdrawal by Subject|0
7930699|NCT02296424|12462655|FG001|Part 1|Withdrawal by Subject|2
7930700|NCT02296424|12462656|FG002|Part 1|Withdrawal by Subject|0
7930701|NCT02296424|12462657|FG003|Part 1|Withdrawal by Subject|0
7930702|NCT02296424|12462654|FG000|Part 1|Study terminated by sponsor|0
7930703|NCT02296424|12462655|FG001|Part 1|Study terminated by sponsor|1
7930704|NCT02296424|12462656|FG002|Part 1|Study terminated by sponsor|0
7930705|NCT02296424|12462657|FG003|Part 1|Study terminated by sponsor|0
7930706|NCT02296424|12462654|FG000|Part 1|Adverse Event|2
7930707|NCT02296424|12462655|FG001|Part 1|Adverse Event|11
7930708|NCT02296424|12462656|FG002|Part 1|Adverse Event|0
7930709|NCT02296424|12462657|FG003|Part 1|Adverse Event|0
7930710|NCT02296424|12462654|FG000|Part 1|Lack of Efficacy|5
7930711|NCT02296424|12462655|FG001|Part 1|Lack of Efficacy|17
7930712|NCT02296424|12462656|FG002|Part 1|Lack of Efficacy|0
7930713|NCT02296424|12462657|FG003|Part 1|Lack of Efficacy|0
7930714|NCT02296424|12462654|FG000|Part 1|16 directly started part II|16
7930715|NCT02296424|12462655|FG001|Part 1|16 directly started part II|0
7930716|NCT02296424|12462656|FG002|Part 1|16 directly started part II|0
7930717|NCT02296424|12462657|FG003|Part 1|16 directly started part II|0
7930718|NCT02296424|12462654|FG000|Part 2|Lack of Efficacy|0
7930719|NCT02296424|12462655|FG001|Part 2|Lack of Efficacy|0
7930720|NCT02296424|12462656|FG002|Part 2|Lack of Efficacy|1
7930721|NCT02296424|12462657|FG003|Part 2|Lack of Efficacy|0
7930722|NCT02296424|12462654|FG000|Part 2|Adverse Event|0
7930723|NCT02296424|12462655|FG001|Part 2|Adverse Event|0
7930724|NCT02296424|12462656|FG002|Part 2|Adverse Event|1
7930725|NCT02296424|12462657|FG003|Part 2|Adverse Event|0
7930726|NCT02296424|12462654|FG000|Part 2|Lost to Follow-up|0
7930727|NCT02296424|12462655|FG001|Part 2|Lost to Follow-up|0
7930728|NCT02296424|12462656|FG002|Part 2|Lost to Follow-up|1
7930729|NCT02296424|12462657|FG003|Part 2|Lost to Follow-up|0
7930730|NCT02296476|12462668|FG000|Overall Study|Disease Progression|6
7930731|NCT02296476|12462669|FG001|Overall Study|Disease Progression|4
7930732|NCT02296476|12462670|FG002|Overall Study|Disease Progression|2
7930733|NCT02296840|12462717|FG000|Overall Study|Adverse Event|1
7930734|NCT02296840|12462718|FG001|Overall Study|Adverse Event|1
7930735|NCT02296840|12462717|FG000|Overall Study|Protocol Violation|2
7930736|NCT02296840|12462718|FG001|Overall Study|Protocol Violation|1
7930737|NCT02296840|12462717|FG000|Overall Study|Lost to Follow-up|6
7930738|NCT02296840|12462718|FG001|Overall Study|Lost to Follow-up|17
7930739|NCT02296892|12462736|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7
7930740|NCT02296892|12462737|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4
7930741|NCT02296892|12462738|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4
7930742|NCT02296892|12462736|FG000|Overall Study|Lost to Follow-up|5
7930743|NCT02296892|12462737|FG001|Overall Study|Lost to Follow-up|0
7930744|NCT02296892|12462738|FG002|Overall Study|Lost to Follow-up|1
7930745|NCT02296931|12462748|FG000|Overall Study|Protocol Violation|0
7930746|NCT02296931|12462749|FG001|Overall Study|Protocol Violation|2
7930747|NCT02297516|12462771|FG000|Single Treatment Phase (6 Months)|Medical reason|1
7930748|NCT02297516|12462772|FG001|Single Treatment Phase (6 Months)|Medical reason|0
7930749|NCT02297516|12462771|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0
7930750|NCT02297516|12462772|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2
7930751|NCT02297516|12462771|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0
7930752|NCT02297516|12462772|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1
7930753|NCT02297815|12462787|FG000|Overall Study|Lost to Follow-up|236
7930754|NCT02297815|12462788|FG001|Overall Study|Lost to Follow-up|140
7930755|NCT02297841|12462796|FG000|Overall Study|Withdrawal by Subject|1
7930756|NCT02297841|12462796|FG000|Overall Study|Protocol Violation|7
7964751|NCT01524991|12520409|FG000|Overall Study|Adverse Event|12
7964752|NCT01524991|12520409|FG000|Overall Study|Death|1
7964753|NCT01524991|12520409|FG000|Overall Study|Disease ProgressionDu|17
7964754|NCT01524991|12520409|FG000|Overall Study|Other complicating disease|1
7964755|NCT01524991|12520409|FG000|Overall Study|Withdrawal by Subject|2
7964756|NCT01524991|12520409|FG000|Overall Study|Symptomatic Deterioration|1
7964757|NCT01085084|12520433|FG000|Overall Study|Withdrawal by Subject|1
7964758|NCT01085084|12520434|FG001|Overall Study|Withdrawal by Subject|0
7964759|NCT01085084|12520435|FG002|Overall Study|Withdrawal by Subject|0
7964760|NCT01085084|12520433|FG000|Overall Study|Lost to Follow-up|2
7964761|NCT01085084|12520434|FG001|Overall Study|Lost to Follow-up|1
7930757|NCT02298023|12462803|FG000|Overall Study|Withdrawal by Subject|1
7930758|NCT02298023|12462804|FG001|Overall Study|Withdrawal by Subject|0
7930759|NCT02298023|12462805|FG002|Overall Study|Withdrawal by Subject|0
7930760|NCT02298179|12462828|FG000|Overall Study|Lost to Follow-up|0
7930761|NCT02298179|12462829|FG001|Overall Study|Lost to Follow-up|0
7930762|NCT02298179|12462830|FG002|Overall Study|Lost to Follow-up|1
7930763|NCT02298179|12462831|FG003|Overall Study|Lost to Follow-up|0
7930764|NCT02298179|12462832|FG004|Overall Study|Lost to Follow-up|0
7930765|NCT02298179|12462833|FG005|Overall Study|Lost to Follow-up|0
7930766|NCT02298179|12462834|FG006|Overall Study|Lost to Follow-up|0
7930767|NCT02298179|12462835|FG007|Overall Study|Lost to Follow-up|1
7930768|NCT02298179|12462836|FG008|Overall Study|Lost to Follow-up|0
7930769|NCT02298179|12462837|FG009|Overall Study|Lost to Follow-up|0
7930770|NCT02298179|12462838|FG010|Overall Study|Lost to Follow-up|0
7930771|NCT02298179|12462839|FG011|Overall Study|Lost to Follow-up|0
7930772|NCT02298192|12462867|FG000|Overall Study|Unclassified|3
7930773|NCT02298192|12462868|FG001|Overall Study|Unclassified|2
7930774|NCT02298192|12462867|FG000|Overall Study|Withdrawal criteria|2
7930775|NCT02298192|12462868|FG001|Overall Study|Withdrawal criteria|0
7930776|NCT02298192|12462867|FG000|Overall Study|Withdrawal by Subject|6
7930777|NCT02298192|12462868|FG001|Overall Study|Withdrawal by Subject|1
7930778|NCT02298192|12462867|FG000|Overall Study|Lost to Follow-up|2
7930779|NCT02298192|12462868|FG001|Overall Study|Lost to Follow-up|1
7930780|NCT02298192|12462867|FG000|Overall Study|Adverse Event|6
7930781|NCT02298192|12462868|FG001|Overall Study|Adverse Event|2
7930782|NCT02298868|12462920|FG000|Overall Study|Adverse Event|1
7930783|NCT02298868|12462920|FG000|Overall Study|Death|1
7930784|NCT02298868|12462920|FG000|Overall Study|Patient underwent transplant|1
7930785|NCT02298946|12462930|FG000|Overall Study|Did not receive treatment|2
7930786|NCT02298946|12462931|FG001|Overall Study|Did not receive treatment|0
7930787|NCT02298946|12462930|FG000|Overall Study|Unevaluable|2
7930788|NCT02298946|12462931|FG001|Overall Study|Unevaluable|1
7930789|NCT02299076|12462944|FG000|Overall Study|Fraudulent Entries|20
7930790|NCT02299076|12462945|FG001|Overall Study|Fraudulent Entries|14
7930791|NCT02299167|12462989|FG000|Overall Study|patients were excluded from the study|11
7930792|NCT02299336|12463006|FG000|Overall Study|Withdrawal by Subject|11
7930793|NCT02299336|12463006|FG000|Overall Study|Adverse Event|1
7930794|NCT02299336|12463006|FG000|Overall Study|Death|1
7930795|NCT02299336|12463006|FG000|Overall Study|Lost to Follow-up|1
7930796|NCT02299375|12463021|FG000|Overall Study|Adverse Event, serious fatal|1
7930797|NCT02299375|12463022|FG001|Overall Study|Adverse Event, serious fatal|3
7930798|NCT02299375|12463021|FG000|Overall Study|Adverse Event, non-fatal|8
7930799|NCT02299375|12463022|FG001|Overall Study|Adverse Event, non-fatal|9
7930800|NCT02299375|12463021|FG000|Overall Study|Lack of Efficacy|1
7930801|NCT02299375|12463022|FG001|Overall Study|Lack of Efficacy|3
7930802|NCT02299375|12463021|FG000|Overall Study|Protocol Violation|1
7930803|NCT02299375|12463022|FG001|Overall Study|Protocol Violation|3
7930804|NCT02299375|12463021|FG000|Overall Study|Other: Met stopping criteria|1
7930805|NCT02299375|12463022|FG001|Overall Study|Other: Met stopping criteria|0
7930806|NCT02299375|12463021|FG000|Overall Study|Other: Study closed/terminated|66
7930807|NCT02299375|12463022|FG001|Overall Study|Other: Study closed/terminated|55
7930808|NCT02299375|12463021|FG000|Overall Study|Lost to Follow-up|0
7930809|NCT02299375|12463022|FG001|Overall Study|Lost to Follow-up|2
7930810|NCT02299375|12463021|FG000|Overall Study|Physician Decision|1
7930811|NCT02299375|12463022|FG001|Overall Study|Physician Decision|1
7930812|NCT02299375|12463021|FG000|Overall Study|Withdrawal by Subject|1
7930813|NCT02299375|12463022|FG001|Overall Study|Withdrawal by Subject|4
7930814|NCT02299388|12463031|FG000|Overall Study|Withdrawal by Subject|0
7930815|NCT02299388|12463032|FG001|Overall Study|Withdrawal by Subject|1
7930816|NCT02299427|12463040|FG000|Overall Study|Withdrawal by Subject|1
7930817|NCT02299427|12463041|FG001|Overall Study|Withdrawal by Subject|0
7930818|NCT02299427|12463040|FG000|Overall Study|Lost to Follow-up|1
7930819|NCT02299427|12463041|FG001|Overall Study|Lost to Follow-up|3
7930820|NCT02299427|12463040|FG000|Overall Study|not adherent to dog website use|21
7930821|NCT02299427|12463041|FG001|Overall Study|not adherent to dog website use|0
7930822|NCT02299635|12463069|FG000|Overall Study|Adverse Event|2
7930823|NCT02299635|12463069|FG000|Overall Study|Death|1
7930824|NCT02299635|12463069|FG000|Overall Study|Global deterioration of health status|1
7930825|NCT02299635|12463069|FG000|Overall Study|Objective progression or relapse|10
7930826|NCT02299635|12463069|FG000|Overall Study|Withdrawal by Subject|2
7930827|NCT02299635|12463069|FG000|Overall Study|Other|3
7930828|NCT02300103|12463127|FG000|Overall Study|Lack of Efficacy|3
7930829|NCT02300103|12463127|FG000|Overall Study|Protocol Violation|1
7930830|NCT02300103|12463127|FG000|Overall Study|Withdrew Consent|2
7930831|NCT02300129|12463131|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
7930832|NCT02300129|12463132|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
7930833|NCT02300129|12463133|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
7930834|NCT02300129|12463134|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
7930835|NCT02300129|12463131|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
7930836|NCT02300129|12463132|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
7930837|NCT02300129|12463133|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
7930838|NCT02300129|12463134|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
7930839|NCT02300129|12463131|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
7930840|NCT02300129|12463132|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
7930841|NCT02300129|12463133|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
7930842|NCT02300129|12463134|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
7930843|NCT02300220|12463146|FG000|Overall Study|Lost to Follow-up|1
7930844|NCT02300220|12463147|FG001|Overall Study|Lost to Follow-up|2
7930845|NCT02300220|12463146|FG000|Overall Study|Death|1
7930846|NCT02300220|12463147|FG001|Overall Study|Death|1
7930847|NCT02300220|12463146|FG000|Overall Study|Adverse Event|1
7930848|NCT02300220|12463147|FG001|Overall Study|Adverse Event|1
7930849|NCT02300220|12463146|FG000|Overall Study|Protocol Violation|1
7930850|NCT02300220|12463147|FG001|Overall Study|Protocol Violation|0
7930851|NCT02300220|12463146|FG000|Overall Study|Withdrawal by Subject|0
7930852|NCT02300220|12463147|FG001|Overall Study|Withdrawal by Subject|2
7930853|NCT02300220|12463146|FG000|Overall Study|Did not tolerate IMP|0
7930854|NCT02300220|12463147|FG001|Overall Study|Did not tolerate IMP|1
7930855|NCT02300259|12463156|FG000|Period 1|Adverse Event|0
7930856|NCT02300259|12463157|FG001|Period 1|Adverse Event|0
7930857|NCT02300259|12463158|FG002|Period 1|Adverse Event|1
7930858|NCT02300259|12463156|FG000|Period 1|Withdrawal by Subject|0
7930859|NCT02300259|12463157|FG001|Period 1|Withdrawal by Subject|0
7930860|NCT02300259|12463158|FG002|Period 1|Withdrawal by Subject|1
7930861|NCT02300259|12463156|FG000|Period 2|Adverse Event|1
7930862|NCT02300259|12463157|FG001|Period 2|Adverse Event|0
7930863|NCT02300259|12463158|FG002|Period 2|Adverse Event|0
7930864|NCT02300259|12463156|FG000|Period 2|Withdrawal by Subject|0
7930865|NCT02300259|12463157|FG001|Period 2|Withdrawal by Subject|0
7930866|NCT02300259|12463158|FG002|Period 2|Withdrawal by Subject|1
7930867|NCT02300298|12463186|FG000|Disposition for Nintedanib|Progressive disease|10
7930868|NCT02300298|12463187|FG001|Disposition for Nintedanib|Progressive disease|0
7930869|NCT02300298|12463186|FG000|Disposition for Docetaxel|Progressive disease|0
7930870|NCT02300298|12463187|FG001|Disposition for Docetaxel|Progressive disease|6
7930871|NCT02300298|12463186|FG000|Disposition for Docetaxel|other adverse event|0
7930872|NCT02300298|12463187|FG001|Disposition for Docetaxel|other adverse event|4
7930873|NCT02300311|12463193|FG000|Overall Study|Other than the reason specified|1
7930874|NCT02300311|12463194|FG001|Overall Study|Other than the reason specified|0
7930875|NCT02300311|12463193|FG000|Overall Study|Refused to continue taking medication|18
7930876|NCT02300311|12463194|FG001|Overall Study|Refused to continue taking medication|0
7930877|NCT02300558|12463204|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
7930878|NCT02300558|12463204|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2
7930879|NCT02300558|12463204|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1
7930880|NCT02300558|12463204|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
7930881|NCT02300610|12463215|FG000|Overall Study|Withdrawal by Subject|1
7930882|NCT02300610|12463216|FG001|Overall Study|Withdrawal by Subject|0
7930883|NCT02300610|12463217|FG002|Overall Study|Withdrawal by Subject|1
7930884|NCT02300987|12463254|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1
7930885|NCT02300987|12463255|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0
7930886|NCT02300987|12463254|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2
7930887|NCT02300987|12463255|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0
7930888|NCT02300987|12463254|FG000|Primary Phase : Prior to Cross-over|progressive disease|3
7930889|NCT02300987|12463255|FG001|Primary Phase : Prior to Cross-over|progressive disease|2
7930890|NCT02300987|12463254|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1
7930891|NCT02300987|12463255|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0
7930892|NCT02300987|12463254|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0
7930893|NCT02300987|12463255|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1
7930894|NCT02301143|12463275|FG000|Induction Period|Enrolled But Not Treated|1
7930895|NCT02301143|12463276|FG001|Induction Period|Enrolled But Not Treated|0
7930896|NCT02301143|12463275|FG000|Induction Period|Death|1
7930897|NCT02301143|12463276|FG001|Induction Period|Death|0
7930898|NCT02301143|12463275|FG000|Induction Period|Adverse Event|22
7930899|NCT02301143|12463276|FG001|Induction Period|Adverse Event|0
7930900|NCT02301143|12463275|FG000|Induction Period|Progressive Disease|8
7930901|NCT02301143|12463276|FG001|Induction Period|Progressive Disease|0
7930902|NCT02301143|12463275|FG000|Induction Period|Withdrawal by Subject|3
7930903|NCT02301143|12463276|FG001|Induction Period|Withdrawal by Subject|0
7930904|NCT02301143|12463275|FG000|Induction Period|Noncompliance with Study Drug|1
7930905|NCT02301143|12463276|FG001|Induction Period|Noncompliance with Study Drug|0
7930906|NCT02301143|12463275|FG000|Induction Period|Physician Decision|4
7930907|NCT02301143|12463276|FG001|Induction Period|Physician Decision|0
7930908|NCT02301143|12463275|FG000|Induction Period|Symptomatic Deterioration|2
7930909|NCT02301143|12463276|FG001|Induction Period|Symptomatic Deterioration|0
7930910|NCT02301143|12463275|FG000|Induction Period|Protocol Violation|2
7930911|NCT02301143|12463276|FG001|Induction Period|Protocol Violation|0
7930912|NCT02301143|12463275|FG000|Induction Period|Other|1
7930913|NCT02301143|12463276|FG001|Induction Period|Other|0
7930914|NCT02301143|12463275|FG000|Investigator's Choice|Adverse Event|0
7930915|NCT02301143|12463276|FG001|Investigator's Choice|Adverse Event|3
7930916|NCT02301143|12463275|FG000|Investigator's Choice|Progressive Disease|0
7930917|NCT02301143|12463276|FG001|Investigator's Choice|Progressive Disease|3
7930918|NCT02301143|12463275|FG000|Investigator's Choice|Noncompliance With Study Drug|0
7930919|NCT02301143|12463276|FG001|Investigator's Choice|Noncompliance With Study Drug|1
7930920|NCT02301143|12463275|FG000|Investigator's Choice|Symptomatic Deterioration|0
7930921|NCT02301143|12463276|FG001|Investigator's Choice|Symptomatic Deterioration|1
7930922|NCT02301143|12463275|FG000|Investigator's Choice|Other|0
7930923|NCT02301143|12463276|FG001|Investigator's Choice|Other|1
7822097|NCT01259726|12291066|FG001|Overall Study|Physician Decision|0
7822098|NCT01259726|12291067|FG002|Overall Study|Physician Decision|1
7822099|NCT01259726|12291068|FG003|Overall Study|Physician Decision|1
7822100|NCT01259726|12291065|FG000|Overall Study|Withdrawal by Subject|1
7822101|NCT01259726|12291066|FG001|Overall Study|Withdrawal by Subject|3
7822102|NCT01259726|12291067|FG002|Overall Study|Withdrawal by Subject|2
7822103|NCT01259726|12291068|FG003|Overall Study|Withdrawal by Subject|1
7822104|NCT01259726|12291065|FG000|Overall Study|Lost to Follow-up|1
7822105|NCT01259726|12291066|FG001|Overall Study|Lost to Follow-up|1
7822106|NCT01259726|12291067|FG002|Overall Study|Lost to Follow-up|1
7822107|NCT01259726|12291068|FG003|Overall Study|Lost to Follow-up|3
7822108|NCT01259856|12291080|FG000|Overall Study|Adverse Event|12
7822109|NCT01259856|12291081|FG001|Overall Study|Adverse Event|9
7822110|NCT01259856|12291080|FG000|Overall Study|Death|0
7822111|NCT01259856|12291081|FG001|Overall Study|Death|1
7822112|NCT01259856|12291080|FG000|Overall Study|Lack of Efficacy|3
7822113|NCT01259856|12291081|FG001|Overall Study|Lack of Efficacy|1
7822114|NCT01259856|12291080|FG000|Overall Study|Lost to Follow-up|1
7822115|NCT01259856|12291081|FG001|Overall Study|Lost to Follow-up|1
7822116|NCT01259856|12291080|FG000|Overall Study|Physician Decision|2
7822117|NCT01259856|12291081|FG001|Overall Study|Physician Decision|1
7930924|NCT02301143|12463275|FG000|Investigator's Choice|Unresectable Surgery|0
7930925|NCT02301143|12463276|FG001|Investigator's Choice|Unresectable Surgery|1
7930926|NCT02301169|12463289|FG000|Overall Study|Adverse Event|1
7930927|NCT02301169|12463290|FG001|Overall Study|Adverse Event|0
7930928|NCT02301390|12463318|FG000|Overall Study|Withdrawal by Subject|3
7930929|NCT02301390|12463319|FG001|Overall Study|Withdrawal by Subject|5
7930930|NCT02301390|12463318|FG000|Overall Study|Protocol Violation|1
7930931|NCT02301390|12463319|FG001|Overall Study|Protocol Violation|0
7930932|NCT02301390|12463318|FG000|Overall Study|Physician Decision|1
7930933|NCT02301390|12463319|FG001|Overall Study|Physician Decision|0
7930934|NCT02301390|12463318|FG000|Overall Study|Lost to Follow-up|0
7930935|NCT02301390|12463319|FG001|Overall Study|Lost to Follow-up|1
7930936|NCT02301390|12463318|FG000|Overall Study|Death|2
7930937|NCT02301390|12463319|FG001|Overall Study|Death|2
7930938|NCT02301390|12463318|FG000|Overall Study|Procedure not completed|0
7930939|NCT02301390|12463319|FG001|Overall Study|Procedure not completed|4
7930940|NCT02301390|12463318|FG000|Overall Study|Missed multiple visits|1
7930941|NCT02301390|12463319|FG001|Overall Study|Missed multiple visits|1
7930942|NCT02301390|12463318|FG000|Overall Study|study terminated|2
7930943|NCT02301390|12463319|FG001|Overall Study|study terminated|0
7930944|NCT02301403|12463327|FG000|Overall Study|Withdrawal by Subject|28
7930945|NCT02301403|12463328|FG001|Overall Study|Withdrawal by Subject|41
7930946|NCT02301429|12463343|FG000|Overall Study|not acceptable vascular anatomy|3
7930947|NCT02301546|12463349|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7
7930948|NCT02301546|12463350|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8
7930949|NCT02301546|12463349|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10
7930950|NCT02301546|12463350|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7
7930951|NCT02301546|12463349|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1
7930952|NCT02301546|12463350|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0
7930953|NCT02301546|12463349|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
7930954|NCT02301546|12463350|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
7930955|NCT02301546|12463349|FG000|Long Term Effectiveness (~1 Year)|Death|2
7930956|NCT02301546|12463350|FG001|Long Term Effectiveness (~1 Year)|Death|0
7930957|NCT02301546|12463349|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6
7930958|NCT02301546|12463350|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2
7930959|NCT02301546|12463349|FG000|Long Term Effectiveness (~1 Year)|moved away|1
7930960|NCT02301546|12463350|FG001|Long Term Effectiveness (~1 Year)|moved away|2
7930961|NCT02301624|12463358|FG000|Blind Induction Phase|Withdrawal by Subject|1
7930962|NCT02301624|12463359|FG001|Blind Induction Phase|Withdrawal by Subject|0
7930963|NCT02301624|12463358|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4
7930964|NCT02301624|12463359|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8
7930965|NCT02301624|12463358|FG000|Open-label Maintenance Phase|Adverse Event|2
7930966|NCT02301624|12463359|FG001|Open-label Maintenance Phase|Adverse Event|5
7930967|NCT02301624|12463358|FG000|Open-label Maintenance Phase|Physician Decision|3
7930968|NCT02301624|12463359|FG001|Open-label Maintenance Phase|Physician Decision|3
7930969|NCT02301624|12463358|FG000|Open-label Maintenance Phase|Death|2
7930970|NCT02301624|12463359|FG001|Open-label Maintenance Phase|Death|1
7930971|NCT02301624|12463358|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1
7930972|NCT02301624|12463359|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0
7930973|NCT02301897|12463378|FG000|Treatment Course 1|Non-Compliance|0
7930974|NCT02301897|12463379|FG001|Treatment Course 1|Non-Compliance|0
7930975|NCT02301897|12463380|FG002|Treatment Course 1|Non-Compliance|1
7930976|NCT02301897|12463378|FG000|Treatment Course 1|Adverse Event|1
7930977|NCT02301897|12463379|FG001|Treatment Course 1|Adverse Event|1
7930978|NCT02301897|12463380|FG002|Treatment Course 1|Adverse Event|0
7930979|NCT02301897|12463378|FG000|Treatment Course 1|Lost to Follow-up|1
7719706|NCT00533897|12143616|FG001|Long Term Extension (LTE)|Pregnancy|0
7719707|NCT00533897|12143617|FG002|Long Term Extension (LTE)|Pregnancy|0
7719708|NCT00533897|12143618|FG003|Long Term Extension (LTE)|Pregnancy|0
7719709|NCT00533897|12143619|FG004|Long Term Extension (LTE)|Pregnancy|0
7719710|NCT00533897|12143620|FG005|Long Term Extension (LTE)|Pregnancy|0
7719711|NCT00533897|12143621|FG006|Long Term Extension (LTE)|Pregnancy|0
7719712|NCT00533897|12143622|FG007|Long Term Extension (LTE)|Pregnancy|2
7719713|NCT00533897|12143615|FG000|Long Term Extension (LTE)|Lost to Follow-up|0
7719714|NCT00533897|12143616|FG001|Long Term Extension (LTE)|Lost to Follow-up|0
7930980|NCT02301897|12463379|FG001|Treatment Course 1|Lost to Follow-up|2
7930981|NCT02301897|12463380|FG002|Treatment Course 1|Lost to Follow-up|1
7930982|NCT02301897|12463378|FG000|Treatment Course 1|Withdrawal by Sponsor|0
7930983|NCT02301897|12463379|FG001|Treatment Course 1|Withdrawal by Sponsor|0
7719715|NCT00533897|12143617|FG002|Long Term Extension (LTE)|Lost to Follow-up|0
7930984|NCT02301897|12463380|FG002|Treatment Course 1|Withdrawal by Sponsor|2
7930985|NCT02301897|12463378|FG000|Treatment Course 1|Withdrawal by Subject|0
7930986|NCT02301897|12463379|FG001|Treatment Course 1|Withdrawal by Subject|0
7930987|NCT02301897|12463380|FG002|Treatment Course 1|Withdrawal by Subject|2
7930988|NCT02301897|12463378|FG000|Treatment Course 1|Other Miscellaneous Reasons|1
7930989|NCT02301897|12463379|FG001|Treatment Course 1|Other Miscellaneous Reasons|0
7930990|NCT02301897|12463380|FG002|Treatment Course 1|Other Miscellaneous Reasons|0
7930991|NCT02301897|12463378|FG000|Treatment Course 2|Lost to Follow-up|0
7930992|NCT02301897|12463379|FG001|Treatment Course 2|Lost to Follow-up|2
7930993|NCT02301897|12463380|FG002|Treatment Course 2|Lost to Follow-up|0
7930994|NCT02301897|12463378|FG000|Treatment Course 2|Pregnancy|0
7930995|NCT02301897|12463379|FG001|Treatment Course 2|Pregnancy|1
7930996|NCT02301897|12463380|FG002|Treatment Course 2|Pregnancy|1
7930997|NCT02301897|12463378|FG000|Treatment Course 2|Withdrawal by Subject|0
7930998|NCT02301897|12463379|FG001|Treatment Course 2|Withdrawal by Subject|2
7930999|NCT02301897|12463380|FG002|Treatment Course 2|Withdrawal by Subject|0
7931000|NCT02301897|12463378|FG000|Treatment Course 2|Other Miscellaneous Reasons|1
7931001|NCT02301897|12463379|FG001|Treatment Course 2|Other Miscellaneous Reasons|0
7931002|NCT02301897|12463380|FG002|Treatment Course 2|Other Miscellaneous Reasons|0
7931003|NCT02301936|12463390|FG000|Overall Study|Lost to Follow-up|1
7931004|NCT02301936|12463391|FG001|Overall Study|Lost to Follow-up|0
7931005|NCT02301975|12463400|FG000|Overall Study|Adverse Event|8
7931006|NCT02301975|12463401|FG001|Overall Study|Adverse Event|3
7931007|NCT02301975|12463402|FG002|Overall Study|Adverse Event|2
7931008|NCT02301975|12463400|FG000|Overall Study|Lack of Efficacy|1
7931009|NCT02301975|12463401|FG001|Overall Study|Lack of Efficacy|1
7931010|NCT02301975|12463402|FG002|Overall Study|Lack of Efficacy|1
7931011|NCT02301975|12463400|FG000|Overall Study|Protocol Violation|3
7931012|NCT02301975|12463401|FG001|Overall Study|Protocol Violation|5
7931013|NCT02301975|12463402|FG002|Overall Study|Protocol Violation|3
7931014|NCT02301975|12463400|FG000|Overall Study|Lost to Follow-up|0
7931015|NCT02301975|12463401|FG001|Overall Study|Lost to Follow-up|2
7931016|NCT02301975|12463402|FG002|Overall Study|Lost to Follow-up|2
7931017|NCT02301975|12463400|FG000|Overall Study|Physician Decision|4
7931018|NCT02301975|12463401|FG001|Overall Study|Physician Decision|2
7719716|NCT00533897|12143618|FG003|Long Term Extension (LTE)|Lost to Follow-up|0
7719717|NCT00533897|12143619|FG004|Long Term Extension (LTE)|Lost to Follow-up|0
7719718|NCT00533897|12143620|FG005|Long Term Extension (LTE)|Lost to Follow-up|0
7719719|NCT00533897|12143621|FG006|Long Term Extension (LTE)|Lost to Follow-up|1
7719720|NCT00533897|12143622|FG007|Long Term Extension (LTE)|Lost to Follow-up|1
7719721|NCT00533897|12143615|FG000|Long Term Extension (LTE)|Other|0
7931019|NCT02301975|12463402|FG002|Overall Study|Physician Decision|3
7931020|NCT02301975|12463400|FG000|Overall Study|Withdrawal by Subject|15
7931021|NCT02301975|12463401|FG001|Overall Study|Withdrawal by Subject|12
7931022|NCT02301975|12463402|FG002|Overall Study|Withdrawal by Subject|11
7931023|NCT02301988|12463412|FG000|Overall Study|Withdrawal by Subject|2
7931024|NCT02301988|12463413|FG001|Overall Study|Withdrawal by Subject|1
7931025|NCT02301988|12463412|FG000|Overall Study|Physician Decision|2
7931026|NCT02301988|12463413|FG001|Overall Study|Physician Decision|2
7931027|NCT02301988|12463412|FG000|Overall Study|Unknown Reason|1
7931028|NCT02301988|12463413|FG001|Overall Study|Unknown Reason|3
7931029|NCT02301988|12463412|FG000|Overall Study|Lack of Efficacy|3
7931030|NCT02301988|12463413|FG001|Overall Study|Lack of Efficacy|2
7931031|NCT02301988|12463412|FG000|Overall Study|Death|1
7931032|NCT02301988|12463413|FG001|Overall Study|Death|0
7931033|NCT02301988|12463412|FG000|Overall Study|Adverse Event|1
7931034|NCT02301988|12463413|FG001|Overall Study|Adverse Event|1
7931035|NCT02302066|12463423|FG000|Overall Study|Adverse Event|1
7931036|NCT02302066|12463424|FG001|Overall Study|Adverse Event|1
7931037|NCT02302066|12463425|FG002|Overall Study|Adverse Event|3
7931038|NCT02302066|12463426|FG003|Overall Study|Adverse Event|0
7931039|NCT02302066|12463423|FG000|Overall Study|Lost to Follow-up|4
7931040|NCT02302066|12463424|FG001|Overall Study|Lost to Follow-up|5
7931041|NCT02302066|12463425|FG002|Overall Study|Lost to Follow-up|24
7931042|NCT02302066|12463426|FG003|Overall Study|Lost to Follow-up|7
7931043|NCT02302066|12463423|FG000|Overall Study|Withdrawal by Subject|25
7931044|NCT02302066|12463424|FG001|Overall Study|Withdrawal by Subject|58
7931045|NCT02302066|12463425|FG002|Overall Study|Withdrawal by Subject|124
7931046|NCT02302066|12463426|FG003|Overall Study|Withdrawal by Subject|33
7931047|NCT02302066|12463423|FG000|Overall Study|Pregnancy|2
7931048|NCT02302066|12463424|FG001|Overall Study|Pregnancy|10
7931049|NCT02302066|12463425|FG002|Overall Study|Pregnancy|12
7931050|NCT02302066|12463426|FG003|Overall Study|Pregnancy|0
7931051|NCT02302066|12463423|FG000|Overall Study|Reason Not Specified|1
7931052|NCT02302066|12463424|FG001|Overall Study|Reason Not Specified|1
7931053|NCT02302066|12463425|FG002|Overall Study|Reason Not Specified|9
7931054|NCT02302066|12463426|FG003|Overall Study|Reason Not Specified|1
7931055|NCT02302339|12463485|FG000|Overall Study|Lost to Follow-up|1
7931056|NCT02302339|12463486|FG001|Overall Study|Lost to Follow-up|0
7931057|NCT02302339|12463487|FG002|Overall Study|Lost to Follow-up|0
7931058|NCT02302339|12463488|FG003|Overall Study|Lost to Follow-up|0
7931059|NCT02302339|12463485|FG000|Overall Study|Withdrawal by Subject|0
7931060|NCT02302339|12463486|FG001|Overall Study|Withdrawal by Subject|2
7931061|NCT02302339|12463487|FG002|Overall Study|Withdrawal by Subject|1
7931062|NCT02302339|12463488|FG003|Overall Study|Withdrawal by Subject|0
7931063|NCT02302716|12463509|FG000|Overall Study|Adverse Event|1
7931064|NCT02302716|12463510|FG001|Overall Study|Adverse Event|1
7931065|NCT02302716|12463509|FG000|Overall Study|Death|0
7931066|NCT02302716|12463510|FG001|Overall Study|Death|1
7931067|NCT02302716|12463509|FG000|Overall Study|Lack of Efficacy|0
7931068|NCT02302716|12463510|FG001|Overall Study|Lack of Efficacy|1
7931069|NCT02302716|12463509|FG000|Overall Study|Lost to Follow-up|2
7931070|NCT02302716|12463510|FG001|Overall Study|Lost to Follow-up|4
7931071|NCT02302716|12463509|FG000|Overall Study|Physician Decision|3
7931072|NCT02302716|12463510|FG001|Overall Study|Physician Decision|4
7931073|NCT02302716|12463509|FG000|Overall Study|Withdrawal by Subject|13
7931074|NCT02302716|12463510|FG001|Overall Study|Withdrawal by Subject|7
7931075|NCT02302716|12463509|FG000|Overall Study|Protocol Violation|0
7931076|NCT02302716|12463510|FG001|Overall Study|Protocol Violation|1
7931077|NCT02302807|12463518|FG000|Overall Study|Withdrawal by Subject|28
7931078|NCT02302807|12463519|FG001|Overall Study|Withdrawal by Subject|11
7931079|NCT02302807|12463518|FG000|Overall Study|Lost to Follow-up|4
7931080|NCT02302807|12463519|FG001|Overall Study|Lost to Follow-up|6
7931081|NCT02302807|12463518|FG000|Overall Study|Death|397
7931082|NCT02302807|12463519|FG001|Overall Study|Death|385
7931083|NCT02302807|12463518|FG000|Overall Study|Study Terminated By Sponsor|35
7931084|NCT02302807|12463519|FG001|Overall Study|Study Terminated By Sponsor|64
7931085|NCT02302807|12463518|FG000|Overall Study|Physician Decision|0
7931086|NCT02302807|12463519|FG001|Overall Study|Physician Decision|1
7931087|NCT02302846|12463538|FG000|Overall Study|Withdrawal by Subject|1
7931088|NCT02303041|12463544|FG000|Overall Study|Adverse Event|1
7931089|NCT02303041|12463545|FG001|Overall Study|Adverse Event|2
7931090|NCT02303262|12463576|FG000|Overall Study|Withdrawal by Subject|2
7931091|NCT02303574|12463592|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7931092|NCT02303574|12463593|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7931093|NCT02303574|12463594|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
7931094|NCT02303574|12463595|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7931095|NCT02303574|12463596|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7931096|NCT02303574|12463597|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7931097|NCT02303574|12463598|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7931098|NCT02303574|12463599|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7931099|NCT02303574|12463600|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7931100|NCT02303574|12463601|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7931101|NCT02303574|12463592|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7931102|NCT02303574|12463593|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7931103|NCT02303574|12463594|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7931104|NCT02303574|12463595|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7931105|NCT02303574|12463596|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7931106|NCT02303574|12463597|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7931107|NCT02303574|12463598|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7931108|NCT02303574|12463599|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
7931109|NCT02303574|12463600|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7931110|NCT02303574|12463601|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7931111|NCT02303704|12463636|FG000|Overall Study|Protocol Violation|5
7931112|NCT02303704|12463637|FG001|Overall Study|Protocol Violation|9
7931113|NCT02304380|12463676|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7931114|NCT02304380|12463677|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7931115|NCT02304380|12463678|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7931116|NCT02304380|12463679|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34
7931117|NCT02304380|12463680|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7931118|NCT02304380|12463681|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7931119|NCT02304484|12463717|FG000|Overall Study|Death|9
7931120|NCT02304484|12463717|FG000|Overall Study|Withdrawal by Subject|14
7931121|NCT02304484|12463717|FG000|Overall Study|Lost to Follow-up|2
7931122|NCT02304705|12463723|FG000|Overall Study|Withdrawal by Subject|2
7931123|NCT02304705|12463724|FG001|Overall Study|Withdrawal by Subject|0
7931124|NCT02304705|12463723|FG000|Overall Study|Physician Decision|2
7931125|NCT02304705|12463724|FG001|Overall Study|Physician Decision|4
7931126|NCT02304705|12463723|FG000|Overall Study|Death|0
7931127|NCT02304705|12463724|FG001|Overall Study|Death|1
7931128|NCT02304705|12463723|FG000|Overall Study|Lost to Follow-up|0
7931129|NCT02304705|12463724|FG001|Overall Study|Lost to Follow-up|2
7931130|NCT02304926|12463741|FG000|Overall Study|Lost to Follow-up|2
7931131|NCT02304926|12463742|FG001|Overall Study|Lost to Follow-up|1
7931132|NCT02305238|12463766|FG000|Overall Study|Death|2
7931133|NCT02305238|12463767|FG001|Overall Study|Death|1
7931134|NCT02305238|12463768|FG002|Overall Study|Death|0
7931135|NCT02305238|12463766|FG000|Overall Study|Progressive disease|4
7931136|NCT02305238|12463767|FG001|Overall Study|Progressive disease|4
7931137|NCT02305238|12463768|FG002|Overall Study|Progressive disease|0
7931138|NCT02305238|12463766|FG000|Overall Study|Logistical difficulties|1
7931139|NCT02305238|12463767|FG001|Overall Study|Logistical difficulties|3
7931140|NCT02305238|12463768|FG002|Overall Study|Logistical difficulties|0
7931141|NCT02305238|12463766|FG000|Overall Study|Protocol Violation|0
7931142|NCT02305238|12463767|FG001|Overall Study|Protocol Violation|3
7931143|NCT02305238|12463768|FG002|Overall Study|Protocol Violation|0
7931144|NCT02305238|12463766|FG000|Overall Study|Physician Decision|2
7931145|NCT02305238|12463767|FG001|Overall Study|Physician Decision|1
7931146|NCT02305238|12463768|FG002|Overall Study|Physician Decision|0
7931147|NCT02305238|12463766|FG000|Overall Study|Adverse Event|4
7931148|NCT02305238|12463767|FG001|Overall Study|Adverse Event|2
7931149|NCT02305238|12463768|FG002|Overall Study|Adverse Event|0
7931150|NCT02305238|12463766|FG000|Overall Study|Withdrawal by Subject|3
7931151|NCT02305238|12463767|FG001|Overall Study|Withdrawal by Subject|4
7931152|NCT02305238|12463768|FG002|Overall Study|Withdrawal by Subject|0
7931153|NCT02305238|12463766|FG000|Overall Study|Randomized failure|0
7931154|NCT02305238|12463767|FG001|Overall Study|Randomized failure|0
7931155|NCT02305238|12463768|FG002|Overall Study|Randomized failure|8
7931156|NCT02305238|12463766|FG000|Overall Study|Required procedure failed|0
7931157|NCT02305238|12463767|FG001|Overall Study|Required procedure failed|1
7931158|NCT02305238|12463768|FG002|Overall Study|Required procedure failed|0
7931159|NCT02305381|12463829|FG000|Overall Study|Unclassified|5
7931160|NCT02305381|12463830|FG001|Overall Study|Unclassified|5
7931161|NCT02305381|12463831|FG002|Overall Study|Unclassified|7
7931162|NCT02305446|12463839|FG000|Overall Study|Adverse Event|1
7931163|NCT02305563|12463848|FG000|Treatment Period|Disease progression|0
7931164|NCT02305563|12463849|FG001|Treatment Period|Disease progression|0
7931165|NCT02305563|12463850|FG002|Treatment Period|Disease progression|15
7931166|NCT02305563|12463851|FG003|Treatment Period|Disease progression|6
7931167|NCT02305563|12463852|FG004|Treatment Period|Disease progression|6
7931168|NCT02305563|12463848|FG000|Treatment Period|Study drug toxicity|0
7931169|NCT02305563|12463849|FG001|Treatment Period|Study drug toxicity|0
7931170|NCT02305563|12463850|FG002|Treatment Period|Study drug toxicity|0
7931171|NCT02305563|12463851|FG003|Treatment Period|Study drug toxicity|1
7931172|NCT02305563|12463852|FG004|Treatment Period|Study drug toxicity|2
7931173|NCT02305563|12463848|FG000|Treatment Period|Death|0
7931174|NCT02305563|12463849|FG001|Treatment Period|Death|0
7931175|NCT02305563|12463850|FG002|Treatment Period|Death|1
7931176|NCT02305563|12463851|FG003|Treatment Period|Death|2
7931177|NCT02305563|12463852|FG004|Treatment Period|Death|1
7931178|NCT02305563|12463848|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0
7931179|NCT02305563|12463849|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0
7931180|NCT02305563|12463850|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7
7931181|NCT02305563|12463851|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1
7931182|NCT02305563|12463852|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2
7931183|NCT02305563|12463848|FG000|Treatment Period|Participant request to stop therapy|0
7931184|NCT02305563|12463849|FG001|Treatment Period|Participant request to stop therapy|2
7931185|NCT02305563|12463850|FG002|Treatment Period|Participant request to stop therapy|0
7931186|NCT02305563|12463851|FG003|Treatment Period|Participant request to stop therapy|1
7931187|NCT02305563|12463852|FG004|Treatment Period|Participant request to stop therapy|0
7931188|NCT02305563|12463848|FG000|Treatment Period|Participant withdrew consent|0
7931189|NCT02305563|12463849|FG001|Treatment Period|Participant withdrew consent|0
7931190|NCT02305563|12463850|FG002|Treatment Period|Participant withdrew consent|1
7931191|NCT02305563|12463851|FG003|Treatment Period|Participant withdrew consent|1
7931192|NCT02305563|12463852|FG004|Treatment Period|Participant withdrew consent|1
7931193|NCT02305563|12463848|FG000|Treatment Period|Maximum clinical benefit|0
7931194|NCT02305563|12463849|FG001|Treatment Period|Maximum clinical benefit|0
7931195|NCT02305563|12463850|FG002|Treatment Period|Maximum clinical benefit|0
7931196|NCT02305563|12463851|FG003|Treatment Period|Maximum clinical benefit|0
7931197|NCT02305563|12463852|FG004|Treatment Period|Maximum clinical benefit|1
7931198|NCT02305563|12463848|FG000|Treatment Period|Poor/non-compliance|0
7931199|NCT02305563|12463849|FG001|Treatment Period|Poor/non-compliance|0
7931200|NCT02305563|12463850|FG002|Treatment Period|Poor/non-compliance|0
7931201|NCT02305563|12463851|FG003|Treatment Period|Poor/non-compliance|0
7931202|NCT02305563|12463852|FG004|Treatment Period|Poor/non-compliance|1
7931203|NCT02305563|12463848|FG000|Treatment Period|Administrative reason by Sponsor|0
7931204|NCT02305563|12463849|FG001|Treatment Period|Administrative reason by Sponsor|0
7931205|NCT02305563|12463850|FG002|Treatment Period|Administrative reason by Sponsor|0
7931206|NCT02305563|12463851|FG003|Treatment Period|Administrative reason by Sponsor|0
7931207|NCT02305563|12463852|FG004|Treatment Period|Administrative reason by Sponsor|1
7931208|NCT02305563|12463848|FG000|Treatment Period|other reason|2
7931209|NCT02305563|12463849|FG001|Treatment Period|other reason|0
7931210|NCT02305563|12463850|FG002|Treatment Period|other reason|2
7931211|NCT02305563|12463851|FG003|Treatment Period|other reason|2
7931212|NCT02305563|12463852|FG004|Treatment Period|other reason|1
7931213|NCT02305563|12463848|FG000|Treatment Period|Randomized but not treated|0
7931214|NCT02305563|12463849|FG001|Treatment Period|Randomized but not treated|0
7931215|NCT02305563|12463850|FG002|Treatment Period|Randomized but not treated|0
7931216|NCT02305563|12463851|FG003|Treatment Period|Randomized but not treated|0
7931217|NCT02305563|12463852|FG004|Treatment Period|Randomized but not treated|2
7931218|NCT02305563|12463848|FG000|Treatment Period|added ULO, then disease progression|0
7931219|NCT02305563|12463849|FG001|Treatment Period|added ULO, then disease progression|0
7931220|NCT02305563|12463850|FG002|Treatment Period|added ULO, then disease progression|0
7931221|NCT02305563|12463851|FG003|Treatment Period|added ULO, then disease progression|0
7931222|NCT02305563|12463852|FG004|Treatment Period|added ULO, then disease progression|4
7931223|NCT02305563|12463848|FG000|Treatment Period|added ULO; then other reason|0
7931224|NCT02305563|12463849|FG001|Treatment Period|added ULO; then other reason|0
7931225|NCT02305563|12463850|FG002|Treatment Period|added ULO; then other reason|0
7931226|NCT02305563|12463851|FG003|Treatment Period|added ULO; then other reason|0
7931227|NCT02305563|12463852|FG004|Treatment Period|added ULO; then other reason|1
7931228|NCT02305563|12463848|FG000|Treatment Period|added ULO, then request to stop|0
7931229|NCT02305563|12463849|FG001|Treatment Period|added ULO, then request to stop|0
7931230|NCT02305563|12463850|FG002|Treatment Period|added ULO, then request to stop|0
7931231|NCT02305563|12463851|FG003|Treatment Period|added ULO, then request to stop|0
7931232|NCT02305563|12463852|FG004|Treatment Period|added ULO, then request to stop|1
7931233|NCT02305563|12463848|FG000|Follow-up Period|Death|0
7931234|NCT02305563|12463849|FG001|Follow-up Period|Death|0
7931235|NCT02305563|12463850|FG002|Follow-up Period|Death|5
7931236|NCT02305563|12463851|FG003|Follow-up Period|Death|4
7931237|NCT02305563|12463852|FG004|Follow-up Period|Death|7
7931238|NCT02305563|12463848|FG000|Follow-up Period|Participant withdrew consent|0
7931239|NCT02305563|12463849|FG001|Follow-up Period|Participant withdrew consent|0
7931240|NCT02305563|12463850|FG002|Follow-up Period|Participant withdrew consent|2
7931241|NCT02305563|12463851|FG003|Follow-up Period|Participant withdrew consent|1
7931242|NCT02305563|12463852|FG004|Follow-up Period|Participant withdrew consent|0
7931243|NCT02305563|12463848|FG000|Follow-up Period|other reason|0
7931244|NCT02305563|12463849|FG001|Follow-up Period|other reason|0
7931245|NCT02305563|12463850|FG002|Follow-up Period|other reason|0
7931246|NCT02305563|12463851|FG003|Follow-up Period|other reason|0
7931247|NCT02305563|12463852|FG004|Follow-up Period|other reason|1
7931248|NCT02305563|12463848|FG000|Follow-up Period|Followup no longer required per protocol|3
7931249|NCT02305563|12463849|FG001|Follow-up Period|Followup no longer required per protocol|3
7931250|NCT02305563|12463850|FG002|Follow-up Period|Followup no longer required per protocol|4
7931251|NCT02305563|12463851|FG003|Follow-up Period|Followup no longer required per protocol|1
7931252|NCT02305563|12463852|FG004|Follow-up Period|Followup no longer required per protocol|4
7931253|NCT02305758|12463875|FG000|Overall Study|Death|27
7931254|NCT02305758|12463876|FG001|Overall Study|Death|27
7931255|NCT02305758|12463875|FG000|Overall Study|Withdrew consent|9
7931256|NCT02305758|12463876|FG001|Overall Study|Withdrew consent|2
7931257|NCT02305758|12463875|FG000|Overall Study|Lost to Follow-up|6
7931258|NCT02305758|12463876|FG001|Overall Study|Lost to Follow-up|1
7931259|NCT02305758|12463875|FG000|Overall Study|Study Terminated by Sponsor|21
7931260|NCT02305758|12463876|FG001|Overall Study|Study Terminated by Sponsor|34
7931261|NCT02305758|12463875|FG000|Overall Study|Other, not specified|2
7931262|NCT02305758|12463876|FG001|Overall Study|Other, not specified|1
7931263|NCT02305797|12463884|FG000|Overall Study|Adverse Event|11
7931264|NCT02305797|12463885|FG001|Overall Study|Adverse Event|2
7931265|NCT02305797|12463884|FG000|Overall Study|Withdrawal by Subject|9
7931266|NCT02305797|12463885|FG001|Overall Study|Withdrawal by Subject|10
7931267|NCT02305797|12463884|FG000|Overall Study|Lack of Efficacy|6
7931268|NCT02305797|12463885|FG001|Overall Study|Lack of Efficacy|0
7931269|NCT02305797|12463884|FG000|Overall Study|Lost to Follow-up|5
7931270|NCT02305797|12463885|FG001|Overall Study|Lost to Follow-up|11
7931271|NCT02305797|12463884|FG000|Overall Study|Pregnancy|0
7931272|NCT02305797|12463885|FG001|Overall Study|Pregnancy|2
7931273|NCT02305797|12463884|FG000|Overall Study|Noncompliance|14
7931274|NCT02305797|12463885|FG001|Overall Study|Noncompliance|12
7931275|NCT02305797|12463884|FG000|Overall Study|Reason not collected|0
7931276|NCT02305797|12463885|FG001|Overall Study|Reason not collected|1
7931277|NCT02305849|12463894|FG000|Overall Study|Adverse Event|10
7931278|NCT02305849|12463895|FG001|Overall Study|Adverse Event|12
7931279|NCT02305849|12463896|FG002|Overall Study|Adverse Event|7
7931280|NCT02305849|12463897|FG003|Overall Study|Adverse Event|3
7931281|NCT02305849|12463894|FG000|Overall Study|Lack of Efficacy|10
7931282|NCT02305849|12463895|FG001|Overall Study|Lack of Efficacy|6
7931283|NCT02305849|12463896|FG002|Overall Study|Lack of Efficacy|3
7931284|NCT02305849|12463897|FG003|Overall Study|Lack of Efficacy|9
7931285|NCT02305849|12463894|FG000|Overall Study|Withdrawal by Subject|2
7931286|NCT02305849|12463895|FG001|Overall Study|Withdrawal by Subject|2
7931287|NCT02305849|12463896|FG002|Overall Study|Withdrawal by Subject|1
7931288|NCT02305849|12463897|FG003|Overall Study|Withdrawal by Subject|4
7931289|NCT02305849|12463894|FG000|Overall Study|Lost to Follow-up|0
7931290|NCT02305849|12463895|FG001|Overall Study|Lost to Follow-up|2
7931291|NCT02305849|12463896|FG002|Overall Study|Lost to Follow-up|0
7931292|NCT02305849|12463897|FG003|Overall Study|Lost to Follow-up|0
7931293|NCT02305849|12463894|FG000|Overall Study|Protocol Violation|3
7931294|NCT02305849|12463895|FG001|Overall Study|Protocol Violation|2
7931295|NCT02305849|12463896|FG002|Overall Study|Protocol Violation|1
7931296|NCT02305849|12463897|FG003|Overall Study|Protocol Violation|1
7931297|NCT02305849|12463894|FG000|Overall Study|Lab data met discontinuation criteria|0
7931298|NCT02305849|12463895|FG001|Overall Study|Lab data met discontinuation criteria|1
7931299|NCT02305849|12463896|FG002|Overall Study|Lab data met discontinuation criteria|2
7931300|NCT02305849|12463897|FG003|Overall Study|Lab data met discontinuation criteria|1
7931301|NCT02305849|12463894|FG000|Overall Study|Miscellaneous|1
7931302|NCT02305849|12463895|FG001|Overall Study|Miscellaneous|2
7931303|NCT02305849|12463896|FG002|Overall Study|Miscellaneous|4
7931304|NCT02305849|12463897|FG003|Overall Study|Miscellaneous|1
7931305|NCT02305849|12463894|FG000|Overall Study|Not fulfill eligibility criteria|1
7931306|NCT02305849|12463895|FG001|Overall Study|Not fulfill eligibility criteria|1
7931307|NCT02305849|12463896|FG002|Overall Study|Not fulfill eligibility criteria|0
7931308|NCT02305849|12463897|FG003|Overall Study|Not fulfill eligibility criteria|0
7931309|NCT02305888|12463931|FG000|Overall Study|Lost to Follow-up|0
7822118|NCT01259856|12291080|FG000|Overall Study|Withdrawal by Subject|9
7822119|NCT01259856|12291081|FG001|Overall Study|Withdrawal by Subject|10
7931310|NCT02305888|12463932|FG001|Overall Study|Lost to Follow-up|0
7931311|NCT02305888|12463933|FG002|Overall Study|Lost to Follow-up|1
7931312|NCT02305888|12463931|FG000|Overall Study|Adverse Event|0
7931313|NCT02305888|12463932|FG001|Overall Study|Adverse Event|1
7931314|NCT02305888|12463933|FG002|Overall Study|Adverse Event|0
7931315|NCT02306265|12463941|FG000|Overall Study|Withdrawal by Subject|1
7931316|NCT02306694|12463946|FG000|Overall Study|Withdrawal by Subject|3
7931317|NCT02306694|12463946|FG000|Overall Study|Lost to Follow-up|1
7964762|NCT01085084|12520435|FG002|Overall Study|Lost to Follow-up|1
7964763|NCT01085084|12520433|FG000|Overall Study|Adverse Event|4
7964764|NCT01085084|12520434|FG001|Overall Study|Adverse Event|3
7964765|NCT01085084|12520435|FG002|Overall Study|Adverse Event|6
7964766|NCT01085084|12520433|FG000|Overall Study|Treatment Failure|0
7964767|NCT01085084|12520434|FG001|Overall Study|Treatment Failure|1
7964768|NCT01085084|12520435|FG002|Overall Study|Treatment Failure|2
7964769|NCT01084252|12520457|FG000|Phase 1 (120 Weeks)|Adverse Event|0
7964770|NCT01084252|12520458|FG001|Phase 1 (120 Weeks)|Adverse Event|0
7964771|NCT01084252|12520459|FG002|Phase 1 (120 Weeks)|Adverse Event|1
7964772|NCT01084252|12520460|FG003|Phase 1 (120 Weeks)|Adverse Event|1
7964773|NCT01084252|12520461|FG004|Phase 1 (120 Weeks)|Adverse Event|1
7964774|NCT01084252|12520462|FG005|Phase 1 (120 Weeks)|Adverse Event|0
7964775|NCT01084252|12520463|FG006|Phase 1 (120 Weeks)|Adverse Event|1
7964776|NCT01084252|12520464|FG007|Phase 1 (120 Weeks)|Adverse Event|0
7964777|NCT01084252|12520465|FG008|Phase 1 (120 Weeks)|Adverse Event|0
7964778|NCT01084252|12520466|FG009|Phase 1 (120 Weeks)|Adverse Event|0
7964779|NCT01084252|12520467|FG010|Phase 1 (120 Weeks)|Adverse Event|0
7964780|NCT01084252|12520468|FG011|Phase 1 (120 Weeks)|Adverse Event|0
7964781|NCT01084252|12520469|FG012|Phase 1 (120 Weeks)|Adverse Event|0
7964782|NCT01084252|12520470|FG013|Phase 1 (120 Weeks)|Adverse Event|0
7964783|NCT01084252|12520457|FG000|Phase 1 (120 Weeks)|Progressive disease|15
7964784|NCT01084252|12520458|FG001|Phase 1 (120 Weeks)|Progressive disease|5
7964785|NCT01084252|12520459|FG002|Phase 1 (120 Weeks)|Progressive disease|2
7964786|NCT01084252|12520460|FG003|Phase 1 (120 Weeks)|Progressive disease|22
7964787|NCT01084252|12520461|FG004|Phase 1 (120 Weeks)|Progressive disease|16
7964788|NCT01084252|12520462|FG005|Phase 1 (120 Weeks)|Progressive disease|6
7822120|NCT01259856|12291080|FG000|Overall Study|Treatment never started|0
7822121|NCT01259856|12291081|FG001|Overall Study|Treatment never started|6
7822122|NCT01259856|12291080|FG000|Overall Study|Study closure by sponsor|40
7822123|NCT01259856|12291081|FG001|Overall Study|Study closure by sponsor|41
7964789|NCT01084252|12520463|FG006|Phase 1 (120 Weeks)|Progressive disease|5
7964790|NCT01084252|12520464|FG007|Phase 1 (120 Weeks)|Progressive disease|6
7931318|NCT02306850|12463961|FG000|Overall Study|Lack of Efficacy|2
7931319|NCT02307266|12463977|FG000|Overall Study|Adverse Event|3
7931320|NCT02307266|12463978|FG001|Overall Study|Adverse Event|1
7931321|NCT02307266|12463979|FG002|Overall Study|Adverse Event|5
7931322|NCT02307266|12463977|FG000|Overall Study|Withdrawal by Subject|2
7931323|NCT02307266|12463978|FG001|Overall Study|Withdrawal by Subject|0
7931324|NCT02307266|12463979|FG002|Overall Study|Withdrawal by Subject|1
7931325|NCT02307266|12463977|FG000|Overall Study|Lost to Follow-up|3
7931326|NCT02307266|12463978|FG001|Overall Study|Lost to Follow-up|0
7931327|NCT02307266|12463979|FG002|Overall Study|Lost to Follow-up|0
7931328|NCT02307370|12463991|FG000|Overall Study|Death|5
7931329|NCT02307370|12463991|FG000|Overall Study|Lost to Follow-up|1
7931330|NCT02307370|12463991|FG000|Overall Study|Withdrawal by Subject|1
7931331|NCT02307370|12463991|FG000|Overall Study|Declined Addendum ICF|6
7931332|NCT02307370|12463991|FG000|Overall Study|No response during telephone contact|5
7931333|NCT02307370|12463991|FG000|Overall Study|Protocol Violation|1
7964791|NCT01084252|12520465|FG008|Phase 1 (120 Weeks)|Progressive disease|0
7719722|NCT00533897|12143616|FG001|Long Term Extension (LTE)|Other|0
7719723|NCT00533897|12143617|FG002|Long Term Extension (LTE)|Other|0
7719724|NCT00533897|12143618|FG003|Long Term Extension (LTE)|Other|0
7719725|NCT00533897|12143619|FG004|Long Term Extension (LTE)|Other|0
7931334|NCT02307513|12463999|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4
7931335|NCT02307513|12464000|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3
7931336|NCT02307513|12463999|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8
7931337|NCT02307513|12464000|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0
7931338|NCT02307513|12463999|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1
7931339|NCT02307513|12464000|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0
7931340|NCT02307513|12463999|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5
7931341|NCT02307513|12464000|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4
7931342|NCT02307513|12463999|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1
7931343|NCT02307513|12464000|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0
7931344|NCT02307513|12463999|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
7931345|NCT02307513|12464000|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
7931346|NCT02307513|12463999|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0
7931347|NCT02307513|12464000|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1
7931348|NCT02307513|12463999|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4
7931349|NCT02307513|12464000|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9
7931350|NCT02307513|12463999|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
7931351|NCT02307513|12464000|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
7931352|NCT02307513|12463999|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
7931353|NCT02307513|12464000|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
7931354|NCT02307513|12463999|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
7931355|NCT02307513|12464000|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
7931356|NCT02307513|12463999|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1
7931357|NCT02307513|12464000|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0
7931358|NCT02307513|12463999|FG000|Long-term Extension|Physician Decision|1
7931359|NCT02307513|12464000|FG001|Long-term Extension|Physician Decision|0
7931360|NCT02307682|12464023|FG000|Overall Study|Adverse Event|9
7931361|NCT02307682|12464024|FG001|Overall Study|Adverse Event|8
7931362|NCT02307682|12464025|FG002|Overall Study|Adverse Event|12
7931363|NCT02307682|12464023|FG000|Overall Study|Lack of Efficacy|1
7931364|NCT02307682|12464024|FG001|Overall Study|Lack of Efficacy|0
7931365|NCT02307682|12464025|FG002|Overall Study|Lack of Efficacy|1
7931366|NCT02307682|12464023|FG000|Overall Study|Physician Decision|2
7931367|NCT02307682|12464024|FG001|Overall Study|Physician Decision|2
7931368|NCT02307682|12464025|FG002|Overall Study|Physician Decision|8
7931369|NCT02307682|12464023|FG000|Overall Study|Progressive Disease|1
7931370|NCT02307682|12464024|FG001|Overall Study|Progressive Disease|0
7931371|NCT02307682|12464025|FG002|Overall Study|Progressive Disease|0
7931372|NCT02307682|12464023|FG000|Overall Study|Withdrawal by Subject|26
7931373|NCT02307682|12464024|FG001|Overall Study|Withdrawal by Subject|34
7931374|NCT02307682|12464025|FG002|Overall Study|Withdrawal by Subject|23
7931375|NCT02307682|12464023|FG000|Overall Study|Death|9
7931376|NCT02307682|12464024|FG001|Overall Study|Death|7
7931377|NCT02307682|12464025|FG002|Overall Study|Death|12
7931378|NCT02307682|12464023|FG000|Overall Study|Lost to Follow-up|1
7931379|NCT02307682|12464024|FG001|Overall Study|Lost to Follow-up|5
7931380|NCT02307682|12464025|FG002|Overall Study|Lost to Follow-up|6
7931381|NCT02307682|12464023|FG000|Overall Study|Protocol Deviation|0
7931382|NCT02307682|12464024|FG001|Overall Study|Protocol Deviation|0
7931383|NCT02307682|12464025|FG002|Overall Study|Protocol Deviation|2
7931384|NCT02307682|12464023|FG000|Overall Study|Other|1
7931385|NCT02307682|12464024|FG001|Overall Study|Other|1
7931386|NCT02307682|12464025|FG002|Overall Study|Other|0
7931387|NCT02308007|12464059|FG000|Overall Study|Normal Gram stain or neg yeast culture|66
7931388|NCT02308007|12464060|FG001|Overall Study|Normal Gram stain or neg yeast culture|64
7931389|NCT02308007|12464061|FG002|Overall Study|Normal Gram stain or neg yeast culture|67
7931390|NCT02308007|12464059|FG000|Overall Study|Positive for STD at Baseline|7
7931391|NCT02308007|12464060|FG001|Overall Study|Positive for STD at Baseline|11
7931392|NCT02308007|12464061|FG002|Overall Study|Positive for STD at Baseline|7
7931393|NCT02308007|12464059|FG000|Overall Study|Lost to Follow-up|3
7931394|NCT02308007|12464060|FG001|Overall Study|Lost to Follow-up|0
7931395|NCT02308007|12464061|FG002|Overall Study|Lost to Follow-up|1
7931396|NCT02308020|12464075|FG000|Overall Study|Lost to Follow-up|1
7931397|NCT02308020|12464076|FG001|Overall Study|Lost to Follow-up|7
7931398|NCT02308020|12464077|FG002|Overall Study|Lost to Follow-up|0
7931399|NCT02308020|12464078|FG003|Overall Study|Lost to Follow-up|0
7931400|NCT02308020|12464079|FG004|Overall Study|Lost to Follow-up|1
7931401|NCT02308020|12464080|FG005|Overall Study|Lost to Follow-up|2
7931402|NCT02308020|12464075|FG000|Overall Study|Sponsor Decision|0
7931403|NCT02308020|12464076|FG001|Overall Study|Sponsor Decision|8
7931404|NCT02308020|12464077|FG002|Overall Study|Sponsor Decision|0
7931405|NCT02308020|12464078|FG003|Overall Study|Sponsor Decision|2
7931406|NCT02308020|12464079|FG004|Overall Study|Sponsor Decision|2
7931407|NCT02308020|12464080|FG005|Overall Study|Sponsor Decision|1
7931408|NCT02308020|12464075|FG000|Overall Study|Withdrawal by Subject|3
7931409|NCT02308020|12464076|FG001|Overall Study|Withdrawal by Subject|5
7931410|NCT02308020|12464077|FG002|Overall Study|Withdrawal by Subject|3
7931411|NCT02308020|12464078|FG003|Overall Study|Withdrawal by Subject|2
7931412|NCT02308020|12464079|FG004|Overall Study|Withdrawal by Subject|1
7931413|NCT02308020|12464080|FG005|Overall Study|Withdrawal by Subject|2
7931414|NCT02308033|12464102|FG000|Overall Study|Normal Gram stain at Baseline|13
7931415|NCT02308033|12464103|FG001|Overall Study|Normal Gram stain at Baseline|10
7931416|NCT02308033|12464102|FG000|Overall Study|Positive for STD at Baseline|7
7931417|NCT02308033|12464103|FG001|Overall Study|Positive for STD at Baseline|4
7931418|NCT02308033|12464102|FG000|Overall Study|Lost to Follow-up|6
7931419|NCT02308033|12464103|FG001|Overall Study|Lost to Follow-up|5
7931420|NCT02308046|12464111|FG000|Overall Study|Negative yeast culture at Baseline|32
7931421|NCT02308046|12464112|FG001|Overall Study|Negative yeast culture at Baseline|33
7931422|NCT02308046|12464111|FG000|Overall Study|Positive for STD at Baseline|1
7931423|NCT02308046|12464112|FG001|Overall Study|Positive for STD at Baseline|2
7931424|NCT02308046|12464111|FG000|Overall Study|Lost to Follow-up|1
7931425|NCT02308046|12464112|FG001|Overall Study|Lost to Follow-up|3
7931426|NCT02308124|12464121|FG000|Overall Study|Lost to Follow-up|6
7931427|NCT02308124|12464122|FG001|Overall Study|Lost to Follow-up|6
7931428|NCT02308124|12464123|FG002|Overall Study|Lost to Follow-up|6
7931429|NCT02308124|12464121|FG000|Overall Study|Adverse Event|0
7931430|NCT02308124|12464122|FG001|Overall Study|Adverse Event|2
7931431|NCT02308124|12464123|FG002|Overall Study|Adverse Event|2
7931432|NCT02308163|12464135|FG000|Overall Study|Not fulfill eligible criteria|1
7931433|NCT02308163|12464136|FG001|Overall Study|Not fulfill eligible criteria|2
7931434|NCT02308163|12464137|FG002|Overall Study|Not fulfill eligible criteria|0
7931435|NCT02308163|12464138|FG003|Overall Study|Not fulfill eligible criteria|1
7931436|NCT02308163|12464139|FG004|Overall Study|Not fulfill eligible criteria|1
7931437|NCT02308163|12464135|FG000|Overall Study|Adverse Event|9
7931438|NCT02308163|12464136|FG001|Overall Study|Adverse Event|5
7931439|NCT02308163|12464137|FG002|Overall Study|Adverse Event|2
7931440|NCT02308163|12464138|FG003|Overall Study|Adverse Event|2
7931441|NCT02308163|12464139|FG004|Overall Study|Adverse Event|11
7931442|NCT02308163|12464135|FG000|Overall Study|Lack of Efficacy|11
7931443|NCT02308163|12464136|FG001|Overall Study|Lack of Efficacy|3
7931444|NCT02308163|12464137|FG002|Overall Study|Lack of Efficacy|8
7931445|NCT02308163|12464138|FG003|Overall Study|Lack of Efficacy|4
7931446|NCT02308163|12464139|FG004|Overall Study|Lack of Efficacy|6
7931447|NCT02308163|12464135|FG000|Overall Study|Withdrawal of consent|2
7931448|NCT02308163|12464136|FG001|Overall Study|Withdrawal of consent|3
7931449|NCT02308163|12464137|FG002|Overall Study|Withdrawal of consent|0
7931450|NCT02308163|12464138|FG003|Overall Study|Withdrawal of consent|2
7931451|NCT02308163|12464139|FG004|Overall Study|Withdrawal of consent|6
7931452|NCT02308163|12464135|FG000|Overall Study|Protocol Violation|3
7931453|NCT02308163|12464136|FG001|Overall Study|Protocol Violation|3
7931454|NCT02308163|12464137|FG002|Overall Study|Protocol Violation|3
7931455|NCT02308163|12464138|FG003|Overall Study|Protocol Violation|2
7931456|NCT02308163|12464139|FG004|Overall Study|Protocol Violation|5
7931457|NCT02308163|12464135|FG000|Overall Study|Lab data met discontinuation criteria|3
7931458|NCT02308163|12464136|FG001|Overall Study|Lab data met discontinuation criteria|0
7931459|NCT02308163|12464137|FG002|Overall Study|Lab data met discontinuation criteria|0
7931460|NCT02308163|12464138|FG003|Overall Study|Lab data met discontinuation criteria|2
7931461|NCT02308163|12464139|FG004|Overall Study|Lab data met discontinuation criteria|0
7931462|NCT02308163|12464135|FG000|Overall Study|Miscellaneous|2
7931463|NCT02308163|12464136|FG001|Overall Study|Miscellaneous|2
7931464|NCT02308163|12464137|FG002|Overall Study|Miscellaneous|1
7931465|NCT02308163|12464138|FG003|Overall Study|Miscellaneous|0
7931466|NCT02308163|12464139|FG004|Overall Study|Miscellaneous|5
7931467|NCT02308228|12464177|FG000|Overall Study|Adverse Event|3
7931468|NCT02308228|12464178|FG001|Overall Study|Adverse Event|4
7931469|NCT02308228|12464177|FG000|Overall Study|Withdrawal by Subject|5
7931470|NCT02308228|12464178|FG001|Overall Study|Withdrawal by Subject|3
7931471|NCT02308540|12464216|FG000|Overall Study|Lost to Follow-up|0
7931472|NCT02308540|12464217|FG001|Overall Study|Lost to Follow-up|0
7931473|NCT02308540|12464218|FG002|Overall Study|Lost to Follow-up|0
7931474|NCT02308540|12464219|FG003|Overall Study|Lost to Follow-up|0
7931475|NCT02308540|12464220|FG004|Overall Study|Lost to Follow-up|0
7931476|NCT02308540|12464221|FG005|Overall Study|Lost to Follow-up|1
7931477|NCT02308696|12464272|FG000|Overall Study|Lost to Follow-up|28
7931478|NCT02308696|12464273|FG001|Overall Study|Lost to Follow-up|21
7931479|NCT02308696|12464272|FG000|Overall Study|Death|8
7931480|NCT02308696|12464273|FG001|Overall Study|Death|4
7931481|NCT02308696|12464272|FG000|Overall Study|Moved to a Higher Level of Care|17
7931482|NCT02308696|12464273|FG001|Overall Study|Moved to a Higher Level of Care|6
7931483|NCT02308748|12464279|FG000|Period 1|Withdrawal by Subject|0
7931484|NCT02308748|12464280|FG001|Period 1|Withdrawal by Subject|0
7931485|NCT02308748|12464281|FG002|Period 1|Withdrawal by Subject|1
7931486|NCT02308748|12464282|FG003|Period 1|Withdrawal by Subject|0
7931487|NCT02308748|12464283|FG004|Period 1|Withdrawal by Subject|0
7931488|NCT02308748|12464284|FG005|Period 1|Withdrawal by Subject|0
7931489|NCT02308748|12464285|FG006|Period 1|Withdrawal by Subject|0
7931490|NCT02308748|12464286|FG007|Period 1|Withdrawal by Subject|0
7931491|NCT02308748|12464287|FG008|Period 1|Withdrawal by Subject|0
7931492|NCT02308748|12464288|FG009|Period 1|Withdrawal by Subject|0
7931493|NCT02308748|12464279|FG000|Period 2|Adverse Event|0
7931494|NCT02308748|12464280|FG001|Period 2|Adverse Event|0
7931495|NCT02308748|12464281|FG002|Period 2|Adverse Event|0
7931496|NCT02308748|12464282|FG003|Period 2|Adverse Event|0
7931497|NCT02308748|12464283|FG004|Period 2|Adverse Event|0
7931498|NCT02308748|12464284|FG005|Period 2|Adverse Event|0
7931499|NCT02308748|12464285|FG006|Period 2|Adverse Event|0
7931500|NCT02308748|12464286|FG007|Period 2|Adverse Event|1
7931501|NCT02308748|12464287|FG008|Period 2|Adverse Event|0
7931502|NCT02308748|12464288|FG009|Period 2|Adverse Event|0
7931503|NCT02308748|12464279|FG000|Period 3|Protocol Violation|0
7931504|NCT02308748|12464280|FG001|Period 3|Protocol Violation|0
7931505|NCT02308748|12464281|FG002|Period 3|Protocol Violation|0
7931506|NCT02308748|12464282|FG003|Period 3|Protocol Violation|0
7931507|NCT02308748|12464283|FG004|Period 3|Protocol Violation|0
7931508|NCT02308748|12464284|FG005|Period 3|Protocol Violation|0
7931509|NCT02308748|12464285|FG006|Period 3|Protocol Violation|0
7931510|NCT02308748|12464286|FG007|Period 3|Protocol Violation|0
7931511|NCT02308748|12464287|FG008|Period 3|Protocol Violation|0
7931512|NCT02308748|12464288|FG009|Period 3|Protocol Violation|1
7931513|NCT02308748|12464279|FG000|Period 5|Adverse Event|1
7931514|NCT02308748|12464280|FG001|Period 5|Adverse Event|0
7931515|NCT02308748|12464281|FG002|Period 5|Adverse Event|0
7931516|NCT02308748|12464282|FG003|Period 5|Adverse Event|0
7931517|NCT02308748|12464283|FG004|Period 5|Adverse Event|0
7931518|NCT02308748|12464284|FG005|Period 5|Adverse Event|0
7931519|NCT02308748|12464285|FG006|Period 5|Adverse Event|0
7931520|NCT02308748|12464286|FG007|Period 5|Adverse Event|0
7931521|NCT02308748|12464287|FG008|Period 5|Adverse Event|1
7931522|NCT02308748|12464288|FG009|Period 5|Adverse Event|0
7931523|NCT02309099|12464310|FG000|Overall Study|Adverse Event|2
7931524|NCT02309099|12464311|FG001|Overall Study|Adverse Event|0
7931525|NCT02309112|12464320|FG000|Overall Study|Withdrawal by Subject|1
7931526|NCT02309112|12464321|FG001|Overall Study|Withdrawal by Subject|0
7931527|NCT02309112|12464322|FG002|Overall Study|Withdrawal by Subject|1
7931528|NCT02309112|12464320|FG000|Overall Study|Lost to Follow-up|0
7931529|NCT02309112|12464321|FG001|Overall Study|Lost to Follow-up|1
7931530|NCT02309112|12464322|FG002|Overall Study|Lost to Follow-up|0
7931531|NCT02309138|12464334|FG000|Overall Study|Withdrawal by Subject|44
7931532|NCT02309138|12464335|FG001|Overall Study|Withdrawal by Subject|15
7931533|NCT02309138|12464334|FG000|Overall Study|Protocol Violation|4
7931534|NCT02309138|12464335|FG001|Overall Study|Protocol Violation|2
7931535|NCT02309138|12464334|FG000|Overall Study|delivered before visit 2|0
7931536|NCT02309138|12464335|FG001|Overall Study|delivered before visit 2|1
7931537|NCT02309294|12464351|FG000|Overall Study|Withdrawal by Subject|2
7931538|NCT02309359|12464360|FG000|Overall Study|Adverse Event|4
7931539|NCT02309359|12464361|FG001|Overall Study|Adverse Event|5
7931540|NCT02309359|12464362|FG002|Overall Study|Adverse Event|5
7931541|NCT02309359|12464363|FG003|Overall Study|Adverse Event|4
7931542|NCT02309359|12464364|FG004|Overall Study|Adverse Event|4
7931543|NCT02309359|12464360|FG000|Overall Study|Death|1
7931544|NCT02309359|12464361|FG001|Overall Study|Death|0
7931545|NCT02309359|12464362|FG002|Overall Study|Death|0
7931546|NCT02309359|12464363|FG003|Overall Study|Death|0
7931547|NCT02309359|12464364|FG004|Overall Study|Death|0
7931548|NCT02309359|12464360|FG000|Overall Study|Withdrawal by Subject|2
7931549|NCT02309359|12464361|FG001|Overall Study|Withdrawal by Subject|2
7931550|NCT02309359|12464362|FG002|Overall Study|Withdrawal by Subject|4
7931551|NCT02309359|12464363|FG003|Overall Study|Withdrawal by Subject|4
7931552|NCT02309359|12464364|FG004|Overall Study|Withdrawal by Subject|0
7931553|NCT02309359|12464360|FG000|Overall Study|Lack of Efficacy|3
7931554|NCT02309359|12464361|FG001|Overall Study|Lack of Efficacy|1
7931555|NCT02309359|12464362|FG002|Overall Study|Lack of Efficacy|0
7931556|NCT02309359|12464363|FG003|Overall Study|Lack of Efficacy|0
7931557|NCT02309359|12464364|FG004|Overall Study|Lack of Efficacy|3
7931558|NCT02309359|12464360|FG000|Overall Study|Lost to Follow-up|0
7931559|NCT02309359|12464361|FG001|Overall Study|Lost to Follow-up|0
7931560|NCT02309359|12464362|FG002|Overall Study|Lost to Follow-up|0
7931561|NCT02309359|12464363|FG003|Overall Study|Lost to Follow-up|1
7931562|NCT02309359|12464364|FG004|Overall Study|Lost to Follow-up|0
7931563|NCT02309359|12464360|FG000|Overall Study|Other|2
7931564|NCT02309359|12464361|FG001|Overall Study|Other|0
7931565|NCT02309359|12464362|FG002|Overall Study|Other|2
7931566|NCT02309359|12464363|FG003|Overall Study|Other|3
7931567|NCT02309359|12464364|FG004|Overall Study|Other|2
7931568|NCT02309372|12464379|FG000|Overall Study|Lost to Follow-up|3
7931569|NCT02309372|12464380|FG001|Overall Study|Lost to Follow-up|2
7931570|NCT02309411|12464389|FG000|Overall Study|Physician Decision|1
7931571|NCT02309411|12464390|FG001|Overall Study|Physician Decision|0
7931572|NCT02309411|12464391|FG002|Overall Study|Physician Decision|0
7931573|NCT02309411|12464389|FG000|Overall Study|Withdrawal by Subject|1
7931574|NCT02309411|12464390|FG001|Overall Study|Withdrawal by Subject|1
7931575|NCT02309411|12464391|FG002|Overall Study|Withdrawal by Subject|0
7931576|NCT02309515|12464409|FG000|Overall Study|Withdrawal by Subject|0
7931577|NCT02309515|12464410|FG001|Overall Study|Withdrawal by Subject|1
7931578|NCT02309723|12464419|FG000|Overall Study|Withdrawal by Subject|24
7931579|NCT02309723|12464420|FG001|Overall Study|Withdrawal by Subject|23
7931580|NCT02309723|12464421|FG002|Overall Study|Withdrawal by Subject|24
7931581|NCT02310100|12464438|FG000|Overall Study|Physician Decision|3
7931582|NCT02310100|12464438|FG000|Overall Study|Withdrawal by Subject|10
7931583|NCT02310100|12464438|FG000|Overall Study|Enrollment closure|1
7931584|NCT02310100|12464438|FG000|Overall Study|Unapproved ablation operator|1
7931585|NCT02310100|12464438|FG000|Overall Study|Visit compliance|1
7931586|NCT02310100|12464438|FG000|Overall Study|Lost to Follow-up|2
7931587|NCT02310126|12464445|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0
7931588|NCT02310126|12464446|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1
7931589|NCT02310126|12464445|FG000|Period 1 (15 Minutes)|Protocol Violation|0
7931590|NCT02310126|12464446|FG001|Period 1 (15 Minutes)|Protocol Violation|1
7931591|NCT02310568|12464457|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7931592|NCT02310568|12464458|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7931593|NCT02310568|12464459|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7931594|NCT02310568|12464460|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7931595|NCT02310568|12464461|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
7931596|NCT02310568|12464457|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
7931597|NCT02310568|12464458|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7931598|NCT02310568|12464459|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7931599|NCT02310568|12464460|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7931600|NCT02310568|12464461|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7931601|NCT02310568|12464457|FG000|Stage 1 ( 4 Weeks)|Other|1
7931602|NCT02310568|12464458|FG001|Stage 1 ( 4 Weeks)|Other|1
7931603|NCT02310568|12464459|FG002|Stage 1 ( 4 Weeks)|Other|0
7931604|NCT02310568|12464460|FG003|Stage 1 ( 4 Weeks)|Other|0
7931605|NCT02310568|12464461|FG004|Stage 1 ( 4 Weeks)|Other|0
7931606|NCT02310568|12464457|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1
7931607|NCT02310568|12464458|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1
7931608|NCT02310568|12464459|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1
7931609|NCT02310568|12464460|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0
7931610|NCT02310568|12464461|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0
7931611|NCT02310568|12464457|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7931612|NCT02310568|12464458|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7931613|NCT02310568|12464459|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7931614|NCT02310568|12464460|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
7931615|NCT02310568|12464461|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7931616|NCT02310568|12464457|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7931617|NCT02310568|12464458|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7931618|NCT02310568|12464459|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7931619|NCT02310568|12464460|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
7931620|NCT02310568|12464461|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7931621|NCT02310568|12464457|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1
7931622|NCT02310568|12464458|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0
7931623|NCT02310568|12464459|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0
7931624|NCT02310568|12464460|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1
7931625|NCT02310568|12464461|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0
7931626|NCT02310568|12464457|FG000|Stage 2 (4 Weeks)|Other|0
7931627|NCT02310568|12464458|FG001|Stage 2 (4 Weeks)|Other|1
7931628|NCT02310568|12464459|FG002|Stage 2 (4 Weeks)|Other|1
7931629|NCT02310568|12464460|FG003|Stage 2 (4 Weeks)|Other|0
7931630|NCT02310568|12464461|FG004|Stage 2 (4 Weeks)|Other|0
7931631|NCT02310568|12464457|FG000|Stage 2 (4 Weeks)|Adverse Event|0
7931632|NCT02310568|12464458|FG001|Stage 2 (4 Weeks)|Adverse Event|0
7931633|NCT02310568|12464459|FG002|Stage 2 (4 Weeks)|Adverse Event|0
7931634|NCT02310568|12464460|FG003|Stage 2 (4 Weeks)|Adverse Event|1
7931635|NCT02310568|12464461|FG004|Stage 2 (4 Weeks)|Adverse Event|1
7931636|NCT02310568|12464457|FG000|Stage 2 (4 Weeks)|Protocol Violation|0
7931637|NCT02310568|12464458|FG001|Stage 2 (4 Weeks)|Protocol Violation|0
7931638|NCT02310568|12464459|FG002|Stage 2 (4 Weeks)|Protocol Violation|0
7931639|NCT02310568|12464460|FG003|Stage 2 (4 Weeks)|Protocol Violation|1
7931640|NCT02310568|12464461|FG004|Stage 2 (4 Weeks)|Protocol Violation|0
7931641|NCT02310568|12464457|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0
7931642|NCT02310568|12464458|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0
7931643|NCT02310568|12464459|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0
7931644|NCT02310568|12464460|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2
7931645|NCT02310568|12464461|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0
7931646|NCT02310581|12464483|FG000|Overall Study|Adverse Event|1
7931647|NCT02310581|12464484|FG001|Overall Study|Adverse Event|1
7931648|NCT02310581|12464485|FG002|Overall Study|Adverse Event|1
7931649|NCT02310581|12464486|FG003|Overall Study|Adverse Event|0
7931650|NCT02310581|12464483|FG000|Overall Study|Withdrawal by Subject|2
7931651|NCT02310581|12464484|FG001|Overall Study|Withdrawal by Subject|1
7931652|NCT02310581|12464485|FG002|Overall Study|Withdrawal by Subject|0
7931653|NCT02310581|12464486|FG003|Overall Study|Withdrawal by Subject|1
7931654|NCT02310646|12464498|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
7931655|NCT02310646|12464499|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
7931656|NCT02310646|12464498|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
7931657|NCT02310646|12464499|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
7931658|NCT02310672|12464521|FG000|Overall Study|Death|1
7931659|NCT02310672|12464521|FG000|Overall Study|Lost to Follow-up|1
7931660|NCT02310672|12464521|FG000|Overall Study|Withdrawal by Subject|1
7931661|NCT02310672|12464521|FG000|Overall Study|Sponsor's decision|12
7931662|NCT02310750|12464536|FG000|HP Period 1|Lost to Follow-up|0
7931663|NCT02310750|12464537|FG001|HP Period 1|Lost to Follow-up|0
7931664|NCT02310750|12464538|FG002|HP Period 1|Lost to Follow-up|0
7931665|NCT02310750|12464539|FG003|HP Period 1|Lost to Follow-up|0
7931666|NCT02310750|12464540|FG004|HP Period 1|Lost to Follow-up|0
7931667|NCT02310750|12464541|FG005|HP Period 1|Lost to Follow-up|0
7931668|NCT02310750|12464542|FG006|HP Period 1|Lost to Follow-up|1
7931669|NCT02310750|12464543|FG007|HP Period 1|Lost to Follow-up|0
7931670|NCT02310750|12464544|FG008|HP Period 1|Lost to Follow-up|0
7931671|NCT02310750|12464545|FG009|HP Period 1|Lost to Follow-up|0
7931672|NCT02310750|12464546|FG010|HP Period 1|Lost to Follow-up|0
7931673|NCT02310750|12464547|FG011|HP Period 1|Lost to Follow-up|0
7931674|NCT02310750|12464548|FG012|HP Period 1|Lost to Follow-up|0
7931675|NCT02310750|12464549|FG013|HP Period 1|Lost to Follow-up|0
7931676|NCT02310750|12464550|FG014|HP Period 1|Lost to Follow-up|0
7931677|NCT02310750|12464551|FG015|HP Period 1|Lost to Follow-up|0
7931678|NCT02310750|12464536|FG000|HP Period 1|Withdrawal by Subject|1
7931679|NCT02310750|12464537|FG001|HP Period 1|Withdrawal by Subject|0
7931680|NCT02310750|12464538|FG002|HP Period 1|Withdrawal by Subject|0
7931681|NCT02310750|12464539|FG003|HP Period 1|Withdrawal by Subject|1
7931682|NCT02310750|12464540|FG004|HP Period 1|Withdrawal by Subject|0
7931683|NCT02310750|12464541|FG005|HP Period 1|Withdrawal by Subject|0
7931684|NCT02310750|12464542|FG006|HP Period 1|Withdrawal by Subject|0
7931685|NCT02310750|12464543|FG007|HP Period 1|Withdrawal by Subject|0
7931686|NCT02310750|12464544|FG008|HP Period 1|Withdrawal by Subject|0
7931687|NCT02310750|12464545|FG009|HP Period 1|Withdrawal by Subject|0
7931688|NCT02310750|12464546|FG010|HP Period 1|Withdrawal by Subject|0
7931689|NCT02310750|12464547|FG011|HP Period 1|Withdrawal by Subject|0
7931690|NCT02310750|12464548|FG012|HP Period 1|Withdrawal by Subject|0
7931691|NCT02310750|12464549|FG013|HP Period 1|Withdrawal by Subject|0
7931692|NCT02310750|12464550|FG014|HP Period 1|Withdrawal by Subject|0
7931693|NCT02310750|12464551|FG015|HP Period 1|Withdrawal by Subject|0
7931694|NCT02310750|12464536|FG000|HP Washout 1|Lost to Follow-up|0
7931695|NCT02310750|12464537|FG001|HP Washout 1|Lost to Follow-up|0
7931696|NCT02310750|12464538|FG002|HP Washout 1|Lost to Follow-up|1
7931697|NCT02310750|12464539|FG003|HP Washout 1|Lost to Follow-up|1
7931698|NCT02310750|12464540|FG004|HP Washout 1|Lost to Follow-up|2
7931699|NCT02310750|12464541|FG005|HP Washout 1|Lost to Follow-up|2
7931700|NCT02310750|12464542|FG006|HP Washout 1|Lost to Follow-up|3
7931701|NCT02310750|12464543|FG007|HP Washout 1|Lost to Follow-up|0
7931702|NCT02310750|12464544|FG008|HP Washout 1|Lost to Follow-up|0
7931703|NCT02310750|12464545|FG009|HP Washout 1|Lost to Follow-up|0
7931704|NCT02310750|12464546|FG010|HP Washout 1|Lost to Follow-up|0
7931705|NCT02310750|12464547|FG011|HP Washout 1|Lost to Follow-up|0
7931706|NCT02310750|12464548|FG012|HP Washout 1|Lost to Follow-up|0
7931707|NCT02310750|12464549|FG013|HP Washout 1|Lost to Follow-up|0
7931708|NCT02310750|12464550|FG014|HP Washout 1|Lost to Follow-up|0
7931709|NCT02310750|12464551|FG015|HP Washout 1|Lost to Follow-up|0
7931710|NCT02310750|12464536|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7931711|NCT02310750|12464537|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7931712|NCT02310750|12464538|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7931713|NCT02310750|12464539|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
7931714|NCT02310750|12464540|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7931715|NCT02310750|12464541|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
7931716|NCT02310750|12464542|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7931717|NCT02310750|12464543|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7931718|NCT02310750|12464544|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
7931719|NCT02310750|12464545|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
7931720|NCT02310750|12464546|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7931721|NCT02310750|12464547|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7931722|NCT02310750|12464548|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7931723|NCT02310750|12464549|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7931724|NCT02310750|12464550|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7931725|NCT02310750|12464551|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7931726|NCT02310750|12464536|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7931727|NCT02310750|12464537|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7931728|NCT02310750|12464538|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7931729|NCT02310750|12464539|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7931730|NCT02310750|12464540|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7931731|NCT02310750|12464541|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7931732|NCT02310750|12464542|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7931733|NCT02310750|12464543|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7931734|NCT02310750|12464544|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7931735|NCT02310750|12464545|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
7931736|NCT02310750|12464546|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7931737|NCT02310750|12464547|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7931738|NCT02310750|12464548|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7931739|NCT02310750|12464549|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7931740|NCT02310750|12464550|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7931741|NCT02310750|12464551|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7931742|NCT02310750|12464536|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7931743|NCT02310750|12464537|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7931744|NCT02310750|12464538|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7931745|NCT02310750|12464539|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7931746|NCT02310750|12464540|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7931747|NCT02310750|12464541|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7931748|NCT02310750|12464542|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7931749|NCT02310750|12464543|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
7931750|NCT02310750|12464544|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
7931751|NCT02310750|12464545|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
7931752|NCT02310750|12464546|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7931753|NCT02310750|12464547|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7931754|NCT02310750|12464548|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7931755|NCT02310750|12464549|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7931756|NCT02310750|12464550|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7931757|NCT02310750|12464551|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7931758|NCT02310750|12464536|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7931759|NCT02310750|12464537|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7931760|NCT02310750|12464538|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7931761|NCT02310750|12464539|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7931762|NCT02310750|12464540|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7931763|NCT02310750|12464541|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7931764|NCT02310750|12464542|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7931765|NCT02310750|12464543|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
7931766|NCT02310750|12464544|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
7931767|NCT02310750|12464545|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7931768|NCT02310750|12464546|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7931769|NCT02310750|12464547|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7931770|NCT02310750|12464548|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7931771|NCT02310750|12464549|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7931772|NCT02310750|12464550|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7931773|NCT02310750|12464551|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7931774|NCT02310750|12464536|FG000|HP Washout 2|Lost to Follow-up|0
7931775|NCT02310750|12464537|FG001|HP Washout 2|Lost to Follow-up|0
7931776|NCT02310750|12464538|FG002|HP Washout 2|Lost to Follow-up|0
7931777|NCT02310750|12464539|FG003|HP Washout 2|Lost to Follow-up|0
7931778|NCT02310750|12464540|FG004|HP Washout 2|Lost to Follow-up|1
7931779|NCT02310750|12464541|FG005|HP Washout 2|Lost to Follow-up|0
7931780|NCT02310750|12464542|FG006|HP Washout 2|Lost to Follow-up|7
7931781|NCT02310750|12464543|FG007|HP Washout 2|Lost to Follow-up|0
7931782|NCT02310750|12464544|FG008|HP Washout 2|Lost to Follow-up|0
7931783|NCT02310750|12464545|FG009|HP Washout 2|Lost to Follow-up|0
7931784|NCT02310750|12464546|FG010|HP Washout 2|Lost to Follow-up|0
7931785|NCT02310750|12464547|FG011|HP Washout 2|Lost to Follow-up|0
7931786|NCT02310750|12464548|FG012|HP Washout 2|Lost to Follow-up|0
7931787|NCT02310750|12464549|FG013|HP Washout 2|Lost to Follow-up|0
7931788|NCT02310750|12464550|FG014|HP Washout 2|Lost to Follow-up|0
7931789|NCT02310750|12464551|FG015|HP Washout 2|Lost to Follow-up|0
7931790|NCT02310763|12464635|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
7931791|NCT02310763|12464636|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
7931792|NCT02310763|12464637|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
7931793|NCT02310763|12464635|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0
7931794|NCT02310763|12464636|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
7931795|NCT02310763|12464637|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
7931796|NCT02310763|12464635|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1
7931797|NCT02310763|12464636|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
7931798|NCT02310763|12464637|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
7931799|NCT02310763|12464635|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1
7931800|NCT02310763|12464636|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0
7931801|NCT02310763|12464637|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0
7931802|NCT02310763|12464635|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
7931803|NCT02310763|12464636|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
7931804|NCT02310763|12464637|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
7931805|NCT02310789|12464667|FG000|Overall Study|Adverse Event|1
7931806|NCT02310906|12464675|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
7931807|NCT02310906|12464676|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
7931808|NCT02310906|12464677|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
7931809|NCT02310906|12464678|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2
7931810|NCT02310906|12464675|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
7931811|NCT02310906|12464676|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
7931812|NCT02310906|12464677|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2
7931813|NCT02310906|12464678|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4
7931814|NCT02310906|12464675|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
7931815|NCT02310906|12464676|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
7931816|NCT02310906|12464677|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
7931817|NCT02310906|12464678|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1
7931818|NCT02310906|12464675|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
7931819|NCT02310906|12464676|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
7931820|NCT02310906|12464677|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
7931821|NCT02310906|12464678|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1
7931822|NCT02311153|12464701|FG000|Overall Study|Lost to Follow-up|5
7931823|NCT02311153|12464702|FG001|Overall Study|Lost to Follow-up|7
7931824|NCT02311361|12464725|FG000|Overall Study|Did not receive treatment|0
7931825|NCT02311361|12464726|FG001|Overall Study|Did not receive treatment|1
7931826|NCT02311361|12464727|FG002|Overall Study|Did not receive treatment|0
7931827|NCT02311361|12464728|FG003|Overall Study|Did not receive treatment|1
7931828|NCT02311881|12464745|FG000|Overall Study|Did not meet the study criteria|2
7931829|NCT02311881|12464746|FG001|Overall Study|Did not meet the study criteria|2
7931830|NCT02311881|12464747|FG002|Overall Study|Did not meet the study criteria|0
7931831|NCT02311881|12464745|FG000|Overall Study|Adverse Event|7
7931832|NCT02311881|12464746|FG001|Overall Study|Adverse Event|15
7931833|NCT02311881|12464747|FG002|Overall Study|Adverse Event|8
7931834|NCT02311881|12464745|FG000|Overall Study|Lost to Follow-up|3
7931835|NCT02311881|12464746|FG001|Overall Study|Lost to Follow-up|3
7931836|NCT02311881|12464747|FG002|Overall Study|Lost to Follow-up|2
7931837|NCT02311881|12464745|FG000|Overall Study|Protocol Violation|1
7931838|NCT02311881|12464746|FG001|Overall Study|Protocol Violation|2
7931839|NCT02311881|12464747|FG002|Overall Study|Protocol Violation|3
7931840|NCT02311881|12464745|FG000|Overall Study|Withdrawal of consent|14
7931841|NCT02311881|12464746|FG001|Overall Study|Withdrawal of consent|16
7931842|NCT02311881|12464747|FG002|Overall Study|Withdrawal of consent|17
7931843|NCT02311881|12464745|FG000|Overall Study|Other|0
7931844|NCT02311881|12464746|FG001|Overall Study|Other|0
7931845|NCT02311881|12464747|FG002|Overall Study|Other|1
7931846|NCT02311881|12464745|FG000|Overall Study|Lack of Efficacy|1
7931847|NCT02311881|12464746|FG001|Overall Study|Lack of Efficacy|2
7931848|NCT02311881|12464747|FG002|Overall Study|Lack of Efficacy|0
7931849|NCT02311881|12464745|FG000|Overall Study|Subject has border line pregnancy test|1
7931850|NCT02311881|12464746|FG001|Overall Study|Subject has border line pregnancy test|0
7931851|NCT02311881|12464747|FG002|Overall Study|Subject has border line pregnancy test|0
7931852|NCT02311881|12464745|FG000|Overall Study|Withdrawal by Subject|3
7931853|NCT02311881|12464746|FG001|Overall Study|Withdrawal by Subject|1
7931854|NCT02311881|12464747|FG002|Overall Study|Withdrawal by Subject|4
7931855|NCT02311881|12464745|FG000|Overall Study|Sponsor Decision|1
7931856|NCT02311881|12464746|FG001|Overall Study|Sponsor Decision|1
7931857|NCT02311881|12464747|FG002|Overall Study|Sponsor Decision|1
7931858|NCT02311881|12464745|FG000|Overall Study|Protocol Deviation|1
7931859|NCT02311881|12464746|FG001|Overall Study|Protocol Deviation|0
7931860|NCT02311881|12464747|FG002|Overall Study|Protocol Deviation|0
7931861|NCT02311881|12464745|FG000|Overall Study|Non-Compliance|1
7931862|NCT02311881|12464746|FG001|Overall Study|Non-Compliance|0
7931863|NCT02311881|12464747|FG002|Overall Study|Non-Compliance|2
7931864|NCT02311881|12464745|FG000|Overall Study|Physician Decision|0
7931865|NCT02311881|12464746|FG001|Overall Study|Physician Decision|0
7931866|NCT02311881|12464747|FG002|Overall Study|Physician Decision|1
7931867|NCT02311881|12464745|FG000|Overall Study|Medical Monitor Discretion|0
7931868|NCT02311881|12464746|FG001|Overall Study|Medical Monitor Discretion|0
7931869|NCT02311881|12464747|FG002|Overall Study|Medical Monitor Discretion|1
7931870|NCT02311881|12464745|FG000|Overall Study|Participant taking another medication|0
7931871|NCT02311881|12464746|FG001|Overall Study|Participant taking another medication|0
7931872|NCT02311881|12464747|FG002|Overall Study|Participant taking another medication|1
7931873|NCT02311881|12464745|FG000|Overall Study|Serious Adverse Event|0
7931874|NCT02311881|12464746|FG001|Overall Study|Serious Adverse Event|1
7931875|NCT02311881|12464747|FG002|Overall Study|Serious Adverse Event|0
7931876|NCT02311894|12464758|FG000|Overall Study|Discontinued in error|1
7931877|NCT02311894|12464758|FG000|Overall Study|Lost to Follow-up|1
7931878|NCT02311894|12464758|FG000|Overall Study|Adverse Event|1
7931879|NCT02311894|12464758|FG000|Overall Study|Withdrawal by Subject|1
7931880|NCT02312063|12464792|FG000|Overall Study|Withdrawal by Subject|0
7931881|NCT02312063|12464793|FG001|Overall Study|Withdrawal by Subject|1
7931882|NCT02312206|12464807|FG000|Overall Study|Adverse Event|3
7931883|NCT02312206|12464808|FG001|Overall Study|Adverse Event|6
7931884|NCT02312206|12464807|FG000|Overall Study|Withdrawal by Subject|7
7931885|NCT02312206|12464808|FG001|Overall Study|Withdrawal by Subject|6
7931886|NCT02312206|12464807|FG000|Overall Study|Physician Decision|7
7931887|NCT02312206|12464808|FG001|Overall Study|Physician Decision|6
7931888|NCT02312206|12464807|FG000|Overall Study|Death|30
7931889|NCT02312206|12464808|FG001|Overall Study|Death|36
7931890|NCT02312206|12464807|FG000|Overall Study|Study Terminated by Sponsor|81
7931891|NCT02312206|12464808|FG001|Overall Study|Study Terminated by Sponsor|74
7931892|NCT02312206|12464807|FG000|Overall Study|Disease Progression|1
7931893|NCT02312206|12464808|FG001|Overall Study|Disease Progression|0
7931894|NCT02312206|12464807|FG000|Overall Study|Patient progression and new therapy|1
7931895|NCT02312206|12464808|FG001|Overall Study|Patient progression and new therapy|0
7931896|NCT02312206|12464807|FG000|Overall Study|Patient transferred to hospice|0
7931897|NCT02312206|12464808|FG001|Overall Study|Patient transferred to hospice|1
7931898|NCT02312206|12464807|FG000|Overall Study|Subject missed 3 consecutive tx visits|0
7931899|NCT02312206|12464808|FG001|Overall Study|Subject missed 3 consecutive tx visits|1
7931900|NCT02312219|12464816|FG000|Overall Study|Withdrawal by Subject|1
7931901|NCT02312219|12464817|FG001|Overall Study|Withdrawal by Subject|2
7931902|NCT02312219|12464816|FG000|Overall Study|could not schedule imaging in time|0
7931903|NCT02312219|12464817|FG001|Overall Study|could not schedule imaging in time|2
7931904|NCT02312219|12464816|FG000|Overall Study|Other|0
7931905|NCT02312219|12464817|FG001|Overall Study|Other|1
7931906|NCT02312219|12464816|FG000|Overall Study|Not randomized. Ineligible|0
7931907|NCT02312219|12464817|FG001|Overall Study|Not randomized. Ineligible|1
7931908|NCT02312687|12464860|FG000|Overall Study|Other, Not Specified|1
7931909|NCT02312856|12464904|FG000|Overall Study|Death|1
7931910|NCT02312856|12464904|FG000|Overall Study|Lost to Follow-up|3
7931911|NCT02312934|12464914|FG000|Overall Study|Lost to Follow-up|1
7931912|NCT02312934|12464915|FG001|Overall Study|Lost to Follow-up|0
7931913|NCT02312934|12464914|FG000|Overall Study|Physician Decision|1
7931914|NCT02312934|12464915|FG001|Overall Study|Physician Decision|0
7931915|NCT02313155|12464928|FG000|Overall Study|Lost to Follow-up|0
7931916|NCT02313155|12464929|FG001|Overall Study|Lost to Follow-up|1
7931917|NCT02313233|12464937|FG000|Overall Study|Withdrawal by Subject|1
7931918|NCT02313233|12464938|FG001|Overall Study|Withdrawal by Subject|2
7931919|NCT02313233|12464937|FG000|Overall Study|Administrative reason|1
7931920|NCT02313233|12464938|FG001|Overall Study|Administrative reason|1
7931921|NCT02313558|12464965|FG000|Overall Study|Withdrawal by Subject|2
7931922|NCT02313558|12464966|FG001|Overall Study|Withdrawal by Subject|0
7931923|NCT02313558|12464965|FG000|Overall Study|Lost to Follow-up|4
7931924|NCT02313558|12464966|FG001|Overall Study|Lost to Follow-up|4
7931925|NCT02313766|12465001|FG000|Overall Study|surgery cancelled|1
7931926|NCT02313766|12465002|FG001|Overall Study|surgery cancelled|0
7931927|NCT02313766|12465003|FG002|Overall Study|surgery cancelled|0
7931928|NCT02313766|12465001|FG000|Overall Study|Lost to Follow-up|0
7931929|NCT02313766|12465002|FG001|Overall Study|Lost to Follow-up|2
7931930|NCT02313766|12465003|FG002|Overall Study|Lost to Follow-up|0
7931931|NCT02313766|12465001|FG000|Overall Study|Adverse Event|0
7931932|NCT02313766|12465002|FG001|Overall Study|Adverse Event|1
7931933|NCT02313766|12465003|FG002|Overall Study|Adverse Event|0
7931934|NCT02313909|12465013|FG000|Overall Study|Consent withdrawn by participant|33
7931935|NCT02313909|12465014|FG001|Overall Study|Consent withdrawn by participant|33
7931936|NCT02313909|12465013|FG000|Overall Study|Lost to Follow-up|24
7931937|NCT02313909|12465014|FG001|Overall Study|Lost to Follow-up|17
7931938|NCT02314026|12465030|FG000|Overall Study|Protocol Violation|28
7931939|NCT02314052|12465034|FG000|Cycle One|Adverse Event|0
7931940|NCT02314052|12465035|FG001|Cycle One|Adverse Event|0
7931941|NCT02314052|12465036|FG002|Cycle One|Adverse Event|0
7931942|NCT02314052|12465037|FG003|Cycle One|Adverse Event|1
7931943|NCT02314052|12465038|FG004|Cycle One|Adverse Event|0
7931944|NCT02314052|12465039|FG005|Cycle One|Adverse Event|0
7931945|NCT02314117|12465068|FG000|Overall Study|Lost to Follow-up|9
7931946|NCT02314117|12465069|FG001|Overall Study|Lost to Follow-up|14
7931947|NCT02314117|12465068|FG000|Overall Study|Withdrawal by Subject|3
7931948|NCT02314117|12465069|FG001|Overall Study|Withdrawal by Subject|2
7931949|NCT02314143|12465079|FG000|Overall Study|Adverse Event|0
7931950|NCT02314143|12465080|FG001|Overall Study|Adverse Event|6
7931951|NCT02314143|12465081|FG002|Overall Study|Adverse Event|4
7931952|NCT02314143|12465079|FG000|Overall Study|Other (Study Closed/Terminated)|5
7931953|NCT02314143|12465080|FG001|Overall Study|Other (Study Closed/Terminated)|3
7931954|NCT02314143|12465081|FG002|Overall Study|Other (Study Closed/Terminated)|4
7931955|NCT02314143|12465079|FG000|Overall Study|Physician Decision|2
7931956|NCT02314143|12465080|FG001|Overall Study|Physician Decision|1
7931957|NCT02314143|12465081|FG002|Overall Study|Physician Decision|0
7931958|NCT02314143|12465079|FG000|Overall Study|Withdrawal by Subject|1
7931959|NCT02314143|12465080|FG001|Overall Study|Withdrawal by Subject|0
7931960|NCT02314143|12465081|FG002|Overall Study|Withdrawal by Subject|1
7931961|NCT02314247|12465092|FG000|Overall Study|Adverse Event|2
7931962|NCT02314247|12465093|FG001|Overall Study|Adverse Event|1
7931963|NCT02314247|12465094|FG002|Overall Study|Adverse Event|0
7931964|NCT02314247|12465092|FG000|Overall Study|Withdrawal by Subject|1
7931965|NCT02314247|12465093|FG001|Overall Study|Withdrawal by Subject|3
7931966|NCT02314247|12465094|FG002|Overall Study|Withdrawal by Subject|1
7931967|NCT02314247|12465092|FG000|Overall Study|Progression of Disease|6
7931968|NCT02314247|12465093|FG001|Overall Study|Progression of Disease|2
7931969|NCT02314247|12465094|FG002|Overall Study|Progression of Disease|0
7931970|NCT02314637|12465141|FG000|Overall Study|Adverse Event|4
7931971|NCT02314637|12465142|FG001|Overall Study|Adverse Event|8
7931972|NCT02314637|12465141|FG000|Overall Study|Lack of Efficacy|1
7931973|NCT02314637|12465142|FG001|Overall Study|Lack of Efficacy|0
7931974|NCT02314637|12465141|FG000|Overall Study|Physician Decision|5
7931975|NCT02314637|12465142|FG001|Overall Study|Physician Decision|2
7931976|NCT02314637|12465141|FG000|Overall Study|Withdrawal by Subject|5
7931977|NCT02314637|12465142|FG001|Overall Study|Withdrawal by Subject|4
7931978|NCT02314637|12465141|FG000|Overall Study|Other Reason|1
7931979|NCT02314637|12465142|FG001|Overall Study|Other Reason|0
7931980|NCT02314728|12465154|FG000|Overall Study|Protocol Violation|1
7931981|NCT02314728|12465155|FG001|Overall Study|Protocol Violation|0
7931982|NCT02314728|12465154|FG000|Overall Study|Lost to Follow-up|0
7931983|NCT02314728|12465155|FG001|Overall Study|Lost to Follow-up|1
7931984|NCT02314780|12465166|FG000|Overall Study|organizational reasons|0
7931985|NCT02314780|12465167|FG001|Overall Study|organizational reasons|2
7931986|NCT02314780|12465168|FG002|Overall Study|organizational reasons|0
7931987|NCT02314780|12465166|FG000|Overall Study|Adverse Event|0
7931988|NCT02314780|12465167|FG001|Overall Study|Adverse Event|1
7931989|NCT02314780|12465168|FG002|Overall Study|Adverse Event|0
7964792|NCT01084252|12520466|FG009|Phase 1 (120 Weeks)|Progressive disease|0
7964793|NCT01084252|12520467|FG010|Phase 1 (120 Weeks)|Progressive disease|0
7964794|NCT01084252|12520468|FG011|Phase 1 (120 Weeks)|Progressive disease|0
7964795|NCT01084252|12520469|FG012|Phase 1 (120 Weeks)|Progressive disease|0
7964796|NCT01084252|12520470|FG013|Phase 1 (120 Weeks)|Progressive disease|0
7964797|NCT01084252|12520457|FG000|Phase 1 (120 Weeks)|Other than specified above|1
7964798|NCT01084252|12520458|FG001|Phase 1 (120 Weeks)|Other than specified above|1
7964799|NCT01084252|12520459|FG002|Phase 1 (120 Weeks)|Other than specified above|0
7964800|NCT01084252|12520460|FG003|Phase 1 (120 Weeks)|Other than specified above|3
7964801|NCT01084252|12520461|FG004|Phase 1 (120 Weeks)|Other than specified above|1
7964802|NCT01084252|12520462|FG005|Phase 1 (120 Weeks)|Other than specified above|0
7964803|NCT01084252|12520463|FG006|Phase 1 (120 Weeks)|Other than specified above|1
7964804|NCT01084252|12520464|FG007|Phase 1 (120 Weeks)|Other than specified above|1
7964805|NCT01084252|12520465|FG008|Phase 1 (120 Weeks)|Other than specified above|0
7964806|NCT01084252|12520466|FG009|Phase 1 (120 Weeks)|Other than specified above|0
7964807|NCT01084252|12520467|FG010|Phase 1 (120 Weeks)|Other than specified above|0
7964808|NCT01084252|12520468|FG011|Phase 1 (120 Weeks)|Other than specified above|0
7964809|NCT01084252|12520469|FG012|Phase 1 (120 Weeks)|Other than specified above|0
7964810|NCT01084252|12520470|FG013|Phase 1 (120 Weeks)|Other than specified above|0
7964811|NCT01084252|12520457|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7964812|NCT01084252|12520458|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7964813|NCT01084252|12520459|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7931990|NCT02315560|12465229|FG000|Overall Study|noncompliance by subjects|3
7931991|NCT02315625|12465235|FG000|First Intervention|Disease Progression|1
7931992|NCT02315625|12465236|FG001|First Intervention|Disease Progression|0
7931993|NCT02315625|12465235|FG000|Second Intervention|Physician Decision|2
7931994|NCT02315625|12465236|FG001|Second Intervention|Physician Decision|1
7931995|NCT02315625|12465235|FG000|Second Intervention|Study closure|1
7931996|NCT02315625|12465236|FG001|Second Intervention|Study closure|0
7931997|NCT02315625|12465235|FG000|Second Intervention|Disease Progression|1
7931998|NCT02315625|12465236|FG001|Second Intervention|Disease Progression|0
7931999|NCT02315664|12465246|FG000|Overall Study|Lost to Follow-up|1
7932000|NCT02315664|12465247|FG001|Overall Study|Lost to Follow-up|1
7932001|NCT02315664|12465246|FG000|Overall Study|Withdrawal by Subject|0
7932002|NCT02315664|12465247|FG001|Overall Study|Withdrawal by Subject|3
7932003|NCT02316223|12465277|FG000|Overall Study|Lack of Efficacy|0
7932004|NCT02316223|12465278|FG001|Overall Study|Lack of Efficacy|1
7932005|NCT02316223|12465279|FG002|Overall Study|Lack of Efficacy|1
7932006|NCT02316223|12465277|FG000|Overall Study|Lost to Follow-up|27
7932007|NCT02316223|12465278|FG001|Overall Study|Lost to Follow-up|34
7932008|NCT02316223|12465279|FG002|Overall Study|Lost to Follow-up|36
7932009|NCT02316223|12465277|FG000|Overall Study|COPD Diagnosis|3
7932010|NCT02316223|12465278|FG001|Overall Study|COPD Diagnosis|2
7932011|NCT02316223|12465279|FG002|Overall Study|COPD Diagnosis|3
7932012|NCT02316223|12465277|FG000|Overall Study|Reside outside study area|1
7932013|NCT02316223|12465278|FG001|Overall Study|Reside outside study area|1
7932014|NCT02316223|12465279|FG002|Overall Study|Reside outside study area|1
7932015|NCT02316223|12465277|FG000|Overall Study|No asthma|2
7932016|NCT02316223|12465278|FG001|Overall Study|No asthma|0
7932017|NCT02316223|12465279|FG002|Overall Study|No asthma|0
7932018|NCT02316223|12465277|FG000|Overall Study|Discontinued by PI|11
7932019|NCT02316223|12465278|FG001|Overall Study|Discontinued by PI|19
7932020|NCT02316223|12465279|FG002|Overall Study|Discontinued by PI|3
7932021|NCT02316353|12465289|FG000|Overall Study|Pregnancy|1
7932022|NCT02316353|12465290|FG001|Overall Study|Pregnancy|3
7932023|NCT02316353|12465289|FG000|Overall Study|Adverse Event|1
7932024|NCT02316353|12465290|FG001|Overall Study|Adverse Event|3
7932025|NCT02316353|12465289|FG000|Overall Study|Withdrawal by Subject|6
7932026|NCT02316353|12465290|FG001|Overall Study|Withdrawal by Subject|2
7932027|NCT02316548|12465327|FG000|Overall Study|Protocol Violation|0
7932028|NCT02316548|12465328|FG001|Overall Study|Protocol Violation|1
7932029|NCT02316613|12465334|FG000|Overall Study|Death|63
7932030|NCT02316613|12465334|FG000|Overall Study|Lost to Follow-up|9
7932031|NCT02316613|12465334|FG000|Overall Study|Lymphoma transformation|2
7932032|NCT02316613|12465334|FG000|Overall Study|Participant moved/changed medical team|11
7932033|NCT02316613|12465334|FG000|Overall Study|No data and duplicate cases|5
7932034|NCT02316613|12465334|FG000|Overall Study|Did not met selection criteria|14
7932035|NCT02316717|12465361|FG000|Overall Study|Adverse Event|2
7932036|NCT02316717|12465362|FG001|Overall Study|Adverse Event|2
7932037|NCT02316717|12465363|FG002|Overall Study|Adverse Event|0
7932038|NCT02316717|12465361|FG000|Overall Study|Lost to Follow-up|1
7932039|NCT02316717|12465362|FG001|Overall Study|Lost to Follow-up|2
7932040|NCT02316717|12465363|FG002|Overall Study|Lost to Follow-up|1
7932041|NCT02316717|12465361|FG000|Overall Study|Non compliance|3
7932042|NCT02316717|12465362|FG001|Overall Study|Non compliance|1
7932043|NCT02316717|12465363|FG002|Overall Study|Non compliance|0
7932044|NCT02316717|12465361|FG000|Overall Study|Protocol Violation|2
7932045|NCT02316717|12465362|FG001|Overall Study|Protocol Violation|0
7932046|NCT02316717|12465363|FG002|Overall Study|Protocol Violation|0
7932047|NCT02316717|12465361|FG000|Overall Study|Withdrawal by Subject|2
7932048|NCT02316717|12465362|FG001|Overall Study|Withdrawal by Subject|1
7932049|NCT02316717|12465363|FG002|Overall Study|Withdrawal by Subject|1
7932050|NCT02316717|12465361|FG000|Overall Study|Death|0
7932051|NCT02316717|12465362|FG001|Overall Study|Death|0
7932052|NCT02316717|12465363|FG002|Overall Study|Death|1
7932053|NCT02316717|12465361|FG000|Overall Study|Physician Decision|0
7932054|NCT02316717|12465362|FG001|Overall Study|Physician Decision|1
7932055|NCT02316717|12465363|FG002|Overall Study|Physician Decision|0
7932056|NCT02316717|12465361|FG000|Overall Study|TBC|1
7932057|NCT02316717|12465362|FG001|Overall Study|TBC|0
7932058|NCT02316717|12465363|FG002|Overall Study|TBC|0
7932059|NCT02316769|12465376|FG000|Overall Study|Physician Decision|1
7932060|NCT02316769|12465377|FG001|Overall Study|Physician Decision|0
7932061|NCT02316769|12465376|FG000|Overall Study|Withdrawal by Subject|1
7932062|NCT02316769|12465377|FG001|Overall Study|Withdrawal by Subject|0
7932063|NCT02316847|12465385|FG000|Overall Study|Adverse Event|0
7932064|NCT02316847|12465386|FG001|Overall Study|Adverse Event|3
7932065|NCT02316847|12465385|FG000|Overall Study|Lost to Follow-up|0
7932066|NCT02316847|12465386|FG001|Overall Study|Lost to Follow-up|2
7932067|NCT02316847|12465385|FG000|Overall Study|Physician Decision|0
7932068|NCT02316847|12465386|FG001|Overall Study|Physician Decision|1
7932069|NCT02316847|12465385|FG000|Overall Study|Pregnancy|0
7932070|NCT02316847|12465386|FG001|Overall Study|Pregnancy|1
7932071|NCT02316847|12465385|FG000|Overall Study|Withdrawal by Subject|2
7932072|NCT02316847|12465386|FG001|Overall Study|Withdrawal by Subject|9
7932073|NCT02316847|12465385|FG000|Overall Study|Noncompliance with study drug|0
7932074|NCT02316847|12465386|FG001|Overall Study|Noncompliance with study drug|3
7932075|NCT02316847|12465385|FG000|Overall Study|Withdrawn due to termination by Sponsor|7
7932076|NCT02316847|12465386|FG001|Overall Study|Withdrawn due to termination by Sponsor|67
7932077|NCT02317016|12465394|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
7932078|NCT02317016|12465394|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
7932079|NCT02317016|12465394|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
7932080|NCT02317016|12465394|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
7932081|NCT02317016|12465394|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
7932082|NCT02317016|12465394|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
7932083|NCT02317016|12465394|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5
7932084|NCT02317432|12465413|FG000|Overall Study|Death|4
7932085|NCT02317432|12465414|FG001|Overall Study|Death|1
7932086|NCT02317432|12465413|FG000|Overall Study|Lost to Follow-up|0
7932087|NCT02317432|12465414|FG001|Overall Study|Lost to Follow-up|5
7932088|NCT02317432|12465413|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27
7932089|NCT02317432|12465414|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0
7932090|NCT02317510|12465422|FG000|Overall Study|Adverse Event|0
7932091|NCT02317510|12465423|FG001|Overall Study|Adverse Event|1
7932092|NCT02317562|12465441|FG000|Overall Study|Physician Decision|1
7932093|NCT02317562|12465441|FG000|Overall Study|early termination of the study|8
7932094|NCT02317562|12465441|FG000|Overall Study|Lack of Efficacy|4
7932095|NCT02317562|12465441|FG000|Overall Study|Withdrawal by Subject|1
7932096|NCT02317575|12465445|FG000|Period 1|Difficulty with venous cannulation|0
7932097|NCT02317575|12465446|FG001|Period 1|Difficulty with venous cannulation|1
7932098|NCT02317575|12465447|FG002|Period 1|Difficulty with venous cannulation|0
7932099|NCT02317575|12465448|FG003|Period 1|Difficulty with venous cannulation|0
7932100|NCT02317575|12465449|FG004|Period 1|Difficulty with venous cannulation|0
7932101|NCT02317575|12465445|FG000|Period 1|Withdrawal by Subject|1
7932102|NCT02317575|12465446|FG001|Period 1|Withdrawal by Subject|0
7932103|NCT02317575|12465447|FG002|Period 1|Withdrawal by Subject|0
7932104|NCT02317575|12465448|FG003|Period 1|Withdrawal by Subject|0
7932105|NCT02317575|12465449|FG004|Period 1|Withdrawal by Subject|0
7932106|NCT02317614|12465469|FG000|Overall Study|Lost to Follow-up|1
7932107|NCT02317614|12465470|FG001|Overall Study|Lost to Follow-up|1
7932108|NCT02317614|12465469|FG000|Overall Study|Withdrawal by Subject|1
7932109|NCT02317614|12465470|FG001|Overall Study|Withdrawal by Subject|0
7932110|NCT02317614|12465469|FG000|Overall Study|Death|1
7932111|NCT02317614|12465470|FG001|Overall Study|Death|1
7932112|NCT02317809|12465494|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2
7932113|NCT02317809|12465495|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0
7932114|NCT02317809|12465494|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
7932115|NCT02317809|12465495|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
7932116|NCT02318134|12465506|FG000|Overall Study|Withdrawal by Subject|2
7932117|NCT02318134|12465507|FG001|Overall Study|Withdrawal by Subject|1
7932118|NCT02318368|12465546|FG000|Overall Study|Withdrawal by Subject|2
7932119|NCT02318368|12465547|FG001|Overall Study|Withdrawal by Subject|0
7932120|NCT02318368|12465546|FG000|Overall Study|Study terminated by the sponsor|5
7932121|NCT02318368|12465547|FG001|Overall Study|Study terminated by the sponsor|2
7932122|NCT02318368|12465546|FG000|Overall Study|Death|0
7932123|NCT02318368|12465547|FG001|Overall Study|Death|1
7932124|NCT02318602|12465560|FG000|Overall Study|Adverse Event|0
7932125|NCT02318602|12465561|FG001|Overall Study|Adverse Event|1
7932126|NCT02318602|12465562|FG002|Overall Study|Adverse Event|1
7932127|NCT02318602|12465560|FG000|Overall Study|Withdrawal by Subject|0
7932128|NCT02318602|12465561|FG001|Overall Study|Withdrawal by Subject|3
7932129|NCT02318602|12465562|FG002|Overall Study|Withdrawal by Subject|0
7932130|NCT02318602|12465560|FG000|Overall Study|Death|1
7932131|NCT02318602|12465561|FG001|Overall Study|Death|0
7932132|NCT02318602|12465562|FG002|Overall Study|Death|0
7932133|NCT02318602|12465560|FG000|Overall Study|Guardian decision to withdraw|0
7932134|NCT02318602|12465561|FG001|Overall Study|Guardian decision to withdraw|0
7932135|NCT02318602|12465562|FG002|Overall Study|Guardian decision to withdraw|1
7932136|NCT02318667|12465576|FG000|Overall Study|Adverse Event|1
7932137|NCT02318667|12465576|FG000|Overall Study|Lack of Efficacy|6
7932138|NCT02318667|12465576|FG000|Overall Study|Protocol Violation|2
7932139|NCT02318693|12465586|FG000|Overall Study|Protocol Violation|0
7932140|NCT02318693|12465587|FG001|Overall Study|Protocol Violation|1
7932141|NCT02318706|12465597|FG000|Double-blind Phase|Adverse Event|7
7932142|NCT02318706|12465598|FG001|Double-blind Phase|Adverse Event|4
7932143|NCT02318706|12465599|FG002|Double-blind Phase|Adverse Event|3
7932144|NCT02318706|12465600|FG003|Double-blind Phase|Adverse Event|10
7932145|NCT02318706|12465601|FG004|Double-blind Phase|Adverse Event|0
7932146|NCT02318706|12465597|FG000|Double-blind Phase|Lost to Follow-up|1
7932147|NCT02318706|12465598|FG001|Double-blind Phase|Lost to Follow-up|0
7932148|NCT02318706|12465599|FG002|Double-blind Phase|Lost to Follow-up|0
7932149|NCT02318706|12465600|FG003|Double-blind Phase|Lost to Follow-up|0
7932150|NCT02318706|12465601|FG004|Double-blind Phase|Lost to Follow-up|0
7932151|NCT02318706|12465597|FG000|Double-blind Phase|Protocol Violation|4
7932152|NCT02318706|12465598|FG001|Double-blind Phase|Protocol Violation|2
7932153|NCT02318706|12465599|FG002|Double-blind Phase|Protocol Violation|4
7932154|NCT02318706|12465600|FG003|Double-blind Phase|Protocol Violation|3
7932155|NCT02318706|12465601|FG004|Double-blind Phase|Protocol Violation|0
7932156|NCT02318706|12465597|FG000|Double-blind Phase|Withdrawal by Subject|9
7932157|NCT02318706|12465598|FG001|Double-blind Phase|Withdrawal by Subject|5
7932158|NCT02318706|12465599|FG002|Double-blind Phase|Withdrawal by Subject|7
7932159|NCT02318706|12465600|FG003|Double-blind Phase|Withdrawal by Subject|10
7932160|NCT02318706|12465601|FG004|Double-blind Phase|Withdrawal by Subject|0
7932161|NCT02318706|12465597|FG000|Double-blind Phase|Other|4
7932162|NCT02318706|12465598|FG001|Double-blind Phase|Other|1
7932163|NCT02318706|12465599|FG002|Double-blind Phase|Other|2
7932164|NCT02318706|12465600|FG003|Double-blind Phase|Other|1
7932165|NCT02318706|12465601|FG004|Double-blind Phase|Other|0
7932166|NCT02318706|12465597|FG000|Double-blind Phase|Death|0
7932167|NCT02318706|12465598|FG001|Double-blind Phase|Death|0
7932168|NCT02318706|12465599|FG002|Double-blind Phase|Death|2
7932169|NCT02318706|12465600|FG003|Double-blind Phase|Death|0
7932170|NCT02318706|12465601|FG004|Double-blind Phase|Death|0
7932171|NCT02318706|12465597|FG000|Open-label Extension Phase|Adverse Event|0
7932172|NCT02318706|12465598|FG001|Open-label Extension Phase|Adverse Event|0
7932173|NCT02318706|12465599|FG002|Open-label Extension Phase|Adverse Event|0
7932174|NCT02318706|12465600|FG003|Open-label Extension Phase|Adverse Event|0
7932175|NCT02318706|12465601|FG004|Open-label Extension Phase|Adverse Event|21
7932176|NCT02318706|12465597|FG000|Open-label Extension Phase|Lack of Efficacy|0
7932177|NCT02318706|12465598|FG001|Open-label Extension Phase|Lack of Efficacy|0
7932178|NCT02318706|12465599|FG002|Open-label Extension Phase|Lack of Efficacy|0
7932179|NCT02318706|12465600|FG003|Open-label Extension Phase|Lack of Efficacy|0
7932180|NCT02318706|12465601|FG004|Open-label Extension Phase|Lack of Efficacy|1
7932181|NCT02318706|12465597|FG000|Open-label Extension Phase|Death|0
7932182|NCT02318706|12465598|FG001|Open-label Extension Phase|Death|0
7932183|NCT02318706|12465599|FG002|Open-label Extension Phase|Death|0
7932184|NCT02318706|12465600|FG003|Open-label Extension Phase|Death|0
7932185|NCT02318706|12465601|FG004|Open-label Extension Phase|Death|1
7932186|NCT02318706|12465597|FG000|Open-label Extension Phase|Withdrawal by Subject|0
7932187|NCT02318706|12465598|FG001|Open-label Extension Phase|Withdrawal by Subject|0
7932188|NCT02318706|12465599|FG002|Open-label Extension Phase|Withdrawal by Subject|0
7932189|NCT02318706|12465600|FG003|Open-label Extension Phase|Withdrawal by Subject|0
7932190|NCT02318706|12465601|FG004|Open-label Extension Phase|Withdrawal by Subject|19
7932191|NCT02318719|12465617|FG000|Double-blind Phase|Adverse Event|7
7932192|NCT02318719|12465618|FG001|Double-blind Phase|Adverse Event|6
7932193|NCT02318719|12465619|FG002|Double-blind Phase|Adverse Event|12
7932194|NCT02318719|12465620|FG003|Double-blind Phase|Adverse Event|4
7932195|NCT02318719|12465621|FG004|Double-blind Phase|Adverse Event|0
7932196|NCT02318719|12465617|FG000|Double-blind Phase|Lack of Efficacy|5
7932197|NCT02318719|12465618|FG001|Double-blind Phase|Lack of Efficacy|0
7932198|NCT02318719|12465619|FG002|Double-blind Phase|Lack of Efficacy|1
7932199|NCT02318719|12465620|FG003|Double-blind Phase|Lack of Efficacy|1
7932200|NCT02318719|12465621|FG004|Double-blind Phase|Lack of Efficacy|0
7932201|NCT02318719|12465617|FG000|Double-blind Phase|Protocol Violation|0
7932202|NCT02318719|12465618|FG001|Double-blind Phase|Protocol Violation|1
7932203|NCT02318719|12465619|FG002|Double-blind Phase|Protocol Violation|3
7932204|NCT02318719|12465620|FG003|Double-blind Phase|Protocol Violation|0
7932205|NCT02318719|12465621|FG004|Double-blind Phase|Protocol Violation|0
7932206|NCT02318719|12465617|FG000|Double-blind Phase|Withdrawal by Subject|25
7932207|NCT02318719|12465618|FG001|Double-blind Phase|Withdrawal by Subject|7
7932208|NCT02318719|12465619|FG002|Double-blind Phase|Withdrawal by Subject|9
7932209|NCT02318719|12465620|FG003|Double-blind Phase|Withdrawal by Subject|10
7932210|NCT02318719|12465621|FG004|Double-blind Phase|Withdrawal by Subject|0
7932211|NCT02318719|12465617|FG000|Double-blind Phase|Other|1
7932212|NCT02318719|12465618|FG001|Double-blind Phase|Other|2
7932213|NCT02318719|12465619|FG002|Double-blind Phase|Other|0
7932214|NCT02318719|12465620|FG003|Double-blind Phase|Other|0
7932215|NCT02318719|12465621|FG004|Double-blind Phase|Other|0
7932216|NCT02318719|12465617|FG000|Open-label Extension Phase|Adverse Event|0
7932217|NCT02318719|12465618|FG001|Open-label Extension Phase|Adverse Event|0
7932218|NCT02318719|12465619|FG002|Open-label Extension Phase|Adverse Event|0
7932219|NCT02318719|12465620|FG003|Open-label Extension Phase|Adverse Event|0
7932220|NCT02318719|12465621|FG004|Open-label Extension Phase|Adverse Event|15
7932221|NCT02318719|12465617|FG000|Open-label Extension Phase|Death|0
7932222|NCT02318719|12465618|FG001|Open-label Extension Phase|Death|0
7932223|NCT02318719|12465619|FG002|Open-label Extension Phase|Death|0
7932224|NCT02318719|12465620|FG003|Open-label Extension Phase|Death|0
7932225|NCT02318719|12465621|FG004|Open-label Extension Phase|Death|1
7932226|NCT02318719|12465617|FG000|Open-label Extension Phase|Lack of Efficacy|0
7932227|NCT02318719|12465618|FG001|Open-label Extension Phase|Lack of Efficacy|0
7932228|NCT02318719|12465619|FG002|Open-label Extension Phase|Lack of Efficacy|0
7932229|NCT02318719|12465620|FG003|Open-label Extension Phase|Lack of Efficacy|0
7932230|NCT02318719|12465621|FG004|Open-label Extension Phase|Lack of Efficacy|1
7932231|NCT02318719|12465617|FG000|Open-label Extension Phase|Withdrawal by Subject|0
7932232|NCT02318719|12465618|FG001|Open-label Extension Phase|Withdrawal by Subject|0
7932233|NCT02318719|12465619|FG002|Open-label Extension Phase|Withdrawal by Subject|0
7932234|NCT02318719|12465620|FG003|Open-label Extension Phase|Withdrawal by Subject|0
7932235|NCT02318719|12465621|FG004|Open-label Extension Phase|Withdrawal by Subject|31
7932236|NCT02318719|12465617|FG000|Open-label Extension Phase|Other|0
7932237|NCT02318719|12465618|FG001|Open-label Extension Phase|Other|0
7932238|NCT02318719|12465619|FG002|Open-label Extension Phase|Other|0
7932239|NCT02318719|12465620|FG003|Open-label Extension Phase|Other|0
7932240|NCT02318719|12465621|FG004|Open-label Extension Phase|Other|7
7932241|NCT02318797|12465635|FG000|Overall Study|Death|3
7932242|NCT02318797|12465636|FG001|Overall Study|Death|6
7932243|NCT02318797|12465635|FG000|Overall Study|Lost to Follow-up|85
7932244|NCT02318797|12465636|FG001|Overall Study|Lost to Follow-up|96
7932245|NCT02318940|12465644|FG000|Overall Study|lost the record|1
7932246|NCT02318940|12465645|FG001|Overall Study|lost the record|0
7932247|NCT02319031|12465679|FG000|Treatment Period|Death|1
7932248|NCT02319031|12465680|FG001|Treatment Period|Death|0
7932249|NCT02319044|12465689|FG000|Overall Study|Death, PI/sponsor decision, med history|0
7932250|NCT02319044|12465690|FG001|Overall Study|Death, PI/sponsor decision, med history|1
7932251|NCT02319044|12465691|FG002|Overall Study|Death, PI/sponsor decision, med history|4
7932252|NCT02319044|12465689|FG000|Overall Study|Withdrawal by Subject|3
7932253|NCT02319044|12465690|FG001|Overall Study|Withdrawal by Subject|3
7932254|NCT02319044|12465691|FG002|Overall Study|Withdrawal by Subject|6
7932255|NCT02319044|12465689|FG000|Overall Study|Condition under investigation worsened|100
7932256|NCT02319044|12465690|FG001|Overall Study|Condition under investigation worsened|50
7932257|NCT02319044|12465691|FG002|Overall Study|Condition under investigation worsened|46
7932258|NCT02319044|12465689|FG000|Overall Study|Adverse Event|17
7932259|NCT02319044|12465690|FG001|Overall Study|Adverse Event|2
7932260|NCT02319044|12465691|FG002|Overall Study|Adverse Event|8
7932261|NCT02319044|12465689|FG000|Overall Study|Study specific discontinuation criteria|2
7932262|NCT02319044|12465690|FG001|Overall Study|Study specific discontinuation criteria|2
7932263|NCT02319044|12465691|FG002|Overall Study|Study specific discontinuation criteria|1
7932264|NCT02319044|12465689|FG000|Overall Study|Not treated|0
7932265|NCT02319044|12465690|FG001|Overall Study|Not treated|2
7932266|NCT02319044|12465691|FG002|Overall Study|Not treated|2
7932267|NCT02319148|12465703|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0
7932268|NCT02319148|12465704|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0
7932269|NCT02319148|12465705|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1
7932270|NCT02319148|12465706|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1
7932271|NCT02319148|12465703|FG000|Second Intervention Period|No longer willing to participate|0
7932272|NCT02319148|12465704|FG001|Second Intervention Period|No longer willing to participate|1
7932273|NCT02319148|12465705|FG002|Second Intervention Period|No longer willing to participate|0
7932274|NCT02319148|12465706|FG003|Second Intervention Period|No longer willing to participate|0
7932275|NCT02319148|12465703|FG000|Second Intervention Period|Other|0
7932276|NCT02319148|12465704|FG001|Second Intervention Period|Other|0
7932277|NCT02319148|12465705|FG002|Second Intervention Period|Other|0
7932278|NCT02319148|12465706|FG003|Second Intervention Period|Other|1
7932279|NCT02319525|12465814|FG000|Overall Study|Withdrawal by Subject|2
7932280|NCT02319525|12465815|FG001|Overall Study|Withdrawal by Subject|1
7932281|NCT02319642|12465823|FG000|Overall Study|Adverse Event|2
7932282|NCT02319642|12465824|FG001|Overall Study|Adverse Event|4
7932283|NCT02319642|12465823|FG000|Overall Study|Lack of Efficacy|1
7932284|NCT02319642|12465824|FG001|Overall Study|Lack of Efficacy|1
7932285|NCT02319642|12465823|FG000|Overall Study|Withdrawal by Subject|1
7932286|NCT02319642|12465824|FG001|Overall Study|Withdrawal by Subject|1
7932287|NCT02319668|12465834|FG000|Overall Study|Other (Not specified)|0
7932288|NCT02319668|12465835|FG001|Overall Study|Other (Not specified)|2
7932289|NCT02319759|12465846|FG000|Week 0 - 16|Lack of Efficacy|1
7932290|NCT02319759|12465847|FG001|Week 0 - 16|Lack of Efficacy|0
7932291|NCT02319759|12465848|FG002|Week 0 - 16|Lack of Efficacy|0
7932292|NCT02319759|12465849|FG003|Week 0 - 16|Lack of Efficacy|0
7932293|NCT02319759|12465850|FG004|Week 0 - 16|Lack of Efficacy|0
7932294|NCT02319759|12465846|FG000|Week 0 - 16|Not met all Inclusion Criteria|0
7932295|NCT02319759|12465847|FG001|Week 0 - 16|Not met all Inclusion Criteria|0
7932296|NCT02319759|12465848|FG002|Week 0 - 16|Not met all Inclusion Criteria|1
7932297|NCT02319759|12465849|FG003|Week 0 - 16|Not met all Inclusion Criteria|0
7932298|NCT02319759|12465850|FG004|Week 0 - 16|Not met all Inclusion Criteria|0
7932299|NCT02319759|12465846|FG000|Week 16 - 24|Lack of Efficacy|1
7932300|NCT02319759|12465847|FG001|Week 16 - 24|Lack of Efficacy|0
7932301|NCT02319759|12465848|FG002|Week 16 - 24|Lack of Efficacy|1
7932302|NCT02319759|12465849|FG003|Week 16 - 24|Lack of Efficacy|0
7932303|NCT02319759|12465850|FG004|Week 16 - 24|Lack of Efficacy|0
7932304|NCT02319759|12465846|FG000|Week 16 - 24|Lost to Follow-up|1
7932305|NCT02319759|12465847|FG001|Week 16 - 24|Lost to Follow-up|0
7932306|NCT02319759|12465848|FG002|Week 16 - 24|Lost to Follow-up|0
7932307|NCT02319759|12465849|FG003|Week 16 - 24|Lost to Follow-up|0
7932308|NCT02319759|12465850|FG004|Week 16 - 24|Lost to Follow-up|0
7932309|NCT02319759|12465846|FG000|Week 16 - 24|Withdrawal by Subject|0
7932310|NCT02319759|12465847|FG001|Week 16 - 24|Withdrawal by Subject|0
7932311|NCT02319759|12465848|FG002|Week 16 - 24|Withdrawal by Subject|2
7932312|NCT02319759|12465849|FG003|Week 16 - 24|Withdrawal by Subject|0
7932313|NCT02319759|12465850|FG004|Week 16 - 24|Withdrawal by Subject|0
7932314|NCT02319759|12465846|FG000|Week 24 - 56|Adverse Event|0
7932315|NCT02319759|12465847|FG001|Week 24 - 56|Adverse Event|0
7932316|NCT02319759|12465848|FG002|Week 24 - 56|Adverse Event|2
7932317|NCT02319759|12465849|FG003|Week 24 - 56|Adverse Event|0
7932318|NCT02319759|12465850|FG004|Week 24 - 56|Adverse Event|0
7932319|NCT02319759|12465846|FG000|Week 24 - 56|Lack of Efficacy|0
7932320|NCT02319759|12465847|FG001|Week 24 - 56|Lack of Efficacy|0
7932321|NCT02319759|12465848|FG002|Week 24 - 56|Lack of Efficacy|0
7932322|NCT02319759|12465849|FG003|Week 24 - 56|Lack of Efficacy|2
7932323|NCT02319759|12465850|FG004|Week 24 - 56|Lack of Efficacy|1
7932324|NCT02319759|12465846|FG000|Week 24 - 56|Withdrawal by Subject|0
7932325|NCT02319759|12465847|FG001|Week 24 - 56|Withdrawal by Subject|1
7932326|NCT02319759|12465848|FG002|Week 24 - 56|Withdrawal by Subject|0
7932327|NCT02319759|12465849|FG003|Week 24 - 56|Withdrawal by Subject|0
7932328|NCT02319759|12465850|FG004|Week 24 - 56|Withdrawal by Subject|0
7932329|NCT02319759|12465846|FG000|Week 24 - 56|Lost to Follow-up|0
7932330|NCT02319759|12465847|FG001|Week 24 - 56|Lost to Follow-up|0
7932331|NCT02319759|12465848|FG002|Week 24 - 56|Lost to Follow-up|0
7932332|NCT02319759|12465849|FG003|Week 24 - 56|Lost to Follow-up|0
7932333|NCT02319759|12465850|FG004|Week 24 - 56|Lost to Follow-up|1
7932334|NCT02320058|12465883|FG000|Overall Study|Death|25
7932335|NCT02320058|12465884|FG001|Overall Study|Death|10
7932336|NCT02320058|12465883|FG000|Overall Study|Lost to Follow-up|4
7932337|NCT02320058|12465884|FG001|Overall Study|Lost to Follow-up|0
7932338|NCT02320058|12465883|FG000|Overall Study|Other reasons|4
7932339|NCT02320058|12465884|FG001|Overall Study|Other reasons|1
7932340|NCT02320058|12465883|FG000|Overall Study|Withdrawal by Subject|8
7932341|NCT02320058|12465884|FG001|Overall Study|Withdrawal by Subject|2
7932342|NCT02320058|12465883|FG000|Overall Study|Not reported|1
7932343|NCT02320058|12465884|FG001|Overall Study|Not reported|0
7932344|NCT02320123|12465892|FG000|Overall Study|Lost to Follow-up|4
7932345|NCT02320123|12465893|FG001|Overall Study|Lost to Follow-up|6
7932346|NCT02320123|12465892|FG000|Overall Study|Death|6
7932347|NCT02320123|12465893|FG001|Overall Study|Death|5
7932348|NCT02320149|12465905|FG000|Overall Study|Adverse Event|3
7932349|NCT02320149|12465906|FG001|Overall Study|Adverse Event|7
7932350|NCT02320149|12465905|FG000|Overall Study|Withdrawal of Consent|28
7932351|NCT02320149|12465906|FG001|Overall Study|Withdrawal of Consent|32
7932352|NCT02320149|12465905|FG000|Overall Study|Lost to Follow-up|21
7932353|NCT02320149|12465906|FG001|Overall Study|Lost to Follow-up|34
7932354|NCT02320149|12465905|FG000|Overall Study|Protocol Violation|2
7932355|NCT02320149|12465906|FG001|Overall Study|Protocol Violation|1
7932356|NCT02320149|12465905|FG000|Overall Study|Noncompliance with Study Treatment|7
7932357|NCT02320149|12465906|FG001|Overall Study|Noncompliance with Study Treatment|2
7932358|NCT02320149|12465905|FG000|Overall Study|Lack of Efficacy|0
7932359|NCT02320149|12465906|FG001|Overall Study|Lack of Efficacy|1
7932360|NCT02320149|12465905|FG000|Overall Study|Other Miscellaneous Reasons|2
7932361|NCT02320149|12465906|FG001|Overall Study|Other Miscellaneous Reasons|3
7932362|NCT02320253|12465936|FG000|Overall Study|Withdrawal by Subject|3
7932363|NCT02320253|12465937|FG001|Overall Study|Withdrawal by Subject|0
7932364|NCT02320253|12465938|FG002|Overall Study|Withdrawal by Subject|0
7932365|NCT02320253|12465936|FG000|Overall Study|Lost to Follow-up|2
7932366|NCT02320253|12465937|FG001|Overall Study|Lost to Follow-up|2
7932367|NCT02320253|12465938|FG002|Overall Study|Lost to Follow-up|1
7932368|NCT02320253|12465936|FG000|Overall Study|Death|1
7932369|NCT02320253|12465937|FG001|Overall Study|Death|0
7932370|NCT02320253|12465938|FG002|Overall Study|Death|1
7932371|NCT02320487|12465946|FG000|Overall Study|Reason not Specified|1
7932372|NCT02320487|12465946|FG000|Overall Study|Physician Decision|5
7932373|NCT02320487|12465946|FG000|Overall Study|Withdrawal by Subject|1
7932374|NCT02320487|12465946|FG000|Overall Study|Death|3
7932375|NCT02320487|12465946|FG000|Overall Study|Adverse Event|11
7932376|NCT02320721|12465961|FG000|Overall Study|Adverse Event|6
7932377|NCT02320721|12465962|FG001|Overall Study|Adverse Event|6
7932378|NCT02320721|12465961|FG000|Overall Study|Lack of Efficacy|2
7932379|NCT02320721|12465962|FG001|Overall Study|Lack of Efficacy|0
7932380|NCT02320721|12465961|FG000|Overall Study|Poor compliance to protocol|3
7932381|NCT02320721|12465962|FG001|Overall Study|Poor compliance to protocol|7
7932382|NCT02320721|12465961|FG000|Overall Study|Randomized but not treated|0
7932383|NCT02320721|12465962|FG001|Overall Study|Randomized but not treated|1
7932384|NCT02320721|12465961|FG000|Overall Study|Hypoglycemia|1
7932385|NCT02320721|12465962|FG001|Overall Study|Hypoglycemia|0
7932386|NCT02320721|12465961|FG000|Overall Study|Other than specified above|15
7932387|NCT02320721|12465962|FG001|Overall Study|Other than specified above|20
7932388|NCT02320903|12465991|FG000|Overall Study|Withdrawal by Subject|0
7932389|NCT02320903|12465992|FG001|Overall Study|Withdrawal by Subject|9
7932390|NCT02320903|12465993|FG002|Overall Study|Withdrawal by Subject|9
7932391|NCT02320903|12465991|FG000|Overall Study|Exited therapy; no longer eligible|8
7932392|NCT02320903|12465992|FG001|Overall Study|Exited therapy; no longer eligible|2
7932393|NCT02320903|12465993|FG002|Overall Study|Exited therapy; no longer eligible|2
7932394|NCT02320903|12465991|FG000|Overall Study|Lost to Follow-up|0
7932395|NCT02320903|12465992|FG001|Overall Study|Lost to Follow-up|5
7932396|NCT02320903|12465993|FG002|Overall Study|Lost to Follow-up|5
7932397|NCT02321098|12466005|FG000|12 Weeks Treament|Lost to Follow-up|1
7932398|NCT02321098|12466006|FG001|12 Weeks Treament|Lost to Follow-up|1
7932399|NCT02321098|12466007|FG002|12 Weeks Treament|Lost to Follow-up|0
7932400|NCT02321098|12466005|FG000|Additional 15 Months Treatment|Lack of Efficacy|0
7932401|NCT02321098|12466006|FG001|Additional 15 Months Treatment|Lack of Efficacy|0
7932402|NCT02321098|12466007|FG002|Additional 15 Months Treatment|Lack of Efficacy|6
7932403|NCT02321098|12466005|FG000|Additional 15 Months Treatment|Lost to Follow-up|0
7932404|NCT02321098|12466006|FG001|Additional 15 Months Treatment|Lost to Follow-up|0
7932405|NCT02321098|12466007|FG002|Additional 15 Months Treatment|Lost to Follow-up|1
7932406|NCT02321098|12466005|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0
7932407|NCT02321098|12466006|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0
7932408|NCT02321098|12466007|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1
7932409|NCT02321319|12466029|FG000|Overall Study|Product discontinued|5
7932410|NCT02321462|12466035|FG000|Overall Study|Withdrawal by Subject|5
7932411|NCT02321462|12466036|FG001|Overall Study|Withdrawal by Subject|2
7932412|NCT02321462|12466035|FG000|Overall Study|Subject withdrawn before any treatment|1
7932413|NCT02321462|12466036|FG001|Overall Study|Subject withdrawn before any treatment|1
7932414|NCT02321800|12466061|FG000|Overall Study|Withdrawal by Subject|3
7932415|NCT02321800|12466062|FG001|Overall Study|Withdrawal by Subject|3
7932416|NCT02321800|12466061|FG000|Overall Study|Death|1
7932417|NCT02321800|12466062|FG001|Overall Study|Death|0
7932418|NCT02321800|12466061|FG000|Overall Study|Protocol Violation|1
7932419|NCT02321800|12466062|FG001|Overall Study|Protocol Violation|0
7932420|NCT02321800|12466061|FG000|Overall Study|Lost to Follow-up|10
7932421|NCT02321800|12466062|FG001|Overall Study|Lost to Follow-up|4
7932422|NCT02321800|12466061|FG000|Overall Study|Adverse Event|2
7932423|NCT02321800|12466062|FG001|Overall Study|Adverse Event|3
7932424|NCT02321800|12466061|FG000|Overall Study|Other, Miscellaneous|3
7932425|NCT02321800|12466062|FG001|Overall Study|Other, Miscellaneous|1
7932426|NCT02321930|12466068|FG000|Overall Study|Lost to Follow-up|1
7932427|NCT02322021|12466076|FG000|Core Phase|Adverse Event|1
7932428|NCT02322021|12466077|FG001|Core Phase|Adverse Event|3
7932429|NCT02322021|12466078|FG002|Core Phase|Adverse Event|4
7932430|NCT02322021|12466079|FG003|Core Phase|Adverse Event|2
7932431|NCT02322021|12466080|FG004|Core Phase|Adverse Event|0
7932432|NCT02322021|12466076|FG000|Core Phase|Participant Choice|4
7932433|NCT02322021|12466077|FG001|Core Phase|Participant Choice|5
7932434|NCT02322021|12466078|FG002|Core Phase|Participant Choice|4
7932435|NCT02322021|12466079|FG003|Core Phase|Participant Choice|2
7932436|NCT02322021|12466080|FG004|Core Phase|Participant Choice|0
7932437|NCT02322021|12466076|FG000|Core Phase|Lost to Follow-up|0
7932438|NCT02322021|12466077|FG001|Core Phase|Lost to Follow-up|0
7932439|NCT02322021|12466078|FG002|Core Phase|Lost to Follow-up|0
7932440|NCT02322021|12466079|FG003|Core Phase|Lost to Follow-up|1
7932441|NCT02322021|12466080|FG004|Core Phase|Lost to Follow-up|0
7932442|NCT02322021|12466076|FG000|Core Phase|Other|0
7932443|NCT02322021|12466077|FG001|Core Phase|Other|0
7932444|NCT02322021|12466078|FG002|Core Phase|Other|1
7932445|NCT02322021|12466079|FG003|Core Phase|Other|0
7932446|NCT02322021|12466080|FG004|Core Phase|Other|0
7932447|NCT02322021|12466076|FG000|Extension Phase|Adverse Event|0
7932448|NCT02322021|12466077|FG001|Extension Phase|Adverse Event|0
7932449|NCT02322021|12466078|FG002|Extension Phase|Adverse Event|0
7932450|NCT02322021|12466079|FG003|Extension Phase|Adverse Event|0
7932451|NCT02322021|12466080|FG004|Extension Phase|Adverse Event|3
7932452|NCT02322021|12466076|FG000|Extension Phase|Participant Choice|0
7932453|NCT02322021|12466077|FG001|Extension Phase|Participant Choice|0
7932454|NCT02322021|12466078|FG002|Extension Phase|Participant Choice|0
7932455|NCT02322021|12466079|FG003|Extension Phase|Participant Choice|0
7932456|NCT02322021|12466080|FG004|Extension Phase|Participant Choice|6
7932457|NCT02322021|12466076|FG000|Extension Phase|Other|0
7932458|NCT02322021|12466077|FG001|Extension Phase|Other|0
7932459|NCT02322021|12466078|FG002|Extension Phase|Other|0
7932460|NCT02322021|12466079|FG003|Extension Phase|Other|0
7932461|NCT02322021|12466080|FG004|Extension Phase|Other|3
7932462|NCT02322021|12466076|FG000|Extension Phase|Lost to Follow-up|0
7932463|NCT02322021|12466077|FG001|Extension Phase|Lost to Follow-up|0
7932464|NCT02322021|12466078|FG002|Extension Phase|Lost to Follow-up|0
7932465|NCT02322021|12466079|FG003|Extension Phase|Lost to Follow-up|0
7932466|NCT02322021|12466080|FG004|Extension Phase|Lost to Follow-up|1
7932467|NCT02322021|12466076|FG000|Extension Phase|Study terminated by sponsor|0
7932468|NCT02322021|12466077|FG001|Extension Phase|Study terminated by sponsor|0
7932469|NCT02322021|12466078|FG002|Extension Phase|Study terminated by sponsor|0
7932470|NCT02322021|12466079|FG003|Extension Phase|Study terminated by sponsor|0
7932471|NCT02322021|12466080|FG004|Extension Phase|Study terminated by sponsor|28
7932472|NCT02322047|12466099|FG000|Overall Study|Physician Decision|1
7932473|NCT02322047|12466100|FG001|Overall Study|Physician Decision|0
7932474|NCT02322047|12466101|FG002|Overall Study|Physician Decision|0
7932475|NCT02322047|12466102|FG003|Overall Study|Physician Decision|0
7932476|NCT02322047|12466099|FG000|Overall Study|Withdrawal by Subject|1
7932477|NCT02322047|12466100|FG001|Overall Study|Withdrawal by Subject|0
7932478|NCT02322047|12466101|FG002|Overall Study|Withdrawal by Subject|0
7932479|NCT02322047|12466102|FG003|Overall Study|Withdrawal by Subject|1
7932480|NCT02322047|12466099|FG000|Overall Study|Adverse Event|0
7932481|NCT02322047|12466100|FG001|Overall Study|Adverse Event|1
7932482|NCT02322047|12466101|FG002|Overall Study|Adverse Event|0
7932483|NCT02322047|12466102|FG003|Overall Study|Adverse Event|0
7932484|NCT02322047|12466099|FG000|Overall Study|Lost to Follow-up|0
7932485|NCT02322047|12466100|FG001|Overall Study|Lost to Follow-up|0
7932486|NCT02322047|12466101|FG002|Overall Study|Lost to Follow-up|1
7932487|NCT02322047|12466102|FG003|Overall Study|Lost to Follow-up|1
7932488|NCT02322125|12466112|FG000|Overall Study|Withdrawal by Subject|2
7932489|NCT02322190|12466116|FG000|Overall Study|Death on study|1
7932490|NCT02322190|12466117|FG001|Overall Study|Death on study|0
7932491|NCT02322216|12466124|FG000|Overall Study|Adverse Event|1
7932492|NCT02322216|12466125|FG001|Overall Study|Adverse Event|0
7932493|NCT02322216|12466124|FG000|Overall Study|Withdrawal by Subject|1
7932494|NCT02322216|12466125|FG001|Overall Study|Withdrawal by Subject|4
7932495|NCT02322229|12466132|FG000|Overall Study|Physician Decision|2
7932496|NCT02322281|12466149|FG000|Overall Study|Progressive Disease|42
7932497|NCT02322281|12466150|FG001|Overall Study|Progressive Disease|14
7932498|NCT02322281|12466151|FG002|Overall Study|Progressive Disease|49
7932499|NCT02322281|12466149|FG000|Overall Study|Adverse Event|3
7932500|NCT02322281|12466150|FG001|Overall Study|Adverse Event|4
7932501|NCT02322281|12466151|FG002|Overall Study|Adverse Event|6
7932502|NCT02322281|12466149|FG000|Overall Study|Death|3
7932503|NCT02322281|12466150|FG001|Overall Study|Death|3
7932504|NCT02322281|12466151|FG002|Overall Study|Death|3
7932505|NCT02322281|12466149|FG000|Overall Study|Withdrawal by Subject|1
7932506|NCT02322281|12466150|FG001|Overall Study|Withdrawal by Subject|1
7932507|NCT02322281|12466151|FG002|Overall Study|Withdrawal by Subject|6
7932508|NCT02322281|12466149|FG000|Overall Study|Physician Decision|2
7932509|NCT02322281|12466150|FG001|Overall Study|Physician Decision|0
7932510|NCT02322281|12466151|FG002|Overall Study|Physician Decision|5
7932511|NCT02322281|12466149|FG000|Overall Study|Study Terminated by Sponsor|2
7932512|NCT02322281|12466150|FG001|Overall Study|Study Terminated by Sponsor|0
7932513|NCT02322281|12466151|FG002|Overall Study|Study Terminated by Sponsor|0
7932514|NCT02322281|12466149|FG000|Overall Study|Missing|0
7932515|NCT02322281|12466150|FG001|Overall Study|Missing|0
7932516|NCT02322281|12466151|FG002|Overall Study|Missing|1
7932517|NCT02322281|12466149|FG000|Overall Study|Miscellaneous|0
7932518|NCT02322281|12466150|FG001|Overall Study|Miscellaneous|0
7932519|NCT02322281|12466151|FG002|Overall Study|Miscellaneous|4
7932520|NCT02322411|12466185|FG000|Overall Study|Lost to Follow-up|4
7932521|NCT02322411|12466186|FG001|Overall Study|Lost to Follow-up|7
7932522|NCT02322411|12466185|FG000|Overall Study|Withdrawal by Subject|1
7932523|NCT02322411|12466186|FG001|Overall Study|Withdrawal by Subject|0
7932524|NCT02322749|12466196|FG000|Period 2|Adverse Event|0
7932525|NCT02322749|12466197|FG001|Period 2|Adverse Event|0
7932526|NCT02322749|12466198|FG002|Period 2|Adverse Event|0
7932527|NCT02322749|12466199|FG003|Period 2|Adverse Event|1
7932528|NCT02322749|12466200|FG004|Period 2|Adverse Event|0
7932529|NCT02322749|12466201|FG005|Period 2|Adverse Event|0
7932530|NCT02322749|12466196|FG000|Period 2|Withdrawal by Subject|0
7932531|NCT02322749|12466197|FG001|Period 2|Withdrawal by Subject|0
7932532|NCT02322749|12466198|FG002|Period 2|Withdrawal by Subject|0
7932533|NCT02322749|12466199|FG003|Period 2|Withdrawal by Subject|1
7932534|NCT02322749|12466200|FG004|Period 2|Withdrawal by Subject|0
7932535|NCT02322749|12466201|FG005|Period 2|Withdrawal by Subject|0
7932536|NCT02322749|12466196|FG000|Period 3|Withdrawal by Subject|0
7932537|NCT02322749|12466197|FG001|Period 3|Withdrawal by Subject|0
7932538|NCT02322749|12466198|FG002|Period 3|Withdrawal by Subject|1
7932539|NCT02322749|12466199|FG003|Period 3|Withdrawal by Subject|0
7932540|NCT02322749|12466200|FG004|Period 3|Withdrawal by Subject|0
7932541|NCT02322749|12466201|FG005|Period 3|Withdrawal by Subject|0
7932542|NCT02322775|12466212|FG000|Overall Study|Adverse Event|1
7932543|NCT02322775|12466213|FG001|Overall Study|Adverse Event|0
7932544|NCT02322775|12466212|FG000|Overall Study|Lost to Follow-up|0
7932545|NCT02322775|12466213|FG001|Overall Study|Lost to Follow-up|1
7932546|NCT02322775|12466212|FG000|Overall Study|Protocol Violation|1
7932547|NCT02322775|12466213|FG001|Overall Study|Protocol Violation|0
7932548|NCT02322775|12466212|FG000|Overall Study|Withdrawal by Subject|3
7932549|NCT02322775|12466213|FG001|Overall Study|Withdrawal by Subject|4
7932550|NCT02322775|12466212|FG000|Overall Study|Not willing to perform all FU visits|0
7932551|NCT02322775|12466213|FG001|Overall Study|Not willing to perform all FU visits|1
7932552|NCT02322814|12466237|FG000|Overall Study|Ongoing Study|0
7932553|NCT02322814|12466238|FG001|Overall Study|Ongoing Study|13
7932554|NCT02322814|12466239|FG002|Overall Study|Ongoing Study|14
7932555|NCT02322814|12466240|FG003|Overall Study|Ongoing Study|20
7932556|NCT02322814|12466241|FG004|Overall Study|Ongoing Study|22
7932557|NCT02322814|12466237|FG000|Overall Study|Progressive Disease|0
7932558|NCT02322814|12466238|FG001|Overall Study|Progressive Disease|2
7932559|NCT02322814|12466239|FG002|Overall Study|Progressive Disease|0
7932560|NCT02322814|12466240|FG003|Overall Study|Progressive Disease|1
7932561|NCT02322814|12466241|FG004|Overall Study|Progressive Disease|0
7932562|NCT02322814|12466237|FG000|Overall Study|Lost to Follow-up|1
7932563|NCT02322814|12466238|FG001|Overall Study|Lost to Follow-up|2
7932564|NCT02322814|12466239|FG002|Overall Study|Lost to Follow-up|1
7932565|NCT02322814|12466240|FG003|Overall Study|Lost to Follow-up|0
7932566|NCT02322814|12466241|FG004|Overall Study|Lost to Follow-up|0
7932567|NCT02322814|12466237|FG000|Overall Study|Other|2
7932568|NCT02322814|12466238|FG001|Overall Study|Other|0
7932569|NCT02322814|12466239|FG002|Overall Study|Other|0
7932570|NCT02322814|12466240|FG003|Overall Study|Other|0
7932571|NCT02322814|12466241|FG004|Overall Study|Other|0
7932572|NCT02322814|12466237|FG000|Overall Study|Protocol Violation|1
7932573|NCT02322814|12466238|FG001|Overall Study|Protocol Violation|0
7932574|NCT02322814|12466239|FG002|Overall Study|Protocol Violation|0
7932575|NCT02322814|12466240|FG003|Overall Study|Protocol Violation|0
7932576|NCT02322814|12466241|FG004|Overall Study|Protocol Violation|0
7932577|NCT02322814|12466237|FG000|Overall Study|Death|7
7932578|NCT02322814|12466238|FG001|Overall Study|Death|22
7932579|NCT02322814|12466239|FG002|Overall Study|Death|30
7932580|NCT02322814|12466240|FG003|Overall Study|Death|10
7932581|NCT02322814|12466241|FG004|Overall Study|Death|6
7932582|NCT02322814|12466237|FG000|Overall Study|Withdrawal by Subject|5
7932583|NCT02322814|12466238|FG001|Overall Study|Withdrawal by Subject|4
7932584|NCT02322814|12466239|FG002|Overall Study|Withdrawal by Subject|2
7932585|NCT02322814|12466240|FG003|Overall Study|Withdrawal by Subject|1
7932586|NCT02322814|12466241|FG004|Overall Study|Withdrawal by Subject|3
7932587|NCT02322866|12466254|FG000|Overall Study|Adverse Event|6
7932588|NCT02322866|12466255|FG001|Overall Study|Adverse Event|11
7932589|NCT02322866|12466254|FG000|Overall Study|Withdrawal of Consent|16
7932590|NCT02322866|12466255|FG001|Overall Study|Withdrawal of Consent|25
7932591|NCT02322866|12466254|FG000|Overall Study|Lost to Follow-up|36
7932592|NCT02322866|12466255|FG001|Overall Study|Lost to Follow-up|39
7932593|NCT02322866|12466254|FG000|Overall Study|Protocol Violation|1
7932594|NCT02322866|12466255|FG001|Overall Study|Protocol Violation|0
7932595|NCT02322866|12466254|FG000|Overall Study|Noncompliance with Treatment|3
7932596|NCT02322866|12466255|FG001|Overall Study|Noncompliance with Treatment|4
7932597|NCT02322866|12466254|FG000|Overall Study|Lack of Efficacy|3
7932598|NCT02322866|12466255|FG001|Overall Study|Lack of Efficacy|1
7932599|NCT02322866|12466254|FG000|Overall Study|Other Miscellaneous Reasons|6
7932600|NCT02322866|12466255|FG001|Overall Study|Other Miscellaneous Reasons|6
7932601|NCT02322879|12466263|FG000|First Intervention|Physician Decision|1
7932602|NCT02322879|12466264|FG001|First Intervention|Physician Decision|0
7932603|NCT02322892|12466272|FG000|Overall Study|Surgery cancelled|1
7932604|NCT02322892|12466273|FG001|Overall Study|Surgery cancelled|2
7932605|NCT02322892|12466272|FG000|Overall Study|Met exclusion criteria|0
7932606|NCT02322892|12466273|FG001|Overall Study|Met exclusion criteria|1
7932607|NCT02322892|12466272|FG000|Overall Study|Protocol Violation|1
7932608|NCT02322892|12466273|FG001|Overall Study|Protocol Violation|0
7932609|NCT02323113|12466307|FG000|Overall Study|Adverse Event|3
7932610|NCT02323113|12466308|FG001|Overall Study|Adverse Event|3
7932611|NCT02323113|12466309|FG002|Overall Study|Adverse Event|2
7932612|NCT02323113|12466310|FG003|Overall Study|Adverse Event|5
7932613|NCT02323113|12466311|FG004|Overall Study|Adverse Event|8
7932614|NCT02323113|12466312|FG005|Overall Study|Adverse Event|3
7932615|NCT02323113|12466313|FG006|Overall Study|Adverse Event|6
7932616|NCT02323113|12466314|FG007|Overall Study|Adverse Event|0
7932617|NCT02323113|12466307|FG000|Overall Study|Progressive Disease|0
7932618|NCT02323113|12466308|FG001|Overall Study|Progressive Disease|1
7932619|NCT02323113|12466309|FG002|Overall Study|Progressive Disease|1
7932620|NCT02323113|12466310|FG003|Overall Study|Progressive Disease|0
7932621|NCT02323113|12466311|FG004|Overall Study|Progressive Disease|0
7932622|NCT02323113|12466312|FG005|Overall Study|Progressive Disease|3
7932623|NCT02323113|12466313|FG006|Overall Study|Progressive Disease|0
7932624|NCT02323113|12466314|FG007|Overall Study|Progressive Disease|0
7932625|NCT02323113|12466307|FG000|Overall Study|Symptomatic Deterioration|0
7932626|NCT02323113|12466308|FG001|Overall Study|Symptomatic Deterioration|0
7932627|NCT02323113|12466309|FG002|Overall Study|Symptomatic Deterioration|1
7932628|NCT02323113|12466310|FG003|Overall Study|Symptomatic Deterioration|0
7932629|NCT02323113|12466311|FG004|Overall Study|Symptomatic Deterioration|1
7932630|NCT02323113|12466312|FG005|Overall Study|Symptomatic Deterioration|0
7932631|NCT02323113|12466313|FG006|Overall Study|Symptomatic Deterioration|0
7932632|NCT02323113|12466314|FG007|Overall Study|Symptomatic Deterioration|0
7932633|NCT02323113|12466307|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
7932634|NCT02323113|12466308|FG001|Overall Study|Unsatisfactory Therapeutic Response|2
7932635|NCT02323113|12466309|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
7932636|NCT02323113|12466310|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
7932637|NCT02323113|12466311|FG004|Overall Study|Unsatisfactory Therapeutic Response|0
7932638|NCT02323113|12466312|FG005|Overall Study|Unsatisfactory Therapeutic Response|2
7932639|NCT02323113|12466313|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
7932640|NCT02323113|12466314|FG007|Overall Study|Unsatisfactory Therapeutic Response|0
7932641|NCT02323113|12466307|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7932642|NCT02323113|12466308|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1
7932643|NCT02323113|12466309|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7932644|NCT02323113|12466310|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7932645|NCT02323113|12466311|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7932646|NCT02323113|12466312|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7967136|NCT02760654|12523652|FG001|Overall Study|Withdrawal by Subject|3
7967137|NCT02760810|12523658|FG000|Overall Study|Protocol Violation|1
7967138|NCT02760927|12523671|FG000|Overall Study|Tube Slippage from Device|1
7967139|NCT02761330|12523690|FG000|Treatment Week 1|Withdrawal by Subject|0
7967140|NCT02761330|12523691|FG001|Treatment Week 1|Withdrawal by Subject|0
7967141|NCT02761330|12523692|FG002|Treatment Week 1|Withdrawal by Subject|0
7967142|NCT02761330|12523693|FG003|Treatment Week 1|Withdrawal by Subject|1
7967143|NCT02761330|12523694|FG004|Treatment Week 1|Withdrawal by Subject|0
7967144|NCT02761330|12523695|FG005|Treatment Week 1|Withdrawal by Subject|1
7967145|NCT02761629|12523711|FG000|Overall Study|Adverse Event/Intercurrent Illness|7
7967146|NCT02761629|12523712|FG001|Overall Study|Adverse Event/Intercurrent Illness|5
7967147|NCT02761629|12523711|FG000|Overall Study|Insufficient Therapeutic Response|2
7967148|NCT02761629|12523712|FG001|Overall Study|Insufficient Therapeutic Response|7
7967149|NCT02761629|12523711|FG000|Overall Study|Failure to Return|2
7967150|NCT02761629|12523712|FG001|Overall Study|Failure to Return|4
7967151|NCT02761629|12523711|FG000|Overall Study|Did not Cooperate/Refused Treatment|2
7967152|NCT02761629|12523712|FG001|Overall Study|Did not Cooperate/Refused Treatment|4
7967153|NCT02761629|12523711|FG000|Overall Study|Protocol Violation|2
7967154|NCT02761629|12523712|FG001|Overall Study|Protocol Violation|2
7967155|NCT02761629|12523711|FG000|Overall Study|Withdrawal by Subject|0
7967156|NCT02761629|12523712|FG001|Overall Study|Withdrawal by Subject|3
7967157|NCT02761629|12523711|FG000|Overall Study|Other|0
7967158|NCT02761629|12523712|FG001|Overall Study|Other|2
7967159|NCT02761629|12523711|FG000|Overall Study|Lost to Follow-up|4
7967160|NCT02761629|12523712|FG001|Overall Study|Lost to Follow-up|1
7967161|NCT02761629|12523711|FG000|Overall Study|Randomized But Not Treated|8
7967162|NCT02761629|12523712|FG001|Overall Study|Randomized But Not Treated|4
7967163|NCT02761642|12523718|FG000|Overall Study|Did not Receive Study Treatment|3
7967164|NCT02761642|12523718|FG000|Overall Study|Adverse Event|13
7967165|NCT02761642|12523718|FG000|Overall Study|Withdrawal by Subject|2
7967166|NCT02761642|12523718|FG000|Overall Study|Non-compliant|7
7967167|NCT02761642|12523718|FG000|Overall Study|Death|3
7967168|NCT02761642|12523718|FG000|Overall Study|Lack of Efficacy|20
7967169|NCT02761642|12523718|FG000|Overall Study|Physician Decision|1
7967170|NCT02761642|12523718|FG000|Overall Study|Reason Unspecified|21
7967171|NCT02761733|12523726|FG000|Overall Study|Death|3
7967172|NCT02761733|12523727|FG001|Overall Study|Death|5
7932647|NCT02323113|12466313|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7932648|NCT02323113|12466314|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7932649|NCT02323204|12466337|FG000|Baseline Survey Completion|Withdrawal by Subject|10
7932650|NCT02323204|12466338|FG001|Baseline Survey Completion|Withdrawal by Subject|9
7932651|NCT02323204|12466339|FG002|Baseline Survey Completion|Withdrawal by Subject|5
7932652|NCT02323204|12466340|FG003|Baseline Survey Completion|Withdrawal by Subject|3
7932653|NCT02323204|12466337|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29
7932654|NCT02323204|12466338|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28
7932655|NCT02323204|12466339|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39
7932656|NCT02323204|12466340|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35
7932657|NCT02323204|12466337|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12
7932658|NCT02323204|12466338|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8
7932659|NCT02323204|12466339|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3
7932660|NCT02323204|12466340|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2
7932661|NCT02323204|12466337|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0
7932662|NCT02323204|12466338|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35
7932663|NCT02323204|12466339|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0
7932664|NCT02323204|12466340|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34
7932665|NCT02323204|12466337|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
7932666|NCT02323204|12466338|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8
7932667|NCT02323204|12466339|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
7932668|NCT02323204|12466340|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2
7932669|NCT02323204|12466337|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54
7932670|NCT02323204|12466338|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45
7932671|NCT02323204|12466339|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41
7932672|NCT02323204|12466340|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42
7932673|NCT02323204|12466337|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0
7932674|NCT02323204|12466338|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2
7932675|NCT02323204|12466339|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0
7932676|NCT02323204|12466340|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2
7932677|NCT02323204|12466337|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49
7932678|NCT02323204|12466338|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50
7932679|NCT02323204|12466339|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38
7932680|NCT02323204|12466340|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43
7932681|NCT02323204|12466337|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0
7932682|NCT02323204|12466338|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0
7932683|NCT02323204|12466339|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3
7932684|NCT02323204|12466340|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1
7964814|NCT01084252|12520460|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7964815|NCT01084252|12520461|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7964816|NCT01084252|12520462|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7964817|NCT01084252|12520463|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7964818|NCT01084252|12520464|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7964819|NCT01084252|12520465|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7964820|NCT01084252|12520466|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
7964821|NCT01084252|12520467|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
7964822|NCT01084252|12520468|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1
7964823|NCT01084252|12520469|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7964824|NCT01084252|12520470|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7964825|NCT01084252|12520457|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7964826|NCT01084252|12520458|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7932685|NCT02323334|12466364|FG000|Period 3|Lost to Follow-up|0
7932686|NCT02323334|12466365|FG001|Period 3|Lost to Follow-up|0
7932687|NCT02323334|12466366|FG002|Period 3|Lost to Follow-up|1
7932688|NCT02323334|12466367|FG003|Period 3|Lost to Follow-up|0
7932689|NCT02323334|12466368|FG004|Period 3|Lost to Follow-up|0
7932690|NCT02323334|12466369|FG005|Period 3|Lost to Follow-up|0
7932691|NCT02323334|12466370|FG006|Period 3|Lost to Follow-up|0
7932692|NCT02323334|12466371|FG007|Period 3|Lost to Follow-up|0
7932693|NCT02323334|12466372|FG008|Period 3|Lost to Follow-up|0
7932694|NCT02323334|12466373|FG009|Period 3|Lost to Follow-up|0
7932695|NCT02323334|12466374|FG010|Period 3|Lost to Follow-up|0
7932696|NCT02323334|12466375|FG011|Period 3|Lost to Follow-up|0
7932697|NCT02323334|12466376|FG012|Period 3|Lost to Follow-up|0
7932698|NCT02323334|12466377|FG013|Period 3|Lost to Follow-up|0
7932699|NCT02323334|12466378|FG014|Period 3|Lost to Follow-up|0
7932700|NCT02323334|12466379|FG015|Period 3|Lost to Follow-up|0
7932701|NCT02323334|12466380|FG016|Period 3|Lost to Follow-up|0
7932702|NCT02323334|12466364|FG000|Period 3|Withdrawal by Subject|1
7932703|NCT02323334|12466365|FG001|Period 3|Withdrawal by Subject|0
7932704|NCT02323334|12466366|FG002|Period 3|Withdrawal by Subject|0
7932705|NCT02323334|12466367|FG003|Period 3|Withdrawal by Subject|0
7932706|NCT02323334|12466368|FG004|Period 3|Withdrawal by Subject|0
7932707|NCT02323334|12466369|FG005|Period 3|Withdrawal by Subject|0
7932708|NCT02323334|12466370|FG006|Period 3|Withdrawal by Subject|0
7932709|NCT02323334|12466371|FG007|Period 3|Withdrawal by Subject|0
7932710|NCT02323334|12466372|FG008|Period 3|Withdrawal by Subject|0
7932711|NCT02323334|12466373|FG009|Period 3|Withdrawal by Subject|0
7932712|NCT02323334|12466374|FG010|Period 3|Withdrawal by Subject|0
7932713|NCT02323334|12466375|FG011|Period 3|Withdrawal by Subject|0
7932714|NCT02323334|12466376|FG012|Period 3|Withdrawal by Subject|0
7932715|NCT02323334|12466377|FG013|Period 3|Withdrawal by Subject|0
7932716|NCT02323334|12466378|FG014|Period 3|Withdrawal by Subject|0
7932717|NCT02323334|12466379|FG015|Period 3|Withdrawal by Subject|0
7932718|NCT02323334|12466380|FG016|Period 3|Withdrawal by Subject|0
7932719|NCT02323646|12466445|FG000|Treatment Course 1|Adverse Event|1
7932720|NCT02323646|12466446|FG001|Treatment Course 1|Adverse Event|0
7932721|NCT02323646|12466447|FG002|Treatment Course 1|Adverse Event|1
7932722|NCT02323646|12466445|FG000|Treatment Course 1|Heavy Bleeding|1
7932723|NCT02323646|12466446|FG001|Treatment Course 1|Heavy Bleeding|1
7932724|NCT02323646|12466447|FG002|Treatment Course 1|Heavy Bleeding|0
7932725|NCT02323646|12466445|FG000|Treatment Course 1|Lost to Follow-up|1
7932726|NCT02323646|12466446|FG001|Treatment Course 1|Lost to Follow-up|0
7932727|NCT02323646|12466447|FG002|Treatment Course 1|Lost to Follow-up|2
7932728|NCT02323646|12466445|FG000|Treatment Course 1|Withdrawal by Subject|0
7932729|NCT02323646|12466446|FG001|Treatment Course 1|Withdrawal by Subject|2
7932730|NCT02323646|12466447|FG002|Treatment Course 1|Withdrawal by Subject|0
7932731|NCT02323646|12466445|FG000|Treatment Course 2|Adverse Event|1
7932732|NCT02323646|12466446|FG001|Treatment Course 2|Adverse Event|0
7932733|NCT02323646|12466447|FG002|Treatment Course 2|Adverse Event|1
7932734|NCT02323646|12466445|FG000|Treatment Course 2|Lost to Follow-up|0
7932735|NCT02323646|12466446|FG001|Treatment Course 2|Lost to Follow-up|0
7932736|NCT02323646|12466447|FG002|Treatment Course 2|Lost to Follow-up|1
7932737|NCT02323646|12466445|FG000|Treatment Course 2|Non-compliance|0
7932738|NCT02323646|12466446|FG001|Treatment Course 2|Non-compliance|1
7932739|NCT02323646|12466447|FG002|Treatment Course 2|Non-compliance|1
7932740|NCT02324049|12466459|FG000|Part C|Study terminated|11
7932741|NCT02324153|12466475|FG000|Overall Study|Withdrawal by Subject|4
7932742|NCT02324153|12466476|FG001|Overall Study|Withdrawal by Subject|1
7932743|NCT02324153|12466475|FG000|Overall Study|Surgery postponed after randomization|3
7932744|NCT02324153|12466476|FG001|Overall Study|Surgery postponed after randomization|0
7932745|NCT02324153|12466475|FG000|Overall Study|Developed delirium preoperatively|1
7932746|NCT02324153|12466476|FG001|Overall Study|Developed delirium preoperatively|0
7932747|NCT02324205|12466482|FG000|Overall Study|Withdrawal by Subject|37
7932748|NCT02324270|12466489|FG000|Overall Study|Withdrawal by Subject|0
7932749|NCT02324270|12466490|FG001|Overall Study|Withdrawal by Subject|1
7932750|NCT02324270|12466491|FG002|Overall Study|Withdrawal by Subject|0
7932751|NCT02324270|12466489|FG000|Overall Study|Lost to Follow-up|4
7932752|NCT02324270|12466490|FG001|Overall Study|Lost to Follow-up|3
7932753|NCT02324270|12466491|FG002|Overall Study|Lost to Follow-up|4
7932754|NCT02324270|12466489|FG000|Overall Study|Protocol Violation|0
7932755|NCT02324270|12466490|FG001|Overall Study|Protocol Violation|1
7932756|NCT02324270|12466491|FG002|Overall Study|Protocol Violation|1
7932757|NCT02324270|12466489|FG000|Overall Study|Non Compliance with Study Drug|1
7932758|NCT02324270|12466490|FG001|Overall Study|Non Compliance with Study Drug|2
7932759|NCT02324270|12466491|FG002|Overall Study|Non Compliance with Study Drug|0
7932760|NCT02324361|12466510|FG000|Overall Study|Lost to Follow-up|5
7932761|NCT02324361|12466511|FG001|Overall Study|Lost to Follow-up|2
7932762|NCT02324465|12466519|FG000|Overall Study|device failure|0
7932763|NCT02324465|12466520|FG001|Overall Study|device failure|1
7932764|NCT02324569|12466549|FG000|Overall Study|Pretreatment Event/Adverse Event|9
7932765|NCT02324569|12466550|FG001|Overall Study|Pretreatment Event/Adverse Event|10
7932766|NCT02324569|12466549|FG000|Overall Study|Voluntary Withdrawal|3
7932767|NCT02324569|12466550|FG001|Overall Study|Voluntary Withdrawal|6
7932768|NCT02324569|12466549|FG000|Overall Study|Lack of Efficacy|2
7932769|NCT02324569|12466550|FG001|Overall Study|Lack of Efficacy|3
7932770|NCT02324569|12466549|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0
7932771|NCT02324569|12466550|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2
7932772|NCT02324569|12466549|FG000|Overall Study|Inconvenient Schedule|2
7932773|NCT02324569|12466550|FG001|Overall Study|Inconvenient Schedule|0
7932774|NCT02324699|12466574|FG000|Overall Study|study terminated|1
7932775|NCT02324842|12466581|FG000|Overall Study|Lost to Follow-up|1
7932776|NCT02324842|12466582|FG001|Overall Study|Lost to Follow-up|1
7932777|NCT02324842|12466583|FG002|Overall Study|Lost to Follow-up|2
7932778|NCT02325219|12466612|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6
7932779|NCT02325219|12466613|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1
7932780|NCT02325219|12466614|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0
7932781|NCT02325219|12466615|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0
7932782|NCT02325219|12466616|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0
7932783|NCT02325219|12466612|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6
7932784|NCT02325219|12466613|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
7932785|NCT02325219|12466614|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7932786|NCT02325219|12466615|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7932787|NCT02325219|12466616|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7932788|NCT02325219|12466612|FG000|Controlled Period (Week 0 - 16)|Other|0
7932789|NCT02325219|12466613|FG001|Controlled Period (Week 0 - 16)|Other|0
7932790|NCT02325219|12466614|FG002|Controlled Period (Week 0 - 16)|Other|1
7932791|NCT02325219|12466615|FG003|Controlled Period (Week 0 - 16)|Other|0
7932792|NCT02325219|12466616|FG004|Controlled Period (Week 0 - 16)|Other|0
7932793|NCT02325219|12466612|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0
7932794|NCT02325219|12466613|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0
7932795|NCT02325219|12466614|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0
7932796|NCT02325219|12466615|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0
7932797|NCT02325219|12466616|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1
7932798|NCT02325219|12466612|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7932799|NCT02325219|12466613|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2
7932800|NCT02325219|12466614|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7932801|NCT02325219|12466615|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7932802|NCT02325219|12466616|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7932803|NCT02325219|12466612|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0
7932804|NCT02325219|12466613|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1
7932805|NCT02325219|12466614|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0
7932806|NCT02325219|12466615|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0
7932807|NCT02325219|12466616|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0
7932808|NCT02325401|12466632|FG000|Overall Study|Withdrawal by Subject|0
7932809|NCT02325401|12466633|FG001|Overall Study|Withdrawal by Subject|1
7932810|NCT02325401|12466634|FG002|Overall Study|Withdrawal by Subject|1
7932811|NCT02325414|12466650|FG000|Overall Study|Withdrawal by Subject|3
7932812|NCT02325414|12466651|FG001|Overall Study|Withdrawal by Subject|1
7932813|NCT02325414|12466650|FG000|Overall Study|Lost to Follow-up|5
7932814|NCT02325414|12466651|FG001|Overall Study|Lost to Follow-up|5
7932815|NCT02325518|12466661|FG000|Overall Study|Adverse Event|4
7932816|NCT02325518|12466662|FG001|Overall Study|Adverse Event|1
7932817|NCT02325518|12466661|FG000|Overall Study|Physician Decision|0
7932818|NCT02325518|12466662|FG001|Overall Study|Physician Decision|1
7932819|NCT02325518|12466661|FG000|Overall Study|Withdrawal by Subject|0
7932820|NCT02325518|12466662|FG001|Overall Study|Withdrawal by Subject|1
7932821|NCT02325713|12466698|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7932822|NCT02325713|12466699|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7932823|NCT02325713|12466700|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7932824|NCT02325713|12466701|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7932825|NCT02325713|12466702|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7932826|NCT02325713|12466703|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7932827|NCT02325713|12466704|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7932828|NCT02325713|12466705|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7932829|NCT02325713|12466706|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7932830|NCT02325713|12466707|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7932831|NCT02325713|12466708|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
7932832|NCT02325713|12466709|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7932833|NCT02325713|12466710|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7932834|NCT02325713|12466711|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7932835|NCT02325713|12466712|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7932836|NCT02325713|12466713|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7932837|NCT02325713|12466698|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
7932838|NCT02325713|12466699|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7932839|NCT02325713|12466700|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7932840|NCT02325713|12466701|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7932841|NCT02325713|12466702|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7932842|NCT02325713|12466703|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7932843|NCT02325713|12466704|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7932844|NCT02325713|12466705|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7932845|NCT02325713|12466706|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7932846|NCT02325713|12466707|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7932847|NCT02325713|12466708|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7932848|NCT02325713|12466709|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7932849|NCT02325713|12466710|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7932850|NCT02325713|12466711|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7932851|NCT02325713|12466712|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7932852|NCT02325713|12466713|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7932853|NCT02325713|12466698|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7932854|NCT02325713|12466699|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7932855|NCT02325713|12466700|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7932856|NCT02325713|12466701|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7932857|NCT02325713|12466702|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7932858|NCT02325713|12466703|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7932859|NCT02325713|12466704|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7932860|NCT02325713|12466705|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7932861|NCT02325713|12466706|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7932862|NCT02325713|12466707|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
7932863|NCT02325713|12466708|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7932864|NCT02325713|12466709|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7932865|NCT02325713|12466710|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7932866|NCT02325713|12466711|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7932867|NCT02325713|12466712|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7932868|NCT02325713|12466713|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7932869|NCT02325739|12466739|FG000|Phase I Part|Adverse Event|1
7932870|NCT02325739|12466740|FG001|Phase I Part|Adverse Event|0
7932871|NCT02325739|12466741|FG002|Phase I Part|Adverse Event|1
7932872|NCT02325739|12466742|FG003|Phase I Part|Adverse Event|2
7932873|NCT02325739|12466743|FG004|Phase I Part|Adverse Event|3
7932874|NCT02325739|12466744|FG005|Phase I Part|Adverse Event|1
7932875|NCT02325739|12466745|FG006|Phase I Part|Adverse Event|0
7932876|NCT02325739|12466746|FG007|Phase I Part|Adverse Event|2
7932877|NCT02325739|12466747|FG008|Phase I Part|Adverse Event|0
7932878|NCT02325739|12466748|FG009|Phase I Part|Adverse Event|0
7932879|NCT02325739|12466749|FG010|Phase I Part|Adverse Event|0
7932880|NCT02325739|12466739|FG000|Phase I Part|Progressive disease|9
7932881|NCT02325739|12466740|FG001|Phase I Part|Progressive disease|6
7932882|NCT02325739|12466741|FG002|Phase I Part|Progressive disease|3
7932883|NCT02325739|12466742|FG003|Phase I Part|Progressive disease|23
7932884|NCT02325739|12466743|FG004|Phase I Part|Progressive disease|14
7932885|NCT02325739|12466744|FG005|Phase I Part|Progressive disease|6
7932886|NCT02325739|12466745|FG006|Phase I Part|Progressive disease|6
7932887|NCT02325739|12466746|FG007|Phase I Part|Progressive disease|3
7932888|NCT02325739|12466747|FG008|Phase I Part|Progressive disease|0
7932889|NCT02325739|12466748|FG009|Phase I Part|Progressive disease|0
7932890|NCT02325739|12466749|FG010|Phase I Part|Progressive disease|0
7932891|NCT02325739|12466739|FG000|Phase I Part|Subject/guardian decision|1
7932892|NCT02325739|12466740|FG001|Phase I Part|Subject/guardian decision|0
7932893|NCT02325739|12466741|FG002|Phase I Part|Subject/guardian decision|1
7932894|NCT02325739|12466742|FG003|Phase I Part|Subject/guardian decision|1
7932895|NCT02325739|12466743|FG004|Phase I Part|Subject/guardian decision|0
7932896|NCT02325739|12466744|FG005|Phase I Part|Subject/guardian decision|0
7932897|NCT02325739|12466745|FG006|Phase I Part|Subject/guardian decision|0
7932898|NCT02325739|12466746|FG007|Phase I Part|Subject/guardian decision|1
7932899|NCT02325739|12466747|FG008|Phase I Part|Subject/guardian decision|0
7932900|NCT02325739|12466748|FG009|Phase I Part|Subject/guardian decision|0
7932901|NCT02325739|12466749|FG010|Phase I Part|Subject/guardian decision|0
7932902|NCT02325739|12466739|FG000|Phase I Part|Death|0
7932903|NCT02325739|12466740|FG001|Phase I Part|Death|0
7932904|NCT02325739|12466741|FG002|Phase I Part|Death|0
7932905|NCT02325739|12466742|FG003|Phase I Part|Death|0
7932906|NCT02325739|12466743|FG004|Phase I Part|Death|2
7932907|NCT02325739|12466744|FG005|Phase I Part|Death|0
7932908|NCT02325739|12466745|FG006|Phase I Part|Death|0
7932909|NCT02325739|12466746|FG007|Phase I Part|Death|0
7932910|NCT02325739|12466747|FG008|Phase I Part|Death|0
7932911|NCT02325739|12466748|FG009|Phase I Part|Death|0
7932912|NCT02325739|12466749|FG010|Phase I Part|Death|0
7932913|NCT02325739|12466739|FG000|Phase II Part|Adverse Event|0
7932914|NCT02325739|12466740|FG001|Phase II Part|Adverse Event|0
7932915|NCT02325739|12466741|FG002|Phase II Part|Adverse Event|0
7932916|NCT02325739|12466742|FG003|Phase II Part|Adverse Event|0
7932917|NCT02325739|12466743|FG004|Phase II Part|Adverse Event|0
7932918|NCT02325739|12466744|FG005|Phase II Part|Adverse Event|0
7932919|NCT02325739|12466745|FG006|Phase II Part|Adverse Event|0
7932920|NCT02325739|12466746|FG007|Phase II Part|Adverse Event|0
7932921|NCT02325739|12466747|FG008|Phase II Part|Adverse Event|4
7932922|NCT02325739|12466748|FG009|Phase II Part|Adverse Event|5
7932923|NCT02325739|12466749|FG010|Phase II Part|Adverse Event|1
7932924|NCT02325739|12466739|FG000|Phase II Part|Physician Decision|0
7932925|NCT02325739|12466740|FG001|Phase II Part|Physician Decision|0
7932926|NCT02325739|12466741|FG002|Phase II Part|Physician Decision|0
7932927|NCT02325739|12466742|FG003|Phase II Part|Physician Decision|0
7932928|NCT02325739|12466743|FG004|Phase II Part|Physician Decision|0
7932929|NCT02325739|12466744|FG005|Phase II Part|Physician Decision|0
7932930|NCT02325739|12466745|FG006|Phase II Part|Physician Decision|0
7932931|NCT02325739|12466746|FG007|Phase II Part|Physician Decision|0
7932932|NCT02325739|12466747|FG008|Phase II Part|Physician Decision|0
7932933|NCT02325739|12466748|FG009|Phase II Part|Physician Decision|1
7932934|NCT02325739|12466749|FG010|Phase II Part|Physician Decision|0
7932935|NCT02325739|12466739|FG000|Phase II Part|Progressive disease|0
7932936|NCT02325739|12466740|FG001|Phase II Part|Progressive disease|0
7932937|NCT02325739|12466741|FG002|Phase II Part|Progressive disease|0
7932938|NCT02325739|12466742|FG003|Phase II Part|Progressive disease|0
7932939|NCT02325739|12466743|FG004|Phase II Part|Progressive disease|0
7932940|NCT02325739|12466744|FG005|Phase II Part|Progressive disease|0
7932941|NCT02325739|12466745|FG006|Phase II Part|Progressive disease|0
7932942|NCT02325739|12466746|FG007|Phase II Part|Progressive disease|0
7932943|NCT02325739|12466747|FG008|Phase II Part|Progressive disease|22
7932944|NCT02325739|12466748|FG009|Phase II Part|Progressive disease|29
7932945|NCT02325739|12466749|FG010|Phase II Part|Progressive disease|18
7932946|NCT02325739|12466739|FG000|Phase II Part|Subject/guardian decision|0
7932947|NCT02325739|12466740|FG001|Phase II Part|Subject/guardian decision|0
7932948|NCT02325739|12466741|FG002|Phase II Part|Subject/guardian decision|0
7932949|NCT02325739|12466742|FG003|Phase II Part|Subject/guardian decision|0
7932950|NCT02325739|12466743|FG004|Phase II Part|Subject/guardian decision|0
7932951|NCT02325739|12466744|FG005|Phase II Part|Subject/guardian decision|0
7932952|NCT02325739|12466745|FG006|Phase II Part|Subject/guardian decision|0
7932953|NCT02325739|12466746|FG007|Phase II Part|Subject/guardian decision|0
7932954|NCT02325739|12466747|FG008|Phase II Part|Subject/guardian decision|4
7932955|NCT02325739|12466748|FG009|Phase II Part|Subject/guardian decision|1
7932956|NCT02325739|12466749|FG010|Phase II Part|Subject/guardian decision|1
7932957|NCT02325791|12466798|FG000|Overall Study|Adverse Event|0
7932958|NCT02325791|12466799|FG001|Overall Study|Adverse Event|1
7932959|NCT02325791|12466800|FG002|Overall Study|Adverse Event|1
7932960|NCT02325791|12466801|FG003|Overall Study|Adverse Event|0
7932961|NCT02325791|12466798|FG000|Overall Study|Death|0
7932962|NCT02325791|12466799|FG001|Overall Study|Death|3
7932963|NCT02325791|12466800|FG002|Overall Study|Death|0
7932964|NCT02325791|12466801|FG003|Overall Study|Death|1
7932965|NCT02325791|12466798|FG000|Overall Study|Lost to Follow-up|0
7932966|NCT02325791|12466799|FG001|Overall Study|Lost to Follow-up|15
7932967|NCT02325791|12466800|FG002|Overall Study|Lost to Follow-up|14
7932968|NCT02325791|12466801|FG003|Overall Study|Lost to Follow-up|9
7932969|NCT02325791|12466798|FG000|Overall Study|Physician Decision|0
7932970|NCT02325791|12466799|FG001|Overall Study|Physician Decision|1
7932971|NCT02325791|12466800|FG002|Overall Study|Physician Decision|1
7932972|NCT02325791|12466801|FG003|Overall Study|Physician Decision|0
7932973|NCT02325791|12466798|FG000|Overall Study|Protocol Violation|0
7932974|NCT02325791|12466799|FG001|Overall Study|Protocol Violation|0
7932975|NCT02325791|12466800|FG002|Overall Study|Protocol Violation|1
7932976|NCT02325791|12466801|FG003|Overall Study|Protocol Violation|0
7932977|NCT02325791|12466798|FG000|Overall Study|Withdrawal by Subject|0
7932978|NCT02325791|12466799|FG001|Overall Study|Withdrawal by Subject|5
7932979|NCT02325791|12466800|FG002|Overall Study|Withdrawal by Subject|8
7932980|NCT02325791|12466801|FG003|Overall Study|Withdrawal by Subject|16
7932981|NCT02326025|12466825|FG000|Overall Study|Adverse Event|3
7932982|NCT02326025|12466826|FG001|Overall Study|Adverse Event|0
7932983|NCT02326025|12466825|FG000|Overall Study|Physician Decision|1
7932984|NCT02326025|12466826|FG001|Overall Study|Physician Decision|2
7932985|NCT02326025|12466825|FG000|Overall Study|Physician and Participant Decision|1
7932986|NCT02326025|12466826|FG001|Overall Study|Physician and Participant Decision|0
7932987|NCT02326025|12466825|FG000|Overall Study|Withdrawal by Subject|0
7932988|NCT02326025|12466826|FG001|Overall Study|Withdrawal by Subject|2
7932989|NCT02326025|12466825|FG000|Overall Study|Protocol Violation|0
7932990|NCT02326025|12466826|FG001|Overall Study|Protocol Violation|1
7932991|NCT02326220|12466847|FG000|Double-blind Treatment Period|Adverse Event|1
7932992|NCT02326220|12466848|FG001|Double-blind Treatment Period|Adverse Event|2
7932993|NCT02326220|12466849|FG002|Double-blind Treatment Period|Adverse Event|0
7932994|NCT02326220|12466847|FG000|Double-blind Treatment Period|Protocol Violation|0
7932995|NCT02326220|12466848|FG001|Double-blind Treatment Period|Protocol Violation|1
7932996|NCT02326220|12466849|FG002|Double-blind Treatment Period|Protocol Violation|0
7932997|NCT02326220|12466847|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
7932998|NCT02326220|12466848|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
7932999|NCT02326220|12466849|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7933000|NCT02326220|12466847|FG000|Open-label Treatment Period|Withdrawal by Subject|0
7933001|NCT02326220|12466848|FG001|Open-label Treatment Period|Withdrawal by Subject|0
7933002|NCT02326220|12466849|FG002|Open-label Treatment Period|Withdrawal by Subject|1
7933003|NCT02326220|12466847|FG000|Open-label Treatment Period|Lost to Follow-up|0
7933004|NCT02326220|12466848|FG001|Open-label Treatment Period|Lost to Follow-up|0
7933005|NCT02326220|12466849|FG002|Open-label Treatment Period|Lost to Follow-up|1
7933006|NCT02326272|12466871|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933007|NCT02326272|12466872|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3
7933008|NCT02326272|12466873|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
7933009|NCT02326272|12466874|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933010|NCT02326272|12466875|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933011|NCT02326272|12466876|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933012|NCT02326272|12466877|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933013|NCT02326272|12466878|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933014|NCT02326272|12466879|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933015|NCT02326272|12466880|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933016|NCT02326272|12466881|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933017|NCT02326272|12466882|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933018|NCT02326272|12466883|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933019|NCT02326272|12466884|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933020|NCT02326272|12466885|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933021|NCT02326272|12466871|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
7933022|NCT02326272|12466872|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
7933023|NCT02326272|12466873|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933024|NCT02326272|12466874|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933025|NCT02326272|12466875|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933026|NCT02326272|12466876|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933027|NCT02326272|12466877|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933028|NCT02326272|12466878|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933029|NCT02326272|12466879|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933030|NCT02326272|12466880|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933031|NCT02326272|12466881|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933032|NCT02326272|12466882|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933033|NCT02326272|12466883|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933034|NCT02326272|12466884|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933035|NCT02326272|12466885|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933036|NCT02326272|12466871|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
7933037|NCT02326272|12466872|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
7933038|NCT02326272|12466873|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
7933039|NCT02326272|12466874|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933040|NCT02326272|12466875|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933041|NCT02326272|12466876|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933042|NCT02326272|12466877|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933043|NCT02326272|12466878|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933044|NCT02326272|12466879|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933045|NCT02326272|12466880|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933046|NCT02326272|12466881|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933047|NCT02326272|12466882|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933048|NCT02326272|12466883|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933049|NCT02326272|12466884|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933050|NCT02326272|12466885|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933051|NCT02326272|12466871|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7933052|NCT02326272|12466872|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7933053|NCT02326272|12466873|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1
7933054|NCT02326272|12466874|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7933055|NCT02326272|12466875|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7933056|NCT02326272|12466876|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7933057|NCT02326272|12466877|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7933058|NCT02326272|12466878|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7933059|NCT02326272|12466879|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7933060|NCT02326272|12466880|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7933061|NCT02326272|12466881|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7933062|NCT02326272|12466882|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7933063|NCT02326272|12466883|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7933064|NCT02326272|12466884|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7933065|NCT02326272|12466885|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7933066|NCT02326272|12466871|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0
7933067|NCT02326272|12466872|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0
7933068|NCT02326272|12466873|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1
7933069|NCT02326272|12466874|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0
7933070|NCT02326272|12466875|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0
7933071|NCT02326272|12466876|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0
7933072|NCT02326272|12466877|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0
7933073|NCT02326272|12466878|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0
7933074|NCT02326272|12466879|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0
7933075|NCT02326272|12466880|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0
7933076|NCT02326272|12466881|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0
7933077|NCT02326272|12466882|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0
7933078|NCT02326272|12466883|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0
7933079|NCT02326272|12466884|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0
7933080|NCT02326272|12466885|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0
7933081|NCT02326272|12466871|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7933082|NCT02326272|12466872|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7933083|NCT02326272|12466873|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
7933084|NCT02326272|12466874|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7933085|NCT02326272|12466875|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7933086|NCT02326272|12466876|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7933087|NCT02326272|12466877|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7933088|NCT02326272|12466878|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7933089|NCT02326272|12466879|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7933090|NCT02326272|12466880|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7933091|NCT02326272|12466881|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7933092|NCT02326272|12466882|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7933093|NCT02326272|12466883|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7933094|NCT02326272|12466884|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7933095|NCT02326272|12466885|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7933096|NCT02326272|12466871|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7933097|NCT02326272|12466872|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7933098|NCT02326272|12466873|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
7933099|NCT02326272|12466874|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7933100|NCT02326272|12466875|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7933101|NCT02326272|12466876|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7933102|NCT02326272|12466877|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7933103|NCT02326272|12466878|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7933104|NCT02326272|12466879|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7933105|NCT02326272|12466880|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7933106|NCT02326272|12466881|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7933107|NCT02326272|12466882|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7933108|NCT02326272|12466883|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7933109|NCT02326272|12466884|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7933110|NCT02326272|12466885|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7933111|NCT02326272|12466871|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933112|NCT02326272|12466872|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933113|NCT02326272|12466873|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933114|NCT02326272|12466874|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933115|NCT02326272|12466875|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7933116|NCT02326272|12466876|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
7933117|NCT02326272|12466877|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
7933118|NCT02326272|12466878|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7933119|NCT02326272|12466879|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7933120|NCT02326272|12466880|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933121|NCT02326272|12466881|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933122|NCT02326272|12466882|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933123|NCT02326272|12466883|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933124|NCT02326272|12466884|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933125|NCT02326272|12466885|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933126|NCT02326272|12466871|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7933127|NCT02326272|12466872|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7933128|NCT02326272|12466873|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7933129|NCT02326272|12466874|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7933130|NCT02326272|12466875|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7933131|NCT02326272|12466876|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
7933132|NCT02326272|12466877|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7933133|NCT02326272|12466878|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7933134|NCT02326272|12466879|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7933135|NCT02326272|12466880|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7933136|NCT02326272|12466881|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7933137|NCT02326272|12466882|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7933138|NCT02326272|12466883|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7933139|NCT02326272|12466884|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7933140|NCT02326272|12466885|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7933141|NCT02326272|12466871|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933142|NCT02326272|12466872|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933143|NCT02326272|12466873|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933144|NCT02326272|12466874|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933145|NCT02326272|12466875|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933146|NCT02326272|12466876|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
7933147|NCT02326272|12466877|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933148|NCT02326272|12466878|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
7933149|NCT02326272|12466879|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933150|NCT02326272|12466880|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933151|NCT02326272|12466881|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933152|NCT02326272|12466882|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933153|NCT02326272|12466883|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933154|NCT02326272|12466884|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933155|NCT02326272|12466885|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933156|NCT02326272|12466871|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933157|NCT02326272|12466872|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933158|NCT02326272|12466873|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933159|NCT02326272|12466874|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7933160|NCT02326272|12466875|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933161|NCT02326272|12466876|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
7933162|NCT02326272|12466877|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7933163|NCT02326272|12466878|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7933164|NCT02326272|12466879|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933165|NCT02326272|12466880|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7933166|NCT02326272|12466881|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933167|NCT02326272|12466882|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933168|NCT02326272|12466883|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933169|NCT02326272|12466884|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933170|NCT02326272|12466885|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933171|NCT02326272|12466871|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7933172|NCT02326272|12466872|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7933173|NCT02326272|12466873|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7933174|NCT02326272|12466874|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7933175|NCT02326272|12466875|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7933176|NCT02326272|12466876|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7933177|NCT02326272|12466877|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7933178|NCT02326272|12466878|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
7933179|NCT02326272|12466879|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7933180|NCT02326272|12466880|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7933181|NCT02326272|12466881|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7933182|NCT02326272|12466882|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7933183|NCT02326272|12466883|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7933184|NCT02326272|12466884|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7933185|NCT02326272|12466885|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7933186|NCT02326272|12466871|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933187|NCT02326272|12466872|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933188|NCT02326272|12466873|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933189|NCT02326272|12466874|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933190|NCT02326272|12466875|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933191|NCT02326272|12466876|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933192|NCT02326272|12466877|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
7933193|NCT02326272|12466878|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933194|NCT02326272|12466879|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933195|NCT02326272|12466880|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933196|NCT02326272|12466881|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933197|NCT02326272|12466882|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933198|NCT02326272|12466883|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933199|NCT02326272|12466884|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933200|NCT02326272|12466885|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933201|NCT02326272|12466871|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7933202|NCT02326272|12466872|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7933203|NCT02326272|12466873|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7933204|NCT02326272|12466874|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7933205|NCT02326272|12466875|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7933206|NCT02326272|12466876|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7933207|NCT02326272|12466877|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7933208|NCT02326272|12466878|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7933209|NCT02326272|12466879|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
7933210|NCT02326272|12466880|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7933211|NCT02326272|12466881|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7933212|NCT02326272|12466882|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7933213|NCT02326272|12466883|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7933214|NCT02326272|12466884|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7933215|NCT02326272|12466885|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7933216|NCT02326272|12466871|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7933217|NCT02326272|12466872|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7933218|NCT02326272|12466873|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7933219|NCT02326272|12466874|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7933220|NCT02326272|12466875|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7933221|NCT02326272|12466876|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
7933222|NCT02326272|12466877|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
7933223|NCT02326272|12466878|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
7933224|NCT02326272|12466879|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
7933225|NCT02326272|12466880|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7933226|NCT02326272|12466881|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7933227|NCT02326272|12466882|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7933228|NCT02326272|12466883|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7933229|NCT02326272|12466884|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7933230|NCT02326272|12466885|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7933231|NCT02326272|12466871|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7933232|NCT02326272|12466872|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7933233|NCT02326272|12466873|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7933234|NCT02326272|12466874|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7933235|NCT02326272|12466875|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7933236|NCT02326272|12466876|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1
7967173|NCT02761733|12523728|FG002|Overall Study|Death|1
7933237|NCT02326272|12466877|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7933238|NCT02326272|12466878|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7933239|NCT02326272|12466879|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7933240|NCT02326272|12466880|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7933241|NCT02326272|12466881|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7933242|NCT02326272|12466882|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7933243|NCT02326272|12466883|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7933244|NCT02326272|12466884|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7933245|NCT02326272|12466885|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7933246|NCT02326272|12466871|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7933247|NCT02326272|12466872|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7933248|NCT02326272|12466873|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7933249|NCT02326272|12466874|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7933250|NCT02326272|12466875|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7933251|NCT02326272|12466876|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7933252|NCT02326272|12466877|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1
7933253|NCT02326272|12466878|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7933254|NCT02326272|12466879|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7933255|NCT02326272|12466880|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7933256|NCT02326272|12466881|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7933257|NCT02326272|12466882|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7933258|NCT02326272|12466883|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7933259|NCT02326272|12466884|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7933260|NCT02326272|12466885|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7933261|NCT02326272|12466871|FG000|Open-label Period (Week 48 to Week 144)|Death|0
7933262|NCT02326272|12466872|FG001|Open-label Period (Week 48 to Week 144)|Death|0
7933263|NCT02326272|12466873|FG002|Open-label Period (Week 48 to Week 144)|Death|0
7933264|NCT02326272|12466874|FG003|Open-label Period (Week 48 to Week 144)|Death|0
7933265|NCT02326272|12466875|FG004|Open-label Period (Week 48 to Week 144)|Death|0
7933266|NCT02326272|12466876|FG005|Open-label Period (Week 48 to Week 144)|Death|0
7933267|NCT02326272|12466877|FG006|Open-label Period (Week 48 to Week 144)|Death|0
7933268|NCT02326272|12466878|FG007|Open-label Period (Week 48 to Week 144)|Death|0
7933269|NCT02326272|12466879|FG008|Open-label Period (Week 48 to Week 144)|Death|0
7933270|NCT02326272|12466880|FG009|Open-label Period (Week 48 to Week 144)|Death|0
7933271|NCT02326272|12466881|FG010|Open-label Period (Week 48 to Week 144)|Death|0
7933272|NCT02326272|12466882|FG011|Open-label Period (Week 48 to Week 144)|Death|0
7933273|NCT02326272|12466883|FG012|Open-label Period (Week 48 to Week 144)|Death|1
7933274|NCT02326272|12466884|FG013|Open-label Period (Week 48 to Week 144)|Death|0
7933275|NCT02326272|12466885|FG014|Open-label Period (Week 48 to Week 144)|Death|0
7933276|NCT02326272|12466871|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933277|NCT02326272|12466872|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933278|NCT02326272|12466873|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933279|NCT02326272|12466874|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933280|NCT02326272|12466875|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933281|NCT02326272|12466876|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933282|NCT02326272|12466877|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933283|NCT02326272|12466878|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933284|NCT02326272|12466879|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933285|NCT02326272|12466880|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933286|NCT02326272|12466881|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1
7933287|NCT02326272|12466882|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8
7933288|NCT02326272|12466883|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3
7933289|NCT02326272|12466884|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933290|NCT02326272|12466885|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1
7933291|NCT02326272|12466871|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933292|NCT02326272|12466872|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933293|NCT02326272|12466873|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933294|NCT02326272|12466874|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933295|NCT02326272|12466875|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933296|NCT02326272|12466876|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933297|NCT02326272|12466877|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933298|NCT02326272|12466878|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933299|NCT02326272|12466879|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933300|NCT02326272|12466880|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933301|NCT02326272|12466881|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7933302|NCT02326272|12466882|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933303|NCT02326272|12466883|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7933304|NCT02326272|12466884|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933305|NCT02326272|12466885|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933306|NCT02326272|12466871|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933307|NCT02326272|12466872|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933308|NCT02326272|12466873|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933309|NCT02326272|12466874|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933310|NCT02326272|12466875|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933311|NCT02326272|12466876|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933312|NCT02326272|12466877|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933313|NCT02326272|12466878|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933314|NCT02326272|12466879|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933315|NCT02326272|12466880|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933316|NCT02326272|12466881|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933317|NCT02326272|12466882|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1
7933318|NCT02326272|12466883|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933319|NCT02326272|12466884|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933320|NCT02326272|12466885|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933321|NCT02326272|12466871|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933322|NCT02326272|12466872|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933323|NCT02326272|12466873|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933324|NCT02326272|12466874|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933325|NCT02326272|12466875|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933326|NCT02326272|12466876|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933327|NCT02326272|12466877|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933328|NCT02326272|12466878|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933329|NCT02326272|12466879|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933330|NCT02326272|12466880|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933331|NCT02326272|12466881|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1
7933332|NCT02326272|12466882|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933333|NCT02326272|12466883|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2
7933334|NCT02326272|12466884|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933335|NCT02326272|12466885|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
7933336|NCT02326272|12466871|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933337|NCT02326272|12466872|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933338|NCT02326272|12466873|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933339|NCT02326272|12466874|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933340|NCT02326272|12466875|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933341|NCT02326272|12466876|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933342|NCT02326272|12466877|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933343|NCT02326272|12466878|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933344|NCT02326272|12466879|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933345|NCT02326272|12466880|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933346|NCT02326272|12466881|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933347|NCT02326272|12466882|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4
7933348|NCT02326272|12466883|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933349|NCT02326272|12466884|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933350|NCT02326272|12466885|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
7933351|NCT02326272|12466871|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933352|NCT02326272|12466872|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933353|NCT02326272|12466873|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933354|NCT02326272|12466874|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933355|NCT02326272|12466875|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933356|NCT02326272|12466876|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933357|NCT02326272|12466877|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933358|NCT02326272|12466878|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933359|NCT02326272|12466879|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933360|NCT02326272|12466880|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933361|NCT02326272|12466881|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933362|NCT02326272|12466882|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1
7933363|NCT02326272|12466883|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
7933364|NCT02326272|12466884|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933365|NCT02326272|12466885|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
7933366|NCT02326272|12466871|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7933367|NCT02326272|12466872|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7933368|NCT02326272|12466873|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7933369|NCT02326272|12466874|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7933370|NCT02326272|12466875|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7933371|NCT02326272|12466876|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7933372|NCT02326272|12466877|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7933373|NCT02326272|12466878|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7933374|NCT02326272|12466879|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7933375|NCT02326272|12466880|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7933376|NCT02326272|12466881|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7933377|NCT02326272|12466882|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1
7933378|NCT02326272|12466883|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7933379|NCT02326272|12466884|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7933380|NCT02326272|12466885|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7933381|NCT02326272|12466871|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7933382|NCT02326272|12466872|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7933383|NCT02326272|12466873|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7933384|NCT02326272|12466874|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7933385|NCT02326272|12466875|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7933386|NCT02326272|12466876|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7933387|NCT02326272|12466877|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7933388|NCT02326272|12466878|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7933389|NCT02326272|12466879|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7933390|NCT02326272|12466880|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7933391|NCT02326272|12466881|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7933392|NCT02326272|12466882|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7933393|NCT02326272|12466883|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1
7933394|NCT02326272|12466884|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7933395|NCT02326272|12466885|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7933396|NCT02326298|12466897|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933397|NCT02326298|12466898|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933398|NCT02326298|12466899|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
7933399|NCT02326298|12466900|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933400|NCT02326298|12466901|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933401|NCT02326298|12466902|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933402|NCT02326298|12466903|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933403|NCT02326298|12466904|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933404|NCT02326298|12466905|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933405|NCT02326298|12466906|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933406|NCT02326298|12466907|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933407|NCT02326298|12466908|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933408|NCT02326298|12466909|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933409|NCT02326298|12466910|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0
7933410|NCT02326298|12466897|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1
7933411|NCT02326298|12466898|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7933412|NCT02326298|12466899|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7933413|NCT02326298|12466900|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7933414|NCT02326298|12466901|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7933415|NCT02326298|12466902|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7933416|NCT02326298|12466903|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7933417|NCT02326298|12466904|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7933418|NCT02326298|12466905|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7933419|NCT02326298|12466906|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7933420|NCT02326298|12466907|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7933421|NCT02326298|12466908|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7933422|NCT02326298|12466909|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7933423|NCT02326298|12466910|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7933424|NCT02326298|12466897|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
7933425|NCT02326298|12466898|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
7933426|NCT02326298|12466899|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933427|NCT02326298|12466900|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933428|NCT02326298|12466901|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933429|NCT02326298|12466902|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933430|NCT02326298|12466903|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933431|NCT02326298|12466904|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933432|NCT02326298|12466905|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933433|NCT02326298|12466906|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933434|NCT02326298|12466907|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933435|NCT02326298|12466908|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933436|NCT02326298|12466909|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933437|NCT02326298|12466910|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7933438|NCT02326298|12466897|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
7933439|NCT02326298|12466898|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
7933440|NCT02326298|12466899|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933441|NCT02326298|12466900|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933442|NCT02326298|12466901|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933443|NCT02326298|12466902|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933444|NCT02326298|12466903|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933445|NCT02326298|12466904|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933446|NCT02326298|12466905|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933447|NCT02326298|12466906|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933448|NCT02326298|12466907|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933449|NCT02326298|12466908|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933450|NCT02326298|12466909|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933451|NCT02326298|12466910|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7933452|NCT02326298|12466897|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7933453|NCT02326298|12466898|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7933454|NCT02326298|12466899|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2
7933455|NCT02326298|12466900|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7933456|NCT02326298|12466901|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7933457|NCT02326298|12466902|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7933458|NCT02326298|12466903|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7933459|NCT02326298|12466904|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7933460|NCT02326298|12466905|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7933461|NCT02326298|12466906|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7933462|NCT02326298|12466907|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7933463|NCT02326298|12466908|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7933464|NCT02326298|12466909|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7933465|NCT02326298|12466910|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7933466|NCT02326298|12466897|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933467|NCT02326298|12466898|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933468|NCT02326298|12466899|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933469|NCT02326298|12466900|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933470|NCT02326298|12466901|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933471|NCT02326298|12466902|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7933472|NCT02326298|12466903|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
7933473|NCT02326298|12466904|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7933474|NCT02326298|12466905|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7933475|NCT02326298|12466906|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7933476|NCT02326298|12466907|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933477|NCT02326298|12466908|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933478|NCT02326298|12466909|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933479|NCT02326298|12466910|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7933480|NCT02326298|12466897|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7933481|NCT02326298|12466898|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7967174|NCT02761733|12523729|FG003|Overall Study|Death|1
7933482|NCT02326298|12466899|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7933483|NCT02326298|12466900|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7933484|NCT02326298|12466901|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7933485|NCT02326298|12466902|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1
7933486|NCT02326298|12466903|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2
7933487|NCT02326298|12466904|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7933488|NCT02326298|12466905|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4
7933489|NCT02326298|12466906|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7933490|NCT02326298|12466907|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7933491|NCT02326298|12466908|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7933492|NCT02326298|12466909|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7933493|NCT02326298|12466910|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7933494|NCT02326298|12466897|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7933495|NCT02326298|12466898|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7933496|NCT02326298|12466899|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7933497|NCT02326298|12466900|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7933498|NCT02326298|12466901|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7933499|NCT02326298|12466902|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1
7933500|NCT02326298|12466903|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7933501|NCT02326298|12466904|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7933502|NCT02326298|12466905|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7933503|NCT02326298|12466906|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7933504|NCT02326298|12466907|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7933505|NCT02326298|12466908|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7933506|NCT02326298|12466909|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7933507|NCT02326298|12466910|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7933508|NCT02326298|12466897|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933509|NCT02326298|12466898|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933510|NCT02326298|12466899|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933511|NCT02326298|12466900|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933512|NCT02326298|12466901|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933513|NCT02326298|12466902|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933514|NCT02326298|12466903|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
7933515|NCT02326298|12466904|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933516|NCT02326298|12466905|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933517|NCT02326298|12466906|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933518|NCT02326298|12466907|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933519|NCT02326298|12466908|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933520|NCT02326298|12466909|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933521|NCT02326298|12466910|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7933522|NCT02326298|12466897|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7933523|NCT02326298|12466898|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7933524|NCT02326298|12466899|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7933525|NCT02326298|12466900|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7933526|NCT02326298|12466901|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7933527|NCT02326298|12466902|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7933528|NCT02326298|12466903|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7933529|NCT02326298|12466904|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1
7933530|NCT02326298|12466905|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7933531|NCT02326298|12466906|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7933532|NCT02326298|12466907|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7933533|NCT02326298|12466908|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7933534|NCT02326298|12466909|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7933535|NCT02326298|12466910|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7933536|NCT02326298|12466897|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933537|NCT02326298|12466898|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933538|NCT02326298|12466899|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933539|NCT02326298|12466900|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933540|NCT02326298|12466901|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933541|NCT02326298|12466902|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933542|NCT02326298|12466903|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
7933543|NCT02326298|12466904|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
7933544|NCT02326298|12466905|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933545|NCT02326298|12466906|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933546|NCT02326298|12466907|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933547|NCT02326298|12466908|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933548|NCT02326298|12466909|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933549|NCT02326298|12466910|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7933550|NCT02326298|12466897|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933551|NCT02326298|12466898|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933552|NCT02326298|12466899|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933553|NCT02326298|12466900|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933554|NCT02326298|12466901|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933555|NCT02326298|12466902|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933556|NCT02326298|12466903|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933557|NCT02326298|12466904|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7933558|NCT02326298|12466905|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933559|NCT02326298|12466906|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933560|NCT02326298|12466907|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933561|NCT02326298|12466908|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933562|NCT02326298|12466909|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933563|NCT02326298|12466910|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7933564|NCT02326298|12466897|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7933565|NCT02326298|12466898|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7933566|NCT02326298|12466899|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7933567|NCT02326298|12466900|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7933568|NCT02326298|12466901|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7933569|NCT02326298|12466902|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2
7933570|NCT02326298|12466903|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7933571|NCT02326298|12466904|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7933572|NCT02326298|12466905|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7933573|NCT02326298|12466906|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7933574|NCT02326298|12466907|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7933575|NCT02326298|12466908|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7933576|NCT02326298|12466909|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7933577|NCT02326298|12466910|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7933578|NCT02326298|12466897|FG000|Open-label Period (Week 48 to Week 144)|Death|0
7933579|NCT02326298|12466898|FG001|Open-label Period (Week 48 to Week 144)|Death|0
7933580|NCT02326298|12466899|FG002|Open-label Period (Week 48 to Week 144)|Death|0
7933581|NCT02326298|12466900|FG003|Open-label Period (Week 48 to Week 144)|Death|0
7933582|NCT02326298|12466901|FG004|Open-label Period (Week 48 to Week 144)|Death|0
7933583|NCT02326298|12466902|FG005|Open-label Period (Week 48 to Week 144)|Death|0
7933584|NCT02326298|12466903|FG006|Open-label Period (Week 48 to Week 144)|Death|0
7933585|NCT02326298|12466904|FG007|Open-label Period (Week 48 to Week 144)|Death|0
7933586|NCT02326298|12466905|FG008|Open-label Period (Week 48 to Week 144)|Death|0
7933587|NCT02326298|12466906|FG009|Open-label Period (Week 48 to Week 144)|Death|0
7933588|NCT02326298|12466907|FG010|Open-label Period (Week 48 to Week 144)|Death|0
7933589|NCT02326298|12466908|FG011|Open-label Period (Week 48 to Week 144)|Death|1
7933590|NCT02326298|12466909|FG012|Open-label Period (Week 48 to Week 144)|Death|0
7933591|NCT02326298|12466910|FG013|Open-label Period (Week 48 to Week 144)|Death|0
7933592|NCT02326298|12466897|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933593|NCT02326298|12466898|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933594|NCT02326298|12466899|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933595|NCT02326298|12466900|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933596|NCT02326298|12466901|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933597|NCT02326298|12466902|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933598|NCT02326298|12466903|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933599|NCT02326298|12466904|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933600|NCT02326298|12466905|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933601|NCT02326298|12466906|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933602|NCT02326298|12466907|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933603|NCT02326298|12466908|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3
7933604|NCT02326298|12466909|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3
7933605|NCT02326298|12466910|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7933606|NCT02326298|12466897|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933607|NCT02326298|12466898|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933608|NCT02326298|12466899|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933609|NCT02326298|12466900|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933610|NCT02326298|12466901|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933611|NCT02326298|12466902|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933612|NCT02326298|12466903|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933613|NCT02326298|12466904|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933614|NCT02326298|12466905|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933615|NCT02326298|12466906|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933616|NCT02326298|12466907|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933617|NCT02326298|12466908|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7933618|NCT02326298|12466909|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7933619|NCT02326298|12466910|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7933620|NCT02326298|12466897|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933621|NCT02326298|12466898|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933622|NCT02326298|12466899|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933623|NCT02326298|12466900|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933624|NCT02326298|12466901|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933625|NCT02326298|12466902|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933626|NCT02326298|12466903|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933627|NCT02326298|12466904|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933628|NCT02326298|12466905|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933629|NCT02326298|12466906|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933630|NCT02326298|12466907|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933631|NCT02326298|12466908|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933632|NCT02326298|12466909|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7933633|NCT02326298|12466910|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2
7933634|NCT02326298|12466897|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933635|NCT02326298|12466898|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933636|NCT02326298|12466899|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933637|NCT02326298|12466900|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933638|NCT02326298|12466901|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933639|NCT02326298|12466902|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933640|NCT02326298|12466903|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933641|NCT02326298|12466904|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933642|NCT02326298|12466905|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933643|NCT02326298|12466906|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933644|NCT02326298|12466907|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7933645|NCT02326298|12466908|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7
7933646|NCT02326298|12466909|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
7933647|NCT02326298|12466910|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7933648|NCT02326298|12466897|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933649|NCT02326298|12466898|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933650|NCT02326298|12466899|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933651|NCT02326298|12466900|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933652|NCT02326298|12466901|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933653|NCT02326298|12466902|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933654|NCT02326298|12466903|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933655|NCT02326298|12466904|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933656|NCT02326298|12466905|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933657|NCT02326298|12466906|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933658|NCT02326298|12466907|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7933659|NCT02326298|12466908|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2
7933660|NCT02326298|12466909|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7
7933661|NCT02326298|12466910|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
7933662|NCT02326298|12466897|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933663|NCT02326298|12466898|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933664|NCT02326298|12466899|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933665|NCT02326298|12466900|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933666|NCT02326298|12466901|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933667|NCT02326298|12466902|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933668|NCT02326298|12466903|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933669|NCT02326298|12466904|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933670|NCT02326298|12466905|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933671|NCT02326298|12466906|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933672|NCT02326298|12466907|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7933673|NCT02326298|12466908|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
7933674|NCT02326298|12466909|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
7933675|NCT02326298|12466910|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
7933676|NCT02326467|12466930|FG000|Overall Study|Withdrawal by Subject|1
7933677|NCT02326597|12466937|FG000|Overall Study|Lost to Follow-up|42
7933678|NCT02326597|12466938|FG001|Overall Study|Lost to Follow-up|32
7933679|NCT02326883|12466966|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84
7933680|NCT02326883|12466967|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85
7933681|NCT02326883|12466968|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69
7933682|NCT02327013|12466979|FG000|Overall Study|Adverse Event|4
7933683|NCT02327013|12466980|FG001|Overall Study|Adverse Event|4
7933684|NCT02327013|12466981|FG002|Overall Study|Adverse Event|3
7933685|NCT02327013|12466982|FG003|Overall Study|Adverse Event|0
7933686|NCT02327013|12466983|FG004|Overall Study|Adverse Event|1
7933687|NCT02327013|12466979|FG000|Overall Study|Lack of Efficacy|2
7933688|NCT02327013|12466980|FG001|Overall Study|Lack of Efficacy|0
7933689|NCT02327013|12466981|FG002|Overall Study|Lack of Efficacy|5
7933690|NCT02327013|12466982|FG003|Overall Study|Lack of Efficacy|0
7933691|NCT02327013|12466983|FG004|Overall Study|Lack of Efficacy|1
7933692|NCT02327013|12466979|FG000|Overall Study|Non-compliance with IMP|1
7933693|NCT02327013|12466980|FG001|Overall Study|Non-compliance with IMP|2
7933694|NCT02327013|12466981|FG002|Overall Study|Non-compliance with IMP|7
7933695|NCT02327013|12466982|FG003|Overall Study|Non-compliance with IMP|0
7933696|NCT02327013|12466983|FG004|Overall Study|Non-compliance with IMP|0
7933697|NCT02327013|12466979|FG000|Overall Study|Withdrawal of Consent|1
7933698|NCT02327013|12466980|FG001|Overall Study|Withdrawal of Consent|0
7933699|NCT02327013|12466981|FG002|Overall Study|Withdrawal of Consent|3
7933700|NCT02327013|12466982|FG003|Overall Study|Withdrawal of Consent|0
7933701|NCT02327013|12466983|FG004|Overall Study|Withdrawal of Consent|0
7933702|NCT02327013|12466979|FG000|Overall Study|Lost to Follow-up|2
7933703|NCT02327013|12466980|FG001|Overall Study|Lost to Follow-up|4
7933704|NCT02327013|12466981|FG002|Overall Study|Lost to Follow-up|5
7933705|NCT02327013|12466982|FG003|Overall Study|Lost to Follow-up|0
7933706|NCT02327013|12466983|FG004|Overall Study|Lost to Follow-up|0
7933707|NCT02327013|12466979|FG000|Overall Study|Administrative or other reason(s)|1
7933708|NCT02327013|12466980|FG001|Overall Study|Administrative or other reason(s)|5
7933709|NCT02327013|12466981|FG002|Overall Study|Administrative or other reason(s)|11
7933710|NCT02327013|12466982|FG003|Overall Study|Administrative or other reason(s)|1
7933711|NCT02327013|12466983|FG004|Overall Study|Administrative or other reason(s)|1
7933712|NCT02327013|12466979|FG000|Overall Study|Protocol Violation|0
7933713|NCT02327013|12466980|FG001|Overall Study|Protocol Violation|0
7933714|NCT02327013|12466981|FG002|Overall Study|Protocol Violation|3
7933715|NCT02327013|12466982|FG003|Overall Study|Protocol Violation|0
7933716|NCT02327013|12466983|FG004|Overall Study|Protocol Violation|1
7933717|NCT02327013|12466979|FG000|Overall Study|Withdrawal before treatment|2
7933718|NCT02327013|12466980|FG001|Overall Study|Withdrawal before treatment|1
7933719|NCT02327013|12466981|FG002|Overall Study|Withdrawal before treatment|5
7933720|NCT02327013|12466982|FG003|Overall Study|Withdrawal before treatment|0
7933721|NCT02327013|12466983|FG004|Overall Study|Withdrawal before treatment|0
7933722|NCT02327130|12467016|FG000|Overall Study|Discharged in less than 5 days|5
7933723|NCT02327130|12467016|FG000|Overall Study|Physician Decision|2
7933724|NCT02327130|12467016|FG000|Overall Study|Unable to provide breath sample|1
7933725|NCT02327130|12467016|FG000|Overall Study|Incorrectly place ventilator adaptor|1
7933726|NCT02327130|12467016|FG000|Overall Study|Met exclusion criteria|3
7933727|NCT02327169|12467045|FG000|Overall Study|Progressive Disease|1
7933728|NCT02327169|12467046|FG001|Overall Study|Progressive Disease|3
7933729|NCT02327169|12467047|FG002|Overall Study|Progressive Disease|4
7933730|NCT02327169|12467048|FG003|Overall Study|Progressive Disease|3
7933731|NCT02327169|12467049|FG004|Overall Study|Progressive Disease|4
7933732|NCT02327169|12467050|FG005|Overall Study|Progressive Disease|3
7933733|NCT02327169|12467051|FG006|Overall Study|Progressive Disease|3
7933734|NCT02327169|12467052|FG007|Overall Study|Progressive Disease|3
7933735|NCT02327169|12467053|FG008|Overall Study|Progressive Disease|4
7933736|NCT02327169|12467054|FG009|Overall Study|Progressive Disease|4
7933737|NCT02327169|12467055|FG010|Overall Study|Progressive Disease|4
7933738|NCT02327169|12467056|FG011|Overall Study|Progressive Disease|3
7933739|NCT02327169|12467057|FG012|Overall Study|Progressive Disease|1
7933740|NCT02327169|12467058|FG013|Overall Study|Progressive Disease|3
7933741|NCT02327169|12467059|FG014|Overall Study|Progressive Disease|3
7933742|NCT02327169|12467045|FG000|Overall Study|Adverse Event|2
7933743|NCT02327169|12467046|FG001|Overall Study|Adverse Event|0
7933744|NCT02327169|12467047|FG002|Overall Study|Adverse Event|1
7933745|NCT02327169|12467048|FG003|Overall Study|Adverse Event|0
7933746|NCT02327169|12467049|FG004|Overall Study|Adverse Event|1
7933747|NCT02327169|12467050|FG005|Overall Study|Adverse Event|0
7933748|NCT02327169|12467051|FG006|Overall Study|Adverse Event|0
7933749|NCT02327169|12467052|FG007|Overall Study|Adverse Event|0
7933750|NCT02327169|12467053|FG008|Overall Study|Adverse Event|0
7933751|NCT02327169|12467054|FG009|Overall Study|Adverse Event|2
7933752|NCT02327169|12467055|FG010|Overall Study|Adverse Event|0
7933753|NCT02327169|12467056|FG011|Overall Study|Adverse Event|3
7933754|NCT02327169|12467057|FG012|Overall Study|Adverse Event|0
7933755|NCT02327169|12467058|FG013|Overall Study|Adverse Event|2
7933756|NCT02327169|12467059|FG014|Overall Study|Adverse Event|1
7933757|NCT02327169|12467045|FG000|Overall Study|Symptomatic Deterioration|0
7933758|NCT02327169|12467046|FG001|Overall Study|Symptomatic Deterioration|0
7933759|NCT02327169|12467047|FG002|Overall Study|Symptomatic Deterioration|1
7933760|NCT02327169|12467048|FG003|Overall Study|Symptomatic Deterioration|0
7933761|NCT02327169|12467049|FG004|Overall Study|Symptomatic Deterioration|1
7933762|NCT02327169|12467050|FG005|Overall Study|Symptomatic Deterioration|1
7933763|NCT02327169|12467051|FG006|Overall Study|Symptomatic Deterioration|0
7933764|NCT02327169|12467052|FG007|Overall Study|Symptomatic Deterioration|0
7933765|NCT02327169|12467053|FG008|Overall Study|Symptomatic Deterioration|2
7933766|NCT02327169|12467054|FG009|Overall Study|Symptomatic Deterioration|1
7933767|NCT02327169|12467055|FG010|Overall Study|Symptomatic Deterioration|0
7933768|NCT02327169|12467056|FG011|Overall Study|Symptomatic Deterioration|0
7933769|NCT02327169|12467057|FG012|Overall Study|Symptomatic Deterioration|0
7933770|NCT02327169|12467058|FG013|Overall Study|Symptomatic Deterioration|2
7933771|NCT02327169|12467059|FG014|Overall Study|Symptomatic Deterioration|1
7933772|NCT02327169|12467045|FG000|Overall Study|Reason Not Specified|0
7933773|NCT02327169|12467046|FG001|Overall Study|Reason Not Specified|0
7933774|NCT02327169|12467047|FG002|Overall Study|Reason Not Specified|1
7933775|NCT02327169|12467048|FG003|Overall Study|Reason Not Specified|0
7933776|NCT02327169|12467049|FG004|Overall Study|Reason Not Specified|0
7933777|NCT02327169|12467050|FG005|Overall Study|Reason Not Specified|0
7933778|NCT02327169|12467051|FG006|Overall Study|Reason Not Specified|0
7933779|NCT02327169|12467052|FG007|Overall Study|Reason Not Specified|0
7933780|NCT02327169|12467053|FG008|Overall Study|Reason Not Specified|0
7933781|NCT02327169|12467054|FG009|Overall Study|Reason Not Specified|1
7933782|NCT02327169|12467055|FG010|Overall Study|Reason Not Specified|2
7933783|NCT02327169|12467056|FG011|Overall Study|Reason Not Specified|1
7933784|NCT02327169|12467057|FG012|Overall Study|Reason Not Specified|0
7933785|NCT02327169|12467058|FG013|Overall Study|Reason Not Specified|0
7933786|NCT02327169|12467059|FG014|Overall Study|Reason Not Specified|2
7933787|NCT02327169|12467045|FG000|Overall Study|Withdrawal by Subject|1
7933788|NCT02327169|12467046|FG001|Overall Study|Withdrawal by Subject|0
7933789|NCT02327169|12467047|FG002|Overall Study|Withdrawal by Subject|0
7933790|NCT02327169|12467048|FG003|Overall Study|Withdrawal by Subject|0
7933791|NCT02327169|12467049|FG004|Overall Study|Withdrawal by Subject|1
7933792|NCT02327169|12467050|FG005|Overall Study|Withdrawal by Subject|0
7933793|NCT02327169|12467051|FG006|Overall Study|Withdrawal by Subject|0
7933794|NCT02327169|12467052|FG007|Overall Study|Withdrawal by Subject|1
7933795|NCT02327169|12467053|FG008|Overall Study|Withdrawal by Subject|0
7933796|NCT02327169|12467054|FG009|Overall Study|Withdrawal by Subject|0
7933797|NCT02327169|12467055|FG010|Overall Study|Withdrawal by Subject|0
7933798|NCT02327169|12467056|FG011|Overall Study|Withdrawal by Subject|0
7933799|NCT02327169|12467057|FG012|Overall Study|Withdrawal by Subject|0
7933800|NCT02327169|12467058|FG013|Overall Study|Withdrawal by Subject|0
7933801|NCT02327169|12467059|FG014|Overall Study|Withdrawal by Subject|3
7933802|NCT02327169|12467045|FG000|Overall Study|Lost to Follow-up|0
7933803|NCT02327169|12467046|FG001|Overall Study|Lost to Follow-up|0
7933804|NCT02327169|12467047|FG002|Overall Study|Lost to Follow-up|0
7933805|NCT02327169|12467048|FG003|Overall Study|Lost to Follow-up|0
7933806|NCT02327169|12467049|FG004|Overall Study|Lost to Follow-up|1
7933807|NCT02327169|12467050|FG005|Overall Study|Lost to Follow-up|0
7933808|NCT02327169|12467051|FG006|Overall Study|Lost to Follow-up|0
7933809|NCT02327169|12467052|FG007|Overall Study|Lost to Follow-up|0
7933810|NCT02327169|12467053|FG008|Overall Study|Lost to Follow-up|0
7933811|NCT02327169|12467054|FG009|Overall Study|Lost to Follow-up|0
7933812|NCT02327169|12467055|FG010|Overall Study|Lost to Follow-up|0
7933813|NCT02327169|12467056|FG011|Overall Study|Lost to Follow-up|0
7933814|NCT02327169|12467057|FG012|Overall Study|Lost to Follow-up|0
7933815|NCT02327169|12467058|FG013|Overall Study|Lost to Follow-up|0
7933816|NCT02327169|12467059|FG014|Overall Study|Lost to Follow-up|0
7933817|NCT02327260|12467104|FG000|Overall Study|Lost to Follow-up|2
7933818|NCT02327260|12467105|FG001|Overall Study|Lost to Follow-up|3
7933819|NCT02327260|12467106|FG002|Overall Study|Lost to Follow-up|2
7933820|NCT02327260|12467104|FG000|Overall Study|invalid phone number|1
7933821|NCT02327260|12467105|FG001|Overall Study|invalid phone number|1
7933822|NCT02327260|12467106|FG002|Overall Study|invalid phone number|0
7933823|NCT02327260|12467104|FG000|Overall Study|non-adherence to protocol|2
7933824|NCT02327260|12467105|FG001|Overall Study|non-adherence to protocol|0
7933825|NCT02327260|12467106|FG002|Overall Study|non-adherence to protocol|0
7933826|NCT02327260|12467104|FG000|Overall Study|cognitive concerns|1
7933827|NCT02327260|12467105|FG001|Overall Study|cognitive concerns|0
7933828|NCT02327260|12467106|FG002|Overall Study|cognitive concerns|0
7933829|NCT02327325|12467118|FG000|Overall Study|Withdrawal by Subject|1
7933830|NCT02327325|12467119|FG001|Overall Study|Withdrawal by Subject|4
7933831|NCT02327325|12467120|FG002|Overall Study|Withdrawal by Subject|4
7933832|NCT02327325|12467118|FG000|Overall Study|Excluded by Study Team|0
7933833|NCT02327325|12467119|FG001|Overall Study|Excluded by Study Team|0
7933834|NCT02327325|12467120|FG002|Overall Study|Excluded by Study Team|1
7933835|NCT02328027|12467151|FG000|Overall Study|Withdrawal by Subject|0
7933836|NCT02328027|12467152|FG001|Overall Study|Withdrawal by Subject|1
7933837|NCT02328040|12467159|FG000|First Intervention (2 Days)|Withdrawal by Subject|1
7933838|NCT02328040|12467160|FG001|First Intervention (2 Days)|Withdrawal by Subject|1
7933839|NCT02328326|12467168|FG000|Overall Study|Withdrawal by Subject|10
7933840|NCT02328326|12467169|FG001|Overall Study|Withdrawal by Subject|3
7933841|NCT02328326|12467168|FG000|Overall Study|Death|2
7933842|NCT02328326|12467169|FG001|Overall Study|Death|1
7933843|NCT02328326|12467168|FG000|Overall Study|Lost to Follow-up|10
7933844|NCT02328326|12467169|FG001|Overall Study|Lost to Follow-up|4
7933845|NCT02328547|12467192|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1
7933846|NCT02328547|12467193|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0
7933847|NCT02328547|12467192|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2
7933848|NCT02328547|12467193|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0
7933849|NCT02328937|12467226|FG000|Period 1|Lost to Follow-up|0
7933850|NCT02328937|12467227|FG001|Period 1|Lost to Follow-up|0
7933851|NCT02328937|12467228|FG002|Period 1|Lost to Follow-up|0
7933852|NCT02328937|12467229|FG003|Period 1|Lost to Follow-up|1
7933853|NCT02328937|12467230|FG004|Period 1|Lost to Follow-up|0
7933854|NCT02328937|12467231|FG005|Period 1|Lost to Follow-up|0
7933855|NCT02328937|12467226|FG000|Period 2|Adverse Event|0
7933856|NCT02328937|12467227|FG001|Period 2|Adverse Event|0
7933857|NCT02328937|12467228|FG002|Period 2|Adverse Event|1
7933858|NCT02328937|12467229|FG003|Period 2|Adverse Event|0
7933859|NCT02328937|12467230|FG004|Period 2|Adverse Event|0
7933860|NCT02328937|12467231|FG005|Period 2|Adverse Event|0
7933861|NCT02329223|12467251|FG000|Overall Study|Withdrawal by Subject|1
7933862|NCT02329223|12467252|FG001|Overall Study|Withdrawal by Subject|2
7933863|NCT02329223|12467253|FG002|Overall Study|Withdrawal by Subject|5
7933864|NCT02329223|12467251|FG000|Overall Study|Physician Decision|0
7933865|NCT02329223|12467252|FG001|Overall Study|Physician Decision|0
7933866|NCT02329223|12467253|FG002|Overall Study|Physician Decision|1
7933867|NCT02329223|12467251|FG000|Overall Study|Adverse Event|0
7933868|NCT02329223|12467252|FG001|Overall Study|Adverse Event|1
7933869|NCT02329223|12467253|FG002|Overall Study|Adverse Event|0
7933870|NCT02329431|12467263|FG000|Overall Study|Lost to Follow-up|20
7933871|NCT02329431|12467264|FG001|Overall Study|Lost to Follow-up|13
7933872|NCT02329730|12467296|FG000|Overall Study|Protocol Violation|0
7933873|NCT02329730|12467297|FG001|Overall Study|Protocol Violation|0
7933874|NCT02329730|12467298|FG002|Overall Study|Protocol Violation|0
7933875|NCT02329730|12467299|FG003|Overall Study|Protocol Violation|0
7933876|NCT02329730|12467300|FG004|Overall Study|Protocol Violation|2
7933877|NCT02329730|12467301|FG005|Overall Study|Protocol Violation|2
7933878|NCT02329730|12467302|FG006|Overall Study|Protocol Violation|0
7933879|NCT02329730|12467303|FG007|Overall Study|Protocol Violation|0
7933880|NCT02329730|12467304|FG008|Overall Study|Protocol Violation|0
7933881|NCT02329730|12467305|FG009|Overall Study|Protocol Violation|0
7933882|NCT02329730|12467306|FG010|Overall Study|Protocol Violation|0
7933883|NCT02329730|12467307|FG011|Overall Study|Protocol Violation|0
7933884|NCT02329730|12467296|FG000|Overall Study|Withdrawal by Subject|0
7933885|NCT02329730|12467297|FG001|Overall Study|Withdrawal by Subject|0
7933886|NCT02329730|12467298|FG002|Overall Study|Withdrawal by Subject|0
7933887|NCT02329730|12467299|FG003|Overall Study|Withdrawal by Subject|0
7933888|NCT02329730|12467300|FG004|Overall Study|Withdrawal by Subject|1
7933889|NCT02329730|12467301|FG005|Overall Study|Withdrawal by Subject|0
7933890|NCT02329730|12467302|FG006|Overall Study|Withdrawal by Subject|1
7933891|NCT02329730|12467303|FG007|Overall Study|Withdrawal by Subject|1
7933892|NCT02329730|12467304|FG008|Overall Study|Withdrawal by Subject|1
7933893|NCT02329730|12467305|FG009|Overall Study|Withdrawal by Subject|1
7933894|NCT02329730|12467306|FG010|Overall Study|Withdrawal by Subject|0
7933895|NCT02329730|12467307|FG011|Overall Study|Withdrawal by Subject|0
7933896|NCT02329743|12467328|FG000|Overall Study|Adverse Event|1
7933897|NCT02329743|12467329|FG001|Overall Study|Adverse Event|1
7933898|NCT02329743|12467330|FG002|Overall Study|Adverse Event|3
7933899|NCT02329743|12467328|FG000|Overall Study|Lost to Follow-up|1
7933900|NCT02329743|12467329|FG001|Overall Study|Lost to Follow-up|0
7933901|NCT02329743|12467330|FG002|Overall Study|Lost to Follow-up|1
7933902|NCT02329743|12467328|FG000|Overall Study|Withdrawal by Subject|4
7933903|NCT02329743|12467329|FG001|Overall Study|Withdrawal by Subject|4
7933904|NCT02329743|12467330|FG002|Overall Study|Withdrawal by Subject|1
7933905|NCT02329743|12467328|FG000|Overall Study|Other|0
7933906|NCT02329743|12467329|FG001|Overall Study|Other|2
7933907|NCT02329743|12467330|FG002|Overall Study|Other|3
7933908|NCT02330055|12467349|FG000|Overall Study|technical issues|2
7933909|NCT02330055|12467350|FG001|Overall Study|technical issues|0
7933910|NCT02330055|12467349|FG000|Overall Study|participant forgot to wear device|5
7933911|NCT02330055|12467350|FG001|Overall Study|participant forgot to wear device|5
7933912|NCT02330055|12467349|FG000|Overall Study|data for less than 60 minutes|3
7933913|NCT02330055|12467350|FG001|Overall Study|data for less than 60 minutes|3
7933914|NCT02330055|12467349|FG000|Overall Study|participant did not sleep|0
7933915|NCT02330055|12467350|FG001|Overall Study|participant did not sleep|1
7933916|NCT02330081|12467356|FG000|Overall Study|Adverse Event|1
7933917|NCT02330081|12467356|FG000|Overall Study|Donation did not meet criteria|1
7933918|NCT02330081|12467356|FG000|Overall Study|Protocol Violation|6
7933919|NCT02330549|12467414|FG000|Overall Study|Adverse Event|1
7933920|NCT02330549|12467415|FG001|Overall Study|Adverse Event|0
7933921|NCT02330549|12467414|FG000|Overall Study|Subject withdrew consent|2
7933922|NCT02330549|12467415|FG001|Overall Study|Subject withdrew consent|1
7933923|NCT02330549|12467414|FG000|Overall Study|Failure to meet randomization criteria|1
7933924|NCT02330549|12467415|FG001|Overall Study|Failure to meet randomization criteria|0
7933925|NCT02331368|12467503|FG000|Overall Study|Withdrawal by Subject|3
7933926|NCT02331394|12467507|FG000|Overall Study|Disease progression|1
7933927|NCT02331446|12467526|FG000|Overall Study|Lost to Follow-up|2
7933928|NCT02331446|12467527|FG001|Overall Study|Lost to Follow-up|1
7933929|NCT02331446|12467528|FG002|Overall Study|Lost to Follow-up|0
7933930|NCT02331446|12467529|FG003|Overall Study|Lost to Follow-up|1
7933931|NCT02331446|12467526|FG000|Overall Study|Personal Problem|2
7933932|NCT02331446|12467527|FG001|Overall Study|Personal Problem|0
7933933|NCT02331446|12467528|FG002|Overall Study|Personal Problem|0
7933934|NCT02331446|12467529|FG003|Overall Study|Personal Problem|0
7933935|NCT02331446|12467526|FG000|Overall Study|Disease|0
7933936|NCT02331446|12467527|FG001|Overall Study|Disease|2
7933937|NCT02331446|12467528|FG002|Overall Study|Disease|2
7933938|NCT02331446|12467529|FG003|Overall Study|Disease|1
7933939|NCT02331446|12467526|FG000|Overall Study|Physician Decision|0
7933940|NCT02331446|12467527|FG001|Overall Study|Physician Decision|1
7933941|NCT02331446|12467528|FG002|Overall Study|Physician Decision|0
7933942|NCT02331446|12467529|FG003|Overall Study|Physician Decision|1
7933943|NCT02331446|12467526|FG000|Overall Study|Lost before baseline analysis|0
7933944|NCT02331446|12467527|FG001|Overall Study|Lost before baseline analysis|1
7933945|NCT02331446|12467528|FG002|Overall Study|Lost before baseline analysis|1
7933946|NCT02331446|12467529|FG003|Overall Study|Lost before baseline analysis|0
7933947|NCT02331680|12467551|FG000|Overall Study|Adverse Event|3
7933948|NCT02331680|12467552|FG001|Overall Study|Adverse Event|0
7933949|NCT02331680|12467553|FG002|Overall Study|Adverse Event|2
7933950|NCT02331680|12467551|FG000|Overall Study|Physician Decision|1
7933951|NCT02331680|12467552|FG001|Overall Study|Physician Decision|1
7933952|NCT02331680|12467553|FG002|Overall Study|Physician Decision|2
7933953|NCT02331680|12467551|FG000|Overall Study|Withdrawal by Subject|0
7933954|NCT02331680|12467552|FG001|Overall Study|Withdrawal by Subject|1
7933955|NCT02331680|12467553|FG002|Overall Study|Withdrawal by Subject|2
7933956|NCT02331680|12467551|FG000|Overall Study|Met withdrawal criteria|2
7933957|NCT02331680|12467552|FG001|Overall Study|Met withdrawal criteria|2
7933958|NCT02331680|12467553|FG002|Overall Study|Met withdrawal criteria|5
7933959|NCT02331680|12467551|FG000|Overall Study|Non-compliance with study drug|0
7933960|NCT02331680|12467552|FG001|Overall Study|Non-compliance with study drug|0
7933961|NCT02331680|12467553|FG002|Overall Study|Non-compliance with study drug|1
7933962|NCT02331680|12467551|FG000|Overall Study|Protocol Violation|0
7933963|NCT02331680|12467552|FG001|Overall Study|Protocol Violation|0
7933964|NCT02331680|12467553|FG002|Overall Study|Protocol Violation|3
7933965|NCT02332239|12467576|FG000|Overall Study|Lost to Follow-up|4
7933966|NCT02332239|12467577|FG001|Overall Study|Lost to Follow-up|6
7933967|NCT02332291|12467587|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3
7933968|NCT02332291|12467588|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5
7933969|NCT02332291|12467587|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0
7933970|NCT02332291|12467588|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4
7933971|NCT02332291|12467587|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1
7933972|NCT02332291|12467588|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0
7933973|NCT02332291|12467587|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2
7933974|NCT02332291|12467588|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7
7933975|NCT02332291|12467587|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0
7933976|NCT02332291|12467588|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1
7933977|NCT02332291|12467587|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1
7933978|NCT02332291|12467588|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0
7933979|NCT02332707|12467616|FG000|Overall Study|Adverse Event|0
7933980|NCT02332707|12467617|FG001|Overall Study|Adverse Event|0
7933981|NCT02332707|12467618|FG002|Overall Study|Adverse Event|0
7933982|NCT02332707|12467619|FG003|Overall Study|Adverse Event|0
7933983|NCT02332707|12467620|FG004|Overall Study|Adverse Event|0
7933984|NCT02332707|12467621|FG005|Overall Study|Adverse Event|0
7933985|NCT02332707|12467622|FG006|Overall Study|Adverse Event|0
7933986|NCT02332707|12467623|FG007|Overall Study|Adverse Event|0
7933987|NCT02332707|12467624|FG008|Overall Study|Adverse Event|0
7933988|NCT02332707|12467625|FG009|Overall Study|Adverse Event|0
7933989|NCT02332707|12467626|FG010|Overall Study|Adverse Event|0
7933990|NCT02332707|12467627|FG011|Overall Study|Adverse Event|0
7933991|NCT02332707|12467628|FG012|Overall Study|Adverse Event|1
7933992|NCT02332707|12467629|FG013|Overall Study|Adverse Event|0
7933993|NCT02332707|12467630|FG014|Overall Study|Adverse Event|0
7933994|NCT02332707|12467631|FG015|Overall Study|Adverse Event|0
7933995|NCT02332707|12467632|FG016|Overall Study|Adverse Event|0
7933996|NCT02332707|12467633|FG017|Overall Study|Adverse Event|0
7933997|NCT02332707|12467616|FG000|Overall Study|Lost to Follow-up|0
7933998|NCT02332707|12467617|FG001|Overall Study|Lost to Follow-up|0
7933999|NCT02332707|12467618|FG002|Overall Study|Lost to Follow-up|0
7934000|NCT02332707|12467619|FG003|Overall Study|Lost to Follow-up|0
7934001|NCT02332707|12467620|FG004|Overall Study|Lost to Follow-up|0
7934002|NCT02332707|12467621|FG005|Overall Study|Lost to Follow-up|1
7934003|NCT02332707|12467622|FG006|Overall Study|Lost to Follow-up|0
7934004|NCT02332707|12467623|FG007|Overall Study|Lost to Follow-up|0
7934005|NCT02332707|12467624|FG008|Overall Study|Lost to Follow-up|0
7934006|NCT02332707|12467625|FG009|Overall Study|Lost to Follow-up|0
7934007|NCT02332707|12467626|FG010|Overall Study|Lost to Follow-up|2
7934008|NCT02332707|12467627|FG011|Overall Study|Lost to Follow-up|0
7934009|NCT02332707|12467628|FG012|Overall Study|Lost to Follow-up|3
7934010|NCT02332707|12467629|FG013|Overall Study|Lost to Follow-up|0
7934011|NCT02332707|12467630|FG014|Overall Study|Lost to Follow-up|0
7934012|NCT02332707|12467631|FG015|Overall Study|Lost to Follow-up|0
7934013|NCT02332707|12467632|FG016|Overall Study|Lost to Follow-up|0
7934014|NCT02332707|12467633|FG017|Overall Study|Lost to Follow-up|0
7934015|NCT02332707|12467616|FG000|Overall Study|Physician Decision|0
7934016|NCT02332707|12467617|FG001|Overall Study|Physician Decision|0
7934017|NCT02332707|12467618|FG002|Overall Study|Physician Decision|0
7934018|NCT02332707|12467619|FG003|Overall Study|Physician Decision|1
7934019|NCT02332707|12467620|FG004|Overall Study|Physician Decision|0
7934020|NCT02332707|12467621|FG005|Overall Study|Physician Decision|0
7934021|NCT02332707|12467622|FG006|Overall Study|Physician Decision|0
7934022|NCT02332707|12467623|FG007|Overall Study|Physician Decision|0
7934023|NCT02332707|12467624|FG008|Overall Study|Physician Decision|0
7934024|NCT02332707|12467625|FG009|Overall Study|Physician Decision|0
7934025|NCT02332707|12467626|FG010|Overall Study|Physician Decision|0
7934026|NCT02332707|12467627|FG011|Overall Study|Physician Decision|0
7934027|NCT02332707|12467628|FG012|Overall Study|Physician Decision|1
7934028|NCT02332707|12467629|FG013|Overall Study|Physician Decision|0
7934029|NCT02332707|12467630|FG014|Overall Study|Physician Decision|0
7934030|NCT02332707|12467631|FG015|Overall Study|Physician Decision|0
7934031|NCT02332707|12467632|FG016|Overall Study|Physician Decision|0
7934032|NCT02332707|12467633|FG017|Overall Study|Physician Decision|0
7934033|NCT02332707|12467616|FG000|Overall Study|Withdrawal by Subject|0
7934034|NCT02332707|12467617|FG001|Overall Study|Withdrawal by Subject|0
7934035|NCT02332707|12467618|FG002|Overall Study|Withdrawal by Subject|1
7934036|NCT02332707|12467619|FG003|Overall Study|Withdrawal by Subject|0
7934037|NCT02332707|12467620|FG004|Overall Study|Withdrawal by Subject|0
7934038|NCT02332707|12467621|FG005|Overall Study|Withdrawal by Subject|0
7934039|NCT02332707|12467622|FG006|Overall Study|Withdrawal by Subject|0
7934040|NCT02332707|12467623|FG007|Overall Study|Withdrawal by Subject|0
7934041|NCT02332707|12467624|FG008|Overall Study|Withdrawal by Subject|0
7934042|NCT02332707|12467625|FG009|Overall Study|Withdrawal by Subject|3
7934043|NCT02332707|12467626|FG010|Overall Study|Withdrawal by Subject|0
7934044|NCT02332707|12467627|FG011|Overall Study|Withdrawal by Subject|0
7934045|NCT02332707|12467628|FG012|Overall Study|Withdrawal by Subject|0
7934046|NCT02332707|12467629|FG013|Overall Study|Withdrawal by Subject|0
7934047|NCT02332707|12467630|FG014|Overall Study|Withdrawal by Subject|0
7934048|NCT02332707|12467631|FG015|Overall Study|Withdrawal by Subject|0
7934049|NCT02332707|12467632|FG016|Overall Study|Withdrawal by Subject|0
7934050|NCT02332707|12467633|FG017|Overall Study|Withdrawal by Subject|0
7934051|NCT02332720|12467694|FG000|Part A and Part B|Lost to Follow-up|1
7934052|NCT02332720|12467695|FG001|Part A and Part B|Lost to Follow-up|0
7934053|NCT02332720|12467696|FG002|Part A and Part B|Lost to Follow-up|0
7934054|NCT02332720|12467697|FG003|Part A and Part B|Lost to Follow-up|0
7934055|NCT02332720|12467698|FG004|Part A and Part B|Lost to Follow-up|0
7934056|NCT02332720|12467699|FG005|Part A and Part B|Lost to Follow-up|2
7934057|NCT02332720|12467700|FG006|Part A and Part B|Lost to Follow-up|1
7934058|NCT02332720|12467701|FG007|Part A and Part B|Lost to Follow-up|1
7934059|NCT02332720|12467702|FG008|Part A and Part B|Lost to Follow-up|0
7934060|NCT02332720|12467703|FG009|Part A and Part B|Lost to Follow-up|0
7934061|NCT02332720|12467704|FG010|Part A and Part B|Lost to Follow-up|0
7934062|NCT02332720|12467705|FG011|Part A and Part B|Lost to Follow-up|0
7934063|NCT02332720|12467706|FG012|Part A and Part B|Lost to Follow-up|0
7934064|NCT02332720|12467707|FG013|Part A and Part B|Lost to Follow-up|0
7934065|NCT02332720|12467708|FG014|Part A and Part B|Lost to Follow-up|0
7934066|NCT02332720|12467709|FG015|Part A and Part B|Lost to Follow-up|1
7934067|NCT02332720|12467710|FG016|Part A and Part B|Lost to Follow-up|0
7934068|NCT02332720|12467711|FG017|Part A and Part B|Lost to Follow-up|0
7934069|NCT02332720|12467712|FG018|Part A and Part B|Lost to Follow-up|0
7934070|NCT02332720|12467713|FG019|Part A and Part B|Lost to Follow-up|0
7934071|NCT02332720|12467714|FG020|Part A and Part B|Lost to Follow-up|0
7934072|NCT02332720|12467715|FG021|Part A and Part B|Lost to Follow-up|0
7934073|NCT02332720|12467716|FG022|Part A and Part B|Lost to Follow-up|0
7934074|NCT02332720|12467694|FG000|Part A and Part B|Adverse Event|0
7934075|NCT02332720|12467695|FG001|Part A and Part B|Adverse Event|0
7934076|NCT02332720|12467696|FG002|Part A and Part B|Adverse Event|0
7934077|NCT02332720|12467697|FG003|Part A and Part B|Adverse Event|0
7934078|NCT02332720|12467698|FG004|Part A and Part B|Adverse Event|0
7934079|NCT02332720|12467699|FG005|Part A and Part B|Adverse Event|0
7934080|NCT02332720|12467700|FG006|Part A and Part B|Adverse Event|0
7934081|NCT02332720|12467701|FG007|Part A and Part B|Adverse Event|0
7934082|NCT02332720|12467702|FG008|Part A and Part B|Adverse Event|0
7934083|NCT02332720|12467703|FG009|Part A and Part B|Adverse Event|0
7934084|NCT02332720|12467704|FG010|Part A and Part B|Adverse Event|0
7934085|NCT02332720|12467705|FG011|Part A and Part B|Adverse Event|0
7934086|NCT02332720|12467706|FG012|Part A and Part B|Adverse Event|0
7934087|NCT02332720|12467707|FG013|Part A and Part B|Adverse Event|0
7934088|NCT02332720|12467708|FG014|Part A and Part B|Adverse Event|0
7934089|NCT02332720|12467709|FG015|Part A and Part B|Adverse Event|0
7934090|NCT02332720|12467710|FG016|Part A and Part B|Adverse Event|0
7934091|NCT02332720|12467711|FG017|Part A and Part B|Adverse Event|1
7934092|NCT02332720|12467712|FG018|Part A and Part B|Adverse Event|0
7934093|NCT02332720|12467713|FG019|Part A and Part B|Adverse Event|0
7934094|NCT02332720|12467714|FG020|Part A and Part B|Adverse Event|0
7934095|NCT02332720|12467715|FG021|Part A and Part B|Adverse Event|0
7934096|NCT02332720|12467716|FG022|Part A and Part B|Adverse Event|0
7934097|NCT02332720|12467694|FG000|Part A and Part B|Physician Decision|0
7934098|NCT02332720|12467695|FG001|Part A and Part B|Physician Decision|0
7934099|NCT02332720|12467696|FG002|Part A and Part B|Physician Decision|0
7934100|NCT02332720|12467697|FG003|Part A and Part B|Physician Decision|0
7934101|NCT02332720|12467698|FG004|Part A and Part B|Physician Decision|0
7934102|NCT02332720|12467699|FG005|Part A and Part B|Physician Decision|0
7934103|NCT02332720|12467700|FG006|Part A and Part B|Physician Decision|0
7934104|NCT02332720|12467701|FG007|Part A and Part B|Physician Decision|0
7934105|NCT02332720|12467702|FG008|Part A and Part B|Physician Decision|0
7934106|NCT02332720|12467703|FG009|Part A and Part B|Physician Decision|0
7934107|NCT02332720|12467704|FG010|Part A and Part B|Physician Decision|0
7934108|NCT02332720|12467705|FG011|Part A and Part B|Physician Decision|0
7934109|NCT02332720|12467706|FG012|Part A and Part B|Physician Decision|0
7934110|NCT02332720|12467707|FG013|Part A and Part B|Physician Decision|0
7934111|NCT02332720|12467708|FG014|Part A and Part B|Physician Decision|0
7934112|NCT02332720|12467709|FG015|Part A and Part B|Physician Decision|0
7934113|NCT02332720|12467710|FG016|Part A and Part B|Physician Decision|0
7934114|NCT02332720|12467711|FG017|Part A and Part B|Physician Decision|0
7934115|NCT02332720|12467712|FG018|Part A and Part B|Physician Decision|1
7934116|NCT02332720|12467713|FG019|Part A and Part B|Physician Decision|0
7934117|NCT02332720|12467714|FG020|Part A and Part B|Physician Decision|0
7934118|NCT02332720|12467715|FG021|Part A and Part B|Physician Decision|0
7934119|NCT02332720|12467716|FG022|Part A and Part B|Physician Decision|0
7934120|NCT02332720|12467694|FG000|Part A and Part B|Withdrawal by Subject|0
7934121|NCT02332720|12467695|FG001|Part A and Part B|Withdrawal by Subject|0
7934122|NCT02332720|12467696|FG002|Part A and Part B|Withdrawal by Subject|0
7934123|NCT02332720|12467697|FG003|Part A and Part B|Withdrawal by Subject|0
7934124|NCT02332720|12467698|FG004|Part A and Part B|Withdrawal by Subject|0
7934125|NCT02332720|12467699|FG005|Part A and Part B|Withdrawal by Subject|1
7934126|NCT02332720|12467700|FG006|Part A and Part B|Withdrawal by Subject|0
7934127|NCT02332720|12467701|FG007|Part A and Part B|Withdrawal by Subject|0
7934128|NCT02332720|12467702|FG008|Part A and Part B|Withdrawal by Subject|0
7934129|NCT02332720|12467703|FG009|Part A and Part B|Withdrawal by Subject|0
7934130|NCT02332720|12467704|FG010|Part A and Part B|Withdrawal by Subject|0
7934131|NCT02332720|12467705|FG011|Part A and Part B|Withdrawal by Subject|0
7934132|NCT02332720|12467706|FG012|Part A and Part B|Withdrawal by Subject|0
7934133|NCT02332720|12467707|FG013|Part A and Part B|Withdrawal by Subject|0
7934134|NCT02332720|12467708|FG014|Part A and Part B|Withdrawal by Subject|0
7934135|NCT02332720|12467709|FG015|Part A and Part B|Withdrawal by Subject|0
7934136|NCT02332720|12467710|FG016|Part A and Part B|Withdrawal by Subject|0
7934137|NCT02332720|12467711|FG017|Part A and Part B|Withdrawal by Subject|0
7934138|NCT02332720|12467712|FG018|Part A and Part B|Withdrawal by Subject|0
7934139|NCT02332720|12467713|FG019|Part A and Part B|Withdrawal by Subject|1
7934140|NCT02332720|12467714|FG020|Part A and Part B|Withdrawal by Subject|0
7934141|NCT02332720|12467715|FG021|Part A and Part B|Withdrawal by Subject|0
7934142|NCT02332720|12467716|FG022|Part A and Part B|Withdrawal by Subject|0
7934143|NCT02332798|12467781|FG000|Overall Study|Unwilling to Participate in Study|0
7934144|NCT02332798|12467782|FG001|Overall Study|Unwilling to Participate in Study|1
7934145|NCT02332798|12467783|FG002|Overall Study|Unwilling to Participate in Study|1
7934146|NCT02332798|12467781|FG000|Overall Study|Positive Urine Drug Test|0
7934147|NCT02332798|12467782|FG001|Overall Study|Positive Urine Drug Test|1
7934148|NCT02332798|12467783|FG002|Overall Study|Positive Urine Drug Test|0
7934149|NCT02332798|12467781|FG000|Overall Study|Abnormal Laboratory Findings|1
7934150|NCT02332798|12467782|FG001|Overall Study|Abnormal Laboratory Findings|0
7934151|NCT02332798|12467783|FG002|Overall Study|Abnormal Laboratory Findings|0
7934152|NCT02332824|12467797|FG000|Overall Study|Pretreatment Event/Adverse Event|4
7934153|NCT02332824|12467798|FG001|Overall Study|Pretreatment Event/Adverse Event|0
7934154|NCT02332824|12467799|FG002|Overall Study|Pretreatment Event/Adverse Event|1
7934155|NCT02332824|12467800|FG003|Overall Study|Pretreatment Event/Adverse Event|1
7934156|NCT02332824|12467801|FG004|Overall Study|Pretreatment Event/Adverse Event|4
7934157|NCT02332824|12467802|FG005|Overall Study|Pretreatment Event/Adverse Event|1
7934158|NCT02332824|12467797|FG000|Overall Study|Voluntary Withdrawal|1
7934159|NCT02332824|12467798|FG001|Overall Study|Voluntary Withdrawal|0
7934160|NCT02332824|12467799|FG002|Overall Study|Voluntary Withdrawal|0
7934161|NCT02332824|12467800|FG003|Overall Study|Voluntary Withdrawal|0
7934162|NCT02332824|12467801|FG004|Overall Study|Voluntary Withdrawal|0
7934163|NCT02332824|12467802|FG005|Overall Study|Voluntary Withdrawal|0
7934164|NCT02332824|12467797|FG000|Overall Study|Inconvenient schedule|1
7934165|NCT02332824|12467798|FG001|Overall Study|Inconvenient schedule|1
7934166|NCT02332824|12467799|FG002|Overall Study|Inconvenient schedule|0
7934167|NCT02332824|12467800|FG003|Overall Study|Inconvenient schedule|0
7934168|NCT02332824|12467801|FG004|Overall Study|Inconvenient schedule|0
7934169|NCT02332824|12467802|FG005|Overall Study|Inconvenient schedule|0
7934170|NCT02332824|12467797|FG000|Overall Study|Transfer|0
7934171|NCT02332824|12467798|FG001|Overall Study|Transfer|0
7934172|NCT02332824|12467799|FG002|Overall Study|Transfer|1
7934173|NCT02332824|12467800|FG003|Overall Study|Transfer|1
7934174|NCT02332824|12467801|FG004|Overall Study|Transfer|0
7934175|NCT02332824|12467802|FG005|Overall Study|Transfer|0
7934176|NCT02332876|12467827|FG000|Overall Study|Lost to Follow-up|1
7934177|NCT02332876|12467828|FG001|Overall Study|Lost to Follow-up|1
7934178|NCT02332889|12467834|FG000|Overall Study|Physician Decision|1
7964827|NCT01084252|12520459|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7964828|NCT01084252|12520460|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7964829|NCT01084252|12520461|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7964830|NCT01084252|12520462|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7964831|NCT01084252|12520463|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7934179|NCT02333331|12467869|FG000|Overall Study|Adverse Event|1
7934180|NCT02333331|12467870|FG001|Overall Study|Adverse Event|0
7934181|NCT02333331|12467871|FG002|Overall Study|Adverse Event|4
7934182|NCT02333331|12467872|FG003|Overall Study|Adverse Event|1
7934183|NCT02333331|12467869|FG000|Overall Study|Death|0
7934184|NCT02333331|12467870|FG001|Overall Study|Death|0
7934185|NCT02333331|12467871|FG002|Overall Study|Death|2
7934186|NCT02333331|12467872|FG003|Overall Study|Death|0
7934187|NCT02333331|12467869|FG000|Overall Study|Lost to Follow-up|0
7934188|NCT02333331|12467870|FG001|Overall Study|Lost to Follow-up|0
7934189|NCT02333331|12467871|FG002|Overall Study|Lost to Follow-up|1
7934190|NCT02333331|12467872|FG003|Overall Study|Lost to Follow-up|0
7934191|NCT02333331|12467869|FG000|Overall Study|Physician Decision|0
7934192|NCT02333331|12467870|FG001|Overall Study|Physician Decision|1
7934193|NCT02333331|12467871|FG002|Overall Study|Physician Decision|0
7934194|NCT02333331|12467872|FG003|Overall Study|Physician Decision|0
7934195|NCT02333331|12467869|FG000|Overall Study|Protocol Deviation|0
7934196|NCT02333331|12467870|FG001|Overall Study|Protocol Deviation|3
7934197|NCT02333331|12467871|FG002|Overall Study|Protocol Deviation|2
7934198|NCT02333331|12467872|FG003|Overall Study|Protocol Deviation|1
7934199|NCT02333331|12467869|FG000|Overall Study|Patient/Guardian Decision|1
7934200|NCT02333331|12467870|FG001|Overall Study|Patient/Guardian Decision|2
7934201|NCT02333331|12467871|FG002|Overall Study|Patient/Guardian Decision|9
7934202|NCT02333331|12467872|FG003|Overall Study|Patient/Guardian Decision|1
7934203|NCT02333383|12467882|FG000|Overall Study|Adalimumab discontinuation|21
7934204|NCT02333383|12467882|FG000|Overall Study|Lost to Follow-up|15
7934205|NCT02333383|12467882|FG000|Overall Study|Withdrawal by Subject|3
7934206|NCT02333383|12467882|FG000|Overall Study|Transfer to another hospital|2
7934207|NCT02333487|12467889|FG000|Overall Study|Adverse Event|0
7934208|NCT02333487|12467890|FG001|Overall Study|Adverse Event|2
7934209|NCT02333487|12467891|FG002|Overall Study|Adverse Event|0
7934210|NCT02333630|12467902|FG000|Overall Study|Lost to Follow-up|5
7934211|NCT02333630|12467903|FG001|Overall Study|Lost to Follow-up|2
7934212|NCT02334215|12467929|FG000|Overall Study|Death|1
7934213|NCT02334215|12467930|FG001|Overall Study|Death|1
7934214|NCT02334215|12467931|FG002|Overall Study|Death|0
7934215|NCT02334215|12467929|FG000|Overall Study|Lost to Follow-up|1
7934216|NCT02334215|12467930|FG001|Overall Study|Lost to Follow-up|0
7934217|NCT02334215|12467931|FG002|Overall Study|Lost to Follow-up|4
7934218|NCT02334215|12467929|FG000|Overall Study|Withdrawal by Subject|2
7934219|NCT02334215|12467930|FG001|Overall Study|Withdrawal by Subject|2
7934220|NCT02334215|12467931|FG002|Overall Study|Withdrawal by Subject|1
7934221|NCT02334215|12467929|FG000|Overall Study|Not released from incarceration on time|3
7934222|NCT02334215|12467930|FG001|Overall Study|Not released from incarceration on time|3
7934223|NCT02334215|12467931|FG002|Overall Study|Not released from incarceration on time|3
7934224|NCT02334215|12467929|FG000|Overall Study|Incarcerated|0
7934225|NCT02334215|12467930|FG001|Overall Study|Incarcerated|0
7934226|NCT02334215|12467931|FG002|Overall Study|Incarcerated|7
7934227|NCT02334306|12467956|FG000|Double-blind Period|Adverse Event|0
7934228|NCT02334306|12467957|FG001|Double-blind Period|Adverse Event|1
7934229|NCT02334306|12467956|FG000|Double-blind Period|Withdrawal by Subject|1
7934230|NCT02334306|12467957|FG001|Double-blind Period|Withdrawal by Subject|1
7934231|NCT02334384|12467970|FG000|Overall Study|Lost to Follow-up|1
7934232|NCT02334384|12467971|FG001|Overall Study|Lost to Follow-up|1
7934233|NCT02334423|12467979|FG000|Overall Study|Protocol Violation|10
7934234|NCT02334423|12467980|FG001|Overall Study|Protocol Violation|3
7934235|NCT02334683|12468005|FG000|First 12 Week Period|Lost to Follow-up|1
7934236|NCT02334683|12468006|FG001|First 12 Week Period|Lost to Follow-up|0
7934237|NCT02334683|12468005|FG000|Second 12 Week Period|Adverse Event|0
7934238|NCT02334683|12468006|FG001|Second 12 Week Period|Adverse Event|1
7934239|NCT02334748|12468012|FG000|Overall Study|Adverse Event|1
7934240|NCT02334748|12468012|FG000|Overall Study|Inclusion in the CACZ8852306 study|1
7934241|NCT02334748|12468012|FG000|Overall Study|Patient no longer required study drug|2
7934242|NCT02334748|12468012|FG000|Overall Study|Lack of Efficacy|4
7934243|NCT02335346|12468147|FG000|Overall Study|Adverse Event|11
7934244|NCT02335346|12468147|FG000|Overall Study|Withdrawal by Subject|1
7934245|NCT02335450|12468151|FG000|Overall Study|Pregnancy|1
7934246|NCT02335489|12468161|FG000|Overall Study|Sponsor terminated study|4
7934247|NCT02335489|12468161|FG000|Overall Study|Lost to Follow-up|1
7934248|NCT02335489|12468161|FG000|Overall Study|Withdrawal by Subject|2
7934249|NCT02335489|12468161|FG000|Overall Study|Physician Decision|2
7934250|NCT02335489|12468161|FG000|Overall Study|Lack of Efficacy|1
7934251|NCT02335983|12468188|FG000|Overall Study|Sponsor Decision|0
7934252|NCT02335983|12468189|FG001|Overall Study|Sponsor Decision|0
7934253|NCT02335983|12468190|FG002|Overall Study|Sponsor Decision|1
7934254|NCT02335983|12468191|FG003|Overall Study|Sponsor Decision|1
7934255|NCT02335983|12468192|FG004|Overall Study|Sponsor Decision|0
7934256|NCT02335983|12468193|FG005|Overall Study|Sponsor Decision|1
7934257|NCT02335983|12468188|FG000|Overall Study|Withdrawal by Subject|3
7934258|NCT02335983|12468189|FG001|Overall Study|Withdrawal by Subject|2
7934259|NCT02335983|12468190|FG002|Overall Study|Withdrawal by Subject|2
7934260|NCT02335983|12468191|FG003|Overall Study|Withdrawal by Subject|1
7934261|NCT02335983|12468192|FG004|Overall Study|Withdrawal by Subject|3
7934262|NCT02335983|12468193|FG005|Overall Study|Withdrawal by Subject|9
7934263|NCT02335983|12468188|FG000|Overall Study|Death|0
7934264|NCT02335983|12468189|FG001|Overall Study|Death|0
7934265|NCT02335983|12468190|FG002|Overall Study|Death|2
7934266|NCT02335983|12468191|FG003|Overall Study|Death|0
7934267|NCT02335983|12468192|FG004|Overall Study|Death|0
7934268|NCT02335983|12468193|FG005|Overall Study|Death|0
7934269|NCT02335983|12468188|FG000|Overall Study|Lost to Follow-up|0
7934270|NCT02335983|12468189|FG001|Overall Study|Lost to Follow-up|0
7934271|NCT02335983|12468190|FG002|Overall Study|Lost to Follow-up|0
7934272|NCT02335983|12468191|FG003|Overall Study|Lost to Follow-up|0
7934273|NCT02335983|12468192|FG004|Overall Study|Lost to Follow-up|0
7934274|NCT02335983|12468193|FG005|Overall Study|Lost to Follow-up|1
7934275|NCT02335983|12468188|FG000|Overall Study|Protocol Specified Criteria|5
7934276|NCT02335983|12468189|FG001|Overall Study|Protocol Specified Criteria|7
7934277|NCT02335983|12468190|FG002|Overall Study|Protocol Specified Criteria|27
7934278|NCT02335983|12468191|FG003|Overall Study|Protocol Specified Criteria|7
7934279|NCT02335983|12468192|FG004|Overall Study|Protocol Specified Criteria|5
7934280|NCT02335983|12468193|FG005|Overall Study|Protocol Specified Criteria|21
7934281|NCT02336074|12468218|FG000|Overall Study|Adverse Event|0
7934282|NCT02336074|12468219|FG001|Overall Study|Adverse Event|2
7934283|NCT02336165|12468235|FG000|Overall Study|Death|3
7934284|NCT02336165|12468236|FG001|Overall Study|Death|0
7934285|NCT02336165|12468237|FG002|Overall Study|Death|0
7934286|NCT02336165|12468238|FG003|Overall Study|Death|0
7934287|NCT02336165|12468239|FG004|Overall Study|Death|1
7934288|NCT02336165|12468235|FG000|Overall Study|Physician Decision|2
7934289|NCT02336165|12468236|FG001|Overall Study|Physician Decision|2
7934290|NCT02336165|12468237|FG002|Overall Study|Physician Decision|1
7934291|NCT02336165|12468238|FG003|Overall Study|Physician Decision|1
7934292|NCT02336165|12468239|FG004|Overall Study|Physician Decision|0
7934293|NCT02336165|12468235|FG000|Overall Study|Withdrawal by Subject|0
7934294|NCT02336165|12468236|FG001|Overall Study|Withdrawal by Subject|0
7934295|NCT02336165|12468237|FG002|Overall Study|Withdrawal by Subject|1
7934296|NCT02336165|12468238|FG003|Overall Study|Withdrawal by Subject|0
7934297|NCT02336165|12468239|FG004|Overall Study|Withdrawal by Subject|1
7934298|NCT02336165|12468235|FG000|Overall Study|Adverse Event|4
7934299|NCT02336165|12468236|FG001|Overall Study|Adverse Event|1
7934300|NCT02336165|12468237|FG002|Overall Study|Adverse Event|2
7934301|NCT02336165|12468238|FG003|Overall Study|Adverse Event|4
7934302|NCT02336165|12468239|FG004|Overall Study|Adverse Event|1
7934303|NCT02336165|12468235|FG000|Overall Study|Progressive disease|23
7934304|NCT02336165|12468236|FG001|Overall Study|Progressive disease|22
7934305|NCT02336165|12468237|FG002|Overall Study|Progressive disease|27
7934306|NCT02336165|12468238|FG003|Overall Study|Progressive disease|24
7934307|NCT02336165|12468239|FG004|Overall Study|Progressive disease|19
7934308|NCT02336165|12468235|FG000|Overall Study|Non-compliance|1
7934309|NCT02336165|12468236|FG001|Overall Study|Non-compliance|0
7934310|NCT02336165|12468237|FG002|Overall Study|Non-compliance|0
7934311|NCT02336165|12468238|FG003|Overall Study|Non-compliance|1
7934312|NCT02336165|12468239|FG004|Overall Study|Non-compliance|0
7934313|NCT02336165|12468235|FG000|Overall Study|Other|1
7934314|NCT02336165|12468236|FG001|Overall Study|Other|0
7934315|NCT02336165|12468237|FG002|Overall Study|Other|0
7934316|NCT02336165|12468238|FG003|Overall Study|Other|1
7934317|NCT02336165|12468239|FG004|Overall Study|Other|0
7934318|NCT02336178|12468255|FG000|Overall Study|Lost to Follow-up|1
7934319|NCT02336178|12468255|FG000|Overall Study|Protocol Violation|1
7934320|NCT02336178|12468255|FG000|Overall Study|Withdrawal by Subject|1
7934321|NCT02336178|12468255|FG000|Overall Study|Other|1
7934322|NCT02336282|12468267|FG000|Overall Study|Unrelated illness|1
7934323|NCT02336282|12468267|FG000|Overall Study|Uncomfortable with technology|1
7934324|NCT02336282|12468267|FG000|Overall Study|Lost to Follow-up|1
7934325|NCT02336282|12468267|FG000|Overall Study|Not enough time to complete sessions|2
7934326|NCT02336373|12468283|FG000|Overall Study|Protocol closed early|4
7934327|NCT02336373|12468283|FG000|Overall Study|Physician Decision|14
7934328|NCT02336451|12468298|FG000|Overall Study|Adverse Event|1
7934329|NCT02336451|12468299|FG001|Overall Study|Adverse Event|2
7934330|NCT02336451|12468300|FG002|Overall Study|Adverse Event|0
7934331|NCT02336451|12468301|FG003|Overall Study|Adverse Event|6
7934332|NCT02336451|12468302|FG004|Overall Study|Adverse Event|4
7934333|NCT02336451|12468298|FG000|Overall Study|Death|6
7934334|NCT02336451|12468299|FG001|Overall Study|Death|2
7934335|NCT02336451|12468300|FG002|Overall Study|Death|3
7934336|NCT02336451|12468301|FG003|Overall Study|Death|6
7934337|NCT02336451|12468302|FG004|Overall Study|Death|6
7934338|NCT02336451|12468298|FG000|Overall Study|Physician Decision|9
7934339|NCT02336451|12468299|FG001|Overall Study|Physician Decision|6
7934340|NCT02336451|12468300|FG002|Overall Study|Physician Decision|7
7934341|NCT02336451|12468301|FG003|Overall Study|Physician Decision|16
7934342|NCT02336451|12468302|FG004|Overall Study|Physician Decision|3
7934343|NCT02336451|12468298|FG000|Overall Study|Progressive disease|23
7934344|NCT02336451|12468299|FG001|Overall Study|Progressive disease|26
7934345|NCT02336451|12468300|FG002|Overall Study|Progressive disease|2
7934346|NCT02336451|12468301|FG003|Overall Study|Progressive disease|14
7934347|NCT02336451|12468302|FG004|Overall Study|Progressive disease|4
7934348|NCT02336451|12468298|FG000|Overall Study|Protocol Violation|1
7934349|NCT02336451|12468299|FG001|Overall Study|Protocol Violation|0
7934350|NCT02336451|12468300|FG002|Overall Study|Protocol Violation|0
7934351|NCT02336451|12468301|FG003|Overall Study|Protocol Violation|0
7934352|NCT02336451|12468302|FG004|Overall Study|Protocol Violation|0
7934353|NCT02336451|12468298|FG000|Overall Study|Patient/guardian decision|2
7934354|NCT02336451|12468299|FG001|Overall Study|Patient/guardian decision|4
7934355|NCT02336451|12468300|FG002|Overall Study|Patient/guardian decision|0
7934356|NCT02336451|12468301|FG003|Overall Study|Patient/guardian decision|2
7934357|NCT02336451|12468302|FG004|Overall Study|Patient/guardian decision|1
7934358|NCT02336555|12468318|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7934359|NCT02336555|12468319|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7934360|NCT02336555|12468318|FG000|Treatment Period 1 (28 Days)|Physician Decision|2
7934361|NCT02336555|12468319|FG001|Treatment Period 1 (28 Days)|Physician Decision|0
7934362|NCT02336555|12468318|FG000|Treatment Period 2 (28 Days)|Adverse Event|0
7934363|NCT02336555|12468319|FG001|Treatment Period 2 (28 Days)|Adverse Event|1
7934364|NCT02336607|12468349|FG000|Overall Study|Physician Decision|1
7934365|NCT02336607|12468350|FG001|Overall Study|Physician Decision|4
7934366|NCT02336607|12468351|FG002|Overall Study|Physician Decision|3
7934367|NCT02336607|12468352|FG003|Overall Study|Physician Decision|15
7934368|NCT02336607|12468349|FG000|Overall Study|Lack of Efficacy|1
7934369|NCT02336607|12468350|FG001|Overall Study|Lack of Efficacy|0
7934370|NCT02336607|12468351|FG002|Overall Study|Lack of Efficacy|0
7934371|NCT02336607|12468352|FG003|Overall Study|Lack of Efficacy|2
7934372|NCT02336607|12468349|FG000|Overall Study|Lost to Follow-up|2
7934373|NCT02336607|12468350|FG001|Overall Study|Lost to Follow-up|1
7934374|NCT02336607|12468351|FG002|Overall Study|Lost to Follow-up|0
7934375|NCT02336607|12468352|FG003|Overall Study|Lost to Follow-up|21
7934376|NCT02336607|12468349|FG000|Overall Study|Protocol Violation|0
7934377|NCT02336607|12468350|FG001|Overall Study|Protocol Violation|1
7934378|NCT02336607|12468351|FG002|Overall Study|Protocol Violation|1
7934379|NCT02336607|12468352|FG003|Overall Study|Protocol Violation|3
7934380|NCT02336607|12468349|FG000|Overall Study|Adverse Event|0
7934381|NCT02336607|12468350|FG001|Overall Study|Adverse Event|2
7934382|NCT02336607|12468351|FG002|Overall Study|Adverse Event|2
7934383|NCT02336607|12468352|FG003|Overall Study|Adverse Event|26
7934384|NCT02336607|12468349|FG000|Overall Study|Withdrawal by Subject|0
7934385|NCT02336607|12468350|FG001|Overall Study|Withdrawal by Subject|2
7934386|NCT02336607|12468351|FG002|Overall Study|Withdrawal by Subject|0
7934387|NCT02336607|12468352|FG003|Overall Study|Withdrawal by Subject|20
7934388|NCT02336737|12468362|FG000|Overall Study|Withdrawal by Subject|5
7934389|NCT02336737|12468362|FG000|Overall Study|Physician Decision|8
7934390|NCT02336815|12468369|FG000|Overall Study|Disease Progression|45
7934391|NCT02336815|12468370|FG001|Overall Study|Disease Progression|70
7934392|NCT02336815|12468369|FG000|Overall Study|Adverse Event|18
7934393|NCT02336815|12468370|FG001|Overall Study|Adverse Event|39
7934394|NCT02336815|12468369|FG000|Overall Study|Physician Decision|11
7934395|NCT02336815|12468370|FG001|Overall Study|Physician Decision|4
7934396|NCT02336815|12468369|FG000|Overall Study|Withdrawal by Subject|3
7934397|NCT02336815|12468370|FG001|Overall Study|Withdrawal by Subject|2
7934398|NCT02336815|12468369|FG000|Overall Study|Lost to Follow-up|1
7934399|NCT02336815|12468370|FG001|Overall Study|Lost to Follow-up|3
7934400|NCT02336815|12468369|FG000|Overall Study|Other|1
7934401|NCT02336815|12468370|FG001|Overall Study|Other|5
7934402|NCT02337361|12468409|FG000|3-month Follow-up|Lost to Follow-up|19
7934403|NCT02337361|12468410|FG001|3-month Follow-up|Lost to Follow-up|14
7934404|NCT02337361|12468409|FG000|6-month Follow-up|Lost to Follow-up|2
7934405|NCT02337361|12468410|FG001|6-month Follow-up|Lost to Follow-up|4
7934406|NCT02337387|12468421|FG000|Overall Study|Adverse Event|0
7934407|NCT02337387|12468422|FG001|Overall Study|Adverse Event|1
7934408|NCT02337387|12468423|FG002|Overall Study|Adverse Event|0
7934409|NCT02337387|12468424|FG003|Overall Study|Adverse Event|0
7934410|NCT02337387|12468421|FG000|Overall Study|Sponsor Decision to Terminate Study|14
7934411|NCT02337387|12468422|FG001|Overall Study|Sponsor Decision to Terminate Study|7
7934412|NCT02337387|12468423|FG002|Overall Study|Sponsor Decision to Terminate Study|3
7934413|NCT02337387|12468424|FG003|Overall Study|Sponsor Decision to Terminate Study|3
7934414|NCT02337478|12468438|FG000|Overall Study|Lack of Efficacy|5
7934415|NCT02337491|12468444|FG000|Overall Study|Death|1
7934416|NCT02337491|12468445|FG001|Overall Study|Death|1
7934417|NCT02337491|12468444|FG000|Overall Study|Adverse Event|0
7934418|NCT02337491|12468445|FG001|Overall Study|Adverse Event|1
7934419|NCT02337491|12468444|FG000|Overall Study|Withdrawal by Subject|3
7934420|NCT02337491|12468445|FG001|Overall Study|Withdrawal by Subject|0
7934421|NCT02337491|12468444|FG000|Overall Study|Progressive Disease|44
7934422|NCT02337491|12468445|FG001|Overall Study|Progressive Disease|28
7934423|NCT02337491|12468444|FG000|Overall Study|On Treatment|2
7934424|NCT02337491|12468445|FG001|Overall Study|On Treatment|0
7934425|NCT02337907|12468475|FG000|Overall Study|Other than listed|1
7934426|NCT02337907|12468476|FG001|Overall Study|Other than listed|0
7934427|NCT02337907|12468477|FG002|Overall Study|Other than listed|0
7934428|NCT02337907|12468478|FG003|Overall Study|Other than listed|1
7934429|NCT02337907|12468479|FG004|Overall Study|Other than listed|1
7934430|NCT02337907|12468480|FG005|Overall Study|Other than listed|0
7934431|NCT02337907|12468475|FG000|Overall Study|Withdrawal by Subject|2
7934432|NCT02337907|12468476|FG001|Overall Study|Withdrawal by Subject|3
7934433|NCT02337907|12468477|FG002|Overall Study|Withdrawal by Subject|0
7934434|NCT02337907|12468478|FG003|Overall Study|Withdrawal by Subject|2
7934435|NCT02337907|12468479|FG004|Overall Study|Withdrawal by Subject|5
7934436|NCT02337907|12468480|FG005|Overall Study|Withdrawal by Subject|0
7934437|NCT02337907|12468475|FG000|Overall Study|Lost to Follow-up|0
7934438|NCT02337907|12468476|FG001|Overall Study|Lost to Follow-up|0
7934439|NCT02337907|12468477|FG002|Overall Study|Lost to Follow-up|0
7934440|NCT02337907|12468478|FG003|Overall Study|Lost to Follow-up|0
7934441|NCT02337907|12468479|FG004|Overall Study|Lost to Follow-up|0
7934442|NCT02337907|12468480|FG005|Overall Study|Lost to Follow-up|1
7934443|NCT02337907|12468475|FG000|Overall Study|Adverse Event|1
7934444|NCT02337907|12468476|FG001|Overall Study|Adverse Event|1
7934445|NCT02337907|12468477|FG002|Overall Study|Adverse Event|1
7934446|NCT02337907|12468478|FG003|Overall Study|Adverse Event|1
7934447|NCT02337907|12468479|FG004|Overall Study|Adverse Event|4
7934448|NCT02337907|12468480|FG005|Overall Study|Adverse Event|0
7934449|NCT02337946|12468504|FG000|Protocol Treatment 1 Period|Adverse Event|7
7934450|NCT02337946|12468505|FG001|Protocol Treatment 1 Period|Adverse Event|0
7934451|NCT02337946|12468506|FG002|Protocol Treatment 1 Period|Adverse Event|0
7934452|NCT02337946|12468504|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1
7934453|NCT02337946|12468505|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0
7934454|NCT02337946|12468506|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0
7934455|NCT02337946|12468504|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6
7934456|NCT02337946|12468505|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0
7934457|NCT02337946|12468506|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0
7934458|NCT02337946|12468504|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15
7934459|NCT02337946|12468505|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0
7934460|NCT02337946|12468506|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0
7934461|NCT02337946|12468504|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3
7934462|NCT02337946|12468505|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0
7934463|NCT02337946|12468506|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0
7934464|NCT02337946|12468504|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9
7934465|NCT02337946|12468505|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
7934466|NCT02337946|12468506|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
7934467|NCT02337946|12468504|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1
7934468|NCT02337946|12468505|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
7934469|NCT02337946|12468506|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
7934470|NCT02337946|12468504|FG000|Protocol Treatment 1 Period|Reason not specified|8
7934471|NCT02337946|12468505|FG001|Protocol Treatment 1 Period|Reason not specified|0
7934472|NCT02337946|12468506|FG002|Protocol Treatment 1 Period|Reason not specified|0
7934473|NCT02337946|12468504|FG000|In-between Period|Without Informed Consent|1
7934474|NCT02337946|12468505|FG001|In-between Period|Without Informed Consent|0
7934475|NCT02337946|12468506|FG002|In-between Period|Without Informed Consent|0
7934476|NCT02337946|12468504|FG000|Protocol Treatment 2 Period|Adverse Event|0
7934477|NCT02337946|12468505|FG001|Protocol Treatment 2 Period|Adverse Event|9
7934478|NCT02337946|12468506|FG002|Protocol Treatment 2 Period|Adverse Event|9
7934479|NCT02337946|12468504|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0
7934480|NCT02337946|12468505|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3
7934481|NCT02337946|12468506|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1
7934482|NCT02337946|12468504|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0
7934483|NCT02337946|12468505|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29
7934484|NCT02337946|12468506|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29
7934485|NCT02337946|12468504|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0
7934486|NCT02337946|12468505|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1
7934487|NCT02337946|12468506|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0
7934488|NCT02337946|12468504|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0
7934489|NCT02337946|12468505|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5
7934490|NCT02337946|12468506|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7
7934491|NCT02337946|12468504|FG000|Protocol Treatment 2 Period|Reason not specified|0
7934492|NCT02337946|12468505|FG001|Protocol Treatment 2 Period|Reason not specified|4
7934493|NCT02337946|12468506|FG002|Protocol Treatment 2 Period|Reason not specified|4
7934494|NCT02338154|12468531|FG000|Overall Study|Death|46
7934495|NCT02338154|12468531|FG000|Overall Study|Valve Implant Failure|17
7934496|NCT02338154|12468531|FG000|Overall Study|Valve Explant|11
7934497|NCT02338154|12468531|FG000|Overall Study|Withdrawal by Subject or by Investigator|10
7934498|NCT02338154|12468531|FG000|Overall Study|Lost to Follow-up|8
7934499|NCT02338154|12468531|FG000|Overall Study|Other Reason|3
7934500|NCT02338154|12468531|FG000|Overall Study|Patients Without Exit Form|47
7934501|NCT02338154|12468531|FG000|Overall Study|Missing Exit Reason on Exit Form|1
7934502|NCT02338193|12468546|FG000|Overall Study|Withdrawal by Subject|0
7934503|NCT02338193|12468547|FG001|Overall Study|Withdrawal by Subject|0
7934504|NCT02338193|12468548|FG002|Overall Study|Withdrawal by Subject|2
7934505|NCT02338193|12468546|FG000|Overall Study|Pregnancy|0
7934506|NCT02338193|12468547|FG001|Overall Study|Pregnancy|1
7934507|NCT02338193|12468548|FG002|Overall Study|Pregnancy|1
7934508|NCT02338193|12468546|FG000|Overall Study|Noncompliant with visits|2
7934509|NCT02338193|12468547|FG001|Overall Study|Noncompliant with visits|2
7934510|NCT02338193|12468548|FG002|Overall Study|Noncompliant with visits|7
7934511|NCT02338193|12468546|FG000|Overall Study|moved out of state|0
7934512|NCT02338193|12468547|FG001|Overall Study|moved out of state|1
7934513|NCT02338193|12468548|FG002|Overall Study|moved out of state|0
7934514|NCT02338193|12468546|FG000|Overall Study|intolerant of side effects|1
7934515|NCT02338193|12468547|FG001|Overall Study|intolerant of side effects|0
7934516|NCT02338193|12468548|FG002|Overall Study|intolerant of side effects|0
7934517|NCT02338362|12468569|FG000|Overall Study|Withdrawal by Subject|1
7934518|NCT02338362|12468570|FG001|Overall Study|Withdrawal by Subject|1
7934519|NCT02338492|12468576|FG000|Overall Study|Death|32
7934520|NCT02338492|12468576|FG000|Overall Study|Adverse Event|3
7934521|NCT02338492|12468576|FG000|Overall Study|Lost to Follow-up|4
7934522|NCT02338492|12468576|FG000|Overall Study|Reason not captured above|6
7934523|NCT02338843|12468588|FG000|Overall Study|Adverse Event|2
7934524|NCT02338843|12468589|FG001|Overall Study|Adverse Event|1
7934525|NCT02338843|12468588|FG000|Overall Study|Death|40
7934526|NCT02338843|12468589|FG001|Overall Study|Death|53
7934527|NCT02338843|12468588|FG000|Overall Study|Physician Decision|1
7934528|NCT02338843|12468589|FG001|Overall Study|Physician Decision|0
7934529|NCT02338843|12468588|FG000|Overall Study|Withdrawal by Subject|0
7934530|NCT02338843|12468589|FG001|Overall Study|Withdrawal by Subject|2
7934531|NCT02338843|12468588|FG000|Overall Study|Subject Recovered|0
7934532|NCT02338843|12468589|FG001|Overall Study|Subject Recovered|2
7934533|NCT02338843|12468588|FG000|Overall Study|Discontinued prior to randomizat|1
7934534|NCT02338843|12468589|FG001|Overall Study|Discontinued prior to randomizat|0
7934535|NCT02338882|12468597|FG000|Overall Study|Death|1
7934536|NCT02338882|12468598|FG001|Overall Study|Death|0
7934537|NCT02338882|12468597|FG000|Overall Study|Lost to Follow-up|6
7934538|NCT02338882|12468598|FG001|Overall Study|Lost to Follow-up|3
7934539|NCT02338999|12468704|FG000|First Intervention|Withdrawal by Subject|3
7934540|NCT02338999|12468705|FG001|First Intervention|Withdrawal by Subject|1
7934541|NCT02338999|12468704|FG000|Washout Period|Withdrawal by Subject|0
7934542|NCT02338999|12468705|FG001|Washout Period|Withdrawal by Subject|2
7934543|NCT02338999|12468704|FG000|Second Intervention|Withdrawal by Subject|0
7934544|NCT02338999|12468705|FG001|Second Intervention|Withdrawal by Subject|2
7934545|NCT02339155|12468717|FG000|Overall Study|Adverse Event|0
7934546|NCT02339155|12468718|FG001|Overall Study|Adverse Event|6
7934547|NCT02339155|12468717|FG000|Overall Study|Death|1
7934548|NCT02339155|12468718|FG001|Overall Study|Death|1
7934549|NCT02339155|12468717|FG000|Overall Study|Lost to Follow-up|8
7934550|NCT02339155|12468718|FG001|Overall Study|Lost to Follow-up|9
7934551|NCT02339155|12468717|FG000|Overall Study|Physician Decision|2
7934552|NCT02339155|12468718|FG001|Overall Study|Physician Decision|1
7934553|NCT02339155|12468717|FG000|Overall Study|Withdrawal by Subject|4
7934554|NCT02339155|12468718|FG001|Overall Study|Withdrawal by Subject|4
7934555|NCT02339285|12468741|FG000|Overall Study|Withdrawal by Subject|0
7934556|NCT02339285|12468742|FG001|Overall Study|Withdrawal by Subject|1
7934557|NCT02339285|12468743|FG002|Overall Study|Withdrawal by Subject|1
7934558|NCT02339285|12468741|FG000|Overall Study|Lost to Follow-up|1
7934559|NCT02339285|12468742|FG001|Overall Study|Lost to Follow-up|1
7934560|NCT02339285|12468743|FG002|Overall Study|Lost to Follow-up|1
7934561|NCT02339285|12468741|FG000|Overall Study|Protocol Deviation|0
7934562|NCT02339285|12468742|FG001|Overall Study|Protocol Deviation|1
7934563|NCT02339285|12468743|FG002|Overall Study|Protocol Deviation|0
7934564|NCT02339584|12468778|FG000|Overall Study|Adverse Event|11
7934565|NCT02339584|12468779|FG001|Overall Study|Adverse Event|7
7934566|NCT02339584|12468778|FG000|Overall Study|Lack of Efficacy|0
7934567|NCT02339584|12468779|FG001|Overall Study|Lack of Efficacy|1
7934568|NCT02339584|12468778|FG000|Overall Study|Physician Decision|1
7934569|NCT02339584|12468779|FG001|Overall Study|Physician Decision|2
7934570|NCT02339584|12468778|FG000|Overall Study|Protocol Violation|1
7934571|NCT02339584|12468779|FG001|Overall Study|Protocol Violation|1
7934572|NCT02339584|12468778|FG000|Overall Study|Withdrawal by Subject|2
7934573|NCT02339584|12468779|FG001|Overall Study|Withdrawal by Subject|4
7934574|NCT02339909|12468797|FG000|Overall Study|Became ineligible after randomisation|89
7934575|NCT02339909|12468798|FG001|Overall Study|Became ineligible after randomisation|63
7934576|NCT02339909|12468799|FG002|Overall Study|Became ineligible after randomisation|71
7934577|NCT02340000|12468809|FG000|Time Period 1|Withdrawal by Subject|6
7934578|NCT02340000|12468810|FG001|Time Period 1|Withdrawal by Subject|8
7934579|NCT02340000|12468809|FG000|Time Period 1|Lost to Follow-up|6
7934580|NCT02340000|12468810|FG001|Time Period 1|Lost to Follow-up|7
7934581|NCT02340000|12468809|FG000|Time Period 2|Withdrawal by Subject|9
7934582|NCT02340000|12468810|FG001|Time Period 2|Withdrawal by Subject|7
7934583|NCT02340000|12468809|FG000|Time Period 2|Lost to Follow-up|10
7934584|NCT02340000|12468810|FG001|Time Period 2|Lost to Follow-up|8
7934585|NCT02340078|12468823|FG000|Overall Study|Protocol Violation|1
7934586|NCT02340520|12468880|FG000|Overall Study|Lost to Follow-up|1
7934587|NCT02340520|12468880|FG000|Overall Study|Patient did not take drug as specified|1
7934588|NCT02340520|12468880|FG000|Overall Study|Withdrawal by Subject|1
7934589|NCT02340663|12468886|FG000|Overall Study|Lost to Follow-up|1
7934590|NCT02340663|12468887|FG001|Overall Study|Lost to Follow-up|0
7934591|NCT02340663|12468886|FG000|Overall Study|Protocol Violation|1
7934592|NCT02340663|12468887|FG001|Overall Study|Protocol Violation|0
7719726|NCT00533897|12143620|FG005|Long Term Extension (LTE)|Other|0
7719727|NCT00533897|12143621|FG006|Long Term Extension (LTE)|Other|1
7719728|NCT00533897|12143622|FG007|Long Term Extension (LTE)|Other|6
7719729|NCT00534092|12143673|FG000|Overall Study|Lost to Follow-up|1
7719730|NCT00534092|12143674|FG001|Overall Study|Lost to Follow-up|0
7719731|NCT00534092|12143673|FG000|Overall Study|personal reasons/family concerns|1
7719732|NCT00534092|12143674|FG001|Overall Study|personal reasons/family concerns|0
7719733|NCT00534105|12143684|FG000|Overall Study|Lost to Follow-up|23
7719734|NCT00534105|12143685|FG001|Overall Study|Lost to Follow-up|39
7719735|NCT00534248|12143720|FG000|Overall Study|Adverse Event|19
7719736|NCT00534248|12143721|FG001|Overall Study|Adverse Event|29
7719737|NCT00534248|12143720|FG000|Overall Study|Lost to Follow-up|353
7719738|NCT00534248|12143721|FG001|Overall Study|Lost to Follow-up|375
7719739|NCT00534248|12143720|FG000|Overall Study|Other protocol specified criteria|13
7719740|NCT00534248|12143721|FG001|Overall Study|Other protocol specified criteria|3
7719741|NCT00534248|12143720|FG000|Overall Study|Physician Decision|10
7934593|NCT02340663|12468886|FG000|Overall Study|Withdrawal by Subject|3
7934594|NCT02340663|12468887|FG001|Overall Study|Withdrawal by Subject|1
7934595|NCT02340780|12468929|FG000|Overall Study|Ineligible|1
7934596|NCT02340806|12468935|FG000|Overall Study|Protocol Violation|2
7934597|NCT02340806|12468936|FG001|Overall Study|Protocol Violation|0
7934598|NCT02340806|12468935|FG000|Overall Study|epidural catheter replaced|2
7934599|NCT02340806|12468936|FG001|Overall Study|epidural catheter replaced|1
7934600|NCT02340806|12468935|FG000|Overall Study|history of chronic pain medication|1
7934601|NCT02340806|12468936|FG001|Overall Study|history of chronic pain medication|0
7934602|NCT02340806|12468935|FG000|Overall Study|re-dose < 90 min of CSE|1
7934603|NCT02340806|12468936|FG001|Overall Study|re-dose < 90 min of CSE|3
7934604|NCT02340819|12468942|FG000|Overall Study|Adverse Event|1
7934605|NCT02340819|12468942|FG000|Overall Study|Withdrawal by Subject|2
7934606|NCT02340819|12468942|FG000|Overall Study|Discontinued with other reason|1
7934607|NCT02340949|12468948|FG000|Overall Study|Adverse Event|4
7934608|NCT02340949|12468949|FG001|Overall Study|Adverse Event|2
7934609|NCT02340949|12468948|FG000|Overall Study|Withdrawal by Subject|2
7934610|NCT02340949|12468949|FG001|Overall Study|Withdrawal by Subject|0
7934611|NCT02340949|12468948|FG000|Overall Study|Progression disease|6
7934612|NCT02340949|12468949|FG001|Overall Study|Progression disease|2
7934613|NCT02340949|12468948|FG000|Overall Study|Death|3
7934614|NCT02340949|12468949|FG001|Overall Study|Death|0
7934615|NCT02340949|12468948|FG000|Overall Study|Physician Decision|1
7934616|NCT02340949|12468949|FG001|Overall Study|Physician Decision|0
7934617|NCT02340962|12468957|FG000|Overall Study|Lost to Follow-up|1
7934618|NCT02340962|12468958|FG001|Overall Study|Lost to Follow-up|0
7934619|NCT02340975|12468970|FG000|Overall Study|Death|6
7934620|NCT02340975|12468971|FG001|Overall Study|Death|23
7934621|NCT02340975|12468972|FG002|Overall Study|Death|21
7934622|NCT02340975|12468973|FG003|Overall Study|Death|7
7934623|NCT02340975|12468974|FG004|Overall Study|Death|21
7934624|NCT02340975|12468975|FG005|Overall Study|Death|13
7934625|NCT02340975|12468970|FG000|Overall Study|Lost to Follow-up|0
7934626|NCT02340975|12468971|FG001|Overall Study|Lost to Follow-up|0
7934627|NCT02340975|12468972|FG002|Overall Study|Lost to Follow-up|0
7934628|NCT02340975|12468973|FG003|Overall Study|Lost to Follow-up|0
7934629|NCT02340975|12468974|FG004|Overall Study|Lost to Follow-up|2
7934630|NCT02340975|12468975|FG005|Overall Study|Lost to Follow-up|0
7934631|NCT02340975|12468970|FG000|Overall Study|Withdrawal by Subject|0
7934632|NCT02340975|12468971|FG001|Overall Study|Withdrawal by Subject|0
7934633|NCT02340975|12468972|FG002|Overall Study|Withdrawal by Subject|3
7934634|NCT02340975|12468973|FG003|Overall Study|Withdrawal by Subject|3
7934635|NCT02340975|12468974|FG004|Overall Study|Withdrawal by Subject|2
7934636|NCT02340975|12468975|FG005|Overall Study|Withdrawal by Subject|0
7934637|NCT02340975|12468970|FG000|Overall Study|Other|0
7934638|NCT02340975|12468971|FG001|Overall Study|Other|4
7934639|NCT02340975|12468972|FG002|Overall Study|Other|0
7934640|NCT02340975|12468973|FG003|Overall Study|Other|2
7934641|NCT02340975|12468974|FG004|Overall Study|Other|0
7934642|NCT02340975|12468975|FG005|Overall Study|Other|6
7934643|NCT02341417|12469002|FG000|Overall Study|Withdrawal by Subject|0
7934644|NCT02341417|12469003|FG001|Overall Study|Withdrawal by Subject|2
7934645|NCT02341417|12469004|FG002|Overall Study|Withdrawal by Subject|0
7934646|NCT02341417|12469002|FG000|Overall Study|Decision by sponsor|2
7934647|NCT02341417|12469003|FG001|Overall Study|Decision by sponsor|0
7934648|NCT02341417|12469004|FG002|Overall Study|Decision by sponsor|0
7934649|NCT02341417|12469002|FG000|Overall Study|Death|0
7934650|NCT02341417|12469003|FG001|Overall Study|Death|0
7934651|NCT02341417|12469004|FG002|Overall Study|Death|1
7934652|NCT02341456|12469016|FG000|Overall Study|Disease progression|2
7934653|NCT02341456|12469017|FG001|Overall Study|Disease progression|3
7934654|NCT02341456|12469018|FG002|Overall Study|Disease progression|1
7934655|NCT02341456|12469016|FG000|Overall Study|Death|1
7934656|NCT02341456|12469017|FG001|Overall Study|Death|1
7934657|NCT02341456|12469018|FG002|Overall Study|Death|1
7934658|NCT02341456|12469016|FG000|Overall Study|Withdrawal by Subject|0
7934659|NCT02341456|12469017|FG001|Overall Study|Withdrawal by Subject|1
7934660|NCT02341456|12469018|FG002|Overall Study|Withdrawal by Subject|1
7934661|NCT02341456|12469016|FG000|Overall Study|Moved to local access programme.|0
7934662|NCT02341456|12469017|FG001|Overall Study|Moved to local access programme.|1
7934663|NCT02341456|12469018|FG002|Overall Study|Moved to local access programme.|1
7934664|NCT02341456|12469016|FG000|Overall Study|Physician Decision|1
7934665|NCT02341456|12469017|FG001|Overall Study|Physician Decision|0
7934666|NCT02341456|12469018|FG002|Overall Study|Physician Decision|0
7964832|NCT01084252|12520464|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7964833|NCT01084252|12520465|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20
7964834|NCT01084252|12520466|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18
7964835|NCT01084252|12520467|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17
7964836|NCT01084252|12520468|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19
7964837|NCT01084252|12520469|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7964838|NCT01084252|12520470|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7964839|NCT01084252|12520457|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7964840|NCT01084252|12520458|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7964841|NCT01084252|12520459|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7964842|NCT01084252|12520460|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7964843|NCT01084252|12520461|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7964844|NCT01084252|12520462|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7964845|NCT01084252|12520463|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7719742|NCT00534248|12143721|FG001|Overall Study|Physician Decision|7
7719743|NCT00534248|12143720|FG000|Overall Study|Protocol Violation|3
7719744|NCT00534248|12143721|FG001|Overall Study|Protocol Violation|4
7719745|NCT00534248|12143720|FG000|Overall Study|Withdrawal by Subject|263
7719746|NCT00534248|12143721|FG001|Overall Study|Withdrawal by Subject|255
7719747|NCT00534313|12143731|FG000|Short-term Period|Adverse Event|1
7719748|NCT00534313|12143732|FG001|Short-term Period|Adverse Event|2
7719749|NCT00534313|12143733|FG002|Short-term Period|Adverse Event|1
7719750|NCT00534313|12143734|FG003|Short-term Period|Adverse Event|3
7719751|NCT00534313|12143731|FG000|Short-term Period|Lack of Efficacy|3
7719752|NCT00534313|12143732|FG001|Short-term Period|Lack of Efficacy|4
7719753|NCT00534313|12143733|FG002|Short-term Period|Lack of Efficacy|0
7719754|NCT00534313|12143734|FG003|Short-term Period|Lack of Efficacy|3
7719755|NCT00534313|12143731|FG000|Short-term Period|Participant not meeting study criteria|0
7719756|NCT00534313|12143732|FG001|Short-term Period|Participant not meeting study criteria|0
7719757|NCT00534313|12143733|FG002|Short-term Period|Participant not meeting study criteria|0
7719758|NCT00534313|12143734|FG003|Short-term Period|Participant not meeting study criteria|1
7719759|NCT00534313|12143731|FG000|Short-term Period|Participant withdrew consent|2
7719760|NCT00534313|12143732|FG001|Short-term Period|Participant withdrew consent|0
7719761|NCT00534313|12143733|FG002|Short-term Period|Participant withdrew consent|0
7964846|NCT01084252|12520464|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7964847|NCT01084252|12520465|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2
7964848|NCT01084252|12520466|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7964849|NCT01084252|12520467|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4
7964850|NCT01084252|12520468|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3
7964851|NCT01084252|12520469|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7964852|NCT01084252|12520470|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7964853|NCT01084252|12520457|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7964854|NCT01084252|12520458|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7964855|NCT01084252|12520459|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7964856|NCT01084252|12520460|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7964857|NCT01084252|12520461|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7964858|NCT01084252|12520462|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7964859|NCT01084252|12520463|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7964860|NCT01084252|12520464|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7964861|NCT01084252|12520465|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1
7964862|NCT01084252|12520466|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4
7964863|NCT01084252|12520467|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
7964864|NCT01084252|12520468|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
7964865|NCT01084252|12520469|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7934667|NCT02341482|12469026|FG000|Overall Study|Adverse Event|1
7934668|NCT02342171|12469079|FG000|Overall Study|Death|4
7934669|NCT02342171|12469080|FG001|Overall Study|Death|87
7934670|NCT02342171|12469079|FG000|Overall Study|Received favipiravir|10
7934671|NCT02342171|12469080|FG001|Overall Study|Received favipiravir|0
7934672|NCT02342171|12469079|FG000|Overall Study|Missing cycle treshold value|1
7934673|NCT02342171|12469080|FG001|Overall Study|Missing cycle treshold value|0
7934674|NCT02342171|12469079|FG000|Overall Study|Unknown outcome|0
7934675|NCT02342171|12469080|FG001|Overall Study|Unknown outcome|1
7934676|NCT02342171|12469079|FG000|Overall Study|Missing age data|0
7934677|NCT02342171|12469080|FG001|Overall Study|Missing age data|1
7934678|NCT02342223|12469094|FG000|Overall Study|Lost to Follow-up|1
7934679|NCT02342288|12469100|FG000|Overall Study|no protocol anesthesiologist available|3
7934680|NCT02342288|12469101|FG001|Overall Study|no protocol anesthesiologist available|2
7934681|NCT02342288|12469100|FG000|Overall Study|anesthesia leak in system|1
7934682|NCT02342288|12469101|FG001|Overall Study|anesthesia leak in system|0
7934683|NCT02342288|12469100|FG000|Overall Study|Withdrawal by Subject|1
7934684|NCT02342288|12469101|FG001|Overall Study|Withdrawal by Subject|0
7934685|NCT02342288|12469100|FG000|Overall Study|coordinator contaminated with blood|0
7934686|NCT02342288|12469101|FG001|Overall Study|coordinator contaminated with blood|1
7934687|NCT02342288|12469100|FG000|Overall Study|subject cannot tolerate numbing drops|0
7934688|NCT02342288|12469101|FG001|Overall Study|subject cannot tolerate numbing drops|1
7934689|NCT02342288|12469100|FG000|Overall Study|coordinator not available|0
7934690|NCT02342288|12469101|FG001|Overall Study|coordinator not available|2
7934691|NCT02342418|12469211|FG000|Overall Study|Adverse Event|0
7934692|NCT02342418|12469212|FG001|Overall Study|Adverse Event|1
7934693|NCT02342548|12469225|FG000|Overall Study|Adverse Event|12
7934694|NCT02342548|12469226|FG001|Overall Study|Adverse Event|17
7934695|NCT02342548|12469227|FG002|Overall Study|Adverse Event|13
7934696|NCT02342548|12469225|FG000|Overall Study|Lost to Follow-up|0
7719762|NCT00534313|12143734|FG003|Short-term Period|Participant withdrew consent|2
7719763|NCT00534313|12143731|FG000|Short-term Period|Pregnancy|0
7934697|NCT02342548|12469226|FG001|Overall Study|Lost to Follow-up|1
7934698|NCT02342548|12469227|FG002|Overall Study|Lost to Follow-up|0
7934699|NCT02342548|12469225|FG000|Overall Study|Study terminated by sponsor|20
7934700|NCT02342548|12469226|FG001|Overall Study|Study terminated by sponsor|39
7934701|NCT02342548|12469227|FG002|Overall Study|Study terminated by sponsor|25
7934702|NCT02342548|12469225|FG000|Overall Study|Protocol Violation|0
7719764|NCT00534313|12143732|FG001|Short-term Period|Pregnancy|0
7719765|NCT00534313|12143733|FG002|Short-term Period|Pregnancy|1
7719766|NCT00534313|12143734|FG003|Short-term Period|Pregnancy|0
7719767|NCT00534313|12143731|FG000|Long-term Period|Adverse Event|2
7934703|NCT02342548|12469226|FG001|Overall Study|Protocol Violation|1
7934704|NCT02342548|12469227|FG002|Overall Study|Protocol Violation|0
7934705|NCT02342548|12469225|FG000|Overall Study|Withdrawal by Subject|1
7934706|NCT02342548|12469226|FG001|Overall Study|Withdrawal by Subject|3
7934707|NCT02342548|12469227|FG002|Overall Study|Withdrawal by Subject|4
7934708|NCT02342548|12469225|FG000|Overall Study|Other|1
7934709|NCT02342548|12469226|FG001|Overall Study|Other|1
7934710|NCT02342548|12469227|FG002|Overall Study|Other|1
7934711|NCT02342639|12469245|FG000|Overall Study|Acute illness, unrelated to study drug|2
7934712|NCT02342639|12469246|FG001|Overall Study|Acute illness, unrelated to study drug|3
7934713|NCT02342639|12469245|FG000|Overall Study|Protocol Violation|0
7934714|NCT02342639|12469246|FG001|Overall Study|Protocol Violation|2
7934715|NCT02342678|12469256|FG000|Overall Study|Lost to Follow-up|0
7934716|NCT02342678|12469257|FG001|Overall Study|Lost to Follow-up|1
7934717|NCT02342678|12469256|FG000|Overall Study|Too busy to complete study|0
7934718|NCT02342678|12469257|FG001|Overall Study|Too busy to complete study|2
7934719|NCT02342678|12469256|FG000|Overall Study|Family illness/emergency|0
7934720|NCT02342678|12469257|FG001|Overall Study|Family illness/emergency|1
7934721|NCT02342678|12469256|FG000|Overall Study|Illness/medical reason|1
7934722|NCT02342678|12469257|FG001|Overall Study|Illness/medical reason|1
7934723|NCT02342704|12469265|FG000|Overall Study|Physician Decision|0
7934724|NCT02342704|12469266|FG001|Overall Study|Physician Decision|3
7934725|NCT02342704|12469265|FG000|Overall Study|Sponsor Termination|49
7934726|NCT02342704|12469266|FG001|Overall Study|Sponsor Termination|43
7934727|NCT02342704|12469265|FG000|Overall Study|Other|0
7822124|NCT01259856|12291080|FG000|Overall Study|Patient developed other disease|0
7822125|NCT01259856|12291081|FG001|Overall Study|Patient developed other disease|1
7822126|NCT01259856|12291080|FG000|Overall Study|Transfer to another study|0
7822127|NCT01259856|12291081|FG001|Overall Study|Transfer to another study|1
7934728|NCT02342704|12469266|FG001|Overall Study|Other|1
7934729|NCT02342704|12469265|FG000|Overall Study|Withdrawal by Subject|1
7934730|NCT02342704|12469266|FG001|Overall Study|Withdrawal by Subject|0
7934731|NCT02342704|12469265|FG000|Overall Study|Lost to Follow-up|2
7934732|NCT02342704|12469266|FG001|Overall Study|Lost to Follow-up|1
7934733|NCT02342704|12469265|FG000|Overall Study|Adverse Event|1
7934734|NCT02342704|12469266|FG001|Overall Study|Adverse Event|3
7934735|NCT02342743|12469272|FG000|Baseline Period|Withdrawal by Subject|3
7934736|NCT02342743|12469272|FG000|Baseline Period|Lost to Follow-up|2
7934737|NCT02342743|12469272|FG000|Baseline Period|Change in prophylactic medication|3
7934738|NCT02342743|12469272|FG000|Baseline Period|Screening failure regarding baseline|7
7934739|NCT02342743|12469272|FG000|Treatment Period|Withdrawal by Subject|2
7934740|NCT02342743|12469272|FG000|Treatment Period|Lost to Follow-up|8
7934741|NCT02342743|12469272|FG000|Treatment Period|Change in prophylactic medication|1
7934742|NCT02342886|12469281|FG000|Overall Study|Treatment non-compliance|1
7934743|NCT02342886|12469282|FG001|Overall Study|Treatment non-compliance|0
7934744|NCT02342886|12469283|FG002|Overall Study|Treatment non-compliance|0
7934745|NCT02342886|12469284|FG003|Overall Study|Treatment non-compliance|1
7934746|NCT02342886|12469285|FG004|Overall Study|Treatment non-compliance|0
7934747|NCT02342886|12469281|FG000|Overall Study|Late exclusion: rifampicin resistance|1
7934748|NCT02342886|12469282|FG001|Overall Study|Late exclusion: rifampicin resistance|0
7934749|NCT02342886|12469283|FG002|Overall Study|Late exclusion: rifampicin resistance|0
7934750|NCT02342886|12469284|FG003|Overall Study|Late exclusion: rifampicin resistance|0
7934751|NCT02342886|12469285|FG004|Overall Study|Late exclusion: rifampicin resistance|0
7934752|NCT02342886|12469281|FG000|Overall Study|Adverse event/specific toxicity|4
7934753|NCT02342886|12469282|FG001|Overall Study|Adverse event/specific toxicity|3
7934754|NCT02342886|12469283|FG002|Overall Study|Adverse event/specific toxicity|11
7934755|NCT02342886|12469284|FG003|Overall Study|Adverse event/specific toxicity|2
7934756|NCT02342886|12469285|FG004|Overall Study|Adverse event/specific toxicity|1
7934757|NCT02342886|12469281|FG000|Overall Study|Lost to Follow-up|1
7934758|NCT02342886|12469282|FG001|Overall Study|Lost to Follow-up|0
7934759|NCT02342886|12469283|FG002|Overall Study|Lost to Follow-up|0
7934760|NCT02342886|12469284|FG003|Overall Study|Lost to Follow-up|0
7934761|NCT02342886|12469285|FG004|Overall Study|Lost to Follow-up|0
7934762|NCT02342886|12469281|FG000|Overall Study|Death|1
7934763|NCT02342886|12469282|FG001|Overall Study|Death|2
7934764|NCT02342886|12469283|FG002|Overall Study|Death|1
7934765|NCT02342886|12469284|FG003|Overall Study|Death|0
7934766|NCT02342886|12469285|FG004|Overall Study|Death|1
7934767|NCT02342886|12469281|FG000|Overall Study|Withdrawal by Subject|0
7934768|NCT02342886|12469282|FG001|Overall Study|Withdrawal by Subject|1
7934769|NCT02342886|12469283|FG002|Overall Study|Withdrawal by Subject|0
7934770|NCT02342886|12469284|FG003|Overall Study|Withdrawal by Subject|1
7934771|NCT02342886|12469285|FG004|Overall Study|Withdrawal by Subject|0
7934772|NCT02342886|12469281|FG000|Overall Study|Investigator/sponsor decision|0
7719768|NCT00534313|12143732|FG001|Long-term Period|Adverse Event|1
7719769|NCT00534313|12143733|FG002|Long-term Period|Adverse Event|0
7719770|NCT00534313|12143734|FG003|Long-term Period|Adverse Event|1
7719771|NCT00534313|12143731|FG000|Long-term Period|Lack of Efficacy|14
7934773|NCT02342886|12469282|FG001|Overall Study|Investigator/sponsor decision|2
7934774|NCT02342886|12469283|FG002|Overall Study|Investigator/sponsor decision|0
7934775|NCT02342886|12469284|FG003|Overall Study|Investigator/sponsor decision|3
7934776|NCT02342886|12469285|FG004|Overall Study|Investigator/sponsor decision|1
7934777|NCT02342886|12469281|FG000|Overall Study|Pregnancy|0
7934778|NCT02342886|12469282|FG001|Overall Study|Pregnancy|0
7934779|NCT02342886|12469283|FG002|Overall Study|Pregnancy|2
7934780|NCT02342886|12469284|FG003|Overall Study|Pregnancy|0
7934781|NCT02342886|12469285|FG004|Overall Study|Pregnancy|0
7934782|NCT02342886|12469281|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0
7934783|NCT02342886|12469282|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0
7934784|NCT02342886|12469283|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1
7934785|NCT02342886|12469284|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0
7934786|NCT02342886|12469285|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0
7934787|NCT02342886|12469281|FG000|Overall Study|Protocol Violation|0
7934788|NCT02342886|12469282|FG001|Overall Study|Protocol Violation|0
7934789|NCT02342886|12469283|FG002|Overall Study|Protocol Violation|0
7934790|NCT02342886|12469284|FG003|Overall Study|Protocol Violation|2
7934791|NCT02342886|12469285|FG004|Overall Study|Protocol Violation|0
7934792|NCT02343003|12469299|FG000|Overall Study|Withdrawal by Subject|9
7934793|NCT02343003|12469300|FG001|Overall Study|Withdrawal by Subject|4
7934794|NCT02343003|12469299|FG000|Overall Study|Lost to Follow-up|5
7934795|NCT02343003|12469300|FG001|Overall Study|Lost to Follow-up|1
7934796|NCT02343003|12469299|FG000|Overall Study|Protocol Violation|1
7934797|NCT02343003|12469300|FG001|Overall Study|Protocol Violation|0
7934798|NCT02343003|12469299|FG000|Overall Study|Death|0
7934799|NCT02343003|12469300|FG001|Overall Study|Death|1
7934800|NCT02343003|12469299|FG000|Overall Study|exclusion criteria met|1
7934801|NCT02343003|12469300|FG001|Overall Study|exclusion criteria met|1
7934802|NCT02343003|12469299|FG000|Overall Study|terminated by sponsor|2
7934803|NCT02343003|12469300|FG001|Overall Study|terminated by sponsor|0
7934804|NCT02343406|12469348|FG000|Overall Study|Progressive disease|72
7934805|NCT02343406|12469349|FG001|Overall Study|Progressive disease|70
7934806|NCT02343406|12469350|FG002|Overall Study|Progressive disease|43
7934807|NCT02343406|12469351|FG003|Overall Study|Progressive disease|15
7934808|NCT02343406|12469352|FG004|Overall Study|Progressive disease|5
7934809|NCT02343406|12469348|FG000|Overall Study|Adverse Event|6
7934810|NCT02343406|12469349|FG001|Overall Study|Adverse Event|8
7934811|NCT02343406|12469350|FG002|Overall Study|Adverse Event|6
7934812|NCT02343406|12469351|FG003|Overall Study|Adverse Event|3
7934813|NCT02343406|12469352|FG004|Overall Study|Adverse Event|0
7934814|NCT02343406|12469348|FG000|Overall Study|Withdrawal by Subject|6
7934815|NCT02343406|12469349|FG001|Overall Study|Withdrawal by Subject|4
7934816|NCT02343406|12469350|FG002|Overall Study|Withdrawal by Subject|8
7934817|NCT02343406|12469351|FG003|Overall Study|Withdrawal by Subject|3
7934818|NCT02343406|12469352|FG004|Overall Study|Withdrawal by Subject|0
7934819|NCT02343406|12469348|FG000|Overall Study|Death|2
7934820|NCT02343406|12469349|FG001|Overall Study|Death|1
7934821|NCT02343406|12469350|FG002|Overall Study|Death|0
7934822|NCT02343406|12469351|FG003|Overall Study|Death|0
7934823|NCT02343406|12469352|FG004|Overall Study|Death|0
7934824|NCT02343406|12469348|FG000|Overall Study|Start of a new anti-cancer treatment|0
7934825|NCT02343406|12469349|FG001|Overall Study|Start of a new anti-cancer treatment|1
7934826|NCT02343406|12469350|FG002|Overall Study|Start of a new anti-cancer treatment|0
7934827|NCT02343406|12469351|FG003|Overall Study|Start of a new anti-cancer treatment|1
7967175|NCT02761733|12523726|FG000|Overall Study|Lost to Follow-up|6
7719772|NCT00534313|12143732|FG001|Long-term Period|Lack of Efficacy|10
7719773|NCT00534313|12143733|FG002|Long-term Period|Lack of Efficacy|14
7719774|NCT00534313|12143734|FG003|Long-term Period|Lack of Efficacy|12
7719775|NCT00534313|12143731|FG000|Long-term Period|Lost to Follow-up|1
7719776|NCT00534313|12143732|FG001|Long-term Period|Lost to Follow-up|2
7719777|NCT00534313|12143733|FG002|Long-term Period|Lost to Follow-up|0
7719778|NCT00534313|12143734|FG003|Long-term Period|Lost to Follow-up|0
7719779|NCT00534313|12143731|FG000|Long-term Period|Withdrawal by Subject|2
7934828|NCT02343406|12469352|FG004|Overall Study|Start of a new anti-cancer treatment|0
7934829|NCT02343406|12469348|FG000|Overall Study|Other primary malignancy|0
7934830|NCT02343406|12469349|FG001|Overall Study|Other primary malignancy|1
7934831|NCT02343406|12469350|FG002|Overall Study|Other primary malignancy|0
7934832|NCT02343406|12469351|FG003|Overall Study|Other primary malignancy|0
7934833|NCT02343406|12469352|FG004|Overall Study|Other primary malignancy|0
7934834|NCT02343406|12469348|FG000|Overall Study|Other, not specified|2
7934835|NCT02343406|12469349|FG001|Overall Study|Other, not specified|1
7934836|NCT02343406|12469350|FG002|Overall Study|Other, not specified|1
7934837|NCT02343406|12469351|FG003|Overall Study|Other, not specified|4
7934838|NCT02343406|12469352|FG004|Overall Study|Other, not specified|0
7934839|NCT02343458|12469367|FG000|Overall Study|Adverse Event|15
7934840|NCT02343458|12469368|FG001|Overall Study|Adverse Event|14
7934841|NCT02343458|12469369|FG002|Overall Study|Adverse Event|15
7934842|NCT02343458|12469370|FG003|Overall Study|Adverse Event|3
7934843|NCT02343458|12469367|FG000|Overall Study|Lack of Efficacy|3
7934844|NCT02343458|12469368|FG001|Overall Study|Lack of Efficacy|8
7934845|NCT02343458|12469369|FG002|Overall Study|Lack of Efficacy|4
7934846|NCT02343458|12469370|FG003|Overall Study|Lack of Efficacy|8
7934847|NCT02343458|12469367|FG000|Overall Study|Withdrawal by Subject|18
7934848|NCT02343458|12469368|FG001|Overall Study|Withdrawal by Subject|17
7934849|NCT02343458|12469369|FG002|Overall Study|Withdrawal by Subject|23
7934850|NCT02343458|12469370|FG003|Overall Study|Withdrawal by Subject|14
7934851|NCT02343458|12469367|FG000|Overall Study|Physician Decision|1
7934852|NCT02343458|12469368|FG001|Overall Study|Physician Decision|4
7934853|NCT02343458|12469369|FG002|Overall Study|Physician Decision|2
7934854|NCT02343458|12469370|FG003|Overall Study|Physician Decision|2
7934855|NCT02343458|12469367|FG000|Overall Study|Lost to Follow-up|5
7934856|NCT02343458|12469368|FG001|Overall Study|Lost to Follow-up|5
7934857|NCT02343458|12469369|FG002|Overall Study|Lost to Follow-up|3
7934858|NCT02343458|12469370|FG003|Overall Study|Lost to Follow-up|1
7934859|NCT02343458|12469367|FG000|Overall Study|Protocol Violation|2
7934860|NCT02343458|12469368|FG001|Overall Study|Protocol Violation|5
7934861|NCT02343458|12469369|FG002|Overall Study|Protocol Violation|2
7934862|NCT02343458|12469370|FG003|Overall Study|Protocol Violation|2
7934863|NCT02343458|12469367|FG000|Overall Study|Protocol Specified Criteria|17
7934864|NCT02343458|12469368|FG001|Overall Study|Protocol Specified Criteria|13
7934865|NCT02343458|12469369|FG002|Overall Study|Protocol Specified Criteria|14
7934866|NCT02343458|12469370|FG003|Overall Study|Protocol Specified Criteria|8
7934867|NCT02343939|12469407|FG000|Overall Study|Death|0
7934868|NCT02343939|12469408|FG001|Overall Study|Death|15
7934869|NCT02343939|12469409|FG002|Overall Study|Death|4
7934870|NCT02343939|12469410|FG003|Overall Study|Death|2
7934871|NCT02343939|12469411|FG004|Overall Study|Death|5
7934872|NCT02343939|12469412|FG005|Overall Study|Death|11
7934873|NCT02343939|12469413|FG006|Overall Study|Death|8
7934874|NCT02343939|12469414|FG007|Overall Study|Death|22
7934875|NCT02343939|12469415|FG008|Overall Study|Death|1
7934876|NCT02343939|12469407|FG000|Overall Study|Study terminated by sponsor|0
7934877|NCT02343939|12469408|FG001|Overall Study|Study terminated by sponsor|27
7934878|NCT02343939|12469409|FG002|Overall Study|Study terminated by sponsor|0
7934879|NCT02343939|12469410|FG003|Overall Study|Study terminated by sponsor|1
7934880|NCT02343939|12469411|FG004|Overall Study|Study terminated by sponsor|1
7934881|NCT02343939|12469412|FG005|Overall Study|Study terminated by sponsor|5
7934882|NCT02343939|12469413|FG006|Overall Study|Study terminated by sponsor|3
7934883|NCT02343939|12469414|FG007|Overall Study|Study terminated by sponsor|4
7934884|NCT02343939|12469415|FG008|Overall Study|Study terminated by sponsor|0
7934885|NCT02343939|12469407|FG000|Overall Study|Withdrew consent|3
7934886|NCT02343939|12469408|FG001|Overall Study|Withdrew consent|6
7934887|NCT02343939|12469409|FG002|Overall Study|Withdrew consent|1
7934888|NCT02343939|12469410|FG003|Overall Study|Withdrew consent|2
7934889|NCT02343939|12469411|FG004|Overall Study|Withdrew consent|2
7934890|NCT02343939|12469412|FG005|Overall Study|Withdrew consent|0
7934891|NCT02343939|12469413|FG006|Overall Study|Withdrew consent|0
7934892|NCT02343939|12469414|FG007|Overall Study|Withdrew consent|8
7934893|NCT02343939|12469415|FG008|Overall Study|Withdrew consent|6
7934894|NCT02343939|12469407|FG000|Overall Study|Treatment failure|0
7934895|NCT02343939|12469408|FG001|Overall Study|Treatment failure|0
7934896|NCT02343939|12469409|FG002|Overall Study|Treatment failure|0
7934897|NCT02343939|12469410|FG003|Overall Study|Treatment failure|0
7934898|NCT02343939|12469411|FG004|Overall Study|Treatment failure|0
7934899|NCT02343939|12469412|FG005|Overall Study|Treatment failure|0
7934900|NCT02343939|12469413|FG006|Overall Study|Treatment failure|2
7934901|NCT02343939|12469414|FG007|Overall Study|Treatment failure|1
7934902|NCT02343939|12469415|FG008|Overall Study|Treatment failure|0
7934903|NCT02343939|12469407|FG000|Overall Study|Investigator's discretion|0
7934904|NCT02343939|12469408|FG001|Overall Study|Investigator's discretion|0
7934905|NCT02343939|12469409|FG002|Overall Study|Investigator's discretion|0
7934906|NCT02343939|12469410|FG003|Overall Study|Investigator's discretion|1
7934907|NCT02343939|12469411|FG004|Overall Study|Investigator's discretion|0
7934908|NCT02343939|12469412|FG005|Overall Study|Investigator's discretion|0
7934909|NCT02343939|12469413|FG006|Overall Study|Investigator's discretion|1
7934910|NCT02343939|12469414|FG007|Overall Study|Investigator's discretion|0
7934911|NCT02343939|12469415|FG008|Overall Study|Investigator's discretion|0
7934912|NCT02343939|12469407|FG000|Overall Study|Adverse Event|0
7934913|NCT02343939|12469408|FG001|Overall Study|Adverse Event|0
7934914|NCT02343939|12469409|FG002|Overall Study|Adverse Event|0
7934915|NCT02343939|12469410|FG003|Overall Study|Adverse Event|0
7934916|NCT02343939|12469411|FG004|Overall Study|Adverse Event|0
7934917|NCT02343939|12469412|FG005|Overall Study|Adverse Event|1
7934918|NCT02343939|12469413|FG006|Overall Study|Adverse Event|0
7934919|NCT02343939|12469414|FG007|Overall Study|Adverse Event|0
7934920|NCT02343939|12469415|FG008|Overall Study|Adverse Event|0
7934921|NCT02343939|12469407|FG000|Overall Study|Never Treated With ENTO|0
7934922|NCT02343939|12469408|FG001|Overall Study|Never Treated With ENTO|0
7934923|NCT02343939|12469409|FG002|Overall Study|Never Treated With ENTO|0
7934924|NCT02343939|12469410|FG003|Overall Study|Never Treated With ENTO|0
7934925|NCT02343939|12469411|FG004|Overall Study|Never Treated With ENTO|0
7934926|NCT02343939|12469412|FG005|Overall Study|Never Treated With ENTO|0
7934927|NCT02343939|12469413|FG006|Overall Study|Never Treated With ENTO|1
7934928|NCT02343939|12469414|FG007|Overall Study|Never Treated With ENTO|2
7934929|NCT02343939|12469415|FG008|Overall Study|Never Treated With ENTO|0
7934930|NCT02344004|12469451|FG000|Overall Study|Adverse Event|11
7934931|NCT02344004|12469452|FG001|Overall Study|Adverse Event|1
7934932|NCT02344004|12469451|FG000|Overall Study|Death|9
7934933|NCT02344004|12469452|FG001|Overall Study|Death|7
7934934|NCT02344004|12469451|FG000|Overall Study|Physician Decision|4
7934935|NCT02344004|12469452|FG001|Overall Study|Physician Decision|1
7934936|NCT02344004|12469451|FG000|Overall Study|Withdrawal by Subject|22
7934937|NCT02344004|12469452|FG001|Overall Study|Withdrawal by Subject|5
7934938|NCT02344004|12469451|FG000|Overall Study|Rescue Medication|2
7934939|NCT02344004|12469452|FG001|Overall Study|Rescue Medication|0
7934940|NCT02344004|12469451|FG000|Overall Study|Other Not Specified|12
7934941|NCT02344004|12469452|FG001|Overall Study|Other Not Specified|0
7934942|NCT02344004|12469451|FG000|Overall Study|Protocol Violation|1
7934943|NCT02344004|12469452|FG001|Overall Study|Protocol Violation|0
7934944|NCT02344173|12469459|FG000|Procedure|Ablation Procedure Not Performed|7
7934945|NCT02344173|12469459|FG000|12-month Visit|Death|8
7934946|NCT02344173|12469459|FG000|12-month Visit|Withdrawal by Subject|30
7934947|NCT02344173|12469459|FG000|12-month Visit|Lost to Follow-up|58
7934948|NCT02344342|12469519|FG000|Overall Study|Industry partner dropped out|11
7934949|NCT02344342|12469520|FG001|Overall Study|Industry partner dropped out|9
7934950|NCT02344342|12469521|FG002|Overall Study|Industry partner dropped out|14
7934951|NCT02344342|12469522|FG003|Overall Study|Industry partner dropped out|10
7934952|NCT02344576|12469553|FG000|Enrollment|Agreed to Medical Record Review Only|7
7934953|NCT02344576|12469554|FG001|Enrollment|Agreed to Medical Record Review Only|8
7934954|NCT02344576|12469555|FG002|Enrollment|Agreed to Medical Record Review Only|0
7934955|NCT02344576|12469556|FG003|Enrollment|Agreed to Medical Record Review Only|0
7934956|NCT02344576|12469553|FG000|1-Month Follow-Up|Death|13
7934957|NCT02344576|12469554|FG001|1-Month Follow-Up|Death|8
7934958|NCT02344576|12469555|FG002|1-Month Follow-Up|Death|0
7934959|NCT02344576|12469556|FG003|1-Month Follow-Up|Death|0
7934960|NCT02344576|12469553|FG000|1-Month Follow-Up|Withdrawal by Subject|3
7934961|NCT02344576|12469554|FG001|1-Month Follow-Up|Withdrawal by Subject|14
7934962|NCT02344576|12469555|FG002|1-Month Follow-Up|Withdrawal by Subject|8
7934963|NCT02344576|12469556|FG003|1-Month Follow-Up|Withdrawal by Subject|10
7934964|NCT02344576|12469553|FG000|1-Month Follow-Up|Lost to Follow-up|2
7934965|NCT02344576|12469554|FG001|1-Month Follow-Up|Lost to Follow-up|5
7934966|NCT02344576|12469555|FG002|1-Month Follow-Up|Lost to Follow-up|11
7934967|NCT02344576|12469556|FG003|1-Month Follow-Up|Lost to Follow-up|3
7934968|NCT02344576|12469553|FG000|6-Month Follow-Up|Death|14
7934969|NCT02344576|12469554|FG001|6-Month Follow-Up|Death|14
7934970|NCT02344576|12469555|FG002|6-Month Follow-Up|Death|0
7934971|NCT02344576|12469556|FG003|6-Month Follow-Up|Death|0
7934972|NCT02344576|12469553|FG000|6-Month Follow-Up|Withdrawal by Subject|1
7934973|NCT02344576|12469554|FG001|6-Month Follow-Up|Withdrawal by Subject|0
7934974|NCT02344576|12469555|FG002|6-Month Follow-Up|Withdrawal by Subject|1
7934975|NCT02344576|12469556|FG003|6-Month Follow-Up|Withdrawal by Subject|2
7934976|NCT02344576|12469553|FG000|6-Month Follow-Up|Lost to Follow-up|4
7934977|NCT02344576|12469554|FG001|6-Month Follow-Up|Lost to Follow-up|5
7934978|NCT02344576|12469555|FG002|6-Month Follow-Up|Lost to Follow-up|13
7934979|NCT02344576|12469556|FG003|6-Month Follow-Up|Lost to Follow-up|6
7934980|NCT02344745|12469579|FG000|Overall Study|Data collection sheets were lost|2
7934981|NCT02344745|12469580|FG001|Overall Study|Data collection sheets were lost|0
7934982|NCT02345161|12469599|FG000|Overall Study|Withdrawal by Subject|25
7934983|NCT02345161|12469600|FG001|Overall Study|Withdrawal by Subject|33
7934984|NCT02345161|12469599|FG000|Overall Study|Adverse Event|16
7934985|NCT02345161|12469600|FG001|Overall Study|Adverse Event|19
7934986|NCT02345161|12469599|FG000|Overall Study|Physician Decision|4
7934987|NCT02345161|12469600|FG001|Overall Study|Physician Decision|4
7934988|NCT02345161|12469599|FG000|Overall Study|Lost to Follow-up|0
7934989|NCT02345161|12469600|FG001|Overall Study|Lost to Follow-up|1
7934990|NCT02345226|12469613|FG000|Double-Blind Phase|Adverse Event|5
7934991|NCT02345226|12469614|FG001|Double-Blind Phase|Adverse Event|6
7934992|NCT02345226|12469613|FG000|Double-Blind Phase|Death|3
7934993|NCT02345226|12469614|FG001|Double-Blind Phase|Death|0
7934994|NCT02345226|12469613|FG000|Double-Blind Phase|Pregnancy|0
7934995|NCT02345226|12469614|FG001|Double-Blind Phase|Pregnancy|1
7934996|NCT02345226|12469613|FG000|Double-Blind Phase|Lack of Efficacy|1
7934997|NCT02345226|12469614|FG001|Double-Blind Phase|Lack of Efficacy|0
7934998|NCT02345226|12469613|FG000|Double-Blind Phase|Investigator's Discretion|4
7934999|NCT02345226|12469614|FG001|Double-Blind Phase|Investigator's Discretion|3
7935000|NCT02345226|12469613|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
7935001|NCT02345226|12469614|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2
7935002|NCT02345226|12469613|FG000|Double-Blind Phase|Withdrew Consent|41
7935003|NCT02345226|12469614|FG001|Double-Blind Phase|Withdrew Consent|39
7935004|NCT02345226|12469613|FG000|Double-Blind Phase|Lost to Follow-up|12
7935005|NCT02345226|12469614|FG001|Double-Blind Phase|Lost to Follow-up|16
7935006|NCT02345226|12469613|FG000|Double-Blind Phase|Randomized but Never Treated|2
7935007|NCT02345226|12469614|FG001|Double-Blind Phase|Randomized but Never Treated|4
7935008|NCT02345226|12469613|FG000|Open-Label Extension Phase|Lost to Follow-up|0
7935009|NCT02345226|12469614|FG001|Open-Label Extension Phase|Lost to Follow-up|1
7935010|NCT02345252|12469624|FG000|Double-Blind Phase|Adverse Event|2
7935011|NCT02345252|12469625|FG001|Double-Blind Phase|Adverse Event|3
7935012|NCT02345252|12469624|FG000|Double-Blind Phase|Death|1
7935013|NCT02345252|12469625|FG001|Double-Blind Phase|Death|2
7935014|NCT02345252|12469624|FG000|Double-Blind Phase|Lack of Efficacy|1
7935015|NCT02345252|12469625|FG001|Double-Blind Phase|Lack of Efficacy|0
7935016|NCT02345252|12469624|FG000|Double-Blind Phase|Investigator's Discretion|4
7935017|NCT02345252|12469625|FG001|Double-Blind Phase|Investigator's Discretion|6
7935018|NCT02345252|12469624|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
7935019|NCT02345252|12469625|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2
7935020|NCT02345252|12469624|FG000|Double-Blind Phase|Protocol Violation|2
7935021|NCT02345252|12469625|FG001|Double-Blind Phase|Protocol Violation|1
7935022|NCT02345252|12469624|FG000|Double-Blind Phase|Withdrew Consent|21
7935023|NCT02345252|12469625|FG001|Double-Blind Phase|Withdrew Consent|23
7935024|NCT02345252|12469624|FG000|Double-Blind Phase|Lost to Follow-up|8
7935025|NCT02345252|12469625|FG001|Double-Blind Phase|Lost to Follow-up|10
7935026|NCT02345252|12469624|FG000|Double-Blind Phase|Randomized but Never Treated|0
7935027|NCT02345252|12469625|FG001|Double-Blind Phase|Randomized but Never Treated|2
7935028|NCT02345330|12469633|FG000|Overall Study|Death|1
7935029|NCT02345330|12469633|FG000|Overall Study|Progressive Disease|2
7935030|NCT02345434|12469639|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5
7935031|NCT02345434|12469640|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2
7935032|NCT02345512|12469655|FG000|Overall Study|Adverse Event|1
7935033|NCT02345512|12469655|FG000|Overall Study|Withdrawal by Subject|1
7935034|NCT02345811|12469677|FG000|First Intervention|Withdrawal by Subject|1
7935035|NCT02345811|12469678|FG001|First Intervention|Withdrawal by Subject|1
7935036|NCT02345889|12469690|FG000|Overall Study|Inadequate Bowel Prep|17
7935037|NCT02345889|12469691|FG001|Overall Study|Inadequate Bowel Prep|16
7935038|NCT02345889|12469692|FG002|Overall Study|Inadequate Bowel Prep|18
7935039|NCT02345889|12469693|FG003|Overall Study|Inadequate Bowel Prep|14
7935040|NCT02345889|12469690|FG000|Overall Study|Polyposis identified during procedure|1
7935041|NCT02345889|12469691|FG001|Overall Study|Polyposis identified during procedure|1
7935042|NCT02345889|12469692|FG002|Overall Study|Polyposis identified during procedure|0
7935043|NCT02345889|12469693|FG003|Overall Study|Polyposis identified during procedure|1
7935044|NCT02345889|12469690|FG000|Overall Study|Recognized ineligible post-randomization|1
7935045|NCT02345889|12469691|FG001|Overall Study|Recognized ineligible post-randomization|0
7935046|NCT02345889|12469692|FG002|Overall Study|Recognized ineligible post-randomization|2
7935047|NCT02345889|12469693|FG003|Overall Study|Recognized ineligible post-randomization|1
7935048|NCT02345889|12469690|FG000|Overall Study|Ulcerative Colitis identified|1
7935049|NCT02345889|12469691|FG001|Overall Study|Ulcerative Colitis identified|0
7935050|NCT02345889|12469692|FG002|Overall Study|Ulcerative Colitis identified|0
7935051|NCT02345889|12469693|FG003|Overall Study|Ulcerative Colitis identified|0
7935052|NCT02345889|12469690|FG000|Overall Study|Cecum not intubated|1
7935053|NCT02345889|12469691|FG001|Overall Study|Cecum not intubated|0
7935054|NCT02345889|12469692|FG002|Overall Study|Cecum not intubated|0
7935055|NCT02345889|12469693|FG003|Overall Study|Cecum not intubated|0
7935056|NCT02346136|12469705|FG000|Overall Study|Withdrawal by Subject|7
7935057|NCT02346136|12469706|FG001|Overall Study|Withdrawal by Subject|5
7935058|NCT02346136|12469705|FG000|Overall Study|Death|1
7935059|NCT02346136|12469706|FG001|Overall Study|Death|0
7935060|NCT02346136|12469705|FG000|Overall Study|Study termination|14
7935061|NCT02346136|12469706|FG001|Overall Study|Study termination|18
7935062|NCT02346240|12469716|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0
7935063|NCT02346240|12469717|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4
7935064|NCT02346240|12469718|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1
7935065|NCT02346240|12469719|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1
7935066|NCT02346240|12469720|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0
7935067|NCT02346240|12469721|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0
7935068|NCT02346240|12469722|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0
7935069|NCT02346240|12469723|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0
7935070|NCT02346240|12469724|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0
7935071|NCT02346240|12469725|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0
7935072|NCT02346240|12469726|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0
7935073|NCT02346240|12469727|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0
7935074|NCT02346240|12469728|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0
7935075|NCT02346240|12469729|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0
7935076|NCT02346240|12469730|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0
7935077|NCT02346240|12469731|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0
7935078|NCT02346240|12469732|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0
7935079|NCT02346240|12469733|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0
7935080|NCT02346240|12469734|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0
7935081|NCT02346240|12469735|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0
7935082|NCT02346240|12469736|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0
7935083|NCT02346240|12469737|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0
7935084|NCT02346240|12469738|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0
7967176|NCT02761733|12523727|FG001|Overall Study|Lost to Follow-up|7
7935085|NCT02346240|12469739|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0
7935086|NCT02346240|12469716|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935087|NCT02346240|12469717|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
7935088|NCT02346240|12469718|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935089|NCT02346240|12469719|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935090|NCT02346240|12469720|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935091|NCT02346240|12469721|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935092|NCT02346240|12469722|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935093|NCT02346240|12469723|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935094|NCT02346240|12469724|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935095|NCT02346240|12469725|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935096|NCT02346240|12469726|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935097|NCT02346240|12469727|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935098|NCT02346240|12469728|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935099|NCT02346240|12469729|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935100|NCT02346240|12469730|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935101|NCT02346240|12469731|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935102|NCT02346240|12469732|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935103|NCT02346240|12469733|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935104|NCT02346240|12469734|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935105|NCT02346240|12469735|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935106|NCT02346240|12469736|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935107|NCT02346240|12469737|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935108|NCT02346240|12469738|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935109|NCT02346240|12469739|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7935110|NCT02346240|12469716|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935111|NCT02346240|12469717|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1
7935112|NCT02346240|12469718|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935113|NCT02346240|12469719|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935114|NCT02346240|12469720|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935115|NCT02346240|12469721|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935116|NCT02346240|12469722|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935117|NCT02346240|12469723|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935118|NCT02346240|12469724|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935119|NCT02346240|12469725|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935120|NCT02346240|12469726|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935121|NCT02346240|12469727|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935122|NCT02346240|12469728|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935123|NCT02346240|12469729|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935124|NCT02346240|12469730|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935125|NCT02346240|12469731|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935126|NCT02346240|12469732|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935127|NCT02346240|12469733|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935128|NCT02346240|12469734|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935129|NCT02346240|12469735|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935130|NCT02346240|12469736|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935131|NCT02346240|12469737|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935132|NCT02346240|12469738|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935133|NCT02346240|12469739|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0
7935134|NCT02346240|12469716|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
7935135|NCT02346240|12469717|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
7935136|NCT02346240|12469718|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
7935137|NCT02346240|12469719|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
7935138|NCT02346240|12469720|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935139|NCT02346240|12469721|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935140|NCT02346240|12469722|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935141|NCT02346240|12469723|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935142|NCT02346240|12469724|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935143|NCT02346240|12469725|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935144|NCT02346240|12469726|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935145|NCT02346240|12469727|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935146|NCT02346240|12469728|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935147|NCT02346240|12469729|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935148|NCT02346240|12469730|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935149|NCT02346240|12469731|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935150|NCT02346240|12469732|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935151|NCT02346240|12469733|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935152|NCT02346240|12469734|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935153|NCT02346240|12469735|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935154|NCT02346240|12469736|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935155|NCT02346240|12469737|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935156|NCT02346240|12469738|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935157|NCT02346240|12469739|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7935158|NCT02346240|12469716|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
7935159|NCT02346240|12469717|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
7935160|NCT02346240|12469718|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
7935161|NCT02346240|12469719|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
7935162|NCT02346240|12469720|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935163|NCT02346240|12469721|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935164|NCT02346240|12469722|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935165|NCT02346240|12469723|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935166|NCT02346240|12469724|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935167|NCT02346240|12469725|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935168|NCT02346240|12469726|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935169|NCT02346240|12469727|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935170|NCT02346240|12469728|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935171|NCT02346240|12469729|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935172|NCT02346240|12469730|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935173|NCT02346240|12469731|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935174|NCT02346240|12469732|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935175|NCT02346240|12469733|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935176|NCT02346240|12469734|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935177|NCT02346240|12469735|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935178|NCT02346240|12469736|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935179|NCT02346240|12469737|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935180|NCT02346240|12469738|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935181|NCT02346240|12469739|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7935182|NCT02346240|12469716|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0
7935183|NCT02346240|12469717|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1
7935184|NCT02346240|12469718|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0
7935185|NCT02346240|12469719|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1
7935186|NCT02346240|12469720|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0
7935187|NCT02346240|12469721|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0
7935188|NCT02346240|12469722|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0
7935189|NCT02346240|12469723|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0
7935190|NCT02346240|12469724|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0
7935191|NCT02346240|12469725|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0
7935192|NCT02346240|12469726|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0
7935193|NCT02346240|12469727|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0
7935194|NCT02346240|12469728|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0
7935195|NCT02346240|12469729|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0
7935196|NCT02346240|12469730|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0
7935197|NCT02346240|12469731|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0
7935198|NCT02346240|12469732|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0
7935199|NCT02346240|12469733|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0
7935200|NCT02346240|12469734|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0
7935201|NCT02346240|12469735|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0
7935202|NCT02346240|12469736|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0
7935203|NCT02346240|12469737|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0
7935204|NCT02346240|12469738|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0
7935205|NCT02346240|12469739|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0
7935206|NCT02346240|12469716|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935207|NCT02346240|12469717|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935208|NCT02346240|12469718|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
7935209|NCT02346240|12469719|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935210|NCT02346240|12469720|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935211|NCT02346240|12469721|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935212|NCT02346240|12469722|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935213|NCT02346240|12469723|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935214|NCT02346240|12469724|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7967177|NCT02761733|12523728|FG002|Overall Study|Lost to Follow-up|0
7935215|NCT02346240|12469725|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935216|NCT02346240|12469726|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935217|NCT02346240|12469727|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935218|NCT02346240|12469728|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935219|NCT02346240|12469729|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935220|NCT02346240|12469730|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935221|NCT02346240|12469731|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935222|NCT02346240|12469732|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935223|NCT02346240|12469733|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935224|NCT02346240|12469734|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935225|NCT02346240|12469735|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935226|NCT02346240|12469736|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935227|NCT02346240|12469737|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935228|NCT02346240|12469738|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935229|NCT02346240|12469739|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7935230|NCT02346240|12469716|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935231|NCT02346240|12469717|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935232|NCT02346240|12469718|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935233|NCT02346240|12469719|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935234|NCT02346240|12469720|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935235|NCT02346240|12469721|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935236|NCT02346240|12469722|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935237|NCT02346240|12469723|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7935238|NCT02346240|12469724|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7935239|NCT02346240|12469725|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935240|NCT02346240|12469726|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935241|NCT02346240|12469727|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935242|NCT02346240|12469728|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935243|NCT02346240|12469729|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7935244|NCT02346240|12469730|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
7935245|NCT02346240|12469731|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7935246|NCT02346240|12469732|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7935247|NCT02346240|12469733|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935248|NCT02346240|12469734|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935249|NCT02346240|12469735|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935250|NCT02346240|12469736|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935251|NCT02346240|12469737|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935252|NCT02346240|12469738|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935253|NCT02346240|12469739|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7935254|NCT02346240|12469716|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935255|NCT02346240|12469717|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935256|NCT02346240|12469718|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935257|NCT02346240|12469719|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935258|NCT02346240|12469720|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935259|NCT02346240|12469721|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935260|NCT02346240|12469722|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935261|NCT02346240|12469723|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935262|NCT02346240|12469724|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935263|NCT02346240|12469725|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935264|NCT02346240|12469726|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935265|NCT02346240|12469727|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935266|NCT02346240|12469728|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935267|NCT02346240|12469729|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7935268|NCT02346240|12469730|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935269|NCT02346240|12469731|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3
7935270|NCT02346240|12469732|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935271|NCT02346240|12469733|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935272|NCT02346240|12469734|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935273|NCT02346240|12469735|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935274|NCT02346240|12469736|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935275|NCT02346240|12469737|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935276|NCT02346240|12469738|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935277|NCT02346240|12469739|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7935278|NCT02346240|12469716|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935279|NCT02346240|12469717|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935280|NCT02346240|12469718|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935281|NCT02346240|12469719|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935282|NCT02346240|12469720|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935283|NCT02346240|12469721|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935284|NCT02346240|12469722|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935285|NCT02346240|12469723|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935286|NCT02346240|12469724|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935287|NCT02346240|12469725|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935288|NCT02346240|12469726|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935289|NCT02346240|12469727|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935290|NCT02346240|12469728|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935291|NCT02346240|12469729|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935292|NCT02346240|12469730|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
7935293|NCT02346240|12469731|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935294|NCT02346240|12469732|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935295|NCT02346240|12469733|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935296|NCT02346240|12469734|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935297|NCT02346240|12469735|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935298|NCT02346240|12469736|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935299|NCT02346240|12469737|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935300|NCT02346240|12469738|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935301|NCT02346240|12469739|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7935302|NCT02346240|12469716|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7935303|NCT02346240|12469717|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7935304|NCT02346240|12469718|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7935305|NCT02346240|12469719|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7935306|NCT02346240|12469720|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7935307|NCT02346240|12469721|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7935308|NCT02346240|12469722|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7935309|NCT02346240|12469723|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7935310|NCT02346240|12469724|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7935311|NCT02346240|12469725|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7935312|NCT02346240|12469726|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7935313|NCT02346240|12469727|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
7935314|NCT02346240|12469728|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7935315|NCT02346240|12469729|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
7935316|NCT02346240|12469730|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5
7935317|NCT02346240|12469731|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
7935318|NCT02346240|12469732|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7935319|NCT02346240|12469733|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7935320|NCT02346240|12469734|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7935321|NCT02346240|12469735|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7935322|NCT02346240|12469736|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7935323|NCT02346240|12469737|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7935324|NCT02346240|12469738|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7935325|NCT02346240|12469739|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7935326|NCT02346240|12469716|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935327|NCT02346240|12469717|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935328|NCT02346240|12469718|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935329|NCT02346240|12469719|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935330|NCT02346240|12469720|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935331|NCT02346240|12469721|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935332|NCT02346240|12469722|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935333|NCT02346240|12469723|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935334|NCT02346240|12469724|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935335|NCT02346240|12469725|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935336|NCT02346240|12469726|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935337|NCT02346240|12469727|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935338|NCT02346240|12469728|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935339|NCT02346240|12469729|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
7935340|NCT02346240|12469730|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
7935341|NCT02346240|12469731|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8
7935342|NCT02346240|12469732|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4
7935343|NCT02346240|12469733|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935344|NCT02346240|12469734|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935345|NCT02346240|12469735|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935346|NCT02346240|12469736|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935347|NCT02346240|12469737|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935348|NCT02346240|12469738|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935349|NCT02346240|12469739|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7935350|NCT02346240|12469716|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935351|NCT02346240|12469717|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935352|NCT02346240|12469718|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935353|NCT02346240|12469719|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935354|NCT02346240|12469720|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935355|NCT02346240|12469721|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935356|NCT02346240|12469722|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1
7935357|NCT02346240|12469723|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935358|NCT02346240|12469724|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935359|NCT02346240|12469725|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935360|NCT02346240|12469726|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935361|NCT02346240|12469727|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935362|NCT02346240|12469728|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935363|NCT02346240|12469729|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935364|NCT02346240|12469730|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935365|NCT02346240|12469731|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935366|NCT02346240|12469732|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935367|NCT02346240|12469733|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935368|NCT02346240|12469734|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935369|NCT02346240|12469735|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935370|NCT02346240|12469736|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935371|NCT02346240|12469737|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935372|NCT02346240|12469738|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935373|NCT02346240|12469739|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7935374|NCT02346240|12469716|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935375|NCT02346240|12469717|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935376|NCT02346240|12469718|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935377|NCT02346240|12469719|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935378|NCT02346240|12469720|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935379|NCT02346240|12469721|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935380|NCT02346240|12469722|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935381|NCT02346240|12469723|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935382|NCT02346240|12469724|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7935383|NCT02346240|12469725|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935384|NCT02346240|12469726|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935385|NCT02346240|12469727|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7935386|NCT02346240|12469728|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935387|NCT02346240|12469729|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7935388|NCT02346240|12469730|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7935389|NCT02346240|12469731|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935390|NCT02346240|12469732|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935391|NCT02346240|12469733|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935392|NCT02346240|12469734|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935393|NCT02346240|12469735|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935394|NCT02346240|12469736|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935395|NCT02346240|12469737|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935396|NCT02346240|12469738|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935397|NCT02346240|12469739|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7935398|NCT02346240|12469716|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935399|NCT02346240|12469717|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935400|NCT02346240|12469718|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935401|NCT02346240|12469719|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935402|NCT02346240|12469720|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935403|NCT02346240|12469721|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935404|NCT02346240|12469722|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935405|NCT02346240|12469723|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935406|NCT02346240|12469724|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935407|NCT02346240|12469725|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1
7935408|NCT02346240|12469726|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935409|NCT02346240|12469727|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935410|NCT02346240|12469728|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935411|NCT02346240|12469729|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935412|NCT02346240|12469730|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935413|NCT02346240|12469731|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935414|NCT02346240|12469732|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935415|NCT02346240|12469733|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935416|NCT02346240|12469734|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935417|NCT02346240|12469735|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935418|NCT02346240|12469736|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935419|NCT02346240|12469737|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935420|NCT02346240|12469738|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935421|NCT02346240|12469739|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7935422|NCT02346240|12469716|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935423|NCT02346240|12469717|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935424|NCT02346240|12469718|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935425|NCT02346240|12469719|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935426|NCT02346240|12469720|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935427|NCT02346240|12469721|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935428|NCT02346240|12469722|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935429|NCT02346240|12469723|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935430|NCT02346240|12469724|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935431|NCT02346240|12469725|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935432|NCT02346240|12469726|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1
7935433|NCT02346240|12469727|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935434|NCT02346240|12469728|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935435|NCT02346240|12469729|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935436|NCT02346240|12469730|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935437|NCT02346240|12469731|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935438|NCT02346240|12469732|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935439|NCT02346240|12469733|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935440|NCT02346240|12469734|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935441|NCT02346240|12469735|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935442|NCT02346240|12469736|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935443|NCT02346240|12469737|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935444|NCT02346240|12469738|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935445|NCT02346240|12469739|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7935446|NCT02346240|12469716|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935447|NCT02346240|12469717|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935448|NCT02346240|12469718|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935449|NCT02346240|12469719|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935450|NCT02346240|12469720|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935451|NCT02346240|12469721|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935452|NCT02346240|12469722|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935453|NCT02346240|12469723|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935454|NCT02346240|12469724|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935455|NCT02346240|12469725|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935456|NCT02346240|12469726|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935457|NCT02346240|12469727|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935458|NCT02346240|12469728|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935459|NCT02346240|12469729|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935460|NCT02346240|12469730|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1
7935461|NCT02346240|12469731|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935462|NCT02346240|12469732|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935463|NCT02346240|12469733|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935464|NCT02346240|12469734|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935465|NCT02346240|12469735|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935466|NCT02346240|12469736|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935467|NCT02346240|12469737|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935468|NCT02346240|12469738|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935469|NCT02346240|12469739|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7935470|NCT02346240|12469716|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935471|NCT02346240|12469717|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935472|NCT02346240|12469718|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935473|NCT02346240|12469719|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7719780|NCT00534313|12143732|FG001|Long-term Period|Withdrawal by Subject|2
7719781|NCT00534313|12143733|FG002|Long-term Period|Withdrawal by Subject|0
7719782|NCT00534313|12143734|FG003|Long-term Period|Withdrawal by Subject|0
7767841|NCT00856284|12210626|FG002|Overall Study|Voluntary withdrawal|62
7935474|NCT02346240|12469720|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935475|NCT02346240|12469721|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935476|NCT02346240|12469722|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935477|NCT02346240|12469723|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935478|NCT02346240|12469724|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935479|NCT02346240|12469725|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935480|NCT02346240|12469726|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935481|NCT02346240|12469727|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935482|NCT02346240|12469728|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935483|NCT02346240|12469729|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935484|NCT02346240|12469730|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1
7935485|NCT02346240|12469731|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935486|NCT02346240|12469732|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935487|NCT02346240|12469733|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935488|NCT02346240|12469734|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935489|NCT02346240|12469735|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935490|NCT02346240|12469736|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7822128|NCT01259856|12291080|FG000|Overall Study|Unknown/missing|2
7822129|NCT01259856|12291081|FG001|Overall Study|Unknown/missing|2
7822130|NCT01259869|12291087|FG000|Overall Study|Duplicated registration|1
7822131|NCT01260142|12291097|FG000|Treatment Period 1|Study on hold|1
7822132|NCT01260142|12291098|FG001|Treatment Period 1|Study on hold|1
7822133|NCT01260142|12291099|FG002|Treatment Period 1|Study on hold|0
7822134|NCT01260142|12291100|FG003|Treatment Period 1|Study on hold|0
7822135|NCT01260142|12291101|FG004|Treatment Period 1|Study on hold|1
7822136|NCT01260142|12291102|FG005|Treatment Period 1|Study on hold|2
7822137|NCT01260142|12291097|FG000|Treatment Period 1|Unexplained elevated sys. BP|0
7822138|NCT01260142|12291098|FG001|Treatment Period 1|Unexplained elevated sys. BP|0
7822139|NCT01260142|12291099|FG002|Treatment Period 1|Unexplained elevated sys. BP|0
7822140|NCT01260142|12291100|FG003|Treatment Period 1|Unexplained elevated sys. BP|0
7935491|NCT02346240|12469737|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935492|NCT02346240|12469738|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7935493|NCT02346240|12469739|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7822141|NCT01260142|12291101|FG004|Treatment Period 1|Unexplained elevated sys. BP|1
7822142|NCT01260142|12291102|FG005|Treatment Period 1|Unexplained elevated sys. BP|0
7822143|NCT01260142|12291097|FG000|Treatment Period 1|Withdrawal by Subject|0
7822144|NCT01260142|12291098|FG001|Treatment Period 1|Withdrawal by Subject|0
7822145|NCT01260142|12291099|FG002|Treatment Period 1|Withdrawal by Subject|0
7822146|NCT01260142|12291100|FG003|Treatment Period 1|Withdrawal by Subject|0
7822147|NCT01260142|12291101|FG004|Treatment Period 1|Withdrawal by Subject|0
7822148|NCT01260142|12291102|FG005|Treatment Period 1|Withdrawal by Subject|1
7822149|NCT01260181|12291122|FG000|Overall Study|Decision of Investigator|1
7822150|NCT01260194|12291126|FG000|Overall Study|Withdrawal of Consent|1
7822151|NCT01260311|12291141|FG000|Overall Study|Adverse Event|11
7822152|NCT01260311|12291141|FG000|Overall Study|Lack of Efficacy|4
7822153|NCT01260311|12291141|FG000|Overall Study|Lost to Follow-up|25
7822154|NCT01260311|12291141|FG000|Overall Study|Withdrawal by Subject|6
7822155|NCT01260311|12291141|FG000|Overall Study|Financial Constraints|77
7822156|NCT01260311|12291141|FG000|Overall Study|Gone to Province|2
7822157|NCT01260311|12291141|FG000|Overall Study|Medication Stopped|1
7822158|NCT01260311|12291141|FG000|Overall Study|Fesoterodine Started Before Enrollment|1
7822159|NCT01260350|12291174|FG000|Overall Study|Lack of Efficacy|0
7822160|NCT01260350|12291175|FG001|Overall Study|Lack of Efficacy|0
7822161|NCT01260350|12291176|FG002|Overall Study|Lack of Efficacy|0
7822162|NCT01260350|12291177|FG003|Overall Study|Lack of Efficacy|0
7822163|NCT01260350|12291178|FG004|Overall Study|Lack of Efficacy|0
7822164|NCT01260350|12291179|FG005|Overall Study|Lack of Efficacy|0
7822165|NCT01260350|12291180|FG006|Overall Study|Lack of Efficacy|0
7822166|NCT01260350|12291181|FG007|Overall Study|Lack of Efficacy|0
7822167|NCT01260350|12291182|FG008|Overall Study|Lack of Efficacy|0
7822168|NCT01260350|12291183|FG009|Overall Study|Lack of Efficacy|0
7822169|NCT01260350|12291184|FG010|Overall Study|Lack of Efficacy|0
7822170|NCT01260350|12291185|FG011|Overall Study|Lack of Efficacy|0
7822171|NCT01260350|12291186|FG012|Overall Study|Lack of Efficacy|0
7822172|NCT01260350|12291187|FG013|Overall Study|Lack of Efficacy|0
7935494|NCT02346240|12469716|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935495|NCT02346240|12469717|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935496|NCT02346240|12469718|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935497|NCT02346240|12469719|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935498|NCT02346240|12469720|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935499|NCT02346240|12469721|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935500|NCT02346240|12469722|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935501|NCT02346240|12469723|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935502|NCT02346240|12469724|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935503|NCT02346240|12469725|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935504|NCT02346240|12469726|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935505|NCT02346240|12469727|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935506|NCT02346240|12469728|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935507|NCT02346240|12469729|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935508|NCT02346240|12469730|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1
7935509|NCT02346240|12469731|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935510|NCT02346240|12469732|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935511|NCT02346240|12469733|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935512|NCT02346240|12469734|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935513|NCT02346240|12469735|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935514|NCT02346240|12469736|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935515|NCT02346240|12469737|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935516|NCT02346240|12469738|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935517|NCT02346240|12469739|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7935518|NCT02346240|12469716|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935519|NCT02346240|12469717|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935520|NCT02346240|12469718|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935521|NCT02346240|12469719|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935522|NCT02346240|12469720|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935523|NCT02346240|12469721|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935524|NCT02346240|12469722|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935525|NCT02346240|12469723|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935526|NCT02346240|12469724|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935527|NCT02346240|12469725|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935528|NCT02346240|12469726|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935529|NCT02346240|12469727|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935530|NCT02346240|12469728|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935531|NCT02346240|12469729|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935532|NCT02346240|12469730|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935533|NCT02346240|12469731|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935534|NCT02346240|12469732|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7935535|NCT02346240|12469733|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1
7935536|NCT02346240|12469734|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6
7935537|NCT02346240|12469735|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2
7935538|NCT02346240|12469736|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
7935539|NCT02346240|12469737|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13
7935540|NCT02346240|12469738|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
7935541|NCT02346240|12469739|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
7935542|NCT02346240|12469716|FG000|Open-Label Period (Week 48 to Week 144)|Death|0
7935543|NCT02346240|12469717|FG001|Open-Label Period (Week 48 to Week 144)|Death|0
7935544|NCT02346240|12469718|FG002|Open-Label Period (Week 48 to Week 144)|Death|0
7935545|NCT02346240|12469719|FG003|Open-Label Period (Week 48 to Week 144)|Death|0
7935546|NCT02346240|12469720|FG004|Open-Label Period (Week 48 to Week 144)|Death|0
7935547|NCT02346240|12469721|FG005|Open-Label Period (Week 48 to Week 144)|Death|0
7935548|NCT02346240|12469722|FG006|Open-Label Period (Week 48 to Week 144)|Death|0
7935549|NCT02346240|12469723|FG007|Open-Label Period (Week 48 to Week 144)|Death|0
7935550|NCT02346240|12469724|FG008|Open-Label Period (Week 48 to Week 144)|Death|0
7935551|NCT02346240|12469725|FG009|Open-Label Period (Week 48 to Week 144)|Death|0
7935552|NCT02346240|12469726|FG010|Open-Label Period (Week 48 to Week 144)|Death|0
7935553|NCT02346240|12469727|FG011|Open-Label Period (Week 48 to Week 144)|Death|0
7935554|NCT02346240|12469728|FG012|Open-Label Period (Week 48 to Week 144)|Death|0
7935555|NCT02346240|12469729|FG013|Open-Label Period (Week 48 to Week 144)|Death|0
7935556|NCT02346240|12469730|FG014|Open-Label Period (Week 48 to Week 144)|Death|0
7935557|NCT02346240|12469731|FG015|Open-Label Period (Week 48 to Week 144)|Death|0
7935558|NCT02346240|12469732|FG016|Open-Label Period (Week 48 to Week 144)|Death|0
7935559|NCT02346240|12469733|FG017|Open-Label Period (Week 48 to Week 144)|Death|0
7935560|NCT02346240|12469734|FG018|Open-Label Period (Week 48 to Week 144)|Death|1
7935561|NCT02346240|12469735|FG019|Open-Label Period (Week 48 to Week 144)|Death|1
7935562|NCT02346240|12469736|FG020|Open-Label Period (Week 48 to Week 144)|Death|0
7935563|NCT02346240|12469737|FG021|Open-Label Period (Week 48 to Week 144)|Death|1
7935564|NCT02346240|12469738|FG022|Open-Label Period (Week 48 to Week 144)|Death|0
7935565|NCT02346240|12469739|FG023|Open-Label Period (Week 48 to Week 144)|Death|0
7935566|NCT02346240|12469716|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935567|NCT02346240|12469717|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935568|NCT02346240|12469718|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935569|NCT02346240|12469719|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935570|NCT02346240|12469720|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935571|NCT02346240|12469721|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935572|NCT02346240|12469722|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935573|NCT02346240|12469723|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935574|NCT02346240|12469724|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935575|NCT02346240|12469725|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935576|NCT02346240|12469726|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935577|NCT02346240|12469727|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935578|NCT02346240|12469728|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935579|NCT02346240|12469729|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935580|NCT02346240|12469730|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935581|NCT02346240|12469731|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935582|NCT02346240|12469732|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935583|NCT02346240|12469733|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935584|NCT02346240|12469734|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
7935585|NCT02346240|12469735|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935586|NCT02346240|12469736|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935587|NCT02346240|12469737|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
7935588|NCT02346240|12469738|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935589|NCT02346240|12469739|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7935590|NCT02346240|12469716|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935591|NCT02346240|12469717|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935592|NCT02346240|12469718|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935593|NCT02346240|12469719|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935594|NCT02346240|12469720|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935595|NCT02346240|12469721|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935596|NCT02346240|12469722|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935597|NCT02346240|12469723|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935598|NCT02346240|12469724|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935599|NCT02346240|12469725|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935600|NCT02346240|12469726|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935601|NCT02346240|12469727|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935602|NCT02346240|12469728|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935603|NCT02346240|12469729|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935604|NCT02346240|12469730|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935605|NCT02346240|12469731|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935606|NCT02346240|12469732|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935607|NCT02346240|12469733|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935608|NCT02346240|12469734|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935609|NCT02346240|12469735|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935610|NCT02346240|12469736|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935611|NCT02346240|12469737|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1
7935612|NCT02346240|12469738|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935613|NCT02346240|12469739|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7935614|NCT02346240|12469716|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935615|NCT02346240|12469717|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935616|NCT02346240|12469718|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935617|NCT02346240|12469719|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935618|NCT02346240|12469720|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935619|NCT02346240|12469721|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935620|NCT02346240|12469722|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935621|NCT02346240|12469723|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935622|NCT02346240|12469724|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935623|NCT02346240|12469725|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935624|NCT02346240|12469726|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935625|NCT02346240|12469727|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935626|NCT02346240|12469728|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935627|NCT02346240|12469729|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935628|NCT02346240|12469730|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935629|NCT02346240|12469731|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935630|NCT02346240|12469732|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935631|NCT02346240|12469733|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
7935632|NCT02346240|12469734|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
7935633|NCT02346240|12469735|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3
7935634|NCT02346240|12469736|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7935635|NCT02346240|12469737|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
7935636|NCT02346240|12469738|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
7935637|NCT02346240|12469739|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
7935638|NCT02346240|12469716|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935639|NCT02346240|12469717|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935640|NCT02346240|12469718|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935641|NCT02346240|12469719|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935642|NCT02346240|12469720|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935643|NCT02346240|12469721|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935644|NCT02346240|12469722|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935645|NCT02346240|12469723|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935646|NCT02346240|12469724|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935647|NCT02346240|12469725|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935648|NCT02346240|12469726|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935649|NCT02346240|12469727|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935650|NCT02346240|12469728|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935651|NCT02346240|12469729|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935652|NCT02346240|12469730|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935653|NCT02346240|12469731|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935654|NCT02346240|12469732|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935655|NCT02346240|12469733|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935656|NCT02346240|12469734|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4
7935657|NCT02346240|12469735|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7935658|NCT02346240|12469736|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7935659|NCT02346240|12469737|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10
7935660|NCT02346240|12469738|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7935661|NCT02346240|12469739|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7935662|NCT02346240|12469716|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935663|NCT02346240|12469717|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935664|NCT02346240|12469718|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935665|NCT02346240|12469719|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935666|NCT02346240|12469720|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935667|NCT02346240|12469721|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935668|NCT02346240|12469722|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935669|NCT02346240|12469723|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935670|NCT02346240|12469724|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935671|NCT02346240|12469725|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935672|NCT02346240|12469726|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935673|NCT02346240|12469727|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935674|NCT02346240|12469728|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935675|NCT02346240|12469729|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935676|NCT02346240|12469730|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935677|NCT02346240|12469731|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935678|NCT02346240|12469732|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935679|NCT02346240|12469733|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935680|NCT02346240|12469734|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
7935681|NCT02346240|12469735|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935682|NCT02346240|12469736|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7935683|NCT02346240|12469737|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4
7935684|NCT02346240|12469738|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
7935685|NCT02346240|12469739|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3
7935686|NCT02346240|12469716|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935687|NCT02346240|12469717|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935688|NCT02346240|12469718|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935689|NCT02346240|12469719|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935690|NCT02346240|12469720|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935691|NCT02346240|12469721|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935692|NCT02346240|12469722|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935693|NCT02346240|12469723|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935694|NCT02346240|12469724|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935695|NCT02346240|12469725|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935696|NCT02346240|12469726|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935697|NCT02346240|12469727|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935698|NCT02346240|12469728|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935699|NCT02346240|12469729|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935700|NCT02346240|12469730|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935701|NCT02346240|12469731|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935702|NCT02346240|12469732|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935703|NCT02346240|12469733|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935704|NCT02346240|12469734|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1
7935705|NCT02346240|12469735|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935706|NCT02346240|12469736|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935707|NCT02346240|12469737|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935708|NCT02346240|12469738|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935709|NCT02346240|12469739|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7935710|NCT02346370|12469764|FG000|Overall Study|Not treated|1
7935711|NCT02346370|12469765|FG001|Overall Study|Not treated|0
7935712|NCT02346370|12469766|FG002|Overall Study|Not treated|0
7935713|NCT02346370|12469764|FG000|Overall Study|Withdrawal of consent|1
7935714|NCT02346370|12469765|FG001|Overall Study|Withdrawal of consent|0
7935715|NCT02346370|12469766|FG002|Overall Study|Withdrawal of consent|0
7935716|NCT02346370|12469764|FG000|Overall Study|Death|1
7935717|NCT02346370|12469765|FG001|Overall Study|Death|3
7935718|NCT02346370|12469766|FG002|Overall Study|Death|1
7935719|NCT02346370|12469764|FG000|Overall Study|Sponsor discontinued study|5
7935720|NCT02346370|12469765|FG001|Overall Study|Sponsor discontinued study|0
7935721|NCT02346370|12469766|FG002|Overall Study|Sponsor discontinued study|2
7935722|NCT02346370|12469764|FG000|Overall Study|Radiologic progression|0
7935723|NCT02346370|12469765|FG001|Overall Study|Radiologic progression|0
7935724|NCT02346370|12469766|FG002|Overall Study|Radiologic progression|1
7935725|NCT02346370|12469764|FG000|Overall Study|Physician Decision|0
7935726|NCT02346370|12469765|FG001|Overall Study|Physician Decision|1
7935727|NCT02346370|12469766|FG002|Overall Study|Physician Decision|0
7935728|NCT02346708|12469800|FG000|Overall Study|Adverse Event|2
7935729|NCT02346708|12469801|FG001|Overall Study|Adverse Event|0
7935730|NCT02346708|12469800|FG000|Overall Study|Protocol Violation|0
7935731|NCT02346708|12469801|FG001|Overall Study|Protocol Violation|1
7935732|NCT02346721|12469808|FG000|Overall Study|Withdrew Consent|3
7935733|NCT02346721|12469808|FG000|Overall Study|Lack of Efficacy|1
7935734|NCT02347072|12469822|FG000|Overall Study|Adverse Event|2
7935735|NCT02347072|12469822|FG000|Overall Study|Withdrawal by Subject|6
7935736|NCT02347072|12469822|FG000|Overall Study|Physician Decision|1
7935737|NCT02347072|12469822|FG000|Overall Study|Lost to Follow-up|2
7935738|NCT02347072|12469822|FG000|Overall Study|Protocol Violation|1
7935739|NCT02347072|12469822|FG000|Overall Study|Disc due to Protocol-specified Criteria|6
7935740|NCT02347085|12469830|FG000|Overall Study|Adverse Event|2
7935741|NCT02347085|12469830|FG000|Overall Study|Lack of Efficacy|1
7935742|NCT02347085|12469830|FG000|Overall Study|Withdrawal by Subject|4
7935743|NCT02347085|12469830|FG000|Overall Study|Lost to Follow-up|1
7935744|NCT02347085|12469830|FG000|Overall Study|Protocol Criteria|2
7935745|NCT02347098|12469838|FG000|Overall Study|Death|1
7935746|NCT02347098|12469839|FG001|Overall Study|Death|0
7935747|NCT02347098|12469838|FG000|Overall Study|Withdrawal by Subject|1
7935748|NCT02347098|12469839|FG001|Overall Study|Withdrawal by Subject|0
7935749|NCT02347098|12469838|FG000|Overall Study|Lost to Follow-up|2
7935750|NCT02347098|12469839|FG001|Overall Study|Lost to Follow-up|2
7935751|NCT02347098|12469838|FG000|Overall Study|Refuse Follow-up Visit|1
7935752|NCT02347098|12469839|FG001|Overall Study|Refuse Follow-up Visit|5
7935753|NCT02347098|12469838|FG000|Overall Study|no visit due to illness|2
7935754|NCT02347098|12469839|FG001|Overall Study|no visit due to illness|1
7935755|NCT02347176|12469858|FG000|Overall Study|Lost to Follow-up|2
7935756|NCT02347176|12469859|FG001|Overall Study|Lost to Follow-up|3
7935757|NCT02347176|12469860|FG002|Overall Study|Lost to Follow-up|1
7935758|NCT02347176|12469861|FG003|Overall Study|Lost to Follow-up|1
7935759|NCT02347176|12469858|FG000|Overall Study|Withdrawal by Subject|9
7935760|NCT02347176|12469859|FG001|Overall Study|Withdrawal by Subject|5
7935761|NCT02347176|12469860|FG002|Overall Study|Withdrawal by Subject|5
7935762|NCT02347176|12469861|FG003|Overall Study|Withdrawal by Subject|3
7935763|NCT02347176|12469858|FG000|Overall Study|Other|1
7935764|NCT02347176|12469859|FG001|Overall Study|Other|2
7935765|NCT02347176|12469860|FG002|Overall Study|Other|2
7935766|NCT02347176|12469861|FG003|Overall Study|Other|0
7935767|NCT02347189|12469871|FG000|Overall Study|No implant attempted of study device|9
7935768|NCT02347189|12469871|FG000|Overall Study|No primary outcome data available|2
7935769|NCT02347332|12469888|FG000|Overall Study|Not treated|5
7935770|NCT02347332|12469889|FG001|Overall Study|Not treated|2
7935771|NCT02347332|12469888|FG000|Overall Study|Progressive disease|141
7935772|NCT02347332|12469889|FG001|Overall Study|Progressive disease|159
7935773|NCT02347332|12469888|FG000|Overall Study|Adverse Event|50
7935774|NCT02347332|12469889|FG001|Overall Study|Adverse Event|41
7935775|NCT02347332|12469888|FG000|Overall Study|Death (Unknown, Various reasons)|6
7935776|NCT02347332|12469889|FG001|Overall Study|Death (Unknown, Various reasons)|6
7935777|NCT02347332|12469888|FG000|Overall Study|Protocol Violation|1
7935778|NCT02347332|12469889|FG001|Overall Study|Protocol Violation|1
7935779|NCT02347332|12469888|FG000|Overall Study|Lost to Follow-up|2
7935780|NCT02347332|12469889|FG001|Overall Study|Lost to Follow-up|1
7935781|NCT02347332|12469888|FG000|Overall Study|Physician Decision|4
7935782|NCT02347332|12469889|FG001|Overall Study|Physician Decision|3
7935783|NCT02347332|12469888|FG000|Overall Study|Withdrawal by Subject|20
7935784|NCT02347332|12469889|FG001|Overall Study|Withdrawal by Subject|14
7935785|NCT02347332|12469888|FG000|Overall Study|Protocol requirement|1
7935786|NCT02347332|12469889|FG001|Overall Study|Protocol requirement|1
7935787|NCT02347332|12469888|FG000|Overall Study|Switch Post-Trial program|0
7935788|NCT02347332|12469889|FG001|Overall Study|Switch Post-Trial program|1
7935789|NCT02347631|12469948|FG000|First Intervention (2 Months)|Adverse Event|1
7935790|NCT02347631|12469949|FG001|First Intervention (2 Months)|Adverse Event|1
7935791|NCT02347631|12469948|FG000|First Intervention (2 Months)|Pregnancy|1
7935792|NCT02347631|12469949|FG001|First Intervention (2 Months)|Pregnancy|0
7935793|NCT02347631|12469948|FG000|First Intervention (2 Months)|Moved out of area|0
7935794|NCT02347631|12469949|FG001|First Intervention (2 Months)|Moved out of area|2
7935795|NCT02347631|12469948|FG000|First Intervention (2 Months)|Lost to Follow-up|5
7935796|NCT02347631|12469949|FG001|First Intervention (2 Months)|Lost to Follow-up|3
7935797|NCT02347631|12469948|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2
7935798|NCT02347631|12469949|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2
7935799|NCT02347631|12469948|FG000|Washout 2 (1 Month)|Lost to Follow-up|0
7935800|NCT02347631|12469949|FG001|Washout 2 (1 Month)|Lost to Follow-up|1
7935801|NCT02347631|12469948|FG000|Second Intervention (2 Months)|Lost to Follow-up|7
7935802|NCT02347631|12469949|FG001|Second Intervention (2 Months)|Lost to Follow-up|4
7935803|NCT02347631|12469948|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6
7935804|NCT02347631|12469949|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0
7935805|NCT02347657|12469959|FG000|Overall Study|Physician Decision|0
7935806|NCT02347657|12469960|FG001|Overall Study|Physician Decision|1
7935807|NCT02347657|12469959|FG000|Overall Study|Adverse Event|8
7935808|NCT02347657|12469960|FG001|Overall Study|Adverse Event|4
7935809|NCT02347657|12469959|FG000|Overall Study|Withdrawal by Subject|6
7935810|NCT02347657|12469960|FG001|Overall Study|Withdrawal by Subject|7
7935811|NCT02347657|12469959|FG000|Overall Study|Randomized but not treated|1
7935812|NCT02347657|12469960|FG001|Overall Study|Randomized but not treated|0
7935813|NCT02347657|12469959|FG000|Overall Study|Other|3
7935814|NCT02347657|12469960|FG001|Overall Study|Other|3
7935815|NCT02347761|12469970|FG000|All Collected|Death|1
7935816|NCT02347761|12469971|FG001|All Collected|Death|0
7935817|NCT02347761|12469972|FG002|All Collected|Death|0
7935818|NCT02347761|12469970|FG000|All Collected|Lost to Follow-up|3
7935819|NCT02347761|12469971|FG001|All Collected|Lost to Follow-up|2
7935820|NCT02347761|12469972|FG002|All Collected|Lost to Follow-up|3
7935821|NCT02347761|12469970|FG000|All Collected|Withdrawal by Subject|11
7935822|NCT02347761|12469971|FG001|All Collected|Withdrawal by Subject|11
7935823|NCT02347761|12469972|FG002|All Collected|Withdrawal by Subject|22
7935824|NCT02347761|12469970|FG000|All Collected|invetigator disretion|2
7935825|NCT02347761|12469971|FG001|All Collected|invetigator disretion|0
7935826|NCT02347761|12469972|FG002|All Collected|invetigator disretion|0
7935827|NCT02347761|12469970|FG000|All Collected|instillation site pain|0
7935828|NCT02347761|12469971|FG001|All Collected|instillation site pain|0
7935829|NCT02347761|12469972|FG002|All Collected|instillation site pain|1
7935830|NCT02347761|12469970|FG000|All Collected|exacerbation of COPD|0
7935831|NCT02347761|12469971|FG001|All Collected|exacerbation of COPD|0
7935832|NCT02347761|12469972|FG002|All Collected|exacerbation of COPD|1
7935833|NCT02347761|12469970|FG000|All Collected|moved/travel|0
7935834|NCT02347761|12469971|FG001|All Collected|moved/travel|1
7935835|NCT02347761|12469972|FG002|All Collected|moved/travel|0
7935836|NCT02347761|12469970|FG000|On Study Treatment|Lack of Efficacy|2
7935837|NCT02347761|12469971|FG001|On Study Treatment|Lack of Efficacy|3
7935838|NCT02347761|12469972|FG002|On Study Treatment|Lack of Efficacy|4
7935839|NCT02347761|12469970|FG000|On Study Treatment|non-compliance with study medication|0
7935840|NCT02347761|12469971|FG001|On Study Treatment|non-compliance with study medication|0
7935841|NCT02347761|12469972|FG002|On Study Treatment|non-compliance with study medication|2
7935842|NCT02347761|12469970|FG000|On Study Treatment|Withdrawal by Subject|7
7935843|NCT02347761|12469971|FG001|On Study Treatment|Withdrawal by Subject|3
7935844|NCT02347761|12469972|FG002|On Study Treatment|Withdrawal by Subject|5
7935845|NCT02347761|12469970|FG000|On Study Treatment|move/travel|2
7935846|NCT02347761|12469971|FG001|On Study Treatment|move/travel|6
7935847|NCT02347761|12469972|FG002|On Study Treatment|move/travel|5
7935848|NCT02347761|12469970|FG000|On Study Treatment|dissastisfaction with device|2
7935849|NCT02347761|12469971|FG001|On Study Treatment|dissastisfaction with device|1
7935850|NCT02347761|12469972|FG002|On Study Treatment|dissastisfaction with device|4
7935851|NCT02347761|12469970|FG000|On Study Treatment|Lost to Follow-up|2
7935852|NCT02347761|12469971|FG001|On Study Treatment|Lost to Follow-up|1
7935853|NCT02347761|12469972|FG002|On Study Treatment|Lost to Follow-up|1
7935854|NCT02347761|12469970|FG000|On Study Treatment|investigator discretion|2
7935855|NCT02347761|12469971|FG001|On Study Treatment|investigator discretion|0
7935856|NCT02347761|12469972|FG002|On Study Treatment|investigator discretion|0
7935857|NCT02347761|12469970|FG000|On Study Treatment|durg not working|0
7935858|NCT02347761|12469971|FG001|On Study Treatment|durg not working|1
7935859|NCT02347761|12469972|FG002|On Study Treatment|durg not working|1
7935860|NCT02347761|12469970|FG000|On Study Treatment|Adverse Event|10
7935861|NCT02347761|12469971|FG001|On Study Treatment|Adverse Event|8
7935862|NCT02347761|12469972|FG002|On Study Treatment|Adverse Event|20
7935863|NCT02347774|12469983|FG000|Study Participation|Lost to Follow-up|3
7935864|NCT02347774|12469984|FG001|Study Participation|Lost to Follow-up|6
7935865|NCT02347774|12469985|FG002|Study Participation|Lost to Follow-up|2
7935866|NCT02347774|12469983|FG000|Study Participation|Withdrawal by Subject|8
7935867|NCT02347774|12469984|FG001|Study Participation|Withdrawal by Subject|9
7935868|NCT02347774|12469985|FG002|Study Participation|Withdrawal by Subject|15
7935869|NCT02347774|12469983|FG000|Study Participation|Adverse Event|1
7935870|NCT02347774|12469984|FG001|Study Participation|Adverse Event|4
7935871|NCT02347774|12469985|FG002|Study Participation|Adverse Event|6
7935872|NCT02347774|12469983|FG000|Study Participation|withdrew consent|1
7935873|NCT02347774|12469984|FG001|Study Participation|withdrew consent|1
7935874|NCT02347774|12469985|FG002|Study Participation|withdrew consent|1
7935875|NCT02347774|12469983|FG000|Study Participation|Met Prolonged QT criteria|1
7935876|NCT02347774|12469984|FG001|Study Participation|Met Prolonged QT criteria|0
7935877|NCT02347774|12469985|FG002|Study Participation|Met Prolonged QT criteria|0
7935878|NCT02347774|12469983|FG000|Study Participation|non-compliance with study drug|0
7935879|NCT02347774|12469984|FG001|Study Participation|non-compliance with study drug|1
7935880|NCT02347774|12469985|FG002|Study Participation|non-compliance with study drug|0
7935881|NCT02347774|12469983|FG000|Study Participation|incarceration|1
7935882|NCT02347774|12469984|FG001|Study Participation|incarceration|0
7935883|NCT02347774|12469985|FG002|Study Participation|incarceration|0
7935884|NCT02347774|12469983|FG000|Study Participation|randomized in error|0
7935885|NCT02347774|12469984|FG001|Study Participation|randomized in error|0
7935886|NCT02347774|12469985|FG002|Study Participation|randomized in error|1
7935887|NCT02347774|12469983|FG000|On Study Treatment|Adverse Event|9
7935888|NCT02347774|12469984|FG001|On Study Treatment|Adverse Event|15
7935889|NCT02347774|12469985|FG002|On Study Treatment|Adverse Event|19
7935890|NCT02347774|12469983|FG000|On Study Treatment|Lack of Efficacy|3
7935891|NCT02347774|12469984|FG001|On Study Treatment|Lack of Efficacy|0
7935892|NCT02347774|12469985|FG002|On Study Treatment|Lack of Efficacy|2
7935893|NCT02347774|12469983|FG000|On Study Treatment|non-complicance with study medication|0
7935894|NCT02347774|12469984|FG001|On Study Treatment|non-complicance with study medication|2
7935895|NCT02347774|12469985|FG002|On Study Treatment|non-complicance with study medication|0
7935896|NCT02347774|12469983|FG000|On Study Treatment|Protocol Violation|0
7935897|NCT02347774|12469984|FG001|On Study Treatment|Protocol Violation|0
7935898|NCT02347774|12469985|FG002|On Study Treatment|Protocol Violation|1
7935899|NCT02347774|12469983|FG000|On Study Treatment|withdrew consent|9
7935900|NCT02347774|12469984|FG001|On Study Treatment|withdrew consent|8
7935901|NCT02347774|12469985|FG002|On Study Treatment|withdrew consent|12
7935902|NCT02347774|12469983|FG000|On Study Treatment|Lost to Follow-up|2
7935903|NCT02347774|12469984|FG001|On Study Treatment|Lost to Follow-up|6
7935904|NCT02347774|12469985|FG002|On Study Treatment|Lost to Follow-up|1
7935905|NCT02347774|12469983|FG000|On Study Treatment|Met Prolonged QT criteria|1
7935906|NCT02347774|12469984|FG001|On Study Treatment|Met Prolonged QT criteria|0
7935907|NCT02347774|12469985|FG002|On Study Treatment|Met Prolonged QT criteria|0
7935908|NCT02347774|12469983|FG000|On Study Treatment|ranomized in error|0
7935909|NCT02347774|12469984|FG001|On Study Treatment|ranomized in error|0
7935910|NCT02347774|12469985|FG002|On Study Treatment|ranomized in error|1
7935911|NCT02347787|12469995|FG000|6 Month Follow-Up|Lost to Follow-up|63
7935912|NCT02347787|12469996|FG001|6 Month Follow-Up|Lost to Follow-up|47
7935913|NCT02347787|12469995|FG000|6 Month Follow-Up|Withdrawal by Subject|3
7935914|NCT02347787|12469996|FG001|6 Month Follow-Up|Withdrawal by Subject|9
7935915|NCT02347787|12469995|FG000|9 Month Follow-Up|Lost to Follow-up|52
7935916|NCT02347787|12469996|FG001|9 Month Follow-Up|Lost to Follow-up|59
7935917|NCT02347787|12469995|FG000|9 Month Follow-Up|Withdrawal by Subject|9
7935918|NCT02347787|12469996|FG001|9 Month Follow-Up|Withdrawal by Subject|12
7935919|NCT02347813|12470009|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1
7935920|NCT02347813|12470010|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1
7935921|NCT02347813|12470009|FG000|First Intervention, 24 Weeks|Adverse Event|1
7935922|NCT02347813|12470010|FG001|First Intervention, 24 Weeks|Adverse Event|1
7935923|NCT02348489|12470029|FG000|Overall Study|Death|336
7935924|NCT02348489|12470030|FG001|Overall Study|Death|335
7935925|NCT02348489|12470029|FG000|Overall Study|Withdrawal by Subject|14
7935926|NCT02348489|12470030|FG001|Overall Study|Withdrawal by Subject|27
7935927|NCT02348489|12470029|FG000|Overall Study|Lost to Follow-up|3
7935928|NCT02348489|12470030|FG001|Overall Study|Lost to Follow-up|5
7935929|NCT02348723|12470103|FG000|Overall Study|No ablation|21
7935930|NCT02348723|12470104|FG001|Overall Study|No ablation|20
7935931|NCT02348723|12470103|FG000|Overall Study|Non-compliant with Protocol|1
7935932|NCT02348723|12470104|FG001|Overall Study|Non-compliant with Protocol|0
7935933|NCT02348723|12470103|FG000|Overall Study|Lost to Follow-up|1
7935934|NCT02348723|12470104|FG001|Overall Study|Lost to Follow-up|1
7935935|NCT02348723|12470103|FG000|Overall Study|Consent withdrawn|1
7935936|NCT02348723|12470104|FG001|Overall Study|Consent withdrawn|3
7935937|NCT02348723|12470103|FG000|Overall Study|Reason other than specified|1
7935938|NCT02348723|12470104|FG001|Overall Study|Reason other than specified|1
7935939|NCT02348723|12470103|FG000|Overall Study|Adverse Event|3
7935940|NCT02348723|12470104|FG001|Overall Study|Adverse Event|1
7935941|NCT02348840|12470123|FG000|Overall Study|Withdrawal by Subject|2
7935942|NCT02348840|12470124|FG001|Overall Study|Withdrawal by Subject|1
7935943|NCT02348840|12470125|FG002|Overall Study|Withdrawal by Subject|0
7935944|NCT02348840|12470126|FG003|Overall Study|Withdrawal by Subject|0
7935945|NCT02349048|12470175|FG000|Overall Study|Withdrawal by Subject|4
7935946|NCT02349048|12470176|FG001|Overall Study|Withdrawal by Subject|0
7935947|NCT02349048|12470175|FG000|Overall Study|Lost to Follow-up|1
7935948|NCT02349048|12470176|FG001|Overall Study|Lost to Follow-up|0
7935949|NCT02349061|12470184|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4
7935950|NCT02349061|12470185|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3
7935951|NCT02349061|12470186|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0
7935952|NCT02349061|12470184|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1
7935953|NCT02349061|12470185|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
7935954|NCT02349061|12470186|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
7935955|NCT02349061|12470184|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1
7935956|NCT02349061|12470185|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0
7935957|NCT02349061|12470186|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0
7935958|NCT02349061|12470184|FG000|Main Study: PCP (Up to Week 24)|Other|1
7935959|NCT02349061|12470185|FG001|Main Study: PCP (Up to Week 24)|Other|1
7935960|NCT02349061|12470186|FG002|Main Study: PCP (Up to Week 24)|Other|0
7935961|NCT02349061|12470184|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2
7767842|NCT00856284|12210624|FG000|Overall Study|Pregnancy|1
7935962|NCT02349061|12470185|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
7935963|NCT02349061|12470186|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
7935964|NCT02349061|12470184|FG000|Main Study: Week 24 to 56|Adverse Event|0
7935965|NCT02349061|12470185|FG001|Main Study: Week 24 to 56|Adverse Event|2
7935966|NCT02349061|12470186|FG002|Main Study: Week 24 to 56|Adverse Event|1
7935967|NCT02349061|12470184|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0
7935968|NCT02349061|12470185|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1
7935969|NCT02349061|12470186|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0
7935970|NCT02349061|12470184|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0
7935971|NCT02349061|12470185|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0
7935972|NCT02349061|12470186|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1
7935973|NCT02349061|12470184|FG000|Main Study: Week 24 to 56|Physician Decision|0
7935974|NCT02349061|12470185|FG001|Main Study: Week 24 to 56|Physician Decision|0
7935975|NCT02349061|12470186|FG002|Main Study: Week 24 to 56|Physician Decision|1
7935976|NCT02349061|12470184|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0
7935977|NCT02349061|12470185|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3
7935978|NCT02349061|12470186|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0
7935979|NCT02349061|12470184|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
7935980|NCT02349061|12470185|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
7935981|NCT02349061|12470186|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1
7935982|NCT02349061|12470184|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0
7935983|NCT02349061|12470185|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2
7935984|NCT02349061|12470186|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1
7935985|NCT02349061|12470184|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0
7935986|NCT02349061|12470185|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0
7935987|NCT02349061|12470186|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1
7935988|NCT02349295|12470212|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7
7935989|NCT02349295|12470213|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5
7935990|NCT02349295|12470214|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5
7935991|NCT02349295|12470215|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0
7935992|NCT02349295|12470216|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0
7935993|NCT02349295|12470217|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0
7935994|NCT02349295|12470218|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0
7935995|NCT02349295|12470219|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0
7935996|NCT02349295|12470220|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0
7935997|NCT02349295|12470221|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0
7935998|NCT02349295|12470222|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0
7935999|NCT02349295|12470223|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0
7936000|NCT02349295|12470224|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0
7936001|NCT02349295|12470225|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0
7936002|NCT02349295|12470212|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
7936003|NCT02349295|12470213|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
7936004|NCT02349295|12470214|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
7936005|NCT02349295|12470215|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7936006|NCT02349295|12470216|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7936007|NCT02349295|12470217|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7936008|NCT02349295|12470218|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7936009|NCT02349295|12470219|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7936010|NCT02349295|12470220|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7936011|NCT02349295|12470221|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7936012|NCT02349295|12470222|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7936013|NCT02349295|12470223|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7936014|NCT02349295|12470224|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7936015|NCT02349295|12470225|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7936016|NCT02349295|12470212|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
7936017|NCT02349295|12470213|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
7936018|NCT02349295|12470214|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
7936019|NCT02349295|12470215|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7936020|NCT02349295|12470216|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7936021|NCT02349295|12470217|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7936022|NCT02349295|12470218|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7936023|NCT02349295|12470219|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7936024|NCT02349295|12470220|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7936025|NCT02349295|12470221|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7936026|NCT02349295|12470222|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7936027|NCT02349295|12470223|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7936028|NCT02349295|12470224|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7936029|NCT02349295|12470225|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7936030|NCT02349295|12470212|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
7936031|NCT02349295|12470213|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
7936032|NCT02349295|12470214|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
7936033|NCT02349295|12470215|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7936034|NCT02349295|12470216|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7936035|NCT02349295|12470217|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7719783|NCT00534313|12143731|FG000|Long-term Period|No longer meets study criteria|0
7936036|NCT02349295|12470218|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7936037|NCT02349295|12470219|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7936038|NCT02349295|12470220|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7936039|NCT02349295|12470221|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7936040|NCT02349295|12470222|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7936041|NCT02349295|12470223|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7936042|NCT02349295|12470224|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7936043|NCT02349295|12470225|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7936044|NCT02349295|12470212|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7936045|NCT02349295|12470213|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
7936046|NCT02349295|12470214|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
7936047|NCT02349295|12470215|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7936048|NCT02349295|12470216|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7936049|NCT02349295|12470217|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7936050|NCT02349295|12470218|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7936051|NCT02349295|12470219|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7936052|NCT02349295|12470220|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7936053|NCT02349295|12470221|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7936054|NCT02349295|12470222|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7936055|NCT02349295|12470223|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7936056|NCT02349295|12470224|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7936057|NCT02349295|12470225|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7936058|NCT02349295|12470212|FG000|IR (Week 16-24)|Lack of Efficacy|0
7936059|NCT02349295|12470213|FG001|IR (Week 16-24)|Lack of Efficacy|0
7936060|NCT02349295|12470214|FG002|IR (Week 16-24)|Lack of Efficacy|0
7936061|NCT02349295|12470215|FG003|IR (Week 16-24)|Lack of Efficacy|1
7936062|NCT02349295|12470216|FG004|IR (Week 16-24)|Lack of Efficacy|0
7936063|NCT02349295|12470217|FG005|IR (Week 16-24)|Lack of Efficacy|0
7936064|NCT02349295|12470218|FG006|IR (Week 16-24)|Lack of Efficacy|0
7936065|NCT02349295|12470219|FG007|IR (Week 16-24)|Lack of Efficacy|0
7936066|NCT02349295|12470220|FG008|IR (Week 16-24)|Lack of Efficacy|0
7936067|NCT02349295|12470221|FG009|IR (Week 16-24)|Lack of Efficacy|0
7936068|NCT02349295|12470222|FG010|IR (Week 16-24)|Lack of Efficacy|0
7936069|NCT02349295|12470223|FG011|IR (Week 16-24)|Lack of Efficacy|0
7936070|NCT02349295|12470224|FG012|IR (Week 16-24)|Lack of Efficacy|0
7936071|NCT02349295|12470225|FG013|IR (Week 16-24)|Lack of Efficacy|0
7936072|NCT02349295|12470212|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7936073|NCT02349295|12470213|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7936074|NCT02349295|12470214|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7936075|NCT02349295|12470215|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7936076|NCT02349295|12470216|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7936077|NCT02349295|12470217|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7936078|NCT02349295|12470218|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7936079|NCT02349295|12470219|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32
7936080|NCT02349295|12470220|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25
7936081|NCT02349295|12470221|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19
7936082|NCT02349295|12470222|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18
7936083|NCT02349295|12470223|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7936084|NCT02349295|12470224|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7936085|NCT02349295|12470225|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7936086|NCT02349295|12470212|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7936087|NCT02349295|12470213|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7936088|NCT02349295|12470214|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7936089|NCT02349295|12470215|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7936090|NCT02349295|12470216|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7936091|NCT02349295|12470217|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7936092|NCT02349295|12470218|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7936093|NCT02349295|12470219|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9
7936094|NCT02349295|12470220|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9
7936095|NCT02349295|12470221|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2
7936096|NCT02349295|12470222|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2
7936097|NCT02349295|12470223|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7936098|NCT02349295|12470224|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7936099|NCT02349295|12470225|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7936100|NCT02349295|12470212|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7936101|NCT02349295|12470213|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7936102|NCT02349295|12470214|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7936103|NCT02349295|12470215|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7936104|NCT02349295|12470216|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7936105|NCT02349295|12470217|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7936106|NCT02349295|12470218|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7936107|NCT02349295|12470219|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2
7936108|NCT02349295|12470220|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7936109|NCT02349295|12470221|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3
7936110|NCT02349295|12470222|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7936111|NCT02349295|12470223|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7936112|NCT02349295|12470224|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7936113|NCT02349295|12470225|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7936114|NCT02349295|12470212|FG000|Long-Term Extension Period (Week 24-156)|Death|0
7936115|NCT02349295|12470213|FG001|Long-Term Extension Period (Week 24-156)|Death|0
7936116|NCT02349295|12470214|FG002|Long-Term Extension Period (Week 24-156)|Death|0
7936117|NCT02349295|12470215|FG003|Long-Term Extension Period (Week 24-156)|Death|0
7936118|NCT02349295|12470216|FG004|Long-Term Extension Period (Week 24-156)|Death|0
7936119|NCT02349295|12470217|FG005|Long-Term Extension Period (Week 24-156)|Death|0
7936120|NCT02349295|12470218|FG006|Long-Term Extension Period (Week 24-156)|Death|0
7936121|NCT02349295|12470219|FG007|Long-Term Extension Period (Week 24-156)|Death|1
7936122|NCT02349295|12470220|FG008|Long-Term Extension Period (Week 24-156)|Death|1
7936123|NCT02349295|12470221|FG009|Long-Term Extension Period (Week 24-156)|Death|1
7936124|NCT02349295|12470222|FG010|Long-Term Extension Period (Week 24-156)|Death|0
7936125|NCT02349295|12470223|FG011|Long-Term Extension Period (Week 24-156)|Death|0
7936126|NCT02349295|12470224|FG012|Long-Term Extension Period (Week 24-156)|Death|0
7936127|NCT02349295|12470225|FG013|Long-Term Extension Period (Week 24-156)|Death|0
7936128|NCT02349295|12470212|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7936129|NCT02349295|12470213|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7936130|NCT02349295|12470214|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7936131|NCT02349295|12470215|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7936132|NCT02349295|12470216|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7936133|NCT02349295|12470217|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7936134|NCT02349295|12470218|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7936135|NCT02349295|12470219|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4
7936136|NCT02349295|12470220|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2
7936137|NCT02349295|12470221|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1
7936138|NCT02349295|12470222|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3
7936139|NCT02349295|12470223|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7936140|NCT02349295|12470224|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7936141|NCT02349295|12470225|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7936142|NCT02349295|12470212|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7936143|NCT02349295|12470213|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7936144|NCT02349295|12470214|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7936145|NCT02349295|12470215|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7936146|NCT02349295|12470216|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7936147|NCT02349295|12470217|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7936148|NCT02349295|12470218|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7936149|NCT02349295|12470219|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
7936150|NCT02349295|12470220|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
7936151|NCT02349295|12470221|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7936152|NCT02349295|12470222|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7936153|NCT02349295|12470223|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7936154|NCT02349295|12470224|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7936155|NCT02349295|12470225|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7936156|NCT02349295|12470212|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7936157|NCT02349295|12470213|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7936158|NCT02349295|12470214|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7936159|NCT02349295|12470215|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7936160|NCT02349295|12470216|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7936161|NCT02349295|12470217|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7936162|NCT02349295|12470218|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7936163|NCT02349295|12470219|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2
7936164|NCT02349295|12470220|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2
7936165|NCT02349295|12470221|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7936166|NCT02349295|12470222|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7936167|NCT02349295|12470223|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7936168|NCT02349295|12470224|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7936169|NCT02349295|12470225|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7936170|NCT02349295|12470212|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7936171|NCT02349295|12470213|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7936172|NCT02349295|12470214|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7936173|NCT02349295|12470215|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7936174|NCT02349295|12470216|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7936175|NCT02349295|12470217|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7936176|NCT02349295|12470218|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7936177|NCT02349295|12470219|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7936178|NCT02349295|12470220|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7936179|NCT02349295|12470221|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7936180|NCT02349295|12470222|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7936181|NCT02349295|12470223|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
7936182|NCT02349295|12470224|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5
7936183|NCT02349295|12470225|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
7936184|NCT02349295|12470212|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7936185|NCT02349295|12470213|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7936186|NCT02349295|12470214|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7936187|NCT02349295|12470215|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7936188|NCT02349295|12470216|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7936189|NCT02349295|12470217|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7936190|NCT02349295|12470218|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7936191|NCT02349295|12470219|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7936192|NCT02349295|12470220|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7936193|NCT02349295|12470221|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7936194|NCT02349295|12470222|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7936195|NCT02349295|12470223|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1
7936196|NCT02349295|12470224|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2
7936197|NCT02349295|12470225|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7936198|NCT02349295|12470212|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7936199|NCT02349295|12470213|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7936200|NCT02349295|12470214|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7936201|NCT02349295|12470215|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7936202|NCT02349295|12470216|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7936203|NCT02349295|12470217|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7936204|NCT02349295|12470218|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7936205|NCT02349295|12470219|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7936206|NCT02349295|12470220|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7936207|NCT02349295|12470221|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7936208|NCT02349295|12470222|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7936209|NCT02349295|12470223|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
7936210|NCT02349295|12470224|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
7936211|NCT02349295|12470225|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7936212|NCT02349295|12470212|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7936213|NCT02349295|12470213|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7936214|NCT02349295|12470214|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7936215|NCT02349295|12470215|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7936216|NCT02349295|12470216|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7936217|NCT02349295|12470217|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7936218|NCT02349295|12470218|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7936219|NCT02349295|12470219|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7936220|NCT02349295|12470220|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7936221|NCT02349295|12470221|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7936222|NCT02349295|12470222|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7936223|NCT02349295|12470223|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2
7936224|NCT02349295|12470224|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7936225|NCT02349295|12470225|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7936226|NCT02349295|12470212|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7936227|NCT02349295|12470213|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7936228|NCT02349295|12470214|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7936229|NCT02349295|12470215|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7936230|NCT02349295|12470216|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7936231|NCT02349295|12470217|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7936232|NCT02349295|12470218|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7936233|NCT02349295|12470219|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7936234|NCT02349295|12470220|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7936235|NCT02349295|12470221|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7936236|NCT02349295|12470222|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7936237|NCT02349295|12470223|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4
7936238|NCT02349295|12470224|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7936239|NCT02349295|12470225|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7936240|NCT02349360|12470252|FG000|Overall Study|Withdrawal by Subject|0
7936241|NCT02349360|12470253|FG001|Overall Study|Withdrawal by Subject|1
7719784|NCT00534313|12143732|FG001|Long-term Period|No longer meets study criteria|1
7719785|NCT00534313|12143733|FG002|Long-term Period|No longer meets study criteria|0
7719786|NCT00534313|12143734|FG003|Long-term Period|No longer meets study criteria|0
7719787|NCT00534313|12143731|FG000|Long-term Period|Poor compliance/noncompliance|0
7719788|NCT00534313|12143732|FG001|Long-term Period|Poor compliance/noncompliance|1
7936242|NCT02349412|12470261|FG000|Overall Study|Withdrawal by Subject|7
7936243|NCT02349412|12470262|FG001|Overall Study|Withdrawal by Subject|7
7936244|NCT02349425|12470272|FG000|Period 1|Adverse Event|1
7936245|NCT02349425|12470273|FG001|Period 1|Adverse Event|1
7936246|NCT02349425|12470274|FG002|Period 1|Adverse Event|0
7936247|NCT02349425|12470275|FG003|Period 1|Adverse Event|0
7936248|NCT02349425|12470272|FG000|Period 2|Adverse Event|0
7936249|NCT02349425|12470273|FG001|Period 2|Adverse Event|1
7936250|NCT02349425|12470274|FG002|Period 2|Adverse Event|1
7936251|NCT02349425|12470275|FG003|Period 2|Adverse Event|0
7964866|NCT01084252|12520470|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7964867|NCT01084252|12520457|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7964868|NCT01084252|12520458|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7964869|NCT01084252|12520459|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7964870|NCT01084252|12520460|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7964871|NCT01084252|12520461|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7964872|NCT01084252|12520462|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7964873|NCT01084252|12520463|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7964874|NCT01084252|12520464|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7964875|NCT01084252|12520465|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7964876|NCT01084252|12520466|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7964877|NCT01084252|12520467|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7964878|NCT01084252|12520468|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7964879|NCT01084252|12520469|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13
7964880|NCT01084252|12520470|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5
7964881|NCT01084252|12520457|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7964882|NCT01084252|12520458|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7964883|NCT01084252|12520459|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7964884|NCT01084252|12520460|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7964885|NCT01084252|12520461|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7964886|NCT01084252|12520462|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7964887|NCT01084252|12520463|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7964888|NCT01084252|12520464|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7964889|NCT01084252|12520465|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7964890|NCT01084252|12520466|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7964891|NCT01084252|12520467|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7964892|NCT01084252|12520468|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7964893|NCT01084252|12520469|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70
7964894|NCT01084252|12520470|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33
7964895|NCT01084252|12520457|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7964896|NCT01084252|12520458|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7964897|NCT01084252|12520459|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7964898|NCT01084252|12520460|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7964899|NCT01084252|12520461|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7964900|NCT01084252|12520462|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7964901|NCT01084252|12520463|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7964902|NCT01084252|12520464|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7964903|NCT01084252|12520465|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7964904|NCT01084252|12520466|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7964905|NCT01084252|12520467|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7964906|NCT01084252|12520468|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7964907|NCT01084252|12520469|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1
7964908|NCT01084252|12520470|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7964909|NCT01084252|12520457|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7964910|NCT01084252|12520458|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7964911|NCT01084252|12520459|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7964912|NCT01084252|12520460|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7964913|NCT01084252|12520461|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7936252|NCT02349451|12470324|FG000|Overall Study|Withdrawal by Subject|0
7936253|NCT02349451|12470325|FG001|Overall Study|Withdrawal by Subject|1
7936254|NCT02349451|12470326|FG002|Overall Study|Withdrawal by Subject|2
7936255|NCT02349451|12470327|FG003|Overall Study|Withdrawal by Subject|1
7936256|NCT02349542|12470353|FG000|Overall Study|Withdrawal by Subject|5
7936257|NCT02349633|12470371|FG000|Overall Study|Death|0
7936258|NCT02349633|12470372|FG001|Overall Study|Death|1
7936259|NCT02349633|12470373|FG002|Overall Study|Death|0
7936260|NCT02349633|12470374|FG003|Overall Study|Death|0
7936261|NCT02349633|12470375|FG004|Overall Study|Death|0
7936262|NCT02349633|12470376|FG005|Overall Study|Death|1
7936263|NCT02349633|12470377|FG006|Overall Study|Death|1
7936264|NCT02349633|12470378|FG007|Overall Study|Death|1
7936265|NCT02349633|12470379|FG008|Overall Study|Death|0
7936266|NCT02349633|12470380|FG009|Overall Study|Death|1
7936267|NCT02349633|12470381|FG010|Overall Study|Death|0
7936268|NCT02349633|12470382|FG011|Overall Study|Death|0
7936269|NCT02349633|12470383|FG012|Overall Study|Death|0
7936270|NCT02349633|12470384|FG013|Overall Study|Death|0
7936271|NCT02349633|12470371|FG000|Overall Study|Withdrawal by Subject|0
7936272|NCT02349633|12470372|FG001|Overall Study|Withdrawal by Subject|0
7936273|NCT02349633|12470373|FG002|Overall Study|Withdrawal by Subject|0
7936274|NCT02349633|12470374|FG003|Overall Study|Withdrawal by Subject|1
7936275|NCT02349633|12470375|FG004|Overall Study|Withdrawal by Subject|0
7936276|NCT02349633|12470376|FG005|Overall Study|Withdrawal by Subject|0
7936277|NCT02349633|12470377|FG006|Overall Study|Withdrawal by Subject|0
7936278|NCT02349633|12470378|FG007|Overall Study|Withdrawal by Subject|2
7936279|NCT02349633|12470379|FG008|Overall Study|Withdrawal by Subject|2
7936280|NCT02349633|12470380|FG009|Overall Study|Withdrawal by Subject|1
7936281|NCT02349633|12470381|FG010|Overall Study|Withdrawal by Subject|0
7936282|NCT02349633|12470382|FG011|Overall Study|Withdrawal by Subject|0
7936283|NCT02349633|12470383|FG012|Overall Study|Withdrawal by Subject|0
7936284|NCT02349633|12470384|FG013|Overall Study|Withdrawal by Subject|0
7936285|NCT02349633|12470371|FG000|Overall Study|Withdrawal of informed consent|0
7936286|NCT02349633|12470372|FG001|Overall Study|Withdrawal of informed consent|0
7936287|NCT02349633|12470373|FG002|Overall Study|Withdrawal of informed consent|0
7936288|NCT02349633|12470374|FG003|Overall Study|Withdrawal of informed consent|1
7936289|NCT02349633|12470375|FG004|Overall Study|Withdrawal of informed consent|1
7936290|NCT02349633|12470376|FG005|Overall Study|Withdrawal of informed consent|0
7936291|NCT02349633|12470377|FG006|Overall Study|Withdrawal of informed consent|0
7936292|NCT02349633|12470378|FG007|Overall Study|Withdrawal of informed consent|3
7936293|NCT02349633|12470379|FG008|Overall Study|Withdrawal of informed consent|0
7936294|NCT02349633|12470380|FG009|Overall Study|Withdrawal of informed consent|0
7936295|NCT02349633|12470381|FG010|Overall Study|Withdrawal of informed consent|0
7936296|NCT02349633|12470382|FG011|Overall Study|Withdrawal of informed consent|0
7936297|NCT02349633|12470383|FG012|Overall Study|Withdrawal of informed consent|0
7936298|NCT02349633|12470384|FG013|Overall Study|Withdrawal of informed consent|0
7936299|NCT02349633|12470371|FG000|Overall Study|Transition to compassionate use|0
7936300|NCT02349633|12470372|FG001|Overall Study|Transition to compassionate use|0
7936301|NCT02349633|12470373|FG002|Overall Study|Transition to compassionate use|0
7936302|NCT02349633|12470374|FG003|Overall Study|Transition to compassionate use|0
7936303|NCT02349633|12470375|FG004|Overall Study|Transition to compassionate use|1
7936304|NCT02349633|12470376|FG005|Overall Study|Transition to compassionate use|0
7936305|NCT02349633|12470377|FG006|Overall Study|Transition to compassionate use|0
7936306|NCT02349633|12470378|FG007|Overall Study|Transition to compassionate use|3
7936307|NCT02349633|12470379|FG008|Overall Study|Transition to compassionate use|0
7936308|NCT02349633|12470380|FG009|Overall Study|Transition to compassionate use|1
7936309|NCT02349633|12470381|FG010|Overall Study|Transition to compassionate use|0
7936310|NCT02349633|12470382|FG011|Overall Study|Transition to compassionate use|0
7936311|NCT02349633|12470383|FG012|Overall Study|Transition to compassionate use|0
7936312|NCT02349633|12470384|FG013|Overall Study|Transition to compassionate use|0
7936313|NCT02349633|12470371|FG000|Overall Study|Early termination of survival follow-up|0
7936314|NCT02349633|12470372|FG001|Overall Study|Early termination of survival follow-up|0
7936315|NCT02349633|12470373|FG002|Overall Study|Early termination of survival follow-up|0
7936316|NCT02349633|12470374|FG003|Overall Study|Early termination of survival follow-up|0
7936317|NCT02349633|12470375|FG004|Overall Study|Early termination of survival follow-up|0
7936318|NCT02349633|12470376|FG005|Overall Study|Early termination of survival follow-up|0
7936319|NCT02349633|12470377|FG006|Overall Study|Early termination of survival follow-up|0
7936320|NCT02349633|12470378|FG007|Overall Study|Early termination of survival follow-up|4
7936321|NCT02349633|12470379|FG008|Overall Study|Early termination of survival follow-up|0
7936322|NCT02349633|12470380|FG009|Overall Study|Early termination of survival follow-up|0
7936323|NCT02349633|12470381|FG010|Overall Study|Early termination of survival follow-up|0
7936324|NCT02349633|12470382|FG011|Overall Study|Early termination of survival follow-up|0
7936325|NCT02349633|12470383|FG012|Overall Study|Early termination of survival follow-up|0
7936326|NCT02349633|12470384|FG013|Overall Study|Early termination of survival follow-up|0
7936327|NCT02349633|12470371|FG000|Overall Study|Termination by sponsor|0
7936328|NCT02349633|12470372|FG001|Overall Study|Termination by sponsor|0
7936329|NCT02349633|12470373|FG002|Overall Study|Termination by sponsor|0
7936330|NCT02349633|12470374|FG003|Overall Study|Termination by sponsor|0
7936331|NCT02349633|12470375|FG004|Overall Study|Termination by sponsor|0
7936332|NCT02349633|12470376|FG005|Overall Study|Termination by sponsor|0
7936333|NCT02349633|12470377|FG006|Overall Study|Termination by sponsor|0
7936334|NCT02349633|12470378|FG007|Overall Study|Termination by sponsor|1
7936335|NCT02349633|12470379|FG008|Overall Study|Termination by sponsor|0
7936336|NCT02349633|12470380|FG009|Overall Study|Termination by sponsor|2
7936337|NCT02349633|12470381|FG010|Overall Study|Termination by sponsor|0
7936338|NCT02349633|12470382|FG011|Overall Study|Termination by sponsor|0
7936339|NCT02349633|12470383|FG012|Overall Study|Termination by sponsor|0
7936340|NCT02349633|12470384|FG013|Overall Study|Termination by sponsor|0
7936341|NCT02349633|12470371|FG000|Overall Study|Other|0
7936342|NCT02349633|12470372|FG001|Overall Study|Other|0
7936343|NCT02349633|12470373|FG002|Overall Study|Other|0
7936344|NCT02349633|12470374|FG003|Overall Study|Other|0
7936345|NCT02349633|12470375|FG004|Overall Study|Other|0
7936346|NCT02349633|12470376|FG005|Overall Study|Other|0
7936347|NCT02349633|12470377|FG006|Overall Study|Other|0
7936348|NCT02349633|12470378|FG007|Overall Study|Other|2
7936349|NCT02349633|12470379|FG008|Overall Study|Other|0
7936350|NCT02349633|12470380|FG009|Overall Study|Other|0
7936351|NCT02349633|12470381|FG010|Overall Study|Other|0
7936352|NCT02349633|12470382|FG011|Overall Study|Other|0
7936353|NCT02349633|12470383|FG012|Overall Study|Other|0
7936354|NCT02349633|12470384|FG013|Overall Study|Other|0
7936355|NCT02349711|12470464|FG000|Overall Study|Withdrawal by Subject|2
7936356|NCT02349711|12470465|FG001|Overall Study|Withdrawal by Subject|1
7936357|NCT02349711|12470464|FG000|Overall Study|Lost to Follow-up|1
7936358|NCT02349711|12470465|FG001|Overall Study|Lost to Follow-up|1
7936359|NCT02349789|12470471|FG000|Overall Study|Withdrawal by Subject|2
7936360|NCT02350127|12470477|FG000|4-Month Assessment|Withdrawal by Subject|10
7936361|NCT02350127|12470478|FG001|4-Month Assessment|Withdrawal by Subject|9
7936362|NCT02350127|12470477|FG000|4-Month Assessment|Death|1
7936363|NCT02350127|12470478|FG001|4-Month Assessment|Death|0
7936364|NCT02350127|12470477|FG000|8-Month Assessment|Death|1
7936365|NCT02350127|12470478|FG001|8-Month Assessment|Death|1
7936366|NCT02350127|12470477|FG000|8-Month Assessment|Withdrawal by Subject|5
7936367|NCT02350127|12470478|FG001|8-Month Assessment|Withdrawal by Subject|8
7936368|NCT02350309|12470491|FG000|Treatment Period 1 (2 Days)|Physician Decision|0
7936369|NCT02350309|12470492|FG001|Treatment Period 1 (2 Days)|Physician Decision|0
7936370|NCT02350309|12470493|FG002|Treatment Period 1 (2 Days)|Physician Decision|1
7936371|NCT02350309|12470494|FG003|Treatment Period 1 (2 Days)|Physician Decision|0
7936372|NCT02350309|12470495|FG004|Treatment Period 1 (2 Days)|Physician Decision|0
7936373|NCT02350309|12470496|FG005|Treatment Period 1 (2 Days)|Physician Decision|0
7936374|NCT02350309|12470491|FG000|Treatment Period 4 (2 Days)|Death in the Family|0
7936375|NCT02350309|12470492|FG001|Treatment Period 4 (2 Days)|Death in the Family|0
7936376|NCT02350309|12470493|FG002|Treatment Period 4 (2 Days)|Death in the Family|0
7936377|NCT02350309|12470494|FG003|Treatment Period 4 (2 Days)|Death in the Family|0
7936378|NCT02350309|12470495|FG004|Treatment Period 4 (2 Days)|Death in the Family|0
7936379|NCT02350309|12470496|FG005|Treatment Period 4 (2 Days)|Death in the Family|1
7936380|NCT02350478|12470513|FG000|Overall Study|Lost to Follow-up|5
7936381|NCT02350478|12470514|FG001|Overall Study|Lost to Follow-up|1
7936382|NCT02351167|12470630|FG000|Overall Study|Withdrawal by Subject|19
7936383|NCT02351167|12470631|FG001|Overall Study|Withdrawal by Subject|18
7936384|NCT02351167|12470632|FG002|Overall Study|Withdrawal by Subject|21
7936385|NCT02351349|12470660|FG000|Overall Study|Withdrawal by Subject|2
7936386|NCT02351349|12470661|FG001|Overall Study|Withdrawal by Subject|3
7936387|NCT02351817|12470697|FG000|Period 1|Adverse Event|1
7936388|NCT02351817|12470698|FG001|Period 1|Adverse Event|2
7936389|NCT02351817|12470697|FG000|Period 1|Lack of Efficacy|0
7936390|NCT02351817|12470698|FG001|Period 1|Lack of Efficacy|1
7936391|NCT02351817|12470697|FG000|Period 2|Adverse Event|0
7936392|NCT02351817|12470698|FG001|Period 2|Adverse Event|2
7936393|NCT02351817|12470697|FG000|Period 2|Protocol Violation|1
7936394|NCT02351817|12470698|FG001|Period 2|Protocol Violation|0
7936395|NCT02351934|12470707|FG000|Allocation|POD weight<pre-op weight|3
7936396|NCT02351934|12470708|FG001|Allocation|POD weight<pre-op weight|0
7967178|NCT02761733|12523729|FG003|Overall Study|Lost to Follow-up|3
7936397|NCT02351934|12470707|FG000|Allocation|Hypotension preventing administration|2
7936398|NCT02351934|12470708|FG001|Allocation|Hypotension preventing administration|0
7936399|NCT02351934|12470707|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1
7936400|NCT02351934|12470708|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0
7936401|NCT02351934|12470707|FG000|Follow-Up|POD weight<pre-op weight|3
7936402|NCT02351934|12470708|FG001|Follow-Up|POD weight<pre-op weight|0
7936403|NCT02351934|12470707|FG000|Follow-Up|Acute Kidney Injury|1
7936404|NCT02351934|12470708|FG001|Follow-Up|Acute Kidney Injury|0
7936405|NCT02351934|12470707|FG000|Follow-Up|Early dismissal|3
7936406|NCT02351934|12470708|FG001|Follow-Up|Early dismissal|0
7936407|NCT02351934|12470707|FG000|Follow-Up|Hypotension|3
7936408|NCT02351934|12470708|FG001|Follow-Up|Hypotension|0
7936409|NCT02351934|12470707|FG000|Follow-Up|No documentation|2
7936410|NCT02351934|12470708|FG001|Follow-Up|No documentation|0
7936411|NCT02351934|12470707|FG000|Follow-Up|1 ERAS Component Noncompliant|0
7936412|NCT02351934|12470708|FG001|Follow-Up|1 ERAS Component Noncompliant|6
7936413|NCT02351934|12470707|FG000|Follow-Up|2 ERAS Components Noncompliant|0
7936414|NCT02351934|12470708|FG001|Follow-Up|2 ERAS Components Noncompliant|4
7936415|NCT02351960|12470716|FG000|Overall Study|Pretreatment Event/Adverse Event|6
7936416|NCT02351960|12470717|FG001|Overall Study|Pretreatment Event/Adverse Event|3
7936417|NCT02351960|12470716|FG000|Overall Study|Voluntary Withdrawal|5
7936418|NCT02351960|12470717|FG001|Overall Study|Voluntary Withdrawal|4
7936419|NCT02351960|12470716|FG000|Overall Study|Significant Protocol Deviation|0
7936420|NCT02351960|12470717|FG001|Overall Study|Significant Protocol Deviation|5
7936421|NCT02352493|12470760|FG000|Overall Study|Pregnancy|0
7936422|NCT02352493|12470761|FG001|Overall Study|Pregnancy|0
7936423|NCT02352493|12470762|FG002|Overall Study|Pregnancy|0
7936424|NCT02352493|12470763|FG003|Overall Study|Pregnancy|0
7936425|NCT02352493|12470764|FG004|Overall Study|Pregnancy|0
7936426|NCT02352493|12470765|FG005|Overall Study|Pregnancy|0
7936427|NCT02352493|12470766|FG006|Overall Study|Pregnancy|1
7936428|NCT02352493|12470767|FG007|Overall Study|Pregnancy|0
7936429|NCT02352493|12470768|FG008|Overall Study|Pregnancy|1
7936430|NCT02352493|12470769|FG009|Overall Study|Pregnancy|0
7936431|NCT02352493|12470770|FG010|Overall Study|Pregnancy|0
7936432|NCT02352493|12470771|FG011|Overall Study|Pregnancy|0
7936433|NCT02352493|12470772|FG012|Overall Study|Pregnancy|0
7936434|NCT02352493|12470773|FG013|Overall Study|Pregnancy|0
7936435|NCT02352493|12470774|FG014|Overall Study|Pregnancy|0
7936436|NCT02352493|12470775|FG015|Overall Study|Pregnancy|0
7936437|NCT02352493|12470776|FG016|Overall Study|Pregnancy|0
7936438|NCT02352493|12470777|FG017|Overall Study|Pregnancy|0
7936439|NCT02352493|12470760|FG000|Overall Study|Withdrawal by Subject|0
7936440|NCT02352493|12470761|FG001|Overall Study|Withdrawal by Subject|0
7936441|NCT02352493|12470762|FG002|Overall Study|Withdrawal by Subject|0
7936442|NCT02352493|12470763|FG003|Overall Study|Withdrawal by Subject|0
7936443|NCT02352493|12470764|FG004|Overall Study|Withdrawal by Subject|0
7936444|NCT02352493|12470765|FG005|Overall Study|Withdrawal by Subject|0
7936445|NCT02352493|12470766|FG006|Overall Study|Withdrawal by Subject|0
7936446|NCT02352493|12470767|FG007|Overall Study|Withdrawal by Subject|0
7936447|NCT02352493|12470768|FG008|Overall Study|Withdrawal by Subject|1
7936448|NCT02352493|12470769|FG009|Overall Study|Withdrawal by Subject|0
7936449|NCT02352493|12470770|FG010|Overall Study|Withdrawal by Subject|0
7936450|NCT02352493|12470771|FG011|Overall Study|Withdrawal by Subject|0
7936451|NCT02352493|12470772|FG012|Overall Study|Withdrawal by Subject|0
7936452|NCT02352493|12470773|FG013|Overall Study|Withdrawal by Subject|0
7936453|NCT02352493|12470774|FG014|Overall Study|Withdrawal by Subject|1
7936454|NCT02352493|12470775|FG015|Overall Study|Withdrawal by Subject|0
7936455|NCT02352493|12470776|FG016|Overall Study|Withdrawal by Subject|0
7936456|NCT02352493|12470777|FG017|Overall Study|Withdrawal by Subject|0
7936457|NCT02352493|12470760|FG000|Overall Study|Lost to Follow-up|0
7936458|NCT02352493|12470761|FG001|Overall Study|Lost to Follow-up|0
7936459|NCT02352493|12470762|FG002|Overall Study|Lost to Follow-up|0
7936460|NCT02352493|12470763|FG003|Overall Study|Lost to Follow-up|0
7936461|NCT02352493|12470764|FG004|Overall Study|Lost to Follow-up|0
7936462|NCT02352493|12470765|FG005|Overall Study|Lost to Follow-up|0
7936463|NCT02352493|12470766|FG006|Overall Study|Lost to Follow-up|0
7936464|NCT02352493|12470767|FG007|Overall Study|Lost to Follow-up|0
7936465|NCT02352493|12470768|FG008|Overall Study|Lost to Follow-up|0
7936466|NCT02352493|12470769|FG009|Overall Study|Lost to Follow-up|1
7936467|NCT02352493|12470770|FG010|Overall Study|Lost to Follow-up|0
7936468|NCT02352493|12470771|FG011|Overall Study|Lost to Follow-up|0
7936469|NCT02352493|12470772|FG012|Overall Study|Lost to Follow-up|1
7936470|NCT02352493|12470773|FG013|Overall Study|Lost to Follow-up|2
7936471|NCT02352493|12470774|FG014|Overall Study|Lost to Follow-up|0
7936472|NCT02352493|12470775|FG015|Overall Study|Lost to Follow-up|0
7936473|NCT02352493|12470776|FG016|Overall Study|Lost to Follow-up|0
7936474|NCT02352493|12470777|FG017|Overall Study|Lost to Follow-up|0
7936475|NCT02352779|12470835|FG000|Overall Study|Personal Issues|1
7936476|NCT02352779|12470836|FG001|Overall Study|Personal Issues|1
7936477|NCT02352779|12470837|FG002|Overall Study|Personal Issues|0
7936478|NCT02352779|12470835|FG000|Overall Study|Too Many Forms|2
7936479|NCT02352779|12470836|FG001|Overall Study|Too Many Forms|0
7936480|NCT02352779|12470837|FG002|Overall Study|Too Many Forms|0
7936481|NCT02352779|12470835|FG000|Overall Study|Feeling Overwhelmed|1
7936482|NCT02352779|12470836|FG001|Overall Study|Feeling Overwhelmed|0
7936483|NCT02352779|12470837|FG002|Overall Study|Feeling Overwhelmed|0
7936484|NCT02352779|12470835|FG000|Overall Study|Disliked Intervention|1
7936485|NCT02352779|12470836|FG001|Overall Study|Disliked Intervention|0
7936486|NCT02352779|12470837|FG002|Overall Study|Disliked Intervention|0
7936487|NCT02352779|12470835|FG000|Overall Study|Changed Mind|1
7936488|NCT02352779|12470836|FG001|Overall Study|Changed Mind|0
7936489|NCT02352779|12470837|FG002|Overall Study|Changed Mind|0
7936490|NCT02352779|12470835|FG000|Overall Study|Study Related Symptoms|1
7936491|NCT02352779|12470836|FG001|Overall Study|Study Related Symptoms|0
7936492|NCT02352779|12470837|FG002|Overall Study|Study Related Symptoms|0
7936493|NCT02352779|12470835|FG000|Overall Study|Absence of Symptoms|1
7936494|NCT02352779|12470836|FG001|Overall Study|Absence of Symptoms|0
7936495|NCT02352779|12470837|FG002|Overall Study|Absence of Symptoms|0
7936496|NCT02352779|12470835|FG000|Overall Study|Other Medical Reason|0
7936497|NCT02352779|12470836|FG001|Overall Study|Other Medical Reason|0
7936498|NCT02352779|12470837|FG002|Overall Study|Other Medical Reason|1
7936499|NCT02352779|12470835|FG000|Overall Study|No Reason|0
7936500|NCT02352779|12470836|FG001|Overall Study|No Reason|0
7936501|NCT02352779|12470837|FG002|Overall Study|No Reason|1
7936502|NCT02353169|12470895|FG000|Overall Study|QTc > 450 msec|1
7936503|NCT02353169|12470896|FG001|Overall Study|QTc > 450 msec|1
7936504|NCT02353169|12470897|FG002|Overall Study|QTc > 450 msec|1
7936505|NCT02353169|12470898|FG003|Overall Study|QTc > 450 msec|1
7936506|NCT02353169|12470895|FG000|Overall Study|OR team declined|2
7936507|NCT02353169|12470896|FG001|Overall Study|OR team declined|0
7936508|NCT02353169|12470897|FG002|Overall Study|OR team declined|0
7936509|NCT02353169|12470898|FG003|Overall Study|OR team declined|0
7936510|NCT02353169|12470895|FG000|Overall Study|Inhalational induction|0
7936511|NCT02353169|12470896|FG001|Overall Study|Inhalational induction|2
7936512|NCT02353169|12470897|FG002|Overall Study|Inhalational induction|0
7936513|NCT02353169|12470898|FG003|Overall Study|Inhalational induction|0
7936514|NCT02353169|12470895|FG000|Overall Study|ECG data error|0
7936515|NCT02353169|12470896|FG001|Overall Study|ECG data error|3
7936516|NCT02353169|12470897|FG002|Overall Study|ECG data error|2
7936517|NCT02353169|12470898|FG003|Overall Study|ECG data error|2
7936518|NCT02353169|12470895|FG000|Overall Study|Pre-op medication|0
7936519|NCT02353169|12470896|FG001|Overall Study|Pre-op medication|0
7936520|NCT02353169|12470897|FG002|Overall Study|Pre-op medication|1
7936521|NCT02353169|12470898|FG003|Overall Study|Pre-op medication|0
7936522|NCT02353442|12470931|FG000|Overall Study|Withdrawal by Subject|3
7936523|NCT02353442|12470932|FG001|Overall Study|Withdrawal by Subject|4
7936524|NCT02354222|12470986|FG000|Overall Study|Adverse Event|0
7936525|NCT02354222|12470987|FG001|Overall Study|Adverse Event|3
7936526|NCT02354222|12470986|FG000|Overall Study|Physician Decision|1
7936527|NCT02354222|12470987|FG001|Overall Study|Physician Decision|1
7936528|NCT02354222|12470986|FG000|Overall Study|Pregnancy|1
7936529|NCT02354222|12470987|FG001|Overall Study|Pregnancy|0
7936530|NCT02354222|12470986|FG000|Overall Study|Withdrawal by Subject|2
7936531|NCT02354222|12470987|FG001|Overall Study|Withdrawal by Subject|3
7936532|NCT02354222|12470986|FG000|Overall Study|Conflict with the stopping criteria|0
7936533|NCT02354222|12470987|FG001|Overall Study|Conflict with the stopping criteria|4
7936534|NCT02354235|12470995|FG000|Overall Study|Adverse Event|2
7936535|NCT02354235|12470996|FG001|Overall Study|Adverse Event|2
7936536|NCT02354235|12470995|FG000|Overall Study|Physician Decision|0
7936537|NCT02354235|12470996|FG001|Overall Study|Physician Decision|1
7936538|NCT02354235|12470995|FG000|Overall Study|Withdrawal by Subject|1
7936539|NCT02354235|12470996|FG001|Overall Study|Withdrawal by Subject|3
7936540|NCT02354235|12470995|FG000|Overall Study|Conflict with the stopping criteria|0
7936541|NCT02354235|12470996|FG001|Overall Study|Conflict with the stopping criteria|1
7936542|NCT02354417|12471029|FG000|Overall Study|Physician Decision|1
7936543|NCT02354508|12471054|FG000|Period 1: Core Phase|Adverse Event|1
7936544|NCT02354508|12471055|FG001|Period 1: Core Phase|Adverse Event|1
7936545|NCT02354508|12471056|FG002|Period 1: Core Phase|Adverse Event|2
7936546|NCT02354508|12471054|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1
7936547|NCT02354508|12471055|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0
7936548|NCT02354508|12471056|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2
7936549|NCT02354508|12471054|FG000|Period 1: Core Phase|Withdrawal by Subject|0
7936550|NCT02354508|12471055|FG001|Period 1: Core Phase|Withdrawal by Subject|1
7936551|NCT02354508|12471056|FG002|Period 1: Core Phase|Withdrawal by Subject|2
7936552|NCT02354508|12471054|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1
7936553|NCT02354508|12471055|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3
7936554|NCT02354508|12471056|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2
7936555|NCT02354508|12471054|FG000|Period 2: Extension Phase|Withdrawal by Subject|0
7936556|NCT02354508|12471055|FG001|Period 2: Extension Phase|Withdrawal by Subject|1
7936557|NCT02354508|12471056|FG002|Period 2: Extension Phase|Withdrawal by Subject|0
7936558|NCT02354508|12471054|FG000|Period 2: Extension Phase|Physician Decision|5
7936559|NCT02354508|12471055|FG001|Period 2: Extension Phase|Physician Decision|0
7936560|NCT02354508|12471056|FG002|Period 2: Extension Phase|Physician Decision|1
7936561|NCT02354508|12471054|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1
7936562|NCT02354508|12471055|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
7936563|NCT02354508|12471056|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
7936564|NCT02354508|12471054|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
7936565|NCT02354508|12471055|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1
7936566|NCT02354508|12471056|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
7936567|NCT02354508|12471054|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3
7936568|NCT02354508|12471055|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0
7936569|NCT02354508|12471056|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1
7936570|NCT02354599|12471128|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7936571|NCT02354599|12471129|FG001|Overall Study|Pretreatment Event/Adverse Event|0
7936572|NCT02354599|12471130|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7936573|NCT02354599|12471131|FG003|Overall Study|Pretreatment Event/Adverse Event|0
7936574|NCT02354599|12471132|FG004|Overall Study|Pretreatment Event/Adverse Event|0
7936575|NCT02354599|12471133|FG005|Overall Study|Pretreatment Event/Adverse Event|1
7936576|NCT02354599|12471128|FG000|Overall Study|Withdrawal by Subject|1
7936577|NCT02354599|12471129|FG001|Overall Study|Withdrawal by Subject|1
7936578|NCT02354599|12471130|FG002|Overall Study|Withdrawal by Subject|0
7936579|NCT02354599|12471131|FG003|Overall Study|Withdrawal by Subject|0
7936580|NCT02354599|12471132|FG004|Overall Study|Withdrawal by Subject|0
7936581|NCT02354599|12471133|FG005|Overall Study|Withdrawal by Subject|0
7936582|NCT02354690|12471153|FG000|Overall Study|Physician Decision|1
7936583|NCT02354976|12471196|FG000|Overall Study|Other - reason not specified|1
7936584|NCT02354976|12471197|FG001|Overall Study|Other - reason not specified|0
7936585|NCT02354976|12471198|FG002|Overall Study|Other - reason not specified|1
7936586|NCT02354976|12471196|FG000|Overall Study|Study-specifc withdrawal criteria|0
7936587|NCT02354976|12471197|FG001|Overall Study|Study-specifc withdrawal criteria|1
7936588|NCT02354976|12471198|FG002|Overall Study|Study-specifc withdrawal criteria|0
7936589|NCT02354976|12471196|FG000|Overall Study|Adverse Event|1
7936590|NCT02354976|12471197|FG001|Overall Study|Adverse Event|0
7936591|NCT02354976|12471198|FG002|Overall Study|Adverse Event|2
7936592|NCT02355028|12471208|FG000|Overall Study|Adverse Event|2
7936593|NCT02355028|12471209|FG001|Overall Study|Adverse Event|0
7936594|NCT02355028|12471208|FG000|Overall Study|Withdrawal by Subject|1
7936595|NCT02355028|12471209|FG001|Overall Study|Withdrawal by Subject|1
7936596|NCT02355028|12471208|FG000|Overall Study|Deemed ineligible after randomization|8
7967179|NCT02761733|12523726|FG000|Overall Study|Physician Decision|4
7936597|NCT02355028|12471209|FG001|Overall Study|Deemed ineligible after randomization|4
7936598|NCT02355665|12471264|FG000|Overall Study|Adverse Event|16
7936599|NCT02355665|12471265|FG001|Overall Study|Adverse Event|24
7936600|NCT02355665|12471264|FG000|Overall Study|Protocol Violation|2
7936601|NCT02355665|12471265|FG001|Overall Study|Protocol Violation|0
7936602|NCT02355665|12471264|FG000|Overall Study|Withdrawal by Subject|90
7936603|NCT02355665|12471265|FG001|Overall Study|Withdrawal by Subject|100
7936604|NCT02355665|12471264|FG000|Overall Study|Lost to Follow-up|131
7936605|NCT02355665|12471265|FG001|Overall Study|Lost to Follow-up|103
7936606|NCT02355665|12471264|FG000|Overall Study|Death|4
7936607|NCT02355665|12471265|FG001|Overall Study|Death|2
7936608|NCT02355665|12471264|FG000|Overall Study|Compliance, PI decision, move, eligible|6
7936609|NCT02355665|12471265|FG001|Overall Study|Compliance, PI decision, move, eligible|3
7936610|NCT02355691|12471273|FG000|Overall Study|Loss of Research Personnel|7
7936611|NCT02355691|12471274|FG001|Overall Study|Loss of Research Personnel|9
7936612|NCT02355743|12471280|FG000|Overall Study|Withdrawal by Subject|1
7936613|NCT02355743|12471280|FG000|Overall Study|Lost to Follow-up|1
7936614|NCT02356211|12471335|FG000|Overall Study|Withdrawal by Subject|2
7936615|NCT02356211|12471336|FG001|Overall Study|Withdrawal by Subject|2
7936616|NCT02356211|12471335|FG000|Overall Study|ineligible|1
7936617|NCT02356211|12471336|FG001|Overall Study|ineligible|8
7936618|NCT02356562|12471352|FG000|Overall Study|Withdrawal by Subject|0
7936619|NCT02356562|12471353|FG001|Overall Study|Withdrawal by Subject|1
7936620|NCT02356562|12471352|FG000|Overall Study|Re-entered treatment in a previous study|1
7936621|NCT02356562|12471353|FG001|Overall Study|Re-entered treatment in a previous study|0
7936622|NCT02356562|12471352|FG000|Overall Study|site closure|1
7936623|NCT02356562|12471353|FG001|Overall Study|site closure|0
7936624|NCT02356588|12471362|FG000|Overall Study|Lack of Efficacy|4
7936625|NCT02356588|12471363|FG001|Overall Study|Lack of Efficacy|10
7936626|NCT02356588|12471362|FG000|Overall Study|Adverse Event|0
7936627|NCT02356588|12471363|FG001|Overall Study|Adverse Event|2
7936628|NCT02356588|12471362|FG000|Overall Study|Withdrawal by Subject|1
7936629|NCT02356588|12471363|FG001|Overall Study|Withdrawal by Subject|0
7936630|NCT02356588|12471362|FG000|Overall Study|Protocol Violation|0
7936631|NCT02356588|12471363|FG001|Overall Study|Protocol Violation|1
7936632|NCT02356783|12471380|FG000|Overall Study|Lost to Follow-up|1
7936633|NCT02356783|12471381|FG001|Overall Study|Lost to Follow-up|3
7936634|NCT02356887|12471387|FG000|Overall Study|poor compliance|2
7936635|NCT02357134|12471414|FG000|Overall Study|Lost to Follow-up|1
7936636|NCT02357134|12471415|FG001|Overall Study|Lost to Follow-up|0
7936637|NCT02357134|12471416|FG002|Overall Study|Lost to Follow-up|0
7936638|NCT02357134|12471417|FG003|Overall Study|Lost to Follow-up|0
7936639|NCT02357147|12471429|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
7936640|NCT02357147|12471430|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
7936641|NCT02357147|12471429|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0
7936642|NCT02357147|12471430|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1
7936643|NCT02357147|12471429|FG000|Combination Treatment Phase|Investigator Discretion|1
7936644|NCT02357147|12471430|FG001|Combination Treatment Phase|Investigator Discretion|1
7936645|NCT02357147|12471429|FG000|Combination Treatment Phase|Withdrawal by Subject|4
7936646|NCT02357147|12471430|FG001|Combination Treatment Phase|Withdrawal by Subject|2
7936647|NCT02357147|12471429|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4
7936648|NCT02357147|12471430|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1
7936649|NCT02357147|12471429|FG000|Combination Treatment Phase|Adverse Event|12
7936650|NCT02357147|12471430|FG001|Combination Treatment Phase|Adverse Event|4
7936651|NCT02357147|12471429|FG000|Combination Treatment Phase|Death|1
7936652|NCT02357147|12471430|FG001|Combination Treatment Phase|Death|1
7936653|NCT02357147|12471429|FG000|Combination Treatment Phase|Sponsor Decision|0
7936654|NCT02357147|12471430|FG001|Combination Treatment Phase|Sponsor Decision|12
7936655|NCT02357147|12471429|FG000|Combination Treatment Phase|Other|1
7936656|NCT02357147|12471430|FG001|Combination Treatment Phase|Other|0
7936657|NCT02357147|12471429|FG000|Combination Treatment Phase|Not treated|0
7936658|NCT02357147|12471430|FG001|Combination Treatment Phase|Not treated|2
7936659|NCT02357147|12471429|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15
7936660|NCT02357147|12471430|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10
7936661|NCT02357147|12471429|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
7936662|NCT02357147|12471430|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1
7936663|NCT02357147|12471429|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10
7936664|NCT02357147|12471430|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0
7936665|NCT02357147|12471429|FG000|Maintenance Treatment Phase|Adverse Event|0
7936666|NCT02357147|12471430|FG001|Maintenance Treatment Phase|Adverse Event|3
7936667|NCT02357147|12471429|FG000|Maintenance Treatment Phase|Sponsor Decision|0
7936668|NCT02357147|12471430|FG001|Maintenance Treatment Phase|Sponsor Decision|15
7936669|NCT02357147|12471429|FG000|Maintenance Treatment Phase|Not Treated|1
7936670|NCT02357147|12471430|FG001|Maintenance Treatment Phase|Not Treated|0
7936671|NCT02357342|12471468|FG000|First 6 Months|Death|2
7936672|NCT02357342|12471469|FG001|First 6 Months|Death|0
7936673|NCT02357368|12471479|FG000|Overall Study|Lost to Follow-up|0
7936674|NCT02357368|12471480|FG001|Overall Study|Lost to Follow-up|0
7936675|NCT02357368|12471481|FG002|Overall Study|Lost to Follow-up|0
7936676|NCT02357368|12471482|FG003|Overall Study|Lost to Follow-up|1
7936677|NCT02357368|12471479|FG000|Overall Study|Pregnancy|3
7936678|NCT02357368|12471480|FG001|Overall Study|Pregnancy|2
7936679|NCT02357368|12471481|FG002|Overall Study|Pregnancy|0
7936680|NCT02357368|12471482|FG003|Overall Study|Pregnancy|0
7936681|NCT02357368|12471479|FG000|Overall Study|Withdrawal by Subject|3
7936682|NCT02357368|12471480|FG001|Overall Study|Withdrawal by Subject|1
7936683|NCT02357368|12471481|FG002|Overall Study|Withdrawal by Subject|1
7936684|NCT02357368|12471482|FG003|Overall Study|Withdrawal by Subject|2
7936685|NCT02357420|12471505|FG000|Overall Study|Adverse Event|3
7936686|NCT02357420|12471506|FG001|Overall Study|Adverse Event|3
7936687|NCT02357420|12471507|FG002|Overall Study|Adverse Event|8
7936688|NCT02357420|12471508|FG003|Overall Study|Adverse Event|9
7936689|NCT02357420|12471505|FG000|Overall Study|Investigator Decision|1
7936690|NCT02357420|12471506|FG001|Overall Study|Investigator Decision|0
7936691|NCT02357420|12471507|FG002|Overall Study|Investigator Decision|0
7936692|NCT02357420|12471508|FG003|Overall Study|Investigator Decision|0
7936693|NCT02357420|12471505|FG000|Overall Study|Prohibited Medication|1
7936694|NCT02357420|12471506|FG001|Overall Study|Prohibited Medication|1
7936695|NCT02357420|12471507|FG002|Overall Study|Prohibited Medication|0
7936696|NCT02357420|12471508|FG003|Overall Study|Prohibited Medication|0
7936697|NCT02357420|12471505|FG000|Overall Study|Protocol Non-compliance|0
7936698|NCT02357420|12471506|FG001|Overall Study|Protocol Non-compliance|0
7936699|NCT02357420|12471507|FG002|Overall Study|Protocol Non-compliance|0
7936700|NCT02357420|12471508|FG003|Overall Study|Protocol Non-compliance|1
7936701|NCT02357420|12471505|FG000|Overall Study|Withdrawn Consent|4
7936702|NCT02357420|12471506|FG001|Overall Study|Withdrawn Consent|8
7936703|NCT02357420|12471507|FG002|Overall Study|Withdrawn Consent|6
7936704|NCT02357420|12471508|FG003|Overall Study|Withdrawn Consent|6
7936705|NCT02357420|12471505|FG000|Overall Study|Lost to Follow-up|3
7936706|NCT02357420|12471506|FG001|Overall Study|Lost to Follow-up|0
7936707|NCT02357420|12471507|FG002|Overall Study|Lost to Follow-up|2
7936708|NCT02357420|12471508|FG003|Overall Study|Lost to Follow-up|3
7936709|NCT02357459|12471521|FG000|Overall Study|Adverse Event|0
7936710|NCT02357459|12471522|FG001|Overall Study|Adverse Event|1
7936711|NCT02357459|12471523|FG002|Overall Study|Adverse Event|1
7936712|NCT02357459|12471521|FG000|Overall Study|Withdrawal by Subject|5
7936713|NCT02357459|12471522|FG001|Overall Study|Withdrawal by Subject|3
7936714|NCT02357459|12471523|FG002|Overall Study|Withdrawal by Subject|3
7936715|NCT02357459|12471521|FG000|Overall Study|Physician Decision|0
7936716|NCT02357459|12471522|FG001|Overall Study|Physician Decision|2
7936717|NCT02357459|12471523|FG002|Overall Study|Physician Decision|0
7936718|NCT02357459|12471521|FG000|Overall Study|Protocol Violation|1
7936719|NCT02357459|12471522|FG001|Overall Study|Protocol Violation|1
7936720|NCT02357459|12471523|FG002|Overall Study|Protocol Violation|0
7936721|NCT02357459|12471521|FG000|Overall Study|Lost to Follow-up|1
7936722|NCT02357459|12471522|FG001|Overall Study|Lost to Follow-up|3
7936723|NCT02357459|12471523|FG002|Overall Study|Lost to Follow-up|0
7936724|NCT02357459|12471521|FG000|Overall Study|Lack of Efficacy|7
7936725|NCT02357459|12471522|FG001|Overall Study|Lack of Efficacy|4
7936726|NCT02357459|12471523|FG002|Overall Study|Lack of Efficacy|4
7936727|NCT02357459|12471521|FG000|Overall Study|Patient Relocated|2
7936728|NCT02357459|12471522|FG001|Overall Study|Patient Relocated|0
7936729|NCT02357459|12471523|FG002|Overall Study|Patient Relocated|0
7936730|NCT02357459|12471521|FG000|Overall Study|Instruction from PCP|1
7936731|NCT02357459|12471522|FG001|Overall Study|Instruction from PCP|0
7936732|NCT02357459|12471523|FG002|Overall Study|Instruction from PCP|0
7936733|NCT02357459|12471521|FG000|Overall Study|Incarceration|0
7936734|NCT02357459|12471522|FG001|Overall Study|Incarceration|0
7936735|NCT02357459|12471523|FG002|Overall Study|Incarceration|1
7936736|NCT02357459|12471521|FG000|Overall Study|Pre-planned Knee surgery|0
7936737|NCT02357459|12471522|FG001|Overall Study|Pre-planned Knee surgery|0
7936738|NCT02357459|12471523|FG002|Overall Study|Pre-planned Knee surgery|2
7936739|NCT02357459|12471521|FG000|Overall Study|Job Commitments|0
7936740|NCT02357459|12471522|FG001|Overall Study|Job Commitments|0
7936741|NCT02357459|12471523|FG002|Overall Study|Job Commitments|1
7936742|NCT02357576|12471541|FG000|Treatment Period|Withdrawal by Subject|0
7936743|NCT02357576|12471542|FG001|Treatment Period|Withdrawal by Subject|1
7936744|NCT02357576|12471541|FG000|Treatment Period|Physician Decision|0
7936745|NCT02357576|12471542|FG001|Treatment Period|Physician Decision|1
7936746|NCT02357576|12471541|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1
7936747|NCT02357576|12471542|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1
7936748|NCT02357576|12471541|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1
7936749|NCT02357576|12471542|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0
7936750|NCT02357576|12471541|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1
7936751|NCT02357576|12471542|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4
7936752|NCT02357576|12471541|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2
7936753|NCT02357576|12471542|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0
7964914|NCT01084252|12520462|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7964915|NCT01084252|12520463|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7964916|NCT01084252|12520464|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7964917|NCT01084252|12520465|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7964918|NCT01084252|12520466|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7964919|NCT01084252|12520467|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7964920|NCT01084252|12520468|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7964921|NCT01084252|12520469|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12
7964922|NCT01084252|12520470|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2
7964923|NCT01084252|12520457|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7964924|NCT01084252|12520458|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7964925|NCT01084252|12520459|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7964926|NCT01084252|12520460|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7964927|NCT01084252|12520461|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7964928|NCT01084252|12520462|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7964929|NCT01084252|12520463|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7964930|NCT01084252|12520464|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7964931|NCT01084252|12520465|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7964932|NCT01084252|12520466|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7964933|NCT01084252|12520467|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7964934|NCT01084252|12520468|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7964935|NCT01084252|12520469|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13
7964936|NCT01084252|12520470|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15
7964937|NCT01084252|12520457|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7964938|NCT01084252|12520458|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7964939|NCT01084252|12520459|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7964940|NCT01084252|12520460|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7964941|NCT01084252|12520461|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7964942|NCT01084252|12520462|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7964943|NCT01084252|12520463|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7964944|NCT01084252|12520464|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7964945|NCT01084252|12520465|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7964946|NCT01084252|12520466|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7964947|NCT01084252|12520467|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7964948|NCT01084252|12520468|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7964949|NCT01084252|12520469|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1
7964950|NCT01084252|12520470|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7964951|NCT01034631|12520537|FG000|Phase I|Symptomatic Deterioration before Treatme|3
7964952|NCT01034631|12520538|FG001|Phase I|Symptomatic Deterioration before Treatme|0
7964953|NCT01034631|12520539|FG002|Phase I|Symptomatic Deterioration before Treatme|0
7964954|NCT01034631|12520537|FG000|Phase II|Not Evaluable per protocol|0
7964955|NCT01034631|12520538|FG001|Phase II|Not Evaluable per protocol|0
7964956|NCT01034631|12520539|FG002|Phase II|Not Evaluable per protocol|2
7964957|NCT01034631|12520537|FG000|Phase II|Determined Ineligible per protocol|0
7936754|NCT02357901|12471579|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161
7936755|NCT02357901|12471580|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0
7936756|NCT02357901|12471581|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0
7936757|NCT02357901|12471582|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0
7936758|NCT02357901|12471579|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
7936759|NCT02357901|12471580|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
7936760|NCT02357901|12471581|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
7936761|NCT02357901|12471582|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
7936762|NCT02357901|12471579|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
7936763|NCT02357901|12471580|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
7936764|NCT02357901|12471581|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
7936765|NCT02357901|12471582|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
7936766|NCT02357901|12471579|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
7936767|NCT02357901|12471580|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
7936768|NCT02357901|12471581|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
7936769|NCT02357901|12471582|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
7936770|NCT02357901|12471579|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0
7936771|NCT02357901|12471580|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6
7936772|NCT02357901|12471581|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10
7936773|NCT02357901|12471582|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2
7936774|NCT02357901|12471579|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
7936775|NCT02357901|12471580|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
7936776|NCT02357901|12471581|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
7936777|NCT02357901|12471582|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
7936778|NCT02357901|12471579|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
7936779|NCT02357901|12471580|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
7936780|NCT02357901|12471581|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
7936781|NCT02357901|12471582|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
7936782|NCT02357901|12471579|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
7936783|NCT02357901|12471580|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
7936784|NCT02357901|12471581|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
7936785|NCT02357901|12471582|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
7936786|NCT02357901|12471579|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
7936787|NCT02357901|12471580|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
7936788|NCT02357901|12471581|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
7936789|NCT02357901|12471582|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
7936790|NCT02357901|12471579|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0
7936791|NCT02357901|12471580|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0
7936792|NCT02357901|12471581|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1
7936793|NCT02357901|12471582|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1
7936794|NCT02357901|12471579|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
7936795|NCT02357901|12471580|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
7936796|NCT02357901|12471581|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
7936797|NCT02357901|12471582|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
7936798|NCT02357940|12471592|FG000|Overall Study|Adverse Event|0
7936799|NCT02357940|12471593|FG001|Overall Study|Adverse Event|1
7936800|NCT02357940|12471592|FG000|Overall Study|Investigator's judgement|0
7936801|NCT02357940|12471593|FG001|Overall Study|Investigator's judgement|1
7936802|NCT02357979|12471601|FG000|Overall Study|Lost to Follow-up|5
7936803|NCT02357979|12471602|FG001|Overall Study|Lost to Follow-up|5
7936804|NCT02358044|12471610|FG000|Overall Study|Adverse Event|0
7936805|NCT02358044|12471611|FG001|Overall Study|Adverse Event|1
7936806|NCT02358044|12471610|FG000|Overall Study|Lost to Follow-up|2
7936807|NCT02358044|12471611|FG001|Overall Study|Lost to Follow-up|1
7936808|NCT02358044|12471610|FG000|Overall Study|Physician Decision|0
7936809|NCT02358044|12471611|FG001|Overall Study|Physician Decision|1
7936810|NCT02358044|12471610|FG000|Overall Study|Withdrawal by Subject|0
7936811|NCT02358044|12471611|FG001|Overall Study|Withdrawal by Subject|4
7936812|NCT02358343|12471631|FG000|Screening Intervention|Death|0
7936813|NCT02358343|12471632|FG001|Screening Intervention|Death|2
7936814|NCT02358343|12471633|FG002|Screening Intervention|Death|0
7936815|NCT02358343|12471634|FG003|Screening Intervention|Death|0
7936816|NCT02358343|12471635|FG004|Screening Intervention|Death|0
7936817|NCT02358343|12471631|FG000|Screening Intervention|Withdrawal by Subject|1
7936818|NCT02358343|12471632|FG001|Screening Intervention|Withdrawal by Subject|0
7936819|NCT02358343|12471633|FG002|Screening Intervention|Withdrawal by Subject|0
7936820|NCT02358343|12471634|FG003|Screening Intervention|Withdrawal by Subject|0
7936821|NCT02358343|12471635|FG004|Screening Intervention|Withdrawal by Subject|0
7936822|NCT02358343|12471631|FG000|Screening Intervention|Determined Ineligible|5
7936823|NCT02358343|12471632|FG001|Screening Intervention|Determined Ineligible|6
7936824|NCT02358343|12471633|FG002|Screening Intervention|Determined Ineligible|0
7936825|NCT02358343|12471634|FG003|Screening Intervention|Determined Ineligible|0
7936826|NCT02358343|12471635|FG004|Screening Intervention|Determined Ineligible|0
7936827|NCT02358343|12471631|FG000|Comparative Efficacy Trial / Observation|Death|0
7936828|NCT02358343|12471632|FG001|Comparative Efficacy Trial / Observation|Death|0
7936829|NCT02358343|12471633|FG002|Comparative Efficacy Trial / Observation|Death|2
7936830|NCT02358343|12471634|FG003|Comparative Efficacy Trial / Observation|Death|0
7936831|NCT02358343|12471635|FG004|Comparative Efficacy Trial / Observation|Death|0
7936832|NCT02358343|12471631|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
7936833|NCT02358343|12471632|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
7936834|NCT02358343|12471633|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
7936835|NCT02358343|12471634|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
7936836|NCT02358343|12471635|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
7936837|NCT02358343|12471631|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7936838|NCT02358343|12471632|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7936839|NCT02358343|12471633|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1
7936840|NCT02358343|12471634|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7936841|NCT02358343|12471635|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7936842|NCT02358369|12471649|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35
7936843|NCT02358369|12471650|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7936844|NCT02358369|12471651|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7936845|NCT02358369|12471652|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7936846|NCT02358369|12471653|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7936847|NCT02358369|12471649|FG000|Treatment Period A/B|Adverse Event|0
7936848|NCT02358369|12471650|FG001|Treatment Period A/B|Adverse Event|0
7936849|NCT02358369|12471651|FG002|Treatment Period A/B|Adverse Event|1
7936850|NCT02358369|12471652|FG003|Treatment Period A/B|Adverse Event|2
7936851|NCT02358369|12471653|FG004|Treatment Period A/B|Adverse Event|0
7936852|NCT02358369|12471649|FG000|Treatment Period A/B|Death|0
7936853|NCT02358369|12471650|FG001|Treatment Period A/B|Death|0
7936854|NCT02358369|12471651|FG002|Treatment Period A/B|Death|1
7936855|NCT02358369|12471652|FG003|Treatment Period A/B|Death|0
7936856|NCT02358369|12471653|FG004|Treatment Period A/B|Death|0
7936857|NCT02358369|12471649|FG000|Treatment Period A/B|Withdrawal by Subject|0
7936858|NCT02358369|12471650|FG001|Treatment Period A/B|Withdrawal by Subject|2
7936859|NCT02358369|12471651|FG002|Treatment Period A/B|Withdrawal by Subject|0
7936860|NCT02358369|12471652|FG003|Treatment Period A/B|Withdrawal by Subject|2
7936861|NCT02358369|12471653|FG004|Treatment Period A/B|Withdrawal by Subject|0
7936862|NCT02358369|12471649|FG000|Treatment Period C|Adverse Event|0
7936863|NCT02358369|12471650|FG001|Treatment Period C|Adverse Event|0
7936864|NCT02358369|12471651|FG002|Treatment Period C|Adverse Event|0
7719789|NCT00534313|12143733|FG002|Long-term Period|Poor compliance/noncompliance|1
7719790|NCT00534313|12143734|FG003|Long-term Period|Poor compliance/noncompliance|0
7719791|NCT00534313|12143731|FG000|Long-term Period|Administrative reason by sponsor|17
7719792|NCT00534313|12143732|FG001|Long-term Period|Administrative reason by sponsor|15
7936865|NCT02358369|12471652|FG003|Treatment Period C|Adverse Event|0
7936866|NCT02358369|12471653|FG004|Treatment Period C|Adverse Event|7
7936867|NCT02358473|12471663|FG000|Overall Study|Disease Progession|6
7936868|NCT02358473|12471663|FG000|Overall Study|Adverse Event|3
7936869|NCT02358473|12471663|FG000|Overall Study|Withdrawal by Subject|2
7936870|NCT02358473|12471663|FG000|Overall Study|Physician Decision|2
7936871|NCT02358668|12471679|FG000|Overall Study|Adverse Event|2
7936872|NCT02358668|12471680|FG001|Overall Study|Adverse Event|0
7936873|NCT02358668|12471681|FG002|Overall Study|Adverse Event|0
7936874|NCT02358668|12471679|FG000|Overall Study|Withdrawal by Subject|0
7936875|NCT02358668|12471680|FG001|Overall Study|Withdrawal by Subject|1
7936876|NCT02358668|12471681|FG002|Overall Study|Withdrawal by Subject|0
7936877|NCT02358863|12471689|FG000|Overall Study|Physician Decision|3
7936878|NCT02359045|12471723|FG000|Overall Study|Eligibility criteria not fulfilled|3
7936879|NCT02359045|12471724|FG001|Overall Study|Eligibility criteria not fulfilled|1
7936880|NCT02359045|12471723|FG000|Overall Study|Lost to Follow-up|1
7936881|NCT02359045|12471724|FG001|Overall Study|Lost to Follow-up|1
7936882|NCT02359045|12471723|FG000|Overall Study|Adverse Event|0
7936883|NCT02359045|12471724|FG001|Overall Study|Adverse Event|1
7936884|NCT02359435|12471774|FG000|Overall Study|Lost to Follow-up|4
7936885|NCT02359435|12471775|FG001|Overall Study|Lost to Follow-up|4
7936886|NCT02359552|12471783|FG000|Overall Study|Lost to Follow-up|3
7936887|NCT02359552|12471784|FG001|Overall Study|Lost to Follow-up|4
7936888|NCT02359851|12471790|FG000|Overall Study|Death|1
7936889|NCT02359851|12471790|FG000|Overall Study|Disease progression|1
7936890|NCT02359877|12471798|FG000|Overall Study|Withdrawal by Subject|1
7936891|NCT02359877|12471799|FG001|Overall Study|Withdrawal by Subject|0
7936892|NCT02359877|12471800|FG002|Overall Study|Withdrawal by Subject|0
7936893|NCT02359877|12471801|FG003|Overall Study|Withdrawal by Subject|2
7936894|NCT02359877|12471798|FG000|Overall Study|Adverse Event|0
7936895|NCT02359877|12471799|FG001|Overall Study|Adverse Event|0
7936896|NCT02359877|12471800|FG002|Overall Study|Adverse Event|0
7936897|NCT02359877|12471801|FG003|Overall Study|Adverse Event|1
7936898|NCT02359890|12471829|FG000|Overall Study|Not meeting eligibility|4
7936899|NCT02359890|12471829|FG000|Overall Study|Never treated with study catheter|6
7936900|NCT02359903|12471835|FG000|Overall Study|Adverse Event|0
7936901|NCT02359903|12471836|FG001|Overall Study|Adverse Event|2
7936902|NCT02360098|12471902|FG000|Overall Study|Physician Decision|7
7936903|NCT02360228|12471935|FG000|Overall Study|Withdrawal by Subject|1
7936904|NCT02360228|12471936|FG001|Overall Study|Withdrawal by Subject|0
7936905|NCT02360228|12471937|FG002|Overall Study|Withdrawal by Subject|0
7936906|NCT02360228|12471935|FG000|Overall Study|Self-discontinued medication|0
7936907|NCT02360228|12471936|FG001|Overall Study|Self-discontinued medication|1
7936908|NCT02360228|12471937|FG002|Overall Study|Self-discontinued medication|0
7936909|NCT02360228|12471935|FG000|Overall Study|Unstable symptoms during screening|0
7936910|NCT02360228|12471936|FG001|Overall Study|Unstable symptoms during screening|0
7936911|NCT02360228|12471937|FG002|Overall Study|Unstable symptoms during screening|1
7936912|NCT02360293|12471947|FG000|Overall Study|Lost to Follow-up|73
7936913|NCT02360293|12471948|FG001|Overall Study|Lost to Follow-up|95
7936914|NCT02360293|12471947|FG000|Overall Study|Withdrawal by Subject|2
7936915|NCT02360293|12471948|FG001|Overall Study|Withdrawal by Subject|1
7936916|NCT02360293|12471947|FG000|Overall Study|Excluded|1
7936917|NCT02360293|12471948|FG001|Overall Study|Excluded|0
7936918|NCT02360397|12471976|FG000|Overall Study|Incomplete screening|3
7936919|NCT02360397|12471976|FG000|Overall Study|Adverse Event|1
7936920|NCT02360475|12471985|FG000|Overall Study|Lost to Follow-up|4
7936921|NCT02360475|12471986|FG001|Overall Study|Lost to Follow-up|12
7936922|NCT02360475|12471987|FG002|Overall Study|Lost to Follow-up|6
7936923|NCT02360475|12471988|FG003|Overall Study|Lost to Follow-up|4
7936924|NCT02360475|12471985|FG000|Overall Study|Withdrawal by Subject|0
7936925|NCT02360475|12471986|FG001|Overall Study|Withdrawal by Subject|1
7936926|NCT02360475|12471987|FG002|Overall Study|Withdrawal by Subject|2
7936927|NCT02360475|12471988|FG003|Overall Study|Withdrawal by Subject|0
7936928|NCT02360475|12471985|FG000|Overall Study|Migrated/moved from study area|0
7936929|NCT02360475|12471986|FG001|Overall Study|Migrated/moved from study area|0
7936930|NCT02360475|12471987|FG002|Overall Study|Migrated/moved from study area|0
7936931|NCT02360475|12471988|FG003|Overall Study|Migrated/moved from study area|1
7936932|NCT02360605|12472009|FG000|Overall Study|Withdrawal by Subject|4
7936933|NCT02360605|12472010|FG001|Overall Study|Withdrawal by Subject|9
7936934|NCT02360605|12472009|FG000|Overall Study|Lost to Follow-up|7
7936935|NCT02360605|12472010|FG001|Overall Study|Lost to Follow-up|8
7936936|NCT02360605|12472009|FG000|Overall Study|Death|0
7936937|NCT02360605|12472010|FG001|Overall Study|Death|1
7936938|NCT02360995|12472041|FG000|Overall Study|Lost to Follow-up|2
7936939|NCT02360995|12472042|FG001|Overall Study|Lost to Follow-up|0
7936940|NCT02360995|12472043|FG002|Overall Study|Lost to Follow-up|2
7936941|NCT02360995|12472041|FG000|Overall Study|Withdrawal by Subject|0
7936942|NCT02360995|12472042|FG001|Overall Study|Withdrawal by Subject|1
7936943|NCT02360995|12472043|FG002|Overall Study|Withdrawal by Subject|0
7936944|NCT02361216|12472053|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
7936945|NCT02361216|12472054|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
7936946|NCT02361216|12472053|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
7936947|NCT02361216|12472054|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
7936948|NCT02361216|12472053|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
7936949|NCT02361216|12472054|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
7936950|NCT02361216|12472053|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
7936951|NCT02361216|12472054|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
7936952|NCT02361216|12472053|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
7936953|NCT02361216|12472054|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
7936954|NCT02361216|12472053|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
7936955|NCT02361216|12472054|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
7936956|NCT02361307|12472065|FG000|Overall Study|Unstable medical condition.|0
7936957|NCT02361307|12472066|FG001|Overall Study|Unstable medical condition.|1
7936958|NCT02361762|12472092|FG000|Overall Study|Withdrawal by Subject|0
7936959|NCT02361762|12472093|FG001|Overall Study|Withdrawal by Subject|1
7936960|NCT02361762|12472092|FG000|Overall Study|Lost to Follow-up|0
7936961|NCT02361762|12472093|FG001|Overall Study|Lost to Follow-up|1
7936962|NCT02362269|12472114|FG000|Overall Study|Moved|1
7936963|NCT02362269|12472115|FG001|Overall Study|Moved|0
7936964|NCT02362269|12472114|FG000|Overall Study|Lost to Follow-up|0
7936965|NCT02362269|12472115|FG001|Overall Study|Lost to Follow-up|6
7936966|NCT02362282|12472123|FG000|Overall Study|Withdrawal by Subject|1
7936967|NCT02362282|12472124|FG001|Overall Study|Withdrawal by Subject|0
7936968|NCT02362360|12472139|FG000|Period 1|Lack of Efficacy|1
7936969|NCT02362360|12472140|FG001|Period 1|Lack of Efficacy|0
7936970|NCT02362360|12472139|FG000|Period 1|Withdrawal by Subject|2
7936971|NCT02362360|12472140|FG001|Period 1|Withdrawal by Subject|1
7936972|NCT02362412|12472150|FG000|Treatment Period III|Lost to Follow-up|0
7936973|NCT02362412|12472151|FG001|Treatment Period III|Lost to Follow-up|1
7936974|NCT02362425|12472167|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2
7936975|NCT02362425|12472168|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
7936976|NCT02362425|12472169|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
7936977|NCT02362425|12472170|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
7936978|NCT02362425|12472167|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1
7936979|NCT02362425|12472168|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0
7936980|NCT02362425|12472169|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0
7936981|NCT02362425|12472170|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0
7936982|NCT02362425|12472167|FG000|Phase 1 (up to 6 Months)|Screening failure|1
7936983|NCT02362425|12472168|FG001|Phase 1 (up to 6 Months)|Screening failure|0
7936984|NCT02362425|12472169|FG002|Phase 1 (up to 6 Months)|Screening failure|0
7936985|NCT02362425|12472170|FG003|Phase 1 (up to 6 Months)|Screening failure|0
7936986|NCT02362425|12472167|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3
7936987|NCT02362425|12472168|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
7936988|NCT02362425|12472169|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
7936989|NCT02362425|12472170|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
7936990|NCT02362425|12472167|FG000|Phase 1 (up to 6 Months)|Study closure|9
7936991|NCT02362425|12472168|FG001|Phase 1 (up to 6 Months)|Study closure|0
7936992|NCT02362425|12472169|FG002|Phase 1 (up to 6 Months)|Study closure|0
7936993|NCT02362425|12472170|FG003|Phase 1 (up to 6 Months)|Study closure|0
7936994|NCT02362425|12472167|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
7936995|NCT02362425|12472168|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
7936996|NCT02362425|12472169|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
7936997|NCT02362425|12472170|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2
7936998|NCT02362425|12472167|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
7936999|NCT02362425|12472168|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
7937000|NCT02362425|12472169|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
7937001|NCT02362425|12472170|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1
7937002|NCT02362425|12472167|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
7937003|NCT02362425|12472168|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
7937004|NCT02362425|12472169|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1
7937005|NCT02362425|12472170|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
7937006|NCT02362646|12472183|FG000|Overall Study|Death|15
7937007|NCT02362646|12472184|FG001|Overall Study|Death|8
7937008|NCT02362646|12472183|FG000|Overall Study|Withdrawal by Subject|2
7937009|NCT02362646|12472184|FG001|Overall Study|Withdrawal by Subject|2
7937010|NCT02362646|12472183|FG000|Overall Study|received transplant|21
7937011|NCT02362646|12472184|FG001|Overall Study|received transplant|14
7937012|NCT02362724|12472207|FG000|Overall Study|Withdrawal by Subject|3
7937013|NCT02362724|12472208|FG001|Overall Study|Withdrawal by Subject|1
7937014|NCT02362724|12472207|FG000|Overall Study|Adverse Event|3
7937015|NCT02362724|12472208|FG001|Overall Study|Adverse Event|0
7937016|NCT02362789|12472216|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
7937017|NCT02362789|12472217|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
7937018|NCT02362789|12472218|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
7937019|NCT02362789|12472216|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1
7937020|NCT02362789|12472217|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0
7937021|NCT02362789|12472218|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0
7937022|NCT02362789|12472216|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
7937023|NCT02362789|12472217|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
7937024|NCT02362789|12472218|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
7937025|NCT02362789|12472216|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
7937026|NCT02362789|12472217|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
7937027|NCT02362789|12472218|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
7937028|NCT02362789|12472216|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
7937029|NCT02362789|12472217|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
7937030|NCT02362789|12472218|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
7937031|NCT02363283|12472234|FG000|Overall Study|Withdrawal by Subject|1
7937032|NCT02363283|12472234|FG000|Overall Study|Not eligible due to transaminitis|1
7937033|NCT02363322|12472240|FG000|Overall Study|Lost to Follow-up|1
7719793|NCT00534313|12143733|FG002|Long-term Period|Administrative reason by sponsor|26
7719794|NCT00534313|12143734|FG003|Long-term Period|Administrative reason by sponsor|18
7719795|NCT00534313|12143731|FG000|Long-term Period|Other|1
7719796|NCT00534313|12143732|FG001|Long-term Period|Other|2
7719797|NCT00534313|12143733|FG002|Long-term Period|Other|2
7719798|NCT00534313|12143734|FG003|Long-term Period|Other|2
7719799|NCT00534352|12143779|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
7719800|NCT00534352|12143779|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
7719801|NCT00534352|12143779|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
7719802|NCT00534352|12143779|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
7719803|NCT00534352|12143779|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
7719804|NCT00534352|12143779|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
7719805|NCT00534404|12143806|FG000|Overall Study|Death|0
7719806|NCT00534404|12143807|FG001|Overall Study|Death|0
7719807|NCT00534404|12143808|FG002|Overall Study|Death|2
7719808|NCT00534404|12143806|FG000|Overall Study|Withdrawal by Subject|8
7719809|NCT00534404|12143807|FG001|Overall Study|Withdrawal by Subject|2
7719810|NCT00534404|12143808|FG002|Overall Study|Withdrawal by Subject|38
7719811|NCT00534404|12143806|FG000|Overall Study|Removed by study staff|2
7719812|NCT00534404|12143807|FG001|Overall Study|Removed by study staff|3
7719813|NCT00534404|12143808|FG002|Overall Study|Removed by study staff|1
7719814|NCT00534404|12143806|FG000|Overall Study|Lost to Follow-up|170
7719815|NCT00534404|12143807|FG001|Overall Study|Lost to Follow-up|138
7719816|NCT00534404|12143808|FG002|Overall Study|Lost to Follow-up|201
7719817|NCT00534495|12143822|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0
7719818|NCT00534495|12143823|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1
7719819|NCT00534495|12143824|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0
7767843|NCT00856284|12210625|FG001|Overall Study|Pregnancy|2
7937034|NCT02363322|12472241|FG001|Overall Study|Lost to Follow-up|0
7937035|NCT02363439|12472247|FG000|Overall Study|Lack of Efficacy|4
7937036|NCT02363478|12472251|FG000|Overall Study|Lost to Follow-up|4
7937037|NCT02363478|12472251|FG000|Overall Study|Adverse Event|4
7937038|NCT02363686|12472265|FG000|Overall Study|Withdrawal by Subject|22
7937039|NCT02363686|12472265|FG000|Overall Study|incomplete FEES examinations|13
7937040|NCT02363738|12472271|FG000|Overall Study|Adverse Event|5
7937041|NCT02363738|12472272|FG001|Overall Study|Adverse Event|2
7937042|NCT02363738|12472271|FG000|Overall Study|Lack of Efficacy|1
7937043|NCT02363738|12472272|FG001|Overall Study|Lack of Efficacy|2
7937044|NCT02363738|12472271|FG000|Overall Study|Lost to Follow-up|2
7937045|NCT02363738|12472272|FG001|Overall Study|Lost to Follow-up|1
7937046|NCT02363946|12472314|FG000|Overall Study|Lost to Follow-up|0
7937047|NCT02363946|12472315|FG001|Overall Study|Lost to Follow-up|0
7937048|NCT02363946|12472316|FG002|Overall Study|Lost to Follow-up|0
7937049|NCT02363946|12472317|FG003|Overall Study|Lost to Follow-up|0
7937050|NCT02363946|12472318|FG004|Overall Study|Lost to Follow-up|0
7937051|NCT02363946|12472319|FG005|Overall Study|Lost to Follow-up|0
7937052|NCT02363946|12472320|FG006|Overall Study|Lost to Follow-up|0
7937053|NCT02363946|12472321|FG007|Overall Study|Lost to Follow-up|1
7937054|NCT02363946|12472322|FG008|Overall Study|Lost to Follow-up|0
7937055|NCT02363946|12472323|FG009|Overall Study|Lost to Follow-up|0
7937056|NCT02363946|12472324|FG010|Overall Study|Lost to Follow-up|0
7937057|NCT02363946|12472325|FG011|Overall Study|Lost to Follow-up|0
7937058|NCT02363946|12472326|FG012|Overall Study|Lost to Follow-up|0
7937059|NCT02363959|12472356|FG000|Overall Study|Medical instability|1
7937060|NCT02363959|12472357|FG001|Overall Study|Medical instability|0
7937061|NCT02364037|12472369|FG000|Overall Study|Withdrawal by Subject|7
7937062|NCT02364037|12472370|FG001|Overall Study|Withdrawal by Subject|4
7937063|NCT02364037|12472369|FG000|Overall Study|Lost to Follow-up|37
7937064|NCT02364037|12472370|FG001|Overall Study|Lost to Follow-up|49
7937065|NCT02364180|12472380|FG000|Overall Study|Screen Fail|1
7937066|NCT02364336|12472396|FG000|Overall Study|Adverse Event|0
7937067|NCT02364336|12472397|FG001|Overall Study|Adverse Event|1
7937068|NCT02364388|12472404|FG000|Overall Study|Protocol Violation|1
7937069|NCT02364388|12472404|FG000|Overall Study|Technical Failure|3
7937070|NCT02364388|12472404|FG000|Overall Study|No OA/US data|2
7937071|NCT02364388|12472404|FG000|Overall Study|No Biopsy|2
7937072|NCT02364947|12472448|FG000|Overall Study|Withdrawal by Subject|10
7937073|NCT02364947|12472449|FG001|Overall Study|Withdrawal by Subject|8
7937074|NCT02364947|12472450|FG002|Overall Study|Withdrawal by Subject|9
7937075|NCT02364947|12472448|FG000|Overall Study|Adverse Event|45
7937076|NCT02364947|12472449|FG001|Overall Study|Adverse Event|33
7937077|NCT02364947|12472450|FG002|Overall Study|Adverse Event|11
7937078|NCT02364947|12472448|FG000|Overall Study|Protocol Violation|1
7937079|NCT02364947|12472449|FG001|Overall Study|Protocol Violation|1
7937080|NCT02364947|12472450|FG002|Overall Study|Protocol Violation|1
7937081|NCT02364947|12472448|FG000|Overall Study|Physician Decision|3
7937082|NCT02364947|12472449|FG001|Overall Study|Physician Decision|2
7937083|NCT02364947|12472450|FG002|Overall Study|Physician Decision|5
7937084|NCT02364947|12472448|FG000|Overall Study|Death|0
7937085|NCT02364947|12472449|FG001|Overall Study|Death|1
7937086|NCT02364947|12472450|FG002|Overall Study|Death|0
7937087|NCT02364999|12472460|FG000|Overall Study|Death|136
7937088|NCT02364999|12472461|FG001|Overall Study|Death|138
7937089|NCT02364999|12472460|FG000|Overall Study|Lost to Follow-up|10
7937090|NCT02364999|12472461|FG001|Overall Study|Lost to Follow-up|15
7937091|NCT02364999|12472460|FG000|Overall Study|Protocol Violation|3
7937092|NCT02364999|12472461|FG001|Overall Study|Protocol Violation|2
7937093|NCT02364999|12472460|FG000|Overall Study|Withdrawal by Subject|14
7937094|NCT02364999|12472461|FG001|Overall Study|Withdrawal by Subject|14
7937095|NCT02364999|12472460|FG000|Overall Study|Other|0
7937096|NCT02364999|12472461|FG001|Overall Study|Other|1
7937097|NCT02364999|12472460|FG000|Overall Study|Randomized but did not receive treatment|2
7937098|NCT02364999|12472461|FG001|Overall Study|Randomized but did not receive treatment|3
7937099|NCT02365064|12472470|FG000|Overall Study|Patients met baseline exclusion requirem|2
7937100|NCT02365064|12472471|FG001|Overall Study|Patients met baseline exclusion requirem|15
7937101|NCT02365064|12472470|FG000|Overall Study|Withdrawal by Subject|6
7937102|NCT02365064|12472471|FG001|Overall Study|Withdrawal by Subject|9
7937103|NCT02365064|12472470|FG000|Overall Study|Treatment intolerance|2
7937104|NCT02365064|12472471|FG001|Overall Study|Treatment intolerance|4
7937105|NCT02365285|12472481|FG000|Overall Study|Physician Decision|0
7937106|NCT02365285|12472482|FG001|Overall Study|Physician Decision|1
7937107|NCT02365285|12472483|FG002|Overall Study|Physician Decision|1
7937108|NCT02365285|12472484|FG003|Overall Study|Physician Decision|0
7937109|NCT02365285|12472481|FG000|Overall Study|Adverse Event|0
7937110|NCT02365285|12472482|FG001|Overall Study|Adverse Event|0
7937111|NCT02365285|12472483|FG002|Overall Study|Adverse Event|0
7937112|NCT02365285|12472484|FG003|Overall Study|Adverse Event|2
7937113|NCT02365298|12472496|FG000|Period 2|incorrect Rx dispensed|1
7937114|NCT02365298|12472497|FG001|Period 2|incorrect Rx dispensed|0
7937115|NCT02365298|12472496|FG000|Period 2|Discontinued at request of Sponsor|1
7937116|NCT02365298|12472497|FG001|Period 2|Discontinued at request of Sponsor|0
7937117|NCT02365298|12472496|FG000|Period 2|Test Article longer available|0
7937118|NCT02365298|12472497|FG001|Period 2|Test Article longer available|1
7937119|NCT02365298|12472496|FG000|Period 2|Protocol Violation|0
7937120|NCT02365298|12472497|FG001|Period 2|Protocol Violation|1
7937121|NCT02365480|12472505|FG000|Overall Study|Withdrawal by Subject|2
7937122|NCT02365480|12472506|FG001|Overall Study|Withdrawal by Subject|0
7937123|NCT02365506|12472515|FG000|Overall Study|Investigator's Discretion|0
7937124|NCT02365506|12472516|FG001|Overall Study|Investigator's Discretion|0
7937125|NCT02365506|12472517|FG002|Overall Study|Investigator's Discretion|1
7937126|NCT02365519|12472527|FG000|Randomized and Treated|Adverse Event|0
7937127|NCT02365519|12472528|FG001|Randomized and Treated|Adverse Event|1
7937128|NCT02365519|12472529|FG002|Randomized and Treated|Adverse Event|0
7937129|NCT02365519|12472527|FG000|Randomized and Treated|Withdrawal by Subject|0
7937130|NCT02365519|12472528|FG001|Randomized and Treated|Withdrawal by Subject|1
7937131|NCT02365519|12472529|FG002|Randomized and Treated|Withdrawal by Subject|1
7937132|NCT02365558|12472538|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1
7937133|NCT02365558|12472539|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0
7937134|NCT02365558|12472538|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
7937135|NCT02365558|12472539|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
7937136|NCT02365584|12472550|FG000|Overall Study|Adverse Event|2
7937137|NCT02365584|12472551|FG001|Overall Study|Adverse Event|2
7937138|NCT02365584|12472550|FG000|Overall Study|Withdrawal by Subject|1
7937139|NCT02365584|12472551|FG001|Overall Study|Withdrawal by Subject|0
7937140|NCT02365584|12472550|FG000|Overall Study|Disease Progression|9
7937141|NCT02365584|12472551|FG001|Overall Study|Disease Progression|12
7937142|NCT02365636|12472560|FG000|Overall Study|Adverse Event|3
7937143|NCT02365636|12472561|FG001|Overall Study|Adverse Event|3
7937144|NCT02365636|12472562|FG002|Overall Study|Adverse Event|2
7937145|NCT02365636|12472560|FG000|Overall Study|Protocol Violation|1
7937146|NCT02365636|12472561|FG001|Overall Study|Protocol Violation|4
7937147|NCT02365636|12472562|FG002|Overall Study|Protocol Violation|0
7937148|NCT02365636|12472560|FG000|Overall Study|Lost to Follow-up|0
7937149|NCT02365636|12472561|FG001|Overall Study|Lost to Follow-up|0
7937150|NCT02365636|12472562|FG002|Overall Study|Lost to Follow-up|1
7937151|NCT02365636|12472560|FG000|Overall Study|Other|2
7937152|NCT02365636|12472561|FG001|Overall Study|Other|0
7937153|NCT02365636|12472562|FG002|Overall Study|Other|0
7937154|NCT02366091|12472596|FG000|Overall Study|Withdrawal by Subject|3
7937155|NCT02366091|12472597|FG001|Overall Study|Withdrawal by Subject|7
7937156|NCT02366091|12472598|FG002|Overall Study|Withdrawal by Subject|3
7937157|NCT02366091|12472599|FG003|Overall Study|Withdrawal by Subject|1
7964958|NCT01034631|12520538|FG001|Phase II|Determined Ineligible per protocol|1
7964959|NCT01034631|12520539|FG002|Phase II|Determined Ineligible per protocol|0
7964960|NCT00402298|12520551|FG000|Overall Study|Withdrawal by Subject|1
7964961|NCT00402298|12520552|FG001|Overall Study|Withdrawal by Subject|0
7967180|NCT02761733|12523727|FG001|Overall Study|Physician Decision|0
7967181|NCT02761733|12523728|FG002|Overall Study|Physician Decision|0
7967182|NCT02761733|12523729|FG003|Overall Study|Physician Decision|0
7967183|NCT02761733|12523726|FG000|Overall Study|Withdrawal by Subject|2
7967184|NCT02761733|12523727|FG001|Overall Study|Withdrawal by Subject|0
7967185|NCT02761733|12523728|FG002|Overall Study|Withdrawal by Subject|0
7967186|NCT02761733|12523729|FG003|Overall Study|Withdrawal by Subject|0
7967187|NCT02761733|12523726|FG000|Overall Study|Discharged from Study Site|10
7967188|NCT02761733|12523727|FG001|Overall Study|Discharged from Study Site|9
7967189|NCT02761733|12523728|FG002|Overall Study|Discharged from Study Site|25
7967190|NCT02761733|12523729|FG003|Overall Study|Discharged from Study Site|11
7967191|NCT02761733|12523726|FG000|Overall Study|Cognitive Impairment|5
7967192|NCT02761733|12523727|FG001|Overall Study|Cognitive Impairment|0
7967193|NCT02761733|12523728|FG002|Overall Study|Cognitive Impairment|1
7967194|NCT02761733|12523729|FG003|Overall Study|Cognitive Impairment|0
7967195|NCT02761915|12523745|FG000|Overall Study|Death|3
7937158|NCT02366130|12472609|FG000|Overall Study|Withdrawal by Subject|3
7937159|NCT02366130|12472609|FG000|Overall Study|Ineligible|6
7937160|NCT02366143|12472616|FG000|Overall Study|Death|307
7937161|NCT02366143|12472617|FG001|Overall Study|Death|278
7937162|NCT02366143|12472618|FG002|Overall Study|Death|280
7937163|NCT02366143|12472616|FG000|Overall Study|Lost to Follow-up|2
7937164|NCT02366143|12472617|FG001|Overall Study|Lost to Follow-up|4
7937165|NCT02366143|12472618|FG002|Overall Study|Lost to Follow-up|2
7937166|NCT02366143|12472616|FG000|Overall Study|Physician Decision|1
7937167|NCT02366143|12472617|FG001|Overall Study|Physician Decision|2
7937168|NCT02366143|12472618|FG002|Overall Study|Physician Decision|1
7937169|NCT02366143|12472616|FG000|Overall Study|Protocol Violation|0
7937170|NCT02366143|12472617|FG001|Overall Study|Protocol Violation|0
7937171|NCT02366143|12472618|FG002|Overall Study|Protocol Violation|2
7937172|NCT02366143|12472616|FG000|Overall Study|Withdrawal by Subject|16
7937173|NCT02366143|12472617|FG001|Overall Study|Withdrawal by Subject|17
7937174|NCT02366143|12472618|FG002|Overall Study|Withdrawal by Subject|22
7937175|NCT02366143|12472616|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0
7937176|NCT02366143|12472617|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6
7937177|NCT02366143|12472618|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0
7937178|NCT02366143|12472616|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0
7937179|NCT02366143|12472617|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1
7937180|NCT02366143|12472618|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0
7937181|NCT02366143|12472616|FG000|Overall Study|Randomization Error|1
7937182|NCT02366143|12472617|FG001|Overall Study|Randomization Error|0
7937183|NCT02366143|12472618|FG002|Overall Study|Randomization Error|0
7937184|NCT02366143|12472616|FG000|Overall Study|PI Move and Site Closure|1
7937185|NCT02366143|12472617|FG001|Overall Study|PI Move and Site Closure|0
7937186|NCT02366143|12472618|FG002|Overall Study|PI Move and Site Closure|1
7937187|NCT02366143|12472616|FG000|Overall Study|Study Terminated By Sponsor|0
7937188|NCT02366143|12472617|FG001|Overall Study|Study Terminated By Sponsor|0
7937189|NCT02366143|12472618|FG002|Overall Study|Study Terminated By Sponsor|2
7937190|NCT02366143|12472616|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70
7937191|NCT02366143|12472617|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57
7937192|NCT02366143|12472618|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52
7937193|NCT02366143|12472616|FG000|Overall Study|Patient moved to roll-over study|1
7937194|NCT02366143|12472617|FG001|Overall Study|Patient moved to roll-over study|19
7937195|NCT02366143|12472618|FG002|Overall Study|Patient moved to roll-over study|28
7937196|NCT02366143|12472616|FG000|Overall Study|Patient moved to commercial stock|0
7937197|NCT02366143|12472617|FG001|Overall Study|Patient moved to commercial stock|0
7937198|NCT02366143|12472618|FG002|Overall Study|Patient moved to commercial stock|1
7937199|NCT02366143|12472616|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0
7937200|NCT02366143|12472617|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0
7937201|NCT02366143|12472618|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1
7937202|NCT02366143|12472616|FG000|Overall Study|Patient rolling over to patient assistance program|0
7937203|NCT02366143|12472617|FG001|Overall Study|Patient rolling over to patient assistance program|0
7937204|NCT02366143|12472618|FG002|Overall Study|Patient rolling over to patient assistance program|1
7937205|NCT02366143|12472616|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0
7937206|NCT02366143|12472617|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0
7937207|NCT02366143|12472618|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1
7937208|NCT02366143|12472616|FG000|Overall Study|Requester's instructions|1
7937209|NCT02366143|12472617|FG001|Overall Study|Requester's instructions|1
7937210|NCT02366143|12472618|FG002|Overall Study|Requester's instructions|1
7937211|NCT02366143|12472616|FG000|Overall Study|Uneligible|0
7937212|NCT02366143|12472617|FG001|Overall Study|Uneligible|1
7937213|NCT02366143|12472618|FG002|Overall Study|Uneligible|0
7937214|NCT02366143|12472616|FG000|Overall Study|Post Trial Migration|0
7937215|NCT02366143|12472617|FG001|Overall Study|Post Trial Migration|1
7937216|NCT02366143|12472618|FG002|Overall Study|Post Trial Migration|0
7937217|NCT02366143|12472616|FG000|Overall Study|Patient moving onto PTAP commercial stock|0
7937218|NCT02366143|12472617|FG001|Overall Study|Patient moving onto PTAP commercial stock|1
7937219|NCT02366143|12472618|FG002|Overall Study|Patient moving onto PTAP commercial stock|0
7937220|NCT02366143|12472616|FG000|Overall Study|Patient switched to PTAP|0
7937221|NCT02366143|12472617|FG001|Overall Study|Patient switched to PTAP|1
7937222|NCT02366143|12472618|FG002|Overall Study|Patient switched to PTAP|0
7937223|NCT02366143|12472616|FG000|Overall Study|Patient moved to commercial atezolizumab use|0
7937224|NCT02366143|12472617|FG001|Overall Study|Patient moved to commercial atezolizumab use|11
7937225|NCT02366143|12472618|FG002|Overall Study|Patient moved to commercial atezolizumab use|7
7937226|NCT02366195|12472630|FG000|Overall Study|Protocol-specified criteria|3
7937227|NCT02366195|12472630|FG000|Overall Study|Withdrawal by Subject|9
7937228|NCT02366195|12472630|FG000|Overall Study|Lost to Follow-up|1
7937229|NCT02366195|12472630|FG000|Overall Study|Death|41
7937230|NCT02366312|12472636|FG000|Overall Study|Lost to Follow-up|0
7937231|NCT02366312|12472637|FG001|Overall Study|Lost to Follow-up|1
7937232|NCT02366468|12472658|FG000|Overall Study|Adverse Event|2
7937233|NCT02366468|12472659|FG001|Overall Study|Adverse Event|0
7937234|NCT02366468|12472658|FG000|Overall Study|Withdrawal by Subject|1
7937235|NCT02366468|12472659|FG001|Overall Study|Withdrawal by Subject|5
7937236|NCT02366468|12472658|FG000|Overall Study|Lost to Follow-up|2
7937237|NCT02366468|12472659|FG001|Overall Study|Lost to Follow-up|0
7937238|NCT02366468|12472658|FG000|Overall Study|Death|1
7937239|NCT02366468|12472659|FG001|Overall Study|Death|2
7937240|NCT02366468|12472658|FG000|Overall Study|Other|0
7937241|NCT02366468|12472659|FG001|Overall Study|Other|2
7937242|NCT02366637|12472675|FG000|First Intervention Period|Adverse Event|0
7937243|NCT02366637|12472676|FG001|First Intervention Period|Adverse Event|1
7937244|NCT02366637|12472675|FG000|First Intervention Period|Study Terminated by Sponsor|6
7937245|NCT02366637|12472676|FG001|First Intervention Period|Study Terminated by Sponsor|4
7937246|NCT02366637|12472675|FG000|Second Intervention Period|Study Terminated by Sponsor|1
7937247|NCT02366637|12472676|FG001|Second Intervention Period|Study Terminated by Sponsor|1
7937248|NCT02366689|12472694|FG000|Overall Study|Withdrawal by Subject|1
7937249|NCT02366689|12472695|FG001|Overall Study|Withdrawal by Subject|0
7937250|NCT02366689|12472696|FG002|Overall Study|Withdrawal by Subject|1
7937251|NCT02366689|12472694|FG000|Overall Study|Lost to Follow-up|3
7937252|NCT02366689|12472695|FG001|Overall Study|Lost to Follow-up|2
7937253|NCT02366689|12472696|FG002|Overall Study|Lost to Follow-up|0
7937254|NCT02366689|12472694|FG000|Overall Study|Pregnancy|0
7937255|NCT02366689|12472695|FG001|Overall Study|Pregnancy|1
7937256|NCT02366689|12472696|FG002|Overall Study|Pregnancy|1
7937257|NCT02366767|12472706|FG000|Overall Study|left for home after 1 day at camp|1
7937258|NCT02366767|12472707|FG001|Overall Study|left for home after 1 day at camp|0
7937259|NCT02366910|12472731|FG000|Overall Study|Withdrawal by Subject|2
7937260|NCT02366910|12472731|FG000|Overall Study|Screen Failure|3
7937261|NCT02366923|12472737|FG000|Overall Study|Withdrawal by Subject|1
7937262|NCT02366923|12472737|FG000|Overall Study|Positive Slit Lamp Findings|2
7937263|NCT02366923|12472737|FG000|Overall Study|High Astigmatism|3
7937264|NCT02366936|12472742|FG000|Overall Study|Withdrawal by Subject|2
7937265|NCT02366936|12472742|FG000|Overall Study|Lost to Follow-up|4
7937266|NCT02366936|12472742|FG000|Overall Study|Physician Decision|2
7937267|NCT02367131|12472779|FG000|Overall Study|Adverse Event|64
7937268|NCT02367131|12472779|FG000|Overall Study|No visit since the first visit|4
7937269|NCT02367131|12472779|FG000|Overall Study|Request by patient|54
7937270|NCT02367131|12472779|FG000|Overall Study|Improvement/remission|2
7937271|NCT02367131|12472779|FG000|Overall Study|No change/progressive disease|78
7937272|NCT02367131|12472779|FG000|Overall Study|Other than stated above|20
7937273|NCT02367352|12472783|FG000|Overall Study|Progressive disease|7
7937274|NCT02367352|12472784|FG001|Overall Study|Progressive disease|0
7937275|NCT02367352|12472785|FG002|Overall Study|Progressive disease|0
7937276|NCT02367352|12472783|FG000|Overall Study|Participant Received Alternative Therapy|1
7937277|NCT02367352|12472784|FG001|Overall Study|Participant Received Alternative Therapy|0
7937278|NCT02367352|12472785|FG002|Overall Study|Participant Received Alternative Therapy|0
7937279|NCT02367352|12472783|FG000|Overall Study|Adverse Event|1
7937280|NCT02367352|12472784|FG001|Overall Study|Adverse Event|0
7937281|NCT02367352|12472785|FG002|Overall Study|Adverse Event|0
7937282|NCT02367521|12472806|FG000|Overall Study|severe headache after intervention|2
7937283|NCT02367521|12472807|FG001|Overall Study|severe headache after intervention|0
7937284|NCT02367521|12472806|FG000|Overall Study|unable to find transportation|2
7937285|NCT02367521|12472807|FG001|Overall Study|unable to find transportation|0
7937286|NCT02367716|12472822|FG000|Overall Study|Patient did not meet inclusion criteria|1
7937287|NCT02367729|12472829|FG000|Overall Study|Organic disorder diagnosed|2
7937288|NCT02367729|12472830|FG001|Overall Study|Organic disorder diagnosed|1
7937289|NCT02367729|12472829|FG000|Overall Study|Adverse Event|1
7937290|NCT02367729|12472830|FG001|Overall Study|Adverse Event|2
7937291|NCT02367729|12472829|FG000|Overall Study|Withdrawal by Subject|0
7937292|NCT02367729|12472830|FG001|Overall Study|Withdrawal by Subject|5
7937293|NCT02367781|12472839|FG000|Overall Study|Withdrawal by Subject|20
7937294|NCT02367781|12472840|FG001|Overall Study|Withdrawal by Subject|13
7937295|NCT02367781|12472839|FG000|Overall Study|Protocol Violation|0
7937296|NCT02367781|12472840|FG001|Overall Study|Protocol Violation|1
7937297|NCT02367781|12472839|FG000|Overall Study|Physician Decision|7
7937298|NCT02367781|12472840|FG001|Overall Study|Physician Decision|0
7937299|NCT02367781|12472839|FG000|Overall Study|Randomized in Error|5
7937300|NCT02367781|12472840|FG001|Overall Study|Randomized in Error|4
7937301|NCT02367781|12472839|FG000|Overall Study|Non-Compliance|1
7937302|NCT02367781|12472840|FG001|Overall Study|Non-Compliance|0
7937303|NCT02367781|12472839|FG000|Overall Study|Lost to Follow-up|1
7937304|NCT02367781|12472840|FG001|Overall Study|Lost to Follow-up|2
7937305|NCT02367781|12472839|FG000|Overall Study|Death|330
7937306|NCT02367781|12472840|FG001|Overall Study|Death|176
7937307|NCT02367781|12472839|FG000|Overall Study|Patient Moving to Roll-Over Study|17
7937308|NCT02367781|12472840|FG001|Overall Study|Patient Moving to Roll-Over Study|5
7937309|NCT02367781|12472839|FG000|Overall Study|Prolonged Hospitalization|1
7937310|NCT02367781|12472840|FG001|Overall Study|Prolonged Hospitalization|0
7937311|NCT02367781|12472839|FG000|Overall Study|Death Prior First Dose|1
7937312|NCT02367781|12472840|FG001|Overall Study|Death Prior First Dose|0
7937313|NCT02367781|12472839|FG000|Overall Study|Administrative-Change Facility|1
7937314|NCT02367781|12472840|FG001|Overall Study|Administrative-Change Facility|0
7937315|NCT02367781|12472839|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78
7937316|NCT02367781|12472840|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29
7937317|NCT02367781|12472839|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14
7937318|NCT02367781|12472840|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9
7937319|NCT02367781|12472839|FG000|Overall Study|Study Terminated by Sponsor|3
7937320|NCT02367781|12472840|FG001|Overall Study|Study Terminated by Sponsor|1
7937321|NCT02367781|12472839|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1
7937322|NCT02367781|12472840|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0
7937323|NCT02367781|12472839|FG000|Overall Study|Sponsor Decision|2
7937324|NCT02367781|12472840|FG001|Overall Study|Sponsor Decision|0
7937325|NCT02367781|12472839|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1
7937326|NCT02367781|12472840|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0
7937327|NCT02367833|12472865|FG000|Overall Study|Withdrawal by Subject|1
7937328|NCT02367833|12472866|FG001|Overall Study|Withdrawal by Subject|1
7937329|NCT02367833|12472867|FG002|Overall Study|Withdrawal by Subject|0
7937330|NCT02367885|12472924|FG000|Overall Study|Lost to Follow-up|1
7937331|NCT02367885|12472925|FG001|Overall Study|Lost to Follow-up|0
7937332|NCT02367885|12472926|FG002|Overall Study|Lost to Follow-up|0
7937333|NCT02367885|12472924|FG000|Overall Study|Withdrawal by Subject|1
7937334|NCT02367885|12472925|FG001|Overall Study|Withdrawal by Subject|0
7937335|NCT02367885|12472926|FG002|Overall Study|Withdrawal by Subject|0
7937336|NCT02367911|12472939|FG000|Overall Study|Withdrawal by Subject|3
7937337|NCT02367911|12472940|FG001|Overall Study|Withdrawal by Subject|2
7937338|NCT02367911|12472939|FG000|Overall Study|Lost to Follow-up|2
7937339|NCT02367911|12472940|FG001|Overall Study|Lost to Follow-up|2
7937340|NCT02368210|12472957|FG000|Overall Study|Withdrawal by Subject|1
7937341|NCT02368210|12472958|FG001|Overall Study|Withdrawal by Subject|0
7937342|NCT02368210|12472957|FG000|Overall Study|Adverse Event|0
7937343|NCT02368210|12472958|FG001|Overall Study|Adverse Event|1
7937344|NCT02368314|12472966|FG000|Overall Study|Withdrawal by Subject|2
7937345|NCT02368314|12472967|FG001|Overall Study|Withdrawal by Subject|1
7937346|NCT02368314|12472966|FG000|Overall Study|Adverse Event|1
7937347|NCT02368314|12472967|FG001|Overall Study|Adverse Event|2
7937348|NCT02368691|12472992|FG000|Overall Study|Death|13
7719820|NCT00534495|12143822|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1
7719821|NCT00534495|12143823|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0
7719822|NCT00534495|12143824|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0
7719823|NCT00534495|12143822|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
7719824|NCT00534495|12143823|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
7719825|NCT00534495|12143824|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
7719826|NCT00534495|12143822|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
7719827|NCT00534495|12143823|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
7719828|NCT00534495|12143824|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
7719829|NCT00534495|12143822|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
7719830|NCT00534495|12143823|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
7937349|NCT02368691|12472992|FG000|Overall Study|Lack of Efficacy|15
7937350|NCT02368691|12472992|FG000|Overall Study|Physician Decision|4
7937351|NCT02369159|12473007|FG000|Overall Study|Adverse Event|0
7937352|NCT02369159|12473008|FG001|Overall Study|Adverse Event|1
7937353|NCT02369159|12473007|FG000|Overall Study|Lost to Follow-up|1
7937354|NCT02369159|12473008|FG001|Overall Study|Lost to Follow-up|1
7937355|NCT02369159|12473007|FG000|Overall Study|Withdrawal by Subject|7
7937356|NCT02369159|12473008|FG001|Overall Study|Withdrawal by Subject|0
7937357|NCT02369341|12473058|FG000|Overall Study|Migrated/moved from study area|1
7937358|NCT02369341|12473059|FG001|Overall Study|Migrated/moved from study area|0
7937359|NCT02369510|12473072|FG000|Overall Study|Spilled Medication|1
7937360|NCT02369510|12473073|FG001|Overall Study|Spilled Medication|2
7937361|NCT02369510|12473074|FG002|Overall Study|Spilled Medication|1
7937362|NCT02369510|12473072|FG000|Overall Study|Epidural Activation|1
7937363|NCT02369510|12473073|FG001|Overall Study|Epidural Activation|1
7937364|NCT02369510|12473074|FG002|Overall Study|Epidural Activation|5
7937365|NCT02369848|12473112|FG000|Overall Study|Death|1
7937366|NCT02369848|12473112|FG000|Overall Study|Withdrawal by Subject|2
7937367|NCT02369848|12473112|FG000|Overall Study|Lost to Follow-up|1
7937368|NCT02369874|12473119|FG000|Overall Study|Lost to Follow-up|2
7937369|NCT02369874|12473120|FG001|Overall Study|Lost to Follow-up|2
7937370|NCT02369874|12473121|FG002|Overall Study|Lost to Follow-up|2
7937371|NCT02369874|12473119|FG000|Overall Study|Withdrawal by Subject|7
7937372|NCT02369874|12473120|FG001|Overall Study|Withdrawal by Subject|9
7937373|NCT02369874|12473121|FG002|Overall Study|Withdrawal by Subject|27
7937374|NCT02369874|12473119|FG000|Overall Study|Miscellaneous|1
7937375|NCT02369874|12473120|FG001|Overall Study|Miscellaneous|1
7937376|NCT02369874|12473121|FG002|Overall Study|Miscellaneous|0
7937377|NCT02369874|12473119|FG000|Overall Study|On Treatment/Off Study|34
7937378|NCT02369874|12473120|FG001|Overall Study|On Treatment/Off Study|45
7937379|NCT02369874|12473121|FG002|Overall Study|On Treatment/Off Study|32
7937380|NCT02370043|12473147|FG000|Overall Study|Withdrawal by Subject|0
7937381|NCT02370043|12473148|FG001|Overall Study|Withdrawal by Subject|0
7937382|NCT02370043|12473149|FG002|Overall Study|Withdrawal by Subject|0
7937383|NCT02370043|12473150|FG003|Overall Study|Withdrawal by Subject|0
7937384|NCT02370043|12473151|FG004|Overall Study|Withdrawal by Subject|1
7937385|NCT02370043|12473152|FG005|Overall Study|Withdrawal by Subject|1
7937386|NCT02370095|12473191|FG000|Overall Study|Withdrawal by Subject|0
7937387|NCT02370095|12473192|FG001|Overall Study|Withdrawal by Subject|1
7937388|NCT02370121|12473200|FG000|Overall Study|Lost to Follow-up|1
7937389|NCT02370121|12473201|FG001|Overall Study|Lost to Follow-up|1
7937390|NCT02370160|12473207|FG000|Overall Study|Death|3
7937391|NCT02370160|12473208|FG001|Overall Study|Death|4
7937392|NCT02370160|12473209|FG002|Overall Study|Death|1
7937393|NCT02370251|12473222|FG000|Overall Study|Received less than 8 days of Omegaven|7
7937394|NCT02370251|12473222|FG000|Overall Study|Death|4
7937395|NCT02370368|12473228|FG000|Overall Study|Adverse Event|1
7937396|NCT02370368|12473229|FG001|Overall Study|Adverse Event|2
7937397|NCT02370368|12473228|FG000|Overall Study|Withdrawal by Subject|5
7937398|NCT02370368|12473229|FG001|Overall Study|Withdrawal by Subject|4
7937399|NCT02370394|12473237|FG000|Overall Study|Lost to Follow-up|2
7937400|NCT02370394|12473238|FG001|Overall Study|Lost to Follow-up|1
7937401|NCT02370394|12473237|FG000|Overall Study|Withdrawal by Subject|0
7937402|NCT02370394|12473238|FG001|Overall Study|Withdrawal by Subject|1
7937403|NCT02370420|12473260|FG000|Overall Study|Physician Decision|3
7937404|NCT02370420|12473261|FG001|Overall Study|Physician Decision|3
7937405|NCT02370420|12473260|FG000|Overall Study|Lost to Follow-up|11
7937406|NCT02370420|12473261|FG001|Overall Study|Lost to Follow-up|9
7937407|NCT02370498|12473269|FG000|Overall Study|Adverse Event|10
7937408|NCT02370498|12473270|FG001|Overall Study|Adverse Event|8
7937409|NCT02370498|12473269|FG000|Overall Study|Death|263
7937410|NCT02370498|12473270|FG001|Overall Study|Death|265
7937411|NCT02370498|12473269|FG000|Overall Study|Protocol Violation|1
7937412|NCT02370498|12473270|FG001|Overall Study|Protocol Violation|2
7937413|NCT02370498|12473269|FG000|Overall Study|Withdrawal by Subject|7
7937414|NCT02370498|12473270|FG001|Overall Study|Withdrawal by Subject|12
7937415|NCT02370498|12473269|FG000|Overall Study|Sponsor's decision|15
7937416|NCT02370498|12473270|FG001|Overall Study|Sponsor's decision|9
7937417|NCT02370511|12473280|FG000|Overall Study|Death|10
7937418|NCT02370511|12473281|FG001|Overall Study|Death|7
7937419|NCT02370511|12473282|FG002|Overall Study|Death|1
7937420|NCT02370511|12473280|FG000|Overall Study|Withdrawal by Subject|2
7937421|NCT02370511|12473281|FG001|Overall Study|Withdrawal by Subject|0
7937422|NCT02370511|12473282|FG002|Overall Study|Withdrawal by Subject|0
7937423|NCT02370511|12473280|FG000|Overall Study|Lost to Follow-up|0
7937424|NCT02370511|12473281|FG001|Overall Study|Lost to Follow-up|4
7937425|NCT02370511|12473282|FG002|Overall Study|Lost to Follow-up|0
7937426|NCT02370537|12473293|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0
7937427|NCT02370537|12473294|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1
7937428|NCT02370537|12473295|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0
7937429|NCT02370537|12473293|FG000|Part A (Open-label Recruitment)|Adverse Event|0
7937430|NCT02370537|12473294|FG001|Part A (Open-label Recruitment)|Adverse Event|0
7937431|NCT02370537|12473295|FG002|Part A (Open-label Recruitment)|Adverse Event|1
7937432|NCT02370537|12473293|FG000|Part B|Not randomised to receive treatment|1
7937433|NCT02370537|12473294|FG001|Part B|Not randomised to receive treatment|2
7937434|NCT02370537|12473295|FG002|Part B|Not randomised to receive treatment|259
7937435|NCT02370537|12473293|FG000|Part B|Withdrawal by Subject|0
7937436|NCT02370537|12473294|FG001|Part B|Withdrawal by Subject|1
7937437|NCT02370537|12473295|FG002|Part B|Withdrawal by Subject|0
7937438|NCT02370602|12473318|FG000|Overall Study|Pretreatment Event/Adverse Event|1
7937439|NCT02370602|12473319|FG001|Overall Study|Pretreatment Event/Adverse Event|0
7937440|NCT02370602|12473320|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7937441|NCT02370602|12473321|FG003|Overall Study|Pretreatment Event/Adverse Event|0
7937442|NCT02370602|12473322|FG004|Overall Study|Pretreatment Event/Adverse Event|0
7937443|NCT02370602|12473323|FG005|Overall Study|Pretreatment Event/Adverse Event|0
7937444|NCT02370615|12473342|FG000|Overall Study|Adverse Event|1
7937445|NCT02370615|12473343|FG001|Overall Study|Adverse Event|0
7937446|NCT02370641|12473358|FG000|Overall Study|dropped study|4
7937447|NCT02370641|12473359|FG001|Overall Study|dropped study|2
7937448|NCT02370667|12473368|FG000|Overall Study|Lost to Follow-up|0
7937449|NCT02370667|12473369|FG001|Overall Study|Lost to Follow-up|1
7937450|NCT02370667|12473370|FG002|Overall Study|Lost to Follow-up|0
7937451|NCT02370784|12473390|FG000|Overall Study|Patient started prohibited medication|0
7937452|NCT02370784|12473391|FG001|Overall Study|Patient started prohibited medication|1
7937453|NCT02371616|12473455|FG000|Overall Study|Protocol Violation|2
7937454|NCT02371616|12473456|FG001|Overall Study|Protocol Violation|1
7937455|NCT02371616|12473455|FG000|Overall Study|Adverse Event|0
7937456|NCT02371616|12473456|FG001|Overall Study|Adverse Event|1
7937457|NCT02371616|12473455|FG000|Overall Study|Withdrawal of Consent|1
7937458|NCT02371616|12473456|FG001|Overall Study|Withdrawal of Consent|0
7937459|NCT02371616|12473455|FG000|Overall Study|Other (Not specified)|1
7937460|NCT02371616|12473456|FG001|Overall Study|Other (Not specified)|5
7937461|NCT02371629|12473464|FG000|Overall Study|Patient decision|14
7937462|NCT02371629|12473465|FG001|Overall Study|Patient decision|10
7937463|NCT02371629|12473464|FG000|Overall Study|Adverse Event|8
7937464|NCT02371629|12473465|FG001|Overall Study|Adverse Event|8
7937465|NCT02371629|12473464|FG000|Overall Study|Physician Decision|2
7937466|NCT02371629|12473465|FG001|Overall Study|Physician Decision|3
7937467|NCT02371629|12473464|FG000|Overall Study|Death|1
7937468|NCT02371629|12473465|FG001|Overall Study|Death|1
7937469|NCT02371629|12473464|FG000|Overall Study|Noncompliance with study treatment|1
7937470|NCT02371629|12473465|FG001|Overall Study|Noncompliance with study treatment|0
7937471|NCT02371629|12473464|FG000|Overall Study|Lack of Efficacy|0
7937472|NCT02371629|12473465|FG001|Overall Study|Lack of Efficacy|2
7937473|NCT02371629|12473464|FG000|Overall Study|Protocol deviation|0
7937474|NCT02371629|12473465|FG001|Overall Study|Protocol deviation|1
7937475|NCT02371746|12473487|FG000|Overall Study|Consent withdrawn|0
7937476|NCT02371746|12473488|FG001|Overall Study|Consent withdrawn|0
7937477|NCT02371746|12473489|FG002|Overall Study|Consent withdrawn|0
7937478|NCT02371746|12473490|FG003|Overall Study|Consent withdrawn|0
7937479|NCT02371746|12473491|FG004|Overall Study|Consent withdrawn|0
7937480|NCT02371746|12473492|FG005|Overall Study|Consent withdrawn|0
7937481|NCT02371746|12473493|FG006|Overall Study|Consent withdrawn|1
7937482|NCT02371759|12473517|FG000|Overall Study|Protocol Violation|3
7937483|NCT02371759|12473518|FG001|Overall Study|Protocol Violation|1
7937484|NCT02371759|12473519|FG002|Overall Study|Protocol Violation|1
7937485|NCT02371759|12473520|FG003|Overall Study|Protocol Violation|0
7937486|NCT02371759|12473521|FG004|Overall Study|Protocol Violation|3
7937487|NCT02371759|12473522|FG005|Overall Study|Protocol Violation|1
7937488|NCT02371759|12473523|FG006|Overall Study|Protocol Violation|0
7937489|NCT02371759|12473524|FG007|Overall Study|Protocol Violation|3
7937490|NCT02371759|12473517|FG000|Overall Study|Withdrawal by Subject|0
7937491|NCT02371759|12473518|FG001|Overall Study|Withdrawal by Subject|0
7937492|NCT02371759|12473519|FG002|Overall Study|Withdrawal by Subject|0
7937493|NCT02371759|12473520|FG003|Overall Study|Withdrawal by Subject|0
7937494|NCT02371759|12473521|FG004|Overall Study|Withdrawal by Subject|0
7937495|NCT02371759|12473522|FG005|Overall Study|Withdrawal by Subject|0
7937496|NCT02371759|12473523|FG006|Overall Study|Withdrawal by Subject|0
7937497|NCT02371759|12473524|FG007|Overall Study|Withdrawal by Subject|1
7937498|NCT02371980|12473571|FG000|Open-label Period|Pretreatment Event/Adverse Event|63
7937499|NCT02371980|12473572|FG001|Open-label Period|Pretreatment Event/Adverse Event|0
7937500|NCT02371980|12473573|FG002|Open-label Period|Pretreatment Event/Adverse Event|0
7937501|NCT02371980|12473574|FG003|Open-label Period|Pretreatment Event/Adverse Event|0
7937502|NCT02371980|12473575|FG004|Open-label Period|Pretreatment Event/Adverse Event|0
7937503|NCT02371980|12473571|FG000|Open-label Period|Significant Protocol Deviation|19
7937504|NCT02371980|12473572|FG001|Open-label Period|Significant Protocol Deviation|0
7937505|NCT02371980|12473573|FG002|Open-label Period|Significant Protocol Deviation|0
7937506|NCT02371980|12473574|FG003|Open-label Period|Significant Protocol Deviation|0
7937507|NCT02371980|12473575|FG004|Open-label Period|Significant Protocol Deviation|0
7937508|NCT02371980|12473571|FG000|Open-label Period|Noncompliance with Study Drug|10
7937509|NCT02371980|12473572|FG001|Open-label Period|Noncompliance with Study Drug|0
7937510|NCT02371980|12473573|FG002|Open-label Period|Noncompliance with Study Drug|0
7937511|NCT02371980|12473574|FG003|Open-label Period|Noncompliance with Study Drug|0
7937512|NCT02371980|12473575|FG004|Open-label Period|Noncompliance with Study Drug|0
7937513|NCT02371980|12473571|FG000|Open-label Period|Lost to Follow-up|55
7937514|NCT02371980|12473572|FG001|Open-label Period|Lost to Follow-up|0
7937515|NCT02371980|12473573|FG002|Open-label Period|Lost to Follow-up|0
7937516|NCT02371980|12473574|FG003|Open-label Period|Lost to Follow-up|0
7937517|NCT02371980|12473575|FG004|Open-label Period|Lost to Follow-up|0
7937518|NCT02371980|12473571|FG000|Open-label Period|Voluntary Withdrawal|91
7937519|NCT02371980|12473572|FG001|Open-label Period|Voluntary Withdrawal|0
7937520|NCT02371980|12473573|FG002|Open-label Period|Voluntary Withdrawal|0
7937521|NCT02371980|12473574|FG003|Open-label Period|Voluntary Withdrawal|0
7937522|NCT02371980|12473575|FG004|Open-label Period|Voluntary Withdrawal|0
7937523|NCT02371980|12473571|FG000|Open-label Period|Pregnancy|1
7937524|NCT02371980|12473572|FG001|Open-label Period|Pregnancy|0
7937525|NCT02371980|12473573|FG002|Open-label Period|Pregnancy|0
7937526|NCT02371980|12473574|FG003|Open-label Period|Pregnancy|0
7937527|NCT02371980|12473575|FG004|Open-label Period|Pregnancy|0
7937528|NCT02371980|12473571|FG000|Open-label Period|Lack of Efficacy|116
7937529|NCT02371980|12473572|FG001|Open-label Period|Lack of Efficacy|0
7937530|NCT02371980|12473573|FG002|Open-label Period|Lack of Efficacy|0
7937531|NCT02371980|12473574|FG003|Open-label Period|Lack of Efficacy|0
7937532|NCT02371980|12473575|FG004|Open-label Period|Lack of Efficacy|0
7937533|NCT02371980|12473571|FG000|Open-label Period|Did not Meet Randomization Criteria|162
7937534|NCT02371980|12473572|FG001|Open-label Period|Did not Meet Randomization Criteria|0
7937535|NCT02371980|12473573|FG002|Open-label Period|Did not Meet Randomization Criteria|0
7937536|NCT02371980|12473574|FG003|Open-label Period|Did not Meet Randomization Criteria|0
7937537|NCT02371980|12473575|FG004|Open-label Period|Did not Meet Randomization Criteria|0
7937538|NCT02371980|12473571|FG000|Open-label Period|Reason not Specified|9
7937539|NCT02371980|12473572|FG001|Open-label Period|Reason not Specified|0
7937540|NCT02371980|12473573|FG002|Open-label Period|Reason not Specified|0
7937541|NCT02371980|12473574|FG003|Open-label Period|Reason not Specified|0
7937542|NCT02371980|12473575|FG004|Open-label Period|Reason not Specified|0
7937543|NCT02371980|12473571|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0
7937544|NCT02371980|12473572|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4
7937545|NCT02371980|12473573|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3
7937546|NCT02371980|12473574|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2
7937547|NCT02371980|12473575|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9
7937548|NCT02371980|12473571|FG000|Double-blind Period|Significant Protocol Deviation|0
7937549|NCT02371980|12473572|FG001|Double-blind Period|Significant Protocol Deviation|2
7937550|NCT02371980|12473573|FG002|Double-blind Period|Significant Protocol Deviation|7
7937551|NCT02371980|12473574|FG003|Double-blind Period|Significant Protocol Deviation|3
7937552|NCT02371980|12473575|FG004|Double-blind Period|Significant Protocol Deviation|3
7937553|NCT02371980|12473571|FG000|Double-blind Period|Noncompliance with Study Drug|0
7937554|NCT02371980|12473572|FG001|Double-blind Period|Noncompliance with Study Drug|1
7937555|NCT02371980|12473573|FG002|Double-blind Period|Noncompliance with Study Drug|2
7937556|NCT02371980|12473574|FG003|Double-blind Period|Noncompliance with Study Drug|2
7937557|NCT02371980|12473575|FG004|Double-blind Period|Noncompliance with Study Drug|3
7937558|NCT02371980|12473571|FG000|Double-blind Period|Lost to Follow-up|0
7937559|NCT02371980|12473572|FG001|Double-blind Period|Lost to Follow-up|8
7937560|NCT02371980|12473573|FG002|Double-blind Period|Lost to Follow-up|8
7937561|NCT02371980|12473574|FG003|Double-blind Period|Lost to Follow-up|6
7937562|NCT02371980|12473575|FG004|Double-blind Period|Lost to Follow-up|5
7937563|NCT02371980|12473571|FG000|Double-blind Period|Voluntary Withdrawal|0
7937564|NCT02371980|12473572|FG001|Double-blind Period|Voluntary Withdrawal|12
7937565|NCT02371980|12473573|FG002|Double-blind Period|Voluntary Withdrawal|8
7937566|NCT02371980|12473574|FG003|Double-blind Period|Voluntary Withdrawal|9
7937567|NCT02371980|12473575|FG004|Double-blind Period|Voluntary Withdrawal|11
7937568|NCT02371980|12473571|FG000|Double-blind Period|Relapse|0
7937569|NCT02371980|12473572|FG001|Double-blind Period|Relapse|50
7937570|NCT02371980|12473573|FG002|Double-blind Period|Relapse|25
7937571|NCT02371980|12473574|FG003|Double-blind Period|Relapse|25
7937572|NCT02371980|12473575|FG004|Double-blind Period|Relapse|26
7937573|NCT02371980|12473571|FG000|Double-blind Period|Reason not Specified|0
7937574|NCT02371980|12473572|FG001|Double-blind Period|Reason not Specified|3
7937575|NCT02371980|12473573|FG002|Double-blind Period|Reason not Specified|3
7937576|NCT02371980|12473574|FG003|Double-blind Period|Reason not Specified|2
7937577|NCT02371980|12473575|FG004|Double-blind Period|Reason not Specified|1
7937578|NCT02371980|12473571|FG000|Double-blind Period|Missing|0
7937579|NCT02371980|12473572|FG001|Double-blind Period|Missing|1
7937580|NCT02371980|12473573|FG002|Double-blind Period|Missing|0
7937581|NCT02371980|12473574|FG003|Double-blind Period|Missing|0
7937582|NCT02371980|12473575|FG004|Double-blind Period|Missing|0
7937583|NCT02372006|12473589|FG000|Overall Study|Progressive disease|8
7937584|NCT02372006|12473590|FG001|Overall Study|Progressive disease|7
7937585|NCT02372006|12473591|FG002|Overall Study|Progressive disease|34
7937586|NCT02372006|12473589|FG000|Overall Study|Dose limiting toxicity|0
7937587|NCT02372006|12473590|FG001|Overall Study|Dose limiting toxicity|1
7937588|NCT02372006|12473591|FG002|Overall Study|Dose limiting toxicity|0
7937589|NCT02372006|12473589|FG000|Overall Study|Adverse Event|0
7937590|NCT02372006|12473590|FG001|Overall Study|Adverse Event|0
7937591|NCT02372006|12473591|FG002|Overall Study|Adverse Event|3
7937592|NCT02372006|12473589|FG000|Overall Study|Withdrawal by Subject|0
7937593|NCT02372006|12473590|FG001|Overall Study|Withdrawal by Subject|1
7937594|NCT02372006|12473591|FG002|Overall Study|Withdrawal by Subject|1
7937595|NCT02372006|12473589|FG000|Overall Study|Other reason for not completing|0
7937596|NCT02372006|12473590|FG001|Overall Study|Other reason for not completing|0
7937597|NCT02372006|12473591|FG002|Overall Study|Other reason for not completing|1
7937598|NCT02372058|12473600|FG000|Overall Study|Withdrawal by Subject|3
7937599|NCT02372071|12473606|FG000|Overall Study|Protocol Violation|18
7937600|NCT02372253|12473622|FG000|Overall Study|Non Compliance|2
7937601|NCT02372253|12473623|FG001|Overall Study|Non Compliance|0
7937602|NCT02372383|12473643|FG000|First Intervention (1 Day)|Unable to collect blood|0
7937603|NCT02372383|12473644|FG001|First Intervention (1 Day)|Unable to collect blood|1
7937604|NCT02372383|12473645|FG002|First Intervention (1 Day)|Unable to collect blood|0
7937605|NCT02372396|12473657|FG000|Overall Study|Lost to Follow-up|7
7937606|NCT02372396|12473658|FG001|Overall Study|Lost to Follow-up|9
7937607|NCT02372799|12473683|FG000|Treatment Period|Adverse Event|3
7937608|NCT02372799|12473684|FG001|Treatment Period|Adverse Event|10
7937609|NCT02372799|12473685|FG002|Treatment Period|Adverse Event|6
7937610|NCT02372799|12473683|FG000|Treatment Period|Insufficient therapeutic response|2
7937611|NCT02372799|12473684|FG001|Treatment Period|Insufficient therapeutic response|2
7937612|NCT02372799|12473685|FG002|Treatment Period|Insufficient therapeutic response|0
7937613|NCT02372799|12473683|FG000|Treatment Period|Withdrawal by Subject|10
7937614|NCT02372799|12473684|FG001|Treatment Period|Withdrawal by Subject|10
7937615|NCT02372799|12473685|FG002|Treatment Period|Withdrawal by Subject|2
7937616|NCT02372799|12473683|FG000|Treatment Period|Lost to Follow-up|11
7937617|NCT02372799|12473684|FG001|Treatment Period|Lost to Follow-up|5
7937618|NCT02372799|12473685|FG002|Treatment Period|Lost to Follow-up|3
7937619|NCT02372799|12473683|FG000|Treatment Period|Protocol Violation|3
7937620|NCT02372799|12473684|FG001|Treatment Period|Protocol Violation|0
7937621|NCT02372799|12473685|FG002|Treatment Period|Protocol Violation|0
7937622|NCT02372799|12473683|FG000|Treatment Period|Non-compliance with study drug|4
7937623|NCT02372799|12473684|FG001|Treatment Period|Non-compliance with study drug|4
7937624|NCT02372799|12473685|FG002|Treatment Period|Non-compliance with study drug|4
7937625|NCT02372799|12473683|FG000|Treatment Period|Miscellaneous Reasons|1
7937626|NCT02372799|12473684|FG001|Treatment Period|Miscellaneous Reasons|1
7937627|NCT02372799|12473685|FG002|Treatment Period|Miscellaneous Reasons|0
7937628|NCT02372799|12473683|FG000|Down-taper Period|Lost to Follow-up|1
7937629|NCT02372799|12473684|FG001|Down-taper Period|Lost to Follow-up|2
7937630|NCT02372799|12473685|FG002|Down-taper Period|Lost to Follow-up|2
7937631|NCT02373098|12473695|FG000|Overall Study|Lost to Follow-up|1
7937632|NCT02373098|12473696|FG001|Overall Study|Lost to Follow-up|0
7937633|NCT02373098|12473695|FG000|Overall Study|Protocol Violation|3
7937634|NCT02373098|12473696|FG001|Overall Study|Protocol Violation|0
7937635|NCT02373098|12473695|FG000|Overall Study|Withdrawal by Subject|5
7937636|NCT02373098|12473696|FG001|Overall Study|Withdrawal by Subject|0
7937637|NCT02373098|12473695|FG000|Overall Study|Adverse Event|3
7937638|NCT02373098|12473696|FG001|Overall Study|Adverse Event|0
7937639|NCT02373202|12473726|FG000|Overall Study|Adverse Event|2
7937640|NCT02373202|12473727|FG001|Overall Study|Adverse Event|5
7937641|NCT02373202|12473728|FG002|Overall Study|Adverse Event|2
7937642|NCT02373202|12473729|FG003|Overall Study|Adverse Event|1
7937643|NCT02373202|12473726|FG000|Overall Study|Lack of Efficacy|0
7937644|NCT02373202|12473727|FG001|Overall Study|Lack of Efficacy|0
7937645|NCT02373202|12473728|FG002|Overall Study|Lack of Efficacy|1
7937646|NCT02373202|12473729|FG003|Overall Study|Lack of Efficacy|0
7937647|NCT02373202|12473726|FG000|Overall Study|Other|0
7937648|NCT02373202|12473727|FG001|Overall Study|Other|1
7937649|NCT02373202|12473728|FG002|Overall Study|Other|0
7937650|NCT02373202|12473729|FG003|Overall Study|Other|0
7937651|NCT02373813|12473751|FG000|Run-In Period|Other, Not Specified|5
7937652|NCT02373813|12473752|FG001|Run-In Period|Other, Not Specified|0
7937653|NCT02373813|12473753|FG002|Run-In Period|Other, Not Specified|0
7937654|NCT02373813|12473754|FG003|Run-In Period|Other, Not Specified|0
7937655|NCT02373813|12473751|FG000|Run-In Period|Withdrawal by Subject|16
7937656|NCT02373813|12473752|FG001|Run-In Period|Withdrawal by Subject|0
7937657|NCT02373813|12473753|FG002|Run-In Period|Withdrawal by Subject|0
7937658|NCT02373813|12473754|FG003|Run-In Period|Withdrawal by Subject|0
7937659|NCT02373813|12473751|FG000|Run-In Period|Decision by Sponsor|11
7937660|NCT02373813|12473752|FG001|Run-In Period|Decision by Sponsor|0
7937661|NCT02373813|12473753|FG002|Run-In Period|Decision by Sponsor|0
7937662|NCT02373813|12473754|FG003|Run-In Period|Decision by Sponsor|0
7937663|NCT02373813|12473751|FG000|Run-In Period|Protocol Violation|75
7937664|NCT02373813|12473752|FG001|Run-In Period|Protocol Violation|0
7937665|NCT02373813|12473753|FG002|Run-In Period|Protocol Violation|0
7937666|NCT02373813|12473754|FG003|Run-In Period|Protocol Violation|0
7937667|NCT02373813|12473751|FG000|Run-In Period|Lost to Follow-up|2
7937668|NCT02373813|12473752|FG001|Run-In Period|Lost to Follow-up|0
7937669|NCT02373813|12473753|FG002|Run-In Period|Lost to Follow-up|0
7937670|NCT02373813|12473754|FG003|Run-In Period|Lost to Follow-up|0
7937671|NCT02373813|12473751|FG000|Run-In Period|Adverse Event|3
7937672|NCT02373813|12473752|FG001|Run-In Period|Adverse Event|0
7937673|NCT02373813|12473753|FG002|Run-In Period|Adverse Event|0
7937674|NCT02373813|12473754|FG003|Run-In Period|Adverse Event|0
7937675|NCT02373813|12473751|FG000|Run-In Period|Noncompliance|1
7937676|NCT02373813|12473752|FG001|Run-In Period|Noncompliance|0
7937677|NCT02373813|12473753|FG002|Run-In Period|Noncompliance|0
7937678|NCT02373813|12473754|FG003|Run-In Period|Noncompliance|0
7937679|NCT02373813|12473751|FG000|Run-In Period|Ineligibility Determined|3
7937680|NCT02373813|12473752|FG001|Run-In Period|Ineligibility Determined|0
7937681|NCT02373813|12473753|FG002|Run-In Period|Ineligibility Determined|0
7937682|NCT02373813|12473754|FG003|Run-In Period|Ineligibility Determined|0
7937683|NCT02373813|12473751|FG000|Double-Blind Treatment Period|Decision by Sponsor|0
7937684|NCT02373813|12473752|FG001|Double-Blind Treatment Period|Decision by Sponsor|1
7937685|NCT02373813|12473753|FG002|Double-Blind Treatment Period|Decision by Sponsor|2
7937686|NCT02373813|12473754|FG003|Double-Blind Treatment Period|Decision by Sponsor|0
7937687|NCT02373813|12473751|FG000|Double-Blind Treatment Period|Protocol Violation|0
7937688|NCT02373813|12473752|FG001|Double-Blind Treatment Period|Protocol Violation|2
7937689|NCT02373813|12473753|FG002|Double-Blind Treatment Period|Protocol Violation|0
7937690|NCT02373813|12473754|FG003|Double-Blind Treatment Period|Protocol Violation|0
7937691|NCT02373813|12473751|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7937692|NCT02373813|12473752|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
7937693|NCT02373813|12473753|FG002|Double-Blind Treatment Period|Lost to Follow-up|1
7937694|NCT02373813|12473754|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
7937695|NCT02373813|12473751|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7937696|NCT02373813|12473752|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10
7937697|NCT02373813|12473753|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6
7937698|NCT02373813|12473754|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3
7964962|NCT04320745|12520575|FG000|Overall Study|Adverse Event|26
7964963|NCT04320745|12520575|FG000|Overall Study|Withdrawal by Subject|4
7964964|NCT04320745|12520575|FG000|Overall Study|Lost to Follow-up|12
7964965|NCT04320745|12520575|FG000|Overall Study|Protocol Deviation|2
7964966|NCT04320745|12520575|FG000|Overall Study|Non-compliance With Study Drug|2
7964967|NCT04320745|12520575|FG000|Overall Study|Reason Not Specified|1
7964968|NCT04016779|12520594|FG000|Overall Study|Adverse Event|9
7964969|NCT04016779|12520595|FG001|Overall Study|Adverse Event|17
7964970|NCT04016779|12520594|FG000|Overall Study|Lack of Efficacy|4
7964971|NCT04016779|12520595|FG001|Overall Study|Lack of Efficacy|1
7964972|NCT04016779|12520594|FG000|Overall Study|Lost to Follow-up|5
7964973|NCT04016779|12520595|FG001|Overall Study|Lost to Follow-up|14
7964974|NCT04016779|12520594|FG000|Overall Study|Physician Decision|1
7964975|NCT04016779|12520595|FG001|Overall Study|Physician Decision|3
7964976|NCT04016779|12520594|FG000|Overall Study|Withdrawal by Subject|6
7964977|NCT04016779|12520595|FG001|Overall Study|Withdrawal by Subject|8
7964978|NCT04016779|12520594|FG000|Overall Study|Non-compliance with Study Drug|2
7964979|NCT04016779|12520595|FG001|Overall Study|Non-compliance with Study Drug|3
7964980|NCT04016779|12520594|FG000|Overall Study|Other, Multiple categories|17
7964981|NCT04016779|12520595|FG001|Overall Study|Other, Multiple categories|17
7964982|NCT04000165|12520603|FG000|Overall Study|Physician Decision|1
7964983|NCT04000165|12520603|FG000|Overall Study|Withdrawal by Subject|1
7964984|NCT03952650|12520614|FG000|Overall Study|TRAVEL|0
7964985|NCT03952650|12520615|FG001|Overall Study|TRAVEL|4
7964986|NCT03952650|12520616|FG002|Overall Study|TRAVEL|0
7964987|NCT03952650|12520617|FG003|Overall Study|TRAVEL|4
7964988|NCT03952650|12520618|FG004|Overall Study|TRAVEL|0
7964989|NCT03952650|12520619|FG005|Overall Study|TRAVEL|3
7964990|NCT03952650|12520620|FG006|Overall Study|TRAVEL|2
7964991|NCT03952650|12520614|FG000|Overall Study|Withdrawal by Subject|0
7964992|NCT03952650|12520615|FG001|Overall Study|Withdrawal by Subject|2
7964993|NCT03952650|12520616|FG002|Overall Study|Withdrawal by Subject|0
7964994|NCT03952650|12520617|FG003|Overall Study|Withdrawal by Subject|3
7964995|NCT03952650|12520618|FG004|Overall Study|Withdrawal by Subject|0
7964996|NCT03952650|12520619|FG005|Overall Study|Withdrawal by Subject|1
7964997|NCT03952650|12520620|FG006|Overall Study|Withdrawal by Subject|1
7964998|NCT03952650|12520614|FG000|Overall Study|Lost to Follow-up|0
7964999|NCT03952650|12520615|FG001|Overall Study|Lost to Follow-up|1
7965000|NCT03952650|12520616|FG002|Overall Study|Lost to Follow-up|0
7965001|NCT03952650|12520617|FG003|Overall Study|Lost to Follow-up|0
7965002|NCT03952650|12520618|FG004|Overall Study|Lost to Follow-up|0
7965003|NCT03952650|12520619|FG005|Overall Study|Lost to Follow-up|1
7965004|NCT03952650|12520620|FG006|Overall Study|Lost to Follow-up|1
7965005|NCT03952650|12520614|FG000|Overall Study|Received wrong vaccine and travelled|0
7965006|NCT03952650|12520615|FG001|Overall Study|Received wrong vaccine and travelled|0
7965007|NCT03952650|12520616|FG002|Overall Study|Received wrong vaccine and travelled|0
7965008|NCT03952650|12520617|FG003|Overall Study|Received wrong vaccine and travelled|0
7965009|NCT03952650|12520618|FG004|Overall Study|Received wrong vaccine and travelled|0
7965010|NCT03952650|12520619|FG005|Overall Study|Received wrong vaccine and travelled|1
7965011|NCT03952650|12520620|FG006|Overall Study|Received wrong vaccine and travelled|0
7965012|NCT03952650|12520614|FG000|Overall Study|Unable to make study visit|0
7965013|NCT03952650|12520615|FG001|Overall Study|Unable to make study visit|0
7965014|NCT03952650|12520616|FG002|Overall Study|Unable to make study visit|0
7965015|NCT03952650|12520617|FG003|Overall Study|Unable to make study visit|0
7965016|NCT03952650|12520618|FG004|Overall Study|Unable to make study visit|0
7965017|NCT03952650|12520619|FG005|Overall Study|Unable to make study visit|1
7965018|NCT03952650|12520620|FG006|Overall Study|Unable to make study visit|0
7965019|NCT03794089|12520638|FG000|Overall Study|Lost to Follow-up|4
7965020|NCT03794089|12520639|FG001|Overall Study|Lost to Follow-up|1
7965021|NCT03794089|12520638|FG000|Overall Study|Withdrawal by Subject|2
7965022|NCT03794089|12520639|FG001|Overall Study|Withdrawal by Subject|0
7965023|NCT03713021|12520654|FG000|Overall Study|Did not have CT sim scan available|6
7965024|NCT03713021|12520654|FG000|Overall Study|Not eligible|4
7965025|NCT03713021|12520654|FG000|Overall Study|Issues with TraceIT markers|5
7965026|NCT03631407|12520660|FG000|Overall Study|Withdrawal by Subject|3
7965027|NCT03631407|12520661|FG001|Overall Study|Withdrawal by Subject|2
7965028|NCT03631407|12520660|FG000|Overall Study|Sponsor Decision|0
7965029|NCT03631407|12520661|FG001|Overall Study|Sponsor Decision|2
7965030|NCT03631407|12520660|FG000|Overall Study|Death|16
7937699|NCT02374099|12473784|FG000|Overall Study|Adverse Event|1
7937700|NCT02374099|12473785|FG001|Overall Study|Adverse Event|0
7937701|NCT02374099|12473784|FG000|Overall Study|Progressive Disease|35
7937702|NCT02374099|12473785|FG001|Overall Study|Progressive Disease|40
7937703|NCT02374099|12473784|FG000|Overall Study|Withdrawal by Subject|5
7937704|NCT02374099|12473785|FG001|Overall Study|Withdrawal by Subject|1
7937705|NCT02374099|12473784|FG000|Overall Study|Miscellaneous|2
7937706|NCT02374099|12473785|FG001|Overall Study|Miscellaneous|3
7937707|NCT02374099|12473784|FG000|Overall Study|Randomized, but not treated|2
7937708|NCT02374099|12473785|FG001|Overall Study|Randomized, but not treated|1
7937709|NCT02374099|12473784|FG000|Overall Study|Study Terminated by Sponsor|3
7937710|NCT02374099|12473785|FG001|Overall Study|Study Terminated by Sponsor|4
7937711|NCT02374255|12473818|FG000|Overall Study|Withdrawal by Subject|2
7937712|NCT02374255|12473819|FG001|Overall Study|Withdrawal by Subject|0
7937713|NCT02374255|12473820|FG002|Overall Study|Withdrawal by Subject|0
7937714|NCT02374255|12473821|FG003|Overall Study|Withdrawal by Subject|0
7937715|NCT02374307|12473839|FG000|3-months Follow-up|Lost to Follow-up|1
7937716|NCT02374307|12473840|FG001|3-months Follow-up|Lost to Follow-up|2
7937717|NCT02374307|12473839|FG000|3-months Follow-up|Withdrawal by Subject|1
7937718|NCT02374307|12473840|FG001|3-months Follow-up|Withdrawal by Subject|4
7937719|NCT02374307|12473839|FG000|3-months Follow-up|Death|1
7937720|NCT02374307|12473840|FG001|3-months Follow-up|Death|2
7937721|NCT02374307|12473839|FG000|3-months Follow-up|Missed first follow-up|5
7937722|NCT02374307|12473840|FG001|3-months Follow-up|Missed first follow-up|1
7937723|NCT02374307|12473839|FG000|6-months Follow-up|Lost to Follow-up|1
7937724|NCT02374307|12473840|FG001|6-months Follow-up|Lost to Follow-up|2
7937725|NCT02374307|12473839|FG000|6-months Follow-up|Death|2
7937726|NCT02374307|12473840|FG001|6-months Follow-up|Death|1
7937727|NCT02374307|12473839|FG000|6-months Follow-up|Withdrawal by Subject|0
7937728|NCT02374307|12473840|FG001|6-months Follow-up|Withdrawal by Subject|3
7937729|NCT02374346|12473846|FG000|Overall Study|operated or discharged during weekend|48
7937730|NCT02374463|12473872|FG000|Overall Study|Withdrawal by Subject|3
7937731|NCT02374463|12473873|FG001|Overall Study|Withdrawal by Subject|3
7937732|NCT02374593|12473882|FG000|Overall Study|non-compliant|2
7937733|NCT02374593|12473883|FG001|Overall Study|non-compliant|0
7937734|NCT02374671|12473896|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0
7937735|NCT02374671|12473897|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0
7937736|NCT02374671|12473898|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4
7937737|NCT02374671|12473896|FG000|Observation (Deferred Implantation)|Adverse Event|0
7937738|NCT02374671|12473897|FG001|Observation (Deferred Implantation)|Adverse Event|0
7937739|NCT02374671|12473898|FG002|Observation (Deferred Implantation)|Adverse Event|1
7937740|NCT02374671|12473896|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17
7937741|NCT02374671|12473897|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
7937742|NCT02374671|12473898|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2
7937743|NCT02374671|12473896|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7
7937744|NCT02374671|12473897|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0
7937745|NCT02374671|12473898|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1
7937746|NCT02374671|12473896|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
7937747|NCT02374671|12473897|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
7937748|NCT02374671|12473898|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
7937749|NCT02374918|12473908|FG000|Overall Study|Protocol Violation|2
7937750|NCT02374918|12473909|FG001|Overall Study|Protocol Violation|0
7937751|NCT02374918|12473910|FG002|Overall Study|Protocol Violation|2
7937752|NCT02374918|12473911|FG003|Overall Study|Protocol Violation|1
7937753|NCT02374918|12473908|FG000|Overall Study|Withdrawal by Subject|1
7937754|NCT02374918|12473909|FG001|Overall Study|Withdrawal by Subject|1
7937755|NCT02374918|12473910|FG002|Overall Study|Withdrawal by Subject|1
7937756|NCT02374918|12473911|FG003|Overall Study|Withdrawal by Subject|0
7937757|NCT02374918|12473908|FG000|Overall Study|Lack of Efficacy|0
7937758|NCT02374918|12473909|FG001|Overall Study|Lack of Efficacy|0
7937759|NCT02374918|12473910|FG002|Overall Study|Lack of Efficacy|1
7937760|NCT02374918|12473911|FG003|Overall Study|Lack of Efficacy|1
7937761|NCT02374957|12473921|FG000|Overall Study|Patient did not complete forms correctly|1
7937762|NCT02374957|12473922|FG001|Overall Study|Patient did not complete forms correctly|0
7937763|NCT02375347|12473928|FG000|Overall Study|Protocol Violation|1
7937764|NCT02375373|12473932|FG000|Overall Study|Withdrawal by Subject|11
7937765|NCT02375698|12473938|FG000|Overall Study|Withdrawal by Subject|0
7937766|NCT02375698|12473939|FG001|Overall Study|Withdrawal by Subject|2
7937767|NCT02375698|12473938|FG000|Overall Study|Physician Decision|2
7937768|NCT02375698|12473939|FG001|Overall Study|Physician Decision|0
7937769|NCT02375724|12473947|FG000|Overall Study|Lack of Efficacy|1
7937770|NCT02375724|12473948|FG001|Overall Study|Lack of Efficacy|1
7937771|NCT02375724|12473947|FG000|Overall Study|Withdrawal by Subject|1
7937772|NCT02375724|12473948|FG001|Overall Study|Withdrawal by Subject|1
7937773|NCT02375724|12473947|FG000|Overall Study|Lost to Follow-up|1
7937774|NCT02375724|12473948|FG001|Overall Study|Lost to Follow-up|0
7937775|NCT02375724|12473947|FG000|Overall Study|Protocol Violation|1
7937776|NCT02375724|12473948|FG001|Overall Study|Protocol Violation|0
7937777|NCT02375724|12473947|FG000|Overall Study|Adverse Event|2
7937778|NCT02375724|12473948|FG001|Overall Study|Adverse Event|4
7937779|NCT02375971|12473957|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
7937780|NCT02375971|12473958|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
7937781|NCT02375971|12473959|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
7937782|NCT02375971|12473957|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1
7937783|NCT02375971|12473958|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1
7937784|NCT02375971|12473959|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1
7937785|NCT02375971|12473957|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
7937786|NCT02375971|12473958|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
7937787|NCT02375971|12473959|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
7937788|NCT02375971|12473957|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0
7937789|NCT02375971|12473958|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0
7937790|NCT02375971|12473959|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1
7937791|NCT02375971|12473957|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1
7937792|NCT02375971|12473958|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0
7937793|NCT02375971|12473959|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0
7937794|NCT02375971|12473957|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
7937795|NCT02375971|12473958|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
7937796|NCT02375971|12473959|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
7937797|NCT02375971|12473957|FG000|Follow-Up Phase (up to Day 169)|Death|4
7937798|NCT02375971|12473958|FG001|Follow-Up Phase (up to Day 169)|Death|4
7937799|NCT02375971|12473959|FG002|Follow-Up Phase (up to Day 169)|Death|4
7937800|NCT02375971|12473957|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
7937801|NCT02375971|12473958|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
7937802|NCT02375971|12473959|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
7937803|NCT02376166|12473980|FG000|Overall Study|Adverse Event|1
7937804|NCT02376166|12473980|FG000|Overall Study|Discontinued metformin early|2
7937805|NCT02377063|12474045|FG000|Overall Study|Non-compliance|5
7937806|NCT02377349|12474051|FG000|Overall Study|Serious Adverse Event|1
7937807|NCT02377349|12474052|FG001|Overall Study|Serious Adverse Event|0
7937808|NCT02377349|12474051|FG000|Overall Study|Protocol Violation|3
7937809|NCT02377349|12474052|FG001|Overall Study|Protocol Violation|2
7937810|NCT02377349|12474051|FG000|Overall Study|Withdrawal by Subject|5
7937811|NCT02377349|12474052|FG001|Overall Study|Withdrawal by Subject|3
7937812|NCT02377349|12474051|FG000|Overall Study|Lost to follow-up (partial vaccination)|1
7937813|NCT02377349|12474052|FG001|Overall Study|Lost to follow-up (partial vaccination)|0
7937814|NCT02377349|12474051|FG000|Overall Study|Lost to follow-up (complete vaccination)|6
7937815|NCT02377349|12474052|FG001|Overall Study|Lost to follow-up (complete vaccination)|5
7937816|NCT02377349|12474051|FG000|Overall Study|Other|0
7937817|NCT02377349|12474052|FG001|Overall Study|Other|1
7937818|NCT02377362|12474080|FG000|Part A Second Treatment|Protocol Violation|0
7937819|NCT02377362|12474081|FG001|Part A Second Treatment|Protocol Violation|0
7937820|NCT02377362|12474082|FG002|Part A Second Treatment|Protocol Violation|0
7937821|NCT02377362|12474083|FG003|Part A Second Treatment|Protocol Violation|0
7937822|NCT02377362|12474084|FG004|Part A Second Treatment|Protocol Violation|1
7937823|NCT02377362|12474085|FG005|Part A Second Treatment|Protocol Violation|0
7937824|NCT02377362|12474086|FG006|Part A Second Treatment|Protocol Violation|0
7937825|NCT02377362|12474087|FG007|Part A Second Treatment|Protocol Violation|0
7937826|NCT02377362|12474088|FG008|Part A Second Treatment|Protocol Violation|0
7937827|NCT02377362|12474089|FG009|Part A Second Treatment|Protocol Violation|0
7937828|NCT02377362|12474090|FG010|Part A Second Treatment|Protocol Violation|0
7937829|NCT02377362|12474091|FG011|Part A Second Treatment|Protocol Violation|0
7937830|NCT02377362|12474092|FG012|Part A Second Treatment|Protocol Violation|0
7937831|NCT02377362|12474080|FG000|Part A Third Treatment|Highest dose level 1200 not used|0
7937832|NCT02377362|12474081|FG001|Part A Third Treatment|Highest dose level 1200 not used|0
7937833|NCT02377362|12474082|FG002|Part A Third Treatment|Highest dose level 1200 not used|0
7937834|NCT02377362|12474083|FG003|Part A Third Treatment|Highest dose level 1200 not used|4
7937835|NCT02377362|12474084|FG004|Part A Third Treatment|Highest dose level 1200 not used|3
7937836|NCT02377362|12474085|FG005|Part A Third Treatment|Highest dose level 1200 not used|4
7937837|NCT02377362|12474086|FG006|Part A Third Treatment|Highest dose level 1200 not used|0
7937838|NCT02377362|12474087|FG007|Part A Third Treatment|Highest dose level 1200 not used|0
7937839|NCT02377362|12474088|FG008|Part A Third Treatment|Highest dose level 1200 not used|0
7937840|NCT02377362|12474089|FG009|Part A Third Treatment|Highest dose level 1200 not used|0
7965031|NCT03631407|12520661|FG001|Overall Study|Death|16
7937841|NCT02377362|12474090|FG010|Part A Third Treatment|Highest dose level 1200 not used|0
7937842|NCT02377362|12474091|FG011|Part A Third Treatment|Highest dose level 1200 not used|0
7937843|NCT02377362|12474092|FG012|Part A Third Treatment|Highest dose level 1200 not used|0
7937844|NCT02377362|12474080|FG000|Part B Overall|Protocol Violation|0
7937845|NCT02377362|12474081|FG001|Part B Overall|Protocol Violation|0
7937846|NCT02377362|12474082|FG002|Part B Overall|Protocol Violation|0
7937847|NCT02377362|12474083|FG003|Part B Overall|Protocol Violation|0
7937848|NCT02377362|12474084|FG004|Part B Overall|Protocol Violation|0
7937849|NCT02377362|12474085|FG005|Part B Overall|Protocol Violation|0
7937850|NCT02377362|12474086|FG006|Part B Overall|Protocol Violation|0
7937851|NCT02377362|12474087|FG007|Part B Overall|Protocol Violation|0
7937852|NCT02377362|12474088|FG008|Part B Overall|Protocol Violation|0
7937853|NCT02377362|12474089|FG009|Part B Overall|Protocol Violation|1
7937854|NCT02377362|12474090|FG010|Part B Overall|Protocol Violation|0
7937855|NCT02377362|12474091|FG011|Part B Overall|Protocol Violation|0
7937856|NCT02377362|12474092|FG012|Part B Overall|Protocol Violation|0
7937857|NCT02377362|12474080|FG000|Part B Overall|Adverse Event|0
7937858|NCT02377362|12474081|FG001|Part B Overall|Adverse Event|0
7937859|NCT02377362|12474082|FG002|Part B Overall|Adverse Event|0
7937860|NCT02377362|12474083|FG003|Part B Overall|Adverse Event|0
7937861|NCT02377362|12474084|FG004|Part B Overall|Adverse Event|0
7937862|NCT02377362|12474085|FG005|Part B Overall|Adverse Event|0
7937863|NCT02377362|12474086|FG006|Part B Overall|Adverse Event|1
7937864|NCT02377362|12474087|FG007|Part B Overall|Adverse Event|1
7937865|NCT02377362|12474088|FG008|Part B Overall|Adverse Event|0
7937866|NCT02377362|12474089|FG009|Part B Overall|Adverse Event|0
7937867|NCT02377362|12474090|FG010|Part B Overall|Adverse Event|0
7937868|NCT02377362|12474091|FG011|Part B Overall|Adverse Event|0
7937869|NCT02377362|12474092|FG012|Part B Overall|Adverse Event|0
7937870|NCT02377362|12474080|FG000|Part B Overall|Withdrawal by Subject|0
7937871|NCT02377362|12474081|FG001|Part B Overall|Withdrawal by Subject|0
7937872|NCT02377362|12474082|FG002|Part B Overall|Withdrawal by Subject|0
7937873|NCT02377362|12474083|FG003|Part B Overall|Withdrawal by Subject|0
7937874|NCT02377362|12474084|FG004|Part B Overall|Withdrawal by Subject|0
7937875|NCT02377362|12474085|FG005|Part B Overall|Withdrawal by Subject|0
7937876|NCT02377362|12474086|FG006|Part B Overall|Withdrawal by Subject|1
7937877|NCT02377362|12474087|FG007|Part B Overall|Withdrawal by Subject|0
7937878|NCT02377362|12474088|FG008|Part B Overall|Withdrawal by Subject|0
7937879|NCT02377362|12474089|FG009|Part B Overall|Withdrawal by Subject|0
7937880|NCT02377362|12474090|FG010|Part B Overall|Withdrawal by Subject|0
7937881|NCT02377362|12474091|FG011|Part B Overall|Withdrawal by Subject|1
7937882|NCT02377362|12474092|FG012|Part B Overall|Withdrawal by Subject|0
7937883|NCT02377427|12474132|FG000|Part A (Up to Week 20)|Physician Decision|1
7937884|NCT02377427|12474133|FG001|Part A (Up to Week 20)|Physician Decision|0
7937885|NCT02377427|12474134|FG002|Part A (Up to Week 20)|Physician Decision|0
7937886|NCT02377427|12474135|FG003|Part A (Up to Week 20)|Physician Decision|0
7937887|NCT02377427|12474136|FG004|Part A (Up to Week 20)|Physician Decision|0
7937888|NCT02377427|12474132|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
7937889|NCT02377427|12474133|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7937890|NCT02377427|12474134|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7937891|NCT02377427|12474135|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7937892|NCT02377427|12474136|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7937893|NCT02377427|12474132|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2
7937894|NCT02377427|12474133|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0
7937895|NCT02377427|12474134|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0
7937896|NCT02377427|12474135|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0
7937897|NCT02377427|12474136|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0
7937898|NCT02377427|12474132|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7937899|NCT02377427|12474133|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7937900|NCT02377427|12474134|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
7937901|NCT02377427|12474135|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7937902|NCT02377427|12474136|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7937903|NCT02377466|12474151|FG000|Overall Study|Other: Randomized and not treated|0
7937904|NCT02377466|12474152|FG001|Overall Study|Other: Randomized and not treated|2
7937905|NCT02377817|12474195|FG000|Overall Study|Transportation/childcare barriers.|2
7937906|NCT02377817|12474196|FG001|Overall Study|Transportation/childcare barriers.|0
7937907|NCT02377817|12474195|FG000|Overall Study|Unrelated injury prevented lateral sleep|1
7937908|NCT02377817|12474196|FG001|Overall Study|Unrelated injury prevented lateral sleep|0
7937909|NCT02377921|12474206|FG000|Overall Study|Subject non-compliance|1
7937910|NCT02377921|12474207|FG001|Overall Study|Subject non-compliance|1
7937911|NCT02378220|12474253|FG000|Overall Study|Death|6
7937912|NCT02378220|12474254|FG001|Overall Study|Death|1
7937913|NCT02378480|12474276|FG000|Overall Study|Physician Decision|1
7937914|NCT02378480|12474277|FG001|Overall Study|Physician Decision|1
7937915|NCT02378480|12474276|FG000|Overall Study|Death|1
7937916|NCT02378480|12474277|FG001|Overall Study|Death|2
7937917|NCT02378480|12474276|FG000|Overall Study|Randomized, but Not Treated|6
7937918|NCT02378480|12474277|FG001|Overall Study|Randomized, but Not Treated|4
7937919|NCT02378480|12474276|FG000|Overall Study|Adverse Event|0
7937920|NCT02378480|12474277|FG001|Overall Study|Adverse Event|1
7937921|NCT02378480|12474276|FG000|Overall Study|Missed EOT/PTE Visit|1
7937922|NCT02378480|12474277|FG001|Overall Study|Missed EOT/PTE Visit|2
7937923|NCT02378480|12474276|FG000|Overall Study|Withdrawal by Subject|9
7937924|NCT02378480|12474277|FG001|Overall Study|Withdrawal by Subject|4
7937925|NCT02378480|12474276|FG000|Overall Study|Lost to Follow-up|10
7937926|NCT02378480|12474277|FG001|Overall Study|Lost to Follow-up|18
7937927|NCT02378506|12474283|FG000|Overall Study|Lack of Efficacy|3
7937928|NCT02378506|12474283|FG000|Overall Study|Withdrawal by Subject|4
7937929|NCT02378506|12474283|FG000|Overall Study|Protocol Violation|2
7937930|NCT02378506|12474283|FG000|Overall Study|Death|1
7937931|NCT02378506|12474283|FG000|Overall Study|Adverse Event|14
7937932|NCT02378506|12474283|FG000|Overall Study|Randomized But Not Treated|1
7937933|NCT02378662|12474289|FG000|Overall Study|Early Discontinuation|2
7937934|NCT02378662|12474290|FG001|Overall Study|Early Discontinuation|0
7937935|NCT02378883|12474358|FG000|Enrollment|Subject did not meet Inclusion criteria|6
7937936|NCT02378883|12474358|FG000|Enrollment|Attempt to use Apollo was not performed|3
7937937|NCT02378883|12474358|FG000|30 Day Follow-Up|Withdrawal by Subject|1
7937938|NCT02378883|12474358|FG000|30 Day Follow-Up|Physician Decision|2
7937939|NCT02378883|12474358|FG000|30 Day Follow-Up|Missed Visit|2
7937940|NCT02378883|12474358|FG000|30 Day Follow-Up|Death|1
7937941|NCT02378883|12474358|FG000|12 Months Follow-Up|Lost to Follow-up|3
7937942|NCT02378883|12474358|FG000|12 Months Follow-Up|Death|2
7937943|NCT02378935|12474370|FG000|Overall Study|Lack of Efficacy|10
7937944|NCT02378935|12474371|FG001|Overall Study|Lack of Efficacy|0
7937945|NCT02378935|12474372|FG002|Overall Study|Lack of Efficacy|2
7937946|NCT02378935|12474373|FG003|Overall Study|Lack of Efficacy|6
7937947|NCT02378935|12474374|FG004|Overall Study|Lack of Efficacy|0
7937948|NCT02378935|12474375|FG005|Overall Study|Lack of Efficacy|0
7937949|NCT02378935|12474376|FG006|Overall Study|Lack of Efficacy|0
7937950|NCT02378935|12474370|FG000|Overall Study|Death|0
7937951|NCT02378935|12474371|FG001|Overall Study|Death|0
7937952|NCT02378935|12474372|FG002|Overall Study|Death|1
7937953|NCT02378935|12474373|FG003|Overall Study|Death|0
7937954|NCT02378935|12474374|FG004|Overall Study|Death|0
7937955|NCT02378935|12474375|FG005|Overall Study|Death|0
7937956|NCT02378935|12474376|FG006|Overall Study|Death|0
7937957|NCT02378961|12474396|FG000|Overall Study|Lack of Efficacy|4
7937958|NCT02378961|12474397|FG001|Overall Study|Lack of Efficacy|2
7937959|NCT02378961|12474398|FG002|Overall Study|Lack of Efficacy|0
7937960|NCT02378961|12474399|FG003|Overall Study|Lack of Efficacy|1
7937961|NCT02378961|12474396|FG000|Overall Study|Death|0
7937962|NCT02378961|12474397|FG001|Overall Study|Death|0
7937963|NCT02378961|12474398|FG002|Overall Study|Death|1
7937964|NCT02378961|12474399|FG003|Overall Study|Death|0
7937965|NCT02379052|12474411|FG000|Overall Study|Protocol Violation|0
7937966|NCT02379052|12474412|FG001|Overall Study|Protocol Violation|1
7937967|NCT02379052|12474411|FG000|Overall Study|Adverse Event|0
7937968|NCT02379052|12474412|FG001|Overall Study|Adverse Event|1
7937969|NCT02379052|12474411|FG000|Overall Study|Physician Decision|1
7937970|NCT02379052|12474412|FG001|Overall Study|Physician Decision|1
7937971|NCT02379052|12474411|FG000|Overall Study|Withdrawal by Subject|2
7937972|NCT02379052|12474412|FG001|Overall Study|Withdrawal by Subject|0
7937973|NCT02379052|12474411|FG000|Overall Study|Lost to Follow-up|2
7937974|NCT02379052|12474412|FG001|Overall Study|Lost to Follow-up|1
7937975|NCT02379052|12474411|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1
7937976|NCT02379052|12474412|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0
7937977|NCT02379052|12474411|FG000|Overall Study|Subject was Incarcerated|0
7937978|NCT02379052|12474412|FG001|Overall Study|Subject was Incarcerated|1
7937979|NCT02379078|12474420|FG000|Overall Study|Lost to Follow-up|33
7937980|NCT02379078|12474421|FG001|Overall Study|Lost to Follow-up|30
7937981|NCT02379078|12474420|FG000|Overall Study|Withdrawal by Subject|6
7937982|NCT02379078|12474421|FG001|Overall Study|Withdrawal by Subject|5
7937983|NCT02379091|12474431|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7937984|NCT02379091|12474432|FG001|Overall Study|Pretreatment Event/Adverse Event|2
7937985|NCT02379091|12474433|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7937986|NCT02379091|12474434|FG003|Overall Study|Pretreatment Event/Adverse Event|1
7937987|NCT02379091|12474431|FG000|Overall Study|Principal Investigator Discretion|0
7937988|NCT02379091|12474432|FG001|Overall Study|Principal Investigator Discretion|1
7937989|NCT02379091|12474433|FG002|Overall Study|Principal Investigator Discretion|0
7937990|NCT02379091|12474434|FG003|Overall Study|Principal Investigator Discretion|0
7937991|NCT02379091|12474431|FG000|Overall Study|Lost to Follow-up|0
7937992|NCT02379091|12474432|FG001|Overall Study|Lost to Follow-up|0
7937993|NCT02379091|12474433|FG002|Overall Study|Lost to Follow-up|0
7937994|NCT02379091|12474434|FG003|Overall Study|Lost to Follow-up|1
7937995|NCT02379091|12474431|FG000|Overall Study|Voluntary Withdrawal|2
7937996|NCT02379091|12474432|FG001|Overall Study|Voluntary Withdrawal|5
7937997|NCT02379091|12474433|FG002|Overall Study|Voluntary Withdrawal|2
7937998|NCT02379091|12474434|FG003|Overall Study|Voluntary Withdrawal|4
7937999|NCT02379091|12474431|FG000|Overall Study|Study Termination|7
7938000|NCT02379091|12474432|FG001|Overall Study|Study Termination|2
7938001|NCT02379091|12474433|FG002|Overall Study|Study Termination|5
7938002|NCT02379091|12474434|FG003|Overall Study|Study Termination|8
7938003|NCT02379091|12474431|FG000|Overall Study|Lack of Efficacy|3
7938004|NCT02379091|12474432|FG001|Overall Study|Lack of Efficacy|0
7938005|NCT02379091|12474433|FG002|Overall Study|Lack of Efficacy|0
7938006|NCT02379091|12474434|FG003|Overall Study|Lack of Efficacy|0
7938007|NCT02379221|12474459|FG000|Overall Study|Lost to Follow-up|1
7938008|NCT02379637|12474478|FG000|Overall Study|Protocol Violation|0
7938009|NCT02379637|12474479|FG001|Overall Study|Protocol Violation|1
7938010|NCT02379637|12474478|FG000|Overall Study|Adverse Event|1
7938011|NCT02379637|12474479|FG001|Overall Study|Adverse Event|0
7938012|NCT02379637|12474478|FG000|Overall Study|Withdrawal by Subject|1
7938013|NCT02379637|12474479|FG001|Overall Study|Withdrawal by Subject|0
7938014|NCT02379728|12474487|FG000|Overall Study|Lost to Follow-up|1
7938015|NCT02379728|12474488|FG001|Overall Study|Lost to Follow-up|0
7938016|NCT02379728|12474489|FG002|Overall Study|Lost to Follow-up|3
7938017|NCT02379728|12474490|FG003|Overall Study|Lost to Follow-up|0
7938018|NCT02379728|12474487|FG000|Overall Study|Withdrawal by Subject|5
7938019|NCT02379728|12474488|FG001|Overall Study|Withdrawal by Subject|0
7938020|NCT02379728|12474489|FG002|Overall Study|Withdrawal by Subject|5
7938021|NCT02379728|12474490|FG003|Overall Study|Withdrawal by Subject|3
7938022|NCT02379728|12474487|FG000|Overall Study|Protocol Violation|0
7938023|NCT02379728|12474488|FG001|Overall Study|Protocol Violation|0
7938024|NCT02379728|12474489|FG002|Overall Study|Protocol Violation|2
7938025|NCT02379728|12474490|FG003|Overall Study|Protocol Violation|0
7938026|NCT02379923|12474508|FG000|Overall Study|Death|5
7938027|NCT02380248|12474524|FG000|Overall Study|Lost to Follow-up|11
7938028|NCT02380248|12474524|FG000|Overall Study|Withdrawal by Subject|3
7938029|NCT02380287|12474541|FG000|Overall Study|Adverse Event|0
7938030|NCT02380287|12474542|FG001|Overall Study|Adverse Event|0
7938031|NCT02380287|12474543|FG002|Overall Study|Adverse Event|1
7938032|NCT02380287|12474544|FG003|Overall Study|Adverse Event|0
7938033|NCT02380287|12474545|FG004|Overall Study|Adverse Event|0
7938034|NCT02380287|12474546|FG005|Overall Study|Adverse Event|0
7938035|NCT02380287|12474547|FG006|Overall Study|Adverse Event|0
7938036|NCT02380287|12474548|FG007|Overall Study|Adverse Event|0
7938037|NCT02380677|12474592|FG000|Overall Study|Adverse Event|0
7938038|NCT02380677|12474593|FG001|Overall Study|Adverse Event|0
7938039|NCT02380677|12474594|FG002|Overall Study|Adverse Event|0
7938040|NCT02380677|12474595|FG003|Overall Study|Adverse Event|1
7938041|NCT02380677|12474596|FG004|Overall Study|Adverse Event|1
7938042|NCT02380677|12474597|FG005|Overall Study|Adverse Event|4
7938043|NCT02380677|12474598|FG006|Overall Study|Adverse Event|2
7938044|NCT02380677|12474599|FG007|Overall Study|Adverse Event|2
7938045|NCT02380677|12474600|FG008|Overall Study|Adverse Event|2
7938046|NCT02380677|12474601|FG009|Overall Study|Adverse Event|1
7938047|NCT02380677|12474602|FG010|Overall Study|Adverse Event|2
7938048|NCT02380677|12474603|FG011|Overall Study|Adverse Event|1
7938049|NCT02380677|12474592|FG000|Overall Study|Physician Decision|1
7938050|NCT02380677|12474593|FG001|Overall Study|Physician Decision|0
7938051|NCT02380677|12474594|FG002|Overall Study|Physician Decision|1
7938052|NCT02380677|12474595|FG003|Overall Study|Physician Decision|1
7938053|NCT02380677|12474596|FG004|Overall Study|Physician Decision|0
7938054|NCT02380677|12474597|FG005|Overall Study|Physician Decision|0
7938055|NCT02380677|12474598|FG006|Overall Study|Physician Decision|0
7938056|NCT02380677|12474599|FG007|Overall Study|Physician Decision|0
7938057|NCT02380677|12474600|FG008|Overall Study|Physician Decision|0
7938058|NCT02380677|12474601|FG009|Overall Study|Physician Decision|0
7938059|NCT02380677|12474602|FG010|Overall Study|Physician Decision|0
7938060|NCT02380677|12474603|FG011|Overall Study|Physician Decision|0
7938061|NCT02380677|12474592|FG000|Overall Study|Lack of Efficacy|0
7938062|NCT02380677|12474593|FG001|Overall Study|Lack of Efficacy|1
7938063|NCT02380677|12474594|FG002|Overall Study|Lack of Efficacy|2
7938064|NCT02380677|12474595|FG003|Overall Study|Lack of Efficacy|0
7938065|NCT02380677|12474596|FG004|Overall Study|Lack of Efficacy|4
7938066|NCT02380677|12474597|FG005|Overall Study|Lack of Efficacy|1
7938067|NCT02380677|12474598|FG006|Overall Study|Lack of Efficacy|1
7938068|NCT02380677|12474599|FG007|Overall Study|Lack of Efficacy|2
7938069|NCT02380677|12474600|FG008|Overall Study|Lack of Efficacy|2
7938070|NCT02380677|12474601|FG009|Overall Study|Lack of Efficacy|0
7938071|NCT02380677|12474602|FG010|Overall Study|Lack of Efficacy|2
7938072|NCT02380677|12474603|FG011|Overall Study|Lack of Efficacy|1
7938073|NCT02380677|12474592|FG000|Overall Study|Withdrawal by Subject|0
7938074|NCT02380677|12474593|FG001|Overall Study|Withdrawal by Subject|0
7938075|NCT02380677|12474594|FG002|Overall Study|Withdrawal by Subject|0
7938076|NCT02380677|12474595|FG003|Overall Study|Withdrawal by Subject|0
7938077|NCT02380677|12474596|FG004|Overall Study|Withdrawal by Subject|0
7938078|NCT02380677|12474597|FG005|Overall Study|Withdrawal by Subject|0
7938079|NCT02380677|12474598|FG006|Overall Study|Withdrawal by Subject|0
7938080|NCT02380677|12474599|FG007|Overall Study|Withdrawal by Subject|0
7938081|NCT02380677|12474600|FG008|Overall Study|Withdrawal by Subject|0
7938082|NCT02380677|12474601|FG009|Overall Study|Withdrawal by Subject|1
7938083|NCT02380677|12474602|FG010|Overall Study|Withdrawal by Subject|0
7938084|NCT02380677|12474603|FG011|Overall Study|Withdrawal by Subject|3
7938085|NCT02380677|12474592|FG000|Overall Study|Other|0
7938086|NCT02380677|12474593|FG001|Overall Study|Other|0
7938087|NCT02380677|12474594|FG002|Overall Study|Other|0
7938088|NCT02380677|12474595|FG003|Overall Study|Other|1
7938089|NCT02380677|12474596|FG004|Overall Study|Other|1
7938090|NCT02380677|12474597|FG005|Overall Study|Other|1
7938091|NCT02380677|12474598|FG006|Overall Study|Other|0
7938092|NCT02380677|12474599|FG007|Overall Study|Other|0
7938093|NCT02380677|12474600|FG008|Overall Study|Other|0
7938094|NCT02380677|12474601|FG009|Overall Study|Other|0
7938095|NCT02380677|12474602|FG010|Overall Study|Other|0
7938096|NCT02380677|12474603|FG011|Overall Study|Other|0
7938097|NCT02380690|12474633|FG000|Overall Study|Lost to Follow-up|14
7938098|NCT02380690|12474634|FG001|Overall Study|Lost to Follow-up|4
7938099|NCT02380690|12474633|FG000|Overall Study|Withdrawal by Subject|20
7938100|NCT02380690|12474634|FG001|Overall Study|Withdrawal by Subject|8
7938101|NCT02380703|12474642|FG000|Overall Study|Withdrawal by Subject|12
7938102|NCT02380703|12474643|FG001|Overall Study|Withdrawal by Subject|9
7938103|NCT02380703|12474642|FG000|Overall Study|Lost to Follow-up|12
7938104|NCT02380703|12474643|FG001|Overall Study|Lost to Follow-up|12
7938105|NCT02380703|12474642|FG000|Overall Study|Caregiver death|1
7938106|NCT02380703|12474643|FG001|Overall Study|Caregiver death|0
7938107|NCT02380703|12474642|FG000|Overall Study|Person with dementia (PWD) death|7
7938108|NCT02380703|12474643|FG001|Overall Study|Person with dementia (PWD) death|8
7938109|NCT02380703|12474642|FG000|Overall Study|Entered Long-term Care|4
7938110|NCT02380703|12474643|FG001|Overall Study|Entered Long-term Care|7
7938111|NCT02380742|12474651|FG000|Overall Study|Withdrawal by Subject|1
7938112|NCT02380742|12474652|FG001|Overall Study|Withdrawal by Subject|0
7938113|NCT02380859|12474660|FG000|Overall Study|Withdrawal by Subject|2
7938114|NCT02380859|12474661|FG001|Overall Study|Withdrawal by Subject|0
7938115|NCT02381795|12474731|FG000|Overall Study|Withdrawal by Subject|1
7938116|NCT02381795|12474731|FG000|Overall Study|Study Terminated|2
7938117|NCT02382016|12474737|FG000|Double-blind (DB) Treatment Period|Physician Decision|3
7938118|NCT02382016|12474738|FG001|Double-blind (DB) Treatment Period|Physician Decision|0
7938119|NCT02382016|12474737|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1
7938120|NCT02382016|12474738|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0
7938121|NCT02382016|12474737|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0
7938122|NCT02382016|12474738|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1
7938123|NCT02382016|12474737|FG000|Open-label (OL) Treatment Period|Physician Decision|3
7938124|NCT02382016|12474738|FG001|Open-label (OL) Treatment Period|Physician Decision|0
7938125|NCT02382016|12474737|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2
7938126|NCT02382016|12474738|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0
7938127|NCT02382016|12474737|FG000|Open-label (OL) Treatment Period|Death|4
7938128|NCT02382016|12474738|FG001|Open-label (OL) Treatment Period|Death|0
7938129|NCT02382016|12474737|FG000|OL Extension Period|Physician Decision|3
7938130|NCT02382016|12474738|FG001|OL Extension Period|Physician Decision|0
7938131|NCT02382016|12474737|FG000|OL Extension Period|Death|2
7938132|NCT02382016|12474738|FG001|OL Extension Period|Death|0
7938133|NCT02382016|12474737|FG000|OL Extension Period|Withdrawal by Subject|1
7938134|NCT02382016|12474738|FG001|OL Extension Period|Withdrawal by Subject|0
7938135|NCT02382133|12474746|FG000|Overall Study|Death|22
7938136|NCT02382133|12474746|FG000|Overall Study|transfer out of ICU|4
7938137|NCT02382133|12474746|FG000|Overall Study|Physician Decision|2
7938138|NCT02382133|12474746|FG000|Overall Study|arterial catheter loss|4
7938139|NCT02382133|12474746|FG000|Overall Study|pressure injury both sites|1
7938140|NCT02382276|12474753|FG000|Overall Study|Withdrawal by Subject|4
7938141|NCT02382276|12474754|FG001|Overall Study|Withdrawal by Subject|8
7938142|NCT02382276|12474755|FG002|Overall Study|Withdrawal by Subject|5
7938143|NCT02382276|12474753|FG000|Overall Study|Adverse Event|7
7938144|NCT02382276|12474754|FG001|Overall Study|Adverse Event|2
7938145|NCT02382276|12474755|FG002|Overall Study|Adverse Event|32
7938146|NCT02382276|12474753|FG000|Overall Study|Physician Decision|0
7938147|NCT02382276|12474754|FG001|Overall Study|Physician Decision|0
7938148|NCT02382276|12474755|FG002|Overall Study|Physician Decision|2
7938149|NCT02382640|12474765|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
7938150|NCT02382640|12474766|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
7938151|NCT02382640|12474767|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
7938152|NCT02382640|12474768|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
7938153|NCT02382796|12474795|FG000|Overall Study|Global deterioration of health status|1
7938154|NCT02382796|12474795|FG000|Overall Study|Objective progression or relapse|3
7938155|NCT02382796|12474795|FG000|Overall Study|Commercial dacomitinib became available|3
7938156|NCT02382939|12474849|FG000|Overall Study|Adverse Event|1
7938157|NCT02382939|12474850|FG001|Overall Study|Adverse Event|1
7938158|NCT02382939|12474849|FG000|Overall Study|Withdrawal by Subject|2
7938159|NCT02382939|12474850|FG001|Overall Study|Withdrawal by Subject|2
7938160|NCT02382991|12474859|FG000|Overall Study|Adverse Event|1
7938161|NCT02382991|12474860|FG001|Overall Study|Adverse Event|2
7938162|NCT02382991|12474859|FG000|Overall Study|Lost to Follow-up|1
7938163|NCT02382991|12474860|FG001|Overall Study|Lost to Follow-up|0
7938164|NCT02382991|12474859|FG000|Overall Study|Withdrawal by Subject|0
7938165|NCT02382991|12474860|FG001|Overall Study|Withdrawal by Subject|1
7938166|NCT02383017|12474867|FG000|Overall Study|Injury Sustained Outside Study|1
7938167|NCT02383017|12474868|FG001|Overall Study|Injury Sustained Outside Study|0
7938168|NCT02383017|12474867|FG000|Overall Study|Compliance|3
7938169|NCT02383017|12474868|FG001|Overall Study|Compliance|2
7938170|NCT02383017|12474867|FG000|Overall Study|Found to be Hypogonadal|1
7938171|NCT02383017|12474868|FG001|Overall Study|Found to be Hypogonadal|0
7938172|NCT02383056|12474890|FG000|Overall Study|Adverse Event|1
7938173|NCT02383056|12474891|FG001|Overall Study|Adverse Event|0
7938174|NCT02383056|12474890|FG000|Overall Study|Lost to Follow-up|0
7938175|NCT02383056|12474891|FG001|Overall Study|Lost to Follow-up|2
7938176|NCT02383173|12474899|FG000|Overall Study|Palliative Care Team withdrew|0
7938177|NCT02383173|12474900|FG001|Overall Study|Palliative Care Team withdrew|2
7938178|NCT02383355|12474908|FG000|Overall Study|Adverse Event|2
7938179|NCT02383355|12474909|FG001|Overall Study|Adverse Event|0
7938180|NCT02383472|12474930|FG000|Overall Study|Withdrawal by Subject|1
7938181|NCT02383472|12474931|FG001|Overall Study|Withdrawal by Subject|1
7965032|NCT03631407|12520660|FG000|Overall Study|Randomized by mistake without study treatment|1
7965033|NCT03631407|12520661|FG001|Overall Study|Randomized by mistake without study treatment|0
7965034|NCT03531827|12520667|FG000|Overall Study|Adverse Event|2
7965035|NCT03531827|12520668|FG001|Overall Study|Adverse Event|0
7965036|NCT03531827|12520667|FG000|Overall Study|Progressive disease|1
7965037|NCT03531827|12520668|FG001|Overall Study|Progressive disease|0
7967196|NCT02761915|12523746|FG001|Overall Study|Death|1
7967197|NCT02761915|12523747|FG002|Overall Study|Death|1
7967198|NCT02761915|12523748|FG003|Overall Study|Death|1
7967199|NCT02761915|12523749|FG004|Overall Study|Death|0
7967200|NCT02761915|12523750|FG005|Overall Study|Death|1
7967201|NCT02761915|12523745|FG000|Overall Study|Withdrawal by Subject|1
7967202|NCT02761915|12523746|FG001|Overall Study|Withdrawal by Subject|0
7967203|NCT02761915|12523747|FG002|Overall Study|Withdrawal by Subject|0
7967204|NCT02761915|12523748|FG003|Overall Study|Withdrawal by Subject|0
7967205|NCT02761915|12523749|FG004|Overall Study|Withdrawal by Subject|1
7967206|NCT02761915|12523750|FG005|Overall Study|Withdrawal by Subject|2
7967207|NCT02761915|12523745|FG000|Overall Study|Disease Progression|0
7967208|NCT02761915|12523746|FG001|Overall Study|Disease Progression|0
7967209|NCT02761915|12523747|FG002|Overall Study|Disease Progression|0
7967210|NCT02761915|12523748|FG003|Overall Study|Disease Progression|2
7967211|NCT02761915|12523749|FG004|Overall Study|Disease Progression|2
7967212|NCT02761915|12523750|FG005|Overall Study|Disease Progression|2
7967213|NCT02761980|12523784|FG000|Overall Study|Adverse Event|4
7967214|NCT02761980|12523785|FG001|Overall Study|Adverse Event|6
7967215|NCT02761980|12523786|FG002|Overall Study|Adverse Event|5
7967216|NCT02761980|12523787|FG003|Overall Study|Adverse Event|6
7967217|NCT02761980|12523784|FG000|Overall Study|Withdrawal by Subject|0
7967218|NCT02761980|12523785|FG001|Overall Study|Withdrawal by Subject|1
7967219|NCT02761980|12523786|FG002|Overall Study|Withdrawal by Subject|0
7967220|NCT02761980|12523787|FG003|Overall Study|Withdrawal by Subject|0
7967221|NCT02761980|12523784|FG000|Overall Study|Other|0
7967222|NCT02761980|12523785|FG001|Overall Study|Other|0
7967223|NCT02761980|12523786|FG002|Overall Study|Other|1
7967224|NCT02761980|12523787|FG003|Overall Study|Other|0
7967225|NCT02761993|12523800|FG000|Overall Study|Adverse Event|0
7967226|NCT02761993|12523801|FG001|Overall Study|Adverse Event|2
7967227|NCT02761993|12523802|FG002|Overall Study|Adverse Event|0
7967228|NCT02761993|12523800|FG000|Overall Study|Lost to Follow-up|1
7967229|NCT02761993|12523801|FG001|Overall Study|Lost to Follow-up|3
7967230|NCT02761993|12523802|FG002|Overall Study|Lost to Follow-up|2
7967231|NCT02761993|12523800|FG000|Overall Study|Withdrawal by Subject|1
7967232|NCT02761993|12523801|FG001|Overall Study|Withdrawal by Subject|1
7967233|NCT02761993|12523802|FG002|Overall Study|Withdrawal by Subject|2
7967234|NCT02762084|12523823|FG000|Overall Study|Withdrawal by Subject|1
7967235|NCT02762084|12523824|FG001|Overall Study|Withdrawal by Subject|0
7967236|NCT02762084|12523825|FG002|Overall Study|Withdrawal by Subject|0
7967237|NCT02762084|12523823|FG000|Overall Study|Adverse Event|0
7967238|NCT02762084|12523824|FG001|Overall Study|Adverse Event|0
7967239|NCT02762084|12523825|FG002|Overall Study|Adverse Event|1
7967240|NCT02762370|12523846|FG000|Overall Study|Protocol Violation|1
7967241|NCT02762370|12523847|FG001|Overall Study|Protocol Violation|0
7967242|NCT02762500|12523857|FG000|Overall Study|Lack of Efficacy|1
7967243|NCT02762500|12523858|FG001|Overall Study|Lack of Efficacy|0
7967244|NCT02762500|12523857|FG000|Overall Study|Withdrawal by Subject|1
7967245|NCT02762500|12523858|FG001|Overall Study|Withdrawal by Subject|1
7967246|NCT02762500|12523857|FG000|Overall Study|Adverse Event|0
7938182|NCT02383576|12474941|FG000|Overall Study|Death|53
7938183|NCT02383576|12474942|FG001|Overall Study|Death|33
7938184|NCT02383576|12474941|FG000|Overall Study|Lost to Follow-up|7
7938185|NCT02383576|12474942|FG001|Overall Study|Lost to Follow-up|1
7938186|NCT02383576|12474941|FG000|Overall Study|Withdrew Consent|1
7938187|NCT02383576|12474942|FG001|Overall Study|Withdrew Consent|6
7938188|NCT02383576|12474941|FG000|Overall Study|Investigator's Decision|0
7938189|NCT02383576|12474942|FG001|Overall Study|Investigator's Decision|1
7938190|NCT02383576|12474941|FG000|Overall Study|Administrative/Other|2
7938191|NCT02383576|12474942|FG001|Overall Study|Administrative/Other|4
7938192|NCT02383589|12474950|FG000|Treatment Period|Adverse Event|1
7938193|NCT02383589|12474951|FG001|Treatment Period|Adverse Event|3
7938194|NCT02383589|12474950|FG000|Treatment Period|Lost to Follow-up|0
7938195|NCT02383589|12474951|FG001|Treatment Period|Lost to Follow-up|1
7938196|NCT02383589|12474950|FG000|Treatment Period|Withdrawal by Subject|0
7938197|NCT02383589|12474951|FG001|Treatment Period|Withdrawal by Subject|5
7938198|NCT02383589|12474950|FG000|Treatment Period|Non-compliance with study drug|0
7938199|NCT02383589|12474951|FG001|Treatment Period|Non-compliance with study drug|1
7938200|NCT02383589|12474950|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2
7938201|NCT02383589|12474951|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4
7938202|NCT02383589|12474950|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5
7938203|NCT02383589|12474951|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0
7938204|NCT02383589|12474950|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0
7938205|NCT02383589|12474951|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1
7938206|NCT02383758|12474974|FG000|Overall Study|Withdrawal by Subject|0
7938207|NCT02383758|12474975|FG001|Overall Study|Withdrawal by Subject|2
7938208|NCT02383862|12474983|FG000|3 Month Follow up|Lost to Follow-up|23
7938209|NCT02383862|12474984|FG001|3 Month Follow up|Lost to Follow-up|21
7938210|NCT02383940|12474999|FG000|Overall Study|Adverse Event|1
7938211|NCT02383940|12475000|FG001|Overall Study|Adverse Event|0
7938212|NCT02383940|12474999|FG000|Overall Study|Lost to Follow-up|2
7938213|NCT02383940|12475000|FG001|Overall Study|Lost to Follow-up|2
7938214|NCT02383940|12474999|FG000|Overall Study|Physician Decision|2
7938215|NCT02383940|12475000|FG001|Overall Study|Physician Decision|0
7938216|NCT02383940|12474999|FG000|Overall Study|Withdrawal by Subject|1
7938217|NCT02383940|12475000|FG001|Overall Study|Withdrawal by Subject|1
7938218|NCT02383940|12474999|FG000|Overall Study|Randomized but not treated|2
7938219|NCT02383940|12475000|FG001|Overall Study|Randomized but not treated|0
7938220|NCT02383940|12474999|FG000|Overall Study|Other than specified above|1
7938221|NCT02383940|12475000|FG001|Overall Study|Other than specified above|0
7938222|NCT02384382|12475045|FG000|Overall Study|Transitioned to study-NCT02960022|5
7938223|NCT02384382|12475045|FG000|Overall Study|Death|1
7938224|NCT02384382|12475045|FG000|Overall Study|Adverse Event|1
7938225|NCT02384382|12475045|FG000|Overall Study|Disease progression|16
7938226|NCT02384395|12475049|FG000|Overall Study|Physician Decision|4
7938227|NCT02384395|12475049|FG000|Overall Study|Withdrawal by Subject|3
7938228|NCT02384395|12475049|FG000|Overall Study|Lost to Follow-up|3
7938229|NCT02384460|12475055|FG000|Overall Study|Protocol Violation|0
7938230|NCT02384460|12475056|FG001|Overall Study|Protocol Violation|1
7938231|NCT02384460|12475055|FG000|Overall Study|Returned to previous therapeutic regimen|0
7938232|NCT02384460|12475056|FG001|Overall Study|Returned to previous therapeutic regimen|1
7938233|NCT02384460|12475055|FG000|Overall Study|Adverse Event|5
7938234|NCT02384460|12475056|FG001|Overall Study|Adverse Event|2
7938235|NCT02384460|12475055|FG000|Overall Study|Withdrawal by Subject|0
7938236|NCT02384460|12475056|FG001|Overall Study|Withdrawal by Subject|3
7938237|NCT02384460|12475055|FG000|Overall Study|Elective medical treatment|1
7938238|NCT02384460|12475056|FG001|Overall Study|Elective medical treatment|0
7938239|NCT02384460|12475055|FG000|Overall Study|Non-compliance|1
7938240|NCT02384460|12475056|FG001|Overall Study|Non-compliance|0
7938241|NCT02384538|12475064|FG000|Overall Study|Adverse Event|1
7938242|NCT02384538|12475065|FG001|Overall Study|Adverse Event|4
7938243|NCT02384538|12475064|FG000|Overall Study|Lack of Efficacy|4
7938244|NCT02384538|12475065|FG001|Overall Study|Lack of Efficacy|4
7938245|NCT02384538|12475064|FG000|Overall Study|Withdrew Consent|0
7938246|NCT02384538|12475065|FG001|Overall Study|Withdrew Consent|4
7938247|NCT02384538|12475064|FG000|Overall Study|Other|1
7938248|NCT02384538|12475065|FG001|Overall Study|Other|3
7938249|NCT02384941|12475074|FG000|Overall Study|Adverse Event|11
7938250|NCT02384941|12475075|FG001|Overall Study|Adverse Event|13
7938251|NCT02384941|12475076|FG002|Overall Study|Adverse Event|17
7938252|NCT02384941|12475074|FG000|Overall Study|Lost to Follow-up|3
7938253|NCT02384941|12475075|FG001|Overall Study|Lost to Follow-up|2
7938254|NCT02384941|12475076|FG002|Overall Study|Lost to Follow-up|1
7938255|NCT02384941|12475074|FG000|Overall Study|Non-Compliance With Study Drug|2
7938256|NCT02384941|12475075|FG001|Overall Study|Non-Compliance With Study Drug|0
7938257|NCT02384941|12475076|FG002|Overall Study|Non-Compliance With Study Drug|1
7938258|NCT02384941|12475074|FG000|Overall Study|Physician Decision|1
7938259|NCT02384941|12475075|FG001|Overall Study|Physician Decision|1
7938260|NCT02384941|12475076|FG002|Overall Study|Physician Decision|0
7938261|NCT02384941|12475074|FG000|Overall Study|Protocol Violation|3
7938262|NCT02384941|12475075|FG001|Overall Study|Protocol Violation|0
7938263|NCT02384941|12475076|FG002|Overall Study|Protocol Violation|0
7938264|NCT02384941|12475074|FG000|Overall Study|Withdrawal by Subject|26
7938265|NCT02384941|12475075|FG001|Overall Study|Withdrawal by Subject|19
7938266|NCT02384941|12475076|FG002|Overall Study|Withdrawal by Subject|20
7938267|NCT02384941|12475074|FG000|Overall Study|Pregnancy|0
7938268|NCT02384941|12475075|FG001|Overall Study|Pregnancy|0
7938269|NCT02384941|12475076|FG002|Overall Study|Pregnancy|1
7938270|NCT02384941|12475074|FG000|Overall Study|Other than specified above|4
7938271|NCT02384941|12475075|FG001|Overall Study|Other than specified above|0
7938272|NCT02384941|12475076|FG002|Overall Study|Other than specified above|1
7938273|NCT02385084|12475085|FG000|Period 2|Protocol Violation|0
7938274|NCT02385084|12475086|FG001|Period 2|Protocol Violation|0
7938275|NCT02385084|12475087|FG002|Period 2|Protocol Violation|1
7938276|NCT02385084|12475088|FG003|Period 2|Protocol Violation|0
7938277|NCT02385084|12475089|FG004|Period 2|Protocol Violation|0
7938278|NCT02385084|12475090|FG005|Period 2|Protocol Violation|0
7938279|NCT02385526|12475137|FG000|Overall Study|Withdrawal by Subject|0
7938280|NCT02385526|12475138|FG001|Overall Study|Withdrawal by Subject|2
7938281|NCT02385526|12475139|FG002|Overall Study|Withdrawal by Subject|0
7938282|NCT02385526|12475137|FG000|Overall Study|Lost to Follow-up|0
7938283|NCT02385526|12475138|FG001|Overall Study|Lost to Follow-up|1
7938284|NCT02385526|12475139|FG002|Overall Study|Lost to Follow-up|0
7938285|NCT02385526|12475137|FG000|Overall Study|Physician Decision|1
7938286|NCT02385526|12475138|FG001|Overall Study|Physician Decision|0
7938287|NCT02385526|12475139|FG002|Overall Study|Physician Decision|0
7938288|NCT02385526|12475137|FG000|Overall Study|Protocol Violation|1
7938289|NCT02385526|12475138|FG001|Overall Study|Protocol Violation|0
7938290|NCT02385526|12475139|FG002|Overall Study|Protocol Violation|0
7938291|NCT02385669|12475147|FG000|Overall Study|Adverse Event|2
7938292|NCT02385708|12475153|FG000|Overall Study|Withdrawal by Subject|0
7938293|NCT02385708|12475154|FG001|Overall Study|Withdrawal by Subject|2
7938294|NCT02385708|12475153|FG000|Overall Study|Withdrawn - surgery canceled|2
7938295|NCT02385708|12475154|FG001|Overall Study|Withdrawn - surgery canceled|5
7938296|NCT02385708|12475153|FG000|Overall Study|Investigator decision|5
7938297|NCT02385708|12475154|FG001|Overall Study|Investigator decision|7
7938298|NCT02385708|12475153|FG000|Overall Study|Protocol Violation|1
7938299|NCT02385708|12475154|FG001|Overall Study|Protocol Violation|1
7938300|NCT02385799|12475166|FG000|Overall Study|Lost to Follow-up|1
7938301|NCT02385799|12475167|FG001|Overall Study|Lost to Follow-up|2
7938302|NCT02385799|12475166|FG000|Overall Study|Adverse Event|4
7938303|NCT02385799|12475167|FG001|Overall Study|Adverse Event|2
7938304|NCT02385799|12475166|FG000|Overall Study|Withdrawal by Subject|0
7938305|NCT02385799|12475167|FG001|Overall Study|Withdrawal by Subject|4
7967247|NCT02762500|12523858|FG001|Overall Study|Adverse Event|2
7822173|NCT01260350|12291188|FG014|Overall Study|Lack of Efficacy|0
7822174|NCT01260350|12291189|FG015|Overall Study|Lack of Efficacy|0
7938306|NCT02386098|12475178|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
7938307|NCT02386098|12475179|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
7938308|NCT02386098|12475180|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
7938309|NCT02386098|12475181|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
7938310|NCT02386098|12475182|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
7938311|NCT02386098|12475178|FG000|Stage 1 (96 Weeks)|Adverse Event|2
7938312|NCT02386098|12475179|FG001|Stage 1 (96 Weeks)|Adverse Event|1
7938313|NCT02386098|12475180|FG002|Stage 1 (96 Weeks)|Adverse Event|0
7938314|NCT02386098|12475181|FG003|Stage 1 (96 Weeks)|Adverse Event|0
7938315|NCT02386098|12475182|FG004|Stage 1 (96 Weeks)|Adverse Event|0
7938316|NCT02386098|12475178|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2
7938317|NCT02386098|12475179|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2
7938318|NCT02386098|12475180|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0
7938319|NCT02386098|12475181|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0
7938320|NCT02386098|12475182|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0
7938321|NCT02386098|12475178|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7938322|NCT02386098|12475179|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
7938323|NCT02386098|12475180|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7938324|NCT02386098|12475181|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7938325|NCT02386098|12475182|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7938326|NCT02386098|12475178|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3
7938327|NCT02386098|12475179|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1
7938328|NCT02386098|12475180|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0
7938329|NCT02386098|12475181|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0
7938330|NCT02386098|12475182|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0
7938331|NCT02386098|12475178|FG000|Stage 1 (96 Weeks)|Other|1
7938332|NCT02386098|12475179|FG001|Stage 1 (96 Weeks)|Other|0
7938333|NCT02386098|12475180|FG002|Stage 1 (96 Weeks)|Other|0
7938334|NCT02386098|12475181|FG003|Stage 1 (96 Weeks)|Other|0
7938335|NCT02386098|12475182|FG004|Stage 1 (96 Weeks)|Other|0
7938336|NCT02386098|12475178|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
7938337|NCT02386098|12475179|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
7938338|NCT02386098|12475180|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
7938339|NCT02386098|12475181|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
7938340|NCT02386098|12475182|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
7938341|NCT02386189|12475196|FG000|Overall Study|Lost to Follow-up|2
7938342|NCT02386189|12475197|FG001|Overall Study|Lost to Follow-up|3
7938343|NCT02386189|12475196|FG000|Overall Study|Withdrawal by Subject|1
7938344|NCT02386189|12475197|FG001|Overall Study|Withdrawal by Subject|0
7938345|NCT02386189|12475196|FG000|Overall Study|Death|1
7938346|NCT02386189|12475197|FG001|Overall Study|Death|0
7938347|NCT02386345|12475212|FG000|Overall Study|Not treated|14
7938348|NCT02386345|12475212|FG000|Overall Study|Lost to Follow-up|1
7938349|NCT02386345|12475212|FG000|Overall Study|Adverse Event|5
7938350|NCT02386345|12475212|FG000|Overall Study|Repeat Procedure|10
7938351|NCT02386345|12475212|FG000|Overall Study|Did not complete 12-month follow-up|72
7938352|NCT02387164|12475245|FG000|Overall Study|Lost to Follow-up|2
7938353|NCT02387164|12475246|FG001|Overall Study|Lost to Follow-up|0
7938354|NCT02387164|12475245|FG000|Overall Study|Diagnosed|1
7938355|NCT02387164|12475246|FG001|Overall Study|Diagnosed|2
7938356|NCT02387216|12475254|FG000|Overall Study|Progressive disease|2
7938357|NCT02387216|12475255|FG001|Overall Study|Progressive disease|0
7938358|NCT02387216|12475254|FG000|Overall Study|Withdrawal by Subject|3
7938359|NCT02387216|12475255|FG001|Overall Study|Withdrawal by Subject|5
7938360|NCT02387216|12475254|FG000|Overall Study|Physician Decision|2
7938361|NCT02387216|12475255|FG001|Overall Study|Physician Decision|0
7938362|NCT02387216|12475254|FG000|Overall Study|Sponsor Decision|28
7938363|NCT02387216|12475255|FG001|Overall Study|Sponsor Decision|12
7938364|NCT02387216|12475254|FG000|Overall Study|Death|60
7938365|NCT02387216|12475255|FG001|Overall Study|Death|23
7822175|NCT01260350|12291190|FG016|Overall Study|Lack of Efficacy|0
7938366|NCT02387216|12475254|FG000|Overall Study|Other|5
7938367|NCT02387216|12475255|FG001|Overall Study|Other|4
7938368|NCT02387216|12475254|FG000|Overall Study|Lost to Follow-up|0
7938369|NCT02387216|12475255|FG001|Overall Study|Lost to Follow-up|3
7938370|NCT02387372|12475290|FG000|Overall Study|Not Treated|1
7938371|NCT02387372|12475291|FG001|Overall Study|Not Treated|0
7938372|NCT02387580|12475352|FG000|Overall Study|Withdrawal by Subject|0
7938373|NCT02387580|12475353|FG001|Overall Study|Withdrawal by Subject|0
7938374|NCT02387580|12475354|FG002|Overall Study|Withdrawal by Subject|0
7938375|NCT02387580|12475355|FG003|Overall Study|Withdrawal by Subject|1
7938376|NCT02387580|12475356|FG004|Overall Study|Withdrawal by Subject|0
7938377|NCT02387580|12475357|FG005|Overall Study|Withdrawal by Subject|0
7938378|NCT02387762|12475393|FG000|Overall Study|Withdrawal by Subject|1
7938379|NCT02387762|12475394|FG001|Overall Study|Withdrawal by Subject|0
7938380|NCT02387840|12475434|FG000|Overall Study|Death|0
7938381|NCT02387840|12475435|FG001|Overall Study|Death|0
7938382|NCT02387840|12475436|FG002|Overall Study|Death|0
7938383|NCT02387840|12475437|FG003|Overall Study|Death|0
7938384|NCT02387840|12475438|FG004|Overall Study|Death|0
7938385|NCT02387840|12475439|FG005|Overall Study|Death|1
7938386|NCT02387957|12475466|FG000|Overall Study|The study was discontinued|21
7938387|NCT02387957|12475467|FG001|Overall Study|The study was discontinued|21
7938388|NCT02387957|12475468|FG002|Overall Study|The study was discontinued|20
7938389|NCT02387970|12475478|FG000|Overall Study|Did not complete 1-year follow up|1
7938390|NCT02387970|12475479|FG001|Overall Study|Did not complete 1-year follow up|2
7938391|NCT02387983|12475485|FG000|Overall Study|Adverse Event|4
7938392|NCT02387983|12475485|FG000|Overall Study|Protocol Violation|1
7938393|NCT02387983|12475485|FG000|Overall Study|Withdrawal by Subject|2
7938394|NCT02388074|12475489|FG000|Overall Study|Lost in Transit|2
7938395|NCT02388074|12475489|FG000|Overall Study|Sample Not Returned|1
7938396|NCT02388165|12475495|FG000|Overall Study|Study terminated by sponsor|5
7938397|NCT02388165|12475496|FG001|Overall Study|Study terminated by sponsor|5
7938398|NCT02388165|12475495|FG000|Overall Study|Other|11
7938399|NCT02388165|12475496|FG001|Overall Study|Other|13
7822176|NCT01260350|12291191|FG017|Overall Study|Lack of Efficacy|1
7938400|NCT02388165|12475495|FG000|Overall Study|No longer meet eligibility criteria|40
7938401|NCT02388165|12475496|FG001|Overall Study|No longer meet eligibility criteria|43
7938402|NCT02388165|12475495|FG000|Overall Study|Withdrawal of consent|31
7938403|NCT02388165|12475496|FG001|Overall Study|Withdrawal of consent|32
7938404|NCT02388165|12475495|FG000|Overall Study|Lost to Follow-up|19
7938405|NCT02388165|12475496|FG001|Overall Study|Lost to Follow-up|20
7938406|NCT02388165|12475495|FG000|Overall Study|Death|13
7938407|NCT02388165|12475496|FG001|Overall Study|Death|10
7938408|NCT02388165|12475495|FG000|Overall Study|Adverse Event|3
7938409|NCT02388165|12475496|FG001|Overall Study|Adverse Event|5
7938410|NCT02388165|12475495|FG000|Overall Study|Did not meet entrance criteria|5
7938411|NCT02388165|12475496|FG001|Overall Study|Did not meet entrance criteria|2
7938412|NCT02388191|12475504|FG000|Overall Study|Patient did not receive IUD|1
7938413|NCT02388191|12475505|FG001|Overall Study|Patient did not receive IUD|0
7938414|NCT02388269|12475515|FG000|Overall Study|Adverse Event|2
7938415|NCT02388269|12475516|FG001|Overall Study|Adverse Event|0
7938416|NCT02388269|12475517|FG002|Overall Study|Adverse Event|0
7938417|NCT02388269|12475515|FG000|Overall Study|Withdrawal by Subject|1
7938418|NCT02388269|12475516|FG001|Overall Study|Withdrawal by Subject|2
7938419|NCT02388269|12475517|FG002|Overall Study|Withdrawal by Subject|0
7938420|NCT02388269|12475515|FG000|Overall Study|less than 50% stimulations|1
7938421|NCT02388269|12475516|FG001|Overall Study|less than 50% stimulations|0
7938422|NCT02388269|12475517|FG002|Overall Study|less than 50% stimulations|0
7938423|NCT02388269|12475515|FG000|Overall Study|no diary data|3
7938424|NCT02388269|12475516|FG001|Overall Study|no diary data|0
7938425|NCT02388269|12475517|FG002|Overall Study|no diary data|0
7822177|NCT01260350|12291192|FG018|Overall Study|Lack of Efficacy|0
7938426|NCT02388269|12475515|FG000|Overall Study|Protocol Violation|2
7938427|NCT02388269|12475516|FG001|Overall Study|Protocol Violation|0
7938428|NCT02388269|12475517|FG002|Overall Study|Protocol Violation|0
7938429|NCT02388269|12475515|FG000|Overall Study|Screen Failure|0
7938430|NCT02388269|12475516|FG001|Overall Study|Screen Failure|0
7938431|NCT02388269|12475517|FG002|Overall Study|Screen Failure|10
7938432|NCT02388295|12475544|FG000|Dose Escalation Week 1|Adverse Event|1
7938433|NCT02388295|12475545|FG001|Dose Escalation Week 1|Adverse Event|2
7938434|NCT02388295|12475546|FG002|Dose Escalation Week 1|Adverse Event|1
7938435|NCT02388295|12475544|FG000|Dose Escalation Week 1|Determined not eligible|1
7938436|NCT02388295|12475545|FG001|Dose Escalation Week 1|Determined not eligible|1
7938437|NCT02388295|12475546|FG002|Dose Escalation Week 1|Determined not eligible|1
7938438|NCT02388295|12475544|FG000|Dose Escalation Week 2|Protocol Violation|0
7938439|NCT02388295|12475545|FG001|Dose Escalation Week 2|Protocol Violation|1
7938440|NCT02388295|12475546|FG002|Dose Escalation Week 2|Protocol Violation|0
7938441|NCT02388295|12475544|FG000|Dose Escalation Week 2|Determined not eligible|1
7938442|NCT02388295|12475545|FG001|Dose Escalation Week 2|Determined not eligible|1
7938443|NCT02388295|12475546|FG002|Dose Escalation Week 2|Determined not eligible|1
7938444|NCT02388295|12475544|FG000|Treatment Weeks 3 to 12|Adverse Event|1
7938445|NCT02388295|12475545|FG001|Treatment Weeks 3 to 12|Adverse Event|1
7938446|NCT02388295|12475546|FG002|Treatment Weeks 3 to 12|Adverse Event|0
7822178|NCT01260350|12291193|FG019|Overall Study|Lack of Efficacy|0
7938447|NCT02388347|12475568|FG000|Overall Study|Withdrawal by Subject|0
7938448|NCT02388347|12475569|FG001|Overall Study|Withdrawal by Subject|0
7938449|NCT02388347|12475570|FG002|Overall Study|Withdrawal by Subject|1
7938450|NCT02388347|12475571|FG003|Overall Study|Withdrawal by Subject|0
7938451|NCT02388347|12475572|FG004|Overall Study|Withdrawal by Subject|0
7938452|NCT02388724|12475624|FG000|Overall Study|Reason not Specified|0
7938453|NCT02388724|12475625|FG001|Overall Study|Reason not Specified|1
7938454|NCT02388724|12475624|FG000|Overall Study|Major Protocol Deviation|3
7938455|NCT02388724|12475625|FG001|Overall Study|Major Protocol Deviation|3
7938456|NCT02388724|12475624|FG000|Overall Study|Pretreatment Event/Adverse Event|3
7938457|NCT02388724|12475625|FG001|Overall Study|Pretreatment Event/Adverse Event|2
7938458|NCT02388724|12475624|FG000|Overall Study|Voluntary Withdrawal|6
7938459|NCT02388724|12475625|FG001|Overall Study|Voluntary Withdrawal|5
7938460|NCT02388724|12475624|FG000|Overall Study|Randomized but not Treated|0
7938461|NCT02388724|12475625|FG001|Overall Study|Randomized but not Treated|2
7938462|NCT02388737|12475634|FG000|Overall Study|Pretreatment Event/Adverse Event|13
7938463|NCT02388737|12475635|FG001|Overall Study|Pretreatment Event/Adverse Event|11
7938464|NCT02388737|12475636|FG002|Overall Study|Pretreatment Event/Adverse Event|12
7938465|NCT02388737|12475634|FG000|Overall Study|Major Protocol Deviation|18
7938466|NCT02388737|12475635|FG001|Overall Study|Major Protocol Deviation|25
7938467|NCT02388737|12475636|FG002|Overall Study|Major Protocol Deviation|22
7938468|NCT02388737|12475634|FG000|Overall Study|Lost to Follow-up|5
7938469|NCT02388737|12475635|FG001|Overall Study|Lost to Follow-up|1
7938470|NCT02388737|12475636|FG002|Overall Study|Lost to Follow-up|4
7938471|NCT02388737|12475634|FG000|Overall Study|Voluntary Withdrawal|10
7938472|NCT02388737|12475635|FG001|Overall Study|Voluntary Withdrawal|18
7938473|NCT02388737|12475636|FG002|Overall Study|Voluntary Withdrawal|17
7938474|NCT02388737|12475634|FG000|Overall Study|Lack of Efficacy|3
7938475|NCT02388737|12475635|FG001|Overall Study|Lack of Efficacy|0
7938476|NCT02388737|12475636|FG002|Overall Study|Lack of Efficacy|3
7938477|NCT02388737|12475634|FG000|Overall Study|Reason Not Specified|5
7938478|NCT02388737|12475635|FG001|Overall Study|Reason Not Specified|5
7938479|NCT02388737|12475636|FG002|Overall Study|Reason Not Specified|4
7938480|NCT02388763|12475644|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1
7938481|NCT02388763|12475645|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1
7938482|NCT02388763|12475644|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1
7938483|NCT02388763|12475645|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1
7938484|NCT02388932|12475662|FG000|Overall Study|Death|1
7938485|NCT02388997|12475669|FG000|Overall Study|Adverse Event|1
7938486|NCT02388997|12475670|FG001|Overall Study|Adverse Event|2
7938487|NCT02388997|12475669|FG000|Overall Study|Withdrawal by Subject|2
7938488|NCT02388997|12475670|FG001|Overall Study|Withdrawal by Subject|1
7938489|NCT02388997|12475669|FG000|Overall Study|Lung function exclusion criteria|0
7938490|NCT02388997|12475670|FG001|Overall Study|Lung function exclusion criteria|2
7938491|NCT02388997|12475669|FG000|Overall Study|Tested positive for virus during run-in|0
7938492|NCT02388997|12475670|FG001|Overall Study|Tested positive for virus during run-in|1
7938493|NCT02389452|12475703|FG000|Overall Study|Lost to Follow-up|13
7938494|NCT02389452|12475703|FG000|Overall Study|Adverse Event|1
7938495|NCT02389452|12475703|FG000|Overall Study|Withdrawal by Subject|5
7938496|NCT02389452|12475703|FG000|Overall Study|Enrolled but Not Eligible for Study|6
7938497|NCT02389621|12475710|FG000|Treatment Period|Withdrawal by Subject|1
7938498|NCT02389621|12475711|FG001|Treatment Period|Withdrawal by Subject|1
7938499|NCT02389621|12475710|FG000|Posttreatment Period|Adverse Event|3
7938500|NCT02389621|12475711|FG001|Posttreatment Period|Adverse Event|1
7938501|NCT02389621|12475710|FG000|Posttreatment Period|Withdrawal by Subject|3
7938502|NCT02389621|12475711|FG001|Posttreatment Period|Withdrawal by Subject|2
7938503|NCT02389621|12475710|FG000|Posttreatment Period|Lost to Follow-up|1
7938504|NCT02389621|12475711|FG001|Posttreatment Period|Lost to Follow-up|1
7938505|NCT02389621|12475710|FG000|Posttreatment Period|Other - Miscellaneous|2
7938506|NCT02389621|12475711|FG001|Posttreatment Period|Other - Miscellaneous|0
7938507|NCT02389764|12475736|FG000|Overall Study|Lack of Efficacy|9
7938508|NCT02389816|12475743|FG000|Overall Study|Randomized but Not Treated|1
7938509|NCT02389816|12475744|FG001|Overall Study|Randomized but Not Treated|0
7938510|NCT02389816|12475745|FG002|Overall Study|Randomized but Not Treated|0
7938511|NCT02389816|12475743|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4
7938512|NCT02389816|12475744|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6
7938513|NCT02389816|12475745|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7
7938514|NCT02389816|12475743|FG000|Overall Study|Major Protocol Deviation|1
7938515|NCT02389816|12475744|FG001|Overall Study|Major Protocol Deviation|0
7938516|NCT02389816|12475745|FG002|Overall Study|Major Protocol Deviation|0
7938517|NCT02389816|12475743|FG000|Overall Study|Lost to Follow-up|1
7938518|NCT02389816|12475744|FG001|Overall Study|Lost to Follow-up|0
7938519|NCT02389816|12475745|FG002|Overall Study|Lost to Follow-up|0
7938520|NCT02389816|12475743|FG000|Overall Study|Withdrawal of Consent|6
7938521|NCT02389816|12475744|FG001|Overall Study|Withdrawal of Consent|4
7938522|NCT02389816|12475745|FG002|Overall Study|Withdrawal of Consent|4
7938523|NCT02389816|12475743|FG000|Overall Study|Lack of Efficacy|1
7938524|NCT02389816|12475744|FG001|Overall Study|Lack of Efficacy|0
7938525|NCT02389816|12475745|FG002|Overall Study|Lack of Efficacy|0
7938526|NCT02389816|12475743|FG000|Overall Study|Non Compliance with Study Drug|1
7938527|NCT02389816|12475744|FG001|Overall Study|Non Compliance with Study Drug|1
7938528|NCT02389816|12475745|FG002|Overall Study|Non Compliance with Study Drug|1
7938529|NCT02389816|12475743|FG000|Overall Study|Reason not Specified|0
7938530|NCT02389816|12475744|FG001|Overall Study|Reason not Specified|2
7938531|NCT02389816|12475745|FG002|Overall Study|Reason not Specified|0
7938532|NCT02389829|12475755|FG000|Overall Study|Lost to Follow-up|0
7938533|NCT02389829|12475756|FG001|Overall Study|Lost to Follow-up|1
7938534|NCT02389894|12475794|FG000|Overall Study|Death|4
7938535|NCT02389894|12475795|FG001|Overall Study|Death|5
7938536|NCT02389894|12475796|FG002|Overall Study|Death|3
7938537|NCT02389894|12475794|FG000|Overall Study|Withdrawal by Subject|2
7938538|NCT02389894|12475795|FG001|Overall Study|Withdrawal by Subject|4
7938539|NCT02389894|12475796|FG002|Overall Study|Withdrawal by Subject|5
7938540|NCT02389894|12475794|FG000|Overall Study|Lost to Follow-up|2
7938541|NCT02389894|12475795|FG001|Overall Study|Lost to Follow-up|1
7938542|NCT02389894|12475796|FG002|Overall Study|Lost to Follow-up|1
7938543|NCT02389998|12475815|FG000|Overall Study|car accident|1
7938544|NCT02389998|12475816|FG001|Overall Study|car accident|0
7938545|NCT02390076|12475844|FG000|Overall Study|Lost to Follow-up|2
7938546|NCT02390076|12475845|FG001|Overall Study|Lost to Follow-up|1
7938547|NCT02390076|12475846|FG002|Overall Study|Lost to Follow-up|4
7938548|NCT02390167|12475854|FG000|Overall Study|Lost to Follow-up|1
7938549|NCT02390219|12475862|FG000|Overall Study|Death|1
7938550|NCT02390219|12475862|FG000|Overall Study|Physician Decision|1
7938551|NCT02390219|12475862|FG000|Overall Study|Adverse Event|6
7938552|NCT02390219|12475862|FG000|Overall Study|Withdrawal by Subject|1
7938553|NCT02390219|12475862|FG000|Overall Study|Lost to Follow-up|2
7938554|NCT02390219|12475862|FG000|Overall Study|Other|2
7938555|NCT02390557|12475869|FG000|Wave 2|Survey non-respondent|72
7938556|NCT02390557|12475870|FG001|Wave 2|Survey non-respondent|41
7938557|NCT02390557|12475871|FG002|Wave 2|Survey non-respondent|23
7938558|NCT02391038|12475914|FG000|Overall Study|Progressive disease|3
7938559|NCT02391038|12475915|FG001|Overall Study|Progressive disease|3
7938560|NCT02391038|12475916|FG002|Overall Study|Progressive disease|6
7938561|NCT02391116|12475925|FG000|Treatment|Withdrawal by Subject|1
7938562|NCT02391116|12475925|FG000|Treatment|Protocol Violation|1
7938563|NCT02391116|12475925|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9
7938564|NCT02391116|12475925|FG000|Treatment|AE with Clinical PD|3
7938565|NCT02391116|12475925|FG000|Safety Follow-up|Adverse Event|1
7938566|NCT02391116|12475925|FG000|Safety Follow-up|Withdrawal by Subject|4
7938567|NCT02391116|12475925|FG000|Safety Follow-up|Switching to Other Therapy|4
7938568|NCT02391116|12475925|FG000|Safety Follow-up|No Follow Up|1
7938569|NCT02391116|12475925|FG000|Safety Follow-up|Deterioration of General Conditions|3
7938570|NCT02391116|12475925|FG000|Active Follow-up|Withdrawal by Subject|1
7938571|NCT02391116|12475925|FG000|Active Follow-up|Switching to Other Therapy|2
7938572|NCT02391116|12475925|FG000|Survival Follow-up|Withdrawal by Subject|3
7938573|NCT02391116|12475925|FG000|Survival Follow-up|Switching to Other Therapy|1
7938574|NCT02391311|12475938|FG000|Overall Study|Lost to Follow-up|2
7938575|NCT02391311|12475939|FG001|Overall Study|Lost to Follow-up|1
7938576|NCT02391311|12475938|FG000|Overall Study|deemed ineligible after baseline|1
7938577|NCT02391311|12475939|FG001|Overall Study|deemed ineligible after baseline|1
7938578|NCT02391337|12475947|FG000|6 Months Follow-up|Death|5
7938579|NCT02391337|12475948|FG001|6 Months Follow-up|Death|4
7938580|NCT02391337|12475947|FG000|6 Months Follow-up|Withdrawal by Subject|1
7938581|NCT02391337|12475948|FG001|6 Months Follow-up|Withdrawal by Subject|1
7938582|NCT02391337|12475947|FG000|12 Months Follow-up|Death|2
7938583|NCT02391337|12475948|FG001|12 Months Follow-up|Death|0
7938584|NCT02391337|12475947|FG000|12 Months Follow-up|Withdrawal by Subject|0
7938585|NCT02391337|12475948|FG001|12 Months Follow-up|Withdrawal by Subject|1
7938586|NCT02391337|12475947|FG000|12 Months Follow-up|Lost to Follow-up|0
7938587|NCT02391337|12475948|FG001|12 Months Follow-up|Lost to Follow-up|2
7938588|NCT02391363|12475965|FG000|Overall Study|Lost to Follow-up|5
7938589|NCT02391363|12475966|FG001|Overall Study|Lost to Follow-up|5
7938590|NCT02391363|12475965|FG000|Overall Study|Withdrawal by Subject|6
7938591|NCT02391363|12475966|FG001|Overall Study|Withdrawal by Subject|3
7938592|NCT02391545|12475974|FG000|Overall Study|Death|0
7938593|NCT02391545|12475975|FG001|Overall Study|Death|2
7938594|NCT02391545|12475974|FG000|Overall Study|Lost to Follow-up|0
7938595|NCT02391545|12475975|FG001|Overall Study|Lost to Follow-up|1
7938596|NCT02391545|12475974|FG000|Overall Study|Termination of study by sponsor|20
7938597|NCT02391545|12475975|FG001|Overall Study|Termination of study by sponsor|20
7938598|NCT02391545|12475974|FG000|Overall Study|Withdrawal by Subject|0
7938599|NCT02391545|12475975|FG001|Overall Study|Withdrawal by Subject|1
7938600|NCT02391545|12475974|FG000|Overall Study|Other Reasons|6
7938601|NCT02391545|12475975|FG001|Overall Study|Other Reasons|4
7938602|NCT02391584|12475984|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1
7938603|NCT02391584|12475985|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2
7938604|NCT02391584|12475984|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
7938605|NCT02391584|12475985|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
7938606|NCT02391584|12475984|FG000|3 Month|Lost to Follow-up|1
7938607|NCT02391584|12475985|FG001|3 Month|Lost to Follow-up|0
7938608|NCT02391584|12475984|FG000|6 Month|Withdrawal by Subject|1
7938609|NCT02391584|12475985|FG001|6 Month|Withdrawal by Subject|0
7938610|NCT02391584|12475984|FG000|12 Month (End of Study)|Lost to Follow-up|2
7938611|NCT02391584|12475985|FG001|12 Month (End of Study)|Lost to Follow-up|0
7965038|NCT03368664|12520706|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1
7965039|NCT03368664|12520706|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1
7965040|NCT03368664|12520706|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1
7965041|NCT03368664|12520706|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1
7965042|NCT02998671|12520734|FG000|Period 1|Study Terminated By Sponsor|2
7965043|NCT02998671|12520735|FG001|Period 1|Study Terminated By Sponsor|1
7965044|NCT02998671|12520736|FG002|Period 1|Study Terminated By Sponsor|0
7965045|NCT02998671|12520737|FG003|Period 1|Study Terminated By Sponsor|0
7965046|NCT02998671|12520738|FG004|Period 1|Study Terminated By Sponsor|1
7965047|NCT02998671|12520734|FG000|Period 1|Withdrawal by Subject|1
7965048|NCT02998671|12520735|FG001|Period 1|Withdrawal by Subject|2
7965049|NCT02998671|12520736|FG002|Period 1|Withdrawal by Subject|0
7965050|NCT02998671|12520737|FG003|Period 1|Withdrawal by Subject|0
7965051|NCT02998671|12520738|FG004|Period 1|Withdrawal by Subject|2
7965052|NCT02998671|12520734|FG000|Period 1|Pregnancy|1
7965053|NCT02998671|12520735|FG001|Period 1|Pregnancy|0
7965054|NCT02998671|12520736|FG002|Period 1|Pregnancy|0
7965055|NCT02998671|12520737|FG003|Period 1|Pregnancy|0
7965056|NCT02998671|12520738|FG004|Period 1|Pregnancy|0
7965057|NCT02998671|12520734|FG000|Period 1|Adverse Event|0
7965058|NCT02998671|12520735|FG001|Period 1|Adverse Event|0
7965059|NCT02998671|12520736|FG002|Period 1|Adverse Event|0
7965060|NCT02998671|12520737|FG003|Period 1|Adverse Event|0
7965061|NCT02998671|12520738|FG004|Period 1|Adverse Event|1
7965062|NCT02998671|12520734|FG000|Period 2|Adverse Event|0
7965063|NCT02998671|12520735|FG001|Period 2|Adverse Event|1
7965064|NCT02998671|12520736|FG002|Period 2|Adverse Event|0
7965065|NCT02998671|12520737|FG003|Period 2|Adverse Event|0
7965066|NCT02998671|12520738|FG004|Period 2|Adverse Event|0
7965067|NCT02998671|12520734|FG000|Period 2|Study Terminated By Sponsor|3
7965068|NCT02998671|12520735|FG001|Period 2|Study Terminated By Sponsor|5
7965069|NCT02998671|12520736|FG002|Period 2|Study Terminated By Sponsor|1
7965070|NCT02998671|12520737|FG003|Period 2|Study Terminated By Sponsor|3
7965071|NCT02998671|12520738|FG004|Period 2|Study Terminated By Sponsor|0
7965072|NCT02998671|12520734|FG000|Period 2|Withdrawal by Subject|0
7965073|NCT02998671|12520735|FG001|Period 2|Withdrawal by Subject|1
7965074|NCT02998671|12520736|FG002|Period 2|Withdrawal by Subject|0
7965075|NCT02998671|12520737|FG003|Period 2|Withdrawal by Subject|0
7965076|NCT02998671|12520738|FG004|Period 2|Withdrawal by Subject|0
7965077|NCT02998671|12520734|FG000|Period 2|Lost to Follow-up|0
7965078|NCT02998671|12520735|FG001|Period 2|Lost to Follow-up|0
7965079|NCT02998671|12520736|FG002|Period 2|Lost to Follow-up|0
7965080|NCT02998671|12520737|FG003|Period 2|Lost to Follow-up|1
7965081|NCT02998671|12520738|FG004|Period 2|Lost to Follow-up|0
7965082|NCT02860039|12520760|FG000|Overall Study|Death|4
7965083|NCT02860039|12520761|FG001|Overall Study|Death|0
7965084|NCT02860039|12520760|FG000|Overall Study|Lost to Follow-up|2
7965085|NCT02860039|12520761|FG001|Overall Study|Lost to Follow-up|2
7965086|NCT02860039|12520760|FG000|Overall Study|Protocol Violation|3
7965087|NCT02860039|12520761|FG001|Overall Study|Protocol Violation|1
7965088|NCT02860039|12520760|FG000|Overall Study|Withdrawal by Subject|1
7965089|NCT02860039|12520761|FG001|Overall Study|Withdrawal by Subject|0
7965090|NCT02860039|12520760|FG000|Overall Study|Not otherwise eligible|1
7965091|NCT02860039|12520761|FG001|Overall Study|Not otherwise eligible|1
7965092|NCT02499146|12520771|FG000|Overall Study|Lost to Follow-up|1
7965093|NCT02499146|12520771|FG000|Overall Study|Withdrawal by Subject|1
7965094|NCT02499146|12520771|FG000|Overall Study|Other|2
7965095|NCT02499146|12520771|FG000|Overall Study|Ongoing at date of cut-off|9
7965096|NCT02499146|12520771|FG000|Overall Study|Began other treatment/therapy|13
7965097|NCT02499120|12520777|FG000|Overall Study|Death|45
7965098|NCT02499120|12520778|FG001|Overall Study|Death|42
7965099|NCT02499120|12520777|FG000|Overall Study|Lost to Follow-up|1
7965100|NCT02499120|12520778|FG001|Overall Study|Lost to Follow-up|2
7965101|NCT02499120|12520777|FG000|Overall Study|Participant refused further follow-up|1
7965102|NCT02499120|12520778|FG001|Overall Study|Participant refused further follow-up|0
7965103|NCT02499120|12520777|FG000|Overall Study|Withdrawal by Subject|2
7965104|NCT02499120|12520778|FG001|Overall Study|Withdrawal by Subject|5
7965105|NCT02499120|12520777|FG000|Overall Study|Other|1
7965106|NCT02499120|12520778|FG001|Overall Study|Other|0
7965107|NCT02499120|12520777|FG000|Overall Study|Ongoing on study|15
7965108|NCT02499120|12520778|FG001|Overall Study|Ongoing on study|11
7965109|NCT02340221|12520812|FG000|Overall Study|Death|100
7965110|NCT02340221|12520813|FG001|Overall Study|Death|197
7965111|NCT02340221|12520812|FG000|Overall Study|Withdrawal by Participant|24
7965112|NCT02340221|12520813|FG001|Overall Study|Withdrawal by Participant|37
7965113|NCT02340221|12520812|FG000|Overall Study|Lost to Follow-up|4
7938612|NCT02391948|12476019|FG000|6-month Assessment|Death|0
7938613|NCT02391948|12476020|FG001|6-month Assessment|Death|0
7938614|NCT02391948|12476021|FG002|6-month Assessment|Death|0
7938615|NCT02391948|12476022|FG003|6-month Assessment|Death|0
7938616|NCT02391948|12476023|FG004|6-month Assessment|Death|1
7938617|NCT02391948|12476019|FG000|6-month Assessment|Withdrawal by Subject|0
7938618|NCT02391948|12476020|FG001|6-month Assessment|Withdrawal by Subject|0
7938619|NCT02391948|12476021|FG002|6-month Assessment|Withdrawal by Subject|1
7938620|NCT02391948|12476022|FG003|6-month Assessment|Withdrawal by Subject|2
7938621|NCT02391948|12476023|FG004|6-month Assessment|Withdrawal by Subject|0
7938622|NCT02391948|12476019|FG000|6-month Assessment|Lost to Follow-up|4
7938623|NCT02391948|12476020|FG001|6-month Assessment|Lost to Follow-up|5
7938624|NCT02391948|12476021|FG002|6-month Assessment|Lost to Follow-up|2
7938625|NCT02391948|12476022|FG003|6-month Assessment|Lost to Follow-up|3
7938626|NCT02391948|12476023|FG004|6-month Assessment|Lost to Follow-up|1
7938627|NCT02391948|12476019|FG000|6-month Assessment|Medical issue/illness|1
7938628|NCT02391948|12476020|FG001|6-month Assessment|Medical issue/illness|1
7938629|NCT02391948|12476021|FG002|6-month Assessment|Medical issue/illness|0
7938630|NCT02391948|12476022|FG003|6-month Assessment|Medical issue/illness|0
7938631|NCT02391948|12476023|FG004|6-month Assessment|Medical issue/illness|0
7938632|NCT02391948|12476019|FG000|6-month Assessment|Not able to schedule visit in timeframe|6
7938633|NCT02391948|12476020|FG001|6-month Assessment|Not able to schedule visit in timeframe|8
7938634|NCT02391948|12476021|FG002|6-month Assessment|Not able to schedule visit in timeframe|4
7938635|NCT02391948|12476022|FG003|6-month Assessment|Not able to schedule visit in timeframe|5
7938636|NCT02391948|12476023|FG004|6-month Assessment|Not able to schedule visit in timeframe|0
7938637|NCT02391948|12476019|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68
7938638|NCT02391948|12476020|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42
7938639|NCT02391948|12476021|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24
7938640|NCT02391948|12476022|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35
7938641|NCT02391948|12476023|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24
7938642|NCT02391948|12476019|FG000|12-month Assessment|Death|0
7938643|NCT02391948|12476020|FG001|12-month Assessment|Death|0
7938644|NCT02391948|12476021|FG002|12-month Assessment|Death|0
7938645|NCT02391948|12476022|FG003|12-month Assessment|Death|1
7938646|NCT02391948|12476023|FG004|12-month Assessment|Death|0
7938647|NCT02391948|12476019|FG000|12-month Assessment|Withdrawal by Subject|1
7938648|NCT02391948|12476020|FG001|12-month Assessment|Withdrawal by Subject|0
7938649|NCT02391948|12476021|FG002|12-month Assessment|Withdrawal by Subject|0
7938650|NCT02391948|12476022|FG003|12-month Assessment|Withdrawal by Subject|1
7938651|NCT02391948|12476023|FG004|12-month Assessment|Withdrawal by Subject|0
7938652|NCT02391948|12476019|FG000|12-month Assessment|Lost to Follow-up|5
7938653|NCT02391948|12476020|FG001|12-month Assessment|Lost to Follow-up|4
7938654|NCT02391948|12476021|FG002|12-month Assessment|Lost to Follow-up|4
7938655|NCT02391948|12476022|FG003|12-month Assessment|Lost to Follow-up|4
7938656|NCT02391948|12476023|FG004|12-month Assessment|Lost to Follow-up|5
7938657|NCT02391948|12476019|FG000|12-month Assessment|Medical issue/illness|0
7938658|NCT02391948|12476020|FG001|12-month Assessment|Medical issue/illness|1
7938659|NCT02391948|12476021|FG002|12-month Assessment|Medical issue/illness|0
7938660|NCT02391948|12476022|FG003|12-month Assessment|Medical issue/illness|1
7938661|NCT02391948|12476023|FG004|12-month Assessment|Medical issue/illness|0
7938662|NCT02391948|12476019|FG000|12-month Assessment|Not able to schedule visit in timeframe|2
7938663|NCT02391948|12476020|FG001|12-month Assessment|Not able to schedule visit in timeframe|4
7938664|NCT02391948|12476021|FG002|12-month Assessment|Not able to schedule visit in timeframe|0
7938665|NCT02391948|12476022|FG003|12-month Assessment|Not able to schedule visit in timeframe|2
7938666|NCT02391948|12476023|FG004|12-month Assessment|Not able to schedule visit in timeframe|1
7938667|NCT02391948|12476019|FG000|18-month Assessment|Death|0
7938668|NCT02391948|12476020|FG001|18-month Assessment|Death|0
7938669|NCT02391948|12476021|FG002|18-month Assessment|Death|0
7938670|NCT02391948|12476022|FG003|18-month Assessment|Death|1
7938671|NCT02391948|12476023|FG004|18-month Assessment|Death|1
7938672|NCT02391948|12476019|FG000|18-month Assessment|Withdrawal by Subject|1
7938673|NCT02391948|12476020|FG001|18-month Assessment|Withdrawal by Subject|0
7938674|NCT02391948|12476021|FG002|18-month Assessment|Withdrawal by Subject|0
7938675|NCT02391948|12476022|FG003|18-month Assessment|Withdrawal by Subject|1
7938676|NCT02391948|12476023|FG004|18-month Assessment|Withdrawal by Subject|0
7938677|NCT02391948|12476019|FG000|18-month Assessment|Lost to Follow-up|2
7938678|NCT02391948|12476020|FG001|18-month Assessment|Lost to Follow-up|6
7938679|NCT02391948|12476021|FG002|18-month Assessment|Lost to Follow-up|2
7938680|NCT02391948|12476022|FG003|18-month Assessment|Lost to Follow-up|2
7938681|NCT02391948|12476023|FG004|18-month Assessment|Lost to Follow-up|3
7938682|NCT02391948|12476019|FG000|18-month Assessment|Not able to schedule visit in timeframe|3
7938683|NCT02391948|12476020|FG001|18-month Assessment|Not able to schedule visit in timeframe|3
7938684|NCT02391948|12476021|FG002|18-month Assessment|Not able to schedule visit in timeframe|2
7938685|NCT02391948|12476022|FG003|18-month Assessment|Not able to schedule visit in timeframe|1
7938686|NCT02391948|12476023|FG004|18-month Assessment|Not able to schedule visit in timeframe|4
7938687|NCT02391948|12476019|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66
7938688|NCT02391948|12476020|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41
7938689|NCT02391948|12476021|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
7938690|NCT02391948|12476022|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31
7938691|NCT02391948|12476023|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
7938692|NCT02391948|12476019|FG000|24-month Assessment|Death|0
7938693|NCT02391948|12476020|FG001|24-month Assessment|Death|0
7938694|NCT02391948|12476021|FG002|24-month Assessment|Death|0
7938695|NCT02391948|12476022|FG003|24-month Assessment|Death|0
7938696|NCT02391948|12476023|FG004|24-month Assessment|Death|1
7938697|NCT02391948|12476019|FG000|24-month Assessment|Withdrawal by Subject|1
7938698|NCT02391948|12476020|FG001|24-month Assessment|Withdrawal by Subject|1
7938699|NCT02391948|12476021|FG002|24-month Assessment|Withdrawal by Subject|0
7938700|NCT02391948|12476022|FG003|24-month Assessment|Withdrawal by Subject|0
7938701|NCT02391948|12476023|FG004|24-month Assessment|Withdrawal by Subject|1
7938702|NCT02391948|12476019|FG000|24-month Assessment|Lost to Follow-up|5
7938703|NCT02391948|12476020|FG001|24-month Assessment|Lost to Follow-up|4
7938704|NCT02391948|12476021|FG002|24-month Assessment|Lost to Follow-up|0
7938705|NCT02391948|12476022|FG003|24-month Assessment|Lost to Follow-up|0
7938706|NCT02391948|12476023|FG004|24-month Assessment|Lost to Follow-up|0
7938707|NCT02391948|12476019|FG000|24-month Assessment|Medical issue/illness|0
7938708|NCT02391948|12476020|FG001|24-month Assessment|Medical issue/illness|0
7938709|NCT02391948|12476021|FG002|24-month Assessment|Medical issue/illness|1
7938710|NCT02391948|12476022|FG003|24-month Assessment|Medical issue/illness|0
7938711|NCT02391948|12476023|FG004|24-month Assessment|Medical issue/illness|0
7938712|NCT02391948|12476019|FG000|24-month Assessment|Not able to schedule visit in timeframe|8
7938713|NCT02391948|12476020|FG001|24-month Assessment|Not able to schedule visit in timeframe|5
7938714|NCT02391948|12476021|FG002|24-month Assessment|Not able to schedule visit in timeframe|2
7938715|NCT02391948|12476022|FG003|24-month Assessment|Not able to schedule visit in timeframe|9
7938716|NCT02391948|12476023|FG004|24-month Assessment|Not able to schedule visit in timeframe|8
7938717|NCT02391961|12476040|FG000|First Intervention (4 Weeks)|Adverse Event|2
7938718|NCT02391961|12476041|FG001|First Intervention (4 Weeks)|Adverse Event|0
7938719|NCT02391961|12476040|FG000|Washout (2 Weeks)|Withdrawal by Subject|1
7938720|NCT02391961|12476041|FG001|Washout (2 Weeks)|Withdrawal by Subject|1
7938721|NCT02391961|12476040|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7938722|NCT02391961|12476041|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7938723|NCT02392000|12476056|FG000|Overall Study|Greater than mild sleep apnea exclusion|18
7938724|NCT02392000|12476056|FG000|Overall Study|Withdrawal by Subject|1
7938725|NCT02392000|12476056|FG000|Overall Study|Lost to Follow-up|8
7938726|NCT02392104|12476061|FG000|Overall Study|discontinuation of warfarin|3
7938727|NCT02392104|12476061|FG000|Overall Study|bleeding event|1
7938728|NCT02392104|12476061|FG000|Overall Study|transferred care to another doctor|2
7938729|NCT02392104|12476061|FG000|Overall Study|INR goal range changed|1
7938730|NCT02392104|12476061|FG000|Overall Study|admitted to skilled nursing facility|3
7938731|NCT02392104|12476061|FG000|Overall Study|INRs drawn by visiting nurse services|1
7938732|NCT02392195|12476065|FG000|Overall Study|Lost to Follow-up|4
7938733|NCT02392195|12476065|FG000|Overall Study|Withdrawal by Subject|4
7938734|NCT02392234|12476080|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1
7938735|NCT02392234|12476081|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0
7938736|NCT02392234|12476082|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1
7938737|NCT02392234|12476083|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0
7938738|NCT02392234|12476084|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1
7938739|NCT02392234|12476085|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1
7938740|NCT02392234|12476080|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7938741|NCT02392234|12476081|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7938742|NCT02392234|12476082|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7938743|NCT02392234|12476083|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7938744|NCT02392234|12476084|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
7938745|NCT02392234|12476085|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7938746|NCT02392234|12476080|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7938747|NCT02392234|12476081|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7938748|NCT02392234|12476082|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7938749|NCT02392234|12476083|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7938750|NCT02392234|12476084|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7938751|NCT02392234|12476085|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
7938752|NCT02392234|12476080|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1
7938753|NCT02392234|12476081|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0
7938754|NCT02392234|12476082|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0
7938755|NCT02392234|12476083|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1
7938756|NCT02392234|12476084|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0
7938757|NCT02392234|12476085|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0
7938758|NCT02392234|12476080|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0
7938759|NCT02392234|12476081|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0
7938760|NCT02392234|12476082|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0
7938761|NCT02392234|12476083|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0
7938762|NCT02392234|12476084|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0
7938763|NCT02392234|12476085|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1
7938764|NCT02392234|12476080|FG000|Treatment Period 1 (8 Weeks)|Other|1
7938765|NCT02392234|12476081|FG001|Treatment Period 1 (8 Weeks)|Other|0
7938766|NCT02392234|12476082|FG002|Treatment Period 1 (8 Weeks)|Other|0
7938767|NCT02392234|12476083|FG003|Treatment Period 1 (8 Weeks)|Other|0
7938768|NCT02392234|12476084|FG004|Treatment Period 1 (8 Weeks)|Other|0
7938769|NCT02392234|12476085|FG005|Treatment Period 1 (8 Weeks)|Other|0
7938770|NCT02392234|12476080|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7938771|NCT02392234|12476081|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7938772|NCT02392234|12476082|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
7938773|NCT02392234|12476083|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7938774|NCT02392234|12476084|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
7938775|NCT02392234|12476085|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7938776|NCT02392234|12476080|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1
7938777|NCT02392234|12476081|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0
7938778|NCT02392234|12476082|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0
7938779|NCT02392234|12476083|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0
7938780|NCT02392234|12476084|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0
7938781|NCT02392234|12476085|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0
7938782|NCT02392247|12476096|FG000|Overall Study|Withdrawal by Subject|1
7938783|NCT02392247|12476096|FG000|Overall Study|Surgery cancelled; no data|1
7938784|NCT02392403|12476118|FG000|Overall Study|Adverse Event|1
7938785|NCT02392403|12476118|FG000|Overall Study|Death|1
7938786|NCT02392403|12476118|FG000|Overall Study|Withdrawal by Subject|1
7938787|NCT02392481|12476126|FG000|Overall Study|Adverse Event|0
7938788|NCT02392481|12476127|FG001|Overall Study|Adverse Event|0
7938789|NCT02392481|12476128|FG002|Overall Study|Adverse Event|1
7938790|NCT02392481|12476129|FG003|Overall Study|Adverse Event|2
7938791|NCT02392481|12476126|FG000|Overall Study|Withdrawal by Subject|0
7938792|NCT02392481|12476127|FG001|Overall Study|Withdrawal by Subject|0
7938793|NCT02392481|12476128|FG002|Overall Study|Withdrawal by Subject|1
7938794|NCT02392481|12476129|FG003|Overall Study|Withdrawal by Subject|0
7938795|NCT02392507|12476153|FG000|Induction Regimen|Death|3
7938796|NCT02392507|12476153|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1
7938797|NCT02392507|12476153|FG000|Induction Regimen|Physician Decision|1
7938798|NCT02392507|12476153|FG000|Induction Regimen|Withdrawal by Subject|2
7938799|NCT02392507|12476153|FG000|Maintenance Regimen|Death|1
7938800|NCT02392507|12476153|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1
7938801|NCT02392559|12476164|FG000|Overall Study|Withdrawal by Subject|0
7938802|NCT02392559|12476165|FG001|Overall Study|Withdrawal by Subject|1
7938803|NCT02392611|12476181|FG000|Overall Study|Adverse Event|0
7938804|NCT02392611|12476182|FG001|Overall Study|Adverse Event|0
7938805|NCT02392611|12476183|FG002|Overall Study|Adverse Event|0
7938806|NCT02392611|12476184|FG003|Overall Study|Adverse Event|1
7938807|NCT02392611|12476185|FG004|Overall Study|Adverse Event|0
7938808|NCT02392611|12476186|FG005|Overall Study|Adverse Event|0
7938809|NCT02392611|12476187|FG006|Overall Study|Adverse Event|0
7938810|NCT02392611|12476188|FG007|Overall Study|Adverse Event|0
7938811|NCT02392611|12476189|FG008|Overall Study|Adverse Event|0
7938812|NCT02392611|12476181|FG000|Overall Study|Progressive disease|0
7938813|NCT02392611|12476182|FG001|Overall Study|Progressive disease|0
7938814|NCT02392611|12476183|FG002|Overall Study|Progressive disease|0
7938815|NCT02392611|12476184|FG003|Overall Study|Progressive disease|2
7938816|NCT02392611|12476185|FG004|Overall Study|Progressive disease|1
7938817|NCT02392611|12476186|FG005|Overall Study|Progressive disease|0
7938818|NCT02392611|12476187|FG006|Overall Study|Progressive disease|0
7938819|NCT02392611|12476188|FG007|Overall Study|Progressive disease|0
7938820|NCT02392611|12476189|FG008|Overall Study|Progressive disease|0
7938821|NCT02392611|12476181|FG000|Overall Study|Death|1
7938822|NCT02392611|12476182|FG001|Overall Study|Death|0
7938823|NCT02392611|12476183|FG002|Overall Study|Death|0
7938824|NCT02392611|12476184|FG003|Overall Study|Death|0
7938825|NCT02392611|12476185|FG004|Overall Study|Death|0
7938826|NCT02392611|12476186|FG005|Overall Study|Death|1
7938827|NCT02392611|12476187|FG006|Overall Study|Death|0
7938828|NCT02392611|12476188|FG007|Overall Study|Death|0
7938829|NCT02392611|12476189|FG008|Overall Study|Death|0
7938830|NCT02392611|12476181|FG000|Overall Study|Withdrawal by Subject|0
7938831|NCT02392611|12476182|FG001|Overall Study|Withdrawal by Subject|0
7938832|NCT02392611|12476183|FG002|Overall Study|Withdrawal by Subject|0
7938833|NCT02392611|12476184|FG003|Overall Study|Withdrawal by Subject|1
7938834|NCT02392611|12476185|FG004|Overall Study|Withdrawal by Subject|0
7938835|NCT02392611|12476186|FG005|Overall Study|Withdrawal by Subject|0
7938836|NCT02392611|12476187|FG006|Overall Study|Withdrawal by Subject|0
7938837|NCT02392611|12476188|FG007|Overall Study|Withdrawal by Subject|0
7938838|NCT02392611|12476189|FG008|Overall Study|Withdrawal by Subject|0
7938839|NCT02392611|12476181|FG000|Overall Study|Lost to Follow-up|0
7938840|NCT02392611|12476182|FG001|Overall Study|Lost to Follow-up|0
7938841|NCT02392611|12476183|FG002|Overall Study|Lost to Follow-up|0
7938842|NCT02392611|12476184|FG003|Overall Study|Lost to Follow-up|0
7938843|NCT02392611|12476185|FG004|Overall Study|Lost to Follow-up|0
7938844|NCT02392611|12476186|FG005|Overall Study|Lost to Follow-up|0
7938845|NCT02392611|12476187|FG006|Overall Study|Lost to Follow-up|1
7938846|NCT02392611|12476188|FG007|Overall Study|Lost to Follow-up|0
7938847|NCT02392611|12476189|FG008|Overall Study|Lost to Follow-up|0
7938848|NCT02392611|12476181|FG000|Overall Study|Enrolled, not treated|0
7938849|NCT02392611|12476182|FG001|Overall Study|Enrolled, not treated|0
7938850|NCT02392611|12476183|FG002|Overall Study|Enrolled, not treated|0
7938851|NCT02392611|12476184|FG003|Overall Study|Enrolled, not treated|2
7938852|NCT02392611|12476185|FG004|Overall Study|Enrolled, not treated|0
7938853|NCT02392611|12476186|FG005|Overall Study|Enrolled, not treated|0
7938854|NCT02392611|12476187|FG006|Overall Study|Enrolled, not treated|0
7938855|NCT02392611|12476188|FG007|Overall Study|Enrolled, not treated|0
7938856|NCT02392611|12476189|FG008|Overall Study|Enrolled, not treated|0
7822179|NCT01260350|12291194|FG020|Overall Study|Lack of Efficacy|3
7822180|NCT01260350|12291195|FG021|Overall Study|Lack of Efficacy|0
7822181|NCT01260350|12291174|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0
7938857|NCT02392624|12476212|FG000|Overall Study|Withdrawal by Subject|15
7938858|NCT02392624|12476213|FG001|Overall Study|Withdrawal by Subject|12
7938859|NCT02392624|12476214|FG002|Overall Study|Withdrawal by Subject|9
7938860|NCT02392624|12476212|FG000|Overall Study|Adverse Event|4
7938861|NCT02392624|12476213|FG001|Overall Study|Adverse Event|1
7938862|NCT02392624|12476214|FG002|Overall Study|Adverse Event|2
7938863|NCT02392624|12476212|FG000|Overall Study|Pregnancy|1
7938864|NCT02392624|12476213|FG001|Overall Study|Pregnancy|0
7938865|NCT02392624|12476214|FG002|Overall Study|Pregnancy|0
7938866|NCT02392624|12476212|FG000|Overall Study|Protocol Violation|0
7938867|NCT02392624|12476213|FG001|Overall Study|Protocol Violation|0
7938868|NCT02392624|12476214|FG002|Overall Study|Protocol Violation|1
7938869|NCT02392624|12476212|FG000|Overall Study|Sponsor/Investigator Decision|2
7938870|NCT02392624|12476213|FG001|Overall Study|Sponsor/Investigator Decision|1
7938871|NCT02392624|12476214|FG002|Overall Study|Sponsor/Investigator Decision|0
7938872|NCT02392624|12476212|FG000|Overall Study|Other|49
7938873|NCT02392624|12476213|FG001|Overall Study|Other|1
7938874|NCT02392624|12476214|FG002|Overall Study|Other|1
7938875|NCT02393209|12476244|FG000|Overall Study|Study Terminated by Sponsor|1
7938876|NCT02393209|12476245|FG001|Overall Study|Study Terminated by Sponsor|1
7938877|NCT02393209|12476246|FG002|Overall Study|Study Terminated by Sponsor|0
7938878|NCT02393209|12476247|FG003|Overall Study|Study Terminated by Sponsor|0
7938879|NCT02393209|12476244|FG000|Overall Study|Withdrawal by Patient|1
7938880|NCT02393209|12476245|FG001|Overall Study|Withdrawal by Patient|0
7938881|NCT02393209|12476246|FG002|Overall Study|Withdrawal by Patient|0
7938882|NCT02393209|12476247|FG003|Overall Study|Withdrawal by Patient|0
7938883|NCT02393209|12476244|FG000|Overall Study|Death|2
7938884|NCT02393209|12476245|FG001|Overall Study|Death|2
7938885|NCT02393209|12476246|FG002|Overall Study|Death|0
7938886|NCT02393209|12476247|FG003|Overall Study|Death|0
7938887|NCT02393209|12476244|FG000|Overall Study|Death due to Disease Progression|2
7938888|NCT02393209|12476245|FG001|Overall Study|Death due to Disease Progression|2
7938889|NCT02393209|12476246|FG002|Overall Study|Death due to Disease Progression|0
7938890|NCT02393209|12476247|FG003|Overall Study|Death due to Disease Progression|0
7938891|NCT02393209|12476244|FG000|Overall Study|Death from Legionella Infection|0
7938892|NCT02393209|12476245|FG001|Overall Study|Death from Legionella Infection|1
7938893|NCT02393209|12476246|FG002|Overall Study|Death from Legionella Infection|0
7938894|NCT02393209|12476247|FG003|Overall Study|Death from Legionella Infection|0
7938895|NCT02393209|12476244|FG000|Overall Study|Patient Seen by Another Oncologist|0
7938896|NCT02393209|12476245|FG001|Overall Study|Patient Seen by Another Oncologist|1
7938897|NCT02393209|12476246|FG002|Overall Study|Patient Seen by Another Oncologist|0
7938898|NCT02393209|12476247|FG003|Overall Study|Patient Seen by Another Oncologist|0
7938899|NCT02393209|12476244|FG000|Overall Study|Lost to Follow-up|0
7938900|NCT02393209|12476245|FG001|Overall Study|Lost to Follow-up|1
7938901|NCT02393209|12476246|FG002|Overall Study|Lost to Follow-up|0
7938902|NCT02393209|12476247|FG003|Overall Study|Lost to Follow-up|0
7938903|NCT02393547|12476292|FG000|Overall Study|Adverse Event|2
7938904|NCT02393547|12476292|FG000|Overall Study|Withdrawal by Subject|3
7938905|NCT02393547|12476292|FG000|Overall Study|Lost to Follow-up|1
7938906|NCT02393755|12476307|FG000|Overall Study|Withdrawal by Subject|0
7938907|NCT02393755|12476308|FG001|Overall Study|Withdrawal by Subject|3
7938908|NCT02393755|12476307|FG000|Overall Study|Adverse Event|0
7938909|NCT02393755|12476308|FG001|Overall Study|Adverse Event|2
7938910|NCT02393755|12476307|FG000|Overall Study|Physician Decision|0
7938911|NCT02393755|12476308|FG001|Overall Study|Physician Decision|2
7938912|NCT02393950|12476315|FG000|Overall Study|Adverse Event|1
7938913|NCT02393950|12476316|FG001|Overall Study|Adverse Event|0
7938914|NCT02393950|12476315|FG000|Overall Study|Withdrawal by Subject|0
7938915|NCT02393950|12476316|FG001|Overall Study|Withdrawal by Subject|1
7938916|NCT02394275|12476351|FG000|Overall Study|Adverse Event|22
7938917|NCT02394275|12476351|FG000|Overall Study|Lost to Follow-up|7
7938918|NCT02394340|12476356|FG000|Overall Study|Failed drug screen test|1
7938919|NCT02394340|12476356|FG000|Overall Study|Adverse Event|1
7938920|NCT02394561|12476371|FG000|CORE Phase|Adverse Event|7
7938921|NCT02394561|12476372|FG001|CORE Phase|Adverse Event|9
7822182|NCT01260350|12291175|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0
7938922|NCT02394561|12476371|FG000|CORE Phase|Death|0
7938923|NCT02394561|12476372|FG001|CORE Phase|Death|1
7938924|NCT02394561|12476371|FG000|CORE Phase|Pregnancy|1
7938925|NCT02394561|12476372|FG001|CORE Phase|Pregnancy|0
7938926|NCT02394561|12476371|FG000|CORE Phase|Lost to Follow-up|1
7938927|NCT02394561|12476372|FG001|CORE Phase|Lost to Follow-up|0
7938928|NCT02394561|12476371|FG000|CORE Phase|Physician Decision|1
7938929|NCT02394561|12476372|FG001|CORE Phase|Physician Decision|1
7938930|NCT02394561|12476371|FG000|CORE Phase|Withdrawal by Subject|2
7938931|NCT02394561|12476372|FG001|CORE Phase|Withdrawal by Subject|2
7938932|NCT02394561|12476371|FG000|CORE Phase|Lack of Efficacy|1
7938933|NCT02394561|12476372|FG001|CORE Phase|Lack of Efficacy|6
7938934|NCT02394561|12476371|FG000|Extension Phase|Adverse Event|6
7938935|NCT02394561|12476372|FG001|Extension Phase|Adverse Event|1
7938936|NCT02394561|12476371|FG000|Extension Phase|Death|0
7938937|NCT02394561|12476372|FG001|Extension Phase|Death|1
7938938|NCT02394561|12476371|FG000|Extension Phase|Protocol Violation|1
7938939|NCT02394561|12476372|FG001|Extension Phase|Protocol Violation|0
7938940|NCT02394561|12476371|FG000|Extension Phase|Lost to Follow-up|1
7938941|NCT02394561|12476372|FG001|Extension Phase|Lost to Follow-up|0
7938942|NCT02394561|12476371|FG000|Extension Phase|Physician Decision|0
7938943|NCT02394561|12476372|FG001|Extension Phase|Physician Decision|2
7938944|NCT02394561|12476371|FG000|Extension Phase|Withdrawal by Subject|0
7938945|NCT02394561|12476372|FG001|Extension Phase|Withdrawal by Subject|5
7938946|NCT02394561|12476371|FG000|Extension Phase|Lack of Efficacy|3
7938947|NCT02394561|12476372|FG001|Extension Phase|Lack of Efficacy|3
7938948|NCT02394600|12476383|FG000|Overall Study|Adverse Event|3
7938949|NCT02394600|12476384|FG001|Overall Study|Adverse Event|0
7938950|NCT02394600|12476383|FG000|Overall Study|Lost to Follow-up|0
7938951|NCT02394600|12476384|FG001|Overall Study|Lost to Follow-up|1
7938952|NCT02394600|12476383|FG000|Overall Study|Withdrawal by Subject|0
7938953|NCT02394600|12476384|FG001|Overall Study|Withdrawal by Subject|1
7938954|NCT02394600|12476383|FG000|Overall Study|Protocol Violation|1
7938955|NCT02394600|12476384|FG001|Overall Study|Protocol Violation|0
7938956|NCT02394730|12476392|FG000|Overall Study|Lost to Follow-up|1
7938957|NCT02394730|12476393|FG001|Overall Study|Lost to Follow-up|0
7938958|NCT02394730|12476392|FG000|Overall Study|Withdrawal by Subject|0
7938959|NCT02394730|12476393|FG001|Overall Study|Withdrawal by Subject|1
7938960|NCT02394756|12476399|FG000|Period 1|Lens Discomfort|0
7938961|NCT02394756|12476400|FG001|Period 1|Lens Discomfort|0
7938962|NCT02394756|12476401|FG002|Period 1|Lens Discomfort|0
7938963|NCT02394756|12476402|FG003|Period 1|Lens Discomfort|0
7938964|NCT02394756|12476403|FG004|Period 1|Lens Discomfort|0
7938965|NCT02394756|12476404|FG005|Period 1|Lens Discomfort|1
7938966|NCT02394756|12476399|FG000|Period 1|Withdrawal by Subject|0
7938967|NCT02394756|12476400|FG001|Period 1|Withdrawal by Subject|1
7938968|NCT02394756|12476401|FG002|Period 1|Withdrawal by Subject|1
7938969|NCT02394756|12476402|FG003|Period 1|Withdrawal by Subject|1
7938970|NCT02394756|12476403|FG004|Period 1|Withdrawal by Subject|0
7938971|NCT02394756|12476404|FG005|Period 1|Withdrawal by Subject|0
7938972|NCT02394756|12476399|FG000|Period 2|Unsatisfactory Visual Response|0
7938973|NCT02394756|12476400|FG001|Period 2|Unsatisfactory Visual Response|0
7938974|NCT02394756|12476401|FG002|Period 2|Unsatisfactory Visual Response|0
7938975|NCT02394756|12476402|FG003|Period 2|Unsatisfactory Visual Response|0
7938976|NCT02394756|12476403|FG004|Period 2|Unsatisfactory Visual Response|1
7938977|NCT02394756|12476404|FG005|Period 2|Unsatisfactory Visual Response|0
7938978|NCT02394808|12476412|FG000|Period 1|Unsatisfactory lens fitting|0
7938979|NCT02394808|12476413|FG001|Period 1|Unsatisfactory lens fitting|1
7938980|NCT02394808|12476412|FG000|Period 2|Lost to Follow-up|1
7938981|NCT02394808|12476413|FG001|Period 2|Lost to Follow-up|0
7938982|NCT02394925|12476425|FG000|Overall Study|Adverse Event|1
7938983|NCT02394925|12476425|FG000|Overall Study|Lens Discomfort|3
7938984|NCT02394925|12476425|FG000|Overall Study|Lens handling difficulities|5
7938985|NCT02394925|12476425|FG000|Overall Study|Lost to Follow-up|9
7938986|NCT02394925|12476425|FG000|Overall Study|Protocol Violation|5
7938987|NCT02394925|12476425|FG000|Overall Study|No longer meet eligibility criteria|1
7938988|NCT02394925|12476425|FG000|Overall Study|Unsatisfactory Visual Response|5
7938989|NCT02395042|12476441|FG000|Treatment 1 Period|Adverse Event|1
7938990|NCT02395042|12476442|FG001|Treatment 1 Period|Adverse Event|3
7938991|NCT02395042|12476443|FG002|Treatment 1 Period|Adverse Event|1
7938992|NCT02395042|12476441|FG000|Treatment 1 Period|Lack of Efficacy|1
7938993|NCT02395042|12476442|FG001|Treatment 1 Period|Lack of Efficacy|1
7938994|NCT02395042|12476443|FG002|Treatment 1 Period|Lack of Efficacy|0
7938995|NCT02395042|12476441|FG000|Treatment 1 Period|Lost to Follow-up|1
7938996|NCT02395042|12476442|FG001|Treatment 1 Period|Lost to Follow-up|0
7938997|NCT02395042|12476443|FG002|Treatment 1 Period|Lost to Follow-up|0
7938998|NCT02395042|12476441|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0
7938999|NCT02395042|12476442|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2
7939000|NCT02395042|12476443|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1
7939001|NCT02395042|12476441|FG000|Treatment 2 Period|Lack of Efficacy|1
7939002|NCT02395042|12476442|FG001|Treatment 2 Period|Lack of Efficacy|1
7939003|NCT02395042|12476443|FG002|Treatment 2 Period|Lack of Efficacy|0
7939004|NCT02395055|12476456|FG000|Overall Study|Withdrawal by Subject|7
7939005|NCT02395055|12476457|FG001|Overall Study|Withdrawal by Subject|3
7939006|NCT02395081|12476466|FG000|Overall Study|Withdrawal by Subject|1
7939007|NCT02395081|12476467|FG001|Overall Study|Withdrawal by Subject|1
7939008|NCT02395081|12476468|FG002|Overall Study|Withdrawal by Subject|0
7939009|NCT02395081|12476466|FG000|Overall Study|Moved where blood couldn't be collected|4
7939010|NCT02395081|12476467|FG001|Overall Study|Moved where blood couldn't be collected|1
7939011|NCT02395081|12476468|FG002|Overall Study|Moved where blood couldn't be collected|3
7939012|NCT02395081|12476466|FG000|Overall Study|Fetal Loss|2
7939013|NCT02395081|12476467|FG001|Overall Study|Fetal Loss|3
7939014|NCT02395081|12476468|FG002|Overall Study|Fetal Loss|1
7939015|NCT02395133|12476483|FG000|Overall Study|Adverse Event|4
7939016|NCT02395133|12476484|FG001|Overall Study|Adverse Event|1
7939017|NCT02395133|12476485|FG002|Overall Study|Adverse Event|3
7939018|NCT02395133|12476486|FG003|Overall Study|Adverse Event|0
7939019|NCT02395133|12476483|FG000|Overall Study|Lack of Efficacy|1
7939020|NCT02395133|12476484|FG001|Overall Study|Lack of Efficacy|0
7939021|NCT02395133|12476485|FG002|Overall Study|Lack of Efficacy|1
7939022|NCT02395133|12476486|FG003|Overall Study|Lack of Efficacy|1
7939023|NCT02395133|12476483|FG000|Overall Study|Protocol Violation|1
7939024|NCT02395133|12476484|FG001|Overall Study|Protocol Violation|1
7939025|NCT02395133|12476485|FG002|Overall Study|Protocol Violation|0
7939026|NCT02395133|12476486|FG003|Overall Study|Protocol Violation|3
7939027|NCT02395133|12476483|FG000|Overall Study|Lost to Follow-up|0
7939028|NCT02395133|12476484|FG001|Overall Study|Lost to Follow-up|1
7939029|NCT02395133|12476485|FG002|Overall Study|Lost to Follow-up|1
7939030|NCT02395133|12476486|FG003|Overall Study|Lost to Follow-up|0
7939031|NCT02395133|12476483|FG000|Overall Study|Pregnancy|0
7939032|NCT02395133|12476484|FG001|Overall Study|Pregnancy|0
7939033|NCT02395133|12476485|FG002|Overall Study|Pregnancy|3
7939034|NCT02395133|12476486|FG003|Overall Study|Pregnancy|0
7939035|NCT02395133|12476483|FG000|Overall Study|Consent withdrawn with no reason given|1
7939036|NCT02395133|12476484|FG001|Overall Study|Consent withdrawn with no reason given|3
7939037|NCT02395133|12476485|FG002|Overall Study|Consent withdrawn with no reason given|0
7939038|NCT02395133|12476486|FG003|Overall Study|Consent withdrawn with no reason given|2
7939039|NCT02395133|12476483|FG000|Overall Study|Consent withdrawn with personal reason|0
7939040|NCT02395133|12476484|FG001|Overall Study|Consent withdrawn with personal reason|1
7939041|NCT02395133|12476485|FG002|Overall Study|Consent withdrawn with personal reason|0
7939042|NCT02395133|12476486|FG003|Overall Study|Consent withdrawn with personal reason|3
7939043|NCT02395133|12476483|FG000|Overall Study|Sponsor decision|2
7939044|NCT02395133|12476484|FG001|Overall Study|Sponsor decision|0
7939045|NCT02395133|12476485|FG002|Overall Study|Sponsor decision|0
7939046|NCT02395133|12476486|FG003|Overall Study|Sponsor decision|1
7939047|NCT02395133|12476483|FG000|Overall Study|Other than specified above|5
7939048|NCT02395133|12476484|FG001|Overall Study|Other than specified above|2
7939049|NCT02395133|12476485|FG002|Overall Study|Other than specified above|2
7939050|NCT02395133|12476486|FG003|Overall Study|Other than specified above|4
7939051|NCT02395172|12476498|FG000|Overall Study|Participants randomized but not treated|3
7939052|NCT02395172|12476499|FG001|Overall Study|Participants randomized but not treated|31
7939053|NCT02395302|12476513|FG000|Overall Study|Screen Failure|3
7939054|NCT02395302|12476513|FG000|Overall Study|Run In Failure|7
7939055|NCT02395302|12476513|FG000|Overall Study|Withdrawal by Subject|2
7939056|NCT02395302|12476513|FG000|Overall Study|Physician Decision|2
7939057|NCT02395471|12476519|FG000|Overall Study|Lost to Follow-up|2
7939058|NCT02395471|12476520|FG001|Overall Study|Lost to Follow-up|0
7939059|NCT02395471|12476519|FG000|Overall Study|Withdrawal by Subject|2
7939060|NCT02395471|12476520|FG001|Overall Study|Withdrawal by Subject|1
7939061|NCT02395471|12476519|FG000|Overall Study|Physician Decision|1
7939062|NCT02395471|12476520|FG001|Overall Study|Physician Decision|0
7939063|NCT02395471|12476519|FG000|Overall Study|Protocol Violation|0
7939064|NCT02395471|12476520|FG001|Overall Study|Protocol Violation|1
7939065|NCT02395471|12476519|FG000|Overall Study|Failure to swollow sponge twice|1
7939066|NCT02395471|12476520|FG001|Overall Study|Failure to swollow sponge twice|0
7939067|NCT02395471|12476519|FG000|Overall Study|Patient did not return for procedure|0
7939068|NCT02395471|12476520|FG001|Overall Study|Patient did not return for procedure|1
7939069|NCT02395471|12476519|FG000|Overall Study|Subject not eligible|1
7939070|NCT02395471|12476520|FG001|Overall Study|Subject not eligible|0
7939071|NCT02395536|12476537|FG000|Overall Study|Lost to Follow-up|4
7939072|NCT02395536|12476538|FG001|Overall Study|Lost to Follow-up|4
7939073|NCT02395536|12476537|FG000|Overall Study|Death|2
7939074|NCT02395536|12476538|FG001|Overall Study|Death|0
7939075|NCT02395536|12476537|FG000|Overall Study|Physician Decision|4
7939076|NCT02395536|12476538|FG001|Overall Study|Physician Decision|6
7939077|NCT02395536|12476537|FG000|Overall Study|Withdrawal by Subject|9
7939078|NCT02395536|12476538|FG001|Overall Study|Withdrawal by Subject|17
7939079|NCT02395536|12476537|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1
7939080|NCT02395536|12476538|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2
7939081|NCT02395536|12476537|FG000|Overall Study|Insurance issue|0
7939082|NCT02395536|12476538|FG001|Overall Study|Insurance issue|1
7939083|NCT02395627|12476547|FG000|Overall Study|Withdrawal by Subject|0
7939084|NCT02395627|12476548|FG001|Overall Study|Withdrawal by Subject|2
7939085|NCT02395627|12476549|FG002|Overall Study|Withdrawal by Subject|0
7939086|NCT02395627|12476547|FG000|Overall Study|Did not receive pembrolizumab|3
7939087|NCT02395627|12476548|FG001|Overall Study|Did not receive pembrolizumab|1
7939088|NCT02395627|12476549|FG002|Overall Study|Did not receive pembrolizumab|0
7939089|NCT02395653|12476559|FG000|Overall Study|Exclusion Criteria Met at Screening|4
7939090|NCT02395653|12476559|FG000|Overall Study|Consent Withdrawn at Screening|1
7939091|NCT02395653|12476559|FG000|Overall Study|SSEC Application But With 0 Dose|1
7939092|NCT02395653|12476559|FG000|Overall Study|Investigator Decision at Screening|1
7939093|NCT02395653|12476559|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3
7939094|NCT02395653|12476559|FG000|Overall Study|Withdrawal by Subject|1
7939095|NCT02395653|12476559|FG000|Overall Study|Lost to Follow-up|1
7939096|NCT02395822|12476571|FG000|Overall Study|Withdrawal by Subject|1
7939097|NCT02395822|12476571|FG000|Overall Study|Death|1
7939098|NCT02396212|12476628|FG000|Overall Study|Adverse Event|1
7939099|NCT02396212|12476628|FG000|Overall Study|Lack of Efficacy|2
7939100|NCT02396316|12476634|FG000|Overall Study|Physician Decision|1
7939101|NCT02396316|12476635|FG001|Overall Study|Physician Decision|0
7939102|NCT02396316|12476634|FG000|Overall Study|Progressive disease|6
7939103|NCT02396316|12476635|FG001|Overall Study|Progressive disease|3
7939104|NCT02396316|12476634|FG000|Overall Study|Protocol Violation|0
7939105|NCT02396316|12476635|FG001|Overall Study|Protocol Violation|1
7939106|NCT02396316|12476634|FG000|Overall Study|Treatment unblinded|0
7939107|NCT02396316|12476635|FG001|Overall Study|Treatment unblinded|1
7939108|NCT02396381|12476647|FG000|Overall Study|Adverse Event|3
7939109|NCT02396381|12476648|FG001|Overall Study|Adverse Event|2
7939110|NCT02396381|12476647|FG000|Overall Study|Withdrawal by Subject|33
7939111|NCT02396381|12476648|FG001|Overall Study|Withdrawal by Subject|24
7939112|NCT02396381|12476647|FG000|Overall Study|Lost to Follow-up|49
7939113|NCT02396381|12476648|FG001|Overall Study|Lost to Follow-up|31
7939114|NCT02396381|12476647|FG000|Overall Study|Protocol Violation|1
7939115|NCT02396381|12476648|FG001|Overall Study|Protocol Violation|0
7939116|NCT02396381|12476647|FG000|Overall Study|Site terminated by sponsor|7
7939117|NCT02396381|12476648|FG001|Overall Study|Site terminated by sponsor|8
7939118|NCT02396381|12476647|FG000|Overall Study|Physician Decision|5
7939119|NCT02396381|12476648|FG001|Overall Study|Physician Decision|5
7939120|NCT02396381|12476647|FG000|Overall Study|Pregnancy|2
7939121|NCT02396381|12476648|FG001|Overall Study|Pregnancy|0
7939122|NCT02396381|12476647|FG000|Overall Study|Non-compliance with study procedures|1
7939123|NCT02396381|12476648|FG001|Overall Study|Non-compliance with study procedures|0
7939124|NCT02396381|12476647|FG000|Overall Study|Moved out of town/state|1
7939125|NCT02396381|12476648|FG001|Overall Study|Moved out of town/state|3
7939126|NCT02396381|12476647|FG000|Overall Study|Could not complete visit|1
7939127|NCT02396381|12476648|FG001|Overall Study|Could not complete visit|0
7939128|NCT02396381|12476647|FG000|Overall Study|Possible conflict of interest|1
7939129|NCT02396381|12476648|FG001|Overall Study|Possible conflict of interest|0
7939130|NCT02396381|12476647|FG000|Overall Study|Randomization/Screening Error|3
7939131|NCT02396381|12476648|FG001|Overall Study|Randomization/Screening Error|1
7939132|NCT02396420|12476657|FG000|Overall Study|Death|1
7939133|NCT02396537|12476668|FG000|Overall Study|Protocol Violation|0
7939134|NCT02396537|12476669|FG001|Overall Study|Protocol Violation|1
7939135|NCT02396758|12476692|FG000|Overall Study|Withdrawal by Subject|2
7939136|NCT02396758|12476693|FG001|Overall Study|Withdrawal by Subject|0
7939137|NCT02396758|12476694|FG002|Overall Study|Withdrawal by Subject|0
7939138|NCT02396758|12476695|FG003|Overall Study|Withdrawal by Subject|1
7939139|NCT02396758|12476692|FG000|Overall Study|Lost to Follow-up|8
7939140|NCT02396758|12476693|FG001|Overall Study|Lost to Follow-up|5
7939141|NCT02396758|12476694|FG002|Overall Study|Lost to Follow-up|3
7939142|NCT02396758|12476695|FG003|Overall Study|Lost to Follow-up|3
7939143|NCT02396758|12476692|FG000|Overall Study|Death|1
7939144|NCT02396758|12476693|FG001|Overall Study|Death|1
7939145|NCT02396758|12476694|FG002|Overall Study|Death|0
7939146|NCT02396758|12476695|FG003|Overall Study|Death|1
7939147|NCT02396758|12476692|FG000|Overall Study|Randomized but not treated|1
7939148|NCT02396758|12476693|FG001|Overall Study|Randomized but not treated|0
7939149|NCT02396758|12476694|FG002|Overall Study|Randomized but not treated|1
7939150|NCT02396758|12476695|FG003|Overall Study|Randomized but not treated|0
7939151|NCT02396849|12476707|FG000|Overall Study|Lost to Follow-up|1
7939152|NCT02396849|12476708|FG001|Overall Study|Lost to Follow-up|1
7939153|NCT02396849|12476707|FG000|Overall Study|Did not tolerate intervention|1
7939154|NCT02396849|12476708|FG001|Overall Study|Did not tolerate intervention|1
7939155|NCT02396953|12476719|FG000|Overall Study|Withdrawal by Subject|0
7939156|NCT02396953|12476720|FG001|Overall Study|Withdrawal by Subject|0
7939157|NCT02396953|12476721|FG002|Overall Study|Withdrawal by Subject|1
7939158|NCT02396953|12476719|FG000|Overall Study|Insulin like Growth Factor-1 increased|3
7939159|NCT02396953|12476720|FG001|Overall Study|Insulin like Growth Factor-1 increased|2
7939160|NCT02396953|12476721|FG002|Overall Study|Insulin like Growth Factor-1 increased|2
7939161|NCT02396953|12476719|FG000|Overall Study|Personal Reasons|1
7939162|NCT02396953|12476720|FG001|Overall Study|Personal Reasons|1
7939163|NCT02396953|12476721|FG002|Overall Study|Personal Reasons|0
7939164|NCT02397057|12476738|FG000|Overall Study|Withdrawal by Subject|6
7939165|NCT02397057|12476739|FG001|Overall Study|Withdrawal by Subject|7
7939166|NCT02397057|12476738|FG000|Overall Study|Lost to Follow-up|4
7939167|NCT02397057|12476739|FG001|Overall Study|Lost to Follow-up|3
7939168|NCT02397057|12476738|FG000|Overall Study|Death|1
7939169|NCT02397057|12476739|FG001|Overall Study|Death|0
7939170|NCT02397057|12476738|FG000|Overall Study|Adverse Event|0
7939171|NCT02397057|12476739|FG001|Overall Study|Adverse Event|1
7939172|NCT02397057|12476738|FG000|Overall Study|Physician Decision|0
7939173|NCT02397057|12476739|FG001|Overall Study|Physician Decision|1
7939174|NCT02397057|12476738|FG000|Overall Study|Subject did not receive study drug|0
7939175|NCT02397057|12476739|FG001|Overall Study|Subject did not receive study drug|1
7939176|NCT02397278|12476770|FG000|Overall Study|Withdrawal by Subject|0
7939177|NCT02397278|12476771|FG001|Overall Study|Withdrawal by Subject|2
7939178|NCT02397278|12476770|FG000|Overall Study|Deemed ineligible following surgery|1
7939179|NCT02397278|12476771|FG001|Overall Study|Deemed ineligible following surgery|1
7939180|NCT02397408|12476786|FG000|Overall Study|Physician Decision|4
7939181|NCT02397408|12476786|FG000|Overall Study|Surgery not completed within protocol timeframe|2
7939182|NCT02397447|12476792|FG000|Overall Study|Lost to Follow-up|2
7939183|NCT02397447|12476793|FG001|Overall Study|Lost to Follow-up|2
7939184|NCT02397460|12476807|FG000|Treatment Period 2|Adverse Event|0
7939185|NCT02397460|12476808|FG001|Treatment Period 2|Adverse Event|0
7939186|NCT02397460|12476809|FG002|Treatment Period 2|Adverse Event|0
7939187|NCT02397460|12476810|FG003|Treatment Period 2|Adverse Event|0
7939188|NCT02397460|12476811|FG004|Treatment Period 2|Adverse Event|0
7939189|NCT02397460|12476812|FG005|Treatment Period 2|Adverse Event|0
7939190|NCT02397460|12476813|FG006|Treatment Period 2|Adverse Event|0
7939191|NCT02397460|12476814|FG007|Treatment Period 2|Adverse Event|1
7939192|NCT02397460|12476807|FG000|Treatment Period 4|Adverse Event|0
7939193|NCT02397460|12476808|FG001|Treatment Period 4|Adverse Event|1
7939194|NCT02397460|12476809|FG002|Treatment Period 4|Adverse Event|0
7939195|NCT02397460|12476810|FG003|Treatment Period 4|Adverse Event|0
7939196|NCT02397460|12476811|FG004|Treatment Period 4|Adverse Event|0
7939197|NCT02397460|12476812|FG005|Treatment Period 4|Adverse Event|0
7939198|NCT02397460|12476813|FG006|Treatment Period 4|Adverse Event|0
7822183|NCT01260350|12291176|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0
7822184|NCT01260350|12291177|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0
7939199|NCT02397460|12476814|FG007|Treatment Period 4|Adverse Event|0
7939200|NCT02397460|12476807|FG000|Treatment Period 4|Physician Decision|0
7939201|NCT02397460|12476808|FG001|Treatment Period 4|Physician Decision|0
7939202|NCT02397460|12476809|FG002|Treatment Period 4|Physician Decision|0
7939203|NCT02397460|12476810|FG003|Treatment Period 4|Physician Decision|0
7939204|NCT02397460|12476811|FG004|Treatment Period 4|Physician Decision|1
7939205|NCT02397460|12476812|FG005|Treatment Period 4|Physician Decision|0
7939206|NCT02397460|12476813|FG006|Treatment Period 4|Physician Decision|0
7939207|NCT02397460|12476814|FG007|Treatment Period 4|Physician Decision|0
7939208|NCT02397473|12476890|FG000|Treatment Phase|Adverse Event|1
7939209|NCT02397473|12476891|FG001|Treatment Phase|Adverse Event|2
7939210|NCT02397473|12476890|FG000|Treatment Phase|Lack of Efficacy|8
7939211|NCT02397473|12476891|FG001|Treatment Phase|Lack of Efficacy|1
7939212|NCT02397473|12476890|FG000|Treatment Phase|Lost to Follow-up|1
7939213|NCT02397473|12476891|FG001|Treatment Phase|Lost to Follow-up|0
7939214|NCT02397473|12476890|FG000|Treatment Phase|Withdrawal by Subject|2
7939215|NCT02397473|12476891|FG001|Treatment Phase|Withdrawal by Subject|1
7939216|NCT02397473|12476890|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0
7939217|NCT02397473|12476891|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3
7939218|NCT02397473|12476890|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1
7939219|NCT02397473|12476891|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1
7939220|NCT02397473|12476890|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1
7939221|NCT02397473|12476891|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0
7939222|NCT02397473|12476890|FG000|Post Treatment Follow-up Phase|Protocol Violation|1
7939223|NCT02397473|12476891|FG001|Post Treatment Follow-up Phase|Protocol Violation|0
7939224|NCT02397473|12476890|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0
7939225|NCT02397473|12476891|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1
7939226|NCT02397655|12476905|FG000|Overall Study|data not completed|1301
7939227|NCT02397694|12476911|FG000|Double-Blinded Phase|Adverse Event|1
7939228|NCT02397694|12476912|FG001|Double-Blinded Phase|Adverse Event|0
7939229|NCT02397694|12476911|FG000|Double-Blinded Phase|Non-compliance with study drug|0
7939230|NCT02397694|12476912|FG001|Double-Blinded Phase|Non-compliance with study drug|2
7939231|NCT02397694|12476911|FG000|Double-Blinded Phase|Withdrawal by Subject|1
7939232|NCT02397694|12476912|FG001|Double-Blinded Phase|Withdrawal by Subject|0
7939233|NCT02397694|12476911|FG000|Double-Blinded Phase|Lost to Follow-up|1
7939234|NCT02397694|12476912|FG001|Double-Blinded Phase|Lost to Follow-up|1
7939235|NCT02397694|12476911|FG000|Open Label Extension Phase|Protocol Violation|1
7939236|NCT02397694|12476912|FG001|Open Label Extension Phase|Protocol Violation|0
7939237|NCT02397694|12476911|FG000|Open Label Extension Phase|Withdrew Consent|3
7939238|NCT02397694|12476912|FG001|Open Label Extension Phase|Withdrew Consent|1
7939239|NCT02397694|12476911|FG000|Open Label Extension Phase|Lost to Follow-up|4
7939240|NCT02397694|12476912|FG001|Open Label Extension Phase|Lost to Follow-up|0
7939241|NCT02397837|12476947|FG000|Overall Study|Withdrawal by Subject|6
7939242|NCT02397837|12476948|FG001|Overall Study|Withdrawal by Subject|5
7939243|NCT02397837|12476947|FG000|Overall Study|Physician Decision|1
7939244|NCT02397837|12476948|FG001|Overall Study|Physician Decision|1
7939245|NCT02397889|12476956|FG000|Overall Study|Physician Decision|1
7939246|NCT02397889|12476957|FG001|Overall Study|Physician Decision|0
7939247|NCT02397915|12476963|FG000|Period 1|Protocol Violation|0
7939248|NCT02397915|12476964|FG001|Period 1|Protocol Violation|1
7939249|NCT02397915|12476965|FG002|Period 1|Protocol Violation|0
7939250|NCT02397915|12476966|FG003|Period 1|Protocol Violation|0
7939251|NCT02397915|12476963|FG000|Period 1|Physician Decision|1
7939252|NCT02397915|12476964|FG001|Period 1|Physician Decision|0
7939253|NCT02397915|12476965|FG002|Period 1|Physician Decision|0
7939254|NCT02397915|12476966|FG003|Period 1|Physician Decision|0
7939255|NCT02398188|12476980|FG000|Overall Study|Adverse Event|2
7939256|NCT02398188|12476981|FG001|Overall Study|Adverse Event|3
7939257|NCT02398188|12476980|FG000|Overall Study|Lost to Follow-up|5
7939258|NCT02398188|12476981|FG001|Overall Study|Lost to Follow-up|0
7939259|NCT02398188|12476980|FG000|Overall Study|Non-compliance|4
7939260|NCT02398188|12476981|FG001|Overall Study|Non-compliance|4
7939261|NCT02398188|12476980|FG000|Overall Study|Protocol Violation|6
7939262|NCT02398188|12476981|FG001|Overall Study|Protocol Violation|10
7939263|NCT02398188|12476980|FG000|Overall Study|Sponsor Decision|2
7939264|NCT02398188|12476981|FG001|Overall Study|Sponsor Decision|1
7939265|NCT02398188|12476980|FG000|Overall Study|Pregnancy|1
7939266|NCT02398188|12476981|FG001|Overall Study|Pregnancy|0
7939267|NCT02398188|12476980|FG000|Overall Study|Withdrawal by Subject|7
7939268|NCT02398188|12476981|FG001|Overall Study|Withdrawal by Subject|16
7939269|NCT02398227|12476989|FG000|Overall Study|Lost to Follow-up|21
7939270|NCT02398227|12476990|FG001|Overall Study|Lost to Follow-up|12
7939271|NCT02398227|12476989|FG000|Overall Study|Withdrawal by Subject|5
7939272|NCT02398227|12476990|FG001|Overall Study|Withdrawal by Subject|6
7939273|NCT02398227|12476989|FG000|Overall Study|Removed from treatment and dropped out|1
7939274|NCT02398227|12476990|FG001|Overall Study|Removed from treatment and dropped out|0
7939275|NCT02399163|12477009|FG000|Overall Study|Adverse Event|2
7939276|NCT02399163|12477009|FG000|Overall Study|Protocol Deviation|2
7939277|NCT02399163|12477009|FG000|Overall Study|Withdrawal by Participant|5
7939278|NCT02399254|12477025|FG000|Overall Study|Physician Decision|2
7939279|NCT02399475|12477036|FG000|Overall Study|Physician Decision|1
7939280|NCT02399475|12477037|FG001|Overall Study|Physician Decision|0
7939281|NCT02400307|12477063|FG000|Overall Study|Enrolled and Never Dosed|1
7939282|NCT02400307|12477064|FG001|Overall Study|Enrolled and Never Dosed|0
7939283|NCT02400333|12477074|FG000|Overall Study|Withdrawal by Subject|0
7939284|NCT02400333|12477075|FG001|Overall Study|Withdrawal by Subject|1
7939285|NCT02400333|12477076|FG002|Overall Study|Withdrawal by Subject|0
7939286|NCT02400333|12477077|FG003|Overall Study|Withdrawal by Subject|1
7939287|NCT02400333|12477074|FG000|Overall Study|Protocol Violation|1
7939288|NCT02400333|12477075|FG001|Overall Study|Protocol Violation|0
7939289|NCT02400333|12477076|FG002|Overall Study|Protocol Violation|2
7939290|NCT02400333|12477077|FG003|Overall Study|Protocol Violation|1
7965114|NCT02340221|12520813|FG001|Overall Study|Lost to Follow-up|15
7965115|NCT02340221|12520812|FG000|Overall Study|Reason Not Specified|85
7965116|NCT02340221|12520813|FG001|Overall Study|Reason Not Specified|165
7965117|NCT02340221|12520812|FG000|Overall Study|Study Terminated by Sponsor|1
7965118|NCT02340221|12520813|FG001|Overall Study|Study Terminated by Sponsor|3
7965119|NCT02332915|12520822|FG000|Overall Study|Moved out of region|3
7965120|NCT02332915|12520823|FG001|Overall Study|Moved out of region|0
7965121|NCT02332915|12520822|FG000|Overall Study|Unrelated illness|1
7965122|NCT02332915|12520823|FG001|Overall Study|Unrelated illness|1
7965123|NCT02332915|12520822|FG000|Overall Study|Travel distance prohibitive|0
7965124|NCT02332915|12520823|FG001|Overall Study|Travel distance prohibitive|1
7965125|NCT02332915|12520822|FG000|Overall Study|did not meet inclusion criteria|2
7965126|NCT02332915|12520823|FG001|Overall Study|did not meet inclusion criteria|4
7965127|NCT02288247|12520843|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52
7965128|NCT02288247|12520844|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0
7965129|NCT02288247|12520843|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35
7965130|NCT02288247|12520844|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0
7965131|NCT02288247|12520843|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1
7965132|NCT02288247|12520844|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0
7965133|NCT02288247|12520843|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392
7965134|NCT02288247|12520844|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0
7965135|NCT02288247|12520843|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9
7965136|NCT02288247|12520844|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0
7965137|NCT02288247|12520843|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52
7965138|NCT02288247|12520844|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0
7965139|NCT02288247|12520843|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106
7965140|NCT02288247|12520844|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0
7965141|NCT02288247|12520843|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10
7965142|NCT02288247|12520844|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8
7965143|NCT02288247|12520843|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8
7965144|NCT02288247|12520844|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4
7965145|NCT02288247|12520843|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1
7965146|NCT02288247|12520844|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0
7965147|NCT02288247|12520843|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87
7965148|NCT02288247|12520844|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94
7965149|NCT02288247|12520843|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2
7965150|NCT02288247|12520844|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1
7965151|NCT02288247|12520843|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7
7965152|NCT02288247|12520844|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7
7965153|NCT02288247|12520843|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20
7965154|NCT02288247|12520844|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21
7965155|NCT02288247|12520843|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1
7965156|NCT02288247|12520844|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0
7965157|NCT02177175|12520854|FG000|Overall Study|stopped trastuzumab so was taken off study|1
7965158|NCT02177175|12520855|FG001|Overall Study|stopped trastuzumab so was taken off study|0
7965159|NCT02049138|12520864|FG000|Overall Study|Adverse Event|46
7965160|NCT02049138|12520865|FG001|Overall Study|Adverse Event|25
7965161|NCT02049138|12520866|FG002|Overall Study|Adverse Event|1
7965162|NCT02049138|12520864|FG000|Overall Study|Withdrawal by Subject|57
7965163|NCT02049138|12520865|FG001|Overall Study|Withdrawal by Subject|21
7965164|NCT02049138|12520866|FG002|Overall Study|Withdrawal by Subject|5
7822185|NCT01260350|12291178|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0
7822186|NCT01260350|12291179|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0
7939291|NCT02400346|12477088|FG000|Overall Study|Adverse Event|24
7939292|NCT02400346|12477088|FG000|Overall Study|Lack of Efficacy|9
7939293|NCT02400346|12477088|FG000|Overall Study|Non-compliance with IMP|1
7939294|NCT02400346|12477088|FG000|Overall Study|Withdrawal by Subject|7
7939295|NCT02400346|12477088|FG000|Overall Study|Administrative or other reason(s)|2
7939296|NCT02400346|12477088|FG000|Overall Study|Lost to Follow-up|1
7939297|NCT02400580|12477104|FG000|Overall Study|Withdrawal by Subject|1
7939298|NCT02400580|12477105|FG001|Overall Study|Withdrawal by Subject|1
7939299|NCT02400580|12477104|FG000|Overall Study|Adverse Event|1
7939300|NCT02400580|12477105|FG001|Overall Study|Adverse Event|0
7939301|NCT02400749|12477122|FG000|Week 0 -16|Withdrawal by Subject|5
7939302|NCT02400749|12477123|FG001|Week 0 -16|Withdrawal by Subject|5
7939303|NCT02400749|12477122|FG000|Week 0 -16|Adverse Event|3
7939304|NCT02400749|12477123|FG001|Week 0 -16|Adverse Event|1
7939305|NCT02400749|12477122|FG000|Week 0 -16|Lost to Follow-up|2
7939306|NCT02400749|12477123|FG001|Week 0 -16|Lost to Follow-up|0
7939307|NCT02400749|12477122|FG000|Week 0 -16|Protocol Violation|1
7939308|NCT02400749|12477123|FG001|Week 0 -16|Protocol Violation|0
7939309|NCT02400749|12477122|FG000|Week 17 - 32|Withdrawal by Subject|3
7939310|NCT02400749|12477123|FG001|Week 17 - 32|Withdrawal by Subject|2
7939311|NCT02400749|12477122|FG000|Week 17 - 32|Adverse Event|2
7939312|NCT02400749|12477123|FG001|Week 17 - 32|Adverse Event|1
7939313|NCT02400905|12477129|FG000|Overall Study|Death|24
7939314|NCT02400905|12477129|FG000|Overall Study|Lost to Follow-up|18
7939315|NCT02400905|12477129|FG000|Overall Study|Withdrawal by Subject|16
7939316|NCT02400905|12477129|FG000|Overall Study|Physician Decision|4
7939317|NCT02400905|12477129|FG000|Overall Study|Other|1
7939318|NCT02401230|12477164|FG000|Overall Study|Adverse Event|3
7939319|NCT02401230|12477165|FG001|Overall Study|Adverse Event|2
7939320|NCT02401230|12477166|FG002|Overall Study|Adverse Event|0
7939321|NCT02401230|12477164|FG000|Overall Study|Withdrawal by Subject|2
7939322|NCT02401230|12477165|FG001|Overall Study|Withdrawal by Subject|1
7939323|NCT02401230|12477166|FG002|Overall Study|Withdrawal by Subject|1
7939324|NCT02401230|12477164|FG000|Overall Study|Lost to Follow-up|1
7939325|NCT02401230|12477165|FG001|Overall Study|Lost to Follow-up|3
7939326|NCT02401230|12477166|FG002|Overall Study|Lost to Follow-up|3
7939327|NCT02401256|12477178|FG000|Overall Study|Adverse Event|5
7939328|NCT02401256|12477178|FG000|Overall Study|Withdrawal by Subject|12
7939329|NCT02401412|12477186|FG000|Overall Study|Lost to Follow-up|1
7939330|NCT02401412|12477187|FG001|Overall Study|Lost to Follow-up|0
7939331|NCT02401412|12477186|FG000|Overall Study|Discontinued Intervention|15
7939332|NCT02401412|12477187|FG001|Overall Study|Discontinued Intervention|21
7939333|NCT02401412|12477186|FG000|Overall Study|Withdrawal by Subject|4
7939334|NCT02401412|12477187|FG001|Overall Study|Withdrawal by Subject|4
7939335|NCT02401412|12477186|FG000|Overall Study|Subject withdrawal prior to intervention|0
7939336|NCT02401412|12477187|FG001|Overall Study|Subject withdrawal prior to intervention|1
7939337|NCT02401412|12477186|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10
7939338|NCT02401412|12477187|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6
7939339|NCT02401529|12477214|FG000|Overall Study|Lost to Follow-up|2
7939340|NCT02401529|12477215|FG001|Overall Study|Lost to Follow-up|1
7939341|NCT02401529|12477214|FG000|Overall Study|Physician Decision|2
7939342|NCT02401529|12477215|FG001|Overall Study|Physician Decision|6
7939343|NCT02401529|12477214|FG000|Overall Study|Protocol Violation|5
7939344|NCT02401529|12477215|FG001|Overall Study|Protocol Violation|0
7939345|NCT02401672|12477252|FG000|Overall Study|Withdrawal by Subject|1
7939346|NCT02401672|12477253|FG001|Overall Study|Withdrawal by Subject|3
7939347|NCT02401867|12477259|FG000|Specimen Collection|Didn't receive 1 or more tests|10
7939348|NCT02401867|12477259|FG000|Analysis|Cervical assay could not be conducted|9
7939349|NCT02402166|12477294|FG000|Overall Study|Adverse Event|2
7939350|NCT02402166|12477294|FG000|Overall Study|Withdrawal by Subject|2
7939351|NCT02402166|12477294|FG000|Overall Study|Lost to Follow-up|1
7939352|NCT02402218|12477315|FG000|Overall Study|Did not pickup study medication|12
7939353|NCT02402218|12477316|FG001|Overall Study|Did not pickup study medication|9
7939354|NCT02402218|12477317|FG002|Overall Study|Did not pickup study medication|13
7939355|NCT02402218|12477315|FG000|Overall Study|Lack of Efficacy|0
7939356|NCT02402218|12477316|FG001|Overall Study|Lack of Efficacy|1
7939357|NCT02402218|12477317|FG002|Overall Study|Lack of Efficacy|1
7939358|NCT02402218|12477315|FG000|Overall Study|Death|1
7939359|NCT02402218|12477316|FG001|Overall Study|Death|0
7939360|NCT02402218|12477317|FG002|Overall Study|Death|0
7939361|NCT02402218|12477315|FG000|Overall Study|Reinfection|0
7939362|NCT02402218|12477316|FG001|Overall Study|Reinfection|0
7939363|NCT02402218|12477317|FG002|Overall Study|Reinfection|1
7939364|NCT02402218|12477315|FG000|Overall Study|Adverse Event|0
7939365|NCT02402218|12477316|FG001|Overall Study|Adverse Event|2
7939366|NCT02402218|12477317|FG002|Overall Study|Adverse Event|1
7939367|NCT02402218|12477315|FG000|Overall Study|Withdrawal by Subject|1
7939368|NCT02402218|12477316|FG001|Overall Study|Withdrawal by Subject|1
7939369|NCT02402218|12477317|FG002|Overall Study|Withdrawal by Subject|1
7939370|NCT02402322|12477337|FG000|Pretreatment|Withdrawal by Subject|3
7939371|NCT02402322|12477338|FG001|Pretreatment|Withdrawal by Subject|1
7939372|NCT02402322|12477339|FG002|Pretreatment|Withdrawal by Subject|1
7939373|NCT02402322|12477337|FG000|Follow-up|Withdrawal by Subject|6
7939374|NCT02402322|12477338|FG001|Follow-up|Withdrawal by Subject|3
7939375|NCT02402322|12477339|FG002|Follow-up|Withdrawal by Subject|24
7939376|NCT02402907|12477371|FG000|Overall Study|Delivered vaginally|9
7939377|NCT02402907|12477372|FG001|Overall Study|Delivered vaginally|3
7939378|NCT02402907|12477371|FG000|Overall Study|Delivered outside of Sinai|1
7939379|NCT02402907|12477372|FG001|Overall Study|Delivered outside of Sinai|1
7939380|NCT02402907|12477371|FG000|Overall Study|Lost to follow up after C-Section|10
7939381|NCT02402907|12477372|FG001|Overall Study|Lost to follow up after C-Section|23
7939382|NCT02402933|12477378|FG000|Overall Study|Withdrawal by Subject|4
7939383|NCT02402933|12477378|FG000|Overall Study|Discontinued; Site Termination|10
7939384|NCT02403180|12477384|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
7939385|NCT02403180|12477385|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
7939386|NCT02403180|12477384|FG000|Period 2 (5 Days)|Withdrawal by Subject|0
7939387|NCT02403180|12477385|FG001|Period 2 (5 Days)|Withdrawal by Subject|1
7939388|NCT02403206|12477393|FG000|Overall Study|Lost to Follow-up|4
7939389|NCT02403206|12477394|FG001|Overall Study|Lost to Follow-up|3
7939390|NCT02403206|12477393|FG000|Overall Study|Physician Decision|2
7939391|NCT02403206|12477394|FG001|Overall Study|Physician Decision|0
7939392|NCT02403206|12477393|FG000|Overall Study|Withdrawal by Subject|3
7939393|NCT02403206|12477394|FG001|Overall Study|Withdrawal by Subject|3
7939394|NCT02403206|12477393|FG000|Overall Study|Reason not given|2
7939395|NCT02403206|12477394|FG001|Overall Study|Reason not given|4
7939396|NCT02403271|12477401|FG000|Period 1|Other varied reasons|1
7939397|NCT02403271|12477402|FG001|Period 1|Other varied reasons|0
7939398|NCT02403271|12477401|FG000|Period 2|Withdrawal by Subject|0
7939399|NCT02403271|12477402|FG001|Period 2|Withdrawal by Subject|14
7939400|NCT02403271|12477401|FG000|Period 2|Death|0
7939401|NCT02403271|12477402|FG001|Period 2|Death|84
7939402|NCT02403271|12477401|FG000|Period 2|Lost to Follow-up|0
7939403|NCT02403271|12477402|FG001|Period 2|Lost to Follow-up|2
7939404|NCT02403271|12477401|FG000|Period 2|Study Terminated by Sponsor|0
7939405|NCT02403271|12477402|FG001|Period 2|Study Terminated by Sponsor|14
7939406|NCT02403271|12477401|FG000|Period 2|Other varied reasons|0
7939407|NCT02403271|12477402|FG001|Period 2|Other varied reasons|10
7939408|NCT02403635|12477423|FG000|Overall Study|Not eligible|9
7939409|NCT02403817|12477445|FG000|Overall Study|Withdrawal by Subject|5
7939410|NCT02403817|12477446|FG001|Overall Study|Withdrawal by Subject|0
7939411|NCT02404025|12477476|FG000|Overall Study|Adverse Event|1
7939412|NCT02404025|12477476|FG000|Overall Study|Lack of Efficacy|3
7939413|NCT02404103|12477482|FG000|Overall Study|Adverse Event|1
7939414|NCT02404103|12477483|FG001|Overall Study|Adverse Event|0
7939415|NCT02404103|12477482|FG000|Overall Study|Lost to Follow-up|3
7939416|NCT02404103|12477483|FG001|Overall Study|Lost to Follow-up|3
7939417|NCT02404220|12477509|FG000|Overall Study|Adverse Event|0
7939418|NCT02404220|12477510|FG001|Overall Study|Adverse Event|0
7939419|NCT02404220|12477511|FG002|Overall Study|Adverse Event|1
7939420|NCT02404220|12477512|FG003|Overall Study|Adverse Event|0
7939421|NCT02404220|12477509|FG000|Overall Study|Death|5
7939422|NCT02404220|12477510|FG001|Overall Study|Death|5
7939423|NCT02404220|12477511|FG002|Overall Study|Death|3
7939424|NCT02404220|12477512|FG003|Overall Study|Death|8
7939425|NCT02404220|12477509|FG000|Overall Study|Progressive Disease|0
7939426|NCT02404220|12477510|FG001|Overall Study|Progressive Disease|0
7939427|NCT02404220|12477511|FG002|Overall Study|Progressive Disease|1
7939428|NCT02404220|12477512|FG003|Overall Study|Progressive Disease|1
7939429|NCT02404220|12477509|FG000|Overall Study|Study Terminated by Sponsor|0
7939430|NCT02404220|12477510|FG001|Overall Study|Study Terminated by Sponsor|0
7939431|NCT02404220|12477511|FG002|Overall Study|Study Terminated by Sponsor|2
7939432|NCT02404220|12477512|FG003|Overall Study|Study Terminated by Sponsor|1
7939433|NCT02404220|12477509|FG000|Overall Study|Withdrawal by Subject|0
7939434|NCT02404220|12477510|FG001|Overall Study|Withdrawal by Subject|1
7939435|NCT02404220|12477511|FG002|Overall Study|Withdrawal by Subject|0
7939436|NCT02404220|12477512|FG003|Overall Study|Withdrawal by Subject|0
7939437|NCT02404220|12477509|FG000|Overall Study|Enrolled but Never Treated|0
7939438|NCT02404220|12477510|FG001|Overall Study|Enrolled but Never Treated|2
7939439|NCT02404220|12477511|FG002|Overall Study|Enrolled but Never Treated|0
7939440|NCT02404220|12477512|FG003|Overall Study|Enrolled but Never Treated|0
7939441|NCT02404311|12477542|FG000|Part A: Month 0-18|Death|2
7939442|NCT02404311|12477543|FG001|Part A: Month 0-18|Death|0
7939443|NCT02404311|12477544|FG002|Part A: Month 0-18|Death|0
7939444|NCT02404311|12477545|FG003|Part A: Month 0-18|Death|0
7939445|NCT02404311|12477546|FG004|Part A: Month 0-18|Death|0
7939446|NCT02404311|12477542|FG000|Part A: Month 0-18|Physician Decision|1
7939447|NCT02404311|12477543|FG001|Part A: Month 0-18|Physician Decision|0
7939448|NCT02404311|12477544|FG002|Part A: Month 0-18|Physician Decision|0
7939449|NCT02404311|12477545|FG003|Part A: Month 0-18|Physician Decision|0
7939450|NCT02404311|12477546|FG004|Part A: Month 0-18|Physician Decision|0
7939451|NCT02404311|12477542|FG000|Part A: Month 0-18|Lost to Follow-up|4
7939452|NCT02404311|12477543|FG001|Part A: Month 0-18|Lost to Follow-up|2
7939453|NCT02404311|12477544|FG002|Part A: Month 0-18|Lost to Follow-up|0
7939454|NCT02404311|12477545|FG003|Part A: Month 0-18|Lost to Follow-up|0
7939455|NCT02404311|12477546|FG004|Part A: Month 0-18|Lost to Follow-up|0
7939456|NCT02404311|12477542|FG000|Part A: Month 0-18|Withdrawal by Subject|6
7939457|NCT02404311|12477543|FG001|Part A: Month 0-18|Withdrawal by Subject|2
7939458|NCT02404311|12477544|FG002|Part A: Month 0-18|Withdrawal by Subject|0
7939459|NCT02404311|12477545|FG003|Part A: Month 0-18|Withdrawal by Subject|0
7939460|NCT02404311|12477546|FG004|Part A: Month 0-18|Withdrawal by Subject|0
7939461|NCT02404311|12477542|FG000|Part A: Month 0-18|HIV Infection|6
7939462|NCT02404311|12477543|FG001|Part A: Month 0-18|HIV Infection|2
7939463|NCT02404311|12477544|FG002|Part A: Month 0-18|HIV Infection|0
7939464|NCT02404311|12477545|FG003|Part A: Month 0-18|HIV Infection|0
7939465|NCT02404311|12477546|FG004|Part A: Month 0-18|HIV Infection|0
7939466|NCT02404311|12477542|FG000|Part A: Month 0-18|Participant unable to adhere|7
7939467|NCT02404311|12477543|FG001|Part A: Month 0-18|Participant unable to adhere|0
7939468|NCT02404311|12477544|FG002|Part A: Month 0-18|Participant unable to adhere|0
7939469|NCT02404311|12477545|FG003|Part A: Month 0-18|Participant unable to adhere|0
7939470|NCT02404311|12477546|FG004|Part A: Month 0-18|Participant unable to adhere|0
7939471|NCT02404350|12477562|FG000|Overall Study|Adverse Event|2
7939472|NCT02404350|12477563|FG001|Overall Study|Adverse Event|2
7939473|NCT02404350|12477564|FG002|Overall Study|Adverse Event|3
7939474|NCT02404350|12477565|FG003|Overall Study|Adverse Event|9
7939475|NCT02404350|12477562|FG000|Overall Study|Lack of Efficacy|3
7939476|NCT02404350|12477563|FG001|Overall Study|Lack of Efficacy|1
7939477|NCT02404350|12477564|FG002|Overall Study|Lack of Efficacy|0
7939478|NCT02404350|12477565|FG003|Overall Study|Lack of Efficacy|3
7939479|NCT02404350|12477562|FG000|Overall Study|Lost to Follow-up|2
7939480|NCT02404350|12477563|FG001|Overall Study|Lost to Follow-up|0
7939481|NCT02404350|12477564|FG002|Overall Study|Lost to Follow-up|0
7939482|NCT02404350|12477565|FG003|Overall Study|Lost to Follow-up|1
7939483|NCT02404350|12477562|FG000|Overall Study|Physician Decision|1
7939484|NCT02404350|12477563|FG001|Overall Study|Physician Decision|0
7939485|NCT02404350|12477564|FG002|Overall Study|Physician Decision|0
7939486|NCT02404350|12477565|FG003|Overall Study|Physician Decision|2
7939487|NCT02404350|12477562|FG000|Overall Study|Pregnancy|0
7939488|NCT02404350|12477563|FG001|Overall Study|Pregnancy|0
7939489|NCT02404350|12477564|FG002|Overall Study|Pregnancy|0
7939490|NCT02404350|12477565|FG003|Overall Study|Pregnancy|1
7939491|NCT02404350|12477562|FG000|Overall Study|Withdrawal by Subject|7
7939492|NCT02404350|12477563|FG001|Overall Study|Withdrawal by Subject|3
7939493|NCT02404350|12477564|FG002|Overall Study|Withdrawal by Subject|3
7939494|NCT02404350|12477565|FG003|Overall Study|Withdrawal by Subject|19
7939495|NCT02404350|12477562|FG000|Overall Study|Due to Non-compliance with treatment|0
7939496|NCT02404350|12477563|FG001|Overall Study|Due to Non-compliance with treatment|0
7939497|NCT02404350|12477564|FG002|Overall Study|Due to Non-compliance with treatment|0
7939498|NCT02404350|12477565|FG003|Overall Study|Due to Non-compliance with treatment|1
7939499|NCT02404350|12477562|FG000|Overall Study|Due to Technical problems|0
7939500|NCT02404350|12477563|FG001|Overall Study|Due to Technical problems|0
7939501|NCT02404350|12477564|FG002|Overall Study|Due to Technical problems|0
7939502|NCT02404350|12477565|FG003|Overall Study|Due to Technical problems|1
7939503|NCT02404389|12477581|FG000|Overall Study|Adverse Event|1
7939504|NCT02404389|12477582|FG001|Overall Study|Adverse Event|0
7939505|NCT02404389|12477583|FG002|Overall Study|Adverse Event|1
7939506|NCT02404389|12477584|FG003|Overall Study|Adverse Event|0
7939507|NCT02404389|12477585|FG004|Overall Study|Adverse Event|2
7939508|NCT02404389|12477581|FG000|Overall Study|Subject/guardian decision|1
7939509|NCT02404389|12477582|FG001|Overall Study|Subject/guardian decision|0
7939510|NCT02404389|12477583|FG002|Overall Study|Subject/guardian decision|0
7939511|NCT02404389|12477584|FG003|Overall Study|Subject/guardian decision|1
7939512|NCT02404389|12477585|FG004|Overall Study|Subject/guardian decision|1
7939513|NCT02404493|12477601|FG000|Overall Study|Adverse Event|1
7939514|NCT02404493|12477602|FG001|Overall Study|Adverse Event|1
7939515|NCT02404649|12477628|FG000|Overall Study|Adverse Event|1
7939516|NCT02404649|12477629|FG001|Overall Study|Adverse Event|2
7939517|NCT02404805|12477652|FG000|Overall Study|Withdrawal by Subject|1
7939518|NCT02404805|12477653|FG001|Overall Study|Withdrawal by Subject|0
7939519|NCT02404805|12477654|FG002|Overall Study|Withdrawal by Subject|0
7939520|NCT02404805|12477655|FG003|Overall Study|Withdrawal by Subject|0
7939521|NCT02404805|12477656|FG004|Overall Study|Withdrawal by Subject|0
7939522|NCT02404805|12477657|FG005|Overall Study|Withdrawal by Subject|0
7939523|NCT02405091|12477669|FG000|Overall Study|Adverse Event|16
7939524|NCT02405091|12477670|FG001|Overall Study|Adverse Event|10
7939525|NCT02405091|12477671|FG002|Overall Study|Adverse Event|0
7939526|NCT02405091|12477669|FG000|Overall Study|Protocol Violation|1
7939527|NCT02405091|12477670|FG001|Overall Study|Protocol Violation|0
7939528|NCT02405091|12477671|FG002|Overall Study|Protocol Violation|0
7939529|NCT02405091|12477669|FG000|Overall Study|Noncompliance|1
7939530|NCT02405091|12477670|FG001|Overall Study|Noncompliance|6
7939531|NCT02405091|12477671|FG002|Overall Study|Noncompliance|2
7939532|NCT02405091|12477669|FG000|Overall Study|Withdrawal by Subject|4
7939533|NCT02405091|12477670|FG001|Overall Study|Withdrawal by Subject|8
7939534|NCT02405091|12477671|FG002|Overall Study|Withdrawal by Subject|0
7939535|NCT02405091|12477669|FG000|Overall Study|Death|0
7939536|NCT02405091|12477670|FG001|Overall Study|Death|1
7939537|NCT02405091|12477671|FG002|Overall Study|Death|0
7939538|NCT02405091|12477669|FG000|Overall Study|Lost to Follow-up|5
7939539|NCT02405091|12477670|FG001|Overall Study|Lost to Follow-up|6
7939540|NCT02405091|12477671|FG002|Overall Study|Lost to Follow-up|0
7939541|NCT02405091|12477669|FG000|Overall Study|Physician Decision|2
7939542|NCT02405091|12477670|FG001|Overall Study|Physician Decision|2
7939543|NCT02405091|12477671|FG002|Overall Study|Physician Decision|0
7939544|NCT02405442|12477712|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0
7939545|NCT02405442|12477713|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2
7939546|NCT02405442|12477714|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4
7939547|NCT02405442|12477715|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1
7939548|NCT02405442|12477712|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
7939549|NCT02405442|12477713|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1
7939550|NCT02405442|12477714|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2
7939551|NCT02405442|12477715|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
7939552|NCT02405442|12477712|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
7939553|NCT02405442|12477713|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
7939554|NCT02405442|12477714|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
7939555|NCT02405442|12477715|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
7939556|NCT02405442|12477712|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
7939557|NCT02405442|12477713|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1
7939558|NCT02405442|12477714|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
7939559|NCT02405442|12477715|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
7939560|NCT02405442|12477712|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27
7939561|NCT02405442|12477713|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
7939562|NCT02405442|12477714|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
7939563|NCT02405442|12477715|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13
7939564|NCT02405442|12477712|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14
7939565|NCT02405442|12477713|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
7939566|NCT02405442|12477714|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
7939567|NCT02405442|12477715|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2
7939568|NCT02405442|12477712|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6
7939569|NCT02405442|12477713|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1
7939570|NCT02405442|12477714|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2
7939571|NCT02405442|12477715|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6
7939572|NCT02405442|12477712|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0
7939573|NCT02405442|12477713|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1
7939574|NCT02405442|12477714|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3
7939575|NCT02405442|12477715|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2
7939576|NCT02405442|12477712|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1
7939577|NCT02405442|12477713|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2
7939578|NCT02405442|12477714|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1
7939579|NCT02405442|12477715|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1
7939580|NCT02405442|12477712|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
7939581|NCT02405442|12477713|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1
7939582|NCT02405442|12477714|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
7939583|NCT02405442|12477715|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
7939584|NCT02405442|12477712|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
7939585|NCT02405442|12477713|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1
7939586|NCT02405442|12477714|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
7939587|NCT02405442|12477715|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
7939588|NCT02405442|12477712|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
7939589|NCT02405442|12477713|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1
7939590|NCT02405442|12477714|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
7939591|NCT02405442|12477715|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
7939592|NCT02405442|12477712|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
7939593|NCT02405442|12477713|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1
7939594|NCT02405442|12477714|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
7939595|NCT02405442|12477715|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
7939596|NCT02405442|12477712|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1
7939597|NCT02405442|12477713|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
7939598|NCT02405442|12477714|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
7939599|NCT02405442|12477715|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
7939600|NCT02405780|12477733|FG000|Period I|Adverse Event|8
7939601|NCT02405780|12477734|FG001|Period I|Adverse Event|0
7939602|NCT02405780|12477735|FG002|Period I|Adverse Event|3
7939603|NCT02405780|12477736|FG003|Period I|Adverse Event|7
7939604|NCT02405780|12477733|FG000|Period I|Medical reasons|1
7939605|NCT02405780|12477734|FG001|Period I|Medical reasons|1
7939606|NCT02405780|12477735|FG002|Period I|Medical reasons|0
7939607|NCT02405780|12477736|FG003|Period I|Medical reasons|1
7939608|NCT02405780|12477733|FG000|Period I|Screening Failure|1
7939609|NCT02405780|12477734|FG001|Period I|Screening Failure|0
7939610|NCT02405780|12477735|FG002|Period I|Screening Failure|1
7939611|NCT02405780|12477736|FG003|Period I|Screening Failure|0
7939612|NCT02405780|12477733|FG000|Period I|Withdrawal by Subject|9
7939613|NCT02405780|12477734|FG001|Period I|Withdrawal by Subject|1
7939614|NCT02405780|12477735|FG002|Period I|Withdrawal by Subject|3
7939615|NCT02405780|12477736|FG003|Period I|Withdrawal by Subject|4
7939616|NCT02405780|12477733|FG000|Period I|Non-compliance with study procedures|8
7939617|NCT02405780|12477734|FG001|Period I|Non-compliance with study procedures|6
7939618|NCT02405780|12477735|FG002|Period I|Non-compliance with study procedures|8
7939619|NCT02405780|12477736|FG003|Period I|Non-compliance with study procedures|11
7939620|NCT02405780|12477733|FG000|Period II|Adverse Event|3
7939621|NCT02405780|12477734|FG001|Period II|Adverse Event|5
7939622|NCT02405780|12477735|FG002|Period II|Adverse Event|4
7939623|NCT02405780|12477736|FG003|Period II|Adverse Event|11
7939624|NCT02405780|12477733|FG000|Period II|Medical reason|0
7939625|NCT02405780|12477734|FG001|Period II|Medical reason|1
7939626|NCT02405780|12477735|FG002|Period II|Medical reason|0
7939627|NCT02405780|12477736|FG003|Period II|Medical reason|0
7939628|NCT02405780|12477733|FG000|Period II|Pregnancy|0
7939629|NCT02405780|12477734|FG001|Period II|Pregnancy|0
7939630|NCT02405780|12477735|FG002|Period II|Pregnancy|1
7939631|NCT02405780|12477736|FG003|Period II|Pregnancy|0
7939632|NCT02405780|12477733|FG000|Period II|Withdrawal by Subject|7
7939633|NCT02405780|12477734|FG001|Period II|Withdrawal by Subject|4
7939634|NCT02405780|12477735|FG002|Period II|Withdrawal by Subject|0
7939635|NCT02405780|12477736|FG003|Period II|Withdrawal by Subject|3
7939636|NCT02405780|12477733|FG000|Period II|Non-compliance with study procedures|5
7939637|NCT02405780|12477734|FG001|Period II|Non-compliance with study procedures|2
7939638|NCT02405780|12477735|FG002|Period II|Non-compliance with study procedures|7
7939639|NCT02405780|12477736|FG003|Period II|Non-compliance with study procedures|4
7939640|NCT02405962|12477763|FG000|Overall Study|Lost to Follow-up|1
7939641|NCT02405962|12477764|FG001|Overall Study|Lost to Follow-up|4
7939642|NCT02405962|12477763|FG000|Overall Study|A participant has moved to another place|0
7939643|NCT02405962|12477764|FG001|Overall Study|A participant has moved to another place|1
7939644|NCT02406248|12477770|FG000|Overall Study|Death|7
7939645|NCT02406248|12477770|FG000|Overall Study|Withdrawal by Subject|2
7939646|NCT02406261|12477776|FG000|Period 1|Lost to Follow-up|2
7939647|NCT02406261|12477777|FG001|Period 1|Lost to Follow-up|0
7939648|NCT02406261|12477776|FG000|Period 1|Adverse Event|1
7939649|NCT02406261|12477777|FG001|Period 1|Adverse Event|0
7939650|NCT02406261|12477776|FG000|Period 2|Physician Decision|0
7939651|NCT02406261|12477777|FG001|Period 2|Physician Decision|1
7939652|NCT02406261|12477776|FG000|Period 2|Protocol Violation|0
7939653|NCT02406261|12477777|FG001|Period 2|Protocol Violation|1
7939654|NCT02406261|12477776|FG000|Period 2|Withdrawal by Subject|0
7939655|NCT02406261|12477777|FG001|Period 2|Withdrawal by Subject|1
7939656|NCT02406586|12477813|FG000|Overall Study|Lost to Follow-up|0
7939657|NCT02406586|12477814|FG001|Overall Study|Lost to Follow-up|4
7939658|NCT02406586|12477815|FG002|Overall Study|Lost to Follow-up|2
7939659|NCT02406586|12477813|FG000|Overall Study|Withdrawal by Subject|1
7939660|NCT02406586|12477814|FG001|Overall Study|Withdrawal by Subject|0
7939661|NCT02406586|12477815|FG002|Overall Study|Withdrawal by Subject|0
7939662|NCT02406612|12477828|FG000|Overall Study|Screening Failure|3
7939663|NCT02406612|12477829|FG001|Overall Study|Screening Failure|0
7939664|NCT02406612|12477828|FG000|Overall Study|Intra-procedural Exclusion|1
7939665|NCT02406612|12477829|FG001|Overall Study|Intra-procedural Exclusion|3
7939666|NCT02406612|12477828|FG000|Overall Study|Guidewire Failure|0
7939667|NCT02406612|12477829|FG001|Overall Study|Guidewire Failure|1
7939668|NCT02406651|12477835|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3
7939669|NCT02406677|12477842|FG000|Overall Study|Death|16
7939670|NCT02406677|12477843|FG001|Overall Study|Death|8
7939671|NCT02406677|12477842|FG000|Overall Study|Discharged without P2Y12|1
7939672|NCT02406677|12477843|FG001|Overall Study|Discharged without P2Y12|3
7939673|NCT02406677|12477842|FG000|Overall Study|Discharged on prasugrel|283
7939674|NCT02406677|12477843|FG001|Overall Study|Discharged on prasugrel|587
7939675|NCT02406677|12477842|FG000|Overall Study|Withdrawal by Subject|1
7939676|NCT02406677|12477843|FG001|Overall Study|Withdrawal by Subject|0
7939677|NCT02406742|12477856|FG000|Overall Study|Progression of Disease|5
7939678|NCT02406742|12477857|FG001|Overall Study|Progression of Disease|1
7939679|NCT02406742|12477858|FG002|Overall Study|Progression of Disease|6
7939680|NCT02406742|12477856|FG000|Overall Study|Adverse Event|3
7939681|NCT02406742|12477857|FG001|Overall Study|Adverse Event|0
7939682|NCT02406742|12477858|FG002|Overall Study|Adverse Event|2
7939683|NCT02406742|12477856|FG000|Overall Study|Death|1
7939684|NCT02406742|12477857|FG001|Overall Study|Death|0
7939685|NCT02406742|12477858|FG002|Overall Study|Death|0
7939686|NCT02406742|12477856|FG000|Overall Study|Lack of Efficacy|0
7939687|NCT02406742|12477857|FG001|Overall Study|Lack of Efficacy|0
7939688|NCT02406742|12477858|FG002|Overall Study|Lack of Efficacy|1
7939689|NCT02406742|12477856|FG000|Overall Study|Withdrawal by Participant|1
7939690|NCT02406742|12477857|FG001|Overall Study|Withdrawal by Participant|2
7939691|NCT02406742|12477858|FG002|Overall Study|Withdrawal by Participant|0
7939692|NCT02406742|12477856|FG000|Overall Study|Physician Decision|1
7939693|NCT02406742|12477857|FG001|Overall Study|Physician Decision|2
7939694|NCT02406742|12477858|FG002|Overall Study|Physician Decision|1
7939695|NCT02406742|12477856|FG000|Overall Study|Transition to other treatment|2
7939696|NCT02406742|12477857|FG001|Overall Study|Transition to other treatment|0
7939697|NCT02406742|12477858|FG002|Overall Study|Transition to other treatment|1
7939698|NCT02406742|12477856|FG000|Overall Study|Other Reasons|1
7939699|NCT02406742|12477857|FG001|Overall Study|Other Reasons|11
7939700|NCT02406742|12477858|FG002|Overall Study|Other Reasons|5
7939701|NCT02407054|12477920|FG000|Overall Study|Adverse Event|1
7939702|NCT02407054|12477921|FG001|Overall Study|Adverse Event|4
7939703|NCT02407054|12477922|FG002|Overall Study|Adverse Event|1
7939704|NCT02407054|12477920|FG000|Overall Study|Non-compliance with Study|0
7939705|NCT02407054|12477921|FG001|Overall Study|Non-compliance with Study|2
7939706|NCT02407054|12477922|FG002|Overall Study|Non-compliance with Study|1
7939707|NCT02407054|12477920|FG000|Overall Study|Physician Decision|1
7939708|NCT02407054|12477921|FG001|Overall Study|Physician Decision|3
7939709|NCT02407054|12477922|FG002|Overall Study|Physician Decision|3
7939710|NCT02407054|12477920|FG000|Overall Study|Withdrawal by Subject|5
7939711|NCT02407054|12477921|FG001|Overall Study|Withdrawal by Subject|9
7939712|NCT02407054|12477922|FG002|Overall Study|Withdrawal by Subject|2
7939713|NCT02407223|12477943|FG000|Overall Study|Adverse Event|1
7939714|NCT02407223|12477944|FG001|Overall Study|Adverse Event|0
7939715|NCT02407223|12477945|FG002|Overall Study|Adverse Event|1
7939716|NCT02407223|12477943|FG000|Overall Study|Lack of Efficacy|6
7939717|NCT02407223|12477944|FG001|Overall Study|Lack of Efficacy|6
7939718|NCT02407223|12477945|FG002|Overall Study|Lack of Efficacy|4
7939719|NCT02407223|12477943|FG000|Overall Study|Lost to Follow-up|1
7939720|NCT02407223|12477944|FG001|Overall Study|Lost to Follow-up|0
7939721|NCT02407223|12477945|FG002|Overall Study|Lost to Follow-up|2
7939722|NCT02407223|12477943|FG000|Overall Study|Withdrawal by Subject|2
7939723|NCT02407223|12477944|FG001|Overall Study|Withdrawal by Subject|4
7939724|NCT02407223|12477945|FG002|Overall Study|Withdrawal by Subject|4
7939725|NCT02407223|12477943|FG000|Overall Study|Study Terminated by Sponsor|77
7939726|NCT02407223|12477944|FG001|Overall Study|Study Terminated by Sponsor|80
7939727|NCT02407223|12477945|FG002|Overall Study|Study Terminated by Sponsor|86
7939728|NCT02407223|12477943|FG000|Overall Study|Subject Refused Further Study Treatment|0
7939729|NCT02407223|12477944|FG001|Overall Study|Subject Refused Further Study Treatment|1
7939730|NCT02407223|12477945|FG002|Overall Study|Subject Refused Further Study Treatment|0
7939731|NCT02407223|12477943|FG000|Overall Study|Other|29
7939732|NCT02407223|12477944|FG001|Overall Study|Other|27
7939733|NCT02407223|12477945|FG002|Overall Study|Other|25
7939734|NCT02407249|12477955|FG000|Overall Study|Did not complete 12-month follow-up|13
7939735|NCT02407249|12477955|FG000|Overall Study|Not treated|13
7939736|NCT02407457|12477961|FG000|1 Month|Death|3
7939737|NCT02407457|12477962|FG001|1 Month|Death|0
7939738|NCT02407457|12477961|FG000|1 Month|Lost to Follow-up|1
7939739|NCT02407457|12477962|FG001|1 Month|Lost to Follow-up|1
7939740|NCT02407457|12477961|FG000|1 Month|missed visit|2
7939741|NCT02407457|12477962|FG001|1 Month|missed visit|6
7939742|NCT02407457|12477961|FG000|6-Month|Death|2
7939743|NCT02407457|12477962|FG001|6-Month|Death|8
7939744|NCT02407457|12477961|FG000|6-Month|Lost to Follow-up|2
7939745|NCT02407457|12477962|FG001|6-Month|Lost to Follow-up|2
7939746|NCT02407457|12477961|FG000|6-Month|missed visit|15
7939747|NCT02407457|12477962|FG001|6-Month|missed visit|12
7939748|NCT02407457|12477961|FG000|6-Month|Over Due|1
7939749|NCT02407457|12477962|FG001|6-Month|Over Due|2
7939750|NCT02407457|12477961|FG000|6-Month|Open Repair|0
7939751|NCT02407457|12477962|FG001|6-Month|Open Repair|1
7939752|NCT02407457|12477961|FG000|1 Year|Death|6
7939753|NCT02407457|12477962|FG001|1 Year|Death|11
7939754|NCT02407457|12477961|FG000|1 Year|Lost to Follow-up|3
7939755|NCT02407457|12477962|FG001|1 Year|Lost to Follow-up|2
7939756|NCT02407457|12477961|FG000|1 Year|Missed Visit|18
7939757|NCT02407457|12477962|FG001|1 Year|Missed Visit|10
7939758|NCT02407457|12477961|FG000|1 Year|Over Due|6
7939759|NCT02407457|12477962|FG001|1 Year|Over Due|4
7939760|NCT02407457|12477961|FG000|1 Year|Open Repair|0
7939761|NCT02407457|12477962|FG001|1 Year|Open Repair|1
7939762|NCT02407457|12477961|FG000|2-year|Death|14
7939763|NCT02407457|12477962|FG001|2-year|Death|8
7939764|NCT02407457|12477961|FG000|2-year|Lost to Follow-up|6
7939765|NCT02407457|12477962|FG001|2-year|Lost to Follow-up|9
7939766|NCT02407457|12477961|FG000|2-year|Missed Visit|13
7939767|NCT02407457|12477962|FG001|2-year|Missed Visit|11
7939768|NCT02407457|12477961|FG000|2-year|Over Due|1
7939769|NCT02407457|12477962|FG001|2-year|Over Due|5
7939770|NCT02407457|12477961|FG000|2-year|Open Repair|0
7939771|NCT02407457|12477962|FG001|2-year|Open Repair|2
7939772|NCT02407457|12477961|FG000|3-year|Death|11
7939773|NCT02407457|12477962|FG001|3-year|Death|10
7939774|NCT02407457|12477961|FG000|3-year|Lost to Follow-up|6
7939775|NCT02407457|12477962|FG001|3-year|Lost to Follow-up|9
7939776|NCT02407457|12477961|FG000|3-year|Missed Visit|21
7939777|NCT02407457|12477962|FG001|3-year|Missed Visit|16
7939778|NCT02407457|12477961|FG000|3-year|Over Due|4
7939779|NCT02407457|12477962|FG001|3-year|Over Due|3
7939780|NCT02407457|12477961|FG000|4-year|Death|14
7939781|NCT02407457|12477962|FG001|4-year|Death|7
7939782|NCT02407457|12477961|FG000|4-year|Lost to Follow-up|9
7939783|NCT02407457|12477962|FG001|4-year|Lost to Follow-up|12
7939784|NCT02407457|12477961|FG000|4-year|Over Due|10
7939785|NCT02407457|12477962|FG001|4-year|Over Due|5
7939786|NCT02407457|12477961|FG000|4-year|Missed Visit|13
7939787|NCT02407457|12477962|FG001|4-year|Missed Visit|13
7939788|NCT02407457|12477961|FG000|4-year|Pending visit|19
7939789|NCT02407457|12477962|FG001|4-year|Pending visit|14
7939790|NCT02407457|12477961|FG000|4-year|Not Due|16
7939791|NCT02407457|12477962|FG001|4-year|Not Due|10
7939792|NCT02407457|12477961|FG000|5-year|Death|6
7939793|NCT02407457|12477962|FG001|5-year|Death|1
7939794|NCT02407457|12477961|FG000|5-year|Lost to Follow-up|4
7939795|NCT02407457|12477962|FG001|5-year|Lost to Follow-up|4
7939796|NCT02407457|12477961|FG000|5-year|Missed Visit|10
7939797|NCT02407457|12477962|FG001|5-year|Missed Visit|9
7939798|NCT02407457|12477961|FG000|5-year|Pending Visit|18
7939799|NCT02407457|12477962|FG001|5-year|Pending Visit|17
7939800|NCT02407457|12477961|FG000|5-year|Not Due|54
7939801|NCT02407457|12477962|FG001|5-year|Not Due|46
7939802|NCT02407704|12477972|FG000|Overall Study|Lost to Follow-up|0
7939803|NCT02407704|12477973|FG001|Overall Study|Lost to Follow-up|0
7939804|NCT02407704|12477974|FG002|Overall Study|Lost to Follow-up|0
7939805|NCT02407704|12477975|FG003|Overall Study|Lost to Follow-up|2
7939806|NCT02407704|12477972|FG000|Overall Study|Protocol Violation|0
7939807|NCT02407704|12477973|FG001|Overall Study|Protocol Violation|0
7939808|NCT02407704|12477974|FG002|Overall Study|Protocol Violation|0
7939809|NCT02407704|12477975|FG003|Overall Study|Protocol Violation|1
7939810|NCT02407704|12477972|FG000|Overall Study|Withdrawal by Subject|0
7939811|NCT02407704|12477973|FG001|Overall Study|Withdrawal by Subject|0
7939812|NCT02407704|12477974|FG002|Overall Study|Withdrawal by Subject|1
7939813|NCT02407704|12477975|FG003|Overall Study|Withdrawal by Subject|0
7939814|NCT02407990|12478014|FG000|Overall Study|Death|2
7939815|NCT02407990|12478015|FG001|Overall Study|Death|22
7939816|NCT02407990|12478016|FG002|Overall Study|Death|23
7939817|NCT02407990|12478017|FG003|Overall Study|Death|7
7939818|NCT02407990|12478018|FG004|Overall Study|Death|17
7939819|NCT02407990|12478019|FG005|Overall Study|Death|16
7939820|NCT02407990|12478020|FG006|Overall Study|Death|10
7939821|NCT02407990|12478021|FG007|Overall Study|Death|248
7939822|NCT02407990|12478014|FG000|Overall Study|Lost to Follow-up|0
7939823|NCT02407990|12478015|FG001|Overall Study|Lost to Follow-up|1
7939824|NCT02407990|12478016|FG002|Overall Study|Lost to Follow-up|0
7939825|NCT02407990|12478017|FG003|Overall Study|Lost to Follow-up|0
7939826|NCT02407990|12478018|FG004|Overall Study|Lost to Follow-up|0
7939827|NCT02407990|12478019|FG005|Overall Study|Lost to Follow-up|0
7939828|NCT02407990|12478020|FG006|Overall Study|Lost to Follow-up|0
7939829|NCT02407990|12478021|FG007|Overall Study|Lost to Follow-up|17
7939830|NCT02407990|12478014|FG000|Overall Study|Progressive Disease|0
7939831|NCT02407990|12478015|FG001|Overall Study|Progressive Disease|0
7939832|NCT02407990|12478016|FG002|Overall Study|Progressive Disease|0
7939833|NCT02407990|12478017|FG003|Overall Study|Progressive Disease|0
7939834|NCT02407990|12478018|FG004|Overall Study|Progressive Disease|0
7939835|NCT02407990|12478019|FG005|Overall Study|Progressive Disease|0
7939836|NCT02407990|12478020|FG006|Overall Study|Progressive Disease|0
7939837|NCT02407990|12478021|FG007|Overall Study|Progressive Disease|1
7939838|NCT02407990|12478014|FG000|Overall Study|Withdrawal by Subject|0
7939839|NCT02407990|12478015|FG001|Overall Study|Withdrawal by Subject|0
7939840|NCT02407990|12478016|FG002|Overall Study|Withdrawal by Subject|0
7939841|NCT02407990|12478017|FG003|Overall Study|Withdrawal by Subject|0
7939842|NCT02407990|12478018|FG004|Overall Study|Withdrawal by Subject|1
7939843|NCT02407990|12478019|FG005|Overall Study|Withdrawal by Subject|0
7939844|NCT02407990|12478020|FG006|Overall Study|Withdrawal by Subject|0
7939845|NCT02407990|12478021|FG007|Overall Study|Withdrawal by Subject|30
7939846|NCT02407990|12478014|FG000|Overall Study|Study Terminated by Sponsor|1
7939847|NCT02407990|12478015|FG001|Overall Study|Study Terminated by Sponsor|3
7939848|NCT02407990|12478016|FG002|Overall Study|Study Terminated by Sponsor|3
7939849|NCT02407990|12478017|FG003|Overall Study|Study Terminated by Sponsor|0
7939850|NCT02407990|12478018|FG004|Overall Study|Study Terminated by Sponsor|3
7939851|NCT02407990|12478019|FG005|Overall Study|Study Terminated by Sponsor|4
7939852|NCT02407990|12478020|FG006|Overall Study|Study Terminated by Sponsor|3
7939853|NCT02407990|12478021|FG007|Overall Study|Study Terminated by Sponsor|37
7939854|NCT02407990|12478014|FG000|Overall Study|Logistics|0
7939855|NCT02407990|12478015|FG001|Overall Study|Logistics|0
7939856|NCT02407990|12478016|FG002|Overall Study|Logistics|0
7939857|NCT02407990|12478017|FG003|Overall Study|Logistics|0
7939858|NCT02407990|12478018|FG004|Overall Study|Logistics|0
7939859|NCT02407990|12478019|FG005|Overall Study|Logistics|0
7939860|NCT02407990|12478020|FG006|Overall Study|Logistics|0
7939861|NCT02407990|12478021|FG007|Overall Study|Logistics|1
7939862|NCT02407990|12478014|FG000|Overall Study|Rolled into long-term extension study|0
7939863|NCT02407990|12478015|FG001|Overall Study|Rolled into long-term extension study|0
7939864|NCT02407990|12478016|FG002|Overall Study|Rolled into long-term extension study|0
7939865|NCT02407990|12478017|FG003|Overall Study|Rolled into long-term extension study|0
7939866|NCT02407990|12478018|FG004|Overall Study|Rolled into long-term extension study|0
7939867|NCT02407990|12478019|FG005|Overall Study|Rolled into long-term extension study|0
7939868|NCT02407990|12478020|FG006|Overall Study|Rolled into long-term extension study|0
7939869|NCT02407990|12478021|FG007|Overall Study|Rolled into long-term extension study|1
7939870|NCT02408016|12478048|FG000|Overall Study|Death|6
7939871|NCT02408016|12478049|FG001|Overall Study|Death|1
7939872|NCT02408016|12478050|FG002|Overall Study|Death|0
7939873|NCT02408016|12478048|FG000|Overall Study|Physician Decision|0
7939874|NCT02408016|12478049|FG001|Overall Study|Physician Decision|2
7939875|NCT02408016|12478050|FG002|Overall Study|Physician Decision|0
7939876|NCT02408120|12478060|FG000|Overall Study|Withdrawal by Subject|0
7939877|NCT02408120|12478061|FG001|Overall Study|Withdrawal by Subject|1
7939878|NCT02408120|12478060|FG000|Overall Study|Treatment Refusal|1
7939879|NCT02408120|12478061|FG001|Overall Study|Treatment Refusal|0
7939880|NCT02408120|12478060|FG000|Overall Study|Received Steroids|1
7939881|NCT02408120|12478061|FG001|Overall Study|Received Steroids|1
7939882|NCT02408120|12478060|FG000|Overall Study|Discharged same day|1
7939883|NCT02408120|12478061|FG001|Overall Study|Discharged same day|1
7939884|NCT02408120|12478060|FG000|Overall Study|Did not receive insulin|1
7939885|NCT02408120|12478061|FG001|Overall Study|Did not receive insulin|2
7939886|NCT02408484|12478090|FG000|Overall Study|Withdrawal by Subject|3
7939887|NCT02408484|12478090|FG000|Overall Study|Not treated during study period|1
7939888|NCT02408523|12478112|FG000|Overall Study|Adverse Event|4
7939889|NCT02408523|12478113|FG001|Overall Study|Adverse Event|10
7939890|NCT02408523|12478112|FG000|Overall Study|Lack of Efficacy|0
7939891|NCT02408523|12478113|FG001|Overall Study|Lack of Efficacy|1
7939892|NCT02408523|12478112|FG000|Overall Study|Protocol Violation|1
7939893|NCT02408523|12478113|FG001|Overall Study|Protocol Violation|2
7939894|NCT02408523|12478112|FG000|Overall Study|Lost to Follow-up|2
7939895|NCT02408523|12478113|FG001|Overall Study|Lost to Follow-up|3
7939896|NCT02408523|12478112|FG000|Overall Study|Withdrawal by Subject|3
7939897|NCT02408523|12478113|FG001|Overall Study|Withdrawal by Subject|1
7939898|NCT02408523|12478112|FG000|Overall Study|Sponsor request|1
7939899|NCT02408523|12478113|FG001|Overall Study|Sponsor request|0
7939900|NCT02408523|12478112|FG000|Overall Study|Did not satisfy extension conditions|0
7939901|NCT02408523|12478113|FG001|Overall Study|Did not satisfy extension conditions|1
7939902|NCT02409667|12478206|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6
7939903|NCT02409667|12478207|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7939904|NCT02409667|12478208|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7939905|NCT02409667|12478209|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7939906|NCT02409667|12478210|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7939907|NCT02409667|12478206|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6
7939908|NCT02409667|12478207|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7939909|NCT02409667|12478208|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7939910|NCT02409667|12478209|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7939911|NCT02409667|12478210|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7939912|NCT02409667|12478206|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20
7939913|NCT02409667|12478207|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7939914|NCT02409667|12478208|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7939915|NCT02409667|12478209|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7939916|NCT02409667|12478210|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7939917|NCT02409667|12478206|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1
7939918|NCT02409667|12478207|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7939919|NCT02409667|12478208|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7939920|NCT02409667|12478209|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7939921|NCT02409667|12478210|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7939922|NCT02409667|12478206|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4
7939923|NCT02409667|12478207|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7939924|NCT02409667|12478208|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7939925|NCT02409667|12478209|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7939926|NCT02409667|12478210|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7939927|NCT02409667|12478206|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5
7939928|NCT02409667|12478207|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7939929|NCT02409667|12478208|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7939930|NCT02409667|12478209|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7939931|NCT02409667|12478210|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7939932|NCT02409667|12478206|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6
7939933|NCT02409667|12478207|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7939934|NCT02409667|12478208|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7939935|NCT02409667|12478209|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7939936|NCT02409667|12478210|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7939937|NCT02409667|12478206|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48
7939938|NCT02409667|12478207|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7939939|NCT02409667|12478208|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7939940|NCT02409667|12478209|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7939941|NCT02409667|12478210|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7939942|NCT02409667|12478206|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25
7939943|NCT02409667|12478207|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7939944|NCT02409667|12478208|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7939945|NCT02409667|12478209|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7939946|NCT02409667|12478210|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7939947|NCT02409667|12478206|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
7939948|NCT02409667|12478207|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7
7939949|NCT02409667|12478208|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4
7939950|NCT02409667|12478209|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3
7939951|NCT02409667|12478210|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
7939952|NCT02409667|12478206|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7939953|NCT02409667|12478207|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7939954|NCT02409667|12478208|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7939955|NCT02409667|12478209|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2
7939956|NCT02409667|12478210|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7939957|NCT02409667|12478206|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0
7939958|NCT02409667|12478207|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7
7939959|NCT02409667|12478208|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4
7939960|NCT02409667|12478209|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1
7939961|NCT02409667|12478210|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2
7939962|NCT02409667|12478206|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
7939963|NCT02409667|12478207|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5
7939964|NCT02409667|12478208|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4
7939965|NCT02409667|12478209|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
7939966|NCT02409667|12478210|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
7939967|NCT02409667|12478206|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
7939968|NCT02409667|12478207|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4
7939969|NCT02409667|12478208|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5
7939970|NCT02409667|12478209|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2
7939971|NCT02409667|12478210|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
7939972|NCT02409667|12478206|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
7939973|NCT02409667|12478207|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
7939974|NCT02409667|12478208|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
7939975|NCT02409667|12478209|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
7939976|NCT02409667|12478210|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
7939977|NCT02409667|12478206|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7939978|NCT02409667|12478207|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7939979|NCT02409667|12478208|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3
7939980|NCT02409667|12478209|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7939981|NCT02409667|12478210|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7939982|NCT02409680|12478223|FG000|Overall Study|Lost to Follow-up|15
7939983|NCT02409680|12478224|FG001|Overall Study|Lost to Follow-up|30
7965165|NCT02049138|12520864|FG000|Overall Study|Lost to Follow-up|18
7965166|NCT02049138|12520865|FG001|Overall Study|Lost to Follow-up|5
7965167|NCT02049138|12520866|FG002|Overall Study|Lost to Follow-up|1
7965168|NCT02049138|12520864|FG000|Overall Study|Lack of Efficacy|10
7965169|NCT02049138|12520865|FG001|Overall Study|Lack of Efficacy|26
7965170|NCT02049138|12520866|FG002|Overall Study|Lack of Efficacy|1
7965171|NCT02049138|12520864|FG000|Overall Study|Non-Compliance|15
7965172|NCT02049138|12520865|FG001|Overall Study|Non-Compliance|6
7965173|NCT02049138|12520866|FG002|Overall Study|Non-Compliance|0
7965174|NCT02049138|12520864|FG000|Overall Study|Required Alternative / Prohibited Therapy|1
7965175|NCT02049138|12520865|FG001|Overall Study|Required Alternative / Prohibited Therapy|1
7965176|NCT02049138|12520866|FG002|Overall Study|Required Alternative / Prohibited Therapy|0
7965177|NCT02049138|12520864|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1
7965178|NCT02049138|12520865|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0
7965179|NCT02049138|12520866|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0
7965180|NCT02049138|12520864|FG000|Overall Study|COVID-19 Logistical Restrictions|1
7965181|NCT02049138|12520865|FG001|Overall Study|COVID-19 Logistical Restrictions|0
7965182|NCT02049138|12520866|FG002|Overall Study|COVID-19 Logistical Restrictions|0
7965183|NCT02049138|12520864|FG000|Overall Study|Other|15
7965184|NCT02049138|12520865|FG001|Overall Study|Other|13
7965185|NCT02049138|12520866|FG002|Overall Study|Other|0
7965186|NCT02049138|12520864|FG000|Overall Study|Missing|0
7965187|NCT02049138|12520865|FG001|Overall Study|Missing|1
7965188|NCT02049138|12520866|FG002|Overall Study|Missing|0
7965189|NCT01721772|12520879|FG000|Pre-Treatment|Participant no longer meets study criteria|3
7939984|NCT02409719|12478232|FG000|Overall Study|Lost to Follow-up|3
7939985|NCT02409719|12478233|FG001|Overall Study|Lost to Follow-up|3
7939986|NCT02409732|12478239|FG000|Overall Study|Withdrawal by Subject|4
7939987|NCT02409732|12478239|FG000|Overall Study|Lost to Follow-up|2
7939988|NCT02410200|12478275|FG000|Overall Study|Adverse Event|2
7939989|NCT02410252|12478279|FG000|Overall Study|Withdrawal by Subject|4
7939990|NCT02410252|12478279|FG000|Overall Study|Physician Decision|2
7939991|NCT02410278|12478287|FG000|Run-in Period|Adverse Event|5
7939992|NCT02410278|12478288|FG001|Run-in Period|Adverse Event|0
7939993|NCT02410278|12478289|FG002|Run-in Period|Adverse Event|0
7939994|NCT02410278|12478287|FG000|Run-in Period|GSRS Threshold Not Met|30
7939995|NCT02410278|12478288|FG001|Run-in Period|GSRS Threshold Not Met|0
7939996|NCT02410278|12478289|FG002|Run-in Period|GSRS Threshold Not Met|0
7939997|NCT02410278|12478287|FG000|Run-in Period|Lost to Follow-up|1
7939998|NCT02410278|12478288|FG001|Run-in Period|Lost to Follow-up|0
7939999|NCT02410278|12478289|FG002|Run-in Period|Lost to Follow-up|0
7940000|NCT02410278|12478287|FG000|Run-in Period|Withdrawal by Subject|1
7940001|NCT02410278|12478288|FG001|Run-in Period|Withdrawal by Subject|0
7940002|NCT02410278|12478289|FG002|Run-in Period|Withdrawal by Subject|0
7940003|NCT02410278|12478287|FG000|Run-in Period|Pregnancy|1
7940004|NCT02410278|12478288|FG001|Run-in Period|Pregnancy|0
7940005|NCT02410278|12478289|FG002|Run-in Period|Pregnancy|0
7940006|NCT02410278|12478287|FG000|Study Treatment Period|Adverse Event|0
7940007|NCT02410278|12478288|FG001|Study Treatment Period|Adverse Event|6
7940008|NCT02410278|12478289|FG002|Study Treatment Period|Adverse Event|3
7940009|NCT02410278|12478287|FG000|Study Treatment Period|Physician Decision|0
7940010|NCT02410278|12478288|FG001|Study Treatment Period|Physician Decision|0
7940011|NCT02410278|12478289|FG002|Study Treatment Period|Physician Decision|1
7940012|NCT02410278|12478287|FG000|Study Treatment Period|Withdrawal by Subject|0
7940013|NCT02410278|12478288|FG001|Study Treatment Period|Withdrawal by Subject|1
7940014|NCT02410278|12478289|FG002|Study Treatment Period|Withdrawal by Subject|0
7940015|NCT02410278|12478287|FG000|Study Treatment Period|Other|0
7940016|NCT02410278|12478288|FG001|Study Treatment Period|Other|3
7940017|NCT02410278|12478289|FG002|Study Treatment Period|Other|0
7940018|NCT02410278|12478287|FG000|Study Treatment Period|GSRS Threshold Not Met|0
7940019|NCT02410278|12478288|FG001|Study Treatment Period|GSRS Threshold Not Met|1
7940020|NCT02410278|12478289|FG002|Study Treatment Period|GSRS Threshold Not Met|0
7940021|NCT02410629|12478316|FG000|Overall Study|Family cannot commit to the study|2
7940022|NCT02410629|12478317|FG001|Overall Study|Family cannot commit to the study|1
7940023|NCT02410629|12478316|FG000|Overall Study|Subject returned to work|1
7940024|NCT02410629|12478317|FG001|Overall Study|Subject returned to work|0
7940025|NCT02410629|12478316|FG000|Overall Study|Subject moved back to home country|0
7940026|NCT02410629|12478317|FG001|Overall Study|Subject moved back to home country|1
7940027|NCT02410629|12478316|FG000|Overall Study|Subject underwent heart surgery|0
7940028|NCT02410629|12478317|FG001|Overall Study|Subject underwent heart surgery|1
7940029|NCT02410772|12478332|FG000|Overall Study|Death|3
7940030|NCT02410772|12478333|FG001|Overall Study|Death|4
7940031|NCT02410772|12478334|FG002|Overall Study|Death|8
7940032|NCT02410772|12478332|FG000|Overall Study|Lost to Follow-up|31
7940033|NCT02410772|12478333|FG001|Overall Study|Lost to Follow-up|23
7940034|NCT02410772|12478334|FG002|Overall Study|Lost to Follow-up|22
7940035|NCT02410772|12478332|FG000|Overall Study|Pregnancy|8
7940036|NCT02410772|12478333|FG001|Overall Study|Pregnancy|4
7940037|NCT02410772|12478334|FG002|Overall Study|Pregnancy|5
7940038|NCT02410772|12478332|FG000|Overall Study|Protocol Violation|8
7940039|NCT02410772|12478333|FG001|Overall Study|Protocol Violation|8
7940040|NCT02410772|12478334|FG002|Overall Study|Protocol Violation|4
7940041|NCT02410772|12478332|FG000|Overall Study|Baseline Drug Resistance|49
7940042|NCT02410772|12478333|FG001|Overall Study|Baseline Drug Resistance|40
7940043|NCT02410772|12478334|FG002|Overall Study|Baseline Drug Resistance|51
7940044|NCT02410772|12478332|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4
7940045|NCT02410772|12478333|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6
7940046|NCT02410772|12478334|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3
7940047|NCT02410772|12478332|FG000|Overall Study|Reinfection with a new strain of MTB|0
7940048|NCT02410772|12478333|FG001|Overall Study|Reinfection with a new strain of MTB|1
7940049|NCT02410772|12478334|FG002|Overall Study|Reinfection with a new strain of MTB|0
7940050|NCT02410811|12478351|FG000|Overall Study|Withdrawal by Subject|0
7940051|NCT02410811|12478352|FG001|Overall Study|Withdrawal by Subject|0
7940052|NCT02410811|12478353|FG002|Overall Study|Withdrawal by Subject|1
7940053|NCT02410811|12478354|FG003|Overall Study|Withdrawal by Subject|0
7940054|NCT02410824|12478364|FG000|First Intervention (One Week)|Headache|0
7940055|NCT02410824|12478365|FG001|First Intervention (One Week)|Headache|1
7940056|NCT02410837|12478372|FG000|Overall Study|Death|387
7940057|NCT02410837|12478372|FG000|Overall Study|Lost to Follow-up|50
7940058|NCT02410837|12478372|FG000|Overall Study|Withdrawal by Subject|44
7940059|NCT02410837|12478372|FG000|Overall Study|Physician Decision|6
7940060|NCT02410837|12478372|FG000|Overall Study|Moved to nursing home, cannot communicat|1
7940061|NCT02411084|12478387|FG000|Overall Study|Lack of Efficacy|6
7940062|NCT02411084|12478388|FG001|Overall Study|Lack of Efficacy|3
7940063|NCT02411084|12478387|FG000|Overall Study|Death|5
7940064|NCT02411084|12478388|FG001|Overall Study|Death|4
7940065|NCT02411084|12478387|FG000|Overall Study|Adverse Event|2
7940066|NCT02411084|12478388|FG001|Overall Study|Adverse Event|1
7940067|NCT02411084|12478387|FG000|Overall Study|Other reasons|0
7940068|NCT02411084|12478388|FG001|Overall Study|Other reasons|5
7940069|NCT02411110|12478396|FG000|Treatment Period 1|Adverse Event|4
7940070|NCT02411110|12478397|FG001|Treatment Period 1|Adverse Event|2
7940071|NCT02411110|12478396|FG000|Treatment Period 1|Lost to Follow-up|1
7940072|NCT02411110|12478397|FG001|Treatment Period 1|Lost to Follow-up|0
7940073|NCT02411110|12478396|FG000|Treatment Period 1|Personal Reasons|2
7940074|NCT02411110|12478397|FG001|Treatment Period 1|Personal Reasons|5
7940075|NCT02411110|12478396|FG000|Treatment Period 1|Other Miscellaneous Reasons|2
7940076|NCT02411110|12478397|FG001|Treatment Period 1|Other Miscellaneous Reasons|0
7940077|NCT02411110|12478396|FG000|Treatment Period 2|Adverse Event|1
7940078|NCT02411110|12478397|FG001|Treatment Period 2|Adverse Event|0
7940079|NCT02411110|12478396|FG000|Treatment Period 2|Lost to Follow-up|0
7940080|NCT02411110|12478397|FG001|Treatment Period 2|Lost to Follow-up|2
7940081|NCT02411110|12478396|FG000|Treatment Period 2|Personal Reasons|0
7940082|NCT02411110|12478397|FG001|Treatment Period 2|Personal Reasons|2
7940083|NCT02411201|12478405|FG000|Overall Study|Adverse Event|2
7940084|NCT02411201|12478405|FG000|Overall Study|Withdrawal by Subject|2
7940085|NCT02411201|12478405|FG000|Overall Study|Age group completed|2
7940086|NCT02411292|12478411|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16
7940087|NCT02411292|12478411|FG000|Overall Study|Death|2
7940088|NCT02411292|12478411|FG000|Overall Study|Lost to Follow-up|3
7719831|NCT00534495|12143824|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
7719832|NCT00534495|12143822|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
7719833|NCT00534495|12143823|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
7719834|NCT00534495|12143824|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
7940089|NCT02411396|12478417|FG000|Overall Study|Lost to Follow-up|31
7940090|NCT02411396|12478417|FG000|Overall Study|Death|10
7940091|NCT02411539|12478441|FG000|Overall Study|Lost to Follow-up|2
7940092|NCT02411539|12478442|FG001|Overall Study|Lost to Follow-up|0
7767844|NCT00856284|12210626|FG002|Overall Study|Pregnancy|0
7940093|NCT02411539|12478441|FG000|Overall Study|Confounding medical condition|0
7940094|NCT02411539|12478442|FG001|Overall Study|Confounding medical condition|1
7940095|NCT02411578|12478462|FG000|Crossover Trial Phase|Pregnancy|0
7940096|NCT02411578|12478463|FG001|Crossover Trial Phase|Pregnancy|1
7940097|NCT02411591|12478474|FG000|Overall Study|Adverse Event|0
7940098|NCT02411591|12478475|FG001|Overall Study|Adverse Event|4
7940099|NCT02411591|12478476|FG002|Overall Study|Adverse Event|2
7940100|NCT02411591|12478474|FG000|Overall Study|Withdrawal by Subject|0
7940101|NCT02411591|12478475|FG001|Overall Study|Withdrawal by Subject|3
7940102|NCT02411591|12478476|FG002|Overall Study|Withdrawal by Subject|0
7940103|NCT02411591|12478474|FG000|Overall Study|Physician Decision|0
7940104|NCT02411591|12478475|FG001|Overall Study|Physician Decision|3
7940105|NCT02411591|12478476|FG002|Overall Study|Physician Decision|1
7940106|NCT02411747|12478494|FG000|Overall Study|Withdrawal by Subject|1
7940107|NCT02411747|12478495|FG001|Overall Study|Withdrawal by Subject|0
7940108|NCT02411747|12478494|FG000|Overall Study|Protocol Violation|2
7940109|NCT02411747|12478495|FG001|Overall Study|Protocol Violation|4
7940110|NCT02412111|12478538|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1
7940111|NCT02412111|12478539|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
7940112|NCT02412111|12478540|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
7940113|NCT02412111|12478538|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2
7940114|NCT02412111|12478539|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
7940115|NCT02412111|12478540|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
7940116|NCT02412111|12478538|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0
7940117|NCT02412111|12478539|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0
7940118|NCT02412111|12478540|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2
7940119|NCT02412111|12478538|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
7940120|NCT02412111|12478539|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
7940121|NCT02412111|12478540|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1
7940122|NCT02412111|12478538|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
7940123|NCT02412111|12478539|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
7940124|NCT02412111|12478540|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1
7940125|NCT02412111|12478538|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0
7940126|NCT02412111|12478539|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1
7940127|NCT02412111|12478540|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0
7940128|NCT02412111|12478538|FG000|Active Comparator Period (8 Weeks)|Other|0
7940129|NCT02412111|12478539|FG001|Active Comparator Period (8 Weeks)|Other|0
7940130|NCT02412111|12478540|FG002|Active Comparator Period (8 Weeks)|Other|2
7940131|NCT02412371|12478556|FG000|Overall Study|Withdrawal by Subject|0
7940132|NCT02412371|12478557|FG001|Overall Study|Withdrawal by Subject|2
7940133|NCT02412371|12478558|FG002|Overall Study|Withdrawal by Subject|0
7940134|NCT02412371|12478559|FG003|Overall Study|Withdrawal by Subject|1
7940135|NCT02412371|12478560|FG004|Overall Study|Withdrawal by Subject|1
7940136|NCT02412371|12478561|FG005|Overall Study|Withdrawal by Subject|0
7940137|NCT02412371|12478556|FG000|Overall Study|Sponsor Discontinued Study|1
7940138|NCT02412371|12478557|FG001|Overall Study|Sponsor Discontinued Study|4
7940139|NCT02412371|12478558|FG002|Overall Study|Sponsor Discontinued Study|6
7940140|NCT02412371|12478559|FG003|Overall Study|Sponsor Discontinued Study|4
7940141|NCT02412371|12478560|FG004|Overall Study|Sponsor Discontinued Study|5
7940142|NCT02412371|12478561|FG005|Overall Study|Sponsor Discontinued Study|0
7940143|NCT02412371|12478556|FG000|Overall Study|Death|4
7940144|NCT02412371|12478557|FG001|Overall Study|Death|2
7940145|NCT02412371|12478558|FG002|Overall Study|Death|1
7940146|NCT02412371|12478559|FG003|Overall Study|Death|3
7719835|NCT00534495|12143822|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
7719836|NCT00534495|12143823|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
7940147|NCT02412371|12478560|FG004|Overall Study|Death|5
7940148|NCT02412371|12478561|FG005|Overall Study|Death|2
7940149|NCT02412371|12478556|FG000|Overall Study|Other|2
7940150|NCT02412371|12478557|FG001|Overall Study|Other|1
7940151|NCT02412371|12478558|FG002|Overall Study|Other|0
7940152|NCT02412371|12478559|FG003|Overall Study|Other|0
7940153|NCT02412371|12478560|FG004|Overall Study|Other|1
7940154|NCT02412371|12478561|FG005|Overall Study|Other|3
7940155|NCT02412436|12478576|FG000|Overall Study|Protocol-mandated Discontinuation|7
7940156|NCT02412436|12478576|FG000|Overall Study|Lost to Follow-up|6
7940157|NCT02412436|12478576|FG000|Overall Study|Unable to get to clinic|3
7940158|NCT02412436|12478576|FG000|Overall Study|Death|1
7940159|NCT02412436|12478576|FG000|Overall Study|Not Willing to Adhere to Requirements|1
7940160|NCT02412488|12478580|FG000|Overall Study|Lost to Follow-up|10
7940161|NCT02412488|12478580|FG000|Overall Study|Withdrawal by Subject|5
7940162|NCT02412488|12478580|FG000|Overall Study|Physician Decision|1
7940163|NCT02412488|12478580|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1
7940164|NCT02412488|12478580|FG000|Overall Study|Reveal LINQ explant|1
7940165|NCT02412631|12478591|FG000|Overall Study|Adverse Event|1
7940166|NCT02412631|12478592|FG001|Overall Study|Adverse Event|2
7940167|NCT02412631|12478591|FG000|Overall Study|Lost to Follow-up|5
7940168|NCT02412631|12478592|FG001|Overall Study|Lost to Follow-up|9
7940169|NCT02412631|12478591|FG000|Overall Study|Withdrawal by Subject|9
7940170|NCT02412631|12478592|FG001|Overall Study|Withdrawal by Subject|3
7940171|NCT02412631|12478591|FG000|Overall Study|Early stop by FDA|5
7940172|NCT02412631|12478592|FG001|Overall Study|Early stop by FDA|2
7940173|NCT02412631|12478591|FG000|Overall Study|Unspecified reason|6
7940174|NCT02412631|12478592|FG001|Overall Study|Unspecified reason|8
7940175|NCT02412657|12478614|FG000|Overall Study|Lost to Follow-up|1
7940176|NCT02412657|12478615|FG001|Overall Study|Lost to Follow-up|0
7940177|NCT02412657|12478616|FG002|Overall Study|Lost to Follow-up|0
7940178|NCT02412657|12478614|FG000|Overall Study|Protocol Violation|0
7940179|NCT02412657|12478615|FG001|Overall Study|Protocol Violation|2
7940180|NCT02412657|12478616|FG002|Overall Study|Protocol Violation|3
7940181|NCT02412722|12478630|FG000|Overall Study|Adverse Event|0
7940182|NCT02412722|12478631|FG001|Overall Study|Adverse Event|2
7940183|NCT02412722|12478632|FG002|Overall Study|Adverse Event|0
7940184|NCT02412722|12478633|FG003|Overall Study|Adverse Event|3
7940185|NCT02412722|12478634|FG004|Overall Study|Adverse Event|0
7940186|NCT02412722|12478635|FG005|Overall Study|Adverse Event|3
7940187|NCT02412722|12478630|FG000|Overall Study|Progressive Disease|6
7940188|NCT02412722|12478631|FG001|Overall Study|Progressive Disease|4
7940189|NCT02412722|12478632|FG002|Overall Study|Progressive Disease|4
7940190|NCT02412722|12478633|FG003|Overall Study|Progressive Disease|9
7940191|NCT02412722|12478634|FG004|Overall Study|Progressive Disease|3
7940192|NCT02412722|12478635|FG005|Overall Study|Progressive Disease|3
7940193|NCT02412722|12478630|FG000|Overall Study|Withdrawal by Subject|2
7940194|NCT02412722|12478631|FG001|Overall Study|Withdrawal by Subject|0
7940195|NCT02412722|12478632|FG002|Overall Study|Withdrawal by Subject|1
7940196|NCT02412722|12478633|FG003|Overall Study|Withdrawal by Subject|2
7940197|NCT02412722|12478634|FG004|Overall Study|Withdrawal by Subject|1
7940198|NCT02412722|12478635|FG005|Overall Study|Withdrawal by Subject|1
7940199|NCT02412722|12478630|FG000|Overall Study|Lost to Follow-up|0
7940200|NCT02412722|12478631|FG001|Overall Study|Lost to Follow-up|0
7940201|NCT02412722|12478632|FG002|Overall Study|Lost to Follow-up|0
7940202|NCT02412722|12478633|FG003|Overall Study|Lost to Follow-up|0
7940203|NCT02412722|12478634|FG004|Overall Study|Lost to Follow-up|1
7940204|NCT02412722|12478635|FG005|Overall Study|Lost to Follow-up|0
7940205|NCT02412722|12478630|FG000|Overall Study|Received drug in run-in and discontinued|0
7940206|NCT02412722|12478631|FG001|Overall Study|Received drug in run-in and discontinued|2
7940207|NCT02412722|12478632|FG002|Overall Study|Received drug in run-in and discontinued|0
7940208|NCT02412722|12478633|FG003|Overall Study|Received drug in run-in and discontinued|0
7940209|NCT02412722|12478634|FG004|Overall Study|Received drug in run-in and discontinued|0
7940210|NCT02412722|12478635|FG005|Overall Study|Received drug in run-in and discontinued|0
7940211|NCT02412722|12478630|FG000|Overall Study|Reason not Specified|3
7940212|NCT02412722|12478631|FG001|Overall Study|Reason not Specified|0
7940213|NCT02412722|12478632|FG002|Overall Study|Reason not Specified|2
7940214|NCT02412722|12478633|FG003|Overall Study|Reason not Specified|1
7940215|NCT02412722|12478634|FG004|Overall Study|Reason not Specified|2
7940216|NCT02412722|12478635|FG005|Overall Study|Reason not Specified|6
7940217|NCT02412761|12478669|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0
7940218|NCT02412761|12478670|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1
7940219|NCT02412761|12478671|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1
7940220|NCT02412761|12478672|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0
7940221|NCT02412761|12478673|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0
7940222|NCT02412761|12478674|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1
7940223|NCT02412852|12478686|FG000|Overall Study|Withdrawal by Subject|0
7940224|NCT02412852|12478687|FG001|Overall Study|Withdrawal by Subject|1
7940225|NCT02412852|12478688|FG002|Overall Study|Withdrawal by Subject|0
7940226|NCT02412852|12478689|FG003|Overall Study|Withdrawal by Subject|0
7940227|NCT02412852|12478686|FG000|Overall Study|Physician Decision|0
7940228|NCT02412852|12478687|FG001|Overall Study|Physician Decision|0
7940229|NCT02412852|12478688|FG002|Overall Study|Physician Decision|0
7940230|NCT02412852|12478689|FG003|Overall Study|Physician Decision|1
7940231|NCT02413229|12478768|FG000|Overall Study|Adverse Event|0
7940232|NCT02413229|12478769|FG001|Overall Study|Adverse Event|0
7940233|NCT02413229|12478770|FG002|Overall Study|Adverse Event|0
7940234|NCT02413229|12478771|FG003|Overall Study|Adverse Event|1
7940235|NCT02413229|12478772|FG004|Overall Study|Adverse Event|0
7940236|NCT02413229|12478773|FG005|Overall Study|Adverse Event|0
7940237|NCT02413229|12478774|FG006|Overall Study|Adverse Event|0
7940238|NCT02413229|12478775|FG007|Overall Study|Adverse Event|1
7940239|NCT02413229|12478768|FG000|Overall Study|Lost to Follow-up|0
7940240|NCT02413229|12478769|FG001|Overall Study|Lost to Follow-up|0
7940241|NCT02413229|12478770|FG002|Overall Study|Lost to Follow-up|1
7940242|NCT02413229|12478771|FG003|Overall Study|Lost to Follow-up|0
7940243|NCT02413229|12478772|FG004|Overall Study|Lost to Follow-up|2
7940244|NCT02413229|12478773|FG005|Overall Study|Lost to Follow-up|0
7940245|NCT02413229|12478774|FG006|Overall Study|Lost to Follow-up|0
7940246|NCT02413229|12478775|FG007|Overall Study|Lost to Follow-up|0
7940247|NCT02413229|12478768|FG000|Overall Study|Withdrawal by Subject|1
7940248|NCT02413229|12478769|FG001|Overall Study|Withdrawal by Subject|1
7940249|NCT02413229|12478770|FG002|Overall Study|Withdrawal by Subject|0
7940250|NCT02413229|12478771|FG003|Overall Study|Withdrawal by Subject|0
7940251|NCT02413229|12478772|FG004|Overall Study|Withdrawal by Subject|1
7940252|NCT02413229|12478773|FG005|Overall Study|Withdrawal by Subject|0
7940253|NCT02413229|12478774|FG006|Overall Study|Withdrawal by Subject|0
7940254|NCT02413229|12478775|FG007|Overall Study|Withdrawal by Subject|2
7940255|NCT02413229|12478768|FG000|Overall Study|Progressive Disease|0
7940256|NCT02413229|12478769|FG001|Overall Study|Progressive Disease|0
7940257|NCT02413229|12478770|FG002|Overall Study|Progressive Disease|0
7940258|NCT02413229|12478771|FG003|Overall Study|Progressive Disease|0
7940259|NCT02413229|12478772|FG004|Overall Study|Progressive Disease|0
7940260|NCT02413229|12478773|FG005|Overall Study|Progressive Disease|0
7940261|NCT02413229|12478774|FG006|Overall Study|Progressive Disease|0
7940262|NCT02413229|12478775|FG007|Overall Study|Progressive Disease|1
7940263|NCT02413255|12478810|FG000|Overall Study|Voluntary Withdrawal|0
7940264|NCT02413255|12478811|FG001|Overall Study|Voluntary Withdrawal|0
7940265|NCT02413255|12478812|FG002|Overall Study|Voluntary Withdrawal|0
7940266|NCT02413255|12478813|FG003|Overall Study|Voluntary Withdrawal|0
7940267|NCT02413255|12478814|FG004|Overall Study|Voluntary Withdrawal|0
7940268|NCT02413255|12478815|FG005|Overall Study|Voluntary Withdrawal|0
7940269|NCT02413255|12478816|FG006|Overall Study|Voluntary Withdrawal|0
7940270|NCT02413255|12478817|FG007|Overall Study|Voluntary Withdrawal|0
7940271|NCT02413255|12478818|FG008|Overall Study|Voluntary Withdrawal|0
7940272|NCT02413255|12478819|FG009|Overall Study|Voluntary Withdrawal|0
7940273|NCT02413255|12478820|FG010|Overall Study|Voluntary Withdrawal|0
7940274|NCT02413255|12478821|FG011|Overall Study|Voluntary Withdrawal|0
7940275|NCT02413255|12478822|FG012|Overall Study|Voluntary Withdrawal|0
7940276|NCT02413255|12478823|FG013|Overall Study|Voluntary Withdrawal|0
7940277|NCT02413255|12478824|FG014|Overall Study|Voluntary Withdrawal|1
7940278|NCT02413255|12478825|FG015|Overall Study|Voluntary Withdrawal|0
7940279|NCT02413255|12478826|FG016|Overall Study|Voluntary Withdrawal|0
7940280|NCT02413294|12478877|FG000|Overall Study|Withdrawal by Subject|1
7940281|NCT02413333|12478894|FG000|Period 1|Adverse Event|1
7940282|NCT02413333|12478895|FG001|Period 1|Adverse Event|0
7940283|NCT02413333|12478894|FG000|Period 1|Reason Not Specified|0
7940284|NCT02413333|12478895|FG001|Period 1|Reason Not Specified|1
7940285|NCT02413333|12478894|FG000|Period 2|Protocol Deviation|1
7940286|NCT02413333|12478895|FG001|Period 2|Protocol Deviation|0
7940287|NCT02413346|12478903|FG000|Overall Study|Adverse Event|6
7940288|NCT02413346|12478904|FG001|Overall Study|Adverse Event|6
7940289|NCT02413346|12478903|FG000|Overall Study|Withdrawal by Subject|30
7940290|NCT02413346|12478904|FG001|Overall Study|Withdrawal by Subject|40
7940291|NCT02413346|12478903|FG000|Overall Study|Lost to Follow-up|17
7940292|NCT02413346|12478904|FG001|Overall Study|Lost to Follow-up|21
7940293|NCT02413346|12478903|FG000|Overall Study|Protocol Violation|2
7940294|NCT02413346|12478904|FG001|Overall Study|Protocol Violation|0
7940295|NCT02413346|12478903|FG000|Overall Study|Other Miscellaneous Reasons|4
7940296|NCT02413346|12478904|FG001|Overall Study|Other Miscellaneous Reasons|3
7940297|NCT02413372|12478913|FG000|Treatment|Lost to Follow-up|0
7940298|NCT02413372|12478914|FG001|Treatment|Lost to Follow-up|2
7940299|NCT02413372|12478915|FG002|Treatment|Lost to Follow-up|1
7940300|NCT02413372|12478913|FG000|Treatment|Withdrawal by Subject|1
7940301|NCT02413372|12478914|FG001|Treatment|Withdrawal by Subject|0
7940302|NCT02413372|12478915|FG002|Treatment|Withdrawal by Subject|0
7940303|NCT02413372|12478913|FG000|Follow-up|Lost to Follow-up|1
7940304|NCT02413372|12478914|FG001|Follow-up|Lost to Follow-up|1
7940305|NCT02413372|12478915|FG002|Follow-up|Lost to Follow-up|0
7940306|NCT02413372|12478913|FG000|Follow-up|Subject Withdrew Consent|1
7940307|NCT02413372|12478914|FG001|Follow-up|Subject Withdrew Consent|0
7940308|NCT02413372|12478915|FG002|Follow-up|Subject Withdrew Consent|1
7940309|NCT02413372|12478913|FG000|Follow-up|Subject unable to return for visit|0
7940310|NCT02413372|12478914|FG001|Follow-up|Subject unable to return for visit|0
7940311|NCT02413372|12478915|FG002|Follow-up|Subject unable to return for visit|1
7940312|NCT02413398|12478925|FG000|Overall Study|Lost to Follow-up|2
7940313|NCT02413398|12478926|FG001|Overall Study|Lost to Follow-up|4
7940314|NCT02413398|12478925|FG000|Overall Study|Withdrawal by Subject|1
7940315|NCT02413398|12478926|FG001|Overall Study|Withdrawal by Subject|1
7940316|NCT02413398|12478925|FG000|Overall Study|Other Eligibility criteria|1
7940317|NCT02413398|12478926|FG001|Overall Study|Other Eligibility criteria|2
7940318|NCT02413489|12478944|FG000|Overall Study|Death|11
7940319|NCT02413489|12478945|FG001|Overall Study|Death|3
7940320|NCT02413489|12478946|FG002|Overall Study|Death|4
7940321|NCT02413489|12478944|FG000|Overall Study|Withdrawal by Subject|2
7940322|NCT02413489|12478945|FG001|Overall Study|Withdrawal by Subject|0
7940323|NCT02413489|12478946|FG002|Overall Study|Withdrawal by Subject|0
7940324|NCT02413489|12478944|FG000|Overall Study|Study Terminated By Sponsor|2
7940325|NCT02413489|12478945|FG001|Overall Study|Study Terminated By Sponsor|13
7940326|NCT02413489|12478946|FG002|Overall Study|Study Terminated By Sponsor|1
7940327|NCT02413593|12478958|FG000|Overall Study|Lost to Follow-up|3
7940328|NCT02413593|12478958|FG000|Overall Study|Adverse Event|1
7940329|NCT02413996|12478979|FG000|Overall Study|not comfortable with the intervention|9
7940330|NCT02413996|12478980|FG001|Overall Study|not comfortable with the intervention|2
7940331|NCT02414828|12479013|FG000|Overall Study|Lost to Follow-up|0
7940332|NCT02414828|12479014|FG001|Overall Study|Lost to Follow-up|1
7940333|NCT02414828|12479015|FG002|Overall Study|Lost to Follow-up|1
7940334|NCT02414828|12479016|FG003|Overall Study|Lost to Follow-up|2
7940335|NCT02414841|12479029|FG000|Overall Study|Withdrawal by Subject|7
7940336|NCT02414841|12479030|FG001|Overall Study|Withdrawal by Subject|5
7940337|NCT02414841|12479029|FG000|Overall Study|Lost to Follow-up|13
7940338|NCT02414841|12479030|FG001|Overall Study|Lost to Follow-up|6
7940339|NCT02414841|12479029|FG000|Overall Study|Death|17
7940340|NCT02414841|12479030|FG001|Overall Study|Death|14
7940341|NCT02414841|12479029|FG000|Overall Study|Received a Kidney Transplant|13
7940342|NCT02414841|12479030|FG001|Overall Study|Received a Kidney Transplant|4
7940343|NCT02414841|12479029|FG000|Overall Study|Randomized But Not Treated|6
7940344|NCT02414841|12479030|FG001|Overall Study|Randomized But Not Treated|4
7940345|NCT02414854|12479042|FG000|Overall Study|Adverse Event|9
7940346|NCT02414854|12479043|FG001|Overall Study|Adverse Event|7
7940347|NCT02414854|12479044|FG002|Overall Study|Adverse Event|1
7940348|NCT02414854|12479045|FG003|Overall Study|Adverse Event|12
7940349|NCT02414854|12479042|FG000|Overall Study|Poor compliance to protocol|1
7940350|NCT02414854|12479043|FG001|Overall Study|Poor compliance to protocol|1
7940351|NCT02414854|12479044|FG002|Overall Study|Poor compliance to protocol|2
7940352|NCT02414854|12479045|FG003|Overall Study|Poor compliance to protocol|2
7940353|NCT02414854|12479042|FG000|Overall Study|Other than specified above|12
7940354|NCT02414854|12479043|FG001|Overall Study|Other than specified above|37
7940355|NCT02414854|12479044|FG002|Overall Study|Other than specified above|17
7940356|NCT02414854|12479045|FG003|Overall Study|Other than specified above|37
7940357|NCT02414932|12479057|FG000|Overall Study|Withdrawal by Subject|2
7940358|NCT02414932|12479058|FG001|Overall Study|Withdrawal by Subject|3
7940359|NCT02414932|12479057|FG000|Overall Study|Adverse Event|1
7940360|NCT02414932|12479058|FG001|Overall Study|Adverse Event|0
7940361|NCT02414958|12479067|FG000|Overall Study|Adverse Event|6
7940362|NCT02414958|12479068|FG001|Overall Study|Adverse Event|6
7940363|NCT02414958|12479069|FG002|Overall Study|Adverse Event|3
7940364|NCT02414958|12479067|FG000|Overall Study|Protocol Violation|10
7940365|NCT02414958|12479068|FG001|Overall Study|Protocol Violation|3
7940366|NCT02414958|12479069|FG002|Overall Study|Protocol Violation|1
7940367|NCT02414958|12479067|FG000|Overall Study|Lost to Follow-up|7
7940368|NCT02414958|12479068|FG001|Overall Study|Lost to Follow-up|4
7940369|NCT02414958|12479069|FG002|Overall Study|Lost to Follow-up|0
7940370|NCT02414958|12479067|FG000|Overall Study|Withdrawal by Subject|5
7940371|NCT02414958|12479068|FG001|Overall Study|Withdrawal by Subject|3
7940372|NCT02414958|12479069|FG002|Overall Study|Withdrawal by Subject|5
7940373|NCT02414958|12479067|FG000|Overall Study|Other than specified|4
7940374|NCT02414958|12479068|FG001|Overall Study|Other than specified|4
7940375|NCT02414958|12479069|FG002|Overall Study|Other than specified|5
7940376|NCT02415127|12479079|FG000|Overall Study|Adverse Event|1
7940377|NCT02415127|12479080|FG001|Overall Study|Adverse Event|0
7940378|NCT02415400|12479099|FG000|Overall Study|Adverse Event|0
7940379|NCT02415400|12479100|FG001|Overall Study|Adverse Event|1
7940380|NCT02415400|12479101|FG002|Overall Study|Adverse Event|1
7940381|NCT02415400|12479102|FG003|Overall Study|Adverse Event|2
7940382|NCT02415400|12479099|FG000|Overall Study|Participant request to stop therapy|4
7940383|NCT02415400|12479100|FG001|Overall Study|Participant request to stop therapy|3
7940384|NCT02415400|12479101|FG002|Overall Study|Participant request to stop therapy|8
7719837|NCT00534495|12143824|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
7940385|NCT02415400|12479102|FG003|Overall Study|Participant request to stop therapy|6
7940386|NCT02415400|12479099|FG000|Overall Study|Participant withdrew consent|14
7940387|NCT02415400|12479100|FG001|Overall Study|Participant withdrew consent|12
7940388|NCT02415400|12479101|FG002|Overall Study|Participant withdrew consent|30
7940389|NCT02415400|12479102|FG003|Overall Study|Participant withdrew consent|21
7940390|NCT02415400|12479099|FG000|Overall Study|Death|39
7940391|NCT02415400|12479100|FG001|Overall Study|Death|41
7940392|NCT02415400|12479101|FG002|Overall Study|Death|35
7940393|NCT02415400|12479102|FG003|Overall Study|Death|42
7940394|NCT02415400|12479099|FG000|Overall Study|Lost to Follow-up|3
7940395|NCT02415400|12479100|FG001|Overall Study|Lost to Follow-up|3
7940396|NCT02415400|12479101|FG002|Overall Study|Lost to Follow-up|2
7940397|NCT02415400|12479102|FG003|Overall Study|Lost to Follow-up|5
7940398|NCT02415400|12479099|FG000|Overall Study|Poor/Non-Compliance|0
7940399|NCT02415400|12479100|FG001|Overall Study|Poor/Non-Compliance|1
7940400|NCT02415400|12479101|FG002|Overall Study|Poor/Non-Compliance|3
7940401|NCT02415400|12479102|FG003|Overall Study|Poor/Non-Compliance|4
7940402|NCT02415400|12479099|FG000|Overall Study|Participant no longer meets criteria|2
7940403|NCT02415400|12479100|FG001|Overall Study|Participant no longer meets criteria|0
7940404|NCT02415400|12479101|FG002|Overall Study|Participant no longer meets criteria|0
7940405|NCT02415400|12479102|FG003|Overall Study|Participant no longer meets criteria|1
7940406|NCT02415400|12479099|FG000|Overall Study|Participant doesn't answer phone|1
7940407|NCT02415400|12479100|FG001|Overall Study|Participant doesn't answer phone|0
7940408|NCT02415400|12479101|FG002|Overall Study|Participant doesn't answer phone|0
7940409|NCT02415400|12479102|FG003|Overall Study|Participant doesn't answer phone|0
7940410|NCT02415400|12479099|FG000|Overall Study|Participant wanted home visits|1
7940411|NCT02415400|12479100|FG001|Overall Study|Participant wanted home visits|0
7940412|NCT02415400|12479101|FG002|Overall Study|Participant wanted home visits|0
7940413|NCT02415400|12479102|FG003|Overall Study|Participant wanted home visits|0
7940414|NCT02415400|12479099|FG000|Overall Study|Randomized in error|2
7940415|NCT02415400|12479100|FG001|Overall Study|Randomized in error|0
7940416|NCT02415400|12479101|FG002|Overall Study|Randomized in error|0
7940417|NCT02415400|12479102|FG003|Overall Study|Randomized in error|0
7940418|NCT02415400|12479099|FG000|Overall Study|No study drug on site|0
7940419|NCT02415400|12479100|FG001|Overall Study|No study drug on site|1
7940420|NCT02415400|12479101|FG002|Overall Study|No study drug on site|0
7940421|NCT02415400|12479102|FG003|Overall Study|No study drug on site|0
7940422|NCT02415400|12479099|FG000|Overall Study|Stroke and stroke rehabilitation|0
7940423|NCT02415400|12479100|FG001|Overall Study|Stroke and stroke rehabilitation|0
7940424|NCT02415400|12479101|FG002|Overall Study|Stroke and stroke rehabilitation|1
7940425|NCT02415400|12479102|FG003|Overall Study|Stroke and stroke rehabilitation|0
7940426|NCT02415400|12479099|FG000|Overall Study|Coagulation values cannot be set|0
7940427|NCT02415400|12479100|FG001|Overall Study|Coagulation values cannot be set|0
7940428|NCT02415400|12479101|FG002|Overall Study|Coagulation values cannot be set|1
7940429|NCT02415400|12479102|FG003|Overall Study|Coagulation values cannot be set|0
7940430|NCT02415400|12479099|FG000|Overall Study|State regulations prevent participation|0
7940431|NCT02415400|12479100|FG001|Overall Study|State regulations prevent participation|0
7940432|NCT02415400|12479101|FG002|Overall Study|State regulations prevent participation|1
7940433|NCT02415400|12479102|FG003|Overall Study|State regulations prevent participation|0
7940434|NCT02415400|12479099|FG000|Overall Study|Poor treatment monitoring|0
7940435|NCT02415400|12479100|FG001|Overall Study|Poor treatment monitoring|0
7940436|NCT02415400|12479101|FG002|Overall Study|Poor treatment monitoring|1
7940437|NCT02415400|12479102|FG003|Overall Study|Poor treatment monitoring|0
7940438|NCT02415400|12479099|FG000|Overall Study|Participant in jail|0
7940439|NCT02415400|12479100|FG001|Overall Study|Participant in jail|0
7940440|NCT02415400|12479101|FG002|Overall Study|Participant in jail|1
7940441|NCT02415400|12479102|FG003|Overall Study|Participant in jail|0
7940442|NCT02415400|12479099|FG000|Overall Study|Investigator decision|0
7940443|NCT02415400|12479100|FG001|Overall Study|Investigator decision|0
7940444|NCT02415400|12479101|FG002|Overall Study|Investigator decision|1
7940445|NCT02415400|12479102|FG003|Overall Study|Investigator decision|1
7940446|NCT02415400|12479099|FG000|Overall Study|Site closure; participant won't transfer|0
7940447|NCT02415400|12479100|FG001|Overall Study|Site closure; participant won't transfer|0
7940448|NCT02415400|12479101|FG002|Overall Study|Site closure; participant won't transfer|0
7940449|NCT02415400|12479102|FG003|Overall Study|Site closure; participant won't transfer|1
7940450|NCT02415595|12479175|FG000|Overall Study|Administrative reason by sponsor|39
7940451|NCT02415595|12479176|FG001|Overall Study|Administrative reason by sponsor|40
7940452|NCT02415595|12479177|FG002|Overall Study|Administrative reason by sponsor|41
7940453|NCT02415595|12479178|FG003|Overall Study|Administrative reason by sponsor|39
7940454|NCT02415595|12479175|FG000|Overall Study|Adverse Event|1
7940455|NCT02415595|12479176|FG001|Overall Study|Adverse Event|3
7940456|NCT02415595|12479177|FG002|Overall Study|Adverse Event|5
7940457|NCT02415595|12479178|FG003|Overall Study|Adverse Event|10
7940458|NCT02415595|12479175|FG000|Overall Study|Lack of Efficacy|4
7940459|NCT02415595|12479176|FG001|Overall Study|Lack of Efficacy|4
7940460|NCT02415595|12479177|FG002|Overall Study|Lack of Efficacy|0
7940461|NCT02415595|12479178|FG003|Overall Study|Lack of Efficacy|0
7940462|NCT02415595|12479175|FG000|Overall Study|Lost to Follow-up|1
7940463|NCT02415595|12479176|FG001|Overall Study|Lost to Follow-up|3
7940464|NCT02415595|12479177|FG002|Overall Study|Lost to Follow-up|1
7940465|NCT02415595|12479178|FG003|Overall Study|Lost to Follow-up|1
7940466|NCT02415595|12479175|FG000|Overall Study|Poor/Non-compliance|1
7940467|NCT02415595|12479176|FG001|Overall Study|Poor/Non-compliance|0
7940468|NCT02415595|12479177|FG002|Overall Study|Poor/Non-compliance|1
7940469|NCT02415595|12479178|FG003|Overall Study|Poor/Non-compliance|0
7940470|NCT02415595|12479175|FG000|Overall Study|Reached stopping criteria|0
7940471|NCT02415595|12479176|FG001|Overall Study|Reached stopping criteria|1
7940472|NCT02415595|12479177|FG002|Overall Study|Reached stopping criteria|1
7940473|NCT02415595|12479178|FG003|Overall Study|Reached stopping criteria|0
7940474|NCT02415595|12479175|FG000|Overall Study|Withdrawal by Subject|4
7940475|NCT02415595|12479176|FG001|Overall Study|Withdrawal by Subject|0
7940476|NCT02415595|12479177|FG002|Overall Study|Withdrawal by Subject|1
7940477|NCT02415595|12479178|FG003|Overall Study|Withdrawal by Subject|3
7940478|NCT02415595|12479175|FG000|Overall Study|Other|0
7940479|NCT02415595|12479176|FG001|Overall Study|Other|1
7940480|NCT02415595|12479177|FG002|Overall Study|Other|1
7940481|NCT02415595|12479178|FG003|Overall Study|Other|0
7940482|NCT02415959|12479282|FG000|Overall Study|Adverse Event|0
7940483|NCT02415959|12479283|FG001|Overall Study|Adverse Event|1
7940484|NCT02415959|12479284|FG002|Overall Study|Adverse Event|0
7940485|NCT02415959|12479285|FG003|Overall Study|Adverse Event|0
7940486|NCT02415959|12479286|FG004|Overall Study|Adverse Event|0
7940487|NCT02415959|12479282|FG000|Overall Study|Protocol Violation|0
7940488|NCT02415959|12479283|FG001|Overall Study|Protocol Violation|0
7940489|NCT02415959|12479284|FG002|Overall Study|Protocol Violation|0
7940490|NCT02415959|12479285|FG003|Overall Study|Protocol Violation|1
7940491|NCT02415959|12479286|FG004|Overall Study|Protocol Violation|0
7940492|NCT02416180|12479315|FG000|Overall Study|Withdrawal by Subject|1
7719838|NCT00534495|12143822|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
7719839|NCT00534495|12143823|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
7719840|NCT00534495|12143824|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
7719841|NCT00534495|12143822|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0
7940493|NCT02416453|12479339|FG000|Overall Study|Adverse Event|0
7940494|NCT02416453|12479340|FG001|Overall Study|Adverse Event|0
7822187|NCT01260350|12291180|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0
7940495|NCT02416453|12479341|FG002|Overall Study|Adverse Event|0
7940496|NCT02416453|12479342|FG003|Overall Study|Adverse Event|2
7940497|NCT02416453|12479343|FG004|Overall Study|Adverse Event|0
7940498|NCT02416453|12479344|FG005|Overall Study|Adverse Event|1
7940499|NCT02416453|12479345|FG006|Overall Study|Adverse Event|0
7940500|NCT02416453|12479346|FG007|Overall Study|Adverse Event|0
7940501|NCT02416453|12479347|FG008|Overall Study|Adverse Event|0
7940502|NCT02416453|12479348|FG009|Overall Study|Adverse Event|0
7940503|NCT02416453|12479349|FG010|Overall Study|Adverse Event|0
7940504|NCT02416453|12479339|FG000|Overall Study|Lost to Follow-up|1
7940505|NCT02416453|12479340|FG001|Overall Study|Lost to Follow-up|3
7940506|NCT02416453|12479341|FG002|Overall Study|Lost to Follow-up|0
7940507|NCT02416453|12479342|FG003|Overall Study|Lost to Follow-up|8
7940508|NCT02416453|12479343|FG004|Overall Study|Lost to Follow-up|0
7940509|NCT02416453|12479344|FG005|Overall Study|Lost to Follow-up|5
7940510|NCT02416453|12479345|FG006|Overall Study|Lost to Follow-up|1
7940511|NCT02416453|12479346|FG007|Overall Study|Lost to Follow-up|3
7940512|NCT02416453|12479347|FG008|Overall Study|Lost to Follow-up|1
7940513|NCT02416453|12479348|FG009|Overall Study|Lost to Follow-up|0
7940514|NCT02416453|12479349|FG010|Overall Study|Lost to Follow-up|0
7940515|NCT02416453|12479339|FG000|Overall Study|Physician Decision|0
7940516|NCT02416453|12479340|FG001|Overall Study|Physician Decision|0
7940517|NCT02416453|12479341|FG002|Overall Study|Physician Decision|0
7940518|NCT02416453|12479342|FG003|Overall Study|Physician Decision|0
7940519|NCT02416453|12479343|FG004|Overall Study|Physician Decision|0
7940520|NCT02416453|12479344|FG005|Overall Study|Physician Decision|1
7940521|NCT02416453|12479345|FG006|Overall Study|Physician Decision|1
7940522|NCT02416453|12479346|FG007|Overall Study|Physician Decision|1
7940523|NCT02416453|12479347|FG008|Overall Study|Physician Decision|0
7940524|NCT02416453|12479348|FG009|Overall Study|Physician Decision|0
7940525|NCT02416453|12479349|FG010|Overall Study|Physician Decision|0
7940526|NCT02416453|12479339|FG000|Overall Study|Withdrawal by Subject|2
7940527|NCT02416453|12479340|FG001|Overall Study|Withdrawal by Subject|0
7940528|NCT02416453|12479341|FG002|Overall Study|Withdrawal by Subject|0
7940529|NCT02416453|12479342|FG003|Overall Study|Withdrawal by Subject|5
7940530|NCT02416453|12479343|FG004|Overall Study|Withdrawal by Subject|1
7940531|NCT02416453|12479344|FG005|Overall Study|Withdrawal by Subject|8
7940532|NCT02416453|12479345|FG006|Overall Study|Withdrawal by Subject|0
7940533|NCT02416453|12479346|FG007|Overall Study|Withdrawal by Subject|8
7940534|NCT02416453|12479347|FG008|Overall Study|Withdrawal by Subject|4
7940535|NCT02416453|12479348|FG009|Overall Study|Withdrawal by Subject|0
7940536|NCT02416453|12479349|FG010|Overall Study|Withdrawal by Subject|0
7940537|NCT02416453|12479339|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7940538|NCT02416453|12479340|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7940539|NCT02416453|12479341|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1
7940540|NCT02416453|12479342|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7940541|NCT02416453|12479343|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7940542|NCT02416453|12479344|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7940543|NCT02416453|12479345|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7940544|NCT02416453|12479346|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7940545|NCT02416453|12479347|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7940546|NCT02416453|12479348|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7940547|NCT02416453|12479349|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7940548|NCT02416453|12479339|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7940549|NCT02416453|12479340|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7940550|NCT02416453|12479341|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7940551|NCT02416453|12479342|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7940552|NCT02416453|12479343|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7940553|NCT02416453|12479344|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1
7940554|NCT02416453|12479345|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7940555|NCT02416453|12479346|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7940556|NCT02416453|12479347|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7940557|NCT02416453|12479348|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7940558|NCT02416453|12479349|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7940559|NCT02416791|12479399|FG000|6 Months|Lost to Follow-up|0
7940560|NCT02416791|12479400|FG001|6 Months|Lost to Follow-up|0
7940561|NCT02416791|12479401|FG002|6 Months|Lost to Follow-up|1
7940562|NCT02416908|12479412|FG000|Dose Escalation Phase|Adverse Event|0
7940563|NCT02416908|12479413|FG001|Dose Escalation Phase|Adverse Event|0
7940564|NCT02416908|12479414|FG002|Dose Escalation Phase|Adverse Event|3
7940565|NCT02416908|12479415|FG003|Dose Escalation Phase|Adverse Event|0
7940566|NCT02416908|12479412|FG000|Dose Escalation Phase|Withdrawal by Subject|0
7940567|NCT02416908|12479413|FG001|Dose Escalation Phase|Withdrawal by Subject|0
7940568|NCT02416908|12479414|FG002|Dose Escalation Phase|Withdrawal by Subject|1
7940569|NCT02416908|12479415|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7940570|NCT02416934|12479424|FG000|Overall Study|given steroids|1
7940571|NCT02416934|12479425|FG001|Overall Study|given steroids|2
7940572|NCT02416934|12479424|FG000|Overall Study|Lost to Follow-up|0
7940573|NCT02416934|12479425|FG001|Overall Study|Lost to Follow-up|2
7940574|NCT02416934|12479424|FG000|Overall Study|Withdrawal by Subject|1
7940575|NCT02416934|12479425|FG001|Overall Study|Withdrawal by Subject|0
7940576|NCT02416934|12479424|FG000|Overall Study|recruited during continuing renewal proc|0
7940577|NCT02416934|12479425|FG001|Overall Study|recruited during continuing renewal proc|1
7940578|NCT02416934|12479424|FG000|Overall Study|Protocol Violation|0
7940579|NCT02416934|12479425|FG001|Overall Study|Protocol Violation|1
7940580|NCT02416934|12479424|FG000|Overall Study|surgery started late|0
7940581|NCT02416934|12479425|FG001|Overall Study|surgery started late|1
7940582|NCT02416934|12479424|FG000|Overall Study|re-operation|1
7940583|NCT02416934|12479425|FG001|Overall Study|re-operation|0
7940584|NCT02417064|12479453|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1
7940585|NCT02417064|12479454|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7
7940586|NCT02417064|12479455|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
7940587|NCT02417064|12479453|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
7940588|NCT02417064|12479454|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
7940589|NCT02417064|12479455|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0
7940590|NCT02417064|12479453|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
7940591|NCT02417064|12479454|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
7940592|NCT02417064|12479455|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
7940593|NCT02417064|12479453|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2
7940594|NCT02417064|12479454|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
7940595|NCT02417064|12479455|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
7940596|NCT02417064|12479453|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
7940597|NCT02417064|12479454|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5
7940598|NCT02417064|12479455|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
7940599|NCT02417064|12479453|FG000|Double-blind Induction Phase (4 Weeks)|Other|1
7940600|NCT02417064|12479454|FG001|Double-blind Induction Phase (4 Weeks)|Other|4
7940601|NCT02417064|12479455|FG002|Double-blind Induction Phase (4 Weeks)|Other|2
7940602|NCT02417064|12479453|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0
7940603|NCT02417064|12479454|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2
7940604|NCT02417064|12479455|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1
7940605|NCT02417064|12479453|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0
7940606|NCT02417064|12479454|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0
7940607|NCT02417064|12479455|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1
7940608|NCT02417064|12479453|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
7940609|NCT02417064|12479454|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9
7940610|NCT02417064|12479455|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2
7940611|NCT02417064|12479453|FG000|Follow-up Phase (24 Weeks)|PI Decision|34
7940612|NCT02417064|12479454|FG001|Follow-up Phase (24 Weeks)|PI Decision|29
7940613|NCT02417064|12479455|FG002|Follow-up Phase (24 Weeks)|PI Decision|44
7940614|NCT02417064|12479453|FG000|Follow-up Phase (24 Weeks)|Other|2
7940615|NCT02417064|12479454|FG001|Follow-up Phase (24 Weeks)|Other|2
7940616|NCT02417064|12479455|FG002|Follow-up Phase (24 Weeks)|Other|3
7940617|NCT02417233|12479476|FG000|Overall Study|Death|4
7940618|NCT02417233|12479477|FG001|Overall Study|Death|10
7940619|NCT02417233|12479478|FG002|Overall Study|Death|14
7940620|NCT02417233|12479476|FG000|Overall Study|Lost to Follow-up|27
7940621|NCT02417233|12479477|FG001|Overall Study|Lost to Follow-up|39
7940622|NCT02417233|12479478|FG002|Overall Study|Lost to Follow-up|34
7940623|NCT02417233|12479476|FG000|Overall Study|Protocol Violation|2
7940624|NCT02417233|12479477|FG001|Overall Study|Protocol Violation|0
7940625|NCT02417233|12479478|FG002|Overall Study|Protocol Violation|2
7940626|NCT02417233|12479476|FG000|Overall Study|Withdrawal by Subject|2
7940627|NCT02417233|12479477|FG001|Overall Study|Withdrawal by Subject|1
7940628|NCT02417233|12479478|FG002|Overall Study|Withdrawal by Subject|8
7940629|NCT02417233|12479476|FG000|Overall Study|Relocation out of study area|1
7940630|NCT02417233|12479477|FG001|Overall Study|Relocation out of study area|0
7940631|NCT02417233|12479478|FG002|Overall Study|Relocation out of study area|1
7940632|NCT02417233|12479476|FG000|Overall Study|Mentally unstable|0
7940633|NCT02417233|12479477|FG001|Overall Study|Mentally unstable|1
7940634|NCT02417233|12479478|FG002|Overall Study|Mentally unstable|0
7940635|NCT02417246|12479489|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
7940636|NCT02417246|12479490|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
7940637|NCT02417246|12479489|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1
7940638|NCT02417246|12479490|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0
7940639|NCT02417246|12479489|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2
7940640|NCT02417246|12479490|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3
7940641|NCT02417246|12479489|FG000|Phase 2 1st Generic Administered|Physician Decision|1
7940642|NCT02417246|12479490|FG001|Phase 2 1st Generic Administered|Physician Decision|0
7965190|NCT01721772|12520880|FG001|Pre-Treatment|Participant no longer meets study criteria|1
7965191|NCT01721772|12520879|FG000|Pre-Treatment|Poor/non-compliance|0
7965192|NCT01721772|12520880|FG001|Pre-Treatment|Poor/non-compliance|1
7965193|NCT01721772|12520879|FG000|Pre-Treatment|Participant withdrew consent|0
7965194|NCT01721772|12520880|FG001|Pre-Treatment|Participant withdrew consent|1
7965195|NCT01721772|12520879|FG000|Pre-Treatment|Adverse event unrelated to study drug|1
7965196|NCT01721772|12520880|FG001|Pre-Treatment|Adverse event unrelated to study drug|0
7965197|NCT01721772|12520879|FG000|Treatment|Disease progression|119
7965198|NCT01721772|12520880|FG001|Treatment|Disease progression|168
7965199|NCT01721772|12520879|FG000|Treatment|Study drug toxicity|19
7965200|NCT01721772|12520880|FG001|Treatment|Study drug toxicity|10
7965201|NCT01721772|12520879|FG000|Treatment|Adverse event unrelated to study drug|7
7965202|NCT01721772|12520880|FG001|Treatment|Adverse event unrelated to study drug|7
7965203|NCT01721772|12520879|FG000|Treatment|Maximum clinical benefit|16
7965204|NCT01721772|12520880|FG001|Treatment|Maximum clinical benefit|4
7965205|NCT01721772|12520879|FG000|Treatment|Other|19
7965206|NCT01721772|12520880|FG001|Treatment|Other|2
7965207|NCT01721772|12520879|FG000|Treatment|Participant withdrew consent|2
7965208|NCT01721772|12520880|FG001|Treatment|Participant withdrew consent|5
7965209|NCT01721772|12520879|FG000|Treatment|Participant request to discontinue study treatment|21
7965210|NCT01721772|12520880|FG001|Treatment|Participant request to discontinue study treatment|8
7965211|NCT01721772|12520879|FG000|Treatment|Death|1
7965212|NCT01721772|12520880|FG001|Treatment|Death|0
7965213|NCT01721772|12520879|FG000|Treatment|Not reported|1
7965214|NCT01721772|12520880|FG001|Treatment|Not reported|0
7965215|NCT01721772|12520879|FG000|Treatment|Poor/non-compliance|1
7965216|NCT01721772|12520880|FG001|Treatment|Poor/non-compliance|0
7965217|NCT01721772|12520879|FG000|Treatment|Lost to Follow-up|0
7965218|NCT01721772|12520880|FG001|Treatment|Lost to Follow-up|1
7965219|NCT01412333|12520888|FG000|Overall Study|Death|1
7965220|NCT01412333|12520889|FG001|Overall Study|Death|1
7965221|NCT01412333|12520888|FG000|Overall Study|Physician Decision|0
7965222|NCT01412333|12520889|FG001|Overall Study|Physician Decision|1
7965223|NCT01412333|12520888|FG000|Overall Study|Reason not specified|16
7965224|NCT01412333|12520889|FG001|Overall Study|Reason not specified|10
7965225|NCT01412333|12520888|FG000|Overall Study|Non-compliance with study drug|1
7965226|NCT01412333|12520889|FG001|Overall Study|Non-compliance with study drug|1
7940643|NCT02417441|12479509|FG000|Overall Study|Inconclusive due to missing data|52
7940644|NCT02417441|12479510|FG001|Overall Study|Inconclusive due to missing data|19
7940645|NCT02417753|12479523|FG000|Overall Study|Death|1
7940646|NCT02417935|12479543|FG000|Treatment Period|Adverse Event|12
7940647|NCT02417935|12479544|FG001|Treatment Period|Adverse Event|10
7940648|NCT02417935|12479543|FG000|Treatment Period|Lost to Follow-up|1
7940649|NCT02417935|12479544|FG001|Treatment Period|Lost to Follow-up|0
7940650|NCT02417935|12479543|FG000|Treatment Period|Entry Criteria not met|0
7940651|NCT02417935|12479544|FG001|Treatment Period|Entry Criteria not met|1
7940652|NCT02417935|12479543|FG000|Treatment Period|Protocol Violation|2
7940653|NCT02417935|12479544|FG001|Treatment Period|Protocol Violation|1
7940654|NCT02417935|12479543|FG000|Treatment Period|Withdrawal by Subject|3
7940655|NCT02417935|12479544|FG001|Treatment Period|Withdrawal by Subject|3
7940656|NCT02417935|12479543|FG000|Treatment Period|Physician Decision|3
7940657|NCT02417935|12479544|FG001|Treatment Period|Physician Decision|1
7940658|NCT02417961|12479550|FG000|Overall Study|Adverse Event|1
7940659|NCT02417961|12479550|FG000|Overall Study|Lost to Follow-up|1
7940660|NCT02417961|12479550|FG000|Overall Study|Withdrawal by Subject|2
7940661|NCT02418000|12479559|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2
7940662|NCT02418000|12479560|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7940663|NCT02418000|12479561|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7940664|NCT02418000|12479562|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7940665|NCT02418000|12479563|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7940666|NCT02418000|12479559|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4
7940667|NCT02418000|12479560|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7940668|NCT02418000|12479561|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7940669|NCT02418000|12479562|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7940670|NCT02418000|12479563|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7940671|NCT02418000|12479559|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1
7940672|NCT02418000|12479560|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7940673|NCT02418000|12479561|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7940674|NCT02418000|12479562|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7940675|NCT02418000|12479563|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7940676|NCT02418000|12479559|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7940677|NCT02418000|12479560|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1
7940678|NCT02418000|12479561|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7940679|NCT02418000|12479562|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7940680|NCT02418000|12479563|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7940681|NCT02418000|12479559|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7940682|NCT02418000|12479560|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9
7940683|NCT02418000|12479561|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7940684|NCT02418000|12479562|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7940685|NCT02418000|12479563|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7940686|NCT02418000|12479559|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7940687|NCT02418000|12479560|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7940688|NCT02418000|12479561|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3
7940689|NCT02418000|12479562|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7940690|NCT02418000|12479563|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7940691|NCT02418000|12479559|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7940692|NCT02418000|12479560|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7940693|NCT02418000|12479561|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7940694|NCT02418000|12479562|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3
7940695|NCT02418000|12479563|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7940696|NCT02418000|12479559|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7940697|NCT02418000|12479560|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7940698|NCT02418000|12479561|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7940699|NCT02418000|12479562|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7940700|NCT02418000|12479563|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1
7940701|NCT02418000|12479559|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7940702|NCT02418000|12479560|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7940703|NCT02418000|12479561|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7940704|NCT02418000|12479562|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7940705|NCT02418000|12479563|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3
7940706|NCT02418156|12479596|FG000|Overall Study|Lost to Follow-up|12
7940707|NCT02418156|12479596|FG000|Overall Study|Death|2
7940708|NCT02418156|12479596|FG000|Overall Study|Physician Decision|1
7940709|NCT02418156|12479596|FG000|Overall Study|Withdrawal by Subject|1
7940710|NCT02418156|12479596|FG000|Overall Study|Subject refused to return|1
7940711|NCT02418182|12479602|FG000|Overall Study|Unable to re-consent|18
7940712|NCT02418182|12479603|FG001|Overall Study|Unable to re-consent|15
7940713|NCT02418182|12479602|FG000|Overall Study|Lost to Follow-up|0
7940714|NCT02418182|12479603|FG001|Overall Study|Lost to Follow-up|2
7940715|NCT02418455|12479626|FG000|48-Week Treatment Period|Other- Not Specified|1
7940716|NCT02418455|12479626|FG000|Continuation Period|Sponsor Decision|7
7940717|NCT02418468|12479634|FG000|Overall Study|Adverse Event|1
7940718|NCT02418468|12479635|FG001|Overall Study|Adverse Event|0
7940719|NCT02418468|12479634|FG000|Overall Study|Withdrawal of informed consent|1
7940720|NCT02418468|12479635|FG001|Overall Study|Withdrawal of informed consent|1
7940721|NCT02418585|12479656|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
7940722|NCT02418585|12479657|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
7940723|NCT02418585|12479656|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
7940724|NCT02418585|12479657|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
7940725|NCT02418585|12479656|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4
7940726|NCT02418585|12479657|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7
7940727|NCT02418585|12479656|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2
7940728|NCT02418585|12479657|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0
7940729|NCT02418585|12479656|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9
7940730|NCT02418585|12479657|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1
7940731|NCT02418585|12479656|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0
7940732|NCT02418585|12479657|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1
7940733|NCT02418585|12479656|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
7822188|NCT01260350|12291181|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0
7822189|NCT01260350|12291182|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1
7822190|NCT01260350|12291183|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0
7822191|NCT01260350|12291184|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0
7822192|NCT01260350|12291185|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0
7822193|NCT01260350|12291186|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0
7822194|NCT01260350|12291187|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0
7822195|NCT01260350|12291188|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0
7822196|NCT01260350|12291189|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0
7822197|NCT01260350|12291190|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0
7822198|NCT01260350|12291191|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0
7822199|NCT01260350|12291192|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0
7822200|NCT01260350|12291193|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0
7940734|NCT02418585|12479657|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
7940735|NCT02418585|12479656|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6
7940736|NCT02418585|12479657|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
7940737|NCT02418585|12479656|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6
7940738|NCT02418585|12479657|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17
7940739|NCT02418585|12479656|FG000|Follow-up Phase (24 Weeks)|Other|3
7940740|NCT02418585|12479657|FG001|Follow-up Phase (24 Weeks)|Other|2
7940741|NCT02418754|12479681|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0
7940742|NCT02418754|12479682|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2
7940743|NCT02418754|12479683|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0
7940744|NCT02418754|12479684|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0
7940745|NCT02418754|12479685|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0
7940746|NCT02418754|12479681|FG000|Period 1 (Day 1 to Week 12)|Death|1
7940747|NCT02418754|12479682|FG001|Period 1 (Day 1 to Week 12)|Death|0
7940748|NCT02418754|12479683|FG002|Period 1 (Day 1 to Week 12)|Death|0
7940749|NCT02418754|12479684|FG003|Period 1 (Day 1 to Week 12)|Death|0
7940750|NCT02418754|12479685|FG004|Period 1 (Day 1 to Week 12)|Death|0
7940751|NCT02418754|12479681|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1
7940752|NCT02418754|12479682|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0
7940753|NCT02418754|12479683|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0
7940754|NCT02418754|12479684|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0
7940755|NCT02418754|12479685|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0
7940756|NCT02418754|12479681|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
7940757|NCT02418754|12479682|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2
7940758|NCT02418754|12479683|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1
7940759|NCT02418754|12479684|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
7940760|NCT02418754|12479685|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
7940761|NCT02418754|12479681|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7940762|NCT02418754|12479682|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7940763|NCT02418754|12479683|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1
7940764|NCT02418754|12479684|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7940765|NCT02418754|12479685|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7940766|NCT02418754|12479681|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3
7940767|NCT02418754|12479682|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7
7940768|NCT02418754|12479683|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6
7940769|NCT02418754|12479684|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
7940770|NCT02418754|12479685|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
7940771|NCT02418754|12479681|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1
7940772|NCT02418754|12479682|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7940773|NCT02418754|12479683|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7940774|NCT02418754|12479684|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7940775|NCT02418754|12479685|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7940776|NCT02418754|12479681|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
7940777|NCT02418754|12479682|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28
7940778|NCT02418754|12479683|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
7940779|NCT02418754|12479684|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21
7940780|NCT02418754|12479685|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24
7940781|NCT02418754|12479681|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3
7940782|NCT02418754|12479682|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
7940783|NCT02418754|12479683|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
7940784|NCT02418754|12479684|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1
7940785|NCT02418754|12479685|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0
7940786|NCT02418754|12479681|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0
7940787|NCT02418754|12479682|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
7940788|NCT02418754|12479683|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
7940789|NCT02418754|12479684|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
7940790|NCT02418754|12479685|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
7940791|NCT02418754|12479681|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
7940792|NCT02418754|12479682|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
7940793|NCT02418754|12479683|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
7940794|NCT02418754|12479684|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
7940795|NCT02418754|12479685|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
7940796|NCT02418819|12479699|FG000|Overall Study|Adverse Event|0
7940797|NCT02418819|12479700|FG001|Overall Study|Adverse Event|0
7940798|NCT02418819|12479701|FG002|Overall Study|Adverse Event|1
7940799|NCT02418819|12479702|FG003|Overall Study|Adverse Event|0
7940800|NCT02418819|12479699|FG000|Overall Study|Lost to Follow-up|1
7940801|NCT02418819|12479700|FG001|Overall Study|Lost to Follow-up|0
7940802|NCT02418819|12479701|FG002|Overall Study|Lost to Follow-up|0
7940803|NCT02418819|12479702|FG003|Overall Study|Lost to Follow-up|0
7940804|NCT02418819|12479699|FG000|Overall Study|No longer meets eligibility criteria|0
7940805|NCT02418819|12479700|FG001|Overall Study|No longer meets eligibility criteria|0
7940806|NCT02418819|12479701|FG002|Overall Study|No longer meets eligibility criteria|1
7940807|NCT02418819|12479702|FG003|Overall Study|No longer meets eligibility criteria|0
7940808|NCT02418819|12479699|FG000|Overall Study|No longer willing to participate|0
7940809|NCT02418819|12479700|FG001|Overall Study|No longer willing to participate|0
7940810|NCT02418819|12479701|FG002|Overall Study|No longer willing to participate|2
7940811|NCT02418819|12479702|FG003|Overall Study|No longer willing to participate|1
7940812|NCT02418845|12479714|FG000|Overall Study|Lost to Follow-up|7
7940813|NCT02418845|12479715|FG001|Overall Study|Lost to Follow-up|2
7940814|NCT02418845|12479714|FG000|Overall Study|Lack of Efficacy|0
7940815|NCT02418845|12479715|FG001|Overall Study|Lack of Efficacy|3
7940816|NCT02418845|12479714|FG000|Overall Study|Physician Decision|5
7940817|NCT02418845|12479715|FG001|Overall Study|Physician Decision|5
7940818|NCT02418845|12479714|FG000|Overall Study|Protocol Violation|1
7940819|NCT02418845|12479715|FG001|Overall Study|Protocol Violation|0
7940820|NCT02418845|12479714|FG000|Overall Study|Withdrawal by Subject|3
7940821|NCT02418845|12479715|FG001|Overall Study|Withdrawal by Subject|2
7940822|NCT02418910|12479721|FG000|Overall Study|Lost to Follow-up|3
7940823|NCT02418910|12479721|FG000|Overall Study|Withdrawal by Subject|4
7940824|NCT02418949|12479729|FG000|Overall Study|Withdrawal by Subject|1
7940825|NCT02418949|12479730|FG001|Overall Study|Withdrawal by Subject|0
7940826|NCT02418949|12479731|FG002|Overall Study|Withdrawal by Subject|1
7940827|NCT02418949|12479732|FG003|Overall Study|Withdrawal by Subject|1
7940828|NCT02418949|12479729|FG000|Overall Study|Lost to Follow-up|1
7940829|NCT02418949|12479730|FG001|Overall Study|Lost to Follow-up|0
7940830|NCT02418949|12479731|FG002|Overall Study|Lost to Follow-up|1
7940831|NCT02418949|12479732|FG003|Overall Study|Lost to Follow-up|0
7940832|NCT02418949|12479729|FG000|Overall Study|Physician Decision|1
7940833|NCT02418949|12479730|FG001|Overall Study|Physician Decision|1
7940834|NCT02418949|12479731|FG002|Overall Study|Physician Decision|1
7940835|NCT02418949|12479732|FG003|Overall Study|Physician Decision|0
7940836|NCT02419001|12479744|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
7940837|NCT02419001|12479745|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
7940838|NCT02419313|12479751|FG000|First Intervention|Lost to Follow-up|2
7940839|NCT02419313|12479752|FG001|First Intervention|Lost to Follow-up|0
7940840|NCT02419313|12479751|FG000|Second Intervention|Lost to Follow-up|1
7940841|NCT02419313|12479752|FG001|Second Intervention|Lost to Follow-up|0
7940842|NCT02419469|12479758|FG000|Overall Study|Withdrawal by Subject|1
7940843|NCT02419508|12479764|FG000|Overall Study|Adverse Event|9
7940844|NCT02419508|12479765|FG001|Overall Study|Adverse Event|3
7940845|NCT02419508|12479764|FG000|Overall Study|Withdrawal by Subject|1
7940846|NCT02419508|12479765|FG001|Overall Study|Withdrawal by Subject|0
7940847|NCT02419508|12479764|FG000|Overall Study|Other - Reason not specified|0
7940848|NCT02419508|12479765|FG001|Overall Study|Other - Reason not specified|1
7940849|NCT02419573|12479781|FG000|Overall Study|Lost to Follow-up|3
7940850|NCT02419573|12479782|FG001|Overall Study|Lost to Follow-up|0
7940851|NCT02419573|12479781|FG000|Overall Study|Withdrawal by Subject|1
7940852|NCT02419573|12479782|FG001|Overall Study|Withdrawal by Subject|0
7940853|NCT02419612|12479790|FG000|Short-term Treatment Period|Adverse Event|1
7940854|NCT02419612|12479791|FG001|Short-term Treatment Period|Adverse Event|1
7940855|NCT02419612|12479790|FG000|Short-term Treatment Period|Death|0
7940856|NCT02419612|12479791|FG001|Short-term Treatment Period|Death|2
7940857|NCT02419612|12479790|FG000|Short-term Treatment Period|Lost to Follow-up|6
7940858|NCT02419612|12479791|FG001|Short-term Treatment Period|Lost to Follow-up|6
7940859|NCT02419612|12479790|FG000|Short-term Treatment Period|Withdrawal by Subject|9
7940860|NCT02419612|12479791|FG001|Short-term Treatment Period|Withdrawal by Subject|9
7940861|NCT02419612|12479790|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
7940862|NCT02419612|12479791|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
7940863|NCT02419612|12479790|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0
7940864|NCT02419612|12479791|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2
7940865|NCT02419612|12479790|FG000|Short-term Treatment Period|Worsening of liver function|0
7940866|NCT02419612|12479791|FG001|Short-term Treatment Period|Worsening of liver function|1
7940867|NCT02419612|12479790|FG000|Short-term Treatment Period|Subject moved out of state|0
7940868|NCT02419612|12479791|FG001|Short-term Treatment Period|Subject moved out of state|1
7940869|NCT02419612|12479790|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1
7940870|NCT02419612|12479791|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1
7940871|NCT02419612|12479790|FG000|Long-term Treatment Period|Lost to Follow-up|6
7940872|NCT02419612|12479791|FG001|Long-term Treatment Period|Lost to Follow-up|4
7940873|NCT02419612|12479790|FG000|Long-term Treatment Period|Lack of Efficacy|1
7940874|NCT02419612|12479791|FG001|Long-term Treatment Period|Lack of Efficacy|1
7940875|NCT02419612|12479790|FG000|Long-term Treatment Period|Death|0
7940876|NCT02419612|12479791|FG001|Long-term Treatment Period|Death|1
7940877|NCT02419612|12479790|FG000|Long-term Treatment Period|Adverse Event|0
7940878|NCT02419612|12479791|FG001|Long-term Treatment Period|Adverse Event|5
7940879|NCT02419612|12479790|FG000|Long-term Treatment Period|Other|4
7940880|NCT02419612|12479791|FG001|Long-term Treatment Period|Other|4
7940881|NCT02419612|12479790|FG000|Long-term Treatment Period|Subject Decision|2
7940882|NCT02419612|12479791|FG001|Long-term Treatment Period|Subject Decision|4
7940883|NCT02419612|12479790|FG000|Long-term Treatment Period|Withdrawal by Subject|8
7940884|NCT02419612|12479791|FG001|Long-term Treatment Period|Withdrawal by Subject|2
7940885|NCT02419755|12479808|FG000|Overall Study|Death|1
7940886|NCT02419755|12479809|FG001|Overall Study|Death|3
7940887|NCT02419755|12479808|FG000|Overall Study|Relapse|0
7940888|NCT02419755|12479809|FG001|Overall Study|Relapse|1
7940889|NCT02419755|12479808|FG000|Overall Study|Ineligible|1
7940890|NCT02419755|12479809|FG001|Overall Study|Ineligible|0
7940891|NCT02419755|12479808|FG000|Overall Study|Withdrawal by Subject|1
7940892|NCT02419755|12479809|FG001|Overall Study|Withdrawal by Subject|0
7940893|NCT02419937|12479821|FG000|Overall Study|Lost to Follow-up|1
7940894|NCT02419937|12479822|FG001|Overall Study|Lost to Follow-up|0
7940895|NCT02420093|12479848|FG000|Overall Study|Withdrawal by Subject|1
7940896|NCT02420093|12479849|FG001|Overall Study|Withdrawal by Subject|1
7940897|NCT02420223|12479861|FG000|Overall Study|Adverse Event|1
7940898|NCT02420223|12479862|FG001|Overall Study|Adverse Event|0
7940899|NCT02420223|12479861|FG000|Overall Study|Physician Decision|0
7940900|NCT02420223|12479862|FG001|Overall Study|Physician Decision|2
7940901|NCT02420262|12479870|FG000|Overall Study|Adverse Event|1
7940902|NCT02420262|12479871|FG001|Overall Study|Adverse Event|0
7940903|NCT02420262|12479870|FG000|Overall Study|Withdrawal by Subject|1
7940904|NCT02420262|12479871|FG001|Overall Study|Withdrawal by Subject|4
7940905|NCT02420262|12479870|FG000|Overall Study|Unclassified|0
7940906|NCT02420262|12479871|FG001|Overall Study|Unclassified|1
7940907|NCT02420327|12479877|FG000|Overall Study|Adverse Event|7
7940908|NCT02420327|12479877|FG000|Overall Study|Pregnancy|1
7940909|NCT02420327|12479877|FG000|Overall Study|Withdrawal by Subject|6
7940910|NCT02420327|12479877|FG000|Overall Study|Lost to Follow-up|1
7940911|NCT02420327|12479877|FG000|Overall Study|Protocol Violation|1
7940912|NCT02420353|12479889|FG000|Overall Study|Withdrawal by Subject|0
7940913|NCT02420353|12479890|FG001|Overall Study|Withdrawal by Subject|1
7940914|NCT02420379|12479898|FG000|Overall Study|Withdrawal by Subject|0
7940915|NCT02420379|12479899|FG001|Overall Study|Withdrawal by Subject|3
7940916|NCT02420379|12479898|FG000|Overall Study|Unable to complete due to schooling|0
7940917|NCT02420379|12479899|FG001|Overall Study|Unable to complete due to schooling|1
7940918|NCT02420379|12479898|FG000|Overall Study|Transitioned to commercial drug|1
7940919|NCT02420379|12479899|FG001|Overall Study|Transitioned to commercial drug|0
7940920|NCT02420691|12479909|FG000|Overall Study|Adverse Event|3
7940921|NCT02420691|12479909|FG000|Overall Study|Withdrawal by Subject|3
7940922|NCT02421120|12479957|FG000|Overall Study|Adverse Event|1
7940923|NCT02421419|12480035|FG000|Overall Study|Physician Decision|0
7940924|NCT02421419|12480036|FG001|Overall Study|Physician Decision|0
7940925|NCT02421419|12480037|FG002|Overall Study|Physician Decision|1
7940926|NCT02421510|12480048|FG000|Overall Study|Other|4
7940927|NCT02421510|12480049|FG001|Overall Study|Other|2
7940928|NCT02421510|12480050|FG002|Overall Study|Other|3
7940929|NCT02421510|12480048|FG000|Overall Study|Protocol Violation|1
7940930|NCT02421510|12480049|FG001|Overall Study|Protocol Violation|2
7940931|NCT02421510|12480050|FG002|Overall Study|Protocol Violation|0
7940932|NCT02421510|12480048|FG000|Overall Study|Death|1
7940933|NCT02421510|12480049|FG001|Overall Study|Death|0
7940934|NCT02421510|12480050|FG002|Overall Study|Death|0
7940935|NCT02421510|12480048|FG000|Overall Study|Noncompliance with study drug|1
7940936|NCT02421510|12480049|FG001|Overall Study|Noncompliance with study drug|0
7940937|NCT02421510|12480050|FG002|Overall Study|Noncompliance with study drug|0
7940938|NCT02421510|12480048|FG000|Overall Study|Physician Decision|1
7940939|NCT02421510|12480049|FG001|Overall Study|Physician Decision|1
7940940|NCT02421510|12480050|FG002|Overall Study|Physician Decision|3
7940941|NCT02421510|12480048|FG000|Overall Study|Adverse Event|9
7940942|NCT02421510|12480049|FG001|Overall Study|Adverse Event|10
7940943|NCT02421510|12480050|FG002|Overall Study|Adverse Event|18
7940944|NCT02421510|12480048|FG000|Overall Study|Pregnancy|1
7940945|NCT02421510|12480049|FG001|Overall Study|Pregnancy|1
7940946|NCT02421510|12480050|FG002|Overall Study|Pregnancy|0
7940947|NCT02421510|12480048|FG000|Overall Study|Withdrawal by Subject|14
7940948|NCT02421510|12480049|FG001|Overall Study|Withdrawal by Subject|18
7940949|NCT02421510|12480050|FG002|Overall Study|Withdrawal by Subject|12
7940950|NCT02421510|12480048|FG000|Overall Study|Lost to Follow-up|1
7940951|NCT02421510|12480049|FG001|Overall Study|Lost to Follow-up|1
7940952|NCT02421510|12480050|FG002|Overall Study|Lost to Follow-up|0
7940953|NCT02421588|12480060|FG000|Overall Study|Non-treatment-related AE|8
7940954|NCT02421588|12480061|FG001|Overall Study|Non-treatment-related AE|8
7940955|NCT02421588|12480060|FG000|Overall Study|Progressive disease|152
7940956|NCT02421588|12480061|FG001|Overall Study|Progressive disease|135
7940957|NCT02421588|12480060|FG000|Overall Study|Death|11
7940958|NCT02421588|12480061|FG001|Overall Study|Death|3
7940959|NCT02421588|12480060|FG000|Overall Study|Physician Decision|8
7940960|NCT02421588|12480061|FG001|Overall Study|Physician Decision|17
7940961|NCT02421588|12480060|FG000|Overall Study|Other reason not specified|3
7940962|NCT02421588|12480061|FG001|Overall Study|Other reason not specified|1
7940963|NCT02421588|12480060|FG000|Overall Study|Symptomatic deterioration|13
7940964|NCT02421588|12480061|FG001|Overall Study|Symptomatic deterioration|19
7940965|NCT02421588|12480060|FG000|Overall Study|Treatment-related AE|10
7940966|NCT02421588|12480061|FG001|Overall Study|Treatment-related AE|14
7940967|NCT02421588|12480060|FG000|Overall Study|Withdrawal by Subject|14
7940968|NCT02421588|12480061|FG001|Overall Study|Withdrawal by Subject|16
7940969|NCT02421588|12480060|FG000|Overall Study|Not treated|2
7940970|NCT02421588|12480061|FG001|Overall Study|Not treated|8
7940971|NCT02421601|12480067|FG000|Overall Study|Adverse Event|4
7940972|NCT02421601|12480067|FG000|Overall Study|Lack of Efficacy|5
7940973|NCT02421601|12480067|FG000|Overall Study|Physician Decision|1
7940974|NCT02421601|12480067|FG000|Overall Study|Withdrawal by Subject|31
7940975|NCT02421601|12480067|FG000|Overall Study|Others|41
7940976|NCT02421666|12480073|FG000|6-month Follow-up|Lost to Follow-up|8
7940977|NCT02421666|12480074|FG001|6-month Follow-up|Lost to Follow-up|7
7940978|NCT02421666|12480073|FG000|6-month Follow-up|Withdrawal by Subject|5
7940979|NCT02421666|12480074|FG001|6-month Follow-up|Withdrawal by Subject|6
7940980|NCT02421666|12480073|FG000|12-month Follow-up|Lost to Follow-up|5
7940981|NCT02421666|12480074|FG001|12-month Follow-up|Lost to Follow-up|5
7940982|NCT02421666|12480073|FG000|12-month Follow-up|Withdrawal by Subject|6
7940983|NCT02421666|12480074|FG001|12-month Follow-up|Withdrawal by Subject|11
7940984|NCT02421887|12480091|FG000|Overall Study|Lost to Follow-up|5
7940985|NCT02421887|12480092|FG001|Overall Study|Lost to Follow-up|0
7940986|NCT02421887|12480091|FG000|Overall Study|Withdrawal by Subject|8
7940987|NCT02421887|12480092|FG001|Overall Study|Withdrawal by Subject|5
7940988|NCT02421887|12480091|FG000|Overall Study|Physician Decision|2
7940989|NCT02421887|12480092|FG001|Overall Study|Physician Decision|4
7940990|NCT02421887|12480091|FG000|Overall Study|Adverse Event|2
7940991|NCT02421887|12480092|FG001|Overall Study|Adverse Event|0
7940992|NCT02421952|12480098|FG000|Overall Study|Diary Not Returned|93
7940993|NCT02421952|12480098|FG000|Overall Study|Failed seriation task|13
7940994|NCT02421952|12480098|FG000|Overall Study|Subject uncooperative for baseline test|2
7940995|NCT02421952|12480098|FG000|Overall Study|Surgery cancelled|1
7940996|NCT02422186|12480107|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
7940997|NCT02422186|12480108|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
7940998|NCT02422186|12480107|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0
7940999|NCT02422186|12480108|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
7941000|NCT02422186|12480107|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
7941001|NCT02422186|12480108|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2
7941002|NCT02422186|12480107|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3
7941003|NCT02422186|12480108|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
7941004|NCT02422186|12480107|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4
7941005|NCT02422186|12480108|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
7941006|NCT02422186|12480107|FG000|Double-blind Induction Phase (4 Weeks)|Other|1
7941007|NCT02422186|12480108|FG001|Double-blind Induction Phase (4 Weeks)|Other|0
7941008|NCT02422186|12480107|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1
7941009|NCT02422186|12480108|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0
7941010|NCT02422186|12480107|FG000|Follow-up Phase (2 Weeks)|Other|3
7941011|NCT02422186|12480108|FG001|Follow-up Phase (2 Weeks)|Other|0
7941012|NCT02422264|12480118|FG000|Overall Study|Serious Adverse Event|1
7941013|NCT02422264|12480119|FG001|Overall Study|Serious Adverse Event|0
7941014|NCT02422264|12480118|FG000|Overall Study|Withdrawal by Subject|1
7941015|NCT02422264|12480119|FG001|Overall Study|Withdrawal by Subject|2
7941016|NCT02422264|12480118|FG000|Overall Study|Migrated/moved from study area|3
7941017|NCT02422264|12480119|FG001|Overall Study|Migrated/moved from study area|1
7941018|NCT02422264|12480118|FG000|Overall Study|Subject vaccinated outside of the study|0
7941019|NCT02422264|12480119|FG001|Overall Study|Subject vaccinated outside of the study|1
7941020|NCT02423109|12480171|FG000|Lens 1|Adverse Event|1
7941021|NCT02423109|12480172|FG001|Lens 1|Adverse Event|0
7941022|NCT02423291|12480199|FG000|Overall Study|Lack of Efficacy|14
7941023|NCT02423291|12480199|FG000|Overall Study|Adverse Event|1
7941024|NCT02423343|12480218|FG000|Overall Study|Withdrawal by Subject|0
7941025|NCT02423343|12480219|FG001|Overall Study|Withdrawal by Subject|1
7941026|NCT02423343|12480220|FG002|Overall Study|Withdrawal by Subject|0
7941027|NCT02423343|12480221|FG003|Overall Study|Withdrawal by Subject|0
7941028|NCT02423343|12480222|FG004|Overall Study|Withdrawal by Subject|0
7941029|NCT02423343|12480223|FG005|Overall Study|Withdrawal by Subject|0
7941030|NCT02423343|12480218|FG000|Overall Study|Progressive Disease|0
7941031|NCT02423343|12480219|FG001|Overall Study|Progressive Disease|0
7941032|NCT02423343|12480220|FG002|Overall Study|Progressive Disease|0
7941033|NCT02423343|12480221|FG003|Overall Study|Progressive Disease|0
7941034|NCT02423343|12480222|FG004|Overall Study|Progressive Disease|2
7941035|NCT02423343|12480223|FG005|Overall Study|Progressive Disease|0
7941036|NCT02423343|12480218|FG000|Overall Study|Adverse Event|0
7941037|NCT02423343|12480219|FG001|Overall Study|Adverse Event|0
7941038|NCT02423343|12480220|FG002|Overall Study|Adverse Event|0
7941039|NCT02423343|12480221|FG003|Overall Study|Adverse Event|0
7941040|NCT02423343|12480222|FG004|Overall Study|Adverse Event|2
7941041|NCT02423343|12480223|FG005|Overall Study|Adverse Event|0
7941042|NCT02423343|12480218|FG000|Overall Study|Death|0
7941043|NCT02423343|12480219|FG001|Overall Study|Death|0
7941044|NCT02423343|12480220|FG002|Overall Study|Death|0
7941045|NCT02423343|12480221|FG003|Overall Study|Death|0
7941046|NCT02423343|12480222|FG004|Overall Study|Death|1
7941047|NCT02423343|12480223|FG005|Overall Study|Death|0
7941048|NCT02423798|12480279|FG000|Overall Study|Withdrawal by Subject|3
7941049|NCT02424097|12480309|FG000|Overall Study|Lost to Follow-up|1
7941050|NCT02424097|12480310|FG001|Overall Study|Lost to Follow-up|2
7941051|NCT02424149|12480318|FG000|Overall Study|surgery cancelled|2
7941052|NCT02424149|12480319|FG001|Overall Study|surgery cancelled|0
7941053|NCT02424149|12480318|FG000|Overall Study|Withdrawal by Subject|0
7941054|NCT02424149|12480319|FG001|Overall Study|Withdrawal by Subject|1
7941055|NCT02424253|12480331|FG000|Overall Study|Other, unspecified|1
7941056|NCT02424253|12480332|FG001|Overall Study|Other, unspecified|0
7941057|NCT02424253|12480331|FG000|Overall Study|Compliance problems|1
7941058|NCT02424253|12480332|FG001|Overall Study|Compliance problems|0
7941059|NCT02424253|12480331|FG000|Overall Study|Physician Decision|2
7941060|NCT02424253|12480332|FG001|Overall Study|Physician Decision|0
7941061|NCT02424253|12480331|FG000|Overall Study|Lack of Efficacy|0
7941062|NCT02424253|12480332|FG001|Overall Study|Lack of Efficacy|7
7941063|NCT02424253|12480331|FG000|Overall Study|Adverse Event|2
7941064|NCT02424253|12480332|FG001|Overall Study|Adverse Event|0
7941065|NCT02424253|12480331|FG000|Overall Study|Consent withdrawn by subject|4
7941066|NCT02424253|12480332|FG001|Overall Study|Consent withdrawn by subject|1
7941067|NCT02424253|12480331|FG000|Overall Study|Lost to Follow-up|1
7941068|NCT02424253|12480332|FG001|Overall Study|Lost to Follow-up|1
7941069|NCT02424344|12480340|FG000|Overall Study|Lack of Efficacy|0
7941070|NCT02424344|12480341|FG001|Overall Study|Lack of Efficacy|1
7941071|NCT02424344|12480340|FG000|Overall Study|Withdrawal by Subject|2
7941072|NCT02424344|12480341|FG001|Overall Study|Withdrawal by Subject|1
7941073|NCT02424344|12480340|FG000|Overall Study|Lost to Follow-up|1
7941074|NCT02424344|12480341|FG001|Overall Study|Lost to Follow-up|0
7941075|NCT02424344|12480340|FG000|Overall Study|Adverse Event|4
7941076|NCT02424344|12480341|FG001|Overall Study|Adverse Event|8
7941077|NCT02424383|12480358|FG000|Overall Study|Withdrawal by Subject|32
7941078|NCT02424383|12480358|FG000|Overall Study|Death|170
7941079|NCT02424383|12480358|FG000|Overall Study|Sponsor's decision|3
7941080|NCT02424383|12480358|FG000|Overall Study|Investigator's decision|44
7941081|NCT02424383|12480358|FG000|Overall Study|Lost to Follow-up|81
7941082|NCT02424383|12480358|FG000|Overall Study|Other|7
7941083|NCT02424383|12480358|FG000|Overall Study|Ineligible for Major Protocol Deviation|39
7941084|NCT02424539|12480376|FG000|Overall Study|Adverse Event|0
7941085|NCT02424539|12480377|FG001|Overall Study|Adverse Event|0
7941086|NCT02424539|12480378|FG002|Overall Study|Adverse Event|1
7941087|NCT02424539|12480376|FG000|Overall Study|Physician Decision|0
7941088|NCT02424539|12480377|FG001|Overall Study|Physician Decision|0
7941089|NCT02424539|12480378|FG002|Overall Study|Physician Decision|1
7941090|NCT02424539|12480376|FG000|Overall Study|Withdrawal by Subject|3
7941091|NCT02424539|12480377|FG001|Overall Study|Withdrawal by Subject|1
7941092|NCT02424539|12480378|FG002|Overall Study|Withdrawal by Subject|0
7941093|NCT02424539|12480376|FG000|Overall Study|Other: Reached stopping criteria|11
7941094|NCT02424539|12480377|FG001|Overall Study|Other: Reached stopping criteria|7
7941095|NCT02424539|12480378|FG002|Overall Study|Other: Reached stopping criteria|6
7941096|NCT02424578|12480388|FG000|Overall Study|Withdrawal by Subject|0
7941097|NCT02424578|12480389|FG001|Overall Study|Withdrawal by Subject|1
7941098|NCT02424591|12480397|FG000|Overall Study|Protocol Violation|2
7941099|NCT02424591|12480398|FG001|Overall Study|Protocol Violation|3
7941100|NCT02424630|12480406|FG000|Overall Study|No rotator cuff tear|1
7941101|NCT02424630|12480407|FG001|Overall Study|No rotator cuff tear|2
7941102|NCT02424630|12480406|FG000|Overall Study|Open procedure|0
7941103|NCT02424630|12480407|FG001|Overall Study|Open procedure|1
7941104|NCT02424734|12480416|FG000|Overall Study|Treatment stopped to be discharged home|2
7941105|NCT02424734|12480417|FG001|Overall Study|Treatment stopped to be discharged home|2
7965227|NCT01412333|12520888|FG000|Overall Study|Protocol Violation|1
7941106|NCT02424734|12480418|FG002|Overall Study|Treatment stopped to be discharged home|0
7941107|NCT02425098|12480476|FG000|Overall Study|Lost to Follow-up|7
7941108|NCT02425098|12480477|FG001|Overall Study|Lost to Follow-up|7
7941109|NCT02425098|12480476|FG000|Overall Study|Withdrawal by Subject|4
7941110|NCT02425098|12480477|FG001|Overall Study|Withdrawal by Subject|8
7941111|NCT02425098|12480476|FG000|Overall Study|Pregnancy|2
7941112|NCT02425098|12480477|FG001|Overall Study|Pregnancy|0
7941113|NCT02425098|12480476|FG000|Overall Study|Reason not Specified|0
7941114|NCT02425098|12480477|FG001|Overall Study|Reason not Specified|1
7941115|NCT02425111|12480483|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
7941116|NCT02425111|12480483|FG000|Part A: Treatment Period|Lack of Efficacy|15
7941117|NCT02425111|12480483|FG000|Part A: Treatment Period|Voluntary Withdrawal|4
7941118|NCT02425111|12480483|FG000|Part A: Treatment Period|Lost to Follow-up|2
7941119|NCT02425111|12480483|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
7941120|NCT02425111|12480483|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7
7941121|NCT02426086|12480515|FG000|Overall Study|Death|33
7941122|NCT02426086|12480516|FG001|Overall Study|Death|36
7941123|NCT02426086|12480515|FG000|Overall Study|Lost to Follow-up|2
7941124|NCT02426086|12480516|FG001|Overall Study|Lost to Follow-up|0
7941125|NCT02426086|12480515|FG000|Overall Study|Study Terminated by Sponsor|5
7941126|NCT02426086|12480516|FG001|Overall Study|Study Terminated by Sponsor|14
7941127|NCT02426086|12480515|FG000|Overall Study|Withdrawal by Subject|8
7941128|NCT02426086|12480516|FG001|Overall Study|Withdrawal by Subject|9
7965228|NCT01412333|12520889|FG001|Overall Study|Protocol Violation|1
7965229|NCT01412333|12520888|FG000|Overall Study|Non-compliance|1
7965230|NCT01412333|12520889|FG001|Overall Study|Non-compliance|3
7965231|NCT01412333|12520888|FG000|Overall Study|Lack of Efficacy|15
7965232|NCT01412333|12520889|FG001|Overall Study|Lack of Efficacy|6
7965233|NCT01412333|12520888|FG000|Overall Study|Pregnancy|3
7965234|NCT01412333|12520889|FG001|Overall Study|Pregnancy|0
7965235|NCT01412333|12520888|FG000|Overall Study|Consent withdrawn by participant|25
7965236|NCT01412333|12520889|FG001|Overall Study|Consent withdrawn by participant|12
7965237|NCT01412333|12520888|FG000|Overall Study|Adverse Event|25
7965238|NCT01412333|12520889|FG001|Overall Study|Adverse Event|16
7965239|NCT01412333|12520888|FG000|Overall Study|Lost to Follow-up|10
7965240|NCT01412333|12520889|FG001|Overall Study|Lost to Follow-up|6
7965241|NCT01306331|12520898|FG000|Overall Study|Adverse Event|28
7965242|NCT01306331|12520899|FG001|Overall Study|Adverse Event|25
7965243|NCT01306331|12520898|FG000|Overall Study|Lost to Follow-up|321
7965244|NCT01306331|12520899|FG001|Overall Study|Lost to Follow-up|323
7965245|NCT01306331|12520898|FG000|Overall Study|Physician Decision|26
7965246|NCT01306331|12520899|FG001|Overall Study|Physician Decision|22
7965247|NCT01306331|12520898|FG000|Overall Study|Pregnancy|136
7965248|NCT01306331|12520899|FG001|Overall Study|Pregnancy|151
7965249|NCT01306331|12520898|FG000|Overall Study|Protocol Violation|154
7965250|NCT01306331|12520899|FG001|Overall Study|Protocol Violation|124
7965251|NCT01306331|12520898|FG000|Overall Study|Withdrawal by Subject|163
7965252|NCT01306331|12520899|FG001|Overall Study|Withdrawal by Subject|152
7965253|NCT01306331|12520898|FG000|Overall Study|Not sexually active|29
7965254|NCT01306331|12520899|FG001|Overall Study|Not sexually active|28
7965255|NCT01306331|12520898|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10
7965256|NCT01306331|12520899|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20
7965257|NCT01306331|12520898|FG000|Overall Study|Other|34
7965258|NCT01306331|12520899|FG001|Overall Study|Other|32
7965259|NCT01247324|12520907|FG000|Overall Study|Death|1
7965260|NCT01247324|12520908|FG001|Overall Study|Death|0
7965261|NCT01247324|12520907|FG000|Overall Study|Physician Decision|0
7965262|NCT01247324|12520908|FG001|Overall Study|Physician Decision|1
7965263|NCT01247324|12520907|FG000|Overall Study|Non-compliance with study drug|3
7965264|NCT01247324|12520908|FG001|Overall Study|Non-compliance with study drug|0
7965265|NCT01247324|12520907|FG000|Overall Study|Lack of Efficacy|12
7965266|NCT01247324|12520908|FG001|Overall Study|Lack of Efficacy|8
7965267|NCT01247324|12520907|FG000|Overall Study|Non-compliance|2
7965268|NCT01247324|12520908|FG001|Overall Study|Non-compliance|0
7965269|NCT01247324|12520907|FG000|Overall Study|Pregnancy|2
7965270|NCT01247324|12520908|FG001|Overall Study|Pregnancy|3
7965271|NCT01247324|12520907|FG000|Overall Study|Protocol Violation|1
7965272|NCT01247324|12520908|FG001|Overall Study|Protocol Violation|2
7965273|NCT01247324|12520907|FG000|Overall Study|Reason not specified|11
7965274|NCT01247324|12520908|FG001|Overall Study|Reason not specified|8
7965275|NCT01247324|12520907|FG000|Overall Study|Consent withdrawn by participant|13
7965276|NCT01247324|12520908|FG001|Overall Study|Consent withdrawn by participant|8
7965277|NCT01247324|12520907|FG000|Overall Study|Adverse Event|25
7965278|NCT01247324|12520908|FG001|Overall Study|Adverse Event|13
7965279|NCT01247324|12520907|FG000|Overall Study|Lost to Follow-up|1
7965280|NCT01247324|12520908|FG001|Overall Study|Lost to Follow-up|1
7965281|NCT01194570|12520917|FG000|Overall Study|Death|1
7965282|NCT01194570|12520918|FG001|Overall Study|Death|3
7965283|NCT01194570|12520917|FG000|Overall Study|Ongoing at CCOD|162
7965284|NCT01194570|12520918|FG001|Overall Study|Ongoing at CCOD|387
7965285|NCT01194570|12520917|FG000|Overall Study|Physician Decision|2
7965286|NCT01194570|12520918|FG001|Overall Study|Physician Decision|6
7965287|NCT01194570|12520917|FG000|Overall Study|Reason not specified|13
7965288|NCT01194570|12520918|FG001|Overall Study|Reason not specified|20
7965289|NCT01194570|12520917|FG000|Overall Study|Protocol Violation|0
7941129|NCT02426138|12480529|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
7941130|NCT02426138|12480530|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1
7941131|NCT02426541|12480551|FG000|Overall Study|Protocol Violation|1
7941132|NCT02426541|12480552|FG001|Overall Study|Protocol Violation|0
7941133|NCT02426580|12480560|FG000|Overall Study|Death|2
7941134|NCT02426580|12480561|FG001|Overall Study|Death|2
7941135|NCT02426580|12480560|FG000|Overall Study|Lost to Follow-up|0
7941136|NCT02426580|12480561|FG001|Overall Study|Lost to Follow-up|9
7941137|NCT02426580|12480560|FG000|Overall Study|transfer to hemodialysis|5
7941138|NCT02426580|12480561|FG001|Overall Study|transfer to hemodialysis|5
7941139|NCT02426580|12480560|FG000|Overall Study|Kidney transplant|3
7941140|NCT02426580|12480561|FG001|Overall Study|Kidney transplant|0
7941141|NCT02426580|12480560|FG000|Overall Study|Allergic to egg white|1
7941142|NCT02426580|12480561|FG001|Overall Study|Allergic to egg white|0
7941143|NCT02426918|12480570|FG000|Overall Study|Adverse Event|2
7941144|NCT02426918|12480571|FG001|Overall Study|Adverse Event|2
7941145|NCT02426918|12480572|FG002|Overall Study|Adverse Event|0
7941146|NCT02426918|12480570|FG000|Overall Study|Physician Decision|1
7941147|NCT02426918|12480571|FG001|Overall Study|Physician Decision|1
7941148|NCT02426918|12480572|FG002|Overall Study|Physician Decision|1
7941149|NCT02426918|12480570|FG000|Overall Study|Withdrawal by Subject|5
7941150|NCT02426918|12480571|FG001|Overall Study|Withdrawal by Subject|5
7941151|NCT02426918|12480572|FG002|Overall Study|Withdrawal by Subject|4
7941152|NCT02426918|12480570|FG000|Overall Study|Other|9
7941153|NCT02426918|12480571|FG001|Overall Study|Other|11
7941154|NCT02426918|12480572|FG002|Overall Study|Other|9
7941155|NCT02427100|12480582|FG000|Overall Study|Lost to Follow-up|0
7941156|NCT02427100|12480583|FG001|Overall Study|Lost to Follow-up|2
7941157|NCT02427399|12480594|FG000|Overall Study|Protocol Violation|14
7941158|NCT02427399|12480595|FG001|Overall Study|Protocol Violation|16
7941159|NCT02427399|12480596|FG002|Overall Study|Protocol Violation|12
7941160|NCT02427399|12480597|FG003|Overall Study|Protocol Violation|18
7941161|NCT02427399|12480598|FG004|Overall Study|Protocol Violation|15
7941162|NCT02427477|12480612|FG000|Period 1|Adverse Event|1
7941163|NCT02427477|12480613|FG001|Period 1|Adverse Event|0
7941164|NCT02427607|12480619|FG000|Overall Study|Withdrawal by Subject|1
7941165|NCT02427646|12480625|FG000|Overall Study|Lack of Efficacy|2
7941166|NCT02427646|12480626|FG001|Overall Study|Lack of Efficacy|3
7941167|NCT02427646|12480625|FG000|Overall Study|Physician Decision|1
7941168|NCT02427646|12480626|FG001|Overall Study|Physician Decision|4
7941169|NCT02427646|12480625|FG000|Overall Study|Protocol Violation|3
7941170|NCT02427646|12480626|FG001|Overall Study|Protocol Violation|3
7941171|NCT02427646|12480625|FG000|Overall Study|Bothersome hand weakness|2
7941172|NCT02427646|12480626|FG001|Overall Study|Bothersome hand weakness|4
7941173|NCT02427802|12480673|FG000|Overall Study|Adverse Event|11
7941174|NCT02427802|12480674|FG001|Overall Study|Adverse Event|3
7941175|NCT02427802|12480675|FG002|Overall Study|Adverse Event|7
7941176|NCT02427802|12480673|FG000|Overall Study|Death|0
7941177|NCT02427802|12480674|FG001|Overall Study|Death|4
7941178|NCT02427802|12480675|FG002|Overall Study|Death|1
7941179|NCT02427802|12480673|FG000|Overall Study|Lost to Follow-up|13
7941180|NCT02427802|12480674|FG001|Overall Study|Lost to Follow-up|8
7941181|NCT02427802|12480675|FG002|Overall Study|Lost to Follow-up|8
7941182|NCT02427802|12480673|FG000|Overall Study|Physician Decision|4
7941183|NCT02427802|12480674|FG001|Overall Study|Physician Decision|2
7941184|NCT02427802|12480675|FG002|Overall Study|Physician Decision|4
7941185|NCT02427802|12480673|FG000|Overall Study|Withdrawal by Subject|10
7941186|NCT02427802|12480674|FG001|Overall Study|Withdrawal by Subject|5
7941187|NCT02427802|12480675|FG002|Overall Study|Withdrawal by Subject|11
7941188|NCT02427802|12480673|FG000|Overall Study|Protocol Violation|3
7941189|NCT02427802|12480674|FG001|Overall Study|Protocol Violation|1
7941190|NCT02427802|12480675|FG002|Overall Study|Protocol Violation|1
7941191|NCT02427802|12480673|FG000|Overall Study|protocol specific treatment unrelated|18
7941192|NCT02427802|12480674|FG001|Overall Study|protocol specific treatment unrelated|11
7941193|NCT02427802|12480675|FG002|Overall Study|protocol specific treatment unrelated|11
7941194|NCT02427841|12480683|FG000|Overall Study|Physician Decision|8
7941195|NCT02427984|12480690|FG000|Overall Study|Lost to Follow-up|13
7941196|NCT02427984|12480691|FG001|Overall Study|Lost to Follow-up|5
7941197|NCT02427984|12480692|FG002|Overall Study|Lost to Follow-up|18
7941198|NCT02428296|12480701|FG000|Overall Study|Adverse Event|7
7941199|NCT02428296|12480701|FG000|Overall Study|Withdrawal by Subject|2
7941200|NCT02428413|12480715|FG000|Overall Study|Device to measure WAG malfunctioned|3
7941201|NCT02428413|12480716|FG001|Overall Study|Device to measure WAG malfunctioned|5
7941202|NCT02428413|12480715|FG000|Overall Study|Protocol Violation|1
7941203|NCT02428413|12480716|FG001|Overall Study|Protocol Violation|2
7941204|NCT02428413|12480715|FG000|Overall Study|Case Cancelled|2
7941205|NCT02428413|12480716|FG001|Overall Study|Case Cancelled|0
7941206|NCT02428413|12480715|FG000|Overall Study|Missed Cases|1
7941207|NCT02428413|12480716|FG001|Overall Study|Missed Cases|2
7941208|NCT02428413|12480715|FG000|Overall Study|Nurse Refusal|1
7941209|NCT02428413|12480716|FG001|Overall Study|Nurse Refusal|0
7941210|NCT02428608|12480742|FG000|Overall Study|Pregnancy|2
7941211|NCT02428608|12480742|FG000|Overall Study|Lost to Follow-up|37
7941212|NCT02428608|12480742|FG000|Overall Study|Withdrawal by Subject|2
7941213|NCT02428608|12480742|FG000|Overall Study|scheduling conflicts|15
7941214|NCT02428608|12480742|FG000|Overall Study|moved away|10
7941215|NCT02428608|12480742|FG000|Overall Study|Death|1
7941216|NCT02428608|12480742|FG000|Overall Study|various|16
7941217|NCT02428699|12480747|FG000|Washout Period 1|Screen Failure|1
7941218|NCT02428699|12480748|FG001|Washout Period 1|Screen Failure|2
7941219|NCT02428855|12480759|FG000|Overall Study|Withdrawal by Subject|2
7941220|NCT02429258|12480790|FG000|Overall Study|Withdrawal by Subject|2
7941221|NCT02429258|12480791|FG001|Overall Study|Withdrawal by Subject|0
7941222|NCT02429258|12480790|FG000|Overall Study|Protocol Violation|0
7941223|NCT02429258|12480791|FG001|Overall Study|Protocol Violation|1
7941224|NCT02429310|12480799|FG000|Overall Study|Lost to Follow-up|1
7941225|NCT02429310|12480800|FG001|Overall Study|Lost to Follow-up|2
7941226|NCT02429310|12480799|FG000|Overall Study|Protocol Violation|1
7941227|NCT02429310|12480800|FG001|Overall Study|Protocol Violation|1
7941228|NCT02429427|12480808|FG000|Overall Study|Adverse Event|220
7941229|NCT02429427|12480809|FG001|Overall Study|Adverse Event|92
7941230|NCT02429427|12480808|FG000|Overall Study|Protocol Violation|10
7941231|NCT02429427|12480809|FG001|Overall Study|Protocol Violation|6
7941232|NCT02429427|12480808|FG000|Overall Study|Lost to Follow-up|15
7941233|NCT02429427|12480809|FG001|Overall Study|Lost to Follow-up|6
7941234|NCT02429427|12480808|FG000|Overall Study|Withdrawal by Subject|64
7941235|NCT02429427|12480809|FG001|Overall Study|Withdrawal by Subject|34
7941236|NCT02429427|12480808|FG000|Overall Study|Other|62
7941237|NCT02429427|12480809|FG001|Overall Study|Other|41
7941238|NCT02429778|12480817|FG000|Overall Study|Lost to Follow-up|2
7941239|NCT02429778|12480818|FG001|Overall Study|Lost to Follow-up|0
7941240|NCT02429778|12480817|FG000|Overall Study|Withdrawal by Subject|5
7941241|NCT02429778|12480818|FG001|Overall Study|Withdrawal by Subject|0
7941242|NCT02429856|12480826|FG000|Overall Study|Death|12
7941243|NCT02429856|12480827|FG001|Overall Study|Death|13
7941244|NCT02429856|12480826|FG000|Overall Study|Lost to Follow-up|6
7941245|NCT02429856|12480827|FG001|Overall Study|Lost to Follow-up|5
7941246|NCT02429856|12480826|FG000|Overall Study|Withdrawal by Subject|1
7941247|NCT02429856|12480827|FG001|Overall Study|Withdrawal by Subject|1
7941248|NCT02429934|12480841|FG000|Overall Study|Withdrawal by Subject|0
7941249|NCT02429934|12480842|FG001|Overall Study|Withdrawal by Subject|2
7941250|NCT02429934|12480841|FG000|Overall Study|Adverse Event|2
7941251|NCT02429934|12480842|FG001|Overall Study|Adverse Event|0
7941252|NCT02429934|12480841|FG000|Overall Study|Lost to Follow-up|1
7941253|NCT02429934|12480842|FG001|Overall Study|Lost to Follow-up|1
7941254|NCT02429934|12480841|FG000|Overall Study|Physician Decision|1
7941255|NCT02429934|12480842|FG001|Overall Study|Physician Decision|0
7941256|NCT02430311|12480865|FG000|Part A|Adverse Event|0
7941257|NCT02430311|12480866|FG001|Part A|Adverse Event|1
7941258|NCT02430311|12480865|FG000|Part A|Withdrawal by Subject|1
7941259|NCT02430311|12480866|FG001|Part A|Withdrawal by Subject|0
7941260|NCT02430311|12480865|FG000|Part B|Meet study-specific withdrawal criteria|6
7941261|NCT02430311|12480866|FG001|Part B|Meet study-specific withdrawal criteria|6
7941262|NCT02430311|12480865|FG000|Part B|Withdrawal by Subject|2
7941263|NCT02430311|12480866|FG001|Part B|Withdrawal by Subject|2
7941264|NCT02430311|12480865|FG000|Part B|Adverse Event|1
7941265|NCT02430311|12480866|FG001|Part B|Adverse Event|0
7941266|NCT02430311|12480865|FG000|Part B|Death|1
7941267|NCT02430311|12480866|FG001|Part B|Death|0
7941268|NCT02430870|12480924|FG000|Part 2|Voluntary Withdrawal|0
7941269|NCT02430870|12480925|FG001|Part 2|Voluntary Withdrawal|0
7941270|NCT02430870|12480926|FG002|Part 2|Voluntary Withdrawal|0
7941271|NCT02430870|12480927|FG003|Part 2|Voluntary Withdrawal|0
7941272|NCT02430870|12480928|FG004|Part 2|Voluntary Withdrawal|0
7941273|NCT02430870|12480929|FG005|Part 2|Voluntary Withdrawal|0
7941274|NCT02430870|12480930|FG006|Part 2|Voluntary Withdrawal|1
7941275|NCT02430870|12480931|FG007|Part 2|Voluntary Withdrawal|0
7941276|NCT02430870|12480924|FG000|Part 2|Other Reason Not Specified|0
7941277|NCT02430870|12480925|FG001|Part 2|Other Reason Not Specified|0
7941278|NCT02430870|12480926|FG002|Part 2|Other Reason Not Specified|0
7941279|NCT02430870|12480927|FG003|Part 2|Other Reason Not Specified|0
7941280|NCT02430870|12480928|FG004|Part 2|Other Reason Not Specified|0
7941281|NCT02430870|12480929|FG005|Part 2|Other Reason Not Specified|0
7941282|NCT02430870|12480930|FG006|Part 2|Other Reason Not Specified|0
7941283|NCT02430870|12480931|FG007|Part 2|Other Reason Not Specified|1
7941284|NCT02431260|12480989|FG000|Overall Study|Subject Decision|0
7941285|NCT02431260|12480990|FG001|Overall Study|Subject Decision|1
7941286|NCT02431260|12480991|FG002|Overall Study|Subject Decision|1
7941287|NCT02431260|12480992|FG003|Overall Study|Subject Decision|0
7941288|NCT02431260|12480993|FG004|Overall Study|Subject Decision|0
7941289|NCT02431260|12480994|FG005|Overall Study|Subject Decision|0
7941290|NCT02431260|12480995|FG006|Overall Study|Subject Decision|0
7941291|NCT02431260|12480996|FG007|Overall Study|Subject Decision|0
7941292|NCT02431260|12480997|FG008|Overall Study|Subject Decision|1
7941293|NCT02431260|12480998|FG009|Overall Study|Subject Decision|1
7941294|NCT02431260|12480999|FG010|Overall Study|Subject Decision|0
7941295|NCT02431260|12481000|FG011|Overall Study|Subject Decision|1
7941296|NCT02431260|12481001|FG012|Overall Study|Subject Decision|0
7941297|NCT02431260|12481002|FG013|Overall Study|Subject Decision|0
7941298|NCT02431260|12480989|FG000|Overall Study|Death|4
7941299|NCT02431260|12480990|FG001|Overall Study|Death|4
7941300|NCT02431260|12480991|FG002|Overall Study|Death|3
7941301|NCT02431260|12480992|FG003|Overall Study|Death|4
7941302|NCT02431260|12480993|FG004|Overall Study|Death|2
7941303|NCT02431260|12480994|FG005|Overall Study|Death|2
7941304|NCT02431260|12480995|FG006|Overall Study|Death|3
7941305|NCT02431260|12480996|FG007|Overall Study|Death|1
7941306|NCT02431260|12480997|FG008|Overall Study|Death|6
7941307|NCT02431260|12480998|FG009|Overall Study|Death|6
7941308|NCT02431260|12480999|FG010|Overall Study|Death|3
7941309|NCT02431260|12481000|FG011|Overall Study|Death|2
7941310|NCT02431260|12481001|FG012|Overall Study|Death|5
7941311|NCT02431260|12481002|FG013|Overall Study|Death|1
7822201|NCT01260350|12291194|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0
7822202|NCT01260350|12291195|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0
7822203|NCT01260467|12291253|FG000|Overall Study|Withdrawal by Subject|2
7822204|NCT01260584|12291272|FG000|Period 1|Protocol Violation|0
7822205|NCT01260584|12291273|FG001|Period 1|Protocol Violation|0
7822206|NCT01260584|12291274|FG002|Period 1|Protocol Violation|1
7822207|NCT01260584|12291275|FG003|Period 1|Protocol Violation|1
7822208|NCT01260584|12291272|FG000|Period 1|Adverse Event|0
7822209|NCT01260584|12291273|FG001|Period 1|Adverse Event|0
7822210|NCT01260584|12291274|FG002|Period 1|Adverse Event|1
7822211|NCT01260584|12291275|FG003|Period 1|Adverse Event|0
7822212|NCT01260584|12291272|FG000|Period 2|Protocol Violation|0
7941312|NCT02431260|12480989|FG000|Overall Study|Lost to Follow-up|0
7822213|NCT01260584|12291273|FG001|Period 2|Protocol Violation|2
7941313|NCT02431260|12480990|FG001|Overall Study|Lost to Follow-up|0
7941314|NCT02431260|12480991|FG002|Overall Study|Lost to Follow-up|0
7941315|NCT02431260|12480992|FG003|Overall Study|Lost to Follow-up|0
7941316|NCT02431260|12480993|FG004|Overall Study|Lost to Follow-up|0
7941317|NCT02431260|12480994|FG005|Overall Study|Lost to Follow-up|1
7941318|NCT02431260|12480995|FG006|Overall Study|Lost to Follow-up|0
7941319|NCT02431260|12480996|FG007|Overall Study|Lost to Follow-up|0
7941320|NCT02431260|12480997|FG008|Overall Study|Lost to Follow-up|0
7941321|NCT02431260|12480998|FG009|Overall Study|Lost to Follow-up|0
7941322|NCT02431260|12480999|FG010|Overall Study|Lost to Follow-up|0
7941323|NCT02431260|12481000|FG011|Overall Study|Lost to Follow-up|0
7941324|NCT02431260|12481001|FG012|Overall Study|Lost to Follow-up|0
7941325|NCT02431260|12481002|FG013|Overall Study|Lost to Follow-up|0
7941326|NCT02431260|12480989|FG000|Overall Study|Study Terminated by the Sponsor|0
7941327|NCT02431260|12480990|FG001|Overall Study|Study Terminated by the Sponsor|0
7941328|NCT02431260|12480991|FG002|Overall Study|Study Terminated by the Sponsor|2
7941329|NCT02431260|12480992|FG003|Overall Study|Study Terminated by the Sponsor|1
7941330|NCT02431260|12480993|FG004|Overall Study|Study Terminated by the Sponsor|1
7941331|NCT02431260|12480994|FG005|Overall Study|Study Terminated by the Sponsor|0
7941332|NCT02431260|12480995|FG006|Overall Study|Study Terminated by the Sponsor|1
7941333|NCT02431260|12480996|FG007|Overall Study|Study Terminated by the Sponsor|2
7941334|NCT02431260|12480997|FG008|Overall Study|Study Terminated by the Sponsor|1
7941335|NCT02431260|12480998|FG009|Overall Study|Study Terminated by the Sponsor|1
7941336|NCT02431260|12480999|FG010|Overall Study|Study Terminated by the Sponsor|1
7941337|NCT02431260|12481000|FG011|Overall Study|Study Terminated by the Sponsor|0
7941338|NCT02431260|12481001|FG012|Overall Study|Study Terminated by the Sponsor|4
7941339|NCT02431260|12481002|FG013|Overall Study|Study Terminated by the Sponsor|0
7941340|NCT02431260|12480989|FG000|Overall Study|Physician Decision|0
7941341|NCT02431260|12480990|FG001|Overall Study|Physician Decision|0
7941342|NCT02431260|12480991|FG002|Overall Study|Physician Decision|0
7941343|NCT02431260|12480992|FG003|Overall Study|Physician Decision|0
7941344|NCT02431260|12480993|FG004|Overall Study|Physician Decision|0
7941345|NCT02431260|12480994|FG005|Overall Study|Physician Decision|1
7941346|NCT02431260|12480995|FG006|Overall Study|Physician Decision|0
7941347|NCT02431260|12480996|FG007|Overall Study|Physician Decision|0
7941348|NCT02431260|12480997|FG008|Overall Study|Physician Decision|0
7941349|NCT02431260|12480998|FG009|Overall Study|Physician Decision|0
7941350|NCT02431260|12480999|FG010|Overall Study|Physician Decision|0
7941351|NCT02431260|12481000|FG011|Overall Study|Physician Decision|0
7941352|NCT02431260|12481001|FG012|Overall Study|Physician Decision|0
7941353|NCT02431260|12481002|FG013|Overall Study|Physician Decision|0
7941354|NCT02431260|12480989|FG000|Overall Study|Other Unspecified|0
7941355|NCT02431260|12480990|FG001|Overall Study|Other Unspecified|0
7941356|NCT02431260|12480991|FG002|Overall Study|Other Unspecified|0
7941357|NCT02431260|12480992|FG003|Overall Study|Other Unspecified|0
7941358|NCT02431260|12480993|FG004|Overall Study|Other Unspecified|0
7941359|NCT02431260|12480994|FG005|Overall Study|Other Unspecified|0
7941360|NCT02431260|12480995|FG006|Overall Study|Other Unspecified|0
7941361|NCT02431260|12480996|FG007|Overall Study|Other Unspecified|0
7941362|NCT02431260|12480997|FG008|Overall Study|Other Unspecified|0
7941363|NCT02431260|12480998|FG009|Overall Study|Other Unspecified|0
7941364|NCT02431260|12480999|FG010|Overall Study|Other Unspecified|0
7941365|NCT02431260|12481000|FG011|Overall Study|Other Unspecified|1
7941366|NCT02431260|12481001|FG012|Overall Study|Other Unspecified|1
7941367|NCT02431260|12481002|FG013|Overall Study|Other Unspecified|0
7941368|NCT02431364|12481067|FG000|Overall Study|Adverse Event|0
7941369|NCT02431364|12481068|FG001|Overall Study|Adverse Event|1
7941370|NCT02431364|12481069|FG002|Overall Study|Adverse Event|0
7941371|NCT02431364|12481070|FG003|Overall Study|Adverse Event|0
7941372|NCT02431364|12481071|FG004|Overall Study|Adverse Event|0
7941373|NCT02431364|12481067|FG000|Overall Study|Randomized but never treated|0
7941374|NCT02431364|12481068|FG001|Overall Study|Randomized but never treated|0
7941375|NCT02431364|12481069|FG002|Overall Study|Randomized but never treated|0
7941376|NCT02431364|12481070|FG003|Overall Study|Randomized but never treated|1
7941377|NCT02431364|12481071|FG004|Overall Study|Randomized but never treated|0
7941378|NCT02431468|12481099|FG000|Overall Study|Adverse Event|2
7941379|NCT02431468|12481100|FG001|Overall Study|Adverse Event|4
7941380|NCT02431468|12481101|FG002|Overall Study|Adverse Event|5
7941381|NCT02431468|12481099|FG000|Overall Study|Withdrawal by Subject|4
7941382|NCT02431468|12481100|FG001|Overall Study|Withdrawal by Subject|12
7941383|NCT02431468|12481101|FG002|Overall Study|Withdrawal by Subject|2
7941384|NCT02431468|12481099|FG000|Overall Study|noncompliance, investigator termination,|2
7941385|NCT02431468|12481100|FG001|Overall Study|noncompliance, investigator termination,|2
7941386|NCT02431468|12481101|FG002|Overall Study|noncompliance, investigator termination,|2
7941387|NCT02431533|12481117|FG000|Overall Study|Withdrawal by Subject|1
7941388|NCT02431533|12481118|FG001|Overall Study|Withdrawal by Subject|3
7941389|NCT02431533|12481117|FG000|Overall Study|Developed Exclusionary criteria|1
7941390|NCT02431533|12481118|FG001|Overall Study|Developed Exclusionary criteria|0
7941391|NCT02431559|12481128|FG000|Overall Study|Adverse Event|0
7941392|NCT02431559|12481129|FG001|Overall Study|Adverse Event|1
7941393|NCT02431559|12481130|FG002|Overall Study|Adverse Event|0
7941394|NCT02431559|12481131|FG003|Overall Study|Adverse Event|4
7941395|NCT02431559|12481128|FG000|Overall Study|Progressive disease|2
7941396|NCT02431559|12481129|FG001|Overall Study|Progressive disease|1
7941397|NCT02431559|12481130|FG002|Overall Study|Progressive disease|4
7941398|NCT02431559|12481131|FG003|Overall Study|Progressive disease|22
7941399|NCT02431559|12481128|FG000|Overall Study|Withdrawal by Subject|0
7941400|NCT02431559|12481129|FG001|Overall Study|Withdrawal by Subject|1
7941401|NCT02431559|12481130|FG002|Overall Study|Withdrawal by Subject|0
7941402|NCT02431559|12481131|FG003|Overall Study|Withdrawal by Subject|4
7941403|NCT02431559|12481128|FG000|Overall Study|Physician Decision|0
7941404|NCT02431559|12481129|FG001|Overall Study|Physician Decision|0
7941405|NCT02431559|12481130|FG002|Overall Study|Physician Decision|0
7941406|NCT02431559|12481131|FG003|Overall Study|Physician Decision|1
7941407|NCT02431676|12481192|FG000|Overall Study|no lab obtained|0
7941408|NCT02431676|12481193|FG001|Overall Study|no lab obtained|1
7941409|NCT02431676|12481194|FG002|Overall Study|no lab obtained|2
7941410|NCT02431793|12481220|FG000|Overall Study|Ineligible doe to not filling Rx|11
7941411|NCT02431793|12481221|FG001|Overall Study|Ineligible doe to not filling Rx|7
7941412|NCT02431793|12481222|FG002|Overall Study|Ineligible doe to not filling Rx|8
7941413|NCT02431793|12481220|FG000|Overall Study|Withdrawal by Subject|7
7941414|NCT02431793|12481221|FG001|Overall Study|Withdrawal by Subject|5
7941415|NCT02431793|12481222|FG002|Overall Study|Withdrawal by Subject|5
7941416|NCT02431793|12481220|FG000|Overall Study|Lost to Follow-up|101
7941417|NCT02431793|12481221|FG001|Overall Study|Lost to Follow-up|122
7941418|NCT02431793|12481222|FG002|Overall Study|Lost to Follow-up|104
7941419|NCT02431806|12481234|FG000|Double-blind Treatment Period|Did not Receive Treatment|1
7822214|NCT01260584|12291274|FG002|Period 2|Protocol Violation|3
7822215|NCT01260584|12291275|FG003|Period 2|Protocol Violation|1
7822216|NCT01260584|12291272|FG000|Period 2|Adverse Event|1
7822217|NCT01260584|12291273|FG001|Period 2|Adverse Event|0
7822218|NCT01260584|12291274|FG002|Period 2|Adverse Event|2
7822219|NCT01260584|12291275|FG003|Period 2|Adverse Event|0
7822220|NCT01260584|12291272|FG000|Period 2|Withdrawal by Subject|0
7822221|NCT01260584|12291273|FG001|Period 2|Withdrawal by Subject|1
7822222|NCT01260584|12291274|FG002|Period 2|Withdrawal by Subject|0
7822223|NCT01260584|12291275|FG003|Period 2|Withdrawal by Subject|0
7941420|NCT02431806|12481235|FG001|Double-blind Treatment Period|Did not Receive Treatment|2
7941421|NCT02431806|12481236|FG002|Double-blind Treatment Period|Did not Receive Treatment|1
7941422|NCT02431806|12481237|FG003|Double-blind Treatment Period|Did not Receive Treatment|1
7941423|NCT02431806|12481234|FG000|Double-blind Treatment Period|Adverse Event|4
7941424|NCT02431806|12481235|FG001|Double-blind Treatment Period|Adverse Event|7
7941425|NCT02431806|12481236|FG002|Double-blind Treatment Period|Adverse Event|11
7941426|NCT02431806|12481237|FG003|Double-blind Treatment Period|Adverse Event|7
7941427|NCT02431806|12481234|FG000|Double-blind Treatment Period|Lack of Efficacy|2
7941428|NCT02431806|12481235|FG001|Double-blind Treatment Period|Lack of Efficacy|0
7941429|NCT02431806|12481236|FG002|Double-blind Treatment Period|Lack of Efficacy|2
7822224|NCT01260701|12291319|FG000|Overall Study|Adverse Event|9
7941430|NCT02431806|12481237|FG003|Double-blind Treatment Period|Lack of Efficacy|2
7941431|NCT02431806|12481234|FG000|Double-blind Treatment Period|Withdrawal of Consent|10
7941432|NCT02431806|12481235|FG001|Double-blind Treatment Period|Withdrawal of Consent|7
7941433|NCT02431806|12481236|FG002|Double-blind Treatment Period|Withdrawal of Consent|5
7941434|NCT02431806|12481237|FG003|Double-blind Treatment Period|Withdrawal of Consent|5
7941435|NCT02431806|12481234|FG000|Double-blind Treatment Period|Lost to Follow-up|7
7941436|NCT02431806|12481235|FG001|Double-blind Treatment Period|Lost to Follow-up|4
7941437|NCT02431806|12481236|FG002|Double-blind Treatment Period|Lost to Follow-up|5
7941438|NCT02431806|12481237|FG003|Double-blind Treatment Period|Lost to Follow-up|8
7941439|NCT02431806|12481234|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1
7941440|NCT02431806|12481235|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0
7941441|NCT02431806|12481236|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3
7941442|NCT02431806|12481237|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1
7941443|NCT02431806|12481234|FG000|Double-blind Treatment Period|Reason Not Specified|0
7941444|NCT02431806|12481235|FG001|Double-blind Treatment Period|Reason Not Specified|1
7941445|NCT02431806|12481236|FG002|Double-blind Treatment Period|Reason Not Specified|5
7941446|NCT02431806|12481237|FG003|Double-blind Treatment Period|Reason Not Specified|2
7941447|NCT02432040|12481249|FG000|Overall Study|Lack of Efficacy|3
7822225|NCT01260701|12291319|FG000|Overall Study|Withdrawal by Subject|2
7822226|NCT01260701|12291319|FG000|Overall Study|Progression|53
7822227|NCT01260701|12291319|FG000|Overall Study|Death|2
7941448|NCT02432040|12481250|FG001|Overall Study|Lack of Efficacy|0
7941449|NCT02432040|12481249|FG000|Overall Study|Lost to Follow-up|4
7941450|NCT02432040|12481250|FG001|Overall Study|Lost to Follow-up|5
7941451|NCT02432040|12481249|FG000|Overall Study|Physician Decision|1
7941452|NCT02432040|12481250|FG001|Overall Study|Physician Decision|1
7941453|NCT02432105|12481259|FG000|Overall Study|Lost to Follow-up|1
7941454|NCT02432105|12481260|FG001|Overall Study|Lost to Follow-up|1
7941455|NCT02432105|12481261|FG002|Overall Study|Lost to Follow-up|0
7941456|NCT02432105|12481259|FG000|Overall Study|Withdrawal by Subject|1
7941457|NCT02432105|12481260|FG001|Overall Study|Withdrawal by Subject|0
7941458|NCT02432105|12481261|FG002|Overall Study|Withdrawal by Subject|1
7941459|NCT02432105|12481259|FG000|Overall Study|Culture positive for yeast|0
7941460|NCT02432105|12481260|FG001|Overall Study|Culture positive for yeast|1
7941461|NCT02432105|12481261|FG002|Overall Study|Culture positive for yeast|0
7941462|NCT02432105|12481259|FG000|Overall Study|Randomized in error|0
7941463|NCT02432105|12481260|FG001|Overall Study|Randomized in error|0
7941464|NCT02432105|12481261|FG002|Overall Study|Randomized in error|2
7941465|NCT02432144|12481270|FG000|Overall Study|Participant Non-Compliance|1
7941466|NCT02432235|12481303|FG000|Overall Study|Death|1
7941467|NCT02432235|12481304|FG001|Overall Study|Death|1
7941468|NCT02432235|12481305|FG002|Overall Study|Death|2
7941469|NCT02432235|12481306|FG003|Overall Study|Death|2
7941470|NCT02432235|12481307|FG004|Overall Study|Death|1
7941471|NCT02432235|12481308|FG005|Overall Study|Death|3
7941472|NCT02432235|12481309|FG006|Overall Study|Death|11
7941473|NCT02432235|12481310|FG007|Overall Study|Death|15
7941474|NCT02432235|12481311|FG008|Overall Study|Death|15
7941475|NCT02432235|12481312|FG009|Overall Study|Death|3
7941476|NCT02432235|12481313|FG010|Overall Study|Death|1
7941477|NCT02432235|12481314|FG011|Overall Study|Death|0
7941478|NCT02432235|12481303|FG000|Overall Study|Withdrawal by Subject|0
7941479|NCT02432235|12481304|FG001|Overall Study|Withdrawal by Subject|1
7941480|NCT02432235|12481305|FG002|Overall Study|Withdrawal by Subject|0
7941481|NCT02432235|12481306|FG003|Overall Study|Withdrawal by Subject|0
7941482|NCT02432235|12481307|FG004|Overall Study|Withdrawal by Subject|0
7941483|NCT02432235|12481308|FG005|Overall Study|Withdrawal by Subject|2
7941484|NCT02432235|12481309|FG006|Overall Study|Withdrawal by Subject|5
7941485|NCT02432235|12481310|FG007|Overall Study|Withdrawal by Subject|3
7941486|NCT02432235|12481311|FG008|Overall Study|Withdrawal by Subject|1
7941487|NCT02432235|12481312|FG009|Overall Study|Withdrawal by Subject|0
7941488|NCT02432235|12481313|FG010|Overall Study|Withdrawal by Subject|0
7941489|NCT02432235|12481314|FG011|Overall Study|Withdrawal by Subject|0
7941490|NCT02432235|12481303|FG000|Overall Study|Lost to Follow-up|0
7941491|NCT02432235|12481304|FG001|Overall Study|Lost to Follow-up|0
7941492|NCT02432235|12481305|FG002|Overall Study|Lost to Follow-up|0
7941493|NCT02432235|12481306|FG003|Overall Study|Lost to Follow-up|0
7941494|NCT02432235|12481307|FG004|Overall Study|Lost to Follow-up|0
7941495|NCT02432235|12481308|FG005|Overall Study|Lost to Follow-up|1
7941496|NCT02432235|12481309|FG006|Overall Study|Lost to Follow-up|0
7941497|NCT02432235|12481310|FG007|Overall Study|Lost to Follow-up|0
7941498|NCT02432235|12481311|FG008|Overall Study|Lost to Follow-up|1
7941499|NCT02432235|12481312|FG009|Overall Study|Lost to Follow-up|0
7941500|NCT02432235|12481313|FG010|Overall Study|Lost to Follow-up|0
7941501|NCT02432235|12481314|FG011|Overall Study|Lost to Follow-up|0
7941502|NCT02432235|12481303|FG000|Overall Study|Miscellaneous|0
7941503|NCT02432235|12481304|FG001|Overall Study|Miscellaneous|0
7941504|NCT02432235|12481305|FG002|Overall Study|Miscellaneous|0
7941505|NCT02432235|12481306|FG003|Overall Study|Miscellaneous|0
7941506|NCT02432235|12481307|FG004|Overall Study|Miscellaneous|1
7941507|NCT02432235|12481308|FG005|Overall Study|Miscellaneous|6
7941508|NCT02432235|12481309|FG006|Overall Study|Miscellaneous|2
7941509|NCT02432235|12481310|FG007|Overall Study|Miscellaneous|2
7941510|NCT02432235|12481311|FG008|Overall Study|Miscellaneous|4
7941511|NCT02432235|12481312|FG009|Overall Study|Miscellaneous|0
7941512|NCT02432235|12481313|FG010|Overall Study|Miscellaneous|0
7941513|NCT02432235|12481314|FG011|Overall Study|Miscellaneous|1
7941514|NCT02432703|12481368|FG000|Overall Study|Adverse Event|1
7941515|NCT02432703|12481369|FG001|Overall Study|Adverse Event|4
7941516|NCT02432703|12481368|FG000|Overall Study|Lack of Efficacy|1
7941517|NCT02432703|12481369|FG001|Overall Study|Lack of Efficacy|0
7941518|NCT02432703|12481368|FG000|Overall Study|Lost to Follow-up|5
7941519|NCT02432703|12481369|FG001|Overall Study|Lost to Follow-up|3
7941520|NCT02432703|12481368|FG000|Overall Study|Withdrawal by Subject|9
7941521|NCT02432703|12481369|FG001|Overall Study|Withdrawal by Subject|6
7941522|NCT02432703|12481368|FG000|Overall Study|Other|6
7941523|NCT02432703|12481369|FG001|Overall Study|Other|5
7941524|NCT02433080|12481391|FG000|Overall Study|Lost to Follow-up|1
7941525|NCT02433080|12481392|FG001|Overall Study|Lost to Follow-up|2
7941526|NCT02433080|12481391|FG000|Overall Study|Withdrawal by Subject|0
7941527|NCT02433080|12481392|FG001|Overall Study|Withdrawal by Subject|2
7941528|NCT02433288|12481401|FG000|Overall Study|Severe non-compliance to protocol|13
7941529|NCT02433288|12481402|FG001|Overall Study|Severe non-compliance to protocol|7
7941530|NCT02433288|12481401|FG000|Overall Study|Eligibility criteria not fullfilled|7
7941531|NCT02433288|12481402|FG001|Overall Study|Eligibility criteria not fullfilled|3
7941532|NCT02433288|12481401|FG000|Overall Study|Withdrawal by Subject|101
7941533|NCT02433288|12481402|FG001|Overall Study|Withdrawal by Subject|99
7941534|NCT02433288|12481401|FG000|Overall Study|Lost to Follow-up|2
7941535|NCT02433288|12481402|FG001|Overall Study|Lost to Follow-up|14
7941536|NCT02433288|12481401|FG000|Overall Study|Death|0
7941537|NCT02433288|12481402|FG001|Overall Study|Death|3
7941538|NCT02433340|12481412|FG000|Overall Study|Adverse Event|0
7941539|NCT02433340|12481413|FG001|Overall Study|Adverse Event|0
7941540|NCT02433340|12481414|FG002|Overall Study|Adverse Event|1
7941541|NCT02433340|12481415|FG003|Overall Study|Adverse Event|0
7941542|NCT02433340|12481412|FG000|Overall Study|Withdrawal by Subject|1
7941543|NCT02433340|12481413|FG001|Overall Study|Withdrawal by Subject|0
7941544|NCT02433340|12481414|FG002|Overall Study|Withdrawal by Subject|1
7941545|NCT02433340|12481415|FG003|Overall Study|Withdrawal by Subject|2
7941546|NCT02433340|12481412|FG000|Overall Study|Lost to Follow-up|0
7941547|NCT02433340|12481413|FG001|Overall Study|Lost to Follow-up|1
7941548|NCT02433340|12481414|FG002|Overall Study|Lost to Follow-up|0
7941549|NCT02433340|12481415|FG003|Overall Study|Lost to Follow-up|0
7941550|NCT02433340|12481412|FG000|Overall Study|Required Alternative/Prohibited Therapy|1
7941551|NCT02433340|12481413|FG001|Overall Study|Required Alternative/Prohibited Therapy|0
7941552|NCT02433340|12481414|FG002|Overall Study|Required Alternative/Prohibited Therapy|0
7941553|NCT02433340|12481415|FG003|Overall Study|Required Alternative/Prohibited Therapy|0
7941554|NCT02433340|12481412|FG000|Overall Study|Other|0
7941555|NCT02433340|12481413|FG001|Overall Study|Other|1
7941556|NCT02433340|12481414|FG002|Overall Study|Other|0
7941557|NCT02433340|12481415|FG003|Overall Study|Other|0
7941558|NCT02433379|12481436|FG000|Overall Study|Screen Failures|55
7941559|NCT02433379|12481436|FG000|Overall Study|Death|57
7941560|NCT02433379|12481436|FG000|Overall Study|Total Withdrawals|209
7941561|NCT02433483|12481442|FG000|Overall Study|Unacceptable toxicity|1
7941562|NCT02433483|12481442|FG000|Overall Study|Other antineoplastic therapy/HSCT|1
7941563|NCT02433678|12481473|FG000|Overall Study|Lost to Follow-up|1
7941564|NCT02433678|12481474|FG001|Overall Study|Lost to Follow-up|2
7941565|NCT02433834|12481480|FG000|Overall Study|Protocol-specified criteria|7
7941566|NCT02433834|12481480|FG000|Overall Study|Protocol Violation|3
7941567|NCT02433834|12481480|FG000|Overall Study|Lost to Follow-up|6
7941568|NCT02433834|12481480|FG000|Overall Study|Withdrawal by Subject|14
7941569|NCT02433834|12481480|FG000|Overall Study|Adverse Event|6
7941570|NCT02433834|12481480|FG000|Overall Study|Physician Decision|1
7941571|NCT02434328|12481502|FG000|Overall Study|Adverse Event|9
7941572|NCT02434328|12481503|FG001|Overall Study|Adverse Event|4
7941573|NCT02434328|12481502|FG000|Overall Study|Lack of Efficacy|0
7941574|NCT02434328|12481503|FG001|Overall Study|Lack of Efficacy|2
7941575|NCT02434328|12481502|FG000|Overall Study|Physician Decision|0
7941576|NCT02434328|12481503|FG001|Overall Study|Physician Decision|1
7941577|NCT02434328|12481502|FG000|Overall Study|Withdrawal by Subject|12
7941578|NCT02434328|12481503|FG001|Overall Study|Withdrawal by Subject|21
7941579|NCT02434328|12481502|FG000|Overall Study|Death|4
7941580|NCT02434328|12481503|FG001|Overall Study|Death|7
7941581|NCT02434328|12481502|FG000|Overall Study|Lost to Follow-up|1
7941582|NCT02434328|12481503|FG001|Overall Study|Lost to Follow-up|6
7941583|NCT02434328|12481502|FG000|Overall Study|Other|4
7941584|NCT02434328|12481503|FG001|Overall Study|Other|1
7941585|NCT02434471|12481510|FG000|Overall Study|Physician Decision|9
7941586|NCT02434770|12481535|FG000|Week 1 to Week 18|Lost to Follow-up|0
7941587|NCT02434770|12481536|FG001|Week 1 to Week 18|Lost to Follow-up|0
7941588|NCT02434770|12481537|FG002|Week 1 to Week 18|Lost to Follow-up|2
7941589|NCT02434770|12481535|FG000|Week 1 to Week 18|Withdrawal by Subject|6
7941590|NCT02434770|12481536|FG001|Week 1 to Week 18|Withdrawal by Subject|12
7941591|NCT02434770|12481537|FG002|Week 1 to Week 18|Withdrawal by Subject|5
7941592|NCT02434770|12481535|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8
7941593|NCT02434770|12481536|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10
7941594|NCT02434770|12481537|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9
7941595|NCT02434770|12481535|FG000|Week 1 to Week 18|Relocated Out of Study Area|0
7941596|NCT02434770|12481536|FG001|Week 1 to Week 18|Relocated Out of Study Area|0
7941597|NCT02434770|12481537|FG002|Week 1 to Week 18|Relocated Out of Study Area|1
7941598|NCT02434770|12481535|FG000|Week 1 to Week 18|Death|1
7941599|NCT02434770|12481536|FG001|Week 1 to Week 18|Death|0
7941600|NCT02434770|12481537|FG002|Week 1 to Week 18|Death|0
7941601|NCT02434770|12481535|FG000|Week 18 to Week|Lost to Follow-up|2
7941602|NCT02434770|12481536|FG001|Week 18 to Week|Lost to Follow-up|2
7941603|NCT02434770|12481537|FG002|Week 18 to Week|Lost to Follow-up|1
7941604|NCT02434770|12481535|FG000|Week 18 to Week|Withdrawal by Subject|0
7941605|NCT02434770|12481536|FG001|Week 18 to Week|Withdrawal by Subject|0
7941606|NCT02434770|12481537|FG002|Week 18 to Week|Withdrawal by Subject|2
7941607|NCT02434770|12481535|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6
7941608|NCT02434770|12481536|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6
7941609|NCT02434770|12481537|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3
7941610|NCT02434939|12481549|FG000|Overall Study|Lack of Efficacy|34
7941611|NCT02434939|12481550|FG001|Overall Study|Lack of Efficacy|48
7941612|NCT02434939|12481549|FG000|Overall Study|Withdrawal by Subject|3
7941613|NCT02434939|12481550|FG001|Overall Study|Withdrawal by Subject|0
7941614|NCT02434939|12481549|FG000|Overall Study|Adverse Event|0
7941615|NCT02434939|12481550|FG001|Overall Study|Adverse Event|1
7941616|NCT02435069|12481557|FG000|Dose Response - First Intervention|Adverse Event|0
7941617|NCT02435069|12481558|FG001|Dose Response - First Intervention|Adverse Event|1
7941618|NCT02435069|12481559|FG002|Dose Response - First Intervention|Adverse Event|1
7941619|NCT02435069|12481560|FG003|Dose Response - First Intervention|Adverse Event|0
7941620|NCT02435069|12481561|FG004|Dose Response - First Intervention|Adverse Event|0
7941621|NCT02435069|12481557|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0
7941622|NCT02435069|12481558|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0
7941623|NCT02435069|12481559|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0
7941624|NCT02435069|12481560|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0
7941625|NCT02435069|12481561|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1
7941626|NCT02435147|12481581|FG000|Overall Study|non-evaluable DXA scan|11
7941627|NCT02435277|12481589|FG000|Overall Study|Adverse Event|1
7941628|NCT02435277|12481590|FG001|Overall Study|Adverse Event|1
7941629|NCT02435277|12481591|FG002|Overall Study|Adverse Event|0
7941630|NCT02435277|12481592|FG003|Overall Study|Adverse Event|0
7941631|NCT02435277|12481589|FG000|Overall Study|Withdrawal by Subject|1
7941632|NCT02435277|12481590|FG001|Overall Study|Withdrawal by Subject|0
7941633|NCT02435277|12481591|FG002|Overall Study|Withdrawal by Subject|0
7941634|NCT02435277|12481592|FG003|Overall Study|Withdrawal by Subject|0
7941635|NCT02435381|12481602|FG000|Overall Study|Lost to Follow-up|2
7941636|NCT02435381|12481603|FG001|Overall Study|Lost to Follow-up|1
7941637|NCT02435680|12481631|FG000|Overall Study|Physician Decision|3
7941638|NCT02435680|12481632|FG001|Overall Study|Physician Decision|0
7941639|NCT02435680|12481633|FG002|Overall Study|Physician Decision|0
7941640|NCT02435680|12481631|FG000|Overall Study|subject / guardian decision|0
7941641|NCT02435680|12481632|FG001|Overall Study|subject / guardian decision|3
7941642|NCT02435680|12481633|FG002|Overall Study|subject / guardian decision|2
7941643|NCT02435680|12481631|FG000|Overall Study|Adverse Event|8
7941644|NCT02435680|12481632|FG001|Overall Study|Adverse Event|3
7941645|NCT02435680|12481633|FG002|Overall Study|Adverse Event|2
7941646|NCT02435680|12481631|FG000|Overall Study|progressive disease|10
7941647|NCT02435680|12481632|FG001|Overall Study|progressive disease|7
7941648|NCT02435680|12481633|FG002|Overall Study|progressive disease|11
7941649|NCT02435680|12481631|FG000|Overall Study|not treated|0
7941650|NCT02435680|12481632|FG001|Overall Study|not treated|0
7941651|NCT02435680|12481633|FG002|Overall Study|not treated|1
7941652|NCT02435836|12481654|FG000|Overall Study|Lost to Follow-up|21
7941653|NCT02435836|12481654|FG000|Overall Study|Lack of Efficacy|1
7941654|NCT02435836|12481654|FG000|Overall Study|Withdrawal by Subject|236
7941655|NCT02435836|12481654|FG000|Overall Study|Insufficient Clinical Response|26
7941656|NCT02435836|12481654|FG000|Overall Study|Adverse Event|44
7941657|NCT02435836|12481654|FG000|Overall Study|Sponsor discontinued trial|167
7941658|NCT02435836|12481654|FG000|Overall Study|Noncompliance|27
7941659|NCT02435836|12481654|FG000|Overall Study|Protocol Violation|6
7941660|NCT02435836|12481654|FG000|Overall Study|Met Withdrawal Criteria|7
7941661|NCT02435836|12481654|FG000|Overall Study|AE of Worsening Schizophrenia|96
7941662|NCT02435914|12481667|FG000|Overall Study|Ocular Adverse Event|1
7941663|NCT02435914|12481668|FG001|Overall Study|Ocular Adverse Event|0
7941664|NCT02435914|12481669|FG002|Overall Study|Ocular Adverse Event|0
7941665|NCT02435914|12481670|FG003|Overall Study|Ocular Adverse Event|0
7941666|NCT02435914|12481667|FG000|Overall Study|Withdrawal by Subject|0
7941667|NCT02435914|12481668|FG001|Overall Study|Withdrawal by Subject|1
7941668|NCT02435914|12481669|FG002|Overall Study|Withdrawal by Subject|0
7941669|NCT02435914|12481670|FG003|Overall Study|Withdrawal by Subject|0
7941670|NCT02435914|12481667|FG000|Overall Study|Other Miscellaneous Reason|0
7941671|NCT02435914|12481668|FG001|Overall Study|Other Miscellaneous Reason|0
7941672|NCT02435914|12481669|FG002|Overall Study|Other Miscellaneous Reason|1
7941673|NCT02435914|12481670|FG003|Overall Study|Other Miscellaneous Reason|0
7941674|NCT02435966|12481683|FG000|Overall Study|Withdrawal by Subject|0
7941675|NCT02435966|12481684|FG001|Overall Study|Withdrawal by Subject|1
7941676|NCT02435966|12481685|FG002|Overall Study|Withdrawal by Subject|0
7941677|NCT02435992|12481698|FG000|Overall Study|non compliance with protocol|2
7941678|NCT02435992|12481699|FG001|Overall Study|non compliance with protocol|0
7941679|NCT02435992|12481700|FG002|Overall Study|non compliance with protocol|1
7941680|NCT02435992|12481701|FG003|Overall Study|non compliance with protocol|0
7941681|NCT02435992|12481702|FG004|Overall Study|non compliance with protocol|0
7941682|NCT02435992|12481698|FG000|Overall Study|Adverse Event|11
7941683|NCT02435992|12481699|FG001|Overall Study|Adverse Event|6
7941684|NCT02435992|12481700|FG002|Overall Study|Adverse Event|12
7941685|NCT02435992|12481701|FG003|Overall Study|Adverse Event|0
7941686|NCT02435992|12481702|FG004|Overall Study|Adverse Event|0
7941687|NCT02435992|12481698|FG000|Overall Study|Lack of Efficacy|4
7941688|NCT02435992|12481699|FG001|Overall Study|Lack of Efficacy|10
7941689|NCT02435992|12481700|FG002|Overall Study|Lack of Efficacy|9
7941690|NCT02435992|12481701|FG003|Overall Study|Lack of Efficacy|0
7941691|NCT02435992|12481702|FG004|Overall Study|Lack of Efficacy|0
7941692|NCT02435992|12481698|FG000|Overall Study|Withdrawal by Subject|10
7941693|NCT02435992|12481699|FG001|Overall Study|Withdrawal by Subject|8
7941694|NCT02435992|12481700|FG002|Overall Study|Withdrawal by Subject|20
7941695|NCT02435992|12481701|FG003|Overall Study|Withdrawal by Subject|0
7941696|NCT02435992|12481702|FG004|Overall Study|Withdrawal by Subject|0
7941697|NCT02435992|12481698|FG000|Overall Study|Other Reason|1
7941698|NCT02435992|12481699|FG001|Overall Study|Other Reason|0
7941699|NCT02435992|12481700|FG002|Overall Study|Other Reason|0
7941700|NCT02435992|12481701|FG003|Overall Study|Other Reason|0
7941701|NCT02435992|12481702|FG004|Overall Study|Other Reason|0
7941702|NCT02435992|12481698|FG000|Overall Study|Physician Decision|0
7941703|NCT02435992|12481699|FG001|Overall Study|Physician Decision|0
7941704|NCT02435992|12481700|FG002|Overall Study|Physician Decision|1
7941705|NCT02435992|12481701|FG003|Overall Study|Physician Decision|0
7941706|NCT02435992|12481702|FG004|Overall Study|Physician Decision|0
7941707|NCT02436005|12481714|FG000|Second Intervention|Adverse Event|0
7941708|NCT02436005|12481715|FG001|Second Intervention|Adverse Event|1
7941709|NCT02436135|12481730|FG000|Overall Study|Progressive Disease|3
7941710|NCT02436135|12481731|FG001|Overall Study|Progressive Disease|1
7941711|NCT02436135|12481730|FG000|Overall Study|Investigator Discretion|1
7941712|NCT02436135|12481731|FG001|Overall Study|Investigator Discretion|2
7941713|NCT02436135|12481730|FG000|Overall Study|Adverse Event|1
7941714|NCT02436135|12481731|FG001|Overall Study|Adverse Event|0
7941715|NCT02436135|12481730|FG000|Overall Study|Withdrawal by Participant|1
7941716|NCT02436135|12481731|FG001|Overall Study|Withdrawal by Participant|0
7941717|NCT02436135|12481730|FG000|Overall Study|Study Terminated By Sponsor|0
7941718|NCT02436135|12481731|FG001|Overall Study|Study Terminated By Sponsor|1
7965290|NCT01194570|12520918|FG001|Overall Study|Protocol Violation|2
7965291|NCT01194570|12520917|FG000|Overall Study|Non-compliance with study drug|2
7965292|NCT01194570|12520918|FG001|Overall Study|Non-compliance with study drug|2
7965293|NCT01194570|12520917|FG000|Overall Study|Adverse Event|12
7965294|NCT01194570|12520918|FG001|Overall Study|Adverse Event|18
7965295|NCT01194570|12520917|FG000|Overall Study|Non-compliance|2
7965296|NCT01194570|12520918|FG001|Overall Study|Non-compliance|2
7965297|NCT01194570|12520917|FG000|Overall Study|Lack of Efficacy|27
7965298|NCT01194570|12520918|FG001|Overall Study|Lack of Efficacy|21
7965299|NCT01194570|12520917|FG000|Overall Study|Withdrawal by Subject|21
7965300|NCT01194570|12520918|FG001|Overall Study|Withdrawal by Subject|22
7965301|NCT01194570|12520917|FG000|Overall Study|Pregnancy|1
7965302|NCT01194570|12520918|FG001|Overall Study|Pregnancy|1
7965303|NCT01194570|12520917|FG000|Overall Study|Lost to Follow-up|1
7965304|NCT01194570|12520918|FG001|Overall Study|Lost to Follow-up|4
7965305|NCT01190930|12520926|FG000|Induction|Adverse Event|17
7965306|NCT01190930|12520927|FG001|Induction|Adverse Event|0
7965307|NCT01190930|12520928|FG002|Induction|Adverse Event|0
7965308|NCT01190930|12520929|FG003|Induction|Adverse Event|0
7965309|NCT01190930|12520930|FG004|Induction|Adverse Event|0
7965310|NCT01190930|12520931|FG005|Induction|Adverse Event|0
7965311|NCT01190930|12520932|FG006|Induction|Adverse Event|0
7965312|NCT01190930|12520933|FG007|Induction|Adverse Event|0
7965313|NCT01190930|12520934|FG008|Induction|Adverse Event|0
7965314|NCT01190930|12520935|FG009|Induction|Adverse Event|0
7965315|NCT01190930|12520926|FG000|Induction|Death|34
7965316|NCT01190930|12520927|FG001|Induction|Death|0
7965317|NCT01190930|12520928|FG002|Induction|Death|0
7965318|NCT01190930|12520929|FG003|Induction|Death|0
7965319|NCT01190930|12520930|FG004|Induction|Death|0
7965320|NCT01190930|12520931|FG005|Induction|Death|0
7965321|NCT01190930|12520932|FG006|Induction|Death|0
7965322|NCT01190930|12520933|FG007|Induction|Death|0
7965323|NCT01190930|12520934|FG008|Induction|Death|0
7965324|NCT01190930|12520935|FG009|Induction|Death|0
7965325|NCT01190930|12520926|FG000|Induction|Lost to Follow-up|1
7965326|NCT01190930|12520927|FG001|Induction|Lost to Follow-up|0
7965327|NCT01190930|12520928|FG002|Induction|Lost to Follow-up|0
7965328|NCT01190930|12520929|FG003|Induction|Lost to Follow-up|0
7965329|NCT01190930|12520930|FG004|Induction|Lost to Follow-up|0
7965330|NCT01190930|12520931|FG005|Induction|Lost to Follow-up|0
7965331|NCT01190930|12520932|FG006|Induction|Lost to Follow-up|0
7965332|NCT01190930|12520933|FG007|Induction|Lost to Follow-up|0
7965333|NCT01190930|12520934|FG008|Induction|Lost to Follow-up|0
7965334|NCT01190930|12520935|FG009|Induction|Lost to Follow-up|0
7965335|NCT01190930|12520926|FG000|Induction|Physician Decision|125
7965336|NCT01190930|12520927|FG001|Induction|Physician Decision|3
7965337|NCT01190930|12520928|FG002|Induction|Physician Decision|0
7965338|NCT01190930|12520929|FG003|Induction|Physician Decision|0
7965339|NCT01190930|12520930|FG004|Induction|Physician Decision|0
7965340|NCT01190930|12520931|FG005|Induction|Physician Decision|0
7965341|NCT01190930|12520932|FG006|Induction|Physician Decision|0
7965342|NCT01190930|12520933|FG007|Induction|Physician Decision|0
7965343|NCT01190930|12520934|FG008|Induction|Physician Decision|0
7965344|NCT01190930|12520935|FG009|Induction|Physician Decision|0
7965345|NCT01190930|12520926|FG000|Induction|Withdrawal by Subject|9
7965346|NCT01190930|12520927|FG001|Induction|Withdrawal by Subject|0
7965347|NCT01190930|12520928|FG002|Induction|Withdrawal by Subject|0
7965348|NCT01190930|12520929|FG003|Induction|Withdrawal by Subject|0
7965349|NCT01190930|12520930|FG004|Induction|Withdrawal by Subject|0
7965350|NCT01190930|12520931|FG005|Induction|Withdrawal by Subject|0
7965351|NCT01190930|12520932|FG006|Induction|Withdrawal by Subject|0
7965352|NCT01190930|12520933|FG007|Induction|Withdrawal by Subject|0
7965353|NCT01190930|12520934|FG008|Induction|Withdrawal by Subject|0
7965354|NCT01190930|12520935|FG009|Induction|Withdrawal by Subject|0
7965355|NCT01190930|12520926|FG000|Induction|Refusal|235
7965356|NCT01190930|12520927|FG001|Induction|Refusal|0
7965357|NCT01190930|12520928|FG002|Induction|Refusal|0
7965358|NCT01190930|12520929|FG003|Induction|Refusal|0
7965359|NCT01190930|12520930|FG004|Induction|Refusal|0
7965360|NCT01190930|12520931|FG005|Induction|Refusal|0
7965361|NCT01190930|12520932|FG006|Induction|Refusal|0
7965362|NCT01190930|12520933|FG007|Induction|Refusal|0
7965363|NCT01190930|12520934|FG008|Induction|Refusal|0
7965364|NCT01190930|12520935|FG009|Induction|Refusal|0
7965365|NCT01190930|12520926|FG000|Induction|Inevaluable|23
7965366|NCT01190930|12520927|FG001|Induction|Inevaluable|1
7965367|NCT01190930|12520928|FG002|Induction|Inevaluable|0
7965368|NCT01190930|12520929|FG003|Induction|Inevaluable|0
7965369|NCT01190930|12520930|FG004|Induction|Inevaluable|0
7965370|NCT01190930|12520931|FG005|Induction|Inevaluable|0
7965371|NCT01190930|12520932|FG006|Induction|Inevaluable|0
7965372|NCT01190930|12520933|FG007|Induction|Inevaluable|0
7965373|NCT01190930|12520934|FG008|Induction|Inevaluable|0
7965374|NCT01190930|12520935|FG009|Induction|Inevaluable|0
7965375|NCT01190930|12520926|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61
7965376|NCT01190930|12520927|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7941719|NCT02436200|12481737|FG000|Overall Study|Significant outlier|1
7941720|NCT02436239|12481745|FG000|Open-Lable Treatment Period|Adverse Event|12
7941721|NCT02436239|12481746|FG001|Open-Lable Treatment Period|Adverse Event|3
7941722|NCT02436239|12481747|FG002|Open-Lable Treatment Period|Adverse Event|4
7941723|NCT02436239|12481748|FG003|Open-Lable Treatment Period|Adverse Event|2
7941724|NCT02436239|12481745|FG000|Open-Lable Treatment Period|Lack of Efficacy|1
7941725|NCT02436239|12481746|FG001|Open-Lable Treatment Period|Lack of Efficacy|6
7941726|NCT02436239|12481747|FG002|Open-Lable Treatment Period|Lack of Efficacy|6
7941727|NCT02436239|12481748|FG003|Open-Lable Treatment Period|Lack of Efficacy|1
7941728|NCT02436239|12481745|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10
7941729|NCT02436239|12481746|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15
7941730|NCT02436239|12481747|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9
7941731|NCT02436239|12481748|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0
7941732|NCT02436239|12481745|FG000|Open-Lable Treatment Period|Lost to Follow-up|4
7941733|NCT02436239|12481746|FG001|Open-Lable Treatment Period|Lost to Follow-up|2
7941734|NCT02436239|12481747|FG002|Open-Lable Treatment Period|Lost to Follow-up|4
7941735|NCT02436239|12481748|FG003|Open-Lable Treatment Period|Lost to Follow-up|1
7941736|NCT02436239|12481745|FG000|Open-Lable Treatment Period|Protocol Violation|0
7941737|NCT02436239|12481746|FG001|Open-Lable Treatment Period|Protocol Violation|1
7941738|NCT02436239|12481747|FG002|Open-Lable Treatment Period|Protocol Violation|1
7941739|NCT02436239|12481748|FG003|Open-Lable Treatment Period|Protocol Violation|0
7941740|NCT02436239|12481745|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5
7941741|NCT02436239|12481746|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6
7941742|NCT02436239|12481747|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3
7941743|NCT02436239|12481748|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1
7941744|NCT02436239|12481745|FG000|Open-Lable Treatment Period|Other Reason|1
7941745|NCT02436239|12481746|FG001|Open-Lable Treatment Period|Other Reason|1
7941746|NCT02436239|12481747|FG002|Open-Lable Treatment Period|Other Reason|0
7941747|NCT02436239|12481748|FG003|Open-Lable Treatment Period|Other Reason|0
7941748|NCT02436239|12481745|FG000|Down-Taper Period|Withdrawal by Subject|4
7941749|NCT02436239|12481746|FG001|Down-Taper Period|Withdrawal by Subject|4
7941750|NCT02436239|12481747|FG002|Down-Taper Period|Withdrawal by Subject|1
7941751|NCT02436239|12481748|FG003|Down-Taper Period|Withdrawal by Subject|2
7941752|NCT02436304|12481761|FG000|Overall Study|Lost to Follow-up|0
7941753|NCT02436304|12481762|FG001|Overall Study|Lost to Follow-up|1
7941754|NCT02436304|12481763|FG002|Overall Study|Lost to Follow-up|0
7941755|NCT02436304|12481761|FG000|Overall Study|Withdrawal by Subject|0
7941756|NCT02436304|12481762|FG001|Overall Study|Withdrawal by Subject|1
7941757|NCT02436304|12481763|FG002|Overall Study|Withdrawal by Subject|0
7941758|NCT02436304|12481761|FG000|Overall Study|Randomized in error didn't meet I/E crit|0
7941759|NCT02436304|12481762|FG001|Overall Study|Randomized in error didn't meet I/E crit|0
7941760|NCT02436304|12481763|FG002|Overall Study|Randomized in error didn't meet I/E crit|1
7941761|NCT02436330|12481774|FG000|Cohort 1|Lost to Follow-up|5
7941762|NCT02436330|12481775|FG001|Cohort 1|Lost to Follow-up|2
7941763|NCT02436330|12481774|FG000|Cohort 1|Withdrawal by Subject|0
7941764|NCT02436330|12481775|FG001|Cohort 1|Withdrawal by Subject|1
7941765|NCT02436330|12481774|FG000|Cohort 2|Lost to Follow-up|2
7941766|NCT02436330|12481775|FG001|Cohort 2|Lost to Follow-up|0
7941767|NCT02436330|12481774|FG000|Cohort 2|Withdrawal by Subject|2
7941768|NCT02436330|12481775|FG001|Cohort 2|Withdrawal by Subject|3
7941769|NCT02436330|12481774|FG000|Cohort 3|Lost to Follow-up|1
7941770|NCT02436330|12481775|FG001|Cohort 3|Lost to Follow-up|0
7941771|NCT02436330|12481774|FG000|Cohort 3|Withdrawal by Subject|4
7941772|NCT02436330|12481775|FG001|Cohort 3|Withdrawal by Subject|0
7941773|NCT02436330|12481774|FG000|Cohort 4|Lost to Follow-up|1
7941774|NCT02436330|12481775|FG001|Cohort 4|Lost to Follow-up|0
7941775|NCT02436330|12481774|FG000|Cohort 4|Withdrawal by Subject|1
7941776|NCT02436330|12481775|FG001|Cohort 4|Withdrawal by Subject|0
7941777|NCT02436330|12481774|FG000|Cohort 5|Lost to Follow-up|3
7941778|NCT02436330|12481775|FG001|Cohort 5|Lost to Follow-up|2
7941779|NCT02436330|12481774|FG000|Cohort 5|Withdrawal by Subject|3
7941780|NCT02436330|12481775|FG001|Cohort 5|Withdrawal by Subject|2
7941781|NCT02436330|12481774|FG000|Cohort 6|Lost to Follow-up|2
7941782|NCT02436330|12481775|FG001|Cohort 6|Lost to Follow-up|0
7941783|NCT02436330|12481774|FG000|Cohort 6|Withdrawal by Subject|1
7941784|NCT02436330|12481775|FG001|Cohort 6|Withdrawal by Subject|1
7941785|NCT02436356|12481790|FG000|Overall Study|Excluded by MRI Screening|0
7941786|NCT02436356|12481791|FG001|Overall Study|Excluded by MRI Screening|0
7941787|NCT02436356|12481792|FG002|Overall Study|Excluded by MRI Screening|2
7941788|NCT02436356|12481790|FG000|Overall Study|Lost to Follow-up|0
7941789|NCT02436356|12481791|FG001|Overall Study|Lost to Follow-up|1
7941790|NCT02436356|12481792|FG002|Overall Study|Lost to Follow-up|0
7941791|NCT02436356|12481790|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1
7941792|NCT02436356|12481791|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0
7941793|NCT02436356|12481792|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0
7941794|NCT02436356|12481790|FG000|Overall Study|Excluded due to other medical conditions|3
7941795|NCT02436356|12481791|FG001|Overall Study|Excluded due to other medical conditions|0
7941796|NCT02436356|12481792|FG002|Overall Study|Excluded due to other medical conditions|0
7941797|NCT02436356|12481790|FG000|Overall Study|Withdrawal by Subject|1
7941798|NCT02436356|12481791|FG001|Overall Study|Withdrawal by Subject|0
7941799|NCT02436356|12481792|FG002|Overall Study|Withdrawal by Subject|0
7941800|NCT02436408|12481805|FG000|Overall Study|Death|1
7941801|NCT02436577|12481815|FG000|Overall Study|Protocol Deviation|0
7941802|NCT02436577|12481816|FG001|Overall Study|Protocol Deviation|1
7941803|NCT02436577|12481817|FG002|Overall Study|Protocol Deviation|0
7941804|NCT02436577|12481818|FG003|Overall Study|Protocol Deviation|0
7941805|NCT02436577|12481819|FG004|Overall Study|Protocol Deviation|0
7941806|NCT02436577|12481820|FG005|Overall Study|Protocol Deviation|0
7941807|NCT02436681|12481840|FG000|Overall Study|Lost to Follow-up|10
7941808|NCT02436681|12481840|FG000|Overall Study|Withdrawal by Subject|2
7941809|NCT02436681|12481840|FG000|Overall Study|Death|2
7941810|NCT02436759|12481846|FG000|Overall Study|Adverse Event|3
7941811|NCT02436759|12481847|FG001|Overall Study|Adverse Event|0
7941812|NCT02436759|12481846|FG000|Overall Study|Protocol Violation|1
7941813|NCT02436759|12481847|FG001|Overall Study|Protocol Violation|0
7941814|NCT02436759|12481846|FG000|Overall Study|Withdrawal by Subject|0
7941815|NCT02436759|12481847|FG001|Overall Study|Withdrawal by Subject|1
7941816|NCT02436811|12481856|FG000|Overall Study|Lost to Follow-up|2
7941817|NCT02436811|12481857|FG001|Overall Study|Lost to Follow-up|9
7941818|NCT02436811|12481858|FG002|Overall Study|Lost to Follow-up|7
7941819|NCT02436876|12481870|FG000|Overall Study|Lost to Follow-up|0
7941820|NCT02436876|12481871|FG001|Overall Study|Lost to Follow-up|1
7941821|NCT02436876|12481872|FG002|Overall Study|Lost to Follow-up|1
7941822|NCT02436876|12481873|FG003|Overall Study|Lost to Follow-up|1
7941823|NCT02436876|12481870|FG000|Overall Study|Withdrawal by Subject|1
7941824|NCT02436876|12481871|FG001|Overall Study|Withdrawal by Subject|0
7941825|NCT02436876|12481872|FG002|Overall Study|Withdrawal by Subject|0
7941826|NCT02436876|12481873|FG003|Overall Study|Withdrawal by Subject|1
7941827|NCT02436876|12481870|FG000|Overall Study|Physician Decision|0
7941828|NCT02436876|12481871|FG001|Overall Study|Physician Decision|2
7941829|NCT02436876|12481872|FG002|Overall Study|Physician Decision|1
7941830|NCT02436876|12481873|FG003|Overall Study|Physician Decision|0
7941831|NCT02436876|12481870|FG000|Overall Study|Inadequate amount of study drug available for randomization|0
7941832|NCT02436876|12481871|FG001|Overall Study|Inadequate amount of study drug available for randomization|1
7941833|NCT02436876|12481872|FG002|Overall Study|Inadequate amount of study drug available for randomization|0
7941834|NCT02436876|12481873|FG003|Overall Study|Inadequate amount of study drug available for randomization|0
7941835|NCT02436889|12481890|FG000|Overall Study|No improvement in symptoms|1
7941836|NCT02436889|12481891|FG001|Overall Study|No improvement in symptoms|0
7941837|NCT02436889|12481890|FG000|Overall Study|Does not like/could not tolerate medicat|0
7941838|NCT02436889|12481891|FG001|Overall Study|Does not like/could not tolerate medicat|1
7941839|NCT02436915|12481899|FG000|Overall Study|Withdrawal by Subject|0
7941840|NCT02436915|12481900|FG001|Overall Study|Withdrawal by Subject|1
7941841|NCT02437084|12481908|FG000|Overall Study|Withdrawal by Subject|2
7941842|NCT02437084|12481908|FG000|Overall Study|Physician Decision|1
7941843|NCT02437162|12481915|FG000|Overall Study|Protocol Violation|0
7941844|NCT02437162|12481916|FG001|Overall Study|Protocol Violation|1
7941845|NCT02437162|12481917|FG002|Overall Study|Protocol Violation|0
7941846|NCT02437162|12481915|FG000|Overall Study|Randomized but not treated|0
7941847|NCT02437162|12481916|FG001|Overall Study|Randomized but not treated|0
7941848|NCT02437162|12481917|FG002|Overall Study|Randomized but not treated|1
7941849|NCT02437162|12481915|FG000|Overall Study|Study discontinued by Sponsor|93
7941850|NCT02437162|12481916|FG001|Overall Study|Study discontinued by Sponsor|98
7941851|NCT02437162|12481917|FG002|Overall Study|Study discontinued by Sponsor|97
7941852|NCT02437162|12481915|FG000|Overall Study|Withdrawal by Subject|13
7941853|NCT02437162|12481916|FG001|Overall Study|Withdrawal by Subject|7
7941854|NCT02437162|12481917|FG002|Overall Study|Withdrawal by Subject|9
7941855|NCT02437162|12481915|FG000|Overall Study|Adverse Event|0
7941856|NCT02437162|12481916|FG001|Overall Study|Adverse Event|1
7941857|NCT02437162|12481917|FG002|Overall Study|Adverse Event|0
7941858|NCT02437162|12481915|FG000|Overall Study|Lost to Follow-up|1
7941859|NCT02437162|12481916|FG001|Overall Study|Lost to Follow-up|0
7941860|NCT02437162|12481917|FG002|Overall Study|Lost to Follow-up|1
7941861|NCT02437162|12481915|FG000|Overall Study|Death|0
7941862|NCT02437162|12481916|FG001|Overall Study|Death|1
7941863|NCT02437162|12481917|FG002|Overall Study|Death|0
7941864|NCT02437162|12481915|FG000|Overall Study|Other|0
7941865|NCT02437162|12481916|FG001|Overall Study|Other|0
7941866|NCT02437162|12481917|FG002|Overall Study|Other|1
7941867|NCT02437188|12481932|FG000|Overall Study|Randomized but did not receive surgery|4
7941868|NCT02437188|12481933|FG001|Overall Study|Randomized but did not receive surgery|8
7941869|NCT02437188|12481932|FG000|Overall Study|Adverse Event|0
7941870|NCT02437188|12481933|FG001|Overall Study|Adverse Event|1
7941871|NCT02437305|12481955|FG000|Overall Study|Lost to Follow-up|18
7941872|NCT02437305|12481956|FG001|Overall Study|Lost to Follow-up|12
7941873|NCT02437409|12481975|FG000|Overall Study|Withdrawal by Subject|3
7941874|NCT02437409|12481975|FG000|Overall Study|Screening failure|12
7941875|NCT02437513|12481989|FG000|Overall Study|Withdrawal by Subject|2
7941876|NCT02437864|12482000|FG000|Overall Study|Protocol Violation|4
7941877|NCT02437864|12482001|FG001|Overall Study|Protocol Violation|0
7941878|NCT02437890|12482012|FG000|Overall Study|Non-compliance to study drug|0
7941879|NCT02437890|12482013|FG001|Overall Study|Non-compliance to study drug|1
7941880|NCT02437890|12482014|FG002|Overall Study|Non-compliance to study drug|0
7941881|NCT02437890|12482015|FG003|Overall Study|Non-compliance to study drug|0
7941882|NCT02437890|12482016|FG004|Overall Study|Non-compliance to study drug|1
7941883|NCT02437890|12482012|FG000|Overall Study|Sponsor's decision|1
7941884|NCT02437890|12482013|FG001|Overall Study|Sponsor's decision|1
7941885|NCT02437890|12482014|FG002|Overall Study|Sponsor's decision|4
7941886|NCT02437890|12482015|FG003|Overall Study|Sponsor's decision|0
7941887|NCT02437890|12482016|FG004|Overall Study|Sponsor's decision|2
7941888|NCT02437890|12482012|FG000|Overall Study|Physician Decision|0
7941889|NCT02437890|12482013|FG001|Overall Study|Physician Decision|0
7941890|NCT02437890|12482014|FG002|Overall Study|Physician Decision|0
7941891|NCT02437890|12482015|FG003|Overall Study|Physician Decision|1
7941892|NCT02437890|12482016|FG004|Overall Study|Physician Decision|0
7941893|NCT02437890|12482012|FG000|Overall Study|Unable to attend visit(s)|1
7941894|NCT02437890|12482013|FG001|Overall Study|Unable to attend visit(s)|0
7941895|NCT02437890|12482014|FG002|Overall Study|Unable to attend visit(s)|0
7941896|NCT02437890|12482015|FG003|Overall Study|Unable to attend visit(s)|0
7941897|NCT02437890|12482016|FG004|Overall Study|Unable to attend visit(s)|0
7941898|NCT02437890|12482012|FG000|Overall Study|Lack of Efficacy|1
7941899|NCT02437890|12482013|FG001|Overall Study|Lack of Efficacy|3
7941900|NCT02437890|12482014|FG002|Overall Study|Lack of Efficacy|0
7941901|NCT02437890|12482015|FG003|Overall Study|Lack of Efficacy|3
7941902|NCT02437890|12482016|FG004|Overall Study|Lack of Efficacy|1
7941903|NCT02437890|12482012|FG000|Overall Study|Adverse Event|4
7941904|NCT02437890|12482013|FG001|Overall Study|Adverse Event|9
7941905|NCT02437890|12482014|FG002|Overall Study|Adverse Event|5
7941906|NCT02437890|12482015|FG003|Overall Study|Adverse Event|11
7941907|NCT02437890|12482016|FG004|Overall Study|Adverse Event|7
7941908|NCT02437890|12482012|FG000|Overall Study|Withdrawal by Subject|1
7941909|NCT02437890|12482013|FG001|Overall Study|Withdrawal by Subject|2
7941910|NCT02437890|12482014|FG002|Overall Study|Withdrawal by Subject|6
7941911|NCT02437890|12482015|FG003|Overall Study|Withdrawal by Subject|5
7941912|NCT02437890|12482016|FG004|Overall Study|Withdrawal by Subject|5
7941913|NCT02437890|12482012|FG000|Overall Study|Death|0
7941914|NCT02437890|12482013|FG001|Overall Study|Death|0
7941915|NCT02437890|12482014|FG002|Overall Study|Death|0
7941916|NCT02437890|12482015|FG003|Overall Study|Death|2
7941917|NCT02437890|12482016|FG004|Overall Study|Death|0
7941918|NCT02437903|12482032|FG000|Overall Study|Adverse Event|1
7941919|NCT02437903|12482032|FG000|Overall Study|Withdrawal by Subject|1
7941920|NCT02437903|12482032|FG000|Overall Study|Lost to Follow-up|3
7941921|NCT02438137|12482039|FG000|Overall Study|Lost to Follow-up|3
7941922|NCT02438137|12482040|FG001|Overall Study|Lost to Follow-up|2
7941923|NCT02438137|12482039|FG000|Overall Study|Adverse Event|1
7941924|NCT02438137|12482040|FG001|Overall Study|Adverse Event|0
7941925|NCT02438137|12482039|FG000|Overall Study|Withdrawal by Subject|4
7941926|NCT02438137|12482040|FG001|Overall Study|Withdrawal by Subject|3
7941927|NCT02438137|12482039|FG000|Overall Study|Physician Decision|0
7941928|NCT02438137|12482040|FG001|Overall Study|Physician Decision|1
7941929|NCT02438280|12482050|FG000|Overall Study|Physician Decision|1
7941930|NCT02438280|12482051|FG001|Overall Study|Physician Decision|0
7941931|NCT02438371|12482060|FG000|Overall Study|Lost to Follow-up|3
7941932|NCT02438371|12482061|FG001|Overall Study|Lost to Follow-up|2
7941933|NCT02438371|12482060|FG000|Overall Study|Withdrawal by Subject|1
7941934|NCT02438371|12482061|FG001|Overall Study|Withdrawal by Subject|1
7941935|NCT02438384|12482070|FG000|Overall Study|Lost to Follow-up|8
7941936|NCT02438384|12482071|FG001|Overall Study|Lost to Follow-up|6
7941937|NCT02438384|12482072|FG002|Overall Study|Lost to Follow-up|4
7941938|NCT02438787|12482121|FG000|Overall Study|Adverse Event|1
7941939|NCT02438787|12482122|FG001|Overall Study|Adverse Event|0
7941940|NCT02438787|12482123|FG002|Overall Study|Adverse Event|2
7941941|NCT02438787|12482121|FG000|Overall Study|Lack of Efficacy|1
7941942|NCT02438787|12482122|FG001|Overall Study|Lack of Efficacy|2
7941943|NCT02438787|12482123|FG002|Overall Study|Lack of Efficacy|0
7941944|NCT02438787|12482121|FG000|Overall Study|Lost to Follow-up|0
7941945|NCT02438787|12482122|FG001|Overall Study|Lost to Follow-up|1
7941946|NCT02438787|12482123|FG002|Overall Study|Lost to Follow-up|0
7941947|NCT02438787|12482121|FG000|Overall Study|Protocol Violation|0
7941948|NCT02438787|12482122|FG001|Overall Study|Protocol Violation|0
7941949|NCT02438787|12482123|FG002|Overall Study|Protocol Violation|1
7941950|NCT02438787|12482121|FG000|Overall Study|Withdrawal by Subject|15
7941951|NCT02438787|12482122|FG001|Overall Study|Withdrawal by Subject|7
7941952|NCT02438787|12482123|FG002|Overall Study|Withdrawal by Subject|10
7941953|NCT02438787|12482121|FG000|Overall Study|Study discontinued by sponsor|64
7941954|NCT02438787|12482122|FG001|Overall Study|Study discontinued by sponsor|72
7941955|NCT02438787|12482123|FG002|Overall Study|Study discontinued by sponsor|69
7941956|NCT02438787|12482121|FG000|Overall Study|Other|0
7941957|NCT02438787|12482122|FG001|Overall Study|Other|1
7941958|NCT02438787|12482123|FG002|Overall Study|Other|0
7941959|NCT02438787|12482121|FG000|Overall Study|Site terminated by sponsor|0
7941960|NCT02438787|12482122|FG001|Overall Study|Site terminated by sponsor|0
7941961|NCT02438787|12482123|FG002|Overall Study|Site terminated by sponsor|1
7941962|NCT02438813|12482136|FG000|Overall Study|Patient Decision|59
7941963|NCT02438813|12482136|FG000|Overall Study|Patient Lost to Follow-Up|137
7941964|NCT02438813|12482136|FG000|Overall Study|Study Ended by Sponsor|80
7941965|NCT02438813|12482136|FG000|Overall Study|Patients Not Treated/No EOT Visit|249
7941966|NCT02438826|12482152|FG000|Double-Blind Treatment Phase|Adverse Event|1
7941967|NCT02438826|12482153|FG001|Double-Blind Treatment Phase|Adverse Event|1
7941968|NCT02438826|12482154|FG002|Double-Blind Treatment Phase|Adverse Event|0
7941969|NCT02438826|12482155|FG003|Double-Blind Treatment Phase|Adverse Event|0
7941970|NCT02438826|12482152|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1
7941971|NCT02438826|12482153|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0
7941972|NCT02438826|12482154|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0
7941973|NCT02438826|12482155|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0
7941974|NCT02438826|12482152|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1
7941975|NCT02438826|12482153|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1
7941976|NCT02438826|12482154|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0
7941977|NCT02438826|12482155|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0
7941978|NCT02438826|12482152|FG000|Double-Blind Treatment Phase|Protocol Violation|1
7941979|NCT02438826|12482153|FG001|Double-Blind Treatment Phase|Protocol Violation|2
7941980|NCT02438826|12482154|FG002|Double-Blind Treatment Phase|Protocol Violation|0
7941981|NCT02438826|12482155|FG003|Double-Blind Treatment Phase|Protocol Violation|0
7941982|NCT02438826|12482152|FG000|Double-Blind Treatment Phase|Screen Failure|2
7941983|NCT02438826|12482153|FG001|Double-Blind Treatment Phase|Screen Failure|0
7941984|NCT02438826|12482154|FG002|Double-Blind Treatment Phase|Screen Failure|0
7941985|NCT02438826|12482155|FG003|Double-Blind Treatment Phase|Screen Failure|0
7941986|NCT02438826|12482152|FG000|Open-Label Treatment Phase|Adverse Event|11
7941987|NCT02438826|12482153|FG001|Open-Label Treatment Phase|Adverse Event|6
7941988|NCT02438826|12482154|FG002|Open-Label Treatment Phase|Adverse Event|0
7941989|NCT02438826|12482155|FG003|Open-Label Treatment Phase|Adverse Event|0
7941990|NCT02438826|12482152|FG000|Open-Label Treatment Phase|Lack of Efficacy|27
7941991|NCT02438826|12482153|FG001|Open-Label Treatment Phase|Lack of Efficacy|18
7941992|NCT02438826|12482154|FG002|Open-Label Treatment Phase|Lack of Efficacy|0
7941993|NCT02438826|12482155|FG003|Open-Label Treatment Phase|Lack of Efficacy|0
7941994|NCT02438826|12482152|FG000|Open-Label Treatment Phase|Lost to Follow-up|0
7941995|NCT02438826|12482153|FG001|Open-Label Treatment Phase|Lost to Follow-up|2
7941996|NCT02438826|12482154|FG002|Open-Label Treatment Phase|Lost to Follow-up|0
7941997|NCT02438826|12482155|FG003|Open-Label Treatment Phase|Lost to Follow-up|0
7941998|NCT02438826|12482152|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6
7941999|NCT02438826|12482153|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7
7942000|NCT02438826|12482154|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0
7942001|NCT02438826|12482155|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0
7942002|NCT02438826|12482152|FG000|Post-Treatment Phase|Adverse Event|3
7942003|NCT02438826|12482153|FG001|Post-Treatment Phase|Adverse Event|0
7942004|NCT02438826|12482154|FG002|Post-Treatment Phase|Adverse Event|0
7942005|NCT02438826|12482155|FG003|Post-Treatment Phase|Adverse Event|0
7942006|NCT02438826|12482152|FG000|Post-Treatment Phase|Lack of Efficacy|4
7942007|NCT02438826|12482153|FG001|Post-Treatment Phase|Lack of Efficacy|0
7942008|NCT02438826|12482154|FG002|Post-Treatment Phase|Lack of Efficacy|0
7942009|NCT02438826|12482155|FG003|Post-Treatment Phase|Lack of Efficacy|0
7942010|NCT02438826|12482152|FG000|Post-Treatment Phase|Physician Decision|1
7942011|NCT02438826|12482153|FG001|Post-Treatment Phase|Physician Decision|0
7942012|NCT02438826|12482154|FG002|Post-Treatment Phase|Physician Decision|0
7942013|NCT02438826|12482155|FG003|Post-Treatment Phase|Physician Decision|0
7942014|NCT02438826|12482152|FG000|Post-Treatment Phase|Withdrawal by Subject|1
7942015|NCT02438826|12482153|FG001|Post-Treatment Phase|Withdrawal by Subject|1
7942016|NCT02438826|12482154|FG002|Post-Treatment Phase|Withdrawal by Subject|0
7942017|NCT02438826|12482155|FG003|Post-Treatment Phase|Withdrawal by Subject|0
7942018|NCT02439138|12482170|FG000|Overall Study|Adverse Event|1
7942019|NCT02439138|12482170|FG000|Overall Study|PI decision to terminate the study|2
7942020|NCT02439320|12482198|FG000|Overall Study|Adverse Event|0
7942021|NCT02439320|12482199|FG001|Overall Study|Adverse Event|2
7942022|NCT02439320|12482200|FG002|Overall Study|Adverse Event|0
7942023|NCT02439320|12482198|FG000|Overall Study|Lost to Follow-up|37
7942024|NCT02439320|12482199|FG001|Overall Study|Lost to Follow-up|34
7942025|NCT02439320|12482200|FG002|Overall Study|Lost to Follow-up|42
7942026|NCT02439320|12482198|FG000|Overall Study|Death|0
7942027|NCT02439320|12482199|FG001|Overall Study|Death|1
7942028|NCT02439320|12482200|FG002|Overall Study|Death|0
7942029|NCT02439320|12482198|FG000|Overall Study|Noncompliance with Protocol|10
7942030|NCT02439320|12482199|FG001|Overall Study|Noncompliance with Protocol|11
7942031|NCT02439320|12482200|FG002|Overall Study|Noncompliance with Protocol|7
7942032|NCT02439320|12482198|FG000|Overall Study|Pregnancy|0
7942033|NCT02439320|12482199|FG001|Overall Study|Pregnancy|1
7942034|NCT02439320|12482200|FG002|Overall Study|Pregnancy|1
7942035|NCT02439320|12482198|FG000|Overall Study|Withdrawal by Subject|12
7942036|NCT02439320|12482199|FG001|Overall Study|Withdrawal by Subject|16
7942037|NCT02439320|12482200|FG002|Overall Study|Withdrawal by Subject|14
7942038|NCT02439320|12482198|FG000|Overall Study|Physician Decision|2
7942039|NCT02439320|12482199|FG001|Overall Study|Physician Decision|1
7942040|NCT02439320|12482200|FG002|Overall Study|Physician Decision|0
7942041|NCT02439320|12482198|FG000|Overall Study|Sponsor Request|0
7942042|NCT02439320|12482199|FG001|Overall Study|Sponsor Request|2
7942043|NCT02439320|12482200|FG002|Overall Study|Sponsor Request|1
7942044|NCT02439320|12482198|FG000|Overall Study|Randomization Failure|35
7942045|NCT02439320|12482199|FG001|Overall Study|Randomization Failure|46
7942046|NCT02439320|12482200|FG002|Overall Study|Randomization Failure|34
7942047|NCT02440568|12482288|FG000|Overall Study|Death|1
7942048|NCT02440568|12482289|FG001|Overall Study|Death|3
7942049|NCT02440568|12482290|FG002|Overall Study|Death|4
7942050|NCT02440568|12482291|FG003|Overall Study|Death|2
7942051|NCT02440568|12482288|FG000|Overall Study|Lack of Efficacy|2
7942052|NCT02440568|12482289|FG001|Overall Study|Lack of Efficacy|0
7942053|NCT02440568|12482290|FG002|Overall Study|Lack of Efficacy|1
7942054|NCT02440568|12482291|FG003|Overall Study|Lack of Efficacy|0
7942055|NCT02440568|12482288|FG000|Overall Study|Lost to Follow-up|1
7942056|NCT02440568|12482289|FG001|Overall Study|Lost to Follow-up|0
7942057|NCT02440568|12482290|FG002|Overall Study|Lost to Follow-up|0
7942058|NCT02440568|12482291|FG003|Overall Study|Lost to Follow-up|0
7942059|NCT02440594|12482310|FG000|Overall Study|Lost to Follow-up|34
7942060|NCT02440594|12482311|FG001|Overall Study|Lost to Follow-up|33
7942061|NCT02440594|12482312|FG002|Overall Study|Lost to Follow-up|54
7942062|NCT02440594|12482313|FG003|Overall Study|Lost to Follow-up|47
7942063|NCT02440594|12482314|FG004|Overall Study|Lost to Follow-up|5
7942064|NCT02440594|12482315|FG005|Overall Study|Lost to Follow-up|4
7942065|NCT02440594|12482316|FG006|Overall Study|Lost to Follow-up|28
7942066|NCT02440594|12482317|FG007|Overall Study|Lost to Follow-up|48
7942067|NCT02440594|12482310|FG000|Overall Study|Cognitive Impairment/Communication Issue|14
7942068|NCT02440594|12482311|FG001|Overall Study|Cognitive Impairment/Communication Issue|6
7942069|NCT02440594|12482312|FG002|Overall Study|Cognitive Impairment/Communication Issue|4
7942070|NCT02440594|12482313|FG003|Overall Study|Cognitive Impairment/Communication Issue|4
7942071|NCT02440594|12482314|FG004|Overall Study|Cognitive Impairment/Communication Issue|2
7942072|NCT02440594|12482315|FG005|Overall Study|Cognitive Impairment/Communication Issue|1
7942073|NCT02440594|12482316|FG006|Overall Study|Cognitive Impairment/Communication Issue|0
7942074|NCT02440594|12482317|FG007|Overall Study|Cognitive Impairment/Communication Issue|0
7942075|NCT02440594|12482310|FG000|Overall Study|Withdrawal by Subject|81
7942076|NCT02440594|12482311|FG001|Overall Study|Withdrawal by Subject|67
7942077|NCT02440594|12482312|FG002|Overall Study|Withdrawal by Subject|59
7942078|NCT02440594|12482313|FG003|Overall Study|Withdrawal by Subject|38
7942079|NCT02440594|12482314|FG004|Overall Study|Withdrawal by Subject|2
7942080|NCT02440594|12482315|FG005|Overall Study|Withdrawal by Subject|2
7942081|NCT02440594|12482316|FG006|Overall Study|Withdrawal by Subject|7
7942082|NCT02440594|12482317|FG007|Overall Study|Withdrawal by Subject|7
7942083|NCT02440594|12482310|FG000|Overall Study|Administratively w/drawn|3
7942084|NCT02440594|12482311|FG001|Overall Study|Administratively w/drawn|2
7942085|NCT02440594|12482312|FG002|Overall Study|Administratively w/drawn|0
7942086|NCT02440594|12482313|FG003|Overall Study|Administratively w/drawn|0
7942087|NCT02440594|12482314|FG004|Overall Study|Administratively w/drawn|0
7942088|NCT02440594|12482315|FG005|Overall Study|Administratively w/drawn|0
7942089|NCT02440594|12482316|FG006|Overall Study|Administratively w/drawn|2
7942090|NCT02440594|12482317|FG007|Overall Study|Administratively w/drawn|1
7942091|NCT02440789|12482359|FG000|Overall Study|Withdrawal by Subject|3
7942092|NCT02440789|12482359|FG000|Overall Study|Not willing to adhere to reqs|1
7942093|NCT02441114|12482367|FG000|Washout2|Withdrawal by Subject|4
7942094|NCT02441179|12482373|FG000|Overall Study|Withdrawal by Subject|1
7942095|NCT02441179|12482374|FG001|Overall Study|Withdrawal by Subject|1
7942096|NCT02441218|12482383|FG000|Overall Study|Death|503
7942097|NCT02441218|12482384|FG001|Overall Study|Death|553
7942098|NCT02441218|12482383|FG000|Overall Study|Withdrawal by Subject|73
7942099|NCT02441218|12482384|FG001|Overall Study|Withdrawal by Subject|58
7942100|NCT02441218|12482383|FG000|Overall Study|Lost to Follow-up|2
7942101|NCT02441218|12482384|FG001|Overall Study|Lost to Follow-up|1
7942102|NCT02441283|12482390|FG000|Overall Study|Withdrew consent|15
7942103|NCT02441283|12482390|FG000|Overall Study|Lost to Follow-up|42
7942104|NCT02441283|12482390|FG000|Overall Study|Death|1
7942105|NCT02441283|12482390|FG000|Overall Study|Other, not specified|32
7942106|NCT02441309|12482397|FG000|Overall Study|Disease progression|2
7942107|NCT02441309|12482398|FG001|Overall Study|Disease progression|1
7942108|NCT02441309|12482399|FG002|Overall Study|Disease progression|2
7942109|NCT02441309|12482397|FG000|Overall Study|Adverse Event|0
7942110|NCT02441309|12482398|FG001|Overall Study|Adverse Event|1
7942111|NCT02441309|12482399|FG002|Overall Study|Adverse Event|0
7942112|NCT02441309|12482397|FG000|Overall Study|Withdrawal by Subject|1
7942113|NCT02441309|12482398|FG001|Overall Study|Withdrawal by Subject|0
7942114|NCT02441309|12482399|FG002|Overall Study|Withdrawal by Subject|1
7942115|NCT02441517|12482410|FG000|Overall Study|Lost to Follow-up|1
7942116|NCT02441517|12482410|FG000|Overall Study|Withdrawal by Subject|2
7942117|NCT02441517|12482410|FG000|Overall Study|Study Terminated by Sponsor|1
7942118|NCT02441946|12482417|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
7942119|NCT02441946|12482418|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
7942120|NCT02441946|12482419|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
7942121|NCT02441946|12482417|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
7942122|NCT02441946|12482418|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
7942123|NCT02441946|12482419|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
7942124|NCT02441946|12482417|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
7942125|NCT02441946|12482418|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
7942126|NCT02441946|12482419|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
7942127|NCT02441946|12482417|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
7942128|NCT02441946|12482418|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
7942129|NCT02441946|12482419|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
7942130|NCT02441946|12482417|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
7942131|NCT02441946|12482418|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
7942132|NCT02441946|12482419|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
7942133|NCT02441946|12482417|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
7942134|NCT02441946|12482418|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
7942135|NCT02441946|12482419|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
7942136|NCT02441946|12482417|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
7942137|NCT02441946|12482418|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
7942138|NCT02441946|12482419|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
7942139|NCT02441946|12482417|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
7942140|NCT02441946|12482418|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
7942141|NCT02441946|12482419|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
7942142|NCT02441946|12482417|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
7942143|NCT02441946|12482418|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
7942144|NCT02441946|12482419|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
7942145|NCT02441946|12482417|FG000|Extension Period (8 Weeks)|Adverse Event|1
7942146|NCT02441946|12482418|FG001|Extension Period (8 Weeks)|Adverse Event|0
7942147|NCT02441946|12482419|FG002|Extension Period (8 Weeks)|Adverse Event|0
7942148|NCT02441946|12482417|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1
7942149|NCT02441946|12482418|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0
7942150|NCT02441946|12482419|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0
7942151|NCT02442206|12482432|FG000|Period 1|Adverse Event|1
7942152|NCT02442206|12482433|FG001|Period 1|Adverse Event|1
7942153|NCT02442206|12482432|FG000|Period 1|withdrew consent|0
7942154|NCT02442206|12482433|FG001|Period 1|withdrew consent|1
7942155|NCT02442206|12482432|FG000|Period 1|COPD exacerbation|0
7942156|NCT02442206|12482433|FG001|Period 1|COPD exacerbation|1
7942157|NCT02442206|12482432|FG000|Period 2|Adverse Event|1
7942158|NCT02442206|12482433|FG001|Period 2|Adverse Event|0
7942159|NCT02442271|12482440|FG000|Overall Study|Adverse Event|1
7942160|NCT02442271|12482440|FG000|Overall Study|Withdrew Consent|1
7942161|NCT02442271|12482440|FG000|Overall Study|Lost to Follow-up|1
7942162|NCT02442271|12482440|FG000|Overall Study|Other|1
7942163|NCT02442284|12482458|FG000|Overall Study|Adverse Event|1
7942164|NCT02442284|12482458|FG000|Overall Study|Withdrew Consent|2
7942165|NCT02442284|12482458|FG000|Overall Study|Lost to Follow-up|3
7942166|NCT02442284|12482458|FG000|Overall Study|Other|1
7942167|NCT02442310|12482462|FG000|Overall Study|Adverse Event|2
7942168|NCT02442310|12482462|FG000|Overall Study|Withdrawal by Subject|1
7942169|NCT02442336|12482472|FG000|Overall Study|6 patients assisted with the intervention development only.|6
7942170|NCT02442336|12482472|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19
7942171|NCT02442336|12482472|FG000|Overall Study|Lost to Follow-up|11
7942172|NCT02442622|12482478|FG000|Overall Study|Withdrawal by Subject|3
7942173|NCT02442622|12482479|FG001|Overall Study|Withdrawal by Subject|1
7942174|NCT02442804|12482510|FG000|Overall Study|Withdrawal by Subject|0
7942175|NCT02442804|12482511|FG001|Overall Study|Withdrawal by Subject|1
7942176|NCT02442804|12482510|FG000|Overall Study|Adverse Event|1
7942177|NCT02442804|12482511|FG001|Overall Study|Adverse Event|0
7942178|NCT02442830|12482519|FG000|Overall Study|Technical Failure|0
7942179|NCT02442830|12482520|FG001|Overall Study|Technical Failure|1
7942180|NCT02443103|12482566|FG000|Overall Study|Adverse Event|2
7942181|NCT02443103|12482566|FG000|Overall Study|Noncompliance|1
7942182|NCT02443155|12482574|FG000|Overall Study|Adverse Event|3
7942183|NCT02443155|12482575|FG001|Overall Study|Adverse Event|4
7942184|NCT02443155|12482576|FG002|Overall Study|Adverse Event|1
7942185|NCT02443155|12482577|FG003|Overall Study|Adverse Event|2
7942186|NCT02443155|12482574|FG000|Overall Study|Unclassified|0
7942187|NCT02443155|12482575|FG001|Overall Study|Unclassified|0
7942188|NCT02443155|12482576|FG002|Overall Study|Unclassified|2
7942189|NCT02443155|12482577|FG003|Overall Study|Unclassified|1
7942190|NCT02443155|12482574|FG000|Overall Study|Withdrawal by Subject|4
7942191|NCT02443155|12482575|FG001|Overall Study|Withdrawal by Subject|7
7942192|NCT02443155|12482576|FG002|Overall Study|Withdrawal by Subject|3
7942193|NCT02443155|12482577|FG003|Overall Study|Withdrawal by Subject|9
7942194|NCT02443155|12482574|FG000|Overall Study|Pregnancy|3
7942195|NCT02443155|12482575|FG001|Overall Study|Pregnancy|1
7942196|NCT02443155|12482576|FG002|Overall Study|Pregnancy|1
7942197|NCT02443155|12482577|FG003|Overall Study|Pregnancy|2
7942198|NCT02443155|12482574|FG000|Overall Study|Lost to Follow-up|1
7942199|NCT02443155|12482575|FG001|Overall Study|Lost to Follow-up|2
7942200|NCT02443155|12482576|FG002|Overall Study|Lost to Follow-up|0
7942201|NCT02443155|12482577|FG003|Overall Study|Lost to Follow-up|1
7942202|NCT02443155|12482574|FG000|Overall Study|Protocol Violation|1
7942203|NCT02443155|12482575|FG001|Overall Study|Protocol Violation|0
7942204|NCT02443155|12482576|FG002|Overall Study|Protocol Violation|1
7942205|NCT02443155|12482577|FG003|Overall Study|Protocol Violation|1
7942206|NCT02443155|12482574|FG000|Overall Study|Death|0
7942207|NCT02443155|12482575|FG001|Overall Study|Death|0
7942208|NCT02443155|12482576|FG002|Overall Study|Death|1
7942209|NCT02443155|12482577|FG003|Overall Study|Death|0
7942210|NCT02443298|12482590|FG000|Overall Study|Adverse Event|3
7942211|NCT02443298|12482591|FG001|Overall Study|Adverse Event|3
7942212|NCT02443298|12482590|FG000|Overall Study|Withdrawal by Subject|1
7942213|NCT02443298|12482591|FG001|Overall Study|Withdrawal by Subject|2
7942214|NCT02443337|12482599|FG000|Overall Study|Adverse Event|0
7942215|NCT02443337|12482600|FG001|Overall Study|Adverse Event|1
7942216|NCT02443337|12482599|FG000|Overall Study|Clinical Progressive Disease|3
7942217|NCT02443337|12482600|FG001|Overall Study|Clinical Progressive Disease|0
7942218|NCT02443337|12482599|FG000|Overall Study|Withdrawal by Subject|2
7942219|NCT02443337|12482600|FG001|Overall Study|Withdrawal by Subject|1
7942220|NCT02443402|12482613|FG000|Overall Study|Withdrawal by Subject|3
7942221|NCT02443402|12482614|FG001|Overall Study|Withdrawal by Subject|1
7942222|NCT02443402|12482613|FG000|Overall Study|Screen Failure|1
7942223|NCT02443402|12482614|FG001|Overall Study|Screen Failure|2
7942224|NCT02443688|12482645|FG000|Overall Study|Adverse Event|2
7942225|NCT02443688|12482646|FG001|Overall Study|Adverse Event|3
7942226|NCT02443688|12482647|FG002|Overall Study|Adverse Event|2
7942227|NCT02443688|12482645|FG000|Overall Study|Lost to Follow-up|1
7942228|NCT02443688|12482646|FG001|Overall Study|Lost to Follow-up|0
7942229|NCT02443688|12482647|FG002|Overall Study|Lost to Follow-up|0
7942230|NCT02443688|12482645|FG000|Overall Study|Physician Decision|3
7942231|NCT02443688|12482646|FG001|Overall Study|Physician Decision|0
7942232|NCT02443688|12482647|FG002|Overall Study|Physician Decision|1
7942233|NCT02443688|12482645|FG000|Overall Study|Pregnancy|0
7942234|NCT02443688|12482646|FG001|Overall Study|Pregnancy|0
7942235|NCT02443688|12482647|FG002|Overall Study|Pregnancy|1
7942236|NCT02443688|12482645|FG000|Overall Study|Withdrawal by Subject|3
7942237|NCT02443688|12482646|FG001|Overall Study|Withdrawal by Subject|3
7942238|NCT02443688|12482647|FG002|Overall Study|Withdrawal by Subject|4
7942239|NCT02443688|12482645|FG000|Overall Study|Non-compliance with study drug|1
7942240|NCT02443688|12482646|FG001|Overall Study|Non-compliance with study drug|2
7942241|NCT02443688|12482647|FG002|Overall Study|Non-compliance with study drug|4
7942242|NCT02443688|12482645|FG000|Overall Study|Sponsor Request|2
7942243|NCT02443688|12482646|FG001|Overall Study|Sponsor Request|1
7942244|NCT02443688|12482647|FG002|Overall Study|Sponsor Request|0
7942245|NCT02443740|12482663|FG000|Intervention Period 1 (3 Days)|Adverse Event|0
7942246|NCT02443740|12482664|FG001|Intervention Period 1 (3 Days)|Adverse Event|0
7942247|NCT02443740|12482665|FG002|Intervention Period 1 (3 Days)|Adverse Event|0
7942248|NCT02443740|12482666|FG003|Intervention Period 1 (3 Days)|Adverse Event|0
7942249|NCT02443740|12482667|FG004|Intervention Period 1 (3 Days)|Adverse Event|0
7942250|NCT02443740|12482668|FG005|Intervention Period 1 (3 Days)|Adverse Event|1
7942251|NCT02443740|12482669|FG006|Intervention Period 1 (3 Days)|Adverse Event|0
7942252|NCT02443740|12482670|FG007|Intervention Period 1 (3 Days)|Adverse Event|0
7942253|NCT02443740|12482671|FG008|Intervention Period 1 (3 Days)|Adverse Event|0
7942254|NCT02443740|12482672|FG009|Intervention Period 1 (3 Days)|Adverse Event|0
7942255|NCT02443740|12482673|FG010|Intervention Period 1 (3 Days)|Adverse Event|0
7942256|NCT02443740|12482663|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1
7942257|NCT02443740|12482664|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0
7942258|NCT02443740|12482665|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0
7942259|NCT02443740|12482666|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0
7942260|NCT02443740|12482667|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0
7942261|NCT02443740|12482668|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0
7942262|NCT02443740|12482669|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1
7942263|NCT02443740|12482670|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0
7942264|NCT02443740|12482671|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0
7942265|NCT02443740|12482672|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0
7942266|NCT02443740|12482673|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0
7942267|NCT02443740|12482663|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7942268|NCT02443740|12482664|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7942269|NCT02443740|12482665|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7942270|NCT02443740|12482666|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7942271|NCT02443740|12482667|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7942272|NCT02443740|12482668|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
7942273|NCT02443740|12482669|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7942274|NCT02443740|12482670|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7942275|NCT02443740|12482671|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7942276|NCT02443740|12482672|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7942277|NCT02443740|12482673|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7942278|NCT02443805|12482714|FG000|Overall Study|Adverse Event|100
7942279|NCT02443805|12482715|FG001|Overall Study|Adverse Event|18
7942280|NCT02443805|12482714|FG000|Overall Study|Withdrawal by Subject|73
7942281|NCT02443805|12482715|FG001|Overall Study|Withdrawal by Subject|74
7942282|NCT02443805|12482714|FG000|Overall Study|Lost to Follow-up|19
7942283|NCT02443805|12482715|FG001|Overall Study|Lost to Follow-up|14
7942284|NCT02443805|12482714|FG000|Overall Study|Pregnancy|6
7942285|NCT02443805|12482715|FG001|Overall Study|Pregnancy|5
7942286|NCT02443805|12482714|FG000|Overall Study|Protocol Violation|2
7942287|NCT02443805|12482715|FG001|Overall Study|Protocol Violation|4
7942288|NCT02443805|12482714|FG000|Overall Study|Lack of Efficacy|1
7942289|NCT02443805|12482715|FG001|Overall Study|Lack of Efficacy|1
7942290|NCT02443805|12482714|FG000|Overall Study|Non-compliance with study drug|6
7942291|NCT02443805|12482715|FG001|Overall Study|Non-compliance with study drug|4
7942292|NCT02443805|12482714|FG000|Overall Study|Withdrawal by parent/guardian|3
7942293|NCT02443805|12482715|FG001|Overall Study|Withdrawal by parent/guardian|5
7942294|NCT02443805|12482714|FG000|Overall Study|Any other reason not above-mentioned|3
7942295|NCT02443805|12482715|FG001|Overall Study|Any other reason not above-mentioned|2
7942296|NCT02443883|12482725|FG000|Overall Study|Adverse Event|0
7942297|NCT02443883|12482726|FG001|Overall Study|Adverse Event|1
7942298|NCT02443883|12482727|FG002|Overall Study|Adverse Event|0
7942299|NCT02443883|12482728|FG003|Overall Study|Adverse Event|0
7942300|NCT02443883|12482725|FG000|Overall Study|Lost to Follow-up|3
7942301|NCT02443883|12482726|FG001|Overall Study|Lost to Follow-up|2
7942302|NCT02443883|12482727|FG002|Overall Study|Lost to Follow-up|1
7942303|NCT02443883|12482728|FG003|Overall Study|Lost to Follow-up|0
7942304|NCT02443883|12482725|FG000|Overall Study|Physician Decision|1
7942305|NCT02443883|12482726|FG001|Overall Study|Physician Decision|1
7942306|NCT02443883|12482727|FG002|Overall Study|Physician Decision|0
7942307|NCT02443883|12482728|FG003|Overall Study|Physician Decision|3
7942308|NCT02443883|12482725|FG000|Overall Study|Withdrawal by Subject|1
7942309|NCT02443883|12482726|FG001|Overall Study|Withdrawal by Subject|0
7942310|NCT02443883|12482727|FG002|Overall Study|Withdrawal by Subject|0
7942311|NCT02443883|12482728|FG003|Overall Study|Withdrawal by Subject|2
7942312|NCT02443883|12482725|FG000|Overall Study|Randomized, but never treated|1
7942313|NCT02443883|12482726|FG001|Overall Study|Randomized, but never treated|0
7942314|NCT02443883|12482727|FG002|Overall Study|Randomized, but never treated|0
7942315|NCT02443883|12482728|FG003|Overall Study|Randomized, but never treated|0
7942316|NCT02444182|12482751|FG000|Overall Study|non-compliance|2
7942317|NCT02444182|12482752|FG001|Overall Study|non-compliance|1
7942318|NCT02444182|12482751|FG000|Overall Study|Lost to Follow-up|0
7942319|NCT02444182|12482752|FG001|Overall Study|Lost to Follow-up|4
7942320|NCT02444533|12482769|FG000|Overall Study|Not able to complete forms|0
7942321|NCT02444533|12482770|FG001|Overall Study|Not able to complete forms|2
7942322|NCT02444533|12482769|FG000|Overall Study|Only gave post-procedure complications|2
7942323|NCT02444533|12482770|FG001|Overall Study|Only gave post-procedure complications|2
7942324|NCT02444793|12482812|FG000|Overall Study|Lost to Follow-up|2
7942325|NCT02444793|12482813|FG001|Overall Study|Lost to Follow-up|2
7942326|NCT02444793|12482814|FG002|Overall Study|Lost to Follow-up|0
7942327|NCT02444793|12482815|FG003|Overall Study|Lost to Follow-up|0
7942328|NCT02444793|12482812|FG000|Overall Study|Death|0
7942329|NCT02444793|12482813|FG001|Overall Study|Death|3
7942330|NCT02444793|12482814|FG002|Overall Study|Death|0
7942331|NCT02444793|12482815|FG003|Overall Study|Death|0
7942332|NCT02444793|12482812|FG000|Overall Study|Other|0
7942333|NCT02444793|12482813|FG001|Overall Study|Other|0
7942334|NCT02444793|12482814|FG002|Overall Study|Other|2
7942335|NCT02444793|12482815|FG003|Overall Study|Other|0
7942336|NCT02444793|12482812|FG000|Overall Study|Objective progression or relapse|9
7942337|NCT02444793|12482813|FG001|Overall Study|Objective progression or relapse|1
7942338|NCT02444793|12482814|FG002|Overall Study|Objective progression or relapse|2
7942339|NCT02444793|12482815|FG003|Overall Study|Objective progression or relapse|3
7965377|NCT01190930|12520928|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7965378|NCT01190930|12520929|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7965379|NCT01190930|12520930|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7965380|NCT01190930|12520931|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7965381|NCT01190930|12520932|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7965382|NCT01190930|12520933|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7965383|NCT01190930|12520934|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7965384|NCT01190930|12520935|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7965385|NCT01190930|12520926|FG000|Induction|High Risk Downs|80
7965386|NCT01190930|12520927|FG001|Induction|High Risk Downs|0
7965387|NCT01190930|12520928|FG002|Induction|High Risk Downs|0
7965388|NCT01190930|12520929|FG003|Induction|High Risk Downs|0
7965389|NCT01190930|12520930|FG004|Induction|High Risk Downs|0
7965390|NCT01190930|12520931|FG005|Induction|High Risk Downs|0
7965391|NCT01190930|12520932|FG006|Induction|High Risk Downs|0
7965392|NCT01190930|12520933|FG007|Induction|High Risk Downs|0
7965393|NCT01190930|12520934|FG008|Induction|High Risk Downs|0
7965394|NCT01190930|12520935|FG009|Induction|High Risk Downs|0
7965395|NCT01190930|12520926|FG000|Induction|Enrollment onto another COG Protocol|1
7965396|NCT01190930|12520927|FG001|Induction|Enrollment onto another COG Protocol|0
7965397|NCT01190930|12520928|FG002|Induction|Enrollment onto another COG Protocol|0
7965398|NCT01190930|12520929|FG003|Induction|Enrollment onto another COG Protocol|0
7965399|NCT01190930|12520930|FG004|Induction|Enrollment onto another COG Protocol|0
7965400|NCT01190930|12520931|FG005|Induction|Enrollment onto another COG Protocol|0
7965401|NCT01190930|12520932|FG006|Induction|Enrollment onto another COG Protocol|0
7965402|NCT01190930|12520933|FG007|Induction|Enrollment onto another COG Protocol|0
7965403|NCT01190930|12520934|FG008|Induction|Enrollment onto another COG Protocol|0
7965404|NCT01190930|12520935|FG009|Induction|Enrollment onto another COG Protocol|0
7965405|NCT01190930|12520926|FG000|Induction|Average Risk|1847
7965406|NCT01190930|12520927|FG001|Induction|Average Risk|0
7965407|NCT01190930|12520928|FG002|Induction|Average Risk|0
7965408|NCT01190930|12520929|FG003|Induction|Average Risk|0
7965409|NCT01190930|12520930|FG004|Induction|Average Risk|0
7965410|NCT01190930|12520931|FG005|Induction|Average Risk|0
7965411|NCT01190930|12520932|FG006|Induction|Average Risk|0
7965412|NCT01190930|12520933|FG007|Induction|Average Risk|0
7965413|NCT01190930|12520934|FG008|Induction|Average Risk|0
7965414|NCT01190930|12520935|FG009|Induction|Average Risk|0
7965415|NCT01190930|12520926|FG000|Induction|High Risk|1227
7965416|NCT01190930|12520927|FG001|Induction|High Risk|0
7965417|NCT01190930|12520928|FG002|Induction|High Risk|0
7965418|NCT01190930|12520929|FG003|Induction|High Risk|0
7965419|NCT01190930|12520930|FG004|Induction|High Risk|0
7965420|NCT01190930|12520931|FG005|Induction|High Risk|0
7965421|NCT01190930|12520932|FG006|Induction|High Risk|0
7965422|NCT01190930|12520933|FG007|Induction|High Risk|0
7965423|NCT01190930|12520934|FG008|Induction|High Risk|0
7965424|NCT01190930|12520935|FG009|Induction|High Risk|0
7965425|NCT01190930|12520926|FG000|Induction|Low Risk|443
7965426|NCT01190930|12520927|FG001|Induction|Low Risk|0
7965427|NCT01190930|12520928|FG002|Induction|Low Risk|0
7965428|NCT01190930|12520929|FG003|Induction|Low Risk|0
7965429|NCT01190930|12520930|FG004|Induction|Low Risk|0
7965430|NCT01190930|12520931|FG005|Induction|Low Risk|0
7965431|NCT01190930|12520932|FG006|Induction|Low Risk|0
7965432|NCT01190930|12520933|FG007|Induction|Low Risk|0
7965433|NCT01190930|12520934|FG008|Induction|Low Risk|0
7965434|NCT01190930|12520935|FG009|Induction|Low Risk|0
7965435|NCT01190930|12520926|FG000|Induction|Very High Risk|1012
7965436|NCT01190930|12520927|FG001|Induction|Very High Risk|0
7965437|NCT01190930|12520928|FG002|Induction|Very High Risk|0
7965438|NCT01190930|12520929|FG003|Induction|Very High Risk|0
7965439|NCT01190930|12520930|FG004|Induction|Very High Risk|0
7965440|NCT01190930|12520931|FG005|Induction|Very High Risk|0
7965441|NCT01190930|12520932|FG006|Induction|Very High Risk|0
7965442|NCT01190930|12520933|FG007|Induction|Very High Risk|0
7965443|NCT01190930|12520934|FG008|Induction|Very High Risk|0
7965444|NCT01190930|12520935|FG009|Induction|Very High Risk|0
7965445|NCT01190930|12520926|FG000|Induction|Philadelphia chromosome-positive|99
7965446|NCT01190930|12520927|FG001|Induction|Philadelphia chromosome-positive|0
7965447|NCT01190930|12520928|FG002|Induction|Philadelphia chromosome-positive|0
7965448|NCT01190930|12520929|FG003|Induction|Philadelphia chromosome-positive|0
7965449|NCT01190930|12520930|FG004|Induction|Philadelphia chromosome-positive|0
7965450|NCT01190930|12520931|FG005|Induction|Philadelphia chromosome-positive|0
7965451|NCT01190930|12520932|FG006|Induction|Philadelphia chromosome-positive|0
7965452|NCT01190930|12520933|FG007|Induction|Philadelphia chromosome-positive|0
7965453|NCT01190930|12520934|FG008|Induction|Philadelphia chromosome-positive|0
7965454|NCT01190930|12520935|FG009|Induction|Philadelphia chromosome-positive|0
7942340|NCT02445573|12482886|FG000|Overall Study|Withdrawal by Subject|1
7942341|NCT02445573|12482887|FG001|Overall Study|Withdrawal by Subject|1
7942342|NCT02445573|12482886|FG000|Overall Study|Lost to Follow-up|0
7942343|NCT02445573|12482887|FG001|Overall Study|Lost to Follow-up|1
7942344|NCT02445586|12482893|FG000|Overall Study|Death|14
7942345|NCT02445586|12482893|FG000|Overall Study|Withdrawal by Subject|13
7942346|NCT02445586|12482893|FG000|Overall Study|Disease Progression|10
7942347|NCT02445586|12482893|FG000|Overall Study|Protocol Violation|1
7942348|NCT02445586|12482893|FG000|Overall Study|Medical Condition|1
7942349|NCT02445755|12482902|FG000|Overall Study|Withdrawal by Subject|2
7942350|NCT02445755|12482902|FG000|Overall Study|Protocol Violation|6
7942351|NCT02445755|12482902|FG000|Overall Study|Screen Failure|5
7942352|NCT02445794|12482913|FG000|Overall Study|Adverse Event|0
7942353|NCT02445794|12482914|FG001|Overall Study|Adverse Event|0
7942354|NCT02445794|12482915|FG002|Overall Study|Adverse Event|2
7942355|NCT02445794|12482916|FG003|Overall Study|Adverse Event|0
7942356|NCT02445963|12482970|FG000|Overall Study|Lost to Follow-up|1
7942357|NCT02445963|12482971|FG001|Overall Study|Lost to Follow-up|0
7942358|NCT02445963|12482972|FG002|Overall Study|Lost to Follow-up|0
7942359|NCT02445963|12482973|FG003|Overall Study|Lost to Follow-up|0
7942360|NCT02445963|12482970|FG000|Overall Study|Change in employment|1
7942361|NCT02445963|12482971|FG001|Overall Study|Change in employment|0
7942362|NCT02445963|12482972|FG002|Overall Study|Change in employment|0
7942363|NCT02445963|12482973|FG003|Overall Study|Change in employment|0
7942364|NCT02445963|12482970|FG000|Overall Study|Symptoms post-vaccination|0
7942365|NCT02445963|12482971|FG001|Overall Study|Symptoms post-vaccination|0
7942366|NCT02445963|12482972|FG002|Overall Study|Symptoms post-vaccination|1
7942367|NCT02445963|12482973|FG003|Overall Study|Symptoms post-vaccination|0
7942368|NCT02446015|12482987|FG000|Overall Study|Adverse Event|0
7942369|NCT02446015|12482988|FG001|Overall Study|Adverse Event|1
7942370|NCT02446015|12482987|FG000|Overall Study|Withdrawal by Subject|1
7942371|NCT02446015|12482988|FG001|Overall Study|Withdrawal by Subject|0
7942372|NCT02446171|12482999|FG000|Overall Study|Withdrawal by Subject|0
7942373|NCT02446171|12483000|FG001|Overall Study|Withdrawal by Subject|0
7942374|NCT02446171|12483001|FG002|Overall Study|Withdrawal by Subject|2
7942375|NCT02446171|12483002|FG003|Overall Study|Withdrawal by Subject|0
7942376|NCT02446418|12483041|FG000|Overall Study|Adverse Event|4
7942377|NCT02446418|12483042|FG001|Overall Study|Adverse Event|8
7942378|NCT02446418|12483041|FG000|Overall Study|Physician Decision|5
7942379|NCT02446418|12483042|FG001|Overall Study|Physician Decision|1
7942380|NCT02446418|12483041|FG000|Overall Study|Withdrawal by Subject|3
7942381|NCT02446418|12483042|FG001|Overall Study|Withdrawal by Subject|3
7942382|NCT02446418|12483041|FG000|Overall Study|Lost to Follow-up|2
7942383|NCT02446418|12483042|FG001|Overall Study|Lost to Follow-up|2
7942384|NCT02446418|12483041|FG000|Overall Study|Protocol Violation|1
7942385|NCT02446418|12483042|FG001|Overall Study|Protocol Violation|2
7942386|NCT02446418|12483041|FG000|Overall Study|Lack of Efficacy|2
7942387|NCT02446418|12483042|FG001|Overall Study|Lack of Efficacy|0
7942388|NCT02446418|12483041|FG000|Overall Study|Protocol defined stopping criteria reach|1
7942389|NCT02446418|12483042|FG001|Overall Study|Protocol defined stopping criteria reach|0
7942390|NCT02446691|12483074|FG000|Overall Study|Withdrawal by Subject|2
7942391|NCT02446691|12483074|FG000|Overall Study|Lost to Follow-up|8
7942392|NCT02446691|12483074|FG000|Overall Study|Protocol Violation|1
7942393|NCT02446717|12483083|FG000|Overall Study|Adverse Event|0
7942394|NCT02446717|12483084|FG001|Overall Study|Adverse Event|0
7942395|NCT02446717|12483085|FG002|Overall Study|Adverse Event|1
7942396|NCT02446717|12483086|FG003|Overall Study|Adverse Event|0
7942397|NCT02446717|12483087|FG004|Overall Study|Adverse Event|0
7942398|NCT02446717|12483083|FG000|Overall Study|Lost to Follow-up|0
7942399|NCT02446717|12483084|FG001|Overall Study|Lost to Follow-up|1
7942400|NCT02446717|12483085|FG002|Overall Study|Lost to Follow-up|1
7942401|NCT02446717|12483086|FG003|Overall Study|Lost to Follow-up|0
7942402|NCT02446717|12483087|FG004|Overall Study|Lost to Follow-up|1
7942403|NCT02446717|12483083|FG000|Overall Study|Withdrew consent|0
7942404|NCT02446717|12483084|FG001|Overall Study|Withdrew consent|0
7942405|NCT02446717|12483085|FG002|Overall Study|Withdrew consent|0
7942406|NCT02446717|12483086|FG003|Overall Study|Withdrew consent|1
7942407|NCT02446717|12483087|FG004|Overall Study|Withdrew consent|0
7942408|NCT02446743|12483101|FG000|Overall Study|Withdrawal by Subject|1
7942409|NCT02446743|12483102|FG001|Overall Study|Withdrawal by Subject|1
7942410|NCT02446743|12483101|FG000|Overall Study|Lost to Follow-up|1
7942411|NCT02446743|12483102|FG001|Overall Study|Lost to Follow-up|0
7942412|NCT02446743|12483101|FG000|Overall Study|Adverse Event|1
7942413|NCT02446743|12483102|FG001|Overall Study|Adverse Event|1
7942414|NCT02446743|12483101|FG000|Overall Study|Other|2
7942415|NCT02446743|12483102|FG001|Overall Study|Other|3
7942416|NCT02446769|12483117|FG000|Screening Period|Screen Failure|11
7942417|NCT02446769|12483118|FG001|Screening Period|Screen Failure|0
7942418|NCT02446769|12483119|FG002|Screening Period|Screen Failure|0
7942419|NCT02446769|12483117|FG000|Study Period|Randomized in Error|0
7942420|NCT02446769|12483118|FG001|Study Period|Randomized in Error|2
7942421|NCT02446769|12483119|FG002|Study Period|Randomized in Error|0
7942422|NCT02446886|12483137|FG000|Overall Study|Adverse Event|1
7942423|NCT02446886|12483138|FG001|Overall Study|Adverse Event|3
7942424|NCT02446886|12483137|FG000|Overall Study|Withdrawal by Subject|1
7942425|NCT02446886|12483138|FG001|Overall Study|Withdrawal by Subject|1
7942426|NCT02446899|12483147|FG000|Overall Study|Adverse Event|4
7942427|NCT02446899|12483148|FG001|Overall Study|Adverse Event|7
7942428|NCT02446899|12483147|FG000|Overall Study|Condition Under Investigation Worsened|1
7942429|NCT02446899|12483148|FG001|Overall Study|Condition Under Investigation Worsened|4
7942430|NCT02446899|12483147|FG000|Overall Study|Study Specific Withdrawal Criteria|1
7942431|NCT02446899|12483148|FG001|Overall Study|Study Specific Withdrawal Criteria|0
7942432|NCT02446899|12483147|FG000|Overall Study|Lack of Efficacy|2
7942433|NCT02446899|12483148|FG001|Overall Study|Lack of Efficacy|8
7942434|NCT02446899|12483147|FG000|Overall Study|Lost to Follow-up|1
7942435|NCT02446899|12483148|FG001|Overall Study|Lost to Follow-up|3
7942436|NCT02446899|12483147|FG000|Overall Study|Severe Non-Compliance to Protocol|0
7942437|NCT02446899|12483148|FG001|Overall Study|Severe Non-Compliance to Protocol|1
7942438|NCT02446899|12483147|FG000|Overall Study|Withdrawal by Subject|11
7942439|NCT02446899|12483148|FG001|Overall Study|Withdrawal by Subject|19
7942440|NCT02446899|12483147|FG000|Overall Study|Miscellaneous|5
7942441|NCT02446899|12483148|FG001|Overall Study|Miscellaneous|4
7942442|NCT02446899|12483147|FG000|Overall Study|Failure to Meet Randomization Criteria|0
7942443|NCT02446899|12483148|FG001|Overall Study|Failure to Meet Randomization Criteria|2
7942444|NCT02446912|12483157|FG000|Overall Study|Adverse Event|3
7942445|NCT02446912|12483158|FG001|Overall Study|Adverse Event|13
7942446|NCT02446912|12483159|FG002|Overall Study|Adverse Event|5
7942447|NCT02446912|12483157|FG000|Overall Study|Condition under investigation worsened|0
7942448|NCT02446912|12483158|FG001|Overall Study|Condition under investigation worsened|1
7942449|NCT02446912|12483159|FG002|Overall Study|Condition under investigation worsened|1
7942450|NCT02446912|12483157|FG000|Overall Study|Study-specific withdrawal criteria|1
7942451|NCT02446912|12483158|FG001|Overall Study|Study-specific withdrawal criteria|0
7942452|NCT02446912|12483159|FG002|Overall Study|Study-specific withdrawal criteria|0
7942453|NCT02446912|12483157|FG000|Overall Study|Lack of Efficacy|1
7942454|NCT02446912|12483158|FG001|Overall Study|Lack of Efficacy|4
7942455|NCT02446912|12483159|FG002|Overall Study|Lack of Efficacy|7
7942456|NCT02446912|12483157|FG000|Overall Study|Lost to Follow-up|0
7942457|NCT02446912|12483158|FG001|Overall Study|Lost to Follow-up|0
7942458|NCT02446912|12483159|FG002|Overall Study|Lost to Follow-up|2
7942459|NCT02446912|12483157|FG000|Overall Study|Severe non-compliance to protocol|1
7942460|NCT02446912|12483158|FG001|Overall Study|Severe non-compliance to protocol|0
7942461|NCT02446912|12483159|FG002|Overall Study|Severe non-compliance to protocol|1
7942462|NCT02446912|12483157|FG000|Overall Study|Withdrawal by Subject|10
7942463|NCT02446912|12483158|FG001|Overall Study|Withdrawal by Subject|15
7942464|NCT02446912|12483159|FG002|Overall Study|Withdrawal by Subject|15
7942465|NCT02446912|12483157|FG000|Overall Study|Miscellaneous|2
7942466|NCT02446912|12483158|FG001|Overall Study|Miscellaneous|2
7942467|NCT02446912|12483159|FG002|Overall Study|Miscellaneous|4
7942468|NCT02446990|12483169|FG000|Overall Study|Death|485
7942469|NCT02446990|12483170|FG001|Overall Study|Death|458
7942470|NCT02446990|12483169|FG000|Overall Study|Lost to Follow-up|3
7942471|NCT02446990|12483170|FG001|Overall Study|Lost to Follow-up|1
7942472|NCT02446990|12483169|FG000|Overall Study|Physician Decision|1
7942473|NCT02446990|12483170|FG001|Overall Study|Physician Decision|0
7942474|NCT02446990|12483169|FG000|Overall Study|Withdrawal by Subject|231
7942475|NCT02446990|12483170|FG001|Overall Study|Withdrawal by Subject|199
7942476|NCT02447003|12483178|FG000|Overall Study|Other|0
7942477|NCT02447003|12483179|FG001|Overall Study|Other|4
7942478|NCT02447003|12483178|FG000|Overall Study|Site discontinued|0
7942479|NCT02447003|12483179|FG001|Overall Study|Site discontinued|2
7942480|NCT02447003|12483178|FG000|Overall Study|Physician Decision|0
7942481|NCT02447003|12483179|FG001|Overall Study|Physician Decision|1
7942482|NCT02447003|12483178|FG000|Overall Study|Withdrawal by Subject|4
7942483|NCT02447003|12483179|FG001|Overall Study|Withdrawal by Subject|3
7942484|NCT02447003|12483178|FG000|Overall Study|Sponsor Decision|6
7942485|NCT02447003|12483179|FG001|Overall Study|Sponsor Decision|11
7942486|NCT02447003|12483178|FG000|Overall Study|Progressive Disease|1
7942487|NCT02447003|12483179|FG001|Overall Study|Progressive Disease|0
7942488|NCT02447003|12483178|FG000|Overall Study|Lost to Follow-up|5
7942489|NCT02447003|12483179|FG001|Overall Study|Lost to Follow-up|0
7942490|NCT02447003|12483178|FG000|Overall Study|Death|154
7942491|NCT02447003|12483179|FG001|Overall Study|Death|63
7942492|NCT02447029|12483189|FG000|Overall Study|Withdrawal by Subject|3
7942493|NCT02447029|12483190|FG001|Overall Study|Withdrawal by Subject|2
7942494|NCT02447081|12483196|FG000|Overall Study|Death|161
7942495|NCT02447081|12483196|FG000|Overall Study|Lost to Follow-up|36
7942496|NCT02447081|12483196|FG000|Overall Study|Visit not completed|17
7942497|NCT02447081|12483196|FG000|Overall Study|unsuccessful implant procedure|10
7942498|NCT02447172|12483203|FG000|Overall Study|Adverse Event|11
7942499|NCT02447172|12483204|FG001|Overall Study|Adverse Event|8
7942500|NCT02447172|12483205|FG002|Overall Study|Adverse Event|7
7942501|NCT02447172|12483203|FG000|Overall Study|Death|3
7942502|NCT02447172|12483204|FG001|Overall Study|Death|1
7942503|NCT02447172|12483205|FG002|Overall Study|Death|0
7942504|NCT02447172|12483203|FG000|Overall Study|Protocol Violation|2
7942505|NCT02447172|12483204|FG001|Overall Study|Protocol Violation|1
7942506|NCT02447172|12483205|FG002|Overall Study|Protocol Violation|2
7942507|NCT02447172|12483203|FG000|Overall Study|Lost to Follow-up|7
7942508|NCT02447172|12483204|FG001|Overall Study|Lost to Follow-up|4
7942509|NCT02447172|12483205|FG002|Overall Study|Lost to Follow-up|4
7942510|NCT02447172|12483203|FG000|Overall Study|Withdrawal by Subject|5
7942511|NCT02447172|12483204|FG001|Overall Study|Withdrawal by Subject|1
7942512|NCT02447172|12483205|FG002|Overall Study|Withdrawal by Subject|3
7942513|NCT02447172|12483203|FG000|Overall Study|protocol specific treatment unrelated|3
7942514|NCT02447172|12483204|FG001|Overall Study|protocol specific treatment unrelated|0
7942515|NCT02447172|12483205|FG002|Overall Study|protocol specific treatment unrelated|2
7942516|NCT02447250|12483213|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1
7942517|NCT02447250|12483213|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1
7942518|NCT02447250|12483213|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4
7942519|NCT02447302|12483221|FG000|Overall Study|Physician Decision|1
7942520|NCT02447302|12483222|FG001|Overall Study|Physician Decision|0
7942521|NCT02447302|12483223|FG002|Overall Study|Physician Decision|0
7942522|NCT02447302|12483221|FG000|Overall Study|Adverse Event|4
7942523|NCT02447302|12483222|FG001|Overall Study|Adverse Event|3
7942524|NCT02447302|12483223|FG002|Overall Study|Adverse Event|0
7942525|NCT02447302|12483221|FG000|Overall Study|Withdrawal by Subject|0
7942526|NCT02447302|12483222|FG001|Overall Study|Withdrawal by Subject|1
7942527|NCT02447302|12483223|FG002|Overall Study|Withdrawal by Subject|5
7942528|NCT02447302|12483221|FG000|Overall Study|Sponsor Decision|0
7942529|NCT02447302|12483222|FG001|Overall Study|Sponsor Decision|0
7942530|NCT02447302|12483223|FG002|Overall Study|Sponsor Decision|1
7942531|NCT02447328|12483231|FG000|Overall Study|Withdrawal by Subject|1
7942532|NCT02447432|12483237|FG000|Epoch 001|Adverse Event|1
7942533|NCT02447432|12483238|FG001|Epoch 001|Adverse Event|1
7942534|NCT02447432|12483237|FG000|Epoch 001|Withdrawal by Subject|0
7942535|NCT02447432|12483238|FG001|Epoch 001|Withdrawal by Subject|4
7942536|NCT02447432|12483237|FG000|Epoch 001|Migrated/moved from study area|3
7942537|NCT02447432|12483238|FG001|Epoch 001|Migrated/moved from study area|5
7942538|NCT02447432|12483237|FG000|Epoch 001|Lost to Follow-up|1
7942539|NCT02447432|12483238|FG001|Epoch 001|Lost to Follow-up|3
7942540|NCT02447458|12483250|FG000|Overall Study|Other|0
7942541|NCT02447458|12483251|FG001|Overall Study|Other|0
7942542|NCT02447458|12483252|FG002|Overall Study|Other|1
7942543|NCT02447458|12483253|FG003|Overall Study|Other|0
7942544|NCT02447458|12483254|FG004|Overall Study|Other|0
7942545|NCT02447458|12483255|FG005|Overall Study|Other|0
7942546|NCT02447497|12483278|FG000|Overall Study|Did not meet treatment day baseline.|6
7942547|NCT02447497|12483279|FG001|Overall Study|Did not meet treatment day baseline.|5
7942548|NCT02447497|12483280|FG002|Overall Study|Did not meet treatment day baseline.|2
7942549|NCT02447497|12483281|FG003|Overall Study|Did not meet treatment day baseline.|2
7942550|NCT02447497|12483278|FG000|Overall Study|Dressing was compromised|0
7942551|NCT02447497|12483279|FG001|Overall Study|Dressing was compromised|1
7942552|NCT02447497|12483280|FG002|Overall Study|Dressing was compromised|0
7942553|NCT02447497|12483281|FG003|Overall Study|Dressing was compromised|0
7942554|NCT02447744|12483305|FG000|Overall Study|Withdrawal by Subject|3
7942555|NCT02447744|12483306|FG001|Overall Study|Withdrawal by Subject|1
7942556|NCT02447744|12483305|FG000|Overall Study|Data not collected b/c logistic reasons|3
7942557|NCT02447744|12483306|FG001|Overall Study|Data not collected b/c logistic reasons|0
7942558|NCT02447848|12483312|FG000|Overall Study|Patient discharged|3
7942559|NCT02447848|12483312|FG000|Overall Study|Lack of Efficacy|4
7942560|NCT02447848|12483312|FG000|Overall Study|Withdrawal by Subject|4
7942561|NCT02447952|12483320|FG000|Overall Study|Adverse Event|2
7942562|NCT02447952|12483320|FG000|Overall Study|Physician Decision|1
7942563|NCT02447952|12483320|FG000|Overall Study|Withdrawal by Subject|4
7942564|NCT02447991|12483326|FG000|Overall Study|Withdrawn by subject - no data|0
7942565|NCT02447991|12483327|FG001|Overall Study|Withdrawn by subject - no data|2
7942566|NCT02447991|12483326|FG000|Overall Study|Withdrawn by Subject - with data|4
7942567|NCT02447991|12483327|FG001|Overall Study|Withdrawn by Subject - with data|4
7942568|NCT02447991|12483326|FG000|Overall Study|Lost to Follow-up - no data|3
7942569|NCT02447991|12483327|FG001|Overall Study|Lost to Follow-up - no data|6
7942570|NCT02447991|12483326|FG000|Overall Study|Lost to follow-up - with data|0
7942571|NCT02447991|12483327|FG001|Overall Study|Lost to follow-up - with data|3
7942572|NCT02447991|12483326|FG000|Overall Study|End of study - no treatment results|3
7942573|NCT02447991|12483327|FG001|Overall Study|End of study - no treatment results|6
7942574|NCT02447991|12483326|FG000|Overall Study|End of study - partial treatment results|0
7942575|NCT02447991|12483327|FG001|Overall Study|End of study - partial treatment results|9
7942576|NCT02448043|12483339|FG000|Overall Study|Withdrawal by Subject|2
7942577|NCT02448043|12483340|FG001|Overall Study|Withdrawal by Subject|2
7942578|NCT02448043|12483339|FG000|Overall Study|Protocol Violation|1
7942579|NCT02448043|12483340|FG001|Overall Study|Protocol Violation|2
7942580|NCT02448446|12483399|FG000|Overall Study|Withdrawal by Subject|1
7942581|NCT02448446|12483400|FG001|Overall Study|Withdrawal by Subject|0
7942582|NCT02448537|12483409|FG000|Overall Study|Withdrawal by Subject|1
7942583|NCT02448537|12483410|FG001|Overall Study|Withdrawal by Subject|1
7942584|NCT02448537|12483411|FG002|Overall Study|Withdrawal by Subject|1
7942585|NCT02448563|12483423|FG000|Overall Study|Lost to Follow-up|16
7942586|NCT02448563|12483424|FG001|Overall Study|Lost to Follow-up|10
7942587|NCT02448563|12483423|FG000|Overall Study|Withdrawal by Subject|0
7942588|NCT02448563|12483424|FG001|Overall Study|Withdrawal by Subject|1
7942589|NCT02448706|12483463|FG000|Overall Study|Withdrawal by Subject|4
7942590|NCT02448706|12483464|FG001|Overall Study|Withdrawal by Subject|3
7942591|NCT02448706|12483463|FG000|Overall Study|Protocol Violation|1
7942592|NCT02448706|12483464|FG001|Overall Study|Protocol Violation|1
7942593|NCT02448719|12483483|FG000|Overall Study|Withdrawal by Subject|0
7942594|NCT02448719|12483484|FG001|Overall Study|Withdrawal by Subject|0
7942595|NCT02448719|12483485|FG002|Overall Study|Withdrawal by Subject|0
7942596|NCT02448719|12483486|FG003|Overall Study|Withdrawal by Subject|0
7942597|NCT02448719|12483487|FG004|Overall Study|Withdrawal by Subject|1
7942598|NCT02448719|12483488|FG005|Overall Study|Withdrawal by Subject|0
7942599|NCT02448719|12483489|FG006|Overall Study|Withdrawal by Subject|0
7942600|NCT02448719|12483490|FG007|Overall Study|Withdrawal by Subject|0
7942601|NCT02448719|12483491|FG008|Overall Study|Withdrawal by Subject|0
7942602|NCT02448719|12483492|FG009|Overall Study|Withdrawal by Subject|0
7942603|NCT02448719|12483493|FG010|Overall Study|Withdrawal by Subject|0
7942604|NCT02448810|12483562|FG000|Overall Study|Adverse Event|0
7942605|NCT02448810|12483563|FG001|Overall Study|Adverse Event|0
7942606|NCT02448810|12483564|FG002|Overall Study|Adverse Event|1
7942607|NCT02448810|12483565|FG003|Overall Study|Adverse Event|0
7942608|NCT02448810|12483566|FG004|Overall Study|Adverse Event|0
7942609|NCT02448810|12483567|FG005|Overall Study|Adverse Event|0
7942610|NCT02448810|12483568|FG006|Overall Study|Adverse Event|0
7942611|NCT02448810|12483569|FG007|Overall Study|Adverse Event|0
7942612|NCT02448810|12483562|FG000|Overall Study|Withdrawal by Subject|0
7942613|NCT02448810|12483563|FG001|Overall Study|Withdrawal by Subject|0
7942614|NCT02448810|12483564|FG002|Overall Study|Withdrawal by Subject|1
7942615|NCT02448810|12483565|FG003|Overall Study|Withdrawal by Subject|0
7942616|NCT02448810|12483566|FG004|Overall Study|Withdrawal by Subject|3
7942617|NCT02448810|12483567|FG005|Overall Study|Withdrawal by Subject|5
7942618|NCT02448810|12483568|FG006|Overall Study|Withdrawal by Subject|0
7942619|NCT02448810|12483569|FG007|Overall Study|Withdrawal by Subject|2
7942620|NCT02448810|12483562|FG000|Overall Study|Other (study terminated by sponsor)|0
7942621|NCT02448810|12483563|FG001|Overall Study|Other (study terminated by sponsor)|0
7942622|NCT02448810|12483564|FG002|Overall Study|Other (study terminated by sponsor)|0
7942623|NCT02448810|12483565|FG003|Overall Study|Other (study terminated by sponsor)|0
7942624|NCT02448810|12483566|FG004|Overall Study|Other (study terminated by sponsor)|4
7942625|NCT02448810|12483567|FG005|Overall Study|Other (study terminated by sponsor)|2
7942626|NCT02448810|12483568|FG006|Overall Study|Other (study terminated by sponsor)|2
7942627|NCT02448810|12483569|FG007|Overall Study|Other (study terminated by sponsor)|1
7942628|NCT02448810|12483562|FG000|Overall Study|Death|1
7942629|NCT02448810|12483563|FG001|Overall Study|Death|0
7942630|NCT02448810|12483564|FG002|Overall Study|Death|1
7942631|NCT02448810|12483565|FG003|Overall Study|Death|0
7942632|NCT02448810|12483566|FG004|Overall Study|Death|1
7942633|NCT02448810|12483567|FG005|Overall Study|Death|0
7942634|NCT02448810|12483568|FG006|Overall Study|Death|0
7942635|NCT02448810|12483569|FG007|Overall Study|Death|0
7942636|NCT02448810|12483562|FG000|Overall Study|Other (Progressive disease)|2
7942637|NCT02448810|12483563|FG001|Overall Study|Other (Progressive disease)|2
7942638|NCT02448810|12483564|FG002|Overall Study|Other (Progressive disease)|0
7942639|NCT02448810|12483565|FG003|Overall Study|Other (Progressive disease)|3
7942640|NCT02448810|12483566|FG004|Overall Study|Other (Progressive disease)|23
7942641|NCT02448810|12483567|FG005|Overall Study|Other (Progressive disease)|9
7942642|NCT02448810|12483568|FG006|Overall Study|Other (Progressive disease)|14
7942643|NCT02448810|12483569|FG007|Overall Study|Other (Progressive disease)|5
7942644|NCT02448810|12483562|FG000|Overall Study|Lost to Follow-up|0
7942645|NCT02448810|12483563|FG001|Overall Study|Lost to Follow-up|1
7942646|NCT02448810|12483564|FG002|Overall Study|Lost to Follow-up|0
7942647|NCT02448810|12483565|FG003|Overall Study|Lost to Follow-up|0
7942648|NCT02448810|12483566|FG004|Overall Study|Lost to Follow-up|0
7942649|NCT02448810|12483567|FG005|Overall Study|Lost to Follow-up|0
7942650|NCT02448810|12483568|FG006|Overall Study|Lost to Follow-up|0
7942651|NCT02448810|12483569|FG007|Overall Study|Lost to Follow-up|0
7942652|NCT02448810|12483562|FG000|Overall Study|Other (unspecified)|0
7942653|NCT02448810|12483563|FG001|Overall Study|Other (unspecified)|0
7942654|NCT02448810|12483564|FG002|Overall Study|Other (unspecified)|0
7942655|NCT02448810|12483565|FG003|Overall Study|Other (unspecified)|0
7942656|NCT02448810|12483566|FG004|Overall Study|Other (unspecified)|0
7942657|NCT02448810|12483567|FG005|Overall Study|Other (unspecified)|0
7942658|NCT02448810|12483568|FG006|Overall Study|Other (unspecified)|2
7942659|NCT02448810|12483569|FG007|Overall Study|Other (unspecified)|0
7942660|NCT02448875|12483603|FG000|Overall Study|Adverse Event|2
7942661|NCT02448875|12483604|FG001|Overall Study|Adverse Event|1
7942662|NCT02448875|12483605|FG002|Overall Study|Adverse Event|0
7942663|NCT02448875|12483603|FG000|Overall Study|Lost to Follow-up|1
7942664|NCT02448875|12483604|FG001|Overall Study|Lost to Follow-up|0
7942665|NCT02448875|12483605|FG002|Overall Study|Lost to Follow-up|0
7942666|NCT02448875|12483603|FG000|Overall Study|Investigator Decision|3
7942667|NCT02448875|12483604|FG001|Overall Study|Investigator Decision|0
7942668|NCT02448875|12483605|FG002|Overall Study|Investigator Decision|1
7942669|NCT02448875|12483603|FG000|Overall Study|Withdrawal by Subject|1
7942670|NCT02448875|12483604|FG001|Overall Study|Withdrawal by Subject|0
7942671|NCT02448875|12483605|FG002|Overall Study|Withdrawal by Subject|0
7942672|NCT02449018|12483626|FG000|Overall Study|Abnormal laboratory value|0
7942673|NCT02449018|12483627|FG001|Overall Study|Abnormal laboratory value|1
7942674|NCT02449018|12483626|FG000|Overall Study|Administrative problems|1
7942675|NCT02449018|12483627|FG001|Overall Study|Administrative problems|0
7942676|NCT02449018|12483626|FG000|Overall Study|Adverse Event|5
7942677|NCT02449018|12483627|FG001|Overall Study|Adverse Event|1
7942678|NCT02449018|12483626|FG000|Overall Study|Protocol deviation|4
7942679|NCT02449018|12483627|FG001|Overall Study|Protocol deviation|0
7942680|NCT02449018|12483626|FG000|Overall Study|Patient decision|2
7942681|NCT02449018|12483627|FG001|Overall Study|Patient decision|0
7942682|NCT02449044|12483633|FG000|Overall Study|Lost to Follow-up|2
7942683|NCT02449044|12483633|FG000|Overall Study|Withdrawal by Subject|13
7942684|NCT02449044|12483633|FG000|Overall Study|Adverse Event|30
7942685|NCT02449044|12483633|FG000|Overall Study|Met Withdrawal Criteria|7
7942686|NCT02449044|12483633|FG000|Overall Study|Physician Decision|9
7942687|NCT02449044|12483633|FG000|Overall Study|Sponsor Discontinued Trial|3
7942688|NCT02449889|12483698|FG000|Overall Study|Adverse Event|1
7942689|NCT02449889|12483699|FG001|Overall Study|Adverse Event|2
7942690|NCT02449889|12483700|FG002|Overall Study|Adverse Event|0
7942691|NCT02449889|12483698|FG000|Overall Study|Protocol Violation|0
7942692|NCT02449889|12483699|FG001|Overall Study|Protocol Violation|4
7942693|NCT02449889|12483700|FG002|Overall Study|Protocol Violation|1
7942694|NCT02449902|12483710|FG000|Overall Study|Adverse Event|0
7942695|NCT02449902|12483711|FG001|Overall Study|Adverse Event|1
7942696|NCT02449902|12483710|FG000|Overall Study|Withdrawal by Subject|0
7942697|NCT02449902|12483711|FG001|Overall Study|Withdrawal by Subject|1
7942698|NCT02449915|12483721|FG000|Overall Study|Exclusion criteria - drug use|1
7942699|NCT02449915|12483722|FG001|Overall Study|Exclusion criteria - drug use|0
7942700|NCT02449915|12483721|FG000|Overall Study|Withdrawal by Subject|0
7942701|NCT02449915|12483722|FG001|Overall Study|Withdrawal by Subject|2
7942702|NCT02449915|12483721|FG000|Overall Study|Intraoperative surgical findings|1
7942703|NCT02449915|12483722|FG001|Overall Study|Intraoperative surgical findings|1
7942704|NCT02449915|12483721|FG000|Overall Study|Abnormal preop lab|0
7942705|NCT02449915|12483722|FG001|Overall Study|Abnormal preop lab|1
7942706|NCT02450487|12483737|FG000|Overall Study|Lost to Follow-up|3
7942707|NCT02450526|12483746|FG000|DB Period (Cycle 1)|Adverse Event|0
7942708|NCT02450526|12483747|FG001|DB Period (Cycle 1)|Adverse Event|0
7942709|NCT02450526|12483748|FG002|DB Period (Cycle 1)|Adverse Event|2
7942710|NCT02450526|12483749|FG003|DB Period (Cycle 1)|Adverse Event|0
7942711|NCT02450526|12483750|FG004|DB Period (Cycle 1)|Adverse Event|0
7942712|NCT02450526|12483746|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28
7942713|NCT02450526|12483747|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3
7942714|NCT02450526|12483748|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8
7942715|NCT02450526|12483749|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1
7942716|NCT02450526|12483750|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0
7942717|NCT02450526|12483746|FG000|DB Period (Cycle 1)|Lost to Follow-up|1
7942718|NCT02450526|12483747|FG001|DB Period (Cycle 1)|Lost to Follow-up|0
7942719|NCT02450526|12483748|FG002|DB Period (Cycle 1)|Lost to Follow-up|0
7942720|NCT02450526|12483749|FG003|DB Period (Cycle 1)|Lost to Follow-up|0
7942721|NCT02450526|12483750|FG004|DB Period (Cycle 1)|Lost to Follow-up|0
7942722|NCT02450526|12483746|FG000|DB Period (Cycle 1)|Protocol Violation|2
7942723|NCT02450526|12483747|FG001|DB Period (Cycle 1)|Protocol Violation|0
7942724|NCT02450526|12483748|FG002|DB Period (Cycle 1)|Protocol Violation|0
7942725|NCT02450526|12483749|FG003|DB Period (Cycle 1)|Protocol Violation|1
7942726|NCT02450526|12483750|FG004|DB Period (Cycle 1)|Protocol Violation|0
7942727|NCT02450526|12483746|FG000|OL Period (Cycles 2-5)|Adverse Event|0
7942728|NCT02450526|12483747|FG001|OL Period (Cycles 2-5)|Adverse Event|0
7942729|NCT02450526|12483748|FG002|OL Period (Cycles 2-5)|Adverse Event|0
7942730|NCT02450526|12483749|FG003|OL Period (Cycles 2-5)|Adverse Event|0
7942731|NCT02450526|12483750|FG004|OL Period (Cycles 2-5)|Adverse Event|2
7942732|NCT02450526|12483746|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7942733|NCT02450526|12483747|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7942734|NCT02450526|12483748|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7942735|NCT02450526|12483749|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7942736|NCT02450526|12483750|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31
7942737|NCT02450526|12483746|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0
7942738|NCT02450526|12483747|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0
7942739|NCT02450526|12483748|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0
7942740|NCT02450526|12483749|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0
7942741|NCT02450526|12483750|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1
7942742|NCT02450526|12483746|FG000|OL Period (Cycles 2-5)|Protocol Violation|0
7942743|NCT02450526|12483747|FG001|OL Period (Cycles 2-5)|Protocol Violation|0
7942744|NCT02450526|12483748|FG002|OL Period (Cycles 2-5)|Protocol Violation|0
7942745|NCT02450526|12483749|FG003|OL Period (Cycles 2-5)|Protocol Violation|0
7942746|NCT02450526|12483750|FG004|OL Period (Cycles 2-5)|Protocol Violation|7
7942747|NCT02450539|12483772|FG000|Overall Study|Withdrawal by Subject|12
7942748|NCT02450539|12483773|FG001|Overall Study|Withdrawal by Subject|6
7942749|NCT02450539|12483772|FG000|Overall Study|Lost to Follow-up|4
7942750|NCT02450539|12483773|FG001|Overall Study|Lost to Follow-up|1
7942751|NCT02450552|12483785|FG000|Overall Study|Withdrawal by Subject|4
7942752|NCT02450552|12483786|FG001|Overall Study|Withdrawal by Subject|0
7942753|NCT02450552|12483787|FG002|Overall Study|Withdrawal by Subject|4
7942754|NCT02450552|12483785|FG000|Overall Study|Physician Decision|1
7942755|NCT02450552|12483786|FG001|Overall Study|Physician Decision|0
7942756|NCT02450552|12483787|FG002|Overall Study|Physician Decision|1
7942757|NCT02450578|12483799|FG000|Overall Study|ECG abnormality so not treated|1
7942758|NCT02450578|12483800|FG001|Overall Study|ECG abnormality so not treated|0
7942759|NCT02450578|12483801|FG002|Overall Study|ECG abnormality so not treated|0
7942760|NCT02450578|12483802|FG003|Overall Study|ECG abnormality so not treated|0
7942761|NCT02450903|12483840|FG000|Overall Study|Adverse Event|3
7942762|NCT02450903|12483840|FG000|Overall Study|Progressive disease|15
7942763|NCT02450903|12483840|FG000|Overall Study|Switched to commercial drug|1
7942764|NCT02450903|12483840|FG000|Overall Study|Subject/guardian decision|1
7942765|NCT02451007|12483844|FG000|Overall Study|Withdrawal by Subject|4
7942766|NCT02451007|12483844|FG000|Overall Study|Adverse Event|1
7942767|NCT02451007|12483844|FG000|Overall Study|Disease Progression|2
7942768|NCT02451124|12483848|FG000|Overall Study|Withdrawal by Subject|1
7942769|NCT02451137|12483858|FG000|Overall Study|Randomized but not treated|19
7942770|NCT02451137|12483859|FG001|Overall Study|Randomized but not treated|27
7942771|NCT02451137|12483858|FG000|Overall Study|Adverse Event|43
7942772|NCT02451137|12483859|FG001|Overall Study|Adverse Event|42
7942773|NCT02451137|12483858|FG000|Overall Study|Lack of Efficacy|4
7942774|NCT02451137|12483859|FG001|Overall Study|Lack of Efficacy|9
7942775|NCT02451137|12483858|FG000|Overall Study|Participant decision:discontinue insulin|41
7942776|NCT02451137|12483859|FG001|Overall Study|Participant decision:discontinue insulin|43
7942777|NCT02451137|12483858|FG000|Overall Study|Hypoglycemia|2
7942778|NCT02451137|12483859|FG001|Overall Study|Hypoglycemia|1
7942779|NCT02451137|12483858|FG000|Overall Study|Investigator's decision|23
7942780|NCT02451137|12483859|FG001|Overall Study|Investigator's decision|19
7942781|NCT02451137|12483858|FG000|Overall Study|Lost to Follow-up|53
7942782|NCT02451137|12483859|FG001|Overall Study|Lost to Follow-up|61
7942783|NCT02451137|12483858|FG000|Overall Study|Physician Decision|6
7942784|NCT02451137|12483859|FG001|Overall Study|Physician Decision|5
7942785|NCT02451137|12483858|FG000|Overall Study|Sponsor decision|13
7942786|NCT02451137|12483859|FG001|Overall Study|Sponsor decision|25
7942787|NCT02451137|12483858|FG000|Overall Study|Withdrawal by Subject|40
7942788|NCT02451137|12483859|FG001|Overall Study|Withdrawal by Subject|63
7942789|NCT02451137|12483858|FG000|Overall Study|Other than specified above|2
7942790|NCT02451137|12483859|FG001|Overall Study|Other than specified above|3
7942791|NCT02451670|12483917|FG000|Overall Study|Did not have qualifying follow-up visit.|714
7942792|NCT02451670|12483918|FG001|Overall Study|Did not have qualifying follow-up visit.|696
7942793|NCT02451696|12483926|FG000|Overall Study|Surgery postponed|1
7942794|NCT02451696|12483927|FG001|Overall Study|Surgery postponed|0
7942795|NCT02451917|12483947|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2
7942796|NCT02451917|12483948|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0
7942797|NCT02451917|12483947|FG000|First Intervention (24 Weeks)|Death|0
7942798|NCT02451917|12483948|FG001|First Intervention (24 Weeks)|Death|1
7942799|NCT02451917|12483947|FG000|First Intervention (24 Weeks)|Adverse Event|0
7942800|NCT02451917|12483948|FG001|First Intervention (24 Weeks)|Adverse Event|2
7942801|NCT02451930|12483960|FG000|Overall Study|Death|0
7942802|NCT02451930|12483961|FG001|Overall Study|Death|15
7942803|NCT02451930|12483960|FG000|Overall Study|Lost to Follow-up|0
7942804|NCT02451930|12483961|FG001|Overall Study|Lost to Follow-up|3
7942805|NCT02451930|12483960|FG000|Overall Study|Sponsor Decision|2
7942806|NCT02451930|12483961|FG001|Overall Study|Sponsor Decision|10
7942807|NCT02451930|12483960|FG000|Overall Study|Withdrawal by Subject|0
7942808|NCT02451930|12483961|FG001|Overall Study|Withdrawal by Subject|1
7942809|NCT02451930|12483960|FG000|Overall Study|Other|0
7942810|NCT02451930|12483961|FG001|Overall Study|Other|1
7942811|NCT02452034|12483992|FG000|Overall Study|Adverse Event|0
7942812|NCT02452034|12483993|FG001|Overall Study|Adverse Event|0
7942813|NCT02452034|12483994|FG002|Overall Study|Adverse Event|0
7942814|NCT02452034|12483995|FG003|Overall Study|Adverse Event|0
7942815|NCT02452034|12483996|FG004|Overall Study|Adverse Event|0
7942816|NCT02452034|12483997|FG005|Overall Study|Adverse Event|1
7942817|NCT02452034|12483992|FG000|Overall Study|Death|0
7942818|NCT02452034|12483993|FG001|Overall Study|Death|0
7942819|NCT02452034|12483994|FG002|Overall Study|Death|0
7942820|NCT02452034|12483995|FG003|Overall Study|Death|0
7942821|NCT02452034|12483996|FG004|Overall Study|Death|1
7942822|NCT02452034|12483997|FG005|Overall Study|Death|1
7942823|NCT02452034|12483992|FG000|Overall Study|Physician Decision|0
7942824|NCT02452034|12483993|FG001|Overall Study|Physician Decision|1
7942825|NCT02452034|12483994|FG002|Overall Study|Physician Decision|1
7942826|NCT02452034|12483995|FG003|Overall Study|Physician Decision|0
7942827|NCT02452034|12483996|FG004|Overall Study|Physician Decision|0
7942828|NCT02452034|12483997|FG005|Overall Study|Physician Decision|0
7942829|NCT02452034|12483992|FG000|Overall Study|Protocol Violation|0
7942830|NCT02452034|12483993|FG001|Overall Study|Protocol Violation|0
7942831|NCT02452034|12483994|FG002|Overall Study|Protocol Violation|0
7942832|NCT02452034|12483995|FG003|Overall Study|Protocol Violation|0
7942833|NCT02452034|12483996|FG004|Overall Study|Protocol Violation|0
7942834|NCT02452034|12483997|FG005|Overall Study|Protocol Violation|1
7942835|NCT02452034|12483992|FG000|Overall Study|Screen Failure|1
7942836|NCT02452034|12483993|FG001|Overall Study|Screen Failure|0
7942837|NCT02452034|12483994|FG002|Overall Study|Screen Failure|0
7942838|NCT02452034|12483995|FG003|Overall Study|Screen Failure|1
7942839|NCT02452034|12483996|FG004|Overall Study|Screen Failure|0
7942840|NCT02452034|12483997|FG005|Overall Study|Screen Failure|0
7942841|NCT02452034|12483992|FG000|Overall Study|Withdrawn by Parent/Guardian|1
7942842|NCT02452034|12483993|FG001|Overall Study|Withdrawn by Parent/Guardian|0
7942843|NCT02452034|12483994|FG002|Overall Study|Withdrawn by Parent/Guardian|0
7942844|NCT02452034|12483995|FG003|Overall Study|Withdrawn by Parent/Guardian|0
7942845|NCT02452034|12483996|FG004|Overall Study|Withdrawn by Parent/Guardian|0
7942846|NCT02452034|12483997|FG005|Overall Study|Withdrawn by Parent/Guardian|0
7942847|NCT02452047|12484014|FG000|Overall Study|Adverse Event|0
7942848|NCT02452047|12484015|FG001|Overall Study|Adverse Event|1
7942849|NCT02452047|12484016|FG002|Overall Study|Adverse Event|1
7942850|NCT02452047|12484014|FG000|Overall Study|Death|1
7942851|NCT02452047|12484015|FG001|Overall Study|Death|3
7942852|NCT02452047|12484016|FG002|Overall Study|Death|1
7942853|NCT02452047|12484014|FG000|Overall Study|Physician Decision|1
7942854|NCT02452047|12484015|FG001|Overall Study|Physician Decision|0
7942855|NCT02452047|12484016|FG002|Overall Study|Physician Decision|0
7942856|NCT02452047|12484014|FG000|Overall Study|Lost to Follow-up|1
7942857|NCT02452047|12484015|FG001|Overall Study|Lost to Follow-up|1
7942858|NCT02452047|12484016|FG002|Overall Study|Lost to Follow-up|0
7942859|NCT02452047|12484014|FG000|Overall Study|Withdrawal by Subject|1
7942860|NCT02452047|12484015|FG001|Overall Study|Withdrawal by Subject|0
7942861|NCT02452047|12484016|FG002|Overall Study|Withdrawal by Subject|0
7942862|NCT02452190|12484035|FG000|Overall Study|Withdrawal by Sponsor|1
7942863|NCT02452190|12484036|FG001|Overall Study|Withdrawal by Sponsor|3
7942864|NCT02452190|12484035|FG000|Overall Study|Pregnancy|1
7942865|NCT02452190|12484036|FG001|Overall Study|Pregnancy|0
7942866|NCT02452190|12484035|FG000|Overall Study|Investigator's Decision|2
7942867|NCT02452190|12484036|FG001|Overall Study|Investigator's Decision|0
7942868|NCT02452190|12484035|FG000|Overall Study|Lack of Efficacy|3
7942869|NCT02452190|12484036|FG001|Overall Study|Lack of Efficacy|1
7942870|NCT02452190|12484035|FG000|Overall Study|Lost to Follow-up|4
7942871|NCT02452190|12484036|FG001|Overall Study|Lost to Follow-up|3
7942872|NCT02452190|12484035|FG000|Overall Study|Adverse Event|2
7942873|NCT02452190|12484036|FG001|Overall Study|Adverse Event|5
7942874|NCT02452190|12484035|FG000|Overall Study|Withdrawal by Subject|20
7942875|NCT02452190|12484036|FG001|Overall Study|Withdrawal by Subject|11
7942876|NCT02452190|12484035|FG000|Overall Study|Noncompliance with study drug|1
7942877|NCT02452190|12484036|FG001|Overall Study|Noncompliance with study drug|0
7942878|NCT02452190|12484035|FG000|Overall Study|Participant traveled abroad|1
7942879|NCT02452190|12484036|FG001|Overall Study|Participant traveled abroad|0
7942880|NCT02452190|12484035|FG000|Overall Study|Death|0
7942881|NCT02452190|12484036|FG001|Overall Study|Death|1
7942882|NCT02452320|12484044|FG000|Overall Study|Adverse Event|0
7942883|NCT02452320|12484045|FG001|Overall Study|Adverse Event|1
7942884|NCT02452424|12484066|FG000|Overall Study|Death|2
7942885|NCT02452424|12484067|FG001|Overall Study|Death|2
7942886|NCT02452424|12484068|FG002|Overall Study|Death|2
7942887|NCT02452424|12484069|FG003|Overall Study|Death|6
7942888|NCT02452424|12484070|FG004|Overall Study|Death|2
7942889|NCT02452424|12484071|FG005|Overall Study|Death|0
7942890|NCT02452424|12484072|FG006|Overall Study|Death|5
7942891|NCT02452424|12484073|FG007|Overall Study|Death|1
7942892|NCT02452424|12484074|FG008|Overall Study|Death|3
7942893|NCT02452424|12484075|FG009|Overall Study|Death|1
7942894|NCT02452424|12484076|FG010|Overall Study|Death|0
7942895|NCT02452424|12484066|FG000|Overall Study|Lost to Follow-up|0
7942896|NCT02452424|12484067|FG001|Overall Study|Lost to Follow-up|1
7942897|NCT02452424|12484068|FG002|Overall Study|Lost to Follow-up|1
7942898|NCT02452424|12484069|FG003|Overall Study|Lost to Follow-up|0
7942899|NCT02452424|12484070|FG004|Overall Study|Lost to Follow-up|0
7942900|NCT02452424|12484071|FG005|Overall Study|Lost to Follow-up|0
7942901|NCT02452424|12484072|FG006|Overall Study|Lost to Follow-up|0
7942902|NCT02452424|12484073|FG007|Overall Study|Lost to Follow-up|0
7942903|NCT02452424|12484074|FG008|Overall Study|Lost to Follow-up|0
7942904|NCT02452424|12484075|FG009|Overall Study|Lost to Follow-up|0
7942905|NCT02452424|12484076|FG010|Overall Study|Lost to Follow-up|0
7942906|NCT02452424|12484066|FG000|Overall Study|Withdrawal by Subject|0
7942907|NCT02452424|12484067|FG001|Overall Study|Withdrawal by Subject|0
7942908|NCT02452424|12484068|FG002|Overall Study|Withdrawal by Subject|3
7942909|NCT02452424|12484069|FG003|Overall Study|Withdrawal by Subject|2
7942910|NCT02452424|12484070|FG004|Overall Study|Withdrawal by Subject|0
7942911|NCT02452424|12484071|FG005|Overall Study|Withdrawal by Subject|0
7942912|NCT02452424|12484072|FG006|Overall Study|Withdrawal by Subject|1
7942913|NCT02452424|12484073|FG007|Overall Study|Withdrawal by Subject|0
7942914|NCT02452424|12484074|FG008|Overall Study|Withdrawal by Subject|1
7942915|NCT02452424|12484075|FG009|Overall Study|Withdrawal by Subject|1
7942916|NCT02452424|12484076|FG010|Overall Study|Withdrawal by Subject|0
7942917|NCT02452424|12484066|FG000|Overall Study|Other|0
7942918|NCT02452424|12484067|FG001|Overall Study|Other|0
7942919|NCT02452424|12484068|FG002|Overall Study|Other|1
7942920|NCT02452424|12484069|FG003|Overall Study|Other|0
7942921|NCT02452424|12484070|FG004|Overall Study|Other|0
7942922|NCT02452424|12484071|FG005|Overall Study|Other|1
7942923|NCT02452424|12484072|FG006|Overall Study|Other|4
7942924|NCT02452424|12484073|FG007|Overall Study|Other|3
7942925|NCT02452424|12484074|FG008|Overall Study|Other|0
7942926|NCT02452424|12484075|FG009|Overall Study|Other|0
7942927|NCT02452424|12484076|FG010|Overall Study|Other|1
7942928|NCT02452424|12484066|FG000|Overall Study|Progressive disease (per RECIST)|0
7942929|NCT02452424|12484067|FG001|Overall Study|Progressive disease (per RECIST)|0
7942930|NCT02452424|12484068|FG002|Overall Study|Progressive disease (per RECIST)|0
7942931|NCT02452424|12484069|FG003|Overall Study|Progressive disease (per RECIST)|0
7942932|NCT02452424|12484070|FG004|Overall Study|Progressive disease (per RECIST)|0
7942933|NCT02452424|12484071|FG005|Overall Study|Progressive disease (per RECIST)|0
7942934|NCT02452424|12484072|FG006|Overall Study|Progressive disease (per RECIST)|0
7942935|NCT02452424|12484073|FG007|Overall Study|Progressive disease (per RECIST)|0
7942936|NCT02452424|12484074|FG008|Overall Study|Progressive disease (per RECIST)|2
7942937|NCT02452424|12484075|FG009|Overall Study|Progressive disease (per RECIST)|0
7942938|NCT02452424|12484076|FG010|Overall Study|Progressive disease (per RECIST)|0
7942939|NCT02452424|12484066|FG000|Overall Study|Adverse Event|0
7942940|NCT02452424|12484067|FG001|Overall Study|Adverse Event|0
7942941|NCT02452424|12484068|FG002|Overall Study|Adverse Event|0
7942942|NCT02452424|12484069|FG003|Overall Study|Adverse Event|0
7942943|NCT02452424|12484070|FG004|Overall Study|Adverse Event|0
7942944|NCT02452424|12484071|FG005|Overall Study|Adverse Event|0
7942945|NCT02452424|12484072|FG006|Overall Study|Adverse Event|0
7942946|NCT02452424|12484073|FG007|Overall Study|Adverse Event|0
7942947|NCT02452424|12484074|FG008|Overall Study|Adverse Event|0
7942948|NCT02452424|12484075|FG009|Overall Study|Adverse Event|0
7942949|NCT02452424|12484076|FG010|Overall Study|Adverse Event|1
7942950|NCT02452463|12484105|FG000|Overall Study|Death|1
7942951|NCT02452463|12484106|FG001|Overall Study|Death|0
7942952|NCT02452463|12484107|FG002|Overall Study|Death|0
7942953|NCT02452463|12484105|FG000|Overall Study|Study Suspended|1
7942954|NCT02452463|12484106|FG001|Overall Study|Study Suspended|0
7942955|NCT02452463|12484107|FG002|Overall Study|Study Suspended|0
7942956|NCT02452463|12484105|FG000|Overall Study|Recommended by DSMB|0
7942957|NCT02452463|12484106|FG001|Overall Study|Recommended by DSMB|1
7942958|NCT02452463|12484107|FG002|Overall Study|Recommended by DSMB|0
7942959|NCT02452463|12484105|FG000|Overall Study|Withdrawal by Subject|0
7942960|NCT02452463|12484106|FG001|Overall Study|Withdrawal by Subject|1
7942961|NCT02452463|12484107|FG002|Overall Study|Withdrawal by Subject|0
7965455|NCT01190930|12520926|FG000|Induction|Incomplete Induction data|63
7965456|NCT01190930|12520927|FG001|Induction|Incomplete Induction data|0
7965457|NCT01190930|12520928|FG002|Induction|Incomplete Induction data|0
7965458|NCT01190930|12520929|FG003|Induction|Incomplete Induction data|0
7965459|NCT01190930|12520930|FG004|Induction|Incomplete Induction data|0
7965460|NCT01190930|12520931|FG005|Induction|Incomplete Induction data|0
7965461|NCT01190930|12520932|FG006|Induction|Incomplete Induction data|0
7965462|NCT01190930|12520933|FG007|Induction|Incomplete Induction data|0
7965463|NCT01190930|12520934|FG008|Induction|Incomplete Induction data|0
7965464|NCT01190930|12520935|FG009|Induction|Incomplete Induction data|0
7965465|NCT01190930|12520926|FG000|Induction|Progressive disease|0
7965466|NCT01190930|12520927|FG001|Induction|Progressive disease|1
7965467|NCT01190930|12520928|FG002|Induction|Progressive disease|0
7965468|NCT01190930|12520929|FG003|Induction|Progressive disease|0
7965469|NCT01190930|12520930|FG004|Induction|Progressive disease|0
7965470|NCT01190930|12520931|FG005|Induction|Progressive disease|0
7965471|NCT01190930|12520932|FG006|Induction|Progressive disease|0
7965472|NCT01190930|12520933|FG007|Induction|Progressive disease|0
7965473|NCT01190930|12520934|FG008|Induction|Progressive disease|0
7965474|NCT01190930|12520935|FG009|Induction|Progressive disease|0
7965475|NCT01190930|12520926|FG000|Induction|No treatment|3
7965476|NCT01190930|12520927|FG001|Induction|No treatment|0
7965477|NCT01190930|12520928|FG002|Induction|No treatment|0
7965478|NCT01190930|12520929|FG003|Induction|No treatment|0
7965479|NCT01190930|12520930|FG004|Induction|No treatment|0
7965480|NCT01190930|12520931|FG005|Induction|No treatment|0
7965481|NCT01190930|12520932|FG006|Induction|No treatment|0
7965482|NCT01190930|12520933|FG007|Induction|No treatment|0
7965483|NCT01190930|12520934|FG008|Induction|No treatment|0
7965484|NCT01190930|12520935|FG009|Induction|No treatment|0
7965485|NCT01190930|12520926|FG000|Induction|Ineligible|69
7965486|NCT01190930|12520927|FG001|Induction|Ineligible|4
7965487|NCT01190930|12520928|FG002|Induction|Ineligible|0
7965488|NCT01190930|12520929|FG003|Induction|Ineligible|0
7965489|NCT01190930|12520930|FG004|Induction|Ineligible|0
7965490|NCT01190930|12520931|FG005|Induction|Ineligible|0
7965491|NCT01190930|12520932|FG006|Induction|Ineligible|0
7965492|NCT01190930|12520933|FG007|Induction|Ineligible|0
7965493|NCT01190930|12520934|FG008|Induction|Ineligible|0
7965494|NCT01190930|12520935|FG009|Induction|Ineligible|0
7965495|NCT01190930|12520926|FG000|Post Induction Pre-Maintenance|Adverse Event|0
7965496|NCT01190930|12520927|FG001|Post Induction Pre-Maintenance|Adverse Event|0
7965497|NCT01190930|12520928|FG002|Post Induction Pre-Maintenance|Adverse Event|8
7965498|NCT01190930|12520929|FG003|Post Induction Pre-Maintenance|Adverse Event|0
7942962|NCT02452476|12484117|FG000|Overall Study|Death|4
7942963|NCT02452476|12484118|FG001|Overall Study|Death|7
7942964|NCT02452476|12484117|FG000|Overall Study|Lost to Follow-up|1
7942965|NCT02452476|12484118|FG001|Overall Study|Lost to Follow-up|1
7942966|NCT02452476|12484117|FG000|Overall Study|Physician Decision|1
7942967|NCT02452476|12484118|FG001|Overall Study|Physician Decision|1
7942968|NCT02452476|12484117|FG000|Overall Study|Not treated|5
7942969|NCT02452476|12484118|FG001|Overall Study|Not treated|1
7942970|NCT02452762|12484135|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4
7942971|NCT02452762|12484136|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3
7942972|NCT02452762|12484135|FG000|Overall Study|Withdrawal by Subject|1
7942973|NCT02452762|12484136|FG001|Overall Study|Withdrawal by Subject|0
7942974|NCT02452892|12484151|FG000|Week 1 Initial Randommization|Adverse Event|1
7942975|NCT02452892|12484152|FG001|Week 1 Initial Randommization|Adverse Event|0
7942976|NCT02452892|12484153|FG002|Week 1 Initial Randommization|Adverse Event|0
7942977|NCT02452892|12484154|FG003|Week 1 Initial Randommization|Adverse Event|0
7942978|NCT02452892|12484151|FG000|Week 1 Initial Randommization|Lost to Follow-up|0
7942979|NCT02452892|12484152|FG001|Week 1 Initial Randommization|Lost to Follow-up|0
7942980|NCT02452892|12484153|FG002|Week 1 Initial Randommization|Lost to Follow-up|1
7942981|NCT02452892|12484154|FG003|Week 1 Initial Randommization|Lost to Follow-up|0
7942982|NCT02452892|12484151|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
7942983|NCT02452892|12484152|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
7942984|NCT02452892|12484153|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
7942985|NCT02452892|12484154|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
7942986|NCT02452892|12484151|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
7942987|NCT02452892|12484152|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
7942988|NCT02452892|12484153|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
7942989|NCT02452892|12484154|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
7942990|NCT02452892|12484151|FG000|Follow-up|Withdrawal by Subject|0
7942991|NCT02452892|12484152|FG001|Follow-up|Withdrawal by Subject|0
7942992|NCT02452892|12484153|FG002|Follow-up|Withdrawal by Subject|0
7942993|NCT02452892|12484154|FG003|Follow-up|Withdrawal by Subject|1
7942994|NCT02452892|12484151|FG000|Follow-up|Subject left town on Day 42|1
7942995|NCT02452892|12484152|FG001|Follow-up|Subject left town on Day 42|0
7942996|NCT02452892|12484153|FG002|Follow-up|Subject left town on Day 42|0
7942997|NCT02452892|12484154|FG003|Follow-up|Subject left town on Day 42|0
7942998|NCT02453048|12484187|FG000|Overall Study|Only part of initial 6 mo. study|0
7942999|NCT02453048|12484188|FG001|Overall Study|Only part of initial 6 mo. study|0
7943000|NCT02453048|12484189|FG002|Overall Study|Only part of initial 6 mo. study|0
7943001|NCT02453048|12484190|FG003|Overall Study|Only part of initial 6 mo. study|0
7943002|NCT02453048|12484191|FG004|Overall Study|Only part of initial 6 mo. study|6
7943003|NCT02453048|12484187|FG000|Overall Study|Lost to Follow-up|0
7943004|NCT02453048|12484188|FG001|Overall Study|Lost to Follow-up|1
7943005|NCT02453048|12484189|FG002|Overall Study|Lost to Follow-up|2
7943006|NCT02453048|12484190|FG003|Overall Study|Lost to Follow-up|0
7943007|NCT02453048|12484191|FG004|Overall Study|Lost to Follow-up|0
7943008|NCT02453191|12484207|FG000|Overall Study|Withdrawal by Subject|1
7943009|NCT02453256|12484213|FG000|Double Blind Period|Death|1
7943010|NCT02453256|12484214|FG001|Double Blind Period|Death|1
7943011|NCT02453256|12484213|FG000|Double Blind Period|Adverse Event|3
7943012|NCT02453256|12484214|FG001|Double Blind Period|Adverse Event|2
7943013|NCT02453256|12484213|FG000|Double Blind Period|Withdrawal by Subject|9
7943014|NCT02453256|12484214|FG001|Double Blind Period|Withdrawal by Subject|5
7943015|NCT02453256|12484213|FG000|Double Blind Period|Other|0
7943016|NCT02453256|12484214|FG001|Double Blind Period|Other|1
7943017|NCT02453256|12484213|FG000|Open Label Period|Adverse Event|1
7943018|NCT02453256|12484214|FG001|Open Label Period|Adverse Event|3
7943019|NCT02453256|12484213|FG000|Open Label Period|Death|0
7943020|NCT02453256|12484214|FG001|Open Label Period|Death|1
7943021|NCT02453256|12484213|FG000|Open Label Period|Lost to Follow-up|1
7943022|NCT02453256|12484214|FG001|Open Label Period|Lost to Follow-up|0
7943023|NCT02453256|12484213|FG000|Open Label Period|Other|0
7943024|NCT02453256|12484214|FG001|Open Label Period|Other|2
7943025|NCT02453256|12484213|FG000|Open Label Period|Withdrawal by Subject|5
7943026|NCT02453256|12484214|FG001|Open Label Period|Withdrawal by Subject|1
7943027|NCT02453321|12484230|FG000|Overall Study|Weakness|1
7943028|NCT02453321|12484231|FG001|Overall Study|Weakness|1
7943029|NCT02453321|12484232|FG002|Overall Study|Weakness|2
7943030|NCT02453321|12484230|FG000|Overall Study|Deep Venous Thrombosis|0
7943031|NCT02453321|12484231|FG001|Overall Study|Deep Venous Thrombosis|1
7943032|NCT02453321|12484232|FG002|Overall Study|Deep Venous Thrombosis|0
7943033|NCT02453334|12484245|FG000|Overall Study|Death|15
7943034|NCT02453334|12484246|FG001|Overall Study|Death|13
7943035|NCT02453334|12484245|FG000|Overall Study|Adverse Event|2
7943036|NCT02453334|12484246|FG001|Overall Study|Adverse Event|1
7943037|NCT02453334|12484245|FG000|Overall Study|Lost to Follow-up|5
7943038|NCT02453334|12484246|FG001|Overall Study|Lost to Follow-up|9
7943039|NCT02453334|12484245|FG000|Overall Study|Physician Decision|1
7943040|NCT02453334|12484246|FG001|Overall Study|Physician Decision|0
7943041|NCT02453334|12484245|FG000|Overall Study|Withdrawal by Subject|17
7943042|NCT02453334|12484246|FG001|Overall Study|Withdrawal by Subject|13
7943043|NCT02453334|12484245|FG000|Overall Study|Other reason|1
7943044|NCT02453334|12484246|FG001|Overall Study|Other reason|4
7943045|NCT02453386|12484272|FG000|Overall Study|Adverse Event|22
7943046|NCT02453386|12484273|FG001|Overall Study|Adverse Event|30
7943047|NCT02453386|12484274|FG002|Overall Study|Adverse Event|15
7943048|NCT02453386|12484272|FG000|Overall Study|Protocol Violation|1
7943049|NCT02453386|12484273|FG001|Overall Study|Protocol Violation|0
7943050|NCT02453386|12484274|FG002|Overall Study|Protocol Violation|1
7943051|NCT02453386|12484272|FG000|Overall Study|Withdrawal by Subject|10
7943052|NCT02453386|12484273|FG001|Overall Study|Withdrawal by Subject|9
7943053|NCT02453386|12484274|FG002|Overall Study|Withdrawal by Subject|9
7943054|NCT02453386|12484272|FG000|Overall Study|Sponsor Terminated Study|14
7943055|NCT02453386|12484273|FG001|Overall Study|Sponsor Terminated Study|8
7943056|NCT02453386|12484274|FG002|Overall Study|Sponsor Terminated Study|11
7943057|NCT02453386|12484272|FG000|Overall Study|Subject Terminated by Sponsor|1
7943058|NCT02453386|12484273|FG001|Overall Study|Subject Terminated by Sponsor|1
7943059|NCT02453386|12484274|FG002|Overall Study|Subject Terminated by Sponsor|1
7943060|NCT02453386|12484272|FG000|Overall Study|Sponsor Terminated by Investigator|0
7943061|NCT02453386|12484273|FG001|Overall Study|Sponsor Terminated by Investigator|1
7943062|NCT02453386|12484274|FG002|Overall Study|Sponsor Terminated by Investigator|2
7943063|NCT02453386|12484272|FG000|Overall Study|Lost to Follow-up|0
7943064|NCT02453386|12484273|FG001|Overall Study|Lost to Follow-up|0
7943065|NCT02453386|12484274|FG002|Overall Study|Lost to Follow-up|1
7943066|NCT02453386|12484272|FG000|Overall Study|Other|1
7943067|NCT02453386|12484273|FG001|Overall Study|Other|0
7943068|NCT02453386|12484274|FG002|Overall Study|Other|1
7943069|NCT02453555|12484291|FG000|24-week Double-blind Treatment Period|Adverse Event|2
7943070|NCT02453555|12484292|FG001|24-week Double-blind Treatment Period|Adverse Event|0
7943071|NCT02453555|12484293|FG002|24-week Double-blind Treatment Period|Adverse Event|0
7943072|NCT02453555|12484294|FG003|24-week Double-blind Treatment Period|Adverse Event|0
7943073|NCT02453555|12484295|FG004|24-week Double-blind Treatment Period|Adverse Event|0
7943074|NCT02453555|12484296|FG005|24-week Double-blind Treatment Period|Adverse Event|0
7943075|NCT02453555|12484291|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1
7943076|NCT02453555|12484292|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0
7943077|NCT02453555|12484293|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0
7943078|NCT02453555|12484294|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0
7943079|NCT02453555|12484295|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0
7943080|NCT02453555|12484296|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0
7943081|NCT02453555|12484291|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2
7943082|NCT02453555|12484292|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4
7943083|NCT02453555|12484293|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7943084|NCT02453555|12484294|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7943085|NCT02453555|12484295|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7943086|NCT02453555|12484296|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7943087|NCT02453555|12484291|FG000|24-week Double-blind Treatment Period|Other than specified above|0
7943088|NCT02453555|12484292|FG001|24-week Double-blind Treatment Period|Other than specified above|3
7943089|NCT02453555|12484293|FG002|24-week Double-blind Treatment Period|Other than specified above|0
7943090|NCT02453555|12484294|FG003|24-week Double-blind Treatment Period|Other than specified above|0
7943091|NCT02453555|12484295|FG004|24-week Double-blind Treatment Period|Other than specified above|0
7943092|NCT02453555|12484296|FG005|24-week Double-blind Treatment Period|Other than specified above|0
7943093|NCT02453555|12484291|FG000|Extension Period|Adverse Event|0
7943094|NCT02453555|12484292|FG001|Extension Period|Adverse Event|0
7943095|NCT02453555|12484293|FG002|Extension Period|Adverse Event|1
7943096|NCT02453555|12484294|FG003|Extension Period|Adverse Event|2
7943097|NCT02453555|12484295|FG004|Extension Period|Adverse Event|1
7943098|NCT02453555|12484296|FG005|Extension Period|Adverse Event|1
7943099|NCT02453555|12484291|FG000|Extension Period|Protocol Violation|0
7943100|NCT02453555|12484292|FG001|Extension Period|Protocol Violation|0
7943101|NCT02453555|12484293|FG002|Extension Period|Protocol Violation|1
7943102|NCT02453555|12484294|FG003|Extension Period|Protocol Violation|0
7943103|NCT02453555|12484295|FG004|Extension Period|Protocol Violation|0
7943104|NCT02453555|12484296|FG005|Extension Period|Protocol Violation|0
7943105|NCT02453555|12484291|FG000|Extension Period|Withdrawal by Subject|0
7943106|NCT02453555|12484292|FG001|Extension Period|Withdrawal by Subject|0
7943107|NCT02453555|12484293|FG002|Extension Period|Withdrawal by Subject|1
7943108|NCT02453555|12484294|FG003|Extension Period|Withdrawal by Subject|0
7943109|NCT02453555|12484295|FG004|Extension Period|Withdrawal by Subject|0
7943110|NCT02453555|12484296|FG005|Extension Period|Withdrawal by Subject|0
7943111|NCT02453685|12484340|FG000|Overall Study|Adverse Event|0
7943112|NCT02453685|12484341|FG001|Overall Study|Adverse Event|1
7943113|NCT02453685|12484340|FG000|Overall Study|Protocol Violation|7
7943114|NCT02453685|12484341|FG001|Overall Study|Protocol Violation|4
7943115|NCT02453685|12484340|FG000|Overall Study|Lost to Follow-up|0
7943116|NCT02453685|12484341|FG001|Overall Study|Lost to Follow-up|1
7943117|NCT02453685|12484340|FG000|Overall Study|Withdrawal by Subject|8
7943118|NCT02453685|12484341|FG001|Overall Study|Withdrawal by Subject|4
7943119|NCT02453685|12484340|FG000|Overall Study|Unclassified|4
7943120|NCT02453685|12484341|FG001|Overall Study|Unclassified|2
7943121|NCT02453711|12484356|FG000|Overall Study|Withdrawal by Subject|5
7943122|NCT02453711|12484357|FG001|Overall Study|Withdrawal by Subject|4
7943123|NCT02453711|12484358|FG002|Overall Study|Withdrawal by Subject|6
7943124|NCT02453711|12484359|FG003|Overall Study|Withdrawal by Subject|4
7943125|NCT02453711|12484360|FG004|Overall Study|Withdrawal by Subject|1
7943126|NCT02453711|12484361|FG005|Overall Study|Withdrawal by Subject|1
7943127|NCT02453711|12484362|FG006|Overall Study|Withdrawal by Subject|0
7943128|NCT02453711|12484363|FG007|Overall Study|Withdrawal by Subject|1
7943129|NCT02453711|12484364|FG008|Overall Study|Withdrawal by Subject|7
7943130|NCT02453711|12484356|FG000|Overall Study|Lost to Follow-up|5
7943131|NCT02453711|12484357|FG001|Overall Study|Lost to Follow-up|3
7943132|NCT02453711|12484358|FG002|Overall Study|Lost to Follow-up|2
7943133|NCT02453711|12484359|FG003|Overall Study|Lost to Follow-up|3
7943134|NCT02453711|12484360|FG004|Overall Study|Lost to Follow-up|1
7943135|NCT02453711|12484361|FG005|Overall Study|Lost to Follow-up|5
7943136|NCT02453711|12484362|FG006|Overall Study|Lost to Follow-up|2
7943137|NCT02453711|12484363|FG007|Overall Study|Lost to Follow-up|6
7943138|NCT02453711|12484364|FG008|Overall Study|Lost to Follow-up|6
7943139|NCT02453711|12484356|FG000|Overall Study|Death|0
7943140|NCT02453711|12484357|FG001|Overall Study|Death|0
7943141|NCT02453711|12484358|FG002|Overall Study|Death|0
7943142|NCT02453711|12484359|FG003|Overall Study|Death|0
7943143|NCT02453711|12484360|FG004|Overall Study|Death|0
7943144|NCT02453711|12484361|FG005|Overall Study|Death|0
7943145|NCT02453711|12484362|FG006|Overall Study|Death|1
7943146|NCT02453711|12484363|FG007|Overall Study|Death|0
7943147|NCT02453711|12484364|FG008|Overall Study|Death|0
7943148|NCT02453711|12484356|FG000|Overall Study|Unclassified|1
7943149|NCT02453711|12484357|FG001|Overall Study|Unclassified|0
7943150|NCT02453711|12484358|FG002|Overall Study|Unclassified|1
7943151|NCT02453711|12484359|FG003|Overall Study|Unclassified|0
7943152|NCT02453711|12484360|FG004|Overall Study|Unclassified|0
7943153|NCT02453711|12484361|FG005|Overall Study|Unclassified|0
7943154|NCT02453711|12484362|FG006|Overall Study|Unclassified|0
7943155|NCT02453711|12484363|FG007|Overall Study|Unclassified|0
7943156|NCT02453711|12484364|FG008|Overall Study|Unclassified|0
7943157|NCT02453841|12484391|FG000|Overall Study|Protocol Violation|1
7943158|NCT02453841|12484391|FG000|Overall Study|Unable to obtain blood samples|2
7943159|NCT02454101|12484403|FG000|Overall Study|Adverse Event|2
7943160|NCT02454101|12484404|FG001|Overall Study|Adverse Event|3
7943161|NCT02454101|12484403|FG000|Overall Study|Lost to Follow-up|3
7943162|NCT02454101|12484404|FG001|Overall Study|Lost to Follow-up|4
7943163|NCT02454478|12484466|FG000|Overall Study|Incomplete DLT Evaluation|1
7943164|NCT02454530|12484472|FG000|Overall Study|Other|8
7943165|NCT02454530|12484473|FG001|Overall Study|Other|13
7943166|NCT02454530|12484472|FG000|Overall Study|Missing information|56
7943167|NCT02454530|12484473|FG001|Overall Study|Missing information|69
7943168|NCT02454530|12484472|FG000|Overall Study|Death|2
7943169|NCT02454530|12484473|FG001|Overall Study|Death|41
7943170|NCT02454530|12484472|FG000|Overall Study|Lost to Follow-up|4
7943171|NCT02454530|12484473|FG001|Overall Study|Lost to Follow-up|4
7943172|NCT02454608|12484483|FG000|Double-Blind Period|Lack of Efficacy|0
7943173|NCT02454608|12484484|FG001|Double-Blind Period|Lack of Efficacy|2
7943174|NCT02454608|12484485|FG002|Double-Blind Period|Lack of Efficacy|0
7943175|NCT02454608|12484483|FG000|Open Label Period|Lost to Follow-up|0
7943176|NCT02454608|12484484|FG001|Open Label Period|Lost to Follow-up|0
7943177|NCT02454608|12484485|FG002|Open Label Period|Lost to Follow-up|11
7943178|NCT02454608|12484483|FG000|Open Label Period|Withdrawal by Subject|0
7943179|NCT02454608|12484484|FG001|Open Label Period|Withdrawal by Subject|0
7943180|NCT02454608|12484485|FG002|Open Label Period|Withdrawal by Subject|8
7943181|NCT02454959|12484493|FG000|Overall Study|Protocol-Specified Criteria|3
7943182|NCT02454959|12484493|FG000|Overall Study|Physician Decision|1
7943183|NCT02454959|12484493|FG000|Overall Study|Withdrawal by Subject|3
7943184|NCT02454959|12484493|FG000|Overall Study|Adverse Event|2
7943185|NCT02454972|12484508|FG000|Overall Study|Progressive disease|17
7943186|NCT02454972|12484509|FG001|Overall Study|Progressive disease|16
7943187|NCT02454972|12484510|FG002|Overall Study|Progressive disease|59
7943188|NCT02454972|12484511|FG003|Overall Study|Progressive disease|23
7943189|NCT02454972|12484512|FG004|Overall Study|Progressive disease|16
7943190|NCT02454972|12484513|FG005|Overall Study|Progressive disease|12
7943191|NCT02454972|12484514|FG006|Overall Study|Progressive disease|19
7943192|NCT02454972|12484515|FG007|Overall Study|Progressive disease|27
7943193|NCT02454972|12484516|FG008|Overall Study|Progressive disease|84
7943194|NCT02454972|12484508|FG000|Overall Study|Death|0
7943195|NCT02454972|12484509|FG001|Overall Study|Death|0
7943196|NCT02454972|12484510|FG002|Overall Study|Death|5
7943197|NCT02454972|12484511|FG003|Overall Study|Death|1
7943198|NCT02454972|12484512|FG004|Overall Study|Death|0
7943199|NCT02454972|12484513|FG005|Overall Study|Death|0
7943200|NCT02454972|12484514|FG006|Overall Study|Death|0
7943201|NCT02454972|12484515|FG007|Overall Study|Death|0
7943202|NCT02454972|12484516|FG008|Overall Study|Death|2
7943203|NCT02454972|12484508|FG000|Overall Study|Physician Decision|0
7943204|NCT02454972|12484509|FG001|Overall Study|Physician Decision|1
7943205|NCT02454972|12484510|FG002|Overall Study|Physician Decision|2
7943206|NCT02454972|12484511|FG003|Overall Study|Physician Decision|1
7943207|NCT02454972|12484512|FG004|Overall Study|Physician Decision|2
7943208|NCT02454972|12484513|FG005|Overall Study|Physician Decision|0
7943209|NCT02454972|12484514|FG006|Overall Study|Physician Decision|0
7943210|NCT02454972|12484515|FG007|Overall Study|Physician Decision|1
7943211|NCT02454972|12484516|FG008|Overall Study|Physician Decision|4
7943212|NCT02454972|12484508|FG000|Overall Study|Non treatment-related adverse event|2
7943213|NCT02454972|12484509|FG001|Overall Study|Non treatment-related adverse event|0
7943214|NCT02454972|12484510|FG002|Overall Study|Non treatment-related adverse event|1
7943215|NCT02454972|12484511|FG003|Overall Study|Non treatment-related adverse event|0
7943216|NCT02454972|12484512|FG004|Overall Study|Non treatment-related adverse event|0
7943217|NCT02454972|12484513|FG005|Overall Study|Non treatment-related adverse event|1
7943218|NCT02454972|12484514|FG006|Overall Study|Non treatment-related adverse event|0
7943219|NCT02454972|12484515|FG007|Overall Study|Non treatment-related adverse event|1
7943220|NCT02454972|12484516|FG008|Overall Study|Non treatment-related adverse event|0
7943221|NCT02454972|12484508|FG000|Overall Study|Treatment-related adverse events|0
7943222|NCT02454972|12484509|FG001|Overall Study|Treatment-related adverse events|1
7943223|NCT02454972|12484510|FG002|Overall Study|Treatment-related adverse events|1
7943224|NCT02454972|12484511|FG003|Overall Study|Treatment-related adverse events|0
7943225|NCT02454972|12484512|FG004|Overall Study|Treatment-related adverse events|2
7943226|NCT02454972|12484513|FG005|Overall Study|Treatment-related adverse events|0
7943227|NCT02454972|12484514|FG006|Overall Study|Treatment-related adverse events|0
7943228|NCT02454972|12484515|FG007|Overall Study|Treatment-related adverse events|2
7943229|NCT02454972|12484516|FG008|Overall Study|Treatment-related adverse events|2
7943230|NCT02454972|12484508|FG000|Overall Study|Patient moves to compassionate use|0
7943231|NCT02454972|12484509|FG001|Overall Study|Patient moves to compassionate use|0
7943232|NCT02454972|12484510|FG002|Overall Study|Patient moves to compassionate use|0
7943233|NCT02454972|12484511|FG003|Overall Study|Patient moves to compassionate use|0
7943234|NCT02454972|12484512|FG004|Overall Study|Patient moves to compassionate use|0
7943235|NCT02454972|12484513|FG005|Overall Study|Patient moves to compassionate use|0
7943236|NCT02454972|12484514|FG006|Overall Study|Patient moves to compassionate use|2
7943237|NCT02454972|12484515|FG007|Overall Study|Patient moves to compassionate use|0
7943238|NCT02454972|12484516|FG008|Overall Study|Patient moves to compassionate use|11
7943239|NCT02454972|12484508|FG000|Overall Study|Withdrawal by Subject|0
7943240|NCT02454972|12484509|FG001|Overall Study|Withdrawal by Subject|1
7943241|NCT02454972|12484510|FG002|Overall Study|Withdrawal by Subject|5
7943242|NCT02454972|12484511|FG003|Overall Study|Withdrawal by Subject|2
7943243|NCT02454972|12484512|FG004|Overall Study|Withdrawal by Subject|3
7943244|NCT02454972|12484513|FG005|Overall Study|Withdrawal by Subject|2
7943245|NCT02454972|12484514|FG006|Overall Study|Withdrawal by Subject|0
7943246|NCT02454972|12484515|FG007|Overall Study|Withdrawal by Subject|1
7943247|NCT02454972|12484516|FG008|Overall Study|Withdrawal by Subject|2
7943248|NCT02454972|12484508|FG000|Overall Study|Multiple delay/holds on treatment|0
7943249|NCT02454972|12484509|FG001|Overall Study|Multiple delay/holds on treatment|0
7943250|NCT02454972|12484510|FG002|Overall Study|Multiple delay/holds on treatment|0
7943251|NCT02454972|12484511|FG003|Overall Study|Multiple delay/holds on treatment|1
7943252|NCT02454972|12484512|FG004|Overall Study|Multiple delay/holds on treatment|0
7943253|NCT02454972|12484513|FG005|Overall Study|Multiple delay/holds on treatment|0
7943254|NCT02454972|12484514|FG006|Overall Study|Multiple delay/holds on treatment|0
7943255|NCT02454972|12484515|FG007|Overall Study|Multiple delay/holds on treatment|0
7943256|NCT02454972|12484516|FG008|Overall Study|Multiple delay/holds on treatment|0
7943257|NCT02454972|12484508|FG000|Overall Study|Never treated|0
7943258|NCT02454972|12484509|FG001|Overall Study|Never treated|0
7943259|NCT02454972|12484510|FG002|Overall Study|Never treated|3
7943260|NCT02454972|12484511|FG003|Overall Study|Never treated|1
7943261|NCT02454972|12484512|FG004|Overall Study|Never treated|1
7943262|NCT02454972|12484513|FG005|Overall Study|Never treated|0
7943263|NCT02454972|12484514|FG006|Overall Study|Never treated|0
7943264|NCT02454972|12484515|FG007|Overall Study|Never treated|0
7943265|NCT02454972|12484516|FG008|Overall Study|Never treated|5
7943266|NCT02455050|12484532|FG000|Treatment Period 1|Lost to Follow-up|1
7943267|NCT02455050|12484533|FG001|Treatment Period 1|Lost to Follow-up|1
7943268|NCT02455050|12484534|FG002|Treatment Period 1|Lost to Follow-up|1
7943269|NCT02455050|12484535|FG003|Treatment Period 1|Lost to Follow-up|2
7943270|NCT02455050|12484532|FG000|Treatment Period 2|Lost to Follow-up|1
7943271|NCT02455050|12484533|FG001|Treatment Period 2|Lost to Follow-up|0
7943272|NCT02455050|12484534|FG002|Treatment Period 2|Lost to Follow-up|2
7943273|NCT02455050|12484535|FG003|Treatment Period 2|Lost to Follow-up|1
7943274|NCT02455076|12484560|FG000|Inpatient|Withdrawal by Subject|1
7943275|NCT02455076|12484561|FG001|Inpatient|Withdrawal by Subject|0
7943276|NCT02455076|12484562|FG002|Inpatient|Withdrawal by Subject|0
7943277|NCT02455076|12484563|FG003|Inpatient|Withdrawal by Subject|0
7943278|NCT02455076|12484564|FG004|Inpatient|Withdrawal by Subject|0
7943279|NCT02455076|12484560|FG000|Inpatient|Discharged <24 h after admission|0
7943280|NCT02455076|12484561|FG001|Inpatient|Discharged <24 h after admission|1
7943281|NCT02455076|12484562|FG002|Inpatient|Discharged <24 h after admission|0
7943282|NCT02455076|12484563|FG003|Inpatient|Discharged <24 h after admission|0
7943283|NCT02455076|12484564|FG004|Inpatient|Discharged <24 h after admission|0
7943284|NCT02455076|12484560|FG000|Inpatient|Adverse Event|3
7943285|NCT02455076|12484561|FG001|Inpatient|Adverse Event|0
7943286|NCT02455076|12484562|FG002|Inpatient|Adverse Event|0
7943287|NCT02455076|12484563|FG003|Inpatient|Adverse Event|0
7943288|NCT02455076|12484564|FG004|Inpatient|Adverse Event|0
7943289|NCT02455076|12484560|FG000|Outpatient|Adverse Event|0
7943290|NCT02455076|12484561|FG001|Outpatient|Adverse Event|0
7943291|NCT02455076|12484562|FG002|Outpatient|Adverse Event|0
7943292|NCT02455076|12484563|FG003|Outpatient|Adverse Event|5
7943293|NCT02455076|12484564|FG004|Outpatient|Adverse Event|0
7943294|NCT02455076|12484560|FG000|Outpatient|Lost to Follow-up|0
7943295|NCT02455076|12484561|FG001|Outpatient|Lost to Follow-up|0
7943296|NCT02455076|12484562|FG002|Outpatient|Lost to Follow-up|0
7943297|NCT02455076|12484563|FG003|Outpatient|Lost to Follow-up|1
7943298|NCT02455076|12484564|FG004|Outpatient|Lost to Follow-up|12
7943299|NCT02455336|12484582|FG000|Overall Study|Withdrawal by Subject|0
7943300|NCT02455336|12484583|FG001|Overall Study|Withdrawal by Subject|2
7943301|NCT02455336|12484582|FG000|Overall Study|Adverse Event|3
7943302|NCT02455336|12484583|FG001|Overall Study|Adverse Event|0
7943303|NCT02455336|12484582|FG000|Overall Study|Non-responder to treatment|2
7943304|NCT02455336|12484583|FG001|Overall Study|Non-responder to treatment|0
7943305|NCT02455388|12484591|FG000|Overall Study|Protocol Violation|1
7943306|NCT02455388|12484592|FG001|Overall Study|Protocol Violation|0
7943307|NCT02455388|12484593|FG002|Overall Study|Protocol Violation|4
7943308|NCT02455388|12484591|FG000|Overall Study|Withdrawal by Subject|0
7943309|NCT02455388|12484592|FG001|Overall Study|Withdrawal by Subject|0
7943310|NCT02455388|12484593|FG002|Overall Study|Withdrawal by Subject|7
7943311|NCT02455518|12484609|FG000|Overall Study|Protocol Violation|0
7943312|NCT02455518|12484610|FG001|Overall Study|Protocol Violation|1
7943313|NCT02455518|12484611|FG002|Overall Study|Protocol Violation|1
7943314|NCT02455518|12484612|FG003|Overall Study|Protocol Violation|3
7943315|NCT02456103|12484622|FG000|Overall Study|Study Closure|207
7943316|NCT02456103|12484622|FG000|Overall Study|Physician Decision|1
7943317|NCT02456103|12484622|FG000|Overall Study|Required prohibited medications|5
7943318|NCT02456103|12484622|FG000|Overall Study|Protocol Violation|1
7943319|NCT02456103|12484622|FG000|Overall Study|Adverse Event|5
7943320|NCT02456103|12484622|FG000|Overall Study|Abnormal Laboratory Value|2
7943321|NCT02456103|12484622|FG000|Overall Study|Lost to Follow-up|1
7943322|NCT02456103|12484622|FG000|Overall Study|Withdrawal by Subject|24
7943323|NCT02456636|12484629|FG000|Overall Study|Death|0
7943324|NCT02456636|12484630|FG001|Overall Study|Death|3
7943325|NCT02456636|12484631|FG002|Overall Study|Death|0
7943326|NCT02456636|12484629|FG000|Overall Study|Pregnancy|1
7943327|NCT02456636|12484630|FG001|Overall Study|Pregnancy|3
7943328|NCT02456636|12484631|FG002|Overall Study|Pregnancy|5
7943329|NCT02456636|12484629|FG000|Overall Study|Physician Decision|4
7943330|NCT02456636|12484630|FG001|Overall Study|Physician Decision|5
7943331|NCT02456636|12484631|FG002|Overall Study|Physician Decision|4
7943332|NCT02456636|12484629|FG000|Overall Study|Withdrawal by Subject|13
7943333|NCT02456636|12484630|FG001|Overall Study|Withdrawal by Subject|14
7943334|NCT02456636|12484631|FG002|Overall Study|Withdrawal by Subject|16
7943335|NCT02456636|12484629|FG000|Overall Study|Lost to Follow-up|50
7943336|NCT02456636|12484630|FG001|Overall Study|Lost to Follow-up|44
7943337|NCT02456636|12484631|FG002|Overall Study|Lost to Follow-up|50
7943338|NCT02456662|12484641|FG000|Overall Study|Lost to Follow-up|2
7943339|NCT02456662|12484642|FG001|Overall Study|Lost to Follow-up|1
7943340|NCT02456727|12484650|FG000|Overall Study|Lost to Follow-up|63
7943341|NCT02456727|12484651|FG001|Overall Study|Lost to Follow-up|65
7943342|NCT02456727|12484650|FG000|Overall Study|Death|2
7943343|NCT02456727|12484651|FG001|Overall Study|Death|1
7943344|NCT02456727|12484650|FG000|Overall Study|Withdrawal by Subject|1
7943345|NCT02456727|12484651|FG001|Overall Study|Withdrawal by Subject|10
7943346|NCT02456727|12484650|FG000|Overall Study|Never Initiated Treatment|43
7943347|NCT02456727|12484651|FG001|Overall Study|Never Initiated Treatment|30
7943348|NCT02456909|12484684|FG000|Overall Study|Did not receive allocated intervention|24
7943349|NCT02456909|12484685|FG001|Overall Study|Did not receive allocated intervention|26
7943350|NCT02456909|12484684|FG000|Overall Study|Did not complete the primary outcome|0
7943351|NCT02456909|12484685|FG001|Overall Study|Did not complete the primary outcome|1
7943352|NCT02457065|12484693|FG000|Overall Study|Lost to Follow-up|9
7943353|NCT02457065|12484694|FG001|Overall Study|Lost to Follow-up|11
7943354|NCT02457182|12484702|FG000|Overall Study|Lost to Follow-up|1
7943355|NCT02457182|12484703|FG001|Overall Study|Lost to Follow-up|0
7943356|NCT02457195|12484709|FG000|Overall Study|Adverse Event|3
7943357|NCT02457195|12484709|FG000|Overall Study|Protocol Violation|2
7943358|NCT02457195|12484709|FG000|Overall Study|Withdrawal by Subject|4
7943359|NCT02457247|12484717|FG000|Period 1|Pretreatment Event/Adverse Event|0
7943360|NCT02457247|12484718|FG001|Period 1|Pretreatment Event/Adverse Event|1
7943361|NCT02457247|12484719|FG002|Period 1|Pretreatment Event/Adverse Event|0
7943362|NCT02457247|12484720|FG003|Period 1|Pretreatment Event/Adverse Event|0
7943363|NCT02457247|12484717|FG000|Period 1|Significant Protocol Deviation|1
7943364|NCT02457247|12484718|FG001|Period 1|Significant Protocol Deviation|1
7943365|NCT02457247|12484719|FG002|Period 1|Significant Protocol Deviation|0
7943366|NCT02457247|12484720|FG003|Period 1|Significant Protocol Deviation|0
7943367|NCT02457247|12484717|FG000|Period 1|Voluntary Withdrawal|1
7943368|NCT02457247|12484718|FG001|Period 1|Voluntary Withdrawal|0
7943369|NCT02457247|12484719|FG002|Period 1|Voluntary Withdrawal|0
7943370|NCT02457247|12484720|FG003|Period 1|Voluntary Withdrawal|0
7943371|NCT02457247|12484717|FG000|Period 2|Pretreatment Event/Adverse Event|0
7943372|NCT02457247|12484718|FG001|Period 2|Pretreatment Event/Adverse Event|1
7943373|NCT02457247|12484719|FG002|Period 2|Pretreatment Event/Adverse Event|0
7943374|NCT02457247|12484720|FG003|Period 2|Pretreatment Event/Adverse Event|0
7943375|NCT02457247|12484717|FG000|Period 2|Significant Protocol Deviation|1
7943376|NCT02457247|12484718|FG001|Period 2|Significant Protocol Deviation|0
7943377|NCT02457247|12484719|FG002|Period 2|Significant Protocol Deviation|0
7943378|NCT02457247|12484720|FG003|Period 2|Significant Protocol Deviation|0
7943379|NCT02457247|12484717|FG000|Period 2|Lost to Follow-up|0
7943380|NCT02457247|12484718|FG001|Period 2|Lost to Follow-up|1
7943381|NCT02457247|12484719|FG002|Period 2|Lost to Follow-up|0
7943382|NCT02457247|12484720|FG003|Period 2|Lost to Follow-up|0
7943383|NCT02457247|12484717|FG000|Period 2|Voluntary Withdrawal|1
7943384|NCT02457247|12484718|FG001|Period 2|Voluntary Withdrawal|1
7943385|NCT02457247|12484719|FG002|Period 2|Voluntary Withdrawal|0
7943386|NCT02457247|12484720|FG003|Period 2|Voluntary Withdrawal|0
7943387|NCT02457325|12484752|FG000|First Intervention (1 Day)|Lost to Follow-up|2
7943388|NCT02457325|12484753|FG001|First Intervention (1 Day)|Lost to Follow-up|2
7943389|NCT02457520|12484770|FG000|Active Treatment Phase|Adverse Event|10
7943390|NCT02457520|12484770|FG000|Active Treatment Phase|Lost to Follow-up|8
7943391|NCT02457520|12484770|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3
7943392|NCT02457520|12484770|FG000|Active Treatment Phase|other|4
7943393|NCT02457520|12484770|FG000|Active Treatment Phase|Physician Decision|1
7943394|NCT02457520|12484770|FG000|Active Treatment Phase|Protocol Violation|1
7943395|NCT02457520|12484770|FG000|Active Treatment Phase|Withdrawal by Subject|7
7943396|NCT02457520|12484770|FG000|Post-treatment Period|Other: Retreatment Required|7
7943397|NCT02457520|12484770|FG000|Post-treatment Period|Lost to Follow-up|23
7943398|NCT02457520|12484770|FG000|Post-treatment Period|Other|3
7943399|NCT02457520|12484770|FG000|Post-treatment Period|Physician Decision|1
7943400|NCT02457520|12484770|FG000|Post-treatment Period|Withdrawal by Subject|14
7943401|NCT02457546|12484802|FG000|Overall Study|Other reasons|4
7943402|NCT02457546|12484803|FG001|Overall Study|Other reasons|1
7943403|NCT02457546|12484802|FG000|Overall Study|Refused to complete study/procedures|1
7943404|NCT02457546|12484803|FG001|Overall Study|Refused to complete study/procedures|1
7943405|NCT02457546|12484802|FG000|Overall Study|Lost to Follow-up|4
7943406|NCT02457546|12484803|FG001|Overall Study|Lost to Follow-up|1
7943407|NCT02457546|12484802|FG000|Overall Study|Adverse Event|0
7943408|NCT02457546|12484803|FG001|Overall Study|Adverse Event|1
7943409|NCT02457611|12484809|FG000|Overall Study|Lost to Follow-up|3
7943410|NCT02457637|12484813|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71
7943411|NCT02457793|12484828|FG000|Overall Study|Reason not specified|0
7943412|NCT02457793|12484829|FG001|Overall Study|Reason not specified|0
7943413|NCT02457793|12484830|FG002|Overall Study|Reason not specified|0
7943414|NCT02457793|12484831|FG003|Overall Study|Reason not specified|1
7943415|NCT02457793|12484832|FG004|Overall Study|Reason not specified|1
7943416|NCT02457793|12484833|FG005|Overall Study|Reason not specified|1
7943417|NCT02457793|12484828|FG000|Overall Study|Withdrawal by Subject|0
7943418|NCT02457793|12484829|FG001|Overall Study|Withdrawal by Subject|4
7943419|NCT02457793|12484830|FG002|Overall Study|Withdrawal by Subject|2
7943420|NCT02457793|12484831|FG003|Overall Study|Withdrawal by Subject|2
7943421|NCT02457793|12484832|FG004|Overall Study|Withdrawal by Subject|2
7943422|NCT02457793|12484833|FG005|Overall Study|Withdrawal by Subject|2
7943423|NCT02457793|12484828|FG000|Overall Study|Adverse Event|0
7943424|NCT02457793|12484829|FG001|Overall Study|Adverse Event|0
7943425|NCT02457793|12484830|FG002|Overall Study|Adverse Event|0
7943426|NCT02457793|12484831|FG003|Overall Study|Adverse Event|1
7943427|NCT02457793|12484832|FG004|Overall Study|Adverse Event|0
7943428|NCT02457793|12484833|FG005|Overall Study|Adverse Event|0
7943429|NCT02457793|12484828|FG000|Overall Study|Physician Decision|1
7943430|NCT02457793|12484829|FG001|Overall Study|Physician Decision|0
7943431|NCT02457793|12484830|FG002|Overall Study|Physician Decision|1
7943432|NCT02457793|12484831|FG003|Overall Study|Physician Decision|1
7943433|NCT02457793|12484832|FG004|Overall Study|Physician Decision|1
7943434|NCT02457793|12484833|FG005|Overall Study|Physician Decision|3
7943435|NCT02457819|12484848|FG000|Overall Study|reason not given|8
7943436|NCT02457819|12484848|FG000|Overall Study|Withdrawal by Subject|24
7943437|NCT02457819|12484848|FG000|Overall Study|Protocol Violation|1
7943438|NCT02457819|12484848|FG000|Overall Study|non compliance with study drug|4
7943439|NCT02457819|12484848|FG000|Overall Study|Lost to Follow-up|10
7943440|NCT02457819|12484848|FG000|Overall Study|Lack of Efficacy|19
7943441|NCT02457819|12484848|FG000|Overall Study|Adverse Event|33
7943442|NCT02458092|12484858|FG000|Overall Study|Withdrawal by Subject|1
7943443|NCT02458092|12484859|FG001|Overall Study|Withdrawal by Subject|0
7943444|NCT02458287|12484874|FG000|Overall Study|Adverse Event|0
7943445|NCT02458287|12484875|FG001|Overall Study|Adverse Event|0
7943446|NCT02458287|12484876|FG002|Overall Study|Adverse Event|0
7943447|NCT02458287|12484877|FG003|Overall Study|Adverse Event|1
7943448|NCT02458287|12484874|FG000|Overall Study|Lost to Follow-up|0
7943449|NCT02458287|12484875|FG001|Overall Study|Lost to Follow-up|1
7943450|NCT02458287|12484876|FG002|Overall Study|Lost to Follow-up|1
7943451|NCT02458287|12484877|FG003|Overall Study|Lost to Follow-up|0
7943452|NCT02458287|12484874|FG000|Overall Study|Protocol Violation|0
7943453|NCT02458287|12484875|FG001|Overall Study|Protocol Violation|1
7943454|NCT02458287|12484876|FG002|Overall Study|Protocol Violation|0
7943455|NCT02458287|12484877|FG003|Overall Study|Protocol Violation|0
7943456|NCT02458287|12484874|FG000|Overall Study|Withdrawal by Subject|0
7943457|NCT02458287|12484875|FG001|Overall Study|Withdrawal by Subject|2
7943458|NCT02458287|12484876|FG002|Overall Study|Withdrawal by Subject|2
7943459|NCT02458287|12484877|FG003|Overall Study|Withdrawal by Subject|1
7943460|NCT02458287|12484874|FG000|Overall Study|Relocated Out of State|0
7943461|NCT02458287|12484875|FG001|Overall Study|Relocated Out of State|0
7943462|NCT02458287|12484876|FG002|Overall Study|Relocated Out of State|0
7943463|NCT02458287|12484877|FG003|Overall Study|Relocated Out of State|1
7943464|NCT02458469|12484909|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0
7943465|NCT02458469|12484910|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0
7943466|NCT02458469|12484911|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1
7943467|NCT02458469|12484912|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0
7943468|NCT02458469|12484913|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0
7943469|NCT02458469|12484914|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0
7943470|NCT02458469|12484909|FG000|First Intervention (2 Weeks)|Physician Decision|1
7943471|NCT02458469|12484910|FG001|First Intervention (2 Weeks)|Physician Decision|0
7943472|NCT02458469|12484911|FG002|First Intervention (2 Weeks)|Physician Decision|0
7943473|NCT02458469|12484912|FG003|First Intervention (2 Weeks)|Physician Decision|0
7943474|NCT02458469|12484913|FG004|First Intervention (2 Weeks)|Physician Decision|0
7943475|NCT02458469|12484914|FG005|First Intervention (2 Weeks)|Physician Decision|0
7943476|NCT02458469|12484909|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7943477|NCT02458469|12484910|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7943478|NCT02458469|12484911|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7943479|NCT02458469|12484912|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7943480|NCT02458469|12484913|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7943481|NCT02458469|12484914|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1
7943482|NCT02458638|12484922|FG000|Overall Study|Death|309
7943483|NCT02458638|12484922|FG000|Overall Study|End of Cohort/End of Study|67
7943484|NCT02458638|12484922|FG000|Overall Study|Lost to Follow-up|31
7943485|NCT02458638|12484922|FG000|Overall Study|Other Reasons|4
7943486|NCT02458638|12484922|FG000|Overall Study|Physician Decision|1
7943487|NCT02458638|12484922|FG000|Overall Study|Withdrawal by Subject|47
7943488|NCT02459093|12484946|FG000|Overall Study|Protocol Violation|6
7943489|NCT02459093|12484947|FG001|Overall Study|Protocol Violation|11
7943490|NCT02459093|12484946|FG000|Overall Study|Lost to Follow-up|6
7943491|NCT02459093|12484947|FG001|Overall Study|Lost to Follow-up|7
7943492|NCT02459262|12484977|FG000|Overall Study|Withdrawal by Subject|0
7943493|NCT02459262|12484978|FG001|Overall Study|Withdrawal by Subject|0
7943494|NCT02459262|12484979|FG002|Overall Study|Withdrawal by Subject|0
7943495|NCT02459262|12484980|FG003|Overall Study|Withdrawal by Subject|0
7943496|NCT02459262|12484981|FG004|Overall Study|Withdrawal by Subject|0
7943497|NCT02459262|12484982|FG005|Overall Study|Withdrawal by Subject|0
7943498|NCT02459262|12484983|FG006|Overall Study|Withdrawal by Subject|0
7943499|NCT02459262|12484984|FG007|Overall Study|Withdrawal by Subject|0
7943500|NCT02459262|12484985|FG008|Overall Study|Withdrawal by Subject|0
7943501|NCT02459262|12484986|FG009|Overall Study|Withdrawal by Subject|1
7943502|NCT02459262|12484987|FG010|Overall Study|Withdrawal by Subject|0
7943503|NCT02459418|12485022|FG000|Overall Study|Exclusion Criteria|4
7943504|NCT02459418|12485023|FG001|Overall Study|Exclusion Criteria|0
7943505|NCT02459418|12485022|FG000|Overall Study|Protocol Violation|0
7943506|NCT02459418|12485023|FG001|Overall Study|Protocol Violation|2
7943507|NCT02459418|12485022|FG000|Overall Study|Physician Decision|0
7943508|NCT02459418|12485023|FG001|Overall Study|Physician Decision|2
7943509|NCT02459418|12485022|FG000|Overall Study|Endometrial thickness of >5 mm|1
7943510|NCT02459418|12485023|FG001|Overall Study|Endometrial thickness of >5 mm|0
7943511|NCT02459418|12485022|FG000|Overall Study|Adverse Event|0
7943512|NCT02459418|12485023|FG001|Overall Study|Adverse Event|1
7943513|NCT02459418|12485022|FG000|Overall Study|Withdrawal by Subject|1
7943514|NCT02459418|12485023|FG001|Overall Study|Withdrawal by Subject|1
7943515|NCT02459418|12485022|FG000|Overall Study|Elevated Creatine Kinase|1
7943516|NCT02459418|12485023|FG001|Overall Study|Elevated Creatine Kinase|0
7943517|NCT02459418|12485022|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1
7943518|NCT02459418|12485023|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0
7943519|NCT02459587|12485034|FG000|3-Month Follow-up Assessment|Death|0
7943520|NCT02459587|12485035|FG001|3-Month Follow-up Assessment|Death|2
7943521|NCT02459587|12485034|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3
7943522|NCT02459587|12485035|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3
7943523|NCT02459587|12485034|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27
7943524|NCT02459587|12485035|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22
7943525|NCT02459587|12485034|FG000|3-Month Follow-up Assessment|Researcher withdrew|2
7943526|NCT02459587|12485035|FG001|3-Month Follow-up Assessment|Researcher withdrew|4
7943527|NCT02459587|12485034|FG000|6-month Follow-up Assessment|Death|2
7943528|NCT02459587|12485035|FG001|6-month Follow-up Assessment|Death|1
7943529|NCT02459587|12485034|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1
7943530|NCT02459587|12485035|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2
7943531|NCT02459587|12485034|FG000|6-month Follow-up Assessment|Lost to Follow-up|21
7943532|NCT02459587|12485035|FG001|6-month Follow-up Assessment|Lost to Follow-up|22
7943533|NCT02459587|12485034|FG000|12-month Follow-up Assessment|Death|2
7943534|NCT02459587|12485035|FG001|12-month Follow-up Assessment|Death|0
7943535|NCT02459587|12485034|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2
7943536|NCT02459587|12485035|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4
7943537|NCT02459587|12485034|FG000|12-month Follow-up Assessment|Lost to Follow-up|18
7943538|NCT02459587|12485035|FG001|12-month Follow-up Assessment|Lost to Follow-up|22
7943539|NCT02459587|12485034|FG000|12-month Follow-up Assessment|Researcher withdrew|0
7943540|NCT02459587|12485035|FG001|12-month Follow-up Assessment|Researcher withdrew|1
7943541|NCT02459665|12485046|FG000|Overall Study|Withdrawal by Subject|0
7943542|NCT02459665|12485047|FG001|Overall Study|Withdrawal by Subject|1
7943543|NCT02459665|12485048|FG002|Overall Study|Withdrawal by Subject|1
7943544|NCT02459665|12485049|FG003|Overall Study|Withdrawal by Subject|2
7943545|NCT02459899|12485083|FG000|Overall Study|Adverse Event|1
7943546|NCT02459899|12485084|FG001|Overall Study|Adverse Event|1
7943547|NCT02459899|12485085|FG002|Overall Study|Adverse Event|0
7943548|NCT02459899|12485086|FG003|Overall Study|Adverse Event|0
7943549|NCT02459899|12485083|FG000|Overall Study|Lost to Follow-up|1
7943550|NCT02459899|12485084|FG001|Overall Study|Lost to Follow-up|2
7943551|NCT02459899|12485085|FG002|Overall Study|Lost to Follow-up|0
7943552|NCT02459899|12485086|FG003|Overall Study|Lost to Follow-up|1
7943553|NCT02459899|12485083|FG000|Overall Study|Non-compliance with the treatment|0
7943554|NCT02459899|12485084|FG001|Overall Study|Non-compliance with the treatment|0
7943555|NCT02459899|12485085|FG002|Overall Study|Non-compliance with the treatment|0
7943556|NCT02459899|12485086|FG003|Overall Study|Non-compliance with the treatment|1
7943557|NCT02459899|12485083|FG000|Overall Study|Withdrawal by Subject|1
7943558|NCT02459899|12485084|FG001|Overall Study|Withdrawal by Subject|3
7943559|NCT02459899|12485085|FG002|Overall Study|Withdrawal by Subject|0
7943560|NCT02459899|12485086|FG003|Overall Study|Withdrawal by Subject|0
7943561|NCT02459951|12485096|FG000|Overall Study|Unable to meet holding requirement|1
7943562|NCT02459964|12485104|FG000|Overall Study|Withdrawal by Subject|0
7943563|NCT02459964|12485105|FG001|Overall Study|Withdrawal by Subject|0
7943564|NCT02459964|12485106|FG002|Overall Study|Withdrawal by Subject|1
7943565|NCT02459964|12485104|FG000|Overall Study|Abnormal EKG changes|0
7943566|NCT02459964|12485105|FG001|Overall Study|Abnormal EKG changes|0
7943567|NCT02459964|12485106|FG002|Overall Study|Abnormal EKG changes|1
7943568|NCT02460263|12485119|FG000|Transition Period|Withdrawal by Subject|1
7943569|NCT02460263|12485119|FG000|Transition Period|Death|1
7943570|NCT02460380|12485129|FG000|Overall Study|Withdrawal by Subject|10
7943571|NCT02460380|12485130|FG001|Overall Study|Withdrawal by Subject|5
7943572|NCT02460562|12485139|FG000|Overall Study|Lost to Follow-up|15
7943573|NCT02460562|12485140|FG001|Overall Study|Lost to Follow-up|16
7943574|NCT02460575|12485148|FG000|Overall Study|Lost to Follow-up|1
7943575|NCT02460575|12485149|FG001|Overall Study|Lost to Follow-up|0
7943576|NCT02460679|12485164|FG000|Overall Study|Investigator Decision|1
7943577|NCT02460679|12485164|FG000|Overall Study|Withdrawal by Subject|4
7943578|NCT02460822|12485168|FG000|Overall Study|Withdrawal by Subject|1
7943579|NCT02460978|12485175|FG000|Overall Study|Adverse Event|17
7943580|NCT02460978|12485176|FG001|Overall Study|Adverse Event|11
7943581|NCT02460978|12485177|FG002|Overall Study|Adverse Event|11
7943582|NCT02460978|12485175|FG000|Overall Study|Withdrawal by Subject|5
7943583|NCT02460978|12485176|FG001|Overall Study|Withdrawal by Subject|5
7943584|NCT02460978|12485177|FG002|Overall Study|Withdrawal by Subject|14
7943585|NCT02460978|12485175|FG000|Overall Study|Lost to Follow-up|2
7943586|NCT02460978|12485176|FG001|Overall Study|Lost to Follow-up|3
7943587|NCT02460978|12485177|FG002|Overall Study|Lost to Follow-up|1
7943588|NCT02460978|12485175|FG000|Overall Study|Protocol Violation|1
7943589|NCT02460978|12485176|FG001|Overall Study|Protocol Violation|1
7943590|NCT02460978|12485177|FG002|Overall Study|Protocol Violation|1
7943591|NCT02460978|12485175|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2
7943592|NCT02460978|12485176|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5
7943593|NCT02460978|12485177|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4
7943594|NCT02460978|12485175|FG000|Overall Study|Pregnancy|0
7943595|NCT02460978|12485176|FG001|Overall Study|Pregnancy|0
7943596|NCT02460978|12485177|FG002|Overall Study|Pregnancy|2
7943597|NCT02460991|12485187|FG000|Overall Study|Withdrawal by Subject|0
7943598|NCT02460991|12485188|FG001|Overall Study|Withdrawal by Subject|2
7943599|NCT02461134|12485199|FG000|Overall Study|Adverse Event|1
7943600|NCT02461160|12485216|FG000|Overall Study|Lost to Follow-up|0
7943601|NCT02461160|12485217|FG001|Overall Study|Lost to Follow-up|0
7943602|NCT02461160|12485218|FG002|Overall Study|Lost to Follow-up|0
7943603|NCT02461160|12485219|FG003|Overall Study|Lost to Follow-up|0
7943604|NCT02461160|12485220|FG004|Overall Study|Lost to Follow-up|0
7943605|NCT02461160|12485221|FG005|Overall Study|Lost to Follow-up|0
7943606|NCT02461160|12485222|FG006|Overall Study|Lost to Follow-up|0
7943607|NCT02461160|12485223|FG007|Overall Study|Lost to Follow-up|1
7943608|NCT02461160|12485224|FG008|Overall Study|Lost to Follow-up|0
7943609|NCT02461160|12485225|FG009|Overall Study|Lost to Follow-up|0
7943610|NCT02461160|12485226|FG010|Overall Study|Lost to Follow-up|0
7943611|NCT02461160|12485227|FG011|Overall Study|Lost to Follow-up|0
7943612|NCT02461160|12485228|FG012|Overall Study|Lost to Follow-up|0
7943613|NCT02461290|12485277|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7
7943614|NCT02461290|12485277|FG000|Overall Study|Lost to Follow-up|3
7943615|NCT02461589|12485323|FG000|Overall Study|Withdrawal by Subject|5
7943616|NCT02461589|12485324|FG001|Overall Study|Withdrawal by Subject|1
7943617|NCT02461589|12485325|FG002|Overall Study|Withdrawal by Subject|3
7943618|NCT02461589|12485326|FG003|Overall Study|Withdrawal by Subject|2
7943619|NCT02461589|12485327|FG004|Overall Study|Withdrawal by Subject|1
7943620|NCT02461589|12485328|FG005|Overall Study|Withdrawal by Subject|2
7943621|NCT02461589|12485329|FG006|Overall Study|Withdrawal by Subject|1
7943622|NCT02461589|12485330|FG007|Overall Study|Withdrawal by Subject|3
7943623|NCT02461589|12485331|FG008|Overall Study|Withdrawal by Subject|3
7943624|NCT02461589|12485332|FG009|Overall Study|Withdrawal by Subject|1
7943625|NCT02461589|12485323|FG000|Overall Study|Lost to Follow-up|0
7943626|NCT02461589|12485324|FG001|Overall Study|Lost to Follow-up|0
7943627|NCT02461589|12485325|FG002|Overall Study|Lost to Follow-up|2
7943628|NCT02461589|12485326|FG003|Overall Study|Lost to Follow-up|3
7943629|NCT02461589|12485327|FG004|Overall Study|Lost to Follow-up|1
7943630|NCT02461589|12485328|FG005|Overall Study|Lost to Follow-up|1
7943631|NCT02461589|12485329|FG006|Overall Study|Lost to Follow-up|3
7943632|NCT02461589|12485330|FG007|Overall Study|Lost to Follow-up|1
7943633|NCT02461589|12485331|FG008|Overall Study|Lost to Follow-up|3
7943634|NCT02461589|12485332|FG009|Overall Study|Lost to Follow-up|1
7943635|NCT02461589|12485323|FG000|Overall Study|Death|0
7943636|NCT02461589|12485324|FG001|Overall Study|Death|0
7943637|NCT02461589|12485325|FG002|Overall Study|Death|0
7943638|NCT02461589|12485326|FG003|Overall Study|Death|0
7943639|NCT02461589|12485327|FG004|Overall Study|Death|0
7943640|NCT02461589|12485328|FG005|Overall Study|Death|0
7943641|NCT02461589|12485329|FG006|Overall Study|Death|0
7943642|NCT02461589|12485330|FG007|Overall Study|Death|1
7943643|NCT02461589|12485331|FG008|Overall Study|Death|0
7943644|NCT02461589|12485332|FG009|Overall Study|Death|0
7943645|NCT02461589|12485323|FG000|Overall Study|Unclassified|0
7943646|NCT02461589|12485324|FG001|Overall Study|Unclassified|0
7943647|NCT02461589|12485325|FG002|Overall Study|Unclassified|0
7943648|NCT02461589|12485326|FG003|Overall Study|Unclassified|0
7943649|NCT02461589|12485327|FG004|Overall Study|Unclassified|0
7943650|NCT02461589|12485328|FG005|Overall Study|Unclassified|0
7943651|NCT02461589|12485329|FG006|Overall Study|Unclassified|1
7943652|NCT02461589|12485330|FG007|Overall Study|Unclassified|0
7943653|NCT02461589|12485331|FG008|Overall Study|Unclassified|0
7943654|NCT02461589|12485332|FG009|Overall Study|Unclassified|2
7943655|NCT02461589|12485323|FG000|Overall Study|Missing follow-up information|1
7943656|NCT02461589|12485324|FG001|Overall Study|Missing follow-up information|1
7943657|NCT02461589|12485325|FG002|Overall Study|Missing follow-up information|0
7943658|NCT02461589|12485326|FG003|Overall Study|Missing follow-up information|0
7943659|NCT02461589|12485327|FG004|Overall Study|Missing follow-up information|0
7943660|NCT02461589|12485328|FG005|Overall Study|Missing follow-up information|0
7943661|NCT02461589|12485329|FG006|Overall Study|Missing follow-up information|1
7943662|NCT02461589|12485330|FG007|Overall Study|Missing follow-up information|0
7943663|NCT02461589|12485331|FG008|Overall Study|Missing follow-up information|0
7943664|NCT02461589|12485332|FG009|Overall Study|Missing follow-up information|0
7943665|NCT02461589|12485323|FG000|Overall Study|Withdrawal from trial before exposure|0
7943666|NCT02461589|12485324|FG001|Overall Study|Withdrawal from trial before exposure|0
7943667|NCT02461589|12485325|FG002|Overall Study|Withdrawal from trial before exposure|0
7943668|NCT02461589|12485326|FG003|Overall Study|Withdrawal from trial before exposure|0
7943669|NCT02461589|12485327|FG004|Overall Study|Withdrawal from trial before exposure|0
7943670|NCT02461589|12485328|FG005|Overall Study|Withdrawal from trial before exposure|0
7943671|NCT02461589|12485329|FG006|Overall Study|Withdrawal from trial before exposure|0
7943672|NCT02461589|12485330|FG007|Overall Study|Withdrawal from trial before exposure|0
7943673|NCT02461589|12485331|FG008|Overall Study|Withdrawal from trial before exposure|0
7943674|NCT02461589|12485332|FG009|Overall Study|Withdrawal from trial before exposure|1
7965499|NCT01190930|12520930|FG004|Post Induction Pre-Maintenance|Adverse Event|0
7965500|NCT01190930|12520931|FG005|Post Induction Pre-Maintenance|Adverse Event|0
7965501|NCT01190930|12520932|FG006|Post Induction Pre-Maintenance|Adverse Event|0
7965502|NCT01190930|12520933|FG007|Post Induction Pre-Maintenance|Adverse Event|0
7965503|NCT01190930|12520934|FG008|Post Induction Pre-Maintenance|Adverse Event|0
7965504|NCT01190930|12520935|FG009|Post Induction Pre-Maintenance|Adverse Event|0
7965505|NCT01190930|12520926|FG000|Post Induction Pre-Maintenance|Death|0
7965506|NCT01190930|12520927|FG001|Post Induction Pre-Maintenance|Death|0
7965507|NCT01190930|12520928|FG002|Post Induction Pre-Maintenance|Death|8
7965508|NCT01190930|12520929|FG003|Post Induction Pre-Maintenance|Death|4
7965509|NCT01190930|12520930|FG004|Post Induction Pre-Maintenance|Death|0
7965510|NCT01190930|12520931|FG005|Post Induction Pre-Maintenance|Death|0
7965511|NCT01190930|12520932|FG006|Post Induction Pre-Maintenance|Death|0
7965512|NCT01190930|12520933|FG007|Post Induction Pre-Maintenance|Death|0
7965513|NCT01190930|12520934|FG008|Post Induction Pre-Maintenance|Death|0
7965514|NCT01190930|12520935|FG009|Post Induction Pre-Maintenance|Death|0
7965515|NCT01190930|12520926|FG000|Post Induction Pre-Maintenance|Physician Decision|0
7965516|NCT01190930|12520927|FG001|Post Induction Pre-Maintenance|Physician Decision|2
7965517|NCT01190930|12520928|FG002|Post Induction Pre-Maintenance|Physician Decision|35
7965518|NCT01190930|12520929|FG003|Post Induction Pre-Maintenance|Physician Decision|7
7965519|NCT01190930|12520930|FG004|Post Induction Pre-Maintenance|Physician Decision|5
7965520|NCT01190930|12520931|FG005|Post Induction Pre-Maintenance|Physician Decision|3
7965521|NCT01190930|12520932|FG006|Post Induction Pre-Maintenance|Physician Decision|0
7965522|NCT01190930|12520933|FG007|Post Induction Pre-Maintenance|Physician Decision|0
7965523|NCT01190930|12520934|FG008|Post Induction Pre-Maintenance|Physician Decision|0
7965524|NCT01190930|12520935|FG009|Post Induction Pre-Maintenance|Physician Decision|0
7965525|NCT01190930|12520926|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7965526|NCT01190930|12520927|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1
7965527|NCT01190930|12520928|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5
7965528|NCT01190930|12520929|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2
7965529|NCT01190930|12520930|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7965530|NCT01190930|12520931|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7965531|NCT01190930|12520932|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7965532|NCT01190930|12520933|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7965533|NCT01190930|12520934|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7965534|NCT01190930|12520935|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7943675|NCT02461628|12485356|FG000|Overall Study|Refused to complete survey|4
7943676|NCT02461628|12485357|FG001|Overall Study|Refused to complete survey|7
7943677|NCT02461745|12485374|FG000|Overall Study|Lack of Efficacy|9
7943678|NCT02461745|12485375|FG001|Overall Study|Lack of Efficacy|1
7943679|NCT02461745|12485374|FG000|Overall Study|Lost to Follow-up|2
7943680|NCT02461745|12485375|FG001|Overall Study|Lost to Follow-up|2
7943681|NCT02461745|12485374|FG000|Overall Study|Withdrawal by Subject|3
7943682|NCT02461745|12485375|FG001|Overall Study|Withdrawal by Subject|1
7943683|NCT02461758|12485387|FG000|Overall Study|Lost to Follow-up|0
7943684|NCT02461758|12485388|FG001|Overall Study|Lost to Follow-up|1
7943685|NCT02461758|12485389|FG002|Overall Study|Lost to Follow-up|1
7943686|NCT02461758|12485390|FG003|Overall Study|Lost to Follow-up|0
7943687|NCT02462057|12485438|FG000|Overall Study|Left Vitality|32
7943688|NCT02462057|12485439|FG001|Overall Study|Left Vitality|27
7943689|NCT02462057|12485440|FG002|Overall Study|Left Vitality|23
7943690|NCT02462057|12485441|FG003|Overall Study|Left Vitality|35
7943691|NCT02462057|12485442|FG004|Overall Study|Left Vitality|33
7943692|NCT02462057|12485438|FG000|Overall Study|Joined HealthyFood Before Intervention|22
7943693|NCT02462057|12485439|FG001|Overall Study|Joined HealthyFood Before Intervention|13
7943694|NCT02462057|12485440|FG002|Overall Study|Joined HealthyFood Before Intervention|23
7943695|NCT02462057|12485441|FG003|Overall Study|Joined HealthyFood Before Intervention|16
7943696|NCT02462057|12485442|FG004|Overall Study|Joined HealthyFood Before Intervention|17
7943697|NCT02462083|12485463|FG000|Overall Study|Sponsor request|39
7943698|NCT02462083|12485463|FG000|Overall Study|Withdrawal by Subject|87
7943699|NCT02462083|12485463|FG000|Overall Study|Lost to Follow-up|41
7943700|NCT02462083|12485463|FG000|Overall Study|Lack of Efficacy|151
7943701|NCT02462083|12485463|FG000|Overall Study|Pregnancy|1
7943702|NCT02462083|12485463|FG000|Overall Study|Protocol Violation|6
7943703|NCT02462083|12485463|FG000|Overall Study|Adverse Event|33
7943704|NCT02462083|12485463|FG000|Overall Study|Worsening condition|16
7943705|NCT02462083|12485463|FG000|Overall Study|Other than specified|45
7943706|NCT02462473|12485512|FG000|Overall Study|Death|1
7943707|NCT02462473|12485512|FG000|Overall Study|Other|3
7943708|NCT02462486|12485519|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7943709|NCT02462486|12485520|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7943710|NCT02462486|12485521|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3
7943711|NCT02462486|12485519|FG000|Overall Study|Adverse Event|53
7943712|NCT02462486|12485520|FG001|Overall Study|Adverse Event|48
7943713|NCT02462486|12485521|FG002|Overall Study|Adverse Event|21
7943714|NCT02462486|12485519|FG000|Overall Study|Lack of Efficacy|6
7943715|NCT02462486|12485520|FG001|Overall Study|Lack of Efficacy|12
7943716|NCT02462486|12485521|FG002|Overall Study|Lack of Efficacy|3
7943717|NCT02462486|12485519|FG000|Overall Study|Lost to Follow-up|3
7943718|NCT02462486|12485520|FG001|Overall Study|Lost to Follow-up|4
7943719|NCT02462486|12485521|FG002|Overall Study|Lost to Follow-up|2
7943720|NCT02462486|12485519|FG000|Overall Study|Withdrawal by Subject|25
7943721|NCT02462486|12485520|FG001|Overall Study|Withdrawal by Subject|22
7943722|NCT02462486|12485521|FG002|Overall Study|Withdrawal by Subject|19
7943723|NCT02462486|12485519|FG000|Overall Study|Protocol Violation|3
7943724|NCT02462486|12485520|FG001|Overall Study|Protocol Violation|1
7943725|NCT02462486|12485521|FG002|Overall Study|Protocol Violation|1
7943726|NCT02462486|12485519|FG000|Overall Study|Reason not Specified|3
7943727|NCT02462486|12485520|FG001|Overall Study|Reason not Specified|4
7943728|NCT02462486|12485521|FG002|Overall Study|Reason not Specified|3
7943729|NCT02462720|12485529|FG000|Part 2|Withdrawal by Subject|1
7943730|NCT02462720|12485530|FG001|Part 2|Withdrawal by Subject|0
7943731|NCT02462720|12485529|FG000|Part 2|Protocol Violation|0
7943732|NCT02462720|12485530|FG001|Part 2|Protocol Violation|1
7943733|NCT02462759|12485540|FG000|Part 1: Double Blind|Death|1
7943734|NCT02462759|12485541|FG001|Part 1: Double Blind|Death|0
7943735|NCT02462759|12485542|FG002|Part 1: Double Blind|Death|0
7943736|NCT02462928|12485556|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7943737|NCT02462928|12485557|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7943738|NCT02462928|12485558|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2
7943739|NCT02462928|12485556|FG000|Overall Study|Adverse Event|47
7943740|NCT02462928|12485557|FG001|Overall Study|Adverse Event|51
7943741|NCT02462928|12485558|FG002|Overall Study|Adverse Event|25
7943742|NCT02462928|12485556|FG000|Overall Study|Lack of Efficacy|3
7943743|NCT02462928|12485557|FG001|Overall Study|Lack of Efficacy|8
7943744|NCT02462928|12485558|FG002|Overall Study|Lack of Efficacy|3
7943745|NCT02462928|12485556|FG000|Overall Study|Lost to Follow-up|4
7943746|NCT02462928|12485557|FG001|Overall Study|Lost to Follow-up|4
7943747|NCT02462928|12485558|FG002|Overall Study|Lost to Follow-up|1
7943748|NCT02462928|12485556|FG000|Overall Study|Withdrawal by Patient|31
7943749|NCT02462928|12485557|FG001|Overall Study|Withdrawal by Patient|21
7943750|NCT02462928|12485558|FG002|Overall Study|Withdrawal by Patient|21
7943751|NCT02462928|12485556|FG000|Overall Study|Protocol Violation|0
7943752|NCT02462928|12485557|FG001|Overall Study|Protocol Violation|1
7943753|NCT02462928|12485558|FG002|Overall Study|Protocol Violation|0
7943754|NCT02462928|12485556|FG000|Overall Study|Reason not Specified|4
7943755|NCT02462928|12485557|FG001|Overall Study|Reason not Specified|6
7943756|NCT02462928|12485558|FG002|Overall Study|Reason not Specified|5
7943757|NCT02463032|12485581|FG000|Overall Study|Lack of Efficacy|61
7943758|NCT02463032|12485582|FG001|Overall Study|Lack of Efficacy|50
7943759|NCT02463032|12485581|FG000|Overall Study|Death|8
7943760|NCT02463032|12485582|FG001|Overall Study|Death|8
7943761|NCT02463032|12485581|FG000|Overall Study|Adverse Event|2
7943762|NCT02463032|12485582|FG001|Overall Study|Adverse Event|6
7943763|NCT02463071|12485591|FG000|Overall Study|Adverse Event|3
7943764|NCT02463071|12485592|FG001|Overall Study|Adverse Event|5
7943765|NCT02463071|12485593|FG002|Overall Study|Adverse Event|1
7943766|NCT02463071|12485591|FG000|Overall Study|Death|1
7943767|NCT02463071|12485592|FG001|Overall Study|Death|0
7943768|NCT02463071|12485593|FG002|Overall Study|Death|0
7943769|NCT02463071|12485591|FG000|Overall Study|Eligibility criteria not fulfilled|1
7943770|NCT02463071|12485592|FG001|Overall Study|Eligibility criteria not fulfilled|0
7943771|NCT02463071|12485593|FG002|Overall Study|Eligibility criteria not fulfilled|0
7943772|NCT02463071|12485591|FG000|Overall Study|Reason not specified|7
7943773|NCT02463071|12485592|FG001|Overall Study|Reason not specified|9
7943774|NCT02463071|12485593|FG002|Overall Study|Reason not specified|4
7943775|NCT02463071|12485591|FG000|Overall Study|Protocol Violation|0
7943776|NCT02463071|12485592|FG001|Overall Study|Protocol Violation|2
7943777|NCT02463071|12485593|FG002|Overall Study|Protocol Violation|0
7943778|NCT02463071|12485591|FG000|Overall Study|Lost to Follow-up|0
7943779|NCT02463071|12485592|FG001|Overall Study|Lost to Follow-up|0
7943780|NCT02463071|12485593|FG002|Overall Study|Lost to Follow-up|1
7943781|NCT02463097|12485601|FG000|Overall Study|Withdrawal by Subject|1
7943782|NCT02463331|12485611|FG000|Overall Study|Adverse Event|4
7943783|NCT02463331|12485612|FG001|Overall Study|Adverse Event|2
7943784|NCT02463331|12485611|FG000|Overall Study|Lost to Follow-up|1
7943785|NCT02463331|12485612|FG001|Overall Study|Lost to Follow-up|1
7943786|NCT02463331|12485611|FG000|Overall Study|Pregnancy|2
7943787|NCT02463331|12485612|FG001|Overall Study|Pregnancy|3
7943788|NCT02463331|12485611|FG000|Overall Study|Lack of Efficacy|6
7943789|NCT02463331|12485612|FG001|Overall Study|Lack of Efficacy|0
7943790|NCT02463331|12485611|FG000|Overall Study|Physician Decision|3
7943791|NCT02463331|12485612|FG001|Overall Study|Physician Decision|0
7943792|NCT02463357|12485623|FG000|Overall Study|Withdrawal by Subject|1
7943793|NCT02463357|12485624|FG001|Overall Study|Withdrawal by Subject|0
7943794|NCT02463357|12485625|FG002|Overall Study|Withdrawal by Subject|0
7943795|NCT02463357|12485626|FG003|Overall Study|Withdrawal by Subject|0
7943796|NCT02463357|12485627|FG004|Overall Study|Withdrawal by Subject|0
7943797|NCT02463357|12485623|FG000|Overall Study|Withdrawal by Subject|0
7943798|NCT02463357|12485624|FG001|Overall Study|Withdrawal by Subject|0
7943799|NCT02463357|12485625|FG002|Overall Study|Withdrawal by Subject|0
7943800|NCT02463357|12485626|FG003|Overall Study|Withdrawal by Subject|0
7943801|NCT02463357|12485627|FG004|Overall Study|Withdrawal by Subject|1
7943802|NCT02463409|12485639|FG000|Overall Study|Withdrawal by Subject|1
7943803|NCT02463409|12485639|FG000|Overall Study|Screen failure|1
7943804|NCT02464059|12485666|FG000|Overall Study|Lost to Follow-up|6
7943805|NCT02465034|12485741|FG000|Overall Study|Withdrawal by Subject|1
7943806|NCT02465034|12485742|FG001|Overall Study|Withdrawal by Subject|1
7943807|NCT02465034|12485741|FG000|Overall Study|Screen fail|2
7943808|NCT02465034|12485742|FG001|Overall Study|Screen fail|0
7943809|NCT02465034|12485741|FG000|Overall Study|Could not be scheduled for study visit|0
7943810|NCT02465034|12485742|FG001|Overall Study|Could not be scheduled for study visit|5
7943811|NCT02465203|12485781|FG000|Overall Study|Protocol Violation|1
7943812|NCT02465203|12485782|FG001|Overall Study|Protocol Violation|1
7943813|NCT02465203|12485783|FG002|Overall Study|Protocol Violation|1
7943814|NCT02465203|12485781|FG000|Overall Study|Study terminated by sponsor|50
7943815|NCT02465203|12485782|FG001|Overall Study|Study terminated by sponsor|34
7943816|NCT02465203|12485783|FG002|Overall Study|Study terminated by sponsor|11
7943817|NCT02465203|12485781|FG000|Overall Study|New therapy for study indication|4
7943818|NCT02465203|12485782|FG001|Overall Study|New therapy for study indication|0
7943819|NCT02465203|12485783|FG002|Overall Study|New therapy for study indication|0
7943820|NCT02465203|12485781|FG000|Overall Study|Patient/guardian decision|1
7943821|NCT02465203|12485782|FG001|Overall Study|Patient/guardian decision|1
7943822|NCT02465203|12485783|FG002|Overall Study|Patient/guardian decision|1
7943823|NCT02465437|12485824|FG000|Overall Study|Physician Decision|0
7943824|NCT02465437|12485825|FG001|Overall Study|Physician Decision|0
7943825|NCT02465437|12485826|FG002|Overall Study|Physician Decision|1
7943826|NCT02465437|12485827|FG003|Overall Study|Physician Decision|0
7943827|NCT02465437|12485824|FG000|Overall Study|Withdrawal by Subject|1
7943828|NCT02465437|12485825|FG001|Overall Study|Withdrawal by Subject|0
7943829|NCT02465437|12485826|FG002|Overall Study|Withdrawal by Subject|0
7943830|NCT02465437|12485827|FG003|Overall Study|Withdrawal by Subject|1
7943831|NCT02465437|12485824|FG000|Overall Study|Adverse Event|0
7943832|NCT02465437|12485825|FG001|Overall Study|Adverse Event|1
7943833|NCT02465437|12485826|FG002|Overall Study|Adverse Event|0
7943834|NCT02465437|12485827|FG003|Overall Study|Adverse Event|0
7943835|NCT02465463|12485863|FG000|Overall Study|Lost to Follow-up|2
7943836|NCT02465463|12485864|FG001|Overall Study|Lost to Follow-up|1
7943837|NCT02465463|12485863|FG000|Overall Study|Death|1
7943838|NCT02465463|12485864|FG001|Overall Study|Death|0
7943839|NCT02465463|12485863|FG000|Overall Study|Protocol Violation|1
7943840|NCT02465463|12485864|FG001|Overall Study|Protocol Violation|0
7943841|NCT02465489|12485871|FG000|Overall Study|Adverse Event|5
7943842|NCT02465515|12485885|FG000|Overall Study|Investigator site closed|4
7943843|NCT02465515|12485886|FG001|Overall Study|Investigator site closed|5
7943844|NCT02465515|12485885|FG000|Overall Study|Withdrawal by Subject|74
7943845|NCT02465515|12485886|FG001|Overall Study|Withdrawal by Subject|43
7943846|NCT02465515|12485885|FG000|Overall Study|Physician Decision|8
7943847|NCT02465515|12485886|FG001|Overall Study|Physician Decision|12
7943848|NCT02465515|12485885|FG000|Overall Study|Lost to Follow-up|68
7943849|NCT02465515|12485886|FG001|Overall Study|Lost to Follow-up|51
7943850|NCT02465528|12485896|FG000|Overall Study|Progressive disease|0
7943851|NCT02465528|12485897|FG001|Overall Study|Progressive disease|2
7943852|NCT02465528|12485898|FG002|Overall Study|Progressive disease|9
7943853|NCT02465528|12485899|FG003|Overall Study|Progressive disease|4
7943854|NCT02465528|12485896|FG000|Overall Study|Study terminated by sponsor|1
7943855|NCT02465528|12485897|FG001|Overall Study|Study terminated by sponsor|2
7943856|NCT02465528|12485898|FG002|Overall Study|Study terminated by sponsor|0
7943857|NCT02465528|12485899|FG003|Overall Study|Study terminated by sponsor|0
7943858|NCT02465528|12485896|FG000|Overall Study|Withdrawal by Subject|0
7943859|NCT02465528|12485897|FG001|Overall Study|Withdrawal by Subject|0
7943860|NCT02465528|12485898|FG002|Overall Study|Withdrawal by Subject|2
7943861|NCT02465528|12485899|FG003|Overall Study|Withdrawal by Subject|0
7943862|NCT02465528|12485896|FG000|Overall Study|Adverse Event|0
7943863|NCT02465528|12485897|FG001|Overall Study|Adverse Event|0
7943864|NCT02465528|12485898|FG002|Overall Study|Adverse Event|0
7943865|NCT02465528|12485899|FG003|Overall Study|Adverse Event|1
7943866|NCT02465528|12485896|FG000|Overall Study|Physician Decision|0
7943867|NCT02465528|12485897|FG001|Overall Study|Physician Decision|0
7943868|NCT02465528|12485898|FG002|Overall Study|Physician Decision|1
7943869|NCT02465528|12485899|FG003|Overall Study|Physician Decision|0
7943870|NCT02465567|12485915|FG000|Overall Study|Adverse Event|118
7943871|NCT02465567|12485916|FG001|Overall Study|Adverse Event|113
7943872|NCT02465567|12485917|FG002|Overall Study|Adverse Event|147
7943873|NCT02465567|12485918|FG003|Overall Study|Adverse Event|138
7943874|NCT02465567|12485915|FG000|Overall Study|Lack of Efficacy|103
7943875|NCT02465567|12485916|FG001|Overall Study|Lack of Efficacy|102
7943876|NCT02465567|12485917|FG002|Overall Study|Lack of Efficacy|171
7943877|NCT02465567|12485918|FG003|Overall Study|Lack of Efficacy|135
7943878|NCT02465567|12485915|FG000|Overall Study|Withdrawal by Subject|104
7943879|NCT02465567|12485916|FG001|Overall Study|Withdrawal by Subject|94
7943880|NCT02465567|12485917|FG002|Overall Study|Withdrawal by Subject|123
7943881|NCT02465567|12485918|FG003|Overall Study|Withdrawal by Subject|130
7943882|NCT02465567|12485915|FG000|Overall Study|Physician Decision|23
7943883|NCT02465567|12485916|FG001|Overall Study|Physician Decision|33
7943884|NCT02465567|12485917|FG002|Overall Study|Physician Decision|38
7943885|NCT02465567|12485918|FG003|Overall Study|Physician Decision|28
7943886|NCT02465567|12485915|FG000|Overall Study|Major Protocol Deviation|24
7943887|NCT02465567|12485916|FG001|Overall Study|Major Protocol Deviation|26
7943888|NCT02465567|12485917|FG002|Overall Study|Major Protocol Deviation|22
7943889|NCT02465567|12485918|FG003|Overall Study|Major Protocol Deviation|25
7943890|NCT02465567|12485915|FG000|Overall Study|Lost to Follow-up|25
7943891|NCT02465567|12485916|FG001|Overall Study|Lost to Follow-up|21
7943892|NCT02465567|12485917|FG002|Overall Study|Lost to Follow-up|19
7943893|NCT02465567|12485918|FG003|Overall Study|Lost to Follow-up|15
7943894|NCT02465567|12485915|FG000|Overall Study|Protocol Specified Criteria|20
7943895|NCT02465567|12485916|FG001|Overall Study|Protocol Specified Criteria|10
7943896|NCT02465567|12485917|FG002|Overall Study|Protocol Specified Criteria|9
7943897|NCT02465567|12485918|FG003|Overall Study|Protocol Specified Criteria|12
7943898|NCT02465567|12485915|FG000|Overall Study|Administrative Reasons|12
7943899|NCT02465567|12485916|FG001|Overall Study|Administrative Reasons|9
7943900|NCT02465567|12485917|FG002|Overall Study|Administrative Reasons|11
7943901|NCT02465567|12485918|FG003|Overall Study|Administrative Reasons|5
7943902|NCT02465567|12485915|FG000|Overall Study|Randomized but not treated|1
7943903|NCT02465567|12485916|FG001|Overall Study|Randomized but not treated|5
7943904|NCT02465567|12485917|FG002|Overall Study|Randomized but not treated|4
7943905|NCT02465567|12485918|FG003|Overall Study|Randomized but not treated|5
7943906|NCT02465567|12485915|FG000|Overall Study|enrolled in >1 studies|18
7943907|NCT02465567|12485916|FG001|Overall Study|enrolled in >1 studies|11
7943908|NCT02465567|12485917|FG002|Overall Study|enrolled in >1 studies|19
7943909|NCT02465567|12485918|FG003|Overall Study|enrolled in >1 studies|15
7943910|NCT02465567|12485915|FG000|Overall Study|missing PI Signature|1
7943911|NCT02465567|12485916|FG001|Overall Study|missing PI Signature|0
7943912|NCT02465567|12485917|FG002|Overall Study|missing PI Signature|0
7943913|NCT02465567|12485918|FG003|Overall Study|missing PI Signature|0
7943914|NCT02465866|12485942|FG000|Period 3|Withdrawal by Subject|0
7943915|NCT02465866|12485943|FG001|Period 3|Withdrawal by Subject|1
7943916|NCT02465866|12485944|FG002|Period 3|Withdrawal by Subject|0
7943917|NCT02465866|12485945|FG003|Period 3|Withdrawal by Subject|0
7943918|NCT02465931|12485957|FG000|Overall Study|Lost to Follow-up|9
7943919|NCT02465931|12485958|FG001|Overall Study|Lost to Follow-up|11
7943920|NCT02465931|12485957|FG000|Overall Study|Protocol Violation|1
7943921|NCT02465931|12485958|FG001|Overall Study|Protocol Violation|0
7943922|NCT02465931|12485957|FG000|Overall Study|Withdrawal by Subject|1
7943923|NCT02465931|12485958|FG001|Overall Study|Withdrawal by Subject|0
7943924|NCT02466386|12485985|FG000|Overall Study|Adverse Event|5
7943925|NCT02466386|12485985|FG000|Overall Study|Protocol Violation|2
7943926|NCT02466386|12485985|FG000|Overall Study|Withdrawal by Subject|14
7943927|NCT02466386|12485985|FG000|Overall Study|Lost to Follow-up|5
7943928|NCT02466386|12485985|FG000|Overall Study|Lack of Efficacy|8
7943929|NCT02466386|12485985|FG000|Overall Study|Other|10
7943930|NCT02466399|12485991|FG000|Overall Study|Adverse Event|1
7943931|NCT02466399|12485992|FG001|Overall Study|Adverse Event|0
7943932|NCT02466399|12485991|FG000|Overall Study|Early exit due to family emergency|1
7943933|NCT02466399|12485992|FG001|Overall Study|Early exit due to family emergency|0
7943934|NCT02466425|12486010|FG000|Overall Study|Adverse Event|3
7943935|NCT02466425|12486011|FG001|Overall Study|Adverse Event|11
7943936|NCT02466425|12486010|FG000|Overall Study|Lack of Efficacy|4
7943937|NCT02466425|12486011|FG001|Overall Study|Lack of Efficacy|1
7943938|NCT02466425|12486010|FG000|Overall Study|Lost to Follow-up|3
7943939|NCT02466425|12486011|FG001|Overall Study|Lost to Follow-up|0
7943940|NCT02466425|12486010|FG000|Overall Study|Protocol Violation|1
7943941|NCT02466425|12486011|FG001|Overall Study|Protocol Violation|0
7943942|NCT02466425|12486010|FG000|Overall Study|Withdrawal by Subject|0
7943943|NCT02466425|12486011|FG001|Overall Study|Withdrawal by Subject|1
7943944|NCT02466425|12486010|FG000|Overall Study|Other|1
7943945|NCT02466425|12486011|FG001|Overall Study|Other|3
7943946|NCT02466425|12486010|FG000|Overall Study|Withdrawal by Parent/Guardian|2
7943947|NCT02466425|12486011|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7943948|NCT02466516|12486022|FG000|Overall Study|Adverse Event|1
7943949|NCT02466516|12486023|FG001|Overall Study|Adverse Event|1
7943950|NCT02466516|12486024|FG002|Overall Study|Adverse Event|0
7943951|NCT02466516|12486025|FG003|Overall Study|Adverse Event|0
7943952|NCT02466516|12486026|FG004|Overall Study|Adverse Event|0
7943953|NCT02466516|12486022|FG000|Overall Study|Withdrew Consent|1
7943954|NCT02466516|12486023|FG001|Overall Study|Withdrew Consent|0
7943955|NCT02466516|12486024|FG002|Overall Study|Withdrew Consent|0
7943956|NCT02466516|12486025|FG003|Overall Study|Withdrew Consent|0
7943957|NCT02466516|12486026|FG004|Overall Study|Withdrew Consent|0
7943958|NCT02466516|12486022|FG000|Overall Study|Lost to Follow-up|2
7943959|NCT02466516|12486023|FG001|Overall Study|Lost to Follow-up|0
7943960|NCT02466516|12486024|FG002|Overall Study|Lost to Follow-up|1
7943961|NCT02466516|12486025|FG003|Overall Study|Lost to Follow-up|0
7943962|NCT02466516|12486026|FG004|Overall Study|Lost to Follow-up|0
7943963|NCT02466555|12486038|FG000|Overall Study|Lost to Follow-up|2
7943964|NCT02466659|12486061|FG000|Overall Study|Lost to Follow-up|5
7943965|NCT02466659|12486062|FG001|Overall Study|Lost to Follow-up|2
7943966|NCT02467192|12486101|FG000|Overall Study|Death|1
7943967|NCT02467192|12486101|FG000|Overall Study|revealed to have pneumonia before|2
7943968|NCT02468193|12486184|FG000|Overall Study|Adverse Event|4
7943969|NCT02468193|12486184|FG000|Overall Study|Subject/ Guardian decision|2
7943970|NCT02468557|12486204|FG000|Overall Study|Adverse Event|1
7943971|NCT02468557|12486204|FG000|Overall Study|Death|1
7943972|NCT02468557|12486204|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10
7943973|NCT02468557|12486204|FG000|Overall Study|All Enrolled but Never Dosed|4
7943974|NCT02468648|12486221|FG000|Overall Study|Death|1
7943975|NCT02468674|12486234|FG000|Overall Study|Adverse Event|0
7943976|NCT02468674|12486235|FG001|Overall Study|Adverse Event|0
7943977|NCT02468674|12486236|FG002|Overall Study|Adverse Event|0
7943978|NCT02468674|12486237|FG003|Overall Study|Adverse Event|1
7943979|NCT02468674|12486238|FG004|Overall Study|Adverse Event|0
7943980|NCT02468674|12486239|FG005|Overall Study|Adverse Event|1
7943981|NCT02468674|12486240|FG006|Overall Study|Adverse Event|0
7943982|NCT02468674|12486241|FG007|Overall Study|Adverse Event|0
7943983|NCT02468674|12486242|FG008|Overall Study|Adverse Event|0
7943984|NCT02468674|12486234|FG000|Overall Study|Lost to Follow-up|1
7943985|NCT02468674|12486235|FG001|Overall Study|Lost to Follow-up|0
7943986|NCT02468674|12486236|FG002|Overall Study|Lost to Follow-up|0
7943987|NCT02468674|12486237|FG003|Overall Study|Lost to Follow-up|0
7943988|NCT02468674|12486238|FG004|Overall Study|Lost to Follow-up|0
7943989|NCT02468674|12486239|FG005|Overall Study|Lost to Follow-up|0
7943990|NCT02468674|12486240|FG006|Overall Study|Lost to Follow-up|0
7943991|NCT02468674|12486241|FG007|Overall Study|Lost to Follow-up|1
7943992|NCT02468674|12486242|FG008|Overall Study|Lost to Follow-up|1
7943993|NCT02468674|12486234|FG000|Overall Study|Physician Decision|0
7943994|NCT02468674|12486235|FG001|Overall Study|Physician Decision|0
7943995|NCT02468674|12486236|FG002|Overall Study|Physician Decision|0
7943996|NCT02468674|12486237|FG003|Overall Study|Physician Decision|0
7943997|NCT02468674|12486238|FG004|Overall Study|Physician Decision|0
7943998|NCT02468674|12486239|FG005|Overall Study|Physician Decision|0
7943999|NCT02468674|12486240|FG006|Overall Study|Physician Decision|1
7944000|NCT02468674|12486241|FG007|Overall Study|Physician Decision|0
7944001|NCT02468674|12486242|FG008|Overall Study|Physician Decision|0
7944002|NCT02468674|12486234|FG000|Overall Study|Patient/Guardian Decision|0
7944003|NCT02468674|12486235|FG001|Overall Study|Patient/Guardian Decision|0
7944004|NCT02468674|12486236|FG002|Overall Study|Patient/Guardian Decision|0
7944005|NCT02468674|12486237|FG003|Overall Study|Patient/Guardian Decision|0
7944006|NCT02468674|12486238|FG004|Overall Study|Patient/Guardian Decision|1
7944007|NCT02468674|12486239|FG005|Overall Study|Patient/Guardian Decision|0
7944008|NCT02468674|12486240|FG006|Overall Study|Patient/Guardian Decision|0
7944009|NCT02468674|12486241|FG007|Overall Study|Patient/Guardian Decision|2
7944010|NCT02468674|12486242|FG008|Overall Study|Patient/Guardian Decision|1
7944011|NCT02468674|12486234|FG000|Overall Study|Protocol Deviation|0
7944012|NCT02468674|12486235|FG001|Overall Study|Protocol Deviation|0
7944013|NCT02468674|12486236|FG002|Overall Study|Protocol Deviation|0
7944014|NCT02468674|12486237|FG003|Overall Study|Protocol Deviation|0
7944015|NCT02468674|12486238|FG004|Overall Study|Protocol Deviation|0
7944016|NCT02468674|12486239|FG005|Overall Study|Protocol Deviation|0
7944017|NCT02468674|12486240|FG006|Overall Study|Protocol Deviation|0
7944018|NCT02468674|12486241|FG007|Overall Study|Protocol Deviation|1
7944019|NCT02468674|12486242|FG008|Overall Study|Protocol Deviation|1
7944020|NCT02468934|12486284|FG000|Overall Study|Withdrawal by Subject|4
7944021|NCT02468934|12486284|FG000|Overall Study|Screen Failure|3
7944022|NCT02469038|12486292|FG000|Overall Study|Physician Decision|4
7944023|NCT02469038|12486293|FG001|Overall Study|Physician Decision|5
7944024|NCT02469064|12486301|FG000|Overall Study|Request not to receive intervention.|1
7944025|NCT02469064|12486302|FG001|Overall Study|Request not to receive intervention.|3
7944026|NCT02469077|12486310|FG000|Post Randomization/Intervention Period|Scheduling issues|3
7944027|NCT02469077|12486311|FG001|Post Randomization/Intervention Period|Scheduling issues|2
7944028|NCT02469077|12486310|FG000|Post Randomization/Intervention Period|Relocated|1
7944029|NCT02469077|12486311|FG001|Post Randomization/Intervention Period|Relocated|1
7944030|NCT02469077|12486310|FG000|Post Randomization/Intervention Period|Conflicting health issues|0
7944031|NCT02469077|12486311|FG001|Post Randomization/Intervention Period|Conflicting health issues|1
7944032|NCT02469077|12486310|FG000|Post Intervention /Followup|Withdrawal by Subject|2
7944033|NCT02469077|12486311|FG001|Post Intervention /Followup|Withdrawal by Subject|1
7944034|NCT02469090|12486323|FG000|Period 1: Dose Titration Phase|Adverse Event|12
7944035|NCT02469090|12486324|FG001|Period 1: Dose Titration Phase|Adverse Event|0
7944036|NCT02469090|12486325|FG002|Period 1: Dose Titration Phase|Adverse Event|0
7944037|NCT02469090|12486323|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8
7944038|NCT02469090|12486324|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0
7944039|NCT02469090|12486325|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0
7944040|NCT02469090|12486323|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1
7944041|NCT02469090|12486324|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0
7944042|NCT02469090|12486325|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0
7944043|NCT02469090|12486323|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11
7944044|NCT02469090|12486324|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0
7944045|NCT02469090|12486325|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0
7944046|NCT02469090|12486323|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0
7944047|NCT02469090|12486324|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5
7944048|NCT02469090|12486325|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15
7944049|NCT02469090|12486323|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0
7944050|NCT02469090|12486324|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3
7944051|NCT02469090|12486325|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4
7944052|NCT02469090|12486323|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
7944053|NCT02469090|12486324|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1
7944054|NCT02469090|12486325|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
7944055|NCT02469090|12486323|FG000|Period 2: Maintenance Treatment Phase|Death|0
7944056|NCT02469090|12486324|FG001|Period 2: Maintenance Treatment Phase|Death|0
7944057|NCT02469090|12486325|FG002|Period 2: Maintenance Treatment Phase|Death|1
7944058|NCT02469168|12486338|FG000|Overall Study|Trial closed|1
7944059|NCT02469168|12486339|FG001|Overall Study|Trial closed|0
7944060|NCT02469246|12486347|FG000|Double-Blind Phase|Randomized and Never Treated|5
7944061|NCT02469246|12486348|FG001|Double-Blind Phase|Randomized and Never Treated|6
7944062|NCT02469246|12486347|FG000|Double-Blind Phase|Adverse Event|12
7944063|NCT02469246|12486348|FG001|Double-Blind Phase|Adverse Event|9
7944064|NCT02469246|12486347|FG000|Double-Blind Phase|Death|2
7944065|NCT02469246|12486348|FG001|Double-Blind Phase|Death|0
7944066|NCT02469246|12486347|FG000|Double-Blind Phase|Lack of Efficacy|2
7944067|NCT02469246|12486348|FG001|Double-Blind Phase|Lack of Efficacy|1
7944068|NCT02469246|12486347|FG000|Double-Blind Phase|Investigator's Discretion|8
7944069|NCT02469246|12486348|FG001|Double-Blind Phase|Investigator's Discretion|8
7944070|NCT02469246|12486347|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3
7944071|NCT02469246|12486348|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
7944072|NCT02469246|12486347|FG000|Double-Blind Phase|Protocol Violation|1
7944073|NCT02469246|12486348|FG001|Double-Blind Phase|Protocol Violation|1
7944074|NCT02469246|12486347|FG000|Double-Blind Phase|Withdrew Consent|25
7944075|NCT02469246|12486348|FG001|Double-Blind Phase|Withdrew Consent|25
7944076|NCT02469246|12486347|FG000|Double-Blind Phase|Lost to Follow-up|9
7944077|NCT02469246|12486348|FG001|Double-Blind Phase|Lost to Follow-up|5
7944078|NCT02469298|12486360|FG000|Overall Study|Protocol Violation|0
7944079|NCT02469298|12486361|FG001|Overall Study|Protocol Violation|1
7944080|NCT02469298|12486362|FG002|Overall Study|Protocol Violation|1
7944081|NCT02469298|12486363|FG003|Overall Study|Protocol Violation|0
7944082|NCT02469298|12486360|FG000|Overall Study|Lost to Follow-up|1
7944083|NCT02469298|12486361|FG001|Overall Study|Lost to Follow-up|0
7944084|NCT02469298|12486362|FG002|Overall Study|Lost to Follow-up|1
7944085|NCT02469298|12486363|FG003|Overall Study|Lost to Follow-up|0
7944086|NCT02469298|12486360|FG000|Overall Study|Physician Decision|0
7944087|NCT02469298|12486361|FG001|Overall Study|Physician Decision|0
7944088|NCT02469298|12486362|FG002|Overall Study|Physician Decision|0
7944089|NCT02469298|12486363|FG003|Overall Study|Physician Decision|1
7944090|NCT02469298|12486360|FG000|Overall Study|Withdrawal by Subject|0
7944091|NCT02469298|12486361|FG001|Overall Study|Withdrawal by Subject|0
7944092|NCT02469298|12486362|FG002|Overall Study|Withdrawal by Subject|0
7944093|NCT02469298|12486363|FG003|Overall Study|Withdrawal by Subject|1
7944094|NCT02469610|12486400|FG000|Overall Study|Death|1
7822228|NCT01260701|12291319|FG000|Overall Study|Not protocol specified|3
7822229|NCT01260701|12291319|FG000|Overall Study|Under review|1
7944095|NCT02469610|12486401|FG001|Overall Study|Death|0
7944096|NCT02469610|12486400|FG000|Overall Study|Lost to Follow-up|1
7944097|NCT02469610|12486401|FG001|Overall Study|Lost to Follow-up|0
7944098|NCT02469610|12486400|FG000|Overall Study|exclusion criteria|2
7944099|NCT02469610|12486401|FG001|Overall Study|exclusion criteria|1
7944100|NCT02469623|12486407|FG000|Overall Study|Not consented for long-term follow-up|4
7944101|NCT02469623|12486407|FG000|Overall Study|Lost to Follow-up|4
7944102|NCT02469623|12486407|FG000|Overall Study|Withdrawal by Subject|2
7944103|NCT02469623|12486407|FG000|Overall Study|Death|3
7965535|NCT01190930|12520926|FG000|Post Induction Pre-Maintenance|Refusal|0
7965536|NCT01190930|12520927|FG001|Post Induction Pre-Maintenance|Refusal|2
7965537|NCT01190930|12520928|FG002|Post Induction Pre-Maintenance|Refusal|694
7965538|NCT01190930|12520929|FG003|Post Induction Pre-Maintenance|Refusal|4
7965539|NCT01190930|12520930|FG004|Post Induction Pre-Maintenance|Refusal|0
7965540|NCT01190930|12520931|FG005|Post Induction Pre-Maintenance|Refusal|3
7965541|NCT01190930|12520932|FG006|Post Induction Pre-Maintenance|Refusal|0
7965542|NCT01190930|12520933|FG007|Post Induction Pre-Maintenance|Refusal|0
7965543|NCT01190930|12520934|FG008|Post Induction Pre-Maintenance|Refusal|0
7965544|NCT01190930|12520935|FG009|Post Induction Pre-Maintenance|Refusal|0
7965545|NCT01190930|12520926|FG000|Post Induction Pre-Maintenance|Inevaluable|0
7965546|NCT01190930|12520927|FG001|Post Induction Pre-Maintenance|Inevaluable|0
7965547|NCT01190930|12520928|FG002|Post Induction Pre-Maintenance|Inevaluable|6
7965548|NCT01190930|12520929|FG003|Post Induction Pre-Maintenance|Inevaluable|0
7965549|NCT01190930|12520930|FG004|Post Induction Pre-Maintenance|Inevaluable|0
7965550|NCT01190930|12520931|FG005|Post Induction Pre-Maintenance|Inevaluable|0
7965551|NCT01190930|12520932|FG006|Post Induction Pre-Maintenance|Inevaluable|0
7965552|NCT01190930|12520933|FG007|Post Induction Pre-Maintenance|Inevaluable|0
7965553|NCT01190930|12520934|FG008|Post Induction Pre-Maintenance|Inevaluable|0
7965554|NCT01190930|12520935|FG009|Post Induction Pre-Maintenance|Inevaluable|0
7965555|NCT01190930|12520926|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7965556|NCT01190930|12520927|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1
7965557|NCT01190930|12520928|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7965558|NCT01190930|12520929|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7965559|NCT01190930|12520930|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7965560|NCT01190930|12520931|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7965561|NCT01190930|12520932|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7965562|NCT01190930|12520933|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7965563|NCT01190930|12520934|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7965564|NCT01190930|12520935|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7965565|NCT01190930|12520926|FG000|Post Induction Pre-Maintenance|Progressive disease|0
7965566|NCT01190930|12520927|FG001|Post Induction Pre-Maintenance|Progressive disease|0
7965567|NCT01190930|12520928|FG002|Post Induction Pre-Maintenance|Progressive disease|1
7965568|NCT01190930|12520929|FG003|Post Induction Pre-Maintenance|Progressive disease|0
7965569|NCT01190930|12520930|FG004|Post Induction Pre-Maintenance|Progressive disease|0
7965570|NCT01190930|12520931|FG005|Post Induction Pre-Maintenance|Progressive disease|0
7965571|NCT01190930|12520932|FG006|Post Induction Pre-Maintenance|Progressive disease|0
7965572|NCT01190930|12520933|FG007|Post Induction Pre-Maintenance|Progressive disease|0
7965573|NCT01190930|12520934|FG008|Post Induction Pre-Maintenance|Progressive disease|0
7965574|NCT01190930|12520935|FG009|Post Induction Pre-Maintenance|Progressive disease|0
7965575|NCT01190930|12520926|FG000|Post Induction Pre-Maintenance|Relapse|0
7965576|NCT01190930|12520927|FG001|Post Induction Pre-Maintenance|Relapse|0
7965577|NCT01190930|12520928|FG002|Post Induction Pre-Maintenance|Relapse|1
7965578|NCT01190930|12520929|FG003|Post Induction Pre-Maintenance|Relapse|0
7965579|NCT01190930|12520930|FG004|Post Induction Pre-Maintenance|Relapse|0
7965580|NCT01190930|12520931|FG005|Post Induction Pre-Maintenance|Relapse|0
7965581|NCT01190930|12520932|FG006|Post Induction Pre-Maintenance|Relapse|0
7965582|NCT01190930|12520933|FG007|Post Induction Pre-Maintenance|Relapse|0
7965583|NCT01190930|12520934|FG008|Post Induction Pre-Maintenance|Relapse|0
7965584|NCT01190930|12520935|FG009|Post Induction Pre-Maintenance|Relapse|0
7965585|NCT01190930|12520926|FG000|Maintenance|Adverse Event|0
7965586|NCT01190930|12520927|FG001|Maintenance|Adverse Event|0
7965587|NCT01190930|12520928|FG002|Maintenance|Adverse Event|0
7965588|NCT01190930|12520929|FG003|Maintenance|Adverse Event|0
7965589|NCT01190930|12520930|FG004|Maintenance|Adverse Event|0
7965590|NCT01190930|12520931|FG005|Maintenance|Adverse Event|1
7965591|NCT01190930|12520932|FG006|Maintenance|Adverse Event|1
7944104|NCT02469857|12486427|FG000|Overall Study|Death|24
7944105|NCT02469857|12486428|FG001|Overall Study|Death|29
7944106|NCT02469857|12486427|FG000|Overall Study|Discontinuation|1
7944107|NCT02469857|12486428|FG001|Overall Study|Discontinuation|3
7944108|NCT02469896|12486450|FG000|Overall Study|Withdrawal by Subject|2
7944109|NCT02469896|12486451|FG001|Overall Study|Withdrawal by Subject|0
7944110|NCT02469961|12486463|FG000|Overall Study|Physician Decision|4
7944111|NCT02469961|12486464|FG001|Overall Study|Physician Decision|1
7944112|NCT02470403|12486518|FG000|Overall Study|Adverse Event|1
7944113|NCT02470403|12486519|FG001|Overall Study|Adverse Event|0
7944114|NCT02470403|12486520|FG002|Overall Study|Adverse Event|0
7944115|NCT02470403|12486521|FG003|Overall Study|Adverse Event|0
7944116|NCT02470403|12486522|FG004|Overall Study|Adverse Event|0
7944117|NCT02470403|12486518|FG000|Overall Study|Lost to Follow-up|0
7944118|NCT02470403|12486519|FG001|Overall Study|Lost to Follow-up|1
7944119|NCT02470403|12486520|FG002|Overall Study|Lost to Follow-up|0
7944120|NCT02470403|12486521|FG003|Overall Study|Lost to Follow-up|0
7944121|NCT02470403|12486522|FG004|Overall Study|Lost to Follow-up|0
7944122|NCT02470403|12486518|FG000|Overall Study|Subject/guardian decision|1
7944123|NCT02470403|12486519|FG001|Overall Study|Subject/guardian decision|0
7944124|NCT02470403|12486520|FG002|Overall Study|Subject/guardian decision|0
7944125|NCT02470403|12486521|FG003|Overall Study|Subject/guardian decision|4
7944126|NCT02470403|12486522|FG004|Overall Study|Subject/guardian decision|0
7944127|NCT02470429|12486539|FG000|Overall Study|Adverse Event|1
7944128|NCT02470429|12486540|FG001|Overall Study|Adverse Event|0
7944129|NCT02470429|12486539|FG000|Overall Study|Withdrawal by Subject|1
7944130|NCT02470429|12486540|FG001|Overall Study|Withdrawal by Subject|0
7944131|NCT02470806|12486569|FG000|Overall Study|Lost to Follow-up|1
7944132|NCT02470806|12486570|FG001|Overall Study|Lost to Follow-up|1
7944133|NCT02470806|12486569|FG000|Overall Study|Adverse Event|5
7944134|NCT02470806|12486570|FG001|Overall Study|Adverse Event|2
7944135|NCT02470806|12486569|FG000|Overall Study|Protocol Violation|4
7944136|NCT02470806|12486570|FG001|Overall Study|Protocol Violation|11
7944137|NCT02470806|12486569|FG000|Overall Study|Physician Decision|0
7944138|NCT02470806|12486570|FG001|Overall Study|Physician Decision|3
7944139|NCT02470806|12486569|FG000|Overall Study|Withdrawal by Subject|3
7944140|NCT02470806|12486570|FG001|Overall Study|Withdrawal by Subject|10
7944141|NCT02470806|12486569|FG000|Overall Study|Lack of Efficacy|5
7944142|NCT02470806|12486570|FG001|Overall Study|Lack of Efficacy|15
7944143|NCT02471014|12486594|FG000|Overall Study|Lost to Follow-up|2
7944144|NCT02471014|12486595|FG001|Overall Study|Lost to Follow-up|2
7944145|NCT02471183|12486601|FG000|Main Treatment Period|Adverse Event|1
7944146|NCT02471183|12486601|FG000|Main Treatment Period|Withdrawal by Subject|1
7944147|NCT02471183|12486601|FG000|Extended Treatment Period|Lack of Efficacy|1
7944148|NCT02471404|12486616|FG000|Overall Study|Adverse Event|7
7944149|NCT02471404|12486617|FG001|Overall Study|Adverse Event|1
7944150|NCT02471404|12486618|FG002|Overall Study|Adverse Event|2
7944151|NCT02471404|12486616|FG000|Overall Study|Developed Study Withdrawal Criteria|4
7944152|NCT02471404|12486617|FG001|Overall Study|Developed Study Withdrawal Criteria|1
7944153|NCT02471404|12486618|FG002|Overall Study|Developed Study Withdrawal Criteria|2
7944154|NCT02471404|12486616|FG000|Overall Study|Failure to Meet Randomization Criteria|2
7944155|NCT02471404|12486617|FG001|Overall Study|Failure to Meet Randomization Criteria|0
7944156|NCT02471404|12486618|FG002|Overall Study|Failure to Meet Randomization Criteria|1
7944157|NCT02471404|12486616|FG000|Overall Study|Lost to Follow-up|1
7944158|NCT02471404|12486617|FG001|Overall Study|Lost to Follow-up|1
7944159|NCT02471404|12486618|FG002|Overall Study|Lost to Follow-up|3
7944160|NCT02471404|12486616|FG000|Overall Study|Protocol Violation|1
7944161|NCT02471404|12486617|FG001|Overall Study|Protocol Violation|0
7944162|NCT02471404|12486618|FG002|Overall Study|Protocol Violation|0
7944163|NCT02471404|12486616|FG000|Overall Study|Withdrawal by Subject|8
7944164|NCT02471404|12486617|FG001|Overall Study|Withdrawal by Subject|4
7944165|NCT02471404|12486618|FG002|Overall Study|Withdrawal by Subject|5
7944166|NCT02471404|12486616|FG000|Overall Study|Other reasons not specified|10
7944167|NCT02471404|12486617|FG001|Overall Study|Other reasons not specified|7
7944168|NCT02471404|12486618|FG002|Overall Study|Other reasons not specified|12
7944169|NCT02471586|12486638|FG000|Overall Study|Lost to Follow-up|3
7944170|NCT02471586|12486639|FG001|Overall Study|Lost to Follow-up|8
7944171|NCT02471586|12486640|FG002|Overall Study|Lost to Follow-up|4
7944172|NCT02471586|12486638|FG000|Overall Study|Death|2
7944173|NCT02471586|12486639|FG001|Overall Study|Death|2
7944174|NCT02471586|12486640|FG002|Overall Study|Death|0
7944175|NCT02471612|12486650|FG000|Overall Study|Lost to Follow-up|2
7944176|NCT02471716|12486681|FG000|Overall Study|Withdrawal by Subject|0
7944177|NCT02471716|12486682|FG001|Overall Study|Withdrawal by Subject|1
7944178|NCT02471716|12486683|FG002|Overall Study|Withdrawal by Subject|0
7944179|NCT02471716|12486684|FG003|Overall Study|Withdrawal by Subject|2
7944180|NCT02471716|12486685|FG004|Overall Study|Withdrawal by Subject|5
7944181|NCT02471716|12486681|FG000|Overall Study|Study Terminiated by sponsor|0
7944182|NCT02471716|12486682|FG001|Overall Study|Study Terminiated by sponsor|0
7944183|NCT02471716|12486683|FG002|Overall Study|Study Terminiated by sponsor|0
7944184|NCT02471716|12486684|FG003|Overall Study|Study Terminiated by sponsor|1
7944185|NCT02471716|12486685|FG004|Overall Study|Study Terminiated by sponsor|0
7944186|NCT02471716|12486681|FG000|Overall Study|Lost to Follow-up|0
7944187|NCT02471716|12486682|FG001|Overall Study|Lost to Follow-up|0
7944188|NCT02471716|12486683|FG002|Overall Study|Lost to Follow-up|0
7944189|NCT02471716|12486684|FG003|Overall Study|Lost to Follow-up|3
7944190|NCT02471716|12486685|FG004|Overall Study|Lost to Follow-up|2
7944191|NCT02471716|12486681|FG000|Overall Study|Death|0
7944192|NCT02471716|12486682|FG001|Overall Study|Death|0
7944193|NCT02471716|12486683|FG002|Overall Study|Death|0
7944194|NCT02471716|12486684|FG003|Overall Study|Death|1
7944195|NCT02471716|12486685|FG004|Overall Study|Death|0
7944196|NCT02471716|12486681|FG000|Overall Study|Other|0
7944197|NCT02471716|12486682|FG001|Overall Study|Other|0
7944198|NCT02471716|12486683|FG002|Overall Study|Other|0
7944199|NCT02471716|12486684|FG003|Overall Study|Other|8
7944200|NCT02471716|12486685|FG004|Overall Study|Other|9
7944201|NCT02471755|12486701|FG000|Overall Study|Withdrawal by Subject|1
7944202|NCT02471755|12486702|FG001|Overall Study|Withdrawal by Subject|0
7944203|NCT02471755|12486701|FG000|Overall Study|Lost to Follow-up|0
7944204|NCT02471755|12486702|FG001|Overall Study|Lost to Follow-up|1
7944205|NCT02472145|12486711|FG000|Overall Study|Death|10
7944206|NCT02472145|12486712|FG001|Overall Study|Death|101
7944207|NCT02472145|12486713|FG002|Overall Study|Death|99
7944208|NCT02472145|12486711|FG000|Overall Study|Lost to Follow-up|0
7944209|NCT02472145|12486712|FG001|Overall Study|Lost to Follow-up|1
7944210|NCT02472145|12486713|FG002|Overall Study|Lost to Follow-up|0
7944211|NCT02472145|12486711|FG000|Overall Study|Withdrawal by Subject|0
7944212|NCT02472145|12486712|FG001|Overall Study|Withdrawal by Subject|9
7944213|NCT02472145|12486713|FG002|Overall Study|Withdrawal by Subject|13
7944214|NCT02472145|12486711|FG000|Overall Study|Sponsor decision|0
7944215|NCT02472145|12486712|FG001|Overall Study|Sponsor decision|3
7944216|NCT02472145|12486713|FG002|Overall Study|Sponsor decision|2
7944217|NCT02472145|12486711|FG000|Overall Study|Other|0
7944218|NCT02472145|12486712|FG001|Overall Study|Other|45
7944219|NCT02472145|12486713|FG002|Overall Study|Other|43
7944220|NCT02472353|12486753|FG000|Overall Study|Lost to Follow-up|1
7944221|NCT02472353|12486754|FG001|Overall Study|Lost to Follow-up|1
7944222|NCT02472353|12486753|FG000|Overall Study|Withdrawal by Subject|2
7944223|NCT02472353|12486754|FG001|Overall Study|Withdrawal by Subject|1
7944224|NCT02472353|12486753|FG000|Overall Study|Study Termination|1
7944225|NCT02472353|12486754|FG001|Overall Study|Study Termination|4
7944226|NCT02472366|12486762|FG000|Overall Study|Lost to Follow-up|1
7944227|NCT02472366|12486763|FG001|Overall Study|Lost to Follow-up|0
7944228|NCT02472405|12486769|FG000|Overall Study|Lost to Follow-up|9
7944229|NCT02472405|12486769|FG000|Overall Study|Adverse Event|1
7944230|NCT02472652|12486795|FG000|Overall Study|Lost to Follow-up|1
7944231|NCT02472756|12486808|FG000|Induction (Approximately 6 Months)|Adverse Event|1
7944232|NCT02472756|12486808|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
7944233|NCT02472756|12486808|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7
7944234|NCT02472756|12486808|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2
7944235|NCT02472756|12486808|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1
7944236|NCT02472795|12486817|FG000|Overall Study|Adverse Event|0
7944237|NCT02472795|12486818|FG001|Overall Study|Adverse Event|1
7944238|NCT02472795|12486819|FG002|Overall Study|Adverse Event|0
7944239|NCT02472795|12486820|FG003|Overall Study|Adverse Event|0
7944240|NCT02472795|12486821|FG004|Overall Study|Adverse Event|2
7944241|NCT02472795|12486817|FG000|Overall Study|Withdrawal by Subject|0
7944242|NCT02472795|12486818|FG001|Overall Study|Withdrawal by Subject|0
7944243|NCT02472795|12486819|FG002|Overall Study|Withdrawal by Subject|0
7944244|NCT02472795|12486820|FG003|Overall Study|Withdrawal by Subject|0
7944245|NCT02472795|12486821|FG004|Overall Study|Withdrawal by Subject|1
7944246|NCT02472847|12486835|FG000|Overall Study|Withdrawal by Subject|1
7944247|NCT02472847|12486836|FG001|Overall Study|Withdrawal by Subject|5
7944248|NCT02472886|12486845|FG000|Overall Study|Lack of Efficacy|0
7944249|NCT02472886|12486846|FG001|Overall Study|Lack of Efficacy|2
7944250|NCT02472886|12486847|FG002|Overall Study|Lack of Efficacy|1
7944251|NCT02472977|12486863|FG000|Overall Study|Disease progression|4
7944252|NCT02472977|12486864|FG001|Overall Study|Disease progression|25
7944253|NCT02472977|12486865|FG002|Overall Study|Disease progression|6
7944254|NCT02472977|12486863|FG000|Overall Study|Withdrawal by Subject|0
7944255|NCT02472977|12486864|FG001|Overall Study|Withdrawal by Subject|1
7944256|NCT02472977|12486865|FG002|Overall Study|Withdrawal by Subject|0
7944257|NCT02472977|12486863|FG000|Overall Study|Study drug toxicity|2
7944258|NCT02472977|12486864|FG001|Overall Study|Study drug toxicity|0
7944259|NCT02472977|12486865|FG002|Overall Study|Study drug toxicity|2
7944260|NCT02472977|12486863|FG000|Overall Study|Subject request to discontinue treatment|0
7944261|NCT02472977|12486864|FG001|Overall Study|Subject request to discontinue treatment|1
7944262|NCT02472977|12486865|FG002|Overall Study|Subject request to discontinue treatment|0
7944263|NCT02473250|12486873|FG000|Overall Study|Lost to Follow-up|10
7944264|NCT02473250|12486873|FG000|Overall Study|Physician Decision|5
7944265|NCT02473250|12486873|FG000|Overall Study|Did not tolerate medication washout|3
7944266|NCT02473250|12486873|FG000|Overall Study|Antidepressant effect of divalproex|2
7944267|NCT02473289|12486880|FG000|Overall Study|Adverse Event|2
7944268|NCT02473289|12486881|FG001|Overall Study|Adverse Event|3
7944269|NCT02473289|12486880|FG000|Overall Study|Lost to Follow-up|1
7944270|NCT02473289|12486881|FG001|Overall Study|Lost to Follow-up|1
7944271|NCT02473289|12486880|FG000|Overall Study|Protocol Violation|0
7944272|NCT02473289|12486881|FG001|Overall Study|Protocol Violation|1
7944273|NCT02473289|12486880|FG000|Overall Study|Withdrawal of consent|6
7944274|NCT02473289|12486881|FG001|Overall Study|Withdrawal of consent|7
7944275|NCT02473289|12486880|FG000|Overall Study|Treatment Unblinded + Adverse event|0
7944276|NCT02473289|12486881|FG001|Overall Study|Treatment Unblinded + Adverse event|1
7944277|NCT02473289|12486880|FG000|Overall Study|Other|2
7944278|NCT02473289|12486881|FG001|Overall Study|Other|0
7944279|NCT02473367|12486887|FG000|Wait 1|Withdrawal by Subject|1
7944280|NCT02473367|12486887|FG000|Period 4|Lost to Follow-up|1
7944281|NCT02473393|12486901|FG000|Overall Study|Adverse Event|0
7944282|NCT02473393|12486902|FG001|Overall Study|Adverse Event|0
7944283|NCT02473393|12486903|FG002|Overall Study|Adverse Event|1
7944284|NCT02473393|12486904|FG003|Overall Study|Adverse Event|0
7944285|NCT02473393|12486901|FG000|Overall Study|Withdrawal by Subject|0
7944286|NCT02473393|12486902|FG001|Overall Study|Withdrawal by Subject|0
7944287|NCT02473393|12486903|FG002|Overall Study|Withdrawal by Subject|1
7944288|NCT02473393|12486904|FG003|Overall Study|Withdrawal by Subject|1
7944289|NCT02473471|12486914|FG000|Overall Study|poor oral hygiene|2
7944290|NCT02473471|12486914|FG000|Overall Study|Lost to Follow-up|1
7944291|NCT02473510|12486926|FG000|Overall Study|Lost to Follow-up|1
7944292|NCT02473510|12486927|FG001|Overall Study|Lost to Follow-up|2
7944293|NCT02473614|12486933|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1
7944294|NCT02473614|12486934|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0
7944295|NCT02473640|12486941|FG000|Treatment Period 1|Adverse Event|1
7944296|NCT02473913|12486969|FG000|Overall Study|Lost to Follow-up|3
7944297|NCT02473913|12486970|FG001|Overall Study|Lost to Follow-up|3
7944298|NCT02473952|12486978|FG000|Overall Study|Adverse Event|2
7944299|NCT02473952|12486979|FG001|Overall Study|Adverse Event|2
7944300|NCT02473952|12486978|FG000|Overall Study|Withdrawal by Subject|0
7944301|NCT02473952|12486979|FG001|Overall Study|Withdrawal by Subject|6
7944302|NCT02473965|12486987|FG000|Overall Study|Adverse Event|6
7944303|NCT02473965|12486988|FG001|Overall Study|Adverse Event|4
7944304|NCT02473965|12486987|FG000|Overall Study|MG worsening|4
7944305|NCT02473965|12486988|FG001|Overall Study|MG worsening|1
7944306|NCT02473965|12486987|FG000|Overall Study|Withdrawal by Subject|2
7944307|NCT02473965|12486988|FG001|Overall Study|Withdrawal by Subject|3
7944308|NCT02473965|12486987|FG000|Overall Study|Physician Decision|0
7944309|NCT02473965|12486988|FG001|Overall Study|Physician Decision|2
7944310|NCT02474069|12486998|FG000|Selection Phase (SP)|Adverse Event|8
7944311|NCT02474069|12486999|FG001|Selection Phase (SP)|Adverse Event|0
7944312|NCT02474069|12487000|FG002|Selection Phase (SP)|Adverse Event|0
7944313|NCT02474069|12486998|FG000|Selection Phase (SP)|Lack of Efficacy|1
7944314|NCT02474069|12486999|FG001|Selection Phase (SP)|Lack of Efficacy|0
7944315|NCT02474069|12487000|FG002|Selection Phase (SP)|Lack of Efficacy|0
7944316|NCT02474069|12486998|FG000|Selection Phase (SP)|Lost to Follow-up|4
7944317|NCT02474069|12486999|FG001|Selection Phase (SP)|Lost to Follow-up|0
7944318|NCT02474069|12487000|FG002|Selection Phase (SP)|Lost to Follow-up|0
7944319|NCT02474069|12486998|FG000|Selection Phase (SP)|Physician Decision|1
7944320|NCT02474069|12486999|FG001|Selection Phase (SP)|Physician Decision|0
7944321|NCT02474069|12487000|FG002|Selection Phase (SP)|Physician Decision|0
7944322|NCT02474069|12486998|FG000|Selection Phase (SP)|Protocol Violation|1
7944323|NCT02474069|12486999|FG001|Selection Phase (SP)|Protocol Violation|0
7944324|NCT02474069|12487000|FG002|Selection Phase (SP)|Protocol Violation|0
7944325|NCT02474069|12486998|FG000|Selection Phase (SP)|No longer requires treatment|1
7944326|NCT02474069|12486999|FG001|Selection Phase (SP)|No longer requires treatment|0
7944327|NCT02474069|12487000|FG002|Selection Phase (SP)|No longer requires treatment|0
7944328|NCT02474069|12486998|FG000|Selection Phase (SP)|Technical Problem|1
7944329|NCT02474069|12486999|FG001|Selection Phase (SP)|Technical Problem|0
7944330|NCT02474069|12487000|FG002|Selection Phase (SP)|Technical Problem|0
7944331|NCT02474069|12486998|FG000|Selection Phase (SP)|Withdrawal by Subject|3
7944332|NCT02474069|12486999|FG001|Selection Phase (SP)|Withdrawal by Subject|0
7944333|NCT02474069|12487000|FG002|Selection Phase (SP)|Withdrawal by Subject|0
7944334|NCT02474069|12486998|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3
7944335|NCT02474069|12486999|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0
7944336|NCT02474069|12487000|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0
7944337|NCT02474069|12486998|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0
7944338|NCT02474069|12486999|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3
7944339|NCT02474069|12487000|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2
7944340|NCT02474069|12486998|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0
7944341|NCT02474069|12486999|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4
7944342|NCT02474069|12487000|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1
7965592|NCT01190930|12520933|FG007|Maintenance|Adverse Event|3
7944343|NCT02474069|12486998|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
7944344|NCT02474069|12486999|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
7944345|NCT02474069|12487000|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1
7944346|NCT02474069|12486998|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0
7944347|NCT02474069|12486999|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
7944348|NCT02474069|12487000|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
7944349|NCT02474082|12487012|FG000|Overall Study|Adverse Event|2
7944350|NCT02474082|12487013|FG001|Overall Study|Adverse Event|32
7944351|NCT02474082|12487012|FG000|Overall Study|Withdrawal of informed consent|1
7944352|NCT02474082|12487013|FG001|Overall Study|Withdrawal of informed consent|11
7944353|NCT02474082|12487012|FG000|Overall Study|Lost to Follow-up|2
7944354|NCT02474082|12487013|FG001|Overall Study|Lost to Follow-up|2
7944355|NCT02474082|12487012|FG000|Overall Study|Dose tapering not achieved|0
7944356|NCT02474082|12487013|FG001|Overall Study|Dose tapering not achieved|4
7944357|NCT02474082|12487012|FG000|Overall Study|Participant/guardian decision|1
7944358|NCT02474082|12487013|FG001|Overall Study|Participant/guardian decision|2
7944359|NCT02474082|12487012|FG000|Overall Study|Non-compliance with study treatment|0
7944360|NCT02474082|12487013|FG001|Overall Study|Non-compliance with study treatment|2
7944361|NCT02474082|12487012|FG000|Overall Study|Protocol deviation|0
7944362|NCT02474082|12487013|FG001|Overall Study|Protocol deviation|1
7944363|NCT02474199|12487021|FG000|Overall Study|Lost to Follow-up|1
7944364|NCT02474199|12487022|FG001|Overall Study|Lost to Follow-up|0
7944365|NCT02474199|12487023|FG002|Overall Study|Lost to Follow-up|0
7944366|NCT02474199|12487024|FG003|Overall Study|Lost to Follow-up|0
7944367|NCT02474199|12487021|FG000|Overall Study|Withdrawal by Subject|1
7944368|NCT02474199|12487022|FG001|Overall Study|Withdrawal by Subject|2
7944369|NCT02474199|12487023|FG002|Overall Study|Withdrawal by Subject|0
7944370|NCT02474199|12487024|FG003|Overall Study|Withdrawal by Subject|1
7944371|NCT02474199|12487021|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0
7944372|NCT02474199|12487022|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1
7944373|NCT02474199|12487023|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0
7944374|NCT02474199|12487024|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0
7944375|NCT02474199|12487021|FG000|Overall Study|Did not meet eligibility criteria|0
7944376|NCT02474199|12487022|FG001|Overall Study|Did not meet eligibility criteria|0
7944377|NCT02474199|12487023|FG002|Overall Study|Did not meet eligibility criteria|2
7944378|NCT02474199|12487024|FG003|Overall Study|Did not meet eligibility criteria|2
7944379|NCT02474355|12487031|FG000|Overall Study|Other|43
7944380|NCT02474355|12487031|FG000|Overall Study|Eligibility Criteria not Fulfilled|2
7944381|NCT02474355|12487031|FG000|Overall Study|Lost to Follow-up|98
7944382|NCT02474355|12487031|FG000|Overall Study|Withdrawal by Subject|124
7944383|NCT02474355|12487031|FG000|Overall Study|Death|1361
7944384|NCT02474589|12487081|FG000|Overall Study|Adverse Event|6
7944385|NCT02474589|12487082|FG001|Overall Study|Adverse Event|2
7944386|NCT02474589|12487081|FG000|Overall Study|Lost to Follow-up|6
7944387|NCT02474589|12487082|FG001|Overall Study|Lost to Follow-up|1
7944388|NCT02474589|12487081|FG000|Overall Study|Protocol Violation|4
7944389|NCT02474589|12487082|FG001|Overall Study|Protocol Violation|1
7944390|NCT02474589|12487081|FG000|Overall Study|Withdrawal by Subject|4
7944391|NCT02474589|12487082|FG001|Overall Study|Withdrawal by Subject|0
7944392|NCT02474589|12487081|FG000|Overall Study|Inability to complete study procedures|5
7944393|NCT02474589|12487082|FG001|Overall Study|Inability to complete study procedures|1
7944394|NCT02475265|12487118|FG000|Overall Study|Physician Decision|1
7944395|NCT02475265|12487118|FG000|Overall Study|Withdrawal by Subject|2
7944396|NCT02475278|12487122|FG000|Overall Study|Lost to Follow-up|1
7944397|NCT02475278|12487122|FG000|Overall Study|Reason Not Specified|1
7944398|NCT02475369|12487126|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7
7944399|NCT02475369|12487127|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2
7944400|NCT02475395|12487140|FG000|Overall Study|Protocol Violation|30
7944401|NCT02475395|12487141|FG001|Overall Study|Protocol Violation|3
7944402|NCT02475564|12487149|FG000|Overall Study|Withdrawal by Subject|1
7944403|NCT02475564|12487150|FG001|Overall Study|Withdrawal by Subject|0
7944404|NCT02475564|12487149|FG000|Overall Study|Lost to Follow-up|2
7944405|NCT02475564|12487150|FG001|Overall Study|Lost to Follow-up|1
7944406|NCT02475564|12487149|FG000|Overall Study|Intense Menstrual bleeding|1
7944407|NCT02475564|12487150|FG001|Overall Study|Intense Menstrual bleeding|0
7944408|NCT02475629|12487156|FG000|Overall Study|Adverse Event|1
7944409|NCT02475629|12487156|FG000|Overall Study|Death|4
7944410|NCT02475629|12487156|FG000|Overall Study|Physician Decision|1
7944411|NCT02475629|12487156|FG000|Overall Study|Withdrawal by Subject|1
7944412|NCT02475629|12487156|FG000|Overall Study|Lost to Follow-up|1
7944413|NCT02475629|12487156|FG000|Overall Study|Subject non-compliance|1
7944414|NCT02475655|12487162|FG000|Overall Study|Lost to Follow-up|0
7944415|NCT02475655|12487163|FG001|Overall Study|Lost to Follow-up|1
7944416|NCT02475733|12487171|FG000|Overall Study|Withdrawal by Subject|1
7944417|NCT02475733|12487172|FG001|Overall Study|Withdrawal by Subject|0
7944418|NCT02475733|12487171|FG000|Overall Study|Physician Decision|1
7944419|NCT02475733|12487172|FG001|Overall Study|Physician Decision|0
7944420|NCT02475850|12487189|FG000|Overall Study|Death|155
7944421|NCT02475850|12487190|FG001|Overall Study|Death|141
7944422|NCT02475850|12487189|FG000|Overall Study|Lost to Follow-up|217
7944423|NCT02475850|12487190|FG001|Overall Study|Lost to Follow-up|188
7944424|NCT02475850|12487189|FG000|Overall Study|Withdrawal by Subject|221
7944425|NCT02475850|12487190|FG001|Overall Study|Withdrawal by Subject|155
7944426|NCT02475954|12487199|FG000|Overall Study|Withdrawal by Subject|2
7944427|NCT02475954|12487200|FG001|Overall Study|Withdrawal by Subject|2
7944428|NCT02475954|12487199|FG000|Overall Study|Lost to Follow-up|11
7944429|NCT02475954|12487200|FG001|Overall Study|Lost to Follow-up|9
7944430|NCT02475954|12487199|FG000|Overall Study|Death|1
7944431|NCT02475954|12487200|FG001|Overall Study|Death|1
7944432|NCT02475980|12487207|FG000|Overall Study|Lost to Follow-up|4
7944433|NCT02475980|12487207|FG000|Overall Study|Withdrawal by Subject|1
7944434|NCT02476175|12487227|FG000|Overall Study|Adverse Event|2
7944435|NCT02476422|12487244|FG000|Overall Study|Subject/guardian decision|0
7944436|NCT02476422|12487245|FG001|Overall Study|Subject/guardian decision|1
7944437|NCT02476578|12487279|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35
7944438|NCT02476578|12487280|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43
7944439|NCT02476578|12487279|FG000|Overall Study|Lost to Follow-up|6
7944440|NCT02476578|12487280|FG001|Overall Study|Lost to Follow-up|13
7944441|NCT02476617|12487286|FG000|Overall Study|Adverse Event|1
7944442|NCT02476617|12487286|FG000|Overall Study|Lost to Follow-up|1
7944443|NCT02477020|12487311|FG000|Overall Study|Pretreatment Event/Adverse Event|6
7944444|NCT02477020|12487312|FG001|Overall Study|Pretreatment Event/Adverse Event|6
7944445|NCT02477020|12487311|FG000|Overall Study|Voluntary Withdrawal|7
7944446|NCT02477020|12487312|FG001|Overall Study|Voluntary Withdrawal|16
7944447|NCT02477020|12487311|FG000|Overall Study|Reason not Specified|3
7944448|NCT02477020|12487312|FG001|Overall Study|Reason not Specified|1
7944449|NCT02477020|12487311|FG000|Overall Study|Lack of Efficacy|14
7944450|NCT02477020|12487312|FG001|Overall Study|Lack of Efficacy|5
7944451|NCT02477111|12487318|FG000|Overall Study|Death|5
7944452|NCT02477111|12487318|FG000|Overall Study|Withdrawal by Subject|2
7944453|NCT02477111|12487318|FG000|Overall Study|missed visit|4
7944454|NCT02477215|12487328|FG000|Dose Escalation Phase|Physician Decision|1
7944455|NCT02477215|12487329|FG001|Dose Escalation Phase|Physician Decision|2
7944456|NCT02477215|12487330|FG002|Dose Escalation Phase|Physician Decision|0
7944457|NCT02477215|12487328|FG000|Fixed Dose Phase|Physician Decision|0
7944458|NCT02477215|12487329|FG001|Fixed Dose Phase|Physician Decision|7
7944459|NCT02477215|12487330|FG002|Fixed Dose Phase|Physician Decision|0
7944460|NCT02477332|12487361|FG000|Overall Study|Adverse Event|0
7944461|NCT02477332|12487362|FG001|Overall Study|Adverse Event|1
7944462|NCT02477332|12487363|FG002|Overall Study|Adverse Event|1
7944463|NCT02477332|12487364|FG003|Overall Study|Adverse Event|2
7944464|NCT02477332|12487365|FG004|Overall Study|Adverse Event|1
7944465|NCT02477332|12487366|FG005|Overall Study|Adverse Event|2
7944466|NCT02477332|12487361|FG000|Overall Study|Lack of Efficacy|1
7944467|NCT02477332|12487362|FG001|Overall Study|Lack of Efficacy|2
7944468|NCT02477332|12487363|FG002|Overall Study|Lack of Efficacy|1
7944469|NCT02477332|12487364|FG003|Overall Study|Lack of Efficacy|2
7944470|NCT02477332|12487365|FG004|Overall Study|Lack of Efficacy|1
7944471|NCT02477332|12487366|FG005|Overall Study|Lack of Efficacy|1
7944472|NCT02477332|12487361|FG000|Overall Study|Non-compliance with study treatment|0
7944473|NCT02477332|12487362|FG001|Overall Study|Non-compliance with study treatment|1
7944474|NCT02477332|12487363|FG002|Overall Study|Non-compliance with study treatment|2
7944475|NCT02477332|12487364|FG003|Overall Study|Non-compliance with study treatment|0
7944476|NCT02477332|12487365|FG004|Overall Study|Non-compliance with study treatment|0
7944477|NCT02477332|12487366|FG005|Overall Study|Non-compliance with study treatment|0
7944478|NCT02477332|12487361|FG000|Overall Study|Pregnancy|0
7944479|NCT02477332|12487362|FG001|Overall Study|Pregnancy|0
7944480|NCT02477332|12487363|FG002|Overall Study|Pregnancy|0
7944481|NCT02477332|12487364|FG003|Overall Study|Pregnancy|1
7944482|NCT02477332|12487365|FG004|Overall Study|Pregnancy|0
7944483|NCT02477332|12487366|FG005|Overall Study|Pregnancy|0
7944484|NCT02477332|12487361|FG000|Overall Study|Protocol Violation|2
7944485|NCT02477332|12487362|FG001|Overall Study|Protocol Violation|0
7944486|NCT02477332|12487363|FG002|Overall Study|Protocol Violation|3
7944487|NCT02477332|12487364|FG003|Overall Study|Protocol Violation|3
7944488|NCT02477332|12487365|FG004|Overall Study|Protocol Violation|1
7944489|NCT02477332|12487366|FG005|Overall Study|Protocol Violation|1
7944490|NCT02477332|12487361|FG000|Overall Study|Technical problems|0
7944491|NCT02477332|12487362|FG001|Overall Study|Technical problems|0
7944492|NCT02477332|12487363|FG002|Overall Study|Technical problems|1
7944493|NCT02477332|12487364|FG003|Overall Study|Technical problems|0
7944494|NCT02477332|12487365|FG004|Overall Study|Technical problems|0
7944495|NCT02477332|12487366|FG005|Overall Study|Technical problems|0
7944496|NCT02477332|12487361|FG000|Overall Study|Lost to Follow-up|0
7944497|NCT02477332|12487362|FG001|Overall Study|Lost to Follow-up|0
7944498|NCT02477332|12487363|FG002|Overall Study|Lost to Follow-up|2
7944499|NCT02477332|12487364|FG003|Overall Study|Lost to Follow-up|0
7944500|NCT02477332|12487365|FG004|Overall Study|Lost to Follow-up|0
7944501|NCT02477332|12487366|FG005|Overall Study|Lost to Follow-up|0
7944502|NCT02477332|12487361|FG000|Overall Study|Physician Decision|0
7944503|NCT02477332|12487362|FG001|Overall Study|Physician Decision|0
7944504|NCT02477332|12487363|FG002|Overall Study|Physician Decision|1
7944505|NCT02477332|12487364|FG003|Overall Study|Physician Decision|3
7944506|NCT02477332|12487365|FG004|Overall Study|Physician Decision|0
7944507|NCT02477332|12487366|FG005|Overall Study|Physician Decision|1
7944508|NCT02477332|12487361|FG000|Overall Study|Withdrawal by Subject|0
7944509|NCT02477332|12487362|FG001|Overall Study|Withdrawal by Subject|3
7944510|NCT02477332|12487363|FG002|Overall Study|Withdrawal by Subject|1
7944511|NCT02477332|12487364|FG003|Overall Study|Withdrawal by Subject|2
7944512|NCT02477332|12487365|FG004|Overall Study|Withdrawal by Subject|1
7944513|NCT02477332|12487366|FG005|Overall Study|Withdrawal by Subject|0
7944514|NCT02477527|12487391|FG000|Overall Study|Lost to Follow-up|2
7944515|NCT02477527|12487391|FG000|Overall Study|Withdrawal by Subject|1
7944516|NCT02477527|12487391|FG000|Overall Study|Screen Failure|3
7944517|NCT02477553|12487397|FG000|Overall Study|Screening up-to-date|12
7944518|NCT02477553|12487398|FG001|Overall Study|Screening up-to-date|13
7944519|NCT02477553|12487397|FG000|Overall Study|No MD visit|1
7944520|NCT02477553|12487398|FG001|Overall Study|No MD visit|1
7944521|NCT02477553|12487397|FG000|Overall Study|Workup consistent w/CRC|1
7944522|NCT02477553|12487398|FG001|Overall Study|Workup consistent w/CRC|1
7944523|NCT02477553|12487397|FG000|Overall Study|Technical issues with intervention|2
7944524|NCT02477553|12487398|FG001|Overall Study|Technical issues with intervention|0
7944525|NCT02477553|12487397|FG000|Overall Study|Elevated risk for CRC|2
7944526|NCT02477553|12487398|FG001|Overall Study|Elevated risk for CRC|2
7944527|NCT02477553|12487397|FG000|Overall Study|MD advised against screening|1
7944528|NCT02477553|12487398|FG001|Overall Study|MD advised against screening|3
7944529|NCT02477553|12487397|FG000|Overall Study|patient deceased|1
7944530|NCT02477553|12487398|FG001|Overall Study|patient deceased|0
7944531|NCT02477605|12487406|FG000|Overall Study|Discontinued prior to treatment|1
7944532|NCT02477605|12487407|FG001|Overall Study|Discontinued prior to treatment|0
7944533|NCT02477605|12487406|FG000|Overall Study|Lost to Follow-up|0
7944534|NCT02477605|12487407|FG001|Overall Study|Lost to Follow-up|2
7944535|NCT02477605|12487406|FG000|Overall Study|Withdrawal by Subject|0
7944536|NCT02477605|12487407|FG001|Overall Study|Withdrawal by Subject|1
7944537|NCT02477605|12487406|FG000|Overall Study|Administered gas during surgery|0
7944538|NCT02477605|12487407|FG001|Overall Study|Administered gas during surgery|1
7944539|NCT02477670|12487419|FG000|Stage 1|Adverse Event|2
7944540|NCT02477670|12487420|FG001|Stage 1|Adverse Event|7
7944541|NCT02477670|12487421|FG002|Stage 1|Adverse Event|0
7944542|NCT02477670|12487422|FG003|Stage 1|Adverse Event|0
7944543|NCT02477670|12487423|FG004|Stage 1|Adverse Event|0
7944544|NCT02477670|12487424|FG005|Stage 1|Adverse Event|0
7944545|NCT02477670|12487425|FG006|Stage 1|Adverse Event|0
7944546|NCT02477670|12487419|FG000|Stage 1|Lost to Follow-up|0
7944547|NCT02477670|12487420|FG001|Stage 1|Lost to Follow-up|2
7944548|NCT02477670|12487421|FG002|Stage 1|Lost to Follow-up|0
7944549|NCT02477670|12487422|FG003|Stage 1|Lost to Follow-up|0
7944550|NCT02477670|12487423|FG004|Stage 1|Lost to Follow-up|0
7944551|NCT02477670|12487424|FG005|Stage 1|Lost to Follow-up|0
7944552|NCT02477670|12487425|FG006|Stage 1|Lost to Follow-up|0
7944553|NCT02477670|12487419|FG000|Stage 1|Withdrawal by Subject|1
7944554|NCT02477670|12487420|FG001|Stage 1|Withdrawal by Subject|2
7944555|NCT02477670|12487421|FG002|Stage 1|Withdrawal by Subject|0
7944556|NCT02477670|12487422|FG003|Stage 1|Withdrawal by Subject|0
7944557|NCT02477670|12487423|FG004|Stage 1|Withdrawal by Subject|0
7944558|NCT02477670|12487424|FG005|Stage 1|Withdrawal by Subject|0
7944559|NCT02477670|12487425|FG006|Stage 1|Withdrawal by Subject|0
7944560|NCT02477670|12487419|FG000|Stage 1|Non-compliance with Study Drug|1
7944561|NCT02477670|12487420|FG001|Stage 1|Non-compliance with Study Drug|2
7944562|NCT02477670|12487421|FG002|Stage 1|Non-compliance with Study Drug|0
7944563|NCT02477670|12487422|FG003|Stage 1|Non-compliance with Study Drug|0
7944564|NCT02477670|12487423|FG004|Stage 1|Non-compliance with Study Drug|0
7944565|NCT02477670|12487424|FG005|Stage 1|Non-compliance with Study Drug|0
7944566|NCT02477670|12487425|FG006|Stage 1|Non-compliance with Study Drug|0
7944567|NCT02477670|12487419|FG000|Stage 2|Adverse Event|0
7944568|NCT02477670|12487420|FG001|Stage 2|Adverse Event|0
7944569|NCT02477670|12487421|FG002|Stage 2|Adverse Event|1
7944570|NCT02477670|12487422|FG003|Stage 2|Adverse Event|0
7944571|NCT02477670|12487423|FG004|Stage 2|Adverse Event|0
7944572|NCT02477670|12487424|FG005|Stage 2|Adverse Event|0
7944573|NCT02477670|12487425|FG006|Stage 2|Adverse Event|0
7944574|NCT02477670|12487419|FG000|Stage 2|Antipsychotic Medication Changed|0
7944575|NCT02477670|12487420|FG001|Stage 2|Antipsychotic Medication Changed|0
7944576|NCT02477670|12487421|FG002|Stage 2|Antipsychotic Medication Changed|1
7944577|NCT02477670|12487422|FG003|Stage 2|Antipsychotic Medication Changed|0
7944578|NCT02477670|12487423|FG004|Stage 2|Antipsychotic Medication Changed|0
7944579|NCT02477670|12487424|FG005|Stage 2|Antipsychotic Medication Changed|0
7944580|NCT02477670|12487425|FG006|Stage 2|Antipsychotic Medication Changed|0
7944581|NCT02477670|12487419|FG000|Stage 2|Withdrawal by Subject|0
7944582|NCT02477670|12487420|FG001|Stage 2|Withdrawal by Subject|0
7944583|NCT02477670|12487421|FG002|Stage 2|Withdrawal by Subject|0
7944584|NCT02477670|12487422|FG003|Stage 2|Withdrawal by Subject|1
7944585|NCT02477670|12487423|FG004|Stage 2|Withdrawal by Subject|0
7944586|NCT02477670|12487424|FG005|Stage 2|Withdrawal by Subject|0
7944587|NCT02477670|12487425|FG006|Stage 2|Withdrawal by Subject|0
7944588|NCT02477800|12487443|FG000|Placebo-Controlled Period|Adverse Event|16
7944589|NCT02477800|12487444|FG001|Placebo-Controlled Period|Adverse Event|25
7944590|NCT02477800|12487445|FG002|Placebo-Controlled Period|Adverse Event|28
7944591|NCT02477800|12487446|FG003|Placebo-Controlled Period|Adverse Event|0
7944592|NCT02477800|12487447|FG004|Placebo-Controlled Period|Adverse Event|0
7944593|NCT02477800|12487448|FG005|Placebo-Controlled Period|Adverse Event|0
7944594|NCT02477800|12487449|FG006|Placebo-Controlled Period|Adverse Event|0
7944595|NCT02477800|12487443|FG000|Placebo-Controlled Period|Change of Treatment|1
7944596|NCT02477800|12487444|FG001|Placebo-Controlled Period|Change of Treatment|2
7944597|NCT02477800|12487445|FG002|Placebo-Controlled Period|Change of Treatment|1
7944598|NCT02477800|12487446|FG003|Placebo-Controlled Period|Change of Treatment|0
7944599|NCT02477800|12487447|FG004|Placebo-Controlled Period|Change of Treatment|0
7944600|NCT02477800|12487448|FG005|Placebo-Controlled Period|Change of Treatment|0
7944601|NCT02477800|12487449|FG006|Placebo-Controlled Period|Change of Treatment|0
7944602|NCT02477800|12487443|FG000|Placebo-Controlled Period|Consent Withdrawn|26
7944603|NCT02477800|12487444|FG001|Placebo-Controlled Period|Consent Withdrawn|16
7944604|NCT02477800|12487445|FG002|Placebo-Controlled Period|Consent Withdrawn|27
7944605|NCT02477800|12487446|FG003|Placebo-Controlled Period|Consent Withdrawn|0
7944606|NCT02477800|12487447|FG004|Placebo-Controlled Period|Consent Withdrawn|0
7944607|NCT02477800|12487448|FG005|Placebo-Controlled Period|Consent Withdrawn|0
7944608|NCT02477800|12487449|FG006|Placebo-Controlled Period|Consent Withdrawn|0
7944609|NCT02477800|12487443|FG000|Placebo-Controlled Period|Death|0
7944610|NCT02477800|12487444|FG001|Placebo-Controlled Period|Death|3
7944611|NCT02477800|12487445|FG002|Placebo-Controlled Period|Death|2
7944612|NCT02477800|12487446|FG003|Placebo-Controlled Period|Death|0
7944613|NCT02477800|12487447|FG004|Placebo-Controlled Period|Death|0
7944614|NCT02477800|12487448|FG005|Placebo-Controlled Period|Death|0
7944615|NCT02477800|12487449|FG006|Placebo-Controlled Period|Death|0
7944616|NCT02477800|12487443|FG000|Placebo-Controlled Period|Disease Progression|1
7944617|NCT02477800|12487444|FG001|Placebo-Controlled Period|Disease Progression|0
7944618|NCT02477800|12487445|FG002|Placebo-Controlled Period|Disease Progression|1
7944619|NCT02477800|12487446|FG003|Placebo-Controlled Period|Disease Progression|0
7944620|NCT02477800|12487447|FG004|Placebo-Controlled Period|Disease Progression|0
7944621|NCT02477800|12487448|FG005|Placebo-Controlled Period|Disease Progression|0
7944622|NCT02477800|12487449|FG006|Placebo-Controlled Period|Disease Progression|0
7944623|NCT02477800|12487443|FG000|Placebo-Controlled Period|Investigator Decision|3
7944624|NCT02477800|12487444|FG001|Placebo-Controlled Period|Investigator Decision|2
7944625|NCT02477800|12487445|FG002|Placebo-Controlled Period|Investigator Decision|1
7944626|NCT02477800|12487446|FG003|Placebo-Controlled Period|Investigator Decision|0
7944627|NCT02477800|12487447|FG004|Placebo-Controlled Period|Investigator Decision|0
7944628|NCT02477800|12487448|FG005|Placebo-Controlled Period|Investigator Decision|0
7944629|NCT02477800|12487449|FG006|Placebo-Controlled Period|Investigator Decision|0
7944630|NCT02477800|12487443|FG000|Placebo-Controlled Period|Lost to Follow-up|1
7944631|NCT02477800|12487444|FG001|Placebo-Controlled Period|Lost to Follow-up|3
7944632|NCT02477800|12487445|FG002|Placebo-Controlled Period|Lost to Follow-up|3
7944633|NCT02477800|12487446|FG003|Placebo-Controlled Period|Lost to Follow-up|0
7944634|NCT02477800|12487447|FG004|Placebo-Controlled Period|Lost to Follow-up|0
7944635|NCT02477800|12487448|FG005|Placebo-Controlled Period|Lost to Follow-up|0
7944636|NCT02477800|12487449|FG006|Placebo-Controlled Period|Lost to Follow-up|0
7944637|NCT02477800|12487443|FG000|Placebo-Controlled Period|Relocation|2
7944638|NCT02477800|12487444|FG001|Placebo-Controlled Period|Relocation|0
7944639|NCT02477800|12487445|FG002|Placebo-Controlled Period|Relocation|0
7944640|NCT02477800|12487446|FG003|Placebo-Controlled Period|Relocation|0
7944641|NCT02477800|12487447|FG004|Placebo-Controlled Period|Relocation|0
7944642|NCT02477800|12487448|FG005|Placebo-Controlled Period|Relocation|0
7944643|NCT02477800|12487449|FG006|Placebo-Controlled Period|Relocation|0
7944644|NCT02477800|12487443|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1
7944645|NCT02477800|12487444|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1
7944646|NCT02477800|12487445|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1
7944647|NCT02477800|12487446|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0
7944648|NCT02477800|12487447|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0
7944649|NCT02477800|12487448|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0
7944650|NCT02477800|12487449|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0
7944651|NCT02477800|12487443|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2
7944652|NCT02477800|12487444|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1
7944653|NCT02477800|12487445|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0
7944654|NCT02477800|12487446|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0
7944655|NCT02477800|12487447|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0
7944656|NCT02477800|12487448|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0
7944657|NCT02477800|12487449|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0
7944658|NCT02477800|12487443|FG000|Placebo-Controlled Period|Study Visit Burden|5
7944659|NCT02477800|12487444|FG001|Placebo-Controlled Period|Study Visit Burden|3
7944660|NCT02477800|12487445|FG002|Placebo-Controlled Period|Study Visit Burden|11
7944661|NCT02477800|12487446|FG003|Placebo-Controlled Period|Study Visit Burden|0
7944662|NCT02477800|12487447|FG004|Placebo-Controlled Period|Study Visit Burden|0
7944663|NCT02477800|12487448|FG005|Placebo-Controlled Period|Study Visit Burden|0
7944664|NCT02477800|12487449|FG006|Placebo-Controlled Period|Study Visit Burden|0
7944665|NCT02477800|12487443|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7944666|NCT02477800|12487444|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5
7944667|NCT02477800|12487445|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3
7944668|NCT02477800|12487446|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7944669|NCT02477800|12487447|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7944670|NCT02477800|12487448|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7944671|NCT02477800|12487449|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7944672|NCT02477800|12487443|FG000|Placebo-Controlled Period|Reason not Specified|161
7944673|NCT02477800|12487444|FG001|Placebo-Controlled Period|Reason not Specified|161
7944674|NCT02477800|12487445|FG002|Placebo-Controlled Period|Reason not Specified|189
7944675|NCT02477800|12487446|FG003|Placebo-Controlled Period|Reason not Specified|0
7944676|NCT02477800|12487447|FG004|Placebo-Controlled Period|Reason not Specified|0
7944677|NCT02477800|12487448|FG005|Placebo-Controlled Period|Reason not Specified|0
7944678|NCT02477800|12487449|FG006|Placebo-Controlled Period|Reason not Specified|0
7944679|NCT02477800|12487443|FG000|Long Term Extension Period|Adverse Event|0
7944680|NCT02477800|12487444|FG001|Long Term Extension Period|Adverse Event|0
7944681|NCT02477800|12487445|FG002|Long Term Extension Period|Adverse Event|0
7944682|NCT02477800|12487446|FG003|Long Term Extension Period|Adverse Event|6
7944683|NCT02477800|12487447|FG004|Long Term Extension Period|Adverse Event|2
7944684|NCT02477800|12487448|FG005|Long Term Extension Period|Adverse Event|4
7944685|NCT02477800|12487449|FG006|Long Term Extension Period|Adverse Event|3
7944686|NCT02477800|12487443|FG000|Long Term Extension Period|Death|0
7944687|NCT02477800|12487444|FG001|Long Term Extension Period|Death|0
7944688|NCT02477800|12487445|FG002|Long Term Extension Period|Death|0
7944689|NCT02477800|12487446|FG003|Long Term Extension Period|Death|1
7944690|NCT02477800|12487447|FG004|Long Term Extension Period|Death|1
7944691|NCT02477800|12487448|FG005|Long Term Extension Period|Death|1
7944692|NCT02477800|12487449|FG006|Long Term Extension Period|Death|2
7944693|NCT02477800|12487443|FG000|Long Term Extension Period|Consent Withdrawn|0
7944694|NCT02477800|12487444|FG001|Long Term Extension Period|Consent Withdrawn|0
7944695|NCT02477800|12487445|FG002|Long Term Extension Period|Consent Withdrawn|0
7944696|NCT02477800|12487446|FG003|Long Term Extension Period|Consent Withdrawn|10
7944697|NCT02477800|12487447|FG004|Long Term Extension Period|Consent Withdrawn|4
7944698|NCT02477800|12487448|FG005|Long Term Extension Period|Consent Withdrawn|13
7944699|NCT02477800|12487449|FG006|Long Term Extension Period|Consent Withdrawn|16
7944700|NCT02477800|12487443|FG000|Long Term Extension Period|Disease Progression|0
7944701|NCT02477800|12487444|FG001|Long Term Extension Period|Disease Progression|0
7944702|NCT02477800|12487445|FG002|Long Term Extension Period|Disease Progression|0
7944703|NCT02477800|12487446|FG003|Long Term Extension Period|Disease Progression|3
7944704|NCT02477800|12487447|FG004|Long Term Extension Period|Disease Progression|1
7944705|NCT02477800|12487448|FG005|Long Term Extension Period|Disease Progression|1
7944706|NCT02477800|12487449|FG006|Long Term Extension Period|Disease Progression|0
7944707|NCT02477800|12487443|FG000|Long Term Extension Period|Investigator Decision|0
7944708|NCT02477800|12487444|FG001|Long Term Extension Period|Investigator Decision|0
7944709|NCT02477800|12487445|FG002|Long Term Extension Period|Investigator Decision|0
7944710|NCT02477800|12487446|FG003|Long Term Extension Period|Investigator Decision|0
7944711|NCT02477800|12487447|FG004|Long Term Extension Period|Investigator Decision|0
7944712|NCT02477800|12487448|FG005|Long Term Extension Period|Investigator Decision|0
7944713|NCT02477800|12487449|FG006|Long Term Extension Period|Investigator Decision|2
7944714|NCT02477800|12487443|FG000|Long Term Extension Period|Lost to Follow-up|0
7944715|NCT02477800|12487444|FG001|Long Term Extension Period|Lost to Follow-up|0
7944716|NCT02477800|12487445|FG002|Long Term Extension Period|Lost to Follow-up|0
7944717|NCT02477800|12487446|FG003|Long Term Extension Period|Lost to Follow-up|0
7944718|NCT02477800|12487447|FG004|Long Term Extension Period|Lost to Follow-up|1
7944719|NCT02477800|12487448|FG005|Long Term Extension Period|Lost to Follow-up|3
7944720|NCT02477800|12487449|FG006|Long Term Extension Period|Lost to Follow-up|0
7944721|NCT02477800|12487443|FG000|Long Term Extension Period|Site Terminated By Sponsor|0
7944722|NCT02477800|12487444|FG001|Long Term Extension Period|Site Terminated By Sponsor|0
7944723|NCT02477800|12487445|FG002|Long Term Extension Period|Site Terminated By Sponsor|0
7944724|NCT02477800|12487446|FG003|Long Term Extension Period|Site Terminated By Sponsor|0
7944725|NCT02477800|12487447|FG004|Long Term Extension Period|Site Terminated By Sponsor|0
7944726|NCT02477800|12487448|FG005|Long Term Extension Period|Site Terminated By Sponsor|2
7944727|NCT02477800|12487449|FG006|Long Term Extension Period|Site Terminated By Sponsor|1
7944728|NCT02477800|12487443|FG000|Long Term Extension Period|Study Visit Burden|0
7944729|NCT02477800|12487444|FG001|Long Term Extension Period|Study Visit Burden|0
7944730|NCT02477800|12487445|FG002|Long Term Extension Period|Study Visit Burden|0
7944731|NCT02477800|12487446|FG003|Long Term Extension Period|Study Visit Burden|3
7944732|NCT02477800|12487447|FG004|Long Term Extension Period|Study Visit Burden|0
7944733|NCT02477800|12487448|FG005|Long Term Extension Period|Study Visit Burden|2
7944734|NCT02477800|12487449|FG006|Long Term Extension Period|Study Visit Burden|2
7944735|NCT02477800|12487443|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0
7944736|NCT02477800|12487444|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0
7944737|NCT02477800|12487445|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0
7944738|NCT02477800|12487446|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1
7944739|NCT02477800|12487447|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3
7944740|NCT02477800|12487448|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3
7944741|NCT02477800|12487449|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1
7944742|NCT02477800|12487443|FG000|Long Term Extension Period|Reason not Specified|0
7944743|NCT02477800|12487444|FG001|Long Term Extension Period|Reason not Specified|0
7944744|NCT02477800|12487445|FG002|Long Term Extension Period|Reason not Specified|0
7944745|NCT02477800|12487446|FG003|Long Term Extension Period|Reason not Specified|126
7944746|NCT02477800|12487447|FG004|Long Term Extension Period|Reason not Specified|140
7944747|NCT02477800|12487448|FG005|Long Term Extension Period|Reason not Specified|270
7944748|NCT02477800|12487449|FG006|Long Term Extension Period|Reason not Specified|224
7944749|NCT02477839|12487463|FG000|Overall Study|Adverse Event|0
7944750|NCT02477839|12487464|FG001|Overall Study|Adverse Event|1
7944751|NCT02477839|12487463|FG000|Overall Study|Protocol Violation|0
7944752|NCT02477839|12487464|FG001|Overall Study|Protocol Violation|2
7944753|NCT02477839|12487463|FG000|Overall Study|Withdrawal by Subject|3
7944754|NCT02477839|12487464|FG001|Overall Study|Withdrawal by Subject|3
7944755|NCT02477839|12487463|FG000|Overall Study|Participant had PGS during V6|0
7944756|NCT02477839|12487464|FG001|Overall Study|Participant had PGS during V6|1
7944757|NCT02477839|12487463|FG000|Overall Study|Parents decided to stop medication|0
7944758|NCT02477839|12487464|FG001|Overall Study|Parents decided to stop medication|1
7944759|NCT02477839|12487463|FG000|Overall Study|Lack of tolerability|0
7944760|NCT02477839|12487464|FG001|Overall Study|Lack of tolerability|1
7944761|NCT02477839|12487463|FG000|Overall Study|Exclusion criterion|0
7944762|NCT02477839|12487464|FG001|Overall Study|Exclusion criterion|1
7965593|NCT01190930|12520934|FG008|Maintenance|Adverse Event|3
7965594|NCT01190930|12520935|FG009|Maintenance|Adverse Event|0
7965595|NCT01190930|12520926|FG000|Maintenance|Death|0
7965596|NCT01190930|12520927|FG001|Maintenance|Death|0
7965597|NCT01190930|12520928|FG002|Maintenance|Death|0
7965598|NCT01190930|12520929|FG003|Maintenance|Death|1
7965599|NCT01190930|12520930|FG004|Maintenance|Death|0
7965600|NCT01190930|12520931|FG005|Maintenance|Death|0
7965601|NCT01190930|12520932|FG006|Maintenance|Death|2
7965602|NCT01190930|12520933|FG007|Maintenance|Death|2
7965603|NCT01190930|12520934|FG008|Maintenance|Death|2
7965604|NCT01190930|12520935|FG009|Maintenance|Death|2
7965605|NCT01190930|12520926|FG000|Maintenance|Lost to Follow-up|0
7965606|NCT01190930|12520927|FG001|Maintenance|Lost to Follow-up|0
7965607|NCT01190930|12520928|FG002|Maintenance|Lost to Follow-up|0
7965608|NCT01190930|12520929|FG003|Maintenance|Lost to Follow-up|0
7965609|NCT01190930|12520930|FG004|Maintenance|Lost to Follow-up|0
7965610|NCT01190930|12520931|FG005|Maintenance|Lost to Follow-up|0
7965611|NCT01190930|12520932|FG006|Maintenance|Lost to Follow-up|1
7965612|NCT01190930|12520933|FG007|Maintenance|Lost to Follow-up|1
7965613|NCT01190930|12520934|FG008|Maintenance|Lost to Follow-up|1
7965614|NCT01190930|12520935|FG009|Maintenance|Lost to Follow-up|0
7965615|NCT01190930|12520926|FG000|Maintenance|Physician Decision|0
7965616|NCT01190930|12520927|FG001|Maintenance|Physician Decision|1
7965617|NCT01190930|12520928|FG002|Maintenance|Physician Decision|0
7965618|NCT01190930|12520929|FG003|Maintenance|Physician Decision|5
7965619|NCT01190930|12520930|FG004|Maintenance|Physician Decision|9
7965620|NCT01190930|12520931|FG005|Maintenance|Physician Decision|4
7965621|NCT01190930|12520932|FG006|Maintenance|Physician Decision|8
7965622|NCT01190930|12520933|FG007|Maintenance|Physician Decision|8
7965623|NCT01190930|12520934|FG008|Maintenance|Physician Decision|10
7965624|NCT01190930|12520935|FG009|Maintenance|Physician Decision|17
7965625|NCT01190930|12520926|FG000|Maintenance|Withdrawal by Subject|0
7965626|NCT01190930|12520927|FG001|Maintenance|Withdrawal by Subject|0
7965627|NCT01190930|12520928|FG002|Maintenance|Withdrawal by Subject|0
7965628|NCT01190930|12520929|FG003|Maintenance|Withdrawal by Subject|0
7965629|NCT01190930|12520930|FG004|Maintenance|Withdrawal by Subject|0
7965630|NCT01190930|12520931|FG005|Maintenance|Withdrawal by Subject|0
7965631|NCT01190930|12520932|FG006|Maintenance|Withdrawal by Subject|2
7965632|NCT01190930|12520933|FG007|Maintenance|Withdrawal by Subject|1
7965633|NCT01190930|12520934|FG008|Maintenance|Withdrawal by Subject|4
7965634|NCT01190930|12520935|FG009|Maintenance|Withdrawal by Subject|1
7965635|NCT01190930|12520926|FG000|Maintenance|Refusal|0
7965636|NCT01190930|12520927|FG001|Maintenance|Refusal|1
7965637|NCT01190930|12520928|FG002|Maintenance|Refusal|0
7965638|NCT01190930|12520929|FG003|Maintenance|Refusal|2
7965639|NCT01190930|12520930|FG004|Maintenance|Refusal|0
7965640|NCT01190930|12520931|FG005|Maintenance|Refusal|4
7965641|NCT01190930|12520932|FG006|Maintenance|Refusal|5
7965642|NCT01190930|12520933|FG007|Maintenance|Refusal|17
7965643|NCT01190930|12520934|FG008|Maintenance|Refusal|13
7965644|NCT01190930|12520935|FG009|Maintenance|Refusal|6
7965645|NCT01190930|12520926|FG000|Maintenance|second malignant neoplasm|0
7965646|NCT01190930|12520927|FG001|Maintenance|second malignant neoplasm|0
7965647|NCT01190930|12520928|FG002|Maintenance|second malignant neoplasm|0
7965648|NCT01190930|12520929|FG003|Maintenance|second malignant neoplasm|1
7965649|NCT01190930|12520930|FG004|Maintenance|second malignant neoplasm|0
7965650|NCT01190930|12520931|FG005|Maintenance|second malignant neoplasm|1
7965651|NCT01190930|12520932|FG006|Maintenance|second malignant neoplasm|0
7965652|NCT01190930|12520933|FG007|Maintenance|second malignant neoplasm|0
7965653|NCT01190930|12520934|FG008|Maintenance|second malignant neoplasm|1
7965654|NCT01190930|12520935|FG009|Maintenance|second malignant neoplasm|0
7965655|NCT01190930|12520926|FG000|Maintenance|Inevaluable|0
7965656|NCT01190930|12520927|FG001|Maintenance|Inevaluable|0
7965657|NCT01190930|12520928|FG002|Maintenance|Inevaluable|0
7965658|NCT01190930|12520929|FG003|Maintenance|Inevaluable|0
7965659|NCT01190930|12520930|FG004|Maintenance|Inevaluable|0
7965660|NCT01190930|12520931|FG005|Maintenance|Inevaluable|1
7965661|NCT01190930|12520932|FG006|Maintenance|Inevaluable|1
7965662|NCT01190930|12520933|FG007|Maintenance|Inevaluable|1
7965663|NCT01190930|12520934|FG008|Maintenance|Inevaluable|0
7965664|NCT01190930|12520935|FG009|Maintenance|Inevaluable|0
7965665|NCT01190930|12520926|FG000|Maintenance|Enrollment onto another COG Protocol|0
7965666|NCT01190930|12520927|FG001|Maintenance|Enrollment onto another COG Protocol|0
7965667|NCT01190930|12520928|FG002|Maintenance|Enrollment onto another COG Protocol|0
7965668|NCT01190930|12520929|FG003|Maintenance|Enrollment onto another COG Protocol|0
7965669|NCT01190930|12520930|FG004|Maintenance|Enrollment onto another COG Protocol|0
7965670|NCT01190930|12520931|FG005|Maintenance|Enrollment onto another COG Protocol|0
7965671|NCT01190930|12520932|FG006|Maintenance|Enrollment onto another COG Protocol|0
7965672|NCT01190930|12520933|FG007|Maintenance|Enrollment onto another COG Protocol|0
7965673|NCT01190930|12520934|FG008|Maintenance|Enrollment onto another COG Protocol|1
7965674|NCT01190930|12520935|FG009|Maintenance|Enrollment onto another COG Protocol|0
7944763|NCT02478164|12487472|FG000|Overall Study|Lack of Efficacy|13
7944764|NCT02478164|12487472|FG000|Overall Study|Adverse Event|1
7944765|NCT02478164|12487472|FG000|Overall Study|Withdrawal by Subject|1
7944766|NCT02478359|12487478|FG000|Overall Study|Disenrolled from health plan|106
7944767|NCT02478359|12487479|FG001|Overall Study|Disenrolled from health plan|65
7944768|NCT02478372|12487489|FG000|Overall Study|Protocol Violation|12
7944769|NCT02478372|12487490|FG001|Overall Study|Protocol Violation|8
7944770|NCT02478372|12487489|FG000|Overall Study|Lost to Follow-up|1
7944771|NCT02478372|12487490|FG001|Overall Study|Lost to Follow-up|4
7944772|NCT02478372|12487489|FG000|Overall Study|Death|0
7944773|NCT02478372|12487490|FG001|Overall Study|Death|2
7944774|NCT02478398|12487498|FG000|Overall Study|Adverse Event|20
7944775|NCT02478398|12487499|FG001|Overall Study|Adverse Event|5
7944776|NCT02478398|12487498|FG000|Overall Study|Lost to Follow-up|5
7944777|NCT02478398|12487499|FG001|Overall Study|Lost to Follow-up|4
7944778|NCT02478398|12487498|FG000|Overall Study|Non-Compliance With Study Drug|5
7944779|NCT02478398|12487499|FG001|Overall Study|Non-Compliance With Study Drug|1
7944780|NCT02478398|12487498|FG000|Overall Study|Protocol Violation|3
7944781|NCT02478398|12487499|FG001|Overall Study|Protocol Violation|1
7944782|NCT02478398|12487498|FG000|Overall Study|Withdrawal By Parent/Guardian|9
7944783|NCT02478398|12487499|FG001|Overall Study|Withdrawal By Parent/Guardian|6
7944784|NCT02478398|12487498|FG000|Overall Study|Withdrawal By Participant|10
7944785|NCT02478398|12487499|FG001|Overall Study|Withdrawal By Participant|4
7944786|NCT02478463|12487506|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1
7944787|NCT02478463|12487506|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1
7944788|NCT02478463|12487506|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1
7944789|NCT02478632|12487534|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4
7944790|NCT02478632|12487535|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5
7944791|NCT02478632|12487534|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2
7944792|NCT02478632|12487535|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3
7944793|NCT02478632|12487534|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5
7944794|NCT02478632|12487535|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1
7944795|NCT02479139|12487555|FG000|Overall Study|Lost to Follow-up|2
7944796|NCT02479139|12487556|FG001|Overall Study|Lost to Follow-up|4
7944797|NCT02479139|12487557|FG002|Overall Study|Lost to Follow-up|4
7944798|NCT02479139|12487558|FG003|Overall Study|Lost to Follow-up|2
7944799|NCT02479139|12487559|FG004|Overall Study|Lost to Follow-up|3
7944800|NCT02479139|12487560|FG005|Overall Study|Lost to Follow-up|5
7944801|NCT02479139|12487555|FG000|Overall Study|Withdrew Consent|5
7944802|NCT02479139|12487556|FG001|Overall Study|Withdrew Consent|6
7944803|NCT02479139|12487557|FG002|Overall Study|Withdrew Consent|1
7944804|NCT02479139|12487558|FG003|Overall Study|Withdrew Consent|4
7944805|NCT02479139|12487559|FG004|Overall Study|Withdrew Consent|1
7944806|NCT02479139|12487560|FG005|Overall Study|Withdrew Consent|1
7944807|NCT02479139|12487555|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0
7944808|NCT02479139|12487556|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0
7944809|NCT02479139|12487557|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1
7944810|NCT02479139|12487558|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0
7944811|NCT02479139|12487559|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0
7944812|NCT02479139|12487560|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0
7944813|NCT02479139|12487555|FG000|Overall Study|Other Miscellaneous Reasons|1
7944814|NCT02479139|12487556|FG001|Overall Study|Other Miscellaneous Reasons|0
7944815|NCT02479139|12487557|FG002|Overall Study|Other Miscellaneous Reasons|1
7944816|NCT02479139|12487558|FG003|Overall Study|Other Miscellaneous Reasons|1
7944817|NCT02479139|12487559|FG004|Overall Study|Other Miscellaneous Reasons|1
7944818|NCT02479139|12487560|FG005|Overall Study|Other Miscellaneous Reasons|0
7944819|NCT02479412|12487583|FG000|Overall Study|Adverse Event|0
7944820|NCT02479412|12487584|FG001|Overall Study|Adverse Event|0
7944821|NCT02479412|12487585|FG002|Overall Study|Adverse Event|1
7944822|NCT02479412|12487586|FG003|Overall Study|Adverse Event|0
7944823|NCT02479412|12487587|FG004|Overall Study|Adverse Event|0
7944824|NCT02479412|12487588|FG005|Overall Study|Adverse Event|0
7944825|NCT02479412|12487589|FG006|Overall Study|Adverse Event|0
7944826|NCT02479412|12487590|FG007|Overall Study|Adverse Event|0
7944827|NCT02479412|12487591|FG008|Overall Study|Adverse Event|0
7944828|NCT02479412|12487583|FG000|Overall Study|Study-specific withdrawal criteria|0
7944829|NCT02479412|12487584|FG001|Overall Study|Study-specific withdrawal criteria|0
7944830|NCT02479412|12487585|FG002|Overall Study|Study-specific withdrawal criteria|1
7944831|NCT02479412|12487586|FG003|Overall Study|Study-specific withdrawal criteria|1
7944832|NCT02479412|12487587|FG004|Overall Study|Study-specific withdrawal criteria|0
7944833|NCT02479412|12487588|FG005|Overall Study|Study-specific withdrawal criteria|0
7944834|NCT02479412|12487589|FG006|Overall Study|Study-specific withdrawal criteria|0
7944835|NCT02479412|12487590|FG007|Overall Study|Study-specific withdrawal criteria|1
7944836|NCT02479412|12487591|FG008|Overall Study|Study-specific withdrawal criteria|1
7944837|NCT02479412|12487583|FG000|Overall Study|Randomization to wrong PK sampling group|0
7944838|NCT02479412|12487584|FG001|Overall Study|Randomization to wrong PK sampling group|0
7944839|NCT02479412|12487585|FG002|Overall Study|Randomization to wrong PK sampling group|0
7944840|NCT02479412|12487586|FG003|Overall Study|Randomization to wrong PK sampling group|0
7944841|NCT02479412|12487587|FG004|Overall Study|Randomization to wrong PK sampling group|1
7944842|NCT02479412|12487588|FG005|Overall Study|Randomization to wrong PK sampling group|0
7944843|NCT02479412|12487589|FG006|Overall Study|Randomization to wrong PK sampling group|0
7944844|NCT02479412|12487590|FG007|Overall Study|Randomization to wrong PK sampling group|0
7944845|NCT02479412|12487591|FG008|Overall Study|Randomization to wrong PK sampling group|0
7944846|NCT02479802|12487616|FG000|Overall Study|Lost to Follow-up|1
7944847|NCT02479802|12487616|FG000|Overall Study|Adverse Event|1
7944848|NCT02479880|12487622|FG000|Overall Study|Study Terminated by Sponsor|13
7944849|NCT02479880|12487623|FG001|Overall Study|Study Terminated by Sponsor|12
7944850|NCT02479880|12487622|FG000|Overall Study|Pregnancy|0
7944851|NCT02479880|12487623|FG001|Overall Study|Pregnancy|1
7944852|NCT02480010|12487631|FG000|Overall Study|Adverse Event|3
7944853|NCT02480010|12487632|FG001|Overall Study|Adverse Event|1
7944854|NCT02480010|12487631|FG000|Overall Study|Death|1
7944855|NCT02480010|12487632|FG001|Overall Study|Death|0
7944856|NCT02480010|12487631|FG000|Overall Study|Insufficient therapeutic response|31
7944857|NCT02480010|12487632|FG001|Overall Study|Insufficient therapeutic response|29
7944858|NCT02480010|12487631|FG000|Overall Study|Refused Treatment|0
7944859|NCT02480010|12487632|FG001|Overall Study|Refused Treatment|3
7944860|NCT02480114|12487640|FG000|Overall Study|Not completing surveys|3
7944861|NCT02480114|12487641|FG001|Overall Study|Not completing surveys|2
7944862|NCT02480114|12487640|FG000|Overall Study|Withdrawal by Subject|2
7944863|NCT02480114|12487641|FG001|Overall Study|Withdrawal by Subject|4
7944864|NCT02480114|12487640|FG000|Overall Study|Disease progression|3
7944865|NCT02480114|12487641|FG001|Overall Study|Disease progression|0
7944866|NCT02480114|12487640|FG000|Overall Study|Improper completion of survey|1
7944867|NCT02480114|12487641|FG001|Overall Study|Improper completion of survey|1
7944868|NCT02480114|12487640|FG000|Overall Study|Not eligible|0
7944869|NCT02480114|12487641|FG001|Overall Study|Not eligible|1
7944870|NCT02480153|12487649|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
7944871|NCT02480153|12487650|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1
7944872|NCT02480153|12487651|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
7944873|NCT02480153|12487649|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
7944874|NCT02480153|12487650|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1
7944875|NCT02480153|12487651|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
7944876|NCT02480153|12487649|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1
7944877|NCT02480153|12487650|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2
7944878|NCT02480153|12487651|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0
7944879|NCT02480153|12487649|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3
7944880|NCT02480153|12487650|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8
7944881|NCT02480153|12487651|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0
7944882|NCT02480153|12487649|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0
7944883|NCT02480153|12487650|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1
7944884|NCT02480153|12487651|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0
7944885|NCT02480153|12487649|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0
7944886|NCT02480153|12487650|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1
7944887|NCT02480153|12487651|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0
7944888|NCT02480153|12487649|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
7944889|NCT02480153|12487650|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2
7944890|NCT02480153|12487651|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
7944891|NCT02480153|12487649|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4
7944892|NCT02480153|12487650|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1
7944893|NCT02480153|12487651|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3
7944894|NCT02480153|12487649|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
7944895|NCT02480153|12487650|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1
7944896|NCT02480153|12487651|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
7944897|NCT02480153|12487649|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8
7944898|NCT02480153|12487650|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3
7944899|NCT02480153|12487651|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1
7944900|NCT02480153|12487649|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6
7944901|NCT02480153|12487650|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7
7944902|NCT02480153|12487651|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3
7944903|NCT02480153|12487649|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2
7944904|NCT02480153|12487650|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0
7944905|NCT02480153|12487651|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0
7944906|NCT02480153|12487649|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
7944907|NCT02480153|12487650|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1
7944908|NCT02480153|12487651|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
7944909|NCT02480153|12487649|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3
7944910|NCT02480153|12487650|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2
7944911|NCT02480153|12487651|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1
7944912|NCT02480153|12487649|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4
7944913|NCT02480153|12487650|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0
7944914|NCT02480153|12487651|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1
7944915|NCT02480153|12487649|FG000|Period 3: Week 52 Dosing to Week 78|Other|0
7944916|NCT02480153|12487650|FG001|Period 3: Week 52 Dosing to Week 78|Other|0
7944917|NCT02480153|12487651|FG002|Period 3: Week 52 Dosing to Week 78|Other|1
7944918|NCT02480153|12487649|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
7944919|NCT02480153|12487650|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
7944920|NCT02480153|12487651|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1
7944921|NCT02480153|12487649|FG000|Period 3: Week 52 Dosing to Week 78|Death|0
7944922|NCT02480153|12487650|FG001|Period 3: Week 52 Dosing to Week 78|Death|1
7944923|NCT02480153|12487651|FG002|Period 3: Week 52 Dosing to Week 78|Death|0
7944924|NCT02480621|12487721|FG000|Randomization|Withdrawal by Subject|1
7944925|NCT02480621|12487722|FG001|Randomization|Withdrawal by Subject|0
7944926|NCT02480621|12487721|FG000|Randomization|Surgeon did not give intervention|0
7944927|NCT02480621|12487722|FG001|Randomization|Surgeon did not give intervention|1
7944928|NCT02480621|12487721|FG000|Follow Up|Lost to Follow-up|4
7944929|NCT02480621|12487722|FG001|Follow Up|Lost to Follow-up|2
7944930|NCT02480712|12487728|FG000|Overall Study|Enrolled but Never Treated|1
7944931|NCT02480712|12487728|FG000|Overall Study|Lost to Follow-up|5
7944932|NCT02480712|12487728|FG000|Overall Study|Withdrew Consent|3
7944933|NCT02480712|12487728|FG000|Overall Study|Death|1
7944934|NCT02480712|12487728|FG000|Overall Study|Lack of Efficacy|1
7944935|NCT02480764|12487741|FG000|Overall Study|Pretreatment Event/Adverse Event|3
7944936|NCT02480764|12487742|FG001|Overall Study|Pretreatment Event/Adverse Event|6
7944937|NCT02480764|12487743|FG002|Overall Study|Pretreatment Event/Adverse Event|3
7944938|NCT02480764|12487741|FG000|Overall Study|Major Protocol Deviation|1
7944939|NCT02480764|12487742|FG001|Overall Study|Major Protocol Deviation|4
7944940|NCT02480764|12487743|FG002|Overall Study|Major Protocol Deviation|3
7944941|NCT02480764|12487741|FG000|Overall Study|Lost to Follow-up|0
7944942|NCT02480764|12487742|FG001|Overall Study|Lost to Follow-up|1
7944943|NCT02480764|12487743|FG002|Overall Study|Lost to Follow-up|2
7944944|NCT02480764|12487741|FG000|Overall Study|Voluntary Withdrawal|6
7944945|NCT02480764|12487742|FG001|Overall Study|Voluntary Withdrawal|5
7944946|NCT02480764|12487743|FG002|Overall Study|Voluntary Withdrawal|10
7944947|NCT02480764|12487741|FG000|Overall Study|Lack of Efficacy|0
7944948|NCT02480764|12487742|FG001|Overall Study|Lack of Efficacy|3
7944949|NCT02480764|12487743|FG002|Overall Study|Lack of Efficacy|3
7944950|NCT02480764|12487741|FG000|Overall Study|Reason not Specified|0
7944951|NCT02480764|12487742|FG001|Overall Study|Reason not Specified|1
7944952|NCT02480764|12487743|FG002|Overall Study|Reason not Specified|0
7944953|NCT02481050|12487766|FG000|Overall Study|Adverse Event|1
7944954|NCT02481050|12487766|FG000|Overall Study|Disease Progression|47
7944955|NCT02481050|12487766|FG000|Overall Study|Withdrawal by Subject|7
7944956|NCT02481050|12487766|FG000|Overall Study|Other|3
7944957|NCT02481869|12487911|FG000|Overall Study|Lost to Follow-up|3
7944958|NCT02481869|12487912|FG001|Overall Study|Lost to Follow-up|4
7944959|NCT02481869|12487911|FG000|Overall Study|Withdrawal by Subject|2
7944960|NCT02481869|12487912|FG001|Overall Study|Withdrawal by Subject|0
7944961|NCT02481934|12487919|FG000|Overall Study|Death|2
7944962|NCT02481947|12487925|FG000|Overall Study|Withdrawal by Subject|24
7944963|NCT02481947|12487926|FG001|Overall Study|Withdrawal by Subject|10
7944964|NCT02481947|12487925|FG000|Overall Study|Lost to Follow-up|11
7944965|NCT02481947|12487926|FG001|Overall Study|Lost to Follow-up|5
7944966|NCT02481947|12487925|FG000|Overall Study|Adverse Event|6
7944967|NCT02481947|12487926|FG001|Overall Study|Adverse Event|11
7944968|NCT02481947|12487925|FG000|Overall Study|Physician Decision|4
7944969|NCT02481947|12487926|FG001|Overall Study|Physician Decision|5
7944970|NCT02481947|12487925|FG000|Overall Study|Protocol Violation|1
7944971|NCT02481947|12487926|FG001|Overall Study|Protocol Violation|5
7944972|NCT02482129|12487943|FG000|Overall Study|Adverse Event-prior to treatment|0
7944973|NCT02482129|12487944|FG001|Overall Study|Adverse Event-prior to treatment|1
7944974|NCT02482129|12487943|FG000|Overall Study|Withdrawal by subject-prior to treatment|0
7944975|NCT02482129|12487944|FG001|Overall Study|Withdrawal by subject-prior to treatment|1
7944976|NCT02482129|12487943|FG000|Overall Study|Unable to draw blood-prior to treatment|1
7944977|NCT02482129|12487944|FG001|Overall Study|Unable to draw blood-prior to treatment|0
7944978|NCT02482129|12487943|FG000|Overall Study|Criteria not met-prior to treatment|1
7944979|NCT02482129|12487944|FG001|Overall Study|Criteria not met-prior to treatment|0
7944980|NCT02482129|12487943|FG000|Overall Study|Adverse Event|1
7944981|NCT02482129|12487944|FG001|Overall Study|Adverse Event|0
7944982|NCT02482129|12487943|FG000|Overall Study|Withdrawal by Subject|2
7944983|NCT02482129|12487944|FG001|Overall Study|Withdrawal by Subject|0
7944984|NCT02482129|12487943|FG000|Overall Study|Criteria not met|1
7944985|NCT02482129|12487944|FG001|Overall Study|Criteria not met|0
7944986|NCT02482298|12487955|FG000|Overall Study|Withdrawal by Subject|2
7944987|NCT02482298|12487956|FG001|Overall Study|Withdrawal by Subject|1
7944988|NCT02482298|12487957|FG002|Overall Study|Withdrawal by Subject|2
7944989|NCT02482298|12487955|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0
7944990|NCT02482298|12487956|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1
7944991|NCT02482298|12487957|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0
7944992|NCT02482298|12487955|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
7944993|NCT02482298|12487956|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
7944994|NCT02482298|12487957|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
7944995|NCT02482298|12487955|FG000|Overall Study|Lost to Follow-up|0
7944996|NCT02482298|12487956|FG001|Overall Study|Lost to Follow-up|1
7944997|NCT02482298|12487957|FG002|Overall Study|Lost to Follow-up|0
7944998|NCT02482428|12487970|FG000|Overall Study|Lost to Follow-up|4
7944999|NCT02482428|12487971|FG001|Overall Study|Lost to Follow-up|9
7945000|NCT02482428|12487972|FG002|Overall Study|Lost to Follow-up|1
7945001|NCT02482428|12487973|FG003|Overall Study|Lost to Follow-up|2
7945002|NCT02482428|12487974|FG004|Overall Study|Lost to Follow-up|4
7945003|NCT02482428|12487970|FG000|Overall Study|Physician Decision|0
7945004|NCT02482428|12487971|FG001|Overall Study|Physician Decision|0
7945005|NCT02482428|12487972|FG002|Overall Study|Physician Decision|0
7945006|NCT02482428|12487973|FG003|Overall Study|Physician Decision|0
7945007|NCT02482428|12487974|FG004|Overall Study|Physician Decision|1
7945008|NCT02482428|12487970|FG000|Overall Study|protocol deviation|1
7945009|NCT02482428|12487971|FG001|Overall Study|protocol deviation|1
7945010|NCT02482428|12487972|FG002|Overall Study|protocol deviation|0
7945011|NCT02482428|12487973|FG003|Overall Study|protocol deviation|0
7945012|NCT02482428|12487974|FG004|Overall Study|protocol deviation|0
7945013|NCT02482428|12487970|FG000|Overall Study|subject/guardian decision|4
7945014|NCT02482428|12487971|FG001|Overall Study|subject/guardian decision|2
7945015|NCT02482428|12487972|FG002|Overall Study|subject/guardian decision|0
7945016|NCT02482428|12487973|FG003|Overall Study|subject/guardian decision|0
7945017|NCT02482428|12487974|FG004|Overall Study|subject/guardian decision|2
7945018|NCT02482571|12487988|FG000|Overall Study|Adverse Event|1
7945019|NCT02482571|12487988|FG000|Overall Study|Scanner or Respiract failure|3
7945020|NCT02482571|12487988|FG000|Overall Study|Withdrawal by Subject|4
7945021|NCT02482805|12488044|FG000|Overall Study|Lost to Follow-up|4
7945022|NCT02482805|12488045|FG001|Overall Study|Lost to Follow-up|4
7945023|NCT02482805|12488046|FG002|Overall Study|Lost to Follow-up|0
7945024|NCT02482935|12488069|FG000|Period 1|Withdrawal by Subject|1
7945025|NCT02482935|12488070|FG001|Period 1|Withdrawal by Subject|0
7945026|NCT02483416|12488085|FG000|Overall Study|Other reason|0
7945027|NCT02483416|12488086|FG001|Overall Study|Other reason|1
7945028|NCT02483416|12488085|FG000|Overall Study|Treatment stop|3
7945029|NCT02483416|12488086|FG001|Overall Study|Treatment stop|0
7945030|NCT02483520|12488095|FG000|Overall Study|Lost to Follow-up|3
7945031|NCT02483520|12488096|FG001|Overall Study|Lost to Follow-up|4
7945032|NCT02483520|12488095|FG000|Overall Study|Withdrawal by Subject|4
7945033|NCT02483520|12488096|FG001|Overall Study|Withdrawal by Subject|14
7945034|NCT02483520|12488095|FG000|Overall Study|Hospitalized|2
7945035|NCT02483520|12488096|FG001|Overall Study|Hospitalized|3
7945036|NCT02483520|12488095|FG000|Overall Study|Moved to LTC|2
7945037|NCT02483520|12488096|FG001|Overall Study|Moved to LTC|3
7945038|NCT02483572|12488104|FG000|Overall Study|Withdrawal by Subject|1
7945039|NCT02483572|12488105|FG001|Overall Study|Withdrawal by Subject|0
7945040|NCT02483572|12488104|FG000|Overall Study|Lost to Follow-up|1
7945041|NCT02483572|12488105|FG001|Overall Study|Lost to Follow-up|0
7945042|NCT02483572|12488104|FG000|Overall Study|Physician Decision|0
7945043|NCT02483572|12488105|FG001|Overall Study|Physician Decision|1
7945044|NCT02483611|12488114|FG000|Overall Study|Protocol Violation|0
7945045|NCT02483611|12488115|FG001|Overall Study|Protocol Violation|0
7945046|NCT02483611|12488116|FG002|Overall Study|Protocol Violation|1
7945047|NCT02483975|12488135|FG000|Overall Study|Adverse Event|0
7945048|NCT02483975|12488136|FG001|Overall Study|Adverse Event|1
7945049|NCT02483975|12488135|FG000|Overall Study|Lost to Follow-up|0
7945050|NCT02483975|12488136|FG001|Overall Study|Lost to Follow-up|1
7945051|NCT02483975|12488135|FG000|Overall Study|Physician Decision|2
7945052|NCT02483975|12488136|FG001|Overall Study|Physician Decision|0
7945053|NCT02484547|12488158|FG000|Placebo-Controlled Period|Adverse Event|10
7945054|NCT02484547|12488159|FG001|Placebo-Controlled Period|Adverse Event|13
7945055|NCT02484547|12488160|FG002|Placebo-Controlled Period|Adverse Event|20
7945056|NCT02484547|12488161|FG003|Placebo-Controlled Period|Adverse Event|0
7945057|NCT02484547|12488162|FG004|Placebo-Controlled Period|Adverse Event|0
7945058|NCT02484547|12488163|FG005|Placebo-Controlled Period|Adverse Event|0
7945059|NCT02484547|12488164|FG006|Placebo-Controlled Period|Adverse Event|0
7945060|NCT02484547|12488158|FG000|Placebo-Controlled Period|Change of Treatment|0
7945061|NCT02484547|12488159|FG001|Placebo-Controlled Period|Change of Treatment|0
7945062|NCT02484547|12488160|FG002|Placebo-Controlled Period|Change of Treatment|1
7945063|NCT02484547|12488161|FG003|Placebo-Controlled Period|Change of Treatment|0
7945064|NCT02484547|12488162|FG004|Placebo-Controlled Period|Change of Treatment|0
7945065|NCT02484547|12488163|FG005|Placebo-Controlled Period|Change of Treatment|0
7945066|NCT02484547|12488164|FG006|Placebo-Controlled Period|Change of Treatment|0
7945067|NCT02484547|12488158|FG000|Placebo-Controlled Period|Consent Withdrawn|15
7945068|NCT02484547|12488159|FG001|Placebo-Controlled Period|Consent Withdrawn|32
7945069|NCT02484547|12488160|FG002|Placebo-Controlled Period|Consent Withdrawn|26
7945070|NCT02484547|12488161|FG003|Placebo-Controlled Period|Consent Withdrawn|0
7945071|NCT02484547|12488162|FG004|Placebo-Controlled Period|Consent Withdrawn|0
7945072|NCT02484547|12488163|FG005|Placebo-Controlled Period|Consent Withdrawn|0
7945073|NCT02484547|12488164|FG006|Placebo-Controlled Period|Consent Withdrawn|0
7945074|NCT02484547|12488158|FG000|Placebo-Controlled Period|Death|5
7945075|NCT02484547|12488159|FG001|Placebo-Controlled Period|Death|0
7945076|NCT02484547|12488160|FG002|Placebo-Controlled Period|Death|6
7945077|NCT02484547|12488161|FG003|Placebo-Controlled Period|Death|0
7945078|NCT02484547|12488162|FG004|Placebo-Controlled Period|Death|0
7945079|NCT02484547|12488163|FG005|Placebo-Controlled Period|Death|0
7945080|NCT02484547|12488164|FG006|Placebo-Controlled Period|Death|0
7945081|NCT02484547|12488158|FG000|Placebo-Controlled Period|Disease Progression|2
7945082|NCT02484547|12488159|FG001|Placebo-Controlled Period|Disease Progression|0
7945083|NCT02484547|12488160|FG002|Placebo-Controlled Period|Disease Progression|1
7945084|NCT02484547|12488161|FG003|Placebo-Controlled Period|Disease Progression|0
7945085|NCT02484547|12488162|FG004|Placebo-Controlled Period|Disease Progression|0
7945086|NCT02484547|12488163|FG005|Placebo-Controlled Period|Disease Progression|0
7945087|NCT02484547|12488164|FG006|Placebo-Controlled Period|Disease Progression|0
7945088|NCT02484547|12488158|FG000|Placebo-Controlled Period|Investigator Decision|2
7945089|NCT02484547|12488159|FG001|Placebo-Controlled Period|Investigator Decision|2
7945090|NCT02484547|12488160|FG002|Placebo-Controlled Period|Investigator Decision|5
7945091|NCT02484547|12488161|FG003|Placebo-Controlled Period|Investigator Decision|0
7945092|NCT02484547|12488162|FG004|Placebo-Controlled Period|Investigator Decision|0
7945093|NCT02484547|12488163|FG005|Placebo-Controlled Period|Investigator Decision|0
7945094|NCT02484547|12488164|FG006|Placebo-Controlled Period|Investigator Decision|0
7945095|NCT02484547|12488158|FG000|Placebo-Controlled Period|Lost to Follow-up|3
7945096|NCT02484547|12488159|FG001|Placebo-Controlled Period|Lost to Follow-up|1
7945097|NCT02484547|12488160|FG002|Placebo-Controlled Period|Lost to Follow-up|3
7945098|NCT02484547|12488161|FG003|Placebo-Controlled Period|Lost to Follow-up|0
7945099|NCT02484547|12488162|FG004|Placebo-Controlled Period|Lost to Follow-up|0
7945100|NCT02484547|12488163|FG005|Placebo-Controlled Period|Lost to Follow-up|0
7945101|NCT02484547|12488164|FG006|Placebo-Controlled Period|Lost to Follow-up|0
7945102|NCT02484547|12488158|FG000|Placebo-Controlled Period|Relocation|1
7945103|NCT02484547|12488159|FG001|Placebo-Controlled Period|Relocation|1
7945104|NCT02484547|12488160|FG002|Placebo-Controlled Period|Relocation|1
7945105|NCT02484547|12488161|FG003|Placebo-Controlled Period|Relocation|0
7945106|NCT02484547|12488162|FG004|Placebo-Controlled Period|Relocation|0
7945107|NCT02484547|12488163|FG005|Placebo-Controlled Period|Relocation|0
7945108|NCT02484547|12488164|FG006|Placebo-Controlled Period|Relocation|0
7945109|NCT02484547|12488158|FG000|Placebo-Controlled Period|Study Visit Burden|2
7945110|NCT02484547|12488159|FG001|Placebo-Controlled Period|Study Visit Burden|8
7945111|NCT02484547|12488160|FG002|Placebo-Controlled Period|Study Visit Burden|5
7945112|NCT02484547|12488161|FG003|Placebo-Controlled Period|Study Visit Burden|0
7945113|NCT02484547|12488162|FG004|Placebo-Controlled Period|Study Visit Burden|0
7945114|NCT02484547|12488163|FG005|Placebo-Controlled Period|Study Visit Burden|0
7945115|NCT02484547|12488164|FG006|Placebo-Controlled Period|Study Visit Burden|0
7945116|NCT02484547|12488158|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4
7945117|NCT02484547|12488159|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7945118|NCT02484547|12488160|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7945119|NCT02484547|12488161|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7945120|NCT02484547|12488162|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7945121|NCT02484547|12488163|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7945122|NCT02484547|12488164|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7945123|NCT02484547|12488158|FG000|Placebo-Controlled Period|Reason not Specified|216
7945124|NCT02484547|12488159|FG001|Placebo-Controlled Period|Reason not Specified|194
7945125|NCT02484547|12488160|FG002|Placebo-Controlled Period|Reason not Specified|183
7945126|NCT02484547|12488161|FG003|Placebo-Controlled Period|Reason not Specified|0
7945127|NCT02484547|12488162|FG004|Placebo-Controlled Period|Reason not Specified|0
7945128|NCT02484547|12488163|FG005|Placebo-Controlled Period|Reason not Specified|0
7945129|NCT02484547|12488164|FG006|Placebo-Controlled Period|Reason not Specified|0
7945130|NCT02484547|12488158|FG000|Long-Term Extension Period|Adverse Event|0
7945131|NCT02484547|12488159|FG001|Long-Term Extension Period|Adverse Event|0
7945132|NCT02484547|12488160|FG002|Long-Term Extension Period|Adverse Event|0
7945133|NCT02484547|12488161|FG003|Long-Term Extension Period|Adverse Event|0
7945134|NCT02484547|12488162|FG004|Long-Term Extension Period|Adverse Event|1
7945135|NCT02484547|12488163|FG005|Long-Term Extension Period|Adverse Event|3
7945136|NCT02484547|12488164|FG006|Long-Term Extension Period|Adverse Event|2
7945137|NCT02484547|12488158|FG000|Long-Term Extension Period|Death|0
7945138|NCT02484547|12488159|FG001|Long-Term Extension Period|Death|0
7945139|NCT02484547|12488160|FG002|Long-Term Extension Period|Death|0
7945140|NCT02484547|12488161|FG003|Long-Term Extension Period|Death|0
7945141|NCT02484547|12488162|FG004|Long-Term Extension Period|Death|0
7945142|NCT02484547|12488163|FG005|Long-Term Extension Period|Death|3
7945143|NCT02484547|12488164|FG006|Long-Term Extension Period|Death|0
7945144|NCT02484547|12488158|FG000|Long-Term Extension Period|Disease Progression|0
7945145|NCT02484547|12488159|FG001|Long-Term Extension Period|Disease Progression|0
7945146|NCT02484547|12488160|FG002|Long-Term Extension Period|Disease Progression|0
7945147|NCT02484547|12488161|FG003|Long-Term Extension Period|Disease Progression|0
7945148|NCT02484547|12488162|FG004|Long-Term Extension Period|Disease Progression|2
7945149|NCT02484547|12488163|FG005|Long-Term Extension Period|Disease Progression|4
7945150|NCT02484547|12488164|FG006|Long-Term Extension Period|Disease Progression|0
7945151|NCT02484547|12488158|FG000|Long-Term Extension Period|Lost to Follow-up|0
7945152|NCT02484547|12488159|FG001|Long-Term Extension Period|Lost to Follow-up|0
7945153|NCT02484547|12488160|FG002|Long-Term Extension Period|Lost to Follow-up|0
7945154|NCT02484547|12488161|FG003|Long-Term Extension Period|Lost to Follow-up|1
7945155|NCT02484547|12488162|FG004|Long-Term Extension Period|Lost to Follow-up|1
7945156|NCT02484547|12488163|FG005|Long-Term Extension Period|Lost to Follow-up|2
7945157|NCT02484547|12488164|FG006|Long-Term Extension Period|Lost to Follow-up|0
7945158|NCT02484547|12488158|FG000|Long-Term Extension Period|Loss of Capacity|0
7945159|NCT02484547|12488159|FG001|Long-Term Extension Period|Loss of Capacity|0
7945160|NCT02484547|12488160|FG002|Long-Term Extension Period|Loss of Capacity|0
7945161|NCT02484547|12488161|FG003|Long-Term Extension Period|Loss of Capacity|0
7945162|NCT02484547|12488162|FG004|Long-Term Extension Period|Loss of Capacity|1
7945163|NCT02484547|12488163|FG005|Long-Term Extension Period|Loss of Capacity|0
7945164|NCT02484547|12488164|FG006|Long-Term Extension Period|Loss of Capacity|0
7945165|NCT02484547|12488158|FG000|Long-Term Extension Period|Change of Treatment|0
7945166|NCT02484547|12488159|FG001|Long-Term Extension Period|Change of Treatment|0
7945167|NCT02484547|12488160|FG002|Long-Term Extension Period|Change of Treatment|0
7945168|NCT02484547|12488161|FG003|Long-Term Extension Period|Change of Treatment|0
7945169|NCT02484547|12488162|FG004|Long-Term Extension Period|Change of Treatment|0
7945170|NCT02484547|12488163|FG005|Long-Term Extension Period|Change of Treatment|0
7945171|NCT02484547|12488164|FG006|Long-Term Extension Period|Change of Treatment|1
7945172|NCT02484547|12488158|FG000|Long-Term Extension Period|Consent Withdrawn|0
7945173|NCT02484547|12488159|FG001|Long-Term Extension Period|Consent Withdrawn|0
7945174|NCT02484547|12488160|FG002|Long-Term Extension Period|Consent Withdrawn|0
7945175|NCT02484547|12488161|FG003|Long-Term Extension Period|Consent Withdrawn|6
7945176|NCT02484547|12488162|FG004|Long-Term Extension Period|Consent Withdrawn|7
7945177|NCT02484547|12488163|FG005|Long-Term Extension Period|Consent Withdrawn|13
7945178|NCT02484547|12488164|FG006|Long-Term Extension Period|Consent Withdrawn|17
7945179|NCT02484547|12488158|FG000|Long-Term Extension Period|Investigator Decision|0
7945180|NCT02484547|12488159|FG001|Long-Term Extension Period|Investigator Decision|0
7945181|NCT02484547|12488160|FG002|Long-Term Extension Period|Investigator Decision|0
7945182|NCT02484547|12488161|FG003|Long-Term Extension Period|Investigator Decision|2
7945183|NCT02484547|12488162|FG004|Long-Term Extension Period|Investigator Decision|1
7945184|NCT02484547|12488163|FG005|Long-Term Extension Period|Investigator Decision|0
7945185|NCT02484547|12488164|FG006|Long-Term Extension Period|Investigator Decision|1
7945186|NCT02484547|12488158|FG000|Long-Term Extension Period|Relocation|0
7945187|NCT02484547|12488159|FG001|Long-Term Extension Period|Relocation|0
7945188|NCT02484547|12488160|FG002|Long-Term Extension Period|Relocation|0
7945189|NCT02484547|12488161|FG003|Long-Term Extension Period|Relocation|1
7945190|NCT02484547|12488162|FG004|Long-Term Extension Period|Relocation|1
7945191|NCT02484547|12488163|FG005|Long-Term Extension Period|Relocation|0
7945192|NCT02484547|12488164|FG006|Long-Term Extension Period|Relocation|0
7945193|NCT02484547|12488158|FG000|Long-Term Extension Period|Study Visit Burden|0
7945194|NCT02484547|12488159|FG001|Long-Term Extension Period|Study Visit Burden|0
7945195|NCT02484547|12488160|FG002|Long-Term Extension Period|Study Visit Burden|0
7945196|NCT02484547|12488161|FG003|Long-Term Extension Period|Study Visit Burden|2
7945197|NCT02484547|12488162|FG004|Long-Term Extension Period|Study Visit Burden|0
7945198|NCT02484547|12488163|FG005|Long-Term Extension Period|Study Visit Burden|0
7945199|NCT02484547|12488164|FG006|Long-Term Extension Period|Study Visit Burden|3
7945200|NCT02484547|12488158|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7945201|NCT02484547|12488159|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7945202|NCT02484547|12488160|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7945203|NCT02484547|12488161|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7945204|NCT02484547|12488162|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1
7945205|NCT02484547|12488163|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3
7945206|NCT02484547|12488164|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2
7945207|NCT02484547|12488158|FG000|Long-Term Extension Period|Reason not Specified|0
7945208|NCT02484547|12488159|FG001|Long-Term Extension Period|Reason not Specified|0
7945209|NCT02484547|12488160|FG002|Long-Term Extension Period|Reason not Specified|0
7945210|NCT02484547|12488161|FG003|Long-Term Extension Period|Reason not Specified|119
7945211|NCT02484547|12488162|FG004|Long-Term Extension Period|Reason not Specified|117
7945212|NCT02484547|12488163|FG005|Long-Term Extension Period|Reason not Specified|223
7945213|NCT02484547|12488164|FG006|Long-Term Extension Period|Reason not Specified|231
7945214|NCT02484651|12488178|FG000|Overall Study|Patients' data files were corrupted.|1
7945215|NCT02484651|12488179|FG001|Overall Study|Patients' data files were corrupted.|1
7945216|NCT02484651|12488178|FG000|Overall Study|BIS monitoring failed.|1
7945217|NCT02484651|12488179|FG001|Overall Study|BIS monitoring failed.|1
7945218|NCT02484651|12488178|FG000|Overall Study|Time of the procedure less than 90 min.|1
7945219|NCT02484651|12488179|FG001|Overall Study|Time of the procedure less than 90 min.|2
7945220|NCT02484690|12488191|FG000|Overall Study|Adverse Event|1
7945221|NCT02484690|12488192|FG001|Overall Study|Adverse Event|3
7945222|NCT02484690|12488193|FG002|Overall Study|Adverse Event|0
7945223|NCT02484690|12488194|FG003|Overall Study|Adverse Event|0
7945224|NCT02484690|12488195|FG004|Overall Study|Adverse Event|5
7945225|NCT02484690|12488191|FG000|Overall Study|Death|0
7945226|NCT02484690|12488192|FG001|Overall Study|Death|0
7945227|NCT02484690|12488193|FG002|Overall Study|Death|0
7945228|NCT02484690|12488194|FG003|Overall Study|Death|0
7945229|NCT02484690|12488195|FG004|Overall Study|Death|1
7945230|NCT02484690|12488191|FG000|Overall Study|Withdrawal by Subject|1
7945231|NCT02484690|12488192|FG001|Overall Study|Withdrawal by Subject|3
7945232|NCT02484690|12488193|FG002|Overall Study|Withdrawal by Subject|1
7945233|NCT02484690|12488194|FG003|Overall Study|Withdrawal by Subject|2
7945234|NCT02484690|12488195|FG004|Overall Study|Withdrawal by Subject|0
7945235|NCT02484690|12488191|FG000|Overall Study|Physician Decision|2
7945236|NCT02484690|12488192|FG001|Overall Study|Physician Decision|0
7945237|NCT02484690|12488193|FG002|Overall Study|Physician Decision|1
7945238|NCT02484690|12488194|FG003|Overall Study|Physician Decision|0
7945239|NCT02484690|12488195|FG004|Overall Study|Physician Decision|0
7945240|NCT02484690|12488191|FG000|Overall Study|Lost to Follow-up|0
7945241|NCT02484690|12488192|FG001|Overall Study|Lost to Follow-up|0
7945242|NCT02484690|12488193|FG002|Overall Study|Lost to Follow-up|1
7945243|NCT02484690|12488194|FG003|Overall Study|Lost to Follow-up|0
7945244|NCT02484690|12488195|FG004|Overall Study|Lost to Follow-up|0
7945245|NCT02484729|12488218|FG000|Overall Study|Failure of IntelliCap Error|0
7945246|NCT02484729|12488219|FG001|Overall Study|Failure of IntelliCap Error|0
7945247|NCT02484729|12488220|FG002|Overall Study|Failure of IntelliCap Error|0
7945248|NCT02484729|12488221|FG003|Overall Study|Failure of IntelliCap Error|0
7945249|NCT02484729|12488222|FG004|Overall Study|Failure of IntelliCap Error|0
7945250|NCT02484729|12488223|FG005|Overall Study|Failure of IntelliCap Error|0
7945251|NCT02484729|12488224|FG006|Overall Study|Failure of IntelliCap Error|0
7945252|NCT02484729|12488225|FG007|Overall Study|Failure of IntelliCap Error|0
7945253|NCT02484729|12488226|FG008|Overall Study|Failure of IntelliCap Error|0
7945254|NCT02484729|12488227|FG009|Overall Study|Failure of IntelliCap Error|1
7945255|NCT02484911|12488304|FG000|Overall Study|Withdrawal by Subject|2
7945256|NCT02484911|12488305|FG001|Overall Study|Withdrawal by Subject|1
7945257|NCT02484911|12488304|FG000|Overall Study|Protocol Violation|2
7945258|NCT02484911|12488305|FG001|Overall Study|Protocol Violation|1
7945259|NCT02485158|12488312|FG000|Overall Study|Withdrawal by Subject|3
7945260|NCT02485158|12488312|FG000|Overall Study|expected drug side effect|1
7945261|NCT02485301|12488323|FG000|Overall Study|Serious Adverse Events|2
7945262|NCT02485301|12488324|FG001|Overall Study|Serious Adverse Events|1
7945263|NCT02485301|12488323|FG000|Overall Study|Protocol Violation|0
7945264|NCT02485301|12488324|FG001|Overall Study|Protocol Violation|1
7945265|NCT02485301|12488323|FG000|Overall Study|Withdrawal by Subject|6
7945266|NCT02485301|12488324|FG001|Overall Study|Withdrawal by Subject|7
7945267|NCT02485301|12488323|FG000|Overall Study|Migrated/moved from study area|10
7945268|NCT02485301|12488324|FG001|Overall Study|Migrated/moved from study area|19
7945269|NCT02485301|12488323|FG000|Overall Study|Lost to Follow-up|17
7945270|NCT02485301|12488324|FG001|Overall Study|Lost to Follow-up|17
7945271|NCT02485301|12488323|FG000|Overall Study|Other|3
7945272|NCT02485301|12488324|FG001|Overall Study|Other|4
7945273|NCT02485353|12488330|FG000|Overall Study|Death|1
7945274|NCT02485353|12488330|FG000|Overall Study|Disease Progression|1
7945275|NCT02485483|12488336|FG000|Overall Study|Depression at baseline|15
7945276|NCT02485483|12488337|FG001|Overall Study|Depression at baseline|0
7945277|NCT02485483|12488336|FG000|Overall Study|Discontinued after baseline|39
7945278|NCT02485483|12488337|FG001|Overall Study|Discontinued after baseline|0
7945279|NCT02485704|12488358|FG000|Overall Study|Lost to Follow-up|4
7945280|NCT02485704|12488359|FG001|Overall Study|Lost to Follow-up|5
7945281|NCT02485704|12488358|FG000|Overall Study|Withdrawal by Subject|0
7945282|NCT02485704|12488359|FG001|Overall Study|Withdrawal by Subject|3
7945283|NCT02485704|12488358|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1
7945284|NCT02485704|12488359|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0
7945285|NCT02485717|12488368|FG000|Overall Study|Lost to Follow-up|6
7945286|NCT02485717|12488369|FG001|Overall Study|Lost to Follow-up|0
7945287|NCT02485717|12488370|FG002|Overall Study|Lost to Follow-up|0
7945288|NCT02485717|12488368|FG000|Overall Study|Withdrawal by Subject|0
7945289|NCT02485717|12488369|FG001|Overall Study|Withdrawal by Subject|0
7945290|NCT02485717|12488370|FG002|Overall Study|Withdrawal by Subject|1
7945291|NCT02485717|12488368|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0
7945292|NCT02485717|12488369|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1
7945293|NCT02485717|12488370|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0
7945294|NCT02485717|12488368|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0
7945295|NCT02485717|12488369|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1
7945296|NCT02485717|12488370|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0
7945297|NCT02485925|12488393|FG000|Overall Study|Withdrawal by Subject|3
7945298|NCT02485925|12488393|FG000|Overall Study|Death|1
7945299|NCT02485925|12488393|FG000|Overall Study|Lost to Follow-up|11
7945300|NCT02486302|12488430|FG000|Overall Study|Discontinued prematurely|410
7945301|NCT02486302|12488430|FG000|Overall Study|Documentation not completed|255
7945302|NCT02486302|12488430|FG000|Overall Study|Excluded due to legal reasons|8
7945303|NCT02486302|12488430|FG000|Overall Study|Not treated|3
7945304|NCT02486406|12488456|FG000|Overall Study|Withdrew consent|1
7945305|NCT02486406|12488457|FG001|Overall Study|Withdrew consent|0
7945306|NCT02486406|12488458|FG002|Overall Study|Withdrew consent|0
7945307|NCT02486406|12488459|FG003|Overall Study|Withdrew consent|1
7945308|NCT02486406|12488456|FG000|Overall Study|Lost to Follow-up|1
7945309|NCT02486406|12488457|FG001|Overall Study|Lost to Follow-up|3
7945310|NCT02486406|12488458|FG002|Overall Study|Lost to Follow-up|1
7945311|NCT02486406|12488459|FG003|Overall Study|Lost to Follow-up|3
7945312|NCT02486406|12488456|FG000|Overall Study|Other, not specified|0
7945313|NCT02486406|12488457|FG001|Overall Study|Other, not specified|0
7945314|NCT02486406|12488458|FG002|Overall Study|Other, not specified|1
7945315|NCT02486406|12488459|FG003|Overall Study|Other, not specified|0
7719842|NCT00534495|12143823|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0
7719843|NCT00534495|12143824|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2
7719844|NCT00534599|12143837|FG000|Overall Study|Adverse Event|25
7945316|NCT02486588|12488497|FG000|Overall Study|Randomized in error- ineligible|738
7945317|NCT02486588|12488498|FG001|Overall Study|Randomized in error- ineligible|750
7945318|NCT02486588|12488499|FG002|Overall Study|Randomized in error- ineligible|755
7945319|NCT02486588|12488500|FG003|Overall Study|Randomized in error- ineligible|738
7945320|NCT02486588|12488501|FG004|Overall Study|Randomized in error- ineligible|746
7945321|NCT02486588|12488502|FG005|Overall Study|Randomized in error- ineligible|746
7945322|NCT02486627|12488523|FG000|Overall Study|Death|1
7945323|NCT02486627|12488524|FG001|Overall Study|Death|0
7945324|NCT02486627|12488523|FG000|Overall Study|Other Unspecified|0
7945325|NCT02486627|12488524|FG001|Overall Study|Other Unspecified|2
7945326|NCT02486627|12488523|FG000|Overall Study|Consent Withdrawn by Participant|4
7945327|NCT02486627|12488524|FG001|Overall Study|Consent Withdrawn by Participant|3
7945328|NCT02486627|12488523|FG000|Overall Study|Significant Participant Noncompliance|1
7945329|NCT02486627|12488524|FG001|Overall Study|Significant Participant Noncompliance|1
7945330|NCT02486627|12488523|FG000|Overall Study|Lost to Follow-up|1
7945331|NCT02486627|12488524|FG001|Overall Study|Lost to Follow-up|3
7945332|NCT02486653|12488532|FG000|Overall Study|Withdrawal by Subject|1
7945333|NCT02486653|12488533|FG001|Overall Study|Withdrawal by Subject|3
7945334|NCT02486653|12488532|FG000|Overall Study|Protocol Violation|1
7719845|NCT00534599|12143838|FG001|Overall Study|Adverse Event|4
7719846|NCT00534599|12143837|FG000|Overall Study|Incorrect enrollment|2
7719847|NCT00534599|12143838|FG001|Overall Study|Incorrect enrollment|1
7719848|NCT00534599|12143837|FG000|Overall Study|Mis-randomization|2
7719849|NCT00534599|12143838|FG001|Overall Study|Mis-randomization|2
7945335|NCT02486653|12488533|FG001|Overall Study|Protocol Violation|0
7945336|NCT02486653|12488532|FG000|Overall Study|surgery cancelled|4
7945337|NCT02486653|12488533|FG001|Overall Study|surgery cancelled|1
7945338|NCT02486692|12488541|FG000|Overall Study|did not login for randomization|4
7945339|NCT02486692|12488542|FG001|Overall Study|did not login for randomization|7
7945340|NCT02486757|12488548|FG000|Overall Study|Lost to Follow-up|1
7945341|NCT02486796|12488554|FG000|Overall Study|Withdrawal by Subject|1
7945342|NCT02486796|12488555|FG001|Overall Study|Withdrawal by Subject|1
7945343|NCT02486796|12488554|FG000|Overall Study|Physician Decision|1
7945344|NCT02486796|12488555|FG001|Overall Study|Physician Decision|0
7945345|NCT02486952|12488570|FG000|Overall Study|Not Started Induction Therapy|3
7945346|NCT02486952|12488570|FG000|Overall Study|Adverse Event|1
7945347|NCT02486952|12488570|FG000|Overall Study|Death|15
7945348|NCT02486952|12488570|FG000|Overall Study|Lack of Efficacy|3
7945349|NCT02486952|12488570|FG000|Overall Study|Lost to Follow-up|26
7945350|NCT02486952|12488570|FG000|Overall Study|Other|2
7945351|NCT02487030|12488581|FG000|Overall Study|Lack of Efficacy|2
7945352|NCT02487030|12488582|FG001|Overall Study|Lack of Efficacy|4
7945353|NCT02487030|12488583|FG002|Overall Study|Lack of Efficacy|1
7945354|NCT02487030|12488584|FG003|Overall Study|Lack of Efficacy|0
7945355|NCT02487030|12488585|FG004|Overall Study|Lack of Efficacy|1
7945356|NCT02487030|12488586|FG005|Overall Study|Lack of Efficacy|0
7945357|NCT02487030|12488587|FG006|Overall Study|Lack of Efficacy|0
7945358|NCT02487030|12488581|FG000|Overall Study|Lost to Follow-up|0
7945359|NCT02487030|12488582|FG001|Overall Study|Lost to Follow-up|0
7945360|NCT02487030|12488583|FG002|Overall Study|Lost to Follow-up|1
7945361|NCT02487030|12488584|FG003|Overall Study|Lost to Follow-up|1
7945362|NCT02487030|12488585|FG004|Overall Study|Lost to Follow-up|0
7945363|NCT02487030|12488586|FG005|Overall Study|Lost to Follow-up|1
7945364|NCT02487030|12488587|FG006|Overall Study|Lost to Follow-up|0
7945365|NCT02487030|12488581|FG000|Overall Study|Adverse Event|0
7945366|NCT02487030|12488582|FG001|Overall Study|Adverse Event|0
7945367|NCT02487030|12488583|FG002|Overall Study|Adverse Event|0
7945368|NCT02487030|12488584|FG003|Overall Study|Adverse Event|1
7945369|NCT02487030|12488585|FG004|Overall Study|Adverse Event|0
7945370|NCT02487030|12488586|FG005|Overall Study|Adverse Event|0
7945371|NCT02487030|12488587|FG006|Overall Study|Adverse Event|0
7945372|NCT02487030|12488581|FG000|Overall Study|Death|0
7945373|NCT02487030|12488582|FG001|Overall Study|Death|0
7719850|NCT00534599|12143837|FG000|Overall Study|Developed study-specific d/c criteria|5
7719851|NCT00534599|12143838|FG001|Overall Study|Developed study-specific d/c criteria|0
7719852|NCT00534599|12143837|FG000|Overall Study|Lack of Efficacy|0
7719853|NCT00534599|12143838|FG001|Overall Study|Lack of Efficacy|1
7719854|NCT00534599|12143837|FG000|Overall Study|Generalized anxiety disorder worsened|0
7945374|NCT02487030|12488583|FG002|Overall Study|Death|0
7945375|NCT02487030|12488584|FG003|Overall Study|Death|0
7945376|NCT02487030|12488585|FG004|Overall Study|Death|1
7945377|NCT02487030|12488586|FG005|Overall Study|Death|0
7945378|NCT02487030|12488587|FG006|Overall Study|Death|0
7945379|NCT02487199|12488611|FG000|Overall Study|Withdrew Consent|0
7945380|NCT02487199|12488612|FG001|Overall Study|Withdrew Consent|1
7945381|NCT02487446|12488643|FG000|Period 1|Physician Decision|0
7945382|NCT02487446|12488644|FG001|Period 1|Physician Decision|1
7945383|NCT02487446|12488643|FG000|Period 1|Lack of Efficacy|1
7945384|NCT02487446|12488644|FG001|Period 1|Lack of Efficacy|0
7945385|NCT02487446|12488643|FG000|Period 1|Protocol deviation|3
7945386|NCT02487446|12488644|FG001|Period 1|Protocol deviation|2
7945387|NCT02487446|12488643|FG000|Period 1|Lost to Follow-up|2
7945388|NCT02487446|12488644|FG001|Period 1|Lost to Follow-up|0
7945389|NCT02487446|12488643|FG000|Period 1|Withdrawal by Subject|2
7945390|NCT02487446|12488644|FG001|Period 1|Withdrawal by Subject|0
7945391|NCT02487446|12488643|FG000|Period 1|Adverse Event|5
7945392|NCT02487446|12488644|FG001|Period 1|Adverse Event|5
7945393|NCT02487446|12488643|FG000|Washout|Lost to Follow-up|0
7945394|NCT02487446|12488644|FG001|Washout|Lost to Follow-up|2
7945395|NCT02487446|12488643|FG000|Washout|Withdrawal by Subject|1
7945396|NCT02487446|12488644|FG001|Washout|Withdrawal by Subject|4
7945397|NCT02487446|12488643|FG000|Washout|Adverse Event|2
7945398|NCT02487446|12488644|FG001|Washout|Adverse Event|2
7945399|NCT02487446|12488643|FG000|Period 2|Protocol deviation|0
7945400|NCT02487446|12488644|FG001|Period 2|Protocol deviation|1
7945401|NCT02487446|12488643|FG000|Period 2|Lost to Follow-up|1
7945402|NCT02487446|12488644|FG001|Period 2|Lost to Follow-up|1
7945403|NCT02487446|12488643|FG000|Period 2|Withdrawal by Subject|1
7945404|NCT02487446|12488644|FG001|Period 2|Withdrawal by Subject|1
7945405|NCT02487446|12488643|FG000|Period 2|Adverse Event|6
7945406|NCT02487446|12488644|FG001|Period 2|Adverse Event|2
7945407|NCT02487472|12488651|FG000|Overall Study|Did not complete telephonic interviews|9
7945408|NCT02487472|12488651|FG000|Overall Study|Other|2
7965675|NCT01190930|12520926|FG000|Maintenance|Relapse|0
7965676|NCT01190930|12520927|FG001|Maintenance|Relapse|0
7965677|NCT01190930|12520928|FG002|Maintenance|Relapse|0
7965678|NCT01190930|12520929|FG003|Maintenance|Relapse|2
7965679|NCT01190930|12520930|FG004|Maintenance|Relapse|0
7965680|NCT01190930|12520931|FG005|Maintenance|Relapse|1
7965681|NCT01190930|12520932|FG006|Maintenance|Relapse|6
7965682|NCT01190930|12520933|FG007|Maintenance|Relapse|13
7965683|NCT01190930|12520934|FG008|Maintenance|Relapse|11
7965684|NCT01190930|12520935|FG009|Maintenance|Relapse|11
7965685|NCT01190930|12520926|FG000|Maintenance|Still on therapy|0
7965686|NCT01190930|12520927|FG001|Maintenance|Still on therapy|8
7965687|NCT01190930|12520928|FG002|Maintenance|Still on therapy|0
7965688|NCT01190930|12520929|FG003|Maintenance|Still on therapy|29
7965689|NCT01190930|12520930|FG004|Maintenance|Still on therapy|0
7965690|NCT01190930|12520931|FG005|Maintenance|Still on therapy|0
7965691|NCT01190930|12520932|FG006|Maintenance|Still on therapy|0
7965692|NCT01190930|12520933|FG007|Maintenance|Still on therapy|0
7965693|NCT01190930|12520934|FG008|Maintenance|Still on therapy|0
7945409|NCT02487498|12488666|FG000|Period: Period 1|Adverse Event|2
7945410|NCT02487498|12488667|FG001|Period: Period 1|Adverse Event|4
7945411|NCT02487498|12488666|FG000|Period: Period 1|Subject/guardian decision|2
7945412|NCT02487498|12488667|FG001|Period: Period 1|Subject/guardian decision|4
7945413|NCT02487498|12488666|FG000|Period: Period 1|Lost to Follow-up|0
7945414|NCT02487498|12488667|FG001|Period: Period 1|Lost to Follow-up|2
7945415|NCT02487498|12488666|FG000|Period: Period 1|Lack of Efficacy|1
7945416|NCT02487498|12488667|FG001|Period: Period 1|Lack of Efficacy|0
7945417|NCT02487498|12488666|FG000|Period: Period 1|Physician Decision|0
7945418|NCT02487498|12488667|FG001|Period: Period 1|Physician Decision|1
7945419|NCT02487498|12488666|FG000|Period: Period 1|Protocol deviation|1
7945420|NCT02487498|12488667|FG001|Period: Period 1|Protocol deviation|0
7945421|NCT02487498|12488666|FG000|Period: Washout|Subject/guardian decision|0
7822230|NCT01260701|12291319|FG000|Overall Study|Ineligible|4
7822231|NCT01260701|12291319|FG000|Overall Study|Did not begin protocol therapy|1
7822232|NCT01260896|12291359|FG000|First Intervention|Withdrawn Due to Emesis|2
7822233|NCT01260896|12291360|FG001|First Intervention|Withdrawn Due to Emesis|0
7822234|NCT01260922|12291368|FG000|First Intervention|Withdrawal by Subject|0
7822235|NCT01260922|12291369|FG001|First Intervention|Withdrawal by Subject|1
7822236|NCT01260922|12291368|FG000|Washout of 28 Days|Withdrawal by Subject|4
7822237|NCT01260922|12291369|FG001|Washout of 28 Days|Withdrawal by Subject|2
7822238|NCT01260922|12291368|FG000|Second Intervention|Emesis|0
7822239|NCT01260922|12291369|FG001|Second Intervention|Emesis|2
7822240|NCT01260948|12291377|FG000|Washout of 28 Days|Withdrawal by Subject|1
7822241|NCT01260948|12291378|FG001|Washout of 28 Days|Withdrawal by Subject|3
7822242|NCT01260948|12291377|FG000|Second Intervention|Emesis|0
7945422|NCT02487498|12488667|FG001|Period: Washout|Subject/guardian decision|5
7945423|NCT02487498|12488666|FG000|Period: Washout|Lack of Efficacy|1
7945424|NCT02487498|12488667|FG001|Period: Washout|Lack of Efficacy|1
7945425|NCT02487498|12488666|FG000|Period: Washout|Physician Decision|1
7945426|NCT02487498|12488667|FG001|Period: Washout|Physician Decision|0
7945427|NCT02487498|12488666|FG000|Period: Washout|Non-compliance with study treatment|0
7945428|NCT02487498|12488667|FG001|Period: Washout|Non-compliance with study treatment|1
7945429|NCT02487498|12488666|FG000|Period: Period 2|Adverse Event|2
7945430|NCT02487498|12488667|FG001|Period: Period 2|Adverse Event|2
7945431|NCT02487498|12488666|FG000|Period: Period 2|Subject/guardian decision|2
7945432|NCT02487498|12488667|FG001|Period: Period 2|Subject/guardian decision|1
7945433|NCT02487498|12488666|FG000|Period: Period 2|Lost to Follow-up|1
7945434|NCT02487498|12488667|FG001|Period: Period 2|Lost to Follow-up|1
7945435|NCT02487498|12488666|FG000|Period: Period 2|Death|0
7945436|NCT02487498|12488667|FG001|Period: Period 2|Death|1
7945437|NCT02487498|12488666|FG000|Period: Period 2|Physician Decision|1
7945438|NCT02487498|12488667|FG001|Period: Period 2|Physician Decision|0
7945439|NCT02487771|12488692|FG000|Overall Study|Lost to Follow-up|2
7945440|NCT02487771|12488693|FG001|Overall Study|Lost to Follow-up|3
7945441|NCT02487771|12488692|FG000|Overall Study|Moved out of area|5
7945442|NCT02487771|12488693|FG001|Overall Study|Moved out of area|6
7945443|NCT02487771|12488692|FG000|Overall Study|Withdrawal by Subject|3
7945444|NCT02487771|12488693|FG001|Overall Study|Withdrawal by Subject|5
7945445|NCT02487810|12488701|FG000|Overall Study|Withdrawal by Subject|1
7945446|NCT02487810|12488702|FG001|Overall Study|Withdrawal by Subject|0
7945447|NCT02488005|12488708|FG000|Overall Study|Lost to Follow-up|2
7945448|NCT02488109|12488723|FG000|Treatment in Hospital|Withdrawal by Subject|0
7945449|NCT02488109|12488724|FG001|Treatment in Hospital|Withdrawal by Subject|5
7945450|NCT02488109|12488723|FG000|12-month Follow-Up|Lost to Follow-up|4
7945451|NCT02488109|12488724|FG001|12-month Follow-Up|Lost to Follow-up|7
7945452|NCT02488239|12488732|FG000|Overall Study|Death|3
7945453|NCT02488239|12488732|FG000|Overall Study|Withdrawal by Subject|3
7945454|NCT02488239|12488732|FG000|Overall Study|Physician Decision|2
7945455|NCT02488239|12488732|FG000|Overall Study|Consent ineligible|1
7945456|NCT02488239|12488732|FG000|Overall Study|Did not undergo implant procedure|1
7945457|NCT02488330|12488750|FG000|Overall Study|Adverse Event|1
7945458|NCT02488330|12488750|FG000|Overall Study|Physician Decision|2
7945459|NCT02488330|12488750|FG000|Overall Study|Death|2
7945460|NCT02488330|12488750|FG000|Overall Study|Disease Progression|3
7945461|NCT02488330|12488750|FG000|Overall Study|Study Termination by Sponsor|4
7945462|NCT02488681|12488754|FG000|Overall Study|Implant unsuccessful|7
7945463|NCT02488824|12488760|FG000|Overall Study|Adverse Event|1
7945464|NCT02488824|12488761|FG001|Overall Study|Adverse Event|1
7945465|NCT02488915|12488767|FG000|Overall Study|Death|21
7945466|NCT02488915|12488767|FG000|Overall Study|Lost to Follow-up|4
7945467|NCT02488915|12488767|FG000|Overall Study|Withdrawal by Subject|1
7945468|NCT02488980|12488774|FG000|Overall Study|Protocol Violation|2
7945469|NCT02488980|12488775|FG001|Overall Study|Protocol Violation|2
7945470|NCT02488980|12488776|FG002|Overall Study|Protocol Violation|2
7945471|NCT02489045|12488784|FG000|Overall Study|unable to collect usable data|53
7945472|NCT02489045|12488784|FG000|Follow-up|Lost to Follow-up|10
7945473|NCT02489279|12488818|FG000|Overall Study|Lost to Follow-up|12
7945474|NCT02489279|12488819|FG001|Overall Study|Lost to Follow-up|10
7945475|NCT02489344|12488825|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1
7945476|NCT02489344|12488825|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1
7945477|NCT02489344|12488825|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1
7945478|NCT02489344|12488825|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2
7945479|NCT02489500|12488835|FG000|Overall Study|Death|1
7945480|NCT02489500|12488836|FG001|Overall Study|Death|1
7945481|NCT02489630|12488844|FG000|Overall Study|Oversedation|1
7945482|NCT02489630|12488845|FG001|Overall Study|Oversedation|1
7945483|NCT02489630|12488844|FG000|Overall Study|Time to med. admin. > protocol limit|1
7945484|NCT02489630|12488845|FG001|Overall Study|Time to med. admin. > protocol limit|1
7945485|NCT02489773|12488862|FG000|Overall Study|Lost to Follow-up|4
7945486|NCT02489773|12488863|FG001|Overall Study|Lost to Follow-up|1
7945487|NCT02489773|12488862|FG000|Overall Study|Physician Decision|1
7945488|NCT02489773|12488863|FG001|Overall Study|Physician Decision|0
7945489|NCT02489773|12488862|FG000|Overall Study|Withdrawal by Subject|1
7945490|NCT02489773|12488863|FG001|Overall Study|Withdrawal by Subject|0
7945491|NCT02489773|12488862|FG000|Overall Study|Leave the country or the state|1
7945492|NCT02489773|12488863|FG001|Overall Study|Leave the country or the state|1
7945493|NCT02489799|12488871|FG000|Overall Study|Lost to Follow-up|4
7945494|NCT02489799|12488872|FG001|Overall Study|Lost to Follow-up|1
7945495|NCT02489799|12488871|FG000|Overall Study|Failure to Maintain Eligibility|4
7945496|NCT02489799|12488872|FG001|Overall Study|Failure to Maintain Eligibility|6
7945497|NCT02489799|12488871|FG000|Overall Study|Withdrawal by Subject|1
7945498|NCT02489799|12488872|FG001|Overall Study|Withdrawal by Subject|1
7945499|NCT02489799|12488871|FG000|Overall Study|Death|0
7945500|NCT02489799|12488872|FG001|Overall Study|Death|1
7945501|NCT02489968|12488880|FG000|Open-label Treatment Period|Adverse Event|14
7945502|NCT02489968|12488881|FG001|Open-label Treatment Period|Adverse Event|7
7945503|NCT02489968|12488882|FG002|Open-label Treatment Period|Adverse Event|0
7945504|NCT02489968|12488883|FG003|Open-label Treatment Period|Adverse Event|0
7945505|NCT02489968|12488884|FG004|Open-label Treatment Period|Adverse Event|0
7945506|NCT02489968|12488885|FG005|Open-label Treatment Period|Adverse Event|0
7945507|NCT02489968|12488880|FG000|Open-label Treatment Period|Protocol Violation|2
7945508|NCT02489968|12488881|FG001|Open-label Treatment Period|Protocol Violation|2
7945509|NCT02489968|12488882|FG002|Open-label Treatment Period|Protocol Violation|0
7945510|NCT02489968|12488883|FG003|Open-label Treatment Period|Protocol Violation|0
7945511|NCT02489968|12488884|FG004|Open-label Treatment Period|Protocol Violation|0
7945512|NCT02489968|12488885|FG005|Open-label Treatment Period|Protocol Violation|0
7945513|NCT02489968|12488880|FG000|Open-label Treatment Period|Lost to Follow-up|0
7945514|NCT02489968|12488881|FG001|Open-label Treatment Period|Lost to Follow-up|3
7945515|NCT02489968|12488882|FG002|Open-label Treatment Period|Lost to Follow-up|0
7945516|NCT02489968|12488883|FG003|Open-label Treatment Period|Lost to Follow-up|0
7945517|NCT02489968|12488884|FG004|Open-label Treatment Period|Lost to Follow-up|0
7945518|NCT02489968|12488885|FG005|Open-label Treatment Period|Lost to Follow-up|0
7945519|NCT02489968|12488880|FG000|Open-label Treatment Period|Withdrawal by Subject|4
7945520|NCT02489968|12488881|FG001|Open-label Treatment Period|Withdrawal by Subject|7
7945521|NCT02489968|12488882|FG002|Open-label Treatment Period|Withdrawal by Subject|0
7945522|NCT02489968|12488883|FG003|Open-label Treatment Period|Withdrawal by Subject|0
7945523|NCT02489968|12488884|FG004|Open-label Treatment Period|Withdrawal by Subject|0
7945524|NCT02489968|12488885|FG005|Open-label Treatment Period|Withdrawal by Subject|0
7945525|NCT02489968|12488880|FG000|Open-label Treatment Period|Other than specified above|204
7945526|NCT02489968|12488881|FG001|Open-label Treatment Period|Other than specified above|189
7945527|NCT02489968|12488882|FG002|Open-label Treatment Period|Other than specified above|0
7945528|NCT02489968|12488883|FG003|Open-label Treatment Period|Other than specified above|0
7945529|NCT02489968|12488884|FG004|Open-label Treatment Period|Other than specified above|0
7945530|NCT02489968|12488885|FG005|Open-label Treatment Period|Other than specified above|0
7945531|NCT02489968|12488880|FG000|Double-blind Treatment Period|Adverse Event|0
7945532|NCT02489968|12488881|FG001|Double-blind Treatment Period|Adverse Event|0
7945533|NCT02489968|12488882|FG002|Double-blind Treatment Period|Adverse Event|2
7945534|NCT02489968|12488883|FG003|Double-blind Treatment Period|Adverse Event|6
7945535|NCT02489968|12488884|FG004|Double-blind Treatment Period|Adverse Event|4
7945536|NCT02489968|12488885|FG005|Double-blind Treatment Period|Adverse Event|5
7945537|NCT02489968|12488880|FG000|Double-blind Treatment Period|Protocol Violation|0
7945538|NCT02489968|12488881|FG001|Double-blind Treatment Period|Protocol Violation|0
7945539|NCT02489968|12488882|FG002|Double-blind Treatment Period|Protocol Violation|0
7945540|NCT02489968|12488883|FG003|Double-blind Treatment Period|Protocol Violation|0
7945541|NCT02489968|12488884|FG004|Double-blind Treatment Period|Protocol Violation|1
7945542|NCT02489968|12488885|FG005|Double-blind Treatment Period|Protocol Violation|1
7945543|NCT02489968|12488880|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
7945544|NCT02489968|12488881|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
7945545|NCT02489968|12488882|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7945546|NCT02489968|12488883|FG003|Double-blind Treatment Period|Withdrawal by Subject|2
7945547|NCT02489968|12488884|FG004|Double-blind Treatment Period|Withdrawal by Subject|0
7945548|NCT02489968|12488885|FG005|Double-blind Treatment Period|Withdrawal by Subject|2
7945549|NCT02489968|12488880|FG000|Double-blind Treatment Period|Other than specified above|0
7945550|NCT02489968|12488881|FG001|Double-blind Treatment Period|Other than specified above|0
7945551|NCT02489968|12488882|FG002|Double-blind Treatment Period|Other than specified above|0
7945552|NCT02489968|12488883|FG003|Double-blind Treatment Period|Other than specified above|0
7945553|NCT02489968|12488884|FG004|Double-blind Treatment Period|Other than specified above|1
7945554|NCT02489968|12488885|FG005|Double-blind Treatment Period|Other than specified above|0
7945555|NCT02489981|12488897|FG000|Overall Study|Adverse Event|21
7945556|NCT02489981|12488897|FG000|Overall Study|Insufficient effectiveness|16
7945557|NCT02489981|12488897|FG000|Overall Study|Improved|31
7945558|NCT02489981|12488897|FG000|Overall Study|Lost to Follow-up|31
7945559|NCT02489981|12488897|FG000|Overall Study|Other than listed|28
7945560|NCT02490371|12488912|FG000|Overall Study|Lost to Follow-up|1
7945561|NCT02490371|12488913|FG001|Overall Study|Lost to Follow-up|1
7945562|NCT02490475|12488923|FG000|Period 1: First 6 Cycles|Adverse Event|2
7945563|NCT02490475|12488924|FG001|Period 1: First 6 Cycles|Adverse Event|1
7945564|NCT02490475|12488925|FG002|Period 1: First 6 Cycles|Adverse Event|0
7945565|NCT02490475|12488926|FG003|Period 1: First 6 Cycles|Adverse Event|1
7719855|NCT00534599|12143838|FG001|Overall Study|Generalized anxiety disorder worsened|1
7719856|NCT00534599|12143837|FG000|Overall Study|Protocol Violation|1
7719857|NCT00534599|12143838|FG001|Overall Study|Protocol Violation|3
7719858|NCT00534599|12143837|FG000|Overall Study|Lost to Follow-up|11
7719859|NCT00534599|12143838|FG001|Overall Study|Lost to Follow-up|14
7719860|NCT00534599|12143837|FG000|Overall Study|Withdrawal by Subject|4
7719861|NCT00534599|12143838|FG001|Overall Study|Withdrawal by Subject|6
7719862|NCT00534599|12143837|FG000|Overall Study|Other|7
7719863|NCT00534599|12143838|FG001|Overall Study|Other|0
7822243|NCT01260948|12291378|FG001|Second Intervention|Emesis|1
7945566|NCT02490475|12488923|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
7945567|NCT02490475|12488924|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
7945568|NCT02490475|12488925|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
7945569|NCT02490475|12488926|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
7945570|NCT02490475|12488923|FG000|Period 1: First 6 Cycles|Refused Treatment|1
7945571|NCT02490475|12488924|FG001|Period 1: First 6 Cycles|Refused Treatment|0
7945572|NCT02490475|12488925|FG002|Period 1: First 6 Cycles|Refused Treatment|0
7945573|NCT02490475|12488926|FG003|Period 1: First 6 Cycles|Refused Treatment|0
7945574|NCT02490475|12488923|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
7945575|NCT02490475|12488924|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
7945576|NCT02490475|12488925|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
7945577|NCT02490475|12488926|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
7945578|NCT02490475|12488923|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1
7945579|NCT02490475|12488924|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0
7945580|NCT02490475|12488925|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2
7945581|NCT02490475|12488926|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0
7945582|NCT02490475|12488923|FG000|Period 2: Extension Phase|Refused Treatment|0
7945583|NCT02490475|12488924|FG001|Period 2: Extension Phase|Refused Treatment|0
7945584|NCT02490475|12488925|FG002|Period 2: Extension Phase|Refused Treatment|0
7945585|NCT02490475|12488926|FG003|Period 2: Extension Phase|Refused Treatment|1
7945586|NCT02490475|12488923|FG000|Period 2: Extension Phase|Adverse Event|0
7945587|NCT02490475|12488924|FG001|Period 2: Extension Phase|Adverse Event|0
7945588|NCT02490475|12488925|FG002|Period 2: Extension Phase|Adverse Event|1
7719864|NCT00534638|12143846|FG000|Overall Study|Withdrawal by Subject|3
7719865|NCT00534638|12143847|FG001|Overall Study|Withdrawal by Subject|4
7822244|NCT01261000|12291384|FG000|Overall Study|Screen failure|1
7822245|NCT01261338|12291395|FG000|Overall Study|Withdrawal by Subject|3
7822246|NCT01261338|12291396|FG001|Overall Study|Withdrawal by Subject|2
7822247|NCT01261390|12291406|FG000|Overall Study|Significant Concurrent Illness|1
7822248|NCT01261390|12291407|FG001|Overall Study|Significant Concurrent Illness|0
7719866|NCT00534638|12143846|FG000|Overall Study|Migrated/moved from study area|13
7822249|NCT01261390|12291408|FG002|Overall Study|Significant Concurrent Illness|1
7822250|NCT01261390|12291409|FG003|Overall Study|Significant Concurrent Illness|0
7945589|NCT02490475|12488926|FG003|Period 2: Extension Phase|Adverse Event|0
7945590|NCT02490878|12488967|FG000|Overall Study|deemed ineligible|0
7945591|NCT02490878|12488968|FG001|Overall Study|deemed ineligible|1
7945592|NCT02490878|12488967|FG000|Overall Study|progression prior to treatment|0
7945593|NCT02490878|12488968|FG001|Overall Study|progression prior to treatment|1
7945594|NCT02490878|12488967|FG000|Overall Study|only submitted baseline QOL|0
7719867|NCT00534638|12143847|FG001|Overall Study|Migrated/moved from study area|11
7719868|NCT00534638|12143846|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83
7767845|NCT00856284|12210624|FG000|Overall Study|Investigator discretion|9
7945595|NCT02490878|12488968|FG001|Overall Study|only submitted baseline QOL|1
7945596|NCT02491073|12488976|FG000|Overall Study|screen failure|1
7945597|NCT02491073|12488977|FG001|Overall Study|screen failure|0
7945598|NCT02491463|12489020|FG000|Overall Study|Withdrawal by Subject|1
7945599|NCT02491463|12489021|FG001|Overall Study|Withdrawal by Subject|2
7945600|NCT02491463|12489022|FG002|Overall Study|Withdrawal by Subject|0
7945601|NCT02491463|12489023|FG003|Overall Study|Withdrawal by Subject|0
7945602|NCT02491463|12489020|FG000|Overall Study|Migrated/moved from study area|1
7945603|NCT02491463|12489021|FG001|Overall Study|Migrated/moved from study area|5
7945604|NCT02491463|12489022|FG002|Overall Study|Migrated/moved from study area|1
7945605|NCT02491463|12489023|FG003|Overall Study|Migrated/moved from study area|1
7945606|NCT02491463|12489020|FG000|Overall Study|Lost to Follow-up|0
7945607|NCT02491463|12489021|FG001|Overall Study|Lost to Follow-up|3
7945608|NCT02491463|12489022|FG002|Overall Study|Lost to Follow-up|3
7945609|NCT02491463|12489023|FG003|Overall Study|Lost to Follow-up|0
7945610|NCT02491671|12489035|FG000|Overall Study|Adverse Event|6
7945611|NCT02491671|12489036|FG001|Overall Study|Adverse Event|8
7945612|NCT02491671|12489035|FG000|Overall Study|Death|0
7945613|NCT02491671|12489036|FG001|Overall Study|Death|2
7945614|NCT02491671|12489035|FG000|Overall Study|Use of sealants other than Hemopatch|5
7945615|NCT02491671|12489036|FG001|Overall Study|Use of sealants other than Hemopatch|3
7945616|NCT02491684|12489044|FG000|Treatment Phase|Adverse Event|2
7945617|NCT02491684|12489045|FG001|Treatment Phase|Adverse Event|2
7945618|NCT02491684|12489044|FG000|Treatment Phase|Incorrect randomisation|1
7945619|NCT02491684|12489045|FG001|Treatment Phase|Incorrect randomisation|0
7945620|NCT02491684|12489044|FG000|Treatment Phase|Investigator and Sponsor decision|0
7945621|NCT02491684|12489045|FG001|Treatment Phase|Investigator and Sponsor decision|1
7945622|NCT02491892|12489062|FG000|Overall Study|Adverse Event|1
7945623|NCT02491892|12489063|FG001|Overall Study|Adverse Event|1
7945624|NCT02491892|12489062|FG000|Overall Study|Death|1
7945625|NCT02491892|12489063|FG001|Overall Study|Death|1
7945626|NCT02491892|12489062|FG000|Overall Study|Lack of Efficacy|37
7945627|NCT02491892|12489063|FG001|Overall Study|Lack of Efficacy|36
7945628|NCT02491892|12489062|FG000|Overall Study|Refused Treatment|1
7945629|NCT02491892|12489063|FG001|Overall Study|Refused Treatment|0
7945630|NCT02491892|12489062|FG000|Overall Study|Lost to Follow-up|1
7945631|NCT02491892|12489063|FG001|Overall Study|Lost to Follow-up|0
7945632|NCT02492100|12489073|FG000|Overall Study|Death|1
7945633|NCT02492763|12489108|FG000|Overall Study|Withdrawal by Subject|0
7945634|NCT02492763|12489109|FG001|Overall Study|Withdrawal by Subject|2
7945635|NCT02492763|12489110|FG002|Overall Study|Withdrawal by Subject|1
7945636|NCT02492763|12489111|FG003|Overall Study|Withdrawal by Subject|0
7945637|NCT02492763|12489108|FG000|Overall Study|Adverse Event|3
7945638|NCT02492763|12489109|FG001|Overall Study|Adverse Event|1
7945639|NCT02492763|12489110|FG002|Overall Study|Adverse Event|1
7945640|NCT02492763|12489111|FG003|Overall Study|Adverse Event|2
7945641|NCT02492763|12489108|FG000|Overall Study|Death|0
7945642|NCT02492763|12489109|FG001|Overall Study|Death|0
7945643|NCT02492763|12489110|FG002|Overall Study|Death|1
7945644|NCT02492763|12489111|FG003|Overall Study|Death|0
7945645|NCT02492763|12489108|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0
7945646|NCT02492763|12489109|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1
7945647|NCT02492763|12489110|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0
7945648|NCT02492763|12489111|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0
7945649|NCT02492763|12489108|FG000|Overall Study|Lost to Follow-up|0
7945650|NCT02492763|12489109|FG001|Overall Study|Lost to Follow-up|0
7945651|NCT02492763|12489110|FG002|Overall Study|Lost to Follow-up|1
7945652|NCT02492763|12489111|FG003|Overall Study|Lost to Follow-up|0
7945653|NCT02492763|12489108|FG000|Overall Study|Non-Compliance With Study Drug|0
7945654|NCT02492763|12489109|FG001|Overall Study|Non-Compliance With Study Drug|1
7945655|NCT02492763|12489110|FG002|Overall Study|Non-Compliance With Study Drug|0
7945656|NCT02492763|12489111|FG003|Overall Study|Non-Compliance With Study Drug|0
7945657|NCT02492763|12489108|FG000|Overall Study|Screen Failure|0
7945658|NCT02492763|12489109|FG001|Overall Study|Screen Failure|0
7945659|NCT02492763|12489110|FG002|Overall Study|Screen Failure|0
7945660|NCT02492763|12489111|FG003|Overall Study|Screen Failure|1
7945661|NCT02492763|12489108|FG000|Overall Study|Study Terminated by Sponsor|13
7945662|NCT02492763|12489109|FG001|Overall Study|Study Terminated by Sponsor|10
7945663|NCT02492763|12489110|FG002|Overall Study|Study Terminated by Sponsor|6
7945664|NCT02492763|12489111|FG003|Overall Study|Study Terminated by Sponsor|10
7945665|NCT02492841|12489128|FG000|Overall Study|Lost to Follow-up|34
7945666|NCT02492841|12489129|FG001|Overall Study|Lost to Follow-up|31
7945667|NCT02492841|12489130|FG002|Overall Study|Lost to Follow-up|35
7945668|NCT02492880|12489150|FG000|Overall Study|Lost to Follow-up|1
7945669|NCT02492880|12489150|FG000|Overall Study|Protocol Violation|1
7945670|NCT02492958|12489158|FG000|Overall Study|Withdrawal by Subject|0
7945671|NCT02492958|12489159|FG001|Overall Study|Withdrawal by Subject|0
7945672|NCT02492958|12489160|FG002|Overall Study|Withdrawal by Subject|1
7945673|NCT02492958|12489161|FG003|Overall Study|Withdrawal by Subject|0
7945674|NCT02492958|12489158|FG000|Overall Study|Adverse Event|1
7945675|NCT02492958|12489159|FG001|Overall Study|Adverse Event|0
7945676|NCT02492958|12489160|FG002|Overall Study|Adverse Event|1
7945677|NCT02492958|12489161|FG003|Overall Study|Adverse Event|0
7945678|NCT02492984|12489173|FG000|Overall Study|Adverse Event|1
7945679|NCT02492984|12489174|FG001|Overall Study|Adverse Event|0
7945680|NCT02492984|12489173|FG000|Overall Study|Protocol Violation|1
7945681|NCT02492984|12489174|FG001|Overall Study|Protocol Violation|0
7945682|NCT02492984|12489173|FG000|Overall Study|Withdrawal by Subject|1
7945683|NCT02492984|12489174|FG001|Overall Study|Withdrawal by Subject|0
7945684|NCT02492997|12489185|FG000|Overall Study|Withdrawal by Subject|1
7945685|NCT02492997|12489186|FG001|Overall Study|Withdrawal by Subject|0
7945686|NCT02492997|12489185|FG000|Overall Study|Gained Weight|1
7822251|NCT01261390|12291406|FG000|Overall Study|Dissatisfaction with Treatment|2
7822252|NCT01261390|12291407|FG001|Overall Study|Dissatisfaction with Treatment|1
7822253|NCT01261390|12291408|FG002|Overall Study|Dissatisfaction with Treatment|1
7822254|NCT01261390|12291409|FG003|Overall Study|Dissatisfaction with Treatment|2
7822255|NCT01261390|12291406|FG000|Overall Study|Relocation|0
7822256|NCT01261390|12291407|FG001|Overall Study|Relocation|1
7822257|NCT01261390|12291408|FG002|Overall Study|Relocation|0
7822258|NCT01261390|12291409|FG003|Overall Study|Relocation|0
7822259|NCT01261390|12291406|FG000|Overall Study|Loss of Interest in the Study|3
7822260|NCT01261390|12291407|FG001|Overall Study|Loss of Interest in the Study|1
7822261|NCT01261390|12291408|FG002|Overall Study|Loss of Interest in the Study|0
7822262|NCT01261390|12291409|FG003|Overall Study|Loss of Interest in the Study|0
7822263|NCT01261390|12291406|FG000|Overall Study|Lost to Follow-up|1
7822264|NCT01261390|12291407|FG001|Overall Study|Lost to Follow-up|6
7822265|NCT01261390|12291408|FG002|Overall Study|Lost to Follow-up|5
7822266|NCT01261390|12291409|FG003|Overall Study|Lost to Follow-up|6
7862144|NCT01597245|12351192|FG004|Long Term Extension (Week 60 - Week 264)|Death|0
7862145|NCT01597245|12351193|FG005|Long Term Extension (Week 60 - Week 264)|Death|0
7862146|NCT01597245|12351194|FG006|Long Term Extension (Week 60 - Week 264)|Death|0
7862147|NCT01597245|12351195|FG007|Long Term Extension (Week 60 - Week 264)|Death|0
7862148|NCT01597245|12351196|FG008|Long Term Extension (Week 60 - Week 264)|Death|0
7862149|NCT01597245|12351197|FG009|Long Term Extension (Week 60 - Week 264)|Death|0
7862150|NCT01597245|12351198|FG010|Long Term Extension (Week 60 - Week 264)|Death|0
7862151|NCT01597245|12351199|FG011|Long Term Extension (Week 60 - Week 264)|Death|0
7862152|NCT01597245|12351200|FG012|Long Term Extension (Week 60 - Week 264)|Death|0
7862153|NCT01597245|12351201|FG013|Long Term Extension (Week 60 - Week 264)|Death|0
7822267|NCT01261624|12291443|FG000|Week 0 to Week 12|Disease Progression|1
7822268|NCT01261624|12291444|FG001|Week 0 to Week 12|Disease Progression|1
7822269|NCT01261624|12291443|FG000|Week 0 to Week 12|Insufficient Response|0
7822270|NCT01261624|12291444|FG001|Week 0 to Week 12|Insufficient Response|2
7822271|NCT01261624|12291443|FG000|Week 13 to Week 24|Insufficient Response|0
7822272|NCT01261624|12291444|FG001|Week 13 to Week 24|Insufficient Response|1
7822273|NCT01261780|12291458|FG000|Overall Study|Withdrawal by Subject|1
7822274|NCT01261780|12291459|FG001|Overall Study|Withdrawal by Subject|0
7822275|NCT01261780|12291458|FG000|Overall Study|Event not related to subject|1
7945687|NCT02492997|12489186|FG001|Overall Study|Gained Weight|0
7945688|NCT02492997|12489185|FG000|Overall Study|Lost to Follow-up|0
7945689|NCT02492997|12489186|FG001|Overall Study|Lost to Follow-up|1
7945690|NCT02493062|12489205|FG000|Overall Study|Physician Decision|12
7945691|NCT02493127|12489215|FG000|Overall Study|Lost to Follow-up|1
7945692|NCT02493127|12489216|FG001|Overall Study|Lost to Follow-up|1
7945693|NCT02493361|12489233|FG000|Overall Study|Withdrawal by Subject|3
7945694|NCT02493517|12489252|FG000|Overall Study|Protocol Violation|1
7945695|NCT02493517|12489253|FG001|Overall Study|Protocol Violation|2
7945696|NCT02493517|12489252|FG000|Overall Study|Withdrawal by Subject|1
7945697|NCT02493517|12489253|FG001|Overall Study|Withdrawal by Subject|2
7945698|NCT02493517|12489252|FG000|Overall Study|Adverse Event|0
7945699|NCT02493517|12489253|FG001|Overall Study|Adverse Event|2
7945700|NCT02493517|12489252|FG000|Overall Study|Missed study visit|0
7945701|NCT02493517|12489253|FG001|Overall Study|Missed study visit|1
7945702|NCT02493712|12489282|FG000|Overall Study|Withdrawal by Subject|1
7945703|NCT02493712|12489283|FG001|Overall Study|Withdrawal by Subject|0
7945704|NCT02493712|12489284|FG002|Overall Study|Withdrawal by Subject|2
7945705|NCT02493712|12489282|FG000|Overall Study|Protocol Violation|0
7945706|NCT02493712|12489283|FG001|Overall Study|Protocol Violation|0
7945707|NCT02493712|12489284|FG002|Overall Study|Protocol Violation|1
7945708|NCT02493712|12489282|FG000|Overall Study|Lost to Follow-up|1
7945709|NCT02493712|12489283|FG001|Overall Study|Lost to Follow-up|0
7945710|NCT02493712|12489284|FG002|Overall Study|Lost to Follow-up|0
7945711|NCT02493712|12489282|FG000|Overall Study|Physician Decision|0
7945712|NCT02493712|12489283|FG001|Overall Study|Physician Decision|1
7945713|NCT02493712|12489284|FG002|Overall Study|Physician Decision|0
7945714|NCT02493712|12489282|FG000|Overall Study|Lack of Efficacy|0
7945715|NCT02493712|12489283|FG001|Overall Study|Lack of Efficacy|5
7945716|NCT02493712|12489284|FG002|Overall Study|Lack of Efficacy|3
7945717|NCT02493764|12489294|FG000|Overall Study|Adverse Event|2
7945718|NCT02493764|12489295|FG001|Overall Study|Adverse Event|2
7945719|NCT02493764|12489294|FG000|Overall Study|Death|44
7945720|NCT02493764|12489295|FG001|Overall Study|Death|58
7945721|NCT02493764|12489294|FG000|Overall Study|Lost to Follow-up|2
7945722|NCT02493764|12489295|FG001|Overall Study|Lost to Follow-up|1
7945723|NCT02493764|12489294|FG000|Overall Study|Protocol Violation|6
7945724|NCT02493764|12489295|FG001|Overall Study|Protocol Violation|7
7945725|NCT02493764|12489294|FG000|Overall Study|Physician Decision|1
7945726|NCT02493764|12489295|FG001|Overall Study|Physician Decision|1
7945727|NCT02493764|12489294|FG000|Overall Study|Participant moved|17
7945728|NCT02493764|12489295|FG001|Overall Study|Participant moved|5
7945729|NCT02493764|12489294|FG000|Overall Study|Withdrawal parent/guardian|0
7945730|NCT02493764|12489295|FG001|Overall Study|Withdrawal parent/guardian|1
7945731|NCT02493764|12489294|FG000|Overall Study|Withdrawal by Subject|11
7945732|NCT02493764|12489295|FG001|Overall Study|Withdrawal by Subject|7
7945733|NCT02493777|12489303|FG000|Overall Study|Lost to Follow-up|0
7945734|NCT02493777|12489304|FG001|Overall Study|Lost to Follow-up|1
7945735|NCT02493855|12489313|FG000|Overall Study|Non-compliance|1
7945736|NCT02493855|12489314|FG001|Overall Study|Non-compliance|0
7945737|NCT02493855|12489315|FG002|Overall Study|Non-compliance|0
7945738|NCT02493855|12489313|FG000|Overall Study|Adverse Event|0
7945739|NCT02493855|12489314|FG001|Overall Study|Adverse Event|1
7945740|NCT02493855|12489315|FG002|Overall Study|Adverse Event|0
7945741|NCT02493855|12489313|FG000|Overall Study|Withdrawal by Subject|1
7945742|NCT02493855|12489314|FG001|Overall Study|Withdrawal by Subject|0
7945743|NCT02493855|12489315|FG002|Overall Study|Withdrawal by Subject|0
7945744|NCT02493868|12489323|FG000|Induction Phase: DE Participants|Adverse Event|22
7945745|NCT02493868|12489324|FG001|Induction Phase: DE Participants|Adverse Event|0
7945746|NCT02493868|12489323|FG000|Induction Phase: DE Participants|Lost to Follow-up|1
7945747|NCT02493868|12489324|FG001|Induction Phase: DE Participants|Lost to Follow-up|0
7945748|NCT02493868|12489323|FG000|Induction Phase: DE Participants|Lack of Efficacy|2
7945749|NCT02493868|12489324|FG001|Induction Phase: DE Participants|Lack of Efficacy|0
7945750|NCT02493868|12489323|FG000|Induction Phase: DE Participants|Protocol Violation|2
7945751|NCT02493868|12489324|FG001|Induction Phase: DE Participants|Protocol Violation|0
7945752|NCT02493868|12489323|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15
7945753|NCT02493868|12489324|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0
7945754|NCT02493868|12489323|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114
7945755|NCT02493868|12489324|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0
7945756|NCT02493868|12489323|FG000|Induction Phase: DE Participants|Other|8
7945757|NCT02493868|12489324|FG001|Induction Phase: DE Participants|Other|0
7945758|NCT02493868|12489323|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5
7945759|NCT02493868|12489324|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0
7945760|NCT02493868|12489323|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2
7945761|NCT02493868|12489324|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1
7945762|NCT02493868|12489323|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8
7945763|NCT02493868|12489324|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0
7945764|NCT02493868|12489323|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4
7945765|NCT02493868|12489324|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1
7945766|NCT02493868|12489323|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8
7945767|NCT02493868|12489324|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3
7822276|NCT01261780|12291459|FG001|Overall Study|Event not related to subject|2
7945768|NCT02493868|12489323|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14
7945769|NCT02493868|12489324|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5
7945770|NCT02493868|12489323|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107
7945771|NCT02493868|12489324|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20
7945772|NCT02493868|12489323|FG000|Optimization Phase: DE+TE Participants|Other|10
7945773|NCT02493868|12489324|FG001|Optimization Phase: DE+TE Participants|Other|2
7945774|NCT02493868|12489323|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1
7945775|NCT02493868|12489324|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4
7945776|NCT02493868|12489323|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1
7945777|NCT02493868|12489324|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0
7945778|NCT02493868|12489323|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1
7945779|NCT02493868|12489324|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1
7945780|NCT02493868|12489323|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5
7945781|NCT02493868|12489324|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7
7945782|NCT02493868|12489323|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1
7945783|NCT02493868|12489324|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0
7945784|NCT02493868|12489323|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0
7945785|NCT02493868|12489324|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1
7945786|NCT02493868|12489323|FG000|Maintenance Phase: DE+TE Participants|Other|4
7945787|NCT02493868|12489324|FG001|Maintenance Phase: DE+TE Participants|Other|9
7945788|NCT02493868|12489323|FG000|Follow-up Phase|Lost to Follow-up|1
7945789|NCT02493868|12489324|FG001|Follow-up Phase|Lost to Follow-up|0
7945790|NCT02493868|12489323|FG000|Follow-up Phase|Withdrawal by Subject|3
7945791|NCT02493868|12489324|FG001|Follow-up Phase|Withdrawal by Subject|0
7945792|NCT02493868|12489323|FG000|Follow-up Phase|Investigator Decision|5
7945793|NCT02493868|12489324|FG001|Follow-up Phase|Investigator Decision|1
7945794|NCT02493868|12489323|FG000|Follow-up Phase|Other|2
7945795|NCT02493868|12489324|FG001|Follow-up Phase|Other|1
7945796|NCT02494401|12489382|FG000|Overall Study|Lost to Follow-up|22
7945797|NCT02494401|12489383|FG001|Overall Study|Lost to Follow-up|25
7945798|NCT02494401|12489382|FG000|Overall Study|Withdrawal by Subject|3
7945799|NCT02494401|12489383|FG001|Overall Study|Withdrawal by Subject|2
7945800|NCT02494596|12489406|FG000|Overall Study|Insufficient Therapeutic Response|3
7945801|NCT02494596|12489407|FG001|Overall Study|Insufficient Therapeutic Response|3
7945802|NCT02494596|12489408|FG002|Overall Study|Insufficient Therapeutic Response|1
7945803|NCT02494596|12489406|FG000|Overall Study|Adverse Event|0
7945804|NCT02494596|12489407|FG001|Overall Study|Adverse Event|1
7945805|NCT02494596|12489408|FG002|Overall Study|Adverse Event|0
7945806|NCT02494596|12489406|FG000|Overall Study|Refused Treatment|0
7945807|NCT02494596|12489407|FG001|Overall Study|Refused Treatment|1
7945808|NCT02494596|12489408|FG002|Overall Study|Refused Treatment|0
7945809|NCT02494778|12489423|FG000|Overall Study|Death|3
7945810|NCT02494778|12489423|FG000|Overall Study|Other|173
7945811|NCT02494778|12489423|FG000|Overall Study|Lack of Efficacy|4
7945812|NCT02494778|12489423|FG000|Overall Study|Adverse Event|18
7945813|NCT02494778|12489423|FG000|Overall Study|Withdrawal by Subject|20
7945814|NCT02494778|12489423|FG000|Overall Study|Lost to Follow-up|2
7945815|NCT02494778|12489423|FG000|Overall Study|Noncompliant with study drug admin.|1
7945816|NCT02495025|12489438|FG000|Overall Study|Lost to Follow-up|21
7945817|NCT02495025|12489439|FG001|Overall Study|Lost to Follow-up|14
7945818|NCT02495025|12489438|FG000|Overall Study|Withdrawal by Subject|5
7945819|NCT02495025|12489439|FG001|Overall Study|Withdrawal by Subject|0
7945820|NCT02495168|12489472|FG000|Overall Study|Other than Specified|18
7945821|NCT02495168|12489473|FG001|Overall Study|Other than Specified|22
7945822|NCT02495168|12489474|FG002|Overall Study|Other than Specified|5
7945823|NCT02495168|12489472|FG000|Overall Study|Did not Complete Final Visit On Time|4
7945824|NCT02495168|12489473|FG001|Overall Study|Did not Complete Final Visit On Time|3
7945825|NCT02495168|12489474|FG002|Overall Study|Did not Complete Final Visit On Time|2
7945826|NCT02495168|12489472|FG000|Overall Study|Physician Decision|1
7945827|NCT02495168|12489473|FG001|Overall Study|Physician Decision|1
7945828|NCT02495168|12489474|FG002|Overall Study|Physician Decision|0
7945829|NCT02495168|12489472|FG000|Overall Study|Lost to Follow-up|10
7945830|NCT02495168|12489473|FG001|Overall Study|Lost to Follow-up|6
7945831|NCT02495168|12489474|FG002|Overall Study|Lost to Follow-up|1
7945832|NCT02495168|12489472|FG000|Overall Study|Withdrawal by Subject|1
7945833|NCT02495168|12489473|FG001|Overall Study|Withdrawal by Subject|4
7945834|NCT02495168|12489474|FG002|Overall Study|Withdrawal by Subject|2
7945835|NCT02495168|12489472|FG000|Overall Study|Protocol Violation|0
7945836|NCT02495168|12489473|FG001|Overall Study|Protocol Violation|10
7945837|NCT02495168|12489474|FG002|Overall Study|Protocol Violation|1
7945838|NCT02495168|12489472|FG000|Overall Study|Adverse Event|4
7945839|NCT02495168|12489473|FG001|Overall Study|Adverse Event|8
7945840|NCT02495168|12489474|FG002|Overall Study|Adverse Event|3
7945841|NCT02495168|12489472|FG000|Overall Study|Lack of Efficacy|0
7945842|NCT02495168|12489473|FG001|Overall Study|Lack of Efficacy|0
7945843|NCT02495168|12489474|FG002|Overall Study|Lack of Efficacy|3
7945844|NCT02495233|12489484|FG000|Overall Study|Miscellaneous|0
7945845|NCT02495233|12489485|FG001|Overall Study|Miscellaneous|1
7945846|NCT02495389|12489504|FG000|Overall Study|Withdrawal by Subject|40
7945847|NCT02495844|12489548|FG000|Overall Study|Lack of Efficacy|1
7945848|NCT02495844|12489549|FG001|Overall Study|Lack of Efficacy|2
7945849|NCT02495844|12489548|FG000|Overall Study|AE, non-fatal|0
7945850|NCT02495844|12489549|FG001|Overall Study|AE, non-fatal|1
7945851|NCT02495844|12489548|FG000|Overall Study|Hepatitis Positivity|0
7945852|NCT02495844|12489549|FG001|Overall Study|Hepatitis Positivity|1
7945853|NCT02495857|12489560|FG000|Overall Study|Adverse Event|5
7945854|NCT02495857|12489561|FG001|Overall Study|Adverse Event|0
7945855|NCT02495857|12489562|FG002|Overall Study|Adverse Event|1
7945856|NCT02495857|12489560|FG000|Overall Study|Withdrawal by Subject|9
7945857|NCT02495857|12489561|FG001|Overall Study|Withdrawal by Subject|6
7945858|NCT02495857|12489562|FG002|Overall Study|Withdrawal by Subject|10
7945859|NCT02495857|12489560|FG000|Overall Study|Physician Decision|0
7945860|NCT02495857|12489561|FG001|Overall Study|Physician Decision|1
7945861|NCT02495857|12489562|FG002|Overall Study|Physician Decision|0
7945862|NCT02495857|12489560|FG000|Overall Study|Protocol Violation|1
7945863|NCT02495857|12489561|FG001|Overall Study|Protocol Violation|1
7945864|NCT02495857|12489562|FG002|Overall Study|Protocol Violation|2
7945865|NCT02495857|12489560|FG000|Overall Study|Lost to Follow-up|4
7945866|NCT02495857|12489561|FG001|Overall Study|Lost to Follow-up|5
7945867|NCT02495857|12489562|FG002|Overall Study|Lost to Follow-up|3
7945868|NCT02495857|12489560|FG000|Overall Study|Other|3
7945869|NCT02495857|12489561|FG001|Overall Study|Other|3
7945870|NCT02495857|12489562|FG002|Overall Study|Other|2
7945871|NCT02495883|12489572|FG000|Overall Study|Excessive head motion|1
7945872|NCT02495883|12489573|FG001|Overall Study|Excessive head motion|0
7945873|NCT02495948|12489578|FG000|Period 1, First 30 Days of Wear|Adverse Event|0
7945874|NCT02495948|12489579|FG001|Period 1, First 30 Days of Wear|Adverse Event|1
7945875|NCT02495948|12489578|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
7945876|NCT02495948|12489579|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
7945877|NCT02496000|12489589|FG000|Overall Study|Withdrawal by Subject|1
7945878|NCT02496000|12489590|FG001|Overall Study|Withdrawal by Subject|2
7945879|NCT02496000|12489591|FG002|Overall Study|Withdrawal by Subject|0
7945880|NCT02496000|12489589|FG000|Overall Study|Lost to Follow-up|1
7945881|NCT02496000|12489590|FG001|Overall Study|Lost to Follow-up|0
7945882|NCT02496000|12489591|FG002|Overall Study|Lost to Follow-up|1
7945883|NCT02496000|12489589|FG000|Overall Study|Protocol Violation|0
7945884|NCT02496000|12489590|FG001|Overall Study|Protocol Violation|0
7945885|NCT02496000|12489591|FG002|Overall Study|Protocol Violation|1
7945886|NCT02496000|12489589|FG000|Overall Study|Non-compliance or lack of cooperation|0
7945887|NCT02496000|12489590|FG001|Overall Study|Non-compliance or lack of cooperation|2
7945888|NCT02496000|12489591|FG002|Overall Study|Non-compliance or lack of cooperation|0
7945889|NCT02496000|12489589|FG000|Overall Study|undetermined|0
7945890|NCT02496000|12489590|FG001|Overall Study|undetermined|1
7945891|NCT02496000|12489591|FG002|Overall Study|undetermined|0
7965694|NCT01190930|12520935|FG009|Maintenance|Still on therapy|0
7965695|NCT00779324|12520970|FG000|Overall Study|Lost to Follow-up|2
7965696|NCT00779324|12520971|FG001|Overall Study|Lost to Follow-up|1
7965697|NCT00779324|12520970|FG000|Overall Study|Withdrawal by Subject|4
7719869|NCT00534638|12143847|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117
7719870|NCT00534638|12143846|FG000|Overall Study|Lost to follow-up, complete vaccination|4707
7719871|NCT00534638|12143847|FG001|Overall Study|Lost to follow-up, complete vaccination|10757
7719872|NCT00534638|12143846|FG000|Overall Study|Other|1685
7965698|NCT00779324|12520971|FG001|Overall Study|Withdrawal by Subject|2
7965699|NCT00779324|12520970|FG000|Overall Study|Missed visit|1
7965700|NCT00779324|12520971|FG001|Overall Study|Missed visit|1
7965701|NCT00554788|12520980|FG000|Overall Study|Adverse Event|0
7965702|NCT00554788|12520981|FG001|Overall Study|Adverse Event|1
7965703|NCT00554788|12520982|FG002|Overall Study|Adverse Event|2
7965704|NCT00554788|12520980|FG000|Overall Study|Lost to Follow-up|4
7965705|NCT00554788|12520981|FG001|Overall Study|Lost to Follow-up|3
7965706|NCT00554788|12520982|FG002|Overall Study|Lost to Follow-up|3
7719873|NCT00534638|12143847|FG001|Overall Study|Other|902
7945892|NCT02496091|12489600|FG000|Overall Study|Eligibility criteria not fulfilled|2
7945893|NCT02496221|12489605|FG000|Treatment Period 2 - 4 Days|Adverse Event|0
7945894|NCT02496221|12489606|FG001|Treatment Period 2 - 4 Days|Adverse Event|1
7945895|NCT02496221|12489605|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1
7945896|NCT02496221|12489606|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0
7945897|NCT02496221|12489605|FG000|Treatment Period 2 - 4 Days|Physician Decision|1
7945898|NCT02496221|12489606|FG001|Treatment Period 2 - 4 Days|Physician Decision|0
7945899|NCT02496533|12489616|FG000|Overall Study|Lack of data on outcome|3
7945900|NCT02496533|12489617|FG001|Overall Study|Lack of data on outcome|0
7945901|NCT02496533|12489616|FG000|Overall Study|Patient did not complete all measures|0
7945902|NCT02496533|12489617|FG001|Overall Study|Patient did not complete all measures|4
7945903|NCT02496533|12489616|FG000|Overall Study|Late for radiologic testing|0
7945904|NCT02496533|12489617|FG001|Overall Study|Late for radiologic testing|2
7945905|NCT02496702|12489625|FG000|Overall Study|Lost to Follow-up|8
7945906|NCT02496702|12489626|FG001|Overall Study|Lost to Follow-up|6
7945907|NCT02496702|12489625|FG000|Overall Study|Only partially tested|0
7945908|NCT02496702|12489626|FG001|Overall Study|Only partially tested|2
7945909|NCT02496767|12489636|FG000|Open-label Lead-in Phase|Adverse Event|176
7945910|NCT02496767|12489637|FG001|Open-label Lead-in Phase|Adverse Event|0
7945911|NCT02496767|12489638|FG002|Open-label Lead-in Phase|Adverse Event|0
7945912|NCT02496767|12489639|FG003|Open-label Lead-in Phase|Adverse Event|0
7945913|NCT02496767|12489640|FG004|Open-label Lead-in Phase|Adverse Event|0
7945914|NCT02496767|12489641|FG005|Open-label Lead-in Phase|Adverse Event|0
7945915|NCT02496767|12489642|FG006|Open-label Lead-in Phase|Adverse Event|0
7945916|NCT02496767|12489643|FG007|Open-label Lead-in Phase|Adverse Event|0
7945917|NCT02496767|12489636|FG000|Open-label Lead-in Phase|Protocol Violation|2
7945918|NCT02496767|12489637|FG001|Open-label Lead-in Phase|Protocol Violation|0
7945919|NCT02496767|12489638|FG002|Open-label Lead-in Phase|Protocol Violation|0
7945920|NCT02496767|12489639|FG003|Open-label Lead-in Phase|Protocol Violation|0
7945921|NCT02496767|12489640|FG004|Open-label Lead-in Phase|Protocol Violation|0
7945922|NCT02496767|12489641|FG005|Open-label Lead-in Phase|Protocol Violation|0
7945923|NCT02496767|12489642|FG006|Open-label Lead-in Phase|Protocol Violation|0
7945924|NCT02496767|12489643|FG007|Open-label Lead-in Phase|Protocol Violation|0
7945925|NCT02496767|12489636|FG000|Open-label Lead-in Phase|Lost to Follow-up|1
7945926|NCT02496767|12489637|FG001|Open-label Lead-in Phase|Lost to Follow-up|0
7945927|NCT02496767|12489638|FG002|Open-label Lead-in Phase|Lost to Follow-up|0
7945928|NCT02496767|12489639|FG003|Open-label Lead-in Phase|Lost to Follow-up|0
7945929|NCT02496767|12489640|FG004|Open-label Lead-in Phase|Lost to Follow-up|0
7945930|NCT02496767|12489641|FG005|Open-label Lead-in Phase|Lost to Follow-up|0
7945931|NCT02496767|12489642|FG006|Open-label Lead-in Phase|Lost to Follow-up|0
7945932|NCT02496767|12489643|FG007|Open-label Lead-in Phase|Lost to Follow-up|0
7945933|NCT02496767|12489636|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0
7945934|NCT02496767|12489637|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13
7945935|NCT02496767|12489638|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23
7945936|NCT02496767|12489639|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43
7945937|NCT02496767|12489640|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43
7945938|NCT02496767|12489641|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0
7945939|NCT02496767|12489642|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0
7945940|NCT02496767|12489643|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0
7945941|NCT02496767|12489636|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0
7945942|NCT02496767|12489637|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13
7945943|NCT02496767|12489638|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9
7945944|NCT02496767|12489639|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8
7945945|NCT02496767|12489640|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14
7945946|NCT02496767|12489641|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0
7945947|NCT02496767|12489642|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0
7945948|NCT02496767|12489643|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0
7945949|NCT02496767|12489636|FG000|Double-blind, Placebo-controlled Phase|Death|0
7945950|NCT02496767|12489637|FG001|Double-blind, Placebo-controlled Phase|Death|10
7945951|NCT02496767|12489638|FG002|Double-blind, Placebo-controlled Phase|Death|6
7945952|NCT02496767|12489639|FG003|Double-blind, Placebo-controlled Phase|Death|2
7945953|NCT02496767|12489640|FG004|Double-blind, Placebo-controlled Phase|Death|4
7945954|NCT02496767|12489641|FG005|Double-blind, Placebo-controlled Phase|Death|0
7945955|NCT02496767|12489642|FG006|Double-blind, Placebo-controlled Phase|Death|0
7945956|NCT02496767|12489643|FG007|Double-blind, Placebo-controlled Phase|Death|0
7945957|NCT02496767|12489636|FG000|Double-blind, Placebo-controlled Phase|Various|0
7945958|NCT02496767|12489637|FG001|Double-blind, Placebo-controlled Phase|Various|9
7945959|NCT02496767|12489638|FG002|Double-blind, Placebo-controlled Phase|Various|4
7945960|NCT02496767|12489639|FG003|Double-blind, Placebo-controlled Phase|Various|5
7945961|NCT02496767|12489640|FG004|Double-blind, Placebo-controlled Phase|Various|2
7945962|NCT02496767|12489641|FG005|Double-blind, Placebo-controlled Phase|Various|0
7945963|NCT02496767|12489642|FG006|Double-blind, Placebo-controlled Phase|Various|0
7945964|NCT02496767|12489643|FG007|Double-blind, Placebo-controlled Phase|Various|0
7945965|NCT02496767|12489636|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7945966|NCT02496767|12489637|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4
7945967|NCT02496767|12489638|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3
7945968|NCT02496767|12489639|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1
7945969|NCT02496767|12489640|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2
7945970|NCT02496767|12489641|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7945971|NCT02496767|12489642|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7945972|NCT02496767|12489643|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7945973|NCT02496767|12489636|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0
7945974|NCT02496767|12489637|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4
7945975|NCT02496767|12489638|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1
7945976|NCT02496767|12489639|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0
7945977|NCT02496767|12489640|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0
7945978|NCT02496767|12489641|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0
7945979|NCT02496767|12489642|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0
7945980|NCT02496767|12489643|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0
7945981|NCT02496767|12489636|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7945982|NCT02496767|12489637|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
7945983|NCT02496767|12489638|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7945984|NCT02496767|12489639|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
7945985|NCT02496767|12489640|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1
7945986|NCT02496767|12489641|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7945987|NCT02496767|12489642|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7945988|NCT02496767|12489643|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7945989|NCT02496767|12489636|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7945990|NCT02496767|12489637|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1
7945991|NCT02496767|12489638|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7945992|NCT02496767|12489639|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7945993|NCT02496767|12489640|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7945994|NCT02496767|12489641|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7945995|NCT02496767|12489642|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7945996|NCT02496767|12489643|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7945997|NCT02496767|12489636|FG000|Double-blind, Withdrawal Phase|Progressive disease|0
7945998|NCT02496767|12489637|FG001|Double-blind, Withdrawal Phase|Progressive disease|0
7945999|NCT02496767|12489638|FG002|Double-blind, Withdrawal Phase|Progressive disease|0
7946000|NCT02496767|12489639|FG003|Double-blind, Withdrawal Phase|Progressive disease|0
7946001|NCT02496767|12489640|FG004|Double-blind, Withdrawal Phase|Progressive disease|0
7946002|NCT02496767|12489641|FG005|Double-blind, Withdrawal Phase|Progressive disease|4
7946003|NCT02496767|12489642|FG006|Double-blind, Withdrawal Phase|Progressive disease|0
7946004|NCT02496767|12489643|FG007|Double-blind, Withdrawal Phase|Progressive disease|1
7946005|NCT02496767|12489636|FG000|Double-blind, Withdrawal Phase|Adverse Event|0
7946006|NCT02496767|12489637|FG001|Double-blind, Withdrawal Phase|Adverse Event|0
7946007|NCT02496767|12489638|FG002|Double-blind, Withdrawal Phase|Adverse Event|0
7946008|NCT02496767|12489639|FG003|Double-blind, Withdrawal Phase|Adverse Event|0
7946009|NCT02496767|12489640|FG004|Double-blind, Withdrawal Phase|Adverse Event|0
7946010|NCT02496767|12489641|FG005|Double-blind, Withdrawal Phase|Adverse Event|1
7946011|NCT02496767|12489642|FG006|Double-blind, Withdrawal Phase|Adverse Event|2
7946012|NCT02496767|12489643|FG007|Double-blind, Withdrawal Phase|Adverse Event|1
7946013|NCT02496767|12489636|FG000|Double-blind, Withdrawal Phase|Death|0
7946014|NCT02496767|12489637|FG001|Double-blind, Withdrawal Phase|Death|0
7946015|NCT02496767|12489638|FG002|Double-blind, Withdrawal Phase|Death|0
7946016|NCT02496767|12489639|FG003|Double-blind, Withdrawal Phase|Death|0
7946017|NCT02496767|12489640|FG004|Double-blind, Withdrawal Phase|Death|0
7719874|NCT00535132|12143931|FG000|Safety Analysis Set|Did Not Receive Study Medication|2
7719875|NCT00535132|12143932|FG001|Safety Analysis Set|Did Not Receive Study Medication|2
7719876|NCT00535132|12143931|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
7719877|NCT00535132|12143932|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
7719878|NCT00535145|12143940|FG000|Phase I|Adverse Event|3
7719879|NCT00535145|12143940|FG000|Phase I|Lost to Follow-up|7
7719880|NCT00535145|12143940|FG000|Phase I|Withdrawal by Subject|6
7719881|NCT00535145|12143940|FG000|Phase I|(eligibility)|8
7719882|NCT00535145|12143940|FG000|Phase I|(protocol violation)|1
7719883|NCT00535145|12143940|FG000|Phase I|(PI decision)|1
7719884|NCT00535145|12143940|FG000|Phase I|(diagnosis)|3
7719885|NCT00535145|12143940|FG000|Phase II|Adverse Event|2
7719886|NCT00535145|12143940|FG000|Phase II|Lack of Efficacy|1
7719887|NCT00535145|12143940|FG000|Phase II|Lost to Follow-up|5
7719888|NCT00535145|12143940|FG000|Phase II|Withdrawal by Subject|5
7719889|NCT00535145|12143940|FG000|Phase II|Subject non-compliance|2
7719890|NCT00535223|12143950|FG000|Overall Study|Withdrawal by Subject|4
7719891|NCT00535223|12143951|FG001|Overall Study|Withdrawal by Subject|1
7719892|NCT00535236|12143967|FG000|Overall Study|Adverse Event|1
7719893|NCT00535236|12143968|FG001|Overall Study|Adverse Event|0
7719894|NCT00535236|12143969|FG002|Overall Study|Adverse Event|9
7719895|NCT00535236|12143970|FG003|Overall Study|Adverse Event|3
7719896|NCT00535236|12143971|FG004|Overall Study|Adverse Event|3
7719897|NCT00535236|12143972|FG005|Overall Study|Adverse Event|0
7719898|NCT00535236|12143973|FG006|Overall Study|Adverse Event|5
7719899|NCT00535236|12143974|FG007|Overall Study|Adverse Event|1
7719900|NCT00535236|12143975|FG008|Overall Study|Adverse Event|2
7719901|NCT00535236|12143976|FG009|Overall Study|Adverse Event|1
7946018|NCT02496767|12489641|FG005|Double-blind, Withdrawal Phase|Death|0
7946019|NCT02496767|12489642|FG006|Double-blind, Withdrawal Phase|Death|1
7946020|NCT02496767|12489643|FG007|Double-blind, Withdrawal Phase|Death|2
7946021|NCT02496767|12489636|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7946022|NCT02496767|12489637|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7946023|NCT02496767|12489638|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7946024|NCT02496767|12489639|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7946025|NCT02496767|12489640|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7946026|NCT02496767|12489641|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
7946027|NCT02496767|12489642|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
7946028|NCT02496767|12489643|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
7946029|NCT02496884|12489661|FG000|Overall Study|Counted twice as enrolled|2
7946030|NCT02496884|12489662|FG001|Overall Study|Counted twice as enrolled|0
7946031|NCT02496884|12489663|FG002|Overall Study|Counted twice as enrolled|0
7946032|NCT02496884|12489664|FG003|Overall Study|Counted twice as enrolled|0
7946033|NCT02496884|12489661|FG000|Overall Study|Withdrawal by Subject|0
7946034|NCT02496884|12489662|FG001|Overall Study|Withdrawal by Subject|3
7946035|NCT02496884|12489663|FG002|Overall Study|Withdrawal by Subject|0
7946036|NCT02496884|12489664|FG003|Overall Study|Withdrawal by Subject|0
7946037|NCT02497001|12489678|FG000|Overall Study|Lost to Follow-up|10
7946038|NCT02497001|12489679|FG001|Overall Study|Lost to Follow-up|2
7946039|NCT02497001|12489680|FG002|Overall Study|Lost to Follow-up|0
7946040|NCT02497001|12489681|FG003|Overall Study|Lost to Follow-up|2
7946041|NCT02497001|12489678|FG000|Overall Study|Adverse Event|28
7946042|NCT02497001|12489679|FG001|Overall Study|Adverse Event|30
7946043|NCT02497001|12489680|FG002|Overall Study|Adverse Event|11
7946044|NCT02497001|12489681|FG003|Overall Study|Adverse Event|11
7946045|NCT02497001|12489678|FG000|Overall Study|Withdrawal by Subject|14
7946046|NCT02497001|12489679|FG001|Overall Study|Withdrawal by Subject|37
7946047|NCT02497001|12489680|FG002|Overall Study|Withdrawal by Subject|19
7946048|NCT02497001|12489681|FG003|Overall Study|Withdrawal by Subject|15
7946049|NCT02497001|12489678|FG000|Overall Study|Physician Decision|5
7946050|NCT02497001|12489679|FG001|Overall Study|Physician Decision|11
7946051|NCT02497001|12489680|FG002|Overall Study|Physician Decision|5
7946052|NCT02497001|12489681|FG003|Overall Study|Physician Decision|1
7946053|NCT02497001|12489678|FG000|Overall Study|subjects that were not treated|1
7946054|NCT02497001|12489679|FG001|Overall Study|subjects that were not treated|2
7946055|NCT02497001|12489680|FG002|Overall Study|subjects that were not treated|2
7946056|NCT02497001|12489681|FG003|Overall Study|subjects that were not treated|1
7946057|NCT02497001|12489678|FG000|Overall Study|Major Protocol Deviation|3
7946058|NCT02497001|12489679|FG001|Overall Study|Major Protocol Deviation|4
7946059|NCT02497001|12489680|FG002|Overall Study|Major Protocol Deviation|4
7946060|NCT02497001|12489681|FG003|Overall Study|Major Protocol Deviation|4
7946061|NCT02497001|12489678|FG000|Overall Study|Lack of Efficacy|10
7946062|NCT02497001|12489679|FG001|Overall Study|Lack of Efficacy|16
7946063|NCT02497001|12489680|FG002|Overall Study|Lack of Efficacy|6
7946064|NCT02497001|12489681|FG003|Overall Study|Lack of Efficacy|6
7946065|NCT02497001|12489678|FG000|Overall Study|Protocol Violation|3
7946066|NCT02497001|12489679|FG001|Overall Study|Protocol Violation|1
7946067|NCT02497001|12489680|FG002|Overall Study|Protocol Violation|3
7946068|NCT02497001|12489681|FG003|Overall Study|Protocol Violation|1
7946069|NCT02497287|12489731|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84
7946070|NCT02497287|12489731|FG000|Induction Phase (4 Weeks)|Adverse Event|52
7946071|NCT02497287|12489731|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22
7946072|NCT02497287|12489731|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21
7946073|NCT02497287|12489731|FG000|Induction Phase (4 Weeks)|Other|13
7946074|NCT02497287|12489731|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5
7946075|NCT02497287|12489731|FG000|Induction Phase (4 Weeks)|Protocol Violation|1
7946076|NCT02497287|12489731|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1
7946077|NCT02497287|12489731|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331
7946078|NCT02497287|12489731|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30
7946079|NCT02497287|12489731|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25
7946080|NCT02497287|12489731|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25
7946081|NCT02497287|12489731|FG000|Optimization/Maintenance (48 Weeks)|Other|21
7946082|NCT02497287|12489731|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10
7946083|NCT02497287|12489731|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3
7946084|NCT02497287|12489731|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3
7946085|NCT02497287|12489731|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2
7946086|NCT02497287|12489731|FG000|Optimization/Maintenance (48 Weeks)|Death|2
7946087|NCT02497287|12489731|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1
7946088|NCT02497287|12489731|FG000|Follow-up Phase (4 Week)|PI Decision|12
7946089|NCT02497287|12489731|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10
7946090|NCT02497287|12489731|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5
7946091|NCT02497287|12489731|FG000|Follow-up Phase (4 Week)|Adverse Event|3
7946092|NCT02497287|12489731|FG000|Follow-up Phase (4 Week)|Other|1
7946093|NCT02497391|12489737|FG000|Period 2 (14 Days)|Withdrawal by Subject|1
7946094|NCT02497391|12489738|FG001|Period 2 (14 Days)|Withdrawal by Subject|0
7946095|NCT02497391|12489739|FG002|Period 2 (14 Days)|Withdrawal by Subject|1
7946096|NCT02497391|12489740|FG003|Period 2 (14 Days)|Withdrawal by Subject|0
7946097|NCT02497391|12489741|FG004|Period 2 (14 Days)|Withdrawal by Subject|0
7946098|NCT02497391|12489742|FG005|Period 2 (14 Days)|Withdrawal by Subject|0
7946099|NCT02497391|12489737|FG000|Period 2 (14 Days)|Sponsor Decision|3
7946100|NCT02497391|12489738|FG001|Period 2 (14 Days)|Sponsor Decision|1
7946101|NCT02497391|12489739|FG002|Period 2 (14 Days)|Sponsor Decision|2
7946102|NCT02497391|12489740|FG003|Period 2 (14 Days)|Sponsor Decision|3
7946103|NCT02497391|12489741|FG004|Period 2 (14 Days)|Sponsor Decision|2
7946104|NCT02497391|12489742|FG005|Period 2 (14 Days)|Sponsor Decision|3
7946105|NCT02497391|12489737|FG000|Period 3 (14 Days)|Adverse Event|0
7946106|NCT02497391|12489738|FG001|Period 3 (14 Days)|Adverse Event|1
7946107|NCT02497391|12489739|FG002|Period 3 (14 Days)|Adverse Event|0
7946108|NCT02497391|12489740|FG003|Period 3 (14 Days)|Adverse Event|0
7946109|NCT02497391|12489741|FG004|Period 3 (14 Days)|Adverse Event|0
7946110|NCT02497391|12489742|FG005|Period 3 (14 Days)|Adverse Event|0
7946111|NCT02497391|12489737|FG000|Period 3 (14 Days)|Sponsor Decision|0
7946112|NCT02497391|12489738|FG001|Period 3 (14 Days)|Sponsor Decision|0
7946113|NCT02497391|12489739|FG002|Period 3 (14 Days)|Sponsor Decision|0
7946114|NCT02497391|12489740|FG003|Period 3 (14 Days)|Sponsor Decision|0
7946115|NCT02497391|12489741|FG004|Period 3 (14 Days)|Sponsor Decision|1
7946116|NCT02497391|12489742|FG005|Period 3 (14 Days)|Sponsor Decision|0
7946117|NCT02497391|12489737|FG000|Period 3 (14 Days)|Withdrawal by Subject|0
7946118|NCT02497391|12489738|FG001|Period 3 (14 Days)|Withdrawal by Subject|0
7946119|NCT02497391|12489739|FG002|Period 3 (14 Days)|Withdrawal by Subject|1
7946120|NCT02497391|12489740|FG003|Period 3 (14 Days)|Withdrawal by Subject|0
7946121|NCT02497391|12489741|FG004|Period 3 (14 Days)|Withdrawal by Subject|0
7946122|NCT02497391|12489742|FG005|Period 3 (14 Days)|Withdrawal by Subject|0
7946123|NCT02497404|12489750|FG000|Overall Study|Adverse Event|1
7946124|NCT02497469|12489756|FG000|Overall Study|Randomized but not Treated|0
7946125|NCT02497469|12489757|FG001|Overall Study|Randomized but not Treated|2
7946126|NCT02497469|12489756|FG000|Overall Study|Pretreatment Event/Adverse Event|18
7946127|NCT02497469|12489757|FG001|Overall Study|Pretreatment Event/Adverse Event|16
7946128|NCT02497469|12489756|FG000|Overall Study|Leukopenia or Lymphopenia|1
7946129|NCT02497469|12489757|FG001|Overall Study|Leukopenia or Lymphopenia|0
7946130|NCT02497469|12489756|FG000|Overall Study|Significant Protocol Deviation|4
7946131|NCT02497469|12489757|FG001|Overall Study|Significant Protocol Deviation|5
7946132|NCT02497469|12489756|FG000|Overall Study|Lost to Follow-up|14
7946133|NCT02497469|12489757|FG001|Overall Study|Lost to Follow-up|4
7946134|NCT02497469|12489756|FG000|Overall Study|Voluntary Withdrawal|39
7946135|NCT02497469|12489757|FG001|Overall Study|Voluntary Withdrawal|41
7946136|NCT02497469|12489756|FG000|Overall Study|Pregnancy|1
7946137|NCT02497469|12489757|FG001|Overall Study|Pregnancy|1
7946138|NCT02497469|12489756|FG000|Overall Study|Lack of Efficacy|86
7946139|NCT02497469|12489757|FG001|Overall Study|Lack of Efficacy|40
7946140|NCT02497469|12489756|FG000|Overall Study|Reason not Specified|6
7946141|NCT02497469|12489757|FG001|Overall Study|Reason not Specified|6
7946142|NCT02497755|12489765|FG000|Overall Study|Protocol Violation|1
7946143|NCT02497755|12489766|FG001|Overall Study|Protocol Violation|0
7946144|NCT02497781|12489775|FG000|Overall Study|Withdrawal by Subject|2
7946145|NCT02497781|12489776|FG001|Overall Study|Withdrawal by Subject|0
7946146|NCT02497781|12489775|FG000|Overall Study|Lack of Efficacy|0
7946147|NCT02497781|12489776|FG001|Overall Study|Lack of Efficacy|1
7946148|NCT02497781|12489775|FG000|Overall Study|Randomised but not treated|1
7946149|NCT02497781|12489776|FG001|Overall Study|Randomised but not treated|1
7946150|NCT02497781|12489775|FG000|Overall Study|Lost to Follow-up|1
7946151|NCT02497781|12489776|FG001|Overall Study|Lost to Follow-up|1
7946152|NCT02497976|12489792|FG000|Overall Study|Withdrawal by Subject|2
7946153|NCT02497976|12489793|FG001|Overall Study|Withdrawal by Subject|0
7946154|NCT02497976|12489792|FG000|Overall Study|Moved out of area|0
7946155|NCT02497976|12489793|FG001|Overall Study|Moved out of area|1
7946156|NCT02498067|12489799|FG000|Overall Study|Lost to Follow-up|22
7946157|NCT02498067|12489799|FG000|Overall Study|Did not meet inclusion criteria|11
7946158|NCT02498236|12489813|FG000|Overall Study|Did not show for testing|1
7946159|NCT02498236|12489814|FG001|Overall Study|Did not show for testing|0
7946160|NCT02498236|12489815|FG002|Overall Study|Did not show for testing|0
7946161|NCT02498236|12489816|FG003|Overall Study|Did not show for testing|0
7946162|NCT02498236|12489817|FG004|Overall Study|Did not show for testing|0
7946163|NCT02498236|12489818|FG005|Overall Study|Did not show for testing|0
7946164|NCT02498236|12489819|FG006|Overall Study|Did not show for testing|0
7946165|NCT02498236|12489820|FG007|Overall Study|Did not show for testing|1
7946166|NCT02498236|12489813|FG000|Overall Study|Equipment failure|0
7946167|NCT02498236|12489814|FG001|Overall Study|Equipment failure|0
7946168|NCT02498236|12489815|FG002|Overall Study|Equipment failure|0
7946169|NCT02498236|12489816|FG003|Overall Study|Equipment failure|0
7946170|NCT02498236|12489817|FG004|Overall Study|Equipment failure|0
7946171|NCT02498236|12489818|FG005|Overall Study|Equipment failure|0
7946172|NCT02498236|12489819|FG006|Overall Study|Equipment failure|1
7946173|NCT02498236|12489820|FG007|Overall Study|Equipment failure|0
7946174|NCT02498236|12489813|FG000|Overall Study|Withdrawal by Subject|0
7946175|NCT02498236|12489814|FG001|Overall Study|Withdrawal by Subject|0
7946176|NCT02498236|12489815|FG002|Overall Study|Withdrawal by Subject|0
7946177|NCT02498236|12489816|FG003|Overall Study|Withdrawal by Subject|0
7946178|NCT02498236|12489817|FG004|Overall Study|Withdrawal by Subject|1
7946179|NCT02498236|12489818|FG005|Overall Study|Withdrawal by Subject|0
7946180|NCT02498236|12489819|FG006|Overall Study|Withdrawal by Subject|0
7946181|NCT02498236|12489820|FG007|Overall Study|Withdrawal by Subject|0
7946182|NCT02498418|12489844|FG000|Overall Study|Lack of Efficacy|0
7946183|NCT02498418|12489845|FG001|Overall Study|Lack of Efficacy|0
7946184|NCT02498418|12489846|FG002|Overall Study|Lack of Efficacy|1
7946185|NCT02498418|12489844|FG000|Overall Study|Withdrawal by Subject|2
7946186|NCT02498418|12489845|FG001|Overall Study|Withdrawal by Subject|0
7946187|NCT02498418|12489846|FG002|Overall Study|Withdrawal by Subject|3
7946188|NCT02498418|12489844|FG000|Overall Study|Lost to Follow-up|0
7946189|NCT02498418|12489845|FG001|Overall Study|Lost to Follow-up|1
7946190|NCT02498418|12489846|FG002|Overall Study|Lost to Follow-up|1
7946191|NCT02498418|12489844|FG000|Overall Study|Participant taken prohibited medication|0
7946192|NCT02498418|12489845|FG001|Overall Study|Participant taken prohibited medication|1
7946193|NCT02498418|12489846|FG002|Overall Study|Participant taken prohibited medication|1
7946194|NCT02498652|12489874|FG000|Overall Study|Protocol Violation|0
7946195|NCT02498652|12489875|FG001|Overall Study|Protocol Violation|1
7822277|NCT01261793|12291468|FG000|Overall Study|Lack of Efficacy|44
7822278|NCT01261793|12291469|FG001|Overall Study|Lack of Efficacy|37
7822279|NCT01261793|12291470|FG002|Overall Study|Lack of Efficacy|32
7822280|NCT01261793|12291468|FG000|Overall Study|Protocol Violation|3
7822281|NCT01261793|12291469|FG001|Overall Study|Protocol Violation|5
7822282|NCT01261793|12291470|FG002|Overall Study|Protocol Violation|6
7822283|NCT01261793|12291468|FG000|Overall Study|Lost to Follow-up|10
7822284|NCT01261793|12291469|FG001|Overall Study|Lost to Follow-up|3
7822285|NCT01261793|12291470|FG002|Overall Study|Lost to Follow-up|7
7822286|NCT01261793|12291468|FG000|Overall Study|Withdrawal by Subject|12
7822287|NCT01261793|12291469|FG001|Overall Study|Withdrawal by Subject|14
7822288|NCT01261793|12291470|FG002|Overall Study|Withdrawal by Subject|14
7822289|NCT01261793|12291468|FG000|Overall Study|Death|3
7822290|NCT01261793|12291469|FG001|Overall Study|Death|1
7822291|NCT01261793|12291470|FG002|Overall Study|Death|0
7822292|NCT01261793|12291468|FG000|Overall Study|Adverse Event|9
7822293|NCT01261793|12291469|FG001|Overall Study|Adverse Event|24
7822294|NCT01261793|12291470|FG002|Overall Study|Adverse Event|19
7822295|NCT01261793|12291468|FG000|Overall Study|Patient non-availability|1
7822296|NCT01261793|12291469|FG001|Overall Study|Patient non-availability|1
7822297|NCT01261793|12291470|FG002|Overall Study|Patient non-availability|1
7822298|NCT01261793|12291468|FG000|Overall Study|Suspected pregnancy|1
7822299|NCT01261793|12291469|FG001|Overall Study|Suspected pregnancy|1
7822300|NCT01261793|12291470|FG002|Overall Study|Suspected pregnancy|0
7822301|NCT01261793|12291468|FG000|Overall Study|Patient non-compliance|1
7822302|NCT01261793|12291469|FG001|Overall Study|Patient non-compliance|0
7822303|NCT01261793|12291470|FG002|Overall Study|Patient non-compliance|1
7822304|NCT01261793|12291468|FG000|Overall Study|Patient pregnant|1
7822305|NCT01261793|12291469|FG001|Overall Study|Patient pregnant|0
7822306|NCT01261793|12291470|FG002|Overall Study|Patient pregnant|0
7822307|NCT01261793|12291468|FG000|Overall Study|Outside the study area|0
7822308|NCT01261793|12291469|FG001|Overall Study|Outside the study area|2
7822309|NCT01261793|12291470|FG002|Overall Study|Outside the study area|1
7822310|NCT01261793|12291468|FG000|Overall Study|Lack of efficacy & patient not available|0
7946196|NCT02498678|12489901|FG000|Overall Study|interference from the surgical team|0
7946197|NCT02498678|12489902|FG001|Overall Study|interference from the surgical team|2
7946198|NCT02498821|12489919|FG000|Overall Study|Screen failure|3
7946199|NCT02498821|12489920|FG001|Overall Study|Screen failure|5
7946200|NCT02499029|12489937|FG000|Overall Study|Lost to Follow-up|2
7946201|NCT02499029|12489938|FG001|Overall Study|Lost to Follow-up|2
7946202|NCT02499029|12489937|FG000|Overall Study|Physician Decision|2
7946203|NCT02499029|12489938|FG001|Overall Study|Physician Decision|1
7946204|NCT02499029|12489937|FG000|Overall Study|Death|1
7946205|NCT02499029|12489938|FG001|Overall Study|Death|0
7946206|NCT02499159|12489950|FG000|Randomization|Protocol Violation|1
7946207|NCT02499159|12489951|FG001|Randomization|Protocol Violation|1
7946208|NCT02499159|12489950|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
7946209|NCT02499159|12489951|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
7946210|NCT02499159|12489950|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3
7946211|NCT02499159|12489951|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1
7946212|NCT02499159|12489950|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2
7946213|NCT02499159|12489951|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0
7946214|NCT02499159|12489950|FG000|30-Day Follow-Up Phone Call|Other|1
7946215|NCT02499159|12489951|FG001|30-Day Follow-Up Phone Call|Other|0
7946216|NCT02499172|12489961|FG000|Overall Study|Financial reason|0
7946217|NCT02499172|12489962|FG001|Overall Study|Financial reason|0
7946218|NCT02499172|12489963|FG002|Overall Study|Financial reason|523
7946219|NCT02499172|12489964|FG003|Overall Study|Financial reason|436
7946220|NCT02499172|12489961|FG000|Overall Study|Lost to Follow-up|65
7946221|NCT02499172|12489962|FG001|Overall Study|Lost to Follow-up|64
7946222|NCT02499172|12489963|FG002|Overall Study|Lost to Follow-up|0
7946223|NCT02499172|12489964|FG003|Overall Study|Lost to Follow-up|0
7946224|NCT02499263|12489974|FG000|Overall Study|Lost to Follow-up|9
7946225|NCT02499263|12489974|FG000|Overall Study|Participant's withdrawal of consent|4
7946226|NCT02499263|12489974|FG000|Overall Study|Lack of Efficacy|22
7946227|NCT02499263|12489974|FG000|Overall Study|investigator's judgment|12
7946228|NCT02499263|12489974|FG000|Overall Study|Adverse Events/Serious Adverse Events|11
7946229|NCT02499263|12489974|FG000|Overall Study|Participant's decision|3
7946230|NCT02499263|12489974|FG000|Overall Study|Pregnancy|1
7946231|NCT02499406|12489982|FG000|Overall Study|missed 3 treatment sessions|4
7946232|NCT02499575|12490005|FG000|Overall Study|Protocol Violation|0
7946233|NCT02499575|12490006|FG001|Overall Study|Protocol Violation|1
7946234|NCT02499770|12490018|FG000|Overall Study|Death|17
7946235|NCT02499770|12490019|FG001|Overall Study|Death|56
7946236|NCT02499770|12490018|FG000|Overall Study|Study completion|1
7946237|NCT02499770|12490019|FG001|Overall Study|Study completion|10
7946238|NCT02499770|12490018|FG000|Overall Study|Withdrawal by Subject|0
7946239|NCT02499770|12490019|FG001|Overall Study|Withdrawal by Subject|7
7946240|NCT02499770|12490018|FG000|Overall Study|Lost to Follow-up|0
7946241|NCT02499770|12490019|FG001|Overall Study|Lost to Follow-up|2
7946242|NCT02499770|12490018|FG000|Overall Study|Subject declined further treatment|1
7946243|NCT02499770|12490019|FG001|Overall Study|Subject declined further treatment|0
7946244|NCT02499770|12490018|FG000|Overall Study|Withdrawn by PI for compassionate reason|0
7946245|NCT02499770|12490019|FG001|Overall Study|Withdrawn by PI for compassionate reason|1
7946246|NCT02499770|12490018|FG000|Overall Study|Randomized but not enrolled|0
7946247|NCT02499770|12490019|FG001|Overall Study|Randomized but not enrolled|1
7946248|NCT02499783|12490033|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2
7946249|NCT02499783|12490034|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4
7946250|NCT02499783|12490035|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0
7946251|NCT02499783|12490033|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1
7946252|NCT02499783|12490034|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
7946253|NCT02499783|12490035|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
7946254|NCT02499783|12490033|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
7946255|NCT02499783|12490034|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
7822311|NCT01261793|12291469|FG001|Overall Study|Lack of efficacy & patient not available|1
7822312|NCT01261793|12291470|FG002|Overall Study|Lack of efficacy & patient not available|0
7822313|NCT01261793|12291468|FG000|Overall Study|Patient withdrew after cardiology visit|0
7822314|NCT01261793|12291469|FG001|Overall Study|Patient withdrew after cardiology visit|1
7822315|NCT01261793|12291470|FG002|Overall Study|Patient withdrew after cardiology visit|0
7822316|NCT01261793|12291468|FG000|Overall Study|Randomization error|0
7822317|NCT01261793|12291469|FG001|Overall Study|Randomization error|1
7822318|NCT01261793|12291470|FG002|Overall Study|Randomization error|0
7822319|NCT01261793|12291468|FG000|Overall Study|Patient unable to start IV line|0
7822320|NCT01261793|12291469|FG001|Overall Study|Patient unable to start IV line|0
7946256|NCT02499783|12490035|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0
7946257|NCT02499783|12490033|FG000|DB Period: Weeks 0-8|Adverse Event|8
7946258|NCT02499783|12490034|FG001|DB Period: Weeks 0-8|Adverse Event|6
7946259|NCT02499783|12490035|FG002|DB Period: Weeks 0-8|Adverse Event|0
7946260|NCT02499783|12490033|FG000|DB Period: Weeks 0-8|Withdrew Consent|1
7946261|NCT02499783|12490034|FG001|DB Period: Weeks 0-8|Withdrew Consent|0
7946262|NCT02499783|12490035|FG002|DB Period: Weeks 0-8|Withdrew Consent|0
7946263|NCT02499783|12490033|FG000|DB Period: Weeks 0-8|Other|1
7946264|NCT02499783|12490034|FG001|DB Period: Weeks 0-8|Other|1
7946265|NCT02499783|12490035|FG002|DB Period: Weeks 0-8|Other|0
7946266|NCT02499783|12490033|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0
7946267|NCT02499783|12490034|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0
7946268|NCT02499783|12490035|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16
7946269|NCT02499783|12490033|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
7946270|NCT02499783|12490034|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
7946271|NCT02499783|12490035|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2
7946272|NCT02499783|12490033|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
7946273|NCT02499783|12490034|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
7946274|NCT02499783|12490035|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9
7946275|NCT02499783|12490033|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
7946276|NCT02499783|12490034|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
7946277|NCT02499783|12490035|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2
7946278|NCT02500043|12490047|FG000|Overall Study|Randomized, but not Treated|2
7946279|NCT02500043|12490048|FG001|Overall Study|Randomized, but not Treated|2
7946280|NCT02500043|12490047|FG000|Overall Study|Ongoing at Date of Cut-Off|19
7946281|NCT02500043|12490048|FG001|Overall Study|Ongoing at Date of Cut-Off|3
7946282|NCT02500043|12490047|FG000|Overall Study|Adverse Event|33
7946283|NCT02500043|12490048|FG001|Overall Study|Adverse Event|11
7946284|NCT02500043|12490047|FG000|Overall Study|Clinical Progression|54
7946285|NCT02500043|12490048|FG001|Overall Study|Clinical Progression|35
7946286|NCT02500043|12490047|FG000|Overall Study|Radiological Progression|192
7946287|NCT02500043|12490048|FG001|Overall Study|Radiological Progression|110
7946288|NCT02500043|12490047|FG000|Overall Study|Physician's Decision|11
7946289|NCT02500043|12490048|FG001|Overall Study|Physician's Decision|3
7946290|NCT02500043|12490047|FG000|Overall Study|Withdrawal by Subject|14
7946291|NCT02500043|12490048|FG001|Overall Study|Withdrawal by Subject|4
7946292|NCT02500043|12490047|FG000|Overall Study|Death|11
7946293|NCT02500043|12490048|FG001|Overall Study|Death|2
7946294|NCT02500043|12490047|FG000|Overall Study|Protocol Deviation|1
7946295|NCT02500043|12490048|FG001|Overall Study|Protocol Deviation|0
7946296|NCT02500056|12490056|FG000|Overall Study|Lost to Follow-up|3
7946297|NCT02500056|12490057|FG001|Overall Study|Lost to Follow-up|7
7946298|NCT02500056|12490056|FG000|Overall Study|Recurrence|1
7946299|NCT02500056|12490057|FG001|Overall Study|Recurrence|0
7946300|NCT02500056|12490056|FG000|Overall Study|Death|3
7946301|NCT02500056|12490057|FG001|Overall Study|Death|1
7946302|NCT02500537|12490072|FG000|Overall Study|Death|2
7946303|NCT02500537|12490073|FG001|Overall Study|Death|0
7946304|NCT02500537|12490072|FG000|Overall Study|Lost to Follow-up|0
7946305|NCT02500537|12490073|FG001|Overall Study|Lost to Follow-up|1
7946306|NCT02500537|12490072|FG000|Overall Study|Withdrawal by Subject|1
7946307|NCT02500537|12490073|FG001|Overall Study|Withdrawal by Subject|0
7946308|NCT02500550|12490080|FG000|Overall Study|Death|7
7946309|NCT02500641|12490108|FG000|Overall Study|Adverse Event|0
7946310|NCT02500641|12490109|FG001|Overall Study|Adverse Event|2
7946311|NCT02500641|12490108|FG000|Overall Study|Withdrawal by Subject|4
7946312|NCT02500641|12490109|FG001|Overall Study|Withdrawal by Subject|5
7946313|NCT02500641|12490108|FG000|Overall Study|Unable to follow study procedures|3
7946314|NCT02500641|12490109|FG001|Overall Study|Unable to follow study procedures|2
7946315|NCT02500641|12490108|FG000|Overall Study|Protocol Violation|1
7946316|NCT02500641|12490109|FG001|Overall Study|Protocol Violation|2
7946317|NCT02500641|12490108|FG000|Overall Study|Lost to Follow-up|1
7946318|NCT02500641|12490109|FG001|Overall Study|Lost to Follow-up|0
7946319|NCT02500641|12490108|FG000|Overall Study|Sponsor decision|1
7946320|NCT02500641|12490109|FG001|Overall Study|Sponsor decision|0
7946321|NCT02500641|12490108|FG000|Overall Study|Non compliance to study drug|0
7946322|NCT02500641|12490109|FG001|Overall Study|Non compliance to study drug|1
7946323|NCT02500706|12490118|FG000|Overall Study|Adverse Event|0
7946324|NCT02500706|12490119|FG001|Overall Study|Adverse Event|0
7946325|NCT02500706|12490120|FG002|Overall Study|Adverse Event|1
7946326|NCT02500706|12490118|FG000|Overall Study|Lost to Follow-up|0
7946327|NCT02500706|12490119|FG001|Overall Study|Lost to Follow-up|1
7946328|NCT02500706|12490120|FG002|Overall Study|Lost to Follow-up|1
7946329|NCT02500706|12490118|FG000|Overall Study|Withdrawal by Subject|4
7946330|NCT02500706|12490119|FG001|Overall Study|Withdrawal by Subject|6
7946331|NCT02500706|12490120|FG002|Overall Study|Withdrawal by Subject|4
7946332|NCT02500706|12490118|FG000|Overall Study|Unclassified|0
7946333|NCT02500706|12490119|FG001|Overall Study|Unclassified|0
7946334|NCT02500706|12490120|FG002|Overall Study|Unclassified|1
7946335|NCT02500719|12490130|FG000|Overall Study|Lost to Follow-up|2
7946336|NCT02500719|12490131|FG001|Overall Study|Lost to Follow-up|3
7946337|NCT02500719|12490130|FG000|Overall Study|Trauma history|1
7946338|NCT02500719|12490131|FG001|Overall Study|Trauma history|0
7946339|NCT02500719|12490130|FG000|Overall Study|MRI data found to be unusable during analysis|0
7946340|NCT02500719|12490131|FG001|Overall Study|MRI data found to be unusable during analysis|1
7946341|NCT02500719|12490130|FG000|Overall Study|Did not meet criteria for PTSD|0
7946342|NCT02500719|12490131|FG001|Overall Study|Did not meet criteria for PTSD|1
7946343|NCT02500719|12490130|FG000|Overall Study|Claustrophobia|0
7946344|NCT02500719|12490131|FG001|Overall Study|Claustrophobia|1
7946345|NCT02500719|12490130|FG000|Overall Study|History of head trauma|0
7946346|NCT02500719|12490131|FG001|Overall Study|History of head trauma|1
7946347|NCT02500732|12490139|FG000|Overall Study|Physician Decision|0
7946348|NCT02500732|12490140|FG001|Overall Study|Physician Decision|1
7946349|NCT02500758|12490148|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0
7946350|NCT02500758|12490149|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1
7946351|NCT02500758|12490148|FG000|Washout (1 Week)|Lost to Follow-up|2
7946352|NCT02500758|12490149|FG001|Washout (1 Week)|Lost to Follow-up|2
7946353|NCT02500758|12490148|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2
7946354|NCT02500758|12490149|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0
7946355|NCT02500758|12490148|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0
7946356|NCT02500758|12490149|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1
7946357|NCT02500758|12490148|FG000|Second Intervention (2 Minutes)|Protocol Violation|1
7946358|NCT02500758|12490149|FG001|Second Intervention (2 Minutes)|Protocol Violation|1
7946359|NCT02500979|12490171|FG000|Period 1|Hyperglycemia|1
7946360|NCT02500979|12490172|FG001|Period 1|Hyperglycemia|0
7946361|NCT02500979|12490171|FG000|Period 1|Severe non-compliance to protocol|0
7946362|NCT02500979|12490172|FG001|Period 1|Severe non-compliance to protocol|1
7946363|NCT02500979|12490171|FG000|Period 1|Adverse Event|1
7946364|NCT02500979|12490172|FG001|Period 1|Adverse Event|0
7946365|NCT02500979|12490171|FG000|Period 1|Subject decision|2
7946366|NCT02500979|12490172|FG001|Period 1|Subject decision|0
7946367|NCT02500979|12490171|FG000|Period 2|Change in risk|1
7946368|NCT02500979|12490172|FG001|Period 2|Change in risk|0
7946369|NCT02501161|12490190|FG000|Overall Study|Adverse Event|2
7946370|NCT02501161|12490191|FG001|Overall Study|Adverse Event|6
7946371|NCT02501161|12490190|FG000|Overall Study|Lost to Follow-up|7
7946372|NCT02501161|12490191|FG001|Overall Study|Lost to Follow-up|4
7946373|NCT02501161|12490190|FG000|Overall Study|Withdrawal by Subject|10
7946374|NCT02501161|12490191|FG001|Overall Study|Withdrawal by Subject|15
7946375|NCT02501161|12490190|FG000|Overall Study|Other|3
7946376|NCT02501161|12490191|FG001|Overall Study|Other|0
7946377|NCT02501473|12490221|FG000|Overall Study|Study Terminated|2
7946378|NCT02501473|12490222|FG001|Overall Study|Study Terminated|3
7946379|NCT02501473|12490223|FG002|Overall Study|Study Terminated|7
7946380|NCT02501473|12490224|FG003|Overall Study|Study Terminated|9
7946381|NCT02501473|12490225|FG004|Overall Study|Study Terminated|2
7946382|NCT02501473|12490226|FG005|Overall Study|Study Terminated|10
7946383|NCT02501473|12490227|FG006|Overall Study|Study Terminated|1
7946384|NCT02501473|12490228|FG007|Overall Study|Study Terminated|0
7946385|NCT02501473|12490221|FG000|Overall Study|Withdrawal by Subject|0
7946386|NCT02501473|12490222|FG001|Overall Study|Withdrawal by Subject|0
7946387|NCT02501473|12490223|FG002|Overall Study|Withdrawal by Subject|3
7946388|NCT02501473|12490224|FG003|Overall Study|Withdrawal by Subject|3
7946389|NCT02501473|12490225|FG004|Overall Study|Withdrawal by Subject|2
7946390|NCT02501473|12490226|FG005|Overall Study|Withdrawal by Subject|2
7946391|NCT02501473|12490227|FG006|Overall Study|Withdrawal by Subject|0
7946392|NCT02501473|12490228|FG007|Overall Study|Withdrawal by Subject|0
7946393|NCT02501473|12490221|FG000|Overall Study|Death|0
7946394|NCT02501473|12490222|FG001|Overall Study|Death|0
7946395|NCT02501473|12490223|FG002|Overall Study|Death|1
7946396|NCT02501473|12490224|FG003|Overall Study|Death|1
7946397|NCT02501473|12490225|FG004|Overall Study|Death|0
7946398|NCT02501473|12490226|FG005|Overall Study|Death|1
7946399|NCT02501473|12490227|FG006|Overall Study|Death|0
7946400|NCT02501473|12490228|FG007|Overall Study|Death|0
7946401|NCT02501473|12490221|FG000|Overall Study|Lost to Follow-up|1
7946402|NCT02501473|12490222|FG001|Overall Study|Lost to Follow-up|0
7946403|NCT02501473|12490223|FG002|Overall Study|Lost to Follow-up|1
7946404|NCT02501473|12490224|FG003|Overall Study|Lost to Follow-up|0
7946405|NCT02501473|12490225|FG004|Overall Study|Lost to Follow-up|0
7946406|NCT02501473|12490226|FG005|Overall Study|Lost to Follow-up|1
7946407|NCT02501473|12490227|FG006|Overall Study|Lost to Follow-up|0
7946408|NCT02501473|12490228|FG007|Overall Study|Lost to Follow-up|0
7946409|NCT02501473|12490221|FG000|Overall Study|Reason not specified|0
7946410|NCT02501473|12490222|FG001|Overall Study|Reason not specified|0
7946411|NCT02501473|12490223|FG002|Overall Study|Reason not specified|1
7946412|NCT02501473|12490224|FG003|Overall Study|Reason not specified|1
7946413|NCT02501473|12490225|FG004|Overall Study|Reason not specified|0
7946414|NCT02501473|12490226|FG005|Overall Study|Reason not specified|0
7946415|NCT02501473|12490227|FG006|Overall Study|Reason not specified|0
7946416|NCT02501473|12490228|FG007|Overall Study|Reason not specified|0
7946417|NCT02501629|12490262|FG000|Overall Study|Death|0
7946418|NCT02501629|12490263|FG001|Overall Study|Death|1
7946419|NCT02501629|12490262|FG000|Overall Study|Withdrawn from study by sponsor|1
7946420|NCT02501629|12490263|FG001|Overall Study|Withdrawn from study by sponsor|0
7946421|NCT02501629|12490262|FG000|Overall Study|Early termination by sponsor|1
7946422|NCT02501629|12490263|FG001|Overall Study|Early termination by sponsor|0
7946423|NCT02501629|12490262|FG000|Overall Study|Withdrawal by Subject|3
7946424|NCT02501629|12490263|FG001|Overall Study|Withdrawal by Subject|5
7946425|NCT02501629|12490262|FG000|Overall Study|Subject did not return to site|0
7946426|NCT02501629|12490263|FG001|Overall Study|Subject did not return to site|1
7946427|NCT02501642|12490271|FG000|Overall Study|Lost to Follow-up|7
7946428|NCT02501642|12490272|FG001|Overall Study|Lost to Follow-up|11
7946429|NCT02501811|12490282|FG000|Overall Study|Death|1
7946430|NCT02501811|12490283|FG001|Overall Study|Death|3
7946431|NCT02501811|12490284|FG002|Overall Study|Death|2
7946432|NCT02501811|12490285|FG003|Overall Study|Death|3
7946433|NCT02501811|12490282|FG000|Overall Study|Withdrawal by Subject|3
7946434|NCT02501811|12490283|FG001|Overall Study|Withdrawal by Subject|3
7946435|NCT02501811|12490284|FG002|Overall Study|Withdrawal by Subject|2
7946436|NCT02501811|12490285|FG003|Overall Study|Withdrawal by Subject|3
7946437|NCT02501811|12490282|FG000|Overall Study|Lost to Follow-up|0
7946438|NCT02501811|12490283|FG001|Overall Study|Lost to Follow-up|0
7946439|NCT02501811|12490284|FG002|Overall Study|Lost to Follow-up|2
7946440|NCT02501811|12490285|FG003|Overall Study|Lost to Follow-up|1
7946441|NCT02501902|12490303|FG000|Overall Study|Subject Refused Further Follow-up|0
7946442|NCT02501902|12490304|FG001|Overall Study|Subject Refused Further Follow-up|0
7946443|NCT02501902|12490305|FG002|Overall Study|Subject Refused Further Follow-up|0
7946444|NCT02501902|12490306|FG003|Overall Study|Subject Refused Further Follow-up|0
7946445|NCT02501902|12490307|FG004|Overall Study|Subject Refused Further Follow-up|0
7946446|NCT02501902|12490308|FG005|Overall Study|Subject Refused Further Follow-up|0
7946447|NCT02501902|12490309|FG006|Overall Study|Subject Refused Further Follow-up|0
7946448|NCT02501902|12490310|FG007|Overall Study|Subject Refused Further Follow-up|1
7946449|NCT02501902|12490303|FG000|Overall Study|Study Terminated by Sponsor|0
7946450|NCT02501902|12490304|FG001|Overall Study|Study Terminated by Sponsor|3
7946451|NCT02501902|12490305|FG002|Overall Study|Study Terminated by Sponsor|0
7946452|NCT02501902|12490306|FG003|Overall Study|Study Terminated by Sponsor|1
7946453|NCT02501902|12490307|FG004|Overall Study|Study Terminated by Sponsor|1
7946454|NCT02501902|12490308|FG005|Overall Study|Study Terminated by Sponsor|0
7946455|NCT02501902|12490309|FG006|Overall Study|Study Terminated by Sponsor|2
7946456|NCT02501902|12490310|FG007|Overall Study|Study Terminated by Sponsor|4
7946457|NCT02501902|12490303|FG000|Overall Study|Death|3
7946458|NCT02501902|12490304|FG001|Overall Study|Death|4
7946459|NCT02501902|12490305|FG002|Overall Study|Death|4
7946460|NCT02501902|12490306|FG003|Overall Study|Death|10
7946461|NCT02501902|12490307|FG004|Overall Study|Death|10
7946462|NCT02501902|12490308|FG005|Overall Study|Death|11
7946463|NCT02501902|12490309|FG006|Overall Study|Death|7
7946464|NCT02501902|12490310|FG007|Overall Study|Death|15
7946465|NCT02501928|12490336|FG000|Overall Study|Withdrawal By Parent/Guardian|0
7946466|NCT02501928|12490337|FG001|Overall Study|Withdrawal By Parent/Guardian|0
7946467|NCT02501928|12490338|FG002|Overall Study|Withdrawal By Parent/Guardian|0
7946468|NCT02501928|12490339|FG003|Overall Study|Withdrawal By Parent/Guardian|0
7946469|NCT02501928|12490340|FG004|Overall Study|Withdrawal By Parent/Guardian|1
7946470|NCT02501928|12490341|FG005|Overall Study|Withdrawal By Parent/Guardian|0
7946471|NCT02502097|12490366|FG000|Period 1|Adverse Event|0
7946472|NCT02502097|12490367|FG001|Period 1|Adverse Event|0
7946473|NCT02502097|12490368|FG002|Period 1|Adverse Event|1
7946474|NCT02502097|12490369|FG003|Period 1|Adverse Event|0
7946475|NCT02502097|12490366|FG000|Wash Out Period|Adverse Event|0
7946476|NCT02502097|12490367|FG001|Wash Out Period|Adverse Event|1
7946477|NCT02502097|12490368|FG002|Wash Out Period|Adverse Event|1
7946478|NCT02502097|12490369|FG003|Wash Out Period|Adverse Event|1
7946479|NCT02502097|12490366|FG000|Period 2|Adverse Event|0
7946480|NCT02502097|12490367|FG001|Period 2|Adverse Event|0
7946481|NCT02502097|12490368|FG002|Period 2|Adverse Event|1
7946482|NCT02502097|12490369|FG003|Period 2|Adverse Event|0
7946483|NCT02502149|12490376|FG000|Intermediate|Discontinued prematurely|1
7946484|NCT02502149|12490377|FG001|Intermediate|Discontinued prematurely|0
7946485|NCT02502149|12490378|FG002|Intermediate|Discontinued prematurely|0
7946486|NCT02502149|12490379|FG003|Intermediate|Discontinued prematurely|0
7946487|NCT02502149|12490380|FG004|Intermediate|Discontinued prematurely|0
7946488|NCT02502526|12490422|FG000|Overall Study|Lost to Follow-up|2
7946489|NCT02502526|12490423|FG001|Overall Study|Lost to Follow-up|2
7946490|NCT02502526|12490424|FG002|Overall Study|Lost to Follow-up|3
7946491|NCT02502526|12490422|FG000|Overall Study|Withdrawal by Subject|0
7946492|NCT02502526|12490423|FG001|Overall Study|Withdrawal by Subject|1
7946493|NCT02502526|12490424|FG002|Overall Study|Withdrawal by Subject|1
7946494|NCT02502526|12490422|FG000|Overall Study|Disqualified due to cataract grading|0
7946495|NCT02502526|12490423|FG001|Overall Study|Disqualified due to cataract grading|0
7946496|NCT02502526|12490424|FG002|Overall Study|Disqualified due to cataract grading|1
7946497|NCT02502526|12490422|FG000|Overall Study|Enrollment suspension|4
7946498|NCT02502526|12490423|FG001|Overall Study|Enrollment suspension|1
7946499|NCT02502526|12490424|FG002|Overall Study|Enrollment suspension|1
7946500|NCT02502734|12490433|FG000|Double-blind Treatment Period 1|Adverse Event|1
7946501|NCT02502734|12490434|FG001|Double-blind Treatment Period 1|Adverse Event|0
7946502|NCT02502734|12490433|FG000|Washout Period|Adverse Event|1
7946503|NCT02502734|12490434|FG001|Washout Period|Adverse Event|0
7946504|NCT02502864|12490442|FG000|Overall Study|Withdrawal by Subject|1
7946505|NCT02503085|12490446|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1
7946506|NCT02503085|12490447|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0
7946507|NCT02503085|12490448|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1
7946508|NCT02503085|12490449|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0
7946509|NCT02503202|12490461|FG000|Base Study: Up to Month 6|Death|1
7946510|NCT02503202|12490462|FG001|Base Study: Up to Month 6|Death|1
7946511|NCT02503202|12490463|FG002|Base Study: Up to Month 6|Death|0
7946512|NCT02503202|12490464|FG003|Base Study: Up to Month 6|Death|0
7946513|NCT02503202|12490465|FG004|Base Study: Up to Month 6|Death|0
7946514|NCT02503202|12490461|FG000|Base Study: Up to Month 6|Lost to Follow-up|11
7946515|NCT02503202|12490462|FG001|Base Study: Up to Month 6|Lost to Follow-up|8
7946516|NCT02503202|12490463|FG002|Base Study: Up to Month 6|Lost to Follow-up|10
7946517|NCT02503202|12490464|FG003|Base Study: Up to Month 6|Lost to Follow-up|5
7946518|NCT02503202|12490465|FG004|Base Study: Up to Month 6|Lost to Follow-up|1
7946519|NCT02503202|12490461|FG000|Base Study: Up to Month 6|Physician Decision|0
7946520|NCT02503202|12490462|FG001|Base Study: Up to Month 6|Physician Decision|0
7946521|NCT02503202|12490463|FG002|Base Study: Up to Month 6|Physician Decision|0
7946522|NCT02503202|12490464|FG003|Base Study: Up to Month 6|Physician Decision|0
7946523|NCT02503202|12490465|FG004|Base Study: Up to Month 6|Physician Decision|1
7946524|NCT02503202|12490461|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6
7946525|NCT02503202|12490462|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3
7946526|NCT02503202|12490463|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4
7946527|NCT02503202|12490464|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4
7946528|NCT02503202|12490465|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1
7946529|NCT02503202|12490461|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0
7946530|NCT02503202|12490462|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0
7946531|NCT02503202|12490463|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1
7946532|NCT02503202|12490464|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2
7946533|NCT02503202|12490465|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0
7946534|NCT02503202|12490461|FG000|Extension: Month 6 to 24|Protocol Violation|0
7946535|NCT02503202|12490462|FG001|Extension: Month 6 to 24|Protocol Violation|0
7946536|NCT02503202|12490463|FG002|Extension: Month 6 to 24|Protocol Violation|0
7946537|NCT02503202|12490464|FG003|Extension: Month 6 to 24|Protocol Violation|1
7946538|NCT02503202|12490465|FG004|Extension: Month 6 to 24|Protocol Violation|0
7946539|NCT02503202|12490461|FG000|Extension: Month 6 to 24|Death|1
7946540|NCT02503202|12490462|FG001|Extension: Month 6 to 24|Death|0
7946541|NCT02503202|12490463|FG002|Extension: Month 6 to 24|Death|0
7946542|NCT02503202|12490464|FG003|Extension: Month 6 to 24|Death|0
7946543|NCT02503202|12490465|FG004|Extension: Month 6 to 24|Death|0
7946544|NCT02503202|12490461|FG000|Extension: Month 6 to 24|Lost to Follow-up|4
7946545|NCT02503202|12490462|FG001|Extension: Month 6 to 24|Lost to Follow-up|8
7946546|NCT02503202|12490463|FG002|Extension: Month 6 to 24|Lost to Follow-up|6
7946547|NCT02503202|12490464|FG003|Extension: Month 6 to 24|Lost to Follow-up|10
7946548|NCT02503202|12490465|FG004|Extension: Month 6 to 24|Lost to Follow-up|1
7946549|NCT02503202|12490461|FG000|Extension: Month 6 to 24|Physician Decision|1
7946550|NCT02503202|12490462|FG001|Extension: Month 6 to 24|Physician Decision|0
7946551|NCT02503202|12490463|FG002|Extension: Month 6 to 24|Physician Decision|1
7946552|NCT02503202|12490464|FG003|Extension: Month 6 to 24|Physician Decision|3
7946553|NCT02503202|12490465|FG004|Extension: Month 6 to 24|Physician Decision|0
7946554|NCT02503202|12490461|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5
7946555|NCT02503202|12490462|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8
7946556|NCT02503202|12490463|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2
7946557|NCT02503202|12490464|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4
7946558|NCT02503202|12490465|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0
7946559|NCT02503215|12490477|FG000|Overall Study|Unable to wear compression stockings|1
7946560|NCT02503215|12490477|FG000|Overall Study|Unable to use positive airway pressure|2
7946561|NCT02503332|12490494|FG000|Overall Study|Adverse Event|17
7946562|NCT02503332|12490495|FG001|Overall Study|Adverse Event|5
7946563|NCT02503332|12490496|FG002|Overall Study|Adverse Event|3
7946564|NCT02503332|12490497|FG003|Overall Study|Adverse Event|1
7946565|NCT02503332|12490494|FG000|Overall Study|Investigator's Decision|5
7946566|NCT02503332|12490495|FG001|Overall Study|Investigator's Decision|1
7946567|NCT02503332|12490496|FG002|Overall Study|Investigator's Decision|0
7946568|NCT02503332|12490497|FG003|Overall Study|Investigator's Decision|0
7946569|NCT02503332|12490494|FG000|Overall Study|Sponsor's Decision|1
7946570|NCT02503332|12490495|FG001|Overall Study|Sponsor's Decision|0
7946571|NCT02503332|12490496|FG002|Overall Study|Sponsor's Decision|0
7946572|NCT02503332|12490497|FG003|Overall Study|Sponsor's Decision|1
7946573|NCT02503332|12490494|FG000|Overall Study|Subject Request|6
7946574|NCT02503332|12490495|FG001|Overall Study|Subject Request|5
7946575|NCT02503332|12490496|FG002|Overall Study|Subject Request|2
7946576|NCT02503332|12490497|FG003|Overall Study|Subject Request|1
7946577|NCT02503332|12490494|FG000|Overall Study|Death|0
7946578|NCT02503332|12490495|FG001|Overall Study|Death|2
7946579|NCT02503332|12490496|FG002|Overall Study|Death|2
7946580|NCT02503332|12490497|FG003|Overall Study|Death|0
7946581|NCT02503332|12490494|FG000|Overall Study|Other|5
7946582|NCT02503332|12490495|FG001|Overall Study|Other|6
7946583|NCT02503332|12490496|FG002|Overall Study|Other|1
7946584|NCT02503332|12490497|FG003|Overall Study|Other|1
7946585|NCT02503501|12490527|FG000|Overall Study|Physician Decision|1
7946586|NCT02503501|12490528|FG001|Overall Study|Physician Decision|0
7946587|NCT02503501|12490527|FG000|Overall Study|Protocol Violation|0
7946588|NCT02503501|12490528|FG001|Overall Study|Protocol Violation|1
7946589|NCT02503501|12490527|FG000|Overall Study|Withdrawal by Subject|0
7946590|NCT02503501|12490528|FG001|Overall Study|Withdrawal by Subject|2
7946591|NCT02503540|12490534|FG000|Overall Study|Death|2
7946592|NCT02503540|12490534|FG000|Overall Study|Withdrawal by Subject|1
7946593|NCT02503787|12490548|FG000|Enrollment|Withdrawal by Subject|6
7946594|NCT02503787|12490548|FG000|Enrollment|Inclusion/exclusion criteria not met|4
7946595|NCT02503787|12490548|FG000|Enrollment|Physician Decision|2
7946596|NCT02503787|12490548|FG000|Enrollment|Insurance issue|2
7946597|NCT02503787|12490548|FG000|Enrollment|Lost to Follow-up|1
7946598|NCT02503787|12490548|FG000|Enrollment|Study closure|1
7946599|NCT02503787|12490548|FG000|Enrollment|Adverse Event|1
7946600|NCT02503787|12490548|FG000|Enrollment|Protocol Violation|1
7946601|NCT02503787|12490548|FG000|Enrollment|Inability to implant system|1
7946602|NCT02503787|12490548|FG000|Enrollment|Unable to be programmed|1
7946603|NCT02503787|12490548|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6
7946604|NCT02503787|12490548|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
7946605|NCT02503787|12490548|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
7946606|NCT02503787|12490548|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2
7946607|NCT02503787|12490548|FG000|Implant to 3 Month Endpoint|Adverse Event|2
7946608|NCT02503787|12490548|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1
7946609|NCT02503865|12490572|FG000|Overall Study|Moved out of area|1
7946610|NCT02503865|12490573|FG001|Overall Study|Moved out of area|8
7946611|NCT02503865|12490574|FG002|Overall Study|Moved out of area|0
7946612|NCT02503865|12490572|FG000|Overall Study|Refused treatment|4
7946613|NCT02503865|12490573|FG001|Overall Study|Refused treatment|39
7946614|NCT02503865|12490574|FG002|Overall Study|Refused treatment|2
7946615|NCT02504216|12490594|FG000|Overall Study|Lost to Follow-up|3
7946616|NCT02504216|12490595|FG001|Overall Study|Lost to Follow-up|3
7946617|NCT02504216|12490594|FG000|Overall Study|Withdrawal by Subject|8
7946618|NCT02504216|12490595|FG001|Overall Study|Withdrawal by Subject|12
7946619|NCT02504268|12490604|FG000|Overall Study|Adverse Event|18
7946620|NCT02504268|12490605|FG001|Overall Study|Adverse Event|8
7946621|NCT02504268|12490606|FG002|Overall Study|Adverse Event|14
7946622|NCT02504268|12490607|FG003|Overall Study|Adverse Event|0
7946623|NCT02504268|12490608|FG004|Overall Study|Adverse Event|0
7946624|NCT02504268|12490609|FG005|Overall Study|Adverse Event|0
7946625|NCT02504268|12490610|FG006|Overall Study|Adverse Event|0
7946626|NCT02504268|12490611|FG007|Overall Study|Adverse Event|0
7946627|NCT02504268|12490612|FG008|Overall Study|Adverse Event|0
7946628|NCT02504268|12490604|FG000|Overall Study|Withdrawal of Consent|11
7946629|NCT02504268|12490605|FG001|Overall Study|Withdrawal of Consent|10
7946630|NCT02504268|12490606|FG002|Overall Study|Withdrawal of Consent|3
7946631|NCT02504268|12490607|FG003|Overall Study|Withdrawal of Consent|0
7946632|NCT02504268|12490608|FG004|Overall Study|Withdrawal of Consent|0
7946633|NCT02504268|12490609|FG005|Overall Study|Withdrawal of Consent|0
7946634|NCT02504268|12490610|FG006|Overall Study|Withdrawal of Consent|0
7946635|NCT02504268|12490611|FG007|Overall Study|Withdrawal of Consent|0
7946636|NCT02504268|12490612|FG008|Overall Study|Withdrawal of Consent|0
7946637|NCT02504268|12490604|FG000|Overall Study|Pregnancy|2
7946638|NCT02504268|12490605|FG001|Overall Study|Pregnancy|0
7946639|NCT02504268|12490606|FG002|Overall Study|Pregnancy|0
7946640|NCT02504268|12490607|FG003|Overall Study|Pregnancy|0
7946641|NCT02504268|12490608|FG004|Overall Study|Pregnancy|0
7946642|NCT02504268|12490609|FG005|Overall Study|Pregnancy|0
7946643|NCT02504268|12490610|FG006|Overall Study|Pregnancy|0
7946644|NCT02504268|12490611|FG007|Overall Study|Pregnancy|0
7946645|NCT02504268|12490612|FG008|Overall Study|Pregnancy|0
7946646|NCT02504268|12490604|FG000|Overall Study|Lost to Follow-up|3
7946647|NCT02504268|12490605|FG001|Overall Study|Lost to Follow-up|6
7946648|NCT02504268|12490606|FG002|Overall Study|Lost to Follow-up|4
7946649|NCT02504268|12490607|FG003|Overall Study|Lost to Follow-up|0
7946650|NCT02504268|12490608|FG004|Overall Study|Lost to Follow-up|0
7946651|NCT02504268|12490609|FG005|Overall Study|Lost to Follow-up|0
7946652|NCT02504268|12490610|FG006|Overall Study|Lost to Follow-up|0
7946653|NCT02504268|12490611|FG007|Overall Study|Lost to Follow-up|0
7946654|NCT02504268|12490612|FG008|Overall Study|Lost to Follow-up|0
7946655|NCT02504268|12490604|FG000|Overall Study|Death|1
7946656|NCT02504268|12490605|FG001|Overall Study|Death|1
7946657|NCT02504268|12490606|FG002|Overall Study|Death|0
7946658|NCT02504268|12490607|FG003|Overall Study|Death|0
7946659|NCT02504268|12490608|FG004|Overall Study|Death|0
7946660|NCT02504268|12490609|FG005|Overall Study|Death|0
7946661|NCT02504268|12490610|FG006|Overall Study|Death|0
7946662|NCT02504268|12490611|FG007|Overall Study|Death|0
7946663|NCT02504268|12490612|FG008|Overall Study|Death|0
7946664|NCT02504268|12490604|FG000|Overall Study|Subject Request to Discontinue|11
7946665|NCT02504268|12490605|FG001|Overall Study|Subject Request to Discontinue|3
7946666|NCT02504268|12490606|FG002|Overall Study|Subject Request to Discontinue|6
7946667|NCT02504268|12490607|FG003|Overall Study|Subject Request to Discontinue|0
7946668|NCT02504268|12490608|FG004|Overall Study|Subject Request to Discontinue|0
7946669|NCT02504268|12490609|FG005|Overall Study|Subject Request to Discontinue|0
7946670|NCT02504268|12490610|FG006|Overall Study|Subject Request to Discontinue|0
7946671|NCT02504268|12490611|FG007|Overall Study|Subject Request to Discontinue|0
7946672|NCT02504268|12490612|FG008|Overall Study|Subject Request to Discontinue|0
7946673|NCT02504268|12490604|FG000|Overall Study|No Longer Meets Study Criteria|2
7946674|NCT02504268|12490605|FG001|Overall Study|No Longer Meets Study Criteria|3
7946675|NCT02504268|12490606|FG002|Overall Study|No Longer Meets Study Criteria|0
7946676|NCT02504268|12490607|FG003|Overall Study|No Longer Meets Study Criteria|0
7946677|NCT02504268|12490608|FG004|Overall Study|No Longer Meets Study Criteria|0
7946678|NCT02504268|12490609|FG005|Overall Study|No Longer Meets Study Criteria|0
7946679|NCT02504268|12490610|FG006|Overall Study|No Longer Meets Study Criteria|0
7946680|NCT02504268|12490611|FG007|Overall Study|No Longer Meets Study Criteria|0
7946681|NCT02504268|12490612|FG008|Overall Study|No Longer Meets Study Criteria|0
7946682|NCT02504268|12490604|FG000|Overall Study|Lack of Efficacy|11
7946683|NCT02504268|12490605|FG001|Overall Study|Lack of Efficacy|35
7946684|NCT02504268|12490606|FG002|Overall Study|Lack of Efficacy|9
7946685|NCT02504268|12490607|FG003|Overall Study|Lack of Efficacy|0
7946686|NCT02504268|12490608|FG004|Overall Study|Lack of Efficacy|0
7946687|NCT02504268|12490609|FG005|Overall Study|Lack of Efficacy|0
7946688|NCT02504268|12490610|FG006|Overall Study|Lack of Efficacy|0
7946689|NCT02504268|12490611|FG007|Overall Study|Lack of Efficacy|0
7946690|NCT02504268|12490612|FG008|Overall Study|Lack of Efficacy|0
7946691|NCT02504268|12490604|FG000|Overall Study|Poor/Non-Compliance|3
7946692|NCT02504268|12490605|FG001|Overall Study|Poor/Non-Compliance|2
7946693|NCT02504268|12490606|FG002|Overall Study|Poor/Non-Compliance|3
7946694|NCT02504268|12490607|FG003|Overall Study|Poor/Non-Compliance|0
7946695|NCT02504268|12490608|FG004|Overall Study|Poor/Non-Compliance|0
7946696|NCT02504268|12490609|FG005|Overall Study|Poor/Non-Compliance|0
7946697|NCT02504268|12490610|FG006|Overall Study|Poor/Non-Compliance|0
7946698|NCT02504268|12490611|FG007|Overall Study|Poor/Non-Compliance|0
7946699|NCT02504268|12490612|FG008|Overall Study|Poor/Non-Compliance|0
7946700|NCT02504268|12490604|FG000|Overall Study|Not Disclosed|1
7946701|NCT02504268|12490605|FG001|Overall Study|Not Disclosed|0
7946702|NCT02504268|12490606|FG002|Overall Study|Not Disclosed|2
7946703|NCT02504268|12490607|FG003|Overall Study|Not Disclosed|0
7946704|NCT02504268|12490608|FG004|Overall Study|Not Disclosed|0
7946705|NCT02504268|12490609|FG005|Overall Study|Not Disclosed|0
7946706|NCT02504268|12490610|FG006|Overall Study|Not Disclosed|0
7946707|NCT02504268|12490611|FG007|Overall Study|Not Disclosed|0
7946708|NCT02504268|12490612|FG008|Overall Study|Not Disclosed|0
7946709|NCT02504294|12490634|FG000|Overall Study|Adverse Event|15
7946710|NCT02504294|12490635|FG001|Overall Study|Adverse Event|12
7946711|NCT02504294|12490634|FG000|Overall Study|Withdrawal by Subject|7
7946712|NCT02504294|12490635|FG001|Overall Study|Withdrawal by Subject|1
7946713|NCT02504294|12490634|FG000|Overall Study|Protocol Violation|27
7946714|NCT02504294|12490635|FG001|Overall Study|Protocol Violation|26
7946715|NCT02504294|12490634|FG000|Overall Study|Physician Decision|1
7946716|NCT02504294|12490635|FG001|Overall Study|Physician Decision|2
7946717|NCT02504294|12490634|FG000|Overall Study|Lost to Follow-up|6
7946718|NCT02504294|12490635|FG001|Overall Study|Lost to Follow-up|7
7946719|NCT02504320|12490645|FG000|Treatment Period 1|Positive Drug Screen|0
7946720|NCT02504320|12490646|FG001|Treatment Period 1|Positive Drug Screen|0
7946721|NCT02504320|12490647|FG002|Treatment Period 1|Positive Drug Screen|1
7946722|NCT02504320|12490648|FG003|Treatment Period 1|Positive Drug Screen|0
7946723|NCT02504320|12490645|FG000|Treatment Period 2|Positive Drug Screen|0
7946724|NCT02504320|12490646|FG001|Treatment Period 2|Positive Drug Screen|1
7946725|NCT02504320|12490647|FG002|Treatment Period 2|Positive Drug Screen|0
7946726|NCT02504320|12490648|FG003|Treatment Period 2|Positive Drug Screen|0
7946727|NCT02504320|12490645|FG000|Treatment Period 3|Positive Drug Screen|0
7946728|NCT02504320|12490646|FG001|Treatment Period 3|Positive Drug Screen|0
7946729|NCT02504320|12490647|FG002|Treatment Period 3|Positive Drug Screen|0
7946730|NCT02504320|12490648|FG003|Treatment Period 3|Positive Drug Screen|1
7946731|NCT02504320|12490645|FG000|Treatment Period 3|Adverse Event|0
7946732|NCT02504320|12490646|FG001|Treatment Period 3|Adverse Event|0
7946733|NCT02504320|12490647|FG002|Treatment Period 3|Adverse Event|1
7946734|NCT02504320|12490648|FG003|Treatment Period 3|Adverse Event|0
7946735|NCT02504424|12490658|FG000|Overall Study|Withdrawal by Subject|2
7946736|NCT02504502|12490665|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4
7946737|NCT02504502|12490666|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7
7946738|NCT02504502|12490665|FG000|Crossover to Enhanced Report|Lost to Follow-up|5
7946739|NCT02504502|12490666|FG001|Crossover to Enhanced Report|Lost to Follow-up|0
7946740|NCT02504541|12490672|FG000|Overall Study|Adverse Event|4
7946741|NCT02504541|12490672|FG000|Overall Study|Withdrawal by Subject|4
7946742|NCT02504541|12490672|FG000|Overall Study|Lost to Follow-up|1
7946743|NCT02504541|12490672|FG000|Overall Study|Met Stopping Criteria|1
7946744|NCT02504541|12490672|FG000|Overall Study|Protocol Violation|2
7946745|NCT02504541|12490672|FG000|Overall Study|Termination by Sponsor|1
7946746|NCT02504541|12490672|FG000|Overall Study|Other|2
7946747|NCT02504541|12490672|FG000|Overall Study|Multiple|5
7946748|NCT02504671|12490705|FG000|Overall Study|Withdrawal by Subject|1
7946749|NCT02504671|12490706|FG001|Overall Study|Withdrawal by Subject|5
7946750|NCT02504671|12490707|FG002|Overall Study|Withdrawal by Subject|4
7946751|NCT02504671|12490708|FG003|Overall Study|Withdrawal by Subject|4
7946752|NCT02504671|12490709|FG004|Overall Study|Withdrawal by Subject|5
7946753|NCT02504671|12490710|FG005|Overall Study|Withdrawal by Subject|3
7946754|NCT02504671|12490705|FG000|Overall Study|Lack of Efficacy|1
7946755|NCT02504671|12490706|FG001|Overall Study|Lack of Efficacy|3
7946756|NCT02504671|12490707|FG002|Overall Study|Lack of Efficacy|1
7946757|NCT02504671|12490708|FG003|Overall Study|Lack of Efficacy|0
7946758|NCT02504671|12490709|FG004|Overall Study|Lack of Efficacy|4
7946759|NCT02504671|12490710|FG005|Overall Study|Lack of Efficacy|4
7946760|NCT02504671|12490705|FG000|Overall Study|Adverse Event|1
7946761|NCT02504671|12490706|FG001|Overall Study|Adverse Event|1
7946762|NCT02504671|12490707|FG002|Overall Study|Adverse Event|0
7946763|NCT02504671|12490708|FG003|Overall Study|Adverse Event|1
7946764|NCT02504671|12490709|FG004|Overall Study|Adverse Event|0
7946765|NCT02504671|12490710|FG005|Overall Study|Adverse Event|2
7946766|NCT02504671|12490705|FG000|Overall Study|Protocol Violation|2
7946767|NCT02504671|12490706|FG001|Overall Study|Protocol Violation|1
7946768|NCT02504671|12490707|FG002|Overall Study|Protocol Violation|0
7946769|NCT02504671|12490708|FG003|Overall Study|Protocol Violation|0
7946770|NCT02504671|12490709|FG004|Overall Study|Protocol Violation|0
7946771|NCT02504671|12490710|FG005|Overall Study|Protocol Violation|1
7946772|NCT02504671|12490705|FG000|Overall Study|Lost to Follow-up|0
7946773|NCT02504671|12490706|FG001|Overall Study|Lost to Follow-up|0
7946774|NCT02504671|12490707|FG002|Overall Study|Lost to Follow-up|2
7946775|NCT02504671|12490708|FG003|Overall Study|Lost to Follow-up|0
7946776|NCT02504671|12490709|FG004|Overall Study|Lost to Follow-up|0
7946777|NCT02504671|12490710|FG005|Overall Study|Lost to Follow-up|1
7946778|NCT02504671|12490705|FG000|Overall Study|Protocol defined stopping criteria|7
7946779|NCT02504671|12490706|FG001|Overall Study|Protocol defined stopping criteria|4
7946780|NCT02504671|12490707|FG002|Overall Study|Protocol defined stopping criteria|3
7946781|NCT02504671|12490708|FG003|Overall Study|Protocol defined stopping criteria|5
7946782|NCT02504671|12490709|FG004|Overall Study|Protocol defined stopping criteria|3
7946783|NCT02504671|12490710|FG005|Overall Study|Protocol defined stopping criteria|3
7946784|NCT02504827|12490742|FG000|Overall Study|Could not produce sputum|1
7965707|NCT00554788|12520980|FG000|Overall Study|Physician Decision|1
7822321|NCT01261793|12291470|FG002|Overall Study|Patient unable to start IV line|1
7822322|NCT01261975|12291487|FG000|Overall Study|Surgical complication|1
7822323|NCT01262027|12291494|FG000|Overall Study|Adverse Event|1
7822324|NCT01262027|12291494|FG000|Overall Study|Withdrawal by Subject|3
7822325|NCT01262027|12291494|FG000|Overall Study|Protocol Violation|1
7822326|NCT01262092|12291500|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
7822327|NCT01262092|12291501|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
7822328|NCT01262092|12291500|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
7822329|NCT01262092|12291501|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
7822330|NCT01262092|12291500|FG000|Buprenorphine Taper|noncompliance - missed medication|1
7822331|NCT01262092|12291501|FG001|Buprenorphine Taper|noncompliance - missed medication|1
7822332|NCT01262092|12291500|FG000|Gabapentin Taper|noncompliance - missed medications|1
7822333|NCT01262092|12291501|FG001|Gabapentin Taper|noncompliance - missed medications|0
7822334|NCT01262287|12291540|FG000|Overall Study|Lost to Follow-up|2
7822335|NCT01262287|12291541|FG001|Overall Study|Lost to Follow-up|1
7822336|NCT01262352|12291553|FG000|Period 1|Illness after randomization|1
7822337|NCT01262352|12291554|FG001|Period 1|Illness after randomization|0
7965708|NCT00554788|12520981|FG001|Overall Study|Physician Decision|1
7965709|NCT00554788|12520982|FG002|Overall Study|Physician Decision|3
7965710|NCT00554788|12520980|FG000|Overall Study|Withdrawal by Subject|0
7965711|NCT00554788|12520981|FG001|Overall Study|Withdrawal by Subject|0
7965712|NCT00554788|12520982|FG002|Overall Study|Withdrawal by Subject|1
7965713|NCT00554788|12520980|FG000|Overall Study|Refusal of further protocol therapy|0
7822338|NCT01262352|12291553|FG000|Washout|Adverse Event|1
7822339|NCT01262352|12291554|FG001|Washout|Adverse Event|1
7822340|NCT01262352|12291553|FG000|Washout|Extended Washout|0
7965714|NCT00554788|12520981|FG001|Overall Study|Refusal of further protocol therapy|1
7965715|NCT00554788|12520982|FG002|Overall Study|Refusal of further protocol therapy|1
7946785|NCT02504892|12490746|FG000|Overall Study|Adverse event-pneumonitis|2
7946786|NCT02505217|12490761|FG000|Overall Study|Withdrawal by Subject|1
7946787|NCT02505217|12490762|FG001|Overall Study|Withdrawal by Subject|2
7946788|NCT02505334|12490774|FG000|Main Treatment Period|Adverse Event|3
7946789|NCT02505334|12490775|FG001|Main Treatment Period|Adverse Event|3
7946790|NCT02505334|12490774|FG000|Main Treatment Period|Lack of Efficacy|7
7946791|NCT02505334|12490775|FG001|Main Treatment Period|Lack of Efficacy|17
7946792|NCT02505334|12490774|FG000|Main Treatment Period|Protocol Violation|0
7946793|NCT02505334|12490775|FG001|Main Treatment Period|Protocol Violation|1
7946794|NCT02505334|12490774|FG000|Main Treatment Period|Withdrawal by Subject|1
7946795|NCT02505334|12490775|FG001|Main Treatment Period|Withdrawal by Subject|8
7946796|NCT02505334|12490774|FG000|Main Treatment Period|Unclassified|4
7946797|NCT02505334|12490775|FG001|Main Treatment Period|Unclassified|10
7946798|NCT02505334|12490774|FG000|Extension Treatment Period|Adverse Event|5
7946799|NCT02505334|12490775|FG001|Extension Treatment Period|Adverse Event|0
7946800|NCT02505334|12490774|FG000|Extension Treatment Period|Lack of Efficacy|4
7946801|NCT02505334|12490775|FG001|Extension Treatment Period|Lack of Efficacy|0
7946802|NCT02505334|12490774|FG000|Extension Treatment Period|Withdrawal by Subject|6
7946803|NCT02505334|12490775|FG001|Extension Treatment Period|Withdrawal by Subject|0
7946804|NCT02505334|12490774|FG000|Extension Treatment Period|Unclassified|3
7946805|NCT02505334|12490775|FG001|Extension Treatment Period|Unclassified|0
7946806|NCT02505542|12490781|FG000|Part A: Open-Label Period|Adverse Event|31
7946807|NCT02505542|12490782|FG001|Part A: Open-Label Period|Adverse Event|0
7946808|NCT02505542|12490783|FG002|Part A: Open-Label Period|Adverse Event|0
7946809|NCT02505542|12490784|FG003|Part A: Open-Label Period|Adverse Event|0
7946810|NCT02505542|12490781|FG000|Part A: Open-Label Period|Lack of Efficacy|5
7946811|NCT02505542|12490782|FG001|Part A: Open-Label Period|Lack of Efficacy|0
7946812|NCT02505542|12490783|FG002|Part A: Open-Label Period|Lack of Efficacy|0
7946813|NCT02505542|12490784|FG003|Part A: Open-Label Period|Lack of Efficacy|0
7965716|NCT00554788|12520980|FG000|Overall Study|Progressive disease|0
7965717|NCT00554788|12520981|FG001|Overall Study|Progressive disease|0
7965718|NCT00554788|12520982|FG002|Overall Study|Progressive disease|3
7965719|NCT00554788|12520980|FG000|Overall Study|Ineligible|2
7965720|NCT00554788|12520981|FG001|Overall Study|Ineligible|0
7965721|NCT00554788|12520982|FG002|Overall Study|Ineligible|1
7965722|NCT00336024|12520997|FG000|Overall Study|Death|2
7965723|NCT00336024|12520998|FG001|Overall Study|Death|1
7965724|NCT00336024|12520997|FG000|Overall Study|Physician Decision|4
7965725|NCT00336024|12520998|FG001|Overall Study|Physician Decision|1
7965726|NCT00336024|12520997|FG000|Overall Study|Protocol Violation|1
7965727|NCT00336024|12520998|FG001|Overall Study|Protocol Violation|0
7965728|NCT00336024|12520997|FG000|Overall Study|Withdrawal by Subject|1
7965729|NCT00336024|12520998|FG001|Overall Study|Withdrawal by Subject|2
7965730|NCT00336024|12520997|FG000|Overall Study|Failure to fulfill consolidation|1
7965731|NCT00336024|12520998|FG001|Overall Study|Failure to fulfill consolidation|1
7965732|NCT00336024|12520997|FG000|Overall Study|Progressive Disease|4
7965733|NCT00336024|12520998|FG001|Overall Study|Progressive Disease|7
7965734|NCT00336024|12520997|FG000|Overall Study|Ineligible|7
7965735|NCT00336024|12520998|FG001|Overall Study|Ineligible|7
7965736|NCT00274937|12521004|FG000|Overall Study|Physician Decision|10
7965737|NCT00274937|12521004|FG000|Overall Study|Withdrawal by Subject|6
7965738|NCT00274937|12521004|FG000|Overall Study|Progressive Disease|4
7965739|NCT02737722|12521012|FG000|Overall Study|Physician Decision|0
7965740|NCT02737722|12521013|FG001|Overall Study|Physician Decision|0
7965741|NCT02737722|12521014|FG002|Overall Study|Physician Decision|1
7965742|NCT02737722|12521015|FG003|Overall Study|Physician Decision|0
7965743|NCT02737826|12521025|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0
7965744|NCT02737826|12521026|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12
7965745|NCT02737826|12521027|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14
7965746|NCT02737852|12521036|FG000|Overall Study|Withdrawal by Subject|2
7965747|NCT02737930|12521060|FG000|Overall Study|Withdrawal by Subject|0
7965748|NCT02737930|12521061|FG001|Overall Study|Withdrawal by Subject|1
7946814|NCT02505542|12490781|FG000|Part A: Open-Label Period|Protocol Violation|1
7946815|NCT02505542|12490782|FG001|Part A: Open-Label Period|Protocol Violation|0
7946816|NCT02505542|12490783|FG002|Part A: Open-Label Period|Protocol Violation|0
7946817|NCT02505542|12490784|FG003|Part A: Open-Label Period|Protocol Violation|0
7946818|NCT02505542|12490781|FG000|Part A: Open-Label Period|Lost to Follow-up|5
7946819|NCT02505542|12490782|FG001|Part A: Open-Label Period|Lost to Follow-up|0
7946820|NCT02505542|12490783|FG002|Part A: Open-Label Period|Lost to Follow-up|0
7946821|NCT02505542|12490784|FG003|Part A: Open-Label Period|Lost to Follow-up|0
7946822|NCT02505542|12490781|FG000|Part A: Open-Label Period|Withdrawal by Subject|27
7946823|NCT02505542|12490782|FG001|Part A: Open-Label Period|Withdrawal by Subject|0
7946824|NCT02505542|12490783|FG002|Part A: Open-Label Period|Withdrawal by Subject|0
7946825|NCT02505542|12490784|FG003|Part A: Open-Label Period|Withdrawal by Subject|0
7946826|NCT02505542|12490781|FG000|Part A: Open-Label Period|New medical history available|1
7946827|NCT02505542|12490782|FG001|Part A: Open-Label Period|New medical history available|0
7946828|NCT02505542|12490783|FG002|Part A: Open-Label Period|New medical history available|0
7946829|NCT02505542|12490784|FG003|Part A: Open-Label Period|New medical history available|0
7946830|NCT02505542|12490781|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1
7946831|NCT02505542|12490782|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0
7946832|NCT02505542|12490783|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0
7946833|NCT02505542|12490784|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0
7946834|NCT02505542|12490781|FG000|Part A: Open-Label Period|Pregnancy|2
7946835|NCT02505542|12490782|FG001|Part A: Open-Label Period|Pregnancy|0
7946836|NCT02505542|12490783|FG002|Part A: Open-Label Period|Pregnancy|0
7946837|NCT02505542|12490784|FG003|Part A: Open-Label Period|Pregnancy|0
7946838|NCT02505542|12490781|FG000|Part A: Open-Label Period|Sponsor directive|1
7946839|NCT02505542|12490782|FG001|Part A: Open-Label Period|Sponsor directive|0
7946840|NCT02505542|12490783|FG002|Part A: Open-Label Period|Sponsor directive|0
7946841|NCT02505542|12490784|FG003|Part A: Open-Label Period|Sponsor directive|0
7946842|NCT02505542|12490781|FG000|Part A: Open-Label Period|Medical monitor decision|1
7946843|NCT02505542|12490782|FG001|Part A: Open-Label Period|Medical monitor decision|0
7946844|NCT02505542|12490783|FG002|Part A: Open-Label Period|Medical monitor decision|0
7946845|NCT02505542|12490784|FG003|Part A: Open-Label Period|Medical monitor decision|0
7946846|NCT02505542|12490781|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1
7946847|NCT02505542|12490782|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0
7946848|NCT02505542|12490783|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0
7946849|NCT02505542|12490784|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0
7946850|NCT02505542|12490781|FG000|Part A: Open-Label Period|Non-compliance|1
7946851|NCT02505542|12490782|FG001|Part A: Open-Label Period|Non-compliance|0
7946852|NCT02505542|12490783|FG002|Part A: Open-Label Period|Non-compliance|0
7946853|NCT02505542|12490784|FG003|Part A: Open-Label Period|Non-compliance|0
7946854|NCT02505542|12490781|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2
7946855|NCT02505542|12490782|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
7946856|NCT02505542|12490783|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
7946857|NCT02505542|12490784|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
7946858|NCT02505542|12490781|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3
7946859|NCT02505542|12490782|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
7946860|NCT02505542|12490783|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
7946861|NCT02505542|12490784|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
7946862|NCT02505542|12490781|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341
7946863|NCT02505542|12490782|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
7946864|NCT02505542|12490783|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
7946865|NCT02505542|12490784|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
7946866|NCT02505542|12490781|FG000|Part B: Double-Blind Period|Adverse Event|0
7946867|NCT02505542|12490782|FG001|Part B: Double-Blind Period|Adverse Event|0
7946868|NCT02505542|12490783|FG002|Part B: Double-Blind Period|Adverse Event|1
7946869|NCT02505542|12490784|FG003|Part B: Double-Blind Period|Adverse Event|3
7946870|NCT02505542|12490781|FG000|Part B: Double-Blind Period|Lost to Follow-up|0
7946871|NCT02505542|12490782|FG001|Part B: Double-Blind Period|Lost to Follow-up|0
7946872|NCT02505542|12490783|FG002|Part B: Double-Blind Period|Lost to Follow-up|0
7946873|NCT02505542|12490784|FG003|Part B: Double-Blind Period|Lost to Follow-up|1
7946874|NCT02505542|12490781|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0
7946875|NCT02505542|12490782|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8
7946876|NCT02505542|12490783|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7
7946877|NCT02505542|12490784|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2
7946878|NCT02505542|12490781|FG000|Part B: Double-Blind Period|Planning pregnancy|0
7946879|NCT02505542|12490782|FG001|Part B: Double-Blind Period|Planning pregnancy|1
7946880|NCT02505542|12490783|FG002|Part B: Double-Blind Period|Planning pregnancy|0
7946881|NCT02505542|12490784|FG003|Part B: Double-Blind Period|Planning pregnancy|0
7946882|NCT02505542|12490781|FG000|Part B: Double-Blind Period|Week 94 missed|0
7946883|NCT02505542|12490782|FG001|Part B: Double-Blind Period|Week 94 missed|0
7946884|NCT02505542|12490783|FG002|Part B: Double-Blind Period|Week 94 missed|1
7946885|NCT02505542|12490784|FG003|Part B: Double-Blind Period|Week 94 missed|0
7946886|NCT02505542|12490781|FG000|Part B: Double-Blind Period|Patient was moved from the country|0
7946887|NCT02505542|12490782|FG001|Part B: Double-Blind Period|Patient was moved from the country|0
7946888|NCT02505542|12490783|FG002|Part B: Double-Blind Period|Patient was moved from the country|0
7946889|NCT02505542|12490784|FG003|Part B: Double-Blind Period|Patient was moved from the country|1
7946890|NCT02505542|12490781|FG000|Part B: Double-Blind Period|Lack of Efficacy|0
7946891|NCT02505542|12490782|FG001|Part B: Double-Blind Period|Lack of Efficacy|1
7946892|NCT02505542|12490783|FG002|Part B: Double-Blind Period|Lack of Efficacy|0
7946893|NCT02505542|12490784|FG003|Part B: Double-Blind Period|Lack of Efficacy|0
7946894|NCT02505542|12490781|FG000|Part B: Double-Blind Period|Miscalculation|0
7946895|NCT02505542|12490782|FG001|Part B: Double-Blind Period|Miscalculation|1
7946896|NCT02505542|12490783|FG002|Part B: Double-Blind Period|Miscalculation|0
7946897|NCT02505542|12490784|FG003|Part B: Double-Blind Period|Miscalculation|0
7946898|NCT02505542|12490781|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0
7946899|NCT02505542|12490782|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1
7946900|NCT02505542|12490783|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0
7946901|NCT02505542|12490784|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0
7946902|NCT02505867|12490812|FG000|Overall Study|Lack of Efficacy|6
7946903|NCT02505867|12490813|FG001|Overall Study|Lack of Efficacy|6
7946904|NCT02505945|12490830|FG000|Overall Study|Withdrawal by Subject|13
7946905|NCT02505945|12490831|FG001|Overall Study|Withdrawal by Subject|2
7946906|NCT02505945|12490830|FG000|Overall Study|Adverse Event|1
7946907|NCT02505945|12490831|FG001|Overall Study|Adverse Event|0
7946908|NCT02505945|12490830|FG000|Overall Study|Physician Decision|2
7946909|NCT02505945|12490831|FG001|Overall Study|Physician Decision|1
7946910|NCT02505945|12490830|FG000|Overall Study|Lost to Follow-up|6
7946911|NCT02505945|12490831|FG001|Overall Study|Lost to Follow-up|1
7946912|NCT02506036|12490839|FG000|First Intervention (4-6 Weeks)|Death|1
7946913|NCT02506036|12490840|FG001|First Intervention (4-6 Weeks)|Death|0
7946914|NCT02506036|12490839|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0
7946915|NCT02506036|12490840|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1
7946916|NCT02506036|12490839|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0
7946917|NCT02506036|12490840|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1
7946918|NCT02506257|12490863|FG000|Overall Study|Adverse Event|0
7946919|NCT02506257|12490864|FG001|Overall Study|Adverse Event|2
7946920|NCT02506257|12490865|FG002|Overall Study|Adverse Event|3
7946921|NCT02506257|12490866|FG003|Overall Study|Adverse Event|0
7946922|NCT02506257|12490863|FG000|Overall Study|Protocol Violation|0
7946923|NCT02506257|12490864|FG001|Overall Study|Protocol Violation|0
7946924|NCT02506257|12490865|FG002|Overall Study|Protocol Violation|1
7946925|NCT02506257|12490866|FG003|Overall Study|Protocol Violation|0
7946926|NCT02506816|12490949|FG000|Overall Study|Adverse Event|3
7946927|NCT02506881|12490970|FG000|First Intervention (Day 1)|Protocol Violation|0
7946928|NCT02506881|12490971|FG001|First Intervention (Day 1)|Protocol Violation|0
7946929|NCT02506881|12490972|FG002|First Intervention (Day 1)|Protocol Violation|1
7946930|NCT02506881|12490973|FG003|First Intervention (Day 1)|Protocol Violation|0
7946931|NCT02506881|12490970|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
7946932|NCT02506881|12490971|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
7946933|NCT02506881|12490972|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
7946934|NCT02506881|12490973|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
7946935|NCT02506881|12490970|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0
7946936|NCT02506881|12490971|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0
7946937|NCT02506881|12490972|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12
7946938|NCT02506881|12490973|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12
7946939|NCT02507219|12491000|FG000|Overall Study|Physician Decision|1
7946940|NCT02507219|12491001|FG001|Overall Study|Physician Decision|0
7946941|NCT02507219|12491002|FG002|Overall Study|Physician Decision|0
7946942|NCT02507219|12491003|FG003|Overall Study|Physician Decision|0
7946943|NCT02507219|12491004|FG004|Overall Study|Physician Decision|0
7946944|NCT02507219|12491005|FG005|Overall Study|Physician Decision|0
7946945|NCT02507219|12491000|FG000|Overall Study|Withdrawal by Subject|0
7946946|NCT02507219|12491001|FG001|Overall Study|Withdrawal by Subject|0
7946947|NCT02507219|12491002|FG002|Overall Study|Withdrawal by Subject|0
7946948|NCT02507219|12491003|FG003|Overall Study|Withdrawal by Subject|0
7946949|NCT02507219|12491004|FG004|Overall Study|Withdrawal by Subject|1
7946950|NCT02507219|12491005|FG005|Overall Study|Withdrawal by Subject|0
7946951|NCT02507297|12491015|FG000|Overall Study|Withdrawal by Subject|1
7946952|NCT02507297|12491016|FG001|Overall Study|Withdrawal by Subject|0
7946953|NCT02507297|12491015|FG000|Overall Study|Lost to Follow-up|0
7946954|NCT02507297|12491016|FG001|Overall Study|Lost to Follow-up|1
7946955|NCT02507349|12491024|FG000|Overall Study|Death|12
7946956|NCT02507349|12491025|FG001|Overall Study|Death|16
7946957|NCT02507349|12491024|FG000|Overall Study|Withdrawal by Subject|1
7946958|NCT02507349|12491025|FG001|Overall Study|Withdrawal by Subject|1
7946959|NCT02507349|12491024|FG000|Overall Study|Lost to Follow-up|174
7946960|NCT02507349|12491025|FG001|Overall Study|Lost to Follow-up|144
7946961|NCT02507375|12491033|FG000|Overall Study|Progressive Disease|4
7946962|NCT02507375|12491034|FG001|Overall Study|Progressive Disease|5
7946963|NCT02507375|12491033|FG000|Overall Study|Death|0
7946964|NCT02507375|12491034|FG001|Overall Study|Death|1
7946965|NCT02507375|12491033|FG000|Overall Study|Refused treatment|0
7946966|NCT02507375|12491034|FG001|Overall Study|Refused treatment|1
7946967|NCT02507375|12491033|FG000|Overall Study|Adverse Event|0
7946968|NCT02507375|12491034|FG001|Overall Study|Adverse Event|1
7946969|NCT02507752|12491054|FG000|Overall Study|Adverse Event|1
7946970|NCT02507752|12491054|FG000|Overall Study|Protocol Violation|6
7946971|NCT02507752|12491054|FG000|Overall Study|Lost to Follow-up|7
7946972|NCT02507752|12491054|FG000|Overall Study|Infusion reaction at first infusion|1
7946973|NCT02507752|12491054|FG000|Overall Study|Participant didn't perform visit Week 12|1
7946974|NCT02507752|12491054|FG000|Overall Study|Participant didn't perform visit Week 24|1
7946975|NCT02508116|12491073|FG000|Overall Study|Lost to Follow-up|2
7946976|NCT02508116|12491074|FG001|Overall Study|Lost to Follow-up|3
7946977|NCT02508116|12491073|FG000|Overall Study|Withdrawal by Subject|3
7946978|NCT02508116|12491074|FG001|Overall Study|Withdrawal by Subject|2
7946979|NCT02508116|12491073|FG000|Overall Study|Protocol Violation|1
7946980|NCT02508116|12491074|FG001|Overall Study|Protocol Violation|2
7946981|NCT02508116|12491073|FG000|Overall Study|Physician Decision|2
7946982|NCT02508116|12491074|FG001|Overall Study|Physician Decision|0
7946983|NCT02508194|12491082|FG000|Overall Study|Death|5
7946984|NCT02508194|12491083|FG001|Overall Study|Death|3
7946985|NCT02508194|12491082|FG000|Overall Study|Lost to Follow-up|25
7946986|NCT02508194|12491083|FG001|Overall Study|Lost to Follow-up|18
7946987|NCT02508194|12491082|FG000|Overall Study|Withdrawal by Subject|20
7946988|NCT02508194|12491083|FG001|Overall Study|Withdrawal by Subject|18
7946989|NCT02508194|12491082|FG000|Overall Study|Error in Randomization|1
7946990|NCT02508194|12491083|FG001|Overall Study|Error in Randomization|3
7946991|NCT02508194|12491082|FG000|Overall Study|Principal Investigator Decision|1
7946992|NCT02508194|12491083|FG001|Overall Study|Principal Investigator Decision|2
7965749|NCT02738008|12521070|FG000|Overall Study|Study Terminated by Sponsor|1
7965750|NCT02738008|12521071|FG001|Overall Study|Study Terminated by Sponsor|5
7965751|NCT02738008|12521072|FG002|Overall Study|Study Terminated by Sponsor|3
7965752|NCT02738008|12521070|FG000|Overall Study|Adverse Event|0
7965753|NCT02738008|12521071|FG001|Overall Study|Adverse Event|1
7965754|NCT02738008|12521072|FG002|Overall Study|Adverse Event|2
7965755|NCT02738138|12521094|FG000|Overall Study|Adverse Event|0
7965756|NCT02738138|12521095|FG001|Overall Study|Adverse Event|1
7965757|NCT02738138|12521094|FG000|Overall Study|Lost to Follow-up|2
7965758|NCT02738138|12521095|FG001|Overall Study|Lost to Follow-up|0
7965759|NCT02738138|12521094|FG000|Overall Study|Other - not further specified|1
7965760|NCT02738138|12521095|FG001|Overall Study|Other - not further specified|0
7965761|NCT02738151|12521102|FG000|Overall Study|Randomized but not treated|4
7965762|NCT02738151|12521103|FG001|Overall Study|Randomized but not treated|1
7965763|NCT02738151|12521102|FG000|Overall Study|Adverse Event|4
7965764|NCT02738151|12521103|FG001|Overall Study|Adverse Event|5
7965765|NCT02738151|12521102|FG000|Overall Study|Hypoglycemia|0
7965766|NCT02738151|12521103|FG001|Overall Study|Hypoglycemia|1
7965767|NCT02738151|12521102|FG000|Overall Study|Poor Compliance to Protocol|4
7965768|NCT02738151|12521103|FG001|Overall Study|Poor Compliance to Protocol|3
7965769|NCT02738151|12521102|FG000|Overall Study|Other than specified above|11
7965770|NCT02738151|12521103|FG001|Overall Study|Other than specified above|21
7965771|NCT02738203|12521111|FG000|Overall Study|Failed IUD Insertion|2
7965772|NCT02738203|12521112|FG001|Overall Study|Failed IUD Insertion|2
7965773|NCT02738203|12521111|FG000|Overall Study|Protocol Violation|0
7946993|NCT02508428|12491122|FG000|Overall Study|Death|32
7946994|NCT02508428|12491123|FG001|Overall Study|Death|33
7946995|NCT02508428|12491122|FG000|Overall Study|Liner revised|3
7946996|NCT02508428|12491123|FG001|Overall Study|Liner revised|19
7946997|NCT02508428|12491122|FG000|Overall Study|Incomplete follow-up|17
7946998|NCT02508428|12491123|FG001|Overall Study|Incomplete follow-up|15
7946999|NCT02508649|12491146|FG000|Overall Study|Withdrawal by Subject|4
7947000|NCT02508649|12491147|FG001|Overall Study|Withdrawal by Subject|6
7947001|NCT02508649|12491148|FG002|Overall Study|Withdrawal by Subject|5
7947002|NCT02508649|12491149|FG003|Overall Study|Withdrawal by Subject|6
7947003|NCT02508649|12491146|FG000|Overall Study|Investigator withdrew the subject|1
7947004|NCT02508649|12491147|FG001|Overall Study|Investigator withdrew the subject|2
7947005|NCT02508649|12491148|FG002|Overall Study|Investigator withdrew the subject|1
7947006|NCT02508649|12491149|FG003|Overall Study|Investigator withdrew the subject|0
7947007|NCT02508649|12491146|FG000|Overall Study|Post randomization screening failure|12
7947008|NCT02508649|12491147|FG001|Overall Study|Post randomization screening failure|4
7947009|NCT02508649|12491148|FG002|Overall Study|Post randomization screening failure|9
7947010|NCT02508649|12491149|FG003|Overall Study|Post randomization screening failure|3
7947011|NCT02508649|12491146|FG000|Overall Study|Lost to Follow-up|1
7947012|NCT02508649|12491147|FG001|Overall Study|Lost to Follow-up|1
7947013|NCT02508649|12491148|FG002|Overall Study|Lost to Follow-up|0
7947014|NCT02508649|12491149|FG003|Overall Study|Lost to Follow-up|1
7947015|NCT02508701|12491166|FG000|Overall Study|Lost to Follow-up|9
7947016|NCT02508701|12491167|FG001|Overall Study|Lost to Follow-up|5
7947017|NCT02508701|12491168|FG002|Overall Study|Lost to Follow-up|5
7947018|NCT02508701|12491169|FG003|Overall Study|Lost to Follow-up|3
7947019|NCT02508935|12491183|FG000|Overall Study|Withdrawal by Subject|1
7947020|NCT02508935|12491183|FG000|Overall Study|Withdrawal by Caregiver|8
7947021|NCT02508935|12491183|FG000|Overall Study|Pain Score <4|1
7947022|NCT02508935|12491183|FG000|Overall Study|Emesis|3
7947023|NCT02508935|12491183|FG000|Overall Study|Adverse Event|3
7947024|NCT02508935|12491183|FG000|Overall Study|Protocol Violation|1
7947025|NCT02508935|12491183|FG000|Overall Study|Physician Decision|1
7947026|NCT02508935|12491183|FG000|Overall Study|Trial terminated by sponsor|5
7947027|NCT02509026|12491189|FG000|Induction Period (24 Weeks)|Adverse Event|5
7947028|NCT02509026|12491189|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5
7947029|NCT02509026|12491189|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6
7947030|NCT02509026|12491189|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1
7947031|NCT02509026|12491189|FG000|Induction Period (24 Weeks)|Other|2
7947032|NCT02509026|12491189|FG000|Induction Period (24 Weeks)|Protocol Violation|1
7947033|NCT02509026|12491189|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1
7947034|NCT02509026|12491189|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1
7947035|NCT02509026|12491189|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2
7947036|NCT02509026|12491189|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5
7947037|NCT02509026|12491189|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1
7947038|NCT02509026|12491189|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2
7947039|NCT02509026|12491189|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1
7947040|NCT02509078|12491238|FG000|Overall Study|Protocol Violation|1
7947041|NCT02509078|12491239|FG001|Overall Study|Protocol Violation|1
7947042|NCT02509117|12491257|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7947043|NCT02509117|12491258|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
7947044|NCT02509117|12491259|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7947045|NCT02509117|12491260|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7947046|NCT02509117|12491261|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7947047|NCT02509117|12491262|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7947048|NCT02509117|12491263|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7947049|NCT02509117|12491264|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7947050|NCT02509117|12491265|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7947051|NCT02509117|12491266|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7947052|NCT02509117|12491257|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7947053|NCT02509117|12491258|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7947054|NCT02509117|12491259|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7947055|NCT02509117|12491260|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7947056|NCT02509117|12491261|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7947057|NCT02509117|12491262|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7965774|NCT02738203|12521112|FG001|Overall Study|Protocol Violation|1
7947058|NCT02509117|12491263|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7947059|NCT02509117|12491264|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7947060|NCT02509117|12491265|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7947061|NCT02509117|12491266|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
7947062|NCT02509117|12491257|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7947063|NCT02509117|12491258|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7947064|NCT02509117|12491259|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7947065|NCT02509117|12491260|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7947066|NCT02509117|12491261|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7947067|NCT02509117|12491262|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7947068|NCT02509117|12491263|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7947069|NCT02509117|12491264|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7947070|NCT02509117|12491265|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7947071|NCT02509117|12491266|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
7947072|NCT02509156|12491306|FG000|Randomized Phase|Death|1
7947073|NCT02509156|12491307|FG001|Randomized Phase|Death|0
7947074|NCT02509156|12491306|FG000|Randomized Phase|Withdrawal by Subject|1
7947075|NCT02509156|12491307|FG001|Randomized Phase|Withdrawal by Subject|1
7947076|NCT02510001|12491376|FG000|Overall Study|Early disease progression|0
7947077|NCT02510001|12491377|FG001|Overall Study|Early disease progression|0
7947078|NCT02510001|12491378|FG002|Overall Study|Early disease progression|0
7947079|NCT02510001|12491379|FG003|Overall Study|Early disease progression|1
7947080|NCT02510001|12491380|FG004|Overall Study|Early disease progression|1
7947081|NCT02510001|12491381|FG005|Overall Study|Early disease progression|1
7947082|NCT02510001|12491382|FG006|Overall Study|Early disease progression|0
7947083|NCT02510001|12491383|FG007|Overall Study|Early disease progression|0
7947084|NCT02510001|12491376|FG000|Overall Study|Adverse Event|0
7947085|NCT02510001|12491377|FG001|Overall Study|Adverse Event|0
7947086|NCT02510001|12491378|FG002|Overall Study|Adverse Event|0
7947087|NCT02510001|12491379|FG003|Overall Study|Adverse Event|1
7947088|NCT02510001|12491380|FG004|Overall Study|Adverse Event|2
7947089|NCT02510001|12491381|FG005|Overall Study|Adverse Event|1
7947090|NCT02510001|12491382|FG006|Overall Study|Adverse Event|2
7947091|NCT02510001|12491383|FG007|Overall Study|Adverse Event|5
7947092|NCT02510001|12491376|FG000|Overall Study|Physician Decision|0
7947093|NCT02510001|12491377|FG001|Overall Study|Physician Decision|0
7947094|NCT02510001|12491378|FG002|Overall Study|Physician Decision|0
7947095|NCT02510001|12491379|FG003|Overall Study|Physician Decision|0
7947096|NCT02510001|12491380|FG004|Overall Study|Physician Decision|1
7947097|NCT02510001|12491381|FG005|Overall Study|Physician Decision|0
7947098|NCT02510001|12491382|FG006|Overall Study|Physician Decision|0
7947099|NCT02510001|12491383|FG007|Overall Study|Physician Decision|0
7947100|NCT02510001|12491376|FG000|Overall Study|Withdrawal by Subject|0
7947101|NCT02510001|12491377|FG001|Overall Study|Withdrawal by Subject|0
7947102|NCT02510001|12491378|FG002|Overall Study|Withdrawal by Subject|0
7947103|NCT02510001|12491379|FG003|Overall Study|Withdrawal by Subject|0
7947104|NCT02510001|12491380|FG004|Overall Study|Withdrawal by Subject|0
7947105|NCT02510001|12491381|FG005|Overall Study|Withdrawal by Subject|0
7947106|NCT02510001|12491382|FG006|Overall Study|Withdrawal by Subject|0
7947107|NCT02510001|12491383|FG007|Overall Study|Withdrawal by Subject|2
7947108|NCT02510014|12491421|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1
7947109|NCT02510014|12491422|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1
7947110|NCT02510014|12491421|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
7947111|NCT02510014|12491422|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
7947112|NCT02510014|12491421|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
7947113|NCT02510014|12491422|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
7947114|NCT02510014|12491421|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0
7947115|NCT02510014|12491422|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1
7947116|NCT02510014|12491421|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
7947117|NCT02510014|12491422|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
7947118|NCT02510014|12491421|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
7947119|NCT02510014|12491422|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
7947120|NCT02510014|12491421|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
7947121|NCT02510014|12491422|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
7947122|NCT02510014|12491421|FG000|Run-In Period (Days -14 to Day -1)|Other|19
7947123|NCT02510014|12491422|FG001|Run-In Period (Days -14 to Day -1)|Other|1
7947124|NCT02510014|12491421|FG000|Treatment Period|Adverse Event|11
7947125|NCT02510014|12491422|FG001|Treatment Period|Adverse Event|4
7947126|NCT02510014|12491421|FG000|Treatment Period|Withdrawal symptoms|3
7947127|NCT02510014|12491422|FG001|Treatment Period|Withdrawal symptoms|0
7947128|NCT02510014|12491421|FG000|Treatment Period|Lost to Follow-up|80
7947129|NCT02510014|12491422|FG001|Treatment Period|Lost to Follow-up|19
7947130|NCT02510014|12491421|FG000|Treatment Period|Physician Decision|5
7947131|NCT02510014|12491422|FG001|Treatment Period|Physician Decision|0
7947132|NCT02510014|12491421|FG000|Treatment Period|Withdrawal by Subject|67
7947133|NCT02510014|12491422|FG001|Treatment Period|Withdrawal by Subject|24
7947134|NCT02510014|12491421|FG000|Treatment Period|Withdrawn by the investigator|7
7947135|NCT02510014|12491422|FG001|Treatment Period|Withdrawn by the investigator|1
7947136|NCT02510014|12491421|FG000|Treatment Period|Protocol Violation|4
7947137|NCT02510014|12491422|FG001|Treatment Period|Protocol Violation|4
7947138|NCT02510014|12491421|FG000|Treatment Period|Incarceration, pregnancy, misc|29
7947139|NCT02510014|12491422|FG001|Treatment Period|Incarceration, pregnancy, misc|5
7947140|NCT02510664|12491440|FG000|Overall Study|Transferred Care|9
7947141|NCT02510664|12491441|FG001|Overall Study|Transferred Care|9
7947142|NCT02510664|12491442|FG002|Overall Study|Transferred Care|0
7947143|NCT02510664|12491440|FG000|Overall Study|Provider Retired/No Time to Reschedule|10
7947144|NCT02510664|12491441|FG001|Overall Study|Provider Retired/No Time to Reschedule|10
7947145|NCT02510664|12491442|FG002|Overall Study|Provider Retired/No Time to Reschedule|0
7947146|NCT02510664|12491440|FG000|Overall Study|Time Constraints|1
7947147|NCT02510664|12491441|FG001|Overall Study|Time Constraints|1
7947148|NCT02510664|12491442|FG002|Overall Study|Time Constraints|0
7947149|NCT02510794|12491459|FG000|Overall Study|Adverse Event|0
7947150|NCT02510794|12491460|FG001|Overall Study|Adverse Event|1
7947151|NCT02510794|12491461|FG002|Overall Study|Adverse Event|0
7947152|NCT02510794|12491462|FG003|Overall Study|Adverse Event|0
7947153|NCT02510794|12491459|FG000|Overall Study|Death|1
7947154|NCT02510794|12491460|FG001|Overall Study|Death|2
7947155|NCT02510794|12491461|FG002|Overall Study|Death|1
7947156|NCT02510794|12491462|FG003|Overall Study|Death|1
7947157|NCT02510794|12491459|FG000|Overall Study|Lack of Efficacy|3
7947158|NCT02510794|12491460|FG001|Overall Study|Lack of Efficacy|1
7947159|NCT02510794|12491461|FG002|Overall Study|Lack of Efficacy|1
7947160|NCT02510794|12491462|FG003|Overall Study|Lack of Efficacy|0
7947161|NCT02510794|12491459|FG000|Overall Study|Participant moved out of the area|0
7947162|NCT02510794|12491460|FG001|Overall Study|Participant moved out of the area|0
7947163|NCT02510794|12491461|FG002|Overall Study|Participant moved out of the area|0
7947164|NCT02510794|12491462|FG003|Overall Study|Participant moved out of the area|1
7947165|NCT02510794|12491459|FG000|Overall Study|Physician Decision|3
7947166|NCT02510794|12491460|FG001|Overall Study|Physician Decision|0
7947167|NCT02510794|12491461|FG002|Overall Study|Physician Decision|0
7947168|NCT02510794|12491462|FG003|Overall Study|Physician Decision|0
7947169|NCT02510794|12491459|FG000|Overall Study|Protocol Violation|0
7947170|NCT02510794|12491460|FG001|Overall Study|Protocol Violation|0
7947171|NCT02510794|12491461|FG002|Overall Study|Protocol Violation|1
7947172|NCT02510794|12491462|FG003|Overall Study|Protocol Violation|0
7947173|NCT02510794|12491459|FG000|Overall Study|Withdrawal by Subject|1
7947174|NCT02510794|12491460|FG001|Overall Study|Withdrawal by Subject|2
7947175|NCT02510794|12491461|FG002|Overall Study|Withdrawal by Subject|4
7947176|NCT02510794|12491462|FG003|Overall Study|Withdrawal by Subject|3
7947177|NCT02510820|12491474|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0
7947178|NCT02510820|12491475|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1
7947179|NCT02510820|12491474|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7947180|NCT02510820|12491475|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0
7947181|NCT02511184|12491484|FG000|Overall Study|Death|1
7947182|NCT02511184|12491485|FG001|Overall Study|Death|0
7947183|NCT02511184|12491484|FG000|Overall Study|Lost to Follow-up|0
7947184|NCT02511184|12491485|FG001|Overall Study|Lost to Follow-up|1
7947185|NCT02511184|12491484|FG000|Overall Study|Study terminated by sponsor|1
7947186|NCT02511184|12491485|FG001|Overall Study|Study terminated by sponsor|5
7947187|NCT02511184|12491484|FG000|Overall Study|Withdrawal by Subject|0
7947188|NCT02511184|12491485|FG001|Overall Study|Withdrawal by Subject|1
7947189|NCT02511431|12491511|FG000|Treatment|Lost to Follow-up|0
7947190|NCT02511431|12491512|FG001|Treatment|Lost to Follow-up|0
7947191|NCT02511431|12491513|FG002|Treatment|Lost to Follow-up|1
7947192|NCT02511431|12491514|FG003|Treatment|Lost to Follow-up|0
7947193|NCT02511431|12491515|FG004|Treatment|Lost to Follow-up|0
7947194|NCT02511431|12491516|FG005|Treatment|Lost to Follow-up|1
7947195|NCT02511678|12491567|FG000|Overall Study|Withdrawal by Subject|2
7947196|NCT02511678|12491567|FG000|Overall Study|Lost to Follow-up|4
7947197|NCT02511678|12491567|FG000|Overall Study|Death|19
7947198|NCT02511678|12491567|FG000|Overall Study|Adverse Event|1
7947199|NCT02511678|12491567|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5
7947200|NCT02511678|12491567|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1
7947201|NCT02511678|12491567|FG000|Overall Study|Required Radiofrequency Ablation|1
7947202|NCT02511678|12491567|FG000|Overall Study|Biopsy was Negative|1
7947203|NCT02511678|12491567|FG000|Overall Study|Protocol Violation|1
7947204|NCT02511678|12491567|FG000|Overall Study|Received Radiation Treatment|1
7947205|NCT02511782|12491591|FG000|Overall Study|Withdrawal by Subject|1
7947206|NCT02511782|12491592|FG001|Overall Study|Withdrawal by Subject|0
7947207|NCT02511782|12491593|FG002|Overall Study|Withdrawal by Subject|0
7947208|NCT02512042|12491603|FG000|Overall Study|Adverse Event|0
7947209|NCT02512042|12491604|FG001|Overall Study|Adverse Event|4
7947210|NCT02512042|12491603|FG000|Overall Study|Withdrawal by Subject|6
7947211|NCT02512042|12491604|FG001|Overall Study|Withdrawal by Subject|6
7947212|NCT02512042|12491603|FG000|Overall Study|Non-compliance with study drug|1
7947213|NCT02512042|12491604|FG001|Overall Study|Non-compliance with study drug|2
7947214|NCT02512042|12491603|FG000|Overall Study|Lost to Follow-up|5
7947215|NCT02512042|12491604|FG001|Overall Study|Lost to Follow-up|2
7947216|NCT02512042|12491603|FG000|Overall Study|Other|11
7947217|NCT02512042|12491604|FG001|Overall Study|Other|11
7947218|NCT02512068|12491612|FG000|Overall Study|Pretreatment Event/Adverse Event|8
7947219|NCT02512068|12491613|FG001|Overall Study|Pretreatment Event/Adverse Event|6
7947220|NCT02512068|12491612|FG000|Overall Study|Major Protocol Deviation|1
7947221|NCT02512068|12491613|FG001|Overall Study|Major Protocol Deviation|0
7947222|NCT02512068|12491612|FG000|Overall Study|Voluntary Withdrawal|0
7947223|NCT02512068|12491613|FG001|Overall Study|Voluntary Withdrawal|1
7947224|NCT02512068|12491612|FG000|Overall Study|Lack of Efficacy|0
7947225|NCT02512068|12491613|FG001|Overall Study|Lack of Efficacy|1
7947226|NCT02512068|12491612|FG000|Overall Study|Reason Not Specified|3
7947227|NCT02512068|12491613|FG001|Overall Study|Reason Not Specified|5
7947228|NCT02512302|12491641|FG000|Period 1|Adverse Event|0
7947229|NCT02512302|12491642|FG001|Period 1|Adverse Event|1
7947230|NCT02512302|12491643|FG002|Period 1|Adverse Event|0
7947231|NCT02512302|12491644|FG003|Period 1|Adverse Event|0
7947232|NCT02512302|12491645|FG004|Period 1|Adverse Event|0
7947233|NCT02512302|12491646|FG005|Period 1|Adverse Event|0
7947234|NCT02512302|12491647|FG006|Period 1|Adverse Event|0
7947235|NCT02512302|12491648|FG007|Period 1|Adverse Event|0
7947236|NCT02512302|12491649|FG008|Period 1|Adverse Event|0
7947237|NCT02512302|12491650|FG009|Period 1|Adverse Event|0
7947238|NCT02512302|12491641|FG000|Period 2|Adverse Event|0
7947239|NCT02512302|12491642|FG001|Period 2|Adverse Event|0
7947240|NCT02512302|12491643|FG002|Period 2|Adverse Event|0
7947241|NCT02512302|12491644|FG003|Period 2|Adverse Event|0
7947242|NCT02512302|12491645|FG004|Period 2|Adverse Event|0
7947243|NCT02512302|12491646|FG005|Period 2|Adverse Event|0
7947244|NCT02512302|12491647|FG006|Period 2|Adverse Event|0
7947245|NCT02512302|12491648|FG007|Period 2|Adverse Event|0
7947246|NCT02512302|12491649|FG008|Period 2|Adverse Event|0
7947247|NCT02512302|12491650|FG009|Period 2|Adverse Event|1
7947248|NCT02512302|12491641|FG000|Period 3|Lost to Follow-up|0
7947249|NCT02512302|12491642|FG001|Period 3|Lost to Follow-up|0
7947250|NCT02512302|12491643|FG002|Period 3|Lost to Follow-up|1
7947251|NCT02512302|12491644|FG003|Period 3|Lost to Follow-up|0
7947252|NCT02512302|12491645|FG004|Period 3|Lost to Follow-up|0
7947253|NCT02512302|12491646|FG005|Period 3|Lost to Follow-up|0
7947254|NCT02512302|12491647|FG006|Period 3|Lost to Follow-up|0
7947255|NCT02512302|12491648|FG007|Period 3|Lost to Follow-up|0
7947256|NCT02512302|12491649|FG008|Period 3|Lost to Follow-up|0
7947257|NCT02512302|12491650|FG009|Period 3|Lost to Follow-up|0
7947258|NCT02512302|12491641|FG000|Period 4|Adverse Event|0
7947259|NCT02512302|12491642|FG001|Period 4|Adverse Event|0
7947260|NCT02512302|12491643|FG002|Period 4|Adverse Event|0
7947261|NCT02512302|12491644|FG003|Period 4|Adverse Event|0
7947262|NCT02512302|12491645|FG004|Period 4|Adverse Event|0
7947263|NCT02512302|12491646|FG005|Period 4|Adverse Event|0
7947264|NCT02512302|12491647|FG006|Period 4|Adverse Event|1
7947265|NCT02512302|12491648|FG007|Period 4|Adverse Event|0
7947266|NCT02512302|12491649|FG008|Period 4|Adverse Event|0
7947267|NCT02512302|12491650|FG009|Period 4|Adverse Event|0
7947268|NCT02512861|12491745|FG000|Overall Study|Protocol Violation|3
7947269|NCT02512861|12491746|FG001|Overall Study|Protocol Violation|7
7947270|NCT02512861|12491745|FG000|Overall Study|Physician Decision|3
7947271|NCT02512861|12491746|FG001|Overall Study|Physician Decision|1
7947272|NCT02512861|12491745|FG000|Overall Study|Withdrawal by Subject|0
7947273|NCT02512861|12491746|FG001|Overall Study|Withdrawal by Subject|1
7947274|NCT02512965|12491768|FG000|Overall Study|Withdrawal by Subject|0
7947275|NCT02512965|12491769|FG001|Overall Study|Withdrawal by Subject|4
7947276|NCT02513160|12491799|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
7947277|NCT02513160|12491800|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
7947278|NCT02513160|12491801|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
7947279|NCT02513160|12491802|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
7947280|NCT02513160|12491799|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
7947281|NCT02513160|12491800|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
7947282|NCT02513160|12491801|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
7947283|NCT02513160|12491802|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
7947284|NCT02513160|12491799|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
7947285|NCT02513160|12491800|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
7947286|NCT02513160|12491801|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
7947287|NCT02513160|12491802|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
7947288|NCT02513160|12491799|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4
7947289|NCT02513160|12491800|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0
7947290|NCT02513160|12491801|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0
7947291|NCT02513160|12491802|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0
7947292|NCT02513160|12491799|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
7947293|NCT02513160|12491800|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
7947294|NCT02513160|12491801|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
7947295|NCT02513160|12491802|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
7947296|NCT02513160|12491799|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
7947297|NCT02513160|12491800|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
7947298|NCT02513160|12491801|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
7947299|NCT02513160|12491802|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
7947300|NCT02513160|12491799|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
7947301|NCT02513160|12491800|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
7947302|NCT02513160|12491801|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
7947303|NCT02513160|12491802|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
7947304|NCT02513160|12491799|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
7947305|NCT02513160|12491800|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
7947306|NCT02513160|12491801|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
7947307|NCT02513160|12491802|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
7947308|NCT02513160|12491799|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1
7947309|NCT02513160|12491800|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0
7947310|NCT02513160|12491801|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0
7947311|NCT02513160|12491802|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0
7947312|NCT02513160|12491799|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
7947313|NCT02513160|12491800|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
7947314|NCT02513160|12491801|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
7947315|NCT02513160|12491802|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
7947316|NCT02513160|12491799|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
7947317|NCT02513160|12491800|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
7947318|NCT02513160|12491801|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
7947319|NCT02513160|12491802|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
7947320|NCT02513160|12491799|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
7947321|NCT02513160|12491800|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
7947322|NCT02513160|12491801|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
7947323|NCT02513160|12491802|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
7947324|NCT02513459|12491832|FG000|Overall Study|Adverse Event|7
7947325|NCT02513459|12491832|FG000|Overall Study|Withdrew consent|5
7947326|NCT02513459|12491832|FG000|Overall Study|Loss of efficacy|2
7947327|NCT02513459|12491832|FG000|Overall Study|Pregnancy|2
7947328|NCT02513459|12491832|FG000|Overall Study|Subject decision|2
7947329|NCT02513459|12491832|FG000|Overall Study|Lack of response|1
7947330|NCT02513459|12491832|FG000|Overall Study|Reproductive plans|1
7947331|NCT02513459|12491832|FG000|Overall Study|Surgery planned-- not done|1
7947332|NCT02513550|12491853|FG000|Double Blind Treatment Period|Withdrawal by Subject|11
7947333|NCT02513550|12491854|FG001|Double Blind Treatment Period|Withdrawal by Subject|11
7947334|NCT02513550|12491855|FG002|Double Blind Treatment Period|Withdrawal by Subject|25
7947335|NCT02513550|12491856|FG003|Double Blind Treatment Period|Withdrawal by Subject|0
7947336|NCT02513550|12491857|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
7947337|NCT02513550|12491858|FG005|Double Blind Treatment Period|Withdrawal by Subject|0
7947338|NCT02513550|12491853|FG000|Double Blind Treatment Period|Adverse Event|5
7947339|NCT02513550|12491854|FG001|Double Blind Treatment Period|Adverse Event|13
7947340|NCT02513550|12491855|FG002|Double Blind Treatment Period|Adverse Event|17
7947341|NCT02513550|12491856|FG003|Double Blind Treatment Period|Adverse Event|0
7947342|NCT02513550|12491857|FG004|Double Blind Treatment Period|Adverse Event|1
7947343|NCT02513550|12491858|FG005|Double Blind Treatment Period|Adverse Event|0
7947344|NCT02513550|12491853|FG000|Double Blind Treatment Period|Lost to Follow-up|9
7947345|NCT02513550|12491854|FG001|Double Blind Treatment Period|Lost to Follow-up|7
7947346|NCT02513550|12491855|FG002|Double Blind Treatment Period|Lost to Follow-up|11
7947347|NCT02513550|12491856|FG003|Double Blind Treatment Period|Lost to Follow-up|0
7947348|NCT02513550|12491857|FG004|Double Blind Treatment Period|Lost to Follow-up|0
7947349|NCT02513550|12491858|FG005|Double Blind Treatment Period|Lost to Follow-up|1
7947350|NCT02513550|12491853|FG000|Double Blind Treatment Period|Lack of Efficacy|4
7947351|NCT02513550|12491854|FG001|Double Blind Treatment Period|Lack of Efficacy|5
7947352|NCT02513550|12491855|FG002|Double Blind Treatment Period|Lack of Efficacy|6
7947353|NCT02513550|12491856|FG003|Double Blind Treatment Period|Lack of Efficacy|0
7947354|NCT02513550|12491857|FG004|Double Blind Treatment Period|Lack of Efficacy|0
7947355|NCT02513550|12491858|FG005|Double Blind Treatment Period|Lack of Efficacy|0
7947356|NCT02513550|12491853|FG000|Double Blind Treatment Period|Protocol Violation|1
7947357|NCT02513550|12491854|FG001|Double Blind Treatment Period|Protocol Violation|1
7947358|NCT02513550|12491855|FG002|Double Blind Treatment Period|Protocol Violation|4
7947359|NCT02513550|12491856|FG003|Double Blind Treatment Period|Protocol Violation|0
7947360|NCT02513550|12491857|FG004|Double Blind Treatment Period|Protocol Violation|0
7947361|NCT02513550|12491858|FG005|Double Blind Treatment Period|Protocol Violation|0
7947362|NCT02513550|12491853|FG000|Double Blind Treatment Period|Physician Decision|2
7947363|NCT02513550|12491854|FG001|Double Blind Treatment Period|Physician Decision|0
7947364|NCT02513550|12491855|FG002|Double Blind Treatment Period|Physician Decision|4
7947365|NCT02513550|12491856|FG003|Double Blind Treatment Period|Physician Decision|0
7947366|NCT02513550|12491857|FG004|Double Blind Treatment Period|Physician Decision|0
7947367|NCT02513550|12491858|FG005|Double Blind Treatment Period|Physician Decision|0
7947368|NCT02513550|12491853|FG000|Double Blind Treatment Period|Site terminated by sponsor|1
7947369|NCT02513550|12491854|FG001|Double Blind Treatment Period|Site terminated by sponsor|1
7947370|NCT02513550|12491855|FG002|Double Blind Treatment Period|Site terminated by sponsor|3
7947371|NCT02513550|12491856|FG003|Double Blind Treatment Period|Site terminated by sponsor|0
7947372|NCT02513550|12491857|FG004|Double Blind Treatment Period|Site terminated by sponsor|0
7947373|NCT02513550|12491858|FG005|Double Blind Treatment Period|Site terminated by sponsor|0
7947374|NCT02513550|12491853|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7947375|NCT02513550|12491854|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7947376|NCT02513550|12491855|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
7947377|NCT02513550|12491856|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7947378|NCT02513550|12491857|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7947379|NCT02513550|12491858|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7947380|NCT02513550|12491853|FG000|Double Blind Treatment Period|Due to personal business|2
7947381|NCT02513550|12491854|FG001|Double Blind Treatment Period|Due to personal business|0
7947382|NCT02513550|12491855|FG002|Double Blind Treatment Period|Due to personal business|1
7947383|NCT02513550|12491856|FG003|Double Blind Treatment Period|Due to personal business|0
7947384|NCT02513550|12491857|FG004|Double Blind Treatment Period|Due to personal business|0
7947385|NCT02513550|12491858|FG005|Double Blind Treatment Period|Due to personal business|0
7947386|NCT02513550|12491853|FG000|Double Blind Treatment Period|Death|1
7947387|NCT02513550|12491854|FG001|Double Blind Treatment Period|Death|0
7947388|NCT02513550|12491855|FG002|Double Blind Treatment Period|Death|2
7947389|NCT02513550|12491856|FG003|Double Blind Treatment Period|Death|0
7947390|NCT02513550|12491857|FG004|Double Blind Treatment Period|Death|0
7947391|NCT02513550|12491858|FG005|Double Blind Treatment Period|Death|0
7947392|NCT02513550|12491853|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12
7947393|NCT02513550|12491854|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20
7947394|NCT02513550|12491855|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26
7947395|NCT02513550|12491856|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0
7947396|NCT02513550|12491857|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0
7947397|NCT02513550|12491858|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0
7947398|NCT02513550|12491853|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
7947399|NCT02513550|12491854|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
7947400|NCT02513550|12491855|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
7947401|NCT02513550|12491856|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
7947402|NCT02513550|12491857|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
7947403|NCT02513550|12491858|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
7947404|NCT02513550|12491853|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4
7947405|NCT02513550|12491854|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2
7947406|NCT02513550|12491855|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7
7947407|NCT02513550|12491856|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0
7947408|NCT02513550|12491857|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0
7947409|NCT02513550|12491858|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0
7947410|NCT02513550|12491853|FG000|Post-Treatment Follow-up Period|Adverse Event|1
7947411|NCT02513550|12491854|FG001|Post-Treatment Follow-up Period|Adverse Event|1
7947412|NCT02513550|12491855|FG002|Post-Treatment Follow-up Period|Adverse Event|4
7947413|NCT02513550|12491856|FG003|Post-Treatment Follow-up Period|Adverse Event|0
7947414|NCT02513550|12491857|FG004|Post-Treatment Follow-up Period|Adverse Event|0
7947415|NCT02513550|12491858|FG005|Post-Treatment Follow-up Period|Adverse Event|0
7947416|NCT02513550|12491853|FG000|Post-Treatment Follow-up Period|Physician Decision|2
7947417|NCT02513550|12491854|FG001|Post-Treatment Follow-up Period|Physician Decision|0
7947418|NCT02513550|12491855|FG002|Post-Treatment Follow-up Period|Physician Decision|0
7947419|NCT02513550|12491856|FG003|Post-Treatment Follow-up Period|Physician Decision|0
7947420|NCT02513550|12491857|FG004|Post-Treatment Follow-up Period|Physician Decision|0
7947421|NCT02513550|12491858|FG005|Post-Treatment Follow-up Period|Physician Decision|0
7947422|NCT02513550|12491853|FG000|Post-Treatment Follow-up Period|Death|0
7947423|NCT02513550|12491854|FG001|Post-Treatment Follow-up Period|Death|0
7947424|NCT02513550|12491855|FG002|Post-Treatment Follow-up Period|Death|1
7947425|NCT02513550|12491856|FG003|Post-Treatment Follow-up Period|Death|0
7947426|NCT02513550|12491857|FG004|Post-Treatment Follow-up Period|Death|0
7947427|NCT02513550|12491858|FG005|Post-Treatment Follow-up Period|Death|0
7947428|NCT02513550|12491853|FG000|Post-Treatment Follow-up Period|Subject move out of town|0
7947429|NCT02513550|12491854|FG001|Post-Treatment Follow-up Period|Subject move out of town|0
7947430|NCT02513550|12491855|FG002|Post-Treatment Follow-up Period|Subject move out of town|1
7947431|NCT02513550|12491856|FG003|Post-Treatment Follow-up Period|Subject move out of town|0
7947432|NCT02513550|12491857|FG004|Post-Treatment Follow-up Period|Subject move out of town|0
7947433|NCT02513550|12491858|FG005|Post-Treatment Follow-up Period|Subject move out of town|0
7947434|NCT02513550|12491853|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7947435|NCT02513550|12491854|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7947436|NCT02513550|12491855|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
7947437|NCT02513550|12491856|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7947438|NCT02513550|12491857|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7947439|NCT02513550|12491858|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7947440|NCT02513550|12491853|FG000|Post-Treatment Follow-up Period|Labor Reasons|0
7947441|NCT02513550|12491854|FG001|Post-Treatment Follow-up Period|Labor Reasons|0
7947442|NCT02513550|12491855|FG002|Post-Treatment Follow-up Period|Labor Reasons|1
7947443|NCT02513550|12491856|FG003|Post-Treatment Follow-up Period|Labor Reasons|0
7947444|NCT02513550|12491857|FG004|Post-Treatment Follow-up Period|Labor Reasons|0
7947445|NCT02513550|12491858|FG005|Post-Treatment Follow-up Period|Labor Reasons|0
7947446|NCT02513732|12491888|FG000|Overall Study|Lost to Follow-up|11
7947447|NCT02513732|12491888|FG000|Overall Study|Death|9
7947448|NCT02513732|12491888|FG000|Overall Study|Changing hospital|2
7947449|NCT02513745|12491894|FG000|Overall Study|Criteria at time of surgery not met.|3
7947450|NCT02513745|12491895|FG001|Overall Study|Criteria at time of surgery not met.|3
7947451|NCT02513771|12491903|FG000|Overall Study|Lost to Follow-up|1
7947452|NCT02513771|12491904|FG001|Overall Study|Lost to Follow-up|1
7947453|NCT02513771|12491903|FG000|Overall Study|Not being able to get to clinic|1
7947454|NCT02513771|12491904|FG001|Overall Study|Not being able to get to clinic|0
7947455|NCT02513823|12491910|FG000|Overall Study|Lost to Follow-up|4
7947456|NCT02513823|12491910|FG000|Overall Study|Physician Decision|1
7947457|NCT02514122|12491952|FG000|Overall Study|Withdrawal by Subject|2
7947458|NCT02514122|12491953|FG001|Overall Study|Withdrawal by Subject|0
7965775|NCT02738333|12521121|FG000|Overall Study|Death|1
7965776|NCT02738333|12521122|FG001|Overall Study|Death|0
7965777|NCT02738333|12521123|FG002|Overall Study|Death|0
7965778|NCT02738333|12521121|FG000|Overall Study|Lost to Follow-up|1
7965779|NCT02738333|12521122|FG001|Overall Study|Lost to Follow-up|0
7965780|NCT02738333|12521123|FG002|Overall Study|Lost to Follow-up|0
7965781|NCT02738450|12521135|FG000|Overall Study|Withdrawal by Subject|0
7965782|NCT02738450|12521136|FG001|Overall Study|Withdrawal by Subject|2
7965783|NCT02738450|12521137|FG002|Overall Study|Withdrawal by Subject|0
7965784|NCT02738580|12521148|FG000|Overall Study|Adverse Event|1
7965785|NCT02738580|12521149|FG001|Overall Study|Adverse Event|0
7965786|NCT02738580|12521148|FG000|Overall Study|Lack of Efficacy|3
7965787|NCT02738580|12521149|FG001|Overall Study|Lack of Efficacy|2
7965788|NCT02738580|12521148|FG000|Overall Study|Withdrawal by Subject|0
7965789|NCT02738580|12521149|FG001|Overall Study|Withdrawal by Subject|1
7965790|NCT02738580|12521148|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0
7965791|NCT02738580|12521149|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1
7965792|NCT02738775|12521161|FG000|Overall Study|Withdrawal by Subject|0
7965793|NCT02738775|12521162|FG001|Overall Study|Withdrawal by Subject|1
7965794|NCT02738775|12521163|FG002|Overall Study|Withdrawal by Subject|0
7965795|NCT02738775|12521164|FG003|Overall Study|Withdrawal by Subject|0
7965796|NCT02738775|12521165|FG004|Overall Study|Withdrawal by Subject|0
7965797|NCT02738775|12521166|FG005|Overall Study|Withdrawal by Subject|0
7965798|NCT02738775|12521161|FG000|Overall Study|Adverse Event|0
7965799|NCT02738775|12521162|FG001|Overall Study|Adverse Event|0
7965800|NCT02738775|12521163|FG002|Overall Study|Adverse Event|0
7965801|NCT02738775|12521164|FG003|Overall Study|Adverse Event|1
7965802|NCT02738775|12521165|FG004|Overall Study|Adverse Event|0
7965803|NCT02738775|12521166|FG005|Overall Study|Adverse Event|0
7965804|NCT02738775|12521161|FG000|Overall Study|Pregnancy|0
7965805|NCT02738775|12521162|FG001|Overall Study|Pregnancy|1
7965806|NCT02738775|12521163|FG002|Overall Study|Pregnancy|0
7965807|NCT02738775|12521164|FG003|Overall Study|Pregnancy|0
7965808|NCT02738775|12521165|FG004|Overall Study|Pregnancy|0
7965809|NCT02738775|12521166|FG005|Overall Study|Pregnancy|0
7965810|NCT02738775|12521161|FG000|Overall Study|Missing|0
7965811|NCT02738775|12521162|FG001|Overall Study|Missing|0
7965812|NCT02738775|12521163|FG002|Overall Study|Missing|0
7965813|NCT02738775|12521164|FG003|Overall Study|Missing|0
7965814|NCT02738775|12521165|FG004|Overall Study|Missing|0
7965815|NCT02738775|12521166|FG005|Overall Study|Missing|1
7965816|NCT02738801|12521186|FG000|Overall Study|Adverse Event|1
7965817|NCT02738801|12521187|FG001|Overall Study|Adverse Event|1
7965818|NCT02738801|12521186|FG000|Overall Study|Withdrawal by Subject|0
7965819|NCT02738801|12521187|FG001|Overall Study|Withdrawal by Subject|1
7965820|NCT02738840|12521194|FG000|Overall Study|MRI Scan not Performed|5
7965821|NCT02738840|12521194|FG000|Overall Study|Lost to Follow-up|1
7965822|NCT02738840|12521194|FG000|Overall Study|Subject Participation Terminated by Investigator|1
7965823|NCT02738840|12521194|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1
7965824|NCT02738879|12521200|FG000|Overall Study|Adverse Event|1
7947459|NCT02514174|12491959|FG000|Overall Study|Patient refused to continue medication|1
7947460|NCT02514174|12491959|FG000|Overall Study|Adverse Event|2
7947461|NCT02514174|12491959|FG000|Overall Study|Study closed by sponsor|9
7947462|NCT02514174|12491959|FG000|Overall Study|Progressive disease|11
7947463|NCT02514174|12491959|FG000|Overall Study|Treatment change|1
7947464|NCT02514174|12491959|FG000|Overall Study|Treated off study with Afatinib.|1
7947465|NCT02514473|12491965|FG000|Overall Study|Adverse Event|0
7947466|NCT02514473|12491966|FG001|Overall Study|Adverse Event|2
7947467|NCT02514473|12491965|FG000|Overall Study|Withdrawal by Subject|2
7947468|NCT02514473|12491966|FG001|Overall Study|Withdrawal by Subject|1
7947469|NCT02514473|12491965|FG000|Overall Study|Lost to Follow-up|0
7947470|NCT02514473|12491966|FG001|Overall Study|Lost to Follow-up|1
7947471|NCT02514473|12491965|FG000|Overall Study|Other|1
7947472|NCT02514473|12491966|FG001|Overall Study|Other|1
7947473|NCT02514551|12491975|FG000|Overall Study|Lost to Follow-up|0
7947474|NCT02514551|12491976|FG001|Overall Study|Lost to Follow-up|1
7947475|NCT02514551|12491975|FG000|Overall Study|Participant Never Treated|0
7947476|NCT02514551|12491976|FG001|Overall Study|Participant Never Treated|2
7947477|NCT02514577|12491985|FG000|Overall Study|Lost to Follow-up|6
7947478|NCT02514577|12491986|FG001|Overall Study|Lost to Follow-up|6
7947479|NCT02514577|12491985|FG000|Overall Study|Protocol Violation|1
7947480|NCT02514577|12491986|FG001|Overall Study|Protocol Violation|0
7947481|NCT02514577|12491985|FG000|Overall Study|Withdrawal by Subject|6
7947482|NCT02514577|12491986|FG001|Overall Study|Withdrawal by Subject|6
7947483|NCT02514577|12491985|FG000|Overall Study|Adverse Event|1
7947484|NCT02514577|12491986|FG001|Overall Study|Adverse Event|1
7947485|NCT02514746|12491994|FG000|Overall Study|Chronically Ill|1
7947486|NCT02514746|12491995|FG001|Overall Study|Chronically Ill|2
7947487|NCT02514746|12491994|FG000|Overall Study|Physician Decision|4
7947488|NCT02514746|12491995|FG001|Overall Study|Physician Decision|2
7947489|NCT02514746|12491994|FG000|Overall Study|Withdrawal by Subject|12
7947490|NCT02514746|12491995|FG001|Overall Study|Withdrawal by Subject|10
7947491|NCT02514746|12491994|FG000|Overall Study|Other|5
7947492|NCT02514746|12491995|FG001|Overall Study|Other|1
7947493|NCT02514772|12492005|FG000|Overall Study|Adverse Event|1
7947494|NCT02514772|12492006|FG001|Overall Study|Adverse Event|0
7947495|NCT02514772|12492005|FG000|Overall Study|Death|0
7947496|NCT02514772|12492006|FG001|Overall Study|Death|1
7947497|NCT02514772|12492005|FG000|Overall Study|Withdrawal by Subject|2
7947498|NCT02514772|12492006|FG001|Overall Study|Withdrawal by Subject|1
7947499|NCT02514824|12492016|FG000|Overall Study|Withdrawal by Subject|1
7947500|NCT02514824|12492017|FG001|Overall Study|Withdrawal by Subject|0
7947501|NCT02514824|12492018|FG002|Overall Study|Withdrawal by Subject|0
7947502|NCT02514824|12492019|FG003|Overall Study|Withdrawal by Subject|0
7947503|NCT02514824|12492016|FG000|Overall Study|Dose-Limiting Toxicity|0
7947504|NCT02514824|12492017|FG001|Overall Study|Dose-Limiting Toxicity|1
7947505|NCT02514824|12492018|FG002|Overall Study|Dose-Limiting Toxicity|0
7947506|NCT02514824|12492019|FG003|Overall Study|Dose-Limiting Toxicity|0
7947507|NCT02515045|12492037|FG000|Overall Study|Adverse Event|0
7947508|NCT02515045|12492038|FG001|Overall Study|Adverse Event|3
7947509|NCT02515045|12492039|FG002|Overall Study|Adverse Event|3
7947510|NCT02515045|12492037|FG000|Overall Study|Lost to Follow-up|0
7947511|NCT02515045|12492038|FG001|Overall Study|Lost to Follow-up|1
7947512|NCT02515045|12492039|FG002|Overall Study|Lost to Follow-up|1
7947513|NCT02515097|12492058|FG000|Overall Study|Lost to Follow-up|4
7947514|NCT02515097|12492059|FG001|Overall Study|Lost to Follow-up|2
7947515|NCT02515097|12492058|FG000|Overall Study|Withdrawal by Subject|1
7947516|NCT02515097|12492059|FG001|Overall Study|Withdrawal by Subject|3
7947517|NCT02515097|12492058|FG000|Overall Study|Adverse Event|2
7947518|NCT02515097|12492059|FG001|Overall Study|Adverse Event|1
7947519|NCT02515279|12492074|FG000|Overall Study|Adverse Event|7
7947520|NCT02515279|12492074|FG000|Overall Study|Lack of Efficacy|31
7947521|NCT02515279|12492074|FG000|Overall Study|Lost to Follow-up|9
7947522|NCT02515279|12492074|FG000|Overall Study|Withdrawal by Subject|18
7947523|NCT02515279|12492074|FG000|Overall Study|End-of-treatment visit not attended|17
7947524|NCT02515279|12492074|FG000|Overall Study|Other|22
7947525|NCT02515331|12492094|FG000|Overall Study|Withdrawal by Subject|0
7947526|NCT02515331|12492095|FG001|Overall Study|Withdrawal by Subject|0
7947527|NCT02515331|12492096|FG002|Overall Study|Withdrawal by Subject|1
7947528|NCT02515331|12492094|FG000|Overall Study|Protocol deviation|0
7947529|NCT02515331|12492095|FG001|Overall Study|Protocol deviation|0
7947530|NCT02515331|12492096|FG002|Overall Study|Protocol deviation|3
7947531|NCT02515331|12492094|FG000|Overall Study|Adverse Event|2
7947532|NCT02515331|12492095|FG001|Overall Study|Adverse Event|0
7947533|NCT02515331|12492096|FG002|Overall Study|Adverse Event|0
7947534|NCT02515630|12492106|FG000|Overall Study|Withdrawal by Subject|5
7947535|NCT02515630|12492106|FG000|Overall Study|Adverse Event|4
7947536|NCT02515630|12492106|FG000|Overall Study|Physician Decision|4
7947537|NCT02515630|12492106|FG000|Overall Study|Death|2
7947538|NCT02515630|12492106|FG000|Overall Study|Disease Progression|1
7947539|NCT02515669|12492126|FG000|228 Week Open-Label Phase|Other|0
7947540|NCT02515669|12492127|FG001|228 Week Open-Label Phase|Other|0
7947541|NCT02515669|12492128|FG002|228 Week Open-Label Phase|Other|1
7947542|NCT02515669|12492129|FG003|228 Week Open-Label Phase|Other|4
7947543|NCT02515669|12492126|FG000|228 Week Open-Label Phase|Lack of Efficacy|0
7947544|NCT02515669|12492127|FG001|228 Week Open-Label Phase|Lack of Efficacy|0
7947545|NCT02515669|12492128|FG002|228 Week Open-Label Phase|Lack of Efficacy|1
7947546|NCT02515669|12492129|FG003|228 Week Open-Label Phase|Lack of Efficacy|0
7947547|NCT02515669|12492126|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
7947548|NCT02515669|12492127|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
7947549|NCT02515669|12492128|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2
7947550|NCT02515669|12492129|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3
7947551|NCT02515669|12492126|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0
7947552|NCT02515669|12492127|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7
7947553|NCT02515669|12492128|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2
7947554|NCT02515669|12492129|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17
7947555|NCT02515669|12492126|FG000|228 Week Open-Label Phase|Missing|0
7947556|NCT02515669|12492127|FG001|228 Week Open-Label Phase|Missing|2
7947557|NCT02515669|12492128|FG002|228 Week Open-Label Phase|Missing|2
7947558|NCT02515669|12492129|FG003|228 Week Open-Label Phase|Missing|2
7947559|NCT02515942|12492192|FG000|Overall Study|Adverse Event|5
7947560|NCT02515942|12492193|FG001|Overall Study|Adverse Event|0
7947561|NCT02515942|12492194|FG002|Overall Study|Adverse Event|0
7947562|NCT02515942|12492192|FG000|Overall Study|Death|0
7947563|NCT02515942|12492193|FG001|Overall Study|Death|0
7947564|NCT02515942|12492194|FG002|Overall Study|Death|1
7947565|NCT02515942|12492192|FG000|Overall Study|Lack of Efficacy|0
7947566|NCT02515942|12492193|FG001|Overall Study|Lack of Efficacy|0
7947567|NCT02515942|12492194|FG002|Overall Study|Lack of Efficacy|1
7947568|NCT02515942|12492192|FG000|Overall Study|Lost to Follow-up|2
7947569|NCT02515942|12492193|FG001|Overall Study|Lost to Follow-up|0
7947570|NCT02515942|12492194|FG002|Overall Study|Lost to Follow-up|0
7947571|NCT02515942|12492192|FG000|Overall Study|Withdrawal by Subject|0
7947572|NCT02515942|12492193|FG001|Overall Study|Withdrawal by Subject|3
7947573|NCT02515942|12492194|FG002|Overall Study|Withdrawal by Subject|2
7947574|NCT02515994|12492206|FG000|Overall Study|Protocol Violation|3
7947575|NCT02515994|12492207|FG001|Overall Study|Protocol Violation|5
7947576|NCT02515994|12492206|FG000|Overall Study|No Longer Meets Eligibility Criteria|2
7947577|NCT02515994|12492207|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
7947578|NCT02515994|12492206|FG000|Overall Study|Adverse Event|3
7947579|NCT02515994|12492207|FG001|Overall Study|Adverse Event|1
7947580|NCT02515994|12492206|FG000|Overall Study|Withdrawal by Subject|2
7947581|NCT02515994|12492207|FG001|Overall Study|Withdrawal by Subject|0
7947582|NCT02516098|12492229|FG000|Period 1|Protocol Violation|1
7947583|NCT02516098|12492230|FG001|Period 1|Protocol Violation|0
7947584|NCT02516098|12492229|FG000|Washout After Period 1|Adverse Event|0
7947585|NCT02516098|12492230|FG001|Washout After Period 1|Adverse Event|1
7947586|NCT02516098|12492229|FG000|Period 2|Withdrawal by Subject|0
7947587|NCT02516098|12492230|FG001|Period 2|Withdrawal by Subject|1
7947588|NCT02516163|12492242|FG000|Overall Study|Withdrawal by Subject|1
7947589|NCT02516163|12492242|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11
7947590|NCT02516163|12492242|FG000|Overall Study|Unfit/delay in surgery|3
7947591|NCT02516163|12492242|FG000|Overall Study|Use of incorrect measurement technique|5
7947592|NCT02516163|12492242|FG000|Overall Study|Data not recorded|2
7947593|NCT02516163|12492242|FG000|Overall Study|MRI contraindication exclusion|6
7947594|NCT02516202|12492249|FG000|Overall Study|Withdrawal by Subject|1
7947595|NCT02516202|12492250|FG001|Overall Study|Withdrawal by Subject|0
7947596|NCT02516202|12492251|FG002|Overall Study|Withdrawal by Subject|1
7947597|NCT02516202|12492249|FG000|Overall Study|Lost to Follow-up|1
7947598|NCT02516202|12492250|FG001|Overall Study|Lost to Follow-up|1
7947599|NCT02516202|12492251|FG002|Overall Study|Lost to Follow-up|1
7947600|NCT02516202|12492249|FG000|Overall Study|Stopped Follow-up|0
7947601|NCT02516202|12492250|FG001|Overall Study|Stopped Follow-up|0
7947602|NCT02516202|12492251|FG002|Overall Study|Stopped Follow-up|1
7947603|NCT02516306|12492261|FG000|Period 2: Day 8 - 91|Protocol Violation|1
7947604|NCT02516306|12492262|FG001|Period 2: Day 8 - 91|Protocol Violation|2
7947605|NCT02516332|12492271|FG000|Overall Study|Withdrawal by Subject|2
7947606|NCT02516332|12492272|FG001|Overall Study|Withdrawal by Subject|1
7947607|NCT02516332|12492273|FG002|Overall Study|Withdrawal by Subject|2
7947608|NCT02516410|12492283|FG000|Overall Study|Adverse Event|0
7947609|NCT02516410|12492284|FG001|Overall Study|Adverse Event|1
7947610|NCT02516410|12492283|FG000|Overall Study|Withdrawal by Subject|0
7947611|NCT02516410|12492284|FG001|Overall Study|Withdrawal by Subject|1
7947612|NCT02516592|12492297|FG000|Overall Study|Patient withdrew consent|5
7947613|NCT02516592|12492298|FG001|Overall Study|Patient withdrew consent|2
7947614|NCT02516592|12492297|FG000|Overall Study|Protocol deviation|4
7947615|NCT02516592|12492298|FG001|Overall Study|Protocol deviation|4
7947616|NCT02516592|12492297|FG000|Overall Study|Lost to Follow-up|2
7947617|NCT02516592|12492298|FG001|Overall Study|Lost to Follow-up|3
7947618|NCT02516592|12492297|FG000|Overall Study|Patient/guardian decision|2
7947619|NCT02516592|12492298|FG001|Overall Study|Patient/guardian decision|1
7947620|NCT02516592|12492297|FG000|Overall Study|Adverse Event|1
7947621|NCT02516592|12492298|FG001|Overall Study|Adverse Event|2
7947622|NCT02516592|12492297|FG000|Overall Study|Abnormal test procedure result|1
7947623|NCT02516592|12492298|FG001|Overall Study|Abnormal test procedure result|0
7947624|NCT02516592|12492297|FG000|Overall Study|Death|1
7947625|NCT02516592|12492298|FG001|Overall Study|Death|1
7947626|NCT02516605|12492309|FG000|Overall Study|Protocol Violation|0
7947627|NCT02516605|12492310|FG001|Overall Study|Protocol Violation|0
7947628|NCT02516605|12492311|FG002|Overall Study|Protocol Violation|0
7947629|NCT02516605|12492312|FG003|Overall Study|Protocol Violation|0
7947630|NCT02516605|12492313|FG004|Overall Study|Protocol Violation|1
7947631|NCT02516605|12492309|FG000|Overall Study|Withdrawal by Subject|0
7947632|NCT02516605|12492310|FG001|Overall Study|Withdrawal by Subject|0
7947633|NCT02516605|12492311|FG002|Overall Study|Withdrawal by Subject|0
7947634|NCT02516605|12492312|FG003|Overall Study|Withdrawal by Subject|1
7947635|NCT02516605|12492313|FG004|Overall Study|Withdrawal by Subject|0
7947636|NCT02516982|12492333|FG000|Overall Study|Called in to antenatal appointment|32
7947637|NCT02516982|12492334|FG001|Overall Study|Called in to antenatal appointment|35
7947638|NCT02516982|12492335|FG002|Overall Study|Called in to antenatal appointment|0
7947639|NCT02516982|12492336|FG003|Overall Study|Called in to antenatal appointment|0
7947640|NCT02516982|12492333|FG000|Overall Study|Withdrawal by Subject|0
7947641|NCT02516982|12492334|FG001|Overall Study|Withdrawal by Subject|0
7947642|NCT02516982|12492335|FG002|Overall Study|Withdrawal by Subject|1
7947643|NCT02516982|12492336|FG003|Overall Study|Withdrawal by Subject|2
7947644|NCT02516982|12492333|FG000|Overall Study|Protocol Violation|0
7947645|NCT02516982|12492334|FG001|Overall Study|Protocol Violation|0
7947646|NCT02516982|12492335|FG002|Overall Study|Protocol Violation|1
7947647|NCT02516982|12492336|FG003|Overall Study|Protocol Violation|1
7947648|NCT02516982|12492333|FG000|Overall Study|Did not install the app|0
7947649|NCT02516982|12492334|FG001|Overall Study|Did not install the app|0
7947650|NCT02516982|12492335|FG002|Overall Study|Did not install the app|46
7947651|NCT02516982|12492336|FG003|Overall Study|Did not install the app|47
7947652|NCT02517268|12492362|FG000|Overall Study|Withdrawal by Subject|1
7947653|NCT02517268|12492363|FG001|Overall Study|Withdrawal by Subject|0
7947654|NCT02517463|12492371|FG000|Overall Study|Lost to Follow-up|5
7947655|NCT02517463|12492372|FG001|Overall Study|Lost to Follow-up|2
7947656|NCT02517515|12492380|FG000|Overall Study|Adverse Event|0
7947657|NCT02517515|12492381|FG001|Overall Study|Adverse Event|1
7947658|NCT02517515|12492380|FG000|Overall Study|Withdrew Consent|0
7947659|NCT02517515|12492381|FG001|Overall Study|Withdrew Consent|1
7947660|NCT02517515|12492380|FG000|Overall Study|Lost to Follow-up|1
7947661|NCT02517515|12492381|FG001|Overall Study|Lost to Follow-up|0
7947662|NCT02517515|12492380|FG000|Overall Study|Other|1
7947663|NCT02517515|12492381|FG001|Overall Study|Other|0
7947664|NCT02517528|12492388|FG000|Overall Study|Withdrawal by Subject|1
7947665|NCT02517541|12492392|FG000|Baseline Period (Own Product)|Protocol Violation|1
7947666|NCT02517541|12492392|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
7947667|NCT02517541|12492392|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
7947668|NCT02517541|12492392|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
7947669|NCT02517541|12492392|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
7947670|NCT02517541|12492392|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
7947671|NCT02517866|12492427|FG000|Overall Study|Pretreatment Event/Adverse Event|9
7947672|NCT02517866|12492428|FG001|Overall Study|Pretreatment Event/Adverse Event|2
7947673|NCT02517866|12492429|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7947674|NCT02517866|12492427|FG000|Overall Study|Significant Protocol Deviation|4
7947675|NCT02517866|12492428|FG001|Overall Study|Significant Protocol Deviation|1
7947676|NCT02517866|12492429|FG002|Overall Study|Significant Protocol Deviation|0
7947677|NCT02517866|12492427|FG000|Overall Study|Lost to Follow-up|1
7947678|NCT02517866|12492428|FG001|Overall Study|Lost to Follow-up|0
7947679|NCT02517866|12492429|FG002|Overall Study|Lost to Follow-up|0
7947680|NCT02517866|12492427|FG000|Overall Study|Voluntary Withdrawal|2
7947681|NCT02517866|12492428|FG001|Overall Study|Voluntary Withdrawal|2
7947682|NCT02517866|12492429|FG002|Overall Study|Voluntary Withdrawal|0
7947683|NCT02517866|12492427|FG000|Overall Study|Investigator Decision|2
7947684|NCT02517866|12492428|FG001|Overall Study|Investigator Decision|1
7947685|NCT02517866|12492429|FG002|Overall Study|Investigator Decision|0
7947686|NCT02517866|12492427|FG000|Overall Study|Reason not specified|2
7947687|NCT02517866|12492428|FG001|Overall Study|Reason not specified|0
7947688|NCT02517866|12492429|FG002|Overall Study|Reason not specified|0
7947689|NCT02517905|12492441|FG000|Overall Study|Lost to Follow-up|4
7947690|NCT02517905|12492442|FG001|Overall Study|Lost to Follow-up|0
7947691|NCT02517905|12492441|FG000|Overall Study|Withdrawal by Subject|4
7947692|NCT02517905|12492442|FG001|Overall Study|Withdrawal by Subject|0
7947693|NCT02517905|12492441|FG000|Overall Study|Screen failure|2
7947694|NCT02517905|12492442|FG001|Overall Study|Screen failure|2
7947695|NCT02518048|12492457|FG000|Overall Study|Withdrawal by Subject|1
7947696|NCT02518113|12492466|FG000|Overall Study|Adverse Event|1
7947697|NCT02518113|12492467|FG001|Overall Study|Adverse Event|0
7947698|NCT02518113|12492468|FG002|Overall Study|Adverse Event|1
7947699|NCT02518113|12492469|FG003|Overall Study|Adverse Event|0
7947700|NCT02518113|12492466|FG000|Overall Study|Death|1
7947701|NCT02518113|12492467|FG001|Overall Study|Death|2
7947702|NCT02518113|12492468|FG002|Overall Study|Death|0
7947703|NCT02518113|12492469|FG003|Overall Study|Death|0
7947704|NCT02518113|12492466|FG000|Overall Study|Physician Decision|0
7947705|NCT02518113|12492467|FG001|Overall Study|Physician Decision|1
7947706|NCT02518113|12492468|FG002|Overall Study|Physician Decision|0
7947707|NCT02518113|12492469|FG003|Overall Study|Physician Decision|0
7947708|NCT02518113|12492466|FG000|Overall Study|Progressive Disease|1
7947709|NCT02518113|12492467|FG001|Overall Study|Progressive Disease|2
7947710|NCT02518113|12492468|FG002|Overall Study|Progressive Disease|3
7947711|NCT02518113|12492469|FG003|Overall Study|Progressive Disease|0
7947712|NCT02518464|12492503|FG000|Overall Study|Adverse Event|2
7947713|NCT02518490|12492507|FG000|Overall Study|Withdrawal by Subject|1
7947714|NCT02518490|12492508|FG001|Overall Study|Withdrawal by Subject|1
7947715|NCT02518620|12492517|FG000|Overall Study|Adverse Event|23
7947716|NCT02518620|12492518|FG001|Overall Study|Adverse Event|11
7947717|NCT02518620|12492517|FG000|Overall Study|Lack of Efficacy|2
7947718|NCT02518620|12492518|FG001|Overall Study|Lack of Efficacy|0
7947719|NCT02518620|12492517|FG000|Overall Study|Non-Compliance with Study Drug|1
7947720|NCT02518620|12492518|FG001|Overall Study|Non-Compliance with Study Drug|0
7947721|NCT02518620|12492517|FG000|Overall Study|Physician Decision|1
7947722|NCT02518620|12492518|FG001|Overall Study|Physician Decision|1
7947723|NCT02518620|12492517|FG000|Overall Study|Sponsor's Decision|0
7947724|NCT02518620|12492518|FG001|Overall Study|Sponsor's Decision|3
7947725|NCT02518620|12492517|FG000|Overall Study|Lost to Follow-up|1
7947726|NCT02518620|12492518|FG001|Overall Study|Lost to Follow-up|1
7947727|NCT02518620|12492517|FG000|Overall Study|Withdrawal by Subject|17
7947728|NCT02518620|12492518|FG001|Overall Study|Withdrawal by Subject|9
7947729|NCT02518620|12492517|FG000|Overall Study|Death|1
7947730|NCT02518620|12492518|FG001|Overall Study|Death|0
7947731|NCT02518620|12492517|FG000|Overall Study|Pregnancy Wish|3
7947732|NCT02518620|12492518|FG001|Overall Study|Pregnancy Wish|0
7947733|NCT02518620|12492517|FG000|Overall Study|Pregnancy|1
7947734|NCT02518620|12492518|FG001|Overall Study|Pregnancy|0
7947735|NCT02518620|12492517|FG000|Overall Study|Relocation|2
7947736|NCT02518620|12492518|FG001|Overall Study|Relocation|1
7947737|NCT02518685|12492528|FG000|Overall Study|Adverse Event|29
7947738|NCT02518685|12492529|FG001|Overall Study|Adverse Event|1
7947739|NCT02518685|12492528|FG000|Overall Study|Withdrawal by Subject|10
7947740|NCT02518685|12492529|FG001|Overall Study|Withdrawal by Subject|3
7947741|NCT02518685|12492528|FG000|Overall Study|relocation, study fatigue|7
7947742|NCT02518685|12492529|FG001|Overall Study|relocation, study fatigue|2
7947743|NCT02518685|12492528|FG000|Overall Study|Pregnancy|1
7947744|NCT02518685|12492529|FG001|Overall Study|Pregnancy|0
7947745|NCT02518685|12492528|FG000|Overall Study|Physician Decision|1
7947746|NCT02518685|12492529|FG001|Overall Study|Physician Decision|0
7947747|NCT02518685|12492528|FG000|Overall Study|Lost to Follow-up|1
7947748|NCT02518685|12492529|FG001|Overall Study|Lost to Follow-up|4
7947749|NCT02518919|12492539|FG000|Overall Study|Protocol Violation|1
7947750|NCT02518919|12492540|FG001|Overall Study|Protocol Violation|1
7947751|NCT02518919|12492541|FG002|Overall Study|Protocol Violation|2
7947752|NCT02518971|12492551|FG000|Overall Study|Lost to Follow-up|0
7947753|NCT02518971|12492552|FG001|Overall Study|Lost to Follow-up|1
7947754|NCT02518971|12492551|FG000|Overall Study|Physician Decision|6
7947755|NCT02518971|12492552|FG001|Overall Study|Physician Decision|6
7947756|NCT02518971|12492551|FG000|Overall Study|Protocol Violation|6
7947757|NCT02518971|12492552|FG001|Overall Study|Protocol Violation|4
7947758|NCT02518971|12492551|FG000|Overall Study|Withdrawal by Subject|4
7947759|NCT02518971|12492552|FG001|Overall Study|Withdrawal by Subject|5
7947760|NCT02518971|12492551|FG000|Overall Study|Side effects|1
7947761|NCT02518971|12492552|FG001|Overall Study|Side effects|0
7947762|NCT02518971|12492551|FG000|Overall Study|medication lost in mail|0
7947763|NCT02518971|12492552|FG001|Overall Study|medication lost in mail|1
7947764|NCT02518971|12492551|FG000|Overall Study|eligibility criteria no longer met|6
7947765|NCT02518971|12492552|FG001|Overall Study|eligibility criteria no longer met|3
7947766|NCT02519231|12492607|FG000|Overall Study|Lost to Follow-up|2
7947767|NCT02519231|12492608|FG001|Overall Study|Lost to Follow-up|5
7947768|NCT02519231|12492607|FG000|Overall Study|Withdrawal by Subject|0
7947769|NCT02519231|12492608|FG001|Overall Study|Withdrawal by Subject|1
7947770|NCT02519504|12492635|FG000|Overall Study|Protocol Violation|6
7947771|NCT02519504|12492636|FG001|Overall Study|Protocol Violation|5
7947772|NCT02519504|12492635|FG000|Overall Study|Ineligible for direct testing|12
7947773|NCT02519504|12492636|FG001|Overall Study|Ineligible for direct testing|12
7947774|NCT02519504|12492635|FG000|Overall Study|Did not participate in direct testing|95
7947775|NCT02519504|12492636|FG001|Overall Study|Did not participate in direct testing|86
7947776|NCT02519595|12492645|FG000|Overall Study|Protocol Violation|8
7947777|NCT02519595|12492646|FG001|Overall Study|Protocol Violation|22
7947778|NCT02519595|12492647|FG002|Overall Study|Protocol Violation|16
7947779|NCT02519842|12492670|FG000|Base Study: Cycle 1|Screening Failure|1
7947780|NCT02519842|12492671|FG001|Base Study: Cycle 1|Screening Failure|1
7947781|NCT02519842|12492672|FG002|Base Study: Cycle 1|Screening Failure|0
7947782|NCT02519842|12492670|FG000|Base Study: Cycle 1|Adverse Event|1
7947783|NCT02519842|12492671|FG001|Base Study: Cycle 1|Adverse Event|0
7947784|NCT02519842|12492672|FG002|Base Study: Cycle 1|Adverse Event|0
7947785|NCT02519842|12492670|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
7947786|NCT02519842|12492671|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
7947787|NCT02519842|12492672|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
7947788|NCT02519842|12492670|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0
7947789|NCT02519842|12492671|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1
7947790|NCT02519842|12492672|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0
7947791|NCT02519842|12492670|FG000|Optional Extension: Cycles 2-6|Physician Decision|0
7947792|NCT02519842|12492671|FG001|Optional Extension: Cycles 2-6|Physician Decision|0
7947793|NCT02519842|12492672|FG002|Optional Extension: Cycles 2-6|Physician Decision|5
7947794|NCT02519842|12492670|FG000|Optional Extension: Cycles 2-6|Adverse Event|0
7947795|NCT02519842|12492671|FG001|Optional Extension: Cycles 2-6|Adverse Event|0
7947796|NCT02519842|12492672|FG002|Optional Extension: Cycles 2-6|Adverse Event|1
7947797|NCT02519842|12492670|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
7947798|NCT02519842|12492671|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
7947799|NCT02519842|12492672|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
7947800|NCT02519842|12492670|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
7947801|NCT02519842|12492671|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
7947802|NCT02519842|12492672|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
7947803|NCT02519842|12492670|FG000|Optional Extension: Cycles 2-6|Death|0
7947804|NCT02519842|12492671|FG001|Optional Extension: Cycles 2-6|Death|0
7947805|NCT02519842|12492672|FG002|Optional Extension: Cycles 2-6|Death|1
7947806|NCT02519842|12492670|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
7947807|NCT02519842|12492671|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
7947808|NCT02519842|12492672|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
7947809|NCT02519842|12492670|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
7947810|NCT02519842|12492671|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
7947811|NCT02519842|12492672|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
7947812|NCT02519842|12492670|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
7947813|NCT02519842|12492671|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
7947814|NCT02519842|12492672|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
7947815|NCT02519842|12492670|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
7947816|NCT02519842|12492671|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
7947817|NCT02519842|12492672|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
7947818|NCT02519855|12492682|FG000|Overall Study|Adverse Event|0
7947819|NCT02519855|12492683|FG001|Overall Study|Adverse Event|1
7947820|NCT02519855|12492682|FG000|Overall Study|Lost to Follow-up|3
7947821|NCT02519855|12492683|FG001|Overall Study|Lost to Follow-up|3
7947822|NCT02520089|12492691|FG000|Overall Study|Lost to Follow-up|3
7947823|NCT02520089|12492692|FG001|Overall Study|Lost to Follow-up|4
7947824|NCT02520284|12492701|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1
7947825|NCT02520284|12492702|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3
7947826|NCT02520284|12492703|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0
7947827|NCT02520284|12492701|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
7947828|NCT02520284|12492702|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
7947829|NCT02520284|12492703|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
7947830|NCT02520284|12492701|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
7947831|NCT02520284|12492702|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
7947832|NCT02520284|12492703|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1
7947833|NCT02520284|12492701|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17
7947834|NCT02520284|12492702|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11
7947835|NCT02520284|12492703|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15
7947836|NCT02520284|12492701|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
7947837|NCT02520284|12492702|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
7947838|NCT02520284|12492703|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3
7947839|NCT02520284|12492701|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
7947840|NCT02520284|12492702|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
7947841|NCT02520284|12492703|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0
7947842|NCT02520284|12492701|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
7947843|NCT02520284|12492702|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2
7947844|NCT02520284|12492703|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
7947845|NCT02520284|12492701|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25
7947846|NCT02520284|12492702|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29
7947847|NCT02520284|12492703|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28
7947848|NCT02520284|12492701|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3
7947849|NCT02520284|12492702|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4
7947850|NCT02520284|12492703|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2
7947851|NCT02520284|12492701|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2
7947852|NCT02520284|12492702|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1
7947853|NCT02520284|12492703|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3
7947854|NCT02520284|12492701|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2
7947855|NCT02520284|12492702|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
7947856|NCT02520284|12492703|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
7947857|NCT02520310|12492717|FG000|At 6 Months Clinical Follow-up|Death|1
7947858|NCT02520310|12492717|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1
7947859|NCT02520310|12492717|FG000|AT 3 Year Clinical Follow-up|Death|2
7947860|NCT02520310|12492717|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2
7947861|NCT02520310|12492717|FG000|AT 4 Year Clinical Follow-up|Death|1
7947862|NCT02520310|12492717|FG000|AT 4 Year Clinical Follow-up|missed visit|1
7947863|NCT02520388|12492725|FG000|Overall Study|Physician Decision|1
7947864|NCT02520388|12492726|FG001|Overall Study|Physician Decision|0
7947865|NCT02520388|12492725|FG000|Overall Study|Subject or parent/guardian request|0
7947866|NCT02520388|12492726|FG001|Overall Study|Subject or parent/guardian request|6
7947867|NCT02520388|12492725|FG000|Overall Study|Adverse Event|1
7947868|NCT02520388|12492726|FG001|Overall Study|Adverse Event|4
7947869|NCT02520388|12492725|FG000|Overall Study|Lost to Follow-up|3
7947870|NCT02520388|12492726|FG001|Overall Study|Lost to Follow-up|2
7947871|NCT02520388|12492725|FG000|Overall Study|Other (reason not defined)|4
7947872|NCT02520388|12492726|FG001|Overall Study|Other (reason not defined)|4
7947873|NCT02520531|12492757|FG000|Overall Study|Revision of study device components|2
7947874|NCT02520531|12492758|FG001|Overall Study|Revision of study device components|2
7947875|NCT02520531|12492757|FG000|Overall Study|Death|1
7947876|NCT02520531|12492758|FG001|Overall Study|Death|2
7947877|NCT02520531|12492757|FG000|Overall Study|Lost to Follow-up|1
7947878|NCT02520531|12492758|FG001|Overall Study|Lost to Follow-up|1
7947879|NCT02520531|12492757|FG000|Overall Study|Meet exclusion criterion|0
7947880|NCT02520531|12492758|FG001|Overall Study|Meet exclusion criterion|1
7947881|NCT02520531|12492757|FG000|Overall Study|Withdrawal by Subject|1
7947882|NCT02520531|12492758|FG001|Overall Study|Withdrawal by Subject|0
7947883|NCT02520531|12492757|FG000|Overall Study|Not study device|1
7947884|NCT02520531|12492758|FG001|Overall Study|Not study device|0
7947885|NCT02521376|12492790|FG000|Overall Study|Enrolled, But Not Treated|1
7947886|NCT02521376|12492791|FG001|Overall Study|Enrolled, But Not Treated|0
7947887|NCT02521376|12492792|FG002|Overall Study|Enrolled, But Not Treated|0
7947888|NCT02521376|12492793|FG003|Overall Study|Enrolled, But Not Treated|0
7947889|NCT02521792|12492831|FG000|Overall Study|Study Terminated|6
7947890|NCT02521870|12492843|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0
7822341|NCT01262352|12291554|FG001|Washout|Extended Washout|1
7822342|NCT01262365|12291563|FG000|Overall Study|Lack of Efficacy|35
7822343|NCT01262365|12291564|FG001|Overall Study|Lack of Efficacy|30
7822344|NCT01262365|12291565|FG002|Overall Study|Lack of Efficacy|47
7822345|NCT01262365|12291563|FG000|Overall Study|Protocol Violation|3
7822346|NCT01262365|12291564|FG001|Overall Study|Protocol Violation|1
7822347|NCT01262365|12291565|FG002|Overall Study|Protocol Violation|1
7822348|NCT01262365|12291563|FG000|Overall Study|Lost to Follow-up|3
7822349|NCT01262365|12291564|FG001|Overall Study|Lost to Follow-up|7
7822350|NCT01262365|12291565|FG002|Overall Study|Lost to Follow-up|6
7822351|NCT01262365|12291563|FG000|Overall Study|Withdrawal by Subject|17
7822352|NCT01262365|12291564|FG001|Overall Study|Withdrawal by Subject|22
7947891|NCT02521870|12492844|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1
7947892|NCT02521870|12492845|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0
7947893|NCT02521870|12492846|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0
7947894|NCT02521870|12492847|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0
7947895|NCT02521870|12492848|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0
7947896|NCT02521870|12492849|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0
7947897|NCT02521870|12492850|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0
7947898|NCT02521870|12492851|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0
7947899|NCT02521870|12492852|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0
7947900|NCT02521870|12492853|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0
7947901|NCT02521870|12492854|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0
7947902|NCT02521870|12492843|FG000|Phase 1: Dose Escalation|Adverse Event|2
7947903|NCT02521870|12492844|FG001|Phase 1: Dose Escalation|Adverse Event|1
7947904|NCT02521870|12492845|FG002|Phase 1: Dose Escalation|Adverse Event|0
7947905|NCT02521870|12492846|FG003|Phase 1: Dose Escalation|Adverse Event|0
7947906|NCT02521870|12492847|FG004|Phase 1: Dose Escalation|Adverse Event|0
7947907|NCT02521870|12492848|FG005|Phase 1: Dose Escalation|Adverse Event|0
7947908|NCT02521870|12492849|FG006|Phase 1: Dose Escalation|Adverse Event|0
7947909|NCT02521870|12492850|FG007|Phase 1: Dose Escalation|Adverse Event|0
7947910|NCT02521870|12492851|FG008|Phase 1: Dose Escalation|Adverse Event|0
7947911|NCT02521870|12492852|FG009|Phase 1: Dose Escalation|Adverse Event|0
7947912|NCT02521870|12492853|FG010|Phase 1: Dose Escalation|Adverse Event|0
7947913|NCT02521870|12492854|FG011|Phase 1: Dose Escalation|Adverse Event|0
7947914|NCT02521870|12492843|FG000|Phase 1: Dose Escalation|Progressive Disease|3
7822353|NCT01262365|12291565|FG002|Overall Study|Withdrawal by Subject|22
7822354|NCT01262365|12291563|FG000|Overall Study|Death|1
7822355|NCT01262365|12291564|FG001|Overall Study|Death|2
7947915|NCT02521870|12492844|FG001|Phase 1: Dose Escalation|Progressive Disease|2
7947916|NCT02521870|12492845|FG002|Phase 1: Dose Escalation|Progressive Disease|4
7947917|NCT02521870|12492846|FG003|Phase 1: Dose Escalation|Progressive Disease|6
7947918|NCT02521870|12492847|FG004|Phase 1: Dose Escalation|Progressive Disease|0
7947919|NCT02521870|12492848|FG005|Phase 1: Dose Escalation|Progressive Disease|0
7947920|NCT02521870|12492849|FG006|Phase 1: Dose Escalation|Progressive Disease|0
7947921|NCT02521870|12492850|FG007|Phase 1: Dose Escalation|Progressive Disease|0
7947922|NCT02521870|12492851|FG008|Phase 1: Dose Escalation|Progressive Disease|0
7947923|NCT02521870|12492852|FG009|Phase 1: Dose Escalation|Progressive Disease|0
7947924|NCT02521870|12492853|FG010|Phase 1: Dose Escalation|Progressive Disease|0
7947925|NCT02521870|12492854|FG011|Phase 1: Dose Escalation|Progressive Disease|0
7947926|NCT02521870|12492843|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0
7947927|NCT02521870|12492844|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0
7947928|NCT02521870|12492845|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0
7947929|NCT02521870|12492846|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0
7947930|NCT02521870|12492847|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5
7947931|NCT02521870|12492848|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1
7947932|NCT02521870|12492849|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1
7947933|NCT02521870|12492850|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0
7947934|NCT02521870|12492851|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1
7947935|NCT02521870|12492852|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1
7947936|NCT02521870|12492853|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2
7947937|NCT02521870|12492854|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0
7947938|NCT02521870|12492843|FG000|Phase 2: Dose Expansion|Adverse Event|0
7947939|NCT02521870|12492844|FG001|Phase 2: Dose Expansion|Adverse Event|0
7947940|NCT02521870|12492845|FG002|Phase 2: Dose Expansion|Adverse Event|0
7947941|NCT02521870|12492846|FG003|Phase 2: Dose Expansion|Adverse Event|0
7947942|NCT02521870|12492847|FG004|Phase 2: Dose Expansion|Adverse Event|11
7947943|NCT02521870|12492848|FG005|Phase 2: Dose Expansion|Adverse Event|2
7947944|NCT02521870|12492849|FG006|Phase 2: Dose Expansion|Adverse Event|0
7947945|NCT02521870|12492850|FG007|Phase 2: Dose Expansion|Adverse Event|1
7947946|NCT02521870|12492851|FG008|Phase 2: Dose Expansion|Adverse Event|5
7947947|NCT02521870|12492852|FG009|Phase 2: Dose Expansion|Adverse Event|0
7947948|NCT02521870|12492853|FG010|Phase 2: Dose Expansion|Adverse Event|1
7947949|NCT02521870|12492854|FG011|Phase 2: Dose Expansion|Adverse Event|0
7947950|NCT02521870|12492843|FG000|Phase 2: Dose Expansion|Progressive Disease|0
7947951|NCT02521870|12492844|FG001|Phase 2: Dose Expansion|Progressive Disease|0
7947952|NCT02521870|12492845|FG002|Phase 2: Dose Expansion|Progressive Disease|0
7947953|NCT02521870|12492846|FG003|Phase 2: Dose Expansion|Progressive Disease|0
7947954|NCT02521870|12492847|FG004|Phase 2: Dose Expansion|Progressive Disease|22
7947955|NCT02521870|12492848|FG005|Phase 2: Dose Expansion|Progressive Disease|18
7947956|NCT02521870|12492849|FG006|Phase 2: Dose Expansion|Progressive Disease|17
7947957|NCT02521870|12492850|FG007|Phase 2: Dose Expansion|Progressive Disease|7
7947958|NCT02521870|12492851|FG008|Phase 2: Dose Expansion|Progressive Disease|5
7947959|NCT02521870|12492852|FG009|Phase 2: Dose Expansion|Progressive Disease|17
7947960|NCT02521870|12492853|FG010|Phase 2: Dose Expansion|Progressive Disease|17
7947961|NCT02521870|12492854|FG011|Phase 2: Dose Expansion|Progressive Disease|21
7947962|NCT02521870|12492843|FG000|Phase 2: Dose Expansion|Death|0
7947963|NCT02521870|12492844|FG001|Phase 2: Dose Expansion|Death|0
7947964|NCT02521870|12492845|FG002|Phase 2: Dose Expansion|Death|0
7947965|NCT02521870|12492846|FG003|Phase 2: Dose Expansion|Death|0
7947966|NCT02521870|12492847|FG004|Phase 2: Dose Expansion|Death|1
7947967|NCT02521870|12492848|FG005|Phase 2: Dose Expansion|Death|1
7947968|NCT02521870|12492849|FG006|Phase 2: Dose Expansion|Death|3
7947969|NCT02521870|12492850|FG007|Phase 2: Dose Expansion|Death|1
7947970|NCT02521870|12492851|FG008|Phase 2: Dose Expansion|Death|1
7947971|NCT02521870|12492852|FG009|Phase 2: Dose Expansion|Death|5
7947972|NCT02521870|12492853|FG010|Phase 2: Dose Expansion|Death|2
7947973|NCT02521870|12492854|FG011|Phase 2: Dose Expansion|Death|2
7947974|NCT02521870|12492843|FG000|Phase 2: Dose Expansion|Other|0
7947975|NCT02521870|12492844|FG001|Phase 2: Dose Expansion|Other|0
7947976|NCT02521870|12492845|FG002|Phase 2: Dose Expansion|Other|0
7947977|NCT02521870|12492846|FG003|Phase 2: Dose Expansion|Other|0
7947978|NCT02521870|12492847|FG004|Phase 2: Dose Expansion|Other|10
7947979|NCT02521870|12492848|FG005|Phase 2: Dose Expansion|Other|3
7947980|NCT02521870|12492849|FG006|Phase 2: Dose Expansion|Other|2
7947981|NCT02521870|12492850|FG007|Phase 2: Dose Expansion|Other|0
7947982|NCT02521870|12492851|FG008|Phase 2: Dose Expansion|Other|10
7947983|NCT02521870|12492852|FG009|Phase 2: Dose Expansion|Other|5
7947984|NCT02521870|12492853|FG010|Phase 2: Dose Expansion|Other|1
7947985|NCT02521870|12492854|FG011|Phase 2: Dose Expansion|Other|7
7947986|NCT02521870|12492843|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0
7947987|NCT02521870|12492844|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0
7947988|NCT02521870|12492845|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0
7947989|NCT02521870|12492846|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0
7947990|NCT02521870|12492847|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1
7947991|NCT02521870|12492848|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0
7947992|NCT02521870|12492849|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0
7947993|NCT02521870|12492850|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0
7947994|NCT02521870|12492851|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0
7947995|NCT02521870|12492852|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0
7947996|NCT02521870|12492853|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0
7947997|NCT02521870|12492854|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0
7947998|NCT02521870|12492843|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7947999|NCT02521870|12492844|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7948000|NCT02521870|12492845|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7948001|NCT02521870|12492846|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7948002|NCT02521870|12492847|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2
7948003|NCT02521870|12492848|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7948004|NCT02521870|12492849|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7948005|NCT02521870|12492850|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7948006|NCT02521870|12492851|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7948007|NCT02521870|12492852|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7948008|NCT02521870|12492853|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7948009|NCT02521870|12492854|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7948010|NCT02521948|12492884|FG000|Overall Study|Adverse Event|2
7948011|NCT02521948|12492884|FG000|Overall Study|Death|4
7948012|NCT02521948|12492884|FG000|Overall Study|Lost to Follow-up|1
7948013|NCT02521948|12492884|FG000|Overall Study|Did not attend one or both follow-ups|6
7948014|NCT02522286|12492921|FG000|Overall Study|Withdrawal by Subject|3
7948015|NCT02522286|12492922|FG001|Overall Study|Withdrawal by Subject|0
7948016|NCT02522286|12492923|FG002|Overall Study|Withdrawal by Subject|0
7948017|NCT02522286|12492924|FG003|Overall Study|Withdrawal by Subject|3
7948018|NCT02522299|12492936|FG000|Overall Study|Adverse Event|2
7948019|NCT02522299|12492937|FG001|Overall Study|Adverse Event|0
7948020|NCT02522299|12492936|FG000|Overall Study|Physician Decision|0
7948021|NCT02522299|12492937|FG001|Overall Study|Physician Decision|1
7948022|NCT02522299|12492936|FG000|Overall Study|Withdrawal by Subject|2
7948023|NCT02522299|12492937|FG001|Overall Study|Withdrawal by Subject|0
7948024|NCT02522325|12492957|FG000|Overall Study|Adverse Event|0
7948025|NCT02522325|12492958|FG001|Overall Study|Adverse Event|1
7948026|NCT02522377|12492966|FG000|Overall Study|Withdrawal by Subject|1
7948027|NCT02522377|12492967|FG001|Overall Study|Withdrawal by Subject|0
7948028|NCT02522377|12492966|FG000|Overall Study|Remission Achieved|3
7948029|NCT02522377|12492967|FG001|Overall Study|Remission Achieved|0
7948030|NCT02522403|12492975|FG000|Overall Study|Lost to Follow-up|2
7948031|NCT02522403|12492976|FG001|Overall Study|Lost to Follow-up|2
7948032|NCT02522403|12492975|FG000|Overall Study|Withdrawal by Subject|2
7948033|NCT02522403|12492976|FG001|Overall Study|Withdrawal by Subject|4
7948034|NCT02522481|12492991|FG000|Overall Study|discontinued|1
7948035|NCT02522481|12492991|FG000|Overall Study|Not dosed|2
7948036|NCT02522624|12493004|FG000|Overall Study|Technical failure|1
7948037|NCT02522624|12493005|FG001|Overall Study|Technical failure|0
7948038|NCT02522728|12493013|FG000|Overall Study|Withdrawal by Subject|6
7948039|NCT02522728|12493014|FG001|Overall Study|Withdrawal by Subject|6
7948040|NCT02522728|12493013|FG000|Overall Study|Death|4
7948041|NCT02522728|12493014|FG001|Overall Study|Death|3
7948042|NCT02522728|12493013|FG000|Overall Study|Adverse Event|2
7948043|NCT02522728|12493014|FG001|Overall Study|Adverse Event|1
7948044|NCT02522728|12493013|FG000|Overall Study|Did not receive randomized study device|0
7948045|NCT02522728|12493014|FG001|Overall Study|Did not receive randomized study device|1
7948046|NCT02522767|12493022|FG000|Double-blind|Withdrawal by Subject|8
7948047|NCT02522767|12493023|FG001|Double-blind|Withdrawal by Subject|11
7948048|NCT02522767|12493022|FG000|Double-blind|Lost to Follow-up|1
7948049|NCT02522767|12493023|FG001|Double-blind|Lost to Follow-up|0
7948050|NCT02522767|12493022|FG000|Double-blind|Adverse Event|1
7948051|NCT02522767|12493023|FG001|Double-blind|Adverse Event|10
7948052|NCT02522767|12493022|FG000|Double-blind|Protocol Violation|0
7948053|NCT02522767|12493023|FG001|Double-blind|Protocol Violation|1
7948054|NCT02522767|12493022|FG000|Double-blind|Lack of Efficacy|0
7948055|NCT02522767|12493023|FG001|Double-blind|Lack of Efficacy|2
7948056|NCT02522767|12493022|FG000|Double-blind|Protocol Deviation|1
7948057|NCT02522767|12493023|FG001|Double-blind|Protocol Deviation|0
7948058|NCT02522767|12493022|FG000|Open-label|Withdrawal by Subject|2
7948059|NCT02522767|12493023|FG001|Open-label|Withdrawal by Subject|3
7948060|NCT02522767|12493022|FG000|Open-label|Lost to Follow-up|0
7948061|NCT02522767|12493023|FG001|Open-label|Lost to Follow-up|1
7948062|NCT02522767|12493022|FG000|Open-label|Adverse Event|2
7948063|NCT02522767|12493023|FG001|Open-label|Adverse Event|1
7948064|NCT02522767|12493022|FG000|Open-label|Lack of Efficacy|1
7948065|NCT02522767|12493023|FG001|Open-label|Lack of Efficacy|1
7948066|NCT02522767|12493022|FG000|Open-label|Protocol Violation|0
7948067|NCT02522767|12493023|FG001|Open-label|Protocol Violation|1
7948068|NCT02522780|12493033|FG000|Overall Study|Consent withdrawn by subject|5
7948069|NCT02522780|12493034|FG001|Overall Study|Consent withdrawn by subject|7
7948070|NCT02522780|12493033|FG000|Overall Study|Protocol deviation|1
7948071|NCT02522780|12493034|FG001|Overall Study|Protocol deviation|3
7948072|NCT02522780|12493033|FG000|Overall Study|Subject refused endoscopic procedure|0
7948073|NCT02522780|12493034|FG001|Overall Study|Subject refused endoscopic procedure|1
7822356|NCT01262365|12291565|FG002|Overall Study|Death|1
7822357|NCT01262365|12291563|FG000|Overall Study|Adverse Event|26
7822358|NCT01262365|12291564|FG001|Overall Study|Adverse Event|16
7822359|NCT01262365|12291565|FG002|Overall Study|Adverse Event|11
7822360|NCT01262365|12291563|FG000|Overall Study|sponsor decision|1
7822361|NCT01262365|12291564|FG001|Overall Study|sponsor decision|1
7822362|NCT01262365|12291565|FG002|Overall Study|sponsor decision|0
7822363|NCT01262365|12291563|FG000|Overall Study|Randomization error|1
7822364|NCT01262365|12291564|FG001|Overall Study|Randomization error|0
7822365|NCT01262365|12291565|FG002|Overall Study|Randomization error|2
7822366|NCT01262365|12291563|FG000|Overall Study|Non-compliance|1
7822367|NCT01262365|12291564|FG001|Overall Study|Non-compliance|0
7822368|NCT01262365|12291565|FG002|Overall Study|Non-compliance|2
7822369|NCT01262365|12291563|FG000|Overall Study|Suspected pregnancy|1
7822370|NCT01262365|12291564|FG001|Overall Study|Suspected pregnancy|0
7822371|NCT01262365|12291565|FG002|Overall Study|Suspected pregnancy|0
7822372|NCT01262365|12291563|FG000|Overall Study|Patient pregnant|1
7822373|NCT01262365|12291564|FG001|Overall Study|Patient pregnant|0
7822374|NCT01262365|12291565|FG002|Overall Study|Patient pregnant|1
7822375|NCT01262365|12291563|FG000|Overall Study|Toxicity related to study drug|0
7822376|NCT01262365|12291564|FG001|Overall Study|Toxicity related to study drug|1
7822377|NCT01262365|12291565|FG002|Overall Study|Toxicity related to study drug|0
7822378|NCT01262365|12291563|FG000|Overall Study|Cannot tolerate the protocol|0
7822379|NCT01262365|12291564|FG001|Overall Study|Cannot tolerate the protocol|1
7822380|NCT01262365|12291565|FG002|Overall Study|Cannot tolerate the protocol|0
7822381|NCT01262365|12291563|FG000|Overall Study|Patient unavailable|0
7822382|NCT01262365|12291564|FG001|Overall Study|Patient unavailable|0
7822383|NCT01262365|12291565|FG002|Overall Study|Patient unavailable|1
7822384|NCT01262456|12291576|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6
7822385|NCT01262456|12291577|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8
7822386|NCT01262456|12291578|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9
7822387|NCT01262456|12291576|FG000|3-Month Double-Blind Period|Lost to Follow-up|4
7948074|NCT02522780|12493033|FG000|Overall Study|Adverse event, non-fatal|11
7822388|NCT01262456|12291577|FG001|3-Month Double-Blind Period|Lost to Follow-up|5
7822389|NCT01262456|12291578|FG002|3-Month Double-Blind Period|Lost to Follow-up|3
7822390|NCT01262456|12291576|FG000|3-Month Double-Blind Period|Adverse Event|6
7822391|NCT01262456|12291577|FG001|3-Month Double-Blind Period|Adverse Event|4
7822392|NCT01262456|12291578|FG002|3-Month Double-Blind Period|Adverse Event|8
7822393|NCT01262456|12291576|FG000|3-Month Double-Blind Period|Protocol Violation|3
7822394|NCT01262456|12291577|FG001|3-Month Double-Blind Period|Protocol Violation|6
7822395|NCT01262456|12291578|FG002|3-Month Double-Blind Period|Protocol Violation|6
7822396|NCT01262456|12291576|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1
7822397|NCT01262456|12291577|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1
7822398|NCT01262456|12291578|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1
7822399|NCT01262456|12291576|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0
7822400|NCT01262456|12291577|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1
7822401|NCT01262456|12291578|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0
7822402|NCT01262456|12291576|FG000|1-Month Open-Label Extension Period|Adverse Event|2
7822403|NCT01262456|12291577|FG001|1-Month Open-Label Extension Period|Adverse Event|0
7822404|NCT01262456|12291578|FG002|1-Month Open-Label Extension Period|Adverse Event|2
7822405|NCT01262456|12291576|FG000|1-Month Open-Label Extension Period|Protocol Violation|1
7822406|NCT01262456|12291577|FG001|1-Month Open-Label Extension Period|Protocol Violation|0
7822407|NCT01262456|12291578|FG002|1-Month Open-Label Extension Period|Protocol Violation|2
7822408|NCT01262456|12291576|FG000|1-Month Open-Label Extension Period|Other Reason|0
7822409|NCT01262456|12291577|FG001|1-Month Open-Label Extension Period|Other Reason|1
7822410|NCT01262456|12291578|FG002|1-Month Open-Label Extension Period|Other Reason|0
7822411|NCT01262560|12291606|FG000|Overall Study|Protocol Violation|0
7822412|NCT01262560|12291607|FG001|Overall Study|Protocol Violation|1
7822413|NCT01262560|12291608|FG002|Overall Study|Protocol Violation|2
7822414|NCT01262573|12291618|FG000|Overall Study|Withdrawal by Subject|0
7822415|NCT01262573|12291619|FG001|Overall Study|Withdrawal by Subject|1
7822416|NCT01262638|12291640|FG000|Overall Study|Adverse Event|3
7822417|NCT01262638|12291641|FG001|Overall Study|Adverse Event|4
7822418|NCT01262638|12291642|FG002|Overall Study|Adverse Event|3
7822419|NCT01262638|12291643|FG003|Overall Study|Adverse Event|4
7822420|NCT01262638|12291640|FG000|Overall Study|Protocol Violation|1
7822421|NCT01262638|12291641|FG001|Overall Study|Protocol Violation|0
7822422|NCT01262638|12291642|FG002|Overall Study|Protocol Violation|0
7822423|NCT01262638|12291643|FG003|Overall Study|Protocol Violation|1
7822424|NCT01262638|12291640|FG000|Overall Study|Withdrawal by Subject|2
7822425|NCT01262638|12291641|FG001|Overall Study|Withdrawal by Subject|1
7822426|NCT01262638|12291642|FG002|Overall Study|Withdrawal by Subject|0
7822427|NCT01262638|12291643|FG003|Overall Study|Withdrawal by Subject|1
7822428|NCT01262638|12291640|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
7822429|NCT01262638|12291641|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
7822430|NCT01262638|12291642|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1
7822431|NCT01262638|12291643|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
7822432|NCT01262638|12291640|FG000|Overall Study|Lost to Follow-up|1
7822433|NCT01262638|12291641|FG001|Overall Study|Lost to Follow-up|1
7822434|NCT01262638|12291642|FG002|Overall Study|Lost to Follow-up|1
7822435|NCT01262638|12291643|FG003|Overall Study|Lost to Follow-up|1
7822436|NCT01262638|12291640|FG000|Overall Study|Participant Went Out of Town|0
7822437|NCT01262638|12291641|FG001|Overall Study|Participant Went Out of Town|0
7822438|NCT01262638|12291642|FG002|Overall Study|Participant Went Out of Town|1
7822439|NCT01262638|12291643|FG003|Overall Study|Participant Went Out of Town|0
7822440|NCT01262651|12291658|FG000|Overall Study|Adverse Event|40
7822441|NCT01262651|12291659|FG001|Overall Study|Adverse Event|35
7822442|NCT01262651|12291658|FG000|Overall Study|Withdrawal by Subject|15
7822443|NCT01262651|12291659|FG001|Overall Study|Withdrawal by Subject|11
7822444|NCT01262651|12291658|FG000|Overall Study|Withdrawal by Investigator|2
7822445|NCT01262651|12291659|FG001|Overall Study|Withdrawal by Investigator|2
7822446|NCT01262651|12291658|FG000|Overall Study|Met Withdrawal Criteria|1
7822447|NCT01262651|12291659|FG001|Overall Study|Met Withdrawal Criteria|0
7822448|NCT01262677|12291668|FG000|Overall Study|Does not meet entrance criteria|0
7822449|NCT01262677|12291669|FG001|Overall Study|Does not meet entrance criteria|2
7822450|NCT01262677|12291670|FG002|Overall Study|Does not meet entrance criteria|0
7822451|NCT01262677|12291668|FG000|Overall Study|Insufficient clinical response|0
7822452|NCT01262677|12291669|FG001|Overall Study|Insufficient clinical response|0
7822453|NCT01262677|12291670|FG002|Overall Study|Insufficient clinical response|1
7822454|NCT01262677|12291668|FG000|Overall Study|Lost to Follow-up|1
7822455|NCT01262677|12291669|FG001|Overall Study|Lost to Follow-up|0
7822456|NCT01262677|12291670|FG002|Overall Study|Lost to Follow-up|2
7822457|NCT01262677|12291668|FG000|Overall Study|No longer willing to participate|3
7822458|NCT01262677|12291669|FG001|Overall Study|No longer willing to participate|3
7822459|NCT01262677|12291670|FG002|Overall Study|No longer willing to participate|2
7822460|NCT01262677|12291668|FG000|Overall Study|Reason not provided|2
7822461|NCT01262677|12291669|FG001|Overall Study|Reason not provided|1
7822462|NCT01262677|12291670|FG002|Overall Study|Reason not provided|3
7822463|NCT01262677|12291668|FG000|Overall Study|Protocol Violation|0
7822464|NCT01262677|12291669|FG001|Overall Study|Protocol Violation|1
7822465|NCT01262677|12291670|FG002|Overall Study|Protocol Violation|1
7822466|NCT01262677|12291668|FG000|Overall Study|Adverse Event (AE) related to study drug|3
7822467|NCT01262677|12291669|FG001|Overall Study|Adverse Event (AE) related to study drug|8
7719902|NCT00535236|12143967|FG000|Overall Study|Lost to Follow-up|1
7822468|NCT01262677|12291670|FG002|Overall Study|Adverse Event (AE) related to study drug|3
7822469|NCT01262820|12291682|FG000|Overall Study|Adverse Event|5
7822470|NCT01262820|12291682|FG000|Overall Study|Lack of Efficacy|9
7822471|NCT01262820|12291682|FG000|Overall Study|Drug held for 21+ days|1
7822472|NCT01262872|12291703|FG000|Step 2|Death|0
7822473|NCT01262872|12291704|FG001|Step 2|Death|0
7822474|NCT01262872|12291705|FG002|Step 2|Death|0
7822475|NCT01262872|12291706|FG003|Step 2|Death|1
7822476|NCT01262872|12291707|FG004|Step 2|Death|0
7822477|NCT01262872|12291708|FG005|Step 2|Death|2
7822478|NCT01262872|12291709|FG006|Step 2|Death|2
7822479|NCT01262872|12291710|FG007|Step 2|Death|1
7822480|NCT01262872|12291703|FG000|Step 2|Protocol Violation|0
7822481|NCT01262872|12291704|FG001|Step 2|Protocol Violation|0
7822482|NCT01262872|12291705|FG002|Step 2|Protocol Violation|1
7822483|NCT01262872|12291706|FG003|Step 2|Protocol Violation|0
7822484|NCT01262872|12291707|FG004|Step 2|Protocol Violation|0
7822485|NCT01262872|12291708|FG005|Step 2|Protocol Violation|0
7822486|NCT01262872|12291709|FG006|Step 2|Protocol Violation|3
7822487|NCT01262872|12291710|FG007|Step 2|Protocol Violation|1
7822488|NCT01262872|12291703|FG000|Step 2|Withdrawal by Subject|0
7822489|NCT01262872|12291704|FG001|Step 2|Withdrawal by Subject|0
7822490|NCT01262872|12291705|FG002|Step 2|Withdrawal by Subject|4
7822491|NCT01262872|12291706|FG003|Step 2|Withdrawal by Subject|6
7822492|NCT01262872|12291707|FG004|Step 2|Withdrawal by Subject|3
7822493|NCT01262872|12291708|FG005|Step 2|Withdrawal by Subject|1
7822494|NCT01262872|12291709|FG006|Step 2|Withdrawal by Subject|2
7822495|NCT01262872|12291710|FG007|Step 2|Withdrawal by Subject|1
7822496|NCT01262872|12291703|FG000|Step 2|Migrated/moved from study area|0
7822497|NCT01262872|12291704|FG001|Step 2|Migrated/moved from study area|0
7822498|NCT01262872|12291705|FG002|Step 2|Migrated/moved from study area|4
7822499|NCT01262872|12291706|FG003|Step 2|Migrated/moved from study area|3
7822500|NCT01262872|12291707|FG004|Step 2|Migrated/moved from study area|2
7822501|NCT01262872|12291708|FG005|Step 2|Migrated/moved from study area|6
7822502|NCT01262872|12291709|FG006|Step 2|Migrated/moved from study area|2
7822503|NCT01262872|12291710|FG007|Step 2|Migrated/moved from study area|3
7822504|NCT01262898|12291748|FG000|Overall Study|Protocol Violation|1
7822505|NCT01262898|12291749|FG001|Overall Study|Protocol Violation|1
7822506|NCT01262898|12291750|FG002|Overall Study|Protocol Violation|0
7822507|NCT01262898|12291751|FG003|Overall Study|Protocol Violation|0
7822508|NCT01262898|12291748|FG000|Overall Study|Lost to Follow-up|1
7822509|NCT01262898|12291749|FG001|Overall Study|Lost to Follow-up|0
7822510|NCT01262898|12291750|FG002|Overall Study|Lost to Follow-up|0
7822511|NCT01262898|12291751|FG003|Overall Study|Lost to Follow-up|0
7822512|NCT01262898|12291748|FG000|Overall Study|Withdrawal by Subject|1
7822513|NCT01262898|12291749|FG001|Overall Study|Withdrawal by Subject|1
7822514|NCT01262898|12291750|FG002|Overall Study|Withdrawal by Subject|0
7822515|NCT01262898|12291751|FG003|Overall Study|Withdrawal by Subject|0
7822516|NCT01262976|12291770|FG000|Up to Month 2|Serious Adverse Event|0
7822517|NCT01262976|12291771|FG001|Up to Month 2|Serious Adverse Event|0
7822518|NCT01262976|12291772|FG002|Up to Month 2|Serious Adverse Event|1
7822519|NCT01262976|12291773|FG003|Up to Month 2|Serious Adverse Event|0
7822520|NCT01262976|12291774|FG004|Up to Month 2|Serious Adverse Event|0
7822521|NCT01262976|12291775|FG005|Up to Month 2|Serious Adverse Event|0
7822522|NCT01262976|12291770|FG000|Up to Month 2|Withdrawal by Subject|1
7822523|NCT01262976|12291771|FG001|Up to Month 2|Withdrawal by Subject|0
7822524|NCT01262976|12291772|FG002|Up to Month 2|Withdrawal by Subject|0
7822525|NCT01262976|12291773|FG003|Up to Month 2|Withdrawal by Subject|0
7822526|NCT01262976|12291774|FG004|Up to Month 2|Withdrawal by Subject|0
7822527|NCT01262976|12291775|FG005|Up to Month 2|Withdrawal by Subject|0
7822528|NCT01262976|12291770|FG000|Up to Month 2|Migrated/moved from study area|0
7822529|NCT01262976|12291771|FG001|Up to Month 2|Migrated/moved from study area|1
7822530|NCT01262976|12291772|FG002|Up to Month 2|Migrated/moved from study area|0
7822531|NCT01262976|12291773|FG003|Up to Month 2|Migrated/moved from study area|0
7822532|NCT01262976|12291774|FG004|Up to Month 2|Migrated/moved from study area|1
7822533|NCT01262976|12291775|FG005|Up to Month 2|Migrated/moved from study area|1
7822534|NCT01262976|12291770|FG000|Up to Month 2|Lost to Follow-up|1
7822535|NCT01262976|12291771|FG001|Up to Month 2|Lost to Follow-up|0
7948075|NCT02522780|12493034|FG001|Overall Study|Adverse event, non-fatal|16
7948076|NCT02522884|12493041|FG000|Overall Study|Withdrawal by Subject|6
7948077|NCT02522884|12493041|FG000|Overall Study|Death|3
7948078|NCT02522884|12493041|FG000|Overall Study|Missed 12-month Follow-up|9
7965825|NCT02738879|12521201|FG001|Overall Study|Adverse Event|1
7965826|NCT02738879|12521200|FG000|Overall Study|Death|0
7965827|NCT02738879|12521201|FG001|Overall Study|Death|2
7965828|NCT02738879|12521200|FG000|Overall Study|Lost to Follow-up|1
7965829|NCT02738879|12521201|FG001|Overall Study|Lost to Follow-up|5
7965830|NCT02738879|12521200|FG000|Overall Study|Protocol Violation|1
7965831|NCT02738879|12521201|FG001|Overall Study|Protocol Violation|3
7965832|NCT02738879|12521200|FG000|Overall Study|Physician Decision|3
7965833|NCT02738879|12521201|FG001|Overall Study|Physician Decision|4
7965834|NCT02738879|12521200|FG000|Overall Study|Pregnancy|0
7965835|NCT02738879|12521201|FG001|Overall Study|Pregnancy|1
7965836|NCT02738879|12521200|FG000|Overall Study|Screen Failure|1
7965837|NCT02738879|12521201|FG001|Overall Study|Screen Failure|2
7965838|NCT02738879|12521200|FG000|Overall Study|Site Discontinued Study Participation|1
7965839|NCT02738879|12521201|FG001|Overall Study|Site Discontinued Study Participation|0
7965840|NCT02738879|12521200|FG000|Overall Study|Withdrawal by Subject|5
7965841|NCT02738879|12521201|FG001|Overall Study|Withdrawal by Subject|7
7965842|NCT02739269|12521217|FG000|Overall Study|Protocol Violation|5
7965843|NCT02739269|12521218|FG001|Overall Study|Protocol Violation|0
7948079|NCT02523599|12493077|FG000|Overall Study|Adverse Event|1
7948080|NCT02523599|12493078|FG001|Overall Study|Adverse Event|0
7948081|NCT02523599|12493077|FG000|Overall Study|Physician Decision|1
7948082|NCT02523599|12493078|FG001|Overall Study|Physician Decision|0
7948083|NCT02523599|12493077|FG000|Overall Study|Lost to Follow-up|4
7948084|NCT02523599|12493078|FG001|Overall Study|Lost to Follow-up|1
7948085|NCT02523599|12493077|FG000|Overall Study|Did not return for Day 30 visit|2
7948086|NCT02523599|12493078|FG001|Overall Study|Did not return for Day 30 visit|0
7948087|NCT02524145|12493127|FG000|Overall Study|Withdrawal by Subject|2
7948088|NCT02524145|12493128|FG001|Overall Study|Withdrawal by Subject|2
7948089|NCT02524145|12493129|FG002|Overall Study|Withdrawal by Subject|3
7822536|NCT01262976|12291772|FG002|Up to Month 2|Lost to Follow-up|0
7822537|NCT01262976|12291773|FG003|Up to Month 2|Lost to Follow-up|1
7822538|NCT01262976|12291774|FG004|Up to Month 2|Lost to Follow-up|1
7822539|NCT01262976|12291775|FG005|Up to Month 2|Lost to Follow-up|1
7822540|NCT01262976|12291770|FG000|Up to Month 2|Other|1
7822541|NCT01262976|12291771|FG001|Up to Month 2|Other|0
7822542|NCT01262976|12291772|FG002|Up to Month 2|Other|0
7822543|NCT01262976|12291773|FG003|Up to Month 2|Other|1
7822544|NCT01262976|12291774|FG004|Up to Month 2|Other|0
7822545|NCT01262976|12291775|FG005|Up to Month 2|Other|2
7822546|NCT01262976|12291770|FG000|Up to Month 7|Serious Adverse Event|0
7822547|NCT01262976|12291771|FG001|Up to Month 7|Serious Adverse Event|0
7822548|NCT01262976|12291772|FG002|Up to Month 7|Serious Adverse Event|2
7822549|NCT01262976|12291773|FG003|Up to Month 7|Serious Adverse Event|0
7822550|NCT01262976|12291774|FG004|Up to Month 7|Serious Adverse Event|0
7822551|NCT01262976|12291775|FG005|Up to Month 7|Serious Adverse Event|0
7822552|NCT01262976|12291770|FG000|Up to Month 7|Withdrawal by Subject|1
7822553|NCT01262976|12291771|FG001|Up to Month 7|Withdrawal by Subject|0
7822554|NCT01262976|12291772|FG002|Up to Month 7|Withdrawal by Subject|0
7822555|NCT01262976|12291773|FG003|Up to Month 7|Withdrawal by Subject|0
7822556|NCT01262976|12291774|FG004|Up to Month 7|Withdrawal by Subject|0
7822557|NCT01262976|12291775|FG005|Up to Month 7|Withdrawal by Subject|0
7822558|NCT01262976|12291770|FG000|Up to Month 7|Migrated/moved from study area|0
7822559|NCT01262976|12291771|FG001|Up to Month 7|Migrated/moved from study area|0
7822560|NCT01262976|12291772|FG002|Up to Month 7|Migrated/moved from study area|1
7822561|NCT01262976|12291773|FG003|Up to Month 7|Migrated/moved from study area|3
7822562|NCT01262976|12291774|FG004|Up to Month 7|Migrated/moved from study area|1
7822563|NCT01262976|12291775|FG005|Up to Month 7|Migrated/moved from study area|1
7822564|NCT01262976|12291770|FG000|Up to Month 7|Lost to Follow-up|1
7822565|NCT01262976|12291771|FG001|Up to Month 7|Lost to Follow-up|0
7822566|NCT01262976|12291772|FG002|Up to Month 7|Lost to Follow-up|1
7822567|NCT01262976|12291773|FG003|Up to Month 7|Lost to Follow-up|3
7822568|NCT01262976|12291774|FG004|Up to Month 7|Lost to Follow-up|1
7822569|NCT01262976|12291775|FG005|Up to Month 7|Lost to Follow-up|3
7822570|NCT01262976|12291770|FG000|Up to Month 7|Other|3
7822571|NCT01262976|12291771|FG001|Up to Month 7|Other|0
7822572|NCT01262976|12291772|FG002|Up to Month 7|Other|2
7822573|NCT01262976|12291773|FG003|Up to Month 7|Other|0
7822574|NCT01262976|12291774|FG004|Up to Month 7|Other|0
7822575|NCT01262976|12291775|FG005|Up to Month 7|Other|0
7822576|NCT01262976|12291770|FG000|Up to Year 1|Serious Adverse Event|0
7822577|NCT01262976|12291771|FG001|Up to Year 1|Serious Adverse Event|0
7822578|NCT01262976|12291772|FG002|Up to Year 1|Serious Adverse Event|2
7822579|NCT01262976|12291773|FG003|Up to Year 1|Serious Adverse Event|0
7822580|NCT01262976|12291774|FG004|Up to Year 1|Serious Adverse Event|0
7822581|NCT01262976|12291775|FG005|Up to Year 1|Serious Adverse Event|0
7822582|NCT01262976|12291770|FG000|Up to Year 1|Withdrawal by Subject|1
7822583|NCT01262976|12291771|FG001|Up to Year 1|Withdrawal by Subject|0
7822584|NCT01262976|12291772|FG002|Up to Year 1|Withdrawal by Subject|0
7822585|NCT01262976|12291773|FG003|Up to Year 1|Withdrawal by Subject|0
7822586|NCT01262976|12291774|FG004|Up to Year 1|Withdrawal by Subject|0
7822587|NCT01262976|12291775|FG005|Up to Year 1|Withdrawal by Subject|0
7822588|NCT01262976|12291770|FG000|Up to Year 1|Migrated/moved from study area|1
7822589|NCT01262976|12291771|FG001|Up to Year 1|Migrated/moved from study area|0
7822590|NCT01262976|12291772|FG002|Up to Year 1|Migrated/moved from study area|0
7822591|NCT01262976|12291773|FG003|Up to Year 1|Migrated/moved from study area|3
7822592|NCT01262976|12291774|FG004|Up to Year 1|Migrated/moved from study area|3
7822593|NCT01262976|12291775|FG005|Up to Year 1|Migrated/moved from study area|2
7822594|NCT01262976|12291770|FG000|Up to Year 1|Lost to Follow-up|4
7822595|NCT01262976|12291771|FG001|Up to Year 1|Lost to Follow-up|0
7822596|NCT01262976|12291772|FG002|Up to Year 1|Lost to Follow-up|0
7822597|NCT01262976|12291773|FG003|Up to Year 1|Lost to Follow-up|1
7822598|NCT01262976|12291774|FG004|Up to Year 1|Lost to Follow-up|6
7822599|NCT01262976|12291775|FG005|Up to Year 1|Lost to Follow-up|5
7822600|NCT01262976|12291770|FG000|Up to Year 1|Other|3
7822601|NCT01262976|12291771|FG001|Up to Year 1|Other|1
7822602|NCT01262976|12291772|FG002|Up to Year 1|Other|0
7822603|NCT01262976|12291773|FG003|Up to Year 1|Other|0
7822604|NCT01262976|12291774|FG004|Up to Year 1|Other|2
7822605|NCT01262976|12291775|FG005|Up to Year 1|Other|1
7822606|NCT01262976|12291770|FG000|Up to Year 1|Subjects with unknown completion status|0
7822607|NCT01262976|12291771|FG001|Up to Year 1|Subjects with unknown completion status|0
7822608|NCT01262976|12291772|FG002|Up to Year 1|Subjects with unknown completion status|1
7822609|NCT01262976|12291773|FG003|Up to Year 1|Subjects with unknown completion status|0
7822610|NCT01262976|12291774|FG004|Up to Year 1|Subjects with unknown completion status|0
7822611|NCT01262976|12291775|FG005|Up to Year 1|Subjects with unknown completion status|1
7822612|NCT01262976|12291770|FG000|Up to Year 2|Serious Adverse Event|0
7822613|NCT01262976|12291771|FG001|Up to Year 2|Serious Adverse Event|0
7822614|NCT01262976|12291772|FG002|Up to Year 2|Serious Adverse Event|2
7822615|NCT01262976|12291773|FG003|Up to Year 2|Serious Adverse Event|0
7822616|NCT01262976|12291774|FG004|Up to Year 2|Serious Adverse Event|0
7822617|NCT01262976|12291775|FG005|Up to Year 2|Serious Adverse Event|0
7822618|NCT01262976|12291770|FG000|Up to Year 2|Withdrawal by Subject|1
7822619|NCT01262976|12291771|FG001|Up to Year 2|Withdrawal by Subject|0
7822620|NCT01262976|12291772|FG002|Up to Year 2|Withdrawal by Subject|0
7822621|NCT01262976|12291773|FG003|Up to Year 2|Withdrawal by Subject|0
7948090|NCT02524158|12493139|FG000|12-weeks Assessment|Withdrawal by Subject|1
7822622|NCT01262976|12291774|FG004|Up to Year 2|Withdrawal by Subject|0
7822623|NCT01262976|12291775|FG005|Up to Year 2|Withdrawal by Subject|0
7822624|NCT01262976|12291770|FG000|Up to Year 2|Migrated/moved from study area|0
7822625|NCT01262976|12291771|FG001|Up to Year 2|Migrated/moved from study area|0
7822626|NCT01262976|12291772|FG002|Up to Year 2|Migrated/moved from study area|0
7822627|NCT01262976|12291773|FG003|Up to Year 2|Migrated/moved from study area|2
7822628|NCT01262976|12291774|FG004|Up to Year 2|Migrated/moved from study area|1
7822629|NCT01262976|12291775|FG005|Up to Year 2|Migrated/moved from study area|2
7822630|NCT01262976|12291770|FG000|Up to Year 2|Lost to Follow-up|1
7822631|NCT01262976|12291771|FG001|Up to Year 2|Lost to Follow-up|1
7822632|NCT01262976|12291772|FG002|Up to Year 2|Lost to Follow-up|2
7822633|NCT01262976|12291773|FG003|Up to Year 2|Lost to Follow-up|2
7822634|NCT01262976|12291774|FG004|Up to Year 2|Lost to Follow-up|3
7822635|NCT01262976|12291775|FG005|Up to Year 2|Lost to Follow-up|3
7822636|NCT01262976|12291770|FG000|Up to Year 2|Subjects with unknown completion status|0
7822637|NCT01262976|12291771|FG001|Up to Year 2|Subjects with unknown completion status|0
7822638|NCT01262976|12291772|FG002|Up to Year 2|Subjects with unknown completion status|1
7822639|NCT01262976|12291773|FG003|Up to Year 2|Subjects with unknown completion status|0
7822640|NCT01262976|12291774|FG004|Up to Year 2|Subjects with unknown completion status|0
7822641|NCT01262976|12291775|FG005|Up to Year 2|Subjects with unknown completion status|0
7822642|NCT01262976|12291770|FG000|Up to Year 2|Other|3
7822643|NCT01262976|12291771|FG001|Up to Year 2|Other|0
7822644|NCT01262976|12291772|FG002|Up to Year 2|Other|0
7822645|NCT01262976|12291773|FG003|Up to Year 2|Other|0
7822646|NCT01262976|12291774|FG004|Up to Year 2|Other|0
7822647|NCT01262976|12291775|FG005|Up to Year 2|Other|0
7822648|NCT01262976|12291770|FG000|Up to Year 3|Serious Adverse Event|0
7822649|NCT01262976|12291771|FG001|Up to Year 3|Serious Adverse Event|0
7822650|NCT01262976|12291772|FG002|Up to Year 3|Serious Adverse Event|2
7822651|NCT01262976|12291773|FG003|Up to Year 3|Serious Adverse Event|0
7822652|NCT01262976|12291774|FG004|Up to Year 3|Serious Adverse Event|0
7822653|NCT01262976|12291775|FG005|Up to Year 3|Serious Adverse Event|0
7822654|NCT01262976|12291770|FG000|Up to Year 3|Withdrawal by Subject|1
7822655|NCT01262976|12291771|FG001|Up to Year 3|Withdrawal by Subject|0
7822656|NCT01262976|12291772|FG002|Up to Year 3|Withdrawal by Subject|0
7822657|NCT01262976|12291773|FG003|Up to Year 3|Withdrawal by Subject|0
7822658|NCT01262976|12291774|FG004|Up to Year 3|Withdrawal by Subject|0
7822659|NCT01262976|12291775|FG005|Up to Year 3|Withdrawal by Subject|0
7822660|NCT01262976|12291770|FG000|Up to Year 3|Migrated/moved from study area|0
7822661|NCT01262976|12291771|FG001|Up to Year 3|Migrated/moved from study area|0
7822662|NCT01262976|12291772|FG002|Up to Year 3|Migrated/moved from study area|0
7822663|NCT01262976|12291773|FG003|Up to Year 3|Migrated/moved from study area|2
7822664|NCT01262976|12291774|FG004|Up to Year 3|Migrated/moved from study area|1
7822665|NCT01262976|12291775|FG005|Up to Year 3|Migrated/moved from study area|1
7822666|NCT01262976|12291770|FG000|Up to Year 3|Lost to Follow-up|2
7822667|NCT01262976|12291771|FG001|Up to Year 3|Lost to Follow-up|2
7822668|NCT01262976|12291772|FG002|Up to Year 3|Lost to Follow-up|4
7822669|NCT01262976|12291773|FG003|Up to Year 3|Lost to Follow-up|3
7822670|NCT01262976|12291774|FG004|Up to Year 3|Lost to Follow-up|1
7822671|NCT01262976|12291775|FG005|Up to Year 3|Lost to Follow-up|3
7822672|NCT01262976|12291770|FG000|Up to Year 3|Subjects with unknown completion status|0
7822673|NCT01262976|12291771|FG001|Up to Year 3|Subjects with unknown completion status|0
7719903|NCT00535236|12143968|FG001|Overall Study|Lost to Follow-up|2
7719904|NCT00535236|12143969|FG002|Overall Study|Lost to Follow-up|0
7719905|NCT00535236|12143970|FG003|Overall Study|Lost to Follow-up|0
7719906|NCT00535236|12143971|FG004|Overall Study|Lost to Follow-up|2
7719907|NCT00535236|12143972|FG005|Overall Study|Lost to Follow-up|0
7719908|NCT00535236|12143973|FG006|Overall Study|Lost to Follow-up|0
7719909|NCT00535236|12143974|FG007|Overall Study|Lost to Follow-up|0
7719910|NCT00535236|12143975|FG008|Overall Study|Lost to Follow-up|6
7719911|NCT00535236|12143976|FG009|Overall Study|Lost to Follow-up|1
7719912|NCT00535236|12143967|FG000|Overall Study|Physician Decision|0
7719913|NCT00535236|12143968|FG001|Overall Study|Physician Decision|0
7719914|NCT00535236|12143969|FG002|Overall Study|Physician Decision|0
7719915|NCT00535236|12143970|FG003|Overall Study|Physician Decision|0
7719916|NCT00535236|12143971|FG004|Overall Study|Physician Decision|1
7719917|NCT00535236|12143972|FG005|Overall Study|Physician Decision|0
7719918|NCT00535236|12143973|FG006|Overall Study|Physician Decision|1
7719919|NCT00535236|12143974|FG007|Overall Study|Physician Decision|0
7719920|NCT00535236|12143975|FG008|Overall Study|Physician Decision|0
7719921|NCT00535236|12143976|FG009|Overall Study|Physician Decision|0
7719922|NCT00535236|12143967|FG000|Overall Study|Protocol Violation|2
7719923|NCT00535236|12143968|FG001|Overall Study|Protocol Violation|0
7719924|NCT00535236|12143969|FG002|Overall Study|Protocol Violation|1
7719925|NCT00535236|12143970|FG003|Overall Study|Protocol Violation|0
7719926|NCT00535236|12143971|FG004|Overall Study|Protocol Violation|0
7719927|NCT00535236|12143972|FG005|Overall Study|Protocol Violation|0
7719928|NCT00535236|12143973|FG006|Overall Study|Protocol Violation|0
7719929|NCT00535236|12143974|FG007|Overall Study|Protocol Violation|0
7719930|NCT00535236|12143975|FG008|Overall Study|Protocol Violation|1
7719931|NCT00535236|12143976|FG009|Overall Study|Protocol Violation|0
7719932|NCT00535236|12143967|FG000|Overall Study|Withdrawal by Subject|3
7719933|NCT00535236|12143968|FG001|Overall Study|Withdrawal by Subject|0
7719934|NCT00535236|12143969|FG002|Overall Study|Withdrawal by Subject|2
7822674|NCT01262976|12291772|FG002|Up to Year 3|Subjects with unknown completion status|1
7822675|NCT01262976|12291773|FG003|Up to Year 3|Subjects with unknown completion status|0
7822676|NCT01262976|12291774|FG004|Up to Year 3|Subjects with unknown completion status|0
7822677|NCT01262976|12291775|FG005|Up to Year 3|Subjects with unknown completion status|0
7822678|NCT01262976|12291770|FG000|Up to Year 3|Other|3
7822679|NCT01262976|12291771|FG001|Up to Year 3|Other|0
7822680|NCT01262976|12291772|FG002|Up to Year 3|Other|0
7822681|NCT01262976|12291773|FG003|Up to Year 3|Other|0
7822682|NCT01262976|12291774|FG004|Up to Year 3|Other|0
7822683|NCT01262976|12291775|FG005|Up to Year 3|Other|0
7822684|NCT01262989|12291790|FG000|Period 1|Lost to Follow-up|1
7822685|NCT01262989|12291791|FG001|Period 1|Lost to Follow-up|1
7822686|NCT01262989|12291790|FG000|Period 1|Intercurrent disease|0
7822687|NCT01262989|12291791|FG001|Period 1|Intercurrent disease|1
7822688|NCT01262989|12291790|FG000|Period 1|Positive answer for exclusion criteria|0
7822689|NCT01262989|12291791|FG001|Period 1|Positive answer for exclusion criteria|1
7822690|NCT01262989|12291790|FG000|Period 2|Intercurrent disease|0
7822691|NCT01262989|12291791|FG001|Period 2|Intercurrent disease|1
7822692|NCT01263015|12291799|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
7822693|NCT01263015|12291800|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
7822694|NCT01263015|12291799|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
7822695|NCT01263015|12291800|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
7822696|NCT01263015|12291799|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
7822697|NCT01263015|12291800|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
7822698|NCT01263015|12291799|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
7822699|NCT01263015|12291800|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
7948091|NCT02524158|12493140|FG001|12-weeks Assessment|Withdrawal by Subject|1
7719935|NCT00535236|12143970|FG003|Overall Study|Withdrawal by Subject|1
7719936|NCT00535236|12143971|FG004|Overall Study|Withdrawal by Subject|6
7719937|NCT00535236|12143972|FG005|Overall Study|Withdrawal by Subject|1
7719938|NCT00535236|12143973|FG006|Overall Study|Withdrawal by Subject|5
7719939|NCT00535236|12143974|FG007|Overall Study|Withdrawal by Subject|0
7719940|NCT00535236|12143975|FG008|Overall Study|Withdrawal by Subject|4
7719941|NCT00535236|12143976|FG009|Overall Study|Withdrawal by Subject|2
7719942|NCT00535288|12144006|FG000|Overall Study|Adverse Event|20
7719943|NCT00535288|12144007|FG001|Overall Study|Adverse Event|19
7822700|NCT01263015|12291799|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
7822701|NCT01263015|12291800|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
7822702|NCT01263015|12291799|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
7822703|NCT01263015|12291800|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
7822704|NCT01263015|12291799|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3
7822705|NCT01263015|12291800|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10
7822706|NCT01263015|12291799|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
7822707|NCT01263015|12291800|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
7822708|NCT01263015|12291799|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
7822709|NCT01263015|12291800|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
7822710|NCT01263015|12291799|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
7822711|NCT01263015|12291800|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
7822712|NCT01263015|12291799|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0
7822713|NCT01263015|12291800|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2
7822714|NCT01263015|12291799|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
7822715|NCT01263015|12291800|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
7822716|NCT01263054|12291808|FG000|Overall Study|Death|1
7822717|NCT01263054|12291809|FG001|Overall Study|Death|0
7822718|NCT01263054|12291808|FG000|Overall Study|Lost to Follow-up|2
7822719|NCT01263054|12291809|FG001|Overall Study|Lost to Follow-up|2
7822720|NCT01263054|12291808|FG000|Overall Study|Withdrawal by Subject|1
7822721|NCT01263054|12291809|FG001|Overall Study|Withdrawal by Subject|3
7822722|NCT01263054|12291808|FG000|Overall Study|Qualification Violation|1
7822723|NCT01263054|12291809|FG001|Overall Study|Qualification Violation|0
7822724|NCT01263054|12291808|FG000|Overall Study|Other|0
7822725|NCT01263054|12291809|FG001|Overall Study|Other|1
7822726|NCT01263093|12291817|FG000|Washout|Physician Decision|1
7822727|NCT01263093|12291818|FG001|Washout|Physician Decision|0
7822728|NCT01263093|12291817|FG000|Period 2|Adverse Event|1
7822729|NCT01263093|12291818|FG001|Period 2|Adverse Event|0
7822730|NCT01263106|12291825|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1
7822731|NCT01263106|12291826|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1
7822732|NCT01263119|12291835|FG000|Period 1|Protocol Violation|2
7822733|NCT01263119|12291835|FG000|Period 2|Adverse Event|2
7822734|NCT01263197|12291854|FG000|First Intervention (Period 1)|Adverse Event|0
7822735|NCT01263197|12291855|FG001|First Intervention (Period 1)|Adverse Event|0
7822736|NCT01263197|12291856|FG002|First Intervention (Period 1)|Adverse Event|0
7822737|NCT01263197|12291857|FG003|First Intervention (Period 1)|Adverse Event|0
7822738|NCT01263197|12291858|FG004|First Intervention (Period 1)|Adverse Event|0
7822739|NCT01263197|12291859|FG005|First Intervention (Period 1)|Adverse Event|1
7822740|NCT01263197|12291854|FG000|Washout Period 1|Protocol Violation|0
7822741|NCT01263197|12291855|FG001|Washout Period 1|Protocol Violation|0
7822742|NCT01263197|12291856|FG002|Washout Period 1|Protocol Violation|0
7822743|NCT01263197|12291857|FG003|Washout Period 1|Protocol Violation|0
7822744|NCT01263197|12291858|FG004|Washout Period 1|Protocol Violation|1
7822745|NCT01263197|12291859|FG005|Washout Period 1|Protocol Violation|0
7822746|NCT01263197|12291854|FG000|Washout Period 2|Physician Decision|0
7822747|NCT01263197|12291855|FG001|Washout Period 2|Physician Decision|0
7822748|NCT01263197|12291856|FG002|Washout Period 2|Physician Decision|0
7822749|NCT01263197|12291857|FG003|Washout Period 2|Physician Decision|0
7822750|NCT01263197|12291858|FG004|Washout Period 2|Physician Decision|0
7822751|NCT01263197|12291859|FG005|Washout Period 2|Physician Decision|1
7822752|NCT01263197|12291854|FG000|Washout Period 2|Protocol Violation|0
7822753|NCT01263197|12291855|FG001|Washout Period 2|Protocol Violation|0
7822754|NCT01263197|12291856|FG002|Washout Period 2|Protocol Violation|0
7822755|NCT01263197|12291857|FG003|Washout Period 2|Protocol Violation|1
7822756|NCT01263197|12291858|FG004|Washout Period 2|Protocol Violation|0
7822757|NCT01263197|12291859|FG005|Washout Period 2|Protocol Violation|0
7822758|NCT01263197|12291854|FG000|Third Intervention (Period 3)|Adverse Event|0
7822759|NCT01263197|12291855|FG001|Third Intervention (Period 3)|Adverse Event|1
7822760|NCT01263197|12291856|FG002|Third Intervention (Period 3)|Adverse Event|0
7822761|NCT01263197|12291857|FG003|Third Intervention (Period 3)|Adverse Event|0
7822762|NCT01263197|12291858|FG004|Third Intervention (Period 3)|Adverse Event|0
7822763|NCT01263197|12291859|FG005|Third Intervention (Period 3)|Adverse Event|0
7822764|NCT01263223|12291873|FG000|Period 2|Withdrawal by Subject|0
7822765|NCT01263223|12291874|FG001|Period 2|Withdrawal by Subject|1
7822766|NCT01263223|12291873|FG000|7-day Follow-up|Withdrawal by Subject|0
7822767|NCT01263223|12291874|FG001|7-day Follow-up|Withdrawal by Subject|1
7822768|NCT01263223|12291873|FG000|7-day Follow-up|Lost to Follow-up|1
7822769|NCT01263223|12291874|FG001|7-day Follow-up|Lost to Follow-up|0
7822770|NCT01263444|12291931|FG000|Overall Study|Adverse Event|8
7822771|NCT01263444|12291931|FG000|Overall Study|Withdrawal by Subject|1
7822772|NCT01263444|12291931|FG000|Overall Study|Protocol Violation|1
7822773|NCT01263470|12291941|FG000|Overall Study|Adverse Event|2
7822774|NCT01263470|12291942|FG001|Overall Study|Adverse Event|2
7822775|NCT01263470|12291943|FG002|Overall Study|Adverse Event|1
7822776|NCT01263470|12291944|FG003|Overall Study|Adverse Event|1
7822777|NCT01263470|12291945|FG004|Overall Study|Adverse Event|2
7822778|NCT01263470|12291946|FG005|Overall Study|Adverse Event|2
7822779|NCT01263470|12291941|FG000|Overall Study|Protocol Violation|0
7822780|NCT01263470|12291942|FG001|Overall Study|Protocol Violation|1
7822781|NCT01263470|12291943|FG002|Overall Study|Protocol Violation|0
7822782|NCT01263470|12291944|FG003|Overall Study|Protocol Violation|0
7822783|NCT01263470|12291945|FG004|Overall Study|Protocol Violation|0
7822784|NCT01263470|12291946|FG005|Overall Study|Protocol Violation|1
7822785|NCT01263470|12291941|FG000|Overall Study|Withdrawal by Subject|0
7822786|NCT01263470|12291942|FG001|Overall Study|Withdrawal by Subject|1
7822787|NCT01263470|12291943|FG002|Overall Study|Withdrawal by Subject|1
7822788|NCT01263470|12291944|FG003|Overall Study|Withdrawal by Subject|2
7822789|NCT01263470|12291945|FG004|Overall Study|Withdrawal by Subject|0
7822790|NCT01263470|12291946|FG005|Overall Study|Withdrawal by Subject|2
7822791|NCT01263470|12291941|FG000|Overall Study|Lack of Efficacy|0
7822792|NCT01263470|12291942|FG001|Overall Study|Lack of Efficacy|0
7822793|NCT01263470|12291943|FG002|Overall Study|Lack of Efficacy|2
7822794|NCT01263470|12291944|FG003|Overall Study|Lack of Efficacy|0
7822795|NCT01263470|12291945|FG004|Overall Study|Lack of Efficacy|0
7822796|NCT01263470|12291946|FG005|Overall Study|Lack of Efficacy|0
7822797|NCT01263470|12291941|FG000|Overall Study|Participant Unavailability|0
7822798|NCT01263470|12291942|FG001|Overall Study|Participant Unavailability|1
7822799|NCT01263470|12291943|FG002|Overall Study|Participant Unavailability|0
7822800|NCT01263470|12291944|FG003|Overall Study|Participant Unavailability|0
7822801|NCT01263470|12291945|FG004|Overall Study|Participant Unavailability|0
7822802|NCT01263470|12291946|FG005|Overall Study|Participant Unavailability|0
7822803|NCT01263470|12291941|FG000|Overall Study|Study Drug Non-compliance|0
7822804|NCT01263470|12291942|FG001|Overall Study|Study Drug Non-compliance|0
7822805|NCT01263470|12291943|FG002|Overall Study|Study Drug Non-compliance|0
7822806|NCT01263470|12291944|FG003|Overall Study|Study Drug Non-compliance|0
7822807|NCT01263470|12291945|FG004|Overall Study|Study Drug Non-compliance|1
7822808|NCT01263470|12291946|FG005|Overall Study|Study Drug Non-compliance|0
7822809|NCT01263483|12291963|FG000|Overall Study|Adverse Event|4
7822810|NCT01263483|12291964|FG001|Overall Study|Adverse Event|0
7822811|NCT01263483|12291965|FG002|Overall Study|Adverse Event|3
7822812|NCT01263483|12291963|FG000|Overall Study|Withdrawal by Subject|1
7822813|NCT01263483|12291964|FG001|Overall Study|Withdrawal by Subject|0
7822814|NCT01263483|12291965|FG002|Overall Study|Withdrawal by Subject|0
7822815|NCT01263483|12291963|FG000|Overall Study|Lack of Efficacy|2
7822816|NCT01263483|12291964|FG001|Overall Study|Lack of Efficacy|0
7822817|NCT01263483|12291965|FG002|Overall Study|Lack of Efficacy|0
7822818|NCT01263483|12291963|FG000|Overall Study|Protocol Violation|0
7822819|NCT01263483|12291964|FG001|Overall Study|Protocol Violation|1
7822820|NCT01263483|12291965|FG002|Overall Study|Protocol Violation|1
7822821|NCT01263483|12291963|FG000|Overall Study|Participant Unavailability|0
7822822|NCT01263483|12291964|FG001|Overall Study|Participant Unavailability|1
7822823|NCT01263483|12291965|FG002|Overall Study|Participant Unavailability|1
7822824|NCT01263496|12291978|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1
7822825|NCT01263496|12291979|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0
7822826|NCT01263496|12291980|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0
7822827|NCT01263496|12291981|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0
7822828|NCT01263496|12291982|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0
7822829|NCT01263496|12291983|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0
7822830|NCT01263496|12291984|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0
7822831|NCT01263496|12291985|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0
7822832|NCT01263496|12291986|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0
7822833|NCT01263496|12291978|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0
7822834|NCT01263496|12291979|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
7822835|NCT01263496|12291980|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0
7822836|NCT01263496|12291981|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1
7822837|NCT01263496|12291982|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2
7822838|NCT01263496|12291983|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0
7822839|NCT01263496|12291984|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0
7822840|NCT01263496|12291985|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0
7822841|NCT01263496|12291986|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0
7822842|NCT01263496|12291978|FG000|Entered - Long-Term Extension Study|Adverse Event|0
7822843|NCT01263496|12291979|FG001|Entered - Long-Term Extension Study|Adverse Event|5
7822844|NCT01263496|12291980|FG002|Entered - Long-Term Extension Study|Adverse Event|6
7822845|NCT01263496|12291981|FG003|Entered - Long-Term Extension Study|Adverse Event|3
7822846|NCT01263496|12291982|FG004|Entered - Long-Term Extension Study|Adverse Event|1
7822847|NCT01263496|12291983|FG005|Entered - Long-Term Extension Study|Adverse Event|0
7822848|NCT01263496|12291984|FG006|Entered - Long-Term Extension Study|Adverse Event|0
7822849|NCT01263496|12291985|FG007|Entered - Long-Term Extension Study|Adverse Event|0
7822850|NCT01263496|12291986|FG008|Entered - Long-Term Extension Study|Adverse Event|1
7822851|NCT01263496|12291978|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0
7822852|NCT01263496|12291979|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2
7822853|NCT01263496|12291980|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0
7822854|NCT01263496|12291981|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0
7822855|NCT01263496|12291982|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0
7822856|NCT01263496|12291983|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0
7822857|NCT01263496|12291984|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0
7822858|NCT01263496|12291985|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0
7822859|NCT01263496|12291986|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0
7822860|NCT01263496|12291978|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7822861|NCT01263496|12291979|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7822862|NCT01263496|12291980|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7822863|NCT01263496|12291981|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7822864|NCT01263496|12291982|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4
7822865|NCT01263496|12291983|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7822866|NCT01263496|12291984|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7822867|NCT01263496|12291985|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7822868|NCT01263496|12291986|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7822869|NCT01263496|12291978|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8
7948092|NCT02524158|12493139|FG000|12-weeks Assessment|Lost to Follow-up|18
7719944|NCT00535288|12144008|FG002|Overall Study|Adverse Event|25
7719945|NCT00535288|12144009|FG003|Overall Study|Adverse Event|20
7719946|NCT00535288|12144010|FG004|Overall Study|Adverse Event|30
7719947|NCT00535288|12144006|FG000|Overall Study|Lost to Follow-up|0
7719948|NCT00535288|12144007|FG001|Overall Study|Lost to Follow-up|3
7719949|NCT00535288|12144008|FG002|Overall Study|Lost to Follow-up|0
7719950|NCT00535288|12144009|FG003|Overall Study|Lost to Follow-up|0
7719951|NCT00535288|12144010|FG004|Overall Study|Lost to Follow-up|0
7719952|NCT00535288|12144006|FG000|Overall Study|Lack of Efficacy|26
7822870|NCT01263496|12291979|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4
7822871|NCT01263496|12291980|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4
7822872|NCT01263496|12291981|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1
7822873|NCT01263496|12291982|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5
7822874|NCT01263496|12291983|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0
7822875|NCT01263496|12291984|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0
7822876|NCT01263496|12291985|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0
7822877|NCT01263496|12291986|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1
7822878|NCT01263496|12291978|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0
7822879|NCT01263496|12291979|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0
7822880|NCT01263496|12291980|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0
7822881|NCT01263496|12291981|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0
7822882|NCT01263496|12291982|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0
7822883|NCT01263496|12291983|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0
7822884|NCT01263496|12291984|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0
7822885|NCT01263496|12291985|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1
7822886|NCT01263496|12291986|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0
7822887|NCT01263509|12292000|FG000|Entered - Long-Term Extension Study|Adverse Event|5
7822888|NCT01263509|12292001|FG001|Entered - Long-Term Extension Study|Adverse Event|5
7822889|NCT01263509|12292002|FG002|Entered - Long-Term Extension Study|Adverse Event|4
7822890|NCT01263509|12292003|FG003|Entered - Long-Term Extension Study|Adverse Event|1
7822891|NCT01263509|12292000|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1
7822892|NCT01263509|12292001|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4
7822893|NCT01263509|12292002|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1
7822894|NCT01263509|12292003|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0
7822895|NCT01263509|12292000|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7822896|NCT01263509|12292001|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7822897|NCT01263509|12292002|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7822898|NCT01263509|12292003|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7822899|NCT01263509|12292000|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1
7822900|NCT01263509|12292001|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1
7948093|NCT02524158|12493140|FG001|12-weeks Assessment|Lost to Follow-up|12
7822901|NCT01263509|12292002|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0
7822902|NCT01263509|12292003|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0
7822903|NCT01263509|12292000|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
7822904|NCT01263509|12292001|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
7822905|NCT01263509|12292002|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
7822906|NCT01263509|12292003|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
7822907|NCT01263561|12292011|FG000|Overall Study|Death|1
7822908|NCT01263561|12292012|FG001|Overall Study|Death|2
7822909|NCT01263639|12292020|FG000|Overall Study|Lost to Follow-up|66
7822910|NCT01263639|12292021|FG001|Overall Study|Lost to Follow-up|70
7822911|NCT01263639|12292020|FG000|Overall Study|Exclusion =Admission greater than 7 days|7
7822912|NCT01263639|12292021|FG001|Overall Study|Exclusion =Admission greater than 7 days|9
7822913|NCT01263665|12292027|FG000|Overall Study|Withdrew Consent|1
7822914|NCT01263665|12292027|FG000|Overall Study|Lost to Follow-up|3
7822915|NCT01263665|12292027|FG000|Overall Study|Death|2
7822916|NCT01263665|12292027|FG000|Overall Study|Amputation above the ankle|1
7822917|NCT01263665|12292027|FG000|Overall Study|Surgical Bypass|2
7822918|NCT01263691|12292037|FG000|Overall Study|Lost to Follow-up|1
7822919|NCT01263691|12292038|FG001|Overall Study|Lost to Follow-up|0
7822920|NCT01263691|12292039|FG002|Overall Study|Lost to Follow-up|1
7822921|NCT01263691|12292040|FG003|Overall Study|Lost to Follow-up|1
7822922|NCT01263691|12292041|FG004|Overall Study|Lost to Follow-up|0
7822923|NCT01263691|12292042|FG005|Overall Study|Lost to Follow-up|0
7822924|NCT01263691|12292037|FG000|Overall Study|Withdrawal by Subject|1
7822925|NCT01263691|12292038|FG001|Overall Study|Withdrawal by Subject|0
7822926|NCT01263691|12292039|FG002|Overall Study|Withdrawal by Subject|0
7822927|NCT01263691|12292040|FG003|Overall Study|Withdrawal by Subject|0
7822928|NCT01263691|12292041|FG004|Overall Study|Withdrawal by Subject|0
7822929|NCT01263691|12292042|FG005|Overall Study|Withdrawal by Subject|0
7822930|NCT01263691|12292037|FG000|Overall Study|Adverse Event|1
7822931|NCT01263691|12292038|FG001|Overall Study|Adverse Event|0
7822932|NCT01263691|12292039|FG002|Overall Study|Adverse Event|0
7822933|NCT01263691|12292040|FG003|Overall Study|Adverse Event|0
7822934|NCT01263691|12292041|FG004|Overall Study|Adverse Event|0
7822935|NCT01263691|12292042|FG005|Overall Study|Adverse Event|0
7822936|NCT01263704|12292077|FG000|Overall Study|Progressive disease|18
7822937|NCT01263704|12292077|FG000|Overall Study|Adverse Event|3
7822938|NCT01263704|12292077|FG000|Overall Study|Death|2
7822939|NCT01263704|12292077|FG000|Overall Study|Patient withdrew consent|2
7822940|NCT01263704|12292077|FG000|Overall Study|Eligibility criteria not fulfilled|1
7822941|NCT01263704|12292077|FG000|Overall Study|Lost to Follow-up|1
7822942|NCT01263704|12292077|FG000|Overall Study|Colon metastases|1
7822943|NCT01263704|12292077|FG000|Overall Study|Principal Investigator (PI) decision|1
7822944|NCT01263782|12292094|FG000|Overall Study|Death|0
7822945|NCT01263782|12292095|FG001|Overall Study|Death|0
7822946|NCT01263782|12292096|FG002|Overall Study|Death|1
7822947|NCT01263782|12292097|FG003|Overall Study|Death|0
7822948|NCT01263782|12292094|FG000|Overall Study|Progressive disease|0
7822949|NCT01263782|12292095|FG001|Overall Study|Progressive disease|0
7822950|NCT01263782|12292096|FG002|Overall Study|Progressive disease|0
7822951|NCT01263782|12292097|FG003|Overall Study|Progressive disease|1
7822952|NCT01263782|12292094|FG000|Overall Study|Too early|0
7822953|NCT01263782|12292095|FG001|Overall Study|Too early|0
7822954|NCT01263782|12292096|FG002|Overall Study|Too early|1
7822955|NCT01263782|12292097|FG003|Overall Study|Too early|0
7822956|NCT01263782|12292094|FG000|Overall Study|Inevaluable|0
7948094|NCT02524158|12493139|FG000|6-month Assessment|Withdrawal by Subject|1
7822957|NCT01263782|12292095|FG001|Overall Study|Inevaluable|0
7822958|NCT01263782|12292096|FG002|Overall Study|Inevaluable|1
7822959|NCT01263782|12292097|FG003|Overall Study|Inevaluable|0
7822960|NCT01263873|12292109|FG000|Overall Study|One provider unable to complete numbers|1
7822961|NCT01263873|12292110|FG001|Overall Study|One provider unable to complete numbers|1
7822962|NCT01263925|12292118|FG000|Overall Study|Protocol Violation|1
7822963|NCT01263925|12292119|FG001|Overall Study|Protocol Violation|0
7822964|NCT01263925|12292118|FG000|Overall Study|Lack of Efficacy|0
7822965|NCT01263925|12292119|FG001|Overall Study|Lack of Efficacy|1
7822966|NCT01263925|12292118|FG000|Overall Study|Adverse Event|23
7822967|NCT01263925|12292119|FG001|Overall Study|Adverse Event|22
7822968|NCT01263925|12292118|FG000|Overall Study|Unsatisfactory Compliance of Subject|8
7822969|NCT01263925|12292119|FG001|Overall Study|Unsatisfactory Compliance of Subject|5
7822970|NCT01263925|12292118|FG000|Overall Study|Withdrawal by Subject|6
7822971|NCT01263925|12292119|FG001|Overall Study|Withdrawal by Subject|8
7822972|NCT01263925|12292118|FG000|Overall Study|Other|4
7822973|NCT01263925|12292119|FG001|Overall Study|Other|4
7822974|NCT01263925|12292118|FG000|Overall Study|Lost to Follow-up|3
7822975|NCT01263925|12292119|FG001|Overall Study|Lost to Follow-up|1
7822976|NCT01263925|12292118|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
7822977|NCT01263925|12292119|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
7822978|NCT01263925|12292118|FG000|Overall Study|AE/ Unsatisfactory Compliance|2
7822979|NCT01263925|12292119|FG001|Overall Study|AE/ Unsatisfactory Compliance|2
7822980|NCT01263925|12292118|FG000|Overall Study|AE/ Withdrawal|1
7822981|NCT01263925|12292119|FG001|Overall Study|AE/ Withdrawal|4
7822982|NCT01263925|12292118|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
7822983|NCT01263925|12292119|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
7822984|NCT01263925|12292118|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
7822985|NCT01263925|12292119|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
7822986|NCT01263925|12292118|FG000|Overall Study|Withdrawal/ Not specified|0
7822987|NCT01263925|12292119|FG001|Overall Study|Withdrawal/ Not specified|1
7822988|NCT01264016|12292130|FG000|Overall Study|Withdrawal by Subject|1
7822989|NCT01264016|12292130|FG000|Overall Study|Felt faint at sight of blood|1
7822990|NCT01264081|12292135|FG000|Participants Screened|Screening failures|30
7822991|NCT01264081|12292135|FG000|Started Treatment|Withdrawal by Subject|1
7822992|NCT01264081|12292135|FG000|Started Treatment|Not complete cycle 1 due to death|1
7822993|NCT01264380|12292139|FG000|Period C|Disease Progression|0
7822994|NCT01264380|12292140|FG001|Period C|Disease Progression|0
7822995|NCT01264380|12292141|FG002|Period C|Disease Progression|4
7822996|NCT01264380|12292139|FG000|Period C|Death|0
7822997|NCT01264380|12292140|FG001|Period C|Death|0
7822998|NCT01264380|12292141|FG002|Period C|Death|2
7822999|NCT01264380|12292139|FG000|Period C|Follow-up for survival status|0
7823000|NCT01264380|12292140|FG001|Period C|Follow-up for survival status|0
7823001|NCT01264380|12292141|FG002|Period C|Follow-up for survival status|6
7823002|NCT01264380|12292139|FG000|Period C|Withdrawal by Subject|0
7823003|NCT01264380|12292140|FG001|Period C|Withdrawal by Subject|0
7823004|NCT01264380|12292141|FG002|Period C|Withdrawal by Subject|1
7823005|NCT01264380|12292139|FG000|Period C|Adverse Event|0
7823006|NCT01264380|12292140|FG001|Period C|Adverse Event|0
7823007|NCT01264380|12292141|FG002|Period C|Adverse Event|1
7823008|NCT01264419|12292149|FG000|Overall Study|Lost to Follow-up|3
7823009|NCT01264718|12292189|FG000|Overall Study|Lost to Follow-up|3
7823010|NCT01264718|12292190|FG001|Overall Study|Lost to Follow-up|2
7823011|NCT01264718|12292189|FG000|Overall Study|Withdrawal by Subject|9
7823012|NCT01264718|12292190|FG001|Overall Study|Withdrawal by Subject|15
7823013|NCT01264718|12292189|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37
7823014|NCT01264718|12292190|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26
7823015|NCT01264770|12292202|FG000|Overall Study|Not reported|0
7823016|NCT01264770|12292203|FG001|Overall Study|Not reported|0
7823017|NCT01264770|12292204|FG002|Overall Study|Not reported|1
7823018|NCT01264770|12292205|FG003|Overall Study|Not reported|0
7823019|NCT01264770|12292206|FG004|Overall Study|Not reported|0
7823020|NCT01264770|12292207|FG005|Overall Study|Not reported|0
7823021|NCT01264770|12292202|FG000|Overall Study|e.g., change in circumstances|8
7823022|NCT01264770|12292203|FG001|Overall Study|e.g., change in circumstances|3
7823023|NCT01264770|12292204|FG002|Overall Study|e.g., change in circumstances|3
7823024|NCT01264770|12292205|FG003|Overall Study|e.g., change in circumstances|3
7823025|NCT01264770|12292206|FG004|Overall Study|e.g., change in circumstances|4
7823026|NCT01264770|12292207|FG005|Overall Study|e.g., change in circumstances|4
7823027|NCT01264770|12292202|FG000|Overall Study|Severe non-compliance to protocol|0
7823028|NCT01264770|12292203|FG001|Overall Study|Severe non-compliance to protocol|0
7823029|NCT01264770|12292204|FG002|Overall Study|Severe non-compliance to protocol|1
7823030|NCT01264770|12292205|FG003|Overall Study|Severe non-compliance to protocol|1
7823031|NCT01264770|12292206|FG004|Overall Study|Severe non-compliance to protocol|0
7823032|NCT01264770|12292207|FG005|Overall Study|Severe non-compliance to protocol|0
7823033|NCT01264770|12292202|FG000|Overall Study|Lack of therapeutic response|1
7823034|NCT01264770|12292203|FG001|Overall Study|Lack of therapeutic response|0
7823035|NCT01264770|12292204|FG002|Overall Study|Lack of therapeutic response|2
7823036|NCT01264770|12292205|FG003|Overall Study|Lack of therapeutic response|1
7823037|NCT01264770|12292206|FG004|Overall Study|Lack of therapeutic response|1
7823038|NCT01264770|12292207|FG005|Overall Study|Lack of therapeutic response|0
7823039|NCT01264770|12292202|FG000|Overall Study|Dev. of study specific discont. criteria|2
7823040|NCT01264770|12292203|FG001|Overall Study|Dev. of study specific discont. criteria|0
7823041|NCT01264770|12292204|FG002|Overall Study|Dev. of study specific discont. criteria|0
7823042|NCT01264770|12292205|FG003|Overall Study|Dev. of study specific discont. criteria|0
7823043|NCT01264770|12292206|FG004|Overall Study|Dev. of study specific discont. criteria|1
7823044|NCT01264770|12292207|FG005|Overall Study|Dev. of study specific discont. criteria|1
7823045|NCT01264770|12292202|FG000|Overall Study|Lost to Follow-up|0
7823046|NCT01264770|12292203|FG001|Overall Study|Lost to Follow-up|0
7823047|NCT01264770|12292204|FG002|Overall Study|Lost to Follow-up|1
7823048|NCT01264770|12292205|FG003|Overall Study|Lost to Follow-up|1
7823049|NCT01264770|12292206|FG004|Overall Study|Lost to Follow-up|0
7823050|NCT01264770|12292207|FG005|Overall Study|Lost to Follow-up|0
7823051|NCT01264770|12292202|FG000|Overall Study|Adverse Event|7
7823052|NCT01264770|12292203|FG001|Overall Study|Adverse Event|7
7823053|NCT01264770|12292204|FG002|Overall Study|Adverse Event|8
7823054|NCT01264770|12292205|FG003|Overall Study|Adverse Event|0
7823055|NCT01264770|12292206|FG004|Overall Study|Adverse Event|2
7823056|NCT01264770|12292207|FG005|Overall Study|Adverse Event|1
7823057|NCT01264887|12292227|FG000|Overall Study|Adverse Event|5
7823058|NCT01264887|12292227|FG000|Overall Study|Death|7
7823059|NCT01264887|12292227|FG000|Overall Study|Lack of Efficacy|5
7823060|NCT01264887|12292227|FG000|Overall Study|Physician Decision|4
7823061|NCT01264887|12292227|FG000|Overall Study|Withdrawal by Subject|6
7823062|NCT01264887|12292227|FG000|Overall Study|Sponsor Decision Administrative Reasons|2
7823063|NCT01264887|12292227|FG000|Overall Study|Other|2
7823064|NCT01264939|12292235|FG000|Overall Study|Adverse Event|1
7823065|NCT01264939|12292236|FG001|Overall Study|Adverse Event|3
7823066|NCT01264939|12292235|FG000|Overall Study|Lost to Follow-up|0
7823067|NCT01264939|12292236|FG001|Overall Study|Lost to Follow-up|3
7823068|NCT01264939|12292235|FG000|Overall Study|Physician Decision|1
7823069|NCT01264939|12292236|FG001|Overall Study|Physician Decision|1
7823070|NCT01264939|12292235|FG000|Overall Study|Patient/Guardian Decision|8
7823071|NCT01264939|12292236|FG001|Overall Study|Patient/Guardian Decision|10
7823072|NCT01264939|12292235|FG000|Overall Study|Disease Progression|8
7823073|NCT01264939|12292236|FG001|Overall Study|Disease Progression|11
7823074|NCT01265056|12292257|FG000|Initial Study Period|Withdrawal by Subject|1
7823075|NCT01265056|12292258|FG001|Initial Study Period|Withdrawal by Subject|1
7823076|NCT01265056|12292257|FG000|Initial Study Period|Withdrawal by Subject|1
7823077|NCT01265056|12292258|FG001|Initial Study Period|Withdrawal by Subject|1
7823078|NCT01265056|12292257|FG000|Follow up|Lost to Follow-up|7
7823079|NCT01265056|12292258|FG001|Follow up|Lost to Follow-up|3
7823080|NCT01265394|12292264|FG000|Overall Study|Subjects withdrawn|37
7823081|NCT01265420|12292269|FG000|Overall Study|Lost to Follow-up|1
7823082|NCT01265498|12292284|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31
7823083|NCT01265498|12292285|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33
7823084|NCT01265511|12292293|FG000|Overall Study|Lack of Efficacy|2
7823085|NCT01265511|12292294|FG001|Overall Study|Lack of Efficacy|1
7823086|NCT01265511|12292293|FG000|Overall Study|Met stopping rules|0
7823087|NCT01265511|12292294|FG001|Overall Study|Met stopping rules|2
7823088|NCT01265537|12292311|FG000|Overall Study|Adverse Event|2
7823089|NCT01265537|12292312|FG001|Overall Study|Adverse Event|1
7823090|NCT01265537|12292311|FG000|Overall Study|Physician Decision|0
7823091|NCT01265537|12292312|FG001|Overall Study|Physician Decision|1
7823092|NCT01265550|12292322|FG000|Pre Randomization|Withdrawal by Subject|0
7823093|NCT01265550|12292323|FG001|Pre Randomization|Withdrawal by Subject|0
7823094|NCT01265550|12292324|FG002|Pre Randomization|Withdrawal by Subject|0
7823095|NCT01265550|12292325|FG003|Pre Randomization|Withdrawal by Subject|70
7823096|NCT01265550|12292322|FG000|Pre Randomization|Technical Exclusions|0
7823097|NCT01265550|12292323|FG001|Pre Randomization|Technical Exclusions|0
7823098|NCT01265550|12292324|FG002|Pre Randomization|Technical Exclusions|0
7823099|NCT01265550|12292325|FG003|Pre Randomization|Technical Exclusions|54
7823100|NCT01265550|12292322|FG000|Pre Randomization|GERD, PPI-Responsive|0
7823101|NCT01265550|12292323|FG001|Pre Randomization|GERD, PPI-Responsive|0
7823102|NCT01265550|12292324|FG002|Pre Randomization|GERD, PPI-Responsive|0
7823103|NCT01265550|12292325|FG003|Pre Randomization|GERD, PPI-Responsive|42
7823104|NCT01265550|12292322|FG000|Pre Randomization|Non-GERD organic disorders|0
7823105|NCT01265550|12292323|FG001|Pre Randomization|Non-GERD organic disorders|0
7823106|NCT01265550|12292324|FG002|Pre Randomization|Non-GERD organic disorders|0
7948095|NCT02524158|12493140|FG001|6-month Assessment|Withdrawal by Subject|1
7823107|NCT01265550|12292325|FG003|Pre Randomization|Non-GERD organic disorders|23
7823108|NCT01265550|12292322|FG000|Pre Randomization|Functional heartburn|0
7823109|NCT01265550|12292323|FG001|Pre Randomization|Functional heartburn|0
7823110|NCT01265550|12292324|FG002|Pre Randomization|Functional heartburn|0
7823111|NCT01265550|12292325|FG003|Pre Randomization|Functional heartburn|99
7823112|NCT01265563|12292344|FG000|Overall Study|Withdrawal by Subject|0
7823113|NCT01265563|12292345|FG001|Overall Study|Withdrawal by Subject|1
7823114|NCT01265563|12292346|FG002|Overall Study|Withdrawal by Subject|1
7823115|NCT01265563|12292347|FG003|Overall Study|Withdrawal by Subject|0
7823116|NCT01265563|12292348|FG004|Overall Study|Withdrawal by Subject|2
7823117|NCT01265615|12292369|FG000|Overall Study|Protocol Violation|2
7823118|NCT01265615|12292370|FG001|Overall Study|Protocol Violation|2
7823119|NCT01265615|12292371|FG002|Overall Study|Protocol Violation|4
7823120|NCT01265615|12292372|FG003|Overall Study|Protocol Violation|3
7823121|NCT01265719|12292393|FG000|Overall Study|Does not meet entrance criteria|0
7823122|NCT01265719|12292394|FG001|Overall Study|Does not meet entrance criteria|3
7823123|NCT01265719|12292393|FG000|Overall Study|Other reasons|2
7823124|NCT01265719|12292394|FG001|Overall Study|Other reasons|0
7823125|NCT01265719|12292393|FG000|Overall Study|Withdrawal by Subject|8
7823126|NCT01265719|12292394|FG001|Overall Study|Withdrawal by Subject|3
7823127|NCT01265719|12292393|FG000|Overall Study|Lost to Follow-up|2
7823128|NCT01265719|12292394|FG001|Overall Study|Lost to Follow-up|7
7823129|NCT01265719|12292393|FG000|Overall Study|Adverse Event|2
7823130|NCT01265719|12292394|FG001|Overall Study|Adverse Event|0
7823131|NCT01265797|12292402|FG000|Run-in Month|Withdrawal by Subject|0
7823132|NCT01265797|12292403|FG001|Run-in Month|Withdrawal by Subject|4
7823133|NCT01265797|12292402|FG000|Run-in Month|1st seizure during run-in month|0
7823134|NCT01265797|12292403|FG001|Run-in Month|1st seizure during run-in month|1
7823135|NCT01265797|12292402|FG000|Blinded Month|Lack of Efficacy|5
7823136|NCT01265797|12292403|FG001|Blinded Month|Lack of Efficacy|0
7823137|NCT01265797|12292402|FG000|Blinded Month|Lost to Follow-up|1
7823138|NCT01265797|12292403|FG001|Blinded Month|Lost to Follow-up|0
7823139|NCT01265797|12292402|FG000|Blinded Month|Protocol Violation|2
7823140|NCT01265797|12292403|FG001|Blinded Month|Protocol Violation|1
7823141|NCT01265797|12292402|FG000|Blinded Month|Adverse Event|2
7823142|NCT01265797|12292403|FG001|Blinded Month|Adverse Event|0
7823143|NCT01265797|12292402|FG000|Blinded Month|Diary data incomplete|0
7823144|NCT01265797|12292403|FG001|Blinded Month|Diary data incomplete|1
7823145|NCT01265797|12292402|FG000|Open Label Month|Lost to Follow-up|0
7823146|NCT01265797|12292403|FG001|Open Label Month|Lost to Follow-up|1
7823147|NCT01265823|12292411|FG000|Overall Study|Unsatisfactory Response Efficacy|1
7823148|NCT01265823|12292411|FG000|Overall Study|Failure to Return|4
7823149|NCT01265823|12292411|FG000|Overall Study|Protocol Violation|1
7823150|NCT01265823|12292411|FG000|Overall Study|Participant Request|1
7823151|NCT01265875|12292419|FG000|Overall Study|Uncooperative/unreliable|1
7823152|NCT01265953|12292426|FG000|Overall Study|Non compliance|5
7823153|NCT01265953|12292427|FG001|Overall Study|Non compliance|3
7823154|NCT01265992|12292446|FG000|Overall Study|Lost to Follow-up|1
7823155|NCT01265992|12292446|FG000|Overall Study|Withdrawal by Subject|1
7823156|NCT01265992|12292446|FG000|Overall Study|Adverse Event|1
7823157|NCT01265992|12292446|FG000|Overall Study|Administrative reasons|2
7823158|NCT01265992|12292446|FG000|Overall Study|Stopped treatment|3
7823159|NCT01265992|12292446|FG000|Overall Study|Did not receive treatment|1
7823160|NCT01266018|12292450|FG000|Overall Study|Physician Decision|1
7823161|NCT01266018|12292451|FG001|Overall Study|Physician Decision|0
7823162|NCT01266018|12292450|FG000|Overall Study|Progressive disease|0
7823163|NCT01266018|12292451|FG001|Overall Study|Progressive disease|1
7823164|NCT01266070|12292457|FG000|Overall Study|Adverse Event|3
7823165|NCT01266070|12292457|FG000|Overall Study|Protocol Violation|1
7823166|NCT01266122|12292463|FG000|Overall Study|Lost to Follow-up|6
7823167|NCT01266122|12292464|FG001|Overall Study|Lost to Follow-up|6
7823168|NCT01266148|12292472|FG000|Overall Study|Adverse Event|2
7823169|NCT01266148|12292473|FG001|Overall Study|Adverse Event|0
7823170|NCT01266148|12292472|FG000|Overall Study|Ongoing rejection|1
7823171|NCT01266148|12292473|FG001|Overall Study|Ongoing rejection|0
7823172|NCT01266148|12292472|FG000|Overall Study|2 2R rejections|1
7823173|NCT01266148|12292473|FG001|Overall Study|2 2R rejections|0
7823174|NCT01266148|12292472|FG000|Overall Study|Death|2
7823175|NCT01266148|12292473|FG001|Overall Study|Death|3
7823176|NCT01266148|12292472|FG000|Overall Study|missing mGFR value + AE|1
7823177|NCT01266148|12292473|FG001|Overall Study|missing mGFR value + AE|0
7823178|NCT01266161|12292481|FG000|Overall Study|Ineligible|1
7823179|NCT01266161|12292482|FG001|Overall Study|Ineligible|0
7823180|NCT01266161|12292481|FG000|Overall Study|Lack of Efficacy|0
7823181|NCT01266161|12292482|FG001|Overall Study|Lack of Efficacy|1
7823182|NCT01266161|12292481|FG000|Overall Study|Vomited within 4 hours of dosing|3
7823183|NCT01266161|12292482|FG001|Overall Study|Vomited within 4 hours of dosing|0
7823184|NCT01266265|12292490|FG000|Overall Study|Death|95
7823185|NCT01266265|12292491|FG001|Overall Study|Death|73
7823186|NCT01266265|12292490|FG000|Overall Study|Lost to Follow-up|23
7823187|NCT01266265|12292491|FG001|Overall Study|Lost to Follow-up|28
7823188|NCT01266265|12292490|FG000|Overall Study|Withdrawal by Subject|13
7823189|NCT01266265|12292491|FG001|Overall Study|Withdrawal by Subject|11
7823190|NCT01266265|12292490|FG000|Overall Study|Respiratory-related adverse event|2
7823191|NCT01266265|12292491|FG001|Overall Study|Respiratory-related adverse event|1
7823192|NCT01266265|12292490|FG000|Overall Study|Transferred care to another provider|22
7823193|NCT01266265|12292491|FG001|Overall Study|Transferred care to another provider|28
7823194|NCT01266265|12292490|FG000|Overall Study|Stopped/changed PAH medication(s)|16
7823195|NCT01266265|12292491|FG001|Overall Study|Stopped/changed PAH medication(s)|9
7823196|NCT01266265|12292490|FG000|Overall Study|Enrolled in another clinical study|15
7823197|NCT01266265|12292491|FG001|Overall Study|Enrolled in another clinical study|26
7823198|NCT01266265|12292490|FG000|Overall Study|Non-compliance|8
7823199|NCT01266265|12292491|FG001|Overall Study|Non-compliance|5
7823200|NCT01266265|12292490|FG000|Overall Study|Lung transplant|6
7719953|NCT00535288|12144007|FG001|Overall Study|Lack of Efficacy|3
7719954|NCT00535288|12144008|FG002|Overall Study|Lack of Efficacy|4
7719955|NCT00535288|12144009|FG003|Overall Study|Lack of Efficacy|4
7719956|NCT00535288|12144010|FG004|Overall Study|Lack of Efficacy|7
7719957|NCT00535288|12144006|FG000|Overall Study|Unwilling to cooperate|6
7719958|NCT00535288|12144007|FG001|Overall Study|Unwilling to cooperate|6
7719959|NCT00535288|12144008|FG002|Overall Study|Unwilling to cooperate|3
7719960|NCT00535288|12144009|FG003|Overall Study|Unwilling to cooperate|3
7719961|NCT00535288|12144010|FG004|Overall Study|Unwilling to cooperate|4
7719962|NCT00535288|12144006|FG000|Overall Study|Other|2
7719963|NCT00535288|12144007|FG001|Overall Study|Other|1
7719964|NCT00535288|12144008|FG002|Overall Study|Other|1
7719965|NCT00535288|12144009|FG003|Overall Study|Other|2
7719966|NCT00535288|12144010|FG004|Overall Study|Other|1
7719967|NCT00535496|12144044|FG000|Overall Study|Lost to Follow-up|0
7719968|NCT00535496|12144045|FG001|Overall Study|Lost to Follow-up|1
7719969|NCT00535496|12144046|FG002|Overall Study|Lost to Follow-up|0
7719970|NCT00535496|12144047|FG003|Overall Study|Lost to Follow-up|0
7719971|NCT00535496|12144044|FG000|Overall Study|Not treated with sugammadex|0
7823201|NCT01266265|12292491|FG001|Overall Study|Lung transplant|5
7823202|NCT01266265|12292490|FG000|Overall Study|Site closed early|4
7823203|NCT01266265|12292491|FG001|Overall Study|Site closed early|3
7823204|NCT01266265|12292490|FG000|Overall Study|Clinical worsening|1
7823205|NCT01266265|12292491|FG001|Overall Study|Clinical worsening|1
7823206|NCT01266291|12292497|FG000|Overall Study|Adverse Event|1
7823207|NCT01266317|12292501|FG000|Overall Study|Withdrawal by Subject|2
7823208|NCT01266460|12292509|FG000|Overall Study|Adverse Event|3
7823209|NCT01266460|12292509|FG000|Overall Study|Withdrawal by Subject|5
7823210|NCT01266460|12292509|FG000|Overall Study|Disease Progression|18
7823211|NCT01266460|12292509|FG000|Overall Study|Not otherwise specified|8
7823212|NCT01266590|12292513|FG000|Overall Study|Adverse Event|3
7823213|NCT01266590|12292513|FG000|Overall Study|Lost to Follow-up|1
7823214|NCT01266590|12292513|FG000|Overall Study|Withdrawal by Subject|1
7823215|NCT01266590|12292513|FG000|Overall Study|Physician Decision|1
7823216|NCT01266603|12292520|FG000|Overall Study|Adverse Event|1
7823217|NCT01266603|12292520|FG000|Overall Study|Lack of Efficacy|14
7823218|NCT01266603|12292520|FG000|Overall Study|Withdrawal by Subject|1
7823219|NCT01266603|12292520|FG000|Overall Study|Failed screening; MAGE-A3 negative|26
7823220|NCT01266642|12292526|FG000|Overall Study|Protocol Violation|0
7823221|NCT01266642|12292527|FG001|Overall Study|Protocol Violation|1
7823222|NCT01266850|12292538|FG000|Overall Study|Lost to Follow-up|19
7823223|NCT01266850|12292539|FG001|Overall Study|Lost to Follow-up|19
7823224|NCT01266850|12292540|FG002|Overall Study|Lost to Follow-up|13
7823225|NCT01266850|12292541|FG003|Overall Study|Lost to Follow-up|13
7823226|NCT01266850|12292542|FG004|Overall Study|Lost to Follow-up|12
7823227|NCT01266850|12292538|FG000|Overall Study|Withdrawal by Subject|8
7823228|NCT01266850|12292539|FG001|Overall Study|Withdrawal by Subject|9
7823229|NCT01266850|12292540|FG002|Overall Study|Withdrawal by Subject|6
7823230|NCT01266850|12292541|FG003|Overall Study|Withdrawal by Subject|9
7823231|NCT01266850|12292542|FG004|Overall Study|Withdrawal by Subject|12
7823232|NCT01266850|12292538|FG000|Overall Study|Physician Decision|3
7823233|NCT01266850|12292539|FG001|Overall Study|Physician Decision|6
7823234|NCT01266850|12292540|FG002|Overall Study|Physician Decision|4
7823235|NCT01266850|12292541|FG003|Overall Study|Physician Decision|4
7823236|NCT01266850|12292542|FG004|Overall Study|Physician Decision|3
7823237|NCT01266850|12292538|FG000|Overall Study|Protocol Violation|0
7823238|NCT01266850|12292539|FG001|Overall Study|Protocol Violation|1
7823239|NCT01266850|12292540|FG002|Overall Study|Protocol Violation|0
7823240|NCT01266850|12292541|FG003|Overall Study|Protocol Violation|1
7823241|NCT01266850|12292542|FG004|Overall Study|Protocol Violation|2
7823242|NCT01266850|12292538|FG000|Overall Study|Adverse Event|0
7823243|NCT01266850|12292539|FG001|Overall Study|Adverse Event|0
7823244|NCT01266850|12292540|FG002|Overall Study|Adverse Event|0
7823245|NCT01266850|12292541|FG003|Overall Study|Adverse Event|0
7823246|NCT01266850|12292542|FG004|Overall Study|Adverse Event|1
7823247|NCT01266850|12292538|FG000|Overall Study|Site Closure|0
7823248|NCT01266850|12292539|FG001|Overall Study|Site Closure|1
7823249|NCT01266850|12292540|FG002|Overall Study|Site Closure|1
7823250|NCT01266850|12292541|FG003|Overall Study|Site Closure|1
7823251|NCT01266850|12292542|FG004|Overall Study|Site Closure|0
7823252|NCT01266876|12292559|FG000|Overall Study|Adverse Event|0
7823253|NCT01266876|12292560|FG001|Overall Study|Adverse Event|0
7823254|NCT01266876|12292561|FG002|Overall Study|Adverse Event|0
7823255|NCT01266876|12292562|FG003|Overall Study|Adverse Event|1
7823256|NCT01266876|12292563|FG004|Overall Study|Adverse Event|0
7862154|NCT01597245|12351202|FG014|Long Term Extension (Week 60 - Week 264)|Death|8
7862155|NCT01597245|12351203|FG015|Long Term Extension (Week 60 - Week 264)|Death|8
7862156|NCT01597245|12351204|FG016|Long Term Extension (Week 60 - Week 264)|Death|0
7862157|NCT01597245|12351205|FG017|Long Term Extension (Week 60 - Week 264)|Death|0
7862158|NCT01597245|12351206|FG018|Long Term Extension (Week 60 - Week 264)|Death|0
7862159|NCT01597245|12351207|FG019|Long Term Extension (Week 60 - Week 264)|Death|0
7862160|NCT01597245|12351208|FG020|Long Term Extension (Week 60 - Week 264)|Death|0
7862161|NCT01597245|12351188|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862162|NCT01597245|12351189|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862163|NCT01597245|12351190|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862164|NCT01597245|12351191|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862165|NCT01597245|12351192|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862166|NCT01597245|12351193|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862167|NCT01597245|12351194|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862168|NCT01597245|12351195|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862169|NCT01597245|12351196|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862170|NCT01597245|12351197|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862171|NCT01597245|12351198|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862172|NCT01597245|12351199|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862173|NCT01597245|12351200|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7823257|NCT01266902|12292577|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2
7823258|NCT01266902|12292578|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3
7823259|NCT01266902|12292579|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0
7823260|NCT01266902|12292577|FG000|Period 1 (Main Study)|Lost to Follow-up|5
7823261|NCT01266902|12292578|FG001|Period 1 (Main Study)|Lost to Follow-up|12
7823262|NCT01266902|12292579|FG002|Period 1 (Main Study)|Lost to Follow-up|0
7823263|NCT01266902|12292577|FG000|Period 1 (Main Study)|Lack of Efficacy|4
7823264|NCT01266902|12292578|FG001|Period 1 (Main Study)|Lack of Efficacy|2
7823265|NCT01266902|12292579|FG002|Period 1 (Main Study)|Lack of Efficacy|0
7823266|NCT01266902|12292577|FG000|Period 1 (Main Study)|Adverse Event|3
7823267|NCT01266902|12292578|FG001|Period 1 (Main Study)|Adverse Event|11
7823268|NCT01266902|12292579|FG002|Period 1 (Main Study)|Adverse Event|0
7823269|NCT01266902|12292577|FG000|Period 1 (Main Study)|Withdrawal by Subject|2
7823270|NCT01266902|12292578|FG001|Period 1 (Main Study)|Withdrawal by Subject|12
7823271|NCT01266902|12292579|FG002|Period 1 (Main Study)|Withdrawal by Subject|0
7823272|NCT01266902|12292577|FG000|Period 1 (Main Study)|Subject non-compliant|3
7823273|NCT01266902|12292578|FG001|Period 1 (Main Study)|Subject non-compliant|7
7823274|NCT01266902|12292579|FG002|Period 1 (Main Study)|Subject non-compliant|0
7823275|NCT01266902|12292577|FG000|Period 1 (Main Study)|Continued RPV treatment|11
7823276|NCT01266902|12292578|FG001|Period 1 (Main Study)|Continued RPV treatment|34
7823277|NCT01266902|12292579|FG002|Period 1 (Main Study)|Continued RPV treatment|0
7823278|NCT01266902|12292577|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0
7823279|NCT01266902|12292578|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0
7823280|NCT01266902|12292579|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1
7823281|NCT01266902|12292577|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0
7823282|NCT01266902|12292578|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0
7823283|NCT01266902|12292579|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1
7823284|NCT01266902|12292577|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0
7823285|NCT01266902|12292578|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0
7823286|NCT01266902|12292579|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6
7823287|NCT01266967|12292589|FG000|Overall Study|Death|69
7823288|NCT01266967|12292590|FG001|Overall Study|Death|61
7823289|NCT01266967|12292589|FG000|Overall Study|Study Closed/Terminated|15
7823290|NCT01266967|12292590|FG001|Overall Study|Study Closed/Terminated|17
7823291|NCT01266967|12292589|FG000|Overall Study|Lost to Follow-up|2
7823292|NCT01266967|12292590|FG001|Overall Study|Lost to Follow-up|1
7823293|NCT01266967|12292589|FG000|Overall Study|Physician Decision|0
7823294|NCT01266967|12292590|FG001|Overall Study|Physician Decision|1
7823295|NCT01266967|12292589|FG000|Overall Study|Withdrawal by Subject|3
7823296|NCT01266967|12292590|FG001|Overall Study|Withdrawal by Subject|3
7823297|NCT01266993|12292601|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5
7823298|NCT01266993|12292602|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1
7823299|NCT01266993|12292601|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0
7823300|NCT01266993|12292602|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1
7823301|NCT01267175|12292642|FG000|Overall Study|Withdrawal by Subject|1
7823302|NCT01267175|12292642|FG000|Overall Study|Lost to Follow-up|1
7823303|NCT01267201|12292646|FG000|First Intervention Period|Withdrawal by Subject|1
7823304|NCT01267201|12292647|FG001|First Intervention Period|Withdrawal by Subject|0
7823305|NCT01267201|12292648|FG002|First Intervention Period|Withdrawal by Subject|0
7823306|NCT01267201|12292649|FG003|First Intervention Period|Withdrawal by Subject|0
7823307|NCT01267201|12292650|FG004|First Intervention Period|Withdrawal by Subject|0
7823308|NCT01267201|12292651|FG005|First Intervention Period|Withdrawal by Subject|0
7823309|NCT01267201|12292646|FG000|Second Intervention Period|Withdrawal by Subject|0
7823310|NCT01267201|12292647|FG001|Second Intervention Period|Withdrawal by Subject|1
7823311|NCT01267201|12292648|FG002|Second Intervention Period|Withdrawal by Subject|0
7823312|NCT01267201|12292649|FG003|Second Intervention Period|Withdrawal by Subject|0
7823313|NCT01267201|12292650|FG004|Second Intervention Period|Withdrawal by Subject|0
7823314|NCT01267201|12292651|FG005|Second Intervention Period|Withdrawal by Subject|0
7823315|NCT01267253|12292684|FG000|Overall Study|Ineligible - required test not done|1
7823316|NCT01267253|12292684|FG000|Overall Study|Inevaluable-never received study treatme|2
7823317|NCT01267266|12292688|FG000|Enrollment Phase|Withdrawal by Subject|2
7823318|NCT01267266|12292689|FG001|Enrollment Phase|Withdrawal by Subject|0
7823319|NCT01267266|12292688|FG000|Lead-in Phase|Lack of Efficacy|20
7823320|NCT01267266|12292689|FG001|Lead-in Phase|Lack of Efficacy|0
7823321|NCT01267266|12292688|FG000|Lead-in Phase|Adverse Event|2
7823322|NCT01267266|12292689|FG001|Lead-in Phase|Adverse Event|0
7823323|NCT01267266|12292688|FG000|Lead-in Phase|Withdrawal by Subject|1
7823324|NCT01267266|12292689|FG001|Lead-in Phase|Withdrawal by Subject|0
7823325|NCT01267994|12292764|FG000|Overall Study|Adverse Event|2
7823326|NCT01268046|12292773|FG000|Overall Study|Withdrawal by Subject|1
7823327|NCT01268046|12292774|FG001|Overall Study|Withdrawal by Subject|0
7823328|NCT01268046|12292775|FG002|Overall Study|Withdrawal by Subject|0
7823329|NCT01268046|12292776|FG003|Overall Study|Withdrawal by Subject|1
7823330|NCT01268046|12292773|FG000|Overall Study|Lost to Follow-up|0
7823331|NCT01268046|12292774|FG001|Overall Study|Lost to Follow-up|0
7823332|NCT01268046|12292775|FG002|Overall Study|Lost to Follow-up|1
7823333|NCT01268046|12292776|FG003|Overall Study|Lost to Follow-up|0
7823334|NCT01268059|12292790|FG000|Overall Study|Lost to Follow-up|0
7823335|NCT01268059|12292791|FG001|Overall Study|Lost to Follow-up|1
7823336|NCT01268059|12292792|FG002|Overall Study|Lost to Follow-up|0
7823337|NCT01268059|12292793|FG003|Overall Study|Lost to Follow-up|0
7823338|NCT01268059|12292790|FG000|Overall Study|Withdrawal by Subject|7
7823339|NCT01268059|12292791|FG001|Overall Study|Withdrawal by Subject|4
7823340|NCT01268059|12292792|FG002|Overall Study|Withdrawal by Subject|0
7823341|NCT01268059|12292793|FG003|Overall Study|Withdrawal by Subject|0
7823342|NCT01268059|12292790|FG000|Overall Study|Death|20
7823343|NCT01268059|12292791|FG001|Overall Study|Death|30
7823344|NCT01268059|12292792|FG002|Overall Study|Death|3
7823345|NCT01268059|12292793|FG003|Overall Study|Death|5
7823346|NCT01268059|12292790|FG000|Overall Study|Progression of disease|1
7823347|NCT01268059|12292791|FG001|Overall Study|Progression of disease|0
7823348|NCT01268059|12292792|FG002|Overall Study|Progression of disease|0
7823349|NCT01268059|12292793|FG003|Overall Study|Progression of disease|0
7823350|NCT01268098|12292808|FG000|Overall Study|Adverse Event|1
7823351|NCT01268098|12292809|FG001|Overall Study|Adverse Event|0
7823352|NCT01268150|12292824|FG000|Treatment Phase|Progression of disease|18
7823353|NCT01268150|12292824|FG000|Treatment Phase|Adverse Event|3
7823354|NCT01268150|12292824|FG000|Treatment Phase|Withdrawal by Subject|3
7823355|NCT01268150|12292824|FG000|Treatment Phase|Other|4
7823356|NCT01268150|12292824|FG000|Extension Phase|Adverse Event|3
7823357|NCT01268150|12292824|FG000|Extension Phase|Disease progression|18
7823358|NCT01268150|12292824|FG000|Extension Phase|Other|6
7823359|NCT01268267|12292834|FG000|Overall Study|Protocol Violation|1
7823360|NCT01268293|12292839|FG000|Overall Study|Disease progression|7
7823361|NCT01268293|12292839|FG000|Overall Study|Adverse Event|1
7823362|NCT01268293|12292839|FG000|Overall Study|Subject choice|1
7823363|NCT01268306|12292843|FG000|Overall Study|Lost to Follow-up|1
7823364|NCT01268488|12292847|FG000|Overall Study|Adverse Event|3
7823365|NCT01268488|12292847|FG000|Overall Study|Physician Decision|2
7823366|NCT01268501|12292852|FG000|Overall Study|Lost to Follow-up|1
7823367|NCT01268501|12292852|FG000|Overall Study|Withdrawal by Subject|3
7823368|NCT01268501|12292852|FG000|Overall Study|Unacceptable Subjective Vision|3
7823369|NCT01268501|12292852|FG000|Overall Study|Handling Difficulties|2
7823370|NCT01268514|12292856|FG000|Overall Study|Adverse Event|20
7823371|NCT01268514|12292856|FG000|Overall Study|Death|8
7823372|NCT01268514|12292856|FG000|Overall Study|Lost to Follow-up|5
7823373|NCT01268514|12292856|FG000|Overall Study|Withdrawal by Subject|3
7823374|NCT01268514|12292856|FG000|Overall Study|Withdrawal by Surgeon|5
7823375|NCT01268566|12292888|FG000|Overall Study|Lost to Follow-up|1
7823376|NCT01268566|12292888|FG000|Overall Study|Withdrawal by Subject|12
7823377|NCT01268566|12292888|FG000|Overall Study|Death|30
7823378|NCT01268683|12292899|FG000|Overall Study|Lost to Follow-up|1
7823379|NCT01268683|12292899|FG000|Overall Study|Death|1
7823380|NCT01268891|12292905|FG000|Overall Study|Adverse Event|3
7823381|NCT01268891|12292906|FG001|Overall Study|Adverse Event|7
7823382|NCT01268891|12292905|FG000|Overall Study|Lack of Efficacy|1
7823383|NCT01268891|12292906|FG001|Overall Study|Lack of Efficacy|0
7823384|NCT01268891|12292905|FG000|Overall Study|Withdrawal of Consent|3
7823385|NCT01268891|12292906|FG001|Overall Study|Withdrawal of Consent|1
7823386|NCT01268891|12292905|FG000|Overall Study|Administrative or other reason(s)|1
7823387|NCT01268891|12292906|FG001|Overall Study|Administrative or other reason(s)|0
7823388|NCT01269125|12292947|FG000|Overall Study|Adverse Event|3
7823389|NCT01269125|12292948|FG001|Overall Study|Adverse Event|5
7823390|NCT01269125|12292949|FG002|Overall Study|Adverse Event|0
7823391|NCT01269125|12292947|FG000|Overall Study|Lost to Follow-up|4
7823392|NCT01269125|12292948|FG001|Overall Study|Lost to Follow-up|0
7823393|NCT01269125|12292949|FG002|Overall Study|Lost to Follow-up|0
7823394|NCT01269346|12292957|FG000|Treatment Phase|Disease progression|3
7823395|NCT01269346|12292957|FG000|Treatment Phase|Adverse Event|3
7823396|NCT01269346|12292957|FG000|Treatment Phase|Withdrawal by Subject|1
7823397|NCT01269346|12292957|FG000|Treatment Phase|Other|2
7823398|NCT01269346|12292957|FG000|Extension Phase|Adverse Event|6
7823399|NCT01269346|12292957|FG000|Extension Phase|Withdrawal by Subject|4
7823400|NCT01269346|12292957|FG000|Extension Phase|Disease progression|22
7823401|NCT01269346|12292957|FG000|Extension Phase|Physician decision or participant choice|9
7823402|NCT01269346|12292957|FG000|Extension Phase|Clinical progression|1
7823403|NCT01269346|12292957|FG000|Extension Phase|Started a prohibited con med|1
7823404|NCT01269385|12292971|FG000|Overall Study|Adverse Event|1
7823405|NCT01269385|12292972|FG001|Overall Study|Adverse Event|1
7823406|NCT01269385|12292973|FG002|Overall Study|Adverse Event|0
7823407|NCT01269385|12292974|FG003|Overall Study|Adverse Event|0
7823408|NCT01269918|12293010|FG000|Overall Study|Did not receive study drug|0
7823409|NCT01269918|12293011|FG001|Overall Study|Did not receive study drug|3
7823410|NCT01270139|12293029|FG000|Overall Study|Adverse Event|8
7823411|NCT01270139|12293030|FG001|Overall Study|Adverse Event|17
7823412|NCT01270139|12293031|FG002|Overall Study|Adverse Event|18
7823413|NCT01270139|12293029|FG000|Overall Study|Lost to Follow-up|10
7823414|NCT01270139|12293030|FG001|Overall Study|Lost to Follow-up|9
7823415|NCT01270139|12293031|FG002|Overall Study|Lost to Follow-up|2
7823416|NCT01270256|12293048|FG000|Overall Study|Withdrawal by Subject|1
7823417|NCT01270256|12293049|FG001|Overall Study|Withdrawal by Subject|0
7823418|NCT01270321|12293058|FG000|Overall Study|Death|3
7823419|NCT01270321|12293059|FG001|Overall Study|Death|1
7823420|NCT01270321|12293060|FG002|Overall Study|Death|4
7823421|NCT01270321|12293058|FG000|Overall Study|Adverse Event|7
7823422|NCT01270321|12293059|FG001|Overall Study|Adverse Event|9
7823423|NCT01270321|12293060|FG002|Overall Study|Adverse Event|5
7823424|NCT01270464|12293071|FG000|Overall Study|Protocol Violation|4
7823425|NCT01270464|12293072|FG001|Overall Study|Protocol Violation|3
7823426|NCT01270464|12293073|FG002|Overall Study|Protocol Violation|2
7823427|NCT01270464|12293071|FG000|Overall Study|Lack of Efficacy|2
7823428|NCT01270464|12293072|FG001|Overall Study|Lack of Efficacy|3
7823429|NCT01270464|12293073|FG002|Overall Study|Lack of Efficacy|1
7823430|NCT01270464|12293071|FG000|Overall Study|Adverse Event|9
7823431|NCT01270464|12293072|FG001|Overall Study|Adverse Event|1
7823432|NCT01270464|12293073|FG002|Overall Study|Adverse Event|7
7948096|NCT02524158|12493139|FG000|6-month Assessment|Lost to Follow-up|21
7948097|NCT02524158|12493140|FG001|6-month Assessment|Lost to Follow-up|20
7948098|NCT02524665|12493169|FG000|Overall Study|Lost to Follow-up|1
7948099|NCT02524730|12493174|FG000|Overall Study|Lost to Follow-up|5
7948100|NCT02524730|12493174|FG000|Overall Study|Withdrawal by Subject|18
7823433|NCT01270464|12293071|FG000|Overall Study|Withdrawal by Subject|2
7948101|NCT02524730|12493174|FG000|Overall Study|Death|10
7948102|NCT02524730|12493174|FG000|Overall Study|Adverse Event|8
7948103|NCT02524730|12493174|FG000|Overall Study|Protocol Violation|1
7948104|NCT02524730|12493174|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4
7948105|NCT02524847|12493182|FG000|Overall Study|Adverse Event|4
7948106|NCT02524847|12493182|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4
7948107|NCT02524847|12493182|FG000|Overall Study|Condition no Longer Requires Treatment|4
7948108|NCT02524847|12493182|FG000|Overall Study|Death|1
7948109|NCT02524847|12493182|FG000|Overall Study|Reason not Specified|1
7948110|NCT02525094|12493225|FG000|Overall Study|Lost to Follow-up|2
7948111|NCT02525094|12493226|FG001|Overall Study|Lost to Follow-up|1
7948112|NCT02525094|12493225|FG000|Overall Study|Withdrawal by Subject|5
7948113|NCT02525094|12493226|FG001|Overall Study|Withdrawal by Subject|6
7948114|NCT02525094|12493225|FG000|Overall Study|Not Treated|1
7948115|NCT02525094|12493226|FG001|Overall Study|Not Treated|1
7948116|NCT02525133|12493235|FG000|Overall Study|Adverse Event|0
7948117|NCT02525133|12493236|FG001|Overall Study|Adverse Event|1
7948118|NCT02525133|12493235|FG000|Overall Study|Death|0
7948119|NCT02525133|12493236|FG001|Overall Study|Death|1
7948120|NCT02525133|12493235|FG000|Overall Study|did not meet randomization criteria|1
7823434|NCT01270464|12293072|FG001|Overall Study|Withdrawal by Subject|1
7823435|NCT01270464|12293073|FG002|Overall Study|Withdrawal by Subject|4
7823436|NCT01270464|12293071|FG000|Overall Study|Lost to Follow-up|2
7823437|NCT01270464|12293072|FG001|Overall Study|Lost to Follow-up|3
7823438|NCT01270464|12293073|FG002|Overall Study|Lost to Follow-up|1
7823439|NCT01270464|12293071|FG000|Overall Study|Other|1
7823440|NCT01270464|12293072|FG001|Overall Study|Other|1
7823441|NCT01270464|12293073|FG002|Overall Study|Other|3
7823442|NCT01270503|12293081|FG000|Overall Study|Lost to Follow-up|1
7823443|NCT01270620|12293131|FG000|Overall Study|Withdrawal by Subject|1
7823444|NCT01270620|12293132|FG001|Overall Study|Withdrawal by Subject|3
7823445|NCT01270802|12293197|FG000|Overall Study|Withdrawal by Subject|1
7823446|NCT01270802|12293198|FG001|Overall Study|Withdrawal by Subject|0
7823447|NCT01270802|12293197|FG000|Overall Study|Adverse Event|1
7823448|NCT01270802|12293198|FG001|Overall Study|Adverse Event|0
7823449|NCT01270802|12293197|FG000|Overall Study|Lost to Follow-up|0
7823450|NCT01270802|12293198|FG001|Overall Study|Lost to Follow-up|1
7823451|NCT01270828|12293207|FG000|Pregabalin CR SB|Reason Unspecified|0
7823452|NCT01270828|12293208|FG001|Pregabalin CR SB|Reason Unspecified|0
7823453|NCT01270828|12293209|FG002|Pregabalin CR SB|Reason Unspecified|8
7823454|NCT01270828|12293207|FG000|Pregabalin CR SB|Enrolled but not treated|0
7823455|NCT01270828|12293208|FG001|Pregabalin CR SB|Enrolled but not treated|0
7823456|NCT01270828|12293209|FG002|Pregabalin CR SB|Enrolled but not treated|5
7823457|NCT01270828|12293207|FG000|Pregabalin CR SB|Related adverse event|0
7823458|NCT01270828|12293208|FG001|Pregabalin CR SB|Related adverse event|0
7823459|NCT01270828|12293209|FG002|Pregabalin CR SB|Related adverse event|46
7823460|NCT01270828|12293207|FG000|Pregabalin CR SB|Lack of Efficacy|0
7823461|NCT01270828|12293208|FG001|Pregabalin CR SB|Lack of Efficacy|0
7823462|NCT01270828|12293209|FG002|Pregabalin CR SB|Lack of Efficacy|32
7823463|NCT01270828|12293207|FG000|Pregabalin CR SB|Withdrawal by Subject|0
7823464|NCT01270828|12293208|FG001|Pregabalin CR SB|Withdrawal by Subject|0
7823465|NCT01270828|12293209|FG002|Pregabalin CR SB|Withdrawal by Subject|29
7823466|NCT01270828|12293207|FG000|Pregabalin CR SB|Lost to Follow-up|0
7823467|NCT01270828|12293208|FG001|Pregabalin CR SB|Lost to Follow-up|0
7823468|NCT01270828|12293209|FG002|Pregabalin CR SB|Lost to Follow-up|10
7823469|NCT01270828|12293207|FG000|Pregabalin CR SB|Unrelated AE|0
7823470|NCT01270828|12293208|FG001|Pregabalin CR SB|Unrelated AE|0
7823471|NCT01270828|12293209|FG002|Pregabalin CR SB|Unrelated AE|8
7823472|NCT01270828|12293207|FG000|Pregabalin CR SB|Protocol Violation|0
7823473|NCT01270828|12293208|FG001|Pregabalin CR SB|Protocol Violation|0
7823474|NCT01270828|12293209|FG002|Pregabalin CR SB|Protocol Violation|8
7823475|NCT01270828|12293207|FG000|Double Blind Phase|Death|0
7823476|NCT01270828|12293208|FG001|Double Blind Phase|Death|1
7823477|NCT01270828|12293209|FG002|Double Blind Phase|Death|0
7823478|NCT01270828|12293207|FG000|Double Blind Phase|Protocol Violation|0
7823479|NCT01270828|12293208|FG001|Double Blind Phase|Protocol Violation|1
7823480|NCT01270828|12293209|FG002|Double Blind Phase|Protocol Violation|0
7823481|NCT01270828|12293207|FG000|Double Blind Phase|Protocol and GCP non-compliance|4
7823482|NCT01270828|12293208|FG001|Double Blind Phase|Protocol and GCP non-compliance|3
7823483|NCT01270828|12293209|FG002|Double Blind Phase|Protocol and GCP non-compliance|0
7823484|NCT01270828|12293207|FG000|Double Blind Phase|Reason Unspecified|7
7823485|NCT01270828|12293208|FG001|Double Blind Phase|Reason Unspecified|4
7823486|NCT01270828|12293209|FG002|Double Blind Phase|Reason Unspecified|0
7823487|NCT01270828|12293207|FG000|Double Blind Phase|Withdrawal by Subject|6
7823488|NCT01270828|12293208|FG001|Double Blind Phase|Withdrawal by Subject|15
7823489|NCT01270828|12293209|FG002|Double Blind Phase|Withdrawal by Subject|0
7823490|NCT01270828|12293207|FG000|Double Blind Phase|Lost to Follow-up|1
7823491|NCT01270828|12293208|FG001|Double Blind Phase|Lost to Follow-up|2
7823492|NCT01270828|12293209|FG002|Double Blind Phase|Lost to Follow-up|0
7823493|NCT01270828|12293207|FG000|Double Blind Phase|Lack of Efficacy|2
7823494|NCT01270828|12293208|FG001|Double Blind Phase|Lack of Efficacy|11
7823495|NCT01270828|12293209|FG002|Double Blind Phase|Lack of Efficacy|0
7823496|NCT01270828|12293207|FG000|Double Blind Phase|Adverse event not related to study drug|1
7823497|NCT01270828|12293208|FG001|Double Blind Phase|Adverse event not related to study drug|1
7823498|NCT01270828|12293209|FG002|Double Blind Phase|Adverse event not related to study drug|0
7823499|NCT01270828|12293207|FG000|Double Blind Phase|Adverse event related to study drug|5
7823500|NCT01270828|12293208|FG001|Double Blind Phase|Adverse event related to study drug|7
7823501|NCT01270828|12293209|FG002|Double Blind Phase|Adverse event related to study drug|0
7823502|NCT01270841|12293221|FG000|Overall Study|Adverse Event|0
7823503|NCT01270841|12293222|FG001|Overall Study|Adverse Event|1
7823504|NCT01270841|12293223|FG002|Overall Study|Adverse Event|0
7823505|NCT01270841|12293224|FG003|Overall Study|Adverse Event|3
7823506|NCT01270841|12293221|FG000|Overall Study|Withdrawal by Subject|3
7823507|NCT01270841|12293222|FG001|Overall Study|Withdrawal by Subject|2
7823508|NCT01270841|12293223|FG002|Overall Study|Withdrawal by Subject|3
7823509|NCT01270841|12293224|FG003|Overall Study|Withdrawal by Subject|3
7823510|NCT01270841|12293221|FG000|Overall Study|Lost to Follow-up|3
7823511|NCT01270841|12293222|FG001|Overall Study|Lost to Follow-up|1
7823512|NCT01270841|12293223|FG002|Overall Study|Lost to Follow-up|4
7823513|NCT01270841|12293224|FG003|Overall Study|Lost to Follow-up|2
7823514|NCT01270841|12293221|FG000|Overall Study|Physician Decision|0
7823515|NCT01270841|12293222|FG001|Overall Study|Physician Decision|1
7823516|NCT01270841|12293223|FG002|Overall Study|Physician Decision|0
7823517|NCT01270841|12293224|FG003|Overall Study|Physician Decision|0
7823518|NCT01270841|12293221|FG000|Overall Study|Did not qualify|6
7823519|NCT01270841|12293222|FG001|Overall Study|Did not qualify|3
7823520|NCT01270841|12293223|FG002|Overall Study|Did not qualify|4
7823521|NCT01270841|12293224|FG003|Overall Study|Did not qualify|5
7823522|NCT01270841|12293221|FG000|Overall Study|Protocol Violation|1
7823523|NCT01270841|12293222|FG001|Overall Study|Protocol Violation|5
7823524|NCT01270841|12293223|FG002|Overall Study|Protocol Violation|0
7823525|NCT01270841|12293224|FG003|Overall Study|Protocol Violation|0
7823526|NCT01270841|12293221|FG000|Overall Study|Enrolled in error|0
7823527|NCT01270841|12293222|FG001|Overall Study|Enrolled in error|1
7823528|NCT01270841|12293223|FG002|Overall Study|Enrolled in error|0
7823529|NCT01270841|12293224|FG003|Overall Study|Enrolled in error|0
7823530|NCT01270880|12293243|FG000|Overall Study|Never rec'd treatment, but registered.|1
7823531|NCT01270958|12293247|FG000|Overall Study|Lost to Follow-up|2
7823532|NCT01270958|12293247|FG000|Overall Study|Did not meet inclusion criteria for age|2
7823533|NCT01270971|12293253|FG000|Overall Study|Withdrawal by Subject|24
7823534|NCT01270971|12293254|FG001|Overall Study|Withdrawal by Subject|11
7823535|NCT01270971|12293253|FG000|Overall Study|Lost to Follow-up|18
7823536|NCT01270971|12293254|FG001|Overall Study|Lost to Follow-up|5
7823537|NCT01270971|12293253|FG000|Overall Study|Adverse Event|1
7823538|NCT01270971|12293254|FG001|Overall Study|Adverse Event|2
7823539|NCT01270971|12293253|FG000|Overall Study|Non compliance|2
7823540|NCT01270971|12293254|FG001|Overall Study|Non compliance|2
7823541|NCT01270971|12293253|FG000|Overall Study|Non-specific|7
7823542|NCT01270971|12293254|FG001|Overall Study|Non-specific|3
7823543|NCT01271010|12293260|FG000|Overall Study|Reason not specified|11
7823544|NCT01271010|12293260|FG000|Overall Study|Start of new CLL therapy|1
7823545|NCT01271010|12293260|FG000|Overall Study|Protocol Violation|1
7823546|NCT01271010|12293260|FG000|Overall Study|Death|2
7823547|NCT01271010|12293260|FG000|Overall Study|Progression and relapse of disease|1
7823548|NCT01271010|12293260|FG000|Overall Study|Withdrawal by Subject|18
7823549|NCT01271010|12293260|FG000|Overall Study|Disease progression|27
7823550|NCT01271504|12293304|FG000|Overall Study|Death|7
7823551|NCT01271504|12293305|FG001|Overall Study|Death|6
7823552|NCT01271504|12293306|FG002|Overall Study|Death|32
7823553|NCT01271504|12293307|FG003|Overall Study|Death|32
7823554|NCT01271504|12293304|FG000|Overall Study|Lost to Follow-up|0
7823555|NCT01271504|12293305|FG001|Overall Study|Lost to Follow-up|1
7823556|NCT01271504|12293306|FG002|Overall Study|Lost to Follow-up|3
7823557|NCT01271504|12293307|FG003|Overall Study|Lost to Follow-up|1
7823558|NCT01271504|12293304|FG000|Overall Study|Protocol Violation|0
7823559|NCT01271504|12293305|FG001|Overall Study|Protocol Violation|0
7823560|NCT01271504|12293306|FG002|Overall Study|Protocol Violation|0
7823561|NCT01271504|12293307|FG003|Overall Study|Protocol Violation|2
7823562|NCT01271504|12293304|FG000|Overall Study|Administrative Reasons|0
7823563|NCT01271504|12293305|FG001|Overall Study|Administrative Reasons|0
7823564|NCT01271504|12293306|FG002|Overall Study|Administrative Reasons|6
7823565|NCT01271504|12293307|FG003|Overall Study|Administrative Reasons|5
7823566|NCT01271504|12293304|FG000|Overall Study|Withdrawal by Subject|0
7823567|NCT01271504|12293305|FG001|Overall Study|Withdrawal by Subject|0
7823568|NCT01271504|12293306|FG002|Overall Study|Withdrawal by Subject|1
7823569|NCT01271504|12293307|FG003|Overall Study|Withdrawal by Subject|3
7823570|NCT01271504|12293304|FG000|Overall Study|Other|0
7823571|NCT01271504|12293305|FG001|Overall Study|Other|1
7823572|NCT01271504|12293306|FG002|Overall Study|Other|2
7823573|NCT01271504|12293307|FG003|Overall Study|Other|0
7823574|NCT01271712|12293343|FG000|Double Blind Treatment|Death|2
7823575|NCT01271712|12293344|FG001|Double Blind Treatment|Death|0
7823576|NCT01271712|12293343|FG000|Double Blind Treatment|Lack of Efficacy|1
7823577|NCT01271712|12293344|FG001|Double Blind Treatment|Lack of Efficacy|0
7823578|NCT01271712|12293343|FG000|Double Blind Treatment|Adverse Event|9
7823579|NCT01271712|12293344|FG001|Double Blind Treatment|Adverse Event|4
7823580|NCT01271712|12293343|FG000|Double Blind Treatment|Progressive disease|23
7823581|NCT01271712|12293344|FG001|Double Blind Treatment|Progressive disease|3
7823582|NCT01271712|12293343|FG000|Double Blind Treatment|Withdrawal by Subject|4
7823583|NCT01271712|12293344|FG001|Double Blind Treatment|Withdrawal by Subject|1
7823584|NCT01271712|12293343|FG000|Double Blind Treatment|Non compliance with study drug|2
7823585|NCT01271712|12293344|FG001|Double Blind Treatment|Non compliance with study drug|0
7823586|NCT01271712|12293343|FG000|Double Blind Treatment|receive no study drug|1
7823587|NCT01271712|12293344|FG001|Double Blind Treatment|receive no study drug|0
7823588|NCT01271712|12293343|FG000|Open Label Treatment|Death|6
7823589|NCT01271712|12293344|FG001|Open Label Treatment|Death|5
7823590|NCT01271712|12293343|FG000|Open Label Treatment|Withdrawal by Subject|6
7823591|NCT01271712|12293344|FG001|Open Label Treatment|Withdrawal by Subject|11
7823592|NCT01271712|12293343|FG000|Open Label Treatment|Physician Decision|2
7823593|NCT01271712|12293344|FG001|Open Label Treatment|Physician Decision|0
7823594|NCT01271712|12293343|FG000|Open Label Treatment|Adverse Event|14
7823595|NCT01271712|12293344|FG001|Open Label Treatment|Adverse Event|8
7823596|NCT01271712|12293343|FG000|Open Label Treatment|Progressive disease|59
7823597|NCT01271712|12293344|FG001|Open Label Treatment|Progressive disease|32
7823598|NCT01271712|12293343|FG000|Open Label Treatment|transferred to rollover study|1
7823599|NCT01271712|12293344|FG001|Open Label Treatment|transferred to rollover study|0
7823600|NCT01271712|12293343|FG000|Open Label Treatment|Non-compliance with study drug|1
7823601|NCT01271712|12293344|FG001|Open Label Treatment|Non-compliance with study drug|0
7823602|NCT01271712|12293343|FG000|Open Label Treatment|Protocol Violation|0
7823603|NCT01271712|12293344|FG001|Open Label Treatment|Protocol Violation|1
7823604|NCT01271712|12293343|FG000|Open Label Treatment|Switching to other therapy|2
7823605|NCT01271712|12293344|FG001|Open Label Treatment|Switching to other therapy|1
7823606|NCT01271712|12293343|FG000|Safety Follow-up|Death|11
7823607|NCT01271712|12293344|FG001|Safety Follow-up|Death|7
7823608|NCT01271712|12293343|FG000|Safety Follow-up|Withdrawal by Subject|4
7823609|NCT01271712|12293344|FG001|Safety Follow-up|Withdrawal by Subject|2
7823610|NCT01271712|12293343|FG000|Safety Follow-up|Protocol Violation|1
7823611|NCT01271712|12293344|FG001|Safety Follow-up|Protocol Violation|1
7823612|NCT01271712|12293343|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3
7823613|NCT01271712|12293344|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4
7823614|NCT01271712|12293343|FG000|Safety Follow-up|No follow-up|1
7823615|NCT01271712|12293344|FG001|Safety Follow-up|No follow-up|1
7823616|NCT01271712|12293343|FG000|Safety Follow-up|Progressive disease|1
7823617|NCT01271712|12293344|FG001|Safety Follow-up|Progressive disease|0
7823618|NCT01271712|12293343|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15
7823619|NCT01271712|12293344|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6
7823620|NCT01271725|12293353|FG000|Part A|Progressive disease according to RECIST|8
7823621|NCT01271725|12293354|FG001|Part A|Progressive disease according to RECIST|0
7823622|NCT01271725|12293353|FG000|Part A|Clinical signs/symptoms of progression|2
7823623|NCT01271725|12293354|FG001|Part A|Clinical signs/symptoms of progression|0
7823624|NCT01271725|12293353|FG000|Part A|Other Adverse Event|8
7823625|NCT01271725|12293354|FG001|Part A|Other Adverse Event|0
7823626|NCT01271725|12293353|FG000|Part A|Lost to Follow-up|1
7823627|NCT01271725|12293354|FG001|Part A|Lost to Follow-up|0
7823628|NCT01271725|12293353|FG000|Part A|Withdrawal by Subject|12
7823629|NCT01271725|12293354|FG001|Part A|Withdrawal by Subject|0
7823630|NCT01271725|12293353|FG000|Part A|Other than specified|3
7823631|NCT01271725|12293354|FG001|Part A|Other than specified|0
7823632|NCT01271725|12293353|FG000|Part A|Protocol Violation|1
7823633|NCT01271725|12293354|FG001|Part A|Protocol Violation|0
7823634|NCT01271725|12293353|FG000|Part B|Other than specified|0
7823635|NCT01271725|12293354|FG001|Part B|Other than specified|2
7823636|NCT01271725|12293353|FG000|Part B|Clinical signs/symptoms of progression|0
7823637|NCT01271725|12293354|FG001|Part B|Clinical signs/symptoms of progression|2
7823638|NCT01271725|12293353|FG000|Part B|Other Adverse Event|0
7823639|NCT01271725|12293354|FG001|Part B|Other Adverse Event|1
7823640|NCT01271725|12293353|FG000|Part B|Protocol Violation|0
7823641|NCT01271725|12293354|FG001|Part B|Protocol Violation|1
7823642|NCT01271725|12293353|FG000|Part B|Withdrawal by Subject|0
7823643|NCT01271725|12293354|FG001|Part B|Withdrawal by Subject|6
7823644|NCT01271803|12293366|FG000|Overall Study|Progressive disease|0
7823645|NCT01271803|12293367|FG001|Overall Study|Progressive disease|0
7823646|NCT01271803|12293368|FG002|Overall Study|Progressive disease|2
7823647|NCT01271803|12293366|FG000|Overall Study|Death|53
7823648|NCT01271803|12293367|FG001|Overall Study|Death|34
7823649|NCT01271803|12293368|FG002|Overall Study|Death|0
7823650|NCT01271803|12293366|FG000|Overall Study|Withdrawal by Subject|1
7823651|NCT01271803|12293367|FG001|Overall Study|Withdrawal by Subject|5
7823652|NCT01271803|12293368|FG002|Overall Study|Withdrawal by Subject|0
7823653|NCT01271803|12293366|FG000|Overall Study|Lost to Follow-up|1
7823654|NCT01271803|12293367|FG001|Overall Study|Lost to Follow-up|0
7823655|NCT01271803|12293368|FG002|Overall Study|Lost to Follow-up|0
7823656|NCT01271933|12293441|FG000|Single-Blind Phase|Lack of Efficacy|37
7823657|NCT01271933|12293442|FG001|Single-Blind Phase|Lack of Efficacy|0
7823658|NCT01271933|12293443|FG002|Single-Blind Phase|Lack of Efficacy|0
7823659|NCT01271933|12293441|FG000|Single-Blind Phase|Lost to Follow-up|10
7823660|NCT01271933|12293442|FG001|Single-Blind Phase|Lost to Follow-up|0
7823661|NCT01271933|12293443|FG002|Single-Blind Phase|Lost to Follow-up|0
7823662|NCT01271933|12293441|FG000|Single-Blind Phase|Withdrawal by Subject|15
7823663|NCT01271933|12293442|FG001|Single-Blind Phase|Withdrawal by Subject|0
7823664|NCT01271933|12293443|FG002|Single-Blind Phase|Withdrawal by Subject|0
7823665|NCT01271933|12293441|FG000|Single-Blind Phase|Protocol Violation|3
7823666|NCT01271933|12293442|FG001|Single-Blind Phase|Protocol Violation|0
7823667|NCT01271933|12293443|FG002|Single-Blind Phase|Protocol Violation|0
7823668|NCT01271933|12293441|FG000|Single-Blind Phase|Adverse Event|52
7823669|NCT01271933|12293442|FG001|Single-Blind Phase|Adverse Event|0
7823670|NCT01271933|12293443|FG002|Single-Blind Phase|Adverse Event|0
7823671|NCT01271933|12293441|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1
7823672|NCT01271933|12293442|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0
7823673|NCT01271933|12293443|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0
7823674|NCT01271933|12293441|FG000|Single-Blind Phase|(Protocol non-compliance)|2
7823675|NCT01271933|12293442|FG001|Single-Blind Phase|(Protocol non-compliance)|0
7823676|NCT01271933|12293443|FG002|Single-Blind Phase|(Protocol non-compliance)|0
7823677|NCT01271933|12293441|FG000|Single-Blind Phase|(Participant request-personal reason)|1
7823678|NCT01271933|12293442|FG001|Single-Blind Phase|(Participant request-personal reason)|0
7823679|NCT01271933|12293443|FG002|Single-Blind Phase|(Participant request-personal reason)|0
7823680|NCT01271933|12293441|FG000|Double-Blind Phase|Randomized but not treated|0
7823681|NCT01271933|12293442|FG001|Double-Blind Phase|Randomized but not treated|0
7823682|NCT01271933|12293443|FG002|Double-Blind Phase|Randomized but not treated|1
7823683|NCT01271933|12293441|FG000|Double-Blind Phase|Lack of Efficacy|0
7823684|NCT01271933|12293442|FG001|Double-Blind Phase|Lack of Efficacy|6
7823685|NCT01271933|12293443|FG002|Double-Blind Phase|Lack of Efficacy|9
7823686|NCT01271933|12293441|FG000|Double-Blind Phase|Lost to Follow-up|0
7823687|NCT01271933|12293442|FG001|Double-Blind Phase|Lost to Follow-up|1
7823688|NCT01271933|12293443|FG002|Double-Blind Phase|Lost to Follow-up|1
7823689|NCT01271933|12293441|FG000|Double-Blind Phase|Withdrawal by Subject|0
7823690|NCT01271933|12293442|FG001|Double-Blind Phase|Withdrawal by Subject|6
7823691|NCT01271933|12293443|FG002|Double-Blind Phase|Withdrawal by Subject|1
7823692|NCT01271933|12293441|FG000|Double-Blind Phase|Adverse Event|0
7823693|NCT01271933|12293442|FG001|Double-Blind Phase|Adverse Event|3
7823694|NCT01271933|12293443|FG002|Double-Blind Phase|Adverse Event|0
7823695|NCT01271933|12293441|FG000|Double-Blind Phase|Participant request-personal reason|0
7823696|NCT01271933|12293442|FG001|Double-Blind Phase|Participant request-personal reason|1
7823697|NCT01271933|12293443|FG002|Double-Blind Phase|Participant request-personal reason|0
7823698|NCT01272011|12293479|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0
7823699|NCT01272011|12293480|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2
7823700|NCT01272011|12293481|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0
7823701|NCT01272180|12293497|FG000|Overall Study|Adverse Event|0
7823702|NCT01272180|12293498|FG001|Overall Study|Adverse Event|0
7823703|NCT01272180|12293499|FG002|Overall Study|Adverse Event|1
7823704|NCT01272180|12293500|FG003|Overall Study|Adverse Event|0
7823705|NCT01272180|12293497|FG000|Overall Study|Withdrawal by Subject|2
7823706|NCT01272180|12293498|FG001|Overall Study|Withdrawal by Subject|6
7823707|NCT01272180|12293499|FG002|Overall Study|Withdrawal by Subject|3
7823708|NCT01272180|12293500|FG003|Overall Study|Withdrawal by Subject|2
7823709|NCT01272180|12293497|FG000|Overall Study|Lost to Follow-up|15
7823710|NCT01272180|12293498|FG001|Overall Study|Lost to Follow-up|14
7823711|NCT01272180|12293499|FG002|Overall Study|Lost to Follow-up|8
7823712|NCT01272180|12293500|FG003|Overall Study|Lost to Follow-up|10
7823713|NCT01272180|12293497|FG000|Overall Study|Inappropriate enrollment|0
7823714|NCT01272180|12293498|FG001|Overall Study|Inappropriate enrollment|0
7823715|NCT01272180|12293499|FG002|Overall Study|Inappropriate enrollment|1
7823716|NCT01272180|12293500|FG003|Overall Study|Inappropriate enrollment|1
7823717|NCT01272180|12293497|FG000|Overall Study|Protocol Violation|0
7823718|NCT01272180|12293498|FG001|Overall Study|Protocol Violation|1
7823719|NCT01272180|12293499|FG002|Overall Study|Protocol Violation|0
7823720|NCT01272180|12293500|FG003|Overall Study|Protocol Violation|1
7823721|NCT01272193|12293516|FG000|Overall Study|Adverse Event|1
7823722|NCT01272193|12293517|FG001|Overall Study|Adverse Event|1
7823723|NCT01272193|12293516|FG000|Overall Study|Lack of Efficacy|0
7823724|NCT01272193|12293517|FG001|Overall Study|Lack of Efficacy|3
7823725|NCT01272193|12293516|FG000|Overall Study|Withdrawal Criteria|1
7823726|NCT01272193|12293517|FG001|Overall Study|Withdrawal Criteria|1
7823727|NCT01272193|12293516|FG000|Overall Study|Unclassified|8
7823728|NCT01272193|12293517|FG001|Overall Study|Unclassified|7
7823729|NCT01272219|12293527|FG000|Main Period: Week 0 to Week 56|Adverse Event|86
7823730|NCT01272219|12293528|FG001|Main Period: Week 0 to Week 56|Adverse Event|0
7823731|NCT01272219|12293529|FG002|Main Period: Week 0 to Week 56|Adverse Event|0
7823732|NCT01272219|12293530|FG003|Main Period: Week 0 to Week 56|Adverse Event|16
7823733|NCT01272219|12293531|FG004|Main Period: Week 0 to Week 56|Adverse Event|152
7823734|NCT01272219|12293532|FG005|Main Period: Week 0 to Week 56|Adverse Event|29
7823735|NCT01272219|12293527|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11
7823736|NCT01272219|12293528|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0
7823737|NCT01272219|12293529|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0
7948121|NCT02525133|12493236|FG001|Overall Study|did not meet randomization criteria|0
7823738|NCT01272219|12293530|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14
7823739|NCT01272219|12293531|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12
7823740|NCT01272219|12293532|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22
7823741|NCT01272219|12293527|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25
7823742|NCT01272219|12293528|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0
7823743|NCT01272219|12293529|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0
7823744|NCT01272219|12293530|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18
7823745|NCT01272219|12293531|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40
7823746|NCT01272219|12293532|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20
7823747|NCT01272219|12293527|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122
7823748|NCT01272219|12293528|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0
7823749|NCT01272219|12293529|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0
7823750|NCT01272219|12293530|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114
7823751|NCT01272219|12293531|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172
7823752|NCT01272219|12293532|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147
7823753|NCT01272219|12293527|FG000|Main Period: Week 0 to Week 56|Unclassified|36
7823754|NCT01272219|12293528|FG001|Main Period: Week 0 to Week 56|Unclassified|0
7823755|NCT01272219|12293529|FG002|Main Period: Week 0 to Week 56|Unclassified|0
7823756|NCT01272219|12293530|FG003|Main Period: Week 0 to Week 56|Unclassified|29
7823757|NCT01272219|12293531|FG004|Main Period: Week 0 to Week 56|Unclassified|42
7823758|NCT01272219|12293532|FG005|Main Period: Week 0 to Week 56|Unclassified|34
7823759|NCT01272219|12293527|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
7823760|NCT01272219|12293528|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
7823761|NCT01272219|12293529|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
7823762|NCT01272219|12293530|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
7823763|NCT01272219|12293531|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
7823764|NCT01272219|12293532|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
7823765|NCT01272219|12293527|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
7823766|NCT01272219|12293528|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
7823767|NCT01272219|12293529|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
7823768|NCT01272219|12293530|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
7823769|NCT01272219|12293531|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
7823770|NCT01272219|12293532|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
7823771|NCT01272219|12293527|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
7823772|NCT01272219|12293528|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
7823773|NCT01272219|12293529|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
7823774|NCT01272219|12293530|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
7823775|NCT01272219|12293531|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
7823776|NCT01272219|12293532|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
7823777|NCT01272219|12293527|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
7823778|NCT01272219|12293528|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
7948122|NCT02525133|12493235|FG000|Overall Study|Lost to Follow-up|5
7823779|NCT01272219|12293529|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
7823780|NCT01272219|12293530|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
7823781|NCT01272219|12293531|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
7823782|NCT01272219|12293532|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
7823783|NCT01272219|12293527|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0
7823784|NCT01272219|12293528|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1
7823785|NCT01272219|12293529|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2
7823786|NCT01272219|12293530|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2
7823787|NCT01272219|12293531|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0
7823788|NCT01272219|12293532|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0
7823789|NCT01272219|12293527|FG000|Main + Extension Period: Week 0-172|Adverse Event|0
7823790|NCT01272219|12293528|FG001|Main + Extension Period: Week 0-172|Adverse Event|0
7823791|NCT01272219|12293529|FG002|Main + Extension Period: Week 0-172|Adverse Event|0
7823792|NCT01272219|12293530|FG003|Main + Extension Period: Week 0-172|Adverse Event|0
7823793|NCT01272219|12293531|FG004|Main + Extension Period: Week 0-172|Adverse Event|191
7823794|NCT01272219|12293532|FG005|Main + Extension Period: Week 0-172|Adverse Event|43
7823795|NCT01272219|12293527|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0
7823796|NCT01272219|12293528|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0
7823797|NCT01272219|12293529|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0
7823798|NCT01272219|12293530|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0
7823799|NCT01272219|12293531|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29
7823800|NCT01272219|12293532|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36
7823801|NCT01272219|12293527|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0
7823802|NCT01272219|12293528|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0
7823803|NCT01272219|12293529|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0
7823804|NCT01272219|12293530|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0
7823805|NCT01272219|12293531|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76
7823806|NCT01272219|12293532|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36
7823807|NCT01272219|12293527|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0
7823808|NCT01272219|12293528|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0
7823809|NCT01272219|12293529|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0
7823810|NCT01272219|12293530|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0
7823811|NCT01272219|12293531|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364
7823812|NCT01272219|12293532|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256
7823813|NCT01272219|12293527|FG000|Main + Extension Period: Week 0-172|Missing reason|0
7823814|NCT01272219|12293528|FG001|Main + Extension Period: Week 0-172|Missing reason|0
7823815|NCT01272219|12293529|FG002|Main + Extension Period: Week 0-172|Missing reason|0
7823816|NCT01272219|12293530|FG003|Main + Extension Period: Week 0-172|Missing reason|0
7823817|NCT01272219|12293531|FG004|Main + Extension Period: Week 0-172|Missing reason|1
7823818|NCT01272219|12293532|FG005|Main + Extension Period: Week 0-172|Missing reason|0
7823819|NCT01272219|12293527|FG000|Main + Extension Period: Week 0-172|Unclassified|0
7823820|NCT01272219|12293528|FG001|Main + Extension Period: Week 0-172|Unclassified|0
7823821|NCT01272219|12293529|FG002|Main + Extension Period: Week 0-172|Unclassified|0
7823822|NCT01272219|12293530|FG003|Main + Extension Period: Week 0-172|Unclassified|0
7823823|NCT01272219|12293531|FG004|Main + Extension Period: Week 0-172|Unclassified|61
7823824|NCT01272219|12293532|FG005|Main + Extension Period: Week 0-172|Unclassified|51
7823825|NCT01272232|12293548|FG000|Weeks 0-56|Adverse Event|39
7823826|NCT01272232|12293549|FG001|Weeks 0-56|Adverse Event|18
7823827|NCT01272232|12293550|FG002|Weeks 0-56|Adverse Event|7
7823828|NCT01272232|12293548|FG000|Weeks 0-56|Lack of Efficacy|0
7823829|NCT01272232|12293549|FG001|Weeks 0-56|Lack of Efficacy|0
7823830|NCT01272232|12293550|FG002|Weeks 0-56|Lack of Efficacy|3
7823831|NCT01272232|12293548|FG000|Weeks 0-56|Protocol Violation|12
7823832|NCT01272232|12293549|FG001|Weeks 0-56|Protocol Violation|8
7823833|NCT01272232|12293550|FG002|Weeks 0-56|Protocol Violation|13
7823834|NCT01272232|12293548|FG000|Weeks 0-56|Withdrawal criteria|32
7823835|NCT01272232|12293549|FG001|Weeks 0-56|Withdrawal criteria|14
7823836|NCT01272232|12293550|FG002|Weeks 0-56|Withdrawal criteria|37
7823837|NCT01272232|12293548|FG000|Weeks 0-56|Unclassified|16
7823838|NCT01272232|12293549|FG001|Weeks 0-56|Unclassified|7
7823839|NCT01272232|12293550|FG002|Weeks 0-56|Unclassified|12
7823840|NCT01272232|12293548|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
7823841|NCT01272232|12293549|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
7823842|NCT01272232|12293550|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
7823843|NCT01272232|12293548|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
7823844|NCT01272232|12293549|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
7823845|NCT01272232|12293550|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
7823846|NCT01272232|12293548|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
7823847|NCT01272232|12293549|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
7823848|NCT01272232|12293550|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
7823849|NCT01272232|12293548|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
7823850|NCT01272232|12293549|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
7823851|NCT01272232|12293550|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
7823852|NCT01272232|12293548|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
7823853|NCT01272232|12293549|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
7823854|NCT01272232|12293550|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
7823855|NCT01272635|12293589|FG000|Overall Study|Lost to Follow-up|31
7823856|NCT01272635|12293590|FG001|Overall Study|Lost to Follow-up|20
7823857|NCT01272635|12293591|FG002|Overall Study|Lost to Follow-up|31
7823858|NCT01272635|12293592|FG003|Overall Study|Lost to Follow-up|23
7823859|NCT01272661|12293603|FG000|Overall Study|lost to followup/case closed/ no birth|126
7823860|NCT01272661|12293604|FG001|Overall Study|lost to followup/case closed/ no birth|209
7823861|NCT01272661|12293605|FG002|Overall Study|lost to followup/case closed/ no birth|72
7823862|NCT01272804|12293619|FG000|Overall Study|Adverse Event|1
7823863|NCT01272804|12293620|FG001|Overall Study|Adverse Event|0
7823864|NCT01272804|12293621|FG002|Overall Study|Adverse Event|0
7823865|NCT01272804|12293622|FG003|Overall Study|Adverse Event|0
7823866|NCT01272804|12293623|FG004|Overall Study|Adverse Event|2
7823867|NCT01272804|12293624|FG005|Overall Study|Adverse Event|1
7823868|NCT01272869|12293649|FG000|Period 2 (14 Days)|Adverse Event|1
7823869|NCT01272869|12293650|FG001|Period 2 (14 Days)|Adverse Event|0
7823870|NCT01272908|12293660|FG000|Initial Treatment Period|Adverse Event|1
7823871|NCT01272908|12293660|FG000|Initial Treatment Period|Lack of Efficacy|5
7823872|NCT01272908|12293660|FG000|Initial Treatment Period|Protocol Violation|1
7823873|NCT01272908|12293660|FG000|Initial Treatment Period|Withdrawal by Subject|1
7823874|NCT01272908|12293660|FG000|Re-Treatment Period|Adverse Event|2
7823875|NCT01272908|12293660|FG000|Re-Treatment Period|Lack of Efficacy|3
7823876|NCT01272908|12293660|FG000|Re-Treatment Period|Withdrawal by Subject|1
7862174|NCT01597245|12351201|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862175|NCT01597245|12351202|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
7862176|NCT01597245|12351203|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
7862177|NCT01597245|12351204|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862178|NCT01597245|12351205|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862179|NCT01597245|12351206|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862180|NCT01597245|12351207|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862181|NCT01597245|12351208|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7862182|NCT01597245|12351188|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862183|NCT01597245|12351189|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862184|NCT01597245|12351190|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862185|NCT01597245|12351191|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862186|NCT01597245|12351192|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862187|NCT01597245|12351193|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862188|NCT01597245|12351194|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862189|NCT01597245|12351195|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862190|NCT01597245|12351196|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862191|NCT01597245|12351197|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862192|NCT01597245|12351198|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862193|NCT01597245|12351199|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862194|NCT01597245|12351200|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862195|NCT01597245|12351201|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862196|NCT01597245|12351202|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
7862197|NCT01597245|12351203|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
7823877|NCT01272921|12293668|FG000|Overall Study|Protocol Violation|2
7823878|NCT01272921|12293669|FG001|Overall Study|Protocol Violation|1
7823879|NCT01272934|12293679|FG000|Overall Study|Adverse Event|0
7823880|NCT01272934|12293680|FG001|Overall Study|Adverse Event|1
7823881|NCT01272934|12293679|FG000|Overall Study|Abnormal Laboratory Value|0
7823882|NCT01272934|12293680|FG001|Overall Study|Abnormal Laboratory Value|1
7823883|NCT01272947|12293689|FG000|Overall Study|Abnormal Laboratory Value|2
7823884|NCT01272947|12293690|FG001|Overall Study|Abnormal Laboratory Value|2
7823885|NCT01273038|12293719|FG000|Second Intervention (14 Days)|Adverse Event|0
7823886|NCT01273038|12293720|FG001|Second Intervention (14 Days)|Adverse Event|1
7823887|NCT01273038|12293719|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
7823888|NCT01273038|12293720|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
7823889|NCT01273155|12293730|FG000|Overall Study|Off study trmt prior to end of C1/PD|2
7823890|NCT01273155|12293731|FG001|Overall Study|Off study trmt prior to end of C1/PD|3
7823891|NCT01273155|12293732|FG002|Overall Study|Off study trmt prior to end of C1/PD|8
7823892|NCT01273155|12293733|FG003|Overall Study|Off study trmt prior to end of C1/PD|0
7823893|NCT01273155|12293734|FG004|Overall Study|Off study trmt prior to end of C1/PD|0
7823894|NCT01273155|12293735|FG005|Overall Study|Off study trmt prior to end of C1/PD|2
7823895|NCT01273155|12293736|FG006|Overall Study|Off study trmt prior to end of C1/PD|3
7823896|NCT01273155|12293730|FG000|Overall Study|Change in liver function/no longer eval.|0
7823897|NCT01273155|12293731|FG001|Overall Study|Change in liver function/no longer eval.|1
7823898|NCT01273155|12293732|FG002|Overall Study|Change in liver function/no longer eval.|0
7823899|NCT01273155|12293733|FG003|Overall Study|Change in liver function/no longer eval.|0
7823900|NCT01273155|12293734|FG004|Overall Study|Change in liver function/no longer eval.|1
7823901|NCT01273155|12293735|FG005|Overall Study|Change in liver function/no longer eval.|0
7823902|NCT01273155|12293736|FG006|Overall Study|Change in liver function/no longer eval.|0
7823903|NCT01273155|12293730|FG000|Overall Study|Off study prior to C1/due to toxicity|0
7823904|NCT01273155|12293731|FG001|Overall Study|Off study prior to C1/due to toxicity|0
7823905|NCT01273155|12293732|FG002|Overall Study|Off study prior to C1/due to toxicity|2
7823906|NCT01273155|12293733|FG003|Overall Study|Off study prior to C1/due to toxicity|0
7823907|NCT01273155|12293734|FG004|Overall Study|Off study prior to C1/due to toxicity|0
7823908|NCT01273155|12293735|FG005|Overall Study|Off study prior to C1/due to toxicity|0
7823909|NCT01273155|12293736|FG006|Overall Study|Off study prior to C1/due to toxicity|1
7823910|NCT01273155|12293730|FG000|Overall Study|Died during Cycle 1|0
7823911|NCT01273155|12293731|FG001|Overall Study|Died during Cycle 1|0
7823912|NCT01273155|12293732|FG002|Overall Study|Died during Cycle 1|1
7823913|NCT01273155|12293733|FG003|Overall Study|Died during Cycle 1|1
7823914|NCT01273155|12293734|FG004|Overall Study|Died during Cycle 1|0
7823915|NCT01273155|12293735|FG005|Overall Study|Died during Cycle 1|2
7823916|NCT01273155|12293736|FG006|Overall Study|Died during Cycle 1|2
7823917|NCT01273155|12293730|FG000|Overall Study|Withdrew during C1/refused further trmt|0
7823918|NCT01273155|12293731|FG001|Overall Study|Withdrew during C1/refused further trmt|0
7823919|NCT01273155|12293732|FG002|Overall Study|Withdrew during C1/refused further trmt|1
7823920|NCT01273155|12293733|FG003|Overall Study|Withdrew during C1/refused further trmt|0
7823921|NCT01273155|12293734|FG004|Overall Study|Withdrew during C1/refused further trmt|1
7823922|NCT01273155|12293735|FG005|Overall Study|Withdrew during C1/refused further trmt|1
7823923|NCT01273155|12293736|FG006|Overall Study|Withdrew during C1/refused further trmt|0
7823924|NCT01273181|12293763|FG000|Phase I, Dose 1|Study termination|1
7719972|NCT00535496|12144045|FG001|Overall Study|Not treated with sugammadex|1
7719973|NCT00535496|12144046|FG002|Overall Study|Not treated with sugammadex|0
7719974|NCT00535496|12144047|FG003|Overall Study|Not treated with sugammadex|0
7719975|NCT00535626|12144078|FG000|Overall Study|Death|15
7719976|NCT00535626|12144078|FG000|Overall Study|Lost to Follow-up|29
7719977|NCT00535626|12144078|FG000|Overall Study|Withdrawal by Subject|20
7719978|NCT00535626|12144078|FG000|Overall Study|Removal/revision of study component|8
7719979|NCT00535626|12144078|FG000|Overall Study|Subject terminated|31
7719980|NCT00535626|12144078|FG000|Overall Study|Unable to return|2
7719981|NCT00535730|12144089|FG000|Overall Study|Adverse Event|1
7719982|NCT00535730|12144090|FG001|Overall Study|Adverse Event|1
7719983|NCT00535730|12144089|FG000|Overall Study|Lost to Follow-up|0
7719984|NCT00535730|12144090|FG001|Overall Study|Lost to Follow-up|1
7823925|NCT01273181|12293764|FG001|Phase I, Dose 1|Study termination|0
7823926|NCT01273181|12293765|FG002|Phase I, Dose 1|Study termination|0
7823927|NCT01273181|12293766|FG003|Phase I, Dose 1|Study termination|0
7823928|NCT01273181|12293763|FG000|Phase I, Dose 2|Death during treatment|0
7823929|NCT01273181|12293764|FG001|Phase I, Dose 2|Death during treatment|1
7823930|NCT01273181|12293765|FG002|Phase I, Dose 2|Death during treatment|0
7823931|NCT01273181|12293766|FG003|Phase I, Dose 2|Death during treatment|0
7823932|NCT01273181|12293763|FG000|Phase 2, Dose 1|Study termination|0
7823933|NCT01273181|12293764|FG001|Phase 2, Dose 1|Study termination|0
7823934|NCT01273181|12293765|FG002|Phase 2, Dose 1|Study termination|1
7823935|NCT01273181|12293766|FG003|Phase 2, Dose 1|Study termination|0
7823936|NCT01273181|12293763|FG000|Phase 2, Dose 2|Death during treatment|0
7823937|NCT01273181|12293764|FG001|Phase 2, Dose 2|Death during treatment|0
7823938|NCT01273181|12293765|FG002|Phase 2, Dose 2|Death during treatment|0
7823939|NCT01273181|12293766|FG003|Phase 2, Dose 2|Death during treatment|1
7823940|NCT01273519|12293787|FG000|Overall Study|Adverse Event|3
7823941|NCT01273519|12293788|FG001|Overall Study|Adverse Event|0
7823942|NCT01273519|12293789|FG002|Overall Study|Adverse Event|0
7823943|NCT01273519|12293787|FG000|Overall Study|Lost to Follow-up|2
7823944|NCT01273519|12293788|FG001|Overall Study|Lost to Follow-up|1
7823945|NCT01273519|12293789|FG002|Overall Study|Lost to Follow-up|3
7823946|NCT01273519|12293787|FG000|Overall Study|Lack of Efficacy|8
7823947|NCT01273519|12293788|FG001|Overall Study|Lack of Efficacy|3
7823948|NCT01273519|12293789|FG002|Overall Study|Lack of Efficacy|4
7823949|NCT01273519|12293787|FG000|Overall Study|Other|6
7823950|NCT01273519|12293788|FG001|Overall Study|Other|1
7823951|NCT01273519|12293789|FG002|Overall Study|Other|1
7823952|NCT01273597|12293800|FG000|Overall Study|Adverse Event|5
7823953|NCT01273597|12293800|FG000|Overall Study|Underwent Kidney Transplantation|2
7823954|NCT01273597|12293800|FG000|Overall Study|Reason Not Reported|1
7823955|NCT01273623|12293804|FG000|Overall Study|did not meet IVUS criteria|29
7823956|NCT01273805|12293824|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10
7823957|NCT01273805|12293825|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10
7823958|NCT01273818|12293834|FG000|Overall Study|Physician Decision|13
7823959|NCT01273818|12293835|FG001|Overall Study|Physician Decision|2
7823960|NCT01273818|12293836|FG002|Overall Study|Physician Decision|9
7823961|NCT01273883|12293853|FG000|First Intervention|Adverse Event|2
7823962|NCT01273883|12293854|FG001|First Intervention|Adverse Event|1
7823963|NCT01273883|12293853|FG000|Second Intervention|Lost to Follow-up|1
7823964|NCT01273883|12293854|FG001|Second Intervention|Lost to Follow-up|1
7823965|NCT01273883|12293853|FG000|Second Intervention|Lack of Efficacy|1
7823966|NCT01273883|12293854|FG001|Second Intervention|Lack of Efficacy|0
7823967|NCT01274182|12293867|FG000|Overall Study|Unsatisfactory therapeutic effect|6
7823968|NCT01274182|12293868|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7823969|NCT01274182|12293869|FG002|Overall Study|Unsatisfactory therapeutic effect|4
7823970|NCT01274182|12293867|FG000|Overall Study|Adverse Event|4
7823971|NCT01274182|12293868|FG001|Overall Study|Adverse Event|5
7823972|NCT01274182|12293869|FG002|Overall Study|Adverse Event|3
7823973|NCT01274182|12293867|FG000|Overall Study|Withdrawal by Subject|5
7823974|NCT01274182|12293868|FG001|Overall Study|Withdrawal by Subject|5
7823975|NCT01274182|12293869|FG002|Overall Study|Withdrawal by Subject|3
7823976|NCT01274182|12293867|FG000|Overall Study|Lost to Follow-up|2
7823977|NCT01274182|12293868|FG001|Overall Study|Lost to Follow-up|3
7823978|NCT01274182|12293869|FG002|Overall Study|Lost to Follow-up|1
7823979|NCT01274182|12293867|FG000|Overall Study|Protocol Violation|3
7823980|NCT01274182|12293868|FG001|Overall Study|Protocol Violation|2
7823981|NCT01274182|12293869|FG002|Overall Study|Protocol Violation|0
7823982|NCT01274182|12293867|FG000|Overall Study|Death|1
7823983|NCT01274182|12293868|FG001|Overall Study|Death|0
7823984|NCT01274182|12293869|FG002|Overall Study|Death|1
7823985|NCT01274338|12293887|FG000|Overall Study|Lack of Efficacy|72
7823986|NCT01274338|12293888|FG001|Overall Study|Lack of Efficacy|108
7823987|NCT01274338|12293889|FG002|Overall Study|Lack of Efficacy|116
7823988|NCT01274338|12293890|FG003|Overall Study|Lack of Efficacy|0
7823989|NCT01274338|12293891|FG004|Overall Study|Lack of Efficacy|0
7823990|NCT01274338|12293892|FG005|Overall Study|Lack of Efficacy|0
7823991|NCT01274338|12293887|FG000|Overall Study|Adverse Event|272
7823992|NCT01274338|12293888|FG001|Overall Study|Adverse Event|105
7823993|NCT01274338|12293889|FG002|Overall Study|Adverse Event|180
7823994|NCT01274338|12293890|FG003|Overall Study|Adverse Event|1
7823995|NCT01274338|12293891|FG004|Overall Study|Adverse Event|0
7823996|NCT01274338|12293892|FG005|Overall Study|Adverse Event|0
7823997|NCT01274338|12293887|FG000|Overall Study|Death|8
7823998|NCT01274338|12293888|FG001|Overall Study|Death|1
7823999|NCT01274338|12293889|FG002|Overall Study|Death|0
7824000|NCT01274338|12293890|FG003|Overall Study|Death|0
7824001|NCT01274338|12293891|FG004|Overall Study|Death|0
7824002|NCT01274338|12293892|FG005|Overall Study|Death|0
7824003|NCT01274338|12293887|FG000|Overall Study|Withdrawal by Subject|27
7824004|NCT01274338|12293888|FG001|Overall Study|Withdrawal by Subject|99
7824005|NCT01274338|12293889|FG002|Overall Study|Withdrawal by Subject|17
7824006|NCT01274338|12293890|FG003|Overall Study|Withdrawal by Subject|0
7824007|NCT01274338|12293891|FG004|Overall Study|Withdrawal by Subject|0
7824008|NCT01274338|12293892|FG005|Overall Study|Withdrawal by Subject|0
7824009|NCT01274338|12293887|FG000|Overall Study|Did not start treatment|8
7824010|NCT01274338|12293888|FG001|Overall Study|Did not start treatment|116
7824011|NCT01274338|12293889|FG002|Overall Study|Did not start treatment|7
7824012|NCT01274338|12293890|FG003|Overall Study|Did not start treatment|0
7824013|NCT01274338|12293891|FG004|Overall Study|Did not start treatment|0
7824014|NCT01274338|12293892|FG005|Overall Study|Did not start treatment|0
7824015|NCT01274338|12293887|FG000|Overall Study|Alternative therapy|0
7824016|NCT01274338|12293888|FG001|Overall Study|Alternative therapy|1
7824017|NCT01274338|12293889|FG002|Overall Study|Alternative therapy|0
7824018|NCT01274338|12293890|FG003|Overall Study|Alternative therapy|0
7824019|NCT01274338|12293891|FG004|Overall Study|Alternative therapy|0
7824020|NCT01274338|12293892|FG005|Overall Study|Alternative therapy|0
7824021|NCT01274338|12293887|FG000|Overall Study|Other complicating diseases|0
7824022|NCT01274338|12293888|FG001|Overall Study|Other complicating diseases|3
7824023|NCT01274338|12293889|FG002|Overall Study|Other complicating diseases|1
7824024|NCT01274338|12293890|FG003|Overall Study|Other complicating diseases|0
7824025|NCT01274338|12293891|FG004|Overall Study|Other complicating diseases|0
7824026|NCT01274338|12293892|FG005|Overall Study|Other complicating diseases|0
7824027|NCT01274338|12293887|FG000|Overall Study|Treatment arm was suspended due to toxicity|4
7824028|NCT01274338|12293888|FG001|Overall Study|Treatment arm was suspended due to toxicity|0
7824029|NCT01274338|12293889|FG002|Overall Study|Treatment arm was suspended due to toxicity|0
7824030|NCT01274338|12293890|FG003|Overall Study|Treatment arm was suspended due to toxicity|0
7824031|NCT01274338|12293891|FG004|Overall Study|Treatment arm was suspended due to toxicity|0
7824032|NCT01274338|12293892|FG005|Overall Study|Treatment arm was suspended due to toxicity|0
7824033|NCT01274338|12293887|FG000|Overall Study|Pregnancy|0
7824034|NCT01274338|12293888|FG001|Overall Study|Pregnancy|0
7824035|NCT01274338|12293889|FG002|Overall Study|Pregnancy|1
7824036|NCT01274338|12293890|FG003|Overall Study|Pregnancy|0
7824037|NCT01274338|12293891|FG004|Overall Study|Pregnancy|0
7824038|NCT01274338|12293892|FG005|Overall Study|Pregnancy|0
7824039|NCT01274338|12293887|FG000|Overall Study|Reason not reported|12
7824040|NCT01274338|12293888|FG001|Overall Study|Reason not reported|21
7824041|NCT01274338|12293889|FG002|Overall Study|Reason not reported|3
7824042|NCT01274338|12293890|FG003|Overall Study|Reason not reported|0
7824043|NCT01274338|12293891|FG004|Overall Study|Reason not reported|1
7824044|NCT01274338|12293892|FG005|Overall Study|Reason not reported|0
7824045|NCT01274351|12293905|FG000|Overall Study|Lost to Follow-up|1
7824046|NCT01274351|12293905|FG000|Overall Study|patient not compliant with the protocol|1
7824047|NCT01274351|12293905|FG000|Overall Study|Pregnancy|1
7824048|NCT01274351|12293905|FG000|Overall Study|Death|2
7824049|NCT01274351|12293905|FG000|Overall Study|Withdrawal by Subject|3
7824050|NCT01274351|12293905|FG000|Overall Study|Adverse Event|8
7824051|NCT01274351|12293905|FG000|Overall Study|progression of disease|3
7824052|NCT01274351|12293905|FG000|Overall Study|hospitalization|1
7824053|NCT01274637|12293932|FG000|Overall Study|Withdrawal by Subject|0
7824054|NCT01274637|12293933|FG001|Overall Study|Withdrawal by Subject|1
7824055|NCT01274637|12293932|FG000|Overall Study|Lost to Follow-up|0
7824056|NCT01274637|12293933|FG001|Overall Study|Lost to Follow-up|1
7824057|NCT01274715|12293939|FG000|Overall Study|Lost to Follow-up|1
7824058|NCT01274715|12293939|FG000|Overall Study|After consent, met exclusion criteria.|1
7824059|NCT01274715|12293939|FG000|Overall Study|After consent, met exclusion criteria.|1
7824060|NCT01274715|12293939|FG000|Overall Study|After consent, met exclusion criteria.|1
7824061|NCT01275066|12293959|FG000|Overall Study|Withdrawal by Subject|0
7824062|NCT01275066|12293960|FG001|Overall Study|Withdrawal by Subject|0
7824063|NCT01275066|12293961|FG002|Overall Study|Withdrawal by Subject|1
7824064|NCT01275066|12293959|FG000|Overall Study|Not Diagnosed w/ Disease|1
7824065|NCT01275066|12293960|FG001|Overall Study|Not Diagnosed w/ Disease|0
7824066|NCT01275066|12293961|FG002|Overall Study|Not Diagnosed w/ Disease|0
7824067|NCT01275131|12293977|FG000|Period 1|Withdrawal by Subject|1
7824068|NCT01275131|12293978|FG001|Period 1|Withdrawal by Subject|0
7824069|NCT01275131|12293979|FG002|Period 1|Withdrawal by Subject|3
7824070|NCT01275131|12293980|FG003|Period 1|Withdrawal by Subject|2
7824071|NCT01275131|12293977|FG000|Period 1|Physician Decision|1
7824072|NCT01275131|12293978|FG001|Period 1|Physician Decision|0
7824073|NCT01275131|12293979|FG002|Period 1|Physician Decision|0
7824074|NCT01275131|12293980|FG003|Period 1|Physician Decision|0
7824075|NCT01275131|12293977|FG000|Period 2 (Crossover)|Adverse Event|0
7824076|NCT01275131|12293978|FG001|Period 2 (Crossover)|Adverse Event|1
7824077|NCT01275131|12293979|FG002|Period 2 (Crossover)|Adverse Event|0
7824078|NCT01275131|12293980|FG003|Period 2 (Crossover)|Adverse Event|0
7824079|NCT01275131|12293977|FG000|Period 2 (Crossover)|Withdrawal by Subject|1
7824080|NCT01275131|12293978|FG001|Period 2 (Crossover)|Withdrawal by Subject|0
7824081|NCT01275131|12293979|FG002|Period 2 (Crossover)|Withdrawal by Subject|1
7824082|NCT01275131|12293980|FG003|Period 2 (Crossover)|Withdrawal by Subject|2
7824083|NCT01275144|12293998|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1
7824084|NCT01275144|12293999|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0
7824085|NCT01275170|12294015|FG000|Part 1: Period 1|Equipment malfunction before study drug|1
7824086|NCT01275170|12294016|FG001|Part 1: Period 1|Equipment malfunction before study drug|0
7824087|NCT01275170|12294017|FG002|Part 1: Period 1|Equipment malfunction before study drug|0
7824088|NCT01275170|12294018|FG003|Part 1: Period 1|Equipment malfunction before study drug|0
7824089|NCT01275170|12294019|FG004|Part 1: Period 1|Equipment malfunction before study drug|0
7824090|NCT01275170|12294020|FG005|Part 1: Period 1|Equipment malfunction before study drug|0
7824091|NCT01275170|12294021|FG006|Part 1: Period 1|Equipment malfunction before study drug|0
7824092|NCT01275170|12294022|FG007|Part 1: Period 1|Equipment malfunction before study drug|0
7824093|NCT01275196|12294057|FG000|Overall Study|Adverse Event|3
7824094|NCT01275196|12294058|FG001|Overall Study|Adverse Event|5
7824095|NCT01275196|12294057|FG000|Overall Study|Withdrawal by Subject|4
7824096|NCT01275196|12294058|FG001|Overall Study|Withdrawal by Subject|5
7824097|NCT01275196|12294057|FG000|Overall Study|Lost to Follow-up|1
7824098|NCT01275196|12294058|FG001|Overall Study|Lost to Follow-up|0
7824099|NCT01275196|12294057|FG000|Overall Study|Disease Progression|6
7824100|NCT01275196|12294058|FG001|Overall Study|Disease Progression|5
7824101|NCT01275196|12294057|FG000|Overall Study|Protocol Violation|1
7824102|NCT01275196|12294058|FG001|Overall Study|Protocol Violation|0
7824103|NCT01275196|12294057|FG000|Overall Study|Suboptimal response/treatment failure|5
7824104|NCT01275196|12294058|FG001|Overall Study|Suboptimal response/treatment failure|6
7824105|NCT01275222|12294072|FG000|Phase l by Treatment|Adverse Event|1
7824106|NCT01275222|12294073|FG001|Phase l by Treatment|Adverse Event|4
7824107|NCT01275222|12294074|FG002|Phase l by Treatment|Adverse Event|2
7824108|NCT01275222|12294075|FG003|Phase l by Treatment|Adverse Event|3
7824109|NCT01275222|12294076|FG004|Phase l by Treatment|Adverse Event|0
7824110|NCT01275222|12294077|FG005|Phase l by Treatment|Adverse Event|0
7824111|NCT01275222|12294072|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0
7824112|NCT01275222|12294073|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0
7824113|NCT01275222|12294074|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1
7824114|NCT01275222|12294075|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0
7824115|NCT01275222|12294076|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0
7824116|NCT01275222|12294077|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0
7824117|NCT01275222|12294072|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0
7824118|NCT01275222|12294073|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0
7824119|NCT01275222|12294074|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0
7824120|NCT01275222|12294075|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1
7824121|NCT01275222|12294076|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0
7824122|NCT01275222|12294077|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0
7824123|NCT01275222|12294072|FG000|Phase l by Treatment|Disease progression|12
7824124|NCT01275222|12294073|FG001|Phase l by Treatment|Disease progression|8
7824125|NCT01275222|12294074|FG002|Phase l by Treatment|Disease progression|2
7824126|NCT01275222|12294075|FG003|Phase l by Treatment|Disease progression|5
7824127|NCT01275222|12294076|FG004|Phase l by Treatment|Disease progression|0
7824128|NCT01275222|12294077|FG005|Phase l by Treatment|Disease progression|0
7824129|NCT01275222|12294072|FG000|Phase l by Treatment|Withdrawal by Subject|0
7824130|NCT01275222|12294073|FG001|Phase l by Treatment|Withdrawal by Subject|0
7824131|NCT01275222|12294074|FG002|Phase l by Treatment|Withdrawal by Subject|0
7824132|NCT01275222|12294075|FG003|Phase l by Treatment|Withdrawal by Subject|1
7824133|NCT01275222|12294076|FG004|Phase l by Treatment|Withdrawal by Subject|0
7824134|NCT01275222|12294077|FG005|Phase l by Treatment|Withdrawal by Subject|0
7824135|NCT01275222|12294072|FG000|Phase l by Treatment|Death|0
7824136|NCT01275222|12294073|FG001|Phase l by Treatment|Death|1
7824137|NCT01275222|12294074|FG002|Phase l by Treatment|Death|0
7824138|NCT01275222|12294075|FG003|Phase l by Treatment|Death|1
7824139|NCT01275222|12294076|FG004|Phase l by Treatment|Death|0
7824140|NCT01275222|12294077|FG005|Phase l by Treatment|Death|0
7824141|NCT01275222|12294072|FG000|Phase ll by Stratum|Adverse Event|0
7824142|NCT01275222|12294073|FG001|Phase ll by Stratum|Adverse Event|0
7824143|NCT01275222|12294074|FG002|Phase ll by Stratum|Adverse Event|0
7824144|NCT01275222|12294075|FG003|Phase ll by Stratum|Adverse Event|0
7824145|NCT01275222|12294076|FG004|Phase ll by Stratum|Adverse Event|2
7824146|NCT01275222|12294077|FG005|Phase ll by Stratum|Adverse Event|10
7824147|NCT01275222|12294072|FG000|Phase ll by Stratum|Abnormal laboratory values|0
7824148|NCT01275222|12294073|FG001|Phase ll by Stratum|Abnormal laboratory values|0
7824149|NCT01275222|12294074|FG002|Phase ll by Stratum|Abnormal laboratory values|0
7824150|NCT01275222|12294075|FG003|Phase ll by Stratum|Abnormal laboratory values|0
7824151|NCT01275222|12294076|FG004|Phase ll by Stratum|Abnormal laboratory values|0
7824152|NCT01275222|12294077|FG005|Phase ll by Stratum|Abnormal laboratory values|1
7824153|NCT01275222|12294072|FG000|Phase ll by Stratum|Disease progression|0
7824154|NCT01275222|12294073|FG001|Phase ll by Stratum|Disease progression|0
7824155|NCT01275222|12294074|FG002|Phase ll by Stratum|Disease progression|0
7824156|NCT01275222|12294075|FG003|Phase ll by Stratum|Disease progression|0
7824157|NCT01275222|12294076|FG004|Phase ll by Stratum|Disease progression|23
7824158|NCT01275222|12294077|FG005|Phase ll by Stratum|Disease progression|31
7824159|NCT01275222|12294072|FG000|Phase ll by Stratum|Withdrawal by Subject|0
7824160|NCT01275222|12294073|FG001|Phase ll by Stratum|Withdrawal by Subject|0
7824161|NCT01275222|12294074|FG002|Phase ll by Stratum|Withdrawal by Subject|0
7824162|NCT01275222|12294075|FG003|Phase ll by Stratum|Withdrawal by Subject|0
7824163|NCT01275222|12294076|FG004|Phase ll by Stratum|Withdrawal by Subject|2
7824164|NCT01275222|12294077|FG005|Phase ll by Stratum|Withdrawal by Subject|3
7824165|NCT01275222|12294072|FG000|Phase ll by Stratum|Death|0
7824166|NCT01275222|12294073|FG001|Phase ll by Stratum|Death|0
7824167|NCT01275222|12294074|FG002|Phase ll by Stratum|Death|0
7824168|NCT01275222|12294075|FG003|Phase ll by Stratum|Death|0
7824169|NCT01275222|12294076|FG004|Phase ll by Stratum|Death|1
7824170|NCT01275222|12294077|FG005|Phase ll by Stratum|Death|1
7824171|NCT01275339|12294106|FG000|Overall Study|Referred for surgery for AS symptoms|1
7824172|NCT01275339|12294107|FG001|Overall Study|Referred for surgery for AS symptoms|0
7824173|NCT01275339|12294108|FG002|Overall Study|Referred for surgery for AS symptoms|0
7824174|NCT01275339|12294109|FG003|Overall Study|Referred for surgery for AS symptoms|0
7824175|NCT01275339|12294106|FG000|Overall Study|Withdrawal by Subject|0
7824176|NCT01275339|12294107|FG001|Overall Study|Withdrawal by Subject|0
7824177|NCT01275339|12294108|FG002|Overall Study|Withdrawal by Subject|1
7824178|NCT01275339|12294109|FG003|Overall Study|Withdrawal by Subject|0
7824179|NCT01275430|12294136|FG000|Overall Study|Adverse Event|1
7824180|NCT01275430|12294136|FG000|Overall Study|No Contrast Injection|6
7719985|NCT00535730|12144089|FG000|Overall Study|Physician Decision|0
7719986|NCT00535730|12144090|FG001|Overall Study|Physician Decision|1
7824181|NCT01275430|12294136|FG000|Overall Study|Device Malfunction|1
7824182|NCT01275430|12294136|FG000|Overall Study|Inability to achieve maximum p-wave|1
7824183|NCT01275625|12294145|FG000|Overall Study|Death|1
7824184|NCT01275625|12294145|FG000|Overall Study|Lack of Efficacy|2
7824185|NCT01275625|12294145|FG000|Overall Study|Lost to Follow-up|1
7824186|NCT01275625|12294145|FG000|Overall Study|Withdrawal by Subject|3
7824187|NCT01275625|12294145|FG000|Overall Study|Protocol Violation|1
7824188|NCT01275625|12294145|FG000|Overall Study|Adverse Event|4
7824189|NCT01275625|12294145|FG000|Overall Study|Other|1
7824190|NCT01275755|12294155|FG000|Double-blind Treatment Period|Adverse Event|0
7824191|NCT01275755|12294156|FG001|Double-blind Treatment Period|Adverse Event|2
7824192|NCT01275755|12294155|FG000|Double-blind Treatment Period|Lost to Follow-up|1
7824193|NCT01275755|12294156|FG001|Double-blind Treatment Period|Lost to Follow-up|1
7824194|NCT01275755|12294155|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
7824195|NCT01275755|12294156|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
7824196|NCT01275755|12294155|FG000|Run-out Placebo Period|Lost to Follow-up|1
7824197|NCT01275755|12294156|FG001|Run-out Placebo Period|Lost to Follow-up|0
7824198|NCT01275833|12294164|FG000|Overall Study|Study terminated|1
7824199|NCT01275833|12294165|FG001|Overall Study|Study terminated|1
7824200|NCT01276041|12294171|FG000|Overall Study|Adverse Event|2
7824201|NCT01276041|12294171|FG000|Overall Study|Protocol Violation|1
7824202|NCT01276106|12294179|FG000|Overall Study|Adverse Event|3
7824203|NCT01276106|12294180|FG001|Overall Study|Adverse Event|3
7824204|NCT01276106|12294181|FG002|Overall Study|Adverse Event|11
7824205|NCT01276106|12294182|FG003|Overall Study|Adverse Event|3
7824206|NCT01276106|12294179|FG000|Overall Study|Withdrawal by Subject|6
7824207|NCT01276106|12294180|FG001|Overall Study|Withdrawal by Subject|3
7824208|NCT01276106|12294181|FG002|Overall Study|Withdrawal by Subject|1
7824209|NCT01276106|12294182|FG003|Overall Study|Withdrawal by Subject|6
7824210|NCT01276106|12294179|FG000|Overall Study|Lack of Efficacy|0
7824211|NCT01276106|12294180|FG001|Overall Study|Lack of Efficacy|1
7824212|NCT01276106|12294181|FG002|Overall Study|Lack of Efficacy|0
7824213|NCT01276106|12294182|FG003|Overall Study|Lack of Efficacy|1
7824214|NCT01276106|12294179|FG000|Overall Study|Lost to Follow-up|2
7824215|NCT01276106|12294180|FG001|Overall Study|Lost to Follow-up|1
7824216|NCT01276106|12294181|FG002|Overall Study|Lost to Follow-up|1
7824217|NCT01276106|12294182|FG003|Overall Study|Lost to Follow-up|0
7824218|NCT01276106|12294179|FG000|Overall Study|Physician Decision|0
7824219|NCT01276106|12294180|FG001|Overall Study|Physician Decision|0
7824220|NCT01276106|12294181|FG002|Overall Study|Physician Decision|1
7824221|NCT01276106|12294182|FG003|Overall Study|Physician Decision|1
7824222|NCT01276106|12294179|FG000|Overall Study|Protocol Violation|1
7824223|NCT01276106|12294180|FG001|Overall Study|Protocol Violation|1
7824224|NCT01276106|12294181|FG002|Overall Study|Protocol Violation|0
7824225|NCT01276106|12294182|FG003|Overall Study|Protocol Violation|2
7824226|NCT01276106|12294179|FG000|Overall Study|Insufficient therapeutic effects|0
7824227|NCT01276106|12294180|FG001|Overall Study|Insufficient therapeutic effects|0
7824228|NCT01276106|12294181|FG002|Overall Study|Insufficient therapeutic effects|2
7824229|NCT01276106|12294182|FG003|Overall Study|Insufficient therapeutic effects|0
7824230|NCT01276223|12294226|FG000|Overall Study|Adverse Event|7
7824231|NCT01276223|12294227|FG001|Overall Study|Adverse Event|4
7824232|NCT01276223|12294228|FG002|Overall Study|Adverse Event|1
7824233|NCT01276223|12294226|FG000|Overall Study|Lost to Follow-up|0
7824234|NCT01276223|12294227|FG001|Overall Study|Lost to Follow-up|0
7824235|NCT01276223|12294228|FG002|Overall Study|Lost to Follow-up|1
7824236|NCT01276223|12294226|FG000|Overall Study|Other|0
7824237|NCT01276223|12294227|FG001|Overall Study|Other|0
7824238|NCT01276223|12294228|FG002|Overall Study|Other|1
7824239|NCT01276223|12294226|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3
7824240|NCT01276223|12294227|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0
7824241|NCT01276223|12294228|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0
7824242|NCT01276223|12294226|FG000|Overall Study|Protocol Violation|1
7824243|NCT01276223|12294227|FG001|Overall Study|Protocol Violation|0
7824244|NCT01276223|12294228|FG002|Overall Study|Protocol Violation|0
7824245|NCT01276236|12294235|FG000|Overall Study|Lack of Efficacy|2
7824246|NCT01276236|12294235|FG000|Overall Study|Withdrawal by Subject|4
7824247|NCT01276288|12294239|FG000|Overall Study|Adverse Event|1
7824248|NCT01276288|12294240|FG001|Overall Study|Adverse Event|1
7824249|NCT01276288|12294241|FG002|Overall Study|Adverse Event|0
7824250|NCT01276288|12294242|FG003|Overall Study|Adverse Event|0
7824251|NCT01276288|12294239|FG000|Overall Study|not treated|1
7824252|NCT01276288|12294240|FG001|Overall Study|not treated|0
7824253|NCT01276288|12294241|FG002|Overall Study|not treated|0
7824254|NCT01276288|12294242|FG003|Overall Study|not treated|0
7824255|NCT01276327|12294291|FG000|Overall Study|Adverse Event|1
7824256|NCT01276327|12294292|FG001|Overall Study|Adverse Event|3
7824257|NCT01276327|12294291|FG000|Overall Study|Withdrawal by Subject|1
7824258|NCT01276327|12294292|FG001|Overall Study|Withdrawal by Subject|0
7824259|NCT01276353|12294300|FG000|Double-blind|Adverse Event|2
7824260|NCT01276353|12294301|FG001|Double-blind|Adverse Event|0
7824261|NCT01276353|12294300|FG000|Double-blind|Withdrawal by Subject|1
7824262|NCT01276353|12294301|FG001|Double-blind|Withdrawal by Subject|0
7824263|NCT01276353|12294300|FG000|Extension|Adverse Event|2
7824264|NCT01276353|12294301|FG001|Extension|Adverse Event|5
7824265|NCT01276353|12294300|FG000|Extension|Withdrawal by Subject|1
7824266|NCT01276353|12294301|FG001|Extension|Withdrawal by Subject|2
7824267|NCT01276353|12294300|FG000|Extension|Withdrawal of study drug 4 days in a row|3
7824268|NCT01276353|12294301|FG001|Extension|Withdrawal of study drug 4 days in a row|1
7824269|NCT01276353|12294300|FG000|Extension|Physician Decision|1
7824270|NCT01276353|12294301|FG001|Extension|Physician Decision|0
7824271|NCT01276353|12294300|FG000|Extension|Prohibited concomitant medications|0
7824272|NCT01276353|12294301|FG001|Extension|Prohibited concomitant medications|1
7824273|NCT01276379|12294313|FG000|Overall Study|Screening failure|40
7824274|NCT01276457|12294321|FG000|Core Study|Adverse Event|6
7824275|NCT01276457|12294322|FG001|Core Study|Adverse Event|3
7824276|NCT01276457|12294321|FG000|Core Study|Lost to Follow-up|1
7824277|NCT01276457|12294322|FG001|Core Study|Lost to Follow-up|2
7824278|NCT01276457|12294321|FG000|Core Study|Administrative problems|1
7824279|NCT01276457|12294322|FG001|Core Study|Administrative problems|1
7824280|NCT01276457|12294321|FG000|Core Study|Death|2
7824281|NCT01276457|12294322|FG001|Core Study|Death|2
7824282|NCT01276457|12294321|FG000|Core Study|Lack of Efficacy|3
7824283|NCT01276457|12294322|FG001|Core Study|Lack of Efficacy|12
7824284|NCT01276457|12294321|FG000|Extension Study|Lost to Follow-up|3
7824285|NCT01276457|12294322|FG001|Extension Study|Lost to Follow-up|0
7824286|NCT01276457|12294321|FG000|Extension Study|Death|0
7824287|NCT01276457|12294322|FG001|Extension Study|Death|1
7824288|NCT01276457|12294321|FG000|Extension Study|Lack of Efficacy|3
7824289|NCT01276457|12294322|FG001|Extension Study|Lack of Efficacy|1
7824290|NCT01276509|12294332|FG000|Overall Study|Adverse Event|9
7824291|NCT01276509|12294333|FG001|Overall Study|Adverse Event|8
7824292|NCT01276509|12294334|FG002|Overall Study|Adverse Event|4
7824293|NCT01276509|12294335|FG003|Overall Study|Adverse Event|3
7824294|NCT01276509|12294332|FG000|Overall Study|Lack of Efficacy|2
7824295|NCT01276509|12294333|FG001|Overall Study|Lack of Efficacy|1
7824296|NCT01276509|12294334|FG002|Overall Study|Lack of Efficacy|1
7824297|NCT01276509|12294335|FG003|Overall Study|Lack of Efficacy|2
7824298|NCT01276509|12294332|FG000|Overall Study|Pregnancy|1
7824299|NCT01276509|12294333|FG001|Overall Study|Pregnancy|0
7824300|NCT01276509|12294334|FG002|Overall Study|Pregnancy|0
7824301|NCT01276509|12294335|FG003|Overall Study|Pregnancy|0
7719987|NCT00535730|12144089|FG000|Overall Study|Protocol Violation|1
7719988|NCT00535730|12144090|FG001|Overall Study|Protocol Violation|0
7719989|NCT00535730|12144089|FG000|Overall Study|Withdrawal by Subject|0
7824302|NCT01276509|12294332|FG000|Overall Study|Withdrawal by Subject|1
7824303|NCT01276509|12294333|FG001|Overall Study|Withdrawal by Subject|2
7824304|NCT01276509|12294334|FG002|Overall Study|Withdrawal by Subject|0
7824305|NCT01276509|12294335|FG003|Overall Study|Withdrawal by Subject|0
7719990|NCT00535730|12144090|FG001|Overall Study|Withdrawal by Subject|4
7824306|NCT01276509|12294332|FG000|Overall Study|Other|0
7824307|NCT01276509|12294333|FG001|Overall Study|Other|1
7719991|NCT00535847|12144227|FG000|Overall Study|Adverse Event|5
7824308|NCT01276509|12294334|FG002|Overall Study|Other|0
7824309|NCT01276509|12294335|FG003|Overall Study|Other|0
7824310|NCT01276639|12294352|FG000|Week 0 to 16|Death|1
7824311|NCT01276639|12294353|FG001|Week 0 to 16|Death|0
7824312|NCT01276639|12294354|FG002|Week 0 to 16|Death|0
7824313|NCT01276639|12294355|FG003|Week 0 to 16|Death|0
7824314|NCT01276639|12294356|FG004|Week 0 to 16|Death|0
7824315|NCT01276639|12294352|FG000|Week 0 to 16|Adverse Event|11
7824316|NCT01276639|12294353|FG001|Week 0 to 16|Adverse Event|8
7824317|NCT01276639|12294354|FG002|Week 0 to 16|Adverse Event|11
7824318|NCT01276639|12294355|FG003|Week 0 to 16|Adverse Event|0
7824319|NCT01276639|12294356|FG004|Week 0 to 16|Adverse Event|0
7824320|NCT01276639|12294352|FG000|Week 0 to 16|Lack of Efficacy|20
7824321|NCT01276639|12294353|FG001|Week 0 to 16|Lack of Efficacy|15
7824322|NCT01276639|12294354|FG002|Week 0 to 16|Lack of Efficacy|25
7824323|NCT01276639|12294355|FG003|Week 0 to 16|Lack of Efficacy|0
7824324|NCT01276639|12294356|FG004|Week 0 to 16|Lack of Efficacy|0
7824325|NCT01276639|12294352|FG000|Week 0 to 16|Lost to Follow-up|3
7824326|NCT01276639|12294353|FG001|Week 0 to 16|Lost to Follow-up|5
7824327|NCT01276639|12294354|FG002|Week 0 to 16|Lost to Follow-up|3
7824328|NCT01276639|12294355|FG003|Week 0 to 16|Lost to Follow-up|0
7824329|NCT01276639|12294356|FG004|Week 0 to 16|Lost to Follow-up|0
7824330|NCT01276639|12294352|FG000|Week 0 to 16|Withdrawal by Subject|8
7824331|NCT01276639|12294353|FG001|Week 0 to 16|Withdrawal by Subject|5
7824332|NCT01276639|12294354|FG002|Week 0 to 16|Withdrawal by Subject|4
7824333|NCT01276639|12294355|FG003|Week 0 to 16|Withdrawal by Subject|0
7824334|NCT01276639|12294356|FG004|Week 0 to 16|Withdrawal by Subject|0
7824335|NCT01276639|12294352|FG000|Week 0 to 16|Other|7
7824336|NCT01276639|12294353|FG001|Week 0 to 16|Other|7
7824337|NCT01276639|12294354|FG002|Week 0 to 16|Other|2
7824338|NCT01276639|12294355|FG003|Week 0 to 16|Other|0
7824339|NCT01276639|12294356|FG004|Week 0 to 16|Other|0
7824340|NCT01276639|12294352|FG000|Week 0 to 16|Randomized, But Not Treated|0
7824341|NCT01276639|12294353|FG001|Week 0 to 16|Randomized, But Not Treated|1
7824342|NCT01276639|12294354|FG002|Week 0 to 16|Randomized, But Not Treated|0
7824343|NCT01276639|12294355|FG003|Week 0 to 16|Randomized, But Not Treated|0
7824344|NCT01276639|12294356|FG004|Week 0 to 16|Randomized, But Not Treated|0
7824345|NCT01276639|12294352|FG000|Week 16 to 52|Death|1
7824346|NCT01276639|12294353|FG001|Week 16 to 52|Death|0
7824347|NCT01276639|12294354|FG002|Week 16 to 52|Death|0
7824348|NCT01276639|12294355|FG003|Week 16 to 52|Death|0
7824349|NCT01276639|12294356|FG004|Week 16 to 52|Death|0
7824350|NCT01276639|12294352|FG000|Week 16 to 52|Adverse Event|10
7824351|NCT01276639|12294353|FG001|Week 16 to 52|Adverse Event|13
7824352|NCT01276639|12294354|FG002|Week 16 to 52|Adverse Event|0
7824353|NCT01276639|12294355|FG003|Week 16 to 52|Adverse Event|1
7824354|NCT01276639|12294356|FG004|Week 16 to 52|Adverse Event|3
7824355|NCT01276639|12294352|FG000|Week 16 to 52|Lack of Efficacy|99
7824356|NCT01276639|12294353|FG001|Week 16 to 52|Lack of Efficacy|71
7824357|NCT01276639|12294354|FG002|Week 16 to 52|Lack of Efficacy|0
7824358|NCT01276639|12294355|FG003|Week 16 to 52|Lack of Efficacy|14
7824359|NCT01276639|12294356|FG004|Week 16 to 52|Lack of Efficacy|13
7824360|NCT01276639|12294352|FG000|Week 16 to 52|Lost to Follow-up|3
7824361|NCT01276639|12294353|FG001|Week 16 to 52|Lost to Follow-up|1
7824362|NCT01276639|12294354|FG002|Week 16 to 52|Lost to Follow-up|0
7824363|NCT01276639|12294355|FG003|Week 16 to 52|Lost to Follow-up|0
7824364|NCT01276639|12294356|FG004|Week 16 to 52|Lost to Follow-up|1
7824365|NCT01276639|12294352|FG000|Week 16 to 52|Withdrawal by Subject|4
7824366|NCT01276639|12294353|FG001|Week 16 to 52|Withdrawal by Subject|4
7824367|NCT01276639|12294354|FG002|Week 16 to 52|Withdrawal by Subject|0
7824368|NCT01276639|12294355|FG003|Week 16 to 52|Withdrawal by Subject|0
7824369|NCT01276639|12294356|FG004|Week 16 to 52|Withdrawal by Subject|1
7824370|NCT01276639|12294352|FG000|Week 16 to 52|Other|10
7824371|NCT01276639|12294353|FG001|Week 16 to 52|Other|12
7719992|NCT00535847|12144228|FG001|Overall Study|Adverse Event|3
7719993|NCT00535847|12144229|FG002|Overall Study|Adverse Event|2
7719994|NCT00535847|12144227|FG000|Overall Study|Non compliance|1
7719995|NCT00535847|12144228|FG001|Overall Study|Non compliance|1
7719996|NCT00535847|12144229|FG002|Overall Study|Non compliance|0
7719997|NCT00535847|12144227|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16
7719998|NCT00535847|12144228|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10
7719999|NCT00535847|12144229|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0
7720000|NCT00536107|12144267|FG000|Overall Study|Death|5
7720001|NCT00536107|12144268|FG001|Overall Study|Death|1
7720002|NCT00536107|12144267|FG000|Overall Study|Incorrect enrolment|1
7720003|NCT00536107|12144268|FG001|Overall Study|Incorrect enrolment|0
7720004|NCT00536107|12144267|FG000|Overall Study|Withdrawal by Subject|0
7720005|NCT00536107|12144268|FG001|Overall Study|Withdrawal by Subject|1
7720006|NCT00536107|12144267|FG000|Overall Study|Study Termination|2
7720007|NCT00536107|12144268|FG001|Overall Study|Study Termination|4
7720008|NCT00536120|12144276|FG000|Overall Study|Lost to Follow-up|1
7720009|NCT00536120|12144277|FG001|Overall Study|Lost to Follow-up|0
7824372|NCT01276639|12294354|FG002|Week 16 to 52|Other|0
7824373|NCT01276639|12294355|FG003|Week 16 to 52|Other|1
7720010|NCT00536120|12144276|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3
7720011|NCT00536120|12144277|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0
7824374|NCT01276639|12294356|FG004|Week 16 to 52|Other|3
7824375|NCT01276756|12294391|FG000|Overall Study|Lost to Follow-up|2
7824376|NCT01276756|12294392|FG001|Overall Study|Lost to Follow-up|0
7824377|NCT01276756|12294391|FG000|Overall Study|Adverse Event|3
7824378|NCT01276756|12294392|FG001|Overall Study|Adverse Event|2
7824379|NCT01276821|12294400|FG000|Overall Study|Protocol Violation|0
7824380|NCT01276821|12294401|FG001|Overall Study|Protocol Violation|1
7824381|NCT01276847|12294410|FG000|Overall Study|Withdrawal by Subject|1
7824382|NCT01276847|12294411|FG001|Overall Study|Withdrawal by Subject|0
7824383|NCT01276847|12294412|FG002|Overall Study|Withdrawal by Subject|0
7824384|NCT01277042|12294430|FG000|Overall Study|Adverse Event|4
7824385|NCT01277042|12294431|FG001|Overall Study|Adverse Event|3
7824386|NCT01277042|12294430|FG000|Overall Study|Lost to Follow-up|2
7824387|NCT01277042|12294431|FG001|Overall Study|Lost to Follow-up|2
7824388|NCT01277042|12294430|FG000|Overall Study|Withdrawal by Subject|2
7824389|NCT01277042|12294431|FG001|Overall Study|Withdrawal by Subject|0
7824390|NCT01277302|12294471|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
7824391|NCT01277302|12294472|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
7824392|NCT01277302|12294473|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
7824393|NCT01277302|12294471|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0
7824394|NCT01277302|12294472|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0
7824395|NCT01277302|12294473|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2
7824396|NCT01277302|12294471|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
7824397|NCT01277302|12294472|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
7824398|NCT01277302|12294473|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
7824399|NCT01277302|12294471|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0
7824400|NCT01277302|12294472|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0
7824401|NCT01277302|12294473|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1
7824402|NCT01277302|12294471|FG000|8-Month Alternate Dose Regimen Period|Death|0
7824403|NCT01277302|12294472|FG001|8-Month Alternate Dose Regimen Period|Death|1
7824404|NCT01277302|12294473|FG002|8-Month Alternate Dose Regimen Period|Death|0
7824405|NCT01277302|12294471|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
7824406|NCT01277302|12294472|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
7824407|NCT01277302|12294473|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
7824408|NCT01277302|12294471|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
7824409|NCT01277302|12294472|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
7824410|NCT01277302|12294473|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
7720012|NCT00536120|12144276|FG000|Overall Study|Non-compliance|1
7824411|NCT01277302|12294471|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
7824412|NCT01277302|12294472|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
7824413|NCT01277302|12294473|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
7824414|NCT01277302|12294471|FG000|8-Month Alternate Dose Regimen Period|Relocation|1
7824415|NCT01277302|12294472|FG001|8-Month Alternate Dose Regimen Period|Relocation|0
7824416|NCT01277302|12294473|FG002|8-Month Alternate Dose Regimen Period|Relocation|1
7824417|NCT01277510|12294509|FG000|Double-blind Phase|Non-compliance|0
7824418|NCT01277510|12294510|FG001|Double-blind Phase|Non-compliance|1
7824419|NCT01277510|12294509|FG000|Double-blind Phase|Adverse Event|1
7824420|NCT01277510|12294510|FG001|Double-blind Phase|Adverse Event|0
7824421|NCT01277510|12294509|FG000|Double-blind Phase|Withdrawal by Subject|2
7824422|NCT01277510|12294510|FG001|Double-blind Phase|Withdrawal by Subject|0
7824423|NCT01277510|12294509|FG000|Double-blind Phase|Administrative decision|7
7824424|NCT01277510|12294510|FG001|Double-blind Phase|Administrative decision|9
7824425|NCT01277510|12294509|FG000|Double-blind Phase|Death|0
7824426|NCT01277510|12294510|FG001|Double-blind Phase|Death|1
7824427|NCT01277510|12294509|FG000|Double-blind Phase|Protocol-specified criteria|2
7824428|NCT01277510|12294510|FG001|Double-blind Phase|Protocol-specified criteria|6
7824429|NCT01277510|12294509|FG000|Double-blind Phase|Other|1
7824430|NCT01277510|12294510|FG001|Double-blind Phase|Other|1
7824431|NCT01277510|12294509|FG000|Open-label Phase|Administrative decision|4
7824432|NCT01277510|12294510|FG001|Open-label Phase|Administrative decision|3
7824433|NCT01277510|12294509|FG000|Open-label Phase|Protocol-specified criteria|1
7824434|NCT01277510|12294510|FG001|Open-label Phase|Protocol-specified criteria|0
7824435|NCT01277510|12294509|FG000|Open-label Phase|Never received investigational product|2
7824436|NCT01277510|12294510|FG001|Open-label Phase|Never received investigational product|0
7824437|NCT01277523|12294521|FG000|Overall Study|Adverse Event|1
7948123|NCT02525133|12493236|FG001|Overall Study|Lost to Follow-up|1
7948124|NCT02525133|12493235|FG000|Overall Study|randomized not enrolled|3
7948125|NCT02525133|12493236|FG001|Overall Study|randomized not enrolled|0
7948126|NCT02525133|12493235|FG000|Overall Study|Withdrawal by Subject|1
7948127|NCT02525133|12493236|FG001|Overall Study|Withdrawal by Subject|0
7948128|NCT02525471|12493248|FG000|Overall Study|Screen Failure|6
7948129|NCT02525471|12493248|FG000|Overall Study|Withdrawal by Subject|4
7948130|NCT02525471|12493248|FG000|Overall Study|Death|1
7948131|NCT02525588|12493294|FG000|Overall Study|Death|3
7948132|NCT02525588|12493295|FG001|Overall Study|Death|1
7948133|NCT02525588|12493294|FG000|Overall Study|Lost to Follow-up|2
7948134|NCT02525588|12493295|FG001|Overall Study|Lost to Follow-up|0
7948135|NCT02525588|12493294|FG000|Overall Study|Withdrawal by Subject|1
7948136|NCT02525588|12493295|FG001|Overall Study|Withdrawal by Subject|1
7948137|NCT02525588|12493294|FG000|Overall Study|Adverse Event|0
7948138|NCT02525588|12493295|FG001|Overall Study|Adverse Event|1
7948139|NCT02525627|12493303|FG000|Overall Study|Revision|1
7948140|NCT02525627|12493304|FG001|Overall Study|Revision|1
7948141|NCT02525627|12493303|FG000|Overall Study|Withdrawal by Subject|1
7948142|NCT02525627|12493304|FG001|Overall Study|Withdrawal by Subject|2
7948143|NCT02525627|12493303|FG000|Overall Study|Death|1
7948144|NCT02525627|12493304|FG001|Overall Study|Death|0
7948145|NCT02525627|12493303|FG000|Overall Study|Site terminated|11
7948146|NCT02525627|12493304|FG001|Overall Study|Site terminated|10
7948147|NCT02525744|12493323|FG000|Period 1|Physician Decision|0
7948148|NCT02525744|12493324|FG001|Period 1|Physician Decision|0
7948149|NCT02525744|12493325|FG002|Period 1|Physician Decision|1
7948150|NCT02525744|12493326|FG003|Period 1|Physician Decision|0
7948151|NCT02525744|12493323|FG000|Period 3|Adverse Event|0
7948152|NCT02525744|12493324|FG001|Period 3|Adverse Event|1
7948153|NCT02525744|12493325|FG002|Period 3|Adverse Event|0
7948154|NCT02525744|12493326|FG003|Period 3|Adverse Event|0
7948155|NCT02525744|12493323|FG000|Period 4|Withdrawal by Subject|1
7948156|NCT02525744|12493324|FG001|Period 4|Withdrawal by Subject|0
7948157|NCT02525744|12493325|FG002|Period 4|Withdrawal by Subject|0
7948158|NCT02525744|12493326|FG003|Period 4|Withdrawal by Subject|0
7948159|NCT02525744|12493323|FG000|Period 5|Physician Decision|1
7948160|NCT02525744|12493324|FG001|Period 5|Physician Decision|0
7948161|NCT02525744|12493325|FG002|Period 5|Physician Decision|0
7948162|NCT02525744|12493326|FG003|Period 5|Physician Decision|0
7948163|NCT02525861|12493338|FG000|Overall Study|Adverse Event|1
7948164|NCT02525861|12493339|FG001|Overall Study|Adverse Event|0
7948165|NCT02525861|12493338|FG000|Overall Study|Withdrawal by Subject|0
7948166|NCT02525861|12493339|FG001|Overall Study|Withdrawal by Subject|1
7948167|NCT02525861|12493338|FG000|Overall Study|Physician Decision|0
7948168|NCT02525861|12493339|FG001|Overall Study|Physician Decision|1
7948169|NCT02525874|12493347|FG000|Overall Study|Other|1
7948170|NCT02525874|12493347|FG000|Overall Study|Investigator Decision|1
7948171|NCT02525874|12493347|FG000|Overall Study|Consent withdrawn|22
7948172|NCT02525874|12493347|FG000|Overall Study|Non-compliance with study drug|3
7824438|NCT01277523|12294522|FG001|Overall Study|Adverse Event|0
7824439|NCT01277523|12294523|FG002|Overall Study|Adverse Event|0
7824440|NCT01277523|12294521|FG000|Overall Study|Protocol Violation|2
7824441|NCT01277523|12294522|FG001|Overall Study|Protocol Violation|0
7824442|NCT01277523|12294523|FG002|Overall Study|Protocol Violation|0
7824443|NCT01277523|12294521|FG000|Overall Study|Other Reason not Defined|0
7824444|NCT01277523|12294522|FG001|Overall Study|Other Reason not Defined|1
7824445|NCT01277523|12294523|FG002|Overall Study|Other Reason not Defined|0
7824446|NCT01277549|12294533|FG000|Overall Study|Failed to meet eligibility criteria|13
7824447|NCT01277549|12294534|FG001|Overall Study|Failed to meet eligibility criteria|9
7824448|NCT01277549|12294533|FG000|Overall Study|Withdrawal by Subject|1
7824449|NCT01277549|12294534|FG001|Overall Study|Withdrawal by Subject|3
7824450|NCT01277549|12294533|FG000|Overall Study|Protocol Violation|10
7824451|NCT01277549|12294534|FG001|Overall Study|Protocol Violation|1
7824452|NCT01277549|12294533|FG000|Overall Study|Physician Decision|2
7824453|NCT01277549|12294534|FG001|Overall Study|Physician Decision|1
7824454|NCT01277601|12294547|FG000|Overall Study|Adverse Event|5
7824455|NCT01277601|12294548|FG001|Overall Study|Adverse Event|3
7824456|NCT01277601|12294549|FG002|Overall Study|Adverse Event|0
7824457|NCT01277601|12294550|FG003|Overall Study|Adverse Event|7
7824458|NCT01277601|12294547|FG000|Overall Study|Withdrawal by Subject|18
7824459|NCT01277601|12294548|FG001|Overall Study|Withdrawal by Subject|21
7824460|NCT01277601|12294549|FG002|Overall Study|Withdrawal by Subject|8
7824461|NCT01277601|12294550|FG003|Overall Study|Withdrawal by Subject|17
7824462|NCT01277601|12294547|FG000|Overall Study|Lost to Follow-up|7
7824463|NCT01277601|12294548|FG001|Overall Study|Lost to Follow-up|9
7824464|NCT01277601|12294549|FG002|Overall Study|Lost to Follow-up|4
7824465|NCT01277601|12294550|FG003|Overall Study|Lost to Follow-up|2
7824466|NCT01277601|12294547|FG000|Overall Study|Physician Decision|3
7824467|NCT01277601|12294548|FG001|Overall Study|Physician Decision|5
7824468|NCT01277601|12294549|FG002|Overall Study|Physician Decision|1
7948173|NCT02525874|12493347|FG000|Overall Study|Adverse Event|17
7824469|NCT01277601|12294550|FG003|Overall Study|Physician Decision|6
7824470|NCT01277601|12294547|FG000|Overall Study|Pregnancy|2
7824471|NCT01277601|12294548|FG001|Overall Study|Pregnancy|2
7824472|NCT01277601|12294549|FG002|Overall Study|Pregnancy|4
7824473|NCT01277601|12294550|FG003|Overall Study|Pregnancy|1
7824474|NCT01277601|12294547|FG000|Overall Study|Noncompliance with Study Drug|1
7824475|NCT01277601|12294548|FG001|Overall Study|Noncompliance with Study Drug|3
7824476|NCT01277601|12294549|FG002|Overall Study|Noncompliance with Study Drug|2
7824477|NCT01277601|12294550|FG003|Overall Study|Noncompliance with Study Drug|0
7824478|NCT01277601|12294547|FG000|Overall Study|Subject Never Dosed with Study Drug|1
7824479|NCT01277601|12294548|FG001|Overall Study|Subject Never Dosed with Study Drug|2
7824480|NCT01277601|12294549|FG002|Overall Study|Subject Never Dosed with Study Drug|3
7824481|NCT01277601|12294550|FG003|Overall Study|Subject Never Dosed with Study Drug|1
7824482|NCT01277601|12294547|FG000|Overall Study|Protocol Violation|0
7824483|NCT01277601|12294548|FG001|Overall Study|Protocol Violation|2
7824484|NCT01277601|12294549|FG002|Overall Study|Protocol Violation|5
7824485|NCT01277601|12294550|FG003|Overall Study|Protocol Violation|0
7824486|NCT01277601|12294547|FG000|Overall Study|Subject Terminated from Study by Sponsor|0
7824487|NCT01277601|12294548|FG001|Overall Study|Subject Terminated from Study by Sponsor|1
7824488|NCT01277601|12294549|FG002|Overall Study|Subject Terminated from Study by Sponsor|0
7824489|NCT01277601|12294550|FG003|Overall Study|Subject Terminated from Study by Sponsor|2
7824490|NCT01277666|12294580|FG000|Overall Study|Adverse Event|26
7824491|NCT01277666|12294581|FG001|Overall Study|Adverse Event|25
7824492|NCT01277666|12294582|FG002|Overall Study|Adverse Event|20
7824493|NCT01277666|12294580|FG000|Overall Study|Lack of Efficacy|8
7824494|NCT01277666|12294581|FG001|Overall Study|Lack of Efficacy|20
7824495|NCT01277666|12294582|FG002|Overall Study|Lack of Efficacy|12
7824496|NCT01277666|12294580|FG000|Overall Study|Protocol Violation|2
7824497|NCT01277666|12294581|FG001|Overall Study|Protocol Violation|3
7824498|NCT01277666|12294582|FG002|Overall Study|Protocol Violation|2
7824499|NCT01277666|12294580|FG000|Overall Study|Protocol Defined Stopping criteria|1
7824500|NCT01277666|12294581|FG001|Overall Study|Protocol Defined Stopping criteria|2
7824501|NCT01277666|12294582|FG002|Overall Study|Protocol Defined Stopping criteria|6
7824502|NCT01277666|12294580|FG000|Overall Study|Lost to Follow-up|1
7824503|NCT01277666|12294581|FG001|Overall Study|Lost to Follow-up|1
7824504|NCT01277666|12294582|FG002|Overall Study|Lost to Follow-up|2
7824505|NCT01277666|12294580|FG000|Overall Study|Withdrawal by Subject|7
7824506|NCT01277666|12294581|FG001|Overall Study|Withdrawal by Subject|8
7824507|NCT01277666|12294582|FG002|Overall Study|Withdrawal by Subject|6
7824508|NCT01277666|12294580|FG000|Overall Study|Death|0
7824509|NCT01277666|12294581|FG001|Overall Study|Death|0
7824510|NCT01277666|12294582|FG002|Overall Study|Death|1
7824511|NCT01277718|12294590|FG000|Period 2 - Second Intervention|Protocol Violation|0
7824512|NCT01277718|12294591|FG001|Period 2 - Second Intervention|Protocol Violation|1
7824513|NCT01277718|12294590|FG000|Period 2 - Second Intervention|Physician Decision|0
7824514|NCT01277718|12294591|FG001|Period 2 - Second Intervention|Physician Decision|2
7824515|NCT01277744|12294599|FG000|Overall Study|Physician Decision|2
7824516|NCT01277757|12294603|FG000|Overall Study|Disease Progression|1
7824517|NCT01277757|12294603|FG000|Overall Study|Withdrawal by Subject|1
7824518|NCT01277861|12294614|FG000|Overall Study|Physician Decision|2
7824519|NCT01277861|12294615|FG001|Overall Study|Physician Decision|2
7824520|NCT01277887|12294625|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1
7824521|NCT01277887|12294626|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0
7824522|NCT01277887|12294625|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2
7824523|NCT01277887|12294626|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0
7824524|NCT01277887|12294625|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3
7824525|NCT01277887|12294626|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5
7824526|NCT01278030|12294634|FG000|Overall Study|Withdrawal by Subject|8
7824527|NCT01278030|12294635|FG001|Overall Study|Withdrawal by Subject|4
7824528|NCT01278160|12294643|FG000|Overall Study|Adverse Event|1
7824529|NCT01278160|12294644|FG001|Overall Study|Adverse Event|1
7824530|NCT01278160|12294643|FG000|Overall Study|Lost to Follow-up|0
7824531|NCT01278160|12294644|FG001|Overall Study|Lost to Follow-up|1
7824532|NCT01278160|12294643|FG000|Overall Study|Withdrawal by Subject|3
7824533|NCT01278160|12294644|FG001|Overall Study|Withdrawal by Subject|2
7824534|NCT01278160|12294643|FG000|Overall Study|Unclassified|1
7824535|NCT01278160|12294644|FG001|Overall Study|Unclassified|2
7824536|NCT01278173|12294650|FG000|Overall Study|Lack of Efficacy|13
7824537|NCT01278173|12294650|FG000|Overall Study|Adverse Event|8
7824538|NCT01278173|12294650|FG000|Overall Study|Administrative or other reason|4
7824539|NCT01278173|12294650|FG000|Overall Study|Protocol Violation|1
7824540|NCT01278173|12294650|FG000|Overall Study|Withdrawal by Subject|1
7824541|NCT01278342|12294661|FG000|Overall Study|Physician Decision|0
7824542|NCT01278342|12294662|FG001|Overall Study|Physician Decision|1
7824543|NCT01278342|12294663|FG002|Overall Study|Physician Decision|0
7824544|NCT01278342|12294661|FG000|Overall Study|Lost to Follow-up|1
7824545|NCT01278342|12294662|FG001|Overall Study|Lost to Follow-up|0
7824546|NCT01278342|12294663|FG002|Overall Study|Lost to Follow-up|0
7824547|NCT01278342|12294661|FG000|Overall Study|Administrative problems|2
7824548|NCT01278342|12294662|FG001|Overall Study|Administrative problems|0
7824549|NCT01278342|12294663|FG002|Overall Study|Administrative problems|0
7824550|NCT01278342|12294661|FG000|Overall Study|Other|1
7824551|NCT01278342|12294662|FG001|Overall Study|Other|0
7824552|NCT01278342|12294663|FG002|Overall Study|Other|0
7824553|NCT01278394|12294671|FG000|Overall Study|Lost to Follow-up|1
7824554|NCT01278407|12294678|FG000|Confirmatory Phase|Adverse Event|5
7824555|NCT01278407|12294679|FG001|Confirmatory Phase|Adverse Event|10
7824556|NCT01278407|12294680|FG002|Confirmatory Phase|Adverse Event|1
7824557|NCT01278407|12294681|FG003|Confirmatory Phase|Adverse Event|0
7824558|NCT01278407|12294682|FG004|Confirmatory Phase|Adverse Event|0
7824559|NCT01278407|12294678|FG000|Confirmatory Phase|Participant's Choice|3
7824560|NCT01278407|12294679|FG001|Confirmatory Phase|Participant's Choice|5
7824561|NCT01278407|12294680|FG002|Confirmatory Phase|Participant's Choice|3
7824562|NCT01278407|12294681|FG003|Confirmatory Phase|Participant's Choice|0
7824563|NCT01278407|12294682|FG004|Confirmatory Phase|Participant's Choice|0
7824564|NCT01278407|12294678|FG000|Confirmatory Phase|Other|1
7824565|NCT01278407|12294679|FG001|Confirmatory Phase|Other|1
7824566|NCT01278407|12294680|FG002|Confirmatory Phase|Other|2
7824567|NCT01278407|12294681|FG003|Confirmatory Phase|Other|0
7824568|NCT01278407|12294682|FG004|Confirmatory Phase|Other|0
7824569|NCT01278407|12294678|FG000|Extension Phase|Adverse Event|0
7824570|NCT01278407|12294679|FG001|Extension Phase|Adverse Event|0
7824571|NCT01278407|12294680|FG002|Extension Phase|Adverse Event|0
7824572|NCT01278407|12294681|FG003|Extension Phase|Adverse Event|7
7824573|NCT01278407|12294682|FG004|Extension Phase|Adverse Event|16
7824574|NCT01278407|12294678|FG000|Extension Phase|Participant's Choice|0
7824575|NCT01278407|12294679|FG001|Extension Phase|Participant's Choice|0
7720013|NCT00536120|12144277|FG001|Overall Study|Non-compliance|0
7720014|NCT00536120|12144276|FG000|Overall Study|Sponsor Decision Due to Lab Values|1
7720015|NCT00536120|12144277|FG001|Overall Study|Sponsor Decision Due to Lab Values|0
7720016|NCT00536120|12144276|FG000|Overall Study|Steroid Use|0
7720017|NCT00536120|12144277|FG001|Overall Study|Steroid Use|2
7720018|NCT00536120|12144276|FG000|Overall Study|Missed Study Visit|0
7720019|NCT00536120|12144277|FG001|Overall Study|Missed Study Visit|1
7720020|NCT00536198|12144294|FG000|Overall Study|Lost to Follow-up|15
7720021|NCT00536198|12144295|FG001|Overall Study|Lost to Follow-up|14
7720022|NCT00536198|12144294|FG000|Overall Study|Withdrawal by Subject|16
7720023|NCT00536198|12144295|FG001|Overall Study|Withdrawal by Subject|12
7720024|NCT00536198|12144294|FG000|Overall Study|Adverse Event|2
7720025|NCT00536198|12144295|FG001|Overall Study|Adverse Event|2
7720026|NCT00536198|12144294|FG000|Overall Study|Rescue|3
7720027|NCT00536198|12144295|FG001|Overall Study|Rescue|9
7720028|NCT00536198|12144294|FG000|Overall Study|Pregnancy|1
7720029|NCT00536198|12144295|FG001|Overall Study|Pregnancy|1
7720030|NCT00536198|12144294|FG000|Overall Study|Protocol Violation|0
7720031|NCT00536198|12144295|FG001|Overall Study|Protocol Violation|1
7720032|NCT00536263|12144306|FG000|Overall Study|Adverse Event|5
7720033|NCT00536263|12144307|FG001|Overall Study|Adverse Event|5
7824576|NCT01278407|12294680|FG002|Extension Phase|Participant's Choice|0
7824577|NCT01278407|12294681|FG003|Extension Phase|Participant's Choice|4
7824578|NCT01278407|12294682|FG004|Extension Phase|Participant's Choice|11
7824579|NCT01278407|12294678|FG000|Extension Phase|Other|0
7824580|NCT01278407|12294679|FG001|Extension Phase|Other|0
7824581|NCT01278407|12294680|FG002|Extension Phase|Other|0
7824582|NCT01278407|12294681|FG003|Extension Phase|Other|1
7824583|NCT01278407|12294682|FG004|Extension Phase|Other|3
7824584|NCT01278615|12294696|FG000|Overall Study|Withdrawal by Subject|2
7824585|NCT01278745|12294702|FG000|Overall Study|Death|2
7824586|NCT01278745|12294703|FG001|Overall Study|Death|5
7824587|NCT01278745|12294704|FG002|Overall Study|Death|7
7824588|NCT01278745|12294705|FG003|Overall Study|Death|0
7824589|NCT01278745|12294702|FG000|Overall Study|Physician Decision|1
7824590|NCT01278745|12294703|FG001|Overall Study|Physician Decision|0
7824591|NCT01278745|12294704|FG002|Overall Study|Physician Decision|0
7824592|NCT01278745|12294705|FG003|Overall Study|Physician Decision|9
7824593|NCT01278745|12294702|FG000|Overall Study|Withdrawal by Subject|1
7824594|NCT01278745|12294703|FG001|Overall Study|Withdrawal by Subject|1
7824595|NCT01278745|12294704|FG002|Overall Study|Withdrawal by Subject|5
7824596|NCT01278745|12294705|FG003|Overall Study|Withdrawal by Subject|1
7824597|NCT01278745|12294702|FG000|Overall Study|Sponsor Decision|1
7824598|NCT01278745|12294703|FG001|Overall Study|Sponsor Decision|0
7824599|NCT01278745|12294704|FG002|Overall Study|Sponsor Decision|62
7824600|NCT01278745|12294705|FG003|Overall Study|Sponsor Decision|6
7824601|NCT01278745|12294702|FG000|Overall Study|Ineligible|0
7824602|NCT01278745|12294703|FG001|Overall Study|Ineligible|0
7824603|NCT01278745|12294704|FG002|Overall Study|Ineligible|42
7824604|NCT01278745|12294705|FG003|Overall Study|Ineligible|61
7824605|NCT01278745|12294702|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0
7824606|NCT01278745|12294703|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0
7824607|NCT01278745|12294704|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5
7824608|NCT01278745|12294705|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1
7720034|NCT00536263|12144308|FG002|Overall Study|Adverse Event|7
7720035|NCT00536263|12144306|FG000|Overall Study|Lost to Follow-up|3
7720036|NCT00536263|12144307|FG001|Overall Study|Lost to Follow-up|4
7720037|NCT00536263|12144308|FG002|Overall Study|Lost to Follow-up|4
7720038|NCT00536263|12144306|FG000|Overall Study|Subject withdrew - not treatment related|2
7824609|NCT01278797|12294713|FG000|Period 1|Adverse Event|0
7824610|NCT01278797|12294714|FG001|Period 1|Adverse Event|1
7824611|NCT01278797|12294713|FG000|Period 1|Protocol Violation|1
7824612|NCT01278797|12294714|FG001|Period 1|Protocol Violation|0
7824613|NCT01278862|12294722|FG000|Overall Study|Lost to Follow-up|1
7824614|NCT01278862|12294723|FG001|Overall Study|Lost to Follow-up|1
7824615|NCT01279044|12294759|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
7824616|NCT01279044|12294760|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
7824617|NCT01279044|12294761|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
7824618|NCT01279044|12294759|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
7824619|NCT01279044|12294760|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
7824620|NCT01279044|12294761|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
7824621|NCT01279044|12294759|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0
7824622|NCT01279044|12294760|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0
7824623|NCT01279044|12294761|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1
7824624|NCT01279057|12294770|FG000|Overall Study|Adverse Event|1
7824625|NCT01279057|12294771|FG001|Overall Study|Adverse Event|0
7824626|NCT01279057|12294772|FG002|Overall Study|Adverse Event|1
7824627|NCT01279057|12294770|FG000|Overall Study|Insufficient therapeutic response|0
7824628|NCT01279057|12294771|FG001|Overall Study|Insufficient therapeutic response|0
7824629|NCT01279057|12294772|FG002|Overall Study|Insufficient therapeutic response|1
7824630|NCT01279057|12294770|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0
7824631|NCT01279057|12294771|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1
7824632|NCT01279057|12294772|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0
7824633|NCT01279057|12294770|FG000|Overall Study|Withdrew consent|2
7824634|NCT01279057|12294771|FG001|Overall Study|Withdrew consent|0
7824635|NCT01279057|12294772|FG002|Overall Study|Withdrew consent|1
7824636|NCT01279057|12294770|FG000|Overall Study|Pregnancy|0
7824637|NCT01279057|12294771|FG001|Overall Study|Pregnancy|1
7824638|NCT01279057|12294772|FG002|Overall Study|Pregnancy|0
7824639|NCT01279057|12294770|FG000|Overall Study|Other|3
7824640|NCT01279057|12294771|FG001|Overall Study|Other|3
7824641|NCT01279057|12294772|FG002|Overall Study|Other|0
7824642|NCT01279070|12294782|FG000|Overall Study|Withdrawal by Subject|2
7824643|NCT01279070|12294783|FG001|Overall Study|Withdrawal by Subject|3
7824644|NCT01279070|12294782|FG000|Overall Study|Acute exacerbation|3
7824645|NCT01279070|12294783|FG001|Overall Study|Acute exacerbation|1
7862198|NCT01597245|12351204|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862199|NCT01597245|12351205|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862200|NCT01597245|12351206|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862201|NCT01597245|12351207|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862202|NCT01597245|12351208|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7862203|NCT01597245|12351188|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862204|NCT01597245|12351189|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862205|NCT01597245|12351190|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862206|NCT01597245|12351191|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862207|NCT01597245|12351192|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862208|NCT01597245|12351193|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862209|NCT01597245|12351194|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862210|NCT01597245|12351195|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862211|NCT01597245|12351196|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862212|NCT01597245|12351197|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862213|NCT01597245|12351198|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862214|NCT01597245|12351199|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862215|NCT01597245|12351200|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862216|NCT01597245|12351201|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862217|NCT01597245|12351202|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
7862218|NCT01597245|12351203|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
7862219|NCT01597245|12351204|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862220|NCT01597245|12351205|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862221|NCT01597245|12351206|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862222|NCT01597245|12351207|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7824646|NCT01279200|12294813|FG000|Overall Study|Withdrawal by Subject|1
7824647|NCT01279200|12294814|FG001|Overall Study|Withdrawal by Subject|3
7824648|NCT01279200|12294813|FG000|Overall Study|Patient withdrawal due to high cost|0
7824649|NCT01279200|12294814|FG001|Overall Study|Patient withdrawal due to high cost|1
7824650|NCT01279200|12294813|FG000|Overall Study|Inconvenience of ultrasound visit|0
7824651|NCT01279200|12294814|FG001|Overall Study|Inconvenience of ultrasound visit|1
7824652|NCT01279200|12294813|FG000|Overall Study|ultrasound screening failure|0
7824653|NCT01279200|12294814|FG001|Overall Study|ultrasound screening failure|1
7824654|NCT01279200|12294813|FG000|Overall Study|Lost to Follow-up|0
7824655|NCT01279200|12294814|FG001|Overall Study|Lost to Follow-up|1
7824656|NCT01279200|12294813|FG000|Overall Study|Adverse Event|1
7824657|NCT01279200|12294814|FG001|Overall Study|Adverse Event|0
7824658|NCT01279343|12294839|FG000|Overall Study|Did not receive treatment|2
7824659|NCT01279343|12294840|FG001|Overall Study|Did not receive treatment|6
7824660|NCT01279447|12294848|FG000|Overall Study|Lost to Follow-up|3
7824661|NCT01279447|12294849|FG001|Overall Study|Lost to Follow-up|1
7824662|NCT01279486|12294855|FG000|Overall Study|Lost to Follow-up|1
7824663|NCT01279681|12294870|FG000|Overall Study|Disease Progression|9
7824664|NCT01279681|12294871|FG001|Overall Study|Disease Progression|6
7824665|NCT01279681|12294870|FG000|Overall Study|Withdrawal by Subject|3
7824666|NCT01279681|12294871|FG001|Overall Study|Withdrawal by Subject|4
7824667|NCT01279681|12294870|FG000|Overall Study|Adverse Event|2
7824668|NCT01279681|12294871|FG001|Overall Study|Adverse Event|3
7824669|NCT01279681|12294870|FG000|Overall Study|Death|0
7824670|NCT01279681|12294871|FG001|Overall Study|Death|1
7824671|NCT01279681|12294870|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0
7824672|NCT01279681|12294871|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1
7824673|NCT01279681|12294870|FG000|Overall Study|Physician Decision|1
7824674|NCT01279681|12294871|FG001|Overall Study|Physician Decision|0
7824675|NCT01279681|12294870|FG000|Overall Study|Other Reason|0
7824676|NCT01279681|12294871|FG001|Overall Study|Other Reason|2
7824677|NCT01279850|12294877|FG000|Overall Study|Protocol Violation|50
7824678|NCT01279850|12294877|FG000|Overall Study|No Drug Administration Information|7
7824679|NCT01279850|12294877|FG000|Overall Study|No Visit After Treatment|34
7824680|NCT01279954|12294883|FG000|Overall Study|Lack of Efficacy|3
7824681|NCT01279954|12294884|FG001|Overall Study|Lack of Efficacy|4
7824682|NCT01280266|12294934|FG000|First Intervention (Week 1-4)|Adverse Event|1
7824683|NCT01280266|12294935|FG001|First Intervention (Week 1-4)|Adverse Event|0
7824684|NCT01280266|12294934|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0
7824685|NCT01280266|12294935|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2
7824686|NCT01280357|12294945|FG000|Overall Study|Excluded no internal monitoring|14
7824687|NCT01280357|12294945|FG000|Overall Study|IInsufficient data/No data supplied|12
7824688|NCT01280591|12294977|FG000|Overall Study|Withdrawal by Subject|0
7824689|NCT01280591|12294978|FG001|Overall Study|Withdrawal by Subject|0
7824690|NCT01280591|12294979|FG002|Overall Study|Withdrawal by Subject|0
7824691|NCT01280591|12294980|FG003|Overall Study|Withdrawal by Subject|2
7824692|NCT01280591|12294977|FG000|Overall Study|Does not meet exclusion #27 criteria|0
7824693|NCT01280591|12294978|FG001|Overall Study|Does not meet exclusion #27 criteria|0
7824694|NCT01280591|12294979|FG002|Overall Study|Does not meet exclusion #27 criteria|0
7824695|NCT01280591|12294980|FG003|Overall Study|Does not meet exclusion #27 criteria|1
7824696|NCT01280617|12295001|FG000|Overall Study|Adverse Event|0
7824697|NCT01280617|12295002|FG001|Overall Study|Adverse Event|1
7824698|NCT01280656|12295011|FG000|Overall Study|Adverse Event|1
7824699|NCT01280656|12295012|FG001|Overall Study|Adverse Event|14
7824700|NCT01280656|12295013|FG002|Overall Study|Adverse Event|13
7824701|NCT01280656|12295011|FG000|Overall Study|Lack of Efficacy|1
7824702|NCT01280656|12295012|FG001|Overall Study|Lack of Efficacy|22
7824703|NCT01280656|12295013|FG002|Overall Study|Lack of Efficacy|38
7824704|NCT01280656|12295011|FG000|Overall Study|Treatment shortening (RGT)|0
7824705|NCT01280656|12295012|FG001|Overall Study|Treatment shortening (RGT)|4
7824706|NCT01280656|12295013|FG002|Overall Study|Treatment shortening (RGT)|5
7824707|NCT01280656|12295011|FG000|Overall Study|Other|1
7824708|NCT01280656|12295012|FG001|Overall Study|Other|7
7824709|NCT01280656|12295013|FG002|Overall Study|Other|7
7824710|NCT01280721|12295042|FG000|Overall Study|Adverse Event|4
7824711|NCT01280721|12295042|FG000|Overall Study|Physician Decision|3
7824712|NCT01280721|12295042|FG000|Overall Study|Withdrawal by Subject|6
7824713|NCT01280721|12295042|FG000|Overall Study|eGFR under the withdrawal criteria|7
7824714|NCT01280721|12295042|FG000|Overall Study|No tolerability for the lowest dose|2
7824715|NCT01280812|12295060|FG000|Overall Study|Withdrawal by Subject|2
7824716|NCT01280812|12295061|FG001|Overall Study|Withdrawal by Subject|1
7824717|NCT01280812|12295062|FG002|Overall Study|Withdrawal by Subject|0
7824718|NCT01280812|12295060|FG000|Overall Study|Lost to Follow-up|1
7824719|NCT01280812|12295061|FG001|Overall Study|Lost to Follow-up|1
7824720|NCT01280812|12295062|FG002|Overall Study|Lost to Follow-up|1
7824721|NCT01280903|12295073|FG000|Overall Study|Lost to Follow-up|23
7824722|NCT01280903|12295074|FG001|Overall Study|Lost to Follow-up|16
7824723|NCT01280955|12295089|FG000|Overall Study|Death|2
7824724|NCT01280955|12295089|FG000|Overall Study|Withdrawal by Subject|1
7824725|NCT01280968|12295097|FG000|Overall Study|Lost to Follow-up|8
7824726|NCT01280968|12295098|FG001|Overall Study|Lost to Follow-up|2
7824727|NCT01280968|12295097|FG000|Overall Study|Unable to Follow Experimental Protocol|2
7824728|NCT01280968|12295098|FG001|Overall Study|Unable to Follow Experimental Protocol|0
7824729|NCT01280968|12295097|FG000|Overall Study|Commuting Problems|2
7824730|NCT01280968|12295098|FG001|Overall Study|Commuting Problems|0
7824731|NCT01280968|12295097|FG000|Overall Study|Anxiety|2
7824732|NCT01280968|12295098|FG001|Overall Study|Anxiety|0
7824733|NCT01280968|12295097|FG000|Overall Study|Adverse Event|1
7824734|NCT01280968|12295098|FG001|Overall Study|Adverse Event|0
7824735|NCT01280968|12295097|FG000|Overall Study|Scheduling Conflicts|1
7824736|NCT01280968|12295098|FG001|Overall Study|Scheduling Conflicts|1
7824737|NCT01280968|12295097|FG000|Overall Study|Pre-existing Neurological Condition|1
7824738|NCT01280968|12295098|FG001|Overall Study|Pre-existing Neurological Condition|0
7824739|NCT01280968|12295097|FG000|Overall Study|Unable to Smoke in Supine Position|1
7824740|NCT01280968|12295098|FG001|Overall Study|Unable to Smoke in Supine Position|0
7824741|NCT01280981|12295105|FG000|Overall Study|Withdrawal by Subject|11
7824742|NCT01280981|12295105|FG000|Overall Study|Protocol Violation|2
7824743|NCT01280981|12295105|FG000|Overall Study|Lack of Efficacy|13
7824744|NCT01280981|12295105|FG000|Overall Study|Lost to Follow-up|3
7824745|NCT01280981|12295105|FG000|Overall Study|Adverse Event|6
7824746|NCT01280981|12295105|FG000|Overall Study|Irregular or discontinued menses|3
7824747|NCT01280981|12295105|FG000|Overall Study|Failed to return|45
7824748|NCT01280981|12295105|FG000|Overall Study|Non-compliance with protocol|3
7824749|NCT01280981|12295105|FG000|Overall Study|Withdrawal of consent|3
7824750|NCT01280981|12295105|FG000|Overall Study|Elective surgery|2
7824751|NCT01280981|12295105|FG000|Overall Study|Study site closure|1
7824752|NCT01281137|12295120|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0
7824753|NCT01281137|12295121|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1
7824754|NCT01281137|12295120|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4
7824755|NCT01281137|12295121|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9
7824756|NCT01281137|12295120|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0
7824757|NCT01281137|12295121|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5
7824758|NCT01281137|12295120|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1
7824759|NCT01281137|12295121|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0
7824760|NCT01281137|12295120|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1
7824761|NCT01281137|12295121|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2
7824762|NCT01281189|12295147|FG000|Overall Study|Adverse Event|7
7824763|NCT01281189|12295148|FG001|Overall Study|Adverse Event|9
7824764|NCT01281189|12295147|FG000|Overall Study|Lost to Follow-up|6
7824765|NCT01281189|12295148|FG001|Overall Study|Lost to Follow-up|4
7824766|NCT01281189|12295147|FG000|Overall Study|Withdrawal by Subject|21
7824767|NCT01281189|12295148|FG001|Overall Study|Withdrawal by Subject|24
7824768|NCT01281189|12295147|FG000|Overall Study|Physician Decision|2
7824769|NCT01281189|12295148|FG001|Overall Study|Physician Decision|3
7824770|NCT01281189|12295147|FG000|Overall Study|Death|103
7824771|NCT01281189|12295148|FG001|Overall Study|Death|91
7824772|NCT01281189|12295147|FG000|Overall Study|Other|8
7824773|NCT01281189|12295148|FG001|Overall Study|Other|12
7824774|NCT01281202|12295156|FG000|Overall Study|Adverse Event|2
7824775|NCT01281202|12295157|FG001|Overall Study|Adverse Event|0
7824776|NCT01281202|12295156|FG000|Overall Study|Withdrawal by Subject|2
7824777|NCT01281202|12295157|FG001|Overall Study|Withdrawal by Subject|2
7824778|NCT01281202|12295156|FG000|Overall Study|Protocol Violation|11
7824779|NCT01281202|12295157|FG001|Overall Study|Protocol Violation|10
7824780|NCT01281202|12295156|FG000|Overall Study|Administrative|2
7824781|NCT01281202|12295157|FG001|Overall Study|Administrative|8
7824782|NCT01281202|12295156|FG000|Overall Study|Lost to Follow-up|11
7824783|NCT01281202|12295157|FG001|Overall Study|Lost to Follow-up|13
7824784|NCT01281202|12295156|FG000|Overall Study|Incarceration|0
7824785|NCT01281202|12295157|FG001|Overall Study|Incarceration|3
7824786|NCT01281306|12295172|FG000|Overall Study|Lack of Efficacy|0
7824787|NCT01281306|12295173|FG001|Overall Study|Lack of Efficacy|1
7824788|NCT01281306|12295174|FG002|Overall Study|Lack of Efficacy|3
7824789|NCT01281306|12295175|FG003|Overall Study|Lack of Efficacy|0
7824790|NCT01281306|12295176|FG004|Overall Study|Lack of Efficacy|2
7824791|NCT01281306|12295177|FG005|Overall Study|Lack of Efficacy|0
7824792|NCT01281306|12295178|FG006|Overall Study|Lack of Efficacy|1
7824793|NCT01281306|12295172|FG000|Overall Study|Withdrawal by Subject|1
7824794|NCT01281306|12295173|FG001|Overall Study|Withdrawal by Subject|0
7824795|NCT01281306|12295174|FG002|Overall Study|Withdrawal by Subject|2
7824796|NCT01281306|12295175|FG003|Overall Study|Withdrawal by Subject|4
7824797|NCT01281306|12295176|FG004|Overall Study|Withdrawal by Subject|1
7824798|NCT01281306|12295177|FG005|Overall Study|Withdrawal by Subject|3
7824799|NCT01281306|12295178|FG006|Overall Study|Withdrawal by Subject|1
7824800|NCT01281306|12295172|FG000|Overall Study|Protocol deviation|0
7824801|NCT01281306|12295173|FG001|Overall Study|Protocol deviation|1
7824802|NCT01281306|12295174|FG002|Overall Study|Protocol deviation|1
7824803|NCT01281306|12295175|FG003|Overall Study|Protocol deviation|1
7824804|NCT01281306|12295176|FG004|Overall Study|Protocol deviation|1
7824805|NCT01281306|12295177|FG005|Overall Study|Protocol deviation|0
7824806|NCT01281306|12295178|FG006|Overall Study|Protocol deviation|0
7824807|NCT01281306|12295172|FG000|Overall Study|Condition no longer requires study drug|1
7824808|NCT01281306|12295173|FG001|Overall Study|Condition no longer requires study drug|0
7824809|NCT01281306|12295174|FG002|Overall Study|Condition no longer requires study drug|0
7824810|NCT01281306|12295175|FG003|Overall Study|Condition no longer requires study drug|0
7824811|NCT01281306|12295176|FG004|Overall Study|Condition no longer requires study drug|0
7824812|NCT01281306|12295177|FG005|Overall Study|Condition no longer requires study drug|1
7824813|NCT01281306|12295178|FG006|Overall Study|Condition no longer requires study drug|1
7824814|NCT01281306|12295172|FG000|Overall Study|Lost to Follow-up|1
7824815|NCT01281306|12295173|FG001|Overall Study|Lost to Follow-up|0
7824816|NCT01281306|12295174|FG002|Overall Study|Lost to Follow-up|0
7824817|NCT01281306|12295175|FG003|Overall Study|Lost to Follow-up|2
7824818|NCT01281306|12295176|FG004|Overall Study|Lost to Follow-up|0
7824819|NCT01281306|12295177|FG005|Overall Study|Lost to Follow-up|0
7824820|NCT01281306|12295178|FG006|Overall Study|Lost to Follow-up|1
7824821|NCT01281306|12295172|FG000|Overall Study|Death|1
7824822|NCT01281306|12295173|FG001|Overall Study|Death|0
7824823|NCT01281306|12295174|FG002|Overall Study|Death|0
7824824|NCT01281306|12295175|FG003|Overall Study|Death|0
7824825|NCT01281306|12295176|FG004|Overall Study|Death|0
7824826|NCT01281306|12295177|FG005|Overall Study|Death|0
7824827|NCT01281306|12295178|FG006|Overall Study|Death|0
7824828|NCT01281306|12295172|FG000|Overall Study|Adverse Event|3
7824829|NCT01281306|12295173|FG001|Overall Study|Adverse Event|2
7824830|NCT01281306|12295174|FG002|Overall Study|Adverse Event|2
7824831|NCT01281306|12295175|FG003|Overall Study|Adverse Event|3
7824832|NCT01281306|12295176|FG004|Overall Study|Adverse Event|5
7824833|NCT01281306|12295177|FG005|Overall Study|Adverse Event|3
7824834|NCT01281306|12295178|FG006|Overall Study|Adverse Event|3
7824835|NCT01281306|12295172|FG000|Overall Study|Randomized in error|1
7824836|NCT01281306|12295173|FG001|Overall Study|Randomized in error|0
7824837|NCT01281306|12295174|FG002|Overall Study|Randomized in error|0
7824838|NCT01281306|12295175|FG003|Overall Study|Randomized in error|1
7824839|NCT01281306|12295176|FG004|Overall Study|Randomized in error|0
7824840|NCT01281306|12295177|FG005|Overall Study|Randomized in error|0
7824841|NCT01281306|12295178|FG006|Overall Study|Randomized in error|0
7824842|NCT01281839|12295216|FG000|Overall Study|Lost to Follow-up|6
7824843|NCT01281839|12295217|FG001|Overall Study|Lost to Follow-up|3
7824844|NCT01281839|12295216|FG000|Overall Study|Withdrawal by Subject|4
7824845|NCT01281839|12295217|FG001|Overall Study|Withdrawal by Subject|10
7824846|NCT01281839|12295216|FG000|Overall Study|Reason not specified|0
7824847|NCT01281839|12295217|FG001|Overall Study|Reason not specified|1
7824848|NCT01281865|12295225|FG000|Overall Study|Adverse Event|1
7824849|NCT01281865|12295226|FG001|Overall Study|Adverse Event|1
7824850|NCT01281865|12295225|FG000|Overall Study|Withdrawal by Subject|1
7824851|NCT01281865|12295226|FG001|Overall Study|Withdrawal by Subject|0
7824852|NCT01281865|12295225|FG000|Overall Study|Lack of Efficacy|1
7824853|NCT01281865|12295226|FG001|Overall Study|Lack of Efficacy|0
7824854|NCT01281917|12295232|FG000|Overall Study|Withdrawal by Subject|1
7824855|NCT01281956|12295236|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1
7824856|NCT01281956|12295237|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0
7824857|NCT01281969|12295248|FG000|Overall Study|not randomized didn't meet criteria|0
7824858|NCT01281969|12295249|FG001|Overall Study|not randomized didn't meet criteria|0
7824859|NCT01281969|12295250|FG002|Overall Study|not randomized didn't meet criteria|7
7824860|NCT01281969|12295248|FG000|Overall Study|AE during LP prior to IVIG admin|1
7824861|NCT01281969|12295249|FG001|Overall Study|AE during LP prior to IVIG admin|0
7824862|NCT01281969|12295250|FG002|Overall Study|AE during LP prior to IVIG admin|3
7824863|NCT01281969|12295248|FG000|Overall Study|not randomized, child consent not given|0
7824864|NCT01281969|12295249|FG001|Overall Study|not randomized, child consent not given|0
7824865|NCT01281969|12295250|FG002|Overall Study|not randomized, child consent not given|2
7824866|NCT01282164|12295274|FG000|Overall Study|Lack of hypoglycemia during ITT|1
7824867|NCT01282164|12295275|FG001|Overall Study|Lack of hypoglycemia during ITT|0
7824868|NCT01282203|12295289|FG000|Overall Study|Adverse Event|1
7824869|NCT01282229|12295296|FG000|Overall Study|Protocol Violation|2
7824870|NCT01282294|12295323|FG000|Overall Study|Lost to Follow-up|14
7824871|NCT01282294|12295323|FG000|Overall Study|Screening failure|1
7824872|NCT01282294|12295323|FG000|Overall Study|Adverse Event|1
7824873|NCT01282294|12295323|FG000|Overall Study|Patient non-compliance|2
7824874|NCT01282294|12295323|FG000|Overall Study|Physician Decision|1
7824875|NCT01282372|12295327|FG000|Overall Study|Lack of Efficacy / Exacerbation|25
7824876|NCT01282372|12295327|FG000|Overall Study|Lost to Follow-up|23
7824877|NCT01282372|12295327|FG000|Overall Study|Withdrawal by Subject|11
7824878|NCT01282372|12295327|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
7824879|NCT01282372|12295327|FG000|Overall Study|Death|1
7824880|NCT01282372|12295327|FG000|Overall Study|Presence of AE, Lack of Efficacy|1
7824881|NCT01282372|12295327|FG000|Overall Study|Presence of AE, Regression of Symptoms|1
7824882|NCT01282372|12295327|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
7824883|NCT01282372|12295327|FG000|Overall Study|Adverse Event|12
7824884|NCT01282424|12295338|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30
7824885|NCT01282424|12295338|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6
7824886|NCT01282424|12295338|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7
7824887|NCT01282424|12295338|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3
7824888|NCT01282424|12295338|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2
7824889|NCT01282424|12295338|FG000|Long-term Follow-up Period (5 Years)|Death|40
7824890|NCT01282424|12295338|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1
7824891|NCT01282424|12295338|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21
7824892|NCT01282463|12295345|FG000|Overall Study|Lost to Follow-up|1
7824893|NCT01282463|12295346|FG001|Overall Study|Lost to Follow-up|0
7824894|NCT01282463|12295347|FG002|Overall Study|Lost to Follow-up|0
7824895|NCT01282463|12295345|FG000|Overall Study|Withdrawal by Subject|6
7824896|NCT01282463|12295346|FG001|Overall Study|Withdrawal by Subject|2
7824897|NCT01282463|12295347|FG002|Overall Study|Withdrawal by Subject|3
7824898|NCT01282463|12295345|FG000|Overall Study|"Never Treated Death"|0
7824899|NCT01282463|12295346|FG001|Overall Study|"Never Treated Death"|1
7824900|NCT01282463|12295347|FG002|Overall Study|"Never Treated Death"|0
7824901|NCT01282463|12295345|FG000|Overall Study|"Never Treated PD"|0
7824902|NCT01282463|12295346|FG001|Overall Study|"Never Treated PD"|1
7824903|NCT01282463|12295347|FG002|Overall Study|"Never Treated PD"|0
7824904|NCT01282463|12295345|FG000|Overall Study|Protocol Violation|0
7824905|NCT01282463|12295346|FG001|Overall Study|Protocol Violation|0
7824906|NCT01282463|12295347|FG002|Overall Study|Protocol Violation|1
7824907|NCT01282463|12295345|FG000|Overall Study|Physician Decision|1
7824908|NCT01282463|12295346|FG001|Overall Study|Physician Decision|0
7824909|NCT01282463|12295347|FG002|Overall Study|Physician Decision|0
7824910|NCT01282476|12295363|FG000|Overall Study|Death|11
7824911|NCT01282801|12295377|FG000|Second Intervention|Emesis During Critical Breakfast|0
7824912|NCT01282801|12295378|FG001|Second Intervention|Emesis During Critical Breakfast|1
7824913|NCT01282814|12295386|FG000|First Intervention|Emesis During Dosing Interval|0
7824914|NCT01282814|12295387|FG001|First Intervention|Emesis During Dosing Interval|3
7824915|NCT01282814|12295386|FG000|Washout of 7 Days|Withdrawal by Subject|2
7824916|NCT01282814|12295387|FG001|Washout of 7 Days|Withdrawal by Subject|0
7824917|NCT01282866|12295393|FG000|Overall Study|Adverse Event|1
7824918|NCT01283009|12295399|FG000|Overall Study|Death|83
7824919|NCT01283009|12295400|FG001|Overall Study|Death|78
7824920|NCT01283009|12295399|FG000|Overall Study|Study ended early|23
7824921|NCT01283009|12295400|FG001|Overall Study|Study ended early|26
7824922|NCT01283009|12295399|FG000|Overall Study|Withdrawal by Subject|10
7824923|NCT01283009|12295400|FG001|Overall Study|Withdrawal by Subject|8
7824924|NCT01283009|12295399|FG000|Overall Study|Physician Decision|1
7824925|NCT01283009|12295400|FG001|Overall Study|Physician Decision|1
7824926|NCT01283009|12295399|FG000|Overall Study|Lost to Follow-up|1
7824927|NCT01283009|12295400|FG001|Overall Study|Lost to Follow-up|0
7824928|NCT01283009|12295399|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0
7824929|NCT01283009|12295400|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4
7824930|NCT01283035|12295411|FG000|Overall Study|Subject later found ineligible|1
7824931|NCT01283139|12295419|FG000|Overall Study|Lost to Follow-up|5
7824932|NCT01283139|12295420|FG001|Overall Study|Lost to Follow-up|2
7824933|NCT01283139|12295421|FG002|Overall Study|Lost to Follow-up|3
7824934|NCT01283139|12295422|FG003|Overall Study|Lost to Follow-up|1
7824935|NCT01283139|12295419|FG000|Overall Study|Withdrawal by Subject|8
7824936|NCT01283139|12295420|FG001|Overall Study|Withdrawal by Subject|8
7824937|NCT01283139|12295421|FG002|Overall Study|Withdrawal by Subject|6
7824938|NCT01283139|12295422|FG003|Overall Study|Withdrawal by Subject|8
7824939|NCT01283139|12295419|FG000|Overall Study|Death|2
7824940|NCT01283139|12295420|FG001|Overall Study|Death|0
7824941|NCT01283139|12295421|FG002|Overall Study|Death|2
7824942|NCT01283139|12295422|FG003|Overall Study|Death|2
7824943|NCT01283139|12295419|FG000|Overall Study|Lack of Efficacy|1
7824944|NCT01283139|12295420|FG001|Overall Study|Lack of Efficacy|2
7824945|NCT01283139|12295421|FG002|Overall Study|Lack of Efficacy|2
7824946|NCT01283139|12295422|FG003|Overall Study|Lack of Efficacy|1
7824947|NCT01283139|12295419|FG000|Overall Study|Early termination due to AE/SAE|1
7824948|NCT01283139|12295420|FG001|Overall Study|Early termination due to AE/SAE|1
7824949|NCT01283139|12295421|FG002|Overall Study|Early termination due to AE/SAE|0
7824950|NCT01283139|12295422|FG003|Overall Study|Early termination due to AE/SAE|0
7824951|NCT01283139|12295419|FG000|Overall Study|Participant's refusal to continue|0
7824952|NCT01283139|12295420|FG001|Overall Study|Participant's refusal to continue|3
7824953|NCT01283139|12295421|FG002|Overall Study|Participant's refusal to continue|1
7824954|NCT01283139|12295422|FG003|Overall Study|Participant's refusal to continue|1
7824955|NCT01283139|12295419|FG000|Overall Study|Pregnancy|0
7824956|NCT01283139|12295420|FG001|Overall Study|Pregnancy|1
7824957|NCT01283139|12295421|FG002|Overall Study|Pregnancy|1
7824958|NCT01283139|12295422|FG003|Overall Study|Pregnancy|0
7824959|NCT01283139|12295419|FG000|Overall Study|Missed follow-up visit|0
7824960|NCT01283139|12295420|FG001|Overall Study|Missed follow-up visit|1
7824961|NCT01283139|12295421|FG002|Overall Study|Missed follow-up visit|2
7824962|NCT01283139|12295422|FG003|Overall Study|Missed follow-up visit|2
7824963|NCT01283139|12295419|FG000|Overall Study|Participant randomized in error|0
7824964|NCT01283139|12295420|FG001|Overall Study|Participant randomized in error|0
7824965|NCT01283139|12295421|FG002|Overall Study|Participant randomized in error|1
7824966|NCT01283139|12295422|FG003|Overall Study|Participant randomized in error|0
7824967|NCT01283152|12295434|FG000|Overall Study|Discharged prior to 24 hr assessment|1
7824968|NCT01283152|12295435|FG001|Overall Study|Discharged prior to 24 hr assessment|0
7824969|NCT01283152|12295434|FG000|Overall Study|Refused HESA|1
7824970|NCT01283152|12295435|FG001|Overall Study|Refused HESA|0
7824971|NCT01283282|12295441|FG000|First Intervention (6 Weeks)|Physician Decision|0
7824972|NCT01283282|12295442|FG001|First Intervention (6 Weeks)|Physician Decision|1
7824973|NCT01283282|12295441|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2
7824974|NCT01283282|12295442|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3
7824975|NCT01283282|12295441|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1
7824976|NCT01283282|12295442|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0
7824977|NCT01283334|12295460|FG000|Overall Study|Withdrawal by Subject|1
7824978|NCT01283334|12295460|FG000|Overall Study|Inability to Swallow Everolimus Pills|1
7824979|NCT01283334|12295460|FG000|Overall Study|Adverse Event|4
7824980|NCT01283334|12295460|FG000|Overall Study|Physician Decision|1
7824981|NCT01283386|12295468|FG000|Overall Study|Death|2
7824982|NCT01283386|12295469|FG001|Overall Study|Death|0
7824983|NCT01283386|12295468|FG000|Overall Study|Withdrawal by Subject|2
7824984|NCT01283386|12295469|FG001|Overall Study|Withdrawal by Subject|1
7720039|NCT00536263|12144307|FG001|Overall Study|Subject withdrew - not treatment related|0
7720040|NCT00536263|12144308|FG002|Overall Study|Subject withdrew - not treatment related|5
7720041|NCT00536263|12144306|FG000|Overall Study|Subject withdrew - treatment related|0
7720042|NCT00536263|12144307|FG001|Overall Study|Subject withdrew - treatment related|3
7824985|NCT01283386|12295468|FG000|Overall Study|Relapse of underlying disease|1
7824986|NCT01283386|12295469|FG001|Overall Study|Relapse of underlying disease|3
7824987|NCT01283386|12295468|FG000|Overall Study|Progression of underlying disease|2
7824988|NCT01283386|12295469|FG001|Overall Study|Progression of underlying disease|7
7824989|NCT01283386|12295468|FG000|Overall Study|Reason not specified|1
7824990|NCT01283386|12295469|FG001|Overall Study|Reason not specified|0
7824991|NCT01283386|12295468|FG000|Overall Study|Protocol Violation|0
7824992|NCT01283386|12295469|FG001|Overall Study|Protocol Violation|1
7824993|NCT01283464|12295477|FG000|Overall Study|Lost to Follow-up|0
7824994|NCT01283464|12295478|FG001|Overall Study|Lost to Follow-up|1
7824995|NCT01283464|12295477|FG000|Overall Study|Withdrawal by Subject|1
7824996|NCT01283464|12295478|FG001|Overall Study|Withdrawal by Subject|0
7824997|NCT01283464|12295477|FG000|Overall Study|Physician Decision|1
7824998|NCT01283464|12295478|FG001|Overall Study|Physician Decision|0
7824999|NCT01283516|12295493|FG000|Overall Study|Adverse Event|0
7825000|NCT01283516|12295494|FG001|Overall Study|Adverse Event|0
7825001|NCT01283516|12295495|FG002|Overall Study|Adverse Event|0
7825002|NCT01283516|12295496|FG003|Overall Study|Adverse Event|0
7825003|NCT01283516|12295497|FG004|Overall Study|Adverse Event|0
7825004|NCT01283516|12295498|FG005|Overall Study|Adverse Event|0
7825005|NCT01283516|12295499|FG006|Overall Study|Adverse Event|2
7825006|NCT01283516|12295500|FG007|Overall Study|Adverse Event|0
7825007|NCT01283516|12295501|FG008|Overall Study|Adverse Event|28
7825008|NCT01283516|12295493|FG000|Overall Study|Death|0
7825009|NCT01283516|12295494|FG001|Overall Study|Death|0
7825010|NCT01283516|12295495|FG002|Overall Study|Death|0
7825011|NCT01283516|12295496|FG003|Overall Study|Death|0
7825012|NCT01283516|12295497|FG004|Overall Study|Death|0
7825013|NCT01283516|12295498|FG005|Overall Study|Death|1
7825014|NCT01283516|12295499|FG006|Overall Study|Death|0
7825015|NCT01283516|12295500|FG007|Overall Study|Death|1
7825016|NCT01283516|12295501|FG008|Overall Study|Death|12
7825017|NCT01283516|12295493|FG000|Overall Study|Disease Progression|2
7825018|NCT01283516|12295494|FG001|Overall Study|Disease Progression|2
7825019|NCT01283516|12295495|FG002|Overall Study|Disease Progression|3
7825020|NCT01283516|12295496|FG003|Overall Study|Disease Progression|3
7825021|NCT01283516|12295497|FG004|Overall Study|Disease Progression|13
7825022|NCT01283516|12295498|FG005|Overall Study|Disease Progression|8
7825023|NCT01283516|12295499|FG006|Overall Study|Disease Progression|6
7825024|NCT01283516|12295500|FG007|Overall Study|Disease Progression|3
7825025|NCT01283516|12295501|FG008|Overall Study|Disease Progression|139
7825026|NCT01283516|12295493|FG000|Overall Study|Withdrawal by Subject|0
7825027|NCT01283516|12295494|FG001|Overall Study|Withdrawal by Subject|0
7825028|NCT01283516|12295495|FG002|Overall Study|Withdrawal by Subject|0
7825029|NCT01283516|12295496|FG003|Overall Study|Withdrawal by Subject|0
7825030|NCT01283516|12295497|FG004|Overall Study|Withdrawal by Subject|1
7825031|NCT01283516|12295498|FG005|Overall Study|Withdrawal by Subject|0
7825032|NCT01283516|12295499|FG006|Overall Study|Withdrawal by Subject|1
7825033|NCT01283516|12295500|FG007|Overall Study|Withdrawal by Subject|0
7825034|NCT01283516|12295501|FG008|Overall Study|Withdrawal by Subject|36
7825035|NCT01283516|12295493|FG000|Overall Study|Administrative problems|0
7825036|NCT01283516|12295494|FG001|Overall Study|Administrative problems|0
7825037|NCT01283516|12295495|FG002|Overall Study|Administrative problems|0
7825038|NCT01283516|12295496|FG003|Overall Study|Administrative problems|0
7825039|NCT01283516|12295497|FG004|Overall Study|Administrative problems|0
7825040|NCT01283516|12295498|FG005|Overall Study|Administrative problems|1
7825041|NCT01283516|12295499|FG006|Overall Study|Administrative problems|1
7825042|NCT01283516|12295500|FG007|Overall Study|Administrative problems|1
7825043|NCT01283516|12295501|FG008|Overall Study|Administrative problems|39
7825044|NCT01283516|12295493|FG000|Overall Study|Lost to Follow-up|0
7825045|NCT01283516|12295494|FG001|Overall Study|Lost to Follow-up|0
7825046|NCT01283516|12295495|FG002|Overall Study|Lost to Follow-up|0
7825047|NCT01283516|12295496|FG003|Overall Study|Lost to Follow-up|0
7825048|NCT01283516|12295497|FG004|Overall Study|Lost to Follow-up|0
7825049|NCT01283516|12295498|FG005|Overall Study|Lost to Follow-up|0
7825050|NCT01283516|12295499|FG006|Overall Study|Lost to Follow-up|0
7825051|NCT01283516|12295500|FG007|Overall Study|Lost to Follow-up|0
7825052|NCT01283516|12295501|FG008|Overall Study|Lost to Follow-up|1
7825053|NCT01283542|12295529|FG000|Main Phase|Acute or progressive vision loss|1
7825054|NCT01283542|12295529|FG000|Main Phase|Uncontrolled diabetes mellitus|1
7825055|NCT01283542|12295529|FG000|Main Phase|abnormal laboratory values|5
7825056|NCT01283542|12295529|FG000|Extension Phase|Physician Decision|1
7825057|NCT01283542|12295529|FG000|Extension Phase|Adverse Event|1
7825058|NCT01283542|12295529|FG000|Extension Phase|Administrative problems|1
7825059|NCT01283581|12295565|FG000|Overall Study|Lost to Follow-up|8
7825060|NCT01283581|12295566|FG001|Overall Study|Lost to Follow-up|6
7825061|NCT01283581|12295567|FG002|Overall Study|Lost to Follow-up|8
7825062|NCT01283581|12295565|FG000|Overall Study|Withdrawal by Subject|2
7825063|NCT01283581|12295566|FG001|Overall Study|Withdrawal by Subject|5
7825064|NCT01283581|12295567|FG002|Overall Study|Withdrawal by Subject|2
7825065|NCT01283581|12295565|FG000|Overall Study|Adverse Event|1
7825066|NCT01283581|12295566|FG001|Overall Study|Adverse Event|1
7825067|NCT01283581|12295567|FG002|Overall Study|Adverse Event|4
7825068|NCT01283581|12295565|FG000|Overall Study|Physician Decision|0
7825069|NCT01283581|12295566|FG001|Overall Study|Physician Decision|1
7825070|NCT01283581|12295567|FG002|Overall Study|Physician Decision|2
7825071|NCT01283581|12295565|FG000|Overall Study|Protocol Violation|0
7825072|NCT01283581|12295566|FG001|Overall Study|Protocol Violation|1
7825073|NCT01283581|12295567|FG002|Overall Study|Protocol Violation|2
7825074|NCT01283581|12295565|FG000|Overall Study|Noncompliance|1
7825075|NCT01283581|12295566|FG001|Overall Study|Noncompliance|0
7825076|NCT01283581|12295567|FG002|Overall Study|Noncompliance|0
7825077|NCT01283581|12295565|FG000|Overall Study|Investigator unblinded|0
7825078|NCT01283581|12295566|FG001|Overall Study|Investigator unblinded|0
7825079|NCT01283581|12295567|FG002|Overall Study|Investigator unblinded|1
7825080|NCT01283581|12295565|FG000|Overall Study|"Early termination"|0
7825081|NCT01283581|12295566|FG001|Overall Study|"Early termination"|0
7825082|NCT01283581|12295567|FG002|Overall Study|"Early termination"|1
7825083|NCT01283971|12295580|FG000|Overall Study|Adverse Event|3
7825084|NCT01283971|12295581|FG001|Overall Study|Adverse Event|5
7825085|NCT01283971|12295580|FG000|Overall Study|Insufficient therapeutic responses|3
7825086|NCT01283971|12295581|FG001|Overall Study|Insufficient therapeutic responses|3
7825087|NCT01283971|12295580|FG000|Overall Study|Protocol Violation|5
7825088|NCT01283971|12295581|FG001|Overall Study|Protocol Violation|1
7825089|NCT01283971|12295580|FG000|Overall Study|Refused treatment|3
7825090|NCT01283971|12295581|FG001|Overall Study|Refused treatment|1
7825091|NCT01283971|12295580|FG000|Overall Study|Failure to return|0
7825092|NCT01283971|12295581|FG001|Overall Study|Failure to return|1
7825093|NCT01283971|12295580|FG000|Overall Study|Administrative reasons|1
7825094|NCT01283971|12295581|FG001|Overall Study|Administrative reasons|1
7825095|NCT01284062|12295591|FG000|Overall Study|Adverse Event|4
7825096|NCT01284062|12295592|FG001|Overall Study|Adverse Event|5
7825097|NCT01284062|12295593|FG002|Overall Study|Adverse Event|0
7825098|NCT01284062|12295594|FG003|Overall Study|Adverse Event|5
7825099|NCT01284062|12295591|FG000|Overall Study|Lack of Efficacy|3
7825100|NCT01284062|12295592|FG001|Overall Study|Lack of Efficacy|2
7825101|NCT01284062|12295593|FG002|Overall Study|Lack of Efficacy|2
7825102|NCT01284062|12295594|FG003|Overall Study|Lack of Efficacy|1
7825103|NCT01284062|12295591|FG000|Overall Study|Medication error without adverse event|0
7825104|NCT01284062|12295592|FG001|Overall Study|Medication error without adverse event|0
7825105|NCT01284062|12295593|FG002|Overall Study|Medication error without adverse event|1
7825106|NCT01284062|12295594|FG003|Overall Study|Medication error without adverse event|0
7825107|NCT01284062|12295591|FG000|Overall Study|Protocol Violation|1
7825108|NCT01284062|12295592|FG001|Overall Study|Protocol Violation|0
7825109|NCT01284062|12295593|FG002|Overall Study|Protocol Violation|0
7825110|NCT01284062|12295594|FG003|Overall Study|Protocol Violation|2
7825111|NCT01284062|12295591|FG000|Overall Study|Withdrawal by Subject|3
7825112|NCT01284062|12295592|FG001|Overall Study|Withdrawal by Subject|1
7825113|NCT01284062|12295593|FG002|Overall Study|Withdrawal by Subject|2
7825114|NCT01284062|12295594|FG003|Overall Study|Withdrawal by Subject|5
7825115|NCT01284062|12295591|FG000|Overall Study|Other|0
7825116|NCT01284062|12295592|FG001|Overall Study|Other|0
7825117|NCT01284062|12295593|FG002|Overall Study|Other|0
7825118|NCT01284062|12295594|FG003|Overall Study|Other|1
7825119|NCT01284062|12295591|FG000|Overall Study|Site Closed|0
7825120|NCT01284062|12295592|FG001|Overall Study|Site Closed|0
7825121|NCT01284062|12295593|FG002|Overall Study|Site Closed|1
7825122|NCT01284062|12295594|FG003|Overall Study|Site Closed|0
7825123|NCT01284114|12295607|FG000|Overall Study|viral infection|1
7825124|NCT01284114|12295607|FG000|Overall Study|From the results of ALLTITUDE study|1
7825125|NCT01284114|12295607|FG000|Overall Study|Symptomatic hypotension|1
7825126|NCT01284114|12295607|FG000|Overall Study|dizziness|1
7825127|NCT01284127|12295612|FG000|Overall Study|Adverse Event|2
7825128|NCT01284127|12295612|FG000|Overall Study|Withdrawal by Subject|4
7825129|NCT01284127|12295612|FG000|Overall Study|Physician Decision|1
7825130|NCT01284140|12295618|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
7825131|NCT01284140|12295619|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
7825132|NCT01284140|12295618|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
7825133|NCT01284140|12295619|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
7825134|NCT01284361|12295704|FG000|Overall Study|Withdrawal by Subject|1
7825135|NCT01284361|12295704|FG000|Overall Study|Protocol Violation|5
7825136|NCT01284361|12295704|FG000|Overall Study|Adverse Event|1
7825137|NCT01284361|12295704|FG000|Overall Study|Lost to Follow-up|2
7825138|NCT01284621|12295724|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
7825139|NCT01284621|12295725|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
7825140|NCT01284621|12295726|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
7825141|NCT01284621|12295727|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
7825142|NCT01284621|12295728|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
7825143|NCT01284621|12295729|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
7825144|NCT01284634|12295743|FG000|Overall Study|Adverse Event|1
7825145|NCT01284634|12295744|FG001|Overall Study|Adverse Event|0
7825146|NCT01284634|12295745|FG002|Overall Study|Adverse Event|2
7825147|NCT01284634|12295746|FG003|Overall Study|Adverse Event|1
7825148|NCT01284959|12295759|FG000|Overall Study|Withdrawal by Subject|1
7825149|NCT01284959|12295760|FG001|Overall Study|Withdrawal by Subject|0
7948174|NCT02525874|12493347|FG000|Overall Study|Lost to Follow-up|7
7948175|NCT02525874|12493347|FG000|Overall Study|Disease progression, defined by protocol|2
7948176|NCT02525874|12493347|FG000|Overall Study|Disease relapse|4
7948177|NCT02525874|12493347|FG000|Overall Study|Alternative Treatment for MS|2
7825150|NCT01284959|12295761|FG002|Overall Study|Withdrawal by Subject|0
7825151|NCT01284959|12295759|FG000|Overall Study|Adverse Event|0
7825152|NCT01284959|12295760|FG001|Overall Study|Adverse Event|0
7825153|NCT01284959|12295761|FG002|Overall Study|Adverse Event|1
7825154|NCT01285310|12295790|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
7825155|NCT01285310|12295791|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
7825156|NCT01285310|12295792|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
7825157|NCT01285310|12295793|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
7825158|NCT01285310|12295794|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
7825159|NCT01285310|12295790|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
7825160|NCT01285310|12295791|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
7825161|NCT01285310|12295792|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
7825162|NCT01285310|12295793|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
7825163|NCT01285310|12295794|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
7825164|NCT01285310|12295790|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
7825165|NCT01285310|12295791|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
7825166|NCT01285310|12295792|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
7825167|NCT01285310|12295793|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
7825168|NCT01285310|12295794|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
7825169|NCT01285310|12295790|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
7825170|NCT01285310|12295791|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
7825171|NCT01285310|12295792|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
7948178|NCT02525874|12493347|FG000|Overall Study|New lesions in Brain|1
7825172|NCT01285310|12295793|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
7825173|NCT01285310|12295794|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
7825174|NCT01285310|12295790|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
7825175|NCT01285310|12295791|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
7825176|NCT01285310|12295792|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
7825177|NCT01285310|12295793|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
7825178|NCT01285310|12295794|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
7825179|NCT01285310|12295790|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1
7825180|NCT01285310|12295791|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0
7825181|NCT01285310|12295792|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1
7825182|NCT01285310|12295793|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0
7825183|NCT01285310|12295794|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0
7825184|NCT01285310|12295790|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0
7825185|NCT01285310|12295791|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2
7825186|NCT01285310|12295792|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3
7825187|NCT01285310|12295793|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0
7825188|NCT01285310|12295794|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2
7825189|NCT01285310|12295790|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
7825190|NCT01285310|12295791|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
7825191|NCT01285310|12295792|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
7825192|NCT01285310|12295793|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
7825193|NCT01285310|12295794|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
7825194|NCT01285310|12295790|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
7825195|NCT01285310|12295791|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
7825196|NCT01285310|12295792|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
7825197|NCT01285310|12295793|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
7825198|NCT01285310|12295794|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
7825199|NCT01285310|12295790|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
7825200|NCT01285310|12295791|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
7825201|NCT01285310|12295792|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
7825202|NCT01285310|12295793|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
7965844|NCT02739269|12521217|FG000|Overall Study|Cycle cancellation|2
7965845|NCT02739269|12521218|FG001|Overall Study|Cycle cancellation|2
7965846|NCT02739269|12521217|FG000|Overall Study|Withdrawal by Subject|0
7965847|NCT02739269|12521218|FG001|Overall Study|Withdrawal by Subject|2
7965848|NCT02739321|12521226|FG000|Overall Study|Lack of Efficacy|1
7965849|NCT02739321|12521227|FG001|Overall Study|Lack of Efficacy|1
7965850|NCT02739321|12521226|FG000|Overall Study|Lost to Follow-up|1
7965851|NCT02739321|12521227|FG001|Overall Study|Lost to Follow-up|1
7965852|NCT02739321|12521226|FG000|Overall Study|Withdrawal by Subject|1
7965853|NCT02739321|12521227|FG001|Overall Study|Withdrawal by Subject|2
7965854|NCT02739360|12521242|FG000|Overall Study|Adverse Event|1
7965855|NCT02739360|12521242|FG000|Overall Study|Study terminated by Sponsor|2
7965856|NCT02739594|12521248|FG000|Overall Study|Undesired Event|3
7965857|NCT02739594|12521249|FG001|Overall Study|Undesired Event|4
7965858|NCT02739594|12521248|FG000|Overall Study|Violation of Eligibility Criteria|1
7825203|NCT01285310|12295794|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
7825204|NCT01285310|12295790|FG000|Active Treatment Phase: Weeks 25-52|Other|0
7825205|NCT01285310|12295791|FG001|Active Treatment Phase: Weeks 25-52|Other|1
7825206|NCT01285310|12295792|FG002|Active Treatment Phase: Weeks 25-52|Other|0
7825207|NCT01285310|12295793|FG003|Active Treatment Phase: Weeks 25-52|Other|0
7825208|NCT01285310|12295794|FG004|Active Treatment Phase: Weeks 25-52|Other|0
7825209|NCT01285310|12295790|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0
7825210|NCT01285310|12295791|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1
7825211|NCT01285310|12295792|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1
7825212|NCT01285310|12295793|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1
7825213|NCT01285310|12295794|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0
7825214|NCT01285323|12295834|FG000|Overall Study|Adverse Event|9
7825215|NCT01285323|12295835|FG001|Overall Study|Adverse Event|8
7825216|NCT01285323|12295834|FG000|Overall Study|Lack of Efficacy|4
7825217|NCT01285323|12295835|FG001|Overall Study|Lack of Efficacy|2
7825218|NCT01285323|12295834|FG000|Overall Study|Withdrawal by Subject|15
7825219|NCT01285323|12295835|FG001|Overall Study|Withdrawal by Subject|11
7825220|NCT01285323|12295834|FG000|Overall Study|Protocol Violation|1
7825221|NCT01285323|12295835|FG001|Overall Study|Protocol Violation|2
7825222|NCT01285323|12295834|FG000|Overall Study|Non-compliance with study procedures|2
7825223|NCT01285323|12295835|FG001|Overall Study|Non-compliance with study procedures|3
7825224|NCT01285323|12295834|FG000|Overall Study|Lost to Follow-up|1
7825225|NCT01285323|12295835|FG001|Overall Study|Lost to Follow-up|1
7825226|NCT01285323|12295834|FG000|Overall Study|Other|1
7825227|NCT01285323|12295835|FG001|Overall Study|Other|3
7825228|NCT01285349|12295844|FG000|Overall Study|Lost to Follow-up|27
7825229|NCT01285349|12295845|FG001|Overall Study|Lost to Follow-up|20
7825230|NCT01285349|12295846|FG002|Overall Study|Lost to Follow-up|27
7825231|NCT01285401|12295857|FG000|Overall Study|Prematurely withdrawn from the study|17
7825232|NCT01285401|12295858|FG001|Overall Study|Prematurely withdrawn from the study|29
7825233|NCT01285492|12295878|FG000|Overall Study|Adverse Event|11
7825234|NCT01285492|12295879|FG001|Overall Study|Adverse Event|0
7825235|NCT01285492|12295878|FG000|Overall Study|Protocol Violation|3
7825236|NCT01285492|12295879|FG001|Overall Study|Protocol Violation|0
7825237|NCT01285492|12295878|FG000|Overall Study|Withdrawal by Subject|2
7825238|NCT01285492|12295879|FG001|Overall Study|Withdrawal by Subject|1
7825239|NCT01285492|12295878|FG000|Overall Study|Death|1
7825240|NCT01285492|12295879|FG001|Overall Study|Death|0
7825241|NCT01285518|12295893|FG000|Overall Study|Lost to Follow-up|0
7825242|NCT01285518|12295894|FG001|Overall Study|Lost to Follow-up|0
7825243|NCT01285518|12295895|FG002|Overall Study|Lost to Follow-up|0
7825244|NCT01285518|12295896|FG003|Overall Study|Lost to Follow-up|0
7825245|NCT01285518|12295897|FG004|Overall Study|Lost to Follow-up|0
7825246|NCT01285518|12295898|FG005|Overall Study|Lost to Follow-up|1
7825247|NCT01285518|12295899|FG006|Overall Study|Lost to Follow-up|0
7825248|NCT01285518|12295900|FG007|Overall Study|Lost to Follow-up|0
7825249|NCT01285609|12295921|FG000|Randomized|Progressive Disease|41
7825250|NCT01285609|12295922|FG001|Randomized|Progressive Disease|61
7825251|NCT01285609|12295921|FG000|Randomized|Adverse Event Unrelated to Study Drug|18
7825252|NCT01285609|12295922|FG001|Randomized|Adverse Event Unrelated to Study Drug|18
7825253|NCT01285609|12295921|FG000|Randomized|Study Drug Toxicity|13
7825254|NCT01285609|12295922|FG001|Randomized|Study Drug Toxicity|14
7825255|NCT01285609|12295921|FG000|Randomized|Death|5
7825256|NCT01285609|12295922|FG001|Randomized|Death|7
7825257|NCT01285609|12295921|FG000|Randomized|Withdrawal by Subject|8
7825258|NCT01285609|12295922|FG001|Randomized|Withdrawal by Subject|11
7825259|NCT01285609|12295921|FG000|Randomized|Subject No Longer Met Study Criteria|1
7825260|NCT01285609|12295922|FG001|Randomized|Subject No Longer Met Study Criteria|1
7825261|NCT01285609|12295921|FG000|Randomized|Undisclosed Reasons|1
7825262|NCT01285609|12295922|FG001|Randomized|Undisclosed Reasons|0
7825263|NCT01285609|12295921|FG000|Randomized|Randomized but not Treated|4
7825264|NCT01285609|12295922|FG001|Randomized|Randomized but not Treated|4
7825265|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Progressive Disease|223
7825266|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Progressive Disease|305
7825267|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87
7825268|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14
7825269|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
7825270|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
7825271|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20
7825272|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7
7825273|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Death|11
7825274|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Death|3
7825275|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2
7825276|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4
7825277|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Not Reported|0
7825278|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Not Reported|2
7825279|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1
7825280|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2
7825281|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
7825282|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
7825283|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
7825284|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
7825285|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Physician and Patient decision|1
7825286|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Physician and Patient decision|3
7825287|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Participant refused participation|1
7825288|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Participant refused participation|0
7825289|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1
7825290|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0
7825291|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Participant hospitalized|1
7825292|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Participant hospitalized|0
7825293|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Investigator's assessment|1
7825294|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Investigator's assessment|0
7825295|NCT01285609|12295921|FG000|Treated With Blinded Therapy|PI decision to discontinue|0
7825296|NCT01285609|12295922|FG001|Treated With Blinded Therapy|PI decision to discontinue|1
7825297|NCT01285609|12295921|FG000|Treated With Blinded Therapy|Worsening of general condition|0
7825298|NCT01285609|12295922|FG001|Treated With Blinded Therapy|Worsening of general condition|1
7862223|NCT01597245|12351208|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7862224|NCT01597245|12351188|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862225|NCT01597245|12351189|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862226|NCT01597245|12351190|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862227|NCT01597245|12351191|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862228|NCT01597245|12351192|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862229|NCT01597245|12351193|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862230|NCT01597245|12351194|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862231|NCT01597245|12351195|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862232|NCT01597245|12351196|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862233|NCT01597245|12351197|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862234|NCT01597245|12351198|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862235|NCT01597245|12351199|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862236|NCT01597245|12351200|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862237|NCT01597245|12351201|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23
7862238|NCT01597245|12351202|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862239|NCT01597245|12351203|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862240|NCT01597245|12351204|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862241|NCT01597245|12351205|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862242|NCT01597245|12351206|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862243|NCT01597245|12351207|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862244|NCT01597245|12351208|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7862245|NCT01597245|12351188|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862246|NCT01597245|12351189|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862247|NCT01597245|12351190|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862248|NCT01597245|12351191|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862249|NCT01597245|12351192|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862250|NCT01597245|12351193|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862251|NCT01597245|12351194|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862252|NCT01597245|12351195|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862253|NCT01597245|12351196|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862254|NCT01597245|12351197|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862255|NCT01597245|12351198|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862256|NCT01597245|12351199|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862257|NCT01597245|12351200|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862258|NCT01597245|12351201|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862259|NCT01597245|12351202|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862260|NCT01597245|12351203|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7862261|NCT01597245|12351204|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9
7862262|NCT01597245|12351205|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5
7862263|NCT01597245|12351206|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8
7862264|NCT01597245|12351207|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63
7862265|NCT01597245|12351208|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13
7862266|NCT01597245|12351188|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7862267|NCT01597245|12351189|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7862268|NCT01597245|12351190|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7862269|NCT01597245|12351191|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7862270|NCT01597245|12351192|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7862271|NCT01597245|12351193|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7862272|NCT01597245|12351194|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7825299|NCT01285908|12295977|FG000|Baseline Measurement|unable to insert catheter|1
7825300|NCT01285908|12295978|FG001|Baseline Measurement|unable to insert catheter|0
7825301|NCT01285908|12295979|FG002|Baseline Measurement|unable to insert catheter|0
7825302|NCT01285908|12295977|FG000|Baseline Measurement|History of stroke, exclusion criteria|1
7825303|NCT01285908|12295978|FG001|Baseline Measurement|History of stroke, exclusion criteria|0
7825304|NCT01285908|12295979|FG002|Baseline Measurement|History of stroke, exclusion criteria|0
7825305|NCT01285908|12295977|FG000|Baseline Measurement|unable to tolerate procedure|1
7825306|NCT01285908|12295978|FG001|Baseline Measurement|unable to tolerate procedure|0
7825307|NCT01285908|12295979|FG002|Baseline Measurement|unable to tolerate procedure|0
7825308|NCT01285960|12296009|FG000|Overall Study|Withdrawal by Subject|2
7825309|NCT01285960|12296009|FG000|Overall Study|Lost to Follow-up|2
7825310|NCT01285960|12296009|FG000|Overall Study|2 subjects received less 10 sonications|2
7825311|NCT01286012|12296015|FG000|Overall Study|Adverse Event|3
7825312|NCT01286012|12296016|FG001|Overall Study|Adverse Event|3
7825313|NCT01286012|12296015|FG000|Overall Study|Death|2
7825314|NCT01286012|12296016|FG001|Overall Study|Death|3
7825315|NCT01286012|12296015|FG000|Overall Study|Protocol Violation|1
7825316|NCT01286012|12296016|FG001|Overall Study|Protocol Violation|1
7825317|NCT01286012|12296015|FG000|Overall Study|Withdrawal by Subject|4
7825318|NCT01286012|12296016|FG001|Overall Study|Withdrawal by Subject|4
7825319|NCT01286012|12296015|FG000|Overall Study|Physician Decision|2
7825320|NCT01286012|12296016|FG001|Overall Study|Physician Decision|0
7825321|NCT01286012|12296015|FG000|Overall Study|peritoneal dialysis, randomized in error|1
7825322|NCT01286012|12296016|FG001|Overall Study|peritoneal dialysis, randomized in error|3
7825323|NCT01286077|12296025|FG000|Overall Study|Adverse Event|2
7825324|NCT01286077|12296026|FG001|Overall Study|Adverse Event|0
7825325|NCT01286077|12296025|FG000|Overall Study|Death|1
7825326|NCT01286077|12296026|FG001|Overall Study|Death|0
7825327|NCT01286077|12296025|FG000|Overall Study|Protocol Violation|1
7825328|NCT01286077|12296026|FG001|Overall Study|Protocol Violation|1
7825329|NCT01286077|12296025|FG000|Overall Study|Withdrawal by Subject|0
7825330|NCT01286077|12296026|FG001|Overall Study|Withdrawal by Subject|2
7825331|NCT01286077|12296025|FG000|Overall Study|Intercurrent illness|1
7825332|NCT01286077|12296026|FG001|Overall Study|Intercurrent illness|0
7825333|NCT01286077|12296025|FG000|Overall Study|Non-compliance|1
7825334|NCT01286077|12296026|FG001|Overall Study|Non-compliance|0
7825335|NCT01286077|12296025|FG000|Overall Study|The subject starts with alternative MMY|0
7825336|NCT01286077|12296026|FG001|Overall Study|The subject starts with alternative MMY|3
7825337|NCT01286077|12296025|FG000|Overall Study|Patient's decision to stop treatment|3
7825338|NCT01286077|12296026|FG001|Overall Study|Patient's decision to stop treatment|0
7825339|NCT01286077|12296025|FG000|Overall Study|Progression of disease|0
7825340|NCT01286077|12296026|FG001|Overall Study|Progression of disease|1
7825341|NCT01286077|12296025|FG000|Overall Study|refill medication not received in time|1
7825342|NCT01286077|12296026|FG001|Overall Study|refill medication not received in time|0
7825343|NCT01286129|12296034|FG000|Overall Study|Withdrawal by Subject|4
7825344|NCT01286129|12296035|FG001|Overall Study|Withdrawal by Subject|1
7825345|NCT01286129|12296034|FG000|Overall Study|Could not comply with study requirements|4
7825346|NCT01286129|12296035|FG001|Overall Study|Could not comply with study requirements|4
7825347|NCT01286168|12296043|FG000|Overall Study|Withdrawal by Subject|1
7825348|NCT01286168|12296043|FG000|Overall Study|Surgical Drains Fell Out at Home|2
7825349|NCT01286311|12296054|FG000|Overall Study|Physician did not want outreach sent|14
7825350|NCT01286311|12296055|FG001|Overall Study|Physician did not want outreach sent|0
7825351|NCT01286480|12296122|FG000|Overall Study|Withdrawal by Subject|5
7825352|NCT01286480|12296123|FG001|Overall Study|Withdrawal by Subject|3
7825353|NCT01286558|12296135|FG000|Overall Study|Adverse Event|1
7825354|NCT01286558|12296136|FG001|Overall Study|Adverse Event|1
7825355|NCT01286558|12296135|FG000|Overall Study|Withdrawal by Subject|0
7825356|NCT01286558|12296136|FG001|Overall Study|Withdrawal by Subject|1
7825357|NCT01286740|12296142|FG000|Overall Study|Enrolled but not treated|1
7825358|NCT01286740|12296142|FG000|Overall Study|Protocol Violation|1
7825359|NCT01286753|12296148|FG000|Overall Study|Adverse Event|7
7825360|NCT01286753|12296149|FG001|Overall Study|Adverse Event|6
7825361|NCT01286753|12296148|FG000|Overall Study|Progression|11
7825362|NCT01286753|12296149|FG001|Overall Study|Progression|13
7825363|NCT01286753|12296148|FG000|Overall Study|Refused Treatment|1
7825364|NCT01286753|12296149|FG001|Overall Study|Refused Treatment|0
7825365|NCT01286753|12296148|FG000|Overall Study|Withdrawal of Consent|0
7825366|NCT01286753|12296149|FG001|Overall Study|Withdrawal of Consent|2
7825367|NCT01286753|12296148|FG000|Overall Study|Discontinued to Join Extension Study|6
7825368|NCT01286753|12296149|FG001|Overall Study|Discontinued to Join Extension Study|4
7825369|NCT01286753|12296148|FG000|Overall Study|Participant to Receive Radiotherapy|1
7825370|NCT01286753|12296149|FG001|Overall Study|Participant to Receive Radiotherapy|0
7825371|NCT01286779|12296156|FG000|Overall Study|Withdrawal by Subject|9
7825372|NCT01286779|12296156|FG000|Overall Study|Protocol Violation|5
7825373|NCT01286779|12296156|FG000|Overall Study|Physician Decision|2
7825374|NCT01286779|12296156|FG000|Overall Study|Participant had scheduled surgery|1
7825375|NCT01286779|12296156|FG000|Overall Study|Participant moved to another country|1
7825376|NCT01286779|12296156|FG000|Overall Study|Discontinued by sponsor|1
7825377|NCT01286987|12296202|FG000|Part 1: Dose Escalation|Clinical Progression|1
7825378|NCT01286987|12296203|FG001|Part 1: Dose Escalation|Clinical Progression|1
7825379|NCT01286987|12296204|FG002|Part 1: Dose Escalation|Clinical Progression|0
7825380|NCT01286987|12296205|FG003|Part 1: Dose Escalation|Clinical Progression|1
7825381|NCT01286987|12296206|FG004|Part 1: Dose Escalation|Clinical Progression|1
7825382|NCT01286987|12296207|FG005|Part 1: Dose Escalation|Clinical Progression|1
7825383|NCT01286987|12296208|FG006|Part 1: Dose Escalation|Clinical Progression|0
7825384|NCT01286987|12296209|FG007|Part 1: Dose Escalation|Clinical Progression|2
7825385|NCT01286987|12296210|FG008|Part 1: Dose Escalation|Clinical Progression|1
7825386|NCT01286987|12296211|FG009|Part 1: Dose Escalation|Clinical Progression|0
7825387|NCT01286987|12296212|FG010|Part 1: Dose Escalation|Clinical Progression|0
7825388|NCT01286987|12296213|FG011|Part 1: Dose Escalation|Clinical Progression|0
7825389|NCT01286987|12296214|FG012|Part 1: Dose Escalation|Clinical Progression|0
7825390|NCT01286987|12296215|FG013|Part 1: Dose Escalation|Clinical Progression|0
7825391|NCT01286987|12296216|FG014|Part 1: Dose Escalation|Clinical Progression|0
7825392|NCT01286987|12296202|FG000|Part 1: Dose Escalation|Progressive Disease|2
7825393|NCT01286987|12296203|FG001|Part 1: Dose Escalation|Progressive Disease|2
7825394|NCT01286987|12296204|FG002|Part 1: Dose Escalation|Progressive Disease|3
7825395|NCT01286987|12296205|FG003|Part 1: Dose Escalation|Progressive Disease|2
7825396|NCT01286987|12296206|FG004|Part 1: Dose Escalation|Progressive Disease|1
7825397|NCT01286987|12296207|FG005|Part 1: Dose Escalation|Progressive Disease|5
7825398|NCT01286987|12296208|FG006|Part 1: Dose Escalation|Progressive Disease|5
7825399|NCT01286987|12296209|FG007|Part 1: Dose Escalation|Progressive Disease|3
7825400|NCT01286987|12296210|FG008|Part 1: Dose Escalation|Progressive Disease|5
7825401|NCT01286987|12296211|FG009|Part 1: Dose Escalation|Progressive Disease|0
7825402|NCT01286987|12296212|FG010|Part 1: Dose Escalation|Progressive Disease|0
7825403|NCT01286987|12296213|FG011|Part 1: Dose Escalation|Progressive Disease|0
7825404|NCT01286987|12296214|FG012|Part 1: Dose Escalation|Progressive Disease|0
7825405|NCT01286987|12296215|FG013|Part 1: Dose Escalation|Progressive Disease|0
7825406|NCT01286987|12296216|FG014|Part 1: Dose Escalation|Progressive Disease|0
7825407|NCT01286987|12296202|FG000|Part 1: Dose Escalation|Physician Decision|0
7825408|NCT01286987|12296203|FG001|Part 1: Dose Escalation|Physician Decision|0
7825409|NCT01286987|12296204|FG002|Part 1: Dose Escalation|Physician Decision|0
7825410|NCT01286987|12296205|FG003|Part 1: Dose Escalation|Physician Decision|0
7825411|NCT01286987|12296206|FG004|Part 1: Dose Escalation|Physician Decision|1
7825412|NCT01286987|12296207|FG005|Part 1: Dose Escalation|Physician Decision|0
7825413|NCT01286987|12296208|FG006|Part 1: Dose Escalation|Physician Decision|0
7825414|NCT01286987|12296209|FG007|Part 1: Dose Escalation|Physician Decision|0
7825415|NCT01286987|12296210|FG008|Part 1: Dose Escalation|Physician Decision|0
7825416|NCT01286987|12296211|FG009|Part 1: Dose Escalation|Physician Decision|0
7825417|NCT01286987|12296212|FG010|Part 1: Dose Escalation|Physician Decision|0
7825418|NCT01286987|12296213|FG011|Part 1: Dose Escalation|Physician Decision|0
7825419|NCT01286987|12296214|FG012|Part 1: Dose Escalation|Physician Decision|0
7825420|NCT01286987|12296215|FG013|Part 1: Dose Escalation|Physician Decision|0
7825421|NCT01286987|12296216|FG014|Part 1: Dose Escalation|Physician Decision|0
7825422|NCT01286987|12296202|FG000|Part 2: Dose Expansion|Death|0
7825423|NCT01286987|12296203|FG001|Part 2: Dose Expansion|Death|0
7825424|NCT01286987|12296204|FG002|Part 2: Dose Expansion|Death|0
7825425|NCT01286987|12296205|FG003|Part 2: Dose Expansion|Death|0
7825426|NCT01286987|12296206|FG004|Part 2: Dose Expansion|Death|0
7825427|NCT01286987|12296207|FG005|Part 2: Dose Expansion|Death|0
7825428|NCT01286987|12296208|FG006|Part 2: Dose Expansion|Death|0
7825429|NCT01286987|12296209|FG007|Part 2: Dose Expansion|Death|0
7825430|NCT01286987|12296210|FG008|Part 2: Dose Expansion|Death|0
7825431|NCT01286987|12296211|FG009|Part 2: Dose Expansion|Death|0
7825432|NCT01286987|12296212|FG010|Part 2: Dose Expansion|Death|0
7825433|NCT01286987|12296213|FG011|Part 2: Dose Expansion|Death|0
7825434|NCT01286987|12296214|FG012|Part 2: Dose Expansion|Death|1
7825435|NCT01286987|12296215|FG013|Part 2: Dose Expansion|Death|1
7825436|NCT01286987|12296216|FG014|Part 2: Dose Expansion|Death|0
7825437|NCT01286987|12296202|FG000|Part 2: Dose Expansion|Physician Decision|0
7825438|NCT01286987|12296203|FG001|Part 2: Dose Expansion|Physician Decision|0
7825439|NCT01286987|12296204|FG002|Part 2: Dose Expansion|Physician Decision|0
7825440|NCT01286987|12296205|FG003|Part 2: Dose Expansion|Physician Decision|0
7825441|NCT01286987|12296206|FG004|Part 2: Dose Expansion|Physician Decision|0
7825442|NCT01286987|12296207|FG005|Part 2: Dose Expansion|Physician Decision|0
7825443|NCT01286987|12296208|FG006|Part 2: Dose Expansion|Physician Decision|0
7825444|NCT01286987|12296209|FG007|Part 2: Dose Expansion|Physician Decision|0
7825445|NCT01286987|12296210|FG008|Part 2: Dose Expansion|Physician Decision|0
7825446|NCT01286987|12296211|FG009|Part 2: Dose Expansion|Physician Decision|0
7825447|NCT01286987|12296212|FG010|Part 2: Dose Expansion|Physician Decision|1
7825448|NCT01286987|12296213|FG011|Part 2: Dose Expansion|Physician Decision|1
7825449|NCT01286987|12296214|FG012|Part 2: Dose Expansion|Physician Decision|0
7825450|NCT01286987|12296215|FG013|Part 2: Dose Expansion|Physician Decision|1
7825451|NCT01286987|12296216|FG014|Part 2: Dose Expansion|Physician Decision|0
7825452|NCT01286987|12296202|FG000|Part 2: Dose Expansion|Other|0
7825453|NCT01286987|12296203|FG001|Part 2: Dose Expansion|Other|0
7825454|NCT01286987|12296204|FG002|Part 2: Dose Expansion|Other|0
7825455|NCT01286987|12296205|FG003|Part 2: Dose Expansion|Other|0
7825456|NCT01286987|12296206|FG004|Part 2: Dose Expansion|Other|0
7825457|NCT01286987|12296207|FG005|Part 2: Dose Expansion|Other|0
7825458|NCT01286987|12296208|FG006|Part 2: Dose Expansion|Other|0
7825459|NCT01286987|12296209|FG007|Part 2: Dose Expansion|Other|0
7825460|NCT01286987|12296210|FG008|Part 2: Dose Expansion|Other|0
7825461|NCT01286987|12296211|FG009|Part 2: Dose Expansion|Other|0
7825462|NCT01286987|12296212|FG010|Part 2: Dose Expansion|Other|0
7825463|NCT01286987|12296213|FG011|Part 2: Dose Expansion|Other|0
7825464|NCT01286987|12296214|FG012|Part 2: Dose Expansion|Other|0
7825465|NCT01286987|12296215|FG013|Part 2: Dose Expansion|Other|1
7825466|NCT01286987|12296216|FG014|Part 2: Dose Expansion|Other|0
7825467|NCT01286987|12296202|FG000|Part 2: Dose Expansion|Progressive Disease|0
7825468|NCT01286987|12296203|FG001|Part 2: Dose Expansion|Progressive Disease|0
7825469|NCT01286987|12296204|FG002|Part 2: Dose Expansion|Progressive Disease|0
7825470|NCT01286987|12296205|FG003|Part 2: Dose Expansion|Progressive Disease|0
7825471|NCT01286987|12296206|FG004|Part 2: Dose Expansion|Progressive Disease|0
7825472|NCT01286987|12296207|FG005|Part 2: Dose Expansion|Progressive Disease|0
7825473|NCT01286987|12296208|FG006|Part 2: Dose Expansion|Progressive Disease|0
7825474|NCT01286987|12296209|FG007|Part 2: Dose Expansion|Progressive Disease|0
7825475|NCT01286987|12296210|FG008|Part 2: Dose Expansion|Progressive Disease|0
7825476|NCT01286987|12296211|FG009|Part 2: Dose Expansion|Progressive Disease|11
7825477|NCT01286987|12296212|FG010|Part 2: Dose Expansion|Progressive Disease|6
7825478|NCT01286987|12296213|FG011|Part 2: Dose Expansion|Progressive Disease|7
7825479|NCT01286987|12296214|FG012|Part 2: Dose Expansion|Progressive Disease|11
7825480|NCT01286987|12296215|FG013|Part 2: Dose Expansion|Progressive Disease|19
7825481|NCT01286987|12296216|FG014|Part 2: Dose Expansion|Progressive Disease|2
7825482|NCT01286987|12296202|FG000|Part 2: Dose Expansion|Clinical Progression|0
7825483|NCT01286987|12296203|FG001|Part 2: Dose Expansion|Clinical Progression|0
7825484|NCT01286987|12296204|FG002|Part 2: Dose Expansion|Clinical Progression|0
7825485|NCT01286987|12296205|FG003|Part 2: Dose Expansion|Clinical Progression|0
7825486|NCT01286987|12296206|FG004|Part 2: Dose Expansion|Clinical Progression|0
7825487|NCT01286987|12296207|FG005|Part 2: Dose Expansion|Clinical Progression|0
7825488|NCT01286987|12296208|FG006|Part 2: Dose Expansion|Clinical Progression|0
7825489|NCT01286987|12296209|FG007|Part 2: Dose Expansion|Clinical Progression|0
7825490|NCT01286987|12296210|FG008|Part 2: Dose Expansion|Clinical Progression|0
7825491|NCT01286987|12296211|FG009|Part 2: Dose Expansion|Clinical Progression|0
7825492|NCT01286987|12296212|FG010|Part 2: Dose Expansion|Clinical Progression|2
7825493|NCT01286987|12296213|FG011|Part 2: Dose Expansion|Clinical Progression|2
7825494|NCT01286987|12296214|FG012|Part 2: Dose Expansion|Clinical Progression|0
7825495|NCT01286987|12296215|FG013|Part 2: Dose Expansion|Clinical Progression|2
7825496|NCT01286987|12296216|FG014|Part 2: Dose Expansion|Clinical Progression|0
7825497|NCT01286987|12296202|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0
7825498|NCT01286987|12296203|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0
7825499|NCT01286987|12296204|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0
7825500|NCT01286987|12296205|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0
7825501|NCT01286987|12296206|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0
7825502|NCT01286987|12296207|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0
7825503|NCT01286987|12296208|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0
7825504|NCT01286987|12296209|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0
7825505|NCT01286987|12296210|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0
7825506|NCT01286987|12296211|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0
7825507|NCT01286987|12296212|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1
7825508|NCT01286987|12296213|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0
7825509|NCT01286987|12296214|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0
7825510|NCT01286987|12296215|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0
7825511|NCT01286987|12296216|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0
7825512|NCT01287013|12296260|FG000|Overall Study|Non-evaluable|3
7825513|NCT01287013|12296261|FG001|Overall Study|Non-evaluable|5
7825514|NCT01287013|12296262|FG002|Overall Study|Non-evaluable|21
7825515|NCT01287039|12296272|FG000|Overall Study|Noncompliance with study procedures|0
7825516|NCT01287039|12296273|FG001|Overall Study|Noncompliance with study procedures|1
7825517|NCT01287039|12296272|FG000|Overall Study|Change of location/residence|0
7825518|NCT01287039|12296273|FG001|Overall Study|Change of location/residence|3
7825519|NCT01287039|12296272|FG000|Overall Study|Elective surgery|0
7825520|NCT01287039|12296273|FG001|Overall Study|Elective surgery|1
7825521|NCT01287039|12296272|FG000|Overall Study|Protocol Violation|2
7825522|NCT01287039|12296273|FG001|Overall Study|Protocol Violation|3
7825523|NCT01287039|12296272|FG000|Overall Study|Excluded medication taken|1
7825524|NCT01287039|12296273|FG001|Overall Study|Excluded medication taken|0
7825525|NCT01287039|12296272|FG000|Overall Study|Noncompliance with study medication|0
7825526|NCT01287039|12296273|FG001|Overall Study|Noncompliance with study medication|1
7825527|NCT01287039|12296272|FG000|Overall Study|Problem with travel|0
7825528|NCT01287039|12296273|FG001|Overall Study|Problem with travel|1
7825529|NCT01287039|12296272|FG000|Overall Study|Death|1
7825530|NCT01287039|12296273|FG001|Overall Study|Death|0
7825531|NCT01287039|12296272|FG000|Overall Study|Change of residence|1
7825532|NCT01287039|12296273|FG001|Overall Study|Change of residence|0
7825533|NCT01287039|12296272|FG000|Overall Study|Adverse Event|7
7825534|NCT01287039|12296273|FG001|Overall Study|Adverse Event|4
7825535|NCT01287039|12296272|FG000|Overall Study|Withdrawal by Subject|14
7825536|NCT01287039|12296273|FG001|Overall Study|Withdrawal by Subject|11
7825537|NCT01287039|12296272|FG000|Overall Study|Lost to Follow-up|3
7825538|NCT01287039|12296273|FG001|Overall Study|Lost to Follow-up|2
7825539|NCT01287065|12296279|FG000|Treatment Period 1|Adverse Event|0
7825540|NCT01287065|12296280|FG001|Treatment Period 1|Adverse Event|0
7825541|NCT01287065|12296281|FG002|Treatment Period 1|Adverse Event|0
7825542|NCT01287065|12296282|FG003|Treatment Period 1|Adverse Event|0
7825543|NCT01287065|12296283|FG004|Treatment Period 1|Adverse Event|1
7825544|NCT01287065|12296284|FG005|Treatment Period 1|Adverse Event|0
7825545|NCT01287065|12296279|FG000|Treatment Period 1|Withdrawal by Subject|0
7825546|NCT01287065|12296280|FG001|Treatment Period 1|Withdrawal by Subject|0
7825547|NCT01287065|12296281|FG002|Treatment Period 1|Withdrawal by Subject|0
7825548|NCT01287065|12296282|FG003|Treatment Period 1|Withdrawal by Subject|0
7825549|NCT01287065|12296283|FG004|Treatment Period 1|Withdrawal by Subject|0
7825550|NCT01287065|12296284|FG005|Treatment Period 1|Withdrawal by Subject|1
7825551|NCT01287104|12296305|FG000|Overall Study|Patient developed progressive disease|1
7825552|NCT01287104|12296306|FG001|Overall Study|Patient developed progressive disease|1
7825553|NCT01287104|12296307|FG002|Overall Study|Patient developed progressive disease|3
7825554|NCT01287104|12296308|FG003|Overall Study|Patient developed progressive disease|2
7825555|NCT01287104|12296305|FG000|Overall Study|Donor anaphylaxis|0
7825556|NCT01287104|12296306|FG001|Overall Study|Donor anaphylaxis|1
7825557|NCT01287104|12296307|FG002|Overall Study|Donor anaphylaxis|0
7825558|NCT01287104|12296308|FG003|Overall Study|Donor anaphylaxis|1
7825559|NCT01287104|12296305|FG000|Overall Study|Developed GVHD or complications of BMT|0
7825560|NCT01287104|12296306|FG001|Overall Study|Developed GVHD or complications of BMT|1
7825561|NCT01287104|12296307|FG002|Overall Study|Developed GVHD or complications of BMT|4
7825562|NCT01287104|12296308|FG003|Overall Study|Developed GVHD or complications of BMT|0
7825563|NCT01287104|12296305|FG000|Overall Study|Low donor chimerism|0
7825564|NCT01287104|12296306|FG001|Overall Study|Low donor chimerism|1
7825565|NCT01287104|12296307|FG002|Overall Study|Low donor chimerism|0
7825566|NCT01287104|12296308|FG003|Overall Study|Low donor chimerism|0
7825567|NCT01287104|12296305|FG000|Overall Study|NK cells did not meet release criteria|0
7825568|NCT01287104|12296306|FG001|Overall Study|NK cells did not meet release criteria|1
7825569|NCT01287104|12296307|FG002|Overall Study|NK cells did not meet release criteria|0
7825570|NCT01287104|12296308|FG003|Overall Study|NK cells did not meet release criteria|0
7825571|NCT01287117|12296329|FG000|Overall Study|Adverse Event|2
7825572|NCT01287117|12296330|FG001|Overall Study|Adverse Event|1
7825573|NCT01287117|12296331|FG002|Overall Study|Adverse Event|1
7825574|NCT01287117|12296332|FG003|Overall Study|Adverse Event|1
7825575|NCT01287117|12296329|FG000|Overall Study|Lost to Follow-up|1
7825576|NCT01287117|12296330|FG001|Overall Study|Lost to Follow-up|1
7825577|NCT01287117|12296331|FG002|Overall Study|Lost to Follow-up|0
7825578|NCT01287117|12296332|FG003|Overall Study|Lost to Follow-up|0
7825579|NCT01287117|12296329|FG000|Overall Study|Physician Decision|0
7825580|NCT01287117|12296330|FG001|Overall Study|Physician Decision|1
7825581|NCT01287117|12296331|FG002|Overall Study|Physician Decision|1
7825582|NCT01287117|12296332|FG003|Overall Study|Physician Decision|1
7825583|NCT01287117|12296329|FG000|Overall Study|Patient/Legal Guardian's Decision|2
7825584|NCT01287117|12296330|FG001|Overall Study|Patient/Legal Guardian's Decision|6
7825585|NCT01287117|12296331|FG002|Overall Study|Patient/Legal Guardian's Decision|8
7825586|NCT01287117|12296332|FG003|Overall Study|Patient/Legal Guardian's Decision|5
7825587|NCT01287117|12296329|FG000|Overall Study|Disease Progression|10
7825588|NCT01287117|12296330|FG001|Overall Study|Disease Progression|5
7825589|NCT01287117|12296331|FG002|Overall Study|Disease Progression|6
7825590|NCT01287117|12296332|FG003|Overall Study|Disease Progression|5
7825591|NCT01287195|12296342|FG000|Overall Study|Withdrawal by Subject|2
7825592|NCT01287221|12296359|FG000|Overall Study|Lack of Perceived Benefit|1
7825593|NCT01287221|12296360|FG001|Overall Study|Lack of Perceived Benefit|1
7825594|NCT01287221|12296359|FG000|Overall Study|Adverse Event|3
7825595|NCT01287221|12296360|FG001|Overall Study|Adverse Event|3
7825596|NCT01287221|12296359|FG000|Overall Study|Withdrawal by Subject|0
7825597|NCT01287221|12296360|FG001|Overall Study|Withdrawal by Subject|1
7825598|NCT01287364|12296368|FG000|Overall Study|Adverse Event|0
7825599|NCT01287364|12296369|FG001|Overall Study|Adverse Event|3
7825600|NCT01287364|12296368|FG000|Overall Study|Protocol Violation|5
7825601|NCT01287364|12296369|FG001|Overall Study|Protocol Violation|5
7825602|NCT01287364|12296368|FG000|Overall Study|Other Reason|4
7825603|NCT01287364|12296369|FG001|Overall Study|Other Reason|2
7825604|NCT01287403|12296401|FG000|1st Intervention (1 Day)|Adverse Event|1
7825605|NCT01287416|12296417|FG000|Pre-post Training|Withdrawal by Subject|17
7825606|NCT01287416|12296418|FG001|Pre-post Training|Withdrawal by Subject|24
7825607|NCT01287416|12296417|FG000|Pre-post Training|Lost to Follow-up|5
7825608|NCT01287416|12296418|FG001|Pre-post Training|Lost to Follow-up|1
7825609|NCT01287416|12296417|FG000|6 Month Follow-up|Lost to Follow-up|3
7825610|NCT01287416|12296418|FG001|6 Month Follow-up|Lost to Follow-up|2
7825611|NCT01287520|12296433|FG000|Overall Study|Adverse Event|2
7825612|NCT01287520|12296434|FG001|Overall Study|Adverse Event|2
7825613|NCT01287520|12296435|FG002|Overall Study|Adverse Event|2
7825614|NCT01287520|12296436|FG003|Overall Study|Adverse Event|1
7825615|NCT01287520|12296437|FG004|Overall Study|Adverse Event|1
7825616|NCT01287520|12296438|FG005|Overall Study|Adverse Event|2
7825617|NCT01287520|12296439|FG006|Overall Study|Adverse Event|0
7825618|NCT01287520|12296440|FG007|Overall Study|Adverse Event|2
7825619|NCT01287520|12296441|FG008|Overall Study|Adverse Event|0
7825620|NCT01287520|12296433|FG000|Overall Study|Physician Decision|1
7825621|NCT01287520|12296434|FG001|Overall Study|Physician Decision|1
7825622|NCT01287520|12296435|FG002|Overall Study|Physician Decision|2
7825623|NCT01287520|12296436|FG003|Overall Study|Physician Decision|0
7825624|NCT01287520|12296437|FG004|Overall Study|Physician Decision|1
7825625|NCT01287520|12296438|FG005|Overall Study|Physician Decision|1
7825626|NCT01287520|12296439|FG006|Overall Study|Physician Decision|0
7825627|NCT01287520|12296440|FG007|Overall Study|Physician Decision|1
7825628|NCT01287520|12296441|FG008|Overall Study|Physician Decision|0
7825629|NCT01287520|12296433|FG000|Overall Study|Progressive disease|0
7825630|NCT01287520|12296434|FG001|Overall Study|Progressive disease|4
7825631|NCT01287520|12296435|FG002|Overall Study|Progressive disease|1
7825632|NCT01287520|12296436|FG003|Overall Study|Progressive disease|6
7825633|NCT01287520|12296437|FG004|Overall Study|Progressive disease|1
7825634|NCT01287520|12296438|FG005|Overall Study|Progressive disease|0
7825635|NCT01287520|12296439|FG006|Overall Study|Progressive disease|2
7825636|NCT01287520|12296440|FG007|Overall Study|Progressive disease|2
7825637|NCT01287520|12296441|FG008|Overall Study|Progressive disease|4
7825638|NCT01287520|12296433|FG000|Overall Study|Withdrawal by Subject|0
7825639|NCT01287520|12296434|FG001|Overall Study|Withdrawal by Subject|0
7825640|NCT01287520|12296435|FG002|Overall Study|Withdrawal by Subject|0
7825641|NCT01287520|12296436|FG003|Overall Study|Withdrawal by Subject|0
7825642|NCT01287520|12296437|FG004|Overall Study|Withdrawal by Subject|0
7825643|NCT01287520|12296438|FG005|Overall Study|Withdrawal by Subject|1
7825644|NCT01287520|12296439|FG006|Overall Study|Withdrawal by Subject|0
7825645|NCT01287520|12296440|FG007|Overall Study|Withdrawal by Subject|0
7825646|NCT01287520|12296441|FG008|Overall Study|Withdrawal by Subject|1
7825647|NCT01287754|12296492|FG000|Overall Study|Death|2
7825648|NCT01287754|12296493|FG001|Overall Study|Death|12
7825649|NCT01287754|12296492|FG000|Overall Study|Lost to Follow-up|1
7825650|NCT01287754|12296493|FG001|Overall Study|Lost to Follow-up|6
7825651|NCT01287754|12296492|FG000|Overall Study|Protocol Violation|0
7825652|NCT01287754|12296493|FG001|Overall Study|Protocol Violation|3
7825653|NCT01287832|12296501|FG000|Overall Study|Adverse Event|1
7825654|NCT01287832|12296502|FG001|Overall Study|Adverse Event|0
7825655|NCT01287832|12296501|FG000|Overall Study|Death|0
7825656|NCT01287832|12296502|FG001|Overall Study|Death|1
7825657|NCT01287897|12296512|FG000|Overall Study|Adverse Event|5
7825658|NCT01287897|12296513|FG001|Overall Study|Adverse Event|3
7825659|NCT01287897|12296514|FG002|Overall Study|Adverse Event|6
7825660|NCT01287897|12296515|FG003|Overall Study|Adverse Event|4
7825661|NCT01287897|12296512|FG000|Overall Study|Lack of Efficacy|2
7825662|NCT01287897|12296513|FG001|Overall Study|Lack of Efficacy|0
7825663|NCT01287897|12296514|FG002|Overall Study|Lack of Efficacy|0
7825664|NCT01287897|12296515|FG003|Overall Study|Lack of Efficacy|0
7825665|NCT01287897|12296512|FG000|Overall Study|Protocol Violation|1
7825666|NCT01287897|12296513|FG001|Overall Study|Protocol Violation|1
7825667|NCT01287897|12296514|FG002|Overall Study|Protocol Violation|0
7825668|NCT01287897|12296515|FG003|Overall Study|Protocol Violation|1
7825669|NCT01287897|12296512|FG000|Overall Study|Lost to Follow-up|0
7825670|NCT01287897|12296513|FG001|Overall Study|Lost to Follow-up|0
7825671|NCT01287897|12296514|FG002|Overall Study|Lost to Follow-up|2
7825672|NCT01287897|12296515|FG003|Overall Study|Lost to Follow-up|0
7825673|NCT01287897|12296512|FG000|Overall Study|Withdrawal by Subject|1
7825674|NCT01287897|12296513|FG001|Overall Study|Withdrawal by Subject|5
7720043|NCT00536263|12144308|FG002|Overall Study|Subject withdrew - treatment related|2
7720044|NCT00536263|12144306|FG000|Overall Study|Noncompliance with protocol|0
7720045|NCT00536263|12144307|FG001|Overall Study|Noncompliance with protocol|0
7720046|NCT00536263|12144308|FG002|Overall Study|Noncompliance with protocol|1
7825675|NCT01287897|12296514|FG002|Overall Study|Withdrawal by Subject|3
7825676|NCT01287897|12296515|FG003|Overall Study|Withdrawal by Subject|2
7825677|NCT01287897|12296512|FG000|Overall Study|Not consented properly|0
7825678|NCT01287897|12296513|FG001|Overall Study|Not consented properly|1
7825679|NCT01287897|12296514|FG002|Overall Study|Not consented properly|0
7825680|NCT01287897|12296515|FG003|Overall Study|Not consented properly|0
7825681|NCT01287897|12296512|FG000|Overall Study|Not meeting entrance criteria|1
7825682|NCT01287897|12296513|FG001|Overall Study|Not meeting entrance criteria|1
7825683|NCT01287897|12296514|FG002|Overall Study|Not meeting entrance criteria|0
7825684|NCT01287897|12296515|FG003|Overall Study|Not meeting entrance criteria|0
7825685|NCT01287897|12296512|FG000|Overall Study|Other|1
7825686|NCT01287897|12296513|FG001|Overall Study|Other|0
7825687|NCT01287897|12296514|FG002|Overall Study|Other|1
7825688|NCT01287897|12296515|FG003|Overall Study|Other|0
7825689|NCT01288053|12296533|FG000|Overall Study|Death|1
7825690|NCT01288079|12296541|FG000|Overall Study|Withdrawal by Subject|2
7825691|NCT01288079|12296542|FG001|Overall Study|Withdrawal by Subject|4
7825692|NCT01288079|12296543|FG002|Overall Study|Withdrawal by Subject|1
7825693|NCT01288079|12296544|FG003|Overall Study|Withdrawal by Subject|0
7825694|NCT01288079|12296541|FG000|Overall Study|Adverse Event|2
7825695|NCT01288079|12296542|FG001|Overall Study|Adverse Event|1
7825696|NCT01288079|12296543|FG002|Overall Study|Adverse Event|2
7825697|NCT01288079|12296544|FG003|Overall Study|Adverse Event|3
7825698|NCT01288079|12296541|FG000|Overall Study|Severe Non-Compliance to Protocol|1
7825699|NCT01288079|12296542|FG001|Overall Study|Severe Non-Compliance to Protocol|3
7825700|NCT01288079|12296543|FG002|Overall Study|Severe Non-Compliance to Protocol|1
7825701|NCT01288079|12296544|FG003|Overall Study|Severe Non-Compliance to Protocol|3
7825702|NCT01288079|12296541|FG000|Overall Study|Condition under Investigation Worsened|0
7825703|NCT01288079|12296542|FG001|Overall Study|Condition under Investigation Worsened|0
7825704|NCT01288079|12296543|FG002|Overall Study|Condition under Investigation Worsened|0
7825705|NCT01288079|12296544|FG003|Overall Study|Condition under Investigation Worsened|1
7825706|NCT01288079|12296541|FG000|Overall Study|Lack of Efficacy|2
7825707|NCT01288079|12296542|FG001|Overall Study|Lack of Efficacy|2
7825708|NCT01288079|12296543|FG002|Overall Study|Lack of Efficacy|0
7825709|NCT01288079|12296544|FG003|Overall Study|Lack of Efficacy|2
7825710|NCT01288079|12296541|FG000|Overall Study|Study-Specific Withdrawal Criteria|1
7825711|NCT01288079|12296542|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
7825712|NCT01288079|12296543|FG002|Overall Study|Study-Specific Withdrawal Criteria|0
7825713|NCT01288079|12296544|FG003|Overall Study|Study-Specific Withdrawal Criteria|0
7825714|NCT01288079|12296541|FG000|Overall Study|Lost to Follow-up|1
7825715|NCT01288079|12296542|FG001|Overall Study|Lost to Follow-up|1
7825716|NCT01288079|12296543|FG002|Overall Study|Lost to Follow-up|1
7825717|NCT01288079|12296544|FG003|Overall Study|Lost to Follow-up|0
7825718|NCT01288079|12296541|FG000|Overall Study|Other or Study Termination|11
7825719|NCT01288079|12296542|FG001|Overall Study|Other or Study Termination|15
7825720|NCT01288079|12296543|FG002|Overall Study|Other or Study Termination|14
7825721|NCT01288079|12296544|FG003|Overall Study|Other or Study Termination|8
7825722|NCT01288209|12296556|FG000|Overall Study|Withdrawal by Subject|1
7720047|NCT00536263|12144306|FG000|Overall Study|Did not meet protocol eligibility|1
7825723|NCT01288209|12296557|FG001|Overall Study|Withdrawal by Subject|3
7825724|NCT01288209|12296556|FG000|Overall Study|Other|1
7825725|NCT01288209|12296557|FG001|Overall Study|Other|0
7825726|NCT01288287|12296563|FG000|Overall Study|Lost to Follow-up|8
7825727|NCT01288287|12296563|FG000|Overall Study|Withdrawal by Subject|4
7825728|NCT01288287|12296563|FG000|Overall Study|Lack of Efficacy|13
7825729|NCT01288287|12296563|FG000|Overall Study|Other Reason|13
7825730|NCT01288287|12296563|FG000|Overall Study|Unknown Reason|1
7825731|NCT01288287|12296563|FG000|Overall Study|Unknown Status|7
7825732|NCT01288430|12296578|FG000|Part 1|Progressive disease|2
7825733|NCT01288430|12296579|FG001|Part 1|Progressive disease|1
7825734|NCT01288430|12296580|FG002|Part 1|Progressive disease|1
7825735|NCT01288430|12296581|FG003|Part 1|Progressive disease|6
7825736|NCT01288430|12296582|FG004|Part 1|Progressive disease|2
7948179|NCT02526160|12493353|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0
7825737|NCT01288430|12296583|FG005|Part 1|Progressive disease|4
7825738|NCT01288430|12296584|FG006|Part 1|Progressive disease|2
7825739|NCT01288430|12296585|FG007|Part 1|Progressive disease|0
7825740|NCT01288430|12296586|FG008|Part 1|Progressive disease|0
7825741|NCT01288430|12296587|FG009|Part 1|Progressive disease|0
7825742|NCT01288430|12296578|FG000|Part 1|Clinical disease progression|0
7825743|NCT01288430|12296579|FG001|Part 1|Clinical disease progression|0
7825744|NCT01288430|12296580|FG002|Part 1|Clinical disease progression|1
7825745|NCT01288430|12296581|FG003|Part 1|Clinical disease progression|0
7825746|NCT01288430|12296582|FG004|Part 1|Clinical disease progression|0
7825747|NCT01288430|12296583|FG005|Part 1|Clinical disease progression|2
7825748|NCT01288430|12296584|FG006|Part 1|Clinical disease progression|2
7825749|NCT01288430|12296585|FG007|Part 1|Clinical disease progression|0
7825750|NCT01288430|12296586|FG008|Part 1|Clinical disease progression|0
7825751|NCT01288430|12296587|FG009|Part 1|Clinical disease progression|0
7825752|NCT01288430|12296578|FG000|Part 1|Death due to disease progression|0
7825753|NCT01288430|12296579|FG001|Part 1|Death due to disease progression|0
7825754|NCT01288430|12296580|FG002|Part 1|Death due to disease progression|0
7825755|NCT01288430|12296581|FG003|Part 1|Death due to disease progression|0
7825756|NCT01288430|12296582|FG004|Part 1|Death due to disease progression|1
7948180|NCT02526160|12493354|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1
7948181|NCT02526160|12493353|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0
7948182|NCT02526160|12493354|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1
7948183|NCT02526160|12493353|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3
7948184|NCT02526160|12493354|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3
7948185|NCT02526160|12493353|FG000|Open-Label Treatment Extension Period I|Death|0
7948186|NCT02526160|12493354|FG001|Open-Label Treatment Extension Period I|Death|1
7948187|NCT02526160|12493353|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3
7948188|NCT02526160|12493354|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1
7948189|NCT02526160|12493353|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0
7948190|NCT02526160|12493354|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1
7948191|NCT02526160|12493353|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0
7948192|NCT02526160|12493354|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1
7948193|NCT02526160|12493353|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1
7948194|NCT02526160|12493354|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0
7948195|NCT02526212|12493367|FG000|Overall Study|Incarceration|1
7948196|NCT02526212|12493368|FG001|Overall Study|Incarceration|0
7948197|NCT02526212|12493367|FG000|Overall Study|Lost to Follow-up|1
7948198|NCT02526212|12493368|FG001|Overall Study|Lost to Follow-up|0
7948199|NCT02526212|12493367|FG000|Overall Study|Death|0
7948200|NCT02526212|12493368|FG001|Overall Study|Death|1
7948201|NCT02526290|12493394|FG000|Overall Study|Adverse Event|3
7948202|NCT02526290|12493394|FG000|Overall Study|Withdrawal by Subject|4
7948203|NCT02526290|12493394|FG000|Overall Study|Physician Decision|1
7948204|NCT02526524|12493404|FG000|Overall Study|Withdrawal by Subject|3
7948205|NCT02526524|12493405|FG001|Overall Study|Withdrawal by Subject|3
7948206|NCT02526524|12493406|FG002|Overall Study|Withdrawal by Subject|6
7948207|NCT02526524|12493407|FG003|Overall Study|Withdrawal by Subject|1
7948208|NCT02526524|12493408|FG004|Overall Study|Withdrawal by Subject|9
7948209|NCT02526524|12493409|FG005|Overall Study|Withdrawal by Subject|5
7948210|NCT02526524|12493404|FG000|Overall Study|Adverse Event|3
7825757|NCT01288430|12296583|FG005|Part 1|Death due to disease progression|0
7825758|NCT01288430|12296584|FG006|Part 1|Death due to disease progression|0
7825759|NCT01288430|12296585|FG007|Part 1|Death due to disease progression|0
7825760|NCT01288430|12296586|FG008|Part 1|Death due to disease progression|0
7825761|NCT01288430|12296587|FG009|Part 1|Death due to disease progression|0
7825762|NCT01288430|12296578|FG000|Part 1|Adverse Event|0
7948211|NCT02526524|12493405|FG001|Overall Study|Adverse Event|2
7948212|NCT02526524|12493406|FG002|Overall Study|Adverse Event|4
7948213|NCT02526524|12493407|FG003|Overall Study|Adverse Event|2
7948214|NCT02526524|12493408|FG004|Overall Study|Adverse Event|6
7948215|NCT02526524|12493409|FG005|Overall Study|Adverse Event|8
7948216|NCT02526524|12493404|FG000|Overall Study|Lost to Follow-up|2
7948217|NCT02526524|12493405|FG001|Overall Study|Lost to Follow-up|3
7948218|NCT02526524|12493406|FG002|Overall Study|Lost to Follow-up|8
7948219|NCT02526524|12493407|FG003|Overall Study|Lost to Follow-up|1
7948220|NCT02526524|12493408|FG004|Overall Study|Lost to Follow-up|2
7948221|NCT02526524|12493409|FG005|Overall Study|Lost to Follow-up|5
7948222|NCT02526524|12493404|FG000|Overall Study|Protocol Violation|3
7948223|NCT02526524|12493405|FG001|Overall Study|Protocol Violation|1
7948224|NCT02526524|12493406|FG002|Overall Study|Protocol Violation|5
7948225|NCT02526524|12493407|FG003|Overall Study|Protocol Violation|3
7948226|NCT02526524|12493408|FG004|Overall Study|Protocol Violation|4
7948227|NCT02526524|12493409|FG005|Overall Study|Protocol Violation|3
7948228|NCT02526524|12493404|FG000|Overall Study|Loss of Glucose Control|0
7948229|NCT02526524|12493405|FG001|Overall Study|Loss of Glucose Control|0
7948230|NCT02526524|12493406|FG002|Overall Study|Loss of Glucose Control|3
7948231|NCT02526524|12493407|FG003|Overall Study|Loss of Glucose Control|0
7948232|NCT02526524|12493408|FG004|Overall Study|Loss of Glucose Control|2
7948233|NCT02526524|12493409|FG005|Overall Study|Loss of Glucose Control|0
7948234|NCT02526524|12493404|FG000|Overall Study|Physician Decision|0
7948235|NCT02526524|12493405|FG001|Overall Study|Physician Decision|0
7948236|NCT02526524|12493406|FG002|Overall Study|Physician Decision|0
7948237|NCT02526524|12493407|FG003|Overall Study|Physician Decision|0
7948238|NCT02526524|12493408|FG004|Overall Study|Physician Decision|1
7825763|NCT01288430|12296579|FG001|Part 1|Adverse Event|0
7825764|NCT01288430|12296580|FG002|Part 1|Adverse Event|3
7825765|NCT01288430|12296581|FG003|Part 1|Adverse Event|1
7825766|NCT01288430|12296582|FG004|Part 1|Adverse Event|0
7825767|NCT01288430|12296583|FG005|Part 1|Adverse Event|0
7825768|NCT01288430|12296584|FG006|Part 1|Adverse Event|2
7825769|NCT01288430|12296585|FG007|Part 1|Adverse Event|0
7825770|NCT01288430|12296586|FG008|Part 1|Adverse Event|0
7825771|NCT01288430|12296587|FG009|Part 1|Adverse Event|0
7825772|NCT01288430|12296578|FG000|Part 1|Other|0
7825773|NCT01288430|12296579|FG001|Part 1|Other|2
7825774|NCT01288430|12296580|FG002|Part 1|Other|0
7825775|NCT01288430|12296581|FG003|Part 1|Other|0
7825776|NCT01288430|12296582|FG004|Part 1|Other|0
7825777|NCT01288430|12296583|FG005|Part 1|Other|0
7825778|NCT01288430|12296584|FG006|Part 1|Other|1
7825779|NCT01288430|12296585|FG007|Part 1|Other|0
7825780|NCT01288430|12296586|FG008|Part 1|Other|0
7825781|NCT01288430|12296587|FG009|Part 1|Other|0
7825782|NCT01288430|12296578|FG000|Part 2|Progressive disease|0
7825783|NCT01288430|12296579|FG001|Part 2|Progressive disease|0
7825784|NCT01288430|12296580|FG002|Part 2|Progressive disease|0
7825785|NCT01288430|12296581|FG003|Part 2|Progressive disease|0
7825786|NCT01288430|12296582|FG004|Part 2|Progressive disease|0
7825787|NCT01288430|12296583|FG005|Part 2|Progressive disease|0
7825788|NCT01288430|12296584|FG006|Part 2|Progressive disease|0
7825789|NCT01288430|12296585|FG007|Part 2|Progressive disease|8
7825790|NCT01288430|12296586|FG008|Part 2|Progressive disease|7
7825791|NCT01288430|12296587|FG009|Part 2|Progressive disease|2
7825792|NCT01288430|12296578|FG000|Part 2|Clinical disease progression|0
7825793|NCT01288430|12296579|FG001|Part 2|Clinical disease progression|0
7825794|NCT01288430|12296580|FG002|Part 2|Clinical disease progression|0
7825795|NCT01288430|12296581|FG003|Part 2|Clinical disease progression|0
7825796|NCT01288430|12296582|FG004|Part 2|Clinical disease progression|0
7825797|NCT01288430|12296583|FG005|Part 2|Clinical disease progression|0
7825798|NCT01288430|12296584|FG006|Part 2|Clinical disease progression|0
7825799|NCT01288430|12296585|FG007|Part 2|Clinical disease progression|2
7825800|NCT01288430|12296586|FG008|Part 2|Clinical disease progression|0
7825801|NCT01288430|12296587|FG009|Part 2|Clinical disease progression|0
7825802|NCT01288430|12296578|FG000|Part 2|Withdrawal by Subject|0
7825803|NCT01288430|12296579|FG001|Part 2|Withdrawal by Subject|0
7825804|NCT01288430|12296580|FG002|Part 2|Withdrawal by Subject|0
7825805|NCT01288430|12296581|FG003|Part 2|Withdrawal by Subject|0
7825806|NCT01288430|12296582|FG004|Part 2|Withdrawal by Subject|0
7825807|NCT01288430|12296583|FG005|Part 2|Withdrawal by Subject|0
7825808|NCT01288430|12296584|FG006|Part 2|Withdrawal by Subject|0
7825809|NCT01288430|12296585|FG007|Part 2|Withdrawal by Subject|1
7825810|NCT01288430|12296586|FG008|Part 2|Withdrawal by Subject|4
7825811|NCT01288430|12296587|FG009|Part 2|Withdrawal by Subject|0
7825812|NCT01288430|12296578|FG000|Part 2|Adverse Event|0
7825813|NCT01288430|12296579|FG001|Part 2|Adverse Event|0
7825814|NCT01288430|12296580|FG002|Part 2|Adverse Event|0
7825815|NCT01288430|12296581|FG003|Part 2|Adverse Event|0
7825816|NCT01288430|12296582|FG004|Part 2|Adverse Event|0
7825817|NCT01288430|12296583|FG005|Part 2|Adverse Event|0
7825818|NCT01288430|12296584|FG006|Part 2|Adverse Event|0
7825819|NCT01288430|12296585|FG007|Part 2|Adverse Event|1
7825820|NCT01288430|12296586|FG008|Part 2|Adverse Event|1
7825821|NCT01288430|12296587|FG009|Part 2|Adverse Event|0
7825822|NCT01288430|12296578|FG000|Part 2|Other|0
7825823|NCT01288430|12296579|FG001|Part 2|Other|0
7825824|NCT01288430|12296580|FG002|Part 2|Other|0
7948239|NCT02526524|12493409|FG005|Overall Study|Physician Decision|0
7825825|NCT01288430|12296581|FG003|Part 2|Other|0
7825826|NCT01288430|12296582|FG004|Part 2|Other|0
7825827|NCT01288430|12296583|FG005|Part 2|Other|0
7825828|NCT01288430|12296584|FG006|Part 2|Other|0
7825829|NCT01288430|12296585|FG007|Part 2|Other|0
7825830|NCT01288430|12296586|FG008|Part 2|Other|0
7825831|NCT01288430|12296587|FG009|Part 2|Other|1
7825832|NCT01288443|12296620|FG000|Overall Study|Adverse Event|0
7825833|NCT01288443|12296621|FG001|Overall Study|Adverse Event|0
7825834|NCT01288443|12296622|FG002|Overall Study|Adverse Event|1
7825835|NCT01288443|12296623|FG003|Overall Study|Adverse Event|1
7825836|NCT01288443|12296624|FG004|Overall Study|Adverse Event|3
7825837|NCT01288443|12296625|FG005|Overall Study|Adverse Event|1
7825838|NCT01288443|12296620|FG000|Overall Study|Poor compliance to protocol|0
7825839|NCT01288443|12296621|FG001|Overall Study|Poor compliance to protocol|0
7825840|NCT01288443|12296622|FG002|Overall Study|Poor compliance to protocol|0
7720048|NCT00536263|12144307|FG001|Overall Study|Did not meet protocol eligibility|2
7720049|NCT00536263|12144308|FG002|Overall Study|Did not meet protocol eligibility|2
7720050|NCT00536471|12144330|FG000|Overall Study|Lost to Follow-up|48
7720051|NCT00536471|12144331|FG001|Overall Study|Lost to Follow-up|23
7720052|NCT00536471|12144332|FG002|Overall Study|Lost to Follow-up|48
7825841|NCT01288443|12296623|FG003|Overall Study|Poor compliance to protocol|0
7825842|NCT01288443|12296624|FG004|Overall Study|Poor compliance to protocol|0
7825843|NCT01288443|12296625|FG005|Overall Study|Poor compliance to protocol|1
7825844|NCT01288443|12296620|FG000|Overall Study|Participant Moved|0
7825845|NCT01288443|12296621|FG001|Overall Study|Participant Moved|0
7825846|NCT01288443|12296622|FG002|Overall Study|Participant Moved|0
7825847|NCT01288443|12296623|FG003|Overall Study|Participant Moved|1
7825848|NCT01288443|12296624|FG004|Overall Study|Participant Moved|2
7825849|NCT01288443|12296625|FG005|Overall Study|Participant Moved|1
7825850|NCT01288443|12296620|FG000|Overall Study|Consent withdrawn by Participant|0
7825851|NCT01288443|12296621|FG001|Overall Study|Consent withdrawn by Participant|0
7825852|NCT01288443|12296622|FG002|Overall Study|Consent withdrawn by Participant|0
7825853|NCT01288443|12296623|FG003|Overall Study|Consent withdrawn by Participant|0
7825854|NCT01288443|12296624|FG004|Overall Study|Consent withdrawn by Participant|0
7825855|NCT01288443|12296625|FG005|Overall Study|Consent withdrawn by Participant|1
7825856|NCT01288443|12296620|FG000|Overall Study|Lost to Follow-up|0
7825857|NCT01288443|12296621|FG001|Overall Study|Lost to Follow-up|1
7825858|NCT01288443|12296622|FG002|Overall Study|Lost to Follow-up|0
7825859|NCT01288443|12296623|FG003|Overall Study|Lost to Follow-up|0
7825860|NCT01288443|12296624|FG004|Overall Study|Lost to Follow-up|0
7825861|NCT01288443|12296625|FG005|Overall Study|Lost to Follow-up|0
7825862|NCT01288443|12296620|FG000|Overall Study|Study drug auto-injector administration|0
7825863|NCT01288443|12296621|FG001|Overall Study|Study drug auto-injector administration|0
7825864|NCT01288443|12296622|FG002|Overall Study|Study drug auto-injector administration|0
7825865|NCT01288443|12296623|FG003|Overall Study|Study drug auto-injector administration|0
7825866|NCT01288443|12296624|FG004|Overall Study|Study drug auto-injector administration|1
7825867|NCT01288443|12296625|FG005|Overall Study|Study drug auto-injector administration|1
7825868|NCT01288443|12296620|FG000|Overall Study|Other than above|0
7825869|NCT01288443|12296621|FG001|Overall Study|Other than above|0
7825870|NCT01288443|12296622|FG002|Overall Study|Other than above|0
7825871|NCT01288443|12296623|FG003|Overall Study|Other than above|2
7825872|NCT01288443|12296624|FG004|Overall Study|Other than above|1
7825873|NCT01288443|12296625|FG005|Overall Study|Other than above|0
7825874|NCT01288469|12296642|FG000|Overall Study|Adverse Event|4
7825875|NCT01288469|12296643|FG001|Overall Study|Adverse Event|1
7825876|NCT01288469|12296644|FG002|Overall Study|Adverse Event|1
7825877|NCT01288469|12296642|FG000|Overall Study|Poor compliance to protocol|0
7825878|NCT01288469|12296643|FG001|Overall Study|Poor compliance to protocol|1
7825879|NCT01288469|12296644|FG002|Overall Study|Poor compliance to protocol|0
7825880|NCT01288469|12296642|FG000|Overall Study|Participant Moved|1
7825881|NCT01288469|12296643|FG001|Overall Study|Participant Moved|0
7825882|NCT01288469|12296644|FG002|Overall Study|Participant Moved|0
7825883|NCT01288469|12296642|FG000|Overall Study|Consent withdrawn by subject|1
7825884|NCT01288469|12296643|FG001|Overall Study|Consent withdrawn by subject|1
7825885|NCT01288469|12296644|FG002|Overall Study|Consent withdrawn by subject|1
7825886|NCT01288469|12296642|FG000|Overall Study|Exclusion criteria finally met|1
7825887|NCT01288469|12296643|FG001|Overall Study|Exclusion criteria finally met|0
7825888|NCT01288469|12296644|FG002|Overall Study|Exclusion criteria finally met|0
7825889|NCT01288612|12296668|FG000|Overall Study|Unable to contact|11
7825890|NCT01288612|12296669|FG001|Overall Study|Unable to contact|16
7825891|NCT01288612|12296670|FG002|Overall Study|Unable to contact|20
7825892|NCT01288612|12296668|FG000|Overall Study|Declined|78
7825893|NCT01288612|12296669|FG001|Overall Study|Declined|63
7825894|NCT01288612|12296670|FG002|Overall Study|Declined|62
7825895|NCT01288612|12296668|FG000|Overall Study|Unable to intubate|0
7825896|NCT01288612|12296669|FG001|Overall Study|Unable to intubate|3
7825897|NCT01288612|12296670|FG002|Overall Study|Unable to intubate|0
7825898|NCT01288729|12296680|FG000|Overall Study|Withdrawal by Subject|1
7825899|NCT01288729|12296681|FG001|Overall Study|Withdrawal by Subject|0
7825900|NCT01288937|12296736|FG000|Overall Study|Adverse Event|1
7825901|NCT01288937|12296737|FG001|Overall Study|Adverse Event|0
7825902|NCT01288976|12296746|FG000|Overall Study|Withdrawal by Subject|58
7825903|NCT01288976|12296747|FG001|Overall Study|Withdrawal by Subject|12
7825904|NCT01288976|12296748|FG002|Overall Study|Withdrawal by Subject|9
7825905|NCT01288976|12296746|FG000|Overall Study|Death|98
7825906|NCT01288976|12296747|FG001|Overall Study|Death|6
7825907|NCT01288976|12296748|FG002|Overall Study|Death|4
7825908|NCT01288976|12296746|FG000|Overall Study|Data unavailable|22
7825909|NCT01288976|12296747|FG001|Overall Study|Data unavailable|9
7825910|NCT01288976|12296748|FG002|Overall Study|Data unavailable|7
7825911|NCT01288989|12296759|FG000|Overall Study|Death|0
7825912|NCT01288989|12296760|FG001|Overall Study|Death|0
7825913|NCT01288989|12296761|FG002|Overall Study|Death|0
7825914|NCT01288989|12296762|FG003|Overall Study|Death|1
7825915|NCT01288989|12296763|FG004|Overall Study|Death|0
7825916|NCT01288989|12296759|FG000|Overall Study|Dose limiting toxicity|1
7825917|NCT01288989|12296760|FG001|Overall Study|Dose limiting toxicity|0
7825918|NCT01288989|12296761|FG002|Overall Study|Dose limiting toxicity|0
7825919|NCT01288989|12296762|FG003|Overall Study|Dose limiting toxicity|0
7825920|NCT01288989|12296763|FG004|Overall Study|Dose limiting toxicity|0
7825921|NCT01288989|12296759|FG000|Overall Study|Adverse Event|0
7825922|NCT01288989|12296760|FG001|Overall Study|Adverse Event|0
7825923|NCT01288989|12296761|FG002|Overall Study|Adverse Event|0
7825924|NCT01288989|12296762|FG003|Overall Study|Adverse Event|0
7825925|NCT01288989|12296763|FG004|Overall Study|Adverse Event|2
7825926|NCT01288989|12296759|FG000|Overall Study|Physician Decision|0
7825927|NCT01288989|12296760|FG001|Overall Study|Physician Decision|0
7825928|NCT01288989|12296761|FG002|Overall Study|Physician Decision|0
7825929|NCT01288989|12296762|FG003|Overall Study|Physician Decision|0
7825930|NCT01288989|12296763|FG004|Overall Study|Physician Decision|1
7825931|NCT01288989|12296759|FG000|Overall Study|Withdrawal by Subject|0
7825932|NCT01288989|12296760|FG001|Overall Study|Withdrawal by Subject|0
7825933|NCT01288989|12296761|FG002|Overall Study|Withdrawal by Subject|0
7825934|NCT01288989|12296762|FG003|Overall Study|Withdrawal by Subject|0
7825935|NCT01288989|12296763|FG004|Overall Study|Withdrawal by Subject|3
7825936|NCT01289015|12296783|FG000|Overall Study|Protocol Violation|12
7825937|NCT01289015|12296784|FG001|Overall Study|Protocol Violation|9
7825938|NCT01289015|12296783|FG000|Overall Study|Adverse Event|3
7825939|NCT01289015|12296784|FG001|Overall Study|Adverse Event|0
7825940|NCT01289015|12296783|FG000|Overall Study|Lost to Follow-up|33
7825941|NCT01289015|12296784|FG001|Overall Study|Lost to Follow-up|17
7825942|NCT01289015|12296783|FG000|Overall Study|Withdrawal by Subject|17
7825943|NCT01289015|12296784|FG001|Overall Study|Withdrawal by Subject|8
7825944|NCT01289015|12296783|FG000|Overall Study|Disease progression|1
7825945|NCT01289015|12296784|FG001|Overall Study|Disease progression|0
7825946|NCT01289015|12296783|FG000|Overall Study|Negative baseline culture and others|33
7825947|NCT01289015|12296784|FG001|Overall Study|Negative baseline culture and others|20
7825948|NCT01289028|12296790|FG000|Overall Study|Progressive Disease|49
7825949|NCT01289028|12296790|FG000|Overall Study|Adverse Event|14
7825950|NCT01289028|12296790|FG000|Overall Study|Withdrawal by Subject|6
7825951|NCT01289028|12296790|FG000|Overall Study|Death|4
7825952|NCT01289028|12296790|FG000|Overall Study|Lack of Efficacy|2
7825953|NCT01289028|12296790|FG000|Overall Study|No longer required|2
7825954|NCT01289028|12296790|FG000|Overall Study|Lost to Follow-up|2
7825955|NCT01289028|12296790|FG000|Overall Study|New Cancer Therapy|2
7825956|NCT01289028|12296790|FG000|Overall Study|Abnormal Lab Value|1
7825957|NCT01289028|12296790|FG000|Overall Study|Missing reason for discon|1
7825958|NCT01289041|12296796|FG000|Overall Study|Adverse Event|24
7825959|NCT01289041|12296796|FG000|Overall Study|Physician Decision|1
7825960|NCT01289041|12296796|FG000|Overall Study|Progressive Disease|41
7825961|NCT01289041|12296796|FG000|Overall Study|Withdrawal by Subject|3
7825962|NCT01289041|12296796|FG000|Overall Study|Death|1
7825963|NCT01289119|12296822|FG000|Overall Study|Adverse Event|2
7825964|NCT01289119|12296823|FG001|Overall Study|Adverse Event|1
7825965|NCT01289119|12296824|FG002|Overall Study|Adverse Event|0
7825966|NCT01289119|12296825|FG003|Overall Study|Adverse Event|2
7825967|NCT01289119|12296826|FG004|Overall Study|Adverse Event|1
7825968|NCT01289119|12296827|FG005|Overall Study|Adverse Event|0
7825969|NCT01289119|12296822|FG000|Overall Study|Major Protocol Deviation|2
7825970|NCT01289119|12296823|FG001|Overall Study|Major Protocol Deviation|1
7825971|NCT01289119|12296824|FG002|Overall Study|Major Protocol Deviation|3
7825972|NCT01289119|12296825|FG003|Overall Study|Major Protocol Deviation|0
7825973|NCT01289119|12296826|FG004|Overall Study|Major Protocol Deviation|2
7825974|NCT01289119|12296827|FG005|Overall Study|Major Protocol Deviation|1
7825975|NCT01289119|12296822|FG000|Overall Study|Lost to Follow-up|0
7825976|NCT01289119|12296823|FG001|Overall Study|Lost to Follow-up|3
7825977|NCT01289119|12296824|FG002|Overall Study|Lost to Follow-up|0
7825978|NCT01289119|12296825|FG003|Overall Study|Lost to Follow-up|0
7825979|NCT01289119|12296826|FG004|Overall Study|Lost to Follow-up|0
7825980|NCT01289119|12296827|FG005|Overall Study|Lost to Follow-up|1
7825981|NCT01289119|12296822|FG000|Overall Study|Withdrawal by Subject|4
7825982|NCT01289119|12296823|FG001|Overall Study|Withdrawal by Subject|2
7825983|NCT01289119|12296824|FG002|Overall Study|Withdrawal by Subject|4
7825984|NCT01289119|12296825|FG003|Overall Study|Withdrawal by Subject|3
7825985|NCT01289119|12296826|FG004|Overall Study|Withdrawal by Subject|1
7825986|NCT01289119|12296827|FG005|Overall Study|Withdrawal by Subject|1
7825987|NCT01289119|12296822|FG000|Overall Study|Pregnancy|0
7825988|NCT01289119|12296823|FG001|Overall Study|Pregnancy|1
7825989|NCT01289119|12296824|FG002|Overall Study|Pregnancy|0
7825990|NCT01289119|12296825|FG003|Overall Study|Pregnancy|0
7825991|NCT01289119|12296826|FG004|Overall Study|Pregnancy|0
7825992|NCT01289119|12296827|FG005|Overall Study|Pregnancy|0
7825993|NCT01289119|12296822|FG000|Overall Study|Lack of Efficacy|0
7720053|NCT00536471|12144333|FG003|Overall Study|Lost to Follow-up|22
7720054|NCT00536471|12144330|FG000|Overall Study|Adverse Event|32
7720055|NCT00536471|12144331|FG001|Overall Study|Adverse Event|16
7720056|NCT00536471|12144332|FG002|Overall Study|Adverse Event|28
7720057|NCT00536471|12144333|FG003|Overall Study|Adverse Event|13
7720058|NCT00536471|12144330|FG000|Overall Study|Withdrawal by Subject|40
7720059|NCT00536471|12144331|FG001|Overall Study|Withdrawal by Subject|24
7825994|NCT01289119|12296823|FG001|Overall Study|Lack of Efficacy|1
7825995|NCT01289119|12296824|FG002|Overall Study|Lack of Efficacy|1
7825996|NCT01289119|12296825|FG003|Overall Study|Lack of Efficacy|1
7825997|NCT01289119|12296826|FG004|Overall Study|Lack of Efficacy|1
7825998|NCT01289119|12296827|FG005|Overall Study|Lack of Efficacy|1
7825999|NCT01289119|12296822|FG000|Overall Study|Other|1
7826000|NCT01289119|12296823|FG001|Overall Study|Other|0
7826001|NCT01289119|12296824|FG002|Overall Study|Other|1
7826002|NCT01289119|12296825|FG003|Overall Study|Other|0
7826003|NCT01289119|12296826|FG004|Overall Study|Other|0
7826004|NCT01289119|12296827|FG005|Overall Study|Other|0
7826005|NCT01289210|12296841|FG000|Overall Study|Adverse Event|1
7826006|NCT01289353|12296866|FG000|Overall Study|Lost to Follow-up|2
7826007|NCT01289418|12296886|FG000|Day 8 Survey|email address invalid|283
7826008|NCT01289418|12296886|FG000|Day 8 Survey|participants did not complete the survey|1935
7826009|NCT01289418|12296886|FG000|Day 29 Survey|email address invalid|283
7826010|NCT01289418|12296886|FG000|Day 29 Survey|participants did not complete the survey|2185
7826011|NCT01289574|12296954|FG000|Overall Study|Lack of Efficacy|4
7826012|NCT01289574|12296955|FG001|Overall Study|Lack of Efficacy|0
7826013|NCT01289574|12296956|FG002|Overall Study|Lack of Efficacy|1
7826014|NCT01289574|12296954|FG000|Overall Study|Lost to Follow-up|2
7826015|NCT01289574|12296955|FG001|Overall Study|Lost to Follow-up|0
7826016|NCT01289574|12296956|FG002|Overall Study|Lost to Follow-up|1
7826017|NCT01289574|12296954|FG000|Overall Study|Withdrawal by Subject|1
7826018|NCT01289574|12296955|FG001|Overall Study|Withdrawal by Subject|1
7826019|NCT01289574|12296956|FG002|Overall Study|Withdrawal by Subject|1
7826020|NCT01289574|12296954|FG000|Overall Study|Adverse Event|0
7826021|NCT01289574|12296955|FG001|Overall Study|Adverse Event|1
7826022|NCT01289574|12296956|FG002|Overall Study|Adverse Event|0
7826023|NCT01289574|12296954|FG000|Overall Study|Subject wanted alternate treatment|0
7826024|NCT01289574|12296955|FG001|Overall Study|Subject wanted alternate treatment|1
7826025|NCT01289574|12296956|FG002|Overall Study|Subject wanted alternate treatment|0
7826026|NCT01289639|12296968|FG000|Overall Study|Lost to Follow-up|1
7826027|NCT01289639|12296969|FG001|Overall Study|Lost to Follow-up|0
7826028|NCT01289639|12296970|FG002|Overall Study|Lost to Follow-up|0
7826029|NCT01289678|12296987|FG000|Overall Study|Physician Decision|6
7826030|NCT01289782|12296993|FG000|Overall Study|Lost to Follow-up|14
7826031|NCT01289782|12296994|FG001|Overall Study|Lost to Follow-up|7
7826032|NCT01289782|12296993|FG000|Overall Study|Protocol Violation|1
7826033|NCT01289782|12296994|FG001|Overall Study|Protocol Violation|1
7826034|NCT01289782|12296993|FG000|Overall Study|Withdrawal by Subject|8
7826035|NCT01289782|12296994|FG001|Overall Study|Withdrawal by Subject|2
7826036|NCT01289782|12296993|FG000|Overall Study|Sponsor's Decision|1
7826037|NCT01289782|12296994|FG001|Overall Study|Sponsor's Decision|0
7826038|NCT01289782|12296993|FG000|Overall Study|Reason not specified|1
7826039|NCT01289782|12296994|FG001|Overall Study|Reason not specified|2
7826040|NCT01289821|12297000|FG000|Treatment Period|Withdrawal by Subject|1
7826041|NCT01289821|12297000|FG000|Treatment Period|Physician Decision|3
7826042|NCT01289821|12297000|FG000|Treatment Period|Adverse Event|4
7826043|NCT01289821|12297000|FG000|Treatment Period|Radiological Progression|43
7826044|NCT01289821|12297000|FG000|Treatment Period|Clinical Progression|2
7826045|NCT01289821|12297000|FG000|Treatment Period|Therapeutic procedure required|1
7826046|NCT01289821|12297000|FG000|Safety Follow-up Period|Withdrawal by Subject|1
7826047|NCT01289821|12297000|FG000|Safety Follow-up Period|Protocol Violation|3
7826048|NCT01289821|12297000|FG000|Safety Follow-up Period|Unspecified reason|1
7826049|NCT01289821|12297000|FG000|Survival Follow-up Period|Protocol Violation|1
7826050|NCT01289821|12297000|FG000|Survival Follow-up Period|Lost to Follow-up|1
7826051|NCT01289821|12297000|FG000|Survival Follow-up Period|Clinical endpoint reached|16
7826052|NCT01289847|12297004|FG000|Overall Study|Patient could not comply with visits|1
7826053|NCT01289990|12297040|FG000|Overall Study|Death|0
7826054|NCT01289990|12297041|FG001|Overall Study|Death|0
7826055|NCT01289990|12297042|FG002|Overall Study|Death|0
7826056|NCT01289990|12297043|FG003|Overall Study|Death|1
7826057|NCT01289990|12297044|FG004|Overall Study|Death|2
7826058|NCT01289990|12297045|FG005|Overall Study|Death|1
7826059|NCT01289990|12297046|FG006|Overall Study|Death|0
7826060|NCT01289990|12297047|FG007|Overall Study|Death|0
7826061|NCT01289990|12297048|FG008|Overall Study|Death|0
7826062|NCT01289990|12297049|FG009|Overall Study|Death|0
7826063|NCT01289990|12297050|FG010|Overall Study|Death|0
7826064|NCT01289990|12297051|FG011|Overall Study|Death|1
7826065|NCT01289990|12297052|FG012|Overall Study|Death|0
7826066|NCT01289990|12297040|FG000|Overall Study|Lost to Follow-up|3
7826067|NCT01289990|12297041|FG001|Overall Study|Lost to Follow-up|2
7826068|NCT01289990|12297042|FG002|Overall Study|Lost to Follow-up|5
7826069|NCT01289990|12297043|FG003|Overall Study|Lost to Follow-up|5
7948240|NCT02526524|12493404|FG000|Overall Study|Sponsor Decision|1
7948241|NCT02526524|12493405|FG001|Overall Study|Sponsor Decision|0
7948242|NCT02526524|12493406|FG002|Overall Study|Sponsor Decision|0
7948243|NCT02526524|12493407|FG003|Overall Study|Sponsor Decision|0
7948244|NCT02526524|12493408|FG004|Overall Study|Sponsor Decision|0
7948245|NCT02526524|12493409|FG005|Overall Study|Sponsor Decision|0
7948246|NCT02526550|12493423|FG000|Overall Study|Lost to Follow-up|1
7948247|NCT02526693|12493462|FG000|Overall Study|Physician Decision|3
7948248|NCT02526693|12493463|FG001|Overall Study|Physician Decision|1
7948249|NCT02527148|12493475|FG000|Overall Study|Did not receive study intervention|1
7948250|NCT02527148|12493476|FG001|Overall Study|Did not receive study intervention|0
7948251|NCT02527161|12493484|FG000|Overall Study|Failed MRI|52
7948252|NCT02527161|12493484|FG000|Overall Study|Withdrawal by Subject|19
7948253|NCT02527161|12493484|FG000|Overall Study|Delay in or unfit for surgery|16
7948254|NCT02527161|12493484|FG000|Overall Study|MRI contraindication|6
7948255|NCT02527161|12493484|FG000|Overall Study|Consent violation|4
7948256|NCT02527161|12493484|FG000|Overall Study|Only Recruited to Part A|27
7948257|NCT02527161|12493484|FG000|Overall Study|Physician Decision|1
7948258|NCT02527161|12493484|FG000|Overall Study|Adverse Event|1
7948259|NCT02527161|12493484|FG000|Overall Study|Lost to Follow-up|6
7948260|NCT02527343|12493500|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1
7948261|NCT02527343|12493501|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0
7948262|NCT02527343|12493502|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0
7948263|NCT02527343|12493503|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0
7948264|NCT02527343|12493504|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0
7948265|NCT02527343|12493505|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0
7948266|NCT02527343|12493500|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1
7948267|NCT02527343|12493501|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7948268|NCT02527343|12493502|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7948269|NCT02527343|12493503|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7948270|NCT02527343|12493504|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7948271|NCT02527343|12493505|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7948272|NCT02527343|12493500|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7948273|NCT02527343|12493501|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4
7948274|NCT02527343|12493502|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7948275|NCT02527343|12493503|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7948276|NCT02527343|12493504|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7948277|NCT02527343|12493505|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7948278|NCT02527343|12493500|FG000|RT Period: Weeks 1 to 52|Other|4
7948279|NCT02527343|12493501|FG001|RT Period: Weeks 1 to 52|Other|3
7948280|NCT02527343|12493502|FG002|RT Period: Weeks 1 to 52|Other|0
7948281|NCT02527343|12493503|FG003|RT Period: Weeks 1 to 52|Other|0
7948282|NCT02527343|12493504|FG004|RT Period: Weeks 1 to 52|Other|0
7948283|NCT02527343|12493505|FG005|RT Period: Weeks 1 to 52|Other|0
7948284|NCT02527343|12493500|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7948285|NCT02527343|12493501|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7948286|NCT02527343|12493502|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1
7948287|NCT02527343|12493503|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7948288|NCT02527343|12493504|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7948289|NCT02527343|12493505|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7948290|NCT02527343|12493500|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7948291|NCT02527343|12493501|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7948292|NCT02527343|12493502|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7826070|NCT01289990|12297044|FG004|Overall Study|Lost to Follow-up|3
7826071|NCT01289990|12297045|FG005|Overall Study|Lost to Follow-up|4
7948293|NCT02527343|12493503|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2
7948294|NCT02527343|12493504|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7948295|NCT02527343|12493505|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7948296|NCT02527343|12493500|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7948297|NCT02527343|12493501|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7948298|NCT02527343|12493502|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7948299|NCT02527343|12493503|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7948300|NCT02527343|12493504|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1
7948301|NCT02527343|12493505|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7948302|NCT02527343|12493500|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7948303|NCT02527343|12493501|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7948304|NCT02527343|12493502|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7948305|NCT02527343|12493503|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7948306|NCT02527343|12493504|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3
7948307|NCT02527343|12493505|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1
7948308|NCT02527343|12493500|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7948309|NCT02527343|12493501|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7826072|NCT01289990|12297046|FG006|Overall Study|Lost to Follow-up|2
7826073|NCT01289990|12297047|FG007|Overall Study|Lost to Follow-up|2
7826074|NCT01289990|12297048|FG008|Overall Study|Lost to Follow-up|1
7826075|NCT01289990|12297049|FG009|Overall Study|Lost to Follow-up|4
7826076|NCT01289990|12297050|FG010|Overall Study|Lost to Follow-up|2
7826077|NCT01289990|12297051|FG011|Overall Study|Lost to Follow-up|1
7826078|NCT01289990|12297052|FG012|Overall Study|Lost to Follow-up|2
7826079|NCT01289990|12297040|FG000|Overall Study|Withdrawal by Subject|15
7826080|NCT01289990|12297041|FG001|Overall Study|Withdrawal by Subject|14
7826081|NCT01289990|12297042|FG002|Overall Study|Withdrawal by Subject|12
7826082|NCT01289990|12297043|FG003|Overall Study|Withdrawal by Subject|13
7826083|NCT01289990|12297044|FG004|Overall Study|Withdrawal by Subject|8
7826084|NCT01289990|12297045|FG005|Overall Study|Withdrawal by Subject|7
7826085|NCT01289990|12297046|FG006|Overall Study|Withdrawal by Subject|13
7826086|NCT01289990|12297047|FG007|Overall Study|Withdrawal by Subject|9
7826087|NCT01289990|12297048|FG008|Overall Study|Withdrawal by Subject|12
7826088|NCT01289990|12297049|FG009|Overall Study|Withdrawal by Subject|13
7826089|NCT01289990|12297050|FG010|Overall Study|Withdrawal by Subject|11
7826090|NCT01289990|12297051|FG011|Overall Study|Withdrawal by Subject|13
7826091|NCT01289990|12297052|FG012|Overall Study|Withdrawal by Subject|16
7826092|NCT01289990|12297040|FG000|Overall Study|discontinued in preceding trial|18
7826093|NCT01289990|12297041|FG001|Overall Study|discontinued in preceding trial|20
7826094|NCT01289990|12297042|FG002|Overall Study|discontinued in preceding trial|41
7826095|NCT01289990|12297043|FG003|Overall Study|discontinued in preceding trial|17
7826096|NCT01289990|12297044|FG004|Overall Study|discontinued in preceding trial|11
7826097|NCT01289990|12297045|FG005|Overall Study|discontinued in preceding trial|12
7826098|NCT01289990|12297046|FG006|Overall Study|discontinued in preceding trial|18
7826099|NCT01289990|12297047|FG007|Overall Study|discontinued in preceding trial|8
7826100|NCT01289990|12297048|FG008|Overall Study|discontinued in preceding trial|17
7826101|NCT01289990|12297049|FG009|Overall Study|discontinued in preceding trial|21
7826102|NCT01289990|12297050|FG010|Overall Study|discontinued in preceding trial|17
7826103|NCT01289990|12297051|FG011|Overall Study|discontinued in preceding trial|17
7826104|NCT01289990|12297052|FG012|Overall Study|discontinued in preceding trial|24
7826105|NCT01289990|12297040|FG000|Overall Study|did not continue in extension|41
7826106|NCT01289990|12297041|FG001|Overall Study|did not continue in extension|45
7826107|NCT01289990|12297042|FG002|Overall Study|did not continue in extension|51
7826108|NCT01289990|12297043|FG003|Overall Study|did not continue in extension|51
7826109|NCT01289990|12297044|FG004|Overall Study|did not continue in extension|48
7826110|NCT01289990|12297045|FG005|Overall Study|did not continue in extension|50
7826111|NCT01289990|12297046|FG006|Overall Study|did not continue in extension|54
7826112|NCT01289990|12297047|FG007|Overall Study|did not continue in extension|36
7826113|NCT01289990|12297048|FG008|Overall Study|did not continue in extension|44
7826114|NCT01289990|12297049|FG009|Overall Study|did not continue in extension|48
7826115|NCT01289990|12297050|FG010|Overall Study|did not continue in extension|45
7826116|NCT01289990|12297051|FG011|Overall Study|did not continue in extension|34
7826117|NCT01289990|12297052|FG012|Overall Study|did not continue in extension|56
7826118|NCT01289990|12297040|FG000|Overall Study|Not treated|0
7826119|NCT01289990|12297041|FG001|Overall Study|Not treated|0
7826120|NCT01289990|12297042|FG002|Overall Study|Not treated|0
7826121|NCT01289990|12297043|FG003|Overall Study|Not treated|0
7826122|NCT01289990|12297044|FG004|Overall Study|Not treated|0
7826123|NCT01289990|12297045|FG005|Overall Study|Not treated|0
7826124|NCT01289990|12297046|FG006|Overall Study|Not treated|1
7826125|NCT01289990|12297047|FG007|Overall Study|Not treated|0
7826126|NCT01289990|12297048|FG008|Overall Study|Not treated|1
7826127|NCT01289990|12297049|FG009|Overall Study|Not treated|0
7826128|NCT01289990|12297050|FG010|Overall Study|Not treated|1
7826129|NCT01289990|12297051|FG011|Overall Study|Not treated|2
7826130|NCT01289990|12297052|FG012|Overall Study|Not treated|0
7826131|NCT01290029|12297080|FG000|Overall Study|Other|2
7826132|NCT01290068|12297086|FG000|Overall Study|Adverse Event|1
7826133|NCT01290068|12297087|FG001|Overall Study|Adverse Event|3
7826134|NCT01290068|12297086|FG000|Overall Study|Lost to Follow-up|3
7826135|NCT01290068|12297087|FG001|Overall Study|Lost to Follow-up|0
7826136|NCT01290068|12297086|FG000|Overall Study|Withdrawal by subject prior to implant|0
7720060|NCT00536471|12144332|FG002|Overall Study|Withdrawal by Subject|43
7826137|NCT01290068|12297087|FG001|Overall Study|Withdrawal by subject prior to implant|2
7826138|NCT01290068|12297086|FG000|Overall Study|Other|3
7826139|NCT01290068|12297087|FG001|Overall Study|Other|1
7826140|NCT01290094|12297093|FG000|Overall Study|Withdrawal by Subject|1
7826141|NCT01290094|12297093|FG000|Overall Study|Lost to Follow-up|5
7826142|NCT01290224|12297097|FG000|Overall Study|Adverse Event|1
7826143|NCT01290224|12297097|FG000|Overall Study|Refused Further Treatment|4
7826144|NCT01290263|12297116|FG000|Overall Study|Adverse Event|0
7826145|NCT01290263|12297117|FG001|Overall Study|Adverse Event|0
7826146|NCT01290263|12297118|FG002|Overall Study|Adverse Event|0
7826147|NCT01290263|12297119|FG003|Overall Study|Adverse Event|1
7826148|NCT01290263|12297120|FG004|Overall Study|Adverse Event|1
7826149|NCT01290263|12297116|FG000|Overall Study|Lack of Efficacy|8
7826150|NCT01290263|12297117|FG001|Overall Study|Lack of Efficacy|2
7826151|NCT01290263|12297118|FG002|Overall Study|Lack of Efficacy|7
7826152|NCT01290263|12297119|FG003|Overall Study|Lack of Efficacy|24
7826153|NCT01290263|12297120|FG004|Overall Study|Lack of Efficacy|33
7826154|NCT01290263|12297116|FG000|Overall Study|Withdrawal by Subject|3
7826155|NCT01290263|12297117|FG001|Overall Study|Withdrawal by Subject|1
7826156|NCT01290263|12297118|FG002|Overall Study|Withdrawal by Subject|0
7826157|NCT01290263|12297119|FG003|Overall Study|Withdrawal by Subject|1
7826158|NCT01290263|12297120|FG004|Overall Study|Withdrawal by Subject|2
7826159|NCT01290263|12297116|FG000|Overall Study|Participant Non-Compliance|0
7826160|NCT01290263|12297117|FG001|Overall Study|Participant Non-Compliance|0
7826161|NCT01290263|12297118|FG002|Overall Study|Participant Non-Compliance|0
7826162|NCT01290263|12297119|FG003|Overall Study|Participant Non-Compliance|1
7826163|NCT01290263|12297120|FG004|Overall Study|Participant Non-Compliance|1
7826164|NCT01290315|12297132|FG000|Overall Study|Adverse Event|0
7826165|NCT01290315|12297133|FG001|Overall Study|Adverse Event|0
7826166|NCT01290315|12297134|FG002|Overall Study|Adverse Event|0
7826167|NCT01290315|12297135|FG003|Overall Study|Adverse Event|3
7826168|NCT01290315|12297132|FG000|Overall Study|Selection criteria/compliance|2
7826169|NCT01290315|12297133|FG001|Overall Study|Selection criteria/compliance|1
7826170|NCT01290315|12297134|FG002|Overall Study|Selection criteria/compliance|0
7826171|NCT01290315|12297135|FG003|Overall Study|Selection criteria/compliance|2
7826172|NCT01290315|12297132|FG000|Overall Study|Lost to Follow-up|0
7826173|NCT01290315|12297133|FG001|Overall Study|Lost to Follow-up|1
7826174|NCT01290315|12297134|FG002|Overall Study|Lost to Follow-up|0
7826175|NCT01290315|12297135|FG003|Overall Study|Lost to Follow-up|0
7826176|NCT01290315|12297132|FG000|Overall Study|Withdrawal by Subject|1
7826177|NCT01290315|12297133|FG001|Overall Study|Withdrawal by Subject|1
7826178|NCT01290315|12297134|FG002|Overall Study|Withdrawal by Subject|0
7826179|NCT01290315|12297135|FG003|Overall Study|Withdrawal by Subject|0
7826180|NCT01290341|12297146|FG000|Overall Study|Protocol Violation|7
7826181|NCT01290341|12297147|FG001|Overall Study|Protocol Violation|3
7826182|NCT01290341|12297146|FG000|Overall Study|Adverse Event|1
7826183|NCT01290341|12297147|FG001|Overall Study|Adverse Event|0
7826184|NCT01290341|12297146|FG000|Overall Study|Lost to Follow-up|21
7826185|NCT01290341|12297147|FG001|Overall Study|Lost to Follow-up|10
7826186|NCT01290341|12297146|FG000|Overall Study|Withdrawal by Subject|19
7826187|NCT01290341|12297147|FG001|Overall Study|Withdrawal by Subject|5
7826188|NCT01290341|12297146|FG000|Overall Study|Negative baseline culture and others|44
7826189|NCT01290341|12297147|FG001|Overall Study|Negative baseline culture and others|11
7826190|NCT01290523|12297170|FG000|Overall Study|Death|3
7826191|NCT01290601|12297183|FG000|Overall Study|Adverse Event|0
7826192|NCT01290601|12297184|FG001|Overall Study|Adverse Event|2
7826193|NCT01290601|12297185|FG002|Overall Study|Adverse Event|0
7826194|NCT01290601|12297186|FG003|Overall Study|Adverse Event|0
7826195|NCT01290601|12297183|FG000|Overall Study|Lack of Efficacy|2
7826196|NCT01290601|12297184|FG001|Overall Study|Lack of Efficacy|1
7826197|NCT01290601|12297185|FG002|Overall Study|Lack of Efficacy|0
7826198|NCT01290601|12297186|FG003|Overall Study|Lack of Efficacy|0
7826199|NCT01290601|12297183|FG000|Overall Study|Lost to Follow-up|7
7826200|NCT01290601|12297184|FG001|Overall Study|Lost to Follow-up|2
7826201|NCT01290601|12297185|FG002|Overall Study|Lost to Follow-up|0
7826202|NCT01290601|12297186|FG003|Overall Study|Lost to Follow-up|0
7826203|NCT01290601|12297183|FG000|Overall Study|Other|1
7826204|NCT01290601|12297184|FG001|Overall Study|Other|0
7826205|NCT01290601|12297185|FG002|Overall Study|Other|0
7826206|NCT01290601|12297186|FG003|Overall Study|Other|0
7826207|NCT01290601|12297183|FG000|Overall Study|Protocol Violation|1
7826208|NCT01290601|12297184|FG001|Overall Study|Protocol Violation|0
7826209|NCT01290601|12297185|FG002|Overall Study|Protocol Violation|0
7826210|NCT01290601|12297186|FG003|Overall Study|Protocol Violation|0
7862273|NCT01597245|12351195|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7862274|NCT01597245|12351196|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7862275|NCT01597245|12351197|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7862276|NCT01597245|12351198|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7862277|NCT01597245|12351199|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7826211|NCT01290666|12297223|FG000|Overall Study|Lost to Follow-up|11
7720061|NCT00536471|12144333|FG003|Overall Study|Withdrawal by Subject|21
7720062|NCT00536471|12144330|FG000|Overall Study|Lack of Efficacy|17
7826212|NCT01290666|12297223|FG000|Overall Study|Withdrawal by Subject|23
7826213|NCT01290666|12297223|FG000|Overall Study|Early Termination of Study|4
7826214|NCT01290679|12297229|FG000|Overall Study|Adverse Event|2
7826215|NCT01290679|12297230|FG001|Overall Study|Adverse Event|0
7826216|NCT01290679|12297229|FG000|Overall Study|Lost to Follow-up|8
7826217|NCT01290679|12297230|FG001|Overall Study|Lost to Follow-up|10
7826218|NCT01290679|12297229|FG000|Overall Study|Protocol Violation|0
7826219|NCT01290679|12297230|FG001|Overall Study|Protocol Violation|1
7826220|NCT01290679|12297229|FG000|Overall Study|Withdrawal by Subject|6
7826221|NCT01290679|12297230|FG001|Overall Study|Withdrawal by Subject|5
7826222|NCT01290679|12297229|FG000|Overall Study|Subject Entered Another Trial|0
7826223|NCT01290679|12297230|FG001|Overall Study|Subject Entered Another Trial|5
7826224|NCT01290731|12297236|FG000|Overall Study|Withdrawal by Subject|1
7826225|NCT01290757|12297242|FG000|Overall Study|Adverse Event|1
7826226|NCT01290757|12297243|FG001|Overall Study|Adverse Event|0
7826227|NCT01290757|12297242|FG000|Overall Study|Protocol Violation|1
7826228|NCT01290757|12297243|FG001|Overall Study|Protocol Violation|1
7826229|NCT01290757|12297242|FG000|Overall Study|Other|0
7826230|NCT01290757|12297243|FG001|Overall Study|Other|1
7826231|NCT01290796|12297249|FG000|Overall Study|Lost to Follow-up|21
7826232|NCT01290796|12297249|FG000|Overall Study|Withdrawal by Subject|4
7826233|NCT01290796|12297249|FG000|Overall Study|Physician Decision|2
7826234|NCT01290796|12297249|FG000|Overall Study|Secondary Surgical Intervention|2
7826235|NCT01290796|12297249|FG000|Overall Study|Withdrawal by Sponsor|1
7826236|NCT01290887|12297265|FG000|Overall Study|Adverse Event|6
7826237|NCT01290887|12297266|FG001|Overall Study|Adverse Event|11
7826238|NCT01290887|12297265|FG000|Overall Study|Lack of Efficacy|4
7826239|NCT01290887|12297266|FG001|Overall Study|Lack of Efficacy|5
7826240|NCT01290887|12297265|FG000|Overall Study|Withdrawal by Subject|26
7826241|NCT01290887|12297266|FG001|Overall Study|Withdrawal by Subject|32
7826242|NCT01290887|12297265|FG000|Overall Study|Protocol Violation|2
7826243|NCT01290887|12297266|FG001|Overall Study|Protocol Violation|1
7826244|NCT01290887|12297265|FG000|Overall Study|Lost to Follow-up|4
7826245|NCT01290887|12297266|FG001|Overall Study|Lost to Follow-up|4
7826246|NCT01290887|12297265|FG000|Overall Study|Non-compliance to study procedures|0
7826247|NCT01290887|12297266|FG001|Overall Study|Non-compliance to study procedures|1
7826248|NCT01290887|12297265|FG000|Overall Study|Non-compliance to study medications|1
7826249|NCT01290887|12297266|FG001|Overall Study|Non-compliance to study medications|0
7826250|NCT01290887|12297265|FG000|Overall Study|Sponsor closure of study|420
7826251|NCT01290887|12297266|FG001|Overall Study|Sponsor closure of study|476
7826252|NCT01290887|12297265|FG000|Overall Study|Other|3
7826253|NCT01290887|12297266|FG001|Overall Study|Other|6
7826254|NCT01291017|12297292|FG000|Overall Study|Lost to Follow-up|2
7826255|NCT01291017|12297292|FG000|Overall Study|Withdrawal by Subject|3
7826256|NCT01291173|12297338|FG000|Overall Study|Adverse Event|0
7826257|NCT01291173|12297339|FG001|Overall Study|Adverse Event|3
7826258|NCT01291173|12297340|FG002|Overall Study|Adverse Event|1
7826259|NCT01291173|12297341|FG003|Overall Study|Adverse Event|3
7826260|NCT01291173|12297338|FG000|Overall Study|Protocol Violation|7
7826261|NCT01291173|12297339|FG001|Overall Study|Protocol Violation|2
7826262|NCT01291173|12297340|FG002|Overall Study|Protocol Violation|2
7826263|NCT01291173|12297341|FG003|Overall Study|Protocol Violation|5
7826264|NCT01291173|12297338|FG000|Overall Study|Withdrawal by Subject|6
7826265|NCT01291173|12297339|FG001|Overall Study|Withdrawal by Subject|4
7826266|NCT01291173|12297340|FG002|Overall Study|Withdrawal by Subject|4
7826267|NCT01291173|12297341|FG003|Overall Study|Withdrawal by Subject|2
7826268|NCT01291173|12297338|FG000|Overall Study|Lost to Follow-up|4
7826269|NCT01291173|12297339|FG001|Overall Study|Lost to Follow-up|6
7826270|NCT01291173|12297340|FG002|Overall Study|Lost to Follow-up|3
7826271|NCT01291173|12297341|FG003|Overall Study|Lost to Follow-up|2
7826272|NCT01291173|12297338|FG000|Overall Study|Unable to meet visit schedule|0
7826273|NCT01291173|12297339|FG001|Overall Study|Unable to meet visit schedule|0
7826274|NCT01291173|12297340|FG002|Overall Study|Unable to meet visit schedule|1
7826275|NCT01291173|12297341|FG003|Overall Study|Unable to meet visit schedule|0
7826276|NCT01291173|12297338|FG000|Overall Study|Lack of compliance|0
7826277|NCT01291173|12297339|FG001|Overall Study|Lack of compliance|0
7826278|NCT01291173|12297340|FG002|Overall Study|Lack of compliance|0
7826279|NCT01291173|12297341|FG003|Overall Study|Lack of compliance|1
7826280|NCT01291173|12297338|FG000|Overall Study|Subject was unblinded|0
7826281|NCT01291173|12297339|FG001|Overall Study|Subject was unblinded|0
7826282|NCT01291173|12297340|FG002|Overall Study|Subject was unblinded|1
7826283|NCT01291173|12297341|FG003|Overall Study|Subject was unblinded|0
7826284|NCT01291173|12297338|FG000|Overall Study|Excluded therapy|0
7826285|NCT01291173|12297339|FG001|Overall Study|Excluded therapy|0
7826286|NCT01291173|12297340|FG002|Overall Study|Excluded therapy|1
7826287|NCT01291173|12297341|FG003|Overall Study|Excluded therapy|0
7826288|NCT01291225|12297353|FG000|Overall Study|Lost to Follow-up|85
7826289|NCT01291225|12297354|FG001|Overall Study|Lost to Follow-up|39
7826290|NCT01291277|12297370|FG000|Overall Study|Death|2
7826291|NCT01291277|12297371|FG001|Overall Study|Death|2
7826292|NCT01291277|12297370|FG000|Overall Study|Lost to Follow-up|3
7826293|NCT01291277|12297371|FG001|Overall Study|Lost to Follow-up|1
7826294|NCT01292057|12297411|FG000|Overall Study|Protocol Violation|1
7826295|NCT01292057|12297412|FG001|Overall Study|Protocol Violation|1
7826296|NCT01292057|12297411|FG000|Overall Study|Lost to Follow-up|1
7826297|NCT01292057|12297412|FG001|Overall Study|Lost to Follow-up|1
7826298|NCT01292187|12297431|FG000|Overall Study|Adverse Event|10
7826299|NCT01292187|12297432|FG001|Overall Study|Adverse Event|5
7826300|NCT01292187|12297431|FG000|Overall Study|Withdrawal by Subject|6
7826301|NCT01292187|12297432|FG001|Overall Study|Withdrawal by Subject|5
7826302|NCT01292187|12297431|FG000|Overall Study|All other reasons|1
7826303|NCT01292187|12297432|FG001|Overall Study|All other reasons|3
7826304|NCT01292226|12297439|FG000|Overall Study|Adverse Event|5
7826305|NCT01292226|12297439|FG000|Overall Study|Death|1
7826306|NCT01292226|12297439|FG000|Overall Study|Graft loss|1
7826307|NCT01292226|12297439|FG000|Overall Study|Protocol Violation|3
7826308|NCT01292226|12297439|FG000|Overall Study|Withdrawal by Subject|1
7826309|NCT01292226|12297439|FG000|Overall Study|Other|2
7826310|NCT01292239|12297445|FG000|Overall Study|Other|1
7826311|NCT01292239|12297446|FG001|Overall Study|Other|1
7826312|NCT01292239|12297445|FG000|Overall Study|Withdrawal by Subject|3
7826313|NCT01292239|12297446|FG001|Overall Study|Withdrawal by Subject|6
7826314|NCT01292473|12297478|FG000|Overall Study|Adverse Event|1
7826315|NCT01292473|12297479|FG001|Overall Study|Adverse Event|0
7826316|NCT01292473|12297480|FG002|Overall Study|Adverse Event|1
7826317|NCT01292473|12297481|FG003|Overall Study|Adverse Event|1
7826318|NCT01292473|12297478|FG000|Overall Study|Lost to Follow-up|1
7826319|NCT01292473|12297479|FG001|Overall Study|Lost to Follow-up|1
7826320|NCT01292473|12297480|FG002|Overall Study|Lost to Follow-up|2
7826321|NCT01292473|12297481|FG003|Overall Study|Lost to Follow-up|2
7826322|NCT01292473|12297478|FG000|Overall Study|Withdrawal by Subject|3
7826323|NCT01292473|12297479|FG001|Overall Study|Withdrawal by Subject|4
7826324|NCT01292473|12297480|FG002|Overall Study|Withdrawal by Subject|3
7826325|NCT01292473|12297481|FG003|Overall Study|Withdrawal by Subject|3
7826326|NCT01292473|12297478|FG000|Overall Study|Physician Decision|0
7826327|NCT01292473|12297479|FG001|Overall Study|Physician Decision|1
7826328|NCT01292473|12297480|FG002|Overall Study|Physician Decision|0
7826329|NCT01292473|12297481|FG003|Overall Study|Physician Decision|0
7826330|NCT01292473|12297478|FG000|Overall Study|Disease Progression|0
7826331|NCT01292473|12297479|FG001|Overall Study|Disease Progression|1
7826332|NCT01292473|12297480|FG002|Overall Study|Disease Progression|3
7826333|NCT01292473|12297481|FG003|Overall Study|Disease Progression|6
7826334|NCT01292486|12297495|FG000|Overall Study|Protocol Violation|2
7826335|NCT01292486|12297495|FG000|Overall Study|Did not meet screening criteria|2
7826336|NCT01292486|12297495|FG000|Overall Study|Adverse Event|1
7826337|NCT01292486|12297495|FG000|Overall Study|Physician Decision|1
7826338|NCT01292603|12297514|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0
7826339|NCT01292603|12297515|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0
7826340|NCT01292603|12297516|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0
7826341|NCT01292603|12297517|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4
7826342|NCT01292603|12297518|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0
7826343|NCT01292603|12297519|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0
7826344|NCT01292603|12297514|FG000|Part 1: Pilot Dose Selection Period|Death|0
7826345|NCT01292603|12297515|FG001|Part 1: Pilot Dose Selection Period|Death|0
7826346|NCT01292603|12297516|FG002|Part 1: Pilot Dose Selection Period|Death|0
7826347|NCT01292603|12297517|FG003|Part 1: Pilot Dose Selection Period|Death|1
7826348|NCT01292603|12297518|FG004|Part 1: Pilot Dose Selection Period|Death|0
7826349|NCT01292603|12297519|FG005|Part 1: Pilot Dose Selection Period|Death|0
7826350|NCT01292603|12297514|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0
7826351|NCT01292603|12297515|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0
7826352|NCT01292603|12297516|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0
7826353|NCT01292603|12297517|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2
7826354|NCT01292603|12297518|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0
7826355|NCT01292603|12297519|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0
7826356|NCT01292603|12297514|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
7826357|NCT01292603|12297515|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
7826358|NCT01292603|12297516|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
7826359|NCT01292603|12297517|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
7826360|NCT01292603|12297518|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
7826361|NCT01292603|12297519|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
7826362|NCT01292603|12297514|FG000|Part 1: Regular Follow-Up Period|Death|3
7826363|NCT01292603|12297515|FG001|Part 1: Regular Follow-Up Period|Death|1
7826364|NCT01292603|12297516|FG002|Part 1: Regular Follow-Up Period|Death|3
7826365|NCT01292603|12297517|FG003|Part 1: Regular Follow-Up Period|Death|1
7826366|NCT01292603|12297518|FG004|Part 1: Regular Follow-Up Period|Death|0
7826367|NCT01292603|12297519|FG005|Part 1: Regular Follow-Up Period|Death|0
7826368|NCT01292603|12297514|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3
7826369|NCT01292603|12297515|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6
7826370|NCT01292603|12297516|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3
7826371|NCT01292603|12297517|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0
7826372|NCT01292603|12297518|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0
7826373|NCT01292603|12297519|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0
7826374|NCT01292603|12297514|FG000|Part 2: Dose Confirmation Period|Death|0
7826375|NCT01292603|12297515|FG001|Part 2: Dose Confirmation Period|Death|0
7826376|NCT01292603|12297516|FG002|Part 2: Dose Confirmation Period|Death|0
7826377|NCT01292603|12297517|FG003|Part 2: Dose Confirmation Period|Death|0
7826378|NCT01292603|12297518|FG004|Part 2: Dose Confirmation Period|Death|1
7826379|NCT01292603|12297519|FG005|Part 2: Dose Confirmation Period|Death|0
7826380|NCT01292603|12297514|FG000|Part 2: Dose Confirmation Period|Physician Decision|0
7826381|NCT01292603|12297515|FG001|Part 2: Dose Confirmation Period|Physician Decision|0
7826382|NCT01292603|12297516|FG002|Part 2: Dose Confirmation Period|Physician Decision|0
7826383|NCT01292603|12297517|FG003|Part 2: Dose Confirmation Period|Physician Decision|0
7826384|NCT01292603|12297518|FG004|Part 2: Dose Confirmation Period|Physician Decision|2
7826385|NCT01292603|12297519|FG005|Part 2: Dose Confirmation Period|Physician Decision|0
7826386|NCT01292603|12297514|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
7826387|NCT01292603|12297515|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
7826388|NCT01292603|12297516|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
7826389|NCT01292603|12297517|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
7826390|NCT01292603|12297518|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
7826391|NCT01292603|12297519|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
7826392|NCT01292603|12297514|FG000|Part 2: Dose Confirmation Period|Adverse Event|0
7826393|NCT01292603|12297515|FG001|Part 2: Dose Confirmation Period|Adverse Event|0
7826394|NCT01292603|12297516|FG002|Part 2: Dose Confirmation Period|Adverse Event|0
7826395|NCT01292603|12297517|FG003|Part 2: Dose Confirmation Period|Adverse Event|0
7826396|NCT01292603|12297518|FG004|Part 2: Dose Confirmation Period|Adverse Event|7
7826397|NCT01292603|12297519|FG005|Part 2: Dose Confirmation Period|Adverse Event|9
7826398|NCT01292603|12297514|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0
7826399|NCT01292603|12297515|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0
7826400|NCT01292603|12297516|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0
7826401|NCT01292603|12297517|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0
7826402|NCT01292603|12297518|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5
7826403|NCT01292603|12297519|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3
7826404|NCT01292603|12297514|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
7826405|NCT01292603|12297515|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
7826406|NCT01292603|12297516|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
7826407|NCT01292603|12297517|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
7826408|NCT01292603|12297518|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
7826409|NCT01292603|12297519|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
7826410|NCT01292603|12297514|FG000|Part 2: Regular Follow-Up|Death|0
7826411|NCT01292603|12297515|FG001|Part 2: Regular Follow-Up|Death|0
7826412|NCT01292603|12297516|FG002|Part 2: Regular Follow-Up|Death|0
7826413|NCT01292603|12297517|FG003|Part 2: Regular Follow-Up|Death|0
7826414|NCT01292603|12297518|FG004|Part 2: Regular Follow-Up|Death|6
7826415|NCT01292603|12297519|FG005|Part 2: Regular Follow-Up|Death|3
7826416|NCT01292603|12297514|FG000|Part 2: Regular Follow-Up|Disease Progression|0
7826417|NCT01292603|12297515|FG001|Part 2: Regular Follow-Up|Disease Progression|0
7826418|NCT01292603|12297516|FG002|Part 2: Regular Follow-Up|Disease Progression|0
7826419|NCT01292603|12297517|FG003|Part 2: Regular Follow-Up|Disease Progression|0
7826420|NCT01292603|12297518|FG004|Part 2: Regular Follow-Up|Disease Progression|5
7826421|NCT01292603|12297519|FG005|Part 2: Regular Follow-Up|Disease Progression|5
7826422|NCT01292603|12297514|FG000|Part 2: Regular Follow-Up|Noncompliance|0
7826423|NCT01292603|12297515|FG001|Part 2: Regular Follow-Up|Noncompliance|0
7826424|NCT01292603|12297516|FG002|Part 2: Regular Follow-Up|Noncompliance|0
7826425|NCT01292603|12297517|FG003|Part 2: Regular Follow-Up|Noncompliance|0
7826426|NCT01292603|12297518|FG004|Part 2: Regular Follow-Up|Noncompliance|1
7826427|NCT01292603|12297519|FG005|Part 2: Regular Follow-Up|Noncompliance|0
7826428|NCT01292603|12297514|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0
7826429|NCT01292603|12297515|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0
7826430|NCT01292603|12297516|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0
7826431|NCT01292603|12297517|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0
7826432|NCT01292603|12297518|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0
7826433|NCT01292603|12297519|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1
7826434|NCT01292603|12297514|FG000|Part 2: Regular Follow-Up|Protocol Violation|0
7826435|NCT01292603|12297515|FG001|Part 2: Regular Follow-Up|Protocol Violation|0
7826436|NCT01292603|12297516|FG002|Part 2: Regular Follow-Up|Protocol Violation|0
7826437|NCT01292603|12297517|FG003|Part 2: Regular Follow-Up|Protocol Violation|0
7826438|NCT01292603|12297518|FG004|Part 2: Regular Follow-Up|Protocol Violation|2
7826439|NCT01292603|12297519|FG005|Part 2: Regular Follow-Up|Protocol Violation|0
7826440|NCT01292603|12297514|FG000|Part 2: Regular Follow-Up|Physician Decision|0
7826441|NCT01292603|12297515|FG001|Part 2: Regular Follow-Up|Physician Decision|0
7826442|NCT01292603|12297516|FG002|Part 2: Regular Follow-Up|Physician Decision|0
7826443|NCT01292603|12297517|FG003|Part 2: Regular Follow-Up|Physician Decision|0
7826444|NCT01292603|12297518|FG004|Part 2: Regular Follow-Up|Physician Decision|2
7826445|NCT01292603|12297519|FG005|Part 2: Regular Follow-Up|Physician Decision|0
7826446|NCT01292603|12297514|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0
7826447|NCT01292603|12297515|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0
7826448|NCT01292603|12297516|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0
7826449|NCT01292603|12297517|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0
7826450|NCT01292603|12297518|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1
7826451|NCT01292603|12297519|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1
7826452|NCT01292603|12297514|FG000|Part 2: Regular Follow-Up|Adverse Event|0
7826453|NCT01292603|12297515|FG001|Part 2: Regular Follow-Up|Adverse Event|0
7826454|NCT01292603|12297516|FG002|Part 2: Regular Follow-Up|Adverse Event|0
7826455|NCT01292603|12297517|FG003|Part 2: Regular Follow-Up|Adverse Event|0
7826456|NCT01292603|12297518|FG004|Part 2: Regular Follow-Up|Adverse Event|2
7826457|NCT01292603|12297519|FG005|Part 2: Regular Follow-Up|Adverse Event|2
7826458|NCT01292603|12297514|FG000|Overall Survival Status|Death|3
7826459|NCT01292603|12297515|FG001|Overall Survival Status|Death|1
7826460|NCT01292603|12297516|FG002|Overall Survival Status|Death|3
7826461|NCT01292603|12297517|FG003|Overall Survival Status|Death|1
7826462|NCT01292603|12297518|FG004|Overall Survival Status|Death|16
7826463|NCT01292603|12297519|FG005|Overall Survival Status|Death|10
7826464|NCT01292837|12297561|FG000|Overall Study|Adverse Event|1
7826465|NCT01292837|12297561|FG000|Overall Study|Further treatment determined|1
7826466|NCT01292876|12297565|FG000|Overall Study|Physician Decision|4
7826467|NCT01292928|12297571|FG000|Overall Study|Death|8
7826468|NCT01292928|12297571|FG000|Overall Study|Withdrawal by Subject|8
7826469|NCT01292928|12297571|FG000|Overall Study|Lost to Follow-up|6
7826470|NCT01292928|12297571|FG000|Overall Study|Physician Decision|2
7826471|NCT01293006|12297581|FG000|Period 2|Lost to Follow-up|1
7826472|NCT01293006|12297582|FG001|Period 2|Lost to Follow-up|0
7826473|NCT01293006|12297583|FG002|Period 2|Lost to Follow-up|0
7826474|NCT01293006|12297584|FG003|Period 2|Lost to Follow-up|0
7826475|NCT01293032|12297603|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
7826476|NCT01293032|12297604|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
7826477|NCT01293032|12297605|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
7826478|NCT01293032|12297606|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
7826479|NCT01293032|12297603|FG000|Treatment|Adverse Event|0
7826480|NCT01293032|12297604|FG001|Treatment|Adverse Event|0
7826481|NCT01293032|12297605|FG002|Treatment|Adverse Event|1
7826482|NCT01293032|12297606|FG003|Treatment|Adverse Event|1
7826483|NCT01293032|12297603|FG000|Treatment|Withdrawal by Subject|2
7826484|NCT01293032|12297604|FG001|Treatment|Withdrawal by Subject|4
7826485|NCT01293032|12297605|FG002|Treatment|Withdrawal by Subject|0
7826486|NCT01293032|12297606|FG003|Treatment|Withdrawal by Subject|0
7826487|NCT01293032|12297603|FG000|Treatment|Disease Progression, relapse|0
7826488|NCT01293032|12297604|FG001|Treatment|Disease Progression, relapse|1
7826489|NCT01293032|12297605|FG002|Treatment|Disease Progression, relapse|0
7826490|NCT01293032|12297606|FG003|Treatment|Disease Progression, relapse|0
7826491|NCT01293084|12297613|FG000|Overall Study|Physician Decision|3
7826492|NCT01293084|12297613|FG000|Overall Study|Withdrawal by Subject|2
7826493|NCT01293240|12297619|FG000|Overall Study|Noncompliance|2
7826494|NCT01293539|12297633|FG000|Overall Study|Physician Decision|1
7826495|NCT01293695|12297639|FG000|Overall Study|Withdrawal by Subject|7
7826496|NCT01293695|12297640|FG001|Overall Study|Withdrawal by Subject|1
7826497|NCT01293695|12297639|FG000|Overall Study|Lost to Follow-up|8
7826498|NCT01293695|12297640|FG001|Overall Study|Lost to Follow-up|6
7826499|NCT01293968|12297655|FG000|Overall Study|non-cooperation|3
7826500|NCT01293968|12297656|FG001|Overall Study|non-cooperation|3
7826501|NCT01294150|12297677|FG000|Overall Study|Physician Decision|2
7826502|NCT01294150|12297678|FG001|Overall Study|Physician Decision|2
7826503|NCT01294358|12297743|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0
7826504|NCT01294358|12297744|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2
7826505|NCT01294358|12297745|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0
7826506|NCT01294358|12297746|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0
7826507|NCT01294358|12297747|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0
7826508|NCT01294358|12297743|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0
7826509|NCT01294358|12297744|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0
7826510|NCT01294358|12297745|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2
7826511|NCT01294358|12297746|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0
7826512|NCT01294358|12297747|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0
7826513|NCT01294358|12297743|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
7826514|NCT01294358|12297744|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
7826515|NCT01294358|12297745|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
7826516|NCT01294358|12297746|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
7826517|NCT01294358|12297747|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
7826518|NCT01294358|12297743|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
7826519|NCT01294358|12297744|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
7826520|NCT01294358|12297745|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
7826521|NCT01294358|12297746|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
7826522|NCT01294358|12297747|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
7826523|NCT01294371|12297764|FG000|Overall Study|Adverse Event|1
7826524|NCT01294371|12297764|FG000|Overall Study|Withdrawal by Subject|12
7826525|NCT01294371|12297764|FG000|Overall Study|Lost to Follow-up|6
7826526|NCT01294371|12297764|FG000|Overall Study|Administrative Reason|1
7826527|NCT01294371|12297764|FG000|Overall Study|Other|14
7826528|NCT01294397|12297784|FG000|Overall Study|Withdrawal by Subject|1
7826529|NCT01294397|12297784|FG000|Overall Study|Administrative Decision|1
7826530|NCT01294423|12297793|FG000|Overall Study|Adverse Event|1
7826531|NCT01294423|12297794|FG001|Overall Study|Adverse Event|2
7826532|NCT01294423|12297795|FG002|Overall Study|Adverse Event|3
7826533|NCT01294423|12297793|FG000|Overall Study|Withdrawal by Subject|1
7826534|NCT01294423|12297794|FG001|Overall Study|Withdrawal by Subject|2
7826535|NCT01294423|12297795|FG002|Overall Study|Withdrawal by Subject|2
7826536|NCT01294423|12297793|FG000|Overall Study|subject no longer meets study criteria|2
7826537|NCT01294423|12297794|FG001|Overall Study|subject no longer meets study criteria|5
7826538|NCT01294423|12297795|FG002|Overall Study|subject no longer meets study criteria|2
7826539|NCT01294423|12297793|FG000|Overall Study|poor/non-compliance|1
7826540|NCT01294423|12297794|FG001|Overall Study|poor/non-compliance|0
7826541|NCT01294423|12297795|FG002|Overall Study|poor/non-compliance|1
7826542|NCT01294436|12297805|FG000|Overall Study|Adverse Event|10
7826543|NCT01294436|12297806|FG001|Overall Study|Adverse Event|17
7826544|NCT01294436|12297805|FG000|Overall Study|Withdrawal by Subject|11
7826545|NCT01294436|12297806|FG001|Overall Study|Withdrawal by Subject|28
7826546|NCT01294436|12297805|FG000|Overall Study|subject no longer meets study criteria|5
7826547|NCT01294436|12297806|FG001|Overall Study|subject no longer meets study criteria|20
7826548|NCT01294436|12297805|FG000|Overall Study|poor/non-compliance|2
7826549|NCT01294436|12297806|FG001|Overall Study|poor/non-compliance|5
7826550|NCT01294449|12297814|FG000|Overall Study|Death|11
7826551|NCT01294449|12297815|FG001|Overall Study|Death|12
7826552|NCT01294449|12297814|FG000|Overall Study|Withdrawal by Subject|1
7826553|NCT01294449|12297815|FG001|Overall Study|Withdrawal by Subject|3
7826554|NCT01294462|12297823|FG000|Overall Study|Lost to Follow-up|1
7826555|NCT01294462|12297824|FG001|Overall Study|Lost to Follow-up|0
7826556|NCT01294462|12297823|FG000|Overall Study|Withdrawal by Subject|65
7826557|NCT01294462|12297824|FG001|Overall Study|Withdrawal by Subject|63
7826558|NCT01294514|12297830|FG000|Overall Study|Excluded due to Arrhythmia|1
7826559|NCT01294553|12297838|FG000|Overall Study|Duplicated Participants|1
7826560|NCT01294553|12297838|FG000|Overall Study|Protocol Violation|268
7826561|NCT01294579|12297843|FG000|Overall Study|Disease progression|12
7826562|NCT01294579|12297843|FG000|Overall Study|Adverse Event|11
7826563|NCT01294579|12297843|FG000|Overall Study|Study closed/terminated|3
7826564|NCT01294579|12297843|FG000|Overall Study|Lost to Follow-up|1
7826565|NCT01294579|12297843|FG000|Overall Study|Physician Decision|3
7826566|NCT01294579|12297843|FG000|Overall Study|Withdrawal by Subject|5
7826567|NCT01294592|12297849|FG000|Overall Study|Adverse Event|28
7826568|NCT01294592|12297850|FG001|Overall Study|Adverse Event|13
7826569|NCT01294592|12297849|FG000|Overall Study|Lack of Efficacy|7
7826570|NCT01294592|12297850|FG001|Overall Study|Lack of Efficacy|5
7826571|NCT01294592|12297849|FG000|Overall Study|Protocol Violation|1
7826572|NCT01294592|12297850|FG001|Overall Study|Protocol Violation|7
7826573|NCT01294592|12297849|FG000|Overall Study|Lost to Follow-up|7
7826574|NCT01294592|12297850|FG001|Overall Study|Lost to Follow-up|9
7826575|NCT01294592|12297849|FG000|Overall Study|Physician Decision|6
7826576|NCT01294592|12297850|FG001|Overall Study|Physician Decision|11
7826577|NCT01294592|12297849|FG000|Overall Study|Withdrawal by Subject|28
7826578|NCT01294592|12297850|FG001|Overall Study|Withdrawal by Subject|28
7826579|NCT01294644|12297862|FG000|Overall Study|Adverse Event|2
7826580|NCT01294644|12297863|FG001|Overall Study|Adverse Event|0
7826581|NCT01294644|12297864|FG002|Overall Study|Adverse Event|1
7826582|NCT01294644|12297862|FG000|Overall Study|Withdrawal by Subject|3
7826583|NCT01294644|12297863|FG001|Overall Study|Withdrawal by Subject|7
7826584|NCT01294644|12297864|FG002|Overall Study|Withdrawal by Subject|4
7826585|NCT01294644|12297862|FG000|Overall Study|Lost to Follow-up|3
7826586|NCT01294644|12297863|FG001|Overall Study|Lost to Follow-up|2
7826587|NCT01294644|12297864|FG002|Overall Study|Lost to Follow-up|5
7826588|NCT01294644|12297862|FG000|Overall Study|Miscellaneous Reason|2
7826589|NCT01294644|12297863|FG001|Overall Study|Miscellaneous Reason|1
7826590|NCT01294644|12297864|FG002|Overall Study|Miscellaneous Reason|4
7826591|NCT01294683|12297874|FG000|Precrossover (Periods I/II)|Adverse Event|49
7826592|NCT01294683|12297875|FG001|Precrossover (Periods I/II)|Adverse Event|52
7826593|NCT01294683|12297874|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3
7826594|NCT01294683|12297875|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6
7826595|NCT01294683|12297874|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
7826596|NCT01294683|12297875|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
7826597|NCT01294683|12297874|FG000|Precrossover (Periods I/II)|Physician Decision|1
7826598|NCT01294683|12297875|FG001|Precrossover (Periods I/II)|Physician Decision|0
7826599|NCT01294683|12297874|FG000|Precrossover (Periods I/II)|Protocol Violation|5
7826600|NCT01294683|12297875|FG001|Precrossover (Periods I/II)|Protocol Violation|5
7826601|NCT01294683|12297874|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
7826602|NCT01294683|12297875|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
7826603|NCT01294683|12297874|FG000|Precrossover (Periods I/II)|Technical Problems|0
7826604|NCT01294683|12297875|FG001|Precrossover (Periods I/II)|Technical Problems|1
7826605|NCT01294683|12297874|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11
7826606|NCT01294683|12297875|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9
7826607|NCT01294683|12297874|FG000|Post Crossover (Period III)|Adverse Event|6
7826608|NCT01294683|12297875|FG001|Post Crossover (Period III)|Adverse Event|6
7826609|NCT01294683|12297874|FG000|Post Crossover (Period III)|Lost to Follow-up|1
7826610|NCT01294683|12297875|FG001|Post Crossover (Period III)|Lost to Follow-up|3
7826611|NCT01294683|12297874|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23
7826612|NCT01294683|12297875|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21
7826613|NCT01294683|12297874|FG000|Post Crossover (Period III)|Withdrawal by Subject|3
7826614|NCT01294683|12297875|FG001|Post Crossover (Period III)|Withdrawal by Subject|2
7826615|NCT01294787|12297908|FG000|Period 1|Adverse Event|0
7826616|NCT01294787|12297909|FG001|Period 1|Adverse Event|0
7826617|NCT01294787|12297910|FG002|Period 1|Adverse Event|0
7826618|NCT01294787|12297911|FG003|Period 1|Adverse Event|0
7826619|NCT01294787|12297912|FG004|Period 1|Adverse Event|1
7826620|NCT01294787|12297913|FG005|Period 1|Adverse Event|0
7826621|NCT01294787|12297908|FG000|Period 1|Withdrawal by Subject|0
7826622|NCT01294787|12297909|FG001|Period 1|Withdrawal by Subject|0
7826623|NCT01294787|12297910|FG002|Period 1|Withdrawal by Subject|0
7826624|NCT01294787|12297911|FG003|Period 1|Withdrawal by Subject|1
7826625|NCT01294787|12297912|FG004|Period 1|Withdrawal by Subject|1
7826626|NCT01294787|12297913|FG005|Period 1|Withdrawal by Subject|1
7826627|NCT01294787|12297908|FG000|Period 1|Administrative problem|0
7826628|NCT01294787|12297909|FG001|Period 1|Administrative problem|0
7826629|NCT01294787|12297910|FG002|Period 1|Administrative problem|1
7826630|NCT01294787|12297911|FG003|Period 1|Administrative problem|0
7826631|NCT01294787|12297912|FG004|Period 1|Administrative problem|0
7826632|NCT01294787|12297913|FG005|Period 1|Administrative problem|1
7826633|NCT01294787|12297908|FG000|Period 2|Adverse Event|0
7826634|NCT01294787|12297909|FG001|Period 2|Adverse Event|3
7826635|NCT01294787|12297910|FG002|Period 2|Adverse Event|0
7826636|NCT01294787|12297911|FG003|Period 2|Adverse Event|1
7826637|NCT01294787|12297912|FG004|Period 2|Adverse Event|0
7826638|NCT01294787|12297913|FG005|Period 2|Adverse Event|0
7826639|NCT01294787|12297908|FG000|Period 2|No longer needs study drug|0
7826640|NCT01294787|12297909|FG001|Period 2|No longer needs study drug|0
7826641|NCT01294787|12297910|FG002|Period 2|No longer needs study drug|0
7826642|NCT01294787|12297911|FG003|Period 2|No longer needs study drug|1
7826643|NCT01294787|12297912|FG004|Period 2|No longer needs study drug|0
7826644|NCT01294787|12297913|FG005|Period 2|No longer needs study drug|0
7826645|NCT01294787|12297908|FG000|Period 3|Adverse Event|0
7826646|NCT01294787|12297909|FG001|Period 3|Adverse Event|0
7826647|NCT01294787|12297910|FG002|Period 3|Adverse Event|0
7826648|NCT01294787|12297911|FG003|Period 3|Adverse Event|0
7826649|NCT01294787|12297912|FG004|Period 3|Adverse Event|1
7826650|NCT01294787|12297913|FG005|Period 3|Adverse Event|0
7826651|NCT01294800|12297928|FG000|Overall Study|Adverse Event|7
7826652|NCT01294800|12297929|FG001|Overall Study|Adverse Event|6
7826653|NCT01294800|12297930|FG002|Overall Study|Adverse Event|12
7826654|NCT01294800|12297931|FG003|Overall Study|Adverse Event|5
7826655|NCT01294800|12297928|FG000|Overall Study|Subject Withdrew Consent|2
7826656|NCT01294800|12297929|FG001|Overall Study|Subject Withdrew Consent|2
7826657|NCT01294800|12297930|FG002|Overall Study|Subject Withdrew Consent|2
7826658|NCT01294800|12297931|FG003|Overall Study|Subject Withdrew Consent|11
7826659|NCT01294800|12297928|FG000|Overall Study|Lost to Follow-up|0
7826660|NCT01294800|12297929|FG001|Overall Study|Lost to Follow-up|0
7826661|NCT01294800|12297930|FG002|Overall Study|Lost to Follow-up|1
7826662|NCT01294800|12297931|FG003|Overall Study|Lost to Follow-up|0
7826663|NCT01294800|12297928|FG000|Overall Study|Non-compliance With Protocol|0
7826664|NCT01294800|12297929|FG001|Overall Study|Non-compliance With Protocol|1
7826665|NCT01294800|12297930|FG002|Overall Study|Non-compliance With Protocol|1
7826666|NCT01294800|12297931|FG003|Overall Study|Non-compliance With Protocol|0
7826667|NCT01294800|12297928|FG000|Overall Study|Did Not Meet Protocol Eligibility|2
7826668|NCT01294800|12297929|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
7826669|NCT01294800|12297930|FG002|Overall Study|Did Not Meet Protocol Eligibility|1
7826670|NCT01294800|12297931|FG003|Overall Study|Did Not Meet Protocol Eligibility|0
7826671|NCT01294917|12297941|FG000|Overall Study|Relocation|5
7826672|NCT01294917|12297941|FG000|Overall Study|Inconvenience|1
7948310|NCT02527343|12493502|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7948311|NCT02527343|12493503|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7948312|NCT02527343|12493504|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2
7948313|NCT02527343|12493505|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1
7948314|NCT02527343|12493500|FG000|OLE Period-Year 1: Week 53 to 104|Other|0
7948315|NCT02527343|12493501|FG001|OLE Period-Year 1: Week 53 to 104|Other|0
7948316|NCT02527343|12493502|FG002|OLE Period-Year 1: Week 53 to 104|Other|0
7948317|NCT02527343|12493503|FG003|OLE Period-Year 1: Week 53 to 104|Other|0
7948318|NCT02527343|12493504|FG004|OLE Period-Year 1: Week 53 to 104|Other|5
7948319|NCT02527343|12493505|FG005|OLE Period-Year 1: Week 53 to 104|Other|7
7948320|NCT02527343|12493500|FG000|OLE Period-Year 2: Week 105 to 156|Other|0
7948321|NCT02527343|12493501|FG001|OLE Period-Year 2: Week 105 to 156|Other|0
7948322|NCT02527343|12493502|FG002|OLE Period-Year 2: Week 105 to 156|Other|0
7948323|NCT02527343|12493503|FG003|OLE Period-Year 2: Week 105 to 156|Other|0
7948324|NCT02527343|12493504|FG004|OLE Period-Year 2: Week 105 to 156|Other|1
7948325|NCT02527343|12493505|FG005|OLE Period-Year 2: Week 105 to 156|Other|2
7948326|NCT02527343|12493500|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7948327|NCT02527343|12493501|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7948328|NCT02527343|12493502|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7948329|NCT02527343|12493503|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7948330|NCT02527343|12493504|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1
7948331|NCT02527343|12493505|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7948332|NCT02527343|12493500|FG000|PT Follow-up: Weeks 104 to 169|Other|0
7948333|NCT02527343|12493501|FG001|PT Follow-up: Weeks 104 to 169|Other|0
7948334|NCT02527343|12493502|FG002|PT Follow-up: Weeks 104 to 169|Other|0
7948335|NCT02527343|12493503|FG003|PT Follow-up: Weeks 104 to 169|Other|0
7948336|NCT02527343|12493504|FG004|PT Follow-up: Weeks 104 to 169|Other|0
7948337|NCT02527343|12493505|FG005|PT Follow-up: Weeks 104 to 169|Other|1
7948338|NCT02527421|12493522|FG000|Overall Study|Withdrawal by Subject|1
7948339|NCT02527421|12493523|FG001|Overall Study|Withdrawal by Subject|0
7948340|NCT02528188|12493556|FG000|Overall Study|Adverse Event|23
7948341|NCT02528188|12493557|FG001|Overall Study|Adverse Event|22
7948342|NCT02528188|12493558|FG002|Overall Study|Adverse Event|8
7948343|NCT02528188|12493556|FG000|Overall Study|Protocol Violation|4
7948344|NCT02528188|12493557|FG001|Overall Study|Protocol Violation|6
7948345|NCT02528188|12493558|FG002|Overall Study|Protocol Violation|4
7948346|NCT02528188|12493556|FG000|Overall Study|Lack of Efficacy|19
7948347|NCT02528188|12493557|FG001|Overall Study|Lack of Efficacy|21
7948348|NCT02528188|12493558|FG002|Overall Study|Lack of Efficacy|22
7948349|NCT02528188|12493556|FG000|Overall Study|Withdrawal by Subject|97
7948350|NCT02528188|12493557|FG001|Overall Study|Withdrawal by Subject|104
7948351|NCT02528188|12493558|FG002|Overall Study|Withdrawal by Subject|100
7948352|NCT02528188|12493556|FG000|Overall Study|Lost to Follow-up|25
7948353|NCT02528188|12493557|FG001|Overall Study|Lost to Follow-up|21
7948354|NCT02528188|12493558|FG002|Overall Study|Lost to Follow-up|31
7948355|NCT02528188|12493556|FG000|Overall Study|Death|4
7948356|NCT02528188|12493557|FG001|Overall Study|Death|4
7948357|NCT02528188|12493558|FG002|Overall Study|Death|0
7948358|NCT02528188|12493556|FG000|Overall Study|Other|89
7948359|NCT02528188|12493557|FG001|Overall Study|Other|91
7948360|NCT02528188|12493558|FG002|Overall Study|Other|74
7948361|NCT02528188|12493556|FG000|Overall Study|Randomized but not treated|6
7948362|NCT02528188|12493557|FG001|Overall Study|Randomized but not treated|7
7948363|NCT02528188|12493558|FG002|Overall Study|Randomized but not treated|12
7948364|NCT02528214|12493568|FG000|Overall Study|Protocol Violation|0
7948365|NCT02528214|12493569|FG001|Overall Study|Protocol Violation|1
7948366|NCT02528214|12493568|FG000|Overall Study|Adverse Event|0
7948367|NCT02528214|12493569|FG001|Overall Study|Adverse Event|1
7948368|NCT02528214|12493568|FG000|Overall Study|Other than specified above|0
7948369|NCT02528214|12493569|FG001|Overall Study|Other than specified above|1
7948370|NCT02528253|12493581|FG000|Overall Study|Adverse Event|3
7948371|NCT02528253|12493582|FG001|Overall Study|Adverse Event|4
7948372|NCT02528253|12493583|FG002|Overall Study|Adverse Event|4
7948373|NCT02528253|12493584|FG003|Overall Study|Adverse Event|8
7948374|NCT02528253|12493585|FG004|Overall Study|Adverse Event|18
7826673|NCT01295034|12297949|FG000|Overall Study|Lost to Follow-up|5
7948375|NCT02528253|12493581|FG000|Overall Study|Death|2
7948376|NCT02528253|12493582|FG001|Overall Study|Death|2
7948377|NCT02528253|12493583|FG002|Overall Study|Death|1
7948378|NCT02528253|12493584|FG003|Overall Study|Death|0
7948379|NCT02528253|12493585|FG004|Overall Study|Death|1
7948380|NCT02528253|12493581|FG000|Overall Study|Insufficient clinical response|7
7948381|NCT02528253|12493582|FG001|Overall Study|Insufficient clinical response|10
7948382|NCT02528253|12493583|FG002|Overall Study|Insufficient clinical response|13
7948383|NCT02528253|12493584|FG003|Overall Study|Insufficient clinical response|12
7948384|NCT02528253|12493585|FG004|Overall Study|Insufficient clinical response|16
7948385|NCT02528253|12493581|FG000|Overall Study|Lost to Follow-up|16
7948386|NCT02528253|12493582|FG001|Overall Study|Lost to Follow-up|9
7948387|NCT02528253|12493583|FG002|Overall Study|Lost to Follow-up|31
7948388|NCT02528253|12493584|FG003|Overall Study|Lost to Follow-up|16
7948389|NCT02528253|12493585|FG004|Overall Study|Lost to Follow-up|34
7948390|NCT02528253|12493581|FG000|Overall Study|Other|21
7826674|NCT01295034|12297950|FG001|Overall Study|Lost to Follow-up|5
7826675|NCT01295281|12297977|FG000|First Intervention (7 Days)|Death|0
7826676|NCT01295281|12297978|FG001|First Intervention (7 Days)|Death|1
7826677|NCT01295320|12297984|FG000|Overall Study|Adverse Event|2
7826678|NCT01295320|12297984|FG000|Overall Study|Lost to Follow-up|4
7826679|NCT01295320|12297984|FG000|Overall Study|Withdrawal by Subject|2
7826680|NCT01295320|12297984|FG000|Overall Study|Subject was bedridden|1
7826681|NCT01295320|12297984|FG000|Overall Study|Unable to travel|1
7826682|NCT01295580|12297994|FG000|Overall Study|Protocol Violation|4
7826683|NCT01295580|12297995|FG001|Overall Study|Protocol Violation|2
7826684|NCT01295580|12297994|FG000|Overall Study|Withdrawal by Subject|1
7826685|NCT01295580|12297995|FG001|Overall Study|Withdrawal by Subject|4
7826686|NCT01295580|12297994|FG000|Overall Study|Adverse Event|2
7826687|NCT01295580|12297995|FG001|Overall Study|Adverse Event|1
7826688|NCT01295580|12297994|FG000|Overall Study|Lost to Follow-up|1
7826689|NCT01295580|12297995|FG001|Overall Study|Lost to Follow-up|0
7826690|NCT01295580|12297994|FG000|Overall Study|Lack of Efficacy|1
7826691|NCT01295580|12297995|FG001|Overall Study|Lack of Efficacy|0
7826692|NCT01295580|12297994|FG000|Overall Study|Other: inconvenience|1
7826693|NCT01295580|12297995|FG001|Overall Study|Other: inconvenience|0
7826694|NCT01295580|12297994|FG000|Overall Study|Other: family objection|0
7826695|NCT01295580|12297995|FG001|Overall Study|Other: family objection|1
7826696|NCT01295671|12298004|FG000|Overall Study|Lost to Follow-up|4
7826697|NCT01295671|12298005|FG001|Overall Study|Lost to Follow-up|6
7826698|NCT01295671|12298006|FG002|Overall Study|Lost to Follow-up|3
7826699|NCT01295671|12298004|FG000|Overall Study|Withdrawal by Subject|3
7826700|NCT01295671|12298005|FG001|Overall Study|Withdrawal by Subject|1
7826701|NCT01295671|12298006|FG002|Overall Study|Withdrawal by Subject|0
7826702|NCT01295814|12298025|FG000|Overall Study|Lack of Efficacy|0
7826703|NCT01295814|12298026|FG001|Overall Study|Lack of Efficacy|2
7826704|NCT01295814|12298025|FG000|Overall Study|Withdrawal by Subject|2
7826705|NCT01295814|12298026|FG001|Overall Study|Withdrawal by Subject|0
7826706|NCT01295827|12298044|FG000|Overall Study|Adverse Event|1
7826707|NCT01295827|12298045|FG001|Overall Study|Adverse Event|2
7826708|NCT01295827|12298046|FG002|Overall Study|Adverse Event|2
7826709|NCT01295827|12298047|FG003|Overall Study|Adverse Event|1
7826710|NCT01295827|12298048|FG004|Overall Study|Adverse Event|1
7826711|NCT01295827|12298049|FG005|Overall Study|Adverse Event|4
7826712|NCT01295827|12298050|FG006|Overall Study|Adverse Event|15
7826713|NCT01295827|12298051|FG007|Overall Study|Adverse Event|49
7826714|NCT01295827|12298052|FG008|Overall Study|Adverse Event|22
7826715|NCT01295827|12298053|FG009|Overall Study|Adverse Event|7
7826716|NCT01295827|12298054|FG010|Overall Study|Adverse Event|50
7826717|NCT01295827|12298055|FG011|Overall Study|Adverse Event|21
7826718|NCT01295827|12298056|FG012|Overall Study|Adverse Event|0
7826719|NCT01295827|12298057|FG013|Overall Study|Adverse Event|0
7826720|NCT01295827|12298058|FG014|Overall Study|Adverse Event|0
7826721|NCT01295827|12298044|FG000|Overall Study|Lost to Follow-up|0
7826722|NCT01295827|12298045|FG001|Overall Study|Lost to Follow-up|0
7826723|NCT01295827|12298046|FG002|Overall Study|Lost to Follow-up|3
7826724|NCT01295827|12298047|FG003|Overall Study|Lost to Follow-up|0
7826725|NCT01295827|12298048|FG004|Overall Study|Lost to Follow-up|1
7826726|NCT01295827|12298049|FG005|Overall Study|Lost to Follow-up|0
7826727|NCT01295827|12298050|FG006|Overall Study|Lost to Follow-up|4
7826728|NCT01295827|12298051|FG007|Overall Study|Lost to Follow-up|8
7826729|NCT01295827|12298052|FG008|Overall Study|Lost to Follow-up|7
7826730|NCT01295827|12298053|FG009|Overall Study|Lost to Follow-up|4
7826731|NCT01295827|12298054|FG010|Overall Study|Lost to Follow-up|7
7826732|NCT01295827|12298055|FG011|Overall Study|Lost to Follow-up|3
7826733|NCT01295827|12298056|FG012|Overall Study|Lost to Follow-up|0
7826734|NCT01295827|12298057|FG013|Overall Study|Lost to Follow-up|0
7826735|NCT01295827|12298058|FG014|Overall Study|Lost to Follow-up|0
7826736|NCT01295827|12298044|FG000|Overall Study|Not Reported|0
7826737|NCT01295827|12298045|FG001|Overall Study|Not Reported|0
7826738|NCT01295827|12298046|FG002|Overall Study|Not Reported|0
7826739|NCT01295827|12298047|FG003|Overall Study|Not Reported|1
7826740|NCT01295827|12298048|FG004|Overall Study|Not Reported|0
7826741|NCT01295827|12298049|FG005|Overall Study|Not Reported|0
7826742|NCT01295827|12298050|FG006|Overall Study|Not Reported|24
7826743|NCT01295827|12298051|FG007|Overall Study|Not Reported|58
7826744|NCT01295827|12298052|FG008|Overall Study|Not Reported|41
7826745|NCT01295827|12298053|FG009|Overall Study|Not Reported|2
7826746|NCT01295827|12298054|FG010|Overall Study|Not Reported|23
7826747|NCT01295827|12298055|FG011|Overall Study|Not Reported|13
7826748|NCT01295827|12298056|FG012|Overall Study|Not Reported|0
7826749|NCT01295827|12298057|FG013|Overall Study|Not Reported|0
7826750|NCT01295827|12298058|FG014|Overall Study|Not Reported|0
7826751|NCT01295827|12298044|FG000|Overall Study|Progressive Disease|2
7826752|NCT01295827|12298045|FG001|Overall Study|Progressive Disease|1
7826753|NCT01295827|12298046|FG002|Overall Study|Progressive Disease|5
7826754|NCT01295827|12298047|FG003|Overall Study|Progressive Disease|2
7826755|NCT01295827|12298048|FG004|Overall Study|Progressive Disease|0
7826756|NCT01295827|12298049|FG005|Overall Study|Progressive Disease|1
7826757|NCT01295827|12298050|FG006|Overall Study|Progressive Disease|87
7826758|NCT01295827|12298051|FG007|Overall Study|Progressive Disease|144
7826759|NCT01295827|12298052|FG008|Overall Study|Progressive Disease|85
7826760|NCT01295827|12298053|FG009|Overall Study|Progressive Disease|40
7826761|NCT01295827|12298054|FG010|Overall Study|Progressive Disease|175
7826762|NCT01295827|12298055|FG011|Overall Study|Progressive Disease|136
7826763|NCT01295827|12298056|FG012|Overall Study|Progressive Disease|0
7826764|NCT01295827|12298057|FG013|Overall Study|Progressive Disease|0
7826765|NCT01295827|12298058|FG014|Overall Study|Progressive Disease|0
7826766|NCT01295827|12298044|FG000|Overall Study|Screen Failure|0
7826767|NCT01295827|12298045|FG001|Overall Study|Screen Failure|0
7826768|NCT01295827|12298046|FG002|Overall Study|Screen Failure|0
7826769|NCT01295827|12298047|FG003|Overall Study|Screen Failure|0
7826770|NCT01295827|12298048|FG004|Overall Study|Screen Failure|0
7826771|NCT01295827|12298049|FG005|Overall Study|Screen Failure|0
7826772|NCT01295827|12298050|FG006|Overall Study|Screen Failure|2
7826773|NCT01295827|12298051|FG007|Overall Study|Screen Failure|2
7826774|NCT01295827|12298052|FG008|Overall Study|Screen Failure|2
7826775|NCT01295827|12298053|FG009|Overall Study|Screen Failure|0
7826776|NCT01295827|12298054|FG010|Overall Study|Screen Failure|1
7826777|NCT01295827|12298055|FG011|Overall Study|Screen Failure|0
7826778|NCT01295827|12298056|FG012|Overall Study|Screen Failure|0
7826779|NCT01295827|12298057|FG013|Overall Study|Screen Failure|0
7826780|NCT01295827|12298058|FG014|Overall Study|Screen Failure|0
7826781|NCT01295827|12298044|FG000|Overall Study|Withdrawal by Subject|1
7826782|NCT01295827|12298045|FG001|Overall Study|Withdrawal by Subject|0
7826783|NCT01295827|12298046|FG002|Overall Study|Withdrawal by Subject|2
7826784|NCT01295827|12298047|FG003|Overall Study|Withdrawal by Subject|0
7826785|NCT01295827|12298048|FG004|Overall Study|Withdrawal by Subject|0
7826786|NCT01295827|12298049|FG005|Overall Study|Withdrawal by Subject|1
7826787|NCT01295827|12298050|FG006|Overall Study|Withdrawal by Subject|13
7826788|NCT01295827|12298051|FG007|Overall Study|Withdrawal by Subject|35
7826789|NCT01295827|12298052|FG008|Overall Study|Withdrawal by Subject|11
7826790|NCT01295827|12298053|FG009|Overall Study|Withdrawal by Subject|2
7826791|NCT01295827|12298054|FG010|Overall Study|Withdrawal by Subject|18
7826792|NCT01295827|12298055|FG011|Overall Study|Withdrawal by Subject|13
7826793|NCT01295827|12298056|FG012|Overall Study|Withdrawal by Subject|0
7826794|NCT01295827|12298057|FG013|Overall Study|Withdrawal by Subject|0
7826795|NCT01295827|12298058|FG014|Overall Study|Withdrawal by Subject|0
7826796|NCT01295827|12298044|FG000|Overall Study|Other|0
7826797|NCT01295827|12298045|FG001|Overall Study|Other|0
7826798|NCT01295827|12298046|FG002|Overall Study|Other|0
7826799|NCT01295827|12298047|FG003|Overall Study|Other|0
7826800|NCT01295827|12298048|FG004|Overall Study|Other|0
7826801|NCT01295827|12298049|FG005|Overall Study|Other|0
7826802|NCT01295827|12298050|FG006|Overall Study|Other|1
7720063|NCT00536471|12144331|FG001|Overall Study|Lack of Efficacy|18
7826803|NCT01295827|12298051|FG007|Overall Study|Other|1
7826804|NCT01295827|12298052|FG008|Overall Study|Other|1
7720064|NCT00536471|12144332|FG002|Overall Study|Lack of Efficacy|11
7826805|NCT01295827|12298053|FG009|Overall Study|Other|0
7826806|NCT01295827|12298054|FG010|Overall Study|Other|2
7826807|NCT01295827|12298055|FG011|Overall Study|Other|0
7826808|NCT01295827|12298056|FG012|Overall Study|Other|0
7826809|NCT01295827|12298057|FG013|Overall Study|Other|0
7826810|NCT01295827|12298058|FG014|Overall Study|Other|0
7826811|NCT01295905|12298123|FG000|Overall Study|Did not meet inclusion criteria|1
7826812|NCT01295905|12298124|FG001|Overall Study|Did not meet inclusion criteria|0
7826813|NCT01295905|12298123|FG000|Overall Study|Met exclusion criteria|1
7826814|NCT01295905|12298124|FG001|Overall Study|Met exclusion criteria|0
7826815|NCT01296035|12298130|FG000|Overall Study|Withdrawal by Subject|1
7826816|NCT01296152|12298134|FG000|Overall Study|Unwilling to adhere to study requirement|1
7826817|NCT01296347|12298149|FG000|Allocation|Withdrawal by Subject|1
7826818|NCT01296347|12298150|FG001|Allocation|Withdrawal by Subject|2
7826819|NCT01296347|12298149|FG000|Allocation|Lack of Efficacy|1
7826820|NCT01296347|12298150|FG001|Allocation|Lack of Efficacy|2
7826821|NCT01296347|12298149|FG000|Allocation|not received infusion|1
7826822|NCT01296347|12298150|FG001|Allocation|not received infusion|0
7826823|NCT01296347|12298149|FG000|6 Week Follow up|Death|0
7826824|NCT01296347|12298150|FG001|6 Week Follow up|Death|1
7826825|NCT01296347|12298149|FG000|3 Month Follow up|Death|1
7826826|NCT01296347|12298150|FG001|3 Month Follow up|Death|0
7826827|NCT01296347|12298149|FG000|3 Month Follow up|Lost to Follow-up|0
7826828|NCT01296347|12298150|FG001|3 Month Follow up|Lost to Follow-up|1
7826829|NCT01296347|12298149|FG000|6 Month Follow up|Death|2
7826830|NCT01296347|12298150|FG001|6 Month Follow up|Death|1
7826831|NCT01296347|12298149|FG000|6 Month Follow up|Lost to Follow-up|0
7826832|NCT01296347|12298150|FG001|6 Month Follow up|Lost to Follow-up|1
7826833|NCT01296347|12298149|FG000|12 Month Follow up|Lost to Follow-up|3
7826834|NCT01296347|12298150|FG001|12 Month Follow up|Lost to Follow-up|1
7826835|NCT01296347|12298149|FG000|12 Month Follow up|Death|1
7826836|NCT01296347|12298150|FG001|12 Month Follow up|Death|1
7826837|NCT01296347|12298149|FG000|12 Month Follow up|Withdrawal by Subject|0
7826838|NCT01296347|12298150|FG001|12 Month Follow up|Withdrawal by Subject|1
7826839|NCT01296412|12298170|FG000|Overall Study|Adverse Event|8
7826840|NCT01296412|12298171|FG001|Overall Study|Adverse Event|29
7826841|NCT01296412|12298170|FG000|Overall Study|Lack of Efficacy|1
7826842|NCT01296412|12298171|FG001|Overall Study|Lack of Efficacy|0
7826843|NCT01296412|12298170|FG000|Overall Study|Lost to Follow-up|10
7826844|NCT01296412|12298171|FG001|Overall Study|Lost to Follow-up|7
7826845|NCT01296412|12298170|FG000|Overall Study|Non-compliance with study drug|1
7826846|NCT01296412|12298171|FG001|Overall Study|Non-compliance with study drug|2
7826847|NCT01296412|12298170|FG000|Overall Study|Other reason not specified|20
7826848|NCT01296412|12298171|FG001|Overall Study|Other reason not specified|15
7826849|NCT01296412|12298170|FG000|Overall Study|Physician Decision|1
7826850|NCT01296412|12298171|FG001|Overall Study|Physician Decision|3
7826851|NCT01296412|12298170|FG000|Overall Study|Pregnancy|0
7826852|NCT01296412|12298171|FG001|Overall Study|Pregnancy|1
7826853|NCT01296412|12298170|FG000|Overall Study|Withdrawal by Subject|10
7826854|NCT01296412|12298171|FG001|Overall Study|Withdrawal by Subject|13
7826855|NCT01296568|12298186|FG000|Continued Access Phase|Lost to Follow-up|1
7826856|NCT01296568|12298186|FG000|Continued Access Phase|Withdrawal by Subject|1
7826857|NCT01296568|12298186|FG000|Continued Access Phase|Disease Progression|1
7862278|NCT01597245|12351200|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7862279|NCT01597245|12351201|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7862280|NCT01597245|12351202|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7862281|NCT01597245|12351203|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7862282|NCT01597245|12351204|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7862283|NCT01597245|12351205|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
7862284|NCT01597245|12351206|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
7862285|NCT01597245|12351207|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41
7862286|NCT01597245|12351208|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13
7862287|NCT01597245|12351188|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862288|NCT01597245|12351189|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862289|NCT01597245|12351190|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862290|NCT01597245|12351191|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862291|NCT01597245|12351192|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862292|NCT01597245|12351193|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862293|NCT01597245|12351194|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862294|NCT01597245|12351195|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862295|NCT01597245|12351196|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862296|NCT01597245|12351197|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862297|NCT01597245|12351198|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862298|NCT01597245|12351199|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862299|NCT01597245|12351200|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862300|NCT01597245|12351201|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862301|NCT01597245|12351202|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862302|NCT01597245|12351203|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862303|NCT01597245|12351204|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2
7862304|NCT01597245|12351205|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7826858|NCT01296672|12298203|FG000|Overall Study|Lost to Follow-up|73
7826859|NCT01296672|12298204|FG001|Overall Study|Lost to Follow-up|18
7826860|NCT01296698|12298214|FG000|Overall Study|Adverse Event|1
7826861|NCT01296698|12298215|FG001|Overall Study|Adverse Event|0
7826862|NCT01296698|12298214|FG000|Overall Study|Death|1
7826863|NCT01296698|12298215|FG001|Overall Study|Death|0
7826864|NCT01296698|12298214|FG000|Overall Study|Lost to Follow-up|19
7826865|NCT01296698|12298215|FG001|Overall Study|Lost to Follow-up|1
7826866|NCT01296698|12298214|FG000|Overall Study|Withdrawal by Subject|12
7826867|NCT01296698|12298215|FG001|Overall Study|Withdrawal by Subject|0
7826868|NCT01296698|12298214|FG000|Overall Study|Difficulty Contacting Subject|2
7826869|NCT01296698|12298215|FG001|Overall Study|Difficulty Contacting Subject|0
7826870|NCT01296698|12298214|FG000|Overall Study|Study Terminated by Sponsor|209
7826871|NCT01296698|12298215|FG001|Overall Study|Study Terminated by Sponsor|12
7826872|NCT01296932|12298263|FG000|Overall Study|Dose limiting toxicity|0
7826873|NCT01296932|12298264|FG001|Overall Study|Dose limiting toxicity|0
7826874|NCT01296932|12298265|FG002|Overall Study|Dose limiting toxicity|0
7826875|NCT01296932|12298266|FG003|Overall Study|Dose limiting toxicity|0
7826876|NCT01296932|12298267|FG004|Overall Study|Dose limiting toxicity|0
7826877|NCT01296932|12298268|FG005|Overall Study|Dose limiting toxicity|0
7826878|NCT01296932|12298269|FG006|Overall Study|Dose limiting toxicity|1
7826879|NCT01296932|12298270|FG007|Overall Study|Dose limiting toxicity|0
7826880|NCT01296932|12298271|FG008|Overall Study|Dose limiting toxicity|1
7826881|NCT01296932|12298263|FG000|Overall Study|Progressive disease|2
7826882|NCT01296932|12298264|FG001|Overall Study|Progressive disease|0
7826883|NCT01296932|12298265|FG002|Overall Study|Progressive disease|1
7826884|NCT01296932|12298266|FG003|Overall Study|Progressive disease|1
7826885|NCT01296932|12298267|FG004|Overall Study|Progressive disease|2
7826886|NCT01296932|12298268|FG005|Overall Study|Progressive disease|3
7826887|NCT01296932|12298269|FG006|Overall Study|Progressive disease|1
7826888|NCT01296932|12298270|FG007|Overall Study|Progressive disease|0
7826889|NCT01296932|12298271|FG008|Overall Study|Progressive disease|0
7826890|NCT01296932|12298263|FG000|Overall Study|Withdrawal by Subject|0
7826891|NCT01296932|12298264|FG001|Overall Study|Withdrawal by Subject|0
7826892|NCT01296932|12298265|FG002|Overall Study|Withdrawal by Subject|1
7826893|NCT01296932|12298266|FG003|Overall Study|Withdrawal by Subject|1
7826894|NCT01296932|12298267|FG004|Overall Study|Withdrawal by Subject|0
7826895|NCT01296932|12298268|FG005|Overall Study|Withdrawal by Subject|0
7826896|NCT01296932|12298269|FG006|Overall Study|Withdrawal by Subject|3
7826897|NCT01296932|12298270|FG007|Overall Study|Withdrawal by Subject|0
7826898|NCT01296932|12298271|FG008|Overall Study|Withdrawal by Subject|0
7826899|NCT01296932|12298263|FG000|Overall Study|Adverse Event|1
7826900|NCT01296932|12298264|FG001|Overall Study|Adverse Event|1
7826901|NCT01296932|12298265|FG002|Overall Study|Adverse Event|1
7826902|NCT01296932|12298266|FG003|Overall Study|Adverse Event|2
7826903|NCT01296932|12298267|FG004|Overall Study|Adverse Event|1
7826904|NCT01296932|12298268|FG005|Overall Study|Adverse Event|0
7826905|NCT01296932|12298269|FG006|Overall Study|Adverse Event|0
7826906|NCT01296932|12298270|FG007|Overall Study|Adverse Event|0
7826907|NCT01296932|12298271|FG008|Overall Study|Adverse Event|1
7826908|NCT01296932|12298263|FG000|Overall Study|Investigator decision|0
7826909|NCT01296932|12298264|FG001|Overall Study|Investigator decision|1
7826910|NCT01296932|12298265|FG002|Overall Study|Investigator decision|0
7826911|NCT01296932|12298266|FG003|Overall Study|Investigator decision|1
7826912|NCT01296932|12298267|FG004|Overall Study|Investigator decision|0
7826913|NCT01296932|12298268|FG005|Overall Study|Investigator decision|0
7826914|NCT01296932|12298269|FG006|Overall Study|Investigator decision|1
7826915|NCT01296932|12298270|FG007|Overall Study|Investigator decision|0
7826916|NCT01296932|12298271|FG008|Overall Study|Investigator decision|1
7826917|NCT01296932|12298263|FG000|Overall Study|No clinical benefit anymore|0
7826918|NCT01296932|12298264|FG001|Overall Study|No clinical benefit anymore|1
7826919|NCT01296932|12298265|FG002|Overall Study|No clinical benefit anymore|0
7826920|NCT01296932|12298266|FG003|Overall Study|No clinical benefit anymore|0
7826921|NCT01296932|12298267|FG004|Overall Study|No clinical benefit anymore|0
7826922|NCT01296932|12298268|FG005|Overall Study|No clinical benefit anymore|0
7826923|NCT01296932|12298269|FG006|Overall Study|No clinical benefit anymore|0
7826924|NCT01296932|12298270|FG007|Overall Study|No clinical benefit anymore|0
7826925|NCT01296932|12298271|FG008|Overall Study|No clinical benefit anymore|0
7826926|NCT01296932|12298263|FG000|Overall Study|Physician Decision|0
7826927|NCT01296932|12298264|FG001|Overall Study|Physician Decision|0
7826928|NCT01296932|12298265|FG002|Overall Study|Physician Decision|1
7826929|NCT01296932|12298266|FG003|Overall Study|Physician Decision|0
7826930|NCT01296932|12298267|FG004|Overall Study|Physician Decision|0
7826931|NCT01296932|12298268|FG005|Overall Study|Physician Decision|0
7826932|NCT01296932|12298269|FG006|Overall Study|Physician Decision|0
7826933|NCT01296932|12298270|FG007|Overall Study|Physician Decision|0
7826934|NCT01296932|12298271|FG008|Overall Study|Physician Decision|0
7826935|NCT01296932|12298263|FG000|Overall Study|IV problems, administration not possible|0
7826936|NCT01296932|12298264|FG001|Overall Study|IV problems, administration not possible|0
7826937|NCT01296932|12298265|FG002|Overall Study|IV problems, administration not possible|1
7826938|NCT01296932|12298266|FG003|Overall Study|IV problems, administration not possible|0
7826939|NCT01296932|12298267|FG004|Overall Study|IV problems, administration not possible|0
7826940|NCT01296932|12298268|FG005|Overall Study|IV problems, administration not possible|0
7826941|NCT01296932|12298269|FG006|Overall Study|IV problems, administration not possible|0
7826942|NCT01296932|12298270|FG007|Overall Study|IV problems, administration not possible|0
7826943|NCT01296932|12298271|FG008|Overall Study|IV problems, administration not possible|0
7826944|NCT01296932|12298263|FG000|Overall Study|per protocol|0
7826945|NCT01296932|12298264|FG001|Overall Study|per protocol|0
7826946|NCT01296932|12298265|FG002|Overall Study|per protocol|1
7826947|NCT01296932|12298266|FG003|Overall Study|per protocol|1
7826948|NCT01296932|12298267|FG004|Overall Study|per protocol|0
7826949|NCT01296932|12298268|FG005|Overall Study|per protocol|0
7826950|NCT01296932|12298269|FG006|Overall Study|per protocol|0
7826951|NCT01296932|12298270|FG007|Overall Study|per protocol|0
7826952|NCT01296932|12298271|FG008|Overall Study|per protocol|0
7826953|NCT01296932|12298263|FG000|Overall Study|Low benefit and too many side effects|0
7826954|NCT01296932|12298264|FG001|Overall Study|Low benefit and too many side effects|0
7826955|NCT01296932|12298265|FG002|Overall Study|Low benefit and too many side effects|0
7826956|NCT01296932|12298266|FG003|Overall Study|Low benefit and too many side effects|0
7826957|NCT01296932|12298267|FG004|Overall Study|Low benefit and too many side effects|0
7826958|NCT01296932|12298268|FG005|Overall Study|Low benefit and too many side effects|0
7826959|NCT01296932|12298269|FG006|Overall Study|Low benefit and too many side effects|0
7826960|NCT01296932|12298270|FG007|Overall Study|Low benefit and too many side effects|1
7826961|NCT01296932|12298271|FG008|Overall Study|Low benefit and too many side effects|0
7826962|NCT01296932|12298263|FG000|Overall Study|No adequate treatment response|0
7826963|NCT01296932|12298264|FG001|Overall Study|No adequate treatment response|0
7826964|NCT01296932|12298265|FG002|Overall Study|No adequate treatment response|0
7826965|NCT01296932|12298266|FG003|Overall Study|No adequate treatment response|0
7826966|NCT01296932|12298267|FG004|Overall Study|No adequate treatment response|0
7826967|NCT01296932|12298268|FG005|Overall Study|No adequate treatment response|0
7826968|NCT01296932|12298269|FG006|Overall Study|No adequate treatment response|0
7826969|NCT01296932|12298270|FG007|Overall Study|No adequate treatment response|1
7826970|NCT01296932|12298271|FG008|Overall Study|No adequate treatment response|0
7826971|NCT01296932|12298263|FG000|Overall Study|Dosage already reduced, AE still present|0
7826972|NCT01296932|12298264|FG001|Overall Study|Dosage already reduced, AE still present|0
7826973|NCT01296932|12298265|FG002|Overall Study|Dosage already reduced, AE still present|0
7826974|NCT01296932|12298266|FG003|Overall Study|Dosage already reduced, AE still present|0
7826975|NCT01296932|12298267|FG004|Overall Study|Dosage already reduced, AE still present|0
7826976|NCT01296932|12298268|FG005|Overall Study|Dosage already reduced, AE still present|0
7826977|NCT01296932|12298269|FG006|Overall Study|Dosage already reduced, AE still present|0
7826978|NCT01296932|12298270|FG007|Overall Study|Dosage already reduced, AE still present|0
7826979|NCT01296932|12298271|FG008|Overall Study|Dosage already reduced, AE still present|1
7826980|NCT01297062|12298298|FG000|Overall Study|Adverse Event|2
7826981|NCT01297062|12298299|FG001|Overall Study|Adverse Event|0
7826982|NCT01297062|12298300|FG002|Overall Study|Adverse Event|1
7826983|NCT01297062|12298301|FG003|Overall Study|Adverse Event|0
7826984|NCT01297062|12298302|FG004|Overall Study|Adverse Event|0
7826985|NCT01297062|12298303|FG005|Overall Study|Adverse Event|0
7826986|NCT01297062|12298304|FG006|Overall Study|Adverse Event|0
7826987|NCT01297062|12298298|FG000|Overall Study|Physician Decision|1
7826988|NCT01297062|12298299|FG001|Overall Study|Physician Decision|0
7826989|NCT01297062|12298300|FG002|Overall Study|Physician Decision|1
7826990|NCT01297062|12298301|FG003|Overall Study|Physician Decision|0
7826991|NCT01297062|12298302|FG004|Overall Study|Physician Decision|0
7826992|NCT01297062|12298303|FG005|Overall Study|Physician Decision|0
7826993|NCT01297062|12298304|FG006|Overall Study|Physician Decision|6
7826994|NCT01297062|12298298|FG000|Overall Study|Protocol Violation|0
7826995|NCT01297062|12298299|FG001|Overall Study|Protocol Violation|0
7826996|NCT01297062|12298300|FG002|Overall Study|Protocol Violation|0
7826997|NCT01297062|12298301|FG003|Overall Study|Protocol Violation|0
7826998|NCT01297062|12298302|FG004|Overall Study|Protocol Violation|1
7826999|NCT01297062|12298303|FG005|Overall Study|Protocol Violation|0
7827000|NCT01297062|12298304|FG006|Overall Study|Protocol Violation|0
7827001|NCT01297062|12298298|FG000|Overall Study|Subject Decision|1
7827002|NCT01297062|12298299|FG001|Overall Study|Subject Decision|1
7827003|NCT01297062|12298300|FG002|Overall Study|Subject Decision|0
7827004|NCT01297062|12298301|FG003|Overall Study|Subject Decision|1
7827005|NCT01297062|12298302|FG004|Overall Study|Subject Decision|1
7827006|NCT01297062|12298303|FG005|Overall Study|Subject Decision|1
7827007|NCT01297062|12298304|FG006|Overall Study|Subject Decision|2
7827008|NCT01297244|12298314|FG000|Overall Study|Progressive disease|22
7827009|NCT01297244|12298315|FG001|Overall Study|Progressive disease|3
7827010|NCT01297244|12298314|FG000|Overall Study|Adverse Event|9
7827011|NCT01297244|12298315|FG001|Overall Study|Adverse Event|1
7827012|NCT01297244|12298314|FG000|Overall Study|Death|1
7827013|NCT01297244|12298315|FG001|Overall Study|Death|1
7827014|NCT01297244|12298314|FG000|Overall Study|Clinical progression|1
7827015|NCT01297244|12298315|FG001|Overall Study|Clinical progression|1
7827016|NCT01297244|12298314|FG000|Overall Study|Withdrawal by Subject|2
7827017|NCT01297244|12298315|FG001|Overall Study|Withdrawal by Subject|0
7827018|NCT01297270|12298330|FG000|Overall Study|Adverse Event|19
7827019|NCT01297270|12298331|FG001|Overall Study|Adverse Event|32
7827020|NCT01297270|12298332|FG002|Overall Study|Adverse Event|5
7827021|NCT01297270|12298330|FG000|Overall Study|Lack of Efficacy|15
7827022|NCT01297270|12298331|FG001|Overall Study|Lack of Efficacy|17
7827023|NCT01297270|12298332|FG002|Overall Study|Lack of Efficacy|15
7827024|NCT01297270|12298330|FG000|Overall Study|Lost to Follow-up|1
7827025|NCT01297270|12298331|FG001|Overall Study|Lost to Follow-up|2
7827026|NCT01297270|12298332|FG002|Overall Study|Lost to Follow-up|1
7827027|NCT01297270|12298330|FG000|Overall Study|Protocol Violation|0
7827028|NCT01297270|12298331|FG001|Overall Study|Protocol Violation|2
7827029|NCT01297270|12298332|FG002|Overall Study|Protocol Violation|0
7827030|NCT01297270|12298330|FG000|Overall Study|Withdrawal by Subject|7
7827031|NCT01297270|12298331|FG001|Overall Study|Withdrawal by Subject|15
7827032|NCT01297270|12298332|FG002|Overall Study|Withdrawal by Subject|7
7827033|NCT01297270|12298330|FG000|Overall Study|Other reason not defined above|3
7827034|NCT01297270|12298331|FG001|Overall Study|Other reason not defined above|3
7827035|NCT01297270|12298332|FG002|Overall Study|Other reason not defined above|1
7827036|NCT01297270|12298330|FG000|Overall Study|Not treated|0
7827037|NCT01297270|12298331|FG001|Overall Study|Not treated|1
7827038|NCT01297270|12298332|FG002|Overall Study|Not treated|0
7827039|NCT01297309|12298344|FG000|Overall Study|Eligibility failure|2
7827040|NCT01297309|12298344|FG000|Overall Study|Screen failure|2
7827041|NCT01297309|12298344|FG000|Overall Study|Withdrawal by Subject|5
7827042|NCT01297309|12298344|FG000|Overall Study|Adverse Event|1
7827043|NCT01297309|12298344|FG000|Overall Study|Investigator Decision|2
7827044|NCT01297309|12298344|FG000|Overall Study|Death|1
7827045|NCT01297309|12298344|FG000|Overall Study|Participant not entering extensionperiod|1
7827046|NCT01297322|12298350|FG000|Overall Study|Lost to Follow-up|1
7827047|NCT01297322|12298351|FG001|Overall Study|Lost to Follow-up|0
7827048|NCT01297322|12298350|FG000|Overall Study|Withdrawal by Subject|0
7827049|NCT01297322|12298351|FG001|Overall Study|Withdrawal by Subject|1
7827050|NCT01297322|12298350|FG000|Overall Study|Protocol Violation|0
7827051|NCT01297322|12298351|FG001|Overall Study|Protocol Violation|3
7827052|NCT01297465|12298376|FG000|Overall Study|Lack of Ovarian Response|1
7827053|NCT01297465|12298377|FG001|Overall Study|Lack of Ovarian Response|1
7827054|NCT01297465|12298376|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0
7827055|NCT01297465|12298377|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1
7827056|NCT01297465|12298376|FG000|Overall Study|No Oocytes Retrieved|1
7827057|NCT01297465|12298377|FG001|Overall Study|No Oocytes Retrieved|1
7827058|NCT01297465|12298376|FG000|Overall Study|Poor oocyte quality|0
7827059|NCT01297465|12298377|FG001|Overall Study|Poor oocyte quality|1
7827060|NCT01297465|12298376|FG000|Overall Study|No Fertilization|6
7827061|NCT01297465|12298377|FG001|Overall Study|No Fertilization|4
7827062|NCT01297465|12298376|FG000|Overall Study|All Embryos Discarded|0
7827063|NCT01297465|12298377|FG001|Overall Study|All Embryos Discarded|1
7827064|NCT01297465|12298376|FG000|Overall Study|Intention to Freeze all Embryos|0
7827065|NCT01297465|12298377|FG001|Overall Study|Intention to Freeze all Embryos|1
7827066|NCT01297491|12298385|FG000|Overall Study|Adverse Event|11
7827067|NCT01297491|12298386|FG001|Overall Study|Adverse Event|6
7827068|NCT01297491|12298385|FG000|Overall Study|Physician Decision|3
7827069|NCT01297491|12298386|FG001|Overall Study|Physician Decision|2
7827070|NCT01297491|12298385|FG000|Overall Study|Progressive disease|11
7827071|NCT01297491|12298386|FG001|Overall Study|Progressive disease|20
7827072|NCT01297491|12298385|FG000|Overall Study|Patient/Guardian decision|3
7827073|NCT01297491|12298386|FG001|Overall Study|Patient/Guardian decision|4
7827074|NCT01297491|12298385|FG000|Overall Study|Death|2
7827075|NCT01297491|12298386|FG001|Overall Study|Death|1
7827076|NCT01297504|12298392|FG000|Overall Study|Invalid Consent|1
7827077|NCT01297504|12298392|FG000|Overall Study|Received Palivizumab in Previous Season|1
7827078|NCT01297504|12298392|FG000|Overall Study|No Study Visits|4
7827079|NCT01297504|12298392|FG000|Overall Study|Death|3
7827080|NCT01297504|12298392|FG000|Overall Study|Lost to Follow-up|43
7827081|NCT01297504|12298392|FG000|Overall Study|Withdrawal by Subject|9
7827082|NCT01297504|12298392|FG000|Overall Study|Site Closure|3
7827083|NCT01297504|12298392|FG000|Overall Study|Protocol Violation|3
7827084|NCT01297517|12298403|FG000|Overall Study|Adverse Event|21
7827085|NCT01297517|12298404|FG001|Overall Study|Adverse Event|7
7827086|NCT01297517|12298405|FG002|Overall Study|Adverse Event|16
7827087|NCT01297517|12298403|FG000|Overall Study|Lost to Follow-up|1
7827088|NCT01297517|12298404|FG001|Overall Study|Lost to Follow-up|0
7827089|NCT01297517|12298405|FG002|Overall Study|Lost to Follow-up|1
7827090|NCT01297517|12298403|FG000|Overall Study|Patient Decision Unrelated to AE|2
7827091|NCT01297517|12298404|FG001|Overall Study|Patient Decision Unrelated to AE|3
7827092|NCT01297517|12298405|FG002|Overall Study|Patient Decision Unrelated to AE|7
7827093|NCT01297517|12298403|FG000|Overall Study|Noncompliance|1
7827094|NCT01297517|12298404|FG001|Overall Study|Noncompliance|0
7827095|NCT01297517|12298405|FG002|Overall Study|Noncompliance|0
7827096|NCT01297517|12298403|FG000|Overall Study|Protocol Violation|1
7827097|NCT01297517|12298404|FG001|Overall Study|Protocol Violation|1
7827098|NCT01297517|12298405|FG002|Overall Study|Protocol Violation|1
7827099|NCT01297517|12298403|FG000|Overall Study|Inadequate Control of IOP|1
7827100|NCT01297517|12298404|FG001|Overall Study|Inadequate Control of IOP|1
7827101|NCT01297517|12298405|FG002|Overall Study|Inadequate Control of IOP|2
7827102|NCT01297920|12298423|FG000|Overall Study|Adverse Event|42
7827103|NCT01297920|12298424|FG001|Overall Study|Adverse Event|10
7827104|NCT01297920|12298425|FG002|Overall Study|Adverse Event|38
7827105|NCT01297920|12298423|FG000|Overall Study|Patient Decision Unrelated to AE|6
7827106|NCT01297920|12298424|FG001|Overall Study|Patient Decision Unrelated to AE|5
7827107|NCT01297920|12298425|FG002|Overall Study|Patient Decision Unrelated to AE|2
7827108|NCT01297920|12298423|FG000|Overall Study|Noncompliance|1
7827109|NCT01297920|12298424|FG001|Overall Study|Noncompliance|0
7827110|NCT01297920|12298425|FG002|Overall Study|Noncompliance|0
7827111|NCT01297920|12298423|FG000|Overall Study|Protocol Violation|1
7827112|NCT01297920|12298424|FG001|Overall Study|Protocol Violation|3
7827113|NCT01297920|12298425|FG002|Overall Study|Protocol Violation|0
7827114|NCT01297920|12298423|FG000|Overall Study|Inadequate Control of IOP|7
7827115|NCT01297920|12298424|FG001|Overall Study|Inadequate Control of IOP|9
7827116|NCT01297920|12298425|FG002|Overall Study|Inadequate Control of IOP|17
7827117|NCT01297920|12298423|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1
7827118|NCT01297920|12298424|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0
7827119|NCT01297920|12298425|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0
7827120|NCT01297959|12298435|FG000|Overall Study|Adverse Event|0
7827121|NCT01297959|12298436|FG001|Overall Study|Adverse Event|1
7827122|NCT01297959|12298435|FG000|Overall Study|Protocol Violation|2
7827123|NCT01297959|12298436|FG001|Overall Study|Protocol Violation|1
7827124|NCT01297959|12298435|FG000|Overall Study|Withdrawal by Subject|5
7827125|NCT01297959|12298436|FG001|Overall Study|Withdrawal by Subject|4
7827126|NCT01297959|12298435|FG000|Overall Study|Physician Decision|0
7827127|NCT01297959|12298436|FG001|Overall Study|Physician Decision|1
7827128|NCT01297959|12298435|FG000|Overall Study|Unrelated medical illness / complication|0
7827129|NCT01297959|12298436|FG001|Overall Study|Unrelated medical illness / complication|2
7827130|NCT01297959|12298435|FG000|Overall Study|Other|13
7827131|NCT01297959|12298436|FG001|Overall Study|Other|7
7827132|NCT01298141|12298482|FG000|Overall Study|Adverse Event|3
7827133|NCT01298141|12298482|FG000|Overall Study|Refusal of Required Study Procedures|1
7827134|NCT01298141|12298482|FG000|Overall Study|Withdrawal by Subject|6
7827135|NCT01298141|12298482|FG000|Overall Study|Termination of Study by the Investigator|5
7827136|NCT01298141|12298482|FG000|Overall Study|Other|5
7827137|NCT01298141|12298482|FG000|Overall Study|Lost to Follow-up|1
7827138|NCT01298141|12298482|FG000|Overall Study|Death|6
7827139|NCT01298141|12298482|FG000|Overall Study|Not treated|4
7827140|NCT01298193|12298495|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2
7827141|NCT01298193|12298495|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16
7827142|NCT01298193|12298495|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9
7827143|NCT01298193|12298495|FG000|Efficacy Phase (Second Cycle)|Death|1
7827144|NCT01298323|12298513|FG000|Overall Study|Adverse Event|2
7827145|NCT01298323|12298514|FG001|Overall Study|Adverse Event|4
7827146|NCT01298323|12298513|FG000|Overall Study|Death|11
7827147|NCT01298323|12298514|FG001|Overall Study|Death|16
7827148|NCT01298323|12298513|FG000|Overall Study|Lost to Follow-up|1
7827149|NCT01298323|12298514|FG001|Overall Study|Lost to Follow-up|0
7827150|NCT01298323|12298513|FG000|Overall Study|Withdrawal by Subject|6
7827151|NCT01298323|12298514|FG001|Overall Study|Withdrawal by Subject|3
7827152|NCT01298323|12298513|FG000|Overall Study|Protocol Violation|1
7827153|NCT01298323|12298514|FG001|Overall Study|Protocol Violation|0
7827154|NCT01298323|12298513|FG000|Overall Study|Other|10
7827155|NCT01298323|12298514|FG001|Overall Study|Other|9
7827156|NCT01298323|12298513|FG000|Overall Study|Ongoing|55
7827157|NCT01298323|12298514|FG001|Overall Study|Ongoing|55
7827158|NCT01298323|12298513|FG000|Overall Study|Eligibility criteria not fulfilled|0
7827159|NCT01298323|12298514|FG001|Overall Study|Eligibility criteria not fulfilled|1
7827160|NCT01298362|12298522|FG000|Overall Study|Did not provide 12month BMD measurements|38
7827161|NCT01298362|12298523|FG001|Overall Study|Did not provide 12month BMD measurements|43
7827162|NCT01298492|12298531|FG000|Overall Study|Death|2
7827163|NCT01298492|12298531|FG000|Overall Study|Insufficient Clinical Response|22
7827164|NCT01298492|12298531|FG000|Overall Study|Lost to Follow-up|12
7827165|NCT01298492|12298531|FG000|Overall Study|Withdrawal by Subject|47
7827166|NCT01298492|12298531|FG000|Overall Study|Other (Unspecified)|7
7827167|NCT01298492|12298531|FG000|Overall Study|Withdrawn Due to Pregnancy|1
7827168|NCT01298492|12298531|FG000|Overall Study|Protocol Violation|2
7827169|NCT01298492|12298531|FG000|Overall Study|Adverse Event(Related to Study Drug)|8
7827170|NCT01298492|12298531|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18
7827171|NCT01298518|12298538|FG000|Overall Study|Withdrawal by Subject|0
7827172|NCT01298518|12298539|FG001|Overall Study|Withdrawal by Subject|0
7827173|NCT01298518|12298540|FG002|Overall Study|Withdrawal by Subject|1
7827174|NCT01298531|12298550|FG000|Overall Study|Lack of Efficacy|0
7827175|NCT01298531|12298551|FG001|Overall Study|Lack of Efficacy|1
7827176|NCT01298531|12298550|FG000|Overall Study|Lost to Follow-up|2
7827177|NCT01298531|12298551|FG001|Overall Study|Lost to Follow-up|0
7827178|NCT01298531|12298550|FG000|Overall Study|Protocol Violation|1
7827179|NCT01298531|12298551|FG001|Overall Study|Protocol Violation|1
7827180|NCT01298531|12298550|FG000|Overall Study|Adverse Event|4
7827181|NCT01298531|12298551|FG001|Overall Study|Adverse Event|3
7827182|NCT01298531|12298550|FG000|Overall Study|Does not meet entrance criteria|0
7827183|NCT01298531|12298551|FG001|Overall Study|Does not meet entrance criteria|1
7827184|NCT01298531|12298550|FG000|Overall Study|Other|2
7827185|NCT01298531|12298551|FG001|Overall Study|Other|1
7827186|NCT01298570|12298566|FG000|Overall Study|Disease progression, relapse during acti|64
7827187|NCT01298570|12298567|FG001|Overall Study|Disease progression, relapse during acti|40
7827188|NCT01298570|12298566|FG000|Overall Study|Adverse Event|20
7827189|NCT01298570|12298567|FG001|Overall Study|Adverse Event|2
7827190|NCT01298570|12298566|FG000|Overall Study|Withdrawal by Subject|21
7827191|NCT01298570|12298567|FG001|Overall Study|Withdrawal by Subject|6
7827192|NCT01298570|12298566|FG000|Overall Study|Treatment delay > 4 weeks|4
7827193|NCT01298570|12298567|FG001|Overall Study|Treatment delay > 4 weeks|5
7827194|NCT01298570|12298566|FG000|Overall Study|Physician Decision|4
7827195|NCT01298570|12298567|FG001|Overall Study|Physician Decision|2
7827196|NCT01298570|12298566|FG000|Overall Study|Other complicating disease|2
7827197|NCT01298570|12298567|FG001|Overall Study|Other complicating disease|1
7827198|NCT01298570|12298566|FG000|Overall Study|Surgery|2
7827199|NCT01298570|12298567|FG001|Overall Study|Surgery|1
7827200|NCT01298570|12298566|FG000|Overall Study|Symptomatic progression/deterioration|3
7827201|NCT01298570|12298567|FG001|Overall Study|Symptomatic progression/deterioration|2
7827202|NCT01298570|12298566|FG000|Overall Study|Death|0
7827203|NCT01298570|12298567|FG001|Overall Study|Death|1
7827204|NCT01298570|12298566|FG000|Overall Study|Ineligibility|0
7827205|NCT01298570|12298567|FG001|Overall Study|Ineligibility|1
7827206|NCT01298596|12298575|FG000|Overall Study|Withdrawal by Subject|1
7827207|NCT01298596|12298576|FG001|Overall Study|Withdrawal by Subject|1
7827208|NCT01298596|12298575|FG000|Overall Study|Death|5
7827209|NCT01298596|12298576|FG001|Overall Study|Death|3
7827210|NCT01298596|12298575|FG000|Overall Study|Lost to Follow-up|6
7827211|NCT01298596|12298576|FG001|Overall Study|Lost to Follow-up|14
7827212|NCT01298596|12298575|FG000|Overall Study|Referred for further management|16
7827213|NCT01298596|12298576|FG001|Overall Study|Referred for further management|15
7827214|NCT01298648|12298582|FG000|Overall Study|Withdrawal by Subject|2
7827215|NCT01298648|12298582|FG000|Overall Study|Lost to Follow-up|21
7827216|NCT01298661|12298589|FG000|Overall Study|Withdrawal by Subject|2
7827217|NCT01298661|12298590|FG001|Overall Study|Withdrawal by Subject|0
7827218|NCT01298661|12298591|FG002|Overall Study|Withdrawal by Subject|2
7827219|NCT01298700|12298602|FG000|Overall Study|Adverse Event|50
7827220|NCT01298700|12298603|FG001|Overall Study|Adverse Event|51
7827221|NCT01298700|12298602|FG000|Overall Study|Lack of Efficacy|9
7827222|NCT01298700|12298603|FG001|Overall Study|Lack of Efficacy|14
7827223|NCT01298700|12298602|FG000|Overall Study|Lost to Follow-up|5
7827224|NCT01298700|12298603|FG001|Overall Study|Lost to Follow-up|2
7827225|NCT01298700|12298602|FG000|Overall Study|Withdrawal by Subject|12
7827226|NCT01298700|12298603|FG001|Overall Study|Withdrawal by Subject|9
7827227|NCT01298700|12298602|FG000|Overall Study|Protocol Violation|6
7827228|NCT01298700|12298603|FG001|Overall Study|Protocol Violation|4
7827229|NCT01298700|12298602|FG000|Overall Study|Other Miscellaneous Reasons|16
7827230|NCT01298700|12298603|FG001|Overall Study|Other Miscellaneous Reasons|15
7827231|NCT01298700|12298602|FG000|Overall Study|Did not Receive Study Drug|3
7827232|NCT01298700|12298603|FG001|Overall Study|Did not Receive Study Drug|5
7827233|NCT01298765|12298618|FG000|Titration Period|Adverse Event|26
7827234|NCT01298765|12298618|FG000|Titration Period|Death|1
7827235|NCT01298765|12298618|FG000|Titration Period|Lack of Efficacy|21
7827236|NCT01298765|12298618|FG000|Titration Period|Lost to Follow-up|9
7827237|NCT01298765|12298618|FG000|Titration Period|Physician Decision|1
7827238|NCT01298765|12298618|FG000|Titration Period|Withdrawal by Subject|10
7827239|NCT01298765|12298618|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8
7827240|NCT01298765|12298618|FG000|Long-Term Treatment Period|Adverse Event|19
7827241|NCT01298765|12298618|FG000|Long-Term Treatment Period|Lack of Efficacy|6
7827242|NCT01298765|12298618|FG000|Long-Term Treatment Period|Lost to Follow-up|8
7827243|NCT01298765|12298618|FG000|Long-Term Treatment Period|Withdrawal by Subject|19
7827244|NCT01298765|12298618|FG000|Long-Term Treatment Period|Physician Decision|1
7827245|NCT01298765|12298618|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
7827246|NCT01298778|12298624|FG000|Overall Study|Lost to Follow-up|2
7827247|NCT01298778|12298625|FG001|Overall Study|Lost to Follow-up|3
7827248|NCT01298778|12298624|FG000|Overall Study|Incorrect use of VAS|1
7827249|NCT01298778|12298625|FG001|Overall Study|Incorrect use of VAS|0
7827250|NCT01298778|12298624|FG000|Overall Study|Withdrawal by Subject|0
7827251|NCT01298778|12298625|FG001|Overall Study|Withdrawal by Subject|1
7827252|NCT01298778|12298624|FG000|Overall Study|Protocol Violation|0
7827253|NCT01298778|12298625|FG001|Overall Study|Protocol Violation|1
7827254|NCT01298778|12298624|FG000|Overall Study|not meet inclusion/exclusion criteria|0
7827255|NCT01298778|12298625|FG001|Overall Study|not meet inclusion/exclusion criteria|1
7827256|NCT01298999|12298635|FG000|Overall Study|Physician Decision|0
7827257|NCT01298999|12298636|FG001|Overall Study|Physician Decision|1
7827258|NCT01298999|12298635|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3
7827259|NCT01298999|12298636|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0
7827260|NCT01299025|12298644|FG000|Overall Study|Withdrawal by Subject|2
7827261|NCT01299025|12298645|FG001|Overall Study|Withdrawal by Subject|1
7827262|NCT01299025|12298644|FG000|Overall Study|Lost to Follow-up|1
7827263|NCT01299025|12298645|FG001|Overall Study|Lost to Follow-up|0
7827264|NCT01299038|12298653|FG000|Overall Study|Withdrawal by Subject|1
7827265|NCT01299038|12298654|FG001|Overall Study|Withdrawal by Subject|0
7827266|NCT01299116|12298684|FG000|Overall Study|Lost to Follow-up|65
7827267|NCT01299116|12298685|FG001|Overall Study|Lost to Follow-up|9
7827268|NCT01299116|12298686|FG002|Overall Study|Lost to Follow-up|11
7827269|NCT01299272|12298697|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140
7827270|NCT01299272|12298698|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0
7827271|NCT01299272|12298699|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0
7827272|NCT01299272|12298700|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0
7827273|NCT01299272|12298697|FG000|Acute Open-label (OL) Period|Adverse Event|140
7827274|NCT01299272|12298698|FG001|Acute Open-label (OL) Period|Adverse Event|0
7827275|NCT01299272|12298699|FG002|Acute Open-label (OL) Period|Adverse Event|0
7827276|NCT01299272|12298700|FG003|Acute Open-label (OL) Period|Adverse Event|0
7827277|NCT01299272|12298697|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56
7827278|NCT01299272|12298698|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0
7827279|NCT01299272|12298699|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0
7827280|NCT01299272|12298700|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0
7827281|NCT01299272|12298697|FG000|Acute Open-label (OL) Period|Protocol Violation|36
7827282|NCT01299272|12298698|FG001|Acute Open-label (OL) Period|Protocol Violation|0
7827283|NCT01299272|12298699|FG002|Acute Open-label (OL) Period|Protocol Violation|0
7827284|NCT01299272|12298700|FG003|Acute Open-label (OL) Period|Protocol Violation|0
7827285|NCT01299272|12298697|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14
7827286|NCT01299272|12298698|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0
7827287|NCT01299272|12298699|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0
7827288|NCT01299272|12298700|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0
7827289|NCT01299272|12298697|FG000|Acute Open-label (OL) Period|Sponsor Decision|13
7827290|NCT01299272|12298698|FG001|Acute Open-label (OL) Period|Sponsor Decision|0
7827291|NCT01299272|12298699|FG002|Acute Open-label (OL) Period|Sponsor Decision|0
7827292|NCT01299272|12298700|FG003|Acute Open-label (OL) Period|Sponsor Decision|0
7827293|NCT01299272|12298697|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10
7827294|NCT01299272|12298698|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0
7827295|NCT01299272|12298699|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0
7827296|NCT01299272|12298700|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0
7827297|NCT01299272|12298697|FG000|Acute Open-label (OL) Period|Physician Decision|5
7827298|NCT01299272|12298698|FG001|Acute Open-label (OL) Period|Physician Decision|0
7827299|NCT01299272|12298699|FG002|Acute Open-label (OL) Period|Physician Decision|0
7827300|NCT01299272|12298700|FG003|Acute Open-label (OL) Period|Physician Decision|0
7827301|NCT01299272|12298697|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
7827302|NCT01299272|12298698|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
7827303|NCT01299272|12298699|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
7827304|NCT01299272|12298700|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
7827305|NCT01299272|12298697|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0
7827306|NCT01299272|12298698|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44
7827307|NCT01299272|12298699|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0
7827308|NCT01299272|12298700|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0
7827309|NCT01299272|12298697|FG000|Stabilization Open-label (OL) Period|Adverse Event|0
7827310|NCT01299272|12298698|FG001|Stabilization Open-label (OL) Period|Adverse Event|42
7827311|NCT01299272|12298699|FG002|Stabilization Open-label (OL) Period|Adverse Event|0
7827312|NCT01299272|12298700|FG003|Stabilization Open-label (OL) Period|Adverse Event|0
7827313|NCT01299272|12298697|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
7827314|NCT01299272|12298698|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
7827315|NCT01299272|12298699|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
7827316|NCT01299272|12298700|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
7827317|NCT01299272|12298697|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0
7827318|NCT01299272|12298698|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12
7827319|NCT01299272|12298699|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0
7827320|NCT01299272|12298700|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0
7827321|NCT01299272|12298697|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0
7827322|NCT01299272|12298698|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11
7827323|NCT01299272|12298699|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0
7827324|NCT01299272|12298700|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0
7827325|NCT01299272|12298697|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0
7827326|NCT01299272|12298698|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9
7827327|NCT01299272|12298699|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0
7827328|NCT01299272|12298700|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0
7827329|NCT01299272|12298697|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
7827330|NCT01299272|12298698|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
7827331|NCT01299272|12298699|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
7827332|NCT01299272|12298700|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
7827333|NCT01299272|12298697|FG000|Stabilization Open-label (OL) Period|Physician Decision|0
7827334|NCT01299272|12298698|FG001|Stabilization Open-label (OL) Period|Physician Decision|3
7827335|NCT01299272|12298699|FG002|Stabilization Open-label (OL) Period|Physician Decision|0
7827336|NCT01299272|12298700|FG003|Stabilization Open-label (OL) Period|Physician Decision|0
7827337|NCT01299272|12298697|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
7827338|NCT01299272|12298698|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
7827339|NCT01299272|12298699|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
7827340|NCT01299272|12298700|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
7827341|NCT01299272|12298697|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0
7827342|NCT01299272|12298698|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0
7827343|NCT01299272|12298699|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20
7827344|NCT01299272|12298700|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10
7827345|NCT01299272|12298697|FG000|Double-blind (DB) Randomized Period|Adverse Event|0
7827346|NCT01299272|12298698|FG001|Double-blind (DB) Randomized Period|Adverse Event|0
7827347|NCT01299272|12298699|FG002|Double-blind (DB) Randomized Period|Adverse Event|8
7827348|NCT01299272|12298700|FG003|Double-blind (DB) Randomized Period|Adverse Event|9
7827349|NCT01299272|12298697|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0
7827350|NCT01299272|12298698|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0
7827351|NCT01299272|12298699|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8
7827352|NCT01299272|12298700|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7
7827353|NCT01299272|12298697|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0
7827354|NCT01299272|12298698|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0
7827355|NCT01299272|12298699|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5
7827356|NCT01299272|12298700|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5
7827357|NCT01299272|12298697|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
7827358|NCT01299272|12298698|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
7827359|NCT01299272|12298699|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
7827360|NCT01299272|12298700|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
7827361|NCT01299272|12298697|FG000|Double-blind (DB) Randomized Period|Physician Decision|0
7827362|NCT01299272|12298698|FG001|Double-blind (DB) Randomized Period|Physician Decision|0
7827363|NCT01299272|12298699|FG002|Double-blind (DB) Randomized Period|Physician Decision|2
7827364|NCT01299272|12298700|FG003|Double-blind (DB) Randomized Period|Physician Decision|1
7827365|NCT01299272|12298697|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0
7827366|NCT01299272|12298698|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0
7827367|NCT01299272|12298699|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1
7827368|NCT01299272|12298700|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1
7827369|NCT01299376|12298722|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
7827370|NCT01299376|12298723|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
7827371|NCT01299376|12298722|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
7827372|NCT01299376|12298723|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
7827373|NCT01299376|12298722|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
7827374|NCT01299376|12298723|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
7827375|NCT01299376|12298722|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
7827376|NCT01299376|12298723|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
7827377|NCT01299376|12298722|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
7827378|NCT01299376|12298723|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
7827379|NCT01299376|12298722|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
7827380|NCT01299376|12298723|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
7827381|NCT01299376|12298722|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
7827382|NCT01299376|12298723|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
7827383|NCT01299376|12298722|FG000|Extension (Weeks 9 to 52)|Adverse Event|2
7827384|NCT01299376|12298723|FG001|Extension (Weeks 9 to 52)|Adverse Event|3
7827385|NCT01299376|12298722|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1
7827386|NCT01299376|12298723|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2
7827387|NCT01299376|12298722|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
7827388|NCT01299376|12298723|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
7827389|NCT01299376|12298722|FG000|Extension (Weeks 9 to 52)|Physician Decision|1
7827390|NCT01299376|12298723|FG001|Extension (Weeks 9 to 52)|Physician Decision|0
7827391|NCT01299389|12298735|FG000|Double-blind|Adverse Event|45
7827392|NCT01299389|12298736|FG001|Double-blind|Adverse Event|27
7827393|NCT01299389|12298737|FG002|Double-blind|Adverse Event|0
7827394|NCT01299389|12298738|FG003|Double-blind|Adverse Event|0
7827395|NCT01299389|12298735|FG000|Double-blind|Lack of Efficacy|45
7827396|NCT01299389|12298736|FG001|Double-blind|Lack of Efficacy|21
7827397|NCT01299389|12298737|FG002|Double-blind|Lack of Efficacy|0
7827398|NCT01299389|12298738|FG003|Double-blind|Lack of Efficacy|0
7827399|NCT01299389|12298735|FG000|Double-blind|Lost to Follow-up|2
7827400|NCT01299389|12298736|FG001|Double-blind|Lost to Follow-up|1
7827401|NCT01299389|12298737|FG002|Double-blind|Lost to Follow-up|0
7827402|NCT01299389|12298738|FG003|Double-blind|Lost to Follow-up|0
7827403|NCT01299389|12298735|FG000|Double-blind|Withdrawal by Subject|16
7827404|NCT01299389|12298736|FG001|Double-blind|Withdrawal by Subject|13
7827405|NCT01299389|12298737|FG002|Double-blind|Withdrawal by Subject|0
7827406|NCT01299389|12298738|FG003|Double-blind|Withdrawal by Subject|0
7827407|NCT01299389|12298735|FG000|Double-blind|Other|1
7827408|NCT01299389|12298736|FG001|Double-blind|Other|1
7827409|NCT01299389|12298737|FG002|Double-blind|Other|0
7827410|NCT01299389|12298738|FG003|Double-blind|Other|0
7827411|NCT01299389|12298735|FG000|Double-blind|"fail to meet study population criteria"|0
7827412|NCT01299389|12298736|FG001|Double-blind|"fail to meet study population criteria"|1
7827413|NCT01299389|12298737|FG002|Double-blind|"fail to meet study population criteria"|0
7948391|NCT02528253|12493582|FG001|Overall Study|Other|22
7827414|NCT01299389|12298738|FG003|Double-blind|"fail to meet study population criteria"|0
7827415|NCT01299389|12298735|FG000|Post-observational|Other|0
7827416|NCT01299389|12298736|FG001|Post-observational|Other|0
7827417|NCT01299389|12298737|FG002|Post-observational|Other|12
7827418|NCT01299389|12298738|FG003|Post-observational|Other|6
7827419|NCT01299480|12298795|FG000|Overall Study|No longer willing to participate|19
7827420|NCT01299480|12298796|FG001|Overall Study|No longer willing to participate|17
7827421|NCT01299480|12298797|FG002|Overall Study|No longer willing to participate|14
7827422|NCT01299480|12298798|FG003|Overall Study|No longer willing to participate|13
7827423|NCT01299480|12298799|FG004|Overall Study|No longer willing to participate|10
7827424|NCT01299480|12298795|FG000|Overall Study|Protocol Violation|7
7827425|NCT01299480|12298796|FG001|Overall Study|Protocol Violation|5
7827426|NCT01299480|12298797|FG002|Overall Study|Protocol Violation|8
7827427|NCT01299480|12298798|FG003|Overall Study|Protocol Violation|1
7827428|NCT01299480|12298799|FG004|Overall Study|Protocol Violation|1
7827429|NCT01299480|12298795|FG000|Overall Study|Withdrawal by Subject|3
7827430|NCT01299480|12298796|FG001|Overall Study|Withdrawal by Subject|4
7827431|NCT01299480|12298797|FG002|Overall Study|Withdrawal by Subject|7
7827432|NCT01299480|12298798|FG003|Overall Study|Withdrawal by Subject|3
7827433|NCT01299480|12298799|FG004|Overall Study|Withdrawal by Subject|4
7827434|NCT01299480|12298795|FG000|Overall Study|Adverse Event|6
7827435|NCT01299480|12298796|FG001|Overall Study|Adverse Event|4
7827436|NCT01299480|12298797|FG002|Overall Study|Adverse Event|5
7827437|NCT01299480|12298798|FG003|Overall Study|Adverse Event|4
7827438|NCT01299480|12298799|FG004|Overall Study|Adverse Event|0
7827439|NCT01299480|12298795|FG000|Overall Study|Withdrawal due to pregnancy|0
7827440|NCT01299480|12298796|FG001|Overall Study|Withdrawal due to pregnancy|1
7827441|NCT01299480|12298797|FG002|Overall Study|Withdrawal due to pregnancy|1
7827442|NCT01299480|12298798|FG003|Overall Study|Withdrawal due to pregnancy|0
7827443|NCT01299480|12298799|FG004|Overall Study|Withdrawal due to pregnancy|0
7827444|NCT01299480|12298795|FG000|Overall Study|Physician Decision|1
7827445|NCT01299480|12298796|FG001|Overall Study|Physician Decision|1
7827446|NCT01299480|12298797|FG002|Overall Study|Physician Decision|0
7827447|NCT01299480|12298798|FG003|Overall Study|Physician Decision|2
7827448|NCT01299480|12298799|FG004|Overall Study|Physician Decision|0
7827449|NCT01299480|12298795|FG000|Overall Study|Lost to Follow-up|3
7827450|NCT01299480|12298796|FG001|Overall Study|Lost to Follow-up|1
7827451|NCT01299480|12298797|FG002|Overall Study|Lost to Follow-up|2
7827452|NCT01299480|12298798|FG003|Overall Study|Lost to Follow-up|1
7827453|NCT01299480|12298799|FG004|Overall Study|Lost to Follow-up|2
7948392|NCT02528253|12493583|FG002|Overall Study|Other|58
7948393|NCT02528253|12493584|FG003|Overall Study|Other|52
7948394|NCT02528253|12493585|FG004|Overall Study|Other|76
7948395|NCT02528253|12493581|FG000|Overall Study|Withdrawal by Subject|25
7948396|NCT02528253|12493582|FG001|Overall Study|Withdrawal by Subject|20
7948397|NCT02528253|12493583|FG002|Overall Study|Withdrawal by Subject|29
7948398|NCT02528253|12493584|FG003|Overall Study|Withdrawal by Subject|48
7948399|NCT02528253|12493585|FG004|Overall Study|Withdrawal by Subject|73
7948400|NCT02528253|12493581|FG000|Overall Study|Protocol Violation|1
7948401|NCT02528253|12493582|FG001|Overall Study|Protocol Violation|2
7948402|NCT02528253|12493583|FG002|Overall Study|Protocol Violation|4
7948403|NCT02528253|12493584|FG003|Overall Study|Protocol Violation|0
7948404|NCT02528253|12493585|FG004|Overall Study|Protocol Violation|4
7948405|NCT02528253|12493581|FG000|Overall Study|Withdrawn Due to Pregnancy|0
7948406|NCT02528253|12493582|FG001|Overall Study|Withdrawn Due to Pregnancy|1
7948407|NCT02528253|12493583|FG002|Overall Study|Withdrawn Due to Pregnancy|0
7948408|NCT02528253|12493584|FG003|Overall Study|Withdrawn Due to Pregnancy|0
7948409|NCT02528253|12493585|FG004|Overall Study|Withdrawn Due to Pregnancy|1
7948410|NCT02528305|12493616|FG000|Overall Study|Withdrawal by Subject|1
7948411|NCT02528305|12493616|FG000|Overall Study|Adverse Event|1
7948412|NCT02528305|12493616|FG000|Overall Study|Physician Decision|1
7948413|NCT02528331|12493643|FG000|Overall Study|Withdrawal by Subject|2
7948414|NCT02528357|12493666|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948415|NCT02528357|12493667|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1
7948416|NCT02528357|12493668|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948417|NCT02528357|12493669|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948418|NCT02528357|12493670|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948419|NCT02528357|12493671|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948420|NCT02528357|12493672|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948421|NCT02528357|12493673|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948422|NCT02528357|12493674|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948423|NCT02528357|12493675|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948424|NCT02528357|12493676|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948425|NCT02528357|12493677|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948426|NCT02528357|12493678|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7827454|NCT01299480|12298795|FG000|Overall Study|Other|3
7827455|NCT01299480|12298796|FG001|Overall Study|Other|2
7827456|NCT01299480|12298797|FG002|Overall Study|Other|3
7827457|NCT01299480|12298798|FG003|Overall Study|Other|0
7827458|NCT01299480|12298799|FG004|Overall Study|Other|3
7827459|NCT01299480|12298795|FG000|Overall Study|Started, but not vaccinated|0
7948427|NCT02528357|12493679|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948428|NCT02528357|12493680|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948429|NCT02528357|12493681|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948430|NCT02528357|12493682|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948431|NCT02528357|12493683|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7948432|NCT02528357|12493684|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7827460|NCT01299480|12298796|FG001|Overall Study|Started, but not vaccinated|0
7827461|NCT01299480|12298797|FG002|Overall Study|Started, but not vaccinated|1
7827462|NCT01299480|12298798|FG003|Overall Study|Started, but not vaccinated|1
7827463|NCT01299480|12298799|FG004|Overall Study|Started, but not vaccinated|0
7827464|NCT01299571|12298812|FG000|Overall Study|Protocol Violation|107
7827465|NCT01299584|12298817|FG000|Overall Study|Protocol Violation|9
7827466|NCT01299727|12298841|FG000|Overall Study|Withdrawal by Subject|1
7827467|NCT01299727|12298842|FG001|Overall Study|Withdrawal by Subject|0
7827468|NCT01299727|12298843|FG002|Overall Study|Withdrawal by Subject|0
7827469|NCT01299727|12298841|FG000|Overall Study|Adverse Event|0
7827470|NCT01299727|12298842|FG001|Overall Study|Adverse Event|0
7827471|NCT01299727|12298843|FG002|Overall Study|Adverse Event|1
7827472|NCT01299727|12298841|FG000|Overall Study|Completed the Treatment Period|3
7827473|NCT01299727|12298842|FG001|Overall Study|Completed the Treatment Period|4
7827474|NCT01299727|12298843|FG002|Overall Study|Completed the Treatment Period|3
7827475|NCT01299766|12298853|FG000|Overall Study|Death|5
7827476|NCT01299766|12298854|FG001|Overall Study|Death|4
7827477|NCT01299766|12298853|FG000|Overall Study|Withdrawal by Subject|29
7827478|NCT01299766|12298854|FG001|Overall Study|Withdrawal by Subject|19
7827479|NCT01299805|12298862|FG000|Overall Study|Adverse Event|2
7827480|NCT01299805|12298863|FG001|Overall Study|Adverse Event|0
7827481|NCT01299896|12298871|FG000|Overall Study|Withdrawal by Subject|1
7827482|NCT01299896|12298872|FG001|Overall Study|Withdrawal by Subject|7
7827483|NCT01299896|12298871|FG000|Overall Study|Lost to Follow-up|0
7827484|NCT01299896|12298872|FG001|Overall Study|Lost to Follow-up|11
7827485|NCT01299909|12298881|FG000|Overall Study|Lost to Follow-up|22
7827486|NCT01299909|12298882|FG001|Overall Study|Lost to Follow-up|18
7827487|NCT01299909|12298883|FG002|Overall Study|Lost to Follow-up|17
7827488|NCT01299961|12298890|FG000|Overall Study|Adverse Event|3
7827489|NCT01299961|12298890|FG000|Overall Study|Lack of Efficacy|2
7827490|NCT01299961|12298890|FG000|Overall Study|Lost to Follow-up|1
7827491|NCT01300052|12298896|FG000|Overall Study|Adverse Event|3
7827492|NCT01300052|12298897|FG001|Overall Study|Adverse Event|0
7827493|NCT01300052|12298896|FG000|Overall Study|Withdrawal by Subject|2
7827494|NCT01300052|12298897|FG001|Overall Study|Withdrawal by Subject|2
7827495|NCT01300052|12298896|FG000|Overall Study|Protocol Violation|1
7827496|NCT01300052|12298897|FG001|Overall Study|Protocol Violation|1
7827497|NCT01300234|12298914|FG000|Overall Study|Adverse Event|1
7827498|NCT01300234|12298915|FG001|Overall Study|Adverse Event|1
7827499|NCT01300234|12298914|FG000|Overall Study|Protocol Violation|2
7827500|NCT01300234|12298915|FG001|Overall Study|Protocol Violation|3
7827501|NCT01300234|12298914|FG000|Overall Study|Withdrawal by Subject|5
7827502|NCT01300234|12298915|FG001|Overall Study|Withdrawal by Subject|9
7827503|NCT01300234|12298914|FG000|Overall Study|Lost to Follow-up|14
7827504|NCT01300234|12298915|FG001|Overall Study|Lost to Follow-up|12
7827505|NCT01300234|12298914|FG000|Overall Study|Pregnancy|2
7827506|NCT01300234|12298915|FG001|Overall Study|Pregnancy|1
7827507|NCT01300234|12298914|FG000|Overall Study|Participant reached stopping critera|2
7827508|NCT01300234|12298915|FG001|Overall Study|Participant reached stopping critera|0
7827509|NCT01300234|12298914|FG000|Overall Study|Participant stopped medication|1
7827510|NCT01300234|12298915|FG001|Overall Study|Participant stopped medication|1
7827511|NCT01300234|12298914|FG000|Overall Study|Participant refused return to hospital|1
7827512|NCT01300234|12298915|FG001|Overall Study|Participant refused return to hospital|0
7827513|NCT01300247|12298934|FG000|Overall Study|Death|1
7827514|NCT01300247|12298935|FG001|Overall Study|Death|1
7827515|NCT01300247|12298934|FG000|Overall Study|Lost to Follow-up|2
7827516|NCT01300247|12298935|FG001|Overall Study|Lost to Follow-up|0
7827517|NCT01300247|12298934|FG000|Overall Study|Withdrawal by Subject|1
7827518|NCT01300247|12298935|FG001|Overall Study|Withdrawal by Subject|0
7827519|NCT01300247|12298934|FG000|Overall Study|Non-Compliance|0
7827520|NCT01300247|12298935|FG001|Overall Study|Non-Compliance|1
7827521|NCT01300260|12298943|FG000|Period 1 of Study: First Intervention|Adverse Event|0
7827522|NCT01300260|12298944|FG001|Period 1 of Study: First Intervention|Adverse Event|1
7827523|NCT01300260|12298943|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1
7827524|NCT01300260|12298944|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0
7827525|NCT01300260|12298943|FG000|Period 2 of Study: Second Intervention|Adverse Event|0
7827526|NCT01300260|12298944|FG001|Period 2 of Study: Second Intervention|Adverse Event|1
7827527|NCT01300286|12298961|FG000|Overall Study|did not get dosed|1
7827528|NCT01300338|12298968|FG000|Overall Study|Lost to Follow-up|5
7827529|NCT01300338|12298969|FG001|Overall Study|Lost to Follow-up|0
7827530|NCT01300351|12298977|FG000|Overall Study|Did not receive treatment|2
7827531|NCT01300351|12298978|FG001|Overall Study|Did not receive treatment|0
7827532|NCT01300351|12298977|FG000|Overall Study|Ongoing treatment at data cut-off|27
7827533|NCT01300351|12298978|FG001|Overall Study|Ongoing treatment at data cut-off|23
7827534|NCT01300351|12298977|FG000|Overall Study|Lost to Follow-up|0
7827535|NCT01300351|12298978|FG001|Overall Study|Lost to Follow-up|1
7827536|NCT01300351|12298977|FG000|Overall Study|Adverse Event|0
7827537|NCT01300351|12298978|FG001|Overall Study|Adverse Event|4
7827538|NCT01300351|12298977|FG000|Overall Study|Withdrawal by Subject|7
7827539|NCT01300351|12298978|FG001|Overall Study|Withdrawal by Subject|10
7827540|NCT01300455|12298986|FG000|Washout|Withdrawal by Subject|1
7827541|NCT01300455|12298987|FG001|Washout|Withdrawal by Subject|0
7827542|NCT01300546|12298995|FG000|Overall Study|Withdrawal by Subject|1
7827543|NCT01300546|12298996|FG001|Overall Study|Withdrawal by Subject|0
7827544|NCT01300546|12298995|FG000|Overall Study|Lost to Follow-up|0
7827545|NCT01300546|12298996|FG001|Overall Study|Lost to Follow-up|2
7827546|NCT01300546|12298995|FG000|Overall Study|Lack of Efficacy|0
7827547|NCT01300546|12298996|FG001|Overall Study|Lack of Efficacy|3
7827548|NCT01300546|12298995|FG000|Overall Study|Adverse Event|0
7827549|NCT01300546|12298996|FG001|Overall Study|Adverse Event|1
7827550|NCT01300572|12299011|FG000|Overall Study|HAMA + post dosimetry|1
7827551|NCT01300650|12299021|FG000|Overall Study|Adverse Event|1
7827552|NCT01300728|12299028|FG000|Overall Study|Withdrawal by Subject|1
7827553|NCT01300728|12299029|FG001|Overall Study|Withdrawal by Subject|1
7827554|NCT01300728|12299028|FG000|Overall Study|Physician Decision|1
7827555|NCT01300728|12299029|FG001|Overall Study|Physician Decision|0
7827556|NCT01300741|12299035|FG000|Overall Study|Lens deposits|1
7827557|NCT01300741|12299035|FG000|Overall Study|Lost to Follow-up|1
7827558|NCT01300741|12299035|FG000|Overall Study|Discomfort|1
7827559|NCT01300767|12299041|FG000|Overall Study|Discomfort|2
7827560|NCT01300767|12299041|FG000|Overall Study|Biomicroscopy|1
7827561|NCT01300767|12299041|FG000|Overall Study|Unacceptable fit|1
7827562|NCT01300819|12299049|FG000|Overall Study|Adverse Event|9
7827563|NCT01300819|12299050|FG001|Overall Study|Adverse Event|27
7827564|NCT01300819|12299049|FG000|Overall Study|Lack of Efficacy|2
7827565|NCT01300819|12299050|FG001|Overall Study|Lack of Efficacy|1
7827566|NCT01300819|12299049|FG000|Overall Study|Withdrawal by Subject|10
7827567|NCT01300819|12299050|FG001|Overall Study|Withdrawal by Subject|12
7827568|NCT01300819|12299049|FG000|Overall Study|Patient was 1 month late for Visit 10|0
7827569|NCT01300819|12299050|FG001|Overall Study|Patient was 1 month late for Visit 10|1
7827570|NCT01300819|12299049|FG000|Overall Study|Refusal to down titrate study drug|0
7827571|NCT01300819|12299050|FG001|Overall Study|Refusal to down titrate study drug|1
7827572|NCT01300819|12299049|FG000|Overall Study|Administrative reason|0
7827573|NCT01300819|12299050|FG001|Overall Study|Administrative reason|1
7827574|NCT01300819|12299049|FG000|Overall Study|Safety follow up not done by mistake|0
7827575|NCT01300819|12299050|FG001|Overall Study|Safety follow up not done by mistake|1
7827576|NCT01300819|12299049|FG000|Overall Study|Follow up call was not done|1
7827577|NCT01300819|12299050|FG001|Overall Study|Follow up call was not done|0
7827578|NCT01300923|12299056|FG000|Overall Study|Physician Decision|0
7827579|NCT01300923|12299057|FG001|Overall Study|Physician Decision|2
7827580|NCT01301001|12299075|FG000|First Intervention|Lost to Follow-up|4
7827581|NCT01301001|12299076|FG001|First Intervention|Lost to Follow-up|4
7827582|NCT01301001|12299075|FG000|First Intervention|Withdrawal by Subject|1
7827583|NCT01301001|12299076|FG001|First Intervention|Withdrawal by Subject|4
7827584|NCT01301001|12299075|FG000|First Intervention|Adverse Event|5
7827585|NCT01301001|12299076|FG001|First Intervention|Adverse Event|0
7827586|NCT01301001|12299075|FG000|First Intervention|Protocol Violation|0
7827587|NCT01301001|12299076|FG001|First Intervention|Protocol Violation|1
7827588|NCT01301001|12299075|FG000|Second Intervention|Adverse Event|2
7827589|NCT01301001|12299076|FG001|Second Intervention|Adverse Event|0
7827590|NCT01301001|12299075|FG000|Second Intervention|Withdrawal by Subject|2
7827591|NCT01301001|12299076|FG001|Second Intervention|Withdrawal by Subject|0
7827592|NCT01301027|12299085|FG000|Overall Study|Physician Decision|2
7827593|NCT01301027|12299086|FG001|Overall Study|Physician Decision|0
7827594|NCT01301027|12299085|FG000|Overall Study|Withdrawal by Subject|2
7827595|NCT01301027|12299086|FG001|Overall Study|Withdrawal by Subject|3
7827596|NCT01301027|12299085|FG000|Overall Study|Adverse Event|0
7827597|NCT01301027|12299086|FG001|Overall Study|Adverse Event|2
7827598|NCT01301027|12299085|FG000|Overall Study|Fracture|1
7827599|NCT01301027|12299086|FG001|Overall Study|Fracture|3
7827600|NCT01301027|12299085|FG000|Overall Study|Transplant|0
7827601|NCT01301027|12299086|FG001|Overall Study|Transplant|2
7827602|NCT01301027|12299085|FG000|Overall Study|Volume Overload|3
7827603|NCT01301027|12299086|FG001|Overall Study|Volume Overload|0
7827604|NCT01301066|12299094|FG000|Overall Study|Lost to Follow-up|5
7827605|NCT01301066|12299095|FG001|Overall Study|Lost to Follow-up|11
7827606|NCT01301066|12299094|FG000|Overall Study|Protocol Violation|8
7827607|NCT01301066|12299095|FG001|Overall Study|Protocol Violation|7
7827608|NCT01301066|12299094|FG000|Overall Study|Withdrawal by Subject|4
7827609|NCT01301066|12299095|FG001|Overall Study|Withdrawal by Subject|9
7827610|NCT01301066|12299094|FG000|Overall Study|Adverse Event|6
7827611|NCT01301066|12299095|FG001|Overall Study|Adverse Event|6
7827612|NCT01301066|12299094|FG000|Overall Study|Sponsor Decision|2
7827613|NCT01301066|12299095|FG001|Overall Study|Sponsor Decision|1
7827614|NCT01301066|12299094|FG000|Overall Study|Physician Decision|0
7720065|NCT00536471|12144333|FG003|Overall Study|Lack of Efficacy|9
7720066|NCT00536471|12144330|FG000|Overall Study|Protocol Violation|8
7827615|NCT01301066|12299095|FG001|Overall Study|Physician Decision|1
7827616|NCT01301066|12299094|FG000|Overall Study|Other|2
7827617|NCT01301066|12299095|FG001|Overall Study|Other|0
7827618|NCT01301079|12299103|FG000|Overall Study|Lost to Follow-up|2
7827619|NCT01301079|12299104|FG001|Overall Study|Lost to Follow-up|2
7827620|NCT01301092|12299117|FG000|Overall Study|Lost to Follow-up|0
7827621|NCT01301092|12299118|FG001|Overall Study|Lost to Follow-up|0
7827622|NCT01301092|12299119|FG002|Overall Study|Lost to Follow-up|1
7827623|NCT01301274|12299143|FG000|Overall Study|Physician Decision|2
7827624|NCT01301274|12299144|FG001|Overall Study|Physician Decision|1
7827625|NCT01301391|12299155|FG000|Overall Study|Death|13
7827626|NCT01301391|12299155|FG000|Overall Study|Lost to Follow-up|3
7827627|NCT01301391|12299155|FG000|Overall Study|Physician Decision|2
7827628|NCT01301391|12299155|FG000|Overall Study|Sponsor's decision|8
7720067|NCT00536471|12144331|FG001|Overall Study|Protocol Violation|1
7720068|NCT00536471|12144332|FG002|Overall Study|Protocol Violation|2
7720069|NCT00536471|12144333|FG003|Overall Study|Protocol Violation|3
7720070|NCT00536471|12144330|FG000|Overall Study|Physician Decision|11
7827629|NCT01301456|12299171|FG000|Stage 1|Withdrawal by Subject|0
7827630|NCT01301456|12299172|FG001|Stage 1|Withdrawal by Subject|0
7827631|NCT01301456|12299173|FG002|Stage 1|Withdrawal by Subject|1
7827632|NCT01301456|12299174|FG003|Stage 1|Withdrawal by Subject|0
7827633|NCT01301456|12299175|FG004|Stage 1|Withdrawal by Subject|1
7827634|NCT01301456|12299176|FG005|Stage 1|Withdrawal by Subject|0
7827635|NCT01301456|12299177|FG006|Stage 1|Withdrawal by Subject|0
7827636|NCT01301456|12299178|FG007|Stage 1|Withdrawal by Subject|0
7827637|NCT01301456|12299179|FG008|Stage 1|Withdrawal by Subject|0
7827638|NCT01301456|12299180|FG009|Stage 1|Withdrawal by Subject|0
7827639|NCT01301456|12299181|FG010|Stage 1|Withdrawal by Subject|0
7827640|NCT01301456|12299182|FG011|Stage 1|Withdrawal by Subject|0
7827641|NCT01301456|12299171|FG000|Stage 1|Randomized but not treated|0
7827642|NCT01301456|12299172|FG001|Stage 1|Randomized but not treated|0
7827643|NCT01301456|12299173|FG002|Stage 1|Randomized but not treated|0
7827644|NCT01301456|12299174|FG003|Stage 1|Randomized but not treated|0
7827645|NCT01301456|12299175|FG004|Stage 1|Randomized but not treated|0
7827646|NCT01301456|12299176|FG005|Stage 1|Randomized but not treated|0
7827647|NCT01301456|12299177|FG006|Stage 1|Randomized but not treated|1
7827648|NCT01301456|12299178|FG007|Stage 1|Randomized but not treated|0
7827649|NCT01301456|12299179|FG008|Stage 1|Randomized but not treated|0
7827650|NCT01301456|12299180|FG009|Stage 1|Randomized but not treated|0
7827651|NCT01301456|12299181|FG010|Stage 1|Randomized but not treated|0
7827652|NCT01301456|12299182|FG011|Stage 1|Randomized but not treated|0
7827653|NCT01301456|12299171|FG000|Stage 2|Adverse Event|0
7827654|NCT01301456|12299172|FG001|Stage 2|Adverse Event|0
7827655|NCT01301456|12299173|FG002|Stage 2|Adverse Event|0
7827656|NCT01301456|12299174|FG003|Stage 2|Adverse Event|0
7827657|NCT01301456|12299175|FG004|Stage 2|Adverse Event|0
7827658|NCT01301456|12299176|FG005|Stage 2|Adverse Event|0
7827659|NCT01301456|12299177|FG006|Stage 2|Adverse Event|0
7827660|NCT01301456|12299178|FG007|Stage 2|Adverse Event|0
7827661|NCT01301456|12299179|FG008|Stage 2|Adverse Event|0
7827662|NCT01301456|12299180|FG009|Stage 2|Adverse Event|0
7827663|NCT01301456|12299181|FG010|Stage 2|Adverse Event|1
7827664|NCT01301456|12299182|FG011|Stage 2|Adverse Event|0
7827665|NCT01301508|12299228|FG000|Overall Study|Withdrawal by Subject|1
7827666|NCT01301508|12299229|FG001|Overall Study|Withdrawal by Subject|2
7827667|NCT01301508|12299228|FG000|Overall Study|Lost to Follow-up|0
7827668|NCT01301508|12299229|FG001|Overall Study|Lost to Follow-up|1
7827669|NCT01301625|12299235|FG000|Overall Study|Death|5
7827670|NCT01301625|12299235|FG000|Overall Study|Not Due|21
7827671|NCT01301625|12299235|FG000|Overall Study|Expected|8
7827672|NCT01301625|12299235|FG000|Overall Study|Lost to Follow-up|1
7827673|NCT01301729|12299239|FG000|Overall Study|Withdrawal by Subject|2
7827674|NCT01301729|12299239|FG000|Overall Study|Participant did not Return for Treatment|1
7827675|NCT01301729|12299239|FG000|Overall Study|Violated Selection Criteria|1
7827676|NCT01301833|12299256|FG000|Overall Study|Adverse Event|7
7827677|NCT01301833|12299257|FG001|Overall Study|Adverse Event|5
7827678|NCT01301833|12299258|FG002|Overall Study|Adverse Event|5
7827679|NCT01301833|12299259|FG003|Overall Study|Adverse Event|5
7827680|NCT01301833|12299256|FG000|Overall Study|Lack of Efficacy|1
7827681|NCT01301833|12299257|FG001|Overall Study|Lack of Efficacy|1
7827682|NCT01301833|12299258|FG002|Overall Study|Lack of Efficacy|0
7827683|NCT01301833|12299259|FG003|Overall Study|Lack of Efficacy|0
7827684|NCT01301833|12299256|FG000|Overall Study|Physician Decision|3
7827685|NCT01301833|12299257|FG001|Overall Study|Physician Decision|1
7827686|NCT01301833|12299258|FG002|Overall Study|Physician Decision|1
7827687|NCT01301833|12299259|FG003|Overall Study|Physician Decision|0
7827688|NCT01301833|12299256|FG000|Overall Study|Withdrawal by Subject|3
7827689|NCT01301833|12299257|FG001|Overall Study|Withdrawal by Subject|1
7827690|NCT01301833|12299258|FG002|Overall Study|Withdrawal by Subject|1
7827691|NCT01301833|12299259|FG003|Overall Study|Withdrawal by Subject|2
7827692|NCT01301833|12299256|FG000|Overall Study|Personal matter|1
7827693|NCT01301833|12299257|FG001|Overall Study|Personal matter|0
7827694|NCT01301833|12299258|FG002|Overall Study|Personal matter|0
7827695|NCT01301833|12299259|FG003|Overall Study|Personal matter|0
7827696|NCT01301950|12299271|FG000|Overall Study|Surgery was cancelled by patient|0
7827697|NCT01301950|12299272|FG001|Overall Study|Surgery was cancelled by patient|1
7862305|NCT01597245|12351206|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7862306|NCT01597245|12351207|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29
7862307|NCT01597245|12351208|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3
7862308|NCT01597245|12351188|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862309|NCT01597245|12351189|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862310|NCT01597245|12351190|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862311|NCT01597245|12351191|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862312|NCT01597245|12351192|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862313|NCT01597245|12351193|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862314|NCT01597245|12351194|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862315|NCT01597245|12351195|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862316|NCT01597245|12351196|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862317|NCT01597245|12351197|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862318|NCT01597245|12351198|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862319|NCT01597245|12351199|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862320|NCT01597245|12351200|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862321|NCT01597245|12351201|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862322|NCT01597245|12351202|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862323|NCT01597245|12351203|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862324|NCT01597245|12351204|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862325|NCT01597245|12351205|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7862326|NCT01597245|12351206|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1
7862327|NCT01597245|12351207|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14
7862328|NCT01597245|12351208|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4
7862329|NCT01597245|12351188|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862330|NCT01597245|12351189|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862331|NCT01597245|12351190|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862332|NCT01597245|12351191|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862333|NCT01597245|12351192|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862334|NCT01597245|12351193|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862335|NCT01597245|12351194|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862336|NCT01597245|12351195|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862337|NCT01597245|12351196|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862338|NCT01597245|12351197|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862339|NCT01597245|12351198|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862340|NCT01597245|12351199|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862341|NCT01597245|12351200|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862342|NCT01597245|12351201|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862343|NCT01597245|12351202|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7827698|NCT01302041|12299278|FG000|Overall Study|Death|5
7827699|NCT01302041|12299278|FG000|Overall Study|Withdrawal by Subject|4
7827700|NCT01302041|12299278|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29
7827701|NCT01302041|12299278|FG000|Overall Study|Other-Miscellaneous Reason|2
7827702|NCT01302054|12299283|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
7827703|NCT01302054|12299284|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
7827704|NCT01302054|12299285|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
7827705|NCT01302054|12299283|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
7827706|NCT01302054|12299284|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
7827707|NCT01302054|12299285|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
7827708|NCT01302054|12299283|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
7827709|NCT01302054|12299284|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
7827710|NCT01302054|12299285|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
7827711|NCT01302054|12299283|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
7827712|NCT01302054|12299284|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
7827713|NCT01302054|12299285|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
7827714|NCT01302054|12299283|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13
7827715|NCT01302054|12299284|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0
7827716|NCT01302054|12299285|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0
7827717|NCT01302054|12299283|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
7827718|NCT01302054|12299284|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
7827719|NCT01302054|12299285|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
7827720|NCT01302054|12299283|FG000|Tolterodine Open-Label Run-In Phase|Other|7
7827721|NCT01302054|12299284|FG001|Tolterodine Open-Label Run-In Phase|Other|0
7827722|NCT01302054|12299285|FG002|Tolterodine Open-Label Run-In Phase|Other|0
7827723|NCT01302054|12299283|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
7827724|NCT01302054|12299284|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
7827725|NCT01302054|12299285|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
7827726|NCT01302054|12299283|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0
7827727|NCT01302054|12299284|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2
7827728|NCT01302054|12299285|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4
7827729|NCT01302054|12299283|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0
7827730|NCT01302054|12299284|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2
7827731|NCT01302054|12299285|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
7827732|NCT01302054|12299283|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0
7827733|NCT01302054|12299284|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6
7827734|NCT01302054|12299285|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14
7827735|NCT01302054|12299283|FG000|Double-Blind Treatment Phase|Protocol Violation|0
7827736|NCT01302054|12299284|FG001|Double-Blind Treatment Phase|Protocol Violation|3
7827737|NCT01302054|12299285|FG002|Double-Blind Treatment Phase|Protocol Violation|6
7827738|NCT01302054|12299283|FG000|Double-Blind Treatment Phase|Adverse Event|0
7827739|NCT01302054|12299284|FG001|Double-Blind Treatment Phase|Adverse Event|10
7827740|NCT01302054|12299285|FG002|Double-Blind Treatment Phase|Adverse Event|10
7827741|NCT01302054|12299283|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
7827742|NCT01302054|12299284|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
7827743|NCT01302054|12299285|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
7827744|NCT01302054|12299283|FG000|Double-Blind Treatment Phase|Other|0
7827745|NCT01302054|12299284|FG001|Double-Blind Treatment Phase|Other|4
7827746|NCT01302054|12299285|FG002|Double-Blind Treatment Phase|Other|9
7827747|NCT01302067|12299297|FG000|Overall Study|Death|0
7827748|NCT01302067|12299298|FG001|Overall Study|Death|0
7827749|NCT01302067|12299299|FG002|Overall Study|Death|1
7827750|NCT01302067|12299297|FG000|Overall Study|Physician Decision|9
7827751|NCT01302067|12299298|FG001|Overall Study|Physician Decision|5
7827752|NCT01302067|12299299|FG002|Overall Study|Physician Decision|14
7827753|NCT01302067|12299297|FG000|Overall Study|Lack of Efficacy|8
7827754|NCT01302067|12299298|FG001|Overall Study|Lack of Efficacy|4
7827755|NCT01302067|12299299|FG002|Overall Study|Lack of Efficacy|2
7827756|NCT01302067|12299297|FG000|Overall Study|Lost to Follow-up|9
7827757|NCT01302067|12299298|FG001|Overall Study|Lost to Follow-up|4
7827758|NCT01302067|12299299|FG002|Overall Study|Lost to Follow-up|15
7827759|NCT01302067|12299297|FG000|Overall Study|Withdrawal by Subject|13
7827760|NCT01302067|12299298|FG001|Overall Study|Withdrawal by Subject|6
7827761|NCT01302067|12299299|FG002|Overall Study|Withdrawal by Subject|10
7827762|NCT01302067|12299297|FG000|Overall Study|Other|1
7827763|NCT01302067|12299298|FG001|Overall Study|Other|1
7827764|NCT01302067|12299299|FG002|Overall Study|Other|3
7827765|NCT01302067|12299297|FG000|Overall Study|Protocol Violation|11
7827766|NCT01302067|12299298|FG001|Overall Study|Protocol Violation|0
7827767|NCT01302067|12299299|FG002|Overall Study|Protocol Violation|8
7827768|NCT01302067|12299297|FG000|Overall Study|Adverse Event|27
7827769|NCT01302067|12299298|FG001|Overall Study|Adverse Event|14
7827770|NCT01302067|12299299|FG002|Overall Study|Adverse Event|45
7827771|NCT01302080|12299310|FG000|Overall Study|Withdrew Consent|92
7827772|NCT01302080|12299311|FG001|Overall Study|Withdrew Consent|39
7827773|NCT01302080|12299310|FG000|Overall Study|Patient/Family Moved|28
7827774|NCT01302080|12299311|FG001|Overall Study|Patient/Family Moved|3
7827775|NCT01302080|12299310|FG000|Overall Study|Lost to Follow-up|192
7827776|NCT01302080|12299311|FG001|Overall Study|Lost to Follow-up|93
7827777|NCT01302080|12299310|FG000|Overall Study|Death|1
7827778|NCT01302080|12299311|FG001|Overall Study|Death|0
7827779|NCT01302080|12299310|FG000|Overall Study|Other|52
7827780|NCT01302080|12299311|FG001|Overall Study|Other|8
7827781|NCT01302080|12299310|FG000|Overall Study|Reason Missing For Discontinuation|1
7827782|NCT01302080|12299311|FG001|Overall Study|Reason Missing For Discontinuation|0
7827783|NCT01302119|12299343|FG000|Overall Study|Withdrawal by Subject|30
7827784|NCT01302119|12299344|FG001|Overall Study|Withdrawal by Subject|20
7827785|NCT01302119|12299343|FG000|Overall Study|Lost to Follow-up|10
7827786|NCT01302119|12299344|FG001|Overall Study|Lost to Follow-up|4
7827787|NCT01302119|12299343|FG000|Overall Study|Adverse Event|2
7827788|NCT01302119|12299344|FG001|Overall Study|Adverse Event|1
7827789|NCT01302119|12299343|FG000|Overall Study|Non-compliance|4
7827790|NCT01302119|12299344|FG001|Overall Study|Non-compliance|2
7827791|NCT01302119|12299343|FG000|Overall Study|Non-specific|4
7827792|NCT01302119|12299344|FG001|Overall Study|Non-specific|1
7827793|NCT01302366|12299350|FG000|Overall Study|patient choice or noncompliance|5
7827794|NCT01302392|12299371|FG000|Overall Study|Lost to Follow-up|1
7827795|NCT01302392|12299372|FG001|Overall Study|Lost to Follow-up|0
7827796|NCT01302392|12299371|FG000|Overall Study|Withdrawal by Subject|6
7827797|NCT01302392|12299372|FG001|Overall Study|Withdrawal by Subject|1
7827798|NCT01302418|12299378|FG000|Overall Study|Protocol Violation|9
7827799|NCT01302418|12299378|FG000|Overall Study|Non-evaluable|9
7827800|NCT01302548|12299399|FG000|Overall Study|Lost to Follow-up|2
7827801|NCT01302548|12299400|FG001|Overall Study|Lost to Follow-up|1
7827802|NCT01302691|12299408|FG000|Overall Study|Adverse Event|2
7827803|NCT01302691|12299409|FG001|Overall Study|Adverse Event|0
7827804|NCT01302691|12299408|FG000|Overall Study|Death|0
7827805|NCT01302691|12299409|FG001|Overall Study|Death|1
7827806|NCT01302691|12299408|FG000|Overall Study|Lost to Follow-up|1
7827807|NCT01302691|12299409|FG001|Overall Study|Lost to Follow-up|0
7827808|NCT01302691|12299408|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6
7827809|NCT01302691|12299409|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4
7827810|NCT01302691|12299408|FG000|Overall Study|Physician Decision|0
7827811|NCT01302691|12299409|FG001|Overall Study|Physician Decision|1
7827812|NCT01302691|12299408|FG000|Overall Study|Protocol Violation|1
7827813|NCT01302691|12299409|FG001|Overall Study|Protocol Violation|0
7827814|NCT01302899|12299453|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
7827815|NCT01302899|12299454|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
7827816|NCT01302899|12299453|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
7827817|NCT01302899|12299454|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
7827818|NCT01302938|12299466|FG000|Overall Study|Withdrawal by Subject|1
7827819|NCT01302938|12299467|FG001|Overall Study|Withdrawal by Subject|0
7827820|NCT01302938|12299466|FG000|Overall Study|Adverse Event|1
7827821|NCT01302938|12299467|FG001|Overall Study|Adverse Event|0
7827822|NCT01302964|12299476|FG000|Overall Study|Adverse Event|1
7827823|NCT01302964|12299477|FG001|Overall Study|Adverse Event|0
7827824|NCT01303159|12299492|FG000|Overall Study|Death|16
7827825|NCT01303159|12299492|FG000|Overall Study|Study Termination|7
7827826|NCT01303172|12299498|FG000|Overall Study|Physician Decision|9
7827827|NCT01303172|12299499|FG001|Overall Study|Physician Decision|6
7827828|NCT01303172|12299498|FG000|Overall Study|Adverse Event|5
7827829|NCT01303172|12299499|FG001|Overall Study|Adverse Event|2
7827830|NCT01303172|12299498|FG000|Overall Study|Withdrawal by Subject|4
7827831|NCT01303172|12299499|FG001|Overall Study|Withdrawal by Subject|2
7827832|NCT01303172|12299498|FG000|Overall Study|Death|20
7827833|NCT01303172|12299499|FG001|Overall Study|Death|7
7827834|NCT01303172|12299498|FG000|Overall Study|Lack of Efficacy|25
7827835|NCT01303172|12299499|FG001|Overall Study|Lack of Efficacy|17
7827836|NCT01303380|12299523|FG000|Overall Study|Lack of compliance to study procedures|1
7827837|NCT01303419|12299536|FG000|Overall Study|Discontinuation of study|60
7827838|NCT01303419|12299536|FG000|Overall Study|Did not complete both imaging methods|5
7827839|NCT01303419|12299536|FG000|Overall Study|Did not meet all I/E after screening|31
7827840|NCT01303445|12299540|FG000|First Intervention (7 Days)|Withdrawal by Subject|1
7827841|NCT01303445|12299541|FG001|First Intervention (7 Days)|Withdrawal by Subject|0
7827842|NCT01303445|12299540|FG000|Second Intervention (7 Days)|Adverse Event|0
7827843|NCT01303445|12299541|FG001|Second Intervention (7 Days)|Adverse Event|2
7827844|NCT01303445|12299540|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1
7827845|NCT01303445|12299541|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0
7827846|NCT01303445|12299540|FG000|Washout (14 Days)|Protocol Violation|1
7827847|NCT01303445|12299541|FG001|Washout (14 Days)|Protocol Violation|0
7827848|NCT01303445|12299540|FG000|Washout (14 Days)|Lost to Follow-up|0
7827849|NCT01303445|12299541|FG001|Washout (14 Days)|Lost to Follow-up|2
7827850|NCT01303445|12299540|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1
7827851|NCT01303445|12299541|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0
7827852|NCT01303445|12299540|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0
7827853|NCT01303445|12299541|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1
7827854|NCT01303510|12299553|FG000|Overall Study|Lost to Follow-up|1
7827855|NCT01303510|12299554|FG001|Overall Study|Lost to Follow-up|0
7827856|NCT01303627|12299562|FG000|Overall Study|the failure while performing URS|0
7827857|NCT01303627|12299563|FG001|Overall Study|the failure while performing URS|1
7827858|NCT01303861|12299600|FG000|Overall Study|Lost to Follow-up|34
7827859|NCT01303861|12299601|FG001|Overall Study|Lost to Follow-up|14
7827860|NCT01303861|12299602|FG002|Overall Study|Lost to Follow-up|27
7827861|NCT01303861|12299603|FG003|Overall Study|Lost to Follow-up|31
7827862|NCT01303861|12299600|FG000|Overall Study|Lack of Efficacy|3
7827863|NCT01303861|12299601|FG001|Overall Study|Lack of Efficacy|2
7827864|NCT01303861|12299602|FG002|Overall Study|Lack of Efficacy|1
7827865|NCT01303861|12299603|FG003|Overall Study|Lack of Efficacy|0
7827866|NCT01303861|12299600|FG000|Overall Study|Withdrawal by Subject|16
7827867|NCT01303861|12299601|FG001|Overall Study|Withdrawal by Subject|8
7827868|NCT01303861|12299602|FG002|Overall Study|Withdrawal by Subject|8
7827869|NCT01303861|12299603|FG003|Overall Study|Withdrawal by Subject|23
7827870|NCT01303861|12299600|FG000|Overall Study|Adverse Event|4
7827871|NCT01303861|12299601|FG001|Overall Study|Adverse Event|1
7827872|NCT01303861|12299602|FG002|Overall Study|Adverse Event|0
7827873|NCT01303861|12299603|FG003|Overall Study|Adverse Event|5
7827874|NCT01303861|12299600|FG000|Overall Study|Pregnancy|1
7827875|NCT01303861|12299601|FG001|Overall Study|Pregnancy|0
7827876|NCT01303861|12299602|FG002|Overall Study|Pregnancy|0
7827877|NCT01303861|12299603|FG003|Overall Study|Pregnancy|0
7827878|NCT01303965|12299627|FG000|Overall Study|Adverse Event|1
7827879|NCT01303965|12299628|FG001|Overall Study|Adverse Event|1
7827880|NCT01303965|12299627|FG000|Overall Study|Death|0
7827881|NCT01303965|12299628|FG001|Overall Study|Death|3
7827882|NCT01303965|12299627|FG000|Overall Study|Withdrawal by Subject|1
7827883|NCT01303965|12299628|FG001|Overall Study|Withdrawal by Subject|0
7827884|NCT01303965|12299627|FG000|Overall Study|Disease Progression|1
7827885|NCT01303965|12299628|FG001|Overall Study|Disease Progression|6
7827886|NCT01304147|12299646|FG000|Second Intervention (7days)|Withdrawal by Subject|1
7827887|NCT01304147|12299647|FG001|Second Intervention (7days)|Withdrawal by Subject|1
7827888|NCT01304329|12299701|FG000|Third Intervention (3 Days)|Adverse Event|0
7827889|NCT01304329|12299702|FG001|Third Intervention (3 Days)|Adverse Event|1
7827890|NCT01304329|12299703|FG002|Third Intervention (3 Days)|Adverse Event|0
7827891|NCT01304329|12299704|FG003|Third Intervention (3 Days)|Adverse Event|0
7827892|NCT01304329|12299705|FG004|Third Intervention (3 Days)|Adverse Event|0
7827893|NCT01304329|12299706|FG005|Third Intervention (3 Days)|Adverse Event|0
7827894|NCT01304498|12299720|FG000|Overall Study|Adverse Event|1
7827895|NCT01304498|12299721|FG001|Overall Study|Adverse Event|1
7827896|NCT01304498|12299720|FG000|Overall Study|Withdrawal by Subject|2
7827897|NCT01304498|12299721|FG001|Overall Study|Withdrawal by Subject|3
7827898|NCT01304498|12299720|FG000|Overall Study|Protocol Violation|1
7827899|NCT01304498|12299721|FG001|Overall Study|Protocol Violation|0
7827900|NCT01304498|12299720|FG000|Overall Study|Lost to Follow-up|2
7827901|NCT01304498|12299721|FG001|Overall Study|Lost to Follow-up|1
7827902|NCT01304693|12299746|FG000|Overall Study|Adverse Event|0
7827903|NCT01304693|12299747|FG001|Overall Study|Adverse Event|0
7827904|NCT01304693|12299748|FG002|Overall Study|Adverse Event|0
7827905|NCT01304693|12299749|FG003|Overall Study|Adverse Event|0
7827906|NCT01304693|12299750|FG004|Overall Study|Adverse Event|1
7827907|NCT01304693|12299746|FG000|Overall Study|Decision Unrelated to an Adverse Event|0
7827908|NCT01304693|12299747|FG001|Overall Study|Decision Unrelated to an Adverse Event|0
7827909|NCT01304693|12299748|FG002|Overall Study|Decision Unrelated to an Adverse Event|1
7827910|NCT01304693|12299749|FG003|Overall Study|Decision Unrelated to an Adverse Event|1
7827911|NCT01304693|12299750|FG004|Overall Study|Decision Unrelated to an Adverse Event|0
7827912|NCT01304706|12299762|FG000|Overall Study|Adverse Event|2
7827913|NCT01304706|12299762|FG000|Overall Study|Lack of Efficacy|1
7827914|NCT01304706|12299762|FG000|Overall Study|Death|3
7827915|NCT01304706|12299762|FG000|Overall Study|Withdrawal by Subject|3
7827916|NCT01304706|12299762|FG000|Overall Study|Lost to Follow-up|7
7827917|NCT01304706|12299762|FG000|Overall Study|Discontinued due to failed drug admin.|1
7827918|NCT01304940|12299768|FG000|Overall Study|not meet symptom severity requirement|3
7827919|NCT01304940|12299769|FG001|Overall Study|not meet symptom severity requirement|0
7827920|NCT01305044|12299783|FG000|Overall Study|Withdrawal by Subject|3
7827921|NCT01305044|12299784|FG001|Overall Study|Withdrawal by Subject|6
7827922|NCT01305200|12299793|FG000|Overall Study|Physician Decision|4
7827923|NCT01305200|12299794|FG001|Overall Study|Physician Decision|6
7827924|NCT01305200|12299795|FG002|Overall Study|Physician Decision|1
7827925|NCT01305200|12299793|FG000|Overall Study|Withdrawal by Subject|24
7827926|NCT01305200|12299794|FG001|Overall Study|Withdrawal by Subject|21
7827927|NCT01305200|12299795|FG002|Overall Study|Withdrawal by Subject|1
7827928|NCT01305200|12299793|FG000|Overall Study|Ineligible|1
7827929|NCT01305200|12299794|FG001|Overall Study|Ineligible|2
7827930|NCT01305200|12299795|FG002|Overall Study|Ineligible|1
7827931|NCT01305200|12299793|FG000|Overall Study|Death|0
7827932|NCT01305200|12299794|FG001|Overall Study|Death|2
7827933|NCT01305200|12299795|FG002|Overall Study|Death|0
7827934|NCT01305239|12299813|FG000|Overall Study|Adverse Event|22
7827935|NCT01305239|12299813|FG000|Overall Study|Exemestane taken prior to inclusion only|1
7827936|NCT01305408|12299850|FG000|Overall Study|Adverse Event|10
7827937|NCT01305408|12299851|FG001|Overall Study|Adverse Event|7
7827938|NCT01305408|12299850|FG000|Overall Study|Lack of Efficacy|3
7827939|NCT01305408|12299851|FG001|Overall Study|Lack of Efficacy|4
7827940|NCT01305408|12299850|FG000|Overall Study|Withdrawal by Subject|9
7827941|NCT01305408|12299851|FG001|Overall Study|Withdrawal by Subject|9
7827942|NCT01305408|12299850|FG000|Overall Study|Protocol Violation|4
7827943|NCT01305408|12299851|FG001|Overall Study|Protocol Violation|6
7827944|NCT01305408|12299850|FG000|Overall Study|Lost to Follow-up|5
7827945|NCT01305408|12299851|FG001|Overall Study|Lost to Follow-up|3
7827946|NCT01305408|12299850|FG000|Overall Study|Noncompliance with study medication|0
7827947|NCT01305408|12299851|FG001|Overall Study|Noncompliance with study medication|1
7827948|NCT01305408|12299850|FG000|Overall Study|Noncompliance with study procedures|0
7827949|NCT01305408|12299851|FG001|Overall Study|Noncompliance with study procedures|1
7827950|NCT01305408|12299850|FG000|Overall Study|Other|1
7827951|NCT01305408|12299851|FG001|Overall Study|Other|0
7827952|NCT01305564|12299861|FG000|Overall Study|Death|21
7827953|NCT01305564|12299861|FG000|Overall Study|Lost to Follow-up|12
7827954|NCT01305564|12299861|FG000|Overall Study|Withdrawal by Subject|1
7827955|NCT01305564|12299861|FG000|Overall Study|Physician Decision|3
7827956|NCT01305577|12299879|FG000|Overall Study|Adverse Event|2
7827957|NCT01305577|12299880|FG001|Overall Study|Adverse Event|2
7827958|NCT01305577|12299881|FG002|Overall Study|Adverse Event|1
7827959|NCT01305577|12299879|FG000|Overall Study|Withdrawal by Subject|7
7827960|NCT01305577|12299880|FG001|Overall Study|Withdrawal by Subject|5
7827961|NCT01305577|12299881|FG002|Overall Study|Withdrawal by Subject|6
7827962|NCT01305577|12299879|FG000|Overall Study|Lost to Follow-up|4
7827963|NCT01305577|12299880|FG001|Overall Study|Lost to Follow-up|3
7827964|NCT01305577|12299881|FG002|Overall Study|Lost to Follow-up|2
7827965|NCT01305577|12299879|FG000|Overall Study|Protocol Deviation|0
7827966|NCT01305577|12299880|FG001|Overall Study|Protocol Deviation|1
7827967|NCT01305577|12299881|FG002|Overall Study|Protocol Deviation|1
7827968|NCT01305941|12299912|FG000|Overall Study|Adverse Event|6
7827969|NCT01305941|12299912|FG000|Overall Study|Clinical decline|2
7827970|NCT01305941|12299912|FG000|Overall Study|Withdrawal by Subject|1
7827971|NCT01305941|12299912|FG000|Overall Study|Death|1
7827972|NCT01306032|12299922|FG000|First Intervention|Adverse Event|1
7827973|NCT01306032|12299923|FG001|First Intervention|Adverse Event|0
7827974|NCT01306032|12299924|FG002|First Intervention|Adverse Event|1
7827975|NCT01306032|12299925|FG003|First Intervention|Adverse Event|0
7827976|NCT01306032|12299926|FG004|First Intervention|Adverse Event|0
7827977|NCT01306032|12299927|FG005|First Intervention|Adverse Event|1
7827978|NCT01306032|12299922|FG000|First Intervention|Withdrawal by Subject|0
7827979|NCT01306032|12299923|FG001|First Intervention|Withdrawal by Subject|2
7827980|NCT01306032|12299924|FG002|First Intervention|Withdrawal by Subject|0
7827981|NCT01306032|12299925|FG003|First Intervention|Withdrawal by Subject|1
7827982|NCT01306032|12299926|FG004|First Intervention|Withdrawal by Subject|0
7827983|NCT01306032|12299927|FG005|First Intervention|Withdrawal by Subject|0
7827984|NCT01306032|12299922|FG000|First Intervention|Death|0
7827985|NCT01306032|12299923|FG001|First Intervention|Death|0
7827986|NCT01306032|12299924|FG002|First Intervention|Death|1
7827987|NCT01306032|12299925|FG003|First Intervention|Death|0
7827988|NCT01306032|12299926|FG004|First Intervention|Death|0
7827989|NCT01306032|12299927|FG005|First Intervention|Death|0
7827990|NCT01306032|12299922|FG000|First Intervention|Ineligible|0
7827991|NCT01306032|12299923|FG001|First Intervention|Ineligible|0
7827992|NCT01306032|12299924|FG002|First Intervention|Ineligible|0
7827993|NCT01306032|12299925|FG003|First Intervention|Ineligible|0
7827994|NCT01306032|12299926|FG004|First Intervention|Ineligible|0
7827995|NCT01306032|12299927|FG005|First Intervention|Ineligible|1
7827996|NCT01306032|12299922|FG000|First Intervention|Progressive disease|0
7827997|NCT01306032|12299923|FG001|First Intervention|Progressive disease|0
7827998|NCT01306032|12299924|FG002|First Intervention|Progressive disease|0
7827999|NCT01306032|12299925|FG003|First Intervention|Progressive disease|0
7828000|NCT01306032|12299926|FG004|First Intervention|Progressive disease|2
7828001|NCT01306032|12299927|FG005|First Intervention|Progressive disease|0
7828002|NCT01306032|12299922|FG000|Disease Progression/Crossover|Withdrawal by Subject|0
7828003|NCT01306032|12299923|FG001|Disease Progression/Crossover|Withdrawal by Subject|0
7828004|NCT01306032|12299924|FG002|Disease Progression/Crossover|Withdrawal by Subject|0
7828005|NCT01306032|12299925|FG003|Disease Progression/Crossover|Withdrawal by Subject|1
7828006|NCT01306032|12299926|FG004|Disease Progression/Crossover|Withdrawal by Subject|0
7828007|NCT01306032|12299927|FG005|Disease Progression/Crossover|Withdrawal by Subject|0
7828008|NCT01306032|12299922|FG000|Disease Progression/Crossover|other/symptomatic progression|0
7828009|NCT01306032|12299923|FG001|Disease Progression/Crossover|other/symptomatic progression|2
7828010|NCT01306032|12299924|FG002|Disease Progression/Crossover|other/symptomatic progression|0
7828011|NCT01306032|12299925|FG003|Disease Progression/Crossover|other/symptomatic progression|2
7828012|NCT01306032|12299926|FG004|Disease Progression/Crossover|other/symptomatic progression|0
7828013|NCT01306032|12299927|FG005|Disease Progression/Crossover|other/symptomatic progression|0
7828014|NCT01306058|12299953|FG000|Overall Study|Death|1
7828015|NCT01306058|12299953|FG000|Overall Study|Enrolled but did not get treatment|1
7828016|NCT01306162|12299961|FG000|Period 1|Adverse Event|0
7828017|NCT01306162|12299962|FG001|Period 1|Adverse Event|0
7828018|NCT01306162|12299963|FG002|Period 1|Adverse Event|0
7828019|NCT01306162|12299964|FG003|Period 1|Adverse Event|1
7828020|NCT01306162|12299961|FG000|Washout 1|Non-compliance to protocol|0
7828021|NCT01306162|12299962|FG001|Washout 1|Non-compliance to protocol|1
7828022|NCT01306162|12299963|FG002|Washout 1|Non-compliance to protocol|0
7828023|NCT01306162|12299964|FG003|Washout 1|Non-compliance to protocol|0
7828024|NCT01306201|12299983|FG000|Overall Study|Arrhythmia|4
7828025|NCT01306201|12299983|FG000|Overall Study|Files could not be processed|3
7828026|NCT01306201|12299983|FG000|Overall Study|Files unreadable|3
7828027|NCT01306214|12299994|FG000|Overall Study|Death|0
7828028|NCT01306214|12299995|FG001|Overall Study|Death|0
7828029|NCT01306214|12299996|FG002|Overall Study|Death|1
7828030|NCT01306214|12299994|FG000|Overall Study|Lost to Follow-up|3
7828031|NCT01306214|12299995|FG001|Overall Study|Lost to Follow-up|5
7828032|NCT01306214|12299996|FG002|Overall Study|Lost to Follow-up|4
7828033|NCT01306214|12299994|FG000|Overall Study|Withdrawal by Subject|24
7828034|NCT01306214|12299995|FG001|Overall Study|Withdrawal by Subject|22
7828035|NCT01306214|12299996|FG002|Overall Study|Withdrawal by Subject|16
7828036|NCT01306214|12299994|FG000|Overall Study|Not treated|1
7828037|NCT01306214|12299995|FG001|Overall Study|Not treated|1
7828038|NCT01306214|12299996|FG002|Overall Study|Not treated|1
7828039|NCT01306253|12300006|FG000|Overall Study|Lost to Follow-up|1
7828040|NCT01306253|12300007|FG001|Overall Study|Lost to Follow-up|1
7828041|NCT01306305|12300028|FG000|Overall Study|Lost to Follow-up|1
7828042|NCT01306305|12300029|FG001|Overall Study|Lost to Follow-up|0
7828043|NCT01306305|12300028|FG000|Overall Study|Withdrew consent|1
7828044|NCT01306305|12300029|FG001|Overall Study|Withdrew consent|0
7828045|NCT01306617|12300038|FG000|Overall Study|Adverse Event|1
7828046|NCT01306617|12300039|FG001|Overall Study|Adverse Event|0
7828047|NCT01306617|12300040|FG002|Overall Study|Adverse Event|0
7828048|NCT01306617|12300038|FG000|Overall Study|Virologic Failure|0
7828049|NCT01306617|12300039|FG001|Overall Study|Virologic Failure|0
7828050|NCT01306617|12300040|FG002|Overall Study|Virologic Failure|5
7828051|NCT01306617|12300038|FG000|Overall Study|Non-compliance|0
7828052|NCT01306617|12300039|FG001|Overall Study|Non-compliance|1
7828053|NCT01306617|12300040|FG002|Overall Study|Non-compliance|0
7828054|NCT01306643|12300048|FG000|Overall Study|Adverse Event|5
7828055|NCT01306643|12300048|FG000|Overall Study|Disease Progression|7
7828056|NCT01306643|12300048|FG000|Overall Study|Other: Change in Eligibility Status|1
7828057|NCT01306656|12300054|FG000|Overall Study|Lost to Follow-up|1
7828058|NCT01306656|12300055|FG001|Overall Study|Lost to Follow-up|0
7828059|NCT01306877|12300065|FG000|Overall Study|Lost to Follow-up|3
7828060|NCT01306877|12300066|FG001|Overall Study|Lost to Follow-up|3
7828061|NCT01306877|12300065|FG000|Overall Study|Physician Decision|0
7828062|NCT01306877|12300066|FG001|Overall Study|Physician Decision|1
7828063|NCT01306890|12300072|FG000|Overall Study|Adverse Event|2
7828064|NCT01306890|12300072|FG000|Overall Study|Death|1223
7828065|NCT01306890|12300072|FG000|Overall Study|Lost to Follow-up|58
7828066|NCT01306890|12300072|FG000|Overall Study|Withdrawal by Subject|88
7828067|NCT01306890|12300072|FG000|Overall Study|Unspecified reasons|104
7828068|NCT01306890|12300072|FG000|Overall Study|Study Termination|3
7828069|NCT01306890|12300072|FG000|Overall Study|No discontinuation documentation|41
7828070|NCT01306942|12300079|FG000|Phase I|Adverse Event|2
7828071|NCT01306942|12300080|FG001|Phase I|Adverse Event|2
7828072|NCT01306942|12300081|FG002|Phase I|Adverse Event|0
7828073|NCT01306942|12300082|FG003|Phase I|Adverse Event|0
7828074|NCT01306942|12300079|FG000|Phase I|Physician Decision|3
7828075|NCT01306942|12300080|FG001|Phase I|Physician Decision|1
7828076|NCT01306942|12300081|FG002|Phase I|Physician Decision|0
7828077|NCT01306942|12300082|FG003|Phase I|Physician Decision|0
7828078|NCT01306942|12300079|FG000|Phase II|Adverse Event|0
7828079|NCT01306942|12300080|FG001|Phase II|Adverse Event|0
7828080|NCT01306942|12300081|FG002|Phase II|Adverse Event|0
7828081|NCT01306942|12300082|FG003|Phase II|Adverse Event|6
7828082|NCT01306942|12300079|FG000|Phase II|Physician Decision|2
7828083|NCT01306942|12300080|FG001|Phase II|Physician Decision|0
7828084|NCT01306942|12300081|FG002|Phase II|Physician Decision|0
7828085|NCT01306942|12300082|FG003|Phase II|Physician Decision|5
7828086|NCT01306942|12300079|FG000|Phase II|Withdrawal by Subject|0
7828087|NCT01306942|12300080|FG001|Phase II|Withdrawal by Subject|0
7828088|NCT01306942|12300081|FG002|Phase II|Withdrawal by Subject|0
7828089|NCT01306942|12300082|FG003|Phase II|Withdrawal by Subject|2
7828090|NCT01306942|12300079|FG000|Phase II|Death|0
7828091|NCT01306942|12300080|FG001|Phase II|Death|0
7828092|NCT01306942|12300081|FG002|Phase II|Death|0
7828093|NCT01306942|12300082|FG003|Phase II|Death|1
7828094|NCT01306942|12300079|FG000|Phase II|Not finished treatment|0
7828095|NCT01306942|12300080|FG001|Phase II|Not finished treatment|0
7948433|NCT02528357|12493666|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7948434|NCT02528357|12493667|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7948435|NCT02528357|12493668|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7948436|NCT02528357|12493669|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1
7948437|NCT02528357|12493670|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7948438|NCT02528357|12493671|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2
7948439|NCT02528357|12493672|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7948440|NCT02528357|12493673|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1
7948441|NCT02528357|12493674|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7948442|NCT02528357|12493675|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7948443|NCT02528357|12493676|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7948444|NCT02528357|12493677|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7948445|NCT02528357|12493678|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7948446|NCT02528357|12493679|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7948447|NCT02528357|12493680|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7948448|NCT02528357|12493681|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7948449|NCT02528357|12493682|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7828096|NCT01306942|12300081|FG002|Phase II|Not finished treatment|0
7828097|NCT01306942|12300082|FG003|Phase II|Not finished treatment|1
7828098|NCT01306942|12300079|FG000|Phase II|Protocol Violation|0
7828099|NCT01306942|12300080|FG001|Phase II|Protocol Violation|0
7828100|NCT01306942|12300081|FG002|Phase II|Protocol Violation|0
7828101|NCT01306942|12300082|FG003|Phase II|Protocol Violation|1
7948450|NCT02528357|12493683|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7948451|NCT02528357|12493684|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7828102|NCT01306968|12300098|FG000|Overall Study|Lost to Follow-up|1
7828103|NCT01306968|12300099|FG001|Overall Study|Lost to Follow-up|1
7828104|NCT01306968|12300100|FG002|Overall Study|Lost to Follow-up|0
7828105|NCT01306968|12300101|FG003|Overall Study|Lost to Follow-up|0
7828106|NCT01306968|12300098|FG000|Overall Study|Physician Decision|0
7828107|NCT01306968|12300099|FG001|Overall Study|Physician Decision|1
7828108|NCT01306968|12300100|FG002|Overall Study|Physician Decision|0
7828109|NCT01306968|12300101|FG003|Overall Study|Physician Decision|0
7828110|NCT01306968|12300098|FG000|Overall Study|Relocated and left active duty|0
7828111|NCT01306968|12300099|FG001|Overall Study|Relocated and left active duty|1
7828112|NCT01306968|12300100|FG002|Overall Study|Relocated and left active duty|1
7828113|NCT01306968|12300101|FG003|Overall Study|Relocated and left active duty|1
7828114|NCT01306968|12300098|FG000|Overall Study|Withdrew - time commitment|0
7828115|NCT01306968|12300099|FG001|Overall Study|Withdrew - time commitment|0
7828116|NCT01306968|12300100|FG002|Overall Study|Withdrew - time commitment|0
7828117|NCT01306968|12300101|FG003|Overall Study|Withdrew - time commitment|2
7828118|NCT01306968|12300098|FG000|Overall Study|Withdrew over privacy concerns|0
7828119|NCT01306968|12300099|FG001|Overall Study|Withdrew over privacy concerns|0
7828120|NCT01306968|12300100|FG002|Overall Study|Withdrew over privacy concerns|0
7828121|NCT01306968|12300101|FG003|Overall Study|Withdrew over privacy concerns|1
7828122|NCT01307020|12300132|FG000|Overall Study|Lost to Follow-up|0
7828123|NCT01307020|12300133|FG001|Overall Study|Lost to Follow-up|0
7828124|NCT01307020|12300134|FG002|Overall Study|Lost to Follow-up|1
7828125|NCT01307020|12300135|FG003|Overall Study|Lost to Follow-up|1
7828126|NCT01307020|12300136|FG004|Overall Study|Lost to Follow-up|0
7828127|NCT01307020|12300137|FG005|Overall Study|Lost to Follow-up|0
7828128|NCT01307020|12300138|FG006|Overall Study|Lost to Follow-up|1
7828129|NCT01307020|12300139|FG007|Overall Study|Lost to Follow-up|0
7828130|NCT01307020|12300140|FG008|Overall Study|Lost to Follow-up|0
7828131|NCT01307020|12300141|FG009|Overall Study|Lost to Follow-up|0
7828132|NCT01307020|12300132|FG000|Overall Study|Electronic data capture failure|0
7828133|NCT01307020|12300133|FG001|Overall Study|Electronic data capture failure|1
7828134|NCT01307020|12300134|FG002|Overall Study|Electronic data capture failure|0
7828135|NCT01307020|12300135|FG003|Overall Study|Electronic data capture failure|0
7828136|NCT01307020|12300136|FG004|Overall Study|Electronic data capture failure|0
7828137|NCT01307020|12300137|FG005|Overall Study|Electronic data capture failure|0
7828138|NCT01307020|12300138|FG006|Overall Study|Electronic data capture failure|0
7828139|NCT01307020|12300139|FG007|Overall Study|Electronic data capture failure|0
7828140|NCT01307020|12300140|FG008|Overall Study|Electronic data capture failure|0
7828141|NCT01307020|12300141|FG009|Overall Study|Electronic data capture failure|0
7828142|NCT01307111|12300179|FG000|IUD Insertion|Lost to Follow-up|2
7828143|NCT01307111|12300180|FG001|IUD Insertion|Lost to Follow-up|0
7828144|NCT01307111|12300179|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2
7828145|NCT01307111|12300180|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2
7828146|NCT01307267|12300209|FG000|Overall Study|Death|4
7828147|NCT01307267|12300210|FG001|Overall Study|Death|3
7828148|NCT01307267|12300211|FG002|Overall Study|Death|5
7828149|NCT01307267|12300212|FG003|Overall Study|Death|3
7828150|NCT01307267|12300213|FG004|Overall Study|Death|1
7828151|NCT01307267|12300214|FG005|Overall Study|Death|26
7828152|NCT01307267|12300215|FG006|Overall Study|Death|2
7828153|NCT01307267|12300216|FG007|Overall Study|Death|2
7828154|NCT01307267|12300217|FG008|Overall Study|Death|21
7828155|NCT01307267|12300218|FG009|Overall Study|Death|2
7828156|NCT01307267|12300219|FG010|Overall Study|Death|3
7828157|NCT01307267|12300220|FG011|Overall Study|Death|9
7828158|NCT01307267|12300221|FG012|Overall Study|Death|0
7828159|NCT01307267|12300222|FG013|Overall Study|Death|0
7828160|NCT01307267|12300223|FG014|Overall Study|Death|0
7828161|NCT01307267|12300224|FG015|Overall Study|Death|0
7828162|NCT01307267|12300225|FG016|Overall Study|Death|1
7828163|NCT01307267|12300226|FG017|Overall Study|Death|1
7828164|NCT01307267|12300227|FG018|Overall Study|Death|2
7828165|NCT01307267|12300228|FG019|Overall Study|Death|8
7828166|NCT01307267|12300229|FG020|Overall Study|Death|1
7828167|NCT01307267|12300230|FG021|Overall Study|Death|2
7828168|NCT01307267|12300231|FG022|Overall Study|Death|2
7828169|NCT01307267|12300209|FG000|Overall Study|Lost to Follow-up|0
7828170|NCT01307267|12300210|FG001|Overall Study|Lost to Follow-up|0
7828171|NCT01307267|12300211|FG002|Overall Study|Lost to Follow-up|0
7828172|NCT01307267|12300212|FG003|Overall Study|Lost to Follow-up|0
7828173|NCT01307267|12300213|FG004|Overall Study|Lost to Follow-up|0
7828174|NCT01307267|12300214|FG005|Overall Study|Lost to Follow-up|7
7828175|NCT01307267|12300215|FG006|Overall Study|Lost to Follow-up|0
7828176|NCT01307267|12300216|FG007|Overall Study|Lost to Follow-up|0
7828177|NCT01307267|12300217|FG008|Overall Study|Lost to Follow-up|1
7828178|NCT01307267|12300218|FG009|Overall Study|Lost to Follow-up|2
7828179|NCT01307267|12300219|FG010|Overall Study|Lost to Follow-up|1
7828180|NCT01307267|12300220|FG011|Overall Study|Lost to Follow-up|0
7828181|NCT01307267|12300221|FG012|Overall Study|Lost to Follow-up|0
7828182|NCT01307267|12300222|FG013|Overall Study|Lost to Follow-up|0
7828183|NCT01307267|12300223|FG014|Overall Study|Lost to Follow-up|0
7828184|NCT01307267|12300224|FG015|Overall Study|Lost to Follow-up|0
7828185|NCT01307267|12300225|FG016|Overall Study|Lost to Follow-up|0
7828186|NCT01307267|12300226|FG017|Overall Study|Lost to Follow-up|0
7828187|NCT01307267|12300227|FG018|Overall Study|Lost to Follow-up|0
7828188|NCT01307267|12300228|FG019|Overall Study|Lost to Follow-up|2
7828189|NCT01307267|12300229|FG020|Overall Study|Lost to Follow-up|0
7828190|NCT01307267|12300230|FG021|Overall Study|Lost to Follow-up|0
7828191|NCT01307267|12300231|FG022|Overall Study|Lost to Follow-up|0
7828192|NCT01307267|12300209|FG000|Overall Study|Withdrawal by Subject|0
7828193|NCT01307267|12300210|FG001|Overall Study|Withdrawal by Subject|0
7828194|NCT01307267|12300211|FG002|Overall Study|Withdrawal by Subject|0
7828195|NCT01307267|12300212|FG003|Overall Study|Withdrawal by Subject|0
7828196|NCT01307267|12300213|FG004|Overall Study|Withdrawal by Subject|0
7828197|NCT01307267|12300214|FG005|Overall Study|Withdrawal by Subject|1
7828198|NCT01307267|12300215|FG006|Overall Study|Withdrawal by Subject|0
7828199|NCT01307267|12300216|FG007|Overall Study|Withdrawal by Subject|1
7828200|NCT01307267|12300217|FG008|Overall Study|Withdrawal by Subject|5
7828201|NCT01307267|12300218|FG009|Overall Study|Withdrawal by Subject|1
7828202|NCT01307267|12300219|FG010|Overall Study|Withdrawal by Subject|1
7828203|NCT01307267|12300220|FG011|Overall Study|Withdrawal by Subject|1
7828204|NCT01307267|12300221|FG012|Overall Study|Withdrawal by Subject|0
7828205|NCT01307267|12300222|FG013|Overall Study|Withdrawal by Subject|0
7828206|NCT01307267|12300223|FG014|Overall Study|Withdrawal by Subject|0
7828207|NCT01307267|12300224|FG015|Overall Study|Withdrawal by Subject|0
7828208|NCT01307267|12300225|FG016|Overall Study|Withdrawal by Subject|0
7828209|NCT01307267|12300226|FG017|Overall Study|Withdrawal by Subject|0
7828210|NCT01307267|12300227|FG018|Overall Study|Withdrawal by Subject|0
7828211|NCT01307267|12300228|FG019|Overall Study|Withdrawal by Subject|3
7828212|NCT01307267|12300229|FG020|Overall Study|Withdrawal by Subject|0
7828213|NCT01307267|12300230|FG021|Overall Study|Withdrawal by Subject|0
7828214|NCT01307267|12300231|FG022|Overall Study|Withdrawal by Subject|0
7828215|NCT01307267|12300209|FG000|Overall Study|Other|0
7828216|NCT01307267|12300210|FG001|Overall Study|Other|0
7828217|NCT01307267|12300211|FG002|Overall Study|Other|0
7828218|NCT01307267|12300212|FG003|Overall Study|Other|0
7828219|NCT01307267|12300213|FG004|Overall Study|Other|0
7828220|NCT01307267|12300214|FG005|Overall Study|Other|7
7828221|NCT01307267|12300215|FG006|Overall Study|Other|0
7828222|NCT01307267|12300216|FG007|Overall Study|Other|1
7828223|NCT01307267|12300217|FG008|Overall Study|Other|3
7828224|NCT01307267|12300218|FG009|Overall Study|Other|0
7828225|NCT01307267|12300219|FG010|Overall Study|Other|1
7828226|NCT01307267|12300220|FG011|Overall Study|Other|1
7828227|NCT01307267|12300221|FG012|Overall Study|Other|1
7828228|NCT01307267|12300222|FG013|Overall Study|Other|0
7828229|NCT01307267|12300223|FG014|Overall Study|Other|2
7828230|NCT01307267|12300224|FG015|Overall Study|Other|1
7828231|NCT01307267|12300225|FG016|Overall Study|Other|0
7828232|NCT01307267|12300226|FG017|Overall Study|Other|0
7828233|NCT01307267|12300227|FG018|Overall Study|Other|0
7828234|NCT01307267|12300228|FG019|Overall Study|Other|19
7828235|NCT01307267|12300229|FG020|Overall Study|Other|2
7828236|NCT01307267|12300230|FG021|Overall Study|Other|3
7828237|NCT01307267|12300231|FG022|Overall Study|Other|2
7828238|NCT01307319|12300293|FG000|Overall Study|Adverse Event|2
7828239|NCT01307319|12300294|FG001|Overall Study|Adverse Event|2
7828240|NCT01307319|12300295|FG002|Overall Study|Adverse Event|1
7828241|NCT01307319|12300293|FG000|Overall Study|Lost to Follow-up|1
7828242|NCT01307319|12300294|FG001|Overall Study|Lost to Follow-up|0
7828243|NCT01307319|12300295|FG002|Overall Study|Lost to Follow-up|1
7828244|NCT01307319|12300293|FG000|Overall Study|Protocol Violation|1
7828245|NCT01307319|12300294|FG001|Overall Study|Protocol Violation|1
7828246|NCT01307319|12300295|FG002|Overall Study|Protocol Violation|0
7828247|NCT01307319|12300293|FG000|Overall Study|Withdrawal by Subject|0
7828248|NCT01307319|12300294|FG001|Overall Study|Withdrawal by Subject|1
7828249|NCT01307319|12300295|FG002|Overall Study|Withdrawal by Subject|2
7828250|NCT01307319|12300293|FG000|Overall Study|Other|0
7828251|NCT01307319|12300294|FG001|Overall Study|Other|4
7828252|NCT01307319|12300295|FG002|Overall Study|Other|3
7828253|NCT01307449|12300311|FG000|Overall Study|Adverse Event|1
7828254|NCT01307449|12300312|FG001|Overall Study|Adverse Event|0
7828255|NCT01307449|12300313|FG002|Overall Study|Adverse Event|0
7828256|NCT01307449|12300314|FG003|Overall Study|Adverse Event|0
7828257|NCT01307501|12300328|FG000|Overall Study|Treatment Failure|1
7828258|NCT01307501|12300328|FG000|Overall Study|Death|20
7828259|NCT01307501|12300328|FG000|Overall Study|Lost to Follow-up|1
7828260|NCT01307501|12300328|FG000|Overall Study|Starting Hospice|1
7828261|NCT01307579|12300334|FG000|Overall Study|Death|3
7828262|NCT01307579|12300335|FG001|Overall Study|Death|6
7828263|NCT01307579|12300334|FG000|Overall Study|Physician Decision|26
7828264|NCT01307579|12300335|FG001|Overall Study|Physician Decision|29
7828265|NCT01307579|12300334|FG000|Overall Study|Withdrawal by Subject|7
7828266|NCT01307579|12300335|FG001|Overall Study|Withdrawal by Subject|3
7828267|NCT01307579|12300334|FG000|Overall Study|Institutional diagnosis of IFD|21
7828268|NCT01307579|12300335|FG001|Overall Study|Institutional diagnosis of IFD|36
7828269|NCT01307579|12300334|FG000|Overall Study|Begin conditioning for HSCT|42
7828270|NCT01307579|12300335|FG001|Overall Study|Begin conditioning for HSCT|44
7828271|NCT01307579|12300334|FG000|Overall Study|Refractory or relapsed AML|38
7828272|NCT01307579|12300335|FG001|Overall Study|Refractory or relapsed AML|23
7828273|NCT01307579|12300334|FG000|Overall Study|Ineligible|3
7828274|NCT01307579|12300335|FG001|Overall Study|Ineligible|4
7828275|NCT01307891|12300371|FG000|Overall Study|Progressive Disease|3
7828276|NCT01307891|12300372|FG001|Overall Study|Progressive Disease|1
7828277|NCT01308008|12300388|FG000|4 Weeks|Illness, disinterest, time|9
7828278|NCT01308008|12300389|FG001|4 Weeks|Illness, disinterest, time|2
7828279|NCT01308424|12300423|FG000|Baseline Eligibility|Screen Failures|71
7828280|NCT01308424|12300424|FG001|Baseline Eligibility|Screen Failures|0
7828281|NCT01308424|12300425|FG002|Baseline Eligibility|Screen Failures|0
7828282|NCT01308424|12300423|FG000|Randomization|Adverse Event|0
7828283|NCT01308424|12300424|FG001|Randomization|Adverse Event|1
7828284|NCT01308424|12300425|FG002|Randomization|Adverse Event|1
7828285|NCT01308424|12300423|FG000|Randomization|Lost to Follow-up|0
7828286|NCT01308424|12300424|FG001|Randomization|Lost to Follow-up|1
7828287|NCT01308424|12300425|FG002|Randomization|Lost to Follow-up|0
7828288|NCT01308424|12300423|FG000|Randomization|Physician Decision|0
7828289|NCT01308424|12300424|FG001|Randomization|Physician Decision|1
7828290|NCT01308424|12300425|FG002|Randomization|Physician Decision|1
7828291|NCT01308463|12300436|FG000|Overall Study|Study Discontinued|23
7828292|NCT01308463|12300436|FG000|Overall Study|Death|4
7828293|NCT01308463|12300436|FG000|Overall Study|Revision|2
7828294|NCT01308476|12300442|FG000|Overall Study|Lost to Follow-up|2
7828295|NCT01308476|12300443|FG001|Overall Study|Lost to Follow-up|2
7828296|NCT01308476|12300442|FG000|Overall Study|Other|1
7828297|NCT01308476|12300443|FG001|Overall Study|Other|0
7862344|NCT01597245|12351203|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862345|NCT01597245|12351204|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
7862346|NCT01597245|12351205|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862347|NCT01597245|12351206|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7862348|NCT01597245|12351207|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9
7862349|NCT01597245|12351208|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
7862350|NCT01597245|12351188|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862351|NCT01597245|12351189|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862352|NCT01597245|12351190|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862353|NCT01597245|12351191|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862354|NCT01597245|12351192|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862355|NCT01597245|12351193|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862356|NCT01597245|12351194|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862357|NCT01597245|12351195|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862358|NCT01597245|12351196|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862359|NCT01597245|12351197|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862360|NCT01597245|12351198|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862361|NCT01597245|12351199|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862362|NCT01597245|12351200|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862363|NCT01597245|12351201|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862364|NCT01597245|12351202|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862365|NCT01597245|12351203|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862366|NCT01597245|12351204|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1
7862367|NCT01597245|12351205|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862368|NCT01597245|12351206|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7862369|NCT01597245|12351207|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6
7862370|NCT01597245|12351208|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2
7862371|NCT01597245|12351188|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862372|NCT01597245|12351189|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862373|NCT01597245|12351190|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862374|NCT01597245|12351191|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862375|NCT01597245|12351192|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862376|NCT01597245|12351193|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862377|NCT01597245|12351194|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862378|NCT01597245|12351195|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862379|NCT01597245|12351196|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862380|NCT01597245|12351197|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862381|NCT01597245|12351198|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862382|NCT01597245|12351199|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862383|NCT01597245|12351200|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862384|NCT01597245|12351201|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862385|NCT01597245|12351202|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862386|NCT01597245|12351203|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862387|NCT01597245|12351204|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2
7862388|NCT01597245|12351205|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862389|NCT01597245|12351206|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7828298|NCT01308567|12300452|FG000|Overall Study|Lost to Follow-up|2
7828299|NCT01308567|12300453|FG001|Overall Study|Lost to Follow-up|4
7828300|NCT01308567|12300454|FG002|Overall Study|Lost to Follow-up|4
7828301|NCT01308580|12300464|FG000|Overall Study|Lost to Follow-up|12
7828302|NCT01308580|12300465|FG001|Overall Study|Lost to Follow-up|7
7828303|NCT01308736|12300474|FG000|Overall Study|Did not attend a single session|6
7828304|NCT01308736|12300475|FG001|Overall Study|Did not attend a single session|5
7828305|NCT01308749|12300483|FG000|Period 1: Double Blind Treatment|Adverse Event|1
7828306|NCT01308749|12300484|FG001|Period 1: Double Blind Treatment|Adverse Event|0
7828307|NCT01308749|12300483|FG000|Period 2: Open Label Treatment|Adverse Event|0
7828308|NCT01308749|12300484|FG001|Period 2: Open Label Treatment|Adverse Event|1
7828309|NCT01308749|12300483|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0
7828310|NCT01308749|12300484|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1
7828311|NCT01308762|12300507|FG000|Overall Study|Protocol Violation|0
7828312|NCT01308762|12300508|FG001|Overall Study|Protocol Violation|1
7828313|NCT01308762|12300509|FG002|Overall Study|Protocol Violation|0
7828314|NCT01308788|12300522|FG000|2-year Treatment|medication change by treating physician|4
7828315|NCT01308788|12300523|FG001|2-year Treatment|medication change by treating physician|11
7828316|NCT01309100|12300546|FG000|Overall Study|Protocol Violation|1
7828317|NCT01309100|12300546|FG000|Overall Study|Positive Slit lamp finding|1
7828318|NCT01309165|12300555|FG000|Overall Study|Lost to Follow-up|4
7828319|NCT01309165|12300556|FG001|Overall Study|Lost to Follow-up|3
7828320|NCT01309165|12300555|FG000|Overall Study|Return to work|1
7828321|NCT01309165|12300556|FG001|Overall Study|Return to work|2
7828322|NCT01309165|12300555|FG000|Overall Study|Left country|0
7828323|NCT01309165|12300556|FG001|Overall Study|Left country|1
7828324|NCT01309165|12300555|FG000|Overall Study|No transportation|0
7828325|NCT01309165|12300556|FG001|Overall Study|No transportation|1
7828326|NCT01309165|12300555|FG000|Overall Study|Admitted to hospital for second stroke|1
7828327|NCT01309165|12300556|FG001|Overall Study|Admitted to hospital for second stroke|0
7828328|NCT01309204|12300565|FG000|Overall Study|Adverse Event|48
7828329|NCT01309204|12300566|FG001|Overall Study|Adverse Event|58
7828330|NCT01309204|12300565|FG000|Overall Study|Lost to Follow-up|2
7828331|NCT01309204|12300566|FG001|Overall Study|Lost to Follow-up|2
7828332|NCT01309204|12300565|FG000|Overall Study|Subject's decision unrelated to an AE|9
7828333|NCT01309204|12300566|FG001|Overall Study|Subject's decision unrelated to an AE|10
7828334|NCT01309204|12300565|FG000|Overall Study|Inadequate control of IOP|4
7828335|NCT01309204|12300566|FG001|Overall Study|Inadequate control of IOP|4
7828336|NCT01309204|12300565|FG000|Overall Study|Other|4
7828337|NCT01309204|12300566|FG001|Overall Study|Other|1
7828338|NCT01309243|12300574|FG000|Randomized Phase Through Week 96|Randomized but not treated|6
7828339|NCT01309243|12300575|FG001|Randomized Phase Through Week 96|Randomized but not treated|7
7828340|NCT01309243|12300574|FG000|Randomized Phase Through Week 96|Adverse Event|12
7828341|NCT01309243|12300575|FG001|Randomized Phase Through Week 96|Adverse Event|43
7828342|NCT01309243|12300574|FG000|Randomized Phase Through Week 96|Death|0
7828343|NCT01309243|12300575|FG001|Randomized Phase Through Week 96|Death|1
7828344|NCT01309243|12300574|FG000|Randomized Phase Through Week 96|Pregnancy|2
7828345|NCT01309243|12300575|FG001|Randomized Phase Through Week 96|Pregnancy|0
7828346|NCT01309243|12300574|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16
7828347|NCT01309243|12300575|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4
7828348|NCT01309243|12300574|FG000|Randomized Phase Through Week 96|Investigators Discretion|3
7828349|NCT01309243|12300575|FG001|Randomized Phase Through Week 96|Investigators Discretion|6
7828350|NCT01309243|12300574|FG000|Randomized Phase Through Week 96|Withdrew Consent|12
7828351|NCT01309243|12300575|FG001|Randomized Phase Through Week 96|Withdrew Consent|18
7828352|NCT01309243|12300574|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23
7828353|NCT01309243|12300575|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22
7828354|NCT01309243|12300574|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9
7828355|NCT01309243|12300575|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7
7828356|NCT01309243|12300574|FG000|Randomized Phase Through Week 96|Protocol Violation|1
7828357|NCT01309243|12300575|FG001|Randomized Phase Through Week 96|Protocol Violation|1
7828358|NCT01309243|12300574|FG000|Extension Phase|Lost to Follow-up|6
7828359|NCT01309243|12300575|FG001|Extension Phase|Lost to Follow-up|0
7828360|NCT01309269|12300581|FG000|Overall Study|Adverse Event|56
7828361|NCT01309269|12300581|FG000|Overall Study|Withdrawal by Subject|25
7828362|NCT01309269|12300581|FG000|Overall Study|Lack of Acceptance|15
7828363|NCT01309269|12300581|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119
7828364|NCT01309269|12300581|FG000|Overall Study|Kidney Transplant|25
7828365|NCT01309269|12300581|FG000|Overall Study|Administrative Problems|141
7828366|NCT01309269|12300581|FG000|Overall Study|Other|256
7828367|NCT01309269|12300581|FG000|Overall Study|Other|1
7828368|NCT01309269|12300581|FG000|Overall Study|Study Completion Data Not Recorded|95
7828369|NCT01309269|12300581|FG000|Overall Study|Enrolled but not Treated|107
7828370|NCT01309282|12300585|FG000|Overall Study|Lost to Follow-up|1
7828371|NCT01309308|12300591|FG000|Overall Study|Lost to Follow-up|6
7828372|NCT01309308|12300592|FG001|Overall Study|Lost to Follow-up|4
7828373|NCT01309386|12300613|FG000|Overall Study|Other|2
7828374|NCT01309386|12300614|FG001|Overall Study|Other|0
7828375|NCT01309386|12300613|FG000|Overall Study|Withdrawal by Subject|2
7828376|NCT01309386|12300614|FG001|Overall Study|Withdrawal by Subject|0
7828377|NCT01309386|12300613|FG000|Overall Study|Progressive disease|9
7828378|NCT01309386|12300614|FG001|Overall Study|Progressive disease|11
7828379|NCT01309386|12300613|FG000|Overall Study|Physician Decision|1
7828380|NCT01309386|12300614|FG001|Overall Study|Physician Decision|1
7828381|NCT01309386|12300613|FG000|Overall Study|Lack of Efficacy|3
7828382|NCT01309386|12300614|FG001|Overall Study|Lack of Efficacy|1
7828383|NCT01309386|12300613|FG000|Overall Study|Adverse Event|5
7828384|NCT01309386|12300614|FG001|Overall Study|Adverse Event|8
7828385|NCT01309659|12300642|FG000|Overall Study|Protocol Violation|0
7828386|NCT01309659|12300643|FG001|Overall Study|Protocol Violation|1
7828387|NCT01309737|12300652|FG000|Week 0 to 16|Death|1
7828388|NCT01309737|12300653|FG001|Week 0 to 16|Death|0
7828389|NCT01309737|12300654|FG002|Week 0 to 16|Death|1
7828390|NCT01309737|12300655|FG003|Week 0 to 16|Death|0
7828391|NCT01309737|12300656|FG004|Week 0 to 16|Death|0
7828392|NCT01309737|12300652|FG000|Week 0 to 16|Adverse Event|11
7828393|NCT01309737|12300653|FG001|Week 0 to 16|Adverse Event|10
7828394|NCT01309737|12300654|FG002|Week 0 to 16|Adverse Event|5
7828395|NCT01309737|12300655|FG003|Week 0 to 16|Adverse Event|0
7828396|NCT01309737|12300656|FG004|Week 0 to 16|Adverse Event|0
7828397|NCT01309737|12300652|FG000|Week 0 to 16|Lack of Efficacy|15
7828398|NCT01309737|12300653|FG001|Week 0 to 16|Lack of Efficacy|2
7828399|NCT01309737|12300654|FG002|Week 0 to 16|Lack of Efficacy|24
7828400|NCT01309737|12300655|FG003|Week 0 to 16|Lack of Efficacy|0
7828401|NCT01309737|12300656|FG004|Week 0 to 16|Lack of Efficacy|0
7828402|NCT01309737|12300652|FG000|Week 0 to 16|Lost to Follow-up|7
7828403|NCT01309737|12300653|FG001|Week 0 to 16|Lost to Follow-up|8
7828404|NCT01309737|12300654|FG002|Week 0 to 16|Lost to Follow-up|3
7828405|NCT01309737|12300655|FG003|Week 0 to 16|Lost to Follow-up|0
7828406|NCT01309737|12300656|FG004|Week 0 to 16|Lost to Follow-up|0
7828407|NCT01309737|12300652|FG000|Week 0 to 16|Withdrawal by Subject|7
7828408|NCT01309737|12300653|FG001|Week 0 to 16|Withdrawal by Subject|6
7828409|NCT01309737|12300654|FG002|Week 0 to 16|Withdrawal by Subject|7
7828410|NCT01309737|12300655|FG003|Week 0 to 16|Withdrawal by Subject|0
7828411|NCT01309737|12300656|FG004|Week 0 to 16|Withdrawal by Subject|0
7828412|NCT01309737|12300652|FG000|Week 0 to 16|Other|10
7828413|NCT01309737|12300653|FG001|Week 0 to 16|Other|14
7828414|NCT01309737|12300654|FG002|Week 0 to 16|Other|4
7828415|NCT01309737|12300655|FG003|Week 0 to 16|Other|0
7828416|NCT01309737|12300656|FG004|Week 0 to 16|Other|0
7828417|NCT01309737|12300652|FG000|Week 0 to 16|Randomized, but not treated|1
7828418|NCT01309737|12300653|FG001|Week 0 to 16|Randomized, but not treated|0
7828419|NCT01309737|12300654|FG002|Week 0 to 16|Randomized, but not treated|0
7828420|NCT01309737|12300655|FG003|Week 0 to 16|Randomized, but not treated|0
7828421|NCT01309737|12300656|FG004|Week 0 to 16|Randomized, but not treated|0
7828422|NCT01309737|12300652|FG000|Week 16 to 52|Death|0
7828423|NCT01309737|12300653|FG001|Week 16 to 52|Death|0
7828424|NCT01309737|12300654|FG002|Week 16 to 52|Death|0
7828425|NCT01309737|12300655|FG003|Week 16 to 52|Death|0
7828426|NCT01309737|12300656|FG004|Week 16 to 52|Death|1
7828427|NCT01309737|12300652|FG000|Week 16 to 52|Adverse Event|7
7828428|NCT01309737|12300653|FG001|Week 16 to 52|Adverse Event|7
7828429|NCT01309737|12300654|FG002|Week 16 to 52|Adverse Event|0
7828430|NCT01309737|12300655|FG003|Week 16 to 52|Adverse Event|6
7828431|NCT01309737|12300656|FG004|Week 16 to 52|Adverse Event|5
7828432|NCT01309737|12300652|FG000|Week 16 to 52|Lack of Efficacy|107
7828433|NCT01309737|12300653|FG001|Week 16 to 52|Lack of Efficacy|76
7828434|NCT01309737|12300654|FG002|Week 16 to 52|Lack of Efficacy|0
7828435|NCT01309737|12300655|FG003|Week 16 to 52|Lack of Efficacy|25
7828436|NCT01309737|12300656|FG004|Week 16 to 52|Lack of Efficacy|21
7828437|NCT01309737|12300652|FG000|Week 16 to 52|Lost to Follow-up|4
7828438|NCT01309737|12300653|FG001|Week 16 to 52|Lost to Follow-up|2
7828439|NCT01309737|12300654|FG002|Week 16 to 52|Lost to Follow-up|0
7828440|NCT01309737|12300655|FG003|Week 16 to 52|Lost to Follow-up|1
7828441|NCT01309737|12300656|FG004|Week 16 to 52|Lost to Follow-up|4
7828442|NCT01309737|12300652|FG000|Week 16 to 52|Withdrawal by Subject|5
7828443|NCT01309737|12300653|FG001|Week 16 to 52|Withdrawal by Subject|6
7828444|NCT01309737|12300654|FG002|Week 16 to 52|Withdrawal by Subject|0
7828445|NCT01309737|12300655|FG003|Week 16 to 52|Withdrawal by Subject|0
7828446|NCT01309737|12300656|FG004|Week 16 to 52|Withdrawal by Subject|2
7828447|NCT01309737|12300652|FG000|Week 16 to 52|Other|10
7828448|NCT01309737|12300653|FG001|Week 16 to 52|Other|12
7828449|NCT01309737|12300654|FG002|Week 16 to 52|Other|0
7828450|NCT01309737|12300655|FG003|Week 16 to 52|Other|2
7828451|NCT01309737|12300656|FG004|Week 16 to 52|Other|0
7828452|NCT01309828|12300690|FG000|Overall Study|Adverse Event|10
7828453|NCT01309828|12300691|FG001|Overall Study|Adverse Event|11
7828454|NCT01309828|12300690|FG000|Overall Study|Voluntary Withdrawal|5
7828455|NCT01309828|12300691|FG001|Overall Study|Voluntary Withdrawal|4
7828456|NCT01309828|12300690|FG000|Overall Study|Major Protocol Deviation|0
7828457|NCT01309828|12300691|FG001|Overall Study|Major Protocol Deviation|1
7828458|NCT01309828|12300690|FG000|Overall Study|Other|1
7828459|NCT01309828|12300691|FG001|Overall Study|Other|0
7828460|NCT01309841|12300700|FG000|Overall Study|Other|0
7828461|NCT01309841|12300701|FG001|Overall Study|Other|1
7828462|NCT01309841|12300702|FG002|Overall Study|Other|1
7828463|NCT01309841|12300700|FG000|Overall Study|Lost to Follow-up|7
7828464|NCT01309841|12300701|FG001|Overall Study|Lost to Follow-up|6
7828465|NCT01309841|12300702|FG002|Overall Study|Lost to Follow-up|4
7828466|NCT01309841|12300700|FG000|Overall Study|Study-Specific Withdrawal Criteria|3
7828467|NCT01309841|12300701|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
7828468|NCT01309841|12300702|FG002|Overall Study|Study-Specific Withdrawal Criteria|2
7828469|NCT01309841|12300700|FG000|Overall Study|Lack of Efficacy|0
7828470|NCT01309841|12300701|FG001|Overall Study|Lack of Efficacy|0
7828471|NCT01309841|12300702|FG002|Overall Study|Lack of Efficacy|2
7828472|NCT01309841|12300700|FG000|Overall Study|Adverse Event|9
7828473|NCT01309841|12300701|FG001|Overall Study|Adverse Event|22
7828474|NCT01309841|12300702|FG002|Overall Study|Adverse Event|11
7828475|NCT01309841|12300700|FG000|Overall Study|Death|1
7828476|NCT01309841|12300701|FG001|Overall Study|Death|0
7828477|NCT01309841|12300702|FG002|Overall Study|Death|0
7828478|NCT01309841|12300700|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
7828479|NCT01309841|12300701|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
7828480|NCT01309841|12300702|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1
7828481|NCT01309841|12300700|FG000|Overall Study|Withdrawal by Subject|17
7828482|NCT01309841|12300701|FG001|Overall Study|Withdrawal by Subject|6
7828483|NCT01309841|12300702|FG002|Overall Study|Withdrawal by Subject|13
7828484|NCT01309841|12300700|FG000|Overall Study|Did Not Receive Treatment|2
7828485|NCT01309841|12300701|FG001|Overall Study|Did Not Receive Treatment|0
7828486|NCT01309841|12300702|FG002|Overall Study|Did Not Receive Treatment|1
7828487|NCT01309841|12300700|FG000|Overall Study|Severe non-compliance with protocol|0
7828488|NCT01309841|12300701|FG001|Overall Study|Severe non-compliance with protocol|5
7828489|NCT01309841|12300702|FG002|Overall Study|Severe non-compliance with protocol|2
7828490|NCT01309893|12300724|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1
7828491|NCT01309893|12300725|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0
7828492|NCT01309893|12300724|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0
7828493|NCT01309893|12300725|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1
7828494|NCT01309919|12300740|FG000|Overall Study|Did not receive a postpartum IUD|17
7828495|NCT01309919|12300741|FG001|Overall Study|Did not receive a postpartum IUD|48
7828496|NCT01309997|12300749|FG000|Overall Study|Adverse Event|1
7828497|NCT01309997|12300750|FG001|Overall Study|Adverse Event|0
7828498|NCT01309997|12300749|FG000|Overall Study|Death|1
7828499|NCT01309997|12300750|FG001|Overall Study|Death|3
7828500|NCT01309997|12300749|FG000|Overall Study|Lack of Efficacy|2
7828501|NCT01309997|12300750|FG001|Overall Study|Lack of Efficacy|2
7828502|NCT01309997|12300749|FG000|Overall Study|Withdrawal by Subject|1
7828503|NCT01309997|12300750|FG001|Overall Study|Withdrawal by Subject|1
7828504|NCT01310036|12300767|FG000|Overall Study|Administrative/other|10
7828505|NCT01310036|12300767|FG000|Overall Study|Withdrew Consent|11
7828506|NCT01310036|12300767|FG000|Overall Study|Refused Treatment/Did not Cooperate|4
7828507|NCT01310036|12300767|FG000|Overall Study|Progression of Disease|164
7828508|NCT01310036|12300767|FG000|Overall Study|Death|1
7828509|NCT01310036|12300767|FG000|Overall Study|Adverse event or intercurrent illness|12
7828510|NCT01310075|12300773|FG000|Overall Study|Lost to Follow-up|1
7828511|NCT01310075|12300774|FG001|Overall Study|Lost to Follow-up|0
7828512|NCT01310075|12300773|FG000|Overall Study|Physician Decision|10
7828513|NCT01310075|12300774|FG001|Overall Study|Physician Decision|7
7828514|NCT01310075|12300773|FG000|Overall Study|Protocol Violation|2
7828515|NCT01310075|12300774|FG001|Overall Study|Protocol Violation|2
7828516|NCT01310075|12300773|FG000|Overall Study|Withdrawal by Subject|1
7828517|NCT01310075|12300774|FG001|Overall Study|Withdrawal by Subject|1
7828518|NCT01310127|12300782|FG000|Overall Study|Protocol Violation|1
7828519|NCT01310127|12300783|FG001|Overall Study|Protocol Violation|1
7828520|NCT01310127|12300782|FG000|Overall Study|advanced psc cataract outlier|1
7828521|NCT01310127|12300783|FG001|Overall Study|advanced psc cataract outlier|0
7828522|NCT01310413|12300824|FG000|Day 0 to Day 385|Withdrawal by Subject|5
7828523|NCT01310413|12300825|FG001|Day 0 to Day 385|Withdrawal by Subject|2
7828524|NCT01310413|12300826|FG002|Day 0 to Day 385|Withdrawal by Subject|0
7828525|NCT01310413|12300827|FG003|Day 0 to Day 385|Withdrawal by Subject|2
7828526|NCT01310413|12300828|FG004|Day 0 to Day 385|Withdrawal by Subject|1
7828527|NCT01310413|12300829|FG005|Day 0 to Day 385|Withdrawal by Subject|1
7828528|NCT01310413|12300830|FG006|Day 0 to Day 385|Withdrawal by Subject|0
7828529|NCT01310413|12300824|FG000|Day 0 to Day 385|Lost to Follow-up|18
7828530|NCT01310413|12300825|FG001|Day 0 to Day 385|Lost to Follow-up|3
7828531|NCT01310413|12300826|FG002|Day 0 to Day 385|Lost to Follow-up|3
7828532|NCT01310413|12300827|FG003|Day 0 to Day 385|Lost to Follow-up|5
7828533|NCT01310413|12300828|FG004|Day 0 to Day 385|Lost to Follow-up|1
7828534|NCT01310413|12300829|FG005|Day 0 to Day 385|Lost to Follow-up|2
7828535|NCT01310413|12300830|FG006|Day 0 to Day 385|Lost to Follow-up|0
7828536|NCT01310413|12300824|FG000|Day 0 to Day 385|Migrated/moved from study area|3
7828537|NCT01310413|12300825|FG001|Day 0 to Day 385|Migrated/moved from study area|3
7828538|NCT01310413|12300826|FG002|Day 0 to Day 385|Migrated/moved from study area|1
7828539|NCT01310413|12300827|FG003|Day 0 to Day 385|Migrated/moved from study area|1
7828540|NCT01310413|12300828|FG004|Day 0 to Day 385|Migrated/moved from study area|1
7828541|NCT01310413|12300829|FG005|Day 0 to Day 385|Migrated/moved from study area|0
7828542|NCT01310413|12300830|FG006|Day 0 to Day 385|Migrated/moved from study area|0
7828543|NCT01310413|12300824|FG000|Day 0 to Day 385|Other|1
7828544|NCT01310413|12300825|FG001|Day 0 to Day 385|Other|0
7828545|NCT01310413|12300826|FG002|Day 0 to Day 385|Other|3
7828546|NCT01310413|12300827|FG003|Day 0 to Day 385|Other|0
7828547|NCT01310413|12300828|FG004|Day 0 to Day 385|Other|0
7828548|NCT01310413|12300829|FG005|Day 0 to Day 385|Other|0
7828549|NCT01310413|12300830|FG006|Day 0 to Day 385|Other|0
7828550|NCT01310413|12300824|FG000|From Day U0 to Day U385|Withdrawal by Subject|0
7828551|NCT01310413|12300825|FG001|From Day U0 to Day U385|Withdrawal by Subject|0
7828552|NCT01310413|12300826|FG002|From Day U0 to Day U385|Withdrawal by Subject|0
7828553|NCT01310413|12300827|FG003|From Day U0 to Day U385|Withdrawal by Subject|0
7828554|NCT01310413|12300828|FG004|From Day U0 to Day U385|Withdrawal by Subject|0
7828555|NCT01310413|12300829|FG005|From Day U0 to Day U385|Withdrawal by Subject|0
7828556|NCT01310413|12300830|FG006|From Day U0 to Day U385|Withdrawal by Subject|1
7828557|NCT01310413|12300824|FG000|From Day U0 to Day U385|Lost to Follow-up|0
7828558|NCT01310413|12300825|FG001|From Day U0 to Day U385|Lost to Follow-up|0
7828559|NCT01310413|12300826|FG002|From Day U0 to Day U385|Lost to Follow-up|0
7828560|NCT01310413|12300827|FG003|From Day U0 to Day U385|Lost to Follow-up|0
7828561|NCT01310413|12300828|FG004|From Day U0 to Day U385|Lost to Follow-up|0
7828562|NCT01310413|12300829|FG005|From Day U0 to Day U385|Lost to Follow-up|0
7828563|NCT01310413|12300830|FG006|From Day U0 to Day U385|Lost to Follow-up|2
7828564|NCT01310699|12300870|FG000|Overall Study|Patients did not complete tandem.|4
7828565|NCT01310699|12300871|FG001|Overall Study|Patients did not complete tandem.|6
7828566|NCT01310777|12300882|FG000|Overall Study|Adverse Event|23
7828567|NCT01310777|12300883|FG001|Overall Study|Adverse Event|1
7828568|NCT01310777|12300884|FG002|Overall Study|Adverse Event|15
7828569|NCT01310777|12300882|FG000|Overall Study|Lost to Follow-up|0
7828570|NCT01310777|12300883|FG001|Overall Study|Lost to Follow-up|4
7828571|NCT01310777|12300884|FG002|Overall Study|Lost to Follow-up|1
7828572|NCT01310777|12300882|FG000|Overall Study|Patient's Decision Unrelated to AE|1
7828573|NCT01310777|12300883|FG001|Overall Study|Patient's Decision Unrelated to AE|1
7828574|NCT01310777|12300884|FG002|Overall Study|Patient's Decision Unrelated to AE|2
7828575|NCT01310777|12300882|FG000|Overall Study|Inadequate Control of IOP|5
7828576|NCT01310777|12300883|FG001|Overall Study|Inadequate Control of IOP|7
7828577|NCT01310777|12300884|FG002|Overall Study|Inadequate Control of IOP|10
7828578|NCT01310777|12300882|FG000|Overall Study|Other|4
7828579|NCT01310777|12300883|FG001|Overall Study|Other|1
7828580|NCT01310777|12300884|FG002|Overall Study|Other|2
7828581|NCT01310868|12300901|FG000|Overall Study|Do not have histologically confirmed GBM|13
7828582|NCT01311024|12300907|FG000|Overall Study|Protocol Violation|35
7828583|NCT01311024|12300908|FG001|Overall Study|Protocol Violation|22
7828584|NCT01311505|12300934|FG000|First Intervention Period|Protocol Violation|0
7828585|NCT01311505|12300935|FG001|First Intervention Period|Protocol Violation|1
7828586|NCT01311557|12300946|FG000|Overall Study|Serious adverse event|0
7828587|NCT01311557|12300947|FG001|Overall Study|Serious adverse event|1
7828588|NCT01311557|12300946|FG000|Overall Study|Protocol Violation|4
7828589|NCT01311557|12300947|FG001|Overall Study|Protocol Violation|2
7828590|NCT01311557|12300946|FG000|Overall Study|Lost to Follow-up|0
7828591|NCT01311557|12300947|FG001|Overall Study|Lost to Follow-up|1
7828592|NCT01311557|12300946|FG000|Overall Study|Withdrawal by Subject|1
7828593|NCT01311557|12300947|FG001|Overall Study|Withdrawal by Subject|2
7828594|NCT01311648|12300956|FG000|Main Study|Protocol Violation|0
7828595|NCT01311648|12300957|FG001|Main Study|Protocol Violation|1
7828596|NCT01311648|12300956|FG000|Main Study|Adverse Event|0
7828597|NCT01311648|12300957|FG001|Main Study|Adverse Event|1
7828598|NCT01311648|12300956|FG000|Main Study|Inhibitor management|0
7828599|NCT01311648|12300957|FG001|Main Study|Inhibitor management|17
7828600|NCT01311648|12300956|FG000|Main Study|Withdrawal by Subject|0
7828601|NCT01311648|12300957|FG001|Main Study|Withdrawal by Subject|2
7828602|NCT01311648|12300956|FG000|Extension Study|Physician Decision|0
7828603|NCT01311648|12300957|FG001|Extension Study|Physician Decision|1
7828604|NCT01311648|12300956|FG000|Extension Study|ITI therapy with marketed product|0
7828605|NCT01311648|12300957|FG001|Extension Study|ITI therapy with marketed product|1
7828606|NCT01311648|12300956|FG000|Extension Study|Incorrect visit planning|0
7828607|NCT01311648|12300957|FG001|Extension Study|Incorrect visit planning|1
7828608|NCT01311648|12300956|FG000|Extension Study|Family's decision|0
7828609|NCT01311648|12300957|FG001|Extension Study|Family's decision|1
7828610|NCT01311648|12300956|FG000|Extension Study|Failure of ITI therapy|0
7828611|NCT01311648|12300957|FG001|Extension Study|Failure of ITI therapy|3
7828612|NCT01311648|12300956|FG000|Extension Study|Long travel|0
7828613|NCT01311648|12300957|FG001|Extension Study|Long travel|1
7828614|NCT01311648|12300956|FG000|Extension Study|Diagnosed with von Willebrand disease|1
7828615|NCT01311648|12300957|FG001|Extension Study|Diagnosed with von Willebrand disease|0
7828616|NCT01311648|12300956|FG000|Extension Study|Withdrawal by Subject|0
7828617|NCT01311648|12300957|FG001|Extension Study|Withdrawal by Subject|1
7828618|NCT01311648|12300956|FG000|Extension Study|Inhibitor management|0
7828619|NCT01311648|12300957|FG001|Extension Study|Inhibitor management|2
7828620|NCT01311661|12300970|FG000|Overall Study|Adverse Event|2
7828621|NCT01311661|12300970|FG000|Overall Study|Protocol Violation|3
7828622|NCT01311661|12300970|FG000|Overall Study|Withdrawal by Subject|2
7828623|NCT01312129|12301024|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0
7828624|NCT01312129|12301025|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1
7828625|NCT01312467|12301079|FG000|Overall Study|Adverse Event|4
7828626|NCT01312467|12301079|FG000|Overall Study|Lost to Follow-up|1
7828627|NCT01312467|12301079|FG000|Overall Study|Withdrawal by Subject|2
7828628|NCT01312467|12301079|FG000|Overall Study|Deported to country of origin|1
7828629|NCT01312467|12301079|FG000|Overall Study|Another medical condition|1
7828630|NCT01312467|12301079|FG000|Overall Study|Ineligible|4
7828631|NCT01312779|12301111|FG000|Overall Study|Withdrawal by Subject|2
7828632|NCT01312779|12301111|FG000|Overall Study|Death|3
7828633|NCT01312779|12301111|FG000|Overall Study|Not Implanted with Device|27
7828634|NCT01312909|12301151|FG000|Overall Study|Randomized but not treated|1
7828635|NCT01312909|12301152|FG001|Overall Study|Randomized but not treated|3
7828636|NCT01312909|12301153|FG002|Overall Study|Randomized but not treated|1
7828637|NCT01312909|12301151|FG000|Overall Study|Adverse Event|1
7828638|NCT01312909|12301152|FG001|Overall Study|Adverse Event|0
7828639|NCT01312909|12301153|FG002|Overall Study|Adverse Event|3
7828640|NCT01312909|12301151|FG000|Overall Study|Protocol Violation|2
7828641|NCT01312909|12301152|FG001|Overall Study|Protocol Violation|0
7828642|NCT01312909|12301153|FG002|Overall Study|Protocol Violation|2
7828643|NCT01312909|12301151|FG000|Overall Study|Other|9
7828644|NCT01312909|12301152|FG001|Overall Study|Other|6
7828645|NCT01312909|12301153|FG002|Overall Study|Other|11
7828646|NCT01312909|12301151|FG000|Overall Study|Withdrawal by Subject|8
7828647|NCT01312909|12301152|FG001|Overall Study|Withdrawal by Subject|10
7828648|NCT01312909|12301153|FG002|Overall Study|Withdrawal by Subject|7
7828649|NCT01312909|12301151|FG000|Overall Study|Lost to Follow-up|21
7828650|NCT01312909|12301152|FG001|Overall Study|Lost to Follow-up|17
7828651|NCT01312909|12301153|FG002|Overall Study|Lost to Follow-up|20
7828652|NCT01312909|12301151|FG000|Overall Study|Insufficient clinical response|0
7828653|NCT01312909|12301152|FG001|Overall Study|Insufficient clinical response|0
7828654|NCT01312909|12301153|FG002|Overall Study|Insufficient clinical response|1
7828655|NCT01312909|12301151|FG000|Overall Study|Entrance criteria not met|0
7828656|NCT01312909|12301152|FG001|Overall Study|Entrance criteria not met|0
7828657|NCT01312909|12301153|FG002|Overall Study|Entrance criteria not met|2
7828658|NCT01312961|12301170|FG000|Overall Study|Adverse Event|3
7828659|NCT01312961|12301171|FG001|Overall Study|Adverse Event|3
7828660|NCT01312961|12301170|FG000|Overall Study|Lack of Efficacy|11
7828661|NCT01312961|12301171|FG001|Overall Study|Lack of Efficacy|1
7828662|NCT01312961|12301170|FG000|Overall Study|Poor compliance to protocol|1
7828663|NCT01312961|12301171|FG001|Overall Study|Poor compliance to protocol|0
7828664|NCT01312961|12301170|FG000|Overall Study|Other than specified above|2
7828665|NCT01312961|12301171|FG001|Overall Study|Other than specified above|3
7828666|NCT01313039|12301178|FG000|Overall Study|Physician Decision|1
7828667|NCT01313039|12301178|FG000|Overall Study|Adverse Event|1
7828668|NCT01313078|12301182|FG000|Overall Study|Death|1
7828669|NCT01313078|12301182|FG000|Overall Study|Discontinued study drug|1
7828670|NCT01313078|12301182|FG000|Overall Study|Withdrawal by Subject|1
7828671|NCT01313117|12301186|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
7828672|NCT01313117|12301186|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
7828673|NCT01313182|12301193|FG000|Overall Study|Protocol Violation|66
7828674|NCT01313182|12301194|FG001|Overall Study|Protocol Violation|92
7828675|NCT01313208|12301202|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
7828676|NCT01313208|12301203|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
7828677|NCT01313208|12301202|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
7828678|NCT01313208|12301203|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
7828679|NCT01313208|12301202|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
7828680|NCT01313208|12301203|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
7828681|NCT01313208|12301202|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
7828682|NCT01313208|12301203|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
7828683|NCT01313208|12301202|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
7828684|NCT01313208|12301203|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
7828685|NCT01313208|12301202|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
7828686|NCT01313208|12301203|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
7828687|NCT01313208|12301202|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
7828688|NCT01313208|12301203|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
7828689|NCT01313208|12301202|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
7828690|NCT01313208|12301203|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
7828691|NCT01313208|12301202|FG000|Open-label Phase (Weeks 13 - 24)|Other|2
7828692|NCT01313208|12301203|FG001|Open-label Phase (Weeks 13 - 24)|Other|0
7828693|NCT01313221|12301214|FG000|Overall Study|Protocol Violation|0
7828694|NCT01313221|12301215|FG001|Overall Study|Protocol Violation|1
7828695|NCT01313221|12301216|FG002|Overall Study|Protocol Violation|1
7828696|NCT01313221|12301214|FG000|Overall Study|Non-compliance|3
7828697|NCT01313221|12301215|FG001|Overall Study|Non-compliance|0
7828698|NCT01313221|12301216|FG002|Overall Study|Non-compliance|2
7828699|NCT01313221|12301214|FG000|Overall Study|Withdrawal by Subject|2
7828700|NCT01313221|12301215|FG001|Overall Study|Withdrawal by Subject|3
7828701|NCT01313221|12301216|FG002|Overall Study|Withdrawal by Subject|5
7828702|NCT01313221|12301214|FG000|Overall Study|Requirement for alternative therapy|0
7828703|NCT01313221|12301215|FG001|Overall Study|Requirement for alternative therapy|1
7828704|NCT01313221|12301216|FG002|Overall Study|Requirement for alternative therapy|1
7828705|NCT01313221|12301214|FG000|Overall Study|Lost to Follow-up|6
7828706|NCT01313221|12301215|FG001|Overall Study|Lost to Follow-up|3
7828707|NCT01313221|12301216|FG002|Overall Study|Lost to Follow-up|1
7828708|NCT01313221|12301214|FG000|Overall Study|Other|1
7828709|NCT01313221|12301215|FG001|Overall Study|Other|0
7828710|NCT01313221|12301216|FG002|Overall Study|Other|0
7828711|NCT01313221|12301214|FG000|Overall Study|Adverse Event|0
7828712|NCT01313221|12301215|FG001|Overall Study|Adverse Event|0
7828713|NCT01313221|12301216|FG002|Overall Study|Adverse Event|7
7828714|NCT01313221|12301214|FG000|Overall Study|Disease progression|0
7828715|NCT01313221|12301215|FG001|Overall Study|Disease progression|0
7828716|NCT01313221|12301216|FG002|Overall Study|Disease progression|2
7828717|NCT01313221|12301214|FG000|Overall Study|Physician Decision|0
7828718|NCT01313221|12301215|FG001|Overall Study|Physician Decision|0
7828719|NCT01313221|12301216|FG002|Overall Study|Physician Decision|2
7828720|NCT01313221|12301214|FG000|Overall Study|Pregnancy|0
7828721|NCT01313221|12301215|FG001|Overall Study|Pregnancy|0
7828722|NCT01313221|12301216|FG002|Overall Study|Pregnancy|2
7828723|NCT01313286|12301224|FG000|Period 1|Withdrawal by Subject|2
7828724|NCT01313286|12301225|FG001|Period 1|Withdrawal by Subject|0
7828725|NCT01313559|12301257|FG000|Overall Study|Withdrawal by Subject|1
7828726|NCT01313559|12301258|FG001|Overall Study|Withdrawal by Subject|2
7828727|NCT01313559|12301257|FG000|Overall Study|Disease progression|1
7828728|NCT01313559|12301258|FG001|Overall Study|Disease progression|0
7828729|NCT01313559|12301257|FG000|Overall Study|Rising PSA|2
7828730|NCT01313559|12301258|FG001|Overall Study|Rising PSA|0
7828731|NCT01313624|12301266|FG000|Double-Blind Phase|Adverse Event|27
7828732|NCT01313624|12301267|FG001|Double-Blind Phase|Adverse Event|4
7828733|NCT01313624|12301266|FG000|Double-Blind Phase|Withdrawal by Subject|9
7828734|NCT01313624|12301267|FG001|Double-Blind Phase|Withdrawal by Subject|4
7828735|NCT01313624|12301266|FG000|Double-Blind Phase|Lost to Follow-up|0
7828736|NCT01313624|12301267|FG001|Double-Blind Phase|Lost to Follow-up|2
7828737|NCT01313624|12301266|FG000|Double-Blind Phase|Physician Decision|1
7828738|NCT01313624|12301267|FG001|Double-Blind Phase|Physician Decision|0
7828739|NCT01313624|12301266|FG000|Double-Blind Phase|Lack of Efficacy|1
7828740|NCT01313624|12301267|FG001|Double-Blind Phase|Lack of Efficacy|0
7828741|NCT01313624|12301266|FG000|Open-Label Phase|Adverse Event|1
7828742|NCT01313624|12301267|FG001|Open-Label Phase|Adverse Event|10
7828743|NCT01313624|12301266|FG000|Open-Label Phase|Withdrawal by Subject|2
7828744|NCT01313624|12301267|FG001|Open-Label Phase|Withdrawal by Subject|2
7828745|NCT01313624|12301266|FG000|Open-Label Phase|Lost to Follow-up|1
7828746|NCT01313624|12301267|FG001|Open-Label Phase|Lost to Follow-up|1
7828747|NCT01313637|12301279|FG000|Overall Study|Adverse Event|17
7828748|NCT01313637|12301280|FG001|Overall Study|Adverse Event|24
7828749|NCT01313637|12301281|FG002|Overall Study|Adverse Event|25
7828750|NCT01313637|12301282|FG003|Overall Study|Adverse Event|18
7828751|NCT01313637|12301279|FG000|Overall Study|Lack of Efficacy|44
7828752|NCT01313637|12301280|FG001|Overall Study|Lack of Efficacy|38
7828753|NCT01313637|12301281|FG002|Overall Study|Lack of Efficacy|37
7828754|NCT01313637|12301282|FG003|Overall Study|Lack of Efficacy|24
7828755|NCT01313637|12301279|FG000|Overall Study|Protocol Violation|4
7828756|NCT01313637|12301280|FG001|Overall Study|Protocol Violation|3
7828757|NCT01313637|12301281|FG002|Overall Study|Protocol Violation|11
7828758|NCT01313637|12301282|FG003|Overall Study|Protocol Violation|5
7828759|NCT01313637|12301279|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16
7828760|NCT01313637|12301280|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15
7828761|NCT01313637|12301281|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14
7828762|NCT01313637|12301282|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13
7828763|NCT01313637|12301279|FG000|Overall Study|Lost to Follow-up|0
7828764|NCT01313637|12301280|FG001|Overall Study|Lost to Follow-up|2
7828765|NCT01313637|12301281|FG002|Overall Study|Lost to Follow-up|1
7828766|NCT01313637|12301282|FG003|Overall Study|Lost to Follow-up|3
7828767|NCT01313637|12301279|FG000|Overall Study|Withdrawal by Subject|11
7828768|NCT01313637|12301280|FG001|Overall Study|Withdrawal by Subject|13
7828769|NCT01313637|12301281|FG002|Overall Study|Withdrawal by Subject|18
7828770|NCT01313637|12301282|FG003|Overall Study|Withdrawal by Subject|15
7828771|NCT01313650|12301296|FG000|Overall Study|Adverse Event|9
7828772|NCT01313650|12301297|FG001|Overall Study|Adverse Event|34
7828773|NCT01313650|12301298|FG002|Overall Study|Adverse Event|24
7828774|NCT01313650|12301299|FG003|Overall Study|Adverse Event|23
7828775|NCT01313650|12301296|FG000|Overall Study|Lack of Efficacy|37
7828776|NCT01313650|12301297|FG001|Overall Study|Lack of Efficacy|20
7828777|NCT01313650|12301298|FG002|Overall Study|Lack of Efficacy|32
7828778|NCT01313650|12301299|FG003|Overall Study|Lack of Efficacy|20
7828779|NCT01313650|12301296|FG000|Overall Study|Lost to Follow-up|1
7828780|NCT01313650|12301297|FG001|Overall Study|Lost to Follow-up|0
7828781|NCT01313650|12301298|FG002|Overall Study|Lost to Follow-up|3
7828782|NCT01313650|12301299|FG003|Overall Study|Lost to Follow-up|2
7828783|NCT01313650|12301296|FG000|Overall Study|Withdrawal by Subject|16
7828784|NCT01313650|12301297|FG001|Overall Study|Withdrawal by Subject|20
7828785|NCT01313650|12301298|FG002|Overall Study|Withdrawal by Subject|15
7828786|NCT01313650|12301299|FG003|Overall Study|Withdrawal by Subject|15
7720071|NCT00536471|12144331|FG001|Overall Study|Physician Decision|1
7720072|NCT00536471|12144332|FG002|Overall Study|Physician Decision|3
7720073|NCT00536471|12144333|FG003|Overall Study|Physician Decision|2
7720074|NCT00536471|12144330|FG000|Overall Study|Death|0
7828787|NCT01313650|12301296|FG000|Overall Study|Protocol Violation|4
7720075|NCT00536471|12144331|FG001|Overall Study|Death|0
7720076|NCT00536471|12144332|FG002|Overall Study|Death|1
7828788|NCT01313650|12301297|FG001|Overall Study|Protocol Violation|7
7828789|NCT01313650|12301298|FG002|Overall Study|Protocol Violation|5
7828790|NCT01313650|12301299|FG003|Overall Study|Protocol Violation|6
7828791|NCT01313650|12301296|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9
7828792|NCT01313650|12301297|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13
7828793|NCT01313650|12301298|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24
7828794|NCT01313650|12301299|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15
7828795|NCT01313663|12301311|FG000|Overall Study|Study Closed/Terminated|2
7828796|NCT01313663|12301312|FG001|Overall Study|Study Closed/Terminated|4
7828797|NCT01313663|12301311|FG000|Overall Study|Lost to Follow-up|0
7828798|NCT01313663|12301312|FG001|Overall Study|Lost to Follow-up|1
7828799|NCT01313663|12301311|FG000|Overall Study|Physician Decision|0
7828800|NCT01313663|12301312|FG001|Overall Study|Physician Decision|2
7828801|NCT01313663|12301311|FG000|Overall Study|Withdrawal by Subject|2
7828802|NCT01313663|12301312|FG001|Overall Study|Withdrawal by Subject|1
7828803|NCT01313676|12301322|FG000|Overall Study|Adverse Event|395
7828804|NCT01313676|12301323|FG001|Overall Study|Adverse Event|365
7828805|NCT01313676|12301324|FG002|Overall Study|Adverse Event|372
7828806|NCT01313676|12301325|FG003|Overall Study|Adverse Event|333
7828807|NCT01313676|12301322|FG000|Overall Study|Lack of Efficacy|98
7828808|NCT01313676|12301323|FG001|Overall Study|Lack of Efficacy|90
7828809|NCT01313676|12301324|FG002|Overall Study|Lack of Efficacy|65
7828810|NCT01313676|12301325|FG003|Overall Study|Lack of Efficacy|46
7828811|NCT01313676|12301322|FG000|Overall Study|Protocol Violation|37
7828812|NCT01313676|12301323|FG001|Overall Study|Protocol Violation|44
7828813|NCT01313676|12301324|FG002|Overall Study|Protocol Violation|46
7828814|NCT01313676|12301325|FG003|Overall Study|Protocol Violation|44
7828815|NCT01313676|12301322|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3
7828816|NCT01313676|12301323|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4
7828817|NCT01313676|12301324|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2
7828818|NCT01313676|12301325|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11
7828819|NCT01313676|12301322|FG000|Overall Study|Study Closed/terminated|7
7828820|NCT01313676|12301323|FG001|Overall Study|Study Closed/terminated|6
7828821|NCT01313676|12301324|FG002|Overall Study|Study Closed/terminated|9
7828822|NCT01313676|12301325|FG003|Overall Study|Study Closed/terminated|9
7828823|NCT01313676|12301322|FG000|Overall Study|Lost to Follow-up|0
7828824|NCT01313676|12301323|FG001|Overall Study|Lost to Follow-up|0
7828825|NCT01313676|12301324|FG002|Overall Study|Lost to Follow-up|1
7828826|NCT01313676|12301325|FG003|Overall Study|Lost to Follow-up|0
7828827|NCT01313676|12301322|FG000|Overall Study|Physician Decision|53
7828828|NCT01313676|12301323|FG001|Overall Study|Physician Decision|64
7828829|NCT01313676|12301324|FG002|Overall Study|Physician Decision|62
7828830|NCT01313676|12301325|FG003|Overall Study|Physician Decision|48
7828831|NCT01313676|12301322|FG000|Overall Study|Decision by Participant or Proxy|643
7828832|NCT01313676|12301323|FG001|Overall Study|Decision by Participant or Proxy|527
7828833|NCT01313676|12301324|FG002|Overall Study|Decision by Participant or Proxy|515
7828834|NCT01313676|12301325|FG003|Overall Study|Decision by Participant or Proxy|492
7828835|NCT01313676|12301322|FG000|Overall Study|Sponsor Terminated Study Treatment|1
7828836|NCT01313676|12301323|FG001|Overall Study|Sponsor Terminated Study Treatment|1
7948452|NCT02528357|12493666|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7948453|NCT02528357|12493667|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7948454|NCT02528357|12493668|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2
7948455|NCT02528357|12493669|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7948456|NCT02528357|12493670|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3
7948457|NCT02528357|12493671|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7948458|NCT02528357|12493672|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2
7948459|NCT02528357|12493673|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1
7948460|NCT02528357|12493674|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7948461|NCT02528357|12493675|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7948462|NCT02528357|12493676|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7948463|NCT02528357|12493677|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7948464|NCT02528357|12493678|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7948465|NCT02528357|12493679|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7948466|NCT02528357|12493680|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7948467|NCT02528357|12493681|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7948468|NCT02528357|12493682|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7948469|NCT02528357|12493683|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7948470|NCT02528357|12493684|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7948471|NCT02528357|12493666|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948472|NCT02528357|12493667|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948473|NCT02528357|12493668|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948474|NCT02528357|12493669|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948475|NCT02528357|12493670|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1
7948476|NCT02528357|12493671|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948477|NCT02528357|12493672|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948478|NCT02528357|12493673|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948479|NCT02528357|12493674|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948480|NCT02528357|12493675|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948481|NCT02528357|12493676|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948482|NCT02528357|12493677|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948483|NCT02528357|12493678|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948484|NCT02528357|12493679|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948485|NCT02528357|12493680|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948486|NCT02528357|12493681|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948487|NCT02528357|12493682|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948488|NCT02528357|12493683|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948489|NCT02528357|12493684|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948490|NCT02528357|12493666|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7948491|NCT02528357|12493667|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7948492|NCT02528357|12493668|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7948493|NCT02528357|12493669|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7948494|NCT02528357|12493670|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7948495|NCT02528357|12493671|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7948496|NCT02528357|12493672|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7948497|NCT02528357|12493673|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7948498|NCT02528357|12493674|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7948499|NCT02528357|12493675|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7948500|NCT02528357|12493676|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7948501|NCT02528357|12493677|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7948502|NCT02528357|12493678|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7948503|NCT02528357|12493679|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1
7948504|NCT02528357|12493680|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5
7948505|NCT02528357|12493681|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7948506|NCT02528357|12493682|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7828837|NCT01313676|12301324|FG002|Overall Study|Sponsor Terminated Study Treatment|0
7828838|NCT01313676|12301325|FG003|Overall Study|Sponsor Terminated Study Treatment|1
7828839|NCT01313676|12301322|FG000|Overall Study|Investigator Site Closed|12
7828840|NCT01313676|12301323|FG001|Overall Study|Investigator Site Closed|11
7828841|NCT01313676|12301324|FG002|Overall Study|Investigator Site Closed|15
7828842|NCT01313676|12301325|FG003|Overall Study|Investigator Site Closed|10
7828843|NCT01313676|12301322|FG000|Overall Study|Missing|1
7828844|NCT01313676|12301323|FG001|Overall Study|Missing|1
7828845|NCT01313676|12301324|FG002|Overall Study|Missing|1
7828846|NCT01313676|12301325|FG003|Overall Study|Missing|0
7828847|NCT01313728|12301336|FG000|Informed Consent to Baseline|Withdrawal by Subject|1
7828848|NCT01313767|12301343|FG000|Overall Study|Adverse Event|1
7828849|NCT01313767|12301344|FG001|Overall Study|Adverse Event|0
7828850|NCT01313767|12301343|FG000|Overall Study|Lost to Follow-up|1
7828851|NCT01313767|12301344|FG001|Overall Study|Lost to Follow-up|0
7828852|NCT01313767|12301343|FG000|Overall Study|Withdrawal by Subject|2
7828853|NCT01313767|12301344|FG001|Overall Study|Withdrawal by Subject|1
7828854|NCT01313767|12301343|FG000|Overall Study|Protocol Violation|3
7828855|NCT01313767|12301344|FG001|Overall Study|Protocol Violation|1
7828856|NCT01313780|12301352|FG000|Overall Study|Lack of Efficacy|4
7828857|NCT01313780|12301353|FG001|Overall Study|Lack of Efficacy|2
7828858|NCT01313780|12301352|FG000|Overall Study|Adverse Event|6
7828859|NCT01313780|12301353|FG001|Overall Study|Adverse Event|11
7828860|NCT01313780|12301352|FG000|Overall Study|Withdrawal by Subject|2
7828861|NCT01313780|12301353|FG001|Overall Study|Withdrawal by Subject|8
7828862|NCT01313780|12301352|FG000|Overall Study|Protocol Violation|10
7828863|NCT01313780|12301353|FG001|Overall Study|Protocol Violation|4
7828864|NCT01313780|12301352|FG000|Overall Study|missing data|3
7828865|NCT01313780|12301353|FG001|Overall Study|missing data|3
7828866|NCT01313858|12301362|FG000|Overall Study|Premature Treatment Termination|251
7828867|NCT01313858|12301363|FG001|Overall Study|Premature Treatment Termination|219
7828868|NCT01313858|12301364|FG002|Overall Study|Premature Treatment Termination|191
7828869|NCT01313858|12301362|FG000|Overall Study|Lost to Follow-up|35
7828870|NCT01313858|12301363|FG001|Overall Study|Lost to Follow-up|51
7828871|NCT01313858|12301364|FG002|Overall Study|Lost to Follow-up|47
7828872|NCT01313884|12301370|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
7828873|NCT01314105|12301425|FG000|Overall Study|Progressive Disease|6
7828874|NCT01314105|12301426|FG001|Overall Study|Progressive Disease|10
7828875|NCT01314105|12301425|FG000|Overall Study|Refused to continue taking medication|0
7828876|NCT01314105|12301426|FG001|Overall Study|Refused to continue taking medication|1
7828877|NCT01314105|12301425|FG000|Overall Study|Other Adverse Event|1
7828878|NCT01314105|12301426|FG001|Overall Study|Other Adverse Event|1
7828879|NCT01314261|12301438|FG000|Overall Study|Adverse Event|1
7828880|NCT01314261|12301439|FG001|Overall Study|Adverse Event|0
7828881|NCT01314261|12301440|FG002|Overall Study|Adverse Event|0
7828882|NCT01314261|12301441|FG003|Overall Study|Adverse Event|0
7828883|NCT01314261|12301438|FG000|Overall Study|Withdrawal by Subject|0
7828884|NCT01314261|12301439|FG001|Overall Study|Withdrawal by Subject|3
7828885|NCT01314261|12301440|FG002|Overall Study|Withdrawal by Subject|1
7828886|NCT01314261|12301441|FG003|Overall Study|Withdrawal by Subject|0
7828887|NCT01314261|12301438|FG000|Overall Study|Lost to Follow-up|1
7828888|NCT01314261|12301439|FG001|Overall Study|Lost to Follow-up|0
7828889|NCT01314261|12301440|FG002|Overall Study|Lost to Follow-up|2
7828890|NCT01314261|12301441|FG003|Overall Study|Lost to Follow-up|2
7828891|NCT01314261|12301438|FG000|Overall Study|Virologic Failure|0
7828892|NCT01314261|12301439|FG001|Overall Study|Virologic Failure|1
7828893|NCT01314261|12301440|FG002|Overall Study|Virologic Failure|0
7828894|NCT01314261|12301441|FG003|Overall Study|Virologic Failure|1
7828895|NCT01314443|12301459|FG000|Overall Study|Withdrawal by Subject|2
7828896|NCT01314443|12301460|FG001|Overall Study|Withdrawal by Subject|1
7828897|NCT01314443|12301461|FG002|Overall Study|Withdrawal by Subject|1
7828898|NCT01314443|12301462|FG003|Overall Study|Withdrawal by Subject|1
7828899|NCT01314443|12301459|FG000|Overall Study|Protocol Violation|2
7828900|NCT01314443|12301460|FG001|Overall Study|Protocol Violation|2
7828901|NCT01314443|12301461|FG002|Overall Study|Protocol Violation|1
7828902|NCT01314443|12301462|FG003|Overall Study|Protocol Violation|1
7862390|NCT01597245|12351207|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3
7862391|NCT01597245|12351208|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7862392|NCT01597245|12351188|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862393|NCT01597245|12351189|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862394|NCT01597245|12351190|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862395|NCT01597245|12351191|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862396|NCT01597245|12351192|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862397|NCT01597245|12351193|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862398|NCT01597245|12351194|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862399|NCT01597245|12351195|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862400|NCT01597245|12351196|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862401|NCT01597245|12351197|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862402|NCT01597245|12351198|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862403|NCT01597245|12351199|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862404|NCT01597245|12351200|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862405|NCT01597245|12351201|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862406|NCT01597245|12351202|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862407|NCT01597245|12351203|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862408|NCT01597245|12351204|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
7862409|NCT01597245|12351205|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862410|NCT01597245|12351206|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862411|NCT01597245|12351207|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
7862412|NCT01597245|12351208|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7862413|NCT01597245|12351188|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862414|NCT01597245|12351189|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862415|NCT01597245|12351190|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862416|NCT01597245|12351191|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862417|NCT01597245|12351192|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862418|NCT01597245|12351193|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862419|NCT01597245|12351194|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862420|NCT01597245|12351195|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862421|NCT01597245|12351196|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862422|NCT01597245|12351197|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862423|NCT01597245|12351198|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862424|NCT01597245|12351199|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862425|NCT01597245|12351200|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862426|NCT01597245|12351201|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862427|NCT01597245|12351202|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862428|NCT01597245|12351203|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862429|NCT01597245|12351204|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862430|NCT01597245|12351205|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862431|NCT01597245|12351206|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862432|NCT01597245|12351207|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1
7862433|NCT01597245|12351208|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7862434|NCT01597258|12351241|FG000|Overall Study|No Drug Administration|1
7828903|NCT01314703|12301472|FG000|Overall Study|screen failure and closed enrollment|8
7828904|NCT01314716|12301479|FG000|Double-Blind Phase|Randomized but not treated|1
7828905|NCT01314716|12301480|FG001|Double-Blind Phase|Randomized but not treated|1
7828906|NCT01314716|12301479|FG000|Double-Blind Phase|Adverse Event|10
7828907|NCT01314716|12301480|FG001|Double-Blind Phase|Adverse Event|4
7828908|NCT01314716|12301479|FG000|Double-Blind Phase|Withdrawal by Subject|5
7828909|NCT01314716|12301480|FG001|Double-Blind Phase|Withdrawal by Subject|6
7828910|NCT01314716|12301479|FG000|Double-Blind Phase|Lost to Follow-up|0
7828911|NCT01314716|12301480|FG001|Double-Blind Phase|Lost to Follow-up|1
7828912|NCT01314716|12301479|FG000|Double-Blind Phase|Sponsor request|1
7828913|NCT01314716|12301480|FG001|Double-Blind Phase|Sponsor request|2
7828914|NCT01314716|12301479|FG000|Double-Blind Phase|Physician Decision|0
7828915|NCT01314716|12301480|FG001|Double-Blind Phase|Physician Decision|1
7828916|NCT01314716|12301479|FG000|Open-Label Phase|Adverse Event|4
7828917|NCT01314716|12301480|FG001|Open-Label Phase|Adverse Event|6
7828918|NCT01314716|12301479|FG000|Open-Label Phase|Withdrawal by Subject|1
7828919|NCT01314716|12301480|FG001|Open-Label Phase|Withdrawal by Subject|2
7828920|NCT01314716|12301479|FG000|Open-Label Phase|Physician Decision|5
7828921|NCT01314716|12301480|FG001|Open-Label Phase|Physician Decision|4
7828922|NCT01314872|12301510|FG000|Treatment Period 1|Protocol Violation|2
7828923|NCT01314872|12301511|FG001|Treatment Period 1|Protocol Violation|1
7828924|NCT01314872|12301512|FG002|Treatment Period 1|Protocol Violation|1
7828925|NCT01314872|12301513|FG003|Treatment Period 1|Protocol Violation|0
7828926|NCT01314872|12301514|FG004|Treatment Period 1|Protocol Violation|1
7828927|NCT01314872|12301515|FG005|Treatment Period 1|Protocol Violation|0
7828928|NCT01314872|12301516|FG006|Treatment Period 1|Protocol Violation|0
7828929|NCT01314872|12301517|FG007|Treatment Period 1|Protocol Violation|0
7828930|NCT01314872|12301518|FG008|Treatment Period 1|Protocol Violation|0
7828931|NCT01314872|12301519|FG009|Treatment Period 1|Protocol Violation|1
7828932|NCT01314872|12301520|FG010|Treatment Period 1|Protocol Violation|1
7828933|NCT01314872|12301521|FG011|Treatment Period 1|Protocol Violation|0
7828934|NCT01314872|12301522|FG012|Treatment Period 1|Protocol Violation|0
7828935|NCT01314872|12301523|FG013|Treatment Period 1|Protocol Violation|0
7828936|NCT01314872|12301524|FG014|Treatment Period 1|Protocol Violation|0
7828937|NCT01314872|12301510|FG000|Treatment Period 1|Physician Decision|0
7828938|NCT01314872|12301511|FG001|Treatment Period 1|Physician Decision|1
7828939|NCT01314872|12301512|FG002|Treatment Period 1|Physician Decision|0
7828940|NCT01314872|12301513|FG003|Treatment Period 1|Physician Decision|1
7828941|NCT01314872|12301514|FG004|Treatment Period 1|Physician Decision|0
7828942|NCT01314872|12301515|FG005|Treatment Period 1|Physician Decision|0
7828943|NCT01314872|12301516|FG006|Treatment Period 1|Physician Decision|0
7828944|NCT01314872|12301517|FG007|Treatment Period 1|Physician Decision|0
7828945|NCT01314872|12301518|FG008|Treatment Period 1|Physician Decision|0
7828946|NCT01314872|12301519|FG009|Treatment Period 1|Physician Decision|1
7828947|NCT01314872|12301520|FG010|Treatment Period 1|Physician Decision|0
7828948|NCT01314872|12301521|FG011|Treatment Period 1|Physician Decision|0
7828949|NCT01314872|12301522|FG012|Treatment Period 1|Physician Decision|0
7828950|NCT01314872|12301523|FG013|Treatment Period 1|Physician Decision|0
7828951|NCT01314872|12301524|FG014|Treatment Period 1|Physician Decision|0
7828952|NCT01314872|12301510|FG000|Treatment Period 1|Lack of Efficacy|1
7828953|NCT01314872|12301511|FG001|Treatment Period 1|Lack of Efficacy|0
7828954|NCT01314872|12301512|FG002|Treatment Period 1|Lack of Efficacy|0
7828955|NCT01314872|12301513|FG003|Treatment Period 1|Lack of Efficacy|0
7828956|NCT01314872|12301514|FG004|Treatment Period 1|Lack of Efficacy|0
7828957|NCT01314872|12301515|FG005|Treatment Period 1|Lack of Efficacy|1
7828958|NCT01314872|12301516|FG006|Treatment Period 1|Lack of Efficacy|0
7828959|NCT01314872|12301517|FG007|Treatment Period 1|Lack of Efficacy|2
7828960|NCT01314872|12301518|FG008|Treatment Period 1|Lack of Efficacy|0
7828961|NCT01314872|12301519|FG009|Treatment Period 1|Lack of Efficacy|0
7828962|NCT01314872|12301520|FG010|Treatment Period 1|Lack of Efficacy|0
7828963|NCT01314872|12301521|FG011|Treatment Period 1|Lack of Efficacy|0
7828964|NCT01314872|12301522|FG012|Treatment Period 1|Lack of Efficacy|0
7828965|NCT01314872|12301523|FG013|Treatment Period 1|Lack of Efficacy|0
7828966|NCT01314872|12301524|FG014|Treatment Period 1|Lack of Efficacy|0
7828967|NCT01314872|12301510|FG000|Treatment Period 1|Adverse event, non-fatal|4
7828968|NCT01314872|12301511|FG001|Treatment Period 1|Adverse event, non-fatal|2
7828969|NCT01314872|12301512|FG002|Treatment Period 1|Adverse event, non-fatal|3
7828970|NCT01314872|12301513|FG003|Treatment Period 1|Adverse event, non-fatal|2
7828971|NCT01314872|12301514|FG004|Treatment Period 1|Adverse event, non-fatal|2
7828972|NCT01314872|12301515|FG005|Treatment Period 1|Adverse event, non-fatal|4
7828973|NCT01314872|12301516|FG006|Treatment Period 1|Adverse event, non-fatal|4
7828974|NCT01314872|12301517|FG007|Treatment Period 1|Adverse event, non-fatal|2
7828975|NCT01314872|12301518|FG008|Treatment Period 1|Adverse event, non-fatal|3
7828976|NCT01314872|12301519|FG009|Treatment Period 1|Adverse event, non-fatal|0
7828977|NCT01314872|12301520|FG010|Treatment Period 1|Adverse event, non-fatal|1
7828978|NCT01314872|12301521|FG011|Treatment Period 1|Adverse event, non-fatal|0
7828979|NCT01314872|12301522|FG012|Treatment Period 1|Adverse event, non-fatal|0
7828980|NCT01314872|12301523|FG013|Treatment Period 1|Adverse event, non-fatal|0
7828981|NCT01314872|12301524|FG014|Treatment Period 1|Adverse event, non-fatal|0
7828982|NCT01314872|12301510|FG000|Treatment Period 1|Withdrawal by Subject|3
7828983|NCT01314872|12301511|FG001|Treatment Period 1|Withdrawal by Subject|1
7828984|NCT01314872|12301512|FG002|Treatment Period 1|Withdrawal by Subject|0
7828985|NCT01314872|12301513|FG003|Treatment Period 1|Withdrawal by Subject|2
7828986|NCT01314872|12301514|FG004|Treatment Period 1|Withdrawal by Subject|3
7828987|NCT01314872|12301515|FG005|Treatment Period 1|Withdrawal by Subject|1
7828988|NCT01314872|12301516|FG006|Treatment Period 1|Withdrawal by Subject|3
7828989|NCT01314872|12301517|FG007|Treatment Period 1|Withdrawal by Subject|2
7828990|NCT01314872|12301518|FG008|Treatment Period 1|Withdrawal by Subject|2
7828991|NCT01314872|12301519|FG009|Treatment Period 1|Withdrawal by Subject|2
7828992|NCT01314872|12301520|FG010|Treatment Period 1|Withdrawal by Subject|1
7828993|NCT01314872|12301521|FG011|Treatment Period 1|Withdrawal by Subject|0
7828994|NCT01314872|12301522|FG012|Treatment Period 1|Withdrawal by Subject|0
7828995|NCT01314872|12301523|FG013|Treatment Period 1|Withdrawal by Subject|0
7828996|NCT01314872|12301524|FG014|Treatment Period 1|Withdrawal by Subject|0
7828997|NCT01314872|12301510|FG000|Treatment Period 1|Lost to Follow-up|0
7828998|NCT01314872|12301511|FG001|Treatment Period 1|Lost to Follow-up|1
7828999|NCT01314872|12301512|FG002|Treatment Period 1|Lost to Follow-up|2
7829000|NCT01314872|12301513|FG003|Treatment Period 1|Lost to Follow-up|2
7829001|NCT01314872|12301514|FG004|Treatment Period 1|Lost to Follow-up|1
7829002|NCT01314872|12301515|FG005|Treatment Period 1|Lost to Follow-up|1
7829003|NCT01314872|12301516|FG006|Treatment Period 1|Lost to Follow-up|1
7829004|NCT01314872|12301517|FG007|Treatment Period 1|Lost to Follow-up|1
7829005|NCT01314872|12301518|FG008|Treatment Period 1|Lost to Follow-up|1
7829006|NCT01314872|12301519|FG009|Treatment Period 1|Lost to Follow-up|0
7829007|NCT01314872|12301520|FG010|Treatment Period 1|Lost to Follow-up|0
7829008|NCT01314872|12301521|FG011|Treatment Period 1|Lost to Follow-up|0
7829009|NCT01314872|12301522|FG012|Treatment Period 1|Lost to Follow-up|0
7829010|NCT01314872|12301523|FG013|Treatment Period 1|Lost to Follow-up|0
7829011|NCT01314872|12301524|FG014|Treatment Period 1|Lost to Follow-up|0
7829012|NCT01314872|12301510|FG000|Period 2|Protocol Violation|0
7829013|NCT01314872|12301511|FG001|Period 2|Protocol Violation|0
7829014|NCT01314872|12301512|FG002|Period 2|Protocol Violation|0
7829015|NCT01314872|12301513|FG003|Period 2|Protocol Violation|0
7829016|NCT01314872|12301514|FG004|Period 2|Protocol Violation|0
7829017|NCT01314872|12301515|FG005|Period 2|Protocol Violation|0
7829018|NCT01314872|12301516|FG006|Period 2|Protocol Violation|0
7829019|NCT01314872|12301517|FG007|Period 2|Protocol Violation|0
7829020|NCT01314872|12301518|FG008|Period 2|Protocol Violation|0
7829021|NCT01314872|12301519|FG009|Period 2|Protocol Violation|0
7829022|NCT01314872|12301520|FG010|Period 2|Protocol Violation|0
7829023|NCT01314872|12301521|FG011|Period 2|Protocol Violation|3
7829024|NCT01314872|12301522|FG012|Period 2|Protocol Violation|3
7829025|NCT01314872|12301523|FG013|Period 2|Protocol Violation|2
7829026|NCT01314872|12301524|FG014|Period 2|Protocol Violation|0
7829027|NCT01314872|12301510|FG000|Period 2|Non-compliance with study drug|0
7829028|NCT01314872|12301511|FG001|Period 2|Non-compliance with study drug|0
7829029|NCT01314872|12301512|FG002|Period 2|Non-compliance with study drug|0
7829030|NCT01314872|12301513|FG003|Period 2|Non-compliance with study drug|0
7829031|NCT01314872|12301514|FG004|Period 2|Non-compliance with study drug|0
7829032|NCT01314872|12301515|FG005|Period 2|Non-compliance with study drug|0
7829033|NCT01314872|12301516|FG006|Period 2|Non-compliance with study drug|0
7829034|NCT01314872|12301517|FG007|Period 2|Non-compliance with study drug|0
7829035|NCT01314872|12301518|FG008|Period 2|Non-compliance with study drug|0
7829036|NCT01314872|12301519|FG009|Period 2|Non-compliance with study drug|0
7829037|NCT01314872|12301520|FG010|Period 2|Non-compliance with study drug|0
7829038|NCT01314872|12301521|FG011|Period 2|Non-compliance with study drug|3
7829039|NCT01314872|12301522|FG012|Period 2|Non-compliance with study drug|3
7829040|NCT01314872|12301523|FG013|Period 2|Non-compliance with study drug|1
7829041|NCT01314872|12301524|FG014|Period 2|Non-compliance with study drug|2
7829042|NCT01314872|12301510|FG000|Period 2|Lack of Efficacy|0
7829043|NCT01314872|12301511|FG001|Period 2|Lack of Efficacy|0
7829044|NCT01314872|12301512|FG002|Period 2|Lack of Efficacy|0
7829045|NCT01314872|12301513|FG003|Period 2|Lack of Efficacy|0
7829046|NCT01314872|12301514|FG004|Period 2|Lack of Efficacy|0
7829047|NCT01314872|12301515|FG005|Period 2|Lack of Efficacy|0
7829048|NCT01314872|12301516|FG006|Period 2|Lack of Efficacy|0
7829049|NCT01314872|12301517|FG007|Period 2|Lack of Efficacy|0
7829050|NCT01314872|12301518|FG008|Period 2|Lack of Efficacy|0
7829051|NCT01314872|12301519|FG009|Period 2|Lack of Efficacy|0
7829052|NCT01314872|12301520|FG010|Period 2|Lack of Efficacy|0
7829053|NCT01314872|12301521|FG011|Period 2|Lack of Efficacy|7
7829054|NCT01314872|12301522|FG012|Period 2|Lack of Efficacy|12
7829055|NCT01314872|12301523|FG013|Period 2|Lack of Efficacy|9
7829056|NCT01314872|12301524|FG014|Period 2|Lack of Efficacy|2
7829057|NCT01314872|12301510|FG000|Period 2|Pregnancy|0
7829058|NCT01314872|12301511|FG001|Period 2|Pregnancy|0
7829059|NCT01314872|12301512|FG002|Period 2|Pregnancy|0
7829060|NCT01314872|12301513|FG003|Period 2|Pregnancy|0
7829061|NCT01314872|12301514|FG004|Period 2|Pregnancy|0
7829062|NCT01314872|12301515|FG005|Period 2|Pregnancy|0
7829063|NCT01314872|12301516|FG006|Period 2|Pregnancy|0
7829064|NCT01314872|12301517|FG007|Period 2|Pregnancy|0
7829065|NCT01314872|12301518|FG008|Period 2|Pregnancy|0
7829066|NCT01314872|12301519|FG009|Period 2|Pregnancy|0
7829067|NCT01314872|12301520|FG010|Period 2|Pregnancy|0
7829068|NCT01314872|12301521|FG011|Period 2|Pregnancy|0
7829069|NCT01314872|12301522|FG012|Period 2|Pregnancy|0
7829070|NCT01314872|12301523|FG013|Period 2|Pregnancy|0
7829071|NCT01314872|12301524|FG014|Period 2|Pregnancy|1
7829072|NCT01314872|12301510|FG000|Period 2|Study terminated by Sponsor|0
7829073|NCT01314872|12301511|FG001|Period 2|Study terminated by Sponsor|0
7829074|NCT01314872|12301512|FG002|Period 2|Study terminated by Sponsor|0
7829075|NCT01314872|12301513|FG003|Period 2|Study terminated by Sponsor|0
7829076|NCT01314872|12301514|FG004|Period 2|Study terminated by Sponsor|0
7829077|NCT01314872|12301515|FG005|Period 2|Study terminated by Sponsor|0
7829078|NCT01314872|12301516|FG006|Period 2|Study terminated by Sponsor|0
7829079|NCT01314872|12301517|FG007|Period 2|Study terminated by Sponsor|0
7829080|NCT01314872|12301518|FG008|Period 2|Study terminated by Sponsor|0
7829081|NCT01314872|12301519|FG009|Period 2|Study terminated by Sponsor|0
7829082|NCT01314872|12301520|FG010|Period 2|Study terminated by Sponsor|0
7829083|NCT01314872|12301521|FG011|Period 2|Study terminated by Sponsor|2
7829084|NCT01314872|12301522|FG012|Period 2|Study terminated by Sponsor|2
7829085|NCT01314872|12301523|FG013|Period 2|Study terminated by Sponsor|3
7829086|NCT01314872|12301524|FG014|Period 2|Study terminated by Sponsor|0
7829087|NCT01314872|12301510|FG000|Period 2|Adverse event, non-fatal|0
7829088|NCT01314872|12301511|FG001|Period 2|Adverse event, non-fatal|0
7829089|NCT01314872|12301512|FG002|Period 2|Adverse event, non-fatal|0
7829090|NCT01314872|12301513|FG003|Period 2|Adverse event, non-fatal|0
7829091|NCT01314872|12301514|FG004|Period 2|Adverse event, non-fatal|0
7829092|NCT01314872|12301515|FG005|Period 2|Adverse event, non-fatal|0
7829093|NCT01314872|12301516|FG006|Period 2|Adverse event, non-fatal|0
7829094|NCT01314872|12301517|FG007|Period 2|Adverse event, non-fatal|0
7829095|NCT01314872|12301518|FG008|Period 2|Adverse event, non-fatal|0
7829096|NCT01314872|12301519|FG009|Period 2|Adverse event, non-fatal|0
7829097|NCT01314872|12301520|FG010|Period 2|Adverse event, non-fatal|0
7829098|NCT01314872|12301521|FG011|Period 2|Adverse event, non-fatal|13
7829099|NCT01314872|12301522|FG012|Period 2|Adverse event, non-fatal|16
7829100|NCT01314872|12301523|FG013|Period 2|Adverse event, non-fatal|24
7829101|NCT01314872|12301524|FG014|Period 2|Adverse event, non-fatal|9
7829102|NCT01314872|12301510|FG000|Period 2|Withdrawal by Subject|0
7829103|NCT01314872|12301511|FG001|Period 2|Withdrawal by Subject|0
7829104|NCT01314872|12301512|FG002|Period 2|Withdrawal by Subject|0
7829105|NCT01314872|12301513|FG003|Period 2|Withdrawal by Subject|0
7829106|NCT01314872|12301514|FG004|Period 2|Withdrawal by Subject|0
7829107|NCT01314872|12301515|FG005|Period 2|Withdrawal by Subject|0
7829108|NCT01314872|12301516|FG006|Period 2|Withdrawal by Subject|0
7829109|NCT01314872|12301517|FG007|Period 2|Withdrawal by Subject|0
7829110|NCT01314872|12301518|FG008|Period 2|Withdrawal by Subject|0
7829111|NCT01314872|12301519|FG009|Period 2|Withdrawal by Subject|0
7829112|NCT01314872|12301520|FG010|Period 2|Withdrawal by Subject|0
7829113|NCT01314872|12301521|FG011|Period 2|Withdrawal by Subject|14
7829114|NCT01314872|12301522|FG012|Period 2|Withdrawal by Subject|17
7829115|NCT01314872|12301523|FG013|Period 2|Withdrawal by Subject|12
7829116|NCT01314872|12301524|FG014|Period 2|Withdrawal by Subject|4
7829117|NCT01314872|12301510|FG000|Period 2|Lost to Follow-up|0
7829118|NCT01314872|12301511|FG001|Period 2|Lost to Follow-up|0
7829119|NCT01314872|12301512|FG002|Period 2|Lost to Follow-up|0
7829120|NCT01314872|12301513|FG003|Period 2|Lost to Follow-up|0
7829121|NCT01314872|12301514|FG004|Period 2|Lost to Follow-up|0
7829122|NCT01314872|12301515|FG005|Period 2|Lost to Follow-up|0
7829123|NCT01314872|12301516|FG006|Period 2|Lost to Follow-up|0
7829124|NCT01314872|12301517|FG007|Period 2|Lost to Follow-up|0
7829125|NCT01314872|12301518|FG008|Period 2|Lost to Follow-up|0
7829126|NCT01314872|12301519|FG009|Period 2|Lost to Follow-up|0
7829127|NCT01314872|12301520|FG010|Period 2|Lost to Follow-up|0
7829128|NCT01314872|12301521|FG011|Period 2|Lost to Follow-up|6
7829129|NCT01314872|12301522|FG012|Period 2|Lost to Follow-up|7
7829130|NCT01314872|12301523|FG013|Period 2|Lost to Follow-up|2
7829131|NCT01314872|12301524|FG014|Period 2|Lost to Follow-up|6
7829132|NCT01314911|12301558|FG000|Overall Study|Lost to Follow-up|3
7829133|NCT01314911|12301559|FG001|Overall Study|Lost to Follow-up|2
7829134|NCT01314911|12301558|FG000|Overall Study|Withdrawal by Subject|1
7829135|NCT01314911|12301559|FG001|Overall Study|Withdrawal by Subject|3
7829136|NCT01314911|12301558|FG000|Overall Study|Received Non-randomized Study Drug|0
7829137|NCT01314911|12301559|FG001|Overall Study|Received Non-randomized Study Drug|1
7829138|NCT01314911|12301558|FG000|Overall Study|Never Started Treatment|1
7829139|NCT01314911|12301559|FG001|Overall Study|Never Started Treatment|0
7829140|NCT01315028|12301580|FG000|Overall Study|Lost to Follow-up|1
7829141|NCT01315028|12301581|FG001|Overall Study|Lost to Follow-up|0
7829142|NCT01315028|12301580|FG000|Overall Study|Death|0
7829143|NCT01315028|12301581|FG001|Overall Study|Death|1
7829144|NCT01315132|12301587|FG000|Overall Study|not treated due to disease progression|1
7829145|NCT01315236|12301611|FG000|Double-blind Phase|Death|1
7829146|NCT01315236|12301612|FG001|Double-blind Phase|Death|0
7829147|NCT01315236|12301611|FG000|Double-blind Phase|Adverse Event|1
7829148|NCT01315236|12301612|FG001|Double-blind Phase|Adverse Event|0
7829149|NCT01315236|12301611|FG000|Double-blind Phase|Withdrawal of Consent|1
7829150|NCT01315236|12301612|FG001|Double-blind Phase|Withdrawal of Consent|0
7829151|NCT01315236|12301611|FG000|Double-blind Phase|Lost to Follow-up|1
7829152|NCT01315236|12301612|FG001|Double-blind Phase|Lost to Follow-up|0
7829153|NCT01315236|12301611|FG000|Open-label Phase|Death|1
7829154|NCT01315236|12301612|FG001|Open-label Phase|Death|0
7829155|NCT01315236|12301611|FG000|Open-label Phase|Adverse Event|0
7829156|NCT01315236|12301612|FG001|Open-label Phase|Adverse Event|1
7829157|NCT01315236|12301611|FG000|Open-label Phase|Other|0
7829158|NCT01315236|12301612|FG001|Open-label Phase|Other|1
7829159|NCT01315236|12301611|FG000|12-Month Follow-up Period|Death|0
7829160|NCT01315236|12301612|FG001|12-Month Follow-up Period|Death|1
7829161|NCT01315236|12301611|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1
7829162|NCT01315236|12301612|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0
7829163|NCT01315249|12301622|FG000|Overall Study|Adverse Event|22
7829164|NCT01315249|12301623|FG001|Overall Study|Adverse Event|26
7829165|NCT01315249|12301622|FG000|Overall Study|Withdrawal by Subject|11
7829166|NCT01315249|12301623|FG001|Overall Study|Withdrawal by Subject|10
7720077|NCT00536471|12144333|FG003|Overall Study|Death|2
7829167|NCT01315249|12301622|FG000|Overall Study|Protocol Violation|8
7829168|NCT01315249|12301623|FG001|Overall Study|Protocol Violation|5
7829169|NCT01315249|12301622|FG000|Overall Study|Abnormal test results|1
7829170|NCT01315249|12301623|FG001|Overall Study|Abnormal test results|2
7829171|NCT01315249|12301622|FG000|Overall Study|Administrative problems|1
7829172|NCT01315249|12301623|FG001|Overall Study|Administrative problems|0
7829173|NCT01315249|12301622|FG000|Overall Study|inability to use device|1
7829174|NCT01315249|12301623|FG001|Overall Study|inability to use device|0
7829175|NCT01315249|12301622|FG000|Overall Study|Lack of Efficacy|0
7829176|NCT01315249|12301623|FG001|Overall Study|Lack of Efficacy|1
7829177|NCT01315249|12301622|FG000|Overall Study|Lost to Follow-up|0
7829178|NCT01315249|12301623|FG001|Overall Study|Lost to Follow-up|2
7829179|NCT01315249|12301622|FG000|Overall Study|Death|0
7829180|NCT01315249|12301623|FG001|Overall Study|Death|1
7829181|NCT01315678|12301651|FG000|Overall Study|Withdrawal by Subject|7
7829182|NCT01315678|12301652|FG001|Overall Study|Withdrawal by Subject|3
7829183|NCT01315678|12301651|FG000|Overall Study|Adverse Event|3
7829184|NCT01315678|12301652|FG001|Overall Study|Adverse Event|1
7829185|NCT01315678|12301651|FG000|Overall Study|Lost to Follow-up|1
7829186|NCT01315678|12301652|FG001|Overall Study|Lost to Follow-up|0
7829187|NCT01315678|12301651|FG000|Overall Study|similar reason to those listed above|3
7829188|NCT01315678|12301652|FG001|Overall Study|similar reason to those listed above|2
7829189|NCT01315847|12301662|FG000|Part I, Period 1|Reached maximum number of arterial lines|3
7829190|NCT01315847|12301663|FG001|Part I, Period 1|Reached maximum number of arterial lines|0
7829191|NCT01315847|12301662|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0
7829192|NCT01315847|12301663|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1
7829193|NCT01316055|12301681|FG000|Overall Study|Lost to Follow-up|1
7829194|NCT01316055|12301682|FG001|Overall Study|Lost to Follow-up|0
7829195|NCT01316055|12301683|FG002|Overall Study|Lost to Follow-up|0
7829196|NCT01316224|12301703|FG000|Overall Study|Protocol Violation|3
7829197|NCT01316224|12301703|FG000|Overall Study|Adverse Event|3
7829198|NCT01316224|12301703|FG000|Overall Study|Lack of Efficacy|1
7829199|NCT01316224|12301703|FG000|Overall Study|Withdrawal by Subject|1
7829200|NCT01316224|12301703|FG000|Overall Study|Adverse Event With Treatment Failure|1
7829201|NCT01316224|12301703|FG000|Overall Study|Other|1
7829202|NCT01316276|12301718|FG000|Overall Study|Death|1
7829203|NCT01316276|12301718|FG000|Overall Study|Adverse Event|19
7829204|NCT01316276|12301718|FG000|Overall Study|Withdrawal of consent|24
7829205|NCT01316276|12301718|FG000|Overall Study|Lost to Follow-up|1
7829206|NCT01316276|12301718|FG000|Overall Study|Other|22
7829207|NCT01316380|12301770|FG000|Overall Study|Adverse Event|0
7829208|NCT01316380|12301771|FG001|Overall Study|Adverse Event|2
7829209|NCT01316380|12301772|FG002|Overall Study|Adverse Event|1
7829210|NCT01316380|12301770|FG000|Overall Study|Protocol Violation|0
7829211|NCT01316380|12301771|FG001|Overall Study|Protocol Violation|0
7829212|NCT01316380|12301772|FG002|Overall Study|Protocol Violation|1
7829213|NCT01316380|12301770|FG000|Overall Study|Withdrawal by Subject|1
7829214|NCT01316380|12301771|FG001|Overall Study|Withdrawal by Subject|2
7829215|NCT01316380|12301772|FG002|Overall Study|Withdrawal by Subject|0
7829216|NCT01316380|12301770|FG000|Overall Study|Other|0
7829217|NCT01316380|12301771|FG001|Overall Study|Other|1
7829218|NCT01316380|12301772|FG002|Overall Study|Other|1
7829219|NCT01316380|12301770|FG000|Overall Study|Not treated|1
7829220|NCT01316380|12301771|FG001|Overall Study|Not treated|0
7829221|NCT01316380|12301772|FG002|Overall Study|Not treated|0
7829222|NCT01316419|12301780|FG000|Overall Study|Not treated|103
7829223|NCT01316419|12301780|FG000|Overall Study|Violated inclusion/exclusion criterion|143
7829224|NCT01316419|12301780|FG000|Overall Study|Lost to Follow-up|19
7829225|NCT01316575|12301795|FG000|Overall Study|Withdrawal by Subject|2
7829226|NCT01316575|12301796|FG001|Overall Study|Withdrawal by Subject|0
7829227|NCT01316575|12301795|FG000|Overall Study|Required alternate treatment|0
7829228|NCT01316575|12301796|FG001|Overall Study|Required alternate treatment|1
7829229|NCT01316614|12301802|FG000|Overall Study|No solid lesion and FNA not indicated|25
7829230|NCT01316614|12301802|FG000|Overall Study|Cytology slides not available for review|4
7829231|NCT01316614|12301802|FG000|Overall Study|Cystic lesion|5
7829232|NCT01316614|12301802|FG000|Overall Study|Inadequate number of passes|2
7829233|NCT01316614|12301802|FG000|Overall Study|Medically unstable|1
7829234|NCT01316692|12301807|FG000|Overall Study|Adverse Event|5
7829235|NCT01316692|12301807|FG000|Overall Study|Disease Progression|7
7829236|NCT01316887|12301825|FG000|Overall Study|Adverse Event|13
7829237|NCT01316887|12301826|FG001|Overall Study|Adverse Event|21
7829238|NCT01316887|12301827|FG002|Overall Study|Adverse Event|17
7829239|NCT01316887|12301825|FG000|Overall Study|Lack of Efficacy|9
7829240|NCT01316887|12301826|FG001|Overall Study|Lack of Efficacy|3
7829241|NCT01316887|12301827|FG002|Overall Study|Lack of Efficacy|1
7829242|NCT01316887|12301825|FG000|Overall Study|Protocol Violation|2
7829243|NCT01316887|12301826|FG001|Overall Study|Protocol Violation|6
7829244|NCT01316887|12301827|FG002|Overall Study|Protocol Violation|6
7829245|NCT01316887|12301825|FG000|Overall Study|Protocol-defined Stopping Criteria|8
7829246|NCT01316887|12301826|FG001|Overall Study|Protocol-defined Stopping Criteria|37
7829247|NCT01316887|12301827|FG002|Overall Study|Protocol-defined Stopping Criteria|36
7829248|NCT01316887|12301825|FG000|Overall Study|Study Closed/Terminated|2
7829249|NCT01316887|12301826|FG001|Overall Study|Study Closed/Terminated|4
7829250|NCT01316887|12301827|FG002|Overall Study|Study Closed/Terminated|3
7829251|NCT01316887|12301825|FG000|Overall Study|Lost to Follow-up|1
7829252|NCT01316887|12301826|FG001|Overall Study|Lost to Follow-up|7
7829253|NCT01316887|12301827|FG002|Overall Study|Lost to Follow-up|5
7829254|NCT01316887|12301825|FG000|Overall Study|Withdrawal by Subject|8
7829255|NCT01316887|12301826|FG001|Overall Study|Withdrawal by Subject|16
7829256|NCT01316887|12301827|FG002|Overall Study|Withdrawal by Subject|15
7829257|NCT01316900|12301840|FG000|Overall Study|Adverse Event|10
7829258|NCT01316900|12301841|FG001|Overall Study|Adverse Event|10
7829259|NCT01316900|12301842|FG002|Overall Study|Adverse Event|15
7829260|NCT01316900|12301843|FG003|Overall Study|Adverse Event|9
7829261|NCT01316900|12301840|FG000|Overall Study|Lack of Efficacy|17
7829262|NCT01316900|12301841|FG001|Overall Study|Lack of Efficacy|9
7829263|NCT01316900|12301842|FG002|Overall Study|Lack of Efficacy|5
7829264|NCT01316900|12301843|FG003|Overall Study|Lack of Efficacy|7
7829265|NCT01316900|12301840|FG000|Overall Study|Protocol Violation|7
7829266|NCT01316900|12301841|FG001|Overall Study|Protocol Violation|1
7829267|NCT01316900|12301842|FG002|Overall Study|Protocol Violation|4
7829268|NCT01316900|12301843|FG003|Overall Study|Protocol Violation|0
7829269|NCT01316900|12301840|FG000|Overall Study|Protocol-defined Stopping Criteria|2
7829270|NCT01316900|12301841|FG001|Overall Study|Protocol-defined Stopping Criteria|3
7829271|NCT01316900|12301842|FG002|Overall Study|Protocol-defined Stopping Criteria|10
7829272|NCT01316900|12301843|FG003|Overall Study|Protocol-defined Stopping Criteria|5
7829273|NCT01316900|12301840|FG000|Overall Study|Lost to Follow-up|1
7829274|NCT01316900|12301841|FG001|Overall Study|Lost to Follow-up|0
7829275|NCT01316900|12301842|FG002|Overall Study|Lost to Follow-up|1
7829276|NCT01316900|12301843|FG003|Overall Study|Lost to Follow-up|1
7829277|NCT01316900|12301840|FG000|Overall Study|Withdrawal by Subject|7
7829278|NCT01316900|12301841|FG001|Overall Study|Withdrawal by Subject|8
7829279|NCT01316900|12301842|FG002|Overall Study|Withdrawal by Subject|6
7829280|NCT01316900|12301843|FG003|Overall Study|Withdrawal by Subject|9
7829281|NCT01316913|12301857|FG000|Overall Study|Adverse Event|17
7829282|NCT01316913|12301858|FG001|Overall Study|Adverse Event|20
7829283|NCT01316913|12301859|FG002|Overall Study|Adverse Event|15
7829284|NCT01316913|12301860|FG003|Overall Study|Adverse Event|11
7829285|NCT01316913|12301857|FG000|Overall Study|Lack of Efficacy|22
7829286|NCT01316913|12301858|FG001|Overall Study|Lack of Efficacy|12
7829287|NCT01316913|12301859|FG002|Overall Study|Lack of Efficacy|9
7829288|NCT01316913|12301860|FG003|Overall Study|Lack of Efficacy|13
7829289|NCT01316913|12301857|FG000|Overall Study|Protocol Violation|1
7829290|NCT01316913|12301858|FG001|Overall Study|Protocol Violation|4
7829291|NCT01316913|12301859|FG002|Overall Study|Protocol Violation|4
7829292|NCT01316913|12301860|FG003|Overall Study|Protocol Violation|1
7829293|NCT01316913|12301857|FG000|Overall Study|Protocol-defined Stopping Criteria|7
7829294|NCT01316913|12301858|FG001|Overall Study|Protocol-defined Stopping Criteria|8
7829295|NCT01316913|12301859|FG002|Overall Study|Protocol-defined Stopping Criteria|11
7829296|NCT01316913|12301860|FG003|Overall Study|Protocol-defined Stopping Criteria|6
7829297|NCT01316913|12301857|FG000|Overall Study|Lost to Follow-up|0
7829298|NCT01316913|12301858|FG001|Overall Study|Lost to Follow-up|1
7829299|NCT01316913|12301859|FG002|Overall Study|Lost to Follow-up|0
7829300|NCT01316913|12301860|FG003|Overall Study|Lost to Follow-up|2
7829301|NCT01316913|12301857|FG000|Overall Study|Withdrawal by Subject|10
7829302|NCT01316913|12301858|FG001|Overall Study|Withdrawal by Subject|9
7829303|NCT01316913|12301859|FG002|Overall Study|Withdrawal by Subject|10
7829304|NCT01316913|12301860|FG003|Overall Study|Withdrawal by Subject|6
7829305|NCT01316939|12301882|FG000|Overall Study|Study closed/terminated|26
7829306|NCT01316939|12301883|FG001|Overall Study|Study closed/terminated|25
7829307|NCT01316939|12301884|FG002|Overall Study|Study closed/terminated|23
7829308|NCT01316939|12301882|FG000|Overall Study|Lack of Efficacy|24
7829309|NCT01316939|12301883|FG001|Overall Study|Lack of Efficacy|25
7829310|NCT01316939|12301884|FG002|Overall Study|Lack of Efficacy|25
7829311|NCT01316939|12301882|FG000|Overall Study|Adverse Event|9
7829312|NCT01316939|12301883|FG001|Overall Study|Adverse Event|12
7829313|NCT01316939|12301884|FG002|Overall Study|Adverse Event|11
7829314|NCT01316939|12301882|FG000|Overall Study|Withdrawal by Subject|1
7829315|NCT01316939|12301883|FG001|Overall Study|Withdrawal by Subject|3
7829316|NCT01316939|12301884|FG002|Overall Study|Withdrawal by Subject|6
7829317|NCT01316939|12301882|FG000|Overall Study|Physician Decision|2
7829318|NCT01316939|12301883|FG001|Overall Study|Physician Decision|2
7829319|NCT01316939|12301884|FG002|Overall Study|Physician Decision|1
7829320|NCT01316939|12301882|FG000|Overall Study|Lost to Follow-up|0
7829321|NCT01316939|12301883|FG001|Overall Study|Lost to Follow-up|0
7829322|NCT01316939|12301884|FG002|Overall Study|Lost to Follow-up|2
7829323|NCT01316939|12301882|FG000|Overall Study|Met Liver chemistry stopping criteria|1
7829324|NCT01316939|12301883|FG001|Overall Study|Met Liver chemistry stopping criteria|0
7829325|NCT01316939|12301884|FG002|Overall Study|Met Liver chemistry stopping criteria|1
7829326|NCT01316939|12301882|FG000|Overall Study|Protocol Violation|0
7829327|NCT01316939|12301883|FG001|Overall Study|Protocol Violation|1
7829328|NCT01316939|12301884|FG002|Overall Study|Protocol Violation|0
7829329|NCT01317004|12301894|FG000|Overall Study|Withdrawal by Subject|1
7829330|NCT01317004|12301895|FG001|Overall Study|Withdrawal by Subject|4
7829331|NCT01317004|12301894|FG000|Overall Study|Protocol Violation|0
7829332|NCT01317004|12301895|FG001|Overall Study|Protocol Violation|2
7829333|NCT01317004|12301894|FG000|Overall Study|Adverse Event|3
7829334|NCT01317004|12301895|FG001|Overall Study|Adverse Event|3
7829335|NCT01317199|12301923|FG000|Dose-escalation Phase 1|Physician Decision|5
7829336|NCT01317199|12301924|FG001|Dose-escalation Phase 1|Physician Decision|0
7829337|NCT01317199|12301925|FG002|Dose-escalation Phase 1|Physician Decision|0
7829338|NCT01317199|12301926|FG003|Dose-escalation Phase 1|Physician Decision|0
7829339|NCT01317199|12301923|FG000|Dose-escalation Phase 1|Disease progression|1
7829340|NCT01317199|12301924|FG001|Dose-escalation Phase 1|Disease progression|0
7829341|NCT01317199|12301925|FG002|Dose-escalation Phase 1|Disease progression|0
7829342|NCT01317199|12301926|FG003|Dose-escalation Phase 1|Disease progression|0
7829343|NCT01317199|12301923|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
7829344|NCT01317199|12301924|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
7829345|NCT01317199|12301925|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
7829346|NCT01317199|12301926|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
7829347|NCT01317199|12301923|FG000|Randomized Phase 2|Disease progression|0
7829348|NCT01317199|12301924|FG001|Randomized Phase 2|Disease progression|3
7829349|NCT01317199|12301925|FG002|Randomized Phase 2|Disease progression|7
7829350|NCT01317199|12301926|FG003|Randomized Phase 2|Disease progression|5
7829351|NCT01317199|12301923|FG000|Randomized Phase 2|Withdrawal by Subject|0
7829352|NCT01317199|12301924|FG001|Randomized Phase 2|Withdrawal by Subject|3
7829353|NCT01317199|12301925|FG002|Randomized Phase 2|Withdrawal by Subject|5
7829354|NCT01317199|12301926|FG003|Randomized Phase 2|Withdrawal by Subject|4
7829355|NCT01317199|12301923|FG000|Randomized Phase 2|Adverse Event|0
7829356|NCT01317199|12301924|FG001|Randomized Phase 2|Adverse Event|0
7829357|NCT01317199|12301925|FG002|Randomized Phase 2|Adverse Event|0
7829358|NCT01317199|12301926|FG003|Randomized Phase 2|Adverse Event|1
7829359|NCT01317199|12301923|FG000|Randomized Phase 2|Comorbidities|0
7829360|NCT01317199|12301924|FG001|Randomized Phase 2|Comorbidities|2
7829361|NCT01317199|12301925|FG002|Randomized Phase 2|Comorbidities|2
7829362|NCT01317199|12301926|FG003|Randomized Phase 2|Comorbidities|2
7829363|NCT01317199|12301923|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0
7829364|NCT01317199|12301924|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2
7829365|NCT01317199|12301925|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5
7829366|NCT01317199|12301926|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2
7829367|NCT01317199|12301923|FG000|Randomized Phase 2|Disenrolled before treatment|0
7829368|NCT01317199|12301924|FG001|Randomized Phase 2|Disenrolled before treatment|1
7829369|NCT01317199|12301925|FG002|Randomized Phase 2|Disenrolled before treatment|1
7829370|NCT01317199|12301926|FG003|Randomized Phase 2|Disenrolled before treatment|2
7829371|NCT01317199|12301923|FG000|Randomized Phase 2|Patient stopped taking study drug|0
7829372|NCT01317199|12301924|FG001|Randomized Phase 2|Patient stopped taking study drug|0
7829373|NCT01317199|12301925|FG002|Randomized Phase 2|Patient stopped taking study drug|0
7829374|NCT01317199|12301926|FG003|Randomized Phase 2|Patient stopped taking study drug|1
7829375|NCT01317199|12301923|FG000|Randomized Phase 2|Patient transferred to other facility|0
7829376|NCT01317199|12301924|FG001|Randomized Phase 2|Patient transferred to other facility|0
7829377|NCT01317199|12301925|FG002|Randomized Phase 2|Patient transferred to other facility|1
7829378|NCT01317199|12301926|FG003|Randomized Phase 2|Patient transferred to other facility|0
7829379|NCT01317277|12301945|FG000|Overall Study|Lost to Follow-up|3
7829380|NCT01317277|12301946|FG001|Overall Study|Lost to Follow-up|1
7829381|NCT01317277|12301945|FG000|Overall Study|Lost MEMS|1
7829382|NCT01317277|12301946|FG001|Overall Study|Lost MEMS|1
7829383|NCT01317277|12301945|FG000|Overall Study|Unable to comply with intervention|1
7829384|NCT01317277|12301946|FG001|Overall Study|Unable to comply with intervention|0
7829385|NCT01317277|12301945|FG000|Overall Study|Withdrawal by Subject|1
7829386|NCT01317277|12301946|FG001|Overall Study|Withdrawal by Subject|0
7829387|NCT01317277|12301945|FG000|Overall Study|Adverse Event|1
7829388|NCT01317277|12301946|FG001|Overall Study|Adverse Event|0
7829389|NCT01317472|12301954|FG000|Overall Study|Withdrawal by Subject|1
7829390|NCT01317472|12301955|FG001|Overall Study|Withdrawal by Subject|0
7829391|NCT01317472|12301954|FG000|Overall Study|Unrelated hospitalization|1
7829392|NCT01317472|12301955|FG001|Overall Study|Unrelated hospitalization|0
7829393|NCT01317550|12301965|FG000|Overall Study|Withdrawal by Subject|1
7829394|NCT01317550|12301966|FG001|Overall Study|Withdrawal by Subject|0
7829395|NCT01317550|12301967|FG002|Overall Study|Withdrawal by Subject|0
7829396|NCT01317550|12301968|FG003|Overall Study|Withdrawal by Subject|0
7829397|NCT01317550|12301965|FG000|Overall Study|Lack of compliance study med|1
7829398|NCT01317550|12301966|FG001|Overall Study|Lack of compliance study med|0
7829399|NCT01317550|12301967|FG002|Overall Study|Lack of compliance study med|0
7829400|NCT01317550|12301968|FG003|Overall Study|Lack of compliance study med|0
7829401|NCT01317615|12301978|FG000|Overall Study|Disease progression|25
7829402|NCT01317615|12301978|FG000|Overall Study|New cancer therapy|5
7829403|NCT01317615|12301978|FG000|Overall Study|Death|6
7829404|NCT01317615|12301978|FG000|Overall Study|Withdrawal by Subject|5
7829405|NCT01317615|12301978|FG000|Overall Study|Abnormal laboratory value(s)|1
7829406|NCT01317615|12301978|FG000|Overall Study|Adverse Event|7
7829407|NCT01317641|12301991|FG000|Overall Study|Not treated|0
7829408|NCT01317641|12301992|FG001|Overall Study|Not treated|0
7829409|NCT01317641|12301993|FG002|Overall Study|Not treated|0
7829410|NCT01317641|12301994|FG003|Overall Study|Not treated|0
7829411|NCT01317641|12301995|FG004|Overall Study|Not treated|0
7829412|NCT01317641|12301996|FG005|Overall Study|Not treated|0
7829413|NCT01317641|12301997|FG006|Overall Study|Not treated|0
7829414|NCT01317641|12301998|FG007|Overall Study|Not treated|1
7829415|NCT01317641|12301999|FG008|Overall Study|Not treated|1
7829416|NCT01317641|12301991|FG000|Overall Study|Adverse Event|0
7829417|NCT01317641|12301992|FG001|Overall Study|Adverse Event|1
7829418|NCT01317641|12301993|FG002|Overall Study|Adverse Event|0
7829419|NCT01317641|12301994|FG003|Overall Study|Adverse Event|1
7829420|NCT01317641|12301995|FG004|Overall Study|Adverse Event|0
7829421|NCT01317641|12301996|FG005|Overall Study|Adverse Event|0
7829422|NCT01317641|12301997|FG006|Overall Study|Adverse Event|2
7829423|NCT01317641|12301998|FG007|Overall Study|Adverse Event|1
7829424|NCT01317641|12301999|FG008|Overall Study|Adverse Event|0
7829425|NCT01317641|12301991|FG000|Overall Study|Protocol Violation|1
7829426|NCT01317641|12301992|FG001|Overall Study|Protocol Violation|0
7829427|NCT01317641|12301993|FG002|Overall Study|Protocol Violation|0
7829428|NCT01317641|12301994|FG003|Overall Study|Protocol Violation|0
7829429|NCT01317641|12301995|FG004|Overall Study|Protocol Violation|0
7829430|NCT01317641|12301996|FG005|Overall Study|Protocol Violation|0
7829431|NCT01317641|12301997|FG006|Overall Study|Protocol Violation|0
7829432|NCT01317641|12301998|FG007|Overall Study|Protocol Violation|0
7829433|NCT01317641|12301999|FG008|Overall Study|Protocol Violation|0
7829434|NCT01317641|12301991|FG000|Overall Study|Disease progression|0
7829435|NCT01317641|12301992|FG001|Overall Study|Disease progression|0
7829436|NCT01317641|12301993|FG002|Overall Study|Disease progression|0
7829437|NCT01317641|12301994|FG003|Overall Study|Disease progression|0
7829438|NCT01317641|12301995|FG004|Overall Study|Disease progression|0
7829439|NCT01317641|12301996|FG005|Overall Study|Disease progression|0
7829440|NCT01317641|12301997|FG006|Overall Study|Disease progression|0
7829441|NCT01317641|12301998|FG007|Overall Study|Disease progression|3
7829442|NCT01317641|12301999|FG008|Overall Study|Disease progression|4
7829443|NCT01317641|12301991|FG000|Overall Study|Withdrawal by Subject|0
7829444|NCT01317641|12301992|FG001|Overall Study|Withdrawal by Subject|0
7829445|NCT01317641|12301993|FG002|Overall Study|Withdrawal by Subject|0
7829446|NCT01317641|12301994|FG003|Overall Study|Withdrawal by Subject|0
7829447|NCT01317641|12301995|FG004|Overall Study|Withdrawal by Subject|0
7829448|NCT01317641|12301996|FG005|Overall Study|Withdrawal by Subject|0
7829449|NCT01317641|12301997|FG006|Overall Study|Withdrawal by Subject|1
7829450|NCT01317641|12301998|FG007|Overall Study|Withdrawal by Subject|0
7829451|NCT01317641|12301999|FG008|Overall Study|Withdrawal by Subject|0
7829452|NCT01317797|12302051|FG000|Overall Study|Other|0
7829453|NCT01317797|12302052|FG001|Overall Study|Other|1
7829454|NCT01317797|12302053|FG002|Overall Study|Other|0
7829455|NCT01317797|12302051|FG000|Overall Study|Withdrawal of Patient|0
7829456|NCT01317797|12302052|FG001|Overall Study|Withdrawal of Patient|0
7829457|NCT01317797|12302053|FG002|Overall Study|Withdrawal of Patient|1
7829458|NCT01317940|12302076|FG000|Overall Study|Death|1
7829459|NCT01317940|12302077|FG001|Overall Study|Death|0
7829460|NCT01317940|12302078|FG002|Overall Study|Death|1
7829461|NCT01317940|12302079|FG003|Overall Study|Death|0
7829462|NCT01317940|12302080|FG004|Overall Study|Death|0
7829463|NCT01317940|12302081|FG005|Overall Study|Death|0
7829464|NCT01317940|12302076|FG000|Overall Study|Lost to Follow-up|0
7829465|NCT01317940|12302077|FG001|Overall Study|Lost to Follow-up|0
7829466|NCT01317940|12302078|FG002|Overall Study|Lost to Follow-up|1
7829467|NCT01317940|12302079|FG003|Overall Study|Lost to Follow-up|1
7829468|NCT01317940|12302080|FG004|Overall Study|Lost to Follow-up|1
7829469|NCT01317940|12302081|FG005|Overall Study|Lost to Follow-up|0
7829470|NCT01317940|12302076|FG000|Overall Study|Change in therapy plan|0
7829471|NCT01317940|12302077|FG001|Overall Study|Change in therapy plan|0
7829472|NCT01317940|12302078|FG002|Overall Study|Change in therapy plan|3
7829473|NCT01317940|12302079|FG003|Overall Study|Change in therapy plan|0
7829474|NCT01317940|12302080|FG004|Overall Study|Change in therapy plan|0
7829475|NCT01317940|12302081|FG005|Overall Study|Change in therapy plan|0
7829476|NCT01318070|12302108|FG000|Overall Study|Adverse Event|1
7829477|NCT01318070|12302109|FG001|Overall Study|Adverse Event|1
7829478|NCT01318070|12302110|FG002|Overall Study|Adverse Event|5
7829479|NCT01318070|12302108|FG000|Overall Study|Withdrawal by Subject|0
7829480|NCT01318070|12302109|FG001|Overall Study|Withdrawal by Subject|1
7829481|NCT01318070|12302110|FG002|Overall Study|Withdrawal by Subject|1
7829482|NCT01318070|12302108|FG000|Overall Study|Lack of Efficacy|0
7829483|NCT01318070|12302109|FG001|Overall Study|Lack of Efficacy|0
7829484|NCT01318070|12302110|FG002|Overall Study|Lack of Efficacy|1
7829485|NCT01318070|12302108|FG000|Overall Study|Principal Investigator Discretion|1
7829486|NCT01318070|12302109|FG001|Overall Study|Principal Investigator Discretion|0
7829487|NCT01318070|12302110|FG002|Overall Study|Principal Investigator Discretion|0
7829488|NCT01318083|12302121|FG000|Overall Study|Adverse Event|4
7829489|NCT01318083|12302122|FG001|Overall Study|Adverse Event|1
7829490|NCT01318083|12302123|FG002|Overall Study|Adverse Event|2
7829491|NCT01318083|12302121|FG000|Overall Study|Withdrawal by Subject|1
7829492|NCT01318083|12302122|FG001|Overall Study|Withdrawal by Subject|0
7829493|NCT01318083|12302123|FG002|Overall Study|Withdrawal by Subject|2
7829494|NCT01318083|12302121|FG000|Overall Study|Lack of Efficacy|0
7829495|NCT01318083|12302122|FG001|Overall Study|Lack of Efficacy|0
7829496|NCT01318083|12302123|FG002|Overall Study|Lack of Efficacy|1
7829497|NCT01318083|12302121|FG000|Overall Study|Treatment Complications|1
7829498|NCT01318083|12302122|FG001|Overall Study|Treatment Complications|0
7829499|NCT01318083|12302123|FG002|Overall Study|Treatment Complications|0
7829500|NCT01318083|12302121|FG000|Overall Study|Lack of Study Medication Compliance|0
7829501|NCT01318083|12302122|FG001|Overall Study|Lack of Study Medication Compliance|1
7829502|NCT01318083|12302123|FG002|Overall Study|Lack of Study Medication Compliance|0
7829503|NCT01318109|12302134|FG000|Overall Study|Adverse Event|0
7829504|NCT01318109|12302135|FG001|Overall Study|Adverse Event|2
7829505|NCT01318109|12302136|FG002|Overall Study|Adverse Event|0
7829506|NCT01318109|12302134|FG000|Overall Study|Withdrawal by Subject|1
7829507|NCT01318109|12302135|FG001|Overall Study|Withdrawal by Subject|0
7829508|NCT01318109|12302136|FG002|Overall Study|Withdrawal by Subject|0
7829509|NCT01318109|12302134|FG000|Overall Study|Schedule Conflict|0
7829510|NCT01318109|12302135|FG001|Overall Study|Schedule Conflict|1
7829511|NCT01318109|12302136|FG002|Overall Study|Schedule Conflict|0
7829512|NCT01318122|12302146|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0
7829513|NCT01318122|12302147|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
7829514|NCT01318122|12302148|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2
7829515|NCT01318122|12302149|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1
7829516|NCT01318122|12302146|FG000|Enrolled - Long-Term Extension Study|Other|1
7829517|NCT01318122|12302147|FG001|Enrolled - Long-Term Extension Study|Other|0
7829518|NCT01318122|12302148|FG002|Enrolled - Long-Term Extension Study|Other|0
7829519|NCT01318122|12302149|FG003|Enrolled - Long-Term Extension Study|Other|0
7829520|NCT01318122|12302146|FG000|Entered - Long-Term Extension Study|Adverse Event|6
7829521|NCT01318122|12302147|FG001|Entered - Long-Term Extension Study|Adverse Event|6
7829522|NCT01318122|12302148|FG002|Entered - Long-Term Extension Study|Adverse Event|2
7829523|NCT01318122|12302149|FG003|Entered - Long-Term Extension Study|Adverse Event|4
7829524|NCT01318122|12302146|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1
7829525|NCT01318122|12302147|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0
7829526|NCT01318122|12302148|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0
7829527|NCT01318122|12302149|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0
7829528|NCT01318122|12302146|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7829529|NCT01318122|12302147|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3
7829530|NCT01318122|12302148|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7829531|NCT01318122|12302149|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7829532|NCT01318122|12302146|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0
7829533|NCT01318122|12302147|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2
7829534|NCT01318122|12302148|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3
7829535|NCT01318122|12302149|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0
7829536|NCT01318135|12302159|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1
7829537|NCT01318135|12302160|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
7829538|NCT01318135|12302161|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0
7829539|NCT01318135|12302162|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0
7829540|NCT01318135|12302163|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0
7829541|NCT01318135|12302164|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0
7829542|NCT01318135|12302165|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0
7829543|NCT01318135|12302166|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0
7829544|NCT01318135|12302159|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1
7829545|NCT01318135|12302160|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0
7829546|NCT01318135|12302161|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0
7829547|NCT01318135|12302162|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0
7829548|NCT01318135|12302163|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0
7829549|NCT01318135|12302164|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0
7829550|NCT01318135|12302165|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0
7829551|NCT01318135|12302166|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0
7829552|NCT01318135|12302159|FG000|Entered - Long-Term Extension Study|Adverse Event|9
7829553|NCT01318135|12302160|FG001|Entered - Long-Term Extension Study|Adverse Event|3
7829554|NCT01318135|12302161|FG002|Entered - Long-Term Extension Study|Adverse Event|4
7829555|NCT01318135|12302162|FG003|Entered - Long-Term Extension Study|Adverse Event|3
7829556|NCT01318135|12302163|FG004|Entered - Long-Term Extension Study|Adverse Event|4
7829557|NCT01318135|12302164|FG005|Entered - Long-Term Extension Study|Adverse Event|2
7829558|NCT01318135|12302165|FG006|Entered - Long-Term Extension Study|Adverse Event|0
7829559|NCT01318135|12302166|FG007|Entered - Long-Term Extension Study|Adverse Event|0
7829560|NCT01318135|12302159|FG000|Entered - Long-Term Extension Study|Protocol Violation|1
7829561|NCT01318135|12302160|FG001|Entered - Long-Term Extension Study|Protocol Violation|1
7829562|NCT01318135|12302161|FG002|Entered - Long-Term Extension Study|Protocol Violation|0
7829563|NCT01318135|12302162|FG003|Entered - Long-Term Extension Study|Protocol Violation|0
7829564|NCT01318135|12302163|FG004|Entered - Long-Term Extension Study|Protocol Violation|1
7829565|NCT01318135|12302164|FG005|Entered - Long-Term Extension Study|Protocol Violation|0
7948507|NCT02528357|12493683|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7829566|NCT01318135|12302165|FG006|Entered - Long-Term Extension Study|Protocol Violation|0
7829567|NCT01318135|12302166|FG007|Entered - Long-Term Extension Study|Protocol Violation|0
7829568|NCT01318135|12302159|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7829569|NCT01318135|12302160|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7829570|NCT01318135|12302161|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7829571|NCT01318135|12302162|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7829572|NCT01318135|12302163|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7829573|NCT01318135|12302164|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7829574|NCT01318135|12302165|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7829575|NCT01318135|12302166|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7829576|NCT01318135|12302159|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5
7720078|NCT00536471|12144330|FG000|Overall Study|Sponsor Decision|0
7720079|NCT00536471|12144331|FG001|Overall Study|Sponsor Decision|1
7720080|NCT00536471|12144332|FG002|Overall Study|Sponsor Decision|3
7720081|NCT00536471|12144333|FG003|Overall Study|Sponsor Decision|2
7720082|NCT00536484|12144352|FG000|Overall Study|Adverse Event|21
7829577|NCT01318135|12302160|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7
7829578|NCT01318135|12302161|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2
7829579|NCT01318135|12302162|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3
7829580|NCT01318135|12302163|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2
7829581|NCT01318135|12302164|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2
7829582|NCT01318135|12302165|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1
7829583|NCT01318135|12302166|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1
7829584|NCT01318135|12302159|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7829585|NCT01318135|12302160|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7829586|NCT01318135|12302161|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7829587|NCT01318135|12302162|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7829588|NCT01318135|12302163|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7829589|NCT01318135|12302164|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7829590|NCT01318135|12302165|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7829591|NCT01318135|12302166|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1
7829592|NCT01318382|12302203|FG000|Overall Study|Physician Decision|2
7829593|NCT01318382|12302203|FG000|Overall Study|Device Malfunction|10
7829594|NCT01318382|12302203|FG000|Overall Study|Protocol Violation|1
7829595|NCT01318499|12302215|FG000|Overall Study|Adverse Event|16
7829596|NCT01318499|12302216|FG001|Overall Study|Adverse Event|11
7829597|NCT01318499|12302217|FG002|Overall Study|Adverse Event|6
7829598|NCT01318499|12302215|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1
7829599|NCT01318499|12302216|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1
7829600|NCT01318499|12302217|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2
7829601|NCT01318499|12302215|FG000|Overall Study|Noncompliance|2
7829602|NCT01318499|12302216|FG001|Overall Study|Noncompliance|3
7829603|NCT01318499|12302217|FG002|Overall Study|Noncompliance|0
7829604|NCT01318499|12302215|FG000|Overall Study|Treatment Failure|19
7829605|NCT01318499|12302216|FG001|Overall Study|Treatment Failure|19
7829606|NCT01318499|12302217|FG002|Overall Study|Treatment Failure|101
7720083|NCT00536484|12144353|FG001|Overall Study|Adverse Event|34
7720084|NCT00536484|12144352|FG000|Overall Study|Withdrawal by Subject|11
7829607|NCT01318499|12302215|FG000|Overall Study|Protocol Violation|2
7829608|NCT01318499|12302216|FG001|Overall Study|Protocol Violation|4
7829609|NCT01318499|12302217|FG002|Overall Study|Protocol Violation|2
7829610|NCT01318499|12302215|FG000|Overall Study|Patient Did Not Use Study Medication|18
7829611|NCT01318499|12302216|FG001|Overall Study|Patient Did Not Use Study Medication|28
7829612|NCT01318499|12302217|FG002|Overall Study|Patient Did Not Use Study Medication|14
7829613|NCT01318499|12302215|FG000|Overall Study|Other|7
7829614|NCT01318499|12302216|FG001|Overall Study|Other|10
7829615|NCT01318499|12302217|FG002|Overall Study|Other|22
7829616|NCT01318512|12302227|FG000|Maintenance Period (6 Months)|Death|2
7829617|NCT01318512|12302227|FG000|Maintenance Period (6 Months)|Protocol Violation|9
7829618|NCT01318811|12302277|FG000|Overall Study|Physician Decision|1
7829619|NCT01318811|12302278|FG001|Overall Study|Physician Decision|1
7829620|NCT01318811|12302277|FG000|Overall Study|CRRT stopped for head CT|0
7829621|NCT01318811|12302278|FG001|Overall Study|CRRT stopped for head CT|1
7829622|NCT01318811|12302277|FG000|Overall Study|Death|0
7829623|NCT01318811|12302278|FG001|Overall Study|Death|1
7829624|NCT01318811|12302277|FG000|Overall Study|CRRT stopped for head MRI|0
7829625|NCT01318811|12302278|FG001|Overall Study|CRRT stopped for head MRI|1
7829626|NCT01318876|12302284|FG000|Day 8 Survey|email address invalid|96
7829627|NCT01318876|12302284|FG000|Day 8 Survey|survey not completed-don't know why|1724
7829628|NCT01318876|12302284|FG000|Day 29 Survey|survey not completed-don't know why|1825
7829629|NCT01318902|12302292|FG000|Overall Study|Symptomatic Deterioration|0
7829630|NCT01318902|12302293|FG001|Overall Study|Symptomatic Deterioration|1
7829631|NCT01318902|12302294|FG002|Overall Study|Symptomatic Deterioration|1
7829632|NCT01318902|12302295|FG003|Overall Study|Symptomatic Deterioration|2
7829633|NCT01318902|12302292|FG000|Overall Study|Withdrawal by Patient|0
7829634|NCT01318902|12302293|FG001|Overall Study|Withdrawal by Patient|1
7829635|NCT01318902|12302294|FG002|Overall Study|Withdrawal by Patient|0
7829636|NCT01318902|12302295|FG003|Overall Study|Withdrawal by Patient|3
7829637|NCT01318902|12302292|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
7829638|NCT01318902|12302293|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
7829639|NCT01318902|12302294|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
7829640|NCT01318902|12302295|FG003|Overall Study|Unsatisfactory Therapeutic Response|1
7829641|NCT01318902|12302292|FG000|Overall Study|Adverse Event|0
7829642|NCT01318902|12302293|FG001|Overall Study|Adverse Event|1
7829643|NCT01318902|12302294|FG002|Overall Study|Adverse Event|0
7829644|NCT01318902|12302295|FG003|Overall Study|Adverse Event|0
7829645|NCT01318902|12302292|FG000|Overall Study|Terminated by Sponsor|0
7829646|NCT01318902|12302293|FG001|Overall Study|Terminated by Sponsor|0
7829647|NCT01318902|12302294|FG002|Overall Study|Terminated by Sponsor|1
7829648|NCT01318902|12302295|FG003|Overall Study|Terminated by Sponsor|0
7829649|NCT01318915|12302307|FG000|Overall Study|Lost to Follow-up|1
7829650|NCT01319383|12302335|FG000|Overall Study|No ex vivo or in vivo response|4
7829651|NCT01319383|12302336|FG001|Overall Study|No ex vivo or in vivo response|0
7829652|NCT01319383|12302335|FG000|Overall Study|Physician Decision|3
7829653|NCT01319383|12302336|FG001|Overall Study|Physician Decision|0
7829654|NCT01319383|12302335|FG000|Overall Study|Lack of Efficacy|5
7829655|NCT01319383|12302336|FG001|Overall Study|Lack of Efficacy|9
7829656|NCT01319383|12302335|FG000|Overall Study|No in vivo response to interval doses|0
7829657|NCT01319383|12302336|FG001|Overall Study|No in vivo response to interval doses|1
7829658|NCT01319422|12302359|FG000|Overall Study|Withdrawal by Subject|1
7829659|NCT01319422|12302360|FG001|Overall Study|Withdrawal by Subject|0
7829660|NCT01319721|12302397|FG000|Overall Study|Lost to Follow-up|1
7829661|NCT01319721|12302398|FG001|Overall Study|Lost to Follow-up|6
7829662|NCT01319877|12302449|FG000|Overall Study|Lost to Follow-up|100
7829663|NCT01319877|12302450|FG001|Overall Study|Lost to Follow-up|37
7829664|NCT01319877|12302449|FG000|Overall Study|Physician Decision|2
7829665|NCT01319877|12302450|FG001|Overall Study|Physician Decision|0
7829666|NCT01319877|12302449|FG000|Overall Study|Disease Progression|2
7829667|NCT01319877|12302450|FG001|Overall Study|Disease Progression|2
7829668|NCT01319877|12302449|FG000|Overall Study|Withdrawal by Subject|0
7829669|NCT01319877|12302450|FG001|Overall Study|Withdrawal by Subject|1
7829670|NCT01319877|12302449|FG000|Overall Study|Reason Not Specified|4
7829671|NCT01319877|12302450|FG001|Overall Study|Reason Not Specified|5
7829672|NCT01319929|12302457|FG000|First Treatment Period (4 Weeks)|Adverse Event|2
7829673|NCT01319929|12302458|FG001|First Treatment Period (4 Weeks)|Adverse Event|0
7829674|NCT01319929|12302457|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
7829675|NCT01319929|12302458|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
7829676|NCT01319929|12302457|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0
7829677|NCT01319929|12302458|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1
7829678|NCT01319929|12302457|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1
7829679|NCT01319929|12302458|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0
7829680|NCT01319929|12302457|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0
7829681|NCT01319929|12302458|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1
7829682|NCT01319994|12302467|FG000|Overall Study|Protocol Violation|7
7829683|NCT01319994|12302468|FG001|Overall Study|Protocol Violation|6
7829684|NCT01320033|12302477|FG000|Overall Study|Lack of Efficacy|0
7829685|NCT01320033|12302478|FG001|Overall Study|Lack of Efficacy|0
7829686|NCT01320033|12302479|FG002|Overall Study|Lack of Efficacy|1
7829687|NCT01320033|12302477|FG000|Overall Study|Adverse Event|9
7829688|NCT01320033|12302478|FG001|Overall Study|Adverse Event|7
7829689|NCT01320033|12302479|FG002|Overall Study|Adverse Event|8
7829690|NCT01320033|12302477|FG000|Overall Study|Withdrawal by Subject|22
7829691|NCT01320033|12302478|FG001|Overall Study|Withdrawal by Subject|23
7829692|NCT01320033|12302479|FG002|Overall Study|Withdrawal by Subject|23
7829693|NCT01320033|12302477|FG000|Overall Study|Protocol Violation|3
7829694|NCT01320033|12302478|FG001|Overall Study|Protocol Violation|5
7829695|NCT01320033|12302479|FG002|Overall Study|Protocol Violation|3
7829696|NCT01320033|12302477|FG000|Overall Study|Lost to Follow-up|22
7829697|NCT01320033|12302478|FG001|Overall Study|Lost to Follow-up|26
7829698|NCT01320033|12302479|FG002|Overall Study|Lost to Follow-up|17
7829699|NCT01320033|12302477|FG000|Overall Study|Other|2
7829700|NCT01320033|12302478|FG001|Overall Study|Other|3
7829701|NCT01320033|12302479|FG002|Overall Study|Other|1
7829702|NCT01320085|12302490|FG000|Overall Study|Treatment Ongoing|0
7829703|NCT01320085|12302491|FG001|Overall Study|Treatment Ongoing|13
7829704|NCT01320085|12302492|FG002|Overall Study|Treatment Ongoing|2
7829705|NCT01320085|12302490|FG000|Overall Study|Disease Progression|26
7829706|NCT01320085|12302491|FG001|Overall Study|Disease Progression|86
7829707|NCT01320085|12302492|FG002|Overall Study|Disease Progression|16
7829708|NCT01320085|12302490|FG000|Overall Study|Adverse Event|12
7829709|NCT01320085|12302491|FG001|Overall Study|Adverse Event|14
7829710|NCT01320085|12302492|FG002|Overall Study|Adverse Event|5
7829711|NCT01320085|12302490|FG000|Overall Study|Withdrawal by Subject|2
7829712|NCT01320085|12302491|FG001|Overall Study|Withdrawal by Subject|4
7829713|NCT01320085|12302492|FG002|Overall Study|Withdrawal by Subject|1
7829714|NCT01320085|12302490|FG000|Overall Study|Protocol Deviation|1
7829715|NCT01320085|12302491|FG001|Overall Study|Protocol Deviation|0
7829716|NCT01320085|12302492|FG002|Overall Study|Protocol Deviation|1
7829717|NCT01320150|12302511|FG000|Overall Study|Protocol Violation|15
7829718|NCT01320150|12302511|FG000|Overall Study|Withdrawal by Subject|5
7829719|NCT01320150|12302511|FG000|Overall Study|Death|2
7829720|NCT01320150|12302511|FG000|Overall Study|Lost to Follow-up|44
7829721|NCT01320202|12302517|FG000|Overall Study|Adverse Event|5
7948508|NCT02528357|12493684|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7948509|NCT02528357|12493666|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948510|NCT02528357|12493667|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948511|NCT02528357|12493668|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948512|NCT02528357|12493669|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948513|NCT02528357|12493670|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948514|NCT02528357|12493671|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948515|NCT02528357|12493672|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948516|NCT02528357|12493673|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948517|NCT02528357|12493674|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948518|NCT02528357|12493675|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948519|NCT02528357|12493676|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948520|NCT02528357|12493677|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948521|NCT02528357|12493678|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948522|NCT02528357|12493679|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1
7948523|NCT02528357|12493680|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948524|NCT02528357|12493681|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948525|NCT02528357|12493682|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948526|NCT02528357|12493683|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948527|NCT02528357|12493684|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7948528|NCT02528357|12493666|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7948529|NCT02528357|12493667|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7948530|NCT02528357|12493668|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7948531|NCT02528357|12493669|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7948532|NCT02528357|12493670|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7948533|NCT02528357|12493671|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7948534|NCT02528357|12493672|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7948535|NCT02528357|12493673|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7948536|NCT02528357|12493674|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7948537|NCT02528357|12493675|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7948538|NCT02528357|12493676|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3
7948539|NCT02528357|12493677|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7829722|NCT01320202|12302518|FG001|Overall Study|Adverse Event|5
7829723|NCT01320202|12302517|FG000|Overall Study|Death|5
7829724|NCT01320202|12302518|FG001|Overall Study|Death|3
7829725|NCT01320202|12302517|FG000|Overall Study|Lost to Follow-up|1
7829726|NCT01320202|12302518|FG001|Overall Study|Lost to Follow-up|0
7829727|NCT01320202|12302517|FG000|Overall Study|Physician Decision|3
7829728|NCT01320202|12302518|FG001|Overall Study|Physician Decision|1
7829729|NCT01320202|12302517|FG000|Overall Study|Protocol Violation|2
7829730|NCT01320202|12302518|FG001|Overall Study|Protocol Violation|1
7829731|NCT01320202|12302517|FG000|Overall Study|Withdrawal by Subject|10
7829732|NCT01320202|12302518|FG001|Overall Study|Withdrawal by Subject|3
7829733|NCT01320202|12302517|FG000|Overall Study|non-protocol change to ESA or IV iron|17
7829734|NCT01320202|12302518|FG001|Overall Study|non-protocol change to ESA or IV iron|20
7829735|NCT01320202|12302517|FG000|Overall Study|kidney transplant|1
7829736|NCT01320202|12302518|FG001|Overall Study|kidney transplant|2
7829737|NCT01320202|12302517|FG000|Overall Study|blood transfusion|1
7829738|NCT01320202|12302518|FG001|Overall Study|blood transfusion|7
7829739|NCT01320202|12302517|FG000|Overall Study|moved/changed dialysis|5
7829740|NCT01320202|12302518|FG001|Overall Study|moved/changed dialysis|2
7829741|NCT01320202|12302517|FG000|Overall Study|sponsor request|2
7829742|NCT01320202|12302518|FG001|Overall Study|sponsor request|0
7829743|NCT01320202|12302517|FG000|Overall Study|ineligible|3
7829744|NCT01320202|12302518|FG001|Overall Study|ineligible|0
7829745|NCT01320202|12302517|FG000|Overall Study|regained renal function|1
7829746|NCT01320202|12302518|FG001|Overall Study|regained renal function|0
7829747|NCT01320293|12302527|FG000|Overall Study|Lack of Efficacy|1
7829748|NCT01320293|12302527|FG000|Overall Study|Adverse Event|1
7829749|NCT01320722|12302553|FG000|Overall Study|Did not Receive Intervention|3
7829750|NCT01320722|12302554|FG001|Overall Study|Did not Receive Intervention|2
7829751|NCT01320722|12302555|FG002|Overall Study|Did not Receive Intervention|1
7829752|NCT01320722|12302556|FG003|Overall Study|Did not Receive Intervention|1
7829753|NCT01320722|12302557|FG004|Overall Study|Did not Receive Intervention|2
7829754|NCT01320722|12302553|FG000|Overall Study|Lost to Follow-up|0
7829755|NCT01320722|12302554|FG001|Overall Study|Lost to Follow-up|1
7829756|NCT01320722|12302555|FG002|Overall Study|Lost to Follow-up|0
7829757|NCT01320722|12302556|FG003|Overall Study|Lost to Follow-up|1
7829758|NCT01320722|12302557|FG004|Overall Study|Lost to Follow-up|3
7829759|NCT01320722|12302553|FG000|Overall Study|Not Available for the 8 Week Visit|0
7829760|NCT01320722|12302554|FG001|Overall Study|Not Available for the 8 Week Visit|3
7829761|NCT01320722|12302555|FG002|Overall Study|Not Available for the 8 Week Visit|0
7829762|NCT01320722|12302556|FG003|Overall Study|Not Available for the 8 Week Visit|0
7829763|NCT01320722|12302557|FG004|Overall Study|Not Available for the 8 Week Visit|0
7829764|NCT01320722|12302553|FG000|Overall Study|Participant Developed a Rash|0
7829765|NCT01320722|12302554|FG001|Overall Study|Participant Developed a Rash|0
7829766|NCT01320722|12302555|FG002|Overall Study|Participant Developed a Rash|2
7829767|NCT01320722|12302556|FG003|Overall Study|Participant Developed a Rash|1
7829768|NCT01320722|12302557|FG004|Overall Study|Participant Developed a Rash|1
7829769|NCT01320722|12302553|FG000|Overall Study|Non-compliant with Medication|0
7829770|NCT01320722|12302554|FG001|Overall Study|Non-compliant with Medication|0
7829771|NCT01320722|12302555|FG002|Overall Study|Non-compliant with Medication|1
7829772|NCT01320722|12302556|FG003|Overall Study|Non-compliant with Medication|0
7829773|NCT01320722|12302557|FG004|Overall Study|Non-compliant with Medication|0
7829774|NCT01320722|12302553|FG000|Overall Study|Adverse Event|0
7829775|NCT01320722|12302554|FG001|Overall Study|Adverse Event|0
7829776|NCT01320722|12302555|FG002|Overall Study|Adverse Event|3
7829777|NCT01320722|12302556|FG003|Overall Study|Adverse Event|6
7829778|NCT01320722|12302557|FG004|Overall Study|Adverse Event|0
7829779|NCT01320722|12302553|FG000|Overall Study|Not Compliant with Study Procedures|0
7829780|NCT01320722|12302554|FG001|Overall Study|Not Compliant with Study Procedures|0
7829781|NCT01320722|12302555|FG002|Overall Study|Not Compliant with Study Procedures|0
7829782|NCT01320722|12302556|FG003|Overall Study|Not Compliant with Study Procedures|4
7829783|NCT01320722|12302557|FG004|Overall Study|Not Compliant with Study Procedures|0
7829784|NCT01320722|12302553|FG000|Overall Study|Pregnancy|0
7829785|NCT01320722|12302554|FG001|Overall Study|Pregnancy|0
7829786|NCT01320722|12302555|FG002|Overall Study|Pregnancy|0
7829787|NCT01320722|12302556|FG003|Overall Study|Pregnancy|1
7829788|NCT01320722|12302557|FG004|Overall Study|Pregnancy|0
7829789|NCT01320722|12302553|FG000|Overall Study|Started an Exclusionary Medication|0
7829790|NCT01320722|12302554|FG001|Overall Study|Started an Exclusionary Medication|0
7829791|NCT01320722|12302555|FG002|Overall Study|Started an Exclusionary Medication|0
7829792|NCT01320722|12302556|FG003|Overall Study|Started an Exclusionary Medication|0
7829793|NCT01320722|12302557|FG004|Overall Study|Started an Exclusionary Medication|1
7829794|NCT01320722|12302553|FG000|Overall Study|Withdrew due to Health Condition|0
7829795|NCT01320722|12302554|FG001|Overall Study|Withdrew due to Health Condition|0
7829796|NCT01320722|12302555|FG002|Overall Study|Withdrew due to Health Condition|0
7829797|NCT01320722|12302556|FG003|Overall Study|Withdrew due to Health Condition|0
7829798|NCT01320722|12302557|FG004|Overall Study|Withdrew due to Health Condition|1
7829799|NCT01320735|12302572|FG000|Overall Study|Adverse Event|3
7829800|NCT01320735|12302572|FG000|Overall Study|Withdrawal by Subject|3
7829801|NCT01320735|12302572|FG000|Overall Study|Lost to Follow-up|13
7829802|NCT01320735|12302572|FG000|Overall Study|Administrative Reason|6
7829803|NCT01320735|12302572|FG000|Overall Study|Progression/Hormone-Refractory Pca|55
7829804|NCT01320735|12302572|FG000|Overall Study|Protocol Violation|1
7829805|NCT01320735|12302572|FG000|Overall Study|Other|1
7829806|NCT01320735|12302572|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7
7829807|NCT01320735|12302572|FG000|Overall Study|Investigator Unable to be Contacted|17
7862435|NCT01597375|12351245|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1
7862436|NCT01597375|12351246|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0
7862437|NCT01597375|12351245|FG000|First Intervention (4 Weeks)|Needed surgery|1
7862438|NCT01597375|12351246|FG001|First Intervention (4 Weeks)|Needed surgery|0
7862439|NCT01597375|12351245|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0
7829808|NCT01320943|12302593|FG000|Overall Study|Lost to Follow-up|1
7829809|NCT01320943|12302594|FG001|Overall Study|Lost to Follow-up|0
7829810|NCT01320943|12302593|FG000|Overall Study|Physician Decision|0
7829811|NCT01320943|12302594|FG001|Overall Study|Physician Decision|1
7829812|NCT01320943|12302593|FG000|Overall Study|Randomized but not Treated|0
7829813|NCT01320943|12302594|FG001|Overall Study|Randomized but not Treated|1
7829814|NCT01321606|12302653|FG000|Overall Study|Lost to Follow-up|0
7829815|NCT01321606|12302654|FG001|Overall Study|Lost to Follow-up|0
7829816|NCT01321606|12302655|FG002|Overall Study|Lost to Follow-up|0
7829817|NCT01321606|12302656|FG003|Overall Study|Lost to Follow-up|1
7829818|NCT01321710|12302669|FG000|Overall Study|Lost to Follow-up|4
7829819|NCT01321710|12302670|FG001|Overall Study|Lost to Follow-up|5
7829820|NCT01321710|12302671|FG002|Overall Study|Lost to Follow-up|0
7829821|NCT01321723|12302684|FG000|Overall Study|Adverse Event|3
7829822|NCT01321723|12302685|FG001|Overall Study|Adverse Event|5
7829823|NCT01321723|12302686|FG002|Overall Study|Adverse Event|2
7829824|NCT01321723|12302684|FG000|Overall Study|Withdrawal by Subject|2
7829825|NCT01321723|12302685|FG001|Overall Study|Withdrawal by Subject|0
7829826|NCT01321723|12302686|FG002|Overall Study|Withdrawal by Subject|2
7829827|NCT01321749|12302696|FG000|Overall Study|Lost to Follow-up|4
7829828|NCT01321749|12302697|FG001|Overall Study|Lost to Follow-up|11
7829829|NCT01321749|12302696|FG000|Overall Study|Protocol Violation|4
7829830|NCT01321749|12302697|FG001|Overall Study|Protocol Violation|7
7829831|NCT01321749|12302696|FG000|Overall Study|Withdrawal by Subject|5
7829832|NCT01321749|12302697|FG001|Overall Study|Withdrawal by Subject|4
7829833|NCT01321879|12302703|FG000|Overall Study|Lack of Efficacy|5
7829834|NCT01321879|12302703|FG000|Overall Study|Adverse Event|5
7829835|NCT01321879|12302703|FG000|Overall Study|Death|3
7829836|NCT01321879|12302703|FG000|Overall Study|Withdrawal by Subject|1
7829837|NCT01322009|12302709|FG000|Overall Study|Death|0
7829838|NCT01322009|12302710|FG001|Overall Study|Death|1
7829839|NCT01322009|12302709|FG000|Overall Study|Adverse Event|0
7829840|NCT01322009|12302710|FG001|Overall Study|Adverse Event|1
7829841|NCT01322009|12302709|FG000|Overall Study|ng tube discontinued|0
7829842|NCT01322009|12302710|FG001|Overall Study|ng tube discontinued|1
7829843|NCT01322347|12302736|FG000|Overall Study|Adverse Event|7
7829844|NCT01322347|12302737|FG001|Overall Study|Adverse Event|2
7829845|NCT01322347|12302736|FG000|Overall Study|Death|5
7829846|NCT01322347|12302737|FG001|Overall Study|Death|3
7829847|NCT01322347|12302736|FG000|Overall Study|Physician Decision|2
7829848|NCT01322347|12302737|FG001|Overall Study|Physician Decision|1
7829849|NCT01322347|12302736|FG000|Overall Study|Protocol Violation|5
7829850|NCT01322347|12302737|FG001|Overall Study|Protocol Violation|2
7829851|NCT01322347|12302736|FG000|Overall Study|Withdrawal by Subject|1
7829852|NCT01322347|12302737|FG001|Overall Study|Withdrawal by Subject|4
7829853|NCT01322347|12302736|FG000|Overall Study|non-protocol change to ESA or IV iron|14
7829854|NCT01322347|12302737|FG001|Overall Study|non-protocol change to ESA or IV iron|6
7829855|NCT01322347|12302736|FG000|Overall Study|blood transfusion|5
7829856|NCT01322347|12302737|FG001|Overall Study|blood transfusion|5
7829857|NCT01322347|12302736|FG000|Overall Study|sponsor decision|1
7829858|NCT01322347|12302737|FG001|Overall Study|sponsor decision|3
7829859|NCT01322347|12302736|FG000|Overall Study|ineligible|6
7829860|NCT01322347|12302737|FG001|Overall Study|ineligible|3
7829861|NCT01322347|12302736|FG000|Overall Study|kidney transplant|3
7829862|NCT01322347|12302737|FG001|Overall Study|kidney transplant|1
7829863|NCT01322347|12302736|FG000|Overall Study|study drug withheld > 12 wks|0
7829864|NCT01322347|12302737|FG001|Overall Study|study drug withheld > 12 wks|1
7829865|NCT01322347|12302736|FG000|Overall Study|moved/changed dialysis|2
7829866|NCT01322347|12302737|FG001|Overall Study|moved/changed dialysis|4
7829867|NCT01322386|12302751|FG000|Overall Study|Protocol Violation|0
7829868|NCT01322386|12302752|FG001|Overall Study|Protocol Violation|1
7829869|NCT01322386|12302751|FG000|Overall Study|Physician Decision|0
7829870|NCT01322386|12302752|FG001|Overall Study|Physician Decision|1
7829871|NCT01322490|12302763|FG000|Treatment Period|Adverse Event|12
7829872|NCT01322490|12302764|FG001|Treatment Period|Adverse Event|18
7829873|NCT01322490|12302765|FG002|Treatment Period|Adverse Event|15
7829874|NCT01322490|12302763|FG000|Treatment Period|Death|5
7829875|NCT01322490|12302764|FG001|Treatment Period|Death|7
7829876|NCT01322490|12302765|FG002|Treatment Period|Death|3
7829877|NCT01322490|12302763|FG000|Treatment Period|Lack of Efficacy|89
7829878|NCT01322490|12302764|FG001|Treatment Period|Lack of Efficacy|100
7829879|NCT01322490|12302765|FG002|Treatment Period|Lack of Efficacy|112
7829880|NCT01322490|12302763|FG000|Treatment Period|Physician Decision|0
7829881|NCT01322490|12302764|FG001|Treatment Period|Physician Decision|2
7829882|NCT01322490|12302765|FG002|Treatment Period|Physician Decision|1
7829883|NCT01322490|12302763|FG000|Treatment Period|Protocol Violation|7
7829884|NCT01322490|12302764|FG001|Treatment Period|Protocol Violation|5
7829885|NCT01322490|12302765|FG002|Treatment Period|Protocol Violation|4
7829886|NCT01322490|12302763|FG000|Treatment Period|Withdrawal by Subject|14
7829887|NCT01322490|12302764|FG001|Treatment Period|Withdrawal by Subject|16
7829888|NCT01322490|12302765|FG002|Treatment Period|Withdrawal by Subject|11
7829889|NCT01322490|12302763|FG000|Treatment Period|Non-compliance with study drug|0
7829890|NCT01322490|12302764|FG001|Treatment Period|Non-compliance with study drug|0
7829891|NCT01322490|12302765|FG002|Treatment Period|Non-compliance with study drug|1
7829892|NCT01322490|12302763|FG000|Treatment Period|Other per report|2
7829893|NCT01322490|12302764|FG001|Treatment Period|Other per report|2
7829894|NCT01322490|12302765|FG002|Treatment Period|Other per report|1
7829895|NCT01322490|12302763|FG000|Treatment Period|Randomized but Not Treated|3
7829896|NCT01322490|12302764|FG001|Treatment Period|Randomized but Not Treated|3
7829897|NCT01322490|12302765|FG002|Treatment Period|Randomized but Not Treated|5
7829898|NCT01322490|12302763|FG000|Long Term Follow-up Period|Death|235
7829899|NCT01322490|12302764|FG001|Long Term Follow-up Period|Death|239
7829900|NCT01322490|12302765|FG002|Long Term Follow-up Period|Death|236
7829901|NCT01322490|12302763|FG000|Long Term Follow-up Period|Lost to Follow-up|2
7829902|NCT01322490|12302764|FG001|Long Term Follow-up Period|Lost to Follow-up|2
7829903|NCT01322490|12302765|FG002|Long Term Follow-up Period|Lost to Follow-up|3
7829904|NCT01322490|12302763|FG000|Long Term Follow-up Period|Withdrawal by Subject|9
7829905|NCT01322490|12302764|FG001|Long Term Follow-up Period|Withdrawal by Subject|6
7829906|NCT01322490|12302765|FG002|Long Term Follow-up Period|Withdrawal by Subject|6
7829907|NCT01322490|12302763|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160
7829908|NCT01322490|12302764|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158
7829909|NCT01322490|12302765|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165
7829910|NCT01322490|12302763|FG000|Long Term Follow-up Period|Other per report|3
7829911|NCT01322490|12302764|FG001|Long Term Follow-up Period|Other per report|2
7829912|NCT01322490|12302765|FG002|Long Term Follow-up Period|Other per report|2
7829913|NCT01322490|12302763|FG000|Long Term Follow-up Period|Unknown/Missing|0
7829914|NCT01322490|12302764|FG001|Long Term Follow-up Period|Unknown/Missing|1
7829915|NCT01322490|12302765|FG002|Long Term Follow-up Period|Unknown/Missing|1
7829916|NCT01323192|12302881|FG000|Overall Study|Adverse Event|6
7829917|NCT01323192|12302882|FG001|Overall Study|Adverse Event|1
7829918|NCT01323192|12302881|FG000|Overall Study|Withdrawal by Subject|3
7829919|NCT01323192|12302882|FG001|Overall Study|Withdrawal by Subject|1
7829920|NCT01323192|12302881|FG000|Overall Study|Noncompliance with study medication|0
7829921|NCT01323192|12302882|FG001|Overall Study|Noncompliance with study medication|3
7829922|NCT01323192|12302881|FG000|Overall Study|Nonmedical reasons|0
7829923|NCT01323192|12302882|FG001|Overall Study|Nonmedical reasons|1
7829924|NCT01323270|12302890|FG000|Overall Study|Withdrawal by Subject|19
7829925|NCT01323270|12302891|FG001|Overall Study|Withdrawal by Subject|10
7829926|NCT01323270|12302890|FG000|Overall Study|Protocol Violation|9
7829927|NCT01323270|12302891|FG001|Overall Study|Protocol Violation|7
7829928|NCT01323270|12302890|FG000|Overall Study|Lost to Follow-up|4
7829929|NCT01323270|12302891|FG001|Overall Study|Lost to Follow-up|6
7829930|NCT01323270|12302890|FG000|Overall Study|Adverse Event|8
7829931|NCT01323270|12302891|FG001|Overall Study|Adverse Event|0
7829932|NCT01323270|12302890|FG000|Overall Study|Other|0
7829933|NCT01323270|12302891|FG001|Overall Study|Other|3
7829934|NCT01323270|12302890|FG000|Overall Study|Physician Decision|0
7829935|NCT01323270|12302891|FG001|Overall Study|Physician Decision|2
7829936|NCT01323270|12302890|FG000|Overall Study|Not eligible|1
7829937|NCT01323270|12302891|FG001|Overall Study|Not eligible|1
7829938|NCT01323270|12302890|FG000|Overall Study|Death|1
7829939|NCT01323270|12302891|FG001|Overall Study|Death|0
7829940|NCT01323270|12302890|FG000|Overall Study|Randomized, but not vaccinated|1
7829941|NCT01323270|12302891|FG001|Overall Study|Randomized, but not vaccinated|0
7829942|NCT01323387|12302898|FG000|Overall Study|Withdrawal by Subject|41
7829943|NCT01323387|12302898|FG000|Overall Study|Radiographic Data Unavailable|1
7829944|NCT01323387|12302898|FG000|Overall Study|Revision|14
7829945|NCT01323387|12302898|FG000|Overall Study|Protocol Violation|12
7829946|NCT01323387|12302898|FG000|Overall Study|Randomized but Never Treated|16
7829947|NCT01323478|12302904|FG000|Overall Study|Adverse Event|7
7829948|NCT01323478|12302904|FG000|Overall Study|Lack of Efficacy|4
7829949|NCT01323478|12302904|FG000|Overall Study|Non-compliance With Study Product|3
7829950|NCT01323478|12302904|FG000|Overall Study|Protocol Violation|1
7829951|NCT01323478|12302904|FG000|Overall Study|Withdrawal of Consent|1
7829952|NCT01323478|12302904|FG000|Overall Study|Administrative or Other Reasons|8
7829953|NCT01323530|12302919|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2
7829954|NCT01323530|12302920|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0
7829955|NCT01323530|12302921|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0
7829956|NCT01323530|12302922|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0
7829957|NCT01323530|12302923|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0
7829958|NCT01323530|12302924|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2
7829959|NCT01323530|12302925|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0
7829960|NCT01323530|12302919|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
7829961|NCT01323530|12302920|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
7829962|NCT01323530|12302921|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
7829963|NCT01323530|12302922|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
7829964|NCT01323530|12302923|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2
7829965|NCT01323530|12302924|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
7829966|NCT01323530|12302925|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
7829967|NCT01323530|12302919|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
7829968|NCT01323530|12302920|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
7829969|NCT01323530|12302921|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
7829970|NCT01323530|12302922|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
7829971|NCT01323530|12302923|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
7829972|NCT01323530|12302924|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
7829973|NCT01323530|12302925|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
7829974|NCT01323530|12302919|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7829975|NCT01323530|12302920|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7829976|NCT01323530|12302921|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7829977|NCT01323530|12302922|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7829978|NCT01323530|12302923|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7829979|NCT01323530|12302924|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7829980|NCT01323530|12302925|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2
7829981|NCT01323530|12302919|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7829982|NCT01323530|12302920|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7829983|NCT01323530|12302921|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7829984|NCT01323530|12302922|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7829985|NCT01323530|12302923|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7829986|NCT01323530|12302924|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7829987|NCT01323530|12302925|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3
7829988|NCT01323530|12302919|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7829989|NCT01323530|12302920|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7829990|NCT01323530|12302921|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7829991|NCT01323530|12302922|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7829992|NCT01323530|12302923|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7829993|NCT01323530|12302924|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7829994|NCT01323530|12302925|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8
7829995|NCT01323530|12302919|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7829996|NCT01323530|12302920|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7829997|NCT01323530|12302921|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7829998|NCT01323530|12302922|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7829999|NCT01323530|12302923|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7830000|NCT01323530|12302924|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7830001|NCT01323530|12302925|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3
7830002|NCT01323530|12302919|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7830003|NCT01323530|12302920|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7830004|NCT01323530|12302921|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7830005|NCT01323530|12302922|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7830006|NCT01323530|12302923|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7830007|NCT01323530|12302924|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7830008|NCT01323530|12302925|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1
7830009|NCT01323582|12302944|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2
7830010|NCT01323582|12302945|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2
7830011|NCT01323582|12302944|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0
7830012|NCT01323582|12302945|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1
7830013|NCT01323582|12302944|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
7830014|NCT01323582|12302945|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
7830015|NCT01323621|12302966|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
7830016|NCT01323621|12302967|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
7830017|NCT01323621|12302968|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
7830018|NCT01323621|12302966|FG000|2-week, Single-blind Run In Period|Physician Decision|7
7830019|NCT01323621|12302967|FG001|2-week, Single-blind Run In Period|Physician Decision|0
7830020|NCT01323621|12302968|FG002|2-week, Single-blind Run In Period|Physician Decision|0
7830021|NCT01323621|12302966|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12
7830022|NCT01323621|12302967|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0
7830023|NCT01323621|12302968|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0
7830024|NCT01323621|12302966|FG000|2-week, Single-blind Run In Period|Protocol Violation|1
7830025|NCT01323621|12302967|FG001|2-week, Single-blind Run In Period|Protocol Violation|0
7830026|NCT01323621|12302968|FG002|2-week, Single-blind Run In Period|Protocol Violation|0
7830027|NCT01323621|12302966|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1
7830028|NCT01323621|12302967|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0
7830029|NCT01323621|12302968|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0
7830030|NCT01323621|12302966|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
7830031|NCT01323621|12302967|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
7830032|NCT01323621|12302968|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
7830033|NCT01323621|12302966|FG000|12-week, Double-blind Treatment Period|Adverse Event|0
7830034|NCT01323621|12302967|FG001|12-week, Double-blind Treatment Period|Adverse Event|1
7830035|NCT01323621|12302968|FG002|12-week, Double-blind Treatment Period|Adverse Event|5
7948540|NCT02528357|12493678|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1
7830036|NCT01323621|12302966|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0
7830037|NCT01323621|12302967|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2
7830038|NCT01323621|12302968|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6
7830039|NCT01323621|12302966|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0
7830040|NCT01323621|12302967|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4
7830041|NCT01323621|12302968|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4
7830042|NCT01323621|12302966|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0
7830043|NCT01323621|12302967|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1
7830044|NCT01323621|12302968|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0
7830045|NCT01323621|12302966|FG000|12-week, Double-blind Treatment Period|Physician Decision|0
7830046|NCT01323621|12302967|FG001|12-week, Double-blind Treatment Period|Physician Decision|2
7830047|NCT01323621|12302968|FG002|12-week, Double-blind Treatment Period|Physician Decision|1
7830048|NCT01323621|12302966|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
7830049|NCT01323621|12302967|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
7830050|NCT01323621|12302968|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
7830051|NCT01323634|12302976|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
7830052|NCT01323634|12302977|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
7830053|NCT01323634|12302978|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
7830054|NCT01323634|12302976|FG000|2-week Run-in Period|Continuation Criteria not Met|73
7830055|NCT01323634|12302977|FG001|2-week Run-in Period|Continuation Criteria not Met|0
7830056|NCT01323634|12302978|FG002|2-week Run-in Period|Continuation Criteria not Met|0
7830057|NCT01323634|12302976|FG000|2-week Run-in Period|Withdrawal by Subject|7
7830058|NCT01323634|12302977|FG001|2-week Run-in Period|Withdrawal by Subject|0
7830059|NCT01323634|12302978|FG002|2-week Run-in Period|Withdrawal by Subject|0
7830060|NCT01323634|12302976|FG000|2-week Run-in Period|Physician Decision|5
7830061|NCT01323634|12302977|FG001|2-week Run-in Period|Physician Decision|0
7830062|NCT01323634|12302978|FG002|2-week Run-in Period|Physician Decision|0
7830063|NCT01323634|12302976|FG000|2-week Run-in Period|Protocol Violation|1
7830064|NCT01323634|12302977|FG001|2-week Run-in Period|Protocol Violation|0
7830065|NCT01323634|12302978|FG002|2-week Run-in Period|Protocol Violation|0
7830066|NCT01323634|12302976|FG000|2-week Run-in Period|Adverse Event|1
7830067|NCT01323634|12302977|FG001|2-week Run-in Period|Adverse Event|0
7830068|NCT01323634|12302978|FG002|2-week Run-in Period|Adverse Event|0
7830069|NCT01323634|12302976|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0
7830070|NCT01323634|12302977|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8
7830071|NCT01323634|12302978|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4
7830072|NCT01323634|12302976|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7830073|NCT01323634|12302977|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7830074|NCT01323634|12302978|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
7830075|NCT01323634|12302976|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0
7830076|NCT01323634|12302977|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6
7830077|NCT01323634|12302978|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7
7830078|NCT01323634|12302976|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7830079|NCT01323634|12302977|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
7830080|NCT01323634|12302978|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
7830081|NCT01323634|12302976|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0
7830082|NCT01323634|12302977|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2
7830083|NCT01323634|12302978|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3
7830084|NCT01323634|12302976|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7830085|NCT01323634|12302977|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
7830086|NCT01323634|12302978|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
7830087|NCT01323634|12302976|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
7830088|NCT01323634|12302977|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
7830089|NCT01323634|12302978|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
7830090|NCT01323647|12302986|FG000|Overall Study|Migrated/moved from study area|2
7830091|NCT01323647|12302987|FG001|Overall Study|Migrated/moved from study area|0
7830092|NCT01323647|12302986|FG000|Overall Study|Withdrawal by Subject|5
7830093|NCT01323647|12302987|FG001|Overall Study|Withdrawal by Subject|0
7830094|NCT01323647|12302986|FG000|Overall Study|Lost to Follow-up|2
7830095|NCT01323647|12302987|FG001|Overall Study|Lost to Follow-up|0
7830096|NCT01323660|12302993|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6
7830097|NCT01323660|12302994|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1
7830098|NCT01323660|12302995|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1
7830099|NCT01323660|12302996|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3
7830100|NCT01323660|12302997|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3
7830101|NCT01323660|12302998|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4
7830102|NCT01323660|12302993|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
7830103|NCT01323660|12302994|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
7830104|NCT01323660|12302995|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
7830105|NCT01323660|12302996|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
7830106|NCT01323660|12302997|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
7830107|NCT01323660|12302998|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
7830108|NCT01323660|12302993|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2
7830109|NCT01323660|12302994|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0
7830110|NCT01323660|12302995|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1
7830111|NCT01323660|12302996|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1
7830112|NCT01323660|12302997|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1
7830113|NCT01323660|12302998|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2
7830114|NCT01323660|12302993|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7830115|NCT01323660|12302994|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7830116|NCT01323660|12302995|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7830117|NCT01323660|12302996|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7830118|NCT01323660|12302997|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
7830119|NCT01323660|12302998|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7830120|NCT01323660|12302993|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7830121|NCT01323660|12302994|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7830122|NCT01323660|12302995|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7830123|NCT01323660|12302996|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7830124|NCT01323660|12302997|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7830125|NCT01323660|12302998|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7830126|NCT01323660|12302993|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
7830127|NCT01323660|12302994|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7830128|NCT01323660|12302995|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7830129|NCT01323660|12302996|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7830130|NCT01323660|12302997|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
7830131|NCT01323660|12302998|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7830132|NCT01323660|12302993|FG000|Washout Period (14 Days)|Adverse Event|0
7830133|NCT01323660|12302994|FG001|Washout Period (14 Days)|Adverse Event|0
7830134|NCT01323660|12302995|FG002|Washout Period (14 Days)|Adverse Event|0
7830135|NCT01323660|12302996|FG003|Washout Period (14 Days)|Adverse Event|0
7830136|NCT01323660|12302997|FG004|Washout Period (14 Days)|Adverse Event|1
7830137|NCT01323660|12302998|FG005|Washout Period (14 Days)|Adverse Event|0
7830138|NCT01323660|12302993|FG000|Washout Period (14 Days)|Lack of Efficacy|0
7830139|NCT01323660|12302994|FG001|Washout Period (14 Days)|Lack of Efficacy|0
7830140|NCT01323660|12302995|FG002|Washout Period (14 Days)|Lack of Efficacy|1
7830141|NCT01323660|12302996|FG003|Washout Period (14 Days)|Lack of Efficacy|3
7830142|NCT01323660|12302997|FG004|Washout Period (14 Days)|Lack of Efficacy|2
7830143|NCT01323660|12302998|FG005|Washout Period (14 Days)|Lack of Efficacy|2
7830144|NCT01323660|12302993|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1
7830145|NCT01323660|12302994|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0
7830146|NCT01323660|12302995|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0
7830147|NCT01323660|12302996|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1
7830148|NCT01323660|12302997|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1
7830149|NCT01323660|12302998|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2
7830150|NCT01323660|12302993|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
7830151|NCT01323660|12302994|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
7830152|NCT01323660|12302995|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
7830153|NCT01323660|12302996|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
7830154|NCT01323660|12302997|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
7830155|NCT01323660|12302998|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
7830156|NCT01323660|12302993|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
7830157|NCT01323660|12302994|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
7830158|NCT01323660|12302995|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
7830159|NCT01323660|12302996|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
7830160|NCT01323660|12302997|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
7830161|NCT01323660|12302998|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
7830162|NCT01323660|12302993|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
7830163|NCT01323660|12302994|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7830164|NCT01323660|12302995|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7830165|NCT01323660|12302996|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7830166|NCT01323660|12302997|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7830167|NCT01323660|12302998|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
7830168|NCT01323660|12302993|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7830169|NCT01323660|12302994|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7830170|NCT01323660|12302995|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7830171|NCT01323660|12302996|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7830172|NCT01323660|12302997|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
7830173|NCT01323660|12302998|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7830174|NCT01323673|12303014|FG000|Overall Study|Adverse Event|0
7830175|NCT01323673|12303015|FG001|Overall Study|Adverse Event|1
7830176|NCT01323673|12303014|FG000|Overall Study|Lost to Follow-up|0
7830177|NCT01323673|12303015|FG001|Overall Study|Lost to Follow-up|1
7830178|NCT01323673|12303014|FG000|Overall Study|Protocol Violation|1
7830179|NCT01323673|12303015|FG001|Overall Study|Protocol Violation|0
7830180|NCT01323673|12303014|FG000|Overall Study|Withdrawal by Subject|2
7830181|NCT01323673|12303015|FG001|Overall Study|Withdrawal by Subject|3
7830182|NCT01323790|12303035|FG000|Overall Study|Other|3
7830183|NCT01323790|12303036|FG001|Overall Study|Other|2
7830184|NCT01323790|12303037|FG002|Overall Study|Other|1
7830185|NCT01323790|12303035|FG000|Overall Study|Lost to Follow-up|11
7830186|NCT01323790|12303036|FG001|Overall Study|Lost to Follow-up|9
7830187|NCT01323790|12303037|FG002|Overall Study|Lost to Follow-up|9
7830188|NCT01323790|12303035|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
7830189|NCT01323790|12303036|FG001|Overall Study|Study-Specific Withdrawal Criteria|3
7830190|NCT01323790|12303037|FG002|Overall Study|Study-Specific Withdrawal Criteria|3
7830191|NCT01323790|12303035|FG000|Overall Study|Lack of Efficacy|3
7830192|NCT01323790|12303036|FG001|Overall Study|Lack of Efficacy|0
7830193|NCT01323790|12303037|FG002|Overall Study|Lack of Efficacy|3
7830194|NCT01323790|12303035|FG000|Overall Study|Adverse Event|11
7830195|NCT01323790|12303036|FG001|Overall Study|Adverse Event|24
7830196|NCT01323790|12303037|FG002|Overall Study|Adverse Event|12
7830197|NCT01323790|12303035|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
7830198|NCT01323790|12303036|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
7830199|NCT01323790|12303037|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1
7830200|NCT01323790|12303035|FG000|Overall Study|Withdrawal by Subject|23
7830201|NCT01323790|12303036|FG001|Overall Study|Withdrawal by Subject|20
7830202|NCT01323790|12303037|FG002|Overall Study|Withdrawal by Subject|13
7830203|NCT01323790|12303035|FG000|Overall Study|Did Not Receive Treatment|2
7830204|NCT01323790|12303036|FG001|Overall Study|Did Not Receive Treatment|0
7830205|NCT01323790|12303037|FG002|Overall Study|Did Not Receive Treatment|1
7830206|NCT01323790|12303035|FG000|Overall Study|Severe non-compliance with protocol|2
7830207|NCT01323790|12303036|FG001|Overall Study|Severe non-compliance with protocol|2
7830208|NCT01323790|12303037|FG002|Overall Study|Severe non-compliance with protocol|2
7830209|NCT01323920|12303066|FG000|Overall Study|Death|5
7830210|NCT01323920|12303066|FG000|Overall Study|Withdrawal by Subject|1
7830211|NCT01323946|12303073|FG000|Overall Study|Lost to Follow-up|0
7830212|NCT01323946|12303074|FG001|Overall Study|Lost to Follow-up|1
7830213|NCT01323946|12303075|FG002|Overall Study|Lost to Follow-up|0
7830214|NCT01323946|12303073|FG000|Overall Study|Parents refused the last blood draw|1
7830215|NCT01323946|12303074|FG001|Overall Study|Parents refused the last blood draw|0
7830216|NCT01323946|12303075|FG002|Overall Study|Parents refused the last blood draw|0
7830217|NCT01323946|12303073|FG000|Overall Study|Withdrawal by Subject|2
7830218|NCT01323946|12303074|FG001|Overall Study|Withdrawal by Subject|2
7830219|NCT01323946|12303075|FG002|Overall Study|Withdrawal by Subject|0
7830220|NCT01323972|12303102|FG000|Overall Study|Withdrawal by Subject|1
7830221|NCT01323972|12303103|FG001|Overall Study|Withdrawal by Subject|0
7830222|NCT01323972|12303104|FG002|Overall Study|Withdrawal by Subject|1
7830223|NCT01323972|12303105|FG003|Overall Study|Withdrawal by Subject|0
7830224|NCT01323972|12303102|FG000|Overall Study|Migrated/moved from study area|1
7830225|NCT01323972|12303103|FG001|Overall Study|Migrated/moved from study area|2
7830226|NCT01323972|12303104|FG002|Overall Study|Migrated/moved from study area|0
7830227|NCT01323972|12303105|FG003|Overall Study|Migrated/moved from study area|0
7830228|NCT01323972|12303102|FG000|Overall Study|Lost to Follow-up|0
7830229|NCT01323972|12303103|FG001|Overall Study|Lost to Follow-up|1
7830230|NCT01323972|12303104|FG002|Overall Study|Lost to Follow-up|1
7830231|NCT01323972|12303105|FG003|Overall Study|Lost to Follow-up|1
7830232|NCT01324024|12303138|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2
7830233|NCT01324024|12303139|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7830234|NCT01324102|12303151|FG000|Overall Study|illness|1
7830235|NCT01324102|12303152|FG001|Overall Study|illness|6
7830236|NCT01324141|12303174|FG000|Overall Study|Declined to participate before treatment started|1
7830237|NCT01324141|12303174|FG000|Overall Study|Disease progression on study|1
7830238|NCT01324232|12303192|FG000|Overall Study|Protocol Violation|0
7830239|NCT01324232|12303193|FG001|Overall Study|Protocol Violation|0
7830240|NCT01324232|12303194|FG002|Overall Study|Protocol Violation|0
7830241|NCT01324232|12303195|FG003|Overall Study|Protocol Violation|2
7830242|NCT01324232|12303192|FG000|Overall Study|Missing|0
7830243|NCT01324232|12303193|FG001|Overall Study|Missing|0
7830244|NCT01324232|12303194|FG002|Overall Study|Missing|1
7830245|NCT01324232|12303195|FG003|Overall Study|Missing|0
7830246|NCT01324232|12303192|FG000|Overall Study|Participant's Personal Reason/Decision|0
7830247|NCT01324232|12303193|FG001|Overall Study|Participant's Personal Reason/Decision|1
7830248|NCT01324232|12303194|FG002|Overall Study|Participant's Personal Reason/Decision|0
7830249|NCT01324232|12303195|FG003|Overall Study|Participant's Personal Reason/Decision|0
7830250|NCT01324232|12303192|FG000|Overall Study|Lack of Efficacy|2
7830251|NCT01324232|12303193|FG001|Overall Study|Lack of Efficacy|1
7830252|NCT01324232|12303194|FG002|Overall Study|Lack of Efficacy|2
7830253|NCT01324232|12303195|FG003|Overall Study|Lack of Efficacy|2
7830254|NCT01324232|12303192|FG000|Overall Study|Participant Refused Medication|0
7830255|NCT01324232|12303193|FG001|Overall Study|Participant Refused Medication|1
7830256|NCT01324232|12303194|FG002|Overall Study|Participant Refused Medication|0
7830257|NCT01324232|12303195|FG003|Overall Study|Participant Refused Medication|0
7830258|NCT01324232|12303192|FG000|Overall Study|Intercurrent illness|0
7830259|NCT01324232|12303193|FG001|Overall Study|Intercurrent illness|0
7830260|NCT01324232|12303194|FG002|Overall Study|Intercurrent illness|0
7830261|NCT01324232|12303195|FG003|Overall Study|Intercurrent illness|1
7830262|NCT01324232|12303192|FG000|Overall Study|Adverse Event|2
7830263|NCT01324232|12303193|FG001|Overall Study|Adverse Event|5
7830264|NCT01324232|12303194|FG002|Overall Study|Adverse Event|6
7830265|NCT01324232|12303195|FG003|Overall Study|Adverse Event|6
7830266|NCT01324232|12303192|FG000|Overall Study|Withdrawal by Subject|0
7830267|NCT01324232|12303193|FG001|Overall Study|Withdrawal by Subject|3
7830268|NCT01324232|12303194|FG002|Overall Study|Withdrawal by Subject|4
7830269|NCT01324232|12303195|FG003|Overall Study|Withdrawal by Subject|0
7830270|NCT01324232|12303192|FG000|Overall Study|Lost to Follow-up|1
7830271|NCT01324232|12303193|FG001|Overall Study|Lost to Follow-up|0
7830272|NCT01324232|12303194|FG002|Overall Study|Lost to Follow-up|0
7830273|NCT01324232|12303195|FG003|Overall Study|Lost to Follow-up|0
7830274|NCT01324271|12303210|FG000|Overall Study|Lost to Follow-up|3
7830275|NCT01324271|12303211|FG001|Overall Study|Lost to Follow-up|0
7830276|NCT01324271|12303210|FG000|Overall Study|Physician Decision|1
7830277|NCT01324271|12303211|FG001|Overall Study|Physician Decision|0
7830278|NCT01324310|12303217|FG000|Overall Study|Adverse Event|1
7830279|NCT01324310|12303217|FG000|Overall Study|Disease Progression|1
7830280|NCT01324323|12303223|FG000|Overall Study|Withdrawal by Subject|1
7830281|NCT01324349|12303237|FG000|Overall Study|Death|1
7830282|NCT01324349|12303238|FG001|Overall Study|Death|1
7830283|NCT01324349|12303237|FG000|Overall Study|Withdrawal by Subject|0
7830284|NCT01324349|12303238|FG001|Overall Study|Withdrawal by Subject|1
7830285|NCT01324388|12303247|FG000|Part 1 of Study|Adverse Event|2
7830286|NCT01324388|12303248|FG001|Part 1 of Study|Adverse Event|0
7830287|NCT01324388|12303249|FG002|Part 1 of Study|Adverse Event|0
7830288|NCT01324388|12303250|FG003|Part 1 of Study|Adverse Event|0
7830289|NCT01324388|12303247|FG000|Part 1 of Study|Protocol Violation|1
7830290|NCT01324388|12303248|FG001|Part 1 of Study|Protocol Violation|2
7830291|NCT01324388|12303249|FG002|Part 1 of Study|Protocol Violation|0
7830292|NCT01324388|12303250|FG003|Part 1 of Study|Protocol Violation|0
7830293|NCT01324388|12303247|FG000|Part 1 of Study|Physician Decision|1
7830294|NCT01324388|12303248|FG001|Part 1 of Study|Physician Decision|0
7830295|NCT01324388|12303249|FG002|Part 1 of Study|Physician Decision|0
7830296|NCT01324388|12303250|FG003|Part 1 of Study|Physician Decision|0
7830297|NCT01324388|12303247|FG000|Part 2 of Study: First Intervention|Protocol Violation|0
7830298|NCT01324388|12303248|FG001|Part 2 of Study: First Intervention|Protocol Violation|0
7830299|NCT01324388|12303249|FG002|Part 2 of Study: First Intervention|Protocol Violation|0
7830300|NCT01324388|12303250|FG003|Part 2 of Study: First Intervention|Protocol Violation|1
7830301|NCT01324388|12303247|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
7830302|NCT01324388|12303248|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
7830303|NCT01324388|12303249|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
7830304|NCT01324388|12303250|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
7830305|NCT01324401|12303264|FG000|Overall Study|Withdrawn before any treatment|0
7830306|NCT01324401|12303265|FG001|Overall Study|Withdrawn before any treatment|3
7830307|NCT01324401|12303264|FG000|Overall Study|Adverse Event|1
7830308|NCT01324401|12303265|FG001|Overall Study|Adverse Event|3
7830309|NCT01324440|12303273|FG000|Overall Study|Subject moved|0
7830310|NCT01324440|12303274|FG001|Overall Study|Subject moved|1
7830311|NCT01324570|12303304|FG000|Overall Study|Adverse Event|4
7830312|NCT01324570|12303305|FG001|Overall Study|Adverse Event|7
7830313|NCT01324570|12303304|FG000|Overall Study|Withdrawal by Subject|0
7830314|NCT01324570|12303305|FG001|Overall Study|Withdrawal by Subject|3
7830315|NCT01324570|12303304|FG000|Overall Study|Lack of Efficacy|0
7830316|NCT01324570|12303305|FG001|Overall Study|Lack of Efficacy|1
7830317|NCT01324570|12303304|FG000|Overall Study|Confirmed or suspected diversion|0
7830318|NCT01324570|12303305|FG001|Overall Study|Confirmed or suspected diversion|1
7830319|NCT01324570|12303304|FG000|Overall Study|Administrative|0
7830320|NCT01324570|12303305|FG001|Overall Study|Administrative|2
7830321|NCT01324622|12303315|FG000|Overall Study|Lost to Follow-up|7
7830322|NCT01324622|12303316|FG001|Overall Study|Lost to Follow-up|7
7830323|NCT01324622|12303315|FG000|Overall Study|Death|1
7830324|NCT01324622|12303316|FG001|Overall Study|Death|0
7830325|NCT01324622|12303315|FG000|Overall Study|Lack of Efficacy|1
7830326|NCT01324622|12303316|FG001|Overall Study|Lack of Efficacy|0
7830327|NCT01324830|12303368|FG000|Overall Study|Progressive Disease|3
7830328|NCT01324830|12303369|FG001|Overall Study|Progressive Disease|2
7830329|NCT01324830|12303370|FG002|Overall Study|Progressive Disease|3
7830330|NCT01324830|12303371|FG003|Overall Study|Progressive Disease|3
7830331|NCT01324830|12303372|FG004|Overall Study|Progressive Disease|6
7830332|NCT01324830|12303373|FG005|Overall Study|Progressive Disease|6
7830333|NCT01324830|12303374|FG006|Overall Study|Progressive Disease|3
7830334|NCT01324830|12303375|FG007|Overall Study|Progressive Disease|3
7830335|NCT01324830|12303376|FG008|Overall Study|Progressive Disease|3
7830336|NCT01324830|12303377|FG009|Overall Study|Progressive Disease|6
7830337|NCT01324830|12303378|FG010|Overall Study|Progressive Disease|2
7830338|NCT01324830|12303379|FG011|Overall Study|Progressive Disease|1
7830339|NCT01324830|12303380|FG012|Overall Study|Progressive Disease|1
7830340|NCT01324830|12303381|FG013|Overall Study|Progressive Disease|1
7830341|NCT01324830|12303382|FG014|Overall Study|Progressive Disease|1
7830342|NCT01324830|12303383|FG015|Overall Study|Progressive Disease|3
7830343|NCT01324830|12303384|FG016|Overall Study|Progressive Disease|2
7830344|NCT01324830|12303385|FG017|Overall Study|Progressive Disease|3
7830345|NCT01324830|12303386|FG018|Overall Study|Progressive Disease|4
7830346|NCT01324830|12303368|FG000|Overall Study|Dose limiting toxicity|0
7830347|NCT01324830|12303369|FG001|Overall Study|Dose limiting toxicity|0
7830348|NCT01324830|12303370|FG002|Overall Study|Dose limiting toxicity|0
7830349|NCT01324830|12303371|FG003|Overall Study|Dose limiting toxicity|0
7830350|NCT01324830|12303372|FG004|Overall Study|Dose limiting toxicity|1
7830351|NCT01324830|12303373|FG005|Overall Study|Dose limiting toxicity|0
7830352|NCT01324830|12303374|FG006|Overall Study|Dose limiting toxicity|0
7830353|NCT01324830|12303375|FG007|Overall Study|Dose limiting toxicity|0
7830354|NCT01324830|12303376|FG008|Overall Study|Dose limiting toxicity|0
7830355|NCT01324830|12303377|FG009|Overall Study|Dose limiting toxicity|0
7830356|NCT01324830|12303378|FG010|Overall Study|Dose limiting toxicity|0
7830357|NCT01324830|12303379|FG011|Overall Study|Dose limiting toxicity|0
7830358|NCT01324830|12303380|FG012|Overall Study|Dose limiting toxicity|0
7830359|NCT01324830|12303381|FG013|Overall Study|Dose limiting toxicity|0
7830360|NCT01324830|12303382|FG014|Overall Study|Dose limiting toxicity|0
7830361|NCT01324830|12303383|FG015|Overall Study|Dose limiting toxicity|0
7830362|NCT01324830|12303384|FG016|Overall Study|Dose limiting toxicity|1
7830363|NCT01324830|12303385|FG017|Overall Study|Dose limiting toxicity|1
7830364|NCT01324830|12303386|FG018|Overall Study|Dose limiting toxicity|1
7830365|NCT01324830|12303368|FG000|Overall Study|Reason not mentioned above|0
7830366|NCT01324830|12303369|FG001|Overall Study|Reason not mentioned above|0
7830367|NCT01324830|12303370|FG002|Overall Study|Reason not mentioned above|0
7830368|NCT01324830|12303371|FG003|Overall Study|Reason not mentioned above|0
7830369|NCT01324830|12303372|FG004|Overall Study|Reason not mentioned above|0
7830370|NCT01324830|12303373|FG005|Overall Study|Reason not mentioned above|0
7830371|NCT01324830|12303374|FG006|Overall Study|Reason not mentioned above|0
7830372|NCT01324830|12303375|FG007|Overall Study|Reason not mentioned above|0
7830373|NCT01324830|12303376|FG008|Overall Study|Reason not mentioned above|0
7830374|NCT01324830|12303377|FG009|Overall Study|Reason not mentioned above|0
7830375|NCT01324830|12303378|FG010|Overall Study|Reason not mentioned above|0
7830376|NCT01324830|12303379|FG011|Overall Study|Reason not mentioned above|0
7830377|NCT01324830|12303380|FG012|Overall Study|Reason not mentioned above|0
7830378|NCT01324830|12303381|FG013|Overall Study|Reason not mentioned above|0
7830379|NCT01324830|12303382|FG014|Overall Study|Reason not mentioned above|0
7830380|NCT01324830|12303383|FG015|Overall Study|Reason not mentioned above|0
7830381|NCT01324830|12303384|FG016|Overall Study|Reason not mentioned above|0
7830382|NCT01324830|12303385|FG017|Overall Study|Reason not mentioned above|1
7830383|NCT01324830|12303386|FG018|Overall Study|Reason not mentioned above|0
7830384|NCT01324830|12303368|FG000|Overall Study|Adverse Event, serious fatal|0
7830385|NCT01324830|12303369|FG001|Overall Study|Adverse Event, serious fatal|1
7830386|NCT01324830|12303370|FG002|Overall Study|Adverse Event, serious fatal|0
7830387|NCT01324830|12303371|FG003|Overall Study|Adverse Event, serious fatal|0
7830388|NCT01324830|12303372|FG004|Overall Study|Adverse Event, serious fatal|0
7830389|NCT01324830|12303373|FG005|Overall Study|Adverse Event, serious fatal|0
7830390|NCT01324830|12303374|FG006|Overall Study|Adverse Event, serious fatal|0
7830391|NCT01324830|12303375|FG007|Overall Study|Adverse Event, serious fatal|0
7830392|NCT01324830|12303376|FG008|Overall Study|Adverse Event, serious fatal|0
7830393|NCT01324830|12303377|FG009|Overall Study|Adverse Event, serious fatal|0
7830394|NCT01324830|12303378|FG010|Overall Study|Adverse Event, serious fatal|0
7830395|NCT01324830|12303379|FG011|Overall Study|Adverse Event, serious fatal|0
7830396|NCT01324830|12303380|FG012|Overall Study|Adverse Event, serious fatal|0
7830397|NCT01324830|12303381|FG013|Overall Study|Adverse Event, serious fatal|0
7830398|NCT01324830|12303382|FG014|Overall Study|Adverse Event, serious fatal|0
7830399|NCT01324830|12303383|FG015|Overall Study|Adverse Event, serious fatal|0
7830400|NCT01324830|12303384|FG016|Overall Study|Adverse Event, serious fatal|0
7830401|NCT01324830|12303385|FG017|Overall Study|Adverse Event, serious fatal|0
7830402|NCT01324830|12303386|FG018|Overall Study|Adverse Event, serious fatal|0
7830403|NCT01324830|12303368|FG000|Overall Study|Adverse Event, non-fatal|0
7830404|NCT01324830|12303369|FG001|Overall Study|Adverse Event, non-fatal|0
7830405|NCT01324830|12303370|FG002|Overall Study|Adverse Event, non-fatal|0
7830406|NCT01324830|12303371|FG003|Overall Study|Adverse Event, non-fatal|0
7830407|NCT01324830|12303372|FG004|Overall Study|Adverse Event, non-fatal|0
7830408|NCT01324830|12303373|FG005|Overall Study|Adverse Event, non-fatal|0
7830409|NCT01324830|12303374|FG006|Overall Study|Adverse Event, non-fatal|0
7830410|NCT01324830|12303375|FG007|Overall Study|Adverse Event, non-fatal|0
7830411|NCT01324830|12303376|FG008|Overall Study|Adverse Event, non-fatal|2
7830412|NCT01324830|12303377|FG009|Overall Study|Adverse Event, non-fatal|0
7830413|NCT01324830|12303378|FG010|Overall Study|Adverse Event, non-fatal|1
7830414|NCT01324830|12303379|FG011|Overall Study|Adverse Event, non-fatal|0
7830415|NCT01324830|12303380|FG012|Overall Study|Adverse Event, non-fatal|0
7830416|NCT01324830|12303381|FG013|Overall Study|Adverse Event, non-fatal|0
7830417|NCT01324830|12303382|FG014|Overall Study|Adverse Event, non-fatal|0
7830418|NCT01324830|12303383|FG015|Overall Study|Adverse Event, non-fatal|0
7830419|NCT01324830|12303384|FG016|Overall Study|Adverse Event, non-fatal|0
7830420|NCT01324830|12303385|FG017|Overall Study|Adverse Event, non-fatal|1
7830421|NCT01324830|12303386|FG018|Overall Study|Adverse Event, non-fatal|0
7830422|NCT01324830|12303368|FG000|Overall Study|Withdrawal by Subject|0
7830423|NCT01324830|12303369|FG001|Overall Study|Withdrawal by Subject|0
7830424|NCT01324830|12303370|FG002|Overall Study|Withdrawal by Subject|0
7830425|NCT01324830|12303371|FG003|Overall Study|Withdrawal by Subject|0
7830426|NCT01324830|12303372|FG004|Overall Study|Withdrawal by Subject|0
7830427|NCT01324830|12303373|FG005|Overall Study|Withdrawal by Subject|1
7830428|NCT01324830|12303374|FG006|Overall Study|Withdrawal by Subject|0
7830429|NCT01324830|12303375|FG007|Overall Study|Withdrawal by Subject|0
7830430|NCT01324830|12303376|FG008|Overall Study|Withdrawal by Subject|0
7830431|NCT01324830|12303377|FG009|Overall Study|Withdrawal by Subject|0
7830432|NCT01324830|12303378|FG010|Overall Study|Withdrawal by Subject|1
7830433|NCT01324830|12303379|FG011|Overall Study|Withdrawal by Subject|0
7830434|NCT01324830|12303380|FG012|Overall Study|Withdrawal by Subject|0
7830435|NCT01324830|12303381|FG013|Overall Study|Withdrawal by Subject|0
7830436|NCT01324830|12303382|FG014|Overall Study|Withdrawal by Subject|0
7830437|NCT01324830|12303383|FG015|Overall Study|Withdrawal by Subject|0
7830438|NCT01324830|12303384|FG016|Overall Study|Withdrawal by Subject|0
7830439|NCT01324830|12303385|FG017|Overall Study|Withdrawal by Subject|0
7830440|NCT01324830|12303386|FG018|Overall Study|Withdrawal by Subject|1
7830441|NCT01324947|12303443|FG000|Overall Study|Adverse Event|7
7830442|NCT01324947|12303443|FG000|Overall Study|Death|10
7830443|NCT01324947|12303443|FG000|Overall Study|Other|3
7830444|NCT01324947|12303443|FG000|Overall Study|Progressive Disease|50
7830445|NCT01324947|12303443|FG000|Overall Study|Withdrawal by Subject|3
7830446|NCT01324947|12303443|FG000|Overall Study|1 discontinued before starting drug|1
7830447|NCT01324999|12303449|FG000|Overall Study|Adverse Event|3
7830448|NCT01324999|12303449|FG000|Overall Study|Withdrawal by Subject|2
7830449|NCT01325207|12303468|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
7830450|NCT01325207|12303469|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
7830451|NCT01325207|12303470|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
7830452|NCT01325207|12303471|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
7830453|NCT01325207|12303472|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2
7830454|NCT01325207|12303473|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
7830455|NCT01325207|12303468|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
7830456|NCT01325207|12303469|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
7830457|NCT01325207|12303470|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
7830458|NCT01325207|12303471|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
7830459|NCT01325207|12303472|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2
7830460|NCT01325207|12303473|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5
7830461|NCT01325207|12303468|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
7830462|NCT01325207|12303469|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
7830463|NCT01325207|12303470|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
7830464|NCT01325207|12303471|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
7830465|NCT01325207|12303472|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0
7830466|NCT01325207|12303473|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4
7830467|NCT01325207|12303468|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
7830468|NCT01325207|12303469|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1
7830469|NCT01325207|12303470|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
7830470|NCT01325207|12303471|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
7830471|NCT01325207|12303472|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
7830472|NCT01325207|12303473|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
7830473|NCT01325207|12303468|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
7830474|NCT01325207|12303469|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
7830475|NCT01325207|12303470|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
7830476|NCT01325207|12303471|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
7830477|NCT01325207|12303472|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
7830478|NCT01325207|12303473|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1
7830479|NCT01325207|12303468|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
7830480|NCT01325207|12303469|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
7830481|NCT01325207|12303470|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
7830482|NCT01325207|12303471|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
7830483|NCT01325207|12303472|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
7830484|NCT01325207|12303473|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1
7830485|NCT01325207|12303468|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
7830486|NCT01325207|12303469|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
7830487|NCT01325207|12303470|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
7830488|NCT01325207|12303471|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
7830489|NCT01325207|12303472|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1
7830490|NCT01325207|12303473|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
7830491|NCT01325337|12303502|FG000|Overall Study|Adverse Event|0
7830492|NCT01325337|12303503|FG001|Overall Study|Adverse Event|2
7830493|NCT01325337|12303504|FG002|Overall Study|Adverse Event|2
7830494|NCT01325337|12303505|FG003|Overall Study|Adverse Event|1
7830495|NCT01325337|12303506|FG004|Overall Study|Adverse Event|2
7830496|NCT01325337|12303502|FG000|Overall Study|Lost to Follow-up|2
7830497|NCT01325337|12303503|FG001|Overall Study|Lost to Follow-up|2
7830498|NCT01325337|12303504|FG002|Overall Study|Lost to Follow-up|2
7830499|NCT01325337|12303505|FG003|Overall Study|Lost to Follow-up|1
7830500|NCT01325337|12303506|FG004|Overall Study|Lost to Follow-up|2
7830501|NCT01325337|12303502|FG000|Overall Study|Personal Reasons|2
7830502|NCT01325337|12303503|FG001|Overall Study|Personal Reasons|5
7830503|NCT01325337|12303504|FG002|Overall Study|Personal Reasons|4
7830504|NCT01325337|12303505|FG003|Overall Study|Personal Reasons|8
7830505|NCT01325337|12303506|FG004|Overall Study|Personal Reasons|3
7830506|NCT01325337|12303502|FG000|Overall Study|Withdrawal by Subject|1
7830507|NCT01325337|12303503|FG001|Overall Study|Withdrawal by Subject|0
7830508|NCT01325337|12303504|FG002|Overall Study|Withdrawal by Subject|1
7830509|NCT01325337|12303505|FG003|Overall Study|Withdrawal by Subject|0
7830510|NCT01325337|12303506|FG004|Overall Study|Withdrawal by Subject|1
7830511|NCT01325350|12303523|FG000|Overall Study|Adverse Event|3
7830512|NCT01325350|12303524|FG001|Overall Study|Adverse Event|3
7830513|NCT01325350|12303525|FG002|Overall Study|Adverse Event|3
7830514|NCT01325350|12303526|FG003|Overall Study|Adverse Event|1
7830515|NCT01325350|12303527|FG004|Overall Study|Adverse Event|2
7830516|NCT01325350|12303523|FG000|Overall Study|Pregnancy|0
7830517|NCT01325350|12303524|FG001|Overall Study|Pregnancy|0
7830518|NCT01325350|12303525|FG002|Overall Study|Pregnancy|1
7830519|NCT01325350|12303526|FG003|Overall Study|Pregnancy|0
7830520|NCT01325350|12303527|FG004|Overall Study|Pregnancy|1
7830521|NCT01325350|12303523|FG000|Overall Study|Lost to Follow-up|1
7830522|NCT01325350|12303524|FG001|Overall Study|Lost to Follow-up|0
7830523|NCT01325350|12303525|FG002|Overall Study|Lost to Follow-up|5
7830524|NCT01325350|12303526|FG003|Overall Study|Lost to Follow-up|1
7830525|NCT01325350|12303527|FG004|Overall Study|Lost to Follow-up|5
7830526|NCT01325350|12303523|FG000|Overall Study|Personal Reasons|2
7830527|NCT01325350|12303524|FG001|Overall Study|Personal Reasons|1
7830528|NCT01325350|12303525|FG002|Overall Study|Personal Reasons|6
7830529|NCT01325350|12303526|FG003|Overall Study|Personal Reasons|5
7830530|NCT01325350|12303527|FG004|Overall Study|Personal Reasons|3
7830531|NCT01325350|12303523|FG000|Overall Study|Protocol Violation|0
7830532|NCT01325350|12303524|FG001|Overall Study|Protocol Violation|0
7830533|NCT01325350|12303525|FG002|Overall Study|Protocol Violation|0
7830534|NCT01325350|12303526|FG003|Overall Study|Protocol Violation|1
7830535|NCT01325350|12303527|FG004|Overall Study|Protocol Violation|0
7830536|NCT01325350|12303523|FG000|Overall Study|Withdrawal by Subject|0
7830537|NCT01325350|12303524|FG001|Overall Study|Withdrawal by Subject|0
7830538|NCT01325350|12303525|FG002|Overall Study|Withdrawal by Subject|1
7830539|NCT01325350|12303526|FG003|Overall Study|Withdrawal by Subject|1
7830540|NCT01325350|12303527|FG004|Overall Study|Withdrawal by Subject|0
7830541|NCT01325350|12303523|FG000|Overall Study|Did Not Receive Treatment|0
7830542|NCT01325350|12303524|FG001|Overall Study|Did Not Receive Treatment|1
7948541|NCT02528357|12493679|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3
7948542|NCT02528357|12493680|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1
7830543|NCT01325350|12303525|FG002|Overall Study|Did Not Receive Treatment|1
7830544|NCT01325350|12303526|FG003|Overall Study|Did Not Receive Treatment|0
7830545|NCT01325350|12303527|FG004|Overall Study|Did Not Receive Treatment|1
7830546|NCT01325428|12303539|FG000|Part A|Progressive disease according to RECIST|9
7830547|NCT01325428|12303539|FG000|Part A|Clinical signs, symptoms of progression|2
7830548|NCT01325428|12303539|FG000|Part A|Other adverse event|1
7830549|NCT01325428|12303539|FG000|Part A|Refused continue taking trial medication|2
7830550|NCT01325428|12303539|FG000|Part A|Other reason not defined above|2
7830551|NCT01325428|12303539|FG000|Part B|Refused continue taking trial medication|2
7830552|NCT01325428|12303539|FG000|Part B|Other reason not defined above|1
7830553|NCT01325493|12303550|FG000|Overall Study|Protocol Violation|0
7830554|NCT01325493|12303551|FG001|Overall Study|Protocol Violation|1
7830555|NCT01325493|12303550|FG000|Overall Study|loss of neuromonitoring signals|0
7830556|NCT01325493|12303551|FG001|Overall Study|loss of neuromonitoring signals|2
7830557|NCT01325493|12303550|FG000|Overall Study|Allergy|1
7830558|NCT01325493|12303551|FG001|Overall Study|Allergy|0
7830559|NCT01325532|12303559|FG000|Overall Study|Withdrawal by Subject|2
7830560|NCT01325532|12303560|FG001|Overall Study|Withdrawal by Subject|0
7830561|NCT01325584|12303566|FG000|Overall Study|Death|1
7830562|NCT01325623|12303570|FG000|Overall Study|Withdrawal by Subject|3
7830563|NCT01325701|12303609|FG000|Overall Study|Adverse Event|12
7830564|NCT01325701|12303610|FG001|Overall Study|Adverse Event|0
7830565|NCT01325701|12303609|FG000|Overall Study|Protocol Violation|1
7830566|NCT01325701|12303610|FG001|Overall Study|Protocol Violation|0
7830567|NCT01325701|12303609|FG000|Overall Study|Physician Decision|2
7830568|NCT01325701|12303610|FG001|Overall Study|Physician Decision|2
7830569|NCT01325701|12303609|FG000|Overall Study|Withdrawal by Subject|2
7830570|NCT01325701|12303610|FG001|Overall Study|Withdrawal by Subject|1
7830571|NCT01325701|12303609|FG000|Overall Study|Rollerover Extension Study|4
7830572|NCT01325701|12303610|FG001|Overall Study|Rollerover Extension Study|0
7830573|NCT01326026|12303647|FG000|Overall Study|Adverse Event|4
7830574|NCT01326026|12303648|FG001|Overall Study|Adverse Event|3
7830575|NCT01326026|12303647|FG000|Overall Study|Withdrawal Criteria|5
7830576|NCT01326026|12303648|FG001|Overall Study|Withdrawal Criteria|7
7830577|NCT01326026|12303647|FG000|Overall Study|Other|3
7830578|NCT01326026|12303648|FG001|Overall Study|Other|3
7830579|NCT01326481|12303654|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1
7830580|NCT01326533|12303662|FG000|Overall Study|Lost to Follow-up|2
7830581|NCT01326533|12303663|FG001|Overall Study|Lost to Follow-up|0
7830582|NCT01326533|12303662|FG000|Overall Study|Withdrawal by Subject|1
7830583|NCT01326533|12303663|FG001|Overall Study|Withdrawal by Subject|0
7830584|NCT01326533|12303662|FG000|Overall Study|Adverse Event|1
7830585|NCT01326533|12303663|FG001|Overall Study|Adverse Event|0
7830586|NCT01326546|12303671|FG000|Overall Study|Lost to Follow-up|8
7830587|NCT01326546|12303672|FG001|Overall Study|Lost to Follow-up|7
7830588|NCT01326546|12303671|FG000|Overall Study|Protocol Violation|3
7830589|NCT01326546|12303672|FG001|Overall Study|Protocol Violation|4
7830590|NCT01326546|12303671|FG000|Overall Study|Pregnancy|0
7830591|NCT01326546|12303672|FG001|Overall Study|Pregnancy|1
7830592|NCT01326546|12303671|FG000|Overall Study|Adverse Event|1
7830593|NCT01326546|12303672|FG001|Overall Study|Adverse Event|0
7830594|NCT01326546|12303671|FG000|Overall Study|Withdrawal by Subject|5
7830595|NCT01326546|12303672|FG001|Overall Study|Withdrawal by Subject|1
7830596|NCT01326702|12303685|FG000|Overall Study|Other|1
7830597|NCT01326702|12303686|FG001|Overall Study|Other|0
7830598|NCT01326702|12303687|FG002|Overall Study|Other|0
7830599|NCT01326702|12303688|FG003|Overall Study|Other|0
7830600|NCT01326702|12303689|FG004|Overall Study|Other|0
7830601|NCT01326702|12303690|FG005|Overall Study|Other|1
7830602|NCT01326702|12303691|FG006|Overall Study|Other|0
7830603|NCT01326702|12303685|FG000|Overall Study|progressive disease|1
7830604|NCT01326702|12303686|FG001|Overall Study|progressive disease|1
7830605|NCT01326702|12303687|FG002|Overall Study|progressive disease|3
7830606|NCT01326702|12303688|FG003|Overall Study|progressive disease|1
7830607|NCT01326702|12303689|FG004|Overall Study|progressive disease|3
7830608|NCT01326702|12303690|FG005|Overall Study|progressive disease|2
7830609|NCT01326702|12303691|FG006|Overall Study|progressive disease|3
7830610|NCT01326702|12303685|FG000|Overall Study|Death|0
7830611|NCT01326702|12303686|FG001|Overall Study|Death|1
7830612|NCT01326702|12303687|FG002|Overall Study|Death|0
7830613|NCT01326702|12303688|FG003|Overall Study|Death|0
7830614|NCT01326702|12303689|FG004|Overall Study|Death|0
7830615|NCT01326702|12303690|FG005|Overall Study|Death|0
7830616|NCT01326702|12303691|FG006|Overall Study|Death|0
7830617|NCT01326702|12303685|FG000|Overall Study|Adverse Event|0
7830618|NCT01326702|12303686|FG001|Overall Study|Adverse Event|0
7830619|NCT01326702|12303687|FG002|Overall Study|Adverse Event|1
7830620|NCT01326702|12303688|FG003|Overall Study|Adverse Event|1
7830621|NCT01326702|12303689|FG004|Overall Study|Adverse Event|0
7830622|NCT01326702|12303690|FG005|Overall Study|Adverse Event|3
7830623|NCT01326702|12303691|FG006|Overall Study|Adverse Event|1
7830624|NCT01326702|12303685|FG000|Overall Study|Withdrawal by Subject|0
7830625|NCT01326702|12303686|FG001|Overall Study|Withdrawal by Subject|0
7830626|NCT01326702|12303687|FG002|Overall Study|Withdrawal by Subject|1
7830627|NCT01326702|12303688|FG003|Overall Study|Withdrawal by Subject|0
7830628|NCT01326702|12303689|FG004|Overall Study|Withdrawal by Subject|1
7830629|NCT01326702|12303690|FG005|Overall Study|Withdrawal by Subject|1
7830630|NCT01326702|12303691|FG006|Overall Study|Withdrawal by Subject|3
7830631|NCT01326702|12303685|FG000|Overall Study|Not Treated|0
7830632|NCT01326702|12303686|FG001|Overall Study|Not Treated|0
7830633|NCT01326702|12303687|FG002|Overall Study|Not Treated|0
7830634|NCT01326702|12303688|FG003|Overall Study|Not Treated|1
7830635|NCT01326702|12303689|FG004|Overall Study|Not Treated|0
7830636|NCT01326702|12303690|FG005|Overall Study|Not Treated|1
7830637|NCT01326702|12303691|FG006|Overall Study|Not Treated|0
7830638|NCT01326728|12303712|FG000|Overall Study|Death|13
7830639|NCT01326728|12303713|FG001|Overall Study|Death|0
7830640|NCT01326728|12303712|FG000|Overall Study|Early closure of study|34
7830641|NCT01326728|12303713|FG001|Overall Study|Early closure of study|9
7830642|NCT01326910|12303737|FG000|Overall Study|Withdrawal by Subject|3
7830643|NCT01326910|12303738|FG001|Overall Study|Withdrawal by Subject|2
7830644|NCT01326910|12303737|FG000|Overall Study|Protocol Violation|1
7830645|NCT01326910|12303738|FG001|Overall Study|Protocol Violation|1
7830646|NCT01326962|12303744|FG000|Overall Study|Adverse Event|1
7830647|NCT01326962|12303744|FG000|Overall Study|Withdrawal by Subject|1
7830648|NCT01326962|12303744|FG000|Overall Study|Lost to Follow-up|3
7830649|NCT01326962|12303744|FG000|Overall Study|Other|2
7830650|NCT01327053|12303750|FG000|Overall Study|Adverse Event|23
7830651|NCT01327053|12303751|FG001|Overall Study|Adverse Event|57
7830652|NCT01327053|12303750|FG000|Overall Study|Patient/guardian decision|11
7830653|NCT01327053|12303751|FG001|Overall Study|Patient/guardian decision|35
7830654|NCT01327053|12303750|FG000|Overall Study|Physician Decision|10
7830655|NCT01327053|12303751|FG001|Overall Study|Physician Decision|14
7830656|NCT01327053|12303750|FG000|Overall Study|Death|1
7830657|NCT01327053|12303751|FG001|Overall Study|Death|5
7830658|NCT01327053|12303750|FG000|Overall Study|Lost to Follow-up|2
7830659|NCT01327053|12303751|FG001|Overall Study|Lost to Follow-up|4
7830660|NCT01327053|12303750|FG000|Overall Study|Non-compliance with study treatment|0
7830661|NCT01327053|12303751|FG001|Overall Study|Non-compliance with study treatment|5
7830662|NCT01327053|12303750|FG000|Overall Study|Study terminated by Sponsor|1
7830663|NCT01327053|12303751|FG001|Overall Study|Study terminated by Sponsor|3
7830664|NCT01327053|12303750|FG000|Overall Study|Progressive disease|31
7830665|NCT01327053|12303751|FG001|Overall Study|Progressive disease|26
7830666|NCT01327053|12303750|FG000|Overall Study|Protocol Violation|0
7830667|NCT01327053|12303751|FG001|Overall Study|Protocol Violation|1
7830668|NCT01327053|12303750|FG000|Overall Study|Untreated|0
7830669|NCT01327053|12303751|FG001|Overall Study|Untreated|1
7830670|NCT01327300|12303780|FG000|Washout (3 Weeks)|Withdrawal by Subject|1
7830671|NCT01327300|12303781|FG001|Washout (3 Weeks)|Withdrawal by Subject|0
7830672|NCT01327339|12303814|FG000|Overall Study|Protocol Violation|8
7830673|NCT01327482|12303818|FG000|Overall Study|Adverse Event|1
7862440|NCT01597375|12351246|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1
7862441|NCT01597375|12351245|FG000|Washout (2 Weeks)|Adverse Event|1
7862442|NCT01597375|12351246|FG001|Washout (2 Weeks)|Adverse Event|0
7862443|NCT01597375|12351245|FG000|Second Intervention|Failed to react at both Aspirin|1
7862444|NCT01597375|12351246|FG001|Second Intervention|Failed to react at both Aspirin|1
7862445|NCT01597479|12351266|FG000|Overall Study|Protocol Violation|1
7862446|NCT01597479|12351267|FG001|Overall Study|Protocol Violation|0
7862447|NCT01597479|12351266|FG000|Overall Study|Lost to Follow-up|1
7862448|NCT01597479|12351267|FG001|Overall Study|Lost to Follow-up|0
7862449|NCT01597492|12351276|FG000|Overall Study|Withdrawal by Subject|1
7862450|NCT01597492|12351277|FG001|Overall Study|Withdrawal by Subject|2
7862451|NCT01597492|12351276|FG000|Overall Study|Adverse Event|3
7862452|NCT01597492|12351277|FG001|Overall Study|Adverse Event|0
7862453|NCT01597492|12351276|FG000|Overall Study|Lost to Follow-up|0
7862454|NCT01597492|12351277|FG001|Overall Study|Lost to Follow-up|2
7862455|NCT01597492|12351276|FG000|Overall Study|Other Reason|2
7862456|NCT01597492|12351277|FG001|Overall Study|Other Reason|0
7862457|NCT01597505|12351285|FG000|Overall Study|Physician Decision|5
7862458|NCT01597505|12351286|FG001|Overall Study|Physician Decision|0
7862459|NCT01597505|12351285|FG000|Overall Study|Adverse Event|19
7862460|NCT01597505|12351286|FG001|Overall Study|Adverse Event|7
7862461|NCT01597505|12351285|FG000|Overall Study|Lost to Follow-up|4
7862462|NCT01597505|12351286|FG001|Overall Study|Lost to Follow-up|2
7830674|NCT01327495|12303828|FG000|Overall Study|Adverse Event|2
7830675|NCT01327495|12303829|FG001|Overall Study|Adverse Event|1
7830676|NCT01327495|12303830|FG002|Overall Study|Adverse Event|1
7830677|NCT01327495|12303831|FG003|Overall Study|Adverse Event|0
7830678|NCT01327495|12303832|FG004|Overall Study|Adverse Event|0
7830679|NCT01327495|12303833|FG005|Overall Study|Adverse Event|2
7830680|NCT01327495|12303828|FG000|Overall Study|Withdrawal by Subject|0
7830681|NCT01327495|12303829|FG001|Overall Study|Withdrawal by Subject|1
7830682|NCT01327495|12303830|FG002|Overall Study|Withdrawal by Subject|1
7830683|NCT01327495|12303831|FG003|Overall Study|Withdrawal by Subject|0
7830684|NCT01327495|12303832|FG004|Overall Study|Withdrawal by Subject|1
7830685|NCT01327495|12303833|FG005|Overall Study|Withdrawal by Subject|0
7830686|NCT01327495|12303828|FG000|Overall Study|Physician Decision|0
7830687|NCT01327495|12303829|FG001|Overall Study|Physician Decision|0
7830688|NCT01327495|12303830|FG002|Overall Study|Physician Decision|0
7830689|NCT01327495|12303831|FG003|Overall Study|Physician Decision|0
7830690|NCT01327495|12303832|FG004|Overall Study|Physician Decision|2
7830691|NCT01327495|12303833|FG005|Overall Study|Physician Decision|0
7830692|NCT01327547|12303864|FG000|Overall Study|Adverse Event|4
7830693|NCT01327547|12303865|FG001|Overall Study|Adverse Event|1
7830694|NCT01327547|12303864|FG000|Overall Study|Death|1
7830695|NCT01327547|12303865|FG001|Overall Study|Death|2
7830696|NCT01327547|12303864|FG000|Overall Study|Lost to Follow-up|6
7830697|NCT01327547|12303865|FG001|Overall Study|Lost to Follow-up|6
7830698|NCT01327547|12303864|FG000|Overall Study|Non-Compliance With Study Treatment|0
7830699|NCT01327547|12303865|FG001|Overall Study|Non-Compliance With Study Treatment|2
7830700|NCT01327547|12303864|FG000|Overall Study|Withdrawal by Subject|3
7830701|NCT01327547|12303865|FG001|Overall Study|Withdrawal by Subject|7
7830702|NCT01327547|12303864|FG000|Overall Study|Does Not Meet Entrance Criteria|2
7830703|NCT01327547|12303865|FG001|Overall Study|Does Not Meet Entrance Criteria|2
7830704|NCT01327547|12303864|FG000|Overall Study|Protocol Violation|1
7830705|NCT01327547|12303865|FG001|Overall Study|Protocol Violation|0
7830706|NCT01327547|12303864|FG000|Overall Study|Non-compliance due to alcohol intake|0
7830707|NCT01327547|12303865|FG001|Overall Study|Non-compliance due to alcohol intake|1
7830708|NCT01327547|12303864|FG000|Overall Study|Required prohibited medication|2
7830709|NCT01327547|12303865|FG001|Overall Study|Required prohibited medication|0
7830710|NCT01327547|12303864|FG000|Overall Study|Non-compliance with study procedures|1
7830711|NCT01327547|12303865|FG001|Overall Study|Non-compliance with study procedures|0
7830712|NCT01327547|12303864|FG000|Overall Study|By investigator in subject's interest|0
7830713|NCT01327547|12303865|FG001|Overall Study|By investigator in subject's interest|1
7830714|NCT01327573|12303882|FG000|Overall Study|Physician Decision|3
7830715|NCT01327573|12303883|FG001|Overall Study|Physician Decision|1
7830716|NCT01327599|12303890|FG000|Overall Study|Adverse Event|1
7830717|NCT01327599|12303890|FG000|Overall Study|Could Not Attend Visit|1
7830718|NCT01327599|12303890|FG000|Overall Study|Withdrawal of Consent|1
7830719|NCT01327612|12303901|FG000|Overall Study|Withdrawal by Subject|0
7830720|NCT01327612|12303902|FG001|Overall Study|Withdrawal by Subject|0
7830721|NCT01327612|12303903|FG002|Overall Study|Withdrawal by Subject|0
7830722|NCT01327612|12303904|FG003|Overall Study|Withdrawal by Subject|0
7830723|NCT01327612|12303905|FG004|Overall Study|Withdrawal by Subject|0
7830724|NCT01327612|12303906|FG005|Overall Study|Withdrawal by Subject|1
7830725|NCT01327612|12303907|FG006|Overall Study|Withdrawal by Subject|0
7830726|NCT01327612|12303901|FG000|Overall Study|Disease Progression|1
7830727|NCT01327612|12303902|FG001|Overall Study|Disease Progression|1
7830728|NCT01327612|12303903|FG002|Overall Study|Disease Progression|1
7830729|NCT01327612|12303904|FG003|Overall Study|Disease Progression|0
7830730|NCT01327612|12303905|FG004|Overall Study|Disease Progression|1
7830731|NCT01327612|12303906|FG005|Overall Study|Disease Progression|2
7830732|NCT01327612|12303907|FG006|Overall Study|Disease Progression|2
7830733|NCT01327612|12303901|FG000|Overall Study|Administrative Decision|0
7830734|NCT01327612|12303902|FG001|Overall Study|Administrative Decision|0
7830735|NCT01327612|12303903|FG002|Overall Study|Administrative Decision|0
7830736|NCT01327612|12303904|FG003|Overall Study|Administrative Decision|1
7830737|NCT01327612|12303905|FG004|Overall Study|Administrative Decision|0
7830738|NCT01327612|12303906|FG005|Overall Study|Administrative Decision|0
7830739|NCT01327612|12303907|FG006|Overall Study|Administrative Decision|0
7830740|NCT01327612|12303901|FG000|Overall Study|Death|0
7830741|NCT01327612|12303902|FG001|Overall Study|Death|0
7830742|NCT01327612|12303903|FG002|Overall Study|Death|0
7830743|NCT01327612|12303904|FG003|Overall Study|Death|0
7830744|NCT01327612|12303905|FG004|Overall Study|Death|1
7830745|NCT01327612|12303906|FG005|Overall Study|Death|0
7830746|NCT01327612|12303907|FG006|Overall Study|Death|0
7830747|NCT01327703|12303935|FG000|Second Treatment Period|Adverse Event|1
7830748|NCT01327703|12303936|FG001|Second Treatment Period|Adverse Event|1
7830749|NCT01327703|12303935|FG000|Second Treatment Period|Protocol Violation|0
7830750|NCT01327703|12303936|FG001|Second Treatment Period|Protocol Violation|1
7830751|NCT01327846|12303949|FG000|Core Phase|Subject decision (vital status: missing)|1
7830752|NCT01327846|12303950|FG001|Core Phase|Subject decision (vital status: missing)|2
7830753|NCT01327846|12303951|FG002|Core Phase|Subject decision (vital status: missing)|2
7830754|NCT01327846|12303952|FG003|Core Phase|Subject decision (vital status: missing)|1
7830755|NCT01327846|12303949|FG000|Core Phase|Subject decision (vital stat: unkn)|0
7830756|NCT01327846|12303950|FG001|Core Phase|Subject decision (vital stat: unkn)|0
7830757|NCT01327846|12303951|FG002|Core Phase|Subject decision (vital stat: unkn)|3
7830758|NCT01327846|12303952|FG003|Core Phase|Subject decision (vital stat: unkn)|3
7830759|NCT01327846|12303949|FG000|Core Phase|Subject decision (vital stat: dead)|1
7830760|NCT01327846|12303950|FG001|Core Phase|Subject decision (vital stat: dead)|3
7830761|NCT01327846|12303951|FG002|Core Phase|Subject decision (vital stat: dead)|4
7830762|NCT01327846|12303952|FG003|Core Phase|Subject decision (vital stat: dead)|4
7830763|NCT01327846|12303949|FG000|Core Phase|Subject decision (vital stat: alive)|23
7830764|NCT01327846|12303950|FG001|Core Phase|Subject decision (vital stat: alive)|24
7830765|NCT01327846|12303951|FG002|Core Phase|Subject decision (vital stat: alive)|13
7830766|NCT01327846|12303952|FG003|Core Phase|Subject decision (vital stat: alive)|20
7830767|NCT01327846|12303949|FG000|Core Phase|Lost to Follow-up|3
7830768|NCT01327846|12303950|FG001|Core Phase|Lost to Follow-up|3
7830769|NCT01327846|12303951|FG002|Core Phase|Lost to Follow-up|4
7830770|NCT01327846|12303952|FG003|Core Phase|Lost to Follow-up|5
7830771|NCT01327846|12303949|FG000|Extension Phase|Study terminated by sponsor|1073
7830772|NCT01327846|12303950|FG001|Extension Phase|Study terminated by sponsor|1124
7830773|NCT01327846|12303951|FG002|Extension Phase|Study terminated by sponsor|1067
7830774|NCT01327846|12303952|FG003|Extension Phase|Study terminated by sponsor|1660
7830775|NCT01327846|12303949|FG000|Extension Phase|Withdrawal by Subject|20
7830776|NCT01327846|12303950|FG001|Extension Phase|Withdrawal by Subject|13
7830777|NCT01327846|12303951|FG002|Extension Phase|Withdrawal by Subject|19
7830778|NCT01327846|12303952|FG003|Extension Phase|Withdrawal by Subject|37
7830779|NCT01327846|12303949|FG000|Extension Phase|Lost to Follow-up|4
7830780|NCT01327846|12303950|FG001|Extension Phase|Lost to Follow-up|3
7830781|NCT01327846|12303951|FG002|Extension Phase|Lost to Follow-up|4
7830782|NCT01327846|12303952|FG003|Extension Phase|Lost to Follow-up|7
7830783|NCT01327846|12303949|FG000|Extension Phase|Technical Problems|2
7830784|NCT01327846|12303950|FG001|Extension Phase|Technical Problems|4
7830785|NCT01327846|12303951|FG002|Extension Phase|Technical Problems|2
7830786|NCT01327846|12303952|FG003|Extension Phase|Technical Problems|2
7830787|NCT01327885|12303965|FG000|Overall Study|Disease progression-according to RECIST|173
7830788|NCT01327885|12303966|FG001|Overall Study|Disease progression-according to RECIST|165
7830789|NCT01327885|12303965|FG000|Overall Study|Clinical progression|24
7830790|NCT01327885|12303966|FG001|Overall Study|Clinical progression|27
7830791|NCT01327885|12303965|FG000|Overall Study|Adverse Event|14
7830792|NCT01327885|12303966|FG001|Overall Study|Adverse Event|10
7830793|NCT01327885|12303965|FG000|Overall Study|Subject choice|5
7830794|NCT01327885|12303966|FG001|Overall Study|Subject choice|10
7830795|NCT01327885|12303965|FG000|Overall Study|Other|8
7830796|NCT01327885|12303966|FG001|Overall Study|Other|6
7830797|NCT01327885|12303965|FG000|Overall Study|Withdrawal of consent from study|3
7830798|NCT01327885|12303966|FG001|Overall Study|Withdrawal of consent from study|4
7830799|NCT01327885|12303965|FG000|Overall Study|Not treated|1
7830800|NCT01327885|12303966|FG001|Overall Study|Not treated|1
7830801|NCT01327885|12303965|FG000|Overall Study|Administrative decision|0
7830802|NCT01327885|12303966|FG001|Overall Study|Administrative decision|1
7830803|NCT01328002|12303994|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66
7830804|NCT01328002|12303995|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0
7830805|NCT01328002|12303994|FG000|Open-Label Period|Adverse Event|8
7830806|NCT01328002|12303995|FG001|Open-Label Period|Adverse Event|0
7830807|NCT01328002|12303994|FG000|Open-Label Period|Lack of Efficacy|3
7830808|NCT01328002|12303995|FG001|Open-Label Period|Lack of Efficacy|0
7830809|NCT01328002|12303994|FG000|Open-Label Period|Protocol Violation|2
7830810|NCT01328002|12303995|FG001|Open-Label Period|Protocol Violation|0
7830811|NCT01328002|12303994|FG000|Open-Label Period|Withdrawal by Subject|9
7830812|NCT01328002|12303995|FG001|Open-Label Period|Withdrawal by Subject|0
7830813|NCT01328002|12303994|FG000|Open-Label Period|Lost to Follow-up|6
7830814|NCT01328002|12303995|FG001|Open-Label Period|Lost to Follow-up|0
7830815|NCT01328002|12303994|FG000|Open-Label Period|Other Reason|2
7830816|NCT01328002|12303995|FG001|Open-Label Period|Other Reason|0
7830817|NCT01328002|12303994|FG000|Double-Blind Period|Adverse Event|1
7830818|NCT01328002|12303995|FG001|Double-Blind Period|Adverse Event|0
7830819|NCT01328002|12303994|FG000|Double-Blind Period|Lack of Efficacy|1
7830820|NCT01328002|12303995|FG001|Double-Blind Period|Lack of Efficacy|0
7830821|NCT01328041|12304002|FG000|Overall Study|Adverse Event|7
7830822|NCT01328041|12304002|FG000|Overall Study|Lack of Efficacy|27
7830823|NCT01328041|12304002|FG000|Overall Study|Protocol Violation|7
7830824|NCT01328041|12304002|FG000|Overall Study|Lost to Follow-up|7
7830825|NCT01328041|12304002|FG000|Overall Study|Physician Decision|2
7830826|NCT01328041|12304002|FG000|Overall Study|Withdrawal by Subject|7
7830827|NCT01328054|12304006|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
7830828|NCT01328054|12304007|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
7830829|NCT01328054|12304006|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
7830830|NCT01328054|12304007|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
7830831|NCT01328054|12304006|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
7830832|NCT01328054|12304007|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
7830833|NCT01328080|12304019|FG000|Overall Study|Lost to Follow-up|5
7830834|NCT01328249|12304038|FG000|Overall Study|Adverse Event|3
7830835|NCT01328249|12304039|FG001|Overall Study|Adverse Event|0
7830836|NCT01328249|12304038|FG000|Overall Study|Disease progression|1
7830837|NCT01328249|12304039|FG001|Overall Study|Disease progression|0
7830838|NCT01328249|12304038|FG000|Overall Study|Withdrawal by Subject|1
7830839|NCT01328249|12304039|FG001|Overall Study|Withdrawal by Subject|1
7830840|NCT01328249|12304038|FG000|Overall Study|Moved before end of treatment visit|1
7830841|NCT01328249|12304039|FG001|Overall Study|Moved before end of treatment visit|0
7830842|NCT01328249|12304038|FG000|Overall Study|Subject choice|1
7830843|NCT01328249|12304039|FG001|Overall Study|Subject choice|1
7830844|NCT01328249|12304038|FG000|Overall Study|Protocol Violation|0
7830845|NCT01328249|12304039|FG001|Overall Study|Protocol Violation|1
7830846|NCT01328366|12304047|FG000|Overall Study|Death|1
7830847|NCT01328366|12304047|FG000|Overall Study|Withdrawal by Subject|2
7830848|NCT01328366|12304047|FG000|Overall Study|Lost to Follow-up|7
7830849|NCT01328431|12304075|FG000|Baseline|Protocol Violation|0
7830850|NCT01328431|12304076|FG001|Baseline|Protocol Violation|2
7830851|NCT01328431|12304075|FG000|1 Month (1M)|Lost to Follow-up|55
7830852|NCT01328431|12304076|FG001|1 Month (1M)|Lost to Follow-up|58
7830853|NCT01328431|12304075|FG000|3 Month (3M)|Death|2
7830854|NCT01328431|12304076|FG001|3 Month (3M)|Death|2
7830855|NCT01328431|12304075|FG000|3 Month (3M)|Lost to Follow-up|75
7830856|NCT01328431|12304076|FG001|3 Month (3M)|Lost to Follow-up|70
7830857|NCT01328431|12304075|FG000|12 Month (12M)|Death|2
7830858|NCT01328431|12304076|FG001|12 Month (12M)|Death|6
7830859|NCT01328431|12304075|FG000|12 Month (12M)|Lost to Follow-up|82
7830860|NCT01328431|12304076|FG001|12 Month (12M)|Lost to Follow-up|91
7830861|NCT01328444|12304082|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3
7830862|NCT01328444|12304083|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1
7830863|NCT01328444|12304084|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1
7830864|NCT01328444|12304085|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3
7830865|NCT01328444|12304086|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5
7830866|NCT01328444|12304087|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2
7862463|NCT01597505|12351285|FG000|Overall Study|Withdrawal by Subject|10
7830867|NCT01328444|12304082|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
7830868|NCT01328444|12304083|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
7830869|NCT01328444|12304084|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
7830870|NCT01328444|12304085|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
7830871|NCT01328444|12304086|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
7830872|NCT01328444|12304087|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
7830873|NCT01328444|12304082|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0
7830874|NCT01328444|12304083|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0
7830875|NCT01328444|12304084|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0
7830876|NCT01328444|12304085|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1
7830877|NCT01328444|12304086|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0
7830878|NCT01328444|12304087|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1
7830879|NCT01328444|12304082|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
7830880|NCT01328444|12304083|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
7830881|NCT01328444|12304084|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
7830882|NCT01328444|12304085|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
7830883|NCT01328444|12304086|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
7830884|NCT01328444|12304087|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
7830885|NCT01328444|12304082|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
7830886|NCT01328444|12304083|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7830887|NCT01328444|12304084|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7830888|NCT01328444|12304085|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7830889|NCT01328444|12304086|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7830890|NCT01328444|12304087|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7830891|NCT01328444|12304082|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7830892|NCT01328444|12304083|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
7830893|NCT01328444|12304084|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7830894|NCT01328444|12304085|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
7830895|NCT01328444|12304086|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7830896|NCT01328444|12304087|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7830897|NCT01328444|12304082|FG000|Washout Period (14 Days)|Adverse Event|1
7830898|NCT01328444|12304083|FG001|Washout Period (14 Days)|Adverse Event|1
7830899|NCT01328444|12304084|FG002|Washout Period (14 Days)|Adverse Event|0
7830900|NCT01328444|12304085|FG003|Washout Period (14 Days)|Adverse Event|1
7830901|NCT01328444|12304086|FG004|Washout Period (14 Days)|Adverse Event|1
7830902|NCT01328444|12304087|FG005|Washout Period (14 Days)|Adverse Event|2
7830903|NCT01328444|12304082|FG000|Washout Period (14 Days)|Lack of Efficacy|0
7830904|NCT01328444|12304083|FG001|Washout Period (14 Days)|Lack of Efficacy|0
7830905|NCT01328444|12304084|FG002|Washout Period (14 Days)|Lack of Efficacy|0
7830906|NCT01328444|12304085|FG003|Washout Period (14 Days)|Lack of Efficacy|0
7830907|NCT01328444|12304086|FG004|Washout Period (14 Days)|Lack of Efficacy|0
7830908|NCT01328444|12304087|FG005|Washout Period (14 Days)|Lack of Efficacy|1
7830909|NCT01328444|12304082|FG000|Washout Period (14 Days)|Withdrawal by Subject|0
7830910|NCT01328444|12304083|FG001|Washout Period (14 Days)|Withdrawal by Subject|0
7830911|NCT01328444|12304084|FG002|Washout Period (14 Days)|Withdrawal by Subject|0
7830912|NCT01328444|12304085|FG003|Washout Period (14 Days)|Withdrawal by Subject|0
7830913|NCT01328444|12304086|FG004|Washout Period (14 Days)|Withdrawal by Subject|0
7830914|NCT01328444|12304087|FG005|Washout Period (14 Days)|Withdrawal by Subject|1
7830915|NCT01328444|12304082|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5
7830916|NCT01328444|12304083|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0
7830917|NCT01328444|12304084|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1
7830918|NCT01328444|12304085|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1
7830919|NCT01328444|12304086|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1
7830920|NCT01328444|12304087|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0
7830921|NCT01328444|12304082|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
7830922|NCT01328444|12304083|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
7830923|NCT01328444|12304084|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
7830924|NCT01328444|12304085|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
7830925|NCT01328444|12304086|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
7830926|NCT01328444|12304087|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
7830927|NCT01328444|12304082|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1
7830928|NCT01328444|12304083|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0
7830929|NCT01328444|12304084|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0
7830930|NCT01328444|12304085|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0
7830931|NCT01328444|12304086|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1
7830932|NCT01328444|12304087|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0
7830933|NCT01328444|12304082|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
7830934|NCT01328444|12304083|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
7830935|NCT01328444|12304084|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
7830936|NCT01328444|12304085|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
7830937|NCT01328444|12304086|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
7830938|NCT01328444|12304087|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
7862464|NCT01597505|12351286|FG001|Overall Study|Withdrawal by Subject|18
7830939|NCT01328444|12304082|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7830940|NCT01328444|12304083|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7830941|NCT01328444|12304084|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
7830942|NCT01328444|12304085|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
7830943|NCT01328444|12304086|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
7830944|NCT01328444|12304087|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
7830945|NCT01328444|12304082|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7830946|NCT01328444|12304083|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7830947|NCT01328444|12304084|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7830948|NCT01328444|12304085|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7830949|NCT01328444|12304086|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7830950|NCT01328444|12304087|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7830951|NCT01328496|12304103|FG000|Overall Study|Significant Change in Health Status|1
7830952|NCT01328496|12304104|FG001|Overall Study|Significant Change in Health Status|0
7830953|NCT01328535|12304113|FG000|Overall Study|Ineligible|1
7830954|NCT01328548|12304121|FG000|Overall Study|Death|3
7830955|NCT01328548|12304122|FG001|Overall Study|Death|0
7830956|NCT01328548|12304121|FG000|Overall Study|Protocol Violation|1
7830957|NCT01328548|12304122|FG001|Overall Study|Protocol Violation|0
7830958|NCT01328574|12304128|FG000|Overall Study|Refused further treatment|1
7830959|NCT01328717|12304137|FG000|Overall Study|Adverse Event|1
7830960|NCT01328756|12304150|FG000|Overall Study|Protocol Violation|4
7830961|NCT01328756|12304150|FG000|Overall Study|Adverse Event|39
7830962|NCT01328756|12304150|FG000|Overall Study|Lack of Efficacy|5
7830963|NCT01328756|12304150|FG000|Overall Study|Withdrawal by Subject|41
7830964|NCT01328756|12304150|FG000|Overall Study|Lost to Follow-up|5
7830965|NCT01328756|12304150|FG000|Overall Study|Other|29
7830966|NCT01328951|12304184|FG000|Overall Study|Disease Progression|17
7830967|NCT01328951|12304185|FG001|Overall Study|Disease Progression|14
7830968|NCT01328951|12304184|FG000|Overall Study|Adverse Event|2
7830969|NCT01328951|12304185|FG001|Overall Study|Adverse Event|0
7830970|NCT01328951|12304184|FG000|Overall Study|Death|243
7830971|NCT01328951|12304185|FG001|Overall Study|Death|258
7830972|NCT01328951|12304184|FG000|Overall Study|Lost to Follow-up|6
7830973|NCT01328951|12304185|FG001|Overall Study|Lost to Follow-up|7
7830974|NCT01328951|12304184|FG000|Overall Study|Withdrawal by Subject|6
7830975|NCT01328951|12304185|FG001|Overall Study|Withdrawal by Subject|6
7830976|NCT01328951|12304184|FG000|Overall Study|Study Closed by the Sponsor|36
7830977|NCT01328951|12304185|FG001|Overall Study|Study Closed by the Sponsor|31
7830978|NCT01328951|12304184|FG000|Overall Study|Other|11
7830979|NCT01328951|12304185|FG001|Overall Study|Other|6
7830980|NCT01329029|12304210|FG000|Overall Study|Withdrawal by Subject|117
7830981|NCT01329029|12304211|FG001|Overall Study|Withdrawal by Subject|87
7830982|NCT01329029|12304210|FG000|Overall Study|Adverse Event|82
7830983|NCT01329029|12304211|FG001|Overall Study|Adverse Event|29
7830984|NCT01329029|12304210|FG000|Overall Study|Death|16
7830985|NCT01329029|12304211|FG001|Overall Study|Death|19
7830986|NCT01329029|12304210|FG000|Overall Study|Other|14
7830987|NCT01329029|12304211|FG001|Overall Study|Other|20
7830988|NCT01329029|12304210|FG000|Overall Study|COPD Exacerbation|11
7830989|NCT01329029|12304211|FG001|Overall Study|COPD Exacerbation|18
7830990|NCT01329029|12304210|FG000|Overall Study|Physician Decision|16
7830991|NCT01329029|12304211|FG001|Overall Study|Physician Decision|13
7830992|NCT01329029|12304210|FG000|Overall Study|Lost to Follow-up|8
7830993|NCT01329029|12304211|FG001|Overall Study|Lost to Follow-up|5
7830994|NCT01329029|12304210|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5
7830995|NCT01329029|12304211|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1
7830996|NCT01329263|12304242|FG000|Overall Study|Lost to Follow-up|4
7830997|NCT01329263|12304243|FG001|Overall Study|Lost to Follow-up|21
7830998|NCT01329263|12304242|FG000|Overall Study|Withdrawal by Subject|1
7830999|NCT01329263|12304243|FG001|Overall Study|Withdrawal by Subject|2
7831000|NCT01329328|12304254|FG000|Overall Study|Withdrawal by Subject|2
7831001|NCT01329328|12304255|FG001|Overall Study|Withdrawal by Subject|4
7831002|NCT01329328|12304256|FG002|Overall Study|Withdrawal by Subject|3
7831003|NCT01329419|12304268|FG000|Overall Study|Protocol Violation|235
7831004|NCT01329562|12304275|FG000|Overall Study|Protocol Violation|5
7831005|NCT01329562|12304276|FG001|Overall Study|Protocol Violation|3
7831006|NCT01329562|12304275|FG000|Overall Study|Lost to Follow-up|1
7831007|NCT01329562|12304276|FG001|Overall Study|Lost to Follow-up|1
7831008|NCT01329562|12304275|FG000|Overall Study|Subject withdrew due to personal issues.|3
7831009|NCT01329562|12304276|FG001|Overall Study|Subject withdrew due to personal issues.|2
7831010|NCT01329562|12304275|FG000|Overall Study|Physician Decision|0
7831011|NCT01329562|12304276|FG001|Overall Study|Physician Decision|1
7831012|NCT01329900|12304297|FG000|Overall Study|Elevated creatinine/renal function|1
7831013|NCT01329939|12304305|FG000|Overall Study|Lost to Follow-up|3
7831014|NCT01329939|12304306|FG001|Overall Study|Lost to Follow-up|0
7831015|NCT01329939|12304307|FG002|Overall Study|Lost to Follow-up|1
7831016|NCT01329939|12304308|FG003|Overall Study|Lost to Follow-up|2
7831017|NCT01329939|12304305|FG000|Overall Study|Withdrawal by Subject|0
7831018|NCT01329939|12304306|FG001|Overall Study|Withdrawal by Subject|1
7831019|NCT01329939|12304307|FG002|Overall Study|Withdrawal by Subject|0
7831020|NCT01329939|12304308|FG003|Overall Study|Withdrawal by Subject|0
7831021|NCT01329939|12304305|FG000|Overall Study|Adverse Event|0
7831022|NCT01329939|12304306|FG001|Overall Study|Adverse Event|0
7831023|NCT01329939|12304307|FG002|Overall Study|Adverse Event|0
7831024|NCT01329939|12304308|FG003|Overall Study|Adverse Event|3
7831025|NCT01329978|12304321|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
7831026|NCT01329978|12304322|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
7831027|NCT01329978|12304323|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
7831028|NCT01329978|12304324|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
7831029|NCT01329978|12304325|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
7831030|NCT01329978|12304321|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
7831031|NCT01329978|12304322|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
7831032|NCT01329978|12304323|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
7831033|NCT01329978|12304324|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
7831034|NCT01329978|12304325|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
7831035|NCT01329978|12304321|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
7831036|NCT01329978|12304322|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
7831037|NCT01329978|12304323|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
7831038|NCT01329978|12304324|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
7831039|NCT01329978|12304325|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
7831040|NCT01329978|12304321|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
7831041|NCT01329978|12304322|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
7831042|NCT01329978|12304323|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
7831043|NCT01329978|12304324|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
7831044|NCT01329978|12304325|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
7831045|NCT01329978|12304321|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
7831046|NCT01329978|12304322|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
7831047|NCT01329978|12304323|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
7831048|NCT01329978|12304324|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
7831049|NCT01329978|12304325|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
7831050|NCT01329978|12304321|FG000|Rerandomization Treatment Period|Lost to Follow-up|0
7831051|NCT01329978|12304322|FG001|Rerandomization Treatment Period|Lost to Follow-up|0
7831052|NCT01329978|12304323|FG002|Rerandomization Treatment Period|Lost to Follow-up|0
7831053|NCT01329978|12304324|FG003|Rerandomization Treatment Period|Lost to Follow-up|5
7831054|NCT01329978|12304325|FG004|Rerandomization Treatment Period|Lost to Follow-up|3
7831055|NCT01329978|12304321|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0
7831056|NCT01329978|12304322|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0
7831057|NCT01329978|12304323|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0
7831058|NCT01329978|12304324|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0
7831059|NCT01329978|12304325|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1
7831060|NCT01330017|12304342|FG000|Overall Study|Adverse Event|0
7831061|NCT01330017|12304343|FG001|Overall Study|Adverse Event|1
7831062|NCT01330017|12304344|FG002|Overall Study|Adverse Event|1
7831063|NCT01330017|12304345|FG003|Overall Study|Adverse Event|4
7831064|NCT01330017|12304346|FG004|Overall Study|Adverse Event|0
7831065|NCT01330017|12304342|FG000|Overall Study|Withdrawal by Subject|0
7831066|NCT01330017|12304343|FG001|Overall Study|Withdrawal by Subject|0
7831067|NCT01330017|12304344|FG002|Overall Study|Withdrawal by Subject|1
7831068|NCT01330017|12304345|FG003|Overall Study|Withdrawal by Subject|0
7831069|NCT01330017|12304346|FG004|Overall Study|Withdrawal by Subject|1
7831070|NCT01330017|12304342|FG000|Overall Study|Lost to Follow-up|0
7831071|NCT01330017|12304343|FG001|Overall Study|Lost to Follow-up|0
7831072|NCT01330017|12304344|FG002|Overall Study|Lost to Follow-up|1
7831073|NCT01330017|12304345|FG003|Overall Study|Lost to Follow-up|0
7831074|NCT01330017|12304346|FG004|Overall Study|Lost to Follow-up|0
7831075|NCT01330017|12304342|FG000|Overall Study|Protocol Violation|0
7831076|NCT01330017|12304343|FG001|Overall Study|Protocol Violation|0
7831077|NCT01330017|12304344|FG002|Overall Study|Protocol Violation|0
7831078|NCT01330017|12304345|FG003|Overall Study|Protocol Violation|1
7831079|NCT01330017|12304346|FG004|Overall Study|Protocol Violation|0
7831080|NCT01330017|12304342|FG000|Overall Study|Unknown Reason|5
7948543|NCT02528357|12493681|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7948544|NCT02528357|12493682|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7948545|NCT02528357|12493683|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7948546|NCT02528357|12493684|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7948547|NCT02528357|12493666|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948548|NCT02528357|12493667|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948549|NCT02528357|12493668|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948550|NCT02528357|12493669|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948551|NCT02528357|12493670|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948552|NCT02528357|12493671|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7831081|NCT01330017|12304343|FG001|Overall Study|Unknown Reason|3
7831082|NCT01330017|12304344|FG002|Overall Study|Unknown Reason|5
7831083|NCT01330017|12304345|FG003|Overall Study|Unknown Reason|7
7831084|NCT01330017|12304346|FG004|Overall Study|Unknown Reason|2
7831085|NCT01330030|12304360|FG000|Overall Study|Lost to Follow-up|16
7831086|NCT01330030|12304361|FG001|Overall Study|Lost to Follow-up|17
7831087|NCT01330108|12304376|FG000|Overall Study|Withdrawal by Subject|4
7831088|NCT01330303|12304393|FG000|Period 1|Adverse Event|1
7831089|NCT01330303|12304394|FG001|Period 1|Adverse Event|0
7831090|NCT01330303|12304393|FG000|Period 1|Protocol Violation|0
7831091|NCT01330303|12304394|FG001|Period 1|Protocol Violation|1
7831092|NCT01330303|12304393|FG000|Period 1|Withdrawal by Subject|0
7831093|NCT01330303|12304394|FG001|Period 1|Withdrawal by Subject|1
7831094|NCT01330316|12304403|FG000|Overall Study|Adverse Event|2
7831095|NCT01330316|12304404|FG001|Overall Study|Adverse Event|2
7831096|NCT01330316|12304403|FG000|Overall Study|Lack of Efficacy|0
7831097|NCT01330316|12304404|FG001|Overall Study|Lack of Efficacy|10
7831098|NCT01330316|12304403|FG000|Overall Study|Lost to Follow-up|0
7831099|NCT01330316|12304404|FG001|Overall Study|Lost to Follow-up|1
7831100|NCT01330316|12304403|FG000|Overall Study|Withdrawal by Subject|0
7831101|NCT01330316|12304404|FG001|Overall Study|Withdrawal by Subject|1
7831102|NCT01330316|12304403|FG000|Overall Study|other than above|0
7831103|NCT01330316|12304404|FG001|Overall Study|other than above|1
7831104|NCT01330381|12304421|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
7831105|NCT01330381|12304422|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
7831106|NCT01330381|12304423|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
7831107|NCT01330381|12304421|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
7831108|NCT01330381|12304422|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
7831109|NCT01330381|12304423|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
7831110|NCT01330381|12304421|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
7831111|NCT01330381|12304422|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
7831112|NCT01330381|12304423|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
7831113|NCT01330381|12304421|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
7831114|NCT01330381|12304422|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
7831115|NCT01330381|12304423|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
7831116|NCT01330381|12304421|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
7831117|NCT01330381|12304422|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
7831118|NCT01330381|12304423|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
7831119|NCT01330381|12304421|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
7831120|NCT01330381|12304422|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
7831121|NCT01330381|12304423|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
7831122|NCT01330381|12304421|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
7831123|NCT01330381|12304422|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
7831124|NCT01330381|12304423|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
7831125|NCT01330381|12304421|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2
7831126|NCT01330381|12304422|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0
7831127|NCT01330381|12304423|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0
7831128|NCT01330381|12304421|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
7831129|NCT01330381|12304422|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
7831130|NCT01330381|12304423|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
7831131|NCT01330381|12304421|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0
7831132|NCT01330381|12304422|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0
7831133|NCT01330381|12304423|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1
7831134|NCT01330433|12304447|FG000|Overall Study|Death|1
7831135|NCT01330433|12304448|FG001|Overall Study|Death|3
7831136|NCT01330433|12304447|FG000|Overall Study|Lost to Follow-up|1
7831137|NCT01330433|12304448|FG001|Overall Study|Lost to Follow-up|0
7831138|NCT01330459|12304456|FG000|Overall Study|Physician Decision|0
7831139|NCT01330459|12304457|FG001|Overall Study|Physician Decision|2
7831140|NCT01330628|12304467|FG000|Overall Study|Death|2
7831141|NCT01330628|12304468|FG001|Overall Study|Death|3
7831142|NCT01330628|12304467|FG000|Overall Study|Lost to Follow-up|5
7831143|NCT01330628|12304468|FG001|Overall Study|Lost to Follow-up|6
7831144|NCT01330628|12304467|FG000|Overall Study|Adverse Event|44
7831145|NCT01330628|12304468|FG001|Overall Study|Adverse Event|25
7831146|NCT01330628|12304467|FG000|Overall Study|Withdrawn|18
7831147|NCT01330628|12304468|FG001|Overall Study|Withdrawn|6
7831148|NCT01330628|12304467|FG000|Overall Study|Didn't receive study treatment|1
7831149|NCT01330628|12304468|FG001|Overall Study|Didn't receive study treatment|0
7831150|NCT01330914|12304474|FG000|Overall Study|Withdrawal by Subject|4
7831151|NCT01330914|12304474|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3
7831152|NCT01331005|12304510|FG000|Overall Study|Lost to Follow-up|2
7831153|NCT01331005|12304511|FG001|Overall Study|Lost to Follow-up|1
7831154|NCT01331005|12304510|FG000|Overall Study|Withdrawal by Subject|2
7831155|NCT01331005|12304511|FG001|Overall Study|Withdrawal by Subject|3
7831156|NCT01331109|12304526|FG000|Overall Study|Adverse Event|6
7831157|NCT01331109|12304526|FG000|Overall Study|Lack of Efficacy|2
7831158|NCT01331109|12304526|FG000|Overall Study|Protocol Violation|3
7831159|NCT01331109|12304526|FG000|Overall Study|Withdrawal by Subject|7
7831160|NCT01331109|12304526|FG000|Overall Study|Lost to Follow-up|1
7831161|NCT01331109|12304526|FG000|Overall Study|Study Terminated by Sponsor|38
7831162|NCT01331161|12304532|FG000|Overall Study|Physician Decision|1
7831163|NCT01331161|12304533|FG001|Overall Study|Physician Decision|0
7831164|NCT01331161|12304532|FG000|Overall Study|Lost to Follow-up|0
7831165|NCT01331161|12304533|FG001|Overall Study|Lost to Follow-up|1
7831166|NCT01331161|12304532|FG000|Overall Study|Pregnancy|0
7831167|NCT01331161|12304533|FG001|Overall Study|Pregnancy|1
7831168|NCT01331239|12304552|FG000|Part II: Core Study|Adverse Event|0
7831169|NCT01331239|12304553|FG001|Part II: Core Study|Adverse Event|3
7831170|NCT01331239|12304554|FG002|Part II: Core Study|Adverse Event|0
7831171|NCT01331239|12304552|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0
7831172|NCT01331239|12304553|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2
7831173|NCT01331239|12304554|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1
7831174|NCT01331239|12304552|FG000|Part II: Core Study|Withdrawal by Subject|0
7831175|NCT01331239|12304553|FG001|Part II: Core Study|Withdrawal by Subject|2
7831176|NCT01331239|12304554|FG002|Part II: Core Study|Withdrawal by Subject|0
7831177|NCT01331239|12304552|FG000|Part II: Core Study|Administrative problems|0
7831178|NCT01331239|12304553|FG001|Part II: Core Study|Administrative problems|1
7831179|NCT01331239|12304554|FG002|Part II: Core Study|Administrative problems|0
7831180|NCT01331291|12304572|FG000|Overall Study|Lack of Efficacy|2
7831181|NCT01331291|12304573|FG001|Overall Study|Lack of Efficacy|8
7831182|NCT01331291|12304572|FG000|Overall Study|Death|0
7831183|NCT01331291|12304573|FG001|Overall Study|Death|1
7831184|NCT01331681|12304591|FG000|Overall Study|Adverse Event|10
7831185|NCT01331681|12304592|FG001|Overall Study|Adverse Event|13
7831186|NCT01331681|12304593|FG002|Overall Study|Adverse Event|10
7831187|NCT01331681|12304591|FG000|Overall Study|Death|6
7831188|NCT01331681|12304592|FG001|Overall Study|Death|6
7831189|NCT01331681|12304593|FG002|Overall Study|Death|2
7831190|NCT01331681|12304591|FG000|Overall Study|Lack of Efficacy|0
7831191|NCT01331681|12304592|FG001|Overall Study|Lack of Efficacy|1
7831192|NCT01331681|12304593|FG002|Overall Study|Lack of Efficacy|0
7831193|NCT01331681|12304591|FG000|Overall Study|Withdrawal by Subject|12
7831194|NCT01331681|12304592|FG001|Overall Study|Withdrawal by Subject|8
7831195|NCT01331681|12304593|FG002|Overall Study|Withdrawal by Subject|15
7831196|NCT01331681|12304591|FG000|Overall Study|Protocol Violation|1
7831197|NCT01331681|12304592|FG001|Overall Study|Protocol Violation|1
7831198|NCT01331681|12304593|FG002|Overall Study|Protocol Violation|0
7831199|NCT01331681|12304591|FG000|Overall Study|Lost to Follow-up|2
7831200|NCT01331681|12304592|FG001|Overall Study|Lost to Follow-up|4
7831201|NCT01331681|12304593|FG002|Overall Study|Lost to Follow-up|1
7831202|NCT01331681|12304591|FG000|Overall Study|Physician Decision|2
7831203|NCT01331681|12304592|FG001|Overall Study|Physician Decision|0
7831204|NCT01331681|12304593|FG002|Overall Study|Physician Decision|4
7831205|NCT01331681|12304591|FG000|Overall Study|Therapeutic procedure required|1
7831206|NCT01331681|12304592|FG001|Overall Study|Therapeutic procedure required|0
7831207|NCT01331681|12304593|FG002|Overall Study|Therapeutic procedure required|0
7831208|NCT01331681|12304591|FG000|Overall Study|Sponsor decision|1
7831209|NCT01331681|12304592|FG001|Overall Study|Sponsor decision|1
7831210|NCT01331681|12304593|FG002|Overall Study|Sponsor decision|0
7831211|NCT01331681|12304591|FG000|Overall Study|Switching to other therapy|0
7831212|NCT01331681|12304592|FG001|Overall Study|Switching to other therapy|0
7831213|NCT01331681|12304593|FG002|Overall Study|Switching to other therapy|1
7831214|NCT01331681|12304591|FG000|Overall Study|Not Received Study Treatment|0
7831215|NCT01331681|12304592|FG001|Overall Study|Not Received Study Treatment|0
7831216|NCT01331681|12304593|FG002|Overall Study|Not Received Study Treatment|2
7831217|NCT01331824|12304626|FG000|Overall Study|Adverse Event|2
7831218|NCT01331824|12304626|FG000|Overall Study|Death|1
7831219|NCT01331824|12304626|FG000|Overall Study|Disease Progression|9
7831220|NCT01331824|12304626|FG000|Overall Study|Withdrawal by Subject|1
7831221|NCT01331837|12304632|FG000|Overall Study|Death|30
7831222|NCT01331837|12304633|FG001|Overall Study|Death|34
7831223|NCT01331837|12304632|FG000|Overall Study|Lost to Follow-up|3
7831224|NCT01331837|12304633|FG001|Overall Study|Lost to Follow-up|1
7831225|NCT01331837|12304632|FG000|Overall Study|Info not recorded|10
7831226|NCT01331837|12304633|FG001|Overall Study|Info not recorded|16
7831227|NCT01331837|12304632|FG000|Overall Study|Withdrawal by Subject|13
7831228|NCT01331837|12304633|FG001|Overall Study|Withdrawal by Subject|16
7831229|NCT01332019|12304641|FG000|Overall Study|Was Not Dosed|1
7831230|NCT01332019|12304642|FG001|Overall Study|Was Not Dosed|0
7831231|NCT01332019|12304641|FG000|Overall Study|Other|16
7831232|NCT01332019|12304642|FG001|Overall Study|Other|18
7831233|NCT01332019|12304641|FG000|Overall Study|Death|2
7831234|NCT01332019|12304642|FG001|Overall Study|Death|1
7831235|NCT01332019|12304641|FG000|Overall Study|Physician Decision|4
7831236|NCT01332019|12304642|FG001|Overall Study|Physician Decision|3
7831237|NCT01332019|12304641|FG000|Overall Study|Withdrawal by Subject|73
7831238|NCT01332019|12304642|FG001|Overall Study|Withdrawal by Subject|71
7831239|NCT01332019|12304641|FG000|Overall Study|Lost to Follow-up|4
7831240|NCT01332019|12304642|FG001|Overall Study|Lost to Follow-up|7
7831241|NCT01332019|12304641|FG000|Overall Study|Adverse Event|13
7831242|NCT01332019|12304642|FG001|Overall Study|Adverse Event|22
7831243|NCT01332149|12304664|FG000|Overall Study|Adverse Event|11
7831244|NCT01332149|12304665|FG001|Overall Study|Adverse Event|9
7831245|NCT01332149|12304664|FG000|Overall Study|Other unspecified|5
7831246|NCT01332149|12304665|FG001|Overall Study|Other unspecified|7
7831247|NCT01332149|12304664|FG000|Overall Study|Protocol Violation|1
7831248|NCT01332149|12304665|FG001|Overall Study|Protocol Violation|3
7831249|NCT01332149|12304664|FG000|Overall Study|Withdrawal by Subject|4
7831250|NCT01332149|12304665|FG001|Overall Study|Withdrawal by Subject|5
7831251|NCT01332149|12304664|FG000|Overall Study|Lost to Follow-up|1
7831252|NCT01332149|12304665|FG001|Overall Study|Lost to Follow-up|1
7831253|NCT01332149|12304664|FG000|Overall Study|Insufficient clinical response|4
7831254|NCT01332149|12304665|FG001|Overall Study|Insufficient clinical response|7
7831255|NCT01332149|12304664|FG000|Overall Study|Did not meet entrance criteria|3
7831256|NCT01332149|12304665|FG001|Overall Study|Did not meet entrance criteria|4
7831257|NCT01332149|12304664|FG000|Overall Study|Randomized but not treated|1
7831258|NCT01332149|12304665|FG001|Overall Study|Randomized but not treated|2
7831259|NCT01332227|12304690|FG000|Overall Study|Adverse Event|4
7831260|NCT01332227|12304691|FG001|Overall Study|Adverse Event|1
7831261|NCT01332227|12304690|FG000|Overall Study|Withdrawal by Subject|5
7831262|NCT01332227|12304691|FG001|Overall Study|Withdrawal by Subject|1
7831263|NCT01332227|12304690|FG000|Overall Study|Lost to Follow-up|2
7831264|NCT01332227|12304691|FG001|Overall Study|Lost to Follow-up|0
7831265|NCT01332227|12304690|FG000|Overall Study|Lack of Efficacy|3
7831266|NCT01332227|12304691|FG001|Overall Study|Lack of Efficacy|1
7831267|NCT01332227|12304690|FG000|Overall Study|Poor compliance/noncompliance|1
7831268|NCT01332227|12304691|FG001|Overall Study|Poor compliance/noncompliance|1
7831269|NCT01332227|12304690|FG000|Overall Study|Patient moved from area|1
7831270|NCT01332227|12304691|FG001|Overall Study|Patient moved from area|0
7831271|NCT01332227|12304690|FG000|Overall Study|Patient began prohibited medication|0
7831272|NCT01332227|12304691|FG001|Overall Study|Patient began prohibited medication|1
7831273|NCT01332292|12304706|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
7831274|NCT01332292|12304707|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
7831275|NCT01332292|12304706|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1
7831276|NCT01332292|12304707|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1
7831277|NCT01332292|12304706|FG000|Treatment Period 2 (14 Days)|Physician Decision|1
7831278|NCT01332292|12304707|FG001|Treatment Period 2 (14 Days)|Physician Decision|1
7831279|NCT01332305|12304720|FG000|Overall Study|Adverse Event|1
7831280|NCT01332305|12304721|FG001|Overall Study|Adverse Event|4
7831281|NCT01332305|12304722|FG002|Overall Study|Adverse Event|6
7831282|NCT01332305|12304723|FG003|Overall Study|Adverse Event|3
7831283|NCT01332305|12304724|FG004|Overall Study|Adverse Event|5
7831284|NCT01332305|12304720|FG000|Overall Study|Withdrawal by Subject|6
7831285|NCT01332305|12304721|FG001|Overall Study|Withdrawal by Subject|5
7831286|NCT01332305|12304722|FG002|Overall Study|Withdrawal by Subject|4
7831287|NCT01332305|12304723|FG003|Overall Study|Withdrawal by Subject|1
7831288|NCT01332305|12304724|FG004|Overall Study|Withdrawal by Subject|0
7831289|NCT01332305|12304720|FG000|Overall Study|Lost to Follow-up|0
7831290|NCT01332305|12304721|FG001|Overall Study|Lost to Follow-up|2
7831291|NCT01332305|12304722|FG002|Overall Study|Lost to Follow-up|3
7831292|NCT01332305|12304723|FG003|Overall Study|Lost to Follow-up|2
7831293|NCT01332305|12304724|FG004|Overall Study|Lost to Follow-up|3
7831294|NCT01332305|12304720|FG000|Overall Study|Protocol Violation|1
7831295|NCT01332305|12304721|FG001|Overall Study|Protocol Violation|2
7831296|NCT01332305|12304722|FG002|Overall Study|Protocol Violation|1
7831297|NCT01332305|12304723|FG003|Overall Study|Protocol Violation|0
7831298|NCT01332305|12304724|FG004|Overall Study|Protocol Violation|3
7831299|NCT01332305|12304720|FG000|Overall Study|Withdrawal by Sponsor|1
7831300|NCT01332305|12304721|FG001|Overall Study|Withdrawal by Sponsor|0
7831301|NCT01332305|12304722|FG002|Overall Study|Withdrawal by Sponsor|0
7831302|NCT01332305|12304723|FG003|Overall Study|Withdrawal by Sponsor|1
7831303|NCT01332305|12304724|FG004|Overall Study|Withdrawal by Sponsor|1
7831304|NCT01332305|12304720|FG000|Overall Study|Treatment Failure|1
7831305|NCT01332305|12304721|FG001|Overall Study|Treatment Failure|1
7831306|NCT01332305|12304722|FG002|Overall Study|Treatment Failure|0
7831307|NCT01332305|12304723|FG003|Overall Study|Treatment Failure|0
7831308|NCT01332305|12304724|FG004|Overall Study|Treatment Failure|0
7831309|NCT01332305|12304720|FG000|Overall Study|Physician Decision|0
7831310|NCT01332305|12304721|FG001|Overall Study|Physician Decision|0
7831311|NCT01332305|12304722|FG002|Overall Study|Physician Decision|0
7831312|NCT01332305|12304723|FG003|Overall Study|Physician Decision|1
7831313|NCT01332305|12304724|FG004|Overall Study|Physician Decision|0
7831314|NCT01332318|12304740|FG000|Overall Study|Adverse Event|0
7831315|NCT01332318|12304741|FG001|Overall Study|Adverse Event|3
7831316|NCT01332318|12304742|FG002|Overall Study|Adverse Event|0
7831317|NCT01332318|12304743|FG003|Overall Study|Adverse Event|0
7831318|NCT01332318|12304740|FG000|Overall Study|Withdrawal by Subject|1
7831319|NCT01332318|12304741|FG001|Overall Study|Withdrawal by Subject|1
7831320|NCT01332318|12304742|FG002|Overall Study|Withdrawal by Subject|0
7831321|NCT01332318|12304743|FG003|Overall Study|Withdrawal by Subject|1
7831322|NCT01332318|12304740|FG000|Overall Study|Protocol Violation|1
7831323|NCT01332318|12304741|FG001|Overall Study|Protocol Violation|0
7831324|NCT01332318|12304742|FG002|Overall Study|Protocol Violation|1
7831325|NCT01332318|12304743|FG003|Overall Study|Protocol Violation|1
7831326|NCT01332331|12304756|FG000|Overall Study|Lost to Follow-up|0
7831327|NCT01332331|12304757|FG001|Overall Study|Lost to Follow-up|1
7831328|NCT01332331|12304756|FG000|Overall Study|Adverse Event|1
7831329|NCT01332331|12304757|FG001|Overall Study|Adverse Event|1
7831330|NCT01332331|12304756|FG000|Overall Study|Physician Decision|1
7831331|NCT01332331|12304757|FG001|Overall Study|Physician Decision|0
7831332|NCT01332630|12304829|FG000|Overall Study|Withdrawal by Subject|3
7831333|NCT01332851|12304839|FG000|Overall Study|Withdrawal by Subject|4
7831334|NCT01332851|12304840|FG001|Overall Study|Withdrawal by Subject|2
7831335|NCT01332851|12304839|FG000|Overall Study|Lost to Follow-up|7
7831336|NCT01332851|12304840|FG001|Overall Study|Lost to Follow-up|11
7862465|NCT01597505|12351285|FG000|Overall Study|Other|5
7862466|NCT01597505|12351286|FG001|Overall Study|Other|6
7862467|NCT01597505|12351285|FG000|Overall Study|Missing|1
7862468|NCT01597505|12351286|FG001|Overall Study|Missing|0
7862469|NCT01597557|12351295|FG000|Overall Study|Did not undergo cardioversion procedure|4
7862470|NCT01597557|12351296|FG001|Overall Study|Did not undergo cardioversion procedure|3
7862471|NCT01597596|12351304|FG000|Overall Study|Study terminated by sponsor|1
7862472|NCT01597596|12351305|FG001|Overall Study|Study terminated by sponsor|0
7862473|NCT01597596|12351304|FG000|Overall Study|Physician Decision|0
7862474|NCT01597596|12351305|FG001|Overall Study|Physician Decision|1
7862475|NCT01597622|12351311|FG000|Overall Study|Adverse Event|7
7862476|NCT01597622|12351311|FG000|Overall Study|Lack of Efficacy|3
7862477|NCT01597622|12351311|FG000|Overall Study|Protocol Violation|1
7862478|NCT01597622|12351311|FG000|Overall Study|Lost to Follow-up|1
7862479|NCT01597622|12351311|FG000|Overall Study|Investigator Discretion|5
7862480|NCT01597622|12351311|FG000|Overall Study|Withdrawal by Subject|20
7862481|NCT01597622|12351311|FG000|Overall Study|Death|1
7862482|NCT01597635|12351318|FG000|Part A|Adverse Event|3
7862483|NCT01597635|12351319|FG001|Part A|Adverse Event|0
7862484|NCT01597635|12351320|FG002|Part A|Adverse Event|0
7862485|NCT01597635|12351318|FG000|Part B|Adverse Event|0
7862486|NCT01597635|12351319|FG001|Part B|Adverse Event|0
7862487|NCT01597635|12351320|FG002|Part B|Adverse Event|1
7862488|NCT01597635|12351318|FG000|Part B|Protocol Violation|0
7862489|NCT01597635|12351319|FG001|Part B|Protocol Violation|1
7862490|NCT01597635|12351320|FG002|Part B|Protocol Violation|0
7862491|NCT01597635|12351318|FG000|Part B|Protocol-defined stopping criteria|0
7862492|NCT01597635|12351319|FG001|Part B|Protocol-defined stopping criteria|4
7862493|NCT01597635|12351320|FG002|Part B|Protocol-defined stopping criteria|3
7862494|NCT01597635|12351318|FG000|Part B|Withdrawal by Subject|0
7862495|NCT01597635|12351319|FG001|Part B|Withdrawal by Subject|1
7862496|NCT01597635|12351320|FG002|Part B|Withdrawal by Subject|0
7862497|NCT01597791|12351360|FG000|Overall Study|Physician Decision|2
7862498|NCT01597791|12351361|FG001|Overall Study|Physician Decision|1
7862499|NCT01597791|12351360|FG000|Overall Study|Cesarean Section|6
7862500|NCT01597791|12351361|FG001|Overall Study|Cesarean Section|7
7862501|NCT01597791|12351360|FG000|Overall Study|Subject withdrawal|0
7862502|NCT01597791|12351361|FG001|Overall Study|Subject withdrawal|1
7862503|NCT01597791|12351360|FG000|Overall Study|Protocol Violation|0
7862504|NCT01597791|12351361|FG001|Overall Study|Protocol Violation|1
7862505|NCT01597908|12351396|FG000|Randomized Phase|Death|217
7862506|NCT01597908|12351397|FG001|Randomized Phase|Death|238
7862507|NCT01597908|12351398|FG002|Randomized Phase|Death|0
7862508|NCT01597908|12351396|FG000|Randomized Phase|Sponsor Decision|93
7862509|NCT01597908|12351397|FG001|Randomized Phase|Sponsor Decision|39
7862510|NCT01597908|12351398|FG002|Randomized Phase|Sponsor Decision|0
7862511|NCT01597908|12351396|FG000|Randomized Phase|Lost to Follow-up|9
7862512|NCT01597908|12351397|FG001|Randomized Phase|Lost to Follow-up|16
7862513|NCT01597908|12351398|FG002|Randomized Phase|Lost to Follow-up|0
7862514|NCT01597908|12351396|FG000|Randomized Phase|Physician Decision|6
7862515|NCT01597908|12351397|FG001|Randomized Phase|Physician Decision|3
7862516|NCT01597908|12351398|FG002|Randomized Phase|Physician Decision|0
7862517|NCT01597908|12351396|FG000|Randomized Phase|Withdrawal by Subject|26
7862518|NCT01597908|12351397|FG001|Randomized Phase|Withdrawal by Subject|22
7862519|NCT01597908|12351398|FG002|Randomized Phase|Withdrawal by Subject|0
7862520|NCT01597908|12351396|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
7862521|NCT01597908|12351397|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34
7862522|NCT01597908|12351398|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
7831337|NCT01332994|12304857|FG000|Overall Study|Adverse Event|34
7831338|NCT01332994|12304857|FG000|Overall Study|Death|1
7831339|NCT01332994|12304857|FG000|Overall Study|Lack of Efficacy|1
7831340|NCT01332994|12304857|FG000|Overall Study|Lost to Follow-up|4
7831341|NCT01332994|12304857|FG000|Overall Study|Protocol Violation|6
7831342|NCT01332994|12304857|FG000|Overall Study|Withdrawal by Subject|15
7831343|NCT01332994|12304857|FG000|Overall Study|Administrative Problem|2
7831344|NCT01332994|12304857|FG000|Overall Study|Other|8
7831345|NCT01333033|12304863|FG000|Overall Study|Ineligible|0
7831346|NCT01333033|12304864|FG001|Overall Study|Ineligible|0
7831347|NCT01333033|12304865|FG002|Overall Study|Ineligible|0
7831348|NCT01333033|12304866|FG003|Overall Study|Ineligible|0
7831349|NCT01333033|12304867|FG004|Overall Study|Ineligible|6
7831350|NCT01333033|12304868|FG005|Overall Study|Ineligible|8
7831351|NCT01333033|12304863|FG000|Overall Study|Withdrawal by Subject|0
7831352|NCT01333033|12304864|FG001|Overall Study|Withdrawal by Subject|0
7831353|NCT01333033|12304865|FG002|Overall Study|Withdrawal by Subject|0
7831354|NCT01333033|12304866|FG003|Overall Study|Withdrawal by Subject|0
7831355|NCT01333033|12304867|FG004|Overall Study|Withdrawal by Subject|4
7831356|NCT01333033|12304868|FG005|Overall Study|Withdrawal by Subject|2
7831357|NCT01333033|12304863|FG000|Overall Study|PET inevaluable|0
7831358|NCT01333033|12304864|FG001|Overall Study|PET inevaluable|0
7831359|NCT01333033|12304865|FG002|Overall Study|PET inevaluable|0
7831360|NCT01333033|12304866|FG003|Overall Study|PET inevaluable|0
7831361|NCT01333033|12304867|FG004|Overall Study|PET inevaluable|2
7831362|NCT01333033|12304868|FG005|Overall Study|PET inevaluable|4
7831363|NCT01333033|12304863|FG000|Overall Study|Adverse Event|0
7831364|NCT01333033|12304864|FG001|Overall Study|Adverse Event|0
7831365|NCT01333033|12304865|FG002|Overall Study|Adverse Event|0
7831366|NCT01333033|12304866|FG003|Overall Study|Adverse Event|0
7831367|NCT01333033|12304867|FG004|Overall Study|Adverse Event|2
7831368|NCT01333033|12304868|FG005|Overall Study|Adverse Event|1
7831369|NCT01333033|12304863|FG000|Overall Study|Progression|0
7831370|NCT01333033|12304864|FG001|Overall Study|Progression|0
7831371|NCT01333033|12304865|FG002|Overall Study|Progression|0
7831372|NCT01333033|12304866|FG003|Overall Study|Progression|0
7831373|NCT01333033|12304867|FG004|Overall Study|Progression|0
7831374|NCT01333033|12304868|FG005|Overall Study|Progression|1
7831375|NCT01333033|12304863|FG000|Overall Study|MD Decision|0
7831376|NCT01333033|12304864|FG001|Overall Study|MD Decision|0
7831377|NCT01333033|12304865|FG002|Overall Study|MD Decision|0
7831378|NCT01333033|12304866|FG003|Overall Study|MD Decision|0
7831379|NCT01333033|12304867|FG004|Overall Study|MD Decision|0
7831380|NCT01333033|12304868|FG005|Overall Study|MD Decision|2
7831381|NCT01333059|12304888|FG000|Overall Study|Physician Decision|3
7831382|NCT01333059|12304889|FG001|Overall Study|Physician Decision|3
7831383|NCT01333059|12304888|FG000|Overall Study|Protocol Violation|3
7831384|NCT01333059|12304889|FG001|Overall Study|Protocol Violation|0
7831385|NCT01333072|12304899|FG000|Overall Study|Lost to Follow-up|3
7831386|NCT01333072|12304900|FG001|Overall Study|Lost to Follow-up|0
7831387|NCT01333072|12304899|FG000|Overall Study|Adverse Event|2
7831388|NCT01333072|12304900|FG001|Overall Study|Adverse Event|4
7831389|NCT01333072|12304899|FG000|Overall Study|Physician Decision|1
7831390|NCT01333072|12304900|FG001|Overall Study|Physician Decision|0
7831391|NCT01333111|12304915|FG000|Overall Study|patient undergoing major surgery|0
7831392|NCT01333111|12304916|FG001|Overall Study|patient undergoing major surgery|2
7831393|NCT01333111|12304917|FG002|Overall Study|patient undergoing major surgery|0
7831394|NCT01333111|12304915|FG000|Overall Study|personal reasons|0
7831395|NCT01333111|12304916|FG001|Overall Study|personal reasons|0
7831396|NCT01333111|12304917|FG002|Overall Study|personal reasons|1
7831397|NCT01333111|12304915|FG000|Overall Study|unclassified|1
7831398|NCT01333111|12304916|FG001|Overall Study|unclassified|0
7831399|NCT01333111|12304917|FG002|Overall Study|unclassified|0
7831400|NCT01333111|12304915|FG000|Overall Study|withdrawal criteria|0
7831401|NCT01333111|12304916|FG001|Overall Study|withdrawal criteria|1
7831402|NCT01333111|12304917|FG002|Overall Study|withdrawal criteria|0
7831403|NCT01333111|12304915|FG000|Overall Study|Non-compliance|1
7831404|NCT01333111|12304916|FG001|Overall Study|Non-compliance|0
7831405|NCT01333111|12304917|FG002|Overall Study|Non-compliance|0
7831406|NCT01333111|12304915|FG000|Overall Study|Ineffective therapy|0
7831407|NCT01333111|12304916|FG001|Overall Study|Ineffective therapy|0
7831408|NCT01333111|12304917|FG002|Overall Study|Ineffective therapy|1
7831409|NCT01333189|12304927|FG000|Overall Study|Time constraints|1
7831410|NCT01333189|12304928|FG001|Overall Study|Time constraints|0
7831411|NCT01333189|12304927|FG000|Overall Study|Adverse Event|1
7831412|NCT01333189|12304928|FG001|Overall Study|Adverse Event|0
7831413|NCT01333189|12304927|FG000|Overall Study|Transportation difficulties|0
7831414|NCT01333189|12304928|FG001|Overall Study|Transportation difficulties|1
7831415|NCT01333189|12304927|FG000|Overall Study|Moved from region|0
7831416|NCT01333189|12304928|FG001|Overall Study|Moved from region|1
7831417|NCT01333475|12304936|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1
7831418|NCT01333475|12304937|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0
7831419|NCT01333475|12304936|FG000|Overall Study|Toxicity|1
7831420|NCT01333475|12304937|FG001|Overall Study|Toxicity|3
7831421|NCT01333501|12304960|FG000|Overall Study|Adverse Event|3
7831422|NCT01333501|12304961|FG001|Overall Study|Adverse Event|1
7831423|NCT01333501|12304960|FG000|Overall Study|Abnormal laboratory value|2
7831424|NCT01333501|12304961|FG001|Overall Study|Abnormal laboratory value|1
7831425|NCT01333501|12304960|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7831426|NCT01333501|12304961|FG001|Overall Study|Unsatisfactory therapeutic effect|7
7831427|NCT01333501|12304960|FG000|Overall Study|Withdrawn consent|3
7831428|NCT01333501|12304961|FG001|Overall Study|Withdrawn consent|12
7831429|NCT01333722|12304987|FG000|Overall Study|Lack of Efficacy|0
7831430|NCT01333722|12304988|FG001|Overall Study|Lack of Efficacy|2
7831431|NCT01333722|12304987|FG000|Overall Study|Withdrawal by Subject|0
7831432|NCT01333722|12304988|FG001|Overall Study|Withdrawal by Subject|1
7831433|NCT01333865|12305000|FG000|Overall Study|Adverse Event|2
7831434|NCT01333956|12305008|FG000|Overall Study|Lost to Follow-up|1
7831435|NCT01333956|12305009|FG001|Overall Study|Lost to Follow-up|2
7831436|NCT01333956|12305010|FG002|Overall Study|Lost to Follow-up|0
7831437|NCT01333956|12305011|FG003|Overall Study|Lost to Follow-up|1
7831438|NCT01333956|12305008|FG000|Overall Study|Unable to complete study procedure|1
7831439|NCT01333956|12305009|FG001|Overall Study|Unable to complete study procedure|0
7831440|NCT01333956|12305010|FG002|Overall Study|Unable to complete study procedure|0
7831441|NCT01333956|12305011|FG003|Overall Study|Unable to complete study procedure|1
7831442|NCT01333956|12305008|FG000|Overall Study|Withdrawal by Subject|0
7831443|NCT01333956|12305009|FG001|Overall Study|Withdrawal by Subject|2
7831444|NCT01333956|12305010|FG002|Overall Study|Withdrawal by Subject|1
7831445|NCT01333956|12305011|FG003|Overall Study|Withdrawal by Subject|0
7831446|NCT01334125|12305028|FG000|Overall Study|Lost to Follow-up|3
7831447|NCT01334125|12305029|FG001|Overall Study|Lost to Follow-up|3
7831448|NCT01334515|12305056|FG000|Overall Study|Adverse Event|1
7831449|NCT01334515|12305057|FG001|Overall Study|Adverse Event|6
7831450|NCT01334515|12305056|FG000|Overall Study|Death|1
7831451|NCT01334515|12305057|FG001|Overall Study|Death|0
7831452|NCT01334515|12305056|FG000|Overall Study|Lack of Efficacy|8
7831453|NCT01334515|12305057|FG001|Overall Study|Lack of Efficacy|21
7831454|NCT01334515|12305056|FG000|Overall Study|Physician Decision|1
7831455|NCT01334515|12305057|FG001|Overall Study|Physician Decision|1
7831456|NCT01334515|12305056|FG000|Overall Study|Withdrawal by Subject|1
7831457|NCT01334515|12305057|FG001|Overall Study|Withdrawal by Subject|1
7831458|NCT01334554|12305065|FG000|Overall Study|Adverse Event|4
7831459|NCT01334554|12305066|FG001|Overall Study|Adverse Event|2
7831460|NCT01334710|12305074|FG000|Overall Study|Trial was terminated|3
7831461|NCT01334866|12305108|FG000|Overall Study|Withdrawal by Subject|10
7831462|NCT01334866|12305108|FG000|Overall Study|Lost to Follow-up|3
7831463|NCT01334866|12305108|FG000|Overall Study|Physician Decision|3
7831464|NCT01334866|12305108|FG000|Overall Study|medically necessary prior to procedure|2
7831465|NCT01334866|12305108|FG000|Overall Study|medically necessary post-procedure|1
7831466|NCT01334918|12305116|FG000|Overall Study|Did not receive study drug|6
7831467|NCT01334918|12305117|FG001|Overall Study|Did not receive study drug|0
7831468|NCT01334918|12305116|FG000|Overall Study|Adverse Event|2
7831469|NCT01334918|12305117|FG001|Overall Study|Adverse Event|0
7831470|NCT01334918|12305116|FG000|Overall Study|Withdrawal by Subject|0
7831471|NCT01334918|12305117|FG001|Overall Study|Withdrawal by Subject|1
7831472|NCT01335009|12305150|FG000|Overall Study|Too ill to travel to study sites|1
7831473|NCT01335009|12305151|FG001|Overall Study|Too ill to travel to study sites|0
7831474|NCT01335009|12305150|FG000|Overall Study|Death|28
7831475|NCT01335009|12305151|FG001|Overall Study|Death|32
7831476|NCT01335009|12305150|FG000|Overall Study|Withdrawal by Subject|1
7831477|NCT01335009|12305151|FG001|Overall Study|Withdrawal by Subject|1
7831478|NCT01335009|12305150|FG000|Overall Study|Lost to Follow-up|1
7831479|NCT01335009|12305151|FG001|Overall Study|Lost to Follow-up|0
7831480|NCT01335464|12305213|FG000|Overall Study|Adverse Event|15
7831481|NCT01335464|12305214|FG001|Overall Study|Adverse Event|25
7831482|NCT01335464|12305213|FG000|Overall Study|Non compliant with protocol|2
7831483|NCT01335464|12305214|FG001|Overall Study|Non compliant with protocol|0
7831484|NCT01335464|12305213|FG000|Overall Study|Consent withdrawn, not due to AE|12
7831485|NCT01335464|12305214|FG001|Overall Study|Consent withdrawn, not due to AE|23
7831486|NCT01335464|12305213|FG000|Overall Study|Not treated|2
7831487|NCT01335464|12305214|FG001|Overall Study|Not treated|0
7831488|NCT01335464|12305213|FG000|Overall Study|Reason other than those stated above|1
7831489|NCT01335464|12305214|FG001|Overall Study|Reason other than those stated above|1
7831490|NCT01335477|12305222|FG000|Overall Study|Adverse Event|30
7831491|NCT01335477|12305223|FG001|Overall Study|Adverse Event|42
7831492|NCT01335477|12305222|FG000|Overall Study|Non compliant with protocol|0
7831493|NCT01335477|12305223|FG001|Overall Study|Non compliant with protocol|2
7831494|NCT01335477|12305222|FG000|Overall Study|Lost to Follow-up|1
7831495|NCT01335477|12305223|FG001|Overall Study|Lost to Follow-up|2
7831496|NCT01335477|12305222|FG000|Overall Study|Consent withdrawn, not due to AE|7
7831497|NCT01335477|12305223|FG001|Overall Study|Consent withdrawn, not due to AE|9
7831498|NCT01335477|12305222|FG000|Overall Study|Not treated|1
7831499|NCT01335477|12305223|FG001|Overall Study|Not treated|2
7831500|NCT01335477|12305222|FG000|Overall Study|Reason other than those stated above|2
7831501|NCT01335477|12305223|FG001|Overall Study|Reason other than those stated above|2
7831502|NCT01335698|12305247|FG000|Treatment Stage 1|Lack of Efficacy|3
7831503|NCT01335698|12305248|FG001|Treatment Stage 1|Lack of Efficacy|1
7831504|NCT01335698|12305249|FG002|Treatment Stage 1|Lack of Efficacy|3
7831505|NCT01335698|12305250|FG003|Treatment Stage 1|Lack of Efficacy|3
7831506|NCT01335698|12305251|FG004|Treatment Stage 1|Lack of Efficacy|1
7831507|NCT01335698|12305247|FG000|Treatment Stage 1|Adverse Event|1
7831508|NCT01335698|12305248|FG001|Treatment Stage 1|Adverse Event|2
7831509|NCT01335698|12305249|FG002|Treatment Stage 1|Adverse Event|2
7831510|NCT01335698|12305250|FG003|Treatment Stage 1|Adverse Event|1
7831511|NCT01335698|12305251|FG004|Treatment Stage 1|Adverse Event|1
7831512|NCT01335698|12305247|FG000|Treatment Stage 1|Withdrawal by Subject|1
7831513|NCT01335698|12305248|FG001|Treatment Stage 1|Withdrawal by Subject|2
7831514|NCT01335698|12305249|FG002|Treatment Stage 1|Withdrawal by Subject|0
7831515|NCT01335698|12305250|FG003|Treatment Stage 1|Withdrawal by Subject|1
7831516|NCT01335698|12305251|FG004|Treatment Stage 1|Withdrawal by Subject|0
7831517|NCT01335698|12305247|FG000|Treatment Stage 1|Lost to Follow-up|1
7831518|NCT01335698|12305248|FG001|Treatment Stage 1|Lost to Follow-up|1
7831519|NCT01335698|12305249|FG002|Treatment Stage 1|Lost to Follow-up|0
7831520|NCT01335698|12305250|FG003|Treatment Stage 1|Lost to Follow-up|0
7831521|NCT01335698|12305251|FG004|Treatment Stage 1|Lost to Follow-up|0
7831522|NCT01335698|12305247|FG000|Treatment Stage 1|Poor compliance/noncompliance|0
7831523|NCT01335698|12305248|FG001|Treatment Stage 1|Poor compliance/noncompliance|1
7831524|NCT01335698|12305249|FG002|Treatment Stage 1|Poor compliance/noncompliance|0
7831525|NCT01335698|12305250|FG003|Treatment Stage 1|Poor compliance/noncompliance|2
7831526|NCT01335698|12305251|FG004|Treatment Stage 1|Poor compliance/noncompliance|0
7831527|NCT01335698|12305247|FG000|Treatment Stage 1|No longer meets study criteria|1
7831528|NCT01335698|12305248|FG001|Treatment Stage 1|No longer meets study criteria|1
7831529|NCT01335698|12305249|FG002|Treatment Stage 1|No longer meets study criteria|0
7831530|NCT01335698|12305250|FG003|Treatment Stage 1|No longer meets study criteria|1
7831531|NCT01335698|12305251|FG004|Treatment Stage 1|No longer meets study criteria|0
7831532|NCT01335698|12305247|FG000|Treatment Stage 1|Other|1
7831533|NCT01335698|12305248|FG001|Treatment Stage 1|Other|0
7831534|NCT01335698|12305249|FG002|Treatment Stage 1|Other|0
7831535|NCT01335698|12305250|FG003|Treatment Stage 1|Other|1
7831536|NCT01335698|12305251|FG004|Treatment Stage 1|Other|0
7831537|NCT01335698|12305247|FG000|Treatment Stage 2|Lack of Efficacy|2
7831538|NCT01335698|12305248|FG001|Treatment Stage 2|Lack of Efficacy|1
7831539|NCT01335698|12305249|FG002|Treatment Stage 2|Lack of Efficacy|3
7831540|NCT01335698|12305250|FG003|Treatment Stage 2|Lack of Efficacy|1
7831541|NCT01335698|12305251|FG004|Treatment Stage 2|Lack of Efficacy|0
7831542|NCT01335698|12305247|FG000|Treatment Stage 2|Adverse Event|2
7831543|NCT01335698|12305248|FG001|Treatment Stage 2|Adverse Event|0
7831544|NCT01335698|12305249|FG002|Treatment Stage 2|Adverse Event|0
7831545|NCT01335698|12305250|FG003|Treatment Stage 2|Adverse Event|3
7831546|NCT01335698|12305251|FG004|Treatment Stage 2|Adverse Event|0
7831547|NCT01335698|12305247|FG000|Treatment Stage 2|Withdrawal by Subject|3
7831548|NCT01335698|12305248|FG001|Treatment Stage 2|Withdrawal by Subject|1
7831549|NCT01335698|12305249|FG002|Treatment Stage 2|Withdrawal by Subject|1
7831550|NCT01335698|12305250|FG003|Treatment Stage 2|Withdrawal by Subject|0
7831551|NCT01335698|12305251|FG004|Treatment Stage 2|Withdrawal by Subject|0
7831552|NCT01335698|12305247|FG000|Treatment Stage 2|Poor compliance/noncompliance|1
7831553|NCT01335698|12305248|FG001|Treatment Stage 2|Poor compliance/noncompliance|0
7831554|NCT01335698|12305249|FG002|Treatment Stage 2|Poor compliance/noncompliance|1
7831555|NCT01335698|12305250|FG003|Treatment Stage 2|Poor compliance/noncompliance|3
7831556|NCT01335698|12305251|FG004|Treatment Stage 2|Poor compliance/noncompliance|1
7831557|NCT01335698|12305247|FG000|Treatment Stage 2|Lost to Follow-up|1
7831558|NCT01335698|12305248|FG001|Treatment Stage 2|Lost to Follow-up|0
7831559|NCT01335698|12305249|FG002|Treatment Stage 2|Lost to Follow-up|0
7831560|NCT01335698|12305250|FG003|Treatment Stage 2|Lost to Follow-up|0
7831561|NCT01335698|12305251|FG004|Treatment Stage 2|Lost to Follow-up|0
7831562|NCT01335698|12305247|FG000|Treatment Stage 2|Capsules received at state hospital|1
7831563|NCT01335698|12305248|FG001|Treatment Stage 2|Capsules received at state hospital|0
7831564|NCT01335698|12305249|FG002|Treatment Stage 2|Capsules received at state hospital|0
7831565|NCT01335698|12305250|FG003|Treatment Stage 2|Capsules received at state hospital|0
7831566|NCT01335698|12305251|FG004|Treatment Stage 2|Capsules received at state hospital|0
7831567|NCT01335698|12305247|FG000|Treatment Stage 2|Subject no longer meets study criteria|0
7831568|NCT01335698|12305248|FG001|Treatment Stage 2|Subject no longer meets study criteria|0
7831569|NCT01335698|12305249|FG002|Treatment Stage 2|Subject no longer meets study criteria|0
7831570|NCT01335698|12305250|FG003|Treatment Stage 2|Subject no longer meets study criteria|1
7831571|NCT01335698|12305251|FG004|Treatment Stage 2|Subject no longer meets study criteria|0
7831572|NCT01335698|12305247|FG000|Treatment Stage 2|Switched to another formulation|1
7831573|NCT01335698|12305248|FG001|Treatment Stage 2|Switched to another formulation|1
7831574|NCT01335698|12305249|FG002|Treatment Stage 2|Switched to another formulation|0
7831575|NCT01335698|12305250|FG003|Treatment Stage 2|Switched to another formulation|0
7831576|NCT01335698|12305251|FG004|Treatment Stage 2|Switched to another formulation|0
7831577|NCT01335971|12305323|FG000|Overall Study|Withdrawal by Subject|1
7831578|NCT01335971|12305324|FG001|Overall Study|Withdrawal by Subject|0
7831579|NCT01335971|12305325|FG002|Overall Study|Withdrawal by Subject|0
7831580|NCT01335971|12305323|FG000|Overall Study|Did not complete bronchoscopy|1
7831581|NCT01335971|12305324|FG001|Overall Study|Did not complete bronchoscopy|1
7831582|NCT01335971|12305325|FG002|Overall Study|Did not complete bronchoscopy|1
7831583|NCT01336023|12305336|FG000|Week 0 to Week 26|Adverse Event|8
7831584|NCT01336023|12305337|FG001|Week 0 to Week 26|Adverse Event|10
7831585|NCT01336023|12305338|FG002|Week 0 to Week 26|Adverse Event|24
7831586|NCT01336023|12305336|FG000|Week 0 to Week 26|Lack of Efficacy|0
7831587|NCT01336023|12305337|FG001|Week 0 to Week 26|Lack of Efficacy|1
7831588|NCT01336023|12305338|FG002|Week 0 to Week 26|Lack of Efficacy|0
7831589|NCT01336023|12305336|FG000|Week 0 to Week 26|Protocol Violation|1
7831590|NCT01336023|12305337|FG001|Week 0 to Week 26|Protocol Violation|2
7831591|NCT01336023|12305338|FG002|Week 0 to Week 26|Protocol Violation|0
7831592|NCT01336023|12305336|FG000|Week 0 to Week 26|Withdrawal Criteria|34
7831593|NCT01336023|12305337|FG001|Week 0 to Week 26|Withdrawal Criteria|69
7831594|NCT01336023|12305338|FG002|Week 0 to Week 26|Withdrawal Criteria|40
7831595|NCT01336023|12305336|FG000|Week 0 to Week 26|Unclassified|5
7831596|NCT01336023|12305337|FG001|Week 0 to Week 26|Unclassified|16
7831597|NCT01336023|12305338|FG002|Week 0 to Week 26|Unclassified|9
7831598|NCT01336023|12305336|FG000|Week 27 to 52|Adverse Event|1
7831599|NCT01336023|12305337|FG001|Week 27 to 52|Adverse Event|5
7831600|NCT01336023|12305338|FG002|Week 27 to 52|Adverse Event|2
7831601|NCT01336023|12305336|FG000|Week 27 to 52|Protocol Violation|0
7831602|NCT01336023|12305337|FG001|Week 27 to 52|Protocol Violation|2
7831603|NCT01336023|12305338|FG002|Week 27 to 52|Protocol Violation|1
7831604|NCT01336023|12305336|FG000|Week 27 to 52|Withdrawal Criteria|14
7831605|NCT01336023|12305337|FG001|Week 27 to 52|Withdrawal Criteria|19
7831606|NCT01336023|12305338|FG002|Week 27 to 52|Withdrawal Criteria|16
7831607|NCT01336023|12305336|FG000|Week 27 to 52|Unclassified|13
7831608|NCT01336023|12305337|FG001|Week 27 to 52|Unclassified|18
7831609|NCT01336023|12305338|FG002|Week 27 to 52|Unclassified|9
7831610|NCT01336205|12305357|FG000|Overall Study|Other|22
7831611|NCT01336205|12305358|FG001|Overall Study|Other|9
7831612|NCT01336205|12305357|FG000|Overall Study|Lost to Follow-up|40
7831613|NCT01336205|12305358|FG001|Overall Study|Lost to Follow-up|20
7831614|NCT01336205|12305357|FG000|Overall Study|Study-Specific Withdrawal Criteria|16
7831615|NCT01336205|12305358|FG001|Overall Study|Study-Specific Withdrawal Criteria|7
7831616|NCT01336205|12305357|FG000|Overall Study|Lack of Efficacy|4
7831617|NCT01336205|12305358|FG001|Overall Study|Lack of Efficacy|0
7831618|NCT01336205|12305357|FG000|Overall Study|Severe noncompliance with protocol|9
7831619|NCT01336205|12305358|FG001|Overall Study|Severe noncompliance with protocol|2
7831620|NCT01336205|12305357|FG000|Overall Study|Adverse Event|56
7831621|NCT01336205|12305358|FG001|Overall Study|Adverse Event|6
7831622|NCT01336205|12305357|FG000|Overall Study|Death|1
7831623|NCT01336205|12305358|FG001|Overall Study|Death|1
7831624|NCT01336205|12305357|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9
7831625|NCT01336205|12305358|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6
7831626|NCT01336205|12305357|FG000|Overall Study|Withdrawal by Subject|72
7831627|NCT01336205|12305358|FG001|Overall Study|Withdrawal by Subject|38
7831628|NCT01336205|12305357|FG000|Overall Study|Did not receive treatment|4
7831629|NCT01336205|12305358|FG001|Overall Study|Did not receive treatment|0
7831630|NCT01336569|12305384|FG000|Overall Study|Lost to Follow-up|4
7831631|NCT01336608|12305391|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
7831632|NCT01336608|12305392|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7831633|NCT01336608|12305393|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7831634|NCT01336608|12305394|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7831635|NCT01336608|12305391|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
7831636|NCT01336608|12305392|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7831637|NCT01336608|12305393|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7831638|NCT01336608|12305394|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7831639|NCT01336608|12305391|FG000|2-week, Single-blind Run-In Period|Adverse Event|1
7831640|NCT01336608|12305392|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
7831641|NCT01336608|12305393|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
7831642|NCT01336608|12305394|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
7831643|NCT01336608|12305391|FG000|2-week, Single-blind Run-In Period|Physician Decision|1
7831644|NCT01336608|12305392|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
7831645|NCT01336608|12305393|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
7831646|NCT01336608|12305394|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
7831647|NCT01336608|12305391|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2
7831648|NCT01336608|12305392|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7831649|NCT01336608|12305393|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7831650|NCT01336608|12305394|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7831651|NCT01336608|12305391|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
7831652|NCT01336608|12305392|FG001|24-week, Double-blind Treatment Period|Adverse Event|8
7831653|NCT01336608|12305393|FG002|24-week, Double-blind Treatment Period|Adverse Event|6
7831654|NCT01336608|12305394|FG003|24-week, Double-blind Treatment Period|Adverse Event|7
7831655|NCT01336608|12305391|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7831656|NCT01336608|12305392|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
7831657|NCT01336608|12305393|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7831658|NCT01336608|12305394|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7831659|NCT01336608|12305391|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
7831660|NCT01336608|12305392|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
7831661|NCT01336608|12305393|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
7831662|NCT01336608|12305394|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
7831663|NCT01336608|12305391|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
7831664|NCT01336608|12305392|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4
7831665|NCT01336608|12305393|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3
7831666|NCT01336608|12305394|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3
7831667|NCT01336608|12305391|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
7831668|NCT01336608|12305392|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
7948553|NCT02528357|12493672|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948554|NCT02528357|12493673|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948555|NCT02528357|12493674|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7948556|NCT02528357|12493675|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7948557|NCT02528357|12493676|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948558|NCT02528357|12493677|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3
7948559|NCT02528357|12493678|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4
7831669|NCT01336608|12305393|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
7831670|NCT01336608|12305394|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
7831671|NCT01336608|12305391|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7831672|NCT01336608|12305392|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3
7831673|NCT01336608|12305393|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7831674|NCT01336608|12305394|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7831675|NCT01336608|12305391|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
7831676|NCT01336608|12305392|FG001|24-week, Double-blind Treatment Period|Physician Decision|3
7831677|NCT01336608|12305393|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
7831678|NCT01336608|12305394|FG003|24-week, Double-blind Treatment Period|Physician Decision|1
7831679|NCT01336608|12305391|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
7831680|NCT01336608|12305392|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
7831681|NCT01336608|12305393|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
7831682|NCT01336608|12305394|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
7831683|NCT01336647|12305405|FG000|Overall Study|Lost to Follow-up|4
7831684|NCT01336647|12305406|FG001|Overall Study|Lost to Follow-up|1
7831685|NCT01336647|12305407|FG002|Overall Study|Lost to Follow-up|3
7831686|NCT01336712|12305417|FG000|Overall Study|Death|2
7831687|NCT01336712|12305417|FG000|Overall Study|Lack of Efficacy|1
7831688|NCT01336738|12305426|FG000|Overall Study|Adverse Event|0
7831689|NCT01336738|12305427|FG001|Overall Study|Adverse Event|3
7831690|NCT01336738|12305428|FG002|Overall Study|Adverse Event|2
7831691|NCT01336738|12305429|FG003|Overall Study|Adverse Event|1
7831692|NCT01336738|12305430|FG004|Overall Study|Adverse Event|3
7831693|NCT01336738|12305426|FG000|Overall Study|Lost to Follow-up|2
7831694|NCT01336738|12305427|FG001|Overall Study|Lost to Follow-up|1
7831695|NCT01336738|12305428|FG002|Overall Study|Lost to Follow-up|2
7831696|NCT01336738|12305429|FG003|Overall Study|Lost to Follow-up|2
7831697|NCT01336738|12305430|FG004|Overall Study|Lost to Follow-up|2
7831698|NCT01336738|12305426|FG000|Overall Study|Did not meet entrance criteria|0
7831699|NCT01336738|12305427|FG001|Overall Study|Did not meet entrance criteria|1
7831700|NCT01336738|12305428|FG002|Overall Study|Did not meet entrance criteria|0
7831701|NCT01336738|12305429|FG003|Overall Study|Did not meet entrance criteria|0
7831702|NCT01336738|12305430|FG004|Overall Study|Did not meet entrance criteria|0
7831703|NCT01336738|12305426|FG000|Overall Study|Protocol Violation|0
7831704|NCT01336738|12305427|FG001|Overall Study|Protocol Violation|1
7831705|NCT01336738|12305428|FG002|Overall Study|Protocol Violation|0
7831706|NCT01336738|12305429|FG003|Overall Study|Protocol Violation|0
7831707|NCT01336738|12305430|FG004|Overall Study|Protocol Violation|0
7831708|NCT01336738|12305426|FG000|Overall Study|Withdrawal by Subject|2
7831709|NCT01336738|12305427|FG001|Overall Study|Withdrawal by Subject|0
7831710|NCT01336738|12305428|FG002|Overall Study|Withdrawal by Subject|2
7831711|NCT01336738|12305429|FG003|Overall Study|Withdrawal by Subject|1
7831712|NCT01336738|12305430|FG004|Overall Study|Withdrawal by Subject|1
7831713|NCT01336738|12305426|FG000|Overall Study|Other|3
7831714|NCT01336738|12305427|FG001|Overall Study|Other|3
7831715|NCT01336738|12305428|FG002|Overall Study|Other|2
7831716|NCT01336738|12305429|FG003|Overall Study|Other|3
7831717|NCT01336738|12305430|FG004|Overall Study|Other|4
7831718|NCT01336764|12305444|FG000|Overall Study|Withdrawal by Subject|5
7831719|NCT01336764|12305445|FG001|Overall Study|Withdrawal by Subject|5
7831720|NCT01336894|12305465|FG000|Follow-up|Study terminated prematurely|2
7831721|NCT01336894|12305466|FG001|Follow-up|Study terminated prematurely|7
7831722|NCT01336972|12305496|FG000|Overall Study|Adverse Event|1
7831723|NCT01336972|12305497|FG001|Overall Study|Adverse Event|1
7831724|NCT01336972|12305498|FG002|Overall Study|Adverse Event|0
7831725|NCT01337050|12305510|FG000|Overall Study|Death|0
7831726|NCT01337050|12305511|FG001|Overall Study|Death|0
7831727|NCT01337050|12305512|FG002|Overall Study|Death|4
7831728|NCT01337050|12305510|FG000|Overall Study|Other|4
7831729|NCT01337050|12305511|FG001|Overall Study|Other|6
7831730|NCT01337050|12305512|FG002|Overall Study|Other|8
7831731|NCT01337050|12305510|FG000|Overall Study|Participants refused further follow-up|0
7831732|NCT01337050|12305511|FG001|Overall Study|Participants refused further follow-up|7
7831733|NCT01337050|12305512|FG002|Overall Study|Participants refused further follow-up|7
7831734|NCT01337089|12305525|FG000|Overall Study|Adverse Event|237
7831735|NCT01337089|12305525|FG000|Overall Study|Withdrawal by Subject|129
7831736|NCT01337089|12305525|FG000|Overall Study|Withdrawal by Investigator|33
7831737|NCT01337089|12305525|FG000|Overall Study|Met Withdrawal Criteria|3
7831738|NCT01337089|12305525|FG000|Overall Study|Lost to Follow-up|2
7831739|NCT01337115|12305531|FG000|Overall Study|Protocol Violation|2
7831740|NCT01337115|12305532|FG001|Overall Study|Protocol Violation|0
7831741|NCT01337167|12305542|FG000|Infant Series|Adverse Event|1
7831742|NCT01337167|12305543|FG001|Infant Series|Adverse Event|1
7831743|NCT01337167|12305542|FG000|Infant Series|Death|1
7831744|NCT01337167|12305543|FG001|Infant Series|Death|1
7831745|NCT01337167|12305542|FG000|Infant Series|Lost to Follow-up|13
7831746|NCT01337167|12305543|FG001|Infant Series|Lost to Follow-up|7
7831747|NCT01337167|12305542|FG000|Infant Series|Non-compliance with study drug|2
7831748|NCT01337167|12305543|FG001|Infant Series|Non-compliance with study drug|1
7831749|NCT01337167|12305542|FG000|Infant Series|Physician Decision|3
7831750|NCT01337167|12305543|FG001|Infant Series|Physician Decision|1
7831751|NCT01337167|12305542|FG000|Infant Series|Protocol Violation|22
7831752|NCT01337167|12305543|FG001|Infant Series|Protocol Violation|9
7831753|NCT01337167|12305542|FG000|Infant Series|Withdrawal by Subject|15
7831754|NCT01337167|12305543|FG001|Infant Series|Withdrawal by Subject|4
7831755|NCT01337167|12305542|FG000|Infant Series|Randomized but not vaccinated|5
7831756|NCT01337167|12305543|FG001|Infant Series|Randomized but not vaccinated|3
7831757|NCT01337167|12305542|FG000|Interim Period|Lost to Follow-up|51
7831758|NCT01337167|12305543|FG001|Interim Period|Lost to Follow-up|23
7831759|NCT01337167|12305542|FG000|Interim Period|Non-compliance with study drug|1
7831760|NCT01337167|12305543|FG001|Interim Period|Non-compliance with study drug|0
7831761|NCT01337167|12305542|FG000|Interim Period|Physician Decision|6
7831762|NCT01337167|12305543|FG001|Interim Period|Physician Decision|3
7831763|NCT01337167|12305542|FG000|Interim Period|Protocol Violation|5
7831764|NCT01337167|12305543|FG001|Interim Period|Protocol Violation|3
7831765|NCT01337167|12305542|FG000|Interim Period|Withdrawal by Subject|18
7831766|NCT01337167|12305543|FG001|Interim Period|Withdrawal by Subject|10
7831767|NCT01337167|12305542|FG000|Interim Period|Other protocol criterion not met|0
7831768|NCT01337167|12305543|FG001|Interim Period|Other protocol criterion not met|1
7831769|NCT01337167|12305542|FG000|Toddler Vaccinations|Lost to Follow-up|11
7831770|NCT01337167|12305543|FG001|Toddler Vaccinations|Lost to Follow-up|12
7831771|NCT01337167|12305542|FG000|Toddler Vaccinations|Protocol Violation|0
7831772|NCT01337167|12305543|FG001|Toddler Vaccinations|Protocol Violation|1
7831773|NCT01337167|12305542|FG000|Toddler Vaccinations|Withdrawal by Subject|3
7831774|NCT01337167|12305543|FG001|Toddler Vaccinations|Withdrawal by Subject|0
7831775|NCT01337297|12305551|FG000|Overall Study|They entered to single anodal tDCS|4
7831776|NCT01337297|12305552|FG001|Overall Study|They entered to single anodal tDCS|3
7831777|NCT01337297|12305551|FG000|Overall Study|Lost to Follow-up|1
7831778|NCT01337297|12305552|FG001|Overall Study|Lost to Follow-up|3
7831779|NCT01337596|12305576|FG000|Overall Study|Withdrawal by Subject|0
7831780|NCT01337596|12305577|FG001|Overall Study|Withdrawal by Subject|0
7831781|NCT01337596|12305578|FG002|Overall Study|Withdrawal by Subject|0
7831782|NCT01337596|12305579|FG003|Overall Study|Withdrawal by Subject|0
7831783|NCT01337596|12305580|FG004|Overall Study|Withdrawal by Subject|2
7831784|NCT01337596|12305581|FG005|Overall Study|Withdrawal by Subject|0
7831785|NCT01337596|12305582|FG006|Overall Study|Withdrawal by Subject|0
7831786|NCT01337596|12305583|FG007|Overall Study|Withdrawal by Subject|0
7831787|NCT01337596|12305584|FG008|Overall Study|Withdrawal by Subject|0
7831788|NCT01337635|12305609|FG000|Overall Study|Lost to Follow-up|0
7831789|NCT01337635|12305610|FG001|Overall Study|Lost to Follow-up|1
7831790|NCT01337674|12305618|FG000|Treatment Period 1|Adverse Event|0
7831791|NCT01337674|12305619|FG001|Treatment Period 1|Adverse Event|1
7831792|NCT01337674|12305620|FG002|Treatment Period 1|Adverse Event|0
7831793|NCT01337674|12305621|FG003|Treatment Period 1|Adverse Event|0
7831794|NCT01337674|12305618|FG000|Treatment Period 1|Discontinued due to blood draws|0
7831795|NCT01337674|12305619|FG001|Treatment Period 1|Discontinued due to blood draws|0
7831796|NCT01337674|12305620|FG002|Treatment Period 1|Discontinued due to blood draws|0
7831797|NCT01337674|12305621|FG003|Treatment Period 1|Discontinued due to blood draws|1
7831798|NCT01337674|12305618|FG000|Treatment Period 2|Withdrawal by Subject|0
7831799|NCT01337674|12305619|FG001|Treatment Period 2|Withdrawal by Subject|0
7831800|NCT01337674|12305620|FG002|Treatment Period 2|Withdrawal by Subject|1
7831801|NCT01337674|12305621|FG003|Treatment Period 2|Withdrawal by Subject|0
7831802|NCT01337960|12305664|FG000|Overall Study|Lost to Follow-up|1
7831803|NCT01337960|12305665|FG001|Overall Study|Lost to Follow-up|0
7831804|NCT01337960|12305666|FG002|Overall Study|Lost to Follow-up|0
7831805|NCT01337960|12305664|FG000|Overall Study|Withdrawal by Subject|1
7831806|NCT01337960|12305665|FG001|Overall Study|Withdrawal by Subject|0
7831807|NCT01337960|12305666|FG002|Overall Study|Withdrawal by Subject|0
7831808|NCT01337973|12305677|FG000|Overall Study|Lost to Follow-up|2
7831809|NCT01337973|12305678|FG001|Overall Study|Lost to Follow-up|4
7831810|NCT01337973|12305679|FG002|Overall Study|Lost to Follow-up|3
7831811|NCT01337973|12305677|FG000|Overall Study|Death|1
7831812|NCT01337973|12305678|FG001|Overall Study|Death|2
7831813|NCT01337973|12305679|FG002|Overall Study|Death|1
7831814|NCT01337973|12305677|FG000|Overall Study|Withdrawal by Subject|10
7831815|NCT01337973|12305678|FG001|Overall Study|Withdrawal by Subject|8
7831816|NCT01337973|12305679|FG002|Overall Study|Withdrawal by Subject|4
7831817|NCT01337973|12305677|FG000|Overall Study|missing data on primary outcome|3
7831818|NCT01337973|12305678|FG001|Overall Study|missing data on primary outcome|1
7831819|NCT01337973|12305679|FG002|Overall Study|missing data on primary outcome|3
7831820|NCT01337986|12305689|FG000|Overall Study|Adverse Event|2
7831821|NCT01337986|12305690|FG001|Overall Study|Adverse Event|2
7831822|NCT01337986|12305689|FG000|Overall Study|Lost to Follow-up|1
7831823|NCT01337986|12305690|FG001|Overall Study|Lost to Follow-up|0
7831824|NCT01337986|12305689|FG000|Overall Study|Protocol Violation|0
7831825|NCT01337986|12305690|FG001|Overall Study|Protocol Violation|3
7831826|NCT01338012|12305712|FG000|Overall Study|Death|4
7831827|NCT01338012|12305712|FG000|Overall Study|Study terminated|4
7831828|NCT01338025|12305718|FG000|Overall Study|Unexpected closure of study|10
7831829|NCT01338025|12305719|FG001|Overall Study|Unexpected closure of study|9
7831830|NCT01338025|12305718|FG000|Overall Study|Withdrawal by Subject|0
7831831|NCT01338025|12305719|FG001|Overall Study|Withdrawal by Subject|2
7831832|NCT01338025|12305718|FG000|Overall Study|Found ineligible after starting|1
7831833|NCT01338025|12305719|FG001|Overall Study|Found ineligible after starting|0
7831834|NCT01338298|12305727|FG000|Overall Study|Withdrawal by Subject|1
7831835|NCT01338298|12305728|FG001|Overall Study|Withdrawal by Subject|1
7831836|NCT01338298|12305727|FG000|Overall Study|Abdominal Pain and scheduled surgery|0
7831837|NCT01338298|12305728|FG001|Overall Study|Abdominal Pain and scheduled surgery|1
7831838|NCT01338298|12305727|FG000|Overall Study|Administrative error|0
7831839|NCT01338298|12305728|FG001|Overall Study|Administrative error|1
7831840|NCT01338298|12305727|FG000|Overall Study|Positive symptom worsening|1
7831841|NCT01338298|12305728|FG001|Overall Study|Positive symptom worsening|0
7831842|NCT01338298|12305727|FG000|Overall Study|Depressive symptoms and nausea|1
7831843|NCT01338298|12305728|FG001|Overall Study|Depressive symptoms and nausea|0
7831844|NCT01338298|12305727|FG000|Overall Study|Non-adherence|1
7831845|NCT01338298|12305728|FG001|Overall Study|Non-adherence|0
7831846|NCT01338415|12305736|FG000|Core + Extension|Adverse Event|8
7831847|NCT01338415|12305737|FG001|Core + Extension|Adverse Event|6
7831848|NCT01338415|12305738|FG002|Core + Extension|Adverse Event|0
7831849|NCT01338415|12305736|FG000|Core + Extension|Withdrawal by Subject|1
7831850|NCT01338415|12305737|FG001|Core + Extension|Withdrawal by Subject|1
7831851|NCT01338415|12305738|FG002|Core + Extension|Withdrawal by Subject|0
7831852|NCT01338415|12305736|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0
7831853|NCT01338415|12305737|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2
7831854|NCT01338415|12305738|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0
7831855|NCT01338415|12305736|FG000|Core + Extension|Other (administrative reason)|1
7831856|NCT01338415|12305737|FG001|Core + Extension|Other (administrative reason)|0
7831857|NCT01338415|12305738|FG002|Core + Extension|Other (administrative reason)|0
7831858|NCT01338415|12305736|FG000|Exceptional Use Treatment Period|Administrative decision|0
7831859|NCT01338415|12305737|FG001|Exceptional Use Treatment Period|Administrative decision|0
7831860|NCT01338415|12305738|FG002|Exceptional Use Treatment Period|Administrative decision|1
7831861|NCT01338415|12305736|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0
7831862|NCT01338415|12305737|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0
7831863|NCT01338415|12305738|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3
7831864|NCT01338415|12305736|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0
7831865|NCT01338415|12305737|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0
7831866|NCT01338415|12305738|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1
7831867|NCT01338415|12305736|FG000|Exceptional Use Treatment Period|Death|0
7831868|NCT01338415|12305737|FG001|Exceptional Use Treatment Period|Death|0
7831869|NCT01338415|12305738|FG002|Exceptional Use Treatment Period|Death|1
7831870|NCT01338493|12305746|FG000|Enrolled|Withdrawal by Subject|1
7831871|NCT01338493|12305746|FG000|Enrolled|Patient not implanted|4
7831872|NCT01338493|12305746|FG000|Discharge|Death|1
7831873|NCT01338493|12305746|FG000|Discharge|Missed visit|1
7831874|NCT01338493|12305746|FG000|6 Months Follow up|Lost to Follow-up|11
7831875|NCT01338493|12305746|FG000|6 Months Follow up|Missed visit|8
7831876|NCT01338493|12305746|FG000|12 Months Follow up|Lost to Follow-up|9
7831877|NCT01338610|12305766|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1
7831878|NCT01338610|12305767|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1
7831879|NCT01338610|12305768|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0
7831880|NCT01338610|12305766|FG000|Overall Study|Protocol Violation|1
7831881|NCT01338610|12305767|FG001|Overall Study|Protocol Violation|0
7831882|NCT01338610|12305768|FG002|Overall Study|Protocol Violation|1
7831883|NCT01338610|12305766|FG000|Overall Study|Adverse Event|3
7831884|NCT01338610|12305767|FG001|Overall Study|Adverse Event|0
7831885|NCT01338610|12305768|FG002|Overall Study|Adverse Event|0
7831886|NCT01338792|12305784|FG000|Overall Study|Adverse Event|2
7831887|NCT01338792|12305784|FG000|Overall Study|Death|1
7831888|NCT01338792|12305784|FG000|Overall Study|Withdrawal by Subject|1
7831889|NCT01338818|12305788|FG000|Overall Study|Adverse Event|8
7831890|NCT01338818|12305788|FG000|Overall Study|Lack of Efficacy|5
7831891|NCT01338818|12305788|FG000|Overall Study|no longer require study drug|1
7831892|NCT01338818|12305788|FG000|Overall Study|Withdrawal by Subject|11
7831893|NCT01338818|12305788|FG000|Overall Study|Lost to Follow-up|4
7831894|NCT01338818|12305788|FG000|Overall Study|Administrative problems|3
7831895|NCT01338818|12305788|FG000|Overall Study|Protocol Deviation|4
7831896|NCT01338870|12305802|FG000|Overall Study|Lost to Follow-up|0
7831897|NCT01338870|12305803|FG001|Overall Study|Lost to Follow-up|0
7831898|NCT01338870|12305804|FG002|Overall Study|Lost to Follow-up|1
7831899|NCT01338870|12305805|FG003|Overall Study|Lost to Follow-up|0
7831900|NCT01338870|12305806|FG004|Overall Study|Lost to Follow-up|1
7831901|NCT01338870|12305807|FG005|Overall Study|Lost to Follow-up|0
7831902|NCT01338870|12305802|FG000|Overall Study|Withdrawal by Subject|2
7831903|NCT01338870|12305803|FG001|Overall Study|Withdrawal by Subject|3
7831904|NCT01338870|12305804|FG002|Overall Study|Withdrawal by Subject|4
7831905|NCT01338870|12305805|FG003|Overall Study|Withdrawal by Subject|0
7831906|NCT01338870|12305806|FG004|Overall Study|Withdrawal by Subject|0
7831907|NCT01338870|12305807|FG005|Overall Study|Withdrawal by Subject|2
7831908|NCT01338870|12305802|FG000|Overall Study|Other|3
7831909|NCT01338870|12305803|FG001|Overall Study|Other|3
7831910|NCT01338870|12305804|FG002|Overall Study|Other|3
7831911|NCT01338870|12305805|FG003|Overall Study|Other|2
7831912|NCT01338870|12305806|FG004|Overall Study|Other|0
7831913|NCT01338870|12305807|FG005|Overall Study|Other|2
7831914|NCT01338870|12305802|FG000|Overall Study|Protocol Violation|0
7831915|NCT01338870|12305803|FG001|Overall Study|Protocol Violation|2
7831916|NCT01338870|12305804|FG002|Overall Study|Protocol Violation|2
7831917|NCT01338870|12305805|FG003|Overall Study|Protocol Violation|2
7831918|NCT01338870|12305806|FG004|Overall Study|Protocol Violation|1
7831919|NCT01338870|12305807|FG005|Overall Study|Protocol Violation|1
7831920|NCT01338870|12305802|FG000|Overall Study|Adverse Event|4
7831921|NCT01338870|12305803|FG001|Overall Study|Adverse Event|4
7831922|NCT01338870|12305804|FG002|Overall Study|Adverse Event|1
7831923|NCT01338870|12305805|FG003|Overall Study|Adverse Event|5
7831924|NCT01338870|12305806|FG004|Overall Study|Adverse Event|4
7831925|NCT01338870|12305807|FG005|Overall Study|Adverse Event|1
7831926|NCT01338987|12305826|FG000|Overall Study|enrolled on new protocol|0
7831927|NCT01338987|12305827|FG001|Overall Study|enrolled on new protocol|0
7831928|NCT01338987|12305828|FG002|Overall Study|enrolled on new protocol|1
7831929|NCT01338987|12305829|FG003|Overall Study|enrolled on new protocol|0
7831930|NCT01338987|12305830|FG004|Overall Study|enrolled on new protocol|0
7831931|NCT01338987|12305826|FG000|Overall Study|Disease progression on study|2
7831932|NCT01338987|12305827|FG001|Overall Study|Disease progression on study|1
7831933|NCT01338987|12305828|FG002|Overall Study|Disease progression on study|1
7831934|NCT01338987|12305829|FG003|Overall Study|Disease progression on study|0
7831935|NCT01338987|12305830|FG004|Overall Study|Disease progression on study|0
7831936|NCT01339000|12305846|FG000|Overall Study|study closed due to lack of drug supply|1
7831937|NCT01339000|12305847|FG001|Overall Study|study closed due to lack of drug supply|0
7831938|NCT01339052|12305862|FG000|Overall Study|Disease progression|13
7831939|NCT01339052|12305863|FG001|Overall Study|Disease progression|46
7831940|NCT01339052|12305862|FG000|Overall Study|Adverse Event|1
7831941|NCT01339052|12305863|FG001|Overall Study|Adverse Event|1
7831942|NCT01339052|12305862|FG000|Overall Study|Withdrawal by Subject|0
7831943|NCT01339052|12305863|FG001|Overall Study|Withdrawal by Subject|3
7831944|NCT01339052|12305862|FG000|Overall Study|Physician Decision|1
7831945|NCT01339052|12305863|FG001|Overall Study|Physician Decision|0
7831946|NCT01339273|12305901|FG000|Overall Study|Lost to Follow-up|8
7831947|NCT01339273|12305902|FG001|Overall Study|Lost to Follow-up|8
7862523|NCT01597908|12351396|FG000|Crossover Phase|Death|0
7862524|NCT01597908|12351397|FG001|Crossover Phase|Death|0
7862525|NCT01597908|12351398|FG002|Crossover Phase|Death|11
7862526|NCT01597908|12351396|FG000|Crossover Phase|Withdrawal by Subject|0
7862527|NCT01597908|12351397|FG001|Crossover Phase|Withdrawal by Subject|0
7862528|NCT01597908|12351398|FG002|Crossover Phase|Withdrawal by Subject|3
7862529|NCT01597908|12351396|FG000|Crossover Phase|Sponsor Decision|0
7862530|NCT01597908|12351397|FG001|Crossover Phase|Sponsor Decision|0
7862531|NCT01597908|12351398|FG002|Crossover Phase|Sponsor Decision|20
7862532|NCT01597973|12351409|FG000|Overall Study|Found ineligible before study medication started|4
7862533|NCT01597973|12351410|FG001|Overall Study|Found ineligible before study medication started|2
7862534|NCT01597973|12351409|FG000|Overall Study|Eligible pathogen not confirmed|14
7862535|NCT01597973|12351410|FG001|Overall Study|Eligible pathogen not confirmed|15
7862536|NCT01597973|12351409|FG000|Overall Study|LAR not authorized to consent|0
7862537|NCT01597973|12351410|FG001|Overall Study|LAR not authorized to consent|1
7862538|NCT01597973|12351409|FG000|Overall Study|Ineligible due to early seizures|1
7862539|NCT01597973|12351410|FG001|Overall Study|Ineligible due to early seizures|0
7862540|NCT01597973|12351409|FG000|Overall Study|Ineligible due to non-target infection|1
7862541|NCT01597973|12351410|FG001|Overall Study|Ineligible due to non-target infection|1
7862542|NCT01598090|12351432|FG000|Treatment Period|Poor/non-compliance|0
7862543|NCT01598090|12351433|FG001|Treatment Period|Poor/non-compliance|2
7862544|NCT01598090|12351434|FG002|Treatment Period|Poor/non-compliance|0
7862545|NCT01598090|12351432|FG000|Treatment Period|No longer meet study criteria|0
7862546|NCT01598090|12351433|FG001|Treatment Period|No longer meet study criteria|1
7862547|NCT01598090|12351434|FG002|Treatment Period|No longer meet study criteria|0
7862548|NCT01598090|12351432|FG000|Treatment Period|Lack of Efficacy|5
7862549|NCT01598090|12351433|FG001|Treatment Period|Lack of Efficacy|14
7862550|NCT01598090|12351434|FG002|Treatment Period|Lack of Efficacy|6
7862551|NCT01598090|12351432|FG000|Treatment Period|Adverse Event|2
7862552|NCT01598090|12351433|FG001|Treatment Period|Adverse Event|33
7862553|NCT01598090|12351434|FG002|Treatment Period|Adverse Event|17
7831948|NCT01339390|12305919|FG000|Overall Study|Death|32
7831949|NCT01339390|12305920|FG001|Overall Study|Death|29
7831950|NCT01339390|12305919|FG000|Overall Study|Lost to Follow-up|125
7831951|NCT01339390|12305920|FG001|Overall Study|Lost to Follow-up|127
7831952|NCT01339429|12305939|FG000|Overall Study|Withdrawal by Subject|1
7831953|NCT01339429|12305939|FG000|Overall Study|Physician Decision|3
7831954|NCT01339559|12305943|FG000|Overall Study|Adverse Event|92
7831955|NCT01339559|12305943|FG000|Overall Study|Death|5
7831956|NCT01339559|12305943|FG000|Overall Study|Lack of Efficacy|164
7831957|NCT01339559|12305943|FG000|Overall Study|Lost to Follow-up|22
7831958|NCT01339559|12305943|FG000|Overall Study|Subject choice|89
7831959|NCT01339559|12305943|FG000|Overall Study|Protocol Violation|15
7831960|NCT01339559|12305943|FG000|Overall Study|Study closure at site|1
7831961|NCT01339559|12305943|FG000|Overall Study|Incarcerated|2
7831962|NCT01339559|12305943|FG000|Overall Study|Epilepsy surgery|1
7831963|NCT01339559|12305943|FG000|Overall Study|Pregnancy planned|2
7831964|NCT01339559|12305943|FG000|Overall Study|Left the country|1
7831965|NCT01339559|12305943|FG000|Overall Study|Investigator decision|2
7831966|NCT01339559|12305943|FG000|Overall Study|Patient didn't wish to continue|1
7831967|NCT01339559|12305943|FG000|Overall Study|PI decision|1
7831968|NCT01339832|12305948|FG000|Overall Study|Lost to Follow-up|3
7831969|NCT01339832|12305948|FG000|Overall Study|Death|11
7831970|NCT01339897|12305967|FG000|Overall Study|Adverse Event|1
7831971|NCT01339897|12305968|FG001|Overall Study|Adverse Event|0
7831972|NCT01339897|12305969|FG002|Overall Study|Adverse Event|0
7831973|NCT01339897|12305970|FG003|Overall Study|Adverse Event|1
7831974|NCT01339910|12305984|FG000|Overall Study|Withdrawal by Subject|1
7831975|NCT01339910|12305985|FG001|Overall Study|Withdrawal by Subject|0
7831976|NCT01339910|12305984|FG000|Overall Study|Physician Decision|1
7831977|NCT01339910|12305985|FG001|Overall Study|Physician Decision|0
7831978|NCT01339910|12305984|FG000|Overall Study|Disease relapse|1
7831979|NCT01339910|12305985|FG001|Overall Study|Disease relapse|4
7831980|NCT01339923|12305998|FG000|Overall Study|Adverse Event|1
7831981|NCT01339923|12305999|FG001|Overall Study|Adverse Event|1
7831982|NCT01339923|12306000|FG002|Overall Study|Adverse Event|1
7831983|NCT01339923|12306001|FG003|Overall Study|Adverse Event|0
7831984|NCT01339923|12306002|FG004|Overall Study|Adverse Event|0
7831985|NCT01339923|12306003|FG005|Overall Study|Adverse Event|0
7831986|NCT01339923|12306004|FG006|Overall Study|Adverse Event|1
7831987|NCT01339923|12305998|FG000|Overall Study|Inappropriate Enrollment|1
7831988|NCT01339923|12305999|FG001|Overall Study|Inappropriate Enrollment|0
7831989|NCT01339923|12306000|FG002|Overall Study|Inappropriate Enrollment|0
7831990|NCT01339923|12306001|FG003|Overall Study|Inappropriate Enrollment|0
7831991|NCT01339923|12306002|FG004|Overall Study|Inappropriate Enrollment|0
7831992|NCT01339923|12306003|FG005|Overall Study|Inappropriate Enrollment|1
7831993|NCT01339923|12306004|FG006|Overall Study|Inappropriate Enrollment|0
7831994|NCT01339923|12305998|FG000|Overall Study|Lost to Follow-up|4
7831995|NCT01339923|12305999|FG001|Overall Study|Lost to Follow-up|4
7831996|NCT01339923|12306000|FG002|Overall Study|Lost to Follow-up|0
7831997|NCT01339923|12306001|FG003|Overall Study|Lost to Follow-up|3
7831998|NCT01339923|12306002|FG004|Overall Study|Lost to Follow-up|1
7831999|NCT01339923|12306003|FG005|Overall Study|Lost to Follow-up|1
7832000|NCT01339923|12306004|FG006|Overall Study|Lost to Follow-up|5
7832001|NCT01339923|12305998|FG000|Overall Study|Protocol Violation|0
7832002|NCT01339923|12305999|FG001|Overall Study|Protocol Violation|0
7832003|NCT01339923|12306000|FG002|Overall Study|Protocol Violation|0
7832004|NCT01339923|12306001|FG003|Overall Study|Protocol Violation|0
7832005|NCT01339923|12306002|FG004|Overall Study|Protocol Violation|0
7832006|NCT01339923|12306003|FG005|Overall Study|Protocol Violation|3
7832007|NCT01339923|12306004|FG006|Overall Study|Protocol Violation|1
7832008|NCT01339923|12305998|FG000|Overall Study|Unable to Classify|1
7832009|NCT01339923|12305999|FG001|Overall Study|Unable to Classify|0
7832010|NCT01339923|12306000|FG002|Overall Study|Unable to Classify|1
7832011|NCT01339923|12306001|FG003|Overall Study|Unable to Classify|0
7832012|NCT01339923|12306002|FG004|Overall Study|Unable to Classify|0
7832013|NCT01339923|12306003|FG005|Overall Study|Unable to Classify|1
7832014|NCT01339923|12306004|FG006|Overall Study|Unable to Classify|5
7832015|NCT01339923|12305998|FG000|Overall Study|Withdrawal by Subject|7
7832016|NCT01339923|12305999|FG001|Overall Study|Withdrawal by Subject|11
7832017|NCT01339923|12306000|FG002|Overall Study|Withdrawal by Subject|6
7832018|NCT01339923|12306001|FG003|Overall Study|Withdrawal by Subject|1
7832019|NCT01339923|12306002|FG004|Overall Study|Withdrawal by Subject|4
7832020|NCT01339923|12306003|FG005|Overall Study|Withdrawal by Subject|3
7832021|NCT01339923|12306004|FG006|Overall Study|Withdrawal by Subject|2
7832022|NCT01340014|12306039|FG000|Period 1, First 7 Days|Adverse Event|1
7832023|NCT01340014|12306040|FG001|Period 1, First 7 Days|Adverse Event|0
7832024|NCT01340014|12306039|FG000|Period 1, First 7 Days|Personal Reasons|1
7832025|NCT01340014|12306040|FG001|Period 1, First 7 Days|Personal Reasons|0
7832026|NCT01340014|12306039|FG000|Period 2, Second 7 Days|Adverse Event|0
7832027|NCT01340014|12306040|FG001|Period 2, Second 7 Days|Adverse Event|1
7832028|NCT01340027|12306058|FG000|Overall Study|Randomized but Never Received Study Drug|0
7832029|NCT01340027|12306059|FG001|Overall Study|Randomized but Never Received Study Drug|0
7832030|NCT01340027|12306060|FG002|Overall Study|Randomized but Never Received Study Drug|1
7832031|NCT01340027|12306061|FG003|Overall Study|Randomized but Never Received Study Drug|0
7832032|NCT01340027|12306062|FG004|Overall Study|Randomized but Never Received Study Drug|0
7832033|NCT01340027|12306063|FG005|Overall Study|Randomized but Never Received Study Drug|0
7832034|NCT01340027|12306064|FG006|Overall Study|Randomized but Never Received Study Drug|0
7832035|NCT01340027|12306065|FG007|Overall Study|Randomized but Never Received Study Drug|0
7832036|NCT01340027|12306066|FG008|Overall Study|Randomized but Never Received Study Drug|0
7832037|NCT01340027|12306067|FG009|Overall Study|Randomized but Never Received Study Drug|0
7832038|NCT01340027|12306068|FG010|Overall Study|Randomized but Never Received Study Drug|0
7832039|NCT01340027|12306069|FG011|Overall Study|Randomized but Never Received Study Drug|0
7832040|NCT01340027|12306058|FG000|Overall Study|Adverse Event|0
7832041|NCT01340027|12306059|FG001|Overall Study|Adverse Event|1
7832042|NCT01340027|12306060|FG002|Overall Study|Adverse Event|2
7832043|NCT01340027|12306061|FG003|Overall Study|Adverse Event|0
7832044|NCT01340027|12306062|FG004|Overall Study|Adverse Event|1
7832045|NCT01340027|12306063|FG005|Overall Study|Adverse Event|2
7832046|NCT01340027|12306064|FG006|Overall Study|Adverse Event|2
7832047|NCT01340027|12306065|FG007|Overall Study|Adverse Event|1
7832048|NCT01340027|12306066|FG008|Overall Study|Adverse Event|4
7832049|NCT01340027|12306067|FG009|Overall Study|Adverse Event|1
7832050|NCT01340027|12306068|FG010|Overall Study|Adverse Event|1
7832051|NCT01340027|12306069|FG011|Overall Study|Adverse Event|3
7832052|NCT01340027|12306058|FG000|Overall Study|Lack of Efficacy|0
7832053|NCT01340027|12306059|FG001|Overall Study|Lack of Efficacy|0
7832054|NCT01340027|12306060|FG002|Overall Study|Lack of Efficacy|0
7832055|NCT01340027|12306061|FG003|Overall Study|Lack of Efficacy|0
7832056|NCT01340027|12306062|FG004|Overall Study|Lack of Efficacy|0
7832057|NCT01340027|12306063|FG005|Overall Study|Lack of Efficacy|0
7832058|NCT01340027|12306064|FG006|Overall Study|Lack of Efficacy|1
7832059|NCT01340027|12306065|FG007|Overall Study|Lack of Efficacy|1
7832060|NCT01340027|12306066|FG008|Overall Study|Lack of Efficacy|1
7832061|NCT01340027|12306067|FG009|Overall Study|Lack of Efficacy|0
7832062|NCT01340027|12306068|FG010|Overall Study|Lack of Efficacy|0
7832063|NCT01340027|12306069|FG011|Overall Study|Lack of Efficacy|0
7832064|NCT01340027|12306058|FG000|Overall Study|Lost to Follow-up|0
7832065|NCT01340027|12306059|FG001|Overall Study|Lost to Follow-up|1
7832066|NCT01340027|12306060|FG002|Overall Study|Lost to Follow-up|0
7832067|NCT01340027|12306061|FG003|Overall Study|Lost to Follow-up|0
7832068|NCT01340027|12306062|FG004|Overall Study|Lost to Follow-up|0
7832069|NCT01340027|12306063|FG005|Overall Study|Lost to Follow-up|0
7832070|NCT01340027|12306064|FG006|Overall Study|Lost to Follow-up|1
7832071|NCT01340027|12306065|FG007|Overall Study|Lost to Follow-up|0
7832072|NCT01340027|12306066|FG008|Overall Study|Lost to Follow-up|0
7832073|NCT01340027|12306067|FG009|Overall Study|Lost to Follow-up|1
7832074|NCT01340027|12306068|FG010|Overall Study|Lost to Follow-up|0
7832075|NCT01340027|12306069|FG011|Overall Study|Lost to Follow-up|0
7832076|NCT01340027|12306058|FG000|Overall Study|Protocol Violation|1
7832077|NCT01340027|12306059|FG001|Overall Study|Protocol Violation|2
7832078|NCT01340027|12306060|FG002|Overall Study|Protocol Violation|0
7832079|NCT01340027|12306061|FG003|Overall Study|Protocol Violation|0
7832080|NCT01340027|12306062|FG004|Overall Study|Protocol Violation|6
7832081|NCT01340027|12306063|FG005|Overall Study|Protocol Violation|0
7832082|NCT01340027|12306064|FG006|Overall Study|Protocol Violation|0
7832083|NCT01340027|12306065|FG007|Overall Study|Protocol Violation|1
7832084|NCT01340027|12306066|FG008|Overall Study|Protocol Violation|2
7832085|NCT01340027|12306067|FG009|Overall Study|Protocol Violation|2
7832086|NCT01340027|12306068|FG010|Overall Study|Protocol Violation|0
7832087|NCT01340027|12306069|FG011|Overall Study|Protocol Violation|0
7832088|NCT01340027|12306058|FG000|Overall Study|Withdrawal by Subject|4
7832089|NCT01340027|12306059|FG001|Overall Study|Withdrawal by Subject|3
7832090|NCT01340027|12306060|FG002|Overall Study|Withdrawal by Subject|1
7832091|NCT01340027|12306061|FG003|Overall Study|Withdrawal by Subject|3
7832092|NCT01340027|12306062|FG004|Overall Study|Withdrawal by Subject|3
7832093|NCT01340027|12306063|FG005|Overall Study|Withdrawal by Subject|2
7832094|NCT01340027|12306064|FG006|Overall Study|Withdrawal by Subject|3
7832095|NCT01340027|12306065|FG007|Overall Study|Withdrawal by Subject|4
7832096|NCT01340027|12306066|FG008|Overall Study|Withdrawal by Subject|1
7832097|NCT01340027|12306067|FG009|Overall Study|Withdrawal by Subject|2
7832098|NCT01340027|12306068|FG010|Overall Study|Withdrawal by Subject|0
7832099|NCT01340027|12306069|FG011|Overall Study|Withdrawal by Subject|1
7832100|NCT01340027|12306058|FG000|Overall Study|Miscellaneous|0
7832101|NCT01340027|12306059|FG001|Overall Study|Miscellaneous|0
7832102|NCT01340027|12306060|FG002|Overall Study|Miscellaneous|0
7832103|NCT01340027|12306061|FG003|Overall Study|Miscellaneous|1
7832104|NCT01340027|12306062|FG004|Overall Study|Miscellaneous|0
7832105|NCT01340027|12306063|FG005|Overall Study|Miscellaneous|0
7832106|NCT01340027|12306064|FG006|Overall Study|Miscellaneous|0
7832107|NCT01340027|12306065|FG007|Overall Study|Miscellaneous|0
7832108|NCT01340027|12306066|FG008|Overall Study|Miscellaneous|0
7832109|NCT01340027|12306067|FG009|Overall Study|Miscellaneous|0
7832110|NCT01340027|12306068|FG010|Overall Study|Miscellaneous|1
7832111|NCT01340027|12306069|FG011|Overall Study|Miscellaneous|0
7832112|NCT01340066|12306114|FG000|Placebo Run in Period|Screen Failures|27
7832113|NCT01340066|12306115|FG001|Placebo Run in Period|Screen Failures|0
7832114|NCT01340066|12306116|FG002|Placebo Run in Period|Screen Failures|0
7832115|NCT01340066|12306114|FG000|5 Week Double Blind Randomization Period|Adverse Event|0
7832116|NCT01340066|12306115|FG001|5 Week Double Blind Randomization Period|Adverse Event|2
7832117|NCT01340066|12306116|FG002|5 Week Double Blind Randomization Period|Adverse Event|2
7832118|NCT01340066|12306114|FG000|5 Week Double Blind Randomization Period|Physician Decision|0
7832119|NCT01340066|12306115|FG001|5 Week Double Blind Randomization Period|Physician Decision|1
7832120|NCT01340066|12306116|FG002|5 Week Double Blind Randomization Period|Physician Decision|0
7832121|NCT01340066|12306114|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
7832122|NCT01340066|12306115|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
7832123|NCT01340066|12306116|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
7832124|NCT01340196|12306132|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2
7832125|NCT01340209|12306144|FG000|Overall Study|Adverse Event|1
7832126|NCT01340209|12306145|FG001|Overall Study|Adverse Event|1
7832127|NCT01340209|12306146|FG002|Overall Study|Adverse Event|2
7832128|NCT01340209|12306144|FG000|Overall Study|Protocol Violation|1
7832129|NCT01340209|12306145|FG001|Overall Study|Protocol Violation|2
7832130|NCT01340209|12306146|FG002|Overall Study|Protocol Violation|1
7832131|NCT01340209|12306144|FG000|Overall Study|Withdrawal by Subject|0
7832132|NCT01340209|12306145|FG001|Overall Study|Withdrawal by Subject|0
7832133|NCT01340209|12306146|FG002|Overall Study|Withdrawal by Subject|1
7832134|NCT01340209|12306144|FG000|Overall Study|Other reason not defined above|3
7832135|NCT01340209|12306145|FG001|Overall Study|Other reason not defined above|5
7832136|NCT01340209|12306146|FG002|Overall Study|Other reason not defined above|4
7832137|NCT01340300|12306158|FG000|Overall Study|Lost to Follow-up|3
7832138|NCT01340300|12306159|FG001|Overall Study|Lost to Follow-up|0
7832139|NCT01340300|12306160|FG002|Overall Study|Lost to Follow-up|5
7832140|NCT01340300|12306161|FG003|Overall Study|Lost to Follow-up|10
7832141|NCT01340300|12306158|FG000|Overall Study|Withdrawal by Subject|5
7832142|NCT01340300|12306159|FG001|Overall Study|Withdrawal by Subject|6
7832143|NCT01340300|12306160|FG002|Overall Study|Withdrawal by Subject|6
7832144|NCT01340300|12306161|FG003|Overall Study|Withdrawal by Subject|3
7832145|NCT01340300|12306158|FG000|Overall Study|Adverse Event|1
7832146|NCT01340300|12306159|FG001|Overall Study|Adverse Event|0
7832147|NCT01340300|12306160|FG002|Overall Study|Adverse Event|4
7832148|NCT01340300|12306161|FG003|Overall Study|Adverse Event|0
7832149|NCT01340300|12306158|FG000|Overall Study|Physician Decision|0
7832150|NCT01340300|12306159|FG001|Overall Study|Physician Decision|1
7832151|NCT01340300|12306160|FG002|Overall Study|Physician Decision|0
7832152|NCT01340300|12306161|FG003|Overall Study|Physician Decision|0
7832153|NCT01340300|12306158|FG000|Overall Study|Unrelated sickness|0
7832154|NCT01340300|12306159|FG001|Overall Study|Unrelated sickness|2
7832155|NCT01340300|12306160|FG002|Overall Study|Unrelated sickness|0
7832156|NCT01340300|12306161|FG003|Overall Study|Unrelated sickness|1
7832157|NCT01340482|12306174|FG000|Overall Study|Adverse Event|2
7832158|NCT01340482|12306175|FG001|Overall Study|Adverse Event|0
7832159|NCT01340482|12306176|FG002|Overall Study|Adverse Event|0
7832160|NCT01340495|12306186|FG000|Overall Study|Withdrawal by Subject|1
7832161|NCT01340625|12306206|FG000|First Intervention|Adverse Event|1
7832162|NCT01340625|12306207|FG001|First Intervention|Adverse Event|0
7832163|NCT01340625|12306206|FG000|Washout Period of 28 Days|Withdrawal by Subject|1
7832164|NCT01340625|12306207|FG001|Washout Period of 28 Days|Withdrawal by Subject|0
7832165|NCT01340651|12306213|FG000|Overall Study|Adverse Event|3
7832166|NCT01340651|12306213|FG000|Overall Study|Consent Withdrawn|2
7832167|NCT01340651|12306213|FG000|Overall Study|Commercial Supply per Sponsor|12
7832168|NCT01340664|12306222|FG000|Overall Study|Adverse Event|0
7832169|NCT01340664|12306223|FG001|Overall Study|Adverse Event|1
7832170|NCT01340664|12306224|FG002|Overall Study|Adverse Event|7
7832171|NCT01340664|12306222|FG000|Overall Study|Lost to Follow-up|2
7832172|NCT01340664|12306223|FG001|Overall Study|Lost to Follow-up|0
7832173|NCT01340664|12306224|FG002|Overall Study|Lost to Follow-up|2
7832174|NCT01340664|12306222|FG000|Overall Study|Withdrawal by Subject|2
7832175|NCT01340664|12306223|FG001|Overall Study|Withdrawal by Subject|4
7832176|NCT01340664|12306224|FG002|Overall Study|Withdrawal by Subject|0
7832177|NCT01340664|12306222|FG000|Overall Study|Glycemic withdrawal criteria|2
7832178|NCT01340664|12306223|FG001|Overall Study|Glycemic withdrawal criteria|0
7832179|NCT01340664|12306224|FG002|Overall Study|Glycemic withdrawal criteria|0
7832180|NCT01340664|12306222|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0
7832181|NCT01340664|12306223|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1
7832182|NCT01340664|12306224|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2
7832183|NCT01340664|12306222|FG000|Overall Study|Other|1
7832184|NCT01340664|12306223|FG001|Overall Study|Other|2
7832185|NCT01340664|12306224|FG002|Overall Study|Other|2
7832186|NCT01340768|12306234|FG000|Overall Study|Lost to Follow-up|10
7832187|NCT01340768|12306235|FG001|Overall Study|Lost to Follow-up|4
7832188|NCT01340768|12306234|FG000|Overall Study|Withdrawal by Subject|5
7832189|NCT01340768|12306235|FG001|Overall Study|Withdrawal by Subject|1
7832190|NCT01340768|12306234|FG000|Overall Study|Other|2
7832191|NCT01340768|12306235|FG001|Overall Study|Other|0
7832192|NCT01340794|12306243|FG000|Overall Study|Withdrawal by Subject|0
7832193|NCT01340794|12306244|FG001|Overall Study|Withdrawal by Subject|1
7832194|NCT01340872|12306254|FG000|Double-blind Phase|Adverse Event|6
7832195|NCT01340872|12306255|FG001|Double-blind Phase|Adverse Event|4
7832196|NCT01340872|12306256|FG002|Double-blind Phase|Adverse Event|0
7832197|NCT01340872|12306257|FG003|Double-blind Phase|Adverse Event|0
7832198|NCT01340872|12306254|FG000|Double-blind Phase|Withdrawal by Subject|3
7832199|NCT01340872|12306255|FG001|Double-blind Phase|Withdrawal by Subject|5
7832200|NCT01340872|12306256|FG002|Double-blind Phase|Withdrawal by Subject|0
7832201|NCT01340872|12306257|FG003|Double-blind Phase|Withdrawal by Subject|0
7832202|NCT01340872|12306254|FG000|Double-blind Phase|Lost to Follow-up|0
7832203|NCT01340872|12306255|FG001|Double-blind Phase|Lost to Follow-up|1
7832204|NCT01340872|12306256|FG002|Double-blind Phase|Lost to Follow-up|0
7832205|NCT01340872|12306257|FG003|Double-blind Phase|Lost to Follow-up|0
7832206|NCT01340872|12306254|FG000|Double-blind Phase|Protocol Violation|0
7832207|NCT01340872|12306255|FG001|Double-blind Phase|Protocol Violation|1
7832208|NCT01340872|12306256|FG002|Double-blind Phase|Protocol Violation|0
7832209|NCT01340872|12306257|FG003|Double-blind Phase|Protocol Violation|0
7832210|NCT01340872|12306254|FG000|Open-label Phase|Physician Decision|0
7832211|NCT01340872|12306255|FG001|Open-label Phase|Physician Decision|0
7832212|NCT01340872|12306256|FG002|Open-label Phase|Physician Decision|2
7832213|NCT01340872|12306257|FG003|Open-label Phase|Physician Decision|1
7832214|NCT01340872|12306254|FG000|Open-label Phase|Pregnancy|0
7832215|NCT01340872|12306255|FG001|Open-label Phase|Pregnancy|0
7832216|NCT01340872|12306256|FG002|Open-label Phase|Pregnancy|1
7832217|NCT01340872|12306257|FG003|Open-label Phase|Pregnancy|0
7832218|NCT01340872|12306254|FG000|Open-label Phase|Adverse Event|0
7832219|NCT01340872|12306255|FG001|Open-label Phase|Adverse Event|0
7832220|NCT01340872|12306256|FG002|Open-label Phase|Adverse Event|8
7832221|NCT01340872|12306257|FG003|Open-label Phase|Adverse Event|4
7832222|NCT01340872|12306254|FG000|Open-label Phase|Withdrawal by Subject|0
7832223|NCT01340872|12306255|FG001|Open-label Phase|Withdrawal by Subject|0
7832224|NCT01340872|12306256|FG002|Open-label Phase|Withdrawal by Subject|1
7832225|NCT01340872|12306257|FG003|Open-label Phase|Withdrawal by Subject|6
7832226|NCT01340872|12306254|FG000|Open-label Phase|Worsening of IBD|0
7832227|NCT01340872|12306255|FG001|Open-label Phase|Worsening of IBD|0
7832228|NCT01340872|12306256|FG002|Open-label Phase|Worsening of IBD|1
7832229|NCT01340872|12306257|FG003|Open-label Phase|Worsening of IBD|0
7832230|NCT01340898|12306272|FG000|Primary Phase|Serious Adverse Events|0
7832231|NCT01340898|12306273|FG001|Primary Phase|Serious Adverse Events|0
7832232|NCT01340898|12306274|FG002|Primary Phase|Serious Adverse Events|1
7832233|NCT01340898|12306272|FG000|Primary Phase|Withdrawal by Subject|8
7832234|NCT01340898|12306273|FG001|Primary Phase|Withdrawal by Subject|7
7832235|NCT01340898|12306274|FG002|Primary Phase|Withdrawal by Subject|5
7832236|NCT01340898|12306272|FG000|Primary Phase|Migrated/moved from study area|4
7832237|NCT01340898|12306273|FG001|Primary Phase|Migrated/moved from study area|1
7832238|NCT01340898|12306274|FG002|Primary Phase|Migrated/moved from study area|0
7832239|NCT01340898|12306272|FG000|Primary Phase|Lost to Follow-up|4
7832240|NCT01340898|12306273|FG001|Primary Phase|Lost to Follow-up|1
7832241|NCT01340898|12306274|FG002|Primary Phase|Lost to Follow-up|0
7832242|NCT01340898|12306272|FG000|Booster Phase|Withdrawal by Subject|3
7832243|NCT01340898|12306273|FG001|Booster Phase|Withdrawal by Subject|0
7832244|NCT01340898|12306274|FG002|Booster Phase|Withdrawal by Subject|4
7832245|NCT01340898|12306272|FG000|Booster Phase|Migrated/moved from study area|3
7832246|NCT01340898|12306273|FG001|Booster Phase|Migrated/moved from study area|0
7832247|NCT01340898|12306274|FG002|Booster Phase|Migrated/moved from study area|0
7832248|NCT01340898|12306272|FG000|Booster Phase|Lost to Follow-up|4
7832249|NCT01340898|12306273|FG001|Booster Phase|Lost to Follow-up|2
7832250|NCT01340898|12306274|FG002|Booster Phase|Lost to Follow-up|3
7832251|NCT01340937|12306288|FG000|Period 1: Infant Series|Other protocol criterion not met|0
7832252|NCT01340937|12306289|FG001|Period 1: Infant Series|Other protocol criterion not met|1
7832253|NCT01340937|12306290|FG002|Period 1: Infant Series|Other protocol criterion not met|1
7832254|NCT01340937|12306291|FG003|Period 1: Infant Series|Other protocol criterion not met|0
7832255|NCT01340937|12306288|FG000|Period 1: Infant Series|Adverse Event|0
7832256|NCT01340937|12306289|FG001|Period 1: Infant Series|Adverse Event|1
7832257|NCT01340937|12306290|FG002|Period 1: Infant Series|Adverse Event|4
7832258|NCT01340937|12306291|FG003|Period 1: Infant Series|Adverse Event|0
7832259|NCT01340937|12306288|FG000|Period 1: Infant Series|Death|2
7832260|NCT01340937|12306289|FG001|Period 1: Infant Series|Death|0
7832261|NCT01340937|12306290|FG002|Period 1: Infant Series|Death|2
7832262|NCT01340937|12306291|FG003|Period 1: Infant Series|Death|0
7832263|NCT01340937|12306288|FG000|Period 1: Infant Series|Lost to Follow-up|20
7832264|NCT01340937|12306289|FG001|Period 1: Infant Series|Lost to Follow-up|14
7832265|NCT01340937|12306290|FG002|Period 1: Infant Series|Lost to Follow-up|12
7832266|NCT01340937|12306291|FG003|Period 1: Infant Series|Lost to Follow-up|13
7832267|NCT01340937|12306288|FG000|Period 1: Infant Series|Physician Decision|2
7832268|NCT01340937|12306289|FG001|Period 1: Infant Series|Physician Decision|3
7832269|NCT01340937|12306290|FG002|Period 1: Infant Series|Physician Decision|1
7832270|NCT01340937|12306291|FG003|Period 1: Infant Series|Physician Decision|0
7832271|NCT01340937|12306288|FG000|Period 1: Infant Series|Protocol Violation|1
7832272|NCT01340937|12306289|FG001|Period 1: Infant Series|Protocol Violation|4
7832273|NCT01340937|12306290|FG002|Period 1: Infant Series|Protocol Violation|4
7832274|NCT01340937|12306291|FG003|Period 1: Infant Series|Protocol Violation|3
7832275|NCT01340937|12306288|FG000|Period 1: Infant Series|Withdrawal by Subject|33
7832276|NCT01340937|12306289|FG001|Period 1: Infant Series|Withdrawal by Subject|32
7832277|NCT01340937|12306290|FG002|Period 1: Infant Series|Withdrawal by Subject|30
7832278|NCT01340937|12306291|FG003|Period 1: Infant Series|Withdrawal by Subject|15
7832279|NCT01340937|12306288|FG000|Period 1: Infant Series|Randomized but not vaccinated|0
7832280|NCT01340937|12306289|FG001|Period 1: Infant Series|Randomized but not vaccinated|5
7832281|NCT01340937|12306290|FG002|Period 1: Infant Series|Randomized but not vaccinated|2
7832282|NCT01340937|12306291|FG003|Period 1: Infant Series|Randomized but not vaccinated|1
7832283|NCT01340937|12306288|FG000|Period 2: Interim Period|Withdrawal by Subject|28
7832284|NCT01340937|12306289|FG001|Period 2: Interim Period|Withdrawal by Subject|23
7832285|NCT01340937|12306290|FG002|Period 2: Interim Period|Withdrawal by Subject|17
7832286|NCT01340937|12306291|FG003|Period 2: Interim Period|Withdrawal by Subject|12
7832287|NCT01340937|12306288|FG000|Period 2: Interim Period|Adverse Event|1
7832288|NCT01340937|12306289|FG001|Period 2: Interim Period|Adverse Event|0
7832289|NCT01340937|12306290|FG002|Period 2: Interim Period|Adverse Event|1
7832290|NCT01340937|12306291|FG003|Period 2: Interim Period|Adverse Event|0
7832291|NCT01340937|12306288|FG000|Period 2: Interim Period|Lost to Follow-up|29
7832292|NCT01340937|12306289|FG001|Period 2: Interim Period|Lost to Follow-up|48
7832293|NCT01340937|12306290|FG002|Period 2: Interim Period|Lost to Follow-up|53
7832294|NCT01340937|12306291|FG003|Period 2: Interim Period|Lost to Follow-up|23
7832295|NCT01340937|12306288|FG000|Period 2: Interim Period|Physician Decision|0
7832296|NCT01340937|12306289|FG001|Period 2: Interim Period|Physician Decision|1
7832297|NCT01340937|12306290|FG002|Period 2: Interim Period|Physician Decision|1
7832298|NCT01340937|12306291|FG003|Period 2: Interim Period|Physician Decision|0
7832299|NCT01340937|12306288|FG000|Period 2: Interim Period|Protocol Violation|5
7832300|NCT01340937|12306289|FG001|Period 2: Interim Period|Protocol Violation|3
7832301|NCT01340937|12306290|FG002|Period 2: Interim Period|Protocol Violation|6
7832302|NCT01340937|12306291|FG003|Period 2: Interim Period|Protocol Violation|3
7832303|NCT01340937|12306288|FG000|Period 2: Interim Period|Technical problems|4
7832304|NCT01340937|12306289|FG001|Period 2: Interim Period|Technical problems|4
7832305|NCT01340937|12306290|FG002|Period 2: Interim Period|Technical problems|6
7832306|NCT01340937|12306291|FG003|Period 2: Interim Period|Technical problems|3
7832307|NCT01340937|12306288|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
7832308|NCT01340937|12306289|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
7832309|NCT01340937|12306290|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
7832310|NCT01340937|12306291|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
7832311|NCT01340937|12306288|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6
7832312|NCT01340937|12306289|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14
7832313|NCT01340937|12306290|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7
7832314|NCT01340937|12306291|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8
7832315|NCT01340937|12306288|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0
7832316|NCT01340937|12306289|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0
7832317|NCT01340937|12306290|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0
7832318|NCT01340937|12306291|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1
7832319|NCT01340937|12306288|FG000|Period 3: Toddler Vaccinations|Technical problem|1
7832320|NCT01340937|12306289|FG001|Period 3: Toddler Vaccinations|Technical problem|1
7832321|NCT01340937|12306290|FG002|Period 3: Toddler Vaccinations|Technical problem|1
7832322|NCT01340937|12306291|FG003|Period 3: Toddler Vaccinations|Technical problem|0
7832323|NCT01340976|12306313|FG000|Overall Study|Physician Decision|2
7832324|NCT01340976|12306314|FG001|Overall Study|Physician Decision|0
7832325|NCT01340976|12306315|FG002|Overall Study|Physician Decision|1
7832326|NCT01340976|12306316|FG003|Overall Study|Physician Decision|1
7832327|NCT01340976|12306317|FG004|Overall Study|Physician Decision|1
7832328|NCT01340976|12306318|FG005|Overall Study|Physician Decision|0
7832329|NCT01340976|12306313|FG000|Overall Study|Death|0
7832330|NCT01340976|12306314|FG001|Overall Study|Death|1
7832331|NCT01340976|12306315|FG002|Overall Study|Death|0
7832332|NCT01340976|12306316|FG003|Overall Study|Death|0
7832333|NCT01340976|12306317|FG004|Overall Study|Death|0
7832334|NCT01340976|12306318|FG005|Overall Study|Death|0
7832335|NCT01340976|12306313|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1
7832336|NCT01340976|12306314|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0
7832337|NCT01340976|12306315|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0
7832338|NCT01340976|12306316|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0
7832339|NCT01340976|12306317|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0
7832340|NCT01340976|12306318|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0
7832341|NCT01340976|12306313|FG000|Overall Study|Withdrawal by Subject|0
7832342|NCT01340976|12306314|FG001|Overall Study|Withdrawal by Subject|0
7832343|NCT01340976|12306315|FG002|Overall Study|Withdrawal by Subject|0
7832344|NCT01340976|12306316|FG003|Overall Study|Withdrawal by Subject|1
7832345|NCT01340976|12306317|FG004|Overall Study|Withdrawal by Subject|1
7832346|NCT01340976|12306318|FG005|Overall Study|Withdrawal by Subject|0
7832347|NCT01340976|12306313|FG000|Overall Study|Other anemia treatment|1
7832348|NCT01340976|12306314|FG001|Overall Study|Other anemia treatment|0
7832349|NCT01340976|12306315|FG002|Overall Study|Other anemia treatment|2
7832350|NCT01340976|12306316|FG003|Overall Study|Other anemia treatment|1
7832351|NCT01340976|12306317|FG004|Overall Study|Other anemia treatment|0
7832352|NCT01340976|12306318|FG005|Overall Study|Other anemia treatment|1
7832353|NCT01340976|12306313|FG000|Overall Study|Adverse Event|0
7832354|NCT01340976|12306314|FG001|Overall Study|Adverse Event|1
7832355|NCT01340976|12306315|FG002|Overall Study|Adverse Event|0
7832356|NCT01340976|12306316|FG003|Overall Study|Adverse Event|0
7832357|NCT01340976|12306317|FG004|Overall Study|Adverse Event|0
7832358|NCT01340976|12306318|FG005|Overall Study|Adverse Event|0
7832359|NCT01341457|12306350|FG000|Overall Study|Adverse Event|2
7832360|NCT01341457|12306351|FG001|Overall Study|Adverse Event|0
7832361|NCT01341470|12306364|FG000|Overall Study|Sponsor decision|0
7832362|NCT01341470|12306365|FG001|Overall Study|Sponsor decision|0
7832363|NCT01341470|12306366|FG002|Overall Study|Sponsor decision|1
7832364|NCT01341470|12306367|FG003|Overall Study|Sponsor decision|1
7832365|NCT01341470|12306368|FG004|Overall Study|Sponsor decision|0
7832366|NCT01341470|12306369|FG005|Overall Study|Sponsor decision|1
7832367|NCT01341639|12306387|FG000|Infant Series|Protocol Violation|1
7832368|NCT01341639|12306388|FG001|Infant Series|Protocol Violation|0
7832369|NCT01341639|12306387|FG000|Infant Series|Not Vaccinated|0
7832370|NCT01341639|12306388|FG001|Infant Series|Not Vaccinated|1
7832371|NCT01341639|12306387|FG000|Infant Series|Adverse Event|0
7832372|NCT01341639|12306388|FG001|Infant Series|Adverse Event|5
7832373|NCT01341639|12306387|FG000|Infant Series|Withdrawal by Subject|11
7832374|NCT01341639|12306388|FG001|Infant Series|Withdrawal by Subject|8
7832375|NCT01341639|12306387|FG000|Infant Series|Lost to Follow-up|0
7832376|NCT01341639|12306388|FG001|Infant Series|Lost to Follow-up|2
7832377|NCT01341639|12306387|FG000|Infant Series|Site 0048 Participants|17
7832378|NCT01341639|12306388|FG001|Infant Series|Site 0048 Participants|16
7832379|NCT01341639|12306387|FG000|Interim Period|Withdrawal by Subject|6
7832380|NCT01341639|12306388|FG001|Interim Period|Withdrawal by Subject|7
7832381|NCT01341639|12306387|FG000|Interim Period|Lost to Follow-up|2
7832382|NCT01341639|12306388|FG001|Interim Period|Lost to Follow-up|0
7832383|NCT01341639|12306387|FG000|Interim Period|Physician Decision|0
7832384|NCT01341639|12306388|FG001|Interim Period|Physician Decision|1
7832385|NCT01341639|12306387|FG000|Interim Period|Protocol Violation|0
7832386|NCT01341639|12306388|FG001|Interim Period|Protocol Violation|1
7832387|NCT01341639|12306387|FG000|Post-Treatment|Withdrawal by Subject|0
7832388|NCT01341639|12306388|FG001|Post-Treatment|Withdrawal by Subject|1
7832389|NCT01341639|12306387|FG000|Post-Treatment|Adverse Event|0
7832390|NCT01341639|12306388|FG001|Post-Treatment|Adverse Event|2
7832391|NCT01341652|12306396|FG000|Overall Study|Incorrect Random Assignment|0
7948560|NCT02528357|12493679|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7948561|NCT02528357|12493680|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7948562|NCT02528357|12493681|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948563|NCT02528357|12493682|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948564|NCT02528357|12493683|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948565|NCT02528357|12493684|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948566|NCT02528357|12493666|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948567|NCT02528357|12493667|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7832392|NCT01341652|12306397|FG001|Overall Study|Incorrect Random Assignment|1
7832393|NCT01341652|12306396|FG000|Overall Study|ineligible; presence metastatic disease|0
7832394|NCT01341652|12306397|FG001|Overall Study|ineligible; presence metastatic disease|1
7948568|NCT02528357|12493668|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948569|NCT02528357|12493669|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948570|NCT02528357|12493670|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948571|NCT02528357|12493671|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948572|NCT02528357|12493672|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7832395|NCT01341782|12306416|FG000|Overall Study|Adverse Event|1
7832396|NCT01341782|12306417|FG001|Overall Study|Adverse Event|1
7832397|NCT01341782|12306416|FG000|Overall Study|Withdrawal by Subject|6
7832398|NCT01341782|12306417|FG001|Overall Study|Withdrawal by Subject|5
7832399|NCT01341782|12306416|FG000|Overall Study|Missed 3 consecutive doses|0
7832400|NCT01341782|12306417|FG001|Overall Study|Missed 3 consecutive doses|4
7832401|NCT01341782|12306416|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
7832402|NCT01341782|12306417|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
7832403|NCT01341782|12306416|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
7832404|NCT01341782|12306417|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
7832405|NCT01341782|12306416|FG000|Overall Study|Other|5
7832406|NCT01341782|12306417|FG001|Overall Study|Other|0
7832407|NCT01341990|12306438|FG000|Overall Study|Adverse Event|0
7832408|NCT01341990|12306439|FG001|Overall Study|Adverse Event|1
7832409|NCT01341990|12306438|FG000|Overall Study|Torn Study Lens|1
7832410|NCT01341990|12306439|FG001|Overall Study|Torn Study Lens|0
7832411|NCT01341990|12306438|FG000|Overall Study|Withdrawal by Subject|2
7832412|NCT01341990|12306439|FG001|Overall Study|Withdrawal by Subject|0
7832413|NCT01342081|12306457|FG000|Overall Study|Did not receive allocated intervention|0
7832414|NCT01342081|12306458|FG001|Overall Study|Did not receive allocated intervention|0
7832415|NCT01342081|12306459|FG002|Overall Study|Did not receive allocated intervention|1
7832416|NCT01342081|12306457|FG000|Overall Study|Adverse Event|1
7832417|NCT01342081|12306458|FG001|Overall Study|Adverse Event|0
7832418|NCT01342081|12306459|FG002|Overall Study|Adverse Event|0
7832419|NCT01342081|12306457|FG000|Overall Study|Physician Decision|0
7832420|NCT01342081|12306458|FG001|Overall Study|Physician Decision|1
7832421|NCT01342081|12306459|FG002|Overall Study|Physician Decision|0
7832422|NCT01342081|12306457|FG000|Overall Study|Withdrawal by Subject|1
7832423|NCT01342081|12306458|FG001|Overall Study|Withdrawal by Subject|1
7832424|NCT01342081|12306459|FG002|Overall Study|Withdrawal by Subject|0
7832425|NCT01342094|12306469|FG000|Overall Study|Adverse Event|5
7832426|NCT01342094|12306470|FG001|Overall Study|Adverse Event|0
7832427|NCT01342094|12306469|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0
7832428|NCT01342094|12306470|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
7832429|NCT01342094|12306469|FG000|Overall Study|Withdrawal by Subject|0
7832430|NCT01342094|12306470|FG001|Overall Study|Withdrawal by Subject|2
7832431|NCT01342211|12306495|FG000|Overall Study|Lost to Follow-up|0
7832432|NCT01342211|12306496|FG001|Overall Study|Lost to Follow-up|0
7832433|NCT01342211|12306497|FG002|Overall Study|Lost to Follow-up|0
7832434|NCT01342211|12306498|FG003|Overall Study|Lost to Follow-up|1
7832435|NCT01342211|12306499|FG004|Overall Study|Lost to Follow-up|0
7832436|NCT01342211|12306495|FG000|Overall Study|Adverse Event|0
7832437|NCT01342211|12306496|FG001|Overall Study|Adverse Event|0
7832438|NCT01342211|12306497|FG002|Overall Study|Adverse Event|0
7832439|NCT01342211|12306498|FG003|Overall Study|Adverse Event|0
7832440|NCT01342211|12306499|FG004|Overall Study|Adverse Event|1
7832441|NCT01342211|12306495|FG000|Overall Study|Withdrawal by Subject|0
7832442|NCT01342211|12306496|FG001|Overall Study|Withdrawal by Subject|0
7832443|NCT01342211|12306497|FG002|Overall Study|Withdrawal by Subject|0
7832444|NCT01342211|12306498|FG003|Overall Study|Withdrawal by Subject|1
7832445|NCT01342211|12306499|FG004|Overall Study|Withdrawal by Subject|0
7832446|NCT01342211|12306495|FG000|Overall Study|Randomized, but not Treated|0
7832447|NCT01342211|12306496|FG001|Overall Study|Randomized, but not Treated|2
7832448|NCT01342211|12306497|FG002|Overall Study|Randomized, but not Treated|0
7832449|NCT01342211|12306498|FG003|Overall Study|Randomized, but not Treated|0
7832450|NCT01342211|12306499|FG004|Overall Study|Randomized, but not Treated|1
7832451|NCT01342341|12306517|FG000|Overall Study|Lost to Follow-up|4
7832452|NCT01342341|12306518|FG001|Overall Study|Lost to Follow-up|4
7832453|NCT01342367|12306526|FG000|Overall Study|Death|1
7832454|NCT01342367|12306527|FG001|Overall Study|Death|0
7832455|NCT01342367|12306526|FG000|Overall Study|Withdrawal by Subject|1
7832456|NCT01342367|12306527|FG001|Overall Study|Withdrawal by Subject|2
7832457|NCT01342445|12306535|FG000|Overall Study|Experienced side effects|0
7832458|NCT01342445|12306536|FG001|Overall Study|Experienced side effects|2
7832459|NCT01342484|12306581|FG000|Overall Study|Other Reasons|1
7832460|NCT01342484|12306582|FG001|Overall Study|Other Reasons|0
7832461|NCT01342484|12306583|FG002|Overall Study|Other Reasons|0
7832462|NCT01342484|12306581|FG000|Overall Study|Protocol Violation|0
7832463|NCT01342484|12306582|FG001|Overall Study|Protocol Violation|0
7832464|NCT01342484|12306583|FG002|Overall Study|Protocol Violation|1
7832465|NCT01342484|12306581|FG000|Overall Study|Withdrawal by Subject|1
7832466|NCT01342484|12306582|FG001|Overall Study|Withdrawal by Subject|0
7832467|NCT01342484|12306583|FG002|Overall Study|Withdrawal by Subject|0
7832468|NCT01342510|12306595|FG000|Overall Study|Protocol Violation|12
7832469|NCT01342510|12306596|FG001|Overall Study|Protocol Violation|6
7832470|NCT01342510|12306597|FG002|Overall Study|Protocol Violation|13
7832471|NCT01342510|12306598|FG003|Overall Study|Protocol Violation|11
7832472|NCT01342640|12306697|FG000|Overall Study|Adverse Event|3
7832473|NCT01342640|12306697|FG000|Overall Study|Protocol Violation|16
7832474|NCT01342640|12306697|FG000|Overall Study|Lost to Follow-up|21
7832475|NCT01342640|12306697|FG000|Overall Study|Other|1
7832476|NCT01342796|12306720|FG000|Overall Study|Withdrawal by Subject|2
7832477|NCT01342796|12306721|FG001|Overall Study|Withdrawal by Subject|0
7832478|NCT01342796|12306720|FG000|Overall Study|Lost to Follow-up|0
7832479|NCT01342796|12306721|FG001|Overall Study|Lost to Follow-up|3
7832480|NCT01342796|12306720|FG000|Overall Study|Inappropriate enrollment|1
7832481|NCT01342796|12306721|FG001|Overall Study|Inappropriate enrollment|0
7832482|NCT01342887|12306727|FG000|Overall Study|Death|2
7832483|NCT01342913|12306733|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
7832484|NCT01342913|12306734|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
7832485|NCT01342913|12306735|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
7832486|NCT01342913|12306733|FG000|2-week Run-in Period|Physician Decision|6
7832487|NCT01342913|12306734|FG001|2-week Run-in Period|Physician Decision|0
7832488|NCT01342913|12306735|FG002|2-week Run-in Period|Physician Decision|0
7832489|NCT01342913|12306733|FG000|2-week Run-in Period|Withdrawal by Subject|7
7832490|NCT01342913|12306734|FG001|2-week Run-in Period|Withdrawal by Subject|0
7832491|NCT01342913|12306735|FG002|2-week Run-in Period|Withdrawal by Subject|0
7832492|NCT01342913|12306733|FG000|2-week Run-in Period|Adverse Event|2
7832493|NCT01342913|12306734|FG001|2-week Run-in Period|Adverse Event|0
7832494|NCT01342913|12306735|FG002|2-week Run-in Period|Adverse Event|0
7832495|NCT01342913|12306733|FG000|2-week Run-in Period|Protocol Violation|5
7832496|NCT01342913|12306734|FG001|2-week Run-in Period|Protocol Violation|0
7832497|NCT01342913|12306735|FG002|2-week Run-in Period|Protocol Violation|0
7832498|NCT01342913|12306733|FG000|2-week Run-in Period|Continuation Criteria Not Met|88
7832499|NCT01342913|12306734|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
7832500|NCT01342913|12306735|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
7832501|NCT01342913|12306733|FG000|Double-Blind Treatment Period|Adverse Event|0
7832502|NCT01342913|12306734|FG001|Double-Blind Treatment Period|Adverse Event|3
7832503|NCT01342913|12306735|FG002|Double-Blind Treatment Period|Adverse Event|6
7832504|NCT01342913|12306733|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
7832505|NCT01342913|12306734|FG001|Double-Blind Treatment Period|Lack of Efficacy|2
7832506|NCT01342913|12306735|FG002|Double-Blind Treatment Period|Lack of Efficacy|3
7832507|NCT01342913|12306733|FG000|Double-Blind Treatment Period|Protocol Violation|0
7832508|NCT01342913|12306734|FG001|Double-Blind Treatment Period|Protocol Violation|6
7832509|NCT01342913|12306735|FG002|Double-Blind Treatment Period|Protocol Violation|9
7832510|NCT01342913|12306733|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7832511|NCT01342913|12306734|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
7832512|NCT01342913|12306735|FG002|Double-Blind Treatment Period|Lost to Follow-up|3
7832513|NCT01342913|12306733|FG000|Double-Blind Treatment Period|Physician Decision|0
7832514|NCT01342913|12306734|FG001|Double-Blind Treatment Period|Physician Decision|2
7832515|NCT01342913|12306735|FG002|Double-Blind Treatment Period|Physician Decision|0
7832516|NCT01342913|12306733|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7832517|NCT01342913|12306734|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2
7832518|NCT01342913|12306735|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2
7832519|NCT01342926|12306745|FG000|Overall Study|Adverse Event|5
7832520|NCT01342926|12306746|FG001|Overall Study|Adverse Event|8
7832521|NCT01342926|12306747|FG002|Overall Study|Adverse Event|10
7832522|NCT01342926|12306748|FG003|Overall Study|Adverse Event|7
7832523|NCT01342926|12306745|FG000|Overall Study|Lost to Follow-up|0
7832524|NCT01342926|12306746|FG001|Overall Study|Lost to Follow-up|1
7832525|NCT01342926|12306747|FG002|Overall Study|Lost to Follow-up|1
7832526|NCT01342926|12306748|FG003|Overall Study|Lost to Follow-up|0
7832527|NCT01342926|12306745|FG000|Overall Study|Investigator Discretion|2
7832528|NCT01342926|12306746|FG001|Overall Study|Investigator Discretion|2
7832529|NCT01342926|12306747|FG002|Overall Study|Investigator Discretion|0
7832530|NCT01342926|12306748|FG003|Overall Study|Investigator Discretion|0
7832531|NCT01342926|12306745|FG000|Overall Study|Withdrawal by Subject|2
7832532|NCT01342926|12306746|FG001|Overall Study|Withdrawal by Subject|4
7832533|NCT01342926|12306747|FG002|Overall Study|Withdrawal by Subject|3
7832534|NCT01342926|12306748|FG003|Overall Study|Withdrawal by Subject|5
7832535|NCT01342965|12306760|FG000|Overall Study|Death|58
7832536|NCT01342965|12306761|FG001|Overall Study|Death|57
7832537|NCT01342965|12306760|FG000|Overall Study|Lost to Follow-up|5
7832538|NCT01342965|12306761|FG001|Overall Study|Lost to Follow-up|3
7832539|NCT01342965|12306760|FG000|Overall Study|Other Reasons- Unspecified|44
7832540|NCT01342965|12306761|FG001|Overall Study|Other Reasons- Unspecified|38
7832541|NCT01342965|12306760|FG000|Overall Study|Withdrawal by Subject|2
7832542|NCT01342965|12306761|FG001|Overall Study|Withdrawal by Subject|9
7832543|NCT01343043|12306784|FG000|Overall Study|Disease progression before treatment|1
7832544|NCT01343043|12306785|FG001|Overall Study|Disease progression before treatment|0
7832545|NCT01343043|12306786|FG002|Overall Study|Disease progression before treatment|0
7832546|NCT01343043|12306787|FG003|Overall Study|Disease progression before treatment|0
7832547|NCT01343043|12306784|FG000|Overall Study|Withdrawal by Subject|1
7832548|NCT01343043|12306785|FG001|Overall Study|Withdrawal by Subject|0
7832549|NCT01343043|12306786|FG002|Overall Study|Withdrawal by Subject|0
7832550|NCT01343043|12306787|FG003|Overall Study|Withdrawal by Subject|0
7832551|NCT01343043|12306784|FG000|Overall Study|Death|1
7832552|NCT01343043|12306785|FG001|Overall Study|Death|1
7832553|NCT01343043|12306786|FG002|Overall Study|Death|0
7832554|NCT01343043|12306787|FG003|Overall Study|Death|1
7832555|NCT01343056|12306804|FG000|Overall Study|Lost to Follow-up|7
7832556|NCT01343056|12306805|FG001|Overall Study|Lost to Follow-up|5
7832557|NCT01343056|12306806|FG002|Overall Study|Lost to Follow-up|3
7832558|NCT01343056|12306807|FG003|Overall Study|Lost to Follow-up|9
7832559|NCT01343082|12306821|FG000|The run-in Period|Not meeting criteria|3
7832560|NCT01343082|12306822|FG001|The run-in Period|Not meeting criteria|4
7832561|NCT01343082|12306823|FG002|The run-in Period|Not meeting criteria|5
7832562|NCT01343082|12306821|FG000|Treatment Period , Switched to DE-111|Adverse Event|1
7832563|NCT01343082|12306822|FG001|Treatment Period , Switched to DE-111|Adverse Event|4
7832564|NCT01343082|12306823|FG002|Treatment Period , Switched to DE-111|Adverse Event|3
7832565|NCT01343082|12306821|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0
7832566|NCT01343082|12306822|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1
7832567|NCT01343082|12306823|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2
7832568|NCT01343082|12306821|FG000|Treatment Period , Switched to DE-111|Physician Decision|0
7832569|NCT01343082|12306822|FG001|Treatment Period , Switched to DE-111|Physician Decision|2
7832570|NCT01343082|12306823|FG002|Treatment Period , Switched to DE-111|Physician Decision|2
7832571|NCT01343082|12306821|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
7832572|NCT01343082|12306822|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
7832573|NCT01343082|12306823|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
7832574|NCT01343277|12306861|FG000|Overall Study|Other|3
7832575|NCT01343277|12306862|FG001|Overall Study|Other|3
7832576|NCT01343277|12306861|FG000|Overall Study|Withdrawal by Subject|18
7832577|NCT01343277|12306862|FG001|Overall Study|Withdrawal by Subject|13
7832578|NCT01343277|12306861|FG000|Overall Study|Physician Decision|1
7832579|NCT01343277|12306862|FG001|Overall Study|Physician Decision|2
7832580|NCT01343277|12306861|FG000|Overall Study|Death|10
7832581|NCT01343277|12306862|FG001|Overall Study|Death|1
7832582|NCT01343277|12306861|FG000|Overall Study|Adverse Event|67
7832583|NCT01343277|12306862|FG001|Overall Study|Adverse Event|13
7832584|NCT01343277|12306861|FG000|Overall Study|Disease progression|270
7832585|NCT01343277|12306862|FG001|Overall Study|Disease progression|138
7832586|NCT01343277|12306861|FG000|Overall Study|Randomized not treated|6
7832587|NCT01343277|12306862|FG001|Overall Study|Randomized not treated|21
7832588|NCT01343277|12306861|FG000|Overall Study|Treatment ongoing|8
7832589|NCT01343277|12306862|FG001|Overall Study|Treatment ongoing|2
7832590|NCT01343277|12306861|FG000|Overall Study|Subsequent anticancer therapy|1
7832591|NCT01343277|12306862|FG001|Overall Study|Subsequent anticancer therapy|0
7832592|NCT01343368|12306870|FG000|Overall Study|Death|1
7832593|NCT01343368|12306871|FG001|Overall Study|Death|0
7832594|NCT01343368|12306870|FG000|Overall Study|Lost to Follow-up|1
7832595|NCT01343368|12306871|FG001|Overall Study|Lost to Follow-up|0
7832596|NCT01343407|12306877|FG000|Second Treatment Period (Part 2)|Adverse Event|0
7832597|NCT01343407|12306878|FG001|Second Treatment Period (Part 2)|Adverse Event|0
7832598|NCT01343407|12306879|FG002|Second Treatment Period (Part 2)|Adverse Event|1
7832599|NCT01343407|12306880|FG003|Second Treatment Period (Part 2)|Adverse Event|0
7832600|NCT01343407|12306881|FG004|Second Treatment Period (Part 2)|Adverse Event|0
7832601|NCT01343407|12306882|FG005|Second Treatment Period (Part 2)|Adverse Event|0
7832602|NCT01343407|12306877|FG000|Second Washout (Part 2)|Withdrawal by Subject|0
7832603|NCT01343407|12306878|FG001|Second Washout (Part 2)|Withdrawal by Subject|0
7832604|NCT01343407|12306879|FG002|Second Washout (Part 2)|Withdrawal by Subject|1
7832605|NCT01343407|12306880|FG003|Second Washout (Part 2)|Withdrawal by Subject|0
7832606|NCT01343407|12306881|FG004|Second Washout (Part 2)|Withdrawal by Subject|0
7832607|NCT01343407|12306882|FG005|Second Washout (Part 2)|Withdrawal by Subject|0
7832608|NCT01343693|12306908|FG000|Overall Study|Lost to Follow-up|9
7832609|NCT01343823|12306916|FG000|Overall Study|Study Terminated|1
7832610|NCT01343823|12306917|FG001|Overall Study|Study Terminated|0
7832611|NCT01343823|12306918|FG002|Overall Study|Study Terminated|0
7832612|NCT01343823|12306919|FG003|Overall Study|Study Terminated|1
7832613|NCT01343823|12306916|FG000|Overall Study|Withdrawal by Subject|1
7832614|NCT01343823|12306917|FG001|Overall Study|Withdrawal by Subject|0
7832615|NCT01343823|12306918|FG002|Overall Study|Withdrawal by Subject|0
7832616|NCT01343823|12306919|FG003|Overall Study|Withdrawal by Subject|0
7832617|NCT01343888|12306932|FG000|Overall Study|Adverse Event|12
7832618|NCT01343888|12306933|FG001|Overall Study|Adverse Event|22
7832619|NCT01343888|12306934|FG002|Overall Study|Adverse Event|5
7832620|NCT01343888|12306932|FG000|Overall Study|Lack of Efficacy|9
7832621|NCT01343888|12306933|FG001|Overall Study|Lack of Efficacy|9
7832622|NCT01343888|12306934|FG002|Overall Study|Lack of Efficacy|13
7832623|NCT01343888|12306932|FG000|Overall Study|Lost to Follow-up|0
7832624|NCT01343888|12306933|FG001|Overall Study|Lost to Follow-up|2
7832625|NCT01343888|12306934|FG002|Overall Study|Lost to Follow-up|1
7832626|NCT01343888|12306932|FG000|Overall Study|Protocol Violation|0
7832627|NCT01343888|12306933|FG001|Overall Study|Protocol Violation|2
7832628|NCT01343888|12306934|FG002|Overall Study|Protocol Violation|0
7832629|NCT01343888|12306932|FG000|Overall Study|Withdrawal by Subject|4
7832630|NCT01343888|12306933|FG001|Overall Study|Withdrawal by Subject|4
7832631|NCT01343888|12306934|FG002|Overall Study|Withdrawal by Subject|2
7832632|NCT01343888|12306932|FG000|Overall Study|other than stated above|0
7832633|NCT01343888|12306933|FG001|Overall Study|other than stated above|0
7832634|NCT01343888|12306934|FG002|Overall Study|other than stated above|1
7832635|NCT01343901|12306942|FG000|Overall Study|Death|85
7832636|NCT01343901|12306942|FG000|Overall Study|Physician Decision|4
7832637|NCT01343901|12306942|FG000|Overall Study|Lost to Follow-up|12
7832638|NCT01343901|12306942|FG000|Overall Study|Management by another medical team|11
7832639|NCT01343901|12306942|FG000|Overall Study|Participant decision|1
7832640|NCT01344057|12306946|FG000|Overall Study|Premature Withdrawal|1
7832641|NCT01344161|12306952|FG000|Overall Study|Lost to Follow-up|4
7832642|NCT01344161|12306953|FG001|Overall Study|Lost to Follow-up|1
7832643|NCT01344161|12306952|FG000|Overall Study|Pregnancy|0
7832644|NCT01344161|12306953|FG001|Overall Study|Pregnancy|1
7832645|NCT01344161|12306952|FG000|Overall Study|Protocol Violation|1
7832646|NCT01344161|12306953|FG001|Overall Study|Protocol Violation|1
7832647|NCT01344226|12306959|FG000|Overall Study|Protocol Violation|2
7832648|NCT01344226|12306959|FG000|Overall Study|Withdrawal by Subject|3
7832649|NCT01344226|12306959|FG000|Overall Study|Lack of Efficacy|3
7832650|NCT01344356|12306965|FG000|Overall Study|Physician Decision|0
7832651|NCT01344356|12306966|FG001|Overall Study|Physician Decision|3
7832652|NCT01344356|12306965|FG000|Overall Study|Lost to Follow-up|0
7832653|NCT01344356|12306966|FG001|Overall Study|Lost to Follow-up|6
7832654|NCT01344369|12306976|FG000|Washout of 28 Days|Withdrawal by Subject|1
7832655|NCT01344369|12306977|FG001|Washout of 28 Days|Withdrawal by Subject|0
7832656|NCT01344369|12306976|FG000|Washout of 28 Days|Physician Decision|0
7832657|NCT01344369|12306977|FG001|Washout of 28 Days|Physician Decision|1
7832658|NCT01344369|12306976|FG000|Second Intervention|Emesis within 2 x Tmax|0
7832659|NCT01344369|12306977|FG001|Second Intervention|Emesis within 2 x Tmax|1
7832660|NCT01344447|12306983|FG000|Overall Study|Adverse Event|1
7832661|NCT01344447|12306983|FG000|Overall Study|Protocol Violation|1
7832662|NCT01344447|12306983|FG000|Overall Study|Withdrawal by Subject|1
7832663|NCT01344447|12306983|FG000|Overall Study|The contrast was not seen|1
7832664|NCT01344447|12306983|FG000|Overall Study|Physician Decision|1
7832665|NCT01344447|12306983|FG000|Overall Study|MRA unsuccessful|1
7832666|NCT01344447|12306983|FG000|Overall Study|Bolus tracking failed|1
7832667|NCT01344447|12306983|FG000|Overall Study|Error of power injector|1
7832668|NCT01344460|12306991|FG000|Overall Study|Withdrawal by Subject|1
7832669|NCT01344460|12306991|FG000|Overall Study|Lost to Follow-up|2
7832670|NCT01344538|12307001|FG000|Overall Study|Adverse Event|1
7832671|NCT01344538|12307002|FG001|Overall Study|Adverse Event|1
7832672|NCT01344538|12307001|FG000|Overall Study|Lost to Follow-up|1
7832673|NCT01344538|12307002|FG001|Overall Study|Lost to Follow-up|0
7832674|NCT01344629|12307019|FG000|Crossover Period 2|Withdrawal by Subject|0
7832675|NCT01344629|12307020|FG001|Crossover Period 2|Withdrawal by Subject|1
7832676|NCT01344759|12307028|FG000|Overall Study|Patients failed to reach sedation level|0
7832677|NCT01344759|12307029|FG001|Overall Study|Patients failed to reach sedation level|2
7832678|NCT01344824|12307041|FG000|Overall Study|Adverse Event|15
7832679|NCT01344824|12307041|FG000|Overall Study|Withdrawal by Subject|6
7832680|NCT01344824|12307041|FG000|Overall Study|Other complicating disease|1
7832681|NCT01344824|12307041|FG000|Overall Study|Progression|15
7832682|NCT01344876|12307046|FG000|Overall Study|Adverse Event|0
7832683|NCT01344876|12307047|FG001|Overall Study|Adverse Event|0
7832684|NCT01344876|12307048|FG002|Overall Study|Adverse Event|0
7832685|NCT01344876|12307049|FG003|Overall Study|Adverse Event|0
7832686|NCT01344876|12307050|FG004|Overall Study|Adverse Event|1
7832687|NCT01344876|12307046|FG000|Overall Study|Withdrawal by Subject|0
7832688|NCT01344876|12307047|FG001|Overall Study|Withdrawal by Subject|0
7832689|NCT01344876|12307048|FG002|Overall Study|Withdrawal by Subject|1
7832690|NCT01344876|12307049|FG003|Overall Study|Withdrawal by Subject|0
7832691|NCT01344876|12307050|FG004|Overall Study|Withdrawal by Subject|0
7832692|NCT01344876|12307046|FG000|Overall Study|Definite progression of primary disease|1
7832693|NCT01344876|12307047|FG001|Overall Study|Definite progression of primary disease|0
7832694|NCT01344876|12307048|FG002|Overall Study|Definite progression of primary disease|0
7832695|NCT01344876|12307049|FG003|Overall Study|Definite progression of primary disease|3
7832696|NCT01344876|12307050|FG004|Overall Study|Definite progression of primary disease|0
7832697|NCT01345019|12307065|FG000|Blinded Treatment Phase|Death|147
7832698|NCT01345019|12307066|FG001|Blinded Treatment Phase|Death|137
7832699|NCT01345019|12307065|FG000|Blinded Treatment Phase|Withdrawal by Subject|103
7832700|NCT01345019|12307066|FG001|Blinded Treatment Phase|Withdrawal by Subject|112
7832701|NCT01345019|12307065|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21
7832702|NCT01345019|12307066|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9
7832703|NCT01345019|12307065|FG000|Blinded Treatment Phase|Disease Progression|12
7832704|NCT01345019|12307066|FG001|Blinded Treatment Phase|Disease Progression|10
7832705|NCT01345019|12307065|FG000|Blinded Treatment Phase|Adverse Event|6
7832706|NCT01345019|12307066|FG001|Blinded Treatment Phase|Adverse Event|13
7832707|NCT01345019|12307065|FG000|Blinded Treatment Phase|Administrative Decision|10
7832708|NCT01345019|12307066|FG001|Blinded Treatment Phase|Administrative Decision|8
7832709|NCT01345019|12307065|FG000|Blinded Treatment Phase|Noncompliance|5
7832710|NCT01345019|12307066|FG001|Blinded Treatment Phase|Noncompliance|3
7832711|NCT01345019|12307065|FG000|Blinded Treatment Phase|Ineligibility Determined|1
7832712|NCT01345019|12307066|FG001|Blinded Treatment Phase|Ineligibility Determined|6
7832713|NCT01345019|12307065|FG000|Blinded Treatment Phase|Protocol Deviation|5
7832714|NCT01345019|12307066|FG001|Blinded Treatment Phase|Protocol Deviation|0
7832715|NCT01345019|12307065|FG000|Blinded Treatment Phase|Other, Not Specified|2
7832716|NCT01345019|12307066|FG001|Blinded Treatment Phase|Other, Not Specified|3
7832717|NCT01345019|12307065|FG000|Blinded Treatment Phase|Lost to Follow-up|6
7832718|NCT01345019|12307066|FG001|Blinded Treatment Phase|Lost to Follow-up|3
7832719|NCT01345019|12307065|FG000|Open Label Treatment Phase|Death|49
7832720|NCT01345019|12307066|FG001|Open Label Treatment Phase|Death|48
7832721|NCT01345019|12307065|FG000|Open Label Treatment Phase|Withdrawal by Subject|49
7832722|NCT01345019|12307066|FG001|Open Label Treatment Phase|Withdrawal by Subject|47
7832723|NCT01345019|12307065|FG000|Open Label Treatment Phase|Adverse Event|30
7832724|NCT01345019|12307066|FG001|Open Label Treatment Phase|Adverse Event|51
7832725|NCT01345019|12307065|FG000|Open Label Treatment Phase|Administrative Decision|30
7832726|NCT01345019|12307066|FG001|Open Label Treatment Phase|Administrative Decision|15
7832727|NCT01345019|12307065|FG000|Open Label Treatment Phase|Disease Progression|17
7832728|NCT01345019|12307066|FG001|Open Label Treatment Phase|Disease Progression|18
7832729|NCT01345019|12307065|FG000|Open Label Treatment Phase|Noncompliance|5
7832730|NCT01345019|12307066|FG001|Open Label Treatment Phase|Noncompliance|4
7832731|NCT01345019|12307065|FG000|Open Label Treatment Phase|Lost to Follow-up|1
7832732|NCT01345019|12307066|FG001|Open Label Treatment Phase|Lost to Follow-up|2
7832733|NCT01345019|12307065|FG000|Open Label Treatment Phase|Pregnancy|1
7832734|NCT01345019|12307066|FG001|Open Label Treatment Phase|Pregnancy|0
7832735|NCT01345019|12307065|FG000|Open Label Treatment Phase|Other, Not Specified|9
7832736|NCT01345019|12307066|FG001|Open Label Treatment Phase|Other, Not Specified|7
7832737|NCT01345019|12307065|FG000|Open Label Treatment Phase|Protocol Violation|0
7832738|NCT01345019|12307066|FG001|Open Label Treatment Phase|Protocol Violation|1
7832739|NCT01345058|12307076|FG000|Overall Study|Withdrawal by Subject|1
7832740|NCT01345058|12307077|FG001|Overall Study|Withdrawal by Subject|0
7832741|NCT01345058|12307076|FG000|Overall Study|Participant Reported Increase in Events|1
7832742|NCT01345058|12307077|FG001|Overall Study|Participant Reported Increase in Events|0
7832743|NCT01345058|12307076|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1
7832744|NCT01345058|12307077|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0
7832745|NCT01345058|12307076|FG000|Overall Study|Participant Stopped Taking Study Drug|1
7832746|NCT01345058|12307077|FG001|Overall Study|Participant Stopped Taking Study Drug|0
7832747|NCT01345058|12307076|FG000|Overall Study|Participant No-Show at Multiple Visits|1
7832748|NCT01345058|12307077|FG001|Overall Study|Participant No-Show at Multiple Visits|0
7832749|NCT01345123|12307086|FG000|Overall Study|participants no longer with health plan|79
7832750|NCT01345123|12307087|FG001|Overall Study|participants no longer with health plan|85
7832751|NCT01345123|12307088|FG002|Overall Study|participants no longer with health plan|88
7832752|NCT01345162|12307099|FG000|Overall Study|Protocol Violation|2
7832753|NCT01345162|12307100|FG001|Overall Study|Protocol Violation|4
7832754|NCT01345188|12307106|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
7832755|NCT01345188|12307106|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
7862554|NCT01598090|12351432|FG000|Treatment Period|Other reasons|0
7862555|NCT01598090|12351433|FG001|Treatment Period|Other reasons|4
7862556|NCT01598090|12351434|FG002|Treatment Period|Other reasons|1
7862557|NCT01598090|12351432|FG000|Treatment Period|Withdrawal by Subject|3
7862558|NCT01598090|12351433|FG001|Treatment Period|Withdrawal by Subject|13
7862559|NCT01598090|12351434|FG002|Treatment Period|Withdrawal by Subject|10
7862560|NCT01598090|12351432|FG000|Treatment Period|Lost to Follow-up|1
7862561|NCT01598090|12351433|FG001|Treatment Period|Lost to Follow-up|5
7862562|NCT01598090|12351434|FG002|Treatment Period|Lost to Follow-up|1
7862563|NCT01598090|12351432|FG000|Follow-up Period|Death|0
7862564|NCT01598090|12351433|FG001|Follow-up Period|Death|1
7862565|NCT01598090|12351434|FG002|Follow-up Period|Death|0
7832756|NCT01345253|12307115|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22
7832757|NCT01345253|12307116|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27
7832758|NCT01345253|12307115|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11
7832759|NCT01345253|12307116|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7
7832760|NCT01345253|12307115|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1
7832761|NCT01345253|12307116|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5
7832762|NCT01345253|12307115|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6
7832763|NCT01345253|12307116|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1
7832764|NCT01345253|12307115|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3
7832765|NCT01345253|12307116|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8
7832766|NCT01345253|12307115|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4
7832767|NCT01345253|12307116|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12
7832768|NCT01345253|12307115|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9
7832769|NCT01345253|12307116|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19
7832770|NCT01345253|12307115|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7
7832771|NCT01345253|12307116|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18
7832772|NCT01345253|12307115|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0
7832773|NCT01345253|12307116|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1
7832774|NCT01345253|12307115|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3
7832775|NCT01345253|12307116|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7
7832776|NCT01345253|12307115|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2
7832777|NCT01345253|12307116|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5
7832778|NCT01345253|12307115|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4
7832779|NCT01345253|12307116|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6
7832780|NCT01345253|12307115|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11
7832781|NCT01345253|12307116|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24
7832782|NCT01345253|12307115|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37
7832783|NCT01345253|12307116|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82
7832784|NCT01345253|12307115|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
7832785|NCT01345253|12307116|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
7832786|NCT01345292|12307127|FG000|Overall Study|Withdrawal by Subject|2
7832787|NCT01345292|12307128|FG001|Overall Study|Withdrawal by Subject|0
7832788|NCT01345292|12307129|FG002|Overall Study|Withdrawal by Subject|1
7832789|NCT01345318|12307137|FG000|Overall Study|Adverse Event|16
7832790|NCT01345318|12307137|FG000|Overall Study|Lack of Efficacy|17
7832791|NCT01345318|12307137|FG000|Overall Study|Lost to Follow-up|2
7832792|NCT01345318|12307137|FG000|Overall Study|Protocol Violation|1
7832793|NCT01345318|12307137|FG000|Overall Study|Withdrawal by Subject|41
7832794|NCT01345318|12307137|FG000|Overall Study|Other|3
7832795|NCT01345591|12307146|FG000|Overall Study|Lost to Follow-up|1
7832796|NCT01345630|12307157|FG000|Overall Study|Adverse Event|22
7832797|NCT01345630|12307158|FG001|Overall Study|Adverse Event|23
7832798|NCT01345630|12307157|FG000|Overall Study|Lost to Follow-up|17
7832799|NCT01345630|12307158|FG001|Overall Study|Lost to Follow-up|16
7832800|NCT01345630|12307157|FG000|Overall Study|Protocol Violation|4
7832801|NCT01345630|12307158|FG001|Overall Study|Protocol Violation|1
7832802|NCT01345630|12307157|FG000|Overall Study|Medication error without associated AE|0
7832803|NCT01345630|12307158|FG001|Overall Study|Medication error without associated AE|1
7832804|NCT01345630|12307157|FG000|Overall Study|Study terminated by sponsor|254
7832805|NCT01345630|12307158|FG001|Overall Study|Study terminated by sponsor|285
7832806|NCT01345630|12307157|FG000|Overall Study|Other reasons|6
7832807|NCT01345630|12307158|FG001|Overall Study|Other reasons|8
7832808|NCT01345630|12307157|FG000|Overall Study|Withdrawn due to pregnancy|1
7832809|NCT01345630|12307158|FG001|Overall Study|Withdrawn due to pregnancy|2
7832810|NCT01345630|12307157|FG000|Overall Study|No longer willing to participate|9
7832811|NCT01345630|12307158|FG001|Overall Study|No longer willing to participate|12
7832812|NCT01345630|12307157|FG000|Overall Study|Insufficient clinical response|48
7832813|NCT01345630|12307158|FG001|Overall Study|Insufficient clinical response|11
7832814|NCT01345669|12307170|FG000|Overall Study|Primary tumour recurrence|53
7832815|NCT01345669|12307171|FG001|Overall Study|Primary tumour recurrence|32
7832816|NCT01345669|12307170|FG000|Overall Study|Second primary tumour|4
7832817|NCT01345669|12307171|FG001|Overall Study|Second primary tumour|3
7832818|NCT01345669|12307170|FG000|Overall Study|Adverse Event|63
7832819|NCT01345669|12307171|FG001|Overall Study|Adverse Event|9
7832820|NCT01345669|12307170|FG000|Overall Study|Protocol Violation|3
7832821|NCT01345669|12307171|FG001|Overall Study|Protocol Violation|1
7832822|NCT01345669|12307170|FG000|Overall Study|Lost to Follow-up|1
7832823|NCT01345669|12307171|FG001|Overall Study|Lost to Follow-up|1
7832824|NCT01345669|12307170|FG000|Overall Study|Withdrawal by Subject|52
7832825|NCT01345669|12307171|FG001|Overall Study|Withdrawal by Subject|13
7832826|NCT01345669|12307170|FG000|Overall Study|Other Reasons|111
7832827|NCT01345669|12307171|FG001|Overall Study|Other Reasons|60
7832828|NCT01345682|12307179|FG000|Overall Study|Progressive disease per RECIST|226
7832829|NCT01345682|12307180|FG001|Overall Study|Progressive disease per RECIST|93
7832830|NCT01345682|12307179|FG000|Overall Study|Worsening of underlying cancer disease|23
7832831|NCT01345682|12307180|FG001|Overall Study|Worsening of underlying cancer disease|12
7832832|NCT01345682|12307179|FG000|Overall Study|Adverse Event|51
7832833|NCT01345682|12307180|FG001|Overall Study|Adverse Event|41
7832834|NCT01345682|12307179|FG000|Overall Study|Non-compliance with protocol|0
7832835|NCT01345682|12307180|FG001|Overall Study|Non-compliance with protocol|1
7832836|NCT01345682|12307179|FG000|Overall Study|Lost to Follow-up|0
7832837|NCT01345682|12307180|FG001|Overall Study|Lost to Follow-up|1
7832838|NCT01345682|12307179|FG000|Overall Study|Refused to continue trial medication|16
7832839|NCT01345682|12307180|FG001|Overall Study|Refused to continue trial medication|9
7832840|NCT01345682|12307179|FG000|Overall Study|Not treated|2
7832841|NCT01345682|12307180|FG001|Overall Study|Not treated|1
7832842|NCT01345682|12307179|FG000|Overall Study|Reason other than those specified above|4
7832843|NCT01345682|12307180|FG001|Overall Study|Reason other than those specified above|3
7832844|NCT01345929|12307205|FG000|Overall Study|Withdrawal by Subject|9
7832845|NCT01345929|12307206|FG001|Overall Study|Withdrawal by Subject|8
7832846|NCT01345929|12307205|FG000|Overall Study|Lost to Follow-up|9
7832847|NCT01345929|12307206|FG001|Overall Study|Lost to Follow-up|9
7832848|NCT01345929|12307205|FG000|Overall Study|Adverse Event|0
7832849|NCT01345929|12307206|FG001|Overall Study|Adverse Event|1
7832850|NCT01345929|12307205|FG000|Overall Study|Didn't meet eligibility criteria|2
7832851|NCT01345929|12307206|FG001|Overall Study|Didn't meet eligibility criteria|0
7832852|NCT01345929|12307205|FG000|Overall Study|40,000 CFU/ML|1
7832853|NCT01345929|12307206|FG001|Overall Study|40,000 CFU/ML|0
7832854|NCT01345929|12307205|FG000|Overall Study|Patient withdrawal|0
7832855|NCT01345929|12307206|FG001|Overall Study|Patient withdrawal|1
7832856|NCT01346059|12307214|FG000|Overall Study|Withdrawal by Subject|1
7832857|NCT01346059|12307215|FG001|Overall Study|Withdrawal by Subject|0
7832858|NCT01346176|12307237|FG000|Recruited|Protocol Violation|1
7832859|NCT01346176|12307238|FG001|Recruited|Protocol Violation|0
7832860|NCT01346176|12307239|FG002|Recruited|Protocol Violation|0
7832861|NCT01346176|12307237|FG000|Completed Advance Directive|Death|3
7832862|NCT01346176|12307238|FG001|Completed Advance Directive|Death|2
7832863|NCT01346176|12307239|FG002|Completed Advance Directive|Death|2
7832864|NCT01346176|12307237|FG000|Completed Advance Directive|Became Ineligible|3
7832865|NCT01346176|12307238|FG001|Completed Advance Directive|Became Ineligible|0
7832866|NCT01346176|12307239|FG002|Completed Advance Directive|Became Ineligible|1
7832867|NCT01346176|12307237|FG000|Completed Advance Directive|Other reason did not complete AD|7
7832868|NCT01346176|12307238|FG001|Completed Advance Directive|Other reason did not complete AD|12
7832869|NCT01346176|12307239|FG002|Completed Advance Directive|Other reason did not complete AD|7
7832870|NCT01346176|12307237|FG000|Completed Satisfaction Survey|Death|3
7832871|NCT01346176|12307238|FG001|Completed Satisfaction Survey|Death|0
7832872|NCT01346176|12307239|FG002|Completed Satisfaction Survey|Death|2
7832873|NCT01346176|12307237|FG000|Completed Satisfaction Survey|Lost to Follow-up|3
7832874|NCT01346176|12307238|FG001|Completed Satisfaction Survey|Lost to Follow-up|4
7832875|NCT01346176|12307239|FG002|Completed Satisfaction Survey|Lost to Follow-up|4
7832876|NCT01346189|12307251|FG000|Overall Study|Withdrawal by Subject|7
7832877|NCT01346189|12307252|FG001|Overall Study|Withdrawal by Subject|5
7832878|NCT01346189|12307253|FG002|Overall Study|Withdrawal by Subject|3
7832879|NCT01346189|12307254|FG003|Overall Study|Withdrawal by Subject|5
7832880|NCT01346189|12307251|FG000|Overall Study|Physician Decision|4
7832881|NCT01346189|12307252|FG001|Overall Study|Physician Decision|0
7832882|NCT01346189|12307253|FG002|Overall Study|Physician Decision|0
7832883|NCT01346189|12307254|FG003|Overall Study|Physician Decision|0
7832884|NCT01346189|12307251|FG000|Overall Study|Moved|3
7832885|NCT01346189|12307252|FG001|Overall Study|Moved|0
7832886|NCT01346189|12307253|FG002|Overall Study|Moved|4
7832887|NCT01346189|12307254|FG003|Overall Study|Moved|0
7832888|NCT01346189|12307251|FG000|Overall Study|Other|2
7832889|NCT01346189|12307252|FG001|Overall Study|Other|4
7832890|NCT01346189|12307253|FG002|Overall Study|Other|7
7832891|NCT01346189|12307254|FG003|Overall Study|Other|3
7832892|NCT01346189|12307251|FG000|Overall Study|Death|0
7832893|NCT01346189|12307252|FG001|Overall Study|Death|3
7832894|NCT01346189|12307253|FG002|Overall Study|Death|0
7832895|NCT01346189|12307254|FG003|Overall Study|Death|0
7832896|NCT01346189|12307251|FG000|Overall Study|Non-health system primary care physician|0
7832897|NCT01346189|12307252|FG001|Overall Study|Non-health system primary care physician|5
7832898|NCT01346189|12307253|FG002|Overall Study|Non-health system primary care physician|0
7832899|NCT01346189|12307254|FG003|Overall Study|Non-health system primary care physician|0
7832900|NCT01346189|12307251|FG000|Overall Study|Travel|0
7832901|NCT01346189|12307252|FG001|Overall Study|Travel|0
7832902|NCT01346189|12307253|FG002|Overall Study|Travel|0
7832903|NCT01346189|12307254|FG003|Overall Study|Travel|3
7832904|NCT01346293|12307275|FG000|Overall Study|Protocol Violation|30
7832905|NCT01346293|12307276|FG001|Overall Study|Protocol Violation|9
7832906|NCT01346293|12307275|FG000|Overall Study|Lost to Follow-up|21
7832907|NCT01346293|12307276|FG001|Overall Study|Lost to Follow-up|8
7832908|NCT01346293|12307275|FG000|Overall Study|Withdrawal by Subject|15
7832909|NCT01346293|12307276|FG001|Overall Study|Withdrawal by Subject|4
7832910|NCT01346293|12307275|FG000|Overall Study|Other|1
7832911|NCT01346293|12307276|FG001|Overall Study|Other|0
7832912|NCT01346371|12307286|FG000|Overall Study|Lost to Follow-up|2
7832913|NCT01346371|12307287|FG001|Overall Study|Lost to Follow-up|0
7832914|NCT01346410|12307302|FG000|Overall Study|Death|1
7832915|NCT01346475|12307308|FG000|First Intervention|Lost to Follow-up|4
7832916|NCT01346475|12307309|FG001|First Intervention|Lost to Follow-up|3
7832917|NCT01346501|12307321|FG000|Overall Study|Initiated Other Biological Agents|3
7832918|NCT01346501|12307322|FG001|Overall Study|Initiated Other Biological Agents|1
7832919|NCT01346501|12307321|FG000|Overall Study|Other|8
7832920|NCT01346501|12307322|FG001|Overall Study|Other|12
7832921|NCT01346514|12307332|FG000|Overall Study|Lost to Follow-up|19
7832922|NCT01346514|12307333|FG001|Overall Study|Lost to Follow-up|30
7832923|NCT01346514|12307332|FG000|Overall Study|Withdrawal by Subject|7
7832924|NCT01346514|12307333|FG001|Overall Study|Withdrawal by Subject|3
7832925|NCT01346514|12307332|FG000|Overall Study|Death|3
7832926|NCT01346514|12307333|FG001|Overall Study|Death|4
7832927|NCT01346540|12307343|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3
7832928|NCT01346540|12307344|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8
7832929|NCT01346540|12307343|FG000|Overall Study|Adverse Event|0
7832930|NCT01346540|12307344|FG001|Overall Study|Adverse Event|4
7832931|NCT01346592|12307354|FG000|Overall Study|Lost to Follow-up|62
7832932|NCT01346592|12307355|FG001|Overall Study|Lost to Follow-up|29
7832933|NCT01346592|12307356|FG002|Overall Study|Lost to Follow-up|29
7832934|NCT01346592|12307354|FG000|Overall Study|Protocol Violation|2
7832935|NCT01346592|12307355|FG001|Overall Study|Protocol Violation|1
7832936|NCT01346592|12307356|FG002|Overall Study|Protocol Violation|0
7832937|NCT01346592|12307354|FG000|Overall Study|Death|1
7832938|NCT01346592|12307355|FG001|Overall Study|Death|3
7832939|NCT01346592|12307356|FG002|Overall Study|Death|4
7832940|NCT01346592|12307354|FG000|Overall Study|Adverse Event|0
7832941|NCT01346592|12307355|FG001|Overall Study|Adverse Event|1
7832942|NCT01346592|12307356|FG002|Overall Study|Adverse Event|0
7832943|NCT01346592|12307354|FG000|Overall Study|Withdrawal by Subject|77
7832944|NCT01346592|12307355|FG001|Overall Study|Withdrawal by Subject|51
7832945|NCT01346592|12307356|FG002|Overall Study|Withdrawal by Subject|38
7832946|NCT01346592|12307354|FG000|Overall Study|Inappropriate enrollment|3
7832947|NCT01346592|12307355|FG001|Overall Study|Inappropriate enrollment|1
7832948|NCT01346592|12307356|FG002|Overall Study|Inappropriate enrollment|1
7832949|NCT01346592|12307354|FG000|Overall Study|Administrative reason|1
7832950|NCT01346592|12307355|FG001|Overall Study|Administrative reason|0
7832951|NCT01346592|12307356|FG002|Overall Study|Administrative reason|0
7832952|NCT01346592|12307354|FG000|Overall Study|Unable to Classify|7
7832953|NCT01346592|12307355|FG001|Overall Study|Unable to Classify|3
7832954|NCT01346592|12307356|FG002|Overall Study|Unable to Classify|6
7832955|NCT01346696|12307385|FG000|Overall Study|Death|1
7832956|NCT01346774|12307391|FG000|Overall Study|Did not take a single dose|6
7832957|NCT01346774|12307392|FG001|Overall Study|Did not take a single dose|4
7832958|NCT01346774|12307391|FG000|Overall Study|Lost to Follow-up|3
7832959|NCT01346774|12307392|FG001|Overall Study|Lost to Follow-up|4
7832960|NCT01346774|12307391|FG000|Overall Study|Withdrawal by Subject|1
7832961|NCT01346774|12307392|FG001|Overall Study|Withdrawal by Subject|4
7832962|NCT01346774|12307391|FG000|Overall Study|Protocol Violation|2
7832963|NCT01346774|12307392|FG001|Overall Study|Protocol Violation|3
7832964|NCT01346774|12307391|FG000|Overall Study|Adverse Event|1
7832965|NCT01346774|12307392|FG001|Overall Study|Adverse Event|2
7832966|NCT01346969|12307420|FG000|Overall Study|Withdrawal by Subject|0
7832967|NCT01346969|12307421|FG001|Overall Study|Withdrawal by Subject|0
7832968|NCT01346969|12307422|FG002|Overall Study|Withdrawal by Subject|1
7832969|NCT01346969|12307423|FG003|Overall Study|Withdrawal by Subject|0
7832970|NCT01346969|12307420|FG000|Overall Study|Lost to Follow-up|1
7832971|NCT01346969|12307421|FG001|Overall Study|Lost to Follow-up|0
7832972|NCT01346969|12307422|FG002|Overall Study|Lost to Follow-up|2
7832973|NCT01346969|12307423|FG003|Overall Study|Lost to Follow-up|0
7832974|NCT01346969|12307420|FG000|Overall Study|Physician Decision|0
7832975|NCT01346969|12307421|FG001|Overall Study|Physician Decision|0
7832976|NCT01346969|12307422|FG002|Overall Study|Physician Decision|0
7832977|NCT01346969|12307423|FG003|Overall Study|Physician Decision|1
7832978|NCT01346969|12307420|FG000|Overall Study|Randomized but not treated|1
7832979|NCT01346969|12307421|FG001|Overall Study|Randomized but not treated|0
7832980|NCT01346969|12307422|FG002|Overall Study|Randomized but not treated|0
7832981|NCT01346969|12307423|FG003|Overall Study|Randomized but not treated|0
7832982|NCT01347073|12307460|FG000|Overall Study|Adverse Event|1
7832983|NCT01347073|12307460|FG000|Overall Study|Liver Transplant|1
7832984|NCT01347086|12307480|FG000|Overall Study|failed screening visit|0
7832985|NCT01347086|12307481|FG001|Overall Study|failed screening visit|0
7832986|NCT01347086|12307482|FG002|Overall Study|failed screening visit|1
7832987|NCT01347086|12307483|FG003|Overall Study|failed screening visit|0
7832988|NCT01347086|12307484|FG004|Overall Study|failed screening visit|0
7832989|NCT01347086|12307485|FG005|Overall Study|failed screening visit|0
7832990|NCT01347086|12307486|FG006|Overall Study|failed screening visit|1
7832991|NCT01347086|12307487|FG007|Overall Study|failed screening visit|1
7832992|NCT01347086|12307488|FG008|Overall Study|failed screening visit|0
7832993|NCT01347086|12307489|FG009|Overall Study|failed screening visit|1
7832994|NCT01347112|12307523|FG000|Overall Study|Withdrawal by Subject|1
7832995|NCT01347112|12307524|FG001|Overall Study|Withdrawal by Subject|7
7832996|NCT01347112|12307523|FG000|Overall Study|Lost to Follow-up|3
7832997|NCT01347112|12307524|FG001|Overall Study|Lost to Follow-up|5
7832998|NCT01347307|12307540|FG000|Overall Study|Death|0
7832999|NCT01347307|12307541|FG001|Overall Study|Death|4
7833000|NCT01347307|12307540|FG000|Overall Study|Physician Decision|0
7833001|NCT01347307|12307541|FG001|Overall Study|Physician Decision|1
7833002|NCT01347554|12307567|FG000|Overall Study|Lack of Efficacy|7
7833003|NCT01347554|12307568|FG001|Overall Study|Lack of Efficacy|11
7833004|NCT01347580|12307576|FG000|Overall Study|Withdrawal by Subject|13
7833005|NCT01347580|12307577|FG001|Overall Study|Withdrawal by Subject|23
7833006|NCT01347580|12307576|FG000|Overall Study|Death|30
7833007|NCT01347580|12307577|FG001|Overall Study|Death|19
7833008|NCT01347580|12307576|FG000|Overall Study|Protocol Violation|10
7833009|NCT01347580|12307577|FG001|Overall Study|Protocol Violation|7
7833010|NCT01347580|12307576|FG000|Overall Study|Lost to Follow-up|3
7833011|NCT01347580|12307577|FG001|Overall Study|Lost to Follow-up|1
7833012|NCT01347580|12307576|FG000|Overall Study|Had other reason|9
7833013|NCT01347580|12307577|FG001|Overall Study|Had other reason|6
7833014|NCT01347710|12307583|FG000|Overall Study|Withdrawal by Subject|2
7833015|NCT01347710|12307583|FG000|Overall Study|Adverse Event|4
7833016|NCT01347710|12307583|FG000|Overall Study|Angio or SPECT not completed|18
7833017|NCT01347710|12307583|FG000|Overall Study|issue with vitals prior to dosing|1
7833018|NCT01347710|12307583|FG000|Overall Study|Lost to Follow-up|1
7833019|NCT01347710|12307583|FG000|Overall Study|Physician Decision|2
7833020|NCT01347710|12307583|FG000|Overall Study|Other|3
7833021|NCT01347762|12307595|FG000|Overall Study|Lost to Follow-up|0
7833022|NCT01347762|12307596|FG001|Overall Study|Lost to Follow-up|1
7833023|NCT01347762|12307597|FG002|Overall Study|Lost to Follow-up|6
7833024|NCT01347762|12307598|FG003|Overall Study|Lost to Follow-up|5
7833025|NCT01347762|12307595|FG000|Overall Study|Withdrawal by Subject|4
7833026|NCT01347762|12307596|FG001|Overall Study|Withdrawal by Subject|1
7833027|NCT01347762|12307597|FG002|Overall Study|Withdrawal by Subject|3
7833028|NCT01347762|12307598|FG003|Overall Study|Withdrawal by Subject|3
7833029|NCT01347866|12307635|FG000|Overall Study|Death|0
7833030|NCT01347866|12307636|FG001|Overall Study|Death|0
7833031|NCT01347866|12307637|FG002|Overall Study|Death|0
7833032|NCT01347866|12307638|FG003|Overall Study|Death|1
7833033|NCT01347866|12307639|FG004|Overall Study|Death|2
7833034|NCT01347866|12307640|FG005|Overall Study|Death|2
7833035|NCT01347866|12307641|FG006|Overall Study|Death|1
7833036|NCT01347866|12307642|FG007|Overall Study|Death|0
7833037|NCT01347866|12307643|FG008|Overall Study|Death|4
7833038|NCT01347866|12307644|FG009|Overall Study|Death|1
7833039|NCT01347866|12307645|FG010|Overall Study|Death|3
7833040|NCT01347866|12307646|FG011|Overall Study|Death|1
7833041|NCT01347866|12307647|FG012|Overall Study|Death|2
7833042|NCT01347866|12307648|FG013|Overall Study|Death|0
7833043|NCT01347866|12307649|FG014|Overall Study|Death|0
7833044|NCT01347866|12307650|FG015|Overall Study|Death|1
7833045|NCT01347866|12307651|FG016|Overall Study|Death|0
7833046|NCT01347866|12307635|FG000|Overall Study|Lost to Follow-up|0
7833047|NCT01347866|12307636|FG001|Overall Study|Lost to Follow-up|0
7833048|NCT01347866|12307637|FG002|Overall Study|Lost to Follow-up|0
7833049|NCT01347866|12307638|FG003|Overall Study|Lost to Follow-up|0
7833050|NCT01347866|12307639|FG004|Overall Study|Lost to Follow-up|0
7833051|NCT01347866|12307640|FG005|Overall Study|Lost to Follow-up|0
7833052|NCT01347866|12307641|FG006|Overall Study|Lost to Follow-up|0
7833053|NCT01347866|12307642|FG007|Overall Study|Lost to Follow-up|1
7833054|NCT01347866|12307643|FG008|Overall Study|Lost to Follow-up|1
7833055|NCT01347866|12307644|FG009|Overall Study|Lost to Follow-up|0
7833056|NCT01347866|12307645|FG010|Overall Study|Lost to Follow-up|0
7833057|NCT01347866|12307646|FG011|Overall Study|Lost to Follow-up|0
7833058|NCT01347866|12307647|FG012|Overall Study|Lost to Follow-up|0
7833059|NCT01347866|12307648|FG013|Overall Study|Lost to Follow-up|0
7833060|NCT01347866|12307649|FG014|Overall Study|Lost to Follow-up|0
7833061|NCT01347866|12307650|FG015|Overall Study|Lost to Follow-up|0
7833062|NCT01347866|12307651|FG016|Overall Study|Lost to Follow-up|0
7833063|NCT01347866|12307635|FG000|Overall Study|Other|3
7833064|NCT01347866|12307636|FG001|Overall Study|Other|1
7833065|NCT01347866|12307637|FG002|Overall Study|Other|1
7833066|NCT01347866|12307638|FG003|Overall Study|Other|4
7833067|NCT01347866|12307639|FG004|Overall Study|Other|5
7833068|NCT01347866|12307640|FG005|Overall Study|Other|0
7833069|NCT01347866|12307641|FG006|Overall Study|Other|5
7833070|NCT01347866|12307642|FG007|Overall Study|Other|3
7833071|NCT01347866|12307643|FG008|Overall Study|Other|22
7833072|NCT01347866|12307644|FG009|Overall Study|Other|5
7833073|NCT01347866|12307645|FG010|Overall Study|Other|0
7833074|NCT01347866|12307646|FG011|Overall Study|Other|3
7833075|NCT01347866|12307647|FG012|Overall Study|Other|4
7833076|NCT01347866|12307648|FG013|Overall Study|Other|4
7833077|NCT01347866|12307649|FG014|Overall Study|Other|2
7833078|NCT01347866|12307650|FG015|Overall Study|Other|3
7833079|NCT01347866|12307651|FG016|Overall Study|Other|0
7833080|NCT01347866|12307635|FG000|Overall Study|Subject refused further follow-up|2
7833081|NCT01347866|12307636|FG001|Overall Study|Subject refused further follow-up|0
7833082|NCT01347866|12307637|FG002|Overall Study|Subject refused further follow-up|0
7833083|NCT01347866|12307638|FG003|Overall Study|Subject refused further follow-up|2
7833084|NCT01347866|12307639|FG004|Overall Study|Subject refused further follow-up|0
7833085|NCT01347866|12307640|FG005|Overall Study|Subject refused further follow-up|1
7833086|NCT01347866|12307641|FG006|Overall Study|Subject refused further follow-up|0
7833087|NCT01347866|12307642|FG007|Overall Study|Subject refused further follow-up|0
7833088|NCT01347866|12307643|FG008|Overall Study|Subject refused further follow-up|4
7833089|NCT01347866|12307644|FG009|Overall Study|Subject refused further follow-up|1
7833090|NCT01347866|12307645|FG010|Overall Study|Subject refused further follow-up|0
7833091|NCT01347866|12307646|FG011|Overall Study|Subject refused further follow-up|0
7833092|NCT01347866|12307647|FG012|Overall Study|Subject refused further follow-up|1
7833093|NCT01347866|12307648|FG013|Overall Study|Subject refused further follow-up|3
7833094|NCT01347866|12307649|FG014|Overall Study|Subject refused further follow-up|1
7833095|NCT01347866|12307650|FG015|Overall Study|Subject refused further follow-up|0
7833096|NCT01347866|12307651|FG016|Overall Study|Subject refused further follow-up|2
7833097|NCT01347879|12307724|FG000|Overall Study|Adverse Event|0
7833098|NCT01347879|12307725|FG001|Overall Study|Adverse Event|12
7833099|NCT01347879|12307724|FG000|Overall Study|Lost to Follow-up|2
7833100|NCT01347879|12307725|FG001|Overall Study|Lost to Follow-up|0
7833101|NCT01347879|12307724|FG000|Overall Study|Withdrawal by Subject|3
7833102|NCT01347879|12307725|FG001|Overall Study|Withdrawal by Subject|2
7833103|NCT01347879|12307724|FG000|Overall Study|Other|2
7833104|NCT01347879|12307725|FG001|Overall Study|Other|3
7833105|NCT01347931|12307731|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1
7833106|NCT01348087|12307737|FG000|Overall Study|Unsatisfactory therapeutic effect|35
7833107|NCT01348087|12307737|FG000|Overall Study|Administrative problems|79
7833108|NCT01348087|12307737|FG000|Overall Study|protocol deviation|1
7833109|NCT01348087|12307737|FG000|Overall Study|Lost to Follow-up|1
7833110|NCT01348087|12307737|FG000|Overall Study|Subject withdrew consent|7
7833111|NCT01348087|12307737|FG000|Overall Study|Adverse Event|25
7833112|NCT01348100|12307758|FG000|Overall Study|Subject Withdrew Consent|0
7833113|NCT01348100|12307759|FG001|Overall Study|Subject Withdrew Consent|0
7833114|NCT01348100|12307760|FG002|Overall Study|Subject Withdrew Consent|2
7833115|NCT01348100|12307761|FG003|Overall Study|Subject Withdrew Consent|0
7833116|NCT01348100|12307762|FG004|Overall Study|Subject Withdrew Consent|1
7833117|NCT01348100|12307763|FG005|Overall Study|Subject Withdrew Consent|0
7833118|NCT01348100|12307764|FG006|Overall Study|Subject Withdrew Consent|1
7833119|NCT01348100|12307758|FG000|Overall Study|Protocol Deviation|0
7833120|NCT01348100|12307759|FG001|Overall Study|Protocol Deviation|0
7833121|NCT01348100|12307760|FG002|Overall Study|Protocol Deviation|0
7833122|NCT01348100|12307761|FG003|Overall Study|Protocol Deviation|1
7833123|NCT01348100|12307762|FG004|Overall Study|Protocol Deviation|0
7833124|NCT01348100|12307763|FG005|Overall Study|Protocol Deviation|0
7833125|NCT01348100|12307764|FG006|Overall Study|Protocol Deviation|0
7833126|NCT01348100|12307758|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0
7833127|NCT01348100|12307759|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
7833128|NCT01348100|12307760|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0
7833129|NCT01348100|12307761|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0
7833130|NCT01348100|12307762|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0
7833131|NCT01348100|12307763|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1
7833132|NCT01348100|12307764|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0
7833133|NCT01348100|12307758|FG000|Overall Study|Lost to Follow-up|0
7833134|NCT01348100|12307759|FG001|Overall Study|Lost to Follow-up|0
7833135|NCT01348100|12307760|FG002|Overall Study|Lost to Follow-up|0
7833136|NCT01348100|12307761|FG003|Overall Study|Lost to Follow-up|0
7833137|NCT01348100|12307762|FG004|Overall Study|Lost to Follow-up|0
7833138|NCT01348100|12307763|FG005|Overall Study|Lost to Follow-up|0
7833139|NCT01348100|12307764|FG006|Overall Study|Lost to Follow-up|1
7833140|NCT01348100|12307758|FG000|Overall Study|Administrative Problems|0
7833141|NCT01348100|12307759|FG001|Overall Study|Administrative Problems|0
7833142|NCT01348100|12307760|FG002|Overall Study|Administrative Problems|0
7833143|NCT01348100|12307761|FG003|Overall Study|Administrative Problems|0
7833144|NCT01348100|12307762|FG004|Overall Study|Administrative Problems|0
7833145|NCT01348100|12307763|FG005|Overall Study|Administrative Problems|1
7833146|NCT01348100|12307764|FG006|Overall Study|Administrative Problems|1
7833147|NCT01348139|12307785|FG000|Period 1|Adverse Event|1
7833148|NCT01348139|12307786|FG001|Period 1|Adverse Event|0
7833149|NCT01348139|12307787|FG002|Period 1|Adverse Event|0
7833150|NCT01348139|12307788|FG003|Period 1|Adverse Event|0
7833151|NCT01348139|12307789|FG004|Period 1|Adverse Event|0
7833152|NCT01348139|12307790|FG005|Period 1|Adverse Event|0
7833153|NCT01348165|12307811|FG000|Overall Study|Adverse Event|0
7833154|NCT01348165|12307812|FG001|Overall Study|Adverse Event|0
7833155|NCT01348165|12307813|FG002|Overall Study|Adverse Event|0
7833156|NCT01348165|12307814|FG003|Overall Study|Adverse Event|0
7833157|NCT01348165|12307815|FG004|Overall Study|Adverse Event|0
7833158|NCT01348165|12307816|FG005|Overall Study|Adverse Event|0
7833159|NCT01348165|12307817|FG006|Overall Study|Adverse Event|1
7833160|NCT01348347|12307840|FG000|Overall Study|Withdrawal by Subject|1
7833161|NCT01348347|12307841|FG001|Overall Study|Withdrawal by Subject|1
7833162|NCT01348347|12307842|FG002|Overall Study|Withdrawal by Subject|1
7833163|NCT01348347|12307840|FG000|Overall Study|Progressive disease|2
7833164|NCT01348347|12307841|FG001|Overall Study|Progressive disease|5
7833165|NCT01348347|12307842|FG002|Overall Study|Progressive disease|5
7833166|NCT01348425|12307853|FG000|Overall Study|Imaging was not taken.|1
7833167|NCT01348425|12307854|FG001|Overall Study|Imaging was not taken.|1
7833168|NCT01348490|12307859|FG000|Overall Study|Death|1
7833169|NCT01348490|12307859|FG000|Overall Study|Adverse Event|3
7833170|NCT01348490|12307859|FG000|Overall Study|Consent withdrawn|7
7833171|NCT01348490|12307859|FG000|Overall Study|Disease progression|3
7833172|NCT01348490|12307859|FG000|Overall Study|Lost to Follow-up|1
7833173|NCT01348490|12307859|FG000|Overall Study|Termination of clinical trial by sponsor|1
7833174|NCT01348490|12307859|FG000|Overall Study|Other Unspecified|8
7833175|NCT01348542|12307882|FG000|Overall Study|Withdrawal by Subject|3
7833176|NCT01348542|12307883|FG001|Overall Study|Withdrawal by Subject|0
7833177|NCT01348698|12307902|FG000|Overall Study|Does not meet lesion size criteria|1
7833178|NCT01348698|12307902|FG000|Overall Study|Death|3
7833179|NCT01348698|12307902|FG000|Overall Study|PI decision to close study|68
7833180|NCT01348763|12307906|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1
7833181|NCT01348763|12307906|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1
7833182|NCT01348776|12307910|FG000|Overall Study|Lost to Follow-up|3
7833183|NCT01348789|12307923|FG000|Overall Study|Protocol Violation|2
7833184|NCT01348789|12307923|FG000|Overall Study|Withdrawal by Subject|2
7833185|NCT01348828|12307934|FG000|Overall Study|Death|20
7833186|NCT01348828|12307934|FG000|Overall Study|Withdrawals/Lost to Follow-up|10
7833187|NCT01348828|12307934|FG000|Overall Study|Conversion|2
7833188|NCT01348828|12307934|FG000|Overall Study|missed visit|1
7833189|NCT01348854|12307940|FG000|Overall Study|Lost to Follow-up|2
7833190|NCT01348854|12307941|FG001|Overall Study|Lost to Follow-up|1
7833191|NCT01348854|12307940|FG000|Overall Study|Withdrawal by Subject|1
7833192|NCT01348854|12307941|FG001|Overall Study|Withdrawal by Subject|0
7833193|NCT01349036|12307949|FG000|Overall Study|Disease progression|13
7833194|NCT01349036|12307950|FG001|Overall Study|Disease progression|22
7833195|NCT01349036|12307949|FG000|Overall Study|Other|1
7833196|NCT01349036|12307950|FG001|Overall Study|Other|0
7833197|NCT01349036|12307949|FG000|Overall Study|Withdrawal by Subject|0
7833198|NCT01349036|12307950|FG001|Overall Study|Withdrawal by Subject|2
7833199|NCT01349049|12307969|FG000|Overall Study|Disease progression|3
7833200|NCT01349049|12307970|FG001|Overall Study|Disease progression|5
7833201|NCT01349049|12307971|FG002|Overall Study|Disease progression|3
7833202|NCT01349049|12307972|FG003|Overall Study|Disease progression|2
7833203|NCT01349049|12307973|FG004|Overall Study|Disease progression|2
7833204|NCT01349049|12307974|FG005|Overall Study|Disease progression|2
7833205|NCT01349049|12307975|FG006|Overall Study|Disease progression|3
7833206|NCT01349049|12307976|FG007|Overall Study|Disease progression|2
7833207|NCT01349049|12307977|FG008|Overall Study|Disease progression|33
7833208|NCT01349049|12307969|FG000|Overall Study|Adverse Event|0
7833209|NCT01349049|12307970|FG001|Overall Study|Adverse Event|1
7833210|NCT01349049|12307971|FG002|Overall Study|Adverse Event|0
7833211|NCT01349049|12307972|FG003|Overall Study|Adverse Event|0
7833212|NCT01349049|12307973|FG004|Overall Study|Adverse Event|0
7833213|NCT01349049|12307974|FG005|Overall Study|Adverse Event|3
7833214|NCT01349049|12307975|FG006|Overall Study|Adverse Event|1
7833215|NCT01349049|12307976|FG007|Overall Study|Adverse Event|0
7833216|NCT01349049|12307977|FG008|Overall Study|Adverse Event|4
7833217|NCT01349049|12307969|FG000|Overall Study|Physician Decision|0
7833218|NCT01349049|12307970|FG001|Overall Study|Physician Decision|1
7833219|NCT01349049|12307971|FG002|Overall Study|Physician Decision|0
7833220|NCT01349049|12307972|FG003|Overall Study|Physician Decision|0
7833221|NCT01349049|12307973|FG004|Overall Study|Physician Decision|0
7833222|NCT01349049|12307974|FG005|Overall Study|Physician Decision|0
7833223|NCT01349049|12307975|FG006|Overall Study|Physician Decision|0
7833224|NCT01349049|12307976|FG007|Overall Study|Physician Decision|0
7833225|NCT01349049|12307977|FG008|Overall Study|Physician Decision|2
7833226|NCT01349049|12307969|FG000|Overall Study|Protocol Violation|0
7833227|NCT01349049|12307970|FG001|Overall Study|Protocol Violation|0
7833228|NCT01349049|12307971|FG002|Overall Study|Protocol Violation|0
7833229|NCT01349049|12307972|FG003|Overall Study|Protocol Violation|0
7833230|NCT01349049|12307973|FG004|Overall Study|Protocol Violation|0
7833231|NCT01349049|12307974|FG005|Overall Study|Protocol Violation|0
7833232|NCT01349049|12307975|FG006|Overall Study|Protocol Violation|0
7833233|NCT01349049|12307976|FG007|Overall Study|Protocol Violation|0
7833234|NCT01349049|12307977|FG008|Overall Study|Protocol Violation|1
7833235|NCT01349049|12307969|FG000|Overall Study|Hematopoietic stem cell transplant|0
7833236|NCT01349049|12307970|FG001|Overall Study|Hematopoietic stem cell transplant|0
7833237|NCT01349049|12307971|FG002|Overall Study|Hematopoietic stem cell transplant|0
7833238|NCT01349049|12307972|FG003|Overall Study|Hematopoietic stem cell transplant|0
7833239|NCT01349049|12307973|FG004|Overall Study|Hematopoietic stem cell transplant|1
7833240|NCT01349049|12307974|FG005|Overall Study|Hematopoietic stem cell transplant|0
7833241|NCT01349049|12307975|FG006|Overall Study|Hematopoietic stem cell transplant|1
7833242|NCT01349049|12307976|FG007|Overall Study|Hematopoietic stem cell transplant|1
7833243|NCT01349049|12307977|FG008|Overall Study|Hematopoietic stem cell transplant|0
7833244|NCT01349049|12307969|FG000|Overall Study|Other|0
7833245|NCT01349049|12307970|FG001|Overall Study|Other|0
7833246|NCT01349049|12307971|FG002|Overall Study|Other|0
7833247|NCT01349049|12307972|FG003|Overall Study|Other|0
7833248|NCT01349049|12307973|FG004|Overall Study|Other|0
7833249|NCT01349049|12307974|FG005|Overall Study|Other|1
7833250|NCT01349049|12307975|FG006|Overall Study|Other|0
7833251|NCT01349049|12307976|FG007|Overall Study|Other|0
7948573|NCT02528357|12493673|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948574|NCT02528357|12493674|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948575|NCT02528357|12493675|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948576|NCT02528357|12493676|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948577|NCT02528357|12493677|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948578|NCT02528357|12493678|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948579|NCT02528357|12493679|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948580|NCT02528357|12493680|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948581|NCT02528357|12493681|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948582|NCT02528357|12493682|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2
7948583|NCT02528357|12493683|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948584|NCT02528357|12493684|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7948585|NCT02528357|12493666|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948586|NCT02528357|12493667|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948587|NCT02528357|12493668|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948588|NCT02528357|12493669|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948589|NCT02528357|12493670|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948590|NCT02528357|12493671|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948591|NCT02528357|12493672|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948592|NCT02528357|12493673|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948593|NCT02528357|12493674|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948594|NCT02528357|12493675|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7833252|NCT01349049|12307977|FG008|Overall Study|Other|4
7833253|NCT01349049|12307969|FG000|Overall Study|Death|0
7833254|NCT01349049|12307970|FG001|Overall Study|Death|0
7833255|NCT01349049|12307971|FG002|Overall Study|Death|0
7833256|NCT01349049|12307972|FG003|Overall Study|Death|0
7833257|NCT01349049|12307973|FG004|Overall Study|Death|0
7833258|NCT01349049|12307974|FG005|Overall Study|Death|0
7833259|NCT01349049|12307975|FG006|Overall Study|Death|0
7833260|NCT01349049|12307976|FG007|Overall Study|Death|1
7833261|NCT01349049|12307977|FG008|Overall Study|Death|5
7833262|NCT01349049|12307969|FG000|Overall Study|Non-compliance|0
7833263|NCT01349049|12307970|FG001|Overall Study|Non-compliance|0
7833264|NCT01349049|12307971|FG002|Overall Study|Non-compliance|0
7833265|NCT01349049|12307972|FG003|Overall Study|Non-compliance|1
7833266|NCT01349049|12307973|FG004|Overall Study|Non-compliance|0
7833267|NCT01349049|12307974|FG005|Overall Study|Non-compliance|0
7833268|NCT01349049|12307975|FG006|Overall Study|Non-compliance|0
7833269|NCT01349049|12307976|FG007|Overall Study|Non-compliance|0
7833270|NCT01349049|12307977|FG008|Overall Study|Non-compliance|0
7833271|NCT01349049|12307969|FG000|Overall Study|Withdrawal by Subject|0
7833272|NCT01349049|12307970|FG001|Overall Study|Withdrawal by Subject|0
7833273|NCT01349049|12307971|FG002|Overall Study|Withdrawal by Subject|0
7833274|NCT01349049|12307972|FG003|Overall Study|Withdrawal by Subject|0
7833275|NCT01349049|12307973|FG004|Overall Study|Withdrawal by Subject|0
7833276|NCT01349049|12307974|FG005|Overall Study|Withdrawal by Subject|0
7833277|NCT01349049|12307975|FG006|Overall Study|Withdrawal by Subject|0
7833278|NCT01349049|12307976|FG007|Overall Study|Withdrawal by Subject|0
7833279|NCT01349049|12307977|FG008|Overall Study|Withdrawal by Subject|6
7833280|NCT01349192|12308026|FG000|Overall Study|Protocol Violation|0
7833281|NCT01349192|12308027|FG001|Overall Study|Protocol Violation|1
7833282|NCT01349192|12308026|FG000|Overall Study|Withdrawal by Subject|0
7833283|NCT01349192|12308027|FG001|Overall Study|Withdrawal by Subject|2
7833284|NCT01349192|12308026|FG000|Overall Study|Lost to Follow-up|1
7833285|NCT01349192|12308027|FG001|Overall Study|Lost to Follow-up|3
7833286|NCT01349192|12308026|FG000|Overall Study|Failure to adhere to Protocol|2
7833287|NCT01349192|12308027|FG001|Overall Study|Failure to adhere to Protocol|0
7833288|NCT01349465|12308041|FG000|Overall Study|Adverse Event|1
7833289|NCT01349465|12308042|FG001|Overall Study|Adverse Event|0
7833290|NCT01349465|12308041|FG000|Overall Study|Death|3
7833291|NCT01349465|12308042|FG001|Overall Study|Death|0
7833292|NCT01349465|12308041|FG000|Overall Study|Lost to Follow-up|10
7833293|NCT01349465|12308042|FG001|Overall Study|Lost to Follow-up|1
7833294|NCT01349465|12308041|FG000|Overall Study|Withdrawal by Subject|4
7833295|NCT01349465|12308042|FG001|Overall Study|Withdrawal by Subject|2
7833296|NCT01349465|12308041|FG000|Overall Study|Subject Ineligible To Continue The Trial|0
7833297|NCT01349465|12308042|FG001|Overall Study|Subject Ineligible To Continue The Trial|19
7833298|NCT01349569|12308059|FG000|Overall Study|Lack of Efficacy|4
7833299|NCT01349660|12308069|FG000|Overall Study|Still Receiving Study Treatment|0
7833300|NCT01349660|12308070|FG001|Overall Study|Still Receiving Study Treatment|0
7833301|NCT01349660|12308071|FG002|Overall Study|Still Receiving Study Treatment|1
7833302|NCT01349660|12308069|FG000|Overall Study|Disease Progression|2
7833303|NCT01349660|12308070|FG001|Overall Study|Disease Progression|4
7833304|NCT01349660|12308071|FG002|Overall Study|Disease Progression|50
7833305|NCT01349660|12308069|FG000|Overall Study|Adverse Event|1
7833306|NCT01349660|12308070|FG001|Overall Study|Adverse Event|1
7833307|NCT01349660|12308071|FG002|Overall Study|Adverse Event|12
7833308|NCT01349660|12308069|FG000|Overall Study|Withdrawal by Subject|2
7833309|NCT01349660|12308070|FG001|Overall Study|Withdrawal by Subject|0
7833310|NCT01349660|12308071|FG002|Overall Study|Withdrawal by Subject|9
7833311|NCT01349660|12308069|FG000|Overall Study|Death|1
7833312|NCT01349660|12308070|FG001|Overall Study|Death|1
7833313|NCT01349660|12308071|FG002|Overall Study|Death|0
7833314|NCT01349660|12308069|FG000|Overall Study|Non-Permitted Interventions|0
7833315|NCT01349660|12308070|FG001|Overall Study|Non-Permitted Interventions|0
7833316|NCT01349660|12308071|FG002|Overall Study|Non-Permitted Interventions|2
7833317|NCT01349660|12308069|FG000|Overall Study|Study Compliance|0
7833318|NCT01349660|12308070|FG001|Overall Study|Study Compliance|0
7833319|NCT01349660|12308071|FG002|Overall Study|Study Compliance|1
7833320|NCT01349660|12308069|FG000|Overall Study|Declining Performance Status|0
7833321|NCT01349660|12308070|FG001|Overall Study|Declining Performance Status|0
7833322|NCT01349660|12308071|FG002|Overall Study|Declining Performance Status|1
7833323|NCT01349673|12308086|FG000|Overall Study|Progression Of Disease Past 40 cm|1
7833324|NCT01349673|12308086|FG000|Overall Study|No Longer Qualified For Study|1
7833325|NCT01349673|12308086|FG000|Overall Study|Site Closure|10
7833326|NCT01349673|12308086|FG000|Overall Study|Withdrawal by Subject|21
7833327|NCT01349673|12308086|FG000|Overall Study|Lost to Follow-up|6
7833328|NCT01349673|12308086|FG000|Overall Study|Adverse Event|17
7833329|NCT01349673|12308086|FG000|Overall Study|Study Terminated By Sponsor|50
7833330|NCT01349673|12308086|FG000|Overall Study|Lack of Efficacy|8
7833331|NCT01349790|12308090|FG000|Overall Study|Investigator Judgement|3
7833332|NCT01349790|12308090|FG000|Overall Study|Death|2
7833333|NCT01349790|12308090|FG000|Overall Study|Withdrawal by Patient|2
7833334|NCT01349790|12308090|FG000|Overall Study|Adverse Event|1
7833335|NCT01349790|12308090|FG000|Overall Study|Lost to Follow-up|1
7833336|NCT01349803|12308098|FG000|Overall Study|Adverse Event|0
7833337|NCT01349803|12308099|FG001|Overall Study|Adverse Event|0
7833338|NCT01349803|12308100|FG002|Overall Study|Adverse Event|0
7833339|NCT01349803|12308101|FG003|Overall Study|Adverse Event|2
7833340|NCT01349803|12308098|FG000|Overall Study|Withdrawal by Subject|1
7833341|NCT01349803|12308099|FG001|Overall Study|Withdrawal by Subject|0
7833342|NCT01349803|12308100|FG002|Overall Study|Withdrawal by Subject|0
7833343|NCT01349803|12308101|FG003|Overall Study|Withdrawal by Subject|0
7833344|NCT01349803|12308098|FG000|Overall Study|Protocol-specified criteria|0
7833345|NCT01349803|12308099|FG001|Overall Study|Protocol-specified criteria|1
7833346|NCT01349803|12308100|FG002|Overall Study|Protocol-specified criteria|3
7833347|NCT01349803|12308101|FG003|Overall Study|Protocol-specified criteria|0
7833348|NCT01349816|12308119|FG000|Overall Study|Withdrawal by Subject|4
7833349|NCT01349816|12308119|FG000|Overall Study|Physician Decision|1
7833350|NCT01349816|12308119|FG000|Overall Study|Adverse Event|14
7833351|NCT01349816|12308119|FG000|Overall Study|Lost to Follow-up|2
7833352|NCT01349816|12308119|FG000|Overall Study|Protocol Violation|1
7833353|NCT01349816|12308119|FG000|Overall Study|Protocol-specified criteria|8
7833354|NCT01349829|12308135|FG000|Overall Study|Lost to Follow-up|4
7833355|NCT01349829|12308136|FG001|Overall Study|Lost to Follow-up|8
7833356|NCT01349829|12308135|FG000|Overall Study|Consent withdrawal|3
7833357|NCT01349829|12308136|FG001|Overall Study|Consent withdrawal|8
7833358|NCT01349829|12308135|FG000|Overall Study|Migrated/moved|2
7833359|NCT01349829|12308136|FG001|Overall Study|Migrated/moved|7
7833360|NCT01350102|12308167|FG000|Overall Study|Adverse Event|0
7833361|NCT01350102|12308168|FG001|Overall Study|Adverse Event|0
7833362|NCT01350102|12308169|FG002|Overall Study|Adverse Event|1
7833363|NCT01350102|12308170|FG003|Overall Study|Adverse Event|0
7833364|NCT01350115|12308182|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
7833365|NCT01350115|12308183|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
7833366|NCT01350115|12308182|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0
7833367|NCT01350115|12308183|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1
7833368|NCT01350115|12308182|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
7833369|NCT01350115|12308183|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
7833370|NCT01350128|12308191|FG000|Overall Study|Withdrawal by Subject|3
7833371|NCT01350128|12308191|FG000|Overall Study|Protocol discontinuation criteria|8
7833372|NCT01350128|12308191|FG000|Overall Study|Physician Decision|1
7833373|NCT01350128|12308191|FG000|Overall Study|Lost to Follow-up|2
7833374|NCT01350141|12308208|FG000|Overall Study|Lost to Follow-up|1
7833375|NCT01350141|12308209|FG001|Overall Study|Lost to Follow-up|0
7833376|NCT01350141|12308210|FG002|Overall Study|Lost to Follow-up|1
7833377|NCT01350141|12308208|FG000|Overall Study|Withdrawal by Subject|1
7833378|NCT01350141|12308209|FG001|Overall Study|Withdrawal by Subject|0
7833379|NCT01350141|12308210|FG002|Overall Study|Withdrawal by Subject|0
7833380|NCT01350141|12308208|FG000|Overall Study|Randomized but not treated|1
7833381|NCT01350141|12308209|FG001|Overall Study|Randomized but not treated|0
7833382|NCT01350141|12308210|FG002|Overall Study|Randomized but not treated|0
7833383|NCT01350271|12308227|FG000|Overall Study|Lost to Follow-up|21
7833384|NCT01350271|12308228|FG001|Overall Study|Lost to Follow-up|17
7833385|NCT01350271|12308229|FG002|Overall Study|Lost to Follow-up|26
7833386|NCT01350336|12308240|FG000|Overall Study|Lost to Follow-up|31
7833387|NCT01350336|12308240|FG000|Overall Study|Withdrawal by Subject|14
7833388|NCT01350336|12308240|FG000|Overall Study|Physician Decision|8
7833389|NCT01350336|12308240|FG000|Overall Study|Death|4
7833390|NCT01350414|12308306|FG000|Overall Study|Lost to Follow-up|13
7833391|NCT01350414|12308306|FG000|Overall Study|Withdrawal by Subject|4
7833392|NCT01350414|12308306|FG000|Overall Study|Physician Decision|2
7833393|NCT01350492|12308338|FG000|Intervention|Lost to Follow-up|2
7833394|NCT01350492|12308339|FG001|Intervention|Lost to Follow-up|5
7833395|NCT01350492|12308338|FG000|Intervention|Withdrawal by Subject|3
7833396|NCT01350492|12308339|FG001|Intervention|Withdrawal by Subject|1
7833397|NCT01350492|12308338|FG000|Post Intervention Follow-Up|Lost to Follow-up|6
7833398|NCT01350492|12308339|FG001|Post Intervention Follow-Up|Lost to Follow-up|1
7833399|NCT01350492|12308338|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0
7833400|NCT01350492|12308339|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1
7833401|NCT01350505|12308345|FG000|Overall Study|Lost to Follow-up|4
7833402|NCT01350544|12308351|FG000|Overall Study|Administrative Withdrawal|0
7833403|NCT01350544|12308352|FG001|Overall Study|Administrative Withdrawal|1
7833404|NCT01350544|12308351|FG000|Overall Study|Death|1
7833405|NCT01350544|12308352|FG001|Overall Study|Death|2
7833406|NCT01350544|12308351|FG000|Overall Study|Moved out of LA County|2
7833407|NCT01350544|12308352|FG001|Overall Study|Moved out of LA County|2
7833408|NCT01350544|12308351|FG000|Overall Study|Medical Issues|1
7833409|NCT01350544|12308352|FG001|Overall Study|Medical Issues|1
7833410|NCT01350544|12308351|FG000|Overall Study|Withdrawal by Subject|0
7833411|NCT01350544|12308352|FG001|Overall Study|Withdrawal by Subject|1
7833412|NCT01350544|12308351|FG000|Overall Study|Incarceration|1
7833413|NCT01350544|12308352|FG001|Overall Study|Incarceration|0
7833414|NCT01350544|12308351|FG000|Overall Study|Lost to Follow-up|18
7833415|NCT01350544|12308352|FG001|Overall Study|Lost to Follow-up|15
7833416|NCT01350804|12308362|FG000|Core Study|Withdrawal by Subject|11
7833417|NCT01350804|12308363|FG001|Core Study|Withdrawal by Subject|17
7833418|NCT01350804|12308364|FG002|Core Study|Withdrawal by Subject|16
7833419|NCT01350804|12308365|FG003|Core Study|Withdrawal by Subject|7
7833420|NCT01350804|12308362|FG000|Core Study|Study terminated by Sponsor|0
7833421|NCT01350804|12308363|FG001|Core Study|Study terminated by Sponsor|0
7833422|NCT01350804|12308364|FG002|Core Study|Study terminated by Sponsor|0
7833423|NCT01350804|12308365|FG003|Core Study|Study terminated by Sponsor|2
7833424|NCT01350804|12308362|FG000|Core Study|Protocol deviation|1
7833425|NCT01350804|12308363|FG001|Core Study|Protocol deviation|0
7833426|NCT01350804|12308364|FG002|Core Study|Protocol deviation|1
7833427|NCT01350804|12308365|FG003|Core Study|Protocol deviation|0
7833428|NCT01350804|12308362|FG000|Core Study|Physician Decision|1
7833429|NCT01350804|12308363|FG001|Core Study|Physician Decision|0
7833430|NCT01350804|12308364|FG002|Core Study|Physician Decision|1
7833431|NCT01350804|12308365|FG003|Core Study|Physician Decision|3
7833432|NCT01350804|12308362|FG000|Core Study|Lost to Follow-up|3
7833433|NCT01350804|12308363|FG001|Core Study|Lost to Follow-up|0
7833434|NCT01350804|12308364|FG002|Core Study|Lost to Follow-up|2
7833435|NCT01350804|12308365|FG003|Core Study|Lost to Follow-up|1
7833436|NCT01350804|12308362|FG000|Core Study|Lack of Efficacy|16
7833437|NCT01350804|12308363|FG001|Core Study|Lack of Efficacy|19
7833438|NCT01350804|12308364|FG002|Core Study|Lack of Efficacy|18
7833439|NCT01350804|12308365|FG003|Core Study|Lack of Efficacy|5
7833440|NCT01350804|12308362|FG000|Core Study|Death|1
7833441|NCT01350804|12308363|FG001|Core Study|Death|1
7833442|NCT01350804|12308364|FG002|Core Study|Death|1
7833443|NCT01350804|12308365|FG003|Core Study|Death|0
7833444|NCT01350804|12308362|FG000|Core Study|Adverse Event|8
7833445|NCT01350804|12308363|FG001|Core Study|Adverse Event|10
7833446|NCT01350804|12308364|FG002|Core Study|Adverse Event|8
7833447|NCT01350804|12308365|FG003|Core Study|Adverse Event|8
7833448|NCT01350804|12308362|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
7833449|NCT01350804|12308363|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
7833450|NCT01350804|12308364|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
7833451|NCT01350804|12308365|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
7833452|NCT01350804|12308362|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
7833453|NCT01350804|12308363|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
7833454|NCT01350804|12308364|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
7833455|NCT01350804|12308365|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
7833456|NCT01350804|12308362|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1
7833457|NCT01350804|12308363|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0
7833458|NCT01350804|12308364|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2
7833459|NCT01350804|12308365|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0
7833460|NCT01350804|12308362|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
7833461|NCT01350804|12308363|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
7833462|NCT01350804|12308364|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
7833463|NCT01350804|12308365|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
7833464|NCT01350804|12308362|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
7833465|NCT01350804|12308363|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
7833466|NCT01350804|12308364|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
7833467|NCT01350804|12308365|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
7833468|NCT01350804|12308362|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3
7833469|NCT01350804|12308363|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1
7833470|NCT01350804|12308364|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2
7833471|NCT01350804|12308365|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3
7862566|NCT01598090|12351432|FG000|Follow-up Period|No longer required per protocol|1
7862567|NCT01598090|12351433|FG001|Follow-up Period|No longer required per protocol|3
7862568|NCT01598090|12351434|FG002|Follow-up Period|No longer required per protocol|2
7862569|NCT01598090|12351432|FG000|Follow-up Period|Not reported|0
7862570|NCT01598090|12351433|FG001|Follow-up Period|Not reported|10
7862571|NCT01598090|12351434|FG002|Follow-up Period|Not reported|4
7862572|NCT01598090|12351432|FG000|Follow-up Period|Withdrawal by Subject|0
7862573|NCT01598090|12351433|FG001|Follow-up Period|Withdrawal by Subject|3
7862574|NCT01598090|12351434|FG002|Follow-up Period|Withdrawal by Subject|2
7862575|NCT01598090|12351432|FG000|Follow-up Period|Other reasons|2
7862576|NCT01598090|12351433|FG001|Follow-up Period|Other reasons|8
7862577|NCT01598090|12351434|FG002|Follow-up Period|Other reasons|8
7862578|NCT01598090|12351432|FG000|Follow-up Period|Lost to Follow-up|2
7862579|NCT01598090|12351433|FG001|Follow-up Period|Lost to Follow-up|10
7862580|NCT01598090|12351434|FG002|Follow-up Period|Lost to Follow-up|12
7862581|NCT01598129|12351445|FG000|Overall Study|Disease progression|6
7862582|NCT01598129|12351445|FG000|Overall Study|Deterioration of WHO status to WHO 4|2
7862583|NCT01598129|12351445|FG000|Overall Study|Withdrawal by Subject|1
7863972|NCT01609556|12353451|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0
7863973|NCT01609556|12353452|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0
7863974|NCT01609556|12353453|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0
7863975|NCT01609556|12353454|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1
7863976|NCT01609556|12353455|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0
7863977|NCT01609556|12353456|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0
7863978|NCT01609556|12353457|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0
7863979|NCT01609556|12353458|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0
7863980|NCT01609556|12353459|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0
7863981|NCT01609556|12353444|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7863982|NCT01609556|12353445|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7863983|NCT01609556|12353446|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7863984|NCT01609556|12353447|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7863985|NCT01609556|12353448|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7863986|NCT01609556|12353449|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7863987|NCT01609556|12353450|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7863988|NCT01609556|12353451|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7863989|NCT01609556|12353452|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7863990|NCT01609556|12353453|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7863991|NCT01609556|12353454|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7863992|NCT01609556|12353455|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7863993|NCT01609556|12353456|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4
7863994|NCT01609556|12353457|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
7863995|NCT01609556|12353458|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
7833472|NCT01350973|12308392|FG000|Overall Study|Adverse Event|4
7833473|NCT01350973|12308393|FG001|Overall Study|Adverse Event|7
7833474|NCT01350973|12308394|FG002|Overall Study|Adverse Event|7
7833475|NCT01350973|12308392|FG000|Overall Study|Voluntary Withdrawal|2
7833476|NCT01350973|12308393|FG001|Overall Study|Voluntary Withdrawal|1
7833477|NCT01350973|12308394|FG002|Overall Study|Voluntary Withdrawal|1
7833478|NCT01350999|12308405|FG000|Overall Study|Adverse Event|4
7833479|NCT01350999|12308406|FG001|Overall Study|Adverse Event|9
7833480|NCT01350999|12308407|FG002|Overall Study|Adverse Event|10
7833481|NCT01350999|12308405|FG000|Overall Study|Voluntary withdrawal|3
7833482|NCT01350999|12308406|FG001|Overall Study|Voluntary withdrawal|4
7833483|NCT01350999|12308407|FG002|Overall Study|Voluntary withdrawal|6
7833484|NCT01350999|12308405|FG000|Overall Study|Difficulty Making it to Study Visit|1
7833485|NCT01350999|12308406|FG001|Overall Study|Difficulty Making it to Study Visit|1
7833486|NCT01350999|12308407|FG002|Overall Study|Difficulty Making it to Study Visit|5
7833487|NCT01351025|12308417|FG000|Week 0 - 20|Lost to Follow-up|2
7833488|NCT01351025|12308418|FG001|Week 0 - 20|Lost to Follow-up|1
7833489|NCT01351025|12308417|FG000|Week 0 - 20|Withdrawal by Subject|1
7833490|NCT01351025|12308418|FG001|Week 0 - 20|Withdrawal by Subject|0
7833491|NCT01351025|12308417|FG000|Week 24 - 44|Lost to Follow-up|0
7833492|NCT01351025|12308418|FG001|Week 24 - 44|Lost to Follow-up|2
7833493|NCT01351025|12308417|FG000|Week 24 - 44|Site closed|0
7833494|NCT01351025|12308418|FG001|Week 24 - 44|Site closed|1
7833495|NCT01351025|12308417|FG000|Week 24 - 44|unable to get to clinic|1
7833496|NCT01351025|12308418|FG001|Week 24 - 44|unable to get to clinic|1
7833497|NCT01351350|12308471|FG000|Overall Study|Disease Progression|5
7833498|NCT01351350|12308472|FG001|Overall Study|Disease Progression|13
7833499|NCT01351350|12308473|FG002|Overall Study|Disease Progression|6
7833500|NCT01351350|12308474|FG003|Overall Study|Disease Progression|8
7833501|NCT01351350|12308475|FG004|Overall Study|Disease Progression|5
7833502|NCT01351350|12308471|FG000|Overall Study|Adverse Event|1
7833503|NCT01351350|12308472|FG001|Overall Study|Adverse Event|10
7833504|NCT01351350|12308473|FG002|Overall Study|Adverse Event|1
7833505|NCT01351350|12308474|FG003|Overall Study|Adverse Event|2
7833506|NCT01351350|12308475|FG004|Overall Study|Adverse Event|0
7833507|NCT01351350|12308471|FG000|Overall Study|Participant Decision|2
7833508|NCT01351350|12308472|FG001|Overall Study|Participant Decision|6
7833509|NCT01351350|12308473|FG002|Overall Study|Participant Decision|3
7833510|NCT01351350|12308474|FG003|Overall Study|Participant Decision|3
7833511|NCT01351350|12308475|FG004|Overall Study|Participant Decision|2
7833512|NCT01351350|12308471|FG000|Overall Study|Enrolled but not Treated|0
7833513|NCT01351350|12308472|FG001|Overall Study|Enrolled but not Treated|0
7833514|NCT01351350|12308473|FG002|Overall Study|Enrolled but not Treated|1
7833515|NCT01351350|12308474|FG003|Overall Study|Enrolled but not Treated|0
7833516|NCT01351350|12308475|FG004|Overall Study|Enrolled but not Treated|0
7833517|NCT01351415|12308511|FG000|Overall Study|Withdrawal by Subject|15
7833518|NCT01351415|12308512|FG001|Overall Study|Withdrawal by Subject|17
7833519|NCT01351415|12308511|FG000|Overall Study|Trial termination by the Sponsor|28
7833520|NCT01351415|12308512|FG001|Overall Study|Trial termination by the Sponsor|19
7833521|NCT01351415|12308511|FG000|Overall Study|Lost to Follow-up|5
7833522|NCT01351415|12308512|FG001|Overall Study|Lost to Follow-up|7
7833523|NCT01351415|12308511|FG000|Overall Study|Death|190
7833524|NCT01351415|12308512|FG001|Overall Study|Death|187
7833525|NCT01351415|12308511|FG000|Overall Study|Physician Decision|2
7833526|NCT01351415|12308512|FG001|Overall Study|Physician Decision|3
7833527|NCT01351415|12308511|FG000|Overall Study|Reason unknown|0
7833528|NCT01351415|12308512|FG001|Overall Study|Reason unknown|2
7833529|NCT01351415|12308511|FG000|Overall Study|Never Started|5
7833530|NCT01351415|12308512|FG001|Overall Study|Never Started|5
7833531|NCT01351623|12308530|FG000|Overall Study|Protocol Violation|2
7833532|NCT01351623|12308530|FG000|Overall Study|Adverse Event|4
7833533|NCT01351623|12308530|FG000|Overall Study|Withdrawal by Subject|1
7833534|NCT01351623|12308530|FG000|Overall Study|Death|2
7833535|NCT01352117|12308573|FG000|Overall Study|Death|15
7833536|NCT01352117|12308574|FG001|Overall Study|Death|16
7833537|NCT01352117|12308573|FG000|Overall Study|Withdrawal by Subject|1
7833538|NCT01352117|12308574|FG001|Overall Study|Withdrawal by Subject|0
7833539|NCT01352117|12308573|FG000|Overall Study|Lost to Follow-up|2
7833540|NCT01352117|12308574|FG001|Overall Study|Lost to Follow-up|7
7833541|NCT01352117|12308573|FG000|Overall Study|Non-adherent to study requirements|1
7833542|NCT01352117|12308574|FG001|Overall Study|Non-adherent to study requirements|1
7833543|NCT01352117|12308573|FG000|Overall Study|Did not initiate study treatment|1
7833544|NCT01352117|12308574|FG001|Overall Study|Did not initiate study treatment|0
7833545|NCT01352117|12308573|FG000|Overall Study|Ineligible (no KS diagnosis)|1
7833546|NCT01352117|12308574|FG001|Overall Study|Ineligible (no KS diagnosis)|0
7833547|NCT01352221|12308596|FG000|Double-blind Phase|Adverse Event|6
7833548|NCT01352221|12308597|FG001|Double-blind Phase|Adverse Event|4
7833549|NCT01352221|12308598|FG002|Double-blind Phase|Adverse Event|0
7833550|NCT01352221|12308599|FG003|Double-blind Phase|Adverse Event|0
7833551|NCT01352221|12308596|FG000|Double-blind Phase|Withdrawal by Subject|3
7833552|NCT01352221|12308597|FG001|Double-blind Phase|Withdrawal by Subject|5
7833553|NCT01352221|12308598|FG002|Double-blind Phase|Withdrawal by Subject|0
7833554|NCT01352221|12308599|FG003|Double-blind Phase|Withdrawal by Subject|0
7833555|NCT01352221|12308596|FG000|Double-blind Phase|Lost to Follow-up|0
7833556|NCT01352221|12308597|FG001|Double-blind Phase|Lost to Follow-up|1
7833557|NCT01352221|12308598|FG002|Double-blind Phase|Lost to Follow-up|0
7833558|NCT01352221|12308599|FG003|Double-blind Phase|Lost to Follow-up|0
7833559|NCT01352221|12308596|FG000|Double-blind Phase|Protocol Violation|0
7833560|NCT01352221|12308597|FG001|Double-blind Phase|Protocol Violation|1
7833561|NCT01352221|12308598|FG002|Double-blind Phase|Protocol Violation|0
7833562|NCT01352221|12308599|FG003|Double-blind Phase|Protocol Violation|0
7833563|NCT01352221|12308596|FG000|Open-label Phase|Physician Decision|0
7833564|NCT01352221|12308597|FG001|Open-label Phase|Physician Decision|0
7833565|NCT01352221|12308598|FG002|Open-label Phase|Physician Decision|2
7833566|NCT01352221|12308599|FG003|Open-label Phase|Physician Decision|1
7833567|NCT01352221|12308596|FG000|Open-label Phase|Pregnancy|0
7833568|NCT01352221|12308597|FG001|Open-label Phase|Pregnancy|0
7833569|NCT01352221|12308598|FG002|Open-label Phase|Pregnancy|1
7833570|NCT01352221|12308599|FG003|Open-label Phase|Pregnancy|0
7833571|NCT01352221|12308596|FG000|Open-label Phase|Adverse Event|0
7833572|NCT01352221|12308597|FG001|Open-label Phase|Adverse Event|0
7833573|NCT01352221|12308598|FG002|Open-label Phase|Adverse Event|8
7833574|NCT01352221|12308599|FG003|Open-label Phase|Adverse Event|4
7833575|NCT01352221|12308596|FG000|Open-label Phase|Withdrawal by Subject|0
7833576|NCT01352221|12308597|FG001|Open-label Phase|Withdrawal by Subject|0
7833577|NCT01352221|12308598|FG002|Open-label Phase|Withdrawal by Subject|1
7833578|NCT01352221|12308599|FG003|Open-label Phase|Withdrawal by Subject|6
7833579|NCT01352221|12308596|FG000|Open-label Phase|Worsening of IBD|0
7833580|NCT01352221|12308597|FG001|Open-label Phase|Worsening of IBD|0
7833581|NCT01352221|12308598|FG002|Open-label Phase|Worsening of IBD|1
7833582|NCT01352221|12308599|FG003|Open-label Phase|Worsening of IBD|0
7833583|NCT01352507|12308631|FG000|Treatment Period 1|Adverse Event|3
7833584|NCT01352507|12308632|FG001|Treatment Period 1|Adverse Event|0
7833585|NCT01352507|12308631|FG000|Treatment Period 1|Lost to Follow-up|3
7833586|NCT01352507|12308632|FG001|Treatment Period 1|Lost to Follow-up|4
7833587|NCT01352507|12308631|FG000|Treatment Period 1|Withdrawal by Subject|7
7833588|NCT01352507|12308632|FG001|Treatment Period 1|Withdrawal by Subject|5
7833589|NCT01352507|12308631|FG000|Treatment Period 1|Physician Decision|1
7833590|NCT01352507|12308632|FG001|Treatment Period 1|Physician Decision|0
7833591|NCT01352507|12308631|FG000|Washout Period|Withdrawal by Subject|0
7833592|NCT01352507|12308632|FG001|Washout Period|Withdrawal by Subject|1
7833593|NCT01352507|12308631|FG000|Treatment Period 2|Entry Criteria Not Met|1
7833594|NCT01352507|12308632|FG001|Treatment Period 2|Entry Criteria Not Met|0
7833595|NCT01352507|12308631|FG000|Treatment Period 2|Withdrawal by Subject|4
7833596|NCT01352507|12308632|FG001|Treatment Period 2|Withdrawal by Subject|3
7833597|NCT01352507|12308631|FG000|Treatment Period 2|Lack of Efficacy|1
7833598|NCT01352507|12308632|FG001|Treatment Period 2|Lack of Efficacy|0
7833599|NCT01352585|12308650|FG000|Overall Study|Adverse Event|2
7833600|NCT01352585|12308651|FG001|Overall Study|Adverse Event|1
7833601|NCT01352585|12308650|FG000|Overall Study|Lost to Follow-up|1
7833602|NCT01352585|12308651|FG001|Overall Study|Lost to Follow-up|0
7833603|NCT01352585|12308650|FG000|Overall Study|Other|5
7833604|NCT01352585|12308651|FG001|Overall Study|Other|2
7833605|NCT01352715|12308681|FG000|Overall Study|Death|3
7833606|NCT01352715|12308682|FG001|Overall Study|Death|3
7833607|NCT01352715|12308681|FG000|Overall Study|Lost to Follow-up|5
7833608|NCT01352715|12308682|FG001|Overall Study|Lost to Follow-up|7
7833609|NCT01352715|12308681|FG000|Overall Study|Withdrawal by Subject|4
7833610|NCT01352715|12308682|FG001|Overall Study|Withdrawal by Subject|8
7833611|NCT01352715|12308681|FG000|Overall Study|site closure|16
7833612|NCT01352715|12308682|FG001|Overall Study|site closure|15
7833613|NCT01352715|12308681|FG000|Overall Study|no final visit in closeout period|15
7833614|NCT01352715|12308682|FG001|Overall Study|no final visit in closeout period|12
7833615|NCT01352715|12308681|FG000|Overall Study|major ineligibility|2
7833616|NCT01352715|12308682|FG001|Overall Study|major ineligibility|1
7833617|NCT01352741|12308688|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4
7833618|NCT01352741|12308689|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0
7833619|NCT01352741|12308688|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19
7833620|NCT01352741|12308689|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0
7833621|NCT01352741|12308688|FG000|Open-label Tapentadol Titration Period|Adverse Event|34
7833622|NCT01352741|12308689|FG001|Open-label Tapentadol Titration Period|Adverse Event|0
7833623|NCT01352741|12308688|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7
7833624|NCT01352741|12308689|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0
7833625|NCT01352741|12308688|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
7833626|NCT01352741|12308689|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
7833627|NCT01352741|12308688|FG000|Open-label Tapentadol Titration Period|Other|4
7833628|NCT01352741|12308689|FG001|Open-label Tapentadol Titration Period|Other|0
7833629|NCT01352741|12308688|FG000|Double-blind Comparative Period|Protocol Violation|2
7833630|NCT01352741|12308689|FG001|Double-blind Comparative Period|Protocol Violation|0
7833631|NCT01352741|12308688|FG000|Double-blind Comparative Period|Lack of Efficacy|0
7833632|NCT01352741|12308689|FG001|Double-blind Comparative Period|Lack of Efficacy|3
7833633|NCT01352741|12308688|FG000|Double-blind Comparative Period|Adverse Event|16
7862584|NCT01598298|12351474|FG000|Overall Study|Not eligible|5
7833634|NCT01352741|12308689|FG001|Double-blind Comparative Period|Adverse Event|17
7833635|NCT01352741|12308688|FG000|Double-blind Comparative Period|Lost to Follow-up|1
7833636|NCT01352741|12308689|FG001|Double-blind Comparative Period|Lost to Follow-up|0
7833637|NCT01352741|12308688|FG000|Double-blind Comparative Period|Death|0
7833638|NCT01352741|12308689|FG001|Double-blind Comparative Period|Death|1
7833639|NCT01352741|12308688|FG000|Double-blind Comparative Period|Withdrawal of consent|8
7833640|NCT01352741|12308689|FG001|Double-blind Comparative Period|Withdrawal of consent|3
7833641|NCT01352741|12308688|FG000|Double-blind Comparative Period|Other|1
7833642|NCT01352741|12308689|FG001|Double-blind Comparative Period|Other|2
7833643|NCT01352741|12308688|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4
7833644|NCT01352741|12308689|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0
7833645|NCT01352741|12308688|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
7833646|NCT01352741|12308689|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
7833647|NCT01352741|12308688|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
7833648|NCT01352741|12308689|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
7833649|NCT01352741|12308688|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
7833650|NCT01352741|12308689|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
7833651|NCT01352793|12308711|FG000|Overall Study|Lost to Follow-up|289
7833652|NCT01352793|12308712|FG001|Overall Study|Lost to Follow-up|125
7833653|NCT01352793|12308711|FG000|Overall Study|Withdrawal by Subject|120
7833654|NCT01352793|12308712|FG001|Overall Study|Withdrawal by Subject|55
7833655|NCT01352793|12308711|FG000|Overall Study|Protocol Violation|44
7833656|NCT01352793|12308712|FG001|Overall Study|Protocol Violation|23
7833657|NCT01352793|12308711|FG000|Overall Study|Adverse Event|44
7833658|NCT01352793|12308712|FG001|Overall Study|Adverse Event|10
7833659|NCT01352793|12308711|FG000|Overall Study|Physician Decision|1
7833660|NCT01352793|12308712|FG001|Overall Study|Physician Decision|0
7833661|NCT01352793|12308711|FG000|Overall Study|Pregnancy|26
7833662|NCT01352793|12308712|FG001|Overall Study|Pregnancy|8
7833663|NCT01352793|12308711|FG000|Overall Study|Other|25
7833664|NCT01352793|12308712|FG001|Overall Study|Other|7
7833665|NCT01352793|12308711|FG000|Overall Study|Medication error|2
7833666|NCT01352793|12308712|FG001|Overall Study|Medication error|2
7833667|NCT01352793|12308711|FG000|Overall Study|Death|1
7833668|NCT01352793|12308712|FG001|Overall Study|Death|0
7833669|NCT01352793|12308711|FG000|Overall Study|Randomized but not vaccinated|8
7833670|NCT01352793|12308712|FG001|Overall Study|Randomized but not vaccinated|0
7833671|NCT01352793|12308711|FG000|Overall Study|No longer meets eligibility criteria|25
7833672|NCT01352793|12308712|FG001|Overall Study|No longer meets eligibility criteria|15
7833673|NCT01352845|12308720|FG000|Overall Study|Lost to Follow-up|313
7833674|NCT01352845|12308721|FG001|Overall Study|Lost to Follow-up|92
7833675|NCT01352845|12308720|FG000|Overall Study|No Longer Willing to Participate|205
7833676|NCT01352845|12308721|FG001|Overall Study|No Longer Willing to Participate|58
7833677|NCT01352845|12308720|FG000|Overall Study|Withdrawal by Subject|48
7833678|NCT01352845|12308721|FG001|Overall Study|Withdrawal by Subject|16
7833679|NCT01352845|12308720|FG000|Overall Study|No Longer Meets Eligibility Criteria|24
7833680|NCT01352845|12308721|FG001|Overall Study|No Longer Meets Eligibility Criteria|11
7833681|NCT01352845|12308720|FG000|Overall Study|Pregnancy|27
7833682|NCT01352845|12308721|FG001|Overall Study|Pregnancy|7
7833683|NCT01352845|12308720|FG000|Overall Study|Adverse Event|22
7833684|NCT01352845|12308721|FG001|Overall Study|Adverse Event|6
7833685|NCT01352845|12308720|FG000|Overall Study|Other|17
7833686|NCT01352845|12308721|FG001|Overall Study|Other|7
7833687|NCT01352845|12308720|FG000|Overall Study|Protocol Violation|12
7833688|NCT01352845|12308721|FG001|Overall Study|Protocol Violation|6
7833689|NCT01352845|12308720|FG000|Overall Study|Death|3
7833690|NCT01352845|12308721|FG001|Overall Study|Death|0
7833691|NCT01353222|12308760|FG000|Overall Study|Death|30
7833692|NCT01353222|12308761|FG001|Overall Study|Death|30
7833693|NCT01353222|12308760|FG000|Overall Study|Withdrawal by Subject|8
7833694|NCT01353222|12308761|FG001|Overall Study|Withdrawal by Subject|5
7833695|NCT01353222|12308760|FG000|Overall Study|Study Terminated|31
7833696|NCT01353222|12308761|FG001|Overall Study|Study Terminated|37
7833697|NCT01353222|12308760|FG000|Overall Study|Site closed research department|1
7833698|NCT01353222|12308761|FG001|Overall Study|Site closed research department|0
7833699|NCT01353274|12308767|FG000|Overall Study|No case report form (CRF) collected|28
7833700|NCT01353508|12308784|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0
7833701|NCT01353508|12308785|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0
7833702|NCT01353508|12308786|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0
7833703|NCT01353508|12308787|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1
7833704|NCT01353508|12308784|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
7833705|NCT01353508|12308785|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
7833706|NCT01353508|12308786|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
7833707|NCT01353508|12308787|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
7833708|NCT01353586|12308799|FG000|Overall Study|Procedure terminated prior to ablation|3
7833709|NCT01353586|12308800|FG001|Overall Study|Procedure terminated prior to ablation|0
7833710|NCT01353586|12308799|FG000|Overall Study|Never had insertion of study catheter|4
7833711|NCT01353586|12308800|FG001|Overall Study|Never had insertion of study catheter|1
7833712|NCT01353586|12308799|FG000|Overall Study|Neurological exam not done|0
7833713|NCT01353586|12308800|FG001|Overall Study|Neurological exam not done|1
7833714|NCT01353664|12308809|FG000|Overall Study|Other|3
7833715|NCT01353664|12308809|FG000|Overall Study|Disease Progression|16
7833716|NCT01353703|12308815|FG000|Overall Study|Migrated/moved from study area|1
7833717|NCT01353703|12308816|FG001|Overall Study|Migrated/moved from study area|0
7833718|NCT01353859|12308824|FG000|Overall Study|Adverse Event|3
7833719|NCT01353859|12308824|FG000|Overall Study|Lack of Efficacy|1
7833720|NCT01353898|12308834|FG000|Overall Study|Study site terminated|0
7833721|NCT01353898|12308835|FG001|Overall Study|Study site terminated|0
7833722|NCT01353898|12308836|FG002|Overall Study|Study site terminated|0
7833723|NCT01353898|12308837|FG003|Overall Study|Study site terminated|0
7833724|NCT01353898|12308838|FG004|Overall Study|Study site terminated|0
7833725|NCT01353898|12308839|FG005|Overall Study|Study site terminated|1
7833726|NCT01353911|12308861|FG000|Overall Study|Lost to Follow-up|2
7833727|NCT01353911|12308862|FG001|Overall Study|Lost to Follow-up|6
7833728|NCT01353911|12308863|FG002|Overall Study|Lost to Follow-up|4
7833729|NCT01353911|12308864|FG003|Overall Study|Lost to Follow-up|0
7833730|NCT01353911|12308865|FG004|Overall Study|Lost to Follow-up|4
7833731|NCT01353911|12308866|FG005|Overall Study|Lost to Follow-up|4
7833732|NCT01353911|12308867|FG006|Overall Study|Lost to Follow-up|3
7833733|NCT01353911|12308868|FG007|Overall Study|Lost to Follow-up|6
7833734|NCT01353911|12308861|FG000|Overall Study|Withdrawal by Subject|2
7833735|NCT01353911|12308862|FG001|Overall Study|Withdrawal by Subject|3
7833736|NCT01353911|12308863|FG002|Overall Study|Withdrawal by Subject|4
7833737|NCT01353911|12308864|FG003|Overall Study|Withdrawal by Subject|2
7833738|NCT01353911|12308865|FG004|Overall Study|Withdrawal by Subject|2
7833739|NCT01353911|12308866|FG005|Overall Study|Withdrawal by Subject|3
7833740|NCT01353911|12308867|FG006|Overall Study|Withdrawal by Subject|3
7833741|NCT01353911|12308868|FG007|Overall Study|Withdrawal by Subject|9
7833742|NCT01353911|12308861|FG000|Overall Study|Status Not Recorded|4
7833743|NCT01353911|12308862|FG001|Overall Study|Status Not Recorded|0
7833744|NCT01353911|12308863|FG002|Overall Study|Status Not Recorded|1
7833745|NCT01353911|12308864|FG003|Overall Study|Status Not Recorded|0
7833746|NCT01353911|12308865|FG004|Overall Study|Status Not Recorded|0
7833747|NCT01353911|12308866|FG005|Overall Study|Status Not Recorded|0
7833748|NCT01353911|12308867|FG006|Overall Study|Status Not Recorded|0
7833749|NCT01353911|12308868|FG007|Overall Study|Status Not Recorded|0
7948595|NCT02528357|12493676|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7833750|NCT01353963|12308886|FG000|Overall Study|Adverse Event|2
7833751|NCT01354028|12308908|FG000|Overall Study|Physician Decision|0
7833752|NCT01354028|12308909|FG001|Overall Study|Physician Decision|2
7833753|NCT01354028|12308908|FG000|Overall Study|Discharged before study start|2
7833754|NCT01354028|12308909|FG001|Overall Study|Discharged before study start|2
7833755|NCT01354028|12308908|FG000|Overall Study|No quiet alert state|0
7833756|NCT01354028|12308909|FG001|Overall Study|No quiet alert state|1
7833757|NCT01354106|12308921|FG000|Overall Study|Withdrawal by Subject|2
7833758|NCT01354132|12308929|FG000|Randomization|Physician Decision|1
7833759|NCT01354132|12308930|FG001|Randomization|Physician Decision|0
7833760|NCT01354132|12308929|FG000|Randomization|Withdrawal by Subject|0
7833761|NCT01354132|12308930|FG001|Randomization|Withdrawal by Subject|1
7833762|NCT01354132|12308929|FG000|Double Blind (Visits 1-7)|Adverse Event|1
7833763|NCT01354132|12308930|FG001|Double Blind (Visits 1-7)|Adverse Event|0
7833764|NCT01354132|12308929|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8
7833765|NCT01354132|12308930|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11
7833766|NCT01354132|12308929|FG000|1 Month Post Study Medication|Withdrawal by Subject|1
7833767|NCT01354132|12308930|FG001|1 Month Post Study Medication|Withdrawal by Subject|3
7833768|NCT01354223|12308957|FG000|Overall Study|Withdrawal by Subject|3
7833769|NCT01354223|12308958|FG001|Overall Study|Withdrawal by Subject|1
7833770|NCT01354314|12308968|FG000|Overall Study|Lost to Follow-up|1
7833771|NCT01354314|12308969|FG001|Overall Study|Lost to Follow-up|0
7833772|NCT01354314|12308970|FG002|Overall Study|Lost to Follow-up|1
7833773|NCT01354314|12308971|FG003|Overall Study|Lost to Follow-up|1
7833774|NCT01354314|12308968|FG000|Overall Study|Withdrawal by Subject|0
7833775|NCT01354314|12308969|FG001|Overall Study|Withdrawal by Subject|0
7833776|NCT01354314|12308970|FG002|Overall Study|Withdrawal by Subject|1
7833777|NCT01354314|12308971|FG003|Overall Study|Withdrawal by Subject|0
7833778|NCT01354314|12308968|FG000|Overall Study|Adverse Event|0
7833779|NCT01354314|12308969|FG001|Overall Study|Adverse Event|0
7833780|NCT01354314|12308970|FG002|Overall Study|Adverse Event|0
7833781|NCT01354314|12308971|FG003|Overall Study|Adverse Event|1
7833782|NCT01354314|12308968|FG000|Overall Study|Protocol Violation|1
7833783|NCT01354314|12308969|FG001|Overall Study|Protocol Violation|1
7833784|NCT01354314|12308970|FG002|Overall Study|Protocol Violation|0
7833785|NCT01354314|12308971|FG003|Overall Study|Protocol Violation|0
7833786|NCT01354314|12308968|FG000|Overall Study|Less than 90% Adherence|4
7833787|NCT01354314|12308969|FG001|Overall Study|Less than 90% Adherence|2
7833788|NCT01354314|12308970|FG002|Overall Study|Less than 90% Adherence|6
7833789|NCT01354314|12308971|FG003|Overall Study|Less than 90% Adherence|4
7833790|NCT01354496|12308996|FG000|Period 1|Adverse Event|0
7833791|NCT01354496|12308997|FG001|Period 1|Adverse Event|0
7833792|NCT01354496|12308998|FG002|Period 1|Adverse Event|1
7833793|NCT01354496|12308999|FG003|Period 1|Adverse Event|0
7833794|NCT01354496|12309000|FG004|Period 1|Adverse Event|0
7833795|NCT01354496|12309001|FG005|Period 1|Adverse Event|0
7833796|NCT01354496|12308996|FG000|Period 1|Physician Decision|0
7833797|NCT01354496|12308997|FG001|Period 1|Physician Decision|0
7833798|NCT01354496|12308998|FG002|Period 1|Physician Decision|1
7833799|NCT01354496|12308999|FG003|Period 1|Physician Decision|0
7833800|NCT01354496|12309000|FG004|Period 1|Physician Decision|0
7833801|NCT01354496|12309001|FG005|Period 1|Physician Decision|0
7833802|NCT01354496|12308996|FG000|Period 2|Adverse Event|0
7833803|NCT01354496|12308997|FG001|Period 2|Adverse Event|0
7833804|NCT01354496|12308998|FG002|Period 2|Adverse Event|0
7833805|NCT01354496|12308999|FG003|Period 2|Adverse Event|1
7833806|NCT01354496|12309000|FG004|Period 2|Adverse Event|0
7833807|NCT01354496|12309001|FG005|Period 2|Adverse Event|0
7833808|NCT01354496|12308996|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0
7833809|NCT01354496|12308997|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1
7833810|NCT01354496|12308998|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0
7833811|NCT01354496|12308999|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1
7833812|NCT01354496|12309000|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0
7833813|NCT01354496|12309001|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0
7833814|NCT01354899|12309045|FG000|Overall Study|discharge from the hospital|2
7833815|NCT01354899|12309045|FG000|Overall Study|Protocol Violation|1
7833816|NCT01354938|12309049|FG000|Overall Study|Lost to Follow-up|1
7833817|NCT01354964|12309055|FG000|Overall Study|Lost to Follow-up|2
7833818|NCT01354964|12309056|FG001|Overall Study|Lost to Follow-up|0
7833819|NCT01354964|12309055|FG000|Overall Study|IV access issues|1
7833820|NCT01354964|12309056|FG001|Overall Study|IV access issues|1
7833821|NCT01354964|12309055|FG000|Overall Study|Physician Decision|1
7833822|NCT01354964|12309056|FG001|Overall Study|Physician Decision|0
7833823|NCT01355068|12309068|FG000|First Intervention Period|Adverse Event|0
7833824|NCT01355068|12309069|FG001|First Intervention Period|Adverse Event|1
7833825|NCT01355068|12309068|FG000|First Intervention Period|Withdrawal by Subject|0
7833826|NCT01355068|12309069|FG001|First Intervention Period|Withdrawal by Subject|1
7833827|NCT01355081|12309078|FG000|Overall Study|Pretreatment Event or Adverse Event|3
7833828|NCT01355081|12309079|FG001|Overall Study|Pretreatment Event or Adverse Event|4
7833829|NCT01355081|12309080|FG002|Overall Study|Pretreatment Event or Adverse Event|6
7833830|NCT01355081|12309078|FG000|Overall Study|Major Protocol Deviation|0
7833831|NCT01355081|12309079|FG001|Overall Study|Major Protocol Deviation|1
7833832|NCT01355081|12309080|FG002|Overall Study|Major Protocol Deviation|0
7833833|NCT01355081|12309078|FG000|Overall Study|Lost to Follow-up|0
7833834|NCT01355081|12309079|FG001|Overall Study|Lost to Follow-up|0
7833835|NCT01355081|12309080|FG002|Overall Study|Lost to Follow-up|1
7833836|NCT01355081|12309078|FG000|Overall Study|Withdrawal of Consent|2
7833837|NCT01355081|12309079|FG001|Overall Study|Withdrawal of Consent|3
7833838|NCT01355081|12309080|FG002|Overall Study|Withdrawal of Consent|3
7833839|NCT01355081|12309078|FG000|Overall Study|Lack of Efficacy|2
7720085|NCT00536484|12144353|FG001|Overall Study|Withdrawal by Subject|11
7720086|NCT00536484|12144352|FG000|Overall Study|Lost to Follow-up|8
7720087|NCT00536484|12144353|FG001|Overall Study|Lost to Follow-up|6
7833840|NCT01355081|12309079|FG001|Overall Study|Lack of Efficacy|1
7833841|NCT01355081|12309080|FG002|Overall Study|Lack of Efficacy|1
7720088|NCT00536484|12144352|FG000|Overall Study|Lack of Efficacy|16
7720089|NCT00536484|12144353|FG001|Overall Study|Lack of Efficacy|5
7720090|NCT00536484|12144352|FG000|Overall Study|Other|4
7720091|NCT00536484|12144353|FG001|Overall Study|Other|0
7720092|NCT00536510|12144361|FG000|Overall Study|Adverse Event|27
7833842|NCT01355081|12309078|FG000|Overall Study|Non Compliance with Study Medication|0
7833843|NCT01355081|12309079|FG001|Overall Study|Non Compliance with Study Medication|1
7833844|NCT01355081|12309080|FG002|Overall Study|Non Compliance with Study Medication|0
7833845|NCT01355159|12309090|FG000|Overall Study|Withdrew consent|39
7833846|NCT01355159|12309091|FG001|Overall Study|Withdrew consent|47
7833847|NCT01355159|12309090|FG000|Overall Study|No primary outcome data|17
7833848|NCT01355159|12309091|FG001|Overall Study|No primary outcome data|11
7833849|NCT01355159|12309090|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22
7833850|NCT01355159|12309091|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15
7833851|NCT01355159|12309090|FG000|Overall Study|Early intrauterine fetal death|6
7833852|NCT01355159|12309091|FG001|Overall Study|Early intrauterine fetal death|6
7833853|NCT01355289|12309126|FG000|Core Study|Adverse Event, Non-Fatal|1
7833854|NCT01355289|12309127|FG001|Core Study|Adverse Event, Non-Fatal|0
7833855|NCT01355289|12309128|FG002|Core Study|Adverse Event, Non-Fatal|0
7833856|NCT01355289|12309129|FG003|Core Study|Adverse Event, Non-Fatal|0
7833857|NCT01355289|12309130|FG004|Core Study|Adverse Event, Non-Fatal|0
7833858|NCT01355289|12309126|FG000|Core Study|Inadequate Therapeutic Effect|0
7833859|NCT01355289|12309127|FG001|Core Study|Inadequate Therapeutic Effect|0
7833860|NCT01355289|12309128|FG002|Core Study|Inadequate Therapeutic Effect|0
7833861|NCT01355289|12309129|FG003|Core Study|Inadequate Therapeutic Effect|1
7833862|NCT01355289|12309130|FG004|Core Study|Inadequate Therapeutic Effect|0
7833863|NCT01355289|12309126|FG000|Core Study|Other|0
7833864|NCT01355289|12309127|FG001|Core Study|Other|0
7833865|NCT01355289|12309128|FG002|Core Study|Other|0
7833866|NCT01355289|12309129|FG003|Core Study|Other|1
7833867|NCT01355289|12309130|FG004|Core Study|Other|0
7833868|NCT01355289|12309126|FG000|Open Label Extension|Adverse Event, Non-Fatal|0
7833869|NCT01355289|12309127|FG001|Open Label Extension|Adverse Event, Non-Fatal|0
7833870|NCT01355289|12309128|FG002|Open Label Extension|Adverse Event, Non-Fatal|0
7833871|NCT01355289|12309129|FG003|Open Label Extension|Adverse Event, Non-Fatal|0
7833872|NCT01355289|12309130|FG004|Open Label Extension|Adverse Event, Non-Fatal|1
7833873|NCT01355289|12309126|FG000|Open Label Extension|Lost to Follow-up|0
7833874|NCT01355289|12309127|FG001|Open Label Extension|Lost to Follow-up|0
7833875|NCT01355289|12309128|FG002|Open Label Extension|Lost to Follow-up|0
7833876|NCT01355289|12309129|FG003|Open Label Extension|Lost to Follow-up|0
7833877|NCT01355289|12309130|FG004|Open Label Extension|Lost to Follow-up|1
7833878|NCT01355289|12309126|FG000|Open Label Extension|Inadequate Therapeutic Effect|0
7833879|NCT01355289|12309127|FG001|Open Label Extension|Inadequate Therapeutic Effect|0
7833880|NCT01355289|12309128|FG002|Open Label Extension|Inadequate Therapeutic Effect|0
7833881|NCT01355289|12309129|FG003|Open Label Extension|Inadequate Therapeutic Effect|0
7833882|NCT01355289|12309130|FG004|Open Label Extension|Inadequate Therapeutic Effect|29
7833883|NCT01355289|12309126|FG000|Open Label Extension|Other|0
7833884|NCT01355289|12309127|FG001|Open Label Extension|Other|0
7833885|NCT01355289|12309128|FG002|Open Label Extension|Other|0
7833886|NCT01355289|12309129|FG003|Open Label Extension|Other|0
7833887|NCT01355289|12309130|FG004|Open Label Extension|Other|3
7833888|NCT01355302|12309143|FG000|Phase 1b|Death|4
7833889|NCT01355302|12309144|FG001|Phase 1b|Death|0
7833890|NCT01355302|12309145|FG002|Phase 1b|Death|0
7833891|NCT01355302|12309143|FG000|Phase 1b|Study terminated by sponsor|2
7833892|NCT01355302|12309144|FG001|Phase 1b|Study terminated by sponsor|0
7833893|NCT01355302|12309145|FG002|Phase 1b|Study terminated by sponsor|0
7833894|NCT01355497|12309186|FG000|Overall Study|Death|19
7833895|NCT01355497|12309187|FG001|Overall Study|Death|18
7833896|NCT01355497|12309186|FG000|Overall Study|Lost to Follow-up|3
7833897|NCT01355497|12309187|FG001|Overall Study|Lost to Follow-up|0
7833898|NCT01355497|12309186|FG000|Overall Study|Protocol Violation|0
7833899|NCT01355497|12309187|FG001|Overall Study|Protocol Violation|1
7833900|NCT01355497|12309186|FG000|Overall Study|other-not provided|9
7833901|NCT01355497|12309187|FG001|Overall Study|other-not provided|4
7833902|NCT01355497|12309186|FG000|Overall Study|Withdrawal by Subject|12
7833903|NCT01355497|12309187|FG001|Overall Study|Withdrawal by Subject|20
7833904|NCT01355497|12309186|FG000|Overall Study|noncompliance|1
7833905|NCT01355497|12309187|FG001|Overall Study|noncompliance|2
7833906|NCT01355497|12309186|FG000|Overall Study|progressive disease|11
7833907|NCT01355497|12309187|FG001|Overall Study|progressive disease|8
7833908|NCT01355497|12309186|FG000|Overall Study|Adverse Event|11
7833909|NCT01355497|12309187|FG001|Overall Study|Adverse Event|10
7833910|NCT01355523|12309195|FG000|Overall Study|Withdrawal by Subject|1
7833911|NCT01355523|12309196|FG001|Overall Study|Withdrawal by Subject|4
7833912|NCT01355523|12309195|FG000|Overall Study|Lost to Follow-up|0
7833913|NCT01355523|12309196|FG001|Overall Study|Lost to Follow-up|2
7833914|NCT01355523|12309195|FG000|Overall Study|Protocol Violation|0
7833915|NCT01355523|12309196|FG001|Overall Study|Protocol Violation|2
7833916|NCT01355523|12309195|FG000|Overall Study|Adverse Event|0
7833917|NCT01355523|12309196|FG001|Overall Study|Adverse Event|2
7833918|NCT01355575|12309202|FG000|Overall Study|Withdrawal by Subject|2
7833919|NCT01355627|12309229|FG000|Overall Study|Request By the Patient to Discontinue|5
7833920|NCT01355627|12309230|FG001|Overall Study|Request By the Patient to Discontinue|7
7833921|NCT01355627|12309229|FG000|Overall Study|Lost to Follow-up|8
7833922|NCT01355627|12309230|FG001|Overall Study|Lost to Follow-up|7
7833923|NCT01355627|12309229|FG000|Overall Study|Fatal Adverse Event|19
7833924|NCT01355627|12309230|FG001|Overall Study|Fatal Adverse Event|23
7833925|NCT01355627|12309229|FG000|Overall Study|Other|1
7833926|NCT01355627|12309230|FG001|Overall Study|Other|1
7833927|NCT01356407|12309274|FG000|Overall Study|Lost to Follow-up|2
7833928|NCT01356407|12309275|FG001|Overall Study|Lost to Follow-up|0
7833929|NCT01356407|12309274|FG000|Overall Study|Patient Withdrew Consent|2
7833930|NCT01356407|12309275|FG001|Overall Study|Patient Withdrew Consent|1
7833931|NCT01356407|12309274|FG000|Overall Study|Could not afford IMP administration|0
7833932|NCT01356407|12309275|FG001|Overall Study|Could not afford IMP administration|1
7833933|NCT01356407|12309274|FG000|Overall Study|Not complete Endoscopy|2
7833934|NCT01356407|12309275|FG001|Overall Study|Not complete Endoscopy|2
7833935|NCT01356589|12309312|FG000|Overall Study|Enrolled, but not treated|3
7833936|NCT01356589|12309312|FG000|Overall Study|Dose data not recorded|2
7833937|NCT01356602|12309319|FG000|Overall Study|Protocol Deviation|0
7833938|NCT01356602|12309320|FG001|Overall Study|Protocol Deviation|1
7833939|NCT01356602|12309321|FG002|Overall Study|Protocol Deviation|1
7833940|NCT01356602|12309319|FG000|Overall Study|Administrative Problems|1
7833941|NCT01356602|12309320|FG001|Overall Study|Administrative Problems|4
7833942|NCT01356602|12309321|FG002|Overall Study|Administrative Problems|5
7833943|NCT01356602|12309319|FG000|Overall Study|Lost to Follow-up|4
7833944|NCT01356602|12309320|FG001|Overall Study|Lost to Follow-up|5
7833945|NCT01356602|12309321|FG002|Overall Study|Lost to Follow-up|6
7833946|NCT01356602|12309319|FG000|Overall Study|Withdrawal by Subject|4
7833947|NCT01356602|12309320|FG001|Overall Study|Withdrawal by Subject|3
7833948|NCT01356602|12309321|FG002|Overall Study|Withdrawal by Subject|7
7833949|NCT01356602|12309319|FG000|Overall Study|Lack of Efficacy|0
7833950|NCT01356602|12309320|FG001|Overall Study|Lack of Efficacy|1
7833951|NCT01356602|12309321|FG002|Overall Study|Lack of Efficacy|4
7833952|NCT01356602|12309319|FG000|Overall Study|Adverse Event|0
7833953|NCT01356602|12309320|FG001|Overall Study|Adverse Event|1
7833954|NCT01356602|12309321|FG002|Overall Study|Adverse Event|1
7833955|NCT01356940|12309335|FG000|First Intervention (28 Days)|Adverse Event|1
7833956|NCT01356940|12309336|FG001|First Intervention (28 Days)|Adverse Event|0
7833957|NCT01356940|12309335|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1
7833958|NCT01356940|12309336|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0
7833959|NCT01356966|12309346|FG000|Overall Study|Withdrawal by Subject|1
7833960|NCT01356966|12309347|FG001|Overall Study|Withdrawal by Subject|2
7833961|NCT01356966|12309346|FG000|Overall Study|Physician Decision|1
7833962|NCT01356966|12309347|FG001|Overall Study|Physician Decision|0
7833963|NCT01357161|12309373|FG000|Part 1 (Open Label Run-in)|Death|5
7833964|NCT01357161|12309374|FG001|Part 1 (Open Label Run-in)|Death|0
7833965|NCT01357161|12309375|FG002|Part 1 (Open Label Run-in)|Death|0
7833966|NCT01357161|12309373|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3
7833967|NCT01357161|12309374|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0
7833968|NCT01357161|12309375|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0
7833969|NCT01357161|12309373|FG000|Part 1 (Open Label Run-in)|Physician Decision|1
7833970|NCT01357161|12309374|FG001|Part 1 (Open Label Run-in)|Physician Decision|0
7833971|NCT01357161|12309375|FG002|Part 1 (Open Label Run-in)|Physician Decision|0
7833972|NCT01357161|12309373|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
7833973|NCT01357161|12309374|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
7833974|NCT01357161|12309375|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
7833975|NCT01357161|12309373|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
7833976|NCT01357161|12309374|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
7833977|NCT01357161|12309375|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
7833978|NCT01357161|12309373|FG000|Part 2 (Double-Blind Comparison)|Death|0
7833979|NCT01357161|12309374|FG001|Part 2 (Double-Blind Comparison)|Death|22
7833980|NCT01357161|12309375|FG002|Part 2 (Double-Blind Comparison)|Death|19
7833981|NCT01357161|12309373|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
7833982|NCT01357161|12309374|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
7833983|NCT01357161|12309375|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
7833984|NCT01357161|12309373|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0
7833985|NCT01357161|12309374|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1
7833986|NCT01357161|12309375|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4
7833987|NCT01357161|12309373|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0
7833988|NCT01357161|12309374|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1
7833989|NCT01357161|12309375|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3
7833990|NCT01357161|12309373|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
7833991|NCT01357161|12309374|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
7833992|NCT01357161|12309375|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
7833993|NCT01357161|12309373|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
7833994|NCT01357161|12309374|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
7833995|NCT01357161|12309375|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
7833996|NCT01357239|12309387|FG000|Stratum: All Patients|Adverse Event|0
7833997|NCT01357239|12309388|FG001|Stratum: All Patients|Adverse Event|0
7833998|NCT01357239|12309389|FG002|Stratum: All Patients|Adverse Event|1
7833999|NCT01357239|12309390|FG003|Stratum: All Patients|Adverse Event|1
7834000|NCT01357239|12309387|FG000|Stratum: All Patients|Subject withdrew consent|0
7834001|NCT01357239|12309388|FG001|Stratum: All Patients|Subject withdrew consent|0
7834002|NCT01357239|12309389|FG002|Stratum: All Patients|Subject withdrew consent|1
7834003|NCT01357239|12309390|FG003|Stratum: All Patients|Subject withdrew consent|1
7834004|NCT01357239|12309387|FG000|Stratum I: Fully-Methylated|Adverse Event|0
7834005|NCT01357239|12309388|FG001|Stratum I: Fully-Methylated|Adverse Event|0
7834006|NCT01357239|12309389|FG002|Stratum I: Fully-Methylated|Adverse Event|1
7834007|NCT01357239|12309390|FG003|Stratum I: Fully-Methylated|Adverse Event|0
7834008|NCT01357239|12309387|FG000|Stratum II: Partially-Methylated|Adverse Event|0
7834009|NCT01357239|12309388|FG001|Stratum II: Partially-Methylated|Adverse Event|0
7834010|NCT01357239|12309389|FG002|Stratum II: Partially-Methylated|Adverse Event|0
7834011|NCT01357239|12309390|FG003|Stratum II: Partially-Methylated|Adverse Event|1
7834012|NCT01357239|12309387|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0
7834013|NCT01357239|12309388|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0
7834014|NCT01357239|12309389|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1
7834015|NCT01357239|12309390|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1
7834016|NCT01357551|12309437|FG000|Overall Study|Withdrawal by Subject|6
7834017|NCT01357551|12309438|FG001|Overall Study|Withdrawal by Subject|4
7834018|NCT01357551|12309437|FG000|Overall Study|Death|0
7834019|NCT01357551|12309438|FG001|Overall Study|Death|1
7834020|NCT01357551|12309437|FG000|Overall Study|Lost to Follow-up|16
7834021|NCT01357551|12309438|FG001|Overall Study|Lost to Follow-up|6
7834022|NCT01357577|12309460|FG000|Overall Study|Lost to Follow-up|20
7834023|NCT01357577|12309461|FG001|Overall Study|Lost to Follow-up|16
7834024|NCT01357577|12309460|FG000|Overall Study|Withdrawal by Subject|16
7834025|NCT01357577|12309461|FG001|Overall Study|Withdrawal by Subject|8
7834026|NCT01357577|12309460|FG000|Overall Study|look at data in database?|1
7834027|NCT01357577|12309461|FG001|Overall Study|look at data in database?|2
7834028|NCT01357616|12309470|FG000|Overall Study|Adverse Event|1
7834029|NCT01357616|12309471|FG001|Overall Study|Adverse Event|1
7834030|NCT01357616|12309470|FG000|Overall Study|Lost to Follow-up|4
7834031|NCT01357616|12309471|FG001|Overall Study|Lost to Follow-up|3
7834032|NCT01357616|12309470|FG000|Overall Study|Protocol Violation|0
7834033|NCT01357616|12309471|FG001|Overall Study|Protocol Violation|2
7834034|NCT01357616|12309470|FG000|Overall Study|Inadequate Control of IOP|1
7834035|NCT01357616|12309471|FG001|Overall Study|Inadequate Control of IOP|2
7834036|NCT01357616|12309470|FG000|Overall Study|Decision Unrelated to Adverse Event|3
7834037|NCT01357616|12309471|FG001|Overall Study|Decision Unrelated to Adverse Event|1
7834038|NCT01357616|12309470|FG000|Overall Study|Withdrawal by Subject|1
7834039|NCT01357616|12309471|FG001|Overall Study|Withdrawal by Subject|0
7834040|NCT01357655|12309479|FG000|Overall Study|Administrative Reason by Sponsor|45
7834041|NCT01357655|12309480|FG001|Overall Study|Administrative Reason by Sponsor|0
7834042|NCT01357655|12309479|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3
7834043|NCT01357655|12309480|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0
7834044|NCT01357655|12309479|FG000|Overall Study|Disease Progression|1
7834045|NCT01357655|12309480|FG001|Overall Study|Disease Progression|0
7834046|NCT01357655|12309479|FG000|Overall Study|Lost to Follow-up|2
7834047|NCT01357655|12309480|FG001|Overall Study|Lost to Follow-up|0
7834048|NCT01357655|12309479|FG000|Overall Study|Maximum Clinical Benefit|2
7834049|NCT01357655|12309480|FG001|Overall Study|Maximum Clinical Benefit|0
7834050|NCT01357655|12309479|FG000|Overall Study|Reason Unspecified|1
7834051|NCT01357655|12309480|FG001|Overall Study|Reason Unspecified|0
7834052|NCT01357655|12309479|FG000|Overall Study|Study Drug Toxicity|11
7834053|NCT01357655|12309480|FG001|Overall Study|Study Drug Toxicity|0
7834054|NCT01357655|12309479|FG000|Overall Study|Subject Withdrew Consent|1
7834055|NCT01357655|12309480|FG001|Overall Study|Subject Withdrew Consent|0
7862585|NCT01598298|12351475|FG001|Overall Study|Not eligible|5
7862586|NCT01598298|12351474|FG000|Overall Study|Adverse Event|21
7862587|NCT01598298|12351475|FG001|Overall Study|Adverse Event|19
7862588|NCT01598298|12351474|FG000|Overall Study|Progression/relapse|0
7862589|NCT01598298|12351475|FG001|Overall Study|Progression/relapse|2
7862590|NCT01598298|12351474|FG000|Overall Study|Withdrawal by Subject|10
7862591|NCT01598298|12351475|FG001|Overall Study|Withdrawal by Subject|15
7862592|NCT01598298|12351474|FG000|Overall Study|Other reason (not protocol specified)|4
7862593|NCT01598298|12351475|FG001|Overall Study|Other reason (not protocol specified)|0
7862594|NCT01598506|12351490|FG000|Overall Study|Withdrawal by Subject|2
7862595|NCT01598532|12351495|FG000|Overall Study|Lost to Follow-up|3
7862596|NCT01598532|12351495|FG000|Overall Study|Did not meet inclusion criteria|8
7862597|NCT01598610|12351506|FG000|Overall Study|Adverse Event|1
7862598|NCT01598662|12351512|FG000|Overall Study|Lost to Follow-up|10
7862599|NCT01598662|12351513|FG001|Overall Study|Lost to Follow-up|17
7862600|NCT01598662|12351512|FG000|Overall Study|Physician Decision|1
7862601|NCT01598662|12351513|FG001|Overall Study|Physician Decision|2
7862602|NCT01598662|12351512|FG000|Overall Study|IUD expelled before month 6|0
7862603|NCT01598662|12351513|FG001|Overall Study|IUD expelled before month 6|2
7862604|NCT01598753|12351542|FG000|Overall Study|Adverse Event|1
7862605|NCT01598753|12351543|FG001|Overall Study|Adverse Event|9
7862606|NCT01598753|12351544|FG002|Overall Study|Adverse Event|1
7862607|NCT01598753|12351545|FG003|Overall Study|Adverse Event|7
7862608|NCT01598753|12351542|FG000|Overall Study|Lost to Follow-up|4
7862609|NCT01598753|12351543|FG001|Overall Study|Lost to Follow-up|3
7862610|NCT01598753|12351544|FG002|Overall Study|Lost to Follow-up|7
7834056|NCT01357850|12309498|FG000|Overall Study|Lost to Follow-up|1
7948596|NCT02528357|12493677|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948597|NCT02528357|12493678|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948598|NCT02528357|12493679|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948599|NCT02528357|12493680|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948600|NCT02528357|12493681|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7948601|NCT02528357|12493682|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7948602|NCT02528357|12493683|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4
7948603|NCT02528357|12493684|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3
7948604|NCT02528942|12493755|FG000|Overall Study|Did not meet imaging criteria|9
7948605|NCT02528942|12493755|FG000|Overall Study|Lost to Follow-up|25
7948606|NCT02529137|12493768|FG000|Overall Study|Discontinuation for different reasons|8
7948607|NCT02529488|12493773|FG000|Overall Study|Adverse Event|1
7948608|NCT02529488|12493773|FG000|Overall Study|Death|3
7948609|NCT02529553|12493790|FG000|Overall Study|Progressive Disease|1
7948610|NCT02529553|12493791|FG001|Overall Study|Progressive Disease|0
7948611|NCT02529553|12493792|FG002|Overall Study|Progressive Disease|1
7948612|NCT02529553|12493793|FG003|Overall Study|Progressive Disease|3
7948613|NCT02529553|12493794|FG004|Overall Study|Progressive Disease|2
7948614|NCT02529553|12493795|FG005|Overall Study|Progressive Disease|3
7948615|NCT02529553|12493796|FG006|Overall Study|Progressive Disease|3
7948616|NCT02529553|12493797|FG007|Overall Study|Progressive Disease|5
7948617|NCT02529553|12493798|FG008|Overall Study|Progressive Disease|3
7948618|NCT02529553|12493790|FG000|Overall Study|Physician Decision|0
7948619|NCT02529553|12493791|FG001|Overall Study|Physician Decision|1
7948620|NCT02529553|12493792|FG002|Overall Study|Physician Decision|0
7948621|NCT02529553|12493793|FG003|Overall Study|Physician Decision|0
7948622|NCT02529553|12493794|FG004|Overall Study|Physician Decision|1
7948623|NCT02529553|12493795|FG005|Overall Study|Physician Decision|0
7948624|NCT02529553|12493796|FG006|Overall Study|Physician Decision|0
7948625|NCT02529553|12493797|FG007|Overall Study|Physician Decision|0
7948626|NCT02529553|12493798|FG008|Overall Study|Physician Decision|0
7948627|NCT02529553|12493790|FG000|Overall Study|Withdrawal by Subject|0
7948628|NCT02529553|12493791|FG001|Overall Study|Withdrawal by Subject|0
7948629|NCT02529553|12493792|FG002|Overall Study|Withdrawal by Subject|0
7948630|NCT02529553|12493793|FG003|Overall Study|Withdrawal by Subject|0
7948631|NCT02529553|12493794|FG004|Overall Study|Withdrawal by Subject|0
7948632|NCT02529553|12493795|FG005|Overall Study|Withdrawal by Subject|1
7948633|NCT02529553|12493796|FG006|Overall Study|Withdrawal by Subject|0
7948634|NCT02529553|12493797|FG007|Overall Study|Withdrawal by Subject|1
7948635|NCT02529553|12493798|FG008|Overall Study|Withdrawal by Subject|0
7948636|NCT02529995|12493821|FG000|Part A|Ongoing Study at Data Cut-off|14
7948637|NCT02529995|12493822|FG001|Part A|Ongoing Study at Data Cut-off|16
7948638|NCT02529995|12493821|FG000|Part A|Discontinued Study|1
7948639|NCT02529995|12493822|FG001|Part A|Discontinued Study|0
7834057|NCT01357850|12309499|FG001|Overall Study|Lost to Follow-up|0
7834058|NCT01357850|12309500|FG002|Overall Study|Lost to Follow-up|0
7834059|NCT01357850|12309501|FG003|Overall Study|Lost to Follow-up|0
7834060|NCT01357889|12309514|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
7834061|NCT01357889|12309515|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
7834062|NCT01357889|12309514|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
7834063|NCT01357889|12309515|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
7834064|NCT01357889|12309514|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
7834065|NCT01357889|12309515|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
7834066|NCT01357889|12309514|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
7834067|NCT01357889|12309515|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
7834068|NCT01357889|12309514|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
7834069|NCT01357889|12309515|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
7834070|NCT01357889|12309514|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
7834071|NCT01357889|12309515|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
7834072|NCT01357889|12309514|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
7834073|NCT01357889|12309515|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
7834074|NCT01357889|12309514|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
7834075|NCT01357889|12309515|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
7834076|NCT01357889|12309514|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
7834077|NCT01357889|12309515|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
7834078|NCT01357889|12309514|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
7834079|NCT01357889|12309515|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
7834080|NCT01357889|12309514|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
7834081|NCT01357889|12309515|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
7834082|NCT01357889|12309514|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
7834083|NCT01357889|12309515|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
7834084|NCT01357889|12309514|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
7834085|NCT01357889|12309515|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
7834086|NCT01357915|12309525|FG000|Overall Study|Lost to Follow-up|3
7834087|NCT01357915|12309526|FG001|Overall Study|Lost to Follow-up|0
7834088|NCT01358175|12309535|FG000|Overall Study|Death|1
7834089|NCT01358175|12309536|FG001|Overall Study|Death|0
7834090|NCT01358175|12309537|FG002|Overall Study|Death|1
7834091|NCT01358175|12309535|FG000|Overall Study|Withdrawal by Subject|9
7834092|NCT01358175|12309536|FG001|Overall Study|Withdrawal by Subject|5
7834093|NCT01358175|12309537|FG002|Overall Study|Withdrawal by Subject|10
7834094|NCT01358175|12309535|FG000|Overall Study|Technical issues|0
7834095|NCT01358175|12309536|FG001|Overall Study|Technical issues|1
7834096|NCT01358175|12309537|FG002|Overall Study|Technical issues|0
7834097|NCT01358175|12309535|FG000|Overall Study|Pregnancy|0
7834098|NCT01358175|12309536|FG001|Overall Study|Pregnancy|1
7834099|NCT01358175|12309537|FG002|Overall Study|Pregnancy|0
7834100|NCT01358175|12309535|FG000|Overall Study|Physician Decision|1
7834101|NCT01358175|12309536|FG001|Overall Study|Physician Decision|0
7834102|NCT01358175|12309537|FG002|Overall Study|Physician Decision|0
7834103|NCT01358175|12309535|FG000|Overall Study|Non Compliance with Study Treatment|0
7834104|NCT01358175|12309536|FG001|Overall Study|Non Compliance with Study Treatment|1
7834105|NCT01358175|12309537|FG002|Overall Study|Non Compliance with Study Treatment|1
7834106|NCT01358175|12309535|FG000|Overall Study|Lost to Follow-up|1
7834107|NCT01358175|12309536|FG001|Overall Study|Lost to Follow-up|1
7834108|NCT01358175|12309537|FG002|Overall Study|Lost to Follow-up|3
7834109|NCT01358175|12309535|FG000|Overall Study|Lack of Efficacy|3
7834110|NCT01358175|12309536|FG001|Overall Study|Lack of Efficacy|8
7834111|NCT01358175|12309537|FG002|Overall Study|Lack of Efficacy|6
7834112|NCT01358175|12309535|FG000|Overall Study|Adverse Event|6
7834113|NCT01358175|12309536|FG001|Overall Study|Adverse Event|11
7834114|NCT01358175|12309537|FG002|Overall Study|Adverse Event|11
7834115|NCT01358331|12309569|FG000|Overall Study|Lost to Follow-up|0
7834116|NCT01358331|12309570|FG001|Overall Study|Lost to Follow-up|0
7834117|NCT01358331|12309571|FG002|Overall Study|Lost to Follow-up|0
7834118|NCT01358331|12309572|FG003|Overall Study|Lost to Follow-up|1
7834119|NCT01358331|12309573|FG004|Overall Study|Lost to Follow-up|0
7834120|NCT01358331|12309574|FG005|Overall Study|Lost to Follow-up|0
7834121|NCT01358331|12309569|FG000|Overall Study|Withdrawal by Subject|0
7834122|NCT01358331|12309570|FG001|Overall Study|Withdrawal by Subject|0
7834123|NCT01358331|12309571|FG002|Overall Study|Withdrawal by Subject|0
7834124|NCT01358331|12309572|FG003|Overall Study|Withdrawal by Subject|1
7834125|NCT01358331|12309573|FG004|Overall Study|Withdrawal by Subject|1
7834126|NCT01358331|12309574|FG005|Overall Study|Withdrawal by Subject|1
7834127|NCT01358331|12309569|FG000|Overall Study|Adverse Events|1
7834128|NCT01358331|12309570|FG001|Overall Study|Adverse Events|1
7834129|NCT01358331|12309571|FG002|Overall Study|Adverse Events|1
7834130|NCT01358331|12309572|FG003|Overall Study|Adverse Events|0
7834131|NCT01358331|12309573|FG004|Overall Study|Adverse Events|1
7834132|NCT01358331|12309574|FG005|Overall Study|Adverse Events|5
7834133|NCT01358331|12309569|FG000|Overall Study|Symptomatic Deterioration|0
7834134|NCT01358331|12309570|FG001|Overall Study|Symptomatic Deterioration|0
7834135|NCT01358331|12309571|FG002|Overall Study|Symptomatic Deterioration|0
7834136|NCT01358331|12309572|FG003|Overall Study|Symptomatic Deterioration|0
7834137|NCT01358331|12309573|FG004|Overall Study|Symptomatic Deterioration|1
7834138|NCT01358331|12309574|FG005|Overall Study|Symptomatic Deterioration|0
7834139|NCT01358331|12309569|FG000|Overall Study|Participants did not wish to continue|0
7834140|NCT01358331|12309570|FG001|Overall Study|Participants did not wish to continue|0
7834141|NCT01358331|12309571|FG002|Overall Study|Participants did not wish to continue|0
7834142|NCT01358331|12309572|FG003|Overall Study|Participants did not wish to continue|0
7834143|NCT01358331|12309573|FG004|Overall Study|Participants did not wish to continue|1
7834144|NCT01358331|12309574|FG005|Overall Study|Participants did not wish to continue|0
7834145|NCT01358331|12309569|FG000|Overall Study|Progress of disease under investigation|1
7834146|NCT01358331|12309570|FG001|Overall Study|Progress of disease under investigation|2
7834147|NCT01358331|12309571|FG002|Overall Study|Progress of disease under investigation|3
7834148|NCT01358331|12309572|FG003|Overall Study|Progress of disease under investigation|1
7834149|NCT01358331|12309573|FG004|Overall Study|Progress of disease under investigation|3
7834150|NCT01358331|12309574|FG005|Overall Study|Progress of disease under investigation|0
7834151|NCT01358357|12309590|FG000|Open Label Phase|Adverse Event|0
7834152|NCT01358357|12309591|FG001|Open Label Phase|Adverse Event|0
7834153|NCT01358357|12309592|FG002|Open Label Phase|Adverse Event|59
7834154|NCT01358357|12309590|FG000|Open Label Phase|Lack of Efficacy|0
7834155|NCT01358357|12309591|FG001|Open Label Phase|Lack of Efficacy|0
7834156|NCT01358357|12309592|FG002|Open Label Phase|Lack of Efficacy|107
7834157|NCT01358357|12309590|FG000|Open Label Phase|Lost to Follow-up|0
7834158|NCT01358357|12309591|FG001|Open Label Phase|Lost to Follow-up|0
7834159|NCT01358357|12309592|FG002|Open Label Phase|Lost to Follow-up|76
7834160|NCT01358357|12309590|FG000|Open Label Phase|Protocol Violation|0
7834161|NCT01358357|12309591|FG001|Open Label Phase|Protocol Violation|0
7834162|NCT01358357|12309592|FG002|Open Label Phase|Protocol Violation|45
7834163|NCT01358357|12309590|FG000|Open Label Phase|Withdrawal by Subject|0
7834164|NCT01358357|12309591|FG001|Open Label Phase|Withdrawal by Subject|0
7834165|NCT01358357|12309592|FG002|Open Label Phase|Withdrawal by Subject|112
7834166|NCT01358357|12309590|FG000|Open Label Phase|Did not meet criteria for DB phase|0
7834167|NCT01358357|12309591|FG001|Open Label Phase|Did not meet criteria for DB phase|0
7834168|NCT01358357|12309592|FG002|Open Label Phase|Did not meet criteria for DB phase|16
7834169|NCT01358357|12309590|FG000|Open Label Phase|Terminated at study completion|0
7834170|NCT01358357|12309591|FG001|Open Label Phase|Terminated at study completion|0
7834171|NCT01358357|12309592|FG002|Open Label Phase|Terminated at study completion|5
7834172|NCT01358357|12309590|FG000|Open Label Phase|Mood episode|0
7834173|NCT01358357|12309591|FG001|Open Label Phase|Mood episode|0
7834174|NCT01358357|12309592|FG002|Open Label Phase|Mood episode|42
7834175|NCT01358357|12309590|FG000|Double-Blind Phase|Adverse Event|8
7834176|NCT01358357|12309591|FG001|Double-Blind Phase|Adverse Event|5
7834177|NCT01358357|12309592|FG002|Double-Blind Phase|Adverse Event|0
7834178|NCT01358357|12309590|FG000|Double-Blind Phase|Lost to Follow-up|5
7834179|NCT01358357|12309591|FG001|Double-Blind Phase|Lost to Follow-up|7
7834180|NCT01358357|12309592|FG002|Double-Blind Phase|Lost to Follow-up|0
7834181|NCT01358357|12309590|FG000|Double-Blind Phase|Protocol Violation|1
7834182|NCT01358357|12309591|FG001|Double-Blind Phase|Protocol Violation|11
7834183|NCT01358357|12309592|FG002|Double-Blind Phase|Protocol Violation|0
7834184|NCT01358357|12309590|FG000|Double-Blind Phase|Protocol Violation|16
7834185|NCT01358357|12309591|FG001|Double-Blind Phase|Protocol Violation|12
7834186|NCT01358357|12309592|FG002|Double-Blind Phase|Protocol Violation|0
7834187|NCT01358357|12309590|FG000|Double-Blind Phase|Terminated at study completion|2
7834188|NCT01358357|12309591|FG001|Double-Blind Phase|Terminated at study completion|0
7834189|NCT01358357|12309592|FG002|Double-Blind Phase|Terminated at study completion|0
7834190|NCT01358357|12309590|FG000|Double-Blind Phase|Recurrence of mood event|48
7834191|NCT01358357|12309591|FG001|Double-Blind Phase|Recurrence of mood event|64
7834192|NCT01358357|12309592|FG002|Double-Blind Phase|Recurrence of mood event|0
7834193|NCT01358357|12309590|FG000|Double-Blind Phase|Administrative|0
7834194|NCT01358357|12309591|FG001|Double-Blind Phase|Administrative|1
7834195|NCT01358357|12309592|FG002|Double-Blind Phase|Administrative|0
7834196|NCT01358526|12309601|FG000|Open-label Titration Period|Adverse Event|95
7834197|NCT01358526|12309602|FG001|Open-label Titration Period|Adverse Event|0
7834198|NCT01358526|12309603|FG002|Open-label Titration Period|Adverse Event|0
7834199|NCT01358526|12309601|FG000|Open-label Titration Period|Withdrawal by Subject|65
7834200|NCT01358526|12309602|FG001|Open-label Titration Period|Withdrawal by Subject|0
7834201|NCT01358526|12309603|FG002|Open-label Titration Period|Withdrawal by Subject|0
7834202|NCT01358526|12309601|FG000|Open-label Titration Period|Lost to Follow-up|25
7834203|NCT01358526|12309602|FG001|Open-label Titration Period|Lost to Follow-up|0
7834204|NCT01358526|12309603|FG002|Open-label Titration Period|Lost to Follow-up|0
7834205|NCT01358526|12309601|FG000|Open-label Titration Period|Lack of Efficacy|107
7834206|NCT01358526|12309602|FG001|Open-label Titration Period|Lack of Efficacy|0
7834207|NCT01358526|12309603|FG002|Open-label Titration Period|Lack of Efficacy|0
7834208|NCT01358526|12309601|FG000|Open-label Titration Period|Confirmed or suspected diversion|16
7948640|NCT02529995|12493821|FG000|Part B|Ongoing Study at Data Cut-off|0
7834209|NCT01358526|12309602|FG001|Open-label Titration Period|Confirmed or suspected diversion|0
7834210|NCT01358526|12309603|FG002|Open-label Titration Period|Confirmed or suspected diversion|0
7834211|NCT01358526|12309601|FG000|Open-label Titration Period|Administrative|8
7834212|NCT01358526|12309602|FG001|Open-label Titration Period|Administrative|0
7834213|NCT01358526|12309603|FG002|Open-label Titration Period|Administrative|0
7834214|NCT01358526|12309601|FG000|Open-label Titration Period|Did not qualify|178
7834215|NCT01358526|12309602|FG001|Open-label Titration Period|Did not qualify|0
7834216|NCT01358526|12309603|FG002|Open-label Titration Period|Did not qualify|0
7834217|NCT01358526|12309601|FG000|Double-blind Phase|Adverse Event|0
7834218|NCT01358526|12309602|FG001|Double-blind Phase|Adverse Event|24
7834219|NCT01358526|12309603|FG002|Double-blind Phase|Adverse Event|23
7834220|NCT01358526|12309601|FG000|Double-blind Phase|Withdrawal by Subject|0
7834221|NCT01358526|12309602|FG001|Double-blind Phase|Withdrawal by Subject|10
7834222|NCT01358526|12309603|FG002|Double-blind Phase|Withdrawal by Subject|8
7834223|NCT01358526|12309601|FG000|Double-blind Phase|Lost to Follow-up|0
7834224|NCT01358526|12309602|FG001|Double-blind Phase|Lost to Follow-up|4
7834225|NCT01358526|12309603|FG002|Double-blind Phase|Lost to Follow-up|1
7834226|NCT01358526|12309601|FG000|Double-blind Phase|Lack of Efficacy|0
7834227|NCT01358526|12309602|FG001|Double-blind Phase|Lack of Efficacy|31
7834228|NCT01358526|12309603|FG002|Double-blind Phase|Lack of Efficacy|73
7834229|NCT01358526|12309601|FG000|Double-blind Phase|Confirmed or suspected diversion|0
7834230|NCT01358526|12309602|FG001|Double-blind Phase|Confirmed or suspected diversion|5
7834231|NCT01358526|12309603|FG002|Double-blind Phase|Confirmed or suspected diversion|6
7834232|NCT01358526|12309601|FG000|Double-blind Phase|Administrative|0
7834233|NCT01358526|12309602|FG001|Double-blind Phase|Administrative|6
7834234|NCT01358526|12309603|FG002|Double-blind Phase|Administrative|10
7834235|NCT01358578|12309614|FG000|Induction Period|Adverse Event|2
7834236|NCT01358578|12309615|FG001|Induction Period|Adverse Event|4
7834237|NCT01358578|12309616|FG002|Induction Period|Adverse Event|2
7834238|NCT01358578|12309617|FG003|Induction Period|Adverse Event|6
7834239|NCT01358578|12309618|FG004|Induction Period|Adverse Event|0
7834240|NCT01358578|12309619|FG005|Induction Period|Adverse Event|0
7834241|NCT01358578|12309614|FG000|Induction Period|Lack of Efficacy|0
7834242|NCT01358578|12309615|FG001|Induction Period|Lack of Efficacy|0
7834243|NCT01358578|12309616|FG002|Induction Period|Lack of Efficacy|9
7834244|NCT01358578|12309617|FG003|Induction Period|Lack of Efficacy|1
7834245|NCT01358578|12309618|FG004|Induction Period|Lack of Efficacy|0
7834246|NCT01358578|12309619|FG005|Induction Period|Lack of Efficacy|0
7834247|NCT01358578|12309614|FG000|Induction Period|Lost to Follow-up|0
7834248|NCT01358578|12309615|FG001|Induction Period|Lost to Follow-up|0
7834249|NCT01358578|12309616|FG002|Induction Period|Lost to Follow-up|1
7720093|NCT00536510|12144362|FG001|Overall Study|Adverse Event|4
7720094|NCT00536510|12144361|FG000|Overall Study|Lost to Follow-up|11
7720095|NCT00536510|12144362|FG001|Overall Study|Lost to Follow-up|8
7720096|NCT00536510|12144361|FG000|Overall Study|Protocol Violation|4
7720097|NCT00536510|12144362|FG001|Overall Study|Protocol Violation|5
7720098|NCT00536510|12144361|FG000|Overall Study|Withdrawal by Subject|16
7720099|NCT00536510|12144362|FG001|Overall Study|Withdrawal by Subject|9
7720100|NCT00536510|12144361|FG000|Overall Study|Flushing with Product|20
7720101|NCT00536510|12144362|FG001|Overall Study|Flushing with Product|0
7720102|NCT00536510|12144361|FG000|Overall Study|Laboratory Adverse Event|2
7720103|NCT00536510|12144362|FG001|Overall Study|Laboratory Adverse Event|1
7834250|NCT01358578|12309617|FG003|Induction Period|Lost to Follow-up|4
7834251|NCT01358578|12309618|FG004|Induction Period|Lost to Follow-up|0
7834252|NCT01358578|12309619|FG005|Induction Period|Lost to Follow-up|0
7834253|NCT01358578|12309614|FG000|Induction Period|Physician Decision|2
7834254|NCT01358578|12309615|FG001|Induction Period|Physician Decision|1
7834255|NCT01358578|12309616|FG002|Induction Period|Physician Decision|2
7834256|NCT01358578|12309617|FG003|Induction Period|Physician Decision|0
7834257|NCT01358578|12309618|FG004|Induction Period|Physician Decision|0
7834258|NCT01358578|12309619|FG005|Induction Period|Physician Decision|0
7834259|NCT01358578|12309614|FG000|Induction Period|Protocol Deviation|3
7834260|NCT01358578|12309615|FG001|Induction Period|Protocol Deviation|5
7834261|NCT01358578|12309616|FG002|Induction Period|Protocol Deviation|0
7834262|NCT01358578|12309617|FG003|Induction Period|Protocol Deviation|3
7834263|NCT01358578|12309618|FG004|Induction Period|Protocol Deviation|0
7834264|NCT01358578|12309619|FG005|Induction Period|Protocol Deviation|0
7834265|NCT01358578|12309614|FG000|Induction Period|technical problems|0
7834266|NCT01358578|12309615|FG001|Induction Period|technical problems|0
7834267|NCT01358578|12309616|FG002|Induction Period|technical problems|1
7834268|NCT01358578|12309617|FG003|Induction Period|technical problems|1
7834269|NCT01358578|12309618|FG004|Induction Period|technical problems|0
7834270|NCT01358578|12309619|FG005|Induction Period|technical problems|0
7834271|NCT01358578|12309614|FG000|Induction Period|Withdrawal by Subject|5
7834272|NCT01358578|12309615|FG001|Induction Period|Withdrawal by Subject|5
7834273|NCT01358578|12309616|FG002|Induction Period|Withdrawal by Subject|10
7834274|NCT01358578|12309617|FG003|Induction Period|Withdrawal by Subject|6
7834275|NCT01358578|12309618|FG004|Induction Period|Withdrawal by Subject|0
7834276|NCT01358578|12309619|FG005|Induction Period|Withdrawal by Subject|0
7834277|NCT01358578|12309614|FG000|Maintenance Period|Adverse Event|2
7834278|NCT01358578|12309615|FG001|Maintenance Period|Adverse Event|7
7834279|NCT01358578|12309616|FG002|Maintenance Period|Adverse Event|0
7834280|NCT01358578|12309617|FG003|Maintenance Period|Adverse Event|6
7834281|NCT01358578|12309618|FG004|Maintenance Period|Adverse Event|4
7834282|NCT01358578|12309619|FG005|Maintenance Period|Adverse Event|3
7834283|NCT01358578|12309614|FG000|Maintenance Period|Lack of Efficacy|10
7834284|NCT01358578|12309615|FG001|Maintenance Period|Lack of Efficacy|2
7834285|NCT01358578|12309616|FG002|Maintenance Period|Lack of Efficacy|0
7834286|NCT01358578|12309617|FG003|Maintenance Period|Lack of Efficacy|11
7834287|NCT01358578|12309618|FG004|Maintenance Period|Lack of Efficacy|3
7834288|NCT01358578|12309619|FG005|Maintenance Period|Lack of Efficacy|0
7834289|NCT01358578|12309614|FG000|Maintenance Period|Lost to Follow-up|4
7834290|NCT01358578|12309615|FG001|Maintenance Period|Lost to Follow-up|0
7834291|NCT01358578|12309616|FG002|Maintenance Period|Lost to Follow-up|0
7834292|NCT01358578|12309617|FG003|Maintenance Period|Lost to Follow-up|5
7834293|NCT01358578|12309618|FG004|Maintenance Period|Lost to Follow-up|1
7834294|NCT01358578|12309619|FG005|Maintenance Period|Lost to Follow-up|1
7834295|NCT01358578|12309614|FG000|Maintenance Period|Non-compliance with study treatment|3
7834296|NCT01358578|12309615|FG001|Maintenance Period|Non-compliance with study treatment|1
7834297|NCT01358578|12309616|FG002|Maintenance Period|Non-compliance with study treatment|0
7834298|NCT01358578|12309617|FG003|Maintenance Period|Non-compliance with study treatment|2
7834299|NCT01358578|12309618|FG004|Maintenance Period|Non-compliance with study treatment|1
7834300|NCT01358578|12309619|FG005|Maintenance Period|Non-compliance with study treatment|2
7834301|NCT01358578|12309614|FG000|Maintenance Period|Physician Decision|0
7834302|NCT01358578|12309615|FG001|Maintenance Period|Physician Decision|1
7834303|NCT01358578|12309616|FG002|Maintenance Period|Physician Decision|0
7834304|NCT01358578|12309617|FG003|Maintenance Period|Physician Decision|1
7834305|NCT01358578|12309618|FG004|Maintenance Period|Physician Decision|0
7834306|NCT01358578|12309619|FG005|Maintenance Period|Physician Decision|0
7834307|NCT01358578|12309614|FG000|Maintenance Period|Pregnancy|1
7834308|NCT01358578|12309615|FG001|Maintenance Period|Pregnancy|0
7834309|NCT01358578|12309616|FG002|Maintenance Period|Pregnancy|0
7834310|NCT01358578|12309617|FG003|Maintenance Period|Pregnancy|0
7834311|NCT01358578|12309618|FG004|Maintenance Period|Pregnancy|0
7834312|NCT01358578|12309619|FG005|Maintenance Period|Pregnancy|0
7834313|NCT01358578|12309614|FG000|Maintenance Period|Protocol deviation|7
7834314|NCT01358578|12309615|FG001|Maintenance Period|Protocol deviation|4
7834315|NCT01358578|12309616|FG002|Maintenance Period|Protocol deviation|0
7834316|NCT01358578|12309617|FG003|Maintenance Period|Protocol deviation|2
7834317|NCT01358578|12309618|FG004|Maintenance Period|Protocol deviation|2
7834318|NCT01358578|12309619|FG005|Maintenance Period|Protocol deviation|2
7834319|NCT01358578|12309614|FG000|Maintenance Period|Withdrawal by Subject|12
7834320|NCT01358578|12309615|FG001|Maintenance Period|Withdrawal by Subject|7
7834321|NCT01358578|12309616|FG002|Maintenance Period|Withdrawal by Subject|2
7834322|NCT01358578|12309617|FG003|Maintenance Period|Withdrawal by Subject|15
7834323|NCT01358578|12309618|FG004|Maintenance Period|Withdrawal by Subject|6
7834324|NCT01358578|12309619|FG005|Maintenance Period|Withdrawal by Subject|3
7834325|NCT01358578|12309614|FG000|Follow-up Period|Adverse Event|1
7834326|NCT01358578|12309615|FG001|Follow-up Period|Adverse Event|1
7834327|NCT01358578|12309616|FG002|Follow-up Period|Adverse Event|0
7834328|NCT01358578|12309617|FG003|Follow-up Period|Adverse Event|0
7834329|NCT01358578|12309618|FG004|Follow-up Period|Adverse Event|0
7834330|NCT01358578|12309619|FG005|Follow-up Period|Adverse Event|0
7834331|NCT01358578|12309614|FG000|Follow-up Period|Lack of Efficacy|3
7834332|NCT01358578|12309615|FG001|Follow-up Period|Lack of Efficacy|0
7834333|NCT01358578|12309616|FG002|Follow-up Period|Lack of Efficacy|4
7834334|NCT01358578|12309617|FG003|Follow-up Period|Lack of Efficacy|1
7834335|NCT01358578|12309618|FG004|Follow-up Period|Lack of Efficacy|0
7834336|NCT01358578|12309619|FG005|Follow-up Period|Lack of Efficacy|0
7834337|NCT01358578|12309614|FG000|Follow-up Period|Lost to Follow-up|0
7834338|NCT01358578|12309615|FG001|Follow-up Period|Lost to Follow-up|1
7834339|NCT01358578|12309616|FG002|Follow-up Period|Lost to Follow-up|0
7834340|NCT01358578|12309617|FG003|Follow-up Period|Lost to Follow-up|4
7834341|NCT01358578|12309618|FG004|Follow-up Period|Lost to Follow-up|0
7834342|NCT01358578|12309619|FG005|Follow-up Period|Lost to Follow-up|0
7834343|NCT01358578|12309614|FG000|Follow-up Period|non- compliance with study treatment|1
7834344|NCT01358578|12309615|FG001|Follow-up Period|non- compliance with study treatment|0
7834345|NCT01358578|12309616|FG002|Follow-up Period|non- compliance with study treatment|0
7834346|NCT01358578|12309617|FG003|Follow-up Period|non- compliance with study treatment|0
7834347|NCT01358578|12309618|FG004|Follow-up Period|non- compliance with study treatment|0
7834348|NCT01358578|12309619|FG005|Follow-up Period|non- compliance with study treatment|0
7834349|NCT01358578|12309614|FG000|Follow-up Period|Pregnancy|1
7834350|NCT01358578|12309615|FG001|Follow-up Period|Pregnancy|0
7834351|NCT01358578|12309616|FG002|Follow-up Period|Pregnancy|0
7834352|NCT01358578|12309617|FG003|Follow-up Period|Pregnancy|0
7834353|NCT01358578|12309618|FG004|Follow-up Period|Pregnancy|0
7834354|NCT01358578|12309619|FG005|Follow-up Period|Pregnancy|0
7834355|NCT01358578|12309614|FG000|Follow-up Period|Withdrawal by Subject|3
7834356|NCT01358578|12309615|FG001|Follow-up Period|Withdrawal by Subject|3
7834357|NCT01358578|12309616|FG002|Follow-up Period|Withdrawal by Subject|1
7834358|NCT01358578|12309617|FG003|Follow-up Period|Withdrawal by Subject|12
7834359|NCT01358578|12309618|FG004|Follow-up Period|Withdrawal by Subject|0
7834360|NCT01358578|12309619|FG005|Follow-up Period|Withdrawal by Subject|0
7834361|NCT01358578|12309614|FG000|Follow-up Period|Physician Decision|1
7834362|NCT01358578|12309615|FG001|Follow-up Period|Physician Decision|1
7834363|NCT01358578|12309616|FG002|Follow-up Period|Physician Decision|0
7834364|NCT01358578|12309617|FG003|Follow-up Period|Physician Decision|2
7834365|NCT01358578|12309618|FG004|Follow-up Period|Physician Decision|0
7834366|NCT01358578|12309619|FG005|Follow-up Period|Physician Decision|0
7834367|NCT01358708|12309649|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2
7834368|NCT01358708|12309650|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
7834369|NCT01358708|12309649|FG000|Double-Blind Treatment Phase|Protocol Violation|1
7834370|NCT01358708|12309650|FG001|Double-Blind Treatment Phase|Protocol Violation|0
7834371|NCT01358721|12309664|FG000|Overall Study|Withdrawal by Subject|0
7834372|NCT01358721|12309665|FG001|Overall Study|Withdrawal by Subject|0
7834373|NCT01358721|12309666|FG002|Overall Study|Withdrawal by Subject|0
7834374|NCT01358721|12309667|FG003|Overall Study|Withdrawal by Subject|1
7834375|NCT01358721|12309664|FG000|Overall Study|Death|0
7834376|NCT01358721|12309665|FG001|Overall Study|Death|2
7834377|NCT01358721|12309666|FG002|Overall Study|Death|0
7834378|NCT01358721|12309667|FG003|Overall Study|Death|0
7834379|NCT01358721|12309664|FG000|Overall Study|Study Drug Toxicity|1
7834380|NCT01358721|12309665|FG001|Overall Study|Study Drug Toxicity|3
7834381|NCT01358721|12309666|FG002|Overall Study|Study Drug Toxicity|4
7834382|NCT01358721|12309667|FG003|Overall Study|Study Drug Toxicity|5
7834383|NCT01358721|12309664|FG000|Overall Study|SUBJ request to discontinue study TRT|0
7834384|NCT01358721|12309665|FG001|Overall Study|SUBJ request to discontinue study TRT|0
7834385|NCT01358721|12309666|FG002|Overall Study|SUBJ request to discontinue study TRT|0
7834386|NCT01358721|12309667|FG003|Overall Study|SUBJ request to discontinue study TRT|1
7834387|NCT01358721|12309664|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
7834388|NCT01358721|12309665|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
7834389|NCT01358721|12309666|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
7834390|NCT01358721|12309667|FG003|Overall Study|Subject No Longer Meets Study Criteria|1
7834391|NCT01358721|12309664|FG000|Overall Study|Adverse Event related to study drug|1
7834392|NCT01358721|12309665|FG001|Overall Study|Adverse Event related to study drug|0
7834393|NCT01358721|12309666|FG002|Overall Study|Adverse Event related to study drug|0
7834394|NCT01358721|12309667|FG003|Overall Study|Adverse Event related to study drug|1
7834395|NCT01358721|12309664|FG000|Overall Study|Disease Progression|19
7834396|NCT01358721|12309665|FG001|Overall Study|Disease Progression|15
7834397|NCT01358721|12309666|FG002|Overall Study|Disease Progression|17
7834398|NCT01358721|12309667|FG003|Overall Study|Disease Progression|15
7834399|NCT01358721|12309664|FG000|Overall Study|Out of State/Unmet Criteria|0
7834400|NCT01358721|12309665|FG001|Overall Study|Out of State/Unmet Criteria|0
7834401|NCT01358721|12309666|FG002|Overall Study|Out of State/Unmet Criteria|1
7834402|NCT01358721|12309667|FG003|Overall Study|Out of State/Unmet Criteria|0
7834403|NCT01358734|12309680|FG000|Overall Study|Adverse Event|4
7834404|NCT01358734|12309681|FG001|Overall Study|Adverse Event|7
7834405|NCT01358734|12309682|FG002|Overall Study|Adverse Event|3
7834406|NCT01358734|12309680|FG000|Overall Study|Lack of Efficacy|0
7834407|NCT01358734|12309681|FG001|Overall Study|Lack of Efficacy|1
7834408|NCT01358734|12309682|FG002|Overall Study|Lack of Efficacy|3
7834409|NCT01358734|12309680|FG000|Overall Study|Withdrawal by Subject|1
7834410|NCT01358734|12309681|FG001|Overall Study|Withdrawal by Subject|6
7834411|NCT01358734|12309682|FG002|Overall Study|Withdrawal by Subject|3
7834412|NCT01358734|12309680|FG000|Overall Study|Death|3
7834413|NCT01358734|12309681|FG001|Overall Study|Death|7
7834414|NCT01358734|12309682|FG002|Overall Study|Death|2
7834415|NCT01358734|12309680|FG000|Overall Study|Progressive Disease|5
7834416|NCT01358734|12309681|FG001|Overall Study|Progressive Disease|13
7834417|NCT01358734|12309682|FG002|Overall Study|Progressive Disease|16
7834418|NCT01358734|12309680|FG000|Overall Study|Non-compliance with study drug|0
7834419|NCT01358734|12309681|FG001|Overall Study|Non-compliance with study drug|0
7834420|NCT01358734|12309682|FG002|Overall Study|Non-compliance with study drug|1
7834421|NCT01358734|12309680|FG000|Overall Study|Other|2
7834422|NCT01358734|12309681|FG001|Overall Study|Other|5
7834423|NCT01358734|12309682|FG002|Overall Study|Other|4
7834424|NCT01358734|12309680|FG000|Overall Study|Protocol Violation|0
7834425|NCT01358734|12309681|FG001|Overall Study|Protocol Violation|0
7834426|NCT01358734|12309682|FG002|Overall Study|Protocol Violation|2
7834427|NCT01358760|12309693|FG000|Overall Study|Adverse Event|3
7834428|NCT01358760|12309694|FG001|Overall Study|Adverse Event|4
7834429|NCT01358760|12309695|FG002|Overall Study|Adverse Event|3
7834430|NCT01358760|12309693|FG000|Overall Study|Lost to Follow-up|1
7834431|NCT01358760|12309694|FG001|Overall Study|Lost to Follow-up|1
7834432|NCT01358760|12309695|FG002|Overall Study|Lost to Follow-up|3
7834433|NCT01358760|12309693|FG000|Overall Study|Withdrawal by Subject|5
7834434|NCT01358760|12309694|FG001|Overall Study|Withdrawal by Subject|3
7834435|NCT01358760|12309695|FG002|Overall Study|Withdrawal by Subject|2
7834436|NCT01358760|12309693|FG000|Overall Study|Physician Decision|1
7834437|NCT01358760|12309694|FG001|Overall Study|Physician Decision|0
7834438|NCT01358760|12309695|FG002|Overall Study|Physician Decision|1
7834439|NCT01358760|12309693|FG000|Overall Study|Entry criteria not met/Non-compliance|12
7834440|NCT01358760|12309694|FG001|Overall Study|Entry criteria not met/Non-compliance|12
7834441|NCT01358760|12309695|FG002|Overall Study|Entry criteria not met/Non-compliance|16
7834442|NCT01358825|12309705|FG000|Overall Study|Blood sample not drawn|0
7834443|NCT01358825|12309706|FG001|Overall Study|Blood sample not drawn|1
7834444|NCT01358864|12309720|FG000|Overall Study|Adverse Event|0
7834445|NCT01358864|12309721|FG001|Overall Study|Adverse Event|6
7834446|NCT01358864|12309722|FG002|Overall Study|Adverse Event|9
7834447|NCT01358864|12309723|FG003|Overall Study|Adverse Event|0
7834448|NCT01358864|12309724|FG004|Overall Study|Adverse Event|4
7834449|NCT01358864|12309725|FG005|Overall Study|Adverse Event|8
7834450|NCT01358864|12309726|FG006|Overall Study|Adverse Event|12
7834451|NCT01358864|12309727|FG007|Overall Study|Adverse Event|7
7834452|NCT01358864|12309720|FG000|Overall Study|Lack of Efficacy|26
7834453|NCT01358864|12309721|FG001|Overall Study|Lack of Efficacy|3
7834454|NCT01358864|12309722|FG002|Overall Study|Lack of Efficacy|4
7834455|NCT01358864|12309723|FG003|Overall Study|Lack of Efficacy|19
7834456|NCT01358864|12309724|FG004|Overall Study|Lack of Efficacy|7
7834457|NCT01358864|12309725|FG005|Overall Study|Lack of Efficacy|4
7834458|NCT01358864|12309726|FG006|Overall Study|Lack of Efficacy|49
7834459|NCT01358864|12309727|FG007|Overall Study|Lack of Efficacy|44
7834460|NCT01358864|12309720|FG000|Overall Study|Lost to Follow-up|0
7834461|NCT01358864|12309721|FG001|Overall Study|Lost to Follow-up|0
7834462|NCT01358864|12309722|FG002|Overall Study|Lost to Follow-up|1
7834463|NCT01358864|12309723|FG003|Overall Study|Lost to Follow-up|0
7834464|NCT01358864|12309724|FG004|Overall Study|Lost to Follow-up|0
7834465|NCT01358864|12309725|FG005|Overall Study|Lost to Follow-up|0
7834466|NCT01358864|12309726|FG006|Overall Study|Lost to Follow-up|0
7834467|NCT01358864|12309727|FG007|Overall Study|Lost to Follow-up|1
7834468|NCT01358864|12309720|FG000|Overall Study|Withdrawal by Subject|3
7834469|NCT01358864|12309721|FG001|Overall Study|Withdrawal by Subject|4
7834470|NCT01358864|12309722|FG002|Overall Study|Withdrawal by Subject|2
7834471|NCT01358864|12309723|FG003|Overall Study|Withdrawal by Subject|0
7834472|NCT01358864|12309724|FG004|Overall Study|Withdrawal by Subject|0
7834473|NCT01358864|12309725|FG005|Overall Study|Withdrawal by Subject|1
7834474|NCT01358864|12309726|FG006|Overall Study|Withdrawal by Subject|1
7834475|NCT01358864|12309727|FG007|Overall Study|Withdrawal by Subject|3
7834476|NCT01358864|12309720|FG000|Overall Study|Other reason not defined above|2
7834477|NCT01358864|12309721|FG001|Overall Study|Other reason not defined above|0
7834478|NCT01358864|12309722|FG002|Overall Study|Other reason not defined above|0
7834479|NCT01358864|12309723|FG003|Overall Study|Other reason not defined above|0
7834480|NCT01358864|12309724|FG004|Overall Study|Other reason not defined above|0
7834481|NCT01358864|12309725|FG005|Overall Study|Other reason not defined above|0
7834482|NCT01358864|12309726|FG006|Overall Study|Other reason not defined above|2
7834483|NCT01358864|12309727|FG007|Overall Study|Other reason not defined above|0
7834484|NCT01358864|12309720|FG000|Overall Study|Not treated|0
7834485|NCT01358864|12309721|FG001|Overall Study|Not treated|0
7834486|NCT01358864|12309722|FG002|Overall Study|Not treated|0
7834487|NCT01358864|12309723|FG003|Overall Study|Not treated|0
7834488|NCT01358864|12309724|FG004|Overall Study|Not treated|0
7834489|NCT01358864|12309725|FG005|Overall Study|Not treated|0
7834490|NCT01358864|12309726|FG006|Overall Study|Not treated|1
7834491|NCT01358864|12309727|FG007|Overall Study|Not treated|0
7834492|NCT01358968|12309747|FG000|Period 2|Adverse Event|0
7834493|NCT01358968|12309748|FG001|Period 2|Adverse Event|1
7834494|NCT01358968|12309749|FG002|Period 2|Adverse Event|0
7834495|NCT01358968|12309750|FG003|Period 2|Adverse Event|0
7834496|NCT01358968|12309747|FG000|Continued Access Phase|Progression of Disease|0
7834497|NCT01358968|12309748|FG001|Continued Access Phase|Progression of Disease|0
7834498|NCT01358968|12309749|FG002|Continued Access Phase|Progression of Disease|8
7834499|NCT01358968|12309750|FG003|Continued Access Phase|Progression of Disease|4
7834500|NCT01358968|12309747|FG000|Continued Access Phase|Protocol Violation|0
7834501|NCT01358968|12309748|FG001|Continued Access Phase|Protocol Violation|0
7834502|NCT01358968|12309749|FG002|Continued Access Phase|Protocol Violation|0
7834503|NCT01358968|12309750|FG003|Continued Access Phase|Protocol Violation|2
7834504|NCT01358968|12309747|FG000|Continued Access Phase|Withdrawal by Subject|0
7834505|NCT01358968|12309748|FG001|Continued Access Phase|Withdrawal by Subject|0
7834506|NCT01358968|12309749|FG002|Continued Access Phase|Withdrawal by Subject|3
7834507|NCT01358968|12309750|FG003|Continued Access Phase|Withdrawal by Subject|0
7834508|NCT01358968|12309747|FG000|Continued Access Phase|Death|0
7834509|NCT01358968|12309748|FG001|Continued Access Phase|Death|0
7834510|NCT01358968|12309749|FG002|Continued Access Phase|Death|1
7834511|NCT01358968|12309750|FG003|Continued Access Phase|Death|1
7834512|NCT01358981|12309767|FG000|Period 1|Withdrawal by Subject|0
7834513|NCT01358981|12309768|FG001|Period 1|Withdrawal by Subject|0
7834514|NCT01358981|12309769|FG002|Period 1|Withdrawal by Subject|0
7834515|NCT01358981|12309770|FG003|Period 1|Withdrawal by Subject|1
7834516|NCT01358981|12309771|FG004|Period 1|Withdrawal by Subject|0
7834517|NCT01358981|12309772|FG005|Period 1|Withdrawal by Subject|0
7834518|NCT01358981|12309773|FG006|Period 1|Withdrawal by Subject|0
7834519|NCT01359046|12309805|FG000|Overall Study|Did not receive allocated intervention|6
7834520|NCT01359046|12309806|FG001|Overall Study|Did not receive allocated intervention|6
7834521|NCT01359046|12309805|FG000|Overall Study|Physician Decision|1
7834522|NCT01359046|12309806|FG001|Overall Study|Physician Decision|11
7834523|NCT01359150|12309820|FG000|Overall Study|Lack of Efficacy|1
7834524|NCT01359150|12309821|FG001|Overall Study|Lack of Efficacy|1
7834525|NCT01359150|12309820|FG000|Overall Study|Withdrawal by Subject|1
7834526|NCT01359150|12309821|FG001|Overall Study|Withdrawal by Subject|1
7834527|NCT01359150|12309820|FG000|Overall Study|Adverse Event|4
7834528|NCT01359150|12309821|FG001|Overall Study|Adverse Event|3
7834529|NCT01359150|12309820|FG000|Overall Study|Other|1
7834530|NCT01359150|12309821|FG001|Overall Study|Other|0
7834531|NCT01359449|12309847|FG000|Overall Study|Lost to Follow-up|1
7834532|NCT01359449|12309848|FG001|Overall Study|Lost to Follow-up|0
7834533|NCT01359449|12309847|FG000|Overall Study|Protocol Violation|0
7834534|NCT01359449|12309848|FG001|Overall Study|Protocol Violation|2
7834535|NCT01359449|12309847|FG000|Overall Study|Withdrawal by Subject|3
7834536|NCT01359449|12309848|FG001|Overall Study|Withdrawal by Subject|2
7834537|NCT01359644|12309864|FG000|Treatment Period|Lack of Efficacy|0
7834538|NCT01359644|12309865|FG001|Treatment Period|Lack of Efficacy|1
7834539|NCT01359644|12309866|FG002|Treatment Period|Lack of Efficacy|0
7834540|NCT01359644|12309867|FG003|Treatment Period|Lack of Efficacy|0
7834541|NCT01359644|12309868|FG004|Treatment Period|Lack of Efficacy|0
7834542|NCT01359644|12309869|FG005|Treatment Period|Lack of Efficacy|0
7834543|NCT01359644|12309870|FG006|Treatment Period|Lack of Efficacy|0
7834544|NCT01359644|12309871|FG007|Treatment Period|Lack of Efficacy|0
7834545|NCT01359644|12309872|FG008|Treatment Period|Lack of Efficacy|0
7834546|NCT01359644|12309873|FG009|Treatment Period|Lack of Efficacy|0
7834547|NCT01359644|12309864|FG000|Treatment Period|Adverse Event|0
7834548|NCT01359644|12309865|FG001|Treatment Period|Adverse Event|0
7834549|NCT01359644|12309866|FG002|Treatment Period|Adverse Event|1
7834550|NCT01359644|12309867|FG003|Treatment Period|Adverse Event|0
7834551|NCT01359644|12309868|FG004|Treatment Period|Adverse Event|0
7834552|NCT01359644|12309869|FG005|Treatment Period|Adverse Event|1
7834553|NCT01359644|12309870|FG006|Treatment Period|Adverse Event|0
7834554|NCT01359644|12309871|FG007|Treatment Period|Adverse Event|0
7834555|NCT01359644|12309872|FG008|Treatment Period|Adverse Event|0
7834556|NCT01359644|12309873|FG009|Treatment Period|Adverse Event|0
7834557|NCT01359644|12309864|FG000|Treatment Period|Lost to Follow-up|0
7834558|NCT01359644|12309865|FG001|Treatment Period|Lost to Follow-up|0
7834559|NCT01359644|12309866|FG002|Treatment Period|Lost to Follow-up|0
7834560|NCT01359644|12309867|FG003|Treatment Period|Lost to Follow-up|0
7834561|NCT01359644|12309868|FG004|Treatment Period|Lost to Follow-up|0
7834562|NCT01359644|12309869|FG005|Treatment Period|Lost to Follow-up|1
7834563|NCT01359644|12309870|FG006|Treatment Period|Lost to Follow-up|0
7834564|NCT01359644|12309871|FG007|Treatment Period|Lost to Follow-up|0
7834565|NCT01359644|12309872|FG008|Treatment Period|Lost to Follow-up|0
7834566|NCT01359644|12309873|FG009|Treatment Period|Lost to Follow-up|0
7834567|NCT01359644|12309864|FG000|Follow-up Period|Withdrawal by Subject|0
7834568|NCT01359644|12309865|FG001|Follow-up Period|Withdrawal by Subject|0
7834569|NCT01359644|12309866|FG002|Follow-up Period|Withdrawal by Subject|0
7834570|NCT01359644|12309867|FG003|Follow-up Period|Withdrawal by Subject|0
7834571|NCT01359644|12309868|FG004|Follow-up Period|Withdrawal by Subject|0
7834572|NCT01359644|12309869|FG005|Follow-up Period|Withdrawal by Subject|1
7834573|NCT01359644|12309870|FG006|Follow-up Period|Withdrawal by Subject|0
7834574|NCT01359644|12309871|FG007|Follow-up Period|Withdrawal by Subject|0
7834575|NCT01359644|12309872|FG008|Follow-up Period|Withdrawal by Subject|0
7834576|NCT01359644|12309873|FG009|Follow-up Period|Withdrawal by Subject|0
7834577|NCT01359644|12309864|FG000|Follow-up Period|Lost to Follow-up|0
7834578|NCT01359644|12309865|FG001|Follow-up Period|Lost to Follow-up|0
7834579|NCT01359644|12309866|FG002|Follow-up Period|Lost to Follow-up|0
7834580|NCT01359644|12309867|FG003|Follow-up Period|Lost to Follow-up|0
7834581|NCT01359644|12309868|FG004|Follow-up Period|Lost to Follow-up|0
7834582|NCT01359644|12309869|FG005|Follow-up Period|Lost to Follow-up|0
7834583|NCT01359644|12309870|FG006|Follow-up Period|Lost to Follow-up|1
7834584|NCT01359644|12309871|FG007|Follow-up Period|Lost to Follow-up|2
7834585|NCT01359644|12309872|FG008|Follow-up Period|Lost to Follow-up|0
7834586|NCT01359644|12309873|FG009|Follow-up Period|Lost to Follow-up|0
7834587|NCT01359904|12309932|FG000|Overall Study|Withdrawal by Subject|1
7834588|NCT01359904|12309933|FG001|Overall Study|Withdrawal by Subject|0
7834589|NCT01359943|12309942|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
7834590|NCT01359943|12309943|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
7834591|NCT01359943|12309944|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
7834592|NCT01359943|12309942|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1
7834593|NCT01359943|12309943|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2
7834594|NCT01359943|12309944|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0
7834595|NCT01359943|12309942|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
7834596|NCT01359943|12309943|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
7834597|NCT01359943|12309944|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
7834598|NCT01359943|12309942|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
7834599|NCT01359943|12309943|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
7834600|NCT01359943|12309944|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
7834601|NCT01359943|12309942|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
7834602|NCT01359943|12309943|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
7834603|NCT01359943|12309944|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
7834604|NCT01359943|12309942|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
7834605|NCT01359943|12309943|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
7834606|NCT01359943|12309944|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
7834607|NCT01359943|12309942|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
7834608|NCT01359943|12309943|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
7834609|NCT01359943|12309944|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
7834610|NCT01359943|12309942|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
7834611|NCT01359943|12309943|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
7834612|NCT01359943|12309944|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
7834613|NCT01359943|12309942|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
7834614|NCT01359943|12309943|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
7834615|NCT01359943|12309944|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
7834616|NCT01359943|12309942|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
7834617|NCT01359943|12309943|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
7834618|NCT01359943|12309944|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
7834619|NCT01359943|12309942|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1
7834620|NCT01359943|12309943|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0
7834621|NCT01359943|12309944|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0
7834622|NCT01359943|12309942|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0
7834623|NCT01359943|12309943|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1
7834624|NCT01359943|12309944|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0
7834625|NCT01359943|12309942|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
7834626|NCT01359943|12309943|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
7834627|NCT01359943|12309944|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
7834628|NCT01359943|12309942|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
7834629|NCT01359943|12309943|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
7834630|NCT01359943|12309944|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
7834631|NCT01359943|12309942|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3
7834632|NCT01359943|12309943|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5
7834633|NCT01359943|12309944|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1
7834634|NCT01359956|12309958|FG000|Overall Study|Death|61
7834635|NCT01359956|12309959|FG001|Overall Study|Death|64
7834636|NCT01359956|12309960|FG002|Overall Study|Death|67
7834637|NCT01359956|12309961|FG003|Overall Study|Death|58
7834638|NCT01360021|12309974|FG000|Overall Study|Eligibility criteria + other|2
7834639|NCT01360021|12309975|FG001|Overall Study|Eligibility criteria + other|1
7834640|NCT01360021|12309976|FG002|Overall Study|Eligibility criteria + other|1
7834641|NCT01360021|12309974|FG000|Overall Study|Protocol Violation|0
7834642|NCT01360021|12309975|FG001|Overall Study|Protocol Violation|0
7834643|NCT01360021|12309976|FG002|Overall Study|Protocol Violation|1
7834644|NCT01360021|12309974|FG000|Overall Study|Withdrawal by Subject|4
7834645|NCT01360021|12309975|FG001|Overall Study|Withdrawal by Subject|0
7834646|NCT01360021|12309976|FG002|Overall Study|Withdrawal by Subject|2
7834647|NCT01360021|12309974|FG000|Overall Study|Adverse Event|2
7834648|NCT01360021|12309975|FG001|Overall Study|Adverse Event|3
7834649|NCT01360021|12309976|FG002|Overall Study|Adverse Event|3
7834650|NCT01360398|12309993|FG000|Overall Study|Withdrawal by Subject|14
7834651|NCT01360398|12309993|FG000|Overall Study|Other|7
7834652|NCT01360398|12309993|FG000|Overall Study|Migrated/moved from study area|1
7834653|NCT01360554|12310009|FG000|Overall Study|Death|359
7834654|NCT01360554|12310010|FG001|Overall Study|Death|371
7834655|NCT01360554|12310009|FG000|Overall Study|Lost to Follow-up|4
7834656|NCT01360554|12310010|FG001|Overall Study|Lost to Follow-up|4
7834657|NCT01360554|12310009|FG000|Overall Study|Withdrawal by Subject|23
7834658|NCT01360554|12310010|FG001|Overall Study|Withdrawal by Subject|24
7834659|NCT01360554|12310009|FG000|Overall Study|Study terminated by sponsor|49
7834660|NCT01360554|12310010|FG001|Overall Study|Study terminated by sponsor|37
7834661|NCT01360554|12310009|FG000|Overall Study|Other, not specified|1
7834662|NCT01360554|12310010|FG001|Overall Study|Other, not specified|0
7834663|NCT01360554|12310009|FG000|Overall Study|Randomized but not treated.|3
7834664|NCT01360554|12310010|FG001|Overall Study|Randomized but not treated.|3
7834665|NCT01360632|12310019|FG000|Phase A (8 Weeks)|Lost to Follow-up|27
7834666|NCT01360632|12310020|FG001|Phase A (8 Weeks)|Lost to Follow-up|0
7834667|NCT01360632|12310021|FG002|Phase A (8 Weeks)|Lost to Follow-up|0
7834668|NCT01360632|12310022|FG003|Phase A (8 Weeks)|Lost to Follow-up|0
7834669|NCT01360632|12310023|FG004|Phase A (8 Weeks)|Lost to Follow-up|0
7834670|NCT01360632|12310019|FG000|Phase A (8 Weeks)|Adverse Event|60
7834671|NCT01360632|12310020|FG001|Phase A (8 Weeks)|Adverse Event|0
7834672|NCT01360632|12310021|FG002|Phase A (8 Weeks)|Adverse Event|0
7834673|NCT01360632|12310022|FG003|Phase A (8 Weeks)|Adverse Event|0
7834674|NCT01360632|12310023|FG004|Phase A (8 Weeks)|Adverse Event|0
7834675|NCT01360632|12310019|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45
7834676|NCT01360632|12310020|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0
7834677|NCT01360632|12310021|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0
7834678|NCT01360632|12310022|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0
7834679|NCT01360632|12310023|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0
7834680|NCT01360632|12310019|FG000|Phase A (8 Weeks)|Physician Decision|10
7834681|NCT01360632|12310020|FG001|Phase A (8 Weeks)|Physician Decision|0
7834682|NCT01360632|12310021|FG002|Phase A (8 Weeks)|Physician Decision|0
7834683|NCT01360632|12310022|FG003|Phase A (8 Weeks)|Physician Decision|0
7834684|NCT01360632|12310023|FG004|Phase A (8 Weeks)|Physician Decision|0
7834685|NCT01360632|12310019|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74
7834686|NCT01360632|12310020|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0
7834687|NCT01360632|12310021|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0
7834688|NCT01360632|12310022|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0
7834689|NCT01360632|12310023|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0
7834690|NCT01360632|12310019|FG000|Phase A (8 Weeks)|Protocol Deviation|39
7834691|NCT01360632|12310020|FG001|Phase A (8 Weeks)|Protocol Deviation|0
7834692|NCT01360632|12310021|FG002|Phase A (8 Weeks)|Protocol Deviation|0
7834693|NCT01360632|12310022|FG003|Phase A (8 Weeks)|Protocol Deviation|0
7834694|NCT01360632|12310023|FG004|Phase A (8 Weeks)|Protocol Deviation|0
7834695|NCT01360632|12310019|FG000|Phase B (6 Weeks)|Lost to Follow-up|0
7834696|NCT01360632|12310020|FG001|Phase B (6 Weeks)|Lost to Follow-up|1
7834697|NCT01360632|12310021|FG002|Phase B (6 Weeks)|Lost to Follow-up|1
7834698|NCT01360632|12310022|FG003|Phase B (6 Weeks)|Lost to Follow-up|0
7834699|NCT01360632|12310023|FG004|Phase B (6 Weeks)|Lost to Follow-up|0
7834700|NCT01360632|12310019|FG000|Phase B (6 Weeks)|Adverse Event|0
7834701|NCT01360632|12310020|FG001|Phase B (6 Weeks)|Adverse Event|3
7834702|NCT01360632|12310021|FG002|Phase B (6 Weeks)|Adverse Event|9
7834703|NCT01360632|12310022|FG003|Phase B (6 Weeks)|Adverse Event|3
7834704|NCT01360632|12310023|FG004|Phase B (6 Weeks)|Adverse Event|0
7834705|NCT01360632|12310019|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0
7834706|NCT01360632|12310020|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0
7834707|NCT01360632|12310021|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2
7834708|NCT01360632|12310022|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1
7834709|NCT01360632|12310023|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0
7834710|NCT01360632|12310019|FG000|Phase B (6 Weeks)|Physician Decision|0
7834711|NCT01360632|12310020|FG001|Phase B (6 Weeks)|Physician Decision|0
7834712|NCT01360632|12310021|FG002|Phase B (6 Weeks)|Physician Decision|0
7834713|NCT01360632|12310022|FG003|Phase B (6 Weeks)|Physician Decision|1
7834714|NCT01360632|12310023|FG004|Phase B (6 Weeks)|Physician Decision|0
7834715|NCT01360632|12310019|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0
7834716|NCT01360632|12310020|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4
7834717|NCT01360632|12310021|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4
7834718|NCT01360632|12310022|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7
7834719|NCT01360632|12310023|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0
7834720|NCT01360632|12310019|FG000|Phase B (6 Weeks)|Protocol Deviation|0
7834721|NCT01360632|12310020|FG001|Phase B (6 Weeks)|Protocol Deviation|1
7834722|NCT01360632|12310021|FG002|Phase B (6 Weeks)|Protocol Deviation|4
7834723|NCT01360632|12310022|FG003|Phase B (6 Weeks)|Protocol Deviation|1
7834724|NCT01360632|12310023|FG004|Phase B (6 Weeks)|Protocol Deviation|0
7834725|NCT01360632|12310019|FG000|Phase B (6 Weeks)|Lack of Efficacy|0
7834726|NCT01360632|12310020|FG001|Phase B (6 Weeks)|Lack of Efficacy|1
7834727|NCT01360632|12310021|FG002|Phase B (6 Weeks)|Lack of Efficacy|0
7834728|NCT01360632|12310022|FG003|Phase B (6 Weeks)|Lack of Efficacy|0
7834729|NCT01360632|12310023|FG004|Phase B (6 Weeks)|Lack of Efficacy|0
7834730|NCT01360632|12310019|FG000|Phase A+|Lost to Follow-up|0
7834731|NCT01360632|12310020|FG001|Phase A+|Lost to Follow-up|0
7834732|NCT01360632|12310021|FG002|Phase A+|Lost to Follow-up|0
7834733|NCT01360632|12310022|FG003|Phase A+|Lost to Follow-up|0
7834734|NCT01360632|12310023|FG004|Phase A+|Lost to Follow-up|2
7834735|NCT01360632|12310019|FG000|Phase A+|Adverse Event|0
7834736|NCT01360632|12310020|FG001|Phase A+|Adverse Event|0
7834737|NCT01360632|12310021|FG002|Phase A+|Adverse Event|0
7834738|NCT01360632|12310022|FG003|Phase A+|Adverse Event|0
7834739|NCT01360632|12310023|FG004|Phase A+|Adverse Event|2
7834740|NCT01360632|12310019|FG000|Phase A+|Met Withdrawal Criteria|0
7834741|NCT01360632|12310020|FG001|Phase A+|Met Withdrawal Criteria|0
7834742|NCT01360632|12310021|FG002|Phase A+|Met Withdrawal Criteria|0
7834743|NCT01360632|12310022|FG003|Phase A+|Met Withdrawal Criteria|0
7834744|NCT01360632|12310023|FG004|Phase A+|Met Withdrawal Criteria|7
7834745|NCT01360632|12310019|FG000|Phase A+|Physician Decision|0
7834746|NCT01360632|12310020|FG001|Phase A+|Physician Decision|0
7834747|NCT01360632|12310021|FG002|Phase A+|Physician Decision|0
7834748|NCT01360632|12310022|FG003|Phase A+|Physician Decision|0
7834749|NCT01360632|12310023|FG004|Phase A+|Physician Decision|3
7834750|NCT01360632|12310019|FG000|Phase A+|Withdrawal by Subject|0
7834751|NCT01360632|12310020|FG001|Phase A+|Withdrawal by Subject|0
7834752|NCT01360632|12310021|FG002|Phase A+|Withdrawal by Subject|0
7834753|NCT01360632|12310022|FG003|Phase A+|Withdrawal by Subject|0
7834754|NCT01360632|12310023|FG004|Phase A+|Withdrawal by Subject|8
7834755|NCT01360632|12310019|FG000|Phase A+|Protocol Deviation|0
7834756|NCT01360632|12310020|FG001|Phase A+|Protocol Deviation|0
7834757|NCT01360632|12310021|FG002|Phase A+|Protocol Deviation|0
7834758|NCT01360632|12310022|FG003|Phase A+|Protocol Deviation|0
7834759|NCT01360632|12310023|FG004|Phase A+|Protocol Deviation|3
7834760|NCT01360645|12310033|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
7834761|NCT01360645|12310034|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
7834762|NCT01360645|12310035|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
7834763|NCT01360645|12310036|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
7834764|NCT01360645|12310033|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
7834765|NCT01360645|12310034|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
7834766|NCT01360645|12310035|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
7834767|NCT01360645|12310036|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
7834768|NCT01360645|12310033|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
7834769|NCT01360645|12310034|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
7834770|NCT01360645|12310035|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
7834771|NCT01360645|12310036|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
7834772|NCT01360645|12310033|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
7834773|NCT01360645|12310034|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
7834774|NCT01360645|12310035|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
7834775|NCT01360645|12310036|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
7834776|NCT01360645|12310033|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
7834777|NCT01360645|12310034|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
7834778|NCT01360645|12310035|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
7834779|NCT01360645|12310036|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
7834780|NCT01360645|12310033|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
7834781|NCT01360645|12310034|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
7834782|NCT01360645|12310035|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
7834783|NCT01360645|12310036|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
7834784|NCT01360645|12310033|FG000|Phase B (6 Weeks)|Lost to Follow-up|0
7834785|NCT01360645|12310034|FG001|Phase B (6 Weeks)|Lost to Follow-up|1
7834786|NCT01360645|12310035|FG002|Phase B (6 Weeks)|Lost to Follow-up|0
7834787|NCT01360645|12310036|FG003|Phase B (6 Weeks)|Lost to Follow-up|0
7834788|NCT01360645|12310033|FG000|Phase B (6 Weeks)|Adverse Event|0
7834789|NCT01360645|12310034|FG001|Phase B (6 Weeks)|Adverse Event|6
7834790|NCT01360645|12310035|FG002|Phase B (6 Weeks)|Adverse Event|0
7834791|NCT01360645|12310036|FG003|Phase B (6 Weeks)|Adverse Event|0
7834792|NCT01360645|12310033|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0
7834793|NCT01360645|12310034|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3
7948641|NCT02529995|12493822|FG001|Part B|Ongoing Study at Data Cut-off|7
7948642|NCT02529995|12493821|FG000|Part B|Discontinued Study|6
7948643|NCT02529995|12493822|FG001|Part B|Discontinued Study|5
7948644|NCT02530125|12493828|FG000|Completed Treatment|Early termination of study|1
7948645|NCT02530125|12493828|FG000|Followed for Survival for 2 Years|Early termination of study|3
7948646|NCT02530242|12493843|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0
7948647|NCT02530242|12493844|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1
7948648|NCT02530385|12493872|FG000|Overall Study|Withdrawal by Subject|0
7834794|NCT01360645|12310035|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2
7834795|NCT01360645|12310036|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0
7834796|NCT01360645|12310033|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0
7834797|NCT01360645|12310034|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3
7834798|NCT01360645|12310035|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8
7834799|NCT01360645|12310036|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0
7834800|NCT01360645|12310033|FG000|Phase B (6 Weeks)|Protocol Deviation|0
7834801|NCT01360645|12310034|FG001|Phase B (6 Weeks)|Protocol Deviation|1
7834802|NCT01360645|12310035|FG002|Phase B (6 Weeks)|Protocol Deviation|3
7834803|NCT01360645|12310036|FG003|Phase B (6 Weeks)|Protocol Deviation|0
7834804|NCT01360645|12310033|FG000|Phase A+|Lost to Follow-up|0
7834805|NCT01360645|12310034|FG001|Phase A+|Lost to Follow-up|0
7834806|NCT01360645|12310035|FG002|Phase A+|Lost to Follow-up|0
7834807|NCT01360645|12310036|FG003|Phase A+|Lost to Follow-up|7
7834808|NCT01360645|12310033|FG000|Phase A+|Adverse Event|0
7834809|NCT01360645|12310034|FG001|Phase A+|Adverse Event|0
7834810|NCT01360645|12310035|FG002|Phase A+|Adverse Event|0
7834811|NCT01360645|12310036|FG003|Phase A+|Adverse Event|2
7834812|NCT01360645|12310033|FG000|Phase A+|Met Withdrawal Criteria|0
7834813|NCT01360645|12310034|FG001|Phase A+|Met Withdrawal Criteria|0
7834814|NCT01360645|12310035|FG002|Phase A+|Met Withdrawal Criteria|0
7834815|NCT01360645|12310036|FG003|Phase A+|Met Withdrawal Criteria|4
7834816|NCT01360645|12310033|FG000|Phase A+|Physician Decision|0
7834817|NCT01360645|12310034|FG001|Phase A+|Physician Decision|0
7834818|NCT01360645|12310035|FG002|Phase A+|Physician Decision|0
7834819|NCT01360645|12310036|FG003|Phase A+|Physician Decision|2
7834820|NCT01360645|12310033|FG000|Phase A+|Withdrawal by Subject|0
7834821|NCT01360645|12310034|FG001|Phase A+|Withdrawal by Subject|0
7834822|NCT01360645|12310035|FG002|Phase A+|Withdrawal by Subject|0
7834823|NCT01360645|12310036|FG003|Phase A+|Withdrawal by Subject|5
7834824|NCT01360645|12310033|FG000|Phase A+|Protocol Deviation|0
7834825|NCT01360645|12310034|FG001|Phase A+|Protocol Deviation|0
7834826|NCT01360645|12310035|FG002|Phase A+|Protocol Deviation|0
7834827|NCT01360645|12310036|FG003|Phase A+|Protocol Deviation|4
7834828|NCT01360762|12310042|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7
7834829|NCT01360762|12310042|FG000|Main Study Period (12-month Treatment)|Death|5
7834830|NCT01360762|12310042|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1
7834831|NCT01360762|12310042|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15
7834832|NCT01360762|12310042|FG000|Main Study Period (12-month Treatment)|Discontinuation|1
7834833|NCT01360762|12310042|FG000|Whole Study Period|Lost to Follow-up|10
7834834|NCT01360762|12310042|FG000|Whole Study Period|Death|7
7834835|NCT01360762|12310042|FG000|Whole Study Period|Patient relapsed|18
7834836|NCT01360762|12310042|FG000|Whole Study Period|Discontinuation of study drug for safety|1
7834837|NCT01360840|12310049|FG000|Overall Study|Ongoing at data cut-off|10
7834838|NCT01360840|12310050|FG001|Overall Study|Ongoing at data cut-off|10
7834839|NCT01360840|12310051|FG002|Overall Study|Ongoing at data cut-off|9
7834840|NCT01360866|12310065|FG000|Overall Study|Lost to Follow-up|11
7834841|NCT01360866|12310066|FG001|Overall Study|Lost to Follow-up|28
7834842|NCT01360866|12310067|FG002|Overall Study|Lost to Follow-up|41
7834843|NCT01360866|12310068|FG003|Overall Study|Lost to Follow-up|0
7834844|NCT01360866|12310065|FG000|Overall Study|Adverse Event|56
7834845|NCT01360866|12310066|FG001|Overall Study|Adverse Event|61
7834846|NCT01360866|12310067|FG002|Overall Study|Adverse Event|134
7834847|NCT01360866|12310068|FG003|Overall Study|Adverse Event|6
7834848|NCT01360866|12310065|FG000|Overall Study|Paticipant met withdrawal criteria|11
7834849|NCT01360866|12310066|FG001|Overall Study|Paticipant met withdrawal criteria|28
7834850|NCT01360866|12310067|FG002|Overall Study|Paticipant met withdrawal criteria|54
7834851|NCT01360866|12310068|FG003|Overall Study|Paticipant met withdrawal criteria|0
7834852|NCT01360866|12310065|FG000|Overall Study|Withdrawn by Investigator|9
7834853|NCT01360866|12310066|FG001|Overall Study|Withdrawn by Investigator|8
7834854|NCT01360866|12310067|FG002|Overall Study|Withdrawn by Investigator|31
7834855|NCT01360866|12310068|FG003|Overall Study|Withdrawn by Investigator|2
7834856|NCT01360866|12310065|FG000|Overall Study|Withdrawal by participant|79
7834857|NCT01360866|12310066|FG001|Overall Study|Withdrawal by participant|89
7834858|NCT01360866|12310067|FG002|Overall Study|Withdrawal by participant|168
7834859|NCT01360866|12310068|FG003|Overall Study|Withdrawal by participant|8
7834860|NCT01360866|12310065|FG000|Overall Study|Protocol Deviation|25
7834861|NCT01360866|12310066|FG001|Overall Study|Protocol Deviation|33
7834862|NCT01360866|12310067|FG002|Overall Study|Protocol Deviation|61
7834863|NCT01360866|12310068|FG003|Overall Study|Protocol Deviation|2
7834864|NCT01360866|12310065|FG000|Overall Study|Lack of Efficacy|30
7834865|NCT01360866|12310066|FG001|Overall Study|Lack of Efficacy|40
7834866|NCT01360866|12310067|FG002|Overall Study|Lack of Efficacy|30
7834867|NCT01360866|12310068|FG003|Overall Study|Lack of Efficacy|4
7834868|NCT01360996|12310081|FG000|Overall Study|Withdrawal by Subject|4
7834869|NCT01360996|12310082|FG001|Overall Study|Withdrawal by Subject|3
7834870|NCT01360996|12310083|FG002|Overall Study|Withdrawal by Subject|2
7834871|NCT01360996|12310081|FG000|Overall Study|Noncompliant|2
7834872|NCT01360996|12310082|FG001|Overall Study|Noncompliant|0
7834873|NCT01360996|12310083|FG002|Overall Study|Noncompliant|0
7834874|NCT01361009|12310090|FG000|Overall Study|Protocol Violation|116
7834875|NCT01361126|12310118|FG000|Overall Study|Sponsor decision|0
7834876|NCT01361126|12310119|FG001|Overall Study|Sponsor decision|2
7834877|NCT01361178|12310128|FG000|Overall Study|Death|13
7834878|NCT01361178|12310129|FG001|Overall Study|Death|0
7834879|NCT01361308|12310143|FG000|Overall Study|Withdrawal by Subject|9
7834880|NCT01361308|12310144|FG001|Overall Study|Withdrawal by Subject|13
7834881|NCT01361308|12310143|FG000|Overall Study|Physician Decision|3
7834882|NCT01361308|12310144|FG001|Overall Study|Physician Decision|3
7834883|NCT01361308|12310143|FG000|Overall Study|Lack of Efficacy|2
7834884|NCT01361308|12310144|FG001|Overall Study|Lack of Efficacy|0
7834885|NCT01361308|12310143|FG000|Overall Study|Protocol Violation|1
7834886|NCT01361308|12310144|FG001|Overall Study|Protocol Violation|0
7834887|NCT01361308|12310143|FG000|Overall Study|Lost to Follow-up|5
7834888|NCT01361308|12310144|FG001|Overall Study|Lost to Follow-up|4
7834889|NCT01361308|12310143|FG000|Overall Study|Adverse Event|8
7834890|NCT01361308|12310144|FG001|Overall Study|Adverse Event|4
7834891|NCT01361308|12310143|FG000|Overall Study|Eligibility Criteria Not Met|2
7834892|NCT01361308|12310144|FG001|Overall Study|Eligibility Criteria Not Met|3
7834893|NCT01361308|12310143|FG000|Overall Study|Failed C-SSRS|5
7834894|NCT01361308|12310144|FG001|Overall Study|Failed C-SSRS|2
7834895|NCT01361308|12310143|FG000|Overall Study|Other|0
7834896|NCT01361308|12310144|FG001|Overall Study|Other|1
7834897|NCT01361464|12310150|FG000|Overall Study|Death|1
7834898|NCT01361464|12310150|FG000|Overall Study|Withdrawal by Subject|2
7834899|NCT01361568|12310160|FG000|Overall Study|Adverse Event|0
7834900|NCT01361568|12310161|FG001|Overall Study|Adverse Event|0
7834901|NCT01361568|12310162|FG002|Overall Study|Adverse Event|0
7834902|NCT01361568|12310163|FG003|Overall Study|Adverse Event|0
7834903|NCT01361568|12310164|FG004|Overall Study|Adverse Event|1
7834904|NCT01361568|12310165|FG005|Overall Study|Adverse Event|0
7834905|NCT01361568|12310160|FG000|Overall Study|Physician Decision|0
7834906|NCT01361568|12310161|FG001|Overall Study|Physician Decision|0
7834907|NCT01361568|12310162|FG002|Overall Study|Physician Decision|0
7834908|NCT01361568|12310163|FG003|Overall Study|Physician Decision|0
7834909|NCT01361568|12310164|FG004|Overall Study|Physician Decision|0
7834910|NCT01361568|12310165|FG005|Overall Study|Physician Decision|1
7834911|NCT01361568|12310160|FG000|Overall Study|Withdrawal by Subject|2
7834912|NCT01361568|12310161|FG001|Overall Study|Withdrawal by Subject|1
7834913|NCT01361568|12310162|FG002|Overall Study|Withdrawal by Subject|0
7834914|NCT01361568|12310163|FG003|Overall Study|Withdrawal by Subject|0
7834915|NCT01361568|12310164|FG004|Overall Study|Withdrawal by Subject|0
7834916|NCT01361568|12310165|FG005|Overall Study|Withdrawal by Subject|1
7834917|NCT01361594|12310182|FG000|Overall Study|Withdrawal by Subject|1
7834918|NCT01361594|12310183|FG001|Overall Study|Withdrawal by Subject|2
7834919|NCT01361607|12310191|FG000|Overall Study|Adverse Event|38
7834920|NCT01361607|12310192|FG001|Overall Study|Adverse Event|29
7834921|NCT01361607|12310191|FG000|Overall Study|Withdrawal by Subject|19
7834922|NCT01361607|12310192|FG001|Overall Study|Withdrawal by Subject|8
7834923|NCT01361607|12310191|FG000|Overall Study|Withdrawal by Investigator|5
7834924|NCT01361607|12310192|FG001|Overall Study|Withdrawal by Investigator|3
7834925|NCT01361607|12310191|FG000|Overall Study|Lost to Follow-up|1
7834926|NCT01361607|12310192|FG001|Overall Study|Lost to Follow-up|0
7834927|NCT01361607|12310191|FG000|Overall Study|Met Withdrawal Criteria|1
7834928|NCT01361607|12310192|FG001|Overall Study|Met Withdrawal Criteria|1
7834929|NCT01361711|12310214|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1
7834930|NCT01361711|12310214|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1
7834931|NCT01361711|12310214|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7
7834932|NCT01361711|12310214|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2
7834933|NCT01361711|12310214|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1
7834934|NCT01361711|12310214|FG000|Completed Week 18 of Treatment|Complete Remission|2
7834935|NCT01361711|12310214|FG000|Completed Week 18 of Treatment|Other|9
7834936|NCT01361711|12310214|FG000|10 Year Follow-up|Still in follow-up|22
7834937|NCT01361711|12310214|FG000|10 Year Follow-up|Death|7
7834938|NCT01361711|12310214|FG000|10 Year Follow-up|Developed new cancer|1
7834939|NCT01361711|12310214|FG000|10 Year Follow-up|Lost to Follow-up|2
7834940|NCT01361711|12310214|FG000|10 Year Follow-up|New treatment started|6
7834941|NCT01361711|12310214|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11
7834942|NCT01361711|12310214|FG000|10 Year Follow-up|Progressive Disease|1
7834943|NCT01361919|12310232|FG000|Overall Study|technical issues|10
7834944|NCT01361919|12310233|FG001|Overall Study|technical issues|12
7834945|NCT01361919|12310234|FG002|Overall Study|technical issues|10
7834946|NCT01362049|12310246|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3
7834947|NCT01362049|12310247|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3
7834948|NCT01362049|12310248|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2
7834949|NCT01362049|12310249|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1
7834950|NCT01362049|12310246|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
7834951|NCT01362049|12310247|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
7834952|NCT01362049|12310248|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
7834953|NCT01362049|12310249|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
7834954|NCT01362062|12310265|FG000|Overall Study|Adverse Event|1
7834955|NCT01362062|12310266|FG001|Overall Study|Adverse Event|0
7834956|NCT01362062|12310265|FG000|Overall Study|Lost to Follow-up|11
7834957|NCT01362062|12310266|FG001|Overall Study|Lost to Follow-up|0
7834958|NCT01362062|12310265|FG000|Overall Study|Withdrawal by Subject|2
7834959|NCT01362062|12310266|FG001|Overall Study|Withdrawal by Subject|0
7834960|NCT01362062|12310265|FG000|Overall Study|Non-compliant participant|2
7834961|NCT01362062|12310266|FG001|Overall Study|Non-compliant participant|0
7834962|NCT01362062|12310265|FG000|Overall Study|Detected with Spondylo-arthritis|1
7834963|NCT01362062|12310266|FG001|Overall Study|Detected with Spondylo-arthritis|0
7834964|NCT01362062|12310265|FG000|Overall Study|Had significant improvement|9
7834965|NCT01362062|12310266|FG001|Overall Study|Had significant improvement|0
7834966|NCT01362140|12310282|FG000|Overall Study|Noncompliance|1
7834967|NCT01362140|12310283|FG001|Overall Study|Noncompliance|0
7834968|NCT01362140|12310282|FG000|Overall Study|Adverse Event|2
7834969|NCT01362140|12310283|FG001|Overall Study|Adverse Event|2
7834970|NCT01362140|12310282|FG000|Overall Study|Withdrawal by Subject|3
7834971|NCT01362140|12310283|FG001|Overall Study|Withdrawal by Subject|3
7834972|NCT01362140|12310282|FG000|Overall Study|Administrative Decision|0
7834973|NCT01362140|12310283|FG001|Overall Study|Administrative Decision|1
7834974|NCT01362140|12310282|FG000|Overall Study|Death|2
7834975|NCT01362140|12310283|FG001|Overall Study|Death|1
7834976|NCT01362140|12310282|FG000|Overall Study|Other|1
7834977|NCT01362140|12310283|FG001|Overall Study|Other|1
7834978|NCT01362140|12310282|FG000|Overall Study|Protocol-specified Criteria|1
7834979|NCT01362140|12310283|FG001|Overall Study|Protocol-specified Criteria|2
7834980|NCT01362140|12310282|FG000|Overall Study|Discontinued Without Receiving Treatment|0
7834981|NCT01362140|12310283|FG001|Overall Study|Discontinued Without Receiving Treatment|1
7834982|NCT01362244|12310304|FG000|Overall Study|Adverse Event|3
7834983|NCT01362244|12310305|FG001|Overall Study|Adverse Event|5
7834984|NCT01362244|12310304|FG000|Overall Study|Lack of Efficacy|5
7834985|NCT01362244|12310305|FG001|Overall Study|Lack of Efficacy|11
7834986|NCT01362244|12310304|FG000|Overall Study|Lost to Follow-up|0
7834987|NCT01362244|12310305|FG001|Overall Study|Lost to Follow-up|2
7834988|NCT01362244|12310304|FG000|Overall Study|Protocol Violation|5
7834989|NCT01362244|12310305|FG001|Overall Study|Protocol Violation|1
7834990|NCT01362244|12310304|FG000|Overall Study|Withdrawal by Subject|2
7834991|NCT01362244|12310305|FG001|Overall Study|Withdrawal by Subject|1
7834992|NCT01362244|12310304|FG000|Overall Study|Did not Meet Continuation Criteria|17
7834993|NCT01362244|12310305|FG001|Overall Study|Did not Meet Continuation Criteria|11
7834994|NCT01362244|12310304|FG000|Overall Study|Protocol Defined Stopping Criteria|0
7834995|NCT01362244|12310305|FG001|Overall Study|Protocol Defined Stopping Criteria|1
7834996|NCT01362270|12310313|FG000|Overall Study|Withdrawal by Subject|1
7834997|NCT01362270|12310314|FG001|Overall Study|Withdrawal by Subject|0
7834998|NCT01362270|12310313|FG000|Overall Study|Met exclusion criteria after 1st session|0
7834999|NCT01362270|12310314|FG001|Overall Study|Met exclusion criteria after 1st session|1
7835000|NCT01362270|12310313|FG000|Overall Study|Met excl. criteria before 1st session|1
7835001|NCT01362270|12310314|FG001|Overall Study|Met excl. criteria before 1st session|1
7835002|NCT01362296|12310322|FG000|Randomized Phase (RP)|PD including Death due to PD|56
7835003|NCT01362296|12310323|FG001|Randomized Phase (RP)|PD including Death due to PD|28
7835004|NCT01362296|12310324|FG002|Randomized Phase (RP)|PD including Death due to PD|0
7835005|NCT01362296|12310325|FG003|Randomized Phase (RP)|PD including Death due to PD|0
7835006|NCT01362296|12310322|FG000|Randomized Phase (RP)|Physician Decision|1
7835007|NCT01362296|12310323|FG001|Randomized Phase (RP)|Physician Decision|9
7835008|NCT01362296|12310324|FG002|Randomized Phase (RP)|Physician Decision|0
7835009|NCT01362296|12310325|FG003|Randomized Phase (RP)|Physician Decision|0
7835010|NCT01362296|12310322|FG000|Randomized Phase (RP)|Withdrawal by Subject|2
7835011|NCT01362296|12310323|FG001|Randomized Phase (RP)|Withdrawal by Subject|1
7835012|NCT01362296|12310324|FG002|Randomized Phase (RP)|Withdrawal by Subject|0
7835013|NCT01362296|12310325|FG003|Randomized Phase (RP)|Withdrawal by Subject|0
7835014|NCT01362296|12310322|FG000|Randomized Phase (RP)|Adverse Event|20
7835015|NCT01362296|12310323|FG001|Randomized Phase (RP)|Adverse Event|4
7835016|NCT01362296|12310324|FG002|Randomized Phase (RP)|Adverse Event|0
7835017|NCT01362296|12310325|FG003|Randomized Phase (RP)|Adverse Event|0
7835018|NCT01362296|12310322|FG000|Randomized Phase (RP)|Study Closed/Terminated|8
7835019|NCT01362296|12310323|FG001|Randomized Phase (RP)|Study Closed/Terminated|1
7835020|NCT01362296|12310324|FG002|Randomized Phase (RP)|Study Closed/Terminated|0
7835021|NCT01362296|12310325|FG003|Randomized Phase (RP)|Study Closed/Terminated|0
7835022|NCT01362296|12310322|FG000|Crossover Phase|PD including Death due to PD|0
7835023|NCT01362296|12310323|FG001|Crossover Phase|PD including Death due to PD|0
7835024|NCT01362296|12310324|FG002|Crossover Phase|PD including Death due to PD|16
7835025|NCT01362296|12310325|FG003|Crossover Phase|PD including Death due to PD|1
7835026|NCT01362296|12310322|FG000|Crossover Phase|Withdrawal by Subject|0
7835027|NCT01362296|12310323|FG001|Crossover Phase|Withdrawal by Subject|0
7835028|NCT01362296|12310324|FG002|Crossover Phase|Withdrawal by Subject|2
7835029|NCT01362296|12310325|FG003|Crossover Phase|Withdrawal by Subject|1
7835030|NCT01362296|12310322|FG000|Crossover Phase|Adverse Event|0
7835031|NCT01362296|12310323|FG001|Crossover Phase|Adverse Event|0
7835032|NCT01362296|12310324|FG002|Crossover Phase|Adverse Event|4
7835033|NCT01362296|12310325|FG003|Crossover Phase|Adverse Event|0
7835034|NCT01362296|12310322|FG000|Crossover Phase|Study Closed/Terminated|0
7835035|NCT01362296|12310323|FG001|Crossover Phase|Study Closed/Terminated|0
7835036|NCT01362296|12310324|FG002|Crossover Phase|Study Closed/Terminated|1
7835037|NCT01362296|12310325|FG003|Crossover Phase|Study Closed/Terminated|0
7835038|NCT01362322|12310337|FG000|Overall Study|Withdrawal by Subject|3
7835039|NCT01362322|12310338|FG001|Overall Study|Withdrawal by Subject|1
7835040|NCT01362322|12310337|FG000|Overall Study|Lost to Follow-up|2
7835041|NCT01362322|12310338|FG001|Overall Study|Lost to Follow-up|6
7835042|NCT01362348|12310344|FG000|Overall Study|Protocol-defined stopping criteria|9
7835043|NCT01362348|12310344|FG000|Overall Study|Study closed/terminated|5
7835044|NCT01362439|12310348|FG000|Overall Study|Adverse Event|1
7835045|NCT01362439|12310348|FG000|Overall Study|Lack of Efficacy|3
7835046|NCT01362439|12310348|FG000|Overall Study|Lost to Follow-up|2
7835047|NCT01362439|12310348|FG000|Overall Study|Study medication non-compliant|1
7835048|NCT01362439|12310348|FG000|Overall Study|Participant who withdrew consent|8
7835049|NCT01362491|12310356|FG000|Overall Study|Ineligible|1
7835050|NCT01362491|12310357|FG001|Overall Study|Ineligible|0
7835051|NCT01362491|12310358|FG002|Overall Study|Ineligible|0
7835052|NCT01362517|12310367|FG000|Overall Study|Protocol Violation|1
7835053|NCT01362517|12310367|FG000|Overall Study|Lost to Follow-up|1
7835054|NCT01362530|12310376|FG000|Base Study (Cycle 1)|Adverse Event|2
7835055|NCT01362530|12310377|FG001|Base Study (Cycle 1)|Adverse Event|0
7835056|NCT01362530|12310376|FG000|Base Study (Cycle 1)|Physician Decision|0
7835057|NCT01362530|12310377|FG001|Base Study (Cycle 1)|Physician Decision|1
7835058|NCT01362530|12310376|FG000|Base Study (Cycle 1)|Protocol Violation|2
7835059|NCT01362530|12310377|FG001|Base Study (Cycle 1)|Protocol Violation|0
7835060|NCT01362530|12310376|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1
7835061|NCT01362530|12310377|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2
7835062|NCT01362530|12310376|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2
7835063|NCT01362530|12310377|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0
7835064|NCT01362530|12310376|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
7835065|NCT01362530|12310377|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
7835066|NCT01362530|12310376|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
7835067|NCT01362530|12310377|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
7835068|NCT01362530|12310376|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
7835069|NCT01362530|12310377|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
7835070|NCT01362530|12310376|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
7835071|NCT01362530|12310377|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
7835072|NCT01362530|12310376|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
7835073|NCT01362530|12310377|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
7835074|NCT01362530|12310376|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19
7835075|NCT01362530|12310377|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0
7835076|NCT01362530|12310376|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4
7835077|NCT01362530|12310377|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0
7835078|NCT01362530|12310376|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
7835079|NCT01362530|12310377|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
7835080|NCT01362608|12310386|FG000|Overall Study|Protocol Violation|0
7835081|NCT01362608|12310387|FG001|Overall Study|Protocol Violation|1
7835082|NCT01362608|12310386|FG000|Overall Study|Lost to Follow-up|3
7835083|NCT01362608|12310387|FG001|Overall Study|Lost to Follow-up|1
7835084|NCT01362608|12310386|FG000|Overall Study|Withdrawal by Subject|1
7835085|NCT01362608|12310387|FG001|Overall Study|Withdrawal by Subject|2
7835086|NCT01362608|12310386|FG000|Overall Study|Lack of Efficacy|0
7835087|NCT01362608|12310387|FG001|Overall Study|Lack of Efficacy|2
7835088|NCT01362608|12310386|FG000|Overall Study|Adverse Event|0
7835089|NCT01362608|12310387|FG001|Overall Study|Adverse Event|2
7835090|NCT01362790|12310412|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1
7835091|NCT01362790|12310413|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7835092|NCT01362790|12310414|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7835093|NCT01362790|12310415|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7835094|NCT01362790|12310416|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7835095|NCT01362790|12310417|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7835096|NCT01362790|12310418|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7835097|NCT01362790|12310412|FG000|Pilot Phase & Phase 2|Adverse Event|0
7835098|NCT01362790|12310413|FG001|Pilot Phase & Phase 2|Adverse Event|1
7835099|NCT01362790|12310414|FG002|Pilot Phase & Phase 2|Adverse Event|0
7835100|NCT01362790|12310415|FG003|Pilot Phase & Phase 2|Adverse Event|1
7835101|NCT01362790|12310416|FG004|Pilot Phase & Phase 2|Adverse Event|0
7835102|NCT01362790|12310417|FG005|Pilot Phase & Phase 2|Adverse Event|2
7835103|NCT01362790|12310418|FG006|Pilot Phase & Phase 2|Adverse Event|0
7835104|NCT01362790|12310412|FG000|Pilot Phase & Phase 2|Physician Decision|0
7835105|NCT01362790|12310413|FG001|Pilot Phase & Phase 2|Physician Decision|0
7835106|NCT01362790|12310414|FG002|Pilot Phase & Phase 2|Physician Decision|0
7835107|NCT01362790|12310415|FG003|Pilot Phase & Phase 2|Physician Decision|1
7835108|NCT01362790|12310416|FG004|Pilot Phase & Phase 2|Physician Decision|0
7835109|NCT01362790|12310417|FG005|Pilot Phase & Phase 2|Physician Decision|0
7835110|NCT01362790|12310418|FG006|Pilot Phase & Phase 2|Physician Decision|0
7835111|NCT01362790|12310412|FG000|Pilot Phase & Phase 2|Developed antibodies|7
7835112|NCT01362790|12310413|FG001|Pilot Phase & Phase 2|Developed antibodies|2
7948649|NCT02530385|12493873|FG001|Overall Study|Withdrawal by Subject|1
7835113|NCT01362790|12310414|FG002|Pilot Phase & Phase 2|Developed antibodies|3
7835114|NCT01362790|12310415|FG003|Pilot Phase & Phase 2|Developed antibodies|8
7835115|NCT01362790|12310416|FG004|Pilot Phase & Phase 2|Developed antibodies|0
7835116|NCT01362790|12310417|FG005|Pilot Phase & Phase 2|Developed antibodies|0
7835117|NCT01362790|12310418|FG006|Pilot Phase & Phase 2|Developed antibodies|0
7835118|NCT01362790|12310412|FG000|Pilot Phase & Phase 2|Refused further treatment|0
7835119|NCT01362790|12310413|FG001|Pilot Phase & Phase 2|Refused further treatment|1
7835120|NCT01362790|12310414|FG002|Pilot Phase & Phase 2|Refused further treatment|0
7835121|NCT01362790|12310415|FG003|Pilot Phase & Phase 2|Refused further treatment|0
7948650|NCT02530619|12493963|FG000|Registered for Study|Withdrawal by Subject|2
7948651|NCT02530619|12493963|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2
7948652|NCT02530619|12493963|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2
7948653|NCT02530619|12493963|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4
7948654|NCT02530619|12493963|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2
7948655|NCT02530619|12493963|FG000|Follow-up Period (6 Months)|Death|4
7948656|NCT02530619|12493963|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2
7948657|NCT02530619|12493963|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5
7948658|NCT02530671|12493969|FG000|Overall Study|Lost to Follow-up|2
7948659|NCT02530671|12493970|FG001|Overall Study|Lost to Follow-up|0
7948660|NCT02530671|12493969|FG000|Overall Study|Withdrawal by Subject|1
7948661|NCT02530671|12493970|FG001|Overall Study|Withdrawal by Subject|0
7948662|NCT02530905|12493978|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0
7948663|NCT02530905|12493979|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0
7948664|NCT02530905|12493980|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1
7835122|NCT01362790|12310416|FG004|Pilot Phase & Phase 2|Refused further treatment|0
7835123|NCT01362790|12310417|FG005|Pilot Phase & Phase 2|Refused further treatment|0
7835124|NCT01362790|12310418|FG006|Pilot Phase & Phase 2|Refused further treatment|0
7835125|NCT01362790|12310412|FG000|Pilot Phase & Phase 2|Progressive disease|1
7835126|NCT01362790|12310413|FG001|Pilot Phase & Phase 2|Progressive disease|2
7835127|NCT01362790|12310414|FG002|Pilot Phase & Phase 2|Progressive disease|2
7835128|NCT01362790|12310415|FG003|Pilot Phase & Phase 2|Progressive disease|3
7835129|NCT01362790|12310416|FG004|Pilot Phase & Phase 2|Progressive disease|0
7835130|NCT01362790|12310417|FG005|Pilot Phase & Phase 2|Progressive disease|2
7835131|NCT01362790|12310418|FG006|Pilot Phase & Phase 2|Progressive disease|0
7835132|NCT01362790|12310412|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1
7835133|NCT01362790|12310413|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7835134|NCT01362790|12310414|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7835135|NCT01362790|12310415|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7835136|NCT01362790|12310416|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7835137|NCT01362790|12310417|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7835138|NCT01362790|12310418|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7835139|NCT01362790|12310412|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7835140|NCT01362790|12310413|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2
7835141|NCT01362790|12310414|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7835142|NCT01362790|12310415|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7835143|NCT01362790|12310416|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7835144|NCT01362790|12310417|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7835145|NCT01362790|12310418|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7835146|NCT01362790|12310412|FG000|Pilot Phase & Phase 2|Death on study|0
7835147|NCT01362790|12310413|FG001|Pilot Phase & Phase 2|Death on study|0
7835148|NCT01362790|12310414|FG002|Pilot Phase & Phase 2|Death on study|0
7835149|NCT01362790|12310415|FG003|Pilot Phase & Phase 2|Death on study|1
7835150|NCT01362790|12310416|FG004|Pilot Phase & Phase 2|Death on study|0
7835151|NCT01362790|12310417|FG005|Pilot Phase & Phase 2|Death on study|0
7835152|NCT01362790|12310418|FG006|Pilot Phase & Phase 2|Death on study|0
7835153|NCT01362790|12310412|FG000|Dose De-escalation of Regimen A|Adverse Event|0
7835154|NCT01362790|12310413|FG001|Dose De-escalation of Regimen A|Adverse Event|0
7720104|NCT00536510|12144361|FG000|Overall Study|Patient Discontinued for Other Reasons|2
7720105|NCT00536510|12144362|FG001|Overall Study|Patient Discontinued for Other Reasons|2
7720106|NCT00536575|12144368|FG000|Overall Study|Withdrawal by Subject|1
7720107|NCT00536575|12144368|FG000|Overall Study|Death|1
7767846|NCT00856284|12210625|FG001|Overall Study|Investigator discretion|8
7767847|NCT00856284|12210626|FG002|Overall Study|Investigator discretion|10
7767848|NCT00856284|12210624|FG000|Overall Study|Other|15
7767849|NCT00856284|12210625|FG001|Overall Study|Other|17
7767850|NCT00856284|12210626|FG002|Overall Study|Other|14
7767851|NCT00856284|12210624|FG000|Overall Study|Randomized in error|0
7767852|NCT00856284|12210625|FG001|Overall Study|Randomized in error|0
7767853|NCT00856284|12210626|FG002|Overall Study|Randomized in error|1
7767854|NCT00856297|12210639|FG000|Overall Study|Unable to classify|2
7767855|NCT00856297|12210640|FG001|Overall Study|Unable to classify|0
7767856|NCT00856297|12210641|FG002|Overall Study|Unable to classify|0
7767857|NCT00856297|12210642|FG003|Overall Study|Unable to classify|0
7767858|NCT00856297|12210643|FG004|Overall Study|Unable to classify|0
7767859|NCT00856323|12210660|FG000|Overall Study|Withdrawal by Subject|2
7767860|NCT00856349|12210664|FG000|Overall Study|Death|418
7767861|NCT00856349|12210664|FG000|Overall Study|Withdrawal by Subject|116
7767862|NCT00856349|12210664|FG000|Overall Study|Lost to Follow-up|91
7767863|NCT00856349|12210664|FG000|Overall Study|Protocol Violation|38
7767864|NCT00856349|12210664|FG000|Overall Study|Physician Decision|13
7767865|NCT00856349|12210664|FG000|Overall Study|Subject relocation|104
7767866|NCT00856349|12210664|FG000|Overall Study|Device explant|33
7767867|NCT00856349|12210664|FG000|Overall Study|Site closure|78
7767868|NCT00856349|12210664|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130
7767869|NCT00856375|12210672|FG000|Overall Study|Other|0
7767870|NCT00856375|12210673|FG001|Overall Study|Other|1
7767871|NCT00856375|12210672|FG000|Overall Study|Death|32
7767872|NCT00856375|12210673|FG001|Overall Study|Death|30
7767873|NCT00856375|12210672|FG000|Overall Study|Sponsor Terminated Study|7
7767874|NCT00856375|12210673|FG001|Overall Study|Sponsor Terminated Study|7
7767875|NCT00856375|12210672|FG000|Overall Study|Withdrawal by Subject|2
7767876|NCT00856375|12210673|FG001|Overall Study|Withdrawal by Subject|1
7720108|NCT00536731|12144396|FG000|Overall Study|Adverse Event|3
7720109|NCT00536731|12144397|FG001|Overall Study|Adverse Event|2
7720110|NCT00536731|12144398|FG002|Overall Study|Adverse Event|3
7720111|NCT00536731|12144396|FG000|Overall Study|Withdrawal by Subject|0
7720112|NCT00536731|12144397|FG001|Overall Study|Withdrawal by Subject|2
7720113|NCT00536731|12144398|FG002|Overall Study|Withdrawal by Subject|0
7720114|NCT00536731|12144396|FG000|Overall Study|Intake of prohibited conc. medication|0
7720115|NCT00536731|12144397|FG001|Overall Study|Intake of prohibited conc. medication|0
7720116|NCT00536731|12144398|FG002|Overall Study|Intake of prohibited conc. medication|1
7720117|NCT00536731|12144396|FG000|Overall Study|Safety reasons|0
7720118|NCT00536731|12144397|FG001|Overall Study|Safety reasons|0
7720119|NCT00536731|12144398|FG002|Overall Study|Safety reasons|1
7720120|NCT00536731|12144396|FG000|Overall Study|Other|1
7720121|NCT00536731|12144397|FG001|Overall Study|Other|1
7948665|NCT02530970|12494002|FG000|Overall Study|Adverse Event|8
7720122|NCT00536731|12144398|FG002|Overall Study|Other|0
7720123|NCT00536744|12144408|FG000|Overall Study|Adverse Event|13
7720124|NCT00536744|12144409|FG001|Overall Study|Adverse Event|10
7720125|NCT00536744|12144408|FG000|Overall Study|Death|2
7720126|NCT00536744|12144409|FG001|Overall Study|Death|1
7720127|NCT00536744|12144408|FG000|Overall Study|Physician Decision|3
7720128|NCT00536744|12144409|FG001|Overall Study|Physician Decision|1
7720129|NCT00536744|12144408|FG000|Overall Study|Lost to Follow-up|3
7720130|NCT00536744|12144409|FG001|Overall Study|Lost to Follow-up|5
7720131|NCT00536744|12144408|FG000|Overall Study|Withdrawal by Subject|7
7720132|NCT00536744|12144409|FG001|Overall Study|Withdrawal by Subject|8
7720133|NCT00536744|12144408|FG000|Overall Study|PI tried alternative treatment|1
7720134|NCT00536744|12144409|FG001|Overall Study|PI tried alternative treatment|3
7720135|NCT00536809|12144415|FG000|Phase II|Adverse Event|1
7720136|NCT00536809|12144415|FG000|Phase II|Referred for surgical resection|1
7720137|NCT00536874|12144419|FG000|Overall Study|Adverse Event|1
7720138|NCT00536874|12144419|FG000|Overall Study|Death|2
7720139|NCT00536874|12144419|FG000|Overall Study|Withdrawal by Subject|1
7835155|NCT01362790|12310414|FG002|Dose De-escalation of Regimen A|Adverse Event|0
7835156|NCT01362790|12310415|FG003|Dose De-escalation of Regimen A|Adverse Event|0
7835157|NCT01362790|12310416|FG004|Dose De-escalation of Regimen A|Adverse Event|1
7835158|NCT01362790|12310417|FG005|Dose De-escalation of Regimen A|Adverse Event|0
7835159|NCT01362790|12310418|FG006|Dose De-escalation of Regimen A|Adverse Event|0
7835160|NCT01362790|12310412|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0
7835161|NCT01362790|12310413|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0
7835162|NCT01362790|12310414|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0
7835163|NCT01362790|12310415|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0
7835164|NCT01362790|12310416|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3
7835165|NCT01362790|12310417|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0
7835166|NCT01362790|12310418|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0
7835167|NCT01362790|12310412|FG000|Dose De-escalation of Regimen A|Progressive disease|0
7835168|NCT01362790|12310413|FG001|Dose De-escalation of Regimen A|Progressive disease|0
7835169|NCT01362790|12310414|FG002|Dose De-escalation of Regimen A|Progressive disease|0
7835170|NCT01362790|12310415|FG003|Dose De-escalation of Regimen A|Progressive disease|0
7835171|NCT01362790|12310416|FG004|Dose De-escalation of Regimen A|Progressive disease|2
7835172|NCT01362790|12310417|FG005|Dose De-escalation of Regimen A|Progressive disease|0
7835173|NCT01362790|12310418|FG006|Dose De-escalation of Regimen A|Progressive disease|0
7835174|NCT01363011|12310470|FG000|Main Study|Adverse Event|2
7835175|NCT01363011|12310471|FG001|Main Study|Adverse Event|3
7835176|NCT01363011|12310470|FG000|Main Study|Investigator's Discretion|1
7835177|NCT01363011|12310471|FG001|Main Study|Investigator's Discretion|1
7835178|NCT01363011|12310470|FG000|Main Study|Withdrew Consent|1
7835179|NCT01363011|12310471|FG001|Main Study|Withdrew Consent|4
7835180|NCT01363011|12310470|FG000|Main Study|Protocol Violation|0
7835181|NCT01363011|12310471|FG001|Main Study|Protocol Violation|1
7835182|NCT01363011|12310470|FG000|Extension Phase|Adverse Event|1
7835183|NCT01363011|12310471|FG001|Extension Phase|Adverse Event|1
7835184|NCT01363011|12310470|FG000|Extension Phase|Lack of Efficacy|0
7835185|NCT01363011|12310471|FG001|Extension Phase|Lack of Efficacy|1
7835186|NCT01363011|12310470|FG000|Extension Phase|Investigator's Discretion|2
7835187|NCT01363011|12310471|FG001|Extension Phase|Investigator's Discretion|2
7835188|NCT01363011|12310470|FG000|Extension Phase|Withdrew Consent|0
7835189|NCT01363011|12310471|FG001|Extension Phase|Withdrew Consent|1
7835190|NCT01363011|12310470|FG000|Extension Phase|Lost to Follow-up|0
7835191|NCT01363011|12310471|FG001|Extension Phase|Lost to Follow-up|2
7835192|NCT01363011|12310470|FG000|Extension Phase|Rolled Over to Another Gilead Study|2
7835193|NCT01363011|12310471|FG001|Extension Phase|Rolled Over to Another Gilead Study|1
7835194|NCT01363076|12310485|FG000|Overall Study|Withdrawal by Subject|0
7835195|NCT01363076|12310486|FG001|Overall Study|Withdrawal by Subject|1
7835196|NCT01363297|12310510|FG000|Overall Study|Other|0
7835197|NCT01363297|12310511|FG001|Overall Study|Other|0
7835198|NCT01363297|12310512|FG002|Overall Study|Other|0
7720140|NCT00536939|12144432|FG000|Overall Study|Withdrawal by Subject|1
7720141|NCT00536939|12144433|FG001|Overall Study|Withdrawal by Subject|0
7720142|NCT00536939|12144432|FG000|Overall Study|Other Complicating Disease|1
7720143|NCT00536939|12144433|FG001|Overall Study|Other Complicating Disease|0
7835199|NCT01363297|12310513|FG003|Overall Study|Other|0
7835200|NCT01363297|12310514|FG004|Overall Study|Other|1
7835201|NCT01363297|12310510|FG000|Overall Study|Death|3
7835202|NCT01363297|12310511|FG001|Overall Study|Death|6
7835203|NCT01363297|12310512|FG002|Overall Study|Death|6
7835204|NCT01363297|12310513|FG003|Overall Study|Death|10
7835205|NCT01363297|12310514|FG004|Overall Study|Death|30
7835206|NCT01363349|12310533|FG000|Overall Study|Adverse Event|6
7835207|NCT01363349|12310534|FG001|Overall Study|Adverse Event|7
7835208|NCT01363349|12310533|FG000|Overall Study|Lack of Efficacy|3
7835209|NCT01363349|12310534|FG001|Overall Study|Lack of Efficacy|10
7835210|NCT01363349|12310533|FG000|Overall Study|Non compliance/Protocol deviations|2
7835211|NCT01363349|12310534|FG001|Overall Study|Non compliance/Protocol deviations|2
7835212|NCT01363349|12310533|FG000|Overall Study|Withdrawal by Subject|14
7835213|NCT01363349|12310534|FG001|Overall Study|Withdrawal by Subject|6
7835214|NCT01363349|12310533|FG000|Overall Study|Lost to Follow-up|5
7835215|NCT01363349|12310534|FG001|Overall Study|Lost to Follow-up|6
7835216|NCT01363349|12310533|FG000|Overall Study|Not reported|36
7835217|NCT01363349|12310534|FG001|Overall Study|Not reported|37
7835218|NCT01363349|12310533|FG000|Overall Study|missing|1
7835219|NCT01363349|12310534|FG001|Overall Study|missing|2
7835220|NCT01363440|12310556|FG000|Overall Study|Adverse Event|5
7835221|NCT01363440|12310557|FG001|Overall Study|Adverse Event|4
7835222|NCT01363440|12310558|FG002|Overall Study|Adverse Event|4
7835223|NCT01363440|12310556|FG000|Overall Study|Death|3
7835224|NCT01363440|12310557|FG001|Overall Study|Death|7
7835225|NCT01363440|12310558|FG002|Overall Study|Death|5
7835226|NCT01363440|12310556|FG000|Overall Study|Withdrawal by Subject|9
7835227|NCT01363440|12310557|FG001|Overall Study|Withdrawal by Subject|11
7835228|NCT01363440|12310558|FG002|Overall Study|Withdrawal by Subject|11
7835229|NCT01363440|12310556|FG000|Overall Study|Lost to Follow-up|2
7835230|NCT01363440|12310557|FG001|Overall Study|Lost to Follow-up|4
7835231|NCT01363440|12310558|FG002|Overall Study|Lost to Follow-up|5
7835232|NCT01363440|12310556|FG000|Overall Study|Other|4
7835233|NCT01363440|12310557|FG001|Overall Study|Other|5
7835234|NCT01363440|12310558|FG002|Overall Study|Other|2
7835235|NCT01363661|12310586|FG000|Overall Study|Adverse Event|9
7835236|NCT01363661|12310587|FG001|Overall Study|Adverse Event|2
7835237|NCT01363661|12310586|FG000|Overall Study|Withdrawal by Subject|1
7835238|NCT01363661|12310587|FG001|Overall Study|Withdrawal by Subject|1
7835239|NCT01363661|12310586|FG000|Overall Study|Protocol Violation|1
7835240|NCT01363661|12310587|FG001|Overall Study|Protocol Violation|0
7835241|NCT01363661|12310586|FG000|Overall Study|Lost to Follow-up|3
7835242|NCT01363661|12310587|FG001|Overall Study|Lost to Follow-up|1
7835243|NCT01363700|12310596|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0
7835244|NCT01363700|12310597|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1
7835245|NCT01363700|12310598|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0
7835246|NCT01363700|12310599|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0
7835247|NCT01363700|12310600|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0
7835248|NCT01363713|12310611|FG000|Overall Study|Adverse Event|1
7835249|NCT01363713|12310611|FG000|Overall Study|Protocol Violation|3
7835250|NCT01363713|12310611|FG000|Overall Study|Withdrawal by Subject|2
7835251|NCT01363765|12310617|FG000|Overall Study|non-diagnostic|2621
7835252|NCT01363765|12310618|FG001|Overall Study|non-diagnostic|1124
7835253|NCT01363765|12310617|FG000|Overall Study|duplicate records|736
7835254|NCT01363765|12310618|FG001|Overall Study|duplicate records|3177
7835255|NCT01363765|12310617|FG000|Overall Study|non-resident|156
7835256|NCT01363765|12310618|FG001|Overall Study|non-resident|76
7835257|NCT01363765|12310617|FG000|Overall Study|age not recorded (used for cross-linkage|117
7835258|NCT01363765|12310618|FG001|Overall Study|age not recorded (used for cross-linkage|354
7835259|NCT01363765|12310617|FG000|Overall Study|smear during intervention|2170
7835260|NCT01363765|12310618|FG001|Overall Study|smear during intervention|0
7835261|NCT01363908|12310633|FG000|Chronic Dosing (CD) Phase|Adverse Event|1
7835262|NCT01363908|12310634|FG001|Chronic Dosing (CD) Phase|Adverse Event|1
7835263|NCT01363908|12310633|FG000|Chronic Dosing (CD) Phase|Patient decision|0
7835264|NCT01363908|12310634|FG001|Chronic Dosing (CD) Phase|Patient decision|1
7835265|NCT01363908|12310633|FG000|Chronic Dosing (CD) Phase|Physician Decision|0
7835266|NCT01363908|12310634|FG001|Chronic Dosing (CD) Phase|Physician Decision|1
7835267|NCT01363908|12310633|FG000|Chronic Dosing (CD) Phase|Early study termination|9
7835268|NCT01363908|12310634|FG001|Chronic Dosing (CD) Phase|Early study termination|3
7835269|NCT01363986|12310640|FG000|Overall Study|Disease progression|1
7862611|NCT01598753|12351545|FG003|Overall Study|Lost to Follow-up|5
7862612|NCT01598753|12351542|FG000|Overall Study|Physician Decision|0
7862613|NCT01598753|12351543|FG001|Overall Study|Physician Decision|1
7862614|NCT01598753|12351544|FG002|Overall Study|Physician Decision|0
7862615|NCT01598753|12351545|FG003|Overall Study|Physician Decision|2
7862616|NCT01598753|12351542|FG000|Overall Study|Withdrawal by Subject|7
7862617|NCT01598753|12351543|FG001|Overall Study|Withdrawal by Subject|2
7862618|NCT01598753|12351544|FG002|Overall Study|Withdrawal by Subject|0
7862619|NCT01598753|12351545|FG003|Overall Study|Withdrawal by Subject|1
7862620|NCT01598896|12351570|FG000|Overall Study|Withdrawal by Subject|0
7862621|NCT01598896|12351571|FG001|Overall Study|Withdrawal by Subject|1
7862622|NCT01598896|12351570|FG000|Overall Study|Lack of Efficacy|0
7862623|NCT01598896|12351571|FG001|Overall Study|Lack of Efficacy|1
7862624|NCT01598987|12351586|FG000|Baseline to Month 12|Administrative problems|2
7835270|NCT01364233|12310671|FG000|Overall Study|Lost to Follow-up|1
7835271|NCT01364298|12310686|FG000|Overall Study|Adverse Event|3
7835272|NCT01364298|12310687|FG001|Overall Study|Adverse Event|4
7835273|NCT01364298|12310686|FG000|Overall Study|Lack of adherence to treatment|1
7835274|NCT01364298|12310687|FG001|Overall Study|Lack of adherence to treatment|3
7835275|NCT01364298|12310686|FG000|Overall Study|Lack of Efficacy|1
7835276|NCT01364298|12310687|FG001|Overall Study|Lack of Efficacy|0
7835277|NCT01364298|12310686|FG000|Overall Study|Lost to Follow-up|5
7835278|NCT01364298|12310687|FG001|Overall Study|Lost to Follow-up|10
7835279|NCT01364298|12310686|FG000|Overall Study|Withdrawal by Subject|3
7835280|NCT01364298|12310687|FG001|Overall Study|Withdrawal by Subject|3
7835281|NCT01364298|12310686|FG000|Overall Study|Other|1
7835282|NCT01364298|12310687|FG001|Overall Study|Other|3
7835283|NCT01364389|12310696|FG000|Overall Study|Withdrawal by Subject|0
7835284|NCT01364389|12310697|FG001|Overall Study|Withdrawal by Subject|1
7835285|NCT01364389|12310698|FG002|Overall Study|Withdrawal by Subject|0
7835286|NCT01364389|12310696|FG000|Overall Study|Protocol deviation|0
7835287|NCT01364389|12310697|FG001|Overall Study|Protocol deviation|0
7835288|NCT01364389|12310698|FG002|Overall Study|Protocol deviation|1
7835289|NCT01364389|12310696|FG000|Overall Study|Administrative problems|1
7835290|NCT01364389|12310697|FG001|Overall Study|Administrative problems|0
7835291|NCT01364389|12310698|FG002|Overall Study|Administrative problems|0
7835292|NCT01364389|12310696|FG000|Overall Study|Adverse Event|1
7835293|NCT01364389|12310697|FG001|Overall Study|Adverse Event|0
7835294|NCT01364389|12310698|FG002|Overall Study|Adverse Event|0
7835295|NCT01364428|12310708|FG000|Overall Study|Adverse Event|1
7835296|NCT01364428|12310709|FG001|Overall Study|Adverse Event|2
7835297|NCT01364428|12310708|FG000|Overall Study|Protocol Violation|2
7948666|NCT02530970|12494002|FG000|Overall Study|Lost to Follow-up|88
7948667|NCT02530970|12494002|FG000|Overall Study|Physician Decision|5
7948668|NCT02530970|12494002|FG000|Overall Study|Withdrawal by Subject|14
7948669|NCT02530970|12494002|FG000|Overall Study|Death|6
7948670|NCT02530970|12494002|FG000|Overall Study|Hospitalization|1
7948671|NCT02530970|12494002|FG000|Overall Study|Insurance|2
7948672|NCT02530970|12494002|FG000|Overall Study|Explant|2
7948673|NCT02530970|12494002|FG000|Overall Study|Change in Provider|5
7948674|NCT02530970|12494002|FG000|Overall Study|Relocation|3
7948675|NCT02531035|12494028|FG000|Overall Study|Death|0
7948676|NCT02531035|12494029|FG001|Overall Study|Death|1
7948677|NCT02531035|12494028|FG000|Overall Study|Protocol Violation|1
7948678|NCT02531035|12494029|FG001|Overall Study|Protocol Violation|1
7948679|NCT02531035|12494028|FG000|Overall Study|Noncompliance with study drug|8
7948680|NCT02531035|12494029|FG001|Overall Study|Noncompliance with study drug|3
7948681|NCT02531035|12494028|FG000|Overall Study|Physician Decision|1
7948682|NCT02531035|12494029|FG001|Overall Study|Physician Decision|0
7948683|NCT02531035|12494028|FG000|Overall Study|Adverse Event|16
7948684|NCT02531035|12494029|FG001|Overall Study|Adverse Event|45
7948685|NCT02531035|12494028|FG000|Overall Study|Other|3
7948686|NCT02531035|12494029|FG001|Overall Study|Other|2
7948687|NCT02531035|12494028|FG000|Overall Study|Withdrawal by Subject|42
7948688|NCT02531035|12494029|FG001|Overall Study|Withdrawal by Subject|32
7948689|NCT02531035|12494028|FG000|Overall Study|Lost to Follow-up|8
7948690|NCT02531035|12494029|FG001|Overall Study|Lost to Follow-up|10
7948691|NCT02531035|12494028|FG000|Overall Study|Randomized, not treated|2
7948692|NCT02531035|12494029|FG001|Overall Study|Randomized, not treated|1
7948693|NCT02531113|12494035|FG000|Induction Period: Week 0 to 12|Adverse Event|4
7948694|NCT02531113|12494035|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4
7948695|NCT02531113|12494035|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3
7948696|NCT02531113|12494035|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2
7948697|NCT02531113|12494035|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5
7948698|NCT02531113|12494035|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19
7948699|NCT02531113|12494035|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11
7948700|NCT02531113|12494035|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1
7948701|NCT02531373|12494057|FG000|Overall Study|Lack of Efficacy|0
7948702|NCT02531373|12494058|FG001|Overall Study|Lack of Efficacy|0
7948703|NCT02531373|12494059|FG002|Overall Study|Lack of Efficacy|0
7948704|NCT02531373|12494060|FG003|Overall Study|Lack of Efficacy|0
7948705|NCT02531373|12494061|FG004|Overall Study|Lack of Efficacy|3
7948706|NCT02531373|12494062|FG005|Overall Study|Lack of Efficacy|2
7948707|NCT02531373|12494063|FG006|Overall Study|Lack of Efficacy|4
7948708|NCT02531373|12494064|FG007|Overall Study|Lack of Efficacy|8
7948709|NCT02531373|12494065|FG008|Overall Study|Lack of Efficacy|5
7948710|NCT02531373|12494057|FG000|Overall Study|Lost to Follow-up|0
7948711|NCT02531373|12494058|FG001|Overall Study|Lost to Follow-up|0
7948712|NCT02531373|12494059|FG002|Overall Study|Lost to Follow-up|0
7948713|NCT02531373|12494060|FG003|Overall Study|Lost to Follow-up|0
7948714|NCT02531373|12494061|FG004|Overall Study|Lost to Follow-up|0
7948715|NCT02531373|12494062|FG005|Overall Study|Lost to Follow-up|2
7948716|NCT02531373|12494063|FG006|Overall Study|Lost to Follow-up|2
7948717|NCT02531373|12494064|FG007|Overall Study|Lost to Follow-up|0
7720144|NCT00536991|12144438|FG000|Overall Study|Withdrawal by Subject|10
7720145|NCT00536991|12144438|FG000|Overall Study|Physician Decision|1
7948718|NCT02531373|12494065|FG008|Overall Study|Lost to Follow-up|0
7948719|NCT02531373|12494057|FG000|Overall Study|Physician Decision|0
7948720|NCT02531373|12494058|FG001|Overall Study|Physician Decision|0
7948721|NCT02531373|12494059|FG002|Overall Study|Physician Decision|0
7948722|NCT02531373|12494060|FG003|Overall Study|Physician Decision|0
7948723|NCT02531373|12494061|FG004|Overall Study|Physician Decision|2
7948724|NCT02531373|12494062|FG005|Overall Study|Physician Decision|1
7948725|NCT02531373|12494063|FG006|Overall Study|Physician Decision|0
7948726|NCT02531373|12494064|FG007|Overall Study|Physician Decision|0
7948727|NCT02531373|12494065|FG008|Overall Study|Physician Decision|0
7948728|NCT02531373|12494057|FG000|Overall Study|Protocol Violation|0
7948729|NCT02531373|12494058|FG001|Overall Study|Protocol Violation|0
7948730|NCT02531373|12494059|FG002|Overall Study|Protocol Violation|0
7948731|NCT02531373|12494060|FG003|Overall Study|Protocol Violation|0
7948732|NCT02531373|12494061|FG004|Overall Study|Protocol Violation|0
7720146|NCT00536991|12144438|FG000|Overall Study|patient ineligible|2
7720147|NCT00537017|12144443|FG000|Treatment Phase|Adverse Event|19
7720148|NCT00537017|12144443|FG000|Treatment Phase|Withdrawal by Subject|13
7720149|NCT00537017|12144443|FG000|Treatment Phase|Protocol Violation|2
7720150|NCT00537017|12144443|FG000|Follow-up Phase|Withdrawal by Subject|9
7720151|NCT00537030|12144447|FG000|Overall Study|Physician Decision|2
7720152|NCT00537030|12144447|FG000|Overall Study|Withdrawal by Subject|2
7720153|NCT00537030|12144447|FG000|Overall Study|≥ Grade 2 allergy|7
7720154|NCT00537030|12144447|FG000|Overall Study|Disease progression/ relapse during Tx|1
7720155|NCT00537030|12144447|FG000|Overall Study|Ineligible|2
7835298|NCT01364428|12310709|FG001|Overall Study|Protocol Violation|0
7835299|NCT01364428|12310708|FG000|Overall Study|Withdrawal Criteria|14
7835300|NCT01364428|12310709|FG001|Overall Study|Withdrawal Criteria|10
7835301|NCT01364428|12310708|FG000|Overall Study|Other|3
7835302|NCT01364428|12310709|FG001|Overall Study|Other|3
7835303|NCT01364467|12310717|FG000|Overall Study|Lost to Follow-up|1
7835304|NCT01364467|12310718|FG001|Overall Study|Lost to Follow-up|2
7835305|NCT01364649|12310768|FG000|Overall Study|Pretreatment Event or Adverse Event|20
7835306|NCT01364649|12310769|FG001|Overall Study|Pretreatment Event or Adverse Event|14
7835307|NCT01364649|12310768|FG000|Overall Study|Lack of Efficacy|6
7835308|NCT01364649|12310769|FG001|Overall Study|Lack of Efficacy|0
7835309|NCT01364649|12310768|FG000|Overall Study|Non-compliance with Investigational Drug|1
7835310|NCT01364649|12310769|FG001|Overall Study|Non-compliance with Investigational Drug|0
7948733|NCT02531373|12494062|FG005|Overall Study|Protocol Violation|1
7948734|NCT02531373|12494063|FG006|Overall Study|Protocol Violation|1
7720156|NCT00537030|12144447|FG000|Overall Study|Inevaluable|2
7767877|NCT00856375|12210672|FG000|Overall Study|Lost to Follow-up|1
7835311|NCT01364649|12310768|FG000|Overall Study|Protocol Deviations|4
7835312|NCT01364649|12310769|FG001|Overall Study|Protocol Deviations|8
7835313|NCT01364649|12310768|FG000|Overall Study|Withdrawal of Consent|9
7835314|NCT01364649|12310769|FG001|Overall Study|Withdrawal of Consent|7
7835315|NCT01364649|12310768|FG000|Overall Study|Lost to Follow-up|12
7835316|NCT01364649|12310769|FG001|Overall Study|Lost to Follow-up|13
7835317|NCT01364649|12310768|FG000|Overall Study|Other|4
7835318|NCT01364649|12310769|FG001|Overall Study|Other|1
7835319|NCT01364727|12310775|FG000|Overall Study|Not Eligible|2
7835320|NCT01364870|12310789|FG000|Overall Study|Withdrawal by Subject|13
7835321|NCT01364870|12310790|FG001|Overall Study|Withdrawal by Subject|24
7835322|NCT01364870|12310791|FG002|Overall Study|Withdrawal by Subject|10
7835323|NCT01364870|12310789|FG000|Overall Study|Adverse Event|8
7835324|NCT01364870|12310790|FG001|Overall Study|Adverse Event|6
7835325|NCT01364870|12310791|FG002|Overall Study|Adverse Event|4
7835326|NCT01364870|12310789|FG000|Overall Study|Protocol Violation|1
7835327|NCT01364870|12310790|FG001|Overall Study|Protocol Violation|0
7835328|NCT01364870|12310791|FG002|Overall Study|Protocol Violation|0
7835329|NCT01364922|12310806|FG000|Open-label (OL) Period|Adverse Event|7
7835330|NCT01364922|12310807|FG001|Open-label (OL) Period|Adverse Event|0
7835331|NCT01364922|12310808|FG002|Open-label (OL) Period|Adverse Event|0
7835332|NCT01364922|12310806|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
7835333|NCT01364922|12310807|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
7835334|NCT01364922|12310808|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
7835335|NCT01364922|12310806|FG000|Open-label (OL) Period|Withdrawal by Subject|4
7835336|NCT01364922|12310807|FG001|Open-label (OL) Period|Withdrawal by Subject|0
7835337|NCT01364922|12310808|FG002|Open-label (OL) Period|Withdrawal by Subject|0
7835338|NCT01364922|12310806|FG000|Open-label (OL) Period|Lack of Efficacy|3
7835339|NCT01364922|12310807|FG001|Open-label (OL) Period|Lack of Efficacy|0
7835340|NCT01364922|12310808|FG002|Open-label (OL) Period|Lack of Efficacy|0
7835341|NCT01364922|12310806|FG000|Open-label (OL) Period|Lost to Follow-up|1
7835342|NCT01364922|12310807|FG001|Open-label (OL) Period|Lost to Follow-up|0
7835343|NCT01364922|12310808|FG002|Open-label (OL) Period|Lost to Follow-up|0
7835344|NCT01364922|12310806|FG000|Open-label (OL) Period|Other, Unspecified|1
7835345|NCT01364922|12310807|FG001|Open-label (OL) Period|Other, Unspecified|0
7835346|NCT01364922|12310808|FG002|Open-label (OL) Period|Other, Unspecified|0
7835347|NCT01364922|12310806|FG000|Double-Blind (DB) Period|Lack of Efficacy|0
7835348|NCT01364922|12310807|FG001|Double-Blind (DB) Period|Lack of Efficacy|3
7835349|NCT01364922|12310808|FG002|Double-Blind (DB) Period|Lack of Efficacy|4
7835350|NCT01364922|12310806|FG000|Double-Blind (DB) Period|Subject Noncompliant|0
7835351|NCT01364922|12310807|FG001|Double-Blind (DB) Period|Subject Noncompliant|1
7835352|NCT01364922|12310808|FG002|Double-Blind (DB) Period|Subject Noncompliant|0
7835353|NCT01364922|12310806|FG000|Double-Blind (DB) Period|Adverse Event|0
7835354|NCT01364922|12310807|FG001|Double-Blind (DB) Period|Adverse Event|0
7835355|NCT01364922|12310808|FG002|Double-Blind (DB) Period|Adverse Event|1
7835356|NCT01364922|12310806|FG000|Double-Blind (DB) Period|Other, Unspecified|0
7835357|NCT01364922|12310807|FG001|Double-Blind (DB) Period|Other, Unspecified|1
7835358|NCT01364922|12310808|FG002|Double-Blind (DB) Period|Other, Unspecified|0
7835359|NCT01365039|12310817|FG000|Overall Study|Study related symptoms and complaints|1
7835360|NCT01365039|12310818|FG001|Overall Study|Study related symptoms and complaints|0
7835361|NCT01365052|12310827|FG000|Overall Study|Adverse Event|4
7835362|NCT01365052|12310828|FG001|Overall Study|Adverse Event|4
7835363|NCT01365091|12310838|FG000|Period 1|Adverse Event|1
7835364|NCT01365091|12310839|FG001|Period 1|Adverse Event|0
7835365|NCT01365091|12310840|FG002|Period 1|Adverse Event|2
7835366|NCT01365091|12310841|FG003|Period 1|Adverse Event|3
7835367|NCT01365091|12310838|FG000|Period 1|Positive test result for drugs of abuse|1
7835368|NCT01365091|12310839|FG001|Period 1|Positive test result for drugs of abuse|0
7835369|NCT01365091|12310840|FG002|Period 1|Positive test result for drugs of abuse|0
7835370|NCT01365091|12310841|FG003|Period 1|Positive test result for drugs of abuse|0
7835371|NCT01365091|12310838|FG000|Period 1|No longer met study criteria|0
7835372|NCT01365091|12310839|FG001|Period 1|No longer met study criteria|1
7835373|NCT01365091|12310840|FG002|Period 1|No longer met study criteria|0
7835374|NCT01365091|12310841|FG003|Period 1|No longer met study criteria|0
7835375|NCT01365091|12310838|FG000|Period 1|Withdrawal by Subject|0
7835376|NCT01365091|12310839|FG001|Period 1|Withdrawal by Subject|1
7835377|NCT01365091|12310840|FG002|Period 1|Withdrawal by Subject|0
7835378|NCT01365091|12310841|FG003|Period 1|Withdrawal by Subject|0
7835379|NCT01365091|12310838|FG000|Period 1|Personal reasons|0
7835380|NCT01365091|12310839|FG001|Period 1|Personal reasons|0
7835381|NCT01365091|12310840|FG002|Period 1|Personal reasons|1
7835382|NCT01365091|12310841|FG003|Period 1|Personal reasons|0
7835383|NCT01365091|12310838|FG000|Period 2|Withdrawal by Subject|1
7835384|NCT01365091|12310839|FG001|Period 2|Withdrawal by Subject|0
7835385|NCT01365091|12310840|FG002|Period 2|Withdrawal by Subject|0
7835386|NCT01365091|12310841|FG003|Period 2|Withdrawal by Subject|0
7835387|NCT01365091|12310838|FG000|Period 2|Adverse Event|0
7835388|NCT01365091|12310839|FG001|Period 2|Adverse Event|0
7835389|NCT01365091|12310840|FG002|Period 2|Adverse Event|1
7835390|NCT01365091|12310841|FG003|Period 2|Adverse Event|0
7835391|NCT01365130|12310865|FG000|Overall Study|Progression/worsening of Dx prior to txt|2
7835392|NCT01365273|12310871|FG000|Overall Study|Lost to Follow-up|1
7835393|NCT01365273|12310872|FG001|Overall Study|Lost to Follow-up|0
7835394|NCT01365273|12310871|FG000|Overall Study|Protocol Violation|0
7835395|NCT01365273|12310872|FG001|Overall Study|Protocol Violation|1
7835396|NCT01365273|12310871|FG000|Overall Study|Physician Decision|1
7835397|NCT01365273|12310872|FG001|Overall Study|Physician Decision|0
7835398|NCT01365455|12310881|FG000|Induction Period|Adverse Event|5
7835399|NCT01365455|12310882|FG001|Induction Period|Adverse Event|3
7835400|NCT01365455|12310883|FG002|Induction Period|Adverse Event|4
7835401|NCT01365455|12310884|FG003|Induction Period|Adverse Event|0
7835402|NCT01365455|12310885|FG004|Induction Period|Adverse Event|0
7835403|NCT01365455|12310881|FG000|Induction Period|Lack of Efficacy|1
7835404|NCT01365455|12310882|FG001|Induction Period|Lack of Efficacy|1
7835405|NCT01365455|12310883|FG002|Induction Period|Lack of Efficacy|0
7835406|NCT01365455|12310884|FG003|Induction Period|Lack of Efficacy|0
7835407|NCT01365455|12310885|FG004|Induction Period|Lack of Efficacy|0
7835408|NCT01365455|12310881|FG000|Induction Period|Pregnancy|0
7835409|NCT01365455|12310882|FG001|Induction Period|Pregnancy|1
7835410|NCT01365455|12310883|FG002|Induction Period|Pregnancy|0
7835411|NCT01365455|12310884|FG003|Induction Period|Pregnancy|0
7835412|NCT01365455|12310885|FG004|Induction Period|Pregnancy|0
7835413|NCT01365455|12310881|FG000|Induction Period|Protocol deviation|0
7835414|NCT01365455|12310882|FG001|Induction Period|Protocol deviation|1
7835415|NCT01365455|12310883|FG002|Induction Period|Protocol deviation|1
7835416|NCT01365455|12310884|FG003|Induction Period|Protocol deviation|0
7835417|NCT01365455|12310885|FG004|Induction Period|Protocol deviation|0
7835418|NCT01365455|12310881|FG000|Induction Period|Subject/guardian decision|9
7835419|NCT01365455|12310882|FG001|Induction Period|Subject/guardian decision|1
7835420|NCT01365455|12310883|FG002|Induction Period|Subject/guardian decision|8
7835421|NCT01365455|12310884|FG003|Induction Period|Subject/guardian decision|0
7835422|NCT01365455|12310885|FG004|Induction Period|Subject/guardian decision|0
7835423|NCT01365455|12310881|FG000|Induction Period|Lost to Follow-up|0
7835424|NCT01365455|12310882|FG001|Induction Period|Lost to Follow-up|0
7835425|NCT01365455|12310883|FG002|Induction Period|Lost to Follow-up|3
7835426|NCT01365455|12310884|FG003|Induction Period|Lost to Follow-up|0
7835427|NCT01365455|12310885|FG004|Induction Period|Lost to Follow-up|0
7835428|NCT01365455|12310881|FG000|Maintenance Period|Adverse Event|12
7835429|NCT01365455|12310882|FG001|Maintenance Period|Adverse Event|5
7835430|NCT01365455|12310883|FG002|Maintenance Period|Adverse Event|1
7835431|NCT01365455|12310884|FG003|Maintenance Period|Adverse Event|2
7835432|NCT01365455|12310885|FG004|Maintenance Period|Adverse Event|4
7835433|NCT01365455|12310881|FG000|Maintenance Period|Lack of Efficacy|10
7835434|NCT01365455|12310882|FG001|Maintenance Period|Lack of Efficacy|2
7835435|NCT01365455|12310883|FG002|Maintenance Period|Lack of Efficacy|0
7835436|NCT01365455|12310884|FG003|Maintenance Period|Lack of Efficacy|2
7835437|NCT01365455|12310885|FG004|Maintenance Period|Lack of Efficacy|2
7835438|NCT01365455|12310881|FG000|Maintenance Period|Lost to Follow-up|2
7835439|NCT01365455|12310882|FG001|Maintenance Period|Lost to Follow-up|4
7835440|NCT01365455|12310883|FG002|Maintenance Period|Lost to Follow-up|0
7835441|NCT01365455|12310884|FG003|Maintenance Period|Lost to Follow-up|0
7835442|NCT01365455|12310885|FG004|Maintenance Period|Lost to Follow-up|3
7835443|NCT01365455|12310881|FG000|Maintenance Period|Non-compliance with study treatment|0
7835444|NCT01365455|12310882|FG001|Maintenance Period|Non-compliance with study treatment|0
7835445|NCT01365455|12310883|FG002|Maintenance Period|Non-compliance with study treatment|0
7835446|NCT01365455|12310884|FG003|Maintenance Period|Non-compliance with study treatment|1
7835447|NCT01365455|12310885|FG004|Maintenance Period|Non-compliance with study treatment|0
7835448|NCT01365455|12310881|FG000|Maintenance Period|Physician Decision|0
7835449|NCT01365455|12310882|FG001|Maintenance Period|Physician Decision|1
7835450|NCT01365455|12310883|FG002|Maintenance Period|Physician Decision|0
7835451|NCT01365455|12310884|FG003|Maintenance Period|Physician Decision|0
7835452|NCT01365455|12310885|FG004|Maintenance Period|Physician Decision|1
7835453|NCT01365455|12310881|FG000|Maintenance Period|Pregnancy|0
7835454|NCT01365455|12310882|FG001|Maintenance Period|Pregnancy|4
7835455|NCT01365455|12310883|FG002|Maintenance Period|Pregnancy|0
7835456|NCT01365455|12310884|FG003|Maintenance Period|Pregnancy|0
7835457|NCT01365455|12310885|FG004|Maintenance Period|Pregnancy|2
7835458|NCT01365455|12310881|FG000|Maintenance Period|Protocol deviation|1
7835459|NCT01365455|12310882|FG001|Maintenance Period|Protocol deviation|1
7835460|NCT01365455|12310883|FG002|Maintenance Period|Protocol deviation|0
7835461|NCT01365455|12310884|FG003|Maintenance Period|Protocol deviation|0
7835462|NCT01365455|12310885|FG004|Maintenance Period|Protocol deviation|0
7835463|NCT01365455|12310881|FG000|Maintenance Period|Subject/guardian decision|4
7835464|NCT01365455|12310882|FG001|Maintenance Period|Subject/guardian decision|6
7835465|NCT01365455|12310883|FG002|Maintenance Period|Subject/guardian decision|2
7835466|NCT01365455|12310884|FG003|Maintenance Period|Subject/guardian decision|4
7835467|NCT01365455|12310885|FG004|Maintenance Period|Subject/guardian decision|1
7835468|NCT01365468|12310905|FG000|Overall Study|Physician Decision|1
7835469|NCT01365468|12310906|FG001|Overall Study|Physician Decision|0
7835470|NCT01365468|12310905|FG000|Overall Study|Disease progression|1
7835471|NCT01365468|12310906|FG001|Overall Study|Disease progression|0
7835472|NCT01365468|12310905|FG000|Overall Study|Lost to Follow-up|2
7835473|NCT01365468|12310906|FG001|Overall Study|Lost to Follow-up|0
7835474|NCT01365481|12310917|FG000|Overall Study|Adverse Event|6
7835475|NCT01365481|12310918|FG001|Overall Study|Adverse Event|9
7835476|NCT01365481|12310919|FG002|Overall Study|Adverse Event|0
7835477|NCT01365481|12310920|FG003|Overall Study|Adverse Event|2
7835478|NCT01365481|12310917|FG000|Overall Study|Withdrawal by Subject|0
7835479|NCT01365481|12310918|FG001|Overall Study|Withdrawal by Subject|2
7835480|NCT01365481|12310919|FG002|Overall Study|Withdrawal by Subject|1
7720157|NCT00537056|12144451|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5
7720158|NCT00537082|12144460|FG000|Overall Study|Adverse Event|6
7720159|NCT00537082|12144461|FG001|Overall Study|Adverse Event|6
7835481|NCT01365481|12310920|FG003|Overall Study|Withdrawal by Subject|1
7835482|NCT01365481|12310917|FG000|Overall Study|Lost to Follow-up|1
7835483|NCT01365481|12310918|FG001|Overall Study|Lost to Follow-up|1
7835484|NCT01365481|12310919|FG002|Overall Study|Lost to Follow-up|2
7835485|NCT01365481|12310920|FG003|Overall Study|Lost to Follow-up|3
7835486|NCT01365481|12310917|FG000|Overall Study|Abnormal laboratory value(s)|0
7835487|NCT01365481|12310918|FG001|Overall Study|Abnormal laboratory value(s)|1
7835488|NCT01365481|12310919|FG002|Overall Study|Abnormal laboratory value(s)|0
7948735|NCT02531373|12494064|FG007|Overall Study|Protocol Violation|0
7948736|NCT02531373|12494065|FG008|Overall Study|Protocol Violation|1
7720160|NCT00537082|12144462|FG002|Overall Study|Adverse Event|3
7720161|NCT00537082|12144460|FG000|Overall Study|Protocol Violation|0
7720162|NCT00537082|12144461|FG001|Overall Study|Protocol Violation|2
7720163|NCT00537082|12144462|FG002|Overall Study|Protocol Violation|1
7720164|NCT00537082|12144460|FG000|Overall Study|Lack of Efficacy|0
7720165|NCT00537082|12144461|FG001|Overall Study|Lack of Efficacy|0
7720166|NCT00537082|12144462|FG002|Overall Study|Lack of Efficacy|2
7720167|NCT00537082|12144460|FG000|Overall Study|Withdrawal by Subject|0
7720168|NCT00537082|12144461|FG001|Overall Study|Withdrawal by Subject|1
7720169|NCT00537082|12144462|FG002|Overall Study|Withdrawal by Subject|0
7720170|NCT00537082|12144460|FG000|Overall Study|Discontinued before initiating treatment|3
7720171|NCT00537082|12144461|FG001|Overall Study|Discontinued before initiating treatment|0
7720172|NCT00537082|12144462|FG002|Overall Study|Discontinued before initiating treatment|0
7720173|NCT00537095|12144472|FG000|Overall Study|surgery|1
7720174|NCT00537095|12144473|FG001|Overall Study|surgery|0
7720175|NCT00537095|12144472|FG000|Overall Study|Adverse Event|24
7720176|NCT00537095|12144473|FG001|Overall Study|Adverse Event|4
7720177|NCT00537095|12144472|FG000|Overall Study|disease progression|21
7720178|NCT00537095|12144473|FG001|Overall Study|disease progression|48
7720179|NCT00537095|12144472|FG000|Overall Study|Death|3
7720180|NCT00537095|12144473|FG001|Overall Study|Death|1
7720181|NCT00537095|12144472|FG000|Overall Study|Withdrawal by Subject|2
7720182|NCT00537095|12144473|FG001|Overall Study|Withdrawal by Subject|2
7720183|NCT00537095|12144472|FG000|Overall Study|subjective disease progression|0
7720184|NCT00537095|12144473|FG001|Overall Study|subjective disease progression|1
7720185|NCT00537095|12144472|FG000|Overall Study|Incorrect enrolment|0
7720186|NCT00537095|12144473|FG001|Overall Study|Incorrect enrolment|1
7720187|NCT00537238|12144481|FG000|Overall Study|Death|1
7948737|NCT02531373|12494057|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7948738|NCT02531373|12494058|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7948739|NCT02531373|12494059|FG002|Overall Study|Withdrawal by Parent/Guardian|0
7948740|NCT02531373|12494060|FG003|Overall Study|Withdrawal by Parent/Guardian|0
7948741|NCT02531373|12494061|FG004|Overall Study|Withdrawal by Parent/Guardian|0
7948742|NCT02531373|12494062|FG005|Overall Study|Withdrawal by Parent/Guardian|3
7720188|NCT00537238|12144482|FG001|Overall Study|Death|2
7720189|NCT00537238|12144481|FG000|Overall Study|Adverse Event|31
7720190|NCT00537238|12144482|FG001|Overall Study|Adverse Event|22
7720191|NCT00537238|12144481|FG000|Overall Study|Lack of Efficacy|20
7720192|NCT00537238|12144482|FG001|Overall Study|Lack of Efficacy|21
7720193|NCT00537238|12144481|FG000|Overall Study|Lost to Follow-up|12
7720194|NCT00537238|12144482|FG001|Overall Study|Lost to Follow-up|8
7720195|NCT00537238|12144481|FG000|Overall Study|Withdrawal by Subject|51
7948743|NCT02531373|12494063|FG006|Overall Study|Withdrawal by Parent/Guardian|4
7948744|NCT02531373|12494064|FG007|Overall Study|Withdrawal by Parent/Guardian|1
7948745|NCT02531373|12494065|FG008|Overall Study|Withdrawal by Parent/Guardian|3
7948746|NCT02531373|12494057|FG000|Overall Study|Withdrawal by Subject|0
7948747|NCT02531373|12494058|FG001|Overall Study|Withdrawal by Subject|0
7948748|NCT02531373|12494059|FG002|Overall Study|Withdrawal by Subject|0
7948749|NCT02531373|12494060|FG003|Overall Study|Withdrawal by Subject|0
7948750|NCT02531373|12494061|FG004|Overall Study|Withdrawal by Subject|3
7948751|NCT02531373|12494062|FG005|Overall Study|Withdrawal by Subject|0
7948752|NCT02531373|12494063|FG006|Overall Study|Withdrawal by Subject|0
7948753|NCT02531373|12494064|FG007|Overall Study|Withdrawal by Subject|0
7948754|NCT02531373|12494065|FG008|Overall Study|Withdrawal by Subject|0
7948755|NCT02531438|12494088|FG000|Overall Study|Adverse Event|7
7948756|NCT02531438|12494089|FG001|Overall Study|Adverse Event|9
7948757|NCT02531438|12494088|FG000|Overall Study|Lost to Follow-up|0
7720196|NCT00537238|12144482|FG001|Overall Study|Withdrawal by Subject|47
7720197|NCT00537238|12144481|FG000|Overall Study|Protocol Violation|15
7720198|NCT00537238|12144482|FG001|Overall Study|Protocol Violation|19
7720199|NCT00537238|12144481|FG000|Overall Study|Does not meet entrance criteria|0
7720200|NCT00537238|12144482|FG001|Overall Study|Does not meet entrance criteria|2
7720201|NCT00537238|12144481|FG000|Overall Study|Other|44
7720202|NCT00537238|12144482|FG001|Overall Study|Other|52
7720203|NCT00537277|12144488|FG000|Overall Study|Adverse Event|1
7720204|NCT00537277|12144488|FG000|Overall Study|Lack of Efficacy|2
7720205|NCT00537277|12144488|FG000|Overall Study|Lost to Follow-up|12
7720206|NCT00537277|12144488|FG000|Overall Study|Protocol Violation|11
7720207|NCT00537277|12144488|FG000|Overall Study|Unclassified|4
7720208|NCT00537277|12144488|FG000|Overall Study|Inability to tolerate trial medication|4
7720209|NCT00537277|12144488|FG000|Overall Study|Non-compliance with trial procedures|15
7720210|NCT00537303|12144498|FG000|Overall Study|Adverse Event|1
7720211|NCT00537303|12144499|FG001|Overall Study|Adverse Event|4
7720212|NCT00537303|12144498|FG000|Overall Study|Lack of Efficacy|6
7720213|NCT00537303|12144499|FG001|Overall Study|Lack of Efficacy|7
7720214|NCT00537303|12144498|FG000|Overall Study|Protocol Violation|8
7720215|NCT00537303|12144499|FG001|Overall Study|Protocol Violation|4
7720216|NCT00537303|12144498|FG000|Overall Study|Withdrawal criteria|3
7720217|NCT00537303|12144499|FG001|Overall Study|Withdrawal criteria|3
7720218|NCT00537303|12144498|FG000|Overall Study|Unclassified|8
7720219|NCT00537303|12144499|FG001|Overall Study|Unclassified|7
7720220|NCT00537316|12144511|FG000|Part 1|Adverse Event|7
7720221|NCT00537316|12144512|FG001|Part 1|Adverse Event|11
7720222|NCT00537316|12144513|FG002|Part 1|Adverse Event|8
7720223|NCT00537316|12144514|FG003|Part 1|Adverse Event|0
7720224|NCT00537316|12144515|FG004|Part 1|Adverse Event|0
7720225|NCT00537316|12144516|FG005|Part 1|Adverse Event|0
7720226|NCT00537316|12144517|FG006|Part 1|Adverse Event|0
7720227|NCT00537316|12144511|FG000|Part 1|Protocol defined clinical event|1
7720228|NCT00537316|12144512|FG001|Part 1|Protocol defined clinical event|0
7720229|NCT00537316|12144513|FG002|Part 1|Protocol defined clinical event|0
7720230|NCT00537316|12144514|FG003|Part 1|Protocol defined clinical event|0
7720231|NCT00537316|12144515|FG004|Part 1|Protocol defined clinical event|0
7720232|NCT00537316|12144516|FG005|Part 1|Protocol defined clinical event|0
7720233|NCT00537316|12144517|FG006|Part 1|Protocol defined clinical event|0
7720234|NCT00537316|12144511|FG000|Part 1|Lost to Follow-up|1
7720235|NCT00537316|12144512|FG001|Part 1|Lost to Follow-up|0
7720236|NCT00537316|12144513|FG002|Part 1|Lost to Follow-up|0
7720237|NCT00537316|12144514|FG003|Part 1|Lost to Follow-up|0
7720238|NCT00537316|12144515|FG004|Part 1|Lost to Follow-up|0
7720239|NCT00537316|12144516|FG005|Part 1|Lost to Follow-up|0
7720240|NCT00537316|12144517|FG006|Part 1|Lost to Follow-up|0
7720241|NCT00537316|12144511|FG000|Part 1|Withdrawal by Subject|3
7720242|NCT00537316|12144512|FG001|Part 1|Withdrawal by Subject|8
7720243|NCT00537316|12144513|FG002|Part 1|Withdrawal by Subject|4
7720244|NCT00537316|12144514|FG003|Part 1|Withdrawal by Subject|0
7720245|NCT00537316|12144515|FG004|Part 1|Withdrawal by Subject|0
7720246|NCT00537316|12144516|FG005|Part 1|Withdrawal by Subject|0
7720247|NCT00537316|12144517|FG006|Part 1|Withdrawal by Subject|0
7720248|NCT00537316|12144511|FG000|Part 1|Protocol Violation|1
7720249|NCT00537316|12144512|FG001|Part 1|Protocol Violation|5
7720250|NCT00537316|12144513|FG002|Part 1|Protocol Violation|1
7720251|NCT00537316|12144514|FG003|Part 1|Protocol Violation|0
7720252|NCT00537316|12144515|FG004|Part 1|Protocol Violation|0
7720253|NCT00537316|12144516|FG005|Part 1|Protocol Violation|0
7720254|NCT00537316|12144517|FG006|Part 1|Protocol Violation|0
7720255|NCT00537316|12144511|FG000|Part 1|Did not meet protocol eligibility|1
7720256|NCT00537316|12144512|FG001|Part 1|Did not meet protocol eligibility|3
7720257|NCT00537316|12144513|FG002|Part 1|Did not meet protocol eligibility|2
7720258|NCT00537316|12144514|FG003|Part 1|Did not meet protocol eligibility|0
7720259|NCT00537316|12144515|FG004|Part 1|Did not meet protocol eligibility|0
7720260|NCT00537316|12144516|FG005|Part 1|Did not meet protocol eligibility|0
7720261|NCT00537316|12144517|FG006|Part 1|Did not meet protocol eligibility|0
7720262|NCT00537316|12144511|FG000|Part 1|Administrative|0
7720263|NCT00537316|12144512|FG001|Part 1|Administrative|0
7720264|NCT00537316|12144513|FG002|Part 1|Administrative|2
7720265|NCT00537316|12144514|FG003|Part 1|Administrative|0
7720266|NCT00537316|12144515|FG004|Part 1|Administrative|0
7720267|NCT00537316|12144516|FG005|Part 1|Administrative|0
7720268|NCT00537316|12144517|FG006|Part 1|Administrative|0
7720269|NCT00537316|12144511|FG000|Part 2|Never entered follow-up|0
7720270|NCT00537316|12144512|FG001|Part 2|Never entered follow-up|0
7720271|NCT00537316|12144513|FG002|Part 2|Never entered follow-up|0
7720272|NCT00537316|12144514|FG003|Part 2|Never entered follow-up|0
7720273|NCT00537316|12144515|FG004|Part 2|Never entered follow-up|0
7720274|NCT00537316|12144516|FG005|Part 2|Never entered follow-up|0
7720275|NCT00537316|12144517|FG006|Part 2|Never entered follow-up|1
7720276|NCT00537316|12144511|FG000|Part 2|Adverse Event|4
7720277|NCT00537316|12144512|FG001|Part 2|Adverse Event|0
7720278|NCT00537316|12144513|FG002|Part 2|Adverse Event|2
7720279|NCT00537316|12144514|FG003|Part 2|Adverse Event|0
7720280|NCT00537316|12144515|FG004|Part 2|Adverse Event|0
7720281|NCT00537316|12144516|FG005|Part 2|Adverse Event|0
7720282|NCT00537316|12144517|FG006|Part 2|Adverse Event|0
7720283|NCT00537316|12144511|FG000|Part 2|Lost to Follow-up|1
7720284|NCT00537316|12144512|FG001|Part 2|Lost to Follow-up|0
7720285|NCT00537316|12144513|FG002|Part 2|Lost to Follow-up|2
7720286|NCT00537316|12144514|FG003|Part 2|Lost to Follow-up|0
7720287|NCT00537316|12144515|FG004|Part 2|Lost to Follow-up|0
7720288|NCT00537316|12144516|FG005|Part 2|Lost to Follow-up|0
7720289|NCT00537316|12144517|FG006|Part 2|Lost to Follow-up|0
7720290|NCT00537316|12144511|FG000|Part 2|Withdrawal by Subject|5
7720291|NCT00537316|12144512|FG001|Part 2|Withdrawal by Subject|1
7720292|NCT00537316|12144513|FG002|Part 2|Withdrawal by Subject|4
7720293|NCT00537316|12144514|FG003|Part 2|Withdrawal by Subject|0
7720294|NCT00537316|12144515|FG004|Part 2|Withdrawal by Subject|0
7720295|NCT00537316|12144516|FG005|Part 2|Withdrawal by Subject|0
7720296|NCT00537316|12144517|FG006|Part 2|Withdrawal by Subject|0
7720297|NCT00537316|12144511|FG000|Part 2|Administrative|16
7720298|NCT00537316|12144512|FG001|Part 2|Administrative|8
7720299|NCT00537316|12144513|FG002|Part 2|Administrative|24
7720300|NCT00537316|12144514|FG003|Part 2|Administrative|3
7720301|NCT00537316|12144515|FG004|Part 2|Administrative|1
7720302|NCT00537316|12144516|FG005|Part 2|Administrative|4
7720303|NCT00537316|12144517|FG006|Part 2|Administrative|1
7720304|NCT00537329|12144536|FG000|Overall Study|Death|10
7720305|NCT00537329|12144536|FG000|Overall Study|Adverse Event|3
7720306|NCT00537329|12144536|FG000|Overall Study|Lack of Efficacy|2
7720307|NCT00537329|12144536|FG000|Overall Study|Lost to Follow-up|6
7720308|NCT00537329|12144536|FG000|Overall Study|Withdrawal by Subject|4
7720309|NCT00537329|12144536|FG000|Overall Study|Other|1
7720310|NCT00537381|12144542|FG000|Overall Study|Adverse Event|13
7720311|NCT00537381|12144543|FG001|Overall Study|Adverse Event|9
7720312|NCT00537381|12144542|FG000|Overall Study|Death|3
7720313|NCT00537381|12144543|FG001|Overall Study|Death|3
7720314|NCT00537381|12144542|FG000|Overall Study|Withdrawal by Subject|5
7720315|NCT00537381|12144543|FG001|Overall Study|Withdrawal by Subject|14
7720316|NCT00537381|12144542|FG000|Overall Study|Physician Decision|7
7720317|NCT00537381|12144543|FG001|Overall Study|Physician Decision|6
7720318|NCT00537381|12144542|FG000|Overall Study|Disease Progression|9
7720319|NCT00537381|12144543|FG001|Overall Study|Disease Progression|18
7720320|NCT00537381|12144542|FG000|Overall Study|Sponsor decision|14
7720321|NCT00537381|12144543|FG001|Overall Study|Sponsor decision|9
7720322|NCT00537381|12144542|FG000|Overall Study|Other|5
7720323|NCT00537381|12144543|FG001|Overall Study|Other|3
7720324|NCT00537394|12144554|FG000|First Year of Follow-up|Death|7
7720325|NCT00537394|12144555|FG001|First Year of Follow-up|Death|0
7720326|NCT00537394|12144556|FG002|First Year of Follow-up|Death|0
7720327|NCT00537394|12144554|FG000|First Year of Follow-up|Severe debilitation|1
7720328|NCT00537394|12144555|FG001|First Year of Follow-up|Severe debilitation|0
7720329|NCT00537394|12144556|FG002|First Year of Follow-up|Severe debilitation|1
7720330|NCT00537394|12144554|FG000|First Year of Follow-up|Withdrawal by Subject|3
7720331|NCT00537394|12144555|FG001|First Year of Follow-up|Withdrawal by Subject|6
7720332|NCT00537394|12144556|FG002|First Year of Follow-up|Withdrawal by Subject|1
7720333|NCT00537394|12144554|FG000|First Year of Follow-up|Lost to Follow-up|1
7720334|NCT00537394|12144555|FG001|First Year of Follow-up|Lost to Follow-up|5
7720335|NCT00537394|12144556|FG002|First Year of Follow-up|Lost to Follow-up|1
7720336|NCT00537394|12144554|FG000|2nd Year of Follow-up|Death|4
7720337|NCT00537394|12144555|FG001|2nd Year of Follow-up|Death|1
7720338|NCT00537394|12144556|FG002|2nd Year of Follow-up|Death|2
7720339|NCT00537394|12144554|FG000|2nd Year of Follow-up|Withdrawal by Subject|0
7720340|NCT00537394|12144555|FG001|2nd Year of Follow-up|Withdrawal by Subject|1
7720341|NCT00537394|12144556|FG002|2nd Year of Follow-up|Withdrawal by Subject|2
7720342|NCT00537394|12144554|FG000|2nd Year of Follow-up|Lost to Follow-up|6
7720343|NCT00537394|12144555|FG001|2nd Year of Follow-up|Lost to Follow-up|7
7720344|NCT00537394|12144556|FG002|2nd Year of Follow-up|Lost to Follow-up|2
7720345|NCT00537394|12144554|FG000|2nd Year of Follow-up|Clinic site closure|1
7720346|NCT00537394|12144555|FG001|2nd Year of Follow-up|Clinic site closure|0
7720347|NCT00537394|12144556|FG002|2nd Year of Follow-up|Clinic site closure|0
7720348|NCT00537485|12144589|FG000|Overall Study|Adverse Event|10
7720349|NCT00537485|12144590|FG001|Overall Study|Adverse Event|5
7720350|NCT00537485|12144589|FG000|Overall Study|Withdrawal by Subject|3
7720351|NCT00537485|12144590|FG001|Overall Study|Withdrawal by Subject|2
7720352|NCT00537485|12144589|FG000|Overall Study|Withdrawal by Subject|1
7720353|NCT00537485|12144590|FG001|Overall Study|Withdrawal by Subject|3
7720354|NCT00537485|12144589|FG000|Overall Study|Physician Decision|1
7720355|NCT00537485|12144590|FG001|Overall Study|Physician Decision|0
7720356|NCT00537745|12144651|FG000|Overall Study|Did not meet eligibility criteria|2
7720357|NCT00537745|12144651|FG000|Overall Study|Withdrawal by Subject|2
7720358|NCT00537745|12144651|FG000|Overall Study|Subject unable to provide Interlock info|1
7720359|NCT00537771|12144658|FG000|Overall Study|Withdrawal by Subject|6
7720360|NCT00537771|12144659|FG001|Overall Study|Withdrawal by Subject|23
7720361|NCT00537771|12144658|FG000|Overall Study|Adverse Event|8
7720362|NCT00537771|12144659|FG001|Overall Study|Adverse Event|15
7720363|NCT00537771|12144658|FG000|Overall Study|Lost to Follow-up|9
7720364|NCT00537771|12144659|FG001|Overall Study|Lost to Follow-up|15
7720365|NCT00537771|12144658|FG000|Overall Study|Protocol Violation|2
7720366|NCT00537771|12144659|FG001|Overall Study|Protocol Violation|6
7720367|NCT00537771|12144658|FG000|Overall Study|Severe Non-Compliance to Protocol|4
7720368|NCT00537771|12144659|FG001|Overall Study|Severe Non-Compliance to Protocol|2
7720369|NCT00537810|12144669|FG000|Overall Study|Withdrawal by Subject|4
7720370|NCT00537810|12144670|FG001|Overall Study|Withdrawal by Subject|11
7720371|NCT00537810|12144671|FG002|Overall Study|Withdrawal by Subject|4
7720372|NCT00537810|12144672|FG003|Overall Study|Withdrawal by Subject|3
7720373|NCT00537810|12144669|FG000|Overall Study|Medically withdrawn|2
7720374|NCT00537810|12144670|FG001|Overall Study|Medically withdrawn|2
7720375|NCT00537810|12144671|FG002|Overall Study|Medically withdrawn|0
7720376|NCT00537810|12144672|FG003|Overall Study|Medically withdrawn|1
7720377|NCT00537823|12144684|FG000|Overall Study|Adverse Event|2
7720378|NCT00537823|12144685|FG001|Overall Study|Adverse Event|0
7720379|NCT00537940|12144694|FG000|Overall Study|Adverse Event|20
7720380|NCT00537940|12144695|FG001|Overall Study|Adverse Event|19
7720381|NCT00537940|12144694|FG000|Overall Study|Lack of Efficacy|8
7720382|NCT00537940|12144695|FG001|Overall Study|Lack of Efficacy|16
7720383|NCT00537940|12144694|FG000|Overall Study|Lost to Follow-up|23
7720384|NCT00537940|12144695|FG001|Overall Study|Lost to Follow-up|29
7720385|NCT00537940|12144694|FG000|Overall Study|Withdrawal by Subject|113
7720386|NCT00537940|12144695|FG001|Overall Study|Withdrawal by Subject|95
7720387|NCT00537940|12144694|FG000|Overall Study|Protocol Violation|6
7720388|NCT00537940|12144695|FG001|Overall Study|Protocol Violation|4
7720389|NCT00537940|12144694|FG000|Overall Study|Pregnancy|1
7720390|NCT00537940|12144695|FG001|Overall Study|Pregnancy|1
7720391|NCT00537940|12144694|FG000|Overall Study|Study terminated by sponsor|2
7720392|NCT00537940|12144695|FG001|Overall Study|Study terminated by sponsor|3
7720393|NCT00537940|12144694|FG000|Overall Study|Other|10
7720394|NCT00537940|12144695|FG001|Overall Study|Other|12
7720395|NCT00537979|12144703|FG000|Overall Study|Adverse Event|2
7720396|NCT00537979|12144704|FG001|Overall Study|Adverse Event|2
7720397|NCT00537979|12144703|FG000|Overall Study|Withdrawal by Subject|1
7720398|NCT00537979|12144704|FG001|Overall Study|Withdrawal by Subject|4
7720399|NCT00537979|12144703|FG000|Overall Study|Lost to Follow-up|1
7720400|NCT00537979|12144704|FG001|Overall Study|Lost to Follow-up|4
7720401|NCT00537979|12144703|FG000|Overall Study|Lack of Efficacy|0
7720402|NCT00537979|12144704|FG001|Overall Study|Lack of Efficacy|1
7720403|NCT00537979|12144703|FG000|Overall Study|Non-compliance with treatment/procedure|2
7720404|NCT00537979|12144704|FG001|Overall Study|Non-compliance with treatment/procedure|2
7720405|NCT00537979|12144703|FG000|Overall Study|Death|0
7720406|NCT00537979|12144704|FG001|Overall Study|Death|3
7720407|NCT00537979|12144703|FG000|Overall Study|Kidney transplant|0
7720408|NCT00537979|12144704|FG001|Overall Study|Kidney transplant|3
7720409|NCT00537979|12144703|FG000|Overall Study|Heart failure|0
7720410|NCT00537979|12144704|FG001|Overall Study|Heart failure|1
7720411|NCT00538291|12144725|FG000|Overall Study|Adverse Event|2
7720412|NCT00538291|12144725|FG000|Overall Study|Withdrawal by Subject|1
7720413|NCT00538473|12144758|FG000|Overall Study|Adverse Event|1
7720414|NCT00538473|12144759|FG001|Overall Study|Adverse Event|0
7720415|NCT00538590|12144780|FG000|Overall Study|Death|1
7720416|NCT00538590|12144781|FG001|Overall Study|Death|0
7720417|NCT00538629|12144796|FG000|Overall Study|At subject's request|1
7720418|NCT00538629|12144796|FG000|Overall Study|Adverse Event|2
7720419|NCT00538629|12144796|FG000|Overall Study|Lack of Efficacy|12
7720420|NCT00538629|12144796|FG000|Overall Study|Lost to Follow-up|6
7720421|NCT00538629|12144796|FG000|Overall Study|Subject's untimely distrust of medicine|1
7720422|NCT00538681|12144814|FG000|Overall Study|Progressive Disease|7
7720423|NCT00538681|12144815|FG001|Overall Study|Progressive Disease|0
7720424|NCT00538681|12144816|FG002|Overall Study|Progressive Disease|1
7720425|NCT00538681|12144817|FG003|Overall Study|Progressive Disease|0
7720426|NCT00538681|12144814|FG000|Overall Study|Sponsor Decision|1
7720427|NCT00538681|12144815|FG001|Overall Study|Sponsor Decision|3
7720428|NCT00538681|12144816|FG002|Overall Study|Sponsor Decision|8
7720429|NCT00538681|12144817|FG003|Overall Study|Sponsor Decision|9
7720430|NCT00538681|12144814|FG000|Overall Study|Adverse Event|1
7720431|NCT00538681|12144815|FG001|Overall Study|Adverse Event|1
7720432|NCT00538681|12144816|FG002|Overall Study|Adverse Event|1
7720433|NCT00538681|12144817|FG003|Overall Study|Adverse Event|0
7720434|NCT00538681|12144814|FG000|Overall Study|Death|0
7720435|NCT00538681|12144815|FG001|Overall Study|Death|0
7720436|NCT00538681|12144816|FG002|Overall Study|Death|1
7720437|NCT00538681|12144817|FG003|Overall Study|Death|1
7720438|NCT00538681|12144814|FG000|Overall Study|Investigator Decision|0
7720439|NCT00538681|12144815|FG001|Overall Study|Investigator Decision|0
7720440|NCT00538681|12144816|FG002|Overall Study|Investigator Decision|0
7720441|NCT00538681|12144817|FG003|Overall Study|Investigator Decision|1
7720442|NCT00538733|12144828|FG000|Overall Study|Adverse Event|8
7720443|NCT00538733|12144828|FG000|Overall Study|Death|1
7720444|NCT00538733|12144828|FG000|Overall Study|declined to participate|2
7720445|NCT00538733|12144828|FG000|Overall Study|still on therapy|1
7720446|NCT00538785|12144846|FG000|Overall Study|Death|9
7720447|NCT00538785|12144847|FG001|Overall Study|Death|10
7720448|NCT00538785|12144846|FG000|Overall Study|Withdrawal of consent|9
7720449|NCT00538785|12144847|FG001|Overall Study|Withdrawal of consent|7
7720450|NCT00538785|12144846|FG000|Overall Study|Lost to Follow-up|1
7720451|NCT00538785|12144847|FG001|Overall Study|Lost to Follow-up|0
7720452|NCT00538902|12144874|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
7720453|NCT00538902|12144875|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
7720454|NCT00538902|12144876|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
7720455|NCT00538902|12144874|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
7720456|NCT00538902|12144875|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
7720457|NCT00538902|12144876|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
7720458|NCT00538902|12144874|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
7720459|NCT00538902|12144875|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
7720460|NCT00538902|12144876|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
7720461|NCT00538902|12144874|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
7720462|NCT00538902|12144875|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
7720463|NCT00538902|12144876|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
7720464|NCT00538902|12144874|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
7720465|NCT00538902|12144875|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
7720466|NCT00538902|12144876|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
7720467|NCT00538902|12144874|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
7720468|NCT00538902|12144875|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
7720469|NCT00538902|12144876|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
7720470|NCT00538902|12144874|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
7720471|NCT00538902|12144875|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
7720472|NCT00538902|12144876|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
7720473|NCT00538902|12144874|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18
7720474|NCT00538902|12144875|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25
7720475|NCT00538902|12144876|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22
7720476|NCT00539006|12144894|FG000|Pre-treatment|Other|0
7720477|NCT00539006|12144895|FG001|Pre-treatment|Other|1
7720478|NCT00539006|12144896|FG002|Pre-treatment|Other|0
7720479|NCT00539006|12144897|FG003|Pre-treatment|Other|0
7720480|NCT00539006|12144894|FG000|Treatment Period 1|Lost to Follow-up|0
7720481|NCT00539006|12144895|FG001|Treatment Period 1|Lost to Follow-up|0
7720482|NCT00539006|12144896|FG002|Treatment Period 1|Lost to Follow-up|1
7720483|NCT00539006|12144897|FG003|Treatment Period 1|Lost to Follow-up|0
7720484|NCT00539006|12144894|FG000|Treatment Period 1|Protocol Violation|0
7720485|NCT00539006|12144895|FG001|Treatment Period 1|Protocol Violation|0
7720486|NCT00539006|12144896|FG002|Treatment Period 1|Protocol Violation|1
7720487|NCT00539006|12144897|FG003|Treatment Period 1|Protocol Violation|0
7720488|NCT00539006|12144894|FG000|Treatment Period 1|Lack of Efficacy|0
7720489|NCT00539006|12144895|FG001|Treatment Period 1|Lack of Efficacy|0
7720490|NCT00539006|12144896|FG002|Treatment Period 1|Lack of Efficacy|0
7720491|NCT00539006|12144897|FG003|Treatment Period 1|Lack of Efficacy|1
7720492|NCT00539006|12144894|FG000|Washout|Adverse Event|2
7720493|NCT00539006|12144895|FG001|Washout|Adverse Event|1
7720494|NCT00539006|12144896|FG002|Washout|Adverse Event|0
7720495|NCT00539006|12144897|FG003|Washout|Adverse Event|0
7720496|NCT00539006|12144894|FG000|Washout|Protocol Violation|1
7720497|NCT00539006|12144895|FG001|Washout|Protocol Violation|1
7720498|NCT00539006|12144896|FG002|Washout|Protocol Violation|0
7720499|NCT00539006|12144897|FG003|Washout|Protocol Violation|0
7720500|NCT00539006|12144894|FG000|Washout|Withdrawal by Subject|0
7720501|NCT00539006|12144895|FG001|Washout|Withdrawal by Subject|2
7720502|NCT00539006|12144896|FG002|Washout|Withdrawal by Subject|0
7720503|NCT00539006|12144897|FG003|Washout|Withdrawal by Subject|0
7720504|NCT00539006|12144894|FG000|Washout|Failed to meet continuation criteria|16
7720505|NCT00539006|12144895|FG001|Washout|Failed to meet continuation criteria|5
7720506|NCT00539006|12144896|FG002|Washout|Failed to meet continuation criteria|14
7720507|NCT00539006|12144897|FG003|Washout|Failed to meet continuation criteria|6
7720508|NCT00539006|12144894|FG000|Washout|Other|1
7720509|NCT00539006|12144895|FG001|Washout|Other|1
7720510|NCT00539006|12144896|FG002|Washout|Other|2
7720511|NCT00539006|12144897|FG003|Washout|Other|3
7720512|NCT00539006|12144894|FG000|Treatment Period 2|Protocol Violation|1
7720513|NCT00539006|12144895|FG001|Treatment Period 2|Protocol Violation|0
7720514|NCT00539006|12144896|FG002|Treatment Period 2|Protocol Violation|0
7720515|NCT00539006|12144897|FG003|Treatment Period 2|Protocol Violation|0
7720516|NCT00539006|12144894|FG000|Treatment Period 2|Other|0
7720517|NCT00539006|12144895|FG001|Treatment Period 2|Other|1
7720518|NCT00539006|12144896|FG002|Treatment Period 2|Other|0
7720519|NCT00539006|12144897|FG003|Treatment Period 2|Other|0
7720520|NCT00539032|12144915|FG000|Overall Study|Withdrawal by Subject|2
7720521|NCT00539032|12144916|FG001|Overall Study|Withdrawal by Subject|1
7720522|NCT00539188|12144933|FG000|Overall Study|Withdrawal by Subject|1
7720523|NCT00539188|12144934|FG001|Overall Study|Withdrawal by Subject|0
7720524|NCT00539188|12144933|FG000|Overall Study|Lost to Follow-up|2
7720525|NCT00539188|12144934|FG001|Overall Study|Lost to Follow-up|1
7720526|NCT00539240|12144943|FG000|Overall Study|Withdrawal by Subject|0
7720527|NCT00539240|12144944|FG001|Overall Study|Withdrawal by Subject|2
7720528|NCT00539240|12144945|FG002|Overall Study|Withdrawal by Subject|0
7720529|NCT00539240|12144943|FG000|Overall Study|Protocol Violation|1
7720530|NCT00539240|12144944|FG001|Overall Study|Protocol Violation|1
7720531|NCT00539240|12144945|FG002|Overall Study|Protocol Violation|4
7720532|NCT00539240|12144943|FG000|Overall Study|Lost to Follow-up|2
7720533|NCT00539240|12144944|FG001|Overall Study|Lost to Follow-up|3
7720534|NCT00539240|12144945|FG002|Overall Study|Lost to Follow-up|1
7720535|NCT00539240|12144943|FG000|Overall Study|Adverse Event|3
7720536|NCT00539240|12144944|FG001|Overall Study|Adverse Event|1
7720537|NCT00539240|12144945|FG002|Overall Study|Adverse Event|10
7720538|NCT00539279|12144959|FG000|Treatment|Withdrawal by Subject|10
7720539|NCT00539279|12144960|FG001|Treatment|Withdrawal by Subject|8
7720540|NCT00539279|12144959|FG000|Treatment|Death|1
7720541|NCT00539279|12144960|FG001|Treatment|Death|0
7720542|NCT00539279|12144959|FG000|Post-Treatment Assessment|Lost to Follow-up|12
7720543|NCT00539279|12144960|FG001|Post-Treatment Assessment|Lost to Follow-up|9
7720544|NCT00539279|12144959|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1
7720545|NCT00539279|12144960|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7
7720546|NCT00539305|12144968|FG000|Overall Study|Adverse Event|1
7720547|NCT00539305|12144969|FG001|Overall Study|Adverse Event|0
7720548|NCT00539305|12144968|FG000|Overall Study|Substance Use|0
7720549|NCT00539305|12144969|FG001|Overall Study|Substance Use|1
7720550|NCT00539305|12144968|FG000|Overall Study|Withdrawal by Subject|0
7720551|NCT00539305|12144969|FG001|Overall Study|Withdrawal by Subject|1
7720552|NCT00539500|12144975|FG000|Overall Study|Disease Progression|1
7720553|NCT00539500|12144975|FG000|Overall Study|Lost to Follow-up|2
7720554|NCT00539513|12144981|FG000|Overall Study|Withdrawal by Subject|2
7720555|NCT00539513|12144982|FG001|Overall Study|Withdrawal by Subject|1
7720556|NCT00539513|12144981|FG000|Overall Study|Lost to Follow-up|0
7720557|NCT00539513|12144982|FG001|Overall Study|Lost to Follow-up|1
7720558|NCT00539734|12145018|FG000|Overall Study|Protocol Violation|1
7720559|NCT00539864|12145024|FG000|Overall Study|Lost to Follow-up|0
7720560|NCT00539864|12145025|FG001|Overall Study|Lost to Follow-up|1
7720561|NCT00539864|12145024|FG000|Overall Study|Withdrawal by Subject|1
7720562|NCT00539864|12145025|FG001|Overall Study|Withdrawal by Subject|1
7720563|NCT00539994|12145043|FG000|Overall Study|Lost to Follow-up|2
7720564|NCT00539994|12145044|FG001|Overall Study|Lost to Follow-up|1
7720565|NCT00539994|12145045|FG002|Overall Study|Lost to Follow-up|0
7720566|NCT00539994|12145043|FG000|Overall Study|Withdrawal by Subject|1
7720567|NCT00539994|12145044|FG001|Overall Study|Withdrawal by Subject|0
7720568|NCT00539994|12145045|FG002|Overall Study|Withdrawal by Subject|1
7720569|NCT00539994|12145043|FG000|Overall Study|Physician Decision|0
7720570|NCT00539994|12145044|FG001|Overall Study|Physician Decision|0
7720571|NCT00539994|12145045|FG002|Overall Study|Physician Decision|1
7720572|NCT00540046|12145072|FG000|Overall Study|Lost to Follow-up|33
7720573|NCT00540046|12145073|FG001|Overall Study|Lost to Follow-up|23
7720574|NCT00540124|12145084|FG000|Overall Study|Adverse Event|0
7720575|NCT00540124|12145085|FG001|Overall Study|Adverse Event|2
7720576|NCT00540124|12145086|FG002|Overall Study|Adverse Event|1
7720577|NCT00540124|12145084|FG000|Overall Study|Entry Criteria Not Met|2
7720578|NCT00540124|12145085|FG001|Overall Study|Entry Criteria Not Met|0
7720579|NCT00540124|12145086|FG002|Overall Study|Entry Criteria Not Met|0
7720580|NCT00540124|12145084|FG000|Overall Study|Lack of Efficacy|1
7720581|NCT00540124|12145085|FG001|Overall Study|Lack of Efficacy|0
7720582|NCT00540124|12145086|FG002|Overall Study|Lack of Efficacy|0
7720583|NCT00540124|12145084|FG000|Overall Study|Withdrawal by Subject|1
7720584|NCT00540124|12145085|FG001|Overall Study|Withdrawal by Subject|1
7720585|NCT00540124|12145086|FG002|Overall Study|Withdrawal by Subject|0
7720586|NCT00540228|12145099|FG000|Overall Study|Adverse Event|2
7720587|NCT00540228|12145100|FG001|Overall Study|Adverse Event|0
7720588|NCT00540228|12145101|FG002|Overall Study|Adverse Event|0
7720589|NCT00540228|12145102|FG003|Overall Study|Adverse Event|0
7720590|NCT00540228|12145103|FG004|Overall Study|Adverse Event|0
7720591|NCT00540228|12145099|FG000|Overall Study|Lost to Follow-up|1
7720592|NCT00540228|12145100|FG001|Overall Study|Lost to Follow-up|1
7720593|NCT00540228|12145101|FG002|Overall Study|Lost to Follow-up|0
7720594|NCT00540228|12145102|FG003|Overall Study|Lost to Follow-up|0
7720595|NCT00540228|12145103|FG004|Overall Study|Lost to Follow-up|0
7720596|NCT00540293|12145115|FG000|Overall Study|Adverse event related to study drug|10
7720597|NCT00540293|12145115|FG000|Overall Study|Adverse event not related to study drug|7
7720598|NCT00540293|12145115|FG000|Overall Study|Withdrawal by Subject|6
7720599|NCT00540293|12145115|FG000|Overall Study|Protocol violation, & subject schedule|12
7720600|NCT00540423|12145127|FG000|Double-Blind Treatment Period|Adverse Event|0
7720601|NCT00540423|12145128|FG001|Double-Blind Treatment Period|Adverse Event|1
7720602|NCT00540423|12145129|FG002|Double-Blind Treatment Period|Adverse Event|0
7720603|NCT00540423|12145127|FG000|Open-Label Treatment Period|Lack of Efficacy|0
7720604|NCT00540423|12145128|FG001|Open-Label Treatment Period|Lack of Efficacy|0
7720605|NCT00540423|12145129|FG002|Open-Label Treatment Period|Lack of Efficacy|2
7720606|NCT00540436|12145147|FG000|First 12-Week Treatment Period|Adverse Event|1
7720607|NCT00540436|12145147|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1
7720608|NCT00540436|12145147|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1
7720609|NCT00540436|12145147|FG000|Second 12-Week Treatment Period|Adverse Event|1
7720610|NCT00540449|12145153|FG000|Overall Study|Adverse Event|12
7720611|NCT00540449|12145154|FG001|Overall Study|Adverse Event|32
7720612|NCT00540449|12145153|FG000|Overall Study|Sponsor's Decision|1
7720613|NCT00540449|12145154|FG001|Overall Study|Sponsor's Decision|1
7720614|NCT00540449|12145153|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
7720615|NCT00540449|12145154|FG001|Overall Study|Subject Ineligible To Continue The Trial|1
7720616|NCT00540449|12145153|FG000|Overall Study|Lost to Follow-up|19
7720617|NCT00540449|12145154|FG001|Overall Study|Lost to Follow-up|17
7720618|NCT00540449|12145153|FG000|Overall Study|Subject Non-Compliant|7
7720619|NCT00540449|12145154|FG001|Overall Study|Subject Non-Compliant|5
7720620|NCT00540449|12145153|FG000|Overall Study|Subject Reached A Virologic Endpoint|32
7720621|NCT00540449|12145154|FG001|Overall Study|Subject Reached A Virologic Endpoint|8
7720622|NCT00540449|12145153|FG000|Overall Study|Withdrawal by Subject|10
7720623|NCT00540449|12145154|FG001|Overall Study|Withdrawal by Subject|10
7720624|NCT00540449|12145153|FG000|Overall Study|Other|1
7720625|NCT00540449|12145154|FG001|Overall Study|Other|4
7720626|NCT00540514|12145162|FG000|Overall Study|Still on treatment|3
7720627|NCT00540514|12145163|FG001|Overall Study|Still on treatment|0
7720628|NCT00540514|12145162|FG000|Overall Study|Unacceptable Toxicity|61
7720629|NCT00540514|12145163|FG001|Overall Study|Unacceptable Toxicity|62
7720630|NCT00540514|12145162|FG000|Overall Study|Adverse Event|20
7720631|NCT00540514|12145163|FG001|Overall Study|Adverse Event|24
7720632|NCT00540514|12145162|FG000|Overall Study|Physician Decision|86
7720633|NCT00540514|12145163|FG001|Overall Study|Physician Decision|99
7720634|NCT00540514|12145162|FG000|Overall Study|Protocol Deviation|3
7720635|NCT00540514|12145163|FG001|Overall Study|Protocol Deviation|4
7720636|NCT00540514|12145162|FG000|Overall Study|Lost to Follow-up|1
7720637|NCT00540514|12145163|FG001|Overall Study|Lost to Follow-up|1
7720638|NCT00540514|12145162|FG000|Overall Study|Withdrawal by Subject|65
7720639|NCT00540514|12145163|FG001|Overall Study|Withdrawal by Subject|67
7720640|NCT00540514|12145162|FG000|Overall Study|Excluded prior to treatment|7
7720641|NCT00540514|12145163|FG001|Overall Study|Excluded prior to treatment|7
7720642|NCT00540514|12145162|FG000|Overall Study|Paclitaxel not available|0
7720643|NCT00540514|12145163|FG001|Overall Study|Paclitaxel not available|2
7720644|NCT00540592|12145184|FG000|Overall Study|Adverse Event|0
7720645|NCT00540592|12145185|FG001|Overall Study|Adverse Event|1
7720646|NCT00540592|12145186|FG002|Overall Study|Adverse Event|0
7720647|NCT00540592|12145187|FG003|Overall Study|Adverse Event|0
7720648|NCT00540592|12145188|FG004|Overall Study|Adverse Event|1
7720649|NCT00540592|12145189|FG005|Overall Study|Adverse Event|0
7720650|NCT00540592|12145190|FG006|Overall Study|Adverse Event|0
7720651|NCT00540592|12145191|FG007|Overall Study|Adverse Event|1
7720652|NCT00540592|12145192|FG008|Overall Study|Adverse Event|1
7720653|NCT00540592|12145193|FG009|Overall Study|Adverse Event|2
7720654|NCT00540592|12145184|FG000|Overall Study|Lost to Follow-up|2
7720655|NCT00540592|12145185|FG001|Overall Study|Lost to Follow-up|0
7720656|NCT00540592|12145186|FG002|Overall Study|Lost to Follow-up|0
7720657|NCT00540592|12145187|FG003|Overall Study|Lost to Follow-up|0
7720658|NCT00540592|12145188|FG004|Overall Study|Lost to Follow-up|0
7720659|NCT00540592|12145189|FG005|Overall Study|Lost to Follow-up|0
7720660|NCT00540592|12145190|FG006|Overall Study|Lost to Follow-up|0
7720661|NCT00540592|12145191|FG007|Overall Study|Lost to Follow-up|0
7720662|NCT00540592|12145192|FG008|Overall Study|Lost to Follow-up|0
7720663|NCT00540592|12145193|FG009|Overall Study|Lost to Follow-up|0
7720664|NCT00540592|12145184|FG000|Overall Study|Withdrawal by Subject|0
7720665|NCT00540592|12145185|FG001|Overall Study|Withdrawal by Subject|0
7720666|NCT00540592|12145186|FG002|Overall Study|Withdrawal by Subject|1
7720667|NCT00540592|12145187|FG003|Overall Study|Withdrawal by Subject|1
7720668|NCT00540592|12145188|FG004|Overall Study|Withdrawal by Subject|0
7720669|NCT00540592|12145189|FG005|Overall Study|Withdrawal by Subject|0
7720670|NCT00540592|12145190|FG006|Overall Study|Withdrawal by Subject|0
7720671|NCT00540592|12145191|FG007|Overall Study|Withdrawal by Subject|0
7720672|NCT00540592|12145192|FG008|Overall Study|Withdrawal by Subject|0
7720673|NCT00540592|12145193|FG009|Overall Study|Withdrawal by Subject|0
7720674|NCT00540644|12145217|FG000|Overall Study|Adverse Event|3
7720675|NCT00540644|12145218|FG001|Overall Study|Adverse Event|1
7720676|NCT00540644|12145217|FG000|Overall Study|Disease Progression|3
7720677|NCT00540644|12145218|FG001|Overall Study|Disease Progression|1
7720678|NCT00540644|12145217|FG000|Overall Study|Physician Decision|0
7720679|NCT00540644|12145218|FG001|Overall Study|Physician Decision|5
7720680|NCT00540644|12145217|FG000|Overall Study|Withdrawal by Subject|2
7720681|NCT00540644|12145218|FG001|Overall Study|Withdrawal by Subject|2
7720682|NCT00540644|12145217|FG000|Overall Study|Noncomplilance|1
7720683|NCT00540644|12145218|FG001|Overall Study|Noncomplilance|0
7720684|NCT00541034|12145251|FG000|Overall Study|Non-Compliance|3
7720685|NCT00541099|12145255|FG000|Overall Study|Ineligible|3
7720686|NCT00541229|12145276|FG000|Treatment Period I (Week 1)|Physician Decision|0
7720687|NCT00541229|12145277|FG001|Treatment Period I (Week 1)|Physician Decision|0
7720688|NCT00541229|12145278|FG002|Treatment Period I (Week 1)|Physician Decision|1
7720689|NCT00541229|12145279|FG003|Treatment Period I (Week 1)|Physician Decision|0
7720690|NCT00541229|12145280|FG004|Treatment Period I (Week 1)|Physician Decision|0
7720691|NCT00541229|12145281|FG005|Treatment Period I (Week 1)|Physician Decision|0
7720692|NCT00541229|12145276|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0
7720693|NCT00541229|12145277|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0
7720694|NCT00541229|12145278|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0
7720695|NCT00541229|12145279|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0
7720696|NCT00541229|12145280|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0
7720697|NCT00541229|12145281|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1
7720698|NCT00541229|12145276|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0
7720699|NCT00541229|12145277|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0
7720700|NCT00541229|12145278|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0
7720701|NCT00541229|12145279|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0
7720702|NCT00541229|12145280|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0
7720703|NCT00541229|12145281|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1
7720704|NCT00541229|12145276|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
7720705|NCT00541229|12145277|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
7720706|NCT00541229|12145278|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
7720707|NCT00541229|12145279|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
7720708|NCT00541229|12145280|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
7720709|NCT00541229|12145281|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
7720710|NCT00541229|12145276|FG000|Washout Period I (Week 2-5)|Adverse Event|1
7720711|NCT00541229|12145277|FG001|Washout Period I (Week 2-5)|Adverse Event|0
7720712|NCT00541229|12145278|FG002|Washout Period I (Week 2-5)|Adverse Event|1
7720713|NCT00541229|12145279|FG003|Washout Period I (Week 2-5)|Adverse Event|0
7720714|NCT00541229|12145280|FG004|Washout Period I (Week 2-5)|Adverse Event|0
7720715|NCT00541229|12145281|FG005|Washout Period I (Week 2-5)|Adverse Event|0
7720716|NCT00541229|12145276|FG000|Washout Period I (Week 2-5)|Physician Decision|0
7720717|NCT00541229|12145277|FG001|Washout Period I (Week 2-5)|Physician Decision|0
7720718|NCT00541229|12145278|FG002|Washout Period I (Week 2-5)|Physician Decision|0
7720719|NCT00541229|12145279|FG003|Washout Period I (Week 2-5)|Physician Decision|1
7720720|NCT00541229|12145280|FG004|Washout Period I (Week 2-5)|Physician Decision|0
7720721|NCT00541229|12145281|FG005|Washout Period I (Week 2-5)|Physician Decision|0
7720722|NCT00541229|12145276|FG000|Washout Period I (Week 2-5)|Protocol Violation|0
7720723|NCT00541229|12145277|FG001|Washout Period I (Week 2-5)|Protocol Violation|0
7720724|NCT00541229|12145278|FG002|Washout Period I (Week 2-5)|Protocol Violation|0
7720725|NCT00541229|12145279|FG003|Washout Period I (Week 2-5)|Protocol Violation|0
7720726|NCT00541229|12145280|FG004|Washout Period I (Week 2-5)|Protocol Violation|0
7720727|NCT00541229|12145281|FG005|Washout Period I (Week 2-5)|Protocol Violation|1
7720728|NCT00541229|12145276|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
7720729|NCT00541229|12145277|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
7720730|NCT00541229|12145278|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
7720731|NCT00541229|12145279|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
7720732|NCT00541229|12145280|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
7720733|NCT00541229|12145281|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
7720734|NCT00541229|12145276|FG000|Treatment Period II (Week 6)|Protocol Violation|0
7720735|NCT00541229|12145277|FG001|Treatment Period II (Week 6)|Protocol Violation|0
7720736|NCT00541229|12145278|FG002|Treatment Period II (Week 6)|Protocol Violation|0
7720737|NCT00541229|12145279|FG003|Treatment Period II (Week 6)|Protocol Violation|0
7720738|NCT00541229|12145280|FG004|Treatment Period II (Week 6)|Protocol Violation|1
7720739|NCT00541229|12145281|FG005|Treatment Period II (Week 6)|Protocol Violation|1
7720740|NCT00541229|12145276|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
7720741|NCT00541229|12145277|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
7720742|NCT00541229|12145278|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
7720743|NCT00541229|12145279|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
7720744|NCT00541229|12145280|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
7720745|NCT00541229|12145281|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
7720746|NCT00541229|12145276|FG000|Washout Period II (Week 7-10)|Protocol Violation|1
7720747|NCT00541229|12145277|FG001|Washout Period II (Week 7-10)|Protocol Violation|0
7720748|NCT00541229|12145278|FG002|Washout Period II (Week 7-10)|Protocol Violation|0
7720749|NCT00541229|12145279|FG003|Washout Period II (Week 7-10)|Protocol Violation|0
7720750|NCT00541229|12145280|FG004|Washout Period II (Week 7-10)|Protocol Violation|0
7720751|NCT00541229|12145281|FG005|Washout Period II (Week 7-10)|Protocol Violation|0
7720752|NCT00541229|12145276|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0
7720753|NCT00541229|12145277|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0
7720754|NCT00541229|12145278|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0
7720755|NCT00541229|12145279|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0
7720756|NCT00541229|12145280|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1
7720757|NCT00541229|12145281|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0
7720758|NCT00541229|12145276|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
7720759|NCT00541229|12145277|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
7720760|NCT00541229|12145278|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
7720761|NCT00541229|12145279|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
7720762|NCT00541229|12145280|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
7720763|NCT00541229|12145281|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
7720764|NCT00541229|12145276|FG000|Treatment Period III (Week 11)|Adverse Event|0
7720765|NCT00541229|12145277|FG001|Treatment Period III (Week 11)|Adverse Event|0
7720766|NCT00541229|12145278|FG002|Treatment Period III (Week 11)|Adverse Event|0
7720767|NCT00541229|12145279|FG003|Treatment Period III (Week 11)|Adverse Event|0
7720768|NCT00541229|12145280|FG004|Treatment Period III (Week 11)|Adverse Event|1
7720769|NCT00541229|12145281|FG005|Treatment Period III (Week 11)|Adverse Event|0
7720770|NCT00541229|12145276|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0
7720771|NCT00541229|12145277|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0
7720772|NCT00541229|12145278|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0
7835489|NCT01365481|12310920|FG003|Overall Study|Abnormal laboratory value(s)|0
7835490|NCT01365481|12310917|FG000|Overall Study|Administrative problems|0
7835491|NCT01365481|12310918|FG001|Overall Study|Administrative problems|1
7835492|NCT01365481|12310919|FG002|Overall Study|Administrative problems|0
7835493|NCT01365481|12310920|FG003|Overall Study|Administrative problems|0
7835494|NCT01365481|12310917|FG000|Overall Study|Protocol deviation|0
7835495|NCT01365481|12310918|FG001|Overall Study|Protocol deviation|1
7835496|NCT01365481|12310919|FG002|Overall Study|Protocol deviation|0
7835497|NCT01365481|12310920|FG003|Overall Study|Protocol deviation|1
7835498|NCT01365481|12310917|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7835499|NCT01365481|12310918|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7835500|NCT01365481|12310919|FG002|Overall Study|Unsatisfactory therapeutic effect|1
7835501|NCT01365481|12310920|FG003|Overall Study|Unsatisfactory therapeutic effect|0
7835502|NCT01365494|12310932|FG000|Overall Study|Adverse Event|1
7835503|NCT01365494|12310933|FG001|Overall Study|Adverse Event|0
7835504|NCT01365494|12310932|FG000|Overall Study|Withdrawal by Subject|0
7835505|NCT01365494|12310933|FG001|Overall Study|Withdrawal by Subject|1
7835506|NCT01365494|12310932|FG000|Overall Study|Lost to Follow-up|1
7835507|NCT01365494|12310933|FG001|Overall Study|Lost to Follow-up|2
7835508|NCT01365507|12310942|FG000|Overall Study|Withdrawal Criteria|8
7835509|NCT01365507|12310943|FG001|Overall Study|Withdrawal Criteria|5
7835510|NCT01365507|12310942|FG000|Overall Study|Unclassified|1
7835511|NCT01365507|12310943|FG001|Overall Study|Unclassified|4
7835512|NCT01365546|12310949|FG000|Overall Study|Withdrawal by Subject|1
7835513|NCT01365546|12310949|FG000|Overall Study|Screen failure|9
7835514|NCT01365546|12310949|FG000|Overall Study|Study termination|1
7835515|NCT01365910|12311017|FG000|Overall Study|Withdrawal by Subject|7
7835516|NCT01365910|12311017|FG000|Overall Study|disease progression|18
7835517|NCT01365910|12311017|FG000|Overall Study|Adverse Event|3
7835518|NCT01365910|12311017|FG000|Overall Study|other complicating disease|1
7835519|NCT01365910|12311017|FG000|Overall Study|pt did not get tx, nausea/vomiting|1
7835520|NCT01366209|12311032|FG000|Overall Study|Adverse Event|6
7835521|NCT01366209|12311033|FG001|Overall Study|Adverse Event|7
7835522|NCT01366209|12311032|FG000|Overall Study|Withdrawal by Subject|4
7835523|NCT01366209|12311033|FG001|Overall Study|Withdrawal by Subject|4
7835524|NCT01366209|12311032|FG000|Overall Study|Death|12
7835525|NCT01366209|12311033|FG001|Overall Study|Death|19
7835526|NCT01366209|12311032|FG000|Overall Study|Lung transplantation|6
7835527|NCT01366209|12311033|FG001|Overall Study|Lung transplantation|1
7835528|NCT01366209|12311032|FG000|Overall Study|Lost to Follow-up|2
7835529|NCT01366209|12311033|FG001|Overall Study|Lost to Follow-up|1
7835530|NCT01366209|12311032|FG000|Overall Study|Physician Decision|1
7835531|NCT01366209|12311033|FG001|Overall Study|Physician Decision|0
7835532|NCT01366209|12311032|FG000|Overall Study|Sponsors decision|0
7835533|NCT01366209|12311033|FG001|Overall Study|Sponsors decision|1
7835534|NCT01366209|12311032|FG000|Overall Study|Withdrew consent|4
7835535|NCT01366209|12311033|FG001|Overall Study|Withdrew consent|3
7835536|NCT01366443|12311044|FG000|Overall Study|Lost to Follow-up|2
7835537|NCT01366443|12311044|FG000|Overall Study|Under 18 yo|1
7835538|NCT01366521|12311070|FG000|Overall Study|Adverse Event|1
7835539|NCT01366521|12311071|FG001|Overall Study|Adverse Event|0
7835540|NCT01366521|12311072|FG002|Overall Study|Adverse Event|0
7835541|NCT01366521|12311073|FG003|Overall Study|Adverse Event|0
7835542|NCT01366521|12311070|FG000|Overall Study|Protocol Violation|0
7835543|NCT01366521|12311071|FG001|Overall Study|Protocol Violation|0
7835544|NCT01366521|12311072|FG002|Overall Study|Protocol Violation|1
7835545|NCT01366521|12311073|FG003|Overall Study|Protocol Violation|0
7835546|NCT01366521|12311070|FG000|Overall Study|Physician Decision|0
7835547|NCT01366521|12311071|FG001|Overall Study|Physician Decision|0
7835548|NCT01366521|12311072|FG002|Overall Study|Physician Decision|1
7835549|NCT01366521|12311073|FG003|Overall Study|Physician Decision|0
7835550|NCT01366521|12311070|FG000|Overall Study|Withdrawal by Subject|0
7835551|NCT01366521|12311071|FG001|Overall Study|Withdrawal by Subject|1
7835552|NCT01366521|12311072|FG002|Overall Study|Withdrawal by Subject|0
7835553|NCT01366521|12311073|FG003|Overall Study|Withdrawal by Subject|0
7835554|NCT01366534|12311088|FG000|Overall Study|Lost to Follow-up|1
7835555|NCT01366534|12311089|FG001|Overall Study|Lost to Follow-up|0
7835556|NCT01366534|12311090|FG002|Overall Study|Lost to Follow-up|0
7835557|NCT01366534|12311088|FG000|Overall Study|Migrated|1
7835558|NCT01366534|12311089|FG001|Overall Study|Migrated|1
7835559|NCT01366534|12311090|FG002|Overall Study|Migrated|0
7835560|NCT01366534|12311088|FG000|Overall Study|Declined challenged|0
7835561|NCT01366534|12311089|FG001|Overall Study|Declined challenged|1
7835562|NCT01366534|12311090|FG002|Overall Study|Declined challenged|0
7835563|NCT01366638|12311101|FG000|Overall Study|Withdrawal by Subject|0
7835564|NCT01366638|12311102|FG001|Overall Study|Withdrawal by Subject|0
7835565|NCT01366638|12311103|FG002|Overall Study|Withdrawal by Subject|6
7835566|NCT01366638|12311101|FG000|Overall Study|Other|1
7835567|NCT01366638|12311102|FG001|Overall Study|Other|0
7835568|NCT01366638|12311103|FG002|Overall Study|Other|0
7835569|NCT01366846|12311115|FG000|Overall Study|Withdrawal by Subject|2
7835570|NCT01366846|12311116|FG001|Overall Study|Withdrawal by Subject|0
7835571|NCT01366846|12311117|FG002|Overall Study|Withdrawal by Subject|0
7835572|NCT01366846|12311118|FG003|Overall Study|Withdrawal by Subject|0
7835573|NCT01366846|12311115|FG000|Overall Study|Communication Difficulties|1
7835574|NCT01366846|12311116|FG001|Overall Study|Communication Difficulties|4
7767878|NCT00856375|12210673|FG001|Overall Study|Lost to Follow-up|2
7835575|NCT01366846|12311117|FG002|Overall Study|Communication Difficulties|0
7835576|NCT01366846|12311118|FG003|Overall Study|Communication Difficulties|1
7835577|NCT01366846|12311115|FG000|Overall Study|Scheduling Conflicts|0
7835578|NCT01366846|12311116|FG001|Overall Study|Scheduling Conflicts|0
7835579|NCT01366846|12311117|FG002|Overall Study|Scheduling Conflicts|1
7835580|NCT01366846|12311118|FG003|Overall Study|Scheduling Conflicts|0
7835581|NCT01367119|12311161|FG000|Overall Study|Adverse Event|1
7835582|NCT01367119|12311162|FG001|Overall Study|Adverse Event|0
7835583|NCT01367119|12311161|FG000|Overall Study|Withdrawal by Subject|1
7835584|NCT01367119|12311162|FG001|Overall Study|Withdrawal by Subject|1
7835585|NCT01367158|12311179|FG000|Overall Study|Withdrew consent|0
7835586|NCT01367158|12311180|FG001|Overall Study|Withdrew consent|2
7835587|NCT01367158|12311181|FG002|Overall Study|Withdrew consent|1
7835588|NCT01367158|12311182|FG003|Overall Study|Withdrew consent|0
7835589|NCT01367158|12311183|FG004|Overall Study|Withdrew consent|2
7835590|NCT01367158|12311184|FG005|Overall Study|Withdrew consent|0
7835591|NCT01367158|12311185|FG006|Overall Study|Withdrew consent|0
7835592|NCT01367158|12311186|FG007|Overall Study|Withdrew consent|1
7835593|NCT01367158|12311187|FG008|Overall Study|Withdrew consent|0
7835594|NCT01367158|12311188|FG009|Overall Study|Withdrew consent|0
7835595|NCT01367158|12311189|FG010|Overall Study|Withdrew consent|0
7835596|NCT01367158|12311179|FG000|Overall Study|Lost to Follow-up|0
7835597|NCT01367158|12311180|FG001|Overall Study|Lost to Follow-up|0
7835598|NCT01367158|12311181|FG002|Overall Study|Lost to Follow-up|0
7835599|NCT01367158|12311182|FG003|Overall Study|Lost to Follow-up|1
7835600|NCT01367158|12311183|FG004|Overall Study|Lost to Follow-up|0
7835601|NCT01367158|12311184|FG005|Overall Study|Lost to Follow-up|2
7835602|NCT01367158|12311185|FG006|Overall Study|Lost to Follow-up|0
7835603|NCT01367158|12311186|FG007|Overall Study|Lost to Follow-up|1
7835604|NCT01367158|12311187|FG008|Overall Study|Lost to Follow-up|0
7835605|NCT01367158|12311188|FG009|Overall Study|Lost to Follow-up|0
7835606|NCT01367158|12311189|FG010|Overall Study|Lost to Follow-up|1
7835607|NCT01367158|12311179|FG000|Overall Study|Protocol Violation|0
7835608|NCT01367158|12311180|FG001|Overall Study|Protocol Violation|1
7835609|NCT01367158|12311181|FG002|Overall Study|Protocol Violation|0
7835610|NCT01367158|12311182|FG003|Overall Study|Protocol Violation|0
7835611|NCT01367158|12311183|FG004|Overall Study|Protocol Violation|0
7835612|NCT01367158|12311184|FG005|Overall Study|Protocol Violation|0
7835613|NCT01367158|12311185|FG006|Overall Study|Protocol Violation|0
7835614|NCT01367158|12311186|FG007|Overall Study|Protocol Violation|0
7835615|NCT01367158|12311187|FG008|Overall Study|Protocol Violation|0
7835616|NCT01367158|12311188|FG009|Overall Study|Protocol Violation|0
7835617|NCT01367158|12311189|FG010|Overall Study|Protocol Violation|0
7835618|NCT01367236|12311226|FG000|Overall Study|Withdrawal by Subject|3
7835619|NCT01367236|12311227|FG001|Overall Study|Withdrawal by Subject|1
7835620|NCT01367249|12311235|FG000|Overall Study|Withdrawal by Subject|6
7835621|NCT01367249|12311236|FG001|Overall Study|Withdrawal by Subject|6
7835622|NCT01367249|12311235|FG000|Overall Study|Other|3
7835623|NCT01367249|12311236|FG001|Overall Study|Other|10
7835624|NCT01367275|12311246|FG000|Overall Study|Ineligible|1
7835625|NCT01367275|12311246|FG000|Overall Study|Disease Progression|2
7835626|NCT01367457|12311282|FG000|Overall Study|Death|2
7835627|NCT01367457|12311283|FG001|Overall Study|Death|0
7835628|NCT01367457|12311284|FG002|Overall Study|Death|0
7835629|NCT01367457|12311282|FG000|Overall Study|Investigator's decision|2
7835630|NCT01367457|12311283|FG001|Overall Study|Investigator's decision|0
7835631|NCT01367457|12311284|FG002|Overall Study|Investigator's decision|0
7835632|NCT01367457|12311282|FG000|Overall Study|Clinical decline (CD)|2
7835633|NCT01367457|12311283|FG001|Overall Study|Clinical decline (CD)|0
7835634|NCT01367457|12311284|FG002|Overall Study|Clinical decline (CD)|0
7835635|NCT01367457|12311282|FG000|Overall Study|Progression and death|8
7835636|NCT01367457|12311283|FG001|Overall Study|Progression and death|0
7835637|NCT01367457|12311284|FG002|Overall Study|Progression and death|0
7835638|NCT01367457|12311282|FG000|Overall Study|Toxicity|16
7835639|NCT01367457|12311283|FG001|Overall Study|Toxicity|0
7835640|NCT01367457|12311284|FG002|Overall Study|Toxicity|0
7835641|NCT01367457|12311282|FG000|Overall Study|Progression|137
7835642|NCT01367457|12311283|FG001|Overall Study|Progression|0
7835643|NCT01367457|12311284|FG002|Overall Study|Progression|0
7835644|NCT01367457|12311282|FG000|Overall Study|Patient asks for rest + slow progression|1
7835645|NCT01367457|12311283|FG001|Overall Study|Patient asks for rest + slow progression|0
7835646|NCT01367457|12311284|FG002|Overall Study|Patient asks for rest + slow progression|0
7835647|NCT01367457|12311282|FG000|Overall Study|Investigator's opinion, stable disease|1
7835648|NCT01367457|12311283|FG001|Overall Study|Investigator's opinion, stable disease|0
7835649|NCT01367457|12311284|FG002|Overall Study|Investigator's opinion, stable disease|0
7835650|NCT01367457|12311282|FG000|Overall Study|Bleeding from cavernous haemangioma|1
7835651|NCT01367457|12311283|FG001|Overall Study|Bleeding from cavernous haemangioma|0
7835652|NCT01367457|12311284|FG002|Overall Study|Bleeding from cavernous haemangioma|0
7835653|NCT01367457|12311282|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1
7835654|NCT01367457|12311283|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0
7948758|NCT02531438|12494089|FG001|Overall Study|Lost to Follow-up|3
7835655|NCT01367457|12311284|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0
7835656|NCT01367457|12311282|FG000|Overall Study|low grade toxicities + stable disease|1
7835657|NCT01367457|12311283|FG001|Overall Study|low grade toxicities + stable disease|0
7835658|NCT01367457|12311284|FG002|Overall Study|low grade toxicities + stable disease|0
7835659|NCT01367457|12311282|FG000|Overall Study|Choledocolithiasis and pancreatitis|1
7835660|NCT01367457|12311283|FG001|Overall Study|Choledocolithiasis and pancreatitis|0
7835661|NCT01367457|12311284|FG002|Overall Study|Choledocolithiasis and pancreatitis|0
7835662|NCT01367457|12311282|FG000|Overall Study|Withdrawal by Subject|1
7835663|NCT01367457|12311283|FG001|Overall Study|Withdrawal by Subject|0
7835664|NCT01367457|12311284|FG002|Overall Study|Withdrawal by Subject|0
7835665|NCT01367457|12311282|FG000|Overall Study|CD, associated leukaemia|1
7835666|NCT01367457|12311283|FG001|Overall Study|CD, associated leukaemia|0
7835667|NCT01367457|12311284|FG002|Overall Study|CD, associated leukaemia|0
7835668|NCT01367457|12311282|FG000|Overall Study|Uncontrolled pain|1
7835669|NCT01367457|12311283|FG001|Overall Study|Uncontrolled pain|0
7835670|NCT01367457|12311284|FG002|Overall Study|Uncontrolled pain|0
7835671|NCT01367457|12311282|FG000|Overall Study|Overall status worsens to grade 4|1
7835672|NCT01367457|12311283|FG001|Overall Study|Overall status worsens to grade 4|0
7835673|NCT01367457|12311284|FG002|Overall Study|Overall status worsens to grade 4|0
7835674|NCT01367457|12311282|FG000|Overall Study|Stabilisation + frequent infections|1
7835675|NCT01367457|12311283|FG001|Overall Study|Stabilisation + frequent infections|0
7835676|NCT01367457|12311284|FG002|Overall Study|Stabilisation + frequent infections|0
7835677|NCT01367457|12311282|FG000|Overall Study|No clinical benefit|1
7835678|NCT01367457|12311283|FG001|Overall Study|No clinical benefit|0
7835679|NCT01367457|12311284|FG002|Overall Study|No clinical benefit|0
7835680|NCT01367457|12311282|FG000|Overall Study|Intestinal obstruction with necrosis|1
7835681|NCT01367457|12311283|FG001|Overall Study|Intestinal obstruction with necrosis|0
7835682|NCT01367457|12311284|FG002|Overall Study|Intestinal obstruction with necrosis|0
7835683|NCT01367457|12311282|FG000|Overall Study|Overall decline|1
7835684|NCT01367457|12311283|FG001|Overall Study|Overall decline|0
7835685|NCT01367457|12311284|FG002|Overall Study|Overall decline|0
7835686|NCT01367457|12311282|FG000|Overall Study|Rejection of treatment|1
7835687|NCT01367457|12311283|FG001|Overall Study|Rejection of treatment|0
7835688|NCT01367457|12311284|FG002|Overall Study|Rejection of treatment|0
7835689|NCT01367457|12311282|FG000|Overall Study|Lost to Follow-up|1
7835690|NCT01367457|12311283|FG001|Overall Study|Lost to Follow-up|0
7835691|NCT01367457|12311284|FG002|Overall Study|Lost to Follow-up|0
7835692|NCT01367457|12311282|FG000|Overall Study|Death from septic shock|1
7835693|NCT01367457|12311283|FG001|Overall Study|Death from septic shock|0
7835694|NCT01367457|12311284|FG002|Overall Study|Death from septic shock|0
7835695|NCT01367457|12311282|FG000|Overall Study|CD, Suspected disease progression (DP)|1
7835696|NCT01367457|12311283|FG001|Overall Study|CD, Suspected disease progression (DP)|0
7835697|NCT01367457|12311284|FG002|Overall Study|CD, Suspected disease progression (DP)|0
7835698|NCT01367457|12311282|FG000|Overall Study|Patient's Wish|1
7835699|NCT01367457|12311283|FG001|Overall Study|Patient's Wish|0
7835700|NCT01367457|12311284|FG002|Overall Study|Patient's Wish|0
7835701|NCT01367457|12311282|FG000|Overall Study|Palliative. Overall decline|1
7835702|NCT01367457|12311283|FG001|Overall Study|Palliative. Overall decline|0
7835703|NCT01367457|12311284|FG002|Overall Study|Palliative. Overall decline|0
7835704|NCT01367457|12311282|FG000|Overall Study|Suspected DP/suspected active infection|1
7835705|NCT01367457|12311283|FG001|Overall Study|Suspected DP/suspected active infection|0
7835706|NCT01367457|12311284|FG002|Overall Study|Suspected DP/suspected active infection|0
7835707|NCT01367665|12311294|FG000|Overall Study|Death|102
7835708|NCT01367665|12311295|FG001|Overall Study|Death|19
7835709|NCT01367665|12311294|FG000|Overall Study|Lost to Follow-up|222
7835710|NCT01367665|12311295|FG001|Overall Study|Lost to Follow-up|22
7835711|NCT01367665|12311294|FG000|Overall Study|Not Done|118
7835712|NCT01367665|12311295|FG001|Overall Study|Not Done|14
7835713|NCT01367704|12311304|FG000|Overall Study|Lost to Follow-up|47
7835714|NCT01367704|12311305|FG001|Overall Study|Lost to Follow-up|161
7835715|NCT01367834|12311313|FG000|Overall Study|Withdrawal by Subject|2
7835716|NCT01367834|12311314|FG001|Overall Study|Withdrawal by Subject|2
7835717|NCT01367834|12311313|FG000|Overall Study|Study was ended.|0
7835718|NCT01367834|12311314|FG001|Overall Study|Study was ended.|1
7835719|NCT01367847|12311322|FG000|Overall Study|Withdrawal by Subject|2
7835720|NCT01367847|12311323|FG001|Overall Study|Withdrawal by Subject|2
7835721|NCT01367886|12311339|FG000|Overall Study|Lost to Follow-up|4
7835722|NCT01367886|12311339|FG000|Overall Study|Lack of Efficacy|2
7835723|NCT01367886|12311339|FG000|Overall Study|Death|1
7835724|NCT01368042|12311344|FG000|Overall Study|Death|14
7835725|NCT01368042|12311344|FG000|Overall Study|Protocol Violation|11
7835726|NCT01368042|12311344|FG000|Overall Study|Lost to Follow-up|4
7835727|NCT01368042|12311344|FG000|Overall Study|Transplanted|1
7835728|NCT01368081|12311361|FG000|Overall Study|Adverse Event|4
7835729|NCT01368081|12311362|FG001|Overall Study|Adverse Event|4
7835730|NCT01368081|12311363|FG002|Overall Study|Adverse Event|3
7835731|NCT01368081|12311364|FG003|Overall Study|Adverse Event|2
7835732|NCT01368081|12311365|FG004|Overall Study|Adverse Event|2
7835733|NCT01368081|12311366|FG005|Overall Study|Adverse Event|5
7835734|NCT01368081|12311367|FG006|Overall Study|Adverse Event|6
7835735|NCT01368081|12311368|FG007|Overall Study|Adverse Event|2
7835736|NCT01368081|12311369|FG008|Overall Study|Adverse Event|3
7835737|NCT01368081|12311370|FG009|Overall Study|Adverse Event|5
7835738|NCT01368081|12311371|FG010|Overall Study|Adverse Event|6
7835739|NCT01368081|12311372|FG011|Overall Study|Adverse Event|1
7835740|NCT01368081|12311373|FG012|Overall Study|Adverse Event|3
7835741|NCT01368081|12311361|FG000|Overall Study|Lack of Efficacy|0
7835742|NCT01368081|12311362|FG001|Overall Study|Lack of Efficacy|1
7835743|NCT01368081|12311363|FG002|Overall Study|Lack of Efficacy|0
7835744|NCT01368081|12311364|FG003|Overall Study|Lack of Efficacy|1
7835745|NCT01368081|12311365|FG004|Overall Study|Lack of Efficacy|0
7835746|NCT01368081|12311366|FG005|Overall Study|Lack of Efficacy|0
7835747|NCT01368081|12311367|FG006|Overall Study|Lack of Efficacy|0
7835748|NCT01368081|12311368|FG007|Overall Study|Lack of Efficacy|2
7835749|NCT01368081|12311369|FG008|Overall Study|Lack of Efficacy|0
7835750|NCT01368081|12311370|FG009|Overall Study|Lack of Efficacy|0
7835751|NCT01368081|12311371|FG010|Overall Study|Lack of Efficacy|0
7835752|NCT01368081|12311372|FG011|Overall Study|Lack of Efficacy|0
7835753|NCT01368081|12311373|FG012|Overall Study|Lack of Efficacy|0
7835754|NCT01368081|12311361|FG000|Overall Study|Protocol Violation|0
7835755|NCT01368081|12311362|FG001|Overall Study|Protocol Violation|0
7835756|NCT01368081|12311363|FG002|Overall Study|Protocol Violation|0
7835757|NCT01368081|12311364|FG003|Overall Study|Protocol Violation|0
7835758|NCT01368081|12311365|FG004|Overall Study|Protocol Violation|0
7835759|NCT01368081|12311366|FG005|Overall Study|Protocol Violation|1
7835760|NCT01368081|12311367|FG006|Overall Study|Protocol Violation|0
7835761|NCT01368081|12311368|FG007|Overall Study|Protocol Violation|1
7835762|NCT01368081|12311369|FG008|Overall Study|Protocol Violation|0
7835763|NCT01368081|12311370|FG009|Overall Study|Protocol Violation|0
7835764|NCT01368081|12311371|FG010|Overall Study|Protocol Violation|0
7835765|NCT01368081|12311372|FG011|Overall Study|Protocol Violation|0
7835766|NCT01368081|12311373|FG012|Overall Study|Protocol Violation|0
7835767|NCT01368081|12311361|FG000|Overall Study|Lost to Follow-up|0
7835768|NCT01368081|12311362|FG001|Overall Study|Lost to Follow-up|0
7835769|NCT01368081|12311363|FG002|Overall Study|Lost to Follow-up|0
7835770|NCT01368081|12311364|FG003|Overall Study|Lost to Follow-up|0
7835771|NCT01368081|12311365|FG004|Overall Study|Lost to Follow-up|0
7835772|NCT01368081|12311366|FG005|Overall Study|Lost to Follow-up|0
7835773|NCT01368081|12311367|FG006|Overall Study|Lost to Follow-up|0
7835774|NCT01368081|12311368|FG007|Overall Study|Lost to Follow-up|0
7835775|NCT01368081|12311369|FG008|Overall Study|Lost to Follow-up|0
7835776|NCT01368081|12311370|FG009|Overall Study|Lost to Follow-up|0
7835777|NCT01368081|12311371|FG010|Overall Study|Lost to Follow-up|0
7835778|NCT01368081|12311372|FG011|Overall Study|Lost to Follow-up|0
7835779|NCT01368081|12311373|FG012|Overall Study|Lost to Follow-up|1
7835780|NCT01368081|12311361|FG000|Overall Study|Withdrawal by Subject|4
7835781|NCT01368081|12311362|FG001|Overall Study|Withdrawal by Subject|4
7835782|NCT01368081|12311363|FG002|Overall Study|Withdrawal by Subject|1
7835783|NCT01368081|12311364|FG003|Overall Study|Withdrawal by Subject|1
7835784|NCT01368081|12311365|FG004|Overall Study|Withdrawal by Subject|0
7835785|NCT01368081|12311366|FG005|Overall Study|Withdrawal by Subject|3
7835786|NCT01368081|12311367|FG006|Overall Study|Withdrawal by Subject|4
7835787|NCT01368081|12311368|FG007|Overall Study|Withdrawal by Subject|2
7835788|NCT01368081|12311369|FG008|Overall Study|Withdrawal by Subject|5
7835789|NCT01368081|12311370|FG009|Overall Study|Withdrawal by Subject|4
7835790|NCT01368081|12311371|FG010|Overall Study|Withdrawal by Subject|3
7835791|NCT01368081|12311372|FG011|Overall Study|Withdrawal by Subject|2
7835792|NCT01368081|12311373|FG012|Overall Study|Withdrawal by Subject|0
7835793|NCT01368081|12311361|FG000|Overall Study|Other reason not defined above|2
7835794|NCT01368081|12311362|FG001|Overall Study|Other reason not defined above|0
7835795|NCT01368081|12311363|FG002|Overall Study|Other reason not defined above|0
7835796|NCT01368081|12311364|FG003|Overall Study|Other reason not defined above|1
7835797|NCT01368081|12311365|FG004|Overall Study|Other reason not defined above|0
7835798|NCT01368081|12311366|FG005|Overall Study|Other reason not defined above|1
7835799|NCT01368081|12311367|FG006|Overall Study|Other reason not defined above|2
7835800|NCT01368081|12311368|FG007|Overall Study|Other reason not defined above|0
7835801|NCT01368081|12311369|FG008|Overall Study|Other reason not defined above|0
7835802|NCT01368081|12311370|FG009|Overall Study|Other reason not defined above|1
7835803|NCT01368081|12311371|FG010|Overall Study|Other reason not defined above|0
7835804|NCT01368081|12311372|FG011|Overall Study|Other reason not defined above|0
7835805|NCT01368081|12311373|FG012|Overall Study|Other reason not defined above|3
7835806|NCT01368211|12311403|FG000|Second Platelets Transfusion|No need for additional transfusion|1
7835807|NCT01368211|12311404|FG001|Second Platelets Transfusion|No need for additional transfusion|2
7835808|NCT01368276|12311425|FG000|Overall Study|Death|1
7835809|NCT01368276|12311426|FG001|Overall Study|Death|10
7835810|NCT01368406|12311434|FG000|Overall Study|Lost to Follow-up|8
7835811|NCT01368406|12311435|FG001|Overall Study|Lost to Follow-up|4
7835812|NCT01368406|12311434|FG000|Overall Study|Withdrawal by Subject|8
7835813|NCT01368406|12311435|FG001|Overall Study|Withdrawal by Subject|4
7835814|NCT01368406|12311434|FG000|Overall Study|relapse of the disease|3
7835815|NCT01368406|12311435|FG001|Overall Study|relapse of the disease|2
7835816|NCT01368406|12311434|FG000|Overall Study|started working|2
7835817|NCT01368406|12311435|FG001|Overall Study|started working|3
7835818|NCT01368432|12311443|FG000|Overall Study|Lost to Follow-up|0
7835819|NCT01368432|12311444|FG001|Overall Study|Lost to Follow-up|1
7835820|NCT01368536|12311467|FG000|Overall Study|Adverse Event|5
7835821|NCT01368536|12311468|FG001|Overall Study|Adverse Event|6
7835822|NCT01368536|12311469|FG002|Overall Study|Adverse Event|8
7835823|NCT01368536|12311467|FG000|Overall Study|Abnormal laboratory value(s)|0
7835824|NCT01368536|12311468|FG001|Overall Study|Abnormal laboratory value(s)|1
7835825|NCT01368536|12311469|FG002|Overall Study|Abnormal laboratory value(s)|2
7835826|NCT01368536|12311467|FG000|Overall Study|Abnormal test procedure result(s)|0
7835827|NCT01368536|12311468|FG001|Overall Study|Abnormal test procedure result(s)|0
7835828|NCT01368536|12311469|FG002|Overall Study|Abnormal test procedure result(s)|1
7835829|NCT01368536|12311467|FG000|Overall Study|Unsatisfactory therapeutic effect|7
7835830|NCT01368536|12311468|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7835831|NCT01368536|12311469|FG002|Overall Study|Unsatisfactory therapeutic effect|2
7835832|NCT01368536|12311467|FG000|Overall Study|No longer required study medication|0
7835833|NCT01368536|12311468|FG001|Overall Study|No longer required study medication|0
7835834|NCT01368536|12311469|FG002|Overall Study|No longer required study medication|1
7835835|NCT01368536|12311467|FG000|Overall Study|Withdrawal by Subject|2
7835836|NCT01368536|12311468|FG001|Overall Study|Withdrawal by Subject|5
7835837|NCT01368536|12311469|FG002|Overall Study|Withdrawal by Subject|4
7835838|NCT01368536|12311467|FG000|Overall Study|Lost to Follow-up|3
7835839|NCT01368536|12311468|FG001|Overall Study|Lost to Follow-up|3
7835840|NCT01368536|12311469|FG002|Overall Study|Lost to Follow-up|5
7835841|NCT01368536|12311467|FG000|Overall Study|Administrative problems|34
7835842|NCT01368536|12311468|FG001|Overall Study|Administrative problems|39
7835843|NCT01368536|12311469|FG002|Overall Study|Administrative problems|35
7835844|NCT01368536|12311467|FG000|Overall Study|Protocol deviation|0
7720773|NCT00541229|12145279|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0
7835845|NCT01368536|12311468|FG001|Overall Study|Protocol deviation|3
7835846|NCT01368536|12311469|FG002|Overall Study|Protocol deviation|1
7835847|NCT01368562|12311478|FG000|Overall Study|Adverse Event|1
7835848|NCT01368562|12311478|FG000|Overall Study|Disease progression|1
7835849|NCT01368562|12311478|FG000|Overall Study|Lost to Follow-up|1
7835850|NCT01368562|12311478|FG000|Overall Study|Death|6
7835851|NCT01368562|12311478|FG000|Overall Study|Unresponsive to treatment|5
7835852|NCT01368562|12311478|FG000|Overall Study|Other|3
7835853|NCT01368562|12311478|FG000|Overall Study|Other than specified|2
7720774|NCT00541229|12145280|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0
7835854|NCT01368614|12311482|FG000|Screening Period|Screen Failure|58
7835855|NCT01368614|12311483|FG001|Screening Period|Screen Failure|0
7835856|NCT01368614|12311484|FG002|Screening Period|Screen Failure|0
7835857|NCT01368614|12311485|FG003|Screening Period|Screen Failure|0
7835858|NCT01368614|12311482|FG000|Study Period|Withdrawal by Subject|0
7835859|NCT01368614|12311483|FG001|Study Period|Withdrawal by Subject|1
7835860|NCT01368614|12311484|FG002|Study Period|Withdrawal by Subject|1
7835861|NCT01368614|12311485|FG003|Study Period|Withdrawal by Subject|3
7835862|NCT01368614|12311482|FG000|Study Period|Lost to Follow-up|0
7835863|NCT01368614|12311483|FG001|Study Period|Lost to Follow-up|0
7835864|NCT01368614|12311484|FG002|Study Period|Lost to Follow-up|1
7835865|NCT01368614|12311485|FG003|Study Period|Lost to Follow-up|0
7835866|NCT01368835|12311520|FG000|Overall Study|Inclusion criteria/photography quality|22
7835867|NCT01368835|12311520|FG000|Overall Study|Lost to Follow-up|11
7835868|NCT01368900|12311572|FG000|Overall Study|Lost to Follow-up|7
7835869|NCT01368965|12311578|FG000|Overall Study|Lost to Follow-up|12
7835870|NCT01369069|12311590|FG000|Overall Study|Lost to Follow-up|8
7835871|NCT01369069|12311591|FG001|Overall Study|Lost to Follow-up|9
7835872|NCT01369069|12311590|FG000|Overall Study|Withdrawal by Subject|9
7835873|NCT01369069|12311591|FG001|Overall Study|Withdrawal by Subject|7
7835874|NCT01369225|12311608|FG000|Overall Study|Withdrawal by Subject|1
7835875|NCT01369225|12311609|FG001|Overall Study|Withdrawal by Subject|0
7835876|NCT01369225|12311610|FG002|Overall Study|Withdrawal by Subject|2
7835877|NCT01369225|12311611|FG003|Overall Study|Withdrawal by Subject|1
7835878|NCT01369225|12311612|FG004|Overall Study|Withdrawal by Subject|0
7835879|NCT01369225|12311613|FG005|Overall Study|Withdrawal by Subject|0
7835880|NCT01369225|12311608|FG000|Overall Study|Does Not Meet Entrance Criteria|0
7835881|NCT01369225|12311609|FG001|Overall Study|Does Not Meet Entrance Criteria|0
7835882|NCT01369225|12311610|FG002|Overall Study|Does Not Meet Entrance Criteria|1
7835883|NCT01369225|12311611|FG003|Overall Study|Does Not Meet Entrance Criteria|0
7835884|NCT01369225|12311612|FG004|Overall Study|Does Not Meet Entrance Criteria|0
7835885|NCT01369225|12311613|FG005|Overall Study|Does Not Meet Entrance Criteria|0
7835886|NCT01369225|12311608|FG000|Overall Study|Other|1
7835887|NCT01369225|12311609|FG001|Overall Study|Other|0
7835888|NCT01369225|12311610|FG002|Overall Study|Other|0
7835889|NCT01369225|12311611|FG003|Overall Study|Other|0
7835890|NCT01369225|12311612|FG004|Overall Study|Other|1
7835891|NCT01369225|12311613|FG005|Overall Study|Other|0
7835892|NCT01369225|12311608|FG000|Overall Study|Adverse Event|0
7835893|NCT01369225|12311609|FG001|Overall Study|Adverse Event|0
7835894|NCT01369225|12311610|FG002|Overall Study|Adverse Event|0
7835895|NCT01369225|12311611|FG003|Overall Study|Adverse Event|1
7835896|NCT01369225|12311612|FG004|Overall Study|Adverse Event|1
7835897|NCT01369225|12311613|FG005|Overall Study|Adverse Event|0
7835898|NCT01369329|12311630|FG000|Overall Study|Withdrawal by Subject|8
7835899|NCT01369329|12311631|FG001|Overall Study|Withdrawal by Subject|6
7835900|NCT01369329|12311632|FG002|Overall Study|Withdrawal by Subject|10
7835901|NCT01369329|12311630|FG000|Overall Study|Lost to Follow-up|2
7835902|NCT01369329|12311631|FG001|Overall Study|Lost to Follow-up|2
7835903|NCT01369329|12311632|FG002|Overall Study|Lost to Follow-up|2
7835904|NCT01369329|12311630|FG000|Overall Study|Other|2
7835905|NCT01369329|12311631|FG001|Overall Study|Other|3
7835906|NCT01369329|12311632|FG002|Overall Study|Other|2
7835907|NCT01369342|12311643|FG000|Overall Study|Withdrawal by Subject|7
7835908|NCT01369342|12311644|FG001|Overall Study|Withdrawal by Subject|7
7835909|NCT01369342|12311645|FG002|Overall Study|Withdrawal by Subject|2
7835910|NCT01369342|12311643|FG000|Overall Study|Lost to Follow-up|5
7835911|NCT01369342|12311644|FG001|Overall Study|Lost to Follow-up|2
7835912|NCT01369342|12311645|FG002|Overall Study|Lost to Follow-up|1
7835913|NCT01369342|12311643|FG000|Overall Study|Not Treated|1
7835914|NCT01369342|12311644|FG001|Overall Study|Not Treated|0
7835915|NCT01369342|12311645|FG002|Overall Study|Not Treated|0
7835916|NCT01369355|12311659|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9
7835917|NCT01369355|12311660|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12
7835918|NCT01369355|12311661|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6
7835919|NCT01369355|12311662|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7
7835920|NCT01369355|12311663|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14
7835921|NCT01369355|12311664|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25
7835922|NCT01369355|12311665|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0
7835923|NCT01369355|12311666|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0
7835924|NCT01369355|12311667|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0
7835925|NCT01369355|12311659|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
7835926|NCT01369355|12311660|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14
7835927|NCT01369355|12311661|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
7835928|NCT01369355|12311662|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
7835929|NCT01369355|12311663|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126
7835930|NCT01369355|12311664|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217
7835931|NCT01369355|12311665|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
7835932|NCT01369355|12311666|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
7835933|NCT01369355|12311667|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
7835934|NCT01369355|12311659|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7835935|NCT01369355|12311660|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
7835936|NCT01369355|12311661|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
7835937|NCT01369355|12311662|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7835938|NCT01369355|12311663|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7835939|NCT01369355|12311664|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2
7835940|NCT01369355|12311665|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7835941|NCT01369355|12311666|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7835942|NCT01369355|12311667|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7835943|NCT01369355|12311659|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
7835944|NCT01369355|12311660|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
7835945|NCT01369355|12311661|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
7835946|NCT01369355|12311662|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2
7835947|NCT01369355|12311663|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5
7835948|NCT01369355|12311664|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6
7835949|NCT01369355|12311665|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
7835950|NCT01369355|12311666|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
7835951|NCT01369355|12311667|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
7835952|NCT01369355|12311659|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
7835953|NCT01369355|12311660|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2
7835954|NCT01369355|12311661|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7
7835955|NCT01369355|12311662|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
7835956|NCT01369355|12311663|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8
7835957|NCT01369355|12311664|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22
7835958|NCT01369355|12311665|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
7835959|NCT01369355|12311666|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
7835960|NCT01369355|12311667|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
7835961|NCT01369355|12311659|FG000|Week 0 - Week 44 (Maintenance)|Other|0
7835962|NCT01369355|12311660|FG001|Week 0 - Week 44 (Maintenance)|Other|0
7835963|NCT01369355|12311661|FG002|Week 0 - Week 44 (Maintenance)|Other|1
7835964|NCT01369355|12311662|FG003|Week 0 - Week 44 (Maintenance)|Other|0
7835965|NCT01369355|12311663|FG004|Week 0 - Week 44 (Maintenance)|Other|1
7835966|NCT01369355|12311664|FG005|Week 0 - Week 44 (Maintenance)|Other|0
7835967|NCT01369355|12311665|FG006|Week 0 - Week 44 (Maintenance)|Other|0
7835968|NCT01369355|12311666|FG007|Week 0 - Week 44 (Maintenance)|Other|0
7835969|NCT01369355|12311667|FG008|Week 0 - Week 44 (Maintenance)|Other|0
7835970|NCT01369355|12311659|FG000|Long-term Extension (Week 44-272)|Adverse Event|0
7835971|NCT01369355|12311660|FG001|Long-term Extension (Week 44-272)|Adverse Event|0
7835972|NCT01369355|12311661|FG002|Long-term Extension (Week 44-272)|Adverse Event|0
7835973|NCT01369355|12311662|FG003|Long-term Extension (Week 44-272)|Adverse Event|0
7835974|NCT01369355|12311663|FG004|Long-term Extension (Week 44-272)|Adverse Event|0
7835975|NCT01369355|12311664|FG005|Long-term Extension (Week 44-272)|Adverse Event|0
7835976|NCT01369355|12311665|FG006|Long-term Extension (Week 44-272)|Adverse Event|15
7835977|NCT01369355|12311666|FG007|Long-term Extension (Week 44-272)|Adverse Event|29
7835978|NCT01369355|12311667|FG008|Long-term Extension (Week 44-272)|Adverse Event|53
7835979|NCT01369355|12311659|FG000|Long-term Extension (Week 44-272)|Death|0
7835980|NCT01369355|12311660|FG001|Long-term Extension (Week 44-272)|Death|0
7835981|NCT01369355|12311661|FG002|Long-term Extension (Week 44-272)|Death|0
7835982|NCT01369355|12311662|FG003|Long-term Extension (Week 44-272)|Death|0
7835983|NCT01369355|12311663|FG004|Long-term Extension (Week 44-272)|Death|0
7835984|NCT01369355|12311664|FG005|Long-term Extension (Week 44-272)|Death|0
7835985|NCT01369355|12311665|FG006|Long-term Extension (Week 44-272)|Death|0
7835986|NCT01369355|12311666|FG007|Long-term Extension (Week 44-272)|Death|1
7835987|NCT01369355|12311667|FG008|Long-term Extension (Week 44-272)|Death|3
7835988|NCT01369355|12311659|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7835989|NCT01369355|12311660|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7835990|NCT01369355|12311661|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7835991|NCT01369355|12311662|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7835992|NCT01369355|12311663|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7835993|NCT01369355|12311664|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7835994|NCT01369355|12311665|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12
7835995|NCT01369355|12311666|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26
7835996|NCT01369355|12311667|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29
7835997|NCT01369355|12311659|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0
7835998|NCT01369355|12311660|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0
7835999|NCT01369355|12311661|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0
7836000|NCT01369355|12311662|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0
7836001|NCT01369355|12311663|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0
7720775|NCT00541229|12145281|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1
7836002|NCT01369355|12311664|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0
7836003|NCT01369355|12311665|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0
7836004|NCT01369355|12311666|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1
7836005|NCT01369355|12311667|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2
7836006|NCT01369355|12311659|FG000|Long-term Extension (Week 44-272)|Physician Decision|0
7836007|NCT01369355|12311660|FG001|Long-term Extension (Week 44-272)|Physician Decision|0
7836008|NCT01369355|12311661|FG002|Long-term Extension (Week 44-272)|Physician Decision|0
7836009|NCT01369355|12311662|FG003|Long-term Extension (Week 44-272)|Physician Decision|0
7836010|NCT01369355|12311663|FG004|Long-term Extension (Week 44-272)|Physician Decision|0
7836011|NCT01369355|12311664|FG005|Long-term Extension (Week 44-272)|Physician Decision|0
7836012|NCT01369355|12311665|FG006|Long-term Extension (Week 44-272)|Physician Decision|1
7836013|NCT01369355|12311666|FG007|Long-term Extension (Week 44-272)|Physician Decision|5
7836014|NCT01369355|12311667|FG008|Long-term Extension (Week 44-272)|Physician Decision|11
7836015|NCT01369355|12311659|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7836016|NCT01369355|12311660|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7836017|NCT01369355|12311661|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7836018|NCT01369355|12311662|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7836019|NCT01369355|12311663|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7836020|NCT01369355|12311664|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7836021|NCT01369355|12311665|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1
7836022|NCT01369355|12311666|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5
7836023|NCT01369355|12311667|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9
7836024|NCT01369355|12311659|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7836025|NCT01369355|12311660|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7836026|NCT01369355|12311661|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7836027|NCT01369355|12311662|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7836028|NCT01369355|12311663|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7836029|NCT01369355|12311664|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7836030|NCT01369355|12311665|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12
7836031|NCT01369355|12311666|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30
7836032|NCT01369355|12311667|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47
7836033|NCT01369355|12311659|FG000|Long-term Extension (Week 44-272)|Other|0
7836034|NCT01369355|12311660|FG001|Long-term Extension (Week 44-272)|Other|0
7836035|NCT01369355|12311661|FG002|Long-term Extension (Week 44-272)|Other|0
7836036|NCT01369355|12311662|FG003|Long-term Extension (Week 44-272)|Other|0
7836037|NCT01369355|12311663|FG004|Long-term Extension (Week 44-272)|Other|0
7836038|NCT01369355|12311664|FG005|Long-term Extension (Week 44-272)|Other|0
7836039|NCT01369355|12311665|FG006|Long-term Extension (Week 44-272)|Other|110
7836040|NCT01369355|12311666|FG007|Long-term Extension (Week 44-272)|Other|9
7836041|NCT01369355|12311667|FG008|Long-term Extension (Week 44-272)|Other|17
7836042|NCT01369433|12311686|FG000|Overall Study|Adverse Event|31
7836043|NCT01369433|12311687|FG001|Overall Study|Adverse Event|1
7836044|NCT01369433|12311686|FG000|Overall Study|Required significant surgical procedure|1
7836045|NCT01369433|12311687|FG001|Overall Study|Required significant surgical procedure|0
7836046|NCT01369433|12311686|FG000|Overall Study|Non-compliance|1
7836047|NCT01369433|12311687|FG001|Overall Study|Non-compliance|0
7836048|NCT01369433|12311686|FG000|Overall Study|Withdrawal by Subject|5
7836049|NCT01369433|12311687|FG001|Overall Study|Withdrawal by Subject|2
7836050|NCT01369433|12311686|FG000|Overall Study|Study terminated by Sponsor|67
7836051|NCT01369433|12311687|FG001|Overall Study|Study terminated by Sponsor|0
7836052|NCT01369433|12311686|FG000|Overall Study|Lost to Follow-up|1
7836053|NCT01369433|12311687|FG001|Overall Study|Lost to Follow-up|0
7836054|NCT01369433|12311686|FG000|Overall Study|Death|5
7836055|NCT01369433|12311687|FG001|Overall Study|Death|0
7836056|NCT01369433|12311686|FG000|Overall Study|Investigator discretion|6
7836057|NCT01369433|12311687|FG001|Overall Study|Investigator discretion|1
7836058|NCT01369433|12311686|FG000|Overall Study|Progressive Disease|92
7836059|NCT01369433|12311687|FG001|Overall Study|Progressive Disease|12
7948759|NCT02531438|12494088|FG000|Overall Study|Withdrawal by Subject|7
7948760|NCT02531438|12494089|FG001|Overall Study|Withdrawal by Subject|8
7948761|NCT02531438|12494088|FG000|Overall Study|Physician Decision|0
7948762|NCT02531438|12494089|FG001|Overall Study|Physician Decision|1
7948763|NCT02531438|12494088|FG000|Overall Study|Death|6
7948764|NCT02531438|12494089|FG001|Overall Study|Death|3
7948765|NCT02531438|12494088|FG000|Overall Study|Randomized, but Not Treated|4
7948766|NCT02531438|12494089|FG001|Overall Study|Randomized, but Not Treated|0
7948767|NCT02531438|12494088|FG000|Overall Study|Missed EOT/PTE Visit|5
7948768|NCT02531438|12494089|FG001|Overall Study|Missed EOT/PTE Visit|2
7948769|NCT02531438|12494088|FG000|Overall Study|Randomized with Exclusion Criteria|1
7948770|NCT02531438|12494089|FG001|Overall Study|Randomized with Exclusion Criteria|0
7948771|NCT02531633|12494100|FG000|Part A (52 Weeks)|Sponsor request|24
7948772|NCT02531633|12494101|FG001|Part A (52 Weeks)|Sponsor request|24
7948773|NCT02531633|12494102|FG002|Part A (52 Weeks)|Sponsor request|18
7948774|NCT02531633|12494103|FG003|Part A (52 Weeks)|Sponsor request|18
7948775|NCT02531633|12494104|FG004|Part A (52 Weeks)|Sponsor request|19
7948776|NCT02531633|12494105|FG005|Part A (52 Weeks)|Sponsor request|0
7948777|NCT02531633|12494106|FG006|Part A (52 Weeks)|Sponsor request|0
7948778|NCT02531633|12494107|FG007|Part A (52 Weeks)|Sponsor request|0
7948779|NCT02531633|12494108|FG008|Part A (52 Weeks)|Sponsor request|0
7948780|NCT02531633|12494109|FG009|Part A (52 Weeks)|Sponsor request|0
7948781|NCT02531633|12494100|FG000|Part A (52 Weeks)|Protocol Violation|1
7948782|NCT02531633|12494101|FG001|Part A (52 Weeks)|Protocol Violation|0
7948783|NCT02531633|12494102|FG002|Part A (52 Weeks)|Protocol Violation|0
7948784|NCT02531633|12494103|FG003|Part A (52 Weeks)|Protocol Violation|0
7948785|NCT02531633|12494104|FG004|Part A (52 Weeks)|Protocol Violation|0
7948786|NCT02531633|12494105|FG005|Part A (52 Weeks)|Protocol Violation|0
7836060|NCT01369485|12311695|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
7836061|NCT01369485|12311696|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
7836062|NCT01369485|12311695|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
7836063|NCT01369485|12311696|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
7836064|NCT01369485|12311695|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
7836065|NCT01369485|12311696|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
7836066|NCT01369485|12311695|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2
7836067|NCT01369485|12311696|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0
7836068|NCT01369485|12311695|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
7836069|NCT01369485|12311696|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
7836070|NCT01369485|12311695|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
7836071|NCT01369485|12311696|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
7836072|NCT01369485|12311695|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
7836073|NCT01369485|12311696|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
7836074|NCT01369485|12311695|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
7836075|NCT01369485|12311696|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
7836076|NCT01369485|12311695|FG000|Open Label Phase (Week 12 to Month 12)|Death|0
7836077|NCT01369485|12311696|FG001|Open Label Phase (Week 12 to Month 12)|Death|1
7836078|NCT01369485|12311695|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
7836079|NCT01369485|12311696|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
7836080|NCT01369498|12311714|FG000|Overall Study|Lack of Efficacy|9
7836081|NCT01369498|12311715|FG001|Overall Study|Lack of Efficacy|9
7836082|NCT01369498|12311716|FG002|Overall Study|Lack of Efficacy|1
7836083|NCT01369498|12311717|FG003|Overall Study|Lack of Efficacy|3
7836084|NCT01369498|12311714|FG000|Overall Study|Adverse Event|1
7836085|NCT01369498|12311715|FG001|Overall Study|Adverse Event|2
7836086|NCT01369498|12311716|FG002|Overall Study|Adverse Event|0
7836087|NCT01369498|12311717|FG003|Overall Study|Adverse Event|1
7836088|NCT01369498|12311714|FG000|Overall Study|Withdrawal of Consent|0
7836089|NCT01369498|12311715|FG001|Overall Study|Withdrawal of Consent|1
7836090|NCT01369498|12311716|FG002|Overall Study|Withdrawal of Consent|1
7836091|NCT01369498|12311717|FG003|Overall Study|Withdrawal of Consent|1
7836092|NCT01369498|12311714|FG000|Overall Study|Death|0
7836093|NCT01369498|12311715|FG001|Overall Study|Death|0
7836094|NCT01369498|12311716|FG002|Overall Study|Death|1
7836095|NCT01369498|12311717|FG003|Overall Study|Death|0
7836096|NCT01369498|12311714|FG000|Overall Study|Investigator's Discretion|1
7836097|NCT01369498|12311715|FG001|Overall Study|Investigator's Discretion|0
7836098|NCT01369498|12311716|FG002|Overall Study|Investigator's Discretion|1
7836099|NCT01369498|12311717|FG003|Overall Study|Investigator's Discretion|3
7836100|NCT01369498|12311714|FG000|Overall Study|Unknown Reason|1
7836101|NCT01369498|12311715|FG001|Overall Study|Unknown Reason|0
7836102|NCT01369498|12311716|FG002|Overall Study|Unknown Reason|11
7836103|NCT01369498|12311717|FG003|Overall Study|Unknown Reason|6
7836104|NCT01369498|12311714|FG000|Overall Study|Disease Progression|0
7836105|NCT01369498|12311715|FG001|Overall Study|Disease Progression|0
7836106|NCT01369498|12311716|FG002|Overall Study|Disease Progression|0
7836107|NCT01369498|12311717|FG003|Overall Study|Disease Progression|1
7836108|NCT01369511|12311732|FG000|Overall Study|Adverse Event|1
7836109|NCT01369511|12311733|FG001|Overall Study|Adverse Event|1
7836110|NCT01369511|12311734|FG002|Overall Study|Adverse Event|5
7836111|NCT01369511|12311735|FG003|Overall Study|Adverse Event|0
7836112|NCT01369511|12311732|FG000|Overall Study|Entry criteria not met|2
7836113|NCT01369511|12311733|FG001|Overall Study|Entry criteria not met|0
7836114|NCT01369511|12311734|FG002|Overall Study|Entry criteria not met|0
7836115|NCT01369511|12311735|FG003|Overall Study|Entry criteria not met|1
7836116|NCT01369511|12311732|FG000|Overall Study|Lost to Follow-up|0
7836117|NCT01369511|12311733|FG001|Overall Study|Lost to Follow-up|1
7836118|NCT01369511|12311734|FG002|Overall Study|Lost to Follow-up|1
7836119|NCT01369511|12311735|FG003|Overall Study|Lost to Follow-up|2
7836120|NCT01369511|12311732|FG000|Overall Study|Protocol Violation|0
7836121|NCT01369511|12311733|FG001|Overall Study|Protocol Violation|1
7836122|NCT01369511|12311734|FG002|Overall Study|Protocol Violation|0
7836123|NCT01369511|12311735|FG003|Overall Study|Protocol Violation|2
7836124|NCT01369511|12311732|FG000|Overall Study|Physician Decision|3
7836125|NCT01369511|12311733|FG001|Overall Study|Physician Decision|4
7836126|NCT01369511|12311734|FG002|Overall Study|Physician Decision|0
7836127|NCT01369511|12311735|FG003|Overall Study|Physician Decision|0
7836128|NCT01369511|12311732|FG000|Overall Study|Sponsor decision|2
7836129|NCT01369511|12311733|FG001|Overall Study|Sponsor decision|0
7836130|NCT01369511|12311734|FG002|Overall Study|Sponsor decision|1
7836131|NCT01369511|12311735|FG003|Overall Study|Sponsor decision|0
7836132|NCT01369511|12311732|FG000|Overall Study|Withdrawal by Subject|5
7836133|NCT01369511|12311733|FG001|Overall Study|Withdrawal by Subject|6
7836134|NCT01369511|12311734|FG002|Overall Study|Withdrawal by Subject|4
7836135|NCT01369511|12311735|FG003|Overall Study|Withdrawal by Subject|6
7836136|NCT01369615|12311747|FG000|Overall Study|Withdrawal by Subject|0
7836137|NCT01369615|12311748|FG001|Overall Study|Withdrawal by Subject|1
7836138|NCT01369615|12311747|FG000|Overall Study|Lost to Follow-up|0
7836139|NCT01369615|12311748|FG001|Overall Study|Lost to Follow-up|1
7836140|NCT01369680|12311758|FG000|Overall Study|Lost to Follow-up|0
7836141|NCT01369680|12311759|FG001|Overall Study|Lost to Follow-up|0
7836142|NCT01369680|12311760|FG002|Overall Study|Lost to Follow-up|1
7836143|NCT01369680|12311761|FG003|Overall Study|Lost to Follow-up|2
7836144|NCT01369784|12311820|FG000|Overall Study|Protocol Violation|12
7836145|NCT01369849|12311827|FG000|Overall Study|Ineligible prior to treatment|0
7836146|NCT01369849|12311828|FG001|Overall Study|Ineligible prior to treatment|0
7836147|NCT01369849|12311829|FG002|Overall Study|Ineligible prior to treatment|1
7836148|NCT01369849|12311827|FG000|Overall Study|Ineligible after receiving treatment|0
7836149|NCT01369849|12311828|FG001|Overall Study|Ineligible after receiving treatment|1
7836150|NCT01369849|12311829|FG002|Overall Study|Ineligible after receiving treatment|0
7862625|NCT01598987|12351586|FG000|Baseline to Month 12|Withdrawal by Subject|4
7862626|NCT01598987|12351586|FG000|Baseline to 24 Month|Withdrawal by Subject|5
7862627|NCT01598987|12351586|FG000|Baseline to 24 Month|Administrative problems|2
7862628|NCT01598987|12351586|FG000|Baseline to 24 Month|Lost to Follow-up|1
7862629|NCT01599104|12351600|FG000|Overall Study|Withdrawal by Subject|1
7862630|NCT01599104|12351601|FG001|Overall Study|Withdrawal by Subject|1
7862631|NCT01599104|12351602|FG002|Overall Study|Withdrawal by Subject|2
7862632|NCT01599104|12351600|FG000|Overall Study|Technical Problems|1
7862633|NCT01599104|12351601|FG001|Overall Study|Technical Problems|0
7862634|NCT01599104|12351602|FG002|Overall Study|Technical Problems|0
7862635|NCT01599104|12351600|FG000|Overall Study|Physician Decision|3
7862636|NCT01599104|12351601|FG001|Overall Study|Physician Decision|2
7862637|NCT01599104|12351602|FG002|Overall Study|Physician Decision|2
7862638|NCT01599104|12351600|FG000|Overall Study|Non-compliance with study treatment|0
7862639|NCT01599104|12351601|FG001|Overall Study|Non-compliance with study treatment|1
7862640|NCT01599104|12351602|FG002|Overall Study|Non-compliance with study treatment|0
7862641|NCT01599104|12351600|FG000|Overall Study|Lack of Efficacy|4
7862642|NCT01599104|12351601|FG001|Overall Study|Lack of Efficacy|4
7862643|NCT01599104|12351602|FG002|Overall Study|Lack of Efficacy|10
7862644|NCT01599104|12351600|FG000|Overall Study|Adverse Event|7
7862645|NCT01599104|12351601|FG001|Overall Study|Adverse Event|6
7862646|NCT01599104|12351602|FG002|Overall Study|Adverse Event|12
7862647|NCT01599234|12351612|FG000|Overall Study|Adverse Event|9
7862648|NCT01599234|12351613|FG001|Overall Study|Adverse Event|5
7862649|NCT01599234|12351612|FG000|Overall Study|Withdrawal by Subject|2
7862650|NCT01599234|12351613|FG001|Overall Study|Withdrawal by Subject|1
7862651|NCT01599234|12351612|FG000|Overall Study|Lost to Follow-up|1
7862652|NCT01599234|12351613|FG001|Overall Study|Lost to Follow-up|2
7862653|NCT01599234|12351612|FG000|Overall Study|Lack of Efficacy|2
7862654|NCT01599234|12351613|FG001|Overall Study|Lack of Efficacy|4
7862655|NCT01599234|12351612|FG000|Overall Study|Unable to operate spray|1
7862656|NCT01599234|12351613|FG001|Overall Study|Unable to operate spray|0
7862657|NCT01599234|12351612|FG000|Overall Study|Sponsor request as creatinine levels <50|0
7862658|NCT01599234|12351613|FG001|Overall Study|Sponsor request as creatinine levels <50|1
7862659|NCT01599234|12351612|FG000|Overall Study|Death|1
7862660|NCT01599234|12351613|FG001|Overall Study|Death|0
7862661|NCT01599234|12351612|FG000|Overall Study|Patient would not stop driving|1
7862662|NCT01599234|12351613|FG001|Overall Study|Patient would not stop driving|0
7862663|NCT01599234|12351612|FG000|Overall Study|Contra-indication discovered|0
7862664|NCT01599234|12351613|FG001|Overall Study|Contra-indication discovered|1
7862665|NCT01599234|12351612|FG000|Overall Study|Pregnancy|0
7862666|NCT01599234|12351613|FG001|Overall Study|Pregnancy|1
7862667|NCT01599325|12351628|FG000|Primary Parent Phase|Adverse Event|5
7862668|NCT01599325|12351628|FG000|Primary Parent Phase|Disease Progression|7
7862669|NCT01599325|12351628|FG000|Primary Parent Phase|Withdrawal by Subject|20
7862670|NCT01599325|12351628|FG000|Primary Parent Phase|Death|13
7862671|NCT01599325|12351628|FG000|Primary Parent Phase|Protocol Violation|1
7862672|NCT01599325|12351628|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9
7862673|NCT01599325|12351628|FG000|Primary Parent Phase|Other|2
7862674|NCT01599325|12351628|FG000|Extension Phase|Study Closure|1
7862675|NCT01599325|12351628|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1
7862676|NCT01599325|12351628|FG000|Extension Phase|Lack of Therapeutic Effect|4
7862677|NCT01599325|12351628|FG000|Extension Phase|Disease Progression|1
7862678|NCT01599325|12351628|FG000|Extension Phase|Withdrawal by Subject|8
7862679|NCT01599585|12351635|FG000|Overall Study|Withdrawal by Subject|16
7862680|NCT01599585|12351636|FG001|Overall Study|Withdrawal by Subject|9
7862681|NCT01599585|12351635|FG000|Overall Study|Lost to Follow-up|3
7862682|NCT01599585|12351636|FG001|Overall Study|Lost to Follow-up|5
7862683|NCT01599585|12351635|FG000|Overall Study|randomized did not start treatment|3
7862684|NCT01599585|12351636|FG001|Overall Study|randomized did not start treatment|3
7862685|NCT01599637|12351645|FG000|Overall Study|administrative problems|0
7862686|NCT01599637|12351646|FG001|Overall Study|administrative problems|2
7862687|NCT01599637|12351647|FG002|Overall Study|administrative problems|0
7862688|NCT01599637|12351645|FG000|Overall Study|Adverse Event|1
7862689|NCT01599637|12351646|FG001|Overall Study|Adverse Event|0
7862690|NCT01599637|12351647|FG002|Overall Study|Adverse Event|0
7862691|NCT01599650|12351660|FG000|Overall Study|Administrative issue|1
7862692|NCT01599650|12351661|FG001|Overall Study|Administrative issue|0
7862693|NCT01599650|12351662|FG002|Overall Study|Administrative issue|1
7862694|NCT01599650|12351660|FG000|Overall Study|Physician Decision|2
7862695|NCT01599650|12351661|FG001|Overall Study|Physician Decision|0
7836151|NCT01370005|12311864|FG000|Overall Study|Not treated|1
7836152|NCT01370005|12311865|FG001|Overall Study|Not treated|0
7836153|NCT01370005|12311866|FG002|Overall Study|Not treated|0
7836154|NCT01370005|12311864|FG000|Overall Study|Adverse Event|5
7836155|NCT01370005|12311865|FG001|Overall Study|Adverse Event|5
7836156|NCT01370005|12311866|FG002|Overall Study|Adverse Event|6
7836157|NCT01370005|12311864|FG000|Overall Study|Lack of Efficacy|1
7836158|NCT01370005|12311865|FG001|Overall Study|Lack of Efficacy|0
7836159|NCT01370005|12311866|FG002|Overall Study|Lack of Efficacy|0
7836160|NCT01370005|12311864|FG000|Overall Study|Non compliant with protocol|0
7836161|NCT01370005|12311865|FG001|Overall Study|Non compliant with protocol|1
7836162|NCT01370005|12311866|FG002|Overall Study|Non compliant with protocol|2
7836163|NCT01370005|12311864|FG000|Overall Study|Lost to Follow-up|1
7836164|NCT01370005|12311865|FG001|Overall Study|Lost to Follow-up|1
7720776|NCT00541229|12145276|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
7720777|NCT00541229|12145277|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
7720778|NCT00541229|12145278|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
7720779|NCT00541229|12145279|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
7720780|NCT00541229|12145280|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
7720781|NCT00541229|12145281|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
7720782|NCT00541307|12145298|FG000|Overall Study|Death|5
7720783|NCT00541307|12145298|FG000|Overall Study|Physician Decision|3
7720784|NCT00541307|12145298|FG000|Overall Study|Withdrawal by Subject|6
7720785|NCT00541307|12145298|FG000|Overall Study|Lost to Follow-up|4
7720786|NCT00541307|12145298|FG000|Overall Study|Subject returned early (outside window)|1
7720787|NCT00541307|12145298|FG000|Overall Study|Surgical Bypass|5
7720788|NCT00541346|12145302|FG000|Follow-up|Adverse Event|1
7720789|NCT00541385|12145308|FG000|Overall Study|Adverse Event|6
7720790|NCT00541385|12145309|FG001|Overall Study|Adverse Event|3
7836165|NCT01370005|12311866|FG002|Overall Study|Lost to Follow-up|1
7836166|NCT01370005|12311864|FG000|Overall Study|Patient refusal to continue,not due toAE|5
7836167|NCT01370005|12311865|FG001|Overall Study|Patient refusal to continue,not due toAE|4
7836168|NCT01370005|12311866|FG002|Overall Study|Patient refusal to continue,not due toAE|0
7836169|NCT01370005|12311864|FG000|Overall Study|Other reason not defined above|3
7836170|NCT01370005|12311865|FG001|Overall Study|Other reason not defined above|0
7836171|NCT01370005|12311866|FG002|Overall Study|Other reason not defined above|2
7836172|NCT01370018|12311874|FG000|Overall Study|Did not meet criteria for analysis|1
7836173|NCT01370083|12311880|FG000|Overall Study|Lost to Follow-up|2
7836174|NCT01370083|12311881|FG001|Overall Study|Lost to Follow-up|0
7836175|NCT01370083|12311880|FG000|Overall Study|Adverse Event|0
7836176|NCT01370083|12311881|FG001|Overall Study|Adverse Event|1
7836177|NCT01370213|12311907|FG000|Overall Study|Early Death|1
7836178|NCT01370213|12311908|FG001|Overall Study|Early Death|0
7836179|NCT01370213|12311909|FG002|Overall Study|Early Death|0
7836180|NCT01370213|12311907|FG000|Overall Study|Not evaluable|0
7836181|NCT01370213|12311908|FG001|Overall Study|Not evaluable|2
7836182|NCT01370213|12311909|FG002|Overall Study|Not evaluable|0
7836183|NCT01370265|12311916|FG000|First Intervention|Adverse Event|1
7836184|NCT01370265|12311917|FG001|First Intervention|Adverse Event|1
7836185|NCT01370317|12311926|FG000|Overall Study|Participant withdrew consent|1
7836186|NCT01370317|12311927|FG001|Overall Study|Participant withdrew consent|0
7836187|NCT01370317|12311926|FG000|Overall Study|Protocol deviation|0
7836188|NCT01370317|12311927|FG001|Overall Study|Protocol deviation|1
7836189|NCT01370356|12311935|FG000|Overall Study|Death|1
7836190|NCT01370356|12311936|FG001|Overall Study|Death|0
7836191|NCT01370356|12311935|FG000|Overall Study|Lack of Efficacy|6
7836192|NCT01370356|12311936|FG001|Overall Study|Lack of Efficacy|28
7836193|NCT01370356|12311935|FG000|Overall Study|Lost to Follow-up|76
7836194|NCT01370356|12311936|FG001|Overall Study|Lost to Follow-up|81
7836195|NCT01370356|12311935|FG000|Overall Study|Withdrawal by Subject|54
7836196|NCT01370356|12311936|FG001|Overall Study|Withdrawal by Subject|59
7836197|NCT01370356|12311935|FG000|Overall Study|Reason not specified|39
7836198|NCT01370356|12311936|FG001|Overall Study|Reason not specified|43
7836199|NCT01370356|12311935|FG000|Overall Study|Protocol Violation|3
7836200|NCT01370356|12311936|FG001|Overall Study|Protocol Violation|3
7836201|NCT01370356|12311935|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12
7836202|NCT01370356|12311936|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9
7836203|NCT01370356|12311935|FG000|Overall Study|AE Not Related to Study Drug|1
7836204|NCT01370356|12311936|FG001|Overall Study|AE Not Related to Study Drug|4
7836205|NCT01370408|12311955|FG000|Overall Study|treatment failure|9
7836206|NCT01370499|12311971|FG000|Overall Study|Adverse Event|38
7836207|NCT01370499|12311972|FG001|Overall Study|Adverse Event|12
7836208|NCT01370499|12311971|FG000|Overall Study|Lack of Efficacy|4
7836209|NCT01370499|12311972|FG001|Overall Study|Lack of Efficacy|2
7836210|NCT01370499|12311971|FG000|Overall Study|Lost to Follow-up|2
7836211|NCT01370499|12311972|FG001|Overall Study|Lost to Follow-up|1
7836212|NCT01370499|12311971|FG000|Overall Study|Physician Decision|3
7836213|NCT01370499|12311972|FG001|Overall Study|Physician Decision|3
7836214|NCT01370499|12311971|FG000|Overall Study|Protocol Violation|5
7836215|NCT01370499|12311972|FG001|Overall Study|Protocol Violation|4
7836216|NCT01370499|12311971|FG000|Overall Study|Withdrawal by Subject|18
7836217|NCT01370499|12311972|FG001|Overall Study|Withdrawal by Subject|7
7836218|NCT01370499|12311971|FG000|Overall Study|Sponsor Decision|41
7836219|NCT01370499|12311972|FG001|Overall Study|Sponsor Decision|15
7836220|NCT01370525|12311982|FG000|Overall Study|Voluntary Discontinuation by Subject|2
7836221|NCT01370525|12311983|FG001|Overall Study|Voluntary Discontinuation by Subject|3
7836222|NCT01370525|12311982|FG000|Overall Study|Eligibility criteria not fulfilled|2
7836223|NCT01370525|12311983|FG001|Overall Study|Eligibility criteria not fulfilled|0
7836224|NCT01370525|12311982|FG000|Overall Study|Adverse Event|0
7836225|NCT01370525|12311983|FG001|Overall Study|Adverse Event|1
7836226|NCT01370525|12311982|FG000|Overall Study|Protocol Violation|2
7836227|NCT01370525|12311983|FG001|Overall Study|Protocol Violation|1
7836228|NCT01370525|12311982|FG000|Overall Study|Lost to follow up|2
7836229|NCT01370525|12311983|FG001|Overall Study|Lost to follow up|6
7836230|NCT01370538|12311991|FG000|Overall Study|Voluntary Discontinuation by Subject|3
7836231|NCT01370538|12311992|FG001|Overall Study|Voluntary Discontinuation by Subject|2
7836232|NCT01370538|12311991|FG000|Overall Study|Eligibility criteria not fulfilled|0
7836233|NCT01370538|12311992|FG001|Overall Study|Eligibility criteria not fulfilled|1
7836234|NCT01370538|12311991|FG000|Overall Study|Adverse Event|1
7836235|NCT01370538|12311992|FG001|Overall Study|Adverse Event|0
7836236|NCT01370538|12311991|FG000|Overall Study|Protocol Violation|8
7836237|NCT01370538|12311992|FG001|Overall Study|Protocol Violation|5
7836238|NCT01370538|12311991|FG000|Overall Study|Development of study specific withdrawal|1
7836239|NCT01370538|12311992|FG001|Overall Study|Development of study specific withdrawal|1
7836240|NCT01370538|12311991|FG000|Overall Study|Lost to follow up|6
7836241|NCT01370538|12311992|FG001|Overall Study|Lost to follow up|10
7836242|NCT01370616|12312004|FG000|Overall Study|Adverse Event|11
7836243|NCT01370616|12312005|FG001|Overall Study|Adverse Event|16
7836244|NCT01370616|12312004|FG000|Overall Study|Death|1
7836245|NCT01370616|12312005|FG001|Overall Study|Death|0
7836246|NCT01370616|12312004|FG000|Overall Study|Lack of Efficacy|6
7836247|NCT01370616|12312005|FG001|Overall Study|Lack of Efficacy|2
7836248|NCT01370616|12312004|FG000|Overall Study|Lost to Follow-up|0
7836249|NCT01370616|12312005|FG001|Overall Study|Lost to Follow-up|3
7836250|NCT01370616|12312004|FG000|Overall Study|Physician Decision|6
7836251|NCT01370616|12312005|FG001|Overall Study|Physician Decision|6
7836252|NCT01370616|12312004|FG000|Overall Study|Progressive Disease|0
7836253|NCT01370616|12312005|FG001|Overall Study|Progressive Disease|1
7836254|NCT01370616|12312004|FG000|Overall Study|Recovery|1
7836255|NCT01370616|12312005|FG001|Overall Study|Recovery|0
7836256|NCT01370616|12312004|FG000|Overall Study|Technical Problems|3
7836257|NCT01370616|12312005|FG001|Overall Study|Technical Problems|5
7836258|NCT01370616|12312004|FG000|Overall Study|Withdrawal by Subject|34
7836259|NCT01370616|12312005|FG001|Overall Study|Withdrawal by Subject|34
7836260|NCT01370642|12312018|FG000|Overall Study|Adverse Event|2
7836261|NCT01370642|12312019|FG001|Overall Study|Adverse Event|1
7836262|NCT01370642|12312020|FG002|Overall Study|Adverse Event|1
7836263|NCT01370642|12312018|FG000|Overall Study|Detectable HCV RNA|0
7836264|NCT01370642|12312019|FG001|Overall Study|Detectable HCV RNA|0
7836265|NCT01370642|12312020|FG002|Overall Study|Detectable HCV RNA|22
7836266|NCT01370642|12312018|FG000|Overall Study|Lost to Follow-up|0
7836267|NCT01370642|12312019|FG001|Overall Study|Lost to Follow-up|0
7836268|NCT01370642|12312020|FG002|Overall Study|Lost to Follow-up|1
7836269|NCT01370642|12312018|FG000|Overall Study|Physician Decision|4
7836270|NCT01370642|12312019|FG001|Overall Study|Physician Decision|1
7836271|NCT01370642|12312020|FG002|Overall Study|Physician Decision|2
7836272|NCT01370642|12312018|FG000|Overall Study|Withdrawal by Subject|2
7836273|NCT01370642|12312019|FG001|Overall Study|Withdrawal by Subject|4
7836274|NCT01370642|12312020|FG002|Overall Study|Withdrawal by Subject|3
7836275|NCT01370655|12312040|FG000|Period 1|Adverse Event|2
7836276|NCT01370655|12312041|FG001|Period 1|Adverse Event|0
7836277|NCT01370655|12312042|FG002|Period 1|Adverse Event|0
7836278|NCT01370655|12312043|FG003|Period 1|Adverse Event|0
7836279|NCT01370655|12312044|FG004|Period 1|Adverse Event|0
7836280|NCT01370655|12312045|FG005|Period 1|Adverse Event|0
7836281|NCT01370655|12312046|FG006|Period 1|Adverse Event|1
7836282|NCT01370655|12312047|FG007|Period 1|Adverse Event|0
7836283|NCT01370655|12312048|FG008|Period 1|Adverse Event|0
7836284|NCT01370655|12312049|FG009|Period 1|Adverse Event|0
7836285|NCT01370655|12312050|FG010|Period 1|Adverse Event|0
7836286|NCT01370655|12312051|FG011|Period 1|Adverse Event|0
7836287|NCT01370655|12312040|FG000|Period 2|Adverse Event|0
7836288|NCT01370655|12312041|FG001|Period 2|Adverse Event|0
7836289|NCT01370655|12312042|FG002|Period 2|Adverse Event|1
7836290|NCT01370655|12312043|FG003|Period 2|Adverse Event|0
7836291|NCT01370655|12312044|FG004|Period 2|Adverse Event|1
7836292|NCT01370655|12312045|FG005|Period 2|Adverse Event|0
7836293|NCT01370655|12312046|FG006|Period 2|Adverse Event|0
7836294|NCT01370655|12312047|FG007|Period 2|Adverse Event|1
7836295|NCT01370655|12312048|FG008|Period 2|Adverse Event|0
7836296|NCT01370655|12312049|FG009|Period 2|Adverse Event|0
7836297|NCT01370655|12312050|FG010|Period 2|Adverse Event|0
7836298|NCT01370655|12312051|FG011|Period 2|Adverse Event|0
7836299|NCT01370655|12312040|FG000|Period 2|met protocol specified stopping criteria|0
7836300|NCT01370655|12312041|FG001|Period 2|met protocol specified stopping criteria|0
7836301|NCT01370655|12312042|FG002|Period 2|met protocol specified stopping criteria|1
7836302|NCT01370655|12312043|FG003|Period 2|met protocol specified stopping criteria|0
7836303|NCT01370655|12312044|FG004|Period 2|met protocol specified stopping criteria|0
7836304|NCT01370655|12312045|FG005|Period 2|met protocol specified stopping criteria|0
7836305|NCT01370655|12312046|FG006|Period 2|met protocol specified stopping criteria|1
7836306|NCT01370655|12312047|FG007|Period 2|met protocol specified stopping criteria|0
7836307|NCT01370655|12312048|FG008|Period 2|met protocol specified stopping criteria|1
7836308|NCT01370655|12312049|FG009|Period 2|met protocol specified stopping criteria|0
7836309|NCT01370655|12312050|FG010|Period 2|met protocol specified stopping criteria|1
7836310|NCT01370655|12312051|FG011|Period 2|met protocol specified stopping criteria|0
7836311|NCT01370655|12312040|FG000|Period 2|Withdrawal by Subject|0
7836312|NCT01370655|12312041|FG001|Period 2|Withdrawal by Subject|0
7836313|NCT01370655|12312042|FG002|Period 2|Withdrawal by Subject|0
7836314|NCT01370655|12312043|FG003|Period 2|Withdrawal by Subject|0
7836315|NCT01370655|12312044|FG004|Period 2|Withdrawal by Subject|0
7836316|NCT01370655|12312045|FG005|Period 2|Withdrawal by Subject|0
7836317|NCT01370655|12312046|FG006|Period 2|Withdrawal by Subject|0
7836318|NCT01370655|12312047|FG007|Period 2|Withdrawal by Subject|0
7836319|NCT01370655|12312048|FG008|Period 2|Withdrawal by Subject|1
7836320|NCT01370655|12312049|FG009|Period 2|Withdrawal by Subject|0
7836321|NCT01370655|12312050|FG010|Period 2|Withdrawal by Subject|0
7836322|NCT01370655|12312051|FG011|Period 2|Withdrawal by Subject|0
7836323|NCT01370694|12312061|FG000|Overall Study|Switched to rituximab|4
7836324|NCT01370694|12312061|FG000|Overall Study|Progressive disease|2
7836325|NCT01370733|12312067|FG000|Overall Study|Withdrawal by Subject|8
7836326|NCT01370733|12312068|FG001|Overall Study|Withdrawal by Subject|8
7836327|NCT01370733|12312067|FG000|Overall Study|Lost to Follow-up|3
7836328|NCT01370733|12312068|FG001|Overall Study|Lost to Follow-up|0
7836329|NCT01370733|12312067|FG000|Overall Study|Adverse Event|2
7836330|NCT01370733|12312068|FG001|Overall Study|Adverse Event|4
7836331|NCT01370733|12312067|FG000|Overall Study|Lack of Efficacy|3
7836332|NCT01370733|12312068|FG001|Overall Study|Lack of Efficacy|5
7836333|NCT01370733|12312067|FG000|Overall Study|Physician Decision|0
7836334|NCT01370733|12312068|FG001|Overall Study|Physician Decision|2
7836335|NCT01370733|12312067|FG000|Overall Study|Protocol Violation|1
7836336|NCT01370733|12312068|FG001|Overall Study|Protocol Violation|3
7836337|NCT01370863|12312089|FG000|Overall Study|Adverse Event|1
7836338|NCT01370863|12312090|FG001|Overall Study|Adverse Event|1
7836339|NCT01370863|12312089|FG000|Overall Study|Did not want second pH/MII monitoring|1
7836340|NCT01370863|12312090|FG001|Overall Study|Did not want second pH/MII monitoring|1
7836341|NCT01370863|12312089|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0
7836342|NCT01370863|12312090|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
7836343|NCT01371006|12312098|FG000|Overall Study|Adverse Event|1
7836344|NCT01371006|12312099|FG001|Overall Study|Adverse Event|0
7836345|NCT01371539|12312145|FG000|Period One: One Week|Lost to Follow-up|0
7836346|NCT01371539|12312146|FG001|Period One: One Week|Lost to Follow-up|1
7836347|NCT01371539|12312145|FG000|Period Two: One Week|Lost to Follow-up|0
7836348|NCT01371539|12312146|FG001|Period Two: One Week|Lost to Follow-up|1
7836349|NCT01371539|12312145|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0
7836350|NCT01371539|12312146|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1
7836351|NCT01371539|12312145|FG000|Period Two: One Week|Time/job conflict|0
7836352|NCT01371539|12312146|FG001|Period Two: One Week|Time/job conflict|1
7836353|NCT01371552|12312152|FG000|Part 1, First 3 Days|Inconvenience|0
7836354|NCT01371552|12312153|FG001|Part 1, First 3 Days|Inconvenience|0
7836355|NCT01371552|12312154|FG002|Part 1, First 3 Days|Inconvenience|1
7836356|NCT01371552|12312155|FG003|Part 1, First 3 Days|Inconvenience|0
7836357|NCT01371552|12312156|FG004|Part 1, First 3 Days|Inconvenience|0
7836358|NCT01371552|12312157|FG005|Part 1, First 3 Days|Inconvenience|0
7836359|NCT01371565|12312166|FG000|Overall Study|Withdrawal by Subject|1
7836360|NCT01371565|12312166|FG000|Overall Study|Death|1
7836361|NCT01371565|12312166|FG000|Overall Study|Resection of neuroendocrine tumor|1
7836362|NCT01371643|12312172|FG000|Overall Study|Withdrawal by Subject|3
7836363|NCT01371643|12312173|FG001|Overall Study|Withdrawal by Subject|0
7836364|NCT01371656|12312181|FG000|Overall Study|Death|7
7836365|NCT01371656|12312182|FG001|Overall Study|Death|4
7836366|NCT01371656|12312181|FG000|Overall Study|Physician Decision|46
7836367|NCT01371656|12312182|FG001|Overall Study|Physician Decision|7
7836368|NCT01371656|12312181|FG000|Overall Study|Withdrawal by Subject|7
7836369|NCT01371656|12312182|FG001|Overall Study|Withdrawal by Subject|0
7836370|NCT01371656|12312181|FG000|Overall Study|Ineligible|4
7836371|NCT01371656|12312182|FG001|Overall Study|Ineligible|3
7836372|NCT01371708|12312191|FG000|Overall Study|Insufficient clinical response|3
7836373|NCT01371708|12312192|FG001|Overall Study|Insufficient clinical response|2
7836374|NCT01371708|12312193|FG002|Overall Study|Insufficient clinical response|0
7836375|NCT01371708|12312191|FG000|Overall Study|Lost to Follow-up|5
7836376|NCT01371708|12312192|FG001|Overall Study|Lost to Follow-up|9
7836377|NCT01371708|12312193|FG002|Overall Study|Lost to Follow-up|7
7836378|NCT01371708|12312191|FG000|Overall Study|Protocol Violation|2
7836379|NCT01371708|12312192|FG001|Overall Study|Protocol Violation|1
7836380|NCT01371708|12312193|FG002|Overall Study|Protocol Violation|2
7836381|NCT01371708|12312191|FG000|Overall Study|No longer willing to participate|7
7836382|NCT01371708|12312192|FG001|Overall Study|No longer willing to participate|7
7836383|NCT01371708|12312193|FG002|Overall Study|No longer willing to participate|13
7836384|NCT01371708|12312191|FG000|Overall Study|Medication error/not related to AE|0
7836385|NCT01371708|12312192|FG001|Overall Study|Medication error/not related to AE|1
7836386|NCT01371708|12312193|FG002|Overall Study|Medication error/not related to AE|0
7836387|NCT01371708|12312191|FG000|Overall Study|Other|3
7836388|NCT01371708|12312192|FG001|Overall Study|Other|2
7836389|NCT01371708|12312193|FG002|Overall Study|Other|4
7836390|NCT01371708|12312191|FG000|Overall Study|Adverse Event|5
7836391|NCT01371708|12312192|FG001|Overall Study|Adverse Event|8
7836392|NCT01371708|12312193|FG002|Overall Study|Adverse Event|12
7836393|NCT01371708|12312191|FG000|Overall Study|Started but did not receive treatment|1
7836394|NCT01371708|12312192|FG001|Overall Study|Started but did not receive treatment|0
7836395|NCT01371708|12312193|FG002|Overall Study|Started but did not receive treatment|1
7836396|NCT01371721|12312206|FG000|Overall Study|Adverse Event|5
7836397|NCT01371721|12312207|FG001|Overall Study|Adverse Event|4
7836398|NCT01371721|12312208|FG002|Overall Study|Adverse Event|5
7836399|NCT01371721|12312206|FG000|Overall Study|Protocol Violation|6
7836400|NCT01371721|12312207|FG001|Overall Study|Protocol Violation|4
7836401|NCT01371721|12312208|FG002|Overall Study|Protocol Violation|5
7836402|NCT01371721|12312206|FG000|Overall Study|Lost to Follow-up|8
7836403|NCT01371721|12312207|FG001|Overall Study|Lost to Follow-up|2
7836404|NCT01371721|12312208|FG002|Overall Study|Lost to Follow-up|6
7836405|NCT01371721|12312206|FG000|Overall Study|Withdrawal by Subject|5
7836406|NCT01371721|12312207|FG001|Overall Study|Withdrawal by Subject|7
7836407|NCT01371721|12312208|FG002|Overall Study|Withdrawal by Subject|11
7836408|NCT01371721|12312206|FG000|Overall Study|Other|2
7836409|NCT01371721|12312207|FG001|Overall Study|Other|3
7836410|NCT01371721|12312208|FG002|Overall Study|Other|0
7836411|NCT01371721|12312206|FG000|Overall Study|Lack of Efficacy|2
7836412|NCT01371721|12312207|FG001|Overall Study|Lack of Efficacy|4
7836413|NCT01371721|12312208|FG002|Overall Study|Lack of Efficacy|3
7836414|NCT01371721|12312206|FG000|Overall Study|Randomized but not treated|1
7836415|NCT01371721|12312207|FG001|Overall Study|Randomized but not treated|0
7836416|NCT01371721|12312208|FG002|Overall Study|Randomized but not treated|0
7836417|NCT01371734|12312221|FG000|Overall Study|Other|2
7836418|NCT01371734|12312222|FG001|Overall Study|Other|1
7836419|NCT01371734|12312223|FG002|Overall Study|Other|2
7836420|NCT01371734|12312221|FG000|Overall Study|Withdrawal by Subject|3
7836421|NCT01371734|12312222|FG001|Overall Study|Withdrawal by Subject|4
7836422|NCT01371734|12312223|FG002|Overall Study|Withdrawal by Subject|9
7836423|NCT01371734|12312221|FG000|Overall Study|Lost to Follow-up|5
7836424|NCT01371734|12312222|FG001|Overall Study|Lost to Follow-up|3
7836425|NCT01371734|12312223|FG002|Overall Study|Lost to Follow-up|1
7836426|NCT01371734|12312221|FG000|Overall Study|Protocol Violation|3
7836427|NCT01371734|12312222|FG001|Overall Study|Protocol Violation|1
7836428|NCT01371734|12312223|FG002|Overall Study|Protocol Violation|2
7836429|NCT01371734|12312221|FG000|Overall Study|Adverse Event|8
7836430|NCT01371734|12312222|FG001|Overall Study|Adverse Event|8
7836431|NCT01371734|12312223|FG002|Overall Study|Adverse Event|3
7836432|NCT01371734|12312221|FG000|Overall Study|Lack of Efficacy|2
7836433|NCT01371734|12312222|FG001|Overall Study|Lack of Efficacy|2
7836434|NCT01371734|12312223|FG002|Overall Study|Lack of Efficacy|0
7836435|NCT01371747|12312237|FG000|Overall Study|Adverse Event|4
7836436|NCT01371747|12312238|FG001|Overall Study|Adverse Event|2
7836437|NCT01371747|12312239|FG002|Overall Study|Adverse Event|7
7836438|NCT01371747|12312240|FG003|Overall Study|Adverse Event|2
7836439|NCT01371747|12312241|FG004|Overall Study|Adverse Event|2
7836440|NCT01371747|12312242|FG005|Overall Study|Adverse Event|2
7836441|NCT01371747|12312237|FG000|Overall Study|Death|1
7836442|NCT01371747|12312238|FG001|Overall Study|Death|0
7836443|NCT01371747|12312239|FG002|Overall Study|Death|4
7836444|NCT01371747|12312240|FG003|Overall Study|Death|1
7836445|NCT01371747|12312241|FG004|Overall Study|Death|2
7836446|NCT01371747|12312242|FG005|Overall Study|Death|0
7836447|NCT01371747|12312237|FG000|Overall Study|Abnormal Renal Function|0
7836448|NCT01371747|12312238|FG001|Overall Study|Abnormal Renal Function|2
7836449|NCT01371747|12312239|FG002|Overall Study|Abnormal Renal Function|0
7836450|NCT01371747|12312240|FG003|Overall Study|Abnormal Renal Function|1
7836451|NCT01371747|12312241|FG004|Overall Study|Abnormal Renal Function|0
7836452|NCT01371747|12312242|FG005|Overall Study|Abnormal Renal Function|1
7836453|NCT01371747|12312237|FG000|Overall Study|High Serum Potassium Results|1
7836454|NCT01371747|12312238|FG001|Overall Study|High Serum Potassium Results|1
7836455|NCT01371747|12312239|FG002|Overall Study|High Serum Potassium Results|1
7836456|NCT01371747|12312240|FG003|Overall Study|High Serum Potassium Results|2
7836457|NCT01371747|12312241|FG004|Overall Study|High Serum Potassium Results|0
7836458|NCT01371747|12312242|FG005|Overall Study|High Serum Potassium Results|2
7836459|NCT01371747|12312237|FG000|Overall Study|Low Serum Potassium Results|1
7836460|NCT01371747|12312238|FG001|Overall Study|Low Serum Potassium Results|1
7836461|NCT01371747|12312239|FG002|Overall Study|Low Serum Potassium Results|1
7836462|NCT01371747|12312240|FG003|Overall Study|Low Serum Potassium Results|1
7836463|NCT01371747|12312241|FG004|Overall Study|Low Serum Potassium Results|0
7836464|NCT01371747|12312242|FG005|Overall Study|Low Serum Potassium Results|3
7836465|NCT01371747|12312237|FG000|Overall Study|Protocol Violation|0
7836466|NCT01371747|12312238|FG001|Overall Study|Protocol Violation|0
7836467|NCT01371747|12312239|FG002|Overall Study|Protocol Violation|1
7836468|NCT01371747|12312240|FG003|Overall Study|Protocol Violation|0
7836469|NCT01371747|12312241|FG004|Overall Study|Protocol Violation|0
7836470|NCT01371747|12312242|FG005|Overall Study|Protocol Violation|0
7836471|NCT01371747|12312237|FG000|Overall Study|Non-Compliance|3
7836472|NCT01371747|12312238|FG001|Overall Study|Non-Compliance|4
7836473|NCT01371747|12312239|FG002|Overall Study|Non-Compliance|3
7836474|NCT01371747|12312240|FG003|Overall Study|Non-Compliance|0
7836475|NCT01371747|12312241|FG004|Overall Study|Non-Compliance|0
7836476|NCT01371747|12312242|FG005|Overall Study|Non-Compliance|1
7836477|NCT01371747|12312237|FG000|Overall Study|Physician Decision|0
7836478|NCT01371747|12312238|FG001|Overall Study|Physician Decision|0
7836479|NCT01371747|12312239|FG002|Overall Study|Physician Decision|0
7836480|NCT01371747|12312240|FG003|Overall Study|Physician Decision|0
7836481|NCT01371747|12312241|FG004|Overall Study|Physician Decision|1
7836482|NCT01371747|12312242|FG005|Overall Study|Physician Decision|0
7836483|NCT01371747|12312237|FG000|Overall Study|Withdrawal by Subject|6
7836484|NCT01371747|12312238|FG001|Overall Study|Withdrawal by Subject|12
7836485|NCT01371747|12312239|FG002|Overall Study|Withdrawal by Subject|5
7836486|NCT01371747|12312240|FG003|Overall Study|Withdrawal by Subject|2
7836487|NCT01371747|12312241|FG004|Overall Study|Withdrawal by Subject|2
7836488|NCT01371747|12312242|FG005|Overall Study|Withdrawal by Subject|4
7836489|NCT01371747|12312237|FG000|Overall Study|Other Reasons|2
7836490|NCT01371747|12312238|FG001|Overall Study|Other Reasons|1
7836491|NCT01371747|12312239|FG002|Overall Study|Other Reasons|2
7836492|NCT01371747|12312240|FG003|Overall Study|Other Reasons|0
7836493|NCT01371747|12312241|FG004|Overall Study|Other Reasons|0
7720791|NCT00541385|12145308|FG000|Overall Study|Withdrawal by Subject|2
7720792|NCT00541385|12145309|FG001|Overall Study|Withdrawal by Subject|2
7720793|NCT00541385|12145308|FG000|Overall Study|Lost to Follow-up|6
7720794|NCT00541385|12145309|FG001|Overall Study|Lost to Follow-up|1
7720795|NCT00541385|12145308|FG000|Overall Study|Parasite reappearance/malaria|67
7720796|NCT00541385|12145309|FG001|Overall Study|Parasite reappearance/malaria|32
7720797|NCT00541450|12145317|FG000|Phase A|Adverse Event|3
7720798|NCT00541450|12145318|FG001|Phase A|Adverse Event|0
7720799|NCT00541450|12145317|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0
7720800|NCT00541450|12145318|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2
7720801|NCT00541450|12145317|FG000|Phase A|Hyperglycemia|0
7720802|NCT00541450|12145318|FG001|Phase A|Hyperglycemia|1
7720803|NCT00541450|12145317|FG000|Phase A|Lost to Follow-up|6
7720804|NCT00541450|12145318|FG001|Phase A|Lost to Follow-up|4
7720805|NCT00541450|12145317|FG000|Phase A|Physician Decision|2
7720806|NCT00541450|12145318|FG001|Phase A|Physician Decision|0
7720807|NCT00541450|12145317|FG000|Phase A|Protocol Violation|2
7720808|NCT00541450|12145318|FG001|Phase A|Protocol Violation|3
7720809|NCT00541450|12145317|FG000|Phase A|Withdrawal by Subject|7
7720810|NCT00541450|12145318|FG001|Phase A|Withdrawal by Subject|7
7720811|NCT00541450|12145317|FG000|Phase B|Adverse Event|6
7720812|NCT00541450|12145318|FG001|Phase B|Adverse Event|6
7720813|NCT00541450|12145317|FG000|Phase B|Hyperglycemia|10
7836494|NCT01371747|12312242|FG005|Overall Study|Other Reasons|1
7836495|NCT01371825|12312266|FG000|Overall Study|Death|4
7720814|NCT00541450|12145318|FG001|Phase B|Hyperglycemia|9
7720815|NCT00541450|12145317|FG000|Phase B|Lost to Follow-up|6
7720816|NCT00541450|12145318|FG001|Phase B|Lost to Follow-up|4
7720817|NCT00541450|12145317|FG000|Phase B|Physician Decision|4
7720818|NCT00541450|12145318|FG001|Phase B|Physician Decision|2
7720819|NCT00541450|12145317|FG000|Phase B|Pregnancy|0
7720820|NCT00541450|12145318|FG001|Phase B|Pregnancy|1
7720821|NCT00541450|12145317|FG000|Phase B|Protocol Violation|3
7720822|NCT00541450|12145318|FG001|Phase B|Protocol Violation|3
7720823|NCT00541450|12145317|FG000|Phase B|Withdrawal by Subject|8
7720824|NCT00541450|12145318|FG001|Phase B|Withdrawal by Subject|6
7720825|NCT00541658|12145335|FG000|Overall Study|Adverse Event|28
7720826|NCT00541658|12145336|FG001|Overall Study|Adverse Event|37
7720827|NCT00541658|12145337|FG002|Overall Study|Adverse Event|25
7720828|NCT00541658|12145335|FG000|Overall Study|Physician Decision|0
7720829|NCT00541658|12145336|FG001|Overall Study|Physician Decision|0
7720830|NCT00541658|12145337|FG002|Overall Study|Physician Decision|4
7720831|NCT00541658|12145335|FG000|Overall Study|Lost to Follow-up|3
7720832|NCT00541658|12145336|FG001|Overall Study|Lost to Follow-up|3
7720833|NCT00541658|12145337|FG002|Overall Study|Lost to Follow-up|6
7720834|NCT00541658|12145335|FG000|Overall Study|Protocol Violation|0
7720835|NCT00541658|12145336|FG001|Overall Study|Protocol Violation|1
7720836|NCT00541658|12145337|FG002|Overall Study|Protocol Violation|1
7720837|NCT00541658|12145335|FG000|Overall Study|Withdrawal by Subject|28
7720838|NCT00541658|12145336|FG001|Overall Study|Withdrawal by Subject|32
7720839|NCT00541658|12145337|FG002|Overall Study|Withdrawal by Subject|32
7720840|NCT00541658|12145335|FG000|Overall Study|Took No Study Drug|1
7720841|NCT00541658|12145336|FG001|Overall Study|Took No Study Drug|0
7720842|NCT00541658|12145337|FG002|Overall Study|Took No Study Drug|0
7720843|NCT00541775|12145359|FG000|Overall Study|Adverse Event|3
7720844|NCT00541775|12145360|FG001|Overall Study|Adverse Event|2
7720845|NCT00541775|12145361|FG002|Overall Study|Adverse Event|1
7720846|NCT00541775|12145359|FG000|Overall Study|Lack of Efficacy|0
7720847|NCT00541775|12145360|FG001|Overall Study|Lack of Efficacy|0
7720848|NCT00541775|12145361|FG002|Overall Study|Lack of Efficacy|3
7720849|NCT00541775|12145359|FG000|Overall Study|Lost to Follow-up|0
7720850|NCT00541775|12145360|FG001|Overall Study|Lost to Follow-up|0
7836496|NCT01371838|12312272|FG000|Overall Study|Withdrawal by Subject|27
7836497|NCT01371838|12312273|FG001|Overall Study|Withdrawal by Subject|33
7720851|NCT00541775|12145361|FG002|Overall Study|Lost to Follow-up|2
7836498|NCT01371838|12312272|FG000|Overall Study|Lost to Follow-up|10
7836499|NCT01371838|12312273|FG001|Overall Study|Lost to Follow-up|20
7836500|NCT01371838|12312272|FG000|Overall Study|Death|3
7836501|NCT01371838|12312273|FG001|Overall Study|Death|4
7836502|NCT01371838|12312272|FG000|Overall Study|Protocol Violation|3
7836503|NCT01371838|12312273|FG001|Overall Study|Protocol Violation|0
7720852|NCT00541775|12145359|FG000|Overall Study|Protocol Violation|1
7720853|NCT00541775|12145360|FG001|Overall Study|Protocol Violation|0
7720854|NCT00541775|12145361|FG002|Overall Study|Protocol Violation|0
7720855|NCT00541775|12145359|FG000|Overall Study|Withdrawal by Subject and Other|5
7720856|NCT00541775|12145360|FG001|Overall Study|Withdrawal by Subject and Other|0
7720857|NCT00541775|12145361|FG002|Overall Study|Withdrawal by Subject and Other|2
7720858|NCT00541866|12145374|FG000|Overall Study|Adverse Event|3
7720859|NCT00541866|12145375|FG001|Overall Study|Adverse Event|0
7720860|NCT00541866|12145376|FG002|Overall Study|Adverse Event|0
7720861|NCT00541866|12145377|FG003|Overall Study|Adverse Event|0
7720862|NCT00541866|12145378|FG004|Overall Study|Adverse Event|0
7720863|NCT00541866|12145374|FG000|Overall Study|Death|1
7720864|NCT00541866|12145375|FG001|Overall Study|Death|0
7720865|NCT00541866|12145376|FG002|Overall Study|Death|0
7720866|NCT00541866|12145377|FG003|Overall Study|Death|0
7720867|NCT00541866|12145378|FG004|Overall Study|Death|0
7720868|NCT00541866|12145374|FG000|Overall Study|Lack of Efficacy|19
7720869|NCT00541866|12145375|FG001|Overall Study|Lack of Efficacy|15
7720870|NCT00541866|12145376|FG002|Overall Study|Lack of Efficacy|10
7720871|NCT00541866|12145377|FG003|Overall Study|Lack of Efficacy|12
7720872|NCT00541866|12145378|FG004|Overall Study|Lack of Efficacy|14
7720873|NCT00541866|12145374|FG000|Overall Study|Not Reported or Other|11
7720874|NCT00541866|12145375|FG001|Overall Study|Not Reported or Other|3
7720875|NCT00541866|12145376|FG002|Overall Study|Not Reported or Other|3
7720876|NCT00541866|12145377|FG003|Overall Study|Not Reported or Other|3
7720877|NCT00541866|12145378|FG004|Overall Study|Not Reported or Other|1
7720878|NCT00541866|12145374|FG000|Overall Study|Physician Decision|0
7720879|NCT00541866|12145375|FG001|Overall Study|Physician Decision|0
7720880|NCT00541866|12145376|FG002|Overall Study|Physician Decision|2
7720881|NCT00541866|12145377|FG003|Overall Study|Physician Decision|1
7720882|NCT00541866|12145378|FG004|Overall Study|Physician Decision|0
7720883|NCT00541931|12145408|FG000|Overall Study|Adverse Event|1
7720884|NCT00541931|12145409|FG001|Overall Study|Adverse Event|0
7836504|NCT01371838|12312272|FG000|Overall Study|Investigator Decision|3
7836505|NCT01371838|12312273|FG001|Overall Study|Investigator Decision|8
7836506|NCT01371838|12312272|FG000|Overall Study|Last follow-up visit not conducted|2
7836507|NCT01371838|12312273|FG001|Overall Study|Last follow-up visit not conducted|0
7836508|NCT01371838|12312272|FG000|Overall Study|Lack of therapeutic response|0
7836509|NCT01371838|12312273|FG001|Overall Study|Lack of therapeutic response|1
7836510|NCT01371838|12312272|FG000|Overall Study|Surgery|1
7836511|NCT01371838|12312273|FG001|Overall Study|Surgery|0
7836512|NCT01371851|12312281|FG000|Overall Study|Lost to Follow-up|5
7836513|NCT01371851|12312282|FG001|Overall Study|Lost to Follow-up|8
7836514|NCT01371851|12312281|FG000|Overall Study|was arrested and put in jail|0
7836515|NCT01371851|12312282|FG001|Overall Study|was arrested and put in jail|1
7836516|NCT01371851|12312281|FG000|Overall Study|non study related adverse event|1
7836517|NCT01371851|12312282|FG001|Overall Study|non study related adverse event|0
7836518|NCT01371851|12312281|FG000|Overall Study|Blood Pressure outside study parameters|2
7836519|NCT01371851|12312282|FG001|Overall Study|Blood Pressure outside study parameters|0
7836520|NCT01371877|12312290|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0
7836521|NCT01371877|12312291|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4
7836522|NCT01371994|12312299|FG000|Overall Study|Adverse Event|3
7836523|NCT01371994|12312300|FG001|Overall Study|Adverse Event|6
7836524|NCT01371994|12312299|FG000|Overall Study|Lack of Efficacy|3
7836525|NCT01371994|12312300|FG001|Overall Study|Lack of Efficacy|0
7836526|NCT01371994|12312299|FG000|Overall Study|Withdrawal by Subject|13
7836527|NCT01371994|12312300|FG001|Overall Study|Withdrawal by Subject|7
7836528|NCT01371994|12312299|FG000|Overall Study|Lost to Follow-up|1
7836529|NCT01371994|12312300|FG001|Overall Study|Lost to Follow-up|1
7836530|NCT01371994|12312299|FG000|Overall Study|Protocol Violation|24
7836531|NCT01371994|12312300|FG001|Overall Study|Protocol Violation|17
7836532|NCT01371994|12312299|FG000|Overall Study|Randomized but Never Received Study Drug|6
7836533|NCT01371994|12312300|FG001|Overall Study|Randomized but Never Received Study Drug|6
7836534|NCT01371994|12312299|FG000|Overall Study|Physician Decision|1
7836535|NCT01371994|12312300|FG001|Overall Study|Physician Decision|1
7836536|NCT01371994|12312299|FG000|Overall Study|Miscellaneous Reasons|6
7836537|NCT01371994|12312300|FG001|Overall Study|Miscellaneous Reasons|4
7836538|NCT01372085|12312316|FG000|Washout Period 2|Physician Decision|0
7836539|NCT01372085|12312317|FG001|Washout Period 2|Physician Decision|0
7836540|NCT01372085|12312318|FG002|Washout Period 2|Physician Decision|0
7836541|NCT01372085|12312319|FG003|Washout Period 2|Physician Decision|0
7836542|NCT01372085|12312320|FG004|Washout Period 2|Physician Decision|1
7836543|NCT01372085|12312321|FG005|Washout Period 2|Physician Decision|0
7836544|NCT01372085|12312322|FG006|Washout Period 2|Physician Decision|0
7836545|NCT01372085|12312323|FG007|Washout Period 2|Physician Decision|0
7836546|NCT01372085|12312324|FG008|Washout Period 2|Physician Decision|0
7836547|NCT01372085|12312325|FG009|Washout Period 2|Physician Decision|0
7836548|NCT01372085|12312316|FG000|Washout Period 3|Withdrawal by Subject|0
7836549|NCT01372085|12312317|FG001|Washout Period 3|Withdrawal by Subject|0
7836550|NCT01372085|12312318|FG002|Washout Period 3|Withdrawal by Subject|0
7836551|NCT01372085|12312319|FG003|Washout Period 3|Withdrawal by Subject|0
7836552|NCT01372085|12312320|FG004|Washout Period 3|Withdrawal by Subject|0
7836553|NCT01372085|12312321|FG005|Washout Period 3|Withdrawal by Subject|2
7836554|NCT01372085|12312322|FG006|Washout Period 3|Withdrawal by Subject|0
7836555|NCT01372085|12312323|FG007|Washout Period 3|Withdrawal by Subject|0
7836556|NCT01372085|12312324|FG008|Washout Period 3|Withdrawal by Subject|0
7836557|NCT01372085|12312325|FG009|Washout Period 3|Withdrawal by Subject|0
7836558|NCT01372150|12312352|FG000|Overall Study|Lack of Efficacy|3
7836559|NCT01372150|12312353|FG001|Overall Study|Lack of Efficacy|0
7836560|NCT01372150|12312354|FG002|Overall Study|Lack of Efficacy|1
7836561|NCT01372150|12312352|FG000|Overall Study|Lost to Follow-up|4
7836562|NCT01372150|12312353|FG001|Overall Study|Lost to Follow-up|5
7836563|NCT01372150|12312354|FG002|Overall Study|Lost to Follow-up|6
7836564|NCT01372150|12312352|FG000|Overall Study|Protocol Violation|1
7836565|NCT01372150|12312353|FG001|Overall Study|Protocol Violation|0
7836566|NCT01372150|12312354|FG002|Overall Study|Protocol Violation|3
7836567|NCT01372150|12312352|FG000|Overall Study|Withdrawal by Subject|2
7836568|NCT01372150|12312353|FG001|Overall Study|Withdrawal by Subject|7
7836569|NCT01372150|12312354|FG002|Overall Study|Withdrawal by Subject|2
7836570|NCT01372150|12312352|FG000|Overall Study|Other|1
7836571|NCT01372150|12312353|FG001|Overall Study|Other|0
7836572|NCT01372150|12312354|FG002|Overall Study|Other|2
7836573|NCT01372150|12312352|FG000|Overall Study|Adverse Event|2
7836574|NCT01372150|12312353|FG001|Overall Study|Adverse Event|1
7836575|NCT01372150|12312354|FG002|Overall Study|Adverse Event|2
7836576|NCT01372150|12312352|FG000|Overall Study|Randomized but not treated|0
7836577|NCT01372150|12312353|FG001|Overall Study|Randomized but not treated|1
7836578|NCT01372150|12312354|FG002|Overall Study|Randomized but not treated|0
7836579|NCT01372384|12312380|FG000|Overall Study|Progression of disease|3
7836580|NCT01372410|12312384|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1
7836581|NCT01372410|12312385|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1
7836582|NCT01372410|12312386|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0
7836583|NCT01372410|12312387|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0
7836584|NCT01372410|12312388|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1
7836585|NCT01372410|12312389|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0
7836586|NCT01372410|12312390|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0
7836587|NCT01372410|12312391|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0
7836588|NCT01372410|12312384|FG000|Treatment Period 1 (7 Days)|Adverse Event|0
7836589|NCT01372410|12312385|FG001|Treatment Period 1 (7 Days)|Adverse Event|1
7836590|NCT01372410|12312386|FG002|Treatment Period 1 (7 Days)|Adverse Event|0
7836591|NCT01372410|12312387|FG003|Treatment Period 1 (7 Days)|Adverse Event|0
7836592|NCT01372410|12312388|FG004|Treatment Period 1 (7 Days)|Adverse Event|0
7836593|NCT01372410|12312389|FG005|Treatment Period 1 (7 Days)|Adverse Event|0
7836594|NCT01372410|12312390|FG006|Treatment Period 1 (7 Days)|Adverse Event|1
7836595|NCT01372410|12312391|FG007|Treatment Period 1 (7 Days)|Adverse Event|0
7836596|NCT01372410|12312384|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7836597|NCT01372410|12312385|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7836598|NCT01372410|12312386|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7836599|NCT01372410|12312387|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7836600|NCT01372410|12312388|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1
7836601|NCT01372410|12312389|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7836602|NCT01372410|12312390|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7836603|NCT01372410|12312391|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7836604|NCT01372410|12312384|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7836605|NCT01372410|12312385|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7836606|NCT01372410|12312386|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7836607|NCT01372410|12312387|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7836608|NCT01372410|12312388|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7836609|NCT01372410|12312389|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7836610|NCT01372410|12312390|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
7836611|NCT01372410|12312391|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7836612|NCT01372410|12312384|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
7836613|NCT01372410|12312385|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7836614|NCT01372410|12312386|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7836615|NCT01372410|12312387|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7836616|NCT01372410|12312388|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7836617|NCT01372410|12312389|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7836618|NCT01372410|12312390|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7836619|NCT01372410|12312391|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
7836620|NCT01372410|12312384|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0
7836621|NCT01372410|12312385|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0
7836622|NCT01372410|12312386|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0
7836623|NCT01372410|12312387|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0
7836624|NCT01372410|12312388|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1
7836625|NCT01372410|12312389|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0
7836626|NCT01372410|12312390|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0
7836627|NCT01372410|12312391|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0
7836628|NCT01372410|12312384|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
7836629|NCT01372410|12312385|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
7836630|NCT01372410|12312386|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
7836631|NCT01372410|12312387|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
7836632|NCT01372410|12312388|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
7836633|NCT01372410|12312389|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
7836634|NCT01372410|12312390|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
7836635|NCT01372410|12312391|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
7836636|NCT01372410|12312384|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7836637|NCT01372410|12312385|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7836638|NCT01372410|12312386|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7836639|NCT01372410|12312387|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7836640|NCT01372410|12312388|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7836641|NCT01372410|12312389|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7836642|NCT01372410|12312390|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7836643|NCT01372410|12312391|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
7836644|NCT01372410|12312384|FG000|Treatment Period 3 (7 Days)|Adverse Event|0
7836645|NCT01372410|12312385|FG001|Treatment Period 3 (7 Days)|Adverse Event|0
7836646|NCT01372410|12312386|FG002|Treatment Period 3 (7 Days)|Adverse Event|1
7836647|NCT01372410|12312387|FG003|Treatment Period 3 (7 Days)|Adverse Event|0
7836648|NCT01372410|12312388|FG004|Treatment Period 3 (7 Days)|Adverse Event|0
7836649|NCT01372410|12312389|FG005|Treatment Period 3 (7 Days)|Adverse Event|0
7836650|NCT01372410|12312390|FG006|Treatment Period 3 (7 Days)|Adverse Event|0
7836651|NCT01372410|12312391|FG007|Treatment Period 3 (7 Days)|Adverse Event|0
7836652|NCT01372410|12312384|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0
7836653|NCT01372410|12312385|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0
7836654|NCT01372410|12312386|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0
7836655|NCT01372410|12312387|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0
7836656|NCT01372410|12312388|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0
7836657|NCT01372410|12312389|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1
7836658|NCT01372410|12312390|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0
7836659|NCT01372410|12312391|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0
7836660|NCT01372501|12312420|FG000|Overall Study|Adverse Event|4
7836661|NCT01372501|12312420|FG000|Overall Study|Device migration|1
7836662|NCT01372605|12312427|FG000|Overall Study|Death|1
7836663|NCT01372605|12312428|FG001|Overall Study|Death|2
7836664|NCT01372605|12312427|FG000|Overall Study|Lost to Follow-up|2
7948787|NCT02531633|12494106|FG006|Part A (52 Weeks)|Protocol Violation|0
7836665|NCT01372605|12312428|FG001|Overall Study|Lost to Follow-up|1
7836666|NCT01372605|12312427|FG000|Overall Study|Withdrawal by Subject|4
7836667|NCT01372605|12312428|FG001|Overall Study|Withdrawal by Subject|7
7836668|NCT01372605|12312427|FG000|Overall Study|Moved|3
7836669|NCT01372605|12312428|FG001|Overall Study|Moved|0
7836670|NCT01372605|12312427|FG000|Overall Study|Changed medical home|2
7836671|NCT01372605|12312428|FG001|Overall Study|Changed medical home|0
7836672|NCT01372748|12312436|FG000|Overall Study|Lost to Follow-up|16
7836673|NCT01372748|12312437|FG001|Overall Study|Lost to Follow-up|34
7836674|NCT01372748|12312436|FG000|Overall Study|Withdrawal by Subject|7
7836675|NCT01372748|12312437|FG001|Overall Study|Withdrawal by Subject|5
7836676|NCT01372878|12312447|FG000|Overall Study|Withdrawal by Subject|63
7836677|NCT01372878|12312447|FG000|Overall Study|Protocol Violation|17
7836678|NCT01372878|12312447|FG000|Overall Study|incomplete study procedure|104
7836679|NCT01372995|12312454|FG000|Overall Study|Spouse withdrew participant from study|0
7836680|NCT01372995|12312455|FG001|Overall Study|Spouse withdrew participant from study|1
7836681|NCT01372995|12312456|FG002|Overall Study|Spouse withdrew participant from study|0
7836682|NCT01372995|12312454|FG000|Overall Study|Physician Decision|0
7836683|NCT01372995|12312455|FG001|Overall Study|Physician Decision|0
7836684|NCT01372995|12312456|FG002|Overall Study|Physician Decision|1
7836685|NCT01373164|12312469|FG000|Overall Study|Lost to Follow-up|0
7836686|NCT01373164|12312470|FG001|Overall Study|Lost to Follow-up|0
7836687|NCT01373164|12312471|FG002|Overall Study|Lost to Follow-up|1
7836688|NCT01373164|12312472|FG003|Overall Study|Lost to Follow-up|2
7836689|NCT01373164|12312473|FG004|Overall Study|Lost to Follow-up|0
7836690|NCT01373164|12312469|FG000|Overall Study|Withdrawal by Subject|0
7836691|NCT01373164|12312470|FG001|Overall Study|Withdrawal by Subject|1
7836692|NCT01373164|12312471|FG002|Overall Study|Withdrawal by Subject|0
7836693|NCT01373164|12312472|FG003|Overall Study|Withdrawal by Subject|10
7836694|NCT01373164|12312473|FG004|Overall Study|Withdrawal by Subject|2
7836695|NCT01373229|12312488|FG000|Overall Study|Death|3
7836696|NCT01373229|12312488|FG000|Overall Study|Physician Decision|3
7836697|NCT01373294|12312500|FG000|Overall Study|Adverse Event|1
7836698|NCT01373294|12312501|FG001|Overall Study|Adverse Event|0
7836699|NCT01373346|12312507|FG000|Overall Study|Death|1
7836700|NCT01373918|12312555|FG000|Overall Study|Physician Decision|0
7836701|NCT01373918|12312556|FG001|Overall Study|Physician Decision|1
7836702|NCT01373931|12312564|FG000|Lead-in Period|Adverse Event|2
7836703|NCT01373931|12312565|FG001|Lead-in Period|Adverse Event|0
7836704|NCT01373931|12312564|FG000|Period 1|Adverse Event|2
7836705|NCT01373931|12312565|FG001|Period 1|Adverse Event|0
7836706|NCT01373931|12312564|FG000|Period 1|Withdrawal by Subject|0
7836707|NCT01373931|12312565|FG001|Period 1|Withdrawal by Subject|2
7836708|NCT01374087|12312574|FG000|Overall Study|Adverse Event|1
7836709|NCT01374087|12312575|FG001|Overall Study|Adverse Event|0
7836710|NCT01374087|12312574|FG000|Overall Study|Disease progression|2
7836711|NCT01374087|12312575|FG001|Overall Study|Disease progression|2
7836712|NCT01374087|12312574|FG000|Overall Study|Study discontinued|13
7836713|NCT01374087|12312575|FG001|Overall Study|Study discontinued|13
7836714|NCT01374178|12312581|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1
7836715|NCT01374178|12312582|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0
7836716|NCT01374178|12312581|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
7836717|NCT01374178|12312582|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
7836718|NCT01374217|12312588|FG000|Overall Study|Lack of Efficacy|13
7836719|NCT01374269|12312594|FG000|Overall Study|Withdrawal by Subject|4
7836720|NCT01374269|12312595|FG001|Overall Study|Withdrawal by Subject|0
7836721|NCT01374269|12312594|FG000|Overall Study|Lost to Follow-up|1
7836722|NCT01374269|12312595|FG001|Overall Study|Lost to Follow-up|3
7836723|NCT01374269|12312594|FG000|Overall Study|closed research|1
7836724|NCT01374269|12312595|FG001|Overall Study|closed research|2
7836725|NCT01374425|12312603|FG000|Overall Study|Radiographic Disease Progression|86
7836726|NCT01374425|12312604|FG001|Overall Study|Radiographic Disease Progression|81
7836727|NCT01374425|12312603|FG000|Overall Study|Clinical Disease Progression|9
7836728|NCT01374425|12312604|FG001|Overall Study|Clinical Disease Progression|6
7836729|NCT01374425|12312603|FG000|Overall Study|Adverse Event|29
7836730|NCT01374425|12312604|FG001|Overall Study|Adverse Event|18
7836731|NCT01374425|12312603|FG000|Overall Study|Death (Progression of Disease)|1
7836732|NCT01374425|12312604|FG001|Overall Study|Death (Progression of Disease)|0
7836733|NCT01374425|12312603|FG000|Overall Study|Death (Adverse Event)|2
7836734|NCT01374425|12312604|FG001|Overall Study|Death (Adverse Event)|4
7836735|NCT01374425|12312603|FG000|Overall Study|Withdrawal by Subject|6
7836736|NCT01374425|12312604|FG001|Overall Study|Withdrawal by Subject|7
7836737|NCT01374425|12312603|FG000|Overall Study|Refused Treatment|10
7836738|NCT01374425|12312604|FG001|Overall Study|Refused Treatment|24
7836739|NCT01374425|12312603|FG000|Overall Study|Protocol Violation|2
7836740|NCT01374425|12312604|FG001|Overall Study|Protocol Violation|3
7836741|NCT01374425|12312603|FG000|Overall Study|Sponsor Decision|0
7836742|NCT01374425|12312604|FG001|Overall Study|Sponsor Decision|1
7836743|NCT01374425|12312603|FG000|Overall Study|Lost to Follow-up|2
7836744|NCT01374425|12312604|FG001|Overall Study|Lost to Follow-up|1
7836745|NCT01374425|12312603|FG000|Overall Study|Other|41
7836746|NCT01374425|12312604|FG001|Overall Study|Other|43
7836747|NCT01374451|12312642|FG000|Overall Study|Administrative problems|1
7836748|NCT01374451|12312643|FG001|Overall Study|Administrative problems|0
7836749|NCT01374568|12312655|FG000|Overall Study|Lab unable to analyze BTM|0
7836750|NCT01374568|12312656|FG001|Overall Study|Lab unable to analyze BTM|2
7836751|NCT01374906|12312670|FG000|Overall Study|Abnormal laboratory value(s)|0
7836752|NCT01374906|12312671|FG001|Overall Study|Abnormal laboratory value(s)|3
7836753|NCT01374906|12312670|FG000|Overall Study|Administrative problems|2
7836754|NCT01374906|12312671|FG001|Overall Study|Administrative problems|2
7836755|NCT01374906|12312670|FG000|Overall Study|Adverse Event|10
7836756|NCT01374906|12312671|FG001|Overall Study|Adverse Event|11
7836757|NCT01374906|12312670|FG000|Overall Study|Death|0
7836758|NCT01374906|12312671|FG001|Overall Study|Death|2
7836759|NCT01374906|12312670|FG000|Overall Study|Protocol Violation|2
7836760|NCT01374906|12312671|FG001|Overall Study|Protocol Violation|2
7836761|NCT01374906|12312670|FG000|Overall Study|Withdrawal by Subject|15
7836762|NCT01374906|12312671|FG001|Overall Study|Withdrawal by Subject|9
7836763|NCT01374906|12312670|FG000|Overall Study|Unsatisfactory therapeutic effect|11
7836764|NCT01374906|12312671|FG001|Overall Study|Unsatisfactory therapeutic effect|19
7836765|NCT01374919|12312681|FG000|Overall Study|Withdrawal by Subject|2
7836766|NCT01374971|12312685|FG000|Overall Study|Withdrawal by Subject|1
7836767|NCT01375010|12312691|FG000|Overall Study|Lost to Follow-up|8
7836768|NCT01375010|12312692|FG001|Overall Study|Lost to Follow-up|2
7836769|NCT01375010|12312691|FG000|Overall Study|Withdrawal by Subject|4
7836770|NCT01375010|12312692|FG001|Overall Study|Withdrawal by Subject|2
7836771|NCT01375049|12312698|FG000|Overall Study|Adverse Event|2
7836772|NCT01375049|12312698|FG000|Overall Study|Lost to Follow-up|1
7836773|NCT01375049|12312698|FG000|Overall Study|Withdrawal by Subject|2
7836774|NCT01375049|12312698|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45
7836775|NCT01375075|12312712|FG000|Overall Study|Adverse Event|0
7836776|NCT01375075|12312713|FG001|Overall Study|Adverse Event|0
7836777|NCT01375075|12312714|FG002|Overall Study|Adverse Event|3
7836778|NCT01375075|12312715|FG003|Overall Study|Adverse Event|1
7836779|NCT01375075|12312716|FG004|Overall Study|Adverse Event|0
7836780|NCT01375075|12312717|FG005|Overall Study|Adverse Event|1
7836781|NCT01375075|12312712|FG000|Overall Study|Entry Criterion Not Met|1
7836782|NCT01375075|12312713|FG001|Overall Study|Entry Criterion Not Met|0
7836783|NCT01375075|12312714|FG002|Overall Study|Entry Criterion Not Met|0
7836784|NCT01375075|12312715|FG003|Overall Study|Entry Criterion Not Met|0
7836785|NCT01375075|12312716|FG004|Overall Study|Entry Criterion Not Met|0
7836786|NCT01375075|12312717|FG005|Overall Study|Entry Criterion Not Met|1
7836787|NCT01375075|12312712|FG000|Overall Study|Withdrawal by Subject|0
7836788|NCT01375075|12312713|FG001|Overall Study|Withdrawal by Subject|1
7836789|NCT01375075|12312714|FG002|Overall Study|Withdrawal by Subject|0
7836790|NCT01375075|12312715|FG003|Overall Study|Withdrawal by Subject|0
7836791|NCT01375075|12312716|FG004|Overall Study|Withdrawal by Subject|0
7836792|NCT01375075|12312717|FG005|Overall Study|Withdrawal by Subject|1
7836793|NCT01375205|12312766|FG000|Overall Study|Lost to Follow-up|15
7836794|NCT01375205|12312767|FG001|Overall Study|Lost to Follow-up|12
7836795|NCT01375205|12312766|FG000|Overall Study|Withdrawal by Subject|6
7948788|NCT02531633|12494107|FG007|Part A (52 Weeks)|Protocol Violation|0
7948789|NCT02531633|12494108|FG008|Part A (52 Weeks)|Protocol Violation|0
7948790|NCT02531633|12494109|FG009|Part A (52 Weeks)|Protocol Violation|0
7948791|NCT02531633|12494100|FG000|Part A (52 Weeks)|Lost to Follow-up|0
7836796|NCT01375205|12312767|FG001|Overall Study|Withdrawal by Subject|1
7836797|NCT01375374|12312773|FG000|Overall Study|Adverse Event|1
7836798|NCT01375608|12312793|FG000|Overall Study|Withdrawal by Subject|2
7836799|NCT01375673|12312809|FG000|Overall Study|Withdrawal by Subject|0
7836800|NCT01375673|12312810|FG001|Overall Study|Withdrawal by Subject|1
7836801|NCT01375751|12312819|FG000|Overall Study|Other|0
7836802|NCT01375751|12312820|FG001|Overall Study|Other|1
7836803|NCT01375751|12312821|FG002|Overall Study|Other|0
7836804|NCT01375764|12312834|FG000|Overall Study|Lost to Follow-up|0
7836805|NCT01375764|12312835|FG001|Overall Study|Lost to Follow-up|1
7836806|NCT01375764|12312836|FG002|Overall Study|Lost to Follow-up|0
7836807|NCT01375764|12312837|FG003|Overall Study|Lost to Follow-up|0
7836808|NCT01375764|12312838|FG004|Overall Study|Lost to Follow-up|0
7836809|NCT01375764|12312834|FG000|Overall Study|Withdrawal by Subject|2
7836810|NCT01375764|12312835|FG001|Overall Study|Withdrawal by Subject|0
7836811|NCT01375764|12312836|FG002|Overall Study|Withdrawal by Subject|0
7836812|NCT01375764|12312837|FG003|Overall Study|Withdrawal by Subject|0
7836813|NCT01375764|12312838|FG004|Overall Study|Withdrawal by Subject|1
7836814|NCT01375764|12312834|FG000|Overall Study|Other|0
7836815|NCT01375764|12312835|FG001|Overall Study|Other|0
7836816|NCT01375764|12312836|FG002|Overall Study|Other|0
7836817|NCT01375764|12312837|FG003|Overall Study|Other|1
7836818|NCT01375764|12312838|FG004|Overall Study|Other|0
7836819|NCT01375777|12312859|FG000|Overall Study|Withdrawal by Subject|0
7836820|NCT01375777|12312860|FG001|Overall Study|Withdrawal by Subject|2
7836821|NCT01375777|12312861|FG002|Overall Study|Withdrawal by Subject|1
7836822|NCT01375777|12312862|FG003|Overall Study|Withdrawal by Subject|0
7836823|NCT01375777|12312863|FG004|Overall Study|Withdrawal by Subject|1
7836824|NCT01375777|12312864|FG005|Overall Study|Withdrawal by Subject|1
7836825|NCT01375777|12312865|FG006|Overall Study|Withdrawal by Subject|1
7836826|NCT01375777|12312866|FG007|Overall Study|Withdrawal by Subject|2
7836827|NCT01375777|12312867|FG008|Overall Study|Withdrawal by Subject|1
7836828|NCT01375777|12312859|FG000|Overall Study|Lost to Follow-up|1
7836829|NCT01375777|12312860|FG001|Overall Study|Lost to Follow-up|0
7836830|NCT01375777|12312861|FG002|Overall Study|Lost to Follow-up|0
7836831|NCT01375777|12312862|FG003|Overall Study|Lost to Follow-up|0
7836832|NCT01375777|12312863|FG004|Overall Study|Lost to Follow-up|0
7836833|NCT01375777|12312864|FG005|Overall Study|Lost to Follow-up|0
7836834|NCT01375777|12312865|FG006|Overall Study|Lost to Follow-up|1
7836835|NCT01375777|12312866|FG007|Overall Study|Lost to Follow-up|0
7836836|NCT01375777|12312867|FG008|Overall Study|Lost to Follow-up|0
7836837|NCT01375777|12312859|FG000|Overall Study|Other|1
7836838|NCT01375777|12312860|FG001|Overall Study|Other|1
7836839|NCT01375777|12312861|FG002|Overall Study|Other|0
7836840|NCT01375777|12312862|FG003|Overall Study|Other|0
7836841|NCT01375777|12312863|FG004|Overall Study|Other|0
7836842|NCT01375777|12312864|FG005|Overall Study|Other|0
7836843|NCT01375777|12312865|FG006|Overall Study|Other|0
7836844|NCT01375777|12312866|FG007|Overall Study|Other|0
7836845|NCT01375777|12312867|FG008|Overall Study|Other|1
7836846|NCT01376037|12312898|FG000|Overall Study|Lost to Follow-up|0
7836847|NCT01376037|12312899|FG001|Overall Study|Lost to Follow-up|2
7836848|NCT01376089|12312916|FG000|Overall Study|Patient received no contrast media|3
7836849|NCT01376089|12312917|FG001|Overall Study|Patient received no contrast media|4
7836850|NCT01376167|12312930|FG000|Overall Study|Lost to Follow-up|2
7836851|NCT01376167|12312931|FG001|Overall Study|Lost to Follow-up|4
7836852|NCT01376167|12312932|FG002|Overall Study|Lost to Follow-up|2
7836853|NCT01376167|12312930|FG000|Overall Study|Physician Decision|1
7836854|NCT01376167|12312931|FG001|Overall Study|Physician Decision|1
7836855|NCT01376167|12312932|FG002|Overall Study|Physician Decision|0
7836856|NCT01376167|12312930|FG000|Overall Study|Withdrawal by Subject|1
7836857|NCT01376167|12312931|FG001|Overall Study|Withdrawal by Subject|5
7836858|NCT01376167|12312932|FG002|Overall Study|Withdrawal by Subject|4
7836859|NCT01376245|12312947|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
7836860|NCT01376245|12312948|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
7836861|NCT01376245|12312949|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
7836862|NCT01376245|12312950|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
7836863|NCT01376245|12312951|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
7836864|NCT01376245|12312947|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
7836865|NCT01376245|12312948|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
7836866|NCT01376245|12312949|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
7836867|NCT01376245|12312950|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
7836868|NCT01376245|12312951|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
7836869|NCT01376245|12312947|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
7836870|NCT01376245|12312948|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
7836871|NCT01376245|12312949|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
7836872|NCT01376245|12312950|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
7836873|NCT01376245|12312951|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
7836874|NCT01376245|12312947|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
7836875|NCT01376245|12312948|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
7836876|NCT01376245|12312949|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
7836877|NCT01376245|12312950|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
7836878|NCT01376245|12312951|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
7836879|NCT01376245|12312947|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
7836880|NCT01376245|12312948|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
7836881|NCT01376245|12312949|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
7836882|NCT01376245|12312950|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
7836883|NCT01376245|12312951|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
7836884|NCT01376245|12312947|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
7836885|NCT01376245|12312948|FG001|24-week, Double-blind Treatment Period|Adverse Event|16
7836886|NCT01376245|12312949|FG002|24-week, Double-blind Treatment Period|Adverse Event|7
7836887|NCT01376245|12312950|FG003|24-week, Double-blind Treatment Period|Adverse Event|8
7836888|NCT01376245|12312951|FG004|24-week, Double-blind Treatment Period|Adverse Event|18
7836889|NCT01376245|12312947|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0
7836890|NCT01376245|12312948|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4
7836891|NCT01376245|12312949|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5
7836892|NCT01376245|12312950|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4
7836893|NCT01376245|12312951|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3
7836894|NCT01376245|12312947|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
7836895|NCT01376245|12312948|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2
7836896|NCT01376245|12312949|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0
7836897|NCT01376245|12312950|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
7836898|NCT01376245|12312951|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1
7836899|NCT01376245|12312947|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
7836900|NCT01376245|12312948|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
7836901|NCT01376245|12312949|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
7862696|NCT01599650|12351662|FG002|Overall Study|Physician Decision|7
7836902|NCT01376245|12312950|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
7836903|NCT01376245|12312951|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
7836904|NCT01376245|12312947|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7836905|NCT01376245|12312948|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2
7836906|NCT01376245|12312949|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7836907|NCT01376245|12312950|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1
7836908|NCT01376245|12312951|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1
7836909|NCT01376245|12312947|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
7836910|NCT01376245|12312948|FG001|24-week, Double-blind Treatment Period|Physician Decision|0
7836911|NCT01376245|12312949|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
7836912|NCT01376245|12312950|FG003|24-week, Double-blind Treatment Period|Physician Decision|1
7836913|NCT01376245|12312951|FG004|24-week, Double-blind Treatment Period|Physician Decision|0
7836914|NCT01376245|12312947|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
7836915|NCT01376245|12312948|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
7836916|NCT01376245|12312949|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
7836917|NCT01376245|12312950|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
7836918|NCT01376245|12312951|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
7836919|NCT01376310|12312972|FG000|Overall Study|Study closed/terminated|1
7836920|NCT01376310|12312973|FG001|Overall Study|Study closed/terminated|2
7836921|NCT01376310|12312972|FG000|Overall Study|Withdrawal by Subject|8
7836922|NCT01376310|12312973|FG001|Overall Study|Withdrawal by Subject|2
7836923|NCT01376310|12312972|FG000|Overall Study|Physician Decision|26
7836924|NCT01376310|12312973|FG001|Overall Study|Physician Decision|7
7836925|NCT01376310|12312972|FG000|Overall Study|Lost to Follow-up|1
7836926|NCT01376310|12312973|FG001|Overall Study|Lost to Follow-up|0
7862697|NCT01599650|12351660|FG000|Overall Study|Protocol Violation|0
7862698|NCT01599650|12351661|FG001|Overall Study|Protocol Violation|3
7862699|NCT01599650|12351662|FG002|Overall Study|Protocol Violation|0
7862700|NCT01599650|12351660|FG000|Overall Study|Death|2
7862701|NCT01599650|12351661|FG001|Overall Study|Death|1
7862702|NCT01599650|12351662|FG002|Overall Study|Death|2
7862703|NCT01599650|12351660|FG000|Overall Study|Lost to Follow-up|3
7862704|NCT01599650|12351661|FG001|Overall Study|Lost to Follow-up|3
7862705|NCT01599650|12351662|FG002|Overall Study|Lost to Follow-up|3
7862706|NCT01599650|12351660|FG000|Overall Study|Withdrawal by Subject|11
7862707|NCT01599650|12351661|FG001|Overall Study|Withdrawal by Subject|11
7862708|NCT01599650|12351662|FG002|Overall Study|Withdrawal by Subject|10
7862709|NCT01599650|12351660|FG000|Overall Study|Adverse Event|3
7862710|NCT01599650|12351661|FG001|Overall Study|Adverse Event|8
7862711|NCT01599650|12351662|FG002|Overall Study|Adverse Event|4
7862712|NCT01599754|12351674|FG000|Overall Study|Anticancer therapy need not in protocol|5
7862713|NCT01599754|12351675|FG001|Overall Study|Anticancer therapy need not in protocol|2
7862714|NCT01599754|12351674|FG000|Overall Study|Participant noncompliance|4
7862715|NCT01599754|12351675|FG001|Overall Study|Participant noncompliance|4
7862716|NCT01599754|12351674|FG000|Overall Study|Lost to Follow-up|13
7862717|NCT01599754|12351675|FG001|Overall Study|Lost to Follow-up|6
7862718|NCT01599754|12351674|FG000|Overall Study|Death|31
7862719|NCT01599754|12351675|FG001|Overall Study|Death|33
7862720|NCT01599754|12351674|FG000|Overall Study|Adverse Event|3
7862721|NCT01599754|12351675|FG001|Overall Study|Adverse Event|2
7862722|NCT01599754|12351674|FG000|Overall Study|Investigator decision|1
7862723|NCT01599754|12351675|FG001|Overall Study|Investigator decision|3
7862724|NCT01599754|12351674|FG000|Overall Study|Withdrawal by Subject|24
7862725|NCT01599754|12351675|FG001|Overall Study|Withdrawal by Subject|25
7862726|NCT01599754|12351674|FG000|Overall Study|Study terminated by sponsor|282
7862727|NCT01599754|12351675|FG001|Overall Study|Study terminated by sponsor|285
7862728|NCT01599793|12351681|FG000|Overall Study|Adverse Event|2
7862729|NCT01599806|12351687|FG000|Overall Study|Lost to Follow-up|20
7862730|NCT01599806|12351688|FG001|Overall Study|Lost to Follow-up|20
7862731|NCT01599806|12351687|FG000|Overall Study|Withdrawal by Subject|12
7862732|NCT01599806|12351688|FG001|Overall Study|Withdrawal by Subject|12
7862733|NCT01599806|12351687|FG000|Overall Study|Other Eligibility criteria|11
7862734|NCT01599806|12351688|FG001|Overall Study|Other Eligibility criteria|9
7863996|NCT01609556|12353459|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
7863997|NCT01609556|12353444|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7863998|NCT01609556|12353445|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7863999|NCT01609556|12353446|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7864000|NCT01609556|12353447|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7864001|NCT01609556|12353448|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7864002|NCT01609556|12353449|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7864003|NCT01609556|12353450|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7864004|NCT01609556|12353451|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7864005|NCT01609556|12353452|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7864006|NCT01609556|12353453|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7864007|NCT01609556|12353454|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7864008|NCT01609556|12353455|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7864009|NCT01609556|12353456|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32
7836927|NCT01376349|12312982|FG000|Raondomized Treatment|Withdrawal by Subject|10
7836928|NCT01376349|12312983|FG001|Raondomized Treatment|Withdrawal by Subject|16
7836929|NCT01376349|12312984|FG002|Raondomized Treatment|Withdrawal by Subject|13
7836930|NCT01376349|12312982|FG000|Raondomized Treatment|Adverse Event|13
7836931|NCT01376349|12312983|FG001|Raondomized Treatment|Adverse Event|17
7836932|NCT01376349|12312984|FG002|Raondomized Treatment|Adverse Event|14
7836933|NCT01376349|12312982|FG000|Raondomized Treatment|Unkown|1
7836934|NCT01376349|12312983|FG001|Raondomized Treatment|Unkown|2
7836935|NCT01376349|12312984|FG002|Raondomized Treatment|Unkown|1
7836936|NCT01376349|12312982|FG000|Raondomized Treatment|Alternative Treatment|0
7836937|NCT01376349|12312983|FG001|Raondomized Treatment|Alternative Treatment|0
7836938|NCT01376349|12312984|FG002|Raondomized Treatment|Alternative Treatment|1
7836939|NCT01376388|12312997|FG000|Overall Study|Adverse Event|13
7836940|NCT01376388|12312997|FG000|Overall Study|Lack of Efficacy|2
7836941|NCT01376388|12312997|FG000|Overall Study|Withdrawal by Subject|3
7836942|NCT01376700|12313022|FG000|Overall Study|Sponsor terminated study early|8
7836943|NCT01376700|12313022|FG000|Overall Study|Low or high titer inhibitor|8
7836944|NCT01376804|12313029|FG000|Treatment Period|Withdrawal by Subject|1
7836945|NCT01376804|12313029|FG000|Treatment Period|Adverse Event|6
7836946|NCT01376804|12313029|FG000|Treatment Period|Patient did not receive study drug|1
7836947|NCT01376908|12313035|FG000|Overall Study|Protocol Violation|1
7836948|NCT01376908|12313036|FG001|Overall Study|Protocol Violation|1
7836949|NCT01376908|12313035|FG000|Overall Study|Withdrawal by Subject|1
7836950|NCT01376908|12313036|FG001|Overall Study|Withdrawal by Subject|2
7836951|NCT01377012|12313052|FG000|Core Study|Study terminated by Sponsor|47
7836952|NCT01377012|12313053|FG001|Core Study|Study terminated by Sponsor|54
7836953|NCT01377012|12313054|FG002|Core Study|Study terminated by Sponsor|46
7836954|NCT01377012|12313052|FG000|Core Study|Technical problems|1
7836955|NCT01377012|12313053|FG001|Core Study|Technical problems|0
7836956|NCT01377012|12313054|FG002|Core Study|Technical problems|0
7836957|NCT01377012|12313052|FG000|Core Study|Withdrawal by Subject|15
7836958|NCT01377012|12313053|FG001|Core Study|Withdrawal by Subject|23
7836959|NCT01377012|12313054|FG002|Core Study|Withdrawal by Subject|18
7836960|NCT01377012|12313052|FG000|Core Study|Protocol Violation|7
7836961|NCT01377012|12313053|FG001|Core Study|Protocol Violation|3
7836962|NCT01377012|12313054|FG002|Core Study|Protocol Violation|2
7836963|NCT01377012|12313052|FG000|Core Study|Pregnancy|0
7836964|NCT01377012|12313053|FG001|Core Study|Pregnancy|0
7836965|NCT01377012|12313054|FG002|Core Study|Pregnancy|1
7836966|NCT01377012|12313052|FG000|Core Study|Physician Decision|5
7836967|NCT01377012|12313053|FG001|Core Study|Physician Decision|4
7836968|NCT01377012|12313054|FG002|Core Study|Physician Decision|10
7836969|NCT01377012|12313052|FG000|Core Study|Non-Compliant with study treatment|0
7836970|NCT01377012|12313053|FG001|Core Study|Non-Compliant with study treatment|0
7836971|NCT01377012|12313054|FG002|Core Study|Non-Compliant with study treatment|1
7836972|NCT01377012|12313052|FG000|Core Study|No Longer require treatment|0
7836973|NCT01377012|12313053|FG001|Core Study|No Longer require treatment|0
7836974|NCT01377012|12313054|FG002|Core Study|No Longer require treatment|1
7836975|NCT01377012|12313052|FG000|Core Study|Lost to Follow-up|7
7836976|NCT01377012|12313053|FG001|Core Study|Lost to Follow-up|5
7836977|NCT01377012|12313054|FG002|Core Study|Lost to Follow-up|4
7836978|NCT01377012|12313052|FG000|Core Study|Lack of Efficacy|41
7836979|NCT01377012|12313053|FG001|Core Study|Lack of Efficacy|28
7836980|NCT01377012|12313054|FG002|Core Study|Lack of Efficacy|37
7836981|NCT01377012|12313052|FG000|Core Study|Death|1
7836982|NCT01377012|12313053|FG001|Core Study|Death|1
7836983|NCT01377012|12313054|FG002|Core Study|Death|1
7836984|NCT01377012|12313052|FG000|Core Study|Adverse Event|10
7836985|NCT01377012|12313053|FG001|Core Study|Adverse Event|14
7836986|NCT01377012|12313054|FG002|Core Study|Adverse Event|13
7836987|NCT01377012|12313052|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3
7836988|NCT01377012|12313053|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0
7836989|NCT01377012|12313054|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0
7836990|NCT01377012|12313052|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52
7836991|NCT01377012|12313053|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69
7836992|NCT01377012|12313054|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63
7836993|NCT01377012|12313052|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1
7836994|NCT01377012|12313053|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0
7836995|NCT01377012|12313054|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3
7836996|NCT01377012|12313052|FG000|Extension Study, Weeks 104-260|Physician Decision|1
7836997|NCT01377012|12313053|FG001|Extension Study, Weeks 104-260|Physician Decision|0
7836998|NCT01377012|12313054|FG002|Extension Study, Weeks 104-260|Physician Decision|0
7836999|NCT01377012|12313052|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0
7837000|NCT01377012|12313053|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0
7837001|NCT01377012|12313054|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1
7837002|NCT01377012|12313052|FG000|Extension Study, Weeks 104-260|Adverse Event|0
7837003|NCT01377012|12313053|FG001|Extension Study, Weeks 104-260|Adverse Event|2
7837004|NCT01377012|12313054|FG002|Extension Study, Weeks 104-260|Adverse Event|1
7837005|NCT01377194|12313065|FG000|Overall Study|Adverse Event|3
7837006|NCT01377194|12313066|FG001|Overall Study|Adverse Event|12
7837007|NCT01377194|12313067|FG002|Overall Study|Adverse Event|19
7837008|NCT01377194|12313065|FG000|Overall Study|Lack of Efficacy|3
7837009|NCT01377194|12313066|FG001|Overall Study|Lack of Efficacy|3
7837010|NCT01377194|12313067|FG002|Overall Study|Lack of Efficacy|3
7837011|NCT01377194|12313065|FG000|Overall Study|Protocol Violation|4
7837012|NCT01377194|12313066|FG001|Overall Study|Protocol Violation|10
7837013|NCT01377194|12313067|FG002|Overall Study|Protocol Violation|6
7837014|NCT01377194|12313065|FG000|Overall Study|Withdrawal by Subject|8
7837015|NCT01377194|12313066|FG001|Overall Study|Withdrawal by Subject|10
7837016|NCT01377194|12313067|FG002|Overall Study|Withdrawal by Subject|7
7837017|NCT01377194|12313065|FG000|Overall Study|Lost to Follow-up|14
7837018|NCT01377194|12313066|FG001|Overall Study|Lost to Follow-up|8
7837019|NCT01377194|12313067|FG002|Overall Study|Lost to Follow-up|11
7837020|NCT01377233|12313083|FG000|Open-label|Adverse Event|1
7837021|NCT01377233|12313084|FG001|Open-label|Adverse Event|0
7837022|NCT01377233|12313085|FG002|Open-label|Adverse Event|0
7837023|NCT01377233|12313086|FG003|Open-label|Adverse Event|0
7837024|NCT01377233|12313087|FG004|Open-label|Adverse Event|0
7837025|NCT01377233|12313083|FG000|Open-label|Withdrawal by Subject|3
7837026|NCT01377233|12313084|FG001|Open-label|Withdrawal by Subject|0
7837027|NCT01377233|12313085|FG002|Open-label|Withdrawal by Subject|0
7837028|NCT01377233|12313086|FG003|Open-label|Withdrawal by Subject|0
7837029|NCT01377233|12313087|FG004|Open-label|Withdrawal by Subject|0
7837030|NCT01377233|12313083|FG000|Double-blind|Adverse Event|0
7837031|NCT01377233|12313084|FG001|Double-blind|Adverse Event|1
7837032|NCT01377233|12313085|FG002|Double-blind|Adverse Event|2
7837033|NCT01377233|12313086|FG003|Double-blind|Adverse Event|2
7837034|NCT01377233|12313087|FG004|Double-blind|Adverse Event|0
7837035|NCT01377233|12313083|FG000|Double-blind|Protocol Violation|0
7837036|NCT01377233|12313084|FG001|Double-blind|Protocol Violation|0
7837037|NCT01377233|12313085|FG002|Double-blind|Protocol Violation|0
7837038|NCT01377233|12313086|FG003|Double-blind|Protocol Violation|0
7837039|NCT01377233|12313087|FG004|Double-blind|Protocol Violation|1
7837040|NCT01377233|12313083|FG000|Double-blind|Withdrawal by Subject|0
7837041|NCT01377233|12313084|FG001|Double-blind|Withdrawal by Subject|0
7837042|NCT01377233|12313085|FG002|Double-blind|Withdrawal by Subject|0
7837043|NCT01377233|12313086|FG003|Double-blind|Withdrawal by Subject|1
7837044|NCT01377233|12313087|FG004|Double-blind|Withdrawal by Subject|0
7837045|NCT01377233|12313083|FG000|Double-blind|Administrative or other|0
7837046|NCT01377233|12313084|FG001|Double-blind|Administrative or other|0
7837047|NCT01377233|12313085|FG002|Double-blind|Administrative or other|0
7837048|NCT01377233|12313086|FG003|Double-blind|Administrative or other|1
7837049|NCT01377233|12313087|FG004|Double-blind|Administrative or other|1
7837050|NCT01377389|12313103|FG000|Overall Study|Withdrawal by Subject|1
7837051|NCT01377389|12313103|FG000|Overall Study|Screen failure|2
7837052|NCT01377480|12313126|FG000|Overall Study|Protocol Violation|0
7837053|NCT01377480|12313127|FG001|Overall Study|Protocol Violation|0
7837054|NCT01377480|12313128|FG002|Overall Study|Protocol Violation|0
7837055|NCT01377480|12313129|FG003|Overall Study|Protocol Violation|4
7837056|NCT01377480|12313126|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0
7837057|NCT01377480|12313127|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1
7837058|NCT01377480|12313128|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1
7837059|NCT01377480|12313129|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0
7837060|NCT01377480|12313126|FG000|Overall Study|Withdrawal by Subject|0
7837061|NCT01377480|12313127|FG001|Overall Study|Withdrawal by Subject|0
7837062|NCT01377480|12313128|FG002|Overall Study|Withdrawal by Subject|1
7837063|NCT01377480|12313129|FG003|Overall Study|Withdrawal by Subject|0
7837064|NCT01377480|12313126|FG000|Overall Study|Serious adverse event|0
7837065|NCT01377480|12313127|FG001|Overall Study|Serious adverse event|0
7837066|NCT01377480|12313128|FG002|Overall Study|Serious adverse event|1
7837067|NCT01377480|12313129|FG003|Overall Study|Serious adverse event|1
7837068|NCT01377480|12313126|FG000|Overall Study|Other|0
7837069|NCT01377480|12313127|FG001|Overall Study|Other|0
7837070|NCT01377480|12313128|FG002|Overall Study|Other|7
7837071|NCT01377480|12313129|FG003|Overall Study|Other|6
7837072|NCT01377844|12313184|FG000|Overall Study|Withdrawal by Subject|25
7837073|NCT01377844|12313185|FG001|Overall Study|Withdrawal by Subject|28
7837074|NCT01377844|12313184|FG000|Overall Study|Protocol Violation|2
7837075|NCT01377844|12313185|FG001|Overall Study|Protocol Violation|3
7837076|NCT01377844|12313184|FG000|Overall Study|Adverse Event|3
7837077|NCT01377844|12313185|FG001|Overall Study|Adverse Event|0
7837078|NCT01377844|12313184|FG000|Overall Study|Physician Decision|6
7837079|NCT01377844|12313185|FG001|Overall Study|Physician Decision|3
7837080|NCT01377844|12313184|FG000|Overall Study|Study terminated by Sponsor|0
7837081|NCT01377844|12313185|FG001|Overall Study|Study terminated by Sponsor|1
7837082|NCT01377922|12313194|FG000|Overall Study|rescue tx after part 2, entered part 4|1
7837083|NCT01377922|12313195|FG001|Overall Study|rescue tx after part 2, entered part 4|0
7837084|NCT01377987|12313201|FG000|Washout (7 Days)|Withdrawal by Subject|1
7837085|NCT01377987|12313202|FG001|Washout (7 Days)|Withdrawal by Subject|1
7837086|NCT01378104|12313214|FG000|Overall Study|Adverse Event|8
7837087|NCT01378104|12313215|FG001|Overall Study|Adverse Event|8
7837088|NCT01378104|12313214|FG000|Overall Study|Lack of Efficacy|7
7837089|NCT01378104|12313215|FG001|Overall Study|Lack of Efficacy|5
7837090|NCT01378104|12313214|FG000|Overall Study|Withdrawal by Subject|12
7837091|NCT01378104|12313215|FG001|Overall Study|Withdrawal by Subject|13
7837092|NCT01378117|12313226|FG000|Overall Study|withdrawal|2
7837093|NCT01378117|12313227|FG001|Overall Study|withdrawal|1
7837094|NCT01378117|12313228|FG002|Overall Study|withdrawal|2
7837095|NCT01378117|12313226|FG000|Overall Study|discharged before med given|2
7837096|NCT01378117|12313227|FG001|Overall Study|discharged before med given|0
7837097|NCT01378117|12313228|FG002|Overall Study|discharged before med given|1
7837098|NCT01378195|12313243|FG000|Overall Study|Lost to Follow-up|29
7837099|NCT01378195|12313244|FG001|Overall Study|Lost to Follow-up|18
7837100|NCT01378325|12313304|FG000|Overall Study|Protocol Violation|0
7837101|NCT01378325|12313305|FG001|Overall Study|Protocol Violation|1
7837102|NCT01378429|12313335|FG000|Overall Study|Noncompliance with study drug|1
7837103|NCT01378429|12313336|FG001|Overall Study|Noncompliance with study drug|0
7837104|NCT01378858|12313354|FG000|Overall Study|Withdrawal by Subject|4
7837105|NCT01378858|12313355|FG001|Overall Study|Withdrawal by Subject|4
7837106|NCT01378962|12313361|FG000|Overall Study|Death|14
7837107|NCT01378962|12313361|FG000|Overall Study|Lost to Follow-up|1
7837108|NCT01378962|12313361|FG000|Overall Study|Other|2
7837109|NCT01378975|12313367|FG000|Overall Study|Death|77
7837110|NCT01378975|12313368|FG001|Overall Study|Death|46
7837111|NCT01378975|12313367|FG000|Overall Study|Investigator Request|1
7837112|NCT01378975|12313368|FG001|Overall Study|Investigator Request|0
7837113|NCT01378975|12313367|FG000|Overall Study|Lost to Follow-up|4
7837114|NCT01378975|12313368|FG001|Overall Study|Lost to Follow-up|1
7837115|NCT01378975|12313367|FG000|Overall Study|Withdrew Consent|4
7837116|NCT01378975|12313368|FG001|Overall Study|Withdrew Consent|3
7837117|NCT01379508|12313403|FG000|Treatment to Week 104|Adverse Event|2
7837118|NCT01379508|12313404|FG001|Treatment to Week 104|Adverse Event|0
7837119|NCT01379508|12313405|FG002|Treatment to Week 104|Adverse Event|5
7837120|NCT01379508|12313406|FG003|Treatment to Week 104|Adverse Event|0
7837121|NCT01379508|12313403|FG000|Treatment to Week 104|Abnormal lab value|1
7837122|NCT01379508|12313404|FG001|Treatment to Week 104|Abnormal lab value|0
7837123|NCT01379508|12313405|FG002|Treatment to Week 104|Abnormal lab value|0
7837124|NCT01379508|12313406|FG003|Treatment to Week 104|Abnormal lab value|0
7837125|NCT01379508|12313403|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1
7837126|NCT01379508|12313404|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0
7837127|NCT01379508|12313405|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0
7837128|NCT01379508|12313406|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0
7837129|NCT01379508|12313403|FG000|Treatment to Week 104|Withdrawal by Subject|6
7837130|NCT01379508|12313404|FG001|Treatment to Week 104|Withdrawal by Subject|1
7837131|NCT01379508|12313405|FG002|Treatment to Week 104|Withdrawal by Subject|4
7837132|NCT01379508|12313406|FG003|Treatment to Week 104|Withdrawal by Subject|0
7837133|NCT01379508|12313403|FG000|Treatment to Week 104|Lost to Follow-up|5
7837134|NCT01379508|12313404|FG001|Treatment to Week 104|Lost to Follow-up|0
7837135|NCT01379508|12313405|FG002|Treatment to Week 104|Lost to Follow-up|3
7837136|NCT01379508|12313406|FG003|Treatment to Week 104|Lost to Follow-up|0
7837137|NCT01379508|12313403|FG000|Treatment to Week 104|Administrative problems|3
7837138|NCT01379508|12313404|FG001|Treatment to Week 104|Administrative problems|1
7837139|NCT01379508|12313405|FG002|Treatment to Week 104|Administrative problems|0
7837140|NCT01379508|12313406|FG003|Treatment to Week 104|Administrative problems|0
7837141|NCT01379508|12313403|FG000|Treatment to Week 104|Protocol Violation|1
7837142|NCT01379508|12313404|FG001|Treatment to Week 104|Protocol Violation|1
7837143|NCT01379508|12313405|FG002|Treatment to Week 104|Protocol Violation|1
7837144|NCT01379508|12313406|FG003|Treatment to Week 104|Protocol Violation|0
7837145|NCT01379508|12313403|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8
7837146|NCT01379508|12313404|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1
7837147|NCT01379508|12313405|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8
7837148|NCT01379508|12313406|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0
7837149|NCT01379508|12313403|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6
7837150|NCT01379508|12313404|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1
7837151|NCT01379508|12313405|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5
7837152|NCT01379508|12313406|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0
7837153|NCT01379508|12313403|FG000|Extension Period Weeks 109-156|Administrative problems|3
7837154|NCT01379508|12313404|FG001|Extension Period Weeks 109-156|Administrative problems|0
7837155|NCT01379508|12313405|FG002|Extension Period Weeks 109-156|Administrative problems|1
7837156|NCT01379508|12313406|FG003|Extension Period Weeks 109-156|Administrative problems|0
7837157|NCT01379508|12313403|FG000|Extension Period Weeks 109-156|Protocol Violation|2
7837158|NCT01379508|12313404|FG001|Extension Period Weeks 109-156|Protocol Violation|1
7837159|NCT01379508|12313405|FG002|Extension Period Weeks 109-156|Protocol Violation|0
7837160|NCT01379508|12313406|FG003|Extension Period Weeks 109-156|Protocol Violation|0
7837161|NCT01379521|12313422|FG000|Overall Study -Treatment Period|Adverse Event|3
7837162|NCT01379521|12313423|FG001|Overall Study -Treatment Period|Adverse Event|0
7837163|NCT01379521|12313422|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0
7837164|NCT01379521|12313423|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1
7837165|NCT01379521|12313422|FG000|Overall Study -Treatment Period|Disease Progression|23
7837166|NCT01379521|12313423|FG001|Overall Study -Treatment Period|Disease Progression|22
7837167|NCT01379521|12313422|FG000|Overall Study -Treatment Period|New Cancer Therapy|1
7837168|NCT01379521|12313423|FG001|Overall Study -Treatment Period|New Cancer Therapy|0
7837169|NCT01379521|12313422|FG000|Overall Study -Treatment Period|Protocol Deviation|0
7837170|NCT01379521|12313423|FG001|Overall Study -Treatment Period|Protocol Deviation|2
7837171|NCT01379521|12313422|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3
7837172|NCT01379521|12313423|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0
7837173|NCT01379521|12313422|FG000|Overall Study -Treatment Period|Administrative Problems|1
7837174|NCT01379521|12313423|FG001|Overall Study -Treatment Period|Administrative Problems|0
7837175|NCT01379521|12313422|FG000|Overall Study -Treatment Period|Death|2
7837176|NCT01379521|12313423|FG001|Overall Study -Treatment Period|Death|1
7837177|NCT01379521|12313422|FG000|Post-Treatment Evaluations|Disease Progression|22
7837178|NCT01379521|12313423|FG001|Post-Treatment Evaluations|Disease Progression|20
7837179|NCT01379521|12313422|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2
7837180|NCT01379521|12313423|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1
7837181|NCT01379521|12313422|FG000|Post-Treatment Evaluations|Death|1
7837182|NCT01379521|12313423|FG001|Post-Treatment Evaluations|Death|0
7837183|NCT01379534|12313431|FG000|Treatment Phase|Withdrawal by Subject|2
7837184|NCT01379534|12313432|FG001|Treatment Phase|Withdrawal by Subject|2
7837185|NCT01379534|12313431|FG000|Treatment Phase|Progressive disease|13
7837186|NCT01379534|12313432|FG001|Treatment Phase|Progressive disease|22
7837187|NCT01379534|12313431|FG000|Treatment Phase|Adverse Event|7
7837188|NCT01379534|12313432|FG001|Treatment Phase|Adverse Event|7
7837189|NCT01379534|12313431|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0
7837190|NCT01379534|12313432|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1
7837191|NCT01379534|12313431|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
7837192|NCT01379534|12313432|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
7837193|NCT01379534|12313431|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
7837194|NCT01379534|12313432|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
7837195|NCT01379534|12313431|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
7837196|NCT01379534|12313432|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
7837197|NCT01379573|12313438|FG000|Overall Study|Lost to Follow-up|1
7837198|NCT01379573|12313438|FG000|Overall Study|Screen Failure|10
7837199|NCT01379703|12313469|FG000|Study Start Through 9 Months|Lost to Follow-up|2
7837200|NCT01379703|12313470|FG001|Study Start Through 9 Months|Lost to Follow-up|61
7837201|NCT01379703|12313471|FG002|Study Start Through 9 Months|Lost to Follow-up|104
7837202|NCT01379703|12313469|FG000|Study Start Through 9 Months|Adverse Event|0
7837203|NCT01379703|12313470|FG001|Study Start Through 9 Months|Adverse Event|14
7837204|NCT01379703|12313471|FG002|Study Start Through 9 Months|Adverse Event|10
7837205|NCT01379703|12313469|FG000|Study Start Through 9 Months|Withdrawal by Subject|0
7837206|NCT01379703|12313470|FG001|Study Start Through 9 Months|Withdrawal by Subject|6
7837207|NCT01379703|12313471|FG002|Study Start Through 9 Months|Withdrawal by Subject|1
7837208|NCT01379703|12313469|FG000|Study Start Through 9 Months|Treatment Failure|0
7837209|NCT01379703|12313470|FG001|Study Start Through 9 Months|Treatment Failure|2
7837210|NCT01379703|12313471|FG002|Study Start Through 9 Months|Treatment Failure|2
7837211|NCT01379703|12313469|FG000|Study Start Through 9 Months|Patient Noncompliance|0
7837212|NCT01379703|12313470|FG001|Study Start Through 9 Months|Patient Noncompliance|0
7837213|NCT01379703|12313471|FG002|Study Start Through 9 Months|Patient Noncompliance|1
7837214|NCT01379703|12313469|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0
7837215|NCT01379703|12313470|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4
7837216|NCT01379703|12313471|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0
7837217|NCT01379703|12313469|FG000|Study Start Through 9 Months|Medication not available|0
7837218|NCT01379703|12313470|FG001|Study Start Through 9 Months|Medication not available|2
7837219|NCT01379703|12313471|FG002|Study Start Through 9 Months|Medication not available|1
7837220|NCT01379703|12313469|FG000|Study Start Through 9 Months|Poor general condition|0
7837221|NCT01379703|12313470|FG001|Study Start Through 9 Months|Poor general condition|1
7837222|NCT01379703|12313471|FG002|Study Start Through 9 Months|Poor general condition|0
7837223|NCT01379703|12313469|FG000|Study Start Through 9 Months|Increased triglycerides|0
7837224|NCT01379703|12313470|FG001|Study Start Through 9 Months|Increased triglycerides|1
7837225|NCT01379703|12313471|FG002|Study Start Through 9 Months|Increased triglycerides|0
7837226|NCT01379703|12313469|FG000|Study Start Through 9 Months|Reason unknown|2
7837227|NCT01379703|12313470|FG001|Study Start Through 9 Months|Reason unknown|31
7837228|NCT01379703|12313471|FG002|Study Start Through 9 Months|Reason unknown|24
7837229|NCT01379703|12313469|FG000|9 Months Through 18 Months|Lost to Follow-up|0
7837230|NCT01379703|12313470|FG001|9 Months Through 18 Months|Lost to Follow-up|178
7837231|NCT01379703|12313471|FG002|9 Months Through 18 Months|Lost to Follow-up|0
7837232|NCT01379703|12313469|FG000|9 Months Through 18 Months|Withdrawal by Subject|0
7837233|NCT01379703|12313470|FG001|9 Months Through 18 Months|Withdrawal by Subject|11
7837234|NCT01379703|12313471|FG002|9 Months Through 18 Months|Withdrawal by Subject|0
7837235|NCT01379703|12313469|FG000|9 Months Through 18 Months|Adverse Event|0
7837236|NCT01379703|12313470|FG001|9 Months Through 18 Months|Adverse Event|6
7837237|NCT01379703|12313471|FG002|9 Months Through 18 Months|Adverse Event|0
7837238|NCT01379703|12313469|FG000|9 Months Through 18 Months|Treatment failure|0
7837239|NCT01379703|12313470|FG001|9 Months Through 18 Months|Treatment failure|5
7837240|NCT01379703|12313471|FG002|9 Months Through 18 Months|Treatment failure|0
7837241|NCT01379703|12313469|FG000|9 Months Through 18 Months|Patient Noncompliance|0
7837242|NCT01379703|12313470|FG001|9 Months Through 18 Months|Patient Noncompliance|4
7837243|NCT01379703|12313471|FG002|9 Months Through 18 Months|Patient Noncompliance|0
7837244|NCT01379703|12313469|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0
7837245|NCT01379703|12313470|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2
7837246|NCT01379703|12313471|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0
7837247|NCT01379703|12313469|FG000|9 Months Through 18 Months|Fatigue|0
7837248|NCT01379703|12313470|FG001|9 Months Through 18 Months|Fatigue|1
7837249|NCT01379703|12313471|FG002|9 Months Through 18 Months|Fatigue|0
7837250|NCT01379703|12313469|FG000|9 Months Through 18 Months|Reason Unknown|0
7837251|NCT01379703|12313470|FG001|9 Months Through 18 Months|Reason Unknown|23
7837252|NCT01379703|12313471|FG002|9 Months Through 18 Months|Reason Unknown|0
7837253|NCT01379768|12313483|FG000|Overall Study|Adverse Event|1
7837254|NCT01379768|12313484|FG001|Overall Study|Adverse Event|1
7837255|NCT01379768|12313485|FG002|Overall Study|Adverse Event|0
7837256|NCT01379768|12313483|FG000|Overall Study|Lost to Follow-up|2
7837257|NCT01379768|12313484|FG001|Overall Study|Lost to Follow-up|0
7837258|NCT01379768|12313485|FG002|Overall Study|Lost to Follow-up|0
7837259|NCT01379937|12313509|FG000|Overall Study|Protocol Violation|0
7837260|NCT01379937|12313510|FG001|Overall Study|Protocol Violation|0
7837261|NCT01379937|12313511|FG002|Overall Study|Protocol Violation|0
7837262|NCT01379937|12313512|FG003|Overall Study|Protocol Violation|1
7837263|NCT01379937|12313509|FG000|Overall Study|Consent withdrawal|0
7837264|NCT01379937|12313510|FG001|Overall Study|Consent withdrawal|1
7837265|NCT01379937|12313511|FG002|Overall Study|Consent withdrawal|0
7837266|NCT01379937|12313512|FG003|Overall Study|Consent withdrawal|0
7837267|NCT01379937|12313509|FG000|Overall Study|Lost to Follow-up|1
7837268|NCT01379937|12313510|FG001|Overall Study|Lost to Follow-up|2
7837269|NCT01379937|12313511|FG002|Overall Study|Lost to Follow-up|2
7837270|NCT01379937|12313512|FG003|Overall Study|Lost to Follow-up|0
7837271|NCT01380080|12313533|FG000|Overall Study|Death|36
7837272|NCT01380080|12313534|FG001|Overall Study|Death|44
7837273|NCT01380080|12313533|FG000|Overall Study|Site is closing|28
7837274|NCT01380080|12313534|FG001|Overall Study|Site is closing|31
7837275|NCT01380080|12313533|FG000|Overall Study|Not able to get to clinic|7
7837276|NCT01380080|12313534|FG001|Overall Study|Not able to get to clinic|1
7837277|NCT01380080|12313533|FG000|Overall Study|Not willing to adhere to requirements|6
7837278|NCT01380080|12313534|FG001|Overall Study|Not willing to adhere to requirements|2
7837279|NCT01380080|12313533|FG000|Overall Study|Withdrawal by Subject|5
7837280|NCT01380080|12313534|FG001|Overall Study|Withdrawal by Subject|2
7837281|NCT01380080|12313533|FG000|Overall Study|Lost to Follow-up|3
7837282|NCT01380080|12313534|FG001|Overall Study|Lost to Follow-up|3
7837283|NCT01380093|12313540|FG000|Naloxone Challenge Phase|Screen failures|21
7837284|NCT01380093|12313541|FG001|Naloxone Challenge Phase|Screen failures|0
7837285|NCT01380093|12313542|FG002|Naloxone Challenge Phase|Screen failures|0
7837286|NCT01380093|12313543|FG003|Naloxone Challenge Phase|Screen failures|0
7837287|NCT01380093|12313544|FG004|Naloxone Challenge Phase|Screen failures|0
7837288|NCT01380093|12313545|FG005|Naloxone Challenge Phase|Screen failures|0
7837289|NCT01380093|12313546|FG006|Naloxone Challenge Phase|Screen failures|0
7837290|NCT01380093|12313547|FG007|Naloxone Challenge Phase|Screen failures|0
7837291|NCT01380093|12313548|FG008|Naloxone Challenge Phase|Screen failures|0
7837292|NCT01380093|12313540|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0
7837293|NCT01380093|12313541|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1
7837294|NCT01380093|12313542|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0
7837295|NCT01380093|12313543|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0
7837296|NCT01380093|12313544|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0
7837297|NCT01380093|12313545|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0
7837298|NCT01380093|12313546|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0
7837299|NCT01380093|12313547|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0
7837300|NCT01380093|12313548|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0
7837301|NCT01380093|12313540|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0
7837302|NCT01380093|12313541|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3
7837303|NCT01380093|12313542|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1
7837304|NCT01380093|12313543|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0
7837305|NCT01380093|12313544|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0
7837306|NCT01380093|12313545|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0
7837307|NCT01380093|12313546|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0
7837308|NCT01380093|12313547|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0
7837309|NCT01380093|12313548|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0
7837310|NCT01380093|12313540|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7837311|NCT01380093|12313541|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
7837312|NCT01380093|12313542|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7837313|NCT01380093|12313543|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7837314|NCT01380093|12313544|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7837315|NCT01380093|12313545|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7837316|NCT01380093|12313546|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7837317|NCT01380093|12313547|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7837318|NCT01380093|12313548|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7837319|NCT01380093|12313540|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0
7837320|NCT01380093|12313541|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4
7837321|NCT01380093|12313542|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9
7837322|NCT01380093|12313543|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0
7837323|NCT01380093|12313544|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0
7837324|NCT01380093|12313545|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0
7837325|NCT01380093|12313546|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0
7837326|NCT01380093|12313547|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0
7837327|NCT01380093|12313548|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0
7837328|NCT01380093|12313540|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7837329|NCT01380093|12313541|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
7837330|NCT01380093|12313542|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
7837331|NCT01380093|12313543|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7837332|NCT01380093|12313544|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7837333|NCT01380093|12313545|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7837334|NCT01380093|12313546|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7837335|NCT01380093|12313547|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7837336|NCT01380093|12313548|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7837337|NCT01380093|12313540|FG000|Drug Discrimination Phase: Day 2|Backup participant|0
7837338|NCT01380093|12313541|FG001|Drug Discrimination Phase: Day 2|Backup participant|0
7837339|NCT01380093|12313542|FG002|Drug Discrimination Phase: Day 2|Backup participant|1
7837340|NCT01380093|12313543|FG003|Drug Discrimination Phase: Day 2|Backup participant|0
7837341|NCT01380093|12313544|FG004|Drug Discrimination Phase: Day 2|Backup participant|0
7837342|NCT01380093|12313545|FG005|Drug Discrimination Phase: Day 2|Backup participant|0
7837343|NCT01380093|12313546|FG006|Drug Discrimination Phase: Day 2|Backup participant|0
7837344|NCT01380093|12313547|FG007|Drug Discrimination Phase: Day 2|Backup participant|0
7837345|NCT01380093|12313548|FG008|Drug Discrimination Phase: Day 2|Backup participant|0
7837346|NCT01380093|12313540|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0
7837347|NCT01380093|12313541|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0
7837348|NCT01380093|12313542|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1
7837349|NCT01380093|12313543|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0
7837350|NCT01380093|12313544|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0
7837351|NCT01380093|12313545|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0
7837352|NCT01380093|12313546|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0
7837353|NCT01380093|12313547|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0
7837354|NCT01380093|12313548|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0
7837355|NCT01380093|12313540|FG000|Treatment Phase: Second Intervention|Other|0
7837356|NCT01380093|12313541|FG001|Treatment Phase: Second Intervention|Other|0
7837357|NCT01380093|12313542|FG002|Treatment Phase: Second Intervention|Other|0
7837358|NCT01380093|12313543|FG003|Treatment Phase: Second Intervention|Other|1
7837359|NCT01380093|12313544|FG004|Treatment Phase: Second Intervention|Other|0
7837360|NCT01380093|12313545|FG005|Treatment Phase: Second Intervention|Other|0
7837361|NCT01380093|12313546|FG006|Treatment Phase: Second Intervention|Other|0
7837362|NCT01380093|12313547|FG007|Treatment Phase: Second Intervention|Other|0
7837363|NCT01380093|12313548|FG008|Treatment Phase: Second Intervention|Other|0
7837364|NCT01380093|12313540|FG000|Treatment Phase: Third Intervention|Non-compliance|0
7837365|NCT01380093|12313541|FG001|Treatment Phase: Third Intervention|Non-compliance|0
7837366|NCT01380093|12313542|FG002|Treatment Phase: Third Intervention|Non-compliance|0
7837367|NCT01380093|12313543|FG003|Treatment Phase: Third Intervention|Non-compliance|0
7837368|NCT01380093|12313544|FG004|Treatment Phase: Third Intervention|Non-compliance|0
7837369|NCT01380093|12313545|FG005|Treatment Phase: Third Intervention|Non-compliance|0
7837370|NCT01380093|12313546|FG006|Treatment Phase: Third Intervention|Non-compliance|0
7837371|NCT01380093|12313547|FG007|Treatment Phase: Third Intervention|Non-compliance|0
7837372|NCT01380093|12313548|FG008|Treatment Phase: Third Intervention|Non-compliance|1
7837373|NCT01380093|12313540|FG000|Treatment Phase: Third Intervention|Other|0
7837374|NCT01380093|12313541|FG001|Treatment Phase: Third Intervention|Other|0
7837375|NCT01380093|12313542|FG002|Treatment Phase: Third Intervention|Other|0
7837376|NCT01380093|12313543|FG003|Treatment Phase: Third Intervention|Other|0
7837377|NCT01380093|12313544|FG004|Treatment Phase: Third Intervention|Other|0
7837378|NCT01380093|12313545|FG005|Treatment Phase: Third Intervention|Other|0
7837379|NCT01380093|12313546|FG006|Treatment Phase: Third Intervention|Other|0
7837380|NCT01380093|12313547|FG007|Treatment Phase: Third Intervention|Other|0
7837381|NCT01380093|12313548|FG008|Treatment Phase: Third Intervention|Other|1
7837382|NCT01380145|12313571|FG000|Overall Study|Progressive disease|4
7837383|NCT01380184|12313577|FG000|Part 1 (19 Days)|Adverse Event|1
7837384|NCT01380184|12313577|FG000|Part 2|Adverse Event|5
7837385|NCT01380184|12313577|FG000|Part 2|Disease Progression|8
7837386|NCT01380184|12313577|FG000|Part 2|Lost to Follow-up|1
7837387|NCT01380327|12313593|FG000|Overall Study|Lost to Follow-up|0
7837388|NCT01380327|12313594|FG001|Overall Study|Lost to Follow-up|1
7837389|NCT01380327|12313595|FG002|Overall Study|Lost to Follow-up|1
7837390|NCT01380327|12313593|FG000|Overall Study|Protocol Violation|3
7837391|NCT01380327|12313594|FG001|Overall Study|Protocol Violation|2
7837392|NCT01380327|12313595|FG002|Overall Study|Protocol Violation|3
7837393|NCT01380327|12313593|FG000|Overall Study|Withdrawal by Subject|0
7837394|NCT01380327|12313594|FG001|Overall Study|Withdrawal by Subject|0
7837395|NCT01380327|12313595|FG002|Overall Study|Withdrawal by Subject|1
7837396|NCT01380327|12313593|FG000|Overall Study|Housing situation precluded ability to k|0
7837397|NCT01380327|12313594|FG001|Overall Study|Housing situation precluded ability to k|0
7837398|NCT01380327|12313595|FG002|Overall Study|Housing situation precluded ability to k|1
7837399|NCT01380327|12313593|FG000|Overall Study|Questionable onset of epilepsy|0
7837400|NCT01380327|12313594|FG001|Overall Study|Questionable onset of epilepsy|0
7837401|NCT01380327|12313595|FG002|Overall Study|Questionable onset of epilepsy|1
7837402|NCT01380379|12313608|FG000|Overall Study|Pregnancy|1
7837403|NCT01380535|12313614|FG000|Overall Study|Adverse Event|3
7837404|NCT01380535|12313615|FG001|Overall Study|Adverse Event|3
7837405|NCT01380535|12313614|FG000|Overall Study|Death|3
7837406|NCT01380535|12313615|FG001|Overall Study|Death|0
7837407|NCT01380535|12313614|FG000|Overall Study|Study site closed|0
7837408|NCT01380535|12313615|FG001|Overall Study|Study site closed|5
7837409|NCT01380535|12313614|FG000|Overall Study|Withdrawal by Subject|1
7837410|NCT01380535|12313615|FG001|Overall Study|Withdrawal by Subject|2
7837411|NCT01380535|12313614|FG000|Overall Study|Protocol Violation|0
7837412|NCT01380535|12313615|FG001|Overall Study|Protocol Violation|2
7837413|NCT01380535|12313614|FG000|Overall Study|Lack of Efficacy|0
7837414|NCT01380535|12313615|FG001|Overall Study|Lack of Efficacy|3
7837415|NCT01380691|12313630|FG000|Washout (7 Days)|Protocol Violation|0
7837416|NCT01380691|12313631|FG001|Washout (7 Days)|Protocol Violation|0
7837417|NCT01380691|12313632|FG002|Washout (7 Days)|Protocol Violation|0
7837418|NCT01380691|12313633|FG003|Washout (7 Days)|Protocol Violation|1
7837419|NCT01380691|12313630|FG000|Washout (7 Days)|Withdrawal by Subject|0
7837420|NCT01380691|12313631|FG001|Washout (7 Days)|Withdrawal by Subject|0
7837421|NCT01380691|12313632|FG002|Washout (7 Days)|Withdrawal by Subject|1
7837422|NCT01380691|12313633|FG003|Washout (7 Days)|Withdrawal by Subject|0
7837423|NCT01380730|12313652|FG000|Overall Study|Death|0
7837424|NCT01380730|12313653|FG001|Overall Study|Death|0
7837425|NCT01380730|12313654|FG002|Overall Study|Death|0
7837426|NCT01380730|12313655|FG003|Overall Study|Death|0
7837427|NCT01380730|12313656|FG004|Overall Study|Death|1
7837428|NCT01380730|12313657|FG005|Overall Study|Death|0
7837429|NCT01380730|12313658|FG006|Overall Study|Death|0
7837430|NCT01380730|12313659|FG007|Overall Study|Death|0
7837431|NCT01380769|12313696|FG000|Overall Study|Withdrawal by Subject|7
7837432|NCT01380769|12313697|FG001|Overall Study|Withdrawal by Subject|11
7837433|NCT01380769|12313696|FG000|Overall Study|Physician Decision|1
7837434|NCT01380769|12313697|FG001|Overall Study|Physician Decision|1
7837435|NCT01380769|12313696|FG000|Overall Study|Adverse Event|1
7837436|NCT01380769|12313697|FG001|Overall Study|Adverse Event|1
7837437|NCT01380769|12313696|FG000|Overall Study|Protocol Violation|0
7837438|NCT01380769|12313697|FG001|Overall Study|Protocol Violation|1
7837439|NCT01380782|12313705|FG000|Overall Study|Adverse Event|0
7837440|NCT01380782|12313706|FG001|Overall Study|Adverse Event|1
7837441|NCT01380782|12313707|FG002|Overall Study|Adverse Event|0
7837442|NCT01380782|12313708|FG003|Overall Study|Adverse Event|0
7837443|NCT01380782|12313705|FG000|Overall Study|Death|1
7837444|NCT01380782|12313706|FG001|Overall Study|Death|0
7837445|NCT01380782|12313707|FG002|Overall Study|Death|0
7837446|NCT01380782|12313708|FG003|Overall Study|Death|0
7837447|NCT01380782|12313705|FG000|Overall Study|Lack of Efficacy|10
7837448|NCT01380782|12313706|FG001|Overall Study|Lack of Efficacy|9
7837449|NCT01380782|12313707|FG002|Overall Study|Lack of Efficacy|10
7837450|NCT01380782|12313708|FG003|Overall Study|Lack of Efficacy|3
7837451|NCT01380782|12313705|FG000|Overall Study|Physician Decision|1
7837452|NCT01380782|12313706|FG001|Overall Study|Physician Decision|0
7837453|NCT01380782|12313707|FG002|Overall Study|Physician Decision|0
7837454|NCT01380782|12313708|FG003|Overall Study|Physician Decision|0
7837455|NCT01380782|12313705|FG000|Overall Study|Withdrawal by Subject|0
7837456|NCT01380782|12313706|FG001|Overall Study|Withdrawal by Subject|0
7837457|NCT01380782|12313707|FG002|Overall Study|Withdrawal by Subject|1
7837458|NCT01380782|12313708|FG003|Overall Study|Withdrawal by Subject|1
7837459|NCT01380834|12313722|FG000|Overall Study|Physician Decision|1
7837460|NCT01380834|12313723|FG001|Overall Study|Physician Decision|0
7837461|NCT01380990|12313744|FG000|Overall Study|Treatment Failure|1
7837462|NCT01380990|12313745|FG001|Overall Study|Treatment Failure|0
7837463|NCT01380990|12313744|FG000|Overall Study|Death|0
7837464|NCT01380990|12313745|FG001|Overall Study|Death|1
7837465|NCT01381016|12313757|FG000|Overall Study|Lost to Follow-up|1
7837466|NCT01381016|12313758|FG001|Overall Study|Lost to Follow-up|1
7837467|NCT01381016|12313757|FG000|Overall Study|Screen Failure|2
7837468|NCT01381016|12313758|FG001|Overall Study|Screen Failure|2
7837469|NCT01381016|12313757|FG000|Overall Study|Withdrawal by Subject|0
7837470|NCT01381016|12313758|FG001|Overall Study|Withdrawal by Subject|1
7837471|NCT01381016|12313757|FG000|Overall Study|Physician Decision|0
7837472|NCT01381016|12313758|FG001|Overall Study|Physician Decision|2
7837473|NCT01381068|12313768|FG000|Overall Study|Death|1
7837474|NCT01381068|12313769|FG001|Overall Study|Death|0
7837475|NCT01381549|12313809|FG000|Overall Study|Ineligible: No organisms isolated|0
7837476|NCT01381549|12313810|FG001|Overall Study|Ineligible: No organisms isolated|0
7837477|NCT01381549|12313811|FG002|Overall Study|Ineligible: No organisms isolated|1
7837478|NCT01381562|12313823|FG000|Overall Study|Adverse Event|0
7837479|NCT01381562|12313824|FG001|Overall Study|Adverse Event|1
7837480|NCT01381562|12313825|FG002|Overall Study|Adverse Event|0
7837481|NCT01381575|12313836|FG000|Overall Study|Serious Adverse Event|1
7837482|NCT01381575|12313837|FG001|Overall Study|Serious Adverse Event|0
7837483|NCT01381575|12313838|FG002|Overall Study|Serious Adverse Event|0
7837484|NCT01381575|12313836|FG000|Overall Study|Non-Serious Adverse Event|0
7837485|NCT01381575|12313837|FG001|Overall Study|Non-Serious Adverse Event|0
7837486|NCT01381575|12313838|FG002|Overall Study|Non-Serious Adverse Event|1
7837487|NCT01381575|12313836|FG000|Overall Study|Protocol Violation|0
7837488|NCT01381575|12313837|FG001|Overall Study|Protocol Violation|1
7837489|NCT01381575|12313838|FG002|Overall Study|Protocol Violation|1
7837490|NCT01381575|12313836|FG000|Overall Study|Withdrawal by Subject|15
7837491|NCT01381575|12313837|FG001|Overall Study|Withdrawal by Subject|9
7837492|NCT01381575|12313838|FG002|Overall Study|Withdrawal by Subject|7
7837493|NCT01381575|12313836|FG000|Overall Study|Migrated/moved from study area|2
7837494|NCT01381575|12313837|FG001|Overall Study|Migrated/moved from study area|12
7837495|NCT01381575|12313838|FG002|Overall Study|Migrated/moved from study area|2
7837496|NCT01381575|12313836|FG000|Overall Study|Lost to Follow-up|8
7837497|NCT01381575|12313837|FG001|Overall Study|Lost to Follow-up|17
7837498|NCT01381575|12313838|FG002|Overall Study|Lost to Follow-up|9
7837499|NCT01381692|12313849|FG000|Overall Study|Adverse Event|1
7837500|NCT01381692|12313850|FG001|Overall Study|Adverse Event|0
7837501|NCT01381692|12313851|FG002|Overall Study|Adverse Event|0
7837502|NCT01381692|12313852|FG003|Overall Study|Adverse Event|0
7837503|NCT01381692|12313853|FG004|Overall Study|Adverse Event|0
7837504|NCT01381692|12313854|FG005|Overall Study|Adverse Event|0
7837505|NCT01381718|12313864|FG000|Overall Study|Withdrawal by Subject|2
7837506|NCT01381718|12313865|FG001|Overall Study|Withdrawal by Subject|5
7837507|NCT01381718|12313864|FG000|Overall Study|Lost to Follow-up|3
7837508|NCT01381718|12313865|FG001|Overall Study|Lost to Follow-up|5
7837509|NCT01381718|12313864|FG000|Overall Study|Toxicity, side effects or complications related to study|0
7837510|NCT01381718|12313865|FG001|Overall Study|Toxicity, side effects or complications related to study|3
7837511|NCT01381874|12313878|FG000|Overall Study|Lost to Follow-up|1
7837512|NCT01381874|12313879|FG001|Overall Study|Lost to Follow-up|1
7837513|NCT01381874|12313880|FG002|Overall Study|Lost to Follow-up|0
7837514|NCT01381874|12313878|FG000|Overall Study|Withdrawal by Subject|9
7837515|NCT01381874|12313879|FG001|Overall Study|Withdrawal by Subject|10
7837516|NCT01381874|12313880|FG002|Overall Study|Withdrawal by Subject|9
7837517|NCT01381874|12313878|FG000|Overall Study|Other|67
7837518|NCT01381874|12313879|FG001|Overall Study|Other|52
7837519|NCT01381874|12313880|FG002|Overall Study|Other|67
7837520|NCT01381900|12313891|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2
7837521|NCT01381900|12313892|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0
7837522|NCT01381900|12313893|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0
7837523|NCT01381900|12313891|FG000|Overall Study|Adverse Event|4
7837524|NCT01381900|12313892|FG001|Overall Study|Adverse Event|6
7837525|NCT01381900|12313893|FG002|Overall Study|Adverse Event|7
7837526|NCT01381900|12313891|FG000|Overall Study|Noncompliance with study drug|0
7837527|NCT01381900|12313892|FG001|Overall Study|Noncompliance with study drug|0
7837528|NCT01381900|12313893|FG002|Overall Study|Noncompliance with study drug|1
7837529|NCT01381900|12313891|FG000|Overall Study|Physician Decision|0
7837530|NCT01381900|12313892|FG001|Overall Study|Physician Decision|1
7837531|NCT01381900|12313893|FG002|Overall Study|Physician Decision|1
7837532|NCT01381900|12313891|FG000|Overall Study|Protocol Violation|0
7837533|NCT01381900|12313892|FG001|Overall Study|Protocol Violation|1
7837534|NCT01381900|12313893|FG002|Overall Study|Protocol Violation|1
7837535|NCT01381900|12313891|FG000|Overall Study|Withdrawal by Subject|0
7837536|NCT01381900|12313892|FG001|Overall Study|Withdrawal by Subject|0
7837537|NCT01381900|12313893|FG002|Overall Study|Withdrawal by Subject|1
7837538|NCT01381900|12313891|FG000|Overall Study|Early withdraw|3
7837539|NCT01381900|12313892|FG001|Overall Study|Early withdraw|1
7837540|NCT01381900|12313893|FG002|Overall Study|Early withdraw|1
7837541|NCT01381926|12313903|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
7837542|NCT01381926|12313904|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
7837543|NCT01381926|12313903|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
7837544|NCT01381926|12313904|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
7837545|NCT01382212|12313940|FG000|Overall Study|Kidney transplant|1
7837546|NCT01382212|12313940|FG000|Overall Study|Withdrew consent|1
7837547|NCT01382225|12313946|FG000|Overall Study|Adverse Event|3
7837548|NCT01382225|12313947|FG001|Overall Study|Adverse Event|2
7837549|NCT01382225|12313946|FG000|Overall Study|Protocol Violation|2
7837550|NCT01382225|12313947|FG001|Overall Study|Protocol Violation|1
7837551|NCT01382225|12313946|FG000|Overall Study|Subject Withdrew Consent|5
7837552|NCT01382225|12313947|FG001|Overall Study|Subject Withdrew Consent|2
7837553|NCT01382225|12313946|FG000|Overall Study|Other|4
7837554|NCT01382225|12313947|FG001|Overall Study|Other|2
7837555|NCT01382251|12313955|FG000|Overall Study|Surgeries cancelled or delayed|16
7837556|NCT01382251|12313956|FG001|Overall Study|Surgeries cancelled or delayed|16
7837557|NCT01382251|12313955|FG000|Overall Study|Lost to Follow-up|4
7837558|NCT01382251|12313956|FG001|Overall Study|Lost to Follow-up|4
7837559|NCT01382251|12313955|FG000|Overall Study|Contacted after study closed|1
7837560|NCT01382251|12313956|FG001|Overall Study|Contacted after study closed|1
7837561|NCT01382446|12313972|FG000|Overall Study|Withdrawal by Subject|0
7837562|NCT01382446|12313973|FG001|Overall Study|Withdrawal by Subject|1
7837563|NCT01382446|12313972|FG000|Overall Study|Removal from Mechanical Ventilation|3
7837564|NCT01382446|12313973|FG001|Overall Study|Removal from Mechanical Ventilation|3
7837565|NCT01382602|12313981|FG000|Overall Study|Protocol Violation|0
7837566|NCT01382602|12313982|FG001|Overall Study|Protocol Violation|3
7837567|NCT01382602|12313981|FG000|Overall Study|Withdrawal by Subject|0
7837568|NCT01382602|12313982|FG001|Overall Study|Withdrawal by Subject|1
7837569|NCT01382940|12314014|FG000|Overall Study|Adverse Event|19
7837570|NCT01382940|12314014|FG000|Overall Study|Lost to Follow-up|4
7837571|NCT01382940|12314014|FG000|Overall Study|Physician Decision|7
7837572|NCT01382940|12314014|FG000|Overall Study|Withdrawal by Subject|23
7837573|NCT01382940|12314014|FG000|Overall Study|Protocol Violation|20
7837574|NCT01383018|12314027|FG000|Overall Study|Adverse Event|14
7837575|NCT01383018|12314027|FG000|Overall Study|Death|10
7837576|NCT01383018|12314027|FG000|Overall Study|Lost to Follow-up|5
7837577|NCT01383018|12314027|FG000|Overall Study|Physician Decision|5
7837578|NCT01383018|12314027|FG000|Overall Study|Withdrawal by Subject|9
7837579|NCT01383018|12314027|FG000|Overall Study|Subject not implanted|76
7837580|NCT01383018|12314027|FG000|Overall Study|Missed Visit|247
7837581|NCT01383018|12314027|FG000|Overall Study|Site closed early-not compliance related|7
7837582|NCT01383018|12314027|FG000|Overall Study|Patient moved away from site|1
7837583|NCT01383018|12314027|FG000|Overall Study|Subject Incarcerated|1
7837584|NCT01383096|12314044|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
7837585|NCT01383096|12314045|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
7837586|NCT01383096|12314046|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
7837587|NCT01383096|12314044|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
7837588|NCT01383096|12314045|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
7837589|NCT01383096|12314046|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
7837590|NCT01383096|12314044|FG000|Third Intervention (8 Days)|Elevated AST|0
7837591|NCT01383096|12314045|FG001|Third Intervention (8 Days)|Elevated AST|1
7837592|NCT01383096|12314046|FG002|Third Intervention (8 Days)|Elevated AST|0
7837593|NCT01383096|12314044|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
7837594|NCT01383096|12314045|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
7837595|NCT01383096|12314046|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
7837596|NCT01383096|12314044|FG000|Third Intervention (8 Days)|Adverse Event|1
7837597|NCT01383096|12314045|FG001|Third Intervention (8 Days)|Adverse Event|0
7837598|NCT01383096|12314046|FG002|Third Intervention (8 Days)|Adverse Event|0
7837599|NCT01383096|12314044|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1
7837600|NCT01383096|12314045|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0
7837601|NCT01383096|12314046|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0
7837602|NCT01383096|12314044|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
7837603|NCT01383096|12314045|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
7837604|NCT01383096|12314046|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
7837605|NCT01383096|12314044|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
7837606|NCT01383096|12314045|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
7837607|NCT01383096|12314046|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
7837608|NCT01383096|12314044|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
7837609|NCT01383096|12314045|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
7837610|NCT01383096|12314046|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
7837611|NCT01383096|12314044|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1
7837612|NCT01383096|12314045|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0
7837613|NCT01383096|12314046|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0
7837614|NCT01383096|12314044|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
7837615|NCT01383096|12314045|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
7837616|NCT01383096|12314046|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
7837617|NCT01383161|12314085|FG000|Overall Study|Adverse Event|5
7837618|NCT01383161|12314086|FG001|Overall Study|Adverse Event|1
7837619|NCT01383161|12314085|FG000|Overall Study|Withdrawal by Subject|0
7837620|NCT01383161|12314086|FG001|Overall Study|Withdrawal by Subject|2
7837621|NCT01383161|12314085|FG000|Overall Study|Lack of Efficacy|0
7837622|NCT01383161|12314086|FG001|Overall Study|Lack of Efficacy|1
7862735|NCT01600014|12351698|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
7862736|NCT01600014|12351699|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
7862737|NCT01600014|12351698|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
7862738|NCT01600014|12351699|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
7948792|NCT02531633|12494101|FG001|Part A (52 Weeks)|Lost to Follow-up|0
7948793|NCT02531633|12494102|FG002|Part A (52 Weeks)|Lost to Follow-up|0
7948794|NCT02531633|12494103|FG003|Part A (52 Weeks)|Lost to Follow-up|0
7948795|NCT02531633|12494104|FG004|Part A (52 Weeks)|Lost to Follow-up|1
7948796|NCT02531633|12494105|FG005|Part A (52 Weeks)|Lost to Follow-up|0
7948797|NCT02531633|12494106|FG006|Part A (52 Weeks)|Lost to Follow-up|0
7948798|NCT02531633|12494107|FG007|Part A (52 Weeks)|Lost to Follow-up|0
7948799|NCT02531633|12494108|FG008|Part A (52 Weeks)|Lost to Follow-up|0
7948800|NCT02531633|12494109|FG009|Part A (52 Weeks)|Lost to Follow-up|0
7948801|NCT02531633|12494100|FG000|Part A (52 Weeks)|Physician Decision|1
7948802|NCT02531633|12494101|FG001|Part A (52 Weeks)|Physician Decision|4
7948803|NCT02531633|12494102|FG002|Part A (52 Weeks)|Physician Decision|3
7948804|NCT02531633|12494103|FG003|Part A (52 Weeks)|Physician Decision|1
7948805|NCT02531633|12494104|FG004|Part A (52 Weeks)|Physician Decision|0
7948806|NCT02531633|12494105|FG005|Part A (52 Weeks)|Physician Decision|0
7948807|NCT02531633|12494106|FG006|Part A (52 Weeks)|Physician Decision|0
7948808|NCT02531633|12494107|FG007|Part A (52 Weeks)|Physician Decision|0
7948809|NCT02531633|12494108|FG008|Part A (52 Weeks)|Physician Decision|0
7948810|NCT02531633|12494109|FG009|Part A (52 Weeks)|Physician Decision|0
7948811|NCT02531633|12494100|FG000|Part A (52 Weeks)|Withdrawal by Subject|6
7948812|NCT02531633|12494101|FG001|Part A (52 Weeks)|Withdrawal by Subject|6
7948813|NCT02531633|12494102|FG002|Part A (52 Weeks)|Withdrawal by Subject|1
7948814|NCT02531633|12494103|FG003|Part A (52 Weeks)|Withdrawal by Subject|3
7948815|NCT02531633|12494104|FG004|Part A (52 Weeks)|Withdrawal by Subject|3
7948816|NCT02531633|12494105|FG005|Part A (52 Weeks)|Withdrawal by Subject|0
7948817|NCT02531633|12494106|FG006|Part A (52 Weeks)|Withdrawal by Subject|0
7948818|NCT02531633|12494107|FG007|Part A (52 Weeks)|Withdrawal by Subject|0
7948819|NCT02531633|12494108|FG008|Part A (52 Weeks)|Withdrawal by Subject|0
7948820|NCT02531633|12494109|FG009|Part A (52 Weeks)|Withdrawal by Subject|0
7948821|NCT02531633|12494100|FG000|Part A (52 Weeks)|Other|2
7948822|NCT02531633|12494101|FG001|Part A (52 Weeks)|Other|0
7948823|NCT02531633|12494102|FG002|Part A (52 Weeks)|Other|0
7948824|NCT02531633|12494103|FG003|Part A (52 Weeks)|Other|0
7948825|NCT02531633|12494104|FG004|Part A (52 Weeks)|Other|0
7948826|NCT02531633|12494105|FG005|Part A (52 Weeks)|Other|0
7948827|NCT02531633|12494106|FG006|Part A (52 Weeks)|Other|0
7948828|NCT02531633|12494107|FG007|Part A (52 Weeks)|Other|0
7948829|NCT02531633|12494108|FG008|Part A (52 Weeks)|Other|0
7948830|NCT02531633|12494109|FG009|Part A (52 Weeks)|Other|0
7948831|NCT02531633|12494100|FG000|Part B (104 Weeks)|Sponsor request|0
7948832|NCT02531633|12494101|FG001|Part B (104 Weeks)|Sponsor request|0
7948833|NCT02531633|12494102|FG002|Part B (104 Weeks)|Sponsor request|0
7948834|NCT02531633|12494103|FG003|Part B (104 Weeks)|Sponsor request|0
7948835|NCT02531633|12494104|FG004|Part B (104 Weeks)|Sponsor request|0
7948836|NCT02531633|12494105|FG005|Part B (104 Weeks)|Sponsor request|8
7948837|NCT02531633|12494106|FG006|Part B (104 Weeks)|Sponsor request|5
7948838|NCT02531633|12494107|FG007|Part B (104 Weeks)|Sponsor request|3
7948839|NCT02531633|12494108|FG008|Part B (104 Weeks)|Sponsor request|5
7948840|NCT02531633|12494109|FG009|Part B (104 Weeks)|Sponsor request|4
7948841|NCT02531633|12494100|FG000|Part B (104 Weeks)|Lost to Follow-up|0
7948842|NCT02531633|12494101|FG001|Part B (104 Weeks)|Lost to Follow-up|0
7948843|NCT02531633|12494102|FG002|Part B (104 Weeks)|Lost to Follow-up|0
7948844|NCT02531633|12494103|FG003|Part B (104 Weeks)|Lost to Follow-up|0
7948845|NCT02531633|12494104|FG004|Part B (104 Weeks)|Lost to Follow-up|0
7948846|NCT02531633|12494105|FG005|Part B (104 Weeks)|Lost to Follow-up|0
7948847|NCT02531633|12494106|FG006|Part B (104 Weeks)|Lost to Follow-up|0
7948848|NCT02531633|12494107|FG007|Part B (104 Weeks)|Lost to Follow-up|1
7948849|NCT02531633|12494108|FG008|Part B (104 Weeks)|Lost to Follow-up|0
7948850|NCT02531633|12494109|FG009|Part B (104 Weeks)|Lost to Follow-up|0
7948851|NCT02531646|12494152|FG000|Overall Study|equip. image processing issue|5
7948852|NCT02531646|12494153|FG001|Overall Study|equip. image processing issue|1
7948853|NCT02531646|12494154|FG002|Overall Study|equip. image processing issue|0
7948854|NCT02531698|12494164|FG000|Overall Study|Adverse Event|2
7948855|NCT02531698|12494165|FG001|Overall Study|Adverse Event|1
7948856|NCT02531698|12494164|FG000|Overall Study|Withdrawal by Subject|6
7948857|NCT02531698|12494165|FG001|Overall Study|Withdrawal by Subject|1
7948858|NCT02531698|12494164|FG000|Overall Study|Protocol Violation|2
7948859|NCT02531698|12494165|FG001|Overall Study|Protocol Violation|0
7948860|NCT02531698|12494164|FG000|Overall Study|Lost to Follow-up|1
7837623|NCT01383174|12314094|FG000|3 Month Assessment|Death|0
7837624|NCT01383174|12314095|FG001|3 Month Assessment|Death|1
7837625|NCT01383174|12314094|FG000|3 Month Assessment|Lost to Follow-up|2
7837626|NCT01383174|12314095|FG001|3 Month Assessment|Lost to Follow-up|0
7837627|NCT01383174|12314094|FG000|3 Month Assessment|Refused to complete|4
7837628|NCT01383174|12314095|FG001|3 Month Assessment|Refused to complete|0
7837629|NCT01383174|12314094|FG000|6 Month Assessment|Lost to Follow-up|1
7837630|NCT01383174|12314095|FG001|6 Month Assessment|Lost to Follow-up|1
7837631|NCT01383174|12314094|FG000|6 Month Assessment|Refused to complete|4
7837632|NCT01383174|12314095|FG001|6 Month Assessment|Refused to complete|0
7837633|NCT01383317|12314121|FG000|Overall Study|Lost to Follow-up|2
7837634|NCT01383317|12314122|FG001|Overall Study|Lost to Follow-up|1
7837635|NCT01383317|12314121|FG000|Overall Study|Death|1
7837636|NCT01383317|12314122|FG001|Overall Study|Death|0
7837637|NCT01383317|12314121|FG000|Overall Study|Adverse Event|0
7837638|NCT01383317|12314122|FG001|Overall Study|Adverse Event|1
7837639|NCT01383356|12314128|FG000|Period 1|Adverse Event|5
7837640|NCT01383356|12314129|FG001|Period 1|Adverse Event|3
7837641|NCT01383356|12314128|FG000|Period 1|Non-compliance|3
7837642|NCT01383356|12314129|FG001|Period 1|Non-compliance|0
7837643|NCT01383356|12314128|FG000|Period 1|Out of Range Mid-study-Test|0
7837644|NCT01383356|12314129|FG001|Period 1|Out of Range Mid-study-Test|1
7837645|NCT01383356|12314128|FG000|Period 1|Personal|0
7837646|NCT01383356|12314129|FG001|Period 1|Personal|2
7837647|NCT01383486|12314143|FG000|Overall Study|Lost to Follow-up|10
7837648|NCT01383486|12314143|FG000|Overall Study|Incomplete information for analysis|2
7837649|NCT01383486|12314143|FG000|Overall Study|Did not take any product|6
7837650|NCT01383499|12314148|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1
7837651|NCT01383499|12314149|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0
7837652|NCT01383499|12314150|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0
7837653|NCT01383499|12314151|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0
7837654|NCT01383707|12314177|FG000|Overall Study|Consent withdrawal|6
7837655|NCT01383707|12314177|FG000|Overall Study|Death|19
7837656|NCT01383707|12314177|FG000|Overall Study|Other|8
7837657|NCT01383707|12314177|FG000|Overall Study|Sponsor's decision|2
7837658|NCT01383707|12314177|FG000|Overall Study|Adverse Event|14
7837659|NCT01383707|12314177|FG000|Overall Study|Progressive disease|23
7837660|NCT01383928|12314197|FG000|Overall Study|Initiation of ASCT|2
7837661|NCT01383928|12314198|FG001|Overall Study|Initiation of ASCT|1
7837662|NCT01383928|12314199|FG002|Overall Study|Initiation of ASCT|18
7837663|NCT01383928|12314197|FG000|Overall Study|Adverse Event|1
7837664|NCT01383928|12314198|FG001|Overall Study|Adverse Event|2
7837665|NCT01383928|12314199|FG002|Overall Study|Adverse Event|8
7837666|NCT01383928|12314197|FG000|Overall Study|Other|1
7837667|NCT01383928|12314198|FG001|Overall Study|Other|3
7837668|NCT01383928|12314199|FG002|Overall Study|Other|4
7837669|NCT01383928|12314197|FG000|Overall Study|Progressive Disease|1
7837670|NCT01383928|12314198|FG001|Overall Study|Progressive Disease|1
7837671|NCT01383928|12314199|FG002|Overall Study|Progressive Disease|5
7837672|NCT01383928|12314197|FG000|Overall Study|Withdrawal by Subject|0
7837673|NCT01383928|12314198|FG001|Overall Study|Withdrawal by Subject|0
7837674|NCT01383928|12314199|FG002|Overall Study|Withdrawal by Subject|4
7837675|NCT01383928|12314197|FG000|Overall Study|Unsatisfactory Therapeutic Response|0
7837676|NCT01383928|12314198|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
7837677|NCT01383928|12314199|FG002|Overall Study|Unsatisfactory Therapeutic Response|1
7837678|NCT01383954|12314209|FG000|Overall Study|Lack of Efficacy|2
7837679|NCT01383954|12314209|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2
7837680|NCT01383954|12314209|FG000|Overall Study|Adverse Event|1
7837681|NCT01383954|12314209|FG000|Overall Study|Reason Not Specified|9
7837682|NCT01383993|12314216|FG000|Overall Study|Adverse Event|1
7837683|NCT01383993|12314217|FG001|Overall Study|Adverse Event|1
7837684|NCT01383993|12314218|FG002|Overall Study|Adverse Event|0
7837685|NCT01383993|12314216|FG000|Overall Study|Withdrawal by Subject|0
7837686|NCT01383993|12314217|FG001|Overall Study|Withdrawal by Subject|0
7837687|NCT01383993|12314218|FG002|Overall Study|Withdrawal by Subject|1
7837688|NCT01383993|12314216|FG000|Overall Study|Marketed voriconazole in post-therapy|2
7837689|NCT01383993|12314217|FG001|Overall Study|Marketed voriconazole in post-therapy|0
7837690|NCT01383993|12314218|FG002|Overall Study|Marketed voriconazole in post-therapy|0
7837691|NCT01384019|12314229|FG000|Overall Study|Withdrawal by Subject|3
7837692|NCT01384019|12314230|FG001|Overall Study|Withdrawal by Subject|0
7837693|NCT01384019|12314229|FG000|Overall Study|Death|1
7837694|NCT01384019|12314230|FG001|Overall Study|Death|0
7837695|NCT01384019|12314229|FG000|Overall Study|MRI refusal|6
7837696|NCT01384019|12314230|FG001|Overall Study|MRI refusal|6
7837697|NCT01384292|12314239|FG000|Part B|Severe non-compliance to protocol|1
7837698|NCT01384292|12314240|FG001|Part B|Severe non-compliance to protocol|0
7837699|NCT01384292|12314241|FG002|Part B|Severe non-compliance to protocol|0
7837700|NCT01384734|12314278|FG000|Overall Study|Adverse Event|0
7837701|NCT01384734|12314279|FG001|Overall Study|Adverse Event|3
7837702|NCT01384734|12314280|FG002|Overall Study|Adverse Event|0
7837703|NCT01384734|12314281|FG003|Overall Study|Adverse Event|2
7837704|NCT01384734|12314282|FG004|Overall Study|Adverse Event|7
7837705|NCT01384734|12314278|FG000|Overall Study|Death|1
7837706|NCT01384734|12314279|FG001|Overall Study|Death|0
7837707|NCT01384734|12314280|FG002|Overall Study|Death|1
7837708|NCT01384734|12314281|FG003|Overall Study|Death|0
7837709|NCT01384734|12314282|FG004|Overall Study|Death|0
7837710|NCT01384734|12314278|FG000|Overall Study|Continuation criteria not met|0
7837711|NCT01384734|12314279|FG001|Overall Study|Continuation criteria not met|0
7837712|NCT01384734|12314280|FG002|Overall Study|Continuation criteria not met|1
7837713|NCT01384734|12314281|FG003|Overall Study|Continuation criteria not met|1
7837714|NCT01384734|12314282|FG004|Overall Study|Continuation criteria not met|0
7837715|NCT01384734|12314278|FG000|Overall Study|Lack of Efficacy|3
7837716|NCT01384734|12314279|FG001|Overall Study|Lack of Efficacy|7
7837717|NCT01384734|12314280|FG002|Overall Study|Lack of Efficacy|4
7837718|NCT01384734|12314281|FG003|Overall Study|Lack of Efficacy|4
7837719|NCT01384734|12314282|FG004|Overall Study|Lack of Efficacy|2
7837720|NCT01384734|12314278|FG000|Overall Study|Lost to Follow-up|5
7837721|NCT01384734|12314279|FG001|Overall Study|Lost to Follow-up|3
7837722|NCT01384734|12314280|FG002|Overall Study|Lost to Follow-up|3
7837723|NCT01384734|12314281|FG003|Overall Study|Lost to Follow-up|8
7837724|NCT01384734|12314282|FG004|Overall Study|Lost to Follow-up|5
7837725|NCT01384734|12314278|FG000|Overall Study|Non-compliance with study drug|1
7837726|NCT01384734|12314279|FG001|Overall Study|Non-compliance with study drug|2
7837727|NCT01384734|12314280|FG002|Overall Study|Non-compliance with study drug|6
7837728|NCT01384734|12314281|FG003|Overall Study|Non-compliance with study drug|0
7837729|NCT01384734|12314282|FG004|Overall Study|Non-compliance with study drug|2
7837730|NCT01384734|12314278|FG000|Overall Study|Pregnancy|0
7837731|NCT01384734|12314279|FG001|Overall Study|Pregnancy|1
7837732|NCT01384734|12314280|FG002|Overall Study|Pregnancy|0
7837733|NCT01384734|12314281|FG003|Overall Study|Pregnancy|0
7837734|NCT01384734|12314282|FG004|Overall Study|Pregnancy|1
7837735|NCT01384734|12314278|FG000|Overall Study|Sponsor terminated|0
7837736|NCT01384734|12314279|FG001|Overall Study|Sponsor terminated|0
7837737|NCT01384734|12314280|FG002|Overall Study|Sponsor terminated|0
7837738|NCT01384734|12314281|FG003|Overall Study|Sponsor terminated|0
7837739|NCT01384734|12314282|FG004|Overall Study|Sponsor terminated|1
7837740|NCT01384734|12314278|FG000|Overall Study|Withdrawal by Subject|5
7837741|NCT01384734|12314279|FG001|Overall Study|Withdrawal by Subject|5
7837742|NCT01384734|12314280|FG002|Overall Study|Withdrawal by Subject|6
7837743|NCT01384734|12314281|FG003|Overall Study|Withdrawal by Subject|7
7837744|NCT01384734|12314282|FG004|Overall Study|Withdrawal by Subject|9
7837745|NCT01384734|12314278|FG000|Overall Study|Investigator relocating|0
7837746|NCT01384734|12314279|FG001|Overall Study|Investigator relocating|2
7837747|NCT01384734|12314280|FG002|Overall Study|Investigator relocating|0
7837748|NCT01384734|12314281|FG003|Overall Study|Investigator relocating|3
7837749|NCT01384734|12314282|FG004|Overall Study|Investigator relocating|1
7837750|NCT01384734|12314278|FG000|Overall Study|Unable to come back for visit|1
7837751|NCT01384734|12314279|FG001|Overall Study|Unable to come back for visit|0
7837752|NCT01384734|12314280|FG002|Overall Study|Unable to come back for visit|1
7837753|NCT01384734|12314281|FG003|Overall Study|Unable to come back for visit|1
7837754|NCT01384734|12314282|FG004|Overall Study|Unable to come back for visit|0
7837755|NCT01384734|12314278|FG000|Overall Study|Prison|0
7837756|NCT01384734|12314279|FG001|Overall Study|Prison|0
7837757|NCT01384734|12314280|FG002|Overall Study|Prison|1
7837758|NCT01384734|12314281|FG003|Overall Study|Prison|0
7837759|NCT01384734|12314282|FG004|Overall Study|Prison|0
7837760|NCT01384734|12314278|FG000|Overall Study|As per Exclusion criteria|0
7837761|NCT01384734|12314279|FG001|Overall Study|As per Exclusion criteria|1
7837762|NCT01384734|12314280|FG002|Overall Study|As per Exclusion criteria|0
7837763|NCT01384734|12314281|FG003|Overall Study|As per Exclusion criteria|0
7837764|NCT01384734|12314282|FG004|Overall Study|As per Exclusion criteria|0
7837765|NCT01384734|12314278|FG000|Overall Study|Missed End of treatment visit|0
7837766|NCT01384734|12314279|FG001|Overall Study|Missed End of treatment visit|0
7837767|NCT01384734|12314280|FG002|Overall Study|Missed End of treatment visit|0
7837768|NCT01384734|12314281|FG003|Overall Study|Missed End of treatment visit|1
7837769|NCT01384734|12314282|FG004|Overall Study|Missed End of treatment visit|0
7837770|NCT01384734|12314278|FG000|Overall Study|Adhesion problem|0
7837771|NCT01384734|12314279|FG001|Overall Study|Adhesion problem|0
7837772|NCT01384734|12314280|FG002|Overall Study|Adhesion problem|0
7837773|NCT01384734|12314281|FG003|Overall Study|Adhesion problem|1
7837774|NCT01384734|12314282|FG004|Overall Study|Adhesion problem|0
7837775|NCT01384734|12314278|FG000|Overall Study|Early termination|0
7837776|NCT01384734|12314279|FG001|Overall Study|Early termination|0
7837777|NCT01384734|12314280|FG002|Overall Study|Early termination|0
7837778|NCT01384734|12314281|FG003|Overall Study|Early termination|0
7837779|NCT01384734|12314282|FG004|Overall Study|Early termination|1
7837780|NCT01384734|12314278|FG000|Overall Study|Physician Decision|1
7837781|NCT01384734|12314279|FG001|Overall Study|Physician Decision|0
7837782|NCT01384734|12314280|FG002|Overall Study|Physician Decision|0
7837783|NCT01384734|12314281|FG003|Overall Study|Physician Decision|0
7837784|NCT01384734|12314282|FG004|Overall Study|Physician Decision|0
7837785|NCT01384760|12314293|FG000|Overall Study|Lost to Follow-up|0
7837786|NCT01384760|12314294|FG001|Overall Study|Lost to Follow-up|6
7837787|NCT01384760|12314293|FG000|Overall Study|Protocol Violation|16
7837788|NCT01384760|12314294|FG001|Overall Study|Protocol Violation|0
7837789|NCT01384877|12314302|FG000|Treatment 2|Lost to Follow-up|2
7837790|NCT01384877|12314303|FG001|Treatment 2|Lost to Follow-up|2
7837791|NCT01385098|12314309|FG000|Overall Study|Adverse Event|10
7837792|NCT01385098|12314309|FG000|Overall Study|Lost to Follow-up|4
7837793|NCT01385202|12314352|FG000|Overall Study|Lost to Follow-up|6
7837794|NCT01385202|12314352|FG000|Overall Study|Not Eligible|11
7837795|NCT01385202|12314352|FG000|Overall Study|Withdrawn|1
7837796|NCT01385371|12314368|FG000|Overall Study|Adverse Event|54
7837797|NCT01385371|12314369|FG001|Overall Study|Adverse Event|19
7837798|NCT01385371|12314368|FG000|Overall Study|Lost to Follow-up|16
7837799|NCT01385371|12314369|FG001|Overall Study|Lost to Follow-up|16
7837800|NCT01385371|12314368|FG000|Overall Study|Withdrawal by Subject|52
7837801|NCT01385371|12314369|FG001|Overall Study|Withdrawal by Subject|39
7837802|NCT01385371|12314368|FG000|Overall Study|Protocol Violation|25
7837803|NCT01385371|12314369|FG001|Overall Study|Protocol Violation|21
7837804|NCT01385371|12314368|FG000|Overall Study|Administrative|2
7837805|NCT01385371|12314369|FG001|Overall Study|Administrative|2
7837806|NCT01385566|12314381|FG000|Overall Study|Lost to Follow-up|1
7837807|NCT01385566|12314382|FG001|Overall Study|Lost to Follow-up|0
7837808|NCT01385566|12314383|FG002|Overall Study|Lost to Follow-up|0
7837809|NCT01385566|12314384|FG003|Overall Study|Lost to Follow-up|0
7837810|NCT01385566|12314385|FG004|Overall Study|Lost to Follow-up|0
7837811|NCT01385566|12314386|FG005|Overall Study|Lost to Follow-up|0
7837812|NCT01385566|12314381|FG000|Overall Study|Withdrawal by Subject|0
7837813|NCT01385566|12314382|FG001|Overall Study|Withdrawal by Subject|0
7837814|NCT01385566|12314383|FG002|Overall Study|Withdrawal by Subject|0
7837815|NCT01385566|12314384|FG003|Overall Study|Withdrawal by Subject|1
7837816|NCT01385566|12314385|FG004|Overall Study|Withdrawal by Subject|0
7837817|NCT01385566|12314386|FG005|Overall Study|Withdrawal by Subject|0
7837818|NCT01385748|12314431|FG000|Overall Study|Withdrawal by Subject|7
7837819|NCT01385748|12314432|FG001|Overall Study|Withdrawal by Subject|4
7837820|NCT01385748|12314433|FG002|Overall Study|Withdrawal by Subject|5
7837821|NCT01385748|12314431|FG000|Overall Study|Noncompliance|3
7837822|NCT01385748|12314432|FG001|Overall Study|Noncompliance|1
7837823|NCT01385748|12314433|FG002|Overall Study|Noncompliance|6
7837824|NCT01385748|12314431|FG000|Overall Study|Other|1
7837825|NCT01385748|12314432|FG001|Overall Study|Other|7
7837826|NCT01385748|12314433|FG002|Overall Study|Other|1
7837827|NCT01385748|12314431|FG000|Overall Study|Adverse Event|4
7837828|NCT01385748|12314432|FG001|Overall Study|Adverse Event|2
7837829|NCT01385748|12314433|FG002|Overall Study|Adverse Event|1
7837830|NCT01385995|12314447|FG000|Period 1, 2 Months|Physician Decision|1
7837831|NCT01385995|12314448|FG001|Period 1, 2 Months|Physician Decision|0
7837832|NCT01386008|12314456|FG000|Overall Study|exited w/o incident /study discontinued|17
7837833|NCT01386008|12314456|FG000|Overall Study|Adverse Event|3
7837834|NCT01386554|12314467|FG000|Overall Study|Lost to Follow-up|0
7837835|NCT01386554|12314468|FG001|Overall Study|Lost to Follow-up|0
7837836|NCT01386554|12314469|FG002|Overall Study|Lost to Follow-up|1
7837837|NCT01386554|12314467|FG000|Overall Study|Adverse Event|2
7837838|NCT01386554|12314468|FG001|Overall Study|Adverse Event|5
7837839|NCT01386554|12314469|FG002|Overall Study|Adverse Event|2
7837840|NCT01386554|12314467|FG000|Overall Study|Progressive disease|1
7837841|NCT01386554|12314468|FG001|Overall Study|Progressive disease|2
7837842|NCT01386554|12314469|FG002|Overall Study|Progressive disease|2
7837843|NCT01386554|12314467|FG000|Overall Study|Administration of live vaccines|0
7837844|NCT01386554|12314468|FG001|Overall Study|Administration of live vaccines|1
7837845|NCT01386554|12314469|FG002|Overall Study|Administration of live vaccines|0
7837846|NCT01386554|12314467|FG000|Overall Study|Investigator discretion|0
7837847|NCT01386554|12314468|FG001|Overall Study|Investigator discretion|0
7837848|NCT01386554|12314469|FG002|Overall Study|Investigator discretion|1
7837849|NCT01386554|12314467|FG000|Overall Study|Reason not collected|0
7837850|NCT01386554|12314468|FG001|Overall Study|Reason not collected|1
7837851|NCT01386554|12314469|FG002|Overall Study|Reason not collected|0
7837852|NCT01386606|12314483|FG000|Overall Study|Adverse Event|0
7837853|NCT01386606|12314484|FG001|Overall Study|Adverse Event|1
7837854|NCT01386606|12314485|FG002|Overall Study|Adverse Event|0
7837855|NCT01386606|12314486|FG003|Overall Study|Adverse Event|0
7837856|NCT01386606|12314483|FG000|Overall Study|Withdrawal by Subject|0
7837857|NCT01386606|12314484|FG001|Overall Study|Withdrawal by Subject|1
7837858|NCT01386606|12314485|FG002|Overall Study|Withdrawal by Subject|1
7837859|NCT01386606|12314486|FG003|Overall Study|Withdrawal by Subject|0
7837860|NCT01386606|12314483|FG000|Overall Study|Protocol Violation|1
7837861|NCT01386606|12314484|FG001|Overall Study|Protocol Violation|0
7837862|NCT01386606|12314485|FG002|Overall Study|Protocol Violation|1
7837863|NCT01386606|12314486|FG003|Overall Study|Protocol Violation|1
7837864|NCT01386606|12314483|FG000|Overall Study|Lost to Follow-up|2
7837865|NCT01386606|12314484|FG001|Overall Study|Lost to Follow-up|0
7837866|NCT01386606|12314485|FG002|Overall Study|Lost to Follow-up|0
7837867|NCT01386606|12314486|FG003|Overall Study|Lost to Follow-up|0
7837868|NCT01386606|12314483|FG000|Overall Study|Subject incarcerated|0
7837869|NCT01386606|12314484|FG001|Overall Study|Subject incarcerated|1
7837870|NCT01386606|12314485|FG002|Overall Study|Subject incarcerated|0
7837871|NCT01386606|12314486|FG003|Overall Study|Subject incarcerated|0
7837872|NCT01386606|12314483|FG000|Overall Study|Unable to draw PK|1
7837873|NCT01386606|12314484|FG001|Overall Study|Unable to draw PK|0
7837874|NCT01386606|12314485|FG002|Overall Study|Unable to draw PK|0
7837875|NCT01386606|12314486|FG003|Overall Study|Unable to draw PK|0
7837876|NCT01386606|12314483|FG000|Overall Study|T levels too high|0
7837877|NCT01386606|12314484|FG001|Overall Study|T levels too high|1
7837878|NCT01386606|12314485|FG002|Overall Study|T levels too high|1
7837879|NCT01386606|12314486|FG003|Overall Study|T levels too high|0
7837880|NCT01386645|12314512|FG000|Overall Study|Physician Decision|0
7837881|NCT01386645|12314513|FG001|Overall Study|Physician Decision|0
7837882|NCT01386645|12314514|FG002|Overall Study|Physician Decision|1
7837883|NCT01386645|12314512|FG000|Overall Study|Withdrawal by Subject|0
7837884|NCT01386645|12314513|FG001|Overall Study|Withdrawal by Subject|1
7837885|NCT01386645|12314514|FG002|Overall Study|Withdrawal by Subject|1
7837886|NCT01386788|12314522|FG000|Overall Study|Lost to Follow-up|2
7837887|NCT01386944|12314526|FG000|Overall Study|Adverse Event|26
7837888|NCT01386944|12314526|FG000|Overall Study|Lack of Efficacy|14
7837889|NCT01386944|12314526|FG000|Overall Study|Lost to Follow-up|8
7837890|NCT01386944|12314526|FG000|Overall Study|Unspecified reason|8
7837891|NCT01386970|12314532|FG000|Overall Study|Withdrawal by Subject|0
7837892|NCT01386970|12314533|FG001|Overall Study|Withdrawal by Subject|1
7837893|NCT01386970|12314532|FG000|Overall Study|Adverse Event|4
7837894|NCT01386970|12314533|FG001|Overall Study|Adverse Event|1
7837895|NCT01387022|12314552|FG000|Overall Study|Death|1
7837896|NCT01387022|12314553|FG001|Overall Study|Death|1
7837897|NCT01387022|12314552|FG000|Overall Study|Lost to Follow-up|0
7837898|NCT01387022|12314553|FG001|Overall Study|Lost to Follow-up|3
7837899|NCT01387074|12314559|FG000|Overall Study|Lost to Follow-up|7
7837900|NCT01387074|12314559|FG000|Overall Study|Lack of Efficacy|1
7837901|NCT01387230|12314585|FG000|Overall Study|Adverse Event|0
7837902|NCT01387230|12314586|FG001|Overall Study|Adverse Event|1
7837903|NCT01387230|12314587|FG002|Overall Study|Adverse Event|3
7837904|NCT01387230|12314585|FG000|Overall Study|Lack of Efficacy|8
7837905|NCT01387230|12314586|FG001|Overall Study|Lack of Efficacy|5
7837906|NCT01387230|12314587|FG002|Overall Study|Lack of Efficacy|4
7837907|NCT01387230|12314585|FG000|Overall Study|Protocol-defined Stopping Criteria|6
7837908|NCT01387230|12314586|FG001|Overall Study|Protocol-defined Stopping Criteria|0
7837909|NCT01387230|12314587|FG002|Overall Study|Protocol-defined Stopping Criteria|5
7837910|NCT01387230|12314585|FG000|Overall Study|Lost to Follow-up|0
7837911|NCT01387230|12314586|FG001|Overall Study|Lost to Follow-up|0
7837912|NCT01387230|12314587|FG002|Overall Study|Lost to Follow-up|1
7837913|NCT01387230|12314585|FG000|Overall Study|Withdrawal by Subject|4
7837914|NCT01387230|12314586|FG001|Overall Study|Withdrawal by Subject|1
7837915|NCT01387230|12314587|FG002|Overall Study|Withdrawal by Subject|0
7837916|NCT01387269|12314597|FG000|Overall Study|Death|38
7837917|NCT01387269|12314598|FG001|Overall Study|Death|20
7837918|NCT01387269|12314597|FG000|Overall Study|Other|8
7837919|NCT01387269|12314598|FG001|Overall Study|Other|7
7837920|NCT01387269|12314597|FG000|Overall Study|Unrelated AE|12
7837921|NCT01387269|12314598|FG001|Overall Study|Unrelated AE|3
7837922|NCT01387269|12314597|FG000|Overall Study|Withdrawal by patient|32
7837923|NCT01387269|12314598|FG001|Overall Study|Withdrawal by patient|10
7837924|NCT01387269|12314597|FG000|Overall Study|Study drug-related AE|1
7837925|NCT01387269|12314598|FG001|Overall Study|Study drug-related AE|0
7837926|NCT01387269|12314597|FG000|Overall Study|Lost to Follow-up|1
7837927|NCT01387269|12314598|FG001|Overall Study|Lost to Follow-up|0
7837928|NCT01387282|12314606|FG000|Overall Study|Death|47
7837929|NCT01387282|12314607|FG001|Overall Study|Death|16
7837930|NCT01387282|12314606|FG000|Overall Study|Other|5
7837931|NCT01387282|12314607|FG001|Overall Study|Other|1
7837932|NCT01387282|12314606|FG000|Overall Study|Unrelated AE|6
7837933|NCT01387282|12314607|FG001|Overall Study|Unrelated AE|4
7837934|NCT01387282|12314606|FG000|Overall Study|Withdrawal by patient|33
7837935|NCT01387282|12314607|FG001|Overall Study|Withdrawal by patient|23
7837936|NCT01387282|12314606|FG000|Overall Study|Study drug-related AE|2
7837937|NCT01387282|12314607|FG001|Overall Study|Study drug-related AE|2
7837938|NCT01387282|12314606|FG000|Overall Study|Lost to Follow-up|4
7837939|NCT01387282|12314607|FG001|Overall Study|Lost to Follow-up|1
7837940|NCT01387347|12314615|FG000|Overall Study|Lost to Follow-up|2
7837941|NCT01387347|12314616|FG001|Overall Study|Lost to Follow-up|1
7837942|NCT01387516|12314639|FG000|Overall Study|Lost to Follow-up|4
7837943|NCT01387516|12314640|FG001|Overall Study|Lost to Follow-up|4
7837944|NCT01387516|12314641|FG002|Overall Study|Lost to Follow-up|2
7837945|NCT01387516|12314642|FG003|Overall Study|Lost to Follow-up|3
7837946|NCT01387516|12314639|FG000|Overall Study|Withdrawal by Subject|1
7837947|NCT01387516|12314640|FG001|Overall Study|Withdrawal by Subject|1
7837948|NCT01387516|12314641|FG002|Overall Study|Withdrawal by Subject|2
7837949|NCT01387516|12314642|FG003|Overall Study|Withdrawal by Subject|0
7837950|NCT01387516|12314639|FG000|Overall Study|Death|0
7837951|NCT01387516|12314640|FG001|Overall Study|Death|0
7837952|NCT01387516|12314641|FG002|Overall Study|Death|0
7837953|NCT01387516|12314642|FG003|Overall Study|Death|1
7837954|NCT01387542|12314652|FG000|Overall Study|Adverse Event|3
7837955|NCT01387542|12314652|FG000|Overall Study|Withdrawal by Subject|1
7837956|NCT01387542|12314652|FG000|Overall Study|Changed diagnosis|1
7837957|NCT01387542|12314652|FG000|Overall Study|Insufficient response|1
7837958|NCT01387542|12314652|FG000|Overall Study|Non-compliant|1
7837959|NCT01387542|12314652|FG000|Overall Study|Lost to Follow-up|1
7837960|NCT01387594|12314671|FG000|Overall Study|Withdrawal by Subject|0
7837961|NCT01387594|12314672|FG001|Overall Study|Withdrawal by Subject|2
7837962|NCT01387594|12314671|FG000|Overall Study|Lost to Follow-up|0
7837963|NCT01387594|12314672|FG001|Overall Study|Lost to Follow-up|1
7837964|NCT01387607|12314683|FG000|Overall Study|Adverse Event|23
7837965|NCT01387607|12314684|FG001|Overall Study|Adverse Event|11
7837966|NCT01387607|12314683|FG000|Overall Study|Lack of Efficacy|8
7837967|NCT01387607|12314684|FG001|Overall Study|Lack of Efficacy|6
7837968|NCT01387607|12314683|FG000|Overall Study|Lost to Follow-up|2
7837969|NCT01387607|12314684|FG001|Overall Study|Lost to Follow-up|1
7837970|NCT01387607|12314683|FG000|Overall Study|No longer meets eligibility criteria|0
7837971|NCT01387607|12314684|FG001|Overall Study|No longer meets eligibility criteria|1
7837972|NCT01387607|12314683|FG000|Overall Study|Protocol Violation|1
7837973|NCT01387607|12314684|FG001|Overall Study|Protocol Violation|5
7837974|NCT01387607|12314683|FG000|Overall Study|Withdrawal by Subject|13
7837975|NCT01387607|12314684|FG001|Overall Study|Withdrawal by Subject|14
7837976|NCT01387607|12314683|FG000|Overall Study|Other|1
7837977|NCT01387607|12314684|FG001|Overall Study|Other|1
7837978|NCT01387607|12314683|FG000|Overall Study|Randomized, not treated|3
7837979|NCT01387607|12314684|FG001|Overall Study|Randomized, not treated|6
7837980|NCT01387737|12314718|FG000|Overall Study|Adverse Event|20
7837981|NCT01387737|12314719|FG001|Overall Study|Adverse Event|30
7837982|NCT01387737|12314718|FG000|Overall Study|Lack of Efficacy|1
7837983|NCT01387737|12314719|FG001|Overall Study|Lack of Efficacy|0
7837984|NCT01387737|12314718|FG000|Overall Study|Physician Decision|3
7837985|NCT01387737|12314719|FG001|Overall Study|Physician Decision|10
7837986|NCT01387737|12314718|FG000|Overall Study|Withdrawal by Subject|27
7837987|NCT01387737|12314719|FG001|Overall Study|Withdrawal by Subject|31
7837988|NCT01387737|12314718|FG000|Overall Study|Clearly not eligible for the study|1
7837989|NCT01387737|12314719|FG001|Overall Study|Clearly not eligible for the study|3
7837990|NCT01387789|12314725|FG000|Overall Study|Adverse Event|5
7837991|NCT01387789|12314725|FG000|Overall Study|Lack of Efficacy|2
7837992|NCT01387789|12314725|FG000|Overall Study|Lost to Follow-up|1
7837993|NCT01387932|12314740|FG000|Randomized and Treated|Physician Decision|3
7837994|NCT01387932|12314741|FG001|Randomized and Treated|Physician Decision|2
7837995|NCT01387932|12314740|FG000|Randomized and Treated|Withdrawal by Subject|4
7837996|NCT01387932|12314741|FG001|Randomized and Treated|Withdrawal by Subject|2
7837997|NCT01387932|12314740|FG000|Survival Follow-up|Liver Transplant|24
7837998|NCT01387932|12314741|FG001|Survival Follow-up|Liver Transplant|28
7837999|NCT01387932|12314740|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52
7838000|NCT01387932|12314741|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53
7838001|NCT01387932|12314740|FG000|Survival Follow-up|Withdrawal by Subject|2
7838002|NCT01387932|12314741|FG001|Survival Follow-up|Withdrawal by Subject|4
7838003|NCT01387932|12314740|FG000|Survival Follow-up|Lost to Follow-up|6
7838004|NCT01387932|12314741|FG001|Survival Follow-up|Lost to Follow-up|5
7838005|NCT01388166|12314749|FG000|Overall Study|Adverse Event|16
7838006|NCT01388166|12314749|FG000|Overall Study|Lost to Follow-up|30
7838007|NCT01388166|12314749|FG000|Overall Study|Others than specified above|13
7838008|NCT01388335|12314753|FG000|Period 1|Progressive Disease|1
7838009|NCT01388335|12314753|FG000|Period 2|Progressive Disease|2
7838010|NCT01388335|12314753|FG000|Period 2|Sponsor Decision|1
7838011|NCT01388335|12314753|FG000|Safety Extension|Progressive Disease|7
7838012|NCT01388361|12314768|FG000|Overall Study|Adverse Event|0
7838013|NCT01388361|12314769|FG001|Overall Study|Adverse Event|5
7838014|NCT01388361|12314770|FG002|Overall Study|Adverse Event|1
7838015|NCT01388361|12314768|FG000|Overall Study|Protocol Violation|0
7838016|NCT01388361|12314769|FG001|Overall Study|Protocol Violation|0
7838017|NCT01388361|12314770|FG002|Overall Study|Protocol Violation|2
7838018|NCT01388361|12314768|FG000|Overall Study|Withdrawal criteria|12
7948861|NCT02531698|12494165|FG001|Overall Study|Lost to Follow-up|0
7838019|NCT01388361|12314769|FG001|Overall Study|Withdrawal criteria|7
7838020|NCT01388361|12314770|FG002|Overall Study|Withdrawal criteria|10
7838021|NCT01388361|12314768|FG000|Overall Study|Unclassified|0
7838022|NCT01388361|12314769|FG001|Overall Study|Unclassified|0
7838023|NCT01388361|12314770|FG002|Overall Study|Unclassified|1
7838024|NCT01388478|12314778|FG000|Overall Study|Adverse Event|4
7838025|NCT01388478|12314778|FG000|Overall Study|Withdrawal by Subject|1
7838026|NCT01388530|12314782|FG000|Overall Study|Lost to Follow-up|5
7838027|NCT01388543|12314788|FG000|Day 14|Adverse Event|1
7838028|NCT01388543|12314789|FG001|Day 14|Adverse Event|4
7838029|NCT01388647|12314797|FG000|Overall Study|Adverse Event|1
7838030|NCT01388647|12314798|FG001|Overall Study|Adverse Event|2
7838031|NCT01388790|12314809|FG000|Overall Study|Ongoing at data cut-off date|8
7838032|NCT01388816|12314817|FG000|Overall Study|Adverse Event|0
7838033|NCT01388816|12314818|FG001|Overall Study|Adverse Event|2
7838034|NCT01388816|12314819|FG002|Overall Study|Adverse Event|0
7838035|NCT01388816|12314820|FG003|Overall Study|Adverse Event|0
7838036|NCT01388816|12314817|FG000|Overall Study|Lost to Follow-up|0
7838037|NCT01388816|12314818|FG001|Overall Study|Lost to Follow-up|1
7838038|NCT01388816|12314819|FG002|Overall Study|Lost to Follow-up|0
7838039|NCT01388816|12314820|FG003|Overall Study|Lost to Follow-up|0
7838040|NCT01388816|12314817|FG000|Overall Study|Withdrawal by Subject|2
7838041|NCT01388816|12314818|FG001|Overall Study|Withdrawal by Subject|1
7838042|NCT01388816|12314819|FG002|Overall Study|Withdrawal by Subject|1
7838043|NCT01388816|12314820|FG003|Overall Study|Withdrawal by Subject|0
7838044|NCT01388816|12314817|FG000|Overall Study|Protocol Violation|0
7838045|NCT01388816|12314818|FG001|Overall Study|Protocol Violation|0
7838046|NCT01388816|12314819|FG002|Overall Study|Protocol Violation|2
7838047|NCT01388816|12314820|FG003|Overall Study|Protocol Violation|0
7838048|NCT01388907|12314835|FG000|Overall Study|Adverse Event|2
7838049|NCT01388907|12314836|FG001|Overall Study|Adverse Event|0
7838050|NCT01388985|12314855|FG000|Overall Study|Death|0
7838051|NCT01388985|12314856|FG001|Overall Study|Death|1
7838052|NCT01388985|12314855|FG000|Overall Study|Lost to Follow-up|30
7838053|NCT01388985|12314856|FG001|Overall Study|Lost to Follow-up|30
7838054|NCT01388985|12314855|FG000|Overall Study|Withdrawal by Subject|13
7838055|NCT01388985|12314856|FG001|Overall Study|Withdrawal by Subject|4
7838056|NCT01388985|12314855|FG000|Overall Study|Subject unavailable|1
7838057|NCT01388985|12314856|FG001|Overall Study|Subject unavailable|1
7838058|NCT01388985|12314855|FG000|Overall Study|Other (no reason)|0
7838059|NCT01388985|12314856|FG001|Overall Study|Other (no reason)|1
7838060|NCT01388985|12314855|FG000|Overall Study|Error of nurse|5
7838061|NCT01388985|12314856|FG001|Overall Study|Error of nurse|1
7838062|NCT01389102|12314872|FG000|Overall Study|Adverse Event|1
7838063|NCT01389102|12314873|FG001|Overall Study|Adverse Event|3
7838064|NCT01389102|12314874|FG002|Overall Study|Adverse Event|2
7838065|NCT01389102|12314875|FG003|Overall Study|Adverse Event|2
7838066|NCT01389102|12314876|FG004|Overall Study|Adverse Event|2
7838067|NCT01389102|12314877|FG005|Overall Study|Adverse Event|2
7838068|NCT01389102|12314872|FG000|Overall Study|Hurricane Katrina|4
7838069|NCT01389102|12314873|FG001|Overall Study|Hurricane Katrina|2
7838070|NCT01389102|12314874|FG002|Overall Study|Hurricane Katrina|3
7838071|NCT01389102|12314875|FG003|Overall Study|Hurricane Katrina|0
7838072|NCT01389102|12314876|FG004|Overall Study|Hurricane Katrina|3
7838073|NCT01389102|12314877|FG005|Overall Study|Hurricane Katrina|1
7838074|NCT01389102|12314872|FG000|Overall Study|Lost to Follow-up|4
7838075|NCT01389102|12314873|FG001|Overall Study|Lost to Follow-up|1
7838076|NCT01389102|12314874|FG002|Overall Study|Lost to Follow-up|1
7838077|NCT01389102|12314875|FG003|Overall Study|Lost to Follow-up|2
7838078|NCT01389102|12314876|FG004|Overall Study|Lost to Follow-up|4
7838079|NCT01389102|12314877|FG005|Overall Study|Lost to Follow-up|1
7838080|NCT01389102|12314872|FG000|Overall Study|Protocol Violation|0
7838081|NCT01389102|12314873|FG001|Overall Study|Protocol Violation|0
7838082|NCT01389102|12314874|FG002|Overall Study|Protocol Violation|3
7838083|NCT01389102|12314875|FG003|Overall Study|Protocol Violation|0
7838084|NCT01389102|12314876|FG004|Overall Study|Protocol Violation|1
7838085|NCT01389102|12314877|FG005|Overall Study|Protocol Violation|1
7838086|NCT01389102|12314872|FG000|Overall Study|Withdrawal by Subject|7
7838087|NCT01389102|12314873|FG001|Overall Study|Withdrawal by Subject|4
7838088|NCT01389102|12314874|FG002|Overall Study|Withdrawal by Subject|9
7838089|NCT01389102|12314875|FG003|Overall Study|Withdrawal by Subject|2
7838090|NCT01389102|12314876|FG004|Overall Study|Withdrawal by Subject|3
7838091|NCT01389102|12314877|FG005|Overall Study|Withdrawal by Subject|3
7838092|NCT01389102|12314872|FG000|Overall Study|Subject Traveling Out of Country|0
7838093|NCT01389102|12314873|FG001|Overall Study|Subject Traveling Out of Country|0
7838094|NCT01389102|12314874|FG002|Overall Study|Subject Traveling Out of Country|0
7838095|NCT01389102|12314875|FG003|Overall Study|Subject Traveling Out of Country|1
7838096|NCT01389102|12314876|FG004|Overall Study|Subject Traveling Out of Country|0
7838097|NCT01389102|12314877|FG005|Overall Study|Subject Traveling Out of Country|0
7838098|NCT01389102|12314872|FG000|Overall Study|Subject Moved|2
7838099|NCT01389102|12314873|FG001|Overall Study|Subject Moved|0
7838100|NCT01389102|12314874|FG002|Overall Study|Subject Moved|1
7838101|NCT01389102|12314875|FG003|Overall Study|Subject Moved|0
7838102|NCT01389102|12314876|FG004|Overall Study|Subject Moved|0
7838103|NCT01389102|12314877|FG005|Overall Study|Subject Moved|0
7838104|NCT01389102|12314872|FG000|Overall Study|Unavailable due to husband's illness|0
7838105|NCT01389102|12314873|FG001|Overall Study|Unavailable due to husband's illness|1
7838106|NCT01389102|12314874|FG002|Overall Study|Unavailable due to husband's illness|0
7838107|NCT01389102|12314875|FG003|Overall Study|Unavailable due to husband's illness|0
7838108|NCT01389102|12314876|FG004|Overall Study|Unavailable due to husband's illness|0
7838109|NCT01389102|12314877|FG005|Overall Study|Unavailable due to husband's illness|0
7838110|NCT01389102|12314872|FG000|Overall Study|Investigator Judgement|0
7838111|NCT01389102|12314873|FG001|Overall Study|Investigator Judgement|1
7838112|NCT01389102|12314874|FG002|Overall Study|Investigator Judgement|0
7838113|NCT01389102|12314875|FG003|Overall Study|Investigator Judgement|0
7838114|NCT01389102|12314876|FG004|Overall Study|Investigator Judgement|0
7838115|NCT01389102|12314877|FG005|Overall Study|Investigator Judgement|0
7838116|NCT01389128|12314899|FG000|Overall Study|Fetal distress|1
7838117|NCT01389128|12314900|FG001|Overall Study|Fetal distress|0
7838118|NCT01389128|12314899|FG000|Overall Study|Cervix dilation stop|1
7838119|NCT01389128|12314900|FG001|Overall Study|Cervix dilation stop|2
7838120|NCT01389128|12314899|FG000|Overall Study|Rapid labor evolution|3
7838121|NCT01389128|12314900|FG001|Overall Study|Rapid labor evolution|2
7838122|NCT01389128|12314899|FG000|Overall Study|Intolerance to procedure|0
7838123|NCT01389128|12314900|FG001|Overall Study|Intolerance to procedure|2
7838124|NCT01389232|12314910|FG000|Overall Study|Had scaffold removed|15
7838125|NCT01389232|12314910|FG000|Overall Study|Personal reasons|2
7838126|NCT01389232|12314910|FG000|Overall Study|Adverse Event|1
7838127|NCT01389232|12314910|FG000|Overall Study|Death|1
7838128|NCT01389245|12314924|FG000|Overall Study|Protocol Violation|10
7838129|NCT01389245|12314924|FG000|Overall Study|Lost to Follow-up|3
7838130|NCT01389245|12314924|FG000|Overall Study|Withdrawal by Subject|2
7838131|NCT01389258|12314928|FG000|Overall Study|Lost to Follow-up|5
7838132|NCT01389323|12314945|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
7838133|NCT01389323|12314945|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24
7838134|NCT01389323|12314945|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
7838135|NCT01389323|12314945|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
7838136|NCT01389323|12314945|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
7838137|NCT01389323|12314945|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
7838138|NCT01389323|12314945|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
7838139|NCT01389323|12314945|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
7838140|NCT01389323|12314945|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
7838141|NCT01389323|12314945|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
7838142|NCT01389323|12314945|FG000|Follow-up Period (up to 48 Weeks)|Other|3
7838143|NCT01389596|12314959|FG000|Overall Study|Protocol Violation|3
7838144|NCT01389596|12314960|FG001|Overall Study|Protocol Violation|4
7838145|NCT01389596|12314961|FG002|Overall Study|Protocol Violation|3
7838146|NCT01389596|12314959|FG000|Overall Study|Withdrawal by Subject|1
7838147|NCT01389596|12314960|FG001|Overall Study|Withdrawal by Subject|2
7838148|NCT01389596|12314961|FG002|Overall Study|Withdrawal by Subject|2
7838149|NCT01389596|12314959|FG000|Overall Study|Insufficient Clinical Response|3
7838150|NCT01389596|12314960|FG001|Overall Study|Insufficient Clinical Response|4
7838151|NCT01389596|12314961|FG002|Overall Study|Insufficient Clinical Response|5
7838152|NCT01389596|12314959|FG000|Overall Study|Adverse Event|1
7838153|NCT01389596|12314960|FG001|Overall Study|Adverse Event|4
7838154|NCT01389596|12314961|FG002|Overall Study|Adverse Event|0
7838155|NCT01389596|12314959|FG000|Overall Study|Death|0
7838156|NCT01389596|12314960|FG001|Overall Study|Death|1
7838157|NCT01389596|12314961|FG002|Overall Study|Death|0
7838158|NCT01389596|12314959|FG000|Overall Study|Other Unspecified|2
7838159|NCT01389596|12314960|FG001|Overall Study|Other Unspecified|1
7838160|NCT01389596|12314961|FG002|Overall Study|Other Unspecified|0
7838161|NCT01389752|12314969|FG000|Study Period 1|Sponsor decision|0
7838162|NCT01389752|12314970|FG001|Study Period 1|Sponsor decision|2
7838163|NCT01389752|12314969|FG000|Study Period 2|Sponsor decision|1
7838164|NCT01389752|12314970|FG001|Study Period 2|Sponsor decision|0
7838165|NCT01389882|12314995|FG000|Overall Study|Respiratory rate > 80/min during study|1
7838166|NCT01389882|12314996|FG001|Overall Study|Respiratory rate > 80/min during study|3
7838167|NCT01389882|12314995|FG000|Overall Study|Withdrawal by Subject|0
7838168|NCT01389882|12314996|FG001|Overall Study|Withdrawal by Subject|1
7838169|NCT01389973|12315002|FG000|Overall Study|Lost to Follow-up|1
7838170|NCT01389973|12315002|FG000|Overall Study|Trial Stopped by Sponsor|9
7838171|NCT01389973|12315002|FG000|Overall Study|Other|10
7838172|NCT01390038|12315006|FG000|Overall Study|Death|1
7838173|NCT01390038|12315006|FG000|Overall Study|Lost to Follow-up|1
7838174|NCT01390038|12315006|FG000|Overall Study|Withdrawal by Subject|4
7838175|NCT01390038|12315006|FG000|Overall Study|Simpliciti System Removal|2
7838176|NCT01390220|12315028|FG000|Test Dose Phase|Adverse Event|17
7838177|NCT01390220|12315029|FG001|Test Dose Phase|Adverse Event|0
7838178|NCT01390220|12315030|FG002|Test Dose Phase|Adverse Event|0
7838179|NCT01390220|12315028|FG000|Test Dose Phase|Withdrawal by Subject|8
7838180|NCT01390220|12315029|FG001|Test Dose Phase|Withdrawal by Subject|0
7838181|NCT01390220|12315030|FG002|Test Dose Phase|Withdrawal by Subject|0
7838182|NCT01390220|12315028|FG000|Test Dose Phase|Lost to Follow-up|2
7838183|NCT01390220|12315029|FG001|Test Dose Phase|Lost to Follow-up|0
7838184|NCT01390220|12315030|FG002|Test Dose Phase|Lost to Follow-up|0
7838185|NCT01390220|12315028|FG000|Test Dose Phase|Protocol Violation|8
7838186|NCT01390220|12315029|FG001|Test Dose Phase|Protocol Violation|0
7838187|NCT01390220|12315030|FG002|Test Dose Phase|Protocol Violation|0
7838188|NCT01390220|12315028|FG000|Test Dose Phase|No treated seizure cluster episode|37
7838189|NCT01390220|12315029|FG001|Test Dose Phase|No treated seizure cluster episode|0
7838190|NCT01390220|12315030|FG002|Test Dose Phase|No treated seizure cluster episode|0
7838191|NCT01390220|12315028|FG000|Test Dose Phase|Study/Site closure|6
7838192|NCT01390220|12315029|FG001|Test Dose Phase|Study/Site closure|0
7838193|NCT01390220|12315030|FG002|Test Dose Phase|Study/Site closure|0
7838194|NCT01390220|12315028|FG000|Test Dose Phase|Caregiver no longer available|5
7838195|NCT01390220|12315029|FG001|Test Dose Phase|Caregiver no longer available|0
7838196|NCT01390220|12315030|FG002|Test Dose Phase|Caregiver no longer available|0
7838197|NCT01390220|12315028|FG000|Test Dose Phase|Noncompliance|2
7838198|NCT01390220|12315029|FG001|Test Dose Phase|Noncompliance|0
7838199|NCT01390220|12315030|FG002|Test Dose Phase|Noncompliance|0
7838200|NCT01390220|12315028|FG000|Test Dose Phase|Logistical|6
7838201|NCT01390220|12315029|FG001|Test Dose Phase|Logistical|0
7838202|NCT01390220|12315030|FG002|Test Dose Phase|Logistical|0
7838203|NCT01390220|12315028|FG000|Comparative Phase|Withdrawal by Subject|0
7838204|NCT01390220|12315029|FG001|Comparative Phase|Withdrawal by Subject|1
7838205|NCT01390220|12315030|FG002|Comparative Phase|Withdrawal by Subject|0
7838206|NCT01390272|12315069|FG000|Overall Study|Death|3
7838207|NCT01390272|12315070|FG001|Overall Study|Death|2
7838208|NCT01390272|12315069|FG000|Overall Study|Withdrawal by Subject|9
7838209|NCT01390272|12315070|FG001|Overall Study|Withdrawal by Subject|5
7838210|NCT01390272|12315069|FG000|Overall Study|Patient moved, no longer eligible|5
7838211|NCT01390272|12315070|FG001|Overall Study|Patient moved, no longer eligible|8
7838212|NCT01390298|12315076|FG000|Overall Study|Death|1
7838213|NCT01390298|12315076|FG000|Overall Study|long term ICU admission|1
7838214|NCT01390298|12315076|FG000|Overall Study|Withdrawal by Subject|14
7838215|NCT01390298|12315076|FG000|Overall Study|Lost to Follow-up|7
7838216|NCT01390298|12315076|FG000|Overall Study|Surgery cancelled|1
7862739|NCT01600014|12351698|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6
7862740|NCT01600014|12351699|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0
7862741|NCT01600014|12351698|FG000|1. Cycle & Observation Period D1 to W52|Other|27
7862742|NCT01600014|12351699|FG001|1. Cycle & Observation Period D1 to W52|Other|0
7862743|NCT01600014|12351698|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
7862744|NCT01600014|12351699|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
7948862|NCT02531802|12494201|FG000|Received Vaccination 2|Medication interfering with study taken|0
7948863|NCT02531802|12494202|FG001|Received Vaccination 2|Medication interfering with study taken|0
7948864|NCT02531802|12494203|FG002|Received Vaccination 2|Medication interfering with study taken|1
7948865|NCT02531802|12494204|FG003|Received Vaccination 2|Medication interfering with study taken|0
7948866|NCT02531802|12494205|FG004|Received Vaccination 2|Medication interfering with study taken|0
7948867|NCT02531802|12494206|FG005|Received Vaccination 2|Medication interfering with study taken|0
7948868|NCT02531802|12494207|FG006|Received Vaccination 2|Medication interfering with study taken|0
7948869|NCT02531802|12494208|FG007|Received Vaccination 2|Medication interfering with study taken|0
7948870|NCT02531802|12494209|FG008|Received Vaccination 2|Medication interfering with study taken|0
7948871|NCT02531802|12494210|FG009|Received Vaccination 2|Medication interfering with study taken|1
7948872|NCT02531802|12494211|FG010|Received Vaccination 2|Medication interfering with study taken|1
7948873|NCT02531802|12494212|FG011|Received Vaccination 2|Medication interfering with study taken|0
7948874|NCT02531802|12494213|FG012|Received Vaccination 2|Medication interfering with study taken|1
7948875|NCT02531802|12494214|FG013|Received Vaccination 2|Medication interfering with study taken|0
7948876|NCT02531802|12494215|FG014|Received Vaccination 2|Medication interfering with study taken|0
7948877|NCT02531802|12494216|FG015|Received Vaccination 2|Medication interfering with study taken|0
7948878|NCT02531802|12494217|FG016|Received Vaccination 2|Medication interfering with study taken|0
7948879|NCT02531802|12494218|FG017|Received Vaccination 2|Medication interfering with study taken|0
7948880|NCT02531802|12494219|FG018|Received Vaccination 2|Medication interfering with study taken|1
7948881|NCT02531802|12494220|FG019|Received Vaccination 2|Medication interfering with study taken|0
7838217|NCT01390389|12315082|FG000|Overall Study|Withdrawal by Subject|2
7838218|NCT01390389|12315083|FG001|Overall Study|Withdrawal by Subject|0
7838219|NCT01390389|12315082|FG000|Overall Study|Screen Fail|2
7838220|NCT01390389|12315083|FG001|Overall Study|Screen Fail|1
7838221|NCT01390402|12315093|FG000|Overall Study|Death|1
7838222|NCT01390402|12315093|FG000|Overall Study|Disease Progression|4
7838223|NCT01390428|12315103|FG000|Overall Study|Elective Surgery|0
7838224|NCT01390428|12315104|FG001|Overall Study|Elective Surgery|0
7838225|NCT01390428|12315105|FG002|Overall Study|Elective Surgery|0
7838226|NCT01390428|12315106|FG003|Overall Study|Elective Surgery|0
7838227|NCT01390428|12315107|FG004|Overall Study|Elective Surgery|1
7838228|NCT01390428|12315108|FG005|Overall Study|Elective Surgery|0
7838229|NCT01390428|12315103|FG000|Overall Study|Withdrawal by Subject|0
7838230|NCT01390428|12315104|FG001|Overall Study|Withdrawal by Subject|0
7838231|NCT01390428|12315105|FG002|Overall Study|Withdrawal by Subject|1
7838232|NCT01390428|12315106|FG003|Overall Study|Withdrawal by Subject|0
7838233|NCT01390428|12315107|FG004|Overall Study|Withdrawal by Subject|0
7838234|NCT01390428|12315108|FG005|Overall Study|Withdrawal by Subject|0
7838235|NCT01390441|12315127|FG000|Treatment Period|Protocol Violation|0
7838236|NCT01390441|12315128|FG001|Treatment Period|Protocol Violation|1
7838237|NCT01390441|12315129|FG002|Treatment Period|Protocol Violation|0
7838238|NCT01390441|12315130|FG003|Treatment Period|Protocol Violation|0
7838239|NCT01390441|12315131|FG004|Treatment Period|Protocol Violation|0
7838240|NCT01390441|12315127|FG000|Treatment Period|Physician Decision|0
7838241|NCT01390441|12315128|FG001|Treatment Period|Physician Decision|0
7838242|NCT01390441|12315129|FG002|Treatment Period|Physician Decision|0
7838243|NCT01390441|12315130|FG003|Treatment Period|Physician Decision|1
7838244|NCT01390441|12315131|FG004|Treatment Period|Physician Decision|0
7838245|NCT01390441|12315127|FG000|Treatment Period|Lack of Efficacy|0
7838246|NCT01390441|12315128|FG001|Treatment Period|Lack of Efficacy|0
7838247|NCT01390441|12315129|FG002|Treatment Period|Lack of Efficacy|0
7838248|NCT01390441|12315130|FG003|Treatment Period|Lack of Efficacy|0
7838249|NCT01390441|12315131|FG004|Treatment Period|Lack of Efficacy|1
7838250|NCT01390441|12315127|FG000|Treatment Period|Unknown due to early stopping of study|0
7838251|NCT01390441|12315128|FG001|Treatment Period|Unknown due to early stopping of study|0
7838252|NCT01390441|12315129|FG002|Treatment Period|Unknown due to early stopping of study|8
7838253|NCT01390441|12315130|FG003|Treatment Period|Unknown due to early stopping of study|11
7838254|NCT01390441|12315131|FG004|Treatment Period|Unknown due to early stopping of study|7
7838255|NCT01390441|12315127|FG000|Treatment Period|Adverse Event|0
7838256|NCT01390441|12315128|FG001|Treatment Period|Adverse Event|0
7838257|NCT01390441|12315129|FG002|Treatment Period|Adverse Event|1
7838258|NCT01390441|12315130|FG003|Treatment Period|Adverse Event|1
7838259|NCT01390441|12315131|FG004|Treatment Period|Adverse Event|2
7838260|NCT01390441|12315127|FG000|Treatment Period|Withdrawal by Subject|0
7838261|NCT01390441|12315128|FG001|Treatment Period|Withdrawal by Subject|0
7838262|NCT01390441|12315129|FG002|Treatment Period|Withdrawal by Subject|1
7838263|NCT01390441|12315130|FG003|Treatment Period|Withdrawal by Subject|0
7838264|NCT01390441|12315131|FG004|Treatment Period|Withdrawal by Subject|1
7838265|NCT01390441|12315127|FG000|Treatment Period|Lost to Follow-up|1
7838266|NCT01390441|12315128|FG001|Treatment Period|Lost to Follow-up|0
7838267|NCT01390441|12315129|FG002|Treatment Period|Lost to Follow-up|0
7838268|NCT01390441|12315130|FG003|Treatment Period|Lost to Follow-up|0
7838269|NCT01390441|12315131|FG004|Treatment Period|Lost to Follow-up|0
7838270|NCT01390441|12315127|FG000|Extension Period|Protocol Violation|3
7838271|NCT01390441|12315128|FG001|Extension Period|Protocol Violation|1
7838272|NCT01390441|12315129|FG002|Extension Period|Protocol Violation|0
7838273|NCT01390441|12315130|FG003|Extension Period|Protocol Violation|1
7838274|NCT01390441|12315131|FG004|Extension Period|Protocol Violation|0
7838275|NCT01390584|12315171|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
7838276|NCT01390584|12315172|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
7838277|NCT01390584|12315173|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1
7838278|NCT01390649|12315182|FG000|Overall Study|Physician Decision|1
7838279|NCT01390779|12315186|FG000|Overall Study|Physician Decision|1
7838280|NCT01390844|12315323|FG000|Treatment Phase|Adverse Event|12
7838281|NCT01390844|12315324|FG001|Treatment Phase|Adverse Event|2
7838282|NCT01390844|12315325|FG002|Treatment Phase|Adverse Event|3
7838283|NCT01390844|12315326|FG003|Treatment Phase|Adverse Event|2
7838284|NCT01390844|12315323|FG000|Treatment Phase|Treatment Failure|23
7838285|NCT01390844|12315324|FG001|Treatment Phase|Treatment Failure|25
7838286|NCT01390844|12315325|FG002|Treatment Phase|Treatment Failure|10
7838287|NCT01390844|12315326|FG003|Treatment Phase|Treatment Failure|13
7838288|NCT01390844|12315323|FG000|Treatment Phase|Non-Medical Reasons|5
7838289|NCT01390844|12315324|FG001|Treatment Phase|Non-Medical Reasons|1
7838290|NCT01390844|12315325|FG002|Treatment Phase|Non-Medical Reasons|8
7838291|NCT01390844|12315326|FG003|Treatment Phase|Non-Medical Reasons|1
7838292|NCT01390844|12315323|FG000|Treatment Phase|Non-GCP Compliant|0
7838293|NCT01390844|12315324|FG001|Treatment Phase|Non-GCP Compliant|0
7838294|NCT01390844|12315325|FG002|Treatment Phase|Non-GCP Compliant|10
7838295|NCT01390844|12315326|FG003|Treatment Phase|Non-GCP Compliant|3
7838296|NCT01390844|12315323|FG000|Follow-Up Phase|Non-Medical Reasons|1
7838297|NCT01390844|12315324|FG001|Follow-Up Phase|Non-Medical Reasons|1
7838298|NCT01390844|12315325|FG002|Follow-Up Phase|Non-Medical Reasons|1
7838299|NCT01390844|12315326|FG003|Follow-Up Phase|Non-Medical Reasons|0
7838300|NCT01390857|12315336|FG000|Overall Study|Protocol Violation|2
7838301|NCT01390857|12315336|FG000|Overall Study|Lost to Follow-up|1
7838302|NCT01390857|12315336|FG000|Overall Study|No Visit after the First Visit|7
7838303|NCT01390948|12315376|FG000|Overall Study|End of Study|1
7838304|NCT01390948|12315377|FG001|Overall Study|End of Study|0
7838305|NCT01390948|12315378|FG002|Overall Study|End of Study|0
7838306|NCT01390948|12315376|FG000|Overall Study|Withdrew consent|2
7838307|NCT01390948|12315377|FG001|Overall Study|Withdrew consent|2
7838308|NCT01390948|12315378|FG002|Overall Study|Withdrew consent|0
7838309|NCT01390948|12315376|FG000|Overall Study|Progressive Disease|2
7838310|NCT01390948|12315377|FG001|Overall Study|Progressive Disease|5
7838311|NCT01390948|12315378|FG002|Overall Study|Progressive Disease|0
7838312|NCT01390948|12315376|FG000|Overall Study|Death during follow-up|10
7838313|NCT01390948|12315377|FG001|Overall Study|Death during follow-up|11
7838314|NCT01390948|12315378|FG002|Overall Study|Death during follow-up|1
7838315|NCT01391000|12315387|FG000|Overall Study|Lost to Follow-up|2
7838316|NCT01391000|12315388|FG001|Overall Study|Lost to Follow-up|0
7838317|NCT01391130|12315405|FG000|Overall Study|Withdrawal by Subject|3
7838318|NCT01391130|12315406|FG001|Overall Study|Withdrawal by Subject|2
7838319|NCT01391130|12315405|FG000|Overall Study|Physician Decision|2
7838320|NCT01391130|12315406|FG001|Overall Study|Physician Decision|3
7838321|NCT01391130|12315405|FG000|Overall Study|Did not Receive Drug|1
7838322|NCT01391130|12315406|FG001|Overall Study|Did not Receive Drug|1
7838323|NCT01391507|12315483|FG000|Overall Study|Death|0
7838324|NCT01391507|12315484|FG001|Overall Study|Death|0
7838325|NCT01391507|12315485|FG002|Overall Study|Death|0
7838326|NCT01391507|12315486|FG003|Overall Study|Death|1
7838327|NCT01391507|12315483|FG000|Overall Study|Adverse Event|1
7838328|NCT01391507|12315484|FG001|Overall Study|Adverse Event|1
7838329|NCT01391507|12315485|FG002|Overall Study|Adverse Event|2
7838330|NCT01391507|12315486|FG003|Overall Study|Adverse Event|2
7838331|NCT01391507|12315483|FG000|Overall Study|Withdrawal by Subject|1
7838332|NCT01391507|12315484|FG001|Overall Study|Withdrawal by Subject|2
7838333|NCT01391507|12315485|FG002|Overall Study|Withdrawal by Subject|1
7838334|NCT01391507|12315486|FG003|Overall Study|Withdrawal by Subject|1
7838335|NCT01391507|12315483|FG000|Overall Study|Lack of Efficacy|0
7838336|NCT01391507|12315484|FG001|Overall Study|Lack of Efficacy|0
7838337|NCT01391507|12315485|FG002|Overall Study|Lack of Efficacy|0
7838338|NCT01391507|12315486|FG003|Overall Study|Lack of Efficacy|1
7838339|NCT01391507|12315483|FG000|Overall Study|Protocol Violation|2
7838340|NCT01391507|12315484|FG001|Overall Study|Protocol Violation|1
7838341|NCT01391507|12315485|FG002|Overall Study|Protocol Violation|1
7838342|NCT01391507|12315486|FG003|Overall Study|Protocol Violation|2
7838343|NCT01391546|12315498|FG000|Overall Study|History of Herpes Zoster (HZ)|1
7838344|NCT01391546|12315499|FG001|Overall Study|History of Herpes Zoster (HZ)|0
7838345|NCT01391663|12315521|FG000|Overall Study|Withdrawal by Subject|0
7838346|NCT01391663|12315522|FG001|Overall Study|Withdrawal by Subject|0
7838347|NCT01391663|12315523|FG002|Overall Study|Withdrawal by Subject|1
7838348|NCT01391663|12315524|FG003|Overall Study|Withdrawal by Subject|0
7838349|NCT01391793|12315536|FG000|Overall Study|Ineligible|3
7838350|NCT01391793|12315537|FG001|Overall Study|Ineligible|0
7838351|NCT01391793|12315536|FG000|Overall Study|Urine Culture Negative or Indeterminate|71
7838352|NCT01391793|12315537|FG001|Overall Study|Urine Culture Negative or Indeterminate|87
7838353|NCT01391793|12315536|FG000|Overall Study|No DMSA|73
7838354|NCT01391793|12315537|FG001|Overall Study|No DMSA|57
7838355|NCT01391819|12315543|FG000|Overall Study|Withdrawal by Subject|56
7838356|NCT01391819|12315543|FG000|Overall Study|Migrated/moved from study area|82
7838357|NCT01391819|12315543|FG000|Overall Study|Lost to Follow-up|252
7838358|NCT01391819|12315543|FG000|Overall Study|Death|3
7838359|NCT01391819|12315543|FG000|Overall Study|Other|9
7838360|NCT01391832|12315552|FG000|Overall Study|Withdrawal by Subject|21
7838361|NCT01391832|12315553|FG001|Overall Study|Withdrawal by Subject|22
7838362|NCT01391832|12315552|FG000|Overall Study|Lost to Follow-up|0
7838363|NCT01391832|12315553|FG001|Overall Study|Lost to Follow-up|1
7838364|NCT01392183|12315579|FG000|First Drug Administration|Adverse Event|3
7838365|NCT01392183|12315580|FG001|First Drug Administration|Adverse Event|2
7838366|NCT01392183|12315579|FG000|First Drug Administration|Death|1
7838367|NCT01392183|12315580|FG001|First Drug Administration|Death|0
7838368|NCT01392183|12315579|FG000|First Drug Administration|Withdrawal by Subject|10
7838369|NCT01392183|12315580|FG001|First Drug Administration|Withdrawal by Subject|17
7838370|NCT01392300|12315590|FG000|Main Period (MP)|Predefined discontinuation criteria|2
7838371|NCT01392300|12315591|FG001|Main Period (MP)|Predefined discontinuation criteria|3
7838372|NCT01392300|12315592|FG002|Main Period (MP)|Predefined discontinuation criteria|0
7838373|NCT01392300|12315590|FG000|Main Period (MP)|Withdrawal by Subject|5
7838374|NCT01392300|12315591|FG001|Main Period (MP)|Withdrawal by Subject|1
7838375|NCT01392300|12315592|FG002|Main Period (MP)|Withdrawal by Subject|0
7838376|NCT01392300|12315590|FG000|Main Period (MP)|Lost to Follow-up|3
7838377|NCT01392300|12315591|FG001|Main Period (MP)|Lost to Follow-up|3
7838378|NCT01392300|12315592|FG002|Main Period (MP)|Lost to Follow-up|0
7838379|NCT01392300|12315590|FG000|Main Period (MP)|Non-compliance|1
7838380|NCT01392300|12315591|FG001|Main Period (MP)|Non-compliance|0
7838381|NCT01392300|12315592|FG002|Main Period (MP)|Non-compliance|0
7838382|NCT01392300|12315590|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0
7838383|NCT01392300|12315591|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0
7838384|NCT01392300|12315592|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13
7838385|NCT01392300|12315590|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0
7838386|NCT01392300|12315591|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0
7838387|NCT01392300|12315592|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3
7838388|NCT01392300|12315590|FG000|Open Label Extension (OLEX) Period|Non-compliance|0
7838389|NCT01392300|12315591|FG001|Open Label Extension (OLEX) Period|Non-compliance|0
7838390|NCT01392300|12315592|FG002|Open Label Extension (OLEX) Period|Non-compliance|1
7838391|NCT01392300|12315590|FG000|Open Label Extension (OLEX) Period|Death|0
7838392|NCT01392300|12315591|FG001|Open Label Extension (OLEX) Period|Death|0
7838393|NCT01392300|12315592|FG002|Open Label Extension (OLEX) Period|Death|4
7838394|NCT01392300|12315590|FG000|Open Label Extension (OLEX) Period|Adverse Event|0
7838395|NCT01392300|12315591|FG001|Open Label Extension (OLEX) Period|Adverse Event|0
7838396|NCT01392300|12315592|FG002|Open Label Extension (OLEX) Period|Adverse Event|7
7838397|NCT01392300|12315590|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
7838398|NCT01392300|12315591|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
7838399|NCT01392300|12315592|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
7838400|NCT01392300|12315590|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0
7838401|NCT01392300|12315591|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0
7838402|NCT01392300|12315592|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6
7838403|NCT01392326|12315602|FG000|Overall Study|Death|2
7838404|NCT01392326|12315603|FG001|Overall Study|Death|0
7838405|NCT01392326|12315604|FG002|Overall Study|Death|0
7838406|NCT01392326|12315602|FG000|Overall Study|Withdrawal by Subject|12
7838407|NCT01392326|12315603|FG001|Overall Study|Withdrawal by Subject|11
7838408|NCT01392326|12315604|FG002|Overall Study|Withdrawal by Subject|15
7838409|NCT01392326|12315602|FG000|Overall Study|Protocol Violation|2
7838410|NCT01392326|12315603|FG001|Overall Study|Protocol Violation|0
7838411|NCT01392326|12315604|FG002|Overall Study|Protocol Violation|0
7838412|NCT01392326|12315602|FG000|Overall Study|Pregnancy|0
7838413|NCT01392326|12315603|FG001|Overall Study|Pregnancy|0
7838414|NCT01392326|12315604|FG002|Overall Study|Pregnancy|1
7838415|NCT01392326|12315602|FG000|Overall Study|Physician Decision|7
7838416|NCT01392326|12315603|FG001|Overall Study|Physician Decision|5
7838417|NCT01392326|12315604|FG002|Overall Study|Physician Decision|2
7838418|NCT01392326|12315602|FG000|Overall Study|Lost to Follow-up|1
7838419|NCT01392326|12315603|FG001|Overall Study|Lost to Follow-up|3
7838420|NCT01392326|12315604|FG002|Overall Study|Lost to Follow-up|4
7838421|NCT01392326|12315602|FG000|Overall Study|Lack of Efficacy|14
7838422|NCT01392326|12315603|FG001|Overall Study|Lack of Efficacy|10
7838423|NCT01392326|12315604|FG002|Overall Study|Lack of Efficacy|15
7838424|NCT01392326|12315602|FG000|Overall Study|Adverse Event|9
7838425|NCT01392326|12315603|FG001|Overall Study|Adverse Event|6
7838426|NCT01392326|12315604|FG002|Overall Study|Adverse Event|11
7838427|NCT01392378|12315617|FG000|Infant Series|Adverse Event|0
7838428|NCT01392378|12315618|FG001|Infant Series|Adverse Event|0
7838429|NCT01392378|12315619|FG002|Infant Series|Adverse Event|0
7838430|NCT01392378|12315620|FG003|Infant Series|Adverse Event|1
7838431|NCT01392378|12315621|FG004|Infant Series|Adverse Event|0
7838432|NCT01392378|12315617|FG000|Infant Series|Lost to Follow-up|0
7838433|NCT01392378|12315618|FG001|Infant Series|Lost to Follow-up|0
7838434|NCT01392378|12315619|FG002|Infant Series|Lost to Follow-up|0
7838435|NCT01392378|12315620|FG003|Infant Series|Lost to Follow-up|1
7838436|NCT01392378|12315621|FG004|Infant Series|Lost to Follow-up|0
7838437|NCT01392378|12315617|FG000|Infant Series|Protocol Violation|0
7838438|NCT01392378|12315618|FG001|Infant Series|Protocol Violation|1
7838439|NCT01392378|12315619|FG002|Infant Series|Protocol Violation|0
7838440|NCT01392378|12315620|FG003|Infant Series|Protocol Violation|0
7838441|NCT01392378|12315621|FG004|Infant Series|Protocol Violation|0
7838442|NCT01392378|12315617|FG000|Infant Series|Withdrawal by Parent|4
7838443|NCT01392378|12315618|FG001|Infant Series|Withdrawal by Parent|1
7838444|NCT01392378|12315619|FG002|Infant Series|Withdrawal by Parent|0
7838445|NCT01392378|12315620|FG003|Infant Series|Withdrawal by Parent|0
7838446|NCT01392378|12315621|FG004|Infant Series|Withdrawal by Parent|0
7838447|NCT01392378|12315617|FG000|After Infant Series|Lost to Follow-up|0
7838448|NCT01392378|12315618|FG001|After Infant Series|Lost to Follow-up|0
7838449|NCT01392378|12315619|FG002|After Infant Series|Lost to Follow-up|1
7838450|NCT01392378|12315620|FG003|After Infant Series|Lost to Follow-up|0
7838451|NCT01392378|12315621|FG004|After Infant Series|Lost to Follow-up|0
7838452|NCT01392378|12315617|FG000|After Infant Series|Withdrawal by Parent|0
7838453|NCT01392378|12315618|FG001|After Infant Series|Withdrawal by Parent|1
7838454|NCT01392378|12315619|FG002|After Infant Series|Withdrawal by Parent|1
7838455|NCT01392378|12315620|FG003|After Infant Series|Withdrawal by Parent|0
7838456|NCT01392378|12315621|FG004|After Infant Series|Withdrawal by Parent|1
7838457|NCT01392378|12315617|FG000|Toddler Dose|Lost to Follow-up|0
7838458|NCT01392378|12315618|FG001|Toddler Dose|Lost to Follow-up|0
7838459|NCT01392378|12315619|FG002|Toddler Dose|Lost to Follow-up|0
7838460|NCT01392378|12315620|FG003|Toddler Dose|Lost to Follow-up|1
7838461|NCT01392378|12315621|FG004|Toddler Dose|Lost to Follow-up|0
7838462|NCT01392378|12315617|FG000|Toddler Dose|Withdrawal by Parent|0
7838463|NCT01392378|12315618|FG001|Toddler Dose|Withdrawal by Parent|1
7838464|NCT01392378|12315619|FG002|Toddler Dose|Withdrawal by Parent|0
7838465|NCT01392378|12315620|FG003|Toddler Dose|Withdrawal by Parent|1
7838466|NCT01392378|12315621|FG004|Toddler Dose|Withdrawal by Parent|1
7838467|NCT01392443|12315643|FG000|Overall Study|Disease progression|30
7838468|NCT01392443|12315643|FG000|Overall Study|Adverse Event|24
7838469|NCT01392443|12315643|FG000|Overall Study|Death|7
7838470|NCT01392443|12315643|FG000|Overall Study|Withdrawal by Subject|5
7838471|NCT01392443|12315643|FG000|Overall Study|Lost to Follow-up|1
7838472|NCT01392443|12315643|FG000|Overall Study|Protocol Violation|1
7838473|NCT01392469|12315647|FG000|Overall Study|Adverse Event|2
7838474|NCT01392469|12315647|FG000|Overall Study|Withdrawal by Subject|1
7838475|NCT01392469|12315647|FG000|Overall Study|Protocol Violation|1
7838476|NCT01392495|12315662|FG000|Overall Study|Death|3
7838477|NCT01392495|12315662|FG000|Overall Study|Administrative problems|8
7838478|NCT01392495|12315662|FG000|Overall Study|Withdrawal by Subject|2
7838479|NCT01392495|12315662|FG000|Overall Study|Adverse Event|3
7838480|NCT01392547|12315668|FG000|Overall Study|Adverse Event|2
7838481|NCT01392547|12315668|FG000|Overall Study|Non-compliance|2
7838482|NCT01392547|12315668|FG000|Overall Study|Withdrawal criteria|3
7838483|NCT01392547|12315668|FG000|Overall Study|Unclassified|1
7838484|NCT01392560|12315674|FG000|Overall Study|Adverse Event|2
7838485|NCT01392560|12315674|FG000|Overall Study|not entered|8
7838486|NCT01392560|12315674|FG000|Overall Study|discontinued during placebo run-in|2
7838487|NCT01392573|12315682|FG000|Overall Study|Adverse Event|1
7838488|NCT01392573|12315683|FG001|Overall Study|Adverse Event|3
7838489|NCT01392573|12315682|FG000|Overall Study|Lack of Efficacy|1
7838490|NCT01392573|12315683|FG001|Overall Study|Lack of Efficacy|2
7838491|NCT01392573|12315682|FG000|Overall Study|Protocol Violation|0
7838492|NCT01392573|12315683|FG001|Overall Study|Protocol Violation|2
7838493|NCT01392573|12315682|FG000|Overall Study|Withdrawal Criteria|13
7838494|NCT01392573|12315683|FG001|Overall Study|Withdrawal Criteria|15
7838495|NCT01392573|12315682|FG000|Overall Study|Site closure|8
7838496|NCT01392573|12315683|FG001|Overall Study|Site closure|7
7838497|NCT01392573|12315682|FG000|Overall Study|Unclassified|9
7838498|NCT01392573|12315683|FG001|Overall Study|Unclassified|6
7838499|NCT01392677|12315700|FG000|Overall Study|Adverse Event|3
7838500|NCT01392677|12315701|FG001|Overall Study|Adverse Event|1
7838501|NCT01392677|12315700|FG000|Overall Study|Withdrawal by Subject|0
7838502|NCT01392677|12315701|FG001|Overall Study|Withdrawal by Subject|2
7838503|NCT01392677|12315700|FG000|Overall Study|Incorrect enrollment|2
7838504|NCT01392677|12315701|FG001|Overall Study|Incorrect enrollment|3
7838505|NCT01392677|12315700|FG000|Overall Study|Other reason|3
7838506|NCT01392677|12315701|FG001|Overall Study|Other reason|2
7838507|NCT01392742|12315719|FG000|Overall Study|Premature study termination|42
7838508|NCT01392742|12315719|FG000|Overall Study|Failure to return|35
7838509|NCT01392742|12315719|FG000|Overall Study|No treatment/no cooperation/withdrew|12
7838510|NCT01392742|12315719|FG000|Overall Study|Lost to Follow-up|34
7838511|NCT01392742|12315719|FG000|Overall Study|Insufficient therapeutic response (ITR)|30
7838512|NCT01392742|12315719|FG000|Overall Study|ITR and Protocol deviation|1
7838513|NCT01392742|12315719|FG000|Overall Study|Adverse event/intercurrent illness|17
7838514|NCT01392742|12315719|FG000|Overall Study|Protocol Violation|14
7838515|NCT01392742|12315719|FG000|Overall Study|Other|3
7838516|NCT01392742|12315719|FG000|Overall Study|Missing information|13
7838517|NCT01392963|12315733|FG000|Week 0 (First Intervention)|Lost to Follow-up|0
7838518|NCT01392963|12315734|FG001|Week 0 (First Intervention)|Lost to Follow-up|1
7838519|NCT01392963|12315733|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0
7838520|NCT01392963|12315734|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1
7838521|NCT01392963|12315733|FG000|Week 24 Follow-up|Lost to Follow-up|2
7838522|NCT01392963|12315734|FG001|Week 24 Follow-up|Lost to Follow-up|0
7838523|NCT01393106|12315747|FG000|Overall Study|Adverse Event|3
7838524|NCT01393106|12315747|FG000|Overall Study|Withdrawal by Subject|1
7838525|NCT01393106|12315747|FG000|Overall Study|Lack of Efficacy|1
7838526|NCT01393158|12315764|FG000|Overall Study|Adverse Event|1
7838527|NCT01393158|12315765|FG001|Overall Study|Adverse Event|0
7838528|NCT01393301|12315779|FG000|Overall Study|Lost to Follow-up|5
7838529|NCT01393301|12315780|FG001|Overall Study|Lost to Follow-up|3
7838530|NCT01393301|12315779|FG000|Overall Study|Withdrawal by Subject|2
7838531|NCT01393301|12315780|FG001|Overall Study|Withdrawal by Subject|0
7838532|NCT01393301|12315779|FG000|Overall Study|Completed <7 sessions (intervention)|2
7838533|NCT01393301|12315780|FG001|Overall Study|Completed <7 sessions (intervention)|0
7838534|NCT01393405|12315795|FG000|Induction Period (week1-16)|Lack of Efficacy|70
7838535|NCT01393405|12315796|FG001|Induction Period (week1-16)|Lack of Efficacy|0
7838536|NCT01393405|12315797|FG002|Induction Period (week1-16)|Lack of Efficacy|0
7838537|NCT01393405|12315795|FG000|Induction Period (week1-16)|Adverse Event|16
7838538|NCT01393405|12315796|FG001|Induction Period (week1-16)|Adverse Event|0
7838539|NCT01393405|12315797|FG002|Induction Period (week1-16)|Adverse Event|0
7838540|NCT01393405|12315795|FG000|Induction Period (week1-16)|Withdrawal by Subject|9
7838541|NCT01393405|12315796|FG001|Induction Period (week1-16)|Withdrawal by Subject|0
7838542|NCT01393405|12315797|FG002|Induction Period (week1-16)|Withdrawal by Subject|0
7838543|NCT01393405|12315795|FG000|Maintenance Period Week|Lack of Efficacy|0
7838544|NCT01393405|12315796|FG001|Maintenance Period Week|Lack of Efficacy|22
7838545|NCT01393405|12315797|FG002|Maintenance Period Week|Lack of Efficacy|22
7838546|NCT01393405|12315795|FG000|Maintenance Period Week|Adverse Event|0
7838547|NCT01393405|12315796|FG001|Maintenance Period Week|Adverse Event|5
7838548|NCT01393405|12315797|FG002|Maintenance Period Week|Adverse Event|2
7838549|NCT01393405|12315795|FG000|Maintenance Period Week|Withdrawal by Subject|0
7838550|NCT01393405|12315796|FG001|Maintenance Period Week|Withdrawal by Subject|1
7838551|NCT01393405|12315797|FG002|Maintenance Period Week|Withdrawal by Subject|0
7838552|NCT01393405|12315795|FG000|Maintenance Period Week|Lost to Follow-up|0
7838553|NCT01393405|12315796|FG001|Maintenance Period Week|Lost to Follow-up|1
7838554|NCT01393405|12315797|FG002|Maintenance Period Week|Lost to Follow-up|0
7838555|NCT01393444|12315807|FG000|Overall Study|Withdrawal by Subject|1
7838556|NCT01393444|12315807|FG000|Overall Study|Determined ineligible during screening.|2
7838557|NCT01393600|12315828|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
7838558|NCT01393600|12315829|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
7838559|NCT01393600|12315830|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
7838560|NCT01393600|12315831|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
7838561|NCT01393600|12315828|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
7838562|NCT01393600|12315829|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
7838563|NCT01393600|12315830|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
7838564|NCT01393600|12315831|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
7838565|NCT01393600|12315828|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
7838566|NCT01393600|12315829|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
7838567|NCT01393600|12315830|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
7838568|NCT01393600|12315831|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
7838569|NCT01393600|12315828|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
7838570|NCT01393600|12315829|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
7838571|NCT01393600|12315830|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
7838572|NCT01393600|12315831|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
7838573|NCT01393600|12315828|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
7838574|NCT01393600|12315829|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
7838575|NCT01393600|12315830|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
7838576|NCT01393600|12315831|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
7838577|NCT01393600|12315828|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
7838578|NCT01393600|12315829|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
7838579|NCT01393600|12315830|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
7838580|NCT01393600|12315831|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
7838581|NCT01393600|12315828|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
7838582|NCT01393600|12315829|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
7838583|NCT01393600|12315830|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
7838584|NCT01393600|12315831|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
7838585|NCT01393613|12315847|FG000|Overall Study|Adverse Event|11
7838586|NCT01393613|12315848|FG001|Overall Study|Adverse Event|11
7838587|NCT01393613|12315849|FG002|Overall Study|Adverse Event|13
7838588|NCT01393613|12315850|FG003|Overall Study|Adverse Event|22
7838589|NCT01393613|12315847|FG000|Overall Study|Participant Met Withdrawal Criteria|0
7838590|NCT01393613|12315848|FG001|Overall Study|Participant Met Withdrawal Criteria|0
7838591|NCT01393613|12315849|FG002|Overall Study|Participant Met Withdrawal Criteria|2
7838592|NCT01393613|12315850|FG003|Overall Study|Participant Met Withdrawal Criteria|1
7838593|NCT01393613|12315847|FG000|Overall Study|Physician Decision|2
7838594|NCT01393613|12315848|FG001|Overall Study|Physician Decision|0
7838595|NCT01393613|12315849|FG002|Overall Study|Physician Decision|0
7838596|NCT01393613|12315850|FG003|Overall Study|Physician Decision|1
7838597|NCT01393613|12315847|FG000|Overall Study|Withdrawal by Subject|15
7838598|NCT01393613|12315848|FG001|Overall Study|Withdrawal by Subject|25
7838599|NCT01393613|12315849|FG002|Overall Study|Withdrawal by Subject|23
7838600|NCT01393613|12315850|FG003|Overall Study|Withdrawal by Subject|21
7838601|NCT01393613|12315847|FG000|Overall Study|Protocol Deviation|2
7838602|NCT01393613|12315848|FG001|Overall Study|Protocol Deviation|1
7838603|NCT01393613|12315849|FG002|Overall Study|Protocol Deviation|0
7838604|NCT01393613|12315850|FG003|Overall Study|Protocol Deviation|0
7838605|NCT01393613|12315847|FG000|Overall Study|Lack of Efficacy|9
7838606|NCT01393613|12315848|FG001|Overall Study|Lack of Efficacy|20
7838607|NCT01393613|12315849|FG002|Overall Study|Lack of Efficacy|16
7838608|NCT01393613|12315850|FG003|Overall Study|Lack of Efficacy|21
7838609|NCT01393626|12315866|FG000|Overall Study|Adverse Event|2
7838610|NCT01393626|12315867|FG001|Overall Study|Adverse Event|1
7838611|NCT01393626|12315868|FG002|Overall Study|Adverse Event|5
7838612|NCT01393626|12315869|FG003|Overall Study|Adverse Event|0
7838613|NCT01393626|12315866|FG000|Overall Study|Did not meet entrance criteria|1
7838614|NCT01393626|12315867|FG001|Overall Study|Did not meet entrance criteria|0
7838615|NCT01393626|12315868|FG002|Overall Study|Did not meet entrance criteria|0
7838616|NCT01393626|12315869|FG003|Overall Study|Did not meet entrance criteria|0
7838617|NCT01393626|12315866|FG000|Overall Study|Lack of Efficacy|6
7838618|NCT01393626|12315867|FG001|Overall Study|Lack of Efficacy|6
7838619|NCT01393626|12315868|FG002|Overall Study|Lack of Efficacy|4
7838620|NCT01393626|12315869|FG003|Overall Study|Lack of Efficacy|1
7838621|NCT01393626|12315866|FG000|Overall Study|Lost to Follow-up|1
7838622|NCT01393626|12315867|FG001|Overall Study|Lost to Follow-up|1
7838623|NCT01393626|12315868|FG002|Overall Study|Lost to Follow-up|1
7838624|NCT01393626|12315869|FG003|Overall Study|Lost to Follow-up|0
7838625|NCT01393626|12315866|FG000|Overall Study|Withdrawal by Subject|6
7838626|NCT01393626|12315867|FG001|Overall Study|Withdrawal by Subject|4
7838627|NCT01393626|12315868|FG002|Overall Study|Withdrawal by Subject|0
7838628|NCT01393626|12315869|FG003|Overall Study|Withdrawal by Subject|0
7838629|NCT01393626|12315866|FG000|Overall Study|Other|1
7838630|NCT01393626|12315867|FG001|Overall Study|Other|0
7838631|NCT01393626|12315868|FG002|Overall Study|Other|0
7838632|NCT01393626|12315869|FG003|Overall Study|Other|0
7838633|NCT01393626|12315866|FG000|Overall Study|Protocol Violation|1
7838634|NCT01393626|12315867|FG001|Overall Study|Protocol Violation|0
7838635|NCT01393626|12315868|FG002|Overall Study|Protocol Violation|2
7838636|NCT01393626|12315869|FG003|Overall Study|Protocol Violation|0
7838637|NCT01393730|12315906|FG000|Overall Study|Withdrawal by Subject|3
7838638|NCT01393730|12315906|FG000|Overall Study|Other|2
7838639|NCT01393730|12315906|FG000|Overall Study|Adverse Event|1
7838640|NCT01393743|12315912|FG000|Core Study|Adverse Event|5
7838641|NCT01393743|12315913|FG001|Core Study|Adverse Event|9
7838642|NCT01393743|12315914|FG002|Core Study|Adverse Event|0
7838643|NCT01393743|12315912|FG000|Core Study|Lost to Follow-up|1
7838644|NCT01393743|12315913|FG001|Core Study|Lost to Follow-up|1
7838645|NCT01393743|12315914|FG002|Core Study|Lost to Follow-up|0
7838646|NCT01393743|12315912|FG000|Core Study|Participant's Choice|2
7838647|NCT01393743|12315913|FG001|Core Study|Participant's Choice|3
7838648|NCT01393743|12315914|FG002|Core Study|Participant's Choice|0
7838649|NCT01393743|12315912|FG000|Core Study|Inadequate therapeutic effect|2
7838650|NCT01393743|12315913|FG001|Core Study|Inadequate therapeutic effect|0
7838651|NCT01393743|12315914|FG002|Core Study|Inadequate therapeutic effect|0
7838652|NCT01393743|12315912|FG000|Extension Phase|Adverse Event|0
7838653|NCT01393743|12315913|FG001|Extension Phase|Adverse Event|0
7838654|NCT01393743|12315914|FG002|Extension Phase|Adverse Event|12
7838655|NCT01393743|12315912|FG000|Extension Phase|Lost to Follow-up|0
7838656|NCT01393743|12315913|FG001|Extension Phase|Lost to Follow-up|0
7838657|NCT01393743|12315914|FG002|Extension Phase|Lost to Follow-up|2
7838658|NCT01393743|12315912|FG000|Extension Phase|Participant choice|0
7838659|NCT01393743|12315913|FG001|Extension Phase|Participant choice|0
7838660|NCT01393743|12315914|FG002|Extension Phase|Participant choice|16
7838661|NCT01393743|12315912|FG000|Extension Phase|Inadequate therapeutic effect|0
7838662|NCT01393743|12315913|FG001|Extension Phase|Inadequate therapeutic effect|0
7838663|NCT01393743|12315914|FG002|Extension Phase|Inadequate therapeutic effect|7
7838664|NCT01393743|12315912|FG000|Extension Phase|Withdrawal by Subject|0
7838665|NCT01393743|12315913|FG001|Extension Phase|Withdrawal by Subject|0
7838666|NCT01393743|12315914|FG002|Extension Phase|Withdrawal by Subject|8
7838667|NCT01393743|12315912|FG000|Extension Phase|Pregnancy|0
7838668|NCT01393743|12315913|FG001|Extension Phase|Pregnancy|0
7838669|NCT01393743|12315914|FG002|Extension Phase|Pregnancy|1
7838670|NCT01393743|12315912|FG000|Extension Phase|Other|0
7838671|NCT01393743|12315913|FG001|Extension Phase|Other|0
7838672|NCT01393743|12315914|FG002|Extension Phase|Other|14
7838673|NCT01393821|12315927|FG000|Overall Study|Cancel|1
7838674|NCT01393821|12315928|FG001|Overall Study|Cancel|1
7838675|NCT01393821|12315927|FG000|Overall Study|not evaluable for primary endpoint|4
7838676|NCT01393821|12315928|FG001|Overall Study|not evaluable for primary endpoint|2
7838677|NCT01393899|12315937|FG000|Overall Study|Study terminated by sponsor|1
7838678|NCT01393899|12315938|FG001|Overall Study|Study terminated by sponsor|0
7838679|NCT01393899|12315939|FG002|Overall Study|Study terminated by sponsor|1
7838680|NCT01393899|12315937|FG000|Overall Study|Other|1
7838681|NCT01393899|12315938|FG001|Overall Study|Other|0
7838682|NCT01393899|12315939|FG002|Overall Study|Other|0
7838683|NCT01393899|12315937|FG000|Overall Study|Withdrawal by Subject|2
7838684|NCT01393899|12315938|FG001|Overall Study|Withdrawal by Subject|2
7838685|NCT01393899|12315939|FG002|Overall Study|Withdrawal by Subject|1
7838686|NCT01393899|12315937|FG000|Overall Study|Lost to Follow-up|0
7838687|NCT01393899|12315938|FG001|Overall Study|Lost to Follow-up|0
7838688|NCT01393899|12315939|FG002|Overall Study|Lost to Follow-up|1
7838689|NCT01393899|12315937|FG000|Overall Study|Does not meet entrance criteria|1
7838690|NCT01393899|12315938|FG001|Overall Study|Does not meet entrance criteria|0
7838691|NCT01393899|12315939|FG002|Overall Study|Does not meet entrance criteria|1
7838692|NCT01393899|12315937|FG000|Overall Study|Lack of Efficacy|26
7838693|NCT01393899|12315938|FG001|Overall Study|Lack of Efficacy|21
7838694|NCT01393899|12315939|FG002|Overall Study|Lack of Efficacy|16
7838695|NCT01393899|12315937|FG000|Overall Study|Adverse Event|1
7838696|NCT01393899|12315938|FG001|Overall Study|Adverse Event|5
7838697|NCT01393899|12315939|FG002|Overall Study|Adverse Event|3
7838698|NCT01393964|12315952|FG000|Overall Study|Disease Progression|4
7838699|NCT01393964|12315953|FG001|Overall Study|Disease Progression|3
7838700|NCT01393964|12315954|FG002|Overall Study|Disease Progression|5
7838701|NCT01393964|12315952|FG000|Overall Study|Study drug toxicity|1
7838702|NCT01393964|12315953|FG001|Overall Study|Study drug toxicity|0
7838703|NCT01393964|12315954|FG002|Overall Study|Study drug toxicity|0
7838704|NCT01393964|12315952|FG000|Overall Study|Withdrawal by Subject|0
7838705|NCT01393964|12315953|FG001|Overall Study|Withdrawal by Subject|0
7838706|NCT01393964|12315954|FG002|Overall Study|Withdrawal by Subject|1
7838707|NCT01393964|12315952|FG000|Overall Study|Adverse event unrelated to study drug|0
7838708|NCT01393964|12315953|FG001|Overall Study|Adverse event unrelated to study drug|3
7838709|NCT01393964|12315954|FG002|Overall Study|Adverse event unrelated to study drug|0
7838710|NCT01393964|12315952|FG000|Overall Study|Subject request stop study treatment|0
7838711|NCT01393964|12315953|FG001|Overall Study|Subject request stop study treatment|1
7838712|NCT01393964|12315954|FG002|Overall Study|Subject request stop study treatment|0
7838713|NCT01393964|12315952|FG000|Overall Study|Subject decided to move to transplant|1
7838714|NCT01393964|12315953|FG001|Overall Study|Subject decided to move to transplant|0
7838715|NCT01393964|12315954|FG002|Overall Study|Subject decided to move to transplant|0
7838716|NCT01393964|12315952|FG000|Overall Study|Subject switched to commercial supply|1
7838717|NCT01393964|12315953|FG001|Overall Study|Subject switched to commercial supply|0
7838718|NCT01393964|12315954|FG002|Overall Study|Subject switched to commercial supply|2
7838719|NCT01393964|12315952|FG000|Overall Study|Subject plateaued in terms of effect|1
7838720|NCT01393964|12315953|FG001|Overall Study|Subject plateaued in terms of effect|0
7838721|NCT01393964|12315954|FG002|Overall Study|Subject plateaued in terms of effect|0
7838722|NCT01393964|12315952|FG000|Overall Study|Investigator removed subject from study|0
7838723|NCT01393964|12315953|FG001|Overall Study|Investigator removed subject from study|1
7838724|NCT01393964|12315954|FG002|Overall Study|Investigator removed subject from study|0
7838725|NCT01393964|12315952|FG000|Overall Study|Subject converted to roll-over study|0
7838726|NCT01393964|12315953|FG001|Overall Study|Subject converted to roll-over study|1
7838727|NCT01393964|12315954|FG002|Overall Study|Subject converted to roll-over study|0
7838728|NCT01393964|12315952|FG000|Overall Study|Subject to receive non-protocol therapy|0
7838729|NCT01393964|12315953|FG001|Overall Study|Subject to receive non-protocol therapy|0
7838730|NCT01393964|12315954|FG002|Overall Study|Subject to receive non-protocol therapy|1
7838731|NCT01393990|12315986|FG000|Overall Study|Adverse Event|0
7838732|NCT01393990|12315987|FG001|Overall Study|Adverse Event|0
7838733|NCT01393990|12315988|FG002|Overall Study|Adverse Event|0
7838734|NCT01393990|12315989|FG003|Overall Study|Adverse Event|0
7838735|NCT01393990|12315990|FG004|Overall Study|Adverse Event|0
7838736|NCT01393990|12315991|FG005|Overall Study|Adverse Event|0
7838737|NCT01393990|12315992|FG006|Overall Study|Adverse Event|0
7838738|NCT01393990|12315993|FG007|Overall Study|Adverse Event|0
7838739|NCT01393990|12315994|FG008|Overall Study|Adverse Event|0
7838740|NCT01393990|12315995|FG009|Overall Study|Adverse Event|0
7838741|NCT01393990|12315996|FG010|Overall Study|Adverse Event|0
7838742|NCT01393990|12315997|FG011|Overall Study|Adverse Event|0
7838743|NCT01393990|12315998|FG012|Overall Study|Adverse Event|0
7838744|NCT01393990|12315999|FG013|Overall Study|Adverse Event|0
7838745|NCT01393990|12316000|FG014|Overall Study|Adverse Event|1
7838746|NCT01393990|12316001|FG015|Overall Study|Adverse Event|1
7838747|NCT01393990|12316002|FG016|Overall Study|Adverse Event|0
7838748|NCT01393990|12316003|FG017|Overall Study|Adverse Event|0
7838749|NCT01393990|12315986|FG000|Overall Study|Progressive Disease|1
7838750|NCT01393990|12315987|FG001|Overall Study|Progressive Disease|0
7838751|NCT01393990|12315988|FG002|Overall Study|Progressive Disease|0
7838752|NCT01393990|12315989|FG003|Overall Study|Progressive Disease|1
7838753|NCT01393990|12315990|FG004|Overall Study|Progressive Disease|1
7838754|NCT01393990|12315991|FG005|Overall Study|Progressive Disease|1
7838755|NCT01393990|12315992|FG006|Overall Study|Progressive Disease|1
7838756|NCT01393990|12315993|FG007|Overall Study|Progressive Disease|1
7838757|NCT01393990|12315994|FG008|Overall Study|Progressive Disease|3
7838758|NCT01393990|12315995|FG009|Overall Study|Progressive Disease|1
7838759|NCT01393990|12315996|FG010|Overall Study|Progressive Disease|0
7838760|NCT01393990|12315997|FG011|Overall Study|Progressive Disease|0
7838761|NCT01393990|12315998|FG012|Overall Study|Progressive Disease|0
7838762|NCT01393990|12315999|FG013|Overall Study|Progressive Disease|1
7838763|NCT01393990|12316000|FG014|Overall Study|Progressive Disease|6
7838764|NCT01393990|12316001|FG015|Overall Study|Progressive Disease|1
7838765|NCT01393990|12316002|FG016|Overall Study|Progressive Disease|0
7838766|NCT01393990|12316003|FG017|Overall Study|Progressive Disease|0
7838767|NCT01393990|12315986|FG000|Overall Study|Death|0
7838768|NCT01393990|12315987|FG001|Overall Study|Death|0
7838769|NCT01393990|12315988|FG002|Overall Study|Death|0
7838770|NCT01393990|12315989|FG003|Overall Study|Death|0
7838771|NCT01393990|12315990|FG004|Overall Study|Death|1
7838772|NCT01393990|12315991|FG005|Overall Study|Death|0
7838773|NCT01393990|12315992|FG006|Overall Study|Death|0
7838774|NCT01393990|12315993|FG007|Overall Study|Death|0
7838775|NCT01393990|12315994|FG008|Overall Study|Death|0
7838776|NCT01393990|12315995|FG009|Overall Study|Death|0
7838777|NCT01393990|12315996|FG010|Overall Study|Death|0
7838778|NCT01393990|12315997|FG011|Overall Study|Death|0
7838779|NCT01393990|12315998|FG012|Overall Study|Death|0
7838780|NCT01393990|12315999|FG013|Overall Study|Death|1
7838781|NCT01393990|12316000|FG014|Overall Study|Death|1
7838782|NCT01393990|12316001|FG015|Overall Study|Death|0
7838783|NCT01393990|12316002|FG016|Overall Study|Death|0
7838784|NCT01393990|12316003|FG017|Overall Study|Death|0
7838785|NCT01393990|12315986|FG000|Overall Study|Withdrawal by Subject|0
7838786|NCT01393990|12315987|FG001|Overall Study|Withdrawal by Subject|0
7838787|NCT01393990|12315988|FG002|Overall Study|Withdrawal by Subject|0
7838788|NCT01393990|12315989|FG003|Overall Study|Withdrawal by Subject|0
7838789|NCT01393990|12315990|FG004|Overall Study|Withdrawal by Subject|0
7838790|NCT01393990|12315991|FG005|Overall Study|Withdrawal by Subject|0
7838791|NCT01393990|12315992|FG006|Overall Study|Withdrawal by Subject|0
7838792|NCT01393990|12315993|FG007|Overall Study|Withdrawal by Subject|0
7838793|NCT01393990|12315994|FG008|Overall Study|Withdrawal by Subject|0
7838794|NCT01393990|12315995|FG009|Overall Study|Withdrawal by Subject|0
7838795|NCT01393990|12315996|FG010|Overall Study|Withdrawal by Subject|0
7838796|NCT01393990|12315997|FG011|Overall Study|Withdrawal by Subject|0
7838797|NCT01393990|12315998|FG012|Overall Study|Withdrawal by Subject|0
7838798|NCT01393990|12315999|FG013|Overall Study|Withdrawal by Subject|0
7838799|NCT01393990|12316000|FG014|Overall Study|Withdrawal by Subject|1
7838800|NCT01393990|12316001|FG015|Overall Study|Withdrawal by Subject|1
7838801|NCT01393990|12316002|FG016|Overall Study|Withdrawal by Subject|0
7838802|NCT01393990|12316003|FG017|Overall Study|Withdrawal by Subject|0
7838803|NCT01394185|12316111|FG000|Overall Study|Withdrawal by Subject|2
7838804|NCT01394185|12316112|FG001|Overall Study|Withdrawal by Subject|0
7838805|NCT01394185|12316113|FG002|Overall Study|Withdrawal by Subject|0
7838806|NCT01394185|12316114|FG003|Overall Study|Withdrawal by Subject|0
7838807|NCT01394185|12316115|FG004|Overall Study|Withdrawal by Subject|1
7838808|NCT01394185|12316116|FG005|Overall Study|Withdrawal by Subject|0
7838809|NCT01394185|12316111|FG000|Overall Study|Change in protocol|3
7838810|NCT01394185|12316112|FG001|Overall Study|Change in protocol|0
7838811|NCT01394185|12316113|FG002|Overall Study|Change in protocol|0
7838812|NCT01394185|12316114|FG003|Overall Study|Change in protocol|0
7838813|NCT01394185|12316115|FG004|Overall Study|Change in protocol|3
7838814|NCT01394185|12316116|FG005|Overall Study|Change in protocol|0
7838815|NCT01394185|12316111|FG000|Overall Study|Protocol Violation|1
7838816|NCT01394185|12316112|FG001|Overall Study|Protocol Violation|0
7838817|NCT01394185|12316113|FG002|Overall Study|Protocol Violation|0
7838818|NCT01394185|12316114|FG003|Overall Study|Protocol Violation|1
7838819|NCT01394185|12316115|FG004|Overall Study|Protocol Violation|0
7838820|NCT01394185|12316116|FG005|Overall Study|Protocol Violation|1
7838821|NCT01394250|12316126|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
7838822|NCT01394250|12316127|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
7838823|NCT01394250|12316126|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
7838824|NCT01394250|12316127|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
7838825|NCT01394276|12316133|FG000|Overall Study|Related Adverse event (AEs)|15
7838826|NCT01394276|12316133|FG000|Overall Study|Not related AEs|9
7838827|NCT01394276|12316133|FG000|Overall Study|Remission of disease|2
7838828|NCT01394276|12316133|FG000|Overall Study|Insufficient therapeutic effect|17
7838829|NCT01394276|12316133|FG000|Overall Study|Insufficient compliance|9
7838830|NCT01394276|12316133|FG000|Overall Study|Lost to Follow-up|5
7838831|NCT01394276|12316133|FG000|Overall Study|Participant moved to another site|1
7838832|NCT01394276|12316133|FG000|Overall Study|Pregnancy|1
7838833|NCT01394276|12316133|FG000|Overall Study|unavailability of drug at the Hospital|2
7838834|NCT01394276|12316133|FG000|Overall Study|Symptoms of concurrent diseases|1
7838835|NCT01394523|12316149|FG000|Overall Study|Unable to place block|1
7838836|NCT01394523|12316150|FG001|Overall Study|Unable to place block|0
7838837|NCT01394523|12316151|FG002|Overall Study|Unable to place block|0
7838838|NCT01394627|12316168|FG000|First Intervention (1 Day)|poor intravenous access|0
7838839|NCT01394627|12316169|FG001|First Intervention (1 Day)|poor intravenous access|1
7838840|NCT01394627|12316168|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1
7838841|NCT01394627|12316169|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0
7838842|NCT01394718|12316196|FG000|Overall Study|Met protocol-specific stopping criteria|2
7838843|NCT01394718|12316197|FG001|Overall Study|Met protocol-specific stopping criteria|1
7838844|NCT01394939|12316207|FG000|Overall Study|Adverse Event|1
7838845|NCT01394939|12316208|FG001|Overall Study|Adverse Event|3
7838846|NCT01394939|12316209|FG002|Overall Study|Adverse Event|0
7838847|NCT01394939|12316210|FG003|Overall Study|Adverse Event|2
7838848|NCT01394939|12316207|FG000|Overall Study|Death|0
7838849|NCT01394939|12316208|FG001|Overall Study|Death|2
7838850|NCT01394939|12316209|FG002|Overall Study|Death|0
7838851|NCT01394939|12316210|FG003|Overall Study|Death|0
7838852|NCT01394939|12316207|FG000|Overall Study|Physician Decision|0
7838853|NCT01394939|12316208|FG001|Overall Study|Physician Decision|1
7838854|NCT01394939|12316209|FG002|Overall Study|Physician Decision|0
7838855|NCT01394939|12316210|FG003|Overall Study|Physician Decision|0
7838856|NCT01394939|12316207|FG000|Overall Study|Withdrawal by Subject|0
7838857|NCT01394939|12316208|FG001|Overall Study|Withdrawal by Subject|2
7838858|NCT01394939|12316209|FG002|Overall Study|Withdrawal by Subject|0
7838859|NCT01394939|12316210|FG003|Overall Study|Withdrawal by Subject|2
7838860|NCT01394939|12316207|FG000|Overall Study|Others|0
7838861|NCT01394939|12316208|FG001|Overall Study|Others|2
7838862|NCT01394939|12316209|FG002|Overall Study|Others|0
7838863|NCT01394939|12316210|FG003|Overall Study|Others|3
7838864|NCT01394952|12316222|FG000|Overall Study|Lost to Follow-up|0
7838865|NCT01394952|12316223|FG001|Overall Study|Lost to Follow-up|5
7838866|NCT01394952|12316222|FG000|Overall Study|Withdrawal by Subject|10
7838867|NCT01394952|12316223|FG001|Overall Study|Withdrawal by Subject|5
7838868|NCT01394952|12316222|FG000|Overall Study|Physician Decision|2
7838869|NCT01394952|12316223|FG001|Overall Study|Physician Decision|0
7838870|NCT01394952|12316222|FG000|Overall Study|Sponsor Decision|5
7838871|NCT01394952|12316223|FG001|Overall Study|Sponsor Decision|7
7838872|NCT01394978|12316232|FG000|Overall Study|Withdrawal by Subject|2
7838873|NCT01394978|12316233|FG001|Overall Study|Withdrawal by Subject|4
7838874|NCT01394978|12316232|FG000|Overall Study|Lost to Follow-up|13
7838875|NCT01394978|12316233|FG001|Overall Study|Lost to Follow-up|20
7838876|NCT01394978|12316232|FG000|Overall Study|Death|6
7838877|NCT01394978|12316233|FG001|Overall Study|Death|7
7838878|NCT01394991|12316242|FG000|Overall Study|Adverse Event|0
7838879|NCT01394991|12316243|FG001|Overall Study|Adverse Event|4
7838880|NCT01394991|12316242|FG000|Overall Study|Lack of Efficacy|5
7838881|NCT01394991|12316243|FG001|Overall Study|Lack of Efficacy|7
7838882|NCT01394991|12316242|FG000|Overall Study|Lost to Follow-up|6
7838883|NCT01394991|12316243|FG001|Overall Study|Lost to Follow-up|8
7838884|NCT01394991|12316242|FG000|Overall Study|Physician Decision|1
7838885|NCT01394991|12316243|FG001|Overall Study|Physician Decision|3
7838886|NCT01394991|12316242|FG000|Overall Study|Protocol Violation|1
7838887|NCT01394991|12316243|FG001|Overall Study|Protocol Violation|1
7838888|NCT01394991|12316242|FG000|Overall Study|Withdrawal by Subject|20
7838889|NCT01394991|12316243|FG001|Overall Study|Withdrawal by Subject|17
7838890|NCT01394991|12316242|FG000|Overall Study|Chemotherapy Termination|10
7838891|NCT01394991|12316243|FG001|Overall Study|Chemotherapy Termination|15
7838892|NCT01394991|12316242|FG000|Overall Study|Disease Progression|7
7838893|NCT01394991|12316243|FG001|Overall Study|Disease Progression|7
7838894|NCT01394991|12316242|FG000|Overall Study|Prematurely Termination of Trial|9
7838895|NCT01394991|12316243|FG001|Overall Study|Prematurely Termination of Trial|10
7838896|NCT01395017|12316251|FG000|Overall Study|Lost to Follow-up|1
7838897|NCT01395017|12316252|FG001|Overall Study|Lost to Follow-up|0
7838898|NCT01395017|12316251|FG000|Overall Study|Adverse Event|26
7838899|NCT01395017|12316252|FG001|Overall Study|Adverse Event|12
7838900|NCT01395017|12316251|FG000|Overall Study|Physician Decision|11
7838901|NCT01395017|12316252|FG001|Overall Study|Physician Decision|15
7838902|NCT01395017|12316251|FG000|Overall Study|Withdrawal by Subject|14
7838903|NCT01395017|12316252|FG001|Overall Study|Withdrawal by Subject|8
7838904|NCT01395017|12316251|FG000|Overall Study|Protocol deviation|1
7838905|NCT01395017|12316252|FG001|Overall Study|Protocol deviation|2
7838906|NCT01395017|12316251|FG000|Overall Study|Death|4
7838907|NCT01395017|12316252|FG001|Overall Study|Death|3
7838908|NCT01395017|12316251|FG000|Overall Study|Disease progression|42
7838909|NCT01395017|12316252|FG001|Overall Study|Disease progression|58
7838910|NCT01395017|12316251|FG000|Overall Study|Sponsor discontinued study|1
7838911|NCT01395017|12316252|FG001|Overall Study|Sponsor discontinued study|4
7838912|NCT01395030|12316259|FG000|Overall Study|Did not complete FCH PET/CT|7
7838913|NCT01395316|12316281|FG000|Overall Study|Lost to Follow-up|2
7838914|NCT01395316|12316281|FG000|Overall Study|poor MRI quality|1
7838915|NCT01395368|12316301|FG000|Overall Study|Physician Decision|14
7838916|NCT01395368|12316301|FG000|Overall Study|Withdrawal by Subject|2
7838917|NCT01395394|12316308|FG000|Baseline Study Visit|Protocol Violation|1
7838918|NCT01395394|12316309|FG001|Baseline Study Visit|Protocol Violation|0
7838919|NCT01395394|12316310|FG002|Baseline Study Visit|Protocol Violation|0
7838920|NCT01395524|12316321|FG000|Overall Study|Non-compliance with study schedule|1
7838921|NCT01395524|12316322|FG001|Overall Study|Non-compliance with study schedule|0
7838922|NCT01395524|12316323|FG002|Overall Study|Non-compliance with study schedule|1
7838923|NCT01395524|12316321|FG000|Overall Study|Lost to Follow-up|3
7838924|NCT01395524|12316322|FG001|Overall Study|Lost to Follow-up|1
7838925|NCT01395524|12316323|FG002|Overall Study|Lost to Follow-up|1
7838926|NCT01395524|12316321|FG000|Overall Study|Study-Specific Withdrawal Criteria|1
7838927|NCT01395524|12316322|FG001|Overall Study|Study-Specific Withdrawal Criteria|2
7838928|NCT01395524|12316323|FG002|Overall Study|Study-Specific Withdrawal Criteria|0
7838929|NCT01395524|12316321|FG000|Overall Study|Severe noncompliance with protocol|1
7838930|NCT01395524|12316322|FG001|Overall Study|Severe noncompliance with protocol|0
7838931|NCT01395524|12316323|FG002|Overall Study|Severe noncompliance with protocol|0
7838932|NCT01395524|12316321|FG000|Overall Study|Adverse Event|4
7838933|NCT01395524|12316322|FG001|Overall Study|Adverse Event|4
7838934|NCT01395524|12316323|FG002|Overall Study|Adverse Event|3
7838935|NCT01395524|12316321|FG000|Overall Study|Death|1
7838936|NCT01395524|12316322|FG001|Overall Study|Death|0
7838937|NCT01395524|12316323|FG002|Overall Study|Death|0
7838938|NCT01395524|12316321|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2
7838939|NCT01395524|12316322|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
7838940|NCT01395524|12316323|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0
7838941|NCT01395524|12316321|FG000|Overall Study|Withdrawal by Subject|4
7838942|NCT01395524|12316322|FG001|Overall Study|Withdrawal by Subject|8
7838943|NCT01395524|12316323|FG002|Overall Study|Withdrawal by Subject|8
7838944|NCT01395524|12316321|FG000|Overall Study|Did not receive treatment|1
7838945|NCT01395524|12316322|FG001|Overall Study|Did not receive treatment|1
7838946|NCT01395524|12316323|FG002|Overall Study|Did not receive treatment|3
7838947|NCT01395524|12316321|FG000|Overall Study|Subject had spinal surgery|0
7838948|NCT01395524|12316322|FG001|Overall Study|Subject had spinal surgery|0
7838949|NCT01395524|12316323|FG002|Overall Study|Subject had spinal surgery|1
7838950|NCT01395758|12316337|FG000|Open-label Treatment Period|Withdrawal by Subject|4
7838951|NCT01395758|12316338|FG001|Open-label Treatment Period|Withdrawal by Subject|0
7838952|NCT01395758|12316339|FG002|Open-label Treatment Period|Withdrawal by Subject|0
7838953|NCT01395784|12316346|FG000|Overall Study|Lost to Follow-up|7
7838954|NCT01395784|12316346|FG000|Overall Study|Withdrawal by Subject|3
7838955|NCT01395784|12316346|FG000|Overall Study|Physician Decision|5
7838956|NCT01395810|12316385|FG000|Overall Study|Adverse Event|0
7838957|NCT01395810|12316386|FG001|Overall Study|Adverse Event|1
7838958|NCT01395810|12316387|FG002|Overall Study|Adverse Event|0
7838959|NCT01395810|12316388|FG003|Overall Study|Adverse Event|0
7838960|NCT01395810|12316385|FG000|Overall Study|Lack of Efficacy|0
7838961|NCT01395810|12316386|FG001|Overall Study|Lack of Efficacy|1
7838962|NCT01395810|12316387|FG002|Overall Study|Lack of Efficacy|0
7838963|NCT01395810|12316388|FG003|Overall Study|Lack of Efficacy|0
7838964|NCT01395810|12316385|FG000|Overall Study|Withdrawal criteria|0
7838965|NCT01395810|12316386|FG001|Overall Study|Withdrawal criteria|2
7838966|NCT01395810|12316387|FG002|Overall Study|Withdrawal criteria|0
7838967|NCT01395810|12316388|FG003|Overall Study|Withdrawal criteria|0
7838968|NCT01395810|12316385|FG000|Overall Study|Unclassified|2
7838969|NCT01395810|12316386|FG001|Overall Study|Unclassified|0
7838970|NCT01395810|12316387|FG002|Overall Study|Unclassified|0
7838971|NCT01395810|12316388|FG003|Overall Study|Unclassified|0
7862745|NCT01600014|12351698|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
7862746|NCT01600014|12351699|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
7862747|NCT01600014|12351698|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
7862748|NCT01600014|12351699|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
7862749|NCT01600014|12351698|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
7862750|NCT01600014|12351699|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
7862751|NCT01600014|12351698|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
7862752|NCT01600014|12351699|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
7862753|NCT01600014|12351698|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
7862754|NCT01600014|12351699|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
7862755|NCT01600014|12351698|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
7862756|NCT01600014|12351699|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
7862757|NCT01600014|12351698|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
7862758|NCT01600014|12351699|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
7862759|NCT01600014|12351698|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
7862760|NCT01600014|12351699|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
7862761|NCT01600014|12351698|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
7862762|NCT01600014|12351699|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
7862763|NCT01600014|12351698|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
7862764|NCT01600014|12351699|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
7862765|NCT01600014|12351698|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
7862766|NCT01600014|12351699|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
7862767|NCT01600014|12351698|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
7862768|NCT01600014|12351699|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
7862769|NCT01600053|12351717|FG000|Overall Study|Adverse Event|2
7862770|NCT01600053|12351717|FG000|Overall Study|trial will not meet the interim endpoint|9
7862771|NCT01600092|12351723|FG000|Overall Study|Adverse Event|2
7862772|NCT01600092|12351724|FG001|Overall Study|Adverse Event|0
7862773|NCT01600092|12351723|FG000|Overall Study|Lost to Follow-up|4
7862774|NCT01600092|12351724|FG001|Overall Study|Lost to Follow-up|6
7862775|NCT01600092|12351723|FG000|Overall Study|Withdrawal by parent/guardian|8
7862776|NCT01600092|12351724|FG001|Overall Study|Withdrawal by parent/guardian|6
7862777|NCT01600092|12351723|FG000|Overall Study|Physician Decision|1
7862778|NCT01600092|12351724|FG001|Overall Study|Physician Decision|1
7862779|NCT01600092|12351723|FG000|Overall Study|Randomized but not vaccinated|3
7862780|NCT01600092|12351724|FG001|Overall Study|Randomized but not vaccinated|3
7862781|NCT01600105|12351732|FG000|Total Participants|Withdrawal by Subject|1
7862782|NCT01600105|12351733|FG001|Total Participants|Withdrawal by Subject|0
7862783|NCT01600105|12351732|FG000|Total Participants|No images in PACS|10
7862784|NCT01600105|12351733|FG001|Total Participants|No images in PACS|0
7862785|NCT01600105|12351732|FG000|Total Participants|Insufficient image quality|30
7862786|NCT01600105|12351733|FG001|Total Participants|Insufficient image quality|10
7862787|NCT01600105|12351732|FG000|Sub Study I|Insufficient image quality|0
7862788|NCT01600105|12351733|FG001|Sub Study I|Insufficient image quality|10
7862789|NCT01600105|12351732|FG000|Sub Study II|Withdrawal by Subject|1
7862790|NCT01600105|12351733|FG001|Sub Study II|Withdrawal by Subject|0
7862791|NCT01600105|12351732|FG000|Sub Study II|No images in PACS|1
7862792|NCT01600105|12351733|FG001|Sub Study II|No images in PACS|0
7862793|NCT01600105|12351732|FG000|Sub Study II|Insufficient image quality|3
7862794|NCT01600105|12351733|FG001|Sub Study II|Insufficient image quality|0
7862795|NCT01600105|12351732|FG000|Sub Study III|Insufficient image quality|5
7862796|NCT01600105|12351733|FG001|Sub Study III|Insufficient image quality|0
7862797|NCT01600105|12351732|FG000|Sub Study V|Poor Image Quality|2
7862798|NCT01600105|12351733|FG001|Sub Study V|Poor Image Quality|0
7862799|NCT01600326|12351770|FG000|Overall Study|Lost to Follow-up|1
7862800|NCT01600326|12351771|FG001|Overall Study|Lost to Follow-up|1
7862801|NCT01600586|12351798|FG000|Overall Study|Physician Decision|3
7862802|NCT01600586|12351799|FG001|Overall Study|Physician Decision|3
7862803|NCT01600716|12351834|FG000|Overall Study|Other Reasons|3
7862804|NCT01600716|12351835|FG001|Overall Study|Other Reasons|1
7838972|NCT01395823|12316401|FG000|Overall Study|Death|4
7838973|NCT01395823|12316402|FG001|Overall Study|Death|4
7838974|NCT01395823|12316401|FG000|Overall Study|Physician Decision|3
7838975|NCT01395823|12316402|FG001|Overall Study|Physician Decision|1
7838976|NCT01395823|12316401|FG000|Overall Study|Lost to Follow-up|1
7838977|NCT01395823|12316402|FG001|Overall Study|Lost to Follow-up|0
7838978|NCT01395823|12316401|FG000|Overall Study|Transplant|1
7838979|NCT01395823|12316402|FG001|Overall Study|Transplant|0
7838980|NCT01395823|12316401|FG000|Overall Study|GI symptoms|1
7838981|NCT01395823|12316402|FG001|Overall Study|GI symptoms|0
7838982|NCT01395823|12316401|FG000|Overall Study|Withdrawal by Subject|5
7838983|NCT01395823|12316402|FG001|Overall Study|Withdrawal by Subject|4
7838984|NCT01395888|12316410|FG000|2-week Run-in Period|Adverse Event|2
7838985|NCT01395888|12316411|FG001|2-week Run-in Period|Adverse Event|0
7838986|NCT01395888|12316412|FG002|2-week Run-in Period|Adverse Event|0
7838987|NCT01395888|12316410|FG000|2-week Run-in Period|Continuation Criteria Not Met|13
7838988|NCT01395888|12316411|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
7838989|NCT01395888|12316412|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
7838990|NCT01395888|12316410|FG000|2-week Run-in Period|Lost to Follow-up|1
7838991|NCT01395888|12316411|FG001|2-week Run-in Period|Lost to Follow-up|0
7838992|NCT01395888|12316412|FG002|2-week Run-in Period|Lost to Follow-up|0
7838993|NCT01395888|12316410|FG000|2-week Run-in Period|Protocol Violation|2
7838994|NCT01395888|12316411|FG001|2-week Run-in Period|Protocol Violation|0
7838995|NCT01395888|12316412|FG002|2-week Run-in Period|Protocol Violation|0
7838996|NCT01395888|12316410|FG000|2-week Run-in Period|Withdrawal by Subject|4
7838997|NCT01395888|12316411|FG001|2-week Run-in Period|Withdrawal by Subject|0
7838998|NCT01395888|12316412|FG002|2-week Run-in Period|Withdrawal by Subject|0
7838999|NCT01395888|12316410|FG000|Treatment Period (TP)|Adverse Event|0
7839000|NCT01395888|12316411|FG001|Treatment Period (TP)|Adverse Event|7
7839001|NCT01395888|12316412|FG002|Treatment Period (TP)|Adverse Event|6
7839002|NCT01395888|12316410|FG000|Treatment Period (TP)|Lack of Efficacy|0
7839003|NCT01395888|12316411|FG001|Treatment Period (TP)|Lack of Efficacy|4
7839004|NCT01395888|12316412|FG002|Treatment Period (TP)|Lack of Efficacy|3
7839005|NCT01395888|12316410|FG000|Treatment Period (TP)|Protocol Violation|0
7839006|NCT01395888|12316411|FG001|Treatment Period (TP)|Protocol Violation|1
7839007|NCT01395888|12316412|FG002|Treatment Period (TP)|Protocol Violation|5
7839008|NCT01395888|12316410|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
7839009|NCT01395888|12316411|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
7839010|NCT01395888|12316412|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
7839011|NCT01395888|12316410|FG000|Treatment Period (TP)|Withdrawal by Subject|0
7839012|NCT01395888|12316411|FG001|Treatment Period (TP)|Withdrawal by Subject|2
7839013|NCT01395888|12316412|FG002|Treatment Period (TP)|Withdrawal by Subject|3
7839014|NCT01395901|12316420|FG000|Overall Study|Lost to Follow-up|4
7839015|NCT01395901|12316421|FG001|Overall Study|Lost to Follow-up|0
7839016|NCT01395901|12316420|FG000|Overall Study|Randomized but not received study drug|5
7839017|NCT01395901|12316421|FG001|Overall Study|Randomized but not received study drug|4
7839018|NCT01395901|12316420|FG000|Overall Study|Adverse Event|0
7839019|NCT01395901|12316421|FG001|Overall Study|Adverse Event|1
7839020|NCT01395901|12316420|FG000|Overall Study|Withdrawal of consent|1
7839021|NCT01395901|12316421|FG001|Overall Study|Withdrawal of consent|0
7839022|NCT01395914|12316429|FG000|Overall Study|Unrelated to study drug AE|6
7839023|NCT01395914|12316430|FG001|Overall Study|Unrelated to study drug AE|1
7839024|NCT01395914|12316429|FG000|Overall Study|Death|23
7839025|NCT01395914|12316430|FG001|Overall Study|Death|17
7839026|NCT01395914|12316429|FG000|Overall Study|Other|9
7839027|NCT01395914|12316430|FG001|Overall Study|Other|3
7839028|NCT01395914|12316429|FG000|Overall Study|Withdrawal by patient|27
7839029|NCT01395914|12316430|FG001|Overall Study|Withdrawal by patient|14
7839030|NCT01395914|12316429|FG000|Overall Study|Study drug-related AE|1
7839031|NCT01395914|12316430|FG001|Overall Study|Study drug-related AE|0
7839032|NCT01395914|12316429|FG000|Overall Study|Lost to Follow-up|6
7839033|NCT01395914|12316430|FG001|Overall Study|Lost to Follow-up|2
7839034|NCT01396005|12316451|FG000|Overall Study|Withdrawal by Subject|0
7839035|NCT01396005|12316452|FG001|Overall Study|Withdrawal by Subject|1
7839036|NCT01396005|12316451|FG000|Overall Study|Non-compliance with protocol|0
7948882|NCT02531802|12494221|FG020|Received Vaccination 2|Medication interfering with study taken|0
7839037|NCT01396005|12316452|FG001|Overall Study|Non-compliance with protocol|1
7839038|NCT01396057|12316471|FG000|Overall Study|Adverse Event|2
7839039|NCT01396057|12316472|FG001|Overall Study|Adverse Event|6
7839040|NCT01396057|12316471|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7839041|NCT01396057|12316472|FG001|Overall Study|Unsatisfactory therapeutic effect|6
7839042|NCT01396057|12316471|FG000|Overall Study|Protocol deviation|4
7839043|NCT01396057|12316472|FG001|Overall Study|Protocol deviation|4
7839044|NCT01396057|12316471|FG000|Overall Study|Consent withdrawn|3
7839045|NCT01396057|12316472|FG001|Overall Study|Consent withdrawn|2
7839046|NCT01396070|12316478|FG000|Overall Study|Withdrawal by Subject|2
7839047|NCT01396070|12316478|FG000|Overall Study|Death|2
7948883|NCT02531802|12494201|FG000|Received Vaccination 2|Physician Decision|0
7948884|NCT02531802|12494202|FG001|Received Vaccination 2|Physician Decision|0
7948885|NCT02531802|12494203|FG002|Received Vaccination 2|Physician Decision|0
7948886|NCT02531802|12494204|FG003|Received Vaccination 2|Physician Decision|0
7948887|NCT02531802|12494205|FG004|Received Vaccination 2|Physician Decision|0
7948888|NCT02531802|12494206|FG005|Received Vaccination 2|Physician Decision|1
7948889|NCT02531802|12494207|FG006|Received Vaccination 2|Physician Decision|0
7948890|NCT02531802|12494208|FG007|Received Vaccination 2|Physician Decision|0
7948891|NCT02531802|12494209|FG008|Received Vaccination 2|Physician Decision|0
7948892|NCT02531802|12494210|FG009|Received Vaccination 2|Physician Decision|2
7948893|NCT02531802|12494211|FG010|Received Vaccination 2|Physician Decision|0
7948894|NCT02531802|12494212|FG011|Received Vaccination 2|Physician Decision|0
7948895|NCT02531802|12494213|FG012|Received Vaccination 2|Physician Decision|0
7948896|NCT02531802|12494214|FG013|Received Vaccination 2|Physician Decision|1
7948897|NCT02531802|12494215|FG014|Received Vaccination 2|Physician Decision|0
7948898|NCT02531802|12494216|FG015|Received Vaccination 2|Physician Decision|0
7948899|NCT02531802|12494217|FG016|Received Vaccination 2|Physician Decision|0
7948900|NCT02531802|12494218|FG017|Received Vaccination 2|Physician Decision|1
7948901|NCT02531802|12494219|FG018|Received Vaccination 2|Physician Decision|0
7948902|NCT02531802|12494220|FG019|Received Vaccination 2|Physician Decision|0
7948903|NCT02531802|12494221|FG020|Received Vaccination 2|Physician Decision|0
7948904|NCT02531802|12494201|FG000|Received Vaccination 2|Adverse Event|0
7948905|NCT02531802|12494202|FG001|Received Vaccination 2|Adverse Event|0
7948906|NCT02531802|12494203|FG002|Received Vaccination 2|Adverse Event|0
7948907|NCT02531802|12494204|FG003|Received Vaccination 2|Adverse Event|0
7948908|NCT02531802|12494205|FG004|Received Vaccination 2|Adverse Event|0
7948909|NCT02531802|12494206|FG005|Received Vaccination 2|Adverse Event|2
7948910|NCT02531802|12494207|FG006|Received Vaccination 2|Adverse Event|0
7948911|NCT02531802|12494208|FG007|Received Vaccination 2|Adverse Event|0
7948912|NCT02531802|12494209|FG008|Received Vaccination 2|Adverse Event|0
7948913|NCT02531802|12494210|FG009|Received Vaccination 2|Adverse Event|0
7948914|NCT02531802|12494211|FG010|Received Vaccination 2|Adverse Event|0
7948915|NCT02531802|12494212|FG011|Received Vaccination 2|Adverse Event|0
7948916|NCT02531802|12494213|FG012|Received Vaccination 2|Adverse Event|0
7948917|NCT02531802|12494214|FG013|Received Vaccination 2|Adverse Event|0
7948918|NCT02531802|12494215|FG014|Received Vaccination 2|Adverse Event|0
7948919|NCT02531802|12494216|FG015|Received Vaccination 2|Adverse Event|0
7948920|NCT02531802|12494217|FG016|Received Vaccination 2|Adverse Event|0
7948921|NCT02531802|12494218|FG017|Received Vaccination 2|Adverse Event|2
7948922|NCT02531802|12494219|FG018|Received Vaccination 2|Adverse Event|1
7948923|NCT02531802|12494220|FG019|Received Vaccination 2|Adverse Event|0
7948924|NCT02531802|12494221|FG020|Received Vaccination 2|Adverse Event|1
7948925|NCT02531802|12494201|FG000|Received Vaccination 2|Withdrawal by Subject|0
7948926|NCT02531802|12494202|FG001|Received Vaccination 2|Withdrawal by Subject|0
7948927|NCT02531802|12494203|FG002|Received Vaccination 2|Withdrawal by Subject|0
7948928|NCT02531802|12494204|FG003|Received Vaccination 2|Withdrawal by Subject|0
7948929|NCT02531802|12494205|FG004|Received Vaccination 2|Withdrawal by Subject|0
7948930|NCT02531802|12494206|FG005|Received Vaccination 2|Withdrawal by Subject|0
7948931|NCT02531802|12494207|FG006|Received Vaccination 2|Withdrawal by Subject|0
7948932|NCT02531802|12494208|FG007|Received Vaccination 2|Withdrawal by Subject|0
7948933|NCT02531802|12494209|FG008|Received Vaccination 2|Withdrawal by Subject|0
7948934|NCT02531802|12494210|FG009|Received Vaccination 2|Withdrawal by Subject|0
7948935|NCT02531802|12494211|FG010|Received Vaccination 2|Withdrawal by Subject|1
7948936|NCT02531802|12494212|FG011|Received Vaccination 2|Withdrawal by Subject|0
7948937|NCT02531802|12494213|FG012|Received Vaccination 2|Withdrawal by Subject|1
7948938|NCT02531802|12494214|FG013|Received Vaccination 2|Withdrawal by Subject|1
7948939|NCT02531802|12494215|FG014|Received Vaccination 2|Withdrawal by Subject|1
7948940|NCT02531802|12494216|FG015|Received Vaccination 2|Withdrawal by Subject|0
7948941|NCT02531802|12494217|FG016|Received Vaccination 2|Withdrawal by Subject|0
7948942|NCT02531802|12494218|FG017|Received Vaccination 2|Withdrawal by Subject|1
7948943|NCT02531802|12494219|FG018|Received Vaccination 2|Withdrawal by Subject|1
7948944|NCT02531802|12494220|FG019|Received Vaccination 2|Withdrawal by Subject|1
7948945|NCT02531802|12494221|FG020|Received Vaccination 2|Withdrawal by Subject|0
7948946|NCT02532179|12494322|FG000|Overall Study|Lost to Follow-up|1
7948947|NCT02532179|12494322|FG000|Overall Study|Pregnancy|1
7839048|NCT01396070|12316478|FG000|Overall Study|Adverse Event|8
7839049|NCT01396070|12316478|FG000|Overall Study|Physician Decision|3
7839050|NCT01396070|12316478|FG000|Overall Study|Lack of Efficacy|4
7839051|NCT01396083|12316485|FG000|Overall Study|Adverse Event|2
7839052|NCT01396083|12316486|FG001|Overall Study|Adverse Event|28
7839053|NCT01396083|12316485|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7839054|NCT01396083|12316486|FG001|Overall Study|Unsatisfactory therapeutic effect|13
7839055|NCT01396083|12316485|FG000|Overall Study|Consent withdrawn|4
7839056|NCT01396083|12316486|FG001|Overall Study|Consent withdrawn|5
7839057|NCT01396083|12316485|FG000|Overall Study|Protocol deviation(s)|0
7839058|NCT01396083|12316486|FG001|Overall Study|Protocol deviation(s)|1
7839059|NCT01396083|12316485|FG000|Overall Study|Abnormal laboratory value(s)|1
7839060|NCT01396083|12316486|FG001|Overall Study|Abnormal laboratory value(s)|0
7839061|NCT01396083|12316485|FG000|Overall Study|Administrative problems|1
7839062|NCT01396083|12316486|FG001|Overall Study|Administrative problems|0
7839063|NCT01396083|12316485|FG000|Overall Study|Lost to Follow-up|1
7839064|NCT01396083|12316486|FG001|Overall Study|Lost to Follow-up|0
7839065|NCT01396148|12316492|FG000|Overall Study|Patient Decision|1
7839066|NCT01396161|12316505|FG000|Overall Study|Withdrawal by Subject|0
7839067|NCT01396161|12316506|FG001|Overall Study|Withdrawal by Subject|0
7839068|NCT01396161|12316507|FG002|Overall Study|Withdrawal by Subject|0
7839069|NCT01396161|12316508|FG003|Overall Study|Withdrawal by Subject|0
7839070|NCT01396161|12316509|FG004|Overall Study|Withdrawal by Subject|1
7839071|NCT01396161|12316510|FG005|Overall Study|Withdrawal by Subject|0
7839072|NCT01396161|12316511|FG006|Overall Study|Withdrawal by Subject|0
7839073|NCT01396161|12316505|FG000|Overall Study|Other|0
7839074|NCT01396161|12316506|FG001|Overall Study|Other|0
7839075|NCT01396161|12316507|FG002|Overall Study|Other|0
7839076|NCT01396161|12316508|FG003|Overall Study|Other|0
7839077|NCT01396161|12316509|FG004|Overall Study|Other|0
7839078|NCT01396161|12316510|FG005|Overall Study|Other|0
7839079|NCT01396161|12316511|FG006|Overall Study|Other|1
7839080|NCT01396187|12316537|FG000|Overall Study|Adverse Event|0
7839081|NCT01396187|12316538|FG001|Overall Study|Adverse Event|1
7839082|NCT01396187|12316539|FG002|Overall Study|Adverse Event|0
7839083|NCT01396187|12316540|FG003|Overall Study|Adverse Event|0
7839084|NCT01396187|12316541|FG004|Overall Study|Adverse Event|0
7839085|NCT01396187|12316537|FG000|Overall Study|Withdrawal by Subject|0
7839086|NCT01396187|12316538|FG001|Overall Study|Withdrawal by Subject|1
7839087|NCT01396187|12316539|FG002|Overall Study|Withdrawal by Subject|1
7839088|NCT01396187|12316540|FG003|Overall Study|Withdrawal by Subject|0
7839089|NCT01396187|12316541|FG004|Overall Study|Withdrawal by Subject|0
7839090|NCT01396187|12316537|FG000|Overall Study|Other|1
7839091|NCT01396187|12316538|FG001|Overall Study|Other|1
7839092|NCT01396187|12316539|FG002|Overall Study|Other|0
7839093|NCT01396187|12316540|FG003|Overall Study|Other|0
7839094|NCT01396187|12316541|FG004|Overall Study|Other|1
7839095|NCT01396265|12316589|FG000|Rifa+Afatinib|Withdrawal by Subject|1
7839096|NCT01396317|12316597|FG000|Overall Study|Adverse Event|1
7839097|NCT01396317|12316598|FG001|Overall Study|Adverse Event|0
7839098|NCT01396395|12316613|FG000|Overall Study|Withdrawal by Subject|10
7839099|NCT01396395|12316614|FG001|Overall Study|Withdrawal by Subject|12
7839100|NCT01396395|12316613|FG000|Overall Study|Protocol Violation|3
7839101|NCT01396395|12316614|FG001|Overall Study|Protocol Violation|1
7839102|NCT01396395|12316613|FG000|Overall Study|Adverse Event|10
7839103|NCT01396395|12316614|FG001|Overall Study|Adverse Event|2
7839104|NCT01396395|12316613|FG000|Overall Study|Lost to Follow-up|17
7839105|NCT01396395|12316614|FG001|Overall Study|Lost to Follow-up|11
7839106|NCT01396395|12316613|FG000|Overall Study|Other|0
7839107|NCT01396395|12316614|FG001|Overall Study|Other|1
7839108|NCT01396421|12316626|FG000|Overall Study|Lost to Follow-up|0
7839109|NCT01396421|12316627|FG001|Overall Study|Lost to Follow-up|0
7839110|NCT01396421|12316628|FG002|Overall Study|Lost to Follow-up|0
7839111|NCT01396421|12316629|FG003|Overall Study|Lost to Follow-up|1
7839112|NCT01396421|12316626|FG000|Overall Study|Adverse Event|17
7839113|NCT01396421|12316627|FG001|Overall Study|Adverse Event|15
7839114|NCT01396421|12316628|FG002|Overall Study|Adverse Event|12
7839115|NCT01396421|12316629|FG003|Overall Study|Adverse Event|32
7839116|NCT01396421|12316626|FG000|Overall Study|Participant Met Withdrawal Criteria|1
7839117|NCT01396421|12316627|FG001|Overall Study|Participant Met Withdrawal Criteria|0
7839118|NCT01396421|12316628|FG002|Overall Study|Participant Met Withdrawal Criteria|1
7839119|NCT01396421|12316629|FG003|Overall Study|Participant Met Withdrawal Criteria|0
7839120|NCT01396421|12316626|FG000|Overall Study|Physician Decision|1
7839121|NCT01396421|12316627|FG001|Overall Study|Physician Decision|1
7839122|NCT01396421|12316628|FG002|Overall Study|Physician Decision|0
7839123|NCT01396421|12316629|FG003|Overall Study|Physician Decision|3
7839124|NCT01396421|12316626|FG000|Overall Study|Withdrawal by Subject|31
7839125|NCT01396421|12316627|FG001|Overall Study|Withdrawal by Subject|24
7839126|NCT01396421|12316628|FG002|Overall Study|Withdrawal by Subject|13
7839127|NCT01396421|12316629|FG003|Overall Study|Withdrawal by Subject|21
7839128|NCT01396421|12316626|FG000|Overall Study|Protocol Deviation|2
7839129|NCT01396421|12316627|FG001|Overall Study|Protocol Deviation|1
7839130|NCT01396421|12316628|FG002|Overall Study|Protocol Deviation|1
7839131|NCT01396421|12316629|FG003|Overall Study|Protocol Deviation|0
7839132|NCT01396421|12316626|FG000|Overall Study|Lack of Efficacy|7
7839133|NCT01396421|12316627|FG001|Overall Study|Lack of Efficacy|17
7839134|NCT01396421|12316628|FG002|Overall Study|Lack of Efficacy|7
7839135|NCT01396421|12316629|FG003|Overall Study|Lack of Efficacy|18
7839136|NCT01396434|12316656|FG000|Overall Study|Lost to Follow-up|1
7839137|NCT01396434|12316657|FG001|Overall Study|Lost to Follow-up|0
7839138|NCT01396434|12316658|FG002|Overall Study|Lost to Follow-up|0
7839139|NCT01396434|12316656|FG000|Overall Study|Other|10
7839140|NCT01396434|12316657|FG001|Overall Study|Other|0
7839141|NCT01396434|12316658|FG002|Overall Study|Other|0
7839142|NCT01396447|12316670|FG000|Overall Study|Did Not Receive Treatment|3
7839143|NCT01396447|12316671|FG001|Overall Study|Did Not Receive Treatment|2
7839144|NCT01396447|12316672|FG002|Overall Study|Did Not Receive Treatment|1
7839145|NCT01396447|12316673|FG003|Overall Study|Did Not Receive Treatment|0
7839146|NCT01396447|12316670|FG000|Overall Study|Adverse Event|15
7839147|NCT01396447|12316671|FG001|Overall Study|Adverse Event|12
7839148|NCT01396447|12316672|FG002|Overall Study|Adverse Event|12
7839149|NCT01396447|12316673|FG003|Overall Study|Adverse Event|17
7839150|NCT01396447|12316670|FG000|Overall Study|Insufficient Therapeutic Response|5
7839151|NCT01396447|12316671|FG001|Overall Study|Insufficient Therapeutic Response|5
7839152|NCT01396447|12316672|FG002|Overall Study|Insufficient Therapeutic Response|2
7839153|NCT01396447|12316673|FG003|Overall Study|Insufficient Therapeutic Response|4
7839154|NCT01396447|12316670|FG000|Overall Study|Protocol Violation|5
7839155|NCT01396447|12316671|FG001|Overall Study|Protocol Violation|2
7839156|NCT01396447|12316672|FG002|Overall Study|Protocol Violation|3
7839157|NCT01396447|12316673|FG003|Overall Study|Protocol Violation|7
7839158|NCT01396447|12316670|FG000|Overall Study|Withdrawal of Consent|11
7839159|NCT01396447|12316671|FG001|Overall Study|Withdrawal of Consent|9
7839160|NCT01396447|12316672|FG002|Overall Study|Withdrawal of Consent|4
7839161|NCT01396447|12316673|FG003|Overall Study|Withdrawal of Consent|15
7839162|NCT01396447|12316670|FG000|Overall Study|Lost to Follow-up|4
7839163|NCT01396447|12316671|FG001|Overall Study|Lost to Follow-up|8
7839164|NCT01396447|12316672|FG002|Overall Study|Lost to Follow-up|7
7839165|NCT01396447|12316673|FG003|Overall Study|Lost to Follow-up|9
7839166|NCT01396447|12316670|FG000|Overall Study|Other Miscellaneous Reasons|0
7839167|NCT01396447|12316671|FG001|Overall Study|Other Miscellaneous Reasons|2
7839168|NCT01396447|12316672|FG002|Overall Study|Other Miscellaneous Reasons|1
7839169|NCT01396447|12316673|FG003|Overall Study|Other Miscellaneous Reasons|0
7839170|NCT01396512|12316698|FG000|Overall Study|Withdrawal by Subject|0
7839171|NCT01396512|12316699|FG001|Overall Study|Withdrawal by Subject|1
7839172|NCT01396525|12316705|FG000|Overall Study|Withdrawal by Subject|8
7839173|NCT01396525|12316705|FG000|Overall Study|Death|14
7839174|NCT01396525|12316705|FG000|Overall Study|Lost to Follow-up|4
7839175|NCT01397084|12316729|FG000|Overall Study|Severe Non-Compliance to Protocol|1
7839176|NCT01397084|12316729|FG000|Overall Study|Protocol Violation|2
7839177|NCT01397084|12316729|FG000|Overall Study|Adverse Event|2
7839178|NCT01397084|12316729|FG000|Overall Study|Withdrawal by Subject|1
7839179|NCT01397084|12316729|FG000|Overall Study|Lost to Follow-up|1
7839180|NCT01397084|12316729|FG000|Overall Study|Used other proton pump inhibitor|1
7839181|NCT01397253|12316735|FG000|Overall Study|Reviewed by only 1 pharmacist|126
7839182|NCT01397253|12316736|FG001|Overall Study|Reviewed by only 1 pharmacist|149
7839183|NCT01397409|12316752|FG000|Stage 2|Adverse Event|0
7839184|NCT01397409|12316753|FG001|Stage 2|Adverse Event|0
7839185|NCT01397409|12316754|FG002|Stage 2|Adverse Event|0
7839186|NCT01397409|12316755|FG003|Stage 2|Adverse Event|0
7839187|NCT01397409|12316756|FG004|Stage 2|Adverse Event|6
7839188|NCT01397409|12316757|FG005|Stage 2|Adverse Event|3
7839189|NCT01397409|12316758|FG006|Stage 2|Adverse Event|0
7839190|NCT01397409|12316759|FG007|Stage 2|Adverse Event|0
7839191|NCT01397409|12316760|FG008|Stage 2|Adverse Event|0
7839192|NCT01397409|12316761|FG009|Stage 2|Adverse Event|0
7839193|NCT01397409|12316752|FG000|Stage 2|Personal Reasons|0
7839194|NCT01397409|12316753|FG001|Stage 2|Personal Reasons|0
7839195|NCT01397409|12316754|FG002|Stage 2|Personal Reasons|0
7839196|NCT01397409|12316755|FG003|Stage 2|Personal Reasons|0
7839197|NCT01397409|12316756|FG004|Stage 2|Personal Reasons|1
7839198|NCT01397409|12316757|FG005|Stage 2|Personal Reasons|0
7839199|NCT01397409|12316758|FG006|Stage 2|Personal Reasons|0
7839200|NCT01397409|12316759|FG007|Stage 2|Personal Reasons|0
7839201|NCT01397409|12316760|FG008|Stage 2|Personal Reasons|0
7839202|NCT01397409|12316761|FG009|Stage 2|Personal Reasons|0
7839203|NCT01397409|12316752|FG000|Stage 2|Other Miscellaneous Reasons|0
7839204|NCT01397409|12316753|FG001|Stage 2|Other Miscellaneous Reasons|0
7839205|NCT01397409|12316754|FG002|Stage 2|Other Miscellaneous Reasons|0
7839206|NCT01397409|12316755|FG003|Stage 2|Other Miscellaneous Reasons|0
7839207|NCT01397409|12316756|FG004|Stage 2|Other Miscellaneous Reasons|1
7839208|NCT01397409|12316757|FG005|Stage 2|Other Miscellaneous Reasons|1
7839209|NCT01397409|12316758|FG006|Stage 2|Other Miscellaneous Reasons|0
7839210|NCT01397409|12316759|FG007|Stage 2|Other Miscellaneous Reasons|0
7839211|NCT01397409|12316760|FG008|Stage 2|Other Miscellaneous Reasons|0
7839212|NCT01397409|12316761|FG009|Stage 2|Other Miscellaneous Reasons|0
7839213|NCT01397409|12316752|FG000|Stage 3|Adverse Event|0
7839214|NCT01397409|12316753|FG001|Stage 3|Adverse Event|0
7839215|NCT01397409|12316754|FG002|Stage 3|Adverse Event|0
7839216|NCT01397409|12316755|FG003|Stage 3|Adverse Event|0
7839217|NCT01397409|12316756|FG004|Stage 3|Adverse Event|0
7839218|NCT01397409|12316757|FG005|Stage 3|Adverse Event|0
7839219|NCT01397409|12316758|FG006|Stage 3|Adverse Event|0
7839220|NCT01397409|12316759|FG007|Stage 3|Adverse Event|1
7839221|NCT01397409|12316760|FG008|Stage 3|Adverse Event|0
7839222|NCT01397409|12316761|FG009|Stage 3|Adverse Event|0
7839223|NCT01397409|12316752|FG000|Stage 3|Other Miscellaneous Reasons|0
7839224|NCT01397409|12316753|FG001|Stage 3|Other Miscellaneous Reasons|0
7839225|NCT01397409|12316754|FG002|Stage 3|Other Miscellaneous Reasons|0
7839226|NCT01397409|12316755|FG003|Stage 3|Other Miscellaneous Reasons|0
7839227|NCT01397409|12316756|FG004|Stage 3|Other Miscellaneous Reasons|0
7839228|NCT01397409|12316757|FG005|Stage 3|Other Miscellaneous Reasons|0
7839229|NCT01397409|12316758|FG006|Stage 3|Other Miscellaneous Reasons|0
7839230|NCT01397409|12316759|FG007|Stage 3|Other Miscellaneous Reasons|1
7839231|NCT01397409|12316760|FG008|Stage 3|Other Miscellaneous Reasons|0
7839232|NCT01397409|12316761|FG009|Stage 3|Other Miscellaneous Reasons|0
7839233|NCT01397422|12316788|FG000|Overall Study|Adverse Event|0
7839234|NCT01397422|12316789|FG001|Overall Study|Adverse Event|3
7839235|NCT01397422|12316790|FG002|Overall Study|Adverse Event|3
7839236|NCT01397422|12316791|FG003|Overall Study|Adverse Event|8
7839237|NCT01397422|12316788|FG000|Overall Study|Withdrawal by Subject|1
7839238|NCT01397422|12316789|FG001|Overall Study|Withdrawal by Subject|0
7839239|NCT01397422|12316790|FG002|Overall Study|Withdrawal by Subject|0
7839240|NCT01397422|12316791|FG003|Overall Study|Withdrawal by Subject|0
7839241|NCT01397422|12316788|FG000|Overall Study|Increased bradykinesia related to PD|1
7839242|NCT01397422|12316789|FG001|Overall Study|Increased bradykinesia related to PD|0
7839243|NCT01397422|12316790|FG002|Overall Study|Increased bradykinesia related to PD|0
7839244|NCT01397422|12316791|FG003|Overall Study|Increased bradykinesia related to PD|0
7839245|NCT01397448|12316806|FG000|Overall Study|Adverse Event|4
7839246|NCT01397448|12316807|FG001|Overall Study|Adverse Event|4
7839247|NCT01397448|12316808|FG002|Overall Study|Adverse Event|6
7839248|NCT01397448|12316806|FG000|Overall Study|Withdrawal by Subject|4
7839249|NCT01397448|12316807|FG001|Overall Study|Withdrawal by Subject|4
7839250|NCT01397448|12316808|FG002|Overall Study|Withdrawal by Subject|3
7839251|NCT01397448|12316806|FG000|Overall Study|Lack of Efficacy|2
7839252|NCT01397448|12316807|FG001|Overall Study|Lack of Efficacy|0
7839253|NCT01397448|12316808|FG002|Overall Study|Lack of Efficacy|5
7839254|NCT01397448|12316806|FG000|Overall Study|Other|8
7839255|NCT01397448|12316807|FG001|Overall Study|Other|7
7839256|NCT01397448|12316808|FG002|Overall Study|Other|4
7839257|NCT01397461|12316819|FG000|Overall Study|Withdrawal by Subject|2
7839258|NCT01397461|12316820|FG001|Overall Study|Withdrawal by Subject|1
7839259|NCT01397461|12316821|FG002|Overall Study|Withdrawal by Subject|0
7839260|NCT01397461|12316819|FG000|Overall Study|Lost to Follow-up|0
7839261|NCT01397461|12316820|FG001|Overall Study|Lost to Follow-up|2
7839262|NCT01397461|12316821|FG002|Overall Study|Lost to Follow-up|1
7839263|NCT01397461|12316819|FG000|Overall Study|Lack of Efficacy|0
7839264|NCT01397461|12316820|FG001|Overall Study|Lack of Efficacy|3
7839265|NCT01397461|12316821|FG002|Overall Study|Lack of Efficacy|0
7839266|NCT01397461|12316819|FG000|Overall Study|Not treated|0
7839267|NCT01397461|12316820|FG001|Overall Study|Not treated|0
7839268|NCT01397461|12316821|FG002|Overall Study|Not treated|1
7839269|NCT01397747|12316861|FG000|Overall Study|Multitarget DNA test excluded|689
7839270|NCT01397747|12316861|FG000|Overall Study|Colonoscopy excluded|304
7839271|NCT01397747|12316861|FG000|Overall Study|FIT excluded|34
7839272|NCT01397786|12316869|FG000|Phase A|Lost to Follow-up|0
7839273|NCT01397786|12316870|FG001|Phase A|Lost to Follow-up|0
7839274|NCT01397786|12316871|FG002|Phase A|Lost to Follow-up|6
7839275|NCT01397786|12316869|FG000|Phase A|Adverse Event|0
7839276|NCT01397786|12316870|FG001|Phase A|Adverse Event|0
7839277|NCT01397786|12316871|FG002|Phase A|Adverse Event|8
7839278|NCT01397786|12316869|FG000|Phase A|Subject Met Withdrawal Criteria|0
7839279|NCT01397786|12316870|FG001|Phase A|Subject Met Withdrawal Criteria|0
7839280|NCT01397786|12316871|FG002|Phase A|Subject Met Withdrawal Criteria|7
7839281|NCT01397786|12316869|FG000|Phase A|Physician Decision|0
7839282|NCT01397786|12316870|FG001|Phase A|Physician Decision|0
7839283|NCT01397786|12316871|FG002|Phase A|Physician Decision|1
7839284|NCT01397786|12316869|FG000|Phase A|Withdrawal by Subject|0
7839285|NCT01397786|12316870|FG001|Phase A|Withdrawal by Subject|0
7839286|NCT01397786|12316871|FG002|Phase A|Withdrawal by Subject|5
7839287|NCT01397786|12316869|FG000|Phase A|Lack of Efficacy|0
7839288|NCT01397786|12316870|FG001|Phase A|Lack of Efficacy|0
7839289|NCT01397786|12316871|FG002|Phase A|Lack of Efficacy|1
7839290|NCT01397786|12316869|FG000|Phase B|Lost to Follow-up|22
7839291|NCT01397786|12316870|FG001|Phase B|Lost to Follow-up|12
7839292|NCT01397786|12316871|FG002|Phase B|Lost to Follow-up|22
7839293|NCT01397786|12316869|FG000|Phase B|Adverse Event|109
7839294|NCT01397786|12316870|FG001|Phase B|Adverse Event|23
7839295|NCT01397786|12316871|FG002|Phase B|Adverse Event|27
7839296|NCT01397786|12316869|FG000|Phase B|Subject Met Withdrawal Criteria|38
7839297|NCT01397786|12316870|FG001|Phase B|Subject Met Withdrawal Criteria|5
7839298|NCT01397786|12316871|FG002|Phase B|Subject Met Withdrawal Criteria|38
7839299|NCT01397786|12316869|FG000|Phase B|Physician Decision|9
7839300|NCT01397786|12316870|FG001|Phase B|Physician Decision|1
7839301|NCT01397786|12316871|FG002|Phase B|Physician Decision|3
7839302|NCT01397786|12316869|FG000|Phase B|Withdrawal by Subject|102
7839303|NCT01397786|12316870|FG001|Phase B|Withdrawal by Subject|45
7839304|NCT01397786|12316871|FG002|Phase B|Withdrawal by Subject|30
7839305|NCT01397786|12316869|FG000|Phase B|Protocol Deviation|1
7839306|NCT01397786|12316870|FG001|Phase B|Protocol Deviation|2
7839307|NCT01397786|12316871|FG002|Phase B|Protocol Deviation|4
7839308|NCT01397786|12316869|FG000|Phase B|Lack of Efficacy|22
7839309|NCT01397786|12316870|FG001|Phase B|Lack of Efficacy|7
7839310|NCT01397786|12316871|FG002|Phase B|Lack of Efficacy|14
7839311|NCT01397825|12316887|FG000|Overall Study|Progressive Disease|10
7839312|NCT01397825|12316888|FG001|Overall Study|Progressive Disease|3
7839313|NCT01397825|12316889|FG002|Overall Study|Progressive Disease|11
7839314|NCT01397825|12316890|FG003|Overall Study|Progressive Disease|1
7839315|NCT01397825|12316891|FG004|Overall Study|Progressive Disease|0
7839316|NCT01397825|12316887|FG000|Overall Study|Symptomatic Deterioration|2
7839317|NCT01397825|12316888|FG001|Overall Study|Symptomatic Deterioration|0
7839318|NCT01397825|12316889|FG002|Overall Study|Symptomatic Deterioration|4
7839319|NCT01397825|12316890|FG003|Overall Study|Symptomatic Deterioration|0
7839320|NCT01397825|12316891|FG004|Overall Study|Symptomatic Deterioration|0
7839321|NCT01397825|12316887|FG000|Overall Study|Adverse Event|0
7839322|NCT01397825|12316888|FG001|Overall Study|Adverse Event|1
7839323|NCT01397825|12316889|FG002|Overall Study|Adverse Event|5
7839324|NCT01397825|12316890|FG003|Overall Study|Adverse Event|1
7839325|NCT01397825|12316891|FG004|Overall Study|Adverse Event|0
7839326|NCT01397825|12316887|FG000|Overall Study|Withdrawal by Subject|1
7839327|NCT01397825|12316888|FG001|Overall Study|Withdrawal by Subject|0
7839328|NCT01397825|12316889|FG002|Overall Study|Withdrawal by Subject|5
7839329|NCT01397825|12316890|FG003|Overall Study|Withdrawal by Subject|1
7839330|NCT01397825|12316891|FG004|Overall Study|Withdrawal by Subject|0
7839331|NCT01397890|12316916|FG000|Overall Study|Withdrawal by Subject|7
7839332|NCT01397890|12316917|FG001|Overall Study|Withdrawal by Subject|11
7839333|NCT01397890|12316916|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7
7839334|NCT01397890|12316917|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6
7839335|NCT01397890|12316916|FG000|Overall Study|Death|2
7839336|NCT01397890|12316917|FG001|Overall Study|Death|3
7839337|NCT01397890|12316916|FG000|Overall Study|Lost to Follow-up|1
7839338|NCT01397890|12316917|FG001|Overall Study|Lost to Follow-up|4
7839339|NCT01397890|12316916|FG000|Overall Study|Condition under Investigation Worsened|1
7839340|NCT01397890|12316917|FG001|Overall Study|Condition under Investigation Worsened|3
7839341|NCT01397890|12316916|FG000|Overall Study|Adverse Event|1
7839342|NCT01397890|12316917|FG001|Overall Study|Adverse Event|2
7839343|NCT01397890|12316916|FG000|Overall Study|Severe Non-Compliance to Protocol|2
7839344|NCT01397890|12316917|FG001|Overall Study|Severe Non-Compliance to Protocol|1
7839345|NCT01397890|12316916|FG000|Overall Study|Others|2
7839346|NCT01397890|12316917|FG001|Overall Study|Others|1
7839347|NCT01398176|12316938|FG000|Overall Study|Lost to Follow-up|1
7839348|NCT01398176|12316939|FG001|Overall Study|Lost to Follow-up|3
7839349|NCT01398176|12316938|FG000|Overall Study|Physician Decision|2
7839350|NCT01398176|12316939|FG001|Overall Study|Physician Decision|3
7839351|NCT01398358|12316957|FG000|Overall Study|Lost to Follow-up|11
7839352|NCT01398358|12316958|FG001|Overall Study|Lost to Follow-up|21
7839353|NCT01398358|12316959|FG002|Overall Study|Lost to Follow-up|18
7839354|NCT01398358|12316957|FG000|Overall Study|Withdrawal by Subject|3
7839355|NCT01398358|12316958|FG001|Overall Study|Withdrawal by Subject|2
7839356|NCT01398358|12316959|FG002|Overall Study|Withdrawal by Subject|2
7839357|NCT01398358|12316957|FG000|Overall Study|no longer eligible|1
7839358|NCT01398358|12316958|FG001|Overall Study|no longer eligible|0
7839359|NCT01398358|12316959|FG002|Overall Study|no longer eligible|1
7839360|NCT01398410|12316969|FG000|Overall Study|Adverse Event|12
7839361|NCT01398410|12316970|FG001|Overall Study|Adverse Event|16
7839362|NCT01398410|12316969|FG000|Overall Study|Participants Choice|8
7839363|NCT01398410|12316970|FG001|Overall Study|Participants Choice|11
7839364|NCT01398410|12316969|FG000|Overall Study|Inadequate Therapeutic Effect|2
7839365|NCT01398410|12316970|FG001|Overall Study|Inadequate Therapeutic Effect|0
7839366|NCT01398410|12316969|FG000|Overall Study|Other|36
7839367|NCT01398410|12316970|FG001|Overall Study|Other|29
7839368|NCT01398514|12316991|FG000|Overall Study|Adverse Event|1
7839369|NCT01398514|12316992|FG001|Overall Study|Adverse Event|0
7839370|NCT01398514|12316991|FG000|Overall Study|Non-compliance with study procedures|2
7839371|NCT01398514|12316992|FG001|Overall Study|Non-compliance with study procedures|0
7839372|NCT01398514|12316991|FG000|Overall Study|Physiologic non-responsiveness|1
7839373|NCT01398514|12316992|FG001|Overall Study|Physiologic non-responsiveness|3
7839374|NCT01398514|12316991|FG000|Overall Study|Failure to show a conditioned response|4
7839375|NCT01398514|12316992|FG001|Overall Study|Failure to show a conditioned response|3
7839376|NCT01398787|12317004|FG000|Overall Study|Adverse Event|1
7839377|NCT01398956|12317023|FG000|Overall Study|Withdrawal by Subject|4
7839378|NCT01398956|12317023|FG000|Overall Study|AE, non-serious non-fatal|4
7839379|NCT01398956|12317023|FG000|Overall Study|Withdrawal Criteria No.3|1
7839380|NCT01398956|12317023|FG000|Overall Study|Subject moved a long distance|1
7839381|NCT01399047|12317052|FG000|Overall Study|Withdrawal by Subject|0
7839382|NCT01399047|12317053|FG001|Overall Study|Withdrawal by Subject|1
7839383|NCT01399099|12317061|FG000|Overall Study|Lost to Follow-up|11
7839384|NCT01399099|12317061|FG000|Overall Study|Physician Decision|1
7839385|NCT01399099|12317061|FG000|Overall Study|Protocol Violation|1
7839386|NCT01399099|12317061|FG000|Overall Study|Skin Irritation|13
7839387|NCT01399099|12317061|FG000|Overall Study|Infection|1
7839388|NCT01399099|12317061|FG000|Overall Study|Miscellaneous|4
7839389|NCT01399125|12317068|FG000|Overall Study|Adverse Event|32
7839390|NCT01399125|12317069|FG001|Overall Study|Adverse Event|30
7839391|NCT01399125|12317068|FG000|Overall Study|Abnormal Lab values|0
7839392|NCT01399125|12317069|FG001|Overall Study|Abnormal Lab values|1
7839393|NCT01399125|12317068|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0
7839394|NCT01399125|12317069|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4
7839395|NCT01399125|12317068|FG000|Overall Study|Withdrawal by Subject|5
7839396|NCT01399125|12317069|FG001|Overall Study|Withdrawal by Subject|8
7839397|NCT01399125|12317068|FG000|Overall Study|Lost to Follow-up|2
7839398|NCT01399125|12317069|FG001|Overall Study|Lost to Follow-up|3
7839399|NCT01399125|12317068|FG000|Overall Study|Administrative Problems|7
7839400|NCT01399125|12317069|FG001|Overall Study|Administrative Problems|11
7839401|NCT01399125|12317068|FG000|Overall Study|Death|0
7839402|NCT01399125|12317069|FG001|Overall Study|Death|1
7839403|NCT01399125|12317068|FG000|Overall Study|Protocol Deviation|5
7839404|NCT01399125|12317069|FG001|Overall Study|Protocol Deviation|2
7839405|NCT01399190|12317075|FG000|Overall Study|Not Eligible for Final Analysis|5
7839406|NCT01399190|12317075|FG000|Overall Study|Adverse Event|8
7839407|NCT01399190|12317075|FG000|Overall Study|Participant's Request|5
7839408|NCT01399190|12317075|FG000|Overall Study|Physician Decision|2
7839409|NCT01399593|12317096|FG000|Overall Study|Physician Decision|1
7839410|NCT01399593|12317097|FG001|Overall Study|Physician Decision|0
7839411|NCT01399593|12317096|FG000|Overall Study|Adverse Event|1
7839412|NCT01399593|12317097|FG001|Overall Study|Adverse Event|0
7839413|NCT01399593|12317096|FG000|Overall Study|Death|1
7839414|NCT01399593|12317097|FG001|Overall Study|Death|1
7839415|NCT01399593|12317096|FG000|Overall Study|Transplantectomy|0
7839416|NCT01399593|12317097|FG001|Overall Study|Transplantectomy|1
7839417|NCT01399619|12317105|FG000|Overall Study|Adverse Event|10
7839418|NCT01399619|12317106|FG001|Overall Study|Adverse Event|0
7839419|NCT01399619|12317107|FG002|Overall Study|Adverse Event|4
7839420|NCT01399619|12317108|FG003|Overall Study|Adverse Event|10
7839421|NCT01399619|12317105|FG000|Overall Study|Lack of Efficacy|9
7839422|NCT01399619|12317106|FG001|Overall Study|Lack of Efficacy|0
7839423|NCT01399619|12317107|FG002|Overall Study|Lack of Efficacy|5
7839424|NCT01399619|12317108|FG003|Overall Study|Lack of Efficacy|0
7839425|NCT01399619|12317105|FG000|Overall Study|Withdrawal by Subject|6
7839426|NCT01399619|12317106|FG001|Overall Study|Withdrawal by Subject|0
7839427|NCT01399619|12317107|FG002|Overall Study|Withdrawal by Subject|3
7839428|NCT01399619|12317108|FG003|Overall Study|Withdrawal by Subject|4
7839429|NCT01399619|12317105|FG000|Overall Study|Protocol Violation|0
7839430|NCT01399619|12317106|FG001|Overall Study|Protocol Violation|0
7839431|NCT01399619|12317107|FG002|Overall Study|Protocol Violation|0
7839432|NCT01399619|12317108|FG003|Overall Study|Protocol Violation|1
7839433|NCT01399619|12317105|FG000|Overall Study|Not treated|0
7839434|NCT01399619|12317106|FG001|Overall Study|Not treated|0
7839435|NCT01399619|12317107|FG002|Overall Study|Not treated|0
7839436|NCT01399619|12317108|FG003|Overall Study|Not treated|2
7839437|NCT01399697|12317126|FG000|Overall Study|Adverse Event|13
7839438|NCT01399697|12317127|FG001|Overall Study|Adverse Event|3
7839439|NCT01399697|12317128|FG002|Overall Study|Adverse Event|1
7839440|NCT01399697|12317126|FG000|Overall Study|Lost to Follow-up|2
7839441|NCT01399697|12317127|FG001|Overall Study|Lost to Follow-up|0
7839442|NCT01399697|12317128|FG002|Overall Study|Lost to Follow-up|0
7839443|NCT01399697|12317126|FG000|Overall Study|Withdrawal by Subject|8
7839444|NCT01399697|12317127|FG001|Overall Study|Withdrawal by Subject|0
7839445|NCT01399697|12317128|FG002|Overall Study|Withdrawal by Subject|0
7839446|NCT01399697|12317126|FG000|Overall Study|Investigator Decisión|1
7839447|NCT01399697|12317127|FG001|Overall Study|Investigator Decisión|0
7839448|NCT01399697|12317128|FG002|Overall Study|Investigator Decisión|2
7839449|NCT01399697|12317126|FG000|Overall Study|Lack of Efficacy|9
7839450|NCT01399697|12317127|FG001|Overall Study|Lack of Efficacy|0
7839451|NCT01399697|12317128|FG002|Overall Study|Lack of Efficacy|1
7839452|NCT01399697|12317126|FG000|Overall Study|Protocol Violation|2
7839453|NCT01399697|12317127|FG001|Overall Study|Protocol Violation|0
7839454|NCT01399697|12317128|FG002|Overall Study|Protocol Violation|0
7839455|NCT01399697|12317126|FG000|Overall Study|Non-Compliant|1
7839456|NCT01399697|12317127|FG001|Overall Study|Non-Compliant|0
7839457|NCT01399697|12317128|FG002|Overall Study|Non-Compliant|0
7839458|NCT01399697|12317126|FG000|Overall Study|Inclusion Error|2
7839459|NCT01399697|12317127|FG001|Overall Study|Inclusion Error|0
7839460|NCT01399697|12317128|FG002|Overall Study|Inclusion Error|0
7839461|NCT01399697|12317126|FG000|Overall Study|Positive result for hepatitis B|1
7839462|NCT01399697|12317127|FG001|Overall Study|Positive result for hepatitis B|0
7839463|NCT01399697|12317128|FG002|Overall Study|Positive result for hepatitis B|0
7839464|NCT01399697|12317126|FG000|Overall Study|Clinical RA remission|1
7839465|NCT01399697|12317127|FG001|Overall Study|Clinical RA remission|0
7839466|NCT01399697|12317128|FG002|Overall Study|Clinical RA remission|0
7839467|NCT01399697|12317126|FG000|Overall Study|Sponsor Decision|1
7839468|NCT01399697|12317127|FG001|Overall Study|Sponsor Decision|0
7839469|NCT01399697|12317128|FG002|Overall Study|Sponsor Decision|0
7839470|NCT01399723|12317141|FG000|Overall Study|Lost to Follow-up|0
7839471|NCT01399723|12317142|FG001|Overall Study|Lost to Follow-up|1
7839472|NCT01399736|12317151|FG000|Overall Study|Withdrawal by Subject|4
7839473|NCT01399736|12317152|FG001|Overall Study|Withdrawal by Subject|2
7839474|NCT01399736|12317151|FG000|Overall Study|Lost to Follow-up|0
7839475|NCT01399736|12317152|FG001|Overall Study|Lost to Follow-up|2
7839476|NCT01399788|12317166|FG000|First Intervention Period|Adverse Event|1
7839477|NCT01399788|12317167|FG001|First Intervention Period|Adverse Event|0
7839478|NCT01399905|12317193|FG000|Overall Study|Withdrawal by Subject|1
7839479|NCT01399905|12317194|FG001|Overall Study|Withdrawal by Subject|1
7839480|NCT01400113|12317207|FG000|Overall Study|Withdrawal by Subject|1
7839481|NCT01400113|12317208|FG001|Overall Study|Withdrawal by Subject|1
7839482|NCT01400139|12317214|FG000|HYD Core Study|Adverse Event|210
7839483|NCT01400139|12317214|FG000|HYD Core Study|Lack of Efficacy|59
7839484|NCT01400139|12317214|FG000|HYD Core Study|Withdrawal by Subject|114
7839485|NCT01400139|12317214|FG000|HYD Core Study|Lost to Follow-up|39
7839486|NCT01400139|12317214|FG000|HYD Core Study|Confirmed or suspected diversion|20
7839487|NCT01400139|12317214|FG000|HYD Core Study|Administrative|56
7839488|NCT01400139|12317214|FG000|HYD Core Study|Did not qualify for Maintenance Period|14
7839489|NCT01400139|12317214|FG000|HYD Extension Period|Adverse Event|8
7839490|NCT01400139|12317214|FG000|HYD Extension Period|Withdrawal by Subject|5
7839491|NCT01400139|12317214|FG000|HYD Extension Period|Administrative|10
7839492|NCT01400243|12317222|FG000|Overall Study|Protocol Violation|8
7839493|NCT01400243|12317223|FG001|Overall Study|Protocol Violation|11
7839494|NCT01400412|12317233|FG000|Overall Study|Lost to Follow-up|4
7839495|NCT01400412|12317234|FG001|Overall Study|Lost to Follow-up|7
7839496|NCT01400412|12317233|FG000|Overall Study|Withdrawal by Subject|3
7839497|NCT01400412|12317234|FG001|Overall Study|Withdrawal by Subject|4
7839498|NCT01400412|12317233|FG000|Overall Study|Unable to complete|3
7839499|NCT01400412|12317234|FG001|Overall Study|Unable to complete|3
7839500|NCT01400412|12317233|FG000|Overall Study|Never started study treatment|0
7839501|NCT01400412|12317234|FG001|Overall Study|Never started study treatment|3
7839502|NCT01400425|12317242|FG000|Overall Study|Withdrawal by Subject|10
7839503|NCT01400451|12317251|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2
7839504|NCT01400451|12317252|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1
7839505|NCT01400451|12317253|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1
7839506|NCT01400451|12317251|FG000|Combination Treatment (or Intended)|Drug Toxicity|0
7839507|NCT01400451|12317252|FG001|Combination Treatment (or Intended)|Drug Toxicity|1
7839508|NCT01400451|12317253|FG002|Combination Treatment (or Intended)|Drug Toxicity|0
7839509|NCT01400451|12317251|FG000|Combination Treatment (or Intended)|Adverse Event|1
7839510|NCT01400451|12317252|FG001|Combination Treatment (or Intended)|Adverse Event|0
7839511|NCT01400451|12317253|FG002|Combination Treatment (or Intended)|Adverse Event|0
7839512|NCT01400451|12317251|FG000|Combination Treatment (or Intended)|Disease Progression|3
7839513|NCT01400451|12317252|FG001|Combination Treatment (or Intended)|Disease Progression|1
7839514|NCT01400451|12317253|FG002|Combination Treatment (or Intended)|Disease Progression|1
7839515|NCT01400451|12317251|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0
7839516|NCT01400451|12317252|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1
7839517|NCT01400451|12317253|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0
7839518|NCT01400503|12317275|FG000|Overall Study|Withdrawal by Subject|1
7839519|NCT01400503|12317275|FG000|Overall Study|Study Terminated by Sponsor|58
7839520|NCT01400503|12317275|FG000|Overall Study|Other|1
7839521|NCT01400516|12317281|FG000|Primary Trial|Withdrawal by Subject|0
7839522|NCT01400516|12317282|FG001|Primary Trial|Withdrawal by Subject|2
7839523|NCT01400698|12317292|FG000|Overall Study|Lost to Follow-up|2
7839524|NCT01400698|12317293|FG001|Overall Study|Lost to Follow-up|5
7839525|NCT01400698|12317294|FG002|Overall Study|Lost to Follow-up|2
7839526|NCT01400698|12317295|FG003|Overall Study|Lost to Follow-up|1
7839527|NCT01400698|12317296|FG004|Overall Study|Lost to Follow-up|4
7839528|NCT01400698|12317297|FG005|Overall Study|Lost to Follow-up|3
7839529|NCT01400698|12317292|FG000|Overall Study|Withdrawal by Subject|8
7839530|NCT01400698|12317293|FG001|Overall Study|Withdrawal by Subject|2
7839531|NCT01400698|12317294|FG002|Overall Study|Withdrawal by Subject|0
7839532|NCT01400698|12317295|FG003|Overall Study|Withdrawal by Subject|4
7839533|NCT01400698|12317296|FG004|Overall Study|Withdrawal by Subject|1
7839534|NCT01400698|12317297|FG005|Overall Study|Withdrawal by Subject|3
7839535|NCT01400698|12317292|FG000|Overall Study|Protocol Violation|0
7839536|NCT01400698|12317293|FG001|Overall Study|Protocol Violation|1
7839537|NCT01400698|12317294|FG002|Overall Study|Protocol Violation|0
7839538|NCT01400698|12317295|FG003|Overall Study|Protocol Violation|0
7839539|NCT01400698|12317296|FG004|Overall Study|Protocol Violation|1
7839540|NCT01400698|12317297|FG005|Overall Study|Protocol Violation|0
7839541|NCT01400698|12317292|FG000|Overall Study|Non-compliance|0
7839542|NCT01400698|12317293|FG001|Overall Study|Non-compliance|1
7839543|NCT01400698|12317294|FG002|Overall Study|Non-compliance|0
7839544|NCT01400698|12317295|FG003|Overall Study|Non-compliance|1
7839545|NCT01400698|12317296|FG004|Overall Study|Non-compliance|0
7839546|NCT01400698|12317297|FG005|Overall Study|Non-compliance|0
7839547|NCT01400698|12317292|FG000|Overall Study|Adverse Event|1
7839548|NCT01400698|12317293|FG001|Overall Study|Adverse Event|0
7839549|NCT01400698|12317294|FG002|Overall Study|Adverse Event|0
7839550|NCT01400698|12317295|FG003|Overall Study|Adverse Event|0
7839551|NCT01400698|12317296|FG004|Overall Study|Adverse Event|0
7839552|NCT01400698|12317297|FG005|Overall Study|Adverse Event|0
7839553|NCT01400698|12317292|FG000|Overall Study|Other|4
7839554|NCT01400698|12317293|FG001|Overall Study|Other|2
7839555|NCT01400698|12317294|FG002|Overall Study|Other|0
7839556|NCT01400698|12317295|FG003|Overall Study|Other|2
7839557|NCT01400698|12317296|FG004|Overall Study|Other|1
7839558|NCT01400698|12317297|FG005|Overall Study|Other|0
7839559|NCT01400815|12317309|FG000|Overall Study|Adverse Event|3
7839560|NCT01400815|12317310|FG001|Overall Study|Adverse Event|0
7839561|NCT01400815|12317309|FG000|Overall Study|Death|0
7839562|NCT01400815|12317310|FG001|Overall Study|Death|1
7839563|NCT01400815|12317309|FG000|Overall Study|Lost to Follow-up|18
7839564|NCT01400815|12317310|FG001|Overall Study|Lost to Follow-up|11
7839565|NCT01400815|12317309|FG000|Overall Study|Protocol Violation|0
7839566|NCT01400815|12317310|FG001|Overall Study|Protocol Violation|1
7839567|NCT01400815|12317309|FG000|Overall Study|Physician Decision|1
7839568|NCT01400815|12317310|FG001|Overall Study|Physician Decision|0
7839569|NCT01400815|12317309|FG000|Overall Study|Withdrawal by Subject|15
7839570|NCT01400815|12317310|FG001|Overall Study|Withdrawal by Subject|8
7839571|NCT01400815|12317309|FG000|Overall Study|Subject in jail|1
7839572|NCT01400815|12317310|FG001|Overall Study|Subject in jail|0
7839573|NCT01400841|12317316|FG000|Initial Study Phase (6 Months)|Death|1
7839574|NCT01400841|12317316|FG000|Extended Study Phase (2 Years)|Adverse Event|2
7839575|NCT01400893|12317326|FG000|Overall Study|Death|27
7839576|NCT01400893|12317327|FG001|Overall Study|Death|21
7839577|NCT01400893|12317326|FG000|Overall Study|Lost to Follow-up|0
7839578|NCT01400893|12317327|FG001|Overall Study|Lost to Follow-up|6
7839579|NCT01400919|12317348|FG000|Overall Study|Withdrawal by Subject|4
7839580|NCT01400919|12317348|FG000|Overall Study|Lost to Follow-up|2
7839581|NCT01400919|12317348|FG000|Overall Study|Missed visit|2
7839582|NCT01400932|12317354|FG000|Overall Study|Adverse Event|10
7839583|NCT01400932|12317355|FG001|Overall Study|Adverse Event|5
7839584|NCT01400932|12317354|FG000|Overall Study|Lack of Efficacy|0
7839585|NCT01400932|12317355|FG001|Overall Study|Lack of Efficacy|3
7839586|NCT01400932|12317354|FG000|Overall Study|Withdrawal by Subject|2
7839587|NCT01400932|12317355|FG001|Overall Study|Withdrawal by Subject|6
7839588|NCT01400932|12317354|FG000|Overall Study|Lost to Follow-up|1
7839589|NCT01400932|12317355|FG001|Overall Study|Lost to Follow-up|0
7839590|NCT01400932|12317354|FG000|Overall Study|Protocol Deviation|0
7839591|NCT01400932|12317355|FG001|Overall Study|Protocol Deviation|1
7839592|NCT01400932|12317354|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
7839593|NCT01400932|12317355|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0
7839594|NCT01400958|12317363|FG000|Overall Study|Physician Decision|0
7839595|NCT01400958|12317364|FG001|Overall Study|Physician Decision|1
7839596|NCT01400958|12317363|FG000|Overall Study|Withdrawal by Subject|0
7839597|NCT01400958|12317364|FG001|Overall Study|Withdrawal by Subject|1
7839598|NCT01400958|12317363|FG000|Overall Study|Adverse Event|1
7839599|NCT01400958|12317364|FG001|Overall Study|Adverse Event|0
7839600|NCT01400971|12317370|FG000|Overall Study|Death|82
7839601|NCT01400971|12317370|FG000|Overall Study|Lost to Follow-up|196
7839602|NCT01400971|12317370|FG000|Overall Study|Lost to follow up + Subject Decision|2
7839603|NCT01400971|12317370|FG000|Overall Study|Physician Decision|57
7839604|NCT01400971|12317370|FG000|Overall Study|Withdrawal by Subject|158
7839605|NCT01400971|12317370|FG000|Overall Study|Other|422
7839606|NCT01401010|12317376|FG000|Overall Study|Could not interpret assay results|1
7839607|NCT01401010|12317377|FG001|Overall Study|Could not interpret assay results|0
7839608|NCT01401062|12317396|FG000|Overall Study|Death|9
7839609|NCT01401062|12317397|FG001|Overall Study|Death|7
7839610|NCT01401062|12317396|FG000|Overall Study|Physician Decision|1
7839611|NCT01401062|12317397|FG001|Overall Study|Physician Decision|0
7839612|NCT01401062|12317396|FG000|Overall Study|Withdrawal by Subject|1
7839613|NCT01401062|12317397|FG001|Overall Study|Withdrawal by Subject|1
7839614|NCT01401153|12317414|FG000|First Test Day|Learning disabilities; illness|1
7839615|NCT01401153|12317415|FG001|First Test Day|Learning disabilities; illness|10
7839616|NCT01401153|12317414|FG000|Second Test Day|illness|0
7839617|NCT01401153|12317415|FG001|Second Test Day|illness|5
7839618|NCT01401283|12317463|FG000|Overall Study|surgery cancelled|5
7839619|NCT01401283|12317464|FG001|Overall Study|surgery cancelled|8
7839620|NCT01401283|12317463|FG000|Overall Study|preoperative arrhythmia|5
7839621|NCT01401283|12317464|FG001|Overall Study|preoperative arrhythmia|0
7839622|NCT01401283|12317463|FG000|Overall Study|no central venous access|0
7839623|NCT01401283|12317464|FG001|Overall Study|no central venous access|1
7839624|NCT01401283|12317463|FG000|Overall Study|suspicion of malignant hyperthermia|0
7839625|NCT01401283|12317464|FG001|Overall Study|suspicion of malignant hyperthermia|1
7948948|NCT02532179|12494322|FG000|Overall Study|Subject received depot steroid injection|1
7948949|NCT02532283|12494328|FG000|Overall Study|Adverse Event|0
7948950|NCT02532283|12494329|FG001|Overall Study|Adverse Event|1
7948951|NCT02532283|12494328|FG000|Overall Study|Death|1
7948952|NCT02532283|12494329|FG001|Overall Study|Death|0
7948953|NCT02532283|12494328|FG000|Overall Study|Lost to Follow-up|0
7948954|NCT02532283|12494329|FG001|Overall Study|Lost to Follow-up|1
7948955|NCT02532283|12494328|FG000|Overall Study|Withdrawal by Subject|8
7948956|NCT02532283|12494329|FG001|Overall Study|Withdrawal by Subject|3
7948957|NCT02532374|12494337|FG000|Overall Study|Withdrawal by Subject|1
7948958|NCT02532374|12494337|FG000|Overall Study|Physician Decision|1
7948959|NCT02532465|12494351|FG000|Overall Study|Protocol Violation|1
7948960|NCT02532465|12494352|FG001|Overall Study|Protocol Violation|0
7948961|NCT02532465|12494351|FG000|Overall Study|Lack of Efficacy|0
7948962|NCT02532465|12494352|FG001|Overall Study|Lack of Efficacy|1
7965859|NCT02739594|12521249|FG001|Overall Study|Violation of Eligibility Criteria|2
7965860|NCT02739594|12521248|FG000|Overall Study|Protocol Violation|5
7965861|NCT02739594|12521249|FG001|Overall Study|Protocol Violation|6
7965862|NCT02739594|12521248|FG000|Overall Study|Death|4
7965863|NCT02739594|12521249|FG001|Overall Study|Death|2
7965864|NCT02739594|12521248|FG000|Overall Study|Renal Insufficiency|4
7965865|NCT02739594|12521249|FG001|Overall Study|Renal Insufficiency|6
7965866|NCT02739594|12521248|FG000|Overall Study|Administrative Reasons|1
7965867|NCT02739594|12521249|FG001|Overall Study|Administrative Reasons|3
7965868|NCT02739594|12521248|FG000|Overall Study|Withdrawal by Subject|1
7965869|NCT02739594|12521249|FG001|Overall Study|Withdrawal by Subject|1
7965870|NCT02739594|12521248|FG000|Overall Study|Lost to Follow-up|0
7839626|NCT01401322|12317470|FG000|Overall Study|Withdrawal by Subject|1
7839627|NCT01401322|12317470|FG000|Overall Study|Physician Decision|1
7839628|NCT01401361|12317474|FG000|Overall Study|Withdrawal by Subject|16
7839629|NCT01401361|12317474|FG000|Overall Study|Lack of Efficacy|6
7839630|NCT01401361|12317474|FG000|Overall Study|Physician Decision|1
7839631|NCT01401361|12317474|FG000|Overall Study|Lost to Follow-up|3
7839632|NCT01401361|12317474|FG000|Overall Study|Subject/family decision post procedure|2
7839633|NCT01401452|12317478|FG000|Overall Study|Adverse reaction|9
7839634|NCT01401452|12317478|FG000|Overall Study|Lost to Follow-up|12
7839635|NCT01401452|12317478|FG000|Overall Study|Lack of Efficacy|30
7839636|NCT01401452|12317478|FG000|Overall Study|Participant developed breast cancer|1
7839637|NCT01401452|12317478|FG000|Overall Study|Tx stopped due to financial reasons|1
7839638|NCT01401452|12317478|FG000|Overall Study|Tx stopped by psychiatrist|1
7839639|NCT01401452|12317478|FG000|Overall Study|No more visits within the 36 wk followup|4
7839640|NCT01401452|12317478|FG000|Overall Study|Subject did not come to follow up visits|2
7839641|NCT01401452|12317478|FG000|Overall Study|Subject didn't return for routine visits|1
7839642|NCT01401452|12317478|FG000|Overall Study|Subject moved to another city|1
7839643|NCT01401452|12317478|FG000|Overall Study|Subject's wife wants to get pregnant|1
7839644|NCT01401452|12317478|FG000|Overall Study|Psoriatic arthritis|1
7839645|NCT01401452|12317478|FG000|Overall Study|Participant stopped Tx|2
7839646|NCT01401452|12317478|FG000|Overall Study|Discontinuation for personal reasons|1
7839647|NCT01401452|12317478|FG000|Overall Study|Treatment failure|1
7839648|NCT01401452|12317478|FG000|Overall Study|Unsatisfactory output|1
7839649|NCT01401452|12317478|FG000|Overall Study|Subject withdrew because of Tx success|1
7839650|NCT01401452|12317478|FG000|Overall Study|Subject chose to discontinue treatment|1
7839651|NCT01401452|12317478|FG000|Overall Study|Participant withdrew consent|1
7862805|NCT01600716|12351834|FG000|Overall Study|Personal Reasons|0
7862806|NCT01600716|12351835|FG001|Overall Study|Personal Reasons|2
7862807|NCT01600716|12351834|FG000|Overall Study|Lost to Follow-up|0
7862808|NCT01600716|12351835|FG001|Overall Study|Lost to Follow-up|2
7862809|NCT01600716|12351834|FG000|Overall Study|Pregnancy|1
7862810|NCT01600716|12351835|FG001|Overall Study|Pregnancy|0
7862811|NCT01600716|12351834|FG000|Overall Study|Lack of Efficacy|2
7862812|NCT01600716|12351835|FG001|Overall Study|Lack of Efficacy|1
7862813|NCT01600716|12351834|FG000|Overall Study|Adverse Event|1
7862814|NCT01600716|12351835|FG001|Overall Study|Adverse Event|1
7862815|NCT01600885|12351847|FG000|First Period|Adverse Event|1
7862816|NCT01600885|12351848|FG001|First Period|Adverse Event|1
7862817|NCT01600885|12351847|FG000|First Period|moved out of area|1
7862818|NCT01600885|12351848|FG001|First Period|moved out of area|0
7839652|NCT01401465|12317484|FG000|Treatment Period 1|Adverse Event|4
7839653|NCT01401465|12317485|FG001|Treatment Period 1|Adverse Event|1
7839654|NCT01401465|12317484|FG000|Treatment Period 1|Pregnancy|0
7839655|NCT01401465|12317485|FG001|Treatment Period 1|Pregnancy|1
7839656|NCT01401465|12317484|FG000|Treatment Period 1|Protocol Violation|5
7839657|NCT01401465|12317485|FG001|Treatment Period 1|Protocol Violation|0
7839658|NCT01401465|12317484|FG000|Treatment Period 1|Withdrawal by Subject|1
7839659|NCT01401465|12317485|FG001|Treatment Period 1|Withdrawal by Subject|4
7839660|NCT01401465|12317484|FG000|Treatment Period 1|Non-Compliance to Study Drug|1
7839661|NCT01401465|12317485|FG001|Treatment Period 1|Non-Compliance to Study Drug|0
7839662|NCT01401465|12317484|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3
7720885|NCT00541931|12145408|FG000|Overall Study|Lost to Follow-up|3
7839663|NCT01401465|12317485|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9
7839664|NCT01401465|12317484|FG000|Treatment Period 1|Scheduling Difficulties|1
7839665|NCT01401465|12317485|FG001|Treatment Period 1|Scheduling Difficulties|1
7839666|NCT01401465|12317484|FG000|Treatment Period 2|Lost to Follow-up|0
7839667|NCT01401465|12317485|FG001|Treatment Period 2|Lost to Follow-up|1
7839668|NCT01401465|12317484|FG000|Treatment Period 2|Withdrawal by Subject|0
7839669|NCT01401465|12317485|FG001|Treatment Period 2|Withdrawal by Subject|1
7839670|NCT01401478|12317494|FG000|Overall Study|Study drug not available|6
7839671|NCT01401478|12317494|FG000|Overall Study|Adverse Event|5
7839672|NCT01401478|12317494|FG000|Overall Study|Hyperphosphatemia|5
7839673|NCT01401478|12317494|FG000|Overall Study|Lost to Follow-up|5
7839674|NCT01401478|12317494|FG000|Overall Study|Kidney transplantation|3
7839675|NCT01401478|12317494|FG000|Overall Study|Withdrawal by Subject|3
7839676|NCT01401478|12317494|FG000|Overall Study|Blood samples not available|1
7839677|NCT01401478|12317494|FG000|Overall Study|Hyperphosphatemia and adverse event|1
7839678|NCT01401478|12317494|FG000|Overall Study|Low intact parathyroid hormone|1
7839679|NCT01401478|12317494|FG000|Overall Study|Serious adverse event|1
7839680|NCT01401530|12317514|FG000|Overall Study|Disease Progression|1
7839681|NCT01401530|12317515|FG001|Overall Study|Disease Progression|2
7839682|NCT01401530|12317516|FG002|Overall Study|Disease Progression|1
7839683|NCT01401530|12317514|FG000|Overall Study|Adverse Event|1
7839684|NCT01401530|12317515|FG001|Overall Study|Adverse Event|1
7839685|NCT01401530|12317516|FG002|Overall Study|Adverse Event|1
7839686|NCT01401530|12317514|FG000|Overall Study|Participant Choice|1
7839687|NCT01401530|12317515|FG001|Overall Study|Participant Choice|2
7839688|NCT01401530|12317516|FG002|Overall Study|Participant Choice|1
7839689|NCT01401530|12317514|FG000|Overall Study|Physician Decision|0
7839690|NCT01401530|12317515|FG001|Overall Study|Physician Decision|1
7839691|NCT01401530|12317516|FG002|Overall Study|Physician Decision|0
7839692|NCT01401647|12317568|FG000|Overall Study|Withdrawal by Subject|1
7839693|NCT01401647|12317569|FG001|Overall Study|Withdrawal by Subject|5
7839694|NCT01401647|12317570|FG002|Overall Study|Withdrawal by Subject|2
7839695|NCT01401647|12317568|FG000|Overall Study|Lost to Follow-up|3
7839696|NCT01401647|12317569|FG001|Overall Study|Lost to Follow-up|3
7839697|NCT01401647|12317570|FG002|Overall Study|Lost to Follow-up|1
7839698|NCT01401842|12317584|FG000|Overall Study|Withdrawal by Subject|3
7839699|NCT01401842|12317585|FG001|Overall Study|Withdrawal by Subject|2
7839700|NCT01401842|12317584|FG000|Overall Study|academic reason|4
7839701|NCT01401842|12317585|FG001|Overall Study|academic reason|1
7839702|NCT01401842|12317584|FG000|Overall Study|changed companies|20
7839703|NCT01401842|12317585|FG001|Overall Study|changed companies|34
7839704|NCT01401842|12317584|FG000|Overall Study|discharged from US Army|3
7839705|NCT01401842|12317585|FG001|Overall Study|discharged from US Army|4
7839706|NCT01401842|12317584|FG000|Overall Study|invalid follow-up strength data|1
7839707|NCT01401842|12317585|FG001|Overall Study|invalid follow-up strength data|4
7839708|NCT01401842|12317584|FG000|Overall Study|on profile|9
7839709|NCT01401842|12317585|FG001|Overall Study|on profile|5
7839710|NCT01401842|12317584|FG000|Overall Study|other/unknown|28
7839711|NCT01401842|12317585|FG001|Overall Study|other/unknown|17
7839712|NCT01401959|12317605|FG000|Enrolled|Withdrawal by Subject|1
7839713|NCT01401959|12317606|FG001|Enrolled|Withdrawal by Subject|0
7839714|NCT01401959|12317607|FG002|Enrolled|Withdrawal by Subject|0
7839715|NCT01401959|12317605|FG000|Treated|Disease Progression|2
7839716|NCT01401959|12317606|FG001|Treated|Disease Progression|2
7839717|NCT01401959|12317607|FG002|Treated|Disease Progression|1
7839718|NCT01401959|12317605|FG000|Treated|Adverse Event|4
7839719|NCT01401959|12317606|FG001|Treated|Adverse Event|3
7839720|NCT01401959|12317607|FG002|Treated|Adverse Event|2
7839721|NCT01401959|12317605|FG000|Treated|Withdrawal by Subject|1
7839722|NCT01401959|12317606|FG001|Treated|Withdrawal by Subject|2
7839723|NCT01401959|12317607|FG002|Treated|Withdrawal by Subject|2
7839724|NCT01401959|12317605|FG000|Treated|Protocol Violation|0
7839725|NCT01401959|12317606|FG001|Treated|Protocol Violation|1
7839726|NCT01401959|12317607|FG002|Treated|Protocol Violation|0
7839727|NCT01402011|12317620|FG000|Delayed Treatment Period|Withdrawal by Subject|1
7839728|NCT01402011|12317621|FG001|Delayed Treatment Period|Withdrawal by Subject|0
7839729|NCT01402011|12317622|FG002|Delayed Treatment Period|Withdrawal by Subject|0
7839730|NCT01402011|12317620|FG000|Active Treatment Period|Withdrawal by Subject|1
7839731|NCT01402011|12317621|FG001|Active Treatment Period|Withdrawal by Subject|3
7839732|NCT01402011|12317622|FG002|Active Treatment Period|Withdrawal by Subject|0
7839733|NCT01402011|12317620|FG000|Nine Month Follow-up|Withdrawal by Subject|0
7839734|NCT01402011|12317621|FG001|Nine Month Follow-up|Withdrawal by Subject|1
7839735|NCT01402011|12317622|FG002|Nine Month Follow-up|Withdrawal by Subject|0
7839736|NCT01402063|12317644|FG000|Overall Study|Withdrawal by Subject|3
7839737|NCT01402063|12317645|FG001|Overall Study|Withdrawal by Subject|3
7839738|NCT01402102|12317653|FG000|Overall Study|Protocol Violation|1
7839739|NCT01402102|12317654|FG001|Overall Study|Protocol Violation|0
7839740|NCT01402102|12317653|FG000|Overall Study|Insufficiency of compliance|1
7839741|NCT01402102|12317654|FG001|Overall Study|Insufficiency of compliance|1
7839742|NCT01402102|12317653|FG000|Overall Study|Withdrawal by Subject|0
7839743|NCT01402102|12317654|FG001|Overall Study|Withdrawal by Subject|2
7839744|NCT01402284|12317690|FG000|Overall Study|Withdrawal consent|2
7839745|NCT01402284|12317690|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1
7839746|NCT01402284|12317690|FG000|Overall Study|Physician Decision|1
7839747|NCT01402284|12317690|FG000|Overall Study|Disease progression on study|10
7839748|NCT01402492|12317731|FG000|Overall Study|Withdrawal by Subject|17
7839749|NCT01402492|12317732|FG001|Overall Study|Withdrawal by Subject|11
7839750|NCT01402492|12317733|FG002|Overall Study|Withdrawal by Subject|11
7839751|NCT01402492|12317731|FG000|Overall Study|Adverse Event|2
7839752|NCT01402492|12317732|FG001|Overall Study|Adverse Event|3
7839753|NCT01402492|12317733|FG002|Overall Study|Adverse Event|4
7839754|NCT01402492|12317731|FG000|Overall Study|Physician Decision|0
7839755|NCT01402492|12317732|FG001|Overall Study|Physician Decision|3
7839756|NCT01402492|12317733|FG002|Overall Study|Physician Decision|0
7839757|NCT01402492|12317731|FG000|Overall Study|Incarcerated (N=3)|2
7839758|NCT01402492|12317732|FG001|Overall Study|Incarcerated (N=3)|0
7839759|NCT01402492|12317733|FG002|Overall Study|Incarcerated (N=3)|1
7839760|NCT01402544|12317741|FG000|Overall Study|Withdrawal by Subject|6
7839761|NCT01402570|12317745|FG000|Overall Study|Adverse Event|1
7839762|NCT01402700|12317750|FG000|Overall Study|Death|3
7839763|NCT01402700|12317750|FG000|Overall Study|Withdrawal by Subject|3
7839764|NCT01402700|12317750|FG000|Overall Study|Missed Visit|1
7839765|NCT01402817|12317754|FG000|Overall Study|Withdrawal by Subject|3
7839766|NCT01402817|12317754|FG000|Overall Study|Study Suspended by FDA|8
7839767|NCT01402869|12317762|FG000|Overall Study|Required Tooth Extraction|0
7839768|NCT01402869|12317763|FG001|Overall Study|Required Tooth Extraction|0
7839769|NCT01402869|12317764|FG002|Overall Study|Required Tooth Extraction|1
7839770|NCT01402947|12317774|FG000|First Intervention|Adverse Event|0
7839771|NCT01402947|12317775|FG001|First Intervention|Adverse Event|1
7839772|NCT01402986|12317785|FG000|Overall Study|Withdrawal by Subject|7
7839773|NCT01402986|12317786|FG001|Overall Study|Withdrawal by Subject|10
7839774|NCT01402986|12317787|FG002|Overall Study|Withdrawal by Subject|7
7839775|NCT01402986|12317788|FG003|Overall Study|Withdrawal by Subject|13
7839776|NCT01402986|12317785|FG000|Overall Study|Death|0
7839777|NCT01402986|12317786|FG001|Overall Study|Death|0
7839778|NCT01402986|12317787|FG002|Overall Study|Death|0
7839779|NCT01402986|12317788|FG003|Overall Study|Death|2
7839780|NCT01402986|12317785|FG000|Overall Study|Lost to Follow-up|0
7839781|NCT01402986|12317786|FG001|Overall Study|Lost to Follow-up|0
7839782|NCT01402986|12317787|FG002|Overall Study|Lost to Follow-up|0
7839783|NCT01402986|12317788|FG003|Overall Study|Lost to Follow-up|1
7839784|NCT01402986|12317785|FG000|Overall Study|Other|2
7839785|NCT01402986|12317786|FG001|Overall Study|Other|5
7839786|NCT01402986|12317787|FG002|Overall Study|Other|1
7839787|NCT01402986|12317788|FG003|Overall Study|Other|6
7839788|NCT01403051|12317800|FG000|Overall Study|Protocol Violation|2
7839789|NCT01403051|12317801|FG001|Overall Study|Protocol Violation|0
7839790|NCT01403051|12317800|FG000|Overall Study|Death|1
7839791|NCT01403051|12317801|FG001|Overall Study|Death|0
7839792|NCT01403051|12317800|FG000|Overall Study|Withdrawal by Subject|2
7839793|NCT01403051|12317801|FG001|Overall Study|Withdrawal by Subject|1
7839794|NCT01403051|12317800|FG000|Overall Study|Lost to Follow-up|5
7839795|NCT01403051|12317801|FG001|Overall Study|Lost to Follow-up|5
7839796|NCT01403064|12317812|FG000|Overall Study|Death|0
7839797|NCT01403064|12317813|FG001|Overall Study|Death|0
7839798|NCT01403064|12317814|FG002|Overall Study|Death|1
7839799|NCT01403064|12317815|FG003|Overall Study|Death|1
7839800|NCT01403064|12317812|FG000|Overall Study|Withdrawal by Subject|0
7839801|NCT01403064|12317813|FG001|Overall Study|Withdrawal by Subject|0
7839802|NCT01403064|12317814|FG002|Overall Study|Withdrawal by Subject|1
7839803|NCT01403064|12317815|FG003|Overall Study|Withdrawal by Subject|1
7839804|NCT01403064|12317812|FG000|Overall Study|Other|1
7839805|NCT01403064|12317813|FG001|Overall Study|Other|0
7839806|NCT01403064|12317814|FG002|Overall Study|Other|2
7839807|NCT01403064|12317815|FG003|Overall Study|Other|1
7839808|NCT01403116|12317836|FG000|Overall Study|Adverse Event|7
7839809|NCT01403116|12317837|FG001|Overall Study|Adverse Event|4
7839810|NCT01403116|12317836|FG000|Overall Study|Lost to Follow-up|7
7839811|NCT01403116|12317837|FG001|Overall Study|Lost to Follow-up|5
7839812|NCT01403116|12317836|FG000|Overall Study|Withdrawal by Subject|12
7839813|NCT01403116|12317837|FG001|Overall Study|Withdrawal by Subject|15
7839814|NCT01403116|12317836|FG000|Overall Study|Non-compliance of study drug|3
7839815|NCT01403116|12317837|FG001|Overall Study|Non-compliance of study drug|0
7839816|NCT01403116|12317836|FG000|Overall Study|Protocol Violation|0
7839817|NCT01403116|12317837|FG001|Overall Study|Protocol Violation|1
7839818|NCT01403116|12317836|FG000|Overall Study|undisclosed Hx of Prostate Ca|1
7839819|NCT01403116|12317837|FG001|Overall Study|undisclosed Hx of Prostate Ca|0
7839820|NCT01403116|12317836|FG000|Overall Study|Hct >54%|2
7839821|NCT01403116|12317837|FG001|Overall Study|Hct >54%|0
7839822|NCT01403116|12317836|FG000|Overall Study|unable to keep appointments|0
7839823|NCT01403116|12317837|FG001|Overall Study|unable to keep appointments|2
7839824|NCT01403610|12317877|FG000|Overall Study|Withdrawal by Subject|2
7839825|NCT01403610|12317878|FG001|Overall Study|Withdrawal by Subject|0
7839826|NCT01403610|12317879|FG002|Overall Study|Withdrawal by Subject|0
7839827|NCT01403610|12317880|FG003|Overall Study|Withdrawal by Subject|0
7839828|NCT01403610|12317877|FG000|Overall Study|Didn't recover from surgery sufficiently|0
7839829|NCT01403610|12317878|FG001|Overall Study|Didn't recover from surgery sufficiently|3
7839830|NCT01403610|12317879|FG002|Overall Study|Didn't recover from surgery sufficiently|0
7839831|NCT01403610|12317880|FG003|Overall Study|Didn't recover from surgery sufficiently|0
7839832|NCT01403805|12317892|FG000|Overall Study|Withdrawal by Subject|0
7839833|NCT01403805|12317893|FG001|Overall Study|Withdrawal by Subject|4
7839834|NCT01403805|12317892|FG000|Overall Study|Lost to Follow-up|0
7839835|NCT01403805|12317893|FG001|Overall Study|Lost to Follow-up|2
7839836|NCT01403805|12317892|FG000|Overall Study|Death|0
7839837|NCT01403805|12317893|FG001|Overall Study|Death|1
7839838|NCT01403987|12317906|FG000|Overall Study|Residents forgot their secret PIN|18
7839839|NCT01403987|12317907|FG001|Overall Study|Residents forgot their secret PIN|17
7839840|NCT01403987|12317908|FG002|Overall Study|Residents forgot their secret PIN|18
7839841|NCT01404208|12317972|FG000|Overall Study|Discontinued|3
7839842|NCT01404208|12317973|FG001|Overall Study|Discontinued|0
7839843|NCT01404234|12317979|FG000|Overall Study|Withdrawal by Subject|2
7839844|NCT01404325|12317994|FG000|Overall Study|Lost to Follow-up|1
7839845|NCT01404325|12317995|FG001|Overall Study|Lost to Follow-up|0
7839846|NCT01404325|12317994|FG000|Overall Study|Death|2
7839847|NCT01404325|12317995|FG001|Overall Study|Death|0
7839848|NCT01404325|12317994|FG000|Overall Study|Graft loss/Retransplantation|1
7839849|NCT01404325|12317995|FG001|Overall Study|Graft loss/Retransplantation|0
7839850|NCT01404325|12317994|FG000|Overall Study|non-specified reason|0
7839851|NCT01404325|12317995|FG001|Overall Study|non-specified reason|2
7839852|NCT01404949|12318071|FG000|Overall Study|Not Treated|1
7839853|NCT01404988|12318078|FG000|Overall Study|Death|2
7839854|NCT01404988|12318079|FG001|Overall Study|Death|0
7839855|NCT01404988|12318080|FG002|Overall Study|Death|2
7839856|NCT01404988|12318078|FG000|Overall Study|Adverse Event|1
7839857|NCT01404988|12318079|FG001|Overall Study|Adverse Event|0
7839858|NCT01404988|12318080|FG002|Overall Study|Adverse Event|0
7839859|NCT01404988|12318078|FG000|Overall Study|Withdrawal by Subject|2
7839860|NCT01404988|12318079|FG001|Overall Study|Withdrawal by Subject|2
7839861|NCT01404988|12318080|FG002|Overall Study|Withdrawal by Subject|0
7839862|NCT01404988|12318078|FG000|Overall Study|Lost to Follow-up|1
7839863|NCT01404988|12318079|FG001|Overall Study|Lost to Follow-up|2
7839864|NCT01404988|12318080|FG002|Overall Study|Lost to Follow-up|1
7839865|NCT01405027|12318093|FG000|Overall Study|Withdrawn consent|3
7839866|NCT01405027|12318094|FG001|Overall Study|Withdrawn consent|0
7839867|NCT01405027|12318093|FG000|Overall Study|Lost to Follow-up|16
7839868|NCT01405027|12318094|FG001|Overall Study|Lost to Follow-up|24
7839869|NCT01405027|12318093|FG000|Overall Study|Investigator judgement|0
7839870|NCT01405027|12318094|FG001|Overall Study|Investigator judgement|2
7839871|NCT01405027|12318093|FG000|Overall Study|Death|1
7839872|NCT01405027|12318094|FG001|Overall Study|Death|0
7839873|NCT01405027|12318093|FG000|Overall Study|Other or Unknown|12
7839874|NCT01405027|12318094|FG001|Overall Study|Other or Unknown|25
7839875|NCT01405053|12318104|FG000|Overall Study|Adverse Event|3
7839876|NCT01405053|12318105|FG001|Overall Study|Adverse Event|0
7839877|NCT01405053|12318104|FG000|Overall Study|Lost to Follow-up|0
7839878|NCT01405053|12318105|FG001|Overall Study|Lost to Follow-up|1
7839879|NCT01405053|12318104|FG000|Overall Study|Participant choice|2
7839880|NCT01405053|12318105|FG001|Overall Study|Participant choice|1
7839881|NCT01405053|12318104|FG000|Overall Study|Inadequate therapeutic effect|2
7839882|NCT01405053|12318105|FG001|Overall Study|Inadequate therapeutic effect|1
7839883|NCT01405053|12318104|FG000|Overall Study|Withdrawal by Subject|3
7839884|NCT01405053|12318105|FG001|Overall Study|Withdrawal by Subject|4
7839885|NCT01405053|12318104|FG000|Overall Study|Other|0
7839886|NCT01405053|12318105|FG001|Overall Study|Other|1
7839887|NCT01405196|12318115|FG000|Overall Study|Study Terminated by Sponsor|0
7839888|NCT01405196|12318116|FG001|Overall Study|Study Terminated by Sponsor|0
7839889|NCT01405196|12318117|FG002|Overall Study|Study Terminated by Sponsor|9
7839890|NCT01405196|12318118|FG003|Overall Study|Study Terminated by Sponsor|0
7839891|NCT01405196|12318115|FG000|Overall Study|Other|2
7839892|NCT01405196|12318116|FG001|Overall Study|Other|2
7839893|NCT01405196|12318117|FG002|Overall Study|Other|5
7839894|NCT01405196|12318118|FG003|Overall Study|Other|0
7839895|NCT01405196|12318115|FG000|Overall Study|Withdrawal by Subject|4
7839896|NCT01405196|12318116|FG001|Overall Study|Withdrawal by Subject|6
7839897|NCT01405196|12318117|FG002|Overall Study|Withdrawal by Subject|3
7839898|NCT01405196|12318118|FG003|Overall Study|Withdrawal by Subject|6
7839899|NCT01405196|12318115|FG000|Overall Study|Adverse Event|2
7839900|NCT01405196|12318116|FG001|Overall Study|Adverse Event|2
7839901|NCT01405196|12318117|FG002|Overall Study|Adverse Event|0
7839902|NCT01405196|12318118|FG003|Overall Study|Adverse Event|2
7839903|NCT01405196|12318115|FG000|Overall Study|Death|1
7839904|NCT01405196|12318116|FG001|Overall Study|Death|0
7839905|NCT01405196|12318117|FG002|Overall Study|Death|3
7839906|NCT01405196|12318118|FG003|Overall Study|Death|0
7839907|NCT01405196|12318115|FG000|Overall Study|Lost to Follow-up|2
7839908|NCT01405196|12318116|FG001|Overall Study|Lost to Follow-up|2
7839909|NCT01405196|12318117|FG002|Overall Study|Lost to Follow-up|3
7839910|NCT01405196|12318118|FG003|Overall Study|Lost to Follow-up|1
7839911|NCT01405456|12318139|FG000|Overall Study|Lost to Follow-up|2
7839912|NCT01405456|12318140|FG001|Overall Study|Lost to Follow-up|1
7839913|NCT01405456|12318139|FG000|Overall Study|Physician Decision|1
7839914|NCT01405456|12318140|FG001|Overall Study|Physician Decision|0
7839915|NCT01405508|12318155|FG000|Overall Study|AE, non-serious non-fatal|1
7839916|NCT01405508|12318156|FG001|Overall Study|AE, non-serious non-fatal|1
7839917|NCT01405508|12318157|FG002|Overall Study|AE, non-serious non-fatal|0
7839918|NCT01405508|12318158|FG003|Overall Study|AE, non-serious non-fatal|0
7839919|NCT01405560|12318168|FG000|Overall Study|Physician Decision|1
7839920|NCT01405742|12318172|FG000|Overall Study|Lost to Follow-up|1
7839921|NCT01405742|12318173|FG001|Overall Study|Lost to Follow-up|0
7839922|NCT01405768|12318181|FG000|Overall Study|Didn't complete questionnaire correctly|4
7839923|NCT01405768|12318182|FG001|Overall Study|Didn't complete questionnaire correctly|0
7839924|NCT01405820|12318200|FG000|Randomized Treatment Period|Adverse Event|3
7839925|NCT01405820|12318201|FG001|Randomized Treatment Period|Adverse Event|3
7839926|NCT01405820|12318202|FG002|Randomized Treatment Period|Adverse Event|3
7839927|NCT01405820|12318203|FG003|Randomized Treatment Period|Adverse Event|0
7839928|NCT01405820|12318204|FG004|Randomized Treatment Period|Adverse Event|2
7839929|NCT01405820|12318205|FG005|Randomized Treatment Period|Adverse Event|1
7839930|NCT01405820|12318200|FG000|Randomized Treatment Period|Withdrawal by Subject|6
7839931|NCT01405820|12318201|FG001|Randomized Treatment Period|Withdrawal by Subject|2
7839932|NCT01405820|12318202|FG002|Randomized Treatment Period|Withdrawal by Subject|2
7839933|NCT01405820|12318203|FG003|Randomized Treatment Period|Withdrawal by Subject|2
7839934|NCT01405820|12318204|FG004|Randomized Treatment Period|Withdrawal by Subject|0
7839935|NCT01405820|12318205|FG005|Randomized Treatment Period|Withdrawal by Subject|0
7839936|NCT01405820|12318200|FG000|Randomized Treatment Period|Other|2
7839937|NCT01405820|12318201|FG001|Randomized Treatment Period|Other|2
7839938|NCT01405820|12318202|FG002|Randomized Treatment Period|Other|1
7839939|NCT01405820|12318203|FG003|Randomized Treatment Period|Other|1
7839940|NCT01405820|12318204|FG004|Randomized Treatment Period|Other|0
7839941|NCT01405820|12318205|FG005|Randomized Treatment Period|Other|0
7839942|NCT01405820|12318200|FG000|Randomized Treatment Period|Physician Decision|0
7839943|NCT01405820|12318201|FG001|Randomized Treatment Period|Physician Decision|2
7839944|NCT01405820|12318202|FG002|Randomized Treatment Period|Physician Decision|1
7839945|NCT01405820|12318203|FG003|Randomized Treatment Period|Physician Decision|0
7839946|NCT01405820|12318204|FG004|Randomized Treatment Period|Physician Decision|0
7839947|NCT01405820|12318205|FG005|Randomized Treatment Period|Physician Decision|0
7839948|NCT01405820|12318200|FG000|Randomized Treatment Period|Rescue|0
7839949|NCT01405820|12318201|FG001|Randomized Treatment Period|Rescue|1
7839950|NCT01405820|12318202|FG002|Randomized Treatment Period|Rescue|13
7839951|NCT01405820|12318203|FG003|Randomized Treatment Period|Rescue|10
7839952|NCT01405820|12318204|FG004|Randomized Treatment Period|Rescue|8
7839953|NCT01405820|12318205|FG005|Randomized Treatment Period|Rescue|8
7839954|NCT01405820|12318200|FG000|Randomized Treatment Period|Incorrect Study Treatment|0
7839955|NCT01405820|12318201|FG001|Randomized Treatment Period|Incorrect Study Treatment|0
7839956|NCT01405820|12318202|FG002|Randomized Treatment Period|Incorrect Study Treatment|3
7839957|NCT01405820|12318203|FG003|Randomized Treatment Period|Incorrect Study Treatment|0
7839958|NCT01405820|12318204|FG004|Randomized Treatment Period|Incorrect Study Treatment|2
7839959|NCT01405820|12318205|FG005|Randomized Treatment Period|Incorrect Study Treatment|0
7839960|NCT01405820|12318200|FG000|Randomized Treatment Period|Treatment Arm Closed|0
7839961|NCT01405820|12318201|FG001|Randomized Treatment Period|Treatment Arm Closed|0
7839962|NCT01405820|12318202|FG002|Randomized Treatment Period|Treatment Arm Closed|20
7839963|NCT01405820|12318203|FG003|Randomized Treatment Period|Treatment Arm Closed|36
7839964|NCT01405820|12318204|FG004|Randomized Treatment Period|Treatment Arm Closed|33
7839965|NCT01405820|12318205|FG005|Randomized Treatment Period|Treatment Arm Closed|28
7839966|NCT01405820|12318200|FG000|Randomized Treatment Period|Death|0
7839967|NCT01405820|12318201|FG001|Randomized Treatment Period|Death|0
7839968|NCT01405820|12318202|FG002|Randomized Treatment Period|Death|0
7839969|NCT01405820|12318203|FG003|Randomized Treatment Period|Death|1
7839970|NCT01405820|12318204|FG004|Randomized Treatment Period|Death|0
7839971|NCT01405820|12318205|FG005|Randomized Treatment Period|Death|0
7839972|NCT01405820|12318200|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0
7839973|NCT01405820|12318201|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0
7839974|NCT01405820|12318202|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0
7839975|NCT01405820|12318203|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1
7839976|NCT01405820|12318204|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0
7839977|NCT01405820|12318205|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0
7839978|NCT01405820|12318200|FG000|Open-Label Treatment Period|Withdrawal by Subject|3
7839979|NCT01405820|12318201|FG001|Open-Label Treatment Period|Withdrawal by Subject|1
7839980|NCT01405820|12318202|FG002|Open-Label Treatment Period|Withdrawal by Subject|1
7839981|NCT01405820|12318203|FG003|Open-Label Treatment Period|Withdrawal by Subject|1
7839982|NCT01405820|12318204|FG004|Open-Label Treatment Period|Withdrawal by Subject|0
7839983|NCT01405820|12318205|FG005|Open-Label Treatment Period|Withdrawal by Subject|1
7839984|NCT01405820|12318200|FG000|Open-Label Treatment Period|Other|1
7839985|NCT01405820|12318201|FG001|Open-Label Treatment Period|Other|1
7839986|NCT01405820|12318202|FG002|Open-Label Treatment Period|Other|1
7839987|NCT01405820|12318203|FG003|Open-Label Treatment Period|Other|1
7839988|NCT01405820|12318204|FG004|Open-Label Treatment Period|Other|1
7839989|NCT01405820|12318205|FG005|Open-Label Treatment Period|Other|1
7839990|NCT01405820|12318200|FG000|Open-Label Treatment Period|Physician Decision|0
7839991|NCT01405820|12318201|FG001|Open-Label Treatment Period|Physician Decision|0
7839992|NCT01405820|12318202|FG002|Open-Label Treatment Period|Physician Decision|1
7839993|NCT01405820|12318203|FG003|Open-Label Treatment Period|Physician Decision|2
7839994|NCT01405820|12318204|FG004|Open-Label Treatment Period|Physician Decision|1
7839995|NCT01405820|12318205|FG005|Open-Label Treatment Period|Physician Decision|0
7839996|NCT01405820|12318200|FG000|Open-Label Treatment Period|Adverse Event|0
7839997|NCT01405820|12318201|FG001|Open-Label Treatment Period|Adverse Event|0
7839998|NCT01405820|12318202|FG002|Open-Label Treatment Period|Adverse Event|0
7839999|NCT01405820|12318203|FG003|Open-Label Treatment Period|Adverse Event|1
7840000|NCT01405820|12318204|FG004|Open-Label Treatment Period|Adverse Event|0
7840001|NCT01405820|12318205|FG005|Open-Label Treatment Period|Adverse Event|0
7840002|NCT01405898|12318227|FG000|Overall Study|Withdrawal by Subject|2
7840003|NCT01405898|12318228|FG001|Overall Study|Withdrawal by Subject|2
7840004|NCT01405911|12318237|FG000|Overall Study|Pre-treatment lab AE|0
7840005|NCT01405911|12318238|FG001|Overall Study|Pre-treatment lab AE|1
7840006|NCT01405911|12318239|FG002|Overall Study|Pre-treatment lab AE|0
7840007|NCT01405911|12318237|FG000|Overall Study|Lost to Follow-up|0
7840008|NCT01405911|12318238|FG001|Overall Study|Lost to Follow-up|1
7840009|NCT01405911|12318239|FG002|Overall Study|Lost to Follow-up|0
7840010|NCT01405911|12318237|FG000|Overall Study|Protocol Violation|1
7840011|NCT01405911|12318238|FG001|Overall Study|Protocol Violation|0
7840012|NCT01405911|12318239|FG002|Overall Study|Protocol Violation|0
7840013|NCT01405911|12318237|FG000|Overall Study|Withdrawal by Subject|3
7840014|NCT01405911|12318238|FG001|Overall Study|Withdrawal by Subject|1
7840015|NCT01405911|12318239|FG002|Overall Study|Withdrawal by Subject|1
7840016|NCT01405924|12318247|FG000|Overall Study|Protocol Violation|8
7840017|NCT01405924|12318247|FG000|Overall Study|Missing/Incomplete Data|2
7840018|NCT01405950|12318264|FG000|Overall Study|Withdrawal by Subject|1
7840019|NCT01405950|12318265|FG001|Overall Study|Withdrawal by Subject|0
7840020|NCT01405950|12318266|FG002|Overall Study|Withdrawal by Subject|0
7840021|NCT01405950|12318267|FG003|Overall Study|Withdrawal by Subject|0
7840022|NCT01406015|12318277|FG000|Overall Study|Withdrawal by Subject|3
7840023|NCT01406015|12318278|FG001|Overall Study|Withdrawal by Subject|3
7840024|NCT01406574|12318314|FG000|Overall Study|Adverse Event|0
7840025|NCT01406574|12318315|FG001|Overall Study|Adverse Event|0
7840026|NCT01406574|12318316|FG002|Overall Study|Adverse Event|1
7840027|NCT01406574|12318317|FG003|Overall Study|Adverse Event|3
7840028|NCT01406574|12318314|FG000|Overall Study|Physician Decision|0
7840029|NCT01406574|12318315|FG001|Overall Study|Physician Decision|0
7840030|NCT01406574|12318316|FG002|Overall Study|Physician Decision|0
7840031|NCT01406574|12318317|FG003|Overall Study|Physician Decision|1
7840032|NCT01406574|12318314|FG000|Overall Study|Withdrawal by Subject|0
7840033|NCT01406574|12318315|FG001|Overall Study|Withdrawal by Subject|1
7840034|NCT01406574|12318316|FG002|Overall Study|Withdrawal by Subject|0
7840035|NCT01406574|12318317|FG003|Overall Study|Withdrawal by Subject|0
7840036|NCT01406574|12318314|FG000|Overall Study|Definite progression of primary disease|1
7840037|NCT01406574|12318315|FG001|Overall Study|Definite progression of primary disease|0
7840038|NCT01406574|12318316|FG002|Overall Study|Definite progression of primary disease|0
7840039|NCT01406574|12318317|FG003|Overall Study|Definite progression of primary disease|0
7840040|NCT01406652|12318330|FG000|Overall Study|Lost-to-follow-up|3
7840041|NCT01406652|12318331|FG001|Overall Study|Lost-to-follow-up|4
7840042|NCT01406652|12318330|FG000|Overall Study|Withdrawal by Subject|2
7840043|NCT01406652|12318331|FG001|Overall Study|Withdrawal by Subject|2
7840044|NCT01406652|12318330|FG000|Overall Study|Insufficient follow-up|5
7840045|NCT01406652|12318331|FG001|Overall Study|Insufficient follow-up|4
7840046|NCT01406652|12318330|FG000|Overall Study|Infection not sure|10
7840047|NCT01406652|12318331|FG001|Overall Study|Infection not sure|10
7840048|NCT01406717|12318341|FG000|Overall Study|Subject non-compliance|4
7840049|NCT01406717|12318342|FG001|Overall Study|Subject non-compliance|3
7840050|NCT01406717|12318341|FG000|Overall Study|Protocol Violation|5
7840051|NCT01406717|12318342|FG001|Overall Study|Protocol Violation|1
7840052|NCT01406717|12318341|FG000|Overall Study|Lost to Follow-up|14
7840053|NCT01406717|12318342|FG001|Overall Study|Lost to Follow-up|8
7840054|NCT01406717|12318341|FG000|Overall Study|Withdrawal by Subject|19
7840055|NCT01406717|12318342|FG001|Overall Study|Withdrawal by Subject|15
7840056|NCT01406717|12318341|FG000|Overall Study|Adverse Event|1
7840057|NCT01406717|12318342|FG001|Overall Study|Adverse Event|2
7840058|NCT01406717|12318341|FG000|Overall Study|Lack of Efficacy|0
7840059|NCT01406717|12318342|FG001|Overall Study|Lack of Efficacy|1
7840060|NCT01406717|12318341|FG000|Overall Study|Non-completion of visit activity|0
7840061|NCT01406717|12318342|FG001|Overall Study|Non-completion of visit activity|1
7840062|NCT01406795|12318358|FG000|Overall Study|Withdrawal by Subject|1
7840063|NCT01406873|12318364|FG000|Overall Study|Withdrawal by Subject|1
7840064|NCT01406873|12318365|FG001|Overall Study|Withdrawal by Subject|1
7840065|NCT01406938|12318383|FG000|Induction Period|Subject/guardian decision|6
7840066|NCT01406938|12318384|FG001|Induction Period|Subject/guardian decision|8
7840067|NCT01406938|12318385|FG002|Induction Period|Subject/guardian decision|0
7840068|NCT01406938|12318386|FG003|Induction Period|Subject/guardian decision|0
7840069|NCT01406938|12318387|FG004|Induction Period|Subject/guardian decision|0
7840070|NCT01406938|12318388|FG005|Induction Period|Subject/guardian decision|0
7840071|NCT01406938|12318383|FG000|Induction Period|Protocol deviation|1
7840072|NCT01406938|12318384|FG001|Induction Period|Protocol deviation|0
7840073|NCT01406938|12318385|FG002|Induction Period|Protocol deviation|0
7840074|NCT01406938|12318386|FG003|Induction Period|Protocol deviation|0
7840075|NCT01406938|12318387|FG004|Induction Period|Protocol deviation|0
7840076|NCT01406938|12318388|FG005|Induction Period|Protocol deviation|0
7840077|NCT01406938|12318383|FG000|Induction Period|Adverse Event|8
7840078|NCT01406938|12318384|FG001|Induction Period|Adverse Event|9
7840079|NCT01406938|12318385|FG002|Induction Period|Adverse Event|0
7840080|NCT01406938|12318386|FG003|Induction Period|Adverse Event|0
7840081|NCT01406938|12318387|FG004|Induction Period|Adverse Event|0
7840082|NCT01406938|12318388|FG005|Induction Period|Adverse Event|0
7840083|NCT01406938|12318383|FG000|Induction Period|Lack of Efficacy|1
7840084|NCT01406938|12318384|FG001|Induction Period|Lack of Efficacy|0
7840085|NCT01406938|12318385|FG002|Induction Period|Lack of Efficacy|0
7840086|NCT01406938|12318386|FG003|Induction Period|Lack of Efficacy|0
7840087|NCT01406938|12318387|FG004|Induction Period|Lack of Efficacy|0
7840088|NCT01406938|12318388|FG005|Induction Period|Lack of Efficacy|0
7840089|NCT01406938|12318383|FG000|Induction Period|Lost to Follow-up|2
7840090|NCT01406938|12318384|FG001|Induction Period|Lost to Follow-up|3
7840091|NCT01406938|12318385|FG002|Induction Period|Lost to Follow-up|0
7840092|NCT01406938|12318386|FG003|Induction Period|Lost to Follow-up|0
7840093|NCT01406938|12318387|FG004|Induction Period|Lost to Follow-up|0
7840094|NCT01406938|12318388|FG005|Induction Period|Lost to Follow-up|0
7840095|NCT01406938|12318383|FG000|Maintenance Period|Adverse Event|0
7840096|NCT01406938|12318384|FG001|Maintenance Period|Adverse Event|0
7840097|NCT01406938|12318385|FG002|Maintenance Period|Adverse Event|2
7840098|NCT01406938|12318386|FG003|Maintenance Period|Adverse Event|8
7840099|NCT01406938|12318387|FG004|Maintenance Period|Adverse Event|4
7840100|NCT01406938|12318388|FG005|Maintenance Period|Adverse Event|2
7840101|NCT01406938|12318383|FG000|Maintenance Period|Death|0
7840102|NCT01406938|12318384|FG001|Maintenance Period|Death|0
7840103|NCT01406938|12318385|FG002|Maintenance Period|Death|0
7840104|NCT01406938|12318386|FG003|Maintenance Period|Death|0
7840105|NCT01406938|12318387|FG004|Maintenance Period|Death|1
7840106|NCT01406938|12318388|FG005|Maintenance Period|Death|0
7840107|NCT01406938|12318383|FG000|Maintenance Period|Subject/guardian decision|0
7840108|NCT01406938|12318384|FG001|Maintenance Period|Subject/guardian decision|0
7840109|NCT01406938|12318385|FG002|Maintenance Period|Subject/guardian decision|11
7840110|NCT01406938|12318386|FG003|Maintenance Period|Subject/guardian decision|7
7840111|NCT01406938|12318387|FG004|Maintenance Period|Subject/guardian decision|10
7840112|NCT01406938|12318388|FG005|Maintenance Period|Subject/guardian decision|7
7840113|NCT01406938|12318383|FG000|Maintenance Period|Protocol Violation|0
7840114|NCT01406938|12318384|FG001|Maintenance Period|Protocol Violation|0
7840115|NCT01406938|12318385|FG002|Maintenance Period|Protocol Violation|2
7840116|NCT01406938|12318386|FG003|Maintenance Period|Protocol Violation|2
7840117|NCT01406938|12318387|FG004|Maintenance Period|Protocol Violation|2
7840118|NCT01406938|12318388|FG005|Maintenance Period|Protocol Violation|2
7840119|NCT01406938|12318383|FG000|Maintenance Period|Pregnancy|0
7840120|NCT01406938|12318384|FG001|Maintenance Period|Pregnancy|0
7840121|NCT01406938|12318385|FG002|Maintenance Period|Pregnancy|0
7840122|NCT01406938|12318386|FG003|Maintenance Period|Pregnancy|0
7840123|NCT01406938|12318387|FG004|Maintenance Period|Pregnancy|1
7840124|NCT01406938|12318388|FG005|Maintenance Period|Pregnancy|0
7840125|NCT01406938|12318383|FG000|Maintenance Period|Lost to Follow-up|0
7840126|NCT01406938|12318384|FG001|Maintenance Period|Lost to Follow-up|0
7840127|NCT01406938|12318385|FG002|Maintenance Period|Lost to Follow-up|0
7840128|NCT01406938|12318386|FG003|Maintenance Period|Lost to Follow-up|0
7840129|NCT01406938|12318387|FG004|Maintenance Period|Lost to Follow-up|4
7840130|NCT01406938|12318388|FG005|Maintenance Period|Lost to Follow-up|0
7840131|NCT01406938|12318383|FG000|Maintenance Period|Lack of Efficacy|0
7840132|NCT01406938|12318384|FG001|Maintenance Period|Lack of Efficacy|0
7840133|NCT01406938|12318385|FG002|Maintenance Period|Lack of Efficacy|2
7840134|NCT01406938|12318386|FG003|Maintenance Period|Lack of Efficacy|1
7840135|NCT01406938|12318387|FG004|Maintenance Period|Lack of Efficacy|3
7840136|NCT01406938|12318388|FG005|Maintenance Period|Lack of Efficacy|5
7840137|NCT01406938|12318383|FG000|Follow up|Lack of Efficacy|3
7840138|NCT01406938|12318384|FG001|Follow up|Lack of Efficacy|2
7840139|NCT01406938|12318385|FG002|Follow up|Lack of Efficacy|1
7840140|NCT01406938|12318386|FG003|Follow up|Lack of Efficacy|0
7840141|NCT01406938|12318387|FG004|Follow up|Lack of Efficacy|0
7840142|NCT01406938|12318388|FG005|Follow up|Lack of Efficacy|0
7840143|NCT01406938|12318383|FG000|Follow up|Patient/guardian decision|4
7840144|NCT01406938|12318384|FG001|Follow up|Patient/guardian decision|2
7840145|NCT01406938|12318385|FG002|Follow up|Patient/guardian decision|4
7840146|NCT01406938|12318386|FG003|Follow up|Patient/guardian decision|2
7840147|NCT01406938|12318387|FG004|Follow up|Patient/guardian decision|4
7840148|NCT01406938|12318388|FG005|Follow up|Patient/guardian decision|1
7840149|NCT01406938|12318383|FG000|Follow up|Protocol Violation|0
7840150|NCT01406938|12318384|FG001|Follow up|Protocol Violation|0
7840151|NCT01406938|12318385|FG002|Follow up|Protocol Violation|1
7840152|NCT01406938|12318386|FG003|Follow up|Protocol Violation|0
7840153|NCT01406938|12318387|FG004|Follow up|Protocol Violation|0
7840154|NCT01406938|12318388|FG005|Follow up|Protocol Violation|0
7840155|NCT01406938|12318383|FG000|Follow up|Physician Decision|0
7840156|NCT01406938|12318384|FG001|Follow up|Physician Decision|0
7840157|NCT01406938|12318385|FG002|Follow up|Physician Decision|2
7840158|NCT01406938|12318386|FG003|Follow up|Physician Decision|0
7840159|NCT01406938|12318387|FG004|Follow up|Physician Decision|3
7840160|NCT01406938|12318388|FG005|Follow up|Physician Decision|1
7840161|NCT01406938|12318383|FG000|Follow up|Lost to Follow-up|1
7840162|NCT01406938|12318384|FG001|Follow up|Lost to Follow-up|1
7840163|NCT01406938|12318385|FG002|Follow up|Lost to Follow-up|0
7840164|NCT01406938|12318386|FG003|Follow up|Lost to Follow-up|1
7840165|NCT01406938|12318387|FG004|Follow up|Lost to Follow-up|2
7840166|NCT01406938|12318388|FG005|Follow up|Lost to Follow-up|1
7840167|NCT01407276|12318452|FG000|Overall Study|Withdrawal by Subject|0
7840168|NCT01407276|12318453|FG001|Overall Study|Withdrawal by Subject|0
7840169|NCT01407276|12318454|FG002|Overall Study|Withdrawal by Subject|0
7840170|NCT01407276|12318455|FG003|Overall Study|Withdrawal by Subject|0
7840171|NCT01407276|12318456|FG004|Overall Study|Withdrawal by Subject|0
7840172|NCT01407276|12318457|FG005|Overall Study|Withdrawal by Subject|0
7840173|NCT01407276|12318458|FG006|Overall Study|Withdrawal by Subject|0
7840174|NCT01407276|12318459|FG007|Overall Study|Withdrawal by Subject|1
7840175|NCT01407354|12318484|FG000|First Intervention|Withdrawal by Subject|0
7840176|NCT01407354|12318485|FG001|First Intervention|Withdrawal by Subject|2
7840177|NCT01407354|12318484|FG000|First Intervention|Adverse Event|1
7840178|NCT01407354|12318485|FG001|First Intervention|Adverse Event|0
7840179|NCT01407354|12318484|FG000|First Intervention|Physician Decision|1
7840180|NCT01407354|12318485|FG001|First Intervention|Physician Decision|0
7840181|NCT01407367|12318494|FG000|Overall Study|Death|24
7840182|NCT01407367|12318495|FG001|Overall Study|Death|32
7840183|NCT01407367|12318494|FG000|Overall Study|Renal Replacement Therapy (RRT)|12
7840184|NCT01407367|12318495|FG001|Overall Study|Renal Replacement Therapy (RRT)|29
7840185|NCT01407367|12318494|FG000|Overall Study|Withdrawal by Subject|4
7840186|NCT01407367|12318495|FG001|Overall Study|Withdrawal by Subject|15
7840187|NCT01407367|12318494|FG000|Overall Study|Lost to Follow-up|0
7840188|NCT01407367|12318495|FG001|Overall Study|Lost to Follow-up|2
7840189|NCT01407926|12318519|FG000|Overall Study|Lost to Follow-up|55
7840190|NCT01408030|12318537|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1
7840191|NCT01408030|12318538|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0
7840192|NCT01408030|12318539|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1
7840193|NCT01408030|12318540|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0
7840194|NCT01408030|12318537|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2
7840195|NCT01408030|12318538|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6
7840196|NCT01408030|12318539|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0
7840197|NCT01408030|12318540|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3
7840198|NCT01408030|12318537|FG000|Treatment Phase (on Drug)|Protocol Violation|0
7840199|NCT01408030|12318538|FG001|Treatment Phase (on Drug)|Protocol Violation|1
7840200|NCT01408030|12318539|FG002|Treatment Phase (on Drug)|Protocol Violation|0
7840201|NCT01408030|12318540|FG003|Treatment Phase (on Drug)|Protocol Violation|0
7840202|NCT01408030|12318537|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0
7840203|NCT01408030|12318538|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2
7840204|NCT01408030|12318539|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2
7840205|NCT01408030|12318540|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0
7840206|NCT01408030|12318537|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3
7840207|NCT01408030|12318538|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2
7840208|NCT01408030|12318539|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1
7840209|NCT01408030|12318540|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3
7840210|NCT01408030|12318537|FG000|Observation Phase (Off Drug)|Physician Decision|0
7840211|NCT01408030|12318538|FG001|Observation Phase (Off Drug)|Physician Decision|1
7840212|NCT01408030|12318539|FG002|Observation Phase (Off Drug)|Physician Decision|2
7840213|NCT01408030|12318540|FG003|Observation Phase (Off Drug)|Physician Decision|0
7840214|NCT01408030|12318537|FG000|Observation Phase (Off Drug)|Other|1
7840215|NCT01408030|12318538|FG001|Observation Phase (Off Drug)|Other|1
7840216|NCT01408030|12318539|FG002|Observation Phase (Off Drug)|Other|1
7840217|NCT01408030|12318540|FG003|Observation Phase (Off Drug)|Other|1
7840218|NCT01408043|12318550|FG000|Overall Study|unable to collect cells|1
7840219|NCT01408147|12318556|FG000|Overall Study|Withdrawal by Subject|0
7840220|NCT01408147|12318557|FG001|Overall Study|Withdrawal by Subject|1
7840221|NCT01408277|12318565|FG000|Overall Study|Adverse Event|3
7840222|NCT01408277|12318566|FG001|Overall Study|Adverse Event|4
7840223|NCT01408277|12318565|FG000|Overall Study|Lost to Follow-up|1
7840224|NCT01408277|12318566|FG001|Overall Study|Lost to Follow-up|0
7840225|NCT01408277|12318565|FG000|Overall Study|Withdrawal by Subject|2
7840226|NCT01408277|12318566|FG001|Overall Study|Withdrawal by Subject|0
7840227|NCT01408277|12318565|FG000|Overall Study|Protocol Violation|2
7840228|NCT01408277|12318566|FG001|Overall Study|Protocol Violation|0
7840229|NCT01408303|12318575|FG000|Overall Study|Adverse Event|3
7840230|NCT01408303|12318576|FG001|Overall Study|Adverse Event|7
7840231|NCT01408303|12318577|FG002|Overall Study|Adverse Event|2
7840232|NCT01408303|12318575|FG000|Overall Study|Lost to Follow-up|0
7840233|NCT01408303|12318576|FG001|Overall Study|Lost to Follow-up|1
7840234|NCT01408303|12318577|FG002|Overall Study|Lost to Follow-up|2
7840235|NCT01408303|12318575|FG000|Overall Study|Withdrawal by Subject|2
7840236|NCT01408303|12318576|FG001|Overall Study|Withdrawal by Subject|3
7840237|NCT01408303|12318577|FG002|Overall Study|Withdrawal by Subject|1
7840238|NCT01408303|12318575|FG000|Overall Study|Protocol Violation|0
7840239|NCT01408303|12318576|FG001|Overall Study|Protocol Violation|1
7840240|NCT01408303|12318577|FG002|Overall Study|Protocol Violation|0
7840241|NCT01408303|12318575|FG000|Overall Study|Noncompliance|1
7840242|NCT01408303|12318576|FG001|Overall Study|Noncompliance|0
7840243|NCT01408303|12318577|FG002|Overall Study|Noncompliance|1
7862819|NCT01601132|12351870|FG000|Overall Study|Patient withdrew consent|1
7862820|NCT01601132|12351870|FG000|Overall Study|Protocol deviation|1
7862821|NCT01601470|12351906|FG000|Period 2 - LCZ696|Physician Decision|1
7862822|NCT01601496|12351912|FG000|Overall Study|Physician Decision|1
7862823|NCT01601496|12351912|FG000|Overall Study|Withdrawal by Subject|1
7862824|NCT01601496|12351912|FG000|Overall Study|Lost to Follow-up|6
7862825|NCT01601496|12351912|FG000|Overall Study|Death|4
7862826|NCT01601496|12351912|FG000|Overall Study|Other: patient refusal to continue|3
7862827|NCT01601535|12351922|FG000|Phase 1|Adverse Event|1
7862828|NCT01601535|12351923|FG001|Phase 1|Adverse Event|0
7862829|NCT01601535|12351924|FG002|Phase 1|Adverse Event|2
7862830|NCT01601535|12351925|FG003|Phase 1|Adverse Event|1
7862831|NCT01601535|12351926|FG004|Phase 1|Adverse Event|0
7862832|NCT01601535|12351927|FG005|Phase 1|Adverse Event|0
7862833|NCT01601535|12351922|FG000|Phase 1|Withdrawal by Subject|2
7862834|NCT01601535|12351923|FG001|Phase 1|Withdrawal by Subject|1
7862835|NCT01601535|12351924|FG002|Phase 1|Withdrawal by Subject|1
7862836|NCT01601535|12351925|FG003|Phase 1|Withdrawal by Subject|2
7862837|NCT01601535|12351926|FG004|Phase 1|Withdrawal by Subject|0
7862838|NCT01601535|12351927|FG005|Phase 1|Withdrawal by Subject|0
7862839|NCT01601535|12351922|FG000|Phase 1|Progressive Disease|2
7862840|NCT01601535|12351923|FG001|Phase 1|Progressive Disease|3
7862841|NCT01601535|12351924|FG002|Phase 1|Progressive Disease|2
7862842|NCT01601535|12351925|FG003|Phase 1|Progressive Disease|1
7862843|NCT01601535|12351926|FG004|Phase 1|Progressive Disease|0
7862844|NCT01601535|12351927|FG005|Phase 1|Progressive Disease|0
7862845|NCT01601535|12351922|FG000|Phase 1|Started Another Treatment|1
7862846|NCT01601535|12351923|FG001|Phase 1|Started Another Treatment|2
7862847|NCT01601535|12351924|FG002|Phase 1|Started Another Treatment|0
7862848|NCT01601535|12351925|FG003|Phase 1|Started Another Treatment|0
7862849|NCT01601535|12351926|FG004|Phase 1|Started Another Treatment|0
7862850|NCT01601535|12351927|FG005|Phase 1|Started Another Treatment|0
7862851|NCT01601535|12351922|FG000|Phase 2|Adverse Event|0
7862852|NCT01601535|12351923|FG001|Phase 2|Adverse Event|0
7862853|NCT01601535|12351924|FG002|Phase 2|Adverse Event|0
7862854|NCT01601535|12351925|FG003|Phase 2|Adverse Event|0
7862855|NCT01601535|12351926|FG004|Phase 2|Adverse Event|5
7862856|NCT01601535|12351927|FG005|Phase 2|Adverse Event|1
7862857|NCT01601535|12351922|FG000|Phase 2|Withdrawal by Subject|0
7862858|NCT01601535|12351923|FG001|Phase 2|Withdrawal by Subject|0
7862859|NCT01601535|12351924|FG002|Phase 2|Withdrawal by Subject|0
7862860|NCT01601535|12351925|FG003|Phase 2|Withdrawal by Subject|0
7862861|NCT01601535|12351926|FG004|Phase 2|Withdrawal by Subject|8
7862862|NCT01601535|12351927|FG005|Phase 2|Withdrawal by Subject|2
7862863|NCT01601535|12351922|FG000|Phase 2|Progressive Disease|0
7862864|NCT01601535|12351923|FG001|Phase 2|Progressive Disease|0
7862865|NCT01601535|12351924|FG002|Phase 2|Progressive Disease|0
7862866|NCT01601535|12351925|FG003|Phase 2|Progressive Disease|0
7862867|NCT01601535|12351926|FG004|Phase 2|Progressive Disease|5
7862868|NCT01601535|12351927|FG005|Phase 2|Progressive Disease|7
7862869|NCT01601535|12351922|FG000|Phase 2|Started Another Treatment|0
7862870|NCT01601535|12351923|FG001|Phase 2|Started Another Treatment|0
7862871|NCT01601535|12351924|FG002|Phase 2|Started Another Treatment|0
7862872|NCT01601535|12351925|FG003|Phase 2|Started Another Treatment|0
7862873|NCT01601535|12351926|FG004|Phase 2|Started Another Treatment|1
7862874|NCT01601535|12351927|FG005|Phase 2|Started Another Treatment|2
7862875|NCT01601626|12351953|FG000|Overall Study|Death|1
7862876|NCT01601626|12351954|FG001|Overall Study|Death|1
7862877|NCT01601626|12351955|FG002|Overall Study|Death|1
7862878|NCT01601626|12351953|FG000|Overall Study|Lost to Follow-up|1
7862879|NCT01601626|12351954|FG001|Overall Study|Lost to Follow-up|2
7862880|NCT01601626|12351955|FG002|Overall Study|Lost to Follow-up|0
7862881|NCT01601626|12351953|FG000|Overall Study|Unable to Get to Clinic|0
7862882|NCT01601626|12351954|FG001|Overall Study|Unable to Get to Clinic|1
7862883|NCT01601626|12351955|FG002|Overall Study|Unable to Get to Clinic|0
7862884|NCT01601626|12351953|FG000|Overall Study|Withdrawal by Subject|0
7862885|NCT01601626|12351954|FG001|Overall Study|Withdrawal by Subject|1
7862886|NCT01601626|12351955|FG002|Overall Study|Withdrawal by Subject|1
7862887|NCT01601626|12351953|FG000|Overall Study|Not Willing to Adhere to Requirements|1
7862888|NCT01601626|12351954|FG001|Overall Study|Not Willing to Adhere to Requirements|0
7862889|NCT01601626|12351955|FG002|Overall Study|Not Willing to Adhere to Requirements|0
7862890|NCT01601652|12351963|FG000|Overall Study|Death|1
7862891|NCT01601704|12351973|FG000|Overall Study|Randomized but not dispensed study med|1
7862892|NCT01601704|12351974|FG001|Overall Study|Randomized but not dispensed study med|4
7862893|NCT01601821|12351986|FG000|Overall Study|Death|2
7862894|NCT01601821|12351987|FG001|Overall Study|Death|5
7862895|NCT01601821|12351986|FG000|Overall Study|Protocol Violation|2
7862896|NCT01601821|12351987|FG001|Overall Study|Protocol Violation|2
7862897|NCT01601821|12351986|FG000|Overall Study|Lost to Follow-up|6
7862898|NCT01601821|12351987|FG001|Overall Study|Lost to Follow-up|14
7862899|NCT01601821|12351986|FG000|Overall Study|Withdrawal by Subject|1
7840244|NCT01408459|12318596|FG000|Overall Study|Withdrawal by Subject|1
7840245|NCT01408459|12318597|FG001|Overall Study|Withdrawal by Subject|1
7840246|NCT01408485|12318604|FG000|Overall Study|Withdrawal by Subject|21
7840247|NCT01408537|12318608|FG000|Overall Study|Withdrawal by Subject|2
7840248|NCT01408537|12318608|FG000|Overall Study|Protocol Violation|3
7840249|NCT01408537|12318608|FG000|Overall Study|Lost to Follow-up|3
7840250|NCT01408563|12318623|FG000|Overall Study|Ineligible after consent/ registration|2
7840251|NCT01408576|12318630|FG000|Overall Study|Lack of Efficacy|17
7840252|NCT01408576|12318631|FG001|Overall Study|Lack of Efficacy|30
7840253|NCT01408576|12318632|FG002|Overall Study|Lack of Efficacy|48
7840254|NCT01408576|12318630|FG000|Overall Study|Protocol Violation|1
7840255|NCT01408576|12318631|FG001|Overall Study|Protocol Violation|2
7840256|NCT01408576|12318632|FG002|Overall Study|Protocol Violation|2
7840257|NCT01408576|12318630|FG000|Overall Study|Lost to Follow-up|10
7840258|NCT01408576|12318631|FG001|Overall Study|Lost to Follow-up|9
7840259|NCT01408576|12318632|FG002|Overall Study|Lost to Follow-up|17
7840260|NCT01408576|12318630|FG000|Overall Study|Withdrawal by Subject|34
7840261|NCT01408576|12318631|FG001|Overall Study|Withdrawal by Subject|60
7840262|NCT01408576|12318632|FG002|Overall Study|Withdrawal by Subject|66
7840263|NCT01408576|12318630|FG000|Overall Study|Sponsor terminated study|89
7840264|NCT01408576|12318631|FG001|Overall Study|Sponsor terminated study|333
7840265|NCT01408576|12318632|FG002|Overall Study|Sponsor terminated study|330
7948963|NCT02532517|12494358|FG000|Overall Study|Did not complete 24-Month visit|4
7948964|NCT02532517|12494358|FG000|Overall Study|Failed Angiographic eligibility|1
7948965|NCT02532517|12494358|FG000|Overall Study|Lost to Follow-up|4
7948966|NCT02532517|12494358|FG000|Overall Study|Withdrawal by Subject|4
7948967|NCT02532517|12494358|FG000|Overall Study|Death|4
7948968|NCT02532543|12494366|FG000|Overall Study|Lost to Follow-up|0
7948969|NCT02532543|12494367|FG001|Overall Study|Lost to Follow-up|0
7948970|NCT02532543|12494368|FG002|Overall Study|Lost to Follow-up|1
7948971|NCT02532543|12494369|FG003|Overall Study|Lost to Follow-up|0
7948972|NCT02532647|12494392|FG000|Overall Study|Did not receive trial medication|1
7948973|NCT02532647|12494393|FG001|Overall Study|Did not receive trial medication|0
7948974|NCT02532647|12494394|FG002|Overall Study|Did not receive trial medication|1
7948975|NCT02532764|12494412|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7948976|NCT02532764|12494413|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7948977|NCT02532764|12494414|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7948978|NCT02532764|12494415|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7840266|NCT01408576|12318630|FG000|Overall Study|AE, serious fatal|4
7840267|NCT01408576|12318631|FG001|Overall Study|AE, serious fatal|4
7840268|NCT01408576|12318632|FG002|Overall Study|AE, serious fatal|1
7840269|NCT01408576|12318630|FG000|Overall Study|SAE, non-fatal|11
7840270|NCT01408576|12318631|FG001|Overall Study|SAE, non-fatal|23
7840271|NCT01408576|12318632|FG002|Overall Study|SAE, non-fatal|14
7840272|NCT01408576|12318630|FG000|Overall Study|AE, non-serious non-fatal|12
7840273|NCT01408576|12318631|FG001|Overall Study|AE, non-serious non-fatal|19
7840274|NCT01408576|12318632|FG002|Overall Study|AE, non-serious non-fatal|11
7840275|NCT01408576|12318630|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7840276|NCT01408576|12318631|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7840277|NCT01408576|12318632|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7840278|NCT01408576|12318630|FG000|Overall Study|AE, unknown type|0
7840279|NCT01408576|12318631|FG001|Overall Study|AE, unknown type|1
7840280|NCT01408576|12318632|FG002|Overall Study|AE, unknown type|0
7840281|NCT01408576|12318630|FG000|Overall Study|Other|10
7840282|NCT01408576|12318631|FG001|Overall Study|Other|16
7840283|NCT01408576|12318632|FG002|Overall Study|Other|18
7840284|NCT01408628|12318652|FG000|Consented|Withdrawal by Subject|12
7840285|NCT01408628|12318652|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3
7840286|NCT01408628|12318652|FG000|Completed 6 Month Follow-Up|Protocol Violation|6
7840287|NCT01408628|12318652|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5
7840288|NCT01408706|12318659|FG000|Overall Study|Physician Decision|1
7840289|NCT01408706|12318660|FG001|Overall Study|Physician Decision|0
7840290|NCT01408732|12318717|FG000|Overall Study|Withdrawal by Subject|2
7840291|NCT01408732|12318718|FG001|Overall Study|Withdrawal by Subject|2
7840292|NCT01408888|12318729|FG000|First Intervention|Adverse Event|0
7840293|NCT01408888|12318730|FG001|First Intervention|Adverse Event|1
7840294|NCT01408888|12318729|FG000|First Intervention|Withdrawal by Subject|0
7840295|NCT01408888|12318730|FG001|First Intervention|Withdrawal by Subject|2
7840296|NCT01408888|12318729|FG000|Second Intervention|Withdrawal by Subject|1
7840297|NCT01408888|12318730|FG001|Second Intervention|Withdrawal by Subject|0
7840298|NCT01408888|12318729|FG000|Second Intervention|Adverse Event|1
7840299|NCT01408888|12318730|FG001|Second Intervention|Adverse Event|0
7840300|NCT01408901|12318750|FG000|6-Week Follow-Up|Lost to Follow-up|2
7840301|NCT01408901|12318751|FG001|6-Week Follow-Up|Lost to Follow-up|1
7840302|NCT01408901|12318752|FG002|6-Week Follow-Up|Lost to Follow-up|3
7840303|NCT01408901|12318753|FG003|6-Week Follow-Up|Lost to Follow-up|2
7840304|NCT01408901|12318750|FG000|6-Week Follow-Up|Death|1
7840305|NCT01408901|12318751|FG001|6-Week Follow-Up|Death|0
7840306|NCT01408901|12318752|FG002|6-Week Follow-Up|Death|0
7840307|NCT01408901|12318753|FG003|6-Week Follow-Up|Death|0
7840308|NCT01408901|12318750|FG000|6-Week Follow-Up|Cancelled visit|0
7840309|NCT01408901|12318751|FG001|6-Week Follow-Up|Cancelled visit|1
7840310|NCT01408901|12318752|FG002|6-Week Follow-Up|Cancelled visit|0
7840311|NCT01408901|12318753|FG003|6-Week Follow-Up|Cancelled visit|2
7840312|NCT01408901|12318750|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
7840313|NCT01408901|12318751|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
7840314|NCT01408901|12318752|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
7840315|NCT01408901|12318753|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2
7840316|NCT01408901|12318750|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1
7840317|NCT01408901|12318751|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0
7840318|NCT01408901|12318752|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0
7840319|NCT01408901|12318753|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0
7840320|NCT01408901|12318750|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
7840321|NCT01408901|12318751|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2
7840322|NCT01408901|12318752|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
7840323|NCT01408901|12318753|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1
7840324|NCT01408901|12318750|FG000|26-Week Follow-Up|Lost to Follow-up|1
7840325|NCT01408901|12318751|FG001|26-Week Follow-Up|Lost to Follow-up|1
7840326|NCT01408901|12318752|FG002|26-Week Follow-Up|Lost to Follow-up|0
7840327|NCT01408901|12318753|FG003|26-Week Follow-Up|Lost to Follow-up|1
7840328|NCT01408901|12318750|FG000|26-Week Follow-Up|Death|0
7840329|NCT01408901|12318751|FG001|26-Week Follow-Up|Death|1
7840330|NCT01408901|12318752|FG002|26-Week Follow-Up|Death|0
7840331|NCT01408901|12318753|FG003|26-Week Follow-Up|Death|0
7840332|NCT01408914|12318768|FG000|Overall Study|Could not complete tx in protocol period|5
7840333|NCT01408914|12318769|FG001|Overall Study|Could not complete tx in protocol period|5
7840334|NCT01408914|12318770|FG002|Overall Study|Could not complete tx in protocol period|6
7840335|NCT01408914|12318768|FG000|Overall Study|Lost to Follow-up|4
7840336|NCT01408914|12318769|FG001|Overall Study|Lost to Follow-up|1
7840337|NCT01408914|12318770|FG002|Overall Study|Lost to Follow-up|2
7840338|NCT01408914|12318768|FG000|Overall Study|Physician Decision|1
7840339|NCT01408914|12318769|FG001|Overall Study|Physician Decision|1
7840340|NCT01408914|12318770|FG002|Overall Study|Physician Decision|0
7840341|NCT01408914|12318768|FG000|Overall Study|Withdrawal by Subject|1
7840342|NCT01408914|12318769|FG001|Overall Study|Withdrawal by Subject|0
7840343|NCT01408914|12318770|FG002|Overall Study|Withdrawal by Subject|1
7840344|NCT01408914|12318768|FG000|Overall Study|Moved out of study jurisdiction|1
7840345|NCT01408914|12318769|FG001|Overall Study|Moved out of study jurisdiction|1
7840346|NCT01408914|12318770|FG002|Overall Study|Moved out of study jurisdiction|0
7840347|NCT01408914|12318768|FG000|Overall Study|Late exclusion|0
7840348|NCT01408914|12318769|FG001|Overall Study|Late exclusion|3
7840349|NCT01408914|12318770|FG002|Overall Study|Late exclusion|3
7840350|NCT01408914|12318768|FG000|Overall Study|Change in local TB/HIV norms|0
7840351|NCT01408914|12318769|FG001|Overall Study|Change in local TB/HIV norms|1
7840352|NCT01408914|12318770|FG002|Overall Study|Change in local TB/HIV norms|1
7840353|NCT01409382|12318823|FG000|Overall Study|Lost to Follow-up|1
7840354|NCT01409382|12318824|FG001|Overall Study|Lost to Follow-up|1
7840355|NCT01409382|12318823|FG000|Overall Study|Protocol Violation|0
7840356|NCT01409382|12318824|FG001|Overall Study|Protocol Violation|3
7840357|NCT01409382|12318823|FG000|Overall Study|Multiple pregnancy|2
7840358|NCT01409382|12318824|FG001|Overall Study|Multiple pregnancy|4
7840359|NCT01409382|12318823|FG000|Overall Study|Still pregnant when study ended|13
7840360|NCT01409382|12318824|FG001|Overall Study|Still pregnant when study ended|2
7840361|NCT01409382|12318823|FG000|Overall Study|Did not manage to get pregnant|64
7840362|NCT01409382|12318824|FG001|Overall Study|Did not manage to get pregnant|70
7840363|NCT01409382|12318823|FG000|Overall Study|Had a 2nd trimester loss after accident|1
7840364|NCT01409382|12318824|FG001|Overall Study|Had a 2nd trimester loss after accident|0
7840365|NCT01409434|12318834|FG000|Overall Study|Protocol Violation|4
7840366|NCT01409564|12318840|FG000|Overall Study|low medication compliance|4
7840367|NCT01409564|12318841|FG001|Overall Study|low medication compliance|3
7840368|NCT01409564|12318840|FG000|Overall Study|brain abnormalities found in T1 MR|1
7840369|NCT01409564|12318841|FG001|Overall Study|brain abnormalities found in T1 MR|2
7840370|NCT01409707|12318854|FG000|Overall Study|Withdrawal by Subject|5
7840371|NCT01409707|12318855|FG001|Overall Study|Withdrawal by Subject|17
7840372|NCT01409707|12318856|FG002|Overall Study|Withdrawal by Subject|16
7840373|NCT01409811|12318863|FG000|Overall Study|Insurance denial|1
7840374|NCT01409837|12318869|FG000|Overall Study|Withdrawal by Subject|2
7840375|NCT01409837|12318870|FG001|Overall Study|Withdrawal by Subject|1
7840376|NCT01409837|12318869|FG000|Overall Study|Lost to Follow-up|1
7840377|NCT01409837|12318870|FG001|Overall Study|Lost to Follow-up|0
7840378|NCT01409837|12318869|FG000|Overall Study|Physician Decision|0
7840379|NCT01409837|12318870|FG001|Overall Study|Physician Decision|1
7840380|NCT01409915|12318880|FG000|Overall Study|Adverse Event|0
7840381|NCT01409915|12318881|FG001|Overall Study|Adverse Event|2
7840382|NCT01409915|12318880|FG000|Overall Study|Withdrawal by Subject|0
7840383|NCT01409915|12318881|FG001|Overall Study|Withdrawal by Subject|1
7840384|NCT01409915|12318880|FG000|Overall Study|Protocol Violation|1
7840385|NCT01409915|12318881|FG001|Overall Study|Protocol Violation|0
7840386|NCT01409928|12318887|FG000|Overall Study|Physician Decision|12
7840387|NCT01409993|12318893|FG000|Overall Study|Adverse Event|4
7840388|NCT01409993|12318894|FG001|Overall Study|Adverse Event|4
7840389|NCT01409993|12318895|FG002|Overall Study|Adverse Event|3
7840390|NCT01409993|12318896|FG003|Overall Study|Adverse Event|1
7840391|NCT01409993|12318893|FG000|Overall Study|Withdrawal by Subject|0
7840392|NCT01409993|12318894|FG001|Overall Study|Withdrawal by Subject|0
7840393|NCT01409993|12318895|FG002|Overall Study|Withdrawal by Subject|0
7840394|NCT01409993|12318896|FG003|Overall Study|Withdrawal by Subject|4
7840395|NCT01409993|12318893|FG000|Overall Study|Lost to Follow-up|0
7840396|NCT01409993|12318894|FG001|Overall Study|Lost to Follow-up|1
7840397|NCT01409993|12318895|FG002|Overall Study|Lost to Follow-up|0
7840398|NCT01409993|12318896|FG003|Overall Study|Lost to Follow-up|0
7840399|NCT01410110|12318941|FG000|Overall Study|Withdrawal by Subject|4
7840400|NCT01410110|12318942|FG001|Overall Study|Withdrawal by Subject|2
7840401|NCT01410227|12318948|FG000|Overall Study|Adverse Event|1
7840402|NCT01410227|12318949|FG001|Overall Study|Adverse Event|0
7840403|NCT01410227|12318950|FG002|Overall Study|Adverse Event|0
7840404|NCT01410227|12318951|FG003|Overall Study|Adverse Event|0
7840405|NCT01410227|12318948|FG000|Overall Study|Withdrawal by Subject|3
7840406|NCT01410227|12318949|FG001|Overall Study|Withdrawal by Subject|0
7840407|NCT01410227|12318950|FG002|Overall Study|Withdrawal by Subject|1
7840408|NCT01410227|12318951|FG003|Overall Study|Withdrawal by Subject|0
7840409|NCT01410227|12318948|FG000|Overall Study|Pregnancy|0
7840410|NCT01410227|12318949|FG001|Overall Study|Pregnancy|0
7840411|NCT01410227|12318950|FG002|Overall Study|Pregnancy|0
7840412|NCT01410227|12318951|FG003|Overall Study|Pregnancy|1
7840413|NCT01410227|12318948|FG000|Overall Study|Met Excl. Criteria After Starting Study|0
7840414|NCT01410227|12318949|FG001|Overall Study|Met Excl. Criteria After Starting Study|0
7840415|NCT01410227|12318950|FG002|Overall Study|Met Excl. Criteria After Starting Study|1
7840416|NCT01410227|12318951|FG003|Overall Study|Met Excl. Criteria After Starting Study|0
7840417|NCT01410240|12318964|FG000|Overall Study|Physician Decision|0
7840418|NCT01410240|12318965|FG001|Overall Study|Physician Decision|0
7840419|NCT01410240|12318966|FG002|Overall Study|Physician Decision|1
7840420|NCT01410240|12318964|FG000|Overall Study|Missed week 6 assessments|1
7840421|NCT01410240|12318965|FG001|Overall Study|Missed week 6 assessments|1
7840422|NCT01410240|12318966|FG002|Overall Study|Missed week 6 assessments|1
7840423|NCT01410357|12318983|FG000|Overall Study|Death|2
7840424|NCT01410357|12318984|FG001|Overall Study|Death|1
7840425|NCT01410357|12318983|FG000|Overall Study|Withdrawal by Subject|1
7840426|NCT01410357|12318984|FG001|Overall Study|Withdrawal by Subject|2
7840427|NCT01410357|12318983|FG000|Overall Study|Lost to Follow-up|23
7840428|NCT01410357|12318984|FG001|Overall Study|Lost to Follow-up|21
7840429|NCT01410448|12319003|FG000|Overall Study|No conversion to everolimus|0
7840430|NCT01410448|12319004|FG001|Overall Study|No conversion to everolimus|24
7840431|NCT01410448|12319003|FG000|Overall Study|Graft loss|4
7840432|NCT01410448|12319004|FG001|Overall Study|Graft loss|1
7840433|NCT01410448|12319003|FG000|Overall Study|Administrative issues|2
7840434|NCT01410448|12319004|FG001|Overall Study|Administrative issues|1
7840435|NCT01410448|12319003|FG000|Overall Study|Lost to Follow-up|1
7840436|NCT01410448|12319004|FG001|Overall Study|Lost to Follow-up|0
7840437|NCT01410448|12319003|FG000|Overall Study|Withdrawal by Subject|3
7840438|NCT01410448|12319004|FG001|Overall Study|Withdrawal by Subject|2
7840439|NCT01410448|12319003|FG000|Overall Study|Protocol Violation|0
7840440|NCT01410448|12319004|FG001|Overall Study|Protocol Violation|4
7840441|NCT01410448|12319003|FG000|Overall Study|Death|2
7840442|NCT01410448|12319004|FG001|Overall Study|Death|3
7840443|NCT01410474|12319012|FG000|Overall Study|Withdrawal by Subject|0
7840444|NCT01410474|12319013|FG001|Overall Study|Withdrawal by Subject|1
7840445|NCT01410604|12319042|FG000|Overall Study|Adverse Event|2
7840446|NCT01410604|12319043|FG001|Overall Study|Adverse Event|1
7840447|NCT01410604|12319042|FG000|Overall Study|Lost to Follow-up|1
7840448|NCT01410604|12319043|FG001|Overall Study|Lost to Follow-up|0
7840449|NCT01410604|12319042|FG000|Overall Study|Physician Decision|0
7840450|NCT01410604|12319043|FG001|Overall Study|Physician Decision|1
7840451|NCT01411085|12319066|FG000|Overall Study|Physician Decision|1
7840452|NCT01411085|12319066|FG000|Overall Study|Protocol Violation|1
7840453|NCT01411085|12319066|FG000|Overall Study|Adverse Event|1
7840454|NCT01411215|12319087|FG000|Overall Study|Adverse Event|1
7840455|NCT01411215|12319088|FG001|Overall Study|Adverse Event|2
7840456|NCT01411215|12319087|FG000|Overall Study|Lack of Efficacy|2
7840457|NCT01411215|12319088|FG001|Overall Study|Lack of Efficacy|4
7840458|NCT01411215|12319087|FG000|Overall Study|Lost to Follow-up|12
7840459|NCT01411215|12319088|FG001|Overall Study|Lost to Follow-up|18
7840460|NCT01411215|12319087|FG000|Overall Study|Did not meet entrance criteria|0
7840461|NCT01411215|12319088|FG001|Overall Study|Did not meet entrance criteria|1
7840462|NCT01411215|12319087|FG000|Overall Study|Study terminated by sponsor|2
7840463|NCT01411215|12319088|FG001|Overall Study|Study terminated by sponsor|15
7840464|NCT01411215|12319087|FG000|Overall Study|Protocol Violation|3
7840465|NCT01411215|12319088|FG001|Overall Study|Protocol Violation|5
7840466|NCT01411215|12319087|FG000|Overall Study|Withdrawal by Subject|34
7840467|NCT01411215|12319088|FG001|Overall Study|Withdrawal by Subject|21
7840468|NCT01411215|12319087|FG000|Overall Study|Other|12
7840469|NCT01411215|12319088|FG001|Overall Study|Other|17
7840470|NCT01411215|12319087|FG000|Overall Study|Screen failure|0
7840471|NCT01411215|12319088|FG001|Overall Study|Screen failure|1
7840472|NCT01411228|12319097|FG000|Overall Study|Lost to Follow-up|0
7840473|NCT01411228|12319098|FG001|Overall Study|Lost to Follow-up|0
7840474|NCT01411228|12319099|FG002|Overall Study|Lost to Follow-up|1
7840475|NCT01411228|12319097|FG000|Overall Study|Withdrawal by Subject|1
7840476|NCT01411228|12319098|FG001|Overall Study|Withdrawal by Subject|0
7840477|NCT01411228|12319099|FG002|Overall Study|Withdrawal by Subject|0
7840478|NCT01411319|12319107|FG000|Overall Study|Lost to Follow-up|1
7840479|NCT01411774|12319160|FG000|Overall Study|Withdrawal by Subject|0
7840480|NCT01411774|12319161|FG001|Overall Study|Withdrawal by Subject|3
7840481|NCT01411839|12319169|FG000|Overall Study|Lost to Follow-up|4
7840482|NCT01411839|12319170|FG001|Overall Study|Lost to Follow-up|3
7840483|NCT01411852|12319178|FG000|Prehospital Intervention Phase|No qualifying SBP|5
7840484|NCT01411852|12319179|FG001|Prehospital Intervention Phase|No qualifying SBP|4
7840485|NCT01411852|12319178|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
7840486|NCT01411852|12319179|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
7840487|NCT01411852|12319178|FG000|Prehospital Intervention Phase|Found to be under age|0
7840488|NCT01411852|12319179|FG001|Prehospital Intervention Phase|Found to be under age|1
7840489|NCT01411852|12319178|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
7840490|NCT01411852|12319179|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
7840491|NCT01411852|12319178|FG000|Hospital Intervention Phase|Severe head injury|5
7840492|NCT01411852|12319179|FG001|Hospital Intervention Phase|Severe head injury|4
7840493|NCT01411852|12319178|FG000|Hospital Intervention Phase|No qualifying SBP|5
7840494|NCT01411852|12319179|FG001|Hospital Intervention Phase|No qualifying SBP|1
7840495|NCT01411852|12319178|FG000|Hospital Intervention Phase|Miscommunication error|1
7840496|NCT01411852|12319179|FG001|Hospital Intervention Phase|Miscommunication error|2
7840497|NCT01411852|12319178|FG000|Hospital Intervention Phase|CPR administered|3
7840498|NCT01411852|12319179|FG001|Hospital Intervention Phase|CPR administered|1
7840499|NCT01411852|12319178|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4
7840500|NCT01411852|12319179|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1
7840501|NCT01411852|12319178|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0
7840502|NCT01411852|12319179|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2
7840503|NCT01411852|12319178|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0
7840504|NCT01411852|12319179|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1
7840505|NCT01411852|12319178|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
7840506|NCT01411852|12319179|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
7840507|NCT01411852|12319178|FG000|Hospital Intervention Phase|Other ineligible|2
7840508|NCT01411852|12319179|FG001|Hospital Intervention Phase|Other ineligible|2
7840509|NCT01411852|12319178|FG000|Hospital Intervention Phase|Spinal cord injury|2
7840510|NCT01411852|12319179|FG001|Hospital Intervention Phase|Spinal cord injury|0
7840511|NCT01411852|12319178|FG000|Hospital Intervention Phase|Withdrawal by Subject|1
7840512|NCT01411852|12319179|FG001|Hospital Intervention Phase|Withdrawal by Subject|0
7840513|NCT01411852|12319178|FG000|Hospital Intervention Phase|Vascular access failed|1
7840514|NCT01411852|12319179|FG001|Hospital Intervention Phase|Vascular access failed|0
7840515|NCT01411891|12319189|FG000|Overall Study|Catheter dislodgement or loss to follow-|3
7840516|NCT01411891|12319190|FG001|Overall Study|Catheter dislodgement or loss to follow-|2
7840517|NCT01411917|12319198|FG000|Overall Study|Patient did not undergo scheduled surger|0
7840518|NCT01411917|12319199|FG001|Overall Study|Patient did not undergo scheduled surger|1
7840519|NCT01411995|12319207|FG000|Overall Study|Failed IUD insertion|0
7840520|NCT01411995|12319208|FG001|Overall Study|Failed IUD insertion|1
7840521|NCT01412021|12319214|FG000|Overall Study|Case Report Forms Not Retrieved|7
7840522|NCT01412021|12319214|FG000|Overall Study|Treatment Prior to Approval|3
7840523|NCT01412021|12319214|FG000|Overall Study|Transferred to Other Hospital|9
7840524|NCT01412060|12319218|FG000|Open-label Run-in Period (RIP)|Adverse Event|86
7840525|NCT01412060|12319219|FG001|Open-label Run-in Period (RIP)|Adverse Event|0
7840526|NCT01412060|12319220|FG002|Open-label Run-in Period (RIP)|Adverse Event|0
7840527|NCT01412060|12319218|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
7840528|NCT01412060|12319219|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
7840529|NCT01412060|12319220|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
7840530|NCT01412060|12319218|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27
7840531|NCT01412060|12319219|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0
7840532|NCT01412060|12319220|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0
7840533|NCT01412060|12319218|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
7840534|NCT01412060|12319219|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
7840535|NCT01412060|12319220|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
7840536|NCT01412060|12319218|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32
7840537|NCT01412060|12319219|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0
7840538|NCT01412060|12319220|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0
7840539|NCT01412060|12319218|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
7840540|NCT01412060|12319219|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
7840541|NCT01412060|12319220|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
7840542|NCT01412060|12319218|FG000|Period Between RIP and SP|Adverse Event|4
7840543|NCT01412060|12319219|FG001|Period Between RIP and SP|Adverse Event|0
7840544|NCT01412060|12319220|FG002|Period Between RIP and SP|Adverse Event|0
7840545|NCT01412060|12319218|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19
7840546|NCT01412060|12319219|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0
7840547|NCT01412060|12319220|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0
7840548|NCT01412060|12319218|FG000|Period Between RIP and SP|Protocol Violation|2
7840549|NCT01412060|12319219|FG001|Period Between RIP and SP|Protocol Violation|0
7840550|NCT01412060|12319220|FG002|Period Between RIP and SP|Protocol Violation|0
7840551|NCT01412060|12319218|FG000|Period Between RIP and SP|Withdrawal of Consent|1
7840552|NCT01412060|12319219|FG001|Period Between RIP and SP|Withdrawal of Consent|0
7840553|NCT01412060|12319220|FG002|Period Between RIP and SP|Withdrawal of Consent|0
7840554|NCT01412060|12319218|FG000|Period Between RIP and SP|Lost to Follow-up|5
7840555|NCT01412060|12319219|FG001|Period Between RIP and SP|Lost to Follow-up|0
7840556|NCT01412060|12319220|FG002|Period Between RIP and SP|Lost to Follow-up|0
7840557|NCT01412060|12319218|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23
7840558|NCT01412060|12319219|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0
7840559|NCT01412060|12319220|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0
7840560|NCT01412060|12319218|FG000|Open-label Stabilization Period (SP)|Adverse Event|9
7840561|NCT01412060|12319219|FG001|Open-label Stabilization Period (SP)|Adverse Event|0
7840562|NCT01412060|12319220|FG002|Open-label Stabilization Period (SP)|Adverse Event|0
7840563|NCT01412060|12319218|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
7840564|NCT01412060|12319219|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
7840565|NCT01412060|12319220|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
7840566|NCT01412060|12319218|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14
7840567|NCT01412060|12319219|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0
7840568|NCT01412060|12319220|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0
7840569|NCT01412060|12319218|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
7840570|NCT01412060|12319219|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
7840571|NCT01412060|12319220|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
7840572|NCT01412060|12319218|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9
7840573|NCT01412060|12319219|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0
7840574|NCT01412060|12319220|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0
7840575|NCT01412060|12319218|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
7840576|NCT01412060|12319219|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
7840577|NCT01412060|12319220|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
7840578|NCT01412060|12319218|FG000|Period Between SP and DBP|Protocol Violation|2
7840579|NCT01412060|12319219|FG001|Period Between SP and DBP|Protocol Violation|0
7840580|NCT01412060|12319220|FG002|Period Between SP and DBP|Protocol Violation|0
7840581|NCT01412060|12319218|FG000|Period Between SP and DBP|Withdrawal of Consent|2
7840582|NCT01412060|12319219|FG001|Period Between SP and DBP|Withdrawal of Consent|0
7840583|NCT01412060|12319220|FG002|Period Between SP and DBP|Withdrawal of Consent|0
7840584|NCT01412060|12319218|FG000|Period Between SP and DBP|Lost to Follow-up|1
7840585|NCT01412060|12319219|FG001|Period Between SP and DBP|Lost to Follow-up|0
7840586|NCT01412060|12319220|FG002|Period Between SP and DBP|Lost to Follow-up|0
7840587|NCT01412060|12319218|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
7840588|NCT01412060|12319219|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
7840589|NCT01412060|12319220|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
7840590|NCT01412060|12319218|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55
7840591|NCT01412060|12319219|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0
7840592|NCT01412060|12319220|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0
7840593|NCT01412060|12319218|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0
7840594|NCT01412060|12319219|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5
7840595|NCT01412060|12319220|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6
7840596|NCT01412060|12319218|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0
7840597|NCT01412060|12319219|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4
7840598|NCT01412060|12319220|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5
7840599|NCT01412060|12319218|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
7840600|NCT01412060|12319219|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
7840601|NCT01412060|12319220|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
7840602|NCT01412060|12319218|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
7840603|NCT01412060|12319219|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
7840604|NCT01412060|12319220|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
7840605|NCT01412060|12319218|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
7840606|NCT01412060|12319219|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
7840607|NCT01412060|12319220|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
7840608|NCT01412060|12319218|FG000|Double-blind Treatment Phase (DBP)|Relapse|0
7840609|NCT01412060|12319219|FG001|Double-blind Treatment Phase (DBP)|Relapse|47
7840610|NCT01412060|12319220|FG002|Double-blind Treatment Phase (DBP)|Relapse|25
7840611|NCT01412151|12319234|FG000|Week 0 - 306 - Treatment Period|Death|1
7840612|NCT01412151|12319234|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
7840613|NCT01412151|12319234|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
7840614|NCT01412151|12319234|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
7840615|NCT01412229|12319244|FG000|Overall Study|Physician Decision|1
7840616|NCT01412424|12319275|FG000|Core Treatment Period|Treatment Failure|24
7840617|NCT01412424|12319275|FG000|Core Treatment Period|Adverse Event|21
7840618|NCT01412424|12319275|FG000|Core Treatment Period|Patient Request|5
7840619|NCT01412424|12319275|FG000|Core Treatment Period|Lost to Follow-up|2
7840620|NCT01412424|12319275|FG000|Core Treatment Period|Sponsor Request|1
7840621|NCT01412424|12319275|FG000|Extension Treatment Period|Adverse Event|2
7840622|NCT01412424|12319275|FG000|Extension Treatment Period|Treatment Failure|2
7840623|NCT01412424|12319275|FG000|Extension Treatment Period|Patient Request|2
7840624|NCT01412801|12319316|FG000|Overall Study|Death|0
7840625|NCT01412801|12319317|FG001|Overall Study|Death|1
7840626|NCT01412801|12319318|FG002|Overall Study|Death|0
7840627|NCT01412801|12319319|FG003|Overall Study|Death|4
7840628|NCT01412801|12319320|FG004|Overall Study|Death|2
7840629|NCT01412801|12319321|FG005|Overall Study|Death|2
7840630|NCT01412801|12319316|FG000|Overall Study|Lost to Follow-up|1
7840631|NCT01412801|12319317|FG001|Overall Study|Lost to Follow-up|2
7840632|NCT01412801|12319318|FG002|Overall Study|Lost to Follow-up|4
7840633|NCT01412801|12319319|FG003|Overall Study|Lost to Follow-up|0
7840634|NCT01412801|12319320|FG004|Overall Study|Lost to Follow-up|1
7840635|NCT01412801|12319321|FG005|Overall Study|Lost to Follow-up|1
7840636|NCT01412801|12319316|FG000|Overall Study|Withdrawal by Subject|3
7840637|NCT01412801|12319317|FG001|Overall Study|Withdrawal by Subject|2
7840638|NCT01412801|12319318|FG002|Overall Study|Withdrawal by Subject|1
7840639|NCT01412801|12319319|FG003|Overall Study|Withdrawal by Subject|0
7840640|NCT01412801|12319320|FG004|Overall Study|Withdrawal by Subject|0
7840641|NCT01412801|12319321|FG005|Overall Study|Withdrawal by Subject|0
7840642|NCT01412801|12319316|FG000|Overall Study|Relocated to another area|0
7840643|NCT01412801|12319317|FG001|Overall Study|Relocated to another area|0
7840644|NCT01412801|12319318|FG002|Overall Study|Relocated to another area|2
7840645|NCT01412801|12319319|FG003|Overall Study|Relocated to another area|0
7840646|NCT01412801|12319320|FG004|Overall Study|Relocated to another area|0
7840647|NCT01412801|12319321|FG005|Overall Study|Relocated to another area|0
7840648|NCT01412879|12319355|FG000|Initial Registration (Induction Therapy)|Adverse Event|5
7840649|NCT01412879|12319356|FG001|Initial Registration (Induction Therapy)|Adverse Event|3
7840650|NCT01412879|12319357|FG002|Initial Registration (Induction Therapy)|Adverse Event|0
7840651|NCT01412879|12319355|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
7840652|NCT01412879|12319356|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
7840653|NCT01412879|12319357|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
7840654|NCT01412879|12319355|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0
7840655|NCT01412879|12319356|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1
7840656|NCT01412879|12319357|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0
7840657|NCT01412879|12319355|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
7840658|NCT01412879|12319356|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
7840659|NCT01412879|12319357|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
7840660|NCT01412879|12319355|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1
7840661|NCT01412879|12319356|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0
7840662|NCT01412879|12319357|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0
7840663|NCT01412944|12319379|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7840664|NCT01412944|12319380|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7840665|NCT01412944|12319381|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
7840666|NCT01412944|12319382|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7840667|NCT01412944|12319383|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7840668|NCT01412944|12319384|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7840669|NCT01412944|12319379|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7840670|NCT01412944|12319380|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7840671|NCT01412944|12319381|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7840672|NCT01412944|12319382|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7840673|NCT01412944|12319383|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7840674|NCT01412944|12319384|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
7840675|NCT01412944|12319379|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7840676|NCT01412944|12319380|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7840677|NCT01412944|12319381|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7840678|NCT01412944|12319382|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7840679|NCT01412944|12319383|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7840680|NCT01412944|12319384|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
7840681|NCT01412944|12319379|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1
7840682|NCT01412944|12319380|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0
7840683|NCT01412944|12319381|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0
7840684|NCT01412944|12319382|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0
7840685|NCT01412944|12319383|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0
7840686|NCT01412944|12319384|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0
7840687|NCT01412944|12319379|FG000|IV: Per CAIN457A2307|Protocol deviation|0
7840688|NCT01412944|12319380|FG001|IV: Per CAIN457A2307|Protocol deviation|1
7840689|NCT01412944|12319381|FG002|IV: Per CAIN457A2307|Protocol deviation|0
7840690|NCT01412944|12319382|FG003|IV: Per CAIN457A2307|Protocol deviation|0
7840691|NCT01412944|12319383|FG004|IV: Per CAIN457A2307|Protocol deviation|0
7840692|NCT01412944|12319384|FG005|IV: Per CAIN457A2307|Protocol deviation|0
7840693|NCT01412944|12319379|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0
7840694|NCT01412944|12319380|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1
7840695|NCT01412944|12319381|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0
7840696|NCT01412944|12319382|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0
7840697|NCT01412944|12319383|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0
7840698|NCT01412944|12319384|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0
7840699|NCT01412944|12319379|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0
7840700|NCT01412944|12319380|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0
7840701|NCT01412944|12319381|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1
7840702|NCT01412944|12319382|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1
7840703|NCT01412944|12319383|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1
7840704|NCT01412944|12319384|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0
7840705|NCT01412944|12319379|FG000|Entire: IV + Maintenance|Adverse Event|0
7840706|NCT01412944|12319380|FG001|Entire: IV + Maintenance|Adverse Event|0
7840707|NCT01412944|12319381|FG002|Entire: IV + Maintenance|Adverse Event|0
7840708|NCT01412944|12319382|FG003|Entire: IV + Maintenance|Adverse Event|0
7840709|NCT01412944|12319383|FG004|Entire: IV + Maintenance|Adverse Event|1
7840710|NCT01412944|12319384|FG005|Entire: IV + Maintenance|Adverse Event|0
7840711|NCT01412944|12319379|FG000|Entire: IV + Maintenance|Protocol deviation|0
7840712|NCT01412944|12319380|FG001|Entire: IV + Maintenance|Protocol deviation|0
7840713|NCT01412944|12319381|FG002|Entire: IV + Maintenance|Protocol deviation|0
7840714|NCT01412944|12319382|FG003|Entire: IV + Maintenance|Protocol deviation|0
7840715|NCT01412944|12319383|FG004|Entire: IV + Maintenance|Protocol deviation|0
7840716|NCT01412944|12319384|FG005|Entire: IV + Maintenance|Protocol deviation|1
7840717|NCT01412944|12319379|FG000|Entire: IV + Maintenance|Lost to Follow-up|0
7840718|NCT01412944|12319380|FG001|Entire: IV + Maintenance|Lost to Follow-up|0
7840719|NCT01412944|12319381|FG002|Entire: IV + Maintenance|Lost to Follow-up|0
7840720|NCT01412944|12319382|FG003|Entire: IV + Maintenance|Lost to Follow-up|0
7840721|NCT01412944|12319383|FG004|Entire: IV + Maintenance|Lost to Follow-up|0
7840722|NCT01412944|12319384|FG005|Entire: IV + Maintenance|Lost to Follow-up|1
7840723|NCT01412944|12319379|FG000|Entire: IV + Maintenance|Lack of Efficacy|0
7840724|NCT01412944|12319380|FG001|Entire: IV + Maintenance|Lack of Efficacy|0
7840725|NCT01412944|12319381|FG002|Entire: IV + Maintenance|Lack of Efficacy|0
7840726|NCT01412944|12319382|FG003|Entire: IV + Maintenance|Lack of Efficacy|0
7840727|NCT01412944|12319383|FG004|Entire: IV + Maintenance|Lack of Efficacy|1
7840728|NCT01412944|12319384|FG005|Entire: IV + Maintenance|Lack of Efficacy|0
7840729|NCT01412944|12319379|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2
7840730|NCT01412944|12319380|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1
7840731|NCT01412944|12319381|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0
7840732|NCT01412944|12319382|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0
7840733|NCT01412944|12319383|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0
7840734|NCT01412944|12319384|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0
7840735|NCT01412944|12319379|FG000|Entire: IV + Maintenance|Protocol deviation|0
7840736|NCT01412944|12319380|FG001|Entire: IV + Maintenance|Protocol deviation|1
7840737|NCT01412944|12319381|FG002|Entire: IV + Maintenance|Protocol deviation|0
7840738|NCT01412944|12319382|FG003|Entire: IV + Maintenance|Protocol deviation|0
7840739|NCT01412944|12319383|FG004|Entire: IV + Maintenance|Protocol deviation|0
7840740|NCT01412944|12319384|FG005|Entire: IV + Maintenance|Protocol deviation|0
7840741|NCT01412944|12319379|FG000|Entire: IV + Maintenance|Lost to Follow-up|0
7840742|NCT01412944|12319380|FG001|Entire: IV + Maintenance|Lost to Follow-up|1
7840743|NCT01412944|12319381|FG002|Entire: IV + Maintenance|Lost to Follow-up|0
7840744|NCT01412944|12319382|FG003|Entire: IV + Maintenance|Lost to Follow-up|0
7840745|NCT01412944|12319383|FG004|Entire: IV + Maintenance|Lost to Follow-up|0
7840746|NCT01412944|12319384|FG005|Entire: IV + Maintenance|Lost to Follow-up|0
7840747|NCT01412944|12319379|FG000|Entire: IV + Maintenance|Lack of Efficacy|0
7840748|NCT01412944|12319380|FG001|Entire: IV + Maintenance|Lack of Efficacy|1
7840749|NCT01412944|12319381|FG002|Entire: IV + Maintenance|Lack of Efficacy|0
7840750|NCT01412944|12319382|FG003|Entire: IV + Maintenance|Lack of Efficacy|0
7840751|NCT01412944|12319383|FG004|Entire: IV + Maintenance|Lack of Efficacy|0
7840752|NCT01412944|12319384|FG005|Entire: IV + Maintenance|Lack of Efficacy|0
7840753|NCT01412944|12319379|FG000|Entire: IV + Maintenance|Adverse Event|0
7840754|NCT01412944|12319380|FG001|Entire: IV + Maintenance|Adverse Event|1
7840755|NCT01412944|12319381|FG002|Entire: IV + Maintenance|Adverse Event|0
7840756|NCT01412944|12319382|FG003|Entire: IV + Maintenance|Adverse Event|0
7840757|NCT01412944|12319383|FG004|Entire: IV + Maintenance|Adverse Event|0
7840758|NCT01412944|12319384|FG005|Entire: IV + Maintenance|Adverse Event|0
7840759|NCT01412957|12319402|FG000|Overall Study|Withdrawal by Subject|6
7840760|NCT01412957|12319403|FG001|Overall Study|Withdrawal by Subject|22
7840761|NCT01412957|12319402|FG000|Overall Study|Lost to Follow-up|7
7840762|NCT01412957|12319403|FG001|Overall Study|Lost to Follow-up|2
7840763|NCT01412957|12319402|FG000|Overall Study|Death|136
7840764|NCT01412957|12319403|FG001|Overall Study|Death|133
7840765|NCT01412983|12319409|FG000|1st Period|Ineligible|0
7840766|NCT01412983|12319410|FG001|1st Period|Ineligible|1
7840767|NCT01412983|12319409|FG000|1st Period|Positive slit lamp finding|0
7840768|NCT01412983|12319410|FG001|1st Period|Positive slit lamp finding|1
7840769|NCT01412983|12319409|FG000|1st Period|Unacceptable lens movement|0
7840770|NCT01412983|12319410|FG001|1st Period|Unacceptable lens movement|1
7840771|NCT01412983|12319409|FG000|1st Period|Inability to maintain wear|0
7840772|NCT01412983|12319410|FG001|1st Period|Inability to maintain wear|1
7840773|NCT01413178|12319428|FG000|Overall Study|Toxicity|1
7840774|NCT01413178|12319429|FG001|Overall Study|Toxicity|0
7840775|NCT01413178|12319428|FG000|Overall Study|Ineligible|0
7840776|NCT01413178|12319429|FG001|Overall Study|Ineligible|2
7840777|NCT01413191|12319435|FG000|Overall Study|Lost to Follow-up|5
7840778|NCT01413191|12319435|FG000|Overall Study|Disease Progression|5
7840779|NCT01413191|12319435|FG000|Overall Study|Death|1
7840780|NCT01413204|12319442|FG000|Overall Study|Adverse Event|1
7840781|NCT01413204|12319443|FG001|Overall Study|Adverse Event|2
7840782|NCT01413204|12319444|FG002|Overall Study|Adverse Event|2
7840783|NCT01413204|12319442|FG000|Overall Study|Physician Decision|3
7840784|NCT01413204|12319443|FG001|Overall Study|Physician Decision|0
7840785|NCT01413204|12319444|FG002|Overall Study|Physician Decision|2
7840786|NCT01413204|12319442|FG000|Overall Study|Withdrawal by Subject|1
7840787|NCT01413204|12319443|FG001|Overall Study|Withdrawal by Subject|4
7840788|NCT01413204|12319444|FG002|Overall Study|Withdrawal by Subject|4
7840789|NCT01413204|12319442|FG000|Overall Study|Clearly not eligible for the study|0
7840790|NCT01413204|12319443|FG001|Overall Study|Clearly not eligible for the study|0
7840791|NCT01413204|12319444|FG002|Overall Study|Clearly not eligible for the study|1
7840792|NCT01413204|12319442|FG000|Overall Study|Fasting plasma glucose level increased|1
7840793|NCT01413204|12319443|FG001|Overall Study|Fasting plasma glucose level increased|0
7840794|NCT01413204|12319444|FG002|Overall Study|Fasting plasma glucose level increased|10
7840795|NCT01413360|12319452|FG000|Overall Study|Lost to Follow-up|2
7840796|NCT01413360|12319452|FG000|Overall Study|Adverse Event|1
7840797|NCT01413503|12319456|FG000|Overall Study|Lost to Follow-up|1
7840798|NCT01413542|12319471|FG000|Overall Study|Physician Decision|1
7840799|NCT01413542|12319472|FG001|Overall Study|Physician Decision|0
7840800|NCT01413542|12319473|FG002|Overall Study|Physician Decision|3
7840801|NCT01413542|12319474|FG003|Overall Study|Physician Decision|0
7840802|NCT01413542|12319471|FG000|Overall Study|Adverse Event|0
7840803|NCT01413542|12319472|FG001|Overall Study|Adverse Event|0
7840804|NCT01413542|12319473|FG002|Overall Study|Adverse Event|0
7840805|NCT01413542|12319474|FG003|Overall Study|Adverse Event|1
7840806|NCT01413958|12319506|FG000|Overall Study|Lost to Follow-up|0
7840807|NCT01413958|12319507|FG001|Overall Study|Lost to Follow-up|1
7840808|NCT01414075|12319550|FG000|Overall Study|Adverse Event|1
7840809|NCT01414075|12319551|FG001|Overall Study|Adverse Event|0
7840810|NCT01414075|12319552|FG002|Overall Study|Adverse Event|1
7840811|NCT01414075|12319553|FG003|Overall Study|Adverse Event|0
7840812|NCT01414075|12319550|FG000|Overall Study|Death|1
7840813|NCT01414075|12319551|FG001|Overall Study|Death|0
7948979|NCT02532764|12494416|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7948980|NCT02532764|12494417|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7948981|NCT02532764|12494418|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7948982|NCT02532764|12494419|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
7948983|NCT02532764|12494420|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
7948984|NCT02532764|12494421|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
7948985|NCT02532855|12494450|FG000|Overall Study|Lost to Follow-up|4
7948986|NCT02532855|12494451|FG001|Overall Study|Lost to Follow-up|3
7948987|NCT02532855|12494450|FG000|Overall Study|Withdrawal by Subject|4
7948988|NCT02532855|12494451|FG001|Overall Study|Withdrawal by Subject|8
7948989|NCT02532972|12494466|FG000|Overall Study|Withdrawal by Subject|1
7948990|NCT02533258|12494508|FG000|Overall Study|Adverse Event|1
7948991|NCT02533258|12494508|FG000|Overall Study|Death|2
7948992|NCT02533258|12494508|FG000|Overall Study|Other|1
7948993|NCT02533258|12494508|FG000|Overall Study|Economic factor|1
7948994|NCT02533258|12494508|FG000|Overall Study|Progression of pleural effusion|1
7948995|NCT02533258|12494508|FG000|Overall Study|Lack of Efficacy|2
7948996|NCT02533375|12494512|FG000|Overall Study|Lack of Efficacy|3
7948997|NCT02533375|12494512|FG000|Overall Study|Adverse Event|2
7948998|NCT02533401|12494516|FG000|Overall Study|Adverse Event/Intercurrent Disease|3
7948999|NCT02533401|12494516|FG000|Overall Study|Death|5
7949000|NCT02533401|12494516|FG000|Overall Study|Insufficient Response/Progressed Disease|1
7949001|NCT02533401|12494516|FG000|Overall Study|Lost to Follow-up|1
7949002|NCT02533401|12494516|FG000|Overall Study|Violation of Selection Criteria|1
7949003|NCT02533453|12494527|FG000|Overall Study|Adverse Event|6
7949004|NCT02533453|12494527|FG000|Overall Study|Protocol Violation|1
7949005|NCT02533453|12494527|FG000|Overall Study|Withdrawal by Subject|2
7949006|NCT02533570|12494552|FG000|Overall Study|Adverse Event|0
7949007|NCT02533570|12494553|FG001|Overall Study|Adverse Event|1
7949008|NCT02533570|12494554|FG002|Overall Study|Adverse Event|1
7840814|NCT01414075|12319552|FG002|Overall Study|Death|0
7840815|NCT01414075|12319553|FG003|Overall Study|Death|1
7949009|NCT02533674|12494570|FG000|Dose Level I|Progressive disease|1
7949010|NCT02533674|12494571|FG001|Dose Level I|Progressive disease|0
7949011|NCT02533674|12494572|FG002|Dose Level I|Progressive disease|0
7949012|NCT02533674|12494573|FG003|Dose Level I|Progressive disease|0
7949013|NCT02533674|12494574|FG004|Dose Level I|Progressive disease|0
7949014|NCT02533674|12494575|FG005|Dose Level I|Progressive disease|0
7949015|NCT02533674|12494576|FG006|Dose Level I|Progressive disease|0
7949016|NCT02533674|12494577|FG007|Dose Level I|Progressive disease|0
7949017|NCT02533674|12494570|FG000|Dose Level I|Withdrawal by Subject|1
7949018|NCT02533674|12494571|FG001|Dose Level I|Withdrawal by Subject|0
7840816|NCT01414075|12319550|FG000|Overall Study|Withdrawal by Subject|0
7840817|NCT01414075|12319551|FG001|Overall Study|Withdrawal by Subject|0
7840818|NCT01414075|12319552|FG002|Overall Study|Withdrawal by Subject|0
7840819|NCT01414075|12319553|FG003|Overall Study|Withdrawal by Subject|1
7840820|NCT01414075|12319550|FG000|Overall Study|Other than specified|1
7840821|NCT01414075|12319551|FG001|Overall Study|Other than specified|0
7840822|NCT01414075|12319552|FG002|Overall Study|Other than specified|1
7840823|NCT01414075|12319553|FG003|Overall Study|Other than specified|0
7840824|NCT01414114|12319563|FG000|Overall Study|Adverse Event|2
7840825|NCT01414114|12319563|FG000|Overall Study|Withdrawal by Subject|1
7840826|NCT01414114|12319563|FG000|Overall Study|Other|2
7840827|NCT01414205|12319588|FG000|Overall Study|Death|5
7840828|NCT01414205|12319589|FG001|Overall Study|Death|1
7840829|NCT01414205|12319588|FG000|Overall Study|Lost to Follow-up|1
7840830|NCT01414205|12319589|FG001|Overall Study|Lost to Follow-up|4
7840831|NCT01414205|12319588|FG000|Overall Study|Physician Decision|0
7840832|NCT01414205|12319589|FG001|Overall Study|Physician Decision|1
7840833|NCT01414205|12319588|FG000|Overall Study|Randomized but not Treated|1
7840834|NCT01414205|12319589|FG001|Overall Study|Randomized but not Treated|1
7840835|NCT01414257|12319604|FG000|Overall Study|No Visit After First Day of Treatment|12
7840836|NCT01414257|12319604|FG000|Overall Study|Protocol Violation|10
7840837|NCT01414738|12319644|FG000|Overall Study|Death|26
7840838|NCT01414738|12319644|FG000|Overall Study|Refused testing|5
7840839|NCT01414738|12319644|FG000|Overall Study|Lost to Follow-up|2
7840840|NCT01414738|12319644|FG000|Overall Study|Refused, disease progression|8
7840841|NCT01414738|12319644|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3
7862900|NCT01601821|12351987|FG001|Overall Study|Withdrawal by Subject|0
7862901|NCT01601821|12351986|FG000|Overall Study|Graft Loss|6
7862902|NCT01601821|12351987|FG001|Overall Study|Graft Loss|6
7862903|NCT01601821|12351986|FG000|Overall Study|Study Events|7
7862904|NCT01601821|12351987|FG001|Overall Study|Study Events|1
7862905|NCT01601821|12351986|FG000|Overall Study|Other|5
7862906|NCT01601821|12351987|FG001|Overall Study|Other|1
7862907|NCT01601847|12351995|FG000|Overall Study|Death|1
7862908|NCT01601847|12351996|FG001|Overall Study|Death|0
7862909|NCT01601847|12351995|FG000|Overall Study|Withdrawal by Subject|11
7862910|NCT01601847|12351996|FG001|Overall Study|Withdrawal by Subject|7
7862911|NCT01601847|12351995|FG000|Overall Study|Lost to Follow-up|1
7862912|NCT01601847|12351996|FG001|Overall Study|Lost to Follow-up|3
7862913|NCT01601873|12352014|FG000|Overall Study|Lost to Follow-up|2
7862914|NCT01601873|12352015|FG001|Overall Study|Lost to Follow-up|3
7862915|NCT01602120|12352040|FG000|Overall Study|Adverse Event|3
7840842|NCT01414855|12319648|FG000|Overall Study|Death|17
7840843|NCT01414855|12319648|FG000|Overall Study|Lost to Follow-up|5
7840844|NCT01414855|12319648|FG000|Overall Study|Withdrawal by Subject|7
7840845|NCT01415349|12319656|FG000|Treatment Period 1|Adverse Event|0
7840846|NCT01415349|12319657|FG001|Treatment Period 1|Adverse Event|1
7840847|NCT01415349|12319656|FG000|Treatment Period 1|Withdrawal by Subject|0
7840848|NCT01415349|12319657|FG001|Treatment Period 1|Withdrawal by Subject|1
7840849|NCT01415401|12319663|FG000|Overall Study|Adverse Event|5
7840850|NCT01415401|12319663|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1
7840851|NCT01415401|12319663|FG000|Overall Study|Terminated by Sponsor|1
7840852|NCT01415518|12319692|FG000|Overall Study|Withdrawal by Subject|2
7840853|NCT01415518|12319693|FG001|Overall Study|Withdrawal by Subject|12
7840854|NCT01415518|12319692|FG000|Overall Study|Protocol Violation|6
7840855|NCT01415518|12319693|FG001|Overall Study|Protocol Violation|8
7840856|NCT01415518|12319692|FG000|Overall Study|Lost to Follow-up|3
7840857|NCT01415518|12319693|FG001|Overall Study|Lost to Follow-up|5
7840858|NCT01415518|12319692|FG000|Overall Study|Adverse Event|3
7840859|NCT01415518|12319693|FG001|Overall Study|Adverse Event|4
7840860|NCT01415518|12319692|FG000|Overall Study|Death|1
7840861|NCT01415518|12319693|FG001|Overall Study|Death|1
7840862|NCT01415518|12319692|FG000|Overall Study|Condition under Investigation Worsened|1
7840863|NCT01415518|12319693|FG001|Overall Study|Condition under Investigation Worsened|1
7840864|NCT01415531|12319701|FG000|Overall Study|Adverse Event|7
7840865|NCT01415531|12319702|FG001|Overall Study|Adverse Event|10
7840866|NCT01415531|12319701|FG000|Overall Study|Lack of Efficacy|3
7840867|NCT01415531|12319702|FG001|Overall Study|Lack of Efficacy|2
7840868|NCT01415531|12319701|FG000|Overall Study|Protocol Violation|0
7840869|NCT01415531|12319702|FG001|Overall Study|Protocol Violation|1
7840870|NCT01415531|12319701|FG000|Overall Study|Withdrawal by Subject|5
7840871|NCT01415531|12319702|FG001|Overall Study|Withdrawal by Subject|4
7840872|NCT01415531|12319701|FG000|Overall Study|Lost to Follow-up|6
7840873|NCT01415531|12319702|FG001|Overall Study|Lost to Follow-up|14
7840874|NCT01415531|12319701|FG000|Overall Study|Lack of Compliance|1
7840875|NCT01415531|12319702|FG001|Overall Study|Lack of Compliance|4
7840876|NCT01415531|12319701|FG000|Overall Study|Other Reasons|3
7840877|NCT01415531|12319702|FG001|Overall Study|Other Reasons|2
7840878|NCT01415908|12319719|FG000|Overall Study|Withdrawal by Subject|1
7840879|NCT01415908|12319720|FG001|Overall Study|Withdrawal by Subject|0
7840880|NCT01415921|12319728|FG000|Overall Study|Adverse Event|0
7840881|NCT01415921|12319729|FG001|Overall Study|Adverse Event|1
7840882|NCT01415921|12319728|FG000|Overall Study|Physician Decision|1
7840883|NCT01415921|12319729|FG001|Overall Study|Physician Decision|1
7840884|NCT01415921|12319728|FG000|Overall Study|Withdrawal by Subject|0
7840885|NCT01415921|12319729|FG001|Overall Study|Withdrawal by Subject|1
7840886|NCT01415921|12319728|FG000|Overall Study|Other|2
7840887|NCT01415921|12319729|FG001|Overall Study|Other|0
7840888|NCT01416142|12319766|FG000|PureVision2 HD|Inability to maintain lens wear|0
7840889|NCT01416142|12319767|FG001|PureVision2 HD|Inability to maintain lens wear|0
7840890|NCT01416142|12319768|FG002|PureVision2 HD|Inability to maintain lens wear|1
7840891|NCT01416155|12319776|FG000|Overall Study|Adverse Event|8
7840892|NCT01416155|12319776|FG000|Overall Study|Positive for anti-BG00002 antibodies|2
7840893|NCT01416155|12319776|FG000|Overall Study|Withdrawal by Subject|33
7840894|NCT01416155|12319776|FG000|Overall Study|Investigator decision|8
7840895|NCT01416155|12319776|FG000|Overall Study|Other|7
7840896|NCT01416181|12319782|FG000|Part 1|Other|10
7840897|NCT01416181|12319783|FG001|Part 1|Other|24
7840898|NCT01416181|12319782|FG000|Part 1|Death|0
7840899|NCT01416181|12319783|FG001|Part 1|Death|1
7840900|NCT01416181|12319782|FG000|Part 1|Investigator Decision|7
7840901|NCT01416181|12319783|FG001|Part 1|Investigator Decision|6
7840902|NCT01416181|12319782|FG000|Part 1|Withdrawal by Subject|74
7840903|NCT01416181|12319783|FG001|Part 1|Withdrawal by Subject|48
7840904|NCT01416181|12319782|FG000|Part 1|Lack of Efficacy|16
7840905|NCT01416181|12319783|FG001|Part 1|Lack of Efficacy|8
7840906|NCT01416181|12319782|FG000|Part 1|Lost to Follow-up|1
7840907|NCT01416181|12319783|FG001|Part 1|Lost to Follow-up|1
7840908|NCT01416181|12319782|FG000|Part 1|Adverse Event|15
7840909|NCT01416181|12319783|FG001|Part 1|Adverse Event|18
7840910|NCT01416181|12319782|FG000|Part 1|Ongoing in Follow-Up|14
7840911|NCT01416181|12319783|FG001|Part 1|Ongoing in Follow-Up|8
7840912|NCT01416181|12319782|FG000|Part 2|Adverse Event|11
7840913|NCT01416181|12319783|FG001|Part 2|Adverse Event|4
7840914|NCT01416181|12319782|FG000|Part 2|Other|234
7840915|NCT01416181|12319783|FG001|Part 2|Other|267
7840916|NCT01416181|12319782|FG000|Part 2|Investigator Decision|6
7840917|NCT01416181|12319783|FG001|Part 2|Investigator Decision|7
7840918|NCT01416181|12319782|FG000|Part 2|Withdrawal by Subject|14
7840919|NCT01416181|12319783|FG001|Part 2|Withdrawal by Subject|5
7840920|NCT01416181|12319782|FG000|Part 2|Lack of Efficacy|4
7840921|NCT01416181|12319783|FG001|Part 2|Lack of Efficacy|1
7840922|NCT01416181|12319782|FG000|Part 2|Lost to Follow-up|2
7840923|NCT01416181|12319783|FG001|Part 2|Lost to Follow-up|2
7840924|NCT01416389|12319806|FG000|Overall Study|Lost to Follow-up|1
7840925|NCT01416389|12319807|FG001|Overall Study|Lost to Follow-up|0
7840926|NCT01416389|12319806|FG000|Overall Study|Started New Therapy|2
7840927|NCT01416389|12319807|FG001|Overall Study|Started New Therapy|0
7840928|NCT01416441|12319815|FG000|Overall Study|Lost to Follow-up|5
7840929|NCT01416441|12319815|FG000|Overall Study|Adverse Event|6
7840930|NCT01416441|12319815|FG000|Overall Study|Sponsor Discontinued Trial Site|43
7840931|NCT01416441|12319815|FG000|Overall Study|Subject Met Withdrawal Criteria|10
7840932|NCT01416441|12319815|FG000|Overall Study|Investigator Withdrew Subject|2
7840933|NCT01416441|12319815|FG000|Overall Study|Subject Withdrew Consent|12
7840934|NCT01416441|12319815|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3
7862916|NCT01602120|12352041|FG001|Overall Study|Adverse Event|6
7862917|NCT01602120|12352042|FG002|Overall Study|Adverse Event|0
7862918|NCT01602120|12352043|FG003|Overall Study|Adverse Event|2
7862919|NCT01602120|12352040|FG000|Overall Study|Death|0
7862920|NCT01602120|12352041|FG001|Overall Study|Death|4
7862921|NCT01602120|12352042|FG002|Overall Study|Death|0
7862922|NCT01602120|12352043|FG003|Overall Study|Death|0
7862923|NCT01602120|12352040|FG000|Overall Study|Lost to Follow-up|0
7862924|NCT01602120|12352041|FG001|Overall Study|Lost to Follow-up|1
7862925|NCT01602120|12352042|FG002|Overall Study|Lost to Follow-up|0
7862926|NCT01602120|12352043|FG003|Overall Study|Lost to Follow-up|1
7862927|NCT01602120|12352040|FG000|Overall Study|Protocol Violation|1
7862928|NCT01602120|12352041|FG001|Overall Study|Protocol Violation|1
7862929|NCT01602120|12352042|FG002|Overall Study|Protocol Violation|0
7862930|NCT01602120|12352043|FG003|Overall Study|Protocol Violation|0
7862931|NCT01602120|12352040|FG000|Overall Study|Non-compliance|0
7862932|NCT01602120|12352041|FG001|Overall Study|Non-compliance|3
7862933|NCT01602120|12352042|FG002|Overall Study|Non-compliance|0
7862934|NCT01602120|12352043|FG003|Overall Study|Non-compliance|1
7862935|NCT01602120|12352040|FG000|Overall Study|Withdrawal by Subject|8
7862936|NCT01602120|12352041|FG001|Overall Study|Withdrawal by Subject|17
7862937|NCT01602120|12352042|FG002|Overall Study|Withdrawal by Subject|0
7862938|NCT01602120|12352043|FG003|Overall Study|Withdrawal by Subject|3
7862939|NCT01602120|12352040|FG000|Overall Study|Study Terminated by Sponsor|12
7862940|NCT01602120|12352041|FG001|Overall Study|Study Terminated by Sponsor|24
7862941|NCT01602120|12352042|FG002|Overall Study|Study Terminated by Sponsor|17
7862942|NCT01602120|12352043|FG003|Overall Study|Study Terminated by Sponsor|44
7862943|NCT01602120|12352040|FG000|Overall Study|Physician Decision|2
7862944|NCT01602120|12352041|FG001|Overall Study|Physician Decision|3
7862945|NCT01602120|12352042|FG002|Overall Study|Physician Decision|0
7862946|NCT01602120|12352043|FG003|Overall Study|Physician Decision|0
7862947|NCT01602120|12352040|FG000|Overall Study|Unspecified Reason|3
7862948|NCT01602120|12352041|FG001|Overall Study|Unspecified Reason|1
7862949|NCT01602120|12352042|FG002|Overall Study|Unspecified Reason|0
7862950|NCT01602120|12352043|FG003|Overall Study|Unspecified Reason|2
7862951|NCT01602224|12352077|FG000|Overall Study|Adverse Event|0
7862952|NCT01602224|12352078|FG001|Overall Study|Adverse Event|1
7862953|NCT01602224|12352079|FG002|Overall Study|Adverse Event|0
7862954|NCT01602224|12352077|FG000|Overall Study|Investigator Decison|1
7862955|NCT01602224|12352078|FG001|Overall Study|Investigator Decison|0
7862956|NCT01602224|12352079|FG002|Overall Study|Investigator Decison|0
7862957|NCT01602224|12352077|FG000|Overall Study|Lost to Follow-up|0
7862958|NCT01602224|12352078|FG001|Overall Study|Lost to Follow-up|0
7862959|NCT01602224|12352079|FG002|Overall Study|Lost to Follow-up|1
7862960|NCT01602224|12352077|FG000|Overall Study|Protocol Violation|0
7862961|NCT01602224|12352078|FG001|Overall Study|Protocol Violation|1
7862962|NCT01602224|12352079|FG002|Overall Study|Protocol Violation|0
7862963|NCT01602224|12352077|FG000|Overall Study|Sponsor Decision|2
7862964|NCT01602224|12352078|FG001|Overall Study|Sponsor Decision|3
7862965|NCT01602224|12352079|FG002|Overall Study|Sponsor Decision|2
7862966|NCT01602224|12352077|FG000|Overall Study|Withdrawal by Subject|5
7862967|NCT01602224|12352078|FG001|Overall Study|Withdrawal by Subject|3
7862968|NCT01602224|12352079|FG002|Overall Study|Withdrawal by Subject|3
7862969|NCT01602315|12352096|FG000|Overall Study|Protocol Violation|0
7862970|NCT01602315|12352097|FG001|Overall Study|Protocol Violation|0
7862971|NCT01602315|12352098|FG002|Overall Study|Protocol Violation|0
7862972|NCT01602315|12352099|FG003|Overall Study|Protocol Violation|0
7862973|NCT01602315|12352100|FG004|Overall Study|Protocol Violation|0
7862974|NCT01602315|12352101|FG005|Overall Study|Protocol Violation|1
7862975|NCT01602315|12352102|FG006|Overall Study|Protocol Violation|0
7862976|NCT01602315|12352096|FG000|Overall Study|Physician Decision|2
7862977|NCT01602315|12352097|FG001|Overall Study|Physician Decision|0
7862978|NCT01602315|12352098|FG002|Overall Study|Physician Decision|0
7862979|NCT01602315|12352099|FG003|Overall Study|Physician Decision|0
7862980|NCT01602315|12352100|FG004|Overall Study|Physician Decision|2
7862981|NCT01602315|12352101|FG005|Overall Study|Physician Decision|1
7862982|NCT01602315|12352102|FG006|Overall Study|Physician Decision|1
7862983|NCT01602315|12352096|FG000|Overall Study|Disease progression|6
7862984|NCT01602315|12352097|FG001|Overall Study|Disease progression|3
7862985|NCT01602315|12352098|FG002|Overall Study|Disease progression|10
7862986|NCT01602315|12352099|FG003|Overall Study|Disease progression|1
7862987|NCT01602315|12352100|FG004|Overall Study|Disease progression|41
7862988|NCT01602315|12352101|FG005|Overall Study|Disease progression|12
7862989|NCT01602315|12352102|FG006|Overall Study|Disease progression|15
7862990|NCT01602315|12352096|FG000|Overall Study|Death|1
7862991|NCT01602315|12352097|FG001|Overall Study|Death|1
7862992|NCT01602315|12352098|FG002|Overall Study|Death|1
7862993|NCT01602315|12352099|FG003|Overall Study|Death|1
7862994|NCT01602315|12352100|FG004|Overall Study|Death|7
7840935|NCT01416571|12319819|FG000|Overall Study|Lost to Follow-up|2
7840936|NCT01416610|12319842|FG000|Overall Study|Adverse Event|4
7840937|NCT01416610|12319842|FG000|Overall Study|Adverse Event -Patient decision|3
7840938|NCT01416610|12319842|FG000|Overall Study|Lack of Efficacy|4
7840939|NCT01416610|12319842|FG000|Overall Study|No reason given|5
7840940|NCT01416610|12319842|FG000|Overall Study|Withdrawal by Subject|13
7840941|NCT01416610|12319842|FG000|Overall Study|Lost to Follow-up|7
7840942|NCT01416610|12319842|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7
7840943|NCT01416805|12319852|FG000|Overall Study|Lost to Follow-up|4
7840944|NCT01416805|12319853|FG001|Overall Study|Lost to Follow-up|4
7840945|NCT01417000|12319865|FG000|Overall Study|Death|59
7840946|NCT01417000|12319866|FG001|Overall Study|Death|28
7840947|NCT01417000|12319865|FG000|Overall Study|Lost to Follow-up|1
7840948|NCT01417000|12319866|FG001|Overall Study|Lost to Follow-up|0
7840949|NCT01417000|12319865|FG000|Overall Study|Study Terminated by Sponsor|1
7840950|NCT01417000|12319866|FG001|Overall Study|Study Terminated by Sponsor|1
7840951|NCT01417078|12319881|FG000|Overall Study|Withdrawal by Subject|1
7840952|NCT01417104|12319889|FG000|Overall Study|Withdrawal by Subject|5
7840953|NCT01417104|12319890|FG001|Overall Study|Withdrawal by Subject|1
7840954|NCT01417104|12319889|FG000|Overall Study|Failure to make contact|0
7840955|NCT01417104|12319890|FG001|Overall Study|Failure to make contact|1
7840956|NCT01417104|12319889|FG000|Overall Study|Adverse Event|1
7840957|NCT01417104|12319890|FG001|Overall Study|Adverse Event|0
7840958|NCT01417156|12319896|FG000|Overall Study|Adverse Event|12
7840959|NCT01417156|12319896|FG000|Overall Study|Protocol Violation|2
7840960|NCT01417195|12319902|FG000|Overall Study|Stimulation failure|1
7840961|NCT01417195|12319903|FG001|Overall Study|Stimulation failure|0
7840962|NCT01417195|12319902|FG000|Overall Study|No embryos for transfer|0
7840963|NCT01417195|12319903|FG001|Overall Study|No embryos for transfer|1
7840964|NCT01417195|12319902|FG000|Overall Study|No transfer due to risk of OHSS|1
7840965|NCT01417195|12319903|FG001|Overall Study|No transfer due to risk of OHSS|0
7840966|NCT01417195|12319902|FG000|Overall Study|No transfer due to elevated progesterone|1
7840967|NCT01417195|12319903|FG001|Overall Study|No transfer due to elevated progesterone|0
7840968|NCT01417481|12319945|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0
7840969|NCT01417481|12319946|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2
7840970|NCT01418209|12319986|FG000|Overall Study|Withdrawal by Subject|1
7840971|NCT01418209|12319987|FG001|Overall Study|Withdrawal by Subject|0
7840972|NCT01418209|12319988|FG002|Overall Study|Withdrawal by Subject|1
7840973|NCT01418209|12319986|FG000|Overall Study|Did not provide hot flash diary data|1
7840974|NCT01418209|12319987|FG001|Overall Study|Did not provide hot flash diary data|3
7840975|NCT01418209|12319988|FG002|Overall Study|Did not provide hot flash diary data|3
7840976|NCT01418339|12319998|FG000|Overall Study|Adverse Event|5
7840977|NCT01418339|12319999|FG001|Overall Study|Adverse Event|2
7840978|NCT01418339|12319998|FG000|Overall Study|Subject Withdrew Consent|1
7840979|NCT01418339|12319999|FG001|Overall Study|Subject Withdrew Consent|2
7840980|NCT01418339|12319998|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6
7840981|NCT01418339|12319999|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6
7840982|NCT01418352|12320009|FG000|Overall Study|Lost to Follow-up|2
7840983|NCT01418352|12320010|FG001|Overall Study|Lost to Follow-up|0
7840984|NCT01418352|12320011|FG002|Overall Study|Lost to Follow-up|0
7840985|NCT01418352|12320012|FG003|Overall Study|Lost to Follow-up|0
7840986|NCT01418352|12320009|FG000|Overall Study|Adverse Event|0
7840987|NCT01418352|12320010|FG001|Overall Study|Adverse Event|1
7840988|NCT01418352|12320011|FG002|Overall Study|Adverse Event|0
7840989|NCT01418352|12320012|FG003|Overall Study|Adverse Event|0
7840990|NCT01418352|12320009|FG000|Overall Study|Sponsor Discontinued Trial Site|0
7840991|NCT01418352|12320010|FG001|Overall Study|Sponsor Discontinued Trial Site|2
7840992|NCT01418352|12320011|FG002|Overall Study|Sponsor Discontinued Trial Site|2
7840993|NCT01418352|12320012|FG003|Overall Study|Sponsor Discontinued Trial Site|2
7840994|NCT01418352|12320009|FG000|Overall Study|Subject Withdrew Consent|0
7840995|NCT01418352|12320010|FG001|Overall Study|Subject Withdrew Consent|1
7840996|NCT01418352|12320011|FG002|Overall Study|Subject Withdrew Consent|2
7840997|NCT01418352|12320012|FG003|Overall Study|Subject Withdrew Consent|1
7840998|NCT01418352|12320009|FG000|Overall Study|Protocol Deviation|0
7840999|NCT01418352|12320010|FG001|Overall Study|Protocol Deviation|0
7841000|NCT01418352|12320011|FG002|Overall Study|Protocol Deviation|1
7841001|NCT01418352|12320012|FG003|Overall Study|Protocol Deviation|0
7841002|NCT01418352|12320009|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1
7841003|NCT01418352|12320010|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0
7841004|NCT01418352|12320011|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0
7841005|NCT01418352|12320012|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0
7841006|NCT01418365|12320024|FG000|First Intervention|Withdrawal by Subject|0
7841007|NCT01418365|12320025|FG001|First Intervention|Withdrawal by Subject|1
7841008|NCT01418365|12320024|FG000|First Intervention|Non-compliance|1
7841009|NCT01418365|12320025|FG001|First Intervention|Non-compliance|0
7841010|NCT01418365|12320024|FG000|Second Intervention|Withdrawal by Subject|0
7841011|NCT01418365|12320025|FG001|Second Intervention|Withdrawal by Subject|1
7841012|NCT01418378|12320033|FG000|Overall Study|Death|1
7841013|NCT01418378|12320034|FG001|Overall Study|Death|2
7841014|NCT01418378|12320033|FG000|Overall Study|Physician Decision|0
7841015|NCT01418378|12320034|FG001|Overall Study|Physician Decision|1
7841016|NCT01418378|12320033|FG000|Overall Study|ligament imbalance|0
7841017|NCT01418378|12320034|FG001|Overall Study|ligament imbalance|1
7841018|NCT01418378|12320033|FG000|Overall Study|developed chronic myopathy|0
7841019|NCT01418378|12320034|FG001|Overall Study|developed chronic myopathy|1
7841020|NCT01418937|12320056|FG000|Overall Study|Lost to Follow-up|5
7841021|NCT01418937|12320056|FG000|Overall Study|Protocol Violation|1
7841022|NCT01418937|12320056|FG000|Overall Study|Pregnancy|1
7841023|NCT01418937|12320056|FG000|Overall Study|Withdrawal by Subject|1
7841024|NCT01419015|12320060|FG000|Overall Study|Death|2
7841025|NCT01419184|12320074|FG000|Overall Study|Site data not available|3
7841026|NCT01419184|12320075|FG001|Overall Study|Site data not available|2
7841027|NCT01419184|12320074|FG000|Overall Study|No IRLOS-No in-patient end date reported|3
7841028|NCT01419184|12320075|FG001|Overall Study|No IRLOS-No in-patient end date reported|6
7841029|NCT01419184|12320074|FG000|Overall Study|No IRLOS-randomized, not treated|2
7841030|NCT01419184|12320075|FG001|Overall Study|No IRLOS-randomized, not treated|4
7841031|NCT01419184|12320074|FG000|Overall Study|No IRLOS-non trial antibiotic used|1
7841032|NCT01419184|12320075|FG001|Overall Study|No IRLOS-non trial antibiotic used|2
7841033|NCT01419184|12320074|FG000|Overall Study|No IRLOS-No adverse event treatment date|0
7841034|NCT01419184|12320075|FG001|Overall Study|No IRLOS-No adverse event treatment date|1
7841035|NCT01419184|12320074|FG000|Overall Study|Participant randomized, not treated|1
7841036|NCT01419184|12320075|FG001|Overall Study|Participant randomized, not treated|0
7841037|NCT01419197|12320083|FG000|Overall Study|Death|247
7841038|NCT01419197|12320084|FG001|Overall Study|Death|122
7841039|NCT01419197|12320083|FG000|Overall Study|Physician Decision|4
7841040|NCT01419197|12320084|FG001|Overall Study|Physician Decision|4
7841041|NCT01419197|12320083|FG000|Overall Study|Non-compliance|3
7841042|NCT01419197|12320084|FG001|Overall Study|Non-compliance|1
7841043|NCT01419197|12320083|FG000|Overall Study|Withdrawal by Subject|33
7841044|NCT01419197|12320084|FG001|Overall Study|Withdrawal by Subject|32
7841045|NCT01419197|12320083|FG000|Overall Study|Study Completed by Sponsor|103
7841046|NCT01419197|12320084|FG001|Overall Study|Study Completed by Sponsor|34
7841047|NCT01419197|12320083|FG000|Overall Study|Reason Not Specified|0
7841048|NCT01419197|12320084|FG001|Overall Study|Reason Not Specified|1
7841049|NCT01419197|12320083|FG000|Overall Study|Lost to Follow-up|14
7841050|NCT01419197|12320084|FG001|Overall Study|Lost to Follow-up|4
7841051|NCT01419236|12320093|FG000|Overall Study|Adverse Event|1
7841052|NCT01419236|12320094|FG001|Overall Study|Adverse Event|0
7841053|NCT01419236|12320093|FG000|Overall Study|Lack of Efficacy|0
7841054|NCT01419236|12320094|FG001|Overall Study|Lack of Efficacy|1
7841055|NCT01419236|12320093|FG000|Overall Study|Lost to Follow-up|1
7841056|NCT01419236|12320094|FG001|Overall Study|Lost to Follow-up|0
7841057|NCT01419236|12320093|FG000|Overall Study|Physician Decision|1
7841058|NCT01419236|12320094|FG001|Overall Study|Physician Decision|0
7841059|NCT01419236|12320093|FG000|Overall Study|Withdrawal by Subject|1
7841060|NCT01419236|12320094|FG001|Overall Study|Withdrawal by Subject|4
7841061|NCT01419236|12320093|FG000|Overall Study|Entry Criteria Not Met|1
7841062|NCT01419236|12320094|FG001|Overall Study|Entry Criteria Not Met|0
7841063|NCT01419314|12320116|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
7841064|NCT01419314|12320117|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
7841065|NCT01419314|12320116|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
7841066|NCT01419314|12320117|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
7841067|NCT01419314|12320116|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
7841068|NCT01419314|12320117|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
7841069|NCT01419535|12320129|FG000|Overall Study|could not maintain iv line|1
7841070|NCT01419535|12320130|FG001|Overall Study|could not maintain iv line|1
7841071|NCT01419535|12320129|FG000|Overall Study|Withdrawal by Subject|0
7841072|NCT01419535|12320130|FG001|Overall Study|Withdrawal by Subject|1
7841073|NCT01419626|12320139|FG000|Overall Study|Protocol Violation|3
7841074|NCT01419626|12320140|FG001|Overall Study|Protocol Violation|2
7841075|NCT01419626|12320141|FG002|Overall Study|Protocol Violation|2
7841076|NCT01419626|12320139|FG000|Overall Study|Withdrawal by Subject|1
7841077|NCT01419626|12320140|FG001|Overall Study|Withdrawal by Subject|0
7841078|NCT01419626|12320141|FG002|Overall Study|Withdrawal by Subject|0
7841079|NCT01419626|12320139|FG000|Overall Study|Lost to Follow-up|0
7841080|NCT01419626|12320140|FG001|Overall Study|Lost to Follow-up|1
7841081|NCT01419626|12320141|FG002|Overall Study|Lost to Follow-up|1
7841082|NCT01419665|12320155|FG000|Combination Treatment|Adverse Event|7
7841083|NCT01419665|12320156|FG001|Combination Treatment|Adverse Event|10
7841084|NCT01419665|12320155|FG000|Combination Treatment|Physician Decision|5
7841085|NCT01419665|12320156|FG001|Combination Treatment|Physician Decision|8
7841086|NCT01419665|12320155|FG000|Combination Treatment|Protocol Violation|6
7841087|NCT01419665|12320156|FG001|Combination Treatment|Protocol Violation|2
7841088|NCT01419665|12320155|FG000|Combination Treatment|disease progression|10
7841089|NCT01419665|12320156|FG001|Combination Treatment|disease progression|9
7841090|NCT01419665|12320155|FG000|Combination Treatment|Death|5
7841091|NCT01419665|12320156|FG001|Combination Treatment|Death|7
7841092|NCT01419665|12320155|FG000|Combination Treatment|administrative problems|0
7841093|NCT01419665|12320156|FG001|Combination Treatment|administrative problems|1
7841094|NCT01419665|12320155|FG000|Combination Treatment|Withdrawal by Subject|5
7841095|NCT01419665|12320156|FG001|Combination Treatment|Withdrawal by Subject|4
7841096|NCT01419665|12320155|FG000|Maintenance Treatment and/or Follow up|switch to open label|44
7841097|NCT01419665|12320156|FG001|Maintenance Treatment and/or Follow up|switch to open label|39
7841098|NCT01419665|12320155|FG000|Maintenance Treatment and/or Follow up|administrative problems|0
7841099|NCT01419665|12320156|FG001|Maintenance Treatment and/or Follow up|administrative problems|6
7841100|NCT01419665|12320155|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6
7841101|NCT01419665|12320156|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6
7841102|NCT01419665|12320155|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1
7841103|NCT01419665|12320156|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1
7841104|NCT01419665|12320155|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5
7841105|NCT01419665|12320156|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2
7841106|NCT01419665|12320155|FG000|Maintenance Treatment and/or Follow up|disease progression|53
7841107|NCT01419665|12320156|FG001|Maintenance Treatment and/or Follow up|disease progression|37
7841108|NCT01419665|12320155|FG000|Maintenance Treatment and/or Follow up|Death|1
7841109|NCT01419665|12320156|FG001|Maintenance Treatment and/or Follow up|Death|2
7841110|NCT01419665|12320155|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11
7841111|NCT01419665|12320156|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7
7841112|NCT01419665|12320155|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1
7841113|NCT01419665|12320156|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2
7841114|NCT01419665|12320155|FG000|Open Label Phase|Death|1
7841115|NCT01419665|12320156|FG001|Open Label Phase|Death|0
7841116|NCT01419665|12320155|FG000|Open Label Phase|disease progression|0
7841117|NCT01419665|12320156|FG001|Open Label Phase|disease progression|1
7841118|NCT01419717|12320164|FG000|Overall Study|Protocol-specified Criteria|62
7841119|NCT01419717|12320164|FG000|Overall Study|Adverse Event|19
7841120|NCT01419717|12320164|FG000|Overall Study|Death|17
7841121|NCT01419717|12320164|FG000|Overall Study|Withdrawal by Subject|10
7841122|NCT01419717|12320164|FG000|Overall Study|Disease Progression|9
7841123|NCT01419717|12320164|FG000|Overall Study|Other|4
7841124|NCT01419717|12320164|FG000|Overall Study|Lost to Follow-up|2
7841125|NCT01419717|12320164|FG000|Overall Study|Administrative Decision|1
7841126|NCT01419717|12320164|FG000|Overall Study|Noncompliance|1
7841127|NCT01419769|12320168|FG000|Overall Study|Did not receive the AXIOS stent|3
7841128|NCT01419769|12320168|FG000|Overall Study|Not evaluable due to pigtail stents|1
7841129|NCT01420068|12320203|FG000|Overall Study|Administrative problems|1
7841130|NCT01420068|12320204|FG001|Overall Study|Administrative problems|3
7841131|NCT01420068|12320203|FG000|Overall Study|Withdrawal by Subject|1
7841132|NCT01420068|12320204|FG001|Overall Study|Withdrawal by Subject|2
7841133|NCT01420081|12320219|FG000|Overall Study|Death|1
7841134|NCT01420081|12320220|FG001|Overall Study|Death|0
7841135|NCT01420081|12320221|FG002|Overall Study|Death|8
7841136|NCT01420081|12320222|FG003|Overall Study|Death|0
7841137|NCT01420081|12320223|FG004|Overall Study|Death|7
7841138|NCT01420081|12320224|FG005|Overall Study|Death|12
7841139|NCT01420081|12320225|FG006|Overall Study|Death|0
7841140|NCT01420081|12320226|FG007|Overall Study|Death|1
7841141|NCT01420081|12320227|FG008|Overall Study|Death|1
7841142|NCT01420081|12320219|FG000|Overall Study|Lost to Follow-up|0
7841143|NCT01420081|12320220|FG001|Overall Study|Lost to Follow-up|0
7841144|NCT01420081|12320221|FG002|Overall Study|Lost to Follow-up|0
7841145|NCT01420081|12320222|FG003|Overall Study|Lost to Follow-up|0
7841146|NCT01420081|12320223|FG004|Overall Study|Lost to Follow-up|1
7841147|NCT01420081|12320224|FG005|Overall Study|Lost to Follow-up|1
7841148|NCT01420081|12320225|FG006|Overall Study|Lost to Follow-up|0
7841149|NCT01420081|12320226|FG007|Overall Study|Lost to Follow-up|0
7841150|NCT01420081|12320227|FG008|Overall Study|Lost to Follow-up|0
7841151|NCT01420081|12320219|FG000|Overall Study|Study Terminated by Sponsor|2
7841152|NCT01420081|12320220|FG001|Overall Study|Study Terminated by Sponsor|1
7841153|NCT01420081|12320221|FG002|Overall Study|Study Terminated by Sponsor|1
7841154|NCT01420081|12320222|FG003|Overall Study|Study Terminated by Sponsor|3
7841155|NCT01420081|12320223|FG004|Overall Study|Study Terminated by Sponsor|11
7841156|NCT01420081|12320224|FG005|Overall Study|Study Terminated by Sponsor|7
7841157|NCT01420081|12320225|FG006|Overall Study|Study Terminated by Sponsor|3
7841158|NCT01420081|12320226|FG007|Overall Study|Study Terminated by Sponsor|2
7841159|NCT01420081|12320227|FG008|Overall Study|Study Terminated by Sponsor|2
7841160|NCT01420081|12320219|FG000|Overall Study|Subject Refused Futher Follow-up|0
7841161|NCT01420081|12320220|FG001|Overall Study|Subject Refused Futher Follow-up|0
7841162|NCT01420081|12320221|FG002|Overall Study|Subject Refused Futher Follow-up|1
7841163|NCT01420081|12320222|FG003|Overall Study|Subject Refused Futher Follow-up|0
7841164|NCT01420081|12320223|FG004|Overall Study|Subject Refused Futher Follow-up|1
7841165|NCT01420081|12320224|FG005|Overall Study|Subject Refused Futher Follow-up|0
7841166|NCT01420081|12320225|FG006|Overall Study|Subject Refused Futher Follow-up|0
7841167|NCT01420081|12320226|FG007|Overall Study|Subject Refused Futher Follow-up|0
7841168|NCT01420081|12320227|FG008|Overall Study|Subject Refused Futher Follow-up|0
7841169|NCT01420081|12320219|FG000|Overall Study|Other Reasons|0
7841170|NCT01420081|12320220|FG001|Overall Study|Other Reasons|0
7841171|NCT01420081|12320221|FG002|Overall Study|Other Reasons|1
7841172|NCT01420081|12320222|FG003|Overall Study|Other Reasons|0
7841173|NCT01420081|12320223|FG004|Overall Study|Other Reasons|0
7841174|NCT01420081|12320224|FG005|Overall Study|Other Reasons|0
7841175|NCT01420081|12320225|FG006|Overall Study|Other Reasons|0
7841176|NCT01420081|12320226|FG007|Overall Study|Other Reasons|0
7841177|NCT01420081|12320227|FG008|Overall Study|Other Reasons|0
7841178|NCT01420536|12320258|FG000|Period 1 (30 Days)|Withdrawal by Subject|3
7841179|NCT01420536|12320259|FG001|Period 1 (30 Days)|Withdrawal by Subject|0
7841180|NCT01420549|12320269|FG000|Overall Study|Adverse Event|1
7841181|NCT01420549|12320270|FG001|Overall Study|Adverse Event|1
7841182|NCT01420549|12320269|FG000|Overall Study|Lost to Follow-up|2
7841183|NCT01420549|12320270|FG001|Overall Study|Lost to Follow-up|2
7841184|NCT01420549|12320269|FG000|Overall Study|Protocol Violation|0
7841185|NCT01420549|12320270|FG001|Overall Study|Protocol Violation|1
7841186|NCT01420549|12320269|FG000|Overall Study|Non-adherence to medication|4
7841187|NCT01420549|12320270|FG001|Overall Study|Non-adherence to medication|1
7841188|NCT01420627|12320276|FG000|EZN-2279 Treatment Period|Adverse Event|1
7841189|NCT01420679|12320303|FG000|Overall Study|Disease Progression|3
7841190|NCT01420679|12320304|FG001|Overall Study|Disease Progression|2
7841191|NCT01420679|12320303|FG000|Overall Study|Adverse Event|4
7841192|NCT01420679|12320304|FG001|Overall Study|Adverse Event|0
7841193|NCT01420679|12320303|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1
7841194|NCT01420679|12320304|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0
7841195|NCT01420679|12320303|FG000|Overall Study|Patient Decision|1
7841196|NCT01420679|12320304|FG001|Overall Study|Patient Decision|0
7841197|NCT01420679|12320303|FG000|Overall Study|Investigator Decision|1
7841198|NCT01420679|12320304|FG001|Overall Study|Investigator Decision|2
7841199|NCT01420679|12320303|FG000|Overall Study|Sponsor Decision|3
7841200|NCT01420679|12320304|FG001|Overall Study|Sponsor Decision|3
7841201|NCT01420679|12320303|FG000|Overall Study|Other|1
7841202|NCT01420679|12320304|FG001|Overall Study|Other|0
7841203|NCT01421017|12320326|FG000|Overall Study|Withdrawal by Subject|2
7841204|NCT01421017|12320327|FG001|Overall Study|Withdrawal by Subject|0
7841205|NCT01421017|12320328|FG002|Overall Study|Withdrawal by Subject|0
7841206|NCT01421017|12320326|FG000|Overall Study|POD|0
7841207|NCT01421017|12320327|FG001|Overall Study|POD|6
7841208|NCT01421017|12320328|FG002|Overall Study|POD|3
7841209|NCT01421134|12320338|FG000|Overall Study|Adverse Event|3
7841210|NCT01421134|12320339|FG001|Overall Study|Adverse Event|5
7841211|NCT01421134|12320338|FG000|Overall Study|Lack of Efficacy|2
7841212|NCT01421134|12320339|FG001|Overall Study|Lack of Efficacy|4
7841213|NCT01421134|12320338|FG000|Overall Study|Protocol Violation|0
7841214|NCT01421134|12320339|FG001|Overall Study|Protocol Violation|3
7841215|NCT01421134|12320338|FG000|Overall Study|Withdrawal by Subject|1
7841216|NCT01421134|12320339|FG001|Overall Study|Withdrawal by Subject|1
7841217|NCT01421134|12320338|FG000|Overall Study|Administrative|0
7841218|NCT01421134|12320339|FG001|Overall Study|Administrative|1
7841219|NCT01421134|12320338|FG000|Overall Study|Lost to Follow-up|1
7841220|NCT01421134|12320339|FG001|Overall Study|Lost to Follow-up|1
7841221|NCT01421147|12320347|FG000|Treatment Period|Adverse Event|2
7841222|NCT01421147|12320348|FG001|Treatment Period|Adverse Event|3
7841223|NCT01421147|12320347|FG000|Treatment Period|Lost to Follow-up|2
7841224|NCT01421147|12320348|FG001|Treatment Period|Lost to Follow-up|1
7841225|NCT01421147|12320347|FG000|Treatment Period|Physician Decision|2
7841226|NCT01421147|12320348|FG001|Treatment Period|Physician Decision|2
7841227|NCT01421147|12320347|FG000|Treatment Period|Withdrawal by Subject|10
7841228|NCT01421147|12320348|FG001|Treatment Period|Withdrawal by Subject|5
7841229|NCT01421147|12320347|FG000|Extension Period|Adverse Event|0
7841230|NCT01421147|12320348|FG001|Extension Period|Adverse Event|2
7841231|NCT01421147|12320347|FG000|Extension Period|Death|0
7841232|NCT01421147|12320348|FG001|Extension Period|Death|1
7841233|NCT01421147|12320347|FG000|Extension Period|Lost to Follow-up|2
7841234|NCT01421147|12320348|FG001|Extension Period|Lost to Follow-up|5
7841235|NCT01421147|12320347|FG000|Extension Period|Physician Decision|1
7841236|NCT01421147|12320348|FG001|Extension Period|Physician Decision|0
7841237|NCT01421147|12320347|FG000|Extension Period|Withdrawal by Subject|5
7841238|NCT01421147|12320348|FG001|Extension Period|Withdrawal by Subject|3
7841239|NCT01421225|12320383|FG000|Overall Study|Withdrawal by Subject|0
7841240|NCT01421225|12320384|FG001|Overall Study|Withdrawal by Subject|1
7841241|NCT01421277|12320393|FG000|Overall Study|Lack of qualifying event|0
7841242|NCT01421277|12320394|FG001|Overall Study|Lack of qualifying event|61
7841243|NCT01421277|12320393|FG000|Overall Study|Incomplete baseline data|0
7841244|NCT01421277|12320394|FG001|Overall Study|Incomplete baseline data|31
7841245|NCT01421303|12320400|FG000|Overall Study|Lost to Follow-up|13
7841246|NCT01421303|12320400|FG000|Overall Study|Non compliance with study procedure|1
7841247|NCT01421303|12320400|FG000|Overall Study|Other|7
7841248|NCT01421303|12320400|FG000|Overall Study|Withdrawal by Subject|1
7841249|NCT01421342|12320407|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
7841250|NCT01421342|12320408|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
7841251|NCT01421342|12320409|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
7841252|NCT01421342|12320407|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53
7841253|NCT01421342|12320408|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38
7841254|NCT01421342|12320409|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27
7841255|NCT01421342|12320407|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
7841256|NCT01421342|12320408|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
7841257|NCT01421342|12320409|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
7841258|NCT01421342|12320407|FG000|Acute Treatment Phase (12 Weeks)|Death|0
7841259|NCT01421342|12320408|FG001|Acute Treatment Phase (12 Weeks)|Death|0
7841260|NCT01421342|12320409|FG002|Acute Treatment Phase (12 Weeks)|Death|3
7841261|NCT01421342|12320407|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
7841262|NCT01421342|12320408|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
7841263|NCT01421342|12320409|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
7841264|NCT01421342|12320407|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15
7841265|NCT01421342|12320408|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7
7841266|NCT01421342|12320409|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13
7841267|NCT01421342|12320407|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
7841268|NCT01421342|12320408|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
7841269|NCT01421342|12320409|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
7841270|NCT01421342|12320407|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1
7841271|NCT01421342|12320408|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6
7841272|NCT01421342|12320409|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1
7841273|NCT01421342|12320407|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
7841274|NCT01421342|12320408|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
7841275|NCT01421342|12320409|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
7841276|NCT01421342|12320407|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
7841277|NCT01421342|12320408|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
7841278|NCT01421342|12320409|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
7841279|NCT01421342|12320407|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
7841280|NCT01421342|12320408|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
7841281|NCT01421342|12320409|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
7841282|NCT01421342|12320407|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4
7841283|NCT01421342|12320408|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3
7841284|NCT01421342|12320409|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6
7841285|NCT01421342|12320407|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
7841286|NCT01421342|12320408|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
7841287|NCT01421342|12320409|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
7841288|NCT01421342|12320407|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
7841289|NCT01421342|12320408|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
7841290|NCT01421342|12320409|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
7841291|NCT01421342|12320407|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5
7841292|NCT01421342|12320408|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4
7841293|NCT01421342|12320409|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5
7841294|NCT01421342|12320407|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
7841295|NCT01421342|12320408|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
7841296|NCT01421342|12320409|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
7841297|NCT01421342|12320407|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
7841298|NCT01421342|12320408|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
7841299|NCT01421342|12320409|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
7841300|NCT01421342|12320407|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
7841301|NCT01421342|12320408|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
7841302|NCT01421342|12320409|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
7841303|NCT01421342|12320407|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0
7841304|NCT01421342|12320408|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0
7841305|NCT01421342|12320409|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2
7841306|NCT01421342|12320407|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
7841307|NCT01421342|12320408|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
7841308|NCT01421342|12320409|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
7841309|NCT01421342|12320407|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
7841310|NCT01421342|12320408|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
7841311|NCT01421342|12320409|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
7841312|NCT01421342|12320407|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
7841313|NCT01421342|12320408|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
7841314|NCT01421342|12320409|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
7841315|NCT01421342|12320407|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
7841316|NCT01421342|12320408|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
7841317|NCT01421342|12320409|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
7841318|NCT01421342|12320407|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
7841319|NCT01421342|12320408|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
7841320|NCT01421342|12320409|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
7841321|NCT01421342|12320407|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
7841322|NCT01421342|12320408|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
7841323|NCT01421342|12320409|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
7841324|NCT01421342|12320407|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
7841325|NCT01421342|12320408|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
7841326|NCT01421342|12320409|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
7841327|NCT01421342|12320407|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
7841328|NCT01421342|12320408|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
7841329|NCT01421342|12320409|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
7841330|NCT01421342|12320407|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
7841331|NCT01421342|12320408|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
7841332|NCT01421342|12320409|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
7841333|NCT01421459|12320423|FG000|Overall Study|Adverse Event|6
7841334|NCT01421459|12320424|FG001|Overall Study|Adverse Event|10
7841335|NCT01421459|12320423|FG000|Overall Study|Death|1
7841336|NCT01421459|12320424|FG001|Overall Study|Death|1
7841337|NCT01421459|12320423|FG000|Overall Study|Lack of Efficacy|1
7841338|NCT01421459|12320424|FG001|Overall Study|Lack of Efficacy|2
7841339|NCT01421459|12320423|FG000|Overall Study|Lost to Follow-up|8
7841340|NCT01421459|12320424|FG001|Overall Study|Lost to Follow-up|9
7841341|NCT01421459|12320423|FG000|Overall Study|Physician Decision|9
7841342|NCT01421459|12320424|FG001|Overall Study|Physician Decision|9
7841343|NCT01421459|12320423|FG000|Overall Study|Protocol Violation|8
7841344|NCT01421459|12320424|FG001|Overall Study|Protocol Violation|5
7841345|NCT01421459|12320423|FG000|Overall Study|Withdrawal by Subject|12
7841346|NCT01421459|12320424|FG001|Overall Study|Withdrawal by Subject|16
7841347|NCT01421511|12320458|FG000|Overall Study|Lost to Follow-up|11
7841348|NCT01421511|12320459|FG001|Overall Study|Lost to Follow-up|14
7841349|NCT01421511|12320458|FG000|Overall Study|Randomized but didn't receive study drug|1
7841350|NCT01421511|12320459|FG001|Overall Study|Randomized but didn't receive study drug|7
7841351|NCT01421511|12320458|FG000|Overall Study|Physician Decision|0
7841352|NCT01421511|12320459|FG001|Overall Study|Physician Decision|1
7841353|NCT01421511|12320458|FG000|Overall Study|Withdrawal by Subject|6
7841354|NCT01421511|12320459|FG001|Overall Study|Withdrawal by Subject|5
7841355|NCT01421511|12320458|FG000|Overall Study|Death|1
7841356|NCT01421511|12320459|FG001|Overall Study|Death|1
7841357|NCT01421641|12320473|FG000|Overall Study|Protocol Violation|2
7841358|NCT01421641|12320474|FG001|Overall Study|Protocol Violation|2
7841359|NCT01421667|12320493|FG000|Overall Study|Withdrawal by Subject|0
7841360|NCT01421667|12320494|FG001|Overall Study|Withdrawal by Subject|1
7841361|NCT01421667|12320495|FG002|Overall Study|Withdrawal by Subject|2
7841362|NCT01421667|12320496|FG003|Overall Study|Withdrawal by Subject|1
7841363|NCT01421667|12320493|FG000|Overall Study|Lost to Follow-up|0
7841364|NCT01421667|12320494|FG001|Overall Study|Lost to Follow-up|1
7841365|NCT01421667|12320495|FG002|Overall Study|Lost to Follow-up|0
7841366|NCT01421667|12320496|FG003|Overall Study|Lost to Follow-up|0
7841367|NCT01421719|12320514|FG000|Overall Study|Withdrawal by Subject|4
7841368|NCT01422187|12320558|FG000|Overall Study|Personal reason|1
7841369|NCT01422187|12320559|FG001|Overall Study|Personal reason|0
7841370|NCT01422187|12320560|FG002|Overall Study|Personal reason|0
7841371|NCT01422187|12320558|FG000|Overall Study|Lost to Follow-up|0
7841372|NCT01422187|12320559|FG001|Overall Study|Lost to Follow-up|1
7841373|NCT01422187|12320560|FG002|Overall Study|Lost to Follow-up|0
7841374|NCT01422213|12320582|FG000|Overall Study|Adverse Event|8
7841375|NCT01422213|12320583|FG001|Overall Study|Adverse Event|7
7841376|NCT01422213|12320584|FG002|Overall Study|Adverse Event|11
7841377|NCT01422213|12320582|FG000|Overall Study|Lack of Efficacy|10
7841378|NCT01422213|12320583|FG001|Overall Study|Lack of Efficacy|2
7841379|NCT01422213|12320584|FG002|Overall Study|Lack of Efficacy|2
7841380|NCT01422213|12320582|FG000|Overall Study|Non-compliance with study drug|0
7841381|NCT01422213|12320583|FG001|Overall Study|Non-compliance with study drug|1
7841382|NCT01422213|12320584|FG002|Overall Study|Non-compliance with study drug|0
7841383|NCT01422213|12320582|FG000|Overall Study|Protocol Violation|0
7841384|NCT01422213|12320583|FG001|Overall Study|Protocol Violation|2
7841385|NCT01422213|12320584|FG002|Overall Study|Protocol Violation|4
7841386|NCT01422213|12320582|FG000|Overall Study|Withdrawal of Consent|7
7841387|NCT01422213|12320583|FG001|Overall Study|Withdrawal of Consent|3
7841388|NCT01422213|12320584|FG002|Overall Study|Withdrawal of Consent|5
7841389|NCT01422213|12320582|FG000|Overall Study|Lost to Follow-up|3
7841390|NCT01422213|12320583|FG001|Overall Study|Lost to Follow-up|3
7841391|NCT01422213|12320584|FG002|Overall Study|Lost to Follow-up|5
7841392|NCT01422213|12320582|FG000|Overall Study|Administrative or Other Reason(s)|5
7841393|NCT01422213|12320583|FG001|Overall Study|Administrative or Other Reason(s)|4
7841394|NCT01422213|12320584|FG002|Overall Study|Administrative or Other Reason(s)|2
7841395|NCT01422239|12320603|FG000|Overall Study|Lost to Follow-up|4
7841396|NCT01422239|12320604|FG001|Overall Study|Lost to Follow-up|3
7862995|NCT01602315|12352101|FG005|Overall Study|Death|2
7862996|NCT01602315|12352102|FG006|Overall Study|Death|2
7862997|NCT01602315|12352096|FG000|Overall Study|Withdrawal by Subject|2
7862998|NCT01602315|12352097|FG001|Overall Study|Withdrawal by Subject|0
7862999|NCT01602315|12352098|FG002|Overall Study|Withdrawal by Subject|2
7863000|NCT01602315|12352099|FG003|Overall Study|Withdrawal by Subject|0
7863001|NCT01602315|12352100|FG004|Overall Study|Withdrawal by Subject|6
7863002|NCT01602315|12352101|FG005|Overall Study|Withdrawal by Subject|0
7863003|NCT01602315|12352102|FG006|Overall Study|Withdrawal by Subject|1
7863004|NCT01602315|12352096|FG000|Overall Study|Adverse Event|5
7863005|NCT01602315|12352097|FG001|Overall Study|Adverse Event|1
7863006|NCT01602315|12352098|FG002|Overall Study|Adverse Event|5
7863007|NCT01602315|12352099|FG003|Overall Study|Adverse Event|4
7863008|NCT01602315|12352100|FG004|Overall Study|Adverse Event|15
7863009|NCT01602315|12352101|FG005|Overall Study|Adverse Event|3
7863010|NCT01602315|12352102|FG006|Overall Study|Adverse Event|9
7863011|NCT01602315|12352096|FG000|Overall Study|Subject/guardian decision|0
7863012|NCT01602315|12352097|FG001|Overall Study|Subject/guardian decision|0
7863013|NCT01602315|12352098|FG002|Overall Study|Subject/guardian decision|0
7863014|NCT01602315|12352099|FG003|Overall Study|Subject/guardian decision|0
7863015|NCT01602315|12352100|FG004|Overall Study|Subject/guardian decision|0
7863016|NCT01602315|12352101|FG005|Overall Study|Subject/guardian decision|0
7863017|NCT01602315|12352102|FG006|Overall Study|Subject/guardian decision|1
7863018|NCT01602315|12352096|FG000|Overall Study|Cross-over patients to combo treatment|0
7863019|NCT01602315|12352097|FG001|Overall Study|Cross-over patients to combo treatment|0
7863020|NCT01602315|12352098|FG002|Overall Study|Cross-over patients to combo treatment|0
7863021|NCT01602315|12352099|FG003|Overall Study|Cross-over patients to combo treatment|0
7863022|NCT01602315|12352100|FG004|Overall Study|Cross-over patients to combo treatment|0
7863023|NCT01602315|12352101|FG005|Overall Study|Cross-over patients to combo treatment|16
7863024|NCT01602315|12352102|FG006|Overall Study|Cross-over patients to combo treatment|0
7863025|NCT01602341|12352140|FG000|Overall Study|Adverse Event|0
7863026|NCT01602341|12352141|FG001|Overall Study|Adverse Event|1
7863027|NCT01602419|12352151|FG000|Overall Study|Not treated with Wilate|9
7863028|NCT01602419|12352151|FG000|Overall Study|Adverse Drug Reaction|4
7863029|NCT01602419|12352151|FG000|Overall Study|Insurance issues|3
7863030|NCT01602419|12352151|FG000|Overall Study|Changed treatment centre|1
7863031|NCT01602419|12352151|FG000|Overall Study|Treatment centre closed|1
7863032|NCT01602419|12352151|FG000|Overall Study|Withdrawal by Subject|5
7863033|NCT01602419|12352151|FG000|Overall Study|Lost to Follow-up|6
7863034|NCT01602484|12352198|FG000|Overall Study|Airway issues unrelated to study|0
7863035|NCT01602484|12352199|FG001|Overall Study|Airway issues unrelated to study|1
7863036|NCT01602510|12352205|FG000|Open Label Phase|Adverse Event|46
7863037|NCT01602510|12352206|FG001|Open Label Phase|Adverse Event|0
7863038|NCT01602510|12352207|FG002|Open Label Phase|Adverse Event|0
7863039|NCT01602510|12352205|FG000|Open Label Phase|Lack of Efficacy|22
7863040|NCT01602510|12352206|FG001|Open Label Phase|Lack of Efficacy|0
7863041|NCT01602510|12352207|FG002|Open Label Phase|Lack of Efficacy|0
7863042|NCT01602510|12352205|FG000|Open Label Phase|Protocol Violation|15
7863043|NCT01602510|12352206|FG001|Open Label Phase|Protocol Violation|0
7863044|NCT01602510|12352207|FG002|Open Label Phase|Protocol Violation|0
7863045|NCT01602510|12352205|FG000|Open Label Phase|Met protocol-defined stopping criteria|122
7863046|NCT01602510|12352206|FG001|Open Label Phase|Met protocol-defined stopping criteria|0
7863047|NCT01602510|12352207|FG002|Open Label Phase|Met protocol-defined stopping criteria|0
7863048|NCT01602510|12352205|FG000|Open Label Phase|Lost to Follow-up|22
7863049|NCT01602510|12352206|FG001|Open Label Phase|Lost to Follow-up|0
7863050|NCT01602510|12352207|FG002|Open Label Phase|Lost to Follow-up|0
7863051|NCT01602510|12352205|FG000|Open Label Phase|Physician Decision|19
7863052|NCT01602510|12352206|FG001|Open Label Phase|Physician Decision|0
7863053|NCT01602510|12352207|FG002|Open Label Phase|Physician Decision|0
7863054|NCT01602510|12352205|FG000|Open Label Phase|Withdrawal by Subject|57
7863055|NCT01602510|12352206|FG001|Open Label Phase|Withdrawal by Subject|0
7863056|NCT01602510|12352207|FG002|Open Label Phase|Withdrawal by Subject|0
7863057|NCT01602510|12352205|FG000|Randomized Phase|Adverse Event|0
7863058|NCT01602510|12352206|FG001|Randomized Phase|Adverse Event|2
7863059|NCT01602510|12352207|FG002|Randomized Phase|Adverse Event|6
7863060|NCT01602510|12352205|FG000|Randomized Phase|Lack of Efficacy|0
7863061|NCT01602510|12352206|FG001|Randomized Phase|Lack of Efficacy|4
7863062|NCT01602510|12352207|FG002|Randomized Phase|Lack of Efficacy|4
7863063|NCT01602510|12352205|FG000|Randomized Phase|Protocol Violation|0
7863064|NCT01602510|12352206|FG001|Randomized Phase|Protocol Violation|3
7841397|NCT01422304|12320612|FG000|Overall Study|Adverse Event|0
7841398|NCT01422304|12320613|FG001|Overall Study|Adverse Event|1
7841399|NCT01422304|12320612|FG000|Overall Study|Lost to Follow-up|14
7841400|NCT01422304|12320613|FG001|Overall Study|Lost to Follow-up|20
7841401|NCT01422304|12320612|FG000|Overall Study|Never Entered Follow-up|2
7841402|NCT01422304|12320613|FG001|Overall Study|Never Entered Follow-up|1
7841403|NCT01422304|12320612|FG000|Overall Study|Protocol Violation|1
7841404|NCT01422304|12320613|FG001|Overall Study|Protocol Violation|0
7841405|NCT01422304|12320612|FG000|Overall Study|Withdrawal by Subject|4
7841406|NCT01422304|12320613|FG001|Overall Study|Withdrawal by Subject|2
7841407|NCT01422304|12320612|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
7841408|NCT01422304|12320613|FG001|Overall Study|Did Not Meet Protocol Eligibility|2
7841409|NCT01422304|12320612|FG000|Overall Study|Not Treated|3
7841410|NCT01422304|12320613|FG001|Overall Study|Not Treated|11
7841411|NCT01422382|12320628|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
7841412|NCT01422408|12320632|FG000|Overall Study|Adverse Event|1
7841413|NCT01422408|12320632|FG000|Overall Study|Withdrawal by Subject|3
7841414|NCT01422538|12320652|FG000|Overall Study|Lost to Follow-up|0
7841415|NCT01422538|12320653|FG001|Overall Study|Lost to Follow-up|1
7841416|NCT01422538|12320654|FG002|Overall Study|Lost to Follow-up|1
7841417|NCT01422538|12320652|FG000|Overall Study|Missed visit|0
7841418|NCT01422538|12320653|FG001|Overall Study|Missed visit|1
7841419|NCT01422538|12320654|FG002|Overall Study|Missed visit|1
7841420|NCT01422720|12320663|FG000|Overall Study|Adverse Event|16
7841421|NCT01422720|12320663|FG000|Overall Study|Lack of Efficacy|1
7841422|NCT01422720|12320663|FG000|Overall Study|Withdrawal by Subject|4
7841423|NCT01422720|12320663|FG000|Overall Study|Ineligibility|1
7841424|NCT01422824|12320671|FG000|Overall Study|Case record form not evaluated|1
7841425|NCT01422824|12320671|FG000|Overall Study|Lost to Follow-up|37
7841426|NCT01422850|12320675|FG000|Overall Study|Physician Decision|3
7841427|NCT01422876|12320691|FG000|Week 24|Lost to Follow-up|1
7841428|NCT01422876|12320692|FG001|Week 24|Lost to Follow-up|1
7841429|NCT01422876|12320693|FG002|Week 24|Lost to Follow-up|2
7841430|NCT01422876|12320694|FG003|Week 24|Lost to Follow-up|4
7841431|NCT01422876|12320695|FG004|Week 24|Lost to Follow-up|2
7841432|NCT01422876|12320696|FG005|Week 24|Lost to Follow-up|0
7841433|NCT01422876|12320697|FG006|Week 24|Lost to Follow-up|1
7841434|NCT01422876|12320698|FG007|Week 24|Lost to Follow-up|3
7841435|NCT01422876|12320699|FG008|Week 24|Lost to Follow-up|3
7841436|NCT01422876|12320700|FG009|Week 24|Lost to Follow-up|4
7841437|NCT01422876|12320691|FG000|Week 24|Consent withdrawn|5
7841438|NCT01422876|12320692|FG001|Week 24|Consent withdrawn|1
7841439|NCT01422876|12320693|FG002|Week 24|Consent withdrawn|3
7841440|NCT01422876|12320694|FG003|Week 24|Consent withdrawn|4
7841441|NCT01422876|12320695|FG004|Week 24|Consent withdrawn|5
7841442|NCT01422876|12320696|FG005|Week 24|Consent withdrawn|6
7841443|NCT01422876|12320697|FG006|Week 24|Consent withdrawn|5
7841444|NCT01422876|12320698|FG007|Week 24|Consent withdrawn|4
7841445|NCT01422876|12320699|FG008|Week 24|Consent withdrawn|3
7841446|NCT01422876|12320700|FG009|Week 24|Consent withdrawn|6
7841447|NCT01422876|12320691|FG000|Week 24|Death|0
7841448|NCT01422876|12320692|FG001|Week 24|Death|1
7949019|NCT02533674|12494572|FG002|Dose Level I|Withdrawal by Subject|0
7949020|NCT02533674|12494573|FG003|Dose Level I|Withdrawal by Subject|0
7949021|NCT02533674|12494574|FG004|Dose Level I|Withdrawal by Subject|0
7949022|NCT02533674|12494575|FG005|Dose Level I|Withdrawal by Subject|0
7949023|NCT02533674|12494576|FG006|Dose Level I|Withdrawal by Subject|0
7841449|NCT01422876|12320693|FG002|Week 24|Death|0
7841450|NCT01422876|12320694|FG003|Week 24|Death|0
7841451|NCT01422876|12320695|FG004|Week 24|Death|0
7841452|NCT01422876|12320696|FG005|Week 24|Death|0
7841453|NCT01422876|12320697|FG006|Week 24|Death|0
7841454|NCT01422876|12320698|FG007|Week 24|Death|0
7841455|NCT01422876|12320699|FG008|Week 24|Death|0
7841456|NCT01422876|12320700|FG009|Week 24|Death|0
7841457|NCT01422876|12320691|FG000|Week 52|Lost to Follow-up|3
7841458|NCT01422876|12320692|FG001|Week 52|Lost to Follow-up|5
7841459|NCT01422876|12320693|FG002|Week 52|Lost to Follow-up|7
7841460|NCT01422876|12320694|FG003|Week 52|Lost to Follow-up|5
7841461|NCT01422876|12320695|FG004|Week 52|Lost to Follow-up|8
7841462|NCT01422876|12320696|FG005|Week 52|Lost to Follow-up|5
7841463|NCT01422876|12320697|FG006|Week 52|Lost to Follow-up|5
7841464|NCT01422876|12320698|FG007|Week 52|Lost to Follow-up|8
7841465|NCT01422876|12320699|FG008|Week 52|Lost to Follow-up|7
7841466|NCT01422876|12320700|FG009|Week 52|Lost to Follow-up|8
7841467|NCT01422876|12320691|FG000|Week 52|Consent withdrawn|9
7841468|NCT01422876|12320692|FG001|Week 52|Consent withdrawn|4
7841469|NCT01422876|12320693|FG002|Week 52|Consent withdrawn|6
7841470|NCT01422876|12320694|FG003|Week 52|Consent withdrawn|12
7841471|NCT01422876|12320695|FG004|Week 52|Consent withdrawn|7
7841472|NCT01422876|12320696|FG005|Week 52|Consent withdrawn|12
7841473|NCT01422876|12320697|FG006|Week 52|Consent withdrawn|10
7841474|NCT01422876|12320698|FG007|Week 52|Consent withdrawn|12
7841475|NCT01422876|12320699|FG008|Week 52|Consent withdrawn|13
7841476|NCT01422876|12320700|FG009|Week 52|Consent withdrawn|9
7841477|NCT01422876|12320691|FG000|Week 52|Death|0
7841478|NCT01422876|12320692|FG001|Week 52|Death|1
7841479|NCT01422876|12320693|FG002|Week 52|Death|0
7841480|NCT01422876|12320694|FG003|Week 52|Death|1
7841481|NCT01422876|12320695|FG004|Week 52|Death|0
7841482|NCT01422876|12320696|FG005|Week 52|Death|0
7841483|NCT01422876|12320697|FG006|Week 52|Death|1
7841484|NCT01422876|12320698|FG007|Week 52|Death|3
7841485|NCT01422876|12320699|FG008|Week 52|Death|1
7841486|NCT01422876|12320700|FG009|Week 52|Death|0
7841487|NCT01422889|12320718|FG000|Overall Study|No Data Entered for Study Stent|9
7841488|NCT01422915|12320722|FG000|Overall Study|Adverse Event|1
7841489|NCT01423084|12320729|FG000|Overall Study|Adverse Event|0
7841490|NCT01423084|12320730|FG001|Overall Study|Adverse Event|1
7841491|NCT01423084|12320729|FG000|Overall Study|Withdrawal by Subject|2
7841492|NCT01423084|12320730|FG001|Overall Study|Withdrawal by Subject|3
7841493|NCT01423253|12320746|FG000|Overall Study|Adverse Event|2
7841494|NCT01423253|12320746|FG000|Overall Study|Lack of Efficacy|2
7841495|NCT01423253|12320746|FG000|Overall Study|Lost to Follow-up|1
7841496|NCT01423253|12320746|FG000|Overall Study|Protocol Violation|2
7841497|NCT01423253|12320746|FG000|Overall Study|Withdrawal by Subject|2
7841498|NCT01423604|12320753|FG000|Safety Run-In|Adverse Event|3
7841499|NCT01423604|12320754|FG001|Safety Run-In|Adverse Event|0
7841500|NCT01423604|12320753|FG000|Safety Run-In|Death|1
7841501|NCT01423604|12320754|FG001|Safety Run-In|Death|0
7841502|NCT01423604|12320753|FG000|Safety Run-In|Physician Decision|1
7841503|NCT01423604|12320754|FG001|Safety Run-In|Physician Decision|0
7841504|NCT01423604|12320753|FG000|Safety Run-In|Disease progression|3
7841505|NCT01423604|12320754|FG001|Safety Run-In|Disease progression|0
7841506|NCT01423604|12320753|FG000|Safety Run-In|Patient decision|1
7841507|NCT01423604|12320754|FG001|Safety Run-In|Patient decision|0
7841508|NCT01423604|12320753|FG000|Randomized|Adverse Event|4
7841509|NCT01423604|12320754|FG001|Randomized|Adverse Event|10
7841510|NCT01423604|12320753|FG000|Randomized|Death|1
7841511|NCT01423604|12320754|FG001|Randomized|Death|0
7841512|NCT01423604|12320753|FG000|Randomized|Physician Decision|16
7841513|NCT01423604|12320754|FG001|Randomized|Physician Decision|13
7841514|NCT01423604|12320753|FG000|Randomized|Other - unspecified|37
7841515|NCT01423604|12320754|FG001|Randomized|Other - unspecified|31
7841516|NCT01423604|12320753|FG000|Randomized|Patient decision|5
7841517|NCT01423604|12320754|FG001|Randomized|Patient decision|9
7841518|NCT01423617|12320763|FG000|Overall Study|Lost to Follow-up|0
7841519|NCT01423617|12320764|FG001|Overall Study|Lost to Follow-up|1
7841520|NCT01423812|12320788|FG000|Overall Study|Lost to Follow-up|2
7841521|NCT01423812|12320789|FG001|Overall Study|Lost to Follow-up|2
7841522|NCT01423812|12320788|FG000|Overall Study|Withdrawal by Subject|1
7841523|NCT01423812|12320789|FG001|Overall Study|Withdrawal by Subject|2
7841524|NCT01423916|12320800|FG000|Overall Study|Adverse Event|5
7841525|NCT01423916|12320801|FG001|Overall Study|Adverse Event|9
7841526|NCT01423916|12320802|FG002|Overall Study|Adverse Event|2
7841527|NCT01423916|12320800|FG000|Overall Study|Met Withdrawal Criteria|1
7841528|NCT01423916|12320801|FG001|Overall Study|Met Withdrawal Criteria|1
7841529|NCT01423916|12320802|FG002|Overall Study|Met Withdrawal Criteria|1
7841530|NCT01423916|12320800|FG000|Overall Study|Physician Decision|1
7841531|NCT01423916|12320801|FG001|Overall Study|Physician Decision|0
7841532|NCT01423916|12320802|FG002|Overall Study|Physician Decision|1
7841533|NCT01423916|12320800|FG000|Overall Study|Withdrawal by Subject|3
7841534|NCT01423916|12320801|FG001|Overall Study|Withdrawal by Subject|10
7841535|NCT01423916|12320802|FG002|Overall Study|Withdrawal by Subject|3
7841536|NCT01423916|12320800|FG000|Overall Study|Protocol Deviation|1
7841537|NCT01423916|12320801|FG001|Overall Study|Protocol Deviation|0
7841538|NCT01423916|12320802|FG002|Overall Study|Protocol Deviation|0
7841539|NCT01424189|12320840|FG000|Overall Study|Adverse Event|1
7841540|NCT01424189|12320841|FG001|Overall Study|Adverse Event|0
7841541|NCT01424189|12320840|FG000|Overall Study|Lost to Follow-up|4
7841542|NCT01424189|12320841|FG001|Overall Study|Lost to Follow-up|1
7841543|NCT01424189|12320840|FG000|Overall Study|Withdrawal by Subject|4
7841544|NCT01424189|12320841|FG001|Overall Study|Withdrawal by Subject|4
7841545|NCT01424189|12320840|FG000|Overall Study|Subject moved|1
7841546|NCT01424189|12320841|FG001|Overall Study|Subject moved|0
7841547|NCT01424189|12320840|FG000|Overall Study|Death|3
7841548|NCT01424189|12320841|FG001|Overall Study|Death|1
7841549|NCT01424228|12320858|FG000|Overall Study|Withdrawal by Subject|27
7841550|NCT01424228|12320859|FG001|Overall Study|Withdrawal by Subject|11
7841551|NCT01424228|12320858|FG000|Overall Study|Adverse Event|10
7841552|NCT01424228|12320859|FG001|Overall Study|Adverse Event|14
7841553|NCT01424228|12320858|FG000|Overall Study|Sponsor's decision|9
7841554|NCT01424228|12320859|FG001|Overall Study|Sponsor's decision|12
7841555|NCT01424228|12320858|FG000|Overall Study|Lack of Efficacy|5
7841556|NCT01424228|12320859|FG001|Overall Study|Lack of Efficacy|7
7841557|NCT01424228|12320858|FG000|Overall Study|inclusion/exclusion criteria not met|2
7841558|NCT01424228|12320859|FG001|Overall Study|inclusion/exclusion criteria not met|2
7841559|NCT01424228|12320858|FG000|Overall Study|Non-compliance|2
7841560|NCT01424228|12320859|FG001|Overall Study|Non-compliance|0
7841561|NCT01424228|12320858|FG000|Overall Study|Worsening of symptoms|1
7841562|NCT01424228|12320859|FG001|Overall Study|Worsening of symptoms|0
7841563|NCT01424228|12320858|FG000|Overall Study|Unplanned journey|0
7841564|NCT01424228|12320859|FG001|Overall Study|Unplanned journey|1
7841565|NCT01424306|12320869|FG000|Overall Study|Protocol Violation|0
7841566|NCT01424306|12320870|FG001|Overall Study|Protocol Violation|0
7841567|NCT01424306|12320871|FG002|Overall Study|Protocol Violation|0
7841568|NCT01424306|12320872|FG003|Overall Study|Protocol Violation|0
7841569|NCT01424306|12320873|FG004|Overall Study|Protocol Violation|1
7841570|NCT01424306|12320874|FG005|Overall Study|Protocol Violation|0
7841571|NCT01424397|12320918|FG000|Period-2 (8 Days)|Withdrawal by Subject|0
7841572|NCT01424397|12320919|FG001|Period-2 (8 Days)|Withdrawal by Subject|0
7841573|NCT01424397|12320920|FG002|Period-2 (8 Days)|Withdrawal by Subject|1
7841574|NCT01424397|12320921|FG003|Period-2 (8 Days)|Withdrawal by Subject|0
7841575|NCT01424397|12320922|FG004|Period-2 (8 Days)|Withdrawal by Subject|0
7841576|NCT01424397|12320923|FG005|Period-2 (8 Days)|Withdrawal by Subject|0
7841577|NCT01424397|12320924|FG006|Period-2 (8 Days)|Withdrawal by Subject|0
7841578|NCT01424397|12320925|FG007|Period-2 (8 Days)|Withdrawal by Subject|0
7841579|NCT01424397|12320926|FG008|Period-2 (8 Days)|Withdrawal by Subject|0
7841580|NCT01424397|12320927|FG009|Period-2 (8 Days)|Withdrawal by Subject|0
7841581|NCT01424397|12320928|FG010|Period-2 (8 Days)|Withdrawal by Subject|0
7841582|NCT01424397|12320929|FG011|Period-2 (8 Days)|Withdrawal by Subject|0
7841583|NCT01424501|12320949|FG000|Overall Study|Withdrawal by Subject|1
7841584|NCT01424501|12320950|FG001|Overall Study|Withdrawal by Subject|0
7841585|NCT01424501|12320951|FG002|Overall Study|Withdrawal by Subject|1
7841586|NCT01424501|12320952|FG003|Overall Study|Withdrawal by Subject|0
7841587|NCT01424501|12320953|FG004|Overall Study|Withdrawal by Subject|0
7841588|NCT01424501|12320954|FG005|Overall Study|Withdrawal by Subject|0
7841589|NCT01424501|12320949|FG000|Overall Study|Lost to Follow-up|0
7841590|NCT01424501|12320950|FG001|Overall Study|Lost to Follow-up|1
7841591|NCT01424501|12320951|FG002|Overall Study|Lost to Follow-up|1
7841592|NCT01424501|12320952|FG003|Overall Study|Lost to Follow-up|0
7841593|NCT01424501|12320953|FG004|Overall Study|Lost to Follow-up|0
7841594|NCT01424501|12320954|FG005|Overall Study|Lost to Follow-up|0
7841595|NCT01424514|12320969|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
7841596|NCT01424514|12320970|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
7841597|NCT01424514|12320969|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
7841598|NCT01424514|12320970|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
7841599|NCT01424566|12320981|FG000|Single-blind Treatment|Adverse Event|71
7841600|NCT01424566|12320982|FG001|Single-blind Treatment|Adverse Event|0
7841601|NCT01424566|12320983|FG002|Single-blind Treatment|Adverse Event|0
7841602|NCT01424566|12320981|FG000|Single-blind Treatment|Withdrawal by Subject|16
7841603|NCT01424566|12320982|FG001|Single-blind Treatment|Withdrawal by Subject|0
7841604|NCT01424566|12320983|FG002|Single-blind Treatment|Withdrawal by Subject|0
7841605|NCT01424566|12320981|FG000|Single-blind Treatment|Withdrawal by Investigator|2
7841606|NCT01424566|12320982|FG001|Single-blind Treatment|Withdrawal by Investigator|0
7841607|NCT01424566|12320983|FG002|Single-blind Treatment|Withdrawal by Investigator|0
7841608|NCT01424566|12320981|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
7841609|NCT01424566|12320982|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
7841610|NCT01424566|12320983|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
7841611|NCT01424566|12320981|FG000|Single-blind Treatment|Met Exclusion Criteria|1
7841612|NCT01424566|12320982|FG001|Single-blind Treatment|Met Exclusion Criteria|0
7841613|NCT01424566|12320983|FG002|Single-blind Treatment|Met Exclusion Criteria|0
7841614|NCT01424566|12320981|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2
7841615|NCT01424566|12320982|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0
7841616|NCT01424566|12320983|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0
7841617|NCT01424566|12320981|FG000|Double-blind Treatment|Adverse Event|0
7841618|NCT01424566|12320982|FG001|Double-blind Treatment|Adverse Event|21
7841619|NCT01424566|12320983|FG002|Double-blind Treatment|Adverse Event|13
7841620|NCT01424566|12320981|FG000|Double-blind Treatment|Withdrawal by Subject|0
7841621|NCT01424566|12320982|FG001|Double-blind Treatment|Withdrawal by Subject|2
7841622|NCT01424566|12320983|FG002|Double-blind Treatment|Withdrawal by Subject|0
7841623|NCT01424566|12320981|FG000|Double-blind Treatment|Withdrawal by Investigator|0
7841624|NCT01424566|12320982|FG001|Double-blind Treatment|Withdrawal by Investigator|1
7841625|NCT01424566|12320983|FG002|Double-blind Treatment|Withdrawal by Investigator|1
7841626|NCT01424566|12320981|FG000|Double-blind Treatment|Lack of Efficacy|0
7841627|NCT01424566|12320982|FG001|Double-blind Treatment|Lack of Efficacy|1
7841628|NCT01424566|12320983|FG002|Double-blind Treatment|Lack of Efficacy|1
7841629|NCT01424644|12320992|FG000|Overall Study|Adverse Event|2
7841630|NCT01424644|12320993|FG001|Overall Study|Adverse Event|0
7841631|NCT01424644|12320992|FG000|Overall Study|Withdrawal by Subject|9
7841632|NCT01424644|12320993|FG001|Overall Study|Withdrawal by Subject|12
7841633|NCT01424644|12320992|FG000|Overall Study|Lost to Follow-up|16
7841634|NCT01424644|12320993|FG001|Overall Study|Lost to Follow-up|12
7841635|NCT01424644|12320992|FG000|Overall Study|Protocol Violation|4
7841636|NCT01424644|12320993|FG001|Overall Study|Protocol Violation|3
7841637|NCT01424644|12320992|FG000|Overall Study|Administrative Reason|1
7841638|NCT01424644|12320993|FG001|Overall Study|Administrative Reason|0
7841639|NCT01424644|12320992|FG000|Overall Study|Unable to Classify|1
7841640|NCT01424644|12320993|FG001|Overall Study|Unable to Classify|0
7841641|NCT01424670|12321001|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2
7841642|NCT01424670|12321002|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2
7841643|NCT01424670|12321001|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0
7841644|NCT01424670|12321002|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1
7841645|NCT01424670|12321001|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2
7841646|NCT01424670|12321002|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1
7841647|NCT01424670|12321001|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2
7841648|NCT01424670|12321002|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3
7841649|NCT01424670|12321001|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13
7841650|NCT01424670|12321002|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7
7841651|NCT01424670|12321001|FG000|Continuation Period|Adverse Event|13
7841652|NCT01424670|12321002|FG001|Continuation Period|Adverse Event|5
7841653|NCT01424670|12321001|FG000|Continuation Period|Lost to Follow-up|2
7841654|NCT01424670|12321002|FG001|Continuation Period|Lost to Follow-up|0
7841655|NCT01424670|12321001|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1
7841656|NCT01424670|12321002|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1
7841657|NCT01424670|12321001|FG000|Continuation Period|Physician Decision|5
7841658|NCT01424670|12321002|FG001|Continuation Period|Physician Decision|4
7841659|NCT01424670|12321001|FG000|Continuation Period|Withdrawal by Subject|13
7841660|NCT01424670|12321002|FG001|Continuation Period|Withdrawal by Subject|4
7841661|NCT01424722|12321010|FG000|Overall Study|Sponsor terminated investigation|2258
7841662|NCT01424813|12321016|FG000|Overall Study|Withdrawal by Subject|3
7841663|NCT01424813|12321017|FG001|Overall Study|Withdrawal by Subject|0
7841664|NCT01424813|12321016|FG000|Overall Study|Protocol Violation|1
7841665|NCT01424813|12321017|FG001|Overall Study|Protocol Violation|0
7841666|NCT01424813|12321016|FG000|Overall Study|Other|1
7841667|NCT01424813|12321017|FG001|Overall Study|Other|2
7841668|NCT01424930|12321025|FG000|Overall Study|Adverse Event|0
7841669|NCT01424930|12321026|FG001|Overall Study|Adverse Event|1
7841670|NCT01424930|12321025|FG000|Overall Study|Death|1
7841671|NCT01424930|12321026|FG001|Overall Study|Death|0
7841672|NCT01424930|12321025|FG000|Overall Study|Progressive Disease|3
7841673|NCT01424930|12321026|FG001|Overall Study|Progressive Disease|6
7841674|NCT01424930|12321025|FG000|Overall Study|Screen Failure|0
7841675|NCT01424930|12321026|FG001|Overall Study|Screen Failure|1
7841676|NCT01424930|12321025|FG000|Overall Study|Reason not specified|0
7841677|NCT01424930|12321026|FG001|Overall Study|Reason not specified|6
7841678|NCT01425190|12321044|FG000|Overall Study|Full dose not consumed.|1
7841679|NCT01425190|12321045|FG001|Overall Study|Full dose not consumed.|0
7841680|NCT01425190|12321046|FG002|Overall Study|Full dose not consumed.|0
7841681|NCT01425203|12321056|FG000|Treatment Phase|DC during PR Lead-in Phase|3
7841682|NCT01425203|12321057|FG001|Treatment Phase|DC during PR Lead-in Phase|1
7841683|NCT01425203|12321058|FG002|Treatment Phase|DC during PR Lead-in Phase|0
7841684|NCT01425203|12321056|FG000|Treatment Phase|Failure at futility timepoint|8
7841685|NCT01425203|12321057|FG001|Treatment Phase|Failure at futility timepoint|27
7841686|NCT01425203|12321058|FG002|Treatment Phase|Failure at futility timepoint|0
7841687|NCT01425203|12321056|FG000|Treatment Phase|Other virologic failure criteria|5
7841688|NCT01425203|12321057|FG001|Treatment Phase|Other virologic failure criteria|3
7841689|NCT01425203|12321058|FG002|Treatment Phase|Other virologic failure criteria|0
7841690|NCT01425203|12321056|FG000|Treatment Phase|Unidentified reasons|11
7841691|NCT01425203|12321057|FG001|Treatment Phase|Unidentified reasons|5
7841692|NCT01425203|12321058|FG002|Treatment Phase|Unidentified reasons|0
7841693|NCT01425203|12321056|FG000|Treatment Phase|Did not receive treatment|0
7841694|NCT01425203|12321057|FG001|Treatment Phase|Did not receive treatment|1
7841695|NCT01425203|12321058|FG002|Treatment Phase|Did not receive treatment|0
7841696|NCT01425203|12321056|FG000|Crossover Phase|Failure at futility timepoint|0
7841697|NCT01425203|12321057|FG001|Crossover Phase|Failure at futility timepoint|0
7841698|NCT01425203|12321058|FG002|Crossover Phase|Failure at futility timepoint|3
7841699|NCT01425203|12321056|FG000|Crossover Phase|Other virologic failure criteria|0
7841700|NCT01425203|12321057|FG001|Crossover Phase|Other virologic failure criteria|0
7841701|NCT01425203|12321058|FG002|Crossover Phase|Other virologic failure criteria|3
7841702|NCT01425268|12321076|FG000|Overall Study|Withdrawal by Subject|2
7841703|NCT01425268|12321077|FG001|Overall Study|Withdrawal by Subject|0
7841704|NCT01425268|12321076|FG000|Overall Study|Sponsor Decision|5
7841705|NCT01425268|12321077|FG001|Overall Study|Sponsor Decision|0
7841706|NCT01425268|12321076|FG000|Overall Study|Physician Decision|1
7841707|NCT01425268|12321077|FG001|Overall Study|Physician Decision|0
7841708|NCT01425359|12321096|FG000|Overall Study|Randomized but Not Treated|2
7841709|NCT01425359|12321097|FG001|Overall Study|Randomized but Not Treated|3
7841710|NCT01425359|12321096|FG000|Overall Study|Adverse Event|9
7841711|NCT01425359|12321097|FG001|Overall Study|Adverse Event|8
7841712|NCT01425359|12321096|FG000|Overall Study|Revascularization|0
7841713|NCT01425359|12321097|FG001|Overall Study|Revascularization|1
7841714|NCT01425359|12321096|FG000|Overall Study|Death|0
7841715|NCT01425359|12321097|FG001|Overall Study|Death|1
7841716|NCT01425359|12321096|FG000|Overall Study|Unsatisfactory Response|1
7841717|NCT01425359|12321097|FG001|Overall Study|Unsatisfactory Response|0
7841718|NCT01425359|12321096|FG000|Overall Study|Protocol Violation|1
7841719|NCT01425359|12321097|FG001|Overall Study|Protocol Violation|2
7841720|NCT01425359|12321096|FG000|Overall Study|Subject Withdrew Consent|1
7841721|NCT01425359|12321097|FG001|Overall Study|Subject Withdrew Consent|2
7841722|NCT01425359|12321096|FG000|Overall Study|Investigator's Discretion|2
7841723|NCT01425359|12321097|FG001|Overall Study|Investigator's Discretion|0
7841724|NCT01425359|12321096|FG000|Overall Study|Did Not Meet Qualifying Criteria|3
7841725|NCT01425359|12321097|FG001|Overall Study|Did Not Meet Qualifying Criteria|5
7841726|NCT01425463|12321106|FG000|Overall Study|Adverse Event|5
7841727|NCT01425463|12321107|FG001|Overall Study|Adverse Event|7
7841728|NCT01425463|12321106|FG000|Overall Study|Lack of Efficacy|1
7841729|NCT01425463|12321107|FG001|Overall Study|Lack of Efficacy|1
7841730|NCT01425463|12321106|FG000|Overall Study|Protocol Violation|2
7841731|NCT01425463|12321107|FG001|Overall Study|Protocol Violation|2
7841732|NCT01425463|12321106|FG000|Overall Study|Lost to Follow-up|5
7841733|NCT01425463|12321107|FG001|Overall Study|Lost to Follow-up|2
7841734|NCT01425463|12321106|FG000|Overall Study|Withdrawal by Subject|7
7841735|NCT01425463|12321107|FG001|Overall Study|Withdrawal by Subject|5
7841736|NCT01425463|12321106|FG000|Overall Study|Unknown Reason|4
7841737|NCT01425463|12321107|FG001|Overall Study|Unknown Reason|7
7841738|NCT01425528|12321115|FG000|Overall Study|Withdrawal by Subject|1
7841739|NCT01425528|12321116|FG001|Overall Study|Withdrawal by Subject|1
7841740|NCT01425281|12321124|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1
7841741|NCT01425281|12321125|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0
7841742|NCT01425281|12321124|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3
7841743|NCT01425281|12321125|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0
7841744|NCT01425281|12321124|FG000|At 180-day Clinical Follow-up|Death|0
7841745|NCT01425281|12321125|FG001|At 180-day Clinical Follow-up|Death|1
7841746|NCT01425281|12321124|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1
7841747|NCT01425281|12321125|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1
7841748|NCT01425281|12321124|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1
7841749|NCT01425281|12321125|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0
7841750|NCT01425281|12321124|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2
7841751|NCT01425281|12321125|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1
7841752|NCT01425281|12321124|FG000|At 2-year Clinical Follow-up|Death|2
7841753|NCT01425281|12321125|FG001|At 2-year Clinical Follow-up|Death|0
7841754|NCT01425281|12321124|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1
7841755|NCT01425281|12321125|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0
7841756|NCT01425281|12321124|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1
7841757|NCT01425281|12321125|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0
7841758|NCT01425281|12321124|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3
7841759|NCT01425281|12321125|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3
7841760|NCT01425281|12321124|FG000|At 3-year Clinical Follow-up|Death|2
7841761|NCT01425281|12321125|FG001|At 3-year Clinical Follow-up|Death|3
7841762|NCT01425281|12321124|FG000|At 4-year Clinical Follow-up|Death|7
7841763|NCT01425281|12321125|FG001|At 4-year Clinical Follow-up|Death|3
7841764|NCT01425281|12321124|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3
7841765|NCT01425281|12321125|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2
7841766|NCT01425281|12321124|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
7841767|NCT01425281|12321125|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
7841768|NCT01425281|12321124|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6
7841769|NCT01425281|12321125|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5
7841770|NCT01425281|12321124|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4
7841771|NCT01425281|12321125|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1
7841772|NCT01425281|12321124|FG000|At 5-year Clinical Follow-up|Death|2
7841773|NCT01425281|12321125|FG001|At 5-year Clinical Follow-up|Death|0
7841774|NCT01425281|12321124|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2
7841775|NCT01425281|12321125|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1
7841776|NCT01425281|12321124|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19
7841777|NCT01425281|12321125|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7
7841778|NCT01425281|12321124|FG000|At 5-year Clinical Follow-up|Refused/terminated|9
7841779|NCT01425281|12321125|FG001|At 5-year Clinical Follow-up|Refused/terminated|3
7841780|NCT01425632|12321135|FG000|Overall Study|Adverse Event|0
7841781|NCT01425632|12321136|FG001|Overall Study|Adverse Event|1
7841782|NCT01425632|12321137|FG002|Overall Study|Adverse Event|1
7841783|NCT01425632|12321135|FG000|Overall Study|Physician Decision|1
7841784|NCT01425632|12321136|FG001|Overall Study|Physician Decision|0
7841785|NCT01425632|12321137|FG002|Overall Study|Physician Decision|0
7841786|NCT01425632|12321135|FG000|Overall Study|Protocol Violation|0
7841787|NCT01425632|12321136|FG001|Overall Study|Protocol Violation|0
7841788|NCT01425632|12321137|FG002|Overall Study|Protocol Violation|2
7841789|NCT01425632|12321135|FG000|Overall Study|Withdrawal by Subject|0
7841790|NCT01425632|12321136|FG001|Overall Study|Withdrawal by Subject|0
7841791|NCT01425632|12321137|FG002|Overall Study|Withdrawal by Subject|1
7841792|NCT01425723|12321147|FG000|Overall Study|Lack of Efficacy|0
7841793|NCT01425723|12321148|FG001|Overall Study|Lack of Efficacy|1
7841794|NCT01425723|12321147|FG000|Overall Study|Withdrawal by Subject|1
7841795|NCT01425723|12321148|FG001|Overall Study|Withdrawal by Subject|4
7841796|NCT01425723|12321147|FG000|Overall Study|Lost to Follow-up|0
7841797|NCT01425723|12321148|FG001|Overall Study|Lost to Follow-up|3
7841798|NCT01425723|12321147|FG000|Overall Study|Physician Decision|2
7841799|NCT01425723|12321148|FG001|Overall Study|Physician Decision|0
7841800|NCT01425723|12321147|FG000|Overall Study|Other|1
7841801|NCT01425723|12321148|FG001|Overall Study|Other|10
7841802|NCT01425749|12321165|FG000|Overall Study|progression of melanoma|0
7841803|NCT01425749|12321166|FG001|Overall Study|progression of melanoma|1
7841804|NCT01425801|12321175|FG000|Period 1|Withdrawal by Subject|0
7841805|NCT01425801|12321176|FG001|Period 1|Withdrawal by Subject|0
7841806|NCT01425801|12321177|FG002|Period 1|Withdrawal by Subject|0
7841807|NCT01425801|12321178|FG003|Period 1|Withdrawal by Subject|0
7841808|NCT01425801|12321179|FG004|Period 1|Withdrawal by Subject|1
7841809|NCT01425801|12321180|FG005|Period 1|Withdrawal by Subject|0
7841810|NCT01425801|12321175|FG000|Period 2|Withdrawal by Subject|0
7841811|NCT01425801|12321176|FG001|Period 2|Withdrawal by Subject|0
7841812|NCT01425801|12321177|FG002|Period 2|Withdrawal by Subject|0
7841813|NCT01425801|12321178|FG003|Period 2|Withdrawal by Subject|0
7841814|NCT01425801|12321179|FG004|Period 2|Withdrawal by Subject|1
7841815|NCT01425801|12321180|FG005|Period 2|Withdrawal by Subject|0
7841816|NCT01425801|12321175|FG000|Period 3|Stability criteria not fullfilled|0
7841817|NCT01425801|12321176|FG001|Period 3|Stability criteria not fullfilled|0
7841818|NCT01425801|12321177|FG002|Period 3|Stability criteria not fullfilled|1
7841819|NCT01425801|12321178|FG003|Period 3|Stability criteria not fullfilled|0
7841820|NCT01425801|12321179|FG004|Period 3|Stability criteria not fullfilled|0
7841821|NCT01425801|12321180|FG005|Period 3|Stability criteria not fullfilled|0
7841822|NCT01425801|12321175|FG000|Period 4|Not able to maintain visit schedule|0
7841823|NCT01425801|12321176|FG001|Period 4|Not able to maintain visit schedule|0
7841824|NCT01425801|12321177|FG002|Period 4|Not able to maintain visit schedule|1
7841825|NCT01425801|12321178|FG003|Period 4|Not able to maintain visit schedule|0
7841826|NCT01425801|12321179|FG004|Period 4|Not able to maintain visit schedule|0
7841827|NCT01425801|12321180|FG005|Period 4|Not able to maintain visit schedule|0
7841828|NCT01425814|12321194|FG000|Period 1|Stability criteria not fulfilled|0
7841829|NCT01425814|12321195|FG001|Period 1|Stability criteria not fulfilled|1
7841830|NCT01425814|12321196|FG002|Period 1|Stability criteria not fulfilled|0
7841831|NCT01425814|12321197|FG003|Period 1|Stability criteria not fulfilled|0
7841832|NCT01425814|12321198|FG004|Period 1|Stability criteria not fulfilled|0
7841833|NCT01425814|12321199|FG005|Period 1|Stability criteria not fulfilled|0
7841834|NCT01425814|12321194|FG000|Period 2|Stability criteria not fulfilled|0
7841835|NCT01425814|12321195|FG001|Period 2|Stability criteria not fulfilled|1
7841836|NCT01425814|12321196|FG002|Period 2|Stability criteria not fulfilled|0
7841837|NCT01425814|12321197|FG003|Period 2|Stability criteria not fulfilled|0
7841838|NCT01425814|12321198|FG004|Period 2|Stability criteria not fulfilled|0
7841839|NCT01425814|12321199|FG005|Period 2|Stability criteria not fulfilled|0
7841840|NCT01425814|12321194|FG000|Period 3|Adverse Event|0
7841841|NCT01425814|12321195|FG001|Period 3|Adverse Event|0
7841842|NCT01425814|12321196|FG002|Period 3|Adverse Event|0
7841843|NCT01425814|12321197|FG003|Period 3|Adverse Event|0
7841844|NCT01425814|12321198|FG004|Period 3|Adverse Event|0
7841845|NCT01425814|12321199|FG005|Period 3|Adverse Event|1
7841846|NCT01425814|12321194|FG000|Period 4|Adverse Event|1
7841847|NCT01425814|12321195|FG001|Period 4|Adverse Event|0
7841848|NCT01425814|12321196|FG002|Period 4|Adverse Event|1
7841849|NCT01425814|12321197|FG003|Period 4|Adverse Event|0
7841850|NCT01425814|12321198|FG004|Period 4|Adverse Event|0
7841851|NCT01425814|12321199|FG005|Period 4|Adverse Event|0
7841852|NCT01425814|12321194|FG000|Period 5|Stability criteria not fulfilled|0
7841853|NCT01425814|12321195|FG001|Period 5|Stability criteria not fulfilled|0
7841854|NCT01425814|12321196|FG002|Period 5|Stability criteria not fulfilled|1
7841855|NCT01425814|12321197|FG003|Period 5|Stability criteria not fulfilled|0
7841856|NCT01425814|12321198|FG004|Period 5|Stability criteria not fulfilled|0
7841857|NCT01425814|12321199|FG005|Period 5|Stability criteria not fulfilled|1
7841858|NCT01426009|12321227|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1
7841859|NCT01426009|12321227|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1
7841860|NCT01426009|12321227|FG000|Washout 1|Withdrawal by Subject|1
7841861|NCT01426009|12321227|FG000|Washout 1|Personal Reasons|1
7841862|NCT01426009|12321227|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4
7841863|NCT01426009|12321227|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1
7841864|NCT01426009|12321227|FG000|Washout 2|electrive surgery|1
7841865|NCT01426009|12321227|FG000|Washout 3|personal reasons|1
7841866|NCT01426009|12321227|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1
7841867|NCT01426009|12321227|FG000|Washout 4|Lost to Follow-up|1
7841868|NCT01426217|12321249|FG000|Overall Study|lost sample|8
7841869|NCT01426217|12321250|FG001|Overall Study|lost sample|14
7841870|NCT01426347|12321266|FG000|Overall Study|Lost to Follow-up|0
7841871|NCT01426347|12321267|FG001|Overall Study|Lost to Follow-up|3
7841872|NCT01426347|12321266|FG000|Overall Study|Protocol Violation|2
7841873|NCT01426347|12321267|FG001|Overall Study|Protocol Violation|0
7841874|NCT01426347|12321266|FG000|Overall Study|Withdrawal by Subject|5
7841875|NCT01426347|12321267|FG001|Overall Study|Withdrawal by Subject|0
7841876|NCT01426373|12321282|FG000|Overall Study|Adverse Event|6
7841877|NCT01426373|12321282|FG000|Overall Study|Lost to Follow-up|14
7841878|NCT01426373|12321282|FG000|Overall Study|Participant Convenience|10
7841879|NCT01426373|12321282|FG000|Overall Study|Miscellaneous Reasons|4
7841880|NCT01426386|12321294|FG000|Overall Study|Adverse Event|0
7841881|NCT01426386|12321295|FG001|Overall Study|Adverse Event|1
7841882|NCT01426386|12321296|FG002|Overall Study|Adverse Event|0
7841883|NCT01426386|12321297|FG003|Overall Study|Adverse Event|0
7841884|NCT01426386|12321298|FG004|Overall Study|Adverse Event|0
7841885|NCT01426386|12321299|FG005|Overall Study|Adverse Event|0
7841886|NCT01426386|12321294|FG000|Overall Study|Did not attend scheduled visit|1
7841887|NCT01426386|12321295|FG001|Overall Study|Did not attend scheduled visit|4
7841888|NCT01426386|12321296|FG002|Overall Study|Did not attend scheduled visit|0
7841889|NCT01426386|12321297|FG003|Overall Study|Did not attend scheduled visit|0
7841890|NCT01426386|12321298|FG004|Overall Study|Did not attend scheduled visit|2
7841891|NCT01426386|12321299|FG005|Overall Study|Did not attend scheduled visit|1
7841892|NCT01426386|12321294|FG000|Overall Study|Poor response|2
7841893|NCT01426386|12321295|FG001|Overall Study|Poor response|1
7841894|NCT01426386|12321296|FG002|Overall Study|Poor response|2
7841895|NCT01426386|12321297|FG003|Overall Study|Poor response|0
7841896|NCT01426386|12321298|FG004|Overall Study|Poor response|1
7841897|NCT01426386|12321299|FG005|Overall Study|Poor response|0
7841898|NCT01426386|12321294|FG000|Overall Study|Personal reasons|0
7841899|NCT01426386|12321295|FG001|Overall Study|Personal reasons|0
7841900|NCT01426386|12321296|FG002|Overall Study|Personal reasons|0
7841901|NCT01426386|12321297|FG003|Overall Study|Personal reasons|0
7841902|NCT01426386|12321298|FG004|Overall Study|Personal reasons|1
7841903|NCT01426386|12321299|FG005|Overall Study|Personal reasons|0
7841904|NCT01426412|12321322|FG000|Overall Study|Withdrawal by Subject|1
7841905|NCT01426412|12321323|FG001|Overall Study|Withdrawal by Subject|0
7841906|NCT01426412|12321324|FG002|Overall Study|Withdrawal by Subject|0
7841907|NCT01426412|12321325|FG003|Overall Study|Withdrawal by Subject|0
7841908|NCT01426412|12321326|FG004|Overall Study|Withdrawal by Subject|1
7841909|NCT01426412|12321327|FG005|Overall Study|Withdrawal by Subject|0
7841910|NCT01426412|12321328|FG006|Overall Study|Withdrawal by Subject|0
7841911|NCT01426412|12321329|FG007|Overall Study|Withdrawal by Subject|3
7841912|NCT01426412|12321330|FG008|Overall Study|Withdrawal by Subject|1
7841913|NCT01426425|12321361|FG000|Overall Study|Exited prior to EP study|22
7841914|NCT01426425|12321361|FG000|Overall Study|Inclusion/exclusion criteria not met|151
7841915|NCT01426425|12321361|FG000|Overall Study|Met inclusion/exclusion, not treated|2
7841916|NCT01426438|12321368|FG000|Overall Study|Lost to Follow-up|1
7841917|NCT01426438|12321369|FG001|Overall Study|Lost to Follow-up|3
7841918|NCT01426438|12321368|FG000|Overall Study|Off study Treatment|9
7841919|NCT01426438|12321369|FG001|Overall Study|Off study Treatment|3
7841920|NCT01426438|12321368|FG000|Overall Study|Poor scan quality|3
7841921|NCT01426438|12321369|FG001|Overall Study|Poor scan quality|2
7841922|NCT01426438|12321368|FG000|Overall Study|Missed Scan|2
7841923|NCT01426438|12321369|FG001|Overall Study|Missed Scan|2
7841924|NCT01426789|12321399|FG000|Part 1|Protocol deviation|0
7841925|NCT01426789|12321400|FG001|Part 1|Protocol deviation|1
7841926|NCT01426789|12321401|FG002|Part 1|Protocol deviation|0
7841927|NCT01426789|12321402|FG003|Part 1|Protocol deviation|0
7841928|NCT01426789|12321403|FG004|Part 1|Protocol deviation|0
7841929|NCT01426789|12321404|FG005|Part 1|Protocol deviation|0
7841930|NCT01426789|12321399|FG000|Part 1|Lost to Follow-up|1
7841931|NCT01426789|12321400|FG001|Part 1|Lost to Follow-up|2
7841932|NCT01426789|12321401|FG002|Part 1|Lost to Follow-up|0
7841933|NCT01426789|12321402|FG003|Part 1|Lost to Follow-up|0
7841934|NCT01426789|12321403|FG004|Part 1|Lost to Follow-up|0
7841935|NCT01426789|12321404|FG005|Part 1|Lost to Follow-up|0
7841936|NCT01426789|12321399|FG000|Part 1|Lack of Efficacy|2
7841937|NCT01426789|12321400|FG001|Part 1|Lack of Efficacy|1
7841938|NCT01426789|12321401|FG002|Part 1|Lack of Efficacy|0
7841939|NCT01426789|12321402|FG003|Part 1|Lack of Efficacy|0
7841940|NCT01426789|12321403|FG004|Part 1|Lack of Efficacy|0
7841941|NCT01426789|12321404|FG005|Part 1|Lack of Efficacy|0
7841942|NCT01426789|12321399|FG000|Part 1|Adverse Event|3
7841943|NCT01426789|12321400|FG001|Part 1|Adverse Event|0
7841944|NCT01426789|12321401|FG002|Part 1|Adverse Event|0
7841945|NCT01426789|12321402|FG003|Part 1|Adverse Event|0
7841946|NCT01426789|12321403|FG004|Part 1|Adverse Event|0
7841947|NCT01426789|12321404|FG005|Part 1|Adverse Event|0
7841948|NCT01426789|12321399|FG000|Part 2|Protocol deviation|0
7841949|NCT01426789|12321400|FG001|Part 2|Protocol deviation|0
7841950|NCT01426789|12321401|FG002|Part 2|Protocol deviation|1
7841951|NCT01426789|12321402|FG003|Part 2|Protocol deviation|0
7841952|NCT01426789|12321403|FG004|Part 2|Protocol deviation|0
7841953|NCT01426789|12321404|FG005|Part 2|Protocol deviation|0
7841954|NCT01426789|12321399|FG000|Part 2|Death|0
7841955|NCT01426789|12321400|FG001|Part 2|Death|0
7841956|NCT01426789|12321401|FG002|Part 2|Death|1
7841957|NCT01426789|12321402|FG003|Part 2|Death|0
7841958|NCT01426789|12321403|FG004|Part 2|Death|1
7841959|NCT01426789|12321404|FG005|Part 2|Death|0
7841960|NCT01426789|12321399|FG000|Part 2|Administrative problems|0
7841961|NCT01426789|12321400|FG001|Part 2|Administrative problems|0
7841962|NCT01426789|12321401|FG002|Part 2|Administrative problems|2
7841963|NCT01426789|12321402|FG003|Part 2|Administrative problems|0
7841964|NCT01426789|12321403|FG004|Part 2|Administrative problems|1
7841965|NCT01426789|12321404|FG005|Part 2|Administrative problems|0
7841966|NCT01426789|12321399|FG000|Part 2|Lost to Follow-up|0
7841967|NCT01426789|12321400|FG001|Part 2|Lost to Follow-up|0
7841968|NCT01426789|12321401|FG002|Part 2|Lost to Follow-up|4
7841969|NCT01426789|12321402|FG003|Part 2|Lost to Follow-up|0
7841970|NCT01426789|12321403|FG004|Part 2|Lost to Follow-up|1
7841971|NCT01426789|12321404|FG005|Part 2|Lost to Follow-up|0
7841972|NCT01426789|12321399|FG000|Part 2|Withdrawal by Subject|0
7841973|NCT01426789|12321400|FG001|Part 2|Withdrawal by Subject|0
7841974|NCT01426789|12321401|FG002|Part 2|Withdrawal by Subject|0
7841975|NCT01426789|12321402|FG003|Part 2|Withdrawal by Subject|1
7841976|NCT01426789|12321403|FG004|Part 2|Withdrawal by Subject|2
7841977|NCT01426789|12321404|FG005|Part 2|Withdrawal by Subject|0
7841978|NCT01426789|12321399|FG000|Part 2|Lack of Efficacy|0
7841979|NCT01426789|12321400|FG001|Part 2|Lack of Efficacy|0
7841980|NCT01426789|12321401|FG002|Part 2|Lack of Efficacy|5
7841981|NCT01426789|12321402|FG003|Part 2|Lack of Efficacy|0
7841982|NCT01426789|12321403|FG004|Part 2|Lack of Efficacy|2
7841983|NCT01426789|12321404|FG005|Part 2|Lack of Efficacy|0
7841984|NCT01426789|12321399|FG000|Part 2|Adverse Event|0
7841985|NCT01426789|12321400|FG001|Part 2|Adverse Event|0
7841986|NCT01426789|12321401|FG002|Part 2|Adverse Event|2
7841987|NCT01426789|12321402|FG003|Part 2|Adverse Event|0
7841988|NCT01426789|12321403|FG004|Part 2|Adverse Event|1
7841989|NCT01426789|12321404|FG005|Part 2|Adverse Event|0
7841990|NCT01426854|12321423|FG000|Overall Study|Adverse Event|1
7841991|NCT01426854|12321424|FG001|Overall Study|Adverse Event|5
7841992|NCT01426854|12321423|FG000|Overall Study|Subject Decision Unrelated to AE|5
7841993|NCT01426854|12321424|FG001|Overall Study|Subject Decision Unrelated to AE|6
7841994|NCT01426854|12321423|FG000|Overall Study|Lost to Follow-up|3
7841995|NCT01426854|12321424|FG001|Overall Study|Lost to Follow-up|0
7841996|NCT01426854|12321423|FG000|Overall Study|Noncompliance|0
7841997|NCT01426854|12321424|FG001|Overall Study|Noncompliance|1
7841998|NCT01426854|12321423|FG000|Overall Study|Treatment Failure|0
7841999|NCT01426854|12321424|FG001|Overall Study|Treatment Failure|16
7842000|NCT01426854|12321423|FG000|Overall Study|Protocol Deviation|0
7842001|NCT01426854|12321424|FG001|Overall Study|Protocol Deviation|1
7842002|NCT01426854|12321423|FG000|Overall Study|Other|3
7842003|NCT01426854|12321424|FG001|Overall Study|Other|2
7842004|NCT01426958|12321443|FG000|Overall Study|Adverse Event|2
7842005|NCT01427309|12321464|FG000|Overall Study|Lost to Follow-up|130
7842006|NCT01427309|12321465|FG001|Overall Study|Lost to Follow-up|145
7842007|NCT01427309|12321466|FG002|Overall Study|Lost to Follow-up|122
7842008|NCT01427309|12321467|FG003|Overall Study|Lost to Follow-up|135
7842009|NCT01427309|12321464|FG000|Overall Study|Protocol Violation|42
7842010|NCT01427309|12321465|FG001|Overall Study|Protocol Violation|69
7842011|NCT01427309|12321466|FG002|Overall Study|Protocol Violation|125
7842012|NCT01427309|12321467|FG003|Overall Study|Protocol Violation|124
7842013|NCT01427309|12321464|FG000|Overall Study|Adverse Event|0
7842014|NCT01427309|12321465|FG001|Overall Study|Adverse Event|0
7842015|NCT01427309|12321466|FG002|Overall Study|Adverse Event|3
7842016|NCT01427309|12321467|FG003|Overall Study|Adverse Event|1
7842017|NCT01427309|12321464|FG000|Overall Study|Serious adverse event|52
7842018|NCT01427309|12321465|FG001|Overall Study|Serious adverse event|45
7842019|NCT01427309|12321466|FG002|Overall Study|Serious adverse event|50
7842020|NCT01427309|12321467|FG003|Overall Study|Serious adverse event|61
7842021|NCT01427309|12321464|FG000|Overall Study|Withdrawal by Subject|148
7842022|NCT01427309|12321465|FG001|Overall Study|Withdrawal by Subject|148
7842023|NCT01427309|12321466|FG002|Overall Study|Withdrawal by Subject|61
7842024|NCT01427309|12321467|FG003|Overall Study|Withdrawal by Subject|55
7842025|NCT01427608|12321524|FG000|Overall Study|Death|1
7842026|NCT01427608|12321525|FG001|Overall Study|Death|0
7842027|NCT01427608|12321524|FG000|Overall Study|Withdrawal by Subject|7
7842028|NCT01427608|12321525|FG001|Overall Study|Withdrawal by Subject|3
7842029|NCT01427608|12321524|FG000|Overall Study|Relapsed-all cause|13
7842030|NCT01427608|12321525|FG001|Overall Study|Relapsed-all cause|34
7842031|NCT01427608|12321524|FG000|Overall Study|Events not attributed to study meds|0
7842032|NCT01427608|12321525|FG001|Overall Study|Events not attributed to study meds|1
7842033|NCT01427738|12321535|FG000|Overall Study|Death|12
7842034|NCT01427738|12321536|FG001|Overall Study|Death|9
7842035|NCT01427738|12321535|FG000|Overall Study|Severe debilitation, unable to continue|0
7842036|NCT01427738|12321536|FG001|Overall Study|Severe debilitation, unable to continue|1
7842037|NCT01427738|12321535|FG000|Overall Study|Subject unable to get to clinic|5
7842038|NCT01427738|12321536|FG001|Overall Study|Subject unable to get to clinic|2
7842039|NCT01427738|12321535|FG000|Overall Study|Withdrawal by Subject|0
7842040|NCT01427738|12321536|FG001|Overall Study|Withdrawal by Subject|2
7842041|NCT01427738|12321535|FG000|Overall Study|Subject not willing to adhere to reqs|1
7842042|NCT01427738|12321536|FG001|Overall Study|Subject not willing to adhere to reqs|2
7842043|NCT01427738|12321535|FG000|Overall Study|Lost to Follow-up|1
7842044|NCT01427738|12321536|FG001|Overall Study|Lost to Follow-up|5
7842045|NCT01427751|12321544|FG000|Overall Study|Adverse Event|18
7842046|NCT01427751|12321545|FG001|Overall Study|Adverse Event|2
7842047|NCT01427751|12321544|FG000|Overall Study|No further treatment benefit expected|5
7842048|NCT01427751|12321545|FG001|Overall Study|No further treatment benefit expected|1
7842049|NCT01427751|12321544|FG000|Overall Study|Lost to Follow-up|3
7842050|NCT01427751|12321545|FG001|Overall Study|Lost to Follow-up|1
7842051|NCT01427751|12321544|FG000|Overall Study|Withdrawal of consent|2
7842052|NCT01427751|12321545|FG001|Overall Study|Withdrawal of consent|2
7842053|NCT01427751|12321544|FG000|Overall Study|Protocol Violation|6
7842054|NCT01427751|12321545|FG001|Overall Study|Protocol Violation|4
7842055|NCT01427751|12321544|FG000|Overall Study|Death|2
7842056|NCT01427751|12321545|FG001|Overall Study|Death|0
7842057|NCT01427751|12321544|FG000|Overall Study|Other miscellaneous reasons|6
7842058|NCT01427751|12321545|FG001|Overall Study|Other miscellaneous reasons|4
7842059|NCT01427803|12321553|FG000|Overall Study|Lost to Follow-up|32
7842060|NCT01427803|12321554|FG001|Overall Study|Lost to Follow-up|26
7842061|NCT01427803|12321553|FG000|Overall Study|Withdrawal by Subject|20
7842062|NCT01427803|12321554|FG001|Overall Study|Withdrawal by Subject|0
7842063|NCT01427803|12321553|FG000|Overall Study|Unable to complete full treatment period|6
7842064|NCT01427803|12321554|FG001|Overall Study|Unable to complete full treatment period|0
7842065|NCT01427803|12321553|FG000|Overall Study|Protocol Violation|1
7842066|NCT01427803|12321554|FG001|Overall Study|Protocol Violation|0
7842067|NCT01427803|12321553|FG000|Overall Study|Physician Decision|3
7842068|NCT01427803|12321554|FG001|Overall Study|Physician Decision|0
7842069|NCT01427803|12321553|FG000|Overall Study|did not take product|1
7842070|NCT01427803|12321554|FG001|Overall Study|did not take product|0
7842071|NCT01427907|12321564|FG000|Overall Study|Withdrawal by Subject|3
7842072|NCT01427907|12321565|FG001|Overall Study|Withdrawal by Subject|4
7842073|NCT01427920|12321573|FG000|Overall Study|Adverse Event|1
7842074|NCT01427920|12321574|FG001|Overall Study|Adverse Event|2
7842075|NCT01427920|12321573|FG000|Overall Study|Lack of Efficacy|1
7842076|NCT01427920|12321574|FG001|Overall Study|Lack of Efficacy|0
7842077|NCT01427920|12321573|FG000|Overall Study|Protocol Violation|1
7842078|NCT01427920|12321574|FG001|Overall Study|Protocol Violation|3
7842079|NCT01427920|12321573|FG000|Overall Study|Withdrawal Criteria|4
7842080|NCT01427920|12321574|FG001|Overall Study|Withdrawal Criteria|4
7842081|NCT01427920|12321573|FG000|Overall Study|Unclassified|2
7842082|NCT01427920|12321574|FG001|Overall Study|Unclassified|8
7842083|NCT01427933|12321582|FG000|Overall Study|Withdrawal by Subject|5
7842084|NCT01427933|12321583|FG001|Overall Study|Withdrawal by Subject|8
7842085|NCT01427933|12321582|FG000|Overall Study|Lost to Follow-up|1
7842086|NCT01427933|12321583|FG001|Overall Study|Lost to Follow-up|5
7842087|NCT01427933|12321582|FG000|Overall Study|Other|1
7842088|NCT01427933|12321583|FG001|Overall Study|Other|0
7842089|NCT01427933|12321582|FG000|Overall Study|Investigator's Decision|1
7842090|NCT01427933|12321583|FG001|Overall Study|Investigator's Decision|0
7842091|NCT01427972|12321602|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0
7842092|NCT01427972|12321603|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0
7842093|NCT01427972|12321604|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0
7842094|NCT01427972|12321605|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0
7842095|NCT01427972|12321606|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0
7842096|NCT01427972|12321607|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0
7842097|NCT01427972|12321608|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0
7842098|NCT01427972|12321609|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1
7842099|NCT01427972|12321610|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0
7842100|NCT01427972|12321611|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0
7842101|NCT01427972|12321612|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0
7842102|NCT01427972|12321613|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0
7842103|NCT01427972|12321602|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0
7842104|NCT01427972|12321603|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0
7842105|NCT01427972|12321604|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0
7842106|NCT01427972|12321605|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0
7842107|NCT01427972|12321606|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0
7842108|NCT01427972|12321607|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2
7842109|NCT01427972|12321608|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0
7842110|NCT01427972|12321609|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0
7842111|NCT01427972|12321610|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0
7842112|NCT01427972|12321611|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0
7842113|NCT01427972|12321612|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0
7842114|NCT01427972|12321613|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0
7842115|NCT01427972|12321602|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7842116|NCT01427972|12321603|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1
7842117|NCT01427972|12321604|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7842118|NCT01427972|12321605|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7842119|NCT01427972|12321606|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7842120|NCT01427972|12321607|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7842121|NCT01427972|12321608|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7842122|NCT01427972|12321609|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7842123|NCT01427972|12321610|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7842124|NCT01427972|12321611|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7842125|NCT01427972|12321612|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7842126|NCT01427972|12321613|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7842127|NCT01428063|12321626|FG000|Overall Study|Lack of Efficacy|8
7842128|NCT01428063|12321627|FG001|Overall Study|Lack of Efficacy|4
7842129|NCT01428063|12321628|FG002|Overall Study|Lack of Efficacy|1
7842130|NCT01428063|12321626|FG000|Overall Study|Adverse Event|2
7842131|NCT01428063|12321627|FG001|Overall Study|Adverse Event|3
7842132|NCT01428063|12321628|FG002|Overall Study|Adverse Event|0
7842133|NCT01428063|12321626|FG000|Overall Study|Lost to Follow-up|0
7842134|NCT01428063|12321627|FG001|Overall Study|Lost to Follow-up|2
7842135|NCT01428063|12321628|FG002|Overall Study|Lost to Follow-up|0
7842136|NCT01428063|12321626|FG000|Overall Study|No longer meets study criteria|0
7842137|NCT01428063|12321627|FG001|Overall Study|No longer meets study criteria|1
7842138|NCT01428063|12321628|FG002|Overall Study|No longer meets study criteria|0
7842139|NCT01428076|12321649|FG000|Overall Study|Adverse Event|0
7842140|NCT01428076|12321650|FG001|Overall Study|Adverse Event|1
7842141|NCT01428115|12321658|FG000|Overall Study|Lack of Efficacy|3
7842142|NCT01428115|12321658|FG000|Overall Study|Lost to Follow-up|10
7842143|NCT01428115|12321658|FG000|Overall Study|Pregnancy|1
7842144|NCT01428115|12321658|FG000|Overall Study|Protocol Violation|3
7842145|NCT01428115|12321658|FG000|Overall Study|Withdrawal by Subject|4
7842146|NCT01428128|12321663|FG000|Overall Study|Withdrawal by Subject|4
7842147|NCT01428128|12321663|FG000|Overall Study|Screen failure by p53|10
7842148|NCT01428128|12321663|FG000|Overall Study|Received Neulasta in one cycle|2
7842149|NCT01428128|12321663|FG000|Overall Study|Adverse Event|1
7842150|NCT01428193|12321668|FG000|Overall Study|Physician Decision|1
7842151|NCT01428193|12321668|FG000|Overall Study|Elevated screening liver enzymes|1
7842152|NCT01428219|12321672|FG000|Overall Study|25 patients enrolled, 3 were not treated|3
7842153|NCT01428258|12321682|FG000|Intervention 1|Withdrawal by Subject|2
7842154|NCT01428258|12321683|FG001|Intervention 1|Withdrawal by Subject|0
7842155|NCT01428453|12321711|FG000|Overall Study|Adverse Event|2
7842156|NCT01428453|12321712|FG001|Overall Study|Adverse Event|7
7842157|NCT01428453|12321711|FG000|Overall Study|Protocol Violation|1
7842158|NCT01428453|12321712|FG001|Overall Study|Protocol Violation|0
7842159|NCT01428453|12321711|FG000|Overall Study|Lost to Follow-up|0
7842160|NCT01428453|12321712|FG001|Overall Study|Lost to Follow-up|1
7842161|NCT01428453|12321711|FG000|Overall Study|Withdrawal by Subject|3
7842162|NCT01428453|12321712|FG001|Overall Study|Withdrawal by Subject|1
7842163|NCT01428583|12321720|FG000|Overall Study|Adverse Event|75
7842164|NCT01428583|12321720|FG000|Overall Study|Withdrawal by Subject|51
7842165|NCT01428583|12321720|FG000|Overall Study|Lack of Efficacy|37
7842166|NCT01428583|12321720|FG000|Overall Study|Lost to Follow-up|17
7842167|NCT01428583|12321720|FG000|Overall Study|Death|1
7842168|NCT01428583|12321720|FG000|Overall Study|Pregnancy|1
7842169|NCT01428583|12321720|FG000|Overall Study|Protocol Violation|1
7842170|NCT01428583|12321720|FG000|Overall Study|Physician Decision|12
7842171|NCT01428583|12321720|FG000|Overall Study|Non-compliant|25
7842172|NCT01428583|12321720|FG000|Overall Study|Confirmed positive urine drug test|8
7842173|NCT01428583|12321720|FG000|Overall Study|Sponsor's request|3
7842174|NCT01428583|12321720|FG000|Overall Study|Other|6
7842175|NCT01428661|12321727|FG000|Double-Masked Phase|Protocol Violation|9
7842176|NCT01428661|12321728|FG001|Double-Masked Phase|Protocol Violation|4
7842177|NCT01428661|12321729|FG002|Double-Masked Phase|Protocol Violation|0
7842178|NCT01428661|12321727|FG000|Double-Masked Phase|Adverse Event|13
7842179|NCT01428661|12321728|FG001|Double-Masked Phase|Adverse Event|4
7842180|NCT01428661|12321729|FG002|Double-Masked Phase|Adverse Event|0
7842181|NCT01428661|12321727|FG000|Double-Masked Phase|Lost to Follow-up|14
7842182|NCT01428661|12321728|FG001|Double-Masked Phase|Lost to Follow-up|14
7842183|NCT01428661|12321729|FG002|Double-Masked Phase|Lost to Follow-up|0
7842184|NCT01428661|12321727|FG000|Double-Masked Phase|Withdrawal by Subject|18
7842185|NCT01428661|12321728|FG001|Double-Masked Phase|Withdrawal by Subject|20
7842186|NCT01428661|12321729|FG002|Double-Masked Phase|Withdrawal by Subject|0
7842187|NCT01428661|12321727|FG000|Double-Masked Phase|Lack of Efficacy|2
7842188|NCT01428661|12321728|FG001|Double-Masked Phase|Lack of Efficacy|1
7842189|NCT01428661|12321729|FG002|Double-Masked Phase|Lack of Efficacy|0
7842190|NCT01428661|12321727|FG000|Double-Masked Phase|*Various|1
7842191|NCT01428661|12321728|FG001|Double-Masked Phase|*Various|6
7842192|NCT01428661|12321729|FG002|Double-Masked Phase|*Various|0
7842193|NCT01428661|12321727|FG000|Open Label Extension|Protocol Violation|0
7842194|NCT01428661|12321728|FG001|Open Label Extension|Protocol Violation|0
7842195|NCT01428661|12321729|FG002|Open Label Extension|Protocol Violation|9
7842196|NCT01428661|12321727|FG000|Open Label Extension|Adverse Event|0
7842197|NCT01428661|12321728|FG001|Open Label Extension|Adverse Event|0
7842198|NCT01428661|12321729|FG002|Open Label Extension|Adverse Event|15
7842199|NCT01428661|12321727|FG000|Open Label Extension|Lost to Follow-up|0
7842200|NCT01428661|12321728|FG001|Open Label Extension|Lost to Follow-up|0
7842201|NCT01428661|12321729|FG002|Open Label Extension|Lost to Follow-up|38
7842202|NCT01428661|12321727|FG000|Open Label Extension|Withdrawal by Subject|0
7842203|NCT01428661|12321728|FG001|Open Label Extension|Withdrawal by Subject|0
7842204|NCT01428661|12321729|FG002|Open Label Extension|Withdrawal by Subject|49
7842205|NCT01428661|12321727|FG000|Open Label Extension|Lack of Efficacy|0
7842206|NCT01428661|12321728|FG001|Open Label Extension|Lack of Efficacy|0
7842207|NCT01428661|12321729|FG002|Open Label Extension|Lack of Efficacy|24
7842208|NCT01428661|12321727|FG000|Open Label Extension|**Various|0
7842209|NCT01428661|12321728|FG001|Open Label Extension|**Various|0
7842210|NCT01428661|12321729|FG002|Open Label Extension|**Various|185
7842211|NCT01428713|12321737|FG000|Overall Study|Non-compliance|2
7842212|NCT01428713|12321738|FG001|Overall Study|Non-compliance|2
7842213|NCT01428713|12321737|FG000|Overall Study|Withdrawal by Subject|1
7842214|NCT01428713|12321738|FG001|Overall Study|Withdrawal by Subject|1
7842215|NCT01428713|12321737|FG000|Overall Study|Adverse Event|0
7842216|NCT01428713|12321738|FG001|Overall Study|Adverse Event|2
7863065|NCT01602510|12352207|FG002|Randomized Phase|Protocol Violation|3
7863066|NCT01602510|12352205|FG000|Randomized Phase|Met protocol-defined stopping criteria|0
7863067|NCT01602510|12352206|FG001|Randomized Phase|Met protocol-defined stopping criteria|58
7863068|NCT01602510|12352207|FG002|Randomized Phase|Met protocol-defined stopping criteria|48
7863069|NCT01602510|12352205|FG000|Randomized Phase|Lost to Follow-up|0
7863070|NCT01602510|12352206|FG001|Randomized Phase|Lost to Follow-up|1
7863071|NCT01602510|12352207|FG002|Randomized Phase|Lost to Follow-up|3
7863072|NCT01602510|12352205|FG000|Randomized Phase|Physician Decision|0
7863073|NCT01602510|12352206|FG001|Randomized Phase|Physician Decision|0
7863074|NCT01602510|12352207|FG002|Randomized Phase|Physician Decision|2
7863075|NCT01602510|12352205|FG000|Randomized Phase|Withdrawal by Subject|0
7863076|NCT01602510|12352206|FG001|Randomized Phase|Withdrawal by Subject|6
7863077|NCT01602510|12352207|FG002|Randomized Phase|Withdrawal by Subject|7
7863078|NCT01602549|12352215|FG000|Overall Study|Protocol Violation|0
7863079|NCT01602549|12352216|FG001|Overall Study|Protocol Violation|1
7863080|NCT01602549|12352215|FG000|Overall Study|Withdrawal by Subject|1
7863081|NCT01602549|12352216|FG001|Overall Study|Withdrawal by Subject|0
7863082|NCT01602562|12352226|FG000|Overall Study|Adverse Event|3
7863083|NCT01602562|12352227|FG001|Overall Study|Adverse Event|1
7863084|NCT01602562|12352226|FG000|Overall Study|Physician Decision|1
7863085|NCT01602562|12352227|FG001|Overall Study|Physician Decision|1
7863086|NCT01602562|12352226|FG000|Overall Study|Withdrawal by Subject|1
7863087|NCT01602562|12352227|FG001|Overall Study|Withdrawal by Subject|1
7863088|NCT01602744|12352285|FG000|Overall Study|Death|17
7863089|NCT01602744|12352286|FG001|Overall Study|Death|15
7863090|NCT01602744|12352285|FG000|Overall Study|Lost to Follow-up|13
7863091|NCT01602744|12352286|FG001|Overall Study|Lost to Follow-up|8
7863092|NCT01602965|12352294|FG000|Overall Study|Lost to Follow-up|4
7863093|NCT01602965|12352295|FG001|Overall Study|Lost to Follow-up|2
7863094|NCT01603082|12352312|FG000|Overall Study|Adverse Event|0
7863095|NCT01603082|12352313|FG001|Overall Study|Adverse Event|1
7842217|NCT01428882|12321750|FG000|Overall Study|Lack of Efficacy|2
7842218|NCT01428882|12321751|FG001|Overall Study|Lack of Efficacy|7
7842219|NCT01428882|12321750|FG000|Overall Study|Protocol Violation|4
7842220|NCT01428882|12321751|FG001|Overall Study|Protocol Violation|3
7842221|NCT01429051|12321757|FG000|Titration Phase|Death|1
7842222|NCT01429051|12321757|FG000|Titration Phase|Withdrawal by Subject|7
7842223|NCT01429051|12321757|FG000|Titration Phase|Physician Decision|1
7842224|NCT01429051|12321757|FG000|Titration Phase|Unsuccessful titration at any dose|1
7842225|NCT01429051|12321757|FG000|Titration Phase|Less than 3 BTP episodes per week|2
7842226|NCT01429051|12321757|FG000|Efficacy Phase|Adverse Event|1
7842227|NCT01429051|12321757|FG000|Efficacy Phase|Death|1
7842228|NCT01429051|12321757|FG000|Tolerability Phase|Death|5
7842229|NCT01429051|12321757|FG000|Tolerability Phase|Adverse Event|2
7842230|NCT01429051|12321757|FG000|Tolerability Phase|Withdrawal by Subject|5
7842231|NCT01429051|12321757|FG000|Tolerability Phase|Physician Decision|1
7842232|NCT01429051|12321757|FG000|Tolerability Phase|Other|2
7842233|NCT01429077|12321787|FG000|Overall Study|Lost to Follow-up|0
7842234|NCT01429077|12321788|FG001|Overall Study|Lost to Follow-up|3
7842235|NCT01429285|12321817|FG000|Overall Study|Protocol Violation|9
7842236|NCT01429285|12321818|FG001|Overall Study|Protocol Violation|4
7842237|NCT01429285|12321817|FG000|Overall Study|Missing Data|5
7842238|NCT01429285|12321818|FG001|Overall Study|Missing Data|3
7842239|NCT01429285|12321817|FG000|Overall Study|Erroneously Enrolled Twice|8
7842240|NCT01429285|12321818|FG001|Overall Study|Erroneously Enrolled Twice|2
7842241|NCT01429298|12321826|FG000|Overall Study|Protocol Violation|4
7842242|NCT01429298|12321827|FG001|Overall Study|Protocol Violation|6
7842243|NCT01429441|12321844|FG000|Overall Study|Adverse Event|5
7842244|NCT01429441|12321845|FG001|Overall Study|Adverse Event|1
7842245|NCT01429441|12321844|FG000|Overall Study|Death|0
7842246|NCT01429441|12321845|FG001|Overall Study|Death|2
7842247|NCT01429441|12321844|FG000|Overall Study|Lost to Follow-up|5
7842248|NCT01429441|12321845|FG001|Overall Study|Lost to Follow-up|2
7842249|NCT01429441|12321844|FG000|Overall Study|Physician Decision|1
7842250|NCT01429441|12321845|FG001|Overall Study|Physician Decision|0
7842251|NCT01429441|12321844|FG000|Overall Study|Withdrawal by Subject|27
7842252|NCT01429441|12321845|FG001|Overall Study|Withdrawal by Subject|18
7842253|NCT01429584|12321876|FG000|Overall Study|Withdrawal by Subject|1
7842254|NCT01429584|12321877|FG001|Overall Study|Withdrawal by Subject|0
7842255|NCT01429584|12321876|FG000|Overall Study|Protocol Violation|0
7842256|NCT01429584|12321877|FG001|Overall Study|Protocol Violation|1
7842257|NCT01429623|12321885|FG000|Overall Study|Death|1
7842258|NCT01429623|12321886|FG001|Overall Study|Death|0
7842259|NCT01429623|12321885|FG000|Overall Study|Adverse Event|7
7842260|NCT01429623|12321886|FG001|Overall Study|Adverse Event|14
7842261|NCT01429623|12321885|FG000|Overall Study|Withdrawal by Subject|19
7842262|NCT01429623|12321886|FG001|Overall Study|Withdrawal by Subject|13
7842263|NCT01429623|12321885|FG000|Overall Study|Physician Decision|2
7842264|NCT01429623|12321886|FG001|Overall Study|Physician Decision|3
7842265|NCT01429623|12321885|FG000|Overall Study|Protocol Violation|3
7842266|NCT01429623|12321886|FG001|Overall Study|Protocol Violation|2
7842267|NCT01429623|12321885|FG000|Overall Study|Assorted|1
7842268|NCT01429623|12321886|FG001|Overall Study|Assorted|2
7842269|NCT01429623|12321885|FG000|Overall Study|Conversion to Alzheimer's disease|14
7842270|NCT01429623|12321886|FG001|Overall Study|Conversion to Alzheimer's disease|21
7842271|NCT01429623|12321885|FG000|Overall Study|No post baseline data|4
7842272|NCT01429623|12321886|FG001|Overall Study|No post baseline data|4
7842273|NCT01429792|12321892|FG000|Overall Study|Other Reasons|67
7842274|NCT01429792|12321892|FG000|Overall Study|Unknown Disposition|94
7842275|NCT01429792|12321892|FG000|Overall Study|Negative HCV-RNA at Week 4|1
7842276|NCT01429792|12321892|FG000|Overall Study|Negative HCV-RNA at Week 12|4
7842277|NCT01429792|12321892|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32
7842278|NCT01429792|12321892|FG000|Overall Study|Positive HCV-RNA at Week 24|50
7842279|NCT01429792|12321892|FG000|Overall Study|Withdrawal by Subject|70
7842280|NCT01429792|12321892|FG000|Overall Study|Lost to Follow-up|88
7842281|NCT01430104|12321927|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1
7842282|NCT01430130|12321934|FG000|Overall Study|Lost to Follow-up|1
7842283|NCT01430130|12321934|FG000|Overall Study|Infection on Control Side of Incision|1
7842284|NCT01430403|12321982|FG000|Overall Study|Lost to Follow-up|5
7842285|NCT01430403|12321983|FG001|Overall Study|Lost to Follow-up|5
7842286|NCT01430403|12321984|FG002|Overall Study|Lost to Follow-up|3
7842287|NCT01430403|12321982|FG000|Overall Study|Physician Decision|1
7842288|NCT01430403|12321983|FG001|Overall Study|Physician Decision|0
7842289|NCT01430403|12321984|FG002|Overall Study|Physician Decision|0
7842290|NCT01430403|12321982|FG000|Overall Study|Protocol Violation|2
7842291|NCT01430403|12321983|FG001|Overall Study|Protocol Violation|3
7842292|NCT01430403|12321984|FG002|Overall Study|Protocol Violation|2
7842293|NCT01430403|12321982|FG000|Overall Study|Withdrawal by Subject|9
7842294|NCT01430403|12321983|FG001|Overall Study|Withdrawal by Subject|1
7842295|NCT01430403|12321984|FG002|Overall Study|Withdrawal by Subject|3
7842296|NCT01430442|12322005|FG000|Overall Study|Subject Withdrew Consent|3
7842297|NCT01430442|12322006|FG001|Overall Study|Subject Withdrew Consent|0
7842298|NCT01430442|12322007|FG002|Overall Study|Subject Withdrew Consent|1
7842299|NCT01430442|12322008|FG003|Overall Study|Subject Withdrew Consent|0
7842300|NCT01430442|12322009|FG004|Overall Study|Subject Withdrew Consent|2
7842301|NCT01430442|12322010|FG005|Overall Study|Subject Withdrew Consent|1
7842302|NCT01430442|12322011|FG006|Overall Study|Subject Withdrew Consent|5
7842303|NCT01430442|12322012|FG007|Overall Study|Subject Withdrew Consent|2
7842304|NCT01430442|12322005|FG000|Overall Study|Lost to Follow-up|2
7842305|NCT01430442|12322006|FG001|Overall Study|Lost to Follow-up|0
7842306|NCT01430442|12322007|FG002|Overall Study|Lost to Follow-up|1
7842307|NCT01430442|12322008|FG003|Overall Study|Lost to Follow-up|2
7842308|NCT01430442|12322009|FG004|Overall Study|Lost to Follow-up|2
7842309|NCT01430442|12322010|FG005|Overall Study|Lost to Follow-up|1
7842310|NCT01430442|12322011|FG006|Overall Study|Lost to Follow-up|5
7842311|NCT01430442|12322012|FG007|Overall Study|Lost to Follow-up|1
7842312|NCT01430442|12322005|FG000|Overall Study|Pregnancy|1
7842313|NCT01430442|12322006|FG001|Overall Study|Pregnancy|0
7842314|NCT01430442|12322007|FG002|Overall Study|Pregnancy|0
7842315|NCT01430442|12322008|FG003|Overall Study|Pregnancy|0
7842316|NCT01430442|12322009|FG004|Overall Study|Pregnancy|0
7842317|NCT01430442|12322010|FG005|Overall Study|Pregnancy|1
7842318|NCT01430442|12322011|FG006|Overall Study|Pregnancy|0
7842319|NCT01430442|12322012|FG007|Overall Study|Pregnancy|0
7842320|NCT01430442|12322005|FG000|Overall Study|Patient No Longer Meets Study Criteria|7
7842321|NCT01430442|12322006|FG001|Overall Study|Patient No Longer Meets Study Criteria|6
7842322|NCT01430442|12322007|FG002|Overall Study|Patient No Longer Meets Study Criteria|3
7842323|NCT01430442|12322008|FG003|Overall Study|Patient No Longer Meets Study Criteria|2
7842324|NCT01430442|12322009|FG004|Overall Study|Patient No Longer Meets Study Criteria|5
7842325|NCT01430442|12322010|FG005|Overall Study|Patient No Longer Meets Study Criteria|5
7842326|NCT01430442|12322011|FG006|Overall Study|Patient No Longer Meets Study Criteria|9
7842327|NCT01430442|12322012|FG007|Overall Study|Patient No Longer Meets Study Criteria|6
7842328|NCT01430455|12322030|FG000|Overall Study|Withdrawal by Subject|1
7842329|NCT01430455|12322030|FG000|Overall Study|Switched to follow-up phase|1
7842330|NCT01430468|12322036|FG000|Overall Study|Physician Decision|2
7842331|NCT01430468|12322037|FG001|Overall Study|Physician Decision|1
7842332|NCT01430468|12322036|FG000|Overall Study|Withdrawal by Subject|5
7842333|NCT01430468|12322037|FG001|Overall Study|Withdrawal by Subject|5
7842334|NCT01430559|12322045|FG000|Overall Study|Adverse Event|7
7842335|NCT01430559|12322046|FG001|Overall Study|Adverse Event|3
7842336|NCT01430559|12322045|FG000|Overall Study|Entry criteria not met|1
7842337|NCT01430559|12322046|FG001|Overall Study|Entry criteria not met|1
7842338|NCT01430559|12322045|FG000|Overall Study|Lost to Follow-up|1
7842339|NCT01430559|12322046|FG001|Overall Study|Lost to Follow-up|0
7842340|NCT01430559|12322045|FG000|Overall Study|Medication error|1
7842341|NCT01430559|12322046|FG001|Overall Study|Medication error|0
7842342|NCT01430559|12322045|FG000|Overall Study|Withdrawal by Subject|3
7842343|NCT01430559|12322046|FG001|Overall Study|Withdrawal by Subject|2
7842344|NCT01430559|12322045|FG000|Overall Study|Protocol Violation|1
7842345|NCT01430559|12322046|FG001|Overall Study|Protocol Violation|0
7842346|NCT01430559|12322045|FG000|Overall Study|Other|3
7842347|NCT01430559|12322046|FG001|Overall Study|Other|3
7842348|NCT01430559|12322045|FG000|Overall Study|Randomized, Not Treated|3
7842349|NCT01430559|12322046|FG001|Overall Study|Randomized, Not Treated|3
7842350|NCT01430585|12322057|FG000|Overall Study|Death|1
7842351|NCT01430585|12322057|FG000|Overall Study|Objective Progression or Relapse|3
7842352|NCT01430585|12322057|FG000|Overall Study|Study Terminated by Sponsor|3
7842353|NCT01430585|12322057|FG000|Overall Study|Other|7
7842354|NCT01430611|12322069|FG000|Overall Study|Adverse Event|0
7842355|NCT01430611|12322070|FG001|Overall Study|Adverse Event|1
7842356|NCT01430611|12322069|FG000|Overall Study|Protocol Violation|1
7842357|NCT01430611|12322070|FG001|Overall Study|Protocol Violation|0
7842358|NCT01430611|12322069|FG000|Overall Study|Lost to Follow-up|1
7842359|NCT01430611|12322070|FG001|Overall Study|Lost to Follow-up|0
7842360|NCT01430611|12322069|FG000|Overall Study|Withdrawal by Subject|15
7842361|NCT01430611|12322070|FG001|Overall Study|Withdrawal by Subject|14
7842362|NCT01430624|12322079|FG000|Overall Study|Lost to Follow-up|23
7842363|NCT01430624|12322080|FG001|Overall Study|Lost to Follow-up|29
7842364|NCT01430624|12322081|FG002|Overall Study|Lost to Follow-up|27
7842365|NCT01430624|12322079|FG000|Overall Study|technical or eligibility|5
7842366|NCT01430624|12322080|FG001|Overall Study|technical or eligibility|5
7842367|NCT01430624|12322081|FG002|Overall Study|technical or eligibility|2
7842368|NCT01430754|12322113|FG000|Run-In Phase|Circadian Period Ineligible|24
7842369|NCT01430754|12322114|FG001|Run-In Phase|Circadian Period Ineligible|0
7842370|NCT01430754|12322113|FG000|Run-In Phase|Protocol Violation|6
7842371|NCT01430754|12322114|FG001|Run-In Phase|Protocol Violation|0
7842372|NCT01430754|12322113|FG000|Run-In Phase|Adverse Event|2
7842373|NCT01430754|12322114|FG001|Run-In Phase|Adverse Event|0
7842374|NCT01430754|12322113|FG000|Run-In Phase|Other|2
7842375|NCT01430754|12322114|FG001|Run-In Phase|Other|0
7842376|NCT01430754|12322113|FG000|Run-In Phase|Withdrawal by Subject|2
7842377|NCT01430754|12322114|FG001|Run-In Phase|Withdrawal by Subject|0
7842378|NCT01430754|12322113|FG000|Run-In Phase|Lost to Follow-up|1
7842379|NCT01430754|12322114|FG001|Run-In Phase|Lost to Follow-up|0
7842380|NCT01431079|12322142|FG000|Overall Study|Lost to Follow-up|35
7842381|NCT01431079|12322143|FG001|Overall Study|Lost to Follow-up|39
7842382|NCT01431144|12322188|FG000|Overall Study|Implant mobility and removal|2
7842383|NCT01431144|12322189|FG001|Overall Study|Implant mobility and removal|0
7842384|NCT01431274|12322228|FG000|Overall Study|Adverse Event|51
7842385|NCT01431274|12322229|FG001|Overall Study|Adverse Event|37
7842386|NCT01431274|12322230|FG002|Overall Study|Adverse Event|43
7842387|NCT01431274|12322231|FG003|Overall Study|Adverse Event|30
7842388|NCT01431274|12322232|FG004|Overall Study|Adverse Event|37
7842389|NCT01431274|12322228|FG000|Overall Study|Consent withdrawn not due to AE|29
7842390|NCT01431274|12322229|FG001|Overall Study|Consent withdrawn not due to AE|20
7842391|NCT01431274|12322230|FG002|Overall Study|Consent withdrawn not due to AE|17
7842392|NCT01431274|12322231|FG003|Overall Study|Consent withdrawn not due to AE|20
7842393|NCT01431274|12322232|FG004|Overall Study|Consent withdrawn not due to AE|11
7842394|NCT01431274|12322228|FG000|Overall Study|Non compliant with protocol|5
7842395|NCT01431274|12322229|FG001|Overall Study|Non compliant with protocol|8
7842396|NCT01431274|12322230|FG002|Overall Study|Non compliant with protocol|4
7842397|NCT01431274|12322231|FG003|Overall Study|Non compliant with protocol|4
7842398|NCT01431274|12322232|FG004|Overall Study|Non compliant with protocol|4
7949024|NCT02533674|12494577|FG007|Dose Level I|Withdrawal by Subject|0
7949025|NCT02533674|12494570|FG000|Dose Level I|Physician Decision|1
7842399|NCT01431274|12322228|FG000|Overall Study|Lost to Follow-up|6
7949026|NCT02533674|12494571|FG001|Dose Level I|Physician Decision|0
7949027|NCT02533674|12494572|FG002|Dose Level I|Physician Decision|0
7949028|NCT02533674|12494573|FG003|Dose Level I|Physician Decision|0
7949029|NCT02533674|12494574|FG004|Dose Level I|Physician Decision|0
7949030|NCT02533674|12494575|FG005|Dose Level I|Physician Decision|0
7949031|NCT02533674|12494576|FG006|Dose Level I|Physician Decision|0
7949032|NCT02533674|12494577|FG007|Dose Level I|Physician Decision|0
7949033|NCT02533674|12494570|FG000|Dose Level I|Death|1
7949034|NCT02533674|12494571|FG001|Dose Level I|Death|0
7949035|NCT02533674|12494572|FG002|Dose Level I|Death|0
7949036|NCT02533674|12494573|FG003|Dose Level I|Death|0
7949037|NCT02533674|12494574|FG004|Dose Level I|Death|0
7949038|NCT02533674|12494575|FG005|Dose Level I|Death|0
7949039|NCT02533674|12494576|FG006|Dose Level I|Death|0
7949040|NCT02533674|12494577|FG007|Dose Level I|Death|0
7949041|NCT02533674|12494570|FG000|Dose Level I|Never Treated|1
7949042|NCT02533674|12494571|FG001|Dose Level I|Never Treated|0
7949043|NCT02533674|12494572|FG002|Dose Level I|Never Treated|0
7949044|NCT02533674|12494573|FG003|Dose Level I|Never Treated|0
7949045|NCT02533674|12494574|FG004|Dose Level I|Never Treated|0
7949046|NCT02533674|12494575|FG005|Dose Level I|Never Treated|0
7949047|NCT02533674|12494576|FG006|Dose Level I|Never Treated|0
7949048|NCT02533674|12494577|FG007|Dose Level I|Never Treated|0
7949049|NCT02533674|12494570|FG000|Dose Level II|Progressive disease|0
7949050|NCT02533674|12494571|FG001|Dose Level II|Progressive disease|3
7949051|NCT02533674|12494572|FG002|Dose Level II|Progressive disease|0
7949052|NCT02533674|12494573|FG003|Dose Level II|Progressive disease|0
7949053|NCT02533674|12494574|FG004|Dose Level II|Progressive disease|0
7949054|NCT02533674|12494575|FG005|Dose Level II|Progressive disease|0
7949055|NCT02533674|12494576|FG006|Dose Level II|Progressive disease|0
7949056|NCT02533674|12494577|FG007|Dose Level II|Progressive disease|0
7949057|NCT02533674|12494570|FG000|Dose Level II|Withdrawal by Subject|0
7949058|NCT02533674|12494571|FG001|Dose Level II|Withdrawal by Subject|1
7949059|NCT02533674|12494572|FG002|Dose Level II|Withdrawal by Subject|0
7949060|NCT02533674|12494573|FG003|Dose Level II|Withdrawal by Subject|0
7949061|NCT02533674|12494574|FG004|Dose Level II|Withdrawal by Subject|0
7949062|NCT02533674|12494575|FG005|Dose Level II|Withdrawal by Subject|0
7949063|NCT02533674|12494576|FG006|Dose Level II|Withdrawal by Subject|0
7949064|NCT02533674|12494577|FG007|Dose Level II|Withdrawal by Subject|0
7949065|NCT02533674|12494570|FG000|Dose Level II|Treatment-related AE|0
7842400|NCT01431274|12322229|FG001|Overall Study|Lost to Follow-up|7
7842401|NCT01431274|12322230|FG002|Overall Study|Lost to Follow-up|1
7842402|NCT01431274|12322231|FG003|Overall Study|Lost to Follow-up|4
7842403|NCT01431274|12322232|FG004|Overall Study|Lost to Follow-up|0
7842404|NCT01431274|12322228|FG000|Overall Study|Other reason not stated above|6
7842405|NCT01431274|12322229|FG001|Overall Study|Other reason not stated above|5
7842406|NCT01431274|12322230|FG002|Overall Study|Other reason not stated above|7
7842407|NCT01431274|12322231|FG003|Overall Study|Other reason not stated above|2
7842408|NCT01431274|12322232|FG004|Overall Study|Other reason not stated above|4
7842409|NCT01431287|12322249|FG000|Overall Study|not treated|0
7842410|NCT01431287|12322250|FG001|Overall Study|not treated|0
7842411|NCT01431287|12322251|FG002|Overall Study|not treated|1
7842412|NCT01431287|12322252|FG003|Overall Study|not treated|0
7842413|NCT01431287|12322253|FG004|Overall Study|not treated|0
7842414|NCT01431287|12322249|FG000|Overall Study|Adverse Event|59
7842415|NCT01431287|12322250|FG001|Overall Study|Adverse Event|57
7842416|NCT01431287|12322251|FG002|Overall Study|Adverse Event|53
7842417|NCT01431287|12322252|FG003|Overall Study|Adverse Event|33
7842418|NCT01431287|12322253|FG004|Overall Study|Adverse Event|41
7842419|NCT01431287|12322249|FG000|Overall Study|Non compliant with protocol|6
7842420|NCT01431287|12322250|FG001|Overall Study|Non compliant with protocol|6
7842421|NCT01431287|12322251|FG002|Overall Study|Non compliant with protocol|5
7842422|NCT01431287|12322252|FG003|Overall Study|Non compliant with protocol|6
7842423|NCT01431287|12322253|FG004|Overall Study|Non compliant with protocol|5
7842424|NCT01431287|12322249|FG000|Overall Study|Lost to Follow-up|0
7842425|NCT01431287|12322250|FG001|Overall Study|Lost to Follow-up|3
7842426|NCT01431287|12322251|FG002|Overall Study|Lost to Follow-up|2
7842427|NCT01431287|12322252|FG003|Overall Study|Lost to Follow-up|3
7842428|NCT01431287|12322253|FG004|Overall Study|Lost to Follow-up|1
7842429|NCT01431287|12322249|FG000|Overall Study|Consent withdrawn not due to AE|29
7842430|NCT01431287|12322250|FG001|Overall Study|Consent withdrawn not due to AE|30
7842431|NCT01431287|12322251|FG002|Overall Study|Consent withdrawn not due to AE|34
7842432|NCT01431287|12322252|FG003|Overall Study|Consent withdrawn not due to AE|19
7842433|NCT01431287|12322253|FG004|Overall Study|Consent withdrawn not due to AE|29
7842434|NCT01431287|12322249|FG000|Overall Study|not stated above|4
7842435|NCT01431287|12322250|FG001|Overall Study|not stated above|2
7842436|NCT01431287|12322251|FG002|Overall Study|not stated above|2
7842437|NCT01431287|12322252|FG003|Overall Study|not stated above|2
7842438|NCT01431287|12322253|FG004|Overall Study|not stated above|1
7842439|NCT01431521|12322315|FG000|Overall Study|Withdrawal by Subject|0
7842440|NCT01431521|12322316|FG001|Overall Study|Withdrawal by Subject|0
7842441|NCT01431521|12322317|FG002|Overall Study|Withdrawal by Subject|1
7842442|NCT01431521|12322318|FG003|Overall Study|Withdrawal by Subject|0
7842443|NCT01431534|12322330|FG000|Treatment Phase|Adverse Event|0
7842444|NCT01431534|12322331|FG001|Treatment Phase|Adverse Event|0
7842445|NCT01431534|12322332|FG002|Treatment Phase|Adverse Event|1
7842446|NCT01431534|12322330|FG000|Treatment Phase|Progressive Disease|4
7842447|NCT01431534|12322331|FG001|Treatment Phase|Progressive Disease|3
7842448|NCT01431534|12322332|FG002|Treatment Phase|Progressive Disease|10
7842449|NCT01431638|12322347|FG000|Overall Study|Adverse Event|1
7842450|NCT01431638|12322348|FG001|Overall Study|Adverse Event|3
7842451|NCT01431638|12322349|FG002|Overall Study|Adverse Event|1
7842452|NCT01431638|12322347|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7842453|NCT01431638|12322348|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7842454|NCT01431638|12322349|FG002|Overall Study|Unsatisfactory therapeutic effect|4
7842455|NCT01431638|12322347|FG000|Overall Study|Participants condition no longer requires study drug|0
7842456|NCT01431638|12322348|FG001|Overall Study|Participants condition no longer requires study drug|1
7842457|NCT01431638|12322349|FG002|Overall Study|Participants condition no longer requires study drug|0
7842458|NCT01431638|12322347|FG000|Overall Study|Participant withdrew consent|14
7842459|NCT01431638|12322348|FG001|Overall Study|Participant withdrew consent|5
7842460|NCT01431638|12322349|FG002|Overall Study|Participant withdrew consent|8
7842461|NCT01431638|12322347|FG000|Overall Study|Lost to Follow-up|7
7949066|NCT02533674|12494571|FG001|Dose Level II|Treatment-related AE|1
7949067|NCT02533674|12494572|FG002|Dose Level II|Treatment-related AE|0
7949068|NCT02533674|12494573|FG003|Dose Level II|Treatment-related AE|0
7949069|NCT02533674|12494574|FG004|Dose Level II|Treatment-related AE|0
7949070|NCT02533674|12494575|FG005|Dose Level II|Treatment-related AE|0
7842462|NCT01431638|12322348|FG001|Overall Study|Lost to Follow-up|9
7842463|NCT01431638|12322349|FG002|Overall Study|Lost to Follow-up|7
7842464|NCT01431638|12322347|FG000|Overall Study|Administrative problems|1
7842465|NCT01431638|12322348|FG001|Overall Study|Administrative problems|4
7842466|NCT01431638|12322349|FG002|Overall Study|Administrative problems|6
7842467|NCT01431638|12322347|FG000|Overall Study|Death|1
7842468|NCT01431638|12322348|FG001|Overall Study|Death|0
7842469|NCT01431638|12322349|FG002|Overall Study|Death|0
7842470|NCT01431638|12322347|FG000|Overall Study|Protocol deviation|1
7842471|NCT01431638|12322348|FG001|Overall Study|Protocol deviation|1
7842472|NCT01431638|12322349|FG002|Overall Study|Protocol deviation|4
7842473|NCT01431638|12322347|FG000|Overall Study|Participants Did not enter extension study from core study|39
7842474|NCT01431638|12322348|FG001|Overall Study|Participants Did not enter extension study from core study|46
7842475|NCT01431638|12322349|FG002|Overall Study|Participants Did not enter extension study from core study|32
7842476|NCT01431716|12322361|FG000|Overall Study|Withdrawal of consent|1
7842477|NCT01431950|12322401|FG000|Overall Study|Study Site Closed/Terminated|7
7842478|NCT01431950|12322402|FG001|Overall Study|Study Site Closed/Terminated|3
7842479|NCT01431950|12322401|FG000|Overall Study|Withdrawal by Subject|4
7842480|NCT01431950|12322402|FG001|Overall Study|Withdrawal by Subject|3
7842481|NCT01431950|12322401|FG000|Overall Study|Protocol Violation|2
7842482|NCT01431950|12322402|FG001|Overall Study|Protocol Violation|3
7842483|NCT01431950|12322401|FG000|Overall Study|Adverse Event|2
7842484|NCT01431950|12322402|FG001|Overall Study|Adverse Event|2
7842485|NCT01431950|12322401|FG000|Overall Study|Physician Decision|2
7842486|NCT01431950|12322402|FG001|Overall Study|Physician Decision|1
7842487|NCT01431950|12322401|FG000|Overall Study|Lack of Efficacy|2
7842488|NCT01431950|12322402|FG001|Overall Study|Lack of Efficacy|1
7842489|NCT01431950|12322401|FG000|Overall Study|Lost to Follow-up|0
7842490|NCT01431950|12322402|FG001|Overall Study|Lost to Follow-up|1
7842491|NCT01431950|12322401|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0
7842492|NCT01431950|12322402|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
7842493|NCT01431963|12322408|FG000|Overall Study|Adverse Event|18
7842494|NCT01431963|12322408|FG000|Overall Study|Lack of Efficacy|7
7842495|NCT01431963|12322408|FG000|Overall Study|Protocol Violation|1
7842496|NCT01431963|12322408|FG000|Overall Study|Protocol-defined Stopping Criteria|2
7842497|NCT01431963|12322408|FG000|Overall Study|Physician Decision|4
7842498|NCT01431963|12322408|FG000|Overall Study|Withdrawal by Subject|3
7842499|NCT01431976|12322412|FG000|Overall Study|Adverse Event|6
7842500|NCT01431976|12322412|FG000|Overall Study|Lack of Efficacy|2
7842501|NCT01431976|12322412|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4
7842502|NCT01431976|12322412|FG000|Overall Study|Physician Decision|1
7842503|NCT01431976|12322412|FG000|Overall Study|Withdrawal by Subject|1
7842504|NCT01432171|12322438|FG000|Overall Study|Death|1
7842505|NCT01432171|12322439|FG001|Overall Study|Death|2
7842506|NCT01432171|12322438|FG000|Overall Study|Lost to Follow-up|6
7842507|NCT01432171|12322439|FG001|Overall Study|Lost to Follow-up|5
7842508|NCT01432171|12322438|FG000|Overall Study|Withdrawal by Subject|3
7842509|NCT01432171|12322439|FG001|Overall Study|Withdrawal by Subject|1
7842510|NCT01432171|12322438|FG000|Overall Study|Noncompliance|2
7720886|NCT00541931|12145409|FG001|Overall Study|Lost to Follow-up|3
7720887|NCT00541931|12145408|FG000|Overall Study|Withdrawal by Subject|1
7720888|NCT00541931|12145409|FG001|Overall Study|Withdrawal by Subject|0
7720889|NCT00541931|12145408|FG000|Overall Study|Transportation Issue|0
7720890|NCT00541931|12145409|FG001|Overall Study|Transportation Issue|1
7720891|NCT00541970|12145421|FG000|Month 7|Protocol Violation|9
7720892|NCT00541970|12145422|FG001|Month 7|Protocol Violation|13
7842511|NCT01432171|12322439|FG001|Overall Study|Noncompliance|3
7842512|NCT01432171|12322438|FG000|Overall Study|Insurance denial trial coverage|1
7842513|NCT01432171|12322439|FG001|Overall Study|Insurance denial trial coverage|0
7842514|NCT01432171|12322438|FG000|Overall Study|Patient moved to palliative care|1
7842515|NCT01432171|12322439|FG001|Overall Study|Patient moved to palliative care|0
7842516|NCT01432262|12322463|FG000|Overall Study|Withdrawal by Subject|2
7842517|NCT01432262|12322464|FG001|Overall Study|Withdrawal by Subject|1
7842518|NCT01432275|12322470|FG000|First BG Meter System (7 Days)|Adverse Event|0
7842519|NCT01432275|12322471|FG001|First BG Meter System (7 Days)|Adverse Event|2
7842520|NCT01432275|12322470|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0
7842521|NCT01432275|12322471|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1
7842522|NCT01432275|12322470|FG000|Second BG Meter System (7 Days)|Adverse Event|1
7842523|NCT01432275|12322471|FG001|Second BG Meter System (7 Days)|Adverse Event|1
7842524|NCT01432275|12322470|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1
7842525|NCT01432275|12322471|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0
7842526|NCT01432275|12322470|FG000|Second BG Meter System (7 Days)|Physician Decision|0
7842527|NCT01432275|12322471|FG001|Second BG Meter System (7 Days)|Physician Decision|1
7842528|NCT01432275|12322470|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0
7842529|NCT01432275|12322471|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1
7842530|NCT01432275|12322470|FG000|ADC With Calculator (10 Days)|Physician Decision|1
7842531|NCT01432275|12322471|FG001|ADC With Calculator (10 Days)|Physician Decision|1
7842532|NCT01432275|12322470|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2
7863096|NCT01603082|12352312|FG000|Overall Study|Withdrawal by Subject|1
7842533|NCT01432275|12322471|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0
7842534|NCT01432275|12322470|FG000|ADC With Calculator (10 Days)|Protocol Violation|0
7842535|NCT01432275|12322471|FG001|ADC With Calculator (10 Days)|Protocol Violation|1
7842536|NCT01432327|12322481|FG000|Posttest 3 Months|depression|3
7842537|NCT01432327|12322482|FG001|Posttest 3 Months|depression|0
7842538|NCT01432327|12322483|FG002|Posttest 3 Months|depression|0
7842539|NCT01432327|12322484|FG003|Posttest 3 Months|depression|0
7842540|NCT01432327|12322481|FG000|Posttest 3 Months|Lost to Follow-up|1
7842541|NCT01432327|12322482|FG001|Posttest 3 Months|Lost to Follow-up|0
7842542|NCT01432327|12322483|FG002|Posttest 3 Months|Lost to Follow-up|2
7842543|NCT01432327|12322484|FG003|Posttest 3 Months|Lost to Follow-up|1
7842544|NCT01432327|12322481|FG000|Posttest 3 Months|Allergic reaction|0
7842545|NCT01432327|12322482|FG001|Posttest 3 Months|Allergic reaction|2
7842546|NCT01432327|12322483|FG002|Posttest 3 Months|Allergic reaction|0
7842547|NCT01432327|12322484|FG003|Posttest 3 Months|Allergic reaction|0
7842548|NCT01432327|12322481|FG000|Posttest 6 Months|Lost to Follow-up|0
7842549|NCT01432327|12322482|FG001|Posttest 6 Months|Lost to Follow-up|0
7842550|NCT01432327|12322483|FG002|Posttest 6 Months|Lost to Follow-up|3
7842551|NCT01432327|12322484|FG003|Posttest 6 Months|Lost to Follow-up|2
7842552|NCT01432327|12322481|FG000|Posttest 6 Months|Allergic reaction|0
7842553|NCT01432327|12322482|FG001|Posttest 6 Months|Allergic reaction|0
7842554|NCT01432327|12322483|FG002|Posttest 6 Months|Allergic reaction|1
7842555|NCT01432327|12322484|FG003|Posttest 6 Months|Allergic reaction|0
7842556|NCT01432327|12322481|FG000|Posttest 6 Months|Withdrawal by Subject|0
7842557|NCT01432327|12322482|FG001|Posttest 6 Months|Withdrawal by Subject|0
7842558|NCT01432327|12322483|FG002|Posttest 6 Months|Withdrawal by Subject|1
7842559|NCT01432327|12322484|FG003|Posttest 6 Months|Withdrawal by Subject|0
7842560|NCT01432327|12322481|FG000|Posttest 1 Year|Measurement have to take place in future|24
7842561|NCT01432327|12322482|FG001|Posttest 1 Year|Measurement have to take place in future|28
7842562|NCT01432327|12322483|FG002|Posttest 1 Year|Measurement have to take place in future|15
7842563|NCT01432327|12322484|FG003|Posttest 1 Year|Measurement have to take place in future|20
7842564|NCT01432327|12322481|FG000|Posttest 1 Year|Lost to Follow-up|0
7842565|NCT01432327|12322482|FG001|Posttest 1 Year|Lost to Follow-up|0
7842566|NCT01432327|12322483|FG002|Posttest 1 Year|Lost to Follow-up|4
7842567|NCT01432327|12322484|FG003|Posttest 1 Year|Lost to Follow-up|2
7842568|NCT01432327|12322481|FG000|Posttest 1 Year|Allergic reaction|0
7842569|NCT01432327|12322482|FG001|Posttest 1 Year|Allergic reaction|0
7842570|NCT01432327|12322483|FG002|Posttest 1 Year|Allergic reaction|1
7842571|NCT01432327|12322484|FG003|Posttest 1 Year|Allergic reaction|1
7842572|NCT01432366|12322494|FG000|Overall Study|Non-Responder|7
7842573|NCT01432366|12322494|FG000|Overall Study|Adverse Event|8
7842574|NCT01432366|12322494|FG000|Overall Study|Withdrawal Due to Non-Compliance|3
7842575|NCT01432366|12322494|FG000|Overall Study|Pregnancy|1
7842576|NCT01432366|12322494|FG000|Overall Study|Lost to Follow-up|13
7842577|NCT01432366|12322494|FG000|Overall Study|Lack of Efficacy|1
7842578|NCT01432366|12322494|FG000|Overall Study|Site Closed|20
7842579|NCT01432366|12322494|FG000|Overall Study|Investigator Forget to Complete Visits|1
7842580|NCT01432366|12322494|FG000|Overall Study|Other|14
7842581|NCT01432444|12322511|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10
7842582|NCT01432444|12322512|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0
7842583|NCT01432444|12322513|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0
7842584|NCT01432444|12322511|FG000|Tolerability/Cross-titration Phase|Adverse Event|16
7842585|NCT01432444|12322512|FG001|Tolerability/Cross-titration Phase|Adverse Event|0
7842586|NCT01432444|12322513|FG002|Tolerability/Cross-titration Phase|Adverse Event|0
7842587|NCT01432444|12322511|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
7842588|NCT01432444|12322512|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
7842589|NCT01432444|12322513|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
7842590|NCT01432444|12322511|FG000|Tolerability/Cross-titration Phase|Physician Decision|8
7842591|NCT01432444|12322512|FG001|Tolerability/Cross-titration Phase|Physician Decision|0
7842592|NCT01432444|12322513|FG002|Tolerability/Cross-titration Phase|Physician Decision|0
7842593|NCT01432444|12322511|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
7842594|NCT01432444|12322512|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
7842595|NCT01432444|12322513|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
7842596|NCT01432444|12322511|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1
7842597|NCT01432444|12322512|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0
7842598|NCT01432444|12322513|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0
7842599|NCT01432444|12322511|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5
7842600|NCT01432444|12322512|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0
7842601|NCT01432444|12322513|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0
7842602|NCT01432444|12322511|FG000|Treatment Phase|Lost to Follow-up|0
7842603|NCT01432444|12322512|FG001|Treatment Phase|Lost to Follow-up|33
7842604|NCT01432444|12322513|FG002|Treatment Phase|Lost to Follow-up|0
7842605|NCT01432444|12322511|FG000|Treatment Phase|Adverse Event|0
7842606|NCT01432444|12322512|FG001|Treatment Phase|Adverse Event|37
7842607|NCT01432444|12322513|FG002|Treatment Phase|Adverse Event|0
7842608|NCT01432444|12322511|FG000|Treatment Phase|Met Withdrawal Criteria|0
7842609|NCT01432444|12322512|FG001|Treatment Phase|Met Withdrawal Criteria|11
7842610|NCT01432444|12322513|FG002|Treatment Phase|Met Withdrawal Criteria|0
7842611|NCT01432444|12322511|FG000|Treatment Phase|Physician Decision|0
7842612|NCT01432444|12322512|FG001|Treatment Phase|Physician Decision|5
7842613|NCT01432444|12322513|FG002|Treatment Phase|Physician Decision|0
7842614|NCT01432444|12322511|FG000|Treatment Phase|Withdrawal by Subject|0
7842615|NCT01432444|12322512|FG001|Treatment Phase|Withdrawal by Subject|41
7842616|NCT01432444|12322513|FG002|Treatment Phase|Withdrawal by Subject|0
7949071|NCT02533674|12494576|FG006|Dose Level II|Treatment-related AE|0
7949072|NCT02533674|12494577|FG007|Dose Level II|Treatment-related AE|0
7949073|NCT02533674|12494570|FG000|Dose Level II|Physician Decision|0
7949074|NCT02533674|12494571|FG001|Dose Level II|Physician Decision|1
7949075|NCT02533674|12494572|FG002|Dose Level II|Physician Decision|0
7949076|NCT02533674|12494573|FG003|Dose Level II|Physician Decision|0
7949077|NCT02533674|12494574|FG004|Dose Level II|Physician Decision|0
7949078|NCT02533674|12494575|FG005|Dose Level II|Physician Decision|0
7949079|NCT02533674|12494576|FG006|Dose Level II|Physician Decision|0
7842617|NCT01432444|12322511|FG000|Treatment Phase|Protocol Deviation|0
7842618|NCT01432444|12322512|FG001|Treatment Phase|Protocol Deviation|3
7842619|NCT01432444|12322513|FG002|Treatment Phase|Protocol Deviation|0
7842620|NCT01432444|12322511|FG000|Treatment Phase|Lack of Efficacy|0
7842621|NCT01432444|12322512|FG001|Treatment Phase|Lack of Efficacy|10
7842622|NCT01432444|12322513|FG002|Treatment Phase|Lack of Efficacy|0
7842623|NCT01432444|12322511|FG000|Extension Phase|Lost to Follow-up|0
7842624|NCT01432444|12322512|FG001|Extension Phase|Lost to Follow-up|0
7842625|NCT01432444|12322513|FG002|Extension Phase|Lost to Follow-up|17
7842626|NCT01432444|12322511|FG000|Extension Phase|Adverse Event|0
7842627|NCT01432444|12322512|FG001|Extension Phase|Adverse Event|0
7842628|NCT01432444|12322513|FG002|Extension Phase|Adverse Event|10
7842629|NCT01432444|12322511|FG000|Extension Phase|Sponsor Discontinued Trial|0
7842630|NCT01432444|12322512|FG001|Extension Phase|Sponsor Discontinued Trial|0
7842631|NCT01432444|12322513|FG002|Extension Phase|Sponsor Discontinued Trial|7
7842632|NCT01432444|12322511|FG000|Extension Phase|Met Withdrawal Criteria|0
7842633|NCT01432444|12322512|FG001|Extension Phase|Met Withdrawal Criteria|0
7842634|NCT01432444|12322513|FG002|Extension Phase|Met Withdrawal Criteria|144
7842635|NCT01432444|12322511|FG000|Extension Phase|Physician Decision|0
7842636|NCT01432444|12322512|FG001|Extension Phase|Physician Decision|0
7842637|NCT01432444|12322513|FG002|Extension Phase|Physician Decision|1
7842638|NCT01432444|12322511|FG000|Extension Phase|Withdrawal by Subject|0
7842639|NCT01432444|12322512|FG001|Extension Phase|Withdrawal by Subject|0
7842640|NCT01432444|12322513|FG002|Extension Phase|Withdrawal by Subject|13
7842641|NCT01432457|12322521|FG000|Overall Study|Adverse Event|7
7842642|NCT01432457|12322522|FG001|Overall Study|Adverse Event|10
7842643|NCT01432457|12322523|FG002|Overall Study|Adverse Event|16
7842644|NCT01432457|12322521|FG000|Overall Study|Lack of Efficacy|2
7842645|NCT01432457|12322522|FG001|Overall Study|Lack of Efficacy|1
7842646|NCT01432457|12322523|FG002|Overall Study|Lack of Efficacy|1
7842647|NCT01432457|12322521|FG000|Overall Study|Lost to Follow-up|11
7842648|NCT01432457|12322522|FG001|Overall Study|Lost to Follow-up|15
7842649|NCT01432457|12322523|FG002|Overall Study|Lost to Follow-up|20
7842650|NCT01432457|12322521|FG000|Overall Study|Protocol Violation|3
7842651|NCT01432457|12322522|FG001|Overall Study|Protocol Violation|2
7842652|NCT01432457|12322523|FG002|Overall Study|Protocol Violation|6
7842653|NCT01432457|12322521|FG000|Overall Study|Withdrawal by Subject|6
7842654|NCT01432457|12322522|FG001|Overall Study|Withdrawal by Subject|11
7842655|NCT01432457|12322523|FG002|Overall Study|Withdrawal by Subject|9
7842656|NCT01432457|12322521|FG000|Overall Study|Reasons not defined|2
7842657|NCT01432457|12322522|FG001|Overall Study|Reasons not defined|3
7842658|NCT01432457|12322523|FG002|Overall Study|Reasons not defined|4
7842659|NCT01432457|12322521|FG000|Overall Study|Did not take study drug|6
7842660|NCT01432457|12322522|FG001|Overall Study|Did not take study drug|6
7842661|NCT01432457|12322523|FG002|Overall Study|Did not take study drug|3
7842662|NCT01432574|12322548|FG000|Overall Study|Moved|2
7842663|NCT01432574|12322548|FG000|Overall Study|Not interested|1
7842664|NCT01432600|12322557|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0
7842665|NCT01432600|12322558|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1
7842666|NCT01432600|12322559|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1
7842667|NCT01432626|12322569|FG000|Overall Study|LV function recovered|2
7842668|NCT01432626|12322569|FG000|Overall Study|Withdrawal by Subject|2
7842669|NCT01432626|12322569|FG000|Overall Study|Only 1 image competed|2
7842670|NCT01432626|12322569|FG000|Overall Study|Imaging agent not available|1
7842671|NCT01432730|12322573|FG000|Period 1|Adverse Event|2
7842672|NCT01432730|12322574|FG001|Period 1|Adverse Event|0
7842673|NCT01432730|12322573|FG000|Period 2|Adverse Event|0
7842674|NCT01432730|12322574|FG001|Period 2|Adverse Event|4
7842675|NCT01432756|12322584|FG000|Overall Study|Lost to Follow-up|1
7842676|NCT01432756|12322585|FG001|Overall Study|Lost to Follow-up|0
7842677|NCT01432756|12322586|FG002|Overall Study|Lost to Follow-up|2
7842678|NCT01432756|12322587|FG003|Overall Study|Lost to Follow-up|1
7842679|NCT01432938|12322605|FG000|First Intervention|Protocol Violation|1
7842680|NCT01432938|12322606|FG001|First Intervention|Protocol Violation|0
7949080|NCT02533674|12494577|FG007|Dose Level II|Physician Decision|0
7842681|NCT01432938|12322605|FG000|First Intervention|Physician Decision|1
7842682|NCT01432938|12322606|FG001|First Intervention|Physician Decision|0
7842683|NCT01432938|12322605|FG000|Second Intervention|Adverse Event|1
7842684|NCT01432938|12322606|FG001|Second Intervention|Adverse Event|0
7842685|NCT01432951|12322613|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1
7842686|NCT01433055|12322628|FG000|Overall Study|Diagnosed with cancer unrelated to study|1
7842687|NCT01433055|12322629|FG001|Overall Study|Diagnosed with cancer unrelated to study|0
7842688|NCT01433055|12322628|FG000|Overall Study|Severely elevated triglycerides at entry|1
7842689|NCT01433055|12322629|FG001|Overall Study|Severely elevated triglycerides at entry|0
7842690|NCT01433159|12322656|FG000|Overall Study|Adverse Event|1
7842691|NCT01433159|12322657|FG001|Overall Study|Adverse Event|0
7842692|NCT01433159|12322656|FG000|Overall Study|Physician Decision|1
7842693|NCT01433159|12322657|FG001|Overall Study|Physician Decision|0
7842694|NCT01433159|12322656|FG000|Overall Study|Protocol Violation|0
7842695|NCT01433159|12322657|FG001|Overall Study|Protocol Violation|1
7842696|NCT01433172|12322666|FG000|Overall Study|Withdrawal by Subject|0
7842697|NCT01433172|12322667|FG001|Overall Study|Withdrawal by Subject|1
7842698|NCT01433172|12322668|FG002|Overall Study|Withdrawal by Subject|0
7842699|NCT01433172|12322666|FG000|Overall Study|Disease Progression|0
7842700|NCT01433172|12322667|FG001|Overall Study|Disease Progression|0
7842701|NCT01433172|12322668|FG002|Overall Study|Disease Progression|1
7842702|NCT01433172|12322666|FG000|Overall Study|Death|0
7842703|NCT01433172|12322667|FG001|Overall Study|Death|2
7842704|NCT01433172|12322668|FG002|Overall Study|Death|0
7842705|NCT01433250|12322678|FG000|Overall Study|Protocol Violation|0
7842706|NCT01433250|12322679|FG001|Overall Study|Protocol Violation|1
7842707|NCT01433250|12322678|FG000|Overall Study|Withdrawal by Subject|3
7842708|NCT01433250|12322679|FG001|Overall Study|Withdrawal by Subject|2
7842709|NCT01433263|12322687|FG000|Overall Study|Adverse Event|3
7842710|NCT01433263|12322688|FG001|Overall Study|Adverse Event|1
7842711|NCT01433263|12322687|FG000|Overall Study|Death|5
7842712|NCT01433263|12322688|FG001|Overall Study|Death|3
7842713|NCT01433263|12322687|FG000|Overall Study|Lost to Follow-up|0
7842714|NCT01433263|12322688|FG001|Overall Study|Lost to Follow-up|1
7842715|NCT01433263|12322687|FG000|Overall Study|Protocol Deviation|1
7842716|NCT01433263|12322688|FG001|Overall Study|Protocol Deviation|0
7842717|NCT01433263|12322687|FG000|Overall Study|Withdrawal by Subject|10
7842718|NCT01433263|12322688|FG001|Overall Study|Withdrawal by Subject|7
7842719|NCT01433354|12322697|FG000|Overall Study|Adverse Event|6
7842720|NCT01433354|12322697|FG000|Overall Study|Lost to Follow-up|1
7842721|NCT01433354|12322697|FG000|Overall Study|Administrative problems|90
7842722|NCT01433354|12322697|FG000|Overall Study|Protocol Violation|2
7842723|NCT01433354|12322697|FG000|Overall Study|Lack of Efficacy|17
7842724|NCT01433354|12322697|FG000|Overall Study|Subject Withdrew Consent|3
7842725|NCT01433549|12322711|FG000|Phase 2: Second Study Product|Adverse Event|0
7842726|NCT01433549|12322712|FG001|Phase 2: Second Study Product|Adverse Event|1
7842727|NCT01433978|12322745|FG000|Core Study|Adverse Event, Non-Fatal|0
7842728|NCT01433978|12322746|FG001|Core Study|Adverse Event, Non-Fatal|1
7842729|NCT01433978|12322747|FG002|Core Study|Adverse Event, Non-Fatal|0
7842730|NCT01433978|12322745|FG000|Core Study|Lack of Efficacy|5
7842731|NCT01433978|12322746|FG001|Core Study|Lack of Efficacy|1
7842732|NCT01433978|12322747|FG002|Core Study|Lack of Efficacy|0
7842733|NCT01433978|12322745|FG000|Core Study|Study Terminated by Sponsor|6
7842734|NCT01433978|12322746|FG001|Core Study|Study Terminated by Sponsor|9
7842735|NCT01433978|12322747|FG002|Core Study|Study Terminated by Sponsor|0
7842736|NCT01433978|12322745|FG000|Extension Phase|Adverse Event, Non-Fatal|0
7842737|NCT01433978|12322746|FG001|Extension Phase|Adverse Event, Non-Fatal|0
7842738|NCT01433978|12322747|FG002|Extension Phase|Adverse Event, Non-Fatal|1
7842739|NCT01433978|12322745|FG000|Extension Phase|Lack of Efficacy|0
7842740|NCT01433978|12322746|FG001|Extension Phase|Lack of Efficacy|0
7842741|NCT01433978|12322747|FG002|Extension Phase|Lack of Efficacy|1
7842742|NCT01433978|12322745|FG000|Extension Phase|Study Terminated by Sponsor|0
7842743|NCT01433978|12322746|FG001|Extension Phase|Study Terminated by Sponsor|0
7842744|NCT01433978|12322747|FG002|Extension Phase|Study Terminated by Sponsor|4
7842745|NCT01433991|12322758|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2
7842746|NCT01433991|12322759|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
7842747|NCT01433991|12322760|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
7842748|NCT01433991|12322761|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
7842749|NCT01433991|12322758|FG000|Treatment Phase (Combination Agent)|Adverse Event|1
7842750|NCT01433991|12322759|FG001|Treatment Phase (Combination Agent)|Adverse Event|0
7842751|NCT01433991|12322760|FG002|Treatment Phase (Combination Agent)|Adverse Event|3
7842752|NCT01433991|12322761|FG003|Treatment Phase (Combination Agent)|Adverse Event|1
7842753|NCT01433991|12322758|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0
7842754|NCT01433991|12322759|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0
7842755|NCT01433991|12322760|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0
7842756|NCT01433991|12322761|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1
7842757|NCT01433991|12322758|FG000|Treatment Phase (Combination Agent)|Participant Choice|0
7842758|NCT01433991|12322759|FG001|Treatment Phase (Combination Agent)|Participant Choice|0
7842759|NCT01433991|12322760|FG002|Treatment Phase (Combination Agent)|Participant Choice|0
7842760|NCT01433991|12322761|FG003|Treatment Phase (Combination Agent)|Participant Choice|1
7842761|NCT01433991|12322758|FG000|Treatment Phase (Combination Agent)|Clinical progression|0
7842762|NCT01433991|12322759|FG001|Treatment Phase (Combination Agent)|Clinical progression|1
7842763|NCT01433991|12322760|FG002|Treatment Phase (Combination Agent)|Clinical progression|2
7842764|NCT01433991|12322761|FG003|Treatment Phase (Combination Agent)|Clinical progression|3
7842765|NCT01433991|12322758|FG000|Treatment Phase (Combination Agent)|Progressive disease|1
7842766|NCT01433991|12322759|FG001|Treatment Phase (Combination Agent)|Progressive disease|0
7842767|NCT01433991|12322760|FG002|Treatment Phase (Combination Agent)|Progressive disease|0
7842768|NCT01433991|12322761|FG003|Treatment Phase (Combination Agent)|Progressive disease|0
7842769|NCT01433991|12322758|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0
7842770|NCT01433991|12322759|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0
7842771|NCT01433991|12322760|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1
7842772|NCT01433991|12322761|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0
7863097|NCT01603082|12352313|FG001|Overall Study|Withdrawal by Subject|0
7863098|NCT01603082|12352312|FG000|Overall Study|Failed inclusion criterion after dosed|1
7863099|NCT01603082|12352313|FG001|Overall Study|Failed inclusion criterion after dosed|0
7863100|NCT01603277|12352321|FG000|Overall Study|Adverse Event|1
7863101|NCT01603277|12352322|FG001|Overall Study|Adverse Event|2
7863102|NCT01603277|12352321|FG000|Overall Study|Physician Decision|0
7863103|NCT01603277|12352322|FG001|Overall Study|Physician Decision|1
7863104|NCT01603277|12352321|FG000|Overall Study|Protocol Violation|6
7863105|NCT01603277|12352322|FG001|Overall Study|Protocol Violation|10
7863106|NCT01603277|12352321|FG000|Overall Study|Withdrawal by Subject|5
7863107|NCT01603277|12352322|FG001|Overall Study|Withdrawal by Subject|4
7863108|NCT01603277|12352321|FG000|Overall Study|Non-Compliance|2
7863109|NCT01603277|12352322|FG001|Overall Study|Non-Compliance|1
7863110|NCT01603355|12352328|FG000|Overall Study|Lack of Efficacy|2
7863111|NCT01603459|12352353|FG000|Overall Study|Adverse Event|5
7863112|NCT01603459|12352353|FG000|Overall Study|Withdrawal by Subject|5
7863113|NCT01603459|12352353|FG000|Overall Study|Lost to Follow-up|3
7863114|NCT01603459|12352353|FG000|Overall Study|Predefined discontinuation criteria|3
7863115|NCT01603459|12352353|FG000|Overall Study|Non-compliance|1
7863116|NCT01603459|12352353|FG000|Overall Study|Administrative reason|1
7863117|NCT01603602|12352378|FG000|Overall Study|Adverse Event|1
7863118|NCT01603602|12352379|FG001|Overall Study|Adverse Event|0
7863119|NCT01603602|12352380|FG002|Overall Study|Adverse Event|0
7863120|NCT01603602|12352378|FG000|Overall Study|Personal Reasons|1
7863121|NCT01603602|12352379|FG001|Overall Study|Personal Reasons|0
7863122|NCT01603602|12352380|FG002|Overall Study|Personal Reasons|1
7863123|NCT01603615|12352388|FG000|Overall Study|Did not Receive Treatment|7
7863124|NCT01603615|12352388|FG000|Overall Study|Lost to Follow-up|9
7863125|NCT01603615|12352388|FG000|Overall Study|Personal Reasons|17
7863126|NCT01603615|12352388|FG000|Overall Study|Other Miscellaneous|1
7863127|NCT01603628|12352395|FG000|Overall Study|Personal Reasons|1
7863128|NCT01603628|12352396|FG001|Overall Study|Personal Reasons|1
7863129|NCT01603628|12352397|FG002|Overall Study|Personal Reasons|2
7863130|NCT01603628|12352395|FG000|Overall Study|Protocol Violation|1
7863131|NCT01603628|12352396|FG001|Overall Study|Protocol Violation|1
7863132|NCT01603628|12352397|FG002|Overall Study|Protocol Violation|0
7842773|NCT01434654|12322826|FG000|Overall Study|Withdrawal by Subject|1
7842774|NCT01434654|12322827|FG001|Overall Study|Withdrawal by Subject|0
7842775|NCT01434654|12322826|FG000|Overall Study|Lost to Follow-up|1
7842776|NCT01434654|12322827|FG001|Overall Study|Lost to Follow-up|0
7842777|NCT01434667|12322837|FG000|Overall Study|Lost to Follow-up|5
7842778|NCT01434667|12322838|FG001|Overall Study|Lost to Follow-up|10
7842779|NCT01434680|12322848|FG000|Overall Study|Withdrawal by Subject|1
7842780|NCT01434680|12322849|FG001|Overall Study|Withdrawal by Subject|0
7842781|NCT01434680|12322850|FG002|Overall Study|Withdrawal by Subject|2
7842782|NCT01434680|12322851|FG003|Overall Study|Withdrawal by Subject|0
7842783|NCT01434680|12322848|FG000|Overall Study|Lost to Follow-up|1
7842784|NCT01434680|12322849|FG001|Overall Study|Lost to Follow-up|1
7842785|NCT01434680|12322850|FG002|Overall Study|Lost to Follow-up|0
7842786|NCT01434680|12322851|FG003|Overall Study|Lost to Follow-up|0
7842787|NCT01434680|12322848|FG000|Overall Study|Protocol Violation|1
7842788|NCT01434680|12322849|FG001|Overall Study|Protocol Violation|1
7842789|NCT01434680|12322850|FG002|Overall Study|Protocol Violation|0
7842790|NCT01434680|12322851|FG003|Overall Study|Protocol Violation|0
7842791|NCT01434693|12322865|FG000|Overall Study|Adverse Event|1
7842792|NCT01434693|12322866|FG001|Overall Study|Adverse Event|0
7842793|NCT01434693|12322867|FG002|Overall Study|Adverse Event|0
7842794|NCT01434693|12322868|FG003|Overall Study|Adverse Event|0
7842795|NCT01434693|12322865|FG000|Overall Study|Withdrawal by Subject|1
7842796|NCT01434693|12322866|FG001|Overall Study|Withdrawal by Subject|0
7842797|NCT01434693|12322867|FG002|Overall Study|Withdrawal by Subject|1
7842798|NCT01434693|12322868|FG003|Overall Study|Withdrawal by Subject|1
7842799|NCT01434693|12322865|FG000|Overall Study|Lost to Follow-up|1
7842800|NCT01434693|12322866|FG001|Overall Study|Lost to Follow-up|0
7842801|NCT01434693|12322867|FG002|Overall Study|Lost to Follow-up|0
7842802|NCT01434693|12322868|FG003|Overall Study|Lost to Follow-up|0
7842803|NCT01434810|12322880|FG000|Overall Study|Did not receive treatment|11
7842804|NCT01434810|12322881|FG001|Overall Study|Did not receive treatment|3
7842805|NCT01434810|12322880|FG000|Overall Study|Missing data/received <5hr phototherapy|12
7842806|NCT01434810|12322881|FG001|Overall Study|Missing data/received <5hr phototherapy|7
7842807|NCT01434823|12322889|FG000|Overall Study|Incomplete data in medical record|4
7842808|NCT01434823|12322890|FG001|Overall Study|Incomplete data in medical record|7
7842809|NCT01435018|12322900|FG000|Overall Study|Death|37
7842810|NCT01435018|12322901|FG001|Overall Study|Death|18
7842811|NCT01435018|12322902|FG002|Overall Study|Death|25
7842812|NCT01435018|12322900|FG000|Overall Study|Site is closing|4
7842813|NCT01435018|12322901|FG001|Overall Study|Site is closing|9
7842814|NCT01435018|12322902|FG002|Overall Study|Site is closing|7
7842815|NCT01435018|12322900|FG000|Overall Study|Withdrew consent|0
7842816|NCT01435018|12322901|FG001|Overall Study|Withdrew consent|3
7842817|NCT01435018|12322902|FG002|Overall Study|Withdrew consent|1
7842818|NCT01435018|12322900|FG000|Overall Study|Not willing to adhere to requirements|0
7842819|NCT01435018|12322901|FG001|Overall Study|Not willing to adhere to requirements|2
7842820|NCT01435018|12322902|FG002|Overall Study|Not willing to adhere to requirements|3
7842821|NCT01435018|12322900|FG000|Overall Study|Not able to get to clinic|2
7842822|NCT01435018|12322901|FG001|Overall Study|Not able to get to clinic|0
7842823|NCT01435018|12322902|FG002|Overall Study|Not able to get to clinic|2
7842824|NCT01435018|12322900|FG000|Overall Study|Severe debilitation, unable to continue|0
7842825|NCT01435018|12322901|FG001|Overall Study|Severe debilitation, unable to continue|0
7842826|NCT01435018|12322902|FG002|Overall Study|Severe debilitation, unable to continue|1
7842827|NCT01435018|12322900|FG000|Overall Study|Unable to contact participant/parent|1
7842828|NCT01435018|12322901|FG001|Overall Study|Unable to contact participant/parent|1
7842829|NCT01435018|12322902|FG002|Overall Study|Unable to contact participant/parent|1
7842830|NCT01435018|12322900|FG000|Overall Study|Enrollment Violation|0
7842831|NCT01435018|12322901|FG001|Overall Study|Enrollment Violation|1
7842832|NCT01435018|12322902|FG002|Overall Study|Enrollment Violation|0
7842833|NCT01435018|12322900|FG000|Overall Study|Never started chemotherapy|3
7842834|NCT01435018|12322901|FG001|Overall Study|Never started chemotherapy|0
7842835|NCT01435018|12322902|FG002|Overall Study|Never started chemotherapy|1
7842836|NCT01435031|12322912|FG000|ITT at 1 Month|Withdrawal by Subject|1
7842837|NCT01435031|12322912|FG000|ITT at 1 Month|Death|1
7842838|NCT01435031|12322912|FG000|ITT at 1 Month|Lost to Follow-up|4
7842839|NCT01435031|12322912|FG000|ITT at 6 Months|Death|2
7842840|NCT01435031|12322912|FG000|ITT at 6 Months|Lost to Follow-up|3
7842841|NCT01435031|12322912|FG000|ITT at 1 Year|Death|1
7842842|NCT01435031|12322912|FG000|ITT at 1 Year|Withdrawal by Subject|2
7842843|NCT01435031|12322912|FG000|ITT at 1 Year|Lost to Follow-up|6
7842844|NCT01435031|12322912|FG000|ITT at 2 Years|Death|7
7842845|NCT01435031|12322912|FG000|ITT at 2 Years|Withdrawal by Subject|2
7842846|NCT01435031|12322912|FG000|ITT at 2 Years|Lost to Follow-up|4
7842847|NCT01435031|12322912|FG000|ITT at 3 Years|Death|5
7842848|NCT01435031|12322912|FG000|ITT at 3 Years|Withdrawal by Subject|2
7842849|NCT01435031|12322912|FG000|ITT at 3 Years|Lost to Follow-up|4
7842850|NCT01435031|12322912|FG000|ITT at 4 Years|Death|4
7842851|NCT01435031|12322912|FG000|ITT at 4 Years|Withdrawal by Subject|2
7842852|NCT01435031|12322912|FG000|ITT at 4 Years|Lost to Follow-up|1
7842853|NCT01435122|12322916|FG000|Overall Study|Early withdrawal due to toxicity|8
7842854|NCT01435265|12322926|FG000|Overall Study|Lost to Follow-up|0
7842855|NCT01435265|12322927|FG001|Overall Study|Lost to Follow-up|1
7842856|NCT01435356|12322944|FG000|Overall Study|Adverse Event|2
7842857|NCT01435356|12322945|FG001|Overall Study|Adverse Event|0
7842858|NCT01435356|12322944|FG000|Overall Study|Disease progression/recurrence|17
7842859|NCT01435356|12322945|FG001|Overall Study|Disease progression/recurrence|10
7842860|NCT01435356|12322944|FG000|Overall Study|Protocol Violation|0
7842861|NCT01435356|12322945|FG001|Overall Study|Protocol Violation|1
7842862|NCT01435356|12322944|FG000|Overall Study|Study Discontinuation, amendment 4|5
7842863|NCT01435356|12322945|FG001|Overall Study|Study Discontinuation, amendment 4|11
7842864|NCT01435356|12322944|FG000|Overall Study|Withdrawal by Subject|1
7842865|NCT01435356|12322945|FG001|Overall Study|Withdrawal by Subject|1
7842866|NCT01435356|12322944|FG000|Overall Study|Facial palsy|1
7842867|NCT01435356|12322945|FG001|Overall Study|Facial palsy|0
7842868|NCT01435356|12322944|FG000|Overall Study|IC withdrawal due to study cancellation|1
7842869|NCT01435356|12322945|FG001|Overall Study|IC withdrawal due to study cancellation|0
7842870|NCT01435356|12322944|FG000|Overall Study|Physician Decision|1
7842871|NCT01435356|12322945|FG001|Overall Study|Physician Decision|0
7842872|NCT01435356|12322944|FG000|Overall Study|Patient decision|3
7842873|NCT01435356|12322945|FG001|Overall Study|Patient decision|0
7842874|NCT01435356|12322944|FG000|Overall Study|Patient moved to another city|1
7842875|NCT01435356|12322945|FG001|Overall Study|Patient moved to another city|1
7842876|NCT01435382|12322955|FG000|Overall Study|Lost to Follow-up|1
7842877|NCT01435382|12322956|FG001|Overall Study|Lost to Follow-up|0
7842878|NCT01435382|12322957|FG002|Overall Study|Lost to Follow-up|1
7842879|NCT01435382|12322958|FG003|Overall Study|Lost to Follow-up|0
7842880|NCT01435382|12322955|FG000|Overall Study|Withdrawal by Subject|0
7842881|NCT01435382|12322956|FG001|Overall Study|Withdrawal by Subject|2
7842882|NCT01435382|12322957|FG002|Overall Study|Withdrawal by Subject|0
7842883|NCT01435382|12322958|FG003|Overall Study|Withdrawal by Subject|1
7842884|NCT01435460|12322976|FG000|Overall Study|Adverse Event|2
7842885|NCT01435460|12322977|FG001|Overall Study|Adverse Event|1
7842886|NCT01435460|12322976|FG000|Overall Study|Lost to Follow-up|6
7842887|NCT01435460|12322977|FG001|Overall Study|Lost to Follow-up|1
7842888|NCT01435460|12322976|FG000|Overall Study|Withdrawal by Subject|1
7842889|NCT01435460|12322977|FG001|Overall Study|Withdrawal by Subject|3
7842890|NCT01435460|12322976|FG000|Overall Study|Protocol Violation|0
7842891|NCT01435460|12322977|FG001|Overall Study|Protocol Violation|1
7842892|NCT01435460|12322976|FG000|Overall Study|Did not meet eligibility criteria|2
7842893|NCT01435460|12322977|FG001|Overall Study|Did not meet eligibility criteria|0
7842894|NCT01435577|12322994|FG000|Overall Study|Adverse Event|10
7842895|NCT01435577|12322995|FG001|Overall Study|Adverse Event|0
7842896|NCT01435577|12322994|FG000|Overall Study|Lack of Efficacy|7
7842897|NCT01435577|12322995|FG001|Overall Study|Lack of Efficacy|51
7842898|NCT01435577|12322994|FG000|Overall Study|Alternative treatment started|0
7842899|NCT01435577|12322995|FG001|Overall Study|Alternative treatment started|1
7842900|NCT01435616|12323016|FG000|Overall Study|Adverse Event|39
7842901|NCT01435616|12323017|FG001|Overall Study|Adverse Event|21
7842902|NCT01435616|12323016|FG000|Overall Study|Death|7
7842903|NCT01435616|12323017|FG001|Overall Study|Death|2
7842904|NCT01435616|12323016|FG000|Overall Study|Lost to Follow-up|22
7842905|NCT01435616|12323017|FG001|Overall Study|Lost to Follow-up|13
7842906|NCT01435616|12323016|FG000|Overall Study|Protocol Violation|16
7842907|NCT01435616|12323017|FG001|Overall Study|Protocol Violation|13
7842908|NCT01435616|12323016|FG000|Overall Study|Withdrawal by Subject|66
7842909|NCT01435616|12323017|FG001|Overall Study|Withdrawal by Subject|24
7842910|NCT01435616|12323016|FG000|Overall Study|Physician Decision|20
7842911|NCT01435616|12323017|FG001|Overall Study|Physician Decision|7
7842912|NCT01435616|12323016|FG000|Overall Study|Sponsor Decision|1
7842913|NCT01435616|12323017|FG001|Overall Study|Sponsor Decision|0
7842914|NCT01435655|12323025|FG000|Overall Study|Death|2
7842915|NCT01435655|12323025|FG000|Overall Study|Other|1
7842916|NCT01435759|12323034|FG000|Antidepressant Lead-in Phase|Adverse Event|40
7842917|NCT01435759|12323035|FG001|Antidepressant Lead-in Phase|Adverse Event|0
7842918|NCT01435759|12323036|FG002|Antidepressant Lead-in Phase|Adverse Event|0
7842919|NCT01435759|12323037|FG003|Antidepressant Lead-in Phase|Adverse Event|0
7842920|NCT01435759|12323038|FG004|Antidepressant Lead-in Phase|Adverse Event|0
7842921|NCT01435759|12323039|FG005|Antidepressant Lead-in Phase|Adverse Event|0
7842922|NCT01435759|12323034|FG000|Antidepressant Lead-in Phase|Protocol Violation|16
7842923|NCT01435759|12323035|FG001|Antidepressant Lead-in Phase|Protocol Violation|0
7842924|NCT01435759|12323036|FG002|Antidepressant Lead-in Phase|Protocol Violation|0
7842925|NCT01435759|12323037|FG003|Antidepressant Lead-in Phase|Protocol Violation|0
7842926|NCT01435759|12323038|FG004|Antidepressant Lead-in Phase|Protocol Violation|0
7842927|NCT01435759|12323039|FG005|Antidepressant Lead-in Phase|Protocol Violation|0
7842928|NCT01435759|12323034|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74
7842929|NCT01435759|12323035|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7842930|NCT01435759|12323036|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7842931|NCT01435759|12323037|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7842932|NCT01435759|12323038|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7842933|NCT01435759|12323039|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7842934|NCT01435759|12323034|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83
7842935|NCT01435759|12323035|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0
7842936|NCT01435759|12323036|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0
7842937|NCT01435759|12323037|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0
7842938|NCT01435759|12323038|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0
7842939|NCT01435759|12323039|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0
7842940|NCT01435759|12323034|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
7842941|NCT01435759|12323035|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7842942|NCT01435759|12323036|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7842943|NCT01435759|12323037|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7842944|NCT01435759|12323038|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7842945|NCT01435759|12323039|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7842946|NCT01435759|12323034|FG000|Antidepressant Lead-in Phase|Other|119
7842947|NCT01435759|12323035|FG001|Antidepressant Lead-in Phase|Other|0
7842948|NCT01435759|12323036|FG002|Antidepressant Lead-in Phase|Other|0
7842949|NCT01435759|12323037|FG003|Antidepressant Lead-in Phase|Other|0
7842950|NCT01435759|12323038|FG004|Antidepressant Lead-in Phase|Other|0
7842951|NCT01435759|12323039|FG005|Antidepressant Lead-in Phase|Other|0
7842952|NCT01435759|12323034|FG000|Double-blind Phase|Adverse Event|7
7842953|NCT01435759|12323035|FG001|Double-blind Phase|Adverse Event|0
7842954|NCT01435759|12323036|FG002|Double-blind Phase|Adverse Event|1
7842955|NCT01435759|12323037|FG003|Double-blind Phase|Adverse Event|1
7842956|NCT01435759|12323038|FG004|Double-blind Phase|Adverse Event|1
7842957|NCT01435759|12323039|FG005|Double-blind Phase|Adverse Event|3
7842958|NCT01435759|12323034|FG000|Double-blind Phase|Protocol Violation|2
7842959|NCT01435759|12323035|FG001|Double-blind Phase|Protocol Violation|0
7842960|NCT01435759|12323036|FG002|Double-blind Phase|Protocol Violation|1
7842961|NCT01435759|12323037|FG003|Double-blind Phase|Protocol Violation|2
7842962|NCT01435759|12323038|FG004|Double-blind Phase|Protocol Violation|0
7842963|NCT01435759|12323039|FG005|Double-blind Phase|Protocol Violation|1
7842964|NCT01435759|12323034|FG000|Double-blind Phase|Withdrawal by Subject|17
7842965|NCT01435759|12323035|FG001|Double-blind Phase|Withdrawal by Subject|4
7842966|NCT01435759|12323036|FG002|Double-blind Phase|Withdrawal by Subject|3
7842967|NCT01435759|12323037|FG003|Double-blind Phase|Withdrawal by Subject|4
7842968|NCT01435759|12323038|FG004|Double-blind Phase|Withdrawal by Subject|2
7842969|NCT01435759|12323039|FG005|Double-blind Phase|Withdrawal by Subject|2
7842970|NCT01435759|12323034|FG000|Double-blind Phase|Lost to Follow-up|31
7842971|NCT01435759|12323035|FG001|Double-blind Phase|Lost to Follow-up|1
7842972|NCT01435759|12323036|FG002|Double-blind Phase|Lost to Follow-up|2
7842973|NCT01435759|12323037|FG003|Double-blind Phase|Lost to Follow-up|0
7842974|NCT01435759|12323038|FG004|Double-blind Phase|Lost to Follow-up|3
7842975|NCT01435759|12323039|FG005|Double-blind Phase|Lost to Follow-up|3
7842976|NCT01435759|12323034|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
7842977|NCT01435759|12323035|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7842978|NCT01435759|12323036|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7842979|NCT01435759|12323037|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7842980|NCT01435759|12323038|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
7842981|NCT01435759|12323039|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7842982|NCT01435759|12323034|FG000|Double-blind Phase|Other|8
7842983|NCT01435759|12323035|FG001|Double-blind Phase|Other|2
7842984|NCT01435759|12323036|FG002|Double-blind Phase|Other|0
7842985|NCT01435759|12323037|FG003|Double-blind Phase|Other|2
7842986|NCT01435759|12323038|FG004|Double-blind Phase|Other|0
7842987|NCT01435759|12323039|FG005|Double-blind Phase|Other|0
7842988|NCT01435772|12323054|FG000|Overall Study|Adverse Event|1
7842989|NCT01435772|12323055|FG001|Overall Study|Adverse Event|0
7842990|NCT01435772|12323056|FG002|Overall Study|Adverse Event|2
7842991|NCT01435772|12323054|FG000|Overall Study|Withdrawal by Subject|0
7842992|NCT01435772|12323055|FG001|Overall Study|Withdrawal by Subject|1
7842993|NCT01435772|12323056|FG002|Overall Study|Withdrawal by Subject|3
7842994|NCT01435772|12323054|FG000|Overall Study|Other - study termination|2
7842995|NCT01435772|12323055|FG001|Overall Study|Other - study termination|2
7842996|NCT01435772|12323056|FG002|Overall Study|Other - study termination|10
7842997|NCT01435798|12323065|FG000|Overall Study|Withdrawal by Subject|1
7842998|NCT01435928|12323084|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83
7842999|NCT01435928|12323085|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0
7843000|NCT01435928|12323086|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0
7843001|NCT01435928|12323084|FG000|Open Label Phase - up to 24 Weeks|Death|1
7843002|NCT01435928|12323085|FG001|Open Label Phase - up to 24 Weeks|Death|0
7843003|NCT01435928|12323086|FG002|Open Label Phase - up to 24 Weeks|Death|0
7843004|NCT01435928|12323084|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
7843005|NCT01435928|12323085|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
7843006|NCT01435928|12323086|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
7843007|NCT01435928|12323084|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
7843008|NCT01435928|12323085|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
7843009|NCT01435928|12323086|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
7843010|NCT01435928|12323084|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39
7843011|NCT01435928|12323085|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0
7843012|NCT01435928|12323086|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0
7843013|NCT01435928|12323084|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
7843014|NCT01435928|12323085|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
7843015|NCT01435928|12323086|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
7843016|NCT01435928|12323084|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
7843017|NCT01435928|12323085|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
7843018|NCT01435928|12323086|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
7843019|NCT01435928|12323084|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
7843020|NCT01435928|12323085|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
7843021|NCT01435928|12323086|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
7843022|NCT01435928|12323084|FG000|Open Label Phase - up to 24 Weeks|Administrative|14
7843023|NCT01435928|12323085|FG001|Open Label Phase - up to 24 Weeks|Administrative|0
7843024|NCT01435928|12323086|FG002|Open Label Phase - up to 24 Weeks|Administrative|0
7843025|NCT01435928|12323084|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0
7843026|NCT01435928|12323085|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3
7843027|NCT01435928|12323086|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1
7843028|NCT01435928|12323084|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
7843029|NCT01435928|12323085|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
7843030|NCT01435928|12323086|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
7843031|NCT01435928|12323084|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0
7843032|NCT01435928|12323085|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11
7843033|NCT01435928|12323086|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4
7843034|NCT01435928|12323084|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
7843035|NCT01435928|12323085|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
7843036|NCT01435928|12323086|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
7843037|NCT01435928|12323084|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0
7843038|NCT01435928|12323085|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47
7843039|NCT01435928|12323086|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39
7843040|NCT01435928|12323084|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0
7843041|NCT01435928|12323085|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43
7843042|NCT01435928|12323086|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58
7843043|NCT01435928|12323084|FG000|Double Blind Phase - 28 Weeks|Administrative|0
7843044|NCT01435928|12323085|FG001|Double Blind Phase - 28 Weeks|Administrative|5
7843045|NCT01435928|12323086|FG002|Double Blind Phase - 28 Weeks|Administrative|2
7843046|NCT01436071|12323114|FG000|Overall Study|Adverse Event|1
7843047|NCT01436071|12323115|FG001|Overall Study|Adverse Event|0
7843048|NCT01436071|12323114|FG000|Overall Study|Lack of Efficacy|16
7843049|NCT01436071|12323115|FG001|Overall Study|Lack of Efficacy|7
7843050|NCT01436071|12323114|FG000|Overall Study|Protocol Violation|0
7843051|NCT01436071|12323115|FG001|Overall Study|Protocol Violation|1
7843052|NCT01436071|12323114|FG000|Overall Study|Lost to Follow-up|3
7843053|NCT01436071|12323115|FG001|Overall Study|Lost to Follow-up|1
7843054|NCT01436071|12323114|FG000|Overall Study|Physician Decision|1
7843055|NCT01436071|12323115|FG001|Overall Study|Physician Decision|0
7843056|NCT01436071|12323114|FG000|Overall Study|Withdrawal by Subject|2
7843057|NCT01436071|12323115|FG001|Overall Study|Withdrawal by Subject|2
7843058|NCT01436071|12323114|FG000|Overall Study|Did Not Receive Trial Medication|3
7843059|NCT01436071|12323115|FG001|Overall Study|Did Not Receive Trial Medication|3
7843060|NCT01436110|12323124|FG000|Overall Study|Lack of Efficacy|23
7843061|NCT01436110|12323125|FG001|Overall Study|Lack of Efficacy|14
7843062|NCT01436110|12323126|FG002|Overall Study|Lack of Efficacy|9
7843063|NCT01436110|12323124|FG000|Overall Study|Withdrawal by Subject|6
7843064|NCT01436110|12323125|FG001|Overall Study|Withdrawal by Subject|8
7843065|NCT01436110|12323126|FG002|Overall Study|Withdrawal by Subject|4
7843066|NCT01436110|12323124|FG000|Overall Study|Adverse Event|2
7843067|NCT01436110|12323125|FG001|Overall Study|Adverse Event|1
7843068|NCT01436110|12323126|FG002|Overall Study|Adverse Event|2
7843069|NCT01436110|12323124|FG000|Overall Study|Physician Decision|3
7843070|NCT01436110|12323125|FG001|Overall Study|Physician Decision|1
7843071|NCT01436110|12323126|FG002|Overall Study|Physician Decision|1
7843072|NCT01436110|12323124|FG000|Overall Study|Lost to Follow-up|1
7843073|NCT01436110|12323125|FG001|Overall Study|Lost to Follow-up|1
7843074|NCT01436110|12323126|FG002|Overall Study|Lost to Follow-up|3
7843075|NCT01436110|12323124|FG000|Overall Study|Protocol Violation|3
7843076|NCT01436110|12323125|FG001|Overall Study|Protocol Violation|1
7843077|NCT01436110|12323126|FG002|Overall Study|Protocol Violation|1
7843078|NCT01436110|12323124|FG000|Overall Study|Did Not Receive Trial Medication|1
7843079|NCT01436110|12323125|FG001|Overall Study|Did Not Receive Trial Medication|0
7843080|NCT01436110|12323126|FG002|Overall Study|Did Not Receive Trial Medication|3
7843081|NCT01436149|12323136|FG000|Antidepressant Lead-in Phase|Adverse Event|39
7843082|NCT01436149|12323137|FG001|Antidepressant Lead-in Phase|Adverse Event|0
7843083|NCT01436149|12323138|FG002|Antidepressant Lead-in Phase|Adverse Event|0
7843084|NCT01436149|12323136|FG000|Antidepressant Lead-in Phase|Protocol Violation|29
7843085|NCT01436149|12323137|FG001|Antidepressant Lead-in Phase|Protocol Violation|0
7843086|NCT01436149|12323138|FG002|Antidepressant Lead-in Phase|Protocol Violation|0
7843087|NCT01436149|12323136|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61
7843088|NCT01436149|12323137|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7863133|NCT01603628|12352395|FG000|Overall Study|Lost to Follow-up|0
7843089|NCT01436149|12323138|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7843090|NCT01436149|12323136|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96
7843091|NCT01436149|12323137|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0
7843092|NCT01436149|12323138|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0
7843093|NCT01436149|12323136|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
7843094|NCT01436149|12323137|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
7843095|NCT01436149|12323138|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
7843096|NCT01436149|12323136|FG000|Antidepressant Lead-in Phase|Other|119
7843097|NCT01436149|12323137|FG001|Antidepressant Lead-in Phase|Other|0
7843098|NCT01436149|12323138|FG002|Antidepressant Lead-in Phase|Other|0
7843099|NCT01436149|12323136|FG000|Randomized Phase|Adverse Event|9
7843100|NCT01436149|12323137|FG001|Randomized Phase|Adverse Event|10
7843101|NCT01436149|12323138|FG002|Randomized Phase|Adverse Event|11
7843102|NCT01436149|12323136|FG000|Randomized Phase|Protocol Violation|4
7843103|NCT01436149|12323137|FG001|Randomized Phase|Protocol Violation|5
7843104|NCT01436149|12323138|FG002|Randomized Phase|Protocol Violation|0
7843105|NCT01436149|12323136|FG000|Randomized Phase|Withdrawal by Subject|16
7843106|NCT01436149|12323137|FG001|Randomized Phase|Withdrawal by Subject|10
7843107|NCT01436149|12323138|FG002|Randomized Phase|Withdrawal by Subject|10
7843108|NCT01436149|12323136|FG000|Randomized Phase|Lost to Follow-up|34
7843109|NCT01436149|12323137|FG001|Randomized Phase|Lost to Follow-up|5
7843110|NCT01436149|12323138|FG002|Randomized Phase|Lost to Follow-up|6
7843111|NCT01436149|12323136|FG000|Randomized Phase|Lack of Efficacy|0
7843112|NCT01436149|12323137|FG001|Randomized Phase|Lack of Efficacy|0
7843113|NCT01436149|12323138|FG002|Randomized Phase|Lack of Efficacy|1
7843114|NCT01436149|12323136|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
7843115|NCT01436149|12323137|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
7843116|NCT01436149|12323138|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
7843117|NCT01436149|12323136|FG000|Randomized Phase|Other|12
7843118|NCT01436149|12323137|FG001|Randomized Phase|Other|5
7843119|NCT01436149|12323138|FG002|Randomized Phase|Other|11
7843120|NCT01436162|12323146|FG000|Single-blind Lead-in Phase|Adverse Event|26
7843121|NCT01436162|12323147|FG001|Single-blind Lead-in Phase|Adverse Event|0
7843122|NCT01436162|12323148|FG002|Single-blind Lead-in Phase|Adverse Event|0
7843123|NCT01436162|12323146|FG000|Single-blind Lead-in Phase|Protocol Violation|24
7843124|NCT01436162|12323147|FG001|Single-blind Lead-in Phase|Protocol Violation|0
7843125|NCT01436162|12323148|FG002|Single-blind Lead-in Phase|Protocol Violation|0
7843126|NCT01436162|12323146|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69
7843127|NCT01436162|12323147|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0
7843128|NCT01436162|12323148|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0
7843129|NCT01436162|12323146|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43
7843130|NCT01436162|12323147|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0
7843131|NCT01436162|12323148|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0
7843132|NCT01436162|12323146|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
7843133|NCT01436162|12323147|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7843134|NCT01436162|12323148|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7843135|NCT01436162|12323146|FG000|Single-blind Lead-in Phase|Other|107
7843136|NCT01436162|12323147|FG001|Single-blind Lead-in Phase|Other|0
7843137|NCT01436162|12323148|FG002|Single-blind Lead-in Phase|Other|0
7843138|NCT01436162|12323146|FG000|Randomized Phase|Adverse Event|1
7843139|NCT01436162|12323147|FG001|Randomized Phase|Adverse Event|5
7843140|NCT01436162|12323148|FG002|Randomized Phase|Adverse Event|6
7843141|NCT01436162|12323146|FG000|Randomized Phase|Protocol Violation|4
7843142|NCT01436162|12323147|FG001|Randomized Phase|Protocol Violation|4
7843143|NCT01436162|12323148|FG002|Randomized Phase|Protocol Violation|2
7843144|NCT01436162|12323146|FG000|Randomized Phase|Withdrawal by Subject|16
7843145|NCT01436162|12323147|FG001|Randomized Phase|Withdrawal by Subject|9
7843146|NCT01436162|12323148|FG002|Randomized Phase|Withdrawal by Subject|8
7843147|NCT01436162|12323146|FG000|Randomized Phase|Lost to Follow-up|17
7843148|NCT01436162|12323147|FG001|Randomized Phase|Lost to Follow-up|5
7843149|NCT01436162|12323148|FG002|Randomized Phase|Lost to Follow-up|4
7843150|NCT01436162|12323146|FG000|Randomized Phase|Lack of Efficacy|0
7843151|NCT01436162|12323147|FG001|Randomized Phase|Lack of Efficacy|1
7843152|NCT01436162|12323148|FG002|Randomized Phase|Lack of Efficacy|1
7843153|NCT01436162|12323146|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
7843154|NCT01436162|12323147|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
7843155|NCT01436162|12323148|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
7843156|NCT01436162|12323146|FG000|Randomized Phase|Other|2
7843157|NCT01436162|12323147|FG001|Randomized Phase|Other|5
7843158|NCT01436162|12323148|FG002|Randomized Phase|Other|4
7843159|NCT01436175|12323156|FG000|Overall Study|Adverse Event|111
7843160|NCT01436175|12323156|FG000|Overall Study|Protocol Violation|49
7843161|NCT01436175|12323156|FG000|Overall Study|Withdrawal by Subject|108
7843162|NCT01436175|12323156|FG000|Overall Study|Lost to Follow-up|89
7843163|NCT01436175|12323156|FG000|Overall Study|Lack of Efficacy|24
7843164|NCT01436175|12323156|FG000|Overall Study|Met blood pressure or pulse withdrawal|63
7843165|NCT01436175|12323156|FG000|Overall Study|Other|826
7843166|NCT01436201|12323161|FG000|Overall Study|Adverse Event|2
7843167|NCT01436201|12323161|FG000|Overall Study|Withdrawal by Subject|1
7843168|NCT01436201|12323161|FG000|Overall Study|Protocol Violation|1
7843169|NCT01436305|12323190|FG000|Overall Study|Death|1
7843170|NCT01436305|12323191|FG001|Overall Study|Death|0
7843171|NCT01436305|12323192|FG002|Overall Study|Death|0
7843172|NCT01436305|12323190|FG000|Overall Study|Lost to Follow-up|0
7843173|NCT01436305|12323191|FG001|Overall Study|Lost to Follow-up|1
7843174|NCT01436305|12323192|FG002|Overall Study|Lost to Follow-up|0
7843175|NCT01436305|12323190|FG000|Overall Study|Withdrawal by Subject|1
7843176|NCT01436305|12323191|FG001|Overall Study|Withdrawal by Subject|3
7843177|NCT01436305|12323192|FG002|Overall Study|Withdrawal by Subject|0
7843178|NCT01436357|12323202|FG000|Overall Study|Death|5
7843179|NCT01436357|12323203|FG001|Overall Study|Death|1
7843180|NCT01436357|12323202|FG000|Overall Study|Enrolled but not vaccinated|1
7843181|NCT01436357|12323203|FG001|Overall Study|Enrolled but not vaccinated|1
7843182|NCT01436357|12323202|FG000|Overall Study|Incarceration|18
7843183|NCT01436357|12323203|FG001|Overall Study|Incarceration|20
7843184|NCT01436357|12323202|FG000|Overall Study|Lost to Follow-up|67
7843185|NCT01436357|12323203|FG001|Overall Study|Lost to Follow-up|61
7843186|NCT01436357|12323202|FG000|Overall Study|Protocol Violation|1
7843187|NCT01436357|12323203|FG001|Overall Study|Protocol Violation|0
7843188|NCT01436357|12323202|FG000|Overall Study|Withdrawal by Subject|26
7843189|NCT01436357|12323203|FG001|Overall Study|Withdrawal by Subject|38
7843190|NCT01436357|12323202|FG000|Overall Study|Physician Decision|3
7843191|NCT01436357|12323203|FG001|Overall Study|Physician Decision|4
7843192|NCT01436357|12323202|FG000|Overall Study|Moved out of area|1
7843193|NCT01436357|12323203|FG001|Overall Study|Moved out of area|2
7843194|NCT01436357|12323202|FG000|Overall Study|Subject in rehab|0
7843195|NCT01436357|12323203|FG001|Overall Study|Subject in rehab|1
7843196|NCT01436370|12323217|FG000|Overall Study|Lost to Follow-up|0
7843197|NCT01436370|12323218|FG001|Overall Study|Lost to Follow-up|0
7843198|NCT01436370|12323219|FG002|Overall Study|Lost to Follow-up|0
7843199|NCT01436370|12323220|FG003|Overall Study|Lost to Follow-up|0
7843200|NCT01436370|12323221|FG004|Overall Study|Lost to Follow-up|1
7843201|NCT01436370|12323222|FG005|Overall Study|Lost to Follow-up|0
7843202|NCT01436370|12323223|FG006|Overall Study|Lost to Follow-up|0
7843203|NCT01436370|12323224|FG007|Overall Study|Lost to Follow-up|0
7843204|NCT01436500|12323256|FG000|Overall Study|Death|1
7843205|NCT01436500|12323257|FG001|Overall Study|Death|0
7843206|NCT01436500|12323258|FG002|Overall Study|Death|0
7843207|NCT01436500|12323259|FG003|Overall Study|Death|0
7843208|NCT01436500|12323260|FG004|Overall Study|Death|0
7843209|NCT01436500|12323256|FG000|Overall Study|Adverse Event|0
7843210|NCT01436500|12323257|FG001|Overall Study|Adverse Event|2
7843211|NCT01436500|12323258|FG002|Overall Study|Adverse Event|2
7843212|NCT01436500|12323259|FG003|Overall Study|Adverse Event|0
7843213|NCT01436500|12323260|FG004|Overall Study|Adverse Event|1
7843214|NCT01436500|12323256|FG000|Overall Study|Withdrawal by Subject|0
7843215|NCT01436500|12323257|FG001|Overall Study|Withdrawal by Subject|0
7843216|NCT01436500|12323258|FG002|Overall Study|Withdrawal by Subject|2
7843217|NCT01436500|12323259|FG003|Overall Study|Withdrawal by Subject|0
7843218|NCT01436500|12323260|FG004|Overall Study|Withdrawal by Subject|2
7843219|NCT01436500|12323256|FG000|Overall Study|Physician Decision|0
7843220|NCT01436500|12323257|FG001|Overall Study|Physician Decision|0
7843221|NCT01436500|12323258|FG002|Overall Study|Physician Decision|1
7843222|NCT01436500|12323259|FG003|Overall Study|Physician Decision|0
7843223|NCT01436500|12323260|FG004|Overall Study|Physician Decision|0
7843224|NCT01436500|12323256|FG000|Overall Study|liver transplant|1
7843225|NCT01436500|12323257|FG001|Overall Study|liver transplant|0
7843226|NCT01436500|12323258|FG002|Overall Study|liver transplant|0
7843227|NCT01436500|12323259|FG003|Overall Study|liver transplant|0
7843228|NCT01436500|12323260|FG004|Overall Study|liver transplant|0
7843229|NCT01436500|12323256|FG000|Overall Study|initiation of dialysis|0
7843230|NCT01436500|12323257|FG001|Overall Study|initiation of dialysis|0
7843231|NCT01436500|12323258|FG002|Overall Study|initiation of dialysis|0
7843232|NCT01436500|12323259|FG003|Overall Study|initiation of dialysis|0
7843233|NCT01436500|12323260|FG004|Overall Study|initiation of dialysis|1
7843234|NCT01436500|12323256|FG000|Overall Study|discontinued study drug|1
7843235|NCT01436500|12323257|FG001|Overall Study|discontinued study drug|0
7843236|NCT01436500|12323258|FG002|Overall Study|discontinued study drug|0
7843237|NCT01436500|12323259|FG003|Overall Study|discontinued study drug|0
7843238|NCT01436500|12323260|FG004|Overall Study|discontinued study drug|0
7843239|NCT01436500|12323256|FG000|Overall Study|Other|0
7843240|NCT01436500|12323257|FG001|Overall Study|Other|1
7843241|NCT01436500|12323258|FG002|Overall Study|Other|0
7843242|NCT01436500|12323259|FG003|Overall Study|Other|1
7843243|NCT01436500|12323260|FG004|Overall Study|Other|0
7843244|NCT01436643|12323285|FG000|2-week Pre-treatment|Abnormal test result|0
7843245|NCT01436643|12323286|FG001|2-week Pre-treatment|Abnormal test result|0
7843246|NCT01436643|12323287|FG002|2-week Pre-treatment|Abnormal test result|0
7843247|NCT01436643|12323288|FG003|2-week Pre-treatment|Abnormal test result|1
7843248|NCT01436643|12323285|FG000|2-week Pre-treatment|Adverse Event|0
7843249|NCT01436643|12323286|FG001|2-week Pre-treatment|Adverse Event|0
7843250|NCT01436643|12323287|FG002|2-week Pre-treatment|Adverse Event|0
7843251|NCT01436643|12323288|FG003|2-week Pre-treatment|Adverse Event|5
7843252|NCT01436643|12323285|FG000|2-week Pre-treatment|Protocol Violation|0
7843253|NCT01436643|12323286|FG001|2-week Pre-treatment|Protocol Violation|0
7843254|NCT01436643|12323287|FG002|2-week Pre-treatment|Protocol Violation|0
7843255|NCT01436643|12323288|FG003|2-week Pre-treatment|Protocol Violation|4
7843256|NCT01436643|12323285|FG000|Core Phase (16 Weeks)|Adverse Event|0
7843257|NCT01436643|12323286|FG001|Core Phase (16 Weeks)|Adverse Event|3
7843258|NCT01436643|12323287|FG002|Core Phase (16 Weeks)|Adverse Event|1
7843259|NCT01436643|12323288|FG003|Core Phase (16 Weeks)|Adverse Event|0
7843260|NCT01436643|12323285|FG000|Core Phase (16 Weeks)|Abnormal Test result|0
7843261|NCT01436643|12323286|FG001|Core Phase (16 Weeks)|Abnormal Test result|0
7843262|NCT01436643|12323287|FG002|Core Phase (16 Weeks)|Abnormal Test result|1
7843263|NCT01436643|12323288|FG003|Core Phase (16 Weeks)|Abnormal Test result|0
7843264|NCT01436643|12323285|FG000|Core Phase (16 Weeks)|Protocol Violation|1
7843265|NCT01436643|12323286|FG001|Core Phase (16 Weeks)|Protocol Violation|1
7843266|NCT01436643|12323287|FG002|Core Phase (16 Weeks)|Protocol Violation|1
7843267|NCT01436643|12323288|FG003|Core Phase (16 Weeks)|Protocol Violation|0
7843268|NCT01437267|12323329|FG000|Overall Study|Withdrawal by Subject|0
7843269|NCT01437267|12323330|FG001|Overall Study|Withdrawal by Subject|0
7843270|NCT01437267|12323331|FG002|Overall Study|Withdrawal by Subject|0
7843271|NCT01437267|12323332|FG003|Overall Study|Withdrawal by Subject|1
7843272|NCT01437267|12323333|FG004|Overall Study|Withdrawal by Subject|0
7843273|NCT01437267|12323334|FG005|Overall Study|Withdrawal by Subject|0
7843274|NCT01437267|12323329|FG000|Overall Study|Protocol Violation|0
7843275|NCT01437267|12323330|FG001|Overall Study|Protocol Violation|1
7843276|NCT01437267|12323331|FG002|Overall Study|Protocol Violation|0
7843277|NCT01437267|12323332|FG003|Overall Study|Protocol Violation|0
7843278|NCT01437267|12323333|FG004|Overall Study|Protocol Violation|0
7843279|NCT01437267|12323334|FG005|Overall Study|Protocol Violation|0
7843280|NCT01437319|12323348|FG000|Phase I|Lost to Follow-up|2
7843281|NCT01437319|12323349|FG001|Phase I|Lost to Follow-up|0
7843282|NCT01437319|12323350|FG002|Phase I|Lost to Follow-up|0
7843283|NCT01437319|12323348|FG000|Phase I|Protocol Violation|1
7843284|NCT01437319|12323349|FG001|Phase I|Protocol Violation|0
7843285|NCT01437319|12323350|FG002|Phase I|Protocol Violation|0
7843286|NCT01437319|12323348|FG000|Phase I|Study related symptoms/complaints|27
7843287|NCT01437319|12323349|FG001|Phase I|Study related symptoms/complaints|0
7843288|NCT01437319|12323350|FG002|Phase I|Study related symptoms/complaints|0
7843289|NCT01437319|12323348|FG000|Phase I|Withdrawal by Subject|25
7843290|NCT01437319|12323349|FG001|Phase I|Withdrawal by Subject|0
7843291|NCT01437319|12323350|FG002|Phase I|Withdrawal by Subject|0
7843292|NCT01437319|12323348|FG000|Phase II|Withdrawal by Subject|0
7843293|NCT01437319|12323349|FG001|Phase II|Withdrawal by Subject|8
7843294|NCT01437319|12323350|FG002|Phase II|Withdrawal by Subject|16
7843295|NCT01437319|12323348|FG000|Phase II|Lost to Follow-up|0
7843296|NCT01437319|12323349|FG001|Phase II|Lost to Follow-up|7
7843297|NCT01437319|12323350|FG002|Phase II|Lost to Follow-up|2
7843298|NCT01437319|12323348|FG000|Phase II|Study related symptoms/complaints|0
7843299|NCT01437319|12323349|FG001|Phase II|Study related symptoms/complaints|28
7843300|NCT01437319|12323350|FG002|Phase II|Study related symptoms/complaints|19
7843301|NCT01437319|12323348|FG000|Phase II|Protocol Violation|0
7843302|NCT01437319|12323349|FG001|Phase II|Protocol Violation|1
7843303|NCT01437319|12323350|FG002|Phase II|Protocol Violation|0
7843304|NCT01437397|12323364|FG000|Overall Study|Lost to Follow-up|9
7843305|NCT01437397|12323365|FG001|Overall Study|Lost to Follow-up|4
7843306|NCT01437397|12323366|FG002|Overall Study|Lost to Follow-up|2
7843307|NCT01437397|12323367|FG003|Overall Study|Lost to Follow-up|4
7843308|NCT01437397|12323368|FG004|Overall Study|Lost to Follow-up|5
7843309|NCT01437397|12323364|FG000|Overall Study|Withdrawal by Subject|11
7843310|NCT01437397|12323365|FG001|Overall Study|Withdrawal by Subject|12
7843311|NCT01437397|12323366|FG002|Overall Study|Withdrawal by Subject|24
7843312|NCT01437397|12323367|FG003|Overall Study|Withdrawal by Subject|11
7843313|NCT01437397|12323368|FG004|Overall Study|Withdrawal by Subject|22
7843314|NCT01437397|12323364|FG000|Overall Study|Protocol Violation|10
7843315|NCT01437397|12323365|FG001|Overall Study|Protocol Violation|12
7843316|NCT01437397|12323366|FG002|Overall Study|Protocol Violation|13
7843317|NCT01437397|12323367|FG003|Overall Study|Protocol Violation|21
7843318|NCT01437397|12323368|FG004|Overall Study|Protocol Violation|19
7843319|NCT01437397|12323364|FG000|Overall Study|Lack of Efficacy|5
7843320|NCT01437397|12323365|FG001|Overall Study|Lack of Efficacy|4
7843321|NCT01437397|12323366|FG002|Overall Study|Lack of Efficacy|8
7843322|NCT01437397|12323367|FG003|Overall Study|Lack of Efficacy|10
7843323|NCT01437397|12323368|FG004|Overall Study|Lack of Efficacy|20
7843324|NCT01437397|12323364|FG000|Overall Study|Adverse Event|21
7843325|NCT01437397|12323365|FG001|Overall Study|Adverse Event|22
7843326|NCT01437397|12323366|FG002|Overall Study|Adverse Event|16
7843327|NCT01437397|12323367|FG003|Overall Study|Adverse Event|14
7843328|NCT01437397|12323368|FG004|Overall Study|Adverse Event|21
7843329|NCT01437397|12323364|FG000|Overall Study|Site termination/COPD exacerbation/other|10
7843330|NCT01437397|12323365|FG001|Overall Study|Site termination/COPD exacerbation/other|8
7843331|NCT01437397|12323366|FG002|Overall Study|Site termination/COPD exacerbation/other|9
7843332|NCT01437397|12323367|FG003|Overall Study|Site termination/COPD exacerbation/other|9
7843333|NCT01437397|12323368|FG004|Overall Study|Site termination/COPD exacerbation/other|14
7843334|NCT01437540|12323404|FG000|Overall Study|Not listed below|7
7843335|NCT01437540|12323405|FG001|Overall Study|Not listed below|6
7843336|NCT01437540|12323404|FG000|Overall Study|COPD exacerbation|13
7843337|NCT01437540|12323405|FG001|Overall Study|COPD exacerbation|3
7843338|NCT01437540|12323404|FG000|Overall Study|Lost to Follow-up|3
7843339|NCT01437540|12323405|FG001|Overall Study|Lost to Follow-up|5
7843340|NCT01437540|12323404|FG000|Overall Study|Lack of Efficacy|23
7843341|NCT01437540|12323405|FG001|Overall Study|Lack of Efficacy|11
7843342|NCT01437540|12323404|FG000|Overall Study|Protocol Violation|24
7843343|NCT01437540|12323405|FG001|Overall Study|Protocol Violation|12
7843344|NCT01437540|12323404|FG000|Overall Study|Adverse Event|26
7843345|NCT01437540|12323405|FG001|Overall Study|Adverse Event|13
7843346|NCT01437540|12323404|FG000|Overall Study|Withdrawal by Subject|31
7843347|NCT01437540|12323405|FG001|Overall Study|Withdrawal by Subject|15
7843348|NCT01437878|12323427|FG000|Overall Study|Withdrawal by Subject|1
7843349|NCT01437878|12323428|FG001|Overall Study|Withdrawal by Subject|0
7843350|NCT01437943|12323436|FG000|Overall Study|Aliskiren trials terminated by Novartis|4
7843351|NCT01437943|12323437|FG001|Overall Study|Aliskiren trials terminated by Novartis|2
7843352|NCT01437943|12323436|FG000|Overall Study|Subject expressed pregnancy plans|1
7843353|NCT01437943|12323437|FG001|Overall Study|Subject expressed pregnancy plans|0
7843354|NCT01437943|12323436|FG000|Overall Study|Adverse Event|2
7843355|NCT01437943|12323437|FG001|Overall Study|Adverse Event|0
7843356|NCT01437995|12323446|FG000|Overall Study|Lost to Follow-up|11
7843357|NCT01437995|12323447|FG001|Overall Study|Lost to Follow-up|18
7843358|NCT01437995|12323448|FG002|Overall Study|Lost to Follow-up|20
7843359|NCT01438060|12323467|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
7843360|NCT01438060|12323468|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
7843361|NCT01438060|12323467|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
7843362|NCT01438060|12323468|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
7720893|NCT00541970|12145423|FG002|Month 7|Protocol Violation|11
7720894|NCT00541970|12145424|FG003|Month 7|Protocol Violation|5
7720895|NCT00541970|12145421|FG000|Month 12|Adverse Event|0
7720896|NCT00541970|12145422|FG001|Month 12|Adverse Event|1
7720897|NCT00541970|12145423|FG002|Month 12|Adverse Event|1
7720898|NCT00541970|12145424|FG003|Month 12|Adverse Event|1
7720899|NCT00541970|12145421|FG000|Month 12|Protocol Violation|12
7720900|NCT00541970|12145422|FG001|Month 12|Protocol Violation|21
7720901|NCT00541970|12145423|FG002|Month 12|Protocol Violation|20
7720902|NCT00541970|12145424|FG003|Month 12|Protocol Violation|15
7720903|NCT00541970|12145421|FG000|Month 18|Adverse Event|0
7843363|NCT01438060|12323467|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
7843364|NCT01438060|12323468|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
7843365|NCT01438060|12323467|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
7843366|NCT01438060|12323468|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
7843367|NCT01438060|12323467|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0
7843368|NCT01438060|12323468|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2
7843369|NCT01438060|12323467|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
7843370|NCT01438060|12323468|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
7843371|NCT01438060|12323467|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15
7843372|NCT01438060|12323468|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16
7843373|NCT01438060|12323467|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
7843374|NCT01438060|12323468|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
7843375|NCT01438060|12323467|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
7843376|NCT01438060|12323468|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
7843377|NCT01438060|12323467|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
7843378|NCT01438060|12323468|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
7843379|NCT01438060|12323467|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
7843380|NCT01438060|12323468|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
7843381|NCT01438060|12323467|FG000|Extension Phase: Week 10 to Week 130|Death|22
7843382|NCT01438060|12323468|FG001|Extension Phase: Week 10 to Week 130|Death|12
7843383|NCT01438060|12323467|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7
7843384|NCT01438060|12323468|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15
7843385|NCT01438060|12323467|FG000|On Study Beyond Week 140|Adverse Event|0
7843386|NCT01438060|12323468|FG001|On Study Beyond Week 140|Adverse Event|2
7843387|NCT01438060|12323467|FG000|On Study Beyond Week 140|Lack of Efficacy|0
7843388|NCT01438060|12323468|FG001|On Study Beyond Week 140|Lack of Efficacy|1
7843389|NCT01438060|12323467|FG000|On Study Beyond Week 140|Withdrawal by Subject|0
7843390|NCT01438060|12323468|FG001|On Study Beyond Week 140|Withdrawal by Subject|1
7843391|NCT01438060|12323467|FG000|On Study Beyond Week 140|Death|0
7843392|NCT01438060|12323468|FG001|On Study Beyond Week 140|Death|1
7843393|NCT01438060|12323467|FG000|On Study Beyond Week 140|Other Reason|0
7843394|NCT01438060|12323468|FG001|On Study Beyond Week 140|Other Reason|3
7843395|NCT01438151|12323479|FG000|Overall Study|study terminated|8
7843396|NCT01438177|12323483|FG000|Overall Study|Withdrawal by Subject|1
7843397|NCT01438177|12323483|FG000|Overall Study|Initiation of new therapy|1
7843398|NCT01438294|12323493|FG000|Overall Study|Lost to Follow-up|3
7843399|NCT01438294|12323494|FG001|Overall Study|Lost to Follow-up|7
7843400|NCT01438307|12323502|FG000|Overall Study|Death|1
7843401|NCT01438307|12323503|FG001|Overall Study|Death|1
7843402|NCT01438411|12323509|FG000|Overall Study|Adverse Event|8
7843403|NCT01438411|12323509|FG000|Overall Study|Lost to Follow-up|1
7843404|NCT01438411|12323509|FG000|Overall Study|Lack of Efficacy|1
7843405|NCT01438411|12323509|FG000|Overall Study|Withdrawal by Subject|3
7843406|NCT01438424|12323513|FG000|Overall Study|Continuing treatment|29
7843407|NCT01438424|12323513|FG000|Overall Study|Minimal virologic response|95
7843408|NCT01438424|12323513|FG000|Overall Study|Not identified|55
7843409|NCT01438424|12323513|FG000|Overall Study|Withdrawal by Subject|104
7843410|NCT01438424|12323513|FG000|Overall Study|Progression of chronic hepatitis B|22
7843411|NCT01438424|12323513|FG000|Overall Study|Death|22
7843412|NCT01438424|12323513|FG000|Overall Study|Adverse Event|17
7843413|NCT01438424|12323513|FG000|Overall Study|Lost to Follow-up|17
7843414|NCT01438424|12323513|FG000|Overall Study|Abnormal laboratory test result|14
7843415|NCT01438424|12323513|FG000|Overall Study|Need for drug prohibited by protocol|14
7843416|NCT01438424|12323513|FG000|Overall Study|Pregnancy|7
7843417|NCT01438424|12323513|FG000|Overall Study|No longer met inclusion criteria|1
7843418|NCT01438424|12323513|FG000|Overall Study|Participant noncompliance|20
7843419|NCT01438476|12323529|FG000|Overall Study|Protocol Violation|1
7843420|NCT01438476|12323530|FG001|Overall Study|Protocol Violation|0
7843421|NCT01438476|12323529|FG000|Overall Study|Withdrawal by Subject|1
7843422|NCT01438476|12323530|FG001|Overall Study|Withdrawal by Subject|0
7843423|NCT01438476|12323529|FG000|Overall Study|No Surgery- Disease|8
7843424|NCT01438476|12323530|FG001|Overall Study|No Surgery- Disease|10
7843425|NCT01438476|12323529|FG000|Overall Study|Communication barrier|0
7843426|NCT01438476|12323530|FG001|Overall Study|Communication barrier|1
7843427|NCT01438489|12323539|FG000|Overall Study|Lost to Follow-up|4
7843428|NCT01438489|12323540|FG001|Overall Study|Lost to Follow-up|2
7843429|NCT01438489|12323541|FG002|Overall Study|Lost to Follow-up|2
7843430|NCT01438489|12323539|FG000|Overall Study|Withdrawal by Subject|11
7843431|NCT01438489|12323540|FG001|Overall Study|Withdrawal by Subject|3
7843432|NCT01438489|12323541|FG002|Overall Study|Withdrawal by Subject|8
7843433|NCT01438489|12323539|FG000|Overall Study|Death|0
7843434|NCT01438489|12323540|FG001|Overall Study|Death|0
7843435|NCT01438489|12323541|FG002|Overall Study|Death|1
7843436|NCT01438489|12323539|FG000|Overall Study|Sponsor decision|4
7843437|NCT01438489|12323540|FG001|Overall Study|Sponsor decision|1
7843438|NCT01438489|12323541|FG002|Overall Study|Sponsor decision|4
7843439|NCT01438489|12323539|FG000|Overall Study|Subject choice/Subject moved|2
7843440|NCT01438489|12323540|FG001|Overall Study|Subject choice/Subject moved|1
7843441|NCT01438489|12323541|FG002|Overall Study|Subject choice/Subject moved|1
7843442|NCT01438489|12323539|FG000|Overall Study|Investigator decision|0
7843443|NCT01438489|12323540|FG001|Overall Study|Investigator decision|1
7843444|NCT01438489|12323541|FG002|Overall Study|Investigator decision|0
7843445|NCT01438489|12323539|FG000|Overall Study|AE/SAEs|2
7843446|NCT01438489|12323540|FG001|Overall Study|AE/SAEs|1
7843447|NCT01438489|12323541|FG002|Overall Study|AE/SAEs|1
7843448|NCT01438489|12323539|FG000|Overall Study|Received prohibited medication|1
7843449|NCT01438489|12323540|FG001|Overall Study|Received prohibited medication|0
7843450|NCT01438489|12323541|FG002|Overall Study|Received prohibited medication|0
7843451|NCT01438489|12323539|FG000|Overall Study|Did not complete all 3 follow-up visits|2
7843452|NCT01438489|12323540|FG001|Overall Study|Did not complete all 3 follow-up visits|5
7843453|NCT01438489|12323541|FG002|Overall Study|Did not complete all 3 follow-up visits|2
7843454|NCT01438489|12323539|FG000|Overall Study|Inadequate venous access|0
7843455|NCT01438489|12323540|FG001|Overall Study|Inadequate venous access|2
7843456|NCT01438489|12323541|FG002|Overall Study|Inadequate venous access|0
7843457|NCT01438541|12323551|FG000|Overall Study|Physician Decision|1
7843458|NCT01438541|12323551|FG000|Overall Study|Withdrawal by Subject|1
7843459|NCT01438541|12323551|FG000|Overall Study|discharge from the hospital|5
7843460|NCT01438814|12323563|FG000|Overall Study|Adverse Event|3
7843461|NCT01438814|12323564|FG001|Overall Study|Adverse Event|3
7843462|NCT01438814|12323563|FG000|Overall Study|Protocol Violation|1
7843463|NCT01438814|12323564|FG001|Overall Study|Protocol Violation|2
7843464|NCT01438814|12323563|FG000|Overall Study|Lost to Follow-up|4
7843465|NCT01438814|12323564|FG001|Overall Study|Lost to Follow-up|3
7843466|NCT01438814|12323563|FG000|Overall Study|Withdrawal by Subject|4
7843467|NCT01438814|12323564|FG001|Overall Study|Withdrawal by Subject|2
7843468|NCT01438814|12323563|FG000|Overall Study|Other|2
7843469|NCT01438814|12323564|FG001|Overall Study|Other|4
7843470|NCT01438840|12323572|FG000|Core Study|Adverse Event|0
7843471|NCT01438840|12323573|FG001|Core Study|Adverse Event|3
7843472|NCT01438840|12323574|FG002|Core Study|Adverse Event|0
7843473|NCT01438840|12323572|FG000|Core Study|Lack of Efficacy|15
7843474|NCT01438840|12323573|FG001|Core Study|Lack of Efficacy|7
7843475|NCT01438840|12323574|FG002|Core Study|Lack of Efficacy|0
7843476|NCT01438840|12323572|FG000|Core Study|Withdrawal of consent|1
7843477|NCT01438840|12323573|FG001|Core Study|Withdrawal of consent|0
7843478|NCT01438840|12323574|FG002|Core Study|Withdrawal of consent|0
7843479|NCT01438840|12323572|FG000|Extension Phase|Adverse Event|0
7843480|NCT01438840|12323573|FG001|Extension Phase|Adverse Event|0
7843481|NCT01438840|12323574|FG002|Extension Phase|Adverse Event|3
7843482|NCT01438840|12323572|FG000|Extension Phase|Lost to Follow-up|0
7843483|NCT01438840|12323573|FG001|Extension Phase|Lost to Follow-up|0
7843484|NCT01438840|12323574|FG002|Extension Phase|Lost to Follow-up|1
7843485|NCT01438840|12323572|FG000|Extension Phase|Withdrawal by Subject|0
7843486|NCT01438840|12323573|FG001|Extension Phase|Withdrawal by Subject|0
7843487|NCT01438840|12323574|FG002|Extension Phase|Withdrawal by Subject|3
7843488|NCT01438840|12323572|FG000|Extension Phase|Lack of Efficacy|0
7843489|NCT01438840|12323573|FG001|Extension Phase|Lack of Efficacy|0
7843490|NCT01438840|12323574|FG002|Extension Phase|Lack of Efficacy|2
7843491|NCT01438840|12323572|FG000|Extension Phase|Other|0
7843492|NCT01438840|12323573|FG001|Extension Phase|Other|0
7843493|NCT01438840|12323574|FG002|Extension Phase|Other|1
7843494|NCT01438957|12323586|FG000|Overall Study|Physician Decision|1
7843495|NCT01438957|12323587|FG001|Overall Study|Physician Decision|1
7843496|NCT01438957|12323588|FG002|Overall Study|Physician Decision|0
7843497|NCT01438957|12323589|FG003|Overall Study|Physician Decision|1
7843498|NCT01438957|12323590|FG004|Overall Study|Physician Decision|0
7843499|NCT01438996|12323605|FG000|Overall Study|Not meeting Inclusion Criteria|4
7843500|NCT01438996|12323606|FG001|Overall Study|Not meeting Inclusion Criteria|1
7843501|NCT01438996|12323607|FG002|Overall Study|Not meeting Inclusion Criteria|0
7843502|NCT01439009|12323617|FG000|Overall Study|Physician Decision|5
7843503|NCT01439009|12323618|FG001|Overall Study|Physician Decision|3
7843504|NCT01439009|12323617|FG000|Overall Study|Protocol Violation|2
7843505|NCT01439009|12323618|FG001|Overall Study|Protocol Violation|0
7843506|NCT01439009|12323617|FG000|Overall Study|Deviation of exclusion criteria|1
7843507|NCT01439009|12323618|FG001|Overall Study|Deviation of exclusion criteria|0
7843508|NCT01439074|12323630|FG000|Overall Study|Lost to Follow-up|3
7843509|NCT01439074|12323631|FG001|Overall Study|Lost to Follow-up|4
7843510|NCT01439074|12323630|FG000|Overall Study|Subject shedding|1
7843511|NCT01439074|12323631|FG001|Overall Study|Subject shedding|0
7843512|NCT01439074|12323630|FG000|Overall Study|Withdrawal by Subject|1
7843513|NCT01439074|12323631|FG001|Overall Study|Withdrawal by Subject|5
7843514|NCT01439074|12323630|FG000|Overall Study|Other|4
7843515|NCT01439074|12323631|FG001|Overall Study|Other|4
7843516|NCT01439126|12323643|FG000|Overall Study|Adverse Event|2
7843517|NCT01439126|12323644|FG001|Overall Study|Adverse Event|0
7843518|NCT01439126|12323643|FG000|Overall Study|Withdrawal by Subject|5
7843519|NCT01439126|12323644|FG001|Overall Study|Withdrawal by Subject|21
7843520|NCT01439126|12323643|FG000|Overall Study|Protocol Violation|6
7843521|NCT01439126|12323644|FG001|Overall Study|Protocol Violation|4
7843522|NCT01439126|12323643|FG000|Overall Study|Lost to Follow-up|6
7843523|NCT01439126|12323644|FG001|Overall Study|Lost to Follow-up|3
7843524|NCT01439126|12323643|FG000|Overall Study|Other-Use of prohibited treatment|0
7843525|NCT01439126|12323644|FG001|Overall Study|Other-Use of prohibited treatment|2
7843526|NCT01439126|12323643|FG000|Overall Study|Other-Miscellaneous|12
7843527|NCT01439126|12323644|FG001|Overall Study|Other-Miscellaneous|12
7843528|NCT01439204|12323652|FG000|Overall Study|Withdrawal by Subject|0
7843529|NCT01439204|12323653|FG001|Overall Study|Withdrawal by Subject|1
7843530|NCT01439204|12323652|FG000|Overall Study|Lost to Follow-up|0
7843531|NCT01439204|12323653|FG001|Overall Study|Lost to Follow-up|2
7843532|NCT01439204|12323652|FG000|Overall Study|No longer meets study criteria|1
7843533|NCT01439204|12323653|FG001|Overall Study|No longer meets study criteria|0
7843534|NCT01439204|12323652|FG000|Overall Study|poor/non-compliance|3
7843535|NCT01439204|12323653|FG001|Overall Study|poor/non-compliance|0
7843536|NCT01439282|12323661|FG000|Overall Study|Adverse Event|5
7843537|NCT01439282|12323662|FG001|Overall Study|Adverse Event|0
7843538|NCT01439282|12323661|FG000|Overall Study|Withdrawal by Subject|2
7843539|NCT01439282|12323662|FG001|Overall Study|Withdrawal by Subject|0
7843540|NCT01439282|12323661|FG000|Overall Study|Other|1
7843541|NCT01439282|12323662|FG001|Overall Study|Other|1
7843542|NCT01439360|12323671|FG000|Overall Study|Adverse Event|4
7843543|NCT01439360|12323672|FG001|Overall Study|Adverse Event|16
7843544|NCT01439360|12323671|FG000|Overall Study|Lost to Follow-up|43
7843545|NCT01439360|12323672|FG001|Overall Study|Lost to Follow-up|58
7843546|NCT01439360|12323671|FG000|Overall Study|Others|10
7843547|NCT01439360|12323672|FG001|Overall Study|Others|5
7843548|NCT01439360|12323671|FG000|Overall Study|Protocol Violation|1
7843549|NCT01439360|12323672|FG001|Overall Study|Protocol Violation|0
7843550|NCT01439360|12323671|FG000|Overall Study|Withdrawal by Subject|140
7843551|NCT01439360|12323672|FG001|Overall Study|Withdrawal by Subject|129
7843552|NCT01439373|12323680|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
7843553|NCT01439373|12323681|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
7863134|NCT01603628|12352396|FG001|Overall Study|Lost to Follow-up|1
7843554|NCT01439373|12323680|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
7843555|NCT01439373|12323681|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
7843556|NCT01439555|12323691|FG000|Overall Study|Protocol Violation|1
7843557|NCT01439568|12323697|FG000|Overall Study|Lost to Follow-up|1
7843558|NCT01439568|12323698|FG001|Overall Study|Lost to Follow-up|0
7843559|NCT01439568|12323697|FG000|Overall Study|Withdrawal by Subject|2
7843560|NCT01439568|12323698|FG001|Overall Study|Withdrawal by Subject|2
7843561|NCT01439711|12323729|FG000|Overall Study|Ineligible|13
7843562|NCT01439711|12323729|FG000|Overall Study|Cancel|3
7843563|NCT01439711|12323729|FG000|Overall Study|Progression Prior to Beginning Tx|1
7843564|NCT01439711|12323729|FG000|Overall Study|Adverse Event|5
7843565|NCT01439711|12323729|FG000|Overall Study|Withdrawal by Subject|3
7843566|NCT01439711|12323729|FG000|Overall Study|Progression During Active Tx|3
7843567|NCT01439711|12323729|FG000|Overall Study|Noncompliance|3
7843568|NCT01439711|12323729|FG000|Overall Study|No MRI|9
7843569|NCT01439724|12323735|FG000|Overall Study|missing consultation|9
7843570|NCT01439724|12323736|FG001|Overall Study|missing consultation|8
7843571|NCT01439867|12323762|FG000|Overall Study|Non-compliance|0
7843572|NCT01439867|12323763|FG001|Overall Study|Non-compliance|1
7843573|NCT01439867|12323762|FG000|Overall Study|Withdrawal by Subject|1
7843574|NCT01439867|12323763|FG001|Overall Study|Withdrawal by Subject|2
7843575|NCT01439867|12323762|FG000|Overall Study|Administrative Decision|4
7843576|NCT01439867|12323763|FG001|Overall Study|Administrative Decision|5
7843577|NCT01439867|12323762|FG000|Overall Study|Protocol-specified Criteria|1
7843578|NCT01439867|12323763|FG001|Overall Study|Protocol-specified Criteria|0
7843579|NCT01439945|12323774|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3
7843580|NCT01439945|12323775|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3
7843581|NCT01439945|12323776|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3
7843582|NCT01439945|12323777|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1
7843583|NCT01439945|12323774|FG000|Double-Blind Treatment Phase|Ineligible|1
7843584|NCT01439945|12323775|FG001|Double-Blind Treatment Phase|Ineligible|2
7843585|NCT01439945|12323776|FG002|Double-Blind Treatment Phase|Ineligible|0
7843586|NCT01439945|12323777|FG003|Double-Blind Treatment Phase|Ineligible|1
7843587|NCT01439971|12323793|FG000|Overall Study|Required number in cohort dosed|0
7843588|NCT01439971|12323794|FG001|Overall Study|Required number in cohort dosed|1
7843589|NCT01439971|12323795|FG002|Overall Study|Required number in cohort dosed|2
7843590|NCT01439971|12323796|FG003|Overall Study|Required number in cohort dosed|0
7843591|NCT01439971|12323797|FG004|Overall Study|Required number in cohort dosed|1
7863135|NCT01603628|12352397|FG002|Overall Study|Lost to Follow-up|0
7863136|NCT01603628|12352395|FG000|Overall Study|Other Miscellaneous Reason|1
7863137|NCT01603628|12352396|FG001|Overall Study|Other Miscellaneous Reason|0
7863138|NCT01603628|12352397|FG002|Overall Study|Other Miscellaneous Reason|0
7863139|NCT01603641|12352405|FG000|Overall Study|Did not Receive Treatment|3
7863140|NCT01603641|12352405|FG000|Overall Study|Adverse Event|1
7863141|NCT01603641|12352405|FG000|Overall Study|Lack of Efficacy|1
7863142|NCT01603641|12352405|FG000|Overall Study|Lost to Follow-up|6
7863143|NCT01603641|12352405|FG000|Overall Study|Personal Reasons|18
7863144|NCT01603641|12352405|FG000|Overall Study|Other Miscellaneous Reasons|6
7863145|NCT01603875|12352412|FG000|Overall Study|Preexisting rabies antibody|3
7863146|NCT01603875|12352413|FG001|Overall Study|Preexisting rabies antibody|4
7863147|NCT01603875|12352414|FG002|Overall Study|Preexisting rabies antibody|3
7863148|NCT01603875|12352412|FG000|Overall Study|Lost to Follow-up|4
7863149|NCT01603875|12352413|FG001|Overall Study|Lost to Follow-up|3
7863150|NCT01603875|12352414|FG002|Overall Study|Lost to Follow-up|6
7863151|NCT01603875|12352412|FG000|Overall Study|Protocol Violation|0
7863152|NCT01603875|12352413|FG001|Overall Study|Protocol Violation|1
7863153|NCT01603875|12352414|FG002|Overall Study|Protocol Violation|0
7863154|NCT01604265|12352452|FG000|Overall Study|Adverse Event|1
7863155|NCT01604265|12352453|FG001|Overall Study|Adverse Event|0
7863156|NCT01604265|12352452|FG000|Overall Study|Withdrawal by Subject|1
7863157|NCT01604265|12352453|FG001|Overall Study|Withdrawal by Subject|0
7863158|NCT01604278|12352461|FG000|Overall Study|Lack of Efficacy|0
7863159|NCT01604278|12352462|FG001|Overall Study|Lack of Efficacy|1
7863160|NCT01604278|12352461|FG000|Overall Study|Lost to Follow-up|1
7863161|NCT01604278|12352462|FG001|Overall Study|Lost to Follow-up|0
7863162|NCT01604278|12352461|FG000|Overall Study|Administrative problems|2
7863163|NCT01604278|12352462|FG001|Overall Study|Administrative problems|1
7863164|NCT01604278|12352461|FG000|Overall Study|Withdrawal by Subject|3
7863165|NCT01604278|12352462|FG001|Overall Study|Withdrawal by Subject|3
7863166|NCT01604278|12352461|FG000|Overall Study|Adverse Event|3
7863167|NCT01604278|12352462|FG001|Overall Study|Adverse Event|5
7863168|NCT01604278|12352461|FG000|Overall Study|Protocol Deviation|5
7863169|NCT01604278|12352462|FG001|Overall Study|Protocol Deviation|3
7863170|NCT01604343|12352496|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
7863171|NCT01604343|12352497|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
7863172|NCT01604343|12352498|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
7843592|NCT01440049|12323809|FG000|Overall Study|Adverse Event|5
7843593|NCT01440101|12323816|FG000|Overall Study|Adverse Event|2
7843594|NCT01440101|12323817|FG001|Overall Study|Adverse Event|0
7843595|NCT01440101|12323818|FG002|Overall Study|Adverse Event|0
7843596|NCT01440101|12323816|FG000|Overall Study|Withdrawal by Subject|0
7843597|NCT01440101|12323817|FG001|Overall Study|Withdrawal by Subject|3
7843598|NCT01440101|12323818|FG002|Overall Study|Withdrawal by Subject|1
7843599|NCT01440101|12323816|FG000|Overall Study|Other|0
7843600|NCT01440101|12323817|FG001|Overall Study|Other|1
7843601|NCT01440101|12323818|FG002|Overall Study|Other|0
7843602|NCT01440283|12323827|FG000|Overall Study|Death|3
7843603|NCT01440283|12323827|FG000|Overall Study|Withdrawal by Subject|4
7843604|NCT01440283|12323827|FG000|Overall Study|Physician Decision|3
7843605|NCT01440322|12323839|FG000|Overall Study|Discomfort|2
7843606|NCT01440322|12323840|FG001|Overall Study|Discomfort|0
7843607|NCT01440322|12323839|FG000|Overall Study|Biomicroscopy|1
7843608|NCT01440322|12323840|FG001|Overall Study|Biomicroscopy|0
7843609|NCT01440322|12323839|FG000|Overall Study|Symptoms and Problems|1
7843610|NCT01440322|12323840|FG001|Overall Study|Symptoms and Problems|0
7843611|NCT01440322|12323839|FG000|Overall Study|Unacceptable Subjective Vision|1
7843612|NCT01440322|12323840|FG001|Overall Study|Unacceptable Subjective Vision|0
7843613|NCT01440322|12323839|FG000|Overall Study|Other Product Related|1
7843614|NCT01440322|12323840|FG001|Overall Study|Other Product Related|0
7843615|NCT01440322|12323839|FG000|Overall Study|Unrelated Medical Problem|0
7843616|NCT01440322|12323840|FG001|Overall Study|Unrelated Medical Problem|1
7843617|NCT01440322|12323839|FG000|Overall Study|Other Non-Product Related|1
7843618|NCT01440322|12323840|FG001|Overall Study|Other Non-Product Related|0
7843619|NCT01440374|12323849|FG000|Part 1: Open-label Phase|Adverse Event|5
7843620|NCT01440374|12323850|FG001|Part 1: Open-label Phase|Adverse Event|0
7843621|NCT01440374|12323851|FG002|Part 1: Open-label Phase|Adverse Event|0
7843622|NCT01440374|12323852|FG003|Part 1: Open-label Phase|Adverse Event|0
7843623|NCT01440374|12323849|FG000|Part 1: Open-label Phase|Physician Decision|1
7843624|NCT01440374|12323850|FG001|Part 1: Open-label Phase|Physician Decision|0
7843625|NCT01440374|12323851|FG002|Part 1: Open-label Phase|Physician Decision|0
7843626|NCT01440374|12323852|FG003|Part 1: Open-label Phase|Physician Decision|0
7843627|NCT01440374|12323849|FG000|Part 2; Double-blind Phase|Physician Decision|0
7843628|NCT01440374|12323850|FG001|Part 2; Double-blind Phase|Physician Decision|8
7843629|NCT01440374|12323851|FG002|Part 2; Double-blind Phase|Physician Decision|17
7843630|NCT01440374|12323852|FG003|Part 2; Double-blind Phase|Physician Decision|0
7843631|NCT01440374|12323849|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0
7843632|NCT01440374|12323850|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4
7843633|NCT01440374|12323851|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5
7843634|NCT01440374|12323852|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0
7843635|NCT01440374|12323849|FG000|Part 2; Double-blind Phase|Protocol Violation|0
7843636|NCT01440374|12323850|FG001|Part 2; Double-blind Phase|Protocol Violation|0
7843637|NCT01440374|12323851|FG002|Part 2; Double-blind Phase|Protocol Violation|1
7843638|NCT01440374|12323852|FG003|Part 2; Double-blind Phase|Protocol Violation|0
7843639|NCT01440374|12323849|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0
7843640|NCT01440374|12323850|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1
7843641|NCT01440374|12323851|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0
7843642|NCT01440374|12323852|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0
7843643|NCT01440374|12323849|FG000|Part 2; Double-blind Phase|Adverse Event|0
7843644|NCT01440374|12323850|FG001|Part 2; Double-blind Phase|Adverse Event|7
7843645|NCT01440374|12323851|FG002|Part 2; Double-blind Phase|Adverse Event|31
7843646|NCT01440374|12323852|FG003|Part 2; Double-blind Phase|Adverse Event|0
7843647|NCT01440374|12323849|FG000|Part 2; Double-blind Phase|Not treated|0
7843648|NCT01440374|12323850|FG001|Part 2; Double-blind Phase|Not treated|0
7843649|NCT01440374|12323851|FG002|Part 2; Double-blind Phase|Not treated|1
7843650|NCT01440374|12323852|FG003|Part 2; Double-blind Phase|Not treated|0
7843651|NCT01440374|12323849|FG000|Part 3: Extension|Withdrawal by Subject|0
7843652|NCT01440374|12323850|FG001|Part 3: Extension|Withdrawal by Subject|0
7843653|NCT01440374|12323851|FG002|Part 3: Extension|Withdrawal by Subject|0
7843654|NCT01440374|12323852|FG003|Part 3: Extension|Withdrawal by Subject|5
7843655|NCT01440374|12323849|FG000|Part 3: Extension|Adverse Event|0
7843656|NCT01440374|12323850|FG001|Part 3: Extension|Adverse Event|0
7843657|NCT01440374|12323851|FG002|Part 3: Extension|Adverse Event|0
7843658|NCT01440374|12323852|FG003|Part 3: Extension|Adverse Event|13
7843659|NCT01440374|12323849|FG000|Part 3: Extension|Physician Decision|0
7843660|NCT01440374|12323850|FG001|Part 3: Extension|Physician Decision|0
7843661|NCT01440374|12323851|FG002|Part 3: Extension|Physician Decision|0
7843662|NCT01440374|12323852|FG003|Part 3: Extension|Physician Decision|14
7843663|NCT01440569|12323892|FG000|Main Study|Enrolled but not treated|1
7843664|NCT01440569|12323893|FG001|Main Study|Enrolled but not treated|0
7843665|NCT01440569|12323892|FG000|Main Study|Adverse Event|9
7843666|NCT01440569|12323893|FG001|Main Study|Adverse Event|0
7843667|NCT01440569|12323892|FG000|Main Study|Pregnancy|1
7843668|NCT01440569|12323893|FG001|Main Study|Pregnancy|0
7843669|NCT01440569|12323892|FG000|Main Study|Investigator's Discretion|1
7843670|NCT01440569|12323893|FG001|Main Study|Investigator's Discretion|1
7843671|NCT01440569|12323892|FG000|Main Study|Withdrew Consent|7
7843672|NCT01440569|12323893|FG001|Main Study|Withdrew Consent|1
7843673|NCT01440569|12323892|FG000|Main Study|Lost to Follow-up|13
7843674|NCT01440569|12323893|FG001|Main Study|Lost to Follow-up|2
7843675|NCT01440569|12323892|FG000|Main Study|Subject Non-Compliance|3
7843676|NCT01440569|12323893|FG001|Main Study|Subject Non-Compliance|0
7843677|NCT01440569|12323892|FG000|Main Study|Protocol Violation|1
7843678|NCT01440569|12323893|FG001|Main Study|Protocol Violation|0
7843679|NCT01440569|12323892|FG000|Open-Label Rollover Phase|Adverse Event|3
7843680|NCT01440569|12323893|FG001|Open-Label Rollover Phase|Adverse Event|0
7843681|NCT01440569|12323892|FG000|Open-Label Rollover Phase|Pregnancy|1
7843682|NCT01440569|12323893|FG001|Open-Label Rollover Phase|Pregnancy|0
7843683|NCT01440569|12323892|FG000|Open-Label Rollover Phase|Lack of Efficacy|2
7843684|NCT01440569|12323893|FG001|Open-Label Rollover Phase|Lack of Efficacy|0
7843685|NCT01440569|12323892|FG000|Open-Label Rollover Phase|Investigator's Discretion|3
7843686|NCT01440569|12323893|FG001|Open-Label Rollover Phase|Investigator's Discretion|1
7843687|NCT01440569|12323892|FG000|Open-Label Rollover Phase|Withdrew Consent|11
7843688|NCT01440569|12323893|FG001|Open-Label Rollover Phase|Withdrew Consent|1
7843689|NCT01440569|12323892|FG000|Open-Label Rollover Phase|Lost to Follow-up|26
7843690|NCT01440569|12323893|FG001|Open-Label Rollover Phase|Lost to Follow-up|3
7843691|NCT01440569|12323892|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1
7843692|NCT01440569|12323893|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1
7843693|NCT01440647|12323910|FG000|Overall Study|Death|2
7843694|NCT01440647|12323911|FG001|Overall Study|Death|3
7843695|NCT01440803|12323945|FG000|Overall Study|Met study stopping rule|2
7843696|NCT01440803|12323946|FG001|Overall Study|Met study stopping rule|1
7843697|NCT01440803|12323945|FG000|Overall Study|Lost to Follow-up|0
7843698|NCT01440803|12323946|FG001|Overall Study|Lost to Follow-up|2
7843699|NCT01440803|12323945|FG000|Overall Study|Withdrawal by Subject|0
7843700|NCT01440803|12323946|FG001|Overall Study|Withdrawal by Subject|1
7843701|NCT01440816|12323955|FG000|Overall Study|Disease Progression|0
7843702|NCT01440816|12323956|FG001|Overall Study|Disease Progression|9
7843703|NCT01440816|12323955|FG000|Overall Study|To Be Seen By Local Oncologist|1
7843704|NCT01440816|12323956|FG001|Overall Study|To Be Seen By Local Oncologist|2
7843705|NCT01440881|12323966|FG000|Overall Study|Death|0
7843706|NCT01440881|12323967|FG001|Overall Study|Death|1
7843707|NCT01440946|12323989|FG000|Overall Study|Lost to Follow-up|1
7843708|NCT01440946|12323990|FG001|Overall Study|Lost to Follow-up|1
7843709|NCT01440946|12323989|FG000|Overall Study|Physician Decision|1
7843710|NCT01440946|12323990|FG001|Overall Study|Physician Decision|0
7843711|NCT01440972|12324003|FG000|Overall Study|Withdrawal by Subject|3
7843712|NCT01440972|12324004|FG001|Overall Study|Withdrawal by Subject|2
7843713|NCT01441063|12324014|FG000|Tocilizumab Alone|Required AZT/VGC addition|3
7843714|NCT01441063|12324014|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1
7843715|NCT01441102|12324025|FG000|Overall Study|Adverse Event|1
7843716|NCT01441102|12324025|FG000|Overall Study|Withdrawal by Subject|2
7843717|NCT01441180|12324032|FG000|Overall Study|Lost to Follow-up|1
7843718|NCT01441180|12324033|FG001|Overall Study|Lost to Follow-up|1
7843719|NCT01441180|12324034|FG002|Overall Study|Lost to Follow-up|1
7843720|NCT01441180|12324032|FG000|Overall Study|Discontinued|0
7843721|NCT01441180|12324033|FG001|Overall Study|Discontinued|0
7843722|NCT01441180|12324034|FG002|Overall Study|Discontinued|2
7843723|NCT01441414|12324088|FG000|Overall Study|Participant died|9
7843724|NCT01441414|12324088|FG000|Overall Study|Other reasons|3
7843725|NCT01441414|12324088|FG000|Overall Study|Study terminated by sponsor|2
7843726|NCT01441414|12324088|FG000|Overall Study|Subject refused further follow-up|1
7843727|NCT01441440|12324107|FG000|Overall Study|Death|1
7843728|NCT01441440|12324108|FG001|Overall Study|Death|0
7843729|NCT01441440|12324109|FG002|Overall Study|Death|1
7843730|NCT01441440|12324107|FG000|Overall Study|Adverse Event|2
7843731|NCT01441440|12324108|FG001|Overall Study|Adverse Event|9
7843732|NCT01441440|12324109|FG002|Overall Study|Adverse Event|9
7843733|NCT01441440|12324107|FG000|Overall Study|Lost to Follow-up|0
7843734|NCT01441440|12324108|FG001|Overall Study|Lost to Follow-up|2
7843735|NCT01441440|12324109|FG002|Overall Study|Lost to Follow-up|1
7843736|NCT01441440|12324107|FG000|Overall Study|Withdrawal by Subject|11
7843737|NCT01441440|12324108|FG001|Overall Study|Withdrawal by Subject|9
7843738|NCT01441440|12324109|FG002|Overall Study|Withdrawal by Subject|9
7843739|NCT01441440|12324107|FG000|Overall Study|Pregnancy|1
7843740|NCT01441440|12324108|FG001|Overall Study|Pregnancy|0
7843741|NCT01441440|12324109|FG002|Overall Study|Pregnancy|0
7843742|NCT01441440|12324107|FG000|Overall Study|Lack of Efficacy|1
7843743|NCT01441440|12324108|FG001|Overall Study|Lack of Efficacy|0
7843744|NCT01441440|12324109|FG002|Overall Study|Lack of Efficacy|1
7843745|NCT01441440|12324107|FG000|Overall Study|Moving|0
7843746|NCT01441440|12324108|FG001|Overall Study|Moving|1
7843747|NCT01441440|12324109|FG002|Overall Study|Moving|1
7843748|NCT01441440|12324107|FG000|Overall Study|Work-related matter|0
7843749|NCT01441440|12324108|FG001|Overall Study|Work-related matter|1
7843750|NCT01441440|12324109|FG002|Overall Study|Work-related matter|0
7843751|NCT01441440|12324107|FG000|Overall Study|Difficllty in keeping the schedule|1
7843752|NCT01441440|12324108|FG001|Overall Study|Difficllty in keeping the schedule|1
7843753|NCT01441440|12324109|FG002|Overall Study|Difficllty in keeping the schedule|0
7843754|NCT01441596|12324150|FG000|Overall Study|Other reason not defined below|0
7843755|NCT01441596|12324151|FG001|Overall Study|Other reason not defined below|2
7843756|NCT01441596|12324152|FG002|Overall Study|Other reason not defined below|1
7843757|NCT01441596|12324150|FG000|Overall Study|Withdrawal by Subject|4
7843758|NCT01441596|12324151|FG001|Overall Study|Withdrawal by Subject|0
7843759|NCT01441596|12324152|FG002|Overall Study|Withdrawal by Subject|2
7843760|NCT01441596|12324150|FG000|Overall Study|Not treated|0
7843761|NCT01441596|12324151|FG001|Overall Study|Not treated|1
7843762|NCT01441596|12324152|FG002|Overall Study|Not treated|1
7843763|NCT01441635|12324170|FG000|Overall Study|Adverse Event|4
7843764|NCT01441635|12324171|FG001|Overall Study|Adverse Event|3
7843765|NCT01441635|12324172|FG002|Overall Study|Adverse Event|1
7843766|NCT01441635|12324173|FG003|Overall Study|Adverse Event|5
7843767|NCT01441635|12324174|FG004|Overall Study|Adverse Event|1
7843768|NCT01441635|12324175|FG005|Overall Study|Adverse Event|2
7843769|NCT01441635|12324176|FG006|Overall Study|Adverse Event|2
7843770|NCT01441635|12324177|FG007|Overall Study|Adverse Event|2
7843771|NCT01441635|12324178|FG008|Overall Study|Adverse Event|1
7843772|NCT01441635|12324179|FG009|Overall Study|Adverse Event|0
7843773|NCT01441635|12324170|FG000|Overall Study|Withdrawal by Subject|1
7843774|NCT01441635|12324171|FG001|Overall Study|Withdrawal by Subject|1
7843775|NCT01441635|12324172|FG002|Overall Study|Withdrawal by Subject|0
7843776|NCT01441635|12324173|FG003|Overall Study|Withdrawal by Subject|1
7843777|NCT01441635|12324174|FG004|Overall Study|Withdrawal by Subject|0
7843778|NCT01441635|12324175|FG005|Overall Study|Withdrawal by Subject|0
7843779|NCT01441635|12324176|FG006|Overall Study|Withdrawal by Subject|2
7843780|NCT01441635|12324177|FG007|Overall Study|Withdrawal by Subject|0
7843781|NCT01441635|12324178|FG008|Overall Study|Withdrawal by Subject|1
7843782|NCT01441635|12324179|FG009|Overall Study|Withdrawal by Subject|1
7843783|NCT01441635|12324170|FG000|Overall Study|Lost to Follow-up|0
7843784|NCT01441635|12324171|FG001|Overall Study|Lost to Follow-up|1
7843785|NCT01441635|12324172|FG002|Overall Study|Lost to Follow-up|1
7843786|NCT01441635|12324173|FG003|Overall Study|Lost to Follow-up|1
7843787|NCT01441635|12324174|FG004|Overall Study|Lost to Follow-up|1
7843788|NCT01441635|12324175|FG005|Overall Study|Lost to Follow-up|3
7843789|NCT01441635|12324176|FG006|Overall Study|Lost to Follow-up|1
7843790|NCT01441635|12324177|FG007|Overall Study|Lost to Follow-up|1
7843791|NCT01441635|12324178|FG008|Overall Study|Lost to Follow-up|0
7843792|NCT01441635|12324179|FG009|Overall Study|Lost to Follow-up|1
7843793|NCT01441635|12324170|FG000|Overall Study|Noncompliance|0
7843794|NCT01441635|12324171|FG001|Overall Study|Noncompliance|1
7843795|NCT01441635|12324172|FG002|Overall Study|Noncompliance|0
7843796|NCT01441635|12324173|FG003|Overall Study|Noncompliance|0
7843797|NCT01441635|12324174|FG004|Overall Study|Noncompliance|0
7843798|NCT01441635|12324175|FG005|Overall Study|Noncompliance|0
7843799|NCT01441635|12324176|FG006|Overall Study|Noncompliance|1
7843800|NCT01441635|12324177|FG007|Overall Study|Noncompliance|0
7843801|NCT01441635|12324178|FG008|Overall Study|Noncompliance|0
7843802|NCT01441635|12324179|FG009|Overall Study|Noncompliance|0
7843803|NCT01441635|12324170|FG000|Overall Study|Surgery or Invasive Intervention|0
7843804|NCT01441635|12324171|FG001|Overall Study|Surgery or Invasive Intervention|0
7843805|NCT01441635|12324172|FG002|Overall Study|Surgery or Invasive Intervention|1
7843806|NCT01441635|12324173|FG003|Overall Study|Surgery or Invasive Intervention|0
7843807|NCT01441635|12324174|FG004|Overall Study|Surgery or Invasive Intervention|0
7843808|NCT01441635|12324175|FG005|Overall Study|Surgery or Invasive Intervention|0
7843809|NCT01441635|12324176|FG006|Overall Study|Surgery or Invasive Intervention|0
7843810|NCT01441635|12324177|FG007|Overall Study|Surgery or Invasive Intervention|0
7843811|NCT01441635|12324178|FG008|Overall Study|Surgery or Invasive Intervention|0
7843812|NCT01441635|12324179|FG009|Overall Study|Surgery or Invasive Intervention|0
7843813|NCT01441635|12324170|FG000|Overall Study|Received Exclusionary Medication|1
7843814|NCT01441635|12324171|FG001|Overall Study|Received Exclusionary Medication|0
7843815|NCT01441635|12324172|FG002|Overall Study|Received Exclusionary Medication|0
7843816|NCT01441635|12324173|FG003|Overall Study|Received Exclusionary Medication|0
7843817|NCT01441635|12324174|FG004|Overall Study|Received Exclusionary Medication|0
7843818|NCT01441635|12324175|FG005|Overall Study|Received Exclusionary Medication|0
7843819|NCT01441635|12324176|FG006|Overall Study|Received Exclusionary Medication|0
7843820|NCT01441635|12324177|FG007|Overall Study|Received Exclusionary Medication|0
7843821|NCT01441635|12324178|FG008|Overall Study|Received Exclusionary Medication|0
7843822|NCT01441635|12324179|FG009|Overall Study|Received Exclusionary Medication|0
7843823|NCT01441635|12324170|FG000|Overall Study|Other|0
7843824|NCT01441635|12324171|FG001|Overall Study|Other|0
7843825|NCT01441635|12324172|FG002|Overall Study|Other|0
7843826|NCT01441635|12324173|FG003|Overall Study|Other|0
7843827|NCT01441635|12324174|FG004|Overall Study|Other|0
7843828|NCT01441635|12324175|FG005|Overall Study|Other|0
7843829|NCT01441635|12324176|FG006|Overall Study|Other|0
7843830|NCT01441635|12324177|FG007|Overall Study|Other|1
7843831|NCT01441635|12324178|FG008|Overall Study|Other|0
7843832|NCT01441635|12324179|FG009|Overall Study|Other|0
7843833|NCT01441765|12324203|FG000|Overall Study|Death|1
7843834|NCT01441765|12324204|FG001|Overall Study|Death|0
7843835|NCT01441960|12324223|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
7843836|NCT01441960|12324224|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
7843837|NCT01441960|12324223|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1
7843838|NCT01441960|12324224|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1
7843839|NCT01441960|12324223|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
7843840|NCT01441960|12324224|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
7843841|NCT01441973|12324236|FG000|Overall Study|Disease progression|8
7843842|NCT01441973|12324237|FG001|Overall Study|Disease progression|6
7843843|NCT01441973|12324236|FG000|Overall Study|Adverse event unrelated to study drug|3
7843844|NCT01441973|12324237|FG001|Overall Study|Adverse event unrelated to study drug|2
7843845|NCT01441973|12324236|FG000|Overall Study|Participant request to discontinue|1
7843846|NCT01441973|12324237|FG001|Overall Study|Participant request to discontinue|1
7843847|NCT01441973|12324236|FG000|Overall Study|Poor compliance/noncompliance|0
7843848|NCT01441973|12324237|FG001|Overall Study|Poor compliance/noncompliance|1
7843849|NCT01441973|12324236|FG000|Overall Study|Administrative reason by sponsor|3
7843850|NCT01441973|12324237|FG001|Overall Study|Administrative reason by sponsor|5
7843851|NCT01441973|12324236|FG000|Overall Study|Participant withdrew consent|0
7843852|NCT01441973|12324237|FG001|Overall Study|Participant withdrew consent|1
7843853|NCT01442038|12324246|FG000|Overall Study|Death|35
7843854|NCT01442038|12324247|FG001|Overall Study|Death|29
7843855|NCT01442038|12324246|FG000|Overall Study|Investigator-Initiated Early Closure|44
7843856|NCT01442038|12324247|FG001|Overall Study|Investigator-Initiated Early Closure|43
7843857|NCT01442038|12324246|FG000|Overall Study|Participant Withdrew Consent|137
7843858|NCT01442038|12324247|FG001|Overall Study|Participant Withdrew Consent|102
7843859|NCT01442038|12324246|FG000|Overall Study|Lost to Follow-up|37
7843860|NCT01442038|12324247|FG001|Overall Study|Lost to Follow-up|51
7843861|NCT01442038|12324246|FG000|Overall Study|Adverse Event|26
7843862|NCT01442038|12324247|FG001|Overall Study|Adverse Event|15
7843863|NCT01442038|12324246|FG000|Overall Study|Protocol Deviation|9
7843864|NCT01442038|12324247|FG001|Overall Study|Protocol Deviation|20
7843865|NCT01442038|12324246|FG000|Overall Study|Investigator's Discretion|13
7843866|NCT01442038|12324247|FG001|Overall Study|Investigator's Discretion|16
7843867|NCT01442038|12324246|FG000|Overall Study|Study Terminated By Sponsor|2
7843868|NCT01442038|12324247|FG001|Overall Study|Study Terminated By Sponsor|3
7843869|NCT01442064|12324259|FG000|Overall Study|Adverse Event|2
7843870|NCT01442064|12324260|FG001|Overall Study|Adverse Event|2
7843871|NCT01442064|12324261|FG002|Overall Study|Adverse Event|2
7843872|NCT01442064|12324262|FG003|Overall Study|Adverse Event|1
7843873|NCT01442064|12324263|FG004|Overall Study|Adverse Event|2
7843874|NCT01442064|12324264|FG005|Overall Study|Adverse Event|0
7843875|NCT01442064|12324259|FG000|Overall Study|Death|0
7843876|NCT01442064|12324260|FG001|Overall Study|Death|1
7843877|NCT01442064|12324261|FG002|Overall Study|Death|3
7843878|NCT01442064|12324262|FG003|Overall Study|Death|3
7843879|NCT01442064|12324263|FG004|Overall Study|Death|1
7843880|NCT01442064|12324264|FG005|Overall Study|Death|3
7843881|NCT01442064|12324259|FG000|Overall Study|Lost to Follow-up|5
7843882|NCT01442064|12324260|FG001|Overall Study|Lost to Follow-up|5
7843883|NCT01442064|12324261|FG002|Overall Study|Lost to Follow-up|1
7843884|NCT01442064|12324262|FG003|Overall Study|Lost to Follow-up|1
7843885|NCT01442064|12324263|FG004|Overall Study|Lost to Follow-up|3
7843886|NCT01442064|12324264|FG005|Overall Study|Lost to Follow-up|3
7843887|NCT01442064|12324259|FG000|Overall Study|Physician Decision|1
7843888|NCT01442064|12324260|FG001|Overall Study|Physician Decision|1
7843889|NCT01442064|12324261|FG002|Overall Study|Physician Decision|2
7843890|NCT01442064|12324262|FG003|Overall Study|Physician Decision|3
7843891|NCT01442064|12324263|FG004|Overall Study|Physician Decision|3
7843892|NCT01442064|12324264|FG005|Overall Study|Physician Decision|1
7843893|NCT01442064|12324259|FG000|Overall Study|Withdrawal by Subject|6
7843894|NCT01442064|12324260|FG001|Overall Study|Withdrawal by Subject|3
7843895|NCT01442064|12324261|FG002|Overall Study|Withdrawal by Subject|2
7843896|NCT01442064|12324262|FG003|Overall Study|Withdrawal by Subject|2
7843897|NCT01442064|12324263|FG004|Overall Study|Withdrawal by Subject|2
7843898|NCT01442064|12324264|FG005|Overall Study|Withdrawal by Subject|1
7843899|NCT01442064|12324259|FG000|Overall Study|Sponsor decision|82
7843900|NCT01442064|12324260|FG001|Overall Study|Sponsor decision|88
7843901|NCT01442064|12324261|FG002|Overall Study|Sponsor decision|92
7843902|NCT01442064|12324262|FG003|Overall Study|Sponsor decision|88
7843903|NCT01442064|12324263|FG004|Overall Study|Sponsor decision|95
7843904|NCT01442064|12324264|FG005|Overall Study|Sponsor decision|87
7843905|NCT01442064|12324259|FG000|Overall Study|Subject non-compliance|0
7843906|NCT01442064|12324260|FG001|Overall Study|Subject non-compliance|0
7843907|NCT01442064|12324261|FG002|Overall Study|Subject non-compliance|0
7843908|NCT01442064|12324262|FG003|Overall Study|Subject non-compliance|0
7843909|NCT01442064|12324263|FG004|Overall Study|Subject non-compliance|0
7843910|NCT01442064|12324264|FG005|Overall Study|Subject non-compliance|2
7843911|NCT01442064|12324259|FG000|Overall Study|Condition mandated other intervention|1
7843912|NCT01442064|12324260|FG001|Overall Study|Condition mandated other intervention|1
7843913|NCT01442064|12324261|FG002|Overall Study|Condition mandated other intervention|2
7843914|NCT01442064|12324262|FG003|Overall Study|Condition mandated other intervention|0
7843915|NCT01442064|12324263|FG004|Overall Study|Condition mandated other intervention|0
7843916|NCT01442064|12324264|FG005|Overall Study|Condition mandated other intervention|2
7843917|NCT01442103|12324281|FG000|Overall Study|Lost to Follow-up|2
7843918|NCT01442155|12324294|FG000|Overall Study|Complete remission|35
7843919|NCT01442155|12324294|FG000|Overall Study|Recurrence|26
7843920|NCT01442155|12324294|FG000|Overall Study|Adverse Event|2
7843921|NCT01442155|12324294|FG000|Overall Study|Lost to Follow-up|2
7843922|NCT01442181|12324300|FG000|Overall Study|patient refused surgery|1
7843923|NCT01442181|12324301|FG001|Overall Study|patient refused surgery|0
7843924|NCT01442181|12324300|FG000|Overall Study|no insurance for surgery|1
7843925|NCT01442181|12324301|FG001|Overall Study|no insurance for surgery|0
7843926|NCT01442181|12324300|FG000|Overall Study|low ejection factor|0
7843927|NCT01442181|12324301|FG001|Overall Study|low ejection factor|1
7843928|NCT01442181|12324300|FG000|Overall Study|Lost to Follow-up|1
7843929|NCT01442181|12324301|FG001|Overall Study|Lost to Follow-up|1
7843930|NCT01442181|12324300|FG000|Overall Study|patient in an additional study|1
7843931|NCT01442181|12324301|FG001|Overall Study|patient in an additional study|0
7843932|NCT01442181|12324300|FG000|Overall Study|atrial fibrillation not noted|0
7843933|NCT01442181|12324301|FG001|Overall Study|atrial fibrillation not noted|1
7843934|NCT01442376|12324311|FG000|Overall Study|Adverse Event|0
7843935|NCT01442376|12324312|FG001|Overall Study|Adverse Event|3
7843936|NCT01442376|12324313|FG002|Overall Study|Adverse Event|2
7843937|NCT01442376|12324311|FG000|Overall Study|Death|0
7843938|NCT01442376|12324312|FG001|Overall Study|Death|1
7843939|NCT01442376|12324313|FG002|Overall Study|Death|1
7843940|NCT01442376|12324311|FG000|Overall Study|Withdrawal of consent|0
7843941|NCT01442376|12324312|FG001|Overall Study|Withdrawal of consent|0
7843942|NCT01442376|12324313|FG002|Overall Study|Withdrawal of consent|1
7843943|NCT01442376|12324311|FG000|Overall Study|Patients not treated|2
7843944|NCT01442376|12324312|FG001|Overall Study|Patients not treated|3
7843945|NCT01442376|12324313|FG002|Overall Study|Patients not treated|1
7843946|NCT01442376|12324311|FG000|Overall Study|Not eligible for subsequent cycles|1
7843947|NCT01442376|12324312|FG001|Overall Study|Not eligible for subsequent cycles|2
7843948|NCT01442376|12324313|FG002|Overall Study|Not eligible for subsequent cycles|0
7843949|NCT01442493|12324323|FG000|Overall Study|withdrawn from study|3
7843950|NCT01442493|12324324|FG001|Overall Study|withdrawn from study|2
7843951|NCT01442675|12324330|FG000|Overall Study|Protocol Violation|6
7843952|NCT01442675|12324330|FG000|Overall Study|Lost to Follow-up|2
7843953|NCT01442675|12324330|FG000|Overall Study|Withdrawal by Subject|4
7843954|NCT01442688|12324337|FG000|First Intervention|Withdrawal by Subject|1
7843955|NCT01442688|12324338|FG001|First Intervention|Withdrawal by Subject|0
7843956|NCT01442688|12324337|FG000|First Intervention|subject incarcerated|1
7843957|NCT01442688|12324338|FG001|First Intervention|subject incarcerated|0
7843958|NCT01442688|12324337|FG000|Second Intervention|Adverse Event|1
7843959|NCT01442688|12324338|FG001|Second Intervention|Adverse Event|0
7843960|NCT01442714|12324344|FG000|Overall Study|Death|11
7843961|NCT01442714|12324344|FG000|Overall Study|Withdrawal by Subject|1
7843962|NCT01442779|12324350|FG000|Overall Study|Withdrawal by Subject|3
7843963|NCT01442779|12324350|FG000|Overall Study|Death|3
7843964|NCT01442779|12324350|FG000|Overall Study|Non-compliance|1
7843965|NCT01443026|12324365|FG000|Overall Study|Physician Decision|1
7843966|NCT01443026|12324366|FG001|Overall Study|Physician Decision|0
7843967|NCT01443026|12324365|FG000|Overall Study|Death|0
7843968|NCT01443026|12324366|FG001|Overall Study|Death|1
7843969|NCT01443026|12324365|FG000|Overall Study|Withdrawal by Subject|0
7843970|NCT01443026|12324366|FG001|Overall Study|Withdrawal by Subject|3
7843971|NCT01443026|12324365|FG000|Overall Study|Lost to Follow-up|2
7843972|NCT01443026|12324366|FG001|Overall Study|Lost to Follow-up|1
7843973|NCT01443078|12324372|FG000|Overall Study|Responded to neoadjuvant platinum txt|27
7843974|NCT01443078|12324372|FG000|Overall Study|Withdrawal by Subject|1
7843975|NCT01443078|12324372|FG000|Overall Study|Patient had brain mets|1
7843976|NCT01443130|12324382|FG000|Overall Study|Lost to Follow-up|44
7843977|NCT01443130|12324383|FG001|Overall Study|Lost to Follow-up|42
7843978|NCT01443130|12324384|FG002|Overall Study|Lost to Follow-up|50
7843979|NCT01443130|12324385|FG003|Overall Study|Lost to Follow-up|23
7843980|NCT01443130|12324386|FG004|Overall Study|Lost to Follow-up|25
7843981|NCT01443130|12324387|FG005|Overall Study|Lost to Follow-up|21
7843982|NCT01443130|12324382|FG000|Overall Study|Death|0
7843983|NCT01443130|12324383|FG001|Overall Study|Death|1
7843984|NCT01443130|12324384|FG002|Overall Study|Death|0
7843985|NCT01443130|12324385|FG003|Overall Study|Death|7
7843986|NCT01443130|12324386|FG004|Overall Study|Death|10
7843987|NCT01443130|12324387|FG005|Overall Study|Death|8
7843988|NCT01443130|12324382|FG000|Overall Study|Adverse Event|2
7843989|NCT01443130|12324383|FG001|Overall Study|Adverse Event|1
7843990|NCT01443130|12324384|FG002|Overall Study|Adverse Event|1
7843991|NCT01443130|12324385|FG003|Overall Study|Adverse Event|0
7843992|NCT01443130|12324386|FG004|Overall Study|Adverse Event|0
7843993|NCT01443130|12324387|FG005|Overall Study|Adverse Event|0
7843994|NCT01443130|12324382|FG000|Overall Study|Protocol Violation|2
7843995|NCT01443130|12324383|FG001|Overall Study|Protocol Violation|1
7843996|NCT01443130|12324384|FG002|Overall Study|Protocol Violation|3
7843997|NCT01443130|12324385|FG003|Overall Study|Protocol Violation|2
7843998|NCT01443130|12324386|FG004|Overall Study|Protocol Violation|2
7843999|NCT01443130|12324387|FG005|Overall Study|Protocol Violation|3
7844000|NCT01443130|12324382|FG000|Overall Study|Withdrawal by Subject|15
7844001|NCT01443130|12324383|FG001|Overall Study|Withdrawal by Subject|14
7844002|NCT01443130|12324384|FG002|Overall Study|Withdrawal by Subject|12
7844003|NCT01443130|12324385|FG003|Overall Study|Withdrawal by Subject|7
7844004|NCT01443130|12324386|FG004|Overall Study|Withdrawal by Subject|7
7844005|NCT01443130|12324387|FG005|Overall Study|Withdrawal by Subject|2
7844006|NCT01443130|12324382|FG000|Overall Study|Death of Subject's Infant|5
7844007|NCT01443130|12324383|FG001|Overall Study|Death of Subject's Infant|10
7844008|NCT01443130|12324384|FG002|Overall Study|Death of Subject's Infant|11
7844009|NCT01443130|12324385|FG003|Overall Study|Death of Subject's Infant|0
7844010|NCT01443130|12324386|FG004|Overall Study|Death of Subject's Infant|0
7844011|NCT01443130|12324387|FG005|Overall Study|Death of Subject's Infant|0
7844012|NCT01443364|12324401|FG000|Overall Study|Lack of Efficacy|14
7844013|NCT01443364|12324401|FG000|Overall Study|Lost to Follow-up|3
7844014|NCT01443364|12324401|FG000|Overall Study|Withdrawal by Subject|5
7844015|NCT01443364|12324401|FG000|Overall Study|Other Reason|4
7844016|NCT01443364|12324401|FG000|Overall Study|SAE, non-fatal|6
7844017|NCT01443364|12324401|FG000|Overall Study|AE, non-serious non-fatal|8
7844018|NCT01443364|12324401|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7844019|NCT01443403|12324409|FG000|Overall Study|Adverse Event|1
7844020|NCT01443403|12324410|FG001|Overall Study|Adverse Event|1
7844021|NCT01443403|12324411|FG002|Overall Study|Adverse Event|4
7844022|NCT01443403|12324412|FG003|Overall Study|Adverse Event|5
7844023|NCT01443403|12324409|FG000|Overall Study|Withdrawal by Subject|0
7844024|NCT01443403|12324410|FG001|Overall Study|Withdrawal by Subject|1
7844025|NCT01443403|12324411|FG002|Overall Study|Withdrawal by Subject|2
7844026|NCT01443403|12324412|FG003|Overall Study|Withdrawal by Subject|1
7844027|NCT01443403|12324409|FG000|Overall Study|Lost to Follow-up|0
7844028|NCT01443403|12324410|FG001|Overall Study|Lost to Follow-up|0
7844029|NCT01443403|12324411|FG002|Overall Study|Lost to Follow-up|0
7844030|NCT01443403|12324412|FG003|Overall Study|Lost to Follow-up|1
7844031|NCT01443403|12324409|FG000|Overall Study|Protocol Violation|2
7844032|NCT01443403|12324410|FG001|Overall Study|Protocol Violation|1
7844033|NCT01443403|12324411|FG002|Overall Study|Protocol Violation|1
7844034|NCT01443403|12324412|FG003|Overall Study|Protocol Violation|1
7844035|NCT01443403|12324409|FG000|Overall Study|Use of Prohibited Treatment|2
7844036|NCT01443403|12324410|FG001|Overall Study|Use of Prohibited Treatment|3
7844037|NCT01443403|12324411|FG002|Overall Study|Use of Prohibited Treatment|0
7844038|NCT01443403|12324412|FG003|Overall Study|Use of Prohibited Treatment|0
7844039|NCT01443403|12324409|FG000|Overall Study|Other - Miscellaneous|1
7844040|NCT01443403|12324410|FG001|Overall Study|Other - Miscellaneous|0
7844041|NCT01443403|12324411|FG002|Overall Study|Other - Miscellaneous|0
7844042|NCT01443403|12324412|FG003|Overall Study|Other - Miscellaneous|1
7844043|NCT01443845|12324455|FG000|Overall Study|Protocol Violation|43
7844044|NCT01443845|12324456|FG001|Overall Study|Protocol Violation|45
7844045|NCT01443845|12324455|FG000|Overall Study|Other reasons, such as COPD exacerbation|44
7844046|NCT01443845|12324456|FG001|Overall Study|Other reasons, such as COPD exacerbation|44
7844047|NCT01443845|12324455|FG000|Overall Study|Deterioration in pulmonary function|1
7844048|NCT01443845|12324456|FG001|Overall Study|Deterioration in pulmonary function|4
7844049|NCT01443845|12324455|FG000|Overall Study|Lack of Efficacy|10
7844050|NCT01443845|12324456|FG001|Overall Study|Lack of Efficacy|5
7844051|NCT01443845|12324455|FG000|Overall Study|Adverse Event|64
7844052|NCT01443845|12324456|FG001|Overall Study|Adverse Event|138
7844053|NCT01443845|12324455|FG000|Overall Study|Withdrawal by Subject|63
7844054|NCT01443845|12324456|FG001|Overall Study|Withdrawal by Subject|67
7844055|NCT01443845|12324455|FG000|Overall Study|Military Conflict - Site Terminated|20
7844056|NCT01443845|12324456|FG001|Overall Study|Military Conflict - Site Terminated|21
7844057|NCT01443845|12324455|FG000|Overall Study|Lost to Follow-up|9
7844058|NCT01443845|12324456|FG001|Overall Study|Lost to Follow-up|13
7844059|NCT01443858|12324465|FG000|Overall Study|Withdrawal by Subject|9
7844060|NCT01443858|12324466|FG001|Overall Study|Withdrawal by Subject|8
7844061|NCT01443858|12324467|FG002|Overall Study|Withdrawal by Subject|5
7844062|NCT01443858|12324465|FG000|Overall Study|Lack of Efficacy|1
7844063|NCT01443858|12324466|FG001|Overall Study|Lack of Efficacy|0
7844064|NCT01443858|12324467|FG002|Overall Study|Lack of Efficacy|0
7844065|NCT01443858|12324465|FG000|Overall Study|Lost to Follow-up|5
7844066|NCT01443858|12324466|FG001|Overall Study|Lost to Follow-up|5
7844067|NCT01443858|12324467|FG002|Overall Study|Lost to Follow-up|2
7844068|NCT01444027|12324478|FG000|Overall Study|Withdrawal by Subject|4
7844069|NCT01444027|12324479|FG001|Overall Study|Withdrawal by Subject|10
7844070|NCT01444027|12324480|FG002|Overall Study|Withdrawal by Subject|24
7844071|NCT01444027|12324478|FG000|Overall Study|Lost to Follow-up|26
7844072|NCT01444027|12324479|FG001|Overall Study|Lost to Follow-up|20
7844073|NCT01444027|12324480|FG002|Overall Study|Lost to Follow-up|14
7844074|NCT01444300|12324504|FG000|Overall Study|Adverse Event|4
7844075|NCT01444300|12324505|FG001|Overall Study|Adverse Event|0
7844076|NCT01444378|12324512|FG000|Overall Study|Lost to Follow-up|1
7844077|NCT01444378|12324512|FG000|Overall Study|Withdrawal by Subject|1
7844078|NCT01444378|12324512|FG000|Overall Study|Death|3
7844079|NCT01444378|12324512|FG000|Overall Study|Administrative Closure Of The Study|2
7844080|NCT01444378|12324512|FG000|Overall Study|Missed Visits|10
7844081|NCT01444391|12324519|FG000|Overall Study|Death|1
7844082|NCT01444417|12324525|FG000|Overall Study|Ineligibility Determined|0
7844083|NCT01444417|12324526|FG001|Overall Study|Ineligibility Determined|1
7844084|NCT01444417|12324525|FG000|Overall Study|Withdrawal by Subject|2
7844085|NCT01444417|12324526|FG001|Overall Study|Withdrawal by Subject|0
7844086|NCT01444430|12324534|FG000|Overall Study|Withdrawal by Subject|53
7844087|NCT01444430|12324535|FG001|Overall Study|Withdrawal by Subject|72
7844088|NCT01444430|12324534|FG000|Overall Study|Death|6
7844089|NCT01444430|12324535|FG001|Overall Study|Death|8
7844090|NCT01444430|12324534|FG000|Overall Study|Lost to Follow-up|2
7844091|NCT01444430|12324535|FG001|Overall Study|Lost to Follow-up|0
7844092|NCT01444430|12324534|FG000|Overall Study|CRF termination module not completed.|0
7844093|NCT01444430|12324535|FG001|Overall Study|CRF termination module not completed.|1
7844094|NCT01444456|12324541|FG000|Overall Study|Withdrawal by Subject|21
7844095|NCT01444456|12324541|FG000|Overall Study|Physician Decision|9
7844096|NCT01444456|12324541|FG000|Overall Study|Lost to Follow-up|37
7844097|NCT01444456|12324541|FG000|Overall Study|Death|73
7844098|NCT01444456|12324541|FG000|Overall Study|Ineligibility determined|23
7844099|NCT01444456|12324541|FG000|Overall Study|Other|18
7844100|NCT01444456|12324541|FG000|Overall Study|Not treated|104
7844101|NCT01444651|12324547|FG000|Overall Study|Adverse Event|3
7844102|NCT01444651|12324548|FG001|Overall Study|Adverse Event|2
7844103|NCT01444651|12324547|FG000|Overall Study|Lost to Follow-up|5
7844104|NCT01444651|12324548|FG001|Overall Study|Lost to Follow-up|5
7844105|NCT01444651|12324547|FG000|Overall Study|Non-fasting|2
7844106|NCT01444651|12324548|FG001|Overall Study|Non-fasting|1
7844107|NCT01444651|12324547|FG000|Overall Study|Missing data|1
7844108|NCT01444651|12324548|FG001|Overall Study|Missing data|1
7844109|NCT01444742|12324558|FG000|Overall Study|Death|1
7844110|NCT01444781|12324565|FG000|Overall Study|Lost to Follow-up|0
7844111|NCT01444781|12324566|FG001|Overall Study|Lost to Follow-up|3
7844112|NCT01444781|12324567|FG002|Overall Study|Lost to Follow-up|1
7844113|NCT01444781|12324565|FG000|Overall Study|Withdrawal by Subject|3
7844114|NCT01444781|12324566|FG001|Overall Study|Withdrawal by Subject|1
7844115|NCT01444781|12324567|FG002|Overall Study|Withdrawal by Subject|2
7844116|NCT01444898|12324582|FG000|Overall Study|Withdrawal by Subject|1
7844117|NCT01445080|12324622|FG000|Overall Study|Adverse Event|5
7844118|NCT01445080|12324623|FG001|Overall Study|Adverse Event|3
7844119|NCT01445080|12324624|FG002|Overall Study|Adverse Event|11
7844120|NCT01445080|12324625|FG003|Overall Study|Adverse Event|6
7844121|NCT01445080|12324626|FG004|Overall Study|Adverse Event|2
7844122|NCT01445080|12324627|FG005|Overall Study|Adverse Event|3
7844123|NCT01445080|12324628|FG006|Overall Study|Adverse Event|0
7844124|NCT01445080|12324629|FG007|Overall Study|Adverse Event|3
7844125|NCT01445080|12324630|FG008|Overall Study|Adverse Event|10
7844126|NCT01445080|12324622|FG000|Overall Study|Physician Decision|0
7844127|NCT01445080|12324623|FG001|Overall Study|Physician Decision|0
7844128|NCT01445080|12324624|FG002|Overall Study|Physician Decision|1
7844129|NCT01445080|12324625|FG003|Overall Study|Physician Decision|0
7844130|NCT01445080|12324626|FG004|Overall Study|Physician Decision|0
7844131|NCT01445080|12324627|FG005|Overall Study|Physician Decision|3
7844132|NCT01445080|12324628|FG006|Overall Study|Physician Decision|2
7844133|NCT01445080|12324629|FG007|Overall Study|Physician Decision|2
7844134|NCT01445080|12324630|FG008|Overall Study|Physician Decision|0
7844135|NCT01445080|12324622|FG000|Overall Study|Withdrawal by Subject|1
7844136|NCT01445080|12324623|FG001|Overall Study|Withdrawal by Subject|0
7844137|NCT01445080|12324624|FG002|Overall Study|Withdrawal by Subject|0
7844138|NCT01445080|12324625|FG003|Overall Study|Withdrawal by Subject|1
7844139|NCT01445080|12324626|FG004|Overall Study|Withdrawal by Subject|0
7844140|NCT01445080|12324627|FG005|Overall Study|Withdrawal by Subject|0
7844141|NCT01445080|12324628|FG006|Overall Study|Withdrawal by Subject|0
7844142|NCT01445080|12324629|FG007|Overall Study|Withdrawal by Subject|0
7844143|NCT01445080|12324630|FG008|Overall Study|Withdrawal by Subject|2
7844144|NCT01445080|12324622|FG000|Overall Study|Ineligible/Inevaluable|1
7844145|NCT01445080|12324623|FG001|Overall Study|Ineligible/Inevaluable|2
7844146|NCT01445080|12324624|FG002|Overall Study|Ineligible/Inevaluable|0
7844147|NCT01445080|12324625|FG003|Overall Study|Ineligible/Inevaluable|1
7844148|NCT01445080|12324626|FG004|Overall Study|Ineligible/Inevaluable|2
7844149|NCT01445080|12324627|FG005|Overall Study|Ineligible/Inevaluable|3
7844150|NCT01445080|12324628|FG006|Overall Study|Ineligible/Inevaluable|0
7844151|NCT01445080|12324629|FG007|Overall Study|Ineligible/Inevaluable|0
7844152|NCT01445080|12324630|FG008|Overall Study|Ineligible/Inevaluable|6
7844153|NCT01445171|12324665|FG000|Overall Study|Lost to Follow-up|11
7844154|NCT01445171|12324665|FG000|Overall Study|Withdrawal by Subject|16
7844155|NCT01445171|12324665|FG000|Overall Study|Death|51
7844156|NCT01445171|12324665|FG000|Overall Study|Subjects declined to return for followup|9
7844157|NCT01445171|12324665|FG000|Overall Study|Consented but did not receive device|8
7844158|NCT01445301|12324674|FG000|Overall Study|Adverse Event|15
7844159|NCT01445301|12324675|FG001|Overall Study|Adverse Event|25
7844160|NCT01445301|12324676|FG002|Overall Study|Adverse Event|4
7844161|NCT01445301|12324674|FG000|Overall Study|Lack of Efficacy|0
7844162|NCT01445301|12324675|FG001|Overall Study|Lack of Efficacy|1
7844163|NCT01445301|12324676|FG002|Overall Study|Lack of Efficacy|0
7844164|NCT01445301|12324674|FG000|Overall Study|Protocol Violation|1
7844165|NCT01445301|12324675|FG001|Overall Study|Protocol Violation|0
7844166|NCT01445301|12324676|FG002|Overall Study|Protocol Violation|0
7844167|NCT01445301|12324674|FG000|Overall Study|Protocol-Defined Stopping Criteria|0
7844168|NCT01445301|12324675|FG001|Overall Study|Protocol-Defined Stopping Criteria|1
7844169|NCT01445301|12324676|FG002|Overall Study|Protocol-Defined Stopping Criteria|1
7844170|NCT01445301|12324674|FG000|Overall Study|Physician Decision|0
7844171|NCT01445301|12324675|FG001|Overall Study|Physician Decision|2
7844172|NCT01445301|12324676|FG002|Overall Study|Physician Decision|0
7844173|NCT01445301|12324674|FG000|Overall Study|Withdrawal by Subject|5
7844174|NCT01445301|12324675|FG001|Overall Study|Withdrawal by Subject|6
7844175|NCT01445301|12324676|FG002|Overall Study|Withdrawal by Subject|4
7844176|NCT01445535|12324688|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0
7844177|NCT01445535|12324689|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0
7844178|NCT01445535|12324690|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0
7844179|NCT01445535|12324691|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1
7844180|NCT01445535|12324688|FG000|Overall Study|Disease progression|1
7844181|NCT01445535|12324689|FG001|Overall Study|Disease progression|0
7844182|NCT01445535|12324690|FG002|Overall Study|Disease progression|1
7844183|NCT01445535|12324691|FG003|Overall Study|Disease progression|0
7844184|NCT01445535|12324688|FG000|Overall Study|PI discretion|0
7844185|NCT01445535|12324689|FG001|Overall Study|PI discretion|0
7844186|NCT01445535|12324690|FG002|Overall Study|PI discretion|0
7844187|NCT01445535|12324691|FG003|Overall Study|PI discretion|1
7844188|NCT01445548|12324702|FG000|Overall Study|Adverse Event|1
7844189|NCT01445613|12324706|FG000|30-day Follow-up|Withdrawal by Subject|6
7844190|NCT01445613|12324706|FG000|30-day Follow-up|Physician Decision|3
7844191|NCT01445613|12324706|FG000|30-day Follow-up|Missed visit|23
7844192|NCT01445613|12324706|FG000|30-day Follow-up|Death|3
7844193|NCT01445613|12324706|FG000|1-year Follow-up|Withdrawal by Subject|12
7844194|NCT01445613|12324706|FG000|1-year Follow-up|Missed visit|29
7844195|NCT01445613|12324706|FG000|1-year Follow-up|Lost to Follow-up|2
7844196|NCT01445613|12324706|FG000|1-year Follow-up|Death|30
7844197|NCT01445613|12324706|FG000|1-year Follow-up|Physician Decision|2
7844198|NCT01445613|12324706|FG000|1-year Follow-up|Received a non-study stent|2
7844199|NCT01445652|12324722|FG000|Overall Study|Not comfortable in lenses|5
7844200|NCT01445652|12324723|FG001|Overall Study|Not comfortable in lenses|0
7844201|NCT01445652|12324722|FG000|Overall Study|Failed to attend scheduled visit|2
7844202|NCT01445652|12324723|FG001|Overall Study|Failed to attend scheduled visit|3
7844203|NCT01445652|12324722|FG000|Overall Study|Failed teach session|2
7844204|NCT01445652|12324723|FG001|Overall Study|Failed teach session|0
7844205|NCT01445652|12324722|FG000|Overall Study|Adverse Event|1
7844206|NCT01445652|12324723|FG001|Overall Study|Adverse Event|0
7844207|NCT01445678|12324731|FG000|Overall Study|Adverse Event|12
7844208|NCT01445678|12324732|FG001|Overall Study|Adverse Event|8
7844209|NCT01445678|12324731|FG000|Overall Study|Lack of Efficacy|0
7844210|NCT01445678|12324732|FG001|Overall Study|Lack of Efficacy|2
7844211|NCT01445678|12324731|FG000|Overall Study|Lost to Follow-up|8
7949081|NCT02533674|12494570|FG000|Dose Level II|Non-treatment-related AE|0
7949082|NCT02533674|12494571|FG001|Dose Level II|Non-treatment-related AE|1
7949083|NCT02533674|12494572|FG002|Dose Level II|Non-treatment-related AE|0
7949084|NCT02533674|12494573|FG003|Dose Level II|Non-treatment-related AE|0
7949085|NCT02533674|12494574|FG004|Dose Level II|Non-treatment-related AE|0
7949086|NCT02533674|12494575|FG005|Dose Level II|Non-treatment-related AE|0
7949087|NCT02533674|12494576|FG006|Dose Level II|Non-treatment-related AE|0
7949088|NCT02533674|12494577|FG007|Dose Level II|Non-treatment-related AE|0
7844212|NCT01445678|12324732|FG001|Overall Study|Lost to Follow-up|5
7844213|NCT01445678|12324731|FG000|Overall Study|Protocol Violation|1
7844214|NCT01445678|12324732|FG001|Overall Study|Protocol Violation|1
7844215|NCT01445678|12324731|FG000|Overall Study|Withdrawal by Subject|9
7844216|NCT01445678|12324732|FG001|Overall Study|Withdrawal by Subject|5
7844217|NCT01445730|12324738|FG000|Overall Study|Adverse Event|1
7844218|NCT01445730|12324738|FG000|Overall Study|For the advice of a dentist|1
7844219|NCT01445730|12324738|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9
7844220|NCT01445769|12324742|FG000|Overall Study|Consent Withdrawn|2
7844221|NCT01445769|12324742|FG000|Overall Study|Disease Progression|1
7844222|NCT01445769|12324742|FG000|Overall Study|Lost to Follow-up|5
7844223|NCT01445847|12324759|FG000|Overall Study|Protocol Violation|13
7844224|NCT01445847|12324760|FG001|Overall Study|Protocol Violation|14
7844225|NCT01445847|12324759|FG000|Overall Study|Missed Data|1
7844226|NCT01445847|12324760|FG001|Overall Study|Missed Data|0
7844227|NCT01445886|12324770|FG000|Overall Study|Lost to Follow-up|2
7844228|NCT01445886|12324770|FG000|Overall Study|Protocol Violation|3
7844229|NCT01445951|12324779|FG000|Overall Study|Adverse Event|16
7844230|NCT01445951|12324780|FG001|Overall Study|Adverse Event|9
7844231|NCT01445951|12324781|FG002|Overall Study|Adverse Event|0
7844232|NCT01445951|12324779|FG000|Overall Study|Protocol Violation|2
7844233|NCT01445951|12324780|FG001|Overall Study|Protocol Violation|2
7844234|NCT01445951|12324781|FG002|Overall Study|Protocol Violation|2
7844235|NCT01445951|12324779|FG000|Overall Study|Withdrawal by Subject|21
7844236|NCT01445951|12324780|FG001|Overall Study|Withdrawal by Subject|16
7844237|NCT01445951|12324781|FG002|Overall Study|Withdrawal by Subject|8
7844238|NCT01445951|12324779|FG000|Overall Study|Physician Decision|3
7844239|NCT01445951|12324780|FG001|Overall Study|Physician Decision|1
7844240|NCT01445951|12324781|FG002|Overall Study|Physician Decision|0
7844241|NCT01445951|12324779|FG000|Overall Study|Lost to Follow-up|1
7844242|NCT01445951|12324780|FG001|Overall Study|Lost to Follow-up|2
7844243|NCT01445951|12324781|FG002|Overall Study|Lost to Follow-up|4
7844244|NCT01445951|12324779|FG000|Overall Study|Pregnancy|0
7844245|NCT01445951|12324780|FG001|Overall Study|Pregnancy|1
7844246|NCT01445951|12324781|FG002|Overall Study|Pregnancy|4
7844247|NCT01445951|12324779|FG000|Overall Study|Death|0
7844248|NCT01445951|12324780|FG001|Overall Study|Death|0
7844249|NCT01445951|12324781|FG002|Overall Study|Death|1
7844250|NCT01445951|12324779|FG000|Overall Study|Non-compliance with study drug|1
7844251|NCT01445951|12324780|FG001|Overall Study|Non-compliance with study drug|2
7844252|NCT01445951|12324781|FG002|Overall Study|Non-compliance with study drug|0
7844253|NCT01445951|12324779|FG000|Overall Study|Non-compliance with protocol|0
7844254|NCT01445951|12324780|FG001|Overall Study|Non-compliance with protocol|1
7844255|NCT01445951|12324781|FG002|Overall Study|Non-compliance with protocol|0
7844256|NCT01445951|12324779|FG000|Overall Study|Sponsor decision - subject travel|0
7844257|NCT01445951|12324780|FG001|Overall Study|Sponsor decision - subject travel|1
7844258|NCT01445951|12324781|FG002|Overall Study|Sponsor decision - subject travel|0
7844259|NCT01445951|12324779|FG000|Overall Study|Cough|0
7844260|NCT01445951|12324780|FG001|Overall Study|Cough|1
7844261|NCT01445951|12324781|FG002|Overall Study|Cough|0
7844262|NCT01446003|12324789|FG000|Period 1|Protocol Violation|2
7844263|NCT01446003|12324790|FG001|Period 1|Protocol Violation|0
7844264|NCT01446003|12324789|FG000|Period 2|Adverse Event|1
7844265|NCT01446003|12324790|FG001|Period 2|Adverse Event|0
7844266|NCT01446042|12324799|FG000|Overall Study|Withdrawal by Subject|12
7844267|NCT01446042|12324800|FG001|Overall Study|Withdrawal by Subject|2
7844268|NCT01446042|12324801|FG002|Overall Study|Withdrawal by Subject|4
7844269|NCT01446042|12324799|FG000|Overall Study|Adverse Event|1
7844270|NCT01446042|12324800|FG001|Overall Study|Adverse Event|0
7844271|NCT01446042|12324801|FG002|Overall Study|Adverse Event|4
7844272|NCT01446042|12324799|FG000|Overall Study|Lost to Follow-up|5
7844273|NCT01446042|12324800|FG001|Overall Study|Lost to Follow-up|0
7844274|NCT01446042|12324801|FG002|Overall Study|Lost to Follow-up|0
7844275|NCT01446042|12324799|FG000|Overall Study|Other reasons|2
7844276|NCT01446042|12324800|FG001|Overall Study|Other reasons|1
7844277|NCT01446042|12324801|FG002|Overall Study|Other reasons|1
7844278|NCT01446159|12324813|FG000|Overall Study|Withdrawal by Subject|1
7844279|NCT01446159|12324814|FG001|Overall Study|Withdrawal by Subject|0
7844280|NCT01446159|12324815|FG002|Overall Study|Withdrawal by Subject|14
7844281|NCT01446159|12324816|FG003|Overall Study|Withdrawal by Subject|11
7844282|NCT01446159|12324813|FG000|Overall Study|Lost to Follow-up|0
7844283|NCT01446159|12324814|FG001|Overall Study|Lost to Follow-up|0
7844284|NCT01446159|12324815|FG002|Overall Study|Lost to Follow-up|1
7844285|NCT01446159|12324816|FG003|Overall Study|Lost to Follow-up|2
7844286|NCT01446159|12324813|FG000|Overall Study|Death|2
7844287|NCT01446159|12324814|FG001|Overall Study|Death|3
7844288|NCT01446159|12324815|FG002|Overall Study|Death|43
7844289|NCT01446159|12324816|FG003|Overall Study|Death|36
7844290|NCT01446159|12324813|FG000|Overall Study|Other|0
7844291|NCT01446159|12324814|FG001|Overall Study|Other|0
7844292|NCT01446159|12324815|FG002|Overall Study|Other|13
7844293|NCT01446159|12324816|FG003|Overall Study|Other|13
7844294|NCT01446237|12324828|FG000|Overall Study|Adverse Event|1
7844295|NCT01446237|12324828|FG000|Overall Study|Lost to Follow-up|2
7844296|NCT01446237|12324828|FG000|Overall Study|Withdrawal by Subject|7
7844297|NCT01446289|12324836|FG000|Overall Study|Withdrawal by Subject|1
7844298|NCT01446289|12324837|FG001|Overall Study|Withdrawal by Subject|0
7844299|NCT01446289|12324838|FG002|Overall Study|Withdrawal by Subject|1
7844300|NCT01446289|12324839|FG003|Overall Study|Withdrawal by Subject|0
7844301|NCT01446419|12324853|FG000|Overall Study|Death|1
7844302|NCT01446419|12324854|FG001|Overall Study|Death|0
7844303|NCT01446419|12324853|FG000|Overall Study|Withdrawal by Subject|1
7844304|NCT01446419|12324854|FG001|Overall Study|Withdrawal by Subject|1
7844305|NCT01446419|12324853|FG000|Overall Study|Terminated per protocol|3
7844306|NCT01446419|12324854|FG001|Overall Study|Terminated per protocol|0
7863173|NCT01604343|12352499|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
7863174|NCT01604343|12352500|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
7863175|NCT01604343|12352496|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
7863176|NCT01604343|12352497|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
7863177|NCT01604343|12352498|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
7863178|NCT01604343|12352499|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
7863179|NCT01604343|12352500|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
7863180|NCT01604343|12352496|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25
7863181|NCT01604343|12352497|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0
7863182|NCT01604343|12352498|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41
7863183|NCT01604343|12352499|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0
7863184|NCT01604343|12352500|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42
7863185|NCT01604343|12352496|FG000|Prior to W52 Administration(Through W52)|Death|5
7863186|NCT01604343|12352497|FG001|Prior to W52 Administration(Through W52)|Death|0
7863187|NCT01604343|12352498|FG002|Prior to W52 Administration(Through W52)|Death|2
7863188|NCT01604343|12352499|FG003|Prior to W52 Administration(Through W52)|Death|0
7863189|NCT01604343|12352500|FG004|Prior to W52 Administration(Through W52)|Death|4
7863190|NCT01604343|12352496|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
7863191|NCT01604343|12352497|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
7863192|NCT01604343|12352498|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
7863193|NCT01604343|12352499|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
7863194|NCT01604343|12352500|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
7863195|NCT01604343|12352496|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4
7863196|NCT01604343|12352497|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0
7844307|NCT01446809|12324886|FG000|Overall Study|Adverse Event|0
7844308|NCT01446809|12324887|FG001|Overall Study|Adverse Event|0
7844309|NCT01446809|12324888|FG002|Overall Study|Adverse Event|1
7844310|NCT01446809|12324886|FG000|Overall Study|Failure to complete study procedures|0
7844311|NCT01446809|12324887|FG001|Overall Study|Failure to complete study procedures|0
7844312|NCT01446809|12324888|FG002|Overall Study|Failure to complete study procedures|1
7844313|NCT01446874|12324900|FG000|Overall Study|Not eligible|1
7844314|NCT01446874|12324901|FG001|Overall Study|Not eligible|0
7844315|NCT01446874|12324902|FG002|Overall Study|Not eligible|0
7844316|NCT01446874|12324900|FG000|Overall Study|No surgery/No qualifying surgery|1
7844317|NCT01446874|12324901|FG001|Overall Study|No surgery/No qualifying surgery|0
7844318|NCT01446874|12324902|FG002|Overall Study|No surgery/No qualifying surgery|12
7844319|NCT01446874|12324900|FG000|Overall Study|Non-compliance|0
7844320|NCT01446874|12324901|FG001|Overall Study|Non-compliance|4
7844321|NCT01446874|12324902|FG002|Overall Study|Non-compliance|0
7844322|NCT01446874|12324900|FG000|Overall Study|Antibiotics for pre-op infection|0
7844323|NCT01446874|12324901|FG001|Overall Study|Antibiotics for pre-op infection|0
7844324|NCT01446874|12324902|FG002|Overall Study|Antibiotics for pre-op infection|2
7844325|NCT01446874|12324900|FG000|Overall Study|Withdrawal by Subject|0
7844326|NCT01446874|12324901|FG001|Overall Study|Withdrawal by Subject|0
7844327|NCT01446874|12324902|FG002|Overall Study|Withdrawal by Subject|4
7844328|NCT01446913|12324913|FG000|Overall Study|Significant illness|1
7844329|NCT01446913|12324914|FG001|Overall Study|Significant illness|1
7844330|NCT01446913|12324915|FG002|Overall Study|Significant illness|1
7844331|NCT01446913|12324913|FG000|Overall Study|Withdrawal by Subject|5
7844332|NCT01446913|12324914|FG001|Overall Study|Withdrawal by Subject|3
7844333|NCT01446913|12324915|FG002|Overall Study|Withdrawal by Subject|5
7844334|NCT01446913|12324913|FG000|Overall Study|Physician Decision|0
7844335|NCT01446913|12324914|FG001|Overall Study|Physician Decision|0
7844336|NCT01446913|12324915|FG002|Overall Study|Physician Decision|2
7844337|NCT01446913|12324913|FG000|Overall Study|Lost to Follow-up|3
7844338|NCT01446913|12324914|FG001|Overall Study|Lost to Follow-up|5
7844339|NCT01446913|12324915|FG002|Overall Study|Lost to Follow-up|3
7844340|NCT01446965|12324931|FG000|Randominization|One site was dismissed due to IRB irregularity|30
7844341|NCT01446965|12324932|FG001|Randominization|One site was dismissed due to IRB irregularity|16
7844342|NCT01446965|12324931|FG000|Participants Followed and Analyzed|Lost to Follow-up|10
7844343|NCT01446965|12324932|FG001|Participants Followed and Analyzed|Lost to Follow-up|12
7844344|NCT01447407|12325001|FG000|Overall Study|Withdrawal by Subject|2
7844345|NCT01447407|12325002|FG001|Overall Study|Withdrawal by Subject|0
7844346|NCT01447407|12325003|FG002|Overall Study|Withdrawal by Subject|0
7844347|NCT01447407|12325004|FG003|Overall Study|Withdrawal by Subject|1
7844348|NCT01447407|12325001|FG000|Overall Study|Physician Decision|0
7844349|NCT01447407|12325002|FG001|Overall Study|Physician Decision|0
7844350|NCT01447407|12325003|FG002|Overall Study|Physician Decision|1
7844351|NCT01447407|12325004|FG003|Overall Study|Physician Decision|1
7844352|NCT01447420|12325017|FG000|Overall Study|Adverse Event|2
7844353|NCT01447420|12325018|FG001|Overall Study|Adverse Event|4
7844354|NCT01447420|12325019|FG002|Overall Study|Adverse Event|2
7844355|NCT01447420|12325017|FG000|Overall Study|Protocol Violation|3
7844356|NCT01447420|12325018|FG001|Overall Study|Protocol Violation|3
7844357|NCT01447420|12325019|FG002|Overall Study|Protocol Violation|0
7844358|NCT01447420|12325017|FG000|Overall Study|Withdrawal by Subject|4
7844359|NCT01447420|12325018|FG001|Overall Study|Withdrawal by Subject|1
7844360|NCT01447420|12325019|FG002|Overall Study|Withdrawal by Subject|0
7844361|NCT01447420|12325017|FG000|Overall Study|Lack of Efficacy|1
7844362|NCT01447420|12325018|FG001|Overall Study|Lack of Efficacy|19
7844363|NCT01447420|12325019|FG002|Overall Study|Lack of Efficacy|8
7844364|NCT01447433|12325028|FG000|Overall Study|Lost to Follow-up|0
7844365|NCT01447433|12325029|FG001|Overall Study|Lost to Follow-up|2
7844366|NCT01447433|12325028|FG000|Overall Study|Withdrawal by Subject|3
7844367|NCT01447433|12325029|FG001|Overall Study|Withdrawal by Subject|3
7844368|NCT01447433|12325028|FG000|Overall Study|Protocol Violation|1
7844369|NCT01447433|12325029|FG001|Overall Study|Protocol Violation|1
7844370|NCT01447446|12325041|FG000|Overall Study|Death|6
7844371|NCT01447446|12325042|FG001|Overall Study|Death|3
7844372|NCT01447446|12325043|FG002|Overall Study|Death|2
7844373|NCT01447446|12325044|FG003|Overall Study|Death|1
7844374|NCT01447446|12325045|FG004|Overall Study|Death|7
7844375|NCT01447446|12325046|FG005|Overall Study|Death|0
7844376|NCT01447446|12325041|FG000|Overall Study|Adverse Event|3
7844377|NCT01447446|12325042|FG001|Overall Study|Adverse Event|0
7844378|NCT01447446|12325043|FG002|Overall Study|Adverse Event|1
7844379|NCT01447446|12325044|FG003|Overall Study|Adverse Event|0
7844380|NCT01447446|12325045|FG004|Overall Study|Adverse Event|2
7844381|NCT01447446|12325046|FG005|Overall Study|Adverse Event|0
7844382|NCT01447446|12325041|FG000|Overall Study|Failure to Return/Consent Withdrawn|357
7844383|NCT01447446|12325042|FG001|Overall Study|Failure to Return/Consent Withdrawn|78
7844384|NCT01447446|12325043|FG002|Overall Study|Failure to Return/Consent Withdrawn|31
7844385|NCT01447446|12325044|FG003|Overall Study|Failure to Return/Consent Withdrawn|7
7844386|NCT01447446|12325045|FG004|Overall Study|Failure to Return/Consent Withdrawn|69
7844387|NCT01447446|12325046|FG005|Overall Study|Failure to Return/Consent Withdrawn|9
7844388|NCT01447446|12325041|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
7844389|NCT01447446|12325042|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
7844390|NCT01447446|12325043|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
7844391|NCT01447446|12325044|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
7844392|NCT01447446|12325045|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
7844393|NCT01447446|12325046|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
7844394|NCT01447446|12325041|FG000|Overall Study|Administrative/Other|34
7844395|NCT01447446|12325042|FG001|Overall Study|Administrative/Other|9
7844396|NCT01447446|12325043|FG002|Overall Study|Administrative/Other|10
7844397|NCT01447446|12325044|FG003|Overall Study|Administrative/Other|2
7844398|NCT01447446|12325045|FG004|Overall Study|Administrative/Other|33
7844399|NCT01447446|12325046|FG005|Overall Study|Administrative/Other|4
7844400|NCT01447446|12325041|FG000|Overall Study|SVR12 Assessment|13
7844401|NCT01447446|12325042|FG001|Overall Study|SVR12 Assessment|1
7844402|NCT01447446|12325043|FG002|Overall Study|SVR12 Assessment|2
7844403|NCT01447446|12325044|FG003|Overall Study|SVR12 Assessment|1
7844404|NCT01447446|12325045|FG004|Overall Study|SVR12 Assessment|5
7844405|NCT01447446|12325046|FG005|Overall Study|SVR12 Assessment|5
7844406|NCT01447446|12325041|FG000|Overall Study|New Treatment Started|8
7844407|NCT01447446|12325042|FG001|Overall Study|New Treatment Started|2
7844408|NCT01447446|12325043|FG002|Overall Study|New Treatment Started|1
7844409|NCT01447446|12325044|FG003|Overall Study|New Treatment Started|0
7844410|NCT01447446|12325045|FG004|Overall Study|New Treatment Started|2
7844411|NCT01447446|12325046|FG005|Overall Study|New Treatment Started|0
7844412|NCT01447446|12325041|FG000|Overall Study|Reason not Specified|1
7844413|NCT01447446|12325042|FG001|Overall Study|Reason not Specified|1
7844414|NCT01447446|12325043|FG002|Overall Study|Reason not Specified|1
7844415|NCT01447446|12325044|FG003|Overall Study|Reason not Specified|1
7844416|NCT01447446|12325045|FG004|Overall Study|Reason not Specified|1
7844417|NCT01447446|12325046|FG005|Overall Study|Reason not Specified|0
7844418|NCT01447576|12325087|FG000|Overall Study|Lost to Follow-up|52
7844419|NCT01447576|12325087|FG000|Overall Study|Adverse Event|127
7844420|NCT01447576|12325087|FG000|Overall Study|Participant met withdrawal criteria|40
7844421|NCT01447576|12325087|FG000|Overall Study|Withdrawal by Subject|100
7844422|NCT01447576|12325087|FG000|Overall Study|Protocol deviation|83
7844423|NCT01447576|12325087|FG000|Overall Study|Lack of Efficacy|68
7844424|NCT01447576|12325087|FG000|Overall Study|Physician Decision|6
7844425|NCT01447719|12325104|FG000|Overall Study|Image acquisition failure|2
7844426|NCT01447719|12325104|FG000|Overall Study|Invalid image or not imaged|3
7844427|NCT01447719|12325104|FG000|Overall Study|Subject still living at end of study|79
7844428|NCT01447719|12325104|FG000|Overall Study|Withdrawal by Subject|2
7844429|NCT01447719|12325104|FG000|Overall Study|Family withdrew autopsy consent|7
7844430|NCT01447927|12325145|FG000|Overall Study|Adverse Event|4
7844431|NCT01447927|12325146|FG001|Overall Study|Adverse Event|3
7844432|NCT01447927|12325145|FG000|Overall Study|Withdrawal by Subject|1
7844433|NCT01447927|12325146|FG001|Overall Study|Withdrawal by Subject|0
7844434|NCT01448044|12325154|FG000|Treatment Period|Adverse Event|4
7844435|NCT01448044|12325155|FG001|Treatment Period|Adverse Event|3
7844436|NCT01448044|12325154|FG000|Treatment Period|Lack of Efficacy|5
7844437|NCT01448044|12325155|FG001|Treatment Period|Lack of Efficacy|12
7844438|NCT01448044|12325154|FG000|Treatment Period|Subject requested discontinue study drug|1
7844439|NCT01448044|12325155|FG001|Treatment Period|Subject requested discontinue study drug|0
7844440|NCT01448044|12325154|FG000|Treatment Period|Completed 24 weeks treatment period only|8
7844441|NCT01448044|12325155|FG001|Treatment Period|Completed 24 weeks treatment period only|0
7844442|NCT01448044|12325154|FG000|Treatment Period|Participant does not meet study criteria|1
7844443|NCT01448044|12325155|FG001|Treatment Period|Participant does not meet study criteria|0
7844444|NCT01448044|12325154|FG000|Treatment Period|Lost to Follow-up|2
7844445|NCT01448044|12325155|FG001|Treatment Period|Lost to Follow-up|1
7844446|NCT01448044|12325154|FG000|Treatment Period|Other reason|2
7844447|NCT01448044|12325155|FG001|Treatment Period|Other reason|0
7844448|NCT01448044|12325154|FG000|Follow Up Period|Withdrawal by Subject|1
7844449|NCT01448044|12325155|FG001|Follow Up Period|Withdrawal by Subject|1
7844450|NCT01448044|12325154|FG000|Follow Up Period|Lost to Follow-up|6
7844451|NCT01448044|12325155|FG001|Follow Up Period|Lost to Follow-up|2
7844452|NCT01448044|12325154|FG000|Follow Up Period|Other|5
7844453|NCT01448044|12325155|FG001|Follow Up Period|Other|11
7844454|NCT01448057|12325163|FG000|Overall Study|Protocol Violation|3
7844455|NCT01448057|12325164|FG001|Overall Study|Protocol Violation|2
7844456|NCT01448057|12325163|FG000|Overall Study|Lost to Follow-up|3
7844457|NCT01448057|12325164|FG001|Overall Study|Lost to Follow-up|0
7844458|NCT01448057|12325163|FG000|Overall Study|Adverse Event|0
7844459|NCT01448057|12325164|FG001|Overall Study|Adverse Event|2
7844460|NCT01448057|12325163|FG000|Overall Study|Withdrawal by Subject|2
7844461|NCT01448057|12325164|FG001|Overall Study|Withdrawal by Subject|0
7844462|NCT01448213|12325172|FG000|Overall Study|Lost to Follow-up|12
7844463|NCT01448213|12325173|FG001|Overall Study|Lost to Follow-up|10
7844464|NCT01448213|12325172|FG000|Overall Study|Adverse Event|4
7844465|NCT01448213|12325173|FG001|Overall Study|Adverse Event|10
7844466|NCT01448213|12325172|FG000|Overall Study|Protocol Violation|1
7844467|NCT01448213|12325173|FG001|Overall Study|Protocol Violation|2
7844468|NCT01448616|12325218|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3
7844469|NCT01448616|12325219|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0
7844470|NCT01448616|12325220|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0
7844471|NCT01448616|12325221|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0
7844472|NCT01448616|12325218|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6
7844473|NCT01448616|12325219|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0
7844474|NCT01448616|12325220|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0
7844475|NCT01448616|12325221|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0
7844476|NCT01448616|12325218|FG000|Study Drug (Treatment Phase)|Adverse Event|0
7844477|NCT01448616|12325219|FG001|Study Drug (Treatment Phase)|Adverse Event|1
7844478|NCT01448616|12325220|FG002|Study Drug (Treatment Phase)|Adverse Event|1
7844479|NCT01448616|12325221|FG003|Study Drug (Treatment Phase)|Adverse Event|0
7844480|NCT01448616|12325218|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0
7844481|NCT01448616|12325219|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0
7844482|NCT01448616|12325220|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1
7844483|NCT01448616|12325221|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2
7844484|NCT01448616|12325218|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0
7844485|NCT01448616|12325219|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1
7844486|NCT01448616|12325220|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2
7844487|NCT01448616|12325221|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2
7844488|NCT01448707|12325236|FG000|Overall Study|Adverse Event|3
7844489|NCT01448707|12325237|FG001|Overall Study|Adverse Event|1
7844490|NCT01448707|12325236|FG000|Overall Study|Lost to Follow-up|2
7844491|NCT01448707|12325237|FG001|Overall Study|Lost to Follow-up|6
7844492|NCT01448707|12325236|FG000|Overall Study|Withdrawal by Subject|6
7844493|NCT01448707|12325237|FG001|Overall Study|Withdrawal by Subject|7
7844494|NCT01448707|12325236|FG000|Overall Study|Other|7
7844495|NCT01448707|12325237|FG001|Overall Study|Other|4
7844496|NCT01448824|12325251|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7844497|NCT01448824|12325252|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7844498|NCT01448824|12325253|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7844499|NCT01448824|12325254|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7844500|NCT01448824|12325255|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7844501|NCT01448824|12325256|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7844502|NCT01448824|12325257|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1
7844503|NCT01448824|12325258|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7844504|NCT01448824|12325251|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7844505|NCT01448824|12325252|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7844506|NCT01448824|12325253|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7844507|NCT01448824|12325254|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
7844508|NCT01448824|12325255|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2
7844509|NCT01448824|12325256|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
7844510|NCT01448824|12325257|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7844511|NCT01448824|12325258|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7844512|NCT01448824|12325251|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7844513|NCT01448824|12325252|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7844514|NCT01448824|12325253|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7844515|NCT01448824|12325254|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7844516|NCT01448824|12325255|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7844517|NCT01448824|12325256|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1
7844518|NCT01448824|12325257|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7844519|NCT01448824|12325258|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7844520|NCT01448824|12325251|FG000|Part 1: Washout Period|Lost to Follow-up|1
7844521|NCT01448824|12325252|FG001|Part 1: Washout Period|Lost to Follow-up|0
7844522|NCT01448824|12325253|FG002|Part 1: Washout Period|Lost to Follow-up|0
7844523|NCT01448824|12325254|FG003|Part 1: Washout Period|Lost to Follow-up|0
7844524|NCT01448824|12325255|FG004|Part 1: Washout Period|Lost to Follow-up|0
7844525|NCT01448824|12325256|FG005|Part 1: Washout Period|Lost to Follow-up|0
7844526|NCT01448824|12325257|FG006|Part 1: Washout Period|Lost to Follow-up|0
7844527|NCT01448824|12325258|FG007|Part 1: Washout Period|Lost to Follow-up|0
7844528|NCT01448824|12325251|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7844529|NCT01448824|12325252|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7844530|NCT01448824|12325253|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7844531|NCT01448824|12325254|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7844532|NCT01448824|12325255|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7844533|NCT01448824|12325256|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7844534|NCT01448824|12325257|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7844535|NCT01448824|12325258|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1
7844536|NCT01448824|12325251|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7844537|NCT01448824|12325252|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7844538|NCT01448824|12325253|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7844539|NCT01448824|12325254|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7844540|NCT01448824|12325255|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7844541|NCT01448824|12325256|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7844542|NCT01448824|12325257|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7844543|NCT01448824|12325258|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1
7844544|NCT01448824|12325251|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7844545|NCT01448824|12325252|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7844546|NCT01448824|12325253|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7844547|NCT01448824|12325254|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7844548|NCT01448824|12325255|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7844549|NCT01448824|12325256|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7844550|NCT01448824|12325257|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7844551|NCT01448824|12325258|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1
7844552|NCT01448824|12325251|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7844553|NCT01448824|12325252|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7844554|NCT01448824|12325253|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7844555|NCT01448824|12325254|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7844556|NCT01448824|12325255|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7844557|NCT01448824|12325256|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7949089|NCT02533674|12494570|FG000|Dose Level III|Progressive disease|0
7844558|NCT01448824|12325257|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7844559|NCT01448824|12325258|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1
7844560|NCT01448850|12325288|FG000|Overall Study|Death|3
7844561|NCT01448850|12325289|FG001|Overall Study|Death|6
7844562|NCT01448850|12325288|FG000|Overall Study|Withdrawal by Subject|13
7844563|NCT01448850|12325289|FG001|Overall Study|Withdrawal by Subject|21
7844564|NCT01448850|12325288|FG000|Overall Study|Lost to Follow-up|3
7844565|NCT01448850|12325289|FG001|Overall Study|Lost to Follow-up|1
7844566|NCT01448850|12325288|FG000|Overall Study|Other|15
7844567|NCT01448850|12325289|FG001|Overall Study|Other|12
7844568|NCT01449006|12325298|FG000|Overall Study|Lost to Follow-up|1
7844569|NCT01449006|12325299|FG001|Overall Study|Lost to Follow-up|0
7844570|NCT01449006|12325298|FG000|Overall Study|Withdrawal by Subject|1
7844571|NCT01449006|12325299|FG001|Overall Study|Withdrawal by Subject|0
7844572|NCT01449006|12325298|FG000|Overall Study|Protocol Violation|1
7844573|NCT01449006|12325299|FG001|Overall Study|Protocol Violation|0
7844574|NCT01449279|12325313|FG000|Overall Study|Lack of Efficacy|5
7844575|NCT01449279|12325313|FG000|Overall Study|Toxicity|2
7844576|NCT01449370|12325346|FG000|Overall Study|Disease Progression|5
7844577|NCT01449370|12325347|FG001|Overall Study|Disease Progression|4
7844578|NCT01449370|12325348|FG002|Overall Study|Disease Progression|8
7844579|NCT01449370|12325349|FG003|Overall Study|Disease Progression|3
7844580|NCT01449370|12325350|FG004|Overall Study|Disease Progression|3
7844581|NCT01449370|12325351|FG005|Overall Study|Disease Progression|3
7844582|NCT01449370|12325352|FG006|Overall Study|Disease Progression|3
7844583|NCT01449370|12325353|FG007|Overall Study|Disease Progression|2
7844584|NCT01449370|12325354|FG008|Overall Study|Disease Progression|9
7844585|NCT01449370|12325355|FG009|Overall Study|Disease Progression|1
7844586|NCT01449370|12325356|FG010|Overall Study|Disease Progression|3
7844587|NCT01449370|12325357|FG011|Overall Study|Disease Progression|3
7844588|NCT01449370|12325358|FG012|Overall Study|Disease Progression|2
7844589|NCT01449370|12325359|FG013|Overall Study|Disease Progression|8
7844590|NCT01449370|12325360|FG014|Overall Study|Disease Progression|3
7844591|NCT01449370|12325361|FG015|Overall Study|Disease Progression|1
7844592|NCT01449370|12325362|FG016|Overall Study|Disease Progression|4
7844593|NCT01449370|12325363|FG017|Overall Study|Disease Progression|3
7844594|NCT01449370|12325364|FG018|Overall Study|Disease Progression|1
7844595|NCT01449370|12325365|FG019|Overall Study|Disease Progression|2
7844596|NCT01449370|12325366|FG020|Overall Study|Disease Progression|5
7844597|NCT01449370|12325367|FG021|Overall Study|Disease Progression|2
7844598|NCT01449370|12325368|FG022|Overall Study|Disease Progression|3
7844599|NCT01449370|12325369|FG023|Overall Study|Disease Progression|7
7844600|NCT01449370|12325370|FG024|Overall Study|Disease Progression|3
7844601|NCT01449370|12325346|FG000|Overall Study|Adverse Event|1
7844602|NCT01449370|12325347|FG001|Overall Study|Adverse Event|2
7844603|NCT01449370|12325348|FG002|Overall Study|Adverse Event|0
7844604|NCT01449370|12325349|FG003|Overall Study|Adverse Event|1
7844605|NCT01449370|12325350|FG004|Overall Study|Adverse Event|0
7844606|NCT01449370|12325351|FG005|Overall Study|Adverse Event|0
7844607|NCT01449370|12325352|FG006|Overall Study|Adverse Event|0
7844608|NCT01449370|12325353|FG007|Overall Study|Adverse Event|0
7844609|NCT01449370|12325354|FG008|Overall Study|Adverse Event|1
7844610|NCT01449370|12325355|FG009|Overall Study|Adverse Event|1
7844611|NCT01449370|12325356|FG010|Overall Study|Adverse Event|0
7844612|NCT01449370|12325357|FG011|Overall Study|Adverse Event|0
7844613|NCT01449370|12325358|FG012|Overall Study|Adverse Event|0
7844614|NCT01449370|12325359|FG013|Overall Study|Adverse Event|2
7844615|NCT01449370|12325360|FG014|Overall Study|Adverse Event|0
7844616|NCT01449370|12325361|FG015|Overall Study|Adverse Event|1
7844617|NCT01449370|12325362|FG016|Overall Study|Adverse Event|0
7844618|NCT01449370|12325363|FG017|Overall Study|Adverse Event|0
7844619|NCT01449370|12325364|FG018|Overall Study|Adverse Event|1
7844620|NCT01449370|12325365|FG019|Overall Study|Adverse Event|1
7844621|NCT01449370|12325366|FG020|Overall Study|Adverse Event|0
7844622|NCT01449370|12325367|FG021|Overall Study|Adverse Event|1
7844623|NCT01449370|12325368|FG022|Overall Study|Adverse Event|0
7844624|NCT01449370|12325369|FG023|Overall Study|Adverse Event|1
7844625|NCT01449370|12325370|FG024|Overall Study|Adverse Event|3
7844626|NCT01449370|12325346|FG000|Overall Study|Participant Decision|0
7844627|NCT01449370|12325347|FG001|Overall Study|Participant Decision|0
7844628|NCT01449370|12325348|FG002|Overall Study|Participant Decision|0
7844629|NCT01449370|12325349|FG003|Overall Study|Participant Decision|0
7844630|NCT01449370|12325350|FG004|Overall Study|Participant Decision|0
7844631|NCT01449370|12325351|FG005|Overall Study|Participant Decision|0
7844632|NCT01449370|12325352|FG006|Overall Study|Participant Decision|0
7844633|NCT01449370|12325353|FG007|Overall Study|Participant Decision|1
7844634|NCT01449370|12325354|FG008|Overall Study|Participant Decision|1
7844635|NCT01449370|12325355|FG009|Overall Study|Participant Decision|0
7844636|NCT01449370|12325356|FG010|Overall Study|Participant Decision|0
7844637|NCT01449370|12325357|FG011|Overall Study|Participant Decision|0
7844638|NCT01449370|12325358|FG012|Overall Study|Participant Decision|1
7844639|NCT01449370|12325359|FG013|Overall Study|Participant Decision|1
7844640|NCT01449370|12325360|FG014|Overall Study|Participant Decision|0
7844641|NCT01449370|12325361|FG015|Overall Study|Participant Decision|1
7844642|NCT01449370|12325362|FG016|Overall Study|Participant Decision|3
7844643|NCT01449370|12325363|FG017|Overall Study|Participant Decision|0
7844644|NCT01449370|12325364|FG018|Overall Study|Participant Decision|1
7844645|NCT01449370|12325365|FG019|Overall Study|Participant Decision|0
7844646|NCT01449370|12325366|FG020|Overall Study|Participant Decision|0
7844647|NCT01449370|12325367|FG021|Overall Study|Participant Decision|1
7844648|NCT01449370|12325368|FG022|Overall Study|Participant Decision|0
7844649|NCT01449370|12325369|FG023|Overall Study|Participant Decision|0
7844650|NCT01449370|12325370|FG024|Overall Study|Participant Decision|1
7844651|NCT01449370|12325346|FG000|Overall Study|Lost to Follow-up|0
7844652|NCT01449370|12325347|FG001|Overall Study|Lost to Follow-up|0
7844653|NCT01449370|12325348|FG002|Overall Study|Lost to Follow-up|0
7844654|NCT01449370|12325349|FG003|Overall Study|Lost to Follow-up|0
7844655|NCT01449370|12325350|FG004|Overall Study|Lost to Follow-up|0
7844656|NCT01449370|12325351|FG005|Overall Study|Lost to Follow-up|0
7844657|NCT01449370|12325352|FG006|Overall Study|Lost to Follow-up|0
7844658|NCT01449370|12325353|FG007|Overall Study|Lost to Follow-up|0
7844659|NCT01449370|12325354|FG008|Overall Study|Lost to Follow-up|0
7844660|NCT01449370|12325355|FG009|Overall Study|Lost to Follow-up|0
7844661|NCT01449370|12325356|FG010|Overall Study|Lost to Follow-up|0
7844662|NCT01449370|12325357|FG011|Overall Study|Lost to Follow-up|0
7844663|NCT01449370|12325358|FG012|Overall Study|Lost to Follow-up|0
7844664|NCT01449370|12325359|FG013|Overall Study|Lost to Follow-up|0
7844665|NCT01449370|12325360|FG014|Overall Study|Lost to Follow-up|0
7844666|NCT01449370|12325361|FG015|Overall Study|Lost to Follow-up|0
7844667|NCT01449370|12325362|FG016|Overall Study|Lost to Follow-up|0
7844668|NCT01449370|12325363|FG017|Overall Study|Lost to Follow-up|0
7844669|NCT01449370|12325364|FG018|Overall Study|Lost to Follow-up|0
7844670|NCT01449370|12325365|FG019|Overall Study|Lost to Follow-up|0
7844671|NCT01449370|12325366|FG020|Overall Study|Lost to Follow-up|1
7844672|NCT01449370|12325367|FG021|Overall Study|Lost to Follow-up|0
7844673|NCT01449370|12325368|FG022|Overall Study|Lost to Follow-up|0
7844674|NCT01449370|12325369|FG023|Overall Study|Lost to Follow-up|0
7844675|NCT01449370|12325370|FG024|Overall Study|Lost to Follow-up|0
7844676|NCT01449370|12325346|FG000|Overall Study|Other|0
7844677|NCT01449370|12325347|FG001|Overall Study|Other|0
7844678|NCT01449370|12325348|FG002|Overall Study|Other|0
7844679|NCT01449370|12325349|FG003|Overall Study|Other|0
7844680|NCT01449370|12325350|FG004|Overall Study|Other|0
7844681|NCT01449370|12325351|FG005|Overall Study|Other|0
7844682|NCT01449370|12325352|FG006|Overall Study|Other|0
7844683|NCT01449370|12325353|FG007|Overall Study|Other|0
7844684|NCT01449370|12325354|FG008|Overall Study|Other|1
7844685|NCT01449370|12325355|FG009|Overall Study|Other|1
7844686|NCT01449370|12325356|FG010|Overall Study|Other|0
7844687|NCT01449370|12325357|FG011|Overall Study|Other|0
7844688|NCT01449370|12325358|FG012|Overall Study|Other|0
7844689|NCT01449370|12325359|FG013|Overall Study|Other|0
7844690|NCT01449370|12325360|FG014|Overall Study|Other|0
7844691|NCT01449370|12325361|FG015|Overall Study|Other|0
7844692|NCT01449370|12325362|FG016|Overall Study|Other|0
7844693|NCT01449370|12325363|FG017|Overall Study|Other|0
7844694|NCT01449370|12325364|FG018|Overall Study|Other|0
7844695|NCT01449370|12325365|FG019|Overall Study|Other|0
7844696|NCT01449370|12325366|FG020|Overall Study|Other|0
7844697|NCT01449370|12325367|FG021|Overall Study|Other|0
7844698|NCT01449370|12325368|FG022|Overall Study|Other|1
7844699|NCT01449370|12325369|FG023|Overall Study|Other|1
7844700|NCT01449370|12325370|FG024|Overall Study|Other|0
7844701|NCT01449370|12325346|FG000|Overall Study|Medication Prohibited by Protocol|0
7844702|NCT01449370|12325347|FG001|Overall Study|Medication Prohibited by Protocol|0
7844703|NCT01449370|12325348|FG002|Overall Study|Medication Prohibited by Protocol|0
7844704|NCT01449370|12325349|FG003|Overall Study|Medication Prohibited by Protocol|0
7844705|NCT01449370|12325350|FG004|Overall Study|Medication Prohibited by Protocol|0
7844706|NCT01449370|12325351|FG005|Overall Study|Medication Prohibited by Protocol|0
7844707|NCT01449370|12325352|FG006|Overall Study|Medication Prohibited by Protocol|0
7844708|NCT01449370|12325353|FG007|Overall Study|Medication Prohibited by Protocol|0
7844709|NCT01449370|12325354|FG008|Overall Study|Medication Prohibited by Protocol|0
7844710|NCT01449370|12325355|FG009|Overall Study|Medication Prohibited by Protocol|0
7844711|NCT01449370|12325356|FG010|Overall Study|Medication Prohibited by Protocol|0
7844712|NCT01449370|12325357|FG011|Overall Study|Medication Prohibited by Protocol|0
7844713|NCT01449370|12325358|FG012|Overall Study|Medication Prohibited by Protocol|0
7844714|NCT01449370|12325359|FG013|Overall Study|Medication Prohibited by Protocol|0
7844715|NCT01449370|12325360|FG014|Overall Study|Medication Prohibited by Protocol|0
7844716|NCT01449370|12325361|FG015|Overall Study|Medication Prohibited by Protocol|0
7844717|NCT01449370|12325362|FG016|Overall Study|Medication Prohibited by Protocol|0
7844718|NCT01449370|12325363|FG017|Overall Study|Medication Prohibited by Protocol|0
7844719|NCT01449370|12325364|FG018|Overall Study|Medication Prohibited by Protocol|0
7844720|NCT01449370|12325365|FG019|Overall Study|Medication Prohibited by Protocol|0
7844721|NCT01449370|12325366|FG020|Overall Study|Medication Prohibited by Protocol|0
7844722|NCT01449370|12325367|FG021|Overall Study|Medication Prohibited by Protocol|0
7844723|NCT01449370|12325368|FG022|Overall Study|Medication Prohibited by Protocol|0
7844724|NCT01449370|12325369|FG023|Overall Study|Medication Prohibited by Protocol|1
7844725|NCT01449370|12325370|FG024|Overall Study|Medication Prohibited by Protocol|0
7844726|NCT01449370|12325346|FG000|Overall Study|Death|0
7844727|NCT01449370|12325347|FG001|Overall Study|Death|0
7844728|NCT01449370|12325348|FG002|Overall Study|Death|0
7844729|NCT01449370|12325349|FG003|Overall Study|Death|0
7844730|NCT01449370|12325350|FG004|Overall Study|Death|0
7844731|NCT01449370|12325351|FG005|Overall Study|Death|0
7844732|NCT01449370|12325352|FG006|Overall Study|Death|0
7844733|NCT01449370|12325353|FG007|Overall Study|Death|0
7844734|NCT01449370|12325354|FG008|Overall Study|Death|0
7844735|NCT01449370|12325355|FG009|Overall Study|Death|0
7844736|NCT01449370|12325356|FG010|Overall Study|Death|0
7844737|NCT01449370|12325357|FG011|Overall Study|Death|0
7844738|NCT01449370|12325358|FG012|Overall Study|Death|0
7844739|NCT01449370|12325359|FG013|Overall Study|Death|0
7844740|NCT01449370|12325360|FG014|Overall Study|Death|0
7844741|NCT01449370|12325361|FG015|Overall Study|Death|0
7844742|NCT01449370|12325362|FG016|Overall Study|Death|0
7844743|NCT01449370|12325363|FG017|Overall Study|Death|0
7844744|NCT01449370|12325364|FG018|Overall Study|Death|0
7844745|NCT01449370|12325365|FG019|Overall Study|Death|0
7844746|NCT01449370|12325366|FG020|Overall Study|Death|0
7844747|NCT01449370|12325367|FG021|Overall Study|Death|0
7844748|NCT01449370|12325368|FG022|Overall Study|Death|0
7844749|NCT01449370|12325369|FG023|Overall Study|Death|0
7844750|NCT01449370|12325370|FG024|Overall Study|Death|1
7844751|NCT01449461|12325449|FG000|Overall Study|Adverse Event|0
7844752|NCT01449461|12325450|FG001|Overall Study|Adverse Event|3
7844753|NCT01449461|12325451|FG002|Overall Study|Adverse Event|2
7844754|NCT01449461|12325452|FG003|Overall Study|Adverse Event|3
7844755|NCT01449461|12325453|FG004|Overall Study|Adverse Event|4
7844756|NCT01449461|12325454|FG005|Overall Study|Adverse Event|4
7844757|NCT01449461|12325449|FG000|Overall Study|Death|0
7844758|NCT01449461|12325450|FG001|Overall Study|Death|2
7844759|NCT01449461|12325451|FG002|Overall Study|Death|0
7844760|NCT01449461|12325452|FG003|Overall Study|Death|0
7844761|NCT01449461|12325453|FG004|Overall Study|Death|7
7844762|NCT01449461|12325454|FG005|Overall Study|Death|1
7844763|NCT01449461|12325449|FG000|Overall Study|Physician Decision|0
7844764|NCT01449461|12325450|FG001|Overall Study|Physician Decision|1
7844765|NCT01449461|12325451|FG002|Overall Study|Physician Decision|0
7844766|NCT01449461|12325452|FG003|Overall Study|Physician Decision|4
7844767|NCT01449461|12325453|FG004|Overall Study|Physician Decision|1
7844768|NCT01449461|12325454|FG005|Overall Study|Physician Decision|0
7844769|NCT01449461|12325449|FG000|Overall Study|Documented Progressive Disease|4
7844770|NCT01449461|12325450|FG001|Overall Study|Documented Progressive Disease|7
7844771|NCT01449461|12325451|FG002|Overall Study|Documented Progressive Disease|14
7844772|NCT01449461|12325452|FG003|Overall Study|Documented Progressive Disease|15
7844773|NCT01449461|12325453|FG004|Overall Study|Documented Progressive Disease|24
7844774|NCT01449461|12325454|FG005|Overall Study|Documented Progressive Disease|5
7844775|NCT01449461|12325449|FG000|Overall Study|Clinical Progressive Disease|2
7844776|NCT01449461|12325450|FG001|Overall Study|Clinical Progressive Disease|2
7844777|NCT01449461|12325451|FG002|Overall Study|Clinical Progressive Disease|0
7844778|NCT01449461|12325452|FG003|Overall Study|Clinical Progressive Disease|3
7844779|NCT01449461|12325453|FG004|Overall Study|Clinical Progressive Disease|4
7844780|NCT01449461|12325454|FG005|Overall Study|Clinical Progressive Disease|2
7844781|NCT01449461|12325449|FG000|Overall Study|Protocol Violation|0
7844782|NCT01449461|12325450|FG001|Overall Study|Protocol Violation|0
7844783|NCT01449461|12325451|FG002|Overall Study|Protocol Violation|0
7844784|NCT01449461|12325452|FG003|Overall Study|Protocol Violation|1
7844785|NCT01449461|12325453|FG004|Overall Study|Protocol Violation|0
7844786|NCT01449461|12325454|FG005|Overall Study|Protocol Violation|0
7844787|NCT01449461|12325449|FG000|Overall Study|Site Terminated by Sponsor|0
7844788|NCT01449461|12325450|FG001|Overall Study|Site Terminated by Sponsor|1
7844789|NCT01449461|12325451|FG002|Overall Study|Site Terminated by Sponsor|2
7844790|NCT01449461|12325452|FG003|Overall Study|Site Terminated by Sponsor|3
7844791|NCT01449461|12325453|FG004|Overall Study|Site Terminated by Sponsor|4
7844792|NCT01449461|12325454|FG005|Overall Study|Site Terminated by Sponsor|1
7844793|NCT01449461|12325449|FG000|Overall Study|Withdrawal by Subject|0
7844794|NCT01449461|12325450|FG001|Overall Study|Withdrawal by Subject|1
7844795|NCT01449461|12325451|FG002|Overall Study|Withdrawal by Subject|0
7844796|NCT01449461|12325452|FG003|Overall Study|Withdrawal by Subject|0
7844797|NCT01449461|12325453|FG004|Overall Study|Withdrawal by Subject|2
7844798|NCT01449461|12325454|FG005|Overall Study|Withdrawal by Subject|1
7844799|NCT01449461|12325449|FG000|Overall Study|Reason not Specified|0
7844800|NCT01449461|12325450|FG001|Overall Study|Reason not Specified|1
7844801|NCT01449461|12325451|FG002|Overall Study|Reason not Specified|0
7844802|NCT01449461|12325452|FG003|Overall Study|Reason not Specified|3
7844803|NCT01449461|12325453|FG004|Overall Study|Reason not Specified|2
7844804|NCT01449461|12325454|FG005|Overall Study|Reason not Specified|1
7844805|NCT01449526|12325488|FG000|Overall Study|Lost to Follow-up|1
7844806|NCT01449526|12325489|FG001|Overall Study|Lost to Follow-up|2
7844807|NCT01449526|12325488|FG000|Overall Study|Withdrawal by Subject|1
7844808|NCT01449526|12325489|FG001|Overall Study|Withdrawal by Subject|1
7844809|NCT01449526|12325488|FG000|Overall Study|Symptoms/complaints|0
7844810|NCT01449526|12325489|FG001|Overall Study|Symptoms/complaints|1
7844811|NCT01449526|12325488|FG000|Overall Study|Lack of Motivation|0
7844812|NCT01449526|12325489|FG001|Overall Study|Lack of Motivation|1
7844813|NCT01449526|12325488|FG000|Overall Study|Cannot maintain visits|0
7844814|NCT01449526|12325489|FG001|Overall Study|Cannot maintain visits|1
7844815|NCT01449539|12325495|FG000|Overall Study|Withdrawal by Subject|3
7844816|NCT01449539|12325495|FG000|Overall Study|Toxicity not study related|1
7844817|NCT01449630|12325508|FG000|Period 1|Physician Decision|1
7844818|NCT01449630|12325509|FG001|Period 1|Physician Decision|0
7844819|NCT01449630|12325510|FG002|Period 1|Physician Decision|0
7844820|NCT01449630|12325511|FG003|Period 1|Physician Decision|1
7844821|NCT01449630|12325512|FG004|Period 1|Physician Decision|0
7844822|NCT01449630|12325513|FG005|Period 1|Physician Decision|0
7844823|NCT01449630|12325514|FG006|Period 1|Physician Decision|0
7949090|NCT02533674|12494571|FG001|Dose Level III|Progressive disease|0
7949091|NCT02533674|12494572|FG002|Dose Level III|Progressive disease|2
7949092|NCT02533674|12494573|FG003|Dose Level III|Progressive disease|0
7949093|NCT02533674|12494574|FG004|Dose Level III|Progressive disease|0
7949094|NCT02533674|12494575|FG005|Dose Level III|Progressive disease|0
7949095|NCT02533674|12494576|FG006|Dose Level III|Progressive disease|0
7844824|NCT01449630|12325515|FG007|Period 1|Physician Decision|0
7844825|NCT01449630|12325516|FG008|Period 1|Physician Decision|0
7844826|NCT01449630|12325508|FG000|Period 1|Sponsor Decision|0
7844827|NCT01449630|12325509|FG001|Period 1|Sponsor Decision|0
7844828|NCT01449630|12325510|FG002|Period 1|Sponsor Decision|0
7844829|NCT01449630|12325511|FG003|Period 1|Sponsor Decision|0
7844830|NCT01449630|12325512|FG004|Period 1|Sponsor Decision|0
7844831|NCT01449630|12325513|FG005|Period 1|Sponsor Decision|1
7844832|NCT01449630|12325514|FG006|Period 1|Sponsor Decision|0
7844833|NCT01449630|12325515|FG007|Period 1|Sponsor Decision|0
7844834|NCT01449630|12325516|FG008|Period 1|Sponsor Decision|0
7844835|NCT01449630|12325508|FG000|Period 2|Sponsor Decision|0
7844836|NCT01449630|12325509|FG001|Period 2|Sponsor Decision|0
7844837|NCT01449630|12325510|FG002|Period 2|Sponsor Decision|0
7844838|NCT01449630|12325511|FG003|Period 2|Sponsor Decision|0
7844839|NCT01449630|12325512|FG004|Period 2|Sponsor Decision|0
7844840|NCT01449630|12325513|FG005|Period 2|Sponsor Decision|0
7844841|NCT01449630|12325514|FG006|Period 2|Sponsor Decision|1
7844842|NCT01449630|12325515|FG007|Period 2|Sponsor Decision|0
7844843|NCT01449630|12325516|FG008|Period 2|Sponsor Decision|0
7844844|NCT01449682|12325540|FG000|Overall Study|Death|0
7844845|NCT01449682|12325541|FG001|Overall Study|Death|1
7844846|NCT01449682|12325540|FG000|Overall Study|Adverse Event|1
7844847|NCT01449682|12325541|FG001|Overall Study|Adverse Event|0
7844848|NCT01449708|12325549|FG000|Overall Study|Protocol Violation|0
7844849|NCT01449708|12325550|FG001|Overall Study|Protocol Violation|1
7844850|NCT01449708|12325549|FG000|Overall Study|surgical complication|1
7844851|NCT01449708|12325550|FG001|Overall Study|surgical complication|2
7844852|NCT01449708|12325549|FG000|Overall Study|respiratory failure|1
7844853|NCT01449708|12325550|FG001|Overall Study|respiratory failure|0
7844854|NCT01449721|12325561|FG000|Overall Study|Physician Decision|0
7844855|NCT01449721|12325562|FG001|Overall Study|Physician Decision|1
7844856|NCT01449721|12325561|FG000|Overall Study|Physician Decision|0
7844857|NCT01449721|12325562|FG001|Overall Study|Physician Decision|1
7844858|NCT01449812|12325584|FG000|Overall Study|Migrated/moved from study area|1
7844859|NCT01449812|12325585|FG001|Overall Study|Migrated/moved from study area|0
7844860|NCT01449812|12325586|FG002|Overall Study|Migrated/moved from study area|0
7844861|NCT01449812|12325584|FG000|Overall Study|Withdrawal by Subject|0
7844862|NCT01449812|12325585|FG001|Overall Study|Withdrawal by Subject|0
7844863|NCT01449812|12325586|FG002|Overall Study|Withdrawal by Subject|1
7844864|NCT01449812|12325584|FG000|Overall Study|Lost to Follow-up|1
7844865|NCT01449812|12325585|FG001|Overall Study|Lost to Follow-up|0
7844866|NCT01449812|12325586|FG002|Overall Study|Lost to Follow-up|0
7844867|NCT01449929|12325600|FG000|Randomization Phase 96 Week|Adverse Event|5
7844868|NCT01449929|12325601|FG001|Randomization Phase 96 Week|Adverse Event|13
7844869|NCT01449929|12325602|FG002|Randomization Phase 96 Week|Adverse Event|0
7844870|NCT01449929|12325600|FG000|Randomization Phase 96 Week|Lack of Efficacy|3
7844871|NCT01449929|12325601|FG001|Randomization Phase 96 Week|Lack of Efficacy|4
7844872|NCT01449929|12325602|FG002|Randomization Phase 96 Week|Lack of Efficacy|0
7844873|NCT01449929|12325600|FG000|Randomization Phase 96 Week|Protocol Violation|5
7844874|NCT01449929|12325601|FG001|Randomization Phase 96 Week|Protocol Violation|6
7844875|NCT01449929|12325602|FG002|Randomization Phase 96 Week|Protocol Violation|0
7844876|NCT01449929|12325600|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
7844877|NCT01449929|12325601|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
7844878|NCT01449929|12325602|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
7844879|NCT01449929|12325600|FG000|Randomization Phase 96 Week|Lost to Follow-up|15
7844880|NCT01449929|12325601|FG001|Randomization Phase 96 Week|Lost to Follow-up|18
7844881|NCT01449929|12325602|FG002|Randomization Phase 96 Week|Lost to Follow-up|0
7844882|NCT01449929|12325600|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2
7844883|NCT01449929|12325601|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8
7844884|NCT01449929|12325602|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0
7844885|NCT01449929|12325600|FG000|Randomization Phase 96 Week|Physician Decision|2
7844886|NCT01449929|12325601|FG001|Randomization Phase 96 Week|Physician Decision|3
7844887|NCT01449929|12325602|FG002|Randomization Phase 96 Week|Physician Decision|0
7844888|NCT01449929|12325600|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0
7844889|NCT01449929|12325601|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1
7844890|NCT01449929|12325602|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0
7844891|NCT01449929|12325600|FG000|Extension Phase Approximately 3 Years|Adverse Event|0
7844892|NCT01449929|12325601|FG001|Extension Phase Approximately 3 Years|Adverse Event|0
7844893|NCT01449929|12325602|FG002|Extension Phase Approximately 3 Years|Adverse Event|2
7844894|NCT01449929|12325600|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0
7844895|NCT01449929|12325601|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0
7844896|NCT01449929|12325602|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2
7844897|NCT01449929|12325600|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0
7844898|NCT01449929|12325601|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0
7844899|NCT01449929|12325602|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4
7844900|NCT01449955|12325614|FG000|Overall Study|Withdrawal by Subject|1
7844901|NCT01449955|12325615|FG001|Overall Study|Withdrawal by Subject|2
7844902|NCT01450007|12325631|FG000|Overall Study|Late exclusion before treatment|2
7844903|NCT01450007|12325632|FG001|Overall Study|Late exclusion before treatment|3
7844904|NCT01450007|12325633|FG002|Overall Study|Late exclusion before treatment|2
7844905|NCT01450007|12325631|FG000|Overall Study|Protocol Violation|0
7844906|NCT01450007|12325632|FG001|Overall Study|Protocol Violation|1
7844907|NCT01450007|12325633|FG002|Overall Study|Protocol Violation|1
7844908|NCT01450007|12325631|FG000|Overall Study|Adverse Event|0
7844909|NCT01450007|12325632|FG001|Overall Study|Adverse Event|1
7844910|NCT01450007|12325633|FG002|Overall Study|Adverse Event|0
7844911|NCT01450098|12325643|FG000|Period 3|Protocol Violation|0
7844912|NCT01450098|12325644|FG001|Period 3|Protocol Violation|1
7844913|NCT01450098|12325643|FG000|Period 3|Withdrawal by Subject|0
7844914|NCT01450098|12325644|FG001|Period 3|Withdrawal by Subject|2
7844915|NCT01450137|12325659|FG000|Up to Week 12|Adverse Event|2
7844916|NCT01450137|12325660|FG001|Up to Week 12|Adverse Event|1
7844917|NCT01450137|12325659|FG000|Up to Week 12|Withdrawal by Subject|0
7844918|NCT01450137|12325660|FG001|Up to Week 12|Withdrawal by Subject|2
7844919|NCT01450137|12325659|FG000|Week 12 to Study End|Death|0
7844920|NCT01450137|12325660|FG001|Week 12 to Study End|Death|1
7844921|NCT01450137|12325659|FG000|Week 12 to Study End|Withdrawal by Subject|0
7844922|NCT01450137|12325660|FG001|Week 12 to Study End|Withdrawal by Subject|1
7844923|NCT01450540|12325705|FG000|Overall Study|Withdrawal by Subject|19
7844924|NCT01450540|12325706|FG001|Overall Study|Withdrawal by Subject|13
7844925|NCT01450540|12325705|FG000|Overall Study|protocol deviation|3
7844926|NCT01450540|12325706|FG001|Overall Study|protocol deviation|23
7844927|NCT01450683|12325714|FG000|Overall Study|Adverse Event|2
7844928|NCT01450696|12325720|FG000|Overall Study|Never Treated|1
7844929|NCT01450696|12325721|FG001|Overall Study|Never Treated|1
7844930|NCT01450696|12325720|FG000|Overall Study|Death|77
7844931|NCT01450696|12325721|FG001|Overall Study|Death|84
7844932|NCT01450696|12325720|FG000|Overall Study|Lost to Follow-up|3
7844933|NCT01450696|12325721|FG001|Overall Study|Lost to Follow-up|3
7844934|NCT01450696|12325720|FG000|Overall Study|Non-Compliance|1
7844935|NCT01450696|12325721|FG001|Overall Study|Non-Compliance|0
7844936|NCT01450696|12325720|FG000|Overall Study|Withdrawal by Subject|13
7844937|NCT01450696|12325721|FG001|Overall Study|Withdrawal by Subject|2
7844938|NCT01450696|12325720|FG000|Overall Study|Study Terminated by Sponsor|53
7844939|NCT01450696|12325721|FG001|Overall Study|Study Terminated by Sponsor|58
7844940|NCT01450761|12325729|FG000|Randomization|Subject no longer meets study criteria|1
7844941|NCT01450761|12325730|FG001|Randomization|Subject no longer meets study criteria|2
7844942|NCT01450761|12325729|FG000|Randomization|Withdrawal by Subject|2
7844943|NCT01450761|12325730|FG001|Randomization|Withdrawal by Subject|0
7844944|NCT01450761|12325729|FG000|Randomization|Disease progression|0
7844945|NCT01450761|12325730|FG001|Randomization|Disease progression|2
7844946|NCT01450761|12325729|FG000|Randomization|Adverse Event unrelated to study drug|1
7844947|NCT01450761|12325730|FG001|Randomization|Adverse Event unrelated to study drug|0
7844948|NCT01450761|12325729|FG000|Randomization|Other|0
7844949|NCT01450761|12325730|FG001|Randomization|Other|1
7844950|NCT01450761|12325729|FG000|Lead-in Chemotherapy|Disease progression|33
7844951|NCT01450761|12325730|FG001|Lead-in Chemotherapy|Disease progression|32
7844952|NCT01450761|12325729|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
7844953|NCT01450761|12325730|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
7844954|NCT01450761|12325729|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14
7844955|NCT01450761|12325730|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12
7844956|NCT01450761|12325729|FG000|Lead-in Chemotherapy|Study drug toxicity|6
7844957|NCT01450761|12325730|FG001|Lead-in Chemotherapy|Study drug toxicity|10
7844958|NCT01450761|12325729|FG000|Lead-in Chemotherapy|No longer meets study criteria|3
7844959|NCT01450761|12325730|FG001|Lead-in Chemotherapy|No longer meets study criteria|7
7844960|NCT01450761|12325729|FG000|Lead-in Chemotherapy|Death|3
7844961|NCT01450761|12325730|FG001|Lead-in Chemotherapy|Death|3
7844962|NCT01450761|12325729|FG000|Lead-in Chemotherapy|Other|2
7844963|NCT01450761|12325730|FG001|Lead-in Chemotherapy|Other|2
7844964|NCT01450761|12325729|FG000|Lead-in Chemotherapy|Lost to Follow-up|2
7844965|NCT01450761|12325730|FG001|Lead-in Chemotherapy|Lost to Follow-up|0
7844966|NCT01450761|12325729|FG000|Treatment With Blinded Study Therapy|Disease progression|318
7844967|NCT01450761|12325730|FG001|Treatment With Blinded Study Therapy|Disease progression|415
7844968|NCT01450761|12325729|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87
7844969|NCT01450761|12325730|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9
7844970|NCT01450761|12325729|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
7844971|NCT01450761|12325730|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
7844972|NCT01450761|12325729|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
7844973|NCT01450761|12325730|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
7844974|NCT01450761|12325729|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
7844975|NCT01450761|12325730|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
7844976|NCT01450761|12325729|FG000|Treatment With Blinded Study Therapy|Death|5
7844977|NCT01450761|12325730|FG001|Treatment With Blinded Study Therapy|Death|6
7844978|NCT01450761|12325729|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5
7844979|NCT01450761|12325730|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4
7844980|NCT01450761|12325729|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2
7844981|NCT01450761|12325730|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1
7844982|NCT01450761|12325729|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
7844983|NCT01450761|12325730|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
7844984|NCT01450761|12325729|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1
7844985|NCT01450761|12325730|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2
7844986|NCT01450761|12325729|FG000|Treatment With Blinded Study Therapy|Not reported|2
7844987|NCT01450761|12325730|FG001|Treatment With Blinded Study Therapy|Not reported|2
7844988|NCT01450761|12325729|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1
7844989|NCT01450761|12325730|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0
7844990|NCT01450761|12325729|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
7844991|NCT01450761|12325730|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
7844992|NCT01450800|12325747|FG000|Overall Study|Protocol Violation|1
7844993|NCT01450800|12325748|FG001|Overall Study|Protocol Violation|3
7844994|NCT01450813|12325760|FG000|Overall Study|Physician Decision|1
7844995|NCT01450813|12325761|FG001|Overall Study|Physician Decision|1
7844996|NCT01450813|12325762|FG002|Overall Study|Physician Decision|0
7844997|NCT01450813|12325763|FG003|Overall Study|Physician Decision|3
7844998|NCT01450943|12325787|FG000|Overall Study|Screen failure, loss to follow-up|2
7844999|NCT01450943|12325788|FG001|Overall Study|Screen failure, loss to follow-up|7
7845000|NCT01450943|12325789|FG002|Overall Study|Screen failure, loss to follow-up|6
7845001|NCT01451164|12325805|FG000|Overall Study|Adverse Event|19
7845002|NCT01451164|12325806|FG001|Overall Study|Adverse Event|12
7845003|NCT01451164|12325807|FG002|Overall Study|Adverse Event|18
7845004|NCT01451164|12325808|FG003|Overall Study|Adverse Event|21
7845005|NCT01451164|12325805|FG000|Overall Study|Withdrawal Criteria|1
7845006|NCT01451164|12325806|FG001|Overall Study|Withdrawal Criteria|1
7845007|NCT01451164|12325807|FG002|Overall Study|Withdrawal Criteria|1
7845008|NCT01451164|12325808|FG003|Overall Study|Withdrawal Criteria|1
7845009|NCT01451164|12325805|FG000|Overall Study|Physician Decision|2
7845010|NCT01451164|12325806|FG001|Overall Study|Physician Decision|0
7845011|NCT01451164|12325807|FG002|Overall Study|Physician Decision|1
7845012|NCT01451164|12325808|FG003|Overall Study|Physician Decision|0
7845013|NCT01451164|12325805|FG000|Overall Study|Withdrawal by Subject|14
7845014|NCT01451164|12325806|FG001|Overall Study|Withdrawal by Subject|11
7845015|NCT01451164|12325807|FG002|Overall Study|Withdrawal by Subject|16
7845016|NCT01451164|12325808|FG003|Overall Study|Withdrawal by Subject|17
7845017|NCT01451164|12325805|FG000|Overall Study|Protocol Violation|0
7845018|NCT01451164|12325806|FG001|Overall Study|Protocol Violation|1
7845019|NCT01451164|12325807|FG002|Overall Study|Protocol Violation|0
7845020|NCT01451164|12325808|FG003|Overall Study|Protocol Violation|0
7845021|NCT01451164|12325805|FG000|Overall Study|Lack of Efficacy|7
7845022|NCT01451164|12325806|FG001|Overall Study|Lack of Efficacy|9
7845023|NCT01451164|12325807|FG002|Overall Study|Lack of Efficacy|9
7845024|NCT01451164|12325808|FG003|Overall Study|Lack of Efficacy|7
7845025|NCT01451203|12325820|FG000|Double-blind Treatment Period|Did not receive treatment|1
7845026|NCT01451203|12325821|FG001|Double-blind Treatment Period|Did not receive treatment|2
7845027|NCT01451203|12325820|FG000|Double-blind Treatment Period|Consent Withdrawn|3
7845028|NCT01451203|12325821|FG001|Double-blind Treatment Period|Consent Withdrawn|2
7845029|NCT01451203|12325820|FG000|Double-blind Treatment Period|Lack of Efficacy|71
7845030|NCT01451203|12325821|FG001|Double-blind Treatment Period|Lack of Efficacy|36
7845031|NCT01451203|12325820|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
7845032|NCT01451203|12325821|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
7845033|NCT01451203|12325820|FG000|Double-blind Treatment Period|Adverse Event|6
7845034|NCT01451203|12325821|FG001|Double-blind Treatment Period|Adverse Event|9
7845035|NCT01451203|12325820|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1
7845036|NCT01451203|12325821|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0
7845037|NCT01451203|12325820|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1
7845038|NCT01451203|12325821|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0
7845039|NCT01451203|12325820|FG000|Double-blind Treatment Period|Investigator decision|2
7845040|NCT01451203|12325821|FG001|Double-blind Treatment Period|Investigator decision|0
7845041|NCT01451203|12325820|FG000|Post-treatment Period|Consent withdrawn|2
7845042|NCT01451203|12325821|FG001|Post-treatment Period|Consent withdrawn|4
7845043|NCT01451203|12325820|FG000|Post-treatment Period|Lack of Efficacy|12
7845044|NCT01451203|12325821|FG001|Post-treatment Period|Lack of Efficacy|28
7845045|NCT01451203|12325820|FG000|Post-treatment Period|Adverse Event|0
7845046|NCT01451203|12325821|FG001|Post-treatment Period|Adverse Event|1
7845047|NCT01451203|12325820|FG000|Post-treatment Period|Investigator decision|0
7845048|NCT01451203|12325821|FG001|Post-treatment Period|Investigator decision|1
7845049|NCT01451398|12325837|FG000|Overall Study|Adverse Event|7
7845050|NCT01451398|12325838|FG001|Overall Study|Adverse Event|9
7845051|NCT01451398|12325837|FG000|Overall Study|Protocol Violation|1
7845052|NCT01451398|12325838|FG001|Overall Study|Protocol Violation|2
7845053|NCT01451398|12325837|FG000|Overall Study|Physician Decision|1
7845054|NCT01451398|12325838|FG001|Overall Study|Physician Decision|1
7845055|NCT01451398|12325837|FG000|Overall Study|Withdrawal by Subject|10
7845056|NCT01451398|12325838|FG001|Overall Study|Withdrawal by Subject|14
7845057|NCT01451398|12325837|FG000|Overall Study|Lost to Follow-up|6
7845058|NCT01451398|12325838|FG001|Overall Study|Lost to Follow-up|4
7845059|NCT01451398|12325837|FG000|Overall Study|Non-compliance with study drug|1
7845060|NCT01451398|12325838|FG001|Overall Study|Non-compliance with study drug|3
7845061|NCT01451398|12325837|FG000|Overall Study|Non-compliance with protocol|1
7845062|NCT01451398|12325838|FG001|Overall Study|Non-compliance with protocol|1
7845063|NCT01451398|12325837|FG000|Overall Study|Moved out of country|0
7845064|NCT01451398|12325838|FG001|Overall Study|Moved out of country|1
7845065|NCT01451398|12325837|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0
7845066|NCT01451398|12325838|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1
7845067|NCT01451398|12325837|FG000|Overall Study|Lack of Efficacy|0
7845068|NCT01451398|12325838|FG001|Overall Study|Lack of Efficacy|1
7845069|NCT01451424|12325857|FG000|Overall Study|Withdrawal by Subject|1
7845070|NCT01451424|12325858|FG001|Overall Study|Withdrawal by Subject|1
7845071|NCT01451424|12325859|FG002|Overall Study|Withdrawal by Subject|0
7845072|NCT01451424|12325860|FG003|Overall Study|Withdrawal by Subject|2
7845073|NCT01451424|12325857|FG000|Overall Study|Lost to Follow-up|0
7845074|NCT01451424|12325858|FG001|Overall Study|Lost to Follow-up|1
7845075|NCT01451424|12325859|FG002|Overall Study|Lost to Follow-up|0
7845076|NCT01451424|12325860|FG003|Overall Study|Lost to Follow-up|1
7845077|NCT01451424|12325857|FG000|Overall Study|Physician Decision|0
7845078|NCT01451424|12325858|FG001|Overall Study|Physician Decision|0
7845079|NCT01451424|12325859|FG002|Overall Study|Physician Decision|1
7845080|NCT01451424|12325860|FG003|Overall Study|Physician Decision|1
7845081|NCT01451424|12325857|FG000|Overall Study|Adverse Event|0
7845082|NCT01451424|12325858|FG001|Overall Study|Adverse Event|0
7845083|NCT01451424|12325859|FG002|Overall Study|Adverse Event|0
7845084|NCT01451424|12325860|FG003|Overall Study|Adverse Event|1
7845085|NCT01451437|12325884|FG000|Overall Study|Adverse Event|0
7845086|NCT01451437|12325885|FG001|Overall Study|Adverse Event|0
7845087|NCT01451437|12325886|FG002|Overall Study|Adverse Event|0
7845088|NCT01451437|12325887|FG003|Overall Study|Adverse Event|0
7845089|NCT01451437|12325888|FG004|Overall Study|Adverse Event|0
7845090|NCT01451437|12325889|FG005|Overall Study|Adverse Event|1
7845091|NCT01451437|12325890|FG006|Overall Study|Adverse Event|1
7845092|NCT01451437|12325891|FG007|Overall Study|Adverse Event|2
7845093|NCT01451437|12325892|FG008|Overall Study|Adverse Event|1
7845094|NCT01451437|12325884|FG000|Overall Study|Physician Decision|1
7845095|NCT01451437|12325885|FG001|Overall Study|Physician Decision|1
7845096|NCT01451437|12325886|FG002|Overall Study|Physician Decision|2
7845097|NCT01451437|12325887|FG003|Overall Study|Physician Decision|0
7845098|NCT01451437|12325888|FG004|Overall Study|Physician Decision|0
7845099|NCT01451437|12325889|FG005|Overall Study|Physician Decision|0
7845100|NCT01451437|12325890|FG006|Overall Study|Physician Decision|0
7845101|NCT01451437|12325891|FG007|Overall Study|Physician Decision|0
7845102|NCT01451437|12325892|FG008|Overall Study|Physician Decision|0
7845103|NCT01451437|12325884|FG000|Overall Study|Disease Progression|0
7845104|NCT01451437|12325885|FG001|Overall Study|Disease Progression|0
7845105|NCT01451437|12325886|FG002|Overall Study|Disease Progression|1
7845106|NCT01451437|12325887|FG003|Overall Study|Disease Progression|1
7845107|NCT01451437|12325888|FG004|Overall Study|Disease Progression|3
7845108|NCT01451437|12325889|FG005|Overall Study|Disease Progression|2
7845109|NCT01451437|12325890|FG006|Overall Study|Disease Progression|3
7845110|NCT01451437|12325891|FG007|Overall Study|Disease Progression|1
7845111|NCT01451437|12325892|FG008|Overall Study|Disease Progression|3
7845112|NCT01451437|12325884|FG000|Overall Study|Protocol Violation|0
7845113|NCT01451437|12325885|FG001|Overall Study|Protocol Violation|0
7845114|NCT01451437|12325886|FG002|Overall Study|Protocol Violation|0
7845115|NCT01451437|12325887|FG003|Overall Study|Protocol Violation|0
7845116|NCT01451437|12325888|FG004|Overall Study|Protocol Violation|0
7845117|NCT01451437|12325889|FG005|Overall Study|Protocol Violation|0
7845118|NCT01451437|12325890|FG006|Overall Study|Protocol Violation|1
7845119|NCT01451437|12325891|FG007|Overall Study|Protocol Violation|0
7845120|NCT01451437|12325892|FG008|Overall Study|Protocol Violation|0
7845121|NCT01451437|12325884|FG000|Overall Study|Withdrawal by Subject|0
7845122|NCT01451437|12325885|FG001|Overall Study|Withdrawal by Subject|0
7845123|NCT01451437|12325886|FG002|Overall Study|Withdrawal by Subject|0
7845124|NCT01451437|12325887|FG003|Overall Study|Withdrawal by Subject|0
7845125|NCT01451437|12325888|FG004|Overall Study|Withdrawal by Subject|1
7845126|NCT01451437|12325889|FG005|Overall Study|Withdrawal by Subject|0
7845127|NCT01451437|12325890|FG006|Overall Study|Withdrawal by Subject|1
7845128|NCT01451437|12325891|FG007|Overall Study|Withdrawal by Subject|0
7845129|NCT01451437|12325892|FG008|Overall Study|Withdrawal by Subject|0
7845130|NCT01451541|12325933|FG000|Overall Study|Adverse Event|4
7845131|NCT01451541|12325934|FG001|Overall Study|Adverse Event|3
7845132|NCT01451541|12325935|FG002|Overall Study|Adverse Event|6
7845133|NCT01451541|12325933|FG000|Overall Study|Lack of Efficacy|2
7845134|NCT01451541|12325934|FG001|Overall Study|Lack of Efficacy|0
7845135|NCT01451541|12325935|FG002|Overall Study|Lack of Efficacy|0
7845136|NCT01451541|12325933|FG000|Overall Study|Lost to Follow-up|4
7845137|NCT01451541|12325934|FG001|Overall Study|Lost to Follow-up|4
7845138|NCT01451541|12325935|FG002|Overall Study|Lost to Follow-up|7
7845139|NCT01451541|12325933|FG000|Overall Study|Withdrawal by Subject|15
7845140|NCT01451541|12325934|FG001|Overall Study|Withdrawal by Subject|8
7845141|NCT01451541|12325935|FG002|Overall Study|Withdrawal by Subject|6
7845142|NCT01451541|12325933|FG000|Overall Study|randomization error, noncompliance|11
7845143|NCT01451541|12325934|FG001|Overall Study|randomization error, noncompliance|10
7845144|NCT01451541|12325935|FG002|Overall Study|randomization error, noncompliance|8
7845145|NCT01451554|12325947|FG000|Overall Study|Withdrawal by Subject|14
7845146|NCT01451554|12325948|FG001|Overall Study|Withdrawal by Subject|9
7845147|NCT01451606|12325956|FG000|Overall Study|Withdrawal by Subject|4
7845148|NCT01451606|12325957|FG001|Overall Study|Withdrawal by Subject|3
7845149|NCT01451645|12326001|FG000|Overall Study|Protocol Violation|1
7845150|NCT01451645|12326002|FG001|Overall Study|Protocol Violation|0
7845151|NCT01451645|12326001|FG000|Overall Study|Adverse Event|0
7845152|NCT01451645|12326002|FG001|Overall Study|Adverse Event|3
7845153|NCT01451645|12326001|FG000|Overall Study|Withdrawal by Subject|4
7845154|NCT01451645|12326002|FG001|Overall Study|Withdrawal by Subject|2
7845155|NCT01451645|12326001|FG000|Overall Study|Lost to Follow-up|4
7845156|NCT01451645|12326002|FG001|Overall Study|Lost to Follow-up|3
7845157|NCT01451749|12326010|FG000|Overall Study|Protocol Violation|14
7845158|NCT01451749|12326011|FG001|Overall Study|Protocol Violation|7
7845159|NCT01451749|12326010|FG000|Overall Study|Lost to Follow-up|15
7845160|NCT01451749|12326011|FG001|Overall Study|Lost to Follow-up|5
7845161|NCT01451749|12326010|FG000|Overall Study|Meet the exclusion criteria,and|1
7845162|NCT01451749|12326011|FG001|Overall Study|Meet the exclusion criteria,and|1
7845163|NCT01451749|12326010|FG000|Overall Study|Adverse Event|2
7845164|NCT01451749|12326011|FG001|Overall Study|Adverse Event|0
7845165|NCT01451749|12326010|FG000|Overall Study|Withdrawal by Subject|0
7845166|NCT01451749|12326011|FG001|Overall Study|Withdrawal by Subject|1
7845167|NCT01451762|12326022|FG000|Overall Study|Lost to Follow-up|3
7845168|NCT01451762|12326023|FG001|Overall Study|Lost to Follow-up|6
7845169|NCT01451762|12326024|FG002|Overall Study|Lost to Follow-up|6
7845170|NCT01451814|12326047|FG000|Overall Study|Withdrawal by Subject|1
7845171|NCT01451814|12326048|FG001|Overall Study|Withdrawal by Subject|1
7845172|NCT01451814|12326047|FG000|Overall Study|Lost to Follow-up|5
7845173|NCT01451814|12326048|FG001|Overall Study|Lost to Follow-up|4
7845174|NCT01451827|12326058|FG000|Overall Study|Adverse Event|2
7845175|NCT01451827|12326059|FG001|Overall Study|Adverse Event|0
7845176|NCT01451827|12326060|FG002|Overall Study|Adverse Event|1
7845177|NCT01451827|12326061|FG003|Overall Study|Adverse Event|1
7845178|NCT01451827|12326058|FG000|Overall Study|Protocol deviation|1
7845179|NCT01451827|12326059|FG001|Overall Study|Protocol deviation|0
7845180|NCT01451827|12326060|FG002|Overall Study|Protocol deviation|0
7845181|NCT01451827|12326061|FG003|Overall Study|Protocol deviation|0
7845182|NCT01451827|12326058|FG000|Overall Study|Lost to Follow-up|0
7845183|NCT01451827|12326059|FG001|Overall Study|Lost to Follow-up|3
7845184|NCT01451827|12326060|FG002|Overall Study|Lost to Follow-up|0
7845185|NCT01451827|12326061|FG003|Overall Study|Lost to Follow-up|2
7845186|NCT01451827|12326058|FG000|Overall Study|Participant met withdrawal criteria|0
7845187|NCT01451827|12326059|FG001|Overall Study|Participant met withdrawal criteria|2
7845188|NCT01451827|12326060|FG002|Overall Study|Participant met withdrawal criteria|0
7845189|NCT01451827|12326061|FG003|Overall Study|Participant met withdrawal criteria|0
7845190|NCT01451827|12326058|FG000|Overall Study|Withdrawal by Subject|0
7845191|NCT01451827|12326059|FG001|Overall Study|Withdrawal by Subject|0
7845192|NCT01451827|12326060|FG002|Overall Study|Withdrawal by Subject|1
7845193|NCT01451827|12326061|FG003|Overall Study|Withdrawal by Subject|1
7845194|NCT01451931|12326074|FG000|Overall Study|Lost to Follow-up|17
7845195|NCT01451931|12326075|FG001|Overall Study|Lost to Follow-up|36
7845196|NCT01451931|12326076|FG002|Overall Study|Lost to Follow-up|21
7845197|NCT01451931|12326074|FG000|Overall Study|Withdrawal by Subject|16
7845198|NCT01451931|12326075|FG001|Overall Study|Withdrawal by Subject|22
7845199|NCT01451931|12326076|FG002|Overall Study|Withdrawal by Subject|22
7845200|NCT01452347|12326151|FG000|Overall Study|Adverse Event|2
7845201|NCT01452347|12326152|FG001|Overall Study|Adverse Event|1
7845202|NCT01452347|12326151|FG000|Overall Study|Non compliance protocol|2
7845203|NCT01452347|12326152|FG001|Overall Study|Non compliance protocol|0
7845204|NCT01452347|12326151|FG000|Overall Study|Lost to Follow-up|2
7845205|NCT01452347|12326152|FG001|Overall Study|Lost to Follow-up|0
7845206|NCT01452347|12326151|FG000|Overall Study|Withdrawal by Subject|3
7845207|NCT01452347|12326152|FG001|Overall Study|Withdrawal by Subject|3
7845208|NCT01452347|12326151|FG000|Overall Study|Not treated|6
7845209|NCT01452347|12326152|FG001|Overall Study|Not treated|3
7845210|NCT01452347|12326151|FG000|Overall Study|Other reason not defined above|2
7845211|NCT01452347|12326152|FG001|Overall Study|Other reason not defined above|0
7845212|NCT01452412|12326162|FG000|Overall Study|Withdrawal by Subject|15
7845213|NCT01452412|12326163|FG001|Overall Study|Withdrawal by Subject|11
7845214|NCT01452412|12326162|FG000|Overall Study|Adverse Event|4
7845215|NCT01452412|12326163|FG001|Overall Study|Adverse Event|3
7845216|NCT01452412|12326162|FG000|Overall Study|Lost to Follow-up|5
7845217|NCT01452412|12326163|FG001|Overall Study|Lost to Follow-up|3
7845218|NCT01452412|12326162|FG000|Overall Study|Death|1
7845219|NCT01452412|12326163|FG001|Overall Study|Death|0
7845220|NCT01452412|12326162|FG000|Overall Study|Initiated dialysis|1
7845221|NCT01452412|12326163|FG001|Overall Study|Initiated dialysis|0
7845222|NCT01452412|12326162|FG000|Overall Study|Other|2
7845223|NCT01452412|12326163|FG001|Overall Study|Other|0
7845224|NCT01452529|12326176|FG000|Run-in Period|Adverse Event|96
7845225|NCT01452529|12326177|FG001|Run-in Period|Adverse Event|0
7845226|NCT01452529|12326178|FG002|Run-in Period|Adverse Event|0
7845227|NCT01452529|12326176|FG000|Run-in Period|Withdrawal by Subject|49
7845228|NCT01452529|12326177|FG001|Run-in Period|Withdrawal by Subject|0
7845229|NCT01452529|12326178|FG002|Run-in Period|Withdrawal by Subject|0
7845230|NCT01452529|12326176|FG000|Run-in Period|Lost to Follow-up|19
7845231|NCT01452529|12326177|FG001|Run-in Period|Lost to Follow-up|0
7845232|NCT01452529|12326178|FG002|Run-in Period|Lost to Follow-up|0
7845233|NCT01452529|12326176|FG000|Run-in Period|Lack of Efficacy|46
7845234|NCT01452529|12326177|FG001|Run-in Period|Lack of Efficacy|0
7845235|NCT01452529|12326178|FG002|Run-in Period|Lack of Efficacy|0
7845236|NCT01452529|12326176|FG000|Run-in Period|Confirmed or suspected diversion|23
7845237|NCT01452529|12326177|FG001|Run-in Period|Confirmed or suspected diversion|0
7845238|NCT01452529|12326178|FG002|Run-in Period|Confirmed or suspected diversion|0
7845239|NCT01452529|12326176|FG000|Run-in Period|Administrative|21
7845240|NCT01452529|12326177|FG001|Run-in Period|Administrative|0
7845241|NCT01452529|12326178|FG002|Run-in Period|Administrative|0
7845242|NCT01452529|12326176|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59
7845243|NCT01452529|12326177|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0
7845244|NCT01452529|12326178|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0
7845245|NCT01452529|12326176|FG000|Double-blind (DB) Period|Adverse Event|0
7845246|NCT01452529|12326177|FG001|Double-blind (DB) Period|Adverse Event|18
7845247|NCT01452529|12326178|FG002|Double-blind (DB) Period|Adverse Event|11
7845248|NCT01452529|12326176|FG000|Double-blind (DB) Period|Withdrawal by Subject|0
7845249|NCT01452529|12326177|FG001|Double-blind (DB) Period|Withdrawal by Subject|15
7845250|NCT01452529|12326178|FG002|Double-blind (DB) Period|Withdrawal by Subject|14
7845251|NCT01452529|12326176|FG000|Double-blind (DB) Period|Lost to Follow-up|0
7845252|NCT01452529|12326177|FG001|Double-blind (DB) Period|Lost to Follow-up|5
7845253|NCT01452529|12326178|FG002|Double-blind (DB) Period|Lost to Follow-up|3
7845254|NCT01452529|12326176|FG000|Double-blind (DB) Period|Lack of Efficacy|0
7845255|NCT01452529|12326177|FG001|Double-blind (DB) Period|Lack of Efficacy|16
7845256|NCT01452529|12326178|FG002|Double-blind (DB) Period|Lack of Efficacy|44
7845257|NCT01452529|12326176|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0
7845258|NCT01452529|12326177|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2
7845259|NCT01452529|12326178|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3
7845260|NCT01452529|12326176|FG000|Double-blind (DB) Period|Administrative|0
7845261|NCT01452529|12326177|FG001|Double-blind (DB) Period|Administrative|11
7845262|NCT01452529|12326178|FG002|Double-blind (DB) Period|Administrative|7
7845263|NCT01452789|12326187|FG000|Overall Study|Withdrawal by Subject|3
7845264|NCT01452789|12326188|FG001|Overall Study|Withdrawal by Subject|2
7845265|NCT01453023|12326194|FG000|Treatment Period (TP) 1|Protocol Violation|1
7845266|NCT01453023|12326195|FG001|Treatment Period (TP) 1|Protocol Violation|0
7845267|NCT01453023|12326194|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
7845268|NCT01453023|12326195|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
7845269|NCT01453023|12326194|FG000|Treatment Period 2|Protocol Violation|0
7845270|NCT01453023|12326195|FG001|Treatment Period 2|Protocol Violation|1
7845271|NCT01453036|12326204|FG000|Overall Study|Lost to Follow-up|26
7845272|NCT01453036|12326205|FG001|Overall Study|Lost to Follow-up|115
7845273|NCT01453036|12326206|FG002|Overall Study|Lost to Follow-up|31
7845274|NCT01453049|12326216|FG000|Overall Study|Protocol Violation|2
7845275|NCT01453049|12326217|FG001|Overall Study|Protocol Violation|5
7845276|NCT01453049|12326216|FG000|Overall Study|Lost to Follow-up|2
7845277|NCT01453049|12326217|FG001|Overall Study|Lost to Follow-up|1
7845278|NCT01453049|12326216|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35
7845279|NCT01453049|12326217|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36
7845280|NCT01453049|12326216|FG000|Overall Study|Withdrawal by Subject|1
7845281|NCT01453049|12326217|FG001|Overall Study|Withdrawal by Subject|0
7845282|NCT01453049|12326216|FG000|Overall Study|Randomized in Error|1
7845283|NCT01453049|12326217|FG001|Overall Study|Randomized in Error|0
7863197|NCT01604343|12352498|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1
7863198|NCT01604343|12352499|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0
7863199|NCT01604343|12352500|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2
7863200|NCT01604343|12352496|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1
7863201|NCT01604343|12352497|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0
7720904|NCT00541970|12145422|FG001|Month 18|Adverse Event|1
7720905|NCT00541970|12145423|FG002|Month 18|Adverse Event|1
7720906|NCT00541970|12145424|FG003|Month 18|Adverse Event|1
7863202|NCT01604343|12352498|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1
7863203|NCT01604343|12352499|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0
7863204|NCT01604343|12352500|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0
7863205|NCT01604343|12352496|FG000|Prior to W52 Administration(Through W52)|Other|15
7863206|NCT01604343|12352497|FG001|Prior to W52 Administration(Through W52)|Other|0
7863207|NCT01604343|12352498|FG002|Prior to W52 Administration(Through W52)|Other|10
7863208|NCT01604343|12352499|FG003|Prior to W52 Administration(Through W52)|Other|0
7863209|NCT01604343|12352500|FG004|Prior to W52 Administration(Through W52)|Other|6
7863210|NCT01604343|12352496|FG000|Week 52 to Week 104|Lost to Follow-up|0
7863211|NCT01604343|12352497|FG001|Week 52 to Week 104|Lost to Follow-up|2
7863212|NCT01604343|12352498|FG002|Week 52 to Week 104|Lost to Follow-up|4
7863213|NCT01604343|12352499|FG003|Week 52 to Week 104|Lost to Follow-up|2
7863214|NCT01604343|12352500|FG004|Week 52 to Week 104|Lost to Follow-up|1
7863215|NCT01604343|12352496|FG000|Week 52 to Week 104|Withdrawal by Subject|0
7863216|NCT01604343|12352497|FG001|Week 52 to Week 104|Withdrawal by Subject|7
7863217|NCT01604343|12352498|FG002|Week 52 to Week 104|Withdrawal by Subject|12
7863218|NCT01604343|12352499|FG003|Week 52 to Week 104|Withdrawal by Subject|8
7863219|NCT01604343|12352500|FG004|Week 52 to Week 104|Withdrawal by Subject|4
7863220|NCT01604343|12352496|FG000|Week 52 to Week 104|Adverse Event|0
7863221|NCT01604343|12352497|FG001|Week 52 to Week 104|Adverse Event|12
7863222|NCT01604343|12352498|FG002|Week 52 to Week 104|Adverse Event|26
7863223|NCT01604343|12352499|FG003|Week 52 to Week 104|Adverse Event|21
7863224|NCT01604343|12352500|FG004|Week 52 to Week 104|Adverse Event|27
7863225|NCT01604343|12352496|FG000|Week 52 to Week 104|Death|0
7863226|NCT01604343|12352497|FG001|Week 52 to Week 104|Death|4
7863227|NCT01604343|12352498|FG002|Week 52 to Week 104|Death|2
7863228|NCT01604343|12352499|FG003|Week 52 to Week 104|Death|5
7863229|NCT01604343|12352500|FG004|Week 52 to Week 104|Death|0
7863230|NCT01604343|12352496|FG000|Week 52 to Week 104|Lack of Efficacy|0
7863231|NCT01604343|12352497|FG001|Week 52 to Week 104|Lack of Efficacy|6
7863232|NCT01604343|12352498|FG002|Week 52 to Week 104|Lack of Efficacy|11
7863233|NCT01604343|12352499|FG003|Week 52 to Week 104|Lack of Efficacy|2
7863234|NCT01604343|12352500|FG004|Week 52 to Week 104|Lack of Efficacy|3
7863235|NCT01604343|12352496|FG000|Week 52 to Week 104|Physician Decision|0
7863236|NCT01604343|12352497|FG001|Week 52 to Week 104|Physician Decision|1
7720907|NCT00541970|12145421|FG000|Month 18|Protocol Violation|14
7845284|NCT01453153|12326235|FG000|Overall Study|Physician Decision|0
7845285|NCT01453153|12326236|FG001|Overall Study|Physician Decision|0
7845286|NCT01453153|12326237|FG002|Overall Study|Physician Decision|1
7845287|NCT01453153|12326235|FG000|Overall Study|Progressive Disease|3
7845288|NCT01453153|12326236|FG001|Overall Study|Progressive Disease|2
7845289|NCT01453153|12326237|FG002|Overall Study|Progressive Disease|16
7845290|NCT01453153|12326235|FG000|Overall Study|Withdrawal by Subject|0
7845291|NCT01453153|12326236|FG001|Overall Study|Withdrawal by Subject|1
7845292|NCT01453153|12326237|FG002|Overall Study|Withdrawal by Subject|2
7845293|NCT01453153|12326235|FG000|Overall Study|Adverse Event|1
7845294|NCT01453153|12326236|FG001|Overall Study|Adverse Event|1
7845295|NCT01453153|12326237|FG002|Overall Study|Adverse Event|1
7845296|NCT01453205|12326265|FG000|Overall Study|Lost to Follow-up|3
7845297|NCT01453205|12326266|FG001|Overall Study|Lost to Follow-up|0
7845298|NCT01453205|12326267|FG002|Overall Study|Lost to Follow-up|1
7845299|NCT01453205|12326265|FG000|Overall Study|Withdrawal by Subject|8
7845300|NCT01453205|12326266|FG001|Overall Study|Withdrawal by Subject|3
7845301|NCT01453205|12326267|FG002|Overall Study|Withdrawal by Subject|0
7845302|NCT01453205|12326265|FG000|Overall Study|Death|24
7845303|NCT01453205|12326266|FG001|Overall Study|Death|22
7845304|NCT01453205|12326267|FG002|Overall Study|Death|18
7845305|NCT01453205|12326265|FG000|Overall Study|Other|45
7845306|NCT01453205|12326266|FG001|Overall Study|Other|27
7845307|NCT01453205|12326267|FG002|Overall Study|Other|35
7845308|NCT01453296|12326278|FG000|Treatment Period 1|Adverse Event|0
7845309|NCT01453296|12326279|FG001|Treatment Period 1|Adverse Event|1
7845310|NCT01453296|12326278|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
7845311|NCT01453296|12326279|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
7845312|NCT01453296|12326278|FG000|Treatment Period 2|Adverse Event|1
7845313|NCT01453296|12326279|FG001|Treatment Period 2|Adverse Event|0
7845314|NCT01453296|12326278|FG000|Treatment Period 2|Withdrawal by Subject|1
7845315|NCT01453296|12326279|FG001|Treatment Period 2|Withdrawal by Subject|0
7845316|NCT01453348|12326288|FG000|Overall Study|Death|0
7845317|NCT01453348|12326289|FG001|Overall Study|Death|0
7845318|NCT01453348|12326290|FG002|Overall Study|Death|1
7845319|NCT01453348|12326288|FG000|Overall Study|Withdrawal by Subject|0
7845320|NCT01453348|12326289|FG001|Overall Study|Withdrawal by Subject|1
7845321|NCT01453348|12326290|FG002|Overall Study|Withdrawal by Subject|0
7845322|NCT01453348|12326288|FG000|Overall Study|Protocol Violation|1
7845323|NCT01453348|12326289|FG001|Overall Study|Protocol Violation|0
7845324|NCT01453348|12326290|FG002|Overall Study|Protocol Violation|0
7845325|NCT01453361|12326301|FG000|Overall Study|Disease Progression|6
7845326|NCT01453361|12326301|FG000|Overall Study|Screen-Failures|10
7845327|NCT01453374|12326305|FG000|Overall Study|Adverse Event|7
7845328|NCT01453374|12326305|FG000|Overall Study|Lack of Efficacy|1
7845329|NCT01453374|12326305|FG000|Overall Study|Lost to Follow-up|3
7845330|NCT01453374|12326305|FG000|Overall Study|Withdrawal by Subject|5
7845331|NCT01453374|12326305|FG000|Overall Study|Incarcerated|2
7845332|NCT01453439|12326343|FG000|Treatment Phase|Withdrawal by Subject|13
7845333|NCT01453439|12326344|FG001|Treatment Phase|Withdrawal by Subject|10
7845334|NCT01453439|12326343|FG000|Treatment Phase|Suicidal Ideation|2
7845335|NCT01453439|12326344|FG001|Treatment Phase|Suicidal Ideation|0
7845336|NCT01453439|12326343|FG000|Treatment Phase|Need for higher level of care|1
7845337|NCT01453439|12326344|FG001|Treatment Phase|Need for higher level of care|1
7845338|NCT01453439|12326343|FG000|Treatment Phase|Therapist conflict of interest|1
7845339|NCT01453439|12326344|FG001|Treatment Phase|Therapist conflict of interest|0
7845340|NCT01453439|12326343|FG000|Follow-up|Withdrawal by Subject|0
7845341|NCT01453439|12326344|FG001|Follow-up|Withdrawal by Subject|1
7845342|NCT01453439|12326343|FG000|Follow-up|Lost to Follow-up|5
7845343|NCT01453439|12326344|FG001|Follow-up|Lost to Follow-up|10
7845344|NCT01453595|12326366|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2
7845345|NCT01453595|12326367|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1
7845346|NCT01453595|12326368|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2
7845347|NCT01453725|12326376|FG000|Overall Study|Adverse Event|3
7845348|NCT01453725|12326377|FG001|Overall Study|Adverse Event|3
7845349|NCT01453725|12326376|FG000|Overall Study|Lost to Follow-up|4
7845350|NCT01453725|12326377|FG001|Overall Study|Lost to Follow-up|0
7845351|NCT01453725|12326376|FG000|Overall Study|Non-compliance With Protocol|1
7845352|NCT01453725|12326377|FG001|Overall Study|Non-compliance With Protocol|2
7845353|NCT01453725|12326376|FG000|Overall Study|Protocol Violation|1
7845354|NCT01453725|12326377|FG001|Overall Study|Protocol Violation|0
7845355|NCT01453725|12326376|FG000|Overall Study|Withdrawal by Subject|2
7845356|NCT01453725|12326377|FG001|Overall Study|Withdrawal by Subject|3
7845357|NCT01453725|12326376|FG000|Overall Study|Pregnancy Wish|0
7845358|NCT01453725|12326377|FG001|Overall Study|Pregnancy Wish|2
7845359|NCT01453725|12326376|FG000|Overall Study|Pregnancy|1
7845360|NCT01453725|12326377|FG001|Overall Study|Pregnancy|0
7845361|NCT01453725|12326376|FG000|Overall Study|Physician Decision|1
7845362|NCT01453725|12326377|FG001|Overall Study|Physician Decision|1
7845363|NCT01453855|12326387|FG000|Overall Study|Adverse Event|3
7845364|NCT01453855|12326388|FG001|Overall Study|Adverse Event|4
7845365|NCT01453855|12326387|FG000|Overall Study|Lost to Follow-up|2
7845366|NCT01453855|12326388|FG001|Overall Study|Lost to Follow-up|1
7845367|NCT01453855|12326387|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3
7845368|NCT01453855|12326388|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3
7845369|NCT01453855|12326387|FG000|Overall Study|Noncompliance|1
7845370|NCT01453855|12326388|FG001|Overall Study|Noncompliance|0
7845371|NCT01453855|12326387|FG000|Overall Study|Inadequate Control of IOP|1
7845372|NCT01453855|12326388|FG001|Overall Study|Inadequate Control of IOP|5
7845373|NCT01453855|12326387|FG000|Overall Study|Other|0
7845374|NCT01453855|12326388|FG001|Overall Study|Other|1
7845375|NCT01453998|12326406|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1
7845376|NCT01453998|12326407|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0
7845377|NCT01453998|12326408|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0
7845378|NCT01454063|12326421|FG000|Randomized|Adverse Event|1
7845379|NCT01454063|12326422|FG001|Randomized|Adverse Event|1
7845380|NCT01454063|12326421|FG000|Randomized|Protocol Violation|0
7845381|NCT01454063|12326422|FG001|Randomized|Protocol Violation|1
7845382|NCT01454076|12326433|FG000|Overall Study|Other|2
7845383|NCT01454076|12326434|FG001|Overall Study|Other|0
7845384|NCT01454076|12326435|FG002|Overall Study|Other|0
7845385|NCT01454076|12326436|FG003|Overall Study|Other|1
7845386|NCT01454076|12326437|FG004|Overall Study|Other|2
7845387|NCT01454076|12326433|FG000|Overall Study|Withdrawal by Subject|3
7845388|NCT01454076|12326434|FG001|Overall Study|Withdrawal by Subject|4
7845389|NCT01454076|12326435|FG002|Overall Study|Withdrawal by Subject|2
7845390|NCT01454076|12326436|FG003|Overall Study|Withdrawal by Subject|1
7845391|NCT01454076|12326437|FG004|Overall Study|Withdrawal by Subject|2
7845392|NCT01454076|12326433|FG000|Overall Study|Adverse Event|8
7845393|NCT01454076|12326434|FG001|Overall Study|Adverse Event|2
7845394|NCT01454076|12326435|FG002|Overall Study|Adverse Event|7
7845395|NCT01454076|12326436|FG003|Overall Study|Adverse Event|0
7845396|NCT01454076|12326437|FG004|Overall Study|Adverse Event|2
7845397|NCT01454102|12326474|FG000|Overall Study|Continuing in the treatment period|0
7845398|NCT01454102|12326475|FG001|Overall Study|Continuing in the treatment period|0
7845399|NCT01454102|12326476|FG002|Overall Study|Continuing in the treatment period|0
7845400|NCT01454102|12326477|FG003|Overall Study|Continuing in the treatment period|0
7845401|NCT01454102|12326478|FG004|Overall Study|Continuing in the treatment period|3
7845402|NCT01454102|12326479|FG005|Overall Study|Continuing in the treatment period|3
7845403|NCT01454102|12326480|FG006|Overall Study|Continuing in the treatment period|2
7845404|NCT01454102|12326481|FG007|Overall Study|Continuing in the treatment period|0
7845405|NCT01454102|12326482|FG008|Overall Study|Continuing in the treatment period|1
7845406|NCT01454102|12326483|FG009|Overall Study|Continuing in the treatment period|0
7845407|NCT01454102|12326484|FG010|Overall Study|Continuing in the treatment period|0
7845408|NCT01454102|12326485|FG011|Overall Study|Continuing in the treatment period|4
7845409|NCT01454102|12326486|FG012|Overall Study|Continuing in the treatment period|7
7845410|NCT01454102|12326487|FG013|Overall Study|Continuing in the treatment period|4
7845411|NCT01454102|12326488|FG014|Overall Study|Continuing in the treatment period|3
7845412|NCT01454102|12326489|FG015|Overall Study|Continuing in the treatment period|1
7845413|NCT01454284|12326532|FG000|Overall Study|Adverse Event|20
7845414|NCT01454284|12326533|FG001|Overall Study|Adverse Event|7
7845415|NCT01454284|12326532|FG000|Overall Study|Death|0
7845416|NCT01454284|12326533|FG001|Overall Study|Death|3
7845417|NCT01454284|12326532|FG000|Overall Study|Lost to Follow-up|13
7845418|NCT01454284|12326533|FG001|Overall Study|Lost to Follow-up|8
7845419|NCT01454284|12326532|FG000|Overall Study|Protocol Violation|9
7845420|NCT01454284|12326533|FG001|Overall Study|Protocol Violation|6
7845421|NCT01454284|12326532|FG000|Overall Study|Withdrawal by Subject|58
7845422|NCT01454284|12326533|FG001|Overall Study|Withdrawal by Subject|36
7845423|NCT01454284|12326532|FG000|Overall Study|Physician Decision|16
7845424|NCT01454284|12326533|FG001|Overall Study|Physician Decision|11
7845425|NCT01454284|12326532|FG000|Overall Study|Sponsor Decision|0
7845426|NCT01454284|12326533|FG001|Overall Study|Sponsor Decision|2
7845427|NCT01454401|12326550|FG000|Overall Study|Death|1
7845428|NCT01454401|12326550|FG000|Overall Study|hospitalised|1
7845429|NCT01454401|12326550|FG000|Overall Study|osteomyelitis|2
7845430|NCT01454401|12326550|FG000|Overall Study|non-adherence|1
7845431|NCT01454531|12326579|FG000|Overall Study|Adverse Event|14
7845432|NCT01454531|12326579|FG000|Overall Study|Withdrawal by Subject|5
7845433|NCT01454531|12326579|FG000|Overall Study|Lost to Follow-up|1
7845434|NCT01454531|12326579|FG000|Overall Study|Physician Decision|1
7845435|NCT01454531|12326579|FG000|Overall Study|Delay in IMP administration|1
7845436|NCT01454531|12326579|FG000|Overall Study|Other|1
7845437|NCT01454570|12326583|FG000|Overall Study|Withdrawal by Subject|2
7845438|NCT01454570|12326583|FG000|Overall Study|Screen Failure|7
7845439|NCT01454583|12326590|FG000|1st Year|Lost to Follow-up|1057
7845440|NCT01454583|12326591|FG001|1st Year|Lost to Follow-up|318
7845441|NCT01454583|12326592|FG002|1st Year|Lost to Follow-up|180
7845442|NCT01454583|12326590|FG000|2nd Year|Lost to Follow-up|3965
7845443|NCT01454583|12326591|FG001|2nd Year|Lost to Follow-up|1049
7845444|NCT01454583|12326592|FG002|2nd Year|Lost to Follow-up|737
7845445|NCT01454583|12326590|FG000|3rd Year|Lost to Follow-up|1959
7845446|NCT01454583|12326591|FG001|3rd Year|Lost to Follow-up|512
7845447|NCT01454583|12326592|FG002|3rd Year|Lost to Follow-up|297
7845448|NCT01454596|12326612|FG000|Overall Study|Death|0
7845449|NCT01454596|12326613|FG001|Overall Study|Death|0
7845450|NCT01454596|12326614|FG002|Overall Study|Death|0
7845451|NCT01454596|12326615|FG003|Overall Study|Death|0
7845452|NCT01454596|12326616|FG004|Overall Study|Death|0
7845453|NCT01454596|12326617|FG005|Overall Study|Death|0
7845454|NCT01454596|12326618|FG006|Overall Study|Death|0
7845455|NCT01454596|12326619|FG007|Overall Study|Death|0
7845456|NCT01454596|12326620|FG008|Overall Study|Death|0
7845457|NCT01454596|12326621|FG009|Overall Study|Death|1
7845458|NCT01454596|12326622|FG010|Overall Study|Death|1
7845459|NCT01454596|12326623|FG011|Overall Study|Death|0
7845460|NCT01454726|12326651|FG000|Overall Study|Withdrawal by Subject|0
7845461|NCT01454726|12326652|FG001|Overall Study|Withdrawal by Subject|1
7845462|NCT01454739|12326660|FG000|Overall Study|Protocol Violation|2
7845463|NCT01454739|12326661|FG001|Overall Study|Protocol Violation|3
7845464|NCT01454739|12326660|FG000|Overall Study|Withdrawal by Subject|2
7845465|NCT01454739|12326661|FG001|Overall Study|Withdrawal by Subject|6
7845466|NCT01454739|12326660|FG000|Overall Study|Other|3
7845467|NCT01454739|12326661|FG001|Overall Study|Other|5
7845468|NCT01454739|12326660|FG000|Overall Study|Physician Decision|0
7845469|NCT01454739|12326661|FG001|Overall Study|Physician Decision|5
7845470|NCT01454739|12326660|FG000|Overall Study|Lost to Follow-up|0
7845471|NCT01454739|12326661|FG001|Overall Study|Lost to Follow-up|1
7845472|NCT01454739|12326660|FG000|Overall Study|Adverse Event|0
7845473|NCT01454739|12326661|FG001|Overall Study|Adverse Event|1
7845474|NCT01454778|12326674|FG000|Overall Study|Lost to Follow-up|2
7845475|NCT01454778|12326674|FG000|Overall Study|Death|1
7845476|NCT01454830|12326691|FG000|Overall Study|Withdrawal by Subject|4
7845477|NCT01454830|12326692|FG001|Overall Study|Withdrawal by Subject|4
7845478|NCT01454830|12326691|FG000|Overall Study|Post-allocation Exclude- AHI<10|18
7845479|NCT01454830|12326692|FG001|Overall Study|Post-allocation Exclude- AHI<10|12
7845480|NCT01454830|12326691|FG000|Overall Study|Post-allocation Exclude-refused PAP|0
7845481|NCT01454830|12326692|FG001|Overall Study|Post-allocation Exclude-refused PAP|2
7845482|NCT01454830|12326691|FG000|Overall Study|Post-allocation Exclude-other treatment|6
7845483|NCT01454830|12326692|FG001|Overall Study|Post-allocation Exclude-other treatment|7
7845484|NCT01454830|12326691|FG000|Overall Study|Withdrawal - no polysomnography|3
7845485|NCT01454830|12326692|FG001|Overall Study|Withdrawal - no polysomnography|2
7845486|NCT01454934|12326700|FG000|Overall Study|Clinical progression|28
7845487|NCT01454934|12326701|FG001|Overall Study|Clinical progression|25
7845488|NCT01454934|12326700|FG000|Overall Study|Other|6
7845489|NCT01454934|12326701|FG001|Overall Study|Other|17
7845490|NCT01454934|12326700|FG000|Overall Study|Adverse Event|28
7845491|NCT01454934|12326701|FG001|Overall Study|Adverse Event|24
7845492|NCT01454934|12326700|FG000|Overall Study|Withdrawn consent|2
7845493|NCT01454934|12326701|FG001|Overall Study|Withdrawn consent|5
7845494|NCT01454934|12326700|FG000|Overall Study|Withdrawal by Subject|11
7845495|NCT01454934|12326701|FG001|Overall Study|Withdrawal by Subject|15
7845496|NCT01454934|12326700|FG000|Overall Study|Disease progression|194
7845497|NCT01454934|12326701|FG001|Overall Study|Disease progression|181
7845498|NCT01454934|12326700|FG000|Overall Study|Lost to Follow-up|0
7845499|NCT01454934|12326701|FG001|Overall Study|Lost to Follow-up|1
7845500|NCT01454934|12326700|FG000|Overall Study|Not treated|1
7845501|NCT01454934|12326701|FG001|Overall Study|Not treated|2
7845502|NCT01455012|12326742|FG000|Overall Study|Adverse Event|0
7845503|NCT01455012|12326743|FG001|Overall Study|Adverse Event|2
7845504|NCT01455012|12326742|FG000|Overall Study|Lack of Efficacy|6
7845505|NCT01455012|12326743|FG001|Overall Study|Lack of Efficacy|1
7845506|NCT01455012|12326742|FG000|Overall Study|Withdrawal by Subject|3
7845507|NCT01455012|12326743|FG001|Overall Study|Withdrawal by Subject|1
7845508|NCT01455012|12326742|FG000|Overall Study|Unknown reason|2
7845509|NCT01455012|12326743|FG001|Overall Study|Unknown reason|0
7845510|NCT01455194|12326760|FG000|Overall Study|Screen Failure|20
7845511|NCT01455194|12326761|FG001|Overall Study|Screen Failure|0
7845512|NCT01455194|12326762|FG002|Overall Study|Screen Failure|0
7845513|NCT01455194|12326763|FG003|Overall Study|Screen Failure|0
7845514|NCT01455194|12326760|FG000|Overall Study|Randomisation Failure|90
7845515|NCT01455194|12326761|FG001|Overall Study|Randomisation Failure|0
7845516|NCT01455194|12326762|FG002|Overall Study|Randomisation Failure|0
7845517|NCT01455194|12326763|FG003|Overall Study|Randomisation Failure|0
7845518|NCT01455194|12326760|FG000|Overall Study|Deterioration in asthma|12
7845519|NCT01455194|12326761|FG001|Overall Study|Deterioration in asthma|6
7845520|NCT01455194|12326762|FG002|Overall Study|Deterioration in asthma|14
7845521|NCT01455194|12326763|FG003|Overall Study|Deterioration in asthma|9
7845522|NCT01455194|12326760|FG000|Overall Study|Adverse Event|1
7845523|NCT01455194|12326761|FG001|Overall Study|Adverse Event|1
7845524|NCT01455194|12326762|FG002|Overall Study|Adverse Event|1
7845525|NCT01455194|12326763|FG003|Overall Study|Adverse Event|3
7845526|NCT01455194|12326760|FG000|Overall Study|Withdrawal by Subject|21
7845527|NCT01455194|12326761|FG001|Overall Study|Withdrawal by Subject|16
7845528|NCT01455194|12326762|FG002|Overall Study|Withdrawal by Subject|12
7845529|NCT01455194|12326763|FG003|Overall Study|Withdrawal by Subject|9
7845530|NCT01455194|12326760|FG000|Overall Study|Lost to Follow-up|2
7845531|NCT01455194|12326761|FG001|Overall Study|Lost to Follow-up|0
7845532|NCT01455194|12326762|FG002|Overall Study|Lost to Follow-up|1
7845533|NCT01455194|12326763|FG003|Overall Study|Lost to Follow-up|1
7845534|NCT01455194|12326760|FG000|Overall Study|Pregnancy|0
7845535|NCT01455194|12326761|FG001|Overall Study|Pregnancy|1
7845536|NCT01455194|12326762|FG002|Overall Study|Pregnancy|1
7845537|NCT01455194|12326763|FG003|Overall Study|Pregnancy|0
7845538|NCT01455194|12326760|FG000|Overall Study|Discontinuation criterion fulfilled|3
7845539|NCT01455194|12326761|FG001|Overall Study|Discontinuation criterion fulfilled|2
7845540|NCT01455194|12326762|FG002|Overall Study|Discontinuation criterion fulfilled|0
7845541|NCT01455194|12326763|FG003|Overall Study|Discontinuation criterion fulfilled|2
7845542|NCT01455194|12326760|FG000|Overall Study|Miscellaneous|4
7845543|NCT01455194|12326761|FG001|Overall Study|Miscellaneous|5
7845544|NCT01455194|12326762|FG002|Overall Study|Miscellaneous|1
7845545|NCT01455194|12326763|FG003|Overall Study|Miscellaneous|4
7845546|NCT01455220|12326776|FG000|Overall Study|screen fail|30
7845547|NCT01455415|12326785|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9
7845548|NCT01455415|12326786|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6
7845549|NCT01455415|12326785|FG000|Period 1|Lost To Follow-up Related to Study Drug|3
7845550|NCT01455415|12326786|FG001|Period 1|Lost To Follow-up Related to Study Drug|3
7845551|NCT01455415|12326785|FG000|Period 1|Drug Error not Associated to AE|0
7845552|NCT01455415|12326786|FG001|Period 1|Drug Error not Associated to AE|1
7845553|NCT01455415|12326785|FG000|Period 1|AE Not Related to Study Drug|2
7845554|NCT01455415|12326786|FG001|Period 1|AE Not Related to Study Drug|6
7845555|NCT01455415|12326785|FG000|Period 1|Withdrawal by Subject|4
7845556|NCT01455415|12326786|FG001|Period 1|Withdrawal by Subject|5
7845557|NCT01455415|12326785|FG000|Period 1|Unspecified Reason|1
7845558|NCT01455415|12326786|FG001|Period 1|Unspecified Reason|1
7845559|NCT01455415|12326785|FG000|Period 1|Protocol Violation|0
7845560|NCT01455415|12326786|FG001|Period 1|Protocol Violation|2
7845561|NCT01455415|12326785|FG000|Washout|AE Related to Study Drug|2
7845562|NCT01455415|12326786|FG001|Washout|AE Related to Study Drug|0
7845563|NCT01455415|12326785|FG000|Washout|Lost to Follow-up|1
7845564|NCT01455415|12326786|FG001|Washout|Lost to Follow-up|0
7845565|NCT01455415|12326785|FG000|Washout|Drug Error not Associated to AE|2
7845566|NCT01455415|12326786|FG001|Washout|Drug Error not Associated to AE|1
7845567|NCT01455415|12326785|FG000|Washout|AE Not Related to Study Drug|2
7845568|NCT01455415|12326786|FG001|Washout|AE Not Related to Study Drug|3
7845569|NCT01455415|12326785|FG000|Washout|Unspecified Reason|1
7845570|NCT01455415|12326786|FG001|Washout|Unspecified Reason|2
7845571|NCT01455415|12326785|FG000|Washout|Protocol Violation|0
7845572|NCT01455415|12326786|FG001|Washout|Protocol Violation|1
7845573|NCT01455415|12326785|FG000|Period 2|AE Related to Study Drug|1
7845574|NCT01455415|12326786|FG001|Period 2|AE Related to Study Drug|2
7845575|NCT01455415|12326785|FG000|Period 2|Lost to Follow-up|2
7845576|NCT01455415|12326786|FG001|Period 2|Lost to Follow-up|1
7845577|NCT01455415|12326785|FG000|Period 2|AE Not Related to Study Drug|2
7845578|NCT01455415|12326786|FG001|Period 2|AE Not Related to Study Drug|1
7845579|NCT01455415|12326785|FG000|Period 2|Lack of Efficacy|2
7845580|NCT01455415|12326786|FG001|Period 2|Lack of Efficacy|0
7845581|NCT01455415|12326785|FG000|Period 2|Withdrawal by Subject|2
7845582|NCT01455415|12326786|FG001|Period 2|Withdrawal by Subject|3
7845583|NCT01455415|12326785|FG000|Period 2|Unspecified Reason|2
7845584|NCT01455415|12326786|FG001|Period 2|Unspecified Reason|3
7845585|NCT01455415|12326785|FG000|Period 2|Protocol Violation|2
7845586|NCT01455415|12326786|FG001|Period 2|Protocol Violation|0
7845587|NCT01455415|12326785|FG000|Follow-up|AE Related to Study Drug|0
7845588|NCT01455415|12326786|FG001|Follow-up|AE Related to Study Drug|1
7845589|NCT01455415|12326785|FG000|Follow-up|Lack of Efficacy|0
7845590|NCT01455415|12326786|FG001|Follow-up|Lack of Efficacy|1
7845591|NCT01455415|12326785|FG000|Follow-up|Withdrawal by Subject|2
7845592|NCT01455415|12326786|FG001|Follow-up|Withdrawal by Subject|0
7845593|NCT01455415|12326785|FG000|Follow-up|Unspecified Reason|1
7845594|NCT01455415|12326786|FG001|Follow-up|Unspecified Reason|0
7845595|NCT01455428|12326794|FG000|Overall Study|Protocol Violation|2
7845596|NCT01455428|12326795|FG001|Overall Study|Protocol Violation|1
7845597|NCT01455428|12326794|FG000|Overall Study|Adverse Event|6
7845598|NCT01455428|12326795|FG001|Overall Study|Adverse Event|2
7845599|NCT01455428|12326794|FG000|Overall Study|Lost to Follow-up|1
7845600|NCT01455428|12326795|FG001|Overall Study|Lost to Follow-up|1
7845601|NCT01455428|12326794|FG000|Overall Study|Withdrawal by Subject|2
7845602|NCT01455428|12326795|FG001|Overall Study|Withdrawal by Subject|5
7845603|NCT01455428|12326794|FG000|Overall Study|Did not meet entrance criteria|0
7845604|NCT01455428|12326795|FG001|Overall Study|Did not meet entrance criteria|2
7845605|NCT01455428|12326794|FG000|Overall Study|Insufficient clinical response|0
7845606|NCT01455428|12326795|FG001|Overall Study|Insufficient clinical response|2
7845607|NCT01455428|12326794|FG000|Overall Study|Did not receive treatment|1
7845608|NCT01455428|12326795|FG001|Overall Study|Did not receive treatment|1
7845609|NCT01455428|12326794|FG000|Overall Study|Other|2
7845610|NCT01455428|12326795|FG001|Overall Study|Other|4
7845611|NCT01456039|12326838|FG000|Phase 1 (First Step)|Disease Progression|1
7845612|NCT01456039|12326839|FG001|Phase 1 (First Step)|Disease Progression|1
7845613|NCT01456039|12326840|FG002|Phase 1 (First Step)|Disease Progression|0
7845614|NCT01456039|12326838|FG000|Phase 1 (First Step)|Withdrawal by Subject|1
7845615|NCT01456039|12326839|FG001|Phase 1 (First Step)|Withdrawal by Subject|2
7845616|NCT01456039|12326840|FG002|Phase 1 (First Step)|Withdrawal by Subject|0
7845617|NCT01456039|12326838|FG000|Phase 1 (First Step)|Adverse Event|0
7845618|NCT01456039|12326839|FG001|Phase 1 (First Step)|Adverse Event|3
7845619|NCT01456039|12326840|FG002|Phase 1 (First Step)|Adverse Event|0
7845620|NCT01456039|12326838|FG000|Phase 1 (First Step)|Other|0
7845621|NCT01456039|12326839|FG001|Phase 1 (First Step)|Other|1
7845622|NCT01456039|12326840|FG002|Phase 1 (First Step)|Other|0
7845623|NCT01456039|12326838|FG000|Phase 2 (Second Step)|Disease Progression|0
7845624|NCT01456039|12326839|FG001|Phase 2 (Second Step)|Disease Progression|0
7845625|NCT01456039|12326840|FG002|Phase 2 (Second Step)|Disease Progression|17
7845626|NCT01456039|12326838|FG000|Phase 2 (Second Step)|Adverse Event|0
7845627|NCT01456039|12326839|FG001|Phase 2 (Second Step)|Adverse Event|0
7845628|NCT01456039|12326840|FG002|Phase 2 (Second Step)|Adverse Event|10
7845629|NCT01456039|12326838|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0
7845630|NCT01456039|12326839|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0
7845631|NCT01456039|12326840|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4
7845632|NCT01456039|12326838|FG000|Phase 2 (Second Step)|Protocol Violation|0
7845633|NCT01456039|12326839|FG001|Phase 2 (Second Step)|Protocol Violation|0
7845634|NCT01456039|12326840|FG002|Phase 2 (Second Step)|Protocol Violation|1
7845635|NCT01456039|12326838|FG000|Phase 2 (Second Step)|Other|0
7845636|NCT01456039|12326839|FG001|Phase 2 (Second Step)|Other|0
7845637|NCT01456039|12326840|FG002|Phase 2 (Second Step)|Other|1
7845638|NCT01456052|12326859|FG000|Overall Study|Adverse Event|1
7845639|NCT01456052|12326860|FG001|Overall Study|Adverse Event|1
7845640|NCT01456052|12326861|FG002|Overall Study|Adverse Event|2
7845641|NCT01456052|12326859|FG000|Overall Study|Consent withdrawn|0
7845642|NCT01456052|12326860|FG001|Overall Study|Consent withdrawn|2
7845643|NCT01456052|12326861|FG002|Overall Study|Consent withdrawn|1
7845644|NCT01456052|12326859|FG000|Overall Study|Protocol Violation|0
7845645|NCT01456052|12326860|FG001|Overall Study|Protocol Violation|1
7845646|NCT01456052|12326861|FG002|Overall Study|Protocol Violation|0
7845647|NCT01456052|12326859|FG000|Overall Study|Physician Decision|1
7845648|NCT01456052|12326860|FG001|Overall Study|Physician Decision|0
7845649|NCT01456052|12326861|FG002|Overall Study|Physician Decision|1
7845650|NCT01456052|12326859|FG000|Overall Study|Treatment Failure|0
7845651|NCT01456052|12326860|FG001|Overall Study|Treatment Failure|1
7845652|NCT01456052|12326861|FG002|Overall Study|Treatment Failure|1
7845653|NCT01456130|12326870|FG000|Overall Study|Adverse Event|4
7845654|NCT01456130|12326870|FG000|Overall Study|Voluntary Withdrawal|1
7845655|NCT01456130|12326870|FG000|Overall Study|Lack of Efficacy|4
7845656|NCT01456130|12326870|FG000|Overall Study|Other|1
7845657|NCT01456169|12326881|FG000|Overall Study|Adverse Event|1
7845658|NCT01456169|12326882|FG001|Overall Study|Adverse Event|2
7845659|NCT01456169|12326883|FG002|Overall Study|Adverse Event|7
7845660|NCT01456169|12326881|FG000|Overall Study|Major Protocol Deviation|3
7845661|NCT01456169|12326882|FG001|Overall Study|Major Protocol Deviation|2
7845662|NCT01456169|12326883|FG002|Overall Study|Major Protocol Deviation|3
7845663|NCT01456169|12326881|FG000|Overall Study|Voluntary Withdrawal|3
7845664|NCT01456169|12326882|FG001|Overall Study|Voluntary Withdrawal|0
7845665|NCT01456169|12326883|FG002|Overall Study|Voluntary Withdrawal|2
7845666|NCT01456169|12326881|FG000|Overall Study|Lack of Efficacy|2
7845667|NCT01456169|12326882|FG001|Overall Study|Lack of Efficacy|0
7845668|NCT01456169|12326883|FG002|Overall Study|Lack of Efficacy|0
7845669|NCT01456169|12326881|FG000|Overall Study|Other|1
7845670|NCT01456169|12326882|FG001|Overall Study|Other|1
7845671|NCT01456169|12326883|FG002|Overall Study|Other|0
7845672|NCT01456195|12326895|FG000|Overall Study|Pretreatment Event/Adverse Event|1
7845673|NCT01456195|12326896|FG001|Overall Study|Pretreatment Event/Adverse Event|4
7845674|NCT01456195|12326897|FG002|Overall Study|Pretreatment Event/Adverse Event|1
7845675|NCT01456195|12326895|FG000|Overall Study|Lost to Follow-up|3
7845676|NCT01456195|12326896|FG001|Overall Study|Lost to Follow-up|1
7845677|NCT01456195|12326897|FG002|Overall Study|Lost to Follow-up|3
7845678|NCT01456195|12326895|FG000|Overall Study|Voluntary Withdrawal|5
7845679|NCT01456195|12326896|FG001|Overall Study|Voluntary Withdrawal|3
7845680|NCT01456195|12326897|FG002|Overall Study|Voluntary Withdrawal|7
7949096|NCT02533674|12494577|FG007|Dose Level III|Progressive disease|0
7949097|NCT02533674|12494570|FG000|Dose Level III|Withdrawal by Subject|0
7949098|NCT02533674|12494571|FG001|Dose Level III|Withdrawal by Subject|0
7949099|NCT02533674|12494572|FG002|Dose Level III|Withdrawal by Subject|1
7949100|NCT02533674|12494573|FG003|Dose Level III|Withdrawal by Subject|0
7949101|NCT02533674|12494574|FG004|Dose Level III|Withdrawal by Subject|0
7949102|NCT02533674|12494575|FG005|Dose Level III|Withdrawal by Subject|0
7949103|NCT02533674|12494576|FG006|Dose Level III|Withdrawal by Subject|0
7949104|NCT02533674|12494577|FG007|Dose Level III|Withdrawal by Subject|0
7949105|NCT02533674|12494570|FG000|Dose Level III|Treatment-related AE|0
7949106|NCT02533674|12494571|FG001|Dose Level III|Treatment-related AE|0
7949107|NCT02533674|12494572|FG002|Dose Level III|Treatment-related AE|1
7949108|NCT02533674|12494573|FG003|Dose Level III|Treatment-related AE|0
7949109|NCT02533674|12494574|FG004|Dose Level III|Treatment-related AE|0
7949110|NCT02533674|12494575|FG005|Dose Level III|Treatment-related AE|0
7949111|NCT02533674|12494576|FG006|Dose Level III|Treatment-related AE|0
7949112|NCT02533674|12494577|FG007|Dose Level III|Treatment-related AE|0
7949113|NCT02533674|12494570|FG000|Dose Level IV|Progressive disease|0
7949114|NCT02533674|12494571|FG001|Dose Level IV|Progressive disease|0
7949115|NCT02533674|12494572|FG002|Dose Level IV|Progressive disease|0
7949116|NCT02533674|12494573|FG003|Dose Level IV|Progressive disease|3
7949117|NCT02533674|12494574|FG004|Dose Level IV|Progressive disease|0
7949118|NCT02533674|12494575|FG005|Dose Level IV|Progressive disease|0
7949119|NCT02533674|12494576|FG006|Dose Level IV|Progressive disease|0
7949120|NCT02533674|12494577|FG007|Dose Level IV|Progressive disease|0
7949121|NCT02533674|12494570|FG000|Dose Level IV|Withdrawal by Subject|0
7949122|NCT02533674|12494571|FG001|Dose Level IV|Withdrawal by Subject|0
7949123|NCT02533674|12494572|FG002|Dose Level IV|Withdrawal by Subject|0
7845681|NCT01456195|12326895|FG000|Overall Study|Lack of Efficacy|0
7845682|NCT01456195|12326896|FG001|Overall Study|Lack of Efficacy|1
7845683|NCT01456195|12326897|FG002|Overall Study|Lack of Efficacy|0
7845684|NCT01456195|12326895|FG000|Overall Study|Other Reasons|2
7845685|NCT01456195|12326896|FG001|Overall Study|Other Reasons|1
7845686|NCT01456195|12326897|FG002|Overall Study|Other Reasons|3
7845687|NCT01456221|12326907|FG000|Overall Study|Withdrawal by Subject|56
7845688|NCT01456221|12326908|FG001|Overall Study|Withdrawal by Subject|49
7845689|NCT01456221|12326907|FG000|Overall Study|Lost to Follow-up|1
7949124|NCT02533674|12494573|FG003|Dose Level IV|Withdrawal by Subject|1
7949125|NCT02533674|12494574|FG004|Dose Level IV|Withdrawal by Subject|0
7949126|NCT02533674|12494575|FG005|Dose Level IV|Withdrawal by Subject|0
7949127|NCT02533674|12494576|FG006|Dose Level IV|Withdrawal by Subject|0
7949128|NCT02533674|12494577|FG007|Dose Level IV|Withdrawal by Subject|0
7949129|NCT02533674|12494570|FG000|Dose Level IV|Physician Decision|0
7949130|NCT02533674|12494571|FG001|Dose Level IV|Physician Decision|0
7949131|NCT02533674|12494572|FG002|Dose Level IV|Physician Decision|0
7949132|NCT02533674|12494573|FG003|Dose Level IV|Physician Decision|1
7949133|NCT02533674|12494574|FG004|Dose Level IV|Physician Decision|0
7949134|NCT02533674|12494575|FG005|Dose Level IV|Physician Decision|0
7949135|NCT02533674|12494576|FG006|Dose Level IV|Physician Decision|0
7949136|NCT02533674|12494577|FG007|Dose Level IV|Physician Decision|0
7845690|NCT01456221|12326908|FG001|Overall Study|Lost to Follow-up|4
7845691|NCT01456221|12326907|FG000|Overall Study|Received medication|3
7845692|NCT01456221|12326908|FG001|Overall Study|Received medication|2
7845693|NCT01456221|12326907|FG000|Overall Study|Incomplete data|4
7845694|NCT01456221|12326908|FG001|Overall Study|Incomplete data|2
7845695|NCT01456780|12326939|FG000|Overall Study|Lost to Follow-up|3
7845696|NCT01456780|12326940|FG001|Overall Study|Lost to Follow-up|3
7845697|NCT01456780|12326941|FG002|Overall Study|Lost to Follow-up|0
7845698|NCT01456897|12326951|FG000|Overall Study|Adverse Event|19
7845699|NCT01456897|12326952|FG001|Overall Study|Adverse Event|22
7845700|NCT01456897|12326951|FG000|Overall Study|Protocol Violation|3
7845701|NCT01456897|12326952|FG001|Overall Study|Protocol Violation|4
7845702|NCT01456897|12326951|FG000|Overall Study|Physician Decision|5
7845703|NCT01456897|12326952|FG001|Overall Study|Physician Decision|3
7845704|NCT01456897|12326951|FG000|Overall Study|Withdrawal by Subject|44
7845705|NCT01456897|12326952|FG001|Overall Study|Withdrawal by Subject|17
7845706|NCT01456897|12326951|FG000|Overall Study|Lack of Efficacy|4
7845707|NCT01456897|12326952|FG001|Overall Study|Lack of Efficacy|11
7845708|NCT01456936|12326962|FG000|Overall Study|Other reason|41
7845709|NCT01456936|12326963|FG001|Overall Study|Other reason|30
7845710|NCT01456936|12326964|FG002|Overall Study|Other reason|36
7845711|NCT01456936|12326965|FG003|Overall Study|Other reason|33
7845712|NCT01456936|12326962|FG000|Overall Study|No longer meets eligibility criteria|4
7845713|NCT01456936|12326963|FG001|Overall Study|No longer meets eligibility criteria|8
7845714|NCT01456936|12326964|FG002|Overall Study|No longer meets eligibility criteria|6
7845715|NCT01456936|12326965|FG003|Overall Study|No longer meets eligibility criteria|5
7845716|NCT01456936|12326962|FG000|Overall Study|Protocol Violation|4
7845717|NCT01456936|12326963|FG001|Overall Study|Protocol Violation|2
7845718|NCT01456936|12326964|FG002|Overall Study|Protocol Violation|5
7845719|NCT01456936|12326965|FG003|Overall Study|Protocol Violation|5
7845720|NCT01456936|12326962|FG000|Overall Study|Pregnancy|1
7845721|NCT01456936|12326963|FG001|Overall Study|Pregnancy|0
7845722|NCT01456936|12326964|FG002|Overall Study|Pregnancy|0
7845723|NCT01456936|12326965|FG003|Overall Study|Pregnancy|1
7845724|NCT01456936|12326962|FG000|Overall Study|Insufficient clinical response|4
7845725|NCT01456936|12326963|FG001|Overall Study|Insufficient clinical response|4
7845726|NCT01456936|12326964|FG002|Overall Study|Insufficient clinical response|14
7845727|NCT01456936|12326965|FG003|Overall Study|Insufficient clinical response|13
7845728|NCT01456936|12326962|FG000|Overall Study|No longer willing to participate|195
7845729|NCT01456936|12326963|FG001|Overall Study|No longer willing to participate|218
7845730|NCT01456936|12326964|FG002|Overall Study|No longer willing to participate|224
7845731|NCT01456936|12326965|FG003|Overall Study|No longer willing to participate|248
7845732|NCT01456936|12326962|FG000|Overall Study|Lost to Follow-up|135
7845733|NCT01456936|12326963|FG001|Overall Study|Lost to Follow-up|126
7845734|NCT01456936|12326964|FG002|Overall Study|Lost to Follow-up|144
7845735|NCT01456936|12326965|FG003|Overall Study|Lost to Follow-up|127
7845736|NCT01456936|12326962|FG000|Overall Study|Medication error|0
7845737|NCT01456936|12326963|FG001|Overall Study|Medication error|1
7845738|NCT01456936|12326964|FG002|Overall Study|Medication error|0
7845739|NCT01456936|12326965|FG003|Overall Study|Medication error|1
7845740|NCT01456936|12326962|FG000|Overall Study|Adverse event (study drug)|25
7845741|NCT01456936|12326963|FG001|Overall Study|Adverse event (study drug)|21
7845742|NCT01456936|12326964|FG002|Overall Study|Adverse event (study drug)|26
7845743|NCT01456936|12326965|FG003|Overall Study|Adverse event (study drug)|17
7845744|NCT01456936|12326962|FG000|Overall Study|Adverse event (study drug unrelated)|9
7845745|NCT01456936|12326963|FG001|Overall Study|Adverse event (study drug unrelated)|7
7845746|NCT01456936|12326964|FG002|Overall Study|Adverse event (study drug unrelated)|9
7845747|NCT01456936|12326965|FG003|Overall Study|Adverse event (study drug unrelated)|9
7845748|NCT01456936|12326962|FG000|Overall Study|Death|0
7845749|NCT01456936|12326963|FG001|Overall Study|Death|3
7845750|NCT01456936|12326964|FG002|Overall Study|Death|1
7845751|NCT01456936|12326965|FG003|Overall Study|Death|3
7845752|NCT01456936|12326962|FG000|Overall Study|Randomized but not treated|21
7845753|NCT01456936|12326963|FG001|Overall Study|Randomized but not treated|28
7845754|NCT01456936|12326964|FG002|Overall Study|Randomized but not treated|16
7845755|NCT01456936|12326965|FG003|Overall Study|Randomized but not treated|21
7845756|NCT01456949|12326975|FG000|Enrollment|PI death- incomplete data|6
7845757|NCT01456949|12326975|FG000|Enrollment|Death|1
7845758|NCT01456949|12326975|FG000|Enrollment|I/E criteria not met prior to procedure|13
7845759|NCT01456949|12326975|FG000|Enrollment|Physician Decision|10
7845760|NCT01456949|12326975|FG000|Enrollment|Withdrawal by Subject|7
7845761|NCT01456949|12326975|FG000|Study Cryoablation Procedure & Follow-up|Death|5
7845762|NCT01456949|12326975|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23
7845763|NCT01456949|12326975|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11
7845764|NCT01456949|12326975|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1
7845765|NCT01456949|12326975|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10
7845766|NCT01456949|12326975|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2
7845767|NCT01456949|12326975|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6
7845768|NCT01456949|12326975|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4
7845769|NCT01456962|12326981|FG000|Overall Study|Lost to Follow-up|2
7845770|NCT01456962|12326982|FG001|Overall Study|Lost to Follow-up|1
7845771|NCT01457014|12326988|FG000|First Night|Didn't meet inclusion/exclusion criteria|37
7845772|NCT01457014|12326989|FG001|First Night|Didn't meet inclusion/exclusion criteria|0
7845773|NCT01457014|12326990|FG002|First Night|Didn't meet inclusion/exclusion criteria|0
7845774|NCT01457014|12326991|FG003|First Night|Didn't meet inclusion/exclusion criteria|0
7845775|NCT01457014|12326988|FG000|First Night|Withdrawal by Subject|3
7845776|NCT01457014|12326989|FG001|First Night|Withdrawal by Subject|0
7845777|NCT01457014|12326990|FG002|First Night|Withdrawal by Subject|0
7845778|NCT01457014|12326991|FG003|First Night|Withdrawal by Subject|0
7845779|NCT01457118|12327003|FG000|Overall Study|Adverse Event|1
7845780|NCT01457118|12327004|FG001|Overall Study|Adverse Event|0
7845781|NCT01457118|12327005|FG002|Overall Study|Adverse Event|0
7845782|NCT01457118|12327006|FG003|Overall Study|Adverse Event|1
7845783|NCT01457118|12327003|FG000|Overall Study|Clinical Progression|0
7845784|NCT01457118|12327004|FG001|Overall Study|Clinical Progression|1
7845785|NCT01457118|12327005|FG002|Overall Study|Clinical Progression|0
7845786|NCT01457118|12327006|FG003|Overall Study|Clinical Progression|1
7845787|NCT01457118|12327003|FG000|Overall Study|Physician Decision|2
7845788|NCT01457118|12327004|FG001|Overall Study|Physician Decision|0
7845789|NCT01457118|12327005|FG002|Overall Study|Physician Decision|0
7845790|NCT01457118|12327006|FG003|Overall Study|Physician Decision|0
7845791|NCT01457118|12327003|FG000|Overall Study|Progressive Disease by RECIST|12
7845792|NCT01457118|12327004|FG001|Overall Study|Progressive Disease by RECIST|3
7845793|NCT01457118|12327005|FG002|Overall Study|Progressive Disease by RECIST|1
7845794|NCT01457118|12327006|FG003|Overall Study|Progressive Disease by RECIST|0
7845795|NCT01457118|12327003|FG000|Overall Study|Withdrawal by Subject|5
7845796|NCT01457118|12327004|FG001|Overall Study|Withdrawal by Subject|0
7845797|NCT01457118|12327005|FG002|Overall Study|Withdrawal by Subject|0
7845798|NCT01457118|12327006|FG003|Overall Study|Withdrawal by Subject|0
7845799|NCT01457339|12327024|FG000|Period 3 (100 mg)|Adverse Event|0
7845800|NCT01457339|12327025|FG001|Period 3 (100 mg)|Adverse Event|1
7845801|NCT01457339|12327024|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
7845802|NCT01457339|12327025|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
7845803|NCT01457339|12327024|FG000|Period 6 (250 mg)|Family Emergency|1
7845804|NCT01457339|12327025|FG001|Period 6 (250 mg)|Family Emergency|0
7845805|NCT01457339|12327024|FG000|Period 6 (250 mg)|Personal appointment|0
7845806|NCT01457339|12327025|FG001|Period 6 (250 mg)|Personal appointment|1
7845807|NCT01457352|12327050|FG000|Period 1|Adverse Event|2
7845808|NCT01457352|12327051|FG001|Period 1|Adverse Event|0
7845809|NCT01457352|12327050|FG000|Period 1|Withdrawal by Subject|2
7845810|NCT01457352|12327051|FG001|Period 1|Withdrawal by Subject|0
7845811|NCT01457352|12327050|FG000|Period 1|Physician Decision|2
7845812|NCT01457352|12327051|FG001|Period 1|Physician Decision|0
7845813|NCT01457352|12327050|FG000|Period 1|MS related disease progression|1
7845814|NCT01457352|12327051|FG001|Period 1|MS related disease progression|0
7845815|NCT01457352|12327050|FG000|Period 1|Withdrawn|1
7845816|NCT01457352|12327051|FG001|Period 1|Withdrawn|0
7845817|NCT01457352|12327050|FG000|Period 1|withdrew per sponsor|1
7845818|NCT01457352|12327051|FG001|Period 1|withdrew per sponsor|0
7845819|NCT01457352|12327050|FG000|Period 1|Protocol Violation|4
7845820|NCT01457352|12327051|FG001|Period 1|Protocol Violation|0
7845821|NCT01457352|12327050|FG000|Period 1|Did not meet eligibility criteria|3
7845822|NCT01457352|12327051|FG001|Period 1|Did not meet eligibility criteria|0
7845823|NCT01457352|12327050|FG000|Period 2|Withdrawal by Subject|23
7845824|NCT01457352|12327051|FG001|Period 2|Withdrawal by Subject|0
7845825|NCT01457352|12327050|FG000|Period 2|Adverse Event|22
7845826|NCT01457352|12327051|FG001|Period 2|Adverse Event|0
7845827|NCT01457352|12327050|FG000|Period 2|no analysis|10
7845828|NCT01457352|12327051|FG001|Period 2|no analysis|0
7845829|NCT01457352|12327050|FG000|Period 2|Lack of Efficacy|8
7845830|NCT01457352|12327051|FG001|Period 2|Lack of Efficacy|0
7845831|NCT01457352|12327050|FG000|Period 2|Protocol Violation|4
7845832|NCT01457352|12327051|FG001|Period 2|Protocol Violation|0
7845833|NCT01457352|12327050|FG000|Period 2|Sponsor's withdrawal|7
7845834|NCT01457352|12327051|FG001|Period 2|Sponsor's withdrawal|0
7845835|NCT01457352|12327050|FG000|Period 2|Lost to Follow-up|1
7845836|NCT01457352|12327051|FG001|Period 2|Lost to Follow-up|0
7845837|NCT01457352|12327050|FG000|Period 2|dose change|1
7845838|NCT01457352|12327051|FG001|Period 2|dose change|0
7845839|NCT01457352|12327050|FG000|Period 2|Physician Decision|1
7845840|NCT01457352|12327051|FG001|Period 2|Physician Decision|0
7845841|NCT01457352|12327050|FG000|Period 2|Did not meet eligibility criteria|3
7845842|NCT01457352|12327051|FG001|Period 2|Did not meet eligibility criteria|0
7845843|NCT01457352|12327050|FG000|Period 3|Adverse Event|1
7845844|NCT01457352|12327051|FG001|Period 3|Adverse Event|1
7845845|NCT01457352|12327050|FG000|Period 3|Withdrawal by Subject|0
7845846|NCT01457352|12327051|FG001|Period 3|Withdrawal by Subject|2
7845847|NCT01457352|12327050|FG000|Period 3|incorrect treatment|0
7845848|NCT01457352|12327051|FG001|Period 3|incorrect treatment|1
7845849|NCT01457352|12327050|FG000|Period 3|Sponsor's withdrawal|0
7845850|NCT01457352|12327051|FG001|Period 3|Sponsor's withdrawal|1
7845851|NCT01457703|12327105|FG000|Overall Study|Screen Failure|5
7845852|NCT01457703|12327106|FG001|Overall Study|Screen Failure|7
7845853|NCT01457703|12327105|FG000|Overall Study|Withdrawal by Subject|1
7845854|NCT01457703|12327106|FG001|Overall Study|Withdrawal by Subject|4
7845855|NCT01457846|12327116|FG000|Overall Study|Death before treatment|1
7845856|NCT01457846|12327117|FG001|Overall Study|Death before treatment|2
7845857|NCT01457846|12327116|FG000|Overall Study|Did not receive treatment|0
7845858|NCT01457846|12327117|FG001|Overall Study|Did not receive treatment|1
7845859|NCT01457846|12327116|FG000|Overall Study|Death|27
7845860|NCT01457846|12327117|FG001|Overall Study|Death|16
7845861|NCT01457846|12327116|FG000|Overall Study|Unclassified reason for not completed|11
7845862|NCT01457846|12327117|FG001|Overall Study|Unclassified reason for not completed|10
7845863|NCT01457846|12327116|FG000|Overall Study|Withdrawal by Subject|1
7845864|NCT01457846|12327117|FG001|Overall Study|Withdrawal by Subject|1
7845865|NCT01457846|12327116|FG000|Overall Study|Lost to Follow-up|1
7845866|NCT01457846|12327117|FG001|Overall Study|Lost to Follow-up|0
7845867|NCT01457924|12327132|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0
7845868|NCT01457924|12327133|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4
7845869|NCT01457924|12327134|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1
7845870|NCT01457924|12327135|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0
7845871|NCT01457924|12327136|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2
7845872|NCT01457924|12327132|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0
7845873|NCT01457924|12327133|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0
7845874|NCT01457924|12327134|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0
7845875|NCT01457924|12327135|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0
7845876|NCT01457924|12327136|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1
7845877|NCT01457924|12327132|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
7845878|NCT01457924|12327133|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7845879|NCT01457924|12327134|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7845880|NCT01457924|12327135|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7845881|NCT01457924|12327136|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7845882|NCT01457924|12327132|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1
7845883|NCT01457924|12327133|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0
7845884|NCT01457924|12327134|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1
7845885|NCT01457924|12327135|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0
7845886|NCT01457924|12327136|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0
7845887|NCT01457924|12327132|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
7845888|NCT01457924|12327133|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
7845889|NCT01457924|12327134|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
7845890|NCT01457924|12327135|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
7845891|NCT01457924|12327136|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
7845892|NCT01457924|12327132|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
7845893|NCT01457924|12327133|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
7845894|NCT01457924|12327134|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
7845895|NCT01457924|12327135|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
7845896|NCT01457924|12327136|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
7845897|NCT01457924|12327132|FG000|FUP (Weeks 24-48)|Adverse Event|0
7845898|NCT01457924|12327133|FG001|FUP (Weeks 24-48)|Adverse Event|0
7845899|NCT01457924|12327134|FG002|FUP (Weeks 24-48)|Adverse Event|1
7845900|NCT01457924|12327135|FG003|FUP (Weeks 24-48)|Adverse Event|0
7845901|NCT01457924|12327136|FG004|FUP (Weeks 24-48)|Adverse Event|0
7845902|NCT01457924|12327132|FG000|FUP (Weeks 24-48)|Physician Decision|1
7845903|NCT01457924|12327133|FG001|FUP (Weeks 24-48)|Physician Decision|0
7845904|NCT01457924|12327134|FG002|FUP (Weeks 24-48)|Physician Decision|1
7845905|NCT01457924|12327135|FG003|FUP (Weeks 24-48)|Physician Decision|0
7845906|NCT01457924|12327136|FG004|FUP (Weeks 24-48)|Physician Decision|0
7845907|NCT01457924|12327132|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0
7845908|NCT01457924|12327133|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0
7845909|NCT01457924|12327134|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0
7845910|NCT01457924|12327135|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1
7845911|NCT01457924|12327136|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0
7845912|NCT01457924|12327132|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2
7845913|NCT01457924|12327133|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1
7845914|NCT01457924|12327134|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0
7845915|NCT01457924|12327135|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0
7845916|NCT01457924|12327136|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2
7845917|NCT01457924|12327132|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
7845918|NCT01457924|12327133|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
7845919|NCT01457924|12327134|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
7845920|NCT01457924|12327135|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
7845921|NCT01457924|12327136|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
7845922|NCT01457924|12327132|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
7845923|NCT01457924|12327133|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
7845924|NCT01457924|12327134|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
7845925|NCT01457924|12327135|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
7845926|NCT01457924|12327136|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
7845927|NCT01457924|12327132|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
7845928|NCT01457924|12327133|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
7845929|NCT01457924|12327134|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
7845930|NCT01457924|12327135|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
7845931|NCT01457924|12327136|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
7845932|NCT01457950|12327150|FG000|Double-Blind Phase|Continuation Criteria Not Met|1
7845933|NCT01457950|12327151|FG001|Double-Blind Phase|Continuation Criteria Not Met|0
7845934|NCT01457950|12327152|FG002|Double-Blind Phase|Continuation Criteria Not Met|0
7845935|NCT01457950|12327153|FG003|Double-Blind Phase|Continuation Criteria Not Met|0
7845936|NCT01457950|12327150|FG000|Double-Blind Phase|Protocol Violation|2
7845937|NCT01457950|12327151|FG001|Double-Blind Phase|Protocol Violation|1
7845938|NCT01457950|12327152|FG002|Double-Blind Phase|Protocol Violation|0
7845939|NCT01457950|12327153|FG003|Double-Blind Phase|Protocol Violation|0
7845940|NCT01457950|12327150|FG000|Double-Blind Phase|Withdrawal by Subject|6
7845941|NCT01457950|12327151|FG001|Double-Blind Phase|Withdrawal by Subject|2
7845942|NCT01457950|12327152|FG002|Double-Blind Phase|Withdrawal by Subject|0
7845943|NCT01457950|12327153|FG003|Double-Blind Phase|Withdrawal by Subject|0
7845944|NCT01457950|12327150|FG000|Open-Label Phase|Adverse Event|0
7845945|NCT01457950|12327151|FG001|Open-Label Phase|Adverse Event|0
7845946|NCT01457950|12327152|FG002|Open-Label Phase|Adverse Event|0
7845947|NCT01457950|12327153|FG003|Open-Label Phase|Adverse Event|1
7845948|NCT01457950|12327150|FG000|Open-Label Phase|Protocol Violation|0
7845949|NCT01457950|12327151|FG001|Open-Label Phase|Protocol Violation|0
7845950|NCT01457950|12327152|FG002|Open-Label Phase|Protocol Violation|0
7845951|NCT01457950|12327153|FG003|Open-Label Phase|Protocol Violation|1
7845952|NCT01457950|12327150|FG000|Open-Label Phase|Withdrawal by Subject|0
7845953|NCT01457950|12327151|FG001|Open-Label Phase|Withdrawal by Subject|0
7845954|NCT01457950|12327152|FG002|Open-Label Phase|Withdrawal by Subject|2
7845955|NCT01457950|12327153|FG003|Open-Label Phase|Withdrawal by Subject|0
7845956|NCT01458106|12327166|FG000|Overall Study|Withdrawal by Subject|2
7845957|NCT01458106|12327167|FG001|Overall Study|Withdrawal by Subject|0
7845958|NCT01458106|12327166|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1
7845959|NCT01458106|12327167|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0
7845960|NCT01458106|12327166|FG000|Overall Study|Withdrawn Per Protocol|0
7845961|NCT01458106|12327167|FG001|Overall Study|Withdrawn Per Protocol|1
7845962|NCT01458119|12327176|FG000|Overall Study|Physician Decision|4
7845963|NCT01458119|12327176|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1
7845964|NCT01458119|12327176|FG000|Overall Study|Pregnancy|1
7845965|NCT01458119|12327176|FG000|Overall Study|Death|2
7845966|NCT01458119|12327176|FG000|Overall Study|Adverse Event|1
7845967|NCT01458119|12327176|FG000|Overall Study|Consent Withdrawn by Participant|8
7845968|NCT01458119|12327176|FG000|Overall Study|Non-compliance With Study Drug|3
7845969|NCT01458132|12327183|FG000|Overall Study|Other|15
7845970|NCT01458132|12327184|FG001|Overall Study|Other|3
7845971|NCT01458171|12327190|FG000|Overall Study|Adverse Event|1
7845972|NCT01458210|12327196|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
7845973|NCT01458210|12327196|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
7845974|NCT01458210|12327196|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
7845975|NCT01458210|12327196|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
7845976|NCT01458249|12327205|FG000|Overall Study|Not treated|1
7845977|NCT01458249|12327205|FG000|Overall Study|Adverse Event|4
7845978|NCT01458249|12327205|FG000|Overall Study|Other|2
7845979|NCT01458249|12327205|FG000|Overall Study|Ongoing|1
7845980|NCT01458275|12327213|FG000|Overall Study|Adverse Event|3
7845981|NCT01458275|12327214|FG001|Overall Study|Adverse Event|4
7845982|NCT01458275|12327215|FG002|Overall Study|Adverse Event|1
7845983|NCT01458275|12327213|FG000|Overall Study|Lost to Follow-up|3
7845984|NCT01458275|12327214|FG001|Overall Study|Lost to Follow-up|2
7845985|NCT01458275|12327215|FG002|Overall Study|Lost to Follow-up|5
7845986|NCT01458275|12327213|FG000|Overall Study|Protocol Violation|5
7845987|NCT01458275|12327214|FG001|Overall Study|Protocol Violation|5
7845988|NCT01458275|12327215|FG002|Overall Study|Protocol Violation|2
7845989|NCT01458275|12327213|FG000|Overall Study|Withdrawal by Subject|3
7845990|NCT01458275|12327214|FG001|Overall Study|Withdrawal by Subject|2
7845991|NCT01458275|12327215|FG002|Overall Study|Withdrawal by Subject|1
7845992|NCT01458392|12327238|FG000|Overall Study|Death|2
7845993|NCT01458392|12327239|FG001|Overall Study|Death|11
7845994|NCT01458392|12327240|FG002|Overall Study|Death|22
7845995|NCT01458392|12327238|FG000|Overall Study|At the discretion of the sponsor|0
7845996|NCT01458392|12327239|FG001|Overall Study|At the discretion of the sponsor|2
7845997|NCT01458392|12327240|FG002|Overall Study|At the discretion of the sponsor|7
7845998|NCT01458392|12327238|FG000|Overall Study|Patient unwilling to comply with protoco|0
7845999|NCT01458392|12327239|FG001|Overall Study|Patient unwilling to comply with protoco|0
7846000|NCT01458392|12327240|FG002|Overall Study|Patient unwilling to comply with protoco|2
7846001|NCT01458522|12327271|FG000|Overall Study|Withdrawal by Subject|2
7846002|NCT01458522|12327272|FG001|Overall Study|Withdrawal by Subject|2
7846003|NCT01458522|12327271|FG000|Overall Study|Physician Decision|1
7846004|NCT01458522|12327272|FG001|Overall Study|Physician Decision|9
7846005|NCT01458535|12327290|FG000|Overall Study|Other|0
7846006|NCT01458535|12327291|FG001|Overall Study|Other|0
7846007|NCT01458535|12327292|FG002|Overall Study|Other|0
7846008|NCT01458535|12327293|FG003|Overall Study|Other|0
7846009|NCT01458535|12327294|FG004|Overall Study|Other|1
7846010|NCT01458535|12327295|FG005|Overall Study|Other|1
7846011|NCT01458535|12327290|FG000|Overall Study|Withdrawal by Subject|0
7846012|NCT01458535|12327291|FG001|Overall Study|Withdrawal by Subject|0
7846013|NCT01458535|12327292|FG002|Overall Study|Withdrawal by Subject|2
7846014|NCT01458535|12327293|FG003|Overall Study|Withdrawal by Subject|0
7846015|NCT01458535|12327294|FG004|Overall Study|Withdrawal by Subject|1
7846016|NCT01458535|12327295|FG005|Overall Study|Withdrawal by Subject|1
7846017|NCT01458535|12327290|FG000|Overall Study|Lost to Follow-up|0
7846018|NCT01458535|12327291|FG001|Overall Study|Lost to Follow-up|2
7846019|NCT01458535|12327292|FG002|Overall Study|Lost to Follow-up|0
7846020|NCT01458535|12327293|FG003|Overall Study|Lost to Follow-up|3
7846021|NCT01458535|12327294|FG004|Overall Study|Lost to Follow-up|2
7846022|NCT01458535|12327295|FG005|Overall Study|Lost to Follow-up|2
7846023|NCT01458535|12327290|FG000|Overall Study|Adverse Event|0
7846024|NCT01458535|12327291|FG001|Overall Study|Adverse Event|0
7846025|NCT01458535|12327292|FG002|Overall Study|Adverse Event|0
7846026|NCT01458535|12327293|FG003|Overall Study|Adverse Event|1
7846027|NCT01458535|12327294|FG004|Overall Study|Adverse Event|0
7846028|NCT01458535|12327295|FG005|Overall Study|Adverse Event|0
7846029|NCT01458574|12327351|FG000|Overall Study|Adverse Event|5
7846030|NCT01458574|12327352|FG001|Overall Study|Adverse Event|9
7846031|NCT01458574|12327353|FG002|Overall Study|Adverse Event|7
7846032|NCT01458574|12327351|FG000|Overall Study|Lack of Efficacy|70
7846033|NCT01458574|12327352|FG001|Overall Study|Lack of Efficacy|53
7846034|NCT01458574|12327353|FG002|Overall Study|Lack of Efficacy|132
7846035|NCT01458574|12327351|FG000|Overall Study|Lost to Follow-up|3
7846036|NCT01458574|12327352|FG001|Overall Study|Lost to Follow-up|2
7846037|NCT01458574|12327353|FG002|Overall Study|Lost to Follow-up|1
7846038|NCT01458574|12327351|FG000|Overall Study|Pregnancy|1
7846039|NCT01458574|12327352|FG001|Overall Study|Pregnancy|1
7846040|NCT01458574|12327353|FG002|Overall Study|Pregnancy|0
7846041|NCT01458574|12327351|FG000|Overall Study|Protocol Violation|0
7846042|NCT01458574|12327352|FG001|Overall Study|Protocol Violation|1
7846043|NCT01458574|12327353|FG002|Overall Study|Protocol Violation|0
7846044|NCT01458574|12327351|FG000|Overall Study|Withdrawal by Subject|6
7846045|NCT01458574|12327352|FG001|Overall Study|Withdrawal by Subject|3
7846046|NCT01458574|12327353|FG002|Overall Study|Withdrawal by Subject|5
7846047|NCT01458574|12327351|FG000|Overall Study|Other|2
7846048|NCT01458574|12327352|FG001|Overall Study|Other|1
7846049|NCT01458574|12327353|FG002|Overall Study|Other|0
7846050|NCT01458574|12327351|FG000|Overall Study|Randomized but not treated|0
7846051|NCT01458574|12327352|FG001|Overall Study|Randomized but not treated|1
7846052|NCT01458574|12327353|FG002|Overall Study|Randomized but not treated|0
7846053|NCT01458587|12327363|FG000|Overall Study|Withdrawal by Subject|1
7846054|NCT01458587|12327364|FG001|Overall Study|Withdrawal by Subject|0
7846055|NCT01458639|12327372|FG000|Overall Study|Physician Decision|4
7846056|NCT01458639|12327372|FG000|Overall Study|Equipment issue|1
7846057|NCT01458639|12327372|FG000|Overall Study|Inability to obtain subject blood sample|1
7846058|NCT01458951|12327379|FG000|Overall Study|Other|1
7846059|NCT01458951|12327380|FG001|Overall Study|Other|0
7846060|NCT01458951|12327381|FG002|Overall Study|Other|0
7846061|NCT01458951|12327379|FG000|Overall Study|Protocol Violation|5
7846062|NCT01458951|12327380|FG001|Overall Study|Protocol Violation|1
7846063|NCT01458951|12327381|FG002|Overall Study|Protocol Violation|0
7846064|NCT01458951|12327379|FG000|Overall Study|Withdrawal by Subject|2
7846065|NCT01458951|12327380|FG001|Overall Study|Withdrawal by Subject|0
7846066|NCT01458951|12327381|FG002|Overall Study|Withdrawal by Subject|2
7846067|NCT01458951|12327379|FG000|Overall Study|Adverse Event|7
7846068|NCT01458951|12327380|FG001|Overall Study|Adverse Event|0
7846069|NCT01458951|12327381|FG002|Overall Study|Adverse Event|2
7846070|NCT01458951|12327379|FG000|Overall Study|Insufficient Clinical Response|17
7846071|NCT01458951|12327380|FG001|Overall Study|Insufficient Clinical Response|0
7846072|NCT01458951|12327381|FG002|Overall Study|Insufficient Clinical Response|11
7846073|NCT01459016|12327399|FG000|Overall Study|Withdrawal by Subject|11
7846074|NCT01459016|12327399|FG000|Overall Study|Amendment Discontinuation Criteria|4
7846075|NCT01459068|12327405|FG000|Overall Study|Withdrawal by Subject|8
7846076|NCT01459068|12327406|FG001|Overall Study|Withdrawal by Subject|18
7846077|NCT01459068|12327405|FG000|Overall Study|Lost to Follow-up|31
7846078|NCT01459068|12327406|FG001|Overall Study|Lost to Follow-up|15
7846079|NCT01459068|12327405|FG000|Overall Study|Death|0
7846080|NCT01459068|12327406|FG001|Overall Study|Death|1
7846081|NCT01459614|12327431|FG000|Overall Study|Adverse Event|1
7846082|NCT01459614|12327432|FG001|Overall Study|Adverse Event|0
7863237|NCT01604343|12352498|FG002|Week 52 to Week 104|Physician Decision|0
7863238|NCT01604343|12352499|FG003|Week 52 to Week 104|Physician Decision|0
7863239|NCT01604343|12352500|FG004|Week 52 to Week 104|Physician Decision|2
7863240|NCT01604343|12352496|FG000|Week 52 to Week 104|Pregnancy|0
7863241|NCT01604343|12352497|FG001|Week 52 to Week 104|Pregnancy|0
7863242|NCT01604343|12352498|FG002|Week 52 to Week 104|Pregnancy|1
7863243|NCT01604343|12352499|FG003|Week 52 to Week 104|Pregnancy|2
7863244|NCT01604343|12352500|FG004|Week 52 to Week 104|Pregnancy|1
7863245|NCT01604343|12352496|FG000|Week 52 to Week 104|Other|0
7863246|NCT01604343|12352497|FG001|Week 52 to Week 104|Other|11
7863247|NCT01604343|12352498|FG002|Week 52 to Week 104|Other|11
7863248|NCT01604343|12352499|FG003|Week 52 to Week 104|Other|6
7863249|NCT01604343|12352500|FG004|Week 52 to Week 104|Other|3
7863250|NCT01604343|12352496|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
7863251|NCT01604343|12352497|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
7863252|NCT01604343|12352498|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
7863253|NCT01604343|12352499|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
7863254|NCT01604343|12352500|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
7863255|NCT01604343|12352496|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
7863256|NCT01604343|12352497|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
7863257|NCT01604343|12352498|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
7863258|NCT01604343|12352499|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
7863259|NCT01604343|12352500|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
7863260|NCT01604343|12352496|FG000|Safety Follow-up Period (Week 104-120)|Other|15
7863261|NCT01604343|12352497|FG001|Safety Follow-up Period (Week 104-120)|Other|2
7863262|NCT01604343|12352498|FG002|Safety Follow-up Period (Week 104-120)|Other|20
7863263|NCT01604343|12352499|FG003|Safety Follow-up Period (Week 104-120)|Other|6
7863264|NCT01604343|12352500|FG004|Safety Follow-up Period (Week 104-120)|Other|14
7863265|NCT01604408|12352512|FG000|Treatment Period 1|Protocol Violation|0
7846083|NCT01459718|12327522|FG000|Overall Study|Physician Decision|1
7846084|NCT01459718|12327522|FG000|Overall Study|Lost to Follow-up|1
7846085|NCT01459718|12327522|FG000|Overall Study|Adverse Event|1
7846086|NCT01459783|12327528|FG000|Baseline to 6 Months|Death|1
7846087|NCT01459783|12327529|FG001|Baseline to 6 Months|Death|0
7846088|NCT01459783|12327528|FG000|Baseline to 6 Months|Withdrawal by Subject|12
7846089|NCT01459783|12327529|FG001|Baseline to 6 Months|Withdrawal by Subject|6
7846090|NCT01459783|12327528|FG000|Baseline to 6 Months|Lost to Follow-up|19
7846091|NCT01459783|12327529|FG001|Baseline to 6 Months|Lost to Follow-up|14
7846092|NCT01459783|12327528|FG000|6 Months to 12 Months|Death|0
7846093|NCT01459783|12327529|FG001|6 Months to 12 Months|Death|1
7846094|NCT01459783|12327528|FG000|6 Months to 12 Months|Withdrawal by Subject|6
7846095|NCT01459783|12327529|FG001|6 Months to 12 Months|Withdrawal by Subject|5
7846096|NCT01459783|12327528|FG000|6 Months to 12 Months|Lost to Follow-up|2
7846097|NCT01459783|12327529|FG001|6 Months to 12 Months|Lost to Follow-up|7
7846098|NCT01459783|12327528|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11
7846099|NCT01459783|12327529|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17
7846100|NCT01459796|12327537|FG000|Overall Study|Non compliance with protocol|2
7846101|NCT01459796|12327538|FG001|Overall Study|Non compliance with protocol|4
7846102|NCT01459796|12327537|FG000|Overall Study|Adverse Event|5
7846103|NCT01459796|12327538|FG001|Overall Study|Adverse Event|5
7846104|NCT01459796|12327537|FG000|Overall Study|Withdrawal by Subject|6
7846105|NCT01459796|12327538|FG001|Overall Study|Withdrawal by Subject|3
7846106|NCT01459796|12327537|FG000|Overall Study|Lost to Follow-up|5
7846107|NCT01459796|12327538|FG001|Overall Study|Lost to Follow-up|4
7846108|NCT01459796|12327537|FG000|Overall Study|Reason unspecified|1
7846109|NCT01459796|12327538|FG001|Overall Study|Reason unspecified|2
7846110|NCT01459796|12327537|FG000|Overall Study|Decision by the sponsor|75
7846111|NCT01459796|12327538|FG001|Overall Study|Decision by the sponsor|108
7846112|NCT01459913|12327548|FG000|Overall Study|Adverse Event|0
7846113|NCT01459913|12327549|FG001|Overall Study|Adverse Event|0
7846114|NCT01459913|12327550|FG002|Overall Study|Adverse Event|0
7846115|NCT01459913|12327551|FG003|Overall Study|Adverse Event|3
7846116|NCT01459913|12327548|FG000|Overall Study|Withdrawal by Subject|4
7846117|NCT01459913|12327549|FG001|Overall Study|Withdrawal by Subject|0
7846118|NCT01459913|12327550|FG002|Overall Study|Withdrawal by Subject|0
7846119|NCT01459913|12327551|FG003|Overall Study|Withdrawal by Subject|5
7846120|NCT01459913|12327548|FG000|Overall Study|Lost to Follow-up|7
7846121|NCT01459913|12327549|FG001|Overall Study|Lost to Follow-up|4
7846122|NCT01459913|12327550|FG002|Overall Study|Lost to Follow-up|1
7846123|NCT01459913|12327551|FG003|Overall Study|Lost to Follow-up|8
7846124|NCT01459913|12327548|FG000|Overall Study|Death|0
7846125|NCT01459913|12327549|FG001|Overall Study|Death|0
7846126|NCT01459913|12327550|FG002|Overall Study|Death|0
7846127|NCT01459913|12327551|FG003|Overall Study|Death|1
7846128|NCT01459913|12327548|FG000|Overall Study|Non- Compliance|0
7846129|NCT01459913|12327549|FG001|Overall Study|Non- Compliance|0
7846130|NCT01459913|12327550|FG002|Overall Study|Non- Compliance|0
7846131|NCT01459913|12327551|FG003|Overall Study|Non- Compliance|3
7846132|NCT01459913|12327548|FG000|Overall Study|Physician Decision|0
7846133|NCT01459913|12327549|FG001|Overall Study|Physician Decision|1
7846134|NCT01459913|12327550|FG002|Overall Study|Physician Decision|0
7846135|NCT01459913|12327551|FG003|Overall Study|Physician Decision|0
7846136|NCT01459913|12327548|FG000|Overall Study|Study Terminated by Sponsor|30
7846137|NCT01459913|12327549|FG001|Overall Study|Study Terminated by Sponsor|15
7846138|NCT01459913|12327550|FG002|Overall Study|Study Terminated by Sponsor|9
7846139|NCT01459913|12327551|FG003|Overall Study|Study Terminated by Sponsor|11
7846140|NCT01459913|12327548|FG000|Overall Study|Other|0
7846141|NCT01459913|12327549|FG001|Overall Study|Other|0
7846142|NCT01459913|12327550|FG002|Overall Study|Other|3
7846143|NCT01459913|12327551|FG003|Overall Study|Other|1
7846144|NCT01459913|12327548|FG000|Overall Study|Did Not Meet Inclusion Criteria|0
7846145|NCT01459913|12327549|FG001|Overall Study|Did Not Meet Inclusion Criteria|0
7846146|NCT01459913|12327550|FG002|Overall Study|Did Not Meet Inclusion Criteria|0
7846147|NCT01459913|12327551|FG003|Overall Study|Did Not Meet Inclusion Criteria|1
7846148|NCT01460290|12327568|FG000|Overall Study|Adverse Event|3
7846149|NCT01460290|12327568|FG000|Overall Study|Elevated liver function|1
7846150|NCT01460342|12327584|FG000|Overall Study|Adverse Event|5
7846151|NCT01460342|12327585|FG001|Overall Study|Adverse Event|4
7846152|NCT01460342|12327584|FG000|Overall Study|Lost to Follow-up|1
7846153|NCT01460342|12327585|FG001|Overall Study|Lost to Follow-up|2
7846154|NCT01460342|12327584|FG000|Overall Study|Protocol Violation|0
7846155|NCT01460342|12327585|FG001|Overall Study|Protocol Violation|1
7846156|NCT01460342|12327584|FG000|Overall Study|Withdrawal by Subject|3
7846157|NCT01460342|12327585|FG001|Overall Study|Withdrawal by Subject|4
7846158|NCT01460342|12327584|FG000|Overall Study|Physician Decision|1
7846159|NCT01460342|12327585|FG001|Overall Study|Physician Decision|3
7846160|NCT01460342|12327584|FG000|Overall Study|Lack of Efficacy|1
7846161|NCT01460342|12327585|FG001|Overall Study|Lack of Efficacy|0
7846162|NCT01460368|12327593|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7846163|NCT01460368|12327594|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7846164|NCT01460368|12327595|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7846165|NCT01460368|12327596|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7863266|NCT01604408|12352513|FG001|Treatment Period 1|Protocol Violation|1
7846166|NCT01460368|12327597|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1
7846167|NCT01460368|12327598|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7846168|NCT01460368|12327599|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7846169|NCT01460368|12327593|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7846170|NCT01460368|12327594|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
7846171|NCT01460368|12327595|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7846172|NCT01460368|12327596|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7846173|NCT01460368|12327597|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7846174|NCT01460368|12327598|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7846175|NCT01460368|12327599|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
7846176|NCT01460368|12327593|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7846177|NCT01460368|12327594|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
7846178|NCT01460368|12327595|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7846179|NCT01460368|12327596|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7846180|NCT01460368|12327597|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7846181|NCT01460368|12327598|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7846182|NCT01460368|12327599|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7846183|NCT01460368|12327593|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0
7846184|NCT01460368|12327594|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0
7846185|NCT01460368|12327595|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1
7846186|NCT01460368|12327596|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0
7846187|NCT01460368|12327597|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0
7846188|NCT01460368|12327598|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0
7846189|NCT01460368|12327599|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0
7846190|NCT01460368|12327593|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7846191|NCT01460368|12327594|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7846192|NCT01460368|12327595|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
7846193|NCT01460368|12327596|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
7846194|NCT01460368|12327597|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7846195|NCT01460368|12327598|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
7846196|NCT01460368|12327599|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7846197|NCT01460381|12327610|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1
7846198|NCT01460381|12327611|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0
7846199|NCT01460407|12327619|FG000|Period 2: Day 6 to Day 14|Adverse Event|0
7846200|NCT01460407|12327620|FG001|Period 2: Day 6 to Day 14|Adverse Event|1
7846201|NCT01460446|12327629|FG000|Overall Study|Non-compliance|2
7846202|NCT01460446|12327630|FG001|Overall Study|Non-compliance|9
7846203|NCT01460446|12327629|FG000|Overall Study|Consent Withdrawn|0
7846204|NCT01460446|12327630|FG001|Overall Study|Consent Withdrawn|4
7846205|NCT01460446|12327629|FG000|Overall Study|Non-compliance & Consent Withdrawn|1
7846206|NCT01460446|12327630|FG001|Overall Study|Non-compliance & Consent Withdrawn|3
7846207|NCT01460446|12327629|FG000|Overall Study|Surgery/Illness|1
7846208|NCT01460446|12327630|FG001|Overall Study|Surgery/Illness|1
7846209|NCT01460446|12327629|FG000|Overall Study|Pregnancy|1
7846210|NCT01460446|12327630|FG001|Overall Study|Pregnancy|0
7846211|NCT01460446|12327629|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
7846212|NCT01460446|12327630|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
7846213|NCT01460628|12327637|FG000|Overall Study|Adverse Event|3
7846214|NCT01460628|12327637|FG000|Overall Study|Withdrawal by Subject|2
7846215|NCT01460719|12327641|FG000|Overall Study|Adverse Event|1
7846216|NCT01460719|12327641|FG000|Overall Study|Withdrawal by Subject|1
7846217|NCT01460901|12327655|FG000|Overall Study|Withdrawal by Subject|2
7846218|NCT01461005|12327674|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1
7846219|NCT01461044|12327681|FG000|Overall Study|Death|58
7846220|NCT01461044|12327682|FG001|Overall Study|Death|35
7846221|NCT01461044|12327681|FG000|Overall Study|Lost to Follow-up|12
7846222|NCT01461044|12327682|FG001|Overall Study|Lost to Follow-up|5
7846223|NCT01461057|12327693|FG000|Overall Study|Death|10
7846224|NCT01461057|12327694|FG001|Overall Study|Death|9
7846225|NCT01461057|12327693|FG000|Overall Study|Withdrawal by Subject|2
7846226|NCT01461057|12327694|FG001|Overall Study|Withdrawal by Subject|3
7846227|NCT01461057|12327693|FG000|Overall Study|Physician Decision|0
7846228|NCT01461057|12327694|FG001|Overall Study|Physician Decision|2
7846229|NCT01461057|12327693|FG000|Overall Study|Adverse Event|0
7846230|NCT01461057|12327694|FG001|Overall Study|Adverse Event|1
7846231|NCT01461057|12327693|FG000|Overall Study|Progression of Disease|1
7846232|NCT01461057|12327694|FG001|Overall Study|Progression of Disease|0
7846233|NCT01461057|12327693|FG000|Overall Study|Study Terminated by Sponsor|2
7846234|NCT01461057|12327694|FG001|Overall Study|Study Terminated by Sponsor|0
7846235|NCT01461096|12327702|FG000|Overall Study|Death|3
7846236|NCT01461096|12327703|FG001|Overall Study|Death|6
7846237|NCT01461096|12327702|FG000|Overall Study|Severe debilitation, unable to continue|1
7846238|NCT01461096|12327703|FG001|Overall Study|Severe debilitation, unable to continue|1
7846239|NCT01461096|12327702|FG000|Overall Study|Subj not able to get to clinic|15
7846240|NCT01461096|12327703|FG001|Overall Study|Subj not able to get to clinic|13
7846241|NCT01461096|12327702|FG000|Overall Study|Site is closing|27
7846242|NCT01461096|12327703|FG001|Overall Study|Site is closing|30
7846243|NCT01461096|12327702|FG000|Overall Study|Withdrawal by Subject|5
7846244|NCT01461096|12327703|FG001|Overall Study|Withdrawal by Subject|3
7846245|NCT01461096|12327702|FG000|Overall Study|Subj not willing to adhere to reqs|3
7846246|NCT01461096|12327703|FG001|Overall Study|Subj not willing to adhere to reqs|4
7846247|NCT01461096|12327702|FG000|Overall Study|Lost to Follow-up|8
7846248|NCT01461096|12327703|FG001|Overall Study|Lost to Follow-up|4
7846249|NCT01461369|12327713|FG000|Overall Study|Lack of Efficacy|2
7846250|NCT01461369|12327714|FG001|Overall Study|Lack of Efficacy|0
7846251|NCT01461369|12327715|FG002|Overall Study|Lack of Efficacy|6
7846252|NCT01461369|12327713|FG000|Overall Study|Lost to Follow-up|0
7846253|NCT01461369|12327714|FG001|Overall Study|Lost to Follow-up|0
7846254|NCT01461369|12327715|FG002|Overall Study|Lost to Follow-up|3
7846255|NCT01461369|12327713|FG000|Overall Study|Adverse Event|9
7846256|NCT01461369|12327714|FG001|Overall Study|Adverse Event|12
7846257|NCT01461369|12327715|FG002|Overall Study|Adverse Event|4
7846258|NCT01461369|12327713|FG000|Overall Study|Protocol Violation|1
7846259|NCT01461369|12327714|FG001|Overall Study|Protocol Violation|2
7846260|NCT01461369|12327715|FG002|Overall Study|Protocol Violation|2
7846261|NCT01461369|12327713|FG000|Overall Study|Withdrawal by Subject|1
7846262|NCT01461369|12327714|FG001|Overall Study|Withdrawal by Subject|3
7846263|NCT01461369|12327715|FG002|Overall Study|Withdrawal by Subject|2
7846264|NCT01461538|12327746|FG000|Overall Study|Death|15
7846265|NCT01461538|12327747|FG001|Overall Study|Death|6
7846266|NCT01461538|12327748|FG002|Overall Study|Death|2
7846267|NCT01461538|12327746|FG000|Overall Study|Study Stopped by Sponsor|2
7846268|NCT01461538|12327747|FG001|Overall Study|Study Stopped by Sponsor|1
7846269|NCT01461538|12327748|FG002|Overall Study|Study Stopped by Sponsor|0
7846270|NCT01461538|12327746|FG000|Overall Study|Withdrawal by Subject|1
7846271|NCT01461538|12327747|FG001|Overall Study|Withdrawal by Subject|1
7846272|NCT01461538|12327748|FG002|Overall Study|Withdrawal by Subject|0
7846273|NCT01461551|12327761|FG000|Overall Study|Physician Decision|2
7846274|NCT01461551|12327762|FG001|Overall Study|Physician Decision|1
7846275|NCT01461551|12327763|FG002|Overall Study|Physician Decision|2
7846276|NCT01461707|12327787|FG000|Overall Study|Withdrawal by Subject|1
7846277|NCT01461707|12327788|FG001|Overall Study|Withdrawal by Subject|0
7846278|NCT01461811|12327805|FG000|Overall Study|Adverse Event|2
7846279|NCT01461811|12327806|FG001|Overall Study|Adverse Event|1
7846280|NCT01461811|12327805|FG000|Overall Study|Subject decision unrelated to an AE|1
7846281|NCT01461811|12327806|FG001|Overall Study|Subject decision unrelated to an AE|1
7846282|NCT01461811|12327805|FG000|Overall Study|Noncompliance|1
7846283|NCT01461811|12327806|FG001|Overall Study|Noncompliance|1
7846284|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Adverse Event|76
7846285|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Adverse Event|0
7846286|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Adverse Event|0
7846287|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Death|3
7846288|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Death|0
7846289|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Death|0
7846290|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Lost to Follow-up|5
7846291|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Lost to Follow-up|0
7846292|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Lost to Follow-up|0
7846293|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Physician Decision|9
7846294|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Physician Decision|0
7846295|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Physician Decision|0
7846296|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18
7846297|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0
7846298|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0
7846299|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Disease progression|45
7846300|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Disease progression|0
7846301|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Disease progression|0
7846302|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10
7846303|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0
7846304|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0
7846305|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11
7846306|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
7846307|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
7846308|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Not responding to treatment|11
7846309|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Not responding to treatment|0
7846310|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Not responding to treatment|0
7846311|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1
7846312|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0
7846313|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0
7846314|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1
7846315|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
7846316|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
7846317|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Sponsor decision|1
7846318|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Sponsor decision|0
7846319|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Sponsor decision|0
7846320|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Protocol deviation|2
7846321|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Protocol deviation|0
7846322|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Protocol deviation|0
7846323|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1
7846324|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
7846325|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
7846326|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1
7846327|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
7846328|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
7846329|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Promotor request|1
7846330|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Promotor request|0
7846331|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Promotor request|0
7846332|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1
7846333|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
7846334|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
7846335|NCT01461928|12327836|FG000|Induction (up to 8 Months)|Medical advisor request|1
7846336|NCT01461928|12327837|FG001|Induction (up to 8 Months)|Medical advisor request|0
7846337|NCT01461928|12327838|FG002|Induction (up to 8 Months)|Medical advisor request|0
7846338|NCT01461928|12327836|FG000|Maintenance I (24 Months)|Death|3
7846339|NCT01461928|12327837|FG001|Maintenance I (24 Months)|Death|0
7846340|NCT01461928|12327838|FG002|Maintenance I (24 Months)|Death|0
7846341|NCT01461928|12327836|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32
7846342|NCT01461928|12327837|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0
7846343|NCT01461928|12327838|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0
7846344|NCT01461928|12327836|FG000|Maintenance I (24 Months)|Lost to Follow-up|2
7846345|NCT01461928|12327837|FG001|Maintenance I (24 Months)|Lost to Follow-up|0
7846346|NCT01461928|12327838|FG002|Maintenance I (24 Months)|Lost to Follow-up|0
7846347|NCT01461928|12327836|FG000|Maintenance I (24 Months)|Diseases progression|91
7846348|NCT01461928|12327837|FG001|Maintenance I (24 Months)|Diseases progression|0
7846349|NCT01461928|12327838|FG002|Maintenance I (24 Months)|Diseases progression|0
7846350|NCT01461928|12327836|FG000|Maintenance I (24 Months)|Adverse Event|70
7846351|NCT01461928|12327837|FG001|Maintenance I (24 Months)|Adverse Event|0
7846352|NCT01461928|12327838|FG002|Maintenance I (24 Months)|Adverse Event|0
7846353|NCT01461928|12327836|FG000|Maintenance I (24 Months)|Physician Decision|9
7846354|NCT01461928|12327837|FG001|Maintenance I (24 Months)|Physician Decision|0
7846355|NCT01461928|12327838|FG002|Maintenance I (24 Months)|Physician Decision|0
7846356|NCT01461928|12327836|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2
7846357|NCT01461928|12327837|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0
7846358|NCT01461928|12327838|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0
7846359|NCT01461928|12327836|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2
7846360|NCT01461928|12327837|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0
7846361|NCT01461928|12327838|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0
7846362|NCT01461928|12327836|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1
7846363|NCT01461928|12327837|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0
7846364|NCT01461928|12327838|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0
7846365|NCT01461928|12327836|FG000|Maintenance I (24 Months)|Not compliant|1
7846366|NCT01461928|12327837|FG001|Maintenance I (24 Months)|Not compliant|0
7846367|NCT01461928|12327838|FG002|Maintenance I (24 Months)|Not compliant|0
7846368|NCT01461928|12327836|FG000|Maintenance I (24 Months)|Did not meet criteria|5
7846369|NCT01461928|12327837|FG001|Maintenance I (24 Months)|Did not meet criteria|0
7846370|NCT01461928|12327838|FG002|Maintenance I (24 Months)|Did not meet criteria|0
7846371|NCT01461928|12327836|FG000|Maintenance II (15 Months)|Adverse Event|0
7846372|NCT01461928|12327837|FG001|Maintenance II (15 Months)|Adverse Event|2
7846373|NCT01461928|12327838|FG002|Maintenance II (15 Months)|Adverse Event|0
7846374|NCT01461928|12327836|FG000|Maintenance II (15 Months)|Death|0
7846375|NCT01461928|12327837|FG001|Maintenance II (15 Months)|Death|10
7846376|NCT01461928|12327838|FG002|Maintenance II (15 Months)|Death|8
7846377|NCT01461928|12327836|FG000|Maintenance II (15 Months)|Physician Decision|0
7846378|NCT01461928|12327837|FG001|Maintenance II (15 Months)|Physician Decision|0
7846379|NCT01461928|12327838|FG002|Maintenance II (15 Months)|Physician Decision|4
7846380|NCT01461928|12327836|FG000|Maintenance II (15 Months)|Lost to Follow-up|0
7846381|NCT01461928|12327837|FG001|Maintenance II (15 Months)|Lost to Follow-up|1
7846382|NCT01461928|12327838|FG002|Maintenance II (15 Months)|Lost to Follow-up|0
7846383|NCT01461928|12327836|FG000|Maintenance II (15 Months)|Moved to another town|0
7846384|NCT01461928|12327837|FG001|Maintenance II (15 Months)|Moved to another town|1
7846385|NCT01461928|12327838|FG002|Maintenance II (15 Months)|Moved to another town|0
7846386|NCT01461928|12327836|FG000|Maintenance II (15 Months)|Disease progression|0
7846387|NCT01461928|12327837|FG001|Maintenance II (15 Months)|Disease progression|0
7846388|NCT01461928|12327838|FG002|Maintenance II (15 Months)|Disease progression|3
7846389|NCT01461928|12327836|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0
7846390|NCT01461928|12327837|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9
7846391|NCT01461928|12327838|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8
7846392|NCT01461928|12327836|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0
7846393|NCT01461928|12327837|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0
7846394|NCT01461928|12327838|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1
7846395|NCT01461928|12327836|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0
7846396|NCT01461928|12327837|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0
7846397|NCT01461928|12327838|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1
7846398|NCT01461928|12327836|FG000|Maintenance II (15 Months)|Withdrew informed consent|0
7846399|NCT01461928|12327837|FG001|Maintenance II (15 Months)|Withdrew informed consent|0
7846400|NCT01461928|12327838|FG002|Maintenance II (15 Months)|Withdrew informed consent|1
7846401|NCT01461928|12327836|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0
7846402|NCT01461928|12327837|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0
7846403|NCT01461928|12327838|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1
7846404|NCT01461980|12327852|FG000|Overall Study|Other|9
7846405|NCT01461980|12327853|FG001|Overall Study|Other|8
7846406|NCT01461980|12327854|FG002|Overall Study|Other|6
7846407|NCT01461980|12327852|FG000|Overall Study|Medication error|7
7846408|NCT01461980|12327853|FG001|Overall Study|Medication error|5
7949137|NCT02533674|12494570|FG000|Dose Level V|Progressive disease|0
7949138|NCT02533674|12494571|FG001|Dose Level V|Progressive disease|0
7949139|NCT02533674|12494572|FG002|Dose Level V|Progressive disease|0
7949140|NCT02533674|12494573|FG003|Dose Level V|Progressive disease|0
7949141|NCT02533674|12494574|FG004|Dose Level V|Progressive disease|3
7949142|NCT02533674|12494575|FG005|Dose Level V|Progressive disease|0
7949143|NCT02533674|12494576|FG006|Dose Level V|Progressive disease|0
7949144|NCT02533674|12494577|FG007|Dose Level V|Progressive disease|0
7949145|NCT02533674|12494570|FG000|Dose Level V|Withdrawal by Subject|0
7949146|NCT02533674|12494571|FG001|Dose Level V|Withdrawal by Subject|0
7949147|NCT02533674|12494572|FG002|Dose Level V|Withdrawal by Subject|0
7949148|NCT02533674|12494573|FG003|Dose Level V|Withdrawal by Subject|0
7949149|NCT02533674|12494574|FG004|Dose Level V|Withdrawal by Subject|1
7949150|NCT02533674|12494575|FG005|Dose Level V|Withdrawal by Subject|0
7949151|NCT02533674|12494576|FG006|Dose Level V|Withdrawal by Subject|0
7949152|NCT02533674|12494577|FG007|Dose Level V|Withdrawal by Subject|0
7949153|NCT02533674|12494570|FG000|Dose Level V|Physician Decision|0
7949154|NCT02533674|12494571|FG001|Dose Level V|Physician Decision|0
7949155|NCT02533674|12494572|FG002|Dose Level V|Physician Decision|0
7949156|NCT02533674|12494573|FG003|Dose Level V|Physician Decision|0
7846409|NCT01461980|12327854|FG002|Overall Study|Medication error|6
7846410|NCT01461980|12327852|FG000|Overall Study|Adverse Event|12
7846411|NCT01461980|12327853|FG001|Overall Study|Adverse Event|5
7846412|NCT01461980|12327854|FG002|Overall Study|Adverse Event|6
7846413|NCT01461980|12327852|FG000|Overall Study|Protocol Violation|12
7846414|NCT01461980|12327853|FG001|Overall Study|Protocol Violation|19
7846415|NCT01461980|12327854|FG002|Overall Study|Protocol Violation|16
7846416|NCT01461980|12327852|FG000|Overall Study|No longer meets eligibility criteria|18
7846417|NCT01461980|12327853|FG001|Overall Study|No longer meets eligibility criteria|9
7846418|NCT01461980|12327854|FG002|Overall Study|No longer meets eligibility criteria|19
7846419|NCT01461980|12327852|FG000|Overall Study|Lost to Follow-up|52
7846420|NCT01461980|12327853|FG001|Overall Study|Lost to Follow-up|53
7846421|NCT01461980|12327854|FG002|Overall Study|Lost to Follow-up|51
7846422|NCT01461980|12327852|FG000|Overall Study|No longer willing to participate|52
7846423|NCT01461980|12327853|FG001|Overall Study|No longer willing to participate|38
7846424|NCT01461980|12327854|FG002|Overall Study|No longer willing to participate|54
7846425|NCT01461980|12327852|FG000|Overall Study|Randomized but not vaccinated|4
7846426|NCT01461980|12327853|FG001|Overall Study|Randomized but not vaccinated|8
7846427|NCT01461980|12327854|FG002|Overall Study|Randomized but not vaccinated|7
7846428|NCT01461993|12327866|FG000|Overall Study|Withdrawal by Subject|60
7846429|NCT01461993|12327867|FG001|Overall Study|Withdrawal by Subject|53
7846430|NCT01461993|12327868|FG002|Overall Study|Withdrawal by Subject|16
7846431|NCT01461993|12327866|FG000|Overall Study|Lost to Follow-up|44
7846432|NCT01461993|12327867|FG001|Overall Study|Lost to Follow-up|48
7846433|NCT01461993|12327868|FG002|Overall Study|Lost to Follow-up|22
7846434|NCT01461993|12327866|FG000|Overall Study|Protocol Violation|10
7846435|NCT01461993|12327867|FG001|Overall Study|Protocol Violation|9
7846436|NCT01461993|12327868|FG002|Overall Study|Protocol Violation|7
7846437|NCT01461993|12327866|FG000|Overall Study|Adverse Event|9
7846438|NCT01461993|12327867|FG001|Overall Study|Adverse Event|11
7846439|NCT01461993|12327868|FG002|Overall Study|Adverse Event|3
7846440|NCT01461993|12327866|FG000|Overall Study|No longer met eligibility criteria|13
7846441|NCT01461993|12327867|FG001|Overall Study|No longer met eligibility criteria|18
7846442|NCT01461993|12327868|FG002|Overall Study|No longer met eligibility criteria|10
7846443|NCT01461993|12327866|FG000|Overall Study|Did not meet entrance criteria|2
7846444|NCT01461993|12327867|FG001|Overall Study|Did not meet entrance criteria|3
7846445|NCT01461993|12327868|FG002|Overall Study|Did not meet entrance criteria|0
7846446|NCT01461993|12327866|FG000|Overall Study|Other|13
7846447|NCT01461993|12327867|FG001|Overall Study|Other|15
7846448|NCT01461993|12327868|FG002|Overall Study|Other|6
7846449|NCT01462045|12327880|FG000|Overall Study|Family matter|0
7846450|NCT01462045|12327881|FG001|Overall Study|Family matter|1
7846451|NCT01462045|12327882|FG002|Overall Study|Family matter|0
7846452|NCT01462084|12327890|FG000|Overall Study|Withdrawal by Subject|1
7846453|NCT01462084|12327891|FG001|Overall Study|Withdrawal by Subject|0
7846454|NCT01462084|12327890|FG000|Overall Study|Protocol Violation|1
7846455|NCT01462084|12327891|FG001|Overall Study|Protocol Violation|1
7846456|NCT01462110|12327900|FG000|Overall Study|Adverse Event|1
7846457|NCT01462110|12327901|FG001|Overall Study|Adverse Event|0
7846458|NCT01462162|12327907|FG000|Overall Study|Adverse Event|5
7846459|NCT01462162|12327907|FG000|Overall Study|Lack of Efficacy|4
7846460|NCT01462162|12327907|FG000|Overall Study|Abnormal laboratory parameters|1
7846461|NCT01462162|12327907|FG000|Overall Study|Other|2
7846462|NCT01462227|12327914|FG000|Second Assignment|Lost to Follow-up|1
7846463|NCT01462227|12327915|FG001|Second Assignment|Lost to Follow-up|0
7846464|NCT01462227|12327916|FG002|Second Assignment|Lost to Follow-up|0
7846465|NCT01462227|12327917|FG003|Second Assignment|Lost to Follow-up|0
7846466|NCT01462227|12327914|FG000|Second Assignment|Protocol Violation|0
7846467|NCT01462227|12327915|FG001|Second Assignment|Protocol Violation|1
7846468|NCT01462227|12327916|FG002|Second Assignment|Protocol Violation|1
7846469|NCT01462227|12327917|FG003|Second Assignment|Protocol Violation|0
7846470|NCT01462266|12327931|FG000|Overall Study|Adverse Event|7
7846471|NCT01462266|12327932|FG001|Overall Study|Adverse Event|6
7846472|NCT01462266|12327931|FG000|Overall Study|Death|2
7846473|NCT01462266|12327932|FG001|Overall Study|Death|1
7846474|NCT01462266|12327931|FG000|Overall Study|Lack of Efficacy|0
7846475|NCT01462266|12327932|FG001|Overall Study|Lack of Efficacy|2
7846476|NCT01462266|12327931|FG000|Overall Study|Lost to Follow-up|4
7846477|NCT01462266|12327932|FG001|Overall Study|Lost to Follow-up|3
7846478|NCT01462266|12327931|FG000|Overall Study|Non-compliance with study drug|3
7846479|NCT01462266|12327932|FG001|Overall Study|Non-compliance with study drug|0
7846480|NCT01462266|12327931|FG000|Overall Study|Creatinine and eGFR, excluded medication|8
7846481|NCT01462266|12327932|FG001|Overall Study|Creatinine and eGFR, excluded medication|4
7846482|NCT01462266|12327931|FG000|Overall Study|Physician Decision|2
7846483|NCT01462266|12327932|FG001|Overall Study|Physician Decision|5
7846484|NCT01462266|12327931|FG000|Overall Study|Protocol Violation|1
7846485|NCT01462266|12327932|FG001|Overall Study|Protocol Violation|3
7846486|NCT01462266|12327931|FG000|Overall Study|Withdrawal by Subject|7
7846487|NCT01462266|12327932|FG001|Overall Study|Withdrawal by Subject|2
7846488|NCT01462266|12327931|FG000|Overall Study|Screen failure|1
7846489|NCT01462266|12327932|FG001|Overall Study|Screen failure|1
7846490|NCT01462318|12327969|FG000|Main Study / TP-DI Study|Other|2
7846491|NCT01462318|12327970|FG001|Main Study / TP-DI Study|Other|0
7846492|NCT01462318|12327971|FG002|Main Study / TP-DI Study|Other|0
7846493|NCT01462318|12327969|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2
7846494|NCT01462318|12327970|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0
7846495|NCT01462318|12327971|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0
7846496|NCT01462318|12327969|FG000|Main Study / TP-DI Study|Adverse Event|4
7846497|NCT01462318|12327970|FG001|Main Study / TP-DI Study|Adverse Event|0
7846498|NCT01462318|12327971|FG002|Main Study / TP-DI Study|Adverse Event|0
7846499|NCT01462318|12327969|FG000|Extension Phase|Lost to Follow-up|0
7846500|NCT01462318|12327970|FG001|Extension Phase|Lost to Follow-up|0
7846501|NCT01462318|12327971|FG002|Extension Phase|Lost to Follow-up|1
7846502|NCT01462318|12327969|FG000|Extension Phase|Other|0
7846503|NCT01462318|12327970|FG001|Extension Phase|Other|0
7846504|NCT01462318|12327971|FG002|Extension Phase|Other|1
7846505|NCT01462318|12327969|FG000|Extension Phase|Disease Progression|0
7846506|NCT01462318|12327970|FG001|Extension Phase|Disease Progression|0
7846507|NCT01462318|12327971|FG002|Extension Phase|Disease Progression|1
7846508|NCT01462318|12327969|FG000|Extension Phase|Withdrawal by Subject|0
7846509|NCT01462318|12327970|FG001|Extension Phase|Withdrawal by Subject|0
7846510|NCT01462318|12327971|FG002|Extension Phase|Withdrawal by Subject|15
7846511|NCT01462318|12327969|FG000|Extension Phase|Investigator Decision|0
7846512|NCT01462318|12327970|FG001|Extension Phase|Investigator Decision|0
7846513|NCT01462318|12327971|FG002|Extension Phase|Investigator Decision|5
7846514|NCT01462318|12327969|FG000|Extension Phase|Adverse Event|0
7846515|NCT01462318|12327970|FG001|Extension Phase|Adverse Event|0
7846516|NCT01462318|12327971|FG002|Extension Phase|Adverse Event|22
7846517|NCT01462344|12327978|FG000|Overall Study|Withdrawal by Subject|245
7846518|NCT01462344|12327979|FG001|Overall Study|Withdrawal by Subject|226
7846519|NCT01462344|12327978|FG000|Overall Study|Adverse Event|24
7846520|NCT01462344|12327979|FG001|Overall Study|Adverse Event|23
7846521|NCT01462344|12327978|FG000|Overall Study|Asthma Exacerbation|34
7846522|NCT01462344|12327979|FG001|Overall Study|Asthma Exacerbation|35
7846523|NCT01462344|12327978|FG000|Overall Study|Lack of Efficacy|5
7846524|NCT01462344|12327979|FG001|Overall Study|Lack of Efficacy|6
7846525|NCT01462344|12327978|FG000|Overall Study|Protocol Violation|68
7846526|NCT01462344|12327979|FG001|Overall Study|Protocol Violation|53
7846527|NCT01462344|12327978|FG000|Overall Study|Lost to Follow-up|7
7846528|NCT01462344|12327979|FG001|Overall Study|Lost to Follow-up|7
7846529|NCT01462357|12327988|FG000|Overall Study|Death|0
7846530|NCT01462357|12327989|FG001|Overall Study|Death|0
7846531|NCT01462357|12327990|FG002|Overall Study|Death|1
7846532|NCT01462357|12327988|FG000|Overall Study|Withdrawal by Subject|3
7846533|NCT01462357|12327989|FG001|Overall Study|Withdrawal by Subject|11
7846534|NCT01462357|12327990|FG002|Overall Study|Withdrawal by Subject|3
7846535|NCT01462357|12327988|FG000|Overall Study|Migrated/moved from study area|2
7846536|NCT01462357|12327989|FG001|Overall Study|Migrated/moved from study area|3
7846537|NCT01462357|12327990|FG002|Overall Study|Migrated/moved from study area|1
7846538|NCT01462357|12327988|FG000|Overall Study|Lost to Follow-up|3
7846539|NCT01462357|12327989|FG001|Overall Study|Lost to Follow-up|5
7846540|NCT01462357|12327990|FG002|Overall Study|Lost to Follow-up|7
7846541|NCT01462435|12328002|FG000|Overall Study|Lack of Efficacy|1
7846542|NCT01462435|12328003|FG001|Overall Study|Lack of Efficacy|0
7846543|NCT01462435|12328004|FG002|Overall Study|Lack of Efficacy|0
7846544|NCT01462435|12328005|FG003|Overall Study|Lack of Efficacy|3
7846545|NCT01462435|12328002|FG000|Overall Study|Physician Decision|0
7846546|NCT01462435|12328003|FG001|Overall Study|Physician Decision|0
7846547|NCT01462435|12328004|FG002|Overall Study|Physician Decision|1
7846548|NCT01462435|12328005|FG003|Overall Study|Physician Decision|0
7846549|NCT01462435|12328002|FG000|Overall Study|Withdrawal by Subject|0
7846550|NCT01462435|12328003|FG001|Overall Study|Withdrawal by Subject|0
7846551|NCT01462435|12328004|FG002|Overall Study|Withdrawal by Subject|0
7846552|NCT01462435|12328005|FG003|Overall Study|Withdrawal by Subject|1
7846553|NCT01462435|12328002|FG000|Overall Study|Lost to Follow-up|0
7846554|NCT01462435|12328003|FG001|Overall Study|Lost to Follow-up|0
7846555|NCT01462435|12328004|FG002|Overall Study|Lost to Follow-up|0
7846556|NCT01462435|12328005|FG003|Overall Study|Lost to Follow-up|1
7846557|NCT01462695|12328021|FG000|Overall Study|Adverse Event|1
7846558|NCT01462695|12328022|FG001|Overall Study|Adverse Event|1
7846559|NCT01462695|12328021|FG000|Overall Study|Death|2
7846560|NCT01462695|12328022|FG001|Overall Study|Death|0
7846561|NCT01462695|12328021|FG000|Overall Study|Lack of Efficacy|6
7846562|NCT01462695|12328022|FG001|Overall Study|Lack of Efficacy|12
7846563|NCT01462695|12328021|FG000|Overall Study|Physician Decision|5
7846564|NCT01462695|12328022|FG001|Overall Study|Physician Decision|0
7846565|NCT01462695|12328021|FG000|Overall Study|Withdrawal by Subject|2
7846566|NCT01462695|12328022|FG001|Overall Study|Withdrawal by Subject|0
7846567|NCT01462695|12328021|FG000|Overall Study|Inevaluable (did not receive study drug)|1
7846568|NCT01462695|12328022|FG001|Overall Study|Inevaluable (did not receive study drug)|0
7846569|NCT01462929|12328049|FG000|Overall Study|Adverse Event|3
7846570|NCT01462929|12328050|FG001|Overall Study|Adverse Event|3
7846571|NCT01462929|12328051|FG002|Overall Study|Adverse Event|4
7846572|NCT01462929|12328049|FG000|Overall Study|Withdrawal by Subject|2
7846573|NCT01462929|12328050|FG001|Overall Study|Withdrawal by Subject|1
7846574|NCT01462929|12328051|FG002|Overall Study|Withdrawal by Subject|0
7846575|NCT01462929|12328049|FG000|Overall Study|Lack of Efficacy|0
7846576|NCT01462929|12328050|FG001|Overall Study|Lack of Efficacy|0
7846577|NCT01462929|12328051|FG002|Overall Study|Lack of Efficacy|1
7846578|NCT01462942|12328064|FG000|Overall Study|Adverse Event|7
7846579|NCT01462942|12328065|FG001|Overall Study|Adverse Event|12
7846580|NCT01462942|12328066|FG002|Overall Study|Adverse Event|10
7846581|NCT01462942|12328067|FG003|Overall Study|Adverse Event|11
7846582|NCT01462942|12328068|FG004|Overall Study|Adverse Event|11
7846583|NCT01462942|12328064|FG000|Overall Study|Other, including COPD exacerbation|3
7846584|NCT01462942|12328065|FG001|Overall Study|Other, including COPD exacerbation|5
7846585|NCT01462942|12328066|FG002|Overall Study|Other, including COPD exacerbation|2
7846586|NCT01462942|12328067|FG003|Overall Study|Other, including COPD exacerbation|8
7846587|NCT01462942|12328068|FG004|Overall Study|Other, including COPD exacerbation|5
7846588|NCT01462942|12328064|FG000|Overall Study|Withdrawal by Subject|14
7846589|NCT01462942|12328065|FG001|Overall Study|Withdrawal by Subject|10
7846590|NCT01462942|12328066|FG002|Overall Study|Withdrawal by Subject|14
7846591|NCT01462942|12328067|FG003|Overall Study|Withdrawal by Subject|16
7846592|NCT01462942|12328068|FG004|Overall Study|Withdrawal by Subject|19
7846593|NCT01462942|12328064|FG000|Overall Study|Lack of Efficacy|6
7846594|NCT01462942|12328065|FG001|Overall Study|Lack of Efficacy|0
7846595|NCT01462942|12328066|FG002|Overall Study|Lack of Efficacy|4
7846596|NCT01462942|12328067|FG003|Overall Study|Lack of Efficacy|5
7846597|NCT01462942|12328068|FG004|Overall Study|Lack of Efficacy|3
7846598|NCT01462942|12328064|FG000|Overall Study|Lost to Follow-up|0
7846599|NCT01462942|12328065|FG001|Overall Study|Lost to Follow-up|1
7846600|NCT01462942|12328066|FG002|Overall Study|Lost to Follow-up|1
7846601|NCT01462942|12328067|FG003|Overall Study|Lost to Follow-up|1
7846602|NCT01462942|12328068|FG004|Overall Study|Lost to Follow-up|1
7846603|NCT01462942|12328064|FG000|Overall Study|Protocol Violation|4
7846604|NCT01462942|12328065|FG001|Overall Study|Protocol Violation|6
7846605|NCT01462942|12328066|FG002|Overall Study|Protocol Violation|9
7846606|NCT01462942|12328067|FG003|Overall Study|Protocol Violation|9
7846607|NCT01462942|12328068|FG004|Overall Study|Protocol Violation|6
7846608|NCT01463007|12328080|FG000|Overall Study|Physician Decision|1
7846609|NCT01463033|12328087|FG000|Overall Study|Lost to Follow-up|4
7846610|NCT01463033|12328088|FG001|Overall Study|Lost to Follow-up|4
7846611|NCT01463033|12328087|FG000|Overall Study|Death|3
7846612|NCT01463033|12328088|FG001|Overall Study|Death|2
7846613|NCT01463098|12328109|FG000|Part A (11 Days)|Participant Choice|2
7846614|NCT01463098|12328110|FG001|Part A (11 Days)|Participant Choice|0
7846615|NCT01463098|12328111|FG002|Part A (11 Days)|Participant Choice|0
7846616|NCT01463098|12328112|FG003|Part A (11 Days)|Participant Choice|0
7846617|NCT01463098|12328113|FG004|Part A (11 Days)|Participant Choice|0
7846618|NCT01463098|12328114|FG005|Part A (11 Days)|Participant Choice|0
7846619|NCT01463098|12328115|FG006|Part A (11 Days)|Participant Choice|0
7846620|NCT01463098|12328116|FG007|Part A (11 Days)|Participant Choice|0
7846621|NCT01463098|12328117|FG008|Part A (11 Days)|Participant Choice|1
7846622|NCT01463098|12328118|FG009|Part A (11 Days)|Participant Choice|0
7846623|NCT01463098|12328119|FG010|Part A (11 Days)|Participant Choice|0
7846624|NCT01463098|12328120|FG011|Part A (11 Days)|Participant Choice|0
7846625|NCT01463098|12328121|FG012|Part A (11 Days)|Participant Choice|0
7846626|NCT01463098|12328122|FG013|Part A (11 Days)|Participant Choice|0
7846627|NCT01463098|12328109|FG000|Part A (11 Days)|Lost to Follow-up|0
7846628|NCT01463098|12328110|FG001|Part A (11 Days)|Lost to Follow-up|0
7846629|NCT01463098|12328111|FG002|Part A (11 Days)|Lost to Follow-up|0
7846630|NCT01463098|12328112|FG003|Part A (11 Days)|Lost to Follow-up|0
7846631|NCT01463098|12328113|FG004|Part A (11 Days)|Lost to Follow-up|1
7846632|NCT01463098|12328114|FG005|Part A (11 Days)|Lost to Follow-up|0
7846633|NCT01463098|12328115|FG006|Part A (11 Days)|Lost to Follow-up|0
7846634|NCT01463098|12328116|FG007|Part A (11 Days)|Lost to Follow-up|0
7846635|NCT01463098|12328117|FG008|Part A (11 Days)|Lost to Follow-up|0
7846636|NCT01463098|12328118|FG009|Part A (11 Days)|Lost to Follow-up|0
7846637|NCT01463098|12328119|FG010|Part A (11 Days)|Lost to Follow-up|0
7846638|NCT01463098|12328120|FG011|Part A (11 Days)|Lost to Follow-up|0
7846639|NCT01463098|12328121|FG012|Part A (11 Days)|Lost to Follow-up|0
7846640|NCT01463098|12328122|FG013|Part A (11 Days)|Lost to Follow-up|0
7846641|NCT01463098|12328109|FG000|Part B (11 Days)|Participant Choice|0
7846642|NCT01463098|12328110|FG001|Part B (11 Days)|Participant Choice|0
7846643|NCT01463098|12328111|FG002|Part B (11 Days)|Participant Choice|0
7846644|NCT01463098|12328112|FG003|Part B (11 Days)|Participant Choice|0
7846645|NCT01463098|12328113|FG004|Part B (11 Days)|Participant Choice|0
7846646|NCT01463098|12328114|FG005|Part B (11 Days)|Participant Choice|0
7846647|NCT01463098|12328115|FG006|Part B (11 Days)|Participant Choice|0
7846648|NCT01463098|12328116|FG007|Part B (11 Days)|Participant Choice|0
7846649|NCT01463098|12328117|FG008|Part B (11 Days)|Participant Choice|0
7846650|NCT01463098|12328118|FG009|Part B (11 Days)|Participant Choice|0
7846651|NCT01463098|12328119|FG010|Part B (11 Days)|Participant Choice|0
7846652|NCT01463098|12328120|FG011|Part B (11 Days)|Participant Choice|1
7846653|NCT01463098|12328121|FG012|Part B (11 Days)|Participant Choice|0
7846654|NCT01463098|12328122|FG013|Part B (11 Days)|Participant Choice|0
7846655|NCT01463111|12328171|FG000|Overall Study|Withdrawal by Subject|2
7846656|NCT01463111|12328171|FG000|Overall Study|Lost to Follow-up|5
7846657|NCT01463111|12328171|FG000|Overall Study|Physician Decision|2
7846658|NCT01463306|12328204|FG000|Overall Study|Adverse Event|6
7846659|NCT01463306|12328205|FG001|Overall Study|Adverse Event|9
7846660|NCT01463306|12328206|FG002|Overall Study|Adverse Event|3
7846661|NCT01463306|12328204|FG000|Overall Study|Death|3
7846662|NCT01463306|12328205|FG001|Overall Study|Death|3
7846663|NCT01463306|12328206|FG002|Overall Study|Death|0
7846664|NCT01463306|12328204|FG000|Overall Study|Lack of Efficacy|22
7846665|NCT01463306|12328205|FG001|Overall Study|Lack of Efficacy|16
7846666|NCT01463306|12328206|FG002|Overall Study|Lack of Efficacy|1
7846667|NCT01463306|12328204|FG000|Overall Study|Lost to Follow-up|5
7846668|NCT01463306|12328205|FG001|Overall Study|Lost to Follow-up|2
7846669|NCT01463306|12328206|FG002|Overall Study|Lost to Follow-up|0
7846670|NCT01463306|12328204|FG000|Overall Study|Protocol Violation|4
7846671|NCT01463306|12328205|FG001|Overall Study|Protocol Violation|0
7846672|NCT01463306|12328206|FG002|Overall Study|Protocol Violation|0
7846673|NCT01463306|12328204|FG000|Overall Study|Withdrawal by Subject|19
7846674|NCT01463306|12328205|FG001|Overall Study|Withdrawal by Subject|9
7846675|NCT01463306|12328206|FG002|Overall Study|Withdrawal by Subject|1
7846676|NCT01463306|12328204|FG000|Overall Study|Other|26
7846677|NCT01463306|12328205|FG001|Overall Study|Other|13
7846678|NCT01463306|12328206|FG002|Overall Study|Other|0
7846679|NCT01463306|12328204|FG000|Overall Study|Approval expiry at site|1
7846680|NCT01463306|12328205|FG001|Overall Study|Approval expiry at site|0
7846681|NCT01463306|12328206|FG002|Overall Study|Approval expiry at site|0
7846682|NCT01463527|12328231|FG000|Overall Study|Protocol Violation|1
7846683|NCT01463527|12328232|FG001|Overall Study|Protocol Violation|1
7846684|NCT01463527|12328231|FG000|Overall Study|Crying >20% of sedation|5
7846685|NCT01463527|12328232|FG001|Overall Study|Crying >20% of sedation|6
7846686|NCT01463631|12328242|FG000|Overall Study|Withdrawal by Subject|0
7846687|NCT01463631|12328243|FG001|Overall Study|Withdrawal by Subject|0
7846688|NCT01463631|12328244|FG002|Overall Study|Withdrawal by Subject|0
7846689|NCT01463631|12328245|FG003|Overall Study|Withdrawal by Subject|1
7846690|NCT01463631|12328242|FG000|Overall Study|Death|0
7846691|NCT01463631|12328243|FG001|Overall Study|Death|0
7846692|NCT01463631|12328244|FG002|Overall Study|Death|1
7846693|NCT01463631|12328245|FG003|Overall Study|Death|0
7846694|NCT01463631|12328242|FG000|Overall Study|Progressive Disease|0
7846695|NCT01463631|12328243|FG001|Overall Study|Progressive Disease|0
7846696|NCT01463631|12328244|FG002|Overall Study|Progressive Disease|0
7846697|NCT01463631|12328245|FG003|Overall Study|Progressive Disease|5
7846698|NCT01463683|12328260|FG000|Overall Study|Adverse Event|2
7846699|NCT01463683|12328261|FG001|Overall Study|Adverse Event|0
7846700|NCT01463683|12328262|FG002|Overall Study|Adverse Event|0
7846701|NCT01463683|12328260|FG000|Overall Study|Lost to Follow-up|10
7846702|NCT01463683|12328261|FG001|Overall Study|Lost to Follow-up|9
7846703|NCT01463683|12328262|FG002|Overall Study|Lost to Follow-up|7
7846704|NCT01463683|12328260|FG000|Overall Study|Physician Decision|0
7846705|NCT01463683|12328261|FG001|Overall Study|Physician Decision|3
7846706|NCT01463683|12328262|FG002|Overall Study|Physician Decision|1
7846707|NCT01463683|12328260|FG000|Overall Study|Pregnancy|2
7846708|NCT01463683|12328261|FG001|Overall Study|Pregnancy|2
7846709|NCT01463683|12328262|FG002|Overall Study|Pregnancy|1
7846710|NCT01463683|12328260|FG000|Overall Study|Withdrawal by Subject|5
7846711|NCT01463683|12328261|FG001|Overall Study|Withdrawal by Subject|17
7846712|NCT01463683|12328262|FG002|Overall Study|Withdrawal by Subject|2
7846713|NCT01463696|12328278|FG000|Overall Study|Adverse Event|0
7846714|NCT01463696|12328279|FG001|Overall Study|Adverse Event|1
7846715|NCT01463696|12328280|FG002|Overall Study|Adverse Event|0
7846716|NCT01463696|12328281|FG003|Overall Study|Adverse Event|2
7846717|NCT01463696|12328282|FG004|Overall Study|Adverse Event|0
7846718|NCT01463696|12328283|FG005|Overall Study|Adverse Event|1
7846719|NCT01463696|12328284|FG006|Overall Study|Adverse Event|3
7846720|NCT01463696|12328285|FG007|Overall Study|Adverse Event|2
7846721|NCT01463696|12328278|FG000|Overall Study|Lost to Follow-up|0
7846722|NCT01463696|12328279|FG001|Overall Study|Lost to Follow-up|0
7846723|NCT01463696|12328280|FG002|Overall Study|Lost to Follow-up|1
7846724|NCT01463696|12328281|FG003|Overall Study|Lost to Follow-up|0
7846725|NCT01463696|12328282|FG004|Overall Study|Lost to Follow-up|0
7846726|NCT01463696|12328283|FG005|Overall Study|Lost to Follow-up|0
7846727|NCT01463696|12328284|FG006|Overall Study|Lost to Follow-up|0
7846728|NCT01463696|12328285|FG007|Overall Study|Lost to Follow-up|0
7846729|NCT01463696|12328278|FG000|Overall Study|Progressive Disease|0
7846730|NCT01463696|12328279|FG001|Overall Study|Progressive Disease|1
7846731|NCT01463696|12328280|FG002|Overall Study|Progressive Disease|0
7846732|NCT01463696|12328281|FG003|Overall Study|Progressive Disease|1
7846733|NCT01463696|12328282|FG004|Overall Study|Progressive Disease|0
7846734|NCT01463696|12328283|FG005|Overall Study|Progressive Disease|1
7846735|NCT01463696|12328284|FG006|Overall Study|Progressive Disease|4
7846736|NCT01463696|12328285|FG007|Overall Study|Progressive Disease|2
7846737|NCT01463696|12328278|FG000|Overall Study|Withdrawal by Subject|0
7846738|NCT01463696|12328279|FG001|Overall Study|Withdrawal by Subject|0
7846739|NCT01463696|12328280|FG002|Overall Study|Withdrawal by Subject|0
7846740|NCT01463696|12328281|FG003|Overall Study|Withdrawal by Subject|1
7846741|NCT01463696|12328282|FG004|Overall Study|Withdrawal by Subject|1
7846742|NCT01463696|12328283|FG005|Overall Study|Withdrawal by Subject|1
7846743|NCT01463696|12328284|FG006|Overall Study|Withdrawal by Subject|2
7846744|NCT01463696|12328285|FG007|Overall Study|Withdrawal by Subject|0
7846745|NCT01463696|12328278|FG000|Overall Study|Not Treated|0
7846746|NCT01463696|12328279|FG001|Overall Study|Not Treated|0
7846747|NCT01463696|12328280|FG002|Overall Study|Not Treated|0
7846748|NCT01463696|12328281|FG003|Overall Study|Not Treated|0
7846749|NCT01463696|12328282|FG004|Overall Study|Not Treated|0
7846750|NCT01463696|12328283|FG005|Overall Study|Not Treated|0
7846751|NCT01463696|12328284|FG006|Overall Study|Not Treated|1
7846752|NCT01463696|12328285|FG007|Overall Study|Not Treated|0
7846753|NCT01463878|12328305|FG000|Overall Study|no longer met criteria for tube feed|2
7846754|NCT01463878|12328306|FG001|Overall Study|no longer met criteria for tube feed|2
7846755|NCT01463982|12328316|FG000|Overall Study|Withdrawal by Subject|0
7846756|NCT01463982|12328317|FG001|Overall Study|Withdrawal by Subject|1
7846757|NCT01463982|12328318|FG002|Overall Study|Withdrawal by Subject|1
7846758|NCT01463982|12328319|FG003|Overall Study|Withdrawal by Subject|0
7846759|NCT01463982|12328316|FG000|Overall Study|Treatment delay over 5 week|0
7846760|NCT01463982|12328317|FG001|Overall Study|Treatment delay over 5 week|0
7846761|NCT01463982|12328318|FG002|Overall Study|Treatment delay over 5 week|1
7846762|NCT01463982|12328319|FG003|Overall Study|Treatment delay over 5 week|0
7846763|NCT01464021|12328329|FG000|Overall Study|Withdrawal by Subject|13
7846764|NCT01464021|12328329|FG000|Overall Study|Lost to Follow-up|1
7846765|NCT01464021|12328329|FG000|Overall Study|Lack of Efficacy|1
7846766|NCT01464021|12328329|FG000|Overall Study|various|11
7846767|NCT01464255|12328353|FG000|Overall Study|unresolve corneal staining|0
7846768|NCT01464255|12328354|FG001|Overall Study|unresolve corneal staining|1
7846769|NCT01464307|12328363|FG000|Main Period|Death|0
7846770|NCT01464307|12328364|FG001|Main Period|Death|1
7846771|NCT01464307|12328363|FG000|Main Period|Adverse Event|6
7846772|NCT01464307|12328364|FG001|Main Period|Adverse Event|1
7846773|NCT01464307|12328363|FG000|Main Period|Lack of Efficacy|2
7846774|NCT01464307|12328364|FG001|Main Period|Lack of Efficacy|0
7846775|NCT01464307|12328363|FG000|Main Period|Withdrawal by Subject|5
7846776|NCT01464307|12328364|FG001|Main Period|Withdrawal by Subject|2
7846777|NCT01464307|12328363|FG000|Main Period|Predefined discontinuation criteria|2
7846778|NCT01464307|12328364|FG001|Main Period|Predefined discontinuation criteria|1
7846779|NCT01464307|12328363|FG000|Open-Label Extension Period|Adverse Event|15
7846780|NCT01464307|12328364|FG001|Open-Label Extension Period|Adverse Event|0
7846781|NCT01464307|12328363|FG000|Open-Label Extension Period|Withdrawal by Subject|14
7846782|NCT01464307|12328364|FG001|Open-Label Extension Period|Withdrawal by Subject|0
7846783|NCT01464307|12328363|FG000|Open-Label Extension Period|Lack of Efficacy|5
7846784|NCT01464307|12328364|FG001|Open-Label Extension Period|Lack of Efficacy|0
7846785|NCT01464307|12328363|FG000|Open-Label Extension Period|Death|1
7846786|NCT01464307|12328364|FG001|Open-Label Extension Period|Death|0
7846787|NCT01464307|12328363|FG000|Open-Label Extension Period|Lost to Follow-up|1
7846788|NCT01464307|12328364|FG001|Open-Label Extension Period|Lost to Follow-up|0
7846789|NCT01464307|12328363|FG000|Open-Label Extension Period|Non-compliance|9
7846790|NCT01464307|12328364|FG001|Open-Label Extension Period|Non-compliance|0
7846791|NCT01464307|12328363|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6
7846792|NCT01464307|12328364|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0
7846793|NCT01464333|12328371|FG000|Overall Study|Adverse Event|34
7846794|NCT01464333|12328371|FG000|Overall Study|Lack of Efficacy|72
7846795|NCT01464333|12328371|FG000|Overall Study|Withdrawal by Subject|11
7846796|NCT01464333|12328371|FG000|Overall Study|Other|4
7846797|NCT01464333|12328371|FG000|Overall Study|No Hospital Visit|42
7846798|NCT01464346|12328375|FG000|Overall Study|Withdrawal by Subject|0
7846799|NCT01464346|12328376|FG001|Overall Study|Withdrawal by Subject|0
7846800|NCT01464346|12328377|FG002|Overall Study|Withdrawal by Subject|1
7846801|NCT01464424|12328389|FG000|Period 1, First 6 Weeks|Adverse Event|0
7846802|NCT01464424|12328390|FG001|Period 1, First 6 Weeks|Adverse Event|1
7846803|NCT01464619|12328398|FG000|Overall Study|Lost to Follow-up|3
7846804|NCT01464619|12328399|FG001|Overall Study|Lost to Follow-up|4
7846805|NCT01464788|12328430|FG000|Overall Study|Lost to Follow-up|0
7846806|NCT01464788|12328431|FG001|Overall Study|Lost to Follow-up|1
7846807|NCT01464788|12328432|FG002|Overall Study|Lost to Follow-up|0
7846808|NCT01464788|12328430|FG000|Overall Study|Patient had hemorrhage after tPA started|0
7846809|NCT01464788|12328431|FG001|Overall Study|Patient had hemorrhage after tPA started|1
7846810|NCT01464788|12328432|FG002|Overall Study|Patient had hemorrhage after tPA started|0
7846811|NCT01464827|12328456|FG000|Overall Study|Adverse Event|0
7846812|NCT01464827|12328457|FG001|Overall Study|Adverse Event|0
7846813|NCT01464827|12328458|FG002|Overall Study|Adverse Event|0
7846814|NCT01464827|12328459|FG003|Overall Study|Adverse Event|0
7846815|NCT01464827|12328460|FG004|Overall Study|Adverse Event|0
7846816|NCT01464827|12328461|FG005|Overall Study|Adverse Event|0
7846817|NCT01464827|12328462|FG006|Overall Study|Adverse Event|0
7846818|NCT01464827|12328463|FG007|Overall Study|Adverse Event|0
7846819|NCT01464827|12328464|FG008|Overall Study|Adverse Event|0
7846820|NCT01464827|12328465|FG009|Overall Study|Adverse Event|0
7949157|NCT02533674|12494574|FG004|Dose Level V|Physician Decision|1
7846821|NCT01464827|12328466|FG010|Overall Study|Adverse Event|0
7846822|NCT01464827|12328467|FG011|Overall Study|Adverse Event|0
7846823|NCT01464827|12328468|FG012|Overall Study|Adverse Event|1
7846824|NCT01464827|12328469|FG013|Overall Study|Adverse Event|0
7846825|NCT01464827|12328456|FG000|Overall Study|Withdrawal by Subject|1
7846826|NCT01464827|12328457|FG001|Overall Study|Withdrawal by Subject|0
7846827|NCT01464827|12328458|FG002|Overall Study|Withdrawal by Subject|0
7846828|NCT01464827|12328459|FG003|Overall Study|Withdrawal by Subject|0
7846829|NCT01464827|12328460|FG004|Overall Study|Withdrawal by Subject|1
7846830|NCT01464827|12328461|FG005|Overall Study|Withdrawal by Subject|0
7846831|NCT01464827|12328462|FG006|Overall Study|Withdrawal by Subject|0
7846832|NCT01464827|12328463|FG007|Overall Study|Withdrawal by Subject|1
7846833|NCT01464827|12328464|FG008|Overall Study|Withdrawal by Subject|0
7846834|NCT01464827|12328465|FG009|Overall Study|Withdrawal by Subject|0
7846835|NCT01464827|12328466|FG010|Overall Study|Withdrawal by Subject|0
7846836|NCT01464827|12328467|FG011|Overall Study|Withdrawal by Subject|0
7846837|NCT01464827|12328468|FG012|Overall Study|Withdrawal by Subject|0
7846838|NCT01464827|12328469|FG013|Overall Study|Withdrawal by Subject|0
7846839|NCT01464827|12328456|FG000|Overall Study|Lost to Follow-up|0
7846840|NCT01464827|12328457|FG001|Overall Study|Lost to Follow-up|2
7846841|NCT01464827|12328458|FG002|Overall Study|Lost to Follow-up|0
7846842|NCT01464827|12328459|FG003|Overall Study|Lost to Follow-up|2
7846843|NCT01464827|12328460|FG004|Overall Study|Lost to Follow-up|3
7846844|NCT01464827|12328461|FG005|Overall Study|Lost to Follow-up|1
7846845|NCT01464827|12328462|FG006|Overall Study|Lost to Follow-up|2
7846846|NCT01464827|12328463|FG007|Overall Study|Lost to Follow-up|2
7846847|NCT01464827|12328464|FG008|Overall Study|Lost to Follow-up|0
7846848|NCT01464827|12328465|FG009|Overall Study|Lost to Follow-up|0
7846849|NCT01464827|12328466|FG010|Overall Study|Lost to Follow-up|0
7846850|NCT01464827|12328467|FG011|Overall Study|Lost to Follow-up|1
7846851|NCT01464827|12328468|FG012|Overall Study|Lost to Follow-up|0
7846852|NCT01464827|12328469|FG013|Overall Study|Lost to Follow-up|1
7846853|NCT01464827|12328456|FG000|Overall Study|Other|2
7846854|NCT01464827|12328457|FG001|Overall Study|Other|3
7846855|NCT01464827|12328458|FG002|Overall Study|Other|0
7846856|NCT01464827|12328459|FG003|Overall Study|Other|2
7846857|NCT01464827|12328460|FG004|Overall Study|Other|3
7846858|NCT01464827|12328461|FG005|Overall Study|Other|0
7846859|NCT01464827|12328462|FG006|Overall Study|Other|1
7846860|NCT01464827|12328463|FG007|Overall Study|Other|0
7846861|NCT01464827|12328464|FG008|Overall Study|Other|3
7846862|NCT01464827|12328465|FG009|Overall Study|Other|1
7846863|NCT01464827|12328466|FG010|Overall Study|Other|2
7846864|NCT01464827|12328467|FG011|Overall Study|Other|0
7846865|NCT01464827|12328468|FG012|Overall Study|Other|1
7846866|NCT01464827|12328469|FG013|Overall Study|Other|0
7846867|NCT01464827|12328456|FG000|Overall Study|Not Treated|0
7846868|NCT01464827|12328457|FG001|Overall Study|Not Treated|2
7846869|NCT01464827|12328458|FG002|Overall Study|Not Treated|0
7846870|NCT01464827|12328459|FG003|Overall Study|Not Treated|0
7846871|NCT01464827|12328460|FG004|Overall Study|Not Treated|1
7846872|NCT01464827|12328461|FG005|Overall Study|Not Treated|0
7846873|NCT01464827|12328462|FG006|Overall Study|Not Treated|1
7846874|NCT01464827|12328463|FG007|Overall Study|Not Treated|0
7846875|NCT01464827|12328464|FG008|Overall Study|Not Treated|0
7846876|NCT01464827|12328465|FG009|Overall Study|Not Treated|2
7846877|NCT01464827|12328466|FG010|Overall Study|Not Treated|0
7846878|NCT01464827|12328467|FG011|Overall Study|Not Treated|1
7846879|NCT01464827|12328468|FG012|Overall Study|Not Treated|0
7846880|NCT01464827|12328469|FG013|Overall Study|Not Treated|2
7846881|NCT01464879|12328523|FG000|Overall Study|Physician Decision|1
7846882|NCT01464879|12328523|FG000|Overall Study|Non-compliance|1
7846883|NCT01464931|12328535|FG000|Overall Study|Withdrawal by Subject|1
7846884|NCT01464931|12328536|FG001|Overall Study|Withdrawal by Subject|0
7846885|NCT01465022|12328558|FG000|Overall Study|Lost to Follow-up|15
7846886|NCT01465022|12328559|FG001|Overall Study|Lost to Follow-up|14
7846887|NCT01465022|12328560|FG002|Overall Study|Lost to Follow-up|0
7846888|NCT01465022|12328558|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8
7846889|NCT01465022|12328559|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9
7846890|NCT01465022|12328560|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0
7846891|NCT01465022|12328558|FG000|Overall Study|Not Randomized|0
7846892|NCT01465022|12328559|FG001|Overall Study|Not Randomized|0
7846893|NCT01465022|12328560|FG002|Overall Study|Not Randomized|70
7846894|NCT01465178|12328581|FG000|Overall Study|Withdrawal by Subject|1
7846895|NCT01465178|12328582|FG001|Overall Study|Withdrawal by Subject|0
7846896|NCT01465191|12328591|FG000|Overall Study|Protocol Violation|6
7846897|NCT01465191|12328592|FG001|Overall Study|Protocol Violation|3
7846898|NCT01465191|12328593|FG002|Overall Study|Protocol Violation|3
7846899|NCT01465191|12328591|FG000|Overall Study|Lost to Follow-up|3
7846900|NCT01465191|12328592|FG001|Overall Study|Lost to Follow-up|6
7846901|NCT01465191|12328593|FG002|Overall Study|Lost to Follow-up|4
7846902|NCT01465347|12328604|FG000|Overall Study|Withdrawal by Subject|1
7846903|NCT01465347|12328605|FG001|Overall Study|Withdrawal by Subject|1
7846904|NCT01465347|12328604|FG000|Overall Study|Physician Decision|0
7846905|NCT01465347|12328605|FG001|Overall Study|Physician Decision|1
7846906|NCT01465347|12328604|FG000|Overall Study|Admitted to hospice|0
7846907|NCT01465347|12328605|FG001|Overall Study|Admitted to hospice|1
7846908|NCT01465386|12328614|FG000|Overall Study|Lack of Efficacy|3
7846909|NCT01465386|12328614|FG000|Overall Study|Adverse Event|1
7846910|NCT01465464|12328637|FG000|Overall Study|Adverse Event|96
7846911|NCT01465464|12328638|FG001|Overall Study|Adverse Event|49
7846912|NCT01465464|12328637|FG000|Overall Study|Lack of Efficacy|139
7846913|NCT01465464|12328638|FG001|Overall Study|Lack of Efficacy|190
7846914|NCT01465464|12328637|FG000|Overall Study|Physician Decision|13
7846915|NCT01465464|12328638|FG001|Overall Study|Physician Decision|5
7846916|NCT01465464|12328637|FG000|Overall Study|Protocol Violation|1
7846917|NCT01465464|12328638|FG001|Overall Study|Protocol Violation|1
7846918|NCT01465464|12328637|FG000|Overall Study|Withdrawal by Subject|46
7846919|NCT01465464|12328638|FG001|Overall Study|Withdrawal by Subject|30
7846920|NCT01465464|12328637|FG000|Overall Study|Other|9
7846921|NCT01465464|12328638|FG001|Overall Study|Other|3
7846922|NCT01465464|12328637|FG000|Overall Study|Ongoing treatment at cutoff date|140
7846923|NCT01465464|12328638|FG001|Overall Study|Ongoing treatment at cutoff date|166
7863267|NCT01604408|12352512|FG000|Treatment Period 2|Withdrawal by Subject|1
7863268|NCT01604408|12352513|FG001|Treatment Period 2|Withdrawal by Subject|1
7863269|NCT01604408|12352512|FG000|Treatment Period 2|Protocol Violation|1
7863270|NCT01604408|12352513|FG001|Treatment Period 2|Protocol Violation|0
7863271|NCT01604408|12352512|FG000|Treatment Period 2|Adverse Event|0
7863272|NCT01604408|12352513|FG001|Treatment Period 2|Adverse Event|1
7863273|NCT01604408|12352512|FG000|Treatment Period 3|Protocol Violation|1
7863274|NCT01604408|12352513|FG001|Treatment Period 3|Protocol Violation|1
7863275|NCT01604408|12352512|FG000|Treatment Period 3|Adverse Event|0
7863276|NCT01604408|12352513|FG001|Treatment Period 3|Adverse Event|3
7863277|NCT01604408|12352512|FG000|Treatment Period 3|Withdrawal by Subject|3
7863278|NCT01604408|12352513|FG001|Treatment Period 3|Withdrawal by Subject|1
7949158|NCT02533674|12494575|FG005|Dose Level V|Physician Decision|0
7949159|NCT02533674|12494576|FG006|Dose Level V|Physician Decision|0
7949160|NCT02533674|12494577|FG007|Dose Level V|Physician Decision|0
7949161|NCT02533674|12494570|FG000|Dose Level VI|Progressive disease|0
7949162|NCT02533674|12494571|FG001|Dose Level VI|Progressive disease|0
7949163|NCT02533674|12494572|FG002|Dose Level VI|Progressive disease|0
7949164|NCT02533674|12494573|FG003|Dose Level VI|Progressive disease|0
7949165|NCT02533674|12494574|FG004|Dose Level VI|Progressive disease|0
7949166|NCT02533674|12494575|FG005|Dose Level VI|Progressive disease|7
7949167|NCT02533674|12494576|FG006|Dose Level VI|Progressive disease|0
7949168|NCT02533674|12494577|FG007|Dose Level VI|Progressive disease|0
7949169|NCT02533674|12494570|FG000|Dose Level VI|Withdrawal by Subject|0
7949170|NCT02533674|12494571|FG001|Dose Level VI|Withdrawal by Subject|0
7949171|NCT02533674|12494572|FG002|Dose Level VI|Withdrawal by Subject|0
7949172|NCT02533674|12494573|FG003|Dose Level VI|Withdrawal by Subject|0
7949173|NCT02533674|12494574|FG004|Dose Level VI|Withdrawal by Subject|0
7949174|NCT02533674|12494575|FG005|Dose Level VI|Withdrawal by Subject|1
7949175|NCT02533674|12494576|FG006|Dose Level VI|Withdrawal by Subject|0
7949176|NCT02533674|12494577|FG007|Dose Level VI|Withdrawal by Subject|0
7949177|NCT02533674|12494570|FG000|Dose Level VI|Treatment-related AE|0
7949178|NCT02533674|12494571|FG001|Dose Level VI|Treatment-related AE|0
7949179|NCT02533674|12494572|FG002|Dose Level VI|Treatment-related AE|0
7949180|NCT02533674|12494573|FG003|Dose Level VI|Treatment-related AE|0
7949181|NCT02533674|12494574|FG004|Dose Level VI|Treatment-related AE|0
7949182|NCT02533674|12494575|FG005|Dose Level VI|Treatment-related AE|1
7949183|NCT02533674|12494576|FG006|Dose Level VI|Treatment-related AE|0
7949184|NCT02533674|12494577|FG007|Dose Level VI|Treatment-related AE|0
7949185|NCT02533674|12494570|FG000|Dose Level VII|Progressive disease|0
7949186|NCT02533674|12494571|FG001|Dose Level VII|Progressive disease|0
7949187|NCT02533674|12494572|FG002|Dose Level VII|Progressive disease|0
7949188|NCT02533674|12494573|FG003|Dose Level VII|Progressive disease|0
7949189|NCT02533674|12494574|FG004|Dose Level VII|Progressive disease|0
7949190|NCT02533674|12494575|FG005|Dose Level VII|Progressive disease|0
7949191|NCT02533674|12494576|FG006|Dose Level VII|Progressive disease|10
7949192|NCT02533674|12494577|FG007|Dose Level VII|Progressive disease|0
7949193|NCT02533674|12494570|FG000|Dose Level VII|Withdrawal by Subject|0
7949194|NCT02533674|12494571|FG001|Dose Level VII|Withdrawal by Subject|0
7949195|NCT02533674|12494572|FG002|Dose Level VII|Withdrawal by Subject|0
7949196|NCT02533674|12494573|FG003|Dose Level VII|Withdrawal by Subject|0
7949197|NCT02533674|12494574|FG004|Dose Level VII|Withdrawal by Subject|0
7949198|NCT02533674|12494575|FG005|Dose Level VII|Withdrawal by Subject|0
7949199|NCT02533674|12494576|FG006|Dose Level VII|Withdrawal by Subject|3
7949200|NCT02533674|12494577|FG007|Dose Level VII|Withdrawal by Subject|0
7949201|NCT02533674|12494570|FG000|Dose Level VII|Treatment-related AE|0
7863279|NCT01604408|12352512|FG000|Treatment Period 3|Sponsor Decision|1
7863280|NCT01604408|12352513|FG001|Treatment Period 3|Sponsor Decision|0
7863281|NCT01604408|12352512|FG000|Treatment Period 4|Death|1
7863282|NCT01604408|12352513|FG001|Treatment Period 4|Death|0
7863283|NCT01604408|12352512|FG000|Treatment Period 4|Withdrawal by Subject|2
7863284|NCT01604408|12352513|FG001|Treatment Period 4|Withdrawal by Subject|1
7846924|NCT01465659|12328648|FG000|Completed 1 Cycle of Treatment|Death|0
7846925|NCT01465659|12328649|FG001|Completed 1 Cycle of Treatment|Death|1
7846926|NCT01465659|12328650|FG002|Completed 1 Cycle of Treatment|Death|0
7846927|NCT01465659|12328651|FG003|Completed 1 Cycle of Treatment|Death|0
7846928|NCT01465659|12328648|FG000|Completed 1 Cycle of Treatment|Adverse Event|0
7846929|NCT01465659|12328649|FG001|Completed 1 Cycle of Treatment|Adverse Event|0
7846930|NCT01465659|12328650|FG002|Completed 1 Cycle of Treatment|Adverse Event|0
7846931|NCT01465659|12328651|FG003|Completed 1 Cycle of Treatment|Adverse Event|1
7846932|NCT01465659|12328648|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
7846933|NCT01465659|12328649|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0
7846934|NCT01465659|12328650|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
7846935|NCT01465659|12328651|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
7846936|NCT01465659|12328648|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
7846937|NCT01465659|12328649|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
7846938|NCT01465659|12328650|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
7846939|NCT01465659|12328651|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
7846940|NCT01465659|12328648|FG000|Completed Follow for 1 Year|Death|6
7846941|NCT01465659|12328649|FG001|Completed Follow for 1 Year|Death|3
7846942|NCT01465659|12328650|FG002|Completed Follow for 1 Year|Death|2
7846943|NCT01465659|12328651|FG003|Completed Follow for 1 Year|Death|4
7846944|NCT01465763|12328667|FG000|Overall Study|Withdrawal by Subject|4
7846945|NCT01465763|12328668|FG001|Overall Study|Withdrawal by Subject|0
7846946|NCT01465763|12328669|FG002|Overall Study|Withdrawal by Subject|1
7846947|NCT01465763|12328667|FG000|Overall Study|Insufficient Clinical Response|11
7846948|NCT01465763|12328668|FG001|Overall Study|Insufficient Clinical Response|0
7846949|NCT01465763|12328669|FG002|Overall Study|Insufficient Clinical Response|1
7846950|NCT01465763|12328667|FG000|Overall Study|Adverse Event|9
7846951|NCT01465763|12328668|FG001|Overall Study|Adverse Event|0
7846952|NCT01465763|12328669|FG002|Overall Study|Adverse Event|1
7846953|NCT01465763|12328667|FG000|Overall Study|Other|2
7846954|NCT01465763|12328668|FG001|Overall Study|Other|0
7846955|NCT01465763|12328669|FG002|Overall Study|Other|0
7846956|NCT01465763|12328667|FG000|Overall Study|Protocol Violation|4
7846957|NCT01465763|12328668|FG001|Overall Study|Protocol Violation|1
7846958|NCT01465763|12328669|FG002|Overall Study|Protocol Violation|1
7846959|NCT01465763|12328667|FG000|Overall Study|Death|1
7846960|NCT01465763|12328668|FG001|Overall Study|Death|0
7846961|NCT01465763|12328669|FG002|Overall Study|Death|0
7846962|NCT01465802|12328681|FG000|Overall Study|Study terminated by sponsor|1
7846963|NCT01465802|12328682|FG001|Overall Study|Study terminated by sponsor|0
7846964|NCT01465802|12328683|FG002|Overall Study|Study terminated by sponsor|0
7846965|NCT01465802|12328684|FG003|Overall Study|Study terminated by sponsor|1
7846966|NCT01465802|12328685|FG004|Overall Study|Study terminated by sponsor|7
7846967|NCT01465802|12328681|FG000|Overall Study|Withdrawal by Subject|7
7846968|NCT01465802|12328682|FG001|Overall Study|Withdrawal by Subject|7
7846969|NCT01465802|12328683|FG002|Overall Study|Withdrawal by Subject|0
7846970|NCT01465802|12328684|FG003|Overall Study|Withdrawal by Subject|8
7846971|NCT01465802|12328685|FG004|Overall Study|Withdrawal by Subject|1
7846972|NCT01465802|12328681|FG000|Overall Study|Lost to Follow-up|1
7846973|NCT01465802|12328682|FG001|Overall Study|Lost to Follow-up|1
7846974|NCT01465802|12328683|FG002|Overall Study|Lost to Follow-up|0
7846975|NCT01465802|12328684|FG003|Overall Study|Lost to Follow-up|0
7846976|NCT01465802|12328685|FG004|Overall Study|Lost to Follow-up|0
7846977|NCT01465802|12328681|FG000|Overall Study|Reason not specified|9
7846978|NCT01465802|12328682|FG001|Overall Study|Reason not specified|4
7846979|NCT01465802|12328683|FG002|Overall Study|Reason not specified|0
7846980|NCT01465802|12328684|FG003|Overall Study|Reason not specified|10
7846981|NCT01465802|12328685|FG004|Overall Study|Reason not specified|2
7846982|NCT01465802|12328681|FG000|Overall Study|Death|15
7846983|NCT01465802|12328682|FG001|Overall Study|Death|12
7846984|NCT01465802|12328683|FG002|Overall Study|Death|0
7846985|NCT01465802|12328684|FG003|Overall Study|Death|10
7846986|NCT01465802|12328685|FG004|Overall Study|Death|2
7846987|NCT01465958|12328703|FG000|Run-in Phase|Protocol Violation|1
7846988|NCT01465958|12328704|FG001|Run-in Phase|Protocol Violation|0
7846989|NCT01465958|12328703|FG000|Subcutaneous (SC) Phase|Adverse Event|0
7846990|NCT01465958|12328704|FG001|Subcutaneous (SC) Phase|Adverse Event|1
7846991|NCT01465997|12328713|FG000|Overall Study|Adverse Event|12
7846992|NCT01465997|12328714|FG001|Overall Study|Adverse Event|22
7846993|NCT01465997|12328713|FG000|Overall Study|Lack of Efficacy|13
7846994|NCT01465997|12328714|FG001|Overall Study|Lack of Efficacy|1
7846995|NCT01465997|12328713|FG000|Overall Study|Protocol Violation|1
7846996|NCT01465997|12328714|FG001|Overall Study|Protocol Violation|4
7846997|NCT01465997|12328713|FG000|Overall Study|Lost to Follow-up|6
7846998|NCT01465997|12328714|FG001|Overall Study|Lost to Follow-up|9
7846999|NCT01465997|12328713|FG000|Overall Study|Withdrawal by Subject|32
7847000|NCT01465997|12328714|FG001|Overall Study|Withdrawal by Subject|35
7847001|NCT01465997|12328713|FG000|Overall Study|investigator's decision|1
7847002|NCT01465997|12328714|FG001|Overall Study|investigator's decision|1
7847003|NCT01465997|12328713|FG000|Overall Study|Death|0
7847004|NCT01465997|12328714|FG001|Overall Study|Death|1
7847005|NCT01465997|12328713|FG000|Overall Study|sponsor's decision|1
7847006|NCT01465997|12328714|FG001|Overall Study|sponsor's decision|1
7847007|NCT01465997|12328713|FG000|Overall Study|subject withdrew consent|1
7847008|NCT01465997|12328714|FG001|Overall Study|subject withdrew consent|0
7847009|NCT01465997|12328713|FG000|Overall Study|local lab unblinded site|1
7847010|NCT01465997|12328714|FG001|Overall Study|local lab unblinded site|0
7847011|NCT01465997|12328713|FG000|Overall Study|withdrew before follow-up|0
7847012|NCT01465997|12328714|FG001|Overall Study|withdrew before follow-up|13
7847013|NCT01465997|12328713|FG000|Overall Study|decision by site staff|0
7847014|NCT01465997|12328714|FG001|Overall Study|decision by site staff|1
7847015|NCT01465997|12328713|FG000|Overall Study|subject left participation SP0993|0
7847016|NCT01465997|12328714|FG001|Overall Study|subject left participation SP0993|1
7847017|NCT01466062|12328722|FG000|Overall Study|Adverse Event|1
7847018|NCT01466062|12328722|FG000|Overall Study|Withdrawal by Subject|1
7847019|NCT01466153|12328742|FG000|Overall Study|Disease Progression|2
7847020|NCT01466153|12328743|FG001|Overall Study|Disease Progression|2
7847021|NCT01466153|12328744|FG002|Overall Study|Disease Progression|0
7847022|NCT01466153|12328742|FG000|Overall Study|Adverse Event|14
7847023|NCT01466153|12328743|FG001|Overall Study|Adverse Event|13
7847024|NCT01466153|12328744|FG002|Overall Study|Adverse Event|17
7847025|NCT01466153|12328742|FG000|Overall Study|Withdrawal of Consent|2
7847026|NCT01466153|12328743|FG001|Overall Study|Withdrawal of Consent|0
7847027|NCT01466153|12328744|FG002|Overall Study|Withdrawal of Consent|0
7847028|NCT01466153|12328742|FG000|Overall Study|Investigator Discretion|3
7847029|NCT01466153|12328743|FG001|Overall Study|Investigator Discretion|2
7847030|NCT01466153|12328744|FG002|Overall Study|Investigator Discretion|2
7847031|NCT01466153|12328742|FG000|Overall Study|Randomized-Not Treated|2
7847032|NCT01466153|12328743|FG001|Overall Study|Randomized-Not Treated|3
7847033|NCT01466153|12328744|FG002|Overall Study|Randomized-Not Treated|4
7847034|NCT01466153|12328742|FG000|Overall Study|Other-Unspecified|6
7847035|NCT01466153|12328743|FG001|Overall Study|Other-Unspecified|4
7847036|NCT01466153|12328744|FG002|Overall Study|Other-Unspecified|2
7847037|NCT01466166|12328754|FG000|Overall Study|Death|1
7847038|NCT01466166|12328754|FG000|Overall Study|Lost to Follow-up|7
7847039|NCT01466166|12328754|FG000|Overall Study|Infusion Reaction (IR)|27
7847040|NCT01466166|12328754|FG000|Overall Study|Adverse Event (Other than IR)|11
7847041|NCT01466166|12328754|FG000|Overall Study|Elevated Serum Uric Acid|78
7847042|NCT01466166|12328754|FG000|Overall Study|Withdrawal by Subject|13
7847043|NCT01466166|12328754|FG000|Overall Study|Sponsor Decision|4
7847044|NCT01466166|12328754|FG000|Overall Study|Protocol Violation/Noncompliance|2
7847045|NCT01466166|12328754|FG000|Overall Study|Other|20
7847046|NCT01466179|12328758|FG000|Overall Study|Ongoing in core study|2
7847047|NCT01466179|12328758|FG000|Overall Study|Physician Decision|46
7847048|NCT01466179|12328758|FG000|Overall Study|Progressive disease|43
7847049|NCT01466179|12328758|FG000|Overall Study|Adverse Event|32
7847050|NCT01466179|12328758|FG000|Overall Study|Disease relapse|23
7847051|NCT01466179|12328758|FG000|Overall Study|Lack of Efficacy|14
7847052|NCT01466179|12328758|FG000|Overall Study|Death|7
7847053|NCT01466179|12328758|FG000|Overall Study|Withdrawal by Subject|7
7847054|NCT01466179|12328758|FG000|Overall Study|Protocol Violation|2
7847055|NCT01466179|12328758|FG000|Overall Study|Other|3
7847056|NCT01466192|12328765|FG000|Overall Study|Physician Decision|1
7847057|NCT01466192|12328765|FG000|Overall Study|Withdrawal by Subject|3
7847058|NCT01466270|12328771|FG000|Overall Study|Withdrawal by Subject|4
7847059|NCT01466270|12328772|FG001|Overall Study|Withdrawal by Subject|1
7847060|NCT01466270|12328771|FG000|Overall Study|Physician Decision|1
7847061|NCT01466270|12328772|FG001|Overall Study|Physician Decision|0
7847062|NCT01466270|12328771|FG000|Overall Study|Lost to Follow-up|1
7847063|NCT01466270|12328772|FG001|Overall Study|Lost to Follow-up|3
7847064|NCT01466270|12328771|FG000|Overall Study|Progression|1
7847065|NCT01466270|12328772|FG001|Overall Study|Progression|0
7847066|NCT01466270|12328771|FG000|Overall Study|Toxicity|4
7847067|NCT01466270|12328772|FG001|Overall Study|Toxicity|1
7847068|NCT01466270|12328771|FG000|Overall Study|Multiple|1
7847069|NCT01466270|12328772|FG001|Overall Study|Multiple|1
7847070|NCT01466348|12328780|FG000|Period I - First Intervention|Withdrawal by Subject|0
7847071|NCT01466348|12328781|FG001|Period I - First Intervention|Withdrawal by Subject|1
7847072|NCT01466387|12328817|FG000|Overall Study|Adverse Event|0
7847073|NCT01466387|12328818|FG001|Overall Study|Adverse Event|0
7847074|NCT01466387|12328819|FG002|Overall Study|Adverse Event|1
7847075|NCT01466387|12328820|FG003|Overall Study|Adverse Event|1
7847076|NCT01466387|12328821|FG004|Overall Study|Adverse Event|0
7847077|NCT01466387|12328822|FG005|Overall Study|Adverse Event|0
7847078|NCT01466387|12328817|FG000|Overall Study|Lost to Follow-up|0
7847079|NCT01466387|12328818|FG001|Overall Study|Lost to Follow-up|0
7847080|NCT01466387|12328819|FG002|Overall Study|Lost to Follow-up|0
7847081|NCT01466387|12328820|FG003|Overall Study|Lost to Follow-up|0
7847082|NCT01466387|12328821|FG004|Overall Study|Lost to Follow-up|0
7847083|NCT01466387|12328822|FG005|Overall Study|Lost to Follow-up|1
7847084|NCT01466387|12328817|FG000|Overall Study|Protocol Violation|1
7847085|NCT01466387|12328818|FG001|Overall Study|Protocol Violation|0
7847086|NCT01466387|12328819|FG002|Overall Study|Protocol Violation|0
7847087|NCT01466387|12328820|FG003|Overall Study|Protocol Violation|1
7847088|NCT01466387|12328821|FG004|Overall Study|Protocol Violation|0
7847089|NCT01466387|12328822|FG005|Overall Study|Protocol Violation|0
7847090|NCT01466491|12328849|FG000|Overall Study|Protocol Violation|0
7847091|NCT01466491|12328850|FG001|Overall Study|Protocol Violation|3
7847092|NCT01466491|12328851|FG002|Overall Study|Protocol Violation|2
7847093|NCT01466491|12328852|FG003|Overall Study|Protocol Violation|0
7847094|NCT01466491|12328849|FG000|Overall Study|Missing Data|0
7847095|NCT01466491|12328850|FG001|Overall Study|Missing Data|0
7847096|NCT01466491|12328851|FG002|Overall Study|Missing Data|1
7847097|NCT01466491|12328852|FG003|Overall Study|Missing Data|0
7847098|NCT01466595|12328864|FG000|Overall Study|Withdrawal by Subject|0
7847099|NCT01466595|12328865|FG001|Overall Study|Withdrawal by Subject|1
7847100|NCT01466660|12328873|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120
7847101|NCT01466660|12328874|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127
7847102|NCT01466660|12328873|FG000|Overall Study|Worsening of underlying cancer disease|5
7847103|NCT01466660|12328874|FG001|Overall Study|Worsening of underlying cancer disease|2
7847104|NCT01466660|12328873|FG000|Overall Study|Other adverse event|19
7847105|NCT01466660|12328874|FG001|Overall Study|Other adverse event|18
7847106|NCT01466660|12328873|FG000|Overall Study|Protocol Violation|2
7847107|NCT01466660|12328874|FG001|Overall Study|Protocol Violation|1
7847108|NCT01466660|12328873|FG000|Overall Study|Refused continuation of trial medication|4
7847109|NCT01466660|12328874|FG001|Overall Study|Refused continuation of trial medication|3
7847110|NCT01466660|12328873|FG000|Overall Study|Other reason not defined above|10
7847111|NCT01466660|12328874|FG001|Overall Study|Other reason not defined above|8
7847112|NCT01466673|12328882|FG000|Overall Study|Non-compliance with study treatment|2
7847113|NCT01466673|12328883|FG001|Overall Study|Non-compliance with study treatment|0
7847114|NCT01466673|12328882|FG000|Overall Study|Lost to Follow-up|3
7847115|NCT01466673|12328883|FG001|Overall Study|Lost to Follow-up|5
7847116|NCT01466673|12328882|FG000|Overall Study|Adverse Event|2
7847117|NCT01466673|12328883|FG001|Overall Study|Adverse Event|1
7847118|NCT01466790|12328917|FG000|Overall Study|Adverse Event|1
7847119|NCT01466790|12328918|FG001|Overall Study|Adverse Event|0
7847120|NCT01466790|12328919|FG002|Overall Study|Adverse Event|0
7847121|NCT01466790|12328920|FG003|Overall Study|Adverse Event|0
7847122|NCT01466790|12328921|FG004|Overall Study|Adverse Event|2
7847123|NCT01466790|12328922|FG005|Overall Study|Adverse Event|0
7847124|NCT01466790|12328923|FG006|Overall Study|Adverse Event|0
7847125|NCT01466790|12328924|FG007|Overall Study|Adverse Event|0
7847126|NCT01466790|12328917|FG000|Overall Study|Lost to Follow-up|2
7847127|NCT01466790|12328918|FG001|Overall Study|Lost to Follow-up|0
7847128|NCT01466790|12328919|FG002|Overall Study|Lost to Follow-up|0
7847129|NCT01466790|12328920|FG003|Overall Study|Lost to Follow-up|0
7847130|NCT01466790|12328921|FG004|Overall Study|Lost to Follow-up|0
7847131|NCT01466790|12328922|FG005|Overall Study|Lost to Follow-up|0
7847132|NCT01466790|12328923|FG006|Overall Study|Lost to Follow-up|0
7847133|NCT01466790|12328924|FG007|Overall Study|Lost to Follow-up|0
7847134|NCT01466790|12328917|FG000|Overall Study|Withdrawal by Subject|1
7847135|NCT01466790|12328918|FG001|Overall Study|Withdrawal by Subject|1
7847136|NCT01466790|12328919|FG002|Overall Study|Withdrawal by Subject|0
7847137|NCT01466790|12328920|FG003|Overall Study|Withdrawal by Subject|0
7847138|NCT01466790|12328921|FG004|Overall Study|Withdrawal by Subject|1
7847139|NCT01466790|12328922|FG005|Overall Study|Withdrawal by Subject|0
7847140|NCT01466790|12328923|FG006|Overall Study|Withdrawal by Subject|1
7847141|NCT01466790|12328924|FG007|Overall Study|Withdrawal by Subject|1
7847142|NCT01466881|12328938|FG000|Overall Study|Ineligible|5
7847143|NCT01466881|12328938|FG000|Overall Study|Adverse Event|6
7847144|NCT01466881|12328938|FG000|Overall Study|Progression/relapse|20
7847145|NCT01466881|12328938|FG000|Overall Study|Death|4
7847146|NCT01466881|12328938|FG000|Overall Study|Other reason not protocol specified|5
7847147|NCT01467076|12328981|FG000|Overall Study|Lost to Follow-up|1
7847148|NCT01467076|12328982|FG001|Overall Study|Lost to Follow-up|0
7847149|NCT01467076|12328983|FG002|Overall Study|Lost to Follow-up|0
7847150|NCT01467271|12328991|FG000|Overall Study|Death|84
7847151|NCT01467271|12328991|FG000|Overall Study|Lost to Follow-up|83
7847152|NCT01467271|12328991|FG000|Overall Study|Retraction of patient's consent|21
7847153|NCT01467271|12328991|FG000|Overall Study|Other reason|14
7847154|NCT01467427|12328997|FG000|Overall Study|Withdrawal by Subject|1
7847155|NCT01467427|12328998|FG001|Overall Study|Withdrawal by Subject|0
7847156|NCT01467427|12328997|FG000|Overall Study|Entered extension phase|11
7847157|NCT01467427|12328998|FG001|Overall Study|Entered extension phase|11
7847158|NCT01467427|12328997|FG000|Overall Study|Not continuing in extension phase|0
7847159|NCT01467427|12328998|FG001|Overall Study|Not continuing in extension phase|2
7847160|NCT01467479|12329007|FG000|Overall Study|No Study Medication|1
7847161|NCT01467479|12329008|FG001|Overall Study|No Study Medication|0
7847162|NCT01467479|12329009|FG002|Overall Study|No Study Medication|2
7847163|NCT01467479|12329007|FG000|Overall Study|Adverse Event|1
7847164|NCT01467479|12329008|FG001|Overall Study|Adverse Event|2
7847165|NCT01467479|12329009|FG002|Overall Study|Adverse Event|0
7847166|NCT01467479|12329007|FG000|Overall Study|Death|0
7847167|NCT01467479|12329008|FG001|Overall Study|Death|0
7847168|NCT01467479|12329009|FG002|Overall Study|Death|1
7847169|NCT01467479|12329007|FG000|Overall Study|Lost to Follow-up|2
7847170|NCT01467479|12329008|FG001|Overall Study|Lost to Follow-up|5
7847171|NCT01467479|12329009|FG002|Overall Study|Lost to Follow-up|3
7847172|NCT01467479|12329007|FG000|Overall Study|Withdrawal of Consent|3
7847173|NCT01467479|12329008|FG001|Overall Study|Withdrawal of Consent|7
7847174|NCT01467479|12329009|FG002|Overall Study|Withdrawal of Consent|7
7847175|NCT01467479|12329007|FG000|Overall Study|Study Terminated by Sponsor|1
7847176|NCT01467479|12329008|FG001|Overall Study|Study Terminated by Sponsor|3
7847177|NCT01467479|12329009|FG002|Overall Study|Study Terminated by Sponsor|3
7847178|NCT01467479|12329007|FG000|Overall Study|Other|1
7847179|NCT01467479|12329008|FG001|Overall Study|Other|0
7847180|NCT01467479|12329009|FG002|Overall Study|Other|0
7847181|NCT01467492|12329020|FG000|Overall Study|Withdrawal by Subject|6
7847182|NCT01467492|12329021|FG001|Overall Study|Withdrawal by Subject|4
7847183|NCT01467492|12329020|FG000|Overall Study|Study Terminated by Sponsor|6
7847184|NCT01467492|12329021|FG001|Overall Study|Study Terminated by Sponsor|4
7847185|NCT01467492|12329020|FG000|Overall Study|Adverse Event|4
7847186|NCT01467492|12329021|FG001|Overall Study|Adverse Event|3
7847187|NCT01467492|12329020|FG000|Overall Study|Lost to Follow-up|3
7847188|NCT01467492|12329021|FG001|Overall Study|Lost to Follow-up|2
7847189|NCT01467492|12329020|FG000|Overall Study|Undefined|2
7847190|NCT01467492|12329021|FG001|Overall Study|Undefined|0
7847191|NCT01467492|12329020|FG000|Overall Study|Enrolled But Not Treated|1
7847192|NCT01467492|12329021|FG001|Overall Study|Enrolled But Not Treated|0
7847193|NCT01467505|12329030|FG000|Overall Study|Adverse Event|1
7847194|NCT01467505|12329031|FG001|Overall Study|Adverse Event|0
7847195|NCT01467505|12329030|FG000|Overall Study|Withdrawal by Subject|4
7847196|NCT01467505|12329031|FG001|Overall Study|Withdrawal by Subject|0
7847197|NCT01467505|12329030|FG000|Overall Study|Study Terminated by Sponsor|28
7847198|NCT01467505|12329031|FG001|Overall Study|Study Terminated by Sponsor|3
7847199|NCT01467570|12329048|FG000|Overall Study|Lost to Follow-up|8
7847200|NCT01467570|12329049|FG001|Overall Study|Lost to Follow-up|9
7847201|NCT01467583|12329060|FG000|Overall Study|Death|1
7847202|NCT01467583|12329061|FG001|Overall Study|Death|1
7847203|NCT01467583|12329062|FG002|Overall Study|Death|0
7847204|NCT01467583|12329060|FG000|Overall Study|Withdrawal by Subject|1
7847205|NCT01467583|12329061|FG001|Overall Study|Withdrawal by Subject|0
7847206|NCT01467583|12329062|FG002|Overall Study|Withdrawal by Subject|0
7847207|NCT01467583|12329060|FG000|Overall Study|Protocol Violation|0
7847208|NCT01467583|12329061|FG001|Overall Study|Protocol Violation|0
7847209|NCT01467583|12329062|FG002|Overall Study|Protocol Violation|2
7847210|NCT01467661|12329073|FG000|Overall Study|Adverse Event|16
7847211|NCT01467661|12329073|FG000|Overall Study|Withdrawal by Subject|1
7847212|NCT01467661|12329073|FG000|Overall Study|Lack of Efficacy|3
7847213|NCT01467661|12329073|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
7847214|NCT01467700|12329083|FG000|Overall Study|Pretreatment Event or Adverse Event|6
7847215|NCT01467700|12329084|FG001|Overall Study|Pretreatment Event or Adverse Event|4
7847216|NCT01467700|12329085|FG002|Overall Study|Pretreatment Event or Adverse Event|2
7847217|NCT01467700|12329086|FG003|Overall Study|Pretreatment Event or Adverse Event|3
7847218|NCT01467700|12329083|FG000|Overall Study|Major Protocol Deviation|3
7847219|NCT01467700|12329084|FG001|Overall Study|Major Protocol Deviation|3
7847220|NCT01467700|12329085|FG002|Overall Study|Major Protocol Deviation|2
7847221|NCT01467700|12329086|FG003|Overall Study|Major Protocol Deviation|3
7847222|NCT01467700|12329083|FG000|Overall Study|Lost to Follow-up|6
7847223|NCT01467700|12329084|FG001|Overall Study|Lost to Follow-up|5
7847224|NCT01467700|12329085|FG002|Overall Study|Lost to Follow-up|2
7847225|NCT01467700|12329086|FG003|Overall Study|Lost to Follow-up|3
7847226|NCT01467700|12329083|FG000|Overall Study|Voluntary Withdrawal|5
7847227|NCT01467700|12329084|FG001|Overall Study|Voluntary Withdrawal|7
7847228|NCT01467700|12329085|FG002|Overall Study|Voluntary Withdrawal|6
7847229|NCT01467700|12329086|FG003|Overall Study|Voluntary Withdrawal|2
7847230|NCT01467700|12329083|FG000|Overall Study|Study Termination|6
7847231|NCT01467700|12329084|FG001|Overall Study|Study Termination|5
7847232|NCT01467700|12329085|FG002|Overall Study|Study Termination|10
7847233|NCT01467700|12329086|FG003|Overall Study|Study Termination|7
7847234|NCT01467700|12329083|FG000|Overall Study|Pregnancy|0
7847235|NCT01467700|12329084|FG001|Overall Study|Pregnancy|1
7847236|NCT01467700|12329085|FG002|Overall Study|Pregnancy|1
7847237|NCT01467700|12329086|FG003|Overall Study|Pregnancy|0
7847238|NCT01467700|12329083|FG000|Overall Study|Lack of Efficacy|2
7847239|NCT01467700|12329084|FG001|Overall Study|Lack of Efficacy|0
7847240|NCT01467700|12329085|FG002|Overall Study|Lack of Efficacy|2
7847241|NCT01467700|12329086|FG003|Overall Study|Lack of Efficacy|1
7847242|NCT01467700|12329083|FG000|Overall Study|Reason not Specified|1
7847243|NCT01467700|12329084|FG001|Overall Study|Reason not Specified|3
7847244|NCT01467700|12329085|FG002|Overall Study|Reason not Specified|2
7847245|NCT01467700|12329086|FG003|Overall Study|Reason not Specified|8
7847246|NCT01467713|12329100|FG000|Overall Study|Pretreatment Event or Adverse Event|9
7847247|NCT01467713|12329101|FG001|Overall Study|Pretreatment Event or Adverse Event|4
7847248|NCT01467713|12329102|FG002|Overall Study|Pretreatment Event or Adverse Event|6
7847249|NCT01467713|12329103|FG003|Overall Study|Pretreatment Event or Adverse Event|5
7847250|NCT01467713|12329100|FG000|Overall Study|Major Protocol Deviation|2
7847251|NCT01467713|12329101|FG001|Overall Study|Major Protocol Deviation|4
7847252|NCT01467713|12329102|FG002|Overall Study|Major Protocol Deviation|4
7847253|NCT01467713|12329103|FG003|Overall Study|Major Protocol Deviation|1
7847254|NCT01467713|12329100|FG000|Overall Study|Lost to Follow-up|9
7847255|NCT01467713|12329101|FG001|Overall Study|Lost to Follow-up|12
7847256|NCT01467713|12329102|FG002|Overall Study|Lost to Follow-up|6
7847257|NCT01467713|12329103|FG003|Overall Study|Lost to Follow-up|9
7847258|NCT01467713|12329100|FG000|Overall Study|Voluntary Withdrawal|18
7847259|NCT01467713|12329101|FG001|Overall Study|Voluntary Withdrawal|14
7847260|NCT01467713|12329102|FG002|Overall Study|Voluntary Withdrawal|21
7847261|NCT01467713|12329103|FG003|Overall Study|Voluntary Withdrawal|20
7847262|NCT01467713|12329100|FG000|Overall Study|Study Termination|23
7847263|NCT01467713|12329101|FG001|Overall Study|Study Termination|33
7847264|NCT01467713|12329102|FG002|Overall Study|Study Termination|28
7847265|NCT01467713|12329103|FG003|Overall Study|Study Termination|29
7847266|NCT01467713|12329100|FG000|Overall Study|Pregnancy|0
7847267|NCT01467713|12329101|FG001|Overall Study|Pregnancy|1
7847268|NCT01467713|12329102|FG002|Overall Study|Pregnancy|1
7847269|NCT01467713|12329103|FG003|Overall Study|Pregnancy|3
7847270|NCT01467713|12329100|FG000|Overall Study|Relapse|35
7847271|NCT01467713|12329101|FG001|Overall Study|Relapse|25
7847272|NCT01467713|12329102|FG002|Overall Study|Relapse|28
7847273|NCT01467713|12329103|FG003|Overall Study|Relapse|35
7847274|NCT01467713|12329100|FG000|Overall Study|Reason not Specified|6
7847275|NCT01467713|12329101|FG001|Overall Study|Reason not Specified|11
7847276|NCT01467713|12329102|FG002|Overall Study|Reason not Specified|8
7847277|NCT01467713|12329103|FG003|Overall Study|Reason not Specified|7
7847278|NCT01467960|12329147|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0
7847279|NCT01467960|12329148|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0
7847280|NCT01467960|12329149|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0
7847281|NCT01467960|12329150|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30
7847282|NCT01467960|12329151|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30
7847283|NCT01467960|12329152|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30
7847284|NCT01468077|12329186|FG000|Overall Study|Adverse Event|2
7847285|NCT01468077|12329187|FG001|Overall Study|Adverse Event|2
7847286|NCT01468077|12329186|FG000|Overall Study|Lack of Efficacy|1
7847287|NCT01468077|12329187|FG001|Overall Study|Lack of Efficacy|1
7847288|NCT01468077|12329186|FG000|Overall Study|Physician Decision|1
7847289|NCT01468077|12329187|FG001|Overall Study|Physician Decision|0
7847290|NCT01468181|12329198|FG000|Overall Study|Adverse Event|8
7847291|NCT01468181|12329199|FG001|Overall Study|Adverse Event|1
7847292|NCT01468181|12329200|FG002|Overall Study|Adverse Event|6
7847293|NCT01468181|12329201|FG003|Overall Study|Adverse Event|2
7847294|NCT01468181|12329202|FG004|Overall Study|Adverse Event|2
7847295|NCT01468181|12329198|FG000|Overall Study|Protocol Violation|2
7847296|NCT01468181|12329199|FG001|Overall Study|Protocol Violation|0
7847297|NCT01468181|12329200|FG002|Overall Study|Protocol Violation|1
7847298|NCT01468181|12329201|FG003|Overall Study|Protocol Violation|0
7847299|NCT01468181|12329202|FG004|Overall Study|Protocol Violation|1
7847300|NCT01468181|12329198|FG000|Overall Study|Physician Decision|0
7847301|NCT01468181|12329199|FG001|Overall Study|Physician Decision|0
7847302|NCT01468181|12329200|FG002|Overall Study|Physician Decision|0
7847303|NCT01468181|12329201|FG003|Overall Study|Physician Decision|1
7847304|NCT01468181|12329202|FG004|Overall Study|Physician Decision|1
7847305|NCT01468181|12329198|FG000|Overall Study|Lost to Follow-up|0
7847306|NCT01468181|12329199|FG001|Overall Study|Lost to Follow-up|0
7847307|NCT01468181|12329200|FG002|Overall Study|Lost to Follow-up|1
7847308|NCT01468181|12329201|FG003|Overall Study|Lost to Follow-up|0
7847309|NCT01468181|12329202|FG004|Overall Study|Lost to Follow-up|1
7847310|NCT01468181|12329198|FG000|Overall Study|Withdrawal by Subject|0
7847311|NCT01468181|12329199|FG001|Overall Study|Withdrawal by Subject|1
7847312|NCT01468181|12329200|FG002|Overall Study|Withdrawal by Subject|0
7847313|NCT01468181|12329201|FG003|Overall Study|Withdrawal by Subject|0
7847314|NCT01468181|12329202|FG004|Overall Study|Withdrawal by Subject|0
7847315|NCT01468207|12329216|FG000|Treatment Period 1|Adverse Event|1
7847316|NCT01468207|12329217|FG001|Treatment Period 1|Adverse Event|0
7847317|NCT01468207|12329218|FG002|Treatment Period 1|Adverse Event|0
7847318|NCT01468207|12329219|FG003|Treatment Period 1|Adverse Event|0
7847319|NCT01468207|12329220|FG004|Treatment Period 1|Adverse Event|0
7847320|NCT01468207|12329221|FG005|Treatment Period 1|Adverse Event|0
7847321|NCT01468207|12329216|FG000|Treatment Period 1|Protocol Violation|1
7847322|NCT01468207|12329217|FG001|Treatment Period 1|Protocol Violation|1
7847323|NCT01468207|12329218|FG002|Treatment Period 1|Protocol Violation|0
7847324|NCT01468207|12329219|FG003|Treatment Period 1|Protocol Violation|0
7847325|NCT01468207|12329220|FG004|Treatment Period 1|Protocol Violation|0
7847326|NCT01468207|12329221|FG005|Treatment Period 1|Protocol Violation|0
7847327|NCT01468207|12329216|FG000|Treatment Period 1|Withdrawal by Subject|5
7847328|NCT01468207|12329217|FG001|Treatment Period 1|Withdrawal by Subject|4
7847329|NCT01468207|12329218|FG002|Treatment Period 1|Withdrawal by Subject|0
7847330|NCT01468207|12329219|FG003|Treatment Period 1|Withdrawal by Subject|0
7847331|NCT01468207|12329220|FG004|Treatment Period 1|Withdrawal by Subject|0
7847332|NCT01468207|12329221|FG005|Treatment Period 1|Withdrawal by Subject|0
7847333|NCT01468207|12329216|FG000|Treatment Period 1|Lost to Follow-up|2
7847334|NCT01468207|12329217|FG001|Treatment Period 1|Lost to Follow-up|1
7847335|NCT01468207|12329218|FG002|Treatment Period 1|Lost to Follow-up|0
7847336|NCT01468207|12329219|FG003|Treatment Period 1|Lost to Follow-up|0
7847337|NCT01468207|12329220|FG004|Treatment Period 1|Lost to Follow-up|0
7847338|NCT01468207|12329221|FG005|Treatment Period 1|Lost to Follow-up|0
7847339|NCT01468207|12329216|FG000|Treatment Period 1|Other|0
7847340|NCT01468207|12329217|FG001|Treatment Period 1|Other|2
7847341|NCT01468207|12329218|FG002|Treatment Period 1|Other|0
7847342|NCT01468207|12329219|FG003|Treatment Period 1|Other|0
7847343|NCT01468207|12329220|FG004|Treatment Period 1|Other|0
7847344|NCT01468207|12329221|FG005|Treatment Period 1|Other|0
7847345|NCT01468207|12329216|FG000|Treatment Period 2|Adverse Event|0
7847346|NCT01468207|12329217|FG001|Treatment Period 2|Adverse Event|0
7847347|NCT01468207|12329218|FG002|Treatment Period 2|Adverse Event|6
7847348|NCT01468207|12329219|FG003|Treatment Period 2|Adverse Event|1
7847349|NCT01468207|12329220|FG004|Treatment Period 2|Adverse Event|2
7847350|NCT01468207|12329221|FG005|Treatment Period 2|Adverse Event|1
7847351|NCT01468207|12329216|FG000|Treatment Period 2|Lack of Efficacy|0
7847352|NCT01468207|12329217|FG001|Treatment Period 2|Lack of Efficacy|0
7847353|NCT01468207|12329218|FG002|Treatment Period 2|Lack of Efficacy|1
7847354|NCT01468207|12329219|FG003|Treatment Period 2|Lack of Efficacy|1
7847355|NCT01468207|12329220|FG004|Treatment Period 2|Lack of Efficacy|0
7847356|NCT01468207|12329221|FG005|Treatment Period 2|Lack of Efficacy|2
7847357|NCT01468207|12329216|FG000|Treatment Period 2|Withdrawal by Subject|0
7847358|NCT01468207|12329217|FG001|Treatment Period 2|Withdrawal by Subject|0
7847359|NCT01468207|12329218|FG002|Treatment Period 2|Withdrawal by Subject|5
7847360|NCT01468207|12329219|FG003|Treatment Period 2|Withdrawal by Subject|0
7847361|NCT01468207|12329220|FG004|Treatment Period 2|Withdrawal by Subject|0
7847362|NCT01468207|12329221|FG005|Treatment Period 2|Withdrawal by Subject|2
7847363|NCT01468207|12329216|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0
7847364|NCT01468207|12329217|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0
7847365|NCT01468207|12329218|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30
7847366|NCT01468207|12329219|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23
7847367|NCT01468207|12329220|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18
7847368|NCT01468207|12329221|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13
7847369|NCT01468207|12329216|FG000|Treatment Period 2|Lost to Follow-up|0
7847370|NCT01468207|12329217|FG001|Treatment Period 2|Lost to Follow-up|0
7847371|NCT01468207|12329218|FG002|Treatment Period 2|Lost to Follow-up|5
7847372|NCT01468207|12329219|FG003|Treatment Period 2|Lost to Follow-up|1
7847373|NCT01468207|12329220|FG004|Treatment Period 2|Lost to Follow-up|0
7847374|NCT01468207|12329221|FG005|Treatment Period 2|Lost to Follow-up|0
7847375|NCT01468207|12329216|FG000|Treatment Period 2|Other|0
7847376|NCT01468207|12329217|FG001|Treatment Period 2|Other|0
7847377|NCT01468207|12329218|FG002|Treatment Period 2|Other|5
7847378|NCT01468207|12329219|FG003|Treatment Period 2|Other|1
7847379|NCT01468207|12329220|FG004|Treatment Period 2|Other|1
7847380|NCT01468207|12329221|FG005|Treatment Period 2|Other|2
7847381|NCT01468233|12329241|FG000|Treatment Period 1|Adverse Event|5
7847382|NCT01468233|12329242|FG001|Treatment Period 1|Adverse Event|3
7847383|NCT01468233|12329243|FG002|Treatment Period 1|Adverse Event|0
7847384|NCT01468233|12329244|FG003|Treatment Period 1|Adverse Event|0
7847385|NCT01468233|12329245|FG004|Treatment Period 1|Adverse Event|0
7847386|NCT01468233|12329246|FG005|Treatment Period 1|Adverse Event|0
7847387|NCT01468233|12329241|FG000|Treatment Period 1|Withdrawal by Subject|3
7847388|NCT01468233|12329242|FG001|Treatment Period 1|Withdrawal by Subject|4
7847389|NCT01468233|12329243|FG002|Treatment Period 1|Withdrawal by Subject|0
7847390|NCT01468233|12329244|FG003|Treatment Period 1|Withdrawal by Subject|0
7847391|NCT01468233|12329245|FG004|Treatment Period 1|Withdrawal by Subject|0
7847392|NCT01468233|12329246|FG005|Treatment Period 1|Withdrawal by Subject|0
7847393|NCT01468233|12329241|FG000|Treatment Period 1|Lost to Follow-up|3
7847394|NCT01468233|12329242|FG001|Treatment Period 1|Lost to Follow-up|0
7847395|NCT01468233|12329243|FG002|Treatment Period 1|Lost to Follow-up|0
7847396|NCT01468233|12329244|FG003|Treatment Period 1|Lost to Follow-up|0
7847397|NCT01468233|12329245|FG004|Treatment Period 1|Lost to Follow-up|0
7847398|NCT01468233|12329246|FG005|Treatment Period 1|Lost to Follow-up|0
7847399|NCT01468233|12329241|FG000|Treatment Period 1|Other|1
7847400|NCT01468233|12329242|FG001|Treatment Period 1|Other|1
7847401|NCT01468233|12329243|FG002|Treatment Period 1|Other|0
7847402|NCT01468233|12329244|FG003|Treatment Period 1|Other|0
7847403|NCT01468233|12329245|FG004|Treatment Period 1|Other|0
7847404|NCT01468233|12329246|FG005|Treatment Period 1|Other|0
7847405|NCT01468233|12329241|FG000|Treatment Period 2|Adverse Event|0
7847406|NCT01468233|12329242|FG001|Treatment Period 2|Adverse Event|0
7847407|NCT01468233|12329243|FG002|Treatment Period 2|Adverse Event|3
7847408|NCT01468233|12329244|FG003|Treatment Period 2|Adverse Event|0
7847409|NCT01468233|12329245|FG004|Treatment Period 2|Adverse Event|2
7847410|NCT01468233|12329246|FG005|Treatment Period 2|Adverse Event|1
7847411|NCT01468233|12329241|FG000|Treatment Period 2|Lack of Efficacy|0
7847412|NCT01468233|12329242|FG001|Treatment Period 2|Lack of Efficacy|0
7847413|NCT01468233|12329243|FG002|Treatment Period 2|Lack of Efficacy|9
7847414|NCT01468233|12329244|FG003|Treatment Period 2|Lack of Efficacy|2
7847415|NCT01468233|12329245|FG004|Treatment Period 2|Lack of Efficacy|0
7847416|NCT01468233|12329246|FG005|Treatment Period 2|Lack of Efficacy|1
7847417|NCT01468233|12329241|FG000|Treatment Period 2|Withdrawal by Subject|0
7847418|NCT01468233|12329242|FG001|Treatment Period 2|Withdrawal by Subject|0
7847419|NCT01468233|12329243|FG002|Treatment Period 2|Withdrawal by Subject|9
7847420|NCT01468233|12329244|FG003|Treatment Period 2|Withdrawal by Subject|1
7847421|NCT01468233|12329245|FG004|Treatment Period 2|Withdrawal by Subject|1
7847422|NCT01468233|12329246|FG005|Treatment Period 2|Withdrawal by Subject|1
7847423|NCT01468233|12329241|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0
7847424|NCT01468233|12329242|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0
7847425|NCT01468233|12329243|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84
7847426|NCT01468233|12329244|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25
7847427|NCT01468233|12329245|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22
7847428|NCT01468233|12329246|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20
7847429|NCT01468233|12329241|FG000|Treatment Period 2|Lost to Follow-up|0
7847430|NCT01468233|12329242|FG001|Treatment Period 2|Lost to Follow-up|0
7847431|NCT01468233|12329243|FG002|Treatment Period 2|Lost to Follow-up|3
7847432|NCT01468233|12329244|FG003|Treatment Period 2|Lost to Follow-up|0
7847433|NCT01468233|12329245|FG004|Treatment Period 2|Lost to Follow-up|2
7847434|NCT01468233|12329246|FG005|Treatment Period 2|Lost to Follow-up|0
7847435|NCT01468233|12329241|FG000|Treatment Period 2|Other|0
7847436|NCT01468233|12329242|FG001|Treatment Period 2|Other|0
7847437|NCT01468233|12329243|FG002|Treatment Period 2|Other|3
7847438|NCT01468233|12329244|FG003|Treatment Period 2|Other|0
7847439|NCT01468233|12329245|FG004|Treatment Period 2|Other|1
7847440|NCT01468233|12329246|FG005|Treatment Period 2|Other|0
7847441|NCT01468311|12329264|FG000|Overall Study|mobilization failure|1
7847442|NCT01468311|12329264|FG000|Overall Study|Withdrawal by Subject|1
7847443|NCT01468454|12329289|FG000|Overall Study|Did not have surgery after PET|9
7847444|NCT01468597|12329310|FG000|Overall Study|Found ineligible|17
7847445|NCT01468597|12329310|FG000|Overall Study|concomitant valves|12
7847446|NCT01468597|12329310|FG000|Overall Study|off-pump CABG|1
7847447|NCT01468597|12329310|FG000|Overall Study|no platelet function data|5
7847448|NCT01468701|12329340|FG000|Overall Study|Not eligible|91
7847449|NCT01468701|12329341|FG001|Overall Study|Not eligible|140
7847450|NCT01468701|12329342|FG002|Overall Study|Not eligible|29
7847451|NCT01468701|12329343|FG003|Overall Study|Not eligible|12
7847452|NCT01468701|12329344|FG004|Overall Study|Not eligible|22
7847453|NCT01468701|12329345|FG005|Overall Study|Not eligible|2
7847454|NCT01468701|12329346|FG006|Overall Study|Not eligible|39
7847455|NCT01468701|12329347|FG007|Overall Study|Not eligible|1
7847456|NCT01468701|12329348|FG008|Overall Study|Not eligible|40
7847457|NCT01468701|12329349|FG009|Overall Study|Not eligible|126
7847458|NCT01468701|12329350|FG010|Overall Study|Not eligible|39
7847459|NCT01468701|12329351|FG011|Overall Study|Not eligible|33
7847460|NCT01468701|12329352|FG012|Overall Study|Not eligible|1
7847461|NCT01468701|12329353|FG013|Overall Study|Not eligible|19
7847462|NCT01468701|12329354|FG014|Overall Study|Not eligible|1
7847463|NCT01468701|12329355|FG015|Overall Study|Not eligible|32
7847464|NCT01468701|12329356|FG016|Overall Study|Not eligible|0
7847465|NCT01468701|12329340|FG000|Overall Study|Lost to Follow-up|306
7847466|NCT01468701|12329341|FG001|Overall Study|Lost to Follow-up|0
7847467|NCT01468701|12329342|FG002|Overall Study|Lost to Follow-up|0
7847468|NCT01468701|12329343|FG003|Overall Study|Lost to Follow-up|0
7847469|NCT01468701|12329344|FG004|Overall Study|Lost to Follow-up|0
7847470|NCT01468701|12329345|FG005|Overall Study|Lost to Follow-up|0
7847471|NCT01468701|12329346|FG006|Overall Study|Lost to Follow-up|0
7847472|NCT01468701|12329347|FG007|Overall Study|Lost to Follow-up|0
7847473|NCT01468701|12329348|FG008|Overall Study|Lost to Follow-up|215
7847474|NCT01468701|12329349|FG009|Overall Study|Lost to Follow-up|309
7847475|NCT01468701|12329350|FG010|Overall Study|Lost to Follow-up|224
7847476|NCT01468701|12329351|FG011|Overall Study|Lost to Follow-up|212
7847477|NCT01468701|12329352|FG012|Overall Study|Lost to Follow-up|11
7847478|NCT01468701|12329353|FG013|Overall Study|Lost to Follow-up|164
7847479|NCT01468701|12329354|FG014|Overall Study|Lost to Follow-up|17
7847480|NCT01468701|12329355|FG015|Overall Study|Lost to Follow-up|127
7847481|NCT01468701|12329356|FG016|Overall Study|Lost to Follow-up|1
7847482|NCT01468701|12329340|FG000|Overall Study|Withdrawal by Subject|165
7847483|NCT01468701|12329341|FG001|Overall Study|Withdrawal by Subject|0
7847484|NCT01468701|12329342|FG002|Overall Study|Withdrawal by Subject|0
7847485|NCT01468701|12329343|FG003|Overall Study|Withdrawal by Subject|0
7847486|NCT01468701|12329344|FG004|Overall Study|Withdrawal by Subject|0
7847487|NCT01468701|12329345|FG005|Overall Study|Withdrawal by Subject|0
7847488|NCT01468701|12329346|FG006|Overall Study|Withdrawal by Subject|0
7847489|NCT01468701|12329347|FG007|Overall Study|Withdrawal by Subject|0
7847490|NCT01468701|12329348|FG008|Overall Study|Withdrawal by Subject|83
7847491|NCT01468701|12329349|FG009|Overall Study|Withdrawal by Subject|88
7847492|NCT01468701|12329350|FG010|Overall Study|Withdrawal by Subject|100
7847493|NCT01468701|12329351|FG011|Overall Study|Withdrawal by Subject|114
7847494|NCT01468701|12329352|FG012|Overall Study|Withdrawal by Subject|9
7847495|NCT01468701|12329353|FG013|Overall Study|Withdrawal by Subject|47
7847496|NCT01468701|12329354|FG014|Overall Study|Withdrawal by Subject|6
7847497|NCT01468701|12329355|FG015|Overall Study|Withdrawal by Subject|31
7847498|NCT01468701|12329356|FG016|Overall Study|Withdrawal by Subject|0
7847499|NCT01468701|12329340|FG000|Overall Study|Other reasons than listed|437
7847500|NCT01468701|12329341|FG001|Overall Study|Other reasons than listed|0
7847501|NCT01468701|12329342|FG002|Overall Study|Other reasons than listed|0
7847502|NCT01468701|12329343|FG003|Overall Study|Other reasons than listed|0
7847503|NCT01468701|12329344|FG004|Overall Study|Other reasons than listed|0
7847504|NCT01468701|12329345|FG005|Overall Study|Other reasons than listed|0
7847505|NCT01468701|12329346|FG006|Overall Study|Other reasons than listed|0
7847506|NCT01468701|12329347|FG007|Overall Study|Other reasons than listed|0
7847507|NCT01468701|12329348|FG008|Overall Study|Other reasons than listed|318
7847508|NCT01468701|12329349|FG009|Overall Study|Other reasons than listed|658
7847509|NCT01468701|12329350|FG010|Overall Study|Other reasons than listed|433
7847510|NCT01468701|12329351|FG011|Overall Study|Other reasons than listed|504
7847511|NCT01468701|12329352|FG012|Overall Study|Other reasons than listed|28
7847512|NCT01468701|12329353|FG013|Overall Study|Other reasons than listed|239
7847513|NCT01468701|12329354|FG014|Overall Study|Other reasons than listed|39
7847514|NCT01468701|12329355|FG015|Overall Study|Other reasons than listed|172
7847515|NCT01468701|12329356|FG016|Overall Study|Other reasons than listed|0
7847516|NCT01468701|12329340|FG000|Overall Study|No end of study case report form|0
7847517|NCT01468701|12329341|FG001|Overall Study|No end of study case report form|0
7847518|NCT01468701|12329342|FG002|Overall Study|No end of study case report form|0
7847519|NCT01468701|12329343|FG003|Overall Study|No end of study case report form|0
7847520|NCT01468701|12329344|FG004|Overall Study|No end of study case report form|0
7847521|NCT01468701|12329345|FG005|Overall Study|No end of study case report form|0
7847522|NCT01468701|12329346|FG006|Overall Study|No end of study case report form|0
7847523|NCT01468701|12329347|FG007|Overall Study|No end of study case report form|0
7847524|NCT01468701|12329348|FG008|Overall Study|No end of study case report form|4
7847525|NCT01468701|12329349|FG009|Overall Study|No end of study case report form|1
7847526|NCT01468701|12329350|FG010|Overall Study|No end of study case report form|2
7847527|NCT01468701|12329351|FG011|Overall Study|No end of study case report form|3
7847528|NCT01468701|12329352|FG012|Overall Study|No end of study case report form|0
7847529|NCT01468701|12329353|FG013|Overall Study|No end of study case report form|1
7847530|NCT01468701|12329354|FG014|Overall Study|No end of study case report form|0
7847531|NCT01468701|12329355|FG015|Overall Study|No end of study case report form|0
7847532|NCT01468701|12329356|FG016|Overall Study|No end of study case report form|0
7847533|NCT01468701|12329340|FG000|Overall Study|Not being followed up|0
7847534|NCT01468701|12329341|FG001|Overall Study|Not being followed up|4963
7847535|NCT01468701|12329342|FG002|Overall Study|Not being followed up|1755
7847536|NCT01468701|12329343|FG003|Overall Study|Not being followed up|703
7847537|NCT01468701|12329344|FG004|Overall Study|Not being followed up|1714
7847538|NCT01468701|12329345|FG005|Overall Study|Not being followed up|126
7847539|NCT01468701|12329346|FG006|Overall Study|Not being followed up|1170
7847540|NCT01468701|12329347|FG007|Overall Study|Not being followed up|4
7847541|NCT01468701|12329348|FG008|Overall Study|Not being followed up|0
7847542|NCT01468701|12329349|FG009|Overall Study|Not being followed up|0
7847543|NCT01468701|12329350|FG010|Overall Study|Not being followed up|0
7847544|NCT01468701|12329351|FG011|Overall Study|Not being followed up|0
7847545|NCT01468701|12329352|FG012|Overall Study|Not being followed up|0
7847546|NCT01468701|12329353|FG013|Overall Study|Not being followed up|0
7847547|NCT01468701|12329354|FG014|Overall Study|Not being followed up|0
7847548|NCT01468701|12329355|FG015|Overall Study|Not being followed up|0
7847549|NCT01468701|12329356|FG016|Overall Study|Not being followed up|0
7847550|NCT01468818|12329369|FG000|Overall Study|Death during treatment|2
7847551|NCT01468844|12329375|FG000|Overall Study|Adverse Event|1
7847552|NCT01468844|12329376|FG001|Overall Study|Adverse Event|0
7847553|NCT01468844|12329375|FG000|Overall Study|Withdrawal by Subject|1
7847554|NCT01468844|12329376|FG001|Overall Study|Withdrawal by Subject|0
7847555|NCT01468909|12329387|FG000|Overall Study|Never Treated|2
7847556|NCT01468909|12329388|FG001|Overall Study|Never Treated|2
7847557|NCT01468987|12329400|FG000|Overall Study|Adverse Event|12
7847558|NCT01468987|12329401|FG001|Overall Study|Adverse Event|9
7847559|NCT01468987|12329400|FG000|Overall Study|Death|4
7847560|NCT01468987|12329401|FG001|Overall Study|Death|1
7847561|NCT01468987|12329400|FG000|Overall Study|Lost to Follow-up|10
7847562|NCT01468987|12329401|FG001|Overall Study|Lost to Follow-up|5
7847563|NCT01468987|12329400|FG000|Overall Study|Protocol Violation|8
7847564|NCT01468987|12329401|FG001|Overall Study|Protocol Violation|2
7847565|NCT01468987|12329400|FG000|Overall Study|Withdrawal by Subject|28
7847566|NCT01468987|12329401|FG001|Overall Study|Withdrawal by Subject|28
7847567|NCT01468987|12329400|FG000|Overall Study|Physician Decision|8
7847568|NCT01468987|12329401|FG001|Overall Study|Physician Decision|15
7847569|NCT01468987|12329400|FG000|Overall Study|Sponsor Decision|1
7847570|NCT01468987|12329401|FG001|Overall Study|Sponsor Decision|0
7847571|NCT01469000|12329411|FG000|Overall Study|Withdrawal by Subject|16
7847572|NCT01469000|12329412|FG001|Overall Study|Withdrawal by Subject|3
7847573|NCT01469000|12329411|FG000|Overall Study|Sponsor Decision|4
7847574|NCT01469000|12329412|FG001|Overall Study|Sponsor Decision|1
7847575|NCT01469013|12329423|FG000|Part A (Treatment Period)|Adverse Event|1
7847576|NCT01469013|12329424|FG001|Part A (Treatment Period)|Adverse Event|0
7847577|NCT01469013|12329425|FG002|Part A (Treatment Period)|Adverse Event|0
7847578|NCT01469013|12329426|FG003|Part A (Treatment Period)|Adverse Event|0
7847579|NCT01469013|12329427|FG004|Part A (Treatment Period)|Adverse Event|1
7847580|NCT01469013|12329428|FG005|Part A (Treatment Period)|Adverse Event|0
7847581|NCT01469013|12329429|FG006|Part A (Treatment Period)|Adverse Event|0
7847582|NCT01469013|12329430|FG007|Part A (Treatment Period)|Adverse Event|0
7847583|NCT01469013|12329431|FG008|Part A (Treatment Period)|Adverse Event|0
7847584|NCT01469013|12329432|FG009|Part A (Treatment Period)|Adverse Event|0
7847585|NCT01469013|12329433|FG010|Part A (Treatment Period)|Adverse Event|0
7847586|NCT01469013|12329434|FG011|Part A (Treatment Period)|Adverse Event|0
7847587|NCT01469013|12329435|FG012|Part A (Treatment Period)|Adverse Event|0
7847588|NCT01469013|12329423|FG000|Part A (Treatment Period)|Withdrawal by Subject|0
7847589|NCT01469013|12329424|FG001|Part A (Treatment Period)|Withdrawal by Subject|0
7847590|NCT01469013|12329425|FG002|Part A (Treatment Period)|Withdrawal by Subject|1
7847591|NCT01469013|12329426|FG003|Part A (Treatment Period)|Withdrawal by Subject|0
7847592|NCT01469013|12329427|FG004|Part A (Treatment Period)|Withdrawal by Subject|0
7847593|NCT01469013|12329428|FG005|Part A (Treatment Period)|Withdrawal by Subject|0
7847594|NCT01469013|12329429|FG006|Part A (Treatment Period)|Withdrawal by Subject|0
7847595|NCT01469013|12329430|FG007|Part A (Treatment Period)|Withdrawal by Subject|0
7847596|NCT01469013|12329431|FG008|Part A (Treatment Period)|Withdrawal by Subject|0
7847597|NCT01469013|12329432|FG009|Part A (Treatment Period)|Withdrawal by Subject|0
7847598|NCT01469013|12329433|FG010|Part A (Treatment Period)|Withdrawal by Subject|0
7847599|NCT01469013|12329434|FG011|Part A (Treatment Period)|Withdrawal by Subject|0
7847600|NCT01469013|12329435|FG012|Part A (Treatment Period)|Withdrawal by Subject|0
7847601|NCT01469013|12329423|FG000|Part B (Extension Period)|Adverse Event|0
7847602|NCT01469013|12329424|FG001|Part B (Extension Period)|Adverse Event|0
7847603|NCT01469013|12329425|FG002|Part B (Extension Period)|Adverse Event|0
7847604|NCT01469013|12329426|FG003|Part B (Extension Period)|Adverse Event|0
7847605|NCT01469013|12329427|FG004|Part B (Extension Period)|Adverse Event|0
7847606|NCT01469013|12329428|FG005|Part B (Extension Period)|Adverse Event|2
7847607|NCT01469013|12329429|FG006|Part B (Extension Period)|Adverse Event|5
7847608|NCT01469013|12329430|FG007|Part B (Extension Period)|Adverse Event|5
7847609|NCT01469013|12329431|FG008|Part B (Extension Period)|Adverse Event|3
7847610|NCT01469013|12329432|FG009|Part B (Extension Period)|Adverse Event|3
7847611|NCT01469013|12329433|FG010|Part B (Extension Period)|Adverse Event|1
7847612|NCT01469013|12329434|FG011|Part B (Extension Period)|Adverse Event|6
7847613|NCT01469013|12329435|FG012|Part B (Extension Period)|Adverse Event|3
7847614|NCT01469013|12329423|FG000|Part B (Extension Period)|Withdrawal by Subject|0
7847615|NCT01469013|12329424|FG001|Part B (Extension Period)|Withdrawal by Subject|0
7847616|NCT01469013|12329425|FG002|Part B (Extension Period)|Withdrawal by Subject|0
7847617|NCT01469013|12329426|FG003|Part B (Extension Period)|Withdrawal by Subject|0
7847618|NCT01469013|12329427|FG004|Part B (Extension Period)|Withdrawal by Subject|0
7847619|NCT01469013|12329428|FG005|Part B (Extension Period)|Withdrawal by Subject|0
7847620|NCT01469013|12329429|FG006|Part B (Extension Period)|Withdrawal by Subject|0
7847621|NCT01469013|12329430|FG007|Part B (Extension Period)|Withdrawal by Subject|0
7847622|NCT01469013|12329431|FG008|Part B (Extension Period)|Withdrawal by Subject|1
7847623|NCT01469013|12329432|FG009|Part B (Extension Period)|Withdrawal by Subject|0
7847624|NCT01469013|12329433|FG010|Part B (Extension Period)|Withdrawal by Subject|1
7847625|NCT01469013|12329434|FG011|Part B (Extension Period)|Withdrawal by Subject|0
7847626|NCT01469013|12329435|FG012|Part B (Extension Period)|Withdrawal by Subject|3
7847627|NCT01469052|12329481|FG000|Overall Study|Adverse Event|2
7847628|NCT01469052|12329482|FG001|Overall Study|Adverse Event|3
7847629|NCT01469052|12329483|FG002|Overall Study|Adverse Event|0
7847630|NCT01469052|12329484|FG003|Overall Study|Adverse Event|2
7847631|NCT01469052|12329485|FG004|Overall Study|Adverse Event|0
7847632|NCT01469052|12329486|FG005|Overall Study|Adverse Event|1
7847633|NCT01469052|12329481|FG000|Overall Study|Progressive disease|3
7847634|NCT01469052|12329482|FG001|Overall Study|Progressive disease|0
7847635|NCT01469052|12329483|FG002|Overall Study|Progressive disease|5
7847636|NCT01469052|12329484|FG003|Overall Study|Progressive disease|3
7847637|NCT01469052|12329485|FG004|Overall Study|Progressive disease|7
7847638|NCT01469052|12329486|FG005|Overall Study|Progressive disease|2
7847639|NCT01469052|12329481|FG000|Overall Study|Lack of Efficacy|0
7847640|NCT01469052|12329482|FG001|Overall Study|Lack of Efficacy|0
7847641|NCT01469052|12329483|FG002|Overall Study|Lack of Efficacy|0
7847642|NCT01469052|12329484|FG003|Overall Study|Lack of Efficacy|0
7847643|NCT01469052|12329485|FG004|Overall Study|Lack of Efficacy|0
7847644|NCT01469052|12329486|FG005|Overall Study|Lack of Efficacy|2
7847645|NCT01469052|12329481|FG000|Overall Study|Moved to rollover protocol|1
7847646|NCT01469052|12329482|FG001|Overall Study|Moved to rollover protocol|0
7847647|NCT01469052|12329483|FG002|Overall Study|Moved to rollover protocol|1
7847648|NCT01469052|12329484|FG003|Overall Study|Moved to rollover protocol|0
7847649|NCT01469052|12329485|FG004|Overall Study|Moved to rollover protocol|0
7847650|NCT01469052|12329486|FG005|Overall Study|Moved to rollover protocol|1
7847651|NCT01469052|12329481|FG000|Overall Study|Other|0
7847652|NCT01469052|12329482|FG001|Overall Study|Other|1
7847653|NCT01469052|12329483|FG002|Overall Study|Other|0
7847654|NCT01469052|12329484|FG003|Overall Study|Other|0
7847655|NCT01469052|12329485|FG004|Overall Study|Other|1
7847656|NCT01469052|12329486|FG005|Overall Study|Other|0
7847657|NCT01469065|12329503|FG000|Overall Study|Lack of Efficacy|0
7847658|NCT01469065|12329504|FG001|Overall Study|Lack of Efficacy|0
7847659|NCT01469065|12329505|FG002|Overall Study|Lack of Efficacy|0
7847660|NCT01469065|12329506|FG003|Overall Study|Lack of Efficacy|0
7847661|NCT01469065|12329507|FG004|Overall Study|Lack of Efficacy|1
7847662|NCT01469065|12329503|FG000|Overall Study|Other|0
7847663|NCT01469065|12329504|FG001|Overall Study|Other|1
7847664|NCT01469065|12329505|FG002|Overall Study|Other|0
7847665|NCT01469065|12329506|FG003|Overall Study|Other|0
7847666|NCT01469065|12329507|FG004|Overall Study|Other|0
7847667|NCT01469182|12329525|FG000|Overall Study|Adverse Event|21
7847668|NCT01469182|12329526|FG001|Overall Study|Adverse Event|3
7847669|NCT01469182|12329525|FG000|Overall Study|Lost to Follow-up|3
7847670|NCT01469182|12329526|FG001|Overall Study|Lost to Follow-up|0
7847671|NCT01469182|12329525|FG000|Overall Study|Withdrawal by Subject|4
7847672|NCT01469182|12329526|FG001|Overall Study|Withdrawal by Subject|1
7847673|NCT01469182|12329525|FG000|Overall Study|Protocol Violation|4
7847674|NCT01469182|12329526|FG001|Overall Study|Protocol Violation|2
7847675|NCT01469182|12329525|FG000|Overall Study|Did not meet Protocol Eligibility|3
7847676|NCT01469182|12329526|FG001|Overall Study|Did not meet Protocol Eligibility|0
7847677|NCT01469221|12329534|FG000|Double Blind Phase|Protocol Violation|1
7847678|NCT01469221|12329535|FG001|Double Blind Phase|Protocol Violation|0
7847679|NCT01469221|12329536|FG002|Double Blind Phase|Protocol Violation|0
7847680|NCT01469221|12329534|FG000|Double Blind Phase|Physician Decision|1
7847681|NCT01469221|12329535|FG001|Double Blind Phase|Physician Decision|1
7847682|NCT01469221|12329536|FG002|Double Blind Phase|Physician Decision|0
7847683|NCT01469221|12329534|FG000|Double Blind Phase|Sponsor Terminate Study|12
7847684|NCT01469221|12329535|FG001|Double Blind Phase|Sponsor Terminate Study|16
7847685|NCT01469221|12329536|FG002|Double Blind Phase|Sponsor Terminate Study|0
7847686|NCT01469364|12329556|FG000|Overall Study|Adverse Event|1
7847687|NCT01469364|12329556|FG000|Overall Study|Withdrawal by Subject|1
7847688|NCT01469377|12329563|FG000|Overall Study|Protocol Deviation|7
7847689|NCT01469377|12329564|FG001|Overall Study|Protocol Deviation|10
7847690|NCT01469377|12329565|FG002|Overall Study|Protocol Deviation|10
7847691|NCT01469377|12329563|FG000|Overall Study|Lost to Follow-up|3
7847692|NCT01469377|12329564|FG001|Overall Study|Lost to Follow-up|2
7847693|NCT01469377|12329565|FG002|Overall Study|Lost to Follow-up|5
7847694|NCT01469377|12329563|FG000|Overall Study|Withdrawal of Consent|12
7847695|NCT01469377|12329564|FG001|Overall Study|Withdrawal of Consent|14
7847696|NCT01469377|12329565|FG002|Overall Study|Withdrawal of Consent|15
7847697|NCT01469377|12329563|FG000|Overall Study|Adverse Event|8
7847698|NCT01469377|12329564|FG001|Overall Study|Adverse Event|18
7847699|NCT01469377|12329565|FG002|Overall Study|Adverse Event|36
7847700|NCT01469377|12329563|FG000|Overall Study|Insufficient Therapeutic Response|3
7847701|NCT01469377|12329564|FG001|Overall Study|Insufficient Therapeutic Response|4
7847702|NCT01469377|12329565|FG002|Overall Study|Insufficient Therapeutic Response|0
7847703|NCT01469377|12329563|FG000|Overall Study|Other Miscellaneous Reasons|2
7847704|NCT01469377|12329564|FG001|Overall Study|Other Miscellaneous Reasons|0
7847705|NCT01469377|12329565|FG002|Overall Study|Other Miscellaneous Reasons|0
7847706|NCT01469546|12329573|FG000|Received 5 mg Dose|Adverse Event|13
7847707|NCT01469546|12329573|FG000|Received 5 mg Dose|Death|2
7847708|NCT01469546|12329573|FG000|Received 5 mg Dose|Protocol Violation|2
7847709|NCT01469546|12329573|FG000|Received 5 mg Dose|Progressive Disease|3
7847710|NCT01469546|12329573|FG000|Received 5 mg Dose|Physician Decision|3
7847711|NCT01469637|12329590|FG000|First Intervention|Unacceptable behavior|0
7847712|NCT01469637|12329591|FG001|First Intervention|Unacceptable behavior|1
7847713|NCT01469637|12329590|FG000|Second Intervention|Incarcerated|1
7847714|NCT01469637|12329591|FG001|Second Intervention|Incarcerated|0
7847715|NCT01469819|12329605|FG000|Overall Study|Withdrawal by Subject|1
7847716|NCT01469819|12329605|FG000|Overall Study|Did not meet inclusionary criteria|2
7847717|NCT01469819|12329605|FG000|Overall Study|Could not swallow SmartPill|2
7847718|NCT01469819|12329605|FG000|Overall Study|Technical malfunction of SmartPill data|3
7847719|NCT01470001|12329617|FG000|Overall Study|Lost to Follow-up|1
7847720|NCT01470001|12329618|FG001|Overall Study|Lost to Follow-up|1
7847721|NCT01470001|12329617|FG000|Overall Study|Physician Decision|2
7847722|NCT01470001|12329618|FG001|Overall Study|Physician Decision|0
7847723|NCT01470001|12329617|FG000|Overall Study|Withdrawal by Subject|2
7847724|NCT01470001|12329618|FG001|Overall Study|Withdrawal by Subject|1
7847725|NCT01470144|12329659|FG000|Overall Study|Adverse Event|2
7847726|NCT01470144|12329659|FG000|Overall Study|Death|1
7847727|NCT01470144|12329659|FG000|Overall Study|Lung transplant|6
7847728|NCT01470144|12329659|FG000|Overall Study|Patient's and investigator's decision|1
7847729|NCT01470248|12329688|FG000|Overall Study|Withdrawal by Subject|1
7847730|NCT01470417|12329694|FG000|Overall Study|Disease progression|0
7847731|NCT01470417|12329695|FG001|Overall Study|Disease progression|2
7847732|NCT01470469|12329703|FG000|Overall Study|Withdrawal by Subject|4
7847733|NCT01470469|12329704|FG001|Overall Study|Withdrawal by Subject|6
7847734|NCT01470469|12329703|FG000|Overall Study|Lack of Efficacy|1
7847735|NCT01470469|12329704|FG001|Overall Study|Lack of Efficacy|7
7847736|NCT01470469|12329703|FG000|Overall Study|Adverse Event|0
7847737|NCT01470469|12329704|FG001|Overall Study|Adverse Event|7
7847738|NCT01470469|12329703|FG000|Overall Study|Lost to Follow-up|2
7847739|NCT01470469|12329704|FG001|Overall Study|Lost to Follow-up|2
7847740|NCT01470469|12329703|FG000|Overall Study|Protocol Violation|1
7847741|NCT01470469|12329704|FG001|Overall Study|Protocol Violation|1
7847742|NCT01470469|12329703|FG000|Overall Study|Other|2
7847743|NCT01470469|12329704|FG001|Overall Study|Other|1
7847744|NCT01470599|12329712|FG000|Overall Study|Did not meet entrance criteria|1
7847745|NCT01470599|12329713|FG001|Overall Study|Did not meet entrance criteria|0
7847746|NCT01470599|12329712|FG000|Overall Study|Lost to Follow-up|2
7847747|NCT01470599|12329713|FG001|Overall Study|Lost to Follow-up|1
7847748|NCT01470599|12329712|FG000|Overall Study|Withdrawal by Subject|3
7847749|NCT01470599|12329713|FG001|Overall Study|Withdrawal by Subject|4
7847750|NCT01470599|12329712|FG000|Overall Study|Other|1
7847751|NCT01470599|12329713|FG001|Overall Study|Other|0
7847752|NCT01470599|12329712|FG000|Overall Study|Protocol Violation|3
7847753|NCT01470599|12329713|FG001|Overall Study|Protocol Violation|1
7847754|NCT01470599|12329712|FG000|Overall Study|Adverse event related to study drug|2
7847755|NCT01470599|12329713|FG001|Overall Study|Adverse event related to study drug|5
7847756|NCT01470599|12329712|FG000|Overall Study|Insufficient clinical response|6
7847757|NCT01470599|12329713|FG001|Overall Study|Insufficient clinical response|27
7847758|NCT01470599|12329712|FG000|Overall Study|Adverse event not related to study drug|1
7847759|NCT01470599|12329713|FG001|Overall Study|Adverse event not related to study drug|5
7847760|NCT01470612|12329721|FG000|Overall Study|Adverse Event|20
7847761|NCT01470612|12329722|FG001|Overall Study|Adverse Event|80
7847762|NCT01470612|12329721|FG000|Overall Study|Death|0
7847763|NCT01470612|12329722|FG001|Overall Study|Death|1
7847764|NCT01470612|12329721|FG000|Overall Study|Lack of Efficacy|20
7847765|NCT01470612|12329722|FG001|Overall Study|Lack of Efficacy|326
7847766|NCT01470612|12329721|FG000|Overall Study|Lost to Follow-up|2
7847767|NCT01470612|12329722|FG001|Overall Study|Lost to Follow-up|5
7847768|NCT01470612|12329721|FG000|Overall Study|Did not meet entrance criteria|0
7847769|NCT01470612|12329722|FG001|Overall Study|Did not meet entrance criteria|1
7847770|NCT01470612|12329721|FG000|Overall Study|Pregnancy|2
7847771|NCT01470612|12329722|FG001|Overall Study|Pregnancy|10
7847772|NCT01470612|12329721|FG000|Overall Study|Protocol Violation|2
7847773|NCT01470612|12329722|FG001|Overall Study|Protocol Violation|7
7847774|NCT01470612|12329721|FG000|Overall Study|Withdrawal by Subject|24
7847775|NCT01470612|12329722|FG001|Overall Study|Withdrawal by Subject|79
7847776|NCT01470612|12329721|FG000|Overall Study|Other|14
7847777|NCT01470612|12329722|FG001|Overall Study|Other|156
7847778|NCT01470989|12329758|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103
7847779|NCT01470989|12329759|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136
7847780|NCT01470989|12329758|FG000|Overall Study|Adverse Event|2
7847781|NCT01470989|12329759|FG001|Overall Study|Adverse Event|5
7847782|NCT01470989|12329758|FG000|Overall Study|Abnormal laboratory value|1
7847783|NCT01470989|12329759|FG001|Overall Study|Abnormal laboratory value|1
7847784|NCT01470989|12329758|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7847785|NCT01470989|12329759|FG001|Overall Study|Unsatisfactory therapeutic effect|6
7847786|NCT01470989|12329758|FG000|Overall Study|Withdrawal by Subject|19
7847787|NCT01470989|12329759|FG001|Overall Study|Withdrawal by Subject|17
7847788|NCT01470989|12329758|FG000|Overall Study|Lost to Follow-up|18
7847789|NCT01470989|12329759|FG001|Overall Study|Lost to Follow-up|13
7847790|NCT01470989|12329758|FG000|Overall Study|Administrative problems|2
7847791|NCT01470989|12329759|FG001|Overall Study|Administrative problems|4
7847792|NCT01470989|12329758|FG000|Overall Study|Death|2
7847793|NCT01470989|12329759|FG001|Overall Study|Death|2
7847794|NCT01470989|12329758|FG000|Overall Study|Protocol deviation|1
7847795|NCT01470989|12329759|FG001|Overall Study|Protocol deviation|2
7847796|NCT01471015|12329770|FG000|Overall Study|Death|0
7847797|NCT01471015|12329771|FG001|Overall Study|Death|1
7847798|NCT01471015|12329772|FG002|Overall Study|Death|1
7847799|NCT01471028|12329782|FG000|VTI-208|Adverse Event|39
7847800|NCT01471028|12329783|FG001|VTI-208|Adverse Event|41
7847801|NCT01471028|12329782|FG000|VTI-208|Withdrawal by Subject|0
7847802|NCT01471028|12329783|FG001|VTI-208|Withdrawal by Subject|2
7847803|NCT01471028|12329782|FG000|VTI-208|Lost to Follow-up|1
7847804|NCT01471028|12329783|FG001|VTI-208|Lost to Follow-up|1
7847805|NCT01471028|12329782|FG000|VTI-208E|Death|7
7847806|NCT01471028|12329783|FG001|VTI-208E|Death|10
7847807|NCT01471028|12329782|FG000|VTI-208E|Withdrawal by Subject|1
7847808|NCT01471028|12329783|FG001|VTI-208E|Withdrawal by Subject|0
7847809|NCT01471028|12329782|FG000|VTI-208E|Lost to Follow-up|0
7847810|NCT01471028|12329783|FG001|VTI-208E|Lost to Follow-up|2
7863285|NCT01604408|12352512|FG000|Treatment Period 4|Adverse Event|0
7863286|NCT01604408|12352513|FG001|Treatment Period 4|Adverse Event|1
7863287|NCT01604408|12352512|FG000|Treatment Period 5|Adverse Event|4
7863288|NCT01604408|12352513|FG001|Treatment Period 5|Adverse Event|0
7863289|NCT01604408|12352512|FG000|Treatment Period 6|Lost to Follow-up|0
7863290|NCT01604408|12352513|FG001|Treatment Period 6|Lost to Follow-up|1
7863291|NCT01604408|12352512|FG000|Treatment Period 6|Adverse Event|2
7863292|NCT01604408|12352513|FG001|Treatment Period 6|Adverse Event|0
7863293|NCT01604408|12352512|FG000|Treatment Period 6|Sponsor decision|0
7863294|NCT01604408|12352513|FG001|Treatment Period 6|Sponsor decision|1
7863295|NCT01604408|12352512|FG000|Observation Period|Adverse Event|1
7863296|NCT01604408|12352513|FG001|Observation Period|Adverse Event|1
7720908|NCT00541970|12145422|FG001|Month 18|Protocol Violation|23
7720909|NCT00541970|12145423|FG002|Month 18|Protocol Violation|24
7720910|NCT00541970|12145424|FG003|Month 18|Protocol Violation|16
7720911|NCT00541970|12145421|FG000|Month 24|Adverse Event|0
7720912|NCT00541970|12145422|FG001|Month 24|Adverse Event|1
7720913|NCT00541970|12145423|FG002|Month 24|Adverse Event|1
7949202|NCT02533674|12494571|FG001|Dose Level VII|Treatment-related AE|0
7949203|NCT02533674|12494572|FG002|Dose Level VII|Treatment-related AE|0
7949204|NCT02533674|12494573|FG003|Dose Level VII|Treatment-related AE|0
7949205|NCT02533674|12494574|FG004|Dose Level VII|Treatment-related AE|0
7949206|NCT02533674|12494575|FG005|Dose Level VII|Treatment-related AE|0
7949207|NCT02533674|12494576|FG006|Dose Level VII|Treatment-related AE|1
7949208|NCT02533674|12494577|FG007|Dose Level VII|Treatment-related AE|0
7949209|NCT02533674|12494570|FG000|Dose Level VII|Death|0
7949210|NCT02533674|12494571|FG001|Dose Level VII|Death|0
7949211|NCT02533674|12494572|FG002|Dose Level VII|Death|0
7949212|NCT02533674|12494573|FG003|Dose Level VII|Death|0
7949213|NCT02533674|12494574|FG004|Dose Level VII|Death|0
7949214|NCT02533674|12494575|FG005|Dose Level VII|Death|0
7949215|NCT02533674|12494576|FG006|Dose Level VII|Death|2
7949216|NCT02533674|12494577|FG007|Dose Level VII|Death|0
7949217|NCT02533674|12494570|FG000|Dose Level VIII|Progressive disease|0
7949218|NCT02533674|12494571|FG001|Dose Level VIII|Progressive disease|0
7949219|NCT02533674|12494572|FG002|Dose Level VIII|Progressive disease|0
7863297|NCT01604408|12352512|FG000|Observation Period|Withdrawal by Subject|0
7863298|NCT01604408|12352513|FG001|Observation Period|Withdrawal by Subject|2
7863299|NCT01604785|12352526|FG000|Overall Study|Repeat Visits Not Included in Analysis|7
7863300|NCT01604785|12352527|FG001|Overall Study|Repeat Visits Not Included in Analysis|1
7863301|NCT01604824|12352537|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7863302|NCT01604824|12352538|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7863303|NCT01604824|12352539|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7863304|NCT01604824|12352540|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7863305|NCT01604824|12352541|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2
7863306|NCT01604824|12352542|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7863307|NCT01604824|12352537|FG000|Open-label Extension (OLE) Period|Refused to come into office|0
7863308|NCT01604824|12352538|FG001|Open-label Extension (OLE) Period|Refused to come into office|0
7863309|NCT01604824|12352539|FG002|Open-label Extension (OLE) Period|Refused to come into office|0
7863310|NCT01604824|12352540|FG003|Open-label Extension (OLE) Period|Refused to come into office|0
7863311|NCT01604824|12352541|FG004|Open-label Extension (OLE) Period|Refused to come into office|1
7863312|NCT01604824|12352542|FG005|Open-label Extension (OLE) Period|Refused to come into office|0
7863313|NCT01604850|12352556|FG000|Overall Study|Enrolled but never treated|0
7863314|NCT01604850|12352557|FG001|Overall Study|Enrolled but never treated|1
7949220|NCT02533674|12494573|FG003|Dose Level VIII|Progressive disease|0
7949221|NCT02533674|12494574|FG004|Dose Level VIII|Progressive disease|0
7720914|NCT00541970|12145424|FG003|Month 24|Adverse Event|1
7847811|NCT01471054|12329798|FG000|Overall Study|Study terminated prematurely|4
7847812|NCT01471054|12329799|FG001|Overall Study|Study terminated prematurely|0
7847813|NCT01471093|12329817|FG000|Overall Study|Adverse Event|1
7847814|NCT01471093|12329818|FG001|Overall Study|Adverse Event|0
7847815|NCT01471093|12329819|FG002|Overall Study|Adverse Event|0
7847816|NCT01471093|12329820|FG003|Overall Study|Adverse Event|0
7847817|NCT01471171|12329826|FG000|Treatment Period 1|Adverse Event|4
7847818|NCT01471171|12329827|FG001|Treatment Period 1|Adverse Event|1
7847819|NCT01471171|12329826|FG000|Treatment Period 2|Adverse Event|1
7847820|NCT01471171|12329827|FG001|Treatment Period 2|Adverse Event|0
7847821|NCT01471197|12329835|FG000|Overall Study|Disease Progression|4
7847822|NCT01471197|12329836|FG001|Overall Study|Disease Progression|2
7847823|NCT01471197|12329835|FG000|Overall Study|Death|1
7847824|NCT01471197|12329836|FG001|Overall Study|Death|0
7847825|NCT01471197|12329835|FG000|Overall Study|Study Drug Toxicity|1
7847826|NCT01471197|12329836|FG001|Overall Study|Study Drug Toxicity|0
7847827|NCT01471353|12329842|FG000|Overall Study|remain on study|3
7847828|NCT01471379|12329849|FG000|Overall Study|Adverse Event|1
7847829|NCT01471379|12329850|FG001|Overall Study|Adverse Event|0
7847830|NCT01471379|12329851|FG002|Overall Study|Adverse Event|0
7847831|NCT01471379|12329849|FG000|Overall Study|Study terminated|0
7847832|NCT01471379|12329850|FG001|Overall Study|Study terminated|1
7847833|NCT01471379|12329851|FG002|Overall Study|Study terminated|0
7847834|NCT01471574|12329873|FG000|Treatment Period|Lack of Efficacy|12
7847835|NCT01471574|12329874|FG001|Treatment Period|Lack of Efficacy|4
7847836|NCT01471574|12329875|FG002|Treatment Period|Lack of Efficacy|14
7847837|NCT01471574|12329876|FG003|Treatment Period|Lack of Efficacy|1
7847838|NCT01471574|12329873|FG000|Treatment Period|Adverse Event|7
7847839|NCT01471574|12329874|FG001|Treatment Period|Adverse Event|3
7847840|NCT01471574|12329875|FG002|Treatment Period|Adverse Event|6
7847841|NCT01471574|12329876|FG003|Treatment Period|Adverse Event|1
7847842|NCT01471574|12329873|FG000|Treatment Period|Withdrawal by Subject|5
7847843|NCT01471574|12329874|FG001|Treatment Period|Withdrawal by Subject|1
7847844|NCT01471574|12329875|FG002|Treatment Period|Withdrawal by Subject|1
7847845|NCT01471574|12329876|FG003|Treatment Period|Withdrawal by Subject|0
7847846|NCT01471574|12329873|FG000|Treatment Period|Patient Requested Discontinue Study drug|4
7847847|NCT01471574|12329874|FG001|Treatment Period|Patient Requested Discontinue Study drug|0
7847848|NCT01471574|12329875|FG002|Treatment Period|Patient Requested Discontinue Study drug|1
7847849|NCT01471574|12329876|FG003|Treatment Period|Patient Requested Discontinue Study drug|1
7847850|NCT01471574|12329873|FG000|Treatment Period|Lost to Follow-up|1
7847851|NCT01471574|12329874|FG001|Treatment Period|Lost to Follow-up|2
7847852|NCT01471574|12329875|FG002|Treatment Period|Lost to Follow-up|2
7847853|NCT01471574|12329876|FG003|Treatment Period|Lost to Follow-up|0
7847854|NCT01471574|12329873|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1
7847855|NCT01471574|12329874|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0
7847856|NCT01471574|12329875|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0
7847857|NCT01471574|12329876|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0
7847858|NCT01471574|12329873|FG000|Treatment Period|Other|1
7847859|NCT01471574|12329874|FG001|Treatment Period|Other|0
7847860|NCT01471574|12329875|FG002|Treatment Period|Other|0
7847861|NCT01471574|12329876|FG003|Treatment Period|Other|0
7847862|NCT01471574|12329873|FG000|Follow-up Period|Withdrawal by Subject|3
7847863|NCT01471574|12329874|FG001|Follow-up Period|Withdrawal by Subject|0
7847864|NCT01471574|12329875|FG002|Follow-up Period|Withdrawal by Subject|3
7847865|NCT01471574|12329876|FG003|Follow-up Period|Withdrawal by Subject|1
7847866|NCT01471574|12329873|FG000|Follow-up Period|Lost to Follow-up|4
7847867|NCT01471574|12329874|FG001|Follow-up Period|Lost to Follow-up|1
7847868|NCT01471574|12329875|FG002|Follow-up Period|Lost to Follow-up|3
7847869|NCT01471574|12329876|FG003|Follow-up Period|Lost to Follow-up|2
7847870|NCT01471574|12329873|FG000|Follow-up Period|Death|0
7847871|NCT01471574|12329874|FG001|Follow-up Period|Death|0
7847872|NCT01471574|12329875|FG002|Follow-up Period|Death|1
7847873|NCT01471574|12329876|FG003|Follow-up Period|Death|0
7847874|NCT01471574|12329873|FG000|Follow-up Period|Follow-up no longer required|0
7847875|NCT01471574|12329874|FG001|Follow-up Period|Follow-up no longer required|1
7847876|NCT01471574|12329875|FG002|Follow-up Period|Follow-up no longer required|0
7847877|NCT01471574|12329876|FG003|Follow-up Period|Follow-up no longer required|0
7847878|NCT01471691|12329902|FG000|Overall Study|Lack of Efficacy|0
7847879|NCT01471691|12329903|FG001|Overall Study|Lack of Efficacy|1
7847880|NCT01471782|12329915|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2
7847881|NCT01471782|12329916|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2
7847882|NCT01471782|12329917|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1
7847883|NCT01471782|12329918|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0
7847884|NCT01471782|12329919|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5
7847885|NCT01471782|12329920|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3
7847886|NCT01471782|12329915|FG000|Overall Study|Lack of Efficacy|1
7847887|NCT01471782|12329916|FG001|Overall Study|Lack of Efficacy|2
7847888|NCT01471782|12329917|FG002|Overall Study|Lack of Efficacy|1
7847889|NCT01471782|12329918|FG003|Overall Study|Lack of Efficacy|1
7847890|NCT01471782|12329919|FG004|Overall Study|Lack of Efficacy|5
7847891|NCT01471782|12329920|FG005|Overall Study|Lack of Efficacy|18
7847892|NCT01471782|12329915|FG000|Overall Study|Adverse Event|1
7847893|NCT01471782|12329916|FG001|Overall Study|Adverse Event|1
7847894|NCT01471782|12329917|FG002|Overall Study|Adverse Event|2
7847895|NCT01471782|12329918|FG003|Overall Study|Adverse Event|2
7847896|NCT01471782|12329919|FG004|Overall Study|Adverse Event|3
7847897|NCT01471782|12329920|FG005|Overall Study|Adverse Event|1
7847898|NCT01471782|12329915|FG000|Overall Study|Other|0
7847899|NCT01471782|12329916|FG001|Overall Study|Other|0
7847900|NCT01471782|12329917|FG002|Overall Study|Other|1
7847901|NCT01471782|12329918|FG003|Overall Study|Other|1
7847902|NCT01471782|12329919|FG004|Overall Study|Other|6
7847903|NCT01471782|12329920|FG005|Overall Study|Other|5
7847904|NCT01471782|12329915|FG000|Overall Study|Change of Chemotherapy|1
7847905|NCT01471782|12329916|FG001|Overall Study|Change of Chemotherapy|1
7847906|NCT01471782|12329917|FG002|Overall Study|Change of Chemotherapy|0
7847907|NCT01471782|12329918|FG003|Overall Study|Change of Chemotherapy|0
7847908|NCT01471782|12329919|FG004|Overall Study|Change of Chemotherapy|1
7847909|NCT01471782|12329920|FG005|Overall Study|Change of Chemotherapy|4
7847910|NCT01471782|12329915|FG000|Overall Study|Disease Relapse|0
7847911|NCT01471782|12329916|FG001|Overall Study|Disease Relapse|0
7847912|NCT01471782|12329917|FG002|Overall Study|Disease Relapse|0
7847913|NCT01471782|12329918|FG003|Overall Study|Disease Relapse|1
7847914|NCT01471782|12329919|FG004|Overall Study|Disease Relapse|2
7847915|NCT01471782|12329920|FG005|Overall Study|Disease Relapse|1
7847916|NCT01471782|12329915|FG000|Overall Study|Physician Decision|0
7847917|NCT01471782|12329916|FG001|Overall Study|Physician Decision|0
7847918|NCT01471782|12329917|FG002|Overall Study|Physician Decision|0
7847919|NCT01471782|12329918|FG003|Overall Study|Physician Decision|0
7847920|NCT01471782|12329919|FG004|Overall Study|Physician Decision|3
7847921|NCT01471782|12329920|FG005|Overall Study|Physician Decision|8
7847922|NCT01471782|12329915|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7847923|NCT01471782|12329916|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7847924|NCT01471782|12329917|FG002|Overall Study|Withdrawal by Parent/Guardian|0
7847925|NCT01471782|12329918|FG003|Overall Study|Withdrawal by Parent/Guardian|0
7847926|NCT01471782|12329919|FG004|Overall Study|Withdrawal by Parent/Guardian|1
7847927|NCT01471782|12329920|FG005|Overall Study|Withdrawal by Parent/Guardian|0
7847928|NCT01471782|12329915|FG000|Overall Study|Death|0
7847929|NCT01471782|12329916|FG001|Overall Study|Death|0
7847930|NCT01471782|12329917|FG002|Overall Study|Death|0
7847931|NCT01471782|12329918|FG003|Overall Study|Death|0
7847932|NCT01471782|12329919|FG004|Overall Study|Death|0
7847933|NCT01471782|12329920|FG005|Overall Study|Death|1
7847934|NCT01472185|12329947|FG000|Overall Study|Randomized but Not Treated|0
7847935|NCT01472185|12329948|FG001|Overall Study|Randomized but Not Treated|1
7847936|NCT01472185|12329947|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3
7847937|NCT01472185|12329948|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10
7847938|NCT01472185|12329947|FG000|Overall Study|Hyperglycemia|5
7847939|NCT01472185|12329948|FG001|Overall Study|Hyperglycemia|2
7847940|NCT01472185|12329947|FG000|Overall Study|Investigator's Discretion|3
7847941|NCT01472185|12329948|FG001|Overall Study|Investigator's Discretion|1
7847942|NCT01472185|12329947|FG000|Overall Study|Lost to Follow-up|4
7847943|NCT01472185|12329948|FG001|Overall Study|Lost to Follow-up|1
7847944|NCT01472185|12329947|FG000|Overall Study|Protocol Violation|5
7847945|NCT01472185|12329948|FG001|Overall Study|Protocol Violation|1
7847946|NCT01472185|12329947|FG000|Overall Study|Subject Noncompliance|8
7847947|NCT01472185|12329948|FG001|Overall Study|Subject Noncompliance|15
7847948|NCT01472185|12329947|FG000|Overall Study|Subject Withdrew Consent|6
7847949|NCT01472185|12329948|FG001|Overall Study|Subject Withdrew Consent|3
7847950|NCT01472289|12329954|FG000|Overall Study|Death|2
7847951|NCT01472341|12329958|FG000|Overall Study|Started insulin therapy|55
7847952|NCT01472341|12329958|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92
7847953|NCT01472341|12329958|FG000|Overall Study|Withdrawal by Subject|39
7847954|NCT01472341|12329958|FG000|Overall Study|Lost to Follow-up|52
7847955|NCT01472341|12329958|FG000|Overall Study|Laboratory parameters unavailable|25
7847956|NCT01472341|12329958|FG000|Overall Study|Death|9
7847957|NCT01472380|12329962|FG000|Efavirenz Alone|Withdrawal by Subject|1
7847958|NCT01472380|12329962|FG000|1 Day Period Between Dosing|Protocol Violation|1
7847959|NCT01472757|12330013|FG000|Overall Study|Withdrawal by Subject|1
7847960|NCT01472757|12330014|FG001|Overall Study|Withdrawal by Subject|2
7847961|NCT01472757|12330015|FG002|Overall Study|Withdrawal by Subject|2
7847962|NCT01472757|12330016|FG003|Overall Study|Withdrawal by Subject|0
7847963|NCT01472757|12330013|FG000|Overall Study|Asthma exacerbation|4
7847964|NCT01472757|12330014|FG001|Overall Study|Asthma exacerbation|1
7847965|NCT01472757|12330015|FG002|Overall Study|Asthma exacerbation|2
7847966|NCT01472757|12330016|FG003|Overall Study|Asthma exacerbation|1
7847967|NCT01472757|12330013|FG000|Overall Study|Treatment period withdrawal criteria met|21
7847968|NCT01472757|12330014|FG001|Overall Study|Treatment period withdrawal criteria met|8
7847969|NCT01472757|12330015|FG002|Overall Study|Treatment period withdrawal criteria met|9
7847970|NCT01472757|12330016|FG003|Overall Study|Treatment period withdrawal criteria met|12
7847971|NCT01472757|12330013|FG000|Overall Study|Protocol Violation|3
7847972|NCT01472757|12330014|FG001|Overall Study|Protocol Violation|2
7847973|NCT01472757|12330015|FG002|Overall Study|Protocol Violation|4
7847974|NCT01472757|12330016|FG003|Overall Study|Protocol Violation|4
7847975|NCT01472757|12330013|FG000|Overall Study|Other reasons|1
7847976|NCT01472757|12330014|FG001|Overall Study|Other reasons|0
7847977|NCT01472757|12330015|FG002|Overall Study|Other reasons|2
7847978|NCT01472757|12330016|FG003|Overall Study|Other reasons|2
7847979|NCT01472835|12330037|FG000|Overall Study|Lost to Follow-up|2
7847980|NCT01472835|12330038|FG001|Overall Study|Lost to Follow-up|0
7847981|NCT01472939|12330055|FG000|Overall Study|Adverse Event|3
7847982|NCT01472939|12330056|FG001|Overall Study|Adverse Event|7
7847983|NCT01472939|12330057|FG002|Overall Study|Adverse Event|7
7847984|NCT01472939|12330058|FG003|Overall Study|Adverse Event|14
7847985|NCT01472939|12330055|FG000|Overall Study|Lack of Efficacy|1
7847986|NCT01472939|12330056|FG001|Overall Study|Lack of Efficacy|0
7847987|NCT01472939|12330057|FG002|Overall Study|Lack of Efficacy|0
7847988|NCT01472939|12330058|FG003|Overall Study|Lack of Efficacy|1
7847989|NCT01472939|12330055|FG000|Overall Study|Lost to Follow-up|3
7847990|NCT01472939|12330056|FG001|Overall Study|Lost to Follow-up|0
7847991|NCT01472939|12330057|FG002|Overall Study|Lost to Follow-up|2
7847992|NCT01472939|12330058|FG003|Overall Study|Lost to Follow-up|0
7847993|NCT01472939|12330055|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0
7847994|NCT01472939|12330056|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0
7847995|NCT01472939|12330057|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1
7847996|NCT01472939|12330058|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0
7847997|NCT01472939|12330055|FG000|Overall Study|Prohibited Medication|0
7847998|NCT01472939|12330056|FG001|Overall Study|Prohibited Medication|1
7847999|NCT01472939|12330057|FG002|Overall Study|Prohibited Medication|0
7848000|NCT01472939|12330058|FG003|Overall Study|Prohibited Medication|0
7848001|NCT01472939|12330055|FG000|Overall Study|Withdrawal By PI|1
7848002|NCT01472939|12330056|FG001|Overall Study|Withdrawal By PI|0
7848003|NCT01472939|12330057|FG002|Overall Study|Withdrawal By PI|0
7848004|NCT01472939|12330058|FG003|Overall Study|Withdrawal By PI|0
7848005|NCT01472939|12330055|FG000|Overall Study|Protocol Violation|3
7848006|NCT01472939|12330056|FG001|Overall Study|Protocol Violation|3
7848007|NCT01472939|12330057|FG002|Overall Study|Protocol Violation|0
7848008|NCT01472939|12330058|FG003|Overall Study|Protocol Violation|1
7848009|NCT01472939|12330055|FG000|Overall Study|Withdrawal by Subject|9
7848010|NCT01472939|12330056|FG001|Overall Study|Withdrawal by Subject|3
7848011|NCT01472939|12330057|FG002|Overall Study|Withdrawal by Subject|1
7848012|NCT01472939|12330058|FG003|Overall Study|Withdrawal by Subject|4
7848013|NCT01472965|12330073|FG000|Overall Study|Withdrawal by Subject|1
7848014|NCT01472965|12330074|FG001|Overall Study|Withdrawal by Subject|0
7848015|NCT01473355|12330086|FG000|Overall Study|Protocol Violation|2
7848016|NCT01473355|12330086|FG000|Overall Study|Adverse Event|2
7848017|NCT01473355|12330086|FG000|Overall Study|Lost to Follow-up|2
7848018|NCT01473381|12330127|FG000|Overall Study|Adverse Event|8
7848019|NCT01473381|12330128|FG001|Overall Study|Adverse Event|20
7848020|NCT01473381|12330129|FG002|Overall Study|Adverse Event|25
7848021|NCT01473381|12330130|FG003|Overall Study|Adverse Event|17
7848022|NCT01473381|12330127|FG000|Overall Study|Insufficient Therapeutic Response|10
7848023|NCT01473381|12330128|FG001|Overall Study|Insufficient Therapeutic Response|1
7848024|NCT01473381|12330129|FG002|Overall Study|Insufficient Therapeutic Response|2
7848025|NCT01473381|12330130|FG003|Overall Study|Insufficient Therapeutic Response|3
7848026|NCT01473381|12330127|FG000|Overall Study|Protocol Violation|17
7848027|NCT01473381|12330128|FG001|Overall Study|Protocol Violation|23
7848028|NCT01473381|12330129|FG002|Overall Study|Protocol Violation|19
7848029|NCT01473381|12330130|FG003|Overall Study|Protocol Violation|17
7848030|NCT01473381|12330127|FG000|Overall Study|Withdrawal of Consent|20
7848031|NCT01473381|12330128|FG001|Overall Study|Withdrawal of Consent|21
7848032|NCT01473381|12330129|FG002|Overall Study|Withdrawal of Consent|20
7848033|NCT01473381|12330130|FG003|Overall Study|Withdrawal of Consent|26
7848034|NCT01473381|12330127|FG000|Overall Study|Lost to Follow-up|25
7848035|NCT01473381|12330128|FG001|Overall Study|Lost to Follow-up|28
7848036|NCT01473381|12330129|FG002|Overall Study|Lost to Follow-up|35
7848037|NCT01473381|12330130|FG003|Overall Study|Lost to Follow-up|23
7848038|NCT01473381|12330127|FG000|Overall Study|Other Reasons|0
7848039|NCT01473381|12330128|FG001|Overall Study|Other Reasons|0
7848040|NCT01473381|12330129|FG002|Overall Study|Other Reasons|1
7848041|NCT01473381|12330130|FG003|Overall Study|Other Reasons|3
7848042|NCT01473394|12330143|FG000|Overall Study|Adverse Event|13
7848043|NCT01473394|12330144|FG001|Overall Study|Adverse Event|16
7848044|NCT01473394|12330143|FG000|Overall Study|Insufficient Therapeutic Response|4
7848045|NCT01473394|12330144|FG001|Overall Study|Insufficient Therapeutic Response|1
7848046|NCT01473394|12330143|FG000|Overall Study|Protocol Violation|7
7848047|NCT01473394|12330144|FG001|Overall Study|Protocol Violation|5
7848048|NCT01473394|12330143|FG000|Overall Study|Withdrew Consent|12
7848049|NCT01473394|12330144|FG001|Overall Study|Withdrew Consent|10
7848050|NCT01473394|12330143|FG000|Overall Study|Lost to Follow-up|9
7848051|NCT01473394|12330144|FG001|Overall Study|Lost to Follow-up|11
7848052|NCT01473407|12330152|FG000|Overall Study|Physician Decision|1
7848053|NCT01473407|12330153|FG001|Overall Study|Physician Decision|4
7848054|NCT01473407|12330152|FG000|Overall Study|Lost to Follow-up|10
7848055|NCT01473407|12330153|FG001|Overall Study|Lost to Follow-up|4
7848056|NCT01473407|12330152|FG000|Overall Study|Adverse Event|8
7848057|NCT01473407|12330153|FG001|Overall Study|Adverse Event|8
7848058|NCT01473407|12330152|FG000|Overall Study|Randomization Error|3
7848059|NCT01473407|12330153|FG001|Overall Study|Randomization Error|1
7848060|NCT01473407|12330152|FG000|Overall Study|Withdrawal by Subject|4
7848061|NCT01473407|12330153|FG001|Overall Study|Withdrawal by Subject|7
7848062|NCT01473407|12330152|FG000|Overall Study|Kidney Transplant|7
7848063|NCT01473407|12330153|FG001|Overall Study|Kidney Transplant|6
7848064|NCT01473407|12330152|FG000|Overall Study|Vacation/Travel|1
7848065|NCT01473407|12330153|FG001|Overall Study|Vacation/Travel|1
7848066|NCT01473407|12330152|FG000|Overall Study|Elevated Hemoglobin|1
7848067|NCT01473407|12330153|FG001|Overall Study|Elevated Hemoglobin|0
7848068|NCT01473407|12330152|FG000|Overall Study|Patient Received Aranesp|1
7848069|NCT01473407|12330153|FG001|Overall Study|Patient Received Aranesp|0
7848070|NCT01473407|12330152|FG000|Overall Study|Patient Lost Green Card Status|1
7848071|NCT01473407|12330153|FG001|Overall Study|Patient Lost Green Card Status|0
7848072|NCT01473407|12330152|FG000|Overall Study|Temperature Excursion|2
7848073|NCT01473407|12330153|FG001|Overall Study|Temperature Excursion|3
7848074|NCT01473407|12330152|FG000|Overall Study|Transfer to Another Facility/Unit|4
7848075|NCT01473407|12330153|FG001|Overall Study|Transfer to Another Facility/Unit|3
7848076|NCT01473407|12330152|FG000|Overall Study|Sponsor's Decision|10
7848077|NCT01473407|12330153|FG001|Overall Study|Sponsor's Decision|10
7848078|NCT01473407|12330152|FG000|Overall Study|Site Closure|1
7848079|NCT01473407|12330153|FG001|Overall Study|Site Closure|0
7848080|NCT01473420|12330161|FG000|Titration Period (18 Weeks)|Adverse Event|4
7848081|NCT01473420|12330162|FG001|Titration Period (18 Weeks)|Adverse Event|6
7848082|NCT01473420|12330161|FG000|Titration Period (18 Weeks)|Did not meet criteria|32
7848083|NCT01473420|12330162|FG001|Titration Period (18 Weeks)|Did not meet criteria|32
7848084|NCT01473420|12330161|FG000|Maintenance Period (16 Weeks)|Adverse Event|3
7848085|NCT01473420|12330162|FG001|Maintenance Period (16 Weeks)|Adverse Event|2
7848086|NCT01473420|12330161|FG000|Maintenance Period (16 Weeks)|Physician Decision|1
7848087|NCT01473420|12330162|FG001|Maintenance Period (16 Weeks)|Physician Decision|2
7848088|NCT01473420|12330161|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0
7848089|NCT01473420|12330162|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2
7848090|NCT01473420|12330161|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3
7848091|NCT01473420|12330162|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1
7848092|NCT01473420|12330161|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1
7848093|NCT01473420|12330162|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2
7848094|NCT01473420|12330161|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
7848095|NCT01473420|12330162|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
7848096|NCT01473420|12330161|FG000|Maintenance Period (16 Weeks)|Site closure|3
7848097|NCT01473420|12330162|FG001|Maintenance Period (16 Weeks)|Site closure|1
7848098|NCT01473420|12330161|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
7848099|NCT01473420|12330162|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
7848100|NCT01473420|12330161|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0
7848101|NCT01473420|12330162|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1
7848102|NCT01473420|12330161|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1
7848103|NCT01473420|12330162|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0
7848104|NCT01473420|12330161|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
7848105|NCT01473420|12330162|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
7848106|NCT01473524|12330177|FG000|DB Phase|Adverse Event|4
7848107|NCT01473524|12330178|FG001|DB Phase|Adverse Event|8
7848108|NCT01473524|12330179|FG002|DB Phase|Adverse Event|2
7848109|NCT01473524|12330180|FG003|DB Phase|Adverse Event|0
7848110|NCT01473524|12330181|FG004|DB Phase|Adverse Event|0
7848111|NCT01473524|12330182|FG005|DB Phase|Adverse Event|0
7848112|NCT01473524|12330177|FG000|DB Phase|Death|1
7848113|NCT01473524|12330178|FG001|DB Phase|Death|0
7848114|NCT01473524|12330179|FG002|DB Phase|Death|0
7848115|NCT01473524|12330180|FG003|DB Phase|Death|0
7848116|NCT01473524|12330181|FG004|DB Phase|Death|0
7848117|NCT01473524|12330182|FG005|DB Phase|Death|0
7848118|NCT01473524|12330177|FG000|DB Phase|Withdrawal by Subject|2
7848119|NCT01473524|12330178|FG001|DB Phase|Withdrawal by Subject|1
7848120|NCT01473524|12330179|FG002|DB Phase|Withdrawal by Subject|1
7848121|NCT01473524|12330180|FG003|DB Phase|Withdrawal by Subject|0
7848122|NCT01473524|12330181|FG004|DB Phase|Withdrawal by Subject|0
7848123|NCT01473524|12330182|FG005|DB Phase|Withdrawal by Subject|0
7848124|NCT01473524|12330177|FG000|LTSE Phase|Withdrawal by Subject|0
7848125|NCT01473524|12330178|FG001|LTSE Phase|Withdrawal by Subject|0
7848126|NCT01473524|12330179|FG002|LTSE Phase|Withdrawal by Subject|0
7848127|NCT01473524|12330180|FG003|LTSE Phase|Withdrawal by Subject|3
7848128|NCT01473524|12330181|FG004|LTSE Phase|Withdrawal by Subject|3
7848129|NCT01473524|12330182|FG005|LTSE Phase|Withdrawal by Subject|6
7848130|NCT01473524|12330177|FG000|LTSE Phase|Death|0
7848131|NCT01473524|12330178|FG001|LTSE Phase|Death|0
7848132|NCT01473524|12330179|FG002|LTSE Phase|Death|0
7848133|NCT01473524|12330180|FG003|LTSE Phase|Death|0
7848134|NCT01473524|12330181|FG004|LTSE Phase|Death|1
7848135|NCT01473524|12330182|FG005|LTSE Phase|Death|0
7848136|NCT01473524|12330177|FG000|LTSE Phase|Adverse Event of Pruritus|0
7848137|NCT01473524|12330178|FG001|LTSE Phase|Adverse Event of Pruritus|0
7848138|NCT01473524|12330179|FG002|LTSE Phase|Adverse Event of Pruritus|0
7848139|NCT01473524|12330180|FG003|LTSE Phase|Adverse Event of Pruritus|1
7848140|NCT01473524|12330181|FG004|LTSE Phase|Adverse Event of Pruritus|5
7848141|NCT01473524|12330182|FG005|LTSE Phase|Adverse Event of Pruritus|2
7848142|NCT01473524|12330177|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
7848143|NCT01473524|12330178|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
7848144|NCT01473524|12330179|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
7848145|NCT01473524|12330180|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2
7848146|NCT01473524|12330181|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4
7848147|NCT01473524|12330182|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6
7848148|NCT01473524|12330177|FG000|LTSE Phase|Lost to Follow-up|0
7848149|NCT01473524|12330178|FG001|LTSE Phase|Lost to Follow-up|0
7848150|NCT01473524|12330179|FG002|LTSE Phase|Lost to Follow-up|0
7848151|NCT01473524|12330180|FG003|LTSE Phase|Lost to Follow-up|1
7848152|NCT01473524|12330181|FG004|LTSE Phase|Lost to Follow-up|3
7848153|NCT01473524|12330182|FG005|LTSE Phase|Lost to Follow-up|2
7848154|NCT01473524|12330177|FG000|LTSE Phase|Principal Investigator Decision|0
7848155|NCT01473524|12330178|FG001|LTSE Phase|Principal Investigator Decision|0
7848156|NCT01473524|12330179|FG002|LTSE Phase|Principal Investigator Decision|0
7848157|NCT01473524|12330180|FG003|LTSE Phase|Principal Investigator Decision|1
7848158|NCT01473524|12330181|FG004|LTSE Phase|Principal Investigator Decision|1
7848159|NCT01473524|12330182|FG005|LTSE Phase|Principal Investigator Decision|3
7848160|NCT01473524|12330177|FG000|LTSE Phase|Liver Transplantation|0
7848161|NCT01473524|12330178|FG001|LTSE Phase|Liver Transplantation|0
7848162|NCT01473524|12330179|FG002|LTSE Phase|Liver Transplantation|0
7848163|NCT01473524|12330180|FG003|LTSE Phase|Liver Transplantation|0
7848164|NCT01473524|12330181|FG004|LTSE Phase|Liver Transplantation|0
7848165|NCT01473524|12330182|FG005|LTSE Phase|Liver Transplantation|1
7848166|NCT01473524|12330177|FG000|LTSE Phase|Pregnancy|0
7848167|NCT01473524|12330178|FG001|LTSE Phase|Pregnancy|0
7848168|NCT01473524|12330179|FG002|LTSE Phase|Pregnancy|0
7848169|NCT01473524|12330180|FG003|LTSE Phase|Pregnancy|1
7848170|NCT01473524|12330181|FG004|LTSE Phase|Pregnancy|0
7848171|NCT01473524|12330182|FG005|LTSE Phase|Pregnancy|0
7848172|NCT01473524|12330177|FG000|LTSE Phase|Protocol Violation|0
7848173|NCT01473524|12330178|FG001|LTSE Phase|Protocol Violation|0
7848174|NCT01473524|12330179|FG002|LTSE Phase|Protocol Violation|0
7848175|NCT01473524|12330180|FG003|LTSE Phase|Protocol Violation|0
7848176|NCT01473524|12330181|FG004|LTSE Phase|Protocol Violation|0
7848177|NCT01473524|12330182|FG005|LTSE Phase|Protocol Violation|1
7848178|NCT01473563|12330204|FG000|Overall Study|Lost to FU post tx discontinuation|1
7848179|NCT01473589|12330210|FG000|Overall Study|Adverse Event|1
7848180|NCT01473589|12330211|FG001|Overall Study|Adverse Event|1
7848181|NCT01473589|12330210|FG000|Overall Study|Death|2
7848182|NCT01473589|12330211|FG001|Overall Study|Death|0
7848183|NCT01473589|12330210|FG000|Overall Study|Lost to Follow-up|2
7848184|NCT01473589|12330211|FG001|Overall Study|Lost to Follow-up|2
7848185|NCT01473589|12330210|FG000|Overall Study|Protocol Violation|1
7848186|NCT01473589|12330211|FG001|Overall Study|Protocol Violation|0
7848187|NCT01473589|12330210|FG000|Overall Study|Withdrawal by Subject|5
7848188|NCT01473589|12330211|FG001|Overall Study|Withdrawal by Subject|11
7848189|NCT01473589|12330210|FG000|Overall Study|Physician Decision|0
7848190|NCT01473589|12330211|FG001|Overall Study|Physician Decision|1
7848191|NCT01473589|12330210|FG000|Overall Study|Entry criteria not met|0
7848192|NCT01473589|12330211|FG001|Overall Study|Entry criteria not met|1
7848193|NCT01473602|12330221|FG000|Overall Study|Adverse Event|1
7848194|NCT01473602|12330222|FG001|Overall Study|Adverse Event|2
7848195|NCT01473602|12330221|FG000|Overall Study|Death|0
7848196|NCT01473602|12330222|FG001|Overall Study|Death|1
7848197|NCT01473602|12330221|FG000|Overall Study|Lost to Follow-up|1
7848198|NCT01473602|12330222|FG001|Overall Study|Lost to Follow-up|1
7848199|NCT01473602|12330221|FG000|Overall Study|Withdrawal by Subject|5
7848200|NCT01473602|12330222|FG001|Overall Study|Withdrawal by Subject|4
7848201|NCT01473602|12330221|FG000|Overall Study|Physician Decision|1
7848202|NCT01473602|12330222|FG001|Overall Study|Physician Decision|0
7848203|NCT01473758|12330241|FG000|Cycle 1|Adverse Event|10
7848204|NCT01473758|12330242|FG001|Cycle 1|Adverse Event|2
7848205|NCT01473758|12330243|FG002|Cycle 1|Adverse Event|0
7848206|NCT01473758|12330244|FG003|Cycle 1|Adverse Event|0
7848207|NCT01473758|12330241|FG000|Cycle 1|Withdrawal by Subject|1
7848208|NCT01473758|12330242|FG001|Cycle 1|Withdrawal by Subject|1
7848209|NCT01473758|12330243|FG002|Cycle 1|Withdrawal by Subject|0
7848210|NCT01473758|12330244|FG003|Cycle 1|Withdrawal by Subject|0
7848211|NCT01473758|12330241|FG000|Cycle 2|Adverse Event|0
7848212|NCT01473758|12330242|FG001|Cycle 2|Adverse Event|0
7848213|NCT01473758|12330243|FG002|Cycle 2|Adverse Event|5
7848214|NCT01473758|12330244|FG003|Cycle 2|Adverse Event|0
7848215|NCT01473836|12330252|FG000|Overall Study|Adverse Event|4
7848216|NCT01473836|12330252|FG000|Overall Study|Lack of Efficacy|1
7848217|NCT01473836|12330252|FG000|Overall Study|Does not meet entrance criteria|1
7848218|NCT01473940|12330260|FG000|Induction Therapy|Death|0
7848219|NCT01473940|12330261|FG001|Induction Therapy|Death|0
7848220|NCT01473940|12330262|FG002|Induction Therapy|Death|1
7848221|NCT01473940|12330263|FG003|Induction Therapy|Death|1
7848222|NCT01473940|12330260|FG000|Induction Therapy|Progressive Disease|0
7848223|NCT01473940|12330261|FG001|Induction Therapy|Progressive Disease|1
7848224|NCT01473940|12330262|FG002|Induction Therapy|Progressive Disease|1
7848225|NCT01473940|12330263|FG003|Induction Therapy|Progressive Disease|0
7848226|NCT01473940|12330260|FG000|Maintenance Therapy|Progressive Disease|1
7848227|NCT01473940|12330261|FG001|Maintenance Therapy|Progressive Disease|2
7848228|NCT01473940|12330262|FG002|Maintenance Therapy|Progressive Disease|1
7848229|NCT01473940|12330263|FG003|Maintenance Therapy|Progressive Disease|4
7848230|NCT01473953|12330281|FG000|Overall Study|Other|1
7848231|NCT01473953|12330282|FG001|Overall Study|Other|0
7848232|NCT01473953|12330283|FG002|Overall Study|Other|0
7848233|NCT01473953|12330284|FG003|Overall Study|Other|0
7848234|NCT01473953|12330285|FG004|Overall Study|Other|0
7848235|NCT01474018|12330311|FG000|Overall Study|Lost to Follow-up|0
7848236|NCT01474018|12330312|FG001|Overall Study|Lost to Follow-up|1
7848237|NCT01474018|12330311|FG000|Overall Study|Withdrawal by Subject|0
7848238|NCT01474018|12330312|FG001|Overall Study|Withdrawal by Subject|2
7848239|NCT01474239|12330370|FG000|Overall Study|Disease Progression|37
7848240|NCT01474239|12330371|FG001|Overall Study|Disease Progression|25
7848241|NCT01474239|12330370|FG000|Overall Study|Adverse Event|12
7848242|NCT01474239|12330371|FG001|Overall Study|Adverse Event|3
7848243|NCT01474239|12330370|FG000|Overall Study|Withdrawal by Subject|1
7848244|NCT01474239|12330371|FG001|Overall Study|Withdrawal by Subject|2
7848245|NCT01474239|12330370|FG000|Overall Study|Death|1
7848246|NCT01474239|12330371|FG001|Overall Study|Death|1
7848247|NCT01474239|12330370|FG000|Overall Study|Clinical Disease Progression|7
7848248|NCT01474239|12330371|FG001|Overall Study|Clinical Disease Progression|1
7848249|NCT01474239|12330370|FG000|Overall Study|Withdrawal for Economic Reason|1
7848250|NCT01474239|12330371|FG001|Overall Study|Withdrawal for Economic Reason|0
7848251|NCT01474291|12330379|FG000|Overall Study|Not Evaluable for Efficacy|26
7848252|NCT01474291|12330379|FG000|Overall Study|Lack of Treatment Efficacy|88
7848253|NCT01474291|12330379|FG000|Overall Study|Adverse Event|53
7848254|NCT01474291|12330379|FG000|Overall Study|Lost to Follow-up|29
7848255|NCT01474291|12330379|FG000|Overall Study|Patient No Longer Wanted to Participate|12
7848256|NCT01474291|12330379|FG000|Overall Study|No Reason Reported|10
7848257|NCT01474291|12330379|FG000|Overall Study|Death|2
7848258|NCT01474317|12330386|FG000|Overall Study|Adverse Event|1
7848259|NCT01474317|12330386|FG000|Overall Study|Subject ineligible for study|1
7848260|NCT01474434|12330394|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
7848261|NCT01474434|12330395|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
7848262|NCT01474434|12330396|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
7848263|NCT01474434|12330397|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
7848264|NCT01474434|12330394|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
7848265|NCT01474434|12330395|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
7848266|NCT01474434|12330396|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
7848267|NCT01474434|12330397|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
7848268|NCT01474434|12330394|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
7848269|NCT01474434|12330395|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
7848270|NCT01474434|12330396|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
7848271|NCT01474434|12330397|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
7848272|NCT01474486|12330411|FG000|Overall Study|Death|2
7848273|NCT01474486|12330411|FG000|Overall Study|Withdrawal by Subject|4
7848274|NCT01474486|12330411|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2
7848275|NCT01474512|12330422|FG000|Induction Period|Adverse Event|6
7848276|NCT01474512|12330423|FG001|Induction Period|Adverse Event|10
7848277|NCT01474512|12330424|FG002|Induction Period|Adverse Event|10
7848278|NCT01474512|12330425|FG003|Induction Period|Adverse Event|0
7848279|NCT01474512|12330426|FG004|Induction Period|Adverse Event|0
7848280|NCT01474512|12330427|FG005|Induction Period|Adverse Event|0
7848281|NCT01474512|12330428|FG006|Induction Period|Adverse Event|0
7848282|NCT01474512|12330429|FG007|Induction Period|Adverse Event|0
7848283|NCT01474512|12330430|FG008|Induction Period|Adverse Event|0
7848284|NCT01474512|12330431|FG009|Induction Period|Adverse Event|0
7848285|NCT01474512|12330432|FG010|Induction Period|Adverse Event|0
7848286|NCT01474512|12330433|FG011|Induction Period|Adverse Event|0
7848287|NCT01474512|12330434|FG012|Induction Period|Adverse Event|0
7848288|NCT01474512|12330435|FG013|Induction Period|Adverse Event|0
7848289|NCT01474512|12330436|FG014|Induction Period|Adverse Event|0
7848290|NCT01474512|12330437|FG015|Induction Period|Adverse Event|0
7848291|NCT01474512|12330438|FG016|Induction Period|Adverse Event|0
7848292|NCT01474512|12330439|FG017|Induction Period|Adverse Event|0
7848293|NCT01474512|12330422|FG000|Induction Period|Lack of Efficacy|7
7848294|NCT01474512|12330423|FG001|Induction Period|Lack of Efficacy|1
7848295|NCT01474512|12330424|FG002|Induction Period|Lack of Efficacy|0
7848296|NCT01474512|12330425|FG003|Induction Period|Lack of Efficacy|0
7848297|NCT01474512|12330426|FG004|Induction Period|Lack of Efficacy|0
7848298|NCT01474512|12330427|FG005|Induction Period|Lack of Efficacy|0
7848299|NCT01474512|12330428|FG006|Induction Period|Lack of Efficacy|0
7848300|NCT01474512|12330429|FG007|Induction Period|Lack of Efficacy|0
7848301|NCT01474512|12330430|FG008|Induction Period|Lack of Efficacy|0
7848302|NCT01474512|12330431|FG009|Induction Period|Lack of Efficacy|0
7848303|NCT01474512|12330432|FG010|Induction Period|Lack of Efficacy|0
7848304|NCT01474512|12330433|FG011|Induction Period|Lack of Efficacy|0
7848305|NCT01474512|12330434|FG012|Induction Period|Lack of Efficacy|0
7848306|NCT01474512|12330435|FG013|Induction Period|Lack of Efficacy|0
7848307|NCT01474512|12330436|FG014|Induction Period|Lack of Efficacy|0
7848308|NCT01474512|12330437|FG015|Induction Period|Lack of Efficacy|0
7848309|NCT01474512|12330438|FG016|Induction Period|Lack of Efficacy|0
7848310|NCT01474512|12330439|FG017|Induction Period|Lack of Efficacy|0
7848311|NCT01474512|12330422|FG000|Induction Period|Withdrawal by Subject|6
7848312|NCT01474512|12330423|FG001|Induction Period|Withdrawal by Subject|6
7848313|NCT01474512|12330424|FG002|Induction Period|Withdrawal by Subject|5
7848314|NCT01474512|12330425|FG003|Induction Period|Withdrawal by Subject|0
7848315|NCT01474512|12330426|FG004|Induction Period|Withdrawal by Subject|0
7848316|NCT01474512|12330427|FG005|Induction Period|Withdrawal by Subject|0
7848317|NCT01474512|12330428|FG006|Induction Period|Withdrawal by Subject|0
7848318|NCT01474512|12330429|FG007|Induction Period|Withdrawal by Subject|0
7848319|NCT01474512|12330430|FG008|Induction Period|Withdrawal by Subject|0
7848320|NCT01474512|12330431|FG009|Induction Period|Withdrawal by Subject|0
7848321|NCT01474512|12330432|FG010|Induction Period|Withdrawal by Subject|0
7848322|NCT01474512|12330433|FG011|Induction Period|Withdrawal by Subject|0
7848323|NCT01474512|12330434|FG012|Induction Period|Withdrawal by Subject|0
7848324|NCT01474512|12330435|FG013|Induction Period|Withdrawal by Subject|0
7848325|NCT01474512|12330436|FG014|Induction Period|Withdrawal by Subject|0
7848326|NCT01474512|12330437|FG015|Induction Period|Withdrawal by Subject|0
7848327|NCT01474512|12330438|FG016|Induction Period|Withdrawal by Subject|0
7848328|NCT01474512|12330439|FG017|Induction Period|Withdrawal by Subject|0
7848329|NCT01474512|12330422|FG000|Induction Period|Protocol Violation|3
7848330|NCT01474512|12330423|FG001|Induction Period|Protocol Violation|6
7848331|NCT01474512|12330424|FG002|Induction Period|Protocol Violation|0
7848332|NCT01474512|12330425|FG003|Induction Period|Protocol Violation|0
7848333|NCT01474512|12330426|FG004|Induction Period|Protocol Violation|0
7848334|NCT01474512|12330427|FG005|Induction Period|Protocol Violation|0
7848335|NCT01474512|12330428|FG006|Induction Period|Protocol Violation|0
7848336|NCT01474512|12330429|FG007|Induction Period|Protocol Violation|0
7848337|NCT01474512|12330430|FG008|Induction Period|Protocol Violation|0
7848338|NCT01474512|12330431|FG009|Induction Period|Protocol Violation|0
7848339|NCT01474512|12330432|FG010|Induction Period|Protocol Violation|0
7848340|NCT01474512|12330433|FG011|Induction Period|Protocol Violation|0
7848341|NCT01474512|12330434|FG012|Induction Period|Protocol Violation|0
7848342|NCT01474512|12330435|FG013|Induction Period|Protocol Violation|0
7848343|NCT01474512|12330436|FG014|Induction Period|Protocol Violation|0
7848344|NCT01474512|12330437|FG015|Induction Period|Protocol Violation|0
7848345|NCT01474512|12330438|FG016|Induction Period|Protocol Violation|0
7848346|NCT01474512|12330439|FG017|Induction Period|Protocol Violation|0
7848347|NCT01474512|12330422|FG000|Induction Period|Sponsor Decision|1
7848348|NCT01474512|12330423|FG001|Induction Period|Sponsor Decision|1
7848349|NCT01474512|12330424|FG002|Induction Period|Sponsor Decision|1
7848350|NCT01474512|12330425|FG003|Induction Period|Sponsor Decision|0
7848351|NCT01474512|12330426|FG004|Induction Period|Sponsor Decision|0
7848352|NCT01474512|12330427|FG005|Induction Period|Sponsor Decision|0
7848353|NCT01474512|12330428|FG006|Induction Period|Sponsor Decision|0
7848354|NCT01474512|12330429|FG007|Induction Period|Sponsor Decision|0
7848355|NCT01474512|12330430|FG008|Induction Period|Sponsor Decision|0
7848356|NCT01474512|12330431|FG009|Induction Period|Sponsor Decision|0
7848357|NCT01474512|12330432|FG010|Induction Period|Sponsor Decision|0
7848358|NCT01474512|12330433|FG011|Induction Period|Sponsor Decision|0
7848359|NCT01474512|12330434|FG012|Induction Period|Sponsor Decision|0
7848360|NCT01474512|12330435|FG013|Induction Period|Sponsor Decision|0
7848361|NCT01474512|12330436|FG014|Induction Period|Sponsor Decision|0
7848362|NCT01474512|12330437|FG015|Induction Period|Sponsor Decision|0
7848363|NCT01474512|12330438|FG016|Induction Period|Sponsor Decision|0
7848364|NCT01474512|12330439|FG017|Induction Period|Sponsor Decision|0
7848365|NCT01474512|12330422|FG000|Induction Period|Lost to Follow-up|1
7848366|NCT01474512|12330423|FG001|Induction Period|Lost to Follow-up|0
7848367|NCT01474512|12330424|FG002|Induction Period|Lost to Follow-up|2
7848368|NCT01474512|12330425|FG003|Induction Period|Lost to Follow-up|0
7848369|NCT01474512|12330426|FG004|Induction Period|Lost to Follow-up|0
7848370|NCT01474512|12330427|FG005|Induction Period|Lost to Follow-up|0
7848371|NCT01474512|12330428|FG006|Induction Period|Lost to Follow-up|0
7848372|NCT01474512|12330429|FG007|Induction Period|Lost to Follow-up|0
7848373|NCT01474512|12330430|FG008|Induction Period|Lost to Follow-up|0
7848374|NCT01474512|12330431|FG009|Induction Period|Lost to Follow-up|0
7848375|NCT01474512|12330432|FG010|Induction Period|Lost to Follow-up|0
7848376|NCT01474512|12330433|FG011|Induction Period|Lost to Follow-up|0
7848377|NCT01474512|12330434|FG012|Induction Period|Lost to Follow-up|0
7848378|NCT01474512|12330435|FG013|Induction Period|Lost to Follow-up|0
7848379|NCT01474512|12330436|FG014|Induction Period|Lost to Follow-up|0
7848380|NCT01474512|12330437|FG015|Induction Period|Lost to Follow-up|0
7848381|NCT01474512|12330438|FG016|Induction Period|Lost to Follow-up|0
7848382|NCT01474512|12330439|FG017|Induction Period|Lost to Follow-up|0
7848383|NCT01474512|12330422|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0
7848384|NCT01474512|12330423|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0
7848385|NCT01474512|12330424|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0
7848386|NCT01474512|12330425|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186
7848387|NCT01474512|12330426|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111
7848388|NCT01474512|12330427|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39
7848389|NCT01474512|12330428|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9
7848390|NCT01474512|12330429|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0
7848391|NCT01474512|12330430|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0
7848392|NCT01474512|12330431|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0
7848393|NCT01474512|12330432|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0
7848394|NCT01474512|12330433|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0
7848395|NCT01474512|12330434|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0
7848396|NCT01474512|12330435|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0
7848397|NCT01474512|12330436|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0
7848398|NCT01474512|12330437|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0
7848399|NCT01474512|12330438|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0
7848400|NCT01474512|12330439|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0
7848401|NCT01474512|12330422|FG000|Maintenance Period|Adverse Event|0
7848402|NCT01474512|12330423|FG001|Maintenance Period|Adverse Event|0
7848403|NCT01474512|12330424|FG002|Maintenance Period|Adverse Event|0
7848404|NCT01474512|12330425|FG003|Maintenance Period|Adverse Event|4
7848405|NCT01474512|12330426|FG004|Maintenance Period|Adverse Event|2
7848406|NCT01474512|12330427|FG005|Maintenance Period|Adverse Event|7
7848407|NCT01474512|12330428|FG006|Maintenance Period|Adverse Event|0
7848408|NCT01474512|12330429|FG007|Maintenance Period|Adverse Event|19
7848409|NCT01474512|12330430|FG008|Maintenance Period|Adverse Event|1
7848410|NCT01474512|12330431|FG009|Maintenance Period|Adverse Event|3
7848411|NCT01474512|12330432|FG010|Maintenance Period|Adverse Event|0
7848412|NCT01474512|12330433|FG011|Maintenance Period|Adverse Event|0
7848413|NCT01474512|12330434|FG012|Maintenance Period|Adverse Event|0
7848414|NCT01474512|12330435|FG013|Maintenance Period|Adverse Event|0
7848415|NCT01474512|12330436|FG014|Maintenance Period|Adverse Event|0
7848416|NCT01474512|12330437|FG015|Maintenance Period|Adverse Event|0
7848417|NCT01474512|12330438|FG016|Maintenance Period|Adverse Event|0
7848418|NCT01474512|12330439|FG017|Maintenance Period|Adverse Event|0
7848419|NCT01474512|12330422|FG000|Maintenance Period|Withdrawal by Subject|0
7848420|NCT01474512|12330423|FG001|Maintenance Period|Withdrawal by Subject|0
7848421|NCT01474512|12330424|FG002|Maintenance Period|Withdrawal by Subject|0
7848422|NCT01474512|12330425|FG003|Maintenance Period|Withdrawal by Subject|6
7848423|NCT01474512|12330426|FG004|Maintenance Period|Withdrawal by Subject|2
7848424|NCT01474512|12330427|FG005|Maintenance Period|Withdrawal by Subject|3
7848425|NCT01474512|12330428|FG006|Maintenance Period|Withdrawal by Subject|1
7848426|NCT01474512|12330429|FG007|Maintenance Period|Withdrawal by Subject|6
7848427|NCT01474512|12330430|FG008|Maintenance Period|Withdrawal by Subject|3
7848428|NCT01474512|12330431|FG009|Maintenance Period|Withdrawal by Subject|1
7848429|NCT01474512|12330432|FG010|Maintenance Period|Withdrawal by Subject|0
7848430|NCT01474512|12330433|FG011|Maintenance Period|Withdrawal by Subject|0
7848431|NCT01474512|12330434|FG012|Maintenance Period|Withdrawal by Subject|0
7848432|NCT01474512|12330435|FG013|Maintenance Period|Withdrawal by Subject|0
7848433|NCT01474512|12330436|FG014|Maintenance Period|Withdrawal by Subject|0
7848434|NCT01474512|12330437|FG015|Maintenance Period|Withdrawal by Subject|0
7848435|NCT01474512|12330438|FG016|Maintenance Period|Withdrawal by Subject|0
7848436|NCT01474512|12330439|FG017|Maintenance Period|Withdrawal by Subject|0
7848437|NCT01474512|12330422|FG000|Maintenance Period|Lost to Follow-up|0
7848438|NCT01474512|12330423|FG001|Maintenance Period|Lost to Follow-up|0
7848439|NCT01474512|12330424|FG002|Maintenance Period|Lost to Follow-up|0
7848440|NCT01474512|12330425|FG003|Maintenance Period|Lost to Follow-up|3
7848441|NCT01474512|12330426|FG004|Maintenance Period|Lost to Follow-up|3
7848442|NCT01474512|12330427|FG005|Maintenance Period|Lost to Follow-up|0
7848443|NCT01474512|12330428|FG006|Maintenance Period|Lost to Follow-up|0
7848444|NCT01474512|12330429|FG007|Maintenance Period|Lost to Follow-up|2
7848445|NCT01474512|12330430|FG008|Maintenance Period|Lost to Follow-up|1
7848446|NCT01474512|12330431|FG009|Maintenance Period|Lost to Follow-up|1
7848447|NCT01474512|12330432|FG010|Maintenance Period|Lost to Follow-up|0
7848448|NCT01474512|12330433|FG011|Maintenance Period|Lost to Follow-up|0
7848449|NCT01474512|12330434|FG012|Maintenance Period|Lost to Follow-up|0
7848450|NCT01474512|12330435|FG013|Maintenance Period|Lost to Follow-up|0
7848451|NCT01474512|12330436|FG014|Maintenance Period|Lost to Follow-up|0
7848452|NCT01474512|12330437|FG015|Maintenance Period|Lost to Follow-up|0
7848453|NCT01474512|12330438|FG016|Maintenance Period|Lost to Follow-up|0
7848454|NCT01474512|12330439|FG017|Maintenance Period|Lost to Follow-up|0
7848455|NCT01474512|12330422|FG000|Maintenance Period|Death|0
7848456|NCT01474512|12330423|FG001|Maintenance Period|Death|0
7848457|NCT01474512|12330424|FG002|Maintenance Period|Death|0
7848458|NCT01474512|12330425|FG003|Maintenance Period|Death|0
7848459|NCT01474512|12330426|FG004|Maintenance Period|Death|0
7848460|NCT01474512|12330427|FG005|Maintenance Period|Death|2
7848461|NCT01474512|12330428|FG006|Maintenance Period|Death|0
7848462|NCT01474512|12330429|FG007|Maintenance Period|Death|0
7848463|NCT01474512|12330430|FG008|Maintenance Period|Death|0
7848464|NCT01474512|12330431|FG009|Maintenance Period|Death|0
7848465|NCT01474512|12330432|FG010|Maintenance Period|Death|0
7848466|NCT01474512|12330433|FG011|Maintenance Period|Death|0
7848467|NCT01474512|12330434|FG012|Maintenance Period|Death|0
7949222|NCT02533674|12494575|FG005|Dose Level VIII|Progressive disease|0
7949223|NCT02533674|12494576|FG006|Dose Level VIII|Progressive disease|0
7949224|NCT02533674|12494577|FG007|Dose Level VIII|Progressive disease|3
7949225|NCT02533674|12494570|FG000|Dose Level VIII|Withdrawal by Subject|0
7949226|NCT02533674|12494571|FG001|Dose Level VIII|Withdrawal by Subject|0
7949227|NCT02533674|12494572|FG002|Dose Level VIII|Withdrawal by Subject|0
7949228|NCT02533674|12494573|FG003|Dose Level VIII|Withdrawal by Subject|0
7949229|NCT02533674|12494574|FG004|Dose Level VIII|Withdrawal by Subject|0
7949230|NCT02533674|12494575|FG005|Dose Level VIII|Withdrawal by Subject|0
7949231|NCT02533674|12494576|FG006|Dose Level VIII|Withdrawal by Subject|0
7949232|NCT02533674|12494577|FG007|Dose Level VIII|Withdrawal by Subject|1
7949233|NCT02533674|12494570|FG000|Dose Level VIII|Treatment-related AE|0
7949234|NCT02533674|12494571|FG001|Dose Level VIII|Treatment-related AE|0
7949235|NCT02533674|12494572|FG002|Dose Level VIII|Treatment-related AE|0
7848468|NCT01474512|12330435|FG013|Maintenance Period|Death|0
7848469|NCT01474512|12330436|FG014|Maintenance Period|Death|0
7848470|NCT01474512|12330437|FG015|Maintenance Period|Death|0
7848471|NCT01474512|12330438|FG016|Maintenance Period|Death|0
7848472|NCT01474512|12330439|FG017|Maintenance Period|Death|0
7848473|NCT01474512|12330422|FG000|Maintenance Period|Physician Decision|0
7848474|NCT01474512|12330423|FG001|Maintenance Period|Physician Decision|0
7949236|NCT02533674|12494573|FG003|Dose Level VIII|Treatment-related AE|0
7949237|NCT02533674|12494574|FG004|Dose Level VIII|Treatment-related AE|0
7949238|NCT02533674|12494575|FG005|Dose Level VIII|Treatment-related AE|0
7949239|NCT02533674|12494576|FG006|Dose Level VIII|Treatment-related AE|0
7949240|NCT02533674|12494577|FG007|Dose Level VIII|Treatment-related AE|1
7949241|NCT02533674|12494570|FG000|Dose Level VIII|Never treated|0
7949242|NCT02533674|12494571|FG001|Dose Level VIII|Never treated|0
7949243|NCT02533674|12494572|FG002|Dose Level VIII|Never treated|0
7949244|NCT02533674|12494573|FG003|Dose Level VIII|Never treated|0
7949245|NCT02533674|12494574|FG004|Dose Level VIII|Never treated|0
7949246|NCT02533674|12494575|FG005|Dose Level VIII|Never treated|0
7949247|NCT02533674|12494576|FG006|Dose Level VIII|Never treated|0
7949248|NCT02533674|12494577|FG007|Dose Level VIII|Never treated|1
7949249|NCT02533999|12494624|FG000|Overall Study|Lost to Follow-up|3
7949250|NCT02533999|12494625|FG001|Overall Study|Lost to Follow-up|5
7949251|NCT02533999|12494624|FG000|Overall Study|Protocol Violation|3
7949252|NCT02533999|12494625|FG001|Overall Study|Protocol Violation|0
7949253|NCT02533999|12494624|FG000|Overall Study|Adverse Event|0
7949254|NCT02533999|12494625|FG001|Overall Study|Adverse Event|1
7949255|NCT02533999|12494624|FG000|Overall Study|Randomized but intervention not received|0
7949256|NCT02533999|12494625|FG001|Overall Study|Randomized but intervention not received|1
7949257|NCT02534324|12494649|FG000|Overall Study|Protocol Violation|4
7949258|NCT02534324|12494650|FG001|Overall Study|Protocol Violation|1
7949259|NCT02534324|12494649|FG000|Overall Study|Lost to Follow-up|20
7949260|NCT02534324|12494650|FG001|Overall Study|Lost to Follow-up|7
7949261|NCT02534324|12494649|FG000|Overall Study|Adverse Event|1
7949262|NCT02534324|12494650|FG001|Overall Study|Adverse Event|0
7949263|NCT02534350|12494658|FG000|Overall Study|Randomized But Not Treated|1
7949264|NCT02534350|12494659|FG001|Overall Study|Randomized But Not Treated|0
7949265|NCT02534350|12494658|FG000|Overall Study|Protocol Violation|1
7949266|NCT02534350|12494659|FG001|Overall Study|Protocol Violation|0
7949267|NCT02534350|12494658|FG000|Overall Study|Withdrew Consent|2
7949268|NCT02534350|12494659|FG001|Overall Study|Withdrew Consent|0
7949269|NCT02534493|12494665|FG000|Overall Study|Lost to Follow-up|1
7949270|NCT02534493|12494665|FG000|Overall Study|Withdrawal by Subject|1
7949271|NCT02534883|12494673|FG000|Overall Study|Early Termination|8
7949272|NCT02534883|12494674|FG001|Overall Study|Early Termination|3
7949273|NCT02534896|12494683|FG000|Overall Study|Adverse Event|2
7949274|NCT02534896|12494684|FG001|Overall Study|Adverse Event|1
7949275|NCT02534896|12494685|FG002|Overall Study|Adverse Event|1
7949276|NCT02534896|12494683|FG000|Overall Study|Insufficient therapeutic response|2
7949277|NCT02534896|12494684|FG001|Overall Study|Insufficient therapeutic response|0
7949278|NCT02534896|12494685|FG002|Overall Study|Insufficient therapeutic response|0
7949279|NCT02534935|12494696|FG000|Stage 1: 24 Months|Withdrawal by Subject|0
7949280|NCT02534935|12494697|FG001|Stage 1: 24 Months|Withdrawal by Subject|3
7848475|NCT01474512|12330424|FG002|Maintenance Period|Physician Decision|0
7848476|NCT01474512|12330425|FG003|Maintenance Period|Physician Decision|0
7848477|NCT01474512|12330426|FG004|Maintenance Period|Physician Decision|0
7848478|NCT01474512|12330427|FG005|Maintenance Period|Physician Decision|1
7848479|NCT01474512|12330428|FG006|Maintenance Period|Physician Decision|0
7848480|NCT01474512|12330429|FG007|Maintenance Period|Physician Decision|2
7848481|NCT01474512|12330430|FG008|Maintenance Period|Physician Decision|0
7848482|NCT01474512|12330431|FG009|Maintenance Period|Physician Decision|0
7848483|NCT01474512|12330432|FG010|Maintenance Period|Physician Decision|0
7848484|NCT01474512|12330433|FG011|Maintenance Period|Physician Decision|0
7848485|NCT01474512|12330434|FG012|Maintenance Period|Physician Decision|0
7848486|NCT01474512|12330435|FG013|Maintenance Period|Physician Decision|0
7848487|NCT01474512|12330436|FG014|Maintenance Period|Physician Decision|0
7848488|NCT01474512|12330437|FG015|Maintenance Period|Physician Decision|0
7848489|NCT01474512|12330438|FG016|Maintenance Period|Physician Decision|0
7848490|NCT01474512|12330439|FG017|Maintenance Period|Physician Decision|0
7848491|NCT01474512|12330422|FG000|Maintenance Period|Clinical Relapse|0
7848492|NCT01474512|12330423|FG001|Maintenance Period|Clinical Relapse|0
7848493|NCT01474512|12330424|FG002|Maintenance Period|Clinical Relapse|0
7848494|NCT01474512|12330425|FG003|Maintenance Period|Clinical Relapse|1
7848495|NCT01474512|12330426|FG004|Maintenance Period|Clinical Relapse|0
7848496|NCT01474512|12330427|FG005|Maintenance Period|Clinical Relapse|0
7848497|NCT01474512|12330428|FG006|Maintenance Period|Clinical Relapse|0
7848498|NCT01474512|12330429|FG007|Maintenance Period|Clinical Relapse|0
7848499|NCT01474512|12330430|FG008|Maintenance Period|Clinical Relapse|0
7848500|NCT01474512|12330431|FG009|Maintenance Period|Clinical Relapse|0
7848501|NCT01474512|12330432|FG010|Maintenance Period|Clinical Relapse|0
7848502|NCT01474512|12330433|FG011|Maintenance Period|Clinical Relapse|0
7848503|NCT01474512|12330434|FG012|Maintenance Period|Clinical Relapse|0
7848504|NCT01474512|12330435|FG013|Maintenance Period|Clinical Relapse|0
7848505|NCT01474512|12330436|FG014|Maintenance Period|Clinical Relapse|0
7848506|NCT01474512|12330437|FG015|Maintenance Period|Clinical Relapse|0
7848507|NCT01474512|12330438|FG016|Maintenance Period|Clinical Relapse|0
7848508|NCT01474512|12330439|FG017|Maintenance Period|Clinical Relapse|0
7848509|NCT01474512|12330422|FG000|Maintenance Period|Lack of Efficacy|0
7848510|NCT01474512|12330423|FG001|Maintenance Period|Lack of Efficacy|0
7848511|NCT01474512|12330424|FG002|Maintenance Period|Lack of Efficacy|0
7848512|NCT01474512|12330425|FG003|Maintenance Period|Lack of Efficacy|1
7848513|NCT01474512|12330426|FG004|Maintenance Period|Lack of Efficacy|0
7848514|NCT01474512|12330427|FG005|Maintenance Period|Lack of Efficacy|0
7848515|NCT01474512|12330428|FG006|Maintenance Period|Lack of Efficacy|0
7848516|NCT01474512|12330429|FG007|Maintenance Period|Lack of Efficacy|11
7848517|NCT01474512|12330430|FG008|Maintenance Period|Lack of Efficacy|11
7848518|NCT01474512|12330431|FG009|Maintenance Period|Lack of Efficacy|12
7848519|NCT01474512|12330432|FG010|Maintenance Period|Lack of Efficacy|0
7848520|NCT01474512|12330433|FG011|Maintenance Period|Lack of Efficacy|0
7848521|NCT01474512|12330434|FG012|Maintenance Period|Lack of Efficacy|0
7848522|NCT01474512|12330435|FG013|Maintenance Period|Lack of Efficacy|0
7848523|NCT01474512|12330436|FG014|Maintenance Period|Lack of Efficacy|0
7848524|NCT01474512|12330437|FG015|Maintenance Period|Lack of Efficacy|0
7848525|NCT01474512|12330438|FG016|Maintenance Period|Lack of Efficacy|0
7848526|NCT01474512|12330439|FG017|Maintenance Period|Lack of Efficacy|0
7848527|NCT01474512|12330422|FG000|Maintenance Period|Protocol Violation|0
7848528|NCT01474512|12330423|FG001|Maintenance Period|Protocol Violation|0
7848529|NCT01474512|12330424|FG002|Maintenance Period|Protocol Violation|0
7848530|NCT01474512|12330425|FG003|Maintenance Period|Protocol Violation|1
7848531|NCT01474512|12330426|FG004|Maintenance Period|Protocol Violation|0
7848532|NCT01474512|12330427|FG005|Maintenance Period|Protocol Violation|0
7848533|NCT01474512|12330428|FG006|Maintenance Period|Protocol Violation|0
7848534|NCT01474512|12330429|FG007|Maintenance Period|Protocol Violation|1
7848535|NCT01474512|12330430|FG008|Maintenance Period|Protocol Violation|0
7848536|NCT01474512|12330431|FG009|Maintenance Period|Protocol Violation|1
7848537|NCT01474512|12330432|FG010|Maintenance Period|Protocol Violation|0
7848538|NCT01474512|12330433|FG011|Maintenance Period|Protocol Violation|0
7848539|NCT01474512|12330434|FG012|Maintenance Period|Protocol Violation|0
7848540|NCT01474512|12330435|FG013|Maintenance Period|Protocol Violation|0
7848541|NCT01474512|12330436|FG014|Maintenance Period|Protocol Violation|0
7848542|NCT01474512|12330437|FG015|Maintenance Period|Protocol Violation|0
7848543|NCT01474512|12330438|FG016|Maintenance Period|Protocol Violation|0
7848544|NCT01474512|12330439|FG017|Maintenance Period|Protocol Violation|0
7848545|NCT01474512|12330422|FG000|Maintenance Period|Treated but Discontinued in Induction|0
7848546|NCT01474512|12330423|FG001|Maintenance Period|Treated but Discontinued in Induction|0
7848547|NCT01474512|12330424|FG002|Maintenance Period|Treated but Discontinued in Induction|0
7848548|NCT01474512|12330425|FG003|Maintenance Period|Treated but Discontinued in Induction|0
7848549|NCT01474512|12330426|FG004|Maintenance Period|Treated but Discontinued in Induction|1
7848550|NCT01474512|12330427|FG005|Maintenance Period|Treated but Discontinued in Induction|0
7848551|NCT01474512|12330428|FG006|Maintenance Period|Treated but Discontinued in Induction|0
7848552|NCT01474512|12330429|FG007|Maintenance Period|Treated but Discontinued in Induction|0
7848553|NCT01474512|12330430|FG008|Maintenance Period|Treated but Discontinued in Induction|0
7848554|NCT01474512|12330431|FG009|Maintenance Period|Treated but Discontinued in Induction|0
7848555|NCT01474512|12330432|FG010|Maintenance Period|Treated but Discontinued in Induction|0
7848556|NCT01474512|12330433|FG011|Maintenance Period|Treated but Discontinued in Induction|0
7848557|NCT01474512|12330434|FG012|Maintenance Period|Treated but Discontinued in Induction|0
7848558|NCT01474512|12330435|FG013|Maintenance Period|Treated but Discontinued in Induction|0
7848559|NCT01474512|12330436|FG014|Maintenance Period|Treated but Discontinued in Induction|0
7848560|NCT01474512|12330437|FG015|Maintenance Period|Treated but Discontinued in Induction|0
7848561|NCT01474512|12330438|FG016|Maintenance Period|Treated but Discontinued in Induction|0
7848562|NCT01474512|12330439|FG017|Maintenance Period|Treated but Discontinued in Induction|0
7848563|NCT01474512|12330422|FG000|Long-Term Extension Period|Withdrawal by Subject|0
7848564|NCT01474512|12330423|FG001|Long-Term Extension Period|Withdrawal by Subject|0
7848565|NCT01474512|12330424|FG002|Long-Term Extension Period|Withdrawal by Subject|0
7848566|NCT01474512|12330425|FG003|Long-Term Extension Period|Withdrawal by Subject|0
7848567|NCT01474512|12330426|FG004|Long-Term Extension Period|Withdrawal by Subject|0
7848568|NCT01474512|12330427|FG005|Long-Term Extension Period|Withdrawal by Subject|0
7848569|NCT01474512|12330428|FG006|Long-Term Extension Period|Withdrawal by Subject|0
7848570|NCT01474512|12330429|FG007|Long-Term Extension Period|Withdrawal by Subject|0
7848571|NCT01474512|12330430|FG008|Long-Term Extension Period|Withdrawal by Subject|0
7848572|NCT01474512|12330431|FG009|Long-Term Extension Period|Withdrawal by Subject|0
7848573|NCT01474512|12330432|FG010|Long-Term Extension Period|Withdrawal by Subject|0
7848574|NCT01474512|12330433|FG011|Long-Term Extension Period|Withdrawal by Subject|3
7848575|NCT01474512|12330434|FG012|Long-Term Extension Period|Withdrawal by Subject|61
7848576|NCT01474512|12330435|FG013|Long-Term Extension Period|Withdrawal by Subject|61
7848577|NCT01474512|12330436|FG014|Long-Term Extension Period|Withdrawal by Subject|0
7848578|NCT01474512|12330437|FG015|Long-Term Extension Period|Withdrawal by Subject|0
7848579|NCT01474512|12330438|FG016|Long-Term Extension Period|Withdrawal by Subject|0
7848580|NCT01474512|12330439|FG017|Long-Term Extension Period|Withdrawal by Subject|0
7848581|NCT01474512|12330422|FG000|Long-Term Extension Period|Adverse Event|0
7848582|NCT01474512|12330423|FG001|Long-Term Extension Period|Adverse Event|0
7848583|NCT01474512|12330424|FG002|Long-Term Extension Period|Adverse Event|0
7848584|NCT01474512|12330425|FG003|Long-Term Extension Period|Adverse Event|0
7848585|NCT01474512|12330426|FG004|Long-Term Extension Period|Adverse Event|0
7848586|NCT01474512|12330427|FG005|Long-Term Extension Period|Adverse Event|0
7848587|NCT01474512|12330428|FG006|Long-Term Extension Period|Adverse Event|0
7848588|NCT01474512|12330429|FG007|Long-Term Extension Period|Adverse Event|0
7848589|NCT01474512|12330430|FG008|Long-Term Extension Period|Adverse Event|0
7848590|NCT01474512|12330431|FG009|Long-Term Extension Period|Adverse Event|0
7848591|NCT01474512|12330432|FG010|Long-Term Extension Period|Adverse Event|0
7848592|NCT01474512|12330433|FG011|Long-Term Extension Period|Adverse Event|1
7848593|NCT01474512|12330434|FG012|Long-Term Extension Period|Adverse Event|57
7848594|NCT01474512|12330435|FG013|Long-Term Extension Period|Adverse Event|58
7848595|NCT01474512|12330436|FG014|Long-Term Extension Period|Adverse Event|0
7848596|NCT01474512|12330437|FG015|Long-Term Extension Period|Adverse Event|0
7848597|NCT01474512|12330438|FG016|Long-Term Extension Period|Adverse Event|0
7848598|NCT01474512|12330439|FG017|Long-Term Extension Period|Adverse Event|0
7848599|NCT01474512|12330422|FG000|Long-Term Extension Period|Lost to Follow-up|0
7848600|NCT01474512|12330423|FG001|Long-Term Extension Period|Lost to Follow-up|0
7848601|NCT01474512|12330424|FG002|Long-Term Extension Period|Lost to Follow-up|0
7848602|NCT01474512|12330425|FG003|Long-Term Extension Period|Lost to Follow-up|0
7848603|NCT01474512|12330426|FG004|Long-Term Extension Period|Lost to Follow-up|0
7848604|NCT01474512|12330427|FG005|Long-Term Extension Period|Lost to Follow-up|0
7848605|NCT01474512|12330428|FG006|Long-Term Extension Period|Lost to Follow-up|0
7848606|NCT01474512|12330429|FG007|Long-Term Extension Period|Lost to Follow-up|0
7848607|NCT01474512|12330430|FG008|Long-Term Extension Period|Lost to Follow-up|0
7848608|NCT01474512|12330431|FG009|Long-Term Extension Period|Lost to Follow-up|0
7848609|NCT01474512|12330432|FG010|Long-Term Extension Period|Lost to Follow-up|0
7848610|NCT01474512|12330433|FG011|Long-Term Extension Period|Lost to Follow-up|0
7848611|NCT01474512|12330434|FG012|Long-Term Extension Period|Lost to Follow-up|25
7848612|NCT01474512|12330435|FG013|Long-Term Extension Period|Lost to Follow-up|25
7848613|NCT01474512|12330436|FG014|Long-Term Extension Period|Lost to Follow-up|0
7848614|NCT01474512|12330437|FG015|Long-Term Extension Period|Lost to Follow-up|0
7848615|NCT01474512|12330438|FG016|Long-Term Extension Period|Lost to Follow-up|0
7848616|NCT01474512|12330439|FG017|Long-Term Extension Period|Lost to Follow-up|0
7848617|NCT01474512|12330422|FG000|Long-Term Extension Period|Lack of Efficacy|0
7848618|NCT01474512|12330423|FG001|Long-Term Extension Period|Lack of Efficacy|0
7848619|NCT01474512|12330424|FG002|Long-Term Extension Period|Lack of Efficacy|0
7848620|NCT01474512|12330425|FG003|Long-Term Extension Period|Lack of Efficacy|0
7848621|NCT01474512|12330426|FG004|Long-Term Extension Period|Lack of Efficacy|0
7848622|NCT01474512|12330427|FG005|Long-Term Extension Period|Lack of Efficacy|0
7848623|NCT01474512|12330428|FG006|Long-Term Extension Period|Lack of Efficacy|0
7848624|NCT01474512|12330429|FG007|Long-Term Extension Period|Lack of Efficacy|0
7848625|NCT01474512|12330430|FG008|Long-Term Extension Period|Lack of Efficacy|0
7848626|NCT01474512|12330431|FG009|Long-Term Extension Period|Lack of Efficacy|0
7848627|NCT01474512|12330432|FG010|Long-Term Extension Period|Lack of Efficacy|0
7848628|NCT01474512|12330433|FG011|Long-Term Extension Period|Lack of Efficacy|1
7848629|NCT01474512|12330434|FG012|Long-Term Extension Period|Lack of Efficacy|24
7848630|NCT01474512|12330435|FG013|Long-Term Extension Period|Lack of Efficacy|25
7848631|NCT01474512|12330436|FG014|Long-Term Extension Period|Lack of Efficacy|0
7848632|NCT01474512|12330437|FG015|Long-Term Extension Period|Lack of Efficacy|0
7848633|NCT01474512|12330438|FG016|Long-Term Extension Period|Lack of Efficacy|0
7848634|NCT01474512|12330439|FG017|Long-Term Extension Period|Lack of Efficacy|0
7848635|NCT01474512|12330422|FG000|Long-Term Extension Period|Physician Decision|0
7848636|NCT01474512|12330423|FG001|Long-Term Extension Period|Physician Decision|0
7848637|NCT01474512|12330424|FG002|Long-Term Extension Period|Physician Decision|0
7848638|NCT01474512|12330425|FG003|Long-Term Extension Period|Physician Decision|0
7848639|NCT01474512|12330426|FG004|Long-Term Extension Period|Physician Decision|0
7848640|NCT01474512|12330427|FG005|Long-Term Extension Period|Physician Decision|0
7848641|NCT01474512|12330428|FG006|Long-Term Extension Period|Physician Decision|0
7848642|NCT01474512|12330429|FG007|Long-Term Extension Period|Physician Decision|0
7848643|NCT01474512|12330430|FG008|Long-Term Extension Period|Physician Decision|0
7848644|NCT01474512|12330431|FG009|Long-Term Extension Period|Physician Decision|0
7848645|NCT01474512|12330432|FG010|Long-Term Extension Period|Physician Decision|0
7848646|NCT01474512|12330433|FG011|Long-Term Extension Period|Physician Decision|0
7848647|NCT01474512|12330434|FG012|Long-Term Extension Period|Physician Decision|21
7848648|NCT01474512|12330435|FG013|Long-Term Extension Period|Physician Decision|21
7848649|NCT01474512|12330436|FG014|Long-Term Extension Period|Physician Decision|0
7848650|NCT01474512|12330437|FG015|Long-Term Extension Period|Physician Decision|0
7848651|NCT01474512|12330438|FG016|Long-Term Extension Period|Physician Decision|0
7848652|NCT01474512|12330439|FG017|Long-Term Extension Period|Physician Decision|0
7848653|NCT01474512|12330422|FG000|Long-Term Extension Period|Clinical Relapse|0
7848654|NCT01474512|12330423|FG001|Long-Term Extension Period|Clinical Relapse|0
7848655|NCT01474512|12330424|FG002|Long-Term Extension Period|Clinical Relapse|0
7848656|NCT01474512|12330425|FG003|Long-Term Extension Period|Clinical Relapse|0
7848657|NCT01474512|12330426|FG004|Long-Term Extension Period|Clinical Relapse|0
7848658|NCT01474512|12330427|FG005|Long-Term Extension Period|Clinical Relapse|0
7848659|NCT01474512|12330428|FG006|Long-Term Extension Period|Clinical Relapse|0
7848660|NCT01474512|12330429|FG007|Long-Term Extension Period|Clinical Relapse|0
7848661|NCT01474512|12330430|FG008|Long-Term Extension Period|Clinical Relapse|0
7848662|NCT01474512|12330431|FG009|Long-Term Extension Period|Clinical Relapse|0
7848663|NCT01474512|12330432|FG010|Long-Term Extension Period|Clinical Relapse|0
7848664|NCT01474512|12330433|FG011|Long-Term Extension Period|Clinical Relapse|0
7848665|NCT01474512|12330434|FG012|Long-Term Extension Period|Clinical Relapse|9
7848666|NCT01474512|12330435|FG013|Long-Term Extension Period|Clinical Relapse|9
7848667|NCT01474512|12330436|FG014|Long-Term Extension Period|Clinical Relapse|0
7848668|NCT01474512|12330437|FG015|Long-Term Extension Period|Clinical Relapse|0
7848669|NCT01474512|12330438|FG016|Long-Term Extension Period|Clinical Relapse|0
7848670|NCT01474512|12330439|FG017|Long-Term Extension Period|Clinical Relapse|0
7848671|NCT01474512|12330422|FG000|Long-Term Extension Period|Death|0
7848672|NCT01474512|12330423|FG001|Long-Term Extension Period|Death|0
7848673|NCT01474512|12330424|FG002|Long-Term Extension Period|Death|0
7848674|NCT01474512|12330425|FG003|Long-Term Extension Period|Death|0
7848675|NCT01474512|12330426|FG004|Long-Term Extension Period|Death|0
7848676|NCT01474512|12330427|FG005|Long-Term Extension Period|Death|0
7848677|NCT01474512|12330428|FG006|Long-Term Extension Period|Death|0
7848678|NCT01474512|12330429|FG007|Long-Term Extension Period|Death|0
7848679|NCT01474512|12330430|FG008|Long-Term Extension Period|Death|0
7848680|NCT01474512|12330431|FG009|Long-Term Extension Period|Death|0
7848681|NCT01474512|12330432|FG010|Long-Term Extension Period|Death|0
7848682|NCT01474512|12330433|FG011|Long-Term Extension Period|Death|0
7848683|NCT01474512|12330434|FG012|Long-Term Extension Period|Death|9
7848684|NCT01474512|12330435|FG013|Long-Term Extension Period|Death|9
7848685|NCT01474512|12330436|FG014|Long-Term Extension Period|Death|0
7848686|NCT01474512|12330437|FG015|Long-Term Extension Period|Death|0
7848687|NCT01474512|12330438|FG016|Long-Term Extension Period|Death|0
7848688|NCT01474512|12330439|FG017|Long-Term Extension Period|Death|0
7848689|NCT01474512|12330422|FG000|Long-Term Extension Period|Sponsor Decision|0
7848690|NCT01474512|12330423|FG001|Long-Term Extension Period|Sponsor Decision|0
7848691|NCT01474512|12330424|FG002|Long-Term Extension Period|Sponsor Decision|0
7848692|NCT01474512|12330425|FG003|Long-Term Extension Period|Sponsor Decision|0
7848693|NCT01474512|12330426|FG004|Long-Term Extension Period|Sponsor Decision|0
7848694|NCT01474512|12330427|FG005|Long-Term Extension Period|Sponsor Decision|0
7848695|NCT01474512|12330428|FG006|Long-Term Extension Period|Sponsor Decision|0
7848696|NCT01474512|12330429|FG007|Long-Term Extension Period|Sponsor Decision|0
7848697|NCT01474512|12330430|FG008|Long-Term Extension Period|Sponsor Decision|0
7848698|NCT01474512|12330431|FG009|Long-Term Extension Period|Sponsor Decision|0
7848699|NCT01474512|12330432|FG010|Long-Term Extension Period|Sponsor Decision|0
7848700|NCT01474512|12330433|FG011|Long-Term Extension Period|Sponsor Decision|0
7848701|NCT01474512|12330434|FG012|Long-Term Extension Period|Sponsor Decision|6
7848702|NCT01474512|12330435|FG013|Long-Term Extension Period|Sponsor Decision|6
7848703|NCT01474512|12330436|FG014|Long-Term Extension Period|Sponsor Decision|0
7848704|NCT01474512|12330437|FG015|Long-Term Extension Period|Sponsor Decision|0
7848705|NCT01474512|12330438|FG016|Long-Term Extension Period|Sponsor Decision|0
7848706|NCT01474512|12330439|FG017|Long-Term Extension Period|Sponsor Decision|0
7848707|NCT01474512|12330422|FG000|Long-Term Extension Period|Protocol Violation|0
7848708|NCT01474512|12330423|FG001|Long-Term Extension Period|Protocol Violation|0
7848709|NCT01474512|12330424|FG002|Long-Term Extension Period|Protocol Violation|0
7848710|NCT01474512|12330425|FG003|Long-Term Extension Period|Protocol Violation|0
7848711|NCT01474512|12330426|FG004|Long-Term Extension Period|Protocol Violation|0
7848712|NCT01474512|12330427|FG005|Long-Term Extension Period|Protocol Violation|0
7848713|NCT01474512|12330428|FG006|Long-Term Extension Period|Protocol Violation|0
7848714|NCT01474512|12330429|FG007|Long-Term Extension Period|Protocol Violation|0
7848715|NCT01474512|12330430|FG008|Long-Term Extension Period|Protocol Violation|0
7848716|NCT01474512|12330431|FG009|Long-Term Extension Period|Protocol Violation|0
7848717|NCT01474512|12330432|FG010|Long-Term Extension Period|Protocol Violation|0
7848718|NCT01474512|12330433|FG011|Long-Term Extension Period|Protocol Violation|0
7848719|NCT01474512|12330434|FG012|Long-Term Extension Period|Protocol Violation|5
7848720|NCT01474512|12330435|FG013|Long-Term Extension Period|Protocol Violation|5
7848721|NCT01474512|12330436|FG014|Long-Term Extension Period|Protocol Violation|0
7848722|NCT01474512|12330437|FG015|Long-Term Extension Period|Protocol Violation|0
7848723|NCT01474512|12330438|FG016|Long-Term Extension Period|Protocol Violation|0
7848724|NCT01474512|12330439|FG017|Long-Term Extension Period|Protocol Violation|0
7848725|NCT01474512|12330422|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0
7848726|NCT01474512|12330423|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0
7848727|NCT01474512|12330424|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0
7848728|NCT01474512|12330425|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0
7848729|NCT01474512|12330426|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0
7848730|NCT01474512|12330427|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0
7848731|NCT01474512|12330428|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0
7848732|NCT01474512|12330429|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0
7848733|NCT01474512|12330430|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0
7848734|NCT01474512|12330431|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0
7848735|NCT01474512|12330432|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0
7848736|NCT01474512|12330433|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0
7848737|NCT01474512|12330434|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1
7863315|NCT01604850|12352556|FG000|Overall Study|Efficacy Failure|50
7848738|NCT01474512|12330435|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1
7848739|NCT01474512|12330436|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0
7848740|NCT01474512|12330437|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0
7848741|NCT01474512|12330438|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0
7848742|NCT01474512|12330439|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0
7848743|NCT01474512|12330422|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0
7848744|NCT01474512|12330423|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0
7848745|NCT01474512|12330424|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0
7848746|NCT01474512|12330425|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0
7848747|NCT01474512|12330426|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0
7848748|NCT01474512|12330427|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0
7848749|NCT01474512|12330428|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0
7848750|NCT01474512|12330429|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0
7848751|NCT01474512|12330430|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0
7848752|NCT01474512|12330431|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0
7848753|NCT01474512|12330432|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0
7848754|NCT01474512|12330433|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21
7848755|NCT01474512|12330434|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0
7848756|NCT01474512|12330435|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0
7848757|NCT01474512|12330436|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0
7848758|NCT01474512|12330437|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0
7848759|NCT01474512|12330438|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0
7848760|NCT01474512|12330439|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0
7848761|NCT01474512|12330422|FG000|Post-Treatment Follow-Up|Adverse Event|0
7848762|NCT01474512|12330423|FG001|Post-Treatment Follow-Up|Adverse Event|0
7848763|NCT01474512|12330424|FG002|Post-Treatment Follow-Up|Adverse Event|0
7848764|NCT01474512|12330425|FG003|Post-Treatment Follow-Up|Adverse Event|0
7848765|NCT01474512|12330426|FG004|Post-Treatment Follow-Up|Adverse Event|0
7848766|NCT01474512|12330427|FG005|Post-Treatment Follow-Up|Adverse Event|0
7848767|NCT01474512|12330428|FG006|Post-Treatment Follow-Up|Adverse Event|0
7848768|NCT01474512|12330429|FG007|Post-Treatment Follow-Up|Adverse Event|0
7848769|NCT01474512|12330430|FG008|Post-Treatment Follow-Up|Adverse Event|0
7848770|NCT01474512|12330431|FG009|Post-Treatment Follow-Up|Adverse Event|0
7848771|NCT01474512|12330432|FG010|Post-Treatment Follow-Up|Adverse Event|0
7848772|NCT01474512|12330433|FG011|Post-Treatment Follow-Up|Adverse Event|0
7848773|NCT01474512|12330434|FG012|Post-Treatment Follow-Up|Adverse Event|0
7848774|NCT01474512|12330435|FG013|Post-Treatment Follow-Up|Adverse Event|0
7848775|NCT01474512|12330436|FG014|Post-Treatment Follow-Up|Adverse Event|8
7848776|NCT01474512|12330437|FG015|Post-Treatment Follow-Up|Adverse Event|2
7848777|NCT01474512|12330438|FG016|Post-Treatment Follow-Up|Adverse Event|58
7848778|NCT01474512|12330439|FG017|Post-Treatment Follow-Up|Adverse Event|11
7848779|NCT01474512|12330422|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0
7848780|NCT01474512|12330423|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0
7848781|NCT01474512|12330424|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0
7848782|NCT01474512|12330425|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0
7848783|NCT01474512|12330426|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0
7848784|NCT01474512|12330427|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0
7848785|NCT01474512|12330428|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0
7848786|NCT01474512|12330429|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0
7848787|NCT01474512|12330430|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0
7848788|NCT01474512|12330431|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0
7848789|NCT01474512|12330432|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0
7848790|NCT01474512|12330433|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0
7848791|NCT01474512|12330434|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0
7848792|NCT01474512|12330435|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0
7848793|NCT01474512|12330436|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3
7848794|NCT01474512|12330437|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2
7848795|NCT01474512|12330438|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36
7848796|NCT01474512|12330439|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17
7848797|NCT01474512|12330422|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0
7848798|NCT01474512|12330423|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0
7848799|NCT01474512|12330424|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0
7848800|NCT01474512|12330425|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0
7848801|NCT01474512|12330426|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0
7848802|NCT01474512|12330427|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0
7848803|NCT01474512|12330428|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0
7848804|NCT01474512|12330429|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0
7848805|NCT01474512|12330430|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0
7848806|NCT01474512|12330431|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0
7848807|NCT01474512|12330432|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0
7848808|NCT01474512|12330433|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0
7848809|NCT01474512|12330434|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0
7848810|NCT01474512|12330435|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0
7848811|NCT01474512|12330436|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3
7848812|NCT01474512|12330437|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2
7848813|NCT01474512|12330438|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31
7848814|NCT01474512|12330439|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3
7848815|NCT01474512|12330422|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0
7848816|NCT01474512|12330423|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0
7848817|NCT01474512|12330424|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0
7848818|NCT01474512|12330425|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0
7848819|NCT01474512|12330426|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0
7848820|NCT01474512|12330427|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0
7848821|NCT01474512|12330428|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0
7848822|NCT01474512|12330429|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0
7848823|NCT01474512|12330430|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0
7848824|NCT01474512|12330431|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0
7848825|NCT01474512|12330432|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0
7848826|NCT01474512|12330433|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0
7848827|NCT01474512|12330434|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0
7848828|NCT01474512|12330435|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0
7848829|NCT01474512|12330436|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0
7848830|NCT01474512|12330437|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0
7848831|NCT01474512|12330438|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12
7848832|NCT01474512|12330439|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7
7848833|NCT01474512|12330422|FG000|Post-Treatment Follow-Up|Physician Decision|0
7848834|NCT01474512|12330423|FG001|Post-Treatment Follow-Up|Physician Decision|0
7848835|NCT01474512|12330424|FG002|Post-Treatment Follow-Up|Physician Decision|0
7848836|NCT01474512|12330425|FG003|Post-Treatment Follow-Up|Physician Decision|0
7848837|NCT01474512|12330426|FG004|Post-Treatment Follow-Up|Physician Decision|0
7848838|NCT01474512|12330427|FG005|Post-Treatment Follow-Up|Physician Decision|0
7848839|NCT01474512|12330428|FG006|Post-Treatment Follow-Up|Physician Decision|0
7848840|NCT01474512|12330429|FG007|Post-Treatment Follow-Up|Physician Decision|0
7848841|NCT01474512|12330430|FG008|Post-Treatment Follow-Up|Physician Decision|0
7848842|NCT01474512|12330431|FG009|Post-Treatment Follow-Up|Physician Decision|0
7848843|NCT01474512|12330432|FG010|Post-Treatment Follow-Up|Physician Decision|0
7848844|NCT01474512|12330433|FG011|Post-Treatment Follow-Up|Physician Decision|0
7848845|NCT01474512|12330434|FG012|Post-Treatment Follow-Up|Physician Decision|0
7848846|NCT01474512|12330435|FG013|Post-Treatment Follow-Up|Physician Decision|0
7848847|NCT01474512|12330436|FG014|Post-Treatment Follow-Up|Physician Decision|0
7848848|NCT01474512|12330437|FG015|Post-Treatment Follow-Up|Physician Decision|0
7848849|NCT01474512|12330438|FG016|Post-Treatment Follow-Up|Physician Decision|4
7848850|NCT01474512|12330439|FG017|Post-Treatment Follow-Up|Physician Decision|5
7848851|NCT01474512|12330422|FG000|Post-Treatment Follow-Up|Clinical Relapse|0
7848852|NCT01474512|12330423|FG001|Post-Treatment Follow-Up|Clinical Relapse|0
7848853|NCT01474512|12330424|FG002|Post-Treatment Follow-Up|Clinical Relapse|0
7848854|NCT01474512|12330425|FG003|Post-Treatment Follow-Up|Clinical Relapse|0
7848855|NCT01474512|12330426|FG004|Post-Treatment Follow-Up|Clinical Relapse|0
7848856|NCT01474512|12330427|FG005|Post-Treatment Follow-Up|Clinical Relapse|0
7848857|NCT01474512|12330428|FG006|Post-Treatment Follow-Up|Clinical Relapse|0
7848858|NCT01474512|12330429|FG007|Post-Treatment Follow-Up|Clinical Relapse|0
7848859|NCT01474512|12330430|FG008|Post-Treatment Follow-Up|Clinical Relapse|0
7848860|NCT01474512|12330431|FG009|Post-Treatment Follow-Up|Clinical Relapse|0
7848861|NCT01474512|12330432|FG010|Post-Treatment Follow-Up|Clinical Relapse|0
7848862|NCT01474512|12330433|FG011|Post-Treatment Follow-Up|Clinical Relapse|0
7848863|NCT01474512|12330434|FG012|Post-Treatment Follow-Up|Clinical Relapse|0
7848864|NCT01474512|12330435|FG013|Post-Treatment Follow-Up|Clinical Relapse|0
7848865|NCT01474512|12330436|FG014|Post-Treatment Follow-Up|Clinical Relapse|0
7848866|NCT01474512|12330437|FG015|Post-Treatment Follow-Up|Clinical Relapse|0
7848867|NCT01474512|12330438|FG016|Post-Treatment Follow-Up|Clinical Relapse|6
7848868|NCT01474512|12330439|FG017|Post-Treatment Follow-Up|Clinical Relapse|2
7848869|NCT01474512|12330422|FG000|Post-Treatment Follow-Up|Protocol Violation|0
7848870|NCT01474512|12330423|FG001|Post-Treatment Follow-Up|Protocol Violation|0
7848871|NCT01474512|12330424|FG002|Post-Treatment Follow-Up|Protocol Violation|0
7848872|NCT01474512|12330425|FG003|Post-Treatment Follow-Up|Protocol Violation|0
7848873|NCT01474512|12330426|FG004|Post-Treatment Follow-Up|Protocol Violation|0
7848874|NCT01474512|12330427|FG005|Post-Treatment Follow-Up|Protocol Violation|0
7848875|NCT01474512|12330428|FG006|Post-Treatment Follow-Up|Protocol Violation|0
7848876|NCT01474512|12330429|FG007|Post-Treatment Follow-Up|Protocol Violation|0
7848877|NCT01474512|12330430|FG008|Post-Treatment Follow-Up|Protocol Violation|0
7848878|NCT01474512|12330431|FG009|Post-Treatment Follow-Up|Protocol Violation|0
7848879|NCT01474512|12330432|FG010|Post-Treatment Follow-Up|Protocol Violation|0
7848880|NCT01474512|12330433|FG011|Post-Treatment Follow-Up|Protocol Violation|0
7848881|NCT01474512|12330434|FG012|Post-Treatment Follow-Up|Protocol Violation|0
7848882|NCT01474512|12330435|FG013|Post-Treatment Follow-Up|Protocol Violation|0
7848883|NCT01474512|12330436|FG014|Post-Treatment Follow-Up|Protocol Violation|2
7848884|NCT01474512|12330437|FG015|Post-Treatment Follow-Up|Protocol Violation|2
7848885|NCT01474512|12330438|FG016|Post-Treatment Follow-Up|Protocol Violation|4
7848886|NCT01474512|12330439|FG017|Post-Treatment Follow-Up|Protocol Violation|0
7848887|NCT01474512|12330422|FG000|Post-Treatment Follow-Up|Sponsor Decision|0
7848888|NCT01474512|12330423|FG001|Post-Treatment Follow-Up|Sponsor Decision|0
7848889|NCT01474512|12330424|FG002|Post-Treatment Follow-Up|Sponsor Decision|0
7848890|NCT01474512|12330425|FG003|Post-Treatment Follow-Up|Sponsor Decision|0
7848891|NCT01474512|12330426|FG004|Post-Treatment Follow-Up|Sponsor Decision|0
7848892|NCT01474512|12330427|FG005|Post-Treatment Follow-Up|Sponsor Decision|0
7848893|NCT01474512|12330428|FG006|Post-Treatment Follow-Up|Sponsor Decision|0
7848894|NCT01474512|12330429|FG007|Post-Treatment Follow-Up|Sponsor Decision|0
7848895|NCT01474512|12330430|FG008|Post-Treatment Follow-Up|Sponsor Decision|0
7848896|NCT01474512|12330431|FG009|Post-Treatment Follow-Up|Sponsor Decision|0
7848897|NCT01474512|12330432|FG010|Post-Treatment Follow-Up|Sponsor Decision|0
7848898|NCT01474512|12330433|FG011|Post-Treatment Follow-Up|Sponsor Decision|0
7848899|NCT01474512|12330434|FG012|Post-Treatment Follow-Up|Sponsor Decision|0
7848900|NCT01474512|12330435|FG013|Post-Treatment Follow-Up|Sponsor Decision|0
7848901|NCT01474512|12330436|FG014|Post-Treatment Follow-Up|Sponsor Decision|1
7848902|NCT01474512|12330437|FG015|Post-Treatment Follow-Up|Sponsor Decision|0
7848903|NCT01474512|12330438|FG016|Post-Treatment Follow-Up|Sponsor Decision|4
7848904|NCT01474512|12330439|FG017|Post-Treatment Follow-Up|Sponsor Decision|0
7848905|NCT01474512|12330422|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848906|NCT01474512|12330423|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848907|NCT01474512|12330424|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848908|NCT01474512|12330425|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848909|NCT01474512|12330426|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848910|NCT01474512|12330427|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848911|NCT01474512|12330428|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848912|NCT01474512|12330429|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848913|NCT01474512|12330430|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848914|NCT01474512|12330431|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848915|NCT01474512|12330432|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848916|NCT01474512|12330433|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848917|NCT01474512|12330434|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848918|NCT01474512|12330435|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848919|NCT01474512|12330436|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
7848920|NCT01474512|12330437|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848921|NCT01474512|12330438|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7848922|NCT01474512|12330439|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
7848923|NCT01474512|12330422|FG000|Post-Treatment Follow-Up|Death|0
7848924|NCT01474512|12330423|FG001|Post-Treatment Follow-Up|Death|0
7848925|NCT01474512|12330424|FG002|Post-Treatment Follow-Up|Death|0
7848926|NCT01474512|12330425|FG003|Post-Treatment Follow-Up|Death|0
7848927|NCT01474512|12330426|FG004|Post-Treatment Follow-Up|Death|0
7848928|NCT01474512|12330427|FG005|Post-Treatment Follow-Up|Death|0
7848929|NCT01474512|12330428|FG006|Post-Treatment Follow-Up|Death|0
7848930|NCT01474512|12330429|FG007|Post-Treatment Follow-Up|Death|0
7848931|NCT01474512|12330430|FG008|Post-Treatment Follow-Up|Death|0
7848932|NCT01474512|12330431|FG009|Post-Treatment Follow-Up|Death|0
7848933|NCT01474512|12330432|FG010|Post-Treatment Follow-Up|Death|0
7848934|NCT01474512|12330433|FG011|Post-Treatment Follow-Up|Death|0
7848935|NCT01474512|12330434|FG012|Post-Treatment Follow-Up|Death|0
7848936|NCT01474512|12330435|FG013|Post-Treatment Follow-Up|Death|0
7848937|NCT01474512|12330436|FG014|Post-Treatment Follow-Up|Death|0
7848938|NCT01474512|12330437|FG015|Post-Treatment Follow-Up|Death|0
7848939|NCT01474512|12330438|FG016|Post-Treatment Follow-Up|Death|1
7848940|NCT01474512|12330439|FG017|Post-Treatment Follow-Up|Death|0
7848941|NCT01474538|12330471|FG000|Treatment Period 1|Death|1
7848942|NCT01474538|12330472|FG001|Treatment Period 1|Death|0
7848943|NCT01474538|12330471|FG000|Treatment Period 1|Physician Decision|1
7848944|NCT01474538|12330472|FG001|Treatment Period 1|Physician Decision|0
7848945|NCT01474538|12330471|FG000|Treatment Period 1|Withdrawal by Subject|1
7848946|NCT01474538|12330472|FG001|Treatment Period 1|Withdrawal by Subject|3
7848947|NCT01474538|12330471|FG000|Treatment Period 1|Protocol Violation|0
7848948|NCT01474538|12330472|FG001|Treatment Period 1|Protocol Violation|1
7848949|NCT01474538|12330471|FG000|Treatment Period 2|Death|1
7848950|NCT01474538|12330472|FG001|Treatment Period 2|Death|0
7848951|NCT01474538|12330471|FG000|Treatment Period 2|Adverse Event|1
7848952|NCT01474538|12330472|FG001|Treatment Period 2|Adverse Event|1
7848953|NCT01474538|12330471|FG000|Treatment Period 2|Withdrawal by Subject|2
7848954|NCT01474538|12330472|FG001|Treatment Period 2|Withdrawal by Subject|0
7848955|NCT01474538|12330471|FG000|Treatment Period 2|Sponsor decision|1
7848956|NCT01474538|12330472|FG001|Treatment Period 2|Sponsor decision|0
7848957|NCT01474538|12330471|FG000|Treatment Period 2|Physician Decision|0
7848958|NCT01474538|12330472|FG001|Treatment Period 2|Physician Decision|1
7848959|NCT01474538|12330471|FG000|Treatment Period 2|Protocol Violation|1
7848960|NCT01474538|12330472|FG001|Treatment Period 2|Protocol Violation|0
7848961|NCT01474551|12330478|FG000|Overall Study|Death|1
7848962|NCT01474681|12330493|FG000|Overall Study|Death|0
7848963|NCT01474681|12330494|FG001|Overall Study|Death|3
7848964|NCT01474681|12330495|FG002|Overall Study|Death|2
7848965|NCT01474681|12330496|FG003|Overall Study|Death|6
7848966|NCT01474746|12330512|FG000|Overall Study|Lost to Follow-up|1
7848967|NCT01474746|12330513|FG001|Overall Study|Lost to Follow-up|1
7848968|NCT01474746|12330512|FG000|Overall Study|Withdrawal by Subject|2
7848969|NCT01474746|12330513|FG001|Overall Study|Withdrawal by Subject|1
7848970|NCT01474772|12330521|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6
7848971|NCT01474772|12330522|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1
7848972|NCT01474772|12330521|FG000|Period 1|AE not Related to Study Drug|1
7848973|NCT01474772|12330522|FG001|Period 1|AE not Related to Study Drug|0
7848974|NCT01474772|12330521|FG000|Period 1|Withdrawal by Subject|3
7848975|NCT01474772|12330522|FG001|Period 1|Withdrawal by Subject|1
7848976|NCT01474772|12330521|FG000|Period 1|Lost to Follow-up|1
7848977|NCT01474772|12330522|FG001|Period 1|Lost to Follow-up|0
7848978|NCT01474772|12330521|FG000|Period 1|Reason not Specified|1
7848979|NCT01474772|12330522|FG001|Period 1|Reason not Specified|1
7848980|NCT01474772|12330521|FG000|Washout|AE not Related to Study Drug|2
7848981|NCT01474772|12330522|FG001|Washout|AE not Related to Study Drug|0
7848982|NCT01474772|12330521|FG000|Washout|Withdrawal by Subject|1
7848983|NCT01474772|12330522|FG001|Washout|Withdrawal by Subject|0
7848984|NCT01474772|12330521|FG000|Washout|Lost to Follow-up|0
7848985|NCT01474772|12330522|FG001|Washout|Lost to Follow-up|1
7848986|NCT01474772|12330521|FG000|Washout|Reason not Specified|0
7848987|NCT01474772|12330522|FG001|Washout|Reason not Specified|1
7848988|NCT01474772|12330521|FG000|Period 2|Death|0
7848989|NCT01474772|12330522|FG001|Period 2|Death|1
7848990|NCT01474772|12330521|FG000|Period 2|AE Related to Study Drug|0
7848991|NCT01474772|12330522|FG001|Period 2|AE Related to Study Drug|1
7848992|NCT01474772|12330521|FG000|Period 2|AE not Related to Study Drug|4
7848993|NCT01474772|12330522|FG001|Period 2|AE not Related to Study Drug|1
7848994|NCT01474772|12330521|FG000|Period 2|Lack of Efficacy|1
7848995|NCT01474772|12330522|FG001|Period 2|Lack of Efficacy|0
7848996|NCT01474772|12330521|FG000|Period 2|Withdrawal by Subject|3
7848997|NCT01474772|12330522|FG001|Period 2|Withdrawal by Subject|4
7848998|NCT01474772|12330521|FG000|Period 2|Lost to Follow-up|1
7848999|NCT01474772|12330522|FG001|Period 2|Lost to Follow-up|1
7849000|NCT01474772|12330521|FG000|Period 2|Reason not Specified|0
7849001|NCT01474772|12330522|FG001|Period 2|Reason not Specified|2
7849002|NCT01474772|12330521|FG000|Follow-up|AE not Related to Study Drug|0
7849003|NCT01474772|12330522|FG001|Follow-up|AE not Related to Study Drug|1
7849004|NCT01474876|12330544|FG000|Overall Study|Adverse Event|11
7849005|NCT01474876|12330545|FG001|Overall Study|Adverse Event|5
7849006|NCT01474876|12330546|FG002|Overall Study|Adverse Event|0
7849007|NCT01474876|12330544|FG000|Overall Study|Serious Adverse Event|2
7849008|NCT01474876|12330545|FG001|Overall Study|Serious Adverse Event|3
7849009|NCT01474876|12330546|FG002|Overall Study|Serious Adverse Event|0
7849010|NCT01474876|12330544|FG000|Overall Study|Lost to Follow-up|5
7849011|NCT01474876|12330545|FG001|Overall Study|Lost to Follow-up|4
7849012|NCT01474876|12330546|FG002|Overall Study|Lost to Follow-up|0
7849013|NCT01474876|12330544|FG000|Overall Study|Investigator's decision|28
7849014|NCT01474876|12330545|FG001|Overall Study|Investigator's decision|6
7849015|NCT01474876|12330546|FG002|Overall Study|Investigator's decision|0
7849016|NCT01474876|12330544|FG000|Overall Study|Patient's request|19
7849017|NCT01474876|12330545|FG001|Overall Study|Patient's request|5
7849018|NCT01474876|12330546|FG002|Overall Study|Patient's request|0
7849019|NCT01474876|12330544|FG000|Overall Study|Investigator's decision and pt request|1
7849020|NCT01474876|12330545|FG001|Overall Study|Investigator's decision and pt request|0
7849021|NCT01474876|12330546|FG002|Overall Study|Investigator's decision and pt request|0
7849022|NCT01474993|12330564|FG000|Overall Study|Lost to Follow-up|1
7849023|NCT01474993|12330565|FG001|Overall Study|Lost to Follow-up|2
7849024|NCT01474993|12330564|FG000|Overall Study|Adverse Event|0
7849025|NCT01474993|12330565|FG001|Overall Study|Adverse Event|1
7849026|NCT01475071|12330573|FG000|Overall Study|Physician Decision|1
7849027|NCT01475071|12330573|FG000|Overall Study|Withdrawal by Subject|6
7849028|NCT01475071|12330573|FG000|Overall Study|Lost to Follow-up|1
7849029|NCT01475097|12330581|FG000|Overall Study|Protocol Violation|1
7849030|NCT01475097|12330582|FG001|Overall Study|Protocol Violation|1
7849031|NCT01475136|12330592|FG000|Overall Study|Sponsor Decision|0
7849032|NCT01475136|12330593|FG001|Overall Study|Sponsor Decision|1
7849033|NCT01475136|12330594|FG002|Overall Study|Sponsor Decision|0
7849034|NCT01475136|12330595|FG003|Overall Study|Sponsor Decision|0
7849035|NCT01475136|12330592|FG000|Overall Study|Entry Criteria Not Met|0
7849036|NCT01475136|12330593|FG001|Overall Study|Entry Criteria Not Met|2
7849037|NCT01475136|12330594|FG002|Overall Study|Entry Criteria Not Met|3
7849038|NCT01475136|12330595|FG003|Overall Study|Entry Criteria Not Met|1
7849039|NCT01475136|12330592|FG000|Overall Study|Withdrawal by Subject|0
7849040|NCT01475136|12330593|FG001|Overall Study|Withdrawal by Subject|0
7849041|NCT01475136|12330594|FG002|Overall Study|Withdrawal by Subject|0
7849042|NCT01475136|12330595|FG003|Overall Study|Withdrawal by Subject|2
7849043|NCT01475136|12330592|FG000|Overall Study|Adverse Event|1
7849044|NCT01475136|12330593|FG001|Overall Study|Adverse Event|0
7849045|NCT01475136|12330594|FG002|Overall Study|Adverse Event|0
7849046|NCT01475136|12330595|FG003|Overall Study|Adverse Event|1
7849047|NCT01475136|12330592|FG000|Overall Study|Death|0
7849048|NCT01475136|12330593|FG001|Overall Study|Death|0
7849049|NCT01475136|12330594|FG002|Overall Study|Death|0
7849050|NCT01475136|12330595|FG003|Overall Study|Death|1
7849051|NCT01475162|12330605|FG000|Overall Study|Physician Decision|1
7849052|NCT01475162|12330605|FG000|Overall Study|Death|10
7849053|NCT01475162|12330605|FG000|Overall Study|Study closed for safety|3
7849054|NCT01475214|12330617|FG000|Overall Study|Lost to Follow-up|1
7849055|NCT01475214|12330618|FG001|Overall Study|Lost to Follow-up|0
7849056|NCT01475214|12330619|FG002|Overall Study|Lost to Follow-up|1
7849057|NCT01475214|12330617|FG000|Overall Study|Physician Decision|2
7849058|NCT01475214|12330618|FG001|Overall Study|Physician Decision|0
7849059|NCT01475214|12330619|FG002|Overall Study|Physician Decision|0
7849060|NCT01475214|12330617|FG000|Overall Study|Withdrawal by Subject|2
7849061|NCT01475214|12330618|FG001|Overall Study|Withdrawal by Subject|4
7849062|NCT01475214|12330619|FG002|Overall Study|Withdrawal by Subject|1
7849063|NCT01475253|12330631|FG000|Randomized, Blinded Study|Withdrawal by Subject|1
7849064|NCT01475253|12330632|FG001|Randomized, Blinded Study|Withdrawal by Subject|1
7849065|NCT01475253|12330633|FG002|Randomized, Blinded Study|Withdrawal by Subject|0
7849066|NCT01475253|12330634|FG003|Randomized, Blinded Study|Withdrawal by Subject|0
7849067|NCT01475253|12330631|FG000|Randomized, Blinded Study|Lost to Follow-up|1
7849068|NCT01475253|12330632|FG001|Randomized, Blinded Study|Lost to Follow-up|0
7849069|NCT01475253|12330633|FG002|Randomized, Blinded Study|Lost to Follow-up|0
7849070|NCT01475253|12330634|FG003|Randomized, Blinded Study|Lost to Follow-up|0
7849071|NCT01475331|12330654|FG000|Overall Study|Osteophyte obstruction of the proximal|1
7849072|NCT01475331|12330655|FG001|Overall Study|Osteophyte obstruction of the proximal|0
7849073|NCT01475331|12330654|FG000|Overall Study|excessive main duct communication|1
7849074|NCT01475331|12330655|FG001|Overall Study|excessive main duct communication|1
7849075|NCT01475331|12330654|FG000|Overall Study|Loss of needle positioning due pt. cough|1
7849076|NCT01475331|12330655|FG001|Overall Study|Loss of needle positioning due pt. cough|0
7849077|NCT01475331|12330654|FG000|Overall Study|Sign of malignancy during the procedure|2
7849078|NCT01475331|12330655|FG001|Overall Study|Sign of malignancy during the procedure|0
7849079|NCT01475331|12330654|FG000|Overall Study|cyst found to be prohibitively small|0
7849080|NCT01475331|12330655|FG001|Overall Study|cyst found to be prohibitively small|1
7849081|NCT01475370|12330664|FG000|Overall Study|Exacerbation of primary disease|2
7849082|NCT01475370|12330665|FG001|Overall Study|Exacerbation of primary disease|2
7849083|NCT01475370|12330666|FG002|Overall Study|Exacerbation of primary disease|2
7849084|NCT01475370|12330664|FG000|Overall Study|Study drug administration difficult|0
7849085|NCT01475370|12330665|FG001|Overall Study|Study drug administration difficult|1
7849086|NCT01475370|12330666|FG002|Overall Study|Study drug administration difficult|1
7849087|NCT01475370|12330664|FG000|Overall Study|Other than specified|1
7849088|NCT01475370|12330665|FG001|Overall Study|Other than specified|0
7849089|NCT01475370|12330666|FG002|Overall Study|Other than specified|0
7849090|NCT01475461|12330680|FG000|Run-in Period|Not meet eligibility criteria|16
7849091|NCT01475461|12330681|FG001|Run-in Period|Not meet eligibility criteria|0
7849092|NCT01475461|12330682|FG002|Run-in Period|Not meet eligibility criteria|0
7849093|NCT01475461|12330683|FG003|Run-in Period|Not meet eligibility criteria|0
7863316|NCT01604850|12352557|FG001|Overall Study|Efficacy Failure|29
7849094|NCT01475461|12330684|FG004|Run-in Period|Not meet eligibility criteria|0
7849095|NCT01475461|12330685|FG005|Run-in Period|Not meet eligibility criteria|0
7849096|NCT01475461|12330686|FG006|Run-in Period|Not meet eligibility criteria|0
7849097|NCT01475461|12330680|FG000|Run-in Period|Lost to Follow-up|7
7849098|NCT01475461|12330681|FG001|Run-in Period|Lost to Follow-up|0
7849099|NCT01475461|12330682|FG002|Run-in Period|Lost to Follow-up|0
7849100|NCT01475461|12330683|FG003|Run-in Period|Lost to Follow-up|0
7849101|NCT01475461|12330684|FG004|Run-in Period|Lost to Follow-up|0
7849102|NCT01475461|12330685|FG005|Run-in Period|Lost to Follow-up|0
7849103|NCT01475461|12330686|FG006|Run-in Period|Lost to Follow-up|0
7849104|NCT01475461|12330680|FG000|Run-in Period|Withdrawal by Subject|11
7849105|NCT01475461|12330681|FG001|Run-in Period|Withdrawal by Subject|0
7849106|NCT01475461|12330682|FG002|Run-in Period|Withdrawal by Subject|0
7849107|NCT01475461|12330683|FG003|Run-in Period|Withdrawal by Subject|0
7849108|NCT01475461|12330684|FG004|Run-in Period|Withdrawal by Subject|0
7849109|NCT01475461|12330685|FG005|Run-in Period|Withdrawal by Subject|0
7849110|NCT01475461|12330686|FG006|Run-in Period|Withdrawal by Subject|0
7849111|NCT01475461|12330680|FG000|Run-in Period|Other|3
7849112|NCT01475461|12330681|FG001|Run-in Period|Other|0
7849113|NCT01475461|12330682|FG002|Run-in Period|Other|0
7849114|NCT01475461|12330683|FG003|Run-in Period|Other|0
7849115|NCT01475461|12330684|FG004|Run-in Period|Other|0
7849116|NCT01475461|12330685|FG005|Run-in Period|Other|0
7849117|NCT01475461|12330686|FG006|Run-in Period|Other|0
7849118|NCT01475461|12330680|FG000|Run-in Period|Protocol Violation|4
7849119|NCT01475461|12330681|FG001|Run-in Period|Protocol Violation|0
7849120|NCT01475461|12330682|FG002|Run-in Period|Protocol Violation|0
7849121|NCT01475461|12330683|FG003|Run-in Period|Protocol Violation|0
7849122|NCT01475461|12330684|FG004|Run-in Period|Protocol Violation|0
7849123|NCT01475461|12330685|FG005|Run-in Period|Protocol Violation|0
7849124|NCT01475461|12330686|FG006|Run-in Period|Protocol Violation|0
7849125|NCT01475461|12330680|FG000|Treatment Period|Death|0
7849126|NCT01475461|12330681|FG001|Treatment Period|Death|0
7849127|NCT01475461|12330682|FG002|Treatment Period|Death|0
7849128|NCT01475461|12330683|FG003|Treatment Period|Death|1
7849129|NCT01475461|12330684|FG004|Treatment Period|Death|0
7849130|NCT01475461|12330685|FG005|Treatment Period|Death|0
7849131|NCT01475461|12330686|FG006|Treatment Period|Death|0
7849132|NCT01475461|12330680|FG000|Treatment Period|Lost to Follow-up|0
7849133|NCT01475461|12330681|FG001|Treatment Period|Lost to Follow-up|3
7849134|NCT01475461|12330682|FG002|Treatment Period|Lost to Follow-up|2
7849135|NCT01475461|12330683|FG003|Treatment Period|Lost to Follow-up|3
7849136|NCT01475461|12330684|FG004|Treatment Period|Lost to Follow-up|1
7849137|NCT01475461|12330685|FG005|Treatment Period|Lost to Follow-up|2
7849138|NCT01475461|12330686|FG006|Treatment Period|Lost to Follow-up|1
7849139|NCT01475461|12330680|FG000|Treatment Period|Withdrawal by Subject|0
7849140|NCT01475461|12330681|FG001|Treatment Period|Withdrawal by Subject|2
7849141|NCT01475461|12330682|FG002|Treatment Period|Withdrawal by Subject|2
7849142|NCT01475461|12330683|FG003|Treatment Period|Withdrawal by Subject|0
7849143|NCT01475461|12330684|FG004|Treatment Period|Withdrawal by Subject|2
7849144|NCT01475461|12330685|FG005|Treatment Period|Withdrawal by Subject|2
7849145|NCT01475461|12330686|FG006|Treatment Period|Withdrawal by Subject|0
7849146|NCT01475461|12330680|FG000|Treatment Period|Other|0
7849147|NCT01475461|12330681|FG001|Treatment Period|Other|1
7849148|NCT01475461|12330682|FG002|Treatment Period|Other|0
7849149|NCT01475461|12330683|FG003|Treatment Period|Other|0
7849150|NCT01475461|12330684|FG004|Treatment Period|Other|0
7849151|NCT01475461|12330685|FG005|Treatment Period|Other|0
7849152|NCT01475461|12330686|FG006|Treatment Period|Other|0
7849153|NCT01475461|12330680|FG000|Treatment Period|Protocol Violation|0
7849154|NCT01475461|12330681|FG001|Treatment Period|Protocol Violation|1
7849155|NCT01475461|12330682|FG002|Treatment Period|Protocol Violation|0
7849156|NCT01475461|12330683|FG003|Treatment Period|Protocol Violation|0
7849157|NCT01475461|12330684|FG004|Treatment Period|Protocol Violation|0
7849158|NCT01475461|12330685|FG005|Treatment Period|Protocol Violation|0
7849159|NCT01475461|12330686|FG006|Treatment Period|Protocol Violation|1
7849160|NCT01475461|12330680|FG000|Treatment Period|Lack of Efficacy|0
7849161|NCT01475461|12330681|FG001|Treatment Period|Lack of Efficacy|2
7849162|NCT01475461|12330682|FG002|Treatment Period|Lack of Efficacy|0
7849163|NCT01475461|12330683|FG003|Treatment Period|Lack of Efficacy|2
7849164|NCT01475461|12330684|FG004|Treatment Period|Lack of Efficacy|1
7849165|NCT01475461|12330685|FG005|Treatment Period|Lack of Efficacy|1
7849166|NCT01475461|12330686|FG006|Treatment Period|Lack of Efficacy|0
7849167|NCT01475461|12330680|FG000|Treatment Period|Medication Error|0
7849168|NCT01475461|12330681|FG001|Treatment Period|Medication Error|0
7849169|NCT01475461|12330682|FG002|Treatment Period|Medication Error|0
7849170|NCT01475461|12330683|FG003|Treatment Period|Medication Error|1
7849171|NCT01475461|12330684|FG004|Treatment Period|Medication Error|0
7849172|NCT01475461|12330685|FG005|Treatment Period|Medication Error|0
7849173|NCT01475461|12330686|FG006|Treatment Period|Medication Error|0
7849174|NCT01475461|12330680|FG000|Treatment Period|Adverse Event|0
7849175|NCT01475461|12330681|FG001|Treatment Period|Adverse Event|0
7849176|NCT01475461|12330682|FG002|Treatment Period|Adverse Event|0
7849177|NCT01475461|12330683|FG003|Treatment Period|Adverse Event|1
7849178|NCT01475461|12330684|FG004|Treatment Period|Adverse Event|0
7849179|NCT01475461|12330685|FG005|Treatment Period|Adverse Event|0
7849180|NCT01475461|12330686|FG006|Treatment Period|Adverse Event|0
7849181|NCT01475474|12330719|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
7849182|NCT01475474|12330719|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2
7849183|NCT01475487|12330726|FG000|Overall Study|had to leave early for personal reasons|2
7849184|NCT01475487|12330727|FG001|Overall Study|had to leave early for personal reasons|1
7849185|NCT01475721|12330755|FG000|Overall Study|Death|3
7849186|NCT01475721|12330756|FG001|Overall Study|Death|6
7849187|NCT01475721|12330755|FG000|Overall Study|Withdrawal by Subject|8
7849188|NCT01475721|12330756|FG001|Overall Study|Withdrawal by Subject|8
7849189|NCT01475734|12330764|FG000|Overall Study|Withdrawal by Subject|1
7849190|NCT01475734|12330765|FG001|Overall Study|Withdrawal by Subject|0
7849191|NCT01475734|12330764|FG000|Overall Study|Protocol Violation|1
7849192|NCT01475734|12330765|FG001|Overall Study|Protocol Violation|0
7849193|NCT01475734|12330764|FG000|Overall Study|Physician Decision|0
7849194|NCT01475734|12330765|FG001|Overall Study|Physician Decision|1
7849195|NCT01475825|12330775|FG000|Overall Study|Adverse Event|41
7849196|NCT01475825|12330776|FG001|Overall Study|Adverse Event|15
7849197|NCT01475825|12330777|FG002|Overall Study|Adverse Event|27
7849198|NCT01475825|12330778|FG003|Overall Study|Adverse Event|11
7849199|NCT01475825|12330775|FG000|Overall Study|Death|1
7849200|NCT01475825|12330776|FG001|Overall Study|Death|0
7849201|NCT01475825|12330777|FG002|Overall Study|Death|1
7849202|NCT01475825|12330778|FG003|Overall Study|Death|0
7849203|NCT01475825|12330775|FG000|Overall Study|Lack of Efficacy|0
7849204|NCT01475825|12330776|FG001|Overall Study|Lack of Efficacy|0
7849205|NCT01475825|12330777|FG002|Overall Study|Lack of Efficacy|1
7849206|NCT01475825|12330778|FG003|Overall Study|Lack of Efficacy|0
7849207|NCT01475825|12330775|FG000|Overall Study|Lost to Follow-up|0
7849208|NCT01475825|12330776|FG001|Overall Study|Lost to Follow-up|0
7849209|NCT01475825|12330777|FG002|Overall Study|Lost to Follow-up|3
7849210|NCT01475825|12330778|FG003|Overall Study|Lost to Follow-up|1
7849211|NCT01475825|12330775|FG000|Overall Study|Non-compliance with Study Drug|1
7849212|NCT01475825|12330776|FG001|Overall Study|Non-compliance with Study Drug|2
7849213|NCT01475825|12330777|FG002|Overall Study|Non-compliance with Study Drug|4
7849214|NCT01475825|12330778|FG003|Overall Study|Non-compliance with Study Drug|0
7849215|NCT01475825|12330775|FG000|Overall Study|Other: Not available|0
7849216|NCT01475825|12330776|FG001|Overall Study|Other: Not available|0
7849217|NCT01475825|12330777|FG002|Overall Study|Other: Not available|2
7849218|NCT01475825|12330778|FG003|Overall Study|Other: Not available|0
7849219|NCT01475825|12330775|FG000|Overall Study|Protocol Violation|1
7849220|NCT01475825|12330776|FG001|Overall Study|Protocol Violation|0
7849221|NCT01475825|12330777|FG002|Overall Study|Protocol Violation|0
7849222|NCT01475825|12330778|FG003|Overall Study|Protocol Violation|0
7849223|NCT01475825|12330775|FG000|Overall Study|Physician Decision|0
7849224|NCT01475825|12330776|FG001|Overall Study|Physician Decision|1
7849225|NCT01475825|12330777|FG002|Overall Study|Physician Decision|0
7849226|NCT01475825|12330778|FG003|Overall Study|Physician Decision|0
7849227|NCT01475825|12330775|FG000|Overall Study|Withdrawal by Subject|8
7849228|NCT01475825|12330776|FG001|Overall Study|Withdrawal by Subject|3
7849229|NCT01475825|12330777|FG002|Overall Study|Withdrawal by Subject|11
7849230|NCT01475825|12330778|FG003|Overall Study|Withdrawal by Subject|7
7849231|NCT01475825|12330775|FG000|Overall Study|Did not enter OLC|15
7849232|NCT01475825|12330776|FG001|Overall Study|Did not enter OLC|11
7849233|NCT01475825|12330777|FG002|Overall Study|Did not enter OLC|15
7849234|NCT01475825|12330778|FG003|Overall Study|Did not enter OLC|11
7849235|NCT01475838|12330790|FG000|Randomized Phase|Randomized but Not Treated|0
7849236|NCT01475838|12330791|FG001|Randomized Phase|Randomized but Not Treated|5
7849237|NCT01475838|12330790|FG000|Randomized Phase|Adverse Event|6
7849238|NCT01475838|12330791|FG001|Randomized Phase|Adverse Event|1
7849239|NCT01475838|12330790|FG000|Randomized Phase|Pregnancy|0
7849240|NCT01475838|12330791|FG001|Randomized Phase|Pregnancy|1
7849241|NCT01475838|12330790|FG000|Randomized Phase|Investigators Discretion|1
7849242|NCT01475838|12330791|FG001|Randomized Phase|Investigators Discretion|2
7849243|NCT01475838|12330790|FG000|Randomized Phase|Withdrew Consent|10
7849244|NCT01475838|12330791|FG001|Randomized Phase|Withdrew Consent|14
7849245|NCT01475838|12330790|FG000|Randomized Phase|Lost to Follow-up|3
7849246|NCT01475838|12330791|FG001|Randomized Phase|Lost to Follow-up|4
7849247|NCT01475838|12330790|FG000|Randomized Phase|Participant Noncompliance|1
7849248|NCT01475838|12330791|FG001|Randomized Phase|Participant Noncompliance|5
7849249|NCT01475838|12330790|FG000|Randomized Phase|Protocol Violation|9
7849250|NCT01475838|12330791|FG001|Randomized Phase|Protocol Violation|4
7849251|NCT01475838|12330790|FG000|Extension Phase|Participant Noncompliance|1
7849252|NCT01475838|12330791|FG001|Extension Phase|Participant Noncompliance|0
7849253|NCT01475851|12330800|FG000|Overall Study|Protocol defined stopping criteria|1
7849254|NCT01475851|12330801|FG001|Overall Study|Protocol defined stopping criteria|0
7849255|NCT01476475|12330885|FG000|Overall Study|Adverse Event|6
7849256|NCT01476475|12330886|FG001|Overall Study|Adverse Event|0
7849257|NCT01476475|12330885|FG000|Overall Study|Poor compliance to protocol|1
7849258|NCT01476475|12330886|FG001|Overall Study|Poor compliance to protocol|1
7849259|NCT01476475|12330885|FG000|Overall Study|Other reasons|4
7849260|NCT01476475|12330886|FG001|Overall Study|Other reasons|2
7849261|NCT01476644|12330893|FG000|Overall Study|Death|5
7849262|NCT01476644|12330893|FG000|Overall Study|moved to another state|2
7849263|NCT01476644|12330893|FG000|Overall Study|Lost to Follow-up|19
7849264|NCT01476644|12330893|FG000|Overall Study|Withdrawal by Subject|13
7849265|NCT01476696|12330898|FG000|Overall Study|Sponsor decision|2
7849266|NCT01476696|12330899|FG001|Overall Study|Sponsor decision|1
7849267|NCT01476696|12330900|FG002|Overall Study|Sponsor decision|0
7849268|NCT01476696|12330898|FG000|Overall Study|Withdrawal by Subject|1
7849269|NCT01476696|12330899|FG001|Overall Study|Withdrawal by Subject|0
7849270|NCT01476696|12330900|FG002|Overall Study|Withdrawal by Subject|0
7849271|NCT01476722|12330913|FG000|Overall Study|Adverse Event|1
7849272|NCT01477333|12330939|FG000|Overall Study|Adverse Event|1
7849273|NCT01477333|12330939|FG000|Overall Study|Withdrawal by Subject|1
7849274|NCT01477333|12330939|FG000|Overall Study|Clinical Deterioration|1
7863317|NCT01604850|12352556|FG000|Overall Study|Lost to Follow-up|1
7863318|NCT01604850|12352557|FG001|Overall Study|Lost to Follow-up|0
7863319|NCT01604850|12352556|FG000|Overall Study|Subject withdrew consent|1
7863320|NCT01604850|12352557|FG001|Overall Study|Subject withdrew consent|0
7863321|NCT01604941|12352565|FG000|Overall Study|Adverse Event|1
7863322|NCT01604941|12352566|FG001|Overall Study|Adverse Event|2
7863323|NCT01604941|12352567|FG002|Overall Study|Adverse Event|0
7863324|NCT01604941|12352568|FG003|Overall Study|Adverse Event|0
7863325|NCT01604941|12352569|FG004|Overall Study|Adverse Event|1
7863326|NCT01604941|12352570|FG005|Overall Study|Adverse Event|5
7863327|NCT01604941|12352565|FG000|Overall Study|Non-compliance|1
7863328|NCT01604941|12352566|FG001|Overall Study|Non-compliance|0
7863329|NCT01604941|12352567|FG002|Overall Study|Non-compliance|0
7863330|NCT01604941|12352568|FG003|Overall Study|Non-compliance|0
7863331|NCT01604941|12352569|FG004|Overall Study|Non-compliance|0
7863332|NCT01604941|12352570|FG005|Overall Study|Non-compliance|0
7863333|NCT01604941|12352565|FG000|Overall Study|Participant Decision|0
7863334|NCT01604941|12352566|FG001|Overall Study|Participant Decision|0
7863335|NCT01604941|12352567|FG002|Overall Study|Participant Decision|0
7863336|NCT01604941|12352568|FG003|Overall Study|Participant Decision|0
7863337|NCT01604941|12352569|FG004|Overall Study|Participant Decision|0
7863338|NCT01604941|12352570|FG005|Overall Study|Participant Decision|2
7863339|NCT01604941|12352565|FG000|Overall Study|Early Study Termination|9
7863340|NCT01604941|12352566|FG001|Overall Study|Early Study Termination|2
7863341|NCT01604941|12352567|FG002|Overall Study|Early Study Termination|3
7863342|NCT01604941|12352568|FG003|Overall Study|Early Study Termination|3
7863343|NCT01604941|12352569|FG004|Overall Study|Early Study Termination|0
7863344|NCT01604941|12352570|FG005|Overall Study|Early Study Termination|0
7863345|NCT01605071|12352582|FG000|Overall Study|Withdrawal by Subject|3
7863346|NCT01605071|12352583|FG001|Overall Study|Withdrawal by Subject|2
7863347|NCT01605097|12352591|FG000|Overall Study|Protocol Violation|1
7863348|NCT01605136|12352598|FG000|Study Period|Withdrawal by Subject|2
7863349|NCT01605136|12352599|FG001|Study Period|Withdrawal by Subject|0
7863350|NCT01605136|12352598|FG000|Study Period|Physician Decision|1
7863351|NCT01605136|12352599|FG001|Study Period|Physician Decision|1
7863352|NCT01605136|12352598|FG000|Study Period|Lost to Follow-up|0
7863353|NCT01605136|12352599|FG001|Study Period|Lost to Follow-up|2
7863354|NCT01605136|12352598|FG000|Safety Follow-Up Period|Withdrawal by Subject|1
7863355|NCT01605136|12352599|FG001|Safety Follow-Up Period|Withdrawal by Subject|2
7863356|NCT01605227|12352607|FG000|Overall Study|Did not receive study treatment|2
7863357|NCT01605227|12352608|FG001|Overall Study|Did not receive study treatment|3
7863358|NCT01605227|12352607|FG000|Overall Study|Adverse Event|228
7863359|NCT01605227|12352608|FG001|Overall Study|Adverse Event|42
7863360|NCT01605227|12352607|FG000|Overall Study|Progressive Disease|132
7863361|NCT01605227|12352608|FG001|Overall Study|Progressive Disease|128
7863362|NCT01605227|12352607|FG000|Overall Study|Clinical Deterioration|227
7863363|NCT01605227|12352608|FG001|Overall Study|Clinical Deterioration|133
7863364|NCT01605227|12352607|FG000|Overall Study|Lost to Follow-up|1
7863365|NCT01605227|12352608|FG001|Overall Study|Lost to Follow-up|0
7863366|NCT01605227|12352607|FG000|Overall Study|Protocol Violation|1
7863367|NCT01605227|12352608|FG001|Overall Study|Protocol Violation|0
7863368|NCT01605227|12352607|FG000|Overall Study|Physician Decision|9
7863369|NCT01605227|12352608|FG001|Overall Study|Physician Decision|7
7863370|NCT01605227|12352607|FG000|Overall Study|Withdrawal by Subject|18
7863371|NCT01605227|12352608|FG001|Overall Study|Withdrawal by Subject|14
7863372|NCT01605227|12352607|FG000|Overall Study|Sponsor Decision|2
7863373|NCT01605227|12352608|FG001|Overall Study|Sponsor Decision|0
7863374|NCT01605227|12352607|FG000|Overall Study|Started New Therapy|1
7863375|NCT01605227|12352608|FG001|Overall Study|Started New Therapy|0
7863376|NCT01605227|12352607|FG000|Overall Study|Subject Decision|0
7863377|NCT01605227|12352608|FG001|Overall Study|Subject Decision|1
7863378|NCT01605227|12352607|FG000|Overall Study|Dose Held >6 weeks|0
7863379|NCT01605227|12352608|FG001|Overall Study|Dose Held >6 weeks|1
7863380|NCT01605396|12352625|FG000|Overall Study|Adverse Event|5
7863381|NCT01605396|12352626|FG001|Overall Study|Adverse Event|3
7863382|NCT01605396|12352625|FG000|Overall Study|Lost to Follow-up|1
7863383|NCT01605396|12352626|FG001|Overall Study|Lost to Follow-up|0
7863384|NCT01605396|12352625|FG000|Overall Study|Non-Compliance With Study Drug|1
7863385|NCT01605396|12352626|FG001|Overall Study|Non-Compliance With Study Drug|1
7949281|NCT02534935|12494698|FG002|Stage 1: 24 Months|Withdrawal by Subject|3
7863386|NCT01605396|12352625|FG000|Overall Study|Physician Decision|2
7863387|NCT01605396|12352626|FG001|Overall Study|Physician Decision|2
7863388|NCT01605396|12352625|FG000|Overall Study|Progressive Disease|23
7863389|NCT01605396|12352626|FG001|Overall Study|Progressive Disease|27
7863390|NCT01605396|12352625|FG000|Overall Study|Withdrawal by Subject|4
7849275|NCT01477749|12331013|FG000|Overall Study|Physician Decision|4
7849276|NCT01477853|12331037|FG000|Phase A|Adverse Event|1
7849277|NCT01477853|12331038|FG001|Phase A|Adverse Event|2
7849278|NCT01477853|12331039|FG002|Phase A|Adverse Event|2
7849279|NCT01477853|12331037|FG000|Phase A|Lost to Follow-up|4
7849280|NCT01477853|12331038|FG001|Phase A|Lost to Follow-up|3
7849281|NCT01477853|12331039|FG002|Phase A|Lost to Follow-up|2
7849282|NCT01477853|12331037|FG000|Phase A|Physician Decision|1
7849283|NCT01477853|12331038|FG001|Phase A|Physician Decision|0
7849284|NCT01477853|12331039|FG002|Phase A|Physician Decision|1
7849285|NCT01477853|12331037|FG000|Phase A|Study terminated by sponsor|37
7849286|NCT01477853|12331038|FG001|Phase A|Study terminated by sponsor|40
7849287|NCT01477853|12331039|FG002|Phase A|Study terminated by sponsor|39
7849288|NCT01477853|12331037|FG000|Phase B|Lost to Follow-up|0
7849289|NCT01477853|12331038|FG001|Phase B|Lost to Follow-up|1
7849290|NCT01477853|12331039|FG002|Phase B|Lost to Follow-up|0
7849291|NCT01477853|12331037|FG000|Phase B|Study terminated by sponsor|12
7849292|NCT01477853|12331038|FG001|Phase B|Study terminated by sponsor|10
7849293|NCT01477853|12331039|FG002|Phase B|Study terminated by sponsor|11
7849294|NCT01477892|12331049|FG000|Overall Study|Withdrawal by Subject|0
7849295|NCT01477892|12331050|FG001|Overall Study|Withdrawal by Subject|2
7849296|NCT01478048|12331067|FG000|Overall Study|Disease Progression|52
7849297|NCT01478048|12331068|FG001|Overall Study|Disease Progression|35
7849298|NCT01478048|12331067|FG000|Overall Study|study drug toxicity|11
7849299|NCT01478048|12331068|FG001|Overall Study|study drug toxicity|14
7849300|NCT01478048|12331067|FG000|Overall Study|Adverse Event|2
7849301|NCT01478048|12331068|FG001|Overall Study|Adverse Event|11
7849302|NCT01478048|12331067|FG000|Overall Study|subject request to discontinue treatment|3
7849303|NCT01478048|12331068|FG001|Overall Study|subject request to discontinue treatment|5
7849304|NCT01478048|12331067|FG000|Overall Study|Withdrawal by Subject|2
7849305|NCT01478048|12331068|FG001|Overall Study|Withdrawal by Subject|5
7849306|NCT01478048|12331067|FG000|Overall Study|non-specified|6
7849307|NCT01478048|12331068|FG001|Overall Study|non-specified|4
7949282|NCT02534935|12494696|FG000|Stage 1: 24 Months|No longer willing to participate in study|0
7849308|NCT01478048|12331067|FG000|Overall Study|poor/non-compliance|0
7849309|NCT01478048|12331068|FG001|Overall Study|poor/non-compliance|1
7849310|NCT01478048|12331067|FG000|Overall Study|no longer meets study criteria|1
7849311|NCT01478048|12331068|FG001|Overall Study|no longer meets study criteria|0
7849312|NCT01478087|12331074|FG000|Overall Study|due to sponsor closing study|1
7849313|NCT01478321|12331089|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4
7849314|NCT01478321|12331089|FG000|Concurrent Therapy (5 Weeks)|Death|2
7849315|NCT01478321|12331089|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5
7849316|NCT01478321|12331089|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5
7849317|NCT01478321|12331089|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1
7849318|NCT01478321|12331089|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1
7849319|NCT01478321|12331089|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1
7849320|NCT01478321|12331089|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8
7849321|NCT01478347|12331093|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
7849322|NCT01478347|12331093|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
7849323|NCT01478347|12331093|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
7849324|NCT01478360|12331099|FG000|Overall Study|Lost to Follow-up|1
7849325|NCT01478360|12331100|FG001|Overall Study|Lost to Follow-up|0
7849326|NCT01478360|12331099|FG000|Overall Study|Adverse Event|0
7849327|NCT01478360|12331100|FG001|Overall Study|Adverse Event|1
7849328|NCT01478360|12331099|FG000|Overall Study|Administrative problems|1
7849329|NCT01478360|12331100|FG001|Overall Study|Administrative problems|2
7849330|NCT01478373|12331106|FG000|Treatment Phase|Protocol Violation|1
7849331|NCT01478373|12331106|FG000|Survival Phase|Adverse Event|8
7849332|NCT01478373|12331106|FG000|Survival Phase|Protocol Violation|1
7849333|NCT01478373|12331106|FG000|Survival Phase|crossover to another study|2
7849334|NCT01478373|12331106|FG000|Survival Phase|Progressive Disease|27
7849335|NCT01478594|12331133|FG000|Overall Study|Randomized but Never Received Study Drug|0
7849336|NCT01478594|12331134|FG001|Overall Study|Randomized but Never Received Study Drug|1
7849337|NCT01478594|12331133|FG000|Overall Study|Death|45
7849338|NCT01478594|12331134|FG001|Overall Study|Death|18
7849339|NCT01478594|12331133|FG000|Overall Study|Lost to Follow-up|3
7849340|NCT01478594|12331134|FG001|Overall Study|Lost to Follow-up|1
7849341|NCT01478594|12331133|FG000|Overall Study|Withdrawal by Subject|9
7849342|NCT01478594|12331134|FG001|Overall Study|Withdrawal by Subject|3
7849343|NCT01478594|12331133|FG000|Overall Study|Study Closed by Sponsor|8
7849344|NCT01478594|12331134|FG001|Overall Study|Study Closed by Sponsor|5
7849345|NCT01478620|12331193|FG000|Overall Study|Lost to Follow-up|6
7849346|NCT01478828|12331197|FG000|Overall Study|Adverse Event|1
7849347|NCT01478958|12331209|FG000|Overall Study|Withdrawal by Subject|1
7849348|NCT01478958|12331210|FG001|Overall Study|Withdrawal by Subject|1
7849349|NCT01478958|12331211|FG002|Overall Study|Withdrawal by Subject|1
7849350|NCT01478958|12331209|FG000|Overall Study|Weight loss|1
7849351|NCT01478958|12331210|FG001|Overall Study|Weight loss|0
7849352|NCT01478958|12331211|FG002|Overall Study|Weight loss|0
7849353|NCT01478958|12331209|FG000|Overall Study|Re-located|0
7849354|NCT01478958|12331210|FG001|Overall Study|Re-located|1
7849355|NCT01478958|12331211|FG002|Overall Study|Re-located|0
7849356|NCT01478958|12331209|FG000|Overall Study|Unable to comply|0
7849357|NCT01478958|12331210|FG001|Overall Study|Unable to comply|0
7849358|NCT01478958|12331211|FG002|Overall Study|Unable to comply|2
7849359|NCT01478971|12331219|FG000|Standard of Care Period|Adverse Event|1
7849360|NCT01478971|12331219|FG000|Standard of Care Period|Withdrawal by Subject|3
7849361|NCT01478971|12331219|FG000|Standard of Care Period|Death|8
7849362|NCT01478971|12331219|FG000|Standard of Care Period|Lost to Follow-up|9
7849363|NCT01478971|12331219|FG000|Standard of Care Period|Other|4
7849364|NCT01478971|12331219|FG000|Peginesatide Treatment Period|Adverse Event|1
7849365|NCT01478971|12331219|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1
7849366|NCT01478971|12331219|FG000|Peginesatide Treatment Period|Death|4
7849367|NCT01478971|12331219|FG000|Peginesatide Treatment Period|Lost to Follow-up|4
7849368|NCT01478971|12331219|FG000|Peginesatide Treatment Period|Other|4
7849369|NCT01479374|12331255|FG000|Overall Study|Adverse Event|2
7849370|NCT01479374|12331256|FG001|Overall Study|Adverse Event|1
7849371|NCT01479374|12331257|FG002|Overall Study|Adverse Event|0
7849372|NCT01479374|12331255|FG000|Overall Study|Lost to Follow-up|1
7849373|NCT01479374|12331256|FG001|Overall Study|Lost to Follow-up|2
7849374|NCT01479374|12331257|FG002|Overall Study|Lost to Follow-up|0
7849375|NCT01479374|12331255|FG000|Overall Study|Decision Unrelated to Adverse Event|0
7849376|NCT01479374|12331256|FG001|Overall Study|Decision Unrelated to Adverse Event|1
7849377|NCT01479374|12331257|FG002|Overall Study|Decision Unrelated to Adverse Event|0
7849378|NCT01479374|12331255|FG000|Overall Study|Other|0
7849379|NCT01479374|12331256|FG001|Overall Study|Other|4
7849380|NCT01479374|12331257|FG002|Overall Study|Other|5
7849381|NCT01479439|12331277|FG000|Overall Study|Adverse Event|1
7849382|NCT01479439|12331278|FG001|Overall Study|Adverse Event|0
7949283|NCT02534935|12494697|FG001|Stage 1: 24 Months|No longer willing to participate in study|1
7949284|NCT02534935|12494698|FG002|Stage 1: 24 Months|No longer willing to participate in study|1
7949285|NCT02534935|12494696|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0
7949286|NCT02534935|12494697|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3
7949287|NCT02534935|12494698|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0
7949288|NCT02534935|12494696|FG000|Stage 1: 24 Months|Lost to Follow-up|0
7949289|NCT02534935|12494697|FG001|Stage 1: 24 Months|Lost to Follow-up|1
7949290|NCT02534935|12494698|FG002|Stage 1: 24 Months|Lost to Follow-up|1
7949291|NCT02534935|12494696|FG000|Stage 1: 24 Months|Adverse Event|0
7949292|NCT02534935|12494697|FG001|Stage 1: 24 Months|Adverse Event|2
7949293|NCT02534935|12494698|FG002|Stage 1: 24 Months|Adverse Event|0
7949294|NCT02534935|12494696|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0
7949295|NCT02534935|12494697|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4
7949296|NCT02534935|12494698|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0
7949297|NCT02534935|12494696|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0
7949298|NCT02534935|12494697|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1
7949299|NCT02534935|12494698|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0
7949300|NCT02535000|12494726|FG000|Overall Study|Cancellation of surgery.|1
7949301|NCT02535000|12494727|FG001|Overall Study|Cancellation of surgery.|2
7949302|NCT02535364|12494747|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
7949303|NCT02535364|12494747|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
7949304|NCT02535364|12494747|FG000|Part A Screening Through Leukapheresis|Disease progression|1
7849383|NCT01479439|12331279|FG002|Overall Study|Adverse Event|0
7849384|NCT01479439|12331277|FG000|Overall Study|Lost to Follow-up|0
7849385|NCT01479439|12331278|FG001|Overall Study|Lost to Follow-up|1
7849386|NCT01479439|12331279|FG002|Overall Study|Lost to Follow-up|0
7949305|NCT02535364|12494747|FG000|Part B Screening|Study placed on clinical hold by FDA|7
7949306|NCT02535364|12494747|FG000|Part B Screening|Unable to manufacture JCAR015|3
7949307|NCT02535364|12494747|FG000|Part B Screening|Death|2
7949308|NCT02535364|12494747|FG000|Part B Screening|Physician Decision|1
7949309|NCT02535364|12494747|FG000|Part B Screening|Withdrawal by Subject|1
7720915|NCT00541970|12145421|FG000|Month 24|Protocol Violation|29
7949310|NCT02535364|12494747|FG000|Part B Screening|Adverse Event|1
7949311|NCT02535364|12494747|FG000|Part B Screening|Change in diagnosis, no longer eligible|2
7949312|NCT02535364|12494747|FG000|Study Treatment|Death|1
7949313|NCT02535364|12494747|FG000|Study Treatment|Study placed on clinical hold by FDA|1
7949314|NCT02535364|12494747|FG000|12-Month Follow-up Period|Disease progression|22
7949315|NCT02535364|12494747|FG000|12-Month Follow-up Period|Death|5
7949316|NCT02535364|12494747|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5
7949317|NCT02535364|12494747|FG000|12-Month Follow-up Period|Subject received alternative therapy|2
7949318|NCT02535364|12494747|FG000|12-Month Follow-up Period|Subject transferred to hospice|1
7949319|NCT02535416|12494760|FG000|Overall Study|Family bereavement overseas|1
7949320|NCT02535416|12494761|FG001|Overall Study|Family bereavement overseas|0
7949321|NCT02535416|12494762|FG002|Overall Study|Family bereavement overseas|0
7949322|NCT02535416|12494763|FG003|Overall Study|Family bereavement overseas|0
7949323|NCT02535416|12494764|FG004|Overall Study|Family bereavement overseas|0
7949324|NCT02535416|12494765|FG005|Overall Study|Family bereavement overseas|0
7949325|NCT02535416|12494766|FG006|Overall Study|Family bereavement overseas|0
7949326|NCT02535416|12494767|FG007|Overall Study|Family bereavement overseas|0
7949327|NCT02535416|12494768|FG008|Overall Study|Family bereavement overseas|0
7949328|NCT02535715|12494820|FG000|Overall Study|Withdrawal by Subject|0
7949329|NCT02535715|12494821|FG001|Overall Study|Withdrawal by Subject|0
7949330|NCT02535715|12494822|FG002|Overall Study|Withdrawal by Subject|1
7949331|NCT02535741|12494833|FG000|Overall Study|Adverse Event|3
7949332|NCT02535741|12494833|FG000|Overall Study|Withdrawal by Subject|9
7949333|NCT02535741|12494833|FG000|Overall Study|Lost to Follow-up|10
7849387|NCT01479439|12331277|FG000|Overall Study|Protocol Violation|0
7849388|NCT01479439|12331278|FG001|Overall Study|Protocol Violation|0
7849389|NCT01479439|12331279|FG002|Overall Study|Protocol Violation|2
7849390|NCT01479465|12331294|FG000|Overall Study|Disease Progression|9
7849391|NCT01479465|12331295|FG001|Overall Study|Disease Progression|61
7849392|NCT01479465|12331296|FG002|Overall Study|Disease Progression|65
7849393|NCT01479465|12331297|FG003|Overall Study|Disease Progression|70
7849394|NCT01479465|12331294|FG000|Overall Study|Study Discontinued by Sponsor|0
7849395|NCT01479465|12331295|FG001|Overall Study|Study Discontinued by Sponsor|7
7849396|NCT01479465|12331296|FG002|Overall Study|Study Discontinued by Sponsor|5
7849397|NCT01479465|12331297|FG003|Overall Study|Study Discontinued by Sponsor|3
7849398|NCT01479465|12331294|FG000|Overall Study|Adverse Event|0
7849399|NCT01479465|12331295|FG001|Overall Study|Adverse Event|3
7849400|NCT01479465|12331296|FG002|Overall Study|Adverse Event|6
7849401|NCT01479465|12331297|FG003|Overall Study|Adverse Event|4
7849402|NCT01479465|12331294|FG000|Overall Study|Investigator Discretion|1
7849403|NCT01479465|12331295|FG001|Overall Study|Investigator Discretion|4
7849404|NCT01479465|12331296|FG002|Overall Study|Investigator Discretion|2
7849405|NCT01479465|12331297|FG003|Overall Study|Investigator Discretion|4
7849406|NCT01479465|12331294|FG000|Overall Study|Subject Request|1
7849407|NCT01479465|12331295|FG001|Overall Study|Subject Request|3
7849408|NCT01479465|12331296|FG002|Overall Study|Subject Request|4
7849409|NCT01479465|12331297|FG003|Overall Study|Subject Request|2
7849410|NCT01479465|12331294|FG000|Overall Study|Subject Withdrew Consent|0
7849411|NCT01479465|12331295|FG001|Overall Study|Subject Withdrew Consent|5
7849412|NCT01479465|12331296|FG002|Overall Study|Subject Withdrew Consent|2
7849413|NCT01479465|12331297|FG003|Overall Study|Subject Withdrew Consent|1
7849414|NCT01479465|12331294|FG000|Overall Study|Protocol Violation|0
7849415|NCT01479465|12331295|FG001|Overall Study|Protocol Violation|1
7849416|NCT01479465|12331296|FG002|Overall Study|Protocol Violation|1
7849417|NCT01479465|12331297|FG003|Overall Study|Protocol Violation|0
7849418|NCT01479465|12331294|FG000|Overall Study|Death|0
7849419|NCT01479465|12331295|FG001|Overall Study|Death|0
7849420|NCT01479465|12331296|FG002|Overall Study|Death|0
7849421|NCT01479465|12331297|FG003|Overall Study|Death|1
7849422|NCT01479465|12331294|FG000|Overall Study|Lost to Follow-up|0
7849423|NCT01479465|12331295|FG001|Overall Study|Lost to Follow-up|0
7849424|NCT01479465|12331296|FG002|Overall Study|Lost to Follow-up|1
7849425|NCT01479465|12331297|FG003|Overall Study|Lost to Follow-up|0
7849426|NCT01479530|12331331|FG000|Overall Study|Adverse Event|5
7849427|NCT01479530|12331332|FG001|Overall Study|Adverse Event|6
7849428|NCT01479530|12331331|FG000|Overall Study|Lack of Efficacy|0
7849429|NCT01479530|12331332|FG001|Overall Study|Lack of Efficacy|1
7849430|NCT01479530|12331331|FG000|Overall Study|Protocol Violation|2
7849431|NCT01479530|12331332|FG001|Overall Study|Protocol Violation|3
7849432|NCT01479530|12331331|FG000|Overall Study|Withdrawal of Consent|3
7849433|NCT01479530|12331332|FG001|Overall Study|Withdrawal of Consent|2
7849434|NCT01479595|12331361|FG000|Overall Study|Protocol deviation|0
7849435|NCT01479595|12331362|FG001|Overall Study|Protocol deviation|1
7849436|NCT01479595|12331361|FG000|Overall Study|Adverse Event|2
7849437|NCT01479595|12331362|FG001|Overall Study|Adverse Event|1
7849438|NCT01479621|12331374|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
7849439|NCT01479621|12331375|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7849440|NCT01479621|12331376|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7849441|NCT01479621|12331377|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7849442|NCT01479621|12331378|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7849443|NCT01479621|12331379|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7849444|NCT01479621|12331380|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7849445|NCT01479621|12331374|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
7849446|NCT01479621|12331375|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7849447|NCT01479621|12331376|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7849448|NCT01479621|12331377|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7849449|NCT01479621|12331378|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7849450|NCT01479621|12331379|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7849451|NCT01479621|12331380|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7849452|NCT01479621|12331374|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
7849453|NCT01479621|12331375|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7849454|NCT01479621|12331376|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7849455|NCT01479621|12331377|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7849456|NCT01479621|12331378|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7849457|NCT01479621|12331379|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7849458|NCT01479621|12331380|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7849459|NCT01479621|12331374|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
7849460|NCT01479621|12331375|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7849461|NCT01479621|12331376|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7849462|NCT01479621|12331377|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7849463|NCT01479621|12331378|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7849464|NCT01479621|12331379|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7849465|NCT01479621|12331380|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7849466|NCT01479621|12331374|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15
7849467|NCT01479621|12331375|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0
7849468|NCT01479621|12331376|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0
7849469|NCT01479621|12331377|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0
7849470|NCT01479621|12331378|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0
7849471|NCT01479621|12331379|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0
7849472|NCT01479621|12331380|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0
7849473|NCT01479621|12331374|FG000|Treatment Period|Adverse Event|0
7849474|NCT01479621|12331375|FG001|Treatment Period|Adverse Event|0
7849475|NCT01479621|12331376|FG002|Treatment Period|Adverse Event|0
7849476|NCT01479621|12331377|FG003|Treatment Period|Adverse Event|0
7849477|NCT01479621|12331378|FG004|Treatment Period|Adverse Event|1
7849478|NCT01479621|12331379|FG005|Treatment Period|Adverse Event|2
7849479|NCT01479621|12331380|FG006|Treatment Period|Adverse Event|2
7849480|NCT01479621|12331374|FG000|Treatment Period|Withdrawal by Subject|0
7849481|NCT01479621|12331375|FG001|Treatment Period|Withdrawal by Subject|4
7849482|NCT01479621|12331376|FG002|Treatment Period|Withdrawal by Subject|2
7849483|NCT01479621|12331377|FG003|Treatment Period|Withdrawal by Subject|2
7849484|NCT01479621|12331378|FG004|Treatment Period|Withdrawal by Subject|5
7849485|NCT01479621|12331379|FG005|Treatment Period|Withdrawal by Subject|5
7849486|NCT01479621|12331380|FG006|Treatment Period|Withdrawal by Subject|1
7849487|NCT01479621|12331374|FG000|Treatment Period|Physician Decision|0
7849488|NCT01479621|12331375|FG001|Treatment Period|Physician Decision|0
7849489|NCT01479621|12331376|FG002|Treatment Period|Physician Decision|0
7849490|NCT01479621|12331377|FG003|Treatment Period|Physician Decision|0
7849491|NCT01479621|12331378|FG004|Treatment Period|Physician Decision|1
7849492|NCT01479621|12331379|FG005|Treatment Period|Physician Decision|1
7849493|NCT01479621|12331380|FG006|Treatment Period|Physician Decision|0
7849494|NCT01479621|12331374|FG000|Treatment Period|Non-compliance to study drug|0
7849495|NCT01479621|12331375|FG001|Treatment Period|Non-compliance to study drug|1
7849496|NCT01479621|12331376|FG002|Treatment Period|Non-compliance to study drug|0
7849497|NCT01479621|12331377|FG003|Treatment Period|Non-compliance to study drug|0
7849498|NCT01479621|12331378|FG004|Treatment Period|Non-compliance to study drug|0
7849499|NCT01479621|12331379|FG005|Treatment Period|Non-compliance to study drug|0
7849500|NCT01479621|12331380|FG006|Treatment Period|Non-compliance to study drug|1
7849501|NCT01479621|12331374|FG000|Treatment Period|Protocol Violation|0
7849502|NCT01479621|12331375|FG001|Treatment Period|Protocol Violation|9
7849503|NCT01479621|12331376|FG002|Treatment Period|Protocol Violation|6
7849504|NCT01479621|12331377|FG003|Treatment Period|Protocol Violation|5
7849505|NCT01479621|12331378|FG004|Treatment Period|Protocol Violation|2
7849506|NCT01479621|12331379|FG005|Treatment Period|Protocol Violation|10
7849507|NCT01479621|12331380|FG006|Treatment Period|Protocol Violation|6
7849508|NCT01479621|12331374|FG000|Treatment Period|Pregnancy|0
7849509|NCT01479621|12331375|FG001|Treatment Period|Pregnancy|0
7849510|NCT01479621|12331376|FG002|Treatment Period|Pregnancy|2
7849511|NCT01479621|12331377|FG003|Treatment Period|Pregnancy|0
7849512|NCT01479621|12331378|FG004|Treatment Period|Pregnancy|0
7849513|NCT01479621|12331379|FG005|Treatment Period|Pregnancy|0
7849514|NCT01479621|12331380|FG006|Treatment Period|Pregnancy|0
7849515|NCT01479621|12331374|FG000|Treatment Period|Sponsor request subject to be withdrawn|0
7849516|NCT01479621|12331375|FG001|Treatment Period|Sponsor request subject to be withdrawn|2
7849517|NCT01479621|12331376|FG002|Treatment Period|Sponsor request subject to be withdrawn|3
7849518|NCT01479621|12331377|FG003|Treatment Period|Sponsor request subject to be withdrawn|1
7849519|NCT01479621|12331378|FG004|Treatment Period|Sponsor request subject to be withdrawn|1
7849520|NCT01479621|12331379|FG005|Treatment Period|Sponsor request subject to be withdrawn|1
7849521|NCT01479621|12331380|FG006|Treatment Period|Sponsor request subject to be withdrawn|3
7849522|NCT01479621|12331374|FG000|Treatment Period|Lost to Follow-up|0
7849523|NCT01479621|12331375|FG001|Treatment Period|Lost to Follow-up|0
7849524|NCT01479621|12331376|FG002|Treatment Period|Lost to Follow-up|1
7849525|NCT01479621|12331377|FG003|Treatment Period|Lost to Follow-up|0
7849526|NCT01479621|12331378|FG004|Treatment Period|Lost to Follow-up|2
7849527|NCT01479621|12331379|FG005|Treatment Period|Lost to Follow-up|2
7849528|NCT01479621|12331380|FG006|Treatment Period|Lost to Follow-up|1
7849529|NCT01479621|12331374|FG000|Treatment Period|Met stopping criteria|0
7849530|NCT01479621|12331375|FG001|Treatment Period|Met stopping criteria|8
7849531|NCT01479621|12331376|FG002|Treatment Period|Met stopping criteria|7
7849532|NCT01479621|12331377|FG003|Treatment Period|Met stopping criteria|4
7849533|NCT01479621|12331378|FG004|Treatment Period|Met stopping criteria|9
7849534|NCT01479621|12331379|FG005|Treatment Period|Met stopping criteria|20
7849535|NCT01479621|12331380|FG006|Treatment Period|Met stopping criteria|6
7849536|NCT01479764|12331405|FG000|Randomized|Adverse Event|1
7849537|NCT01479764|12331406|FG001|Randomized|Adverse Event|1
7849538|NCT01479764|12331405|FG000|Randomized|Withdrawal by Subject|1
7849539|NCT01479764|12331406|FG001|Randomized|Withdrawal by Subject|0
7849540|NCT01479764|12331405|FG000|Treated|Lost to Follow-up|0
7849541|NCT01479764|12331406|FG001|Treated|Lost to Follow-up|2
7849542|NCT01479777|12331412|FG000|Overall Study|Physician Decision|2
7849543|NCT01479868|12331416|FG000|Overall Study|Adverse Event|1
7849544|NCT01479868|12331416|FG000|Overall Study|Lost to Follow-up|4
7849545|NCT01479868|12331416|FG000|Overall Study|Protocol Violation|1
7849546|NCT01479868|12331416|FG000|Overall Study|Withdrawal by Subject|1
7849547|NCT01479868|12331416|FG000|Overall Study|Sponsor's Decision|1
7849548|NCT01479868|12331416|FG000|Overall Study|Initiation of new HCV Therapy|1
7849549|NCT01479985|12331422|FG000|Overall Study|Tablet malfunction, no data saved|1
7849550|NCT01479985|12331423|FG001|Overall Study|Tablet malfunction, no data saved|1
7849551|NCT01479985|12331422|FG000|Overall Study|No decisional conflict scale responses|0
7849552|NCT01479985|12331423|FG001|Overall Study|No decisional conflict scale responses|2
7849553|NCT01479985|12331422|FG000|Overall Study|No post-visit survey|5
7849554|NCT01479985|12331423|FG001|Overall Study|No post-visit survey|3
7849555|NCT01480076|12331431|FG000|Overall Study|Run-in Failure|52
7849556|NCT01480076|12331431|FG000|Overall Study|Adverse Event|39
7849557|NCT01480076|12331431|FG000|Overall Study|Death|2
7849558|NCT01480076|12331431|FG000|Overall Study|Disease Progression|5
7849559|NCT01480076|12331431|FG000|Overall Study|Non-compliance With Study Protocol|15
7849560|NCT01480076|12331431|FG000|Overall Study|Withdrawal by Subject|105
7849561|NCT01480076|12331431|FG000|Overall Study|Lost to Follow-up|7
7849562|NCT01480076|12331431|FG000|Overall Study|Investigator Decision|13
7849563|NCT01480076|12331431|FG000|Overall Study|Other|52
7849564|NCT01480258|12331484|FG000|Infant Series|Protocol Violation|2
7849565|NCT01480258|12331485|FG001|Infant Series|Protocol Violation|0
7849566|NCT01480258|12331484|FG000|Infant Series|Physician Decision|0
7849567|NCT01480258|12331485|FG001|Infant Series|Physician Decision|1
7849568|NCT01480258|12331484|FG000|Infant Series|Not Vaccinated|3
7849569|NCT01480258|12331485|FG001|Infant Series|Not Vaccinated|0
7849570|NCT01480258|12331484|FG000|Infant Series|Adverse Event|1
7849571|NCT01480258|12331485|FG001|Infant Series|Adverse Event|1
7849572|NCT01480258|12331484|FG000|Infant Series|Withdrawal by Subject|1
7849573|NCT01480258|12331485|FG001|Infant Series|Withdrawal by Subject|6
7849574|NCT01480258|12331484|FG000|Interim Period|Lost to Follow-up|0
7849575|NCT01480258|12331485|FG001|Interim Period|Lost to Follow-up|2
7849576|NCT01480258|12331484|FG000|Interim Period|Physician Decision|1
7849577|NCT01480258|12331485|FG001|Interim Period|Physician Decision|0
7849578|NCT01480258|12331484|FG000|Interim Period|Protocol Violation|0
7849579|NCT01480258|12331485|FG001|Interim Period|Protocol Violation|1
7849580|NCT01480258|12331484|FG000|Interim Period|Withdrawal by Subject|9
7849581|NCT01480258|12331485|FG001|Interim Period|Withdrawal by Subject|6
7849582|NCT01480284|12331493|FG000|Overall Study|Withdrawal by Subject|2
7849583|NCT01480284|12331494|FG001|Overall Study|Withdrawal by Subject|0
7849584|NCT01480284|12331493|FG000|Overall Study|Adverse Event|1
7849585|NCT01480284|12331494|FG001|Overall Study|Adverse Event|0
7849586|NCT01480284|12331493|FG000|Overall Study|Study closed/terminated|3
7849587|NCT01480284|12331494|FG001|Overall Study|Study closed/terminated|0
7849588|NCT01480284|12331493|FG000|Overall Study|Lost to Follow-up|1
7849589|NCT01480284|12331494|FG001|Overall Study|Lost to Follow-up|0
7849590|NCT01480284|12331493|FG000|Overall Study|Physician Decision|1
7849591|NCT01480284|12331494|FG001|Overall Study|Physician Decision|0
7849592|NCT01480596|12331506|FG000|Overall Study|Adverse Event|3
7849593|NCT01480596|12331507|FG001|Overall Study|Adverse Event|0
7849594|NCT01480596|12331506|FG000|Overall Study|MG exacerbation or change in medication|2
7849595|NCT01480596|12331507|FG001|Overall Study|MG exacerbation or change in medication|2
7849596|NCT01480674|12331513|FG000|Overall Study|Death|23
7849597|NCT01480674|12331513|FG000|Overall Study|Lost to Follow-up|2
7849598|NCT01480674|12331513|FG000|Overall Study|visit not done|10
7849599|NCT01481116|12331524|FG000|Overall Study|Adverse Event|26
7849600|NCT01481116|12331525|FG001|Overall Study|Adverse Event|26
7849601|NCT01481116|12331526|FG002|Overall Study|Adverse Event|42
7849602|NCT01481116|12331524|FG000|Overall Study|Major Protocol Deviation|3
7849603|NCT01481116|12331525|FG001|Overall Study|Major Protocol Deviation|7
7849604|NCT01481116|12331526|FG002|Overall Study|Major Protocol Deviation|1
7849605|NCT01481116|12331524|FG000|Overall Study|Lost to Follow-up|8
7849606|NCT01481116|12331525|FG001|Overall Study|Lost to Follow-up|12
7849607|NCT01481116|12331526|FG002|Overall Study|Lost to Follow-up|11
7849608|NCT01481116|12331524|FG000|Overall Study|Withdrawal by Subject|37
7849609|NCT01481116|12331525|FG001|Overall Study|Withdrawal by Subject|33
7849610|NCT01481116|12331526|FG002|Overall Study|Withdrawal by Subject|37
7849611|NCT01481116|12331524|FG000|Overall Study|Study Termination|730
7849612|NCT01481116|12331525|FG001|Overall Study|Study Termination|729
7849613|NCT01481116|12331526|FG002|Overall Study|Study Termination|713
7849614|NCT01481116|12331524|FG000|Overall Study|Pregnancy|0
7849615|NCT01481116|12331525|FG001|Overall Study|Pregnancy|0
7849616|NCT01481116|12331526|FG002|Overall Study|Pregnancy|1
7849617|NCT01481116|12331524|FG000|Overall Study|Lack of Efficacy|3
7849618|NCT01481116|12331525|FG001|Overall Study|Lack of Efficacy|3
7849619|NCT01481116|12331526|FG002|Overall Study|Lack of Efficacy|1
7849620|NCT01481116|12331524|FG000|Overall Study|Contraindications|1
7849621|NCT01481116|12331525|FG001|Overall Study|Contraindications|1
7849622|NCT01481116|12331526|FG002|Overall Study|Contraindications|0
7849623|NCT01481116|12331524|FG000|Overall Study|Other|1
7849624|NCT01481116|12331525|FG001|Overall Study|Other|1
7849625|NCT01481116|12331526|FG002|Overall Study|Other|0
7849626|NCT01481116|12331524|FG000|Overall Study|Participant Started Taking Glipizide|1
7849627|NCT01481116|12331525|FG001|Overall Study|Participant Started Taking Glipizide|0
7849628|NCT01481116|12331526|FG002|Overall Study|Participant Started Taking Glipizide|0
7849629|NCT01481116|12331524|FG000|Overall Study|Participant Moved Out of Area|2
7849630|NCT01481116|12331525|FG001|Overall Study|Participant Moved Out of Area|0
7849631|NCT01481116|12331526|FG002|Overall Study|Participant Moved Out of Area|1
7849632|NCT01481116|12331524|FG000|Overall Study|Participant Moved Out of Country|1
7849633|NCT01481116|12331525|FG001|Overall Study|Participant Moved Out of Country|0
7849634|NCT01481116|12331526|FG002|Overall Study|Participant Moved Out of Country|1
7849635|NCT01481116|12331524|FG000|Overall Study|Investigator Decision|3
7849636|NCT01481116|12331525|FG001|Overall Study|Investigator Decision|2
7849637|NCT01481116|12331526|FG002|Overall Study|Investigator Decision|1
7849638|NCT01481116|12331524|FG000|Overall Study|Sponsor Decision|0
7849639|NCT01481116|12331525|FG001|Overall Study|Sponsor Decision|1
7849640|NCT01481116|12331526|FG002|Overall Study|Sponsor Decision|3
7849641|NCT01481116|12331524|FG000|Overall Study|Non-Compliant With Study Drug|0
7849642|NCT01481116|12331525|FG001|Overall Study|Non-Compliant With Study Drug|1
7849643|NCT01481116|12331526|FG002|Overall Study|Non-Compliant With Study Drug|1
7849644|NCT01481116|12331524|FG000|Overall Study|Investigator's Discretion|2
7849645|NCT01481116|12331525|FG001|Overall Study|Investigator's Discretion|0
7849646|NCT01481116|12331526|FG002|Overall Study|Investigator's Discretion|0
7849647|NCT01481116|12331524|FG000|Overall Study|Death|2
7849648|NCT01481116|12331525|FG001|Overall Study|Death|1
7849649|NCT01481116|12331526|FG002|Overall Study|Death|0
7849650|NCT01481116|12331524|FG000|Overall Study|Hypoglycemic Event|4
7849651|NCT01481116|12331525|FG001|Overall Study|Hypoglycemic Event|0
7849652|NCT01481116|12331526|FG002|Overall Study|Hypoglycemic Event|0
7849653|NCT01481324|12331541|FG000|Overall Study|Missing Data|0
7849654|NCT01481324|12331542|FG001|Overall Study|Missing Data|2
7720916|NCT00541970|12145422|FG001|Month 24|Protocol Violation|31
7720917|NCT00541970|12145423|FG002|Month 24|Protocol Violation|31
7720918|NCT00541970|12145424|FG003|Month 24|Protocol Violation|21
7720919|NCT00541970|12145421|FG000|Month 36|Protocol Violation|61
7720920|NCT00541970|12145422|FG001|Month 36|Protocol Violation|66
7720921|NCT00541970|12145423|FG002|Month 36|Protocol Violation|66
7720922|NCT00541970|12145424|FG003|Month 36|Protocol Violation|60
7720923|NCT00541970|12145421|FG000|Month 48|Withdrawal by Subject|2
7849655|NCT01481324|12331543|FG002|Overall Study|Missing Data|2
7849656|NCT01481779|12331586|FG000|Overall Study|Adverse Event|23
7849657|NCT01481779|12331587|FG001|Overall Study|Adverse Event|5
7849658|NCT01481779|12331586|FG000|Overall Study|Lost to Follow-up|3
7849659|NCT01481779|12331587|FG001|Overall Study|Lost to Follow-up|2
7849660|NCT01481779|12331586|FG000|Overall Study|Protocol Violation|2
7849661|NCT01481779|12331587|FG001|Overall Study|Protocol Violation|3
7849662|NCT01481779|12331586|FG000|Overall Study|Withdrawal by Subject|26
7849663|NCT01481779|12331587|FG001|Overall Study|Withdrawal by Subject|13
7849664|NCT01481779|12331586|FG000|Overall Study|Physician Decision|13
7849665|NCT01481779|12331587|FG001|Overall Study|Physician Decision|4
7849666|NCT01481779|12331586|FG000|Overall Study|Sponsor Decision|3
7849667|NCT01481779|12331587|FG001|Overall Study|Sponsor Decision|1
7849668|NCT01481896|12331593|FG000|Overall Study|Lost to Follow-up|12
7849669|NCT01482065|12331609|FG000|Overall Study|Withdrawal by Subject|0
7849670|NCT01482065|12331610|FG001|Overall Study|Withdrawal by Subject|1
7849671|NCT01482169|12331625|FG000|Overall Study|Physician Decision|2
7849672|NCT01482221|12331635|FG000|Overall Study|Lack of Efficacy|1
7849673|NCT01482221|12331636|FG001|Overall Study|Lack of Efficacy|0
7849674|NCT01482221|12331637|FG002|Overall Study|Lack of Efficacy|1
7849675|NCT01482221|12331635|FG000|Overall Study|Lost to Follow-up|3
7849676|NCT01482221|12331636|FG001|Overall Study|Lost to Follow-up|2
7849677|NCT01482221|12331637|FG002|Overall Study|Lost to Follow-up|1
7849678|NCT01482221|12331635|FG000|Overall Study|Study-Specific Withdrawal Criteria|2
7849679|NCT01482221|12331636|FG001|Overall Study|Study-Specific Withdrawal Criteria|0
7849680|NCT01482221|12331637|FG002|Overall Study|Study-Specific Withdrawal Criteria|1
7849681|NCT01482221|12331635|FG000|Overall Study|Condition under Investigation Worsened|3
7849682|NCT01482221|12331636|FG001|Overall Study|Condition under Investigation Worsened|2
7849683|NCT01482221|12331637|FG002|Overall Study|Condition under Investigation Worsened|4
7849684|NCT01482221|12331635|FG000|Overall Study|Severe Non-Compliance to Protocol|1
7849685|NCT01482221|12331636|FG001|Overall Study|Severe Non-Compliance to Protocol|0
7849686|NCT01482221|12331637|FG002|Overall Study|Severe Non-Compliance to Protocol|1
7849687|NCT01482221|12331635|FG000|Overall Study|Adverse Event|1
7849688|NCT01482221|12331636|FG001|Overall Study|Adverse Event|7
7849689|NCT01482221|12331637|FG002|Overall Study|Adverse Event|3
7849690|NCT01482221|12331635|FG000|Overall Study|Withdrawal by Subject|10
7849691|NCT01482221|12331636|FG001|Overall Study|Withdrawal by Subject|7
7849692|NCT01482221|12331637|FG002|Overall Study|Withdrawal by Subject|12
7849693|NCT01482221|12331635|FG000|Overall Study|Incorrect randomization|0
7849694|NCT01482221|12331636|FG001|Overall Study|Incorrect randomization|1
7849695|NCT01482221|12331637|FG002|Overall Study|Incorrect randomization|0
7849696|NCT01482221|12331635|FG000|Overall Study|Physician Decision|0
7849697|NCT01482221|12331636|FG001|Overall Study|Physician Decision|1
7849698|NCT01482221|12331637|FG002|Overall Study|Physician Decision|0
7849699|NCT01482312|12331645|FG000|Period 1, 90 Minutes of Wear|Other|1
7849700|NCT01482312|12331646|FG001|Period 1, 90 Minutes of Wear|Other|0
7720924|NCT00541970|12145422|FG001|Month 48|Withdrawal by Subject|4
7849701|NCT01482312|12331647|FG002|Period 1, 90 Minutes of Wear|Other|0
7849702|NCT01482312|12331645|FG000|Period 2, 90 Minutes of Wear|Other|1
7849703|NCT01482312|12331646|FG001|Period 2, 90 Minutes of Wear|Other|0
7849704|NCT01482312|12331647|FG002|Period 2, 90 Minutes of Wear|Other|0
7849705|NCT01482429|12331667|FG000|Care Usual|Protocol Violation|0
7849706|NCT01482429|12331668|FG001|Care Usual|Protocol Violation|172
7849707|NCT01482429|12331667|FG000|Care Usual|Lost to Follow-up|0
7849708|NCT01482429|12331668|FG001|Care Usual|Lost to Follow-up|1
7849709|NCT01482429|12331667|FG000|Protocol|Protocol Violation|275
7849710|NCT01482429|12331668|FG001|Protocol|Protocol Violation|0
7849711|NCT01482767|12331742|FG000|Overall Study|Death|1
7849712|NCT01482767|12331743|FG001|Overall Study|Death|1
7849713|NCT01482767|12331742|FG000|Overall Study|Withdrawal by Subject|7
7849714|NCT01482767|12331743|FG001|Overall Study|Withdrawal by Subject|5
7849715|NCT01482767|12331742|FG000|Overall Study|Lost to Follow-up|12
7849716|NCT01482767|12331743|FG001|Overall Study|Lost to Follow-up|6
7849717|NCT01482767|12331742|FG000|Overall Study|Adverse Event|0
7849718|NCT01482767|12331743|FG001|Overall Study|Adverse Event|3
7849719|NCT01482767|12331742|FG000|Overall Study|Site closure|22
7849720|NCT01482767|12331743|FG001|Overall Study|Site closure|14
7849721|NCT01482767|12331742|FG000|Overall Study|Non-adherence to study requirements|4
7849722|NCT01482767|12331743|FG001|Overall Study|Non-adherence to study requirements|7
7849723|NCT01482767|12331742|FG000|Overall Study|Alternate HCV treatment|7
7849724|NCT01482767|12331743|FG001|Overall Study|Alternate HCV treatment|8
7849725|NCT01482767|12331742|FG000|Overall Study|Ineligible|0
7849726|NCT01482767|12331743|FG001|Overall Study|Ineligible|5
7949334|NCT02535741|12494833|FG000|Overall Study|Exclusion criteria: Bilateral implant|4
7849727|NCT01482767|12331742|FG000|Overall Study|Nurse error|1
7849728|NCT01482767|12331743|FG001|Overall Study|Nurse error|0
7849729|NCT01482819|12331749|FG000|Overall Study|Lost to Follow-up|2
7849730|NCT01482884|12331759|FG000|Overall Study|Medical decision due to lack of efficacy|0
7849731|NCT01482884|12331760|FG001|Overall Study|Medical decision due to lack of efficacy|1
7849732|NCT01482884|12331759|FG000|Overall Study|Protocol Violation|1
7849733|NCT01482884|12331760|FG001|Overall Study|Protocol Violation|0
7849734|NCT01482884|12331759|FG000|Overall Study|Lost to Follow-up|2
7849735|NCT01482884|12331760|FG001|Overall Study|Lost to Follow-up|2
7849736|NCT01482884|12331759|FG000|Overall Study|Lack of Efficacy|0
7849737|NCT01482884|12331760|FG001|Overall Study|Lack of Efficacy|1
7849738|NCT01482884|12331759|FG000|Overall Study|Adverse Event|2
7849739|NCT01482884|12331760|FG001|Overall Study|Adverse Event|1
7849740|NCT01482884|12331759|FG000|Overall Study|Withdrawal by Subject|8
7849741|NCT01482884|12331760|FG001|Overall Study|Withdrawal by Subject|13
7849742|NCT01482910|12331768|FG000|Overall Study|Adverse Event|6
7849743|NCT01482910|12331769|FG001|Overall Study|Adverse Event|5
7849744|NCT01482910|12331768|FG000|Overall Study|Lost to Follow-up|0
7849745|NCT01482910|12331769|FG001|Overall Study|Lost to Follow-up|1
7849746|NCT01482910|12331768|FG000|Overall Study|Protocol Violation|1
7849747|NCT01482910|12331769|FG001|Overall Study|Protocol Violation|1
7849748|NCT01482910|12331768|FG000|Overall Study|Withdrawal by Subject|7
7849749|NCT01482910|12331769|FG001|Overall Study|Withdrawal by Subject|2
7849750|NCT01482910|12331768|FG000|Overall Study|Death|1
7849751|NCT01482910|12331769|FG001|Overall Study|Death|0
7849752|NCT01482962|12331779|FG000|Overall Study|Progressive Disease|65
7849753|NCT01482962|12331780|FG001|Overall Study|Progressive Disease|53
7849754|NCT01482962|12331779|FG000|Overall Study|Unsatisfactory Therapeutic Response|37
7849755|NCT01482962|12331780|FG001|Overall Study|Unsatisfactory Therapeutic Response|23
7849756|NCT01482962|12331779|FG000|Overall Study|Adverse Event|18
7849757|NCT01482962|12331780|FG001|Overall Study|Adverse Event|22
7849758|NCT01482962|12331779|FG000|Overall Study|Withdrawal by Participant|8
7849759|NCT01482962|12331780|FG001|Overall Study|Withdrawal by Participant|13
7849760|NCT01482962|12331779|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3
7849761|NCT01482962|12331780|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9
7849762|NCT01482962|12331779|FG000|Overall Study|Other Reason|1
7849763|NCT01482962|12331780|FG001|Overall Study|Other Reason|5
7849764|NCT01482962|12331779|FG000|Overall Study|Study Terminated by Sponsor|5
7849765|NCT01482962|12331780|FG001|Overall Study|Study Terminated by Sponsor|2
7849766|NCT01482962|12331779|FG000|Overall Study|Did not Receive Study Drug|1
7849767|NCT01482962|12331780|FG001|Overall Study|Did not Receive Study Drug|6
7849768|NCT01483118|12331790|FG000|Overall Study|Lost to Follow-up|12
7849769|NCT01483118|12331791|FG001|Overall Study|Lost to Follow-up|16
7849770|NCT01483144|12331802|FG000|Overall Study|Adverse Event|9
7849771|NCT01483144|12331803|FG001|Overall Study|Adverse Event|4
7849772|NCT01483144|12331804|FG002|Overall Study|Adverse Event|6
7849773|NCT01483144|12331802|FG000|Overall Study|Withdrawal by Subject|0
7849774|NCT01483144|12331803|FG001|Overall Study|Withdrawal by Subject|2
7849775|NCT01483144|12331804|FG002|Overall Study|Withdrawal by Subject|5
7849776|NCT01483144|12331802|FG000|Overall Study|Physician Decision|1
7849777|NCT01483144|12331803|FG001|Overall Study|Physician Decision|0
7849778|NCT01483144|12331804|FG002|Overall Study|Physician Decision|0
7849779|NCT01483144|12331802|FG000|Overall Study|Lost to Follow-up|2
7849780|NCT01483144|12331803|FG001|Overall Study|Lost to Follow-up|4
7849781|NCT01483144|12331804|FG002|Overall Study|Lost to Follow-up|1
7849782|NCT01483144|12331802|FG000|Overall Study|Protocol Violation|3
7849783|NCT01483144|12331803|FG001|Overall Study|Protocol Violation|3
7849784|NCT01483144|12331804|FG002|Overall Study|Protocol Violation|3
7849785|NCT01483183|12331822|FG000|Overall Study|Physician Decision|0
7849786|NCT01483183|12331823|FG001|Overall Study|Physician Decision|0
7849787|NCT01483183|12331824|FG002|Overall Study|Physician Decision|0
7849788|NCT01483183|12331825|FG003|Overall Study|Physician Decision|0
7849789|NCT01483183|12331826|FG004|Overall Study|Physician Decision|0
7849790|NCT01483183|12331827|FG005|Overall Study|Physician Decision|0
7849791|NCT01483183|12331828|FG006|Overall Study|Physician Decision|2
7849792|NCT01483183|12331829|FG007|Overall Study|Physician Decision|0
7849793|NCT01483183|12331830|FG008|Overall Study|Physician Decision|0
7849794|NCT01483183|12331831|FG009|Overall Study|Physician Decision|0
7849795|NCT01483183|12331822|FG000|Overall Study|Withdrawal by Subject|0
7849796|NCT01483183|12331823|FG001|Overall Study|Withdrawal by Subject|0
7849797|NCT01483183|12331824|FG002|Overall Study|Withdrawal by Subject|0
7849798|NCT01483183|12331825|FG003|Overall Study|Withdrawal by Subject|0
7849799|NCT01483183|12331826|FG004|Overall Study|Withdrawal by Subject|0
7849800|NCT01483183|12331827|FG005|Overall Study|Withdrawal by Subject|0
7849801|NCT01483183|12331828|FG006|Overall Study|Withdrawal by Subject|0
7849802|NCT01483183|12331829|FG007|Overall Study|Withdrawal by Subject|0
7849803|NCT01483183|12331830|FG008|Overall Study|Withdrawal by Subject|0
7849804|NCT01483183|12331831|FG009|Overall Study|Withdrawal by Subject|1
7849805|NCT01483599|12331886|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2
7849806|NCT01483599|12331887|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7849807|NCT01483599|12331888|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7849808|NCT01483599|12331889|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1
7849809|NCT01483599|12331890|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1
7849810|NCT01483599|12331891|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4
7849811|NCT01483599|12331892|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3
7849812|NCT01483599|12331893|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7849813|NCT01483599|12331894|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7849814|NCT01483599|12331895|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7849815|NCT01483599|12331896|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7849816|NCT01483599|12331897|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7849817|NCT01483599|12331898|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7849818|NCT01483599|12331899|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7849819|NCT01483599|12331886|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7849820|NCT01483599|12331887|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
7849821|NCT01483599|12331888|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7849822|NCT01483599|12331889|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
7849823|NCT01483599|12331890|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7849824|NCT01483599|12331891|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7849825|NCT01483599|12331892|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
7849826|NCT01483599|12331893|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7849827|NCT01483599|12331894|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7849828|NCT01483599|12331895|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7849829|NCT01483599|12331896|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7849830|NCT01483599|12331897|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7849831|NCT01483599|12331898|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7849832|NCT01483599|12331899|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7849833|NCT01483599|12331886|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
7849834|NCT01483599|12331887|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7849835|NCT01483599|12331888|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7849836|NCT01483599|12331889|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7849837|NCT01483599|12331890|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7849838|NCT01483599|12331891|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7849839|NCT01483599|12331892|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7849840|NCT01483599|12331893|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7849841|NCT01483599|12331894|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7849842|NCT01483599|12331895|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7849843|NCT01483599|12331896|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7849844|NCT01483599|12331897|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7849845|NCT01483599|12331898|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7849846|NCT01483599|12331899|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7849847|NCT01483599|12331886|FG000|Controlled Period (CP) (up to Week 16)|Other|0
7849848|NCT01483599|12331887|FG001|Controlled Period (CP) (up to Week 16)|Other|2
7849849|NCT01483599|12331888|FG002|Controlled Period (CP) (up to Week 16)|Other|0
7849850|NCT01483599|12331889|FG003|Controlled Period (CP) (up to Week 16)|Other|1
7849851|NCT01483599|12331890|FG004|Controlled Period (CP) (up to Week 16)|Other|1
7849852|NCT01483599|12331891|FG005|Controlled Period (CP) (up to Week 16)|Other|0
7849853|NCT01483599|12331892|FG006|Controlled Period (CP) (up to Week 16)|Other|0
7849854|NCT01483599|12331893|FG007|Controlled Period (CP) (up to Week 16)|Other|0
7849855|NCT01483599|12331894|FG008|Controlled Period (CP) (up to Week 16)|Other|0
7849856|NCT01483599|12331895|FG009|Controlled Period (CP) (up to Week 16)|Other|0
7849857|NCT01483599|12331896|FG010|Controlled Period (CP) (up to Week 16)|Other|0
7849858|NCT01483599|12331897|FG011|Controlled Period (CP) (up to Week 16)|Other|0
7849859|NCT01483599|12331898|FG012|Controlled Period (CP) (up to Week 16)|Other|0
7849860|NCT01483599|12331899|FG013|Controlled Period (CP) (up to Week 16)|Other|0
7849861|NCT01483599|12331886|FG000|After Controlled Period(Week 16-Week 40)|Death|0
7849862|NCT01483599|12331887|FG001|After Controlled Period(Week 16-Week 40)|Death|0
7849863|NCT01483599|12331888|FG002|After Controlled Period(Week 16-Week 40)|Death|0
7849864|NCT01483599|12331889|FG003|After Controlled Period(Week 16-Week 40)|Death|0
7849865|NCT01483599|12331890|FG004|After Controlled Period(Week 16-Week 40)|Death|0
7849866|NCT01483599|12331891|FG005|After Controlled Period(Week 16-Week 40)|Death|0
7849867|NCT01483599|12331892|FG006|After Controlled Period(Week 16-Week 40)|Death|0
7849868|NCT01483599|12331893|FG007|After Controlled Period(Week 16-Week 40)|Death|0
7849869|NCT01483599|12331894|FG008|After Controlled Period(Week 16-Week 40)|Death|1
7849870|NCT01483599|12331895|FG009|After Controlled Period(Week 16-Week 40)|Death|0
7849871|NCT01483599|12331896|FG010|After Controlled Period(Week 16-Week 40)|Death|0
7849872|NCT01483599|12331897|FG011|After Controlled Period(Week 16-Week 40)|Death|0
7849873|NCT01483599|12331898|FG012|After Controlled Period(Week 16-Week 40)|Death|0
7849874|NCT01483599|12331899|FG013|After Controlled Period(Week 16-Week 40)|Death|0
7849875|NCT01483599|12331886|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7849876|NCT01483599|12331887|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7849877|NCT01483599|12331888|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7849878|NCT01483599|12331889|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7849879|NCT01483599|12331890|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7849880|NCT01483599|12331891|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7849881|NCT01483599|12331892|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7849882|NCT01483599|12331893|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7849883|NCT01483599|12331894|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7849884|NCT01483599|12331895|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7849885|NCT01483599|12331896|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7849886|NCT01483599|12331897|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7849887|NCT01483599|12331898|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7849888|NCT01483599|12331899|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7849889|NCT01483599|12331886|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7849890|NCT01483599|12331887|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7849891|NCT01483599|12331888|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7849892|NCT01483599|12331889|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7849893|NCT01483599|12331890|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7849894|NCT01483599|12331891|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7849895|NCT01483599|12331892|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7849896|NCT01483599|12331893|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7849897|NCT01483599|12331894|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
7849898|NCT01483599|12331895|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7849899|NCT01483599|12331896|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7849900|NCT01483599|12331897|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
7849901|NCT01483599|12331898|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7849902|NCT01483599|12331899|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
7849903|NCT01483599|12331886|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7849904|NCT01483599|12331887|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7849905|NCT01483599|12331888|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7849906|NCT01483599|12331889|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7849907|NCT01483599|12331890|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7849908|NCT01483599|12331891|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7849909|NCT01483599|12331892|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7849910|NCT01483599|12331893|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7849911|NCT01483599|12331894|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
7849912|NCT01483599|12331895|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7849913|NCT01483599|12331896|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
7849914|NCT01483599|12331897|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7849915|NCT01483599|12331898|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7849916|NCT01483599|12331899|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
7849917|NCT01483599|12331886|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7849918|NCT01483599|12331887|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7849919|NCT01483599|12331888|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7849920|NCT01483599|12331889|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7849921|NCT01483599|12331890|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7849922|NCT01483599|12331891|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7849923|NCT01483599|12331892|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7849924|NCT01483599|12331893|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7849925|NCT01483599|12331894|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
7849926|NCT01483599|12331895|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7849927|NCT01483599|12331896|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7849928|NCT01483599|12331897|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7849929|NCT01483599|12331898|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
7849930|NCT01483599|12331899|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
7849931|NCT01483599|12331886|FG000|After Controlled Period(Week 16-Week 40)|Other|0
7849932|NCT01483599|12331887|FG001|After Controlled Period(Week 16-Week 40)|Other|0
7849933|NCT01483599|12331888|FG002|After Controlled Period(Week 16-Week 40)|Other|0
7849934|NCT01483599|12331889|FG003|After Controlled Period(Week 16-Week 40)|Other|0
7849935|NCT01483599|12331890|FG004|After Controlled Period(Week 16-Week 40)|Other|0
7849936|NCT01483599|12331891|FG005|After Controlled Period(Week 16-Week 40)|Other|0
7849937|NCT01483599|12331892|FG006|After Controlled Period(Week 16-Week 40)|Other|0
7849938|NCT01483599|12331893|FG007|After Controlled Period(Week 16-Week 40)|Other|1
7849939|NCT01483599|12331894|FG008|After Controlled Period(Week 16-Week 40)|Other|0
7849940|NCT01483599|12331895|FG009|After Controlled Period(Week 16-Week 40)|Other|4
7849941|NCT01483599|12331896|FG010|After Controlled Period(Week 16-Week 40)|Other|0
7849942|NCT01483599|12331897|FG011|After Controlled Period(Week 16-Week 40)|Other|0
7849943|NCT01483599|12331898|FG012|After Controlled Period(Week 16-Week 40)|Other|1
7849944|NCT01483599|12331899|FG013|After Controlled Period(Week 16-Week 40)|Other|0
7849945|NCT01483625|12331930|FG000|Overall Study|Adverse Event|1
7849946|NCT01483625|12331931|FG001|Overall Study|Adverse Event|1
7849947|NCT01483625|12331930|FG000|Overall Study|Refused to continue medication|2
7849948|NCT01483625|12331931|FG001|Overall Study|Refused to continue medication|1
7849949|NCT01483625|12331930|FG000|Overall Study|Due to other reason|1
7849950|NCT01483625|12331931|FG001|Overall Study|Due to other reason|0
7849951|NCT01483651|12331937|FG000|Overall Study|Withdrawal by Subject|0
7849952|NCT01483651|12331938|FG001|Overall Study|Withdrawal by Subject|1
7849953|NCT01483651|12331939|FG002|Overall Study|Withdrawal by Subject|1
7849954|NCT01483651|12331940|FG003|Overall Study|Withdrawal by Subject|0
7849955|NCT01483651|12331941|FG004|Overall Study|Withdrawal by Subject|0
7849956|NCT01483651|12331942|FG005|Overall Study|Withdrawal by Subject|1
7849957|NCT01483690|12331952|FG000|Overall Study|Adverse Event|1
7849958|NCT01483690|12331953|FG001|Overall Study|Adverse Event|2
7849959|NCT01483690|12331952|FG000|Overall Study|clinical deterioration|1
7849960|NCT01483690|12331953|FG001|Overall Study|clinical deterioration|0
7849961|NCT01483690|12331952|FG000|Overall Study|Physician Decision|0
7849962|NCT01483690|12331953|FG001|Overall Study|Physician Decision|2
7849963|NCT01483690|12331952|FG000|Overall Study|exclusionary procedure|0
7849964|NCT01483690|12331953|FG001|Overall Study|exclusionary procedure|1
7849965|NCT01483924|12331973|FG000|Overall Study|Withdrawal by Subject|2
7849966|NCT01483924|12331974|FG001|Overall Study|Withdrawal by Subject|0
7849967|NCT01483924|12331975|FG002|Overall Study|Withdrawal by Subject|0
7849968|NCT01483924|12331976|FG003|Overall Study|Withdrawal by Subject|1
7849969|NCT01483924|12331977|FG004|Overall Study|Withdrawal by Subject|1
7849970|NCT01483924|12331973|FG000|Overall Study|Adverse Event|0
7849971|NCT01483924|12331974|FG001|Overall Study|Adverse Event|0
7849972|NCT01483924|12331975|FG002|Overall Study|Adverse Event|1
7849973|NCT01483924|12331976|FG003|Overall Study|Adverse Event|1
7849974|NCT01483924|12331977|FG004|Overall Study|Adverse Event|0
7849975|NCT01483924|12331973|FG000|Overall Study|Non-compliance|0
7849976|NCT01483924|12331974|FG001|Overall Study|Non-compliance|0
7849977|NCT01483924|12331975|FG002|Overall Study|Non-compliance|0
7849978|NCT01483924|12331976|FG003|Overall Study|Non-compliance|1
7849979|NCT01483924|12331977|FG004|Overall Study|Non-compliance|1
7849980|NCT01483924|12331973|FG000|Overall Study|Sponsor concern over ECG result|0
7849981|NCT01483924|12331974|FG001|Overall Study|Sponsor concern over ECG result|0
7849982|NCT01483924|12331975|FG002|Overall Study|Sponsor concern over ECG result|0
7849983|NCT01483924|12331976|FG003|Overall Study|Sponsor concern over ECG result|1
7849984|NCT01483924|12331977|FG004|Overall Study|Sponsor concern over ECG result|0
7849985|NCT01483937|12332000|FG000|Overall Study|Withdrawal by Subject|4
7849986|NCT01483937|12332001|FG001|Overall Study|Withdrawal by Subject|3
7849987|NCT01484028|12332032|FG000|Period 1|Lost to Follow-up|0
7849988|NCT01484028|12332033|FG001|Period 1|Lost to Follow-up|1
7849989|NCT01484028|12332034|FG002|Period 1|Lost to Follow-up|0
7849990|NCT01484028|12332035|FG003|Period 1|Lost to Follow-up|0
7849991|NCT01484028|12332032|FG000|Period 1|Non-Compliance to Protocol|0
7849992|NCT01484028|12332033|FG001|Period 1|Non-Compliance to Protocol|1
7849993|NCT01484028|12332034|FG002|Period 1|Non-Compliance to Protocol|0
7849994|NCT01484028|12332035|FG003|Period 1|Non-Compliance to Protocol|1
7849995|NCT01484028|12332032|FG000|Period 1|Lens Discomfort|0
7849996|NCT01484028|12332033|FG001|Period 1|Lens Discomfort|1
7849997|NCT01484028|12332034|FG002|Period 1|Lens Discomfort|0
7849998|NCT01484028|12332035|FG003|Period 1|Lens Discomfort|0
7849999|NCT01484054|12332047|FG000|Period 1|Withdrawal by Subject|0
7850000|NCT01484054|12332048|FG001|Period 1|Withdrawal by Subject|1
7850001|NCT01484132|12332055|FG000|Overall Study|Lost to Follow-up|8
7850002|NCT01484132|12332055|FG000|Overall Study|Difficulty with time commitment|2
7850003|NCT01484132|12332055|FG000|Overall Study|Ineligible|1
7850004|NCT01484132|12332055|FG000|Overall Study|No pre-treatment urine sample collected|1
7850005|NCT01484132|12332055|FG000|Overall Study|No post-treatment urine sample collected|10
7850006|NCT01484197|12332059|FG000|Treatment Period 1|Adverse Event|1
7850007|NCT01484197|12332060|FG001|Treatment Period 1|Adverse Event|0
7850008|NCT01484197|12332061|FG002|Treatment Period 1|Adverse Event|0
7850009|NCT01484197|12332062|FG003|Treatment Period 1|Adverse Event|0
7850010|NCT01484197|12332059|FG000|Treatment Period 2|Subject withdrew consent|0
7850011|NCT01484197|12332060|FG001|Treatment Period 2|Subject withdrew consent|0
7850012|NCT01484197|12332061|FG002|Treatment Period 2|Subject withdrew consent|0
7850013|NCT01484197|12332062|FG003|Treatment Period 2|Subject withdrew consent|1
7850014|NCT01484275|12332074|FG000|Overall Study|Study terminated by sponsor|28
7850015|NCT01484275|12332075|FG001|Overall Study|Study terminated by sponsor|32
7850016|NCT01484275|12332074|FG000|Overall Study|Other|10
7850017|NCT01484275|12332075|FG001|Overall Study|Other|0
7850018|NCT01484275|12332074|FG000|Overall Study|Death|3
7850019|NCT01484275|12332075|FG001|Overall Study|Death|4
7850020|NCT01484275|12332074|FG000|Overall Study|Withdrawal by Subject|1
7850021|NCT01484275|12332075|FG001|Overall Study|Withdrawal by Subject|5
7949335|NCT02535741|12494833|FG000|Overall Study|Missing data|6
7949336|NCT02536313|12494898|FG000|Overall Study|Lack of Efficacy|0
7949337|NCT02536313|12494899|FG001|Overall Study|Lack of Efficacy|1
7949338|NCT02536378|12494909|FG000|Overall Study|Physician Decision|0
7949339|NCT02536378|12494910|FG001|Overall Study|Physician Decision|2
7949340|NCT02536378|12494909|FG000|Overall Study|Withdrawal by Subject|0
7949341|NCT02536378|12494910|FG001|Overall Study|Withdrawal by Subject|1
7949342|NCT02536378|12494909|FG000|Overall Study|Death|1
7949343|NCT02536378|12494910|FG001|Overall Study|Death|2
7949344|NCT02536378|12494909|FG000|Overall Study|Patient refused further follow up|6
7949345|NCT02536378|12494910|FG001|Overall Study|Patient refused further follow up|2
7949346|NCT02536404|12494920|FG000|Overall Study|Adverse Event|5
7949347|NCT02536404|12494921|FG001|Overall Study|Adverse Event|0
7850022|NCT01484275|12332074|FG000|Overall Study|Lost to Follow-up|1
7850023|NCT01484275|12332075|FG001|Overall Study|Lost to Follow-up|1
7850024|NCT01484431|12332097|FG000|Period 1: High Dose|Physician Decision|0
7850025|NCT01484431|12332098|FG001|Period 1: High Dose|Physician Decision|1
7850026|NCT01484431|12332099|FG002|Period 1: High Dose|Physician Decision|0
7850027|NCT01484431|12332097|FG000|Period 2|Death|0
7850028|NCT01484431|12332098|FG001|Period 2|Death|1
7850029|NCT01484431|12332099|FG002|Period 2|Death|1
7850030|NCT01484431|12332097|FG000|Period 2|Physician Decision|0
7850031|NCT01484431|12332098|FG001|Period 2|Physician Decision|0
7949348|NCT02536404|12494920|FG000|Overall Study|Withdrawal by Subject|4
7949349|NCT02536404|12494921|FG001|Overall Study|Withdrawal by Subject|1
7949350|NCT02536404|12494920|FG000|Overall Study|Physician Decision|10
7949351|NCT02536404|12494921|FG001|Overall Study|Physician Decision|0
7949352|NCT02536404|12494920|FG000|Overall Study|Sponsor decision|1
7949353|NCT02536404|12494921|FG001|Overall Study|Sponsor decision|0
7850032|NCT01484431|12332099|FG002|Period 2|Physician Decision|1
7850033|NCT01484431|12332097|FG000|Period 2|Non-Compliance with Study Drug|1
7850034|NCT01484431|12332098|FG001|Period 2|Non-Compliance with Study Drug|0
7850035|NCT01484431|12332099|FG002|Period 2|Non-Compliance with Study Drug|0
7850036|NCT01484496|12332114|FG000|Period 1|Protocol Violation|3
7850037|NCT01484496|12332115|FG001|Period 1|Protocol Violation|4
7850038|NCT01484496|12332116|FG002|Period 1|Protocol Violation|0
7850039|NCT01484496|12332117|FG003|Period 1|Protocol Violation|0
7850040|NCT01484496|12332114|FG000|Period 1|Physician Decision|5
7850041|NCT01484496|12332115|FG001|Period 1|Physician Decision|1
7850042|NCT01484496|12332116|FG002|Period 1|Physician Decision|0
7850043|NCT01484496|12332117|FG003|Period 1|Physician Decision|0
7850044|NCT01484496|12332114|FG000|Period 1|Lack of Efficacy|10
7850045|NCT01484496|12332115|FG001|Period 1|Lack of Efficacy|15
7850046|NCT01484496|12332116|FG002|Period 1|Lack of Efficacy|0
7850047|NCT01484496|12332117|FG003|Period 1|Lack of Efficacy|0
7850048|NCT01484496|12332114|FG000|Period 1|Adverse Event|25
7850049|NCT01484496|12332115|FG001|Period 1|Adverse Event|40
7850050|NCT01484496|12332116|FG002|Period 1|Adverse Event|0
7850051|NCT01484496|12332117|FG003|Period 1|Adverse Event|0
7850052|NCT01484496|12332114|FG000|Period 1|Withdrawal by Subject|15
7850053|NCT01484496|12332115|FG001|Period 1|Withdrawal by Subject|12
7850054|NCT01484496|12332116|FG002|Period 1|Withdrawal by Subject|0
7850055|NCT01484496|12332117|FG003|Period 1|Withdrawal by Subject|0
7850056|NCT01484496|12332114|FG000|Period 1|Lost to Follow-up|2
7850057|NCT01484496|12332115|FG001|Period 1|Lost to Follow-up|6
7850058|NCT01484496|12332116|FG002|Period 1|Lost to Follow-up|0
7850059|NCT01484496|12332117|FG003|Period 1|Lost to Follow-up|0
7850060|NCT01484496|12332114|FG000|Period 1|Positive Pregnancy|1
7850061|NCT01484496|12332115|FG001|Period 1|Positive Pregnancy|6
7850062|NCT01484496|12332116|FG002|Period 1|Positive Pregnancy|0
7850063|NCT01484496|12332117|FG003|Period 1|Positive Pregnancy|0
7850064|NCT01484496|12332114|FG000|Period 1|Treatment Failure|3
7850065|NCT01484496|12332115|FG001|Period 1|Treatment Failure|6
7850066|NCT01484496|12332116|FG002|Period 1|Treatment Failure|0
7850067|NCT01484496|12332117|FG003|Period 1|Treatment Failure|0
7850068|NCT01484496|12332114|FG000|Period 1|Lack of Compliance|2
7850069|NCT01484496|12332115|FG001|Period 1|Lack of Compliance|1
7850070|NCT01484496|12332116|FG002|Period 1|Lack of Compliance|0
7850071|NCT01484496|12332117|FG003|Period 1|Lack of Compliance|0
7850072|NCT01484496|12332114|FG000|Period 1|Unable to Visit Site|0
7850073|NCT01484496|12332115|FG001|Period 1|Unable to Visit Site|2
7850074|NCT01484496|12332116|FG002|Period 1|Unable to Visit Site|0
7850075|NCT01484496|12332117|FG003|Period 1|Unable to Visit Site|0
7850076|NCT01484496|12332114|FG000|Period 2|Lack of Efficacy|0
7850077|NCT01484496|12332115|FG001|Period 2|Lack of Efficacy|0
7850078|NCT01484496|12332116|FG002|Period 2|Lack of Efficacy|1
7850079|NCT01484496|12332117|FG003|Period 2|Lack of Efficacy|3
7850080|NCT01484496|12332114|FG000|Period 2|Adverse Event|0
7850081|NCT01484496|12332115|FG001|Period 2|Adverse Event|0
7850082|NCT01484496|12332116|FG002|Period 2|Adverse Event|5
7850083|NCT01484496|12332117|FG003|Period 2|Adverse Event|13
7850084|NCT01484496|12332114|FG000|Period 2|Other|0
7850085|NCT01484496|12332115|FG001|Period 2|Other|0
7850086|NCT01484496|12332116|FG002|Period 2|Other|9
7850087|NCT01484496|12332117|FG003|Period 2|Other|6
7850088|NCT01484561|12332127|FG000|Overall Study|Lack of Efficacy|3
7850089|NCT01484561|12332128|FG001|Overall Study|Lack of Efficacy|1
7850090|NCT01484561|12332127|FG000|Overall Study|Lost to Follow-up|1
7850091|NCT01484561|12332128|FG001|Overall Study|Lost to Follow-up|0
7850092|NCT01484561|12332127|FG000|Overall Study|Withdrawal by Subject|3
7850093|NCT01484561|12332128|FG001|Overall Study|Withdrawal by Subject|0
7850094|NCT01484561|12332127|FG000|Overall Study|Other|1
7850095|NCT01484561|12332128|FG001|Overall Study|Other|1
7850096|NCT01484561|12332127|FG000|Overall Study|Adverse Event|1
7850097|NCT01484561|12332128|FG001|Overall Study|Adverse Event|4
7850098|NCT01484834|12332151|FG000|Overall Study|Lost to Follow-up|5
7850099|NCT01484834|12332152|FG001|Overall Study|Lost to Follow-up|8
7850100|NCT01484834|12332153|FG002|Overall Study|Lost to Follow-up|1
7850101|NCT01484834|12332154|FG003|Overall Study|Lost to Follow-up|4
7850102|NCT01484873|12332164|FG000|Overall Study|Withdrawal by Subject|2
7850103|NCT01484912|12332171|FG000|Overall Study|Withdrawal by Subject|1
7850104|NCT01484912|12332172|FG001|Overall Study|Withdrawal by Subject|0
7850105|NCT01484912|12332171|FG000|Overall Study|Physician Decision|0
7850106|NCT01484912|12332172|FG001|Overall Study|Physician Decision|1
7850107|NCT01484938|12332178|FG000|Overall Study|Adverse Event|2
7850108|NCT01484938|12332178|FG000|Overall Study|Lost to Follow-up|1
7850109|NCT01484938|12332178|FG000|Overall Study|Noncompliance|1
7863391|NCT01605396|12352626|FG001|Overall Study|Withdrawal by Subject|2
7863392|NCT01605396|12352625|FG000|Overall Study|Transfer Off Study|4
7863393|NCT01605396|12352626|FG001|Overall Study|Transfer Off Study|5
7863394|NCT01605461|12352650|FG000|Overall Study|Lost to Follow-up|3
7863395|NCT01605461|12352650|FG000|Overall Study|Withdrawal by Subject|1
7863396|NCT01605799|12352683|FG000|Overall Study|Withdrawal by Subject|2
7863397|NCT01605799|12352684|FG001|Overall Study|Withdrawal by Subject|1
7863398|NCT01605825|12352692|FG000|Overall Study|Adverse Event|4
7863399|NCT01605825|12352693|FG001|Overall Study|Adverse Event|2
7863400|NCT01605825|12352692|FG000|Overall Study|Withdrawal by Subject|0
7863401|NCT01605825|12352693|FG001|Overall Study|Withdrawal by Subject|1
7863402|NCT01605825|12352692|FG000|Overall Study|Non-Compliance -Investigational Drug|3
7863403|NCT01605825|12352693|FG001|Overall Study|Non-Compliance -Investigational Drug|0
7863404|NCT01605825|12352692|FG000|Overall Study|Non-Compliance with Protocol|3
7863405|NCT01605825|12352693|FG001|Overall Study|Non-Compliance with Protocol|0
7863406|NCT01605877|12352699|FG000|Overall Study|Withdrawal by Subject|1
7863407|NCT01605916|12352739|FG000|Overall Study|Adverse Event|1
7863408|NCT01605916|12352740|FG001|Overall Study|Adverse Event|0
7863409|NCT01605916|12352741|FG002|Overall Study|Adverse Event|0
7863410|NCT01605916|12352742|FG003|Overall Study|Adverse Event|1
7863411|NCT01605916|12352743|FG004|Overall Study|Adverse Event|0
7863412|NCT01605916|12352739|FG000|Overall Study|Lack of Efficacy|2
7863413|NCT01605916|12352740|FG001|Overall Study|Lack of Efficacy|3
7863414|NCT01605916|12352741|FG002|Overall Study|Lack of Efficacy|3
7863415|NCT01605916|12352742|FG003|Overall Study|Lack of Efficacy|5
7863416|NCT01605916|12352743|FG004|Overall Study|Lack of Efficacy|4
7863417|NCT01605916|12352739|FG000|Overall Study|Withdrawal by Subject|1
7863418|NCT01605916|12352740|FG001|Overall Study|Withdrawal by Subject|1
7863419|NCT01605916|12352741|FG002|Overall Study|Withdrawal by Subject|0
7863420|NCT01605916|12352742|FG003|Overall Study|Withdrawal by Subject|0
7863421|NCT01605916|12352743|FG004|Overall Study|Withdrawal by Subject|2
7863422|NCT01606007|12352768|FG000|Overall Study|Reason 'Other' in the protocol|0
7863423|NCT01606007|12352769|FG001|Overall Study|Reason 'Other' in the protocol|1
7863424|NCT01606007|12352770|FG002|Overall Study|Reason 'Other' in the protocol|1
7863425|NCT01606007|12352768|FG000|Overall Study|Pregnancy|0
7863426|NCT01606007|12352769|FG001|Overall Study|Pregnancy|1
7863427|NCT01606007|12352770|FG002|Overall Study|Pregnancy|1
7863428|NCT01606007|12352768|FG000|Overall Study|Withdrawal by Subject|8
7863429|NCT01606007|12352769|FG001|Overall Study|Withdrawal by Subject|6
7863430|NCT01606007|12352770|FG002|Overall Study|Withdrawal by Subject|1
7863431|NCT01606007|12352768|FG000|Overall Study|Adverse Event|0
7863432|NCT01606007|12352769|FG001|Overall Study|Adverse Event|1
7863433|NCT01606007|12352770|FG002|Overall Study|Adverse Event|1
7863434|NCT01606007|12352768|FG000|Overall Study|discontinue study treatment|0
7863435|NCT01606007|12352769|FG001|Overall Study|discontinue study treatment|2
7863436|NCT01606007|12352770|FG002|Overall Study|discontinue study treatment|1
7863437|NCT01606007|12352768|FG000|Overall Study|Lost to Follow-up|6
7863438|NCT01606007|12352769|FG001|Overall Study|Lost to Follow-up|8
7863439|NCT01606007|12352770|FG002|Overall Study|Lost to Follow-up|5
7863440|NCT01606007|12352768|FG000|Overall Study|Poor/Non-compliance|1
7863441|NCT01606007|12352769|FG001|Overall Study|Poor/Non-compliance|0
7863442|NCT01606007|12352770|FG002|Overall Study|Poor/Non-compliance|0
7863443|NCT01606137|12352787|FG000|Overall Study|Adverse Event|85
7863444|NCT01606137|12352787|FG000|Overall Study|Withdrawal by Subject|74
7863445|NCT01606137|12352787|FG000|Overall Study|Lack of Efficacy|56
7863446|NCT01606137|12352787|FG000|Overall Study|Lost to Follow-up|15
7863447|NCT01606137|12352787|FG000|Overall Study|Protocol Violation|1
7863448|NCT01606137|12352787|FG000|Overall Study|Patient non-compliance|9
7863449|NCT01606137|12352787|FG000|Overall Study|Death|1
7863450|NCT01606137|12352787|FG000|Overall Study|Decreased/no pain|4
7863451|NCT01606137|12352787|FG000|Overall Study|Issues with driving|4
7863452|NCT01606137|12352787|FG000|Overall Study|multiple sclerosis less stable|1
7863453|NCT01606137|12352787|FG000|Overall Study|Increased bilirubin|1
7863454|NCT01606137|12352787|FG000|Overall Study|Spray causes nausea|1
7863455|NCT01606137|12352787|FG000|Overall Study|Not enough improvement|4
7949354|NCT02536508|12494930|FG000|Overall Study|Withdrawal by Subject|18
7850110|NCT01484951|12332182|FG000|Overall Study|Adverse Event|3
7850111|NCT01484951|12332182|FG000|Overall Study|Personal Reasons|1
7850112|NCT01484951|12332182|FG000|Overall Study|Non-Compliance|1
7850113|NCT01484977|12332186|FG000|Overall Study|Adverse Event|8
7850114|NCT01484977|12332186|FG000|Overall Study|Lack of Efficacy|4
7850115|NCT01484977|12332186|FG000|Overall Study|Protocol Violation|6
7850116|NCT01484977|12332186|FG000|Overall Study|Lost to Follow-up|1
7850117|NCT01484977|12332186|FG000|Overall Study|Withdrawal by Subject|4
7850118|NCT01484977|12332186|FG000|Overall Study|Subject Protocol Non-compliant|1
7850119|NCT01484977|12332186|FG000|Overall Study|Moving Overseas|1
7850120|NCT01484977|12332186|FG000|Overall Study|Low White Blood Cell Count|1
7850121|NCT01484977|12332186|FG000|Overall Study|Lack of Compliance|1
7850122|NCT01485094|12332197|FG000|Overall Study|Adverse Event|1
7850123|NCT01485094|12332198|FG001|Overall Study|Adverse Event|1
7850124|NCT01485094|12332199|FG002|Overall Study|Adverse Event|1
7850125|NCT01485094|12332197|FG000|Overall Study|Lost to Follow-up|1
7850126|NCT01485094|12332198|FG001|Overall Study|Lost to Follow-up|0
7850127|NCT01485094|12332199|FG002|Overall Study|Lost to Follow-up|0
7850128|NCT01485094|12332197|FG000|Overall Study|Withdrawal by Subject|1
7850129|NCT01485094|12332198|FG001|Overall Study|Withdrawal by Subject|1
7850130|NCT01485094|12332199|FG002|Overall Study|Withdrawal by Subject|0
7850131|NCT01485120|12332207|FG000|Overall Study|Withdrawal by Subject|2
7850132|NCT01485172|12332218|FG000|Overall Study|Adverse Event|2
7850133|NCT01485172|12332219|FG001|Overall Study|Adverse Event|1
7850134|NCT01485172|12332220|FG002|Overall Study|Adverse Event|2
7850135|NCT01485172|12332221|FG003|Overall Study|Adverse Event|2
7850136|NCT01485172|12332222|FG004|Overall Study|Adverse Event|1
7850137|NCT01485172|12332223|FG005|Overall Study|Adverse Event|2
7850138|NCT01485172|12332218|FG000|Overall Study|Lack of Efficacy|2
7850139|NCT01485172|12332219|FG001|Overall Study|Lack of Efficacy|0
7850140|NCT01485172|12332220|FG002|Overall Study|Lack of Efficacy|0
7850141|NCT01485172|12332221|FG003|Overall Study|Lack of Efficacy|0
7850142|NCT01485172|12332222|FG004|Overall Study|Lack of Efficacy|0
7850143|NCT01485172|12332223|FG005|Overall Study|Lack of Efficacy|0
7850144|NCT01485172|12332218|FG000|Overall Study|Protocol Violation|0
7850145|NCT01485172|12332219|FG001|Overall Study|Protocol Violation|0
7850146|NCT01485172|12332220|FG002|Overall Study|Protocol Violation|4
7850147|NCT01485172|12332221|FG003|Overall Study|Protocol Violation|5
7850148|NCT01485172|12332222|FG004|Overall Study|Protocol Violation|1
7850149|NCT01485172|12332223|FG005|Overall Study|Protocol Violation|0
7850150|NCT01485172|12332218|FG000|Overall Study|Protocol defined stopping criteria|1
7850151|NCT01485172|12332219|FG001|Overall Study|Protocol defined stopping criteria|0
7850152|NCT01485172|12332220|FG002|Overall Study|Protocol defined stopping criteria|0
7850153|NCT01485172|12332221|FG003|Overall Study|Protocol defined stopping criteria|0
7850154|NCT01485172|12332222|FG004|Overall Study|Protocol defined stopping criteria|1
7850155|NCT01485172|12332223|FG005|Overall Study|Protocol defined stopping criteria|0
7850156|NCT01485172|12332218|FG000|Overall Study|Lost to Follow-up|0
7850157|NCT01485172|12332219|FG001|Overall Study|Lost to Follow-up|0
7850158|NCT01485172|12332220|FG002|Overall Study|Lost to Follow-up|1
7850159|NCT01485172|12332221|FG003|Overall Study|Lost to Follow-up|0
7850160|NCT01485172|12332222|FG004|Overall Study|Lost to Follow-up|0
7850161|NCT01485172|12332223|FG005|Overall Study|Lost to Follow-up|1
7850162|NCT01485172|12332218|FG000|Overall Study|Physician Decision|0
7850163|NCT01485172|12332219|FG001|Overall Study|Physician Decision|0
7850164|NCT01485172|12332220|FG002|Overall Study|Physician Decision|0
7850165|NCT01485172|12332221|FG003|Overall Study|Physician Decision|0
7850166|NCT01485172|12332222|FG004|Overall Study|Physician Decision|1
7850167|NCT01485172|12332223|FG005|Overall Study|Physician Decision|0
7850168|NCT01485172|12332218|FG000|Overall Study|Withdrawal by Subject|2
7850169|NCT01485172|12332219|FG001|Overall Study|Withdrawal by Subject|0
7850170|NCT01485172|12332220|FG002|Overall Study|Withdrawal by Subject|0
7850171|NCT01485172|12332221|FG003|Overall Study|Withdrawal by Subject|1
7850172|NCT01485172|12332222|FG004|Overall Study|Withdrawal by Subject|1
7850173|NCT01485172|12332223|FG005|Overall Study|Withdrawal by Subject|1
7850174|NCT01485354|12332237|FG000|Overall Study|Withdrawal by Subject|5
7850175|NCT01485536|12332253|FG000|Overall Study|Withdrawal by Subject|3
7850176|NCT01485536|12332253|FG000|Overall Study|Adverse Event|1
7850177|NCT01485627|12332274|FG000|Overall Study|Patient withdrew|6
7850178|NCT01485627|12332275|FG001|Overall Study|Patient withdrew|5
7850179|NCT01485627|12332274|FG000|Overall Study|Patient died|3
7850180|NCT01485627|12332275|FG001|Overall Study|Patient died|1
7850181|NCT01485627|12332274|FG000|Overall Study|Patient lost to followup|0
7850182|NCT01485627|12332275|FG001|Overall Study|Patient lost to followup|1
7850183|NCT01485627|12332274|FG000|Overall Study|Caregiver withdrew|3
7850184|NCT01485627|12332275|FG001|Overall Study|Caregiver withdrew|3
7850185|NCT01485627|12332274|FG000|Overall Study|Caregiver lost to follow up|11
7850186|NCT01485627|12332275|FG001|Overall Study|Caregiver lost to follow up|12
7850187|NCT01485627|12332274|FG000|Overall Study|Caregiver died|1
7850188|NCT01485627|12332275|FG001|Overall Study|Caregiver died|0
7850189|NCT01485627|12332274|FG000|Overall Study|caregiver was not bereaved|42
7850190|NCT01485627|12332275|FG001|Overall Study|caregiver was not bereaved|35
7850191|NCT01485640|12332285|FG000|Overall Study|Adverse Event|10
7850192|NCT01485640|12332285|FG000|Overall Study|Lack of Efficacy|2
7850193|NCT01485640|12332285|FG000|Overall Study|Protocol Violation|1
7850194|NCT01485640|12332285|FG000|Overall Study|Withdrawal by Subject|14
7850195|NCT01485640|12332285|FG000|Overall Study|Terminated by Sponsor|95
7850196|NCT01485796|12332300|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
7850197|NCT01485796|12332300|FG000|Period 2: Epoch 2|Withdrawal by Subject|6
7850198|NCT01485796|12332300|FG000|Period 2: Epoch 2|Adverse Event|3
7850199|NCT01485796|12332300|FG000|Period 2: Epoch 2|Switch to safety follow-up|26
7850200|NCT01485796|12332300|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
7850201|NCT01485796|12332300|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
7850202|NCT01485796|12332300|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
7850203|NCT01485796|12332300|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
7850204|NCT01485887|12332308|FG000|Overall Study|Withdrawal by Subject|2
7850205|NCT01485887|12332308|FG000|Overall Study|Adverse Event|8
7850206|NCT01485887|12332308|FG000|Overall Study|Deterioration of primary disease|1
7850207|NCT01485887|12332308|FG000|Overall Study|Primary disease markedly improved|1
7850208|NCT01485991|12332314|FG000|Overall Study|Adverse Event|0
7850209|NCT01485991|12332315|FG001|Overall Study|Adverse Event|4
7850210|NCT01485991|12332314|FG000|Overall Study|Lost to Follow-up|13
7850211|NCT01485991|12332315|FG001|Overall Study|Lost to Follow-up|10
7850212|NCT01485991|12332314|FG000|Overall Study|Withdrawal by Subject|13
7850213|NCT01485991|12332315|FG001|Overall Study|Withdrawal by Subject|20
7850214|NCT01485991|12332314|FG000|Overall Study|randomized but not treated|6
7850215|NCT01485991|12332315|FG001|Overall Study|randomized but not treated|2
7850216|NCT01486199|12332327|FG000|Two Year Period Between Study Days|Physician Decision|1
7850217|NCT01486199|12332328|FG001|Two Year Period Between Study Days|Physician Decision|0
7850218|NCT01486238|12332336|FG000|Overall Study|Death|0
7949355|NCT02536508|12494931|FG001|Overall Study|Withdrawal by Subject|13
7850219|NCT01486238|12332337|FG001|Overall Study|Death|2
7850220|NCT01486238|12332336|FG000|Overall Study|Withdrawal by Subject|2
7850221|NCT01486238|12332337|FG001|Overall Study|Withdrawal by Subject|1
7850222|NCT01486238|12332336|FG000|Overall Study|Lost to Follow-up|0
7850223|NCT01486238|12332337|FG001|Overall Study|Lost to Follow-up|3
7850224|NCT01486316|12332346|FG000|Overall Study|Device explanted with/without re-implant|3
7850225|NCT01486316|12332347|FG001|Overall Study|Device explanted with/without re-implant|2
7850226|NCT01486316|12332348|FG002|Overall Study|Device explanted with/without re-implant|0
7850227|NCT01486316|12332349|FG003|Overall Study|Device explanted with/without re-implant|2
7850228|NCT01486316|12332346|FG000|Overall Study|Not meeting eligibility criteria|0
7850229|NCT01486316|12332347|FG001|Overall Study|Not meeting eligibility criteria|0
7850230|NCT01486316|12332348|FG002|Overall Study|Not meeting eligibility criteria|1
7850231|NCT01486316|12332349|FG003|Overall Study|Not meeting eligibility criteria|0
7850232|NCT01486316|12332346|FG000|Overall Study|Withdrawal by Subject|1
7850233|NCT01486316|12332347|FG001|Overall Study|Withdrawal by Subject|0
7850234|NCT01486316|12332348|FG002|Overall Study|Withdrawal by Subject|3
7850235|NCT01486316|12332349|FG003|Overall Study|Withdrawal by Subject|0
7850236|NCT01486316|12332346|FG000|Overall Study|Physician Decision|0
7850237|NCT01486316|12332347|FG001|Overall Study|Physician Decision|0
7850238|NCT01486316|12332348|FG002|Overall Study|Physician Decision|1
7850239|NCT01486316|12332349|FG003|Overall Study|Physician Decision|0
7850240|NCT01486316|12332346|FG000|Overall Study|Death|0
7850241|NCT01486316|12332347|FG001|Overall Study|Death|1
7850242|NCT01486316|12332348|FG002|Overall Study|Death|0
7850243|NCT01486316|12332349|FG003|Overall Study|Death|0
7850244|NCT01486446|12332360|FG000|Overall Study|Adverse Event|1
7850245|NCT01486446|12332361|FG001|Overall Study|Adverse Event|0
7850246|NCT01486758|12332386|FG000|Overall Study|Lost to Follow-up|0
7850247|NCT01486758|12332387|FG001|Overall Study|Lost to Follow-up|1
7850248|NCT01486784|12332400|FG000|Overall Study|Withdrawal by Subject|0
7850249|NCT01486784|12332401|FG001|Overall Study|Withdrawal by Subject|0
7850250|NCT01486784|12332402|FG002|Overall Study|Withdrawal by Subject|1
7850251|NCT01486784|12332403|FG003|Overall Study|Withdrawal by Subject|0
7850252|NCT01486784|12332404|FG004|Overall Study|Withdrawal by Subject|1
7850253|NCT01486784|12332405|FG005|Overall Study|Withdrawal by Subject|2
7850254|NCT01486784|12332400|FG000|Overall Study|Subject did not meet entry criteria|0
7850255|NCT01486784|12332401|FG001|Overall Study|Subject did not meet entry criteria|0
7850256|NCT01486784|12332402|FG002|Overall Study|Subject did not meet entry criteria|0
7850257|NCT01486784|12332403|FG003|Overall Study|Subject did not meet entry criteria|0
7850258|NCT01486784|12332404|FG004|Overall Study|Subject did not meet entry criteria|1
7850259|NCT01486784|12332405|FG005|Overall Study|Subject did not meet entry criteria|0
7850260|NCT01486784|12332400|FG000|Overall Study|Death|0
7850261|NCT01486784|12332401|FG001|Overall Study|Death|0
7850262|NCT01486784|12332402|FG002|Overall Study|Death|0
7850263|NCT01486784|12332403|FG003|Overall Study|Death|0
7850264|NCT01486784|12332404|FG004|Overall Study|Death|0
7850265|NCT01486784|12332405|FG005|Overall Study|Death|1
7850266|NCT01486927|12332423|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1
7850267|NCT01486927|12332423|FG000|Overall Study|Physician Decision|1
7850268|NCT01486927|12332423|FG000|Overall Study|50 Exposure days not reached|2
7850269|NCT01486927|12332423|FG000|Overall Study|Withdrawal by Subject|8
7850270|NCT01486927|12332423|FG000|Overall Study|Subject did not reach 6 mo of treatment|1
7850271|NCT01486966|12332436|FG000|Overall Study|Adverse Event|0
7850272|NCT01486966|12332437|FG001|Overall Study|Adverse Event|1
7850273|NCT01486966|12332436|FG000|Overall Study|Withdrawal by Subject|0
7850274|NCT01486966|12332437|FG001|Overall Study|Withdrawal by Subject|1
7850275|NCT01487161|12332447|FG000|Overall Study|Adverse Event|1
7850276|NCT01487161|12332448|FG001|Overall Study|Adverse Event|0
7850277|NCT01487161|12332449|FG002|Overall Study|Adverse Event|0
7850278|NCT01487161|12332450|FG003|Overall Study|Adverse Event|0
7850279|NCT01487161|12332447|FG000|Overall Study|Withdrawal by Subject|1
7850280|NCT01487161|12332448|FG001|Overall Study|Withdrawal by Subject|1
7850281|NCT01487161|12332449|FG002|Overall Study|Withdrawal by Subject|1
7850282|NCT01487161|12332450|FG003|Overall Study|Withdrawal by Subject|2
7850283|NCT01487161|12332447|FG000|Overall Study|missing data|0
7850284|NCT01487161|12332448|FG001|Overall Study|missing data|1
7850285|NCT01487161|12332449|FG002|Overall Study|missing data|0
7850286|NCT01487161|12332450|FG003|Overall Study|missing data|0
7850287|NCT01487200|12332469|FG000|Overall Study|Withdrawal by Subject|0
7850288|NCT01487200|12332470|FG001|Overall Study|Withdrawal by Subject|1
7850289|NCT01487200|12332471|FG002|Overall Study|Withdrawal by Subject|0
7850290|NCT01487200|12332472|FG003|Overall Study|Withdrawal by Subject|0
7850291|NCT01487265|12332483|FG000|Overall Study|Adverse Event|8
7850292|NCT01487265|12332483|FG000|Overall Study|Withdrawal by Subject|5
7850293|NCT01487265|12332483|FG000|Overall Study|Disease Progression|21
7850294|NCT01487265|12332483|FG000|Overall Study|Death|2
7850295|NCT01487265|12332483|FG000|Overall Study|Still on Treatment|1
7850296|NCT01487525|12332489|FG000|Overall Study|Withdrawal by Subject|0
7850297|NCT01487525|12332490|FG001|Overall Study|Withdrawal by Subject|1
7850298|NCT01487577|12332496|FG000|Overall Study|Became ineligible after signing consent|1
7850299|NCT01487863|12332513|FG000|Overall Study|Death|19
7850300|NCT01487863|12332514|FG001|Overall Study|Death|19
7850301|NCT01488071|12332542|FG000|Overall Study|Adverse Event|15
7850302|NCT01488071|12332543|FG001|Overall Study|Adverse Event|23
7850303|NCT01488071|12332542|FG000|Overall Study|Lack of Efficacy|11
7850304|NCT01488071|12332543|FG001|Overall Study|Lack of Efficacy|17
7850305|NCT01488071|12332542|FG000|Overall Study|Non-compliance with study drug|2
7850306|NCT01488071|12332543|FG001|Overall Study|Non-compliance with study drug|0
7850307|NCT01488071|12332542|FG000|Overall Study|Protocol Violation|5
7850308|NCT01488071|12332543|FG001|Overall Study|Protocol Violation|7
7850309|NCT01488071|12332542|FG000|Overall Study|Withdrawal of Consent|14
7850310|NCT01488071|12332543|FG001|Overall Study|Withdrawal of Consent|12
7850311|NCT01488071|12332542|FG000|Overall Study|Lost to Follow-up|1
7850312|NCT01488071|12332543|FG001|Overall Study|Lost to Follow-up|0
7850313|NCT01488071|12332542|FG000|Overall Study|Administrative or Other Reason(s)|5
7850314|NCT01488071|12332543|FG001|Overall Study|Administrative or Other Reason(s)|4
7850315|NCT01488097|12332549|FG000|Overall Study|Lost to Follow-up|1
7850316|NCT01488370|12332581|FG000|Overall Study|Protocol Violation|0
7850317|NCT01488370|12332582|FG001|Overall Study|Protocol Violation|1
7850318|NCT01488370|12332583|FG002|Overall Study|Protocol Violation|1
7850319|NCT01488448|12332602|FG000|Overall Study|Withdrawal by Subject|3
7850320|NCT01488448|12332603|FG001|Overall Study|Withdrawal by Subject|1
7850321|NCT01488448|12332602|FG000|Overall Study|Adverse Event|9
7850322|NCT01488448|12332603|FG001|Overall Study|Adverse Event|4
7850323|NCT01488448|12332602|FG000|Overall Study|Physician Decision|4
7850324|NCT01488448|12332603|FG001|Overall Study|Physician Decision|9
7850325|NCT01488448|12332602|FG000|Overall Study|Protocol Violation|4
7850326|NCT01488448|12332603|FG001|Overall Study|Protocol Violation|3
7850327|NCT01488487|12332611|FG000|Overall Study|Adverse Event|6
7850328|NCT01488487|12332611|FG000|Overall Study|Death|1
7850329|NCT01488487|12332611|FG000|Overall Study|Withdrawal by Subject|2
7850330|NCT01488578|12332615|FG000|Overall Study|Protocol Violation|1836
7850331|NCT01488994|12332667|FG000|Overall Study|Withdrawal by Subject|0
7850332|NCT01488994|12332668|FG001|Overall Study|Withdrawal by Subject|1
7850333|NCT01489020|12332685|FG000|Overall Study|Withdrawal by Subject|1
7850334|NCT01489020|12332686|FG001|Overall Study|Withdrawal by Subject|0
7850335|NCT01489020|12332687|FG002|Overall Study|Withdrawal by Subject|0
7850336|NCT01489020|12332688|FG003|Overall Study|Withdrawal by Subject|0
7850337|NCT01489020|12332689|FG004|Overall Study|Withdrawal by Subject|0
7850338|NCT01489020|12332690|FG005|Overall Study|Withdrawal by Subject|0
7850339|NCT01489020|12332685|FG000|Overall Study|Adverse Event|0
7850340|NCT01489020|12332686|FG001|Overall Study|Adverse Event|0
7850341|NCT01489020|12332687|FG002|Overall Study|Adverse Event|3
7850342|NCT01489020|12332688|FG003|Overall Study|Adverse Event|0
7850343|NCT01489020|12332689|FG004|Overall Study|Adverse Event|3
7850344|NCT01489020|12332690|FG005|Overall Study|Adverse Event|0
7850345|NCT01489020|12332685|FG000|Overall Study|Concomitant disease|0
7850346|NCT01489020|12332686|FG001|Overall Study|Concomitant disease|0
7850347|NCT01489020|12332687|FG002|Overall Study|Concomitant disease|0
7850348|NCT01489020|12332688|FG003|Overall Study|Concomitant disease|0
7850349|NCT01489020|12332689|FG004|Overall Study|Concomitant disease|3
7850350|NCT01489020|12332690|FG005|Overall Study|Concomitant disease|0
7850351|NCT01489111|12332710|FG000|Overall Study|Withdrawal criterion|1
7850352|NCT01489189|12332716|FG000|Overall Study|Withdrawal by Subject|20
7850353|NCT01489189|12332717|FG001|Overall Study|Withdrawal by Subject|23
7850354|NCT01489189|12332716|FG000|Overall Study|Death|10
7850355|NCT01489189|12332717|FG001|Overall Study|Death|8
7850356|NCT01489189|12332716|FG000|Overall Study|Missed Visit|1
7850357|NCT01489189|12332717|FG001|Overall Study|Missed Visit|4
7850358|NCT01489254|12332727|FG000|Double-blind Part|Adverse Event|7
7850359|NCT01489254|12332728|FG001|Double-blind Part|Adverse Event|2
7850360|NCT01489254|12332729|FG002|Double-blind Part|Adverse Event|2
7850361|NCT01489254|12332730|FG003|Double-blind Part|Adverse Event|0
7850362|NCT01489254|12332727|FG000|Double-blind Part|Pregnancy|1
7850363|NCT01489254|12332728|FG001|Double-blind Part|Pregnancy|3
7850364|NCT01489254|12332729|FG002|Double-blind Part|Pregnancy|0
7850365|NCT01489254|12332730|FG003|Double-blind Part|Pregnancy|0
7850366|NCT01489254|12332727|FG000|Double-blind Part|Withdrawal by Subject|12
7850367|NCT01489254|12332728|FG001|Double-blind Part|Withdrawal by Subject|20
7850368|NCT01489254|12332729|FG002|Double-blind Part|Withdrawal by Subject|1
7850369|NCT01489254|12332730|FG003|Double-blind Part|Withdrawal by Subject|0
7850370|NCT01489254|12332727|FG000|Double-blind Part|Lost to Follow-up|1
7850371|NCT01489254|12332728|FG001|Double-blind Part|Lost to Follow-up|2
7850372|NCT01489254|12332729|FG002|Double-blind Part|Lost to Follow-up|0
7850373|NCT01489254|12332730|FG003|Double-blind Part|Lost to Follow-up|0
7850374|NCT01489254|12332727|FG000|Double-blind Part|Other reasons for not completing study|4
7850375|NCT01489254|12332728|FG001|Double-blind Part|Other reasons for not completing study|6
7850376|NCT01489254|12332729|FG002|Double-blind Part|Other reasons for not completing study|0
7850377|NCT01489254|12332730|FG003|Double-blind Part|Other reasons for not completing study|0
7850378|NCT01489254|12332727|FG000|Open-label Extension Part|Adverse Event|0
7850379|NCT01489254|12332728|FG001|Open-label Extension Part|Adverse Event|0
7850380|NCT01489254|12332729|FG002|Open-label Extension Part|Adverse Event|0
7850381|NCT01489254|12332730|FG003|Open-label Extension Part|Adverse Event|10
7850382|NCT01489254|12332727|FG000|Open-label Extension Part|Pregnancy|0
7850383|NCT01489254|12332728|FG001|Open-label Extension Part|Pregnancy|0
7850384|NCT01489254|12332729|FG002|Open-label Extension Part|Pregnancy|0
7850385|NCT01489254|12332730|FG003|Open-label Extension Part|Pregnancy|3
7850386|NCT01489254|12332727|FG000|Open-label Extension Part|Withdrawal by Subject|0
7850387|NCT01489254|12332728|FG001|Open-label Extension Part|Withdrawal by Subject|0
7850388|NCT01489254|12332729|FG002|Open-label Extension Part|Withdrawal by Subject|0
7850389|NCT01489254|12332730|FG003|Open-label Extension Part|Withdrawal by Subject|30
7850390|NCT01489254|12332727|FG000|Open-label Extension Part|Protocol Violation|0
7850391|NCT01489254|12332728|FG001|Open-label Extension Part|Protocol Violation|0
7850392|NCT01489254|12332729|FG002|Open-label Extension Part|Protocol Violation|0
7850393|NCT01489254|12332730|FG003|Open-label Extension Part|Protocol Violation|1
7850394|NCT01489254|12332727|FG000|Open-label Extension Part|Lost to Follow-up|0
7850395|NCT01489254|12332728|FG001|Open-label Extension Part|Lost to Follow-up|0
7850396|NCT01489254|12332729|FG002|Open-label Extension Part|Lost to Follow-up|0
7850397|NCT01489254|12332730|FG003|Open-label Extension Part|Lost to Follow-up|9
7850398|NCT01489254|12332727|FG000|Open-label Extension Part|Other reasons for not completing study|0
7850399|NCT01489254|12332728|FG001|Open-label Extension Part|Other reasons for not completing study|0
7850400|NCT01489254|12332729|FG002|Open-label Extension Part|Other reasons for not completing study|0
7850401|NCT01489254|12332730|FG003|Open-label Extension Part|Other reasons for not completing study|5
7850402|NCT01489358|12332742|FG000|Overall Study|Lost to Follow-up|0
7850403|NCT01489358|12332743|FG001|Overall Study|Lost to Follow-up|0
7850404|NCT01489358|12332744|FG002|Overall Study|Lost to Follow-up|2
7850405|NCT01489527|12332754|FG000|Overall Study|Pregnancy|9
7850406|NCT01489527|12332755|FG001|Overall Study|Pregnancy|14
7850407|NCT01489527|12332754|FG000|Overall Study|Participant moved|6
7850408|NCT01489527|12332755|FG001|Overall Study|Participant moved|7
7850409|NCT01489527|12332754|FG000|Overall Study|Withdrawal by Subject|0
7850410|NCT01489527|12332755|FG001|Overall Study|Withdrawal by Subject|4
7850411|NCT01489527|12332754|FG000|Overall Study|Lost to Follow-up|5
7850412|NCT01489527|12332755|FG001|Overall Study|Lost to Follow-up|1
7850413|NCT01489527|12332754|FG000|Overall Study|Procedures|1
7850414|NCT01489527|12332755|FG001|Overall Study|Procedures|0
7850415|NCT01489527|12332754|FG000|Overall Study|Not compliant|1
7850416|NCT01489527|12332755|FG001|Overall Study|Not compliant|0
7850417|NCT01489891|12332823|FG000|Overall Study|Endoscopy failure|1
7850418|NCT01489891|12332824|FG001|Overall Study|Endoscopy failure|0
7850419|NCT01489956|12332832|FG000|Overall Study|Lost to Follow-up|1
7850420|NCT01489956|12332833|FG001|Overall Study|Lost to Follow-up|0
7850421|NCT01489956|12332834|FG002|Overall Study|Lost to Follow-up|0
7850422|NCT01489956|12332832|FG000|Overall Study|Withdrawal by Subject|0
7850423|NCT01489956|12332833|FG001|Overall Study|Withdrawal by Subject|0
7850424|NCT01489956|12332834|FG002|Overall Study|Withdrawal by Subject|1
7850425|NCT01490060|12332857|FG000|Cycle 1|Change of Treatment|0
7850426|NCT01490060|12332858|FG001|Cycle 1|Change of Treatment|1
7850427|NCT01490060|12332859|FG002|Cycle 1|Change of Treatment|1
7850428|NCT01490060|12332860|FG003|Cycle 1|Change of Treatment|1
7850429|NCT01490060|12332857|FG000|Cycle 1|Insurance Denied|0
7850430|NCT01490060|12332858|FG001|Cycle 1|Insurance Denied|0
7850431|NCT01490060|12332859|FG002|Cycle 1|Insurance Denied|2
7850432|NCT01490060|12332860|FG003|Cycle 1|Insurance Denied|0
7850433|NCT01490060|12332857|FG000|Cycle 1|Withdrawal by Subject|0
7850434|NCT01490060|12332858|FG001|Cycle 1|Withdrawal by Subject|0
7850435|NCT01490060|12332859|FG002|Cycle 1|Withdrawal by Subject|0
7850436|NCT01490060|12332860|FG003|Cycle 1|Withdrawal by Subject|1
7850437|NCT01490060|12332857|FG000|Cycle 1|Treatment at Another Facility|0
7850438|NCT01490060|12332858|FG001|Cycle 1|Treatment at Another Facility|0
7850439|NCT01490060|12332859|FG002|Cycle 1|Treatment at Another Facility|0
7850440|NCT01490060|12332860|FG003|Cycle 1|Treatment at Another Facility|1
7850441|NCT01490060|12332857|FG000|Cycle 2|Change of Treatment|1
7850442|NCT01490060|12332858|FG001|Cycle 2|Change of Treatment|1
7850443|NCT01490060|12332859|FG002|Cycle 2|Change of Treatment|0
7850444|NCT01490060|12332860|FG003|Cycle 2|Change of Treatment|0
7850445|NCT01490060|12332857|FG000|Cycle 2|Non-Compliance|0
7850446|NCT01490060|12332858|FG001|Cycle 2|Non-Compliance|0
7850447|NCT01490060|12332859|FG002|Cycle 2|Non-Compliance|1
7850448|NCT01490060|12332860|FG003|Cycle 2|Non-Compliance|0
7850449|NCT01490060|12332857|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1
7850450|NCT01490060|12332858|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0
7850451|NCT01490060|12332859|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0
7850452|NCT01490060|12332860|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0
7850453|NCT01490086|12332882|FG000|Overall Study|Consent withdrawn|4
7850454|NCT01490086|12332883|FG001|Overall Study|Consent withdrawn|4
7850455|NCT01490086|12332884|FG002|Overall Study|Consent withdrawn|3
7850456|NCT01490086|12332885|FG003|Overall Study|Consent withdrawn|0
7850457|NCT01490086|12332886|FG004|Overall Study|Consent withdrawn|1
7850458|NCT01490086|12332882|FG000|Overall Study|Non-compliance|0
7850459|NCT01490086|12332883|FG001|Overall Study|Non-compliance|1
7850460|NCT01490086|12332884|FG002|Overall Study|Non-compliance|0
7850461|NCT01490086|12332885|FG003|Overall Study|Non-compliance|0
7850462|NCT01490086|12332886|FG004|Overall Study|Non-compliance|0
7850463|NCT01490086|12332882|FG000|Overall Study|Abnormal laboratory findings|1
7850464|NCT01490086|12332883|FG001|Overall Study|Abnormal laboratory findings|0
7850465|NCT01490086|12332884|FG002|Overall Study|Abnormal laboratory findings|0
7850466|NCT01490086|12332885|FG003|Overall Study|Abnormal laboratory findings|0
7850467|NCT01490086|12332886|FG004|Overall Study|Abnormal laboratory findings|0
7850468|NCT01490086|12332882|FG000|Overall Study|Lost to Follow-up|0
7850469|NCT01490086|12332883|FG001|Overall Study|Lost to Follow-up|0
7850470|NCT01490086|12332884|FG002|Overall Study|Lost to Follow-up|0
7850471|NCT01490086|12332885|FG003|Overall Study|Lost to Follow-up|0
7850472|NCT01490086|12332886|FG004|Overall Study|Lost to Follow-up|1
7850473|NCT01490086|12332882|FG000|Overall Study|Physician Decision|3
7850474|NCT01490086|12332883|FG001|Overall Study|Physician Decision|4
7850475|NCT01490086|12332884|FG002|Overall Study|Physician Decision|2
7850476|NCT01490086|12332885|FG003|Overall Study|Physician Decision|3
7850477|NCT01490086|12332886|FG004|Overall Study|Physician Decision|1
7850478|NCT01490086|12332882|FG000|Overall Study|Adverse Event|0
7850479|NCT01490086|12332883|FG001|Overall Study|Adverse Event|0
7850480|NCT01490086|12332884|FG002|Overall Study|Adverse Event|1
7850481|NCT01490086|12332885|FG003|Overall Study|Adverse Event|2
7850482|NCT01490086|12332886|FG004|Overall Study|Adverse Event|0
7850483|NCT01490086|12332882|FG000|Overall Study|Lack of Efficacy|0
7850484|NCT01490086|12332883|FG001|Overall Study|Lack of Efficacy|3
7850485|NCT01490086|12332884|FG002|Overall Study|Lack of Efficacy|1
7850486|NCT01490086|12332885|FG003|Overall Study|Lack of Efficacy|0
7850487|NCT01490086|12332886|FG004|Overall Study|Lack of Efficacy|8
7850488|NCT01490086|12332882|FG000|Overall Study|Worsening of symptoms|0
7850489|NCT01490086|12332883|FG001|Overall Study|Worsening of symptoms|1
7850490|NCT01490086|12332884|FG002|Overall Study|Worsening of symptoms|0
7850491|NCT01490086|12332885|FG003|Overall Study|Worsening of symptoms|1
7850492|NCT01490086|12332886|FG004|Overall Study|Worsening of symptoms|0
7850493|NCT01490086|12332882|FG000|Overall Study|Subject uncontrollable and abusive|0
7850494|NCT01490086|12332883|FG001|Overall Study|Subject uncontrollable and abusive|1
7850495|NCT01490086|12332884|FG002|Overall Study|Subject uncontrollable and abusive|0
7850496|NCT01490086|12332885|FG003|Overall Study|Subject uncontrollable and abusive|0
7850497|NCT01490086|12332886|FG004|Overall Study|Subject uncontrollable and abusive|0
7850498|NCT01490086|12332882|FG000|Overall Study|Subject left hospital|0
7850499|NCT01490086|12332883|FG001|Overall Study|Subject left hospital|1
7850500|NCT01490086|12332884|FG002|Overall Study|Subject left hospital|0
7850501|NCT01490086|12332885|FG003|Overall Study|Subject left hospital|1
7850502|NCT01490086|12332886|FG004|Overall Study|Subject left hospital|0
7850503|NCT01490125|12332898|FG000|Period I|Adverse Event|4
7850504|NCT01490125|12332899|FG001|Period I|Adverse Event|1
7850505|NCT01490125|12332900|FG002|Period I|Adverse Event|1
7850506|NCT01490125|12332901|FG003|Period I|Adverse Event|3
7850507|NCT01490125|12332902|FG004|Period I|Adverse Event|2
7850508|NCT01490125|12332903|FG005|Period I|Adverse Event|4
7850509|NCT01490125|12332898|FG000|Period I|Protocol Violation|1
7850510|NCT01490125|12332899|FG001|Period I|Protocol Violation|1
7850511|NCT01490125|12332900|FG002|Period I|Protocol Violation|1
7850512|NCT01490125|12332901|FG003|Period I|Protocol Violation|1
7850513|NCT01490125|12332902|FG004|Period I|Protocol Violation|0
7850514|NCT01490125|12332903|FG005|Period I|Protocol Violation|0
7850515|NCT01490125|12332898|FG000|Period I|Withdrawal by Subject|1
7850516|NCT01490125|12332899|FG001|Period I|Withdrawal by Subject|3
7850517|NCT01490125|12332900|FG002|Period I|Withdrawal by Subject|2
7850518|NCT01490125|12332901|FG003|Period I|Withdrawal by Subject|1
7850519|NCT01490125|12332902|FG004|Period I|Withdrawal by Subject|2
7850520|NCT01490125|12332903|FG005|Period I|Withdrawal by Subject|1
7850521|NCT01490125|12332898|FG000|Period II|Adverse Event|2
7850522|NCT01490125|12332899|FG001|Period II|Adverse Event|3
7850523|NCT01490125|12332900|FG002|Period II|Adverse Event|2
7850524|NCT01490125|12332901|FG003|Period II|Adverse Event|2
7850525|NCT01490125|12332902|FG004|Period II|Adverse Event|4
7850526|NCT01490125|12332903|FG005|Period II|Adverse Event|2
7850527|NCT01490125|12332898|FG000|Period II|Protocol Violation|0
7850528|NCT01490125|12332899|FG001|Period II|Protocol Violation|0
7850529|NCT01490125|12332900|FG002|Period II|Protocol Violation|1
7850530|NCT01490125|12332901|FG003|Period II|Protocol Violation|1
7850531|NCT01490125|12332902|FG004|Period II|Protocol Violation|0
7850532|NCT01490125|12332903|FG005|Period II|Protocol Violation|0
7850533|NCT01490125|12332898|FG000|Period II|Lost to Follow-up|0
7850534|NCT01490125|12332899|FG001|Period II|Lost to Follow-up|1
7850535|NCT01490125|12332900|FG002|Period II|Lost to Follow-up|0
7850536|NCT01490125|12332901|FG003|Period II|Lost to Follow-up|0
7850537|NCT01490125|12332902|FG004|Period II|Lost to Follow-up|0
7850538|NCT01490125|12332903|FG005|Period II|Lost to Follow-up|0
7850539|NCT01490125|12332898|FG000|Period II|Withdrawal by Subject|1
7850540|NCT01490125|12332899|FG001|Period II|Withdrawal by Subject|0
7850541|NCT01490125|12332900|FG002|Period II|Withdrawal by Subject|0
7850542|NCT01490125|12332901|FG003|Period II|Withdrawal by Subject|0
7850543|NCT01490125|12332902|FG004|Period II|Withdrawal by Subject|0
7850544|NCT01490125|12332903|FG005|Period II|Withdrawal by Subject|0
7850545|NCT01490125|12332898|FG000|Period III|Adverse Event|3
7850546|NCT01490125|12332899|FG001|Period III|Adverse Event|1
7850547|NCT01490125|12332900|FG002|Period III|Adverse Event|0
7850548|NCT01490125|12332901|FG003|Period III|Adverse Event|1
7850549|NCT01490125|12332902|FG004|Period III|Adverse Event|0
7850550|NCT01490125|12332903|FG005|Period III|Adverse Event|0
7850551|NCT01490125|12332898|FG000|Period III|Death|0
7850552|NCT01490125|12332899|FG001|Period III|Death|0
7850553|NCT01490125|12332900|FG002|Period III|Death|0
7850554|NCT01490125|12332901|FG003|Period III|Death|1
7850555|NCT01490125|12332902|FG004|Period III|Death|0
7850556|NCT01490125|12332903|FG005|Period III|Death|0
7850557|NCT01490125|12332898|FG000|Period III|Lack of Efficacy|0
7850558|NCT01490125|12332899|FG001|Period III|Lack of Efficacy|0
7850559|NCT01490125|12332900|FG002|Period III|Lack of Efficacy|0
7850560|NCT01490125|12332901|FG003|Period III|Lack of Efficacy|0
7850561|NCT01490125|12332902|FG004|Period III|Lack of Efficacy|1
7850562|NCT01490125|12332903|FG005|Period III|Lack of Efficacy|0
7850563|NCT01490294|12332921|FG000|Overall Study|Prematurely discontinuation|4
7850564|NCT01490294|12332922|FG001|Overall Study|Prematurely discontinuation|0
7850565|NCT01490294|12332923|FG002|Overall Study|Prematurely discontinuation|1
7850566|NCT01490294|12332924|FG003|Overall Study|Prematurely discontinuation|1
7850567|NCT01490294|12332921|FG000|Overall Study|Adverse Event|1
7850568|NCT01490294|12332922|FG001|Overall Study|Adverse Event|0
7850569|NCT01490294|12332923|FG002|Overall Study|Adverse Event|0
7850570|NCT01490294|12332924|FG003|Overall Study|Adverse Event|0
7850571|NCT01490450|12332948|FG000|Period 1|Lack of Efficacy|2
7850572|NCT01490450|12332949|FG001|Period 1|Lack of Efficacy|0
7850573|NCT01490450|12332950|FG002|Period 1|Lack of Efficacy|3
7850574|NCT01490450|12332951|FG003|Period 1|Lack of Efficacy|0
7850575|NCT01490450|12332948|FG000|Period 1|Adverse Event|0
7850576|NCT01490450|12332949|FG001|Period 1|Adverse Event|0
7850577|NCT01490450|12332950|FG002|Period 1|Adverse Event|0
7850578|NCT01490450|12332951|FG003|Period 1|Adverse Event|5
7850579|NCT01490450|12332948|FG000|Period 1|Request to discontinue treatment|1
7850580|NCT01490450|12332949|FG001|Period 1|Request to discontinue treatment|0
7850581|NCT01490450|12332950|FG002|Period 1|Request to discontinue treatment|0
7850582|NCT01490450|12332951|FG003|Period 1|Request to discontinue treatment|0
7850583|NCT01490450|12332948|FG000|Period 1|Withdrawal by Subject|0
7850584|NCT01490450|12332949|FG001|Period 1|Withdrawal by Subject|0
7850585|NCT01490450|12332950|FG002|Period 1|Withdrawal by Subject|0
7850586|NCT01490450|12332951|FG003|Period 1|Withdrawal by Subject|3
7850587|NCT01490450|12332948|FG000|Period 1|No longer met study criteria|0
7850588|NCT01490450|12332949|FG001|Period 1|No longer met study criteria|1
7850589|NCT01490450|12332950|FG002|Period 1|No longer met study criteria|1
7850590|NCT01490450|12332951|FG003|Period 1|No longer met study criteria|0
7850591|NCT01490450|12332948|FG000|Period 2|Lack of Efficacy|0
7850592|NCT01490450|12332949|FG001|Period 2|Lack of Efficacy|0
7850593|NCT01490450|12332950|FG002|Period 2|Lack of Efficacy|0
7850594|NCT01490450|12332951|FG003|Period 2|Lack of Efficacy|1
7850595|NCT01490450|12332948|FG000|Period 2|Adverse Event|1
7850596|NCT01490450|12332949|FG001|Period 2|Adverse Event|1
7850597|NCT01490450|12332950|FG002|Period 2|Adverse Event|0
7850598|NCT01490450|12332951|FG003|Period 2|Adverse Event|1
7850599|NCT01490450|12332948|FG000|Period 2|Withdrawal by Subject|1
7850600|NCT01490450|12332949|FG001|Period 2|Withdrawal by Subject|0
7850601|NCT01490450|12332950|FG002|Period 2|Withdrawal by Subject|0
7850602|NCT01490450|12332951|FG003|Period 2|Withdrawal by Subject|0
7850603|NCT01490450|12332948|FG000|Period 2|Lost to Follow-up|0
7850604|NCT01490450|12332949|FG001|Period 2|Lost to Follow-up|0
7850605|NCT01490450|12332950|FG002|Period 2|Lost to Follow-up|0
7850606|NCT01490450|12332951|FG003|Period 2|Lost to Follow-up|2
7850607|NCT01490580|12332966|FG000|Overall Study|Parents withdrew consent|0
7850608|NCT01490580|12332967|FG001|Overall Study|Parents withdrew consent|2
7850609|NCT01490632|12332982|FG000|Part A: Initial Treatment Period|Adverse Event|0
7850610|NCT01490632|12332983|FG001|Part A: Initial Treatment Period|Adverse Event|0
7850611|NCT01490632|12332984|FG002|Part A: Initial Treatment Period|Adverse Event|2
7850612|NCT01490632|12332985|FG003|Part A: Initial Treatment Period|Adverse Event|4
7850613|NCT01490632|12332986|FG004|Part A: Initial Treatment Period|Adverse Event|4
7850614|NCT01490632|12332987|FG005|Part A: Initial Treatment Period|Adverse Event|0
7850615|NCT01490632|12332988|FG006|Part A: Initial Treatment Period|Adverse Event|0
7850616|NCT01490632|12332989|FG007|Part A: Initial Treatment Period|Adverse Event|0
7850617|NCT01490632|12332990|FG008|Part A: Initial Treatment Period|Adverse Event|0
7850618|NCT01490632|12332991|FG009|Part A: Initial Treatment Period|Adverse Event|0
7850619|NCT01490632|12332992|FG010|Part A: Initial Treatment Period|Adverse Event|0
7850620|NCT01490632|12332993|FG011|Part A: Initial Treatment Period|Adverse Event|0
7850621|NCT01490632|12332994|FG012|Part A: Initial Treatment Period|Adverse Event|0
7850622|NCT01490632|12332995|FG013|Part A: Initial Treatment Period|Adverse Event|0
7850623|NCT01490632|12332996|FG014|Part A: Initial Treatment Period|Adverse Event|0
7850624|NCT01490632|12332997|FG015|Part A: Initial Treatment Period|Adverse Event|0
7850625|NCT01490632|12332998|FG016|Part A: Initial Treatment Period|Adverse Event|0
7850626|NCT01490632|12332999|FG017|Part A: Initial Treatment Period|Adverse Event|0
7850627|NCT01490632|12333000|FG018|Part A: Initial Treatment Period|Adverse Event|0
7850628|NCT01490632|12333001|FG019|Part A: Initial Treatment Period|Adverse Event|0
7850629|NCT01490632|12332982|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3
7850630|NCT01490632|12332983|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1
7850631|NCT01490632|12332984|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2
7850632|NCT01490632|12332985|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2
7850633|NCT01490632|12332986|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0
7850634|NCT01490632|12332987|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0
7850635|NCT01490632|12332988|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0
7850636|NCT01490632|12332989|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0
7850637|NCT01490632|12332990|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0
7850638|NCT01490632|12332991|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0
7850639|NCT01490632|12332992|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0
7850640|NCT01490632|12332993|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0
7850641|NCT01490632|12332994|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0
7850642|NCT01490632|12332995|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0
7850643|NCT01490632|12332996|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0
7850644|NCT01490632|12332997|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0
7850645|NCT01490632|12332998|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0
7850646|NCT01490632|12332999|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0
7850647|NCT01490632|12333000|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0
7850648|NCT01490632|12333001|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0
7850649|NCT01490632|12332982|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0
7850650|NCT01490632|12332983|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0
7850651|NCT01490632|12332984|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1
7850652|NCT01490632|12332985|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1
7850653|NCT01490632|12332986|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2
7850654|NCT01490632|12332987|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0
7850655|NCT01490632|12332988|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0
7850656|NCT01490632|12332989|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0
7850657|NCT01490632|12332990|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0
7850658|NCT01490632|12332991|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0
7850659|NCT01490632|12332992|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0
7850660|NCT01490632|12332993|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0
7850661|NCT01490632|12332994|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0
7850662|NCT01490632|12332995|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0
7850663|NCT01490632|12332996|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0
7850664|NCT01490632|12332997|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0
7850665|NCT01490632|12332998|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0
7850666|NCT01490632|12332999|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0
7850667|NCT01490632|12333000|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0
7850668|NCT01490632|12333001|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0
7850669|NCT01490632|12332982|FG000|Part A: Initial Treatment Period|Physician Decision|0
7850670|NCT01490632|12332983|FG001|Part A: Initial Treatment Period|Physician Decision|1
7850671|NCT01490632|12332984|FG002|Part A: Initial Treatment Period|Physician Decision|0
7850672|NCT01490632|12332985|FG003|Part A: Initial Treatment Period|Physician Decision|1
7850673|NCT01490632|12332986|FG004|Part A: Initial Treatment Period|Physician Decision|0
7850674|NCT01490632|12332987|FG005|Part A: Initial Treatment Period|Physician Decision|0
7850675|NCT01490632|12332988|FG006|Part A: Initial Treatment Period|Physician Decision|0
7850676|NCT01490632|12332989|FG007|Part A: Initial Treatment Period|Physician Decision|0
7850677|NCT01490632|12332990|FG008|Part A: Initial Treatment Period|Physician Decision|0
7850678|NCT01490632|12332991|FG009|Part A: Initial Treatment Period|Physician Decision|0
7850679|NCT01490632|12332992|FG010|Part A: Initial Treatment Period|Physician Decision|0
7850680|NCT01490632|12332993|FG011|Part A: Initial Treatment Period|Physician Decision|0
7850681|NCT01490632|12332994|FG012|Part A: Initial Treatment Period|Physician Decision|0
7850682|NCT01490632|12332995|FG013|Part A: Initial Treatment Period|Physician Decision|0
7850683|NCT01490632|12332996|FG014|Part A: Initial Treatment Period|Physician Decision|0
7850684|NCT01490632|12332997|FG015|Part A: Initial Treatment Period|Physician Decision|0
7850685|NCT01490632|12332998|FG016|Part A: Initial Treatment Period|Physician Decision|0
7850686|NCT01490632|12332999|FG017|Part A: Initial Treatment Period|Physician Decision|0
7850687|NCT01490632|12333000|FG018|Part A: Initial Treatment Period|Physician Decision|0
7850688|NCT01490632|12333001|FG019|Part A: Initial Treatment Period|Physician Decision|0
7850689|NCT01490632|12332982|FG000|Part A: Initial Treatment Period|Sponsor Decision|2
7850690|NCT01490632|12332983|FG001|Part A: Initial Treatment Period|Sponsor Decision|0
7850691|NCT01490632|12332984|FG002|Part A: Initial Treatment Period|Sponsor Decision|0
7850692|NCT01490632|12332985|FG003|Part A: Initial Treatment Period|Sponsor Decision|0
7850693|NCT01490632|12332986|FG004|Part A: Initial Treatment Period|Sponsor Decision|0
7850694|NCT01490632|12332987|FG005|Part A: Initial Treatment Period|Sponsor Decision|0
7850695|NCT01490632|12332988|FG006|Part A: Initial Treatment Period|Sponsor Decision|0
7850696|NCT01490632|12332989|FG007|Part A: Initial Treatment Period|Sponsor Decision|0
7850697|NCT01490632|12332990|FG008|Part A: Initial Treatment Period|Sponsor Decision|0
7850698|NCT01490632|12332991|FG009|Part A: Initial Treatment Period|Sponsor Decision|0
7850699|NCT01490632|12332992|FG010|Part A: Initial Treatment Period|Sponsor Decision|0
7850700|NCT01490632|12332993|FG011|Part A: Initial Treatment Period|Sponsor Decision|0
7850701|NCT01490632|12332994|FG012|Part A: Initial Treatment Period|Sponsor Decision|0
7850702|NCT01490632|12332995|FG013|Part A: Initial Treatment Period|Sponsor Decision|0
7850703|NCT01490632|12332996|FG014|Part A: Initial Treatment Period|Sponsor Decision|0
7850704|NCT01490632|12332997|FG015|Part A: Initial Treatment Period|Sponsor Decision|0
7850705|NCT01490632|12332998|FG016|Part A: Initial Treatment Period|Sponsor Decision|0
7850706|NCT01490632|12332999|FG017|Part A: Initial Treatment Period|Sponsor Decision|0
7850707|NCT01490632|12333000|FG018|Part A: Initial Treatment Period|Sponsor Decision|0
7850708|NCT01490632|12333001|FG019|Part A: Initial Treatment Period|Sponsor Decision|0
7850709|NCT01490632|12332982|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2
7850710|NCT01490632|12332983|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2
7850711|NCT01490632|12332984|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850712|NCT01490632|12332985|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1
7850713|NCT01490632|12332986|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2
7850714|NCT01490632|12332987|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850715|NCT01490632|12332988|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850716|NCT01490632|12332989|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850717|NCT01490632|12332990|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850718|NCT01490632|12332991|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850719|NCT01490632|12332992|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850720|NCT01490632|12332993|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850721|NCT01490632|12332994|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850722|NCT01490632|12332995|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850723|NCT01490632|12332996|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850724|NCT01490632|12332997|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850725|NCT01490632|12332998|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850726|NCT01490632|12332999|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850727|NCT01490632|12333000|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850728|NCT01490632|12333001|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0
7850729|NCT01490632|12332982|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850730|NCT01490632|12332983|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850731|NCT01490632|12332984|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850732|NCT01490632|12332985|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850733|NCT01490632|12332986|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
7850734|NCT01490632|12332987|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850735|NCT01490632|12332988|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850736|NCT01490632|12332989|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850737|NCT01490632|12332990|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850738|NCT01490632|12332991|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850739|NCT01490632|12332992|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850740|NCT01490632|12332993|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850741|NCT01490632|12332994|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850742|NCT01490632|12332995|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850743|NCT01490632|12332996|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850744|NCT01490632|12332997|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850745|NCT01490632|12332998|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850746|NCT01490632|12332999|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850747|NCT01490632|12333000|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850748|NCT01490632|12333001|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7850749|NCT01490632|12332982|FG000|Part B: Extension or Step-Up Period|Adverse Event|0
7850750|NCT01490632|12332983|FG001|Part B: Extension or Step-Up Period|Adverse Event|0
7850751|NCT01490632|12332984|FG002|Part B: Extension or Step-Up Period|Adverse Event|0
7850752|NCT01490632|12332985|FG003|Part B: Extension or Step-Up Period|Adverse Event|0
7850753|NCT01490632|12332986|FG004|Part B: Extension or Step-Up Period|Adverse Event|0
7850754|NCT01490632|12332987|FG005|Part B: Extension or Step-Up Period|Adverse Event|2
7850755|NCT01490632|12332988|FG006|Part B: Extension or Step-Up Period|Adverse Event|2
7850756|NCT01490632|12332989|FG007|Part B: Extension or Step-Up Period|Adverse Event|0
7850757|NCT01490632|12332990|FG008|Part B: Extension or Step-Up Period|Adverse Event|0
7850758|NCT01490632|12332991|FG009|Part B: Extension or Step-Up Period|Adverse Event|2
7850759|NCT01490632|12332992|FG010|Part B: Extension or Step-Up Period|Adverse Event|3
7850760|NCT01490632|12332993|FG011|Part B: Extension or Step-Up Period|Adverse Event|1
7850761|NCT01490632|12332994|FG012|Part B: Extension or Step-Up Period|Adverse Event|0
7850762|NCT01490632|12332995|FG013|Part B: Extension or Step-Up Period|Adverse Event|0
7850763|NCT01490632|12332996|FG014|Part B: Extension or Step-Up Period|Adverse Event|0
7850764|NCT01490632|12332997|FG015|Part B: Extension or Step-Up Period|Adverse Event|0
7850765|NCT01490632|12332998|FG016|Part B: Extension or Step-Up Period|Adverse Event|0
7850766|NCT01490632|12332999|FG017|Part B: Extension or Step-Up Period|Adverse Event|0
7850767|NCT01490632|12333000|FG018|Part B: Extension or Step-Up Period|Adverse Event|0
7850768|NCT01490632|12333001|FG019|Part B: Extension or Step-Up Period|Adverse Event|0
7850769|NCT01490632|12332982|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850770|NCT01490632|12332983|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850771|NCT01490632|12332984|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850772|NCT01490632|12332985|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850773|NCT01490632|12332986|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850774|NCT01490632|12332987|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850775|NCT01490632|12332988|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1
7850776|NCT01490632|12332989|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850777|NCT01490632|12332990|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1
7850778|NCT01490632|12332991|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3
7850779|NCT01490632|12332992|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1
7850780|NCT01490632|12332993|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850781|NCT01490632|12332994|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850782|NCT01490632|12332995|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850783|NCT01490632|12332996|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850784|NCT01490632|12332997|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850785|NCT01490632|12332998|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850786|NCT01490632|12332999|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850787|NCT01490632|12333000|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850788|NCT01490632|12333001|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7850789|NCT01490632|12332982|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850790|NCT01490632|12332983|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850791|NCT01490632|12332984|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850792|NCT01490632|12332985|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850793|NCT01490632|12332986|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850794|NCT01490632|12332987|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850795|NCT01490632|12332988|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2
7850796|NCT01490632|12332989|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850797|NCT01490632|12332990|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850798|NCT01490632|12332991|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1
7850799|NCT01490632|12332992|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850800|NCT01490632|12332993|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850801|NCT01490632|12332994|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850802|NCT01490632|12332995|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850803|NCT01490632|12332996|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850804|NCT01490632|12332997|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850805|NCT01490632|12332998|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850806|NCT01490632|12332999|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850807|NCT01490632|12333000|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850808|NCT01490632|12333001|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7850809|NCT01490632|12332982|FG000|Part B: Extension or Step-Up Period|Physician Decision|0
7850810|NCT01490632|12332983|FG001|Part B: Extension or Step-Up Period|Physician Decision|0
7850811|NCT01490632|12332984|FG002|Part B: Extension or Step-Up Period|Physician Decision|0
7850812|NCT01490632|12332985|FG003|Part B: Extension or Step-Up Period|Physician Decision|0
7949356|NCT02536508|12494932|FG002|Overall Study|Withdrawal by Subject|7
7949357|NCT02536508|12494930|FG000|Overall Study|Adverse Event|14
7949358|NCT02536508|12494931|FG001|Overall Study|Adverse Event|13
7949359|NCT02536508|12494932|FG002|Overall Study|Adverse Event|6
7949360|NCT02536508|12494930|FG000|Overall Study|Lost to Follow-up|12
7949361|NCT02536508|12494931|FG001|Overall Study|Lost to Follow-up|4
7949362|NCT02536508|12494932|FG002|Overall Study|Lost to Follow-up|0
7949363|NCT02536508|12494930|FG000|Overall Study|Lack of Efficacy|3
7949364|NCT02536508|12494931|FG001|Overall Study|Lack of Efficacy|5
7949365|NCT02536508|12494932|FG002|Overall Study|Lack of Efficacy|4
7949366|NCT02536508|12494930|FG000|Overall Study|Protocol Discontinuation Criteria|3
7949367|NCT02536508|12494931|FG001|Overall Study|Protocol Discontinuation Criteria|2
7949368|NCT02536508|12494932|FG002|Overall Study|Protocol Discontinuation Criteria|2
7949369|NCT02536508|12494930|FG000|Overall Study|Physician Decision|0
7949370|NCT02536508|12494931|FG001|Overall Study|Physician Decision|4
7949371|NCT02536508|12494932|FG002|Overall Study|Physician Decision|2
7949372|NCT02536508|12494930|FG000|Overall Study|Major Protocol Deviation|2
7850813|NCT01490632|12332986|FG004|Part B: Extension or Step-Up Period|Physician Decision|0
7850814|NCT01490632|12332987|FG005|Part B: Extension or Step-Up Period|Physician Decision|0
7850815|NCT01490632|12332988|FG006|Part B: Extension or Step-Up Period|Physician Decision|1
7850816|NCT01490632|12332989|FG007|Part B: Extension or Step-Up Period|Physician Decision|0
7850817|NCT01490632|12332990|FG008|Part B: Extension or Step-Up Period|Physician Decision|0
7850818|NCT01490632|12332991|FG009|Part B: Extension or Step-Up Period|Physician Decision|0
7850819|NCT01490632|12332992|FG010|Part B: Extension or Step-Up Period|Physician Decision|0
7850820|NCT01490632|12332993|FG011|Part B: Extension or Step-Up Period|Physician Decision|0
7850821|NCT01490632|12332994|FG012|Part B: Extension or Step-Up Period|Physician Decision|0
7850822|NCT01490632|12332995|FG013|Part B: Extension or Step-Up Period|Physician Decision|0
7850823|NCT01490632|12332996|FG014|Part B: Extension or Step-Up Period|Physician Decision|0
7850824|NCT01490632|12332997|FG015|Part B: Extension or Step-Up Period|Physician Decision|0
7850825|NCT01490632|12332998|FG016|Part B: Extension or Step-Up Period|Physician Decision|0
7850826|NCT01490632|12332999|FG017|Part B: Extension or Step-Up Period|Physician Decision|0
7850827|NCT01490632|12333000|FG018|Part B: Extension or Step-Up Period|Physician Decision|0
7850828|NCT01490632|12333001|FG019|Part B: Extension or Step-Up Period|Physician Decision|0
7850829|NCT01490632|12332982|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850830|NCT01490632|12332983|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850831|NCT01490632|12332984|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850832|NCT01490632|12332985|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850833|NCT01490632|12332986|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850834|NCT01490632|12332987|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1
7850835|NCT01490632|12332988|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850836|NCT01490632|12332989|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0
7949373|NCT02536508|12494931|FG001|Overall Study|Major Protocol Deviation|2
7949374|NCT02536508|12494932|FG002|Overall Study|Major Protocol Deviation|2
7949375|NCT02536508|12494930|FG000|Overall Study|Administrative Reasons|0
7949376|NCT02536508|12494931|FG001|Overall Study|Administrative Reasons|1
7949377|NCT02536508|12494932|FG002|Overall Study|Administrative Reasons|0
7949378|NCT02536664|12494942|FG000|Overall Study|Inadequate completion of documentation|2
7949379|NCT02536664|12494943|FG001|Overall Study|Inadequate completion of documentation|4
7949380|NCT02536664|12494942|FG000|Overall Study|Progression|13
7949381|NCT02536664|12494943|FG001|Overall Study|Progression|18
7949382|NCT02536664|12494942|FG000|Overall Study|Death due to lymphoma|2
7949383|NCT02536664|12494943|FG001|Overall Study|Death due to lymphoma|1
7949384|NCT02536664|12494942|FG000|Overall Study|Death due to other reason|3
7949385|NCT02536664|12494943|FG001|Overall Study|Death due to other reason|2
7949386|NCT02536664|12494942|FG000|Overall Study|Intolerability|8
7949387|NCT02536664|12494943|FG001|Overall Study|Intolerability|6
7949388|NCT02536664|12494942|FG000|Overall Study|Withdrawal by Subject|8
7949389|NCT02536664|12494943|FG001|Overall Study|Withdrawal by Subject|5
7949390|NCT02536664|12494942|FG000|Overall Study|Other|18
7949391|NCT02536664|12494943|FG001|Overall Study|Other|24
7949392|NCT02536664|12494942|FG000|Overall Study|Missing|53
7949393|NCT02536664|12494943|FG001|Overall Study|Missing|20
7949394|NCT02536781|12494951|FG000|Overall Study|Lost to Follow-up|2
7949395|NCT02536781|12494952|FG001|Overall Study|Lost to Follow-up|0
7949396|NCT02536833|12494962|FG000|Overall Study|Discontinued Before Treatment|0
7949397|NCT02536833|12494963|FG001|Overall Study|Discontinued Before Treatment|0
7949398|NCT02536833|12494964|FG002|Overall Study|Discontinued Before Treatment|1
7949399|NCT02536833|12494965|FG003|Overall Study|Discontinued Before Treatment|2
7949400|NCT02536833|12494962|FG000|Overall Study|Adverse Event|1
7949401|NCT02536833|12494963|FG001|Overall Study|Adverse Event|3
7949402|NCT02536833|12494964|FG002|Overall Study|Adverse Event|4
7949403|NCT02536833|12494965|FG003|Overall Study|Adverse Event|1
7949404|NCT02536833|12494962|FG000|Overall Study|Lost to Follow-up|2
7949405|NCT02536833|12494963|FG001|Overall Study|Lost to Follow-up|1
7949406|NCT02536833|12494964|FG002|Overall Study|Lost to Follow-up|2
7949407|NCT02536833|12494965|FG003|Overall Study|Lost to Follow-up|2
7949408|NCT02536833|12494962|FG000|Overall Study|Physician Decision|0
7949409|NCT02536833|12494963|FG001|Overall Study|Physician Decision|0
7949410|NCT02536833|12494964|FG002|Overall Study|Physician Decision|0
7949411|NCT02536833|12494965|FG003|Overall Study|Physician Decision|1
7949412|NCT02536833|12494962|FG000|Overall Study|Site Terminated by Sponsor|2
7949413|NCT02536833|12494963|FG001|Overall Study|Site Terminated by Sponsor|2
7949414|NCT02536833|12494964|FG002|Overall Study|Site Terminated by Sponsor|2
7949415|NCT02536833|12494965|FG003|Overall Study|Site Terminated by Sponsor|2
7850837|NCT01490632|12332990|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850838|NCT01490632|12332991|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850839|NCT01490632|12332992|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850840|NCT01490632|12332993|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850841|NCT01490632|12332994|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850842|NCT01490632|12332995|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850843|NCT01490632|12332996|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850844|NCT01490632|12332997|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850845|NCT01490632|12332998|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850846|NCT01490632|12332999|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850847|NCT01490632|12333000|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850848|NCT01490632|12333001|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0
7850849|NCT01490632|12332982|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850850|NCT01490632|12332983|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850851|NCT01490632|12332984|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850852|NCT01490632|12332985|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850853|NCT01490632|12332986|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850854|NCT01490632|12332987|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850855|NCT01490632|12332988|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
7850856|NCT01490632|12332989|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850857|NCT01490632|12332990|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
7850858|NCT01490632|12332991|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850859|NCT01490632|12332992|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
7850860|NCT01490632|12332993|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
7850861|NCT01490632|12332994|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850862|NCT01490632|12332995|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850863|NCT01490632|12332996|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850864|NCT01490632|12332997|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850865|NCT01490632|12332998|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850866|NCT01490632|12332999|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850867|NCT01490632|12333000|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850868|NCT01490632|12333001|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7850869|NCT01490632|12332982|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7850870|NCT01490632|12332983|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7850871|NCT01490632|12332984|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7850872|NCT01490632|12332985|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7850873|NCT01490632|12332986|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7850874|NCT01490632|12332987|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
7850875|NCT01490632|12332988|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
7850876|NCT01490632|12332989|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
7850877|NCT01490632|12332990|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
7850878|NCT01490632|12332991|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
7850879|NCT01490632|12332992|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
7850880|NCT01490632|12332993|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
7850881|NCT01490632|12332994|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7850882|NCT01490632|12332995|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7850883|NCT01490632|12332996|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7850884|NCT01490632|12332997|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7850885|NCT01490632|12332998|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7850886|NCT01490632|12332999|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7850887|NCT01490632|12333000|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7850888|NCT01490632|12333001|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7850889|NCT01490632|12332982|FG000|Part C: Washout or Step-Down Period|Adverse Event|0
7949416|NCT02536833|12494962|FG000|Overall Study|Subject Non-Compliance|0
7850890|NCT01490632|12332983|FG001|Part C: Washout or Step-Down Period|Adverse Event|0
7850891|NCT01490632|12332984|FG002|Part C: Washout or Step-Down Period|Adverse Event|0
7850892|NCT01490632|12332985|FG003|Part C: Washout or Step-Down Period|Adverse Event|0
7850893|NCT01490632|12332986|FG004|Part C: Washout or Step-Down Period|Adverse Event|0
7850894|NCT01490632|12332987|FG005|Part C: Washout or Step-Down Period|Adverse Event|0
7850895|NCT01490632|12332988|FG006|Part C: Washout or Step-Down Period|Adverse Event|0
7850896|NCT01490632|12332989|FG007|Part C: Washout or Step-Down Period|Adverse Event|0
7850897|NCT01490632|12332990|FG008|Part C: Washout or Step-Down Period|Adverse Event|0
7850898|NCT01490632|12332991|FG009|Part C: Washout or Step-Down Period|Adverse Event|0
7850899|NCT01490632|12332992|FG010|Part C: Washout or Step-Down Period|Adverse Event|0
7850900|NCT01490632|12332993|FG011|Part C: Washout or Step-Down Period|Adverse Event|0
7850901|NCT01490632|12332994|FG012|Part C: Washout or Step-Down Period|Adverse Event|0
7850902|NCT01490632|12332995|FG013|Part C: Washout or Step-Down Period|Adverse Event|0
7850903|NCT01490632|12332996|FG014|Part C: Washout or Step-Down Period|Adverse Event|2
7850904|NCT01490632|12332997|FG015|Part C: Washout or Step-Down Period|Adverse Event|2
7850905|NCT01490632|12332998|FG016|Part C: Washout or Step-Down Period|Adverse Event|0
7850906|NCT01490632|12332999|FG017|Part C: Washout or Step-Down Period|Adverse Event|0
7850907|NCT01490632|12333000|FG018|Part C: Washout or Step-Down Period|Adverse Event|0
7850908|NCT01490632|12333001|FG019|Part C: Washout or Step-Down Period|Adverse Event|0
7850909|NCT01490632|12332982|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850910|NCT01490632|12332983|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850911|NCT01490632|12332984|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850912|NCT01490632|12332985|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850913|NCT01490632|12332986|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850914|NCT01490632|12332987|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850915|NCT01490632|12332988|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850916|NCT01490632|12332989|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850917|NCT01490632|12332990|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850918|NCT01490632|12332991|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850919|NCT01490632|12332992|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850920|NCT01490632|12332993|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850921|NCT01490632|12332994|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850922|NCT01490632|12332995|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1
7850923|NCT01490632|12332996|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850924|NCT01490632|12332997|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850925|NCT01490632|12332998|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850926|NCT01490632|12332999|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850927|NCT01490632|12333000|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850928|NCT01490632|12333001|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7850929|NCT01490632|12332982|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850930|NCT01490632|12332983|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850931|NCT01490632|12332984|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850932|NCT01490632|12332985|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850933|NCT01490632|12332986|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850934|NCT01490632|12332987|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850935|NCT01490632|12332988|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850936|NCT01490632|12332989|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850937|NCT01490632|12332990|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850938|NCT01490632|12332991|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850939|NCT01490632|12332992|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850940|NCT01490632|12332993|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850941|NCT01490632|12332994|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850942|NCT01490632|12332995|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850943|NCT01490632|12332996|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
7850944|NCT01490632|12332997|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
7850945|NCT01490632|12332998|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850946|NCT01490632|12332999|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850947|NCT01490632|12333000|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850948|NCT01490632|12333001|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7850949|NCT01490632|12332982|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7850950|NCT01490632|12332983|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7850951|NCT01490632|12332984|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7850952|NCT01490632|12332985|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7850953|NCT01490632|12332986|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7850954|NCT01490632|12332987|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7850955|NCT01490632|12332988|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7850956|NCT01490632|12332989|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7850957|NCT01490632|12332990|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7720925|NCT00541970|12145423|FG002|Month 48|Withdrawal by Subject|4
7850958|NCT01490632|12332991|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7850959|NCT01490632|12332992|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7850960|NCT01490632|12332993|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7850961|NCT01490632|12332994|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
7850962|NCT01490632|12332995|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
7850963|NCT01490632|12332996|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
7850964|NCT01490632|12332997|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
7850965|NCT01490632|12332998|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7850966|NCT01490632|12332999|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7850967|NCT01490632|12333000|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7850968|NCT01490632|12333001|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7850969|NCT01490632|12332982|FG000|Part D: Re-Treatment Period|Adverse Event|0
7850970|NCT01490632|12332983|FG001|Part D: Re-Treatment Period|Adverse Event|0
7850971|NCT01490632|12332984|FG002|Part D: Re-Treatment Period|Adverse Event|0
7850972|NCT01490632|12332985|FG003|Part D: Re-Treatment Period|Adverse Event|0
7850973|NCT01490632|12332986|FG004|Part D: Re-Treatment Period|Adverse Event|0
7850974|NCT01490632|12332987|FG005|Part D: Re-Treatment Period|Adverse Event|0
7850975|NCT01490632|12332988|FG006|Part D: Re-Treatment Period|Adverse Event|0
7850976|NCT01490632|12332989|FG007|Part D: Re-Treatment Period|Adverse Event|0
7850977|NCT01490632|12332990|FG008|Part D: Re-Treatment Period|Adverse Event|0
7850978|NCT01490632|12332991|FG009|Part D: Re-Treatment Period|Adverse Event|0
7850979|NCT01490632|12332992|FG010|Part D: Re-Treatment Period|Adverse Event|0
7850980|NCT01490632|12332993|FG011|Part D: Re-Treatment Period|Adverse Event|0
7850981|NCT01490632|12332994|FG012|Part D: Re-Treatment Period|Adverse Event|0
7850982|NCT01490632|12332995|FG013|Part D: Re-Treatment Period|Adverse Event|0
7850983|NCT01490632|12332996|FG014|Part D: Re-Treatment Period|Adverse Event|0
7850984|NCT01490632|12332997|FG015|Part D: Re-Treatment Period|Adverse Event|0
7850985|NCT01490632|12332998|FG016|Part D: Re-Treatment Period|Adverse Event|0
7850986|NCT01490632|12332999|FG017|Part D: Re-Treatment Period|Adverse Event|1
7850987|NCT01490632|12333000|FG018|Part D: Re-Treatment Period|Adverse Event|1
7850988|NCT01490632|12333001|FG019|Part D: Re-Treatment Period|Adverse Event|3
7850989|NCT01490632|12332982|FG000|Part D: Re-Treatment Period|Death|0
7850990|NCT01490632|12332983|FG001|Part D: Re-Treatment Period|Death|0
7850991|NCT01490632|12332984|FG002|Part D: Re-Treatment Period|Death|0
7850992|NCT01490632|12332985|FG003|Part D: Re-Treatment Period|Death|0
7850993|NCT01490632|12332986|FG004|Part D: Re-Treatment Period|Death|0
7850994|NCT01490632|12332987|FG005|Part D: Re-Treatment Period|Death|0
7850995|NCT01490632|12332988|FG006|Part D: Re-Treatment Period|Death|0
7850996|NCT01490632|12332989|FG007|Part D: Re-Treatment Period|Death|0
7850997|NCT01490632|12332990|FG008|Part D: Re-Treatment Period|Death|0
7850998|NCT01490632|12332991|FG009|Part D: Re-Treatment Period|Death|0
7850999|NCT01490632|12332992|FG010|Part D: Re-Treatment Period|Death|0
7851000|NCT01490632|12332993|FG011|Part D: Re-Treatment Period|Death|0
7851001|NCT01490632|12332994|FG012|Part D: Re-Treatment Period|Death|0
7851002|NCT01490632|12332995|FG013|Part D: Re-Treatment Period|Death|0
7851003|NCT01490632|12332996|FG014|Part D: Re-Treatment Period|Death|0
7851004|NCT01490632|12332997|FG015|Part D: Re-Treatment Period|Death|0
7851005|NCT01490632|12332998|FG016|Part D: Re-Treatment Period|Death|0
7851006|NCT01490632|12332999|FG017|Part D: Re-Treatment Period|Death|0
7851007|NCT01490632|12333000|FG018|Part D: Re-Treatment Period|Death|1
7851008|NCT01490632|12333001|FG019|Part D: Re-Treatment Period|Death|0
7851009|NCT01490632|12332982|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0
7851010|NCT01490632|12332983|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0
7851011|NCT01490632|12332984|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0
7851012|NCT01490632|12332985|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0
7851013|NCT01490632|12332986|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0
7851014|NCT01490632|12332987|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0
7851015|NCT01490632|12332988|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0
7851016|NCT01490632|12332989|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0
7851017|NCT01490632|12332990|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0
7851018|NCT01490632|12332991|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0
7851019|NCT01490632|12332992|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0
7851020|NCT01490632|12332993|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0
7851021|NCT01490632|12332994|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0
7851022|NCT01490632|12332995|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0
7851023|NCT01490632|12332996|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0
7851024|NCT01490632|12332997|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0
7851025|NCT01490632|12332998|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0
7851026|NCT01490632|12332999|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3
7851027|NCT01490632|12333000|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1
7851028|NCT01490632|12333001|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2
7851029|NCT01490632|12332982|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0
7851030|NCT01490632|12332983|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0
7851031|NCT01490632|12332984|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0
7851032|NCT01490632|12332985|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0
7851033|NCT01490632|12332986|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0
7851034|NCT01490632|12332987|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0
7851035|NCT01490632|12332988|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0
7851036|NCT01490632|12332989|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0
7851037|NCT01490632|12332990|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0
7851038|NCT01490632|12332991|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0
7851039|NCT01490632|12332992|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0
7851040|NCT01490632|12332993|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0
7851041|NCT01490632|12332994|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0
7851042|NCT01490632|12332995|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0
7851043|NCT01490632|12332996|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0
7851044|NCT01490632|12332997|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0
7851045|NCT01490632|12332998|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0
7851046|NCT01490632|12332999|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0
7851047|NCT01490632|12333000|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1
7851048|NCT01490632|12333001|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0
7851049|NCT01490632|12332982|FG000|Part D: Re-Treatment Period|Physician Decision|0
7851050|NCT01490632|12332983|FG001|Part D: Re-Treatment Period|Physician Decision|0
7851051|NCT01490632|12332984|FG002|Part D: Re-Treatment Period|Physician Decision|0
7851052|NCT01490632|12332985|FG003|Part D: Re-Treatment Period|Physician Decision|0
7851053|NCT01490632|12332986|FG004|Part D: Re-Treatment Period|Physician Decision|0
7851054|NCT01490632|12332987|FG005|Part D: Re-Treatment Period|Physician Decision|0
7851055|NCT01490632|12332988|FG006|Part D: Re-Treatment Period|Physician Decision|0
7851056|NCT01490632|12332989|FG007|Part D: Re-Treatment Period|Physician Decision|0
7851057|NCT01490632|12332990|FG008|Part D: Re-Treatment Period|Physician Decision|0
7851058|NCT01490632|12332991|FG009|Part D: Re-Treatment Period|Physician Decision|0
7851059|NCT01490632|12332992|FG010|Part D: Re-Treatment Period|Physician Decision|0
7851060|NCT01490632|12332993|FG011|Part D: Re-Treatment Period|Physician Decision|0
7851061|NCT01490632|12332994|FG012|Part D: Re-Treatment Period|Physician Decision|0
7851062|NCT01490632|12332995|FG013|Part D: Re-Treatment Period|Physician Decision|0
7851063|NCT01490632|12332996|FG014|Part D: Re-Treatment Period|Physician Decision|0
7851064|NCT01490632|12332997|FG015|Part D: Re-Treatment Period|Physician Decision|0
7851065|NCT01490632|12332998|FG016|Part D: Re-Treatment Period|Physician Decision|0
7851066|NCT01490632|12332999|FG017|Part D: Re-Treatment Period|Physician Decision|0
7720926|NCT00541970|12145424|FG003|Month 48|Withdrawal by Subject|2
7720927|NCT00541970|12145421|FG000|Month 48|Other|3
7720928|NCT00541970|12145422|FG001|Month 48|Other|1
7851067|NCT01490632|12333000|FG018|Part D: Re-Treatment Period|Physician Decision|1
7851068|NCT01490632|12333001|FG019|Part D: Re-Treatment Period|Physician Decision|1
7851069|NCT01490632|12332982|FG000|Part D: Re-Treatment Period|Protocol Violation|0
7851070|NCT01490632|12332983|FG001|Part D: Re-Treatment Period|Protocol Violation|0
7851071|NCT01490632|12332984|FG002|Part D: Re-Treatment Period|Protocol Violation|0
7851072|NCT01490632|12332985|FG003|Part D: Re-Treatment Period|Protocol Violation|0
7851073|NCT01490632|12332986|FG004|Part D: Re-Treatment Period|Protocol Violation|0
7851074|NCT01490632|12332987|FG005|Part D: Re-Treatment Period|Protocol Violation|0
7851075|NCT01490632|12332988|FG006|Part D: Re-Treatment Period|Protocol Violation|0
7851076|NCT01490632|12332989|FG007|Part D: Re-Treatment Period|Protocol Violation|0
7851077|NCT01490632|12332990|FG008|Part D: Re-Treatment Period|Protocol Violation|0
7851078|NCT01490632|12332991|FG009|Part D: Re-Treatment Period|Protocol Violation|0
7851079|NCT01490632|12332992|FG010|Part D: Re-Treatment Period|Protocol Violation|0
7720929|NCT00541970|12145423|FG002|Month 48|Other|1
7851080|NCT01490632|12332993|FG011|Part D: Re-Treatment Period|Protocol Violation|0
7720930|NCT00541970|12145424|FG003|Month 48|Other|0
7851081|NCT01490632|12332994|FG012|Part D: Re-Treatment Period|Protocol Violation|0
7851082|NCT01490632|12332995|FG013|Part D: Re-Treatment Period|Protocol Violation|0
7851083|NCT01490632|12332996|FG014|Part D: Re-Treatment Period|Protocol Violation|0
7851084|NCT01490632|12332997|FG015|Part D: Re-Treatment Period|Protocol Violation|0
7851085|NCT01490632|12332998|FG016|Part D: Re-Treatment Period|Protocol Violation|0
7851086|NCT01490632|12332999|FG017|Part D: Re-Treatment Period|Protocol Violation|0
7851087|NCT01490632|12333000|FG018|Part D: Re-Treatment Period|Protocol Violation|1
7851088|NCT01490632|12333001|FG019|Part D: Re-Treatment Period|Protocol Violation|0
7720931|NCT00541970|12145421|FG000|Month 48|Lost to Follow-up|66
7720932|NCT00541970|12145422|FG001|Month 48|Lost to Follow-up|68
7720933|NCT00541970|12145423|FG002|Month 48|Lost to Follow-up|68
7851089|NCT01490632|12332982|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851090|NCT01490632|12332983|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851091|NCT01490632|12332984|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851092|NCT01490632|12332985|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851093|NCT01490632|12332986|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851094|NCT01490632|12332987|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851095|NCT01490632|12332988|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851096|NCT01490632|12332989|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851097|NCT01490632|12332990|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851098|NCT01490632|12332991|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851099|NCT01490632|12332992|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851100|NCT01490632|12332993|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851101|NCT01490632|12332994|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851102|NCT01490632|12332995|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851103|NCT01490632|12332996|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851104|NCT01490632|12332997|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851105|NCT01490632|12332998|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0
7851106|NCT01490632|12332999|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1
7851107|NCT01490632|12333000|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1
7851108|NCT01490632|12333001|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1
7851109|NCT01490697|12333050|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
7851110|NCT01490697|12333051|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
7851111|NCT01490814|12333076|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3
7851112|NCT01490814|12333077|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3
7851113|NCT01490814|12333076|FG000|Overall Study|Physician Decision|1
7851114|NCT01490814|12333077|FG001|Overall Study|Physician Decision|0
7851115|NCT01490814|12333076|FG000|Overall Study|Withdrawal by Subject|0
7851116|NCT01490814|12333077|FG001|Overall Study|Withdrawal by Subject|5
7851117|NCT01490840|12333085|FG000|Phase 1|Lost to Follow-up|1
7851118|NCT01490840|12333086|FG001|Phase 1|Lost to Follow-up|0
7851119|NCT01490840|12333085|FG000|Phase 1|Adverse Event|2
7851120|NCT01490840|12333086|FG001|Phase 1|Adverse Event|1
7851121|NCT01490840|12333085|FG000|Phase 1|Withdrawal by Subject|6
7851122|NCT01490840|12333086|FG001|Phase 1|Withdrawal by Subject|5
7851123|NCT01490840|12333085|FG000|Phase 1|Visit 6a omitted|1
7851124|NCT01490840|12333086|FG001|Phase 1|Visit 6a omitted|0
7851125|NCT01490840|12333085|FG000|Phase 2|Withdrawal by Subject|4
7851126|NCT01490840|12333086|FG001|Phase 2|Withdrawal by Subject|3
7851127|NCT01490840|12333085|FG000|Phase 2|Permanent interruption of fingolimod|0
7851128|NCT01490840|12333086|FG001|Phase 2|Permanent interruption of fingolimod|1
7851129|NCT01490840|12333085|FG000|Phase 2|Lost to Follow-up|1
7851130|NCT01490840|12333086|FG001|Phase 2|Lost to Follow-up|1
7851131|NCT01490840|12333085|FG000|Phase 2|Adverse Event|1
7851132|NCT01490840|12333086|FG001|Phase 2|Adverse Event|1
7851133|NCT01490866|12333092|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6
7851134|NCT01490866|12333092|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6
7851135|NCT01490866|12333092|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
7851136|NCT01490866|12333092|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
7851137|NCT01490866|12333092|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
7851138|NCT01490866|12333092|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2
7851139|NCT01490866|12333092|FG000|Axitinib Maintenance Therapy|Disease Progression|30
7851140|NCT01490866|12333092|FG000|Axitinib Maintenance Therapy|Adverse Event|12
7851141|NCT01490866|12333092|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3
7851142|NCT01490866|12333092|FG000|Axitinib Maintenance Therapy|Protocol Violation|2
7851143|NCT01490866|12333092|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2
7851144|NCT01490918|12333106|FG000|Overall Study|Lost to Follow-up|2
7851145|NCT01490918|12333107|FG001|Overall Study|Lost to Follow-up|1
7851146|NCT01490918|12333108|FG002|Overall Study|Lost to Follow-up|0
7851147|NCT01490918|12333106|FG000|Overall Study|Withdrawal by Subject|7
7851148|NCT01490918|12333107|FG001|Overall Study|Withdrawal by Subject|8
7851149|NCT01490918|12333108|FG002|Overall Study|Withdrawal by Subject|3
7851150|NCT01490918|12333106|FG000|Overall Study|Adverse Event|0
7851151|NCT01490918|12333107|FG001|Overall Study|Adverse Event|0
7851152|NCT01490918|12333108|FG002|Overall Study|Adverse Event|1
7851153|NCT01490918|12333106|FG000|Overall Study|other cause|4
7851154|NCT01490918|12333107|FG001|Overall Study|other cause|5
7851155|NCT01490918|12333108|FG002|Overall Study|other cause|8
7720934|NCT00541970|12145424|FG003|Month 48|Lost to Follow-up|73
7851156|NCT01491035|12333145|FG000|Overall Study|Lost to Follow-up|0
7851157|NCT01491035|12333146|FG001|Overall Study|Lost to Follow-up|0
7851158|NCT01491035|12333147|FG002|Overall Study|Lost to Follow-up|0
7851159|NCT01491035|12333148|FG003|Overall Study|Lost to Follow-up|0
7851160|NCT01491035|12333149|FG004|Overall Study|Lost to Follow-up|1
7851161|NCT01491035|12333150|FG005|Overall Study|Lost to Follow-up|0
7851162|NCT01491035|12333151|FG006|Overall Study|Lost to Follow-up|0
7851163|NCT01491035|12333152|FG007|Overall Study|Lost to Follow-up|0
7851164|NCT01491178|12333193|FG000|Overall Study|Adverse Event|1016
7851165|NCT01491178|12333193|FG000|Overall Study|Improvement of NVAF|210
7851166|NCT01491178|12333193|FG000|Overall Study|To conduct invasive treatment|59
7851167|NCT01491178|12333193|FG000|Overall Study|Lost to follow-up (unknown reason)|287
7851168|NCT01491178|12333193|FG000|Overall Study|Lost to follow-up (changing hospital)|545
7851169|NCT01491178|12333193|FG000|Overall Study|To take a contraindication|20
7851170|NCT01491178|12333193|FG000|Overall Study|Other than specified above|657
7851171|NCT01491607|12333210|FG000|Overall Study|Lost to Follow-up|7
7851172|NCT01491607|12333210|FG000|Overall Study|Withdrawal by Subject|3
7851173|NCT01491672|12333283|FG000|Overall Study|Lost to Follow-up|0
7851174|NCT01491672|12333284|FG001|Overall Study|Lost to Follow-up|4
7851175|NCT01491672|12333285|FG002|Overall Study|Lost to Follow-up|1
7851176|NCT01491672|12333283|FG000|Overall Study|Withdrawal by Subject|6
7851177|NCT01491672|12333284|FG001|Overall Study|Withdrawal by Subject|7
7851178|NCT01491672|12333285|FG002|Overall Study|Withdrawal by Subject|0
7851179|NCT01491672|12333283|FG000|Overall Study|Adverse Event|8
7851180|NCT01491672|12333284|FG001|Overall Study|Adverse Event|10
7851181|NCT01491672|12333285|FG002|Overall Study|Adverse Event|4
7851182|NCT01491672|12333283|FG000|Overall Study|Disease progression|42
7851183|NCT01491672|12333284|FG001|Overall Study|Disease progression|34
7851184|NCT01491672|12333285|FG002|Overall Study|Disease progression|6
7851185|NCT01491672|12333283|FG000|Overall Study|Protocol deviation|0
7851186|NCT01491672|12333284|FG001|Overall Study|Protocol deviation|1
7851187|NCT01491672|12333285|FG002|Overall Study|Protocol deviation|0
7851188|NCT01491672|12333283|FG000|Overall Study|Death|0
7851189|NCT01491672|12333284|FG001|Overall Study|Death|4
7851190|NCT01491672|12333285|FG002|Overall Study|Death|0
7851191|NCT01491737|12333297|FG000|Overall Study|Withdrawal by Subject|20
7851192|NCT01491737|12333298|FG001|Overall Study|Withdrawal by Subject|17
7851193|NCT01491737|12333297|FG000|Overall Study|Lost to Follow-up|2
7851194|NCT01491737|12333298|FG001|Overall Study|Lost to Follow-up|10
7851195|NCT01491737|12333297|FG000|Overall Study|Death|63
7851196|NCT01491737|12333298|FG001|Overall Study|Death|57
7851197|NCT01491737|12333297|FG000|Overall Study|Study Termination by Sponsor|36
7851198|NCT01491737|12333298|FG001|Overall Study|Study Termination by Sponsor|36
7851199|NCT01491737|12333297|FG000|Overall Study|Reason Not Specified|8
7851200|NCT01491737|12333298|FG001|Overall Study|Reason Not Specified|9
7851201|NCT01491802|12333304|FG000|Overall Study|Adverse Event|1
7851202|NCT01491802|12333305|FG001|Overall Study|Adverse Event|1
7851203|NCT01491802|12333304|FG000|Overall Study|Withdrawal by Subject|0
7851204|NCT01491802|12333305|FG001|Overall Study|Withdrawal by Subject|1
7851205|NCT01491841|12333312|FG000|Overall Study|Screen Failure|10
7851206|NCT01491841|12333312|FG000|Overall Study|Withdrawal by Subject|1
7851207|NCT01491854|12333324|FG000|Overall Study|mainly due to premature termination|93
7851208|NCT01491854|12333324|FG000|Overall Study|Death|1
7851209|NCT01491854|12333324|FG000|Overall Study|Withdrawal by Subject|3
7851210|NCT01491854|12333324|FG000|Overall Study|Lost to Follow-up|33
7851211|NCT01491919|12333331|FG000|Overall Study|Insufficient PK sampling|1
7851212|NCT01491919|12333332|FG001|Overall Study|Insufficient PK sampling|2
7851213|NCT01491919|12333333|FG002|Overall Study|Insufficient PK sampling|1
7851214|NCT01491945|12333343|FG000|Overall Study|Death|30
7851215|NCT01491945|12333343|FG000|Overall Study|Withdrwan/LTF|16
7851216|NCT01491945|12333343|FG000|Overall Study|Conversion|4
7851217|NCT01491945|12333343|FG000|Overall Study|Missed Visit|1
7851218|NCT01492088|12333368|FG000|Overall Study|Withdrawal by Patient|0
7851219|NCT01492088|12333369|FG001|Overall Study|Withdrawal by Patient|2
7851220|NCT01492088|12333370|FG002|Overall Study|Withdrawal by Patient|0
7851221|NCT01492088|12333368|FG000|Overall Study|Death|1
7851222|NCT01492088|12333369|FG001|Overall Study|Death|6
7851223|NCT01492088|12333370|FG002|Overall Study|Death|2
7851224|NCT01492088|12333368|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2
7851225|NCT01492088|12333369|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0
7851226|NCT01492088|12333370|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1
7851227|NCT01492088|12333368|FG000|Overall Study|Alive at Last Follow-up|0
7851228|NCT01492088|12333369|FG001|Overall Study|Alive at Last Follow-up|6
7851229|NCT01492088|12333370|FG002|Overall Study|Alive at Last Follow-up|11
7851230|NCT01492101|12333383|FG000|Overall Study|Death|323
7851231|NCT01492101|12333384|FG001|Overall Study|Death|322
7851232|NCT01492101|12333383|FG000|Overall Study|Withdrawal by Subject|14
7851233|NCT01492101|12333384|FG001|Overall Study|Withdrawal by Subject|18
7851234|NCT01492101|12333383|FG000|Overall Study|Lost to Follow-up|0
7851235|NCT01492101|12333384|FG001|Overall Study|Lost to Follow-up|2
7863456|NCT01606137|12352787|FG000|Overall Study|Wanted to try another treatment|1
7863457|NCT01606137|12352787|FG000|Overall Study|Patient leaving country|1
7863458|NCT01606137|12352787|FG000|Overall Study|Personal reasons|1
7851236|NCT01492400|12333401|FG000|Overall Study|Miscellaneous Reasons|2
7851237|NCT01492400|12333402|FG001|Overall Study|Miscellaneous Reasons|3
7851238|NCT01492400|12333401|FG000|Overall Study|Personal Reasons|0
7851239|NCT01492400|12333402|FG001|Overall Study|Personal Reasons|5
7851240|NCT01492400|12333401|FG000|Overall Study|Lost to Follow-up|3
7851241|NCT01492400|12333402|FG001|Overall Study|Lost to Follow-up|1
7851242|NCT01492400|12333401|FG000|Overall Study|Pregnancy|0
7851243|NCT01492400|12333402|FG001|Overall Study|Pregnancy|1
7851244|NCT01492400|12333401|FG000|Overall Study|Lack of Efficacy|1
7851245|NCT01492400|12333402|FG001|Overall Study|Lack of Efficacy|1
7851246|NCT01492400|12333401|FG000|Overall Study|Adverse Event|10
7851247|NCT01492400|12333402|FG001|Overall Study|Adverse Event|5
7851248|NCT01492426|12333410|FG000|Treatment|Death|0
7851249|NCT01492426|12333411|FG001|Treatment|Death|1
7851250|NCT01492426|12333410|FG000|Treatment|Other|1
7851251|NCT01492426|12333411|FG001|Treatment|Other|0
7851252|NCT01492426|12333410|FG000|Treatment|Adverse Event|25
7851253|NCT01492426|12333411|FG001|Treatment|Adverse Event|25
7851254|NCT01492426|12333410|FG000|Treatment|Lack of Efficacy|38
7851255|NCT01492426|12333411|FG001|Treatment|Lack of Efficacy|5
7851256|NCT01492426|12333410|FG000|Treatment|Participant withdrew consent|1
7851257|NCT01492426|12333411|FG001|Treatment|Participant withdrew consent|2
7851258|NCT01492426|12333410|FG000|Treatment|Poor compliance/noncompliance|1
7851259|NCT01492426|12333411|FG001|Treatment|Poor compliance/noncompliance|0
7851260|NCT01492426|12333410|FG000|Treatment|Subject requested discontinue study drug|7
7851261|NCT01492426|12333411|FG001|Treatment|Subject requested discontinue study drug|3
7851262|NCT01492426|12333410|FG000|Treatment|Lost to Follow-up|9
7851263|NCT01492426|12333411|FG001|Treatment|Lost to Follow-up|4
7851264|NCT01492426|12333410|FG000|Treatment|Participant does not meet study criteria|1
7851265|NCT01492426|12333411|FG001|Treatment|Participant does not meet study criteria|0
7851266|NCT01492426|12333410|FG000|Follow-Up|Protocol Requires no Follow-Up|2
7851267|NCT01492426|12333411|FG001|Follow-Up|Protocol Requires no Follow-Up|1
7851268|NCT01492426|12333410|FG000|Follow-Up|Death|1
7851269|NCT01492426|12333411|FG001|Follow-Up|Death|0
7851270|NCT01492426|12333410|FG000|Follow-Up|Other|4
7851271|NCT01492426|12333411|FG001|Follow-Up|Other|2
7851272|NCT01492426|12333410|FG000|Follow-Up|Participant Withdrew Consent|6
7851273|NCT01492426|12333411|FG001|Follow-Up|Participant Withdrew Consent|1
7851274|NCT01492426|12333410|FG000|Follow-Up|Lost to Follow-up|12
7851275|NCT01492426|12333411|FG001|Follow-Up|Lost to Follow-up|6
7851276|NCT01492439|12333423|FG000|Overall Study|Withdrew from RTE|4
7851277|NCT01492439|12333424|FG001|Overall Study|Withdrew from RTE|9
7851278|NCT01492686|12333462|FG000|Double-blind Phase|Adverse Event|0
7851279|NCT01492686|12333463|FG001|Double-blind Phase|Adverse Event|2
7851280|NCT01492686|12333462|FG000|Double-blind Phase|Physician Decision|0
7851281|NCT01492686|12333463|FG001|Double-blind Phase|Physician Decision|1
7851282|NCT01492686|12333462|FG000|Double-blind Phase|Withdrawal by Subject|0
7851283|NCT01492686|12333463|FG001|Double-blind Phase|Withdrawal by Subject|2
7851284|NCT01492686|12333462|FG000|Double-blind Phase|Due to a discontinuation criterion|2
7851285|NCT01492686|12333463|FG001|Double-blind Phase|Due to a discontinuation criterion|3
7851286|NCT01492686|12333462|FG000|Open-label Phase|Adverse Event|1
7851287|NCT01492686|12333463|FG001|Open-label Phase|Adverse Event|2
7851288|NCT01492686|12333462|FG000|Open-label Phase|Physician Decision|1
7851289|NCT01492686|12333463|FG001|Open-label Phase|Physician Decision|0
7851290|NCT01492686|12333462|FG000|Open-label Phase|Withdrawal by Subject|6
7851291|NCT01492686|12333463|FG001|Open-label Phase|Withdrawal by Subject|7
7851292|NCT01492686|12333462|FG000|Open-label Phase|Due to a discontinuation criterion|4
7851293|NCT01492686|12333463|FG001|Open-label Phase|Due to a discontinuation criterion|9
7851294|NCT01493089|12333491|FG000|Overall Study|Protocol Violation|2
7851295|NCT01493089|12333492|FG001|Overall Study|Protocol Violation|2
7851296|NCT01493089|12333491|FG000|Overall Study|Withdrawal by Subject|1
7851297|NCT01493089|12333492|FG001|Overall Study|Withdrawal by Subject|0
7851298|NCT01493089|12333491|FG000|Overall Study|Physician Decision|0
7851299|NCT01493089|12333492|FG001|Overall Study|Physician Decision|1
7851300|NCT01493284|12333513|FG000|Overall Study|Death|29
7851301|NCT01493284|12333513|FG000|Overall Study|Withdrawal by Subject|32
7851302|NCT01493414|12333517|FG000|Overall Study|Adverse Event|405
7851303|NCT01493414|12333517|FG000|Overall Study|Disease progression|204
7851304|NCT01493414|12333517|FG000|Overall Study|Death|101
7851305|NCT01493414|12333517|FG000|Overall Study|Physician Decision|93
7851306|NCT01493414|12333517|FG000|Overall Study|Withdrawal by Subject|79
7851307|NCT01493414|12333517|FG000|Overall Study|Protocol deviation|27
7851308|NCT01493414|12333517|FG000|Overall Study|Administrative problems|25
7851309|NCT01493414|12333517|FG000|Overall Study|Lost to Follow-up|16
7851310|NCT01493427|12333525|FG000|Overall Study|Adverse Event|10
7851311|NCT01493427|12333525|FG000|Overall Study|Personal Reasons|4
7851312|NCT01493427|12333525|FG000|Overall Study|Lost to Follow-up|2
7851313|NCT01493427|12333525|FG000|Overall Study|Inability to Follow Instructions|2
7851314|NCT01493427|12333525|FG000|Overall Study|Other|2
7851315|NCT01493531|12333532|FG000|Overall Study|Adverse Event|4
7851316|NCT01493531|12333533|FG001|Overall Study|Adverse Event|12
7851317|NCT01493531|12333534|FG002|Overall Study|Adverse Event|9
7851318|NCT01493531|12333532|FG000|Overall Study|Gout flare|3
7851319|NCT01493531|12333533|FG001|Overall Study|Gout flare|0
7851320|NCT01493531|12333534|FG002|Overall Study|Gout flare|2
7851321|NCT01493531|12333532|FG000|Overall Study|Protocol Violation|8
7851322|NCT01493531|12333533|FG001|Overall Study|Protocol Violation|15
7851323|NCT01493531|12333534|FG002|Overall Study|Protocol Violation|12
7851324|NCT01493531|12333532|FG000|Overall Study|Sponsor terminated study|5
7851325|NCT01493531|12333533|FG001|Overall Study|Sponsor terminated study|2
7851326|NCT01493531|12333534|FG002|Overall Study|Sponsor terminated study|3
7851327|NCT01493531|12333532|FG000|Overall Study|Lost to Follow-up|5
7851328|NCT01493531|12333533|FG001|Overall Study|Lost to Follow-up|7
7851329|NCT01493531|12333534|FG002|Overall Study|Lost to Follow-up|11
7851330|NCT01493531|12333532|FG000|Overall Study|Withdrawal by Subject|16
7851331|NCT01493531|12333533|FG001|Overall Study|Withdrawal by Subject|13
7851332|NCT01493531|12333534|FG002|Overall Study|Withdrawal by Subject|11
7851333|NCT01493531|12333532|FG000|Overall Study|Death|0
7851334|NCT01493531|12333533|FG001|Overall Study|Death|1
7851335|NCT01493531|12333534|FG002|Overall Study|Death|0
7851336|NCT01493557|12333545|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
7851337|NCT01493557|12333546|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
7851338|NCT01493557|12333547|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
7851339|NCT01493557|12333545|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
7851340|NCT01493557|12333546|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
7851341|NCT01493557|12333547|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9
7851342|NCT01493557|12333545|FG000|Not Randomized to Management Strategies|Other adverse event|0
7851343|NCT01493557|12333546|FG001|Not Randomized to Management Strategies|Other adverse event|0
7851344|NCT01493557|12333547|FG002|Not Randomized to Management Strategies|Other adverse event|54
7851345|NCT01493557|12333545|FG000|Not Randomized to Management Strategies|Protocol Violation|0
7851346|NCT01493557|12333546|FG001|Not Randomized to Management Strategies|Protocol Violation|0
7851347|NCT01493557|12333547|FG002|Not Randomized to Management Strategies|Protocol Violation|1
7851348|NCT01493557|12333545|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0
7851349|NCT01493557|12333546|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0
7851350|NCT01493557|12333547|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4
7851351|NCT01493557|12333545|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0
7851352|NCT01493557|12333546|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0
7851353|NCT01493557|12333547|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10
7851354|NCT01493557|12333545|FG000|Not Randomized to Management Strategies|Early termination|0
7851355|NCT01493557|12333546|FG001|Not Randomized to Management Strategies|Early termination|0
7851356|NCT01493557|12333547|FG002|Not Randomized to Management Strategies|Early termination|34
7851357|NCT01493557|12333545|FG000|Not Randomized to Management Strategies|Other than stated above|0
7851358|NCT01493557|12333546|FG001|Not Randomized to Management Strategies|Other than stated above|0
7851359|NCT01493557|12333547|FG002|Not Randomized to Management Strategies|Other than stated above|21
7851360|NCT01493557|12333545|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3
7851361|NCT01493557|12333546|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2
7851362|NCT01493557|12333547|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0
7851363|NCT01493557|12333545|FG000|Randomized to Management Strategies|Other adverse event|8
7851364|NCT01493557|12333546|FG001|Randomized to Management Strategies|Other adverse event|5
7949417|NCT02536833|12494963|FG001|Overall Study|Subject Non-Compliance|1
7949418|NCT02536833|12494964|FG002|Overall Study|Subject Non-Compliance|1
7949419|NCT02536833|12494965|FG003|Overall Study|Subject Non-Compliance|0
7949420|NCT02536833|12494962|FG000|Overall Study|Withdrawal by Subject|4
7949421|NCT02536833|12494963|FG001|Overall Study|Withdrawal by Subject|3
7949422|NCT02536833|12494964|FG002|Overall Study|Withdrawal by Subject|5
7949423|NCT02536833|12494965|FG003|Overall Study|Withdrawal by Subject|11
7949424|NCT02536846|12494976|FG000|Overall Study|Withdrawal by Subject|1
7949425|NCT02536963|12494981|FG000|Overall Study|Withdrawal by Subject|18
7949426|NCT02536976|12494987|FG000|Overall Study|Physician Decision|0
7949427|NCT02536976|12494988|FG001|Overall Study|Physician Decision|1
7949428|NCT02537015|12494996|FG000|Overall Study|Adverse Event|3
7949429|NCT02537015|12494996|FG000|Overall Study|Withdrawal by Subject|2
7949430|NCT02537015|12494996|FG000|Overall Study|Other Miscellaneous Reasons|1
7949431|NCT02537431|12495000|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1
7949432|NCT02537522|12495013|FG000|Phase I - Contralateral|Subject no longer eligible|15
7949433|NCT02537522|12495014|FG001|Phase I - Contralateral|Subject no longer eligible|7
7949434|NCT02537522|12495015|FG002|Phase I - Contralateral|Subject no longer eligible|0
7949435|NCT02537522|12495016|FG003|Phase I - Contralateral|Subject no longer eligible|0
7949436|NCT02537522|12495013|FG000|Phase I - Contralateral|Withdrawal by Subject|0
7949437|NCT02537522|12495014|FG001|Phase I - Contralateral|Withdrawal by Subject|1
7949438|NCT02537522|12495015|FG002|Phase I - Contralateral|Withdrawal by Subject|0
7949439|NCT02537522|12495016|FG003|Phase I - Contralateral|Withdrawal by Subject|0
7949440|NCT02537522|12495013|FG000|Phase I - Contralateral|incorrect randomization|0
7949441|NCT02537522|12495014|FG001|Phase I - Contralateral|incorrect randomization|1
7949442|NCT02537522|12495015|FG002|Phase I - Contralateral|incorrect randomization|0
7949443|NCT02537522|12495016|FG003|Phase I - Contralateral|incorrect randomization|0
7949444|NCT02537522|12495013|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0
7949445|NCT02537522|12495014|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1
7949446|NCT02537522|12495015|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0
7949447|NCT02537522|12495016|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0
7949448|NCT02537522|12495013|FG000|Phase II - Period 1 Bilateral|Adverse Event|0
7949449|NCT02537522|12495014|FG001|Phase II - Period 1 Bilateral|Adverse Event|0
7949450|NCT02537522|12495015|FG002|Phase II - Period 1 Bilateral|Adverse Event|0
7851365|NCT01493557|12333547|FG002|Randomized to Management Strategies|Other adverse event|0
7851366|NCT01493557|12333545|FG000|Randomized to Management Strategies|Protocol Violation|3
7851367|NCT01493557|12333546|FG001|Randomized to Management Strategies|Protocol Violation|0
7851368|NCT01493557|12333547|FG002|Randomized to Management Strategies|Protocol Violation|0
7851369|NCT01493557|12333545|FG000|Randomized to Management Strategies|Withdrawal by Subject|0
7851370|NCT01493557|12333546|FG001|Randomized to Management Strategies|Withdrawal by Subject|1
7851371|NCT01493557|12333547|FG002|Randomized to Management Strategies|Withdrawal by Subject|0
7851372|NCT01493557|12333545|FG000|Randomized to Management Strategies|Other than stated above|1
7851373|NCT01493557|12333546|FG001|Randomized to Management Strategies|Other than stated above|3
7851374|NCT01493557|12333547|FG002|Randomized to Management Strategies|Other than stated above|0
7851375|NCT01493557|12333545|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1
7851376|NCT01493557|12333546|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1
7949451|NCT02537522|12495016|FG003|Phase II - Period 1 Bilateral|Adverse Event|1
7949452|NCT02537574|12495025|FG000|Overall Study|Adverse Event|1
7851377|NCT01493557|12333547|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0
7851378|NCT01493557|12333545|FG000|Adding the Second Strategy|Other adverse event|1
7851379|NCT01493557|12333546|FG001|Adding the Second Strategy|Other adverse event|2
7851380|NCT01493557|12333547|FG002|Adding the Second Strategy|Other adverse event|0
7851381|NCT01493557|12333545|FG000|Adding the Second Strategy|Withdrawal by Subject|0
7851382|NCT01493557|12333546|FG001|Adding the Second Strategy|Withdrawal by Subject|1
7851383|NCT01493557|12333547|FG002|Adding the Second Strategy|Withdrawal by Subject|0
7851384|NCT01493687|12333583|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2
7851385|NCT01493687|12333584|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0
7851386|NCT01493687|12333583|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
7851387|NCT01493687|12333584|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
7851388|NCT01493687|12333583|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7
7851389|NCT01493687|12333584|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4
7851390|NCT01493687|12333583|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
7851391|NCT01493687|12333584|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
7851392|NCT01493687|12333583|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
7851393|NCT01493687|12333584|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
7851394|NCT01493687|12333583|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
7851395|NCT01493687|12333584|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
7851396|NCT01493687|12333583|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
7851397|NCT01493687|12333584|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
7851398|NCT01493687|12333583|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5
7851399|NCT01493687|12333584|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1
7851400|NCT01493687|12333583|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
7851401|NCT01493687|12333584|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
7851402|NCT01493687|12333583|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5
7851403|NCT01493687|12333584|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4
7851404|NCT01493687|12333583|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
7851405|NCT01493687|12333584|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
7851406|NCT01493687|12333583|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
7851407|NCT01493687|12333584|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
7851408|NCT01493687|12333583|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
7851409|NCT01493687|12333584|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
7851410|NCT01493687|12333583|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
7851411|NCT01493687|12333584|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
7851412|NCT01493687|12333583|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0
7851413|NCT01493687|12333584|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1
7851414|NCT01493778|12333596|FG000|Overall Study|Withdrawal by Subject|8
7851415|NCT01493960|12333623|FG000|Overall Study|Adverse Event|0
7851416|NCT01493960|12333624|FG001|Overall Study|Adverse Event|1
7851417|NCT01493960|12333623|FG000|Overall Study|Lack of Efficacy|15
7851418|NCT01493960|12333624|FG001|Overall Study|Lack of Efficacy|9
7851419|NCT01493960|12333623|FG000|Overall Study|Protocol Violation|3
7851420|NCT01493960|12333624|FG001|Overall Study|Protocol Violation|0
7851421|NCT01493960|12333623|FG000|Overall Study|Withdrawal by Subject|10
7851422|NCT01493960|12333624|FG001|Overall Study|Withdrawal by Subject|4
7851423|NCT01493960|12333623|FG000|Overall Study|Non-specified|4
7851424|NCT01493960|12333624|FG001|Overall Study|Non-specified|4
7851425|NCT01494038|12333632|FG000|Overall Study|Protocol Violation|1
7851426|NCT01494038|12333633|FG001|Overall Study|Protocol Violation|1
7851427|NCT01494038|12333632|FG000|Overall Study|Lost to Follow-up|18
7851428|NCT01494038|12333633|FG001|Overall Study|Lost to Follow-up|20
7851429|NCT01494038|12333632|FG000|Overall Study|Withdrawal by Subject|44
7851430|NCT01494038|12333633|FG001|Overall Study|Withdrawal by Subject|34
7851431|NCT01494038|12333632|FG000|Overall Study|Not able to get to clinic|21
7851432|NCT01494038|12333633|FG001|Overall Study|Not able to get to clinic|15
7851433|NCT01494038|12333632|FG000|Overall Study|Not willing to adhere to reqs|2
7851434|NCT01494038|12333633|FG001|Overall Study|Not willing to adhere to reqs|9
7851435|NCT01494038|12333632|FG000|Overall Study|Death|2
7851436|NCT01494038|12333633|FG001|Overall Study|Death|4
7851437|NCT01494298|12333665|FG000|Overall Study|Protocol Violation|2
7851438|NCT01494298|12333666|FG001|Overall Study|Protocol Violation|8
7851439|NCT01494350|12333674|FG000|Overall Study|Worsening of lesion|1
7851440|NCT01494467|12333680|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1
7851441|NCT01494467|12333681|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0
7851442|NCT01494467|12333680|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6
7851443|NCT01494467|12333681|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4
7851444|NCT01494467|12333680|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
7851445|NCT01494467|12333681|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
7851446|NCT01494467|12333680|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
7851447|NCT01494467|12333681|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
7851448|NCT01494467|12333680|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
7851449|NCT01494467|12333681|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
7851450|NCT01494467|12333680|FG000|Part A Vehicle Control (12 Weeks)|Other|1
7851451|NCT01494467|12333681|FG001|Part A Vehicle Control (12 Weeks)|Other|1
7851452|NCT01494467|12333680|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
7851453|NCT01494467|12333681|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
7851454|NCT01494467|12333680|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2
7851455|NCT01494467|12333681|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0
7851456|NCT01494467|12333680|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
7851457|NCT01494467|12333681|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
7851458|NCT01494467|12333680|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3
7851459|NCT01494467|12333681|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5
7851460|NCT01494467|12333680|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
7851461|NCT01494467|12333681|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
7851462|NCT01494467|12333680|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
7851463|NCT01494467|12333681|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
7851464|NCT01494467|12333680|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
7851465|NCT01494467|12333681|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
7851466|NCT01494467|12333680|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
7851467|NCT01494467|12333681|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
7851468|NCT01494506|12333696|FG000|Overall Study|Lack of Efficacy|77
7851469|NCT01494506|12333697|FG001|Overall Study|Lack of Efficacy|83
7851470|NCT01494506|12333698|FG002|Overall Study|Lack of Efficacy|57
7851471|NCT01494506|12333696|FG000|Overall Study|Adverse Event|17
7851472|NCT01494506|12333697|FG001|Overall Study|Adverse Event|10
7851473|NCT01494506|12333698|FG002|Overall Study|Adverse Event|11
7851474|NCT01494506|12333696|FG000|Overall Study|Death|9
7851475|NCT01494506|12333697|FG001|Overall Study|Death|5
7851476|NCT01494506|12333698|FG002|Overall Study|Death|2
7851477|NCT01494506|12333696|FG000|Overall Study|Physician Decision|7
7851478|NCT01494506|12333697|FG001|Overall Study|Physician Decision|5
7851479|NCT01494506|12333698|FG002|Overall Study|Physician Decision|4
7851480|NCT01494506|12333696|FG000|Overall Study|Withdrawal by Subject|17
7851481|NCT01494506|12333697|FG001|Overall Study|Withdrawal by Subject|20
7851482|NCT01494506|12333698|FG002|Overall Study|Withdrawal by Subject|14
7851483|NCT01494506|12333696|FG000|Overall Study|Clinical Deterioration|21
7851484|NCT01494506|12333697|FG001|Overall Study|Clinical Deterioration|17
7851485|NCT01494506|12333698|FG002|Overall Study|Clinical Deterioration|13
7851486|NCT01494506|12333696|FG000|Overall Study|Sponsor Decision|0
7851487|NCT01494506|12333697|FG001|Overall Study|Sponsor Decision|0
7851488|NCT01494506|12333698|FG002|Overall Study|Sponsor Decision|1
7851489|NCT01494506|12333696|FG000|Overall Study|Other|0
7851490|NCT01494506|12333697|FG001|Overall Study|Other|3
7851491|NCT01494506|12333698|FG002|Overall Study|Other|1
7851492|NCT01494532|12333714|FG000|Overall Study|Adverse Event|4
7851493|NCT01494532|12333715|FG001|Overall Study|Adverse Event|1
7851494|NCT01494532|12333716|FG002|Overall Study|Adverse Event|8
7851495|NCT01494532|12333717|FG003|Overall Study|Adverse Event|6
7851496|NCT01494532|12333718|FG004|Overall Study|Adverse Event|5
7851497|NCT01494532|12333719|FG005|Overall Study|Adverse Event|0
7851498|NCT01494532|12333714|FG000|Overall Study|Lack of Efficacy|0
7851499|NCT01494532|12333715|FG001|Overall Study|Lack of Efficacy|0
7851500|NCT01494532|12333716|FG002|Overall Study|Lack of Efficacy|0
7851501|NCT01494532|12333717|FG003|Overall Study|Lack of Efficacy|0
7851502|NCT01494532|12333718|FG004|Overall Study|Lack of Efficacy|2
7851503|NCT01494532|12333719|FG005|Overall Study|Lack of Efficacy|0
7851504|NCT01494532|12333714|FG000|Overall Study|Protocol deviation|2
7851505|NCT01494532|12333715|FG001|Overall Study|Protocol deviation|1
7851506|NCT01494532|12333716|FG002|Overall Study|Protocol deviation|3
7851507|NCT01494532|12333717|FG003|Overall Study|Protocol deviation|2
7851508|NCT01494532|12333718|FG004|Overall Study|Protocol deviation|3
7851509|NCT01494532|12333719|FG005|Overall Study|Protocol deviation|0
7851510|NCT01494532|12333714|FG000|Overall Study|Protocol-defined stopping criteria|0
7851511|NCT01494532|12333715|FG001|Overall Study|Protocol-defined stopping criteria|0
7851512|NCT01494532|12333716|FG002|Overall Study|Protocol-defined stopping criteria|1
7851513|NCT01494532|12333717|FG003|Overall Study|Protocol-defined stopping criteria|0
7851514|NCT01494532|12333718|FG004|Overall Study|Protocol-defined stopping criteria|0
7851515|NCT01494532|12333719|FG005|Overall Study|Protocol-defined stopping criteria|0
7851516|NCT01494532|12333714|FG000|Overall Study|Lost to Follow-up|1
7851517|NCT01494532|12333715|FG001|Overall Study|Lost to Follow-up|0
7851518|NCT01494532|12333716|FG002|Overall Study|Lost to Follow-up|0
7851519|NCT01494532|12333717|FG003|Overall Study|Lost to Follow-up|2
7851520|NCT01494532|12333718|FG004|Overall Study|Lost to Follow-up|0
7851521|NCT01494532|12333719|FG005|Overall Study|Lost to Follow-up|0
7851522|NCT01494532|12333714|FG000|Overall Study|Physician Decision|0
7851523|NCT01494532|12333715|FG001|Overall Study|Physician Decision|1
7851524|NCT01494532|12333716|FG002|Overall Study|Physician Decision|1
7851525|NCT01494532|12333717|FG003|Overall Study|Physician Decision|2
7851526|NCT01494532|12333718|FG004|Overall Study|Physician Decision|0
7851527|NCT01494532|12333719|FG005|Overall Study|Physician Decision|0
7851528|NCT01494532|12333714|FG000|Overall Study|Withdrawal by Subject|3
7851529|NCT01494532|12333715|FG001|Overall Study|Withdrawal by Subject|1
7851530|NCT01494532|12333716|FG002|Overall Study|Withdrawal by Subject|4
7851531|NCT01494532|12333717|FG003|Overall Study|Withdrawal by Subject|3
7851532|NCT01494532|12333718|FG004|Overall Study|Withdrawal by Subject|2
7851533|NCT01494532|12333719|FG005|Overall Study|Withdrawal by Subject|0
7851534|NCT01494584|12333741|FG000|Overall Study|Study Closed/Terminated|1
7851535|NCT01494610|12333764|FG000|Period 1|Withdrawal by Subject|1
7851536|NCT01494610|12333765|FG001|Period 1|Withdrawal by Subject|1
7851537|NCT01494610|12333764|FG000|Period 3|Adverse Event|1
7851538|NCT01494610|12333765|FG001|Period 3|Adverse Event|0
7851539|NCT01494610|12333764|FG000|Period 3|Withdrawal by Subject|1
7851540|NCT01494610|12333765|FG001|Period 3|Withdrawal by Subject|0
7851541|NCT01494610|12333764|FG000|Period 4|Protocol Violation|1
7851542|NCT01494610|12333765|FG001|Period 4|Protocol Violation|0
7851543|NCT01494649|12333779|FG000|Overall Study|Lost to Follow-up|0
7851544|NCT01494649|12333780|FG001|Overall Study|Lost to Follow-up|1
7851545|NCT01494818|12333799|FG000|Overall Study|Relocation|1
7851546|NCT01494818|12333800|FG001|Overall Study|Relocation|2
7851547|NCT01494818|12333799|FG000|Overall Study|Lost to Follow-up|1
7851548|NCT01494818|12333800|FG001|Overall Study|Lost to Follow-up|0
7851549|NCT01494922|12333806|FG000|Overall Study|Adverse Event|1
7851550|NCT01494987|12333812|FG000|Overall Study|Adverse Event|6
7851551|NCT01494987|12333813|FG001|Overall Study|Adverse Event|5
7851552|NCT01494987|12333812|FG000|Overall Study|Hyperglycemia|6
7851553|NCT01494987|12333813|FG001|Overall Study|Hyperglycemia|4
7851554|NCT01494987|12333812|FG000|Overall Study|Investigator's Discretion|1
7851555|NCT01494987|12333813|FG001|Overall Study|Investigator's Discretion|2
7851556|NCT01494987|12333812|FG000|Overall Study|Lost to Follow-up|1
7851557|NCT01494987|12333813|FG001|Overall Study|Lost to Follow-up|1
7851558|NCT01494987|12333812|FG000|Overall Study|Protocol Violation|3
7851559|NCT01494987|12333813|FG001|Overall Study|Protocol Violation|3
7851560|NCT01494987|12333812|FG000|Overall Study|Subject Non-Compliance|9
7851561|NCT01494987|12333813|FG001|Overall Study|Subject Non-Compliance|10
7851562|NCT01494987|12333812|FG000|Overall Study|Subject Withdrew Consent|2
7851563|NCT01494987|12333813|FG001|Overall Study|Subject Withdrew Consent|3
7851564|NCT01495000|12333821|FG000|Overall Study|Lost to Follow-up|2
7851565|NCT01495000|12333822|FG001|Overall Study|Lost to Follow-up|2
7851566|NCT01495000|12333821|FG000|Overall Study|Protocol Violation|1
7851567|NCT01495000|12333822|FG001|Overall Study|Protocol Violation|0
7851568|NCT01495000|12333821|FG000|Overall Study|Withdrawal by Subject|10
7851569|NCT01495000|12333822|FG001|Overall Study|Withdrawal by Subject|10
7851570|NCT01495702|12333878|FG000|Randomized Phase|Randomized But Not Treated|1
7851571|NCT01495702|12333879|FG001|Randomized Phase|Randomized But Not Treated|4
7851572|NCT01495702|12333878|FG000|Randomized Phase|Adverse Event|2
7851573|NCT01495702|12333879|FG001|Randomized Phase|Adverse Event|2
7851574|NCT01495702|12333878|FG000|Randomized Phase|Death|1
7851575|NCT01495702|12333879|FG001|Randomized Phase|Death|0
7851576|NCT01495702|12333878|FG000|Randomized Phase|Lack of Efficacy|2
7851577|NCT01495702|12333879|FG001|Randomized Phase|Lack of Efficacy|0
7851578|NCT01495702|12333878|FG000|Randomized Phase|Investigators Discretion|2
7851579|NCT01495702|12333879|FG001|Randomized Phase|Investigators Discretion|0
7851580|NCT01495702|12333878|FG000|Randomized Phase|Withdrew Consent|10
7851581|NCT01495702|12333879|FG001|Randomized Phase|Withdrew Consent|18
7851582|NCT01495702|12333878|FG000|Randomized Phase|Lost to Follow-up|4
7851583|NCT01495702|12333879|FG001|Randomized Phase|Lost to Follow-up|3
7851584|NCT01495702|12333878|FG000|Randomized Phase|Participant Noncompliance|1
7851585|NCT01495702|12333879|FG001|Randomized Phase|Participant Noncompliance|0
7851586|NCT01495702|12333878|FG000|Randomized Phase|Protocol Violation|3
7851587|NCT01495702|12333879|FG001|Randomized Phase|Protocol Violation|1
7851588|NCT01495793|12333886|FG000|Overall Study|Lost to Follow-up|1
7851589|NCT01495793|12333886|FG000|Overall Study|Violation of inclusion criteria|1
7851590|NCT01495975|12333925|FG000|Overall Study|Lost to Follow-up|1
7851591|NCT01495975|12333926|FG001|Overall Study|Lost to Follow-up|0
7851592|NCT01496066|12333934|FG000|Overall Study|Lost to Follow-up|8
7851593|NCT01496066|12333935|FG001|Overall Study|Lost to Follow-up|5
7851594|NCT01496066|12333934|FG000|Overall Study|Explant|3
7851595|NCT01496066|12333935|FG001|Overall Study|Explant|0
7851596|NCT01496066|12333934|FG000|Overall Study|Death|1
7851597|NCT01496066|12333935|FG001|Overall Study|Death|4
7851598|NCT01496183|12333963|FG000|Overall Study|Physician Decision|3
7851599|NCT01496183|12333964|FG001|Overall Study|Physician Decision|1
7851600|NCT01496183|12333963|FG000|Overall Study|Withdrawal by Subject|0
7851601|NCT01496183|12333964|FG001|Overall Study|Withdrawal by Subject|1
7851602|NCT01496274|12333977|FG000|Overall Study|Protocol Violation|0
7851603|NCT01496274|12333978|FG001|Overall Study|Protocol Violation|1
7851604|NCT01496274|12333977|FG000|Overall Study|Adverse Event|1
7851605|NCT01496274|12333978|FG001|Overall Study|Adverse Event|1
7851606|NCT01496274|12333977|FG000|Overall Study|Withdrawal by Subject|2
7851607|NCT01496274|12333978|FG001|Overall Study|Withdrawal by Subject|0
7851608|NCT01496274|12333977|FG000|Overall Study|Lost to Follow-up|0
7851609|NCT01496274|12333978|FG001|Overall Study|Lost to Follow-up|3
7851610|NCT01496287|12333999|FG000|Overall Study|Lost to Follow-up|1
7851611|NCT01496287|12333999|FG000|Overall Study|Incomplete anesthesia|5
7851612|NCT01496365|12334038|FG000|Overall Study|Adverse Event|2
7851613|NCT01496365|12334039|FG001|Overall Study|Adverse Event|3
7851614|NCT01496365|12334040|FG002|Overall Study|Adverse Event|3
7851615|NCT01496365|12334041|FG003|Overall Study|Adverse Event|2
7851616|NCT01496365|12334042|FG004|Overall Study|Adverse Event|5
7851617|NCT01496365|12334043|FG005|Overall Study|Adverse Event|6
7851618|NCT01496365|12334044|FG006|Overall Study|Adverse Event|4
7851619|NCT01496365|12334038|FG000|Overall Study|Withdrawal by Subject|6
7851620|NCT01496365|12334039|FG001|Overall Study|Withdrawal by Subject|6
7851621|NCT01496365|12334040|FG002|Overall Study|Withdrawal by Subject|0
7851622|NCT01496365|12334041|FG003|Overall Study|Withdrawal by Subject|1
7851623|NCT01496365|12334042|FG004|Overall Study|Withdrawal by Subject|3
7851624|NCT01496365|12334043|FG005|Overall Study|Withdrawal by Subject|2
7851625|NCT01496365|12334044|FG006|Overall Study|Withdrawal by Subject|1
7851626|NCT01496365|12334038|FG000|Overall Study|Protocol Violation|2
7851627|NCT01496365|12334039|FG001|Overall Study|Protocol Violation|1
7851628|NCT01496365|12334040|FG002|Overall Study|Protocol Violation|1
7851629|NCT01496365|12334041|FG003|Overall Study|Protocol Violation|0
7851630|NCT01496365|12334042|FG004|Overall Study|Protocol Violation|0
7851631|NCT01496365|12334043|FG005|Overall Study|Protocol Violation|1
7851632|NCT01496365|12334044|FG006|Overall Study|Protocol Violation|0
7851633|NCT01496365|12334038|FG000|Overall Study|Lack of Efficacy|1
7851634|NCT01496365|12334039|FG001|Overall Study|Lack of Efficacy|0
7851635|NCT01496365|12334040|FG002|Overall Study|Lack of Efficacy|0
7851636|NCT01496365|12334041|FG003|Overall Study|Lack of Efficacy|0
7851637|NCT01496365|12334042|FG004|Overall Study|Lack of Efficacy|0
7851638|NCT01496365|12334043|FG005|Overall Study|Lack of Efficacy|1
7851639|NCT01496365|12334044|FG006|Overall Study|Lack of Efficacy|0
7851640|NCT01496365|12334038|FG000|Overall Study|Lost to Follow-up|0
7851641|NCT01496365|12334039|FG001|Overall Study|Lost to Follow-up|1
7851642|NCT01496365|12334040|FG002|Overall Study|Lost to Follow-up|0
7851643|NCT01496365|12334041|FG003|Overall Study|Lost to Follow-up|0
7851644|NCT01496365|12334042|FG004|Overall Study|Lost to Follow-up|2
7851645|NCT01496365|12334043|FG005|Overall Study|Lost to Follow-up|0
7851646|NCT01496365|12334044|FG006|Overall Study|Lost to Follow-up|0
7851647|NCT01496365|12334038|FG000|Overall Study|Other|4
7851648|NCT01496365|12334039|FG001|Overall Study|Other|4
7851649|NCT01496365|12334040|FG002|Overall Study|Other|2
7851650|NCT01496365|12334041|FG003|Overall Study|Other|1
7851651|NCT01496365|12334042|FG004|Overall Study|Other|3
7851652|NCT01496365|12334043|FG005|Overall Study|Other|0
7851653|NCT01496365|12334044|FG006|Overall Study|Other|1
7851654|NCT01496430|12334063|FG000|Overall Study|Adverse Event|0
7851655|NCT01496430|12334064|FG001|Overall Study|Adverse Event|0
7851656|NCT01496430|12334065|FG002|Overall Study|Adverse Event|1
7851657|NCT01496430|12334063|FG000|Overall Study|Major Protocol Deviation|0
7851658|NCT01496430|12334064|FG001|Overall Study|Major Protocol Deviation|0
7851659|NCT01496430|12334065|FG002|Overall Study|Major Protocol Deviation|1
7851660|NCT01496430|12334063|FG000|Overall Study|Lost to Follow-up|2
7851661|NCT01496430|12334064|FG001|Overall Study|Lost to Follow-up|3
7851662|NCT01496430|12334065|FG002|Overall Study|Lost to Follow-up|1
7851663|NCT01496430|12334063|FG000|Overall Study|Voluntary Withdrawal|2
7851664|NCT01496430|12334064|FG001|Overall Study|Voluntary Withdrawal|1
7851665|NCT01496430|12334065|FG002|Overall Study|Voluntary Withdrawal|6
7851666|NCT01496430|12334063|FG000|Overall Study|Principal Investigator Discretion|0
7851667|NCT01496430|12334064|FG001|Overall Study|Principal Investigator Discretion|1
7851668|NCT01496430|12334065|FG002|Overall Study|Principal Investigator Discretion|1
7851669|NCT01496430|12334063|FG000|Overall Study|Other|2
7851670|NCT01496430|12334064|FG001|Overall Study|Other|0
7851671|NCT01496430|12334065|FG002|Overall Study|Other|0
7851672|NCT01496456|12334073|FG000|Overall Study|Protocol Violation|1
7851673|NCT01496456|12334073|FG000|Overall Study|Lost to Follow-up|7
7851674|NCT01496469|12334082|FG000|Overall Study|Adverse Event|1
7851675|NCT01496469|12334083|FG001|Overall Study|Adverse Event|0
7851676|NCT01496469|12334082|FG000|Overall Study|Protocol Violation|2
7851677|NCT01496469|12334083|FG001|Overall Study|Protocol Violation|0
7851678|NCT01496469|12334082|FG000|Overall Study|Lost to Follow-up|1
7851679|NCT01496469|12334083|FG001|Overall Study|Lost to Follow-up|1
7851680|NCT01496469|12334082|FG000|Overall Study|Withdrawal by Subject|4
7851681|NCT01496469|12334083|FG001|Overall Study|Withdrawal by Subject|4
7851682|NCT01496469|12334082|FG000|Overall Study|BP exceeds protocol limits|1
7851683|NCT01496469|12334083|FG001|Overall Study|BP exceeds protocol limits|2
7851684|NCT01496469|12334082|FG000|Overall Study|Other|1
7851685|NCT01496469|12334083|FG001|Overall Study|Other|1
7851686|NCT01496612|12334089|FG000|1st Intervention|Adverse Event|1
7851687|NCT01496612|12334090|FG001|1st Intervention|Adverse Event|0
7851688|NCT01496612|12334089|FG000|1st Intervention|Withdrawal by Subject|1
7851689|NCT01496612|12334090|FG001|1st Intervention|Withdrawal by Subject|0
7851690|NCT01496807|12334098|FG000|Overall Study|Progressive Disease|21
7851691|NCT01496807|12334098|FG000|Overall Study|Participant preference/toxicity|8
7851692|NCT01496807|12334098|FG000|Overall Study|Change in diagnosis|1
7851693|NCT01496846|12334108|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
7851694|NCT01496846|12334109|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
7851695|NCT01496846|12334110|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7851696|NCT01496846|12334111|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7851697|NCT01496846|12334112|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7851698|NCT01496846|12334113|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7851699|NCT01496885|12334124|FG000|Overall Study|Lost to Follow-up|13
7851700|NCT01496885|12334124|FG000|Overall Study|Withdrawal by Subject|7
7851701|NCT01496885|12334124|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2
7851702|NCT01496885|12334124|FG000|Overall Study|Death|1
7851703|NCT01497067|12334128|FG000|Overall Study|Lost to Follow-up|56
7851704|NCT01497067|12334128|FG000|Overall Study|Adverse Event|3
7851705|NCT01497067|12334128|FG000|Overall Study|Patient decision unrel to Adverse Event|10
7851706|NCT01497067|12334128|FG000|Overall Study|Other|13
7851707|NCT01497197|12334135|FG000|Overall Study|Lost to Follow-up|1
7851708|NCT01497197|12334136|FG001|Overall Study|Lost to Follow-up|0
7851709|NCT01497197|12334135|FG000|Overall Study|Protocol Violation|0
7851710|NCT01497197|12334136|FG001|Overall Study|Protocol Violation|2
7851711|NCT01497197|12334135|FG000|Overall Study|Withdrawal by Subject|2
7851712|NCT01497197|12334136|FG001|Overall Study|Withdrawal by Subject|1
7851713|NCT01497197|12334135|FG000|Overall Study|Excessive/lack of response to treatment|1
7851714|NCT01497197|12334136|FG001|Overall Study|Excessive/lack of response to treatment|0
7851715|NCT01497197|12334135|FG000|Overall Study|Risk of OHSS|1
7851716|NCT01497197|12334136|FG001|Overall Study|Risk of OHSS|0
7851717|NCT01497197|12334135|FG000|Overall Study|No oocytes retrieved|3
7851718|NCT01497197|12334136|FG001|Overall Study|No oocytes retrieved|2
7851719|NCT01497197|12334135|FG000|Overall Study|No fertilisation|6
7851720|NCT01497197|12334136|FG001|Overall Study|No fertilisation|5
7851721|NCT01497197|12334135|FG000|Overall Study|Intention to freeze all embryos|0
7851722|NCT01497197|12334136|FG001|Overall Study|Intention to freeze all embryos|1
7851723|NCT01497197|12334135|FG000|Overall Study|All embryos discarded|0
7851724|NCT01497197|12334136|FG001|Overall Study|All embryos discarded|3
7851725|NCT01497197|12334135|FG000|Overall Study|Other|3
7851726|NCT01497197|12334136|FG001|Overall Study|Other|1
7851727|NCT01497262|12334142|FG000|Overall Study|Abnormal Lab Values|4
7851728|NCT01497262|12334142|FG000|Overall Study|Abnormal Test Procedure Result|1
7851729|NCT01497262|12334142|FG000|Overall Study|Physician Decision|1
7851730|NCT01497262|12334142|FG000|Overall Study|Withdrawal by Subject|2
7851731|NCT01497262|12334142|FG000|Overall Study|Adverse Event|2
7851732|NCT01497262|12334142|FG000|Overall Study|Protocol Violation|1
7851733|NCT01497275|12334146|FG000|Overall Study|Death|1
7851734|NCT01497275|12334146|FG000|Overall Study|Adverse Event|1
7851735|NCT01497366|12334152|FG000|Overall Study|Virologic failure|2
7851736|NCT01497366|12334153|FG001|Overall Study|Virologic failure|50
7851737|NCT01497366|12334152|FG000|Overall Study|Lost to Follow-up|11
7851738|NCT01497366|12334153|FG001|Overall Study|Lost to Follow-up|10
7851739|NCT01497366|12334152|FG000|Overall Study|Withdrawal by Subject|6
7851740|NCT01497366|12334153|FG001|Overall Study|Withdrawal by Subject|6
7851741|NCT01497366|12334152|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7
7851742|NCT01497366|12334153|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0
7851743|NCT01497366|12334152|FG000|Overall Study|Other|5
7851744|NCT01497366|12334153|FG001|Overall Study|Other|0
7851745|NCT01497366|12334152|FG000|Overall Study|Death|1
7851746|NCT01497366|12334153|FG001|Overall Study|Death|1
7851747|NCT01497366|12334152|FG000|Overall Study|Randomized but not treated|7
7851748|NCT01497366|12334153|FG001|Overall Study|Randomized but not treated|21
7851749|NCT01497899|12334206|FG000|Double-Blind Phase|Randomized but not Treated|1
7851750|NCT01497899|12334207|FG001|Double-Blind Phase|Randomized but not Treated|0
7851751|NCT01497899|12334208|FG002|Double-Blind Phase|Randomized but not Treated|0
7851752|NCT01497899|12334209|FG003|Double-Blind Phase|Randomized but not Treated|0
7851753|NCT01497899|12334206|FG000|Double-Blind Phase|Adverse Event|1
7851754|NCT01497899|12334207|FG001|Double-Blind Phase|Adverse Event|0
7851755|NCT01497899|12334208|FG002|Double-Blind Phase|Adverse Event|0
7851756|NCT01497899|12334209|FG003|Double-Blind Phase|Adverse Event|0
7851757|NCT01497899|12334206|FG000|Double-Blind Phase|Lack of Efficacy|0
7851758|NCT01497899|12334207|FG001|Double-Blind Phase|Lack of Efficacy|1
7851759|NCT01497899|12334208|FG002|Double-Blind Phase|Lack of Efficacy|0
7851760|NCT01497899|12334209|FG003|Double-Blind Phase|Lack of Efficacy|0
7851761|NCT01497899|12334206|FG000|Double-Blind Phase|Investigator's Discretion|1
7851762|NCT01497899|12334207|FG001|Double-Blind Phase|Investigator's Discretion|0
7851763|NCT01497899|12334208|FG002|Double-Blind Phase|Investigator's Discretion|0
7851764|NCT01497899|12334209|FG003|Double-Blind Phase|Investigator's Discretion|0
7851765|NCT01497899|12334206|FG000|Double-Blind Phase|Withdrew Consent|0
7851766|NCT01497899|12334207|FG001|Double-Blind Phase|Withdrew Consent|1
7851767|NCT01497899|12334208|FG002|Double-Blind Phase|Withdrew Consent|0
7851768|NCT01497899|12334209|FG003|Double-Blind Phase|Withdrew Consent|0
7851769|NCT01497899|12334206|FG000|Double-Blind Phase|Lost to Follow-up|3
7851770|NCT01497899|12334207|FG001|Double-Blind Phase|Lost to Follow-up|2
7851771|NCT01497899|12334208|FG002|Double-Blind Phase|Lost to Follow-up|0
7851772|NCT01497899|12334209|FG003|Double-Blind Phase|Lost to Follow-up|0
7851773|NCT01497899|12334206|FG000|Double-Blind Phase|Subject Non-Compliance|0
7851774|NCT01497899|12334207|FG001|Double-Blind Phase|Subject Non-Compliance|1
7851775|NCT01497899|12334208|FG002|Double-Blind Phase|Subject Non-Compliance|0
7851776|NCT01497899|12334209|FG003|Double-Blind Phase|Subject Non-Compliance|0
7851777|NCT01497899|12334206|FG000|Open-Label Extension Phase|Adverse Event|1
7851778|NCT01497899|12334207|FG001|Open-Label Extension Phase|Adverse Event|0
7851779|NCT01497899|12334208|FG002|Open-Label Extension Phase|Adverse Event|0
7851780|NCT01497899|12334209|FG003|Open-Label Extension Phase|Adverse Event|0
7851781|NCT01497899|12334206|FG000|Open-Label Extension Phase|Death|1
7851782|NCT01497899|12334207|FG001|Open-Label Extension Phase|Death|0
7851783|NCT01497899|12334208|FG002|Open-Label Extension Phase|Death|0
7851784|NCT01497899|12334209|FG003|Open-Label Extension Phase|Death|0
7851785|NCT01497899|12334206|FG000|Open-Label Extension Phase|Withdrew Consent|8
7851786|NCT01497899|12334207|FG001|Open-Label Extension Phase|Withdrew Consent|3
7851787|NCT01497899|12334208|FG002|Open-Label Extension Phase|Withdrew Consent|2
7851788|NCT01497899|12334209|FG003|Open-Label Extension Phase|Withdrew Consent|0
7851789|NCT01497899|12334206|FG000|Open-Label Extension Phase|Pregnancy|0
7851790|NCT01497899|12334207|FG001|Open-Label Extension Phase|Pregnancy|1
7851791|NCT01497899|12334208|FG002|Open-Label Extension Phase|Pregnancy|1
7851792|NCT01497899|12334209|FG003|Open-Label Extension Phase|Pregnancy|0
7851793|NCT01497899|12334206|FG000|Open-Label Extension Phase|Protocol Violation|0
7851794|NCT01497899|12334207|FG001|Open-Label Extension Phase|Protocol Violation|0
7851795|NCT01497899|12334208|FG002|Open-Label Extension Phase|Protocol Violation|1
7851796|NCT01497899|12334209|FG003|Open-Label Extension Phase|Protocol Violation|0
7851797|NCT01497899|12334206|FG000|Open-Label Extension Phase|Lost to Follow-up|9
7851798|NCT01497899|12334207|FG001|Open-Label Extension Phase|Lost to Follow-up|3
7851799|NCT01497899|12334208|FG002|Open-Label Extension Phase|Lost to Follow-up|5
7851800|NCT01497899|12334209|FG003|Open-Label Extension Phase|Lost to Follow-up|5
7851801|NCT01497938|12334218|FG000|Overall Study|Adverse Event|0
7851802|NCT01497938|12334219|FG001|Overall Study|Adverse Event|1
7851803|NCT01497938|12334218|FG000|Overall Study|Physician Decision|0
7851804|NCT01497938|12334219|FG001|Overall Study|Physician Decision|1
7851805|NCT01497938|12334218|FG000|Overall Study|Withdrawal by Subject|4
7851806|NCT01497938|12334219|FG001|Overall Study|Withdrawal by Subject|0
7851807|NCT01497938|12334218|FG000|Overall Study|Device Violation|1
7851808|NCT01497938|12334219|FG001|Overall Study|Device Violation|0
7851809|NCT01498068|12334227|FG000|Overall Study|Withdrawal by Subject|1
7851810|NCT01498068|12334228|FG001|Overall Study|Withdrawal by Subject|1
7851811|NCT01498120|12334234|FG000|Overall Study|Lost to Follow-up|1
7851812|NCT01498120|12334234|FG000|Overall Study|Withdrawal by Subject|5
7851813|NCT01498120|12334234|FG000|Overall Study|AE, non-serious non-fatal|3
7851814|NCT01498120|12334234|FG000|Overall Study|Other|4
7851815|NCT01498185|12334243|FG000|Overall Study|Adverse Event|0
7851816|NCT01498185|12334244|FG001|Overall Study|Adverse Event|0
7851817|NCT01498185|12334245|FG002|Overall Study|Adverse Event|0
7851818|NCT01498185|12334246|FG003|Overall Study|Adverse Event|1
7851819|NCT01498185|12334247|FG004|Overall Study|Adverse Event|0
7851820|NCT01498185|12334243|FG000|Overall Study|Withdrawal by Subject|1
7851821|NCT01498185|12334244|FG001|Overall Study|Withdrawal by Subject|1
7851822|NCT01498185|12334245|FG002|Overall Study|Withdrawal by Subject|0
7851823|NCT01498185|12334246|FG003|Overall Study|Withdrawal by Subject|2
7851824|NCT01498185|12334247|FG004|Overall Study|Withdrawal by Subject|1
7851825|NCT01498185|12334243|FG000|Overall Study|No longer met criteria, etc|0
7851826|NCT01498185|12334244|FG001|Overall Study|No longer met criteria, etc|0
7851827|NCT01498185|12334245|FG002|Overall Study|No longer met criteria, etc|0
7851828|NCT01498185|12334246|FG003|Overall Study|No longer met criteria, etc|0
7851829|NCT01498185|12334247|FG004|Overall Study|No longer met criteria, etc|2
7851830|NCT01498289|12334265|FG000|Overall Study|Adverse Event|16
7851831|NCT01498289|12334266|FG001|Overall Study|Adverse Event|18
7851832|NCT01498289|12334265|FG000|Overall Study|Death|6
7851833|NCT01498289|12334266|FG001|Overall Study|Death|8
7851834|NCT01498289|12334265|FG000|Overall Study|Withdrawal unrelated to AE|16
7851835|NCT01498289|12334266|FG001|Overall Study|Withdrawal unrelated to AE|16
7851836|NCT01498289|12334265|FG000|Overall Study|Progression/relapse|53
7851837|NCT01498289|12334266|FG001|Overall Study|Progression/relapse|59
7851838|NCT01498289|12334265|FG000|Overall Study|Not protocol specified|7
7851839|NCT01498289|12334266|FG001|Overall Study|Not protocol specified|2
7851840|NCT01498289|12334265|FG000|Overall Study|Reason under review|0
7851841|NCT01498289|12334266|FG001|Overall Study|Reason under review|1
7851842|NCT01498445|12334299|FG000|Overall Study|Lack of Efficacy|0
7851843|NCT01498445|12334300|FG001|Overall Study|Lack of Efficacy|0
7851844|NCT01498445|12334301|FG002|Overall Study|Lack of Efficacy|1
7851845|NCT01498445|12334302|FG003|Overall Study|Lack of Efficacy|2
7851846|NCT01498445|12334303|FG004|Overall Study|Lack of Efficacy|0
7851847|NCT01498445|12334304|FG005|Overall Study|Lack of Efficacy|0
7851848|NCT01498445|12334299|FG000|Overall Study|Screen Failure|0
7851849|NCT01498445|12334300|FG001|Overall Study|Screen Failure|0
7851850|NCT01498445|12334301|FG002|Overall Study|Screen Failure|0
7851851|NCT01498445|12334302|FG003|Overall Study|Screen Failure|0
7851852|NCT01498445|12334303|FG004|Overall Study|Screen Failure|1
7851853|NCT01498445|12334304|FG005|Overall Study|Screen Failure|1
7851854|NCT01498575|12334329|FG000|Overall Sample|Withdrawal by Subject|60
7851855|NCT01498575|12334330|FG001|Overall Sample|Withdrawal by Subject|14
7851856|NCT01498575|12334329|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
7851857|NCT01498575|12334330|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
7851858|NCT01498575|12334329|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23
7851859|NCT01498575|12334330|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18
7851860|NCT01498640|12334349|FG000|Overall Study|Lost to Follow-up|1
7851861|NCT01498640|12334349|FG000|Overall Study|Death|1
7851862|NCT01498640|12334349|FG000|Overall Study|Other|3
7851863|NCT01498653|12334359|FG000|Overall Study|Adverse Event|2
7851864|NCT01498653|12334360|FG001|Overall Study|Adverse Event|2
7851865|NCT01498653|12334359|FG000|Overall Study|Lack of Efficacy|12
7851866|NCT01498653|12334360|FG001|Overall Study|Lack of Efficacy|26
7851867|NCT01498653|12334359|FG000|Overall Study|Protocol Violation|0
7851868|NCT01498653|12334360|FG001|Overall Study|Protocol Violation|4
7851869|NCT01498653|12334359|FG000|Overall Study|Lost to Follow-up|1
7851870|NCT01498653|12334360|FG001|Overall Study|Lost to Follow-up|0
7851871|NCT01498653|12334359|FG000|Overall Study|Physician Decision|2
7851872|NCT01498653|12334360|FG001|Overall Study|Physician Decision|0
7851873|NCT01498653|12334359|FG000|Overall Study|Withdrawal by Subject|2
7851874|NCT01498653|12334360|FG001|Overall Study|Withdrawal by Subject|3
7851875|NCT01498679|12334368|FG000|Overall Study|Adverse Event|1
7851876|NCT01498679|12334369|FG001|Overall Study|Adverse Event|4
7851877|NCT01498679|12334368|FG000|Overall Study|Lack of Efficacy|72
7851878|NCT01498679|12334369|FG001|Overall Study|Lack of Efficacy|12
7851879|NCT01498679|12334368|FG000|Overall Study|Protocol Violation|4
7851880|NCT01498679|12334369|FG001|Overall Study|Protocol Violation|0
7851881|NCT01498679|12334368|FG000|Overall Study|Physician Decision|0
7851882|NCT01498679|12334369|FG001|Overall Study|Physician Decision|2
7851883|NCT01498679|12334368|FG000|Overall Study|Withdrawal by Subject|12
7851884|NCT01498679|12334369|FG001|Overall Study|Withdrawal by Subject|4
7851885|NCT01498692|12334375|FG000|Overall Study|Death|4
7851886|NCT01498692|12334375|FG000|Overall Study|Withdrawal by Subject|1
7851887|NCT01498692|12334375|FG000|Overall Study|Missed 12-month visit|3
7851888|NCT01498822|12334390|FG000|Overall Study|Protocol Violation|8
7851889|NCT01498822|12334391|FG001|Overall Study|Protocol Violation|4
7851890|NCT01498822|12334390|FG000|Overall Study|Other Reason|5
7851891|NCT01498822|12334391|FG001|Overall Study|Other Reason|2
7851892|NCT01498822|12334390|FG000|Overall Study|Lack of Efficacy|7
7851893|NCT01498822|12334391|FG001|Overall Study|Lack of Efficacy|2
7851894|NCT01498822|12334390|FG000|Overall Study|AE, non-serious non-fatal|8
7851895|NCT01498822|12334391|FG001|Overall Study|AE, non-serious non-fatal|17
7851896|NCT01498822|12334390|FG000|Overall Study|SAE, non-fatal|2
7851897|NCT01498822|12334391|FG001|Overall Study|SAE, non-fatal|2
7851898|NCT01498822|12334390|FG000|Overall Study|Adverse Event, serious fatal|1
7851899|NCT01498822|12334391|FG001|Overall Study|Adverse Event, serious fatal|1
7851900|NCT01498822|12334390|FG000|Overall Study|Withdrawal by Subject|15
7851901|NCT01498822|12334391|FG001|Overall Study|Withdrawal by Subject|25
7851902|NCT01498822|12334390|FG000|Overall Study|Lost to Follow-up|8
7851903|NCT01498822|12334391|FG001|Overall Study|Lost to Follow-up|3
7851904|NCT01498887|12334401|FG000|Overall Study|Administrative problems|1
7851905|NCT01498887|12334402|FG001|Overall Study|Administrative problems|0
7851906|NCT01498887|12334401|FG000|Overall Study|Lost to Follow-up|1
7851907|NCT01498887|12334402|FG001|Overall Study|Lost to Follow-up|1
7851908|NCT01498887|12334401|FG000|Overall Study|Withdrawal by Subject|1
7851909|NCT01498887|12334402|FG001|Overall Study|Withdrawal by Subject|0
7851910|NCT01498887|12334401|FG000|Overall Study|Protocol Violation|1
7851911|NCT01498887|12334402|FG001|Overall Study|Protocol Violation|3
7851912|NCT01498887|12334401|FG000|Overall Study|Lack of Efficacy|5
7851913|NCT01498887|12334402|FG001|Overall Study|Lack of Efficacy|3
7851914|NCT01498887|12334401|FG000|Overall Study|Abnormal result from test procedure|1
7851915|NCT01498887|12334402|FG001|Overall Study|Abnormal result from test procedure|1
7851916|NCT01498887|12334401|FG000|Overall Study|Abnormal laboratory value|2
7851917|NCT01498887|12334402|FG001|Overall Study|Abnormal laboratory value|2
7851918|NCT01498887|12334401|FG000|Overall Study|Adverse Event|4
7851919|NCT01498887|12334402|FG001|Overall Study|Adverse Event|1
7851920|NCT01498952|12334411|FG000|Overall Study|Death|2
7851921|NCT01498952|12334412|FG001|Overall Study|Death|2
7851922|NCT01498952|12334413|FG002|Overall Study|Death|0
7851923|NCT01498952|12334414|FG003|Overall Study|Death|0
7851924|NCT01498952|12334415|FG004|Overall Study|Death|0
7851925|NCT01499043|12334434|FG000|Overall Study|Progressive disease (radiographic)|2
7851926|NCT01499043|12334434|FG000|Overall Study|Progressive disease (clinical)|1
7851927|NCT01499043|12334434|FG000|Overall Study|Withdrawal by Subject|2
7851928|NCT01499043|12334434|FG000|Overall Study|Adverse Event|1
7851929|NCT01499134|12334445|FG000|Overall Study|Withdrawal by Subject|0
7851930|NCT01499134|12334446|FG001|Overall Study|Withdrawal by Subject|1
7863459|NCT01606137|12352787|FG000|Overall Study|Unable to tolerate study med. taste|1
7863460|NCT01606137|12352787|FG000|Overall Study|Patient moving|1
7863461|NCT01606137|12352787|FG000|Overall Study|Unable to collect consistent data|1
7864010|NCT01609556|12353457|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13
7864011|NCT01609556|12353458|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20
7864012|NCT01609556|12353459|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27
7864013|NCT01609556|12353444|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7864014|NCT01609556|12353445|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7864015|NCT01609556|12353446|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7864016|NCT01609556|12353447|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7864017|NCT01609556|12353448|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7864018|NCT01609556|12353449|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7864019|NCT01609556|12353450|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7864020|NCT01609556|12353451|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7864021|NCT01609556|12353452|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7864022|NCT01609556|12353453|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7864023|NCT01609556|12353454|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7864024|NCT01609556|12353455|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7864025|NCT01609556|12353456|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
7864026|NCT01609556|12353457|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
7864027|NCT01609556|12353458|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
7864028|NCT01609556|12353459|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2
7864029|NCT01609556|12353444|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7864030|NCT01609556|12353445|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7864031|NCT01609556|12353446|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7864032|NCT01609556|12353447|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7864033|NCT01609556|12353448|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7864034|NCT01609556|12353449|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7864035|NCT01609556|12353450|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7864036|NCT01609556|12353451|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7864037|NCT01609556|12353452|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7864038|NCT01609556|12353453|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7864039|NCT01609556|12353454|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7864040|NCT01609556|12353455|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7864041|NCT01609556|12353456|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1
7864042|NCT01609556|12353457|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7864043|NCT01609556|12353458|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7864044|NCT01609556|12353459|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7864045|NCT01609556|12353444|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7864046|NCT01609556|12353445|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7864047|NCT01609556|12353446|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7864048|NCT01609556|12353447|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7864049|NCT01609556|12353448|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7864050|NCT01609556|12353449|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7864051|NCT01609556|12353450|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7864052|NCT01609556|12353451|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7864053|NCT01609556|12353452|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7864054|NCT01609556|12353453|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7864055|NCT01609556|12353454|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7864056|NCT01609556|12353455|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7864057|NCT01609556|12353456|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1
7864058|NCT01609556|12353457|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4
7864059|NCT01609556|12353458|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2
7864060|NCT01609556|12353459|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5
7864061|NCT01609556|12353444|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7864062|NCT01609556|12353445|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7864063|NCT01609556|12353446|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7864064|NCT01609556|12353447|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7864065|NCT01609556|12353448|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7864066|NCT01609556|12353449|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7864067|NCT01609556|12353450|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7864068|NCT01609556|12353451|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7864069|NCT01609556|12353452|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7864070|NCT01609556|12353453|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7864071|NCT01609556|12353454|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7864072|NCT01609556|12353455|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7864073|NCT01609556|12353456|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7864074|NCT01609556|12353457|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7851931|NCT01499199|12334470|FG000|Overall Study|Adverse Event|1
7851932|NCT01499199|12334470|FG000|Overall Study|Lack of Efficacy|1
7851933|NCT01499277|12334476|FG000|Overall Study|Adverse Event|3
7851934|NCT01499277|12334477|FG001|Overall Study|Adverse Event|6
7851935|NCT01499277|12334476|FG000|Overall Study|Death|3
7851936|NCT01499277|12334477|FG001|Overall Study|Death|2
7851937|NCT01499277|12334476|FG000|Overall Study|Lost to Follow-up|15
7851938|NCT01499277|12334477|FG001|Overall Study|Lost to Follow-up|8
7851939|NCT01499277|12334476|FG000|Overall Study|Protocol Violation|2
7851940|NCT01499277|12334477|FG001|Overall Study|Protocol Violation|3
7851941|NCT01499277|12334476|FG000|Overall Study|Withdrawal by Subject|16
7851942|NCT01499277|12334477|FG001|Overall Study|Withdrawal by Subject|6
7851943|NCT01499277|12334476|FG000|Overall Study|Lack of therapeutic response and other|8
7851944|NCT01499277|12334477|FG001|Overall Study|Lack of therapeutic response and other|7
7851945|NCT01499290|12334485|FG000|Overall Study|Withdrawal by Subject|22
7851946|NCT01499290|12334486|FG001|Overall Study|Withdrawal by Subject|15
7851947|NCT01499290|12334485|FG000|Overall Study|Not specified in study report|11
7851948|NCT01499290|12334486|FG001|Overall Study|Not specified in study report|5
7851949|NCT01499290|12334485|FG000|Overall Study|Condition improved/subject recovered|1
7851950|NCT01499290|12334486|FG001|Overall Study|Condition improved/subject recovered|0
7851951|NCT01499290|12334485|FG000|Overall Study|Lack of Efficacy|7
7851952|NCT01499290|12334486|FG001|Overall Study|Lack of Efficacy|8
7851953|NCT01499290|12334485|FG000|Overall Study|Adverse Event|14
7851954|NCT01499290|12334486|FG001|Overall Study|Adverse Event|7
7851955|NCT01499303|12334513|FG000|Overall Study|Ongoing|2
7851956|NCT01499303|12334514|FG001|Overall Study|Ongoing|1
7851957|NCT01499303|12334513|FG000|Overall Study|Withdrawal by Subject|0
7851958|NCT01499303|12334514|FG001|Overall Study|Withdrawal by Subject|1
7851959|NCT01499303|12334513|FG000|Overall Study|Adverse Event|1
7851960|NCT01499303|12334514|FG001|Overall Study|Adverse Event|4
7851961|NCT01499303|12334513|FG000|Overall Study|Other|0
7851962|NCT01499303|12334514|FG001|Overall Study|Other|1
7851963|NCT01499355|12334520|FG000|Run-In Period|Study Termination|15
7851964|NCT01499355|12334521|FG001|Run-In Period|Study Termination|0
7851965|NCT01499355|12334522|FG002|Run-In Period|Study Termination|0
7851966|NCT01499355|12334523|FG003|Run-In Period|Study Termination|0
7851967|NCT01499355|12334520|FG000|Run-In Period|Other|3
7851968|NCT01499355|12334521|FG001|Run-In Period|Other|0
7851969|NCT01499355|12334522|FG002|Run-In Period|Other|0
7851970|NCT01499355|12334523|FG003|Run-In Period|Other|0
7851971|NCT01499355|12334520|FG000|Run-In Period|Death|2
7851972|NCT01499355|12334521|FG001|Run-In Period|Death|0
7851973|NCT01499355|12334522|FG002|Run-In Period|Death|0
7851974|NCT01499355|12334523|FG003|Run-In Period|Death|0
7851975|NCT01499355|12334520|FG000|Run-In Period|Investigator Decision|2
7851976|NCT01499355|12334521|FG001|Run-In Period|Investigator Decision|0
7851977|NCT01499355|12334522|FG002|Run-In Period|Investigator Decision|0
7851978|NCT01499355|12334523|FG003|Run-In Period|Investigator Decision|0
7949453|NCT02537574|12495026|FG001|Overall Study|Adverse Event|3
7949454|NCT02537574|12495027|FG002|Overall Study|Adverse Event|2
7949455|NCT02537574|12495025|FG000|Overall Study|Lost to Follow-up|40
7949456|NCT02537574|12495026|FG001|Overall Study|Lost to Follow-up|51
7949457|NCT02537574|12495027|FG002|Overall Study|Lost to Follow-up|55
7949458|NCT02537574|12495025|FG000|Overall Study|Noncompliance with study drug|0
7949459|NCT02537574|12495026|FG001|Overall Study|Noncompliance with study drug|1
7949460|NCT02537574|12495027|FG002|Overall Study|Noncompliance with study drug|1
7949461|NCT02537574|12495025|FG000|Overall Study|Physician Decision|2
7949462|NCT02537574|12495026|FG001|Overall Study|Physician Decision|0
7949463|NCT02537574|12495027|FG002|Overall Study|Physician Decision|0
7949464|NCT02537574|12495025|FG000|Overall Study|Protocol Violation|4
7949465|NCT02537574|12495026|FG001|Overall Study|Protocol Violation|2
7949466|NCT02537574|12495027|FG002|Overall Study|Protocol Violation|3
7949467|NCT02537574|12495025|FG000|Overall Study|Withdrawal by Subject|37
7949468|NCT02537574|12495026|FG001|Overall Study|Withdrawal by Subject|27
7949469|NCT02537574|12495027|FG002|Overall Study|Withdrawal by Subject|29
7949470|NCT02537574|12495025|FG000|Overall Study|Lack of Efficacy|14
7949471|NCT02537574|12495026|FG001|Overall Study|Lack of Efficacy|16
7949472|NCT02537574|12495027|FG002|Overall Study|Lack of Efficacy|15
7949473|NCT02537574|12495025|FG000|Overall Study|Duplicate Patient|1
7949474|NCT02537574|12495026|FG001|Overall Study|Duplicate Patient|0
7949475|NCT02537574|12495027|FG002|Overall Study|Duplicate Patient|0
7949476|NCT02537574|12495025|FG000|Overall Study|Patient not Stable|0
7949477|NCT02537574|12495026|FG001|Overall Study|Patient not Stable|1
7949478|NCT02537574|12495027|FG002|Overall Study|Patient not Stable|0
7949479|NCT02537574|12495025|FG000|Overall Study|Incarceration|0
7949480|NCT02537574|12495026|FG001|Overall Study|Incarceration|1
7949481|NCT02537574|12495027|FG002|Overall Study|Incarceration|0
7949482|NCT02537574|12495025|FG000|Overall Study|Failed Naloxone Challenge|0
7949483|NCT02537574|12495026|FG001|Overall Study|Failed Naloxone Challenge|1
7949484|NCT02537574|12495027|FG002|Overall Study|Failed Naloxone Challenge|0
7949485|NCT02537574|12495025|FG000|Overall Study|Transportation Issues|0
7949486|NCT02537574|12495026|FG001|Overall Study|Transportation Issues|0
7851979|NCT01499355|12334520|FG000|Run-In Period|Consent Withdrawn|1
7851980|NCT01499355|12334521|FG001|Run-In Period|Consent Withdrawn|0
7949487|NCT02537574|12495027|FG002|Overall Study|Transportation Issues|1
7949488|NCT02537574|12495025|FG000|Overall Study|Subject did not want last Vivitrol Injec|0
7949489|NCT02537574|12495026|FG001|Overall Study|Subject did not want last Vivitrol Injec|0
7949490|NCT02537574|12495027|FG002|Overall Study|Subject did not want last Vivitrol Injec|1
7949491|NCT02537574|12495025|FG000|Overall Study|Noncompliance with Protocol|0
7949492|NCT02537574|12495026|FG001|Overall Study|Noncompliance with Protocol|0
7949493|NCT02537574|12495027|FG002|Overall Study|Noncompliance with Protocol|1
7949494|NCT02538029|12495074|FG000|Overall Study|unable to complete cognitive assessments|1
7720935|NCT00541970|12145421|FG000|Month 60|Protocol Violation|78
7720936|NCT00541970|12145422|FG001|Month 60|Protocol Violation|77
7851981|NCT01499355|12334522|FG002|Run-In Period|Consent Withdrawn|0
7851982|NCT01499355|12334523|FG003|Run-In Period|Consent Withdrawn|0
7851983|NCT01499355|12334520|FG000|Run-In Period|Adverse Event|8
7851984|NCT01499355|12334521|FG001|Run-In Period|Adverse Event|0
7851985|NCT01499355|12334522|FG002|Run-In Period|Adverse Event|0
7851986|NCT01499355|12334523|FG003|Run-In Period|Adverse Event|0
7851987|NCT01499355|12334520|FG000|Double-Blind Period|Adverse Event|0
7851988|NCT01499355|12334521|FG001|Double-Blind Period|Adverse Event|2
7851989|NCT01499355|12334522|FG002|Double-Blind Period|Adverse Event|3
7851990|NCT01499355|12334523|FG003|Double-Blind Period|Adverse Event|2
7851991|NCT01499355|12334520|FG000|Double-Blind Period|Study Termination|0
7851992|NCT01499355|12334521|FG001|Double-Blind Period|Study Termination|18
7851993|NCT01499355|12334522|FG002|Double-Blind Period|Study Termination|16
7851994|NCT01499355|12334523|FG003|Double-Blind Period|Study Termination|14
7851995|NCT01499355|12334520|FG000|Double-Blind Period|Other|0
7851996|NCT01499355|12334521|FG001|Double-Blind Period|Other|1
7851997|NCT01499355|12334522|FG002|Double-Blind Period|Other|2
7851998|NCT01499355|12334523|FG003|Double-Blind Period|Other|2
7851999|NCT01499355|12334520|FG000|Double-Blind Period|Death|0
7852000|NCT01499355|12334521|FG001|Double-Blind Period|Death|1
7852001|NCT01499355|12334522|FG002|Double-Blind Period|Death|0
7852002|NCT01499355|12334523|FG003|Double-Blind Period|Death|0
7852003|NCT01499355|12334520|FG000|Double-Blind Period|Investigator Decision|0
7852004|NCT01499355|12334521|FG001|Double-Blind Period|Investigator Decision|0
7852005|NCT01499355|12334522|FG002|Double-Blind Period|Investigator Decision|3
7720937|NCT00541970|12145423|FG002|Month 60|Protocol Violation|82
7720938|NCT00541970|12145424|FG003|Month 60|Protocol Violation|72
7852006|NCT01499355|12334523|FG003|Double-Blind Period|Investigator Decision|3
7852007|NCT01499355|12334520|FG000|Double-Blind Period|Consent Withdrawn|0
7852008|NCT01499355|12334521|FG001|Double-Blind Period|Consent Withdrawn|0
7852009|NCT01499355|12334522|FG002|Double-Blind Period|Consent Withdrawn|1
7852010|NCT01499355|12334523|FG003|Double-Blind Period|Consent Withdrawn|2
7852011|NCT01499355|12334520|FG000|Double-Blind Period|Lost to Follow-up|0
7852012|NCT01499355|12334521|FG001|Double-Blind Period|Lost to Follow-up|1
7852013|NCT01499355|12334522|FG002|Double-Blind Period|Lost to Follow-up|0
7852014|NCT01499355|12334523|FG003|Double-Blind Period|Lost to Follow-up|0
7852015|NCT01499368|12334536|FG000|Overall Study|Did not meet I/E criteria|8
7852016|NCT01499368|12334537|FG001|Overall Study|Did not meet I/E criteria|4
7852017|NCT01499368|12334538|FG002|Overall Study|Did not meet I/E criteria|4
7852018|NCT01499368|12334536|FG000|Overall Study|Prohibited Concomitant medication|1
7852019|NCT01499368|12334537|FG001|Overall Study|Prohibited Concomitant medication|1
7852020|NCT01499368|12334538|FG002|Overall Study|Prohibited Concomitant medication|0
7852021|NCT01499368|12334536|FG000|Overall Study|Withdrawal by Subject|11
7852022|NCT01499368|12334537|FG001|Overall Study|Withdrawal by Subject|10
7852023|NCT01499368|12334538|FG002|Overall Study|Withdrawal by Subject|8
7852024|NCT01499368|12334536|FG000|Overall Study|Lost to Follow-up|3
7852025|NCT01499368|12334537|FG001|Overall Study|Lost to Follow-up|2
7852026|NCT01499368|12334538|FG002|Overall Study|Lost to Follow-up|5
7852027|NCT01499368|12334536|FG000|Overall Study|Adverse Event|4
7852028|NCT01499368|12334537|FG001|Overall Study|Adverse Event|0
7852029|NCT01499368|12334538|FG002|Overall Study|Adverse Event|2
7852030|NCT01499368|12334536|FG000|Overall Study|Physician Decision|0
7852031|NCT01499368|12334537|FG001|Overall Study|Physician Decision|1
7852032|NCT01499368|12334538|FG002|Overall Study|Physician Decision|0
7852033|NCT01499368|12334536|FG000|Overall Study|Deviation from visit window|0
7852034|NCT01499368|12334537|FG001|Overall Study|Deviation from visit window|0
7852035|NCT01499368|12334538|FG002|Overall Study|Deviation from visit window|1
7852036|NCT01499368|12334536|FG000|Overall Study|Error of Prescriptions|0
7852037|NCT01499368|12334537|FG001|Overall Study|Error of Prescriptions|0
7852038|NCT01499368|12334538|FG002|Overall Study|Error of Prescriptions|1
7852039|NCT01499511|12334555|FG000|Overall Study|Death|1
7852040|NCT01499511|12334556|FG001|Overall Study|Death|0
7852041|NCT01499576|12334563|FG000|Overall Study|Physician Decision|12
7852042|NCT01499576|12334563|FG000|Overall Study|Withdrawal by Subject|9
7852043|NCT01499667|12334581|FG000|Overall Study|administrative problems|4
7852044|NCT01499667|12334582|FG001|Overall Study|administrative problems|5
7852045|NCT01499667|12334583|FG002|Overall Study|administrative problems|5
7852046|NCT01499667|12334581|FG000|Overall Study|Protocol Violation|1
7852047|NCT01499667|12334582|FG001|Overall Study|Protocol Violation|3
7852048|NCT01499667|12334583|FG002|Overall Study|Protocol Violation|2
7852049|NCT01499667|12334581|FG000|Overall Study|Adverse Event|0
7852050|NCT01499667|12334582|FG001|Overall Study|Adverse Event|2
7852051|NCT01499667|12334583|FG002|Overall Study|Adverse Event|2
7852052|NCT01499667|12334581|FG000|Overall Study|Withdrawal by Subject|2
7852053|NCT01499667|12334582|FG001|Overall Study|Withdrawal by Subject|1
7852054|NCT01499667|12334583|FG002|Overall Study|Withdrawal by Subject|1
7852055|NCT01499667|12334581|FG000|Overall Study|Lack of Efficacy|2
7852056|NCT01499667|12334582|FG001|Overall Study|Lack of Efficacy|0
7852057|NCT01499667|12334583|FG002|Overall Study|Lack of Efficacy|0
7852058|NCT01499810|12334591|FG000|Overall Study|Lost to Follow-up|10
7852059|NCT01499810|12334591|FG000|Overall Study|Protocol Violation|1
7852060|NCT01499810|12334591|FG000|Overall Study|Withdrawal by Subject|1
7852061|NCT01499849|12334598|FG000|Overall Study|Adverse Event|28
7852062|NCT01499849|12334599|FG001|Overall Study|Adverse Event|32
7852063|NCT01499849|12334598|FG000|Overall Study|Chemo completed or Change in Therapy|70
7852064|NCT01499849|12334599|FG001|Overall Study|Chemo completed or Change in Therapy|67
7852065|NCT01499849|12334598|FG000|Overall Study|Withdrawal by Subject|43
7852066|NCT01499849|12334599|FG001|Overall Study|Withdrawal by Subject|43
7852067|NCT01499849|12334598|FG000|Overall Study|Death|5
7852068|NCT01499849|12334599|FG001|Overall Study|Death|7
7852069|NCT01499849|12334598|FG000|Overall Study|Disease Progression|11
7852070|NCT01499849|12334599|FG001|Overall Study|Disease Progression|10
7852071|NCT01499849|12334598|FG000|Overall Study|Protocol Violation|11
7852072|NCT01499849|12334599|FG001|Overall Study|Protocol Violation|11
7852073|NCT01499849|12334598|FG000|Overall Study|Physician Decision|20
7852074|NCT01499849|12334599|FG001|Overall Study|Physician Decision|19
7852075|NCT01499849|12334598|FG000|Overall Study|Lack of Efficacy|3
7852076|NCT01499849|12334599|FG001|Overall Study|Lack of Efficacy|4
7852077|NCT01499849|12334598|FG000|Overall Study|Lost to Follow-up|6
7852078|NCT01499849|12334599|FG001|Overall Study|Lost to Follow-up|3
7852079|NCT01499849|12334598|FG000|Overall Study|Other Reasons|27
7852080|NCT01499849|12334599|FG001|Overall Study|Other Reasons|30
7852081|NCT01499940|12334623|FG000|Overall Study|Study was withdrawn before completion.|9
7852082|NCT01500031|12334627|FG000|Overall Study|Death|1
7852083|NCT01500031|12334627|FG000|Overall Study|Withdrawal by Subject|4
7852084|NCT01500057|12334633|FG000|Overall Study|Lost to Follow-up|6
7852085|NCT01500057|12334634|FG001|Overall Study|Lost to Follow-up|4
7852086|NCT01500083|12334642|FG000|Overall Study|Adverse Event|4
7852087|NCT01500083|12334643|FG001|Overall Study|Adverse Event|17
7852088|NCT01500083|12334642|FG000|Overall Study|Death|0
7852089|NCT01500083|12334643|FG001|Overall Study|Death|2
7852090|NCT01500083|12334642|FG000|Overall Study|Lost to Follow-up|1
7852091|NCT01500083|12334643|FG001|Overall Study|Lost to Follow-up|0
7852092|NCT01500083|12334642|FG000|Overall Study|Withdrawal of Consent|0
7852093|NCT01500083|12334643|FG001|Overall Study|Withdrawal of Consent|1
7852094|NCT01500083|12334642|FG000|Overall Study|Disease Progression|2
7852095|NCT01500083|12334643|FG001|Overall Study|Disease Progression|10
7852096|NCT01500083|12334642|FG000|Overall Study|Investigator Discretion|3
7852097|NCT01500083|12334643|FG001|Overall Study|Investigator Discretion|8
7852098|NCT01500083|12334642|FG000|Overall Study|Other Reasons|2
7949495|NCT02538029|12495075|FG001|Overall Study|unable to complete cognitive assessments|0
7949496|NCT02538029|12495076|FG002|Overall Study|unable to complete cognitive assessments|1
7852099|NCT01500083|12334643|FG001|Overall Study|Other Reasons|5
7949497|NCT02538094|12495097|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0
7949498|NCT02538094|12495098|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1
7949499|NCT02538094|12495097|FG000|Washout (4 Weeks)|Withdrawal by Subject|0
7949500|NCT02538094|12495098|FG001|Washout (4 Weeks)|Withdrawal by Subject|1
7949501|NCT02538107|12495104|FG000|Overall Study|Did not receive any Mircera dose|11
7949502|NCT02538107|12495104|FG000|Overall Study|Missing|5
7949503|NCT02538107|12495104|FG000|Overall Study|Necessity of dialysis|20
7949504|NCT02538107|12495104|FG000|Overall Study|Administration of other ESA|11
7949505|NCT02538107|12495104|FG000|Overall Study|No further treatment necessary|18
7949506|NCT02538107|12495104|FG000|Overall Study|Withdrawal by Subject|17
7949507|NCT02538107|12495104|FG000|Overall Study|Death|4
7949508|NCT02538107|12495104|FG000|Overall Study|Administrative reason|5
7949509|NCT02538107|12495104|FG000|Overall Study|Adverse Event|4
7949510|NCT02538107|12495104|FG000|Overall Study|Surgery|1
7949511|NCT02538107|12495104|FG000|Overall Study|Other|7
7949512|NCT02538107|12495104|FG000|Overall Study|Not recorded|7
7949513|NCT02538341|12495120|FG000|Overall Study|Lost to Follow-up|51
7949514|NCT02538341|12495121|FG001|Overall Study|Lost to Follow-up|46
7949515|NCT02538341|12495120|FG000|Overall Study|Withdrawal by Subject|3
7949516|NCT02538341|12495121|FG001|Overall Study|Withdrawal by Subject|1
7949517|NCT02538341|12495120|FG000|Overall Study|Death|2
7949518|NCT02538341|12495121|FG001|Overall Study|Death|0
7949519|NCT02538471|12495145|FG000|Overall Study|Progression of disease|2
7949520|NCT02538614|12495158|FG000|Overall Study|Progressive Disease|2
7949521|NCT02538900|12495189|FG000|Overall Study|Death|2
7949522|NCT02538900|12495190|FG001|Overall Study|Death|2
7852100|NCT01500096|12334653|FG000|Overall Study|Lost to Follow-up|1
7852101|NCT01500096|12334654|FG001|Overall Study|Lost to Follow-up|0
7852102|NCT01500096|12334655|FG002|Overall Study|Lost to Follow-up|0
7852103|NCT01500096|12334656|FG003|Overall Study|Lost to Follow-up|2
7852104|NCT01500135|12334668|FG000|Overall Study|Withdrawal of Consent|4
7852105|NCT01500135|12334669|FG001|Overall Study|Withdrawal of Consent|0
7852106|NCT01500135|12334668|FG000|Overall Study|Lost to Follow-up|6
7852107|NCT01500135|12334669|FG001|Overall Study|Lost to Follow-up|4
7852108|NCT01500135|12334668|FG000|Overall Study|Fatal Adverse Event (AE)|5
7852109|NCT01500135|12334669|FG001|Overall Study|Fatal Adverse Event (AE)|5
7852110|NCT01500135|12334668|FG000|Overall Study|Principal Investigator (PI) Discretion|1
7852111|NCT01500135|12334669|FG001|Overall Study|Principal Investigator (PI) Discretion|0
7852112|NCT01500135|12334668|FG000|Overall Study|Patient Missed Scheduled Appointments|0
7852113|NCT01500135|12334669|FG001|Overall Study|Patient Missed Scheduled Appointments|1
7852114|NCT01500135|12334668|FG000|Overall Study|Participant was a Safety Concern|1
7852115|NCT01500135|12334669|FG001|Overall Study|Participant was a Safety Concern|0
7852116|NCT01500135|12334668|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0
7852117|NCT01500135|12334669|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1
7852118|NCT01500187|12334677|FG000|Overall Study|Lost to Follow-up|6
7852119|NCT01500187|12334678|FG001|Overall Study|Lost to Follow-up|0
7852120|NCT01500200|12334687|FG000|Stage 1|Adverse Event|1
7852121|NCT01500200|12334688|FG001|Stage 1|Adverse Event|4
7852122|NCT01500200|12334689|FG002|Stage 1|Adverse Event|5
7852123|NCT01500200|12334690|FG003|Stage 1|Adverse Event|0
7852124|NCT01500200|12334691|FG004|Stage 1|Adverse Event|0
7852125|NCT01500200|12334692|FG005|Stage 1|Adverse Event|0
7852126|NCT01500200|12334687|FG000|Stage 1|Lost to Follow-up|2
7852127|NCT01500200|12334688|FG001|Stage 1|Lost to Follow-up|2
7852128|NCT01500200|12334689|FG002|Stage 1|Lost to Follow-up|1
7852129|NCT01500200|12334690|FG003|Stage 1|Lost to Follow-up|0
7852130|NCT01500200|12334691|FG004|Stage 1|Lost to Follow-up|0
7852131|NCT01500200|12334692|FG005|Stage 1|Lost to Follow-up|0
7852132|NCT01500200|12334687|FG000|Stage 1|Withdrawal by Subject|3
7852133|NCT01500200|12334688|FG001|Stage 1|Withdrawal by Subject|0
7852134|NCT01500200|12334689|FG002|Stage 1|Withdrawal by Subject|0
7852135|NCT01500200|12334690|FG003|Stage 1|Withdrawal by Subject|0
7852136|NCT01500200|12334691|FG004|Stage 1|Withdrawal by Subject|0
7852137|NCT01500200|12334692|FG005|Stage 1|Withdrawal by Subject|0
7852138|NCT01500200|12334687|FG000|Stage 1|Noncompliance with Study Drug|1
7852139|NCT01500200|12334688|FG001|Stage 1|Noncompliance with Study Drug|0
7852140|NCT01500200|12334689|FG002|Stage 1|Noncompliance with Study Drug|0
7852141|NCT01500200|12334690|FG003|Stage 1|Noncompliance with Study Drug|0
7852142|NCT01500200|12334691|FG004|Stage 1|Noncompliance with Study Drug|0
7852143|NCT01500200|12334692|FG005|Stage 1|Noncompliance with Study Drug|0
7852144|NCT01500200|12334687|FG000|Stage 1|Physician Decision|1
7852145|NCT01500200|12334688|FG001|Stage 1|Physician Decision|0
7852146|NCT01500200|12334689|FG002|Stage 1|Physician Decision|0
7852147|NCT01500200|12334690|FG003|Stage 1|Physician Decision|0
7852148|NCT01500200|12334691|FG004|Stage 1|Physician Decision|0
7852149|NCT01500200|12334692|FG005|Stage 1|Physician Decision|0
7852150|NCT01500200|12334687|FG000|Stage 2|Adverse Event|0
7852151|NCT01500200|12334688|FG001|Stage 2|Adverse Event|0
7852152|NCT01500200|12334689|FG002|Stage 2|Adverse Event|0
7852153|NCT01500200|12334690|FG003|Stage 2|Adverse Event|0
7852154|NCT01500200|12334691|FG004|Stage 2|Adverse Event|5
7852155|NCT01500200|12334692|FG005|Stage 2|Adverse Event|4
7852156|NCT01500213|12334708|FG000|Overall Study|Adverse Event|35
7852157|NCT01500213|12334709|FG001|Overall Study|Adverse Event|35
7852158|NCT01500213|12334708|FG000|Overall Study|Chemo Completed or Change in Therapy|84
7852159|NCT01500213|12334709|FG001|Overall Study|Chemo Completed or Change in Therapy|81
7852160|NCT01500213|12334708|FG000|Overall Study|Withdrawal by Subject|28
7852161|NCT01500213|12334709|FG001|Overall Study|Withdrawal by Subject|37
7852162|NCT01500213|12334708|FG000|Overall Study|Death|7
7852163|NCT01500213|12334709|FG001|Overall Study|Death|3
7852164|NCT01500213|12334708|FG000|Overall Study|Disease Progression|13
7852165|NCT01500213|12334709|FG001|Overall Study|Disease Progression|21
7852166|NCT01500213|12334708|FG000|Overall Study|Protocol Violation|19
7852167|NCT01500213|12334709|FG001|Overall Study|Protocol Violation|19
7852168|NCT01500213|12334708|FG000|Overall Study|Physician Decision|12
7852169|NCT01500213|12334709|FG001|Overall Study|Physician Decision|10
7852170|NCT01500213|12334708|FG000|Overall Study|Lack of Efficacy|9
7852171|NCT01500213|12334709|FG001|Overall Study|Lack of Efficacy|7
7852172|NCT01500213|12334708|FG000|Overall Study|Lost to Follow-up|3
7852173|NCT01500213|12334709|FG001|Overall Study|Lost to Follow-up|6
7852174|NCT01500213|12334708|FG000|Overall Study|Other Reasons|7
7852175|NCT01500213|12334709|FG001|Overall Study|Other Reasons|5
7852176|NCT01500226|12334717|FG000|Overall Study|Adverse Event|31
7852177|NCT01500226|12334718|FG001|Overall Study|Adverse Event|38
7949523|NCT02538900|12495191|FG002|Overall Study|Death|2
7852178|NCT01500226|12334717|FG000|Overall Study|Chemo Completed or Change in Therapy|235
7852179|NCT01500226|12334718|FG001|Overall Study|Chemo Completed or Change in Therapy|237
7852180|NCT01500226|12334717|FG000|Overall Study|Withdrawal by Subject|93
7852181|NCT01500226|12334718|FG001|Overall Study|Withdrawal by Subject|96
7852182|NCT01500226|12334717|FG000|Overall Study|Death|12
7852183|NCT01500226|12334718|FG001|Overall Study|Death|4
7852184|NCT01500226|12334717|FG000|Overall Study|Disease Progression|16
7852185|NCT01500226|12334718|FG001|Overall Study|Disease Progression|14
7852186|NCT01500226|12334717|FG000|Overall Study|Protocol Violation|53
7852187|NCT01500226|12334718|FG001|Overall Study|Protocol Violation|39
7852188|NCT01500226|12334717|FG000|Overall Study|Physician Decision|17
7852189|NCT01500226|12334718|FG001|Overall Study|Physician Decision|15
7852190|NCT01500226|12334717|FG000|Overall Study|Lack of Efficacy|14
7852191|NCT01500226|12334718|FG001|Overall Study|Lack of Efficacy|30
7852192|NCT01500226|12334717|FG000|Overall Study|Lost to Follow-up|9
7852193|NCT01500226|12334718|FG001|Overall Study|Lost to Follow-up|5
7852194|NCT01500226|12334717|FG000|Overall Study|Other Reasons|19
7852195|NCT01500226|12334718|FG001|Overall Study|Other Reasons|16
7852196|NCT01500252|12334726|FG000|Overall Study|Death|4
7852197|NCT01500252|12334727|FG001|Overall Study|Death|2
7852198|NCT01500252|12334726|FG000|Overall Study|Lost to Follow-up|5
7852199|NCT01500252|12334727|FG001|Overall Study|Lost to Follow-up|4
7852200|NCT01500278|12334736|FG000|Week 0 - Week 12|Lack of Efficacy|0
7852201|NCT01500278|12334737|FG001|Week 0 - Week 12|Lack of Efficacy|1
7852202|NCT01500278|12334736|FG000|Week 0 - Week 12|Protocol Violation|10
7852203|NCT01500278|12334737|FG001|Week 0 - Week 12|Protocol Violation|16
7852204|NCT01500278|12334736|FG000|Week 0 - Week 12|Lost to Follow-up|1
7852205|NCT01500278|12334737|FG001|Week 0 - Week 12|Lost to Follow-up|1
7852206|NCT01500278|12334736|FG000|Week 0 - Week 12|Withdrawal by Subject|7
7852207|NCT01500278|12334737|FG001|Week 0 - Week 12|Withdrawal by Subject|2
7852208|NCT01500278|12334736|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1
7852209|NCT01500278|12334737|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0
7852210|NCT01500278|12334736|FG000|Week 0 - Week 12|Patient decision|1
7852211|NCT01500278|12334737|FG001|Week 0 - Week 12|Patient decision|0
7852212|NCT01500278|12334736|FG000|Week 0 - Week 12|Exclusion criteria not met|1
7852213|NCT01500278|12334737|FG001|Week 0 - Week 12|Exclusion criteria not met|0
7852214|NCT01500278|12334736|FG000|Week 0 - Week 12|Investigator decision|1
7852215|NCT01500278|12334737|FG001|Week 0 - Week 12|Investigator decision|0
7852216|NCT01500278|12334736|FG000|Week 0 - Week 12|Prior history of serious disease|1
7852217|NCT01500278|12334737|FG001|Week 0 - Week 12|Prior history of serious disease|0
7852218|NCT01500278|12334736|FG000|Week 0 - Week 12|Sponsor decision|1
7852219|NCT01500278|12334737|FG001|Week 0 - Week 12|Sponsor decision|0
7852220|NCT01500278|12334736|FG000|Week 0 - Week 12|Personal reason|0
7852221|NCT01500278|12334737|FG001|Week 0 - Week 12|Personal reason|1
7852222|NCT01500278|12334736|FG000|Week 0 - Week 12|Other serious disease|0
7852223|NCT01500278|12334737|FG001|Week 0 - Week 12|Other serious disease|1
7852224|NCT01500278|12334736|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7
7852225|NCT01500278|12334737|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8
7852226|NCT01500278|12334736|FG000|Week 13 - Week 104|Lack of Efficacy|11
7852227|NCT01500278|12334737|FG001|Week 13 - Week 104|Lack of Efficacy|12
7852228|NCT01500278|12334736|FG000|Week 13 - Week 104|Protocol Violation|6
7852229|NCT01500278|12334737|FG001|Week 13 - Week 104|Protocol Violation|6
7852230|NCT01500278|12334736|FG000|Week 13 - Week 104|Lost to Follow-up|6
7852231|NCT01500278|12334737|FG001|Week 13 - Week 104|Lost to Follow-up|5
7852232|NCT01500278|12334736|FG000|Week 13 - Week 104|Withdrawal by Subject|22
7852233|NCT01500278|12334737|FG001|Week 13 - Week 104|Withdrawal by Subject|13
7852234|NCT01500278|12334736|FG000|Week 13 - Week 104|Week 24 Non-Responder|20
7852235|NCT01500278|12334737|FG001|Week 13 - Week 104|Week 24 Non-Responder|16
7852236|NCT01500278|12334736|FG000|Week 13 - Week 104|Non/bad compliance|7
7852237|NCT01500278|12334737|FG001|Week 13 - Week 104|Non/bad compliance|5
7852238|NCT01500278|12334736|FG000|Week 13 - Week 104|Recurrent infections|1
7852239|NCT01500278|12334737|FG001|Week 13 - Week 104|Recurrent infections|0
7852240|NCT01500278|12334736|FG000|Week 13 - Week 104|False positive test|1
7852241|NCT01500278|12334737|FG001|Week 13 - Week 104|False positive test|2
7852242|NCT01500278|12334736|FG000|Week 13 - Week 104|Sponsor request|4
7852243|NCT01500278|12334737|FG001|Week 13 - Week 104|Sponsor request|0
7852244|NCT01500278|12334736|FG000|Week 13 - Week 104|Withdrawn in error|1
7852245|NCT01500278|12334737|FG001|Week 13 - Week 104|Withdrawn in error|0
7852246|NCT01500278|12334736|FG000|Week 13 - Week 104|Exclusion criteria not met|1
7852247|NCT01500278|12334737|FG001|Week 13 - Week 104|Exclusion criteria not met|0
7852248|NCT01500278|12334736|FG000|Week 13 - Week 104|Protocol deviation|1
7852249|NCT01500278|12334737|FG001|Week 13 - Week 104|Protocol deviation|0
7852250|NCT01500278|12334736|FG000|Week 13 - Week 104|Principal investigator retiring|1
7852251|NCT01500278|12334737|FG001|Week 13 - Week 104|Principal investigator retiring|0
7852252|NCT01500278|12334736|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
7852253|NCT01500278|12334737|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
7852254|NCT01500278|12334736|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0
7852255|NCT01500278|12334737|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2
7852256|NCT01500278|12334736|FG000|Week 13 - Week 104|Relocation|0
7852257|NCT01500278|12334737|FG001|Week 13 - Week 104|Relocation|1
7852258|NCT01500278|12334736|FG000|Week 13 - Week 104|Sponsor decision|0
7852259|NCT01500278|12334737|FG001|Week 13 - Week 104|Sponsor decision|2
7852260|NCT01500278|12334736|FG000|Week 13 - Week 104|Medical monitor decision|0
7852261|NCT01500278|12334737|FG001|Week 13 - Week 104|Medical monitor decision|2
7852262|NCT01500278|12334736|FG000|Week 13 - Week 104|Personal reason|0
7852263|NCT01500278|12334737|FG001|Week 13 - Week 104|Personal reason|1
7852264|NCT01500278|12334736|FG000|Week 13 - Week 104|Not completed|0
7852265|NCT01500278|12334737|FG001|Week 13 - Week 104|Not completed|1
7852266|NCT01500278|12334736|FG000|Week 13 - Week 104|Death|2
7852267|NCT01500278|12334737|FG001|Week 13 - Week 104|Death|4
7852268|NCT01500278|12334736|FG000|Week 13 - Week 104|Adverse Event|54
7852269|NCT01500278|12334737|FG001|Week 13 - Week 104|Adverse Event|54
7852270|NCT01500317|12334748|FG000|Overall Study|Withdrawal by Subject|3
7852271|NCT01500317|12334749|FG001|Overall Study|Withdrawal by Subject|2
7852272|NCT01500317|12334750|FG002|Overall Study|Withdrawal by Subject|0
7852273|NCT01500382|12334762|FG000|Washout Period|Study site went out of business|0
7852274|NCT01500382|12334763|FG001|Washout Period|Study site went out of business|0
7852275|NCT01500382|12334764|FG002|Washout Period|Study site went out of business|1
7852276|NCT01500382|12334765|FG003|Washout Period|Study site went out of business|0
7852277|NCT01500434|12334775|FG000|Overall Study|Death|1
7852278|NCT01500434|12334775|FG000|Overall Study|Withdrawal by Subject|1
7852279|NCT01500434|12334775|FG000|Overall Study|Missed 12-month follow-up|5
7852280|NCT01500629|12334790|FG000|Washout Period of 14 to 30 Days|Pregnancy|1
7852281|NCT01500629|12334791|FG001|Washout Period of 14 to 30 Days|Pregnancy|0
7852282|NCT01500694|12334806|FG000|Overall Study|Adverse Event|4
7852283|NCT01500694|12334807|FG001|Overall Study|Adverse Event|3
7852284|NCT01500694|12334806|FG000|Overall Study|Protocol Violation|0
7852285|NCT01500694|12334807|FG001|Overall Study|Protocol Violation|1
7852286|NCT01500694|12334806|FG000|Overall Study|Withdrawal by Subject|23
7852287|NCT01500694|12334807|FG001|Overall Study|Withdrawal by Subject|14
7852288|NCT01500694|12334806|FG000|Overall Study|Lost to Follow-up|2
7852289|NCT01500694|12334807|FG001|Overall Study|Lost to Follow-up|3
7852290|NCT01500694|12334806|FG000|Overall Study|Lack of Efficacy|14
7852291|NCT01500694|12334807|FG001|Overall Study|Lack of Efficacy|5
7852292|NCT01500694|12334806|FG000|Overall Study|Other|9
7852293|NCT01500694|12334807|FG001|Overall Study|Other|3
7852294|NCT01500720|12334815|FG000|Overall Study|Randomized But Not Treated|1
7852295|NCT01500720|12334816|FG001|Overall Study|Randomized But Not Treated|1
7852296|NCT01500720|12334815|FG000|Overall Study|Other|4
7852297|NCT01500720|12334816|FG001|Overall Study|Other|8
7852298|NCT01501110|12334851|FG000|Overall Study|Death|0
7852299|NCT01501110|12334852|FG001|Overall Study|Death|1
7852300|NCT01502033|12334874|FG000|Overall Study|1 participant had scalp discomfort|1
7852301|NCT01502033|12334874|FG000|Overall Study|1 participant had worsening depression|1
7852302|NCT01502033|12334874|FG000|Overall Study|1 participant went back to school|1
7852303|NCT01502072|12334883|FG000|Overall Study|Withdrawal by Subject|1
7852304|NCT01502072|12334884|FG001|Overall Study|Withdrawal by Subject|0
7852305|NCT01502072|12334885|FG002|Overall Study|Withdrawal by Subject|0
7852306|NCT01502072|12334883|FG000|Overall Study|Death|0
7852307|NCT01502072|12334884|FG001|Overall Study|Death|1
7852308|NCT01502072|12334885|FG002|Overall Study|Death|0
7852309|NCT01502228|12334893|FG000|Overall Study|Death|1
7852310|NCT01502293|12334900|FG000|Overall Study|Progressive Disease|20
7852311|NCT01502293|12334901|FG001|Overall Study|Progressive Disease|12
7852312|NCT01502293|12334902|FG002|Overall Study|Progressive Disease|2
7852313|NCT01502293|12334900|FG000|Overall Study|Withdrawal by Subject|3
7852314|NCT01502293|12334901|FG001|Overall Study|Withdrawal by Subject|3
7852315|NCT01502293|12334902|FG002|Overall Study|Withdrawal by Subject|1
7852316|NCT01502293|12334900|FG000|Overall Study|Adverse Event|0
7852317|NCT01502293|12334901|FG001|Overall Study|Adverse Event|2
7852318|NCT01502293|12334902|FG002|Overall Study|Adverse Event|0
7852319|NCT01502293|12334900|FG000|Overall Study|Reason Not Specified|2
7852320|NCT01502293|12334901|FG001|Overall Study|Reason Not Specified|0
7852321|NCT01502293|12334902|FG002|Overall Study|Reason Not Specified|0
7852322|NCT01502293|12334900|FG000|Overall Study|Physician Decision|0
7852323|NCT01502293|12334901|FG001|Overall Study|Physician Decision|0
7852324|NCT01502293|12334902|FG002|Overall Study|Physician Decision|1
7852325|NCT01502410|12334939|FG000|Overall Study|Adverse Event|1
7852326|NCT01502410|12334940|FG001|Overall Study|Adverse Event|2
7852327|NCT01502410|12334941|FG002|Overall Study|Adverse Event|0
7852328|NCT01502410|12334942|FG003|Overall Study|Adverse Event|0
7852329|NCT01502410|12334939|FG000|Overall Study|Lack of Efficacy|7
7852330|NCT01502410|12334940|FG001|Overall Study|Lack of Efficacy|7
7852331|NCT01502410|12334941|FG002|Overall Study|Lack of Efficacy|0
7852332|NCT01502410|12334942|FG003|Overall Study|Lack of Efficacy|0
7852333|NCT01502410|12334939|FG000|Overall Study|Physician Decision|0
7852334|NCT01502410|12334940|FG001|Overall Study|Physician Decision|1
7852335|NCT01502410|12334941|FG002|Overall Study|Physician Decision|0
7852336|NCT01502410|12334942|FG003|Overall Study|Physician Decision|0
7852337|NCT01502410|12334939|FG000|Overall Study|Withdrawal by Subject|2
7852338|NCT01502410|12334940|FG001|Overall Study|Withdrawal by Subject|0
7852339|NCT01502410|12334941|FG002|Overall Study|Withdrawal by Subject|0
7852340|NCT01502410|12334942|FG003|Overall Study|Withdrawal by Subject|0
7852341|NCT01502423|12334953|FG000|Overall Study|Withdrawal by Subject|0
7852342|NCT01502423|12334954|FG001|Overall Study|Withdrawal by Subject|1
7852343|NCT01502631|12334962|FG000|Overall Study|Adverse Event|5
7852344|NCT01502631|12334963|FG001|Overall Study|Adverse Event|8
7852345|NCT01502631|12334962|FG000|Overall Study|Lost to Follow-up|2
7852346|NCT01502631|12334963|FG001|Overall Study|Lost to Follow-up|2
7852347|NCT01502631|12334962|FG000|Overall Study|Participant withdrew consent|2
7852348|NCT01502631|12334963|FG001|Overall Study|Participant withdrew consent|4
7852349|NCT01502631|12334962|FG000|Overall Study|Participant non-compliant|1
7852350|NCT01502631|12334963|FG001|Overall Study|Participant non-compliant|0
7852351|NCT01502631|12334962|FG000|Overall Study|Investigator's decision|0
7852352|NCT01502631|12334963|FG001|Overall Study|Investigator's decision|1
7852353|NCT01502631|12334962|FG000|Overall Study|Other|10
7852354|NCT01502631|12334963|FG001|Overall Study|Other|5
7852355|NCT01502644|12334972|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
7852356|NCT01502644|12334973|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
7852357|NCT01502644|12334974|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
7852358|NCT01502644|12334975|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
7852359|NCT01502644|12334972|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
7852360|NCT01502644|12334973|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
7852361|NCT01502644|12334974|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
7852362|NCT01502644|12334975|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
7852363|NCT01502644|12334972|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
7852364|NCT01502644|12334973|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
7852365|NCT01502644|12334974|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
7852366|NCT01502644|12334975|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
7852367|NCT01502644|12334972|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0
7852368|NCT01502644|12334973|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6
7852369|NCT01502644|12334974|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2
7852370|NCT01502644|12334975|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7
7852371|NCT01502644|12334972|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
7852372|NCT01502644|12334973|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
7852373|NCT01502644|12334974|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
7852374|NCT01502644|12334975|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
7852375|NCT01502709|12334985|FG000|Overall Study|Lost to Follow-up|4
7852376|NCT01502709|12334986|FG001|Overall Study|Lost to Follow-up|0
7852377|NCT01502956|12335027|FG000|Overall Study|Death|0
7852378|NCT01502956|12335028|FG001|Overall Study|Death|2
7852379|NCT01502956|12335027|FG000|Overall Study|Lost to Follow-up|14
7852380|NCT01502956|12335028|FG001|Overall Study|Lost to Follow-up|11
7852381|NCT01502956|12335027|FG000|Overall Study|Physician Decision|2
7852382|NCT01502956|12335028|FG001|Overall Study|Physician Decision|3
7852383|NCT01502956|12335027|FG000|Overall Study|Withdrawal by Subject|8
7852384|NCT01502956|12335028|FG001|Overall Study|Withdrawal by Subject|10
7852385|NCT01503021|12335036|FG000|Overall Study|Adverse Event|7
7852386|NCT01503021|12335037|FG001|Overall Study|Adverse Event|6
7852387|NCT01503021|12335036|FG000|Overall Study|Death|0
7852388|NCT01503021|12335037|FG001|Overall Study|Death|2
7852389|NCT01503021|12335036|FG000|Overall Study|Lost to Follow-up|2
7852390|NCT01503021|12335037|FG001|Overall Study|Lost to Follow-up|0
7852391|NCT01503021|12335036|FG000|Overall Study|Physician Decision|3
7852392|NCT01503021|12335037|FG001|Overall Study|Physician Decision|0
7852393|NCT01503021|12335036|FG000|Overall Study|Protocol Violation|1
7852394|NCT01503021|12335037|FG001|Overall Study|Protocol Violation|3
7852395|NCT01503021|12335036|FG000|Overall Study|Withdrawal by Subject|9
7852396|NCT01503021|12335037|FG001|Overall Study|Withdrawal by Subject|8
7852397|NCT01503021|12335036|FG000|Overall Study|Moved, received transplant, etc.|5
7852398|NCT01503021|12335037|FG001|Overall Study|Moved, received transplant, etc.|7
7852399|NCT01503164|12335050|FG000|Overall Study|Withdrawal by Subject|2
7852400|NCT01503164|12335051|FG001|Overall Study|Withdrawal by Subject|1
7852401|NCT01503229|12335057|FG000|Overall Study|Withdrew consent|1
7852402|NCT01504204|12335093|FG000|Overall Study|Lost to Follow-up|1
7852403|NCT01504204|12335094|FG001|Overall Study|Lost to Follow-up|1
7852404|NCT01504412|12335105|FG000|Overall Study|Adverse Event|1
7852405|NCT01504412|12335106|FG001|Overall Study|Adverse Event|8
7852406|NCT01504412|12335107|FG002|Overall Study|Adverse Event|1
7852407|NCT01504412|12335108|FG003|Overall Study|Adverse Event|7
7852408|NCT01504412|12335109|FG004|Overall Study|Adverse Event|10
7852409|NCT01504412|12335105|FG000|Overall Study|Withdrawal by Subject|2
7852410|NCT01504412|12335106|FG001|Overall Study|Withdrawal by Subject|1
7852411|NCT01504412|12335107|FG002|Overall Study|Withdrawal by Subject|1
7852412|NCT01504412|12335108|FG003|Overall Study|Withdrawal by Subject|5
7852413|NCT01504412|12335109|FG004|Overall Study|Withdrawal by Subject|1
7852414|NCT01504412|12335105|FG000|Overall Study|Other|2
7852415|NCT01504412|12335106|FG001|Overall Study|Other|1
7852416|NCT01504412|12335107|FG002|Overall Study|Other|1
7852417|NCT01504412|12335108|FG003|Overall Study|Other|6
7852418|NCT01504412|12335109|FG004|Overall Study|Other|1
7852419|NCT01504412|12335105|FG000|Overall Study|Lost to Follow-up|0
7852420|NCT01504412|12335106|FG001|Overall Study|Lost to Follow-up|2
7852421|NCT01504412|12335107|FG002|Overall Study|Lost to Follow-up|0
7852422|NCT01504412|12335108|FG003|Overall Study|Lost to Follow-up|0
7852423|NCT01504412|12335109|FG004|Overall Study|Lost to Follow-up|0
7852424|NCT01504412|12335105|FG000|Overall Study|Lack of Efficacy|0
7852425|NCT01504412|12335106|FG001|Overall Study|Lack of Efficacy|0
7852426|NCT01504412|12335107|FG002|Overall Study|Lack of Efficacy|1
7852427|NCT01504412|12335108|FG003|Overall Study|Lack of Efficacy|0
7852428|NCT01504412|12335109|FG004|Overall Study|Lack of Efficacy|1
7852429|NCT01504412|12335105|FG000|Overall Study|Death|0
7852430|NCT01504412|12335106|FG001|Overall Study|Death|0
7852431|NCT01504412|12335107|FG002|Overall Study|Death|0
7852432|NCT01504412|12335108|FG003|Overall Study|Death|1
7852433|NCT01504412|12335109|FG004|Overall Study|Death|0
7852434|NCT01504841|12335143|FG000|Overall Study|Withdrawal by Subject|1
7852435|NCT01504841|12335144|FG001|Overall Study|Withdrawal by Subject|1
7852436|NCT01504841|12335145|FG002|Overall Study|Withdrawal by Subject|0
7852437|NCT01504867|12335163|FG000|Overall Study|Inclusion criteria not met|2
7852438|NCT01504867|12335164|FG001|Overall Study|Inclusion criteria not met|2
7852439|NCT01504867|12335163|FG000|Overall Study|Consent revoked|5
7852440|NCT01504867|12335164|FG001|Overall Study|Consent revoked|1
7852441|NCT01504971|12335183|FG000|Overall Study|Physician Decision|13
7852442|NCT01505010|12335197|FG000|Overall Study|Protocol Violation|0
7852443|NCT01505010|12335198|FG001|Overall Study|Protocol Violation|1
7852444|NCT01505010|12335197|FG000|Overall Study|Lost to Follow-up|0
7852445|NCT01505010|12335198|FG001|Overall Study|Lost to Follow-up|1
7852446|NCT01505114|12335208|FG000|Overall Study|Withdrawal by Subject|5
7852447|NCT01505114|12335209|FG001|Overall Study|Withdrawal by Subject|4
7852448|NCT01505114|12335210|FG002|Overall Study|Withdrawal by Subject|4
7852449|NCT01505114|12335211|FG003|Overall Study|Withdrawal by Subject|7
7852450|NCT01505114|12335208|FG000|Overall Study|Death|1
7852451|NCT01505114|12335209|FG001|Overall Study|Death|0
7852452|NCT01505114|12335210|FG002|Overall Study|Death|0
7852453|NCT01505114|12335211|FG003|Overall Study|Death|1
7852454|NCT01505114|12335208|FG000|Overall Study|unable to adhere to visit schedule|3
7852455|NCT01505114|12335209|FG001|Overall Study|unable to adhere to visit schedule|2
7852456|NCT01505114|12335210|FG002|Overall Study|unable to adhere to visit schedule|3
7852457|NCT01505114|12335211|FG003|Overall Study|unable to adhere to visit schedule|3
7852458|NCT01505114|12335208|FG000|Overall Study|Lost to Follow-up|11
7852459|NCT01505114|12335209|FG001|Overall Study|Lost to Follow-up|5
7852460|NCT01505114|12335210|FG002|Overall Study|Lost to Follow-up|8
7852461|NCT01505114|12335211|FG003|Overall Study|Lost to Follow-up|7
7852462|NCT01505114|12335208|FG000|Overall Study|relocated|4
7852463|NCT01505114|12335209|FG001|Overall Study|relocated|2
7852464|NCT01505114|12335210|FG002|Overall Study|relocated|2
7852465|NCT01505114|12335211|FG003|Overall Study|relocated|3
7852466|NCT01505114|12335208|FG000|Overall Study|inadvertent enrollment due to peanut all|0
7852467|NCT01505114|12335209|FG001|Overall Study|inadvertent enrollment due to peanut all|0
7852468|NCT01505114|12335210|FG002|Overall Study|inadvertent enrollment due to peanut all|0
7852469|NCT01505114|12335211|FG003|Overall Study|inadvertent enrollment due to peanut all|1
7852470|NCT01505114|12335208|FG000|Overall Study|staff safety concerns|0
7852471|NCT01505114|12335209|FG001|Overall Study|staff safety concerns|0
7852472|NCT01505114|12335210|FG002|Overall Study|staff safety concerns|0
7852473|NCT01505114|12335211|FG003|Overall Study|staff safety concerns|1
7852474|NCT01505114|12335208|FG000|Overall Study|investigator decision|1
7852475|NCT01505114|12335209|FG001|Overall Study|investigator decision|0
7852476|NCT01505114|12335210|FG002|Overall Study|investigator decision|1
7852477|NCT01505114|12335211|FG003|Overall Study|investigator decision|0
7852478|NCT01505374|12335245|FG000|Overall Study|Lost to Follow-up|1
7852479|NCT01505374|12335246|FG001|Overall Study|Lost to Follow-up|0
7852480|NCT01505387|12335255|FG000|Overall Study|Protocol Violation|1
7852481|NCT01505387|12335256|FG001|Overall Study|Protocol Violation|0
7852482|NCT01505387|12335255|FG000|Overall Study|Withdrawal by Subject|1
7852483|NCT01505387|12335256|FG001|Overall Study|Withdrawal by Subject|1
7852484|NCT01505491|12335265|FG000|Overall Study|Other reason not listed|1
7852485|NCT01505491|12335266|FG001|Overall Study|Other reason not listed|0
7852486|NCT01505491|12335267|FG002|Overall Study|Other reason not listed|0
7852487|NCT01505491|12335265|FG000|Overall Study|Withdrawal by Subject|1
7852488|NCT01505491|12335266|FG001|Overall Study|Withdrawal by Subject|1
7852489|NCT01505491|12335267|FG002|Overall Study|Withdrawal by Subject|4
7852490|NCT01505491|12335265|FG000|Overall Study|Lost to Follow-up|0
7852491|NCT01505491|12335266|FG001|Overall Study|Lost to Follow-up|0
7852492|NCT01505491|12335267|FG002|Overall Study|Lost to Follow-up|1
7852493|NCT01505530|12335278|FG000|Overall Study|Progressive Disease|19
7852494|NCT01505530|12335279|FG001|Overall Study|Progressive Disease|17
7852495|NCT01505530|12335280|FG002|Overall Study|Progressive Disease|18
7852496|NCT01505530|12335278|FG000|Overall Study|Adverse Event|1
7852497|NCT01505530|12335279|FG001|Overall Study|Adverse Event|1
7852498|NCT01505530|12335280|FG002|Overall Study|Adverse Event|0
7852499|NCT01505530|12335278|FG000|Overall Study|Withdrawal by Subject|7
7852500|NCT01505530|12335279|FG001|Overall Study|Withdrawal by Subject|8
7852501|NCT01505530|12335280|FG002|Overall Study|Withdrawal by Subject|6
7852502|NCT01505530|12335278|FG000|Overall Study|Physician Decision|6
7852503|NCT01505530|12335279|FG001|Overall Study|Physician Decision|2
7852504|NCT01505530|12335280|FG002|Overall Study|Physician Decision|5
7852505|NCT01505530|12335278|FG000|Overall Study|Sponsor Decision|1
7852506|NCT01505530|12335279|FG001|Overall Study|Sponsor Decision|8
7852507|NCT01505530|12335280|FG002|Overall Study|Sponsor Decision|7
7852508|NCT01505530|12335278|FG000|Overall Study|Death|7
7852509|NCT01505530|12335279|FG001|Overall Study|Death|6
7852510|NCT01505530|12335280|FG002|Overall Study|Death|5
7852511|NCT01505530|12335278|FG000|Overall Study|entry criteria not met|0
7852512|NCT01505530|12335279|FG001|Overall Study|entry criteria not met|1
7852513|NCT01505530|12335280|FG002|Overall Study|entry criteria not met|0
7852514|NCT01505634|12335291|FG000|Overall Study|Withdrawal by Subject|2
7852515|NCT01505634|12335292|FG001|Overall Study|Withdrawal by Subject|5
7852516|NCT01505634|12335293|FG002|Overall Study|Withdrawal by Subject|1
7852517|NCT01505634|12335291|FG000|Overall Study|Physician Decision|1
7852518|NCT01505634|12335292|FG001|Overall Study|Physician Decision|1
7852519|NCT01505634|12335293|FG002|Overall Study|Physician Decision|0
7852520|NCT01505634|12335291|FG000|Overall Study|Adverse Event|1
7852521|NCT01505634|12335292|FG001|Overall Study|Adverse Event|0
7852522|NCT01505634|12335293|FG002|Overall Study|Adverse Event|0
7852523|NCT01505634|12335291|FG000|Overall Study|Insufficient supply of drug at site|1
7852524|NCT01505634|12335292|FG001|Overall Study|Insufficient supply of drug at site|0
7852525|NCT01505634|12335293|FG002|Overall Study|Insufficient supply of drug at site|0
7852526|NCT01505634|12335291|FG000|Overall Study|Protocol Violation|2
7852527|NCT01505634|12335292|FG001|Overall Study|Protocol Violation|0
7852528|NCT01505634|12335293|FG002|Overall Study|Protocol Violation|0
7852529|NCT01505634|12335291|FG000|Overall Study|Lost to Follow-up|1
7852530|NCT01505634|12335292|FG001|Overall Study|Lost to Follow-up|4
7852531|NCT01505634|12335293|FG002|Overall Study|Lost to Follow-up|4
7852532|NCT01505634|12335291|FG000|Overall Study|Death|1
7852533|NCT01505634|12335292|FG001|Overall Study|Death|0
7852534|NCT01505634|12335293|FG002|Overall Study|Death|0
7852535|NCT01505634|12335291|FG000|Overall Study|In a conflict zone|0
7852536|NCT01505634|12335292|FG001|Overall Study|In a conflict zone|0
7852537|NCT01505634|12335293|FG002|Overall Study|In a conflict zone|1
7852538|NCT01505647|12335303|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
7852539|NCT01505647|12335304|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
7852540|NCT01505647|12335303|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1
7852541|NCT01505647|12335304|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0
7852542|NCT01505647|12335303|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
7852543|NCT01505647|12335304|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
7852544|NCT01505647|12335303|FG000|Day 43 Through Day 182 Follow-up|Death|0
7852545|NCT01505647|12335304|FG001|Day 43 Through Day 182 Follow-up|Death|1
7852546|NCT01505647|12335303|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
7852547|NCT01505647|12335304|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
7852548|NCT01505868|12335334|FG000|Overall Study|Withdrawal by Subject|1
7852549|NCT01505868|12335335|FG001|Overall Study|Withdrawal by Subject|0
7852550|NCT01505868|12335336|FG002|Overall Study|Withdrawal by Subject|0
7852551|NCT01505868|12335337|FG003|Overall Study|Withdrawal by Subject|0
7852552|NCT01505868|12335338|FG004|Overall Study|Withdrawal by Subject|0
7852553|NCT01505881|12335352|FG000|Overall Study|Adverse Event|0
7852554|NCT01505881|12335353|FG001|Overall Study|Adverse Event|1
7852555|NCT01505881|12335352|FG000|Overall Study|Lost to Follow-up|2
7852556|NCT01505881|12335353|FG001|Overall Study|Lost to Follow-up|0
7852557|NCT01505881|12335352|FG000|Overall Study|Withdrawal by Subject|2
7852558|NCT01505881|12335353|FG001|Overall Study|Withdrawal by Subject|0
7852559|NCT01506193|12335372|FG000|Overall Study|Protocol Violation|1
7852560|NCT01506193|12335373|FG001|Overall Study|Protocol Violation|0
7852561|NCT01506193|12335374|FG002|Overall Study|Protocol Violation|1
7852562|NCT01506193|12335372|FG000|Overall Study|Migrated/moved from study area|0
7852563|NCT01506193|12335373|FG001|Overall Study|Migrated/moved from study area|0
7852564|NCT01506193|12335374|FG002|Overall Study|Migrated/moved from study area|1
7852565|NCT01506193|12335372|FG000|Overall Study|Adverse event, non-fatal|0
7852566|NCT01506193|12335373|FG001|Overall Study|Adverse event, non-fatal|0
7852567|NCT01506193|12335374|FG002|Overall Study|Adverse event, non-fatal|1
7852568|NCT01506193|12335372|FG000|Overall Study|Withdrawal by Subject|5
7852569|NCT01506193|12335373|FG001|Overall Study|Withdrawal by Subject|1
7852570|NCT01506193|12335374|FG002|Overall Study|Withdrawal by Subject|8
7852571|NCT01506193|12335372|FG000|Overall Study|Lost to Follow-up|8
7852572|NCT01506193|12335373|FG001|Overall Study|Lost to Follow-up|3
7852573|NCT01506193|12335374|FG002|Overall Study|Lost to Follow-up|3
7852574|NCT01506271|12335386|FG000|Overall Study|Progressive disease|0
7852575|NCT01506271|12335387|FG001|Overall Study|Progressive disease|1
7852576|NCT01506271|12335388|FG002|Overall Study|Progressive disease|0
7852577|NCT01506271|12335386|FG000|Overall Study|Protocol Violation|3
7852578|NCT01506271|12335387|FG001|Overall Study|Protocol Violation|1
7852579|NCT01506271|12335388|FG002|Overall Study|Protocol Violation|0
7852580|NCT01506271|12335386|FG000|Overall Study|Death|0
7852581|NCT01506271|12335387|FG001|Overall Study|Death|1
7852582|NCT01506271|12335388|FG002|Overall Study|Death|0
7852583|NCT01506271|12335386|FG000|Overall Study|Adverse Event|0
7852584|NCT01506271|12335387|FG001|Overall Study|Adverse Event|2
7852585|NCT01506271|12335388|FG002|Overall Study|Adverse Event|0
7852586|NCT01506271|12335386|FG000|Overall Study|Insufficient supply of study drug|1
7852587|NCT01506271|12335387|FG001|Overall Study|Insufficient supply of study drug|0
7852588|NCT01506271|12335388|FG002|Overall Study|Insufficient supply of study drug|0
7852589|NCT01506271|12335386|FG000|Overall Study|Withdrawal by Subject|0
7852590|NCT01506271|12335387|FG001|Overall Study|Withdrawal by Subject|1
7852591|NCT01506271|12335388|FG002|Overall Study|Withdrawal by Subject|1
7852592|NCT01506271|12335386|FG000|Overall Study|Lost to Follow-up|0
7852593|NCT01506271|12335387|FG001|Overall Study|Lost to Follow-up|1
7852594|NCT01506271|12335388|FG002|Overall Study|Lost to Follow-up|2
7852595|NCT01506323|12335398|FG000|Overall Study|Lost to Follow-up|5
7852596|NCT01506323|12335399|FG001|Overall Study|Lost to Follow-up|4
7852597|NCT01506323|12335398|FG000|Overall Study|Withdrawal by Subject|4
7852598|NCT01506323|12335399|FG001|Overall Study|Withdrawal by Subject|4
7852599|NCT01506323|12335398|FG000|Overall Study|Lack of Efficacy|1
7852600|NCT01506323|12335399|FG001|Overall Study|Lack of Efficacy|3
7852601|NCT01506323|12335398|FG000|Overall Study|Moved out of area|5
7852602|NCT01506323|12335399|FG001|Overall Study|Moved out of area|2
7852603|NCT01506323|12335398|FG000|Overall Study|Schedule or Transportation conflict|8
7852604|NCT01506323|12335399|FG001|Overall Study|Schedule or Transportation conflict|0
7852605|NCT01506323|12335398|FG000|Overall Study|Started another treatment|1
7852606|NCT01506323|12335399|FG001|Overall Study|Started another treatment|0
7852607|NCT01506453|12335416|FG000|Overall Study|Withdrawal prior to treatment|0
7852608|NCT01506453|12335417|FG001|Overall Study|Withdrawal prior to treatment|2
7852609|NCT01506479|12335426|FG000|Overall Study|Lost to Follow-up|1
7852610|NCT01506479|12335427|FG001|Overall Study|Lost to Follow-up|2
7852611|NCT01506479|12335428|FG002|Overall Study|Lost to Follow-up|2
7852612|NCT01506479|12335426|FG000|Overall Study|Withdrawal by Subject|1
7852613|NCT01506479|12335427|FG001|Overall Study|Withdrawal by Subject|2
7852614|NCT01506479|12335428|FG002|Overall Study|Withdrawal by Subject|1
7852615|NCT01506479|12335426|FG000|Overall Study|Missing assessment|1
7852616|NCT01506479|12335427|FG001|Overall Study|Missing assessment|0
7852617|NCT01506479|12335428|FG002|Overall Study|Missing assessment|0
7852618|NCT01506479|12335426|FG000|Overall Study|Adverse Event|0
7852619|NCT01506479|12335427|FG001|Overall Study|Adverse Event|1
7852620|NCT01506479|12335428|FG002|Overall Study|Adverse Event|0
7852621|NCT01506596|12335438|FG000|Overall Study|ineligible pathology|1
7852622|NCT01506609|12335448|FG000|Overall Study|Adverse Event Related to Progression|0
7852623|NCT01506609|12335449|FG001|Overall Study|Adverse Event Related to Progression|0
7852624|NCT01506609|12335450|FG002|Overall Study|Adverse Event Related to Progression|0
7852625|NCT01506609|12335451|FG003|Overall Study|Adverse Event Related to Progression|3
7852626|NCT01506609|12335452|FG004|Overall Study|Adverse Event Related to Progression|7
7852627|NCT01506609|12335453|FG005|Overall Study|Adverse Event Related to Progression|3
7852628|NCT01506609|12335448|FG000|Overall Study|Adverse Event Not Related to Progression|0
7852629|NCT01506609|12335449|FG001|Overall Study|Adverse Event Not Related to Progression|1
7852630|NCT01506609|12335450|FG002|Overall Study|Adverse Event Not Related to Progression|0
7852631|NCT01506609|12335451|FG003|Overall Study|Adverse Event Not Related to Progression|6
7852632|NCT01506609|12335452|FG004|Overall Study|Adverse Event Not Related to Progression|10
7852633|NCT01506609|12335453|FG005|Overall Study|Adverse Event Not Related to Progression|5
7852634|NCT01506609|12335448|FG000|Overall Study|Withdrawal by Subject|0
7852635|NCT01506609|12335449|FG001|Overall Study|Withdrawal by Subject|0
7852636|NCT01506609|12335450|FG002|Overall Study|Withdrawal by Subject|0
7852637|NCT01506609|12335451|FG003|Overall Study|Withdrawal by Subject|9
7852638|NCT01506609|12335452|FG004|Overall Study|Withdrawal by Subject|7
7852639|NCT01506609|12335453|FG005|Overall Study|Withdrawal by Subject|7
7852640|NCT01506609|12335448|FG000|Overall Study|Lost to Follow-up|0
7852641|NCT01506609|12335449|FG001|Overall Study|Lost to Follow-up|0
7852642|NCT01506609|12335450|FG002|Overall Study|Lost to Follow-up|0
7852643|NCT01506609|12335451|FG003|Overall Study|Lost to Follow-up|1
7852644|NCT01506609|12335452|FG004|Overall Study|Lost to Follow-up|2
7852645|NCT01506609|12335453|FG005|Overall Study|Lost to Follow-up|0
7852646|NCT01506609|12335448|FG000|Overall Study|Sponsor Discontinued Study|0
7852647|NCT01506609|12335449|FG001|Overall Study|Sponsor Discontinued Study|0
7852648|NCT01506609|12335450|FG002|Overall Study|Sponsor Discontinued Study|0
7852649|NCT01506609|12335451|FG003|Overall Study|Sponsor Discontinued Study|2
7852650|NCT01506609|12335452|FG004|Overall Study|Sponsor Discontinued Study|2
7852651|NCT01506609|12335453|FG005|Overall Study|Sponsor Discontinued Study|0
7852652|NCT01506609|12335448|FG000|Overall Study|Progressive Disease per Protocol|1
7852653|NCT01506609|12335449|FG001|Overall Study|Progressive Disease per Protocol|0
7852654|NCT01506609|12335450|FG002|Overall Study|Progressive Disease per Protocol|0
7852655|NCT01506609|12335451|FG003|Overall Study|Progressive Disease per Protocol|64
7852656|NCT01506609|12335452|FG004|Overall Study|Progressive Disease per Protocol|57
7852657|NCT01506609|12335453|FG005|Overall Study|Progressive Disease per Protocol|74
7852658|NCT01506609|12335448|FG000|Overall Study|Other, Not Specified|0
7852659|NCT01506609|12335449|FG001|Overall Study|Other, Not Specified|0
7852660|NCT01506609|12335450|FG002|Overall Study|Other, Not Specified|0
7852661|NCT01506609|12335451|FG003|Overall Study|Other, Not Specified|10
7852662|NCT01506609|12335452|FG004|Overall Study|Other, Not Specified|7
7852663|NCT01506609|12335453|FG005|Overall Study|Other, Not Specified|3
7852664|NCT01506609|12335448|FG000|Overall Study|Missing / Unknown Reason|1
7852665|NCT01506609|12335449|FG001|Overall Study|Missing / Unknown Reason|0
7852666|NCT01506609|12335450|FG002|Overall Study|Missing / Unknown Reason|1
7852667|NCT01506609|12335451|FG003|Overall Study|Missing / Unknown Reason|4
7852668|NCT01506609|12335452|FG004|Overall Study|Missing / Unknown Reason|4
7852669|NCT01506609|12335453|FG005|Overall Study|Missing / Unknown Reason|2
7852670|NCT01506726|12335466|FG000|Overall Study|Adverse Event|1
7852671|NCT01506726|12335467|FG001|Overall Study|Adverse Event|2
7852672|NCT01506882|12335475|FG000|Overall Study|Lack of Efficacy|4
7852673|NCT01506882|12335476|FG001|Overall Study|Lack of Efficacy|3
7852674|NCT01506882|12335475|FG000|Overall Study|Lost to Follow-up|1
7852675|NCT01506882|12335476|FG001|Overall Study|Lost to Follow-up|0
7852676|NCT01506882|12335475|FG000|Overall Study|Withdrawal by Subject|9
7852677|NCT01506882|12335476|FG001|Overall Study|Withdrawal by Subject|3
7852678|NCT01506882|12335475|FG000|Overall Study|SAE, non-fatal|2
7852679|NCT01506882|12335476|FG001|Overall Study|SAE, non-fatal|0
7852680|NCT01506882|12335475|FG000|Overall Study|AE, non-serious non-fatal|3
7852681|NCT01506882|12335476|FG001|Overall Study|AE, non-serious non-fatal|1
7852682|NCT01506882|12335475|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
7852683|NCT01506882|12335476|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7852684|NCT01506882|12335475|FG000|Overall Study|Other Reason|2
7852685|NCT01506882|12335476|FG001|Overall Study|Other Reason|0
7852686|NCT01506908|12335486|FG000|Overall Study|Adverse Event|1
7852687|NCT01506908|12335487|FG001|Overall Study|Adverse Event|0
7852688|NCT01506947|12335495|FG000|Overall Study|Lost to Follow-up|7
7852689|NCT01506947|12335495|FG000|Overall Study|Adverse Event|5
7852690|NCT01506947|12335495|FG000|Overall Study|Death|1
7852691|NCT01506947|12335495|FG000|Overall Study|Did Not Meet Eligibility Criteria|3
7852692|NCT01506960|12335501|FG000|Overall Study|Did not meet angiographic criteria|47
7852693|NCT01507051|12335511|FG000|Overall Study|Withdrawal by Subject|1
7852694|NCT01507051|12335512|FG001|Overall Study|Withdrawal by Subject|3
7852695|NCT01507051|12335513|FG002|Overall Study|Withdrawal by Subject|1
7852696|NCT01507051|12335514|FG003|Overall Study|Withdrawal by Subject|6
7852697|NCT01507051|12335511|FG000|Overall Study|Physician Decision|0
7852698|NCT01507051|12335512|FG001|Overall Study|Physician Decision|0
7852699|NCT01507051|12335513|FG002|Overall Study|Physician Decision|0
7852700|NCT01507051|12335514|FG003|Overall Study|Physician Decision|1
7852701|NCT01507051|12335511|FG000|Overall Study|Adverse Event|1
7852702|NCT01507051|12335512|FG001|Overall Study|Adverse Event|0
7852703|NCT01507051|12335513|FG002|Overall Study|Adverse Event|0
7852704|NCT01507051|12335514|FG003|Overall Study|Adverse Event|0
7863462|NCT01606176|12352793|FG000|Overall Study|Adverse Event|2
7863463|NCT01606176|12352794|FG001|Overall Study|Adverse Event|3
7863464|NCT01606176|12352793|FG000|Overall Study|Disease progression|1
7863465|NCT01606176|12352794|FG001|Overall Study|Disease progression|0
7863466|NCT01606176|12352793|FG000|Overall Study|Withdrawal by Subject|1
7863467|NCT01606176|12352794|FG001|Overall Study|Withdrawal by Subject|0
7863468|NCT01606189|12352800|FG000|Second Intenvention (14-20 Days)|Adverse Event|0
7863469|NCT01606189|12352801|FG001|Second Intenvention (14-20 Days)|Adverse Event|0
7863470|NCT01606189|12352802|FG002|Second Intenvention (14-20 Days)|Adverse Event|0
7852705|NCT01507090|12335524|FG000|Overall Study|incomplete dataset|18
7852706|NCT01507246|12335572|FG000|Overall Study|Required different surgical procedures|2
7852707|NCT01507246|12335573|FG001|Overall Study|Required different surgical procedures|1
7852708|NCT01507298|12335584|FG000|Overall Study|Protocol Violation|0
7852709|NCT01507298|12335585|FG001|Overall Study|Protocol Violation|6
7852710|NCT01507662|12335607|FG000|Overall Study|Death|26
7852711|NCT01507662|12335608|FG001|Overall Study|Death|18
7852712|NCT01507662|12335607|FG000|Overall Study|Withdrawal by Subject|290
7852713|NCT01507662|12335608|FG001|Overall Study|Withdrawal by Subject|287
7852714|NCT01507662|12335607|FG000|Overall Study|Lost to Follow-up|498
7852715|NCT01507662|12335608|FG001|Overall Study|Lost to Follow-up|523
7852716|NCT01507662|12335607|FG000|Overall Study|Proxy interview done|2
7852717|NCT01507662|12335608|FG001|Overall Study|Proxy interview done|3
7852718|NCT01507831|12335636|FG000|Overall Study|Randomized but not treated|0
7852719|NCT01507831|12335637|FG001|Overall Study|Randomized but not treated|3
7852720|NCT01507831|12335636|FG000|Overall Study|Adverse Event|48
7852721|NCT01507831|12335637|FG001|Overall Study|Adverse Event|113
7852722|NCT01507831|12335636|FG000|Overall Study|Death|6
7852723|NCT01507831|12335637|FG001|Overall Study|Death|2
7852724|NCT01507831|12335636|FG000|Overall Study|Poor compliance to protocol|38
7852725|NCT01507831|12335637|FG001|Overall Study|Poor compliance to protocol|60
7852726|NCT01507831|12335636|FG000|Overall Study|Physician Decision|0
7852727|NCT01507831|12335637|FG001|Overall Study|Physician Decision|4
7852728|NCT01507831|12335636|FG000|Overall Study|Participant moved|5
7852729|NCT01507831|12335637|FG001|Overall Study|Participant moved|19
7852730|NCT01507831|12335636|FG000|Overall Study|Consent withdrawn by participant|34
7852731|NCT01507831|12335637|FG001|Overall Study|Consent withdrawn by participant|72
7852732|NCT01507831|12335636|FG000|Overall Study|Related to study drug administration|5
7852733|NCT01507831|12335637|FG001|Overall Study|Related to study drug administration|14
7852734|NCT01507831|12335636|FG000|Overall Study|Last visit outside protocol visit window|51
7852735|NCT01507831|12335637|FG001|Overall Study|Last visit outside protocol visit window|143
7852736|NCT01507831|12335636|FG000|Overall Study|Selection criteria finally not met|0
7852737|NCT01507831|12335637|FG001|Overall Study|Selection criteria finally not met|1
7852738|NCT01507831|12335636|FG000|Overall Study|Site closure|0
7852739|NCT01507831|12335637|FG001|Overall Study|Site closure|3
7852740|NCT01507831|12335636|FG000|Overall Study|Potential lost to follow-up|3
7852741|NCT01507831|12335637|FG001|Overall Study|Potential lost to follow-up|0
7852742|NCT01507831|12335636|FG000|Overall Study|Other|3
7852743|NCT01507831|12335637|FG001|Overall Study|Other|6
7852744|NCT01507896|12335643|FG000|Overall Study|Withdrawal by Subject|1
7852745|NCT01507896|12335643|FG000|Overall Study|The surgery was denied by the sponsor.|1
7852746|NCT01508130|12335710|FG000|Overall Study|Adverse Event|81
7852747|NCT01508130|12335711|FG001|Overall Study|Adverse Event|28
7852748|NCT01508130|12335710|FG000|Overall Study|Death|3
7852749|NCT01508130|12335711|FG001|Overall Study|Death|1
7852750|NCT01508130|12335710|FG000|Overall Study|Protocol Violation|2
7852751|NCT01508130|12335711|FG001|Overall Study|Protocol Violation|0
7852752|NCT01508130|12335710|FG000|Overall Study|Lost to Follow-up|25
7852753|NCT01508130|12335711|FG001|Overall Study|Lost to Follow-up|2
7852754|NCT01508130|12335710|FG000|Overall Study|Withdrawal by Subject|3
7852755|NCT01508130|12335711|FG001|Overall Study|Withdrawal by Subject|3
7852756|NCT01508130|12335710|FG000|Overall Study|Subject's substantial non-compliance|25
7852757|NCT01508130|12335711|FG001|Overall Study|Subject's substantial non-compliance|9
7852758|NCT01508130|12335710|FG000|Overall Study|Insufficient therapeutic response|74
7852759|NCT01508130|12335711|FG001|Overall Study|Insufficient therapeutic response|23
7852760|NCT01508130|12335710|FG000|Overall Study|Administrative|14
7852761|NCT01508130|12335711|FG001|Overall Study|Administrative|3
7852762|NCT01508169|12335721|FG000|Overall Study|Adverse Event|1
7852763|NCT01508169|12335722|FG001|Overall Study|Adverse Event|0
7852764|NCT01508169|12335721|FG000|Overall Study|Withdrawal by Subject|1
7852765|NCT01508169|12335722|FG001|Overall Study|Withdrawal by Subject|0
7852766|NCT01508169|12335721|FG000|Overall Study|Lost to Follow-up|1
7852767|NCT01508169|12335722|FG001|Overall Study|Lost to Follow-up|2
7852768|NCT01508325|12335736|FG000|Overall Study|Withdrawal by Subject|8
7852769|NCT01508325|12335737|FG001|Overall Study|Withdrawal by Subject|9
7852770|NCT01508325|12335736|FG000|Overall Study|Protocol Violation|0
7852771|NCT01508325|12335737|FG001|Overall Study|Protocol Violation|3
7852772|NCT01508325|12335736|FG000|Overall Study|Physician Decision|2
7852773|NCT01508325|12335737|FG001|Overall Study|Physician Decision|1
7852774|NCT01508325|12335736|FG000|Overall Study|Adverse Event|1
7852775|NCT01508325|12335737|FG001|Overall Study|Adverse Event|0
7852776|NCT01508325|12335736|FG000|Overall Study|Lost to Follow-up|5
7852777|NCT01508325|12335737|FG001|Overall Study|Lost to Follow-up|6
7852778|NCT01508325|12335736|FG000|Overall Study|Other|2
7852779|NCT01508325|12335737|FG001|Overall Study|Other|2
7852780|NCT01508650|12335749|FG000|Overall Study|Lost to Follow-up|0
7852781|NCT01508650|12335750|FG001|Overall Study|Lost to Follow-up|3
7852782|NCT01508676|12335758|FG000|Phase I (2 Weeks)|Medication Exclusion|1
7852783|NCT01508676|12335759|FG001|Phase I (2 Weeks)|Medication Exclusion|1
7852784|NCT01508676|12335758|FG000|Phase I (2 Weeks)|Wrong Pain Type|1
7852785|NCT01508676|12335759|FG001|Phase I (2 Weeks)|Wrong Pain Type|0
7852786|NCT01508676|12335758|FG000|Phase I (2 Weeks)|Positive Drug Screen|0
7852787|NCT01508676|12335759|FG001|Phase I (2 Weeks)|Positive Drug Screen|2
7852788|NCT01508676|12335758|FG000|Phase II (2 Weeks)|Skin Sensitivity|0
7852789|NCT01508676|12335759|FG001|Phase II (2 Weeks)|Skin Sensitivity|1
7852790|NCT01508676|12335758|FG000|Phase II (2 Weeks)|Medication Exclusion|1
7852791|NCT01508676|12335759|FG001|Phase II (2 Weeks)|Medication Exclusion|0
7852792|NCT01508702|12335768|FG000|Overall Study|Adverse Event|7
7852793|NCT01508702|12335769|FG001|Overall Study|Adverse Event|3
7852794|NCT01508702|12335768|FG000|Overall Study|Gout flare|2
7852795|NCT01508702|12335769|FG001|Overall Study|Gout flare|0
7852796|NCT01508702|12335768|FG000|Overall Study|Protocol Violation|2
7852797|NCT01508702|12335769|FG001|Overall Study|Protocol Violation|1
7852798|NCT01508702|12335768|FG000|Overall Study|Lost to Follow-up|1
7852799|NCT01508702|12335769|FG001|Overall Study|Lost to Follow-up|2
7852800|NCT01508702|12335768|FG000|Overall Study|Withdrawal by Subject|11
7852801|NCT01508702|12335769|FG001|Overall Study|Withdrawal by Subject|7
7852802|NCT01508910|12335787|FG000|Treatment|Death|2
7852803|NCT01508910|12335788|FG001|Treatment|Death|3
7852804|NCT01508910|12335789|FG002|Treatment|Death|2
7852805|NCT01508910|12335790|FG003|Treatment|Death|0
7852806|NCT01508910|12335787|FG000|Treatment|Lost to Follow-up|0
7852807|NCT01508910|12335788|FG001|Treatment|Lost to Follow-up|0
7852808|NCT01508910|12335789|FG002|Treatment|Lost to Follow-up|2
7852809|NCT01508910|12335790|FG003|Treatment|Lost to Follow-up|1
7852810|NCT01508910|12335787|FG000|Treatment|Withdrawal by Subject|0
7852811|NCT01508910|12335788|FG001|Treatment|Withdrawal by Subject|1
7852812|NCT01508910|12335789|FG002|Treatment|Withdrawal by Subject|6
7852813|NCT01508910|12335790|FG003|Treatment|Withdrawal by Subject|1
7852814|NCT01508910|12335787|FG000|Treatment|Sponsor Decision|0
7852815|NCT01508910|12335788|FG001|Treatment|Sponsor Decision|0
7852816|NCT01508910|12335789|FG002|Treatment|Sponsor Decision|0
7852817|NCT01508910|12335790|FG003|Treatment|Sponsor Decision|1
7852818|NCT01508936|12335804|FG000|Overall Study|Adverse Event|11
7852819|NCT01508936|12335805|FG001|Overall Study|Adverse Event|32
7852820|NCT01508936|12335804|FG000|Overall Study|Lack of Efficacy|0
7852821|NCT01508936|12335805|FG001|Overall Study|Lack of Efficacy|1
7852822|NCT01508936|12335804|FG000|Overall Study|Withdrawal by Subject|4
7852823|NCT01508936|12335805|FG001|Overall Study|Withdrawal by Subject|18
7852824|NCT01508936|12335804|FG000|Overall Study|Protocol Violation|2
7852825|NCT01508936|12335805|FG001|Overall Study|Protocol Violation|3
7852826|NCT01508936|12335804|FG000|Overall Study|Lost to Follow-up|2
7852827|NCT01508936|12335805|FG001|Overall Study|Lost to Follow-up|9
7852828|NCT01508936|12335804|FG000|Overall Study|Other|0
7852829|NCT01508936|12335805|FG001|Overall Study|Other|5
7852830|NCT01508936|12335804|FG000|Overall Study|Data from 2 sites deemed invalid|4
7852831|NCT01508936|12335805|FG001|Overall Study|Data from 2 sites deemed invalid|11
7852832|NCT01509079|12335833|FG000|Overall Study|Lack of Efficacy|0
7852833|NCT01509079|12335834|FG001|Overall Study|Lack of Efficacy|2
7852834|NCT01509079|12335833|FG000|Overall Study|started an excluded medication|0
7852835|NCT01509079|12335834|FG001|Overall Study|started an excluded medication|1
7852836|NCT01509547|12335866|FG000|Overall Study|Lost to Follow-up|24
7852837|NCT01509547|12335867|FG001|Overall Study|Lost to Follow-up|14
7852838|NCT01509547|12335866|FG000|Overall Study|Withdrawal by Subject|11
7852839|NCT01509547|12335867|FG001|Overall Study|Withdrawal by Subject|24
7852840|NCT01509547|12335866|FG000|Overall Study|Physician Decision|0
7852841|NCT01509547|12335867|FG001|Overall Study|Physician Decision|1
7852842|NCT01509664|12335922|FG000|Overall Study|Lost to Follow-up|15
7852843|NCT01509664|12335923|FG001|Overall Study|Lost to Follow-up|21
7852844|NCT01509846|12335952|FG000|Received Vaccination 2|Withdrawal by Subject|0
7852845|NCT01509846|12335953|FG001|Received Vaccination 2|Withdrawal by Subject|0
7852846|NCT01509846|12335954|FG002|Received Vaccination 2|Withdrawal by Subject|1
7852847|NCT01509846|12335955|FG003|Received Vaccination 2|Withdrawal by Subject|0
7852848|NCT01509846|12335956|FG004|Received Vaccination 2|Withdrawal by Subject|0
7852849|NCT01509846|12335952|FG000|Received Vaccination 2|Illness|0
7852850|NCT01509846|12335953|FG001|Received Vaccination 2|Illness|0
7852851|NCT01509846|12335954|FG002|Received Vaccination 2|Illness|0
7852852|NCT01509846|12335955|FG003|Received Vaccination 2|Illness|0
7852853|NCT01509846|12335956|FG004|Received Vaccination 2|Illness|1
7852854|NCT01509846|12335952|FG000|Received Vaccination 2|Not vaccinated per protocol|5
7852855|NCT01509846|12335953|FG001|Received Vaccination 2|Not vaccinated per protocol|0
7852856|NCT01509846|12335954|FG002|Received Vaccination 2|Not vaccinated per protocol|0
7852857|NCT01509846|12335955|FG003|Received Vaccination 2|Not vaccinated per protocol|0
7852858|NCT01509846|12335956|FG004|Received Vaccination 2|Not vaccinated per protocol|2
7852859|NCT01509846|12335952|FG000|Received Vaccination 3|Withdrawal by Subject|0
7852860|NCT01509846|12335953|FG001|Received Vaccination 3|Withdrawal by Subject|1
7852861|NCT01509846|12335954|FG002|Received Vaccination 3|Withdrawal by Subject|0
7852862|NCT01509846|12335955|FG003|Received Vaccination 3|Withdrawal by Subject|0
7852863|NCT01509846|12335956|FG004|Received Vaccination 3|Withdrawal by Subject|0
7852864|NCT01509846|12335952|FG000|Received Vaccination 3|Pregnancy|0
7852865|NCT01509846|12335953|FG001|Received Vaccination 3|Pregnancy|0
7852866|NCT01509846|12335954|FG002|Received Vaccination 3|Pregnancy|0
7852867|NCT01509846|12335955|FG003|Received Vaccination 3|Pregnancy|1
7852868|NCT01509846|12335956|FG004|Received Vaccination 3|Pregnancy|0
7852869|NCT01509846|12335952|FG000|Received Vaccination 3|Lost to Follow-up|0
7852870|NCT01509846|12335953|FG001|Received Vaccination 3|Lost to Follow-up|0
7852871|NCT01509846|12335954|FG002|Received Vaccination 3|Lost to Follow-up|1
7852872|NCT01509846|12335955|FG003|Received Vaccination 3|Lost to Follow-up|0
7852873|NCT01509846|12335956|FG004|Received Vaccination 3|Lost to Follow-up|0
7852874|NCT01510028|12336000|FG000|Overall Study|Lack of Efficacy|1
7852875|NCT01510028|12336001|FG001|Overall Study|Lack of Efficacy|0
7852876|NCT01510028|12336002|FG002|Overall Study|Lack of Efficacy|0
7852877|NCT01510028|12336003|FG003|Overall Study|Lack of Efficacy|0
7852878|NCT01510145|12336015|FG000|Overall Study|Adverse Event|6
7852879|NCT01510145|12336015|FG000|Overall Study|Lost to Follow-up|5
7852880|NCT01510145|12336015|FG000|Overall Study|Withdrawal by Subject|6
7852881|NCT01510145|12336015|FG000|Overall Study|Relative reported subject withdrew|1
7852882|NCT01510158|12336022|FG000|Overall Study|Adverse Event|7
7852883|NCT01510158|12336023|FG001|Overall Study|Adverse Event|8
7852884|NCT01510158|12336024|FG002|Overall Study|Adverse Event|5
7852885|NCT01510158|12336022|FG000|Overall Study|Gout flare|1
7852886|NCT01510158|12336023|FG001|Overall Study|Gout flare|0
7852887|NCT01510158|12336024|FG002|Overall Study|Gout flare|0
7852888|NCT01510158|12336022|FG000|Overall Study|Protocol Violation|17
7852889|NCT01510158|12336023|FG001|Overall Study|Protocol Violation|16
7852890|NCT01510158|12336024|FG002|Overall Study|Protocol Violation|24
7852891|NCT01510158|12336022|FG000|Overall Study|Sponsor terminated study.|2
7852892|NCT01510158|12336023|FG001|Overall Study|Sponsor terminated study.|0
7852893|NCT01510158|12336024|FG002|Overall Study|Sponsor terminated study.|2
7852894|NCT01510158|12336022|FG000|Overall Study|Lost to Follow-up|13
7852895|NCT01510158|12336023|FG001|Overall Study|Lost to Follow-up|16
7852896|NCT01510158|12336024|FG002|Overall Study|Lost to Follow-up|9
7852897|NCT01510158|12336022|FG000|Overall Study|Withdrawal by Subject|10
7852898|NCT01510158|12336023|FG001|Overall Study|Withdrawal by Subject|13
7852899|NCT01510158|12336024|FG002|Overall Study|Withdrawal by Subject|10
7852900|NCT01510158|12336022|FG000|Overall Study|Death|1
7852901|NCT01510158|12336023|FG001|Overall Study|Death|0
7852902|NCT01510158|12336024|FG002|Overall Study|Death|0
7852903|NCT01510717|12336090|FG000|Overall Study|Adverse Event|1
7852904|NCT01510717|12336091|FG001|Overall Study|Adverse Event|2
7852905|NCT01510717|12336090|FG000|Overall Study|Death|1
7852906|NCT01510717|12336091|FG001|Overall Study|Death|0
7852907|NCT01510717|12336090|FG000|Overall Study|Lost to Follow-up|0
7852908|NCT01510717|12336091|FG001|Overall Study|Lost to Follow-up|1
7852909|NCT01510717|12336090|FG000|Overall Study|Withdrawal by Subject|0
7852910|NCT01510717|12336091|FG001|Overall Study|Withdrawal by Subject|2
7852911|NCT01510769|12336101|FG000|Overall Study|Adverse Event|7
7852912|NCT01510769|12336102|FG001|Overall Study|Adverse Event|6
7852913|NCT01510769|12336103|FG002|Overall Study|Adverse Event|4
7852914|NCT01510769|12336101|FG000|Overall Study|Gout Flare|0
7852915|NCT01510769|12336102|FG001|Overall Study|Gout Flare|3
7852916|NCT01510769|12336103|FG002|Overall Study|Gout Flare|1
7852917|NCT01510769|12336101|FG000|Overall Study|Protocol Violation|11
7852918|NCT01510769|12336102|FG001|Overall Study|Protocol Violation|10
7852919|NCT01510769|12336103|FG002|Overall Study|Protocol Violation|9
7852920|NCT01510769|12336101|FG000|Overall Study|Lost to Follow-up|5
7852921|NCT01510769|12336102|FG001|Overall Study|Lost to Follow-up|1
7852922|NCT01510769|12336103|FG002|Overall Study|Lost to Follow-up|5
7852923|NCT01510769|12336101|FG000|Overall Study|Withdrawal by Subject|3
7852924|NCT01510769|12336102|FG001|Overall Study|Withdrawal by Subject|4
7852925|NCT01510769|12336103|FG002|Overall Study|Withdrawal by Subject|3
7852926|NCT01510769|12336101|FG000|Overall Study|Death|1
7852927|NCT01510769|12336102|FG001|Overall Study|Death|1
7852928|NCT01510769|12336103|FG002|Overall Study|Death|0
7852929|NCT01510912|12336118|FG000|Overall Study|Adverse Event|99
7852930|NCT01510912|12336118|FG000|Overall Study|Lack of Efficacy|12
7852931|NCT01510912|12336118|FG000|Overall Study|Non-compliance with trial drug|23
7852932|NCT01510912|12336118|FG000|Overall Study|Withdrawal by Subject|49
7852933|NCT01510912|12336118|FG000|Overall Study|Physician Decision|1
7852934|NCT01510912|12336118|FG000|Overall Study|Protocol Violation|27
7852935|NCT01510912|12336118|FG000|Overall Study|Lost to Follow-up|26
7852936|NCT01510912|12336118|FG000|Overall Study|Other, including joint replacement|5
7852937|NCT01511055|12336132|FG000|Overall Study|Withdrawal by Subject|6
7852938|NCT01511107|12336142|FG000|Overall Study|Ineligible|3
7852939|NCT01511107|12336143|FG001|Overall Study|Ineligible|2
7852940|NCT01511107|12336142|FG000|Overall Study|Lost to Follow-up|10
7852941|NCT01511107|12336143|FG001|Overall Study|Lost to Follow-up|19
7852942|NCT01511107|12336142|FG000|Overall Study|Withdrawal by Subject|9
7852943|NCT01511107|12336143|FG001|Overall Study|Withdrawal by Subject|20
7852944|NCT01511250|12336159|FG000|Overall Study|Withdrawal of Consent|1
7852945|NCT01511250|12336160|FG001|Overall Study|Withdrawal of Consent|0
7852946|NCT01511250|12336161|FG002|Overall Study|Withdrawal of Consent|0
7852947|NCT01511250|12336162|FG003|Overall Study|Withdrawal of Consent|0
7852948|NCT01511250|12336163|FG004|Overall Study|Withdrawal of Consent|0
7852949|NCT01511250|12336164|FG005|Overall Study|Withdrawal of Consent|0
7852950|NCT01511250|12336165|FG006|Overall Study|Withdrawal of Consent|0
7852951|NCT01511250|12336166|FG007|Overall Study|Withdrawal of Consent|1
7852952|NCT01511250|12336167|FG008|Overall Study|Withdrawal of Consent|1
7852953|NCT01511250|12336168|FG009|Overall Study|Withdrawal of Consent|0
7852954|NCT01511250|12336159|FG000|Overall Study|Sponsor/Investigator Decision|1
7852955|NCT01511250|12336160|FG001|Overall Study|Sponsor/Investigator Decision|0
7852956|NCT01511250|12336161|FG002|Overall Study|Sponsor/Investigator Decision|0
7852957|NCT01511250|12336162|FG003|Overall Study|Sponsor/Investigator Decision|0
7852958|NCT01511250|12336163|FG004|Overall Study|Sponsor/Investigator Decision|0
7852959|NCT01511250|12336164|FG005|Overall Study|Sponsor/Investigator Decision|0
7852960|NCT01511250|12336165|FG006|Overall Study|Sponsor/Investigator Decision|0
7852961|NCT01511250|12336166|FG007|Overall Study|Sponsor/Investigator Decision|0
7852962|NCT01511250|12336167|FG008|Overall Study|Sponsor/Investigator Decision|0
7852963|NCT01511250|12336168|FG009|Overall Study|Sponsor/Investigator Decision|0
7852964|NCT01511250|12336159|FG000|Overall Study|Lost to Follow-up|7
7852965|NCT01511250|12336160|FG001|Overall Study|Lost to Follow-up|3
7852966|NCT01511250|12336161|FG002|Overall Study|Lost to Follow-up|3
7852967|NCT01511250|12336162|FG003|Overall Study|Lost to Follow-up|3
7852968|NCT01511250|12336163|FG004|Overall Study|Lost to Follow-up|0
7852969|NCT01511250|12336164|FG005|Overall Study|Lost to Follow-up|0
7852970|NCT01511250|12336165|FG006|Overall Study|Lost to Follow-up|2
7852971|NCT01511250|12336166|FG007|Overall Study|Lost to Follow-up|3
7852972|NCT01511250|12336167|FG008|Overall Study|Lost to Follow-up|13
7852973|NCT01511250|12336168|FG009|Overall Study|Lost to Follow-up|5
7852974|NCT01511250|12336159|FG000|Overall Study|Protocol Violation|0
7852975|NCT01511250|12336160|FG001|Overall Study|Protocol Violation|2
7852976|NCT01511250|12336161|FG002|Overall Study|Protocol Violation|1
7852977|NCT01511250|12336162|FG003|Overall Study|Protocol Violation|0
7852978|NCT01511250|12336163|FG004|Overall Study|Protocol Violation|0
7852979|NCT01511250|12336164|FG005|Overall Study|Protocol Violation|0
7852980|NCT01511250|12336165|FG006|Overall Study|Protocol Violation|0
7852981|NCT01511250|12336166|FG007|Overall Study|Protocol Violation|0
7852982|NCT01511250|12336167|FG008|Overall Study|Protocol Violation|0
7852983|NCT01511250|12336168|FG009|Overall Study|Protocol Violation|0
7852984|NCT01511419|12336196|FG000|Dose 2|Physician Decision|1
7852985|NCT01511419|12336197|FG001|Dose 2|Physician Decision|0
7852986|NCT01511445|12336229|FG000|Overall Study|Lost to Follow-up|3
7852987|NCT01511445|12336230|FG001|Overall Study|Lost to Follow-up|1
7949524|NCT02538900|12495189|FG000|Overall Study|Withdrawal by Subject|18
7949525|NCT02538900|12495190|FG001|Overall Study|Withdrawal by Subject|16
7949526|NCT02538900|12495191|FG002|Overall Study|Withdrawal by Subject|15
7949527|NCT02538965|12495199|FG000|Treatment Period|Other = Death due to disease progression|1
7949528|NCT02538965|12495199|FG000|Treatment Period|Adverse Event|2
7949529|NCT02538965|12495199|FG000|Treatment Period|Withdrawal by Parent/Guardian|2
7949530|NCT02538965|12495199|FG000|Treatment Period|Treatment Failure|9
7949531|NCT02538965|12495199|FG000|Treatment Period|Disease Progression|1
7949532|NCT02538965|12495199|FG000|Treatment Period|Physician Decision|2
7949533|NCT02538965|12495199|FG000|Follow-Up Period|Other = Death due to disease progression|13
7949534|NCT02538965|12495199|FG000|Follow-Up Period|Withdrawal by Parent|4
7949535|NCT02539134|12495218|FG000|Overall Study|Lost to Follow-up|1
7949536|NCT02539134|12495219|FG001|Overall Study|Lost to Follow-up|0
7949537|NCT02539134|12495220|FG002|Overall Study|Lost to Follow-up|0
7949538|NCT02539134|12495221|FG003|Overall Study|Lost to Follow-up|0
7949539|NCT02539134|12495222|FG004|Overall Study|Lost to Follow-up|0
7949540|NCT02539134|12495223|FG005|Overall Study|Lost to Follow-up|0
7949541|NCT02539368|12495256|FG000|Overall Study|Death|4
7949542|NCT02539368|12495257|FG001|Overall Study|Death|2
7949543|NCT02539368|12495258|FG002|Overall Study|Death|1
7949544|NCT02539368|12495259|FG003|Overall Study|Death|0
7949545|NCT02539368|12495260|FG004|Overall Study|Death|0
7949546|NCT02539368|12495256|FG000|Overall Study|Withdrawal by Subject|44
7949547|NCT02539368|12495257|FG001|Overall Study|Withdrawal by Subject|35
7949548|NCT02539368|12495258|FG002|Overall Study|Withdrawal by Subject|9
7852988|NCT01511445|12336229|FG000|Overall Study|Protocol Violation|1
7852989|NCT01511445|12336230|FG001|Overall Study|Protocol Violation|3
7852990|NCT01511445|12336229|FG000|Overall Study|Protocol Violation|1
7852991|NCT01511445|12336230|FG001|Overall Study|Protocol Violation|0
7852992|NCT01511536|12336239|FG000|Phase 1|Other|0
7852993|NCT01511536|12336240|FG001|Phase 1|Other|1
7852994|NCT01511536|12336241|FG002|Phase 1|Other|0
7852995|NCT01511536|12336239|FG000|Phase 2|Other|0
7852996|NCT01511536|12336240|FG001|Phase 2|Other|0
7852997|NCT01511536|12336241|FG002|Phase 2|Other|9
7852998|NCT01511939|12336278|FG000|Overall Study|Withdrawal by Subject|2
7852999|NCT01511939|12336279|FG001|Overall Study|Withdrawal by Subject|1
7853000|NCT01511939|12336280|FG002|Overall Study|Withdrawal by Subject|0
7853001|NCT01512108|12336301|FG000|Overall Study|Adverse Event|9
7853002|NCT01512108|12336302|FG001|Overall Study|Adverse Event|4
7853003|NCT01512108|12336301|FG000|Overall Study|Protocol Violation|1
7853004|NCT01512108|12336302|FG001|Overall Study|Protocol Violation|2
7853005|NCT01512108|12336301|FG000|Overall Study|Withdrawal Criteria|1
7853006|NCT01512108|12336302|FG001|Overall Study|Withdrawal Criteria|0
7853007|NCT01512108|12336301|FG000|Overall Study|Unclassified|11
7853008|NCT01512108|12336302|FG001|Overall Study|Unclassified|3
7853009|NCT01512160|12336312|FG000|Overall Study|Lost to Follow-up|1
7853010|NCT01512160|12336313|FG001|Overall Study|Lost to Follow-up|0
7853011|NCT01512160|12336314|FG002|Overall Study|Lost to Follow-up|0
7853012|NCT01512160|12336315|FG003|Overall Study|Lost to Follow-up|0
7853013|NCT01512160|12336312|FG000|Overall Study|Withdrawal by Subject|1
7853014|NCT01512160|12336313|FG001|Overall Study|Withdrawal by Subject|0
7853015|NCT01512160|12336314|FG002|Overall Study|Withdrawal by Subject|0
7853016|NCT01512160|12336315|FG003|Overall Study|Withdrawal by Subject|1
7853017|NCT01512264|12336351|FG000|Overall Study|Lost to Follow-up|0
7853018|NCT01512264|12336352|FG001|Overall Study|Lost to Follow-up|0
7853019|NCT01512264|12336353|FG002|Overall Study|Lost to Follow-up|0
7853020|NCT01512264|12336354|FG003|Overall Study|Lost to Follow-up|1
7853021|NCT01512368|12336364|FG000|Overall Study|Protocol Violation|3
7853022|NCT01512693|12336388|FG000|Overall Study|Withdrawal by Subject|0
7853023|NCT01512693|12336389|FG001|Overall Study|Withdrawal by Subject|1
7853024|NCT01512745|12336397|FG000|Overall Study|Adverse Event|22
7853025|NCT01512745|12336398|FG001|Overall Study|Adverse Event|3
7853026|NCT01512745|12336397|FG000|Overall Study|Death|9
7853027|NCT01512745|12336398|FG001|Overall Study|Death|13
7853028|NCT01512745|12336397|FG000|Overall Study|Withdrawal by Subject|2
7853029|NCT01512745|12336398|FG001|Overall Study|Withdrawal by Subject|2
7853030|NCT01512745|12336397|FG000|Overall Study|Lost to Follow-up|4
7853031|NCT01512745|12336398|FG001|Overall Study|Lost to Follow-up|0
7853032|NCT01512745|12336397|FG000|Overall Study|Lack of Efficacy|2
7853033|NCT01512745|12336398|FG001|Overall Study|Lack of Efficacy|2
7853034|NCT01512745|12336397|FG000|Overall Study|Protocol Violation|1
7853035|NCT01512745|12336398|FG001|Overall Study|Protocol Violation|0
7853036|NCT01512979|12336440|FG000|Overall Study|Adverse Event|2
7853037|NCT01512979|12336441|FG001|Overall Study|Adverse Event|2
7853038|NCT01512979|12336440|FG000|Overall Study|Protocol Violation|1
7853039|NCT01512979|12336441|FG001|Overall Study|Protocol Violation|4
7853040|NCT01512979|12336440|FG000|Overall Study|Lost to Follow-up|2
7853041|NCT01512979|12336441|FG001|Overall Study|Lost to Follow-up|5
7853042|NCT01512979|12336440|FG000|Overall Study|Withdrawal by Subject|1
7853043|NCT01512979|12336441|FG001|Overall Study|Withdrawal by Subject|2
7853044|NCT01512979|12336440|FG000|Overall Study|Reason other than stated above|13
7853045|NCT01512979|12336441|FG001|Overall Study|Reason other than stated above|9
7853046|NCT01513148|12336458|FG000|Overall Study|Protocol Violation|2
7853047|NCT01513148|12336459|FG001|Overall Study|Protocol Violation|2
7853048|NCT01513239|12336508|FG000|Period 1: Main Phase|Adverse Event|1
7853049|NCT01513239|12336509|FG001|Period 1: Main Phase|Adverse Event|1
7853050|NCT01513239|12336510|FG002|Period 1: Main Phase|Adverse Event|2
7853051|NCT01513239|12336511|FG003|Period 1: Main Phase|Adverse Event|0
7853052|NCT01513239|12336512|FG004|Period 1: Main Phase|Adverse Event|0
7853053|NCT01513239|12336513|FG005|Period 1: Main Phase|Adverse Event|0
7853054|NCT01513239|12336508|FG000|Period 1: Main Phase|Death|29
7853055|NCT01513239|12336509|FG001|Period 1: Main Phase|Death|22
7853056|NCT01513239|12336510|FG002|Period 1: Main Phase|Death|32
7853057|NCT01513239|12336511|FG003|Period 1: Main Phase|Death|0
7853058|NCT01513239|12336512|FG004|Period 1: Main Phase|Death|0
7853059|NCT01513239|12336513|FG005|Period 1: Main Phase|Death|0
7853060|NCT01513239|12336508|FG000|Period 1: Main Phase|Lost to Follow-up|11
7853061|NCT01513239|12336509|FG001|Period 1: Main Phase|Lost to Follow-up|10
7853062|NCT01513239|12336510|FG002|Period 1: Main Phase|Lost to Follow-up|6
7853063|NCT01513239|12336511|FG003|Period 1: Main Phase|Lost to Follow-up|0
7853064|NCT01513239|12336512|FG004|Period 1: Main Phase|Lost to Follow-up|0
7853065|NCT01513239|12336513|FG005|Period 1: Main Phase|Lost to Follow-up|0
7853066|NCT01513239|12336508|FG000|Period 1: Main Phase|Physician Decision|4
7853067|NCT01513239|12336509|FG001|Period 1: Main Phase|Physician Decision|4
7853068|NCT01513239|12336510|FG002|Period 1: Main Phase|Physician Decision|4
7853069|NCT01513239|12336511|FG003|Period 1: Main Phase|Physician Decision|0
7853070|NCT01513239|12336512|FG004|Period 1: Main Phase|Physician Decision|0
7853071|NCT01513239|12336513|FG005|Period 1: Main Phase|Physician Decision|0
7853072|NCT01513239|12336508|FG000|Period 1: Main Phase|Protocol Violation|2
7853073|NCT01513239|12336509|FG001|Period 1: Main Phase|Protocol Violation|2
7853074|NCT01513239|12336510|FG002|Period 1: Main Phase|Protocol Violation|2
7853075|NCT01513239|12336511|FG003|Period 1: Main Phase|Protocol Violation|0
7853076|NCT01513239|12336512|FG004|Period 1: Main Phase|Protocol Violation|0
7853077|NCT01513239|12336513|FG005|Period 1: Main Phase|Protocol Violation|0
7853078|NCT01513239|12336508|FG000|Period 1: Main Phase|Technical Problems|1
7853079|NCT01513239|12336509|FG001|Period 1: Main Phase|Technical Problems|2
7853080|NCT01513239|12336510|FG002|Period 1: Main Phase|Technical Problems|0
7853081|NCT01513239|12336511|FG003|Period 1: Main Phase|Technical Problems|0
7853082|NCT01513239|12336512|FG004|Period 1: Main Phase|Technical Problems|0
7853083|NCT01513239|12336513|FG005|Period 1: Main Phase|Technical Problems|0
7853084|NCT01513239|12336508|FG000|Period 1: Main Phase|Withdrawal by Subject|27
7853085|NCT01513239|12336509|FG001|Period 1: Main Phase|Withdrawal by Subject|29
7853086|NCT01513239|12336510|FG002|Period 1: Main Phase|Withdrawal by Subject|42
7853087|NCT01513239|12336511|FG003|Period 1: Main Phase|Withdrawal by Subject|0
7853088|NCT01513239|12336512|FG004|Period 1: Main Phase|Withdrawal by Subject|0
7853089|NCT01513239|12336513|FG005|Period 1: Main Phase|Withdrawal by Subject|0
7853090|NCT01513239|12336508|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
7853091|NCT01513239|12336509|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
7853092|NCT01513239|12336510|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
7853093|NCT01513239|12336511|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
7853094|NCT01513239|12336512|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
7853095|NCT01513239|12336513|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
7853096|NCT01513239|12336508|FG000|Period 2: 9 Month Extension Phase|Death|0
7853097|NCT01513239|12336509|FG001|Period 2: 9 Month Extension Phase|Death|0
7853098|NCT01513239|12336510|FG002|Period 2: 9 Month Extension Phase|Death|0
7853099|NCT01513239|12336511|FG003|Period 2: 9 Month Extension Phase|Death|2
7853100|NCT01513239|12336512|FG004|Period 2: 9 Month Extension Phase|Death|5
7853101|NCT01513239|12336513|FG005|Period 2: 9 Month Extension Phase|Death|2
7853102|NCT01513239|12336508|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7853103|NCT01513239|12336509|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7853104|NCT01513239|12336510|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7853105|NCT01513239|12336511|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
7853106|NCT01513239|12336512|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
7853107|NCT01513239|12336513|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7853108|NCT01513239|12336508|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0
7853109|NCT01513239|12336509|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0
7853110|NCT01513239|12336510|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0
7853111|NCT01513239|12336511|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1
7853112|NCT01513239|12336512|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0
7853113|NCT01513239|12336513|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0
7853114|NCT01513239|12336508|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0
7853115|NCT01513239|12336509|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0
7853116|NCT01513239|12336510|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0
7853117|NCT01513239|12336511|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0
7853118|NCT01513239|12336512|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1
7853119|NCT01513239|12336513|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1
7853120|NCT01513291|12336527|FG000|Treatment Period|Adverse Event|8
7853121|NCT01513291|12336528|FG001|Treatment Period|Adverse Event|4
7853122|NCT01513291|12336529|FG002|Treatment Period|Adverse Event|0
7853123|NCT01513291|12336530|FG003|Treatment Period|Adverse Event|0
7853124|NCT01513291|12336531|FG004|Treatment Period|Adverse Event|0
7853125|NCT01513291|12336527|FG000|Treatment Period|Lack of Efficacy|3
7853126|NCT01513291|12336528|FG001|Treatment Period|Lack of Efficacy|0
7853127|NCT01513291|12336529|FG002|Treatment Period|Lack of Efficacy|0
7853128|NCT01513291|12336530|FG003|Treatment Period|Lack of Efficacy|0
7853129|NCT01513291|12336531|FG004|Treatment Period|Lack of Efficacy|0
7853130|NCT01513291|12336527|FG000|Treatment Period|Lost to Follow-up|2
7853131|NCT01513291|12336528|FG001|Treatment Period|Lost to Follow-up|3
7853132|NCT01513291|12336529|FG002|Treatment Period|Lost to Follow-up|0
7853133|NCT01513291|12336530|FG003|Treatment Period|Lost to Follow-up|0
7853134|NCT01513291|12336531|FG004|Treatment Period|Lost to Follow-up|0
7853135|NCT01513291|12336527|FG000|Treatment Period|Physician Decision|1
7853136|NCT01513291|12336528|FG001|Treatment Period|Physician Decision|0
7853137|NCT01513291|12336529|FG002|Treatment Period|Physician Decision|0
7853138|NCT01513291|12336530|FG003|Treatment Period|Physician Decision|0
7853139|NCT01513291|12336531|FG004|Treatment Period|Physician Decision|0
7853140|NCT01513291|12336527|FG000|Treatment Period|Protocol Violation|1
7853141|NCT01513291|12336528|FG001|Treatment Period|Protocol Violation|2
7853142|NCT01513291|12336529|FG002|Treatment Period|Protocol Violation|0
7853143|NCT01513291|12336530|FG003|Treatment Period|Protocol Violation|0
7853144|NCT01513291|12336531|FG004|Treatment Period|Protocol Violation|0
7853145|NCT01513291|12336527|FG000|Treatment Period|Withdrawal by Subject|8
7853146|NCT01513291|12336528|FG001|Treatment Period|Withdrawal by Subject|5
7853147|NCT01513291|12336529|FG002|Treatment Period|Withdrawal by Subject|0
7853148|NCT01513291|12336530|FG003|Treatment Period|Withdrawal by Subject|0
7853149|NCT01513291|12336531|FG004|Treatment Period|Withdrawal by Subject|0
7853150|NCT01513291|12336527|FG000|Treatment Period|Randomized not treated|0
7853151|NCT01513291|12336528|FG001|Treatment Period|Randomized not treated|2
7853152|NCT01513291|12336529|FG002|Treatment Period|Randomized not treated|0
7853153|NCT01513291|12336530|FG003|Treatment Period|Randomized not treated|0
7853154|NCT01513291|12336531|FG004|Treatment Period|Randomized not treated|0
7853155|NCT01513291|12336527|FG000|Run-out Period|Lost to Follow-up|0
7853156|NCT01513291|12336528|FG001|Run-out Period|Lost to Follow-up|0
7853157|NCT01513291|12336529|FG002|Run-out Period|Lost to Follow-up|0
7853158|NCT01513291|12336530|FG003|Run-out Period|Lost to Follow-up|1
7853159|NCT01513291|12336531|FG004|Run-out Period|Lost to Follow-up|0
7853160|NCT01513291|12336527|FG000|Run-out Period|Withdrawal by Subject|0
7853161|NCT01513291|12336528|FG001|Run-out Period|Withdrawal by Subject|0
7853162|NCT01513291|12336529|FG002|Run-out Period|Withdrawal by Subject|0
7853163|NCT01513291|12336530|FG003|Run-out Period|Withdrawal by Subject|1
7853164|NCT01513291|12336531|FG004|Run-out Period|Withdrawal by Subject|0
7853165|NCT01513317|12336545|FG000|Overall Study|Withdrawal by Subject|15
7853166|NCT01513317|12336546|FG001|Overall Study|Withdrawal by Subject|4
7853167|NCT01513317|12336545|FG000|Overall Study|Death|1
7853168|NCT01513317|12336546|FG001|Overall Study|Death|1
7853169|NCT01513317|12336545|FG000|Overall Study|Study terminated by sponsor|18
7853170|NCT01513317|12336546|FG001|Overall Study|Study terminated by sponsor|18
7853171|NCT01513317|12336545|FG000|Overall Study|Other|0
7853172|NCT01513317|12336546|FG001|Overall Study|Other|1
7853173|NCT01513330|12336552|FG000|SenSura Mio First,|Adverse Event|2
7853174|NCT01513330|12336553|FG001|SenSura Mio First,|Adverse Event|0
7853175|NCT01513330|12336552|FG000|SenSura Mio First,|Lack of Efficacy|0
7853176|NCT01513330|12336553|FG001|SenSura Mio First,|Lack of Efficacy|1
7853177|NCT01513330|12336552|FG000|SenSura Mio First,|Withdrawal by Subject|1
7853178|NCT01513330|12336553|FG001|SenSura Mio First,|Withdrawal by Subject|1
7853179|NCT01513330|12336552|FG000|SenSura Mio First,|Other|1
7853180|NCT01513330|12336553|FG001|SenSura Mio First,|Other|0
7853181|NCT01513330|12336552|FG000|Standard Care First,|Lack of Efficacy|2
7853182|NCT01513330|12336553|FG001|Standard Care First,|Lack of Efficacy|2
7853183|NCT01513330|12336552|FG000|Standard Care First,|Withdrawal by Subject|1
7853184|NCT01513330|12336553|FG001|Standard Care First,|Withdrawal by Subject|2
7853185|NCT01513330|12336552|FG000|Standard Care First,|Other|1
7853186|NCT01513330|12336553|FG001|Standard Care First,|Other|0
7853187|NCT01513460|12336571|FG000|Overall Study|Death|0
7853188|NCT01513460|12336572|FG001|Overall Study|Death|0
7853189|NCT01513460|12336573|FG002|Overall Study|Death|1
7853190|NCT01513460|12336571|FG000|Overall Study|Lost to Follow-up|0
7853191|NCT01513460|12336572|FG001|Overall Study|Lost to Follow-up|0
7853192|NCT01513460|12336573|FG002|Overall Study|Lost to Follow-up|2
7853193|NCT01513460|12336571|FG000|Overall Study|Abnormal laboratory value|1
7853194|NCT01513460|12336572|FG001|Overall Study|Abnormal laboratory value|0
7853195|NCT01513460|12336573|FG002|Overall Study|Abnormal laboratory value|1
7853196|NCT01513460|12336571|FG000|Overall Study|Lack of Efficacy|1
7853197|NCT01513460|12336572|FG001|Overall Study|Lack of Efficacy|2
7853198|NCT01513460|12336573|FG002|Overall Study|Lack of Efficacy|5
7853199|NCT01513460|12336571|FG000|Overall Study|Protocol deviations|3
7853200|NCT01513460|12336572|FG001|Overall Study|Protocol deviations|4
7853201|NCT01513460|12336573|FG002|Overall Study|Protocol deviations|3
7853202|NCT01513460|12336571|FG000|Overall Study|Withdrawal by Subject|7
7853203|NCT01513460|12336572|FG001|Overall Study|Withdrawal by Subject|8
7853204|NCT01513460|12336573|FG002|Overall Study|Withdrawal by Subject|21
7853205|NCT01513460|12336571|FG000|Overall Study|Adverse Event|16
7853206|NCT01513460|12336572|FG001|Overall Study|Adverse Event|18
7853207|NCT01513460|12336573|FG002|Overall Study|Adverse Event|23
7853208|NCT01513460|12336571|FG000|Overall Study|Abnormal test procedure|1
7853209|NCT01513460|12336572|FG001|Overall Study|Abnormal test procedure|0
7853210|NCT01513460|12336573|FG002|Overall Study|Abnormal test procedure|0
7853211|NCT01513473|12336585|FG000|Main Trial (26 Weeks)|Adverse Event|0
7853212|NCT01513473|12336586|FG001|Main Trial (26 Weeks)|Adverse Event|2
7853213|NCT01513473|12336585|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4
7853214|NCT01513473|12336586|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7
7853215|NCT01513473|12336585|FG000|Main Trial (26 Weeks)|Unclassified|0
7853216|NCT01513473|12336586|FG001|Main Trial (26 Weeks)|Unclassified|2
7853217|NCT01513473|12336585|FG000|Extension Trial (26 Weeks)|Adverse Event|0
7853218|NCT01513473|12336586|FG001|Extension Trial (26 Weeks)|Adverse Event|1
7853219|NCT01513473|12336585|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1
7853220|NCT01513473|12336586|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5
7853221|NCT01513551|12336599|FG000|Overall Study|Death|0
7853222|NCT01513551|12336600|FG001|Overall Study|Death|1
7853223|NCT01513551|12336601|FG002|Overall Study|Death|0
7853224|NCT01513551|12336599|FG000|Overall Study|Lost to Follow-up|3
7853225|NCT01513551|12336600|FG001|Overall Study|Lost to Follow-up|5
7853226|NCT01513551|12336601|FG002|Overall Study|Lost to Follow-up|2
7853227|NCT01513551|12336599|FG000|Overall Study|Withdrawal by Subject|1
7853228|NCT01513551|12336600|FG001|Overall Study|Withdrawal by Subject|0
7853229|NCT01513551|12336601|FG002|Overall Study|Withdrawal by Subject|2
7853230|NCT01513551|12336599|FG000|Overall Study|Randomized but not vaccinated|0
7853231|NCT01513551|12336600|FG001|Overall Study|Randomized but not vaccinated|0
7853232|NCT01513551|12336601|FG002|Overall Study|Randomized but not vaccinated|1
7853233|NCT01513590|12336611|FG000|Overall Study|Adverse Event|2
7853234|NCT01513590|12336612|FG001|Overall Study|Adverse Event|3
7853235|NCT01513590|12336611|FG000|Overall Study|Withdrawal Criteria|3
7853236|NCT01513590|12336612|FG001|Overall Study|Withdrawal Criteria|0
7853237|NCT01513590|12336611|FG000|Overall Study|Unclassified|5
7853238|NCT01513590|12336612|FG001|Overall Study|Unclassified|10
7853239|NCT01513759|12336618|FG000|Overall Study|Protocol Violation|4
7853240|NCT01513759|12336618|FG000|Overall Study|Death during catheter placement|1
7853241|NCT01513967|12336643|FG000|Overall Study|Pregnancy|0
7853242|NCT01513967|12336644|FG001|Overall Study|Pregnancy|0
7853243|NCT01513967|12336645|FG002|Overall Study|Pregnancy|0
7853244|NCT01513967|12336646|FG003|Overall Study|Pregnancy|0
7853245|NCT01513967|12336647|FG004|Overall Study|Pregnancy|0
7853246|NCT01513967|12336648|FG005|Overall Study|Pregnancy|0
7853247|NCT01513967|12336649|FG006|Overall Study|Pregnancy|1
7853248|NCT01513967|12336650|FG007|Overall Study|Pregnancy|0
7853249|NCT01513967|12336643|FG000|Overall Study|missed a study visit|0
7853250|NCT01513967|12336644|FG001|Overall Study|missed a study visit|0
7853251|NCT01513967|12336645|FG002|Overall Study|missed a study visit|0
7853252|NCT01513967|12336646|FG003|Overall Study|missed a study visit|0
7853253|NCT01513967|12336647|FG004|Overall Study|missed a study visit|0
7853254|NCT01513967|12336648|FG005|Overall Study|missed a study visit|0
7853255|NCT01513967|12336649|FG006|Overall Study|missed a study visit|1
7853256|NCT01513967|12336650|FG007|Overall Study|missed a study visit|0
7853257|NCT01513967|12336643|FG000|Overall Study|excluded due to positive drug screen|0
7853258|NCT01513967|12336644|FG001|Overall Study|excluded due to positive drug screen|0
7853259|NCT01513967|12336645|FG002|Overall Study|excluded due to positive drug screen|0
7853260|NCT01513967|12336646|FG003|Overall Study|excluded due to positive drug screen|0
7853261|NCT01513967|12336647|FG004|Overall Study|excluded due to positive drug screen|0
7853262|NCT01513967|12336648|FG005|Overall Study|excluded due to positive drug screen|0
7853263|NCT01513967|12336649|FG006|Overall Study|excluded due to positive drug screen|0
7853264|NCT01513967|12336650|FG007|Overall Study|excluded due to positive drug screen|2
7853265|NCT01513967|12336643|FG000|Overall Study|Physician Decision|0
7853266|NCT01513967|12336644|FG001|Overall Study|Physician Decision|0
7853267|NCT01513967|12336645|FG002|Overall Study|Physician Decision|0
7853268|NCT01513967|12336646|FG003|Overall Study|Physician Decision|0
7853269|NCT01513967|12336647|FG004|Overall Study|Physician Decision|0
7853270|NCT01513967|12336648|FG005|Overall Study|Physician Decision|1
7853271|NCT01513967|12336649|FG006|Overall Study|Physician Decision|0
7853272|NCT01513967|12336650|FG007|Overall Study|Physician Decision|0
7853273|NCT01514136|12336670|FG000|Test Period 1; Test A|Protocol Violation|1
7853274|NCT01514136|12336671|FG001|Test Period 1; Test A|Protocol Violation|0
7853275|NCT01514136|12336672|FG002|Test Period 1; Test A|Protocol Violation|0
7853276|NCT01514136|12336673|FG003|Test Period 1; Test A|Protocol Violation|0
7853277|NCT01514136|12336674|FG004|Test Period 1; Test A|Protocol Violation|0
7853278|NCT01514136|12336675|FG005|Test Period 1; Test A|Protocol Violation|0
7853279|NCT01514136|12336676|FG006|Test Period 1; Test A|Protocol Violation|0
7853280|NCT01514136|12336677|FG007|Test Period 1; Test A|Protocol Violation|0
7853281|NCT01514136|12336670|FG000|Test Period 1; Test A|Break from study holiday|2
7853282|NCT01514136|12336671|FG001|Test Period 1; Test A|Break from study holiday|0
7853283|NCT01514136|12336672|FG002|Test Period 1; Test A|Break from study holiday|0
7853284|NCT01514136|12336673|FG003|Test Period 1; Test A|Break from study holiday|0
7853285|NCT01514136|12336674|FG004|Test Period 1; Test A|Break from study holiday|0
7853286|NCT01514136|12336675|FG005|Test Period 1; Test A|Break from study holiday|0
7853287|NCT01514136|12336676|FG006|Test Period 1; Test A|Break from study holiday|0
7853288|NCT01514136|12336677|FG007|Test Period 1; Test A|Break from study holiday|0
7853289|NCT01514136|12336670|FG000|Test Period 1; Test B|Withdrawal by Subject|0
7853290|NCT01514136|12336671|FG001|Test Period 1; Test B|Withdrawal by Subject|1
7853291|NCT01514136|12336672|FG002|Test Period 1; Test B|Withdrawal by Subject|0
7853292|NCT01514136|12336673|FG003|Test Period 1; Test B|Withdrawal by Subject|0
7853293|NCT01514136|12336674|FG004|Test Period 1; Test B|Withdrawal by Subject|0
7853294|NCT01514136|12336675|FG005|Test Period 1; Test B|Withdrawal by Subject|0
7853295|NCT01514136|12336676|FG006|Test Period 1; Test B|Withdrawal by Subject|0
7853296|NCT01514136|12336677|FG007|Test Period 1; Test B|Withdrawal by Subject|0
7853297|NCT01514136|12336670|FG000|Test Period 1; Test D|Subject took a break due to holiday|0
7853298|NCT01514136|12336671|FG001|Test Period 1; Test D|Subject took a break due to holiday|0
7853299|NCT01514136|12336672|FG002|Test Period 1; Test D|Subject took a break due to holiday|0
7853300|NCT01514136|12336673|FG003|Test Period 1; Test D|Subject took a break due to holiday|2
7853301|NCT01514136|12336674|FG004|Test Period 1; Test D|Subject took a break due to holiday|0
7853302|NCT01514136|12336675|FG005|Test Period 1; Test D|Subject took a break due to holiday|0
7853303|NCT01514136|12336676|FG006|Test Period 1; Test D|Subject took a break due to holiday|0
7853304|NCT01514136|12336677|FG007|Test Period 1; Test D|Subject took a break due to holiday|0
7853305|NCT01514136|12336670|FG000|Test Period 2; Test A*|Adverse Event|0
7853306|NCT01514136|12336671|FG001|Test Period 2; Test A*|Adverse Event|0
7853307|NCT01514136|12336672|FG002|Test Period 2; Test A*|Adverse Event|0
7853308|NCT01514136|12336673|FG003|Test Period 2; Test A*|Adverse Event|0
7853309|NCT01514136|12336674|FG004|Test Period 2; Test A*|Adverse Event|1
7853310|NCT01514136|12336675|FG005|Test Period 2; Test A*|Adverse Event|0
7853311|NCT01514136|12336676|FG006|Test Period 2; Test A*|Adverse Event|0
7853312|NCT01514136|12336677|FG007|Test Period 2; Test A*|Adverse Event|0
7853313|NCT01514136|12336670|FG000|Test Period 2; Test A*|Holiday|0
7853314|NCT01514136|12336671|FG001|Test Period 2; Test A*|Holiday|0
7853315|NCT01514136|12336672|FG002|Test Period 2; Test A*|Holiday|0
7853316|NCT01514136|12336673|FG003|Test Period 2; Test A*|Holiday|0
7853317|NCT01514136|12336674|FG004|Test Period 2; Test A*|Holiday|1
7853318|NCT01514136|12336675|FG005|Test Period 2; Test A*|Holiday|0
7853319|NCT01514136|12336676|FG006|Test Period 2; Test A*|Holiday|0
7853320|NCT01514136|12336677|FG007|Test Period 2; Test A*|Holiday|0
7853321|NCT01514136|12336670|FG000|Test Period 2; Test B*|Withdrawal by Subject|0
7853322|NCT01514136|12336671|FG001|Test Period 2; Test B*|Withdrawal by Subject|0
7853323|NCT01514136|12336672|FG002|Test Period 2; Test B*|Withdrawal by Subject|0
7853324|NCT01514136|12336673|FG003|Test Period 2; Test B*|Withdrawal by Subject|0
7853325|NCT01514136|12336674|FG004|Test Period 2; Test B*|Withdrawal by Subject|0
7853326|NCT01514136|12336675|FG005|Test Period 2; Test B*|Withdrawal by Subject|2
7853327|NCT01514136|12336676|FG006|Test Period 2; Test B*|Withdrawal by Subject|0
7853328|NCT01514136|12336677|FG007|Test Period 2; Test B*|Withdrawal by Subject|0
7853329|NCT01514136|12336670|FG000|Test Period 2; Test C*|Withdrawal by Subject|0
7853330|NCT01514136|12336671|FG001|Test Period 2; Test C*|Withdrawal by Subject|0
7853331|NCT01514136|12336672|FG002|Test Period 2; Test C*|Withdrawal by Subject|0
7853332|NCT01514136|12336673|FG003|Test Period 2; Test C*|Withdrawal by Subject|0
7853333|NCT01514136|12336674|FG004|Test Period 2; Test C*|Withdrawal by Subject|0
7853334|NCT01514136|12336675|FG005|Test Period 2; Test C*|Withdrawal by Subject|0
7853335|NCT01514136|12336676|FG006|Test Period 2; Test C*|Withdrawal by Subject|1
7853336|NCT01514136|12336677|FG007|Test Period 2; Test C*|Withdrawal by Subject|0
7853337|NCT01514136|12336670|FG000|Test Period 2; Test C*|holiday|0
7853338|NCT01514136|12336671|FG001|Test Period 2; Test C*|holiday|0
7853339|NCT01514136|12336672|FG002|Test Period 2; Test C*|holiday|0
7853340|NCT01514136|12336673|FG003|Test Period 2; Test C*|holiday|0
7853341|NCT01514136|12336674|FG004|Test Period 2; Test C*|holiday|0
7853342|NCT01514136|12336675|FG005|Test Period 2; Test C*|holiday|0
7853343|NCT01514136|12336676|FG006|Test Period 2; Test C*|holiday|1
7853344|NCT01514136|12336677|FG007|Test Period 2; Test C*|holiday|0
7853345|NCT01514136|12336670|FG000|Test Period 2; Test C*|Protocol Violation|0
7853346|NCT01514136|12336671|FG001|Test Period 2; Test C*|Protocol Violation|0
7853347|NCT01514136|12336672|FG002|Test Period 2; Test C*|Protocol Violation|0
7853348|NCT01514136|12336673|FG003|Test Period 2; Test C*|Protocol Violation|0
7853349|NCT01514136|12336674|FG004|Test Period 2; Test C*|Protocol Violation|0
7853350|NCT01514136|12336675|FG005|Test Period 2; Test C*|Protocol Violation|0
7853351|NCT01514136|12336676|FG006|Test Period 2; Test C*|Protocol Violation|1
7853352|NCT01514136|12336677|FG007|Test Period 2; Test C*|Protocol Violation|0
7863471|NCT01606189|12352803|FG003|Second Intenvention (14-20 Days)|Adverse Event|0
7863472|NCT01606189|12352804|FG004|Second Intenvention (14-20 Days)|Adverse Event|0
7863473|NCT01606189|12352805|FG005|Second Intenvention (14-20 Days)|Adverse Event|1
7863474|NCT01606189|12352800|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7863475|NCT01606189|12352801|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7863476|NCT01606189|12352802|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7863477|NCT01606189|12352803|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7863478|NCT01606189|12352804|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7863479|NCT01606189|12352805|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
7863480|NCT01606202|12352815|FG000|Overall Study|Adverse Event|5
7863481|NCT01606202|12352816|FG001|Overall Study|Adverse Event|0
7853353|NCT01514201|12336732|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1
7853354|NCT01514201|12336733|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
7853355|NCT01514201|12336734|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
7853356|NCT01514201|12336735|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
7853357|NCT01514201|12336732|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
7853358|NCT01514201|12336733|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
7853359|NCT01514201|12336734|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
7853360|NCT01514201|12336735|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
7853361|NCT01514201|12336732|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
7853362|NCT01514201|12336733|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
7853363|NCT01514201|12336734|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5
7853364|NCT01514201|12336735|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7853365|NCT01514201|12336732|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
7853366|NCT01514201|12336733|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
7853367|NCT01514201|12336734|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7853368|NCT01514201|12336735|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7853369|NCT01514201|12336732|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
7853370|NCT01514201|12336733|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
7853371|NCT01514201|12336734|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
7853372|NCT01514201|12336735|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1
7853373|NCT01514201|12336732|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
7853374|NCT01514201|12336733|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
7853375|NCT01514201|12336734|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
7853376|NCT01514201|12336735|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2
7853377|NCT01514201|12336732|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0
7853378|NCT01514201|12336733|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0
7853379|NCT01514201|12336734|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0
7853380|NCT01514201|12336735|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1
7853381|NCT01514201|12336732|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
7853382|NCT01514201|12336733|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
7853383|NCT01514201|12336734|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
7853384|NCT01514201|12336735|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2
7853385|NCT01514201|12336732|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
7853386|NCT01514201|12336733|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
7853387|NCT01514201|12336734|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
7853388|NCT01514201|12336735|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6
7853389|NCT01514201|12336732|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
7853390|NCT01514201|12336733|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
7853391|NCT01514201|12336734|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
7853392|NCT01514201|12336735|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4
7853393|NCT01514201|12336732|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7853394|NCT01514201|12336733|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7853395|NCT01514201|12336734|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7853396|NCT01514201|12336735|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7
7853397|NCT01514201|12336732|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7853398|NCT01514201|12336733|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7853399|NCT01514201|12336734|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7853400|NCT01514201|12336735|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22
7853401|NCT01514240|12336757|FG000|Overall Study|Adverse Event|4
7853402|NCT01514240|12336758|FG001|Overall Study|Adverse Event|4
7853403|NCT01514240|12336757|FG000|Overall Study|Subject Decision|2
7853404|NCT01514240|12336758|FG001|Overall Study|Subject Decision|7
7853405|NCT01514357|12336787|FG000|Overall Study|Screen failure|2
7853406|NCT01514357|12336788|FG001|Overall Study|Screen failure|0
7853407|NCT01514357|12336787|FG000|Overall Study|Withdrawal by Subject|2
7853408|NCT01514357|12336788|FG001|Overall Study|Withdrawal by Subject|0
7853409|NCT01514370|12336796|FG000|Overall Study|Protocol Violation|2
7853410|NCT01514370|12336797|FG001|Overall Study|Protocol Violation|3
7853411|NCT01514370|12336796|FG000|Overall Study|Lost to Follow-up|0
7853412|NCT01514370|12336797|FG001|Overall Study|Lost to Follow-up|2
7853413|NCT01514370|12336796|FG000|Overall Study|Withdrawal by Subject|2
7853414|NCT01514370|12336797|FG001|Overall Study|Withdrawal by Subject|1
7853415|NCT01514370|12336796|FG000|Overall Study|Adverse Event|1
7853416|NCT01514370|12336797|FG001|Overall Study|Adverse Event|3
7853417|NCT01514370|12336796|FG000|Overall Study|Other|6
7853418|NCT01514370|12336797|FG001|Overall Study|Other|7
7853419|NCT01514422|12336814|FG000|Overall Study|Lost to Follow-up|1
7853420|NCT01514448|12336820|FG000|Overall Study|Death|7
7853421|NCT01514448|12336821|FG001|Overall Study|Death|8
7853422|NCT01514448|12336820|FG000|Overall Study|Withdrawal by Subject|2
7853423|NCT01514448|12336821|FG001|Overall Study|Withdrawal by Subject|0
7853424|NCT01514448|12336820|FG000|Overall Study|Lost to Follow-up|2
7853425|NCT01514448|12336821|FG001|Overall Study|Lost to Follow-up|0
7853426|NCT01514448|12336820|FG000|Overall Study|New Cancer Therapy|1
7853427|NCT01514448|12336821|FG001|Overall Study|New Cancer Therapy|0
7853428|NCT01514461|12336831|FG000|Overall Study|Adverse Event|2
7853429|NCT01514461|12336832|FG001|Overall Study|Adverse Event|1
7853430|NCT01514461|12336833|FG002|Overall Study|Adverse Event|3
7853431|NCT01514461|12336831|FG000|Overall Study|Physician Decision|1
7853432|NCT01514461|12336832|FG001|Overall Study|Physician Decision|1
7853433|NCT01514461|12336833|FG002|Overall Study|Physician Decision|0
7853434|NCT01514461|12336831|FG000|Overall Study|Patient/guardian decision|1
7853435|NCT01514461|12336832|FG001|Overall Study|Patient/guardian decision|1
7853436|NCT01514461|12336833|FG002|Overall Study|Patient/guardian decision|1
7853437|NCT01514461|12336831|FG000|Overall Study|Death|1
7853438|NCT01514461|12336832|FG001|Overall Study|Death|0
7853439|NCT01514461|12336833|FG002|Overall Study|Death|0
7853440|NCT01514760|12336861|FG000|Overall Study|Lost to Follow-up|2
7853441|NCT01514864|12336876|FG000|Overall Study|Disease progression|7
7853442|NCT01514864|12336877|FG001|Overall Study|Disease progression|5
7853443|NCT01514864|12336876|FG000|Overall Study|Study drug toxicity|2
7853444|NCT01514864|12336877|FG001|Overall Study|Study drug toxicity|0
7853445|NCT01515189|12336924|FG000|Induction|Disease Progression|109
7853446|NCT01515189|12336925|FG001|Induction|Disease Progression|155
7853447|NCT01515189|12336924|FG000|Induction|Study drug toxicity|86
7853448|NCT01515189|12336925|FG001|Induction|Study drug toxicity|36
7853449|NCT01515189|12336924|FG000|Induction|Death|24
7853450|NCT01515189|12336925|FG001|Induction|Death|17
7853451|NCT01515189|12336924|FG000|Induction|Adverse Event|14
7853452|NCT01515189|12336925|FG001|Induction|Adverse Event|9
7853453|NCT01515189|12336924|FG000|Induction|Withdrawal by Subject|3
7853454|NCT01515189|12336925|FG001|Induction|Withdrawal by Subject|9
7853455|NCT01515189|12336924|FG000|Induction|No longer meets study criteria|0
7853456|NCT01515189|12336925|FG001|Induction|No longer meets study criteria|2
7853457|NCT01515189|12336924|FG000|Induction|Lost to Follow-up|1
7853458|NCT01515189|12336925|FG001|Induction|Lost to Follow-up|0
7853459|NCT01515189|12336924|FG000|Induction|Other|0
7853460|NCT01515189|12336925|FG001|Induction|Other|4
7853461|NCT01515189|12336924|FG000|First Re-Induction Phase|Disease progression|6
7853462|NCT01515189|12336925|FG001|First Re-Induction Phase|Disease progression|14
7853463|NCT01515189|12336924|FG000|First Re-Induction Phase|Study drug toxicity|5
7853464|NCT01515189|12336925|FG001|First Re-Induction Phase|Study drug toxicity|0
7853465|NCT01515189|12336924|FG000|First Re-Induction Phase|Withdrawal by Subject|1
7853466|NCT01515189|12336925|FG001|First Re-Induction Phase|Withdrawal by Subject|1
7853467|NCT01515189|12336924|FG000|First Re-Induction Phase|No longer meets study criteria|1
7853468|NCT01515189|12336925|FG001|First Re-Induction Phase|No longer meets study criteria|0
7853469|NCT01515189|12336924|FG000|First Re-Induction Phase|Other|1
7853470|NCT01515189|12336925|FG001|First Re-Induction Phase|Other|0
7853471|NCT01515319|12336941|FG000|Overall Study|Withdrawal by Subject|0
7853472|NCT01515319|12336942|FG001|Overall Study|Withdrawal by Subject|0
7853473|NCT01515319|12336943|FG002|Overall Study|Withdrawal by Subject|0
7853474|NCT01515319|12336944|FG003|Overall Study|Withdrawal by Subject|0
7853475|NCT01515319|12336945|FG004|Overall Study|Withdrawal by Subject|0
7853476|NCT01515319|12336946|FG005|Overall Study|Withdrawal by Subject|0
7853477|NCT01515319|12336947|FG006|Overall Study|Withdrawal by Subject|1
7853478|NCT01515319|12336948|FG007|Overall Study|Withdrawal by Subject|0
7853479|NCT01515319|12336949|FG008|Overall Study|Withdrawal by Subject|0
7853480|NCT01515319|12336950|FG009|Overall Study|Withdrawal by Subject|0
7853481|NCT01515319|12336941|FG000|Overall Study|Adverse Event|0
7853482|NCT01515319|12336942|FG001|Overall Study|Adverse Event|0
7853483|NCT01515319|12336943|FG002|Overall Study|Adverse Event|0
7853484|NCT01515319|12336944|FG003|Overall Study|Adverse Event|0
7853485|NCT01515319|12336945|FG004|Overall Study|Adverse Event|0
7853486|NCT01515319|12336946|FG005|Overall Study|Adverse Event|0
7853487|NCT01515319|12336947|FG006|Overall Study|Adverse Event|0
7853488|NCT01515319|12336948|FG007|Overall Study|Adverse Event|0
7853489|NCT01515319|12336949|FG008|Overall Study|Adverse Event|3
7853490|NCT01515319|12336950|FG009|Overall Study|Adverse Event|0
7853491|NCT01515319|12336941|FG000|Overall Study|Protocol Violation|0
7853492|NCT01515319|12336942|FG001|Overall Study|Protocol Violation|0
7853493|NCT01515319|12336943|FG002|Overall Study|Protocol Violation|0
7853494|NCT01515319|12336944|FG003|Overall Study|Protocol Violation|0
7853495|NCT01515319|12336945|FG004|Overall Study|Protocol Violation|0
7853496|NCT01515319|12336946|FG005|Overall Study|Protocol Violation|0
7853497|NCT01515319|12336947|FG006|Overall Study|Protocol Violation|0
7853498|NCT01515319|12336948|FG007|Overall Study|Protocol Violation|0
7853499|NCT01515319|12336949|FG008|Overall Study|Protocol Violation|2
7853500|NCT01515319|12336950|FG009|Overall Study|Protocol Violation|0
7853501|NCT01515423|12336990|FG000|Open Label Phase|Adverse Event|57
7853502|NCT01515423|12336991|FG001|Open Label Phase|Adverse Event|0
7853503|NCT01515423|12336992|FG002|Open Label Phase|Adverse Event|0
7853504|NCT01515423|12336990|FG000|Open Label Phase|Death|2
7853505|NCT01515423|12336991|FG001|Open Label Phase|Death|0
7853506|NCT01515423|12336992|FG002|Open Label Phase|Death|0
7853507|NCT01515423|12336990|FG000|Open Label Phase|Lack of Efficacy|117
7853508|NCT01515423|12336991|FG001|Open Label Phase|Lack of Efficacy|0
7853509|NCT01515423|12336992|FG002|Open Label Phase|Lack of Efficacy|0
7853510|NCT01515423|12336990|FG000|Open Label Phase|Lost to Follow-up|21
7853511|NCT01515423|12336991|FG001|Open Label Phase|Lost to Follow-up|0
7853512|NCT01515423|12336992|FG002|Open Label Phase|Lost to Follow-up|0
7853513|NCT01515423|12336990|FG000|Open Label Phase|Withdrawal by Subject|118
7853514|NCT01515423|12336991|FG001|Open Label Phase|Withdrawal by Subject|0
7853515|NCT01515423|12336992|FG002|Open Label Phase|Withdrawal by Subject|0
7853516|NCT01515423|12336990|FG000|Open Label Phase|excluded from DB Phase|70
7853517|NCT01515423|12336991|FG001|Open Label Phase|excluded from DB Phase|0
7853518|NCT01515423|12336992|FG002|Open Label Phase|excluded from DB Phase|0
7853519|NCT01515423|12336990|FG000|Open Label Phase|Other|28
7853520|NCT01515423|12336991|FG001|Open Label Phase|Other|0
7853521|NCT01515423|12336992|FG002|Open Label Phase|Other|0
7853522|NCT01515423|12336990|FG000|DOUBLE BLIND|Adverse Event|0
7853523|NCT01515423|12336991|FG001|DOUBLE BLIND|Adverse Event|15
7853524|NCT01515423|12336992|FG002|DOUBLE BLIND|Adverse Event|13
7853525|NCT01515423|12336990|FG000|DOUBLE BLIND|Death|0
7853526|NCT01515423|12336991|FG001|DOUBLE BLIND|Death|1
7853527|NCT01515423|12336992|FG002|DOUBLE BLIND|Death|2
7853528|NCT01515423|12336990|FG000|DOUBLE BLIND|Lost to Follow-up|0
7853529|NCT01515423|12336991|FG001|DOUBLE BLIND|Lost to Follow-up|7
7853530|NCT01515423|12336992|FG002|DOUBLE BLIND|Lost to Follow-up|12
7853531|NCT01515423|12336990|FG000|DOUBLE BLIND|Pregnancy|0
7853532|NCT01515423|12336991|FG001|DOUBLE BLIND|Pregnancy|2
7853533|NCT01515423|12336992|FG002|DOUBLE BLIND|Pregnancy|0
7853534|NCT01515423|12336990|FG000|DOUBLE BLIND|Withdrawal by Subject|0
7853535|NCT01515423|12336991|FG001|DOUBLE BLIND|Withdrawal by Subject|50
7853536|NCT01515423|12336992|FG002|DOUBLE BLIND|Withdrawal by Subject|53
7853537|NCT01515423|12336990|FG000|DOUBLE BLIND|Other|0
7853538|NCT01515423|12336991|FG001|DOUBLE BLIND|Other|6
7853539|NCT01515423|12336992|FG002|DOUBLE BLIND|Other|12
7853540|NCT01515423|12336990|FG000|DOUBLE BLIND|Blind broken by investigator|0
7853541|NCT01515423|12336991|FG001|DOUBLE BLIND|Blind broken by investigator|1
7853542|NCT01515423|12336992|FG002|DOUBLE BLIND|Blind broken by investigator|0
7853543|NCT01515475|12337003|FG000|Overall Study|Lost to Follow-up|20
7853544|NCT01515475|12337004|FG001|Overall Study|Lost to Follow-up|15
7853545|NCT01515475|12337005|FG002|Overall Study|Lost to Follow-up|12
7853546|NCT01515475|12337006|FG003|Overall Study|Lost to Follow-up|12
7853547|NCT01515865|12337062|FG000|Part A (Open-label)|Other|3
7853548|NCT01515865|12337063|FG001|Part A (Open-label)|Other|0
7853549|NCT01515865|12337064|FG002|Part A (Open-label)|Other|0
7853550|NCT01515865|12337062|FG000|Part B (Open-label)|Withdrawal by Subject|1
7853551|NCT01515865|12337063|FG001|Part B (Open-label)|Withdrawal by Subject|0
7853552|NCT01515865|12337064|FG002|Part B (Open-label)|Withdrawal by Subject|0
7853553|NCT01515865|12337062|FG000|Part B (Open-label)|Other|1
7853554|NCT01515865|12337063|FG001|Part B (Open-label)|Other|0
7853555|NCT01515865|12337064|FG002|Part B (Open-label)|Other|0
7853556|NCT01516008|12337108|FG000|Overall Study|Adverse Event|0
7853557|NCT01516008|12337109|FG001|Overall Study|Adverse Event|2
7853558|NCT01516008|12337110|FG002|Overall Study|Adverse Event|7
7853559|NCT01516008|12337108|FG000|Overall Study|Lack of Efficacy|44
7853560|NCT01516008|12337109|FG001|Overall Study|Lack of Efficacy|14
7853561|NCT01516008|12337110|FG002|Overall Study|Lack of Efficacy|10
7853562|NCT01516008|12337108|FG000|Overall Study|Protocol Violation|1
7853563|NCT01516008|12337109|FG001|Overall Study|Protocol Violation|0
7853564|NCT01516008|12337110|FG002|Overall Study|Protocol Violation|0
7853565|NCT01516008|12337108|FG000|Overall Study|Reason not specified|0
7853566|NCT01516008|12337109|FG001|Overall Study|Reason not specified|0
7853567|NCT01516008|12337110|FG002|Overall Study|Reason not specified|1
7853568|NCT01516437|12337140|FG000|Overall Study|Reason not specified|0
7853569|NCT01516437|12337141|FG001|Overall Study|Reason not specified|0
7853570|NCT01516437|12337142|FG002|Overall Study|Reason not specified|1
7853571|NCT01516437|12337143|FG003|Overall Study|Reason not specified|1
7853572|NCT01516736|12337179|FG000|Overall Study|Withdrawal by Subject|10
7853573|NCT01516736|12337180|FG001|Overall Study|Withdrawal by Subject|4
7853574|NCT01516736|12337179|FG000|Overall Study|Adverse Event|4
7853575|NCT01516736|12337180|FG001|Overall Study|Adverse Event|5
7853576|NCT01516736|12337179|FG000|Overall Study|Death|3
7853577|NCT01516736|12337180|FG001|Overall Study|Death|1
7853578|NCT01516736|12337179|FG000|Overall Study|Physician Decision|2
7853579|NCT01516736|12337180|FG001|Overall Study|Physician Decision|1
7853580|NCT01516736|12337179|FG000|Overall Study|Lack of Efficacy|1
7853581|NCT01516736|12337180|FG001|Overall Study|Lack of Efficacy|0
7853582|NCT01516736|12337179|FG000|Overall Study|Protocol Violation|0
7853583|NCT01516736|12337180|FG001|Overall Study|Protocol Violation|1
7853584|NCT01516736|12337179|FG000|Overall Study|Other (not specified)|0
7853585|NCT01516736|12337180|FG001|Overall Study|Other (not specified)|1
7853586|NCT01516749|12337186|FG000|Active Therapy|Lost to Follow-up|1
7853587|NCT01516749|12337186|FG000|Follow-up Off Therapy|Lost to Follow-up|1
7853588|NCT01516892|12337190|FG000|Overall Study|Adverse Event|25
7853589|NCT01516892|12337190|FG000|Overall Study|Lack of Efficacy|35
7853590|NCT01516892|12337190|FG000|Overall Study|Pregnancy|5
7853591|NCT01516892|12337190|FG000|Overall Study|Lost to Follow-up|82
7853592|NCT01516892|12337190|FG000|Overall Study|Subject Withdrew Consent|92
7853593|NCT01516892|12337190|FG000|Overall Study|Protocol Violation|60
7853594|NCT01516892|12337190|FG000|Overall Study|Other Miscellaneous Reasons|43
7853595|NCT01516892|12337190|FG000|Overall Study|Missing|1
7853596|NCT01516970|12337211|FG000|Overall Study|Lost to Follow-up|7
7853597|NCT01516970|12337212|FG001|Overall Study|Lost to Follow-up|8
7853598|NCT01516970|12337211|FG000|Overall Study|Adverse Event|1
7853599|NCT01516970|12337212|FG001|Overall Study|Adverse Event|5
7853600|NCT01516970|12337211|FG000|Overall Study|Withdrawal by Subject|1
7853601|NCT01516970|12337212|FG001|Overall Study|Withdrawal by Subject|1
7853602|NCT01516970|12337211|FG000|Overall Study|Other|9
7853603|NCT01516970|12337212|FG001|Overall Study|Other|7
7853604|NCT01517178|12337227|FG000|Period 1|Adverse Event|1
7853605|NCT01517178|12337228|FG001|Period 1|Adverse Event|2
7853606|NCT01517178|12337227|FG000|Period 1|Lack of Efficacy|0
7853607|NCT01517178|12337228|FG001|Period 1|Lack of Efficacy|1
7853608|NCT01517178|12337227|FG000|Period 1|E.g. study termination|3
7853609|NCT01517178|12337228|FG001|Period 1|E.g. study termination|1
7853610|NCT01517178|12337227|FG000|Period 1|Withdrawal by Subject|0
7853611|NCT01517178|12337228|FG001|Period 1|Withdrawal by Subject|1
7853612|NCT01517178|12337227|FG000|Period 2|Adverse Event|1
7853613|NCT01517178|12337228|FG001|Period 2|Adverse Event|0
7853614|NCT01517178|12337227|FG000|Period 2|Withdrawal by Subject|3
7853615|NCT01517178|12337228|FG001|Period 2|Withdrawal by Subject|0
7853616|NCT01517178|12337227|FG000|Period 2|E.g. study termination|2
7853617|NCT01517178|12337228|FG001|Period 2|E.g. study termination|2
7853618|NCT01517282|12337238|FG000|Overall Study|Consent withdrawn|0
7853619|NCT01517282|12337239|FG001|Overall Study|Consent withdrawn|1
7853620|NCT01517282|12337240|FG002|Overall Study|Consent withdrawn|1
7853621|NCT01517282|12337241|FG003|Overall Study|Consent withdrawn|1
7853622|NCT01517282|12337238|FG000|Overall Study|Physician Decision|1
7853623|NCT01517282|12337239|FG001|Overall Study|Physician Decision|0
7853624|NCT01517282|12337240|FG002|Overall Study|Physician Decision|0
7853625|NCT01517282|12337241|FG003|Overall Study|Physician Decision|0
7853626|NCT01517295|12337253|FG000|Overall Study|Physician Decision|1
7853627|NCT01517295|12337254|FG001|Overall Study|Physician Decision|0
7853628|NCT01517373|12337265|FG000|Run-in Period|Death|1
7853629|NCT01517373|12337266|FG001|Run-in Period|Death|0
7853630|NCT01517373|12337267|FG002|Run-in Period|Death|0
7853631|NCT01517373|12337268|FG003|Run-in Period|Death|0
7853632|NCT01517373|12337269|FG004|Run-in Period|Death|0
7853633|NCT01517373|12337270|FG005|Run-in Period|Death|0
7853634|NCT01517373|12337265|FG000|Run-in Period|Adverse Event|5
7853635|NCT01517373|12337266|FG001|Run-in Period|Adverse Event|0
7853636|NCT01517373|12337267|FG002|Run-in Period|Adverse Event|0
7853637|NCT01517373|12337268|FG003|Run-in Period|Adverse Event|0
7853638|NCT01517373|12337269|FG004|Run-in Period|Adverse Event|0
7853639|NCT01517373|12337270|FG005|Run-in Period|Adverse Event|0
7853640|NCT01517373|12337265|FG000|Run-in Period|Did not meet eligibility criteria|34
7853641|NCT01517373|12337266|FG001|Run-in Period|Did not meet eligibility criteria|0
7853642|NCT01517373|12337267|FG002|Run-in Period|Did not meet eligibility criteria|0
7853643|NCT01517373|12337268|FG003|Run-in Period|Did not meet eligibility criteria|0
7853644|NCT01517373|12337269|FG004|Run-in Period|Did not meet eligibility criteria|0
7853645|NCT01517373|12337270|FG005|Run-in Period|Did not meet eligibility criteria|0
7853646|NCT01517373|12337265|FG000|Run-in Period|Lost to Follow-up|1
7853647|NCT01517373|12337266|FG001|Run-in Period|Lost to Follow-up|0
7853648|NCT01517373|12337267|FG002|Run-in Period|Lost to Follow-up|0
7853649|NCT01517373|12337268|FG003|Run-in Period|Lost to Follow-up|0
7853650|NCT01517373|12337269|FG004|Run-in Period|Lost to Follow-up|0
7853651|NCT01517373|12337270|FG005|Run-in Period|Lost to Follow-up|0
7853652|NCT01517373|12337265|FG000|Run-in Period|Withdrawal by Subject|12
7853653|NCT01517373|12337266|FG001|Run-in Period|Withdrawal by Subject|0
7853654|NCT01517373|12337267|FG002|Run-in Period|Withdrawal by Subject|0
7853655|NCT01517373|12337268|FG003|Run-in Period|Withdrawal by Subject|0
7853656|NCT01517373|12337269|FG004|Run-in Period|Withdrawal by Subject|0
7853657|NCT01517373|12337270|FG005|Run-in Period|Withdrawal by Subject|0
7853658|NCT01517373|12337265|FG000|Run-in Period|Sponsor Decision|3
7853659|NCT01517373|12337266|FG001|Run-in Period|Sponsor Decision|0
7853660|NCT01517373|12337267|FG002|Run-in Period|Sponsor Decision|0
7853661|NCT01517373|12337268|FG003|Run-in Period|Sponsor Decision|0
7853662|NCT01517373|12337269|FG004|Run-in Period|Sponsor Decision|0
7853663|NCT01517373|12337270|FG005|Run-in Period|Sponsor Decision|0
7853664|NCT01517373|12337265|FG000|Run-in Period|Other|1
7853665|NCT01517373|12337266|FG001|Run-in Period|Other|0
7853666|NCT01517373|12337267|FG002|Run-in Period|Other|0
7853667|NCT01517373|12337268|FG003|Run-in Period|Other|0
7853668|NCT01517373|12337269|FG004|Run-in Period|Other|0
7853669|NCT01517373|12337270|FG005|Run-in Period|Other|0
7853670|NCT01517373|12337265|FG000|Treatment Period|Adverse Event|0
7853671|NCT01517373|12337266|FG001|Treatment Period|Adverse Event|0
7853672|NCT01517373|12337267|FG002|Treatment Period|Adverse Event|0
7853673|NCT01517373|12337268|FG003|Treatment Period|Adverse Event|0
7853674|NCT01517373|12337269|FG004|Treatment Period|Adverse Event|0
7853675|NCT01517373|12337270|FG005|Treatment Period|Adverse Event|2
7949549|NCT02539368|12495259|FG003|Overall Study|Withdrawal by Subject|1
7949550|NCT02539368|12495260|FG004|Overall Study|Withdrawal by Subject|3
7853676|NCT01517373|12337265|FG000|Treatment Period|Lost to Follow-up|0
7853677|NCT01517373|12337266|FG001|Treatment Period|Lost to Follow-up|0
7853678|NCT01517373|12337267|FG002|Treatment Period|Lost to Follow-up|1
7949551|NCT02539368|12495256|FG000|Overall Study|Physician Decision|49
7949552|NCT02539368|12495257|FG001|Overall Study|Physician Decision|15
7949553|NCT02539368|12495258|FG002|Overall Study|Physician Decision|7
7949554|NCT02539368|12495259|FG003|Overall Study|Physician Decision|0
7949555|NCT02539368|12495260|FG004|Overall Study|Physician Decision|2
7949556|NCT02539368|12495256|FG000|Overall Study|Lost to Follow-up|96
7949557|NCT02539368|12495257|FG001|Overall Study|Lost to Follow-up|21
7949558|NCT02539368|12495258|FG002|Overall Study|Lost to Follow-up|16
7949559|NCT02539368|12495259|FG003|Overall Study|Lost to Follow-up|4
7949560|NCT02539368|12495260|FG004|Overall Study|Lost to Follow-up|3
7949561|NCT02539368|12495256|FG000|Overall Study|Adverse Event|44
7949562|NCT02539368|12495257|FG001|Overall Study|Adverse Event|5
7949563|NCT02539368|12495258|FG002|Overall Study|Adverse Event|9
7949564|NCT02539368|12495259|FG003|Overall Study|Adverse Event|0
7949565|NCT02539368|12495260|FG004|Overall Study|Adverse Event|3
7949566|NCT02539368|12495256|FG000|Overall Study|Participant Non-compliant|13
7949567|NCT02539368|12495257|FG001|Overall Study|Participant Non-compliant|2
7949568|NCT02539368|12495258|FG002|Overall Study|Participant Non-compliant|1
7949569|NCT02539368|12495259|FG003|Overall Study|Participant Non-compliant|1
7949570|NCT02539368|12495260|FG004|Overall Study|Participant Non-compliant|0
7949571|NCT02539368|12495256|FG000|Overall Study|Other|145
7949572|NCT02539368|12495257|FG001|Overall Study|Other|18
7949573|NCT02539368|12495258|FG002|Overall Study|Other|24
7949574|NCT02539368|12495259|FG003|Overall Study|Other|1
7853679|NCT01517373|12337268|FG003|Treatment Period|Lost to Follow-up|1
7853680|NCT01517373|12337269|FG004|Treatment Period|Lost to Follow-up|0
7853681|NCT01517373|12337270|FG005|Treatment Period|Lost to Follow-up|0
7853682|NCT01517373|12337265|FG000|Treatment Period|Withdrawal by Subject|0
7853683|NCT01517373|12337266|FG001|Treatment Period|Withdrawal by Subject|3
7853684|NCT01517373|12337267|FG002|Treatment Period|Withdrawal by Subject|2
7853685|NCT01517373|12337268|FG003|Treatment Period|Withdrawal by Subject|2
7853686|NCT01517373|12337269|FG004|Treatment Period|Withdrawal by Subject|2
7853687|NCT01517373|12337270|FG005|Treatment Period|Withdrawal by Subject|3
7853688|NCT01517373|12337265|FG000|Treatment Period|Other|0
7853689|NCT01517373|12337266|FG001|Treatment Period|Other|0
7853690|NCT01517373|12337267|FG002|Treatment Period|Other|0
7853691|NCT01517373|12337268|FG003|Treatment Period|Other|0
7853692|NCT01517373|12337269|FG004|Treatment Period|Other|1
7853693|NCT01517373|12337270|FG005|Treatment Period|Other|0
7853694|NCT01517373|12337265|FG000|Treatment Period|Protocol Violation|0
7853695|NCT01517373|12337266|FG001|Treatment Period|Protocol Violation|0
7853696|NCT01517373|12337267|FG002|Treatment Period|Protocol Violation|0
7853697|NCT01517373|12337268|FG003|Treatment Period|Protocol Violation|0
7853698|NCT01517373|12337269|FG004|Treatment Period|Protocol Violation|1
7853699|NCT01517373|12337270|FG005|Treatment Period|Protocol Violation|0
7853700|NCT01517373|12337265|FG000|Treatment Period|Lack of Efficacy|0
7853701|NCT01517373|12337266|FG001|Treatment Period|Lack of Efficacy|1
7853702|NCT01517373|12337267|FG002|Treatment Period|Lack of Efficacy|1
7853703|NCT01517373|12337268|FG003|Treatment Period|Lack of Efficacy|3
7853704|NCT01517373|12337269|FG004|Treatment Period|Lack of Efficacy|2
7853705|NCT01517373|12337270|FG005|Treatment Period|Lack of Efficacy|0
7853706|NCT01517373|12337265|FG000|Treatment Period|Medication error without AEs|0
7853707|NCT01517373|12337266|FG001|Treatment Period|Medication error without AEs|0
7853708|NCT01517373|12337267|FG002|Treatment Period|Medication error without AEs|2
7853709|NCT01517373|12337268|FG003|Treatment Period|Medication error without AEs|1
7853710|NCT01517373|12337269|FG004|Treatment Period|Medication error without AEs|0
7853711|NCT01517373|12337270|FG005|Treatment Period|Medication error without AEs|2
7853712|NCT01517412|12337285|FG000|Overall Study|Adverse Event|10
7853713|NCT01517412|12337286|FG001|Overall Study|Adverse Event|11
7853714|NCT01517412|12337285|FG000|Overall Study|Lack of Efficacy|10
7853715|NCT01517412|12337286|FG001|Overall Study|Lack of Efficacy|5
7853716|NCT01517412|12337285|FG000|Overall Study|Poor compliance to protocol|8
7853717|NCT01517412|12337286|FG001|Overall Study|Poor compliance to protocol|3
7853718|NCT01517412|12337285|FG000|Overall Study|Other than specified above|8
7853719|NCT01517412|12337286|FG001|Overall Study|Other than specified above|5
7853720|NCT01517750|12337300|FG000|Overall Study|Lost to Follow-up|1
7853721|NCT01517750|12337301|FG001|Overall Study|Lost to Follow-up|2
7853722|NCT01517750|12337302|FG002|Overall Study|Lost to Follow-up|4
7853723|NCT01517750|12337303|FG003|Overall Study|Lost to Follow-up|1
7853724|NCT01517867|12337319|FG000|Overall Study|never started treatment|29
7853725|NCT01517867|12337320|FG001|Overall Study|never started treatment|32
7853726|NCT01517867|12337319|FG000|Overall Study|Withdrawal by Subject|34
7853727|NCT01517867|12337320|FG001|Overall Study|Withdrawal by Subject|30
7853728|NCT01517867|12337319|FG000|Overall Study|Still in treatment at study end|0
7853729|NCT01517867|12337320|FG001|Overall Study|Still in treatment at study end|3
7853730|NCT01517893|12337328|FG000|Overall Study|Withdrawal by Subject|3
7853731|NCT01517893|12337329|FG001|Overall Study|Withdrawal by Subject|0
7853732|NCT01517984|12337338|FG000|Overall Study|Lost to Follow-up|0
7853733|NCT01517984|12337339|FG001|Overall Study|Lost to Follow-up|1
7853734|NCT01517984|12337340|FG002|Overall Study|Lost to Follow-up|0
7853735|NCT01517984|12337341|FG003|Overall Study|Lost to Follow-up|0
7853736|NCT01517984|12337338|FG000|Overall Study|Withdrawal by Subject|1
7853737|NCT01517984|12337339|FG001|Overall Study|Withdrawal by Subject|8
7853738|NCT01517984|12337340|FG002|Overall Study|Withdrawal by Subject|4
7853739|NCT01517984|12337341|FG003|Overall Study|Withdrawal by Subject|1
7853740|NCT01517984|12337338|FG000|Overall Study|Screen Failure|4
7853741|NCT01517984|12337339|FG001|Overall Study|Screen Failure|0
7853742|NCT01517984|12337340|FG002|Overall Study|Screen Failure|0
7853743|NCT01517984|12337341|FG003|Overall Study|Screen Failure|0
7853744|NCT01517984|12337338|FG000|Overall Study|Ineligible for randomization|0
7853745|NCT01517984|12337339|FG001|Overall Study|Ineligible for randomization|14
7853746|NCT01517984|12337340|FG002|Overall Study|Ineligible for randomization|0
7853747|NCT01517984|12337341|FG003|Overall Study|Ineligible for randomization|0
7853748|NCT01518153|12337348|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
7853749|NCT01518153|12337349|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
7853750|NCT01518153|12337350|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
7853751|NCT01518153|12337348|FG000|Stem Cell Transplant|Death|2
7853752|NCT01518153|12337349|FG001|Stem Cell Transplant|Death|0
7853753|NCT01518153|12337350|FG002|Stem Cell Transplant|Death|0
7853754|NCT01518153|12337348|FG000|Stem Cell Transplant|Secondary graft failure|1
7853755|NCT01518153|12337349|FG001|Stem Cell Transplant|Secondary graft failure|0
7853756|NCT01518153|12337350|FG002|Stem Cell Transplant|Secondary graft failure|0
7853757|NCT01518153|12337348|FG000|Stem Cell Transplant|Adverse Event|1
7853758|NCT01518153|12337349|FG001|Stem Cell Transplant|Adverse Event|0
7853759|NCT01518153|12337350|FG002|Stem Cell Transplant|Adverse Event|0
7853760|NCT01518153|12337348|FG000|Donor Lymphocyte Infusion|Death|0
7853761|NCT01518153|12337349|FG001|Donor Lymphocyte Infusion|Death|2
7853762|NCT01518153|12337350|FG002|Donor Lymphocyte Infusion|Death|1
7853763|NCT01518192|12337361|FG000|Overall Study|Lost to Follow-up|29
7853764|NCT01518192|12337362|FG001|Overall Study|Lost to Follow-up|26
7853765|NCT01518192|12337363|FG002|Overall Study|Lost to Follow-up|35
7853766|NCT01518244|12337377|FG000|Overall Study|Adverse Event|3
7853767|NCT01518257|12337383|FG000|Overall Study|Lost to Follow-up|1
7853768|NCT01518257|12337384|FG001|Overall Study|Lost to Follow-up|0
7853769|NCT01518257|12337383|FG000|Overall Study|Other Miscellaneous Reason|1
7853770|NCT01518257|12337384|FG001|Overall Study|Other Miscellaneous Reason|0
7853771|NCT01518309|12337394|FG000|Overall Study|Adverse Event|6
7853772|NCT01518309|12337394|FG000|Overall Study|Death|6
7853773|NCT01518309|12337394|FG000|Overall Study|Lack of Efficacy|7
7853774|NCT01518309|12337394|FG000|Overall Study|Withdrawal by Subject|6
7853775|NCT01518309|12337394|FG000|Overall Study|Physician Decision|3
7853776|NCT01518309|12337394|FG000|Overall Study|Sponsor Decision|2
7853777|NCT01518309|12337394|FG000|Overall Study|Not in Predefined Categories|9
7853778|NCT01518322|12337398|FG000|Overall Study|FeNO measurement was missing|13
7853779|NCT01518374|12337407|FG000|Overall Study|Withdrawal by Subject|2
7853780|NCT01518374|12337407|FG000|Overall Study|Protocol Violation|3
7853781|NCT01518374|12337407|FG000|Overall Study|Lost to Follow-up|2
7853782|NCT01518699|12337421|FG000|Period 2|Protocol Violation|1
7853783|NCT01518699|12337422|FG001|Period 2|Protocol Violation|1
7853784|NCT01518699|12337423|FG002|Period 2|Protocol Violation|0
7853785|NCT01518699|12337424|FG003|Period 2|Protocol Violation|0
7853786|NCT01518699|12337425|FG004|Period 2|Protocol Violation|0
7853787|NCT01518699|12337426|FG005|Period 2|Protocol Violation|0
7853788|NCT01518699|12337421|FG000|Period 2|Lost to Follow-up|0
7853789|NCT01518699|12337422|FG001|Period 2|Lost to Follow-up|1
7853790|NCT01518699|12337423|FG002|Period 2|Lost to Follow-up|0
7853791|NCT01518699|12337424|FG003|Period 2|Lost to Follow-up|0
7853792|NCT01518699|12337425|FG004|Period 2|Lost to Follow-up|0
7853793|NCT01518699|12337426|FG005|Period 2|Lost to Follow-up|0
7853794|NCT01518699|12337421|FG000|Period 2|Adverse Event|1
7853795|NCT01518699|12337422|FG001|Period 2|Adverse Event|0
7853796|NCT01518699|12337423|FG002|Period 2|Adverse Event|0
7853797|NCT01518699|12337424|FG003|Period 2|Adverse Event|0
7853798|NCT01518699|12337425|FG004|Period 2|Adverse Event|0
7853799|NCT01518699|12337426|FG005|Period 2|Adverse Event|0
7853800|NCT01518946|12337443|FG000|Open-label Phase|Other|4
7853801|NCT01518946|12337444|FG001|Open-label Phase|Other|0
7853802|NCT01518946|12337445|FG002|Open-label Phase|Other|0
7853803|NCT01518946|12337443|FG000|Randomized Phase (First Intervention)|Other|0
7853804|NCT01518946|12337444|FG001|Randomized Phase (First Intervention)|Other|1
7853805|NCT01518946|12337445|FG002|Randomized Phase (First Intervention)|Other|0
7853806|NCT01518972|12337454|FG000|Overall Study|Lost to Follow-up|2
7853807|NCT01518972|12337455|FG001|Overall Study|Lost to Follow-up|1
7853808|NCT01518972|12337454|FG000|Overall Study|Withdrawal by Subject|1
7853809|NCT01518972|12337455|FG001|Overall Study|Withdrawal by Subject|0
7853810|NCT01518972|12337454|FG000|Overall Study|Moved from area|1
7853811|NCT01518972|12337455|FG001|Overall Study|Moved from area|0
7853812|NCT01518972|12337454|FG000|Overall Study|Transportation problems|1
7853813|NCT01518972|12337455|FG001|Overall Study|Transportation problems|0
7853814|NCT01518972|12337454|FG000|Overall Study|Exclusionary medical condition|1
7853815|NCT01518972|12337455|FG001|Overall Study|Exclusionary medical condition|0
7853816|NCT01518972|12337454|FG000|Overall Study|Missed safety visits|0
7853817|NCT01518972|12337455|FG001|Overall Study|Missed safety visits|1
7853818|NCT01518972|12337454|FG000|Overall Study|Exclusionary medication|0
7853819|NCT01518972|12337455|FG001|Overall Study|Exclusionary medication|1
7853820|NCT01518972|12337454|FG000|Overall Study|Declined medication starting on day 12|0
7853821|NCT01518972|12337455|FG001|Overall Study|Declined medication starting on day 12|1
7853822|NCT01519089|12337472|FG000|Overall Study|Adverse Event|4
7853823|NCT01519089|12337473|FG001|Overall Study|Adverse Event|4
7853824|NCT01519089|12337472|FG000|Overall Study|Lack of Efficacy|0
7853825|NCT01519089|12337473|FG001|Overall Study|Lack of Efficacy|2
7853826|NCT01519089|12337472|FG000|Overall Study|Lost to Follow-up|1
7853827|NCT01519089|12337473|FG001|Overall Study|Lost to Follow-up|0
7853828|NCT01519089|12337472|FG000|Overall Study|Withdrawal by Subject|0
7853829|NCT01519089|12337473|FG001|Overall Study|Withdrawal by Subject|2
7853830|NCT01519089|12337472|FG000|Overall Study|Other|2
7853831|NCT01519089|12337473|FG001|Overall Study|Other|6
7853832|NCT01519089|12337472|FG000|Overall Study|Not received study drug|0
7853833|NCT01519089|12337473|FG001|Overall Study|Not received study drug|1
7853834|NCT01519167|12337483|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
7853835|NCT01519167|12337484|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
7853836|NCT01519167|12337483|FG000|Overall Study|Adverse Event|0
7853837|NCT01519167|12337484|FG001|Overall Study|Adverse Event|1
7853838|NCT01519167|12337483|FG000|Overall Study|Lack of Efficacy|0
7853839|NCT01519167|12337484|FG001|Overall Study|Lack of Efficacy|1
7853840|NCT01519167|12337483|FG000|Overall Study|Medical condition changes&deep sedation|0
7853841|NCT01519167|12337484|FG001|Overall Study|Medical condition changes&deep sedation|2
7853842|NCT01519167|12337483|FG000|Overall Study|Physician Decision|0
7853843|NCT01519167|12337484|FG001|Overall Study|Physician Decision|1
7853844|NCT01519206|12337490|FG000|Overall Study|Lost to Follow-up|3
7853845|NCT01519206|12337490|FG000|Overall Study|Missed Visit|2
7853846|NCT01519245|12337503|FG000|Overall Study|Met exclusion criteria, not analysed|1
7853847|NCT01519245|12337504|FG001|Overall Study|Met exclusion criteria, not analysed|2
7853848|NCT01519323|12337544|FG000|Overall Study|Death|3
7853849|NCT01519323|12337545|FG001|Overall Study|Death|2
7853850|NCT01519323|12337544|FG000|Overall Study|Study terminated by sponsor|0
7853851|NCT01519323|12337545|FG001|Overall Study|Study terminated by sponsor|1
7853852|NCT01519427|12337566|FG000|Overall Study|disease progression|2
7853853|NCT01519518|12337590|FG000|Overall Study|Consent not available|7
7853854|NCT01519518|12337591|FG001|Overall Study|Consent not available|10
7853855|NCT01519635|12337608|FG000|Overall Study|Withdrawal by Subject|0
7853856|NCT01519635|12337609|FG001|Overall Study|Withdrawal by Subject|1
7853857|NCT01519635|12337608|FG000|Overall Study|No possibility to put a catheter|1
7853858|NCT01519635|12337609|FG001|Overall Study|No possibility to put a catheter|2
7853859|NCT01519661|12337624|FG000|Overall Study|Protocol deviation|6
7853860|NCT01519661|12337624|FG000|Overall Study|Lost to Follow-up|3
7853861|NCT01519661|12337624|FG000|Overall Study|Withdrawal by Subject|17
7853862|NCT01519661|12337624|FG000|Overall Study|Lack of Efficacy|6
7853863|NCT01519661|12337624|FG000|Overall Study|Adverse Event|29
7853864|NCT01519674|12337632|FG000|Overall Study|Adverse Event|3
7853865|NCT01519674|12337633|FG001|Overall Study|Adverse Event|3
7853866|NCT01519674|12337634|FG002|Overall Study|Adverse Event|0
7853867|NCT01519674|12337632|FG000|Overall Study|Lack of Efficacy|1
7853868|NCT01519674|12337633|FG001|Overall Study|Lack of Efficacy|1
7853869|NCT01519674|12337634|FG002|Overall Study|Lack of Efficacy|1
7853870|NCT01519674|12337632|FG000|Overall Study|Protocol Violation|0
7853871|NCT01519674|12337633|FG001|Overall Study|Protocol Violation|3
7853872|NCT01519674|12337634|FG002|Overall Study|Protocol Violation|1
7853873|NCT01519674|12337632|FG000|Overall Study|Withdrawal Criteria|7
7853874|NCT01519674|12337633|FG001|Overall Study|Withdrawal Criteria|2
7853875|NCT01519674|12337634|FG002|Overall Study|Withdrawal Criteria|7
7853876|NCT01519674|12337632|FG000|Overall Study|Unsclassified|10
7853877|NCT01519674|12337633|FG001|Overall Study|Unsclassified|4
7853878|NCT01519674|12337634|FG002|Overall Study|Unsclassified|3
7853879|NCT01519700|12337646|FG000|Overall Study|Death|1
7853880|NCT01519700|12337647|FG001|Overall Study|Death|0
7853881|NCT01519700|12337648|FG002|Overall Study|Death|0
7853882|NCT01519700|12337649|FG003|Overall Study|Death|0
7853883|NCT01519700|12337646|FG000|Overall Study|Lost to Follow-up|0
7853884|NCT01519700|12337647|FG001|Overall Study|Lost to Follow-up|0
7853885|NCT01519700|12337648|FG002|Overall Study|Lost to Follow-up|1
7853886|NCT01519700|12337649|FG003|Overall Study|Lost to Follow-up|1
7853887|NCT01519700|12337646|FG000|Overall Study|Physician Decision|1
7853888|NCT01519700|12337647|FG001|Overall Study|Physician Decision|1
7853889|NCT01519700|12337648|FG002|Overall Study|Physician Decision|3
7853890|NCT01519700|12337649|FG003|Overall Study|Physician Decision|0
7853891|NCT01519700|12337646|FG000|Overall Study|Withdrawal by Subject|5
7853892|NCT01519700|12337647|FG001|Overall Study|Withdrawal by Subject|3
7853893|NCT01519700|12337648|FG002|Overall Study|Withdrawal by Subject|3
7853894|NCT01519700|12337649|FG003|Overall Study|Withdrawal by Subject|2
7853895|NCT01519700|12337646|FG000|Overall Study|Other Reason|2
7853896|NCT01519700|12337647|FG001|Overall Study|Other Reason|2
7853897|NCT01519700|12337648|FG002|Overall Study|Other Reason|0
7853898|NCT01519700|12337649|FG003|Overall Study|Other Reason|4
7853899|NCT01519765|12337680|FG000|Overall Study|Adverse Event|0
7853900|NCT01519765|12337681|FG001|Overall Study|Adverse Event|1
7853901|NCT01519765|12337680|FG000|Overall Study|Lack of Efficacy|2
7853902|NCT01519765|12337681|FG001|Overall Study|Lack of Efficacy|0
7853903|NCT01519765|12337680|FG000|Overall Study|Protocol Violation|1
7853904|NCT01519765|12337681|FG001|Overall Study|Protocol Violation|0
7853905|NCT01519765|12337680|FG000|Overall Study|Withdrawal by Subject|0
7853906|NCT01519765|12337681|FG001|Overall Study|Withdrawal by Subject|1
7853907|NCT01519778|12337688|FG000|Overall Study|Withdrawal by Subject|3
7853908|NCT01519778|12337688|FG000|Overall Study|Lost to Follow-up|10
7853909|NCT01519778|12337688|FG000|Overall Study|Physician Decision|1
7853910|NCT01519791|12337694|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
7853911|NCT01519791|12337695|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
7853912|NCT01519791|12337694|FG000|Overall Study|Protocol Violation|6
7853913|NCT01519791|12337695|FG001|Overall Study|Protocol Violation|19
7853914|NCT01519791|12337694|FG000|Overall Study|Other Reason|87
7853915|NCT01519791|12337695|FG001|Overall Study|Other Reason|222
7853916|NCT01519791|12337694|FG000|Overall Study|subjects randomized in error|2
7853917|NCT01519791|12337695|FG001|Overall Study|subjects randomized in error|0
7853918|NCT01519791|12337694|FG000|Overall Study|Lack of Efficacy|16
7853919|NCT01519791|12337695|FG001|Overall Study|Lack of Efficacy|20
7853920|NCT01519791|12337694|FG000|Overall Study|SAE, non-fatal|6
7853921|NCT01519791|12337695|FG001|Overall Study|SAE, non-fatal|22
7853922|NCT01519791|12337694|FG000|Overall Study|AE, serious fatal|0
7853923|NCT01519791|12337695|FG001|Overall Study|AE, serious fatal|1
7853924|NCT01519791|12337694|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0
7853925|NCT01519791|12337695|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1
7853926|NCT01519791|12337694|FG000|Overall Study|AE, non-serious non-fatal|12
7853927|NCT01519791|12337695|FG001|Overall Study|AE, non-serious non-fatal|31
7853928|NCT01519791|12337694|FG000|Overall Study|Withdrawal by Subject|15
7853929|NCT01519791|12337695|FG001|Overall Study|Withdrawal by Subject|37
7853930|NCT01519791|12337694|FG000|Overall Study|Lost to Follow-up|6
7853931|NCT01519791|12337695|FG001|Overall Study|Lost to Follow-up|14
7853932|NCT01519817|12337703|FG000|Overall Study|Withdrawal by Subject|1
7853933|NCT01519817|12337704|FG001|Overall Study|Withdrawal by Subject|0
7853934|NCT01519817|12337705|FG002|Overall Study|Withdrawal by Subject|0
7853935|NCT01519817|12337706|FG003|Overall Study|Withdrawal by Subject|0
7853936|NCT01519817|12337703|FG000|Overall Study|Off study due to infection|0
7853937|NCT01519817|12337704|FG001|Overall Study|Off study due to infection|0
7853938|NCT01519817|12337705|FG002|Overall Study|Off study due to infection|0
7853939|NCT01519817|12337706|FG003|Overall Study|Off study due to infection|1
7853940|NCT01519869|12337716|FG000|Overall Study|Lost to Follow-up|1
7853941|NCT01519921|12337731|FG000|Overall Study|Adverse Event|10
7853942|NCT01519921|12337732|FG001|Overall Study|Adverse Event|9
7853943|NCT01519921|12337731|FG000|Overall Study|Lack of Efficacy|4
7853944|NCT01519921|12337732|FG001|Overall Study|Lack of Efficacy|3
7853945|NCT01519921|12337731|FG000|Overall Study|Withdrawal by Subject|3
7853946|NCT01519921|12337732|FG001|Overall Study|Withdrawal by Subject|0
7853947|NCT01519921|12337731|FG000|Overall Study|Lost to Follow-up|2
7853948|NCT01519921|12337732|FG001|Overall Study|Lost to Follow-up|1
7853949|NCT01519921|12337731|FG000|Overall Study|Treatment refusal|2
7853950|NCT01519921|12337732|FG001|Overall Study|Treatment refusal|1
7853951|NCT01519921|12337731|FG000|Overall Study|High alanine aminotransferase (ALT)|0
7853952|NCT01519921|12337732|FG001|Overall Study|High alanine aminotransferase (ALT)|1
7863482|NCT01606202|12352815|FG000|Overall Study|Withdrawal by Subject|2
7863483|NCT01606202|12352816|FG001|Overall Study|Withdrawal by Subject|1
7863484|NCT01606202|12352815|FG000|Overall Study|Personal problems|0
7863485|NCT01606202|12352816|FG001|Overall Study|Personal problems|1
7863486|NCT01606202|12352815|FG000|Overall Study|Problems with administration|0
7863487|NCT01606202|12352816|FG001|Overall Study|Problems with administration|1
7863488|NCT01606228|12352822|FG000|Overall Study|Lost to Follow-up|20
7863489|NCT01606228|12352822|FG000|Overall Study|Withdrawal by Subject|3
7863490|NCT01606228|12352822|FG000|Overall Study|Non-compliant|3
7863491|NCT01606228|12352822|FG000|Overall Study|Lack of Efficacy|2
7863492|NCT01606228|12352822|FG000|Overall Study|Adverse Event|1
7863493|NCT01606254|12352830|FG000|Overall Study|Withdrawal by Subject|1
7863494|NCT01606254|12352831|FG001|Overall Study|Withdrawal by Subject|3
7863495|NCT01606254|12352832|FG002|Overall Study|Withdrawal by Subject|0
7863496|NCT01606254|12352833|FG003|Overall Study|Withdrawal by Subject|2
7863497|NCT01606254|12352830|FG000|Overall Study|Adverse Event|1
7863498|NCT01606254|12352831|FG001|Overall Study|Adverse Event|1
7863499|NCT01606254|12352832|FG002|Overall Study|Adverse Event|0
7863500|NCT01606254|12352833|FG003|Overall Study|Adverse Event|1
7863501|NCT01606306|12352849|FG000|Overall Study|Lack of Efficacy|2
7863502|NCT01606306|12352850|FG001|Overall Study|Lack of Efficacy|1
7863503|NCT01606306|12352851|FG002|Overall Study|Lack of Efficacy|4
7863504|NCT01606306|12352852|FG003|Overall Study|Lack of Efficacy|4
7863505|NCT01606306|12352853|FG004|Overall Study|Lack of Efficacy|1
7863506|NCT01606306|12352854|FG005|Overall Study|Lack of Efficacy|2
7863507|NCT01606306|12352849|FG000|Overall Study|Adverse Event|1
7863508|NCT01606306|12352850|FG001|Overall Study|Adverse Event|0
7853953|NCT01519934|12337738|FG000|Overall Study|Lost to Follow-up|3
7853954|NCT01519947|12337746|FG000|Overall Study|Death|0
7853955|NCT01519947|12337747|FG001|Overall Study|Death|0
7853956|NCT01519947|12337748|FG002|Overall Study|Death|0
7853957|NCT01519947|12337749|FG003|Overall Study|Death|1
7853958|NCT01519947|12337746|FG000|Overall Study|Protocol Violation|0
7853959|NCT01519947|12337747|FG001|Overall Study|Protocol Violation|0
7853960|NCT01519947|12337748|FG002|Overall Study|Protocol Violation|2
7853961|NCT01519947|12337749|FG003|Overall Study|Protocol Violation|1
7853962|NCT01519947|12337746|FG000|Overall Study|Peritoneal Dialysis Needed|0
7853963|NCT01519947|12337747|FG001|Overall Study|Peritoneal Dialysis Needed|1
7853964|NCT01519947|12337748|FG002|Overall Study|Peritoneal Dialysis Needed|0
7853965|NCT01519947|12337749|FG003|Overall Study|Peritoneal Dialysis Needed|0
7853966|NCT01519947|12337746|FG000|Overall Study|Development of Anemia|0
7853967|NCT01519947|12337747|FG001|Overall Study|Development of Anemia|1
7853968|NCT01519947|12337748|FG002|Overall Study|Development of Anemia|0
7853969|NCT01519947|12337749|FG003|Overall Study|Development of Anemia|1
7853970|NCT01519947|12337746|FG000|Overall Study|Blood Transfusion|0
7853971|NCT01519947|12337747|FG001|Overall Study|Blood Transfusion|1
7853972|NCT01519947|12337748|FG002|Overall Study|Blood Transfusion|1
7853973|NCT01519947|12337749|FG003|Overall Study|Blood Transfusion|0
7853974|NCT01519947|12337746|FG000|Overall Study|Withdrawal by Subject|0
7853975|NCT01519947|12337747|FG001|Overall Study|Withdrawal by Subject|1
7853976|NCT01519947|12337748|FG002|Overall Study|Withdrawal by Subject|0
7853977|NCT01519947|12337749|FG003|Overall Study|Withdrawal by Subject|1
7853978|NCT01519947|12337746|FG000|Overall Study|Lost to Follow-up|0
7853979|NCT01519947|12337747|FG001|Overall Study|Lost to Follow-up|0
7853980|NCT01519947|12337748|FG002|Overall Study|Lost to Follow-up|3
7853981|NCT01519947|12337749|FG003|Overall Study|Lost to Follow-up|2
7853982|NCT01519947|12337746|FG000|Overall Study|Poor Response|1
7853983|NCT01519947|12337747|FG001|Overall Study|Poor Response|0
7853984|NCT01519947|12337748|FG002|Overall Study|Poor Response|0
7853985|NCT01519947|12337749|FG003|Overall Study|Poor Response|1
7853986|NCT01519947|12337746|FG000|Overall Study|Adverse Event|1
7853987|NCT01519947|12337747|FG001|Overall Study|Adverse Event|0
7853988|NCT01519947|12337748|FG002|Overall Study|Adverse Event|1
7853989|NCT01519947|12337749|FG003|Overall Study|Adverse Event|1
7853990|NCT01520324|12337772|FG000|Overall Study|Subject discontinued (moderate illness)|1
7853991|NCT01520363|12337778|FG000|Overall Study|Withdrawal by Subject|2
7853992|NCT01520363|12337779|FG001|Overall Study|Withdrawal by Subject|0
7853993|NCT01520402|12337809|FG000|Overall Study|Withdrawal by Subject|2
7853994|NCT01520402|12337809|FG000|Overall Study|Physician Decision|3
7853995|NCT01520506|12337840|FG000|Overall Study|Missed Visit|4
7853996|NCT01520506|12337840|FG000|Overall Study|Lost to Follow-up|1
7853997|NCT01520506|12337840|FG000|Overall Study|Withdrawal by Subject|1
7853998|NCT01520870|12337916|FG000|Overall Study|Withdrawal by Subject|2
7853999|NCT01520909|12337922|FG000|Part 1 (Randomized Period)|Adverse Event|1
7854000|NCT01520909|12337923|FG001|Part 1 (Randomized Period)|Adverse Event|2
7854001|NCT01520909|12337924|FG002|Part 1 (Randomized Period)|Adverse Event|0
7854002|NCT01520909|12337922|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
7854003|NCT01520909|12337923|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
7854004|NCT01520909|12337924|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
7854005|NCT01520909|12337922|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
7854006|NCT01520909|12337923|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
7854007|NCT01520909|12337924|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
7854008|NCT01520909|12337922|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
7854009|NCT01520909|12337923|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
7854010|NCT01520909|12337924|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
7854011|NCT01520922|12337946|FG000|Treatment Phase|Physician Decision|2
7854012|NCT01520922|12337947|FG001|Treatment Phase|Physician Decision|1
7854013|NCT01520922|12337946|FG000|Treatment Phase|Progression|0
7854014|NCT01520922|12337947|FG001|Treatment Phase|Progression|2
7854015|NCT01520922|12337946|FG000|Treatment Phase|Adverse Event|3
7854016|NCT01520922|12337947|FG001|Treatment Phase|Adverse Event|5
7854017|NCT01520922|12337946|FG000|Follow up|Lost to Follow-up|0
7854018|NCT01520922|12337947|FG001|Follow up|Lost to Follow-up|1
7854019|NCT01520922|12337946|FG000|Survival Follow-up|Withdrawal by Subject|1
7854020|NCT01520922|12337947|FG001|Survival Follow-up|Withdrawal by Subject|0
7854021|NCT01520987|12337961|FG000|Overall Study|Withdrawal by Subject|1
7854022|NCT01520987|12337962|FG001|Overall Study|Withdrawal by Subject|0
7854023|NCT01520987|12337963|FG002|Overall Study|Withdrawal by Subject|0
7854024|NCT01520987|12337964|FG003|Overall Study|Withdrawal by Subject|0
7854025|NCT01520987|12337965|FG004|Overall Study|Withdrawal by Subject|0
7854026|NCT01520987|12337966|FG005|Overall Study|Withdrawal by Subject|1
7854027|NCT01520987|12337967|FG006|Overall Study|Withdrawal by Subject|0
7854028|NCT01520987|12337968|FG007|Overall Study|Withdrawal by Subject|0
7854029|NCT01521117|12337993|FG000|First Intervention (6 Weeks)|Adverse Event|5
7854030|NCT01521117|12337994|FG001|First Intervention (6 Weeks)|Adverse Event|1
7854031|NCT01521117|12337993|FG000|First Intervention (6 Weeks)|Scheduling Issues|0
7854032|NCT01521117|12337994|FG001|First Intervention (6 Weeks)|Scheduling Issues|2
7854033|NCT01521117|12337993|FG000|Second Intervention (6 Weeks)|Adverse Event|0
7854034|NCT01521117|12337994|FG001|Second Intervention (6 Weeks)|Adverse Event|3
7854035|NCT01521364|12338009|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
7854036|NCT01521364|12338009|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
7854037|NCT01521494|12338025|FG000|Overall Study|Adverse Event|1
7854038|NCT01521494|12338026|FG001|Overall Study|Adverse Event|2
7854039|NCT01521494|12338027|FG002|Overall Study|Adverse Event|9
7854040|NCT01521494|12338028|FG003|Overall Study|Adverse Event|6
7854041|NCT01521494|12338029|FG004|Overall Study|Adverse Event|2
7854042|NCT01521494|12338025|FG000|Overall Study|Lack of Efficacy|0
7854043|NCT01521494|12338026|FG001|Overall Study|Lack of Efficacy|0
7854044|NCT01521494|12338027|FG002|Overall Study|Lack of Efficacy|0
7854045|NCT01521494|12338028|FG003|Overall Study|Lack of Efficacy|0
7854046|NCT01521494|12338029|FG004|Overall Study|Lack of Efficacy|2
7854047|NCT01521494|12338025|FG000|Overall Study|Withdrawal by Subject|1
7854048|NCT01521494|12338026|FG001|Overall Study|Withdrawal by Subject|1
7854049|NCT01521494|12338027|FG002|Overall Study|Withdrawal by Subject|0
7854050|NCT01521494|12338028|FG003|Overall Study|Withdrawal by Subject|2
7854051|NCT01521494|12338029|FG004|Overall Study|Withdrawal by Subject|0
7854052|NCT01521494|12338025|FG000|Overall Study|Decrease in serum phosphate|0
7854053|NCT01521494|12338026|FG001|Overall Study|Decrease in serum phosphate|2
7854054|NCT01521494|12338027|FG002|Overall Study|Decrease in serum phosphate|3
7854055|NCT01521494|12338028|FG003|Overall Study|Decrease in serum phosphate|12
7854056|NCT01521494|12338029|FG004|Overall Study|Decrease in serum phosphate|0
7854057|NCT01521494|12338025|FG000|Overall Study|Decrease in serum calcium|0
7854058|NCT01521494|12338026|FG001|Overall Study|Decrease in serum calcium|0
7854059|NCT01521494|12338027|FG002|Overall Study|Decrease in serum calcium|0
7854060|NCT01521494|12338028|FG003|Overall Study|Decrease in serum calcium|1
7854061|NCT01521494|12338029|FG004|Overall Study|Decrease in serum calcium|1
7854062|NCT01521494|12338025|FG000|Overall Study|Physician Decision|0
7854063|NCT01521494|12338026|FG001|Overall Study|Physician Decision|0
7854064|NCT01521494|12338027|FG002|Overall Study|Physician Decision|0
7854065|NCT01521494|12338028|FG003|Overall Study|Physician Decision|0
7854066|NCT01521494|12338029|FG004|Overall Study|Physician Decision|2
7854067|NCT01521507|12338043|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2
7854068|NCT01521507|12338044|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0
7854069|NCT01521507|12338043|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1
7854070|NCT01521507|12338044|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3
7854071|NCT01521507|12338043|FG000|Stage 1: Randomized Design|Lost to Follow-up|0
7854072|NCT01521507|12338044|FG001|Stage 1: Randomized Design|Lost to Follow-up|2
7854073|NCT01521507|12338043|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0
7854074|NCT01521507|12338044|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1
7854075|NCT01521507|12338043|FG000|Stage 2: Observational Design|Withdrawal by Subject|3
7854076|NCT01521507|12338044|FG001|Stage 2: Observational Design|Withdrawal by Subject|1
7854077|NCT01521507|12338043|FG000|Stage 2: Observational Design|Physician Decision|1
7854078|NCT01521507|12338044|FG001|Stage 2: Observational Design|Physician Decision|0
7854079|NCT01521559|12338068|FG000|Overall Study|Adverse Event|0
7854080|NCT01521559|12338069|FG001|Overall Study|Adverse Event|4
7854081|NCT01521559|12338068|FG000|Overall Study|Death|1
7854082|NCT01521559|12338069|FG001|Overall Study|Death|0
7854083|NCT01521559|12338068|FG000|Overall Study|Withdrawal by Subject|9
7854084|NCT01521559|12338069|FG001|Overall Study|Withdrawal by Subject|11
7854085|NCT01521559|12338068|FG000|Overall Study|Lost to Follow-up|3
7854086|NCT01521559|12338069|FG001|Overall Study|Lost to Follow-up|1
7854087|NCT01521559|12338068|FG000|Overall Study|Protocol Violation|1
7854088|NCT01521559|12338069|FG001|Overall Study|Protocol Violation|0
7854089|NCT01521559|12338068|FG000|Overall Study|Other|1
7854090|NCT01521559|12338069|FG001|Overall Study|Other|2
7854091|NCT01521884|12338105|FG000|Overall Study|Non Responders|10
7854092|NCT01521884|12338105|FG000|Overall Study|Adverse Event|5
7854093|NCT01521884|12338105|FG000|Overall Study|Pregnancy|1
7854094|NCT01521884|12338105|FG000|Overall Study|Withdrawal by Subject|1
7854095|NCT01521884|12338105|FG000|Overall Study|Physician Decision|2
7854096|NCT01521884|12338105|FG000|Overall Study|Protocol Violation|3
7854097|NCT01521884|12338105|FG000|Overall Study|Participant non-eligible|1
7854098|NCT01521884|12338105|FG000|Overall Study|Lost to Follow-up|4
7854099|NCT01521897|12338109|FG000|Overall Study|Protocol Violation|18
7854100|NCT01521897|12338109|FG000|Overall Study|Lost to Follow-up|5
7854101|NCT01521923|12338117|FG000|Overall Study|AE, serious fatal|1
7854102|NCT01521923|12338118|FG001|Overall Study|AE, serious fatal|0
7854103|NCT01521923|12338119|FG002|Overall Study|AE, serious fatal|0
7854104|NCT01521923|12338120|FG003|Overall Study|AE, serious fatal|0
7854105|NCT01521923|12338117|FG000|Overall Study|SAE, non-fatal|0
7854106|NCT01521923|12338118|FG001|Overall Study|SAE, non-fatal|2
7854107|NCT01521923|12338119|FG002|Overall Study|SAE, non-fatal|2
7854108|NCT01521923|12338120|FG003|Overall Study|SAE, non-fatal|0
7854109|NCT01521923|12338117|FG000|Overall Study|AE, non-serious, non-fatal|1
7854110|NCT01521923|12338118|FG001|Overall Study|AE, non-serious, non-fatal|3
7854111|NCT01521923|12338119|FG002|Overall Study|AE, non-serious, non-fatal|6
7854112|NCT01521923|12338120|FG003|Overall Study|AE, non-serious, non-fatal|2
7854113|NCT01521923|12338117|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
7854114|NCT01521923|12338118|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
7854115|NCT01521923|12338119|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
7854116|NCT01521923|12338120|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
7854117|NCT01521923|12338117|FG000|Overall Study|Lack of Efficacy|1
7854118|NCT01521923|12338118|FG001|Overall Study|Lack of Efficacy|1
7854119|NCT01521923|12338119|FG002|Overall Study|Lack of Efficacy|0
7854120|NCT01521923|12338120|FG003|Overall Study|Lack of Efficacy|0
7854121|NCT01521923|12338117|FG000|Overall Study|Protocol Violation|0
7854122|NCT01521923|12338118|FG001|Overall Study|Protocol Violation|0
7854123|NCT01521923|12338119|FG002|Overall Study|Protocol Violation|1
7854124|NCT01521923|12338120|FG003|Overall Study|Protocol Violation|0
7854125|NCT01521923|12338117|FG000|Overall Study|Lost to Follow-up|1
7854126|NCT01521923|12338118|FG001|Overall Study|Lost to Follow-up|0
7854127|NCT01521923|12338119|FG002|Overall Study|Lost to Follow-up|2
7854128|NCT01521923|12338120|FG003|Overall Study|Lost to Follow-up|1
7854129|NCT01521923|12338117|FG000|Overall Study|Withdrawal by Subject|1
7854130|NCT01521923|12338118|FG001|Overall Study|Withdrawal by Subject|1
7854131|NCT01521923|12338119|FG002|Overall Study|Withdrawal by Subject|1
7854132|NCT01521923|12338120|FG003|Overall Study|Withdrawal by Subject|2
7854133|NCT01521923|12338117|FG000|Overall Study|Other|2
7854134|NCT01521923|12338118|FG001|Overall Study|Other|1
7854135|NCT01521923|12338119|FG002|Overall Study|Other|3
7854136|NCT01521923|12338120|FG003|Overall Study|Other|6
7854137|NCT01521923|12338117|FG000|Overall Study|AE, captured in Period 1|0
7854138|NCT01521923|12338118|FG001|Overall Study|AE, captured in Period 1|1
7854139|NCT01521923|12338119|FG002|Overall Study|AE, captured in Period 1|0
7854140|NCT01521923|12338120|FG003|Overall Study|AE, captured in Period 1|1
7854141|NCT01522235|12338148|FG000|Overall Study|Physician Decision|1
7854142|NCT01522235|12338149|FG001|Overall Study|Physician Decision|1
7854143|NCT01522248|12338161|FG000|Overall Study|Lost to Follow-up|1
7854144|NCT01522248|12338162|FG001|Overall Study|Lost to Follow-up|0
7854145|NCT01522404|12338189|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1
7854146|NCT01522404|12338190|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0
7854147|NCT01522404|12338189|FG000|First Intervention (up to Week 29)|Adverse Event|1
7854148|NCT01522404|12338190|FG001|First Intervention (up to Week 29)|Adverse Event|0
7854149|NCT01522404|12338189|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1
7854150|NCT01522404|12338190|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0
7854151|NCT01522443|12338219|FG000|Overall Study|No longer receiving clinical benefit|36
7854152|NCT01522443|12338220|FG001|Overall Study|No longer receiving clinical benefit|28
7854153|NCT01522443|12338219|FG000|Overall Study|Adverse Event|10
7854154|NCT01522443|12338220|FG001|Overall Study|Adverse Event|15
7854155|NCT01522443|12338219|FG000|Overall Study|Withdrawal by Subject|5
7854156|NCT01522443|12338220|FG001|Overall Study|Withdrawal by Subject|8
7854157|NCT01522443|12338219|FG000|Overall Study|No study treatment given|1
7854158|NCT01522443|12338220|FG001|Overall Study|No study treatment given|1
7854159|NCT01522443|12338219|FG000|Overall Study|Other|1
7854160|NCT01522443|12338220|FG001|Overall Study|Other|3
7854161|NCT01522651|12338231|FG000|Overall Study|Adverse Event|3
7854162|NCT01522651|12338232|FG001|Overall Study|Adverse Event|4
7854163|NCT01522651|12338233|FG002|Overall Study|Adverse Event|4
7854164|NCT01522651|12338234|FG003|Overall Study|Adverse Event|5
7854165|NCT01522651|12338235|FG004|Overall Study|Adverse Event|4
7854166|NCT01522651|12338231|FG000|Overall Study|Cardioversion|1
7854167|NCT01522651|12338232|FG001|Overall Study|Cardioversion|0
7854168|NCT01522651|12338233|FG002|Overall Study|Cardioversion|0
7854169|NCT01522651|12338234|FG003|Overall Study|Cardioversion|0
7854170|NCT01522651|12338235|FG004|Overall Study|Cardioversion|0
7854171|NCT01522651|12338231|FG000|Overall Study|Device Malfunction|0
7854172|NCT01522651|12338232|FG001|Overall Study|Device Malfunction|1
7854173|NCT01522651|12338233|FG002|Overall Study|Device Malfunction|0
7854174|NCT01522651|12338234|FG003|Overall Study|Device Malfunction|0
7854175|NCT01522651|12338235|FG004|Overall Study|Device Malfunction|0
7854176|NCT01522651|12338231|FG000|Overall Study|Investigator's Discretion|0
7854177|NCT01522651|12338232|FG001|Overall Study|Investigator's Discretion|1
7854178|NCT01522651|12338233|FG002|Overall Study|Investigator's Discretion|0
7854179|NCT01522651|12338234|FG003|Overall Study|Investigator's Discretion|0
7854180|NCT01522651|12338235|FG004|Overall Study|Investigator's Discretion|0
7854181|NCT01522651|12338231|FG000|Overall Study|Protocol Violation|3
7854182|NCT01522651|12338232|FG001|Overall Study|Protocol Violation|0
7854183|NCT01522651|12338233|FG002|Overall Study|Protocol Violation|0
7854184|NCT01522651|12338234|FG003|Overall Study|Protocol Violation|0
7854185|NCT01522651|12338235|FG004|Overall Study|Protocol Violation|0
7854186|NCT01522651|12338231|FG000|Overall Study|Reason Not Specified|0
7854187|NCT01522651|12338232|FG001|Overall Study|Reason Not Specified|0
7854188|NCT01522651|12338233|FG002|Overall Study|Reason Not Specified|0
7854189|NCT01522651|12338234|FG003|Overall Study|Reason Not Specified|1
7854190|NCT01522651|12338235|FG004|Overall Study|Reason Not Specified|0
7854191|NCT01522651|12338231|FG000|Overall Study|Participant Non-Compliance|1
7854192|NCT01522651|12338232|FG001|Overall Study|Participant Non-Compliance|0
7854193|NCT01522651|12338233|FG002|Overall Study|Participant Non-Compliance|0
7854194|NCT01522651|12338234|FG003|Overall Study|Participant Non-Compliance|0
7854195|NCT01522651|12338235|FG004|Overall Study|Participant Non-Compliance|0
7854196|NCT01522651|12338231|FG000|Overall Study|Withdrew Consent|1
7854197|NCT01522651|12338232|FG001|Overall Study|Withdrew Consent|1
7854198|NCT01522651|12338233|FG002|Overall Study|Withdrew Consent|0
7854199|NCT01522651|12338234|FG003|Overall Study|Withdrew Consent|1
7854200|NCT01522651|12338235|FG004|Overall Study|Withdrew Consent|1
7854201|NCT01522651|12338231|FG000|Overall Study|Randomized but Never Treated|0
7854202|NCT01522651|12338232|FG001|Overall Study|Randomized but Never Treated|1
7854203|NCT01522651|12338233|FG002|Overall Study|Randomized but Never Treated|0
7854204|NCT01522651|12338234|FG003|Overall Study|Randomized but Never Treated|1
7854205|NCT01522651|12338235|FG004|Overall Study|Randomized but Never Treated|1
7854206|NCT01522950|12338277|FG000|Overall Study|Withdrawal by Subject|3
7854207|NCT01522950|12338278|FG001|Overall Study|Withdrawal by Subject|2
7854208|NCT01522950|12338279|FG002|Overall Study|Withdrawal by Subject|1
7854209|NCT01522950|12338277|FG000|Overall Study|Adverse Event|3
7854210|NCT01522950|12338278|FG001|Overall Study|Adverse Event|1
7854211|NCT01522950|12338279|FG002|Overall Study|Adverse Event|1
7854212|NCT01522950|12338277|FG000|Overall Study|Protocol Violation|0
7854213|NCT01522950|12338278|FG001|Overall Study|Protocol Violation|0
7854214|NCT01522950|12338279|FG002|Overall Study|Protocol Violation|2
7854215|NCT01522950|12338277|FG000|Overall Study|Death|0
7854216|NCT01522950|12338278|FG001|Overall Study|Death|1
7854217|NCT01522950|12338279|FG002|Overall Study|Death|1
7854218|NCT01522950|12338277|FG000|Overall Study|Study Medication Sensitivity|0
7854219|NCT01522950|12338278|FG001|Overall Study|Study Medication Sensitivity|1
7854220|NCT01522950|12338279|FG002|Overall Study|Study Medication Sensitivity|0
7854221|NCT01523275|12338304|FG000|Overall Study|Lost to Follow-up|1
7854222|NCT01523275|12338305|FG001|Overall Study|Lost to Follow-up|2
7854223|NCT01523275|12338304|FG000|Overall Study|Withdrawal by Subject|1
7854224|NCT01523275|12338305|FG001|Overall Study|Withdrawal by Subject|0
7854225|NCT01523301|12338313|FG000|Overall Study|Adverse Event|25
7854226|NCT01523301|12338314|FG001|Overall Study|Adverse Event|16
7854227|NCT01523301|12338313|FG000|Overall Study|Lack of Efficacy|0
7854228|NCT01523301|12338314|FG001|Overall Study|Lack of Efficacy|2
7854229|NCT01523301|12338313|FG000|Overall Study|Protocol Violation|3
7854230|NCT01523301|12338314|FG001|Overall Study|Protocol Violation|4
7854231|NCT01523301|12338313|FG000|Overall Study|Lost to Follow-up|1
7854232|NCT01523301|12338314|FG001|Overall Study|Lost to Follow-up|0
7854233|NCT01523301|12338313|FG000|Overall Study|Withdrawal by Subject|6
7854234|NCT01523301|12338314|FG001|Overall Study|Withdrawal by Subject|8
7854235|NCT01523301|12338313|FG000|Overall Study|Other Reason|0
7854236|NCT01523301|12338314|FG001|Overall Study|Other Reason|2
7854237|NCT01523366|12338322|FG000|Treatment Period 1|Withdrawal by Subject|1
7854238|NCT01523366|12338323|FG001|Treatment Period 1|Withdrawal by Subject|0
7854239|NCT01523366|12338322|FG000|Treatment Period 2|Not completed at least 7 days treatment|1
7854240|NCT01523366|12338323|FG001|Treatment Period 2|Not completed at least 7 days treatment|0
7854241|NCT01523392|12338333|FG000|Treatment Period 1|Withdrawal by Subject|2
7854242|NCT01523392|12338334|FG001|Treatment Period 1|Withdrawal by Subject|0
7854243|NCT01523392|12338333|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1
7854244|NCT01523392|12338334|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0
7854245|NCT01523392|12338333|FG000|Washout Period - 10 to 14 Days|Adverse Event|1
7854246|NCT01523392|12338334|FG001|Washout Period - 10 to 14 Days|Adverse Event|0
7854247|NCT01523457|12338344|FG000|Overall Study|Withdrawal by Subject|7
7854248|NCT01523457|12338345|FG001|Overall Study|Withdrawal by Subject|2
7854249|NCT01523587|12338374|FG000|Overall Study|Other than listed|5
7854250|NCT01523587|12338375|FG001|Overall Study|Other than listed|5
7854251|NCT01523587|12338374|FG000|Overall Study|Worsening of underlying cancer disease|19
7854252|NCT01523587|12338375|FG001|Overall Study|Worsening of underlying cancer disease|34
7854253|NCT01523587|12338374|FG000|Overall Study|Adverse Event|68
7854254|NCT01523587|12338375|FG001|Overall Study|Adverse Event|52
7854255|NCT01523587|12338374|FG000|Overall Study|Protocol Violation|5
7854256|NCT01523587|12338375|FG001|Overall Study|Protocol Violation|3
7854257|NCT01523587|12338374|FG000|Overall Study|Lost to Follow-up|2
7854258|NCT01523587|12338375|FG001|Overall Study|Lost to Follow-up|2
7854259|NCT01523587|12338374|FG000|Overall Study|Withdrawal by Subject|28
7854260|NCT01523587|12338375|FG001|Overall Study|Withdrawal by Subject|20
7854261|NCT01523587|12338374|FG000|Overall Study|Withdrew due to Progressive disease|265
7854262|NCT01523587|12338375|FG001|Overall Study|Withdrew due to Progressive disease|279
7854263|NCT01523587|12338374|FG000|Overall Study|Randomised but bot treated|6
7854264|NCT01523587|12338375|FG001|Overall Study|Randomised but bot treated|2
7854265|NCT01523743|12338404|FG000|Period 1|Adverse Event|1
7854266|NCT01523743|12338405|FG001|Period 1|Adverse Event|0
7854267|NCT01523743|12338404|FG000|Period 1|Withdrawal by Subject|6
7854268|NCT01523743|12338405|FG001|Period 1|Withdrawal by Subject|2
7854269|NCT01523743|12338404|FG000|Period 1|Lost to Follow-up|1
7854270|NCT01523743|12338405|FG001|Period 1|Lost to Follow-up|0
7854271|NCT01523743|12338404|FG000|Period 1|Lack of Efficacy|1
7854272|NCT01523743|12338405|FG001|Period 1|Lack of Efficacy|0
7854273|NCT01523743|12338404|FG000|Period 1|Felt unable to empty bladder|1
7854274|NCT01523743|12338405|FG001|Period 1|Felt unable to empty bladder|0
7854275|NCT01523743|12338404|FG000|Period 2|Withdrawal by Subject|0
7949575|NCT02539368|12495260|FG004|Overall Study|Other|3
7949576|NCT02539368|12495256|FG000|Overall Study|Missing|10
7949577|NCT02539368|12495257|FG001|Overall Study|Missing|3
7949578|NCT02539368|12495258|FG002|Overall Study|Missing|0
7949579|NCT02539368|12495259|FG003|Overall Study|Missing|0
7949580|NCT02539368|12495260|FG004|Overall Study|Missing|0
7949581|NCT02539797|12495293|FG000|Overall Study|Lost to Follow-up|0
7949582|NCT02539797|12495294|FG001|Overall Study|Lost to Follow-up|1
7949583|NCT02539797|12495295|FG002|Overall Study|Lost to Follow-up|0
7949584|NCT02540083|12495318|FG000|Overall Study|Withdrawal by Subject|16
7949585|NCT02540213|12495339|FG000|Overall Study|Death/adverse event|18
7949586|NCT02540213|12495339|FG000|Overall Study|Administrative reasons|3
7949587|NCT02540213|12495339|FG000|Overall Study|Kidney transplant|3
7949588|NCT02540213|12495339|FG000|Overall Study|Lack of Efficacy|6
7949589|NCT02540213|12495339|FG000|Overall Study|Consent withdrawn|7
7949590|NCT02540213|12495339|FG000|Overall Study|Enrolled but not treated|2
7949591|NCT02540265|12495355|FG000|Overall Study|Lost to Follow-up|0
7949592|NCT02540265|12495356|FG001|Overall Study|Lost to Follow-up|0
7949593|NCT02540265|12495357|FG002|Overall Study|Lost to Follow-up|1
7949594|NCT02540291|12495369|FG000|Overall Study|Death|7
7949595|NCT02540291|12495370|FG001|Overall Study|Death|7
7949596|NCT02540291|12495371|FG002|Overall Study|Death|5
7949597|NCT02540291|12495372|FG003|Overall Study|Death|7
7949598|NCT02540291|12495369|FG000|Overall Study|Lost to Follow-up|0
7949599|NCT02540291|12495370|FG001|Overall Study|Lost to Follow-up|0
7949600|NCT02540291|12495371|FG002|Overall Study|Lost to Follow-up|1
7949601|NCT02540291|12495372|FG003|Overall Study|Lost to Follow-up|0
7949602|NCT02540291|12495369|FG000|Overall Study|Withdrawal Of Consent|0
7949603|NCT02540291|12495370|FG001|Overall Study|Withdrawal Of Consent|1
7949604|NCT02540291|12495371|FG002|Overall Study|Withdrawal Of Consent|0
7949605|NCT02540291|12495372|FG003|Overall Study|Withdrawal Of Consent|0
7949606|NCT02540291|12495369|FG000|Overall Study|Study Terminated By Sponsor|1
7949607|NCT02540291|12495370|FG001|Overall Study|Study Terminated By Sponsor|0
7949608|NCT02540291|12495371|FG002|Overall Study|Study Terminated By Sponsor|0
7949609|NCT02540291|12495372|FG003|Overall Study|Study Terminated By Sponsor|0
7949610|NCT02540291|12495369|FG000|Overall Study|Other|0
7949611|NCT02540291|12495370|FG001|Overall Study|Other|0
7949612|NCT02540291|12495371|FG002|Overall Study|Other|1
7949613|NCT02540291|12495372|FG003|Overall Study|Other|0
7949614|NCT02540356|12495386|FG000|Overall Study|Terminated due to disease progression|1
7949615|NCT02540356|12495387|FG001|Overall Study|Terminated due to disease progression|0
7949616|NCT02540538|12495404|FG000|Overall Study|Pregnancy|0
7949617|NCT02540538|12495405|FG001|Overall Study|Pregnancy|1
7949618|NCT02540538|12495406|FG002|Overall Study|Pregnancy|0
7965871|NCT02739594|12521249|FG001|Overall Study|Lost to Follow-up|1
7965872|NCT02739594|12521248|FG000|Overall Study|Elevated Serum Creatinine|0
7965873|NCT02739594|12521249|FG001|Overall Study|Elevated Serum Creatinine|1
7965874|NCT02739594|12521248|FG000|Overall Study|Other|6
7965875|NCT02739594|12521249|FG001|Overall Study|Other|2
7965876|NCT02739828|12521274|FG000|Overall Study|Adverse Event|1
7965877|NCT02739828|12521274|FG000|Overall Study|Lost to Follow-up|4
7965878|NCT02739984|12521280|FG000|Overall Study|Sponsor Decision|1
7965879|NCT02739984|12521281|FG001|Overall Study|Sponsor Decision|0
7949619|NCT02540668|12495424|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0
7949620|NCT02540668|12495425|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1
7949621|NCT02540850|12495444|FG000|Overall Study|Lost to Follow-up|69
7949622|NCT02540850|12495445|FG001|Overall Study|Lost to Follow-up|66
7949623|NCT02540850|12495446|FG002|Overall Study|Lost to Follow-up|34
7949624|NCT02540954|12495456|FG000|Overall Study|Physician Decision|3
7949625|NCT02540954|12495457|FG001|Overall Study|Physician Decision|1
7949626|NCT02540954|12495456|FG000|Overall Study|Withdrawal by Subject|6
7949627|NCT02540954|12495457|FG001|Overall Study|Withdrawal by Subject|5
7949628|NCT02540954|12495456|FG000|Overall Study|Lost to Follow-up|1
7949629|NCT02540954|12495457|FG001|Overall Study|Lost to Follow-up|1
7949630|NCT02540954|12495456|FG000|Overall Study|Adverse Event|4
7949631|NCT02540954|12495457|FG001|Overall Study|Adverse Event|2
7949632|NCT02540954|12495456|FG000|Overall Study|Death|0
7949633|NCT02540954|12495457|FG001|Overall Study|Death|3
7949634|NCT02540954|12495456|FG000|Overall Study|Treatment failure|1
7949635|NCT02540954|12495457|FG001|Overall Study|Treatment failure|0
7854276|NCT01523743|12338405|FG001|Period 2|Withdrawal by Subject|2
7854277|NCT01523743|12338404|FG000|Period 2|Adverse Event|1
7854278|NCT01523743|12338405|FG001|Period 2|Adverse Event|0
7854279|NCT01523756|12338411|FG000|Baseline Period|Adverse Event|0
7854280|NCT01523756|12338412|FG001|Baseline Period|Adverse Event|1
7854281|NCT01523756|12338411|FG000|Test Period 1|Adverse Event|1
7854282|NCT01523756|12338412|FG001|Test Period 1|Adverse Event|0
7854283|NCT01523756|12338411|FG000|Test Period 2|Withdrawal by Subject|0
7854284|NCT01523756|12338412|FG001|Test Period 2|Withdrawal by Subject|1
7854285|NCT01523873|12338477|FG000|Overall Study|Protocol Violation|422
7854286|NCT01523886|12338485|FG000|Overall Study|surgery cancelled|0
7854287|NCT01523886|12338486|FG001|Overall Study|surgery cancelled|1
7854288|NCT01524133|12338522|FG000|Treatment Phase|Withdrawal by Subject|13
7854289|NCT01524133|12338523|FG001|Treatment Phase|Withdrawal by Subject|28
7854290|NCT01524133|12338524|FG002|Treatment Phase|Withdrawal by Subject|31
7854291|NCT01524133|12338522|FG000|Treatment Phase|Physician Decision|6
7854292|NCT01524133|12338523|FG001|Treatment Phase|Physician Decision|3
7854293|NCT01524133|12338524|FG002|Treatment Phase|Physician Decision|3
7854294|NCT01524133|12338522|FG000|Treatment Phase|Lost to Follow-up|0
7854295|NCT01524133|12338523|FG001|Treatment Phase|Lost to Follow-up|1
7854296|NCT01524133|12338524|FG002|Treatment Phase|Lost to Follow-up|2
7854297|NCT01524133|12338522|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4
7854298|NCT01524133|12338523|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5
7854299|NCT01524133|12338524|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10
7854300|NCT01524133|12338522|FG000|Overall Study 52 Weeks|Physician Decision|1
7854301|NCT01524133|12338523|FG001|Overall Study 52 Weeks|Physician Decision|0
7854302|NCT01524133|12338524|FG002|Overall Study 52 Weeks|Physician Decision|2
7854303|NCT01524133|12338522|FG000|Overall Study 52 Weeks|Lost to Follow-up|16
7854304|NCT01524133|12338523|FG001|Overall Study 52 Weeks|Lost to Follow-up|15
7854305|NCT01524133|12338524|FG002|Overall Study 52 Weeks|Lost to Follow-up|15
7854306|NCT01524198|12338534|FG000|Overall Study|Protocol Violation|8
7854307|NCT01524198|12338535|FG001|Overall Study|Protocol Violation|6
7854308|NCT01524198|12338534|FG000|Overall Study|Withdrawal by Subject|15
7854309|NCT01524198|12338535|FG001|Overall Study|Withdrawal by Subject|10
7854310|NCT01524224|12338549|FG000|Overall Study|Progressive Disease|1
7854311|NCT01524224|12338550|FG001|Overall Study|Progressive Disease|0
7854312|NCT01524224|12338551|FG002|Overall Study|Progressive Disease|2
7854313|NCT01524224|12338552|FG003|Overall Study|Progressive Disease|1
7854314|NCT01524224|12338553|FG004|Overall Study|Progressive Disease|2
7854315|NCT01524224|12338554|FG005|Overall Study|Progressive Disease|1
7854316|NCT01524224|12338555|FG006|Overall Study|Progressive Disease|1
7854317|NCT01524224|12338556|FG007|Overall Study|Progressive Disease|5
7854318|NCT01524224|12338549|FG000|Overall Study|Withdrawal by Subject|2
7854319|NCT01524224|12338550|FG001|Overall Study|Withdrawal by Subject|0
7854320|NCT01524224|12338551|FG002|Overall Study|Withdrawal by Subject|0
7854321|NCT01524224|12338552|FG003|Overall Study|Withdrawal by Subject|0
7854322|NCT01524224|12338553|FG004|Overall Study|Withdrawal by Subject|0
7854323|NCT01524224|12338554|FG005|Overall Study|Withdrawal by Subject|0
7854324|NCT01524224|12338555|FG006|Overall Study|Withdrawal by Subject|2
7854325|NCT01524224|12338556|FG007|Overall Study|Withdrawal by Subject|0
7854326|NCT01524224|12338549|FG000|Overall Study|Adverse Event|0
7854327|NCT01524224|12338550|FG001|Overall Study|Adverse Event|1
7854328|NCT01524224|12338551|FG002|Overall Study|Adverse Event|0
7854329|NCT01524224|12338552|FG003|Overall Study|Adverse Event|0
7854330|NCT01524224|12338553|FG004|Overall Study|Adverse Event|0
7854331|NCT01524224|12338554|FG005|Overall Study|Adverse Event|1
7949636|NCT02540954|12495456|FG000|Overall Study|Other reason|4
7949637|NCT02540954|12495457|FG001|Overall Study|Other reason|2
7949638|NCT02540993|12495465|FG000|Overall Study|Lost to Follow-up|5
7949639|NCT02540993|12495466|FG001|Overall Study|Lost to Follow-up|3
7949640|NCT02540993|12495465|FG000|Overall Study|Withdrawal by Subject|4
7854332|NCT01524224|12338555|FG006|Overall Study|Adverse Event|0
7854333|NCT01524224|12338556|FG007|Overall Study|Adverse Event|0
7854334|NCT01524224|12338549|FG000|Overall Study|Physician Decision|0
7854335|NCT01524224|12338550|FG001|Overall Study|Physician Decision|0
7854336|NCT01524224|12338551|FG002|Overall Study|Physician Decision|0
7854337|NCT01524224|12338552|FG003|Overall Study|Physician Decision|1
7854338|NCT01524224|12338553|FG004|Overall Study|Physician Decision|1
7854339|NCT01524224|12338554|FG005|Overall Study|Physician Decision|0
7854340|NCT01524224|12338555|FG006|Overall Study|Physician Decision|0
7854341|NCT01524224|12338556|FG007|Overall Study|Physician Decision|1
7854342|NCT01524224|12338549|FG000|Overall Study|Sponsor Decision|0
7854343|NCT01524224|12338550|FG001|Overall Study|Sponsor Decision|0
7854344|NCT01524224|12338551|FG002|Overall Study|Sponsor Decision|0
7854345|NCT01524224|12338552|FG003|Overall Study|Sponsor Decision|0
7854346|NCT01524224|12338553|FG004|Overall Study|Sponsor Decision|1
7854347|NCT01524224|12338554|FG005|Overall Study|Sponsor Decision|0
7854348|NCT01524224|12338555|FG006|Overall Study|Sponsor Decision|0
7854349|NCT01524224|12338556|FG007|Overall Study|Sponsor Decision|0
7854350|NCT01524289|12338576|FG000|Overall Study|Lost to Follow-up|0
7854351|NCT01524289|12338577|FG001|Overall Study|Lost to Follow-up|1
7854352|NCT01524289|12338576|FG000|Overall Study|Physician Decision|1
7854353|NCT01524289|12338577|FG001|Overall Study|Physician Decision|0
7854354|NCT01524289|12338576|FG000|Overall Study|Protocol Violation|5
7854355|NCT01524289|12338577|FG001|Overall Study|Protocol Violation|1
7854356|NCT01524289|12338576|FG000|Overall Study|Withdrawal by Subject|11
7854357|NCT01524289|12338577|FG001|Overall Study|Withdrawal by Subject|7
7854358|NCT01524289|12338576|FG000|Overall Study|Adverse Event|12
7854359|NCT01524289|12338577|FG001|Overall Study|Adverse Event|5
7854360|NCT01524289|12338576|FG000|Overall Study|Did not take study medication|1
7854361|NCT01524289|12338577|FG001|Overall Study|Did not take study medication|0
7854362|NCT01524627|12338600|FG000|Overall Study|Physician Decision|0
7854363|NCT01524627|12338601|FG001|Overall Study|Physician Decision|1
7854364|NCT01524627|12338600|FG000|Overall Study|Lost to Follow-up|1
7854365|NCT01524627|12338601|FG001|Overall Study|Lost to Follow-up|1
7854366|NCT01524679|12338609|FG000|Overall Study|Lost to Follow-up|1
7854367|NCT01524679|12338610|FG001|Overall Study|Lost to Follow-up|4
7854368|NCT01524679|12338609|FG000|Overall Study|Withdrawal by Subject|4
7854369|NCT01524679|12338610|FG001|Overall Study|Withdrawal by Subject|4
7854370|NCT01524679|12338609|FG000|Overall Study|Adverse Event|9
7854371|NCT01524679|12338610|FG001|Overall Study|Adverse Event|0
7854372|NCT01524679|12338609|FG000|Overall Study|Protocol Violation|1
7854373|NCT01524679|12338610|FG001|Overall Study|Protocol Violation|0
7854374|NCT01524679|12338609|FG000|Overall Study|Lack of Efficacy|2
7854375|NCT01524679|12338610|FG001|Overall Study|Lack of Efficacy|0
7854376|NCT01524679|12338609|FG000|Overall Study|e.g.wish for children, relocation|6
7854377|NCT01524679|12338610|FG001|Overall Study|e.g.wish for children, relocation|1
7854378|NCT01524692|12338616|FG000|Overall Study|Withdrawal by Subject|3
7854379|NCT01524770|12338621|FG000|First Intervention|Withdrawal by Subject|1
7854380|NCT01524770|12338622|FG001|First Intervention|Withdrawal by Subject|0
7854381|NCT01524770|12338621|FG000|First Intervention|Adverse Event|1
7854382|NCT01524770|12338622|FG001|First Intervention|Adverse Event|1
7854383|NCT01524770|12338621|FG000|First Intervention|Protocol Violation|1
7854384|NCT01524770|12338622|FG001|First Intervention|Protocol Violation|0
7854385|NCT01524783|12338630|FG000|Blinded Period|Adverse Event|64
7854386|NCT01524783|12338631|FG001|Blinded Period|Adverse Event|7
7854387|NCT01524783|12338632|FG002|Blinded Period|Adverse Event|0
7854388|NCT01524783|12338630|FG000|Blinded Period|Disease Progression|89
7854389|NCT01524783|12338631|FG001|Blinded Period|Disease Progression|75
7854390|NCT01524783|12338632|FG002|Blinded Period|Disease Progression|0
7854391|NCT01524783|12338630|FG000|Blinded Period|Withdrawal by Subject|19
7854392|NCT01524783|12338631|FG001|Blinded Period|Withdrawal by Subject|6
7854393|NCT01524783|12338632|FG002|Blinded Period|Withdrawal by Subject|0
7854394|NCT01524783|12338630|FG000|Blinded Period|Protocol deviation|2
7854395|NCT01524783|12338631|FG001|Blinded Period|Protocol deviation|1
7854396|NCT01524783|12338632|FG002|Blinded Period|Protocol deviation|0
7854397|NCT01524783|12338630|FG000|Blinded Period|Death|5
7854398|NCT01524783|12338631|FG001|Blinded Period|Death|2
7854399|NCT01524783|12338632|FG002|Blinded Period|Death|0
7854400|NCT01524783|12338630|FG000|Open-label Period|Disease progression|13
7854401|NCT01524783|12338631|FG001|Open-label Period|Disease progression|0
7854402|NCT01524783|12338632|FG002|Open-label Period|Disease progression|2
7854403|NCT01524783|12338630|FG000|Open-label Period|Administrative problems|5
7854404|NCT01524783|12338631|FG001|Open-label Period|Administrative problems|0
7854405|NCT01524783|12338632|FG002|Open-label Period|Administrative problems|2
7854406|NCT01524783|12338630|FG000|Open-label Period|Adverse Event|5
7854407|NCT01524783|12338631|FG001|Open-label Period|Adverse Event|0
7854408|NCT01524783|12338632|FG002|Open-label Period|Adverse Event|1
7854409|NCT01524783|12338630|FG000|Open-label Period|Withdrawal by Subject|2
7854410|NCT01524783|12338631|FG001|Open-label Period|Withdrawal by Subject|0
7854411|NCT01524783|12338632|FG002|Open-label Period|Withdrawal by Subject|1
7854412|NCT01524783|12338630|FG000|Open-label Period|Protocol deviation|1
7854413|NCT01524783|12338631|FG001|Open-label Period|Protocol deviation|0
7854414|NCT01524783|12338632|FG002|Open-label Period|Protocol deviation|0
7854415|NCT01524796|12338644|FG000|Overall Study|Adverse Event|13
7854416|NCT01524796|12338644|FG000|Overall Study|Lack of Efficacy|3
7854417|NCT01524796|12338644|FG000|Overall Study|Lost to Follow-up|1
7854418|NCT01524796|12338644|FG000|Overall Study|The price|1
7854419|NCT01524796|12338644|FG000|Overall Study|Withdrawal by Subject|4
7854420|NCT01524796|12338644|FG000|Overall Study|Move|1
7854421|NCT01524796|12338644|FG000|Overall Study|Deterioration of pains|1
7854422|NCT01524796|12338644|FG000|Overall Study|Gall stone surgery|1
7854423|NCT01524796|12338644|FG000|Overall Study|Nervous about confidentiality|1
7854424|NCT01524796|12338644|FG000|Overall Study|Switch to carbamazapine|1
7854425|NCT01524796|12338644|FG000|Overall Study|Adverse Event and Lack of Efficacy|1
7854426|NCT01524887|12338651|FG000|Overall Study|Withdrawal by Subject|6
7854427|NCT01524887|12338652|FG001|Overall Study|Withdrawal by Subject|2
7854428|NCT01524887|12338653|FG002|Overall Study|Withdrawal by Subject|3
7854429|NCT01524887|12338651|FG000|Overall Study|Adverse Event|5
7854430|NCT01524887|12338652|FG001|Overall Study|Adverse Event|1
7854431|NCT01524887|12338653|FG002|Overall Study|Adverse Event|1
7854432|NCT01524887|12338651|FG000|Overall Study|Protocol Violation|0
7854433|NCT01524887|12338652|FG001|Overall Study|Protocol Violation|0
7854434|NCT01524887|12338653|FG002|Overall Study|Protocol Violation|1
7854435|NCT01524887|12338651|FG000|Overall Study|Study termination|73
7854436|NCT01524887|12338652|FG001|Overall Study|Study termination|87
7854437|NCT01524887|12338653|FG002|Overall Study|Study termination|79
7854438|NCT01524887|12338651|FG000|Overall Study|Withdrawal by Caregiver|0
7854439|NCT01524887|12338652|FG001|Overall Study|Withdrawal by Caregiver|0
7854440|NCT01524887|12338653|FG002|Overall Study|Withdrawal by Caregiver|2
7854441|NCT01524887|12338651|FG000|Overall Study|Use of prohibited medication|1
7854442|NCT01524887|12338652|FG001|Overall Study|Use of prohibited medication|0
7854443|NCT01524887|12338653|FG002|Overall Study|Use of prohibited medication|0
7854444|NCT01524900|12338666|FG000|Overall Study|Lost to Follow-up|3
7854445|NCT01524900|12338667|FG001|Overall Study|Lost to Follow-up|12
7854446|NCT01524900|12338668|FG002|Overall Study|Lost to Follow-up|1
7854447|NCT01524900|12338669|FG003|Overall Study|Lost to Follow-up|0
7854448|NCT01524900|12338670|FG004|Overall Study|Lost to Follow-up|0
7854449|NCT01524900|12338666|FG000|Overall Study|Other reason than stated above|1
7854450|NCT01524900|12338667|FG001|Overall Study|Other reason than stated above|1
7854451|NCT01524900|12338668|FG002|Overall Study|Other reason than stated above|0
7854452|NCT01524900|12338669|FG003|Overall Study|Other reason than stated above|0
7854453|NCT01524900|12338670|FG004|Overall Study|Other reason than stated above|0
7854454|NCT01524900|12338666|FG000|Overall Study|No reason documented|2
7854455|NCT01524900|12338667|FG001|Overall Study|No reason documented|1
7854456|NCT01524900|12338668|FG002|Overall Study|No reason documented|0
7854457|NCT01524900|12338669|FG003|Overall Study|No reason documented|1
7854458|NCT01524900|12338670|FG004|Overall Study|No reason documented|0
7854459|NCT01524913|12338686|FG000|Overall Study|Lost to Follow-up|4
7854460|NCT01524913|12338687|FG001|Overall Study|Lost to Follow-up|0
7854461|NCT01524913|12338688|FG002|Overall Study|Lost to Follow-up|0
7854462|NCT01524978|12338707|FG000|Overall Study|Other|16
7854463|NCT01524978|12338708|FG001|Overall Study|Other|2
7854464|NCT01524978|12338709|FG002|Overall Study|Other|1
7854465|NCT01524978|12338710|FG003|Overall Study|Other|2
7854466|NCT01524978|12338711|FG004|Overall Study|Other|1
7854467|NCT01524978|12338712|FG005|Overall Study|Other|3
7854468|NCT01524978|12338713|FG006|Overall Study|Other|17
7854469|NCT01524978|12338714|FG007|Overall Study|Other|1
7854470|NCT01524978|12338715|FG008|Overall Study|Other|2
7854471|NCT01524978|12338716|FG009|Overall Study|Other|2
7854472|NCT01524978|12338717|FG010|Overall Study|Other|5
7854473|NCT01524978|12338707|FG000|Overall Study|Withdrawal by Subject|12
7854474|NCT01524978|12338708|FG001|Overall Study|Withdrawal by Subject|0
7854475|NCT01524978|12338709|FG002|Overall Study|Withdrawal by Subject|1
7854476|NCT01524978|12338710|FG003|Overall Study|Withdrawal by Subject|1
7854477|NCT01524978|12338711|FG004|Overall Study|Withdrawal by Subject|3
7854478|NCT01524978|12338712|FG005|Overall Study|Withdrawal by Subject|1
7854479|NCT01524978|12338713|FG006|Overall Study|Withdrawal by Subject|6
7854480|NCT01524978|12338714|FG007|Overall Study|Withdrawal by Subject|2
7854481|NCT01524978|12338715|FG008|Overall Study|Withdrawal by Subject|4
7854482|NCT01524978|12338716|FG009|Overall Study|Withdrawal by Subject|0
7854483|NCT01524978|12338717|FG010|Overall Study|Withdrawal by Subject|5
7854484|NCT01524978|12338707|FG000|Overall Study|Lost to Follow-up|0
7854485|NCT01524978|12338708|FG001|Overall Study|Lost to Follow-up|0
7854486|NCT01524978|12338709|FG002|Overall Study|Lost to Follow-up|3
7854487|NCT01524978|12338710|FG003|Overall Study|Lost to Follow-up|0
7854488|NCT01524978|12338711|FG004|Overall Study|Lost to Follow-up|1
7854489|NCT01524978|12338712|FG005|Overall Study|Lost to Follow-up|1
7854490|NCT01524978|12338713|FG006|Overall Study|Lost to Follow-up|2
7854491|NCT01524978|12338714|FG007|Overall Study|Lost to Follow-up|0
7854492|NCT01524978|12338715|FG008|Overall Study|Lost to Follow-up|1
7854493|NCT01524978|12338716|FG009|Overall Study|Lost to Follow-up|1
7854494|NCT01524978|12338717|FG010|Overall Study|Lost to Follow-up|1
7854495|NCT01524978|12338707|FG000|Overall Study|Death|34
7854496|NCT01524978|12338708|FG001|Overall Study|Death|2
7854497|NCT01524978|12338709|FG002|Overall Study|Death|5
7854498|NCT01524978|12338710|FG003|Overall Study|Death|24
7854499|NCT01524978|12338711|FG004|Overall Study|Death|4
7854500|NCT01524978|12338712|FG005|Overall Study|Death|4
7854501|NCT01524978|12338713|FG006|Overall Study|Death|1
7854502|NCT01524978|12338714|FG007|Overall Study|Death|9
7854503|NCT01524978|12338715|FG008|Overall Study|Death|5
7854504|NCT01524978|12338716|FG009|Overall Study|Death|6
7854505|NCT01524978|12338717|FG010|Overall Study|Death|17
7854506|NCT01525082|12338732|FG000|Overall Study|Death|1
7854507|NCT01525225|12338748|FG000|Enrollment|No longer met study criteria|1
7854508|NCT01525225|12338748|FG000|Enrollment|Other|1
7854509|NCT01525238|12338755|FG000|Overall Study|Withdrawal by Subject|1
7854510|NCT01525238|12338756|FG001|Overall Study|Withdrawal by Subject|0
7854511|NCT01525238|12338757|FG002|Overall Study|Withdrawal by Subject|0
7854512|NCT01525407|12338767|FG000|Overall Study|Change in recipient treatment plan|2
7854513|NCT01525407|12338768|FG001|Overall Study|Change in recipient treatment plan|2
7854514|NCT01525407|12338767|FG000|Overall Study|Withdrawal by Subject|0
7854515|NCT01525407|12338768|FG001|Overall Study|Withdrawal by Subject|1
7854516|NCT01525407|12338767|FG000|Overall Study|Transplant was delayed|0
7854517|NCT01525407|12338768|FG001|Overall Study|Transplant was delayed|1
7854518|NCT01525407|12338767|FG000|Overall Study|Delay in Transplant|1
7854519|NCT01525407|12338768|FG001|Overall Study|Delay in Transplant|0
7854520|NCT01525550|12338785|FG000|Overall Study|Lost to Follow-up|8
7854521|NCT01525550|12338786|FG001|Overall Study|Lost to Follow-up|2
7854522|NCT01525550|12338785|FG000|Overall Study|Death|19
7854523|NCT01525550|12338786|FG001|Overall Study|Death|28
7854524|NCT01525550|12338785|FG000|Overall Study|Other|0
7854525|NCT01525550|12338786|FG001|Overall Study|Other|4
7854526|NCT01525550|12338785|FG000|Overall Study|Sponsor's Decision|30
7854527|NCT01525550|12338786|FG001|Overall Study|Sponsor's Decision|11
7854528|NCT01525550|12338785|FG000|Overall Study|Withdrawal by Subject|4
7854529|NCT01525550|12338786|FG001|Overall Study|Withdrawal by Subject|0
7854530|NCT01525589|12338799|FG000|Overall Study|Non-treatment-related AE|1
7854531|NCT01525589|12338800|FG001|Overall Study|Non-treatment-related AE|0
7854532|NCT01525589|12338801|FG002|Overall Study|Non-treatment-related AE|0
7854533|NCT01525589|12338799|FG000|Overall Study|Progressive disease|48
7854534|NCT01525589|12338800|FG001|Overall Study|Progressive disease|15
7854535|NCT01525589|12338801|FG002|Overall Study|Progressive disease|29
7854536|NCT01525589|12338799|FG000|Overall Study|Never treated|2
7854537|NCT01525589|12338800|FG001|Overall Study|Never treated|0
7854538|NCT01525589|12338801|FG002|Overall Study|Never treated|0
7854539|NCT01525589|12338799|FG000|Overall Study|Physician Decision|4
7854540|NCT01525589|12338800|FG001|Overall Study|Physician Decision|2
7854541|NCT01525589|12338801|FG002|Overall Study|Physician Decision|2
7854542|NCT01525589|12338799|FG000|Overall Study|Death|0
7854543|NCT01525589|12338800|FG001|Overall Study|Death|0
7854544|NCT01525589|12338801|FG002|Overall Study|Death|2
7854545|NCT01525589|12338799|FG000|Overall Study|Treatment-related AE|1
7854546|NCT01525589|12338800|FG001|Overall Study|Treatment-related AE|1
7854547|NCT01525589|12338801|FG002|Overall Study|Treatment-related AE|2
7854548|NCT01525589|12338799|FG000|Overall Study|Other reasons|0
7854549|NCT01525589|12338800|FG001|Overall Study|Other reasons|1
7854550|NCT01525589|12338801|FG002|Overall Study|Other reasons|0
7854551|NCT01525589|12338799|FG000|Overall Study|Withdrawal by Subject|0
7854552|NCT01525589|12338800|FG001|Overall Study|Withdrawal by Subject|1
7854553|NCT01525589|12338801|FG002|Overall Study|Withdrawal by Subject|0
7854554|NCT01525602|12338817|FG000|Overall Study|Adverse Event|1
7854555|NCT01525602|12338818|FG001|Overall Study|Adverse Event|0
7854556|NCT01525602|12338819|FG002|Overall Study|Adverse Event|1
7854557|NCT01525602|12338820|FG003|Overall Study|Adverse Event|1
7854558|NCT01525602|12338821|FG004|Overall Study|Adverse Event|3
7854559|NCT01525602|12338822|FG005|Overall Study|Adverse Event|3
7854560|NCT01525602|12338823|FG006|Overall Study|Adverse Event|0
7854561|NCT01525602|12338824|FG007|Overall Study|Adverse Event|1
7854562|NCT01525602|12338817|FG000|Overall Study|Disease progression|6
7854563|NCT01525602|12338818|FG001|Overall Study|Disease progression|3
7854564|NCT01525602|12338819|FG002|Overall Study|Disease progression|2
7854565|NCT01525602|12338820|FG003|Overall Study|Disease progression|5
7854566|NCT01525602|12338821|FG004|Overall Study|Disease progression|22
7854567|NCT01525602|12338822|FG005|Overall Study|Disease progression|2
7854568|NCT01525602|12338823|FG006|Overall Study|Disease progression|3
7854569|NCT01525602|12338824|FG007|Overall Study|Disease progression|3
7854570|NCT01525602|12338817|FG000|Overall Study|Clinical progression|2
7854571|NCT01525602|12338818|FG001|Overall Study|Clinical progression|0
7854572|NCT01525602|12338819|FG002|Overall Study|Clinical progression|0
7854573|NCT01525602|12338820|FG003|Overall Study|Clinical progression|0
7854574|NCT01525602|12338821|FG004|Overall Study|Clinical progression|0
7854575|NCT01525602|12338822|FG005|Overall Study|Clinical progression|0
7854576|NCT01525602|12338823|FG006|Overall Study|Clinical progression|1
7854577|NCT01525602|12338824|FG007|Overall Study|Clinical progression|1
7854578|NCT01525602|12338817|FG000|Overall Study|Non-compliance|0
7854579|NCT01525602|12338818|FG001|Overall Study|Non-compliance|0
7854580|NCT01525602|12338819|FG002|Overall Study|Non-compliance|0
7854581|NCT01525602|12338820|FG003|Overall Study|Non-compliance|0
7854582|NCT01525602|12338821|FG004|Overall Study|Non-compliance|1
7854583|NCT01525602|12338822|FG005|Overall Study|Non-compliance|0
7854584|NCT01525602|12338823|FG006|Overall Study|Non-compliance|0
7854585|NCT01525602|12338824|FG007|Overall Study|Non-compliance|0
7854586|NCT01525602|12338817|FG000|Overall Study|Withdrawal by Subject|0
7854587|NCT01525602|12338818|FG001|Overall Study|Withdrawal by Subject|0
7854588|NCT01525602|12338819|FG002|Overall Study|Withdrawal by Subject|0
7854589|NCT01525602|12338820|FG003|Overall Study|Withdrawal by Subject|0
7854590|NCT01525602|12338821|FG004|Overall Study|Withdrawal by Subject|3
7854591|NCT01525602|12338822|FG005|Overall Study|Withdrawal by Subject|1
7854592|NCT01525602|12338823|FG006|Overall Study|Withdrawal by Subject|0
7854593|NCT01525602|12338824|FG007|Overall Study|Withdrawal by Subject|1
7854594|NCT01525602|12338817|FG000|Overall Study|Physician Decision|0
7854595|NCT01525602|12338818|FG001|Overall Study|Physician Decision|0
7854596|NCT01525602|12338819|FG002|Overall Study|Physician Decision|0
7854597|NCT01525602|12338820|FG003|Overall Study|Physician Decision|0
7854598|NCT01525602|12338821|FG004|Overall Study|Physician Decision|3
7854599|NCT01525602|12338822|FG005|Overall Study|Physician Decision|0
7854600|NCT01525602|12338823|FG006|Overall Study|Physician Decision|1
7854601|NCT01525602|12338824|FG007|Overall Study|Physician Decision|0
7854602|NCT01525602|12338817|FG000|Overall Study|Death|0
7854603|NCT01525602|12338818|FG001|Overall Study|Death|0
7854604|NCT01525602|12338819|FG002|Overall Study|Death|0
7854605|NCT01525602|12338820|FG003|Overall Study|Death|0
7854606|NCT01525602|12338821|FG004|Overall Study|Death|1
7854607|NCT01525602|12338822|FG005|Overall Study|Death|1
7854608|NCT01525602|12338823|FG006|Overall Study|Death|0
7854609|NCT01525602|12338824|FG007|Overall Study|Death|0
7854610|NCT01525602|12338817|FG000|Overall Study|Unqualified based on biopsy; not dosed|0
7854611|NCT01525602|12338818|FG001|Overall Study|Unqualified based on biopsy; not dosed|0
7854612|NCT01525602|12338819|FG002|Overall Study|Unqualified based on biopsy; not dosed|0
7854613|NCT01525602|12338820|FG003|Overall Study|Unqualified based on biopsy; not dosed|0
7854614|NCT01525602|12338821|FG004|Overall Study|Unqualified based on biopsy; not dosed|0
7854615|NCT01525602|12338822|FG005|Overall Study|Unqualified based on biopsy; not dosed|0
7854616|NCT01525602|12338823|FG006|Overall Study|Unqualified based on biopsy; not dosed|1
7854617|NCT01525602|12338824|FG007|Overall Study|Unqualified based on biopsy; not dosed|1
7854618|NCT01525615|12338852|FG000|Overall Study|Adverse Event|11
7854619|NCT01525615|12338853|FG001|Overall Study|Adverse Event|7
7854620|NCT01525615|12338854|FG002|Overall Study|Adverse Event|5
7854621|NCT01525615|12338852|FG000|Overall Study|Lost to Follow-up|1
7854622|NCT01525615|12338853|FG001|Overall Study|Lost to Follow-up|0
7854623|NCT01525615|12338854|FG002|Overall Study|Lost to Follow-up|0
7854624|NCT01525615|12338852|FG000|Overall Study|Withdrawal by Subject|1
7854625|NCT01525615|12338853|FG001|Overall Study|Withdrawal by Subject|0
7854626|NCT01525615|12338854|FG002|Overall Study|Withdrawal by Subject|0
7854627|NCT01525615|12338852|FG000|Overall Study|Other reason not described above|1
7854628|NCT01525615|12338853|FG001|Overall Study|Other reason not described above|0
7854629|NCT01525615|12338854|FG002|Overall Study|Other reason not described above|1
7854630|NCT01525628|12338867|FG000|Overall Study|Adverse Event|1
7854631|NCT01525628|12338868|FG001|Overall Study|Adverse Event|1
7854632|NCT01525628|12338869|FG002|Overall Study|Adverse Event|2
7854633|NCT01525628|12338870|FG003|Overall Study|Adverse Event|0
7854634|NCT01525628|12338871|FG004|Overall Study|Adverse Event|1
7854635|NCT01525628|12338867|FG000|Overall Study|Lack of Efficacy|0
7854636|NCT01525628|12338868|FG001|Overall Study|Lack of Efficacy|2
7854637|NCT01525628|12338869|FG002|Overall Study|Lack of Efficacy|2
7854638|NCT01525628|12338870|FG003|Overall Study|Lack of Efficacy|1
7854639|NCT01525628|12338871|FG004|Overall Study|Lack of Efficacy|2
7854640|NCT01525628|12338867|FG000|Overall Study|Protocol Violation|0
7854641|NCT01525628|12338868|FG001|Overall Study|Protocol Violation|0
7854642|NCT01525628|12338869|FG002|Overall Study|Protocol Violation|1
7854643|NCT01525628|12338870|FG003|Overall Study|Protocol Violation|0
7854644|NCT01525628|12338871|FG004|Overall Study|Protocol Violation|0
7854645|NCT01525628|12338867|FG000|Overall Study|Lost to Follow-up|1
7854646|NCT01525628|12338868|FG001|Overall Study|Lost to Follow-up|1
7854647|NCT01525628|12338869|FG002|Overall Study|Lost to Follow-up|0
7854648|NCT01525628|12338870|FG003|Overall Study|Lost to Follow-up|0
7854649|NCT01525628|12338871|FG004|Overall Study|Lost to Follow-up|0
7854650|NCT01525628|12338867|FG000|Overall Study|Withdrawal by Subject|0
7854651|NCT01525628|12338868|FG001|Overall Study|Withdrawal by Subject|1
7854652|NCT01525628|12338869|FG002|Overall Study|Withdrawal by Subject|0
7854653|NCT01525628|12338870|FG003|Overall Study|Withdrawal by Subject|0
7854654|NCT01525628|12338871|FG004|Overall Study|Withdrawal by Subject|0
7854655|NCT01525628|12338867|FG000|Overall Study|Other reason not defined above|0
7854656|NCT01525628|12338868|FG001|Overall Study|Other reason not defined above|0
7854657|NCT01525628|12338869|FG002|Overall Study|Other reason not defined above|0
7854658|NCT01525628|12338870|FG003|Overall Study|Other reason not defined above|3
7854659|NCT01525628|12338871|FG004|Overall Study|Other reason not defined above|0
7854660|NCT01525641|12338885|FG000|Overall Study|Case report form not collected|25
7854661|NCT01525641|12338885|FG000|Overall Study|No visit since the first visit|16
7854662|NCT01525641|12338885|FG000|Overall Study|Adverse Event|73
7854663|NCT01525641|12338885|FG000|Overall Study|Lack of Efficacy|24
7854664|NCT01525641|12338885|FG000|Overall Study|Improvement|5
7854665|NCT01525641|12338885|FG000|Overall Study|Lost to follow-up (relocation)|1
7854666|NCT01525641|12338885|FG000|Overall Study|Lost to follow-up (Unknown reason)|10
7854667|NCT01525641|12338885|FG000|Overall Study|Lost to follow-up (Changing hospital)|19
7854668|NCT01525641|12338885|FG000|Overall Study|Other than stated above|7
7854669|NCT01525849|12338906|FG000|Overall Study|Lost to Follow-up|3
7854670|NCT01525849|12338907|FG001|Overall Study|Lost to Follow-up|2
7854671|NCT01525849|12338906|FG000|Overall Study|Withdrawal by Subject|1
7854672|NCT01525849|12338907|FG001|Overall Study|Withdrawal by Subject|9
7854673|NCT01525849|12338906|FG000|Overall Study|Unrelated medical issue (not treated)|1
7854674|NCT01525849|12338907|FG001|Overall Study|Unrelated medical issue (not treated)|2
7854675|NCT01525849|12338906|FG000|Overall Study|Anatomic exclusion criteria identified|0
7854676|NCT01525849|12338907|FG001|Overall Study|Anatomic exclusion criteria identified|3
7854677|NCT01525875|12338919|FG000|Placebo-controlled Period|Withdrawal by Subject|1
7854678|NCT01525875|12338920|FG001|Placebo-controlled Period|Withdrawal by Subject|2
7854679|NCT01525875|12338919|FG000|Open-label Period|Lost to Follow-up|0
7854680|NCT01525875|12338920|FG001|Open-label Period|Lost to Follow-up|2
7854681|NCT01526057|12338929|FG000|Overall Study|Withdrawal by Subject|3
7854682|NCT01526057|12338930|FG001|Overall Study|Withdrawal by Subject|2
7854683|NCT01526057|12338931|FG002|Overall Study|Withdrawal by Subject|2
7854684|NCT01526057|12338929|FG000|Overall Study|Adverse Event|3
7854685|NCT01526057|12338930|FG001|Overall Study|Adverse Event|1
7854686|NCT01526057|12338931|FG002|Overall Study|Adverse Event|1
7854687|NCT01526057|12338929|FG000|Overall Study|Death|1
7854688|NCT01526057|12338930|FG001|Overall Study|Death|0
7854689|NCT01526057|12338931|FG002|Overall Study|Death|0
7854690|NCT01526057|12338929|FG000|Overall Study|Lost to Follow-up|1
7854691|NCT01526057|12338930|FG001|Overall Study|Lost to Follow-up|0
7854692|NCT01526057|12338931|FG002|Overall Study|Lost to Follow-up|1
7854693|NCT01526057|12338929|FG000|Overall Study|Other|1
7854694|NCT01526057|12338930|FG001|Overall Study|Other|0
7854695|NCT01526057|12338931|FG002|Overall Study|Other|1
7854696|NCT01526057|12338929|FG000|Overall Study|Protocol Violation|0
7854697|NCT01526057|12338930|FG001|Overall Study|Protocol Violation|0
7854698|NCT01526057|12338931|FG002|Overall Study|Protocol Violation|1
7863509|NCT01606306|12352851|FG002|Overall Study|Adverse Event|1
7863510|NCT01606306|12352852|FG003|Overall Study|Adverse Event|1
7863511|NCT01606306|12352853|FG004|Overall Study|Adverse Event|2
7863512|NCT01606306|12352854|FG005|Overall Study|Adverse Event|0
7863513|NCT01606306|12352849|FG000|Overall Study|Lost to Follow-up|7
7863514|NCT01606306|12352850|FG001|Overall Study|Lost to Follow-up|4
7863515|NCT01606306|12352851|FG002|Overall Study|Lost to Follow-up|5
7863516|NCT01606306|12352852|FG003|Overall Study|Lost to Follow-up|4
7863517|NCT01606306|12352853|FG004|Overall Study|Lost to Follow-up|3
7863518|NCT01606306|12352854|FG005|Overall Study|Lost to Follow-up|5
7863519|NCT01606306|12352849|FG000|Overall Study|Withdrawal by Subject|4
7863520|NCT01606306|12352850|FG001|Overall Study|Withdrawal by Subject|3
7854699|NCT01526148|12338941|FG000|Overall Study|Adverse Event|6
7854700|NCT01526148|12338942|FG001|Overall Study|Adverse Event|5
7854701|NCT01526148|12338941|FG000|Overall Study|Lost to Follow-up|3
7854702|NCT01526148|12338942|FG001|Overall Study|Lost to Follow-up|6
7854703|NCT01526148|12338941|FG000|Overall Study|Withdrawal by Subject|2
7854704|NCT01526148|12338942|FG001|Overall Study|Withdrawal by Subject|0
7854705|NCT01526148|12338941|FG000|Overall Study|Unstable Medical Condition|1
7854706|NCT01526148|12338942|FG001|Overall Study|Unstable Medical Condition|0
7854707|NCT01526148|12338941|FG000|Overall Study|Unable to discontinue concomitant med|1
7854708|NCT01526148|12338942|FG001|Overall Study|Unable to discontinue concomitant med|0
7854709|NCT01526148|12338941|FG000|Overall Study|Moved out of state|1
7854710|NCT01526148|12338942|FG001|Overall Study|Moved out of state|0
7854711|NCT01526148|12338941|FG000|Overall Study|Incarcerated|0
7854712|NCT01526148|12338942|FG001|Overall Study|Incarcerated|2
7854713|NCT01526551|12339000|FG000|Overall Study|Lack of returned parental consent form|424
7854714|NCT01526733|12339025|FG000|Phase 1|Protocol Violation|1
7854715|NCT01526733|12339026|FG001|Phase 1|Protocol Violation|0
7854716|NCT01526733|12339025|FG000|Phase 1|Withdrawal by Subject|1
7854717|NCT01526733|12339026|FG001|Phase 1|Withdrawal by Subject|1
7854718|NCT01526785|12339033|FG000|Overall Study|Study Terminated by Sponsor|8
7854719|NCT01526785|12339033|FG000|Overall Study|Death|2
7854720|NCT01526785|12339033|FG000|Overall Study|Physician Decision|1
7854721|NCT01526785|12339033|FG000|Overall Study|Withdrawal by Subject|2
7854722|NCT01526889|12339039|FG000|Treatment Period|Adverse Event|2
7854723|NCT01526889|12339040|FG001|Treatment Period|Adverse Event|0
7854724|NCT01526889|12339039|FG000|Treatment Extension Period|Administrative problems|1
7854725|NCT01526889|12339040|FG001|Treatment Extension Period|Administrative problems|0
7854726|NCT01526928|12339059|FG000|Overall Study|Progressive Disease|35
7854727|NCT01526928|12339060|FG001|Overall Study|Progressive Disease|17
7854728|NCT01526928|12339061|FG002|Overall Study|Progressive Disease|150
7854729|NCT01526928|12339062|FG003|Overall Study|Progressive Disease|182
7854730|NCT01526928|12339063|FG004|Overall Study|Progressive Disease|76
7854731|NCT01526928|12339064|FG005|Overall Study|Progressive Disease|4
7854732|NCT01526928|12339059|FG000|Overall Study|Adverse Event|2
7854733|NCT01526928|12339060|FG001|Overall Study|Adverse Event|1
7854734|NCT01526928|12339061|FG002|Overall Study|Adverse Event|29
7854735|NCT01526928|12339062|FG003|Overall Study|Adverse Event|40
7854736|NCT01526928|12339063|FG004|Overall Study|Adverse Event|13
7854737|NCT01526928|12339064|FG005|Overall Study|Adverse Event|2
7854738|NCT01526928|12339059|FG000|Overall Study|Death|0
7854739|NCT01526928|12339060|FG001|Overall Study|Death|0
7854740|NCT01526928|12339061|FG002|Overall Study|Death|3
7854741|NCT01526928|12339062|FG003|Overall Study|Death|0
7854742|NCT01526928|12339063|FG004|Overall Study|Death|0
7854743|NCT01526928|12339064|FG005|Overall Study|Death|0
7854744|NCT01526928|12339059|FG000|Overall Study|Withdrawal by Subject|1
7854745|NCT01526928|12339060|FG001|Overall Study|Withdrawal by Subject|0
7854746|NCT01526928|12339061|FG002|Overall Study|Withdrawal by Subject|13
7854747|NCT01526928|12339062|FG003|Overall Study|Withdrawal by Subject|11
7854748|NCT01526928|12339063|FG004|Overall Study|Withdrawal by Subject|3
7854749|NCT01526928|12339064|FG005|Overall Study|Withdrawal by Subject|0
7854750|NCT01526928|12339059|FG000|Overall Study|Physician Decision|0
7854751|NCT01526928|12339060|FG001|Overall Study|Physician Decision|0
7854752|NCT01526928|12339061|FG002|Overall Study|Physician Decision|2
7854753|NCT01526928|12339062|FG003|Overall Study|Physician Decision|5
7854754|NCT01526928|12339063|FG004|Overall Study|Physician Decision|0
7854755|NCT01526928|12339064|FG005|Overall Study|Physician Decision|0
7854756|NCT01526928|12339059|FG000|Overall Study|Other Reason|0
7854757|NCT01526928|12339060|FG001|Overall Study|Other Reason|1
7854758|NCT01526928|12339061|FG002|Overall Study|Other Reason|11
7854759|NCT01526928|12339062|FG003|Overall Study|Other Reason|4
7854760|NCT01526928|12339063|FG004|Overall Study|Other Reason|1
7854761|NCT01526928|12339064|FG005|Overall Study|Other Reason|0
7854762|NCT01526928|12339059|FG000|Overall Study|Lost to Follow-up|0
7854763|NCT01526928|12339060|FG001|Overall Study|Lost to Follow-up|0
7854764|NCT01526928|12339061|FG002|Overall Study|Lost to Follow-up|0
7854765|NCT01526928|12339062|FG003|Overall Study|Lost to Follow-up|1
7854766|NCT01526928|12339063|FG004|Overall Study|Lost to Follow-up|0
7854767|NCT01526928|12339064|FG005|Overall Study|Lost to Follow-up|0
7854768|NCT01526928|12339059|FG000|Overall Study|Protocol Deviation|0
7854769|NCT01526928|12339060|FG001|Overall Study|Protocol Deviation|0
7854770|NCT01526928|12339061|FG002|Overall Study|Protocol Deviation|0
7854771|NCT01526928|12339062|FG003|Overall Study|Protocol Deviation|2
7854772|NCT01526928|12339063|FG004|Overall Study|Protocol Deviation|0
7854773|NCT01526928|12339064|FG005|Overall Study|Protocol Deviation|0
7854774|NCT01526928|12339059|FG000|Overall Study|Missing|0
7854775|NCT01526928|12339060|FG001|Overall Study|Missing|0
7854776|NCT01526928|12339061|FG002|Overall Study|Missing|1
7854777|NCT01526928|12339062|FG003|Overall Study|Missing|0
7854778|NCT01526928|12339063|FG004|Overall Study|Missing|2
7854779|NCT01526928|12339064|FG005|Overall Study|Missing|0
7854780|NCT01527006|12339122|FG000|Core Study|Adverse Event|0
7854781|NCT01527006|12339123|FG001|Core Study|Adverse Event|2
7854782|NCT01527006|12339122|FG000|Core Study|Lost to Follow-up|0
7854783|NCT01527006|12339123|FG001|Core Study|Lost to Follow-up|1
7854784|NCT01527006|12339122|FG000|Core Study|Subject Choice|1
7854785|NCT01527006|12339123|FG001|Core Study|Subject Choice|0
7854786|NCT01527006|12339122|FG000|Core Study|Inadequate Therapeutic Effect|1
7854787|NCT01527006|12339123|FG001|Core Study|Inadequate Therapeutic Effect|0
7854788|NCT01527006|12339122|FG000|Core Study|Withdrawal by Subject|0
7854789|NCT01527006|12339123|FG001|Core Study|Withdrawal by Subject|1
7854790|NCT01527006|12339122|FG000|Core Study|Other|0
7854791|NCT01527006|12339123|FG001|Core Study|Other|2
7854792|NCT01527006|12339122|FG000|Extension Phase|Adverse Event|4
7854793|NCT01527006|12339123|FG001|Extension Phase|Adverse Event|2
7854794|NCT01527006|12339122|FG000|Extension Phase|Lost to Follow-up|0
7854795|NCT01527006|12339123|FG001|Extension Phase|Lost to Follow-up|1
7854796|NCT01527006|12339122|FG000|Extension Phase|Subject Choice|1
7854797|NCT01527006|12339123|FG001|Extension Phase|Subject Choice|1
7854798|NCT01527006|12339122|FG000|Extension Phase|Inadequate therapeutic effect|1
7854799|NCT01527006|12339123|FG001|Extension Phase|Inadequate therapeutic effect|1
7854800|NCT01527006|12339122|FG000|Extension Phase|Other|0
7854801|NCT01527006|12339123|FG001|Extension Phase|Other|3
7854802|NCT01527110|12339148|FG000|Overall Study|Adverse Event|1
7854803|NCT01527357|12339163|FG000|Overall Study|Death|8
7854804|NCT01527357|12339164|FG001|Overall Study|Death|2
7854805|NCT01527357|12339163|FG000|Overall Study|Lost to Follow-up|6
7854806|NCT01527357|12339164|FG001|Overall Study|Lost to Follow-up|4
7854807|NCT01527357|12339163|FG000|Overall Study|Withdrew Consent|1
7854808|NCT01527357|12339164|FG001|Overall Study|Withdrew Consent|1
7854809|NCT01527357|12339163|FG000|Overall Study|Non-compliance|0
7854810|NCT01527357|12339164|FG001|Overall Study|Non-compliance|1
7854811|NCT01527357|12339163|FG000|Overall Study|No Day 29 Visit|0
7854812|NCT01527357|12339164|FG001|Overall Study|No Day 29 Visit|1
7854813|NCT01527357|12339163|FG000|Overall Study|Did Not Receive Treatment|2
7854814|NCT01527357|12339164|FG001|Overall Study|Did Not Receive Treatment|0
7854815|NCT01527370|12339170|FG000|Overall Study|Withdrawal by Subject|4
7854816|NCT01527370|12339170|FG000|Overall Study|Physician Decision|1
7854817|NCT01527370|12339170|FG000|Overall Study|Death|1
7854818|NCT01527383|12339176|FG000|Overall Study|Adverse Event|5
7854819|NCT01527383|12339177|FG001|Overall Study|Adverse Event|0
7854820|NCT01527383|12339176|FG000|Overall Study|Lost to Follow-up|3
7854821|NCT01527383|12339177|FG001|Overall Study|Lost to Follow-up|0
7854822|NCT01527383|12339176|FG000|Overall Study|Physician Decision|2
7854823|NCT01527383|12339177|FG001|Overall Study|Physician Decision|0
7854824|NCT01527383|12339176|FG000|Overall Study|Pregnancy|1
7854825|NCT01527383|12339177|FG001|Overall Study|Pregnancy|0
7854826|NCT01527383|12339176|FG000|Overall Study|Protocol Violation|1
7854827|NCT01527383|12339177|FG001|Overall Study|Protocol Violation|0
7854828|NCT01527383|12339176|FG000|Overall Study|Screen failure|1
7854829|NCT01527383|12339177|FG001|Overall Study|Screen failure|0
7854830|NCT01527383|12339176|FG000|Overall Study|Participant moved|0
7854831|NCT01527383|12339177|FG001|Overall Study|Participant moved|1
7854832|NCT01527383|12339176|FG000|Overall Study|Withdrawal by Subject|2
7854833|NCT01527383|12339177|FG001|Overall Study|Withdrawal by Subject|3
7854834|NCT01527487|12339185|FG000|Overall Study|MD Discretion/Lack of Efficacy|3
7854835|NCT01527487|12339186|FG001|Overall Study|MD Discretion/Lack of Efficacy|4
7854836|NCT01527487|12339185|FG000|Overall Study|Disease Progression|4
7854837|NCT01527487|12339186|FG001|Overall Study|Disease Progression|1
7854838|NCT01527487|12339185|FG000|Overall Study|Adverse Event|1
7854839|NCT01527487|12339186|FG001|Overall Study|Adverse Event|1
7854840|NCT01527487|12339185|FG000|Overall Study|Death|0
7854841|NCT01527487|12339186|FG001|Overall Study|Death|1
7854842|NCT01527500|12339201|FG000|Part A|Administrative|11
7854843|NCT01527500|12339202|FG001|Part A|Administrative|7
7854844|NCT01527500|12339201|FG000|Part A|Adverse Event|4
7854845|NCT01527500|12339202|FG001|Part A|Adverse Event|2
7854846|NCT01527500|12339201|FG000|Part A|Death|4
7854847|NCT01527500|12339202|FG001|Part A|Death|1
7854848|NCT01527500|12339201|FG000|Part A|Lost to Follow-up|0
7854849|NCT01527500|12339202|FG001|Part A|Lost to Follow-up|1
7854850|NCT01527500|12339201|FG000|Part A|Protocol Deviation|9
7854851|NCT01527500|12339202|FG001|Part A|Protocol Deviation|2
7854852|NCT01527500|12339201|FG000|Part A|Withdrawal by Subject|2
7854853|NCT01527500|12339202|FG001|Part A|Withdrawal by Subject|0
7854854|NCT01527500|12339201|FG000|Part B|Adverse Event|1
7854855|NCT01527500|12339202|FG001|Part B|Adverse Event|0
7854856|NCT01527682|12339229|FG000|Overall Study|Protocol Violation|8
7854857|NCT01528033|12339235|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8
7854858|NCT01528033|12339236|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7
7854859|NCT01528033|12339235|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
7854860|NCT01528033|12339236|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
7854861|NCT01528033|12339235|FG000|Primary Endpoint Assessment ITT|Death|2
7854862|NCT01528033|12339236|FG001|Primary Endpoint Assessment ITT|Death|2
7854863|NCT01528033|12339235|FG000|Primary Endpoint Assessment ITT|Physician Decision|2
7854864|NCT01528033|12339236|FG001|Primary Endpoint Assessment ITT|Physician Decision|1
7854865|NCT01528033|12339235|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2
7854866|NCT01528033|12339236|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2
7854867|NCT01528033|12339235|FG000|Follow Up|No data available|46
7854868|NCT01528033|12339236|FG001|Follow Up|No data available|44
7854869|NCT01528072|12339242|FG000|Overall Study|Withdrawal by Subject|5
7854870|NCT01528072|12339242|FG000|Overall Study|Physician Decision|1
7854871|NCT01528072|12339242|FG000|Overall Study|Determined not eligible by AEAC|1
7854872|NCT01528072|12339242|FG000|Overall Study|Missed Visit|2
7854873|NCT01528072|12339242|FG000|Overall Study|Lost to Follow-up|5
7854874|NCT01528072|12339242|FG000|Overall Study|Explanted|2
7854875|NCT01528072|12339242|FG000|Overall Study|Site Closure|4
7854876|NCT01528072|12339242|FG000|Overall Study|Death|2
7854877|NCT01528072|12339242|FG000|Overall Study|Early Termination of Study|52
7854878|NCT01528215|12339287|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4
7854879|NCT01528215|12339288|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1
7854880|NCT01528215|12339287|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
7854881|NCT01528215|12339288|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
7854882|NCT01528215|12339287|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10
7854883|NCT01528215|12339288|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13
7854884|NCT01528215|12339287|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3
7854885|NCT01528215|12339288|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0
7720939|NCT00542178|12145440|FG000|Overall Study|did not complete year 4 follow-up|75
7720940|NCT00542178|12145441|FG001|Overall Study|did not complete year 4 follow-up|80
7854886|NCT01528254|12339305|FG000|Overall Study|Administrative problems|96
7854887|NCT01528254|12339306|FG001|Overall Study|Administrative problems|94
7854888|NCT01528254|12339305|FG000|Overall Study|Adverse Event|28
7854889|NCT01528254|12339306|FG001|Overall Study|Adverse Event|44
7854890|NCT01528254|12339305|FG000|Overall Study|Lost to Follow-up|17
7949641|NCT02540993|12495466|FG001|Overall Study|Withdrawal by Subject|6
7949642|NCT02540993|12495465|FG000|Overall Study|GCP violations|33
7949643|NCT02540993|12495466|FG001|Overall Study|GCP violations|27
7949644|NCT02541604|12495504|FG000|Overall Study|Death|6
7949645|NCT02541604|12495505|FG001|Overall Study|Death|5
7949646|NCT02541604|12495506|FG002|Overall Study|Death|7
7949647|NCT02541604|12495507|FG003|Overall Study|Death|2
7949648|NCT02541604|12495508|FG004|Overall Study|Death|9
7949649|NCT02541604|12495509|FG005|Overall Study|Death|8
7949650|NCT02541604|12495510|FG006|Overall Study|Death|9
7949651|NCT02541604|12495511|FG007|Overall Study|Death|9
7949652|NCT02541604|12495512|FG008|Overall Study|Death|3
7949653|NCT02541604|12495513|FG009|Overall Study|Death|4
7949654|NCT02541604|12495514|FG010|Overall Study|Death|2
7949655|NCT02541604|12495515|FG011|Overall Study|Death|3
7854891|NCT01528254|12339306|FG001|Overall Study|Lost to Follow-up|24
7854892|NCT01528254|12339305|FG000|Overall Study|Death|13
7854893|NCT01528254|12339306|FG001|Overall Study|Death|9
7854894|NCT01528254|12339305|FG000|Overall Study|Protocol deviation|9
7854895|NCT01528254|12339306|FG001|Overall Study|Protocol deviation|19
7854896|NCT01528254|12339305|FG000|Overall Study|New therapy for study indication|8
7854897|NCT01528254|12339306|FG001|Overall Study|New therapy for study indication|6
7854898|NCT01528254|12339305|FG000|Overall Study|Unsatisfactory therapeutic effect|6
7854899|NCT01528254|12339306|FG001|Overall Study|Unsatisfactory therapeutic effect|8
7854900|NCT01528254|12339305|FG000|Overall Study|Withdrawal by Subject|5
7854901|NCT01528254|12339306|FG001|Overall Study|Withdrawal by Subject|4
7854902|NCT01528254|12339305|FG000|Overall Study|Abnormal laboratory value(s)|3
7854903|NCT01528254|12339306|FG001|Overall Study|Abnormal laboratory value(s)|7
7854904|NCT01528254|12339305|FG000|Overall Study|Abnormal test procedure result(s)|1
7854905|NCT01528254|12339306|FG001|Overall Study|Abnormal test procedure result(s)|0
7949656|NCT02541604|12495504|FG000|Overall Study|Lost to Follow-up|2
7949657|NCT02541604|12495505|FG001|Overall Study|Lost to Follow-up|0
7949658|NCT02541604|12495506|FG002|Overall Study|Lost to Follow-up|1
7949659|NCT02541604|12495507|FG003|Overall Study|Lost to Follow-up|0
7949660|NCT02541604|12495508|FG004|Overall Study|Lost to Follow-up|0
7854906|NCT01528254|12339305|FG000|Overall Study|No longer requires study drug|1
7854907|NCT01528254|12339306|FG001|Overall Study|No longer requires study drug|1
7854908|NCT01528345|12339328|FG000|Overall Study|Adverse Event|10
7854909|NCT01528345|12339329|FG001|Overall Study|Adverse Event|1
7854910|NCT01528345|12339328|FG000|Overall Study|Death|1
7854911|NCT01528345|12339329|FG001|Overall Study|Death|1
7854912|NCT01528345|12339328|FG000|Overall Study|Non-compliance with study treatment|1
7854913|NCT01528345|12339329|FG001|Overall Study|Non-compliance with study treatment|0
7854914|NCT01528345|12339328|FG000|Overall Study|Progressive Disease|26
7854915|NCT01528345|12339329|FG001|Overall Study|Progressive Disease|40
7854916|NCT01528345|12339328|FG000|Overall Study|Study Terminated by Sponsor|4
7854917|NCT01528345|12339329|FG001|Overall Study|Study Terminated by Sponsor|8
7854918|NCT01528345|12339328|FG000|Overall Study|Subject/Guardian Decision|5
7854919|NCT01528345|12339329|FG001|Overall Study|Subject/Guardian Decision|0
7854920|NCT01528605|12339345|FG000|Overall Study|Lost to Follow-up|1
7854921|NCT01528605|12339346|FG001|Overall Study|Lost to Follow-up|0
7854922|NCT01528605|12339347|FG002|Overall Study|Lost to Follow-up|1
7854923|NCT01528605|12339348|FG003|Overall Study|Lost to Follow-up|1
7854924|NCT01528605|12339349|FG004|Overall Study|Lost to Follow-up|0
7854925|NCT01528605|12339350|FG005|Overall Study|Lost to Follow-up|0
7854926|NCT01528605|12339345|FG000|Overall Study|Death|1
7854927|NCT01528605|12339346|FG001|Overall Study|Death|0
7854928|NCT01528605|12339347|FG002|Overall Study|Death|0
7854929|NCT01528605|12339348|FG003|Overall Study|Death|0
7854930|NCT01528605|12339349|FG004|Overall Study|Death|0
7854931|NCT01528605|12339350|FG005|Overall Study|Death|0
7854932|NCT01528709|12339366|FG000|Overall Study|Death|2
7854933|NCT01528709|12339367|FG001|Overall Study|Death|0
7854934|NCT01528709|12339366|FG000|Overall Study|Withdrawal by Subject|10
7854935|NCT01528709|12339367|FG001|Overall Study|Withdrawal by Subject|15
7854936|NCT01528709|12339366|FG000|Overall Study|allergy|1
7854937|NCT01528709|12339367|FG001|Overall Study|allergy|0
7854938|NCT01528735|12339375|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
7854939|NCT01528735|12339376|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
7854940|NCT01528735|12339375|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
7854941|NCT01528735|12339376|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
7854942|NCT01528787|12339388|FG000|Overall Study|Withdrawal by Subject|0
7854943|NCT01528787|12339389|FG001|Overall Study|Withdrawal by Subject|0
7854944|NCT01528787|12339390|FG002|Overall Study|Withdrawal by Subject|0
7854945|NCT01528787|12339391|FG003|Overall Study|Withdrawal by Subject|1
7854946|NCT01528787|12339388|FG000|Overall Study|Family Emergency|0
7854947|NCT01528787|12339389|FG001|Overall Study|Family Emergency|0
7854948|NCT01528787|12339390|FG002|Overall Study|Family Emergency|1
7854949|NCT01528787|12339391|FG003|Overall Study|Family Emergency|0
7854950|NCT01528969|12339420|FG000|Overall Study|absent from the school at baseline|2
7854951|NCT01528969|12339421|FG001|Overall Study|absent from the school at baseline|0
7854952|NCT01529034|12339427|FG000|Overall Study|Discontinued prior to study treatment|14
7854953|NCT01529034|12339427|FG000|Overall Study|Site closure|62
7854954|NCT01529034|12339427|FG000|Overall Study|Study termination|29
7854955|NCT01529034|12339427|FG000|Overall Study|Withdrawal by Subject|25
7854956|NCT01529034|12339427|FG000|Overall Study|No treated SCs within protocol window|13
7854957|NCT01529034|12339427|FG000|Overall Study|Noncompliance|8
7854958|NCT01529034|12339427|FG000|Overall Study|Caregiver no longer available|7
7854959|NCT01529034|12339427|FG000|Overall Study|Adverse Event|4
7854960|NCT01529034|12339427|FG000|Overall Study|Protocol Violation|4
7854961|NCT01529034|12339427|FG000|Overall Study|Lack of Efficacy|4
7854962|NCT01529034|12339427|FG000|Overall Study|Investigator no longer available|2
7854963|NCT01529034|12339427|FG000|Overall Study|Study drug not available|2
7854964|NCT01529112|12339444|FG000|Overall Study|Adverse Event|2
7854965|NCT01529112|12339445|FG001|Overall Study|Adverse Event|0
7854966|NCT01529112|12339444|FG000|Overall Study|Death|59
7854967|NCT01529112|12339445|FG001|Overall Study|Death|38
7854968|NCT01529112|12339444|FG000|Overall Study|Protocol Violation|1
7854969|NCT01529112|12339445|FG001|Overall Study|Protocol Violation|0
7854970|NCT01529112|12339444|FG000|Overall Study|Withdrawal by Subject|7
7854971|NCT01529112|12339445|FG001|Overall Study|Withdrawal by Subject|3
7854972|NCT01529268|12339457|FG000|Overall Study|Lost to Follow-up|9
7854973|NCT01529268|12339458|FG001|Overall Study|Lost to Follow-up|3
7854974|NCT01529268|12339457|FG000|Overall Study|Moved|3
7854975|NCT01529268|12339458|FG001|Overall Study|Moved|0
7854976|NCT01529346|12339469|FG000|Overall Study|Lost to Follow-up|2
7854977|NCT01529346|12339470|FG001|Overall Study|Lost to Follow-up|0
7854978|NCT01529346|12339471|FG002|Overall Study|Lost to Follow-up|1
7854979|NCT01529346|12339472|FG003|Overall Study|Lost to Follow-up|0
7854980|NCT01529346|12339473|FG004|Overall Study|Lost to Follow-up|0
7854981|NCT01529346|12339469|FG000|Overall Study|Other|0
7854982|NCT01529346|12339470|FG001|Overall Study|Other|1
7854983|NCT01529346|12339471|FG002|Overall Study|Other|1
7854984|NCT01529346|12339472|FG003|Overall Study|Other|0
7854985|NCT01529346|12339473|FG004|Overall Study|Other|0
7854986|NCT01529385|12339488|FG000|Overall Study|Lost to Follow-up|2
7854987|NCT01529385|12339489|FG001|Overall Study|Lost to Follow-up|1
7854988|NCT01529515|12339526|FG000|TRANSITION PHASE|Adverse Event|16
7854989|NCT01529515|12339527|FG001|TRANSITION PHASE|Adverse Event|0
7854990|NCT01529515|12339528|FG002|TRANSITION PHASE|Adverse Event|0
7854991|NCT01529515|12339529|FG003|TRANSITION PHASE|Adverse Event|0
7854992|NCT01529515|12339526|FG000|TRANSITION PHASE|Death|1
7854993|NCT01529515|12339527|FG001|TRANSITION PHASE|Death|0
7854994|NCT01529515|12339528|FG002|TRANSITION PHASE|Death|0
7854995|NCT01529515|12339529|FG003|TRANSITION PHASE|Death|0
7854996|NCT01529515|12339526|FG000|TRANSITION PHASE|Lack of Efficacy|19
7854997|NCT01529515|12339527|FG001|TRANSITION PHASE|Lack of Efficacy|0
7854998|NCT01529515|12339528|FG002|TRANSITION PHASE|Lack of Efficacy|0
7854999|NCT01529515|12339529|FG003|TRANSITION PHASE|Lack of Efficacy|0
7855000|NCT01529515|12339526|FG000|TRANSITION PHASE|Lost to Follow-up|19
7855001|NCT01529515|12339527|FG001|TRANSITION PHASE|Lost to Follow-up|0
7855002|NCT01529515|12339528|FG002|TRANSITION PHASE|Lost to Follow-up|0
7855003|NCT01529515|12339529|FG003|TRANSITION PHASE|Lost to Follow-up|0
7855004|NCT01529515|12339526|FG000|TRANSITION PHASE|Protocol Violation|4
7855005|NCT01529515|12339527|FG001|TRANSITION PHASE|Protocol Violation|0
7855006|NCT01529515|12339528|FG002|TRANSITION PHASE|Protocol Violation|0
7855007|NCT01529515|12339529|FG003|TRANSITION PHASE|Protocol Violation|0
7855008|NCT01529515|12339526|FG000|TRANSITION PHASE|Withdrawal by Subject|51
7855009|NCT01529515|12339527|FG001|TRANSITION PHASE|Withdrawal by Subject|0
7855010|NCT01529515|12339528|FG002|TRANSITION PHASE|Withdrawal by Subject|0
7855011|NCT01529515|12339529|FG003|TRANSITION PHASE|Withdrawal by Subject|0
7855012|NCT01529515|12339526|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
7855013|NCT01529515|12339527|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
7855014|NCT01529515|12339528|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
7855015|NCT01529515|12339529|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
7855016|NCT01529515|12339526|FG000|TRANSITION PHASE|Other|9
7855017|NCT01529515|12339527|FG001|TRANSITION PHASE|Other|0
7855018|NCT01529515|12339528|FG002|TRANSITION PHASE|Other|0
7855019|NCT01529515|12339529|FG003|TRANSITION PHASE|Other|0
7855020|NCT01529515|12339526|FG000|MAINTENANCE PHASE|Adverse Event|0
7855021|NCT01529515|12339527|FG001|MAINTENANCE PHASE|Adverse Event|10
7855022|NCT01529515|12339528|FG002|MAINTENANCE PHASE|Adverse Event|0
7855023|NCT01529515|12339529|FG003|MAINTENANCE PHASE|Adverse Event|0
7855024|NCT01529515|12339526|FG000|MAINTENANCE PHASE|Lack of Efficacy|0
7855025|NCT01529515|12339527|FG001|MAINTENANCE PHASE|Lack of Efficacy|9
7855026|NCT01529515|12339528|FG002|MAINTENANCE PHASE|Lack of Efficacy|0
7855027|NCT01529515|12339529|FG003|MAINTENANCE PHASE|Lack of Efficacy|0
7855028|NCT01529515|12339526|FG000|MAINTENANCE PHASE|Lost to Follow-up|0
7855029|NCT01529515|12339527|FG001|MAINTENANCE PHASE|Lost to Follow-up|5
7855030|NCT01529515|12339528|FG002|MAINTENANCE PHASE|Lost to Follow-up|0
7855031|NCT01529515|12339529|FG003|MAINTENANCE PHASE|Lost to Follow-up|0
7855032|NCT01529515|12339526|FG000|MAINTENANCE PHASE|Protocol Violation|0
7855033|NCT01529515|12339527|FG001|MAINTENANCE PHASE|Protocol Violation|12
7855034|NCT01529515|12339528|FG002|MAINTENANCE PHASE|Protocol Violation|0
7855035|NCT01529515|12339529|FG003|MAINTENANCE PHASE|Protocol Violation|0
7855036|NCT01529515|12339526|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0
7855037|NCT01529515|12339527|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15
7855038|NCT01529515|12339528|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0
7855039|NCT01529515|12339529|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0
7855040|NCT01529515|12339526|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0
7855041|NCT01529515|12339527|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13
7855042|NCT01529515|12339528|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0
7855043|NCT01529515|12339529|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0
7855044|NCT01529515|12339526|FG000|MAINTENANCE PHASE|Other|0
7855045|NCT01529515|12339527|FG001|MAINTENANCE PHASE|Other|10
7855046|NCT01529515|12339528|FG002|MAINTENANCE PHASE|Other|0
7855047|NCT01529515|12339529|FG003|MAINTENANCE PHASE|Other|0
7855048|NCT01529515|12339526|FG000|DOUBLE BLIND PHASE|Adverse Event|0
7855049|NCT01529515|12339527|FG001|DOUBLE BLIND PHASE|Adverse Event|0
7855050|NCT01529515|12339528|FG002|DOUBLE BLIND PHASE|Adverse Event|1
7855051|NCT01529515|12339529|FG003|DOUBLE BLIND PHASE|Adverse Event|0
7855052|NCT01529515|12339526|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0
7855053|NCT01529515|12339527|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0
7855054|NCT01529515|12339528|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1
7855055|NCT01529515|12339529|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3
7855056|NCT01529515|12339526|FG000|DOUBLE BLIND PHASE|Pregnancy|0
7855057|NCT01529515|12339527|FG001|DOUBLE BLIND PHASE|Pregnancy|0
7855058|NCT01529515|12339528|FG002|DOUBLE BLIND PHASE|Pregnancy|1
7855059|NCT01529515|12339529|FG003|DOUBLE BLIND PHASE|Pregnancy|0
7855060|NCT01529515|12339526|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0
7855061|NCT01529515|12339527|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0
7855062|NCT01529515|12339528|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10
7855063|NCT01529515|12339529|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7
7855064|NCT01529515|12339526|FG000|DOUBLE BLIND PHASE|Protocol Violation|0
7855065|NCT01529515|12339527|FG001|DOUBLE BLIND PHASE|Protocol Violation|0
7855066|NCT01529515|12339528|FG002|DOUBLE BLIND PHASE|Protocol Violation|1
7855067|NCT01529515|12339529|FG003|DOUBLE BLIND PHASE|Protocol Violation|0
7855068|NCT01529515|12339526|FG000|DOUBLE BLIND PHASE|Other|0
7855069|NCT01529515|12339527|FG001|DOUBLE BLIND PHASE|Other|0
7855070|NCT01529515|12339528|FG002|DOUBLE BLIND PHASE|Other|9
7855071|NCT01529515|12339529|FG003|DOUBLE BLIND PHASE|Other|2
7855072|NCT01529606|12339538|FG000|Overall Study|Lost to Follow-up|21
7855073|NCT01529606|12339539|FG001|Overall Study|Lost to Follow-up|18
7855074|NCT01529632|12339547|FG000|Overall Study|Administrative problem|2
7855075|NCT01529632|12339548|FG001|Overall Study|Administrative problem|1
7855076|NCT01529632|12339547|FG000|Overall Study|Protocol Violation|0
7855077|NCT01529632|12339548|FG001|Overall Study|Protocol Violation|1
7855078|NCT01529632|12339547|FG000|Overall Study|Adverse Event|1
7855079|NCT01529632|12339548|FG001|Overall Study|Adverse Event|1
7855080|NCT01529645|12339564|FG000|Overall Study|Lost to Follow-up|0
7855081|NCT01529645|12339565|FG001|Overall Study|Lost to Follow-up|1
7855082|NCT01529645|12339566|FG002|Overall Study|Lost to Follow-up|1
7855083|NCT01529645|12339567|FG003|Overall Study|Lost to Follow-up|1
7855084|NCT01529645|12339568|FG004|Overall Study|Lost to Follow-up|1
7855085|NCT01529645|12339569|FG005|Overall Study|Lost to Follow-up|0
7855086|NCT01529645|12339570|FG006|Overall Study|Lost to Follow-up|2
7855087|NCT01529645|12339571|FG007|Overall Study|Lost to Follow-up|0
7855088|NCT01529645|12339572|FG008|Overall Study|Lost to Follow-up|1
7855089|NCT01529645|12339573|FG009|Overall Study|Lost to Follow-up|0
7855090|NCT01529645|12339564|FG000|Overall Study|SAE - Premature contractions|0
7855091|NCT01529645|12339565|FG001|Overall Study|SAE - Premature contractions|0
7855092|NCT01529645|12339566|FG002|Overall Study|SAE - Premature contractions|1
7855093|NCT01529645|12339567|FG003|Overall Study|SAE - Premature contractions|0
7855094|NCT01529645|12339568|FG004|Overall Study|SAE - Premature contractions|0
7855095|NCT01529645|12339569|FG005|Overall Study|SAE - Premature contractions|0
7855096|NCT01529645|12339570|FG006|Overall Study|SAE - Premature contractions|0
7855097|NCT01529645|12339571|FG007|Overall Study|SAE - Premature contractions|0
7855098|NCT01529645|12339572|FG008|Overall Study|SAE - Premature contractions|0
7855099|NCT01529645|12339573|FG009|Overall Study|SAE - Premature contractions|0
7855100|NCT01529645|12339564|FG000|Overall Study|Withdrawal by Subject|2
7855101|NCT01529645|12339565|FG001|Overall Study|Withdrawal by Subject|0
7855102|NCT01529645|12339566|FG002|Overall Study|Withdrawal by Subject|0
7855103|NCT01529645|12339567|FG003|Overall Study|Withdrawal by Subject|1
7855104|NCT01529645|12339568|FG004|Overall Study|Withdrawal by Subject|1
7855105|NCT01529645|12339569|FG005|Overall Study|Withdrawal by Subject|1
7855106|NCT01529645|12339570|FG006|Overall Study|Withdrawal by Subject|0
7855107|NCT01529645|12339571|FG007|Overall Study|Withdrawal by Subject|0
7855108|NCT01529645|12339572|FG008|Overall Study|Withdrawal by Subject|0
7855109|NCT01529645|12339573|FG009|Overall Study|Withdrawal by Subject|0
7855110|NCT01529749|12339607|FG000|Overall Study|Lost to Follow-up|0
7855111|NCT01529749|12339608|FG001|Overall Study|Lost to Follow-up|1
7855112|NCT01529749|12339609|FG002|Overall Study|Lost to Follow-up|1
7855113|NCT01529749|12339610|FG003|Overall Study|Lost to Follow-up|0
7855114|NCT01529749|12339607|FG000|Overall Study|Physician Decision|0
7855115|NCT01529749|12339608|FG001|Overall Study|Physician Decision|0
7855116|NCT01529749|12339609|FG002|Overall Study|Physician Decision|0
7855117|NCT01529749|12339610|FG003|Overall Study|Physician Decision|1
7855118|NCT01529749|12339607|FG000|Overall Study|Withdrawal by Subject|0
7855119|NCT01529749|12339608|FG001|Overall Study|Withdrawal by Subject|1
7855120|NCT01529749|12339609|FG002|Overall Study|Withdrawal by Subject|1
7855121|NCT01529749|12339610|FG003|Overall Study|Withdrawal by Subject|0
7855122|NCT01529749|12339607|FG000|Overall Study|Protocol Violation|0
7855123|NCT01529749|12339608|FG001|Overall Study|Protocol Violation|0
7855124|NCT01529749|12339609|FG002|Overall Study|Protocol Violation|0
7855125|NCT01529749|12339610|FG003|Overall Study|Protocol Violation|1
7855126|NCT01530256|12339655|FG000|Overall Study|Death|2
7855127|NCT01530334|12339659|FG000|Overall Study|Adverse Event|3
7855128|NCT01530334|12339659|FG000|Overall Study|unknown reason|1
7855129|NCT01530334|12339659|FG000|Overall Study|Progressive disease|47
7855130|NCT01530464|12339690|FG000|Washout (24h)|Withdrawal by Subject|1
7855131|NCT01530464|12339691|FG001|Washout (24h)|Withdrawal by Subject|0
7855132|NCT01530464|12339690|FG000|Washout (24h)|Withdrawal by Subject|0
7855133|NCT01530464|12339691|FG001|Washout (24h)|Withdrawal by Subject|1
7855134|NCT01531153|12339716|FG000|Overall Study|Withdrawal by Subject|10
7855135|NCT01531153|12339717|FG001|Overall Study|Withdrawal by Subject|9
7855136|NCT01531153|12339718|FG002|Overall Study|Withdrawal by Subject|15
7855137|NCT01531205|12339729|FG000|Overall Study|Did not proceed to surgery|1
7855138|NCT01531673|12339766|FG000|Overall Study|Non-Compliance|0
7855139|NCT01531673|12339767|FG001|Overall Study|Non-Compliance|0
7855140|NCT01531673|12339768|FG002|Overall Study|Non-Compliance|0
7855141|NCT01531673|12339769|FG003|Overall Study|Non-Compliance|0
7855142|NCT01531673|12339770|FG004|Overall Study|Non-Compliance|0
7855143|NCT01531673|12339771|FG005|Overall Study|Non-Compliance|1
7855144|NCT01531673|12339772|FG006|Overall Study|Non-Compliance|0
7855145|NCT01531673|12339773|FG007|Overall Study|Non-Compliance|0
7855146|NCT01531673|12339774|FG008|Overall Study|Non-Compliance|0
7855147|NCT01531673|12339775|FG009|Overall Study|Non-Compliance|0
7855148|NCT01531673|12339776|FG010|Overall Study|Non-Compliance|0
7855149|NCT01531673|12339777|FG011|Overall Study|Non-Compliance|0
7855150|NCT01531673|12339778|FG012|Overall Study|Non-Compliance|0
7855151|NCT01531673|12339766|FG000|Overall Study|Adverse Event|0
7855152|NCT01531673|12339767|FG001|Overall Study|Adverse Event|1
7855153|NCT01531673|12339768|FG002|Overall Study|Adverse Event|0
7855154|NCT01531673|12339769|FG003|Overall Study|Adverse Event|0
7855155|NCT01531673|12339770|FG004|Overall Study|Adverse Event|0
7855156|NCT01531673|12339771|FG005|Overall Study|Adverse Event|0
7855157|NCT01531673|12339772|FG006|Overall Study|Adverse Event|0
7855158|NCT01531673|12339773|FG007|Overall Study|Adverse Event|0
7855159|NCT01531673|12339774|FG008|Overall Study|Adverse Event|0
7855160|NCT01531673|12339775|FG009|Overall Study|Adverse Event|0
7855161|NCT01531673|12339776|FG010|Overall Study|Adverse Event|0
7855162|NCT01531673|12339777|FG011|Overall Study|Adverse Event|0
7855163|NCT01531673|12339778|FG012|Overall Study|Adverse Event|0
7855164|NCT01531673|12339766|FG000|Overall Study|Lost to Follow-up|0
7855165|NCT01531673|12339767|FG001|Overall Study|Lost to Follow-up|0
7855166|NCT01531673|12339768|FG002|Overall Study|Lost to Follow-up|0
7855167|NCT01531673|12339769|FG003|Overall Study|Lost to Follow-up|0
7855168|NCT01531673|12339770|FG004|Overall Study|Lost to Follow-up|1
7855169|NCT01531673|12339771|FG005|Overall Study|Lost to Follow-up|0
7855170|NCT01531673|12339772|FG006|Overall Study|Lost to Follow-up|0
7855171|NCT01531673|12339773|FG007|Overall Study|Lost to Follow-up|0
7855172|NCT01531673|12339774|FG008|Overall Study|Lost to Follow-up|0
7855173|NCT01531673|12339775|FG009|Overall Study|Lost to Follow-up|0
7855174|NCT01531673|12339776|FG010|Overall Study|Lost to Follow-up|0
7855175|NCT01531673|12339777|FG011|Overall Study|Lost to Follow-up|0
7855176|NCT01531673|12339778|FG012|Overall Study|Lost to Follow-up|0
7855177|NCT01531673|12339766|FG000|Overall Study|Other|0
7855178|NCT01531673|12339767|FG001|Overall Study|Other|0
7855179|NCT01531673|12339768|FG002|Overall Study|Other|0
7855180|NCT01531673|12339769|FG003|Overall Study|Other|1
7855181|NCT01531673|12339770|FG004|Overall Study|Other|0
7855182|NCT01531673|12339771|FG005|Overall Study|Other|0
7855183|NCT01531673|12339772|FG006|Overall Study|Other|0
7855184|NCT01531673|12339773|FG007|Overall Study|Other|0
7855185|NCT01531673|12339774|FG008|Overall Study|Other|0
7855186|NCT01531673|12339775|FG009|Overall Study|Other|1
7855187|NCT01531673|12339776|FG010|Overall Study|Other|0
7855188|NCT01531673|12339777|FG011|Overall Study|Other|0
7855189|NCT01531673|12339778|FG012|Overall Study|Other|0
7855190|NCT01531725|12339830|FG000|Overall Study|Protocol Violation|5
7855191|NCT01531894|12339852|FG000|Overall Study|Physician Decision|8
7855192|NCT01531894|12339852|FG000|Overall Study|Death|1
7855193|NCT01531998|12339865|FG000|Overall Study|Withdrawal by Subject|3
7855194|NCT01532388|12339919|FG000|3-month Follow-up|Lost to Follow-up|68
7855195|NCT01532388|12339920|FG001|3-month Follow-up|Lost to Follow-up|68
7855196|NCT01532388|12339919|FG000|6-month Follow-up|Lost to Follow-up|74
7855197|NCT01532388|12339920|FG001|6-month Follow-up|Lost to Follow-up|66
7855198|NCT01532388|12339919|FG000|12-month Follow-up|Lost to Follow-up|69
7855199|NCT01532388|12339920|FG001|12-month Follow-up|Lost to Follow-up|67
7855200|NCT01532414|12339929|FG000|Overall Study|Lost to Follow-up|3
7855201|NCT01532414|12339930|FG001|Overall Study|Lost to Follow-up|0
7855202|NCT01532414|12339931|FG002|Overall Study|Lost to Follow-up|1
7855203|NCT01532414|12339929|FG000|Overall Study|Withdrawal by Subject|3
7855204|NCT01532414|12339930|FG001|Overall Study|Withdrawal by Subject|0
7855205|NCT01532414|12339931|FG002|Overall Study|Withdrawal by Subject|0
7855206|NCT01532414|12339929|FG000|Overall Study|No V6 semen sample|0
7855207|NCT01532414|12339930|FG001|Overall Study|No V6 semen sample|1
7855208|NCT01532414|12339931|FG002|Overall Study|No V6 semen sample|0
7855209|NCT01532414|12339929|FG000|Overall Study|Adverse Event|0
7855210|NCT01532414|12339930|FG001|Overall Study|Adverse Event|1
7855211|NCT01532414|12339931|FG002|Overall Study|Adverse Event|1
7855212|NCT01532414|12339929|FG000|Overall Study|Unable to complete 24 hour PK|0
7855213|NCT01532414|12339930|FG001|Overall Study|Unable to complete 24 hour PK|0
7855214|NCT01532414|12339931|FG002|Overall Study|Unable to complete 24 hour PK|1
7855215|NCT01532414|12339929|FG000|Overall Study|Withdrawn by sponsor|1
7855216|NCT01532414|12339930|FG001|Overall Study|Withdrawn by sponsor|0
7855217|NCT01532414|12339931|FG002|Overall Study|Withdrawn by sponsor|0
7855218|NCT01532570|12339952|FG000|Overall Study|Lack of Efficacy|1
7855219|NCT01532570|12339953|FG001|Overall Study|Lack of Efficacy|0
7855220|NCT01532570|12339954|FG002|Overall Study|Lack of Efficacy|0
7855221|NCT01532570|12339955|FG003|Overall Study|Lack of Efficacy|0
7855222|NCT01532570|12339952|FG000|Overall Study|Withdrawal by Subject|0
7855223|NCT01532570|12339953|FG001|Overall Study|Withdrawal by Subject|1
7855224|NCT01532570|12339954|FG002|Overall Study|Withdrawal by Subject|0
7855225|NCT01532570|12339955|FG003|Overall Study|Withdrawal by Subject|0
7855226|NCT01532648|12339974|FG000|Overall Study|Lost to Follow-up|3
7855227|NCT01532648|12339975|FG001|Overall Study|Lost to Follow-up|4
7855228|NCT01532648|12339974|FG000|Overall Study|Lack of Efficacy|4
7855229|NCT01532648|12339975|FG001|Overall Study|Lack of Efficacy|1
7855230|NCT01532648|12339974|FG000|Overall Study|Protocol Violation|1
7855231|NCT01532648|12339975|FG001|Overall Study|Protocol Violation|1
7855232|NCT01532648|12339974|FG000|Overall Study|Adverse Event|12
7855233|NCT01532648|12339975|FG001|Overall Study|Adverse Event|9
7855234|NCT01532648|12339974|FG000|Overall Study|Withdrawal by Subject|16
7855235|NCT01532648|12339975|FG001|Overall Study|Withdrawal by Subject|2
7855236|NCT01532687|12339983|FG000|Overall Study|Death|2
7855237|NCT01532687|12339984|FG001|Overall Study|Death|0
7855238|NCT01532687|12339983|FG000|Overall Study|Adverse Event|6
7855239|NCT01532687|12339984|FG001|Overall Study|Adverse Event|1
7855240|NCT01532687|12339983|FG000|Overall Study|Withdrawal by Subject|1
7855241|NCT01532687|12339984|FG001|Overall Study|Withdrawal by Subject|0
7855242|NCT01532687|12339983|FG000|Overall Study|Physician Decision|2
7855243|NCT01532687|12339984|FG001|Overall Study|Physician Decision|1
7855244|NCT01532687|12339983|FG000|Overall Study|Protocol-defined delay > 3 weeks|3
7855245|NCT01532687|12339984|FG001|Overall Study|Protocol-defined delay > 3 weeks|0
7855246|NCT01532869|12340006|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0
7855247|NCT01532869|12340007|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1
7855248|NCT01532869|12340006|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
7855249|NCT01532869|12340007|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
7855250|NCT01532869|12340006|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
7855251|NCT01532869|12340007|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
7855252|NCT01532869|12340006|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
7855253|NCT01532869|12340007|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
7855254|NCT01532869|12340006|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
7855255|NCT01532869|12340007|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
7855256|NCT01532869|12340006|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
7855257|NCT01532869|12340007|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
7855258|NCT01532869|12340006|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0
7855259|NCT01532869|12340007|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3
7855260|NCT01532869|12340006|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
7855261|NCT01532869|12340007|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
7855262|NCT01532869|12340006|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
7855263|NCT01532869|12340007|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
7855264|NCT01532869|12340006|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
7855265|NCT01532869|12340007|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
7855266|NCT01532869|12340006|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
7855267|NCT01532869|12340007|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
7855268|NCT01532869|12340006|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
7855269|NCT01532869|12340007|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
7855270|NCT01532869|12340006|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
7855271|NCT01532869|12340007|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
7855272|NCT01532869|12340006|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4
7855273|NCT01532869|12340007|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1
7855274|NCT01532869|12340006|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1
7855275|NCT01532869|12340007|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0
7855276|NCT01532869|12340006|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
7855277|NCT01532869|12340007|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
7855278|NCT01532869|12340006|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
7855279|NCT01532869|12340007|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
7855280|NCT01532908|12340020|FG000|Overall Study|Not Transplanted|1
7855281|NCT01532908|12340021|FG001|Overall Study|Not Transplanted|0
7720941|NCT00542178|12145442|FG002|Overall Study|did not complete year 4 follow-up|74
7855282|NCT01532921|12340027|FG000|Overall Study|Death|3
7855283|NCT01532921|12340027|FG000|Overall Study|Withdrawal by Subject|2
7855284|NCT01532921|12340027|FG000|Overall Study|Lost to Follow-up|3
7855285|NCT01532921|12340027|FG000|Overall Study|Physician Decision|7
7855286|NCT01532921|12340027|FG000|Overall Study|Device was explanted during procedure|1
7855287|NCT01532934|12340037|FG000|Overall Study|Lost to Follow-up|11
7855288|NCT01532934|12340038|FG001|Overall Study|Lost to Follow-up|11
7855289|NCT01532934|12340037|FG000|Overall Study|In controlled environment|3
7855290|NCT01532934|12340038|FG001|Overall Study|In controlled environment|2
7855291|NCT01532986|12340090|FG000|Overall Study|Death|9
7855292|NCT01532986|12340091|FG001|Overall Study|Death|9
7855293|NCT01532986|12340090|FG000|Overall Study|Withdrawal by Subject|7
7855294|NCT01532986|12340091|FG001|Overall Study|Withdrawal by Subject|10
7855295|NCT01532986|12340090|FG000|Overall Study|Physician Decision|7
7855296|NCT01532986|12340091|FG001|Overall Study|Physician Decision|5
7855297|NCT01532999|12340100|FG000|Overall Study|Lost to Follow-up|14
7855298|NCT01532999|12340101|FG001|Overall Study|Lost to Follow-up|8
7855299|NCT01532999|12340100|FG000|Overall Study|Physician Decision|1
7855300|NCT01532999|12340101|FG001|Overall Study|Physician Decision|2
7855301|NCT01532999|12340100|FG000|Overall Study|Withdrawal by Subject|5
7855302|NCT01532999|12340101|FG001|Overall Study|Withdrawal by Subject|0
7855303|NCT01532999|12340100|FG000|Overall Study|Relocated|2
7855304|NCT01532999|12340101|FG001|Overall Study|Relocated|0
7855305|NCT01532999|12340100|FG000|Overall Study|should not have been randomized|1
7855306|NCT01532999|12340101|FG001|Overall Study|should not have been randomized|0
7855307|NCT01532999|12340100|FG000|Overall Study|substantial noncompliance|2
7855308|NCT01532999|12340101|FG001|Overall Study|substantial noncompliance|0
7855309|NCT01532999|12340100|FG000|Overall Study|no show for week 9 assessments|6
7855310|NCT01532999|12340101|FG001|Overall Study|no show for week 9 assessments|4
7855311|NCT01532999|12340100|FG000|Overall Study|Adverse Event|0
7855312|NCT01532999|12340101|FG001|Overall Study|Adverse Event|1
7855313|NCT01532999|12340100|FG000|Overall Study|incarcerated|0
7855314|NCT01532999|12340101|FG001|Overall Study|incarcerated|1
7855315|NCT01532999|12340100|FG000|Overall Study|New job|0
7855316|NCT01532999|12340101|FG001|Overall Study|New job|2
7855317|NCT01533181|12340152|FG000|Overall Study|Disease progression pre-active treatment|0
7855318|NCT01533181|12340153|FG001|Overall Study|Disease progression pre-active treatment|1
7855319|NCT01533181|12340152|FG000|Overall Study|Patient withdrawal pre-active treatment|1
7855320|NCT01533181|12340153|FG001|Overall Study|Patient withdrawal pre-active treatment|0
7863521|NCT01606306|12352851|FG002|Overall Study|Withdrawal by Subject|4
7863522|NCT01606306|12352852|FG003|Overall Study|Withdrawal by Subject|4
7863523|NCT01606306|12352853|FG004|Overall Study|Withdrawal by Subject|5
7863524|NCT01606306|12352854|FG005|Overall Study|Withdrawal by Subject|4
7863525|NCT01606306|12352849|FG000|Overall Study|Physician Decision|1
7863526|NCT01606306|12352850|FG001|Overall Study|Physician Decision|2
7863527|NCT01606306|12352851|FG002|Overall Study|Physician Decision|0
7863528|NCT01606306|12352852|FG003|Overall Study|Physician Decision|0
7720942|NCT00542178|12145443|FG003|Overall Study|did not complete year 4 follow-up|62
7720943|NCT00542178|12145444|FG004|Overall Study|did not complete year 4 follow-up|64
7863529|NCT01606306|12352853|FG004|Overall Study|Physician Decision|0
7863530|NCT01606306|12352854|FG005|Overall Study|Physician Decision|0
7863531|NCT01606319|12352862|FG000|Overall Study|Lost to Follow-up|17
7863532|NCT01606319|12352863|FG001|Overall Study|Lost to Follow-up|14
7863533|NCT01606319|12352862|FG000|Overall Study|Withdrawal by Subject|9
7863534|NCT01606319|12352863|FG001|Overall Study|Withdrawal by Subject|12
7863535|NCT01606319|12352862|FG000|Overall Study|Physician Decision|1
7863536|NCT01606319|12352863|FG001|Overall Study|Physician Decision|2
7863537|NCT01606319|12352862|FG000|Overall Study|Lack of Efficacy|6
7863538|NCT01606319|12352863|FG001|Overall Study|Lack of Efficacy|8
7863539|NCT01606319|12352862|FG000|Overall Study|Adverse Event|1
7863540|NCT01606319|12352863|FG001|Overall Study|Adverse Event|4
7863541|NCT01606670|12352869|FG000|Overall Study|Adverse Event|6
7863542|NCT01606670|12352869|FG000|Overall Study|Lack of Efficacy|2
7863543|NCT01606670|12352869|FG000|Overall Study|Lost to Follow-up|3
7863544|NCT01606670|12352869|FG000|Overall Study|Withdrawal by Subject|3
7863545|NCT01606670|12352869|FG000|Overall Study|Other Reason|2
7863546|NCT01606748|12352888|FG000|Overall Study|Adverse Event|1
7863547|NCT01606748|12352889|FG001|Overall Study|Adverse Event|0
7863548|NCT01606748|12352888|FG000|Overall Study|Progressive Disease|1
7863549|NCT01606748|12352889|FG001|Overall Study|Progressive Disease|0
7863550|NCT01606748|12352888|FG000|Overall Study|Withdrawal by Subject|1
7863551|NCT01606748|12352889|FG001|Overall Study|Withdrawal by Subject|0
7863552|NCT01606761|12352910|FG000|Prior to Week 24|Lost to Follow-up|0
7863553|NCT01606761|12352911|FG001|Prior to Week 24|Lost to Follow-up|3
7863554|NCT01606761|12352912|FG002|Prior to Week 24|Lost to Follow-up|2
7863555|NCT01606761|12352913|FG003|Prior to Week 24|Lost to Follow-up|0
7863556|NCT01606761|12352914|FG004|Prior to Week 24|Lost to Follow-up|0
7863557|NCT01606761|12352910|FG000|Prior to Week 24|Withdrawal by Subject|12
7863558|NCT01606761|12352911|FG001|Prior to Week 24|Withdrawal by Subject|10
7855321|NCT01533246|12340168|FG000|Overall Study|Adverse Event|1
7855322|NCT01533246|12340168|FG000|Overall Study|Withdrawal by Subject|1
7855323|NCT01533428|12340178|FG000|Overall Study|Adverse Event|0
7855324|NCT01533428|12340179|FG001|Overall Study|Adverse Event|1
7855325|NCT01533428|12340178|FG000|Overall Study|Lost to Follow-up|2
7855326|NCT01533428|12340179|FG001|Overall Study|Lost to Follow-up|1
7855327|NCT01533428|12340178|FG000|Overall Study|Withdrawal by Subject|7
7855328|NCT01533428|12340179|FG001|Overall Study|Withdrawal by Subject|6
7855329|NCT01533493|12340187|FG000|Overall Study|Adverse Event|2
7855330|NCT01533493|12340188|FG001|Overall Study|Adverse Event|1
7855331|NCT01533493|12340187|FG000|Overall Study|Withdrawal by Subject|1
7855332|NCT01533493|12340188|FG001|Overall Study|Withdrawal by Subject|2
7855333|NCT01533493|12340187|FG000|Overall Study|Lost to Follow-up|2
7855334|NCT01533493|12340188|FG001|Overall Study|Lost to Follow-up|0
7855335|NCT01533688|12340206|FG000|Overall Study|Withdrawal by Subject|5
7855336|NCT01533688|12340207|FG001|Overall Study|Withdrawal by Subject|4
7855337|NCT01533688|12340208|FG002|Overall Study|Withdrawal by Subject|3
7855338|NCT01533688|12340206|FG000|Overall Study|Medically unstable|1
7855339|NCT01533688|12340207|FG001|Overall Study|Medically unstable|3
7855340|NCT01533688|12340208|FG002|Overall Study|Medically unstable|3
7855341|NCT01533688|12340206|FG000|Overall Study|Had colonoscopy at outside hospital|2
7855342|NCT01533688|12340207|FG001|Overall Study|Had colonoscopy at outside hospital|3
7855343|NCT01533688|12340208|FG002|Overall Study|Had colonoscopy at outside hospital|2
7855344|NCT01533922|12340218|FG000|Overall Study|Adverse Event|5
7855345|NCT01533922|12340219|FG001|Overall Study|Adverse Event|8
7855346|NCT01533922|12340220|FG002|Overall Study|Adverse Event|6
7855347|NCT01533922|12340221|FG003|Overall Study|Adverse Event|3
7855348|NCT01533922|12340222|FG004|Overall Study|Adverse Event|4
7855349|NCT01533922|12340218|FG000|Overall Study|Lack of Efficacy|0
7855350|NCT01533922|12340219|FG001|Overall Study|Lack of Efficacy|0
7855351|NCT01533922|12340220|FG002|Overall Study|Lack of Efficacy|1
7855352|NCT01533922|12340221|FG003|Overall Study|Lack of Efficacy|0
7855353|NCT01533922|12340222|FG004|Overall Study|Lack of Efficacy|0
7855354|NCT01533922|12340218|FG000|Overall Study|Protocol Violation|0
7855355|NCT01533922|12340219|FG001|Overall Study|Protocol Violation|3
7855356|NCT01533922|12340220|FG002|Overall Study|Protocol Violation|0
7855357|NCT01533922|12340221|FG003|Overall Study|Protocol Violation|0
7855358|NCT01533922|12340222|FG004|Overall Study|Protocol Violation|1
7855359|NCT01533922|12340218|FG000|Overall Study|Withdrawal by Subject|3
7855360|NCT01533922|12340219|FG001|Overall Study|Withdrawal by Subject|1
7855361|NCT01533922|12340220|FG002|Overall Study|Withdrawal by Subject|2
7855362|NCT01533922|12340221|FG003|Overall Study|Withdrawal by Subject|2
7855363|NCT01533922|12340222|FG004|Overall Study|Withdrawal by Subject|1
7855364|NCT01533922|12340218|FG000|Overall Study|Other reason not defined above|2
7855365|NCT01533922|12340219|FG001|Overall Study|Other reason not defined above|0
7855366|NCT01533922|12340220|FG002|Overall Study|Other reason not defined above|1
7855367|NCT01533922|12340221|FG003|Overall Study|Other reason not defined above|0
7855368|NCT01533922|12340222|FG004|Overall Study|Other reason not defined above|0
7855369|NCT01533935|12340234|FG000|Overall Study|Adverse Event|5
7855370|NCT01533935|12340235|FG001|Overall Study|Adverse Event|7
7855371|NCT01533935|12340236|FG002|Overall Study|Adverse Event|1
7855372|NCT01533935|12340237|FG003|Overall Study|Adverse Event|5
7855373|NCT01533935|12340238|FG004|Overall Study|Adverse Event|3
7855374|NCT01533935|12340234|FG000|Overall Study|Protocol Violation|0
7855375|NCT01533935|12340235|FG001|Overall Study|Protocol Violation|2
7855376|NCT01533935|12340236|FG002|Overall Study|Protocol Violation|0
7855377|NCT01533935|12340237|FG003|Overall Study|Protocol Violation|0
7855378|NCT01533935|12340238|FG004|Overall Study|Protocol Violation|0
7855379|NCT01533935|12340234|FG000|Overall Study|Lost to Follow-up|0
7855380|NCT01533935|12340235|FG001|Overall Study|Lost to Follow-up|0
7855381|NCT01533935|12340236|FG002|Overall Study|Lost to Follow-up|1
7855382|NCT01533935|12340237|FG003|Overall Study|Lost to Follow-up|0
7855383|NCT01533935|12340238|FG004|Overall Study|Lost to Follow-up|0
7855384|NCT01533935|12340234|FG000|Overall Study|Withdrawal by Subject|0
7855385|NCT01533935|12340235|FG001|Overall Study|Withdrawal by Subject|4
7855386|NCT01533935|12340236|FG002|Overall Study|Withdrawal by Subject|5
7855387|NCT01533935|12340237|FG003|Overall Study|Withdrawal by Subject|2
7855388|NCT01533935|12340238|FG004|Overall Study|Withdrawal by Subject|4
7855389|NCT01533935|12340234|FG000|Overall Study|Other reason not defined above|1
7855390|NCT01533935|12340235|FG001|Overall Study|Other reason not defined above|0
7855391|NCT01533935|12340236|FG002|Overall Study|Other reason not defined above|1
7855392|NCT01533935|12340237|FG003|Overall Study|Other reason not defined above|0
7855393|NCT01533935|12340238|FG004|Overall Study|Other reason not defined above|1
7855394|NCT01534078|12340276|FG000|Overall Study|Death|1
7855395|NCT01534078|12340276|FG000|Overall Study|Withdrawal by Subject|1
7855396|NCT01534182|12340282|FG000|Overall Study|Administrative problems|1
7855397|NCT01534182|12340283|FG001|Overall Study|Administrative problems|0
7855398|NCT01534182|12340282|FG000|Overall Study|Withdrawal by Subject|4
7855399|NCT01534182|12340283|FG001|Overall Study|Withdrawal by Subject|7
7855400|NCT01534182|12340282|FG000|Overall Study|Adverse Event|7
7855401|NCT01534182|12340283|FG001|Overall Study|Adverse Event|3
7855402|NCT01534195|12340292|FG000|Overall Study|Withdrawal by Subject|1
7855403|NCT01534195|12340293|FG001|Overall Study|Withdrawal by Subject|1
7855404|NCT01534208|12340301|FG000|Overall Study|Lost to Follow-up|19
7855405|NCT01534208|12340302|FG001|Overall Study|Lost to Follow-up|14
7855406|NCT01534208|12340301|FG000|Overall Study|Withdrawal by Subject|6
7855407|NCT01534208|12340302|FG001|Overall Study|Withdrawal by Subject|20
7855408|NCT01534208|12340301|FG000|Overall Study|Adverse Event|15
7855409|NCT01534208|12340302|FG001|Overall Study|Adverse Event|8
7855410|NCT01534208|12340301|FG000|Overall Study|Physician Decision|2
7855411|NCT01534208|12340302|FG001|Overall Study|Physician Decision|0
7855412|NCT01534208|12340301|FG000|Overall Study|Lack of Efficacy|0
7855413|NCT01534208|12340302|FG001|Overall Study|Lack of Efficacy|3
7855414|NCT01534208|12340301|FG000|Overall Study|Protocol Violation|2
7855415|NCT01534208|12340302|FG001|Overall Study|Protocol Violation|2
7855416|NCT01534208|12340301|FG000|Overall Study|Sponsor decision|4
7855417|NCT01534208|12340302|FG001|Overall Study|Sponsor decision|1
7855418|NCT01534208|12340301|FG000|Overall Study|Subject relocation|2
7855419|NCT01534208|12340302|FG001|Overall Study|Subject relocation|0
7855420|NCT01534208|12340301|FG000|Overall Study|Lab assessment|2
7855421|NCT01534208|12340302|FG001|Overall Study|Lab assessment|1
7855422|NCT01534208|12340301|FG000|Overall Study|Eligibility error|3
7855423|NCT01534208|12340302|FG001|Overall Study|Eligibility error|0
7855424|NCT01534208|12340301|FG000|Overall Study|PCP decision|1
7855425|NCT01534208|12340302|FG001|Overall Study|PCP decision|0
7855426|NCT01534208|12340301|FG000|Overall Study|Needed prohibited meds|1
7855427|NCT01534208|12340302|FG001|Overall Study|Needed prohibited meds|0
7855428|NCT01534260|12340310|FG000|Overall Study|Adverse Event|1
7855429|NCT01534260|12340311|FG001|Overall Study|Adverse Event|8
7855430|NCT01534260|12340310|FG000|Overall Study|Death|2
7855431|NCT01534260|12340311|FG001|Overall Study|Death|0
7855432|NCT01534260|12340310|FG000|Overall Study|Lack of Efficacy|1
7855433|NCT01534260|12340311|FG001|Overall Study|Lack of Efficacy|1
7855434|NCT01534260|12340310|FG000|Overall Study|Withdrawal by Subject|1
7855435|NCT01534260|12340311|FG001|Overall Study|Withdrawal by Subject|3
7855436|NCT01534260|12340310|FG000|Overall Study|Disease Progression|8
7855437|NCT01534260|12340311|FG001|Overall Study|Disease Progression|6
7855438|NCT01534260|12340310|FG000|Overall Study|Physician Decision|3
7855439|NCT01534260|12340311|FG001|Overall Study|Physician Decision|1
7855440|NCT01534260|12340310|FG000|Overall Study|No treatment, per protocol|0
7855441|NCT01534260|12340311|FG001|Overall Study|No treatment, per protocol|1
7855442|NCT01534273|12340321|FG000|Period 1|Physician Decision|0
7855443|NCT01534273|12340322|FG001|Period 1|Physician Decision|0
7855444|NCT01534273|12340323|FG002|Period 1|Physician Decision|0
7855445|NCT01534273|12340324|FG003|Period 1|Physician Decision|1
7855446|NCT01534273|12340325|FG004|Period 1|Physician Decision|0
7855447|NCT01534273|12340326|FG005|Period 1|Physician Decision|0
7855448|NCT01534273|12340327|FG006|Period 1|Physician Decision|0
7855449|NCT01534351|12340351|FG000|Overall Study|Study Terminated Early|1
7855450|NCT01534351|12340352|FG001|Overall Study|Study Terminated Early|0
7855451|NCT01534351|12340353|FG002|Overall Study|Study Terminated Early|0
7855452|NCT01534520|12340382|FG000|Overall Study|Adverse Event|0
7855453|NCT01534520|12340383|FG001|Overall Study|Adverse Event|1
7855454|NCT01534533|12340397|FG000|Overall Study|Lost to Follow-up|3
7855455|NCT01534533|12340398|FG001|Overall Study|Lost to Follow-up|0
7855456|NCT01534533|12340399|FG002|Overall Study|Lost to Follow-up|4
7855457|NCT01534533|12340400|FG003|Overall Study|Lost to Follow-up|3
7855458|NCT01534533|12340397|FG000|Overall Study|Withdrawal by Subject|5
7855459|NCT01534533|12340398|FG001|Overall Study|Withdrawal by Subject|3
7855460|NCT01534533|12340399|FG002|Overall Study|Withdrawal by Subject|4
7855461|NCT01534533|12340400|FG003|Overall Study|Withdrawal by Subject|1
7855462|NCT01534637|12340412|FG000|Overall Study|Physician Decision|3
7855463|NCT01534637|12340412|FG000|Overall Study|Lack of Efficacy|3
7855464|NCT01534637|12340412|FG000|Overall Study|Withdrawal by Subject|1
7855465|NCT01534637|12340412|FG000|Overall Study|Adverse Event|1
7855466|NCT01534637|12340412|FG000|Overall Study|Liver Mets before treatment|1
7855467|NCT01534663|12340418|FG000|Overall Study|Lost to Follow-up|0
7855468|NCT01534663|12340419|FG001|Overall Study|Lost to Follow-up|2
7855469|NCT01534663|12340418|FG000|Overall Study|Adverse Event|2
7855470|NCT01534663|12340419|FG001|Overall Study|Adverse Event|1
7855471|NCT01534962|12340449|FG000|Overall Study|Randomized but did not start treatment|2
7855472|NCT01534962|12340450|FG001|Overall Study|Randomized but did not start treatment|0
7855473|NCT01534962|12340451|FG002|Overall Study|Randomized but did not start treatment|0
7855474|NCT01534962|12340452|FG003|Overall Study|Randomized but did not start treatment|1
7855475|NCT01534962|12340449|FG000|Overall Study|Discontinued at AF recurrence|35
7855476|NCT01534962|12340450|FG001|Overall Study|Discontinued at AF recurrence|26
7855477|NCT01534962|12340451|FG002|Overall Study|Discontinued at AF recurrence|24
7855478|NCT01534962|12340452|FG003|Overall Study|Discontinued at AF recurrence|31
7855479|NCT01535040|12340505|FG000|Overall Study|Physician Decision|0
7855480|NCT01535040|12340506|FG001|Overall Study|Physician Decision|1
7855481|NCT01535040|12340505|FG000|Overall Study|Withdrawal by Subject|13
7855482|NCT01535040|12340506|FG001|Overall Study|Withdrawal by Subject|10
7855483|NCT01535040|12340505|FG000|Overall Study|Never Started|9
7855484|NCT01535040|12340506|FG001|Overall Study|Never Started|4
7855485|NCT01535040|12340505|FG000|Overall Study|Toxicity|7
7855486|NCT01535040|12340506|FG001|Overall Study|Toxicity|5
7855487|NCT01535040|12340505|FG000|Overall Study|Multiple Reasons|1
7855488|NCT01535040|12340506|FG001|Overall Study|Multiple Reasons|1
7855489|NCT01535222|12340522|FG000|Overall Study|Inclusion/exclusion|0
7855490|NCT01535222|12340523|FG001|Overall Study|Inclusion/exclusion|0
7855491|NCT01535222|12340524|FG002|Overall Study|Inclusion/exclusion|1
7855492|NCT01535222|12340525|FG003|Overall Study|Inclusion/exclusion|0
7855493|NCT01535222|12340526|FG004|Overall Study|Inclusion/exclusion|0
7855494|NCT01535222|12340527|FG005|Overall Study|Inclusion/exclusion|0
7855495|NCT01535235|12340543|FG000|Overall Study|Adverse Event|1
7855496|NCT01535235|12340544|FG001|Overall Study|Adverse Event|0
7855497|NCT01535261|12340550|FG000|Overall Study|Physician Decision|8
7855498|NCT01535261|12340550|FG000|Overall Study|Protocol Violation|3
7855499|NCT01535261|12340550|FG000|Overall Study|Death|5
7855500|NCT01535261|12340550|FG000|Overall Study|Lost to Follow-up|8
7855501|NCT01535261|12340550|FG000|Overall Study|Withdrawal by Subject|14
7855502|NCT01535261|12340550|FG000|Overall Study|Adverse Event|12
7855503|NCT01535287|12340556|FG000|Overall Study|drug not prepared in time|5
7855504|NCT01535287|12340557|FG001|Overall Study|drug not prepared in time|6
7855505|NCT01535443|12340590|FG000|Overall Study|Physician Decision|3
7855506|NCT01535560|12340597|FG000|Overall Study|Adverse Event|12
7855507|NCT01535560|12340598|FG001|Overall Study|Adverse Event|7
7855508|NCT01535560|12340597|FG000|Overall Study|Lost to Follow-up|1
7855509|NCT01535560|12340598|FG001|Overall Study|Lost to Follow-up|3
7855510|NCT01535560|12340597|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3
7855511|NCT01535560|12340598|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1
7855512|NCT01535560|12340597|FG000|Overall Study|Treatment Failure|21
7855513|NCT01535560|12340598|FG001|Overall Study|Treatment Failure|83
7855514|NCT01535560|12340597|FG000|Overall Study|Other|0
7855515|NCT01535560|12340598|FG001|Overall Study|Other|1
7855516|NCT01535560|12340597|FG000|Overall Study|Randomized in Error|0
7855517|NCT01535560|12340598|FG001|Overall Study|Randomized in Error|1
7855518|NCT01535599|12340619|FG000|Overall Study|Adverse Event|6
7855519|NCT01535599|12340620|FG001|Overall Study|Adverse Event|15
7855520|NCT01535599|12340619|FG000|Overall Study|Lost to Follow-up|3
7855521|NCT01535599|12340620|FG001|Overall Study|Lost to Follow-up|4
7855522|NCT01535599|12340619|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4
7855523|NCT01535599|12340620|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3
7855524|NCT01535599|12340619|FG000|Overall Study|Treatment Failure|33
7855525|NCT01535599|12340620|FG001|Overall Study|Treatment Failure|66
7855526|NCT01535599|12340619|FG000|Overall Study|BL Culture + for Group A Strep|0
7855527|NCT01535599|12340620|FG001|Overall Study|BL Culture + for Group A Strep|1
7855528|NCT01535599|12340619|FG000|Overall Study|BL Culture + for Yeast//Fungi|0
7855529|NCT01535599|12340620|FG001|Overall Study|BL Culture + for Yeast//Fungi|1
7855530|NCT01535599|12340619|FG000|Overall Study|Randomized in Error|2
7855531|NCT01535599|12340620|FG001|Overall Study|Randomized in Error|4
7855532|NCT01535599|12340619|FG000|Overall Study|Did not use product|1
7855533|NCT01535599|12340620|FG001|Overall Study|Did not use product|0
7855534|NCT01535599|12340619|FG000|Overall Study|Other|1
7855535|NCT01535599|12340620|FG001|Overall Study|Other|0
7855536|NCT01535599|12340619|FG000|Overall Study|Stopped medication|0
7855537|NCT01535599|12340620|FG001|Overall Study|Stopped medication|1
7855538|NCT01535599|12340619|FG000|Overall Study|Noncompliance|0
7855539|NCT01535599|12340620|FG001|Overall Study|Noncompliance|1
7855540|NCT01535638|12340626|FG000|Treatment 1 (Single Dose)|Protocol Violation|0
7855541|NCT01535638|12340627|FG001|Treatment 1 (Single Dose)|Protocol Violation|0
7855542|NCT01535638|12340628|FG002|Treatment 1 (Single Dose)|Protocol Violation|0
7855543|NCT01535638|12340629|FG003|Treatment 1 (Single Dose)|Protocol Violation|0
7855544|NCT01535638|12340630|FG004|Treatment 1 (Single Dose)|Protocol Violation|0
7855545|NCT01535638|12340631|FG005|Treatment 1 (Single Dose)|Protocol Violation|1
7855546|NCT01535638|12340626|FG000|Treatment 3 (Single Dose)|Protocol Violation|0
7855547|NCT01535638|12340627|FG001|Treatment 3 (Single Dose)|Protocol Violation|0
7855548|NCT01535638|12340628|FG002|Treatment 3 (Single Dose)|Protocol Violation|0
7855549|NCT01535638|12340629|FG003|Treatment 3 (Single Dose)|Protocol Violation|1
7855550|NCT01535638|12340630|FG004|Treatment 3 (Single Dose)|Protocol Violation|0
7855551|NCT01535638|12340631|FG005|Treatment 3 (Single Dose)|Protocol Violation|0
7855552|NCT01535729|12340648|FG000|Overall Study|Withdrawal by Subject|2
7855553|NCT01535729|12340648|FG000|Overall Study|Disease progression|230
7855554|NCT01535729|12340648|FG000|Overall Study|Discontinued treatment|25
7855555|NCT01535729|12340648|FG000|Overall Study|Lost to Follow-up|8
7855556|NCT01535729|12340648|FG000|Overall Study|Death|52
7855557|NCT01535729|12340648|FG000|Overall Study|Other|19
7855558|NCT01535729|12340648|FG000|Overall Study|Did not sign informed consent|1
7855559|NCT01535729|12340648|FG000|Overall Study|No previous chemotherapy|33
7855560|NCT01535729|12340648|FG000|Overall Study|NSCLC grade IV histology not confirmed|20
7855561|NCT01535729|12340648|FG000|Overall Study|Protocol Violation|11
7855562|NCT01535729|12340648|FG000|Overall Study|Screening failure|1
7855563|NCT01535729|12340648|FG000|Overall Study|Not treated|9
7855564|NCT01535729|12340648|FG000|Overall Study|No participant record available|5
7855565|NCT01536067|12340696|FG000|Overall Study|Disease Progression|1
7855566|NCT01536093|12340702|FG000|Overall Study|Death|1
7855567|NCT01536093|12340703|FG001|Overall Study|Death|2
7855568|NCT01536093|12340702|FG000|Overall Study|absence of maternal colostrum|2
7855569|NCT01536093|12340703|FG001|Overall Study|absence of maternal colostrum|0
7855570|NCT01536093|12340702|FG000|Overall Study|Withdrawal by Subject|0
7855571|NCT01536093|12340703|FG001|Overall Study|Withdrawal by Subject|1
7855572|NCT01536119|12340711|FG000|Overall Study|Lost to Follow-up|17
7855573|NCT01536119|12340712|FG001|Overall Study|Lost to Follow-up|14
7855574|NCT01536145|12340718|FG000|Overall Study|Progressive disease|3
7855575|NCT01536145|12340719|FG001|Overall Study|Progressive disease|4
7855576|NCT01536145|12340720|FG002|Overall Study|Progressive disease|1
7855577|NCT01536145|12340721|FG003|Overall Study|Progressive disease|2
7855578|NCT01536145|12340722|FG004|Overall Study|Progressive disease|1
7855579|NCT01536145|12340723|FG005|Overall Study|Progressive disease|2
7855580|NCT01536145|12340724|FG006|Overall Study|Progressive disease|1
7855581|NCT01536145|12340725|FG007|Overall Study|Progressive disease|2
7855582|NCT01536145|12340726|FG008|Overall Study|Progressive disease|1
7855583|NCT01536145|12340727|FG009|Overall Study|Progressive disease|3
7855584|NCT01536145|12340728|FG010|Overall Study|Progressive disease|3
7855585|NCT01536145|12340718|FG000|Overall Study|Withdrawal by Subject|0
7855586|NCT01536145|12340719|FG001|Overall Study|Withdrawal by Subject|0
7855587|NCT01536145|12340720|FG002|Overall Study|Withdrawal by Subject|1
7855588|NCT01536145|12340721|FG003|Overall Study|Withdrawal by Subject|0
7855589|NCT01536145|12340722|FG004|Overall Study|Withdrawal by Subject|0
7855590|NCT01536145|12340723|FG005|Overall Study|Withdrawal by Subject|1
7855591|NCT01536145|12340724|FG006|Overall Study|Withdrawal by Subject|0
7855592|NCT01536145|12340725|FG007|Overall Study|Withdrawal by Subject|0
7855593|NCT01536145|12340726|FG008|Overall Study|Withdrawal by Subject|2
7855594|NCT01536145|12340727|FG009|Overall Study|Withdrawal by Subject|0
7855595|NCT01536145|12340728|FG010|Overall Study|Withdrawal by Subject|2
7855596|NCT01536145|12340718|FG000|Overall Study|Other|0
7720944|NCT00542178|12145445|FG005|Overall Study|did not complete year 4 follow-up|89
7720945|NCT00542178|12145446|FG006|Overall Study|did not complete year 4 follow-up|87
7720946|NCT00542178|12145447|FG007|Overall Study|did not complete year 4 follow-up|85
7720947|NCT00542191|12145461|FG000|Overall Study|Death|3
7767879|NCT00856388|12210679|FG000|Overall Study|Other|1
7767880|NCT00856492|12210691|FG000|Overall Study|Ineligible or withdrew consent|1
7767881|NCT00856492|12210692|FG001|Overall Study|Ineligible or withdrew consent|1
7767882|NCT00856492|12210693|FG002|Overall Study|Ineligible or withdrew consent|2
7767883|NCT00856518|12210706|FG000|Overall Study|Lost to Follow-up|4
7767884|NCT00856518|12210707|FG001|Overall Study|Lost to Follow-up|2
7767885|NCT00856544|12210719|FG000|Overall Study|Randomized but not treated|3
7720948|NCT00542269|12145468|FG000|Overall Study|Adverse Event|10
7720949|NCT00542269|12145469|FG001|Overall Study|Adverse Event|4
7720950|NCT00542269|12145470|FG002|Overall Study|Adverse Event|5
7720951|NCT00542269|12145468|FG000|Overall Study|Protocol Violation|1
7855597|NCT01536145|12340719|FG001|Overall Study|Other|0
7855598|NCT01536145|12340720|FG002|Overall Study|Other|0
7855599|NCT01536145|12340721|FG003|Overall Study|Other|0
7855600|NCT01536145|12340722|FG004|Overall Study|Other|1
7855601|NCT01536145|12340723|FG005|Overall Study|Other|0
7855602|NCT01536145|12340724|FG006|Overall Study|Other|0
7855603|NCT01536145|12340725|FG007|Overall Study|Other|0
7855604|NCT01536145|12340726|FG008|Overall Study|Other|0
7855605|NCT01536145|12340727|FG009|Overall Study|Other|3
7855606|NCT01536145|12340728|FG010|Overall Study|Other|2
7855607|NCT01536145|12340718|FG000|Overall Study|Death|0
7855608|NCT01536145|12340719|FG001|Overall Study|Death|0
7855609|NCT01536145|12340720|FG002|Overall Study|Death|0
7855610|NCT01536145|12340721|FG003|Overall Study|Death|0
7855611|NCT01536145|12340722|FG004|Overall Study|Death|0
7855612|NCT01536145|12340723|FG005|Overall Study|Death|0
7855613|NCT01536145|12340724|FG006|Overall Study|Death|1
7855614|NCT01536145|12340725|FG007|Overall Study|Death|0
7855615|NCT01536145|12340726|FG008|Overall Study|Death|0
7855616|NCT01536145|12340727|FG009|Overall Study|Death|0
7855617|NCT01536145|12340728|FG010|Overall Study|Death|0
7855618|NCT01536145|12340718|FG000|Overall Study|Adverse Event|0
7855619|NCT01536145|12340719|FG001|Overall Study|Adverse Event|0
7855620|NCT01536145|12340720|FG002|Overall Study|Adverse Event|0
7855621|NCT01536145|12340721|FG003|Overall Study|Adverse Event|0
7855622|NCT01536145|12340722|FG004|Overall Study|Adverse Event|0
7855623|NCT01536145|12340723|FG005|Overall Study|Adverse Event|0
7855624|NCT01536145|12340724|FG006|Overall Study|Adverse Event|0
7855625|NCT01536145|12340725|FG007|Overall Study|Adverse Event|2
7855626|NCT01536145|12340726|FG008|Overall Study|Adverse Event|0
7855627|NCT01536145|12340727|FG009|Overall Study|Adverse Event|0
7855628|NCT01536145|12340728|FG010|Overall Study|Adverse Event|3
7855629|NCT01536171|12340759|FG000|Overall Study|Withdrawal by Subject|1
7855630|NCT01536262|12340785|FG000|Overall Study|Adverse Event|6
7855631|NCT01536262|12340786|FG001|Overall Study|Adverse Event|1
7855632|NCT01536262|12340787|FG002|Overall Study|Adverse Event|2
7855633|NCT01536262|12340785|FG000|Overall Study|Withdrawal by Subject|1
7855634|NCT01536262|12340786|FG001|Overall Study|Withdrawal by Subject|1
7855635|NCT01536262|12340787|FG002|Overall Study|Withdrawal by Subject|0
7855636|NCT01536262|12340785|FG000|Overall Study|Other than stated above|1
7855637|NCT01536262|12340786|FG001|Overall Study|Other than stated above|0
7855638|NCT01536262|12340787|FG002|Overall Study|Other than stated above|0
7855639|NCT01536379|12340807|FG000|Overall Study|Adverse Event|1
7855640|NCT01536379|12340808|FG001|Overall Study|Adverse Event|2
7855641|NCT01536379|12340807|FG000|Overall Study|Withdrawal by Subject|1
7855642|NCT01536379|12340808|FG001|Overall Study|Withdrawal by Subject|1
7855643|NCT01536392|12340816|FG000|Overall Study|Adverse Event|2
7855644|NCT01536392|12340817|FG001|Overall Study|Adverse Event|2
7855645|NCT01536392|12340816|FG000|Overall Study|Physician Decision|2
7855646|NCT01536392|12340817|FG001|Overall Study|Physician Decision|3
7855647|NCT01536392|12340816|FG000|Overall Study|Withdrawal by Subject|3
7855648|NCT01536392|12340817|FG001|Overall Study|Withdrawal by Subject|6
7855649|NCT01536392|12340816|FG000|Overall Study|Non Compliance|3
7855650|NCT01536392|12340817|FG001|Overall Study|Non Compliance|4
7855651|NCT01536392|12340816|FG000|Overall Study|Completed therapy early|3
7855652|NCT01536392|12340817|FG001|Overall Study|Completed therapy early|0
7855653|NCT01536405|12340825|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
7855654|NCT01536405|12340826|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
7855655|NCT01536405|12340825|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
7855656|NCT01536405|12340826|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
7855657|NCT01536405|12340825|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
7855658|NCT01536405|12340826|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
7855659|NCT01536405|12340825|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
7855660|NCT01536405|12340826|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
7855661|NCT01536405|12340825|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
7855662|NCT01536405|12340826|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
7855663|NCT01536405|12340825|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
7855664|NCT01536405|12340826|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
7855665|NCT01536405|12340825|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
7855666|NCT01536405|12340826|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
7855667|NCT01536405|12340825|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
7855668|NCT01536405|12340826|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
7855669|NCT01536405|12340825|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
7855670|NCT01536405|12340826|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
7855671|NCT01536405|12340825|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
7855672|NCT01536405|12340826|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
7855673|NCT01536405|12340825|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
7949661|NCT02541604|12495509|FG005|Overall Study|Lost to Follow-up|1
7949662|NCT02541604|12495510|FG006|Overall Study|Lost to Follow-up|1
7949663|NCT02541604|12495511|FG007|Overall Study|Lost to Follow-up|0
7949664|NCT02541604|12495512|FG008|Overall Study|Lost to Follow-up|0
7949665|NCT02541604|12495513|FG009|Overall Study|Lost to Follow-up|0
7949666|NCT02541604|12495514|FG010|Overall Study|Lost to Follow-up|0
7949667|NCT02541604|12495515|FG011|Overall Study|Lost to Follow-up|0
7949668|NCT02541604|12495504|FG000|Overall Study|Withdrawal by Subject|2
7949669|NCT02541604|12495505|FG001|Overall Study|Withdrawal by Subject|0
7949670|NCT02541604|12495506|FG002|Overall Study|Withdrawal by Subject|1
7949671|NCT02541604|12495507|FG003|Overall Study|Withdrawal by Subject|0
7949672|NCT02541604|12495508|FG004|Overall Study|Withdrawal by Subject|1
7949673|NCT02541604|12495509|FG005|Overall Study|Withdrawal by Subject|1
7949674|NCT02541604|12495510|FG006|Overall Study|Withdrawal by Subject|0
7949675|NCT02541604|12495511|FG007|Overall Study|Withdrawal by Subject|0
7949676|NCT02541604|12495512|FG008|Overall Study|Withdrawal by Subject|1
7949677|NCT02541604|12495513|FG009|Overall Study|Withdrawal by Subject|0
7949678|NCT02541604|12495514|FG010|Overall Study|Withdrawal by Subject|0
7949679|NCT02541604|12495515|FG011|Overall Study|Withdrawal by Subject|0
7949680|NCT02541604|12495504|FG000|Overall Study|Study Terminated by Sponsor|1
7949681|NCT02541604|12495505|FG001|Overall Study|Study Terminated by Sponsor|4
7949682|NCT02541604|12495506|FG002|Overall Study|Study Terminated by Sponsor|2
7949683|NCT02541604|12495507|FG003|Overall Study|Study Terminated by Sponsor|1
7949684|NCT02541604|12495508|FG004|Overall Study|Study Terminated by Sponsor|0
7949685|NCT02541604|12495509|FG005|Overall Study|Study Terminated by Sponsor|0
7949686|NCT02541604|12495510|FG006|Overall Study|Study Terminated by Sponsor|0
7949687|NCT02541604|12495511|FG007|Overall Study|Study Terminated by Sponsor|0
7949688|NCT02541604|12495512|FG008|Overall Study|Study Terminated by Sponsor|0
7949689|NCT02541604|12495513|FG009|Overall Study|Study Terminated by Sponsor|0
7949690|NCT02541604|12495514|FG010|Overall Study|Study Terminated by Sponsor|0
7949691|NCT02541604|12495515|FG011|Overall Study|Study Terminated by Sponsor|0
7949692|NCT02541604|12495504|FG000|Overall Study|Medical condition may jeopardize safety|0
7949693|NCT02541604|12495505|FG001|Overall Study|Medical condition may jeopardize safety|0
7949694|NCT02541604|12495506|FG002|Overall Study|Medical condition may jeopardize safety|0
7949695|NCT02541604|12495507|FG003|Overall Study|Medical condition may jeopardize safety|0
7949696|NCT02541604|12495508|FG004|Overall Study|Medical condition may jeopardize safety|0
7949697|NCT02541604|12495509|FG005|Overall Study|Medical condition may jeopardize safety|0
7949698|NCT02541604|12495510|FG006|Overall Study|Medical condition may jeopardize safety|0
7949699|NCT02541604|12495511|FG007|Overall Study|Medical condition may jeopardize safety|1
7949700|NCT02541604|12495512|FG008|Overall Study|Medical condition may jeopardize safety|0
7949701|NCT02541604|12495513|FG009|Overall Study|Medical condition may jeopardize safety|0
7949702|NCT02541604|12495514|FG010|Overall Study|Medical condition may jeopardize safety|0
7949703|NCT02541604|12495515|FG011|Overall Study|Medical condition may jeopardize safety|0
7949704|NCT02541669|12495569|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0
7855674|NCT01536405|12340826|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
7855675|NCT01536405|12340825|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0
7855676|NCT01536405|12340826|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1
7855677|NCT01536405|12340825|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
7855678|NCT01536405|12340826|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
7855679|NCT01536418|12340834|FG000|Overall Study|Protocol Violation|2
7855680|NCT01536418|12340835|FG001|Overall Study|Protocol Violation|3
7855681|NCT01536418|12340834|FG000|Overall Study|Physician Decision|1
7855682|NCT01536418|12340835|FG001|Overall Study|Physician Decision|3
7855683|NCT01536418|12340834|FG000|Overall Study|Study closed/terminated|41
7855684|NCT01536418|12340835|FG001|Overall Study|Study closed/terminated|37
7855685|NCT01536418|12340834|FG000|Overall Study|Lack of Efficacy|10
7855686|NCT01536418|12340835|FG001|Overall Study|Lack of Efficacy|16
7855687|NCT01536418|12340834|FG000|Overall Study|Adverse Event|9
7855688|NCT01536418|12340835|FG001|Overall Study|Adverse Event|4
7855689|NCT01536418|12340834|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1
7855690|NCT01536418|12340835|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0
7855691|NCT01536418|12340834|FG000|Overall Study|Withdrawal by Subject|5
7855692|NCT01536418|12340835|FG001|Overall Study|Withdrawal by Subject|3
7855693|NCT01536535|12340855|FG000|Overall Study|Withdrawal by Subject|10
7855694|NCT01536535|12340856|FG001|Overall Study|Withdrawal by Subject|5
7855695|NCT01536535|12340855|FG000|Overall Study|Lost to Follow-up|4
7855696|NCT01536535|12340856|FG001|Overall Study|Lost to Follow-up|6
7855697|NCT01536535|12340855|FG000|Overall Study|Physician Decision|1
7855698|NCT01536535|12340856|FG001|Overall Study|Physician Decision|1
7855699|NCT01536535|12340855|FG000|Overall Study|Participant moved|0
7855700|NCT01536535|12340856|FG001|Overall Study|Participant moved|1
7855701|NCT01536561|12340863|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40
7855702|NCT01536561|12340863|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
7949705|NCT02541669|12495570|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0
7949706|NCT02541669|12495571|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1
7949707|NCT02541669|12495572|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0
7949708|NCT02541669|12495573|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1
7949709|NCT02541903|12495603|FG000|Overall Study|Death|1
7949710|NCT02542072|12495626|FG000|First Intervention (1 Month)|Adverse Event|1
7855703|NCT01536561|12340863|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1
7855704|NCT01536561|12340863|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
7855705|NCT01536561|12340863|FG000|Dosimetric and Therapeutic Treatment|Death|2
7855706|NCT01536561|12340863|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
7855707|NCT01536574|12340872|FG000|Overall Study|Adverse Event|4
7855708|NCT01536574|12340873|FG001|Overall Study|Adverse Event|5
7855709|NCT01536574|12340872|FG000|Overall Study|Withdrawal by Subject|1
7855710|NCT01536574|12340873|FG001|Overall Study|Withdrawal by Subject|2
7855711|NCT01536574|12340872|FG000|Overall Study|Lack of Efficacy|1
7855712|NCT01536574|12340873|FG001|Overall Study|Lack of Efficacy|0
7855713|NCT01536587|12340879|FG000|Overall Study|Adverse Event|2
7855714|NCT01536704|12340883|FG000|Washout Period 1|Withdrawal by Subject|1
7855715|NCT01536704|12340884|FG001|Washout Period 1|Withdrawal by Subject|2
7855716|NCT01536704|12340885|FG002|Washout Period 1|Withdrawal by Subject|0
7855717|NCT01536704|12340886|FG003|Washout Period 1|Withdrawal by Subject|0
7855718|NCT01536704|12340883|FG000|Washout Period 2|Adverse Event|1
7855719|NCT01536704|12340884|FG001|Washout Period 2|Adverse Event|0
7855720|NCT01536704|12340885|FG002|Washout Period 2|Adverse Event|0
7855721|NCT01536704|12340886|FG003|Washout Period 2|Adverse Event|0
7855722|NCT01536704|12340883|FG000|Washout Period 2|Withdrawal by Subject|0
7855723|NCT01536704|12340884|FG001|Washout Period 2|Withdrawal by Subject|0
7855724|NCT01536704|12340885|FG002|Washout Period 2|Withdrawal by Subject|0
7855725|NCT01536704|12340886|FG003|Washout Period 2|Withdrawal by Subject|1
7855726|NCT01536704|12340883|FG000|Period 3|Adverse Event|0
7855727|NCT01536704|12340884|FG001|Period 3|Adverse Event|0
7855728|NCT01536704|12340885|FG002|Period 3|Adverse Event|0
7855729|NCT01536704|12340886|FG003|Period 3|Adverse Event|1
7855730|NCT01536704|12340883|FG000|Washout Period 3|Adverse Event|0
7855731|NCT01536704|12340884|FG001|Washout Period 3|Adverse Event|0
7855732|NCT01536704|12340885|FG002|Washout Period 3|Adverse Event|1
7855733|NCT01536704|12340886|FG003|Washout Period 3|Adverse Event|0
7855734|NCT01536795|12340902|FG000|Overall Study|Lost to Follow-up|0
7855735|NCT01536795|12340903|FG001|Overall Study|Lost to Follow-up|2
7855736|NCT01536795|12340902|FG000|Overall Study|Lack of Efficacy|1
7855737|NCT01536795|12340903|FG001|Overall Study|Lack of Efficacy|0
7855738|NCT01536860|12340909|FG000|Washout Period (3 Days)|Lost to Follow-up|1
7855739|NCT01536860|12340910|FG001|Washout Period (3 Days)|Lost to Follow-up|0
7855740|NCT01536860|12340911|FG002|Washout Period (3 Days)|Lost to Follow-up|0
7855741|NCT01536951|12340951|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0
7855742|NCT01536951|12340952|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0
7855743|NCT01536951|12340953|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1
7855744|NCT01536951|12340954|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0
7855745|NCT01536951|12340955|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0
7855746|NCT01536951|12340956|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0
7855747|NCT01536951|12340957|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0
7855748|NCT01536951|12340958|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0
7855749|NCT01536951|12340959|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0
7855750|NCT01536951|12340951|FG000|Second Intervention and Washout Period 2|Adverse Event|0
7855751|NCT01536951|12340952|FG001|Second Intervention and Washout Period 2|Adverse Event|0
7855752|NCT01536951|12340953|FG002|Second Intervention and Washout Period 2|Adverse Event|0
7855753|NCT01536951|12340954|FG003|Second Intervention and Washout Period 2|Adverse Event|0
7855754|NCT01536951|12340955|FG004|Second Intervention and Washout Period 2|Adverse Event|0
7855755|NCT01536951|12340956|FG005|Second Intervention and Washout Period 2|Adverse Event|0
7855756|NCT01536951|12340957|FG006|Second Intervention and Washout Period 2|Adverse Event|0
7855757|NCT01536951|12340958|FG007|Second Intervention and Washout Period 2|Adverse Event|1
7855758|NCT01536951|12340959|FG008|Second Intervention and Washout Period 2|Adverse Event|0
7855759|NCT01537042|12340988|FG000|Overall Study|Adverse Event|0
7855760|NCT01537042|12340989|FG001|Overall Study|Adverse Event|2
7855761|NCT01537042|12340988|FG000|Overall Study|Lack of Efficacy|0
7855762|NCT01537042|12340989|FG001|Overall Study|Lack of Efficacy|1
7855763|NCT01537042|12340988|FG000|Overall Study|Protocol Violation|0
7855764|NCT01537042|12340989|FG001|Overall Study|Protocol Violation|1
7855765|NCT01537042|12340988|FG000|Overall Study|Other|0
7855766|NCT01537042|12340989|FG001|Overall Study|Other|1
7855767|NCT01537068|12341001|FG000|Overall Study|Lost to Follow-up|2
7855768|NCT01537068|12341002|FG001|Overall Study|Lost to Follow-up|1
7855769|NCT01537068|12341001|FG000|Overall Study|Adverse Event|0
7855770|NCT01537068|12341002|FG001|Overall Study|Adverse Event|1
7855771|NCT01537068|12341001|FG000|Overall Study|Withdrawal by Subject|1
7855772|NCT01537068|12341002|FG001|Overall Study|Withdrawal by Subject|1
7855773|NCT01537068|12341001|FG000|Overall Study|Lack of Efficacy|1
7855774|NCT01537068|12341002|FG001|Overall Study|Lack of Efficacy|0
7855775|NCT01537081|12341011|FG000|Overall Study|Adverse Event|5
7855776|NCT01537081|12341012|FG001|Overall Study|Adverse Event|2
7855777|NCT01537081|12341013|FG002|Overall Study|Adverse Event|2
7855778|NCT01537081|12341011|FG000|Overall Study|Lack of Efficacy|2
7855779|NCT01537081|12341012|FG001|Overall Study|Lack of Efficacy|1
7855780|NCT01537081|12341013|FG002|Overall Study|Lack of Efficacy|0
7855781|NCT01537081|12341011|FG000|Overall Study|Lost to Follow-up|17
7855782|NCT01537081|12341012|FG001|Overall Study|Lost to Follow-up|15
7855783|NCT01537081|12341013|FG002|Overall Study|Lost to Follow-up|9
7855784|NCT01537081|12341011|FG000|Overall Study|Protocol Violation|3
7855785|NCT01537081|12341012|FG001|Overall Study|Protocol Violation|2
7855786|NCT01537081|12341013|FG002|Overall Study|Protocol Violation|2
7855787|NCT01537081|12341011|FG000|Overall Study|Withdrawal by Subject|6
7855788|NCT01537081|12341012|FG001|Overall Study|Withdrawal by Subject|11
7855789|NCT01537081|12341013|FG002|Overall Study|Withdrawal by Subject|3
7855790|NCT01537081|12341011|FG000|Overall Study|Physician Decision|5
7855791|NCT01537081|12341012|FG001|Overall Study|Physician Decision|6
7855792|NCT01537081|12341013|FG002|Overall Study|Physician Decision|0
7855793|NCT01537081|12341011|FG000|Overall Study|Sponsor decision|0
7855794|NCT01537081|12341012|FG001|Overall Study|Sponsor decision|1
7855795|NCT01537081|12341013|FG002|Overall Study|Sponsor decision|0
7855796|NCT01537081|12341011|FG000|Overall Study|Assigned but never dosed|1
7855797|NCT01537081|12341012|FG001|Overall Study|Assigned but never dosed|0
7855798|NCT01537081|12341013|FG002|Overall Study|Assigned but never dosed|0
7855799|NCT01537120|12341022|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1
7855800|NCT01537120|12341022|FG000|3 Weeks Placebo|Withdrawal by Subject|1
7855801|NCT01537133|12341032|FG000|Overall Study|Withdrawal by Subject|2
7855802|NCT01537133|12341033|FG001|Overall Study|Withdrawal by Subject|0
7855803|NCT01537133|12341034|FG002|Overall Study|Withdrawal by Subject|0
7855804|NCT01537133|12341035|FG003|Overall Study|Withdrawal by Subject|0
7855805|NCT01537133|12341032|FG000|Overall Study|Lost to Follow-up|1
7855806|NCT01537133|12341033|FG001|Overall Study|Lost to Follow-up|0
7855807|NCT01537133|12341034|FG002|Overall Study|Lost to Follow-up|0
7855808|NCT01537133|12341035|FG003|Overall Study|Lost to Follow-up|0
7855809|NCT01537198|12341062|FG000|Overall Study|RSV infection|2
7855810|NCT01537198|12341062|FG000|Overall Study|Adverse Event|4
7855811|NCT01537198|12341062|FG000|Overall Study|No Further Visits to the Clinic|37
7855812|NCT01537198|12341062|FG000|Overall Study|Other|111
7855813|NCT01537211|12341068|FG000|Overall Study|Lost to Follow-up|0
7855814|NCT01537211|12341069|FG001|Overall Study|Lost to Follow-up|1
7855815|NCT01537393|12341107|FG000|Overall Study|Exclude prior to study|32
7855816|NCT01537393|12341108|FG001|Overall Study|Exclude prior to study|44
7855817|NCT01537393|12341107|FG000|Overall Study|Death|20
7855818|NCT01537393|12341108|FG001|Overall Study|Death|32
7855819|NCT01537393|12341107|FG000|Overall Study|Withdrawal by Subject|18
7855820|NCT01537393|12341108|FG001|Overall Study|Withdrawal by Subject|17
7855821|NCT01537393|12341107|FG000|Overall Study|Lost to Follow-up|53
7855822|NCT01537393|12341108|FG001|Overall Study|Lost to Follow-up|48
7855823|NCT01537393|12341107|FG000|Overall Study|Failure - Regrafted|28
7855824|NCT01537393|12341108|FG001|Overall Study|Failure - Regrafted|43
7855825|NCT01537393|12341107|FG000|Overall Study|Failure - Not regrafted|2
7855826|NCT01537393|12341108|FG001|Overall Study|Failure - Not regrafted|6
7855827|NCT01537393|12341107|FG000|Overall Study|Censored (severe event unrelated to PT)|1
7855828|NCT01537393|12341108|FG001|Overall Study|Censored (severe event unrelated to PT)|1
7855829|NCT01537432|12341125|FG000|Overall Study|Lost to Follow-up|3
7855830|NCT01537432|12341126|FG001|Overall Study|Lost to Follow-up|1
7855831|NCT01537432|12341125|FG000|Overall Study|Withdrawal by Subject|0
7855832|NCT01537432|12341126|FG001|Overall Study|Withdrawal by Subject|1
7855833|NCT01537432|12341125|FG000|Overall Study|Administrative problems|1
7855834|NCT01537432|12341126|FG001|Overall Study|Administrative problems|0
7855835|NCT01537432|12341125|FG000|Overall Study|Adverse Event|1
7855836|NCT01537432|12341126|FG001|Overall Study|Adverse Event|0
7855837|NCT01537432|12341125|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7855838|NCT01537432|12341126|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7855839|NCT01537549|12341132|FG000|Overall Study|Lost to Follow-up|1
7855840|NCT01537549|12341132|FG000|Overall Study|Withdrawal by Subject|2
7855841|NCT01537783|12341167|FG000|Overall Study|Lost to Follow-up|11
7855842|NCT01537783|12341168|FG001|Overall Study|Lost to Follow-up|2
7855843|NCT01537887|12341187|FG000|Period 1|Physician Decision|0
7855844|NCT01537887|12341188|FG001|Period 1|Physician Decision|0
7855845|NCT01537887|12341189|FG002|Period 1|Physician Decision|0
7855846|NCT01537887|12341190|FG003|Period 1|Physician Decision|0
7855847|NCT01537887|12341191|FG004|Period 1|Physician Decision|1
7855848|NCT01537887|12341192|FG005|Period 1|Physician Decision|1
7855849|NCT01537887|12341187|FG000|Period 1|Did not receive treatment|0
7855850|NCT01537887|12341188|FG001|Period 1|Did not receive treatment|0
7855851|NCT01537887|12341189|FG002|Period 1|Did not receive treatment|1
7855852|NCT01537887|12341190|FG003|Period 1|Did not receive treatment|0
7855853|NCT01537887|12341191|FG004|Period 1|Did not receive treatment|0
7855854|NCT01537887|12341192|FG005|Period 1|Did not receive treatment|0
7855855|NCT01537887|12341187|FG000|Period 2|Withdrawal by Subject|0
7855856|NCT01537887|12341188|FG001|Period 2|Withdrawal by Subject|1
7855857|NCT01537887|12341189|FG002|Period 2|Withdrawal by Subject|0
7855858|NCT01537887|12341190|FG003|Period 2|Withdrawal by Subject|0
7855859|NCT01537887|12341191|FG004|Period 2|Withdrawal by Subject|0
7855860|NCT01537887|12341192|FG005|Period 2|Withdrawal by Subject|0
7855861|NCT01537887|12341187|FG000|Period 3|Adverse Event|0
7855862|NCT01537887|12341188|FG001|Period 3|Adverse Event|0
7855863|NCT01537887|12341189|FG002|Period 3|Adverse Event|1
7855864|NCT01537887|12341190|FG003|Period 3|Adverse Event|0
7855865|NCT01537887|12341191|FG004|Period 3|Adverse Event|0
7855866|NCT01537887|12341192|FG005|Period 3|Adverse Event|0
7855867|NCT01537887|12341187|FG000|Period 3|Withdrawal by Subject|0
7855868|NCT01537887|12341188|FG001|Period 3|Withdrawal by Subject|1
7855869|NCT01537887|12341189|FG002|Period 3|Withdrawal by Subject|0
7855870|NCT01537887|12341190|FG003|Period 3|Withdrawal by Subject|0
7855871|NCT01537887|12341191|FG004|Period 3|Withdrawal by Subject|0
7855872|NCT01537887|12341192|FG005|Period 3|Withdrawal by Subject|0
7855873|NCT01538199|12341220|FG000|Overall Study|Lost to Follow-up|1
7855874|NCT01538199|12341221|FG001|Overall Study|Lost to Follow-up|2
7855875|NCT01538199|12341222|FG002|Overall Study|Lost to Follow-up|1
7855876|NCT01538199|12341223|FG003|Overall Study|Lost to Follow-up|0
7855877|NCT01538199|12341220|FG000|Overall Study|participant did not have time|1
7855878|NCT01538199|12341221|FG001|Overall Study|participant did not have time|0
7855879|NCT01538199|12341222|FG002|Overall Study|participant did not have time|0
7855880|NCT01538199|12341223|FG003|Overall Study|participant did not have time|2
7855881|NCT01538199|12341220|FG000|Overall Study|Lack of Efficacy|0
7855882|NCT01538199|12341221|FG001|Overall Study|Lack of Efficacy|1
7855883|NCT01538199|12341222|FG002|Overall Study|Lack of Efficacy|0
7855884|NCT01538199|12341223|FG003|Overall Study|Lack of Efficacy|0
7855885|NCT01538472|12341240|FG000|Overall Study|Disease Progression|3
7855886|NCT01538472|12341240|FG000|Overall Study|Death|1
7855887|NCT01538628|12341255|FG000|Overall Study|Withdrawal by Subject|1
7855888|NCT01538628|12341256|FG001|Overall Study|Withdrawal by Subject|1
7855889|NCT01538628|12341255|FG000|Overall Study|Lost to Follow-up|0
7855890|NCT01538628|12341256|FG001|Overall Study|Lost to Follow-up|1
7855891|NCT01538719|12341265|FG000|Overall Study|Lost to Follow-up|2
7855892|NCT01538719|12341266|FG001|Overall Study|Lost to Follow-up|0
7863559|NCT01606761|12352912|FG002|Prior to Week 24|Withdrawal by Subject|9
7863560|NCT01606761|12352913|FG003|Prior to Week 24|Withdrawal by Subject|0
7863561|NCT01606761|12352914|FG004|Prior to Week 24|Withdrawal by Subject|0
7863562|NCT01606761|12352910|FG000|Prior to Week 24|Adverse Event|11
7863563|NCT01606761|12352911|FG001|Prior to Week 24|Adverse Event|18
7863564|NCT01606761|12352912|FG002|Prior to Week 24|Adverse Event|22
7863565|NCT01606761|12352913|FG003|Prior to Week 24|Adverse Event|0
7863566|NCT01606761|12352914|FG004|Prior to Week 24|Adverse Event|0
7863567|NCT01606761|12352910|FG000|Prior to Week 24|Lack of Efficacy|15
7863568|NCT01606761|12352911|FG001|Prior to Week 24|Lack of Efficacy|14
7863569|NCT01606761|12352912|FG002|Prior to Week 24|Lack of Efficacy|8
7863570|NCT01606761|12352913|FG003|Prior to Week 24|Lack of Efficacy|0
7863571|NCT01606761|12352914|FG004|Prior to Week 24|Lack of Efficacy|0
7863572|NCT01606761|12352910|FG000|Prior to Week 24|Physician Decision|0
7863573|NCT01606761|12352911|FG001|Prior to Week 24|Physician Decision|3
7863574|NCT01606761|12352912|FG002|Prior to Week 24|Physician Decision|1
7863575|NCT01606761|12352913|FG003|Prior to Week 24|Physician Decision|0
7863576|NCT01606761|12352914|FG004|Prior to Week 24|Physician Decision|0
7863577|NCT01606761|12352910|FG000|Prior to Week 24|Other|4
7863578|NCT01606761|12352911|FG001|Prior to Week 24|Other|7
7863579|NCT01606761|12352912|FG002|Prior to Week 24|Other|5
7863580|NCT01606761|12352913|FG003|Prior to Week 24|Other|0
7863581|NCT01606761|12352914|FG004|Prior to Week 24|Other|0
7863582|NCT01606761|12352910|FG000|Week 24 to Week 52|Lost to Follow-up|0
7863583|NCT01606761|12352911|FG001|Week 24 to Week 52|Lost to Follow-up|1
7863584|NCT01606761|12352912|FG002|Week 24 to Week 52|Lost to Follow-up|1
7863585|NCT01606761|12352913|FG003|Week 24 to Week 52|Lost to Follow-up|1
7863586|NCT01606761|12352914|FG004|Week 24 to Week 52|Lost to Follow-up|0
7863587|NCT01606761|12352910|FG000|Week 24 to Week 52|Withdrawal by Subject|0
7863588|NCT01606761|12352911|FG001|Week 24 to Week 52|Withdrawal by Subject|6
7863589|NCT01606761|12352912|FG002|Week 24 to Week 52|Withdrawal by Subject|3
7863590|NCT01606761|12352913|FG003|Week 24 to Week 52|Withdrawal by Subject|0
7863591|NCT01606761|12352914|FG004|Week 24 to Week 52|Withdrawal by Subject|0
7863592|NCT01606761|12352910|FG000|Week 24 to Week 52|Adverse Event|0
7863593|NCT01606761|12352911|FG001|Week 24 to Week 52|Adverse Event|11
7863594|NCT01606761|12352912|FG002|Week 24 to Week 52|Adverse Event|14
7863595|NCT01606761|12352913|FG003|Week 24 to Week 52|Adverse Event|3
7863596|NCT01606761|12352914|FG004|Week 24 to Week 52|Adverse Event|15
7863597|NCT01606761|12352910|FG000|Week 24 to Week 52|Death|0
7863598|NCT01606761|12352911|FG001|Week 24 to Week 52|Death|0
7863599|NCT01606761|12352912|FG002|Week 24 to Week 52|Death|2
7863600|NCT01606761|12352913|FG003|Week 24 to Week 52|Death|1
7863601|NCT01606761|12352914|FG004|Week 24 to Week 52|Death|0
7863602|NCT01606761|12352910|FG000|Week 24 to Week 52|Lack of Efficacy|0
7863603|NCT01606761|12352911|FG001|Week 24 to Week 52|Lack of Efficacy|13
7863604|NCT01606761|12352912|FG002|Week 24 to Week 52|Lack of Efficacy|7
7863605|NCT01606761|12352913|FG003|Week 24 to Week 52|Lack of Efficacy|10
7863606|NCT01606761|12352914|FG004|Week 24 to Week 52|Lack of Efficacy|3
7863607|NCT01606761|12352910|FG000|Week 24 to Week 52|Physician Decision|0
7863608|NCT01606761|12352911|FG001|Week 24 to Week 52|Physician Decision|1
7863609|NCT01606761|12352912|FG002|Week 24 to Week 52|Physician Decision|1
7863610|NCT01606761|12352913|FG003|Week 24 to Week 52|Physician Decision|0
7863611|NCT01606761|12352914|FG004|Week 24 to Week 52|Physician Decision|0
7863612|NCT01606761|12352910|FG000|Week 24 to Week 52|Other|0
7863613|NCT01606761|12352911|FG001|Week 24 to Week 52|Other|1
7863614|NCT01606761|12352912|FG002|Week 24 to Week 52|Other|5
7863615|NCT01606761|12352913|FG003|Week 24 to Week 52|Other|2
7863616|NCT01606761|12352914|FG004|Week 24 to Week 52|Other|2
7863617|NCT01606761|12352910|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
7863618|NCT01606761|12352911|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
7863619|NCT01606761|12352912|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
7863620|NCT01606761|12352913|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
7863621|NCT01606761|12352914|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
7863622|NCT01606761|12352910|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
7863623|NCT01606761|12352911|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
7863624|NCT01606761|12352912|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
7863625|NCT01606761|12352913|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
7863626|NCT01606761|12352914|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
7863627|NCT01606761|12352910|FG000|Safety Follow-up Period (Week 52-68)|Death|0
7863628|NCT01606761|12352911|FG001|Safety Follow-up Period (Week 52-68)|Death|0
7863629|NCT01606761|12352912|FG002|Safety Follow-up Period (Week 52-68)|Death|0
7863630|NCT01606761|12352913|FG003|Safety Follow-up Period (Week 52-68)|Death|0
7855893|NCT01539083|12341295|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4
7855894|NCT01539083|12341296|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0
7855895|NCT01539083|12341297|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0
7855896|NCT01539083|12341295|FG000|Before Randomization (VCD Induction)|Adverse Event|14
7855897|NCT01539083|12341296|FG001|Before Randomization (VCD Induction)|Adverse Event|0
7855898|NCT01539083|12341297|FG002|Before Randomization (VCD Induction)|Adverse Event|0
7855899|NCT01539083|12341295|FG000|Before Randomization (VCD Induction)|Death|6
7855900|NCT01539083|12341296|FG001|Before Randomization (VCD Induction)|Death|0
7855901|NCT01539083|12341297|FG002|Before Randomization (VCD Induction)|Death|0
7855902|NCT01539083|12341295|FG000|Before Randomization (VCD Induction)|Protocol Violation|2
7855903|NCT01539083|12341296|FG001|Before Randomization (VCD Induction)|Protocol Violation|0
7855904|NCT01539083|12341297|FG002|Before Randomization (VCD Induction)|Protocol Violation|0
7855905|NCT01539083|12341295|FG000|Before Randomization (VCD Induction)|Physician Decision|14
7855906|NCT01539083|12341296|FG001|Before Randomization (VCD Induction)|Physician Decision|0
7855907|NCT01539083|12341297|FG002|Before Randomization (VCD Induction)|Physician Decision|0
7855908|NCT01539083|12341295|FG000|Before Randomization (VCD Induction)|Progressive Disease|8
7855909|NCT01539083|12341296|FG001|Before Randomization (VCD Induction)|Progressive Disease|0
7855910|NCT01539083|12341297|FG002|Before Randomization (VCD Induction)|Progressive Disease|0
7855911|NCT01539083|12341295|FG000|Before Randomization (VCD Induction)|Other|5
7855912|NCT01539083|12341296|FG001|Before Randomization (VCD Induction)|Other|0
7855913|NCT01539083|12341297|FG002|Before Randomization (VCD Induction)|Other|0
7855914|NCT01539083|12341295|FG000|After Randomization (TP and VTP)|Physician Decision|0
7855915|NCT01539083|12341296|FG001|After Randomization (TP and VTP)|Physician Decision|0
7855916|NCT01539083|12341297|FG002|After Randomization (TP and VTP)|Physician Decision|1
7855917|NCT01539083|12341295|FG000|After Randomization (TP and VTP)|Other|0
7855918|NCT01539083|12341296|FG001|After Randomization (TP and VTP)|Other|1
7855919|NCT01539083|12341297|FG002|After Randomization (TP and VTP)|Other|1
7855920|NCT01539083|12341295|FG000|After Randomization (TP and VTP)|Adverse Event|0
7855921|NCT01539083|12341296|FG001|After Randomization (TP and VTP)|Adverse Event|1
7855922|NCT01539083|12341297|FG002|After Randomization (TP and VTP)|Adverse Event|1
7855923|NCT01539083|12341295|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0
7855924|NCT01539083|12341296|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2
7855925|NCT01539083|12341297|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2
7855926|NCT01539083|12341295|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0
7855927|NCT01539083|12341296|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5
7855928|NCT01539083|12341297|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4
7855929|NCT01539083|12341295|FG000|After Randomization (TP and VTP)|Progressive Disease|0
7855930|NCT01539083|12341296|FG001|After Randomization (TP and VTP)|Progressive Disease|6
7855931|NCT01539083|12341297|FG002|After Randomization (TP and VTP)|Progressive Disease|3
7855932|NCT01539083|12341295|FG000|After Randomization (TP and VTP)|Death|0
7855933|NCT01539083|12341296|FG001|After Randomization (TP and VTP)|Death|6
7855934|NCT01539083|12341297|FG002|After Randomization (TP and VTP)|Death|11
7855935|NCT01539239|12341315|FG000|Overall Study|Death|5
7855936|NCT01539239|12341316|FG001|Overall Study|Death|5
7855937|NCT01539239|12341315|FG000|Overall Study|Lost to Follow-up|7
7855938|NCT01539239|12341316|FG001|Overall Study|Lost to Follow-up|12
7855939|NCT01539291|12341325|FG000|Study GS-US-312-0116|Adverse Event|9
7855940|NCT01539291|12341326|FG001|Study GS-US-312-0116|Adverse Event|0
7855941|NCT01539291|12341327|FG002|Study GS-US-312-0116|Adverse Event|0
7855942|NCT01539291|12341328|FG003|Study GS-US-312-0116|Adverse Event|0
7855943|NCT01539291|12341325|FG000|Study GS-US-312-0116|Physician Decision|1
7855944|NCT01539291|12341326|FG001|Study GS-US-312-0116|Physician Decision|0
7855945|NCT01539291|12341327|FG002|Study GS-US-312-0116|Physician Decision|0
7855946|NCT01539291|12341328|FG003|Study GS-US-312-0116|Physician Decision|0
7855947|NCT01539291|12341325|FG000|Study GS-US-312-0116|Withdrawal by Subject|12
7855948|NCT01539291|12341326|FG001|Study GS-US-312-0116|Withdrawal by Subject|0
7855949|NCT01539291|12341327|FG002|Study GS-US-312-0116|Withdrawal by Subject|0
7855950|NCT01539291|12341328|FG003|Study GS-US-312-0116|Withdrawal by Subject|0
7855951|NCT01539291|12341325|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2
7855952|NCT01539291|12341326|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0
7855953|NCT01539291|12341327|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0
7855954|NCT01539291|12341328|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0
7855955|NCT01539291|12341325|FG000|Study GS-US-312-0116|Other|1
7855956|NCT01539291|12341326|FG001|Study GS-US-312-0116|Other|0
7855957|NCT01539291|12341327|FG002|Study GS-US-312-0116|Other|0
7855958|NCT01539291|12341328|FG003|Study GS-US-312-0116|Other|0
7855959|NCT01539291|12341325|FG000|Study GS-US-312-0117|Adverse Event|22
7855960|NCT01539291|12341326|FG001|Study GS-US-312-0117|Adverse Event|1
7855961|NCT01539291|12341327|FG002|Study GS-US-312-0117|Adverse Event|9
7855962|NCT01539291|12341328|FG003|Study GS-US-312-0117|Adverse Event|12
7855963|NCT01539291|12341325|FG000|Study GS-US-312-0117|Physician Decision|9
7855964|NCT01539291|12341326|FG001|Study GS-US-312-0117|Physician Decision|0
7855965|NCT01539291|12341327|FG002|Study GS-US-312-0117|Physician Decision|6
7855966|NCT01539291|12341328|FG003|Study GS-US-312-0117|Physician Decision|4
7855967|NCT01539291|12341325|FG000|Study GS-US-312-0117|Withdrawal by Subject|5
7855968|NCT01539291|12341326|FG001|Study GS-US-312-0117|Withdrawal by Subject|0
7855969|NCT01539291|12341327|FG002|Study GS-US-312-0117|Withdrawal by Subject|6
7855970|NCT01539291|12341328|FG003|Study GS-US-312-0117|Withdrawal by Subject|4
7855971|NCT01539291|12341325|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3
7855972|NCT01539291|12341326|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0
7855973|NCT01539291|12341327|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0
7855974|NCT01539291|12341328|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5
7855975|NCT01539291|12341325|FG000|Study GS-US-312-0117|Other|2
7855976|NCT01539291|12341326|FG001|Study GS-US-312-0117|Other|1
7855977|NCT01539291|12341327|FG002|Study GS-US-312-0117|Other|1
7855978|NCT01539291|12341328|FG003|Study GS-US-312-0117|Other|1
7855979|NCT01539317|12341347|FG000|Overall Study|Screening Error. Deleted from analysis.|1
7855980|NCT01539317|12341348|FG001|Overall Study|Screening Error. Deleted from analysis.|0
7855981|NCT01539512|12341359|FG000|Overall Study|Adverse Event|9
7855982|NCT01539512|12341360|FG001|Overall Study|Adverse Event|7
7855983|NCT01539512|12341359|FG000|Overall Study|Physician Decision|1
7855984|NCT01539512|12341360|FG001|Overall Study|Physician Decision|1
7855985|NCT01539512|12341359|FG000|Overall Study|Withdrawal by Subject|12
7855986|NCT01539512|12341360|FG001|Overall Study|Withdrawal by Subject|5
7855987|NCT01539512|12341359|FG000|Overall Study|Richter's Transformation|1
7855988|NCT01539512|12341360|FG001|Overall Study|Richter's Transformation|0
7855989|NCT01539525|12341369|FG000|Overall Study|Lost to Follow-up|19
7855990|NCT01539525|12341370|FG001|Overall Study|Lost to Follow-up|12
7855991|NCT01539525|12341371|FG002|Overall Study|Lost to Follow-up|11
7855992|NCT01539525|12341369|FG000|Overall Study|Withdrawal by Subject|0
7855993|NCT01539525|12341370|FG001|Overall Study|Withdrawal by Subject|3
7855994|NCT01539525|12341371|FG002|Overall Study|Withdrawal by Subject|2
7855995|NCT01539525|12341369|FG000|Overall Study|Protocol Violation|1
7855996|NCT01539525|12341370|FG001|Overall Study|Protocol Violation|1
7855997|NCT01539525|12341371|FG002|Overall Study|Protocol Violation|4
7855998|NCT01539538|12341384|FG000|Overall Study|Adverse Event|13
7855999|NCT01539538|12341385|FG001|Overall Study|Adverse Event|18
7856000|NCT01539538|12341384|FG000|Overall Study|Lack of Efficacy|13
7856001|NCT01539538|12341385|FG001|Overall Study|Lack of Efficacy|16
7856002|NCT01539538|12341384|FG000|Overall Study|Withdrawal by Subject|2
7856003|NCT01539538|12341385|FG001|Overall Study|Withdrawal by Subject|3
7856004|NCT01539538|12341384|FG000|Overall Study|PCA no longer required or PCA problem|3
7883490|NCT01782326|12383167|FG001|Double-blind Treatment|Protocol deviation|7
7856005|NCT01539538|12341385|FG001|Overall Study|PCA no longer required or PCA problem|7
7856006|NCT01539642|12341393|FG000|Overall Study|Lack of Efficacy|20
7856007|NCT01539642|12341394|FG001|Overall Study|Lack of Efficacy|18
7856008|NCT01539642|12341393|FG000|Overall Study|Patient ready for early discharge|8
7856009|NCT01539642|12341394|FG001|Overall Study|Patient ready for early discharge|7
7856010|NCT01539642|12341393|FG000|Overall Study|Adverse Event|6
7856011|NCT01539642|12341394|FG001|Overall Study|Adverse Event|4
7856012|NCT01539642|12341393|FG000|Overall Study|Withdrawal by Subject|2
7856013|NCT01539642|12341394|FG001|Overall Study|Withdrawal by Subject|2
7856014|NCT01539759|12341409|FG000|Overall Study|Lost to Follow-up|6
7856015|NCT01539759|12341410|FG001|Overall Study|Lost to Follow-up|8
7856016|NCT01539837|12341419|FG000|Overall Study|reduce neutrophil level|0
7856017|NCT01539837|12341420|FG001|Overall Study|reduce neutrophil level|1
7856018|NCT01539837|12341421|FG002|Overall Study|reduce neutrophil level|1
7856019|NCT01539837|12341419|FG000|Overall Study|bad compliance|0
7856020|NCT01539837|12341420|FG001|Overall Study|bad compliance|0
7856021|NCT01539837|12341421|FG002|Overall Study|bad compliance|1
7856022|NCT01540474|12341517|FG000|Vaccination Period|Lost to Follow-up|0
7856023|NCT01540474|12341518|FG001|Vaccination Period|Lost to Follow-up|1
7856024|NCT01540474|12341519|FG002|Vaccination Period|Lost to Follow-up|0
7856025|NCT01540474|12341520|FG003|Vaccination Period|Lost to Follow-up|0
7856026|NCT01540487|12341533|FG000|Overall Study|Protocol Violation|1
7856027|NCT01540487|12341534|FG001|Overall Study|Protocol Violation|0
7856028|NCT01540565|12341548|FG000|Overall Study|Ineligible|2
7856029|NCT01540838|12341618|FG000|Overall Study|Open nasogastric tube|9
7856030|NCT01540838|12341619|FG001|Overall Study|Open nasogastric tube|7
7856031|NCT01540838|12341618|FG000|Overall Study|Treatment doses missing|8
7856032|NCT01540838|12341619|FG001|Overall Study|Treatment doses missing|12
7856033|NCT01540838|12341618|FG000|Overall Study|Additional antibiotic treatment|1
7856034|NCT01540838|12341619|FG001|Overall Study|Additional antibiotic treatment|2
7856035|NCT01540838|12341618|FG000|Overall Study|Died before treatment initiation|1
7856036|NCT01540838|12341619|FG001|Overall Study|Died before treatment initiation|1
7856037|NCT01540838|12341618|FG000|Overall Study|Not BM. Other treatment|3
7856038|NCT01540838|12341619|FG001|Overall Study|Not BM. Other treatment|1
7856039|NCT01540851|12341627|FG000|Overall Study|Lost to Follow-up|14
7856040|NCT01540851|12341628|FG001|Overall Study|Lost to Follow-up|15
7856041|NCT01540851|12341627|FG000|Overall Study|Withdrawal by Subject|7
7856042|NCT01540851|12341628|FG001|Overall Study|Withdrawal by Subject|3
7856043|NCT01540981|12341638|FG000|Overall Study|Withdrawal by Subject|1
7856044|NCT01540981|12341639|FG001|Overall Study|Withdrawal by Subject|0
7856045|NCT01541215|12341647|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6
7856046|NCT01541215|12341648|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8
7856047|NCT01541215|12341647|FG000|Treatment Period (52 Weeks)|Non-compliance|4
7856048|NCT01541215|12341648|FG001|Treatment Period (52 Weeks)|Non-compliance|4
7856049|NCT01541215|12341647|FG000|Treatment Period (52 Weeks)|Adverse Event|0
7856050|NCT01541215|12341648|FG001|Treatment Period (52 Weeks)|Adverse Event|1
7856051|NCT01541215|12341647|FG000|Treatment Period (52 Weeks)|Unclassified|0
7856052|NCT01541215|12341648|FG001|Treatment Period (52 Weeks)|Unclassified|3
7856053|NCT01541215|12341647|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1
7856054|NCT01541215|12341648|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0
7856055|NCT01541215|12341647|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1
7856056|NCT01541215|12341648|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0
7856057|NCT01541254|12341658|FG000|Overall Study|Withdrawal by Subject|1
7856058|NCT01541254|12341658|FG000|Overall Study|excluded - metal allergy|1
7856059|NCT01541254|12341658|FG000|Overall Study|enrolled after study closed|1
7856060|NCT01541254|12341658|FG000|Overall Study|GI bleed prior to procedure|1
7856061|NCT01541254|12341658|FG000|Overall Study|stent not required|1
7856062|NCT01541254|12341658|FG000|Overall Study|alternate stent used|1
7856063|NCT01541371|12341667|FG000|Overall Study|Withdrawal by Subject|14
7856064|NCT01541371|12341667|FG000|Overall Study|Lost to Follow-up|21
7856065|NCT01541371|12341667|FG000|Overall Study|Adverse Event|15
7856066|NCT01541371|12341667|FG000|Overall Study|Lack of Efficacy|12
7856067|NCT01541371|12341667|FG000|Overall Study|Protocol Violation|6
7856068|NCT01541371|12341667|FG000|Overall Study|Study medication non-compliance|3
7856069|NCT01541371|12341667|FG000|Overall Study|Other|6
7856070|NCT01541644|12341697|FG000|Overall Study|Withdrawal by Subject|3
7856071|NCT01541748|12341710|FG000|Overall Study|Lost to Follow-up|17
7856072|NCT01541748|12341710|FG000|Overall Study|Moved out of state|1
7856073|NCT01541748|12341710|FG000|Overall Study|Withdrawal by Subject|7
7856074|NCT01541748|12341710|FG000|Overall Study|Screen failure|5
7856075|NCT01541748|12341710|FG000|Overall Study|Did not receive study device|1
7856076|NCT01541826|12341726|FG000|Overall Study|Lost to Follow-up|2
7856077|NCT01541826|12341727|FG001|Overall Study|Lost to Follow-up|3
7856078|NCT01541826|12341728|FG002|Overall Study|Lost to Follow-up|0
7856079|NCT01541826|12341726|FG000|Overall Study|Withdrawal by Subject|2
7856080|NCT01541826|12341727|FG001|Overall Study|Withdrawal by Subject|0
7856081|NCT01541826|12341728|FG002|Overall Study|Withdrawal by Subject|0
7856082|NCT01541865|12341736|FG000|Overall Study|Lost to Follow-up|11
7856083|NCT01541865|12341736|FG000|Overall Study|Withdrawal by Subject|9
7856084|NCT01541865|12341736|FG000|Overall Study|Adverse Event|1
7856085|NCT01541865|12341736|FG000|Overall Study|Protocol Violation|1
7856086|NCT01541917|12341754|FG000|Overall Study|Lost to Follow-up|2
7856087|NCT01541917|12341755|FG001|Overall Study|Lost to Follow-up|2
7856088|NCT01541917|12341754|FG000|Overall Study|Withdrawal by Subject|13
7856089|NCT01541917|12341755|FG001|Overall Study|Withdrawal by Subject|7
7856090|NCT01541930|12341764|FG000|Overall Study|Withdrawal by Subject|1
7856091|NCT01541969|12341781|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
7856092|NCT01541969|12341782|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
7856093|NCT01541969|12341781|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
7856094|NCT01541969|12341782|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
7856095|NCT01541969|12341781|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
7856096|NCT01541969|12341782|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
7856097|NCT01541969|12341781|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1
7856098|NCT01541969|12341782|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0
7856099|NCT01541969|12341781|FG000|Double-blind (0-12 Weeks)|Adverse Event|2
7856100|NCT01541969|12341782|FG001|Double-blind (0-12 Weeks)|Adverse Event|0
7856101|NCT01541969|12341781|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
7856102|NCT01541969|12341782|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
7856103|NCT01541969|12341781|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
7856104|NCT01541969|12341782|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
7856105|NCT01541969|12341781|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
7856106|NCT01541969|12341782|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
7856107|NCT01541969|12341781|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
7856108|NCT01541969|12341782|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
7856109|NCT01541969|12341781|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2
7856110|NCT01541969|12341782|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3
7856111|NCT01542034|12341793|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20
7856112|NCT01542034|12341794|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12
7856113|NCT01542034|12341793|FG000|Overall Study|Administrative decision|0
7856114|NCT01542034|12341794|FG001|Overall Study|Administrative decision|3
7856115|NCT01542034|12341793|FG000|Overall Study|Subject Noncompliance|1
7856116|NCT01542034|12341794|FG001|Overall Study|Subject Noncompliance|0
7856117|NCT01542034|12341793|FG000|Overall Study|Adverse Event|2
7856118|NCT01542034|12341794|FG001|Overall Study|Adverse Event|2
7856119|NCT01542034|12341793|FG000|Overall Study|Lost to Follow-up|7
7856120|NCT01542034|12341794|FG001|Overall Study|Lost to Follow-up|6
7856121|NCT01542528|12341858|FG000|Overall Study|Lost to Follow-up|2
7856122|NCT01542528|12341859|FG001|Overall Study|Lost to Follow-up|1
7856123|NCT01542528|12341858|FG000|Overall Study|Physician Decision|1
7856124|NCT01542528|12341859|FG001|Overall Study|Physician Decision|0
7856125|NCT01542528|12341858|FG000|Overall Study|Withdrawal by Subject|9
7856126|NCT01542528|12341859|FG001|Overall Study|Withdrawal by Subject|6
7856127|NCT01542632|12341880|FG000|Overall Study|Withdrawal of Consent|0
7856128|NCT01542632|12341881|FG001|Overall Study|Withdrawal of Consent|0
7856129|NCT01542632|12341882|FG002|Overall Study|Withdrawal of Consent|0
7856130|NCT01542632|12341883|FG003|Overall Study|Withdrawal of Consent|2
7856131|NCT01542632|12341884|FG004|Overall Study|Withdrawal of Consent|3
7856132|NCT01542632|12341885|FG005|Overall Study|Withdrawal of Consent|0
7856133|NCT01542632|12341880|FG000|Overall Study|Adverse Event|0
7856134|NCT01542632|12341881|FG001|Overall Study|Adverse Event|0
7856135|NCT01542632|12341882|FG002|Overall Study|Adverse Event|1
7856136|NCT01542632|12341883|FG003|Overall Study|Adverse Event|0
7856137|NCT01542632|12341884|FG004|Overall Study|Adverse Event|0
7856138|NCT01542632|12341885|FG005|Overall Study|Adverse Event|0
7856139|NCT01542632|12341880|FG000|Overall Study|Lost to Follow-up|0
7856140|NCT01542632|12341881|FG001|Overall Study|Lost to Follow-up|1
7856141|NCT01542632|12341882|FG002|Overall Study|Lost to Follow-up|0
7856142|NCT01542632|12341883|FG003|Overall Study|Lost to Follow-up|0
7856143|NCT01542632|12341884|FG004|Overall Study|Lost to Follow-up|0
7856144|NCT01542632|12341885|FG005|Overall Study|Lost to Follow-up|0
7856145|NCT01542632|12341880|FG000|Overall Study|Sponsor/Investigator Decision|0
7856146|NCT01542632|12341881|FG001|Overall Study|Sponsor/Investigator Decision|0
7856147|NCT01542632|12341882|FG002|Overall Study|Sponsor/Investigator Decision|0
7856148|NCT01542632|12341883|FG003|Overall Study|Sponsor/Investigator Decision|0
7856149|NCT01542632|12341884|FG004|Overall Study|Sponsor/Investigator Decision|1
7856150|NCT01542632|12341885|FG005|Overall Study|Sponsor/Investigator Decision|0
7856151|NCT01542788|12341923|FG000|Overall Study|Randomized but Not Treated|2
7856152|NCT01542788|12341924|FG001|Overall Study|Randomized but Not Treated|0
7856153|NCT01542788|12341923|FG000|Overall Study|Lack of Efficacy|41
7856154|NCT01542788|12341924|FG001|Overall Study|Lack of Efficacy|71
7856155|NCT01542788|12341923|FG000|Overall Study|Lost to Follow-up|5
7856156|NCT01542788|12341924|FG001|Overall Study|Lost to Follow-up|0
7856157|NCT01542788|12341923|FG000|Overall Study|Death|3
7856158|NCT01542788|12341924|FG001|Overall Study|Death|0
7856159|NCT01542788|12341923|FG000|Overall Study|Protocol Violation|2
7856160|NCT01542788|12341924|FG001|Overall Study|Protocol Violation|0
7856161|NCT01542788|12341923|FG000|Overall Study|Physician Decision|1
7856162|NCT01542788|12341924|FG001|Overall Study|Physician Decision|0
7856163|NCT01542788|12341923|FG000|Overall Study|Withdrawal by Subject|1
7856164|NCT01542788|12341924|FG001|Overall Study|Withdrawal by Subject|0
7856165|NCT01543087|12341966|FG000|Stage 1 (48 Months)|Lost to Follow-up|3
7856166|NCT01543087|12341967|FG001|Stage 1 (48 Months)|Lost to Follow-up|4
7856167|NCT01543087|12341968|FG002|Stage 1 (48 Months)|Lost to Follow-up|12
7856168|NCT01543087|12341969|FG003|Stage 1 (48 Months)|Lost to Follow-up|0
7856169|NCT01543087|12341970|FG004|Stage 1 (48 Months)|Lost to Follow-up|0
7856170|NCT01543087|12341971|FG005|Stage 1 (48 Months)|Lost to Follow-up|0
7856171|NCT01543087|12341966|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1
7856172|NCT01543087|12341967|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0
7856173|NCT01543087|12341968|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1
7856174|NCT01543087|12341969|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2
7856175|NCT01543087|12341970|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0
7856176|NCT01543087|12341971|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0
7856177|NCT01543087|12341966|FG000|Stage 1 (48 Months)|No longer willing to participate|5
7856178|NCT01543087|12341967|FG001|Stage 1 (48 Months)|No longer willing to participate|3
7856179|NCT01543087|12341968|FG002|Stage 1 (48 Months)|No longer willing to participate|18
7856180|NCT01543087|12341969|FG003|Stage 1 (48 Months)|No longer willing to participate|6
7856181|NCT01543087|12341970|FG004|Stage 1 (48 Months)|No longer willing to participate|3
7856182|NCT01543087|12341971|FG005|Stage 1 (48 Months)|No longer willing to participate|0
7856183|NCT01543087|12341966|FG000|Stage 1 (48 Months)|Other than specified|5
7856184|NCT01543087|12341967|FG001|Stage 1 (48 Months)|Other than specified|0
7856185|NCT01543087|12341968|FG002|Stage 1 (48 Months)|Other than specified|9
7856186|NCT01543087|12341969|FG003|Stage 1 (48 Months)|Other than specified|0
7856187|NCT01543087|12341970|FG004|Stage 1 (48 Months)|Other than specified|0
7856188|NCT01543087|12341971|FG005|Stage 1 (48 Months)|Other than specified|0
7856189|NCT01543087|12341966|FG000|Stage 1 (48 Months)|Protocol Violation|0
7856190|NCT01543087|12341967|FG001|Stage 1 (48 Months)|Protocol Violation|3
7856191|NCT01543087|12341968|FG002|Stage 1 (48 Months)|Protocol Violation|0
7856192|NCT01543087|12341969|FG003|Stage 1 (48 Months)|Protocol Violation|0
7856193|NCT01543087|12341970|FG004|Stage 1 (48 Months)|Protocol Violation|0
7856194|NCT01543087|12341971|FG005|Stage 1 (48 Months)|Protocol Violation|0
7856195|NCT01543087|12341966|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7856196|NCT01543087|12341967|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1
7856197|NCT01543087|12341968|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7856198|NCT01543087|12341969|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7856199|NCT01543087|12341970|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2
7856200|NCT01543087|12341971|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7856201|NCT01543087|12341966|FG000|Booster Stage (26 Months)|Lost to Follow-up|0
7856202|NCT01543087|12341967|FG001|Booster Stage (26 Months)|Lost to Follow-up|0
7856203|NCT01543087|12341968|FG002|Booster Stage (26 Months)|Lost to Follow-up|1
7856204|NCT01543087|12341969|FG003|Booster Stage (26 Months)|Lost to Follow-up|0
7856205|NCT01543087|12341970|FG004|Booster Stage (26 Months)|Lost to Follow-up|0
7856206|NCT01543087|12341971|FG005|Booster Stage (26 Months)|Lost to Follow-up|0
7856207|NCT01543152|12342012|FG000|Overall Study|Withdrawal by Subject|0
7856208|NCT01543152|12342013|FG001|Overall Study|Withdrawal by Subject|2
7856209|NCT01543152|12342014|FG002|Overall Study|Withdrawal by Subject|0
7856210|NCT01543152|12342015|FG003|Overall Study|Withdrawal by Subject|0
7856211|NCT01543152|12342016|FG004|Overall Study|Withdrawal by Subject|0
7856212|NCT01543204|12342040|FG000|Overall Study|Non-compliance|1
7856213|NCT01543204|12342040|FG000|Overall Study|Adverse Event|1
7856214|NCT01543204|12342040|FG000|Overall Study|Withdrawal by Subject|4
7856215|NCT01543204|12342040|FG000|Overall Study|Requirement for Alternative Therapy|1
7856216|NCT01543204|12342040|FG000|Overall Study|Lost to Follow-up|1
7856217|NCT01543490|12342050|FG000|Overall Study|Adverse Event|4
7856218|NCT01543490|12342051|FG001|Overall Study|Adverse Event|0
7856219|NCT01543490|12342050|FG000|Overall Study|Physician Decision|1
7856220|NCT01543490|12342051|FG001|Overall Study|Physician Decision|0
7856221|NCT01543490|12342050|FG000|Overall Study|Lack of Efficacy|3
7856222|NCT01543490|12342051|FG001|Overall Study|Lack of Efficacy|3
7856223|NCT01543490|12342050|FG000|Overall Study|Lost to Follow-up|5
7856224|NCT01543490|12342051|FG001|Overall Study|Lost to Follow-up|0
7856225|NCT01543490|12342050|FG000|Overall Study|Withdrawal by Subject|2
7856226|NCT01543490|12342051|FG001|Overall Study|Withdrawal by Subject|0
7856227|NCT01543490|12342050|FG000|Overall Study|Other-Various Administrative Reasons|1
7856228|NCT01543490|12342051|FG001|Overall Study|Other-Various Administrative Reasons|2
7856229|NCT01543503|12342059|FG000|Overall Study|Lost to Follow-up|32
7856230|NCT01543503|12342060|FG001|Overall Study|Lost to Follow-up|36
7856231|NCT01543503|12342059|FG000|Overall Study|Adverse Event|9
7856232|NCT01543503|12342060|FG001|Overall Study|Adverse Event|13
7856233|NCT01543503|12342059|FG000|Overall Study|Lack of Efficacy|4
7856234|NCT01543503|12342060|FG001|Overall Study|Lack of Efficacy|16
7856235|NCT01543503|12342059|FG000|Overall Study|Participant withdrew informed consent|8
7856236|NCT01543503|12342060|FG001|Overall Study|Participant withdrew informed consent|10
7856237|NCT01543503|12342059|FG000|Overall Study|Change of jobs|0
7856238|NCT01543503|12342060|FG001|Overall Study|Change of jobs|1
7856239|NCT01543503|12342059|FG000|Overall Study|Intolerance to the biologic treatment|0
7856240|NCT01543503|12342060|FG001|Overall Study|Intolerance to the biologic treatment|1
7856241|NCT01543503|12342059|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1
7856242|NCT01543503|12342060|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0
7856243|NCT01543503|12342059|FG000|Overall Study|Participant did not complete last visit|0
7856244|NCT01543503|12342060|FG001|Overall Study|Participant did not complete last visit|2
7856245|NCT01543503|12342059|FG000|Overall Study|Refused to continue treatment|7
7856246|NCT01543503|12342060|FG001|Overall Study|Refused to continue treatment|0
7856247|NCT01543503|12342059|FG000|Overall Study|Incorrect medication received|1
7856248|NCT01543503|12342060|FG001|Overall Study|Incorrect medication received|0
7856249|NCT01543503|12342059|FG000|Overall Study|Participant moved to another city|2
7856250|NCT01543503|12342060|FG001|Overall Study|Participant moved to another city|0
7856251|NCT01543503|12342059|FG000|Overall Study|Participant will not return for visits|0
7856252|NCT01543503|12342060|FG001|Overall Study|Participant will not return for visits|2
7856253|NCT01543503|12342059|FG000|Overall Study|Participant transferred to another city|1
7856254|NCT01543503|12342060|FG001|Overall Study|Participant transferred to another city|0
7856255|NCT01543503|12342059|FG000|Overall Study|Participant moved to Scotland|1
7856256|NCT01543503|12342060|FG001|Overall Study|Participant moved to Scotland|0
7856257|NCT01543503|12342059|FG000|Overall Study|Participant decision to stop treatment|1
7856258|NCT01543503|12342060|FG001|Overall Study|Participant decision to stop treatment|0
7856259|NCT01543503|12342059|FG000|Overall Study|Investigator did not wish to participate|1
7856260|NCT01543503|12342060|FG001|Overall Study|Investigator did not wish to participate|1
7856261|NCT01543503|12342059|FG000|Overall Study|Participant recruited after closing date|0
7856262|NCT01543503|12342060|FG001|Overall Study|Participant recruited after closing date|1
7856263|NCT01543503|12342059|FG000|Overall Study|Site stopped participation|5
7856264|NCT01543503|12342060|FG001|Overall Study|Site stopped participation|1
7856265|NCT01543503|12342059|FG000|Overall Study|Participant did not attend a visit|1
7856266|NCT01543503|12342060|FG001|Overall Study|Participant did not attend a visit|0
7856267|NCT01543503|12342059|FG000|Overall Study|Moved to other rheumatologic site|0
7856268|NCT01543503|12342060|FG001|Overall Study|Moved to other rheumatologic site|1
7856269|NCT01543503|12342059|FG000|Overall Study|Participant consented to another study|0
7856270|NCT01543503|12342060|FG001|Overall Study|Participant consented to another study|2
7856271|NCT01543503|12342059|FG000|Overall Study|Participant went to United States|1
7856272|NCT01543503|12342060|FG001|Overall Study|Participant went to United States|0
7856273|NCT01543503|12342059|FG000|Overall Study|Screen failure|1
7856274|NCT01543503|12342060|FG001|Overall Study|Screen failure|0
7856275|NCT01543685|12342086|FG000|Overall Study|Lack of Efficacy|1
7856276|NCT01543685|12342087|FG001|Overall Study|Lack of Efficacy|2
7856277|NCT01543685|12342088|FG002|Overall Study|Lack of Efficacy|2
7856278|NCT01543685|12342089|FG003|Overall Study|Lack of Efficacy|0
7856279|NCT01543685|12342090|FG004|Overall Study|Lack of Efficacy|2
7856280|NCT01543685|12342086|FG000|Overall Study|Adverse Event|2
7856281|NCT01543685|12342087|FG001|Overall Study|Adverse Event|1
7856282|NCT01543685|12342088|FG002|Overall Study|Adverse Event|0
7856283|NCT01543685|12342089|FG003|Overall Study|Adverse Event|0
7856284|NCT01543685|12342090|FG004|Overall Study|Adverse Event|2
7856285|NCT01543776|12342104|FG000|Overall Study|Withdrawal by Subject|2
7856286|NCT01543776|12342105|FG001|Overall Study|Withdrawal by Subject|2
7856287|NCT01543828|12342113|FG000|Treatment 2|Lost to Follow-up|1
7856288|NCT01543828|12342114|FG001|Treatment 2|Lost to Follow-up|0
7856289|NCT01543958|12342122|FG000|Overall Study|Loss to follow-up|3
7856290|NCT01543958|12342122|FG000|Overall Study|ART initiation|1
7856291|NCT01544114|12342152|FG000|Overall Study|Withdrawal by Subject|0
7856292|NCT01544114|12342153|FG001|Overall Study|Withdrawal by Subject|0
7856293|NCT01544114|12342154|FG002|Overall Study|Withdrawal by Subject|3
7856294|NCT01544114|12342152|FG000|Overall Study|Lost to Follow-up|0
7856295|NCT01544114|12342153|FG001|Overall Study|Lost to Follow-up|2
7856296|NCT01544114|12342154|FG002|Overall Study|Lost to Follow-up|0
7856297|NCT01544114|12342152|FG000|Overall Study|Adverse Event|1
7856298|NCT01544114|12342153|FG001|Overall Study|Adverse Event|1
7856299|NCT01544114|12342154|FG002|Overall Study|Adverse Event|2
7856300|NCT01544114|12342152|FG000|Overall Study|Protocol Violation|0
7856301|NCT01544114|12342153|FG001|Overall Study|Protocol Violation|1
7856302|NCT01544114|12342154|FG002|Overall Study|Protocol Violation|0
7856303|NCT01544153|12342168|FG000|Overall Study|Under 18|0
7856304|NCT01544153|12342169|FG001|Overall Study|Under 18|1
7856305|NCT01544153|12342170|FG002|Overall Study|Under 18|0
7856306|NCT01544153|12342171|FG003|Overall Study|Under 18|0
7856307|NCT01544153|12342168|FG000|Overall Study|Non-smoker|0
7856308|NCT01544153|12342169|FG001|Overall Study|Non-smoker|0
7856309|NCT01544153|12342170|FG002|Overall Study|Non-smoker|1
7856310|NCT01544153|12342171|FG003|Overall Study|Non-smoker|0
7856311|NCT01544179|12342190|FG000|Overall Study|Death|50
7856312|NCT01544179|12342191|FG001|Overall Study|Death|37
7856313|NCT01544179|12342190|FG000|Overall Study|Lost to Follow-up|0
7856314|NCT01544179|12342191|FG001|Overall Study|Lost to Follow-up|1
7856315|NCT01544179|12342190|FG000|Overall Study|Adverse Event|0
7856316|NCT01544179|12342191|FG001|Overall Study|Adverse Event|1
7856317|NCT01544179|12342190|FG000|Overall Study|Withdrawal by Subject|12
7856318|NCT01544179|12342191|FG001|Overall Study|Withdrawal by Subject|7
7856319|NCT01544179|12342190|FG000|Overall Study|Eligibility criteria not fulfilled|1
7856320|NCT01544179|12342191|FG001|Overall Study|Eligibility criteria not fulfilled|0
7856321|NCT01544309|12342199|FG000|Overall Study|Withdrawal by Subject|12
7856322|NCT01544309|12342200|FG001|Overall Study|Withdrawal by Subject|7
7856323|NCT01544309|12342199|FG000|Overall Study|Protocol Violation|2
7856324|NCT01544309|12342200|FG001|Overall Study|Protocol Violation|1
7856325|NCT01544309|12342199|FG000|Overall Study|Physician Decision|4
7856326|NCT01544309|12342200|FG001|Overall Study|Physician Decision|1
7856327|NCT01544309|12342199|FG000|Overall Study|Not performed pre-dose examination|1
7856328|NCT01544309|12342200|FG001|Overall Study|Not performed pre-dose examination|2
7856329|NCT01544309|12342199|FG000|Overall Study|Administered prohibit prior medication|1
7856330|NCT01544309|12342200|FG001|Overall Study|Administered prohibit prior medication|0
7949711|NCT02542072|12495627|FG001|First Intervention (1 Month)|Adverse Event|1
7856331|NCT01544348|12342216|FG000|Overall Study|Lost to Follow-up|1
7856332|NCT01544348|12342217|FG001|Overall Study|Lost to Follow-up|0
7856333|NCT01544348|12342218|FG002|Overall Study|Lost to Follow-up|0
7856334|NCT01544348|12342219|FG003|Overall Study|Lost to Follow-up|0
7856335|NCT01544348|12342220|FG004|Overall Study|Lost to Follow-up|0
7856336|NCT01544348|12342221|FG005|Overall Study|Lost to Follow-up|0
7856337|NCT01544348|12342222|FG006|Overall Study|Lost to Follow-up|1
7856338|NCT01544348|12342223|FG007|Overall Study|Lost to Follow-up|0
7856339|NCT01544348|12342216|FG000|Overall Study|Withdrawal by Subject|1
7856340|NCT01544348|12342217|FG001|Overall Study|Withdrawal by Subject|0
7856341|NCT01544348|12342218|FG002|Overall Study|Withdrawal by Subject|0
7856342|NCT01544348|12342219|FG003|Overall Study|Withdrawal by Subject|0
7856343|NCT01544348|12342220|FG004|Overall Study|Withdrawal by Subject|1
7856344|NCT01544348|12342221|FG005|Overall Study|Withdrawal by Subject|2
7856345|NCT01544348|12342222|FG006|Overall Study|Withdrawal by Subject|1
7856346|NCT01544348|12342223|FG007|Overall Study|Withdrawal by Subject|0
7856347|NCT01544348|12342216|FG000|Overall Study|Physician Decision|0
7856348|NCT01544348|12342217|FG001|Overall Study|Physician Decision|0
7856349|NCT01544348|12342218|FG002|Overall Study|Physician Decision|0
7856350|NCT01544348|12342219|FG003|Overall Study|Physician Decision|0
7856351|NCT01544348|12342220|FG004|Overall Study|Physician Decision|0
7856352|NCT01544348|12342221|FG005|Overall Study|Physician Decision|1
7856353|NCT01544348|12342222|FG006|Overall Study|Physician Decision|0
7856354|NCT01544348|12342223|FG007|Overall Study|Physician Decision|0
7856355|NCT01544478|12342269|FG000|Overall Study|Adverse Event|1
7856356|NCT01544478|12342269|FG000|Overall Study|Death|1
7856357|NCT01544478|12342269|FG000|Overall Study|Lost to Follow-up|48
7856358|NCT01544478|12342269|FG000|Overall Study|Physician Decision|15
7856359|NCT01544478|12342269|FG000|Overall Study|Pregnancy|1
7856360|NCT01544478|12342269|FG000|Overall Study|Withdrawal by Subject|52
7856361|NCT01544491|12342275|FG000|Overall Study|Withdrawal by Subject|3
7856362|NCT01544491|12342276|FG001|Overall Study|Withdrawal by Subject|2
7856363|NCT01544491|12342275|FG000|Overall Study|Lost to Follow-up|0
7856364|NCT01544491|12342276|FG001|Overall Study|Lost to Follow-up|1
7856365|NCT01544491|12342275|FG000|Overall Study|administrative problems|2
7856366|NCT01544491|12342276|FG001|Overall Study|administrative problems|0
7856367|NCT01544582|12342285|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1
7856368|NCT01544582|12342286|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0
7856369|NCT01544582|12342287|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0
7856370|NCT01544582|12342288|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0
7856371|NCT01544582|12342285|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33
7856372|NCT01544582|12342286|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0
7856373|NCT01544582|12342287|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0
7856374|NCT01544582|12342288|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0
7856375|NCT01544582|12342285|FG000|Analysis Population|Participant Refuses to Continue Study|0
7856376|NCT01544582|12342286|FG001|Analysis Population|Participant Refuses to Continue Study|15
7856377|NCT01544582|12342287|FG002|Analysis Population|Participant Refuses to Continue Study|17
7856378|NCT01544582|12342288|FG003|Analysis Population|Participant Refuses to Continue Study|4
7856379|NCT01544582|12342285|FG000|Analysis Population|Physician Decision|0
7856380|NCT01544582|12342286|FG001|Analysis Population|Physician Decision|13
7856381|NCT01544582|12342287|FG002|Analysis Population|Physician Decision|10
7856382|NCT01544582|12342288|FG003|Analysis Population|Physician Decision|9
7856383|NCT01544582|12342285|FG000|Analysis Population|Safety Reason|0
7856384|NCT01544582|12342286|FG001|Analysis Population|Safety Reason|33
7856385|NCT01544582|12342287|FG002|Analysis Population|Safety Reason|31
7856386|NCT01544582|12342288|FG003|Analysis Population|Safety Reason|8
7856387|NCT01544582|12342285|FG000|Analysis Population|Effectiveness Reason|0
7856388|NCT01544582|12342286|FG001|Analysis Population|Effectiveness Reason|48
7856389|NCT01544582|12342287|FG002|Analysis Population|Effectiveness Reason|29
7856390|NCT01544582|12342288|FG003|Analysis Population|Effectiveness Reason|12
7856391|NCT01544582|12342285|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0
7856392|NCT01544582|12342286|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0
7856393|NCT01544582|12342287|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0
7856394|NCT01544582|12342288|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1
7856395|NCT01544582|12342285|FG000|Analysis Population|Lost to Follow-up|0
7856396|NCT01544582|12342286|FG001|Analysis Population|Lost to Follow-up|6
7856397|NCT01544582|12342287|FG002|Analysis Population|Lost to Follow-up|6
7856398|NCT01544582|12342288|FG003|Analysis Population|Lost to Follow-up|5
7856399|NCT01544582|12342285|FG000|Analysis Population|Bad Tolerance to Treatment|0
7856400|NCT01544582|12342286|FG001|Analysis Population|Bad Tolerance to Treatment|0
7856401|NCT01544582|12342287|FG002|Analysis Population|Bad Tolerance to Treatment|2
7856402|NCT01544582|12342288|FG003|Analysis Population|Bad Tolerance to Treatment|0
7856403|NCT01544582|12342285|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0
7856404|NCT01544582|12342286|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0
7856405|NCT01544582|12342287|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3
7856406|NCT01544582|12342288|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0
7856407|NCT01544582|12342285|FG000|Analysis Population|Intolerance|0
7856408|NCT01544582|12342286|FG001|Analysis Population|Intolerance|1
7856409|NCT01544582|12342287|FG002|Analysis Population|Intolerance|0
7856410|NCT01544582|12342288|FG003|Analysis Population|Intolerance|0
7856411|NCT01544582|12342285|FG000|Analysis Population|Liver Transplantation|0
7856412|NCT01544582|12342286|FG001|Analysis Population|Liver Transplantation|0
7856413|NCT01544582|12342287|FG002|Analysis Population|Liver Transplantation|1
7856414|NCT01544582|12342288|FG003|Analysis Population|Liver Transplantation|0
7856415|NCT01544582|12342285|FG000|Analysis Population|No Social Insurance|0
7856416|NCT01544582|12342286|FG001|Analysis Population|No Social Insurance|0
7856417|NCT01544582|12342287|FG002|Analysis Population|No Social Insurance|1
7856418|NCT01544582|12342288|FG003|Analysis Population|No Social Insurance|0
7856419|NCT01544582|12342285|FG000|Analysis Population|Poor Adherence|0
7856420|NCT01544582|12342286|FG001|Analysis Population|Poor Adherence|0
7856421|NCT01544582|12342287|FG002|Analysis Population|Poor Adherence|1
7856422|NCT01544582|12342288|FG003|Analysis Population|Poor Adherence|0
7856423|NCT01544582|12342285|FG000|Analysis Population|Poor Participant Compliance|0
7856424|NCT01544582|12342286|FG001|Analysis Population|Poor Participant Compliance|1
7856425|NCT01544582|12342287|FG002|Analysis Population|Poor Participant Compliance|0
7856426|NCT01544582|12342288|FG003|Analysis Population|Poor Participant Compliance|0
7856427|NCT01544582|12342285|FG000|Analysis Population|Programmed Surgery|0
7856428|NCT01544582|12342286|FG001|Analysis Population|Programmed Surgery|1
7856429|NCT01544582|12342287|FG002|Analysis Population|Programmed Surgery|0
7856430|NCT01544582|12342288|FG003|Analysis Population|Programmed Surgery|0
7856431|NCT01544582|12342285|FG000|Analysis Population|Participant in Jail|0
7856432|NCT01544582|12342286|FG001|Analysis Population|Participant in Jail|0
7856433|NCT01544582|12342287|FG002|Analysis Population|Participant in Jail|1
7856434|NCT01544582|12342288|FG003|Analysis Population|Participant in Jail|0
7856435|NCT01544595|12342307|FG000|Status at Week 68|Adverse Event|3
7949712|NCT02542072|12495626|FG000|First Intervention (1 Month)|Lost to Follow-up|2
7949713|NCT02542072|12495627|FG001|First Intervention (1 Month)|Lost to Follow-up|0
7949714|NCT02542072|12495626|FG000|First Intervention (1 Month)|Lens discomfort|1
7949715|NCT02542072|12495627|FG001|First Intervention (1 Month)|Lens discomfort|2
7949716|NCT02542072|12495626|FG000|First Intervention (1 Month)|Protocol Violation|1
7949717|NCT02542072|12495627|FG001|First Intervention (1 Month)|Protocol Violation|0
7949718|NCT02542072|12495626|FG000|Second Intervention (1 Month)|Lost to Follow-up|1
7949719|NCT02542072|12495627|FG001|Second Intervention (1 Month)|Lost to Follow-up|0
7949720|NCT02542072|12495626|FG000|Second Intervention (1 Month)|Lens discomfort|1
7949721|NCT02542072|12495627|FG001|Second Intervention (1 Month)|Lens discomfort|0
7949722|NCT02542605|12495702|FG000|Part B: Challenge Phase|Sponsor decision|1
7949723|NCT02542605|12495703|FG001|Part B: Challenge Phase|Sponsor decision|0
7949724|NCT02542605|12495704|FG002|Part B: Challenge Phase|Sponsor decision|0
7949725|NCT02542605|12495702|FG000|Part B: Randomization Phase|Withdrawal by Subject|0
7949726|NCT02542605|12495703|FG001|Part B: Randomization Phase|Withdrawal by Subject|0
7949727|NCT02542605|12495704|FG002|Part B: Randomization Phase|Withdrawal by Subject|1
7949728|NCT02542631|12495715|FG000|Overall Study|Adverse Event|1
7949729|NCT02542631|12495716|FG001|Overall Study|Adverse Event|1
7949730|NCT02542631|12495715|FG000|Overall Study|Sponsor Termination|1
7949731|NCT02542631|12495716|FG001|Overall Study|Sponsor Termination|0
7949732|NCT02542631|12495715|FG000|Overall Study|Withdrawal by Subject|11
7949733|NCT02542631|12495716|FG001|Overall Study|Withdrawal by Subject|16
7949734|NCT02542631|12495715|FG000|Overall Study|Protocol Violation|1
7949735|NCT02542631|12495716|FG001|Overall Study|Protocol Violation|1
7949736|NCT02542631|12495715|FG000|Overall Study|Physician Decision|6
7949737|NCT02542631|12495716|FG001|Overall Study|Physician Decision|4
7949738|NCT02542631|12495715|FG000|Overall Study|Lost to Follow-up|6
7949739|NCT02542631|12495716|FG001|Overall Study|Lost to Follow-up|5
7949740|NCT02542631|12495715|FG000|Overall Study|Death|1
7949741|NCT02542631|12495716|FG001|Overall Study|Death|2
7949742|NCT02542631|12495715|FG000|Overall Study|Other|2
7949743|NCT02542631|12495716|FG001|Overall Study|Other|1
7949744|NCT02542631|12495715|FG000|Overall Study|Used Prohibited Medication|2
7949745|NCT02542631|12495716|FG001|Overall Study|Used Prohibited Medication|1
7949746|NCT02542865|12495731|FG000|Overall Study|Identified as screen failure|1
7949747|NCT02542865|12495732|FG001|Overall Study|Identified as screen failure|0
7949748|NCT02542865|12495731|FG000|Overall Study|Withdrawal by Subject|16
7949749|NCT02542865|12495732|FG001|Overall Study|Withdrawal by Subject|0
7949750|NCT02542943|12495741|FG000|Overall Study|Lost to Follow-up|1
7949751|NCT02542943|12495742|FG001|Overall Study|Lost to Follow-up|0
7949752|NCT02542943|12495743|FG002|Overall Study|Lost to Follow-up|0
7949753|NCT02542943|12495741|FG000|Overall Study|Withdrawal by Subject|0
7949754|NCT02542943|12495742|FG001|Overall Study|Withdrawal by Subject|1
7949755|NCT02542943|12495743|FG002|Overall Study|Withdrawal by Subject|0
7949756|NCT02543203|12495754|FG000|Overall Study|Unpalatable Fragrance|2
7949757|NCT02543203|12495755|FG001|Overall Study|Unpalatable Fragrance|2
7949758|NCT02543203|12495754|FG000|Overall Study|Lost to Follow-up|1
7949759|NCT02543203|12495755|FG001|Overall Study|Lost to Follow-up|0
7949760|NCT02543203|12495754|FG000|Overall Study|Increased Irritability|1
7949761|NCT02543203|12495755|FG001|Overall Study|Increased Irritability|0
7949762|NCT02543203|12495754|FG000|Overall Study|Family|1
7856436|NCT01544595|12342308|FG001|Status at Week 68|Adverse Event|2
7856437|NCT01544595|12342309|FG002|Status at Week 68|Adverse Event|1
7856438|NCT01544595|12342310|FG003|Status at Week 68|Adverse Event|0
7856439|NCT01544595|12342311|FG004|Status at Week 68|Adverse Event|0
7856440|NCT01544595|12342312|FG005|Status at Week 68|Adverse Event|0
7856441|NCT01544595|12342307|FG000|Status at Week 68|Lack of Efficacy|1
7856442|NCT01544595|12342308|FG001|Status at Week 68|Lack of Efficacy|0
7856443|NCT01544595|12342309|FG002|Status at Week 68|Lack of Efficacy|0
7856444|NCT01544595|12342310|FG003|Status at Week 68|Lack of Efficacy|0
7856445|NCT01544595|12342311|FG004|Status at Week 68|Lack of Efficacy|0
7856446|NCT01544595|12342312|FG005|Status at Week 68|Lack of Efficacy|0
7856447|NCT01544595|12342307|FG000|Status at Week 68|Lost to Follow-up|1
7856448|NCT01544595|12342308|FG001|Status at Week 68|Lost to Follow-up|1
7856449|NCT01544595|12342309|FG002|Status at Week 68|Lost to Follow-up|0
7856450|NCT01544595|12342310|FG003|Status at Week 68|Lost to Follow-up|0
7856451|NCT01544595|12342311|FG004|Status at Week 68|Lost to Follow-up|0
7856452|NCT01544595|12342312|FG005|Status at Week 68|Lost to Follow-up|0
7856453|NCT01544595|12342307|FG000|Status at Week 68|Non-compliance with study treatment|1
7856454|NCT01544595|12342308|FG001|Status at Week 68|Non-compliance with study treatment|0
7856455|NCT01544595|12342309|FG002|Status at Week 68|Non-compliance with study treatment|0
7856456|NCT01544595|12342310|FG003|Status at Week 68|Non-compliance with study treatment|1
7856457|NCT01544595|12342311|FG004|Status at Week 68|Non-compliance with study treatment|0
7856458|NCT01544595|12342312|FG005|Status at Week 68|Non-compliance with study treatment|0
7856459|NCT01544595|12342307|FG000|Status at Week 68|Protocol Violation|2
7856460|NCT01544595|12342308|FG001|Status at Week 68|Protocol Violation|0
7856461|NCT01544595|12342309|FG002|Status at Week 68|Protocol Violation|1
7856462|NCT01544595|12342310|FG003|Status at Week 68|Protocol Violation|1
7856463|NCT01544595|12342311|FG004|Status at Week 68|Protocol Violation|0
7856464|NCT01544595|12342312|FG005|Status at Week 68|Protocol Violation|0
7856465|NCT01544595|12342307|FG000|Status at Week 68|Technical problems|1
7856466|NCT01544595|12342308|FG001|Status at Week 68|Technical problems|0
7856467|NCT01544595|12342309|FG002|Status at Week 68|Technical problems|0
7856468|NCT01544595|12342310|FG003|Status at Week 68|Technical problems|1
7856469|NCT01544595|12342311|FG004|Status at Week 68|Technical problems|0
7856470|NCT01544595|12342312|FG005|Status at Week 68|Technical problems|0
7856471|NCT01544595|12342307|FG000|Status at Week 68|Withdrawal by Subject|0
7856472|NCT01544595|12342308|FG001|Status at Week 68|Withdrawal by Subject|1
7856473|NCT01544595|12342309|FG002|Status at Week 68|Withdrawal by Subject|1
7856474|NCT01544595|12342310|FG003|Status at Week 68|Withdrawal by Subject|2
7856475|NCT01544595|12342311|FG004|Status at Week 68|Withdrawal by Subject|0
7856476|NCT01544595|12342312|FG005|Status at Week 68|Withdrawal by Subject|0
7856477|NCT01544595|12342307|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30
7856478|NCT01544595|12342308|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13
7856479|NCT01544595|12342309|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60
7856480|NCT01544595|12342310|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46
7856481|NCT01544595|12342311|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0
7856482|NCT01544595|12342312|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0
7856483|NCT01544595|12342307|FG000|Status at Week 156|Withdrawal by Subject|9
7856484|NCT01544595|12342308|FG001|Status at Week 156|Withdrawal by Subject|10
7856485|NCT01544595|12342309|FG002|Status at Week 156|Withdrawal by Subject|4
7856486|NCT01544595|12342310|FG003|Status at Week 156|Withdrawal by Subject|9
7856487|NCT01544595|12342311|FG004|Status at Week 156|Withdrawal by Subject|20
7856488|NCT01544595|12342312|FG005|Status at Week 156|Withdrawal by Subject|6
7856489|NCT01544595|12342307|FG000|Status at Week 156|Adverse Event|9
7856490|NCT01544595|12342308|FG001|Status at Week 156|Adverse Event|11
7856491|NCT01544595|12342309|FG002|Status at Week 156|Adverse Event|1
7856492|NCT01544595|12342310|FG003|Status at Week 156|Adverse Event|3
7856493|NCT01544595|12342311|FG004|Status at Week 156|Adverse Event|4
7856494|NCT01544595|12342312|FG005|Status at Week 156|Adverse Event|2
7856495|NCT01544595|12342307|FG000|Status at Week 156|Lost to Follow-up|4
7856496|NCT01544595|12342308|FG001|Status at Week 156|Lost to Follow-up|4
7856497|NCT01544595|12342309|FG002|Status at Week 156|Lost to Follow-up|0
7949763|NCT02543203|12495755|FG001|Overall Study|Family|2
7949764|NCT02543203|12495754|FG000|Overall Study|Negative Behavior|1
7856498|NCT01544595|12342310|FG003|Status at Week 156|Lost to Follow-up|1
7856499|NCT01544595|12342311|FG004|Status at Week 156|Lost to Follow-up|4
7856500|NCT01544595|12342312|FG005|Status at Week 156|Lost to Follow-up|1
7856501|NCT01544595|12342307|FG000|Status at Week 156|Non-compliance with study treatement|0
7856502|NCT01544595|12342308|FG001|Status at Week 156|Non-compliance with study treatement|1
7856503|NCT01544595|12342309|FG002|Status at Week 156|Non-compliance with study treatement|0
7856504|NCT01544595|12342310|FG003|Status at Week 156|Non-compliance with study treatement|1
7856505|NCT01544595|12342311|FG004|Status at Week 156|Non-compliance with study treatement|0
7856506|NCT01544595|12342312|FG005|Status at Week 156|Non-compliance with study treatement|1
7856507|NCT01544595|12342307|FG000|Status at Week 156|Physician Decision|0
7856508|NCT01544595|12342308|FG001|Status at Week 156|Physician Decision|3
7856509|NCT01544595|12342309|FG002|Status at Week 156|Physician Decision|1
7856510|NCT01544595|12342310|FG003|Status at Week 156|Physician Decision|0
7856511|NCT01544595|12342311|FG004|Status at Week 156|Physician Decision|0
7856512|NCT01544595|12342312|FG005|Status at Week 156|Physician Decision|0
7856513|NCT01544595|12342307|FG000|Status at Week 156|Pregnancy|2
7856514|NCT01544595|12342308|FG001|Status at Week 156|Pregnancy|3
7856515|NCT01544595|12342309|FG002|Status at Week 156|Pregnancy|0
7856516|NCT01544595|12342310|FG003|Status at Week 156|Pregnancy|0
7856517|NCT01544595|12342311|FG004|Status at Week 156|Pregnancy|0
7856518|NCT01544595|12342312|FG005|Status at Week 156|Pregnancy|0
7856519|NCT01544595|12342307|FG000|Status at Week 156|Protocol Violation|3
7856520|NCT01544595|12342308|FG001|Status at Week 156|Protocol Violation|1
7856521|NCT01544595|12342309|FG002|Status at Week 156|Protocol Violation|2
7856522|NCT01544595|12342310|FG003|Status at Week 156|Protocol Violation|2
7856523|NCT01544595|12342311|FG004|Status at Week 156|Protocol Violation|0
7856524|NCT01544595|12342312|FG005|Status at Week 156|Protocol Violation|0
7856525|NCT01544595|12342307|FG000|Status at Week 156|Technical problems|3
7856526|NCT01544595|12342308|FG001|Status at Week 156|Technical problems|1
7856527|NCT01544595|12342309|FG002|Status at Week 156|Technical problems|0
7856528|NCT01544595|12342310|FG003|Status at Week 156|Technical problems|1
7856529|NCT01544595|12342311|FG004|Status at Week 156|Technical problems|0
7856530|NCT01544595|12342312|FG005|Status at Week 156|Technical problems|0
7856531|NCT01544595|12342307|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86
7856532|NCT01544595|12342308|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44
7856533|NCT01544595|12342309|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131
7856534|NCT01544595|12342310|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145
7856535|NCT01544595|12342311|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0
7856536|NCT01544595|12342312|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0
7856537|NCT01544595|12342307|FG000|Status at Week 156|Lack of Efficacy|1
7856538|NCT01544595|12342308|FG001|Status at Week 156|Lack of Efficacy|0
7856539|NCT01544595|12342309|FG002|Status at Week 156|Lack of Efficacy|1
7856540|NCT01544595|12342310|FG003|Status at Week 156|Lack of Efficacy|4
7856541|NCT01544595|12342311|FG004|Status at Week 156|Lack of Efficacy|10
7856542|NCT01544595|12342312|FG005|Status at Week 156|Lack of Efficacy|5
7856543|NCT01544920|12342332|FG000|Overall Study|Adverse Event|0
7856544|NCT01544920|12342333|FG001|Overall Study|Adverse Event|3
7856545|NCT01544920|12342332|FG000|Overall Study|Death|0
7856546|NCT01544920|12342333|FG001|Overall Study|Death|1
7856547|NCT01544920|12342332|FG000|Overall Study|Lost to Follow-up|11
7856548|NCT01544920|12342333|FG001|Overall Study|Lost to Follow-up|12
7856549|NCT01544920|12342332|FG000|Overall Study|Protocol Violation|0
7856550|NCT01544920|12342333|FG001|Overall Study|Protocol Violation|2
7856551|NCT01544920|12342332|FG000|Overall Study|Physician Decision|4
7856552|NCT01544920|12342333|FG001|Overall Study|Physician Decision|1
7856553|NCT01544920|12342332|FG000|Overall Study|Withdrawal by Subject|4
7856554|NCT01544920|12342333|FG001|Overall Study|Withdrawal by Subject|4
7856555|NCT01545076|12342350|FG000|IgPro10 Restabilization Period|Adverse Event|4
7856556|NCT01545076|12342351|FG001|IgPro10 Restabilization Period|Adverse Event|0
7856557|NCT01545076|12342352|FG002|IgPro10 Restabilization Period|Adverse Event|0
7856558|NCT01545076|12342353|FG003|IgPro10 Restabilization Period|Adverse Event|0
7856559|NCT01545076|12342354|FG004|IgPro10 Restabilization Period|Adverse Event|0
7856560|NCT01545076|12342350|FG000|IgPro10 Restabilization Period|Physician Decision|2
7856561|NCT01545076|12342351|FG001|IgPro10 Restabilization Period|Physician Decision|0
7856562|NCT01545076|12342352|FG002|IgPro10 Restabilization Period|Physician Decision|0
7856563|NCT01545076|12342353|FG003|IgPro10 Restabilization Period|Physician Decision|0
7856564|NCT01545076|12342354|FG004|IgPro10 Restabilization Period|Physician Decision|0
7856565|NCT01545076|12342350|FG000|IgPro10 Restabilization Period|Protocol Violation|1
7856566|NCT01545076|12342351|FG001|IgPro10 Restabilization Period|Protocol Violation|0
7856567|NCT01545076|12342352|FG002|IgPro10 Restabilization Period|Protocol Violation|0
7856568|NCT01545076|12342353|FG003|IgPro10 Restabilization Period|Protocol Violation|0
7856569|NCT01545076|12342354|FG004|IgPro10 Restabilization Period|Protocol Violation|0
7856570|NCT01545076|12342350|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
7856571|NCT01545076|12342351|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7856572|NCT01545076|12342352|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7856573|NCT01545076|12342353|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7856574|NCT01545076|12342354|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7883491|NCT01782326|12383166|FG000|Double-blind Treatment|Technical problems|0
7856575|NCT01545076|12342350|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7
7856576|NCT01545076|12342351|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0
7856577|NCT01545076|12342352|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0
7856578|NCT01545076|12342353|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0
7856579|NCT01545076|12342354|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0
7856580|NCT01545076|12342350|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7856581|NCT01545076|12342351|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7856582|NCT01545076|12342352|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7856583|NCT01545076|12342353|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
7856584|NCT01545076|12342354|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7856585|NCT01545076|12342350|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
7856586|NCT01545076|12342351|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
7856587|NCT01545076|12342352|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
7856588|NCT01545076|12342353|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
7856589|NCT01545076|12342354|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
7856590|NCT01545076|12342350|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
7856591|NCT01545076|12342351|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
7856592|NCT01545076|12342352|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
7856593|NCT01545076|12342353|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
7856594|NCT01545076|12342354|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
7856595|NCT01545076|12342350|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
7856596|NCT01545076|12342351|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
7856597|NCT01545076|12342352|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
7856598|NCT01545076|12342353|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
7856599|NCT01545076|12342354|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
7856600|NCT01545375|12342416|FG000|Overall Study|Adverse Event|2
7856601|NCT01545375|12342417|FG001|Overall Study|Adverse Event|1
7856602|NCT01545375|12342416|FG000|Overall Study|Lost to Follow-up|34
7856603|NCT01545375|12342417|FG001|Overall Study|Lost to Follow-up|31
7856604|NCT01545375|12342416|FG000|Overall Study|Protocol Violation|3
7856605|NCT01545375|12342417|FG001|Overall Study|Protocol Violation|3
7856606|NCT01545375|12342416|FG000|Overall Study|Withdrawal by Subject|58
7856607|NCT01545375|12342417|FG001|Overall Study|Withdrawal by Subject|55
7856608|NCT01545388|12342426|FG000|Overall Study|Adverse Event|2
7856609|NCT01545388|12342427|FG001|Overall Study|Adverse Event|4
7856610|NCT01545388|12342428|FG002|Overall Study|Adverse Event|1
7856611|NCT01545388|12342426|FG000|Overall Study|Lack of Efficacy|3
7856612|NCT01545388|12342427|FG001|Overall Study|Lack of Efficacy|2
7856613|NCT01545388|12342428|FG002|Overall Study|Lack of Efficacy|5
7856614|NCT01545388|12342426|FG000|Overall Study|Participant moved or relocated|1
7856615|NCT01545388|12342427|FG001|Overall Study|Participant moved or relocated|0
7856616|NCT01545388|12342428|FG002|Overall Study|Participant moved or relocated|0
7856617|NCT01545388|12342426|FG000|Overall Study|Withdrawal by Subject|1
7856618|NCT01545388|12342427|FG001|Overall Study|Withdrawal by Subject|4
7856619|NCT01545388|12342428|FG002|Overall Study|Withdrawal by Subject|2
7856620|NCT01545388|12342426|FG000|Overall Study|Other|1
7856621|NCT01545388|12342427|FG001|Overall Study|Other|1
7856622|NCT01545388|12342428|FG002|Overall Study|Other|0
7863631|NCT01606761|12352914|FG004|Safety Follow-up Period (Week 52-68)|Death|1
7863632|NCT01606761|12352910|FG000|Safety Follow-up Period (Week 52-68)|Other|0
7863633|NCT01606761|12352911|FG001|Safety Follow-up Period (Week 52-68)|Other|3
7863634|NCT01606761|12352912|FG002|Safety Follow-up Period (Week 52-68)|Other|9
7863635|NCT01606761|12352913|FG003|Safety Follow-up Period (Week 52-68)|Other|1
7863636|NCT01606761|12352914|FG004|Safety Follow-up Period (Week 52-68)|Other|3
7863637|NCT01606787|12352931|FG000|Overall Study|Withdrawal by Subject|4
7863638|NCT01606787|12352932|FG001|Overall Study|Withdrawal by Subject|5
7863639|NCT01606787|12352931|FG000|Overall Study|Surgery canceled|0
7863640|NCT01606787|12352932|FG001|Overall Study|Surgery canceled|2
7863641|NCT01606800|12352940|FG000|Overall Study|Adverse Event|3
7863642|NCT01606800|12352941|FG001|Overall Study|Adverse Event|1
7863643|NCT01606800|12352940|FG000|Overall Study|Participant withdrew consent|0
7863644|NCT01606800|12352941|FG001|Overall Study|Participant withdrew consent|1
7863645|NCT01606800|12352940|FG000|Overall Study|Missing completion status|2
7863646|NCT01606800|12352941|FG001|Overall Study|Missing completion status|0
7863647|NCT01607073|12352956|FG000|Overall Study|Adverse Event|1
7863648|NCT01607346|12352999|FG000|Overall Study|Adverse Event|3
7863649|NCT01607398|12353005|FG000|Overall Study|Adverse Event|0
7863650|NCT01607398|12353006|FG001|Overall Study|Adverse Event|2
7863651|NCT01607398|12353005|FG000|Overall Study|Severe COPD|2
7863652|NCT01607398|12353006|FG001|Overall Study|Severe COPD|0
7863653|NCT01607476|12353062|FG000|Overall Study|Withdrawal by Subject|1
7863654|NCT01607476|12353063|FG001|Overall Study|Withdrawal by Subject|0
7863655|NCT01607476|12353064|FG002|Overall Study|Withdrawal by Subject|1
7863656|NCT01607476|12353062|FG000|Overall Study|Lost to Follow-up|0
7863657|NCT01607476|12353063|FG001|Overall Study|Lost to Follow-up|0
7863658|NCT01607476|12353064|FG002|Overall Study|Lost to Follow-up|2
7863659|NCT01607554|12353072|FG000|Overall Study|Disease progression|2
7863660|NCT01607593|12353076|FG000|Overall Study|Adverse Event|15
7863661|NCT01607593|12353076|FG000|Overall Study|Lack of Efficacy|16
7863662|NCT01607593|12353076|FG000|Overall Study|Lost to Follow-up|25
7863663|NCT01607593|12353076|FG000|Overall Study|Continuation|33
7863664|NCT01607593|12353076|FG000|Overall Study|Other|4
7863665|NCT01607892|12353118|FG000|Overall Study|Need of treatment not allowed per protocol|0
7863666|NCT01607892|12353119|FG001|Overall Study|Need of treatment not allowed per protocol|0
7863667|NCT01607892|12353120|FG002|Overall Study|Need of treatment not allowed per protocol|0
7863668|NCT01607892|12353121|FG003|Overall Study|Need of treatment not allowed per protocol|1
7863669|NCT01607892|12353122|FG004|Overall Study|Need of treatment not allowed per protocol|0
7863670|NCT01607892|12353118|FG000|Overall Study|Death|4
7863671|NCT01607892|12353119|FG001|Overall Study|Death|2
7863672|NCT01607892|12353120|FG002|Overall Study|Death|8
7863673|NCT01607892|12353121|FG003|Overall Study|Death|10
7863674|NCT01607892|12353122|FG004|Overall Study|Death|3
7863675|NCT01607892|12353118|FG000|Overall Study|Investigator discretion|2
7863676|NCT01607892|12353119|FG001|Overall Study|Investigator discretion|4
7863677|NCT01607892|12353120|FG002|Overall Study|Investigator discretion|4
7863678|NCT01607892|12353121|FG003|Overall Study|Investigator discretion|8
7863679|NCT01607892|12353122|FG004|Overall Study|Investigator discretion|0
7863680|NCT01607892|12353118|FG000|Overall Study|Other treatments became available|1
7863681|NCT01607892|12353119|FG001|Overall Study|Other treatments became available|1
7863682|NCT01607892|12353120|FG002|Overall Study|Other treatments became available|0
7863683|NCT01607892|12353121|FG003|Overall Study|Other treatments became available|0
7863684|NCT01607892|12353122|FG004|Overall Study|Other treatments became available|2
7863685|NCT01607892|12353118|FG000|Overall Study|Intercurrent illness|1
7863686|NCT01607892|12353119|FG001|Overall Study|Intercurrent illness|0
7863687|NCT01607892|12353120|FG002|Overall Study|Intercurrent illness|0
7863688|NCT01607892|12353121|FG003|Overall Study|Intercurrent illness|3
7863689|NCT01607892|12353122|FG004|Overall Study|Intercurrent illness|0
7863690|NCT01607892|12353118|FG000|Overall Study|Non-Compliance with study procedures|0
7863691|NCT01607892|12353119|FG001|Overall Study|Non-Compliance with study procedures|0
7863692|NCT01607892|12353120|FG002|Overall Study|Non-Compliance with study procedures|1
7863693|NCT01607892|12353121|FG003|Overall Study|Non-Compliance with study procedures|0
7863694|NCT01607892|12353122|FG004|Overall Study|Non-Compliance with study procedures|0
7863695|NCT01607892|12353118|FG000|Overall Study|Consent withdrawn by participant|9
7856623|NCT01545817|12342532|FG000|Pazopanib|Disease progression|51
7856624|NCT01545817|12342533|FG001|Pazopanib|Disease progression|0
7856625|NCT01545817|12342532|FG000|Pazopanib|Adverse Event|19
7856626|NCT01545817|12342533|FG001|Pazopanib|Adverse Event|0
7856627|NCT01545817|12342532|FG000|Pazopanib|Other reason|4
7856628|NCT01545817|12342533|FG001|Pazopanib|Other reason|0
7856629|NCT01545817|12342532|FG000|Everolimus|Other reason|0
7856630|NCT01545817|12342533|FG001|Everolimus|Other reason|7
7856631|NCT01545817|12342532|FG000|Everolimus|Disease progression|0
7856632|NCT01545817|12342533|FG001|Everolimus|Disease progression|25
7856633|NCT01545817|12342532|FG000|Everolimus|Adverse Event|0
7856634|NCT01545817|12342533|FG001|Everolimus|Adverse Event|6
7856635|NCT01545934|12342559|FG000|Overall Study|Withdrawal by Subject|4
7856636|NCT01545934|12342560|FG001|Overall Study|Withdrawal by Subject|3
7856637|NCT01545934|12342559|FG000|Overall Study|Lost to Follow-up|1
7856638|NCT01545934|12342560|FG001|Overall Study|Lost to Follow-up|0
7856639|NCT01546038|12342573|FG000|Overall Study|Death|15
7856640|NCT01546038|12342574|FG001|Overall Study|Death|6
7856641|NCT01546038|12342575|FG002|Overall Study|Death|4
7856642|NCT01546038|12342576|FG003|Overall Study|Death|2
7856643|NCT01546038|12342577|FG004|Overall Study|Death|9
7856644|NCT01546038|12342578|FG005|Overall Study|Death|3
7856645|NCT01546038|12342579|FG006|Overall Study|Death|46
7856646|NCT01546038|12342580|FG007|Overall Study|Death|76
7856647|NCT01546038|12342581|FG008|Overall Study|Death|39
7856648|NCT01546038|12342573|FG000|Overall Study|Lost to Follow-up|0
7856649|NCT01546038|12342574|FG001|Overall Study|Lost to Follow-up|0
7856650|NCT01546038|12342575|FG002|Overall Study|Lost to Follow-up|0
7856651|NCT01546038|12342576|FG003|Overall Study|Lost to Follow-up|0
7856652|NCT01546038|12342577|FG004|Overall Study|Lost to Follow-up|1
7856653|NCT01546038|12342578|FG005|Overall Study|Lost to Follow-up|0
7856654|NCT01546038|12342579|FG006|Overall Study|Lost to Follow-up|2
7856655|NCT01546038|12342580|FG007|Overall Study|Lost to Follow-up|1
7856656|NCT01546038|12342581|FG008|Overall Study|Lost to Follow-up|0
7856657|NCT01546038|12342573|FG000|Overall Study|Withdrawal by Subject|1
7856658|NCT01546038|12342574|FG001|Overall Study|Withdrawal by Subject|0
7856659|NCT01546038|12342575|FG002|Overall Study|Withdrawal by Subject|0
7856660|NCT01546038|12342576|FG003|Overall Study|Withdrawal by Subject|1
7856661|NCT01546038|12342577|FG004|Overall Study|Withdrawal by Subject|0
7856662|NCT01546038|12342578|FG005|Overall Study|Withdrawal by Subject|1
7856663|NCT01546038|12342579|FG006|Overall Study|Withdrawal by Subject|3
7856664|NCT01546038|12342580|FG007|Overall Study|Withdrawal by Subject|3
7856665|NCT01546038|12342581|FG008|Overall Study|Withdrawal by Subject|1
7856666|NCT01546038|12342573|FG000|Overall Study|: Randomized, not treated|0
7856667|NCT01546038|12342574|FG001|Overall Study|: Randomized, not treated|0
7856668|NCT01546038|12342575|FG002|Overall Study|: Randomized, not treated|0
7856669|NCT01546038|12342576|FG003|Overall Study|: Randomized, not treated|0
7856670|NCT01546038|12342577|FG004|Overall Study|: Randomized, not treated|0
7856671|NCT01546038|12342578|FG005|Overall Study|: Randomized, not treated|0
7856672|NCT01546038|12342579|FG006|Overall Study|: Randomized, not treated|2
7856673|NCT01546038|12342580|FG007|Overall Study|: Randomized, not treated|4
7856674|NCT01546038|12342581|FG008|Overall Study|: Randomized, not treated|3
7856675|NCT01546142|12342633|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15
7856676|NCT01546142|12342634|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15
7856677|NCT01546142|12342633|FG000|Overall Study|Subject Noncompliance|1
7856678|NCT01546142|12342634|FG001|Overall Study|Subject Noncompliance|1
7856679|NCT01546142|12342633|FG000|Overall Study|Adverse Event|6
7856680|NCT01546142|12342634|FG001|Overall Study|Adverse Event|3
7856681|NCT01546142|12342633|FG000|Overall Study|Lost to Follow-up|20
7856682|NCT01546142|12342634|FG001|Overall Study|Lost to Follow-up|15
7856683|NCT01546142|12342633|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1
7856684|NCT01546142|12342634|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0
7856685|NCT01546142|12342633|FG000|Overall Study|Subject Randomized but Not Treated|1
7856686|NCT01546142|12342634|FG001|Overall Study|Subject Randomized but Not Treated|0
7856687|NCT01546155|12342640|FG000|Overall Study|could not tolerate long scan duration|3
7856688|NCT01546168|12342646|FG000|Overall Study|Lost to Follow-up|1
7856689|NCT01546168|12342647|FG001|Overall Study|Lost to Follow-up|0
7856690|NCT01546168|12342646|FG000|Overall Study|Withdrawal by Subject|1
7856691|NCT01546168|12342647|FG001|Overall Study|Withdrawal by Subject|0
7856692|NCT01546168|12342646|FG000|Overall Study|ineligible after signing consent|2
7856693|NCT01546168|12342647|FG001|Overall Study|ineligible after signing consent|0
7856694|NCT01546519|12342687|FG000|Overall Study|Adverse Event|0
7856695|NCT01546519|12342688|FG001|Overall Study|Adverse Event|0
7856696|NCT01546519|12342689|FG002|Overall Study|Adverse Event|1
7856697|NCT01546519|12342690|FG003|Overall Study|Adverse Event|1
7856698|NCT01546519|12342687|FG000|Overall Study|Death|0
7856699|NCT01546519|12342688|FG001|Overall Study|Death|1
7856700|NCT01546519|12342689|FG002|Overall Study|Death|3
7856701|NCT01546519|12342690|FG003|Overall Study|Death|1
7856702|NCT01546519|12342687|FG000|Overall Study|related to disease progression|2
7856703|NCT01546519|12342688|FG001|Overall Study|related to disease progression|2
7856704|NCT01546519|12342689|FG002|Overall Study|related to disease progression|2
7856705|NCT01546519|12342690|FG003|Overall Study|related to disease progression|1
7856706|NCT01546519|12342687|FG000|Overall Study|Physician Decision|6
7856707|NCT01546519|12342688|FG001|Overall Study|Physician Decision|5
7856708|NCT01546519|12342689|FG002|Overall Study|Physician Decision|2
7856709|NCT01546519|12342690|FG003|Overall Study|Physician Decision|3
7856710|NCT01546519|12342687|FG000|Overall Study|Withdrawal by Subject|1
7856711|NCT01546519|12342688|FG001|Overall Study|Withdrawal by Subject|0
7856712|NCT01546519|12342689|FG002|Overall Study|Withdrawal by Subject|0
7856713|NCT01546519|12342690|FG003|Overall Study|Withdrawal by Subject|0
7856714|NCT01546623|12342706|FG000|Overall Study|Adverse Event|2
7856715|NCT01546623|12342707|FG001|Overall Study|Adverse Event|3
7856716|NCT01546623|12342706|FG000|Overall Study|Major Protocol Deviation|1
7856717|NCT01546623|12342707|FG001|Overall Study|Major Protocol Deviation|1
7856718|NCT01546623|12342706|FG000|Overall Study|High Prostate specific antigen|2
7856719|NCT01546623|12342707|FG001|Overall Study|High Prostate specific antigen|1
7856720|NCT01546623|12342706|FG000|Overall Study|Did Not Receive Study Drug|1
7856721|NCT01546623|12342707|FG001|Overall Study|Did Not Receive Study Drug|1
7856722|NCT01546649|12342724|FG000|Overall Study|Adverse Event|4
7856723|NCT01546649|12342725|FG001|Overall Study|Adverse Event|5
7856724|NCT01546649|12342724|FG000|Overall Study|Protocol Violation|1
7856725|NCT01546649|12342725|FG001|Overall Study|Protocol Violation|0
7856726|NCT01546649|12342724|FG000|Overall Study|Lack of Efficacy|1
7856727|NCT01546649|12342725|FG001|Overall Study|Lack of Efficacy|0
7856728|NCT01546649|12342724|FG000|Overall Study|Recurrence|1
7856729|NCT01546649|12342725|FG001|Overall Study|Recurrence|1
7856730|NCT01546649|12342724|FG000|Overall Study|Discovery of secondary cancer|0
7856731|NCT01546649|12342725|FG001|Overall Study|Discovery of secondary cancer|1
7856732|NCT01546649|12342724|FG000|Overall Study|Withdrawal by Subject|1
7856733|NCT01546649|12342725|FG001|Overall Study|Withdrawal by Subject|2
7856734|NCT01546688|12342742|FG000|Overall Study|Adverse Event|0
7856735|NCT01546688|12342743|FG001|Overall Study|Adverse Event|4
7856736|NCT01546688|12342742|FG000|Overall Study|Withdrawal by Subject|2
7856737|NCT01546688|12342743|FG001|Overall Study|Withdrawal by Subject|1
7856738|NCT01546688|12342742|FG000|Overall Study|Lack of Efficacy|1
7856739|NCT01546688|12342743|FG001|Overall Study|Lack of Efficacy|0
7856740|NCT01546857|12342751|FG000|Overall Study|Withdrawal by Subject|2
7856741|NCT01546857|12342752|FG001|Overall Study|Withdrawal by Subject|3
7856742|NCT01546922|12342759|FG000|First Period of 10 Weeks|Protocol Violation|3
7856743|NCT01546922|12342760|FG001|First Period of 10 Weeks|Protocol Violation|1
7856744|NCT01546922|12342759|FG000|First Period of 10 Weeks|Withdrawal by Subject|1
7856745|NCT01546922|12342760|FG001|First Period of 10 Weeks|Withdrawal by Subject|1
7856746|NCT01546922|12342759|FG000|First Period of 10 Weeks|Investigator's judgment|1
7856747|NCT01546922|12342760|FG001|First Period of 10 Weeks|Investigator's judgment|0
7856748|NCT01546922|12342759|FG000|Second Period of 10 Weeks|Protocol Violation|3
7856749|NCT01546922|12342760|FG001|Second Period of 10 Weeks|Protocol Violation|1
7856750|NCT01546922|12342759|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0
7856751|NCT01546922|12342760|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2
7856752|NCT01547130|12342777|FG000|Overall Study|Lost to Follow-up|9
7856753|NCT01547130|12342778|FG001|Overall Study|Lost to Follow-up|5
7856754|NCT01547286|12342801|FG000|Overall Study|Did not meet all eligibility criteria|1
7856755|NCT01547286|12342801|FG000|Overall Study|Physician Decision|1
7856756|NCT01547299|12342808|FG000|Overall Study|Withdrawal by Subject|2
7856757|NCT01547299|12342809|FG001|Overall Study|Withdrawal by Subject|2
7856758|NCT01547390|12342817|FG000|Overall Study|Withdrawal by Subject|10
7856759|NCT01547390|12342818|FG001|Overall Study|Withdrawal by Subject|7
7856760|NCT01547390|12342817|FG000|Overall Study|termination of pregnancy|0
7856761|NCT01547390|12342818|FG001|Overall Study|termination of pregnancy|1
7856762|NCT01547390|12342817|FG000|Overall Study|Lost to Follow-up|0
7856763|NCT01547390|12342818|FG001|Overall Study|Lost to Follow-up|2
7856764|NCT01547390|12342817|FG000|Overall Study|Adverse Event|3
7856765|NCT01547390|12342818|FG001|Overall Study|Adverse Event|0
7856766|NCT01547598|12342826|FG000|Overall Study|Withdrew consent|1
7856767|NCT01547598|12342827|FG001|Overall Study|Withdrew consent|1
7856768|NCT01547598|12342826|FG000|Overall Study|Lost to Follow-up|1
7856769|NCT01547598|12342827|FG001|Overall Study|Lost to Follow-up|1
7856770|NCT01547598|12342826|FG000|Overall Study|Adverse Event|1
7856771|NCT01547598|12342827|FG001|Overall Study|Adverse Event|1
7856772|NCT01547598|12342826|FG000|Overall Study|Protocol Violation|1
7856773|NCT01547598|12342827|FG001|Overall Study|Protocol Violation|1
7856774|NCT01547598|12342826|FG000|Overall Study|Other Miscellaneous Reasons|2
7856775|NCT01547598|12342827|FG001|Overall Study|Other Miscellaneous Reasons|1
7856776|NCT01547780|12342852|FG000|Baseline PET Scan|Physician Decision|1
7856777|NCT01547780|12342853|FG001|Baseline PET Scan|Physician Decision|0
7856778|NCT01547780|12342854|FG002|Baseline PET Scan|Physician Decision|1
7856779|NCT01547780|12342855|FG003|Baseline PET Scan|Physician Decision|0
7856780|NCT01547780|12342852|FG000|Baseline PET Scan|Withdrawal by Subject|2
7856781|NCT01547780|12342853|FG001|Baseline PET Scan|Withdrawal by Subject|0
7856782|NCT01547780|12342854|FG002|Baseline PET Scan|Withdrawal by Subject|1
7856783|NCT01547780|12342855|FG003|Baseline PET Scan|Withdrawal by Subject|0
7856784|NCT01548287|12342883|FG000|Screening|No reason provided|0
7856785|NCT01548287|12342884|FG001|Screening|No reason provided|0
7856786|NCT01548287|12342885|FG002|Screening|No reason provided|0
7856787|NCT01548287|12342886|FG003|Screening|No reason provided|0
7856788|NCT01548287|12342887|FG004|Screening|No reason provided|9
7856789|NCT01548287|12342883|FG000|Screening|Did not meet eligibility criteria|0
7856790|NCT01548287|12342884|FG001|Screening|Did not meet eligibility criteria|0
7856791|NCT01548287|12342885|FG002|Screening|Did not meet eligibility criteria|0
7856792|NCT01548287|12342886|FG003|Screening|Did not meet eligibility criteria|0
7856793|NCT01548287|12342887|FG004|Screening|Did not meet eligibility criteria|74
7856794|NCT01548287|12342883|FG000|Randomized Period|Did not meet inclusion criteria|0
7856795|NCT01548287|12342884|FG001|Randomized Period|Did not meet inclusion criteria|0
7856796|NCT01548287|12342885|FG002|Randomized Period|Did not meet inclusion criteria|2
7856797|NCT01548287|12342886|FG003|Randomized Period|Did not meet inclusion criteria|0
7856798|NCT01548287|12342887|FG004|Randomized Period|Did not meet inclusion criteria|0
7856799|NCT01548287|12342883|FG000|Randomized Period|Adverse Event|0
7856800|NCT01548287|12342884|FG001|Randomized Period|Adverse Event|2
7856801|NCT01548287|12342885|FG002|Randomized Period|Adverse Event|5
7856802|NCT01548287|12342886|FG003|Randomized Period|Adverse Event|0
7856803|NCT01548287|12342887|FG004|Randomized Period|Adverse Event|0
7856804|NCT01548404|12342908|FG000|Overall Study|Adverse Event|3
7856805|NCT01548404|12342909|FG001|Overall Study|Adverse Event|1
7856806|NCT01548404|12342908|FG000|Overall Study|Physician Decision|2
7856807|NCT01548404|12342909|FG001|Overall Study|Physician Decision|1
7856808|NCT01548404|12342908|FG000|Overall Study|Inadequate response to study treatment|23
7856809|NCT01548404|12342909|FG001|Overall Study|Inadequate response to study treatment|7
7856810|NCT01548404|12342908|FG000|Overall Study|Lost to Follow-up|2
7856811|NCT01548404|12342909|FG001|Overall Study|Lost to Follow-up|0
7856812|NCT01548404|12342908|FG000|Overall Study|Withdrawal by Subject|0
7856813|NCT01548404|12342909|FG001|Overall Study|Withdrawal by Subject|3
7856814|NCT01548404|12342908|FG000|Overall Study|Other than specified above|0
7856815|NCT01548404|12342909|FG001|Overall Study|Other than specified above|2
7856816|NCT01548417|12342918|FG000|Overall Study|Withdrawal by Subject|0
7856817|NCT01548417|12342919|FG001|Overall Study|Withdrawal by Subject|2
7856818|NCT01548573|12342925|FG000|Overall Study|Death|3
7856819|NCT01548573|12342925|FG000|Overall Study|Withdrawal by Subject|2
7856820|NCT01548599|12342932|FG000|Overall Study|Lost to Follow-up|0
7856821|NCT01548599|12342933|FG001|Overall Study|Lost to Follow-up|1
7856822|NCT01548599|12342932|FG000|Overall Study|Withdrawal by Subject|4
7856823|NCT01548599|12342933|FG001|Overall Study|Withdrawal by Subject|0
7856824|NCT01548599|12342932|FG000|Overall Study|Death|2
7856825|NCT01548599|12342933|FG001|Overall Study|Death|1
7856826|NCT01548638|12342942|FG000|Overall Study|Protocol Violation|3
7856827|NCT01548638|12342942|FG000|Overall Study|Withdrawal by Subject|1
7856828|NCT01548768|12342982|FG000|Overall Study|Withdrawal by Subject|0
7856829|NCT01548768|12342983|FG001|Overall Study|Withdrawal by Subject|2
7856830|NCT01548768|12342984|FG002|Overall Study|Withdrawal by Subject|1
7856831|NCT01548768|12342985|FG003|Overall Study|Withdrawal by Subject|0
7856832|NCT01548768|12342982|FG000|Overall Study|Physician Decision|1
7856833|NCT01548768|12342983|FG001|Overall Study|Physician Decision|0
7856834|NCT01548768|12342984|FG002|Overall Study|Physician Decision|0
7856835|NCT01548768|12342985|FG003|Overall Study|Physician Decision|0
7856836|NCT01548768|12342982|FG000|Overall Study|Adverse Event|0
7856837|NCT01548768|12342983|FG001|Overall Study|Adverse Event|0
7856838|NCT01548768|12342984|FG002|Overall Study|Adverse Event|0
7856839|NCT01548768|12342985|FG003|Overall Study|Adverse Event|1
7856840|NCT01548768|12342982|FG000|Overall Study|Non-Compliance|0
7856841|NCT01548768|12342983|FG001|Overall Study|Non-Compliance|0
7856842|NCT01548768|12342984|FG002|Overall Study|Non-Compliance|0
7856843|NCT01548768|12342985|FG003|Overall Study|Non-Compliance|3
7856844|NCT01549002|12343011|FG000|Overall Study|Excessive pain|0
7856845|NCT01549002|12343012|FG001|Overall Study|Excessive pain|2
7856846|NCT01549002|12343011|FG000|Overall Study|Moderate sedation required|0
7856847|NCT01549002|12343012|FG001|Overall Study|Moderate sedation required|2
7856848|NCT01549041|12343020|FG000|Overall Study|Lack of Efficacy|2
7856849|NCT01549041|12343021|FG001|Overall Study|Lack of Efficacy|4
7856850|NCT01549041|12343020|FG000|Overall Study|Adverse Event|0
7856851|NCT01549041|12343021|FG001|Overall Study|Adverse Event|4
7856852|NCT01549275|12343038|FG000|Overall Study|Lost to Follow-up|1
7856853|NCT01549275|12343039|FG001|Overall Study|Lost to Follow-up|0
7856854|NCT01549392|12343073|FG000|Overall Study|Withdrawal by Subject|1
7856855|NCT01549392|12343074|FG001|Overall Study|Withdrawal by Subject|0
7856856|NCT01549613|12343102|FG000|Overall Study|Lost to Follow-up|11
7856857|NCT01549613|12343103|FG001|Overall Study|Lost to Follow-up|11
7856858|NCT01549652|12343112|FG000|Overall Study|Did Not Receive Allocated Intervention|0
7856859|NCT01549652|12343113|FG001|Overall Study|Did Not Receive Allocated Intervention|0
7856860|NCT01549652|12343114|FG002|Overall Study|Did Not Receive Allocated Intervention|2
7856861|NCT01549652|12343115|FG003|Overall Study|Did Not Receive Allocated Intervention|0
7856862|NCT01549652|12343112|FG000|Overall Study|Study Drug Titration Failure|5
7856863|NCT01549652|12343113|FG001|Overall Study|Study Drug Titration Failure|6
7856864|NCT01549652|12343114|FG002|Overall Study|Study Drug Titration Failure|0
7856865|NCT01549652|12343115|FG003|Overall Study|Study Drug Titration Failure|0
7856866|NCT01549652|12343112|FG000|Overall Study|Withdrawal Effect|0
7856867|NCT01549652|12343113|FG001|Overall Study|Withdrawal Effect|2
7856868|NCT01549652|12343114|FG002|Overall Study|Withdrawal Effect|0
7856869|NCT01549652|12343115|FG003|Overall Study|Withdrawal Effect|0
7856870|NCT01549652|12343112|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5
7856871|NCT01549652|12343113|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1
7856872|NCT01549652|12343114|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0
7856873|NCT01549652|12343115|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0
7856874|NCT01549652|12343112|FG000|Overall Study|Problem with Infusion|1
7856875|NCT01549652|12343113|FG001|Overall Study|Problem with Infusion|0
7856876|NCT01549652|12343114|FG002|Overall Study|Problem with Infusion|0
7856877|NCT01549652|12343115|FG003|Overall Study|Problem with Infusion|0
7856878|NCT01549652|12343112|FG000|Overall Study|Titration Non-Compliance|1
7856879|NCT01549652|12343113|FG001|Overall Study|Titration Non-Compliance|3
7856880|NCT01549652|12343114|FG002|Overall Study|Titration Non-Compliance|4
7856881|NCT01549652|12343115|FG003|Overall Study|Titration Non-Compliance|5
7856882|NCT01549652|12343112|FG000|Overall Study|Titration Side Effects|0
7856883|NCT01549652|12343113|FG001|Overall Study|Titration Side Effects|0
7856884|NCT01549652|12343114|FG002|Overall Study|Titration Side Effects|6
7856885|NCT01549652|12343115|FG003|Overall Study|Titration Side Effects|3
7856886|NCT01549652|12343112|FG000|Overall Study|Withdrawal by Subject|0
7856887|NCT01549652|12343113|FG001|Overall Study|Withdrawal by Subject|0
7856888|NCT01549652|12343114|FG002|Overall Study|Withdrawal by Subject|5
7856889|NCT01549652|12343115|FG003|Overall Study|Withdrawal by Subject|3
7856890|NCT01549860|12343123|FG000|Overall Study|Withdrawal by Subject|1
7856891|NCT01549860|12343124|FG001|Overall Study|Withdrawal by Subject|0
7856892|NCT01549860|12343123|FG000|Overall Study|Physician Decision|1
7856893|NCT01549860|12343124|FG001|Overall Study|Physician Decision|1
7856894|NCT01549873|12343132|FG000|Overall Study|Physician Decision|0
7856895|NCT01549873|12343133|FG001|Overall Study|Physician Decision|1
7856896|NCT01549886|12343141|FG000|Overall Study|Sponsor's decision|2
7856897|NCT01549886|12343142|FG001|Overall Study|Sponsor's decision|3
7856898|NCT01549951|12343159|FG000|Overall Study|Adverse Event|15
7856899|NCT01549951|12343159|FG000|Overall Study|Withdrawal by Subject|2
7856900|NCT01549951|12343159|FG000|Overall Study|Unsatisfactory therapeutic response|1
7856901|NCT01549951|12343159|FG000|Overall Study|Progressive disease|29
7856902|NCT01549951|12343159|FG000|Overall Study|Symptomatic deterioration|1
7856903|NCT01549951|12343159|FG000|Overall Study|Other|2
7856904|NCT01549964|12343167|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50
7856905|NCT01549964|12343168|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104
7856906|NCT01549964|12343169|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104
7856907|NCT01549964|12343170|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105
7856908|NCT01549964|12343167|FG000|24-Week Treatment Period|Voluntary Withdrawal|6
7856909|NCT01549964|12343168|FG001|24-Week Treatment Period|Voluntary Withdrawal|3
7856910|NCT01549964|12343169|FG002|24-Week Treatment Period|Voluntary Withdrawal|3
7856911|NCT01549964|12343170|FG003|24-Week Treatment Period|Voluntary Withdrawal|8
7856912|NCT01549964|12343167|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
7856913|NCT01549964|12343168|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
7856914|NCT01549964|12343169|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
7856915|NCT01549964|12343170|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
7856916|NCT01549964|12343167|FG000|24-Week Treatment Period|Lost to Follow-up|1
7856917|NCT01549964|12343168|FG001|24-Week Treatment Period|Lost to Follow-up|0
7856918|NCT01549964|12343169|FG002|24-Week Treatment Period|Lost to Follow-up|1
7856919|NCT01549964|12343170|FG003|24-Week Treatment Period|Lost to Follow-up|2
7856920|NCT01549964|12343167|FG000|24-Week Treatment Period|Lack of Efficacy|1
7856921|NCT01549964|12343168|FG001|24-Week Treatment Period|Lack of Efficacy|0
7856922|NCT01549964|12343169|FG002|24-Week Treatment Period|Lack of Efficacy|1
7856923|NCT01549964|12343170|FG003|24-Week Treatment Period|Lack of Efficacy|1
7856924|NCT01549964|12343167|FG000|24-Week Treatment Period|Other|1
7856925|NCT01549964|12343168|FG001|24-Week Treatment Period|Other|0
7856926|NCT01549964|12343169|FG002|24-Week Treatment Period|Other|1
7856927|NCT01549964|12343170|FG003|24-Week Treatment Period|Other|0
7856928|NCT01549964|12343167|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
7856929|NCT01549964|12343168|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
7856930|NCT01549964|12343169|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
7856931|NCT01549964|12343170|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
7856932|NCT01549964|12343167|FG000|24-Week Treatment Period|Randomized but Not Treated|0
7856933|NCT01549964|12343168|FG001|24-Week Treatment Period|Randomized but Not Treated|0
7856934|NCT01549964|12343169|FG002|24-Week Treatment Period|Randomized but Not Treated|0
7856935|NCT01549964|12343170|FG003|24-Week Treatment Period|Randomized but Not Treated|1
7856936|NCT01549964|12343167|FG000|24-Week Treatment Period|Completion Status Unknown|1
7856937|NCT01549964|12343168|FG001|24-Week Treatment Period|Completion Status Unknown|0
7856938|NCT01549964|12343169|FG002|24-Week Treatment Period|Completion Status Unknown|1
7856939|NCT01549964|12343170|FG003|24-Week Treatment Period|Completion Status Unknown|0
7856940|NCT01549964|12343167|FG000|80-Week Extension Period|Pregnancy|0
7856941|NCT01549964|12343168|FG001|80-Week Extension Period|Pregnancy|0
7856942|NCT01549964|12343169|FG002|80-Week Extension Period|Pregnancy|1
7856943|NCT01549964|12343170|FG003|80-Week Extension Period|Pregnancy|0
7856944|NCT01549964|12343167|FG000|80-Week Extension Period|Study Terminated by Sponsor|65
7856945|NCT01549964|12343168|FG001|80-Week Extension Period|Study Terminated by Sponsor|137
7856946|NCT01549964|12343169|FG002|80-Week Extension Period|Study Terminated by Sponsor|132
7856947|NCT01549964|12343170|FG003|80-Week Extension Period|Study Terminated by Sponsor|132
7856948|NCT01549964|12343167|FG000|80-Week Extension Period|Voluntary Withdrawal|0
7856949|NCT01549964|12343168|FG001|80-Week Extension Period|Voluntary Withdrawal|1
7856950|NCT01549964|12343169|FG002|80-Week Extension Period|Voluntary Withdrawal|4
7856951|NCT01549964|12343170|FG003|80-Week Extension Period|Voluntary Withdrawal|2
7856952|NCT01549964|12343167|FG000|80-Week Extension Period|Lost to Follow-up|1
7856953|NCT01549964|12343168|FG001|80-Week Extension Period|Lost to Follow-up|0
7856954|NCT01549964|12343169|FG002|80-Week Extension Period|Lost to Follow-up|2
7856955|NCT01549964|12343170|FG003|80-Week Extension Period|Lost to Follow-up|1
7856956|NCT01549964|12343167|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0
7856957|NCT01549964|12343168|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0
7856958|NCT01549964|12343169|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1
7856959|NCT01549964|12343170|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2
7856960|NCT01550744|12343244|FG000|Open-Label|Lost to Follow-up|7
7856961|NCT01550744|12343245|FG001|Open-Label|Lost to Follow-up|0
7856962|NCT01550744|12343246|FG002|Open-Label|Lost to Follow-up|0
7856963|NCT01550744|12343244|FG000|Open-Label|Withdrawal by Subject|13
7856964|NCT01550744|12343245|FG001|Open-Label|Withdrawal by Subject|0
7856965|NCT01550744|12343246|FG002|Open-Label|Withdrawal by Subject|0
7856966|NCT01550744|12343244|FG000|Open-Label|Adverse Event|11
7856967|NCT01550744|12343245|FG001|Open-Label|Adverse Event|0
7856968|NCT01550744|12343246|FG002|Open-Label|Adverse Event|0
7856969|NCT01550744|12343244|FG000|Open-Label|Lack of Efficacy|4
7856970|NCT01550744|12343245|FG001|Open-Label|Lack of Efficacy|0
7856971|NCT01550744|12343246|FG002|Open-Label|Lack of Efficacy|0
7856972|NCT01550744|12343244|FG000|Open-Label|Protocol Violation|4
7856973|NCT01550744|12343245|FG001|Open-Label|Protocol Violation|0
7856974|NCT01550744|12343246|FG002|Open-Label|Protocol Violation|0
7856975|NCT01550744|12343244|FG000|Open-Label|Not all 3 study drug injections received|2
7856976|NCT01550744|12343245|FG001|Open-Label|Not all 3 study drug injections received|0
7856977|NCT01550744|12343246|FG002|Open-Label|Not all 3 study drug injections received|0
7856978|NCT01550744|12343244|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58
7856979|NCT01550744|12343245|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0
7856980|NCT01550744|12343246|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0
7856981|NCT01550744|12343244|FG000|Open-Label|Other|1
7856982|NCT01550744|12343245|FG001|Open-Label|Other|0
7856983|NCT01550744|12343246|FG002|Open-Label|Other|0
7856984|NCT01550744|12343244|FG000|Double-Blind|Lost to Follow-up|0
7856985|NCT01550744|12343245|FG001|Double-Blind|Lost to Follow-up|6
7856986|NCT01550744|12343246|FG002|Double-Blind|Lost to Follow-up|12
7856987|NCT01550744|12343244|FG000|Double-Blind|Withdrawal by Subject|0
7856988|NCT01550744|12343245|FG001|Double-Blind|Withdrawal by Subject|2
7856989|NCT01550744|12343246|FG002|Double-Blind|Withdrawal by Subject|15
7856990|NCT01550744|12343244|FG000|Double-Blind|Adverse Event|0
7856991|NCT01550744|12343245|FG001|Double-Blind|Adverse Event|4
7856992|NCT01550744|12343246|FG002|Double-Blind|Adverse Event|15
7856993|NCT01550744|12343244|FG000|Double-Blind|Death|0
7856994|NCT01550744|12343245|FG001|Double-Blind|Death|1
7856995|NCT01550744|12343246|FG002|Double-Blind|Death|0
7856996|NCT01550744|12343244|FG000|Double-Blind|Lack of Efficacy|0
7856997|NCT01550744|12343245|FG001|Double-Blind|Lack of Efficacy|2
7856998|NCT01550744|12343246|FG002|Double-Blind|Lack of Efficacy|8
7856999|NCT01550744|12343244|FG000|Double-Blind|Protocol Violation|0
7857000|NCT01550744|12343245|FG001|Double-Blind|Protocol Violation|0
7857001|NCT01550744|12343246|FG002|Double-Blind|Protocol Violation|4
7857002|NCT01550744|12343244|FG000|Double-Blind|Pregnancy|0
7857003|NCT01550744|12343245|FG001|Double-Blind|Pregnancy|0
7857004|NCT01550744|12343246|FG002|Double-Blind|Pregnancy|3
7857005|NCT01550744|12343244|FG000|Double-Blind|Other|0
7857006|NCT01550744|12343245|FG001|Double-Blind|Other|2
7857007|NCT01550744|12343246|FG002|Double-Blind|Other|10
7857008|NCT01550757|12343257|FG000|Overall Study|Lost to Follow-up|21
7857009|NCT01550757|12343258|FG001|Overall Study|Lost to Follow-up|14
7857010|NCT01550757|12343259|FG002|Overall Study|Lost to Follow-up|42
7857011|NCT01550757|12343260|FG003|Overall Study|Lost to Follow-up|53
7857012|NCT01550757|12343257|FG000|Overall Study|Withdrawal by Subject|2
7857013|NCT01550757|12343258|FG001|Overall Study|Withdrawal by Subject|0
7857014|NCT01550757|12343259|FG002|Overall Study|Withdrawal by Subject|3
7857015|NCT01550757|12343260|FG003|Overall Study|Withdrawal by Subject|1
7857016|NCT01550965|12343283|FG000|Overall Study|Adverse Event|26
7857017|NCT01550965|12343283|FG000|Overall Study|Withdrawal by Subject|10
7857018|NCT01550965|12343283|FG000|Overall Study|Lost to Follow-up|2
7857019|NCT01550965|12343283|FG000|Overall Study|Lack of Efficacy|59
7857020|NCT01550965|12343283|FG000|Overall Study|Other|13
7857021|NCT01551173|12343307|FG000|Overall Study|Withdrawal by Subject|11
7857022|NCT01551173|12343308|FG001|Overall Study|Withdrawal by Subject|16
7857023|NCT01551173|12343307|FG000|Overall Study|Adverse Event|7
7857024|NCT01551173|12343308|FG001|Overall Study|Adverse Event|6
7857025|NCT01551173|12343307|FG000|Overall Study|Lost to Follow-up|5
7857026|NCT01551173|12343308|FG001|Overall Study|Lost to Follow-up|7
7857027|NCT01551173|12343307|FG000|Overall Study|Other|5
7857028|NCT01551173|12343308|FG001|Overall Study|Other|3
7857029|NCT01551212|12343330|FG000|Overall Study|Graft loss/Retransplantation|0
7857030|NCT01551212|12343331|FG001|Overall Study|Graft loss/Retransplantation|1
7857031|NCT01551212|12343330|FG000|Overall Study|Administrative problems|1
7857032|NCT01551212|12343331|FG001|Overall Study|Administrative problems|2
7857033|NCT01551212|12343330|FG000|Overall Study|Lost to Follow-up|0
7857034|NCT01551212|12343331|FG001|Overall Study|Lost to Follow-up|1
7857035|NCT01551212|12343330|FG000|Overall Study|Protocol Violation|0
7857036|NCT01551212|12343331|FG001|Overall Study|Protocol Violation|1
7857037|NCT01551212|12343330|FG000|Overall Study|Withdrawal by Subject|0
7857038|NCT01551212|12343331|FG001|Overall Study|Withdrawal by Subject|7
7857039|NCT01551212|12343330|FG000|Overall Study|Death|2
7857040|NCT01551212|12343331|FG001|Overall Study|Death|4
7857041|NCT01551212|12343330|FG000|Overall Study|Never Received Study Treatment|2
7857042|NCT01551212|12343331|FG001|Overall Study|Never Received Study Treatment|4
7857043|NCT01551303|12343348|FG000|Overall Study|failed awareness check on vision test|4
7857044|NCT01551303|12343349|FG001|Overall Study|failed awareness check on vision test|7
7857045|NCT01551355|12343361|FG000|Overall Study|Lost to Follow-up|51
7857046|NCT01551355|12343362|FG001|Overall Study|Lost to Follow-up|49
7857047|NCT01551355|12343363|FG002|Overall Study|Lost to Follow-up|34
7857048|NCT01551355|12343364|FG003|Overall Study|Lost to Follow-up|24
7857049|NCT01551355|12343365|FG004|Overall Study|Lost to Follow-up|9
7857050|NCT01551355|12343366|FG005|Overall Study|Lost to Follow-up|6
7857051|NCT01551420|12343376|FG000|In-laboratory (Part A)|Lost to Follow-up|2
7857052|NCT01551420|12343377|FG001|In-laboratory (Part A)|Lost to Follow-up|1
7857053|NCT01551420|12343376|FG000|In-laboratory (Part A)|Withdrawal by Subject|2
7857054|NCT01551420|12343377|FG001|In-laboratory (Part A)|Withdrawal by Subject|0
7857055|NCT01551420|12343376|FG000|In-laboratory (Part A)|Scheduling conflict|2
7857056|NCT01551420|12343377|FG001|In-laboratory (Part A)|Scheduling conflict|1
7857057|NCT01551420|12343376|FG000|Screened for Part B Eligibility|Declined participation|8
7857058|NCT01551420|12343377|FG001|Screened for Part B Eligibility|Declined participation|1
7857059|NCT01551420|12343376|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1
7857060|NCT01551420|12343377|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2
7857061|NCT01551420|12343376|FG000|Home Use (Part B)|Withdrawal by Subject|6
7857062|NCT01551420|12343377|FG001|Home Use (Part B)|Withdrawal by Subject|0
7857063|NCT01551420|12343376|FG000|Home Use (Part B)|Withdrawal by staff|0
7857064|NCT01551420|12343377|FG001|Home Use (Part B)|Withdrawal by staff|1
7857065|NCT01551693|12343385|FG000|Overall Study|Disease Progression|1
7857066|NCT01551693|12343386|FG001|Overall Study|Disease Progression|0
7857067|NCT01551693|12343385|FG000|Overall Study|Adverse Event|0
7857068|NCT01551693|12343386|FG001|Overall Study|Adverse Event|1
7857069|NCT01551693|12343385|FG000|Overall Study|Withdrawal by Subject|0
7857070|NCT01551693|12343386|FG001|Overall Study|Withdrawal by Subject|1
7857071|NCT01551745|12343392|FG000|Overall Study|Withdrawal by Subject|1
7857072|NCT01551745|12343392|FG000|Overall Study|Disease Progression|2
7857073|NCT01551758|12343398|FG000|Overall Study|Adverse Event|29
7857074|NCT01551758|12343399|FG001|Overall Study|Adverse Event|43
7857075|NCT01551758|12343398|FG000|Overall Study|Lack of Efficacy|0
7857076|NCT01551758|12343399|FG001|Overall Study|Lack of Efficacy|1
7857077|NCT01551758|12343398|FG000|Overall Study|Protocol Violation|5
7857078|NCT01551758|12343399|FG001|Overall Study|Protocol Violation|6
7857079|NCT01551758|12343398|FG000|Overall Study|Met Protocol-defined stopping criteria|8
7857080|NCT01551758|12343399|FG001|Overall Study|Met Protocol-defined stopping criteria|10
7857081|NCT01551758|12343398|FG000|Overall Study|Lost to Follow-up|29
7857082|NCT01551758|12343399|FG001|Overall Study|Lost to Follow-up|25
7857083|NCT01551758|12343398|FG000|Overall Study|Physician Decision|9
7857084|NCT01551758|12343399|FG001|Overall Study|Physician Decision|3
7857085|NCT01551758|12343398|FG000|Overall Study|Withdrawal by Subject|14
7857086|NCT01551758|12343399|FG001|Overall Study|Withdrawal by Subject|17
7857087|NCT01552057|12343427|FG000|Overall Study|Adverse Event|14
7857088|NCT01552057|12343428|FG001|Overall Study|Adverse Event|15
7857089|NCT01552057|12343427|FG000|Overall Study|Lack of Efficacy|8
7857090|NCT01552057|12343428|FG001|Overall Study|Lack of Efficacy|23
7857091|NCT01552057|12343427|FG000|Overall Study|Withdrawal by Subject|5
7857092|NCT01552057|12343428|FG001|Overall Study|Withdrawal by Subject|8
7857093|NCT01552057|12343427|FG000|Overall Study|Entry Criteria Not Met|2
7857094|NCT01552057|12343428|FG001|Overall Study|Entry Criteria Not Met|2
7857095|NCT01552057|12343427|FG000|Overall Study|Physician Decision|1
7857096|NCT01552057|12343428|FG001|Overall Study|Physician Decision|0
7857097|NCT01552369|12343463|FG000|Overall Study|Did not consent to extended follow up|8
7857098|NCT01552369|12343464|FG001|Overall Study|Did not consent to extended follow up|9
7857099|NCT01552408|12343474|FG000|Overall Study|Lost to Follow-up|2
7857100|NCT01552408|12343475|FG001|Overall Study|Lost to Follow-up|0
7857101|NCT01552408|12343474|FG000|Overall Study|Relocation|0
7857102|NCT01552408|12343475|FG001|Overall Study|Relocation|1
7857103|NCT01552408|12343474|FG000|Overall Study|Withdrawal by Subject|2
7857104|NCT01552408|12343475|FG001|Overall Study|Withdrawal by Subject|1
7857105|NCT01552603|12343482|FG000|Overall Study|Physician Decision|1
7857106|NCT01552681|12343488|FG000|Overall Study|Withdrawal by Subject|4
7857107|NCT01552681|12343489|FG001|Overall Study|Withdrawal by Subject|0
7857108|NCT01552681|12343488|FG000|Overall Study|Physician Decision|1
7857109|NCT01552681|12343489|FG001|Overall Study|Physician Decision|0
7857110|NCT01552681|12343488|FG000|Overall Study|Subject moved away|0
7857111|NCT01552681|12343489|FG001|Overall Study|Subject moved away|1
7857112|NCT01552694|12343497|FG000|Overall Study|Lost to Follow-up|0
7857113|NCT01552694|12343498|FG001|Overall Study|Lost to Follow-up|1
7857114|NCT01552694|12343497|FG000|Overall Study|Protocol Violation|0
7857115|NCT01552694|12343498|FG001|Overall Study|Protocol Violation|1
7857116|NCT01552772|12343504|FG000|Overall Study|Lost to Follow-up|2
7857117|NCT01552772|12343504|FG000|Overall Study|Adverse Event|1
7857118|NCT01552772|12343504|FG000|Overall Study|Protocol Deviation|1
7857119|NCT01552902|12343536|FG000|Overall Study|Adverse Event|1
7857120|NCT01552902|12343537|FG001|Overall Study|Adverse Event|15
7857121|NCT01552902|12343538|FG002|Overall Study|Adverse Event|14
7857122|NCT01552902|12343536|FG000|Overall Study|Protocol Violation|3
7857123|NCT01552902|12343537|FG001|Overall Study|Protocol Violation|3
7857124|NCT01552902|12343538|FG002|Overall Study|Protocol Violation|3
7857125|NCT01552902|12343536|FG000|Overall Study|Lack of Efficacy|4
7949765|NCT02543203|12495755|FG001|Overall Study|Negative Behavior|0
7949766|NCT02543203|12495754|FG000|Overall Study|Withdrawal by Subject|0
7949767|NCT02543203|12495755|FG001|Overall Study|Withdrawal by Subject|1
7949768|NCT02543294|12495769|FG000|Overall Study|Lost to Follow-up|3
7949769|NCT02543294|12495769|FG000|Overall Study|Physician Decision|2
7949770|NCT02543294|12495769|FG000|Overall Study|Withdrawal by Subject|7
7949771|NCT02543346|12495774|FG000|Second Priming Visit|Withdrawal by Subject|0
7949772|NCT02543346|12495775|FG001|Second Priming Visit|Withdrawal by Subject|2
7949773|NCT02543346|12495776|FG002|Second Priming Visit|Withdrawal by Subject|2
7949774|NCT02543346|12495777|FG003|Second Priming Visit|Withdrawal by Subject|2
7949775|NCT02543346|12495774|FG000|Second Priming Visit|Adverse Event|1
7949776|NCT02543346|12495775|FG001|Second Priming Visit|Adverse Event|0
7949777|NCT02543346|12495776|FG002|Second Priming Visit|Adverse Event|0
7949778|NCT02543346|12495777|FG003|Second Priming Visit|Adverse Event|0
7949779|NCT02543528|12495800|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0
7949780|NCT02543528|12495801|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0
7949781|NCT02543528|12495802|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0
7949782|NCT02543528|12495803|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0
7949783|NCT02543528|12495804|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2
7949784|NCT02543528|12495800|FG000|Adaptation Period|Lens Handling Difficultes|0
7949785|NCT02543528|12495801|FG001|Adaptation Period|Lens Handling Difficultes|0
7949786|NCT02543528|12495802|FG002|Adaptation Period|Lens Handling Difficultes|0
7949787|NCT02543528|12495803|FG003|Adaptation Period|Lens Handling Difficultes|0
7949788|NCT02543528|12495804|FG004|Adaptation Period|Lens Handling Difficultes|8
7949789|NCT02543528|12495800|FG000|Adaptation Period|Lost to Follow-up|0
7949790|NCT02543528|12495801|FG001|Adaptation Period|Lost to Follow-up|0
7949791|NCT02543528|12495802|FG002|Adaptation Period|Lost to Follow-up|0
7949792|NCT02543528|12495803|FG003|Adaptation Period|Lost to Follow-up|0
7949793|NCT02543528|12495804|FG004|Adaptation Period|Lost to Follow-up|14
7949794|NCT02543528|12495800|FG000|Adaptation Period|Adverse Event|0
7720952|NCT00542269|12145469|FG001|Overall Study|Protocol Violation|1
7720953|NCT00542269|12145470|FG002|Overall Study|Protocol Violation|0
7720954|NCT00542269|12145468|FG000|Overall Study|Withdrawal by Subject|1
7720955|NCT00542269|12145469|FG001|Overall Study|Withdrawal by Subject|0
7720956|NCT00542269|12145470|FG002|Overall Study|Withdrawal by Subject|0
7720957|NCT00542269|12145468|FG000|Overall Study|Administrative problems|1
7949795|NCT02543528|12495801|FG001|Adaptation Period|Adverse Event|0
7949796|NCT02543528|12495802|FG002|Adaptation Period|Adverse Event|0
7720958|NCT00542269|12145469|FG001|Overall Study|Administrative problems|1
7720959|NCT00542269|12145470|FG002|Overall Study|Administrative problems|1
7720960|NCT00542321|12145486|FG000|Overall Study|Death|0
7720961|NCT00542321|12145487|FG001|Overall Study|Death|1
7720962|NCT00542386|12145499|FG000|Overall Study|Adverse Event|1
7720963|NCT00542386|12145500|FG001|Overall Study|Adverse Event|7
7720964|NCT00542386|12145501|FG002|Overall Study|Adverse Event|7
7720965|NCT00542386|12145502|FG003|Overall Study|Adverse Event|8
7720966|NCT00542386|12145503|FG004|Overall Study|Adverse Event|13
7949797|NCT02543528|12495803|FG003|Adaptation Period|Adverse Event|0
7949798|NCT02543528|12495804|FG004|Adaptation Period|Adverse Event|2
7949799|NCT02543528|12495800|FG000|Extended Wear Period|Adverse Event|17
7949800|NCT02543528|12495801|FG001|Extended Wear Period|Adverse Event|11
7949801|NCT02543528|12495802|FG002|Extended Wear Period|Adverse Event|16
7949802|NCT02543528|12495803|FG003|Extended Wear Period|Adverse Event|3
7949803|NCT02543528|12495804|FG004|Extended Wear Period|Adverse Event|0
7949804|NCT02543528|12495800|FG000|Extended Wear Period|Missed too many scheduled visits|0
7949805|NCT02543528|12495801|FG001|Extended Wear Period|Missed too many scheduled visits|0
7949806|NCT02543528|12495802|FG002|Extended Wear Period|Missed too many scheduled visits|1
7949807|NCT02543528|12495803|FG003|Extended Wear Period|Missed too many scheduled visits|3
7949808|NCT02543528|12495804|FG004|Extended Wear Period|Missed too many scheduled visits|0
7949809|NCT02543528|12495800|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1
7949810|NCT02543528|12495801|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0
7949811|NCT02543528|12495802|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0
7949812|NCT02543528|12495803|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0
7949813|NCT02543528|12495804|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0
7949814|NCT02543528|12495800|FG000|Extended Wear Period|Lost to Follow-up|0
7949815|NCT02543528|12495801|FG001|Extended Wear Period|Lost to Follow-up|1
7949816|NCT02543528|12495802|FG002|Extended Wear Period|Lost to Follow-up|2
7949817|NCT02543528|12495803|FG003|Extended Wear Period|Lost to Follow-up|1
7949818|NCT02543528|12495804|FG004|Extended Wear Period|Lost to Follow-up|0
7949819|NCT02543528|12495800|FG000|Extended Wear Period|Withdrawal by Subject|10
7949820|NCT02543528|12495801|FG001|Extended Wear Period|Withdrawal by Subject|9
7949821|NCT02543528|12495802|FG002|Extended Wear Period|Withdrawal by Subject|4
7949822|NCT02543528|12495803|FG003|Extended Wear Period|Withdrawal by Subject|5
7949823|NCT02543528|12495804|FG004|Extended Wear Period|Withdrawal by Subject|0
7857126|NCT01552902|12343537|FG001|Overall Study|Lack of Efficacy|3
7857127|NCT01552902|12343538|FG002|Overall Study|Lack of Efficacy|1
7857128|NCT01552902|12343536|FG000|Overall Study|Withdrawal by Subject|1
7857129|NCT01552902|12343537|FG001|Overall Study|Withdrawal by Subject|9
7857130|NCT01552902|12343538|FG002|Overall Study|Withdrawal by Subject|6
7857131|NCT01552902|12343536|FG000|Overall Study|Lost to Follow-up|1
7857132|NCT01552902|12343537|FG001|Overall Study|Lost to Follow-up|3
7857133|NCT01552902|12343538|FG002|Overall Study|Lost to Follow-up|6
7857134|NCT01552902|12343536|FG000|Overall Study|Other|3
7857135|NCT01552902|12343537|FG001|Overall Study|Other|4
7857136|NCT01552902|12343538|FG002|Overall Study|Other|3
7863696|NCT01607892|12353119|FG001|Overall Study|Consent withdrawn by participant|4
7863697|NCT01607892|12353120|FG002|Overall Study|Consent withdrawn by participant|24
7863698|NCT01607892|12353121|FG003|Overall Study|Consent withdrawn by participant|14
7863699|NCT01607892|12353122|FG004|Overall Study|Consent withdrawn by participant|4
7863700|NCT01607892|12353118|FG000|Overall Study|Disease progression|38
7863701|NCT01607892|12353119|FG001|Overall Study|Disease progression|13
7863702|NCT01607892|12353120|FG002|Overall Study|Disease progression|37
7863703|NCT01607892|12353121|FG003|Overall Study|Disease progression|57
7863704|NCT01607892|12353122|FG004|Overall Study|Disease progression|9
7863705|NCT01607892|12353118|FG000|Overall Study|Incidence or severity of Adverse events|3
7863706|NCT01607892|12353119|FG001|Overall Study|Incidence or severity of Adverse events|3
7863707|NCT01607892|12353120|FG002|Overall Study|Incidence or severity of Adverse events|7
7863708|NCT01607892|12353121|FG003|Overall Study|Incidence or severity of Adverse events|2
7863709|NCT01607892|12353122|FG004|Overall Study|Incidence or severity of Adverse events|6
7863710|NCT01607905|12353155|FG000|Overall Study|Withdrawal by participant|7
7863711|NCT01607905|12353156|FG001|Overall Study|Withdrawal by participant|2
7863712|NCT01607905|12353157|FG002|Overall Study|Withdrawal by participant|4
7863713|NCT01607905|12353158|FG003|Overall Study|Withdrawal by participant|6
7863714|NCT01607905|12353159|FG004|Overall Study|Withdrawal by participant|0
7863715|NCT01607905|12353160|FG005|Overall Study|Withdrawal by participant|4
7863716|NCT01607905|12353161|FG006|Overall Study|Withdrawal by participant|12
7863717|NCT01607905|12353155|FG000|Overall Study|Incidence or severity of AEs|5
7863718|NCT01607905|12353156|FG001|Overall Study|Incidence or severity of AEs|1
7863719|NCT01607905|12353157|FG002|Overall Study|Incidence or severity of AEs|1
7863720|NCT01607905|12353158|FG003|Overall Study|Incidence or severity of AEs|3
7863721|NCT01607905|12353159|FG004|Overall Study|Incidence or severity of AEs|0
7863722|NCT01607905|12353160|FG005|Overall Study|Incidence or severity of AEs|2
7863723|NCT01607905|12353161|FG006|Overall Study|Incidence or severity of AEs|8
7863724|NCT01607905|12353155|FG000|Overall Study|Disease progression|44
7863725|NCT01607905|12353156|FG001|Overall Study|Disease progression|16
7863726|NCT01607905|12353157|FG002|Overall Study|Disease progression|15
7863727|NCT01607905|12353158|FG003|Overall Study|Disease progression|11
7863728|NCT01607905|12353159|FG004|Overall Study|Disease progression|6
7863729|NCT01607905|12353160|FG005|Overall Study|Disease progression|7
7863730|NCT01607905|12353161|FG006|Overall Study|Disease progression|21
7863731|NCT01607905|12353155|FG000|Overall Study|Non-compliance with study procedures|0
7863732|NCT01607905|12353156|FG001|Overall Study|Non-compliance with study procedures|0
7863733|NCT01607905|12353157|FG002|Overall Study|Non-compliance with study procedures|0
7863734|NCT01607905|12353158|FG003|Overall Study|Non-compliance with study procedures|0
7863735|NCT01607905|12353159|FG004|Overall Study|Non-compliance with study procedures|0
7863736|NCT01607905|12353160|FG005|Overall Study|Non-compliance with study procedures|0
7863737|NCT01607905|12353161|FG006|Overall Study|Non-compliance with study procedures|1
7863738|NCT01607905|12353155|FG000|Overall Study|Death|1
7863739|NCT01607905|12353156|FG001|Overall Study|Death|1
7863740|NCT01607905|12353157|FG002|Overall Study|Death|1
7863741|NCT01607905|12353158|FG003|Overall Study|Death|1
7863742|NCT01607905|12353159|FG004|Overall Study|Death|0
7863743|NCT01607905|12353160|FG005|Overall Study|Death|0
7863744|NCT01607905|12353161|FG006|Overall Study|Death|3
7863745|NCT01607905|12353155|FG000|Overall Study|Other treatments become available|1
7863746|NCT01607905|12353156|FG001|Overall Study|Other treatments become available|0
7863747|NCT01607905|12353157|FG002|Overall Study|Other treatments become available|0
7863748|NCT01607905|12353158|FG003|Overall Study|Other treatments become available|0
7863749|NCT01607905|12353159|FG004|Overall Study|Other treatments become available|0
7949824|NCT02543658|12495829|FG000|Overall Study|Lack of Efficacy|0
7857137|NCT01552915|12343549|FG000|Overall Study|Adverse Event|3
7857138|NCT01552915|12343550|FG001|Overall Study|Adverse Event|14
7857139|NCT01552915|12343551|FG002|Overall Study|Adverse Event|3
7857140|NCT01552915|12343549|FG000|Overall Study|Lost to Follow-up|4
7857141|NCT01552915|12343550|FG001|Overall Study|Lost to Follow-up|6
7857142|NCT01552915|12343551|FG002|Overall Study|Lost to Follow-up|5
7857143|NCT01552915|12343549|FG000|Overall Study|Withdrawal by Subject|6
7857144|NCT01552915|12343550|FG001|Overall Study|Withdrawal by Subject|4
7857145|NCT01552915|12343551|FG002|Overall Study|Withdrawal by Subject|5
7857146|NCT01552915|12343549|FG000|Overall Study|Protocol Violation|0
7857147|NCT01552915|12343550|FG001|Overall Study|Protocol Violation|4
7857148|NCT01552915|12343551|FG002|Overall Study|Protocol Violation|4
7857149|NCT01552915|12343549|FG000|Overall Study|Lack of Efficacy|8
7857150|NCT01552915|12343550|FG001|Overall Study|Lack of Efficacy|1
7857151|NCT01552915|12343551|FG002|Overall Study|Lack of Efficacy|4
7857152|NCT01552915|12343549|FG000|Overall Study|Other|2
7857153|NCT01552915|12343550|FG001|Overall Study|Other|0
7857154|NCT01552915|12343551|FG002|Overall Study|Other|6
7857155|NCT01552928|12343563|FG000|Period 3|Adverse Event|0
7857156|NCT01552928|12343564|FG001|Period 3|Adverse Event|0
7857157|NCT01552928|12343565|FG002|Period 3|Adverse Event|1
7857158|NCT01552928|12343566|FG003|Period 3|Adverse Event|0
7857159|NCT01552954|12343585|FG000|Overall Study|Adverse Event|1
7857160|NCT01552954|12343586|FG001|Overall Study|Adverse Event|2
7857161|NCT01552954|12343585|FG000|Overall Study|Lost to Follow-up|1
7857162|NCT01552954|12343586|FG001|Overall Study|Lost to Follow-up|1
7857163|NCT01552954|12343585|FG000|Overall Study|Withdrawal by Subject|1
7857164|NCT01552954|12343586|FG001|Overall Study|Withdrawal by Subject|1
7857165|NCT01552954|12343585|FG000|Overall Study|Protocol Violation|1
7857166|NCT01552954|12343586|FG001|Overall Study|Protocol Violation|2
7857167|NCT01552954|12343585|FG000|Overall Study|diagnosed DM|1
7857168|NCT01552954|12343586|FG001|Overall Study|diagnosed DM|0
7857169|NCT01553084|12343612|FG000|Overall Study|Withdrawal by Subject|15
7857170|NCT01553084|12343613|FG001|Overall Study|Withdrawal by Subject|13
7857171|NCT01553084|12343614|FG002|Overall Study|Withdrawal by Subject|35
7857172|NCT01553136|12343626|FG000|Overall Study|Adverse Event|3
7857173|NCT01553136|12343627|FG001|Overall Study|Adverse Event|2
7857174|NCT01553136|12343626|FG000|Overall Study|Withdrawal by Subject|2
7857175|NCT01553136|12343627|FG001|Overall Study|Withdrawal by Subject|3
7857176|NCT01553136|12343626|FG000|Overall Study|Lost to Follow-up|4
7857177|NCT01553136|12343627|FG001|Overall Study|Lost to Follow-up|10
7857178|NCT01553136|12343626|FG000|Overall Study|Physician Decision|2
7857179|NCT01553136|12343627|FG001|Overall Study|Physician Decision|3
7857180|NCT01553136|12343626|FG000|Overall Study|Scheduling Difficulties|5
7857181|NCT01553136|12343627|FG001|Overall Study|Scheduling Difficulties|4
7857182|NCT01553188|12343637|FG000|Overall Study|Patient choice|1
7857183|NCT01553188|12343638|FG001|Overall Study|Patient choice|0
7857184|NCT01553188|12343639|FG002|Overall Study|Patient choice|0
7857185|NCT01553188|12343640|FG003|Overall Study|Patient choice|0
7857186|NCT01553188|12343637|FG000|Overall Study|Intercurrent illness and adverse event|0
7857187|NCT01553188|12343638|FG001|Overall Study|Intercurrent illness and adverse event|1
7857188|NCT01553188|12343639|FG002|Overall Study|Intercurrent illness and adverse event|2
7857189|NCT01553188|12343640|FG003|Overall Study|Intercurrent illness and adverse event|0
7857190|NCT01553279|12343664|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1
7857191|NCT01553279|12343665|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0
7857192|NCT01553279|12343664|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
7857193|NCT01553279|12343665|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
7857194|NCT01553279|12343664|FG000|Interim Period|Withdrawal by Subject|2
7857195|NCT01553279|12343665|FG001|Interim Period|Withdrawal by Subject|2
7857196|NCT01553279|12343664|FG000|Interim Period|Lost to Follow-up|1
7857197|NCT01553279|12343665|FG001|Interim Period|Lost to Follow-up|0
7857198|NCT01553279|12343664|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0
7857199|NCT01553279|12343665|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5
7857200|NCT01553279|12343664|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3
7857201|NCT01553279|12343665|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2
7857202|NCT01553318|12343680|FG000|Overall Study|Protocol Violation|3
7857203|NCT01553318|12343681|FG001|Overall Study|Protocol Violation|2
7857204|NCT01553591|12343696|FG000|Overall Study|Voluntarily withdrew|94
7857205|NCT01553591|12343697|FG001|Overall Study|Voluntarily withdrew|79
7857206|NCT01553591|12343698|FG002|Overall Study|Voluntarily withdrew|96
7857207|NCT01553591|12343696|FG000|Overall Study|Adverse Event|36
7857208|NCT01553591|12343697|FG001|Overall Study|Adverse Event|45
7857209|NCT01553591|12343698|FG002|Overall Study|Adverse Event|16
7857210|NCT01553591|12343696|FG000|Overall Study|Lost to Follow-up|25
7857211|NCT01553591|12343697|FG001|Overall Study|Lost to Follow-up|23
7857212|NCT01553591|12343698|FG002|Overall Study|Lost to Follow-up|16
7857213|NCT01553591|12343696|FG000|Overall Study|Physician decision: other|11
7857214|NCT01553591|12343697|FG001|Overall Study|Physician decision: other|14
7857215|NCT01553591|12343698|FG002|Overall Study|Physician decision: other|16
7857216|NCT01553591|12343696|FG000|Overall Study|Physician decision: lack of efficacy|2
7857217|NCT01553591|12343697|FG001|Overall Study|Physician decision: lack of efficacy|3
7857218|NCT01553591|12343698|FG002|Overall Study|Physician decision: lack of efficacy|7
7857219|NCT01553591|12343696|FG000|Overall Study|Protocol Violation|3
7857220|NCT01553591|12343697|FG001|Overall Study|Protocol Violation|4
7857221|NCT01553591|12343698|FG002|Overall Study|Protocol Violation|4
7857222|NCT01553591|12343696|FG000|Overall Study|Sponsor decision|1
7857223|NCT01553591|12343697|FG001|Overall Study|Sponsor decision|0
7857224|NCT01553591|12343698|FG002|Overall Study|Sponsor decision|3
7857225|NCT01553591|12343696|FG000|Overall Study|Randomized and never dispensed drug|0
7857226|NCT01553591|12343697|FG001|Overall Study|Randomized and never dispensed drug|1
7857227|NCT01553591|12343698|FG002|Overall Study|Randomized and never dispensed drug|0
7857228|NCT01553747|12343718|FG000|Overall Study|Protocol Violation|0
7857229|NCT01553747|12343719|FG001|Overall Study|Protocol Violation|2
7857230|NCT01553747|12343720|FG002|Overall Study|Protocol Violation|0
7857231|NCT01553747|12343718|FG000|Overall Study|Voluntarily withdrew|70
7857232|NCT01553747|12343719|FG001|Overall Study|Voluntarily withdrew|66
7857233|NCT01553747|12343720|FG002|Overall Study|Voluntarily withdrew|74
7857234|NCT01553747|12343718|FG000|Overall Study|Adverse event or SAE|32
7857235|NCT01553747|12343719|FG001|Overall Study|Adverse event or SAE|28
7857236|NCT01553747|12343720|FG002|Overall Study|Adverse event or SAE|19
7857237|NCT01553747|12343718|FG000|Overall Study|Physician decision: other|10
7857238|NCT01553747|12343719|FG001|Overall Study|Physician decision: other|8
7857239|NCT01553747|12343720|FG002|Overall Study|Physician decision: other|7
7857240|NCT01553747|12343718|FG000|Overall Study|Lost to Follow-up|11
7857241|NCT01553747|12343719|FG001|Overall Study|Lost to Follow-up|5
7857242|NCT01553747|12343720|FG002|Overall Study|Lost to Follow-up|6
7857243|NCT01553747|12343718|FG000|Overall Study|Sponsor decision, specify|7
7857244|NCT01553747|12343719|FG001|Overall Study|Sponsor decision, specify|5
7857245|NCT01553747|12343720|FG002|Overall Study|Sponsor decision, specify|0
7857246|NCT01553747|12343718|FG000|Overall Study|Physician decision: lack of efficacy|1
7857247|NCT01553747|12343719|FG001|Overall Study|Physician decision: lack of efficacy|5
7857248|NCT01553747|12343720|FG002|Overall Study|Physician decision: lack of efficacy|3
7857249|NCT01553851|12343731|FG000|Overall Study|Adverse Event|2
7857250|NCT01553851|12343731|FG000|Overall Study|constipation|1
7857251|NCT01553916|12343735|FG000|Overall Study|Withdrawal by Subject|2
7857252|NCT01553916|12343735|FG000|Overall Study|Pre-treatment MRI metastatic disease|1
7857253|NCT01554176|12343741|FG000|Treatment Phase|Protocol Violation|1
7857254|NCT01554176|12343742|FG001|Treatment Phase|Protocol Violation|2
7857255|NCT01554176|12343743|FG002|Treatment Phase|Protocol Violation|0
7857256|NCT01554176|12343744|FG003|Treatment Phase|Protocol Violation|0
7857257|NCT01554176|12343745|FG004|Treatment Phase|Protocol Violation|0
7857258|NCT01554176|12343741|FG000|Treatment Phase|Physician Decision|1
7857259|NCT01554176|12343742|FG001|Treatment Phase|Physician Decision|1
7857260|NCT01554176|12343743|FG002|Treatment Phase|Physician Decision|0
7857261|NCT01554176|12343744|FG003|Treatment Phase|Physician Decision|0
7857262|NCT01554176|12343745|FG004|Treatment Phase|Physician Decision|0
7857263|NCT01554176|12343741|FG000|Treatment Phase|Lack of Efficacy|0
7857264|NCT01554176|12343742|FG001|Treatment Phase|Lack of Efficacy|1
7857265|NCT01554176|12343743|FG002|Treatment Phase|Lack of Efficacy|0
7857266|NCT01554176|12343744|FG003|Treatment Phase|Lack of Efficacy|0
7857267|NCT01554176|12343745|FG004|Treatment Phase|Lack of Efficacy|0
7857268|NCT01554176|12343741|FG000|Treatment Phase|Adverse event, non-fatal|1
7857269|NCT01554176|12343742|FG001|Treatment Phase|Adverse event, non-fatal|1
7857270|NCT01554176|12343743|FG002|Treatment Phase|Adverse event, non-fatal|0
7857271|NCT01554176|12343744|FG003|Treatment Phase|Adverse event, non-fatal|0
7857272|NCT01554176|12343745|FG004|Treatment Phase|Adverse event, non-fatal|0
7857273|NCT01554176|12343741|FG000|Treatment Phase|Non-compliance with study drug|1
7857274|NCT01554176|12343742|FG001|Treatment Phase|Non-compliance with study drug|0
7857275|NCT01554176|12343743|FG002|Treatment Phase|Non-compliance with study drug|0
7857276|NCT01554176|12343744|FG003|Treatment Phase|Non-compliance with study drug|0
7857277|NCT01554176|12343745|FG004|Treatment Phase|Non-compliance with study drug|0
7857278|NCT01554176|12343741|FG000|Treatment Phase|Withdrawal by Subject|1
7857279|NCT01554176|12343742|FG001|Treatment Phase|Withdrawal by Subject|0
7857280|NCT01554176|12343743|FG002|Treatment Phase|Withdrawal by Subject|0
7857281|NCT01554176|12343744|FG003|Treatment Phase|Withdrawal by Subject|0
7857282|NCT01554176|12343745|FG004|Treatment Phase|Withdrawal by Subject|0
7857283|NCT01554176|12343741|FG000|Treatment Phase|Lost to Follow-up|3
7857284|NCT01554176|12343742|FG001|Treatment Phase|Lost to Follow-up|0
7857285|NCT01554176|12343743|FG002|Treatment Phase|Lost to Follow-up|0
7857286|NCT01554176|12343744|FG003|Treatment Phase|Lost to Follow-up|0
7857287|NCT01554176|12343745|FG004|Treatment Phase|Lost to Follow-up|0
7857288|NCT01554176|12343741|FG000|Run-out Phase|Protocol Violation|0
7857289|NCT01554176|12343742|FG001|Run-out Phase|Protocol Violation|0
7857290|NCT01554176|12343743|FG002|Run-out Phase|Protocol Violation|0
7857291|NCT01554176|12343744|FG003|Run-out Phase|Protocol Violation|1
7857292|NCT01554176|12343745|FG004|Run-out Phase|Protocol Violation|0
7857293|NCT01554241|12343761|FG000|Overall Study|Death|3
7857294|NCT01554241|12343762|FG001|Overall Study|Death|1
7857295|NCT01554241|12343763|FG002|Overall Study|Death|1
7857296|NCT01554241|12343764|FG003|Overall Study|Death|0
7857297|NCT01554241|12343761|FG000|Overall Study|protocol specified renal stone|0
7857298|NCT01554241|12343762|FG001|Overall Study|protocol specified renal stone|0
7857299|NCT01554241|12343763|FG002|Overall Study|protocol specified renal stone|0
7857300|NCT01554241|12343764|FG003|Overall Study|protocol specified renal stone|1
7857301|NCT01554241|12343761|FG000|Overall Study|protocol specified change in eGFR|0
7857302|NCT01554241|12343762|FG001|Overall Study|protocol specified change in eGFR|0
7857303|NCT01554241|12343763|FG002|Overall Study|protocol specified change in eGFR|1
7857304|NCT01554241|12343764|FG003|Overall Study|protocol specified change in eGFR|0
7857305|NCT01554241|12343761|FG000|Overall Study|Withdrawal by Subject|0
7857306|NCT01554241|12343762|FG001|Overall Study|Withdrawal by Subject|0
7857307|NCT01554241|12343763|FG002|Overall Study|Withdrawal by Subject|2
7857308|NCT01554241|12343764|FG003|Overall Study|Withdrawal by Subject|0
7857309|NCT01554514|12343799|FG000|Overall Study|1 patient ineligible with congenital TTP|1
7857310|NCT01554514|12343799|FG000|Overall Study|Physician Decision|1
7857311|NCT01554527|12343806|FG000|Overall Study|Withdrawal by Subject|1
7857312|NCT01554527|12343807|FG001|Overall Study|Withdrawal by Subject|0
7857313|NCT01554527|12343808|FG002|Overall Study|Withdrawal by Subject|3
7857314|NCT01554527|12343806|FG000|Overall Study|Lost to Follow-up|0
7857315|NCT01554527|12343807|FG001|Overall Study|Lost to Follow-up|0
7857316|NCT01554527|12343808|FG002|Overall Study|Lost to Follow-up|4
7857317|NCT01554527|12343806|FG000|Overall Study|Physician Decision|0
7857318|NCT01554527|12343807|FG001|Overall Study|Physician Decision|0
7857319|NCT01554527|12343808|FG002|Overall Study|Physician Decision|1
7857320|NCT01554579|12343819|FG000|Overall Study|Adverse Event|6
7857321|NCT01554579|12343820|FG001|Overall Study|Adverse Event|25
7857322|NCT01554579|12343819|FG000|Overall Study|Lack of Efficacy|2
7857323|NCT01554579|12343820|FG001|Overall Study|Lack of Efficacy|1
7857324|NCT01554579|12343819|FG000|Overall Study|Withdrawal by Subject|2
7857325|NCT01554579|12343820|FG001|Overall Study|Withdrawal by Subject|1
7857326|NCT01554618|12343829|FG000|Randomized Through Start of Treatment|Adverse Event|1
7857327|NCT01554618|12343830|FG001|Randomized Through Start of Treatment|Adverse Event|0
7857328|NCT01554618|12343829|FG000|Controlled Assessment Period|Lost to Follow-up|2
7857329|NCT01554618|12343830|FG001|Controlled Assessment Period|Lost to Follow-up|1
7857330|NCT01554618|12343829|FG000|Controlled Assessment Period|Withdrawal by Subject|6
7857331|NCT01554618|12343830|FG001|Controlled Assessment Period|Withdrawal by Subject|0
7857332|NCT01554618|12343829|FG000|Open-Label Extension Period|Withdrawal by Subject|2
7857333|NCT01554618|12343830|FG001|Open-Label Extension Period|Withdrawal by Subject|3
7857334|NCT01554618|12343829|FG000|Open-Label Extension Period|Physician Decision|0
7857335|NCT01554618|12343830|FG001|Open-Label Extension Period|Physician Decision|1
7857336|NCT01554618|12343829|FG000|Open-Label Extension Period|Lost to Follow-up|1
7857337|NCT01554618|12343830|FG001|Open-Label Extension Period|Lost to Follow-up|1
7857338|NCT01554904|12343866|FG000|Overall Study|Withdrawal by Subject|3
7857339|NCT01554904|12343866|FG000|Overall Study|Had sleep apnea on Home Study 1|1
7857340|NCT01555125|12343877|FG000|Induction Period|Lost to Follow-up|0
7857341|NCT01555125|12343878|FG001|Induction Period|Lost to Follow-up|2
7857342|NCT01555125|12343879|FG002|Induction Period|Lost to Follow-up|0
7857343|NCT01555125|12343880|FG003|Induction Period|Lost to Follow-up|0
7857344|NCT01555125|12343881|FG004|Induction Period|Lost to Follow-up|0
7857345|NCT01555125|12343877|FG000|Induction Period|Adverse Event|0
7857346|NCT01555125|12343878|FG001|Induction Period|Adverse Event|1
7857347|NCT01555125|12343879|FG002|Induction Period|Adverse Event|0
7857348|NCT01555125|12343880|FG003|Induction Period|Adverse Event|0
7857349|NCT01555125|12343881|FG004|Induction Period|Adverse Event|1
7857350|NCT01555125|12343877|FG000|Induction Period|Subject / guardian decision|0
7857351|NCT01555125|12343878|FG001|Induction Period|Subject / guardian decision|0
7857352|NCT01555125|12343879|FG002|Induction Period|Subject / guardian decision|0
7857353|NCT01555125|12343880|FG003|Induction Period|Subject / guardian decision|0
7857354|NCT01555125|12343881|FG004|Induction Period|Subject / guardian decision|2
7857355|NCT01555125|12343877|FG000|Induction Period|Death|1
7857356|NCT01555125|12343878|FG001|Induction Period|Death|0
7857357|NCT01555125|12343879|FG002|Induction Period|Death|0
7857358|NCT01555125|12343880|FG003|Induction Period|Death|0
7857359|NCT01555125|12343881|FG004|Induction Period|Death|0
7857360|NCT01555125|12343877|FG000|Maintenance Period|Adverse Event|1
7857361|NCT01555125|12343878|FG001|Maintenance Period|Adverse Event|1
7857362|NCT01555125|12343879|FG002|Maintenance Period|Adverse Event|0
7857363|NCT01555125|12343880|FG003|Maintenance Period|Adverse Event|0
7857364|NCT01555125|12343881|FG004|Maintenance Period|Adverse Event|0
7857365|NCT01555125|12343877|FG000|Maintenance Period|Subject / guardian decision|1
7857366|NCT01555125|12343878|FG001|Maintenance Period|Subject / guardian decision|2
7857367|NCT01555125|12343879|FG002|Maintenance Period|Subject / guardian decision|0
7857368|NCT01555125|12343880|FG003|Maintenance Period|Subject / guardian decision|0
7857369|NCT01555125|12343881|FG004|Maintenance Period|Subject / guardian decision|0
7857370|NCT01555125|12343877|FG000|Maintenance Period|Lost to Follow-up|2
7857371|NCT01555125|12343878|FG001|Maintenance Period|Lost to Follow-up|0
7857372|NCT01555125|12343879|FG002|Maintenance Period|Lost to Follow-up|0
7857373|NCT01555125|12343880|FG003|Maintenance Period|Lost to Follow-up|1
7857374|NCT01555125|12343881|FG004|Maintenance Period|Lost to Follow-up|0
7857375|NCT01555125|12343877|FG000|Maintenance Period|Lack of Efficacy|6
7857376|NCT01555125|12343878|FG001|Maintenance Period|Lack of Efficacy|1
7857377|NCT01555125|12343879|FG002|Maintenance Period|Lack of Efficacy|3
7857378|NCT01555125|12343880|FG003|Maintenance Period|Lack of Efficacy|0
7857379|NCT01555125|12343881|FG004|Maintenance Period|Lack of Efficacy|0
7857380|NCT01555125|12343877|FG000|Maintenance Period|Physician Decision|0
7857381|NCT01555125|12343878|FG001|Maintenance Period|Physician Decision|0
7857382|NCT01555125|12343879|FG002|Maintenance Period|Physician Decision|1
7857383|NCT01555125|12343880|FG003|Maintenance Period|Physician Decision|0
7857384|NCT01555125|12343881|FG004|Maintenance Period|Physician Decision|0
7857385|NCT01555125|12343877|FG000|Maintenance Period|Death|0
7857386|NCT01555125|12343878|FG001|Maintenance Period|Death|0
7857387|NCT01555125|12343879|FG002|Maintenance Period|Death|0
7857388|NCT01555125|12343880|FG003|Maintenance Period|Death|1
7857389|NCT01555125|12343881|FG004|Maintenance Period|Death|0
7857390|NCT01555125|12343877|FG000|Extension|Adverse Event|1
7857391|NCT01555125|12343878|FG001|Extension|Adverse Event|2
7857392|NCT01555125|12343879|FG002|Extension|Adverse Event|1
7857393|NCT01555125|12343880|FG003|Extension|Adverse Event|1
7857394|NCT01555125|12343881|FG004|Extension|Adverse Event|0
7857395|NCT01555125|12343877|FG000|Extension|Protocol deviation|1
7857396|NCT01555125|12343878|FG001|Extension|Protocol deviation|0
7857397|NCT01555125|12343879|FG002|Extension|Protocol deviation|0
7857398|NCT01555125|12343880|FG003|Extension|Protocol deviation|0
7857399|NCT01555125|12343881|FG004|Extension|Protocol deviation|0
7857400|NCT01555125|12343877|FG000|Extension|Lack of Efficacy|7
7857401|NCT01555125|12343878|FG001|Extension|Lack of Efficacy|6
7857402|NCT01555125|12343879|FG002|Extension|Lack of Efficacy|3
7857403|NCT01555125|12343880|FG003|Extension|Lack of Efficacy|0
7857404|NCT01555125|12343881|FG004|Extension|Lack of Efficacy|0
7857405|NCT01555125|12343877|FG000|Extension|Lost to Follow-up|2
7857406|NCT01555125|12343878|FG001|Extension|Lost to Follow-up|1
7857407|NCT01555125|12343879|FG002|Extension|Lost to Follow-up|2
7857408|NCT01555125|12343880|FG003|Extension|Lost to Follow-up|0
7857409|NCT01555125|12343881|FG004|Extension|Lost to Follow-up|0
7857410|NCT01555125|12343877|FG000|Extension|Study terminated by sponsor|32
7857411|NCT01555125|12343878|FG001|Extension|Study terminated by sponsor|33
7857412|NCT01555125|12343879|FG002|Extension|Study terminated by sponsor|16
7857413|NCT01555125|12343880|FG003|Extension|Study terminated by sponsor|20
7857414|NCT01555125|12343881|FG004|Extension|Study terminated by sponsor|0
7857415|NCT01555125|12343877|FG000|Extension|Subject/guardian decision|1
7857416|NCT01555125|12343878|FG001|Extension|Subject/guardian decision|9
7857417|NCT01555125|12343879|FG002|Extension|Subject/guardian decision|1
7857418|NCT01555125|12343880|FG003|Extension|Subject/guardian decision|0
7857419|NCT01555125|12343881|FG004|Extension|Subject/guardian decision|0
7857420|NCT01555125|12343877|FG000|Extension|Technical Problems|1
7857421|NCT01555125|12343878|FG001|Extension|Technical Problems|0
7857422|NCT01555125|12343879|FG002|Extension|Technical Problems|0
7857423|NCT01555125|12343880|FG003|Extension|Technical Problems|1
7857424|NCT01555125|12343881|FG004|Extension|Technical Problems|0
7857425|NCT01555125|12343877|FG000|Follow-Up Period|Lost to Follow-up|1
7857426|NCT01555125|12343878|FG001|Follow-Up Period|Lost to Follow-up|0
7857427|NCT01555125|12343879|FG002|Follow-Up Period|Lost to Follow-up|0
7857428|NCT01555125|12343880|FG003|Follow-Up Period|Lost to Follow-up|0
7857429|NCT01555125|12343881|FG004|Follow-Up Period|Lost to Follow-up|0
7857430|NCT01555125|12343877|FG000|Follow-Up Period|Subject / guardian decision|3
7857431|NCT01555125|12343878|FG001|Follow-Up Period|Subject / guardian decision|1
7857432|NCT01555125|12343879|FG002|Follow-Up Period|Subject / guardian decision|1
7857433|NCT01555125|12343880|FG003|Follow-Up Period|Subject / guardian decision|1
7857434|NCT01555125|12343881|FG004|Follow-Up Period|Subject / guardian decision|0
7857435|NCT01555138|12343898|FG000|Overall Study|Death|0
7857436|NCT01555138|12343899|FG001|Overall Study|Death|1
7857437|NCT01555138|12343898|FG000|Overall Study|Lost to Follow-up|1
7857438|NCT01555138|12343899|FG001|Overall Study|Lost to Follow-up|0
7857439|NCT01555138|12343898|FG000|Overall Study|Abnormal Lab reults|1
7857440|NCT01555138|12343899|FG001|Overall Study|Abnormal Lab reults|3
7857441|NCT01555138|12343898|FG000|Overall Study|Lack of Efficacy|2
7857442|NCT01555138|12343899|FG001|Overall Study|Lack of Efficacy|2
7857443|NCT01555138|12343898|FG000|Overall Study|Protocol Violation|5
7857444|NCT01555138|12343899|FG001|Overall Study|Protocol Violation|3
7857445|NCT01555138|12343898|FG000|Overall Study|Administrative problems|8
7857446|NCT01555138|12343899|FG001|Overall Study|Administrative problems|0
7857447|NCT01555138|12343898|FG000|Overall Study|Withdrawal by Subject|16
7857448|NCT01555138|12343899|FG001|Overall Study|Withdrawal by Subject|15
7857449|NCT01555138|12343898|FG000|Overall Study|Adverse Event|14
7857450|NCT01555138|12343899|FG001|Overall Study|Adverse Event|14
7857451|NCT01555151|12343909|FG000|Overall Study|Withdrawal by Subject|6
7857452|NCT01555151|12343910|FG001|Overall Study|Withdrawal by Subject|2
7857453|NCT01555151|12343911|FG002|Overall Study|Withdrawal by Subject|0
7857454|NCT01555151|12343912|FG003|Overall Study|Withdrawal by Subject|2
7857455|NCT01555151|12343909|FG000|Overall Study|Administrative|3
7857456|NCT01555151|12343910|FG001|Overall Study|Administrative|1
7857457|NCT01555151|12343911|FG002|Overall Study|Administrative|2
7857458|NCT01555151|12343912|FG003|Overall Study|Administrative|0
7857459|NCT01555151|12343909|FG000|Overall Study|Protocol Violation|3
7857460|NCT01555151|12343910|FG001|Overall Study|Protocol Violation|3
7857461|NCT01555151|12343911|FG002|Overall Study|Protocol Violation|3
7857462|NCT01555151|12343912|FG003|Overall Study|Protocol Violation|5
7857463|NCT01555151|12343909|FG000|Overall Study|Adverse Event|1
7857464|NCT01555151|12343910|FG001|Overall Study|Adverse Event|2
7857465|NCT01555151|12343911|FG002|Overall Study|Adverse Event|1
7857466|NCT01555151|12343912|FG003|Overall Study|Adverse Event|2
7857467|NCT01555151|12343909|FG000|Overall Study|Lost to Follow-up|0
7857468|NCT01555151|12343910|FG001|Overall Study|Lost to Follow-up|0
7857469|NCT01555151|12343911|FG002|Overall Study|Lost to Follow-up|0
7857470|NCT01555151|12343912|FG003|Overall Study|Lost to Follow-up|1
7857471|NCT01555164|12343925|FG000|Overall Study|Adverse Event|5
7857472|NCT01555164|12343926|FG001|Overall Study|Adverse Event|7
7857473|NCT01555164|12343925|FG000|Overall Study|Hyperglycemia|0
7857474|NCT01555164|12343926|FG001|Overall Study|Hyperglycemia|1
7857475|NCT01555164|12343925|FG000|Overall Study|Investigator's Discretion|2
7857476|NCT01555164|12343926|FG001|Overall Study|Investigator's Discretion|2
7857477|NCT01555164|12343925|FG000|Overall Study|Lost to Follow-up|4
7857478|NCT01555164|12343926|FG001|Overall Study|Lost to Follow-up|3
7857479|NCT01555164|12343925|FG000|Overall Study|Protocol Violation|9
7857480|NCT01555164|12343926|FG001|Overall Study|Protocol Violation|5
7857481|NCT01555164|12343925|FG000|Overall Study|Subject Non-compliance|14
7857482|NCT01555164|12343926|FG001|Overall Study|Subject Non-compliance|6
7857483|NCT01555164|12343925|FG000|Overall Study|Subject Withdrew Consent|6
7857484|NCT01555164|12343926|FG001|Overall Study|Subject Withdrew Consent|11
7857485|NCT01555463|12343934|FG000|Treatment|Adverse Event|6
7857486|NCT01555463|12343935|FG001|Treatment|Adverse Event|12
7857487|NCT01555463|12343934|FG000|Treatment|Withdrawal by Subject|24
7857488|NCT01555463|12343935|FG001|Treatment|Withdrawal by Subject|36
7857489|NCT01555463|12343934|FG000|Treatment|Lost to Follow-up|28
7857490|NCT01555463|12343935|FG001|Treatment|Lost to Follow-up|23
7857491|NCT01555463|12343934|FG000|Treatment|Protocol Violation|4
7857492|NCT01555463|12343935|FG001|Treatment|Protocol Violation|5
7857493|NCT01555463|12343934|FG000|Treatment|Other reason|2
7857494|NCT01555463|12343935|FG001|Treatment|Other reason|3
7857495|NCT01555463|12343934|FG000|Follow up|Adverse Event|2
7857496|NCT01555463|12343935|FG001|Follow up|Adverse Event|5
7857497|NCT01555463|12343934|FG000|Follow up|Death|0
7857498|NCT01555463|12343935|FG001|Follow up|Death|1
7857499|NCT01555463|12343934|FG000|Follow up|Withdrawal by Subject|22
7857500|NCT01555463|12343935|FG001|Follow up|Withdrawal by Subject|22
7857501|NCT01555463|12343934|FG000|Follow up|Lost to Follow-up|9
7857502|NCT01555463|12343935|FG001|Follow up|Lost to Follow-up|10
7857503|NCT01555463|12343934|FG000|Follow up|Protocol Violation|2
7857504|NCT01555463|12343935|FG001|Follow up|Protocol Violation|4
7857505|NCT01555463|12343934|FG000|Follow up|Other reason|3
7857506|NCT01555463|12343935|FG001|Follow up|Other reason|3
7857507|NCT01555671|12343960|FG000|Overall Study|Physician Decision|20
7857508|NCT01555671|12343961|FG001|Overall Study|Physician Decision|25
7857509|NCT01555762|12343969|FG000|Overall Study|No information on Bevacizumab intake|11
7857510|NCT01555762|12343969|FG000|Overall Study|Missing start date of infusion|8
7857511|NCT01555762|12343969|FG000|Overall Study|75 years old or more ticked No|1
7857512|NCT01555762|12343969|FG000|Overall Study|Treatment with Bevacizumab ticked No|24
7857513|NCT01555762|12343969|FG000|Overall Study|Death linked to progression of disease|165
7857514|NCT01555762|12343969|FG000|Overall Study|Lost follow-up/moved house/changed team|35
7857515|NCT01555762|12343969|FG000|Overall Study|Investigator's decision|10
7857516|NCT01555762|12343969|FG000|Overall Study|Participant not wishing to continue|5
7857517|NCT01555762|12343969|FG000|Overall Study|Missing data|1
7857518|NCT01555762|12343969|FG000|Overall Study|Death linked to an adverse event|14
7857519|NCT01555931|12343975|FG000|Overall Study|Lost to Follow-up|2
7857520|NCT01555931|12343976|FG001|Overall Study|Lost to Follow-up|5
7857521|NCT01555983|12343991|FG000|Overall Study|Withdrawal by Subject|1
7857522|NCT01555983|12343992|FG001|Overall Study|Withdrawal by Subject|0
7857523|NCT01555983|12343993|FG002|Overall Study|Withdrawal by Subject|0
7857524|NCT01555983|12343994|FG003|Overall Study|Withdrawal by Subject|0
7857525|NCT01555983|12343995|FG004|Overall Study|Withdrawal by Subject|1
7857526|NCT01555983|12343996|FG005|Overall Study|Withdrawal by Subject|1
7857527|NCT01556165|12344021|FG000|Overall Study|Adverse Event|5
7857528|NCT01556165|12344022|FG001|Overall Study|Adverse Event|3
7857529|NCT01556165|12344021|FG000|Overall Study|Protocol Violation|0
7857530|NCT01556165|12344022|FG001|Overall Study|Protocol Violation|3
7857531|NCT01556165|12344021|FG000|Overall Study|Withdrawal of Consent|7
7857532|NCT01556165|12344022|FG001|Overall Study|Withdrawal of Consent|1
7857533|NCT01556438|12344084|FG000|Overall Study|Adverse Event|4
7857534|NCT01556438|12344085|FG001|Overall Study|Adverse Event|2
7857535|NCT01556438|12344084|FG000|Overall Study|Sponsor Decision|0
7857536|NCT01556438|12344085|FG001|Overall Study|Sponsor Decision|2
7857537|NCT01556438|12344084|FG000|Overall Study|Progressive Disease|0
7857538|NCT01556438|12344085|FG001|Overall Study|Progressive Disease|6
7857539|NCT01556438|12344084|FG000|Overall Study|Death|0
7857540|NCT01556438|12344085|FG001|Overall Study|Death|1
7857541|NCT01556763|12344154|FG000|Overall Study|Withdrawal by Subject|0
7857542|NCT01556763|12344155|FG001|Overall Study|Withdrawal by Subject|1
7857543|NCT01556763|12344156|FG002|Overall Study|Withdrawal by Subject|0
7857544|NCT01556932|12344170|FG000|Time Point 60 Minutes|Withdrawal by Subject|1
7857545|NCT01556932|12344171|FG001|Time Point 60 Minutes|Withdrawal by Subject|1
7857546|NCT01556997|12344179|FG000|Overall Study|Adverse Event|10
7857547|NCT01556997|12344180|FG001|Overall Study|Adverse Event|12
7857548|NCT01556997|12344181|FG002|Overall Study|Adverse Event|12
7857549|NCT01556997|12344179|FG000|Overall Study|Lost to Follow-up|6
7857550|NCT01556997|12344180|FG001|Overall Study|Lost to Follow-up|6
7857551|NCT01556997|12344181|FG002|Overall Study|Lost to Follow-up|4
7857552|NCT01556997|12344179|FG000|Overall Study|Physician Decision|1
7857553|NCT01556997|12344180|FG001|Overall Study|Physician Decision|1
7857554|NCT01556997|12344181|FG002|Overall Study|Physician Decision|1
7857555|NCT01556997|12344179|FG000|Overall Study|Withdrawal by Subject|7
7857556|NCT01556997|12344180|FG001|Overall Study|Withdrawal by Subject|6
7857557|NCT01556997|12344181|FG002|Overall Study|Withdrawal by Subject|8
7857558|NCT01556997|12344179|FG000|Overall Study|Other|2
7857559|NCT01556997|12344180|FG001|Overall Study|Other|3
7857560|NCT01556997|12344181|FG002|Overall Study|Other|7
7857561|NCT01557166|12344191|FG000|Overall Study|Adverse Event|20
7857562|NCT01557166|12344192|FG001|Overall Study|Adverse Event|6
7857563|NCT01557166|12344191|FG000|Overall Study|Lack of Efficacy|2
7857564|NCT01557166|12344192|FG001|Overall Study|Lack of Efficacy|1
7857565|NCT01557166|12344191|FG000|Overall Study|Protocol Violation|8
7857566|NCT01557166|12344192|FG001|Overall Study|Protocol Violation|5
7857567|NCT01557166|12344191|FG000|Overall Study|Withdrawn consent|12
7857568|NCT01557166|12344192|FG001|Overall Study|Withdrawn consent|20
7857569|NCT01557166|12344191|FG000|Overall Study|Target dose not tolerated|1
7857570|NCT01557166|12344192|FG001|Overall Study|Target dose not tolerated|0
7857571|NCT01557166|12344191|FG000|Overall Study|Psychiatric disorder|1
7857572|NCT01557166|12344192|FG001|Overall Study|Psychiatric disorder|0
7857573|NCT01557166|12344191|FG000|Overall Study|Unclassified|2
7857574|NCT01557166|12344192|FG001|Overall Study|Unclassified|5
7857575|NCT01557244|12344203|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
7857576|NCT01557244|12344204|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7857577|NCT01557244|12344205|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7857578|NCT01557244|12344206|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7857579|NCT01557244|12344207|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7857580|NCT01557244|12344208|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
7857581|NCT01557244|12344209|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7857582|NCT01557244|12344203|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2
7857583|NCT01557244|12344204|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7857584|NCT01557244|12344205|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1
7857585|NCT01557244|12344206|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7857586|NCT01557244|12344207|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7857587|NCT01557244|12344208|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7857588|NCT01557244|12344209|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7857589|NCT01557244|12344203|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1
7857590|NCT01557244|12344204|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7857591|NCT01557244|12344205|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7857592|NCT01557244|12344206|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7857593|NCT01557244|12344207|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7857594|NCT01557244|12344208|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7857595|NCT01557244|12344209|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7857596|NCT01557244|12344203|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2
7857597|NCT01557244|12344204|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7857598|NCT01557244|12344205|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7857599|NCT01557244|12344206|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7857600|NCT01557244|12344207|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7857601|NCT01557244|12344208|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3
7857602|NCT01557244|12344209|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7857603|NCT01557244|12344203|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7857604|NCT01557244|12344204|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1
7857605|NCT01557244|12344205|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7857606|NCT01557244|12344206|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7857607|NCT01557244|12344207|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7857608|NCT01557244|12344208|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7857609|NCT01557244|12344209|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7857610|NCT01557244|12344203|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7857611|NCT01557244|12344204|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7857612|NCT01557244|12344205|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7857613|NCT01557244|12344206|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7857614|NCT01557244|12344207|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7857615|NCT01557244|12344208|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
7857616|NCT01557244|12344209|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
7857617|NCT01557244|12344203|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7857618|NCT01557244|12344204|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
7857619|NCT01557244|12344205|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
7857620|NCT01557244|12344206|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7857621|NCT01557244|12344207|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7857622|NCT01557244|12344208|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
7857623|NCT01557244|12344209|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7857624|NCT01557244|12344203|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2
7857625|NCT01557244|12344204|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0
7857626|NCT01557244|12344205|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2
7857627|NCT01557244|12344206|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0
7857628|NCT01557244|12344207|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0
7857629|NCT01557244|12344208|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0
7857630|NCT01557244|12344209|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0
7857631|NCT01557244|12344203|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1
7857632|NCT01557244|12344204|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1
7857633|NCT01557244|12344205|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0
7857634|NCT01557244|12344206|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0
7857635|NCT01557244|12344207|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0
7857636|NCT01557244|12344208|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1
7857637|NCT01557244|12344209|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0
7857638|NCT01557244|12344203|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
7857639|NCT01557244|12344204|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
7857640|NCT01557244|12344205|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7857641|NCT01557244|12344206|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7857642|NCT01557244|12344207|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7857643|NCT01557244|12344208|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7857644|NCT01557244|12344209|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7857645|NCT01557244|12344203|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7857646|NCT01557244|12344204|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7857647|NCT01557244|12344205|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7857648|NCT01557244|12344206|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1
7857649|NCT01557244|12344207|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7857650|NCT01557244|12344208|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7857651|NCT01557244|12344209|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7857652|NCT01557244|12344203|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1
7857653|NCT01557244|12344204|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2
7857654|NCT01557244|12344205|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7857655|NCT01557244|12344206|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7857656|NCT01557244|12344207|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7857657|NCT01557244|12344208|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7857658|NCT01557244|12344209|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7857659|NCT01557283|12344237|FG000|Overall Study|Lost to Follow-up|7
7857660|NCT01557283|12344237|FG000|Overall Study|Non-responder|19
7857661|NCT01557283|12344237|FG000|Overall Study|Adverse Event|7
7857662|NCT01557283|12344237|FG000|Overall Study|Lack of Efficacy|1
7857663|NCT01557283|12344237|FG000|Overall Study|Non-compliance|1
7857664|NCT01557283|12344237|FG000|Overall Study|Withdrawal by Subject|1
7857665|NCT01557283|12344237|FG000|Overall Study|Participant's weight too high for dose|1
7857666|NCT01557283|12344237|FG000|Overall Study|Worsening of psoriasis|1
7857667|NCT01557283|12344237|FG000|Overall Study|Other|6
7857668|NCT01557348|12344252|FG000|Overall Study|Adverse Event|6
7857669|NCT01557348|12344253|FG001|Overall Study|Adverse Event|16
7857670|NCT01557348|12344252|FG000|Overall Study|Infusion reaction event|5
7857671|NCT01557348|12344253|FG001|Overall Study|Infusion reaction event|5
7857672|NCT01557348|12344252|FG000|Overall Study|Death|7
7857673|NCT01557348|12344253|FG001|Overall Study|Death|4
7857674|NCT01557348|12344252|FG000|Overall Study|Insufficient Therapeutic Response|13
7857675|NCT01557348|12344253|FG001|Overall Study|Insufficient Therapeutic Response|28
7857676|NCT01557348|12344252|FG000|Overall Study|Withdrawal by Subject|5
7857677|NCT01557348|12344253|FG001|Overall Study|Withdrawal by Subject|4
7857678|NCT01557348|12344252|FG000|Overall Study|Lost to Follow-up|26
7857679|NCT01557348|12344253|FG001|Overall Study|Lost to Follow-up|22
7857680|NCT01557348|12344252|FG000|Overall Study|Administrative|18
7857681|NCT01557348|12344253|FG001|Overall Study|Administrative|11
7857682|NCT01557400|12344260|FG000|Overall Study|Transitioned to Commercial Drug Product|40
7857683|NCT01557400|12344260|FG000|Overall Study|Adverse Event|3
7857684|NCT01557400|12344260|FG000|Overall Study|Lost to Follow-up|5
7857685|NCT01557400|12344260|FG000|Overall Study|Withdrawal by Subject|9
7857686|NCT01557504|12344271|FG000|Overall Study|Physician Decision|1
7857687|NCT01557504|12344272|FG001|Overall Study|Physician Decision|0
7857688|NCT01557517|12344286|FG000|Overall Study|Death|1
7857689|NCT01557517|12344287|FG001|Overall Study|Death|0
7857690|NCT01557517|12344286|FG000|Overall Study|Refused further treatment|0
7857691|NCT01557517|12344287|FG001|Overall Study|Refused further treatment|2
7857692|NCT01557517|12344286|FG000|Overall Study|Adverse Event|0
7857693|NCT01557517|12344287|FG001|Overall Study|Adverse Event|2
7857694|NCT01557517|12344286|FG000|Overall Study|Pt declined before treatment started|1
7857695|NCT01557517|12344287|FG001|Overall Study|Pt declined before treatment started|0
7857696|NCT01557569|12344302|FG000|Overall Study|Adverse Event|2
7857697|NCT01557569|12344303|FG001|Overall Study|Adverse Event|0
7857698|NCT01557569|12344302|FG000|Overall Study|high blood pressure|0
7857699|NCT01557569|12344303|FG001|Overall Study|high blood pressure|1
7857700|NCT01557569|12344302|FG000|Overall Study|Withdrawal by Subject|3
7857701|NCT01557569|12344303|FG001|Overall Study|Withdrawal by Subject|5
7857702|NCT01557569|12344302|FG000|Overall Study|noncompliance with rules of residential|0
7857703|NCT01557569|12344303|FG001|Overall Study|noncompliance with rules of residential|1
7857704|NCT01557582|12344309|FG000|Overall Study|Protocol Violation|4
7857705|NCT01557582|12344309|FG000|Overall Study|Operator error|2
7857706|NCT01557842|12344339|FG000|Overall Study|Lost to Follow-up|0
7857707|NCT01557842|12344340|FG001|Overall Study|Lost to Follow-up|1
7857708|NCT01557842|12344339|FG000|Overall Study|Death|1
7857709|NCT01557842|12344340|FG001|Overall Study|Death|0
7857710|NCT01557842|12344339|FG000|Overall Study|Lack of Efficacy|0
7949825|NCT02543658|12495830|FG001|Overall Study|Lack of Efficacy|4
7949826|NCT02543801|12495852|FG000|Overall Study|Protocol Violation|1
7949827|NCT02543801|12495853|FG001|Overall Study|Protocol Violation|2
7949828|NCT02543801|12495854|FG002|Overall Study|Protocol Violation|0
7949829|NCT02543801|12495855|FG003|Overall Study|Protocol Violation|0
7949830|NCT02543892|12495883|FG000|Received Vaccination 2|Withdrawal by Subject|1
7949831|NCT02543892|12495884|FG001|Received Vaccination 2|Withdrawal by Subject|0
7949832|NCT02543892|12495885|FG002|Received Vaccination 2|Withdrawal by Subject|0
7949833|NCT02543892|12495886|FG003|Received Vaccination 2|Withdrawal by Subject|0
7949834|NCT02543892|12495887|FG004|Received Vaccination 2|Withdrawal by Subject|0
7949835|NCT02543892|12495888|FG005|Received Vaccination 2|Withdrawal by Subject|0
7949836|NCT02543892|12495889|FG006|Received Vaccination 2|Withdrawal by Subject|0
7949837|NCT02543892|12495890|FG007|Received Vaccination 2|Withdrawal by Subject|1
7857711|NCT01557842|12344340|FG001|Overall Study|Lack of Efficacy|1
7857712|NCT01557842|12344339|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
7857713|NCT01557842|12344340|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
7857714|NCT01557842|12344339|FG000|Overall Study|Study Terminated by Sponsor|3
7857715|NCT01557842|12344340|FG001|Overall Study|Study Terminated by Sponsor|4
7857716|NCT01557842|12344339|FG000|Overall Study|Not Ablated|2
7857717|NCT01557842|12344340|FG001|Overall Study|Not Ablated|0
7857718|NCT01557920|12344365|FG000|Overall Study|Withdrawal by Subject|2
7857719|NCT01557920|12344366|FG001|Overall Study|Withdrawal by Subject|3
7857720|NCT01557920|12344365|FG000|Overall Study|Lack of Efficacy|1
7857721|NCT01557920|12344366|FG001|Overall Study|Lack of Efficacy|0
7857722|NCT01557946|12344401|FG000|Overall Study|Adverse Event|3
7857723|NCT01557946|12344402|FG001|Overall Study|Adverse Event|0
7857724|NCT01558089|12344433|FG000|Overall Study|Adverse Event|1
7857725|NCT01558089|12344433|FG000|Overall Study|Lack of Efficacy|1
7857726|NCT01558089|12344433|FG000|Overall Study|Lost to Follow-up|5
7857727|NCT01558089|12344433|FG000|Overall Study|Withdrawal by Subject|6
7857728|NCT01558271|12344444|FG000|Overall Study|Adverse Event|6
7857729|NCT01558271|12344445|FG001|Overall Study|Adverse Event|3
7857730|NCT01558271|12344446|FG002|Overall Study|Adverse Event|4
7857731|NCT01558271|12344444|FG000|Overall Study|Lost to Follow-up|1
7857732|NCT01558271|12344445|FG001|Overall Study|Lost to Follow-up|0
7857733|NCT01558271|12344446|FG002|Overall Study|Lost to Follow-up|0
7857734|NCT01558271|12344444|FG000|Overall Study|Protocol Violation|1
7857735|NCT01558271|12344445|FG001|Overall Study|Protocol Violation|0
7857736|NCT01558271|12344446|FG002|Overall Study|Protocol Violation|0
7857737|NCT01558271|12344444|FG000|Overall Study|Withdrawal by Subject|10
7857738|NCT01558271|12344445|FG001|Overall Study|Withdrawal by Subject|6
7857739|NCT01558271|12344446|FG002|Overall Study|Withdrawal by Subject|12
7857740|NCT01558271|12344444|FG000|Overall Study|Physician Decision|0
7857741|NCT01558271|12344445|FG001|Overall Study|Physician Decision|2
7857742|NCT01558271|12344446|FG002|Overall Study|Physician Decision|1
7857743|NCT01558297|12344461|FG000|Overall Study|Withdrawal by Subject|2
7857744|NCT01558297|12344462|FG001|Overall Study|Withdrawal by Subject|2
7857745|NCT01558297|12344463|FG002|Overall Study|Withdrawal by Subject|1
7857746|NCT01558596|12344473|FG000|Overall Study|Withdrawal by Subject|1
7857747|NCT01558596|12344474|FG001|Overall Study|Withdrawal by Subject|0
7857748|NCT01558596|12344473|FG000|Overall Study|surgery elsewhere or cancelled|1
7857749|NCT01558596|12344474|FG001|Overall Study|surgery elsewhere or cancelled|1
7857750|NCT01558596|12344473|FG000|Overall Study|Protocol Violation|1
7857751|NCT01558596|12344474|FG001|Overall Study|Protocol Violation|0
7949838|NCT02543892|12495883|FG000|Received Vaccination 2|Physician Decision|0
7949839|NCT02543892|12495884|FG001|Received Vaccination 2|Physician Decision|0
7949840|NCT02543892|12495885|FG002|Received Vaccination 2|Physician Decision|0
7949841|NCT02543892|12495886|FG003|Received Vaccination 2|Physician Decision|0
7949842|NCT02543892|12495887|FG004|Received Vaccination 2|Physician Decision|0
7949843|NCT02543892|12495888|FG005|Received Vaccination 2|Physician Decision|1
7949844|NCT02543892|12495889|FG006|Received Vaccination 2|Physician Decision|0
7949845|NCT02543892|12495890|FG007|Received Vaccination 2|Physician Decision|0
7949846|NCT02543892|12495883|FG000|Received Vaccination 2|Adverse Event|0
7949847|NCT02543892|12495884|FG001|Received Vaccination 2|Adverse Event|1
7949848|NCT02543892|12495885|FG002|Received Vaccination 2|Adverse Event|0
7949849|NCT02543892|12495886|FG003|Received Vaccination 2|Adverse Event|0
7949850|NCT02543892|12495887|FG004|Received Vaccination 2|Adverse Event|0
7949851|NCT02543892|12495888|FG005|Received Vaccination 2|Adverse Event|0
7949852|NCT02543892|12495889|FG006|Received Vaccination 2|Adverse Event|0
7949853|NCT02543892|12495890|FG007|Received Vaccination 2|Adverse Event|0
7949854|NCT02543892|12495883|FG000|Had Immunology Data|Withdrawal by Subject|0
7949855|NCT02543892|12495884|FG001|Had Immunology Data|Withdrawal by Subject|0
7949856|NCT02543892|12495885|FG002|Had Immunology Data|Withdrawal by Subject|0
7949857|NCT02543892|12495886|FG003|Had Immunology Data|Withdrawal by Subject|0
7949858|NCT02543892|12495887|FG004|Had Immunology Data|Withdrawal by Subject|0
7857752|NCT01558635|12344480|FG000|Overall Study|Death|1
7857753|NCT01558635|12344480|FG000|Overall Study|Withdrawal by Subject|2
7857754|NCT01558635|12344480|FG000|Overall Study|Physician Decision|1
7857755|NCT01558635|12344480|FG000|Overall Study|Subject received other treatment|1
7857756|NCT01558635|12344480|FG000|Overall Study|Reveal XT was explanted|1
7857757|NCT01558674|12344497|FG000|Part 1|Study Terminated by Sponsor|10
7857758|NCT01558674|12344498|FG001|Part 1|Study Terminated by Sponsor|0
7857759|NCT01558674|12344497|FG000|Part 1|Withdrawal by Subject|1
7857760|NCT01558674|12344498|FG001|Part 1|Withdrawal by Subject|0
7857761|NCT01558739|12344526|FG000|Overall Study|Adverse Event|7
7857762|NCT01558739|12344526|FG000|Overall Study|Withdrawal by Subject|2
7857763|NCT01558739|12344526|FG000|Overall Study|Death|3
7857764|NCT01558739|12344526|FG000|Overall Study|Disease Progression|4
7857765|NCT01558739|12344526|FG000|Overall Study|Protocol Violation|1
7857766|NCT01558752|12344532|FG000|Overall Study|Physician Decision|2
7857767|NCT01558752|12344533|FG001|Overall Study|Physician Decision|0
7857768|NCT01559012|12344552|FG000|Overall Study|Withdrawal by Subject|0
7857769|NCT01559012|12344553|FG001|Overall Study|Withdrawal by Subject|1
7857770|NCT01559090|12344590|FG000|Stage I|Withdrawal by Subject|2
7857771|NCT01559090|12344591|FG001|Stage I|Withdrawal by Subject|2
7857772|NCT01559090|12344592|FG002|Stage I|Withdrawal by Subject|3
7857773|NCT01559090|12344590|FG000|Stage II|Withdrawal by Subject|1
7857774|NCT01559090|12344591|FG001|Stage II|Withdrawal by Subject|0
7857775|NCT01559090|12344592|FG002|Stage II|Withdrawal by Subject|0
7857776|NCT01559116|12344600|FG000|Overall Study|Adverse Event|10
7857777|NCT01559116|12344600|FG000|Overall Study|Lack of Efficacy|1
7857778|NCT01559116|12344600|FG000|Overall Study|Lost to Follow-up|1
7857779|NCT01559116|12344600|FG000|Overall Study|Protocol Violation|1
7857780|NCT01559116|12344600|FG000|Overall Study|Withdrawal by Subject|4
7857781|NCT01559116|12344600|FG000|Overall Study|other than stated above|9
7857782|NCT01559129|12344619|FG000|Treatment Phase|Adverse Event|0
7857783|NCT01559129|12344620|FG001|Treatment Phase|Adverse Event|2
7857784|NCT01559129|12344619|FG000|Treatment Phase|Progressive Disease|1
7857785|NCT01559129|12344620|FG001|Treatment Phase|Progressive Disease|1
7857786|NCT01559129|12344619|FG000|Treatment Phase|Lack of Efficacy|0
7857787|NCT01559129|12344620|FG001|Treatment Phase|Lack of Efficacy|1
7857788|NCT01559129|12344619|FG000|Treatment Phase|Study Terminated by Sponsor|3
7857789|NCT01559129|12344620|FG001|Treatment Phase|Study Terminated by Sponsor|2
7857790|NCT01559129|12344619|FG000|Treatment Phase|Protocol Exclusion Criteria|1
7857791|NCT01559129|12344620|FG001|Treatment Phase|Protocol Exclusion Criteria|0
7857792|NCT01559129|12344619|FG000|Treatment Phase|Did Not Receive Study Drug|0
7857793|NCT01559129|12344620|FG001|Treatment Phase|Did Not Receive Study Drug|1
7857794|NCT01559129|12344619|FG000|Open-label Extension Period|Adverse Event|1
7857795|NCT01559129|12344620|FG001|Open-label Extension Period|Adverse Event|0
7857796|NCT01559129|12344619|FG000|Open-label Extension Period|Study Terminated by Sponsor|5
7857797|NCT01559129|12344620|FG001|Open-label Extension Period|Study Terminated by Sponsor|2
7857798|NCT01559259|12344637|FG000|Overall Study|Withdrawal by Subject|0
7857799|NCT01559259|12344638|FG001|Overall Study|Withdrawal by Subject|0
7857800|NCT01559259|12344639|FG002|Overall Study|Withdrawal by Subject|0
7857801|NCT01559259|12344640|FG003|Overall Study|Withdrawal by Subject|1
7857802|NCT01559259|12344641|FG004|Overall Study|Withdrawal by Subject|0
7857803|NCT01559259|12344637|FG000|Overall Study|Adverse Event|0
7857804|NCT01559259|12344638|FG001|Overall Study|Adverse Event|1
7857805|NCT01559259|12344639|FG002|Overall Study|Adverse Event|1
7857806|NCT01559259|12344640|FG003|Overall Study|Adverse Event|0
7857807|NCT01559259|12344641|FG004|Overall Study|Adverse Event|0
7857808|NCT01559311|12344656|FG000|Overall Study|Protocol Violation|0
7857809|NCT01559311|12344657|FG001|Overall Study|Protocol Violation|0
7857810|NCT01559311|12344658|FG002|Overall Study|Protocol Violation|2
7857811|NCT01559311|12344656|FG000|Overall Study|Difficulty in cannulating the lateral ve|1
7857812|NCT01559311|12344657|FG001|Overall Study|Difficulty in cannulating the lateral ve|0
7857813|NCT01559311|12344658|FG002|Overall Study|Difficulty in cannulating the lateral ve|0
7857814|NCT01559311|12344656|FG000|Overall Study|Withdrawal by Subject|2
7857815|NCT01559311|12344657|FG001|Overall Study|Withdrawal by Subject|1
7857816|NCT01559311|12344658|FG002|Overall Study|Withdrawal by Subject|0
7857817|NCT01559311|12344656|FG000|Overall Study|Death|0
7857818|NCT01559311|12344657|FG001|Overall Study|Death|2
7857819|NCT01559311|12344658|FG002|Overall Study|Death|3
7857820|NCT01559311|12344656|FG000|Overall Study|Lost to Follow-up|0
7857821|NCT01559311|12344657|FG001|Overall Study|Lost to Follow-up|3
7857822|NCT01559311|12344658|FG002|Overall Study|Lost to Follow-up|2
7857823|NCT01559311|12344656|FG000|Overall Study|Adverse Event|0
7857824|NCT01559311|12344657|FG001|Overall Study|Adverse Event|0
7857825|NCT01559311|12344658|FG002|Overall Study|Adverse Event|1
7857826|NCT01559389|12344668|FG000|Overall Study|Withdrawal by Subject|20
7857827|NCT01559389|12344669|FG001|Overall Study|Withdrawal by Subject|20
7857828|NCT01559454|12344681|FG000|Overall Study|Lost to Follow-up|3
7857829|NCT01559454|12344682|FG001|Overall Study|Lost to Follow-up|2
7857830|NCT01559454|12344681|FG000|Overall Study|Withdrawal by Subject|0
7857831|NCT01559454|12344682|FG001|Overall Study|Withdrawal by Subject|1
7857832|NCT01559454|12344681|FG000|Overall Study|Physician Decision|0
7857833|NCT01559454|12344682|FG001|Overall Study|Physician Decision|1
7857834|NCT01559454|12344681|FG000|Overall Study|Protocol Violation|0
7857835|NCT01559454|12344682|FG001|Overall Study|Protocol Violation|1
7857836|NCT01559454|12344681|FG000|Overall Study|Lack of Efficacy|0
7857837|NCT01559454|12344682|FG001|Overall Study|Lack of Efficacy|1
7863750|NCT01607905|12353160|FG005|Overall Study|Other treatments become available|0
7863751|NCT01607905|12353161|FG006|Overall Study|Other treatments become available|1
7863752|NCT01607905|12353155|FG000|Overall Study|Investigator discretion|0
7863753|NCT01607905|12353156|FG001|Overall Study|Investigator discretion|0
7863754|NCT01607905|12353157|FG002|Overall Study|Investigator discretion|0
7863755|NCT01607905|12353158|FG003|Overall Study|Investigator discretion|0
7863756|NCT01607905|12353159|FG004|Overall Study|Investigator discretion|0
7863757|NCT01607905|12353160|FG005|Overall Study|Investigator discretion|1
7863758|NCT01607905|12353161|FG006|Overall Study|Investigator discretion|0
7863759|NCT01607905|12353155|FG000|Overall Study|Other|1
7863760|NCT01607905|12353156|FG001|Overall Study|Other|0
7863761|NCT01607905|12353157|FG002|Overall Study|Other|0
7863762|NCT01607905|12353158|FG003|Overall Study|Other|0
7863763|NCT01607905|12353159|FG004|Overall Study|Other|0
7863764|NCT01607905|12353160|FG005|Overall Study|Other|0
7863765|NCT01607905|12353161|FG006|Overall Study|Other|1
7863766|NCT01607905|12353155|FG000|Overall Study|Randomized but not treated|1
7863767|NCT01607905|12353156|FG001|Overall Study|Randomized but not treated|0
7863768|NCT01607905|12353157|FG002|Overall Study|Randomized but not treated|0
7863769|NCT01607905|12353158|FG003|Overall Study|Randomized but not treated|0
7863770|NCT01607905|12353159|FG004|Overall Study|Randomized but not treated|1
7863771|NCT01607905|12353160|FG005|Overall Study|Randomized but not treated|1
7863772|NCT01607905|12353161|FG006|Overall Study|Randomized but not treated|0
7863773|NCT01607957|12353221|FG000|Overall Study|Not treated|1
7863774|NCT01607957|12353222|FG001|Overall Study|Not treated|1
7863775|NCT01607957|12353221|FG000|Overall Study|Death|367
7863776|NCT01607957|12353222|FG001|Overall Study|Death|211
7863777|NCT01607957|12353221|FG000|Overall Study|Lost to Follow-up|3
7863778|NCT01607957|12353222|FG001|Overall Study|Lost to Follow-up|3
7863779|NCT01607957|12353221|FG000|Overall Study|Participant refusal|1
7863780|NCT01607957|12353222|FG001|Overall Study|Participant refusal|0
7863781|NCT01608087|12353241|FG000|Overall Study|Lost to Follow-up|0
7863782|NCT01608087|12353242|FG001|Overall Study|Lost to Follow-up|1
7863783|NCT01608087|12353243|FG002|Overall Study|Lost to Follow-up|0
7863784|NCT01608087|12353241|FG000|Overall Study|Other Reason|0
7863785|NCT01608087|12353242|FG001|Overall Study|Other Reason|1
7863786|NCT01608087|12353243|FG002|Overall Study|Other Reason|0
7863787|NCT01608308|12353289|FG000|Overall Study|pretreatment medical and billing reasons|0
7863788|NCT01608308|12353290|FG001|Overall Study|pretreatment medical and billing reasons|2
7863789|NCT01608321|12353298|FG000|Overall Study|Withdrawal by Subject|1
7863790|NCT01608321|12353299|FG001|Overall Study|Withdrawal by Subject|0
7863791|NCT01608724|12353322|FG000|Overall Study|Withdrawal by Subject|131
7863792|NCT01608724|12353322|FG000|Overall Study|Lost to Follow-up|41
7863793|NCT01608724|12353322|FG000|Overall Study|Study-specific discontinuation criteria|32
7863794|NCT01608724|12353322|FG000|Overall Study|Adverse Event|29
7863795|NCT01608724|12353322|FG000|Overall Study|Protocol Violation|6
7863796|NCT01608724|12353322|FG000|Overall Study|bood sugar too high, etc.|3
7863797|NCT01608724|12353322|FG000|Overall Study|Safety reasons|1
7863798|NCT01609010|12353353|FG000|Overall Study|Stable disease (SD)|22
7863799|NCT01609010|12353354|FG001|Overall Study|Stable disease (SD)|16
7863800|NCT01609010|12353353|FG000|Overall Study|Progressive disease (PD)|8
7863801|NCT01609010|12353354|FG001|Overall Study|Progressive disease (PD)|10
7863802|NCT01609010|12353353|FG000|Overall Study|Adverse Event|3
7863803|NCT01609010|12353354|FG001|Overall Study|Adverse Event|6
7863804|NCT01609010|12353353|FG000|Overall Study|Withdrawal by Subject|2
7863805|NCT01609010|12353354|FG001|Overall Study|Withdrawal by Subject|2
7863806|NCT01609010|12353353|FG000|Overall Study|Other|2
7863807|NCT01609010|12353354|FG001|Overall Study|Other|0
7863808|NCT01609010|12353353|FG000|Overall Study|Other malignancy|1
7863809|NCT01609010|12353354|FG001|Overall Study|Other malignancy|0
7863810|NCT01609010|12353353|FG000|Overall Study|Pathology review|2
7863811|NCT01609010|12353354|FG001|Overall Study|Pathology review|1
7863812|NCT01609010|12353353|FG000|Overall Study|Protocol Violation|1
7863813|NCT01609010|12353354|FG001|Overall Study|Protocol Violation|1
7863814|NCT01609010|12353353|FG000|Overall Study|New cancer|1
7863815|NCT01609010|12353354|FG001|Overall Study|New cancer|0
7863816|NCT01609010|12353353|FG000|Overall Study|Lost to Follow-up|1
7863817|NCT01609010|12353354|FG001|Overall Study|Lost to Follow-up|1
7857838|NCT01559675|12344709|FG000|Overall Study|Protocol Violation|1
7857839|NCT01559675|12344710|FG001|Overall Study|Protocol Violation|2
7857840|NCT01559675|12344709|FG000|Overall Study|2nd operation on same patient excluded|14
7857841|NCT01559675|12344710|FG001|Overall Study|2nd operation on same patient excluded|12
7857842|NCT01559844|12344716|FG000|Overall Study|Consent Withdrawn|7
7857843|NCT01559844|12344716|FG000|Overall Study|Death|5
7857844|NCT01559844|12344716|FG000|Overall Study|Efficacy Failure|10
7857845|NCT01559844|12344716|FG000|Overall Study|No Longer A Transplant Candidate|3
7857846|NCT01560234|12344765|FG000|Overall Study|Lost to Follow-up|3
7857847|NCT01560234|12344766|FG001|Overall Study|Lost to Follow-up|0
7857848|NCT01560234|12344767|FG002|Overall Study|Lost to Follow-up|1
7857849|NCT01560234|12344768|FG003|Overall Study|Lost to Follow-up|0
7857850|NCT01560234|12344769|FG004|Overall Study|Lost to Follow-up|0
7857851|NCT01560234|12344770|FG005|Overall Study|Lost to Follow-up|2
7857852|NCT01560234|12344771|FG006|Overall Study|Lost to Follow-up|0
7857853|NCT01560234|12344772|FG007|Overall Study|Lost to Follow-up|2
7857854|NCT01560403|12344806|FG000|Overall Study|Lost to Follow-up|0
7857855|NCT01560403|12344807|FG001|Overall Study|Lost to Follow-up|1
7857856|NCT01560416|12344815|FG000|Randomized Phase|Crossover Participants|7
7949859|NCT02543892|12495888|FG005|Had Immunology Data|Withdrawal by Subject|0
7949860|NCT02543892|12495889|FG006|Had Immunology Data|Withdrawal by Subject|1
7949861|NCT02543892|12495890|FG007|Had Immunology Data|Withdrawal by Subject|0
7949862|NCT02543918|12495915|FG000|Overall Study|Never treated|0
7949863|NCT02543918|12495916|FG001|Overall Study|Never treated|1
7949864|NCT02543918|12495915|FG000|Overall Study|Lost to Follow-up|1
7949865|NCT02543918|12495916|FG001|Overall Study|Lost to Follow-up|1
7949866|NCT02543918|12495915|FG000|Overall Study|Withdrawal by Subject|1
7949867|NCT02543918|12495916|FG001|Overall Study|Withdrawal by Subject|1
7949868|NCT02543918|12495915|FG000|Overall Study|Adverse Event|1
7949869|NCT02543918|12495916|FG001|Overall Study|Adverse Event|1
7949870|NCT02544113|12495924|FG000|Overall Study|Death|3
7949871|NCT02544113|12495925|FG001|Overall Study|Death|4
7949872|NCT02544152|12495933|FG000|Overall Study|Adverse Event|0
7949873|NCT02544152|12495934|FG001|Overall Study|Adverse Event|4
7949874|NCT02544152|12495933|FG000|Overall Study|Withdrawal by Subject|0
7949875|NCT02544152|12495934|FG001|Overall Study|Withdrawal by Subject|3
7949876|NCT02544152|12495933|FG000|Overall Study|Other|1
7949877|NCT02544152|12495934|FG001|Overall Study|Other|0
7949878|NCT02544217|12495946|FG000|Overall Study|Withdrawal by Subject|1
7857857|NCT01560416|12344816|FG001|Randomized Phase|Crossover Participants|0
7857858|NCT01560429|12344826|FG000|Overall Study|Protocol Violation|3
7857859|NCT01560429|12344827|FG001|Overall Study|Protocol Violation|6
7857860|NCT01560780|12344846|FG000|Overall Study|Death|2
7857861|NCT01560780|12344847|FG001|Overall Study|Death|1
7857862|NCT01560780|12344846|FG000|Overall Study|Patient Preference|11
7857863|NCT01560780|12344847|FG001|Overall Study|Patient Preference|11
7857864|NCT01560819|12344855|FG000|Overall Study|Physician Decision|1
7857865|NCT01560819|12344856|FG001|Overall Study|Physician Decision|0
7857866|NCT01560871|12344862|FG000|Overall Study|transportation issues|2
7857867|NCT01560871|12344863|FG001|Overall Study|transportation issues|1
7857868|NCT01560871|12344862|FG000|Overall Study|relocation|1
7857869|NCT01560871|12344863|FG001|Overall Study|relocation|0
7857870|NCT01560871|12344862|FG000|Overall Study|readmission to a hospital|2
7857871|NCT01560871|12344863|FG001|Overall Study|readmission to a hospital|1
7857872|NCT01560871|12344862|FG000|Overall Study|Lost to Follow-up|1
7857873|NCT01560871|12344863|FG001|Overall Study|Lost to Follow-up|0
7857874|NCT01560949|12344879|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6
7857875|NCT01560949|12344879|FG000|Surgery Phase|Physician Decision|3
7857876|NCT01560988|12344895|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7
7857877|NCT01560988|12344896|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4
7857878|NCT01560988|12344895|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3
7857879|NCT01560988|12344896|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0
7857880|NCT01560988|12344895|FG000|Washout (Six Weeks)|Lost to Follow-up|2
7857881|NCT01560988|12344896|FG001|Washout (Six Weeks)|Lost to Follow-up|2
7857882|NCT01561079|12344925|FG000|Overall Study|Physician Decision|17
7857883|NCT01561079|12344925|FG000|Overall Study|Withdrawal by Subject|59
7857884|NCT01561079|12344925|FG000|Overall Study|Protocol Violation|2
7857885|NCT01561300|12344968|FG000|Run in on Placebo|Adverse Event|1
7857886|NCT01561300|12344969|FG001|Run in on Placebo|Adverse Event|0
7857887|NCT01561313|12344978|FG000|Overall Study|Withdrawal by Subject|1
7857888|NCT01561313|12344979|FG001|Overall Study|Withdrawal by Subject|0
7857889|NCT01561313|12344978|FG000|Overall Study|Adverse event and withdrawal by subject|1
7857890|NCT01561313|12344979|FG001|Overall Study|Adverse event and withdrawal by subject|0
7857891|NCT01561560|12344994|FG000|First Two Weeks of Wear|Time/job conflict|0
7857892|NCT01561560|12344995|FG001|First Two Weeks of Wear|Time/job conflict|1
7857893|NCT01561560|12344994|FG000|First Two Weeks of Wear|Adverse Event|0
7857894|NCT01561560|12344995|FG001|First Two Weeks of Wear|Adverse Event|1
7857895|NCT01561560|12344994|FG000|Second Two Weeks of Wear|Adverse Event|0
7857896|NCT01561560|12344995|FG001|Second Two Weeks of Wear|Adverse Event|1
7857897|NCT01561755|12345037|FG000|Overall Study|Lost to Follow-up|0
7949879|NCT02544217|12495947|FG001|Overall Study|Withdrawal by Subject|1
7949880|NCT02544217|12495948|FG002|Overall Study|Withdrawal by Subject|0
7949881|NCT02544217|12495949|FG003|Overall Study|Withdrawal by Subject|0
7857898|NCT01561755|12345038|FG001|Overall Study|Lost to Follow-up|1
7857899|NCT01561898|12345052|FG000|Overall Study|Withdrawal by Subject|0
7857900|NCT01561898|12345053|FG001|Overall Study|Withdrawal by Subject|8
7857901|NCT01561898|12345054|FG002|Overall Study|Withdrawal by Subject|12
7857902|NCT01561898|12345055|FG003|Overall Study|Withdrawal by Subject|5
7857903|NCT01561898|12345052|FG000|Overall Study|Lack of Efficacy|0
7857904|NCT01561898|12345053|FG001|Overall Study|Lack of Efficacy|8
7857905|NCT01561898|12345054|FG002|Overall Study|Lack of Efficacy|10
7857906|NCT01561898|12345055|FG003|Overall Study|Lack of Efficacy|5
7857907|NCT01561898|12345052|FG000|Overall Study|Worsening of complications|0
7857908|NCT01561898|12345053|FG001|Overall Study|Worsening of complications|1
7857909|NCT01561898|12345054|FG002|Overall Study|Worsening of complications|0
7857910|NCT01561898|12345055|FG003|Overall Study|Worsening of complications|0
7857911|NCT01561898|12345052|FG000|Overall Study|Lost to Follow-up|0
7857912|NCT01561898|12345053|FG001|Overall Study|Lost to Follow-up|0
7857913|NCT01561898|12345054|FG002|Overall Study|Lost to Follow-up|1
7857914|NCT01561898|12345055|FG003|Overall Study|Lost to Follow-up|0
7857915|NCT01561898|12345052|FG000|Overall Study|Adverse Event|1
7857916|NCT01561898|12345053|FG001|Overall Study|Adverse Event|19
7857917|NCT01561898|12345054|FG002|Overall Study|Adverse Event|14
7857918|NCT01561898|12345055|FG003|Overall Study|Adverse Event|9
7857919|NCT01561898|12345052|FG000|Overall Study|Physician Decision|1
7857920|NCT01561898|12345053|FG001|Overall Study|Physician Decision|5
7857921|NCT01561898|12345054|FG002|Overall Study|Physician Decision|7
7857922|NCT01561898|12345055|FG003|Overall Study|Physician Decision|1
7857923|NCT01561963|12345063|FG000|Overall Study|Adverse Event|1
7857924|NCT01561976|12345078|FG000|Period 1|Adverse Event|0
7857925|NCT01561976|12345079|FG001|Period 1|Adverse Event|0
7857926|NCT01561976|12345080|FG002|Period 1|Adverse Event|1
7857927|NCT01561976|12345081|FG003|Period 1|Adverse Event|0
7857928|NCT01561976|12345082|FG004|Period 1|Adverse Event|0
7857929|NCT01561976|12345083|FG005|Period 1|Adverse Event|0
7857930|NCT01561976|12345078|FG000|Washout Period 1 (7 Days)|Adverse Event|0
7857931|NCT01561976|12345079|FG001|Washout Period 1 (7 Days)|Adverse Event|0
7857932|NCT01561976|12345080|FG002|Washout Period 1 (7 Days)|Adverse Event|0
7857933|NCT01561976|12345081|FG003|Washout Period 1 (7 Days)|Adverse Event|1
7857934|NCT01561976|12345082|FG004|Washout Period 1 (7 Days)|Adverse Event|0
7857935|NCT01561976|12345083|FG005|Washout Period 1 (7 Days)|Adverse Event|0
7857936|NCT01561976|12345078|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7857937|NCT01561976|12345079|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7857938|NCT01561976|12345080|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7857939|NCT01561976|12345081|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7857940|NCT01561976|12345082|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7857941|NCT01561976|12345083|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7857942|NCT01561976|12345078|FG000|Washout Period 2 (7 Days)|Non-compliance|1
7857943|NCT01561976|12345079|FG001|Washout Period 2 (7 Days)|Non-compliance|0
7857944|NCT01561976|12345080|FG002|Washout Period 2 (7 Days)|Non-compliance|1
7857945|NCT01561976|12345081|FG003|Washout Period 2 (7 Days)|Non-compliance|0
7857946|NCT01561976|12345082|FG004|Washout Period 2 (7 Days)|Non-compliance|0
7857947|NCT01561976|12345083|FG005|Washout Period 2 (7 Days)|Non-compliance|0
7857948|NCT01562275|12345117|FG000|Stage 1|Adverse Event|0
7857949|NCT01562275|12345118|FG001|Stage 1|Adverse Event|0
7857950|NCT01562275|12345119|FG002|Stage 1|Adverse Event|0
7857951|NCT01562275|12345120|FG003|Stage 1|Adverse Event|1
7857952|NCT01562275|12345121|FG004|Stage 1|Adverse Event|1
7857953|NCT01562275|12345122|FG005|Stage 1|Adverse Event|0
7857954|NCT01562275|12345123|FG006|Stage 1|Adverse Event|0
7857955|NCT01562275|12345124|FG007|Stage 1|Adverse Event|0
7857956|NCT01562275|12345125|FG008|Stage 1|Adverse Event|0
7857957|NCT01562275|12345126|FG009|Stage 1|Adverse Event|1
7857958|NCT01562275|12345127|FG010|Stage 1|Adverse Event|0
7857959|NCT01562275|12345128|FG011|Stage 1|Adverse Event|0
7857960|NCT01562275|12345129|FG012|Stage 1|Adverse Event|0
7857961|NCT01562275|12345117|FG000|Stage 1|Death|1
7857962|NCT01562275|12345118|FG001|Stage 1|Death|0
7857963|NCT01562275|12345119|FG002|Stage 1|Death|0
7857964|NCT01562275|12345120|FG003|Stage 1|Death|0
7857965|NCT01562275|12345121|FG004|Stage 1|Death|0
7857966|NCT01562275|12345122|FG005|Stage 1|Death|0
7857967|NCT01562275|12345123|FG006|Stage 1|Death|0
7857968|NCT01562275|12345124|FG007|Stage 1|Death|0
7857969|NCT01562275|12345125|FG008|Stage 1|Death|0
7857970|NCT01562275|12345126|FG009|Stage 1|Death|0
7857971|NCT01562275|12345127|FG010|Stage 1|Death|0
7857972|NCT01562275|12345128|FG011|Stage 1|Death|0
7857973|NCT01562275|12345129|FG012|Stage 1|Death|0
7857974|NCT01562275|12345117|FG000|Stage 1|Non Compliance|0
7857975|NCT01562275|12345118|FG001|Stage 1|Non Compliance|0
7857976|NCT01562275|12345119|FG002|Stage 1|Non Compliance|1
7857977|NCT01562275|12345120|FG003|Stage 1|Non Compliance|0
7857978|NCT01562275|12345121|FG004|Stage 1|Non Compliance|0
7857979|NCT01562275|12345122|FG005|Stage 1|Non Compliance|0
7857980|NCT01562275|12345123|FG006|Stage 1|Non Compliance|0
7857981|NCT01562275|12345124|FG007|Stage 1|Non Compliance|0
7857982|NCT01562275|12345125|FG008|Stage 1|Non Compliance|0
7857983|NCT01562275|12345126|FG009|Stage 1|Non Compliance|0
7857984|NCT01562275|12345127|FG010|Stage 1|Non Compliance|0
7857985|NCT01562275|12345128|FG011|Stage 1|Non Compliance|0
7857986|NCT01562275|12345129|FG012|Stage 1|Non Compliance|0
7857987|NCT01562275|12345117|FG000|Stage 1|Physician Decision|0
7857988|NCT01562275|12345118|FG001|Stage 1|Physician Decision|0
7857989|NCT01562275|12345119|FG002|Stage 1|Physician Decision|0
7857990|NCT01562275|12345120|FG003|Stage 1|Physician Decision|0
7857991|NCT01562275|12345121|FG004|Stage 1|Physician Decision|1
7857992|NCT01562275|12345122|FG005|Stage 1|Physician Decision|0
7857993|NCT01562275|12345123|FG006|Stage 1|Physician Decision|1
7857994|NCT01562275|12345124|FG007|Stage 1|Physician Decision|0
7857995|NCT01562275|12345125|FG008|Stage 1|Physician Decision|1
7857996|NCT01562275|12345126|FG009|Stage 1|Physician Decision|0
7857997|NCT01562275|12345127|FG010|Stage 1|Physician Decision|0
7857998|NCT01562275|12345128|FG011|Stage 1|Physician Decision|0
7857999|NCT01562275|12345129|FG012|Stage 1|Physician Decision|0
7858000|NCT01562275|12345117|FG000|Stage 1|Progression of Disease|2
7858001|NCT01562275|12345118|FG001|Stage 1|Progression of Disease|6
7858002|NCT01562275|12345119|FG002|Stage 1|Progression of Disease|2
7858003|NCT01562275|12345120|FG003|Stage 1|Progression of Disease|1
7858004|NCT01562275|12345121|FG004|Stage 1|Progression of Disease|2
7858005|NCT01562275|12345122|FG005|Stage 1|Progression of Disease|4
7858006|NCT01562275|12345123|FG006|Stage 1|Progression of Disease|1
7858007|NCT01562275|12345124|FG007|Stage 1|Progression of Disease|7
7858008|NCT01562275|12345125|FG008|Stage 1|Progression of Disease|2
7858009|NCT01562275|12345126|FG009|Stage 1|Progression of Disease|5
7858010|NCT01562275|12345127|FG010|Stage 1|Progression of Disease|3
7858011|NCT01562275|12345128|FG011|Stage 1|Progression of Disease|0
7858012|NCT01562275|12345129|FG012|Stage 1|Progression of Disease|0
7858013|NCT01562275|12345117|FG000|Stage 1|Withdrawal by Subject|0
7858014|NCT01562275|12345118|FG001|Stage 1|Withdrawal by Subject|1
7858015|NCT01562275|12345119|FG002|Stage 1|Withdrawal by Subject|0
7858016|NCT01562275|12345120|FG003|Stage 1|Withdrawal by Subject|2
7858017|NCT01562275|12345121|FG004|Stage 1|Withdrawal by Subject|0
7858018|NCT01562275|12345122|FG005|Stage 1|Withdrawal by Subject|0
7858019|NCT01562275|12345123|FG006|Stage 1|Withdrawal by Subject|1
7858020|NCT01562275|12345124|FG007|Stage 1|Withdrawal by Subject|0
7858021|NCT01562275|12345125|FG008|Stage 1|Withdrawal by Subject|0
7858022|NCT01562275|12345126|FG009|Stage 1|Withdrawal by Subject|1
7858023|NCT01562275|12345127|FG010|Stage 1|Withdrawal by Subject|0
7858024|NCT01562275|12345128|FG011|Stage 1|Withdrawal by Subject|0
7858025|NCT01562275|12345129|FG012|Stage 1|Withdrawal by Subject|0
7858026|NCT01562275|12345117|FG000|Stage 2|Death|0
7858027|NCT01562275|12345118|FG001|Stage 2|Death|0
7858028|NCT01562275|12345119|FG002|Stage 2|Death|0
7858029|NCT01562275|12345120|FG003|Stage 2|Death|0
7858030|NCT01562275|12345121|FG004|Stage 2|Death|0
7858031|NCT01562275|12345122|FG005|Stage 2|Death|0
7858032|NCT01562275|12345123|FG006|Stage 2|Death|0
7858033|NCT01562275|12345124|FG007|Stage 2|Death|0
7858034|NCT01562275|12345125|FG008|Stage 2|Death|0
7858035|NCT01562275|12345126|FG009|Stage 2|Death|0
7858036|NCT01562275|12345127|FG010|Stage 2|Death|0
7858037|NCT01562275|12345128|FG011|Stage 2|Death|2
7858038|NCT01562275|12345129|FG012|Stage 2|Death|1
7858039|NCT01562275|12345117|FG000|Stage 2|Progression of Disease|0
7858040|NCT01562275|12345118|FG001|Stage 2|Progression of Disease|0
7858041|NCT01562275|12345119|FG002|Stage 2|Progression of Disease|0
7858042|NCT01562275|12345120|FG003|Stage 2|Progression of Disease|0
7858043|NCT01562275|12345121|FG004|Stage 2|Progression of Disease|0
7858044|NCT01562275|12345122|FG005|Stage 2|Progression of Disease|0
7858045|NCT01562275|12345123|FG006|Stage 2|Progression of Disease|0
7858046|NCT01562275|12345124|FG007|Stage 2|Progression of Disease|0
7858047|NCT01562275|12345125|FG008|Stage 2|Progression of Disease|0
7858048|NCT01562275|12345126|FG009|Stage 2|Progression of Disease|0
7858049|NCT01562275|12345127|FG010|Stage 2|Progression of Disease|0
7858050|NCT01562275|12345128|FG011|Stage 2|Progression of Disease|12
7858051|NCT01562275|12345129|FG012|Stage 2|Progression of Disease|4
7858052|NCT01562314|12345161|FG000|Overall Study|Adverse Event|10
7858053|NCT01562314|12345162|FG001|Overall Study|Adverse Event|5
7858054|NCT01562314|12345161|FG000|Overall Study|Met Withdrawal Criteria|3
7858055|NCT01562314|12345162|FG001|Overall Study|Met Withdrawal Criteria|2
7858056|NCT01562314|12345161|FG000|Overall Study|Withdrawal by Subject|0
7858057|NCT01562314|12345162|FG001|Overall Study|Withdrawal by Subject|1
7858058|NCT01562327|12345168|FG000|Overall Study|Adverse Event|2
7858059|NCT01562327|12345168|FG000|Overall Study|Lack of Efficacy|1
7858060|NCT01562327|12345168|FG000|Overall Study|Participant drop-out|1
7858061|NCT01562327|12345168|FG000|Overall Study|Infusion not received at 6 month window|4
7858062|NCT01562444|12345197|FG000|Overall Study|Did not meet entry criteria|2
7858063|NCT01562444|12345198|FG001|Overall Study|Did not meet entry criteria|0
7858064|NCT01562444|12345199|FG002|Overall Study|Did not meet entry criteria|3
7858065|NCT01562444|12345197|FG000|Overall Study|Did not comply with blood draw schedule|1
7858066|NCT01562444|12345198|FG001|Overall Study|Did not comply with blood draw schedule|0
7858067|NCT01562444|12345199|FG002|Overall Study|Did not comply with blood draw schedule|1
7858068|NCT01562444|12345197|FG000|Overall Study|Unavailable serological results|0
7858069|NCT01562444|12345198|FG001|Overall Study|Unavailable serological results|2
7858070|NCT01562444|12345199|FG002|Overall Study|Unavailable serological results|2
7858071|NCT01562444|12345197|FG000|Overall Study|Protocol forbidden concomitant vaccine|1
7858072|NCT01562444|12345198|FG001|Overall Study|Protocol forbidden concomitant vaccine|0
7858073|NCT01562444|12345199|FG002|Overall Study|Protocol forbidden concomitant vaccine|1
7858074|NCT01562444|12345197|FG000|Overall Study|Protocol forbidden medication|1
7858075|NCT01562444|12345198|FG001|Overall Study|Protocol forbidden medication|0
7858076|NCT01562444|12345199|FG002|Overall Study|Protocol forbidden medication|0
7858077|NCT01562548|12345211|FG000|Overall Study|Lost to Follow-up|0
7858078|NCT01562548|12345212|FG001|Overall Study|Lost to Follow-up|0
7858079|NCT01562548|12345213|FG002|Overall Study|Lost to Follow-up|1
7858080|NCT01562548|12345214|FG003|Overall Study|Lost to Follow-up|0
7858081|NCT01562613|12345226|FG000|Overall Study|Lost to Follow-up|2
7858082|NCT01562613|12345226|FG000|Overall Study|Withdrawal by Subject|2
7858083|NCT01562743|12345239|FG000|Overall Study|Adverse Event|29
7858084|NCT01562743|12345239|FG000|Overall Study|Lack of Efficacy|3
7858085|NCT01562743|12345239|FG000|Overall Study|Withdrawal by Subject|13
7858086|NCT01562743|12345239|FG000|Overall Study|Protocol Violation|1
7858087|NCT01562743|12345239|FG000|Overall Study|Discontinuation criteria|2
7858088|NCT01562743|12345239|FG000|Overall Study|Lost to Follow-up|2
7858089|NCT01562743|12345239|FG000|Overall Study|Physician Decision|2
7858090|NCT01562782|12345249|FG000|Overall Study|Withdrawal by Subject|3
7858091|NCT01562782|12345250|FG001|Overall Study|Withdrawal by Subject|3
7858092|NCT01562782|12345249|FG000|Overall Study|screen failure|1
7858093|NCT01562782|12345250|FG001|Overall Study|screen failure|2
7858094|NCT01562873|12345256|FG000|Overall Study|Disease Progression per RECIST|10
7858095|NCT01562873|12345257|FG001|Overall Study|Disease Progression per RECIST|0
7858096|NCT01562873|12345256|FG000|Overall Study|Adverse Event|1
7858097|NCT01562873|12345257|FG001|Overall Study|Adverse Event|0
7858098|NCT01562873|12345256|FG000|Overall Study|Clinical Disease Progression|9
7858099|NCT01562873|12345257|FG001|Overall Study|Clinical Disease Progression|0
7858100|NCT01562873|12345256|FG000|Overall Study|Clinical PD and adverse event|1
7858101|NCT01562873|12345257|FG001|Overall Study|Clinical PD and adverse event|0
7858102|NCT01563029|12345279|FG000|Overall Study|Adverse Event|1
7858103|NCT01563029|12345280|FG001|Overall Study|Adverse Event|0
7858104|NCT01563029|12345281|FG002|Overall Study|Adverse Event|1
7858105|NCT01563029|12345282|FG003|Overall Study|Adverse Event|2
7858106|NCT01563029|12345283|FG004|Overall Study|Adverse Event|1
7858107|NCT01563029|12345279|FG000|Overall Study|Lack of Efficacy|42
7858108|NCT01563029|12345280|FG001|Overall Study|Lack of Efficacy|16
7858109|NCT01563029|12345281|FG002|Overall Study|Lack of Efficacy|23
7858110|NCT01563029|12345282|FG003|Overall Study|Lack of Efficacy|21
7858111|NCT01563029|12345283|FG004|Overall Study|Lack of Efficacy|19
7858112|NCT01563029|12345279|FG000|Overall Study|Protocol Violation|1
7858113|NCT01563029|12345280|FG001|Overall Study|Protocol Violation|2
7858114|NCT01563029|12345281|FG002|Overall Study|Protocol Violation|3
7858115|NCT01563029|12345282|FG003|Overall Study|Protocol Violation|1
7858116|NCT01563029|12345283|FG004|Overall Study|Protocol Violation|3
7858117|NCT01563029|12345279|FG000|Overall Study|Protocol defined stopping criteria|1
7858118|NCT01563029|12345280|FG001|Overall Study|Protocol defined stopping criteria|0
7858119|NCT01563029|12345281|FG002|Overall Study|Protocol defined stopping criteria|0
7858120|NCT01563029|12345282|FG003|Overall Study|Protocol defined stopping criteria|0
7858121|NCT01563029|12345283|FG004|Overall Study|Protocol defined stopping criteria|0
7858122|NCT01563029|12345279|FG000|Overall Study|Lost to Follow-up|1
7858123|NCT01563029|12345280|FG001|Overall Study|Lost to Follow-up|0
7858124|NCT01563029|12345281|FG002|Overall Study|Lost to Follow-up|1
7858125|NCT01563029|12345282|FG003|Overall Study|Lost to Follow-up|1
7858126|NCT01563029|12345283|FG004|Overall Study|Lost to Follow-up|1
7858127|NCT01563029|12345279|FG000|Overall Study|Physician Decision|3
7858128|NCT01563029|12345280|FG001|Overall Study|Physician Decision|5
7858129|NCT01563029|12345281|FG002|Overall Study|Physician Decision|2
7858130|NCT01563029|12345282|FG003|Overall Study|Physician Decision|4
7858131|NCT01563029|12345283|FG004|Overall Study|Physician Decision|2
7858132|NCT01563029|12345279|FG000|Overall Study|Withdrawal by Subject|4
7858133|NCT01563029|12345280|FG001|Overall Study|Withdrawal by Subject|1
7858134|NCT01563029|12345281|FG002|Overall Study|Withdrawal by Subject|3
7858135|NCT01563029|12345282|FG003|Overall Study|Withdrawal by Subject|4
7858136|NCT01563029|12345283|FG004|Overall Study|Withdrawal by Subject|3
7858137|NCT01563172|12345316|FG000|Overall Study|Adverse Event|5
7858138|NCT01563172|12345316|FG000|Overall Study|Lost to Follow-up|2
7858139|NCT01563172|12345316|FG000|Overall Study|Other (Protocol deviation)|5
7858140|NCT01563172|12345316|FG000|Overall Study|Other (Not specified)|1
7858141|NCT01563185|12345331|FG000|Overall Study|Withdrawal by Subject|1
7858142|NCT01563185|12345331|FG000|Overall Study|Non-Compliance with study drug|1
7858143|NCT01563237|12345339|FG000|Overall Study|Lost to Follow-up|6
7858144|NCT01563237|12345340|FG001|Overall Study|Lost to Follow-up|0
7858145|NCT01563237|12345339|FG000|Overall Study|Withdrawal by Subject|1
7858146|NCT01563237|12345340|FG001|Overall Study|Withdrawal by Subject|0
7858147|NCT01563237|12345339|FG000|Overall Study|Adverse Event|1
7858148|NCT01563237|12345340|FG001|Overall Study|Adverse Event|0
7858149|NCT01563237|12345339|FG000|Overall Study|Medical Reasons|1
7858150|NCT01563237|12345340|FG001|Overall Study|Medical Reasons|0
7858151|NCT01563237|12345339|FG000|Overall Study|Death|1
7858152|NCT01563237|12345340|FG001|Overall Study|Death|0
7858153|NCT01563354|12345348|FG000|Core Phase|Adverse Event|5
7858154|NCT01563354|12345349|FG001|Core Phase|Adverse Event|15
7858155|NCT01563354|12345350|FG002|Core Phase|Adverse Event|13
7858156|NCT01563354|12345348|FG000|Core Phase|Withdrawal by Subject|1
7858157|NCT01563354|12345349|FG001|Core Phase|Withdrawal by Subject|0
7858158|NCT01563354|12345350|FG002|Core Phase|Withdrawal by Subject|3
7858159|NCT01563354|12345348|FG000|Core Phase|Lost to Follow-up|1
7858160|NCT01563354|12345349|FG001|Core Phase|Lost to Follow-up|0
7858161|NCT01563354|12345350|FG002|Core Phase|Lost to Follow-up|0
7858162|NCT01563354|12345348|FG000|Core Phase|Death|1
7858163|NCT01563354|12345349|FG001|Core Phase|Death|5
7858164|NCT01563354|12345350|FG002|Core Phase|Death|2
7858165|NCT01563354|12345348|FG000|Core Phase|Diseasse progression|18
7858166|NCT01563354|12345349|FG001|Core Phase|Diseasse progression|7
7858167|NCT01563354|12345350|FG002|Core Phase|Diseasse progression|8
7858168|NCT01563354|12345348|FG000|Core Phase|Protocol deviation|2
7858169|NCT01563354|12345349|FG001|Core Phase|Protocol deviation|0
7858170|NCT01563354|12345350|FG002|Core Phase|Protocol deviation|0
7858171|NCT01563354|12345348|FG000|Core Phase|PI decision - did not enter extension|0
7858172|NCT01563354|12345349|FG001|Core Phase|PI decision - did not enter extension|1
7858173|NCT01563354|12345350|FG002|Core Phase|PI decision - did not enter extension|0
7858174|NCT01563354|12345348|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1
7858175|NCT01563354|12345349|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0
7858176|NCT01563354|12345350|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0
7858177|NCT01563354|12345348|FG000|Extension Phase|Adverse Event|0
7858178|NCT01563354|12345349|FG001|Extension Phase|Adverse Event|3
7858179|NCT01563354|12345350|FG002|Extension Phase|Adverse Event|2
7858180|NCT01563354|12345348|FG000|Extension Phase|Withdrawal by Subject|0
7858181|NCT01563354|12345349|FG001|Extension Phase|Withdrawal by Subject|1
7949882|NCT02544217|12495950|FG004|Overall Study|Withdrawal by Subject|0
7858182|NCT01563354|12345350|FG002|Extension Phase|Withdrawal by Subject|0
7858183|NCT01563354|12345348|FG000|Extension Phase|Administration problems|3
7858184|NCT01563354|12345349|FG001|Extension Phase|Administration problems|2
7858185|NCT01563354|12345350|FG002|Extension Phase|Administration problems|3
7858186|NCT01563354|12345348|FG000|Extension Phase|Disease progression|9
7858187|NCT01563354|12345349|FG001|Extension Phase|Disease progression|8
7858188|NCT01563354|12345350|FG002|Extension Phase|Disease progression|10
7858189|NCT01563536|12345381|FG000|Overall Study|Withdrawal by Subject|0
7858190|NCT01563536|12345382|FG001|Overall Study|Withdrawal by Subject|2
7858191|NCT01563536|12345381|FG000|Overall Study|Lost to Follow-up|1
7858192|NCT01563536|12345382|FG001|Overall Study|Lost to Follow-up|0
7858193|NCT01563913|12345390|FG000|Overall Study|Physician Decision|1
7858194|NCT01563913|12345391|FG001|Overall Study|Physician Decision|0
7858195|NCT01563913|12345390|FG000|Overall Study|Spouse Passed Away|1
7858196|NCT01563913|12345391|FG001|Overall Study|Spouse Passed Away|0
7858197|NCT01563978|12345399|FG000|Overall Study|Physician Decision|1
7858198|NCT01563978|12345400|FG001|Overall Study|Physician Decision|0
7858199|NCT01563978|12345399|FG000|Overall Study|Lost to Follow-up|1
7858200|NCT01563978|12345400|FG001|Overall Study|Lost to Follow-up|0
7858201|NCT01563978|12345399|FG000|Overall Study|Dev. of study specific discont. criteria|1
7858202|NCT01563978|12345400|FG001|Overall Study|Dev. of study specific discont. criteria|0
7858203|NCT01563978|12345399|FG000|Overall Study|Adverse Event|1
7858204|NCT01563978|12345400|FG001|Overall Study|Adverse Event|2
7858205|NCT01564277|12345408|FG000|Overall Study|Protocol Violation|0
7858206|NCT01564277|12345409|FG001|Overall Study|Protocol Violation|1
7858207|NCT01564277|12345408|FG000|Overall Study|Physician Decision|1
7858208|NCT01564277|12345409|FG001|Overall Study|Physician Decision|0
7858209|NCT01564394|12345417|FG000|Overall Study|Withdrawal by Subject|6
7858210|NCT01564394|12345418|FG001|Overall Study|Withdrawal by Subject|10
7858211|NCT01564407|12345429|FG000|Overall Study|Lost to Follow-up|0
7858212|NCT01564407|12345430|FG001|Overall Study|Lost to Follow-up|1
7858213|NCT01564407|12345431|FG002|Overall Study|Lost to Follow-up|0
7858214|NCT01564407|12345432|FG003|Overall Study|Lost to Follow-up|0
7858215|NCT01564407|12345433|FG004|Overall Study|Lost to Follow-up|0
7858216|NCT01564407|12345429|FG000|Overall Study|Withdrawal by Subject|0
7858217|NCT01564407|12345430|FG001|Overall Study|Withdrawal by Subject|1
7858218|NCT01564407|12345431|FG002|Overall Study|Withdrawal by Subject|0
7858219|NCT01564407|12345432|FG003|Overall Study|Withdrawal by Subject|0
7858220|NCT01564407|12345433|FG004|Overall Study|Withdrawal by Subject|0
7858221|NCT01564407|12345429|FG000|Overall Study|funding lost, study ended|0
7858222|NCT01564407|12345430|FG001|Overall Study|funding lost, study ended|0
7858223|NCT01564407|12345431|FG002|Overall Study|funding lost, study ended|0
7858224|NCT01564407|12345432|FG003|Overall Study|funding lost, study ended|1
7858225|NCT01564407|12345433|FG004|Overall Study|funding lost, study ended|0
7858226|NCT01564459|12345457|FG000|Run-In|Adverse Event|7
7858227|NCT01564459|12345458|FG001|Run-In|Adverse Event|0
7858228|NCT01564459|12345459|FG002|Run-In|Adverse Event|0
7858229|NCT01564459|12345457|FG000|Run-In|Lost to Follow-up|1
7858230|NCT01564459|12345458|FG001|Run-In|Lost to Follow-up|0
7858231|NCT01564459|12345459|FG002|Run-In|Lost to Follow-up|0
7858232|NCT01564459|12345457|FG000|Run-In|Non-compliance with study drug|2
7858233|NCT01564459|12345458|FG001|Run-In|Non-compliance with study drug|0
7858234|NCT01564459|12345459|FG002|Run-In|Non-compliance with study drug|0
7858235|NCT01564459|12345457|FG000|Run-In|Protocol Violation|1
7858236|NCT01564459|12345458|FG001|Run-In|Protocol Violation|0
7858237|NCT01564459|12345459|FG002|Run-In|Protocol Violation|0
7858238|NCT01564459|12345457|FG000|Run-In|Withdrawal by Subject|1
7858239|NCT01564459|12345458|FG001|Run-In|Withdrawal by Subject|0
7858240|NCT01564459|12345459|FG002|Run-In|Withdrawal by Subject|0
7858241|NCT01564459|12345457|FG000|Double-blind Treatment|Adverse Event|0
7858242|NCT01564459|12345458|FG001|Double-blind Treatment|Adverse Event|0
7858243|NCT01564459|12345459|FG002|Double-blind Treatment|Adverse Event|1
7858244|NCT01564758|12345506|FG000|Overall Study|Death|8
7858245|NCT01564758|12345506|FG000|Overall Study|Adverse Event|3
7858246|NCT01564758|12345506|FG000|Overall Study|Other|3
7858247|NCT01564784|12345512|FG000|Overall Study|Other|1
7858248|NCT01564784|12345513|FG001|Overall Study|Other|0
7858249|NCT01564784|12345512|FG000|Overall Study|Subject refused further follow-up|1
7858250|NCT01564784|12345513|FG001|Overall Study|Subject refused further follow-up|6
7858251|NCT01564784|12345512|FG000|Overall Study|Lost to Follow-up|1
7858252|NCT01564784|12345513|FG001|Overall Study|Lost to Follow-up|1
7858253|NCT01564784|12345512|FG000|Overall Study|Death|131
7858254|NCT01564784|12345513|FG001|Overall Study|Death|126
7858255|NCT01564862|12345522|FG000|Overall Study|Pretreatment Event or Adverse Event|6
7858256|NCT01564862|12345523|FG001|Overall Study|Pretreatment Event or Adverse Event|12
7858257|NCT01564862|12345524|FG002|Overall Study|Pretreatment Event or Adverse Event|6
7858258|NCT01564862|12345522|FG000|Overall Study|Major Protocol Deviation|3
7858259|NCT01564862|12345523|FG001|Overall Study|Major Protocol Deviation|3
7858260|NCT01564862|12345524|FG002|Overall Study|Major Protocol Deviation|4
7858261|NCT01564862|12345522|FG000|Overall Study|Lost to Follow-up|10
7858262|NCT01564862|12345523|FG001|Overall Study|Lost to Follow-up|8
7858263|NCT01564862|12345524|FG002|Overall Study|Lost to Follow-up|6
7858264|NCT01564862|12345522|FG000|Overall Study|Voluntary Withdrawal|9
7858265|NCT01564862|12345523|FG001|Overall Study|Voluntary Withdrawal|6
7858266|NCT01564862|12345524|FG002|Overall Study|Voluntary Withdrawal|8
7858267|NCT01564862|12345522|FG000|Overall Study|Lack of Efficacy|1
7858268|NCT01564862|12345523|FG001|Overall Study|Lack of Efficacy|5
7858269|NCT01564862|12345524|FG002|Overall Study|Lack of Efficacy|6
7858270|NCT01564862|12345522|FG000|Overall Study|Other reason(s)|1
7858271|NCT01564862|12345523|FG001|Overall Study|Other reason(s)|0
7858272|NCT01564862|12345524|FG002|Overall Study|Other reason(s)|0
7858273|NCT01565083|12345554|FG000|Overall Study|Withdrawal by Subject|6
7858274|NCT01565083|12345555|FG001|Overall Study|Withdrawal by Subject|4
7858275|NCT01565083|12345554|FG000|Overall Study|Lost to Follow-up|2
7858276|NCT01565083|12345555|FG001|Overall Study|Lost to Follow-up|7
7858277|NCT01565083|12345554|FG000|Overall Study|Death|22
7858278|NCT01565083|12345555|FG001|Overall Study|Death|23
7858279|NCT01565083|12345554|FG000|Overall Study|Other|3
7858280|NCT01565083|12345555|FG001|Overall Study|Other|5
7858281|NCT01565148|12345565|FG000|Overall Study|Withdrawal by Subject|1
7858282|NCT01565148|12345566|FG001|Overall Study|Withdrawal by Subject|1
7858283|NCT01565148|12345567|FG002|Overall Study|Withdrawal by Subject|1
7858284|NCT01565148|12345568|FG003|Overall Study|Withdrawal by Subject|2
7858285|NCT01565148|12345565|FG000|Overall Study|Lost to Follow-up|4
7858286|NCT01565148|12345566|FG001|Overall Study|Lost to Follow-up|4
7858287|NCT01565148|12345567|FG002|Overall Study|Lost to Follow-up|0
7858288|NCT01565148|12345568|FG003|Overall Study|Lost to Follow-up|3
7858289|NCT01565148|12345565|FG000|Overall Study|Rescue Therapy|8
7858290|NCT01565148|12345566|FG001|Overall Study|Rescue Therapy|5
7858291|NCT01565148|12345567|FG002|Overall Study|Rescue Therapy|5
7858292|NCT01565148|12345568|FG003|Overall Study|Rescue Therapy|8
7858293|NCT01565148|12345565|FG000|Overall Study|Death|0
7858294|NCT01565148|12345566|FG001|Overall Study|Death|0
7858295|NCT01565148|12345567|FG002|Overall Study|Death|1
7858296|NCT01565148|12345568|FG003|Overall Study|Death|0
7858297|NCT01565148|12345565|FG000|Overall Study|Physician Decision|2
7858298|NCT01565148|12345566|FG001|Overall Study|Physician Decision|5
7858299|NCT01565148|12345567|FG002|Overall Study|Physician Decision|0
7858300|NCT01565148|12345568|FG003|Overall Study|Physician Decision|0
7858301|NCT01565291|12345584|FG000|Overall Study|Withdrawal by Subject|1
7858302|NCT01565291|12345585|FG001|Overall Study|Withdrawal by Subject|0
7858303|NCT01565343|12345612|FG000|Overall Study|Administrative decision/technical issues|1
7858304|NCT01565343|12345613|FG001|Overall Study|Administrative decision/technical issues|0
7858305|NCT01565343|12345614|FG002|Overall Study|Administrative decision/technical issues|0
7858306|NCT01565499|12345630|FG000|Overall Study|Physician Decision|1
7858307|NCT01565499|12345630|FG000|Overall Study|Adverse Event|5
7858308|NCT01565499|12345630|FG000|Overall Study|Withdrawal by Subject|2
7858309|NCT01565564|12345654|FG000|Overall Study|Lost to Follow-up|5
7858310|NCT01565564|12345655|FG001|Overall Study|Lost to Follow-up|1
7858311|NCT01565642|12345667|FG000|Overall Study|Withdrawal by Subject|2
7858312|NCT01565642|12345668|FG001|Overall Study|Withdrawal by Subject|1
7858313|NCT01565668|12345676|FG000|Overall Study|Death|2
7858314|NCT01565668|12345677|FG001|Overall Study|Death|1
7858315|NCT01565668|12345676|FG000|Overall Study|Lack of Efficacy|4
7858316|NCT01565668|12345677|FG001|Overall Study|Lack of Efficacy|2
7858317|NCT01565668|12345676|FG000|Overall Study|Participant went on Hospice Care|1
7858318|NCT01565668|12345677|FG001|Overall Study|Participant went on Hospice Care|0
7858319|NCT01565668|12345676|FG000|Overall Study|Adverse Event|6
7858320|NCT01565668|12345677|FG001|Overall Study|Adverse Event|1
7858321|NCT01565668|12345676|FG000|Overall Study|Randomized, but never received drug|0
7858322|NCT01565668|12345677|FG001|Overall Study|Randomized, but never received drug|2
7858323|NCT01565668|12345676|FG000|Overall Study|Progressive disease|13
7858324|NCT01565668|12345677|FG001|Overall Study|Progressive disease|14
7858325|NCT01565668|12345676|FG000|Overall Study|Withdrawal by Subject|1
7858326|NCT01565668|12345677|FG001|Overall Study|Withdrawal by Subject|3
7858327|NCT01565668|12345676|FG000|Overall Study|HSCT Transplant|11
7858328|NCT01565668|12345677|FG001|Overall Study|HSCT Transplant|15
7858329|NCT01565694|12345683|FG000|Dose-Titration Period|Adverse Event|4
7858330|NCT01565694|12345683|FG000|Dose-Titration Period|Protocol Violation|10
7858331|NCT01565694|12345683|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4
7858332|NCT01565707|12345691|FG000|Overall Study|Adverse Event|1
7858333|NCT01565707|12345692|FG001|Overall Study|Adverse Event|6
7858334|NCT01565707|12345693|FG002|Overall Study|Adverse Event|2
7858335|NCT01565707|12345694|FG003|Overall Study|Adverse Event|1
7858336|NCT01565707|12345691|FG000|Overall Study|Lost to Follow-up|1
7858337|NCT01565707|12345692|FG001|Overall Study|Lost to Follow-up|0
7858338|NCT01565707|12345693|FG002|Overall Study|Lost to Follow-up|0
7858339|NCT01565707|12345694|FG003|Overall Study|Lost to Follow-up|0
7858340|NCT01565707|12345691|FG000|Overall Study|Protocol Violation|1
7858341|NCT01565707|12345692|FG001|Overall Study|Protocol Violation|0
7858342|NCT01565707|12345693|FG002|Overall Study|Protocol Violation|0
7858343|NCT01565707|12345694|FG003|Overall Study|Protocol Violation|1
7858344|NCT01565707|12345691|FG000|Overall Study|Withdrawal by Subject|3
7858345|NCT01565707|12345692|FG001|Overall Study|Withdrawal by Subject|1
7858346|NCT01565707|12345693|FG002|Overall Study|Withdrawal by Subject|1
7858347|NCT01565707|12345694|FG003|Overall Study|Withdrawal by Subject|1
7858348|NCT01565707|12345691|FG000|Overall Study|Randomized but not evaluable|2
7858349|NCT01565707|12345692|FG001|Overall Study|Randomized but not evaluable|0
7858350|NCT01565707|12345693|FG002|Overall Study|Randomized but not evaluable|0
7858351|NCT01565707|12345694|FG003|Overall Study|Randomized but not evaluable|0
7858352|NCT01565707|12345691|FG000|Overall Study|Miscellaneous|1
7858353|NCT01565707|12345692|FG001|Overall Study|Miscellaneous|1
7858354|NCT01565707|12345693|FG002|Overall Study|Miscellaneous|0
7858355|NCT01565707|12345694|FG003|Overall Study|Miscellaneous|2
7858356|NCT01565850|12345713|FG000|Overall Study|Adverse Event|0
7858357|NCT01565850|12345714|FG001|Overall Study|Adverse Event|1
7858358|NCT01565850|12345713|FG000|Overall Study|Lost to Follow-up|12
7858359|NCT01565850|12345714|FG001|Overall Study|Lost to Follow-up|4
7858360|NCT01565850|12345713|FG000|Overall Study|Investigator's Discretion|2
7858361|NCT01565850|12345714|FG001|Overall Study|Investigator's Discretion|1
7858362|NCT01565850|12345713|FG000|Overall Study|Participant noncompliance|2
7858363|NCT01565850|12345714|FG001|Overall Study|Participant noncompliance|0
7858364|NCT01565850|12345713|FG000|Overall Study|Withdrew Consent|4
7858365|NCT01565850|12345714|FG001|Overall Study|Withdrew Consent|2
7858366|NCT01565889|12345726|FG000|Part A|Withdrawal by Subject|1
7858367|NCT01565889|12345727|FG001|Part A|Withdrawal by Subject|0
7858368|NCT01565889|12345728|FG002|Part A|Withdrawal by Subject|0
7858369|NCT01565889|12345729|FG003|Part A|Withdrawal by Subject|0
7858370|NCT01565889|12345730|FG004|Part A|Withdrawal by Subject|0
7858371|NCT01565889|12345731|FG005|Part A|Withdrawal by Subject|0
7858372|NCT01565889|12345726|FG000|Part B|Withdrawal by Subject|0
7858373|NCT01565889|12345727|FG001|Part B|Withdrawal by Subject|0
7858374|NCT01565889|12345728|FG002|Part B|Withdrawal by Subject|0
7858375|NCT01565889|12345729|FG003|Part B|Withdrawal by Subject|0
7858376|NCT01565889|12345730|FG004|Part B|Withdrawal by Subject|0
7858377|NCT01565889|12345731|FG005|Part B|Withdrawal by Subject|1
7858378|NCT01565889|12345726|FG000|Part B|Lack of Efficacy|0
7858379|NCT01565889|12345727|FG001|Part B|Lack of Efficacy|0
7858380|NCT01565889|12345728|FG002|Part B|Lack of Efficacy|0
7858381|NCT01565889|12345729|FG003|Part B|Lack of Efficacy|0
7858382|NCT01565889|12345730|FG004|Part B|Lack of Efficacy|0
7858383|NCT01565889|12345731|FG005|Part B|Lack of Efficacy|2
7858384|NCT01565889|12345726|FG000|Part B|Lost to Follow-up|0
7858385|NCT01565889|12345727|FG001|Part B|Lost to Follow-up|0
7858386|NCT01565889|12345728|FG002|Part B|Lost to Follow-up|0
7858387|NCT01565889|12345729|FG003|Part B|Lost to Follow-up|0
7858388|NCT01565889|12345730|FG004|Part B|Lost to Follow-up|0
7858389|NCT01565889|12345731|FG005|Part B|Lost to Follow-up|1
7858390|NCT01565928|12345766|FG000|Overall Study|Adverse Event|3
7858391|NCT01565928|12345766|FG000|Overall Study|Other|3
7858392|NCT01565928|12345766|FG000|Overall Study|Progressive Disease|13
7858393|NCT01565928|12345766|FG000|Overall Study|Withdrawal by Subject|1
7858394|NCT01565928|12345766|FG000|Overall Study|Death|2
7858395|NCT01565980|12345775|FG000|Overall Study|Death|1
7858396|NCT01565980|12345776|FG001|Overall Study|Death|0
7858397|NCT01565980|12345775|FG000|Overall Study|Lost to Follow-up|1
7858398|NCT01565980|12345776|FG001|Overall Study|Lost to Follow-up|0
7858399|NCT01565980|12345775|FG000|Overall Study|health complications|1
7858400|NCT01565980|12345776|FG001|Overall Study|health complications|1
7858401|NCT01565980|12345775|FG000|Overall Study|stopped medical treatment|1
7858402|NCT01565980|12345776|FG001|Overall Study|stopped medical treatment|0
7858403|NCT01565980|12345775|FG000|Overall Study|Withdrawal by Subject|0
7858404|NCT01565980|12345776|FG001|Overall Study|Withdrawal by Subject|3
7858405|NCT01565993|12345788|FG000|Overall Study|Physician Decision|0
7858406|NCT01565993|12345789|FG001|Overall Study|Physician Decision|3
7863818|NCT01609023|12353360|FG000|Overall Study|Lack of Efficacy|3
7863819|NCT01609023|12353360|FG000|Overall Study|Withdrawal by Subject|4
7863820|NCT01609023|12353360|FG000|Overall Study|Lost to Follow-up|8
7863821|NCT01609023|12353360|FG000|Overall Study|Toxicity|3
7863822|NCT01609023|12353360|FG000|Overall Study|Disease progression|10
7863823|NCT01609023|12353360|FG000|Overall Study|Physician Decision|2
7863824|NCT01609023|12353360|FG000|Overall Study|Death|2
7863825|NCT01609023|12353360|FG000|Overall Study|Personal reasons|1
7863826|NCT01609062|12353366|FG000|Extension Phase|Terminated by Sponsor|14
7863827|NCT01609062|12353367|FG001|Extension Phase|Terminated by Sponsor|9
7863828|NCT01609062|12353366|FG000|Extension Phase|Discontinued drug and then was pregnant|1
7863829|NCT01609062|12353367|FG001|Extension Phase|Discontinued drug and then was pregnant|0
7863830|NCT01609062|12353366|FG000|Extension Phase|Anticipated surgery & transition to EAP|0
7863831|NCT01609062|12353367|FG001|Extension Phase|Anticipated surgery & transition to EAP|1
7863832|NCT01609218|12353374|FG000|Period 1|Adverse Event|3
7863833|NCT01609218|12353375|FG001|Period 1|Adverse Event|5
7863834|NCT01609218|12353374|FG000|Period 1|Sponsor Decision|0
7863835|NCT01609218|12353375|FG001|Period 1|Sponsor Decision|1
7863836|NCT01609218|12353374|FG000|Period 2|Adverse Event|1
7863837|NCT01609218|12353375|FG001|Period 2|Adverse Event|0
7863838|NCT01609257|12353383|FG000|Overall Study|Lost to Follow-up|2
7863839|NCT01609257|12353384|FG001|Overall Study|Lost to Follow-up|1
7863840|NCT01609257|12353383|FG000|Overall Study|Voluntary Withdrawal by Subject|0
7863841|NCT01609257|12353384|FG001|Overall Study|Voluntary Withdrawal by Subject|1
7863842|NCT01609257|12353383|FG000|Overall Study|Non-compliance/Protocol deviation|4
7863843|NCT01609257|12353384|FG001|Overall Study|Non-compliance/Protocol deviation|6
7863844|NCT01609296|12353393|FG000|Overall Study|Death|253
7863845|NCT01609296|12353393|FG000|Overall Study|Withdrawal by Subject|151
7863846|NCT01609296|12353393|FG000|Overall Study|Lost to Follow-up|21
7863847|NCT01609296|12353393|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35
7863848|NCT01609296|12353393|FG000|Overall Study|missed visit but known to be alive|28
7863849|NCT01609478|12353413|FG000|Overall Study|Adverse Event|3
7863850|NCT01609478|12353414|FG001|Overall Study|Adverse Event|1
7863851|NCT01609478|12353415|FG002|Overall Study|Adverse Event|5
7863852|NCT01609478|12353413|FG000|Overall Study|Protocol Deviation|0
7863853|NCT01609478|12353414|FG001|Overall Study|Protocol Deviation|1
7863854|NCT01609478|12353415|FG002|Overall Study|Protocol Deviation|1
7863855|NCT01609478|12353413|FG000|Overall Study|Non-Compliance with study treatment|1
7863856|NCT01609478|12353414|FG001|Overall Study|Non-Compliance with study treatment|0
7863857|NCT01609478|12353415|FG002|Overall Study|Non-Compliance with study treatment|0
7863858|NCT01609478|12353413|FG000|Overall Study|Physician Decision|1
7863859|NCT01609478|12353414|FG001|Overall Study|Physician Decision|0
7863860|NCT01609478|12353415|FG002|Overall Study|Physician Decision|1
7863861|NCT01609478|12353413|FG000|Overall Study|Withdrawal by Subject|2
7863862|NCT01609478|12353414|FG001|Overall Study|Withdrawal by Subject|0
7863863|NCT01609478|12353415|FG002|Overall Study|Withdrawal by Subject|2
7863864|NCT01609543|12353423|FG000|Overall Study|Disease Progression|28
7863865|NCT01609543|12353423|FG000|Overall Study|Adverse Event|5
7863866|NCT01609543|12353423|FG000|Overall Study|Withdrawal by Subject|1
7863867|NCT01609543|12353423|FG000|Overall Study|Protocol Violation|1
7863868|NCT01609543|12353423|FG000|Overall Study|Death|7
7863869|NCT01609556|12353444|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7863870|NCT01609556|12353445|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7863871|NCT01609556|12353446|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7863872|NCT01609556|12353447|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7863873|NCT01609556|12353448|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7863874|NCT01609556|12353449|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7858407|NCT01566214|12345818|FG000|Overall Study|Lost to Follow-up|3
7858408|NCT01566214|12345819|FG001|Overall Study|Lost to Follow-up|0
7858409|NCT01566435|12345843|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
7858410|NCT01566604|12345912|FG000|Overall Study|Patient's inability to use the device|1
7858411|NCT01566604|12345913|FG001|Overall Study|Patient's inability to use the device|0
7858412|NCT01566604|12345912|FG000|Overall Study|Administrative problems|1
7858413|NCT01566604|12345913|FG001|Overall Study|Administrative problems|0
7858414|NCT01566604|12345912|FG000|Overall Study|Lack of Efficacy|1
7858415|NCT01566604|12345913|FG001|Overall Study|Lack of Efficacy|2
7858416|NCT01566604|12345912|FG000|Overall Study|Protocol deviation|2
7858417|NCT01566604|12345913|FG001|Overall Study|Protocol deviation|0
7858418|NCT01566604|12345912|FG000|Overall Study|Abnormal laboratory value|2
7858419|NCT01566604|12345913|FG001|Overall Study|Abnormal laboratory value|0
7858420|NCT01566604|12345912|FG000|Overall Study|Death|4
7858421|NCT01566604|12345913|FG001|Overall Study|Death|1
7858422|NCT01566604|12345912|FG000|Overall Study|Adverse Event|4
7858423|NCT01566604|12345913|FG001|Overall Study|Adverse Event|2
7858424|NCT01566604|12345912|FG000|Overall Study|Withdrawal by Subject|9
7858425|NCT01566604|12345913|FG001|Overall Study|Withdrawal by Subject|6
7858426|NCT01566721|12345940|FG000|Treatment Period|Withdrawal by Subject|35
7858427|NCT01566721|12345941|FG001|Treatment Period|Withdrawal by Subject|9
7858428|NCT01566721|12345940|FG000|Treatment Period|Disease Progression/Recurrence|37
7858429|NCT01566721|12345941|FG001|Treatment Period|Disease Progression/Recurrence|13
7858430|NCT01566721|12345940|FG000|Treatment Period|Investigator/Sponsor Decision|6
7858431|NCT01566721|12345941|FG001|Treatment Period|Investigator/Sponsor Decision|3
7858432|NCT01566721|12345940|FG000|Treatment Period|Other|13
7858433|NCT01566721|12345941|FG001|Treatment Period|Other|2
7858434|NCT01566721|12345940|FG000|Treatment Period|Lack of Compliance|5
7858435|NCT01566721|12345941|FG001|Treatment Period|Lack of Compliance|1
7858436|NCT01566721|12345940|FG000|Treatment Period|Adverse Event|100
7858437|NCT01566721|12345941|FG001|Treatment Period|Adverse Event|30
7858438|NCT01566721|12345940|FG000|Treatment Period|Pregnancy|1
7858439|NCT01566721|12345941|FG001|Treatment Period|Pregnancy|0
7858440|NCT01566721|12345940|FG000|Safety Follow-up|Physician Decision|6
7858441|NCT01566721|12345941|FG001|Safety Follow-up|Physician Decision|4
7858442|NCT01566721|12345940|FG000|Safety Follow-up|Lost to Follow-up|101
7858443|NCT01566721|12345941|FG001|Safety Follow-up|Lost to Follow-up|48
7858444|NCT01566721|12345940|FG000|Safety Follow-up|Withdrawal by Subject|155
7858445|NCT01566721|12345941|FG001|Safety Follow-up|Withdrawal by Subject|49
7858446|NCT01566721|12345940|FG000|Safety Follow-up|Death|28
7858447|NCT01566721|12345941|FG001|Safety Follow-up|Death|4
7858448|NCT01566721|12345940|FG000|Safety Follow-up|Non-compliance|7
7858449|NCT01566721|12345941|FG001|Safety Follow-up|Non-compliance|3
7858450|NCT01566721|12345940|FG000|Safety Follow-up|Protocol Violation|7
7858451|NCT01566721|12345941|FG001|Safety Follow-up|Protocol Violation|0
7858452|NCT01566721|12345940|FG000|Safety Follow-up|Site closure|2
7858453|NCT01566721|12345941|FG001|Safety Follow-up|Site closure|3
7858454|NCT01566721|12345940|FG000|Safety Follow-up|Erroneous reporting or late reporting|2
7858455|NCT01566721|12345941|FG001|Safety Follow-up|Erroneous reporting or late reporting|0
7858456|NCT01566721|12345940|FG000|Safety Follow-up|Missing|7
7858457|NCT01566721|12345941|FG001|Safety Follow-up|Missing|2
7858458|NCT01566721|12345940|FG000|Safety Follow-up|Disease progression /disease recurrence|223
7858459|NCT01566721|12345941|FG001|Safety Follow-up|Disease progression /disease recurrence|90
7858460|NCT01566721|12345940|FG000|Safety Follow-up|Sponsor decision|1
7858461|NCT01566721|12345941|FG001|Safety Follow-up|Sponsor decision|0
7858462|NCT01566721|12345940|FG000|Safety Follow-up|Adverse Event|8
7858463|NCT01566721|12345941|FG001|Safety Follow-up|Adverse Event|4
7858464|NCT01566773|12345954|FG000|Overall Study|Protocol specified criteria|4
7858465|NCT01566773|12345954|FG000|Overall Study|Protocol Violation|4
7858466|NCT01566773|12345954|FG000|Overall Study|Withdrawal by Subject|9
7858467|NCT01566773|12345954|FG000|Overall Study|Administrative reason|1
7858468|NCT01566773|12345954|FG000|Overall Study|Adverse Event|10
7858469|NCT01566773|12345954|FG000|Overall Study|Physician Decision|2
7858470|NCT01566981|12345985|FG000|Overall Study|Lost to Follow-up|5
7858471|NCT01566981|12345986|FG001|Overall Study|Lost to Follow-up|8
7858472|NCT01567085|12346011|FG000|Overall Study|Death|6
7858473|NCT01567085|12346011|FG000|Overall Study|Adverse Event|6
7858474|NCT01567085|12346011|FG000|Overall Study|Lost to Follow-up|3
7858475|NCT01567085|12346011|FG000|Overall Study|Graft loss|2
7858476|NCT01567085|12346011|FG000|Overall Study|Renal transplantectomy|1
7858477|NCT01567085|12346011|FG000|Overall Study|Returned to chronic dialysis|1
7858478|NCT01567085|12346011|FG000|Overall Study|Terminal chronic kidney dysfunction|1
7858479|NCT01567163|12346024|FG000|Overall Study|Progressive Disease|2
7858480|NCT01567163|12346024|FG000|Overall Study|Lost to Follow-up|2
7858481|NCT01567306|12346039|FG000|Overall Study|Protocol Violation|2
7858482|NCT01567306|12346040|FG001|Overall Study|Protocol Violation|2
7858483|NCT01567306|12346041|FG002|Overall Study|Protocol Violation|0
7858484|NCT01567306|12346042|FG003|Overall Study|Protocol Violation|3
7858485|NCT01567306|12346043|FG004|Overall Study|Protocol Violation|1
7858486|NCT01567306|12346044|FG005|Overall Study|Protocol Violation|1
7858487|NCT01567306|12346039|FG000|Overall Study|Change site living|1
7858488|NCT01567306|12346040|FG001|Overall Study|Change site living|0
7858489|NCT01567306|12346041|FG002|Overall Study|Change site living|0
7858490|NCT01567306|12346042|FG003|Overall Study|Change site living|0
7858491|NCT01567306|12346043|FG004|Overall Study|Change site living|0
7858492|NCT01567306|12346044|FG005|Overall Study|Change site living|0
7858493|NCT01567306|12346039|FG000|Overall Study|Adverse Event|0
7858494|NCT01567306|12346040|FG001|Overall Study|Adverse Event|0
7858495|NCT01567306|12346041|FG002|Overall Study|Adverse Event|0
7858496|NCT01567306|12346042|FG003|Overall Study|Adverse Event|2
7858497|NCT01567306|12346043|FG004|Overall Study|Adverse Event|4
7858498|NCT01567306|12346044|FG005|Overall Study|Adverse Event|1
7858499|NCT01567306|12346039|FG000|Overall Study|Lost to Follow-up|0
7858500|NCT01567306|12346040|FG001|Overall Study|Lost to Follow-up|0
7858501|NCT01567306|12346041|FG002|Overall Study|Lost to Follow-up|0
7858502|NCT01567306|12346042|FG003|Overall Study|Lost to Follow-up|0
7858503|NCT01567306|12346043|FG004|Overall Study|Lost to Follow-up|2
7858504|NCT01567306|12346044|FG005|Overall Study|Lost to Follow-up|0
7858505|NCT01567306|12346039|FG000|Overall Study|Withdrawal by Subject|0
7858506|NCT01567306|12346040|FG001|Overall Study|Withdrawal by Subject|0
7858507|NCT01567306|12346041|FG002|Overall Study|Withdrawal by Subject|0
7858508|NCT01567306|12346042|FG003|Overall Study|Withdrawal by Subject|0
7858509|NCT01567306|12346043|FG004|Overall Study|Withdrawal by Subject|0
7858510|NCT01567306|12346044|FG005|Overall Study|Withdrawal by Subject|1
7858511|NCT01567462|12346064|FG000|Overall Study|Withdrawal by Subject|4
7858512|NCT01567462|12346065|FG001|Overall Study|Withdrawal by Subject|7
7858513|NCT01567527|12346073|FG000|Conversion Phase.|Protocol deviation|3
7858514|NCT01567527|12346074|FG001|Conversion Phase.|Protocol deviation|0
7858515|NCT01567527|12346075|FG002|Conversion Phase.|Protocol deviation|0
7858516|NCT01567527|12346076|FG003|Conversion Phase.|Protocol deviation|0
7858517|NCT01567527|12346077|FG004|Conversion Phase.|Protocol deviation|0
7858518|NCT01567527|12346073|FG000|Conversion Phase.|Met withdrawal criteria|10
7858519|NCT01567527|12346074|FG001|Conversion Phase.|Met withdrawal criteria|0
7858520|NCT01567527|12346075|FG002|Conversion Phase.|Met withdrawal criteria|0
7858521|NCT01567527|12346076|FG003|Conversion Phase.|Met withdrawal criteria|0
7858522|NCT01567527|12346077|FG004|Conversion Phase.|Met withdrawal criteria|0
7858523|NCT01567527|12346073|FG000|Conversion Phase.|Withdrawal by Subject|32
7858524|NCT01567527|12346074|FG001|Conversion Phase.|Withdrawal by Subject|0
7858525|NCT01567527|12346075|FG002|Conversion Phase.|Withdrawal by Subject|0
7858526|NCT01567527|12346076|FG003|Conversion Phase.|Withdrawal by Subject|0
7858527|NCT01567527|12346077|FG004|Conversion Phase.|Withdrawal by Subject|0
7858528|NCT01567527|12346073|FG000|Conversion Phase.|Lost to Follow-up|16
7858529|NCT01567527|12346074|FG001|Conversion Phase.|Lost to Follow-up|0
7858530|NCT01567527|12346075|FG002|Conversion Phase.|Lost to Follow-up|0
7858531|NCT01567527|12346076|FG003|Conversion Phase.|Lost to Follow-up|0
7858532|NCT01567527|12346077|FG004|Conversion Phase.|Lost to Follow-up|0
7858533|NCT01567527|12346073|FG000|Conversion Phase.|Lack of Efficacy|2
7858534|NCT01567527|12346074|FG001|Conversion Phase.|Lack of Efficacy|0
7858535|NCT01567527|12346075|FG002|Conversion Phase.|Lack of Efficacy|0
7858536|NCT01567527|12346076|FG003|Conversion Phase.|Lack of Efficacy|0
7858537|NCT01567527|12346077|FG004|Conversion Phase.|Lack of Efficacy|0
7858538|NCT01567527|12346073|FG000|Conversion Phase.|Adverse Event|33
7858539|NCT01567527|12346074|FG001|Conversion Phase.|Adverse Event|0
7858540|NCT01567527|12346075|FG002|Conversion Phase.|Adverse Event|0
7858541|NCT01567527|12346076|FG003|Conversion Phase.|Adverse Event|0
7858542|NCT01567527|12346077|FG004|Conversion Phase.|Adverse Event|0
7858543|NCT01567527|12346073|FG000|Conversion Phase.|Withdrawn by the investigator|3
7858544|NCT01567527|12346074|FG001|Conversion Phase.|Withdrawn by the investigator|0
7858545|NCT01567527|12346075|FG002|Conversion Phase.|Withdrawn by the investigator|0
7858546|NCT01567527|12346076|FG003|Conversion Phase.|Withdrawn by the investigator|0
7858547|NCT01567527|12346077|FG004|Conversion Phase.|Withdrawn by the investigator|0
7858548|NCT01567527|12346073|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7858549|NCT01567527|12346074|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
7858550|NCT01567527|12346075|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7858551|NCT01567527|12346076|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7858552|NCT01567527|12346077|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7858553|NCT01567527|12346073|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7858554|NCT01567527|12346074|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
7858555|NCT01567527|12346075|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7858556|NCT01567527|12346076|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7858557|NCT01567527|12346077|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7858558|NCT01567527|12346073|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7858559|NCT01567527|12346074|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
7858560|NCT01567527|12346075|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7858561|NCT01567527|12346076|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7858562|NCT01567527|12346077|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7858563|NCT01567527|12346073|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7858564|NCT01567527|12346074|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
7858565|NCT01567527|12346075|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7858566|NCT01567527|12346076|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7858567|NCT01567527|12346077|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7858568|NCT01567527|12346073|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7858569|NCT01567527|12346074|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
7858570|NCT01567527|12346075|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7858571|NCT01567527|12346076|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7858572|NCT01567527|12346077|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7858573|NCT01567527|12346073|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7858574|NCT01567527|12346074|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
7858575|NCT01567527|12346075|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7858576|NCT01567527|12346076|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7858577|NCT01567527|12346077|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7858578|NCT01567527|12346073|FG000|IM Depot Stabilization.|Protocol deviation|0
7858579|NCT01567527|12346074|FG001|IM Depot Stabilization.|Protocol deviation|0
7858580|NCT01567527|12346075|FG002|IM Depot Stabilization.|Protocol deviation|5
7858581|NCT01567527|12346076|FG003|IM Depot Stabilization.|Protocol deviation|0
7858582|NCT01567527|12346077|FG004|IM Depot Stabilization.|Protocol deviation|0
7858583|NCT01567527|12346073|FG000|IM Depot Stabilization.|Met withdrawal criteria|0
7858584|NCT01567527|12346074|FG001|IM Depot Stabilization.|Met withdrawal criteria|0
7858585|NCT01567527|12346075|FG002|IM Depot Stabilization.|Met withdrawal criteria|26
7858586|NCT01567527|12346076|FG003|IM Depot Stabilization.|Met withdrawal criteria|0
7858587|NCT01567527|12346077|FG004|IM Depot Stabilization.|Met withdrawal criteria|0
7858588|NCT01567527|12346073|FG000|IM Depot Stabilization.|Withdrawal by Subject|0
7858589|NCT01567527|12346074|FG001|IM Depot Stabilization.|Withdrawal by Subject|0
7858590|NCT01567527|12346075|FG002|IM Depot Stabilization.|Withdrawal by Subject|56
7858591|NCT01567527|12346076|FG003|IM Depot Stabilization.|Withdrawal by Subject|0
7858592|NCT01567527|12346077|FG004|IM Depot Stabilization.|Withdrawal by Subject|0
7858593|NCT01567527|12346073|FG000|IM Depot Stabilization.|Sponsor discontinued study|0
7858594|NCT01567527|12346074|FG001|IM Depot Stabilization.|Sponsor discontinued study|0
7858595|NCT01567527|12346075|FG002|IM Depot Stabilization.|Sponsor discontinued study|1
7858596|NCT01567527|12346076|FG003|IM Depot Stabilization.|Sponsor discontinued study|0
7858597|NCT01567527|12346077|FG004|IM Depot Stabilization.|Sponsor discontinued study|0
7858598|NCT01567527|12346073|FG000|IM Depot Stabilization.|Lost to Follow-up|0
7858599|NCT01567527|12346074|FG001|IM Depot Stabilization.|Lost to Follow-up|0
7858600|NCT01567527|12346075|FG002|IM Depot Stabilization.|Lost to Follow-up|21
7858601|NCT01567527|12346076|FG003|IM Depot Stabilization.|Lost to Follow-up|0
7858602|NCT01567527|12346077|FG004|IM Depot Stabilization.|Lost to Follow-up|0
7858603|NCT01567527|12346073|FG000|IM Depot Stabilization.|Lack of Efficacy|0
7858604|NCT01567527|12346074|FG001|IM Depot Stabilization.|Lack of Efficacy|0
7858605|NCT01567527|12346075|FG002|IM Depot Stabilization.|Lack of Efficacy|7
7858606|NCT01567527|12346076|FG003|IM Depot Stabilization.|Lack of Efficacy|0
7858607|NCT01567527|12346077|FG004|IM Depot Stabilization.|Lack of Efficacy|0
7858608|NCT01567527|12346073|FG000|IM Depot Stabilization.|Adverse Event|0
7858609|NCT01567527|12346074|FG001|IM Depot Stabilization.|Adverse Event|0
7858610|NCT01567527|12346075|FG002|IM Depot Stabilization.|Adverse Event|37
7858611|NCT01567527|12346076|FG003|IM Depot Stabilization.|Adverse Event|0
7858612|NCT01567527|12346077|FG004|IM Depot Stabilization.|Adverse Event|0
7858613|NCT01567527|12346073|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0
7858614|NCT01567527|12346074|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0
7858615|NCT01567527|12346075|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6
7858616|NCT01567527|12346076|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0
7858617|NCT01567527|12346077|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0
7858618|NCT01567527|12346073|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0
7858619|NCT01567527|12346074|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0
7858620|NCT01567527|12346075|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0
7858621|NCT01567527|12346076|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1
7858622|NCT01567527|12346077|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1
7858623|NCT01567527|12346073|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
7858624|NCT01567527|12346074|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
7883492|NCT01782326|12383167|FG001|Double-blind Treatment|Technical problems|5
7858625|NCT01567527|12346075|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
7858626|NCT01567527|12346076|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
7858627|NCT01567527|12346077|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
7858628|NCT01567527|12346073|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
7858629|NCT01567527|12346074|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
7858630|NCT01567527|12346075|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
7858631|NCT01567527|12346076|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
7858632|NCT01567527|12346077|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
7858633|NCT01567527|12346073|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
7858634|NCT01567527|12346074|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
7858635|NCT01567527|12346075|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
7858636|NCT01567527|12346076|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
7858637|NCT01567527|12346077|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
7858638|NCT01567527|12346073|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7858639|NCT01567527|12346074|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7858640|NCT01567527|12346075|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7858641|NCT01567527|12346076|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
7858642|NCT01567527|12346077|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
7858643|NCT01567527|12346073|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
7858644|NCT01567527|12346074|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
7858645|NCT01567527|12346075|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
7858646|NCT01567527|12346076|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
7858647|NCT01567527|12346077|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
7858648|NCT01567527|12346073|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
7858649|NCT01567527|12346074|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
7858650|NCT01567527|12346075|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
7858651|NCT01567527|12346076|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
7858652|NCT01567527|12346077|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
7858653|NCT01567527|12346073|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7858654|NCT01567527|12346074|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7858655|NCT01567527|12346075|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7858656|NCT01567527|12346076|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
7858657|NCT01567527|12346077|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
7858658|NCT01567826|12346088|FG000|Overall Study|Lost to Follow-up|3
7858659|NCT01567826|12346089|FG001|Overall Study|Lost to Follow-up|2
7858660|NCT01567852|12346107|FG000|Overall Study|Withdrawal by Subject|3
7858661|NCT01567852|12346108|FG001|Overall Study|Withdrawal by Subject|6
7858662|NCT01567852|12346107|FG000|Overall Study|ECT discontinued|1
7858663|NCT01567852|12346108|FG001|Overall Study|ECT discontinued|1
7858664|NCT01567865|12346118|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
7858665|NCT01567865|12346119|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
7858666|NCT01567865|12346120|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
7858667|NCT01567865|12346121|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
7858668|NCT01567865|12346118|FG000|Evaluated for Immunogenicity|Missing blood sample|17
7858669|NCT01567865|12346119|FG001|Evaluated for Immunogenicity|Missing blood sample|24
7858670|NCT01567865|12346120|FG002|Evaluated for Immunogenicity|Missing blood sample|16
7858671|NCT01567865|12346121|FG003|Evaluated for Immunogenicity|Missing blood sample|28
7858672|NCT01568034|12346163|FG000|Overall Study|Withdrawal by Subject|1
7858673|NCT01568034|12346164|FG001|Overall Study|Withdrawal by Subject|0
7858674|NCT01568034|12346165|FG002|Overall Study|Withdrawal by Subject|0
7858675|NCT01568034|12346166|FG003|Overall Study|Withdrawal by Subject|0
7858676|NCT01568047|12346180|FG000|Overall Study|Ineligibility|1
7858677|NCT01568047|12346181|FG001|Overall Study|Ineligibility|0
7858678|NCT01568047|12346182|FG002|Overall Study|Ineligibility|0
7858679|NCT01568047|12346183|FG003|Overall Study|Ineligibility|0
7858680|NCT01568047|12346180|FG000|Overall Study|Withdrawal by Subject|0
7858681|NCT01568047|12346181|FG001|Overall Study|Withdrawal by Subject|1
7858682|NCT01568047|12346182|FG002|Overall Study|Withdrawal by Subject|0
7858683|NCT01568047|12346183|FG003|Overall Study|Withdrawal by Subject|0
7858684|NCT01568047|12346180|FG000|Overall Study|Adverse Event|0
7858685|NCT01568047|12346181|FG001|Overall Study|Adverse Event|0
7858686|NCT01568047|12346182|FG002|Overall Study|Adverse Event|1
7858687|NCT01568047|12346183|FG003|Overall Study|Adverse Event|1
7858688|NCT01568112|12346218|FG000|Overall Study|Randomized But Not Treated|0
7858689|NCT01568112|12346219|FG001|Overall Study|Randomized But Not Treated|1
7858690|NCT01568112|12346220|FG002|Overall Study|Randomized But Not Treated|0
7858691|NCT01568112|12346221|FG003|Overall Study|Randomized But Not Treated|0
7858692|NCT01568112|12346218|FG000|Overall Study|Withdrew due to Adverse Event|2
7858693|NCT01568112|12346219|FG001|Overall Study|Withdrew due to Adverse Event|4
7858694|NCT01568112|12346220|FG002|Overall Study|Withdrew due to Adverse Event|6
7858695|NCT01568112|12346221|FG003|Overall Study|Withdrew due to Adverse Event|3
7858696|NCT01568112|12346218|FG000|Overall Study|Lost to Follow-up|0
7858697|NCT01568112|12346219|FG001|Overall Study|Lost to Follow-up|0
7858698|NCT01568112|12346220|FG002|Overall Study|Lost to Follow-up|0
7858699|NCT01568112|12346221|FG003|Overall Study|Lost to Follow-up|1
7858700|NCT01568112|12346218|FG000|Overall Study|Withdrawal by Subject|2
7858701|NCT01568112|12346219|FG001|Overall Study|Withdrawal by Subject|3
7858702|NCT01568112|12346220|FG002|Overall Study|Withdrawal by Subject|0
7858703|NCT01568112|12346221|FG003|Overall Study|Withdrawal by Subject|7
7858704|NCT01568112|12346218|FG000|Overall Study|Withdrawal by Physician|1
7858705|NCT01568112|12346219|FG001|Overall Study|Withdrawal by Physician|0
7858706|NCT01568112|12346220|FG002|Overall Study|Withdrawal by Physician|1
7858707|NCT01568112|12346221|FG003|Overall Study|Withdrawal by Physician|1
7858708|NCT01568320|12346241|FG000|Overall Study|Death|20
7858709|NCT01568320|12346241|FG000|Overall Study|Lost to Follow-up|9
7858710|NCT01568320|12346241|FG000|Overall Study|Withdrawal by Subject|10
7858711|NCT01568320|12346241|FG000|Overall Study|Conversion to open repair|1
7858712|NCT01568320|12346241|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1
7858713|NCT01568593|12346260|FG000|Overall Study|Lack of Efficacy|4
7858714|NCT01568593|12346261|FG001|Overall Study|Lack of Efficacy|1
7858715|NCT01568593|12346260|FG000|Overall Study|Adverse Event|3
7858716|NCT01568593|12346261|FG001|Overall Study|Adverse Event|2
7858717|NCT01568892|12346282|FG000|Open-label Phase|Adverse Event|2
7858718|NCT01568892|12346283|FG001|Open-label Phase|Adverse Event|0
7858719|NCT01568892|12346282|FG000|Open-label Phase|Lack of Efficacy|4
7858720|NCT01568892|12346283|FG001|Open-label Phase|Lack of Efficacy|2
7858721|NCT01568892|12346282|FG000|Open-label Phase|Lost to Follow-up|0
7720967|NCT00542386|12145504|FG005|Overall Study|Adverse Event|4
7720968|NCT00542386|12145499|FG000|Overall Study|Death|0
7720969|NCT00542386|12145500|FG001|Overall Study|Death|0
7720970|NCT00542386|12145501|FG002|Overall Study|Death|1
7858722|NCT01568892|12346283|FG001|Open-label Phase|Lost to Follow-up|1
7858723|NCT01569022|12346312|FG000|First Intervention|Lost to Follow-up|2
7858724|NCT01569022|12346313|FG001|First Intervention|Lost to Follow-up|1
7858725|NCT01569022|12346312|FG000|Second Intervention|Lost to Follow-up|2
7858726|NCT01569022|12346313|FG001|Second Intervention|Lost to Follow-up|2
7858727|NCT01569074|12346326|FG000|Overall Study|Study stopped|6
7858728|NCT01569074|12346327|FG001|Overall Study|Study stopped|6
7858729|NCT01569074|12346328|FG002|Overall Study|Study stopped|8
7858730|NCT01569074|12346329|FG003|Overall Study|Study stopped|7
7858731|NCT01569074|12346330|FG004|Overall Study|Study stopped|7
7858732|NCT01569074|12346326|FG000|Overall Study|Study-specific discontinuation criteria|0
7858733|NCT01569074|12346327|FG001|Overall Study|Study-specific discontinuation criteria|1
7858734|NCT01569074|12346328|FG002|Overall Study|Study-specific discontinuation criteria|0
7858735|NCT01569074|12346329|FG003|Overall Study|Study-specific discontinuation criteria|0
7858736|NCT01569074|12346330|FG004|Overall Study|Study-specific discontinuation criteria|0
7858737|NCT01569074|12346326|FG000|Overall Study|Severe non-compliance to protocol|0
7858738|NCT01569074|12346327|FG001|Overall Study|Severe non-compliance to protocol|0
7858739|NCT01569074|12346328|FG002|Overall Study|Severe non-compliance to protocol|1
7858740|NCT01569074|12346329|FG003|Overall Study|Severe non-compliance to protocol|0
7858741|NCT01569074|12346330|FG004|Overall Study|Severe non-compliance to protocol|0
7858742|NCT01569074|12346326|FG000|Overall Study|eg change in circumstances|0
7858743|NCT01569074|12346327|FG001|Overall Study|eg change in circumstances|2
7858744|NCT01569074|12346328|FG002|Overall Study|eg change in circumstances|0
7858745|NCT01569074|12346329|FG003|Overall Study|eg change in circumstances|1
7858746|NCT01569074|12346330|FG004|Overall Study|eg change in circumstances|1
7858747|NCT01569074|12346326|FG000|Overall Study|Adverse Event|1
7858748|NCT01569074|12346327|FG001|Overall Study|Adverse Event|0
7858749|NCT01569074|12346328|FG002|Overall Study|Adverse Event|3
7858750|NCT01569074|12346329|FG003|Overall Study|Adverse Event|0
7858751|NCT01569074|12346330|FG004|Overall Study|Adverse Event|0
7858752|NCT01569152|12346391|FG000|Phase IIa, Period 1|Early Escape|5
7858753|NCT01569152|12346392|FG001|Phase IIa, Period 1|Early Escape|22
7858754|NCT01569152|12346393|FG002|Phase IIa, Period 1|Early Escape|0
7858755|NCT01569152|12346391|FG000|Phase IIa, Period 1|Adverse Event|4
7858756|NCT01569152|12346392|FG001|Phase IIa, Period 1|Adverse Event|0
7858757|NCT01569152|12346393|FG002|Phase IIa, Period 1|Adverse Event|0
7858758|NCT01569152|12346391|FG000|Phase IIa, Period 1|Lost to Follow-up|1
7858759|NCT01569152|12346392|FG001|Phase IIa, Period 1|Lost to Follow-up|0
7858760|NCT01569152|12346393|FG002|Phase IIa, Period 1|Lost to Follow-up|0
7858761|NCT01569152|12346391|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9
7858762|NCT01569152|12346392|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8
7858763|NCT01569152|12346393|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0
7858764|NCT01569152|12346391|FG000|Phase IIa, Period 1|Protocol Violation|0
7858765|NCT01569152|12346392|FG001|Phase IIa, Period 1|Protocol Violation|1
7858766|NCT01569152|12346393|FG002|Phase IIa, Period 1|Protocol Violation|0
7858767|NCT01569152|12346391|FG000|Phase IIa, Period 1|Withdrawal by Subject|2
7858768|NCT01569152|12346392|FG001|Phase IIa, Period 1|Withdrawal by Subject|1
7858769|NCT01569152|12346393|FG002|Phase IIa, Period 1|Withdrawal by Subject|0
7858770|NCT01569152|12346391|FG000|Safety Extension, Period 3|Adverse Event|0
7858771|NCT01569152|12346392|FG001|Safety Extension, Period 3|Adverse Event|0
7720971|NCT00542386|12145502|FG003|Overall Study|Death|2
7949883|NCT02544217|12495951|FG005|Overall Study|Withdrawal by Subject|0
7949884|NCT02544321|12496020|FG000|Overall Study|Withdrawal by Subject|1
7949885|NCT02544321|12496021|FG001|Overall Study|Withdrawal by Subject|2
7949886|NCT02544321|12496020|FG000|Overall Study|Adverse Event|1
7858772|NCT01569152|12346393|FG002|Safety Extension, Period 3|Adverse Event|4
7858773|NCT01569152|12346391|FG000|Safety Extension, Period 3|Withdrawal by Subject|0
7858774|NCT01569152|12346392|FG001|Safety Extension, Period 3|Withdrawal by Subject|0
7858775|NCT01569152|12346393|FG002|Safety Extension, Period 3|Withdrawal by Subject|2
7858776|NCT01569152|12346391|FG000|Safety Extension, Period 3|Physician Decision|0
7858777|NCT01569152|12346392|FG001|Safety Extension, Period 3|Physician Decision|0
7858778|NCT01569152|12346393|FG002|Safety Extension, Period 3|Physician Decision|2
7858779|NCT01569152|12346391|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0
7858780|NCT01569152|12346392|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0
7858781|NCT01569152|12346393|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47
7858782|NCT01569295|12346415|FG000|Overall Study|Progressive Disease|75
7858783|NCT01569295|12346416|FG001|Overall Study|Progressive Disease|139
7858784|NCT01569295|12346415|FG000|Overall Study|Adverse Event|39
7858785|NCT01569295|12346416|FG001|Overall Study|Adverse Event|14
7858786|NCT01569295|12346415|FG000|Overall Study|Withdrawal by Subject|25
7858787|NCT01569295|12346416|FG001|Overall Study|Withdrawal by Subject|12
7858788|NCT01569295|12346415|FG000|Overall Study|Death|19
7858789|NCT01569295|12346416|FG001|Overall Study|Death|15
7858790|NCT01569295|12346415|FG000|Overall Study|Physician Decision|13
7858791|NCT01569295|12346416|FG001|Overall Study|Physician Decision|18
7858792|NCT01569295|12346415|FG000|Overall Study|Study Terminated by Sponsor|24
7858793|NCT01569295|12346416|FG001|Overall Study|Study Terminated by Sponsor|2
7858794|NCT01569295|12346415|FG000|Overall Study|Other Reason not Specified|3
7858795|NCT01569295|12346416|FG001|Overall Study|Other Reason not Specified|5
7858796|NCT01569295|12346415|FG000|Overall Study|Non-Compliance with Study Drug|6
7858797|NCT01569295|12346416|FG001|Overall Study|Non-Compliance with Study Drug|1
7858798|NCT01569295|12346415|FG000|Overall Study|Other Anticancer/Experimental Therapy|2
7858799|NCT01569295|12346416|FG001|Overall Study|Other Anticancer/Experimental Therapy|2
7858800|NCT01569295|12346415|FG000|Overall Study|Lost to Follow-up|1
7858801|NCT01569295|12346416|FG001|Overall Study|Lost to Follow-up|1
7858802|NCT01569438|12346425|FG000|Overall Study|Lack of Efficacy|1
7858803|NCT01569438|12346426|FG001|Overall Study|Lack of Efficacy|2
7858804|NCT01569438|12346425|FG000|Overall Study|Withdrawal by Subject|0
7858805|NCT01569438|12346426|FG001|Overall Study|Withdrawal by Subject|3
7858806|NCT01569438|12346425|FG000|Overall Study|Adverse Event|2
7858807|NCT01569438|12346426|FG001|Overall Study|Adverse Event|15
7858808|NCT01569438|12346425|FG000|Overall Study|Protocol Violation|2
7858809|NCT01569438|12346426|FG001|Overall Study|Protocol Violation|0
7858810|NCT01569438|12346425|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1
7858811|NCT01569438|12346426|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0
7858812|NCT01569438|12346425|FG000|Overall Study|Sponsor/Physician decision|1
7858813|NCT01569438|12346426|FG001|Overall Study|Sponsor/Physician decision|1
7858814|NCT01569438|12346425|FG000|Overall Study|Unable to adhere to study schedule|0
7858815|NCT01569438|12346426|FG001|Overall Study|Unable to adhere to study schedule|1
7858816|NCT01569464|12346445|FG000|Overall Study|Adverse Event|4
7858817|NCT01569464|12346446|FG001|Overall Study|Adverse Event|0
7858818|NCT01569464|12346445|FG000|Overall Study|Lack of Efficacy|1
7858819|NCT01569464|12346446|FG001|Overall Study|Lack of Efficacy|0
7858820|NCT01569464|12346445|FG000|Overall Study|Protocol Violation|1
7858821|NCT01569464|12346446|FG001|Overall Study|Protocol Violation|0
7858822|NCT01569464|12346445|FG000|Overall Study|Lost to Follow-up|2
7858823|NCT01569464|12346446|FG001|Overall Study|Lost to Follow-up|3
7858824|NCT01569464|12346445|FG000|Overall Study|Withdrawal by Subject|1
7858825|NCT01569464|12346446|FG001|Overall Study|Withdrawal by Subject|1
7858826|NCT01569464|12346445|FG000|Overall Study|Other|1
7858827|NCT01569464|12346446|FG001|Overall Study|Other|1
7858828|NCT01569568|12346465|FG000|Overall Study|Physician Decision|0
7858829|NCT01569568|12346466|FG001|Overall Study|Physician Decision|2
7858830|NCT01569594|12346472|FG000|Overall Study|Physician Decision|4
7858831|NCT01569594|12346472|FG000|Overall Study|Death|13
7858832|NCT01569594|12346472|FG000|Overall Study|Lost to Follow-up|22
7858833|NCT01569594|12346472|FG000|Overall Study|Adverse Event|2
7858834|NCT01569594|12346472|FG000|Overall Study|Withdrawal by Subject|13
7858835|NCT01569594|12346472|FG000|Overall Study|Other|4
7858836|NCT01569594|12346472|FG000|Overall Study|No ECM used|9
7858837|NCT01569763|12346491|FG000|Overall Study|Lack of Efficacy|2
7858838|NCT01569763|12346492|FG001|Overall Study|Lack of Efficacy|7
7858839|NCT01569763|12346491|FG000|Overall Study|Adverse Event|1
7858840|NCT01569763|12346492|FG001|Overall Study|Adverse Event|0
7858841|NCT01569841|12346526|FG000|Period A (6 Weeks)|Withdrawal by Subject|0
7858842|NCT01569841|12346527|FG001|Period A (6 Weeks)|Withdrawal by Subject|1
7858843|NCT01570192|12346546|FG000|Overall Study|no qualifying organism|6
7858844|NCT01570192|12346547|FG001|Overall Study|no qualifying organism|12
7858845|NCT01570192|12346546|FG000|Overall Study|changed to palliative care|1
7858846|NCT01570192|12346547|FG001|Overall Study|changed to palliative care|0
7858847|NCT01570192|12346546|FG000|Overall Study|Physician Decision|0
7858848|NCT01570192|12346547|FG001|Overall Study|Physician Decision|1
7858849|NCT01570244|12346558|FG000|Microgynon+Faldaprevir|Adverse Event|1
7858850|NCT01570283|12346567|FG000|Cohort 1: Dose Level 1|Death|0
7858851|NCT01570283|12346568|FG001|Cohort 1: Dose Level 1|Death|1
7858852|NCT01570283|12346569|FG002|Cohort 1: Dose Level 1|Death|0
7858853|NCT01570283|12346570|FG003|Cohort 1: Dose Level 1|Death|0
7858854|NCT01570283|12346571|FG004|Cohort 1: Dose Level 1|Death|0
7858855|NCT01570283|12346572|FG005|Cohort 1: Dose Level 1|Death|0
7858856|NCT01570283|12346567|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7858857|NCT01570283|12346568|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1
7858858|NCT01570283|12346569|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7858859|NCT01570283|12346570|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7858860|NCT01570283|12346571|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7858861|NCT01570283|12346572|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7858862|NCT01570283|12346567|FG000|Cohort 2: Dose Level 2|Death|0
7858863|NCT01570283|12346568|FG001|Cohort 2: Dose Level 2|Death|0
7858864|NCT01570283|12346569|FG002|Cohort 2: Dose Level 2|Death|1
7858865|NCT01570283|12346570|FG003|Cohort 2: Dose Level 2|Death|0
7858866|NCT01570283|12346571|FG004|Cohort 2: Dose Level 2|Death|0
7858867|NCT01570283|12346572|FG005|Cohort 2: Dose Level 2|Death|0
7858868|NCT01570283|12346567|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7858869|NCT01570283|12346568|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7858870|NCT01570283|12346569|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7858871|NCT01570283|12346570|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1
7858872|NCT01570283|12346571|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7858873|NCT01570283|12346572|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7858874|NCT01570283|12346567|FG000|Cohort 3: Dose Level 3|Death|0
7858875|NCT01570283|12346568|FG001|Cohort 3: Dose Level 3|Death|0
7858876|NCT01570283|12346569|FG002|Cohort 3: Dose Level 3|Death|0
7858877|NCT01570283|12346570|FG003|Cohort 3: Dose Level 3|Death|0
7858878|NCT01570283|12346571|FG004|Cohort 3: Dose Level 3|Death|0
7858879|NCT01570283|12346572|FG005|Cohort 3: Dose Level 3|Death|1
7858880|NCT01570283|12346567|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7858881|NCT01570283|12346568|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7858882|NCT01570283|12346569|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7858883|NCT01570283|12346570|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7858884|NCT01570283|12346571|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7858885|NCT01570283|12346572|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1
7858886|NCT01570309|12346588|FG000|Overall Study|Withdrawal by Subject|3
7858887|NCT01570309|12346589|FG001|Overall Study|Withdrawal by Subject|3
7858888|NCT01570361|12346605|FG000|Overall Study|Subject discontinued|1
7858889|NCT01570361|12346606|FG001|Overall Study|Subject discontinued|2
7858890|NCT01570361|12346605|FG000|Overall Study|Sponsor closing the study|51
7858891|NCT01570361|12346606|FG001|Overall Study|Sponsor closing the study|50
7858892|NCT01570361|12346605|FG000|Overall Study|Subject excluded|5
7858893|NCT01570361|12346606|FG001|Overall Study|Subject excluded|3
7858894|NCT01570361|12346605|FG000|Overall Study|Subject withdrew consent|14
7858895|NCT01570361|12346606|FG001|Overall Study|Subject withdrew consent|9
7858896|NCT01570361|12346605|FG000|Overall Study|Adverse Event|2
7858897|NCT01570361|12346606|FG001|Overall Study|Adverse Event|1
7858898|NCT01570361|12346605|FG000|Overall Study|Lost to Follow-up|4
7858899|NCT01570361|12346606|FG001|Overall Study|Lost to Follow-up|4
7858900|NCT01570361|12346605|FG000|Overall Study|Death|5
7858901|NCT01570361|12346606|FG001|Overall Study|Death|4
7858902|NCT01570361|12346605|FG000|Overall Study|Other|0
7858903|NCT01570361|12346606|FG001|Overall Study|Other|2
7858904|NCT01570387|12346619|FG000|Overall Study|Adverse Event|1
7858905|NCT01570387|12346620|FG001|Overall Study|Adverse Event|0
7858906|NCT01570387|12346621|FG002|Overall Study|Adverse Event|0
7858907|NCT01570387|12346622|FG003|Overall Study|Adverse Event|0
7858908|NCT01570387|12346619|FG000|Overall Study|Death|0
7858909|NCT01570387|12346620|FG001|Overall Study|Death|0
7858910|NCT01570387|12346621|FG002|Overall Study|Death|0
7858911|NCT01570387|12346622|FG003|Overall Study|Death|1
7858912|NCT01570387|12346619|FG000|Overall Study|Withdrawal by Subject|0
7858913|NCT01570387|12346620|FG001|Overall Study|Withdrawal by Subject|0
7858914|NCT01570387|12346621|FG002|Overall Study|Withdrawal by Subject|0
7858915|NCT01570387|12346622|FG003|Overall Study|Withdrawal by Subject|1
7858916|NCT01570491|12346631|FG000|Overall Study|Lost to Follow-up|3
7858917|NCT01570491|12346632|FG001|Overall Study|Lost to Follow-up|1
7858918|NCT01570491|12346631|FG000|Overall Study|treatment: not given or discontinued|2
7858919|NCT01570491|12346632|FG001|Overall Study|treatment: not given or discontinued|0
7858920|NCT01570686|12346640|FG000|Overall Study|Abnormal test procedure result(s)|1
7858921|NCT01570686|12346641|FG001|Overall Study|Abnormal test procedure result(s)|1
7858922|NCT01570686|12346640|FG000|Overall Study|Administrative problems|0
7858923|NCT01570686|12346641|FG001|Overall Study|Administrative problems|1
7858924|NCT01570686|12346640|FG000|Overall Study|Adverse Event|8
7858925|NCT01570686|12346641|FG001|Overall Study|Adverse Event|6
7858926|NCT01570686|12346640|FG000|Overall Study|Lost to Follow-up|4
7858927|NCT01570686|12346641|FG001|Overall Study|Lost to Follow-up|3
7858928|NCT01570686|12346640|FG000|Overall Study|Protocol Deviation|3
7858929|NCT01570686|12346641|FG001|Overall Study|Protocol Deviation|0
7858930|NCT01570686|12346640|FG000|Overall Study|Withdrawal by Subject|4
7858931|NCT01570686|12346641|FG001|Overall Study|Withdrawal by Subject|4
7858932|NCT01570686|12346640|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7858933|NCT01570686|12346641|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7858934|NCT01570751|12346649|FG000|Period A (16 Weeks)|Protocol Violation|1
7858935|NCT01570751|12346650|FG001|Period A (16 Weeks)|Protocol Violation|1
7858936|NCT01570751|12346649|FG000|Period A (16 Weeks)|Withdrawal criteria|0
7858937|NCT01570751|12346650|FG001|Period A (16 Weeks)|Withdrawal criteria|1
7858938|NCT01570751|12346649|FG000|Period A (16 Weeks)|Unclassified|2
7858939|NCT01570751|12346650|FG001|Period A (16 Weeks)|Unclassified|3
7858940|NCT01570751|12346649|FG000|Period B (16 Weeks)|Adverse Event|1
7858941|NCT01570751|12346650|FG001|Period B (16 Weeks)|Adverse Event|0
7858942|NCT01570751|12346649|FG000|Period B (16 Weeks)|Protocol Violation|0
7858943|NCT01570751|12346650|FG001|Period B (16 Weeks)|Protocol Violation|1
7858944|NCT01570868|12346669|FG000|Overall Study|Adverse Event|8
7858945|NCT01570868|12346670|FG001|Overall Study|Adverse Event|1
7858946|NCT01570868|12346669|FG000|Overall Study|FDA Recommendation|23
7858947|NCT01570868|12346670|FG001|Overall Study|FDA Recommendation|3
7858948|NCT01570868|12346669|FG000|Overall Study|Physician Decision|10
7858949|NCT01570868|12346670|FG001|Overall Study|Physician Decision|4
7858950|NCT01570868|12346669|FG000|Overall Study|Lost to Follow-up|1
7858951|NCT01570868|12346670|FG001|Overall Study|Lost to Follow-up|0
7858952|NCT01570868|12346669|FG000|Overall Study|Withdrawal by Subject|1
7858953|NCT01570868|12346670|FG001|Overall Study|Withdrawal by Subject|0
7858954|NCT01571232|12346682|FG000|Overall Study|Lost to Follow-up|0
7858955|NCT01571232|12346683|FG001|Overall Study|Lost to Follow-up|1
7858956|NCT01571232|12346682|FG000|Overall Study|Withdrawal by Subject|1
7858957|NCT01571232|12346683|FG001|Overall Study|Withdrawal by Subject|0
7858958|NCT01571284|12346690|FG000|Overall Study|Participant's decision|84
7858959|NCT01571284|12346690|FG000|Overall Study|Lost to Follow-up|3
7858960|NCT01571284|12346690|FG000|Overall Study|Enrolled but not treated|2
7858961|NCT01571284|12346690|FG000|Overall Study|Other than specified above|80
7858962|NCT01571362|12346694|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
7858963|NCT01571362|12346695|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
7858964|NCT01571362|12346696|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
7858965|NCT01571362|12346694|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7
7858966|NCT01571362|12346695|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0
7858967|NCT01571362|12346696|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0
7858968|NCT01571362|12346694|FG000|Open-Label Conversion + Titration Period|Adverse Event|57
7858969|NCT01571362|12346695|FG001|Open-Label Conversion + Titration Period|Adverse Event|0
7858970|NCT01571362|12346696|FG002|Open-Label Conversion + Titration Period|Adverse Event|0
7858971|NCT01571362|12346694|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10
7858972|NCT01571362|12346695|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0
7858973|NCT01571362|12346696|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0
7858974|NCT01571362|12346694|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
7858975|NCT01571362|12346695|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
7858976|NCT01571362|12346696|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
7858977|NCT01571362|12346694|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3
7858978|NCT01571362|12346695|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0
7858979|NCT01571362|12346696|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0
7858980|NCT01571362|12346694|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7858981|NCT01571362|12346695|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11
7858982|NCT01571362|12346696|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5
7858983|NCT01571362|12346694|FG000|Double-Blind Treatment Period|Protocol Violation|0
7858984|NCT01571362|12346695|FG001|Double-Blind Treatment Period|Protocol Violation|8
7858985|NCT01571362|12346696|FG002|Double-Blind Treatment Period|Protocol Violation|9
7858986|NCT01571362|12346694|FG000|Double-Blind Treatment Period|Adverse Event|0
7858987|NCT01571362|12346695|FG001|Double-Blind Treatment Period|Adverse Event|9
7858988|NCT01571362|12346696|FG002|Double-Blind Treatment Period|Adverse Event|14
7858989|NCT01571362|12346694|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7858990|NCT01571362|12346695|FG001|Double-Blind Treatment Period|Lost to Follow-up|3
7858991|NCT01571362|12346696|FG002|Double-Blind Treatment Period|Lost to Follow-up|6
7858992|NCT01571362|12346694|FG000|Double-Blind Treatment Period|Insufficient clinical response|0
7858993|NCT01571362|12346695|FG001|Double-Blind Treatment Period|Insufficient clinical response|16
7858994|NCT01571362|12346696|FG002|Double-Blind Treatment Period|Insufficient clinical response|4
7858995|NCT01571362|12346694|FG000|Double-Blind Treatment Period|Other - unspecified|0
7858996|NCT01571362|12346695|FG001|Double-Blind Treatment Period|Other - unspecified|6
7858997|NCT01571362|12346696|FG002|Double-Blind Treatment Period|Other - unspecified|1
7858998|NCT01571453|12346715|FG000|Overall Study|Adverse Event|14
7858999|NCT01571453|12346716|FG001|Overall Study|Adverse Event|32
7859000|NCT01571453|12346715|FG000|Overall Study|Lack of Efficacy|8
7859001|NCT01571453|12346716|FG001|Overall Study|Lack of Efficacy|3
7859002|NCT01571453|12346715|FG000|Overall Study|Non-compliance|2
7859003|NCT01571453|12346716|FG001|Overall Study|Non-compliance|4
7859004|NCT01571453|12346715|FG000|Overall Study|Protocol Violation|1
7859005|NCT01571453|12346716|FG001|Overall Study|Protocol Violation|5
7859006|NCT01571453|12346715|FG000|Overall Study|Withdrawal of consent|5
7859007|NCT01571453|12346716|FG001|Overall Study|Withdrawal of consent|13
7859008|NCT01571453|12346715|FG000|Overall Study|Lost to Follow-up|4
7859009|NCT01571453|12346716|FG001|Overall Study|Lost to Follow-up|2
7859010|NCT01571453|12346715|FG000|Overall Study|Administrative or other reason(s)|4
7859011|NCT01571453|12346716|FG001|Overall Study|Administrative or other reason(s)|3
7859012|NCT01571596|12346729|FG000|Overall Study|Adverse Event|2
7859013|NCT01571596|12346730|FG001|Overall Study|Adverse Event|0
7859014|NCT01571596|12346731|FG002|Overall Study|Adverse Event|0
7859015|NCT01571596|12346729|FG000|Overall Study|Study Terminated by the Sponsor|0
7859016|NCT01571596|12346730|FG001|Overall Study|Study Terminated by the Sponsor|1
7859017|NCT01571596|12346731|FG002|Overall Study|Study Terminated by the Sponsor|1
7859018|NCT01572038|12346741|FG000|Overall Study|Death|648
7859019|NCT01572038|12346741|FG000|Overall Study|Withdrawal by Subject|204
7859020|NCT01572038|12346741|FG000|Overall Study|Lost to Follow-up|81
7859021|NCT01572038|12346741|FG000|Overall Study|Physician Decision|20
7859022|NCT01572038|12346741|FG000|Overall Study|Patient Decision|14
7859023|NCT01572038|12346741|FG000|Overall Study|Progressive Disease|8
7859024|NCT01572038|12346741|FG000|Overall Study|Site Closed Before Completing Form|6
7859025|NCT01572038|12346741|FG000|Overall Study|Enrolled into Another Trial|3
7859026|NCT01572038|12346741|FG000|Overall Study|Participated in Another Trial|3
7859027|NCT01572038|12346741|FG000|Overall Study|Termination by Sponsor|2
7859028|NCT01572038|12346741|FG000|Overall Study|Patient Deterioration|1
7859029|NCT01572038|12346741|FG000|Overall Study|Sponsor Decision|1
7859030|NCT01572389|12346780|FG000|Overall Study|Death|1
7859031|NCT01572389|12346781|FG001|Overall Study|Death|3
7859032|NCT01572389|12346780|FG000|Overall Study|Withdrawal by Subject|14
7859033|NCT01572389|12346781|FG001|Overall Study|Withdrawal by Subject|2
7859034|NCT01572389|12346780|FG000|Overall Study|Lost to Follow-up|25
7859035|NCT01572389|12346781|FG001|Overall Study|Lost to Follow-up|14
7859036|NCT01572389|12346780|FG000|Overall Study|Only A1C or Assessment was Collected|6
7859037|NCT01572389|12346781|FG001|Overall Study|Only A1C or Assessment was Collected|2
7859038|NCT01572727|12346798|FG000|Overall Study|Adverse Event|43
7859039|NCT01572727|12346799|FG001|Overall Study|Adverse Event|15
7859040|NCT01572727|12346798|FG000|Overall Study|Lost to Follow-up|1
7859041|NCT01572727|12346799|FG001|Overall Study|Lost to Follow-up|1
7859042|NCT01572727|12346798|FG000|Overall Study|Physician Decision|23
7859043|NCT01572727|12346799|FG001|Overall Study|Physician Decision|9
7859044|NCT01572727|12346798|FG000|Overall Study|Progressive disease|59
7859045|NCT01572727|12346799|FG001|Overall Study|Progressive disease|82
7859046|NCT01572727|12346798|FG000|Overall Study|Protocol Violation|0
7859047|NCT01572727|12346799|FG001|Overall Study|Protocol Violation|1
7859048|NCT01572727|12346798|FG000|Overall Study|Study terminated by sponsor|61
7859049|NCT01572727|12346799|FG001|Overall Study|Study terminated by sponsor|83
7859050|NCT01572727|12346798|FG000|Overall Study|Parent/guardian decision|14
7859051|NCT01572727|12346799|FG001|Overall Study|Parent/guardian decision|9
7859052|NCT01572727|12346798|FG000|Overall Study|Death|2
7859053|NCT01572727|12346799|FG001|Overall Study|Death|2
7859054|NCT01572727|12346798|FG000|Overall Study|Untreated|4
7859055|NCT01572727|12346799|FG001|Overall Study|Untreated|7
7859056|NCT01572740|12346807|FG000|Overall Study|Adverse Event|1
7859057|NCT01572740|12346808|FG001|Overall Study|Adverse Event|1
7859058|NCT01572740|12346807|FG000|Overall Study|Withdrawal by Subject|1
7859059|NCT01572740|12346808|FG001|Overall Study|Withdrawal by Subject|1
7859060|NCT01572740|12346807|FG000|Overall Study|unclassified|4
7859061|NCT01572740|12346808|FG001|Overall Study|unclassified|3
7859062|NCT01572792|12346819|FG000|Lead-in Study|Lost to Follow-up|5
7859063|NCT01572792|12346820|FG001|Lead-in Study|Lost to Follow-up|9
7859064|NCT01572792|12346821|FG002|Lead-in Study|Lost to Follow-up|4
7859065|NCT01572792|12346822|FG003|Lead-in Study|Lost to Follow-up|2
7859066|NCT01572792|12346823|FG004|Lead-in Study|Lost to Follow-up|4
7859067|NCT01572792|12346819|FG000|Lead-in Study|Withdrawal by Subject|22
7859068|NCT01572792|12346820|FG001|Lead-in Study|Withdrawal by Subject|11
7859069|NCT01572792|12346821|FG002|Lead-in Study|Withdrawal by Subject|12
7859070|NCT01572792|12346822|FG003|Lead-in Study|Withdrawal by Subject|24
7859071|NCT01572792|12346823|FG004|Lead-in Study|Withdrawal by Subject|11
7859072|NCT01572792|12346819|FG000|Lead-in Study|Protocol Violation|19
7859073|NCT01572792|12346820|FG001|Lead-in Study|Protocol Violation|10
7859074|NCT01572792|12346821|FG002|Lead-in Study|Protocol Violation|12
7859075|NCT01572792|12346822|FG003|Lead-in Study|Protocol Violation|13
7859076|NCT01572792|12346823|FG004|Lead-in Study|Protocol Violation|21
7859077|NCT01572792|12346819|FG000|Lead-in Study|Lack of Efficacy|20
7859078|NCT01572792|12346820|FG001|Lead-in Study|Lack of Efficacy|5
7859079|NCT01572792|12346821|FG002|Lead-in Study|Lack of Efficacy|4
7859080|NCT01572792|12346822|FG003|Lead-in Study|Lack of Efficacy|8
7859081|NCT01572792|12346823|FG004|Lead-in Study|Lack of Efficacy|10
7859082|NCT01572792|12346819|FG000|Lead-in Study|Adverse Event|21
7859083|NCT01572792|12346820|FG001|Lead-in Study|Adverse Event|21
7859084|NCT01572792|12346821|FG002|Lead-in Study|Adverse Event|22
7859085|NCT01572792|12346822|FG003|Lead-in Study|Adverse Event|16
7859086|NCT01572792|12346823|FG004|Lead-in Study|Adverse Event|14
7859087|NCT01572792|12346819|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14
7859088|NCT01572792|12346820|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10
7859089|NCT01572792|12346821|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8
7859090|NCT01572792|12346822|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9
7859091|NCT01572792|12346823|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9
7859092|NCT01572792|12346819|FG000|Extension Study|Lost to Follow-up|6
7859093|NCT01572792|12346820|FG001|Extension Study|Lost to Follow-up|2
7859094|NCT01572792|12346821|FG002|Extension Study|Lost to Follow-up|0
7859095|NCT01572792|12346822|FG003|Extension Study|Lost to Follow-up|3
7859096|NCT01572792|12346823|FG004|Extension Study|Lost to Follow-up|3
7859097|NCT01572792|12346819|FG000|Extension Study|Withdrawal by Subject|7
7859098|NCT01572792|12346820|FG001|Extension Study|Withdrawal by Subject|6
7859099|NCT01572792|12346821|FG002|Extension Study|Withdrawal by Subject|11
7859100|NCT01572792|12346822|FG003|Extension Study|Withdrawal by Subject|8
7859101|NCT01572792|12346823|FG004|Extension Study|Withdrawal by Subject|14
7859102|NCT01572792|12346819|FG000|Extension Study|Protocol Violation|0
7859103|NCT01572792|12346820|FG001|Extension Study|Protocol Violation|4
7859104|NCT01572792|12346821|FG002|Extension Study|Protocol Violation|3
7859105|NCT01572792|12346822|FG003|Extension Study|Protocol Violation|4
7859106|NCT01572792|12346823|FG004|Extension Study|Protocol Violation|3
7859107|NCT01572792|12346819|FG000|Extension Study|Lack of Efficacy|2
7859108|NCT01572792|12346820|FG001|Extension Study|Lack of Efficacy|3
7859109|NCT01572792|12346821|FG002|Extension Study|Lack of Efficacy|3
7859110|NCT01572792|12346822|FG003|Extension Study|Lack of Efficacy|2
7859111|NCT01572792|12346823|FG004|Extension Study|Lack of Efficacy|2
7859112|NCT01572792|12346819|FG000|Extension Study|Adverse Event|7
7859113|NCT01572792|12346820|FG001|Extension Study|Adverse Event|6
7859114|NCT01572792|12346821|FG002|Extension Study|Adverse Event|5
7859115|NCT01572792|12346822|FG003|Extension Study|Adverse Event|6
7859116|NCT01572792|12346823|FG004|Extension Study|Adverse Event|4
7859117|NCT01572792|12346819|FG000|Extension Study|Site termination/COPD exacerbation/other|3
7859118|NCT01572792|12346820|FG001|Extension Study|Site termination/COPD exacerbation/other|8
7859119|NCT01572792|12346821|FG002|Extension Study|Site termination/COPD exacerbation/other|4
7859120|NCT01572792|12346822|FG003|Extension Study|Site termination/COPD exacerbation/other|6
7859121|NCT01572792|12346823|FG004|Extension Study|Site termination/COPD exacerbation/other|6
7859122|NCT01572844|12346836|FG000|Overall Study|Physician Decision|1
7859123|NCT01572844|12346837|FG001|Overall Study|Physician Decision|1
7859124|NCT01572909|12346848|FG000|Overall Study|Adverse Event|7
7859125|NCT01572909|12346849|FG001|Overall Study|Adverse Event|2
7859126|NCT01572909|12346848|FG000|Overall Study|Death|3
7859127|NCT01572909|12346849|FG001|Overall Study|Death|1
7859128|NCT01572909|12346848|FG000|Overall Study|Lost to Follow-up|8
7859129|NCT01572909|12346849|FG001|Overall Study|Lost to Follow-up|7
7859130|NCT01572909|12346848|FG000|Overall Study|Physician Decision|1
7859131|NCT01572909|12346849|FG001|Overall Study|Physician Decision|1
7859132|NCT01572909|12346848|FG000|Overall Study|Technical Issues|1
7859133|NCT01572909|12346849|FG001|Overall Study|Technical Issues|0
7859134|NCT01572909|12346848|FG000|Overall Study|Withdrawal by Subject|12
7859135|NCT01572909|12346849|FG001|Overall Study|Withdrawal by Subject|11
7859136|NCT01572909|12346848|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0
7859137|NCT01572909|12346849|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3
7859138|NCT01572922|12346857|FG000|Overall Study|Adverse Event|1
7859139|NCT01572922|12346857|FG000|Overall Study|Protocol Violation|1
7859140|NCT01572922|12346857|FG000|Overall Study|Death|1
7859141|NCT01572948|12346868|FG000|Overall Study|Lost to Follow-up|1
7859142|NCT01572948|12346869|FG001|Overall Study|Lost to Follow-up|0
7859143|NCT01572948|12346868|FG000|Overall Study|unable to contact|0
7859144|NCT01572948|12346869|FG001|Overall Study|unable to contact|1
7859145|NCT01573000|12346881|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
7859146|NCT01573000|12346882|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
7859147|NCT01573000|12346881|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
7859148|NCT01573000|12346882|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
7859149|NCT01573000|12346881|FG000|Dosimetric and Therapeutic Treatment|Death|0
7859150|NCT01573000|12346882|FG001|Dosimetric and Therapeutic Treatment|Death|1
7859151|NCT01573000|12346881|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
7859152|NCT01573000|12346882|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
7859153|NCT01573000|12346881|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
7859154|NCT01573000|12346882|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
7859155|NCT01573000|12346881|FG000|Crossover Phase|Lack of Efficacy|0
7859156|NCT01573000|12346882|FG001|Crossover Phase|Lack of Efficacy|13
7859157|NCT01573000|12346881|FG000|Crossover Phase|Lost to Follow-up|0
7859158|NCT01573000|12346882|FG001|Crossover Phase|Lost to Follow-up|2
7859159|NCT01573000|12346881|FG000|Crossover Phase|Death|0
7859160|NCT01573000|12346882|FG001|Crossover Phase|Death|3
7859161|NCT01573000|12346881|FG000|Long-Term Follow-Up|Death|3
7859162|NCT01573000|12346882|FG001|Long-Term Follow-Up|Death|0
7859163|NCT01573000|12346881|FG000|Long-Term Follow-Up|Lost to Follow-up|0
7859164|NCT01573000|12346882|FG001|Long-Term Follow-Up|Lost to Follow-up|1
7863875|NCT01609556|12353450|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7863876|NCT01609556|12353451|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7863877|NCT01609556|12353452|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7863878|NCT01609556|12353453|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7863879|NCT01609556|12353454|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7863880|NCT01609556|12353455|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7863881|NCT01609556|12353456|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7863882|NCT01609556|12353457|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7863883|NCT01609556|12353458|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7863884|NCT01609556|12353459|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7863885|NCT01609556|12353444|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7863886|NCT01609556|12353445|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
7863887|NCT01609556|12353446|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
7863888|NCT01609556|12353447|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
7863889|NCT01609556|12353448|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8
7863890|NCT01609556|12353449|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13
7863891|NCT01609556|12353450|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5
7863892|NCT01609556|12353451|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4
7863893|NCT01609556|12353452|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
7863894|NCT01609556|12353453|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
7863895|NCT01609556|12353454|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6
7863896|NCT01609556|12353455|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
7863897|NCT01609556|12353456|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7863898|NCT01609556|12353457|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7863899|NCT01609556|12353458|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7863900|NCT01609556|12353459|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7863901|NCT01609556|12353444|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7863902|NCT01609556|12353445|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7863903|NCT01609556|12353446|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7863904|NCT01609556|12353447|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7863905|NCT01609556|12353448|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7863906|NCT01609556|12353449|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
7863907|NCT01609556|12353450|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
7863908|NCT01609556|12353451|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7863909|NCT01609556|12353452|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7863910|NCT01609556|12353453|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
7863911|NCT01609556|12353454|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
7863912|NCT01609556|12353455|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
7863913|NCT01609556|12353456|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7859165|NCT01573442|12346970|FG000|Overall Study|Cancels|9
7859166|NCT01573442|12346971|FG001|Overall Study|Cancels|10
7859167|NCT01573624|12346985|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7859168|NCT01573624|12346986|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7859169|NCT01573624|12346987|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
7859170|NCT01573624|12346988|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7859171|NCT01573624|12346989|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7859172|NCT01573624|12346990|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
7859173|NCT01573624|12346991|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7859174|NCT01573624|12346985|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
7859175|NCT01573624|12346986|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
7859176|NCT01573624|12346987|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
7859177|NCT01573624|12346988|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
7859178|NCT01573624|12346989|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
7859179|NCT01573624|12346990|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
7859180|NCT01573624|12346991|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
7859181|NCT01573624|12346985|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
7859182|NCT01573624|12346986|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7859183|NCT01573624|12346987|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7859184|NCT01573624|12346988|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7859185|NCT01573624|12346989|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7859186|NCT01573624|12346990|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7859187|NCT01573624|12346991|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7859188|NCT01573624|12346985|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7859189|NCT01573624|12346986|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7859190|NCT01573624|12346987|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7859191|NCT01573624|12346988|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7859192|NCT01573624|12346989|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7859193|NCT01573624|12346990|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
7859194|NCT01573624|12346991|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7859195|NCT01573624|12346985|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
7859196|NCT01573624|12346986|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
7859197|NCT01573624|12346987|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7859198|NCT01573624|12346988|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7859199|NCT01573624|12346989|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
7859200|NCT01573624|12346990|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7859201|NCT01573624|12346991|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7859202|NCT01573624|12346985|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7859203|NCT01573624|12346986|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7859204|NCT01573624|12346987|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7859205|NCT01573624|12346988|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7859206|NCT01573624|12346989|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7859207|NCT01573624|12346990|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
7859208|NCT01573624|12346991|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7859209|NCT01573624|12346985|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7859210|NCT01573624|12346986|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
7859211|NCT01573624|12346987|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7859212|NCT01573624|12346988|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
7859213|NCT01573624|12346989|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7859214|NCT01573624|12346990|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7859215|NCT01573624|12346991|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
7859216|NCT01573624|12346985|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
7859217|NCT01573624|12346986|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7859218|NCT01573624|12346987|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
7859219|NCT01573624|12346988|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
7859220|NCT01573624|12346989|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7859221|NCT01573624|12346990|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7859222|NCT01573624|12346991|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7859223|NCT01573624|12346985|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7859224|NCT01573624|12346986|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7859225|NCT01573624|12346987|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7859226|NCT01573624|12346988|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7859227|NCT01573624|12346989|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7859228|NCT01573624|12346990|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
7859229|NCT01573624|12346991|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7859230|NCT01573624|12346985|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7859231|NCT01573624|12346986|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7859232|NCT01573624|12346987|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7859233|NCT01573624|12346988|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
7859234|NCT01573624|12346989|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7859235|NCT01573624|12346990|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7859236|NCT01573624|12346991|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7859237|NCT01573624|12346985|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7859238|NCT01573624|12346986|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7859239|NCT01573624|12346987|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
7859240|NCT01573624|12346988|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
7859241|NCT01573624|12346989|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7859242|NCT01573624|12346990|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
7859243|NCT01573624|12346991|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7859244|NCT01573624|12346985|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
7859245|NCT01573624|12346986|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
7859246|NCT01573624|12346987|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
7859247|NCT01573624|12346988|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
7859248|NCT01573624|12346989|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
7859249|NCT01573624|12346990|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
7859250|NCT01573624|12346991|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
7859251|NCT01573624|12346985|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7859252|NCT01573624|12346986|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
7859253|NCT01573624|12346987|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7859254|NCT01573624|12346988|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7859255|NCT01573624|12346989|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7859256|NCT01573624|12346990|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
7859257|NCT01573624|12346991|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7859258|NCT01573624|12346985|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
7859259|NCT01573624|12346986|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7949887|NCT02544321|12496021|FG001|Overall Study|Adverse Event|1
7949888|NCT02544321|12496020|FG000|Overall Study|Protocol Violation|0
7949889|NCT02544321|12496021|FG001|Overall Study|Protocol Violation|1
7949890|NCT02544451|12496039|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1
7949891|NCT02544451|12496040|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6
7949892|NCT02544451|12496041|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0
7949893|NCT02544451|12496042|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0
7949894|NCT02544451|12496039|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3
7949895|NCT02544451|12496040|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2
7949896|NCT02544451|12496041|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1
7949897|NCT02544451|12496042|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0
7949898|NCT02544451|12496039|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2
7949899|NCT02544451|12496040|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
7949900|NCT02544451|12496041|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
7949901|NCT02544451|12496042|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
7949902|NCT02544451|12496039|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4
7949903|NCT02544451|12496040|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0
7949904|NCT02544451|12496041|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0
7949905|NCT02544451|12496042|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0
7949906|NCT02544451|12496039|FG000|Treatment Period 1 (96 Weeks)|Other|4
7949907|NCT02544451|12496040|FG001|Treatment Period 1 (96 Weeks)|Other|4
7949908|NCT02544451|12496041|FG002|Treatment Period 1 (96 Weeks)|Other|0
7949909|NCT02544451|12496042|FG003|Treatment Period 1 (96 Weeks)|Other|0
7949910|NCT02544451|12496039|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
7949911|NCT02544451|12496040|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
7949912|NCT02544451|12496041|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
7949913|NCT02544451|12496042|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10
7949914|NCT02544633|12496069|FG000|Treatment Period|Patient Still on Treatment/Study|0
7949915|NCT02544633|12496070|FG001|Treatment Period|Patient Still on Treatment/Study|1
7949916|NCT02544633|12496071|FG002|Treatment Period|Patient Still on Treatment/Study|1
7949917|NCT02544633|12496072|FG003|Treatment Period|Patient Still on Treatment/Study|0
7949918|NCT02544633|12496069|FG000|Treatment Period|Adverse Event|7
7949919|NCT02544633|12496070|FG001|Treatment Period|Adverse Event|4
7949920|NCT02544633|12496071|FG002|Treatment Period|Adverse Event|0
7949921|NCT02544633|12496072|FG003|Treatment Period|Adverse Event|5
7949922|NCT02544633|12496069|FG000|Treatment Period|Lack of Efficacy|17
7949923|NCT02544633|12496070|FG001|Treatment Period|Lack of Efficacy|11
7949924|NCT02544633|12496071|FG002|Treatment Period|Lack of Efficacy|5
7949925|NCT02544633|12496072|FG003|Treatment Period|Lack of Efficacy|5
7949926|NCT02544633|12496069|FG000|Treatment Period|Global Deterioration of Health|3
7949927|NCT02544633|12496070|FG001|Treatment Period|Global Deterioration of Health|3
7949928|NCT02544633|12496071|FG002|Treatment Period|Global Deterioration of Health|0
7949929|NCT02544633|12496072|FG003|Treatment Period|Global Deterioration of Health|1
7949930|NCT02544633|12496069|FG000|Treatment Period|Withdrawal by Subject|1
7949931|NCT02544633|12496070|FG001|Treatment Period|Withdrawal by Subject|0
7949932|NCT02544633|12496071|FG002|Treatment Period|Withdrawal by Subject|0
7949933|NCT02544633|12496072|FG003|Treatment Period|Withdrawal by Subject|0
7949934|NCT02544633|12496069|FG000|Treatment Period|Lost to Follow-up|0
7949935|NCT02544633|12496070|FG001|Treatment Period|Lost to Follow-up|1
7949936|NCT02544633|12496071|FG002|Treatment Period|Lost to Follow-up|0
7949937|NCT02544633|12496072|FG003|Treatment Period|Lost to Follow-up|0
7949938|NCT02544633|12496069|FG000|Treatment Period|Death|0
7949939|NCT02544633|12496070|FG001|Treatment Period|Death|0
7949940|NCT02544633|12496071|FG002|Treatment Period|Death|1
7949941|NCT02544633|12496072|FG003|Treatment Period|Death|0
7949942|NCT02544633|12496069|FG000|Treatment Period|Non-compliance|0
7949943|NCT02544633|12496070|FG001|Treatment Period|Non-compliance|0
7949944|NCT02544633|12496071|FG002|Treatment Period|Non-compliance|1
7949945|NCT02544633|12496072|FG003|Treatment Period|Non-compliance|0
7949946|NCT02544633|12496069|FG000|Treatment Period|Clinical Disease Progression|0
7949947|NCT02544633|12496070|FG001|Treatment Period|Clinical Disease Progression|0
7949948|NCT02544633|12496071|FG002|Treatment Period|Clinical Disease Progression|0
7949949|NCT02544633|12496072|FG003|Treatment Period|Clinical Disease Progression|1
7949950|NCT02544633|12496069|FG000|Survival Follow-up Period|Death|12
7949951|NCT02544633|12496070|FG001|Survival Follow-up Period|Death|14
7949952|NCT02544633|12496071|FG002|Survival Follow-up Period|Death|3
7949953|NCT02544633|12496072|FG003|Survival Follow-up Period|Death|9
7949954|NCT02544633|12496069|FG000|Survival Follow-up Period|Lost to Follow-up|0
7949955|NCT02544633|12496070|FG001|Survival Follow-up Period|Lost to Follow-up|1
7949956|NCT02544633|12496071|FG002|Survival Follow-up Period|Lost to Follow-up|1
7949957|NCT02544633|12496072|FG003|Survival Follow-up Period|Lost to Follow-up|0
7949958|NCT02544633|12496069|FG000|Survival Follow-up Period|Withdrawal by Subject|4
7859260|NCT01573624|12346987|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7859261|NCT01573624|12346988|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7859262|NCT01573624|12346989|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7859263|NCT01573624|12346990|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7859264|NCT01573624|12346991|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7859265|NCT01573624|12346985|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7859266|NCT01573624|12346986|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
7859267|NCT01573624|12346987|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
7859268|NCT01573624|12346988|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7859269|NCT01573624|12346989|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7859270|NCT01573624|12346990|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
7859271|NCT01573624|12346991|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7859272|NCT01573624|12346985|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
7859273|NCT01573624|12346986|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7859274|NCT01573624|12346987|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7859275|NCT01573624|12346988|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7859276|NCT01573624|12346989|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7859277|NCT01573624|12346990|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7859278|NCT01573624|12346991|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7859279|NCT01573624|12346985|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
7859280|NCT01573624|12346986|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7859281|NCT01573624|12346987|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7859282|NCT01573624|12346988|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7859283|NCT01573624|12346989|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7859284|NCT01573624|12346990|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7859285|NCT01573624|12346991|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
7859286|NCT01573624|12346985|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
7859287|NCT01573624|12346986|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7859288|NCT01573624|12346987|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7859289|NCT01573624|12346988|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7859290|NCT01573624|12346989|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7859291|NCT01573624|12346990|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
7859292|NCT01573624|12346991|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7859293|NCT01573624|12346985|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7859294|NCT01573624|12346986|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
7859295|NCT01573624|12346987|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7859296|NCT01573624|12346988|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7859297|NCT01573624|12346989|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7859298|NCT01573624|12346990|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7859299|NCT01573624|12346991|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7859300|NCT01573624|12346985|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7859301|NCT01573624|12346986|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
7859302|NCT01573624|12346987|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7859303|NCT01573624|12346988|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7859304|NCT01573624|12346989|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7859305|NCT01573624|12346990|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7859306|NCT01573624|12346991|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7859307|NCT01573624|12346985|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7859308|NCT01573624|12346986|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7859309|NCT01573624|12346987|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7859310|NCT01573624|12346988|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7859311|NCT01573624|12346989|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7859312|NCT01573624|12346990|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7859313|NCT01573624|12346991|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7859314|NCT01573624|12346985|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
7859315|NCT01573624|12346986|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7859316|NCT01573624|12346987|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7859317|NCT01573624|12346988|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7859318|NCT01573624|12346989|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
7859319|NCT01573624|12346990|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7859320|NCT01573624|12346991|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
7949959|NCT02544633|12496070|FG001|Survival Follow-up Period|Withdrawal by Subject|0
7859321|NCT01573624|12346985|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
7859322|NCT01573624|12346986|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
7859323|NCT01573624|12346987|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
7859324|NCT01573624|12346988|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
7859325|NCT01573624|12346989|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
7859326|NCT01573624|12346990|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
7859327|NCT01573624|12346991|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
7859328|NCT01573624|12346985|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7859329|NCT01573624|12346986|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
7859330|NCT01573624|12346987|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7859331|NCT01573624|12346988|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7859332|NCT01573624|12346989|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7859333|NCT01573624|12346990|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
7859334|NCT01573624|12346991|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7859335|NCT01573624|12346985|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
7859336|NCT01573624|12346986|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7859337|NCT01573624|12346987|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7859338|NCT01573624|12346988|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7859339|NCT01573624|12346989|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7859340|NCT01573624|12346990|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7859341|NCT01573624|12346991|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7859342|NCT01573624|12346985|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7859343|NCT01573624|12346986|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7859344|NCT01573624|12346987|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7859345|NCT01573624|12346988|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7859346|NCT01573624|12346989|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
7859347|NCT01573624|12346990|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
7859348|NCT01573624|12346991|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7859349|NCT01573624|12346985|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
7859350|NCT01573624|12346986|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7859351|NCT01573624|12346987|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7859352|NCT01573624|12346988|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7859353|NCT01573624|12346989|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7859354|NCT01573624|12346990|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7859355|NCT01573624|12346991|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7859356|NCT01573767|12347022|FG000|Overall Study|Adverse Event|0
7859357|NCT01573767|12347023|FG001|Overall Study|Adverse Event|1
7859358|NCT01573767|12347024|FG002|Overall Study|Adverse Event|0
7859359|NCT01573767|12347025|FG003|Overall Study|Adverse Event|1
7859360|NCT01573767|12347022|FG000|Overall Study|Lack of Efficacy|18
7859361|NCT01573767|12347023|FG001|Overall Study|Lack of Efficacy|15
7859362|NCT01573767|12347024|FG002|Overall Study|Lack of Efficacy|12
7859363|NCT01573767|12347025|FG003|Overall Study|Lack of Efficacy|17
7859364|NCT01573767|12347022|FG000|Overall Study|Protocol Violation|3
7859365|NCT01573767|12347023|FG001|Overall Study|Protocol Violation|1
7859366|NCT01573767|12347024|FG002|Overall Study|Protocol Violation|1
7859367|NCT01573767|12347025|FG003|Overall Study|Protocol Violation|3
7859368|NCT01573767|12347022|FG000|Overall Study|Lost to Follow-up|0
7859369|NCT01573767|12347023|FG001|Overall Study|Lost to Follow-up|1
7859370|NCT01573767|12347024|FG002|Overall Study|Lost to Follow-up|1
7859371|NCT01573767|12347025|FG003|Overall Study|Lost to Follow-up|1
7859372|NCT01573767|12347022|FG000|Overall Study|Physician Decision|1
7859373|NCT01573767|12347023|FG001|Overall Study|Physician Decision|2
7859374|NCT01573767|12347024|FG002|Overall Study|Physician Decision|0
7859375|NCT01573767|12347025|FG003|Overall Study|Physician Decision|2
7859376|NCT01573767|12347022|FG000|Overall Study|Withdrawal by Subject|0
7859377|NCT01573767|12347023|FG001|Overall Study|Withdrawal by Subject|1
7859378|NCT01573767|12347024|FG002|Overall Study|Withdrawal by Subject|0
7859379|NCT01573767|12347025|FG003|Overall Study|Withdrawal by Subject|0
7859380|NCT01573910|12347037|FG000|Overall Study|Adverse Event|4
7859381|NCT01573910|12347038|FG001|Overall Study|Adverse Event|4
7859382|NCT01573910|12347037|FG000|Overall Study|Lost to Follow-up|2
7859383|NCT01573910|12347038|FG001|Overall Study|Lost to Follow-up|1
7859384|NCT01573910|12347037|FG000|Overall Study|Withdrawal by Subject|0
7859385|NCT01573910|12347038|FG001|Overall Study|Withdrawal by Subject|1
7859386|NCT01573910|12347037|FG000|Overall Study|Protocol Violation|3
7859387|NCT01573910|12347038|FG001|Overall Study|Protocol Violation|0
7859388|NCT01573910|12347037|FG000|Overall Study|Patient decision unrelated to Advs Event|11
7859389|NCT01573910|12347038|FG001|Overall Study|Patient decision unrelated to Advs Event|11
7859390|NCT01574079|12347050|FG000|Overall Study|Physician Decision|0
7859391|NCT01574079|12347051|FG001|Overall Study|Physician Decision|2
7859392|NCT01574079|12347050|FG000|Overall Study|Lost to Follow-up|1
7859393|NCT01574079|12347051|FG001|Overall Study|Lost to Follow-up|0
7859394|NCT01574157|12347073|FG000|Overall Study|Withdrawal by Subject|4
7859395|NCT01574157|12347074|FG001|Overall Study|Withdrawal by Subject|5
7859396|NCT01574157|12347073|FG000|Overall Study|Lost to Follow-up|0
7859397|NCT01574157|12347074|FG001|Overall Study|Lost to Follow-up|3
7859398|NCT01574248|12347097|FG000|Overall Study|Withdrawal by Subject|2
7859399|NCT01574248|12347098|FG001|Overall Study|Withdrawal by Subject|0
7859400|NCT01574248|12347097|FG000|Overall Study|Missing primary endpoint data|1
7859401|NCT01574248|12347098|FG001|Overall Study|Missing primary endpoint data|0
7859402|NCT01574326|12347110|FG000|Overall Study|Randomized but not treated|0
7859403|NCT01574326|12347111|FG001|Overall Study|Randomized but not treated|1
7859404|NCT01574326|12347110|FG000|Overall Study|Withdrawal by Participant|2
7859405|NCT01574326|12347111|FG001|Overall Study|Withdrawal by Participant|4
7859406|NCT01574326|12347110|FG000|Overall Study|Physician Decision|5
7859407|NCT01574326|12347111|FG001|Overall Study|Physician Decision|3
7859408|NCT01574326|12347110|FG000|Overall Study|Adverse Event|1
7859409|NCT01574326|12347111|FG001|Overall Study|Adverse Event|3
7859410|NCT01574326|12347110|FG000|Overall Study|Other: Mainly kidney transplant|8
7859411|NCT01574326|12347111|FG001|Overall Study|Other: Mainly kidney transplant|8
7859412|NCT01574352|12347124|FG000|Overall Study|Withdrawal by Subject|6
7859413|NCT01574352|12347125|FG001|Overall Study|Withdrawal by Subject|13
7859414|NCT01574352|12347124|FG000|Overall Study|Injury in non-camp related sport|1
7859415|NCT01574352|12347125|FG001|Overall Study|Injury in non-camp related sport|0
7859416|NCT01574612|12347131|FG000|Overall Study|Adverse Event|3
7720972|NCT00542386|12145503|FG004|Overall Study|Death|1
7720973|NCT00542386|12145504|FG005|Overall Study|Death|2
7859417|NCT01574612|12347131|FG000|Overall Study|non compliant with drug|2
7859418|NCT01574612|12347131|FG000|Overall Study|Withdrawal by Subject|1
7949960|NCT02544633|12496071|FG002|Survival Follow-up Period|Withdrawal by Subject|1
7949961|NCT02544633|12496072|FG003|Survival Follow-up Period|Withdrawal by Subject|0
7949962|NCT02544633|12496069|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12
7949963|NCT02544633|12496070|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4
7949964|NCT02544633|12496071|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2
7949965|NCT02544633|12496072|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3
7949966|NCT02545075|12496105|FG000|Randomization|Lost to Follow-up|0
7949967|NCT02545075|12496106|FG001|Randomization|Lost to Follow-up|1
7949968|NCT02545075|12496105|FG000|Randomization|Withdrawal by Subject|0
7949969|NCT02545075|12496106|FG001|Randomization|Withdrawal by Subject|6
7949970|NCT02545075|12496105|FG000|Treatment|Disease progression|71
7949971|NCT02545075|12496106|FG001|Treatment|Disease progression|32
7949972|NCT02545075|12496105|FG000|Treatment|Participant dicontinued study treatment|7
7949973|NCT02545075|12496106|FG001|Treatment|Participant dicontinued study treatment|9
7949974|NCT02545075|12496105|FG000|Treatment|Withdrawal by Subject|1
7949975|NCT02545075|12496106|FG001|Treatment|Withdrawal by Subject|0
7949976|NCT02545075|12496105|FG000|Treatment|Adverse event not related to study drug|1
7949977|NCT02545075|12496106|FG001|Treatment|Adverse event not related to study drug|0
7949978|NCT02545075|12496105|FG000|Treatment|Death|1
7949979|NCT02545075|12496106|FG001|Treatment|Death|0
7949980|NCT02545075|12496105|FG000|Treatment|Participant drug toxicity|1
7949981|NCT02545075|12496106|FG001|Treatment|Participant drug toxicity|0
7949982|NCT02545075|12496105|FG000|Treatment|Completed treatment|40
7949983|NCT02545075|12496106|FG001|Treatment|Completed treatment|12
7949984|NCT02545270|12496119|FG000|Overall Study|technical difficulties|0
7949985|NCT02545270|12496120|FG001|Overall Study|technical difficulties|1
7949986|NCT02545270|12496121|FG002|Overall Study|technical difficulties|0
7949987|NCT02545270|12496119|FG000|Overall Study|Videos being too similar to other|0
7949988|NCT02545270|12496120|FG001|Overall Study|Videos being too similar to other|0
7949989|NCT02545270|12496121|FG002|Overall Study|Videos being too similar to other|2
7949990|NCT02545322|12496130|FG000|Overall Study|Withdrawal by Subject|3
7949991|NCT02545504|12496136|FG000|Overall Study|Death|174
7949992|NCT02545504|12496137|FG001|Overall Study|Death|168
7949993|NCT02545504|12496136|FG000|Overall Study|Unknown reason|30
7949994|NCT02545504|12496137|FG001|Overall Study|Unknown reason|32
7949995|NCT02545504|12496136|FG000|Overall Study|Withdrew consent|9
7949996|NCT02545504|12496137|FG001|Overall Study|Withdrew consent|11
7949997|NCT02545504|12496136|FG000|Overall Study|Investigator's discretion|3
7949998|NCT02545504|12496137|FG001|Overall Study|Investigator's discretion|1
7949999|NCT02545504|12496136|FG000|Overall Study|Lost to Follow-up|2
7950000|NCT02545504|12496137|FG001|Overall Study|Lost to Follow-up|2
7950001|NCT02545543|12496149|FG000|Overall Study|Lost to Follow-up|67
7950002|NCT02545543|12496150|FG001|Overall Study|Lost to Follow-up|25
7950003|NCT02545543|12496149|FG000|Overall Study|Physician Decision|3
7950004|NCT02545543|12496150|FG001|Overall Study|Physician Decision|0
7950005|NCT02545543|12496149|FG000|Overall Study|Withdrawal by Subject|9
7950006|NCT02545543|12496150|FG001|Overall Study|Withdrawal by Subject|8
7950007|NCT02545543|12496149|FG000|Overall Study|Noncomplaince|1
7950008|NCT02545543|12496150|FG001|Overall Study|Noncomplaince|0
7950009|NCT02545543|12496149|FG000|Overall Study|Enrolment of subject at >1 study site|1
7950010|NCT02545543|12496150|FG001|Overall Study|Enrolment of subject at >1 study site|1
7950011|NCT02545933|12496174|FG000|Overall Study|Adverse Event|3
7720974|NCT00542386|12145499|FG000|Overall Study|Lack of Efficacy|32
7950012|NCT02545933|12496175|FG001|Overall Study|Adverse Event|0
7950013|NCT02545933|12496176|FG002|Overall Study|Adverse Event|0
7950014|NCT02545933|12496174|FG000|Overall Study|Withdrawal by Subject|2
7950015|NCT02545933|12496175|FG001|Overall Study|Withdrawal by Subject|3
7950016|NCT02545933|12496176|FG002|Overall Study|Withdrawal by Subject|3
7950017|NCT02545933|12496174|FG000|Overall Study|Protocol Violation|1
7950018|NCT02545933|12496175|FG001|Overall Study|Protocol Violation|0
7950019|NCT02545933|12496176|FG002|Overall Study|Protocol Violation|1
7950020|NCT02546193|12496186|FG000|Overall Study|Withdrawal by Subject|2
7859419|NCT01574612|12347131|FG000|Overall Study|Lost to Follow-up|2
7859420|NCT01574651|12347137|FG000|Overall Study|Lost to Follow-up|2
7859421|NCT01574651|12347138|FG001|Overall Study|Lost to Follow-up|4
7859422|NCT01574651|12347137|FG000|Overall Study|Administrative problems|0
7859423|NCT01574651|12347138|FG001|Overall Study|Administrative problems|1
7859424|NCT01574651|12347137|FG000|Overall Study|Death|3
7859425|NCT01574651|12347138|FG001|Overall Study|Death|3
7859426|NCT01574651|12347137|FG000|Overall Study|Patient's inability to use the device|0
7859427|NCT01574651|12347138|FG001|Overall Study|Patient's inability to use the device|1
7859428|NCT01574651|12347137|FG000|Overall Study|Adverse Event|36
7859429|NCT01574651|12347138|FG001|Overall Study|Adverse Event|27
7859430|NCT01574651|12347137|FG000|Overall Study|Abnormal laboratory value(s)|1
7859431|NCT01574651|12347138|FG001|Overall Study|Abnormal laboratory value(s)|0
7859432|NCT01574651|12347137|FG000|Overall Study|Abnormal test procedure result(s)|1
7859433|NCT01574651|12347138|FG001|Overall Study|Abnormal test procedure result(s)|1
7859434|NCT01574651|12347137|FG000|Overall Study|Unsatisfactory therapeutic effect|6
7859435|NCT01574651|12347138|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7859436|NCT01574651|12347137|FG000|Overall Study|Protocol Violation|3
7859437|NCT01574651|12347138|FG001|Overall Study|Protocol Violation|5
7859438|NCT01574651|12347137|FG000|Overall Study|Withdrawal by Subject|9
7859439|NCT01574651|12347138|FG001|Overall Study|Withdrawal by Subject|10
7859440|NCT01574703|12347148|FG000|Overall Study|Adverse Event|0
7859441|NCT01574703|12347149|FG001|Overall Study|Adverse Event|2
7859442|NCT01574703|12347150|FG002|Overall Study|Adverse Event|1
7859443|NCT01574703|12347151|FG003|Overall Study|Adverse Event|1
7859444|NCT01574703|12347148|FG000|Overall Study|Protocol Violation|0
7859445|NCT01574703|12347149|FG001|Overall Study|Protocol Violation|0
7859446|NCT01574703|12347150|FG002|Overall Study|Protocol Violation|0
7859447|NCT01574703|12347151|FG003|Overall Study|Protocol Violation|1
7859448|NCT01574703|12347148|FG000|Overall Study|Unspecified Reason|27
7859449|NCT01574703|12347149|FG001|Overall Study|Unspecified Reason|15
7859450|NCT01574703|12347150|FG002|Overall Study|Unspecified Reason|20
7859451|NCT01574703|12347151|FG003|Overall Study|Unspecified Reason|16
7859452|NCT01574703|12347148|FG000|Overall Study|Withdrawal by Subject|53
7859453|NCT01574703|12347149|FG001|Overall Study|Withdrawal by Subject|52
7859454|NCT01574703|12347150|FG002|Overall Study|Withdrawal by Subject|36
7859455|NCT01574703|12347151|FG003|Overall Study|Withdrawal by Subject|61
7859456|NCT01574703|12347148|FG000|Overall Study|Met Withdrawal Criteria|0
7859457|NCT01574703|12347149|FG001|Overall Study|Met Withdrawal Criteria|1
7859458|NCT01574703|12347150|FG002|Overall Study|Met Withdrawal Criteria|1
7859459|NCT01574703|12347151|FG003|Overall Study|Met Withdrawal Criteria|0
7859460|NCT01574703|12347148|FG000|Overall Study|Lost to Follow-up|43
7859461|NCT01574703|12347149|FG001|Overall Study|Lost to Follow-up|41
7859462|NCT01574703|12347150|FG002|Overall Study|Lost to Follow-up|46
7859463|NCT01574703|12347151|FG003|Overall Study|Lost to Follow-up|35
7859464|NCT01574703|12347148|FG000|Overall Study|Death|2
7859465|NCT01574703|12347149|FG001|Overall Study|Death|1
7859466|NCT01574703|12347150|FG002|Overall Study|Death|1
7859467|NCT01574703|12347151|FG003|Overall Study|Death|0
7859468|NCT01574716|12347166|FG000|Part 1|Death|3
7859469|NCT01574716|12347167|FG001|Part 1|Death|1
7859470|NCT01574716|12347168|FG002|Part 1|Death|8
7859471|NCT01574716|12347169|FG003|Part 1|Death|0
7859472|NCT01574716|12347170|FG004|Part 1|Death|0
7859473|NCT01574716|12347166|FG000|Part 1|Discontinuation of study by sponsor|0
7859474|NCT01574716|12347167|FG001|Part 1|Discontinuation of study by sponsor|0
7859475|NCT01574716|12347168|FG002|Part 1|Discontinuation of study by sponsor|1
7859476|NCT01574716|12347169|FG003|Part 1|Discontinuation of study by sponsor|0
7859477|NCT01574716|12347170|FG004|Part 1|Discontinuation of study by sponsor|0
7859478|NCT01574716|12347166|FG000|Part 1|Withdrawal by Subject|0
7859479|NCT01574716|12347167|FG001|Part 1|Withdrawal by Subject|2
7859480|NCT01574716|12347168|FG002|Part 1|Withdrawal by Subject|0
7859481|NCT01574716|12347169|FG003|Part 1|Withdrawal by Subject|0
7859482|NCT01574716|12347170|FG004|Part 1|Withdrawal by Subject|0
7859483|NCT01574716|12347166|FG000|Part 1|Lost to Follow-up|0
7859484|NCT01574716|12347167|FG001|Part 1|Lost to Follow-up|1
7859485|NCT01574716|12347168|FG002|Part 1|Lost to Follow-up|0
7859486|NCT01574716|12347169|FG003|Part 1|Lost to Follow-up|0
7859487|NCT01574716|12347170|FG004|Part 1|Lost to Follow-up|0
7859488|NCT01574716|12347166|FG000|Part 2|Progressive disease|0
7859489|NCT01574716|12347167|FG001|Part 2|Progressive disease|0
7859490|NCT01574716|12347168|FG002|Part 2|Progressive disease|0
7859491|NCT01574716|12347169|FG003|Part 2|Progressive disease|1
7859492|NCT01574716|12347170|FG004|Part 2|Progressive disease|0
7859493|NCT01574716|12347166|FG000|Part 2|Death|0
7859494|NCT01574716|12347167|FG001|Part 2|Death|0
7859495|NCT01574716|12347168|FG002|Part 2|Death|0
7859496|NCT01574716|12347169|FG003|Part 2|Death|76
7859497|NCT01574716|12347170|FG004|Part 2|Death|35
7859498|NCT01574716|12347166|FG000|Part 2|Discontinuation of study by sponsor|0
7859499|NCT01574716|12347167|FG001|Part 2|Discontinuation of study by sponsor|0
7859500|NCT01574716|12347168|FG002|Part 2|Discontinuation of study by sponsor|0
7859501|NCT01574716|12347169|FG003|Part 2|Discontinuation of study by sponsor|51
7859502|NCT01574716|12347170|FG004|Part 2|Discontinuation of study by sponsor|31
7859503|NCT01574716|12347166|FG000|Part 2|Withdrawal by Subject|0
7859504|NCT01574716|12347167|FG001|Part 2|Withdrawal by Subject|0
7859505|NCT01574716|12347168|FG002|Part 2|Withdrawal by Subject|0
7859506|NCT01574716|12347169|FG003|Part 2|Withdrawal by Subject|5
7859507|NCT01574716|12347170|FG004|Part 2|Withdrawal by Subject|4
7859508|NCT01574716|12347166|FG000|Part 2|Brain metastases|0
7859509|NCT01574716|12347167|FG001|Part 2|Brain metastases|0
7859510|NCT01574716|12347168|FG002|Part 2|Brain metastases|0
7859511|NCT01574716|12347169|FG003|Part 2|Brain metastases|1
7859512|NCT01574716|12347170|FG004|Part 2|Brain metastases|0
7859513|NCT01574716|12347166|FG000|Part 2|Lost to Follow-up|0
7859514|NCT01574716|12347167|FG001|Part 2|Lost to Follow-up|0
7859515|NCT01574716|12347168|FG002|Part 2|Lost to Follow-up|0
7859516|NCT01574716|12347169|FG003|Part 2|Lost to Follow-up|3
7859517|NCT01574716|12347170|FG004|Part 2|Lost to Follow-up|0
7859518|NCT01575054|12347187|FG000|Overall Study|Other Reasons|5
7859519|NCT01575054|12347188|FG001|Overall Study|Other Reasons|3
7859520|NCT01575054|12347187|FG000|Overall Study|Protocol Violation|2
7859521|NCT01575054|12347188|FG001|Overall Study|Protocol Violation|1
7859522|NCT01575054|12347187|FG000|Overall Study|Personal Reasons|10
7859523|NCT01575054|12347188|FG001|Overall Study|Personal Reasons|11
7859524|NCT01575054|12347187|FG000|Overall Study|Lost to Follow-up|3
7859525|NCT01575054|12347188|FG001|Overall Study|Lost to Follow-up|3
7859526|NCT01575054|12347187|FG000|Overall Study|Adverse Event|9
7859527|NCT01575054|12347188|FG001|Overall Study|Adverse Event|8
7859528|NCT01575197|12347206|FG000|Overall Study|Migration out of study area|1
7720975|NCT00542386|12145500|FG001|Overall Study|Lack of Efficacy|12
7720976|NCT00542386|12145501|FG002|Overall Study|Lack of Efficacy|10
7720977|NCT00542386|12145502|FG003|Overall Study|Lack of Efficacy|13
7720978|NCT00542386|12145503|FG004|Overall Study|Lack of Efficacy|7
7720979|NCT00542386|12145504|FG005|Overall Study|Lack of Efficacy|31
7720980|NCT00542386|12145499|FG000|Overall Study|Physician Decision|1
7720981|NCT00542386|12145500|FG001|Overall Study|Physician Decision|0
7720982|NCT00542386|12145501|FG002|Overall Study|Physician Decision|0
7720983|NCT00542386|12145502|FG003|Overall Study|Physician Decision|1
7720984|NCT00542386|12145503|FG004|Overall Study|Physician Decision|0
7720985|NCT00542386|12145504|FG005|Overall Study|Physician Decision|0
7720986|NCT00542386|12145499|FG000|Overall Study|Protocol Violation|0
7720987|NCT00542386|12145500|FG001|Overall Study|Protocol Violation|0
7720988|NCT00542386|12145501|FG002|Overall Study|Protocol Violation|1
7720989|NCT00542386|12145502|FG003|Overall Study|Protocol Violation|0
7720990|NCT00542386|12145503|FG004|Overall Study|Protocol Violation|0
7720991|NCT00542386|12145504|FG005|Overall Study|Protocol Violation|4
7720992|NCT00542386|12145499|FG000|Overall Study|Withdrawal by Subject|5
7720993|NCT00542386|12145500|FG001|Overall Study|Withdrawal by Subject|8
7720994|NCT00542386|12145501|FG002|Overall Study|Withdrawal by Subject|10
7720995|NCT00542386|12145502|FG003|Overall Study|Withdrawal by Subject|11
7720996|NCT00542386|12145503|FG004|Overall Study|Withdrawal by Subject|15
7720997|NCT00542386|12145504|FG005|Overall Study|Withdrawal by Subject|7
7720998|NCT00542386|12145499|FG000|Overall Study|Other Reasons|4
7720999|NCT00542386|12145500|FG001|Overall Study|Other Reasons|1
7721000|NCT00542386|12145501|FG002|Overall Study|Other Reasons|4
7721001|NCT00542386|12145502|FG003|Overall Study|Other Reasons|3
7721002|NCT00542386|12145503|FG004|Overall Study|Other Reasons|4
7721003|NCT00542386|12145504|FG005|Overall Study|Other Reasons|2
7721004|NCT00542425|12145523|FG000|Initial 24 Weeks|Administrative reasons|0
7721005|NCT00542425|12145524|FG001|Initial 24 Weeks|Administrative reasons|0
7859529|NCT01575197|12347207|FG001|Overall Study|Migration out of study area|5
7859530|NCT01575197|12347208|FG002|Overall Study|Migration out of study area|4
7859531|NCT01575197|12347206|FG000|Overall Study|SAE|0
7859532|NCT01575197|12347207|FG001|Overall Study|SAE|1
7859533|NCT01575197|12347208|FG002|Overall Study|SAE|0
7859534|NCT01575197|12347206|FG000|Overall Study|Lost to Follow-up|0
7859535|NCT01575197|12347207|FG001|Overall Study|Lost to Follow-up|1
7859536|NCT01575197|12347208|FG002|Overall Study|Lost to Follow-up|0
7859537|NCT01575197|12347206|FG000|Overall Study|Withdrawal by Subject|0
7859538|NCT01575197|12347207|FG001|Overall Study|Withdrawal by Subject|1
7859539|NCT01575197|12347208|FG002|Overall Study|Withdrawal by Subject|1
7859540|NCT01575197|12347206|FG000|Overall Study|Protocol Violation|2
7859541|NCT01575197|12347207|FG001|Overall Study|Protocol Violation|1
7859542|NCT01575197|12347208|FG002|Overall Study|Protocol Violation|1
7859543|NCT01575561|12347227|FG000|Overall Study|Adverse Event|9
7859544|NCT01575561|12347227|FG000|Overall Study|Lack of Efficacy|8
7859545|NCT01575561|12347227|FG000|Overall Study|Lost to Follow-up|6
7859546|NCT01575561|12347227|FG000|Overall Study|Protocol Violation|4
7859547|NCT01575561|12347227|FG000|Overall Study|Withdrawal by Subject|11
7859548|NCT01575561|12347227|FG000|Overall Study|administration|1
7859549|NCT01575769|12347239|FG000|Overall Study|Adverse Event|1
7859550|NCT01575769|12347239|FG000|Overall Study|Study terminated by sponsor|40
7859551|NCT01575808|12347247|FG000|Overall Study|Death|2
7859552|NCT01575808|12347248|FG001|Overall Study|Death|0
7859553|NCT01575808|12347247|FG000|Overall Study|Withdrawal by Subject|1
7859554|NCT01575808|12347248|FG001|Overall Study|Withdrawal by Subject|0
7859555|NCT01575873|12347260|FG000|Overall Study|Withdrawal by Subject|15
7859556|NCT01575873|12347261|FG001|Overall Study|Withdrawal by Subject|20
7859557|NCT01575873|12347262|FG002|Overall Study|Withdrawal by Subject|34
7859558|NCT01575873|12347263|FG003|Overall Study|Withdrawal by Subject|34
7859559|NCT01575873|12347260|FG000|Overall Study|Adverse Event|7
7859560|NCT01575873|12347261|FG001|Overall Study|Adverse Event|7
7859561|NCT01575873|12347262|FG002|Overall Study|Adverse Event|9
7859562|NCT01575873|12347263|FG003|Overall Study|Adverse Event|12
7859563|NCT01575873|12347260|FG000|Overall Study|Lost to Follow-up|1
7859564|NCT01575873|12347261|FG001|Overall Study|Lost to Follow-up|3
7859565|NCT01575873|12347262|FG002|Overall Study|Lost to Follow-up|13
7859566|NCT01575873|12347263|FG003|Overall Study|Lost to Follow-up|5
7859567|NCT01575873|12347260|FG000|Overall Study|Death|3
7859568|NCT01575873|12347261|FG001|Overall Study|Death|2
7859569|NCT01575873|12347262|FG002|Overall Study|Death|8
7859570|NCT01575873|12347263|FG003|Overall Study|Death|9
7859571|NCT01575873|12347260|FG000|Overall Study|Noncompliance|1
7859572|NCT01575873|12347261|FG001|Overall Study|Noncompliance|2
7859573|NCT01575873|12347262|FG002|Overall Study|Noncompliance|4
7859574|NCT01575873|12347263|FG003|Overall Study|Noncompliance|3
7859575|NCT01575873|12347260|FG000|Overall Study|Administrative decision|1
7859576|NCT01575873|12347261|FG001|Overall Study|Administrative decision|1
7859577|NCT01575873|12347262|FG002|Overall Study|Administrative decision|1
7859578|NCT01575873|12347263|FG003|Overall Study|Administrative decision|0
7859579|NCT01575873|12347260|FG000|Overall Study|Protocol deviation|0
7859580|NCT01575873|12347261|FG001|Overall Study|Protocol deviation|1
7859581|NCT01575873|12347262|FG002|Overall Study|Protocol deviation|0
7859582|NCT01575873|12347263|FG003|Overall Study|Protocol deviation|1
7859583|NCT01575873|12347260|FG000|Overall Study|Requirement for Alternative Therapy|0
7859584|NCT01575873|12347261|FG001|Overall Study|Requirement for Alternative Therapy|0
7859585|NCT01575873|12347262|FG002|Overall Study|Requirement for Alternative Therapy|1
7859586|NCT01575873|12347263|FG003|Overall Study|Requirement for Alternative Therapy|1
7859587|NCT01575873|12347260|FG000|Overall Study|Other|0
7859588|NCT01575873|12347261|FG001|Overall Study|Other|0
7859589|NCT01575873|12347262|FG002|Overall Study|Other|4
7859590|NCT01575873|12347263|FG003|Overall Study|Other|2
7859591|NCT01575899|12347274|FG000|Overall Study|Lost to Follow-up|3
7859592|NCT01575899|12347275|FG001|Overall Study|Lost to Follow-up|4
7859593|NCT01575899|12347276|FG002|Overall Study|Lost to Follow-up|2
7859594|NCT01575899|12347274|FG000|Overall Study|Protocol Violation|2
7859595|NCT01575899|12347275|FG001|Overall Study|Protocol Violation|1
7859596|NCT01575899|12347276|FG002|Overall Study|Protocol Violation|0
7859597|NCT01576016|12347314|FG000|Lead Safety|Death|132
7859598|NCT01576016|12347315|FG001|Lead Safety|Death|0
7859599|NCT01576016|12347314|FG000|Lead Safety|Withdrawal by Subject|81
7859600|NCT01576016|12347315|FG001|Lead Safety|Withdrawal by Subject|0
7859601|NCT01576016|12347314|FG000|Lead Safety|System Explanted without Replacement|24
7859602|NCT01576016|12347315|FG001|Lead Safety|System Explanted without Replacement|0
7859603|NCT01576016|12347314|FG000|Lead Safety|Physician Decision|14
7859604|NCT01576016|12347315|FG001|Lead Safety|Physician Decision|0
7859605|NCT01576016|12347314|FG000|Lead Safety|Lost to Follow-up|13
7859606|NCT01576016|12347315|FG001|Lead Safety|Lost to Follow-up|0
7859607|NCT01576016|12347314|FG000|Lead Safety|Unsuccessful implant|2
7859608|NCT01576016|12347315|FG001|Lead Safety|Unsuccessful implant|0
7859609|NCT01576016|12347314|FG000|Lead Safety|Sponsor request|1
7859610|NCT01576016|12347315|FG001|Lead Safety|Sponsor request|0
7859611|NCT01576016|12347314|FG000|Lead Safety|Device replaced with CRT-D|1
7859612|NCT01576016|12347315|FG001|Lead Safety|Device replaced with CRT-D|0
7859613|NCT01576016|12347314|FG000|Lead Safety|Patient on Palliative Care|1
7859614|NCT01576016|12347315|FG001|Lead Safety|Patient on Palliative Care|0
7859615|NCT01576016|12347314|FG000|Lead Safety|Patient noncompliance|1
7859616|NCT01576016|12347315|FG001|Lead Safety|Patient noncompliance|0
7859617|NCT01576016|12347314|FG000|Lead Safety|Too far from study site|1
7859618|NCT01576016|12347315|FG001|Lead Safety|Too far from study site|0
7859619|NCT01576016|12347314|FG000|Lead Safety|System deactivated|1
7859620|NCT01576016|12347315|FG001|Lead Safety|System deactivated|0
7859621|NCT01576016|12347314|FG000|Lead Safety|Patient no longer followed by study PI|1
7859622|NCT01576016|12347315|FG001|Lead Safety|Patient no longer followed by study PI|0
7859623|NCT01576016|12347314|FG000|MRI Safety|Withdrawal by Subject|0
7859624|NCT01576016|12347315|FG001|MRI Safety|Withdrawal by Subject|10
7859625|NCT01576016|12347314|FG000|MRI Safety|Non-MRI Compatible Device or Material|0
7859626|NCT01576016|12347315|FG001|MRI Safety|Non-MRI Compatible Device or Material|5
7859627|NCT01576016|12347314|FG000|MRI Safety|Has not yet completed MRI scan|0
7859628|NCT01576016|12347315|FG001|MRI Safety|Has not yet completed MRI scan|56
7859629|NCT01576016|12347314|FG000|MRI Safety|MRI scan not performed at MRI visit|0
7859630|NCT01576016|12347315|FG001|MRI Safety|MRI scan not performed at MRI visit|3
7859631|NCT01576042|12347325|FG000|Overall Study|Physician Decision|2
7859632|NCT01576042|12347326|FG001|Overall Study|Physician Decision|0
7859633|NCT01576146|12347350|FG000|Extension Period 1|Adverse Event|2
7859634|NCT01576146|12347350|FG000|Extension Period 1|Death|2
7859635|NCT01576146|12347350|FG000|Extension Period 1|Physician Decision|2
7859636|NCT01576146|12347350|FG000|Extension Period 1|Withdrawal by Subject|1
7859637|NCT01576146|12347350|FG000|Extension Period 1|Lost to Follow-up|1
7859638|NCT01576146|12347350|FG000|Extension Period 1|Parathyroidectomy|1
7859639|NCT01576146|12347350|FG000|Extension Period 1|Renal Transplant|1
7859640|NCT01576146|12347350|FG000|Extension Period 2|Sponsor Decision|13
7859641|NCT01576146|12347350|FG000|Extension Period 2|Death|1
7859642|NCT01576146|12347350|FG000|Extension Period 2|Adverse Event|1
7859643|NCT01576146|12347350|FG000|Extension Period 2|Renal Transplant|1
7859644|NCT01576146|12347350|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
7859645|NCT01576159|12347358|FG000|Overall Study|Withdrawal by Subject|0
7859646|NCT01576159|12347359|FG001|Overall Study|Withdrawal by Subject|1
7859647|NCT01576159|12347360|FG002|Overall Study|Withdrawal by Subject|0
7859648|NCT01576159|12347361|FG003|Overall Study|Withdrawal by Subject|0
7859649|NCT01576159|12347358|FG000|Overall Study|Physician Decision|0
7859650|NCT01576159|12347359|FG001|Overall Study|Physician Decision|0
7859651|NCT01576159|12347360|FG002|Overall Study|Physician Decision|1
7859652|NCT01576159|12347361|FG003|Overall Study|Physician Decision|0
7859653|NCT01576159|12347358|FG000|Overall Study|Lost to Follow-up|0
7859654|NCT01576159|12347359|FG001|Overall Study|Lost to Follow-up|0
7859655|NCT01576159|12347360|FG002|Overall Study|Lost to Follow-up|0
7859656|NCT01576159|12347361|FG003|Overall Study|Lost to Follow-up|1
7859657|NCT01576159|12347358|FG000|Overall Study|Protocol Violation|1
7859658|NCT01576159|12347359|FG001|Overall Study|Protocol Violation|0
7859659|NCT01576159|12347360|FG002|Overall Study|Protocol Violation|0
7859660|NCT01576159|12347361|FG003|Overall Study|Protocol Violation|0
7859661|NCT01576172|12347380|FG000|Overall Study|Ineligible|2
7859662|NCT01576172|12347381|FG001|Overall Study|Ineligible|1
7859663|NCT01576172|12347380|FG000|Overall Study|Withdrawal by Subject|2
7859664|NCT01576172|12347381|FG001|Overall Study|Withdrawal by Subject|0
7859665|NCT01576172|12347380|FG000|Overall Study|Insurance issue|1
7859666|NCT01576172|12347381|FG001|Overall Study|Insurance issue|0
7859667|NCT01576341|12347399|FG000|Overall Study|Withdrawal by Subject|24
7859668|NCT01576341|12347399|FG000|Overall Study|Adverse Event|10
7859669|NCT01576341|12347399|FG000|Overall Study|Death|21
7859670|NCT01576341|12347399|FG000|Overall Study|Physician Decision|2
7859671|NCT01576341|12347399|FG000|Overall Study|Lost to Follow-up|2
7859672|NCT01576341|12347399|FG000|Overall Study|Kidney transplantation|10
7859673|NCT01576341|12347399|FG000|Overall Study|Protocol Violation|12
7859674|NCT01576341|12347399|FG000|Overall Study|Other|12
7859675|NCT01576367|12347406|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7859676|NCT01576367|12347406|FG000|Overall Study|Moved to commercial use after 6 months|1
7859677|NCT01576406|12347416|FG000|Overall Study|Lost to Follow-up|1
7859678|NCT01576406|12347417|FG001|Overall Study|Lost to Follow-up|2
7859679|NCT01576406|12347418|FG002|Overall Study|Lost to Follow-up|0
7859680|NCT01576406|12347419|FG003|Overall Study|Lost to Follow-up|0
7859681|NCT01576406|12347420|FG004|Overall Study|Lost to Follow-up|0
7859682|NCT01576406|12347421|FG005|Overall Study|Lost to Follow-up|0
7859683|NCT01576406|12347416|FG000|Overall Study|Death|3
7859684|NCT01576406|12347417|FG001|Overall Study|Death|4
7859685|NCT01576406|12347418|FG002|Overall Study|Death|8
7859686|NCT01576406|12347419|FG003|Overall Study|Death|5
7859687|NCT01576406|12347420|FG004|Overall Study|Death|7
7859688|NCT01576406|12347421|FG005|Overall Study|Death|9
7859689|NCT01576406|12347416|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0
7859690|NCT01576406|12347417|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0
7859691|NCT01576406|12347418|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1
7859692|NCT01576406|12347419|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1
7859693|NCT01576406|12347420|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0
7859694|NCT01576406|12347421|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0
7859695|NCT01576406|12347416|FG000|Overall Study|Withdrawal the consent|2
7859696|NCT01576406|12347417|FG001|Overall Study|Withdrawal the consent|2
7859697|NCT01576406|12347418|FG002|Overall Study|Withdrawal the consent|5
7859698|NCT01576406|12347419|FG003|Overall Study|Withdrawal the consent|1
7859699|NCT01576406|12347420|FG004|Overall Study|Withdrawal the consent|1
7859700|NCT01576406|12347421|FG005|Overall Study|Withdrawal the consent|3
7859701|NCT01576406|12347416|FG000|Overall Study|Other|0
7859702|NCT01576406|12347417|FG001|Overall Study|Other|0
7859703|NCT01576406|12347418|FG002|Overall Study|Other|2
7859704|NCT01576406|12347419|FG003|Overall Study|Other|2
7859705|NCT01576406|12347420|FG004|Overall Study|Other|0
7859706|NCT01576406|12347421|FG005|Overall Study|Other|0
7859707|NCT01576484|12347446|FG000|Overall Study|Adverse Event|1
7859708|NCT01576484|12347447|FG001|Overall Study|Adverse Event|1
7859709|NCT01576484|12347446|FG000|Overall Study|Protocol Violation|0
7859710|NCT01576484|12347447|FG001|Overall Study|Protocol Violation|2
7859711|NCT01576484|12347446|FG000|Overall Study|Sponsor Decision|2
7859712|NCT01576484|12347447|FG001|Overall Study|Sponsor Decision|8
7859713|NCT01576484|12347446|FG000|Overall Study|Withdrawal by Subject|0
7859714|NCT01576484|12347447|FG001|Overall Study|Withdrawal by Subject|3
7859715|NCT01576484|12347446|FG000|Overall Study|Other|2
7859716|NCT01576484|12347447|FG001|Overall Study|Other|5
7859717|NCT01576705|12347488|FG000|Overall Study|TSH > 7 mIU/L at baseline|3
7859718|NCT01576705|12347489|FG001|Overall Study|TSH > 7 mIU/L at baseline|7
7859719|NCT01576705|12347490|FG002|Overall Study|TSH > 7 mIU/L at baseline|5
7859720|NCT01576705|12347491|FG003|Overall Study|TSH > 7 mIU/L at baseline|3
7859721|NCT01576705|12347488|FG000|Overall Study|invalid ICF|0
7859722|NCT01576705|12347489|FG001|Overall Study|invalid ICF|1
7859723|NCT01576705|12347490|FG002|Overall Study|invalid ICF|0
7859724|NCT01576705|12347491|FG003|Overall Study|invalid ICF|0
7859725|NCT01576718|12347507|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
7859726|NCT01576718|12347508|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7859727|NCT01576718|12347509|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7859728|NCT01576718|12347510|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7859729|NCT01576718|12347511|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7859730|NCT01576718|12347512|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7859731|NCT01576718|12347513|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7859732|NCT01576718|12347507|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
7859733|NCT01576718|12347508|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7859734|NCT01576718|12347509|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7859735|NCT01576718|12347510|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7859736|NCT01576718|12347511|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7859737|NCT01576718|12347512|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7859738|NCT01576718|12347513|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7859739|NCT01576718|12347507|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
7859740|NCT01576718|12347508|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7859741|NCT01576718|12347509|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7859742|NCT01576718|12347510|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7859743|NCT01576718|12347511|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7859744|NCT01576718|12347512|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7859745|NCT01576718|12347513|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7859746|NCT01576718|12347507|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
7859747|NCT01576718|12347508|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7859748|NCT01576718|12347509|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7859749|NCT01576718|12347510|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7859750|NCT01576718|12347511|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7859751|NCT01576718|12347512|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7859752|NCT01576718|12347513|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7859753|NCT01576718|12347507|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15
7859754|NCT01576718|12347508|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0
7859755|NCT01576718|12347509|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0
7859756|NCT01576718|12347510|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0
7859757|NCT01576718|12347511|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0
7859758|NCT01576718|12347512|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0
7859759|NCT01576718|12347513|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0
7859760|NCT01576718|12347507|FG000|Treatment Period|Adverse Event|0
7859761|NCT01576718|12347508|FG001|Treatment Period|Adverse Event|1
7859762|NCT01576718|12347509|FG002|Treatment Period|Adverse Event|1
7859763|NCT01576718|12347510|FG003|Treatment Period|Adverse Event|1
7859764|NCT01576718|12347511|FG004|Treatment Period|Adverse Event|1
7859765|NCT01576718|12347512|FG005|Treatment Period|Adverse Event|1
7859766|NCT01576718|12347513|FG006|Treatment Period|Adverse Event|0
7859767|NCT01576718|12347507|FG000|Treatment Period|Withdrawal by Subject|0
7859768|NCT01576718|12347508|FG001|Treatment Period|Withdrawal by Subject|1
7859769|NCT01576718|12347509|FG002|Treatment Period|Withdrawal by Subject|1
7859770|NCT01576718|12347510|FG003|Treatment Period|Withdrawal by Subject|0
7859771|NCT01576718|12347511|FG004|Treatment Period|Withdrawal by Subject|2
7859772|NCT01576718|12347512|FG005|Treatment Period|Withdrawal by Subject|4
7859773|NCT01576718|12347513|FG006|Treatment Period|Withdrawal by Subject|2
7859774|NCT01576718|12347507|FG000|Treatment Period|Physician Decision|0
7859775|NCT01576718|12347508|FG001|Treatment Period|Physician Decision|1
7859776|NCT01576718|12347509|FG002|Treatment Period|Physician Decision|1
7859777|NCT01576718|12347510|FG003|Treatment Period|Physician Decision|1
7859778|NCT01576718|12347511|FG004|Treatment Period|Physician Decision|1
7859779|NCT01576718|12347512|FG005|Treatment Period|Physician Decision|0
7859780|NCT01576718|12347513|FG006|Treatment Period|Physician Decision|0
7859781|NCT01576718|12347507|FG000|Treatment Period|Protocol Violation|0
7859782|NCT01576718|12347508|FG001|Treatment Period|Protocol Violation|5
7859783|NCT01576718|12347509|FG002|Treatment Period|Protocol Violation|4
7859784|NCT01576718|12347510|FG003|Treatment Period|Protocol Violation|10
7859785|NCT01576718|12347511|FG004|Treatment Period|Protocol Violation|6
7859786|NCT01576718|12347512|FG005|Treatment Period|Protocol Violation|8
7859787|NCT01576718|12347513|FG006|Treatment Period|Protocol Violation|12
7859788|NCT01576718|12347507|FG000|Treatment Period|Sponsor request|0
7859789|NCT01576718|12347508|FG001|Treatment Period|Sponsor request|1
7859790|NCT01576718|12347509|FG002|Treatment Period|Sponsor request|0
7859791|NCT01576718|12347510|FG003|Treatment Period|Sponsor request|0
7859792|NCT01576718|12347511|FG004|Treatment Period|Sponsor request|0
7859793|NCT01576718|12347512|FG005|Treatment Period|Sponsor request|1
7859794|NCT01576718|12347513|FG006|Treatment Period|Sponsor request|0
7859795|NCT01576718|12347507|FG000|Treatment Period|Met stopping criteria|0
7859796|NCT01576718|12347508|FG001|Treatment Period|Met stopping criteria|16
7859797|NCT01576718|12347509|FG002|Treatment Period|Met stopping criteria|13
7859798|NCT01576718|12347510|FG003|Treatment Period|Met stopping criteria|19
7859799|NCT01576718|12347511|FG004|Treatment Period|Met stopping criteria|16
7859800|NCT01576718|12347512|FG005|Treatment Period|Met stopping criteria|33
7859801|NCT01576718|12347513|FG006|Treatment Period|Met stopping criteria|15
7859802|NCT01576718|12347507|FG000|Treatment Period|Lost to Follow-up|0
7859803|NCT01576718|12347508|FG001|Treatment Period|Lost to Follow-up|0
7859804|NCT01576718|12347509|FG002|Treatment Period|Lost to Follow-up|0
7859805|NCT01576718|12347510|FG003|Treatment Period|Lost to Follow-up|0
7859806|NCT01576718|12347511|FG004|Treatment Period|Lost to Follow-up|1
7859807|NCT01576718|12347512|FG005|Treatment Period|Lost to Follow-up|0
7859808|NCT01576718|12347513|FG006|Treatment Period|Lost to Follow-up|0
7859809|NCT01576718|12347507|FG000|Treatment Period|Noncompliance to study medication|0
7859810|NCT01576718|12347508|FG001|Treatment Period|Noncompliance to study medication|0
7859811|NCT01576718|12347509|FG002|Treatment Period|Noncompliance to study medication|0
7859812|NCT01576718|12347510|FG003|Treatment Period|Noncompliance to study medication|0
7859813|NCT01576718|12347511|FG004|Treatment Period|Noncompliance to study medication|0
7859814|NCT01576718|12347512|FG005|Treatment Period|Noncompliance to study medication|1
7859815|NCT01576718|12347513|FG006|Treatment Period|Noncompliance to study medication|1
7859816|NCT01576783|12347529|FG000|Overall Study|Change in Medical Care|1
7859817|NCT01576783|12347530|FG001|Overall Study|Change in Medical Care|0
7859818|NCT01576783|12347529|FG000|Overall Study|Lost to Follow-up|14
7859819|NCT01576783|12347530|FG001|Overall Study|Lost to Follow-up|16
7859820|NCT01576783|12347529|FG000|Overall Study|Withdrawal by Subject|5
7859821|NCT01576783|12347530|FG001|Overall Study|Withdrawal by Subject|1
7859822|NCT01577160|12347571|FG000|Overall Study|Adverse Event|9
7859823|NCT01577160|12347571|FG000|Overall Study|Lack of Efficacy|15
7859824|NCT01577160|12347571|FG000|Overall Study|Lost to Follow-up|40
7859825|NCT01577160|12347571|FG000|Overall Study|Withdrawal by Subject|18
7859826|NCT01577160|12347571|FG000|Overall Study|Subject Uncooperative|7
7859827|NCT01577160|12347571|FG000|Overall Study|Other|9
7859828|NCT01577186|12347575|FG000|Overall Study|Adverse Event|23
7859829|NCT01577186|12347575|FG000|Overall Study|Death|1
7859830|NCT01577186|12347575|FG000|Overall Study|Lost to Follow-up|28
7859831|NCT01577186|12347575|FG000|Overall Study|Withdrawal by Subject|35
7859832|NCT01577186|12347575|FG000|Overall Study|Insufficient Response|18
7859833|NCT01577186|12347575|FG000|Overall Study|Ineligible to Continue|15
7859834|NCT01577186|12347575|FG000|Overall Study|Non-Compliant|8
7859835|NCT01577186|12347575|FG000|Overall Study|Other|2
7859836|NCT01577381|12347601|FG000|Overall Study|Discontinued|2
7859837|NCT01577381|12347602|FG001|Overall Study|Discontinued|1
7859838|NCT01577381|12347603|FG002|Overall Study|Discontinued|2
7859839|NCT01577381|12347604|FG003|Overall Study|Discontinued|2
7859840|NCT01577381|12347601|FG000|Overall Study|Ongoing at Date of Cut-Off|0
7859841|NCT01577381|12347602|FG001|Overall Study|Ongoing at Date of Cut-Off|2
7859842|NCT01577381|12347603|FG002|Overall Study|Ongoing at Date of Cut-Off|1
7859843|NCT01577381|12347604|FG003|Overall Study|Ongoing at Date of Cut-Off|0
7859844|NCT01577745|12347643|FG000|Overall Study|Withdrawal by Subject|0
7859845|NCT01577745|12347644|FG001|Overall Study|Withdrawal by Subject|1
7859846|NCT01577745|12347645|FG002|Overall Study|Withdrawal by Subject|0
7859847|NCT01577745|12347646|FG003|Overall Study|Withdrawal by Subject|3
7859848|NCT01577745|12347647|FG004|Overall Study|Withdrawal by Subject|2
7859849|NCT01577745|12347648|FG005|Overall Study|Withdrawal by Subject|0
7859850|NCT01577745|12347643|FG000|Overall Study|Death|3
7859851|NCT01577745|12347644|FG001|Overall Study|Death|2
7859852|NCT01577745|12347645|FG002|Overall Study|Death|2
7859853|NCT01577745|12347646|FG003|Overall Study|Death|1
7859854|NCT01577745|12347647|FG004|Overall Study|Death|1
7859855|NCT01577745|12347648|FG005|Overall Study|Death|3
7859856|NCT01577745|12347643|FG000|Overall Study|Physician Decision|0
7859857|NCT01577745|12347644|FG001|Overall Study|Physician Decision|0
7859858|NCT01577745|12347645|FG002|Overall Study|Physician Decision|0
7859859|NCT01577745|12347646|FG003|Overall Study|Physician Decision|1
7859860|NCT01577745|12347647|FG004|Overall Study|Physician Decision|1
7859861|NCT01577745|12347648|FG005|Overall Study|Physician Decision|0
7859862|NCT01577745|12347643|FG000|Overall Study|Lost to Follow-up|0
7859863|NCT01577745|12347644|FG001|Overall Study|Lost to Follow-up|0
7859864|NCT01577745|12347645|FG002|Overall Study|Lost to Follow-up|0
7859865|NCT01577745|12347646|FG003|Overall Study|Lost to Follow-up|0
7859866|NCT01577745|12347647|FG004|Overall Study|Lost to Follow-up|0
7859867|NCT01577745|12347648|FG005|Overall Study|Lost to Follow-up|1
7859868|NCT01577745|12347643|FG000|Overall Study|Alternative Therapy|0
7859869|NCT01577745|12347644|FG001|Overall Study|Alternative Therapy|0
7859870|NCT01577745|12347645|FG002|Overall Study|Alternative Therapy|0
7859871|NCT01577745|12347646|FG003|Overall Study|Alternative Therapy|1
7859872|NCT01577745|12347647|FG004|Overall Study|Alternative Therapy|1
7859873|NCT01577745|12347648|FG005|Overall Study|Alternative Therapy|0
7859874|NCT01577758|12347667|FG000|Dose Escalation Phase|Adverse Event|0
7859875|NCT01577758|12347668|FG001|Dose Escalation Phase|Adverse Event|0
7859876|NCT01577758|12347669|FG002|Dose Escalation Phase|Adverse Event|0
7859877|NCT01577758|12347670|FG003|Dose Escalation Phase|Adverse Event|0
7859878|NCT01577758|12347671|FG004|Dose Escalation Phase|Adverse Event|0
7859879|NCT01577758|12347672|FG005|Dose Escalation Phase|Adverse Event|2
7859880|NCT01577758|12347673|FG006|Dose Escalation Phase|Adverse Event|1
7859881|NCT01577758|12347674|FG007|Dose Escalation Phase|Adverse Event|0
7859882|NCT01577758|12347667|FG000|Dose Escalation Phase|Symptomatic Deterioration|0
7859883|NCT01577758|12347668|FG001|Dose Escalation Phase|Symptomatic Deterioration|0
7859884|NCT01577758|12347669|FG002|Dose Escalation Phase|Symptomatic Deterioration|1
7859885|NCT01577758|12347670|FG003|Dose Escalation Phase|Symptomatic Deterioration|0
7859886|NCT01577758|12347671|FG004|Dose Escalation Phase|Symptomatic Deterioration|1
7859887|NCT01577758|12347672|FG005|Dose Escalation Phase|Symptomatic Deterioration|1
7859888|NCT01577758|12347673|FG006|Dose Escalation Phase|Symptomatic Deterioration|0
7859889|NCT01577758|12347674|FG007|Dose Escalation Phase|Symptomatic Deterioration|0
7859890|NCT01577758|12347667|FG000|Dose Escalation Phase|Withdrawal by Subject|0
7859891|NCT01577758|12347668|FG001|Dose Escalation Phase|Withdrawal by Subject|0
7859892|NCT01577758|12347669|FG002|Dose Escalation Phase|Withdrawal by Subject|0
7859893|NCT01577758|12347670|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7859894|NCT01577758|12347671|FG004|Dose Escalation Phase|Withdrawal by Subject|0
7859895|NCT01577758|12347672|FG005|Dose Escalation Phase|Withdrawal by Subject|1
7859896|NCT01577758|12347673|FG006|Dose Escalation Phase|Withdrawal by Subject|0
7859897|NCT01577758|12347674|FG007|Dose Escalation Phase|Withdrawal by Subject|0
7859898|NCT01577758|12347667|FG000|Dose Escalation Phase|Progression Disease|2
7859899|NCT01577758|12347668|FG001|Dose Escalation Phase|Progression Disease|2
7859900|NCT01577758|12347669|FG002|Dose Escalation Phase|Progression Disease|1
7859901|NCT01577758|12347670|FG003|Dose Escalation Phase|Progression Disease|2
7859902|NCT01577758|12347671|FG004|Dose Escalation Phase|Progression Disease|5
7859903|NCT01577758|12347672|FG005|Dose Escalation Phase|Progression Disease|0
7859904|NCT01577758|12347673|FG006|Dose Escalation Phase|Progression Disease|0
7859905|NCT01577758|12347674|FG007|Dose Escalation Phase|Progression Disease|0
7859906|NCT01577758|12347667|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0
7859907|NCT01577758|12347668|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0
7859908|NCT01577758|12347669|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0
7859909|NCT01577758|12347670|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0
7859910|NCT01577758|12347671|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0
7859911|NCT01577758|12347672|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0
7859912|NCT01577758|12347673|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0
7859913|NCT01577758|12347674|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4
7859914|NCT01577758|12347667|FG000|mCRC Expansion Phase|Withdrawal by Subject|0
7859915|NCT01577758|12347668|FG001|mCRC Expansion Phase|Withdrawal by Subject|0
7859916|NCT01577758|12347669|FG002|mCRC Expansion Phase|Withdrawal by Subject|0
7859917|NCT01577758|12347670|FG003|mCRC Expansion Phase|Withdrawal by Subject|0
7859918|NCT01577758|12347671|FG004|mCRC Expansion Phase|Withdrawal by Subject|0
7859919|NCT01577758|12347672|FG005|mCRC Expansion Phase|Withdrawal by Subject|0
7859920|NCT01577758|12347673|FG006|mCRC Expansion Phase|Withdrawal by Subject|0
7859921|NCT01577758|12347674|FG007|mCRC Expansion Phase|Withdrawal by Subject|2
7859922|NCT01577758|12347667|FG000|mCRC Expansion Phase|Progression Disease|0
7859923|NCT01577758|12347668|FG001|mCRC Expansion Phase|Progression Disease|0
7859924|NCT01577758|12347669|FG002|mCRC Expansion Phase|Progression Disease|0
7859925|NCT01577758|12347670|FG003|mCRC Expansion Phase|Progression Disease|0
7859926|NCT01577758|12347671|FG004|mCRC Expansion Phase|Progression Disease|0
7859927|NCT01577758|12347672|FG005|mCRC Expansion Phase|Progression Disease|0
7859928|NCT01577758|12347673|FG006|mCRC Expansion Phase|Progression Disease|0
7859929|NCT01577758|12347674|FG007|mCRC Expansion Phase|Progression Disease|19
7859930|NCT01578187|12347722|FG000|Usability Phase|Withdrawal by Subject|1
7859931|NCT01578330|12347754|FG000|Overall Study|Adverse Event|2
7859932|NCT01578330|12347754|FG000|Overall Study|Protocol Violation|5
7859933|NCT01578486|12347758|FG000|Overall Study|Physician Decision|3
7859934|NCT01578486|12347758|FG000|Overall Study|Withdrawal by Subject|2
7859935|NCT01578499|12347764|FG000|Overall Study|Reason not Specified|0
7859936|NCT01578499|12347765|FG001|Overall Study|Reason not Specified|1
7859937|NCT01578499|12347764|FG000|Overall Study|Lost to Follow-up|2
7859938|NCT01578499|12347765|FG001|Overall Study|Lost to Follow-up|1
7859939|NCT01578499|12347764|FG000|Overall Study|Withdrawal by Subject|10
7859940|NCT01578499|12347765|FG001|Overall Study|Withdrawal by Subject|16
7859941|NCT01578499|12347764|FG000|Overall Study|Death|20
7859942|NCT01578499|12347765|FG001|Overall Study|Death|25
7859943|NCT01578499|12347764|FG000|Overall Study|Died and End of Study Page not Completed|2
7859944|NCT01578499|12347765|FG001|Overall Study|Died and End of Study Page not Completed|0
7859945|NCT01578551|12347777|FG000|Overall Study|Adverse Event|1
7859946|NCT01578551|12347778|FG001|Overall Study|Adverse Event|0
7859947|NCT01578850|12347824|FG000|Period 1|Insufficient Clinical Response|1
7859948|NCT01578850|12347825|FG001|Period 1|Insufficient Clinical Response|0
7859949|NCT01578850|12347826|FG002|Period 1|Insufficient Clinical Response|0
7859950|NCT01578850|12347824|FG000|Period 1|Adverse Event|11
7859951|NCT01578850|12347825|FG001|Period 1|Adverse Event|0
7859952|NCT01578850|12347826|FG002|Period 1|Adverse Event|0
7859953|NCT01578850|12347824|FG000|Period 1|Death|1
7859954|NCT01578850|12347825|FG001|Period 1|Death|0
7859955|NCT01578850|12347826|FG002|Period 1|Death|0
7859956|NCT01578850|12347824|FG000|Period 1|Does Not Meet Entrance Criteria|12
7859957|NCT01578850|12347825|FG001|Period 1|Does Not Meet Entrance Criteria|0
7859958|NCT01578850|12347826|FG002|Period 1|Does Not Meet Entrance Criteria|0
7859959|NCT01578850|12347824|FG000|Period 1|Withdrawal by Subject|9
7859960|NCT01578850|12347825|FG001|Period 1|Withdrawal by Subject|0
7859961|NCT01578850|12347826|FG002|Period 1|Withdrawal by Subject|0
7859962|NCT01578850|12347824|FG000|Period 1|Study Terminated by Sponsor|3
7859963|NCT01578850|12347825|FG001|Period 1|Study Terminated by Sponsor|0
7859964|NCT01578850|12347826|FG002|Period 1|Study Terminated by Sponsor|0
7859965|NCT01578850|12347824|FG000|Period 2|Insufficient Clinical Response|0
7859966|NCT01578850|12347825|FG001|Period 2|Insufficient Clinical Response|1
7859967|NCT01578850|12347826|FG002|Period 2|Insufficient Clinical Response|0
7859968|NCT01578850|12347824|FG000|Period 2|Adverse Event|0
7859969|NCT01578850|12347825|FG001|Period 2|Adverse Event|3
7859970|NCT01578850|12347826|FG002|Period 2|Adverse Event|6
7859971|NCT01578850|12347824|FG000|Period 2|Lost to Follow-up|0
7859972|NCT01578850|12347825|FG001|Period 2|Lost to Follow-up|1
7859973|NCT01578850|12347826|FG002|Period 2|Lost to Follow-up|2
7859974|NCT01578850|12347824|FG000|Period 2|Withdrawal by Subject|0
7859975|NCT01578850|12347825|FG001|Period 2|Withdrawal by Subject|2
7859976|NCT01578850|12347826|FG002|Period 2|Withdrawal by Subject|2
7859977|NCT01578850|12347824|FG000|Period 2|Study Terminated by Sponsor|0
7859978|NCT01578850|12347825|FG001|Period 2|Study Terminated by Sponsor|5
7859979|NCT01578850|12347826|FG002|Period 2|Study Terminated by Sponsor|4
7859980|NCT01578850|12347824|FG000|Period 2|Unspecified Reasons|0
7859981|NCT01578850|12347825|FG001|Period 2|Unspecified Reasons|1
7859982|NCT01578850|12347826|FG002|Period 2|Unspecified Reasons|0
7859983|NCT01579006|12347849|FG000|Overall Study|Lack of Efficacy|10
7859984|NCT01579006|12347849|FG000|Overall Study|Adverse Event|13
7859985|NCT01579006|12347849|FG000|Overall Study|Withdrawal by Subject|5
7859986|NCT01579006|12347849|FG000|Overall Study|Non-compliance|3
7859987|NCT01579006|12347849|FG000|Overall Study|Due to participant's health fund|1
7859988|NCT01579006|12347849|FG000|Overall Study|Scheduled surgery|1
7859989|NCT01579318|12347940|FG000|Overall Study|Disease Progression|1
7859990|NCT01579474|12347950|FG000|Overall Study|Adverse Event|1
7859991|NCT01579474|12347951|FG001|Overall Study|Adverse Event|13
7859992|NCT01579474|12347952|FG002|Overall Study|Adverse Event|2
7859993|NCT01579474|12347953|FG003|Overall Study|Adverse Event|0
7859994|NCT01579474|12347954|FG004|Overall Study|Adverse Event|0
7859995|NCT01579474|12347955|FG005|Overall Study|Adverse Event|1
7859996|NCT01579474|12347950|FG000|Overall Study|Lack of Efficacy|1
7859997|NCT01579474|12347951|FG001|Overall Study|Lack of Efficacy|0
7859998|NCT01579474|12347952|FG002|Overall Study|Lack of Efficacy|0
7859999|NCT01579474|12347953|FG003|Overall Study|Lack of Efficacy|0
7860000|NCT01579474|12347954|FG004|Overall Study|Lack of Efficacy|1
7860001|NCT01579474|12347955|FG005|Overall Study|Lack of Efficacy|0
7860002|NCT01579474|12347950|FG000|Overall Study|Withdrawal by Subject|1
7860003|NCT01579474|12347951|FG001|Overall Study|Withdrawal by Subject|0
7860004|NCT01579474|12347952|FG002|Overall Study|Withdrawal by Subject|0
7860005|NCT01579474|12347953|FG003|Overall Study|Withdrawal by Subject|0
7860006|NCT01579474|12347954|FG004|Overall Study|Withdrawal by Subject|0
7860007|NCT01579474|12347955|FG005|Overall Study|Withdrawal by Subject|0
7860008|NCT01579565|12347979|FG000|Randomized|Adverse Event|1
7860009|NCT01579565|12347980|FG001|Randomized|Adverse Event|3
7860010|NCT01579565|12347979|FG000|Randomized|Withdrawal by Subject|3
7860011|NCT01579565|12347980|FG001|Randomized|Withdrawal by Subject|0
7860012|NCT01579565|12347979|FG000|Randomized|inadequate preoperative pupil dilation|0
7860013|NCT01579565|12347980|FG001|Randomized|inadequate preoperative pupil dilation|1
7860014|NCT01579565|12347979|FG000|Randomized|prohibited preoperative eating|1
7860015|NCT01579565|12347980|FG001|Randomized|prohibited preoperative eating|0
7860016|NCT01579565|12347979|FG000|Randomized|prohibited preoperative medication|0
7860017|NCT01579565|12347980|FG001|Randomized|prohibited preoperative medication|1
7860018|NCT01579565|12347979|FG000|Treated|Physician Decision|0
7860019|NCT01579565|12347980|FG001|Treated|Physician Decision|1
7860020|NCT01579565|12347979|FG000|Treated|Lost to Follow-up|2
7860021|NCT01579565|12347980|FG001|Treated|Lost to Follow-up|1
7860022|NCT01579565|12347979|FG000|Treated|declined to return for final visit|0
7860023|NCT01579565|12347980|FG001|Treated|declined to return for final visit|1
7860024|NCT01579578|12347990|FG000|Overall Study|Death|4
7860025|NCT01579578|12347991|FG001|Overall Study|Death|1
7860026|NCT01579578|12347990|FG000|Overall Study|Lost to Follow-up|1
7860027|NCT01579578|12347991|FG001|Overall Study|Lost to Follow-up|1
7860028|NCT01579578|12347990|FG000|Overall Study|Withdrawal by Subject|2
7860029|NCT01579578|12347991|FG001|Overall Study|Withdrawal by Subject|1
7860030|NCT01579578|12347990|FG000|Overall Study|Eligibility criteria|3
7860031|NCT01579578|12347991|FG001|Overall Study|Eligibility criteria|9
7860032|NCT01579578|12347990|FG000|Overall Study|Ongoing|3
7860033|NCT01579578|12347991|FG001|Overall Study|Ongoing|0
7863914|NCT01609556|12353457|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7863915|NCT01609556|12353458|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7863916|NCT01609556|12353459|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7863917|NCT01609556|12353444|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7863918|NCT01609556|12353445|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7863919|NCT01609556|12353446|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7863920|NCT01609556|12353447|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7863921|NCT01609556|12353448|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7863922|NCT01609556|12353449|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
7863923|NCT01609556|12353450|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7863924|NCT01609556|12353451|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7863925|NCT01609556|12353452|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7860034|NCT01579812|12348015|FG000|Overall Study|Ineligible after treatment start|40
7860035|NCT01579812|12348015|FG000|Overall Study|Patient choice|3
7860036|NCT01579812|12348015|FG000|Overall Study|Noncompliance|3
7860037|NCT01579812|12348015|FG000|Overall Study|Withdrawal by Subject|6
7860038|NCT01579916|12348024|FG000|Overall Study|Lost to Follow-up|6
7860039|NCT01579916|12348025|FG001|Overall Study|Lost to Follow-up|1
7860040|NCT01579916|12348024|FG000|Overall Study|Withdrawal by Subject|1
7860041|NCT01579916|12348025|FG001|Overall Study|Withdrawal by Subject|1
7860042|NCT01579916|12348024|FG000|Overall Study|Death|1
7860043|NCT01579916|12348025|FG001|Overall Study|Death|0
7860044|NCT01580020|12348033|FG000|Overall Study|Lack of Efficacy|0
7860045|NCT01580020|12348034|FG001|Overall Study|Lack of Efficacy|5
7860046|NCT01580020|12348035|FG002|Overall Study|Lack of Efficacy|0
7860047|NCT01580020|12348036|FG003|Overall Study|Lack of Efficacy|1
7860048|NCT01580020|12348033|FG000|Overall Study|Withdrawal by Subject|0
7860049|NCT01580020|12348034|FG001|Overall Study|Withdrawal by Subject|1
7860050|NCT01580020|12348035|FG002|Overall Study|Withdrawal by Subject|1
7860051|NCT01580020|12348036|FG003|Overall Study|Withdrawal by Subject|0
7860052|NCT01580020|12348033|FG000|Overall Study|Adverse Event|1
7860053|NCT01580020|12348034|FG001|Overall Study|Adverse Event|1
7860054|NCT01580020|12348035|FG002|Overall Study|Adverse Event|1
7860055|NCT01580020|12348036|FG003|Overall Study|Adverse Event|1
7860056|NCT01580020|12348033|FG000|Overall Study|Administrative Problems|0
7860057|NCT01580020|12348034|FG001|Overall Study|Administrative Problems|0
7860058|NCT01580020|12348035|FG002|Overall Study|Administrative Problems|1
7860059|NCT01580020|12348036|FG003|Overall Study|Administrative Problems|0
7860060|NCT01580020|12348033|FG000|Overall Study|Lost to Follow-up|0
7860061|NCT01580020|12348034|FG001|Overall Study|Lost to Follow-up|0
7860062|NCT01580020|12348035|FG002|Overall Study|Lost to Follow-up|1
7860063|NCT01580020|12348036|FG003|Overall Study|Lost to Follow-up|0
7860064|NCT01580293|12348077|FG000|Part A_Main Trial|Adverse Event|0
7860065|NCT01580293|12348078|FG001|Part A_Main Trial|Adverse Event|2
7860066|NCT01580293|12348079|FG002|Part A_Main Trial|Adverse Event|0
7860067|NCT01580293|12348077|FG000|Part A_Main Trial|Withdrawal by Subject|1
7860068|NCT01580293|12348078|FG001|Part A_Main Trial|Withdrawal by Subject|4
7860069|NCT01580293|12348079|FG002|Part A_Main Trial|Withdrawal by Subject|0
7860070|NCT01580293|12348077|FG000|Part A_Main Trial|Non-adherence to the protocol|1
7860071|NCT01580293|12348078|FG001|Part A_Main Trial|Non-adherence to the protocol|0
7860072|NCT01580293|12348079|FG002|Part A_Main Trial|Non-adherence to the protocol|0
7860073|NCT01580293|12348077|FG000|Part A_Extension|Adverse Event|0
7860074|NCT01580293|12348078|FG001|Part A_Extension|Adverse Event|2
7860075|NCT01580293|12348079|FG002|Part A_Extension|Adverse Event|0
7860076|NCT01580293|12348077|FG000|Part A_Extension|Withdrawal by Subject|0
7860077|NCT01580293|12348078|FG001|Part A_Extension|Withdrawal by Subject|3
7860078|NCT01580293|12348079|FG002|Part A_Extension|Withdrawal by Subject|0
7860079|NCT01580293|12348077|FG000|Part A_Extension|Lost to Follow-up|0
7860080|NCT01580293|12348078|FG001|Part A_Extension|Lost to Follow-up|1
7860081|NCT01580293|12348079|FG002|Part A_Extension|Lost to Follow-up|0
7860082|NCT01580293|12348077|FG000|Part A_Extension|Other Reason|0
7860083|NCT01580293|12348078|FG001|Part A_Extension|Other Reason|1
7860084|NCT01580293|12348079|FG002|Part A_Extension|Other Reason|0
7860085|NCT01580293|12348077|FG000|Part A_Extension|Completed Japan only|0
7860086|NCT01580293|12348078|FG001|Part A_Extension|Completed Japan only|5
7860087|NCT01580293|12348079|FG002|Part A_Extension|Completed Japan only|0
7860088|NCT01580293|12348077|FG000|Part B|Withdrawal by Subject|0
7860089|NCT01580293|12348078|FG001|Part B|Withdrawal by Subject|0
7860090|NCT01580293|12348079|FG002|Part B|Withdrawal by Subject|1
7860091|NCT01580293|12348077|FG000|Part B|Other reason|0
7860092|NCT01580293|12348078|FG001|Part B|Other reason|0
7860093|NCT01580293|12348079|FG002|Part B|Other reason|1
7860094|NCT01580488|12348140|FG000|Overall Study|Withdrawal by Subject|1
7860095|NCT01580670|12348176|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1
7860096|NCT01580670|12348176|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1
7860097|NCT01580969|12348193|FG000|Overall Study|Physician Decision|3
7860098|NCT01580969|12348194|FG001|Overall Study|Physician Decision|0
7860099|NCT01580969|12348195|FG002|Overall Study|Physician Decision|0
7860100|NCT01580995|12348205|FG000|Overall Study|Lost to Follow-up|2
7860101|NCT01580995|12348206|FG001|Overall Study|Lost to Follow-up|2
7860102|NCT01581021|12348224|FG000|Overall Study|Lost to Follow-up|4
7860103|NCT01581021|12348225|FG001|Overall Study|Lost to Follow-up|6
7860104|NCT01581021|12348224|FG000|Overall Study|More than 2 hooks in thoracic|3
7860105|NCT01581021|12348225|FG001|Overall Study|More than 2 hooks in thoracic|0
7860106|NCT01581021|12348224|FG000|Overall Study|Neuromuscular|2
7860107|NCT01581021|12348225|FG001|Overall Study|Neuromuscular|1
7860108|NCT01581021|12348224|FG000|Overall Study|Not Randomized|1
7860109|NCT01581021|12348225|FG001|Overall Study|Not Randomized|2
7860110|NCT01581021|12348224|FG000|Overall Study|Lenke 6 Classification|0
7860111|NCT01581021|12348225|FG001|Overall Study|Lenke 6 Classification|1
7860112|NCT01581021|12348224|FG000|Overall Study|Lack of Efficacy|0
7860113|NCT01581021|12348225|FG001|Overall Study|Lack of Efficacy|1
7860114|NCT01581281|12348234|FG000|Overall Study|Early Study Closure|15
7860115|NCT01581281|12348235|FG001|Overall Study|Early Study Closure|6
7860116|NCT01581281|12348236|FG002|Overall Study|Early Study Closure|12
7860117|NCT01581307|12348245|FG000|Overall Study|Withdrawal by Subject|1
7860118|NCT01581593|12348292|FG000|Overall Study|Withdrawal by Subject|1
7860119|NCT01581619|12348300|FG000|Overall Study|Withdrawal by Subject|1
7860120|NCT01581619|12348300|FG000|Overall Study|Lost to Follow-up|1
7860121|NCT01581684|12348333|FG000|Overall Study|Other reason not defined|0
7860122|NCT01581684|12348334|FG001|Overall Study|Other reason not defined|0
7860123|NCT01581684|12348335|FG002|Overall Study|Other reason not defined|0
7860124|NCT01581684|12348336|FG003|Overall Study|Other reason not defined|0
7860125|NCT01581684|12348337|FG004|Overall Study|Other reason not defined|0
7860126|NCT01581684|12348338|FG005|Overall Study|Other reason not defined|0
7860127|NCT01581684|12348339|FG006|Overall Study|Other reason not defined|0
7860128|NCT01581684|12348340|FG007|Overall Study|Other reason not defined|0
7860129|NCT01581684|12348341|FG008|Overall Study|Other reason not defined|1
7860130|NCT01581684|12348342|FG009|Overall Study|Other reason not defined|0
7860131|NCT01581931|12348386|FG000|Washout|Adverse Event|0
7860132|NCT01581931|12348387|FG001|Washout|Adverse Event|1
7860133|NCT01582061|12348399|FG000|Overall Study|Lack of Efficacy|3
7860134|NCT01582061|12348400|FG001|Overall Study|Lack of Efficacy|23
7860135|NCT01582061|12348399|FG000|Overall Study|Adverse Event|12
7860136|NCT01582061|12348400|FG001|Overall Study|Adverse Event|8
7860137|NCT01582061|12348399|FG000|Overall Study|Withdrawal by Subject|10
7860138|NCT01582061|12348400|FG001|Overall Study|Withdrawal by Subject|4
7860139|NCT01582061|12348399|FG000|Overall Study|Abnormal laboratory value(s)|1
7860140|NCT01582061|12348400|FG001|Overall Study|Abnormal laboratory value(s)|0
7860141|NCT01582061|12348399|FG000|Overall Study|Death|0
7860142|NCT01582061|12348400|FG001|Overall Study|Death|1
7860143|NCT01582061|12348399|FG000|Overall Study|condition no longer requires study drug|1
7860144|NCT01582061|12348400|FG001|Overall Study|condition no longer requires study drug|0
7860145|NCT01582061|12348399|FG000|Overall Study|Lost to Follow-up|1
7860146|NCT01582061|12348400|FG001|Overall Study|Lost to Follow-up|0
7860147|NCT01582152|12348427|FG000|Overall Study|Disease Progression|4
7860148|NCT01582152|12348428|FG001|Overall Study|Disease Progression|5
7860149|NCT01582152|12348427|FG000|Overall Study|Adverse Event|2
7860150|NCT01582152|12348428|FG001|Overall Study|Adverse Event|1
7860151|NCT01582178|12348436|FG000|Overall Study|Physician Decision|6
7860152|NCT01582178|12348437|FG001|Overall Study|Physician Decision|5
7860153|NCT01582243|12348443|FG000|Overall Study|Withdrawal by Subject|1
7860154|NCT01582243|12348443|FG000|Overall Study|Adverse Event|1
7860155|NCT01582243|12348443|FG000|Overall Study|Lost to Follow-up|1
7860156|NCT01582282|12348450|FG000|Overall Study|Adverse Event|1
7860157|NCT01582282|12348451|FG001|Overall Study|Adverse Event|1
7860158|NCT01582282|12348452|FG002|Overall Study|Adverse Event|0
7860159|NCT01582282|12348450|FG000|Overall Study|Lost to Follow-up|1
7860160|NCT01582282|12348451|FG001|Overall Study|Lost to Follow-up|0
7860161|NCT01582282|12348452|FG002|Overall Study|Lost to Follow-up|0
7860162|NCT01582282|12348450|FG000|Overall Study|fasting blood glucose outside Protocol|0
7860163|NCT01582282|12348451|FG001|Overall Study|fasting blood glucose outside Protocol|1
7860164|NCT01582282|12348452|FG002|Overall Study|fasting blood glucose outside Protocol|0
7860165|NCT01582308|12348460|FG000|Period 1|Withdrawal by Subject|0
7860166|NCT01582308|12348461|FG001|Period 1|Withdrawal by Subject|0
7860167|NCT01582308|12348462|FG002|Period 1|Withdrawal by Subject|0
7860168|NCT01582308|12348463|FG003|Period 1|Withdrawal by Subject|0
7860169|NCT01582308|12348464|FG004|Period 1|Withdrawal by Subject|0
7860170|NCT01582308|12348465|FG005|Period 1|Withdrawal by Subject|0
7860171|NCT01582308|12348466|FG006|Period 1|Withdrawal by Subject|1
7860172|NCT01582308|12348467|FG007|Period 1|Withdrawal by Subject|0
7860173|NCT01582308|12348468|FG008|Period 1|Withdrawal by Subject|0
7860174|NCT01582308|12348469|FG009|Period 1|Withdrawal by Subject|0
7860175|NCT01582308|12348460|FG000|10-day Washout Following Period 1|Physician Decision|0
7860176|NCT01582308|12348461|FG001|10-day Washout Following Period 1|Physician Decision|0
7860177|NCT01582308|12348462|FG002|10-day Washout Following Period 1|Physician Decision|0
7860178|NCT01582308|12348463|FG003|10-day Washout Following Period 1|Physician Decision|0
7860179|NCT01582308|12348464|FG004|10-day Washout Following Period 1|Physician Decision|1
7860180|NCT01582308|12348465|FG005|10-day Washout Following Period 1|Physician Decision|0
7860181|NCT01582308|12348466|FG006|10-day Washout Following Period 1|Physician Decision|0
7860182|NCT01582308|12348467|FG007|10-day Washout Following Period 1|Physician Decision|0
7860183|NCT01582308|12348468|FG008|10-day Washout Following Period 1|Physician Decision|0
7860184|NCT01582308|12348469|FG009|10-day Washout Following Period 1|Physician Decision|0
7860185|NCT01582308|12348460|FG000|Period 4|Physician Decision|1
7860186|NCT01582308|12348461|FG001|Period 4|Physician Decision|0
7860187|NCT01582308|12348462|FG002|Period 4|Physician Decision|0
7860188|NCT01582308|12348463|FG003|Period 4|Physician Decision|0
7860189|NCT01582308|12348464|FG004|Period 4|Physician Decision|0
7860190|NCT01582308|12348465|FG005|Period 4|Physician Decision|1
7860191|NCT01582308|12348466|FG006|Period 4|Physician Decision|0
7860192|NCT01582308|12348467|FG007|Period 4|Physician Decision|0
7860193|NCT01582308|12348468|FG008|Period 4|Physician Decision|0
7860194|NCT01582308|12348469|FG009|Period 4|Physician Decision|1
7860195|NCT01582451|12348484|FG000|Overall Study|Adverse Event|1
7860196|NCT01582451|12348485|FG001|Overall Study|Adverse Event|3
7860197|NCT01582451|12348484|FG000|Overall Study|Death|3
7860198|NCT01582451|12348485|FG001|Overall Study|Death|3
7860199|NCT01582451|12348484|FG000|Overall Study|Lost to Follow-up|0
7860200|NCT01582451|12348485|FG001|Overall Study|Lost to Follow-up|2
7860201|NCT01582451|12348484|FG000|Overall Study|Protocol Violation|11
7860202|NCT01582451|12348485|FG001|Overall Study|Protocol Violation|3
7860203|NCT01582451|12348484|FG000|Overall Study|Withdrawal by Subject|13
7860204|NCT01582451|12348485|FG001|Overall Study|Withdrawal by Subject|9
7860205|NCT01582451|12348484|FG000|Overall Study|Physician Decision|3
7860206|NCT01582451|12348485|FG001|Overall Study|Physician Decision|0
7860207|NCT01582451|12348484|FG000|Overall Study|Sponsor Decision|1
7860208|NCT01582451|12348485|FG001|Overall Study|Sponsor Decision|0
7860209|NCT01582789|12348511|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1
7860210|NCT01582789|12348512|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0
7860211|NCT01582854|12348522|FG000|Overall Study|Death|8
7860212|NCT01582854|12348523|FG001|Overall Study|Death|5
7860213|NCT01582854|12348522|FG000|Overall Study|Adverse Event|2
7860214|NCT01582854|12348523|FG001|Overall Study|Adverse Event|3
7860215|NCT01582854|12348522|FG000|Overall Study|Withdrawal by Participant|8
7860216|NCT01582854|12348523|FG001|Overall Study|Withdrawal by Participant|11
7860217|NCT01582854|12348522|FG000|Overall Study|Lost to Follow-up|1
7860218|NCT01582854|12348523|FG001|Overall Study|Lost to Follow-up|2
7860219|NCT01582854|12348522|FG000|Overall Study|Physician Decision|0
7860220|NCT01582854|12348523|FG001|Overall Study|Physician Decision|1
7860221|NCT01582854|12348522|FG000|Overall Study|Recurrent Stroke|13
7860222|NCT01582854|12348523|FG001|Overall Study|Recurrent Stroke|8
7860223|NCT01582854|12348522|FG000|Overall Study|Disallowed Concomitant Medication|3
7860224|NCT01582854|12348523|FG001|Overall Study|Disallowed Concomitant Medication|2
7860225|NCT01582854|12348522|FG000|Overall Study|Carotid or Neurosurgery|0
7860226|NCT01582854|12348523|FG001|Overall Study|Carotid or Neurosurgery|1
7860227|NCT01582854|12348522|FG000|Overall Study|General Anaesthesia|0
7860228|NCT01582854|12348523|FG001|Overall Study|General Anaesthesia|1
7950021|NCT02546193|12496187|FG001|Overall Study|Withdrawal by Subject|0
7950022|NCT02546193|12496188|FG002|Overall Study|Withdrawal by Subject|1
7950023|NCT02546193|12496189|FG003|Overall Study|Withdrawal by Subject|0
7950024|NCT02546193|12496186|FG000|Overall Study|Not eligible at time of induction|4
7950025|NCT02546193|12496187|FG001|Overall Study|Not eligible at time of induction|6
7950026|NCT02546193|12496188|FG002|Overall Study|Not eligible at time of induction|1
7950027|NCT02546193|12496189|FG003|Overall Study|Not eligible at time of induction|0
7950028|NCT02546323|12496197|FG000|Overall Study|Withdrawal by Subject|36
7950029|NCT02546323|12496198|FG001|Overall Study|Withdrawal by Subject|33
7950030|NCT02546323|12496197|FG000|Overall Study|Eligibility Criteria not Fulfilled|0
7950031|NCT02546323|12496198|FG001|Overall Study|Eligibility Criteria not Fulfilled|1
7950032|NCT02546323|12496197|FG000|Overall Study|Adverse Event|17
7950033|NCT02546323|12496198|FG001|Overall Study|Adverse Event|11
7950034|NCT02546323|12496197|FG000|Overall Study|Patient Specific Reasons|1
7950035|NCT02546323|12496198|FG001|Overall Study|Patient Specific Reasons|2
7950036|NCT02546323|12496197|FG000|Overall Study|Lost to Follow-up|2
7950037|NCT02546323|12496198|FG001|Overall Study|Lost to Follow-up|3
7950038|NCT02546323|12496197|FG000|Overall Study|Non-compliance with Study Drug|2
7950039|NCT02546323|12496198|FG001|Overall Study|Non-compliance with Study Drug|2
7950040|NCT02546323|12496197|FG000|Overall Study|Met Withdrawal Criteria|2
7950041|NCT02546323|12496198|FG001|Overall Study|Met Withdrawal Criteria|14
7950042|NCT02546362|12496204|FG000|4-week Treatment Period|Lost to Follow-up|1
7950043|NCT02546362|12496204|FG000|4-week Treatment Period|Change in medication|2
7950044|NCT02546362|12496204|FG000|12-week Treatment Period|Withdrawal by Subject|6
7950045|NCT02546362|12496204|FG000|12-week Treatment Period|Lost to Follow-up|2
7950046|NCT02546362|12496204|FG000|12-week Treatment Period|Change in medication|1
7950047|NCT02546544|12496222|FG000|Overall Study|Disease Progression|14
7860229|NCT01582854|12348522|FG000|Overall Study|Other Miscellaneous Reason|1
7860230|NCT01582854|12348523|FG001|Overall Study|Other Miscellaneous Reason|0
7860231|NCT01582945|12348533|FG000|Overall Study|Intolerable side-effects|1
7860232|NCT01582945|12348533|FG000|Overall Study|Scheduling conflicts|1
7860233|NCT01582971|12348539|FG000|Overall Study|Death|2
7860234|NCT01582971|12348540|FG001|Overall Study|Death|1
7860235|NCT01582971|12348539|FG000|Overall Study|Lost to Follow-up|18
7860236|NCT01582971|12348540|FG001|Overall Study|Lost to Follow-up|21
7860237|NCT01582971|12348539|FG000|Overall Study|Withdrawal by Subject|4
7860238|NCT01582971|12348540|FG001|Overall Study|Withdrawal by Subject|2
7860239|NCT01582971|12348539|FG000|Overall Study|Other|15
7860240|NCT01582971|12348540|FG001|Overall Study|Other|13
7860241|NCT01583166|12348563|FG000|Overall Study|Withdrawal by Subject|4
7860242|NCT01583166|12348564|FG001|Overall Study|Withdrawal by Subject|6
7860243|NCT01583179|12348572|FG000|Overall Study|Screen failure|1
7860244|NCT01583179|12348573|FG001|Overall Study|Screen failure|2
7860245|NCT01583218|12348581|FG000|Overall Study|Withdrawal by Subject|43
7950048|NCT02546544|12496222|FG000|Overall Study|Adverse Event|1
7950049|NCT02546544|12496222|FG000|Overall Study|Withdrawal by Subject|1
7950050|NCT02546609|12496242|FG000|Overall Study|Withdrawal by Subject|0
7950051|NCT02546609|12496243|FG001|Overall Study|Withdrawal by Subject|1
7950052|NCT02546609|12496244|FG002|Overall Study|Withdrawal by Subject|2
7860246|NCT01583218|12348582|FG001|Overall Study|Withdrawal by Subject|29
7860247|NCT01583218|12348581|FG000|Overall Study|Death|206
7860248|NCT01583218|12348582|FG001|Overall Study|Death|211
7860249|NCT01583218|12348581|FG000|Overall Study|Lost to Follow-up|11
7860250|NCT01583218|12348582|FG001|Overall Study|Lost to Follow-up|17
7860251|NCT01583218|12348581|FG000|Overall Study|Adverse event or serious adverse event|3
7860252|NCT01583218|12348582|FG001|Overall Study|Adverse event or serious adverse event|3
7860253|NCT01583218|12348581|FG000|Overall Study|Patient /Family decision|3
7860254|NCT01583218|12348582|FG001|Overall Study|Patient /Family decision|0
7860255|NCT01583218|12348581|FG000|Overall Study|Cannot contact patient directly|1
7860256|NCT01583218|12348582|FG001|Overall Study|Cannot contact patient directly|2
7860257|NCT01583218|12348581|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
7860258|NCT01583218|12348582|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
7860259|NCT01583218|12348581|FG000|Overall Study|Patient did not wish to attend visits|0
7860260|NCT01583218|12348582|FG001|Overall Study|Patient did not wish to attend visits|1
7860261|NCT01583218|12348581|FG000|Overall Study|Patient randomized but not dosed|17
7860262|NCT01583218|12348582|FG001|Overall Study|Patient randomized but not dosed|16
7860263|NCT01583218|12348581|FG000|Overall Study|Patient was assessed via phone in person|1
7860264|NCT01583218|12348582|FG001|Overall Study|Patient was assessed via phone in person|0
7860265|NCT01583218|12348581|FG000|Overall Study|Patient deemed ineligible after random|2
7860266|NCT01583218|12348582|FG001|Overall Study|Patient deemed ineligible after random|0
7860267|NCT01583218|12348581|FG000|Overall Study|Patient was early terminated from study|0
7860268|NCT01583218|12348582|FG001|Overall Study|Patient was early terminated from study|1
7860269|NCT01583218|12348581|FG000|Overall Study|Patient was randomized due to mistake|1
7860270|NCT01583218|12348582|FG001|Overall Study|Patient was randomized due to mistake|0
7860271|NCT01583218|12348581|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
7860272|NCT01583218|12348582|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
7860273|NCT01583218|12348581|FG000|Overall Study|Withdraw of consent on day of random|1
7860274|NCT01583218|12348582|FG001|Overall Study|Withdraw of consent on day of random|0
7860275|NCT01583296|12348590|FG000|Overall Study|Withdrawal by Subject|11
7860276|NCT01583296|12348591|FG001|Overall Study|Withdrawal by Subject|10
7860277|NCT01583374|12348600|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6
7860278|NCT01583374|12348601|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7
7860279|NCT01583374|12348602|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12
7860280|NCT01583374|12348603|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7860281|NCT01583374|12348604|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7860282|NCT01583374|12348605|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7860283|NCT01583374|12348606|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7860284|NCT01583374|12348607|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7860285|NCT01583374|12348608|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7860286|NCT01583374|12348600|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3
7860287|NCT01583374|12348601|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2
7860288|NCT01583374|12348602|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
7860289|NCT01583374|12348603|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7860290|NCT01583374|12348604|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7860291|NCT01583374|12348605|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7860292|NCT01583374|12348606|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7860293|NCT01583374|12348607|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7860294|NCT01583374|12348608|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7860295|NCT01583374|12348600|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
7860296|NCT01583374|12348601|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
7860297|NCT01583374|12348602|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7860298|NCT01583374|12348603|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7860299|NCT01583374|12348604|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7860300|NCT01583374|12348605|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7860301|NCT01583374|12348606|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7860302|NCT01583374|12348607|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7860303|NCT01583374|12348608|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7860304|NCT01583374|12348600|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8
7860305|NCT01583374|12348601|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
7860306|NCT01583374|12348602|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
7860307|NCT01583374|12348603|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7860308|NCT01583374|12348604|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7860309|NCT01583374|12348605|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7860310|NCT01583374|12348606|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7860311|NCT01583374|12348607|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7860312|NCT01583374|12348608|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7860313|NCT01583374|12348600|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1
7860314|NCT01583374|12348601|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2
7860315|NCT01583374|12348602|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7860316|NCT01583374|12348603|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7860317|NCT01583374|12348604|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7860318|NCT01583374|12348605|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7860319|NCT01583374|12348606|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7860320|NCT01583374|12348607|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7860321|NCT01583374|12348608|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7860322|NCT01583374|12348600|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7860323|NCT01583374|12348601|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7860324|NCT01583374|12348602|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3
7860325|NCT01583374|12348603|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7860326|NCT01583374|12348604|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7860327|NCT01583374|12348605|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7860328|NCT01583374|12348606|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7860329|NCT01583374|12348607|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7860330|NCT01583374|12348608|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7860331|NCT01583374|12348600|FG000|Placebo-controlled Phase (Week 0-24)|Other|0
7860332|NCT01583374|12348601|FG001|Placebo-controlled Phase (Week 0-24)|Other|1
7860333|NCT01583374|12348602|FG002|Placebo-controlled Phase (Week 0-24)|Other|0
7860334|NCT01583374|12348603|FG003|Placebo-controlled Phase (Week 0-24)|Other|0
7860335|NCT01583374|12348604|FG004|Placebo-controlled Phase (Week 0-24)|Other|0
7860336|NCT01583374|12348605|FG005|Placebo-controlled Phase (Week 0-24)|Other|0
7860337|NCT01583374|12348606|FG006|Placebo-controlled Phase (Week 0-24)|Other|0
7860338|NCT01583374|12348607|FG007|Placebo-controlled Phase (Week 0-24)|Other|0
7860339|NCT01583374|12348608|FG008|Placebo-controlled Phase (Week 0-24)|Other|0
7860340|NCT01583374|12348600|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7860341|NCT01583374|12348601|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7860342|NCT01583374|12348602|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7860343|NCT01583374|12348603|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7860344|NCT01583374|12348604|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7860345|NCT01583374|12348605|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7860346|NCT01583374|12348606|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7860347|NCT01583374|12348607|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
7860348|NCT01583374|12348608|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7860349|NCT01583374|12348600|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7860350|NCT01583374|12348601|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7860351|NCT01583374|12348602|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2
7860352|NCT01583374|12348603|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7860353|NCT01583374|12348604|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7860354|NCT01583374|12348605|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7860355|NCT01583374|12348606|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7860356|NCT01583374|12348607|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7860357|NCT01583374|12348608|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7860358|NCT01583374|12348600|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
7860359|NCT01583374|12348601|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
7860360|NCT01583374|12348602|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
7860361|NCT01583374|12348603|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6
7860362|NCT01583374|12348604|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3
7860363|NCT01583374|12348605|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
7860364|NCT01583374|12348606|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5
7860365|NCT01583374|12348607|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
7860366|NCT01583374|12348608|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
7860367|NCT01583374|12348600|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7860368|NCT01583374|12348601|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2
7860369|NCT01583374|12348602|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
7860370|NCT01583374|12348603|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7860371|NCT01583374|12348604|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
7860372|NCT01583374|12348605|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7860373|NCT01583374|12348606|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7950053|NCT02546609|12496242|FG000|Overall Study|Adverse Event|0
7860374|NCT01583374|12348607|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7860375|NCT01583374|12348608|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7860376|NCT01583374|12348600|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7860377|NCT01583374|12348601|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7860378|NCT01583374|12348602|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
7860379|NCT01583374|12348603|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7860380|NCT01583374|12348604|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
7860381|NCT01583374|12348605|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2
7860382|NCT01583374|12348606|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7860383|NCT01583374|12348607|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7860384|NCT01583374|12348608|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7883493|NCT01782378|12383175|FG000|First Series|Lost to Follow-up|7
7860385|NCT01583374|12348600|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0
7860386|NCT01583374|12348601|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5
7860387|NCT01583374|12348602|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7860388|NCT01583374|12348603|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7860389|NCT01583374|12348604|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6
7860390|NCT01583374|12348605|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7860391|NCT01583374|12348606|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7860392|NCT01583374|12348607|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3
7860393|NCT01583374|12348608|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1
7860394|NCT01583374|12348600|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0
7860395|NCT01583374|12348601|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
7860396|NCT01583374|12348602|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6
7860397|NCT01583374|12348603|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
7860398|NCT01583374|12348604|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10
7860399|NCT01583374|12348605|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
7860400|NCT01583374|12348606|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
7860401|NCT01583374|12348607|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2
7860402|NCT01583374|12348608|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
7860403|NCT01583374|12348600|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7860404|NCT01583374|12348601|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7860405|NCT01583374|12348602|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7860406|NCT01583374|12348603|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7860407|NCT01583374|12348604|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
7860408|NCT01583374|12348605|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7860409|NCT01583374|12348606|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7860410|NCT01583374|12348607|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
7860411|NCT01583374|12348608|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
7860412|NCT01583374|12348600|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0
7860413|NCT01583374|12348601|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
7860414|NCT01583374|12348602|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
7860415|NCT01583374|12348603|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1
7860416|NCT01583374|12348604|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12
7860417|NCT01583374|12348605|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7
7860418|NCT01583374|12348606|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5
7860419|NCT01583374|12348607|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
7860420|NCT01583374|12348608|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
7860421|NCT01583374|12348600|FG000|Long-Term Extension Phase Weeks 52-260|Death|0
7860422|NCT01583374|12348601|FG001|Long-Term Extension Phase Weeks 52-260|Death|0
7860423|NCT01583374|12348602|FG002|Long-Term Extension Phase Weeks 52-260|Death|0
7860424|NCT01583374|12348603|FG003|Long-Term Extension Phase Weeks 52-260|Death|0
7860425|NCT01583374|12348604|FG004|Long-Term Extension Phase Weeks 52-260|Death|1
7860426|NCT01583374|12348605|FG005|Long-Term Extension Phase Weeks 52-260|Death|0
7860427|NCT01583374|12348606|FG006|Long-Term Extension Phase Weeks 52-260|Death|1
7860428|NCT01583374|12348607|FG007|Long-Term Extension Phase Weeks 52-260|Death|0
7860429|NCT01583374|12348608|FG008|Long-Term Extension Phase Weeks 52-260|Death|0
7860430|NCT01583374|12348600|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7860431|NCT01583374|12348601|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7860432|NCT01583374|12348602|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7860433|NCT01583374|12348603|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7860434|NCT01583374|12348604|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7860435|NCT01583374|12348605|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7860436|NCT01583374|12348606|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7860437|NCT01583374|12348607|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7860438|NCT01583374|12348608|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7860439|NCT01583374|12348600|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
7860440|NCT01583374|12348601|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
7860441|NCT01583374|12348602|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
7860442|NCT01583374|12348603|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2
7860443|NCT01583374|12348604|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
7860444|NCT01583374|12348605|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
7860445|NCT01583374|12348606|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
7860446|NCT01583374|12348607|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
7860447|NCT01583374|12348608|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
7860448|NCT01583530|12348645|FG000|Overall Study|Adverse Event|0
7860449|NCT01583530|12348646|FG001|Overall Study|Adverse Event|0
7860450|NCT01583530|12348647|FG002|Overall Study|Adverse Event|0
7860451|NCT01583530|12348648|FG003|Overall Study|Adverse Event|0
7860452|NCT01583530|12348649|FG004|Overall Study|Adverse Event|0
7860453|NCT01583530|12348650|FG005|Overall Study|Adverse Event|1
7860454|NCT01583530|12348645|FG000|Overall Study|Withdrawal by Subject|0
7860455|NCT01583530|12348646|FG001|Overall Study|Withdrawal by Subject|3
7860456|NCT01583530|12348647|FG002|Overall Study|Withdrawal by Subject|0
7860457|NCT01583530|12348648|FG003|Overall Study|Withdrawal by Subject|1
7860458|NCT01583530|12348649|FG004|Overall Study|Withdrawal by Subject|1
7860459|NCT01583530|12348650|FG005|Overall Study|Withdrawal by Subject|2
7860460|NCT01583530|12348645|FG000|Overall Study|Lost to Follow-up|0
7860461|NCT01583530|12348646|FG001|Overall Study|Lost to Follow-up|0
7860462|NCT01583530|12348647|FG002|Overall Study|Lost to Follow-up|0
7860463|NCT01583530|12348648|FG003|Overall Study|Lost to Follow-up|0
7860464|NCT01583530|12348649|FG004|Overall Study|Lost to Follow-up|3
7860465|NCT01583530|12348650|FG005|Overall Study|Lost to Follow-up|0
7860466|NCT01583530|12348645|FG000|Overall Study|Lack of compliance|0
7860467|NCT01583530|12348646|FG001|Overall Study|Lack of compliance|0
7860468|NCT01583530|12348647|FG002|Overall Study|Lack of compliance|0
7860469|NCT01583530|12348648|FG003|Overall Study|Lack of compliance|0
7860470|NCT01583530|12348649|FG004|Overall Study|Lack of compliance|1
7860471|NCT01583530|12348650|FG005|Overall Study|Lack of compliance|0
7860472|NCT01584024|12348724|FG000|Overall Study|Lost to Follow-up|10
7860473|NCT01584024|12348724|FG000|Overall Study|Withdrawal by Subject|3
7860474|NCT01584232|12348731|FG000|Overall Study|Adverse Event|3
7860475|NCT01584232|12348732|FG001|Overall Study|Adverse Event|1
7860476|NCT01584232|12348731|FG000|Overall Study|Withdrawal by Subject|2
7860477|NCT01584232|12348732|FG001|Overall Study|Withdrawal by Subject|1
7860478|NCT01584232|12348731|FG000|Overall Study|Physician Decision|2
7860479|NCT01584232|12348732|FG001|Overall Study|Physician Decision|1
7860480|NCT01584232|12348731|FG000|Overall Study|Lost to Follow-up|1
7860481|NCT01584232|12348732|FG001|Overall Study|Lost to Follow-up|0
7860482|NCT01584440|12348758|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1
7860483|NCT01584440|12348759|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
7860484|NCT01584440|12348760|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
7860485|NCT01584440|12348761|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
7860486|NCT01584440|12348762|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
7860487|NCT01584440|12348758|FG000|Stage 1 (5 Weeks)|Adverse Event|5
7860488|NCT01584440|12348759|FG001|Stage 1 (5 Weeks)|Adverse Event|3
7860489|NCT01584440|12348760|FG002|Stage 1 (5 Weeks)|Adverse Event|0
7860490|NCT01584440|12348761|FG003|Stage 1 (5 Weeks)|Adverse Event|0
7860491|NCT01584440|12348762|FG004|Stage 1 (5 Weeks)|Adverse Event|0
7860492|NCT01584440|12348758|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1
7860493|NCT01584440|12348759|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0
7860494|NCT01584440|12348760|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0
7860495|NCT01584440|12348761|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0
7860496|NCT01584440|12348762|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0
7860497|NCT01584440|12348758|FG000|Stage 1 (5 Weeks)|Protocol Violation|2
7860498|NCT01584440|12348759|FG001|Stage 1 (5 Weeks)|Protocol Violation|3
7860499|NCT01584440|12348760|FG002|Stage 1 (5 Weeks)|Protocol Violation|0
7860500|NCT01584440|12348761|FG003|Stage 1 (5 Weeks)|Protocol Violation|0
7860501|NCT01584440|12348762|FG004|Stage 1 (5 Weeks)|Protocol Violation|0
7860502|NCT01584440|12348758|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1
7860503|NCT01584440|12348759|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0
7860504|NCT01584440|12348760|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0
7860505|NCT01584440|12348761|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0
7860506|NCT01584440|12348762|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0
7860507|NCT01584440|12348758|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
7860508|NCT01584440|12348759|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2
7860509|NCT01584440|12348760|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
7860510|NCT01584440|12348761|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
7860511|NCT01584440|12348762|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
7860512|NCT01584440|12348758|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0
7860513|NCT01584440|12348759|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0
7860514|NCT01584440|12348760|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1
7860515|NCT01584440|12348761|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2
7860516|NCT01584440|12348762|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0
7860517|NCT01584440|12348758|FG000|Stage 2 (5 Weeks)|Adverse Event|0
7860518|NCT01584440|12348759|FG001|Stage 2 (5 Weeks)|Adverse Event|0
7860519|NCT01584440|12348760|FG002|Stage 2 (5 Weeks)|Adverse Event|1
7860520|NCT01584440|12348761|FG003|Stage 2 (5 Weeks)|Adverse Event|2
7860521|NCT01584440|12348762|FG004|Stage 2 (5 Weeks)|Adverse Event|1
7860522|NCT01584440|12348758|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
7860523|NCT01584440|12348759|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
7860524|NCT01584440|12348760|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1
7860525|NCT01584440|12348761|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
7860526|NCT01584440|12348762|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
7860527|NCT01584648|12348833|FG000|Overall Study|Death|136
7860528|NCT01584648|12348834|FG001|Overall Study|Death|146
7860529|NCT01584648|12348833|FG000|Overall Study|Lost to Follow-up|9
7860530|NCT01584648|12348834|FG001|Overall Study|Lost to Follow-up|9
7860531|NCT01584648|12348833|FG000|Overall Study|Investigator discretion|3
7860532|NCT01584648|12348834|FG001|Overall Study|Investigator discretion|2
7860533|NCT01584648|12348833|FG000|Overall Study|Withdrew consent|13
7860534|NCT01584648|12348834|FG001|Overall Study|Withdrew consent|4
7860535|NCT01584648|12348833|FG000|Overall Study|Study closed/terminated|50
7860536|NCT01584648|12348834|FG001|Overall Study|Study closed/terminated|23
7860537|NCT01584648|12348833|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0
7860538|NCT01584648|12348834|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28
7860539|NCT01584843|12348847|FG000|First Treatment Period|Adverse Event|0
7860540|NCT01584843|12348848|FG001|First Treatment Period|Adverse Event|0
7860541|NCT01584843|12348849|FG002|First Treatment Period|Adverse Event|1
7860542|NCT01584843|12348850|FG003|First Treatment Period|Adverse Event|0
7860543|NCT01584843|12348851|FG004|First Treatment Period|Adverse Event|0
7860544|NCT01584843|12348852|FG005|First Treatment Period|Adverse Event|0
7860545|NCT01584843|12348847|FG000|First Treatment Period|Protocol Violation|0
7860546|NCT01584843|12348848|FG001|First Treatment Period|Protocol Violation|0
7860547|NCT01584843|12348849|FG002|First Treatment Period|Protocol Violation|0
7860548|NCT01584843|12348850|FG003|First Treatment Period|Protocol Violation|0
7860549|NCT01584843|12348851|FG004|First Treatment Period|Protocol Violation|0
7860550|NCT01584843|12348852|FG005|First Treatment Period|Protocol Violation|1
7860551|NCT01584843|12348847|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7860552|NCT01584843|12348848|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7860553|NCT01584843|12348849|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7860554|NCT01584843|12348850|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7860555|NCT01584843|12348851|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7860556|NCT01584843|12348852|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1
7860557|NCT01584843|12348847|FG000|Second Treatment Period|Withdrawal by Subject|0
7860558|NCT01584843|12348848|FG001|Second Treatment Period|Withdrawal by Subject|0
7860559|NCT01584843|12348849|FG002|Second Treatment Period|Withdrawal by Subject|0
7860560|NCT01584843|12348850|FG003|Second Treatment Period|Withdrawal by Subject|0
7860561|NCT01584843|12348851|FG004|Second Treatment Period|Withdrawal by Subject|0
7860562|NCT01584843|12348852|FG005|Second Treatment Period|Withdrawal by Subject|1
7860563|NCT01585025|12348871|FG000|Overall Study|Withdrawal by Subject|0
7860564|NCT01585025|12348872|FG001|Overall Study|Withdrawal by Subject|3
7860565|NCT01585025|12348873|FG002|Overall Study|Withdrawal by Subject|4
7860566|NCT01585038|12348883|FG000|Overall Study|Adverse Event|2
7860567|NCT01585038|12348884|FG001|Overall Study|Adverse Event|2
7860568|NCT01585155|12348899|FG000|Overall Study|Adverse Event|1
7860569|NCT01585155|12348899|FG000|Overall Study|Lack of Efficacy|2
7860570|NCT01585155|12348899|FG000|Overall Study|Worsening ulcerative colitis|2
7860571|NCT01585168|12348905|FG000|Overall Study|Lost to Follow-up|3
7860572|NCT01585168|12348906|FG001|Overall Study|Lost to Follow-up|1
7860573|NCT01585168|12348907|FG002|Overall Study|Lost to Follow-up|1
7860574|NCT01585168|12348908|FG003|Overall Study|Lost to Follow-up|1
7860575|NCT01585194|12348916|FG000|Overall Study|Withdrawal by Subject|1
7860576|NCT01585194|12348916|FG000|Overall Study|Physician Decision|2
7860577|NCT01585194|12348916|FG000|Overall Study|Lack of insurance|1
7860578|NCT01585246|12348929|FG000|Overall Study|Lost to Follow-up|0
7860579|NCT01585246|12348930|FG001|Overall Study|Lost to Follow-up|0
7860580|NCT01585246|12348931|FG002|Overall Study|Lost to Follow-up|2
7860581|NCT01585246|12348932|FG003|Overall Study|Lost to Follow-up|1
7860582|NCT01585246|12348933|FG004|Overall Study|Lost to Follow-up|0
7860583|NCT01585246|12348929|FG000|Overall Study|Protocol Violation|0
7860584|NCT01585246|12348930|FG001|Overall Study|Protocol Violation|0
7860585|NCT01585246|12348931|FG002|Overall Study|Protocol Violation|0
7860586|NCT01585246|12348932|FG003|Overall Study|Protocol Violation|0
7860587|NCT01585246|12348933|FG004|Overall Study|Protocol Violation|1
7860588|NCT01585246|12348929|FG000|Overall Study|Withdrawal by Subject|0
7860589|NCT01585246|12348930|FG001|Overall Study|Withdrawal by Subject|0
7860590|NCT01585246|12348931|FG002|Overall Study|Withdrawal by Subject|1
7860591|NCT01585246|12348932|FG003|Overall Study|Withdrawal by Subject|2
7860592|NCT01585246|12348933|FG004|Overall Study|Withdrawal by Subject|1
7860593|NCT01585246|12348929|FG000|Overall Study|Other|0
7860594|NCT01585246|12348930|FG001|Overall Study|Other|1
7860595|NCT01585246|12348931|FG002|Overall Study|Other|1
7860596|NCT01585246|12348932|FG003|Overall Study|Other|1
7860597|NCT01585246|12348933|FG004|Overall Study|Other|0
7860598|NCT01585272|12348948|FG000|Overall Study|Adverse Event|22
7860599|NCT01585272|12348948|FG000|Overall Study|Protocol Violation|7
7860600|NCT01585272|12348948|FG000|Overall Study|Withdrawal by Subject|10
7860601|NCT01585298|12348952|FG000|Overall Study|Study completion was not documented.|1
7860602|NCT01585298|12348952|FG000|Overall Study|Protocol deviation|1
7860603|NCT01585298|12348952|FG000|Overall Study|Administrative problems|4
7860604|NCT01585298|12348952|FG000|Overall Study|Lost to Follow-up|2
7860605|NCT01585298|12348952|FG000|Overall Study|Withdrawal by Subject|4
7860606|NCT01585298|12348952|FG000|Overall Study|Abnormal test procedure results|1
7860607|NCT01585298|12348952|FG000|Overall Study|Adverse Event|24
7860608|NCT01585428|12348964|FG000|Overall Study|Death during treatment|1
7860609|NCT01585428|12348965|FG001|Overall Study|Death during treatment|0
7860610|NCT01585558|12348984|FG000|Overall Study|Withdrawal by Subject|4
7860611|NCT01585558|12348985|FG001|Overall Study|Withdrawal by Subject|5
7860612|NCT01585558|12348986|FG002|Overall Study|Withdrawal by Subject|8
7860613|NCT01585558|12348984|FG000|Overall Study|Lost to Follow-up|2
7860614|NCT01585558|12348985|FG001|Overall Study|Lost to Follow-up|0
7860615|NCT01585558|12348986|FG002|Overall Study|Lost to Follow-up|3
7860616|NCT01585558|12348984|FG000|Overall Study|Adverse Event|3
7860617|NCT01585558|12348985|FG001|Overall Study|Adverse Event|4
7860618|NCT01585558|12348986|FG002|Overall Study|Adverse Event|1
7860619|NCT01585558|12348984|FG000|Overall Study|Protocol Violation|4
7860620|NCT01585558|12348985|FG001|Overall Study|Protocol Violation|3
7860621|NCT01585558|12348986|FG002|Overall Study|Protocol Violation|2
7860622|NCT01585558|12348984|FG000|Overall Study|Lack of Efficacy|0
7860623|NCT01585558|12348985|FG001|Overall Study|Lack of Efficacy|0
7860624|NCT01585558|12348986|FG002|Overall Study|Lack of Efficacy|1
7860625|NCT01585584|12348994|FG000|Overall Study|Lack of Efficacy|1
7860626|NCT01585584|12348994|FG000|Overall Study|Withdrawal by Subject|1
7860627|NCT01585584|12348994|FG000|Overall Study|Physician Decision|2
7860628|NCT01585766|12349008|FG000|Overall Study|Withdrawal by Subject|0
7860629|NCT01585766|12349009|FG001|Overall Study|Withdrawal by Subject|1
7860630|NCT01585766|12349010|FG002|Overall Study|Withdrawal by Subject|1
7860631|NCT01585766|12349011|FG003|Overall Study|Withdrawal by Subject|0
7860632|NCT01585766|12349012|FG004|Overall Study|Withdrawal by Subject|0
7860633|NCT01585766|12349013|FG005|Overall Study|Withdrawal by Subject|0
7860634|NCT01585766|12349008|FG000|Overall Study|Death|0
7860635|NCT01585766|12349009|FG001|Overall Study|Death|1
7860636|NCT01585766|12349010|FG002|Overall Study|Death|0
7860637|NCT01585766|12349011|FG003|Overall Study|Death|0
7860638|NCT01585766|12349012|FG004|Overall Study|Death|0
7860639|NCT01585766|12349013|FG005|Overall Study|Death|0
7860640|NCT01585766|12349008|FG000|Overall Study|Physician Decision|0
7860641|NCT01585766|12349009|FG001|Overall Study|Physician Decision|0
7860642|NCT01585766|12349010|FG002|Overall Study|Physician Decision|1
7860643|NCT01585766|12349011|FG003|Overall Study|Physician Decision|0
7860644|NCT01585766|12349012|FG004|Overall Study|Physician Decision|0
7860645|NCT01585766|12349013|FG005|Overall Study|Physician Decision|0
7860646|NCT01585831|12349046|FG000|Overall Study|Physician Decision|0
7860647|NCT01585831|12349047|FG001|Overall Study|Physician Decision|1
7860648|NCT01585831|12349046|FG000|Overall Study|Withdrawal by Subject|2
7860649|NCT01585831|12349047|FG001|Overall Study|Withdrawal by Subject|1
7860650|NCT01585961|12349053|FG000|Overall Study|Death|6
7860651|NCT01585961|12349053|FG000|Overall Study|Physician Decision|1
7860652|NCT01585961|12349053|FG000|Overall Study|Decision to use non-study catheter|1
7860653|NCT01585961|12349053|FG000|Overall Study|Withdrawal by Subject|1
7860654|NCT01585961|12349053|FG000|Overall Study|Lost to Follow-up|23
7860655|NCT01585961|12349053|FG000|Overall Study|Ablation cancelled for slow-heal wound|1
7860656|NCT01585987|12349059|FG000|Randomized|Withdrawal by Subject|0
7860657|NCT01585987|12349060|FG001|Randomized|Withdrawal by Subject|4
7860658|NCT01585987|12349059|FG000|Randomized|No longer met criteria|0
7860659|NCT01585987|12349060|FG001|Randomized|No longer met criteria|2
7860660|NCT01585987|12349059|FG000|Treated|Disease Progression|39
7860661|NCT01585987|12349060|FG001|Treated|Disease Progression|36
7860662|NCT01585987|12349059|FG000|Treated|Study Drug Toxicity|9
7860663|NCT01585987|12349060|FG001|Treated|Study Drug Toxicity|5
7860664|NCT01585987|12349059|FG000|Treated|Adverse Event|3
7860665|NCT01585987|12349060|FG001|Treated|Adverse Event|0
7860666|NCT01585987|12349059|FG000|Treated|Withdrawal by Subject|1
7860667|NCT01585987|12349060|FG001|Treated|Withdrawal by Subject|2
7860668|NCT01585987|12349059|FG000|Treated|Death|1
7860669|NCT01585987|12349060|FG001|Treated|Death|0
7860670|NCT01585987|12349059|FG000|Treated|Lost to Follow-up|0
7860671|NCT01585987|12349060|FG001|Treated|Lost to Follow-up|1
7860672|NCT01585987|12349059|FG000|Treated|Maximum Clinical Benefit|0
7860673|NCT01585987|12349060|FG001|Treated|Maximum Clinical Benefit|1
7860674|NCT01585987|12349059|FG000|Treated|Non-Specified|1
7860675|NCT01585987|12349060|FG001|Treated|Non-Specified|2
7860676|NCT01585987|12349059|FG000|Treated|Subject Request|0
7860677|NCT01585987|12349060|FG001|Treated|Subject Request|1
7860678|NCT01585987|12349059|FG000|Treated|Poor/Non-Compliance|0
7860679|NCT01585987|12349060|FG001|Treated|Poor/Non-Compliance|1
7860680|NCT01586156|12349113|FG000|Overall Study|Pregnancy|0
7860681|NCT01586156|12349114|FG001|Overall Study|Pregnancy|1
7860682|NCT01586156|12349115|FG002|Overall Study|Pregnancy|0
7860683|NCT01586195|12349123|FG000|Overall Study|Death|11
7860684|NCT01586195|12349123|FG000|Overall Study|Withdrawal of Consent|5
7860685|NCT01586195|12349123|FG000|Overall Study|Started new anti-melanoma therapy|1
7860686|NCT01586195|12349123|FG000|Overall Study|Reason not specified|9
7860687|NCT01586338|12349136|FG000|Overall Study|Adverse Event|3
7860688|NCT01586338|12349136|FG000|Overall Study|Lost to Follow-up|1
7860689|NCT01586338|12349136|FG000|Overall Study|Withdrawal by participant|3
7860690|NCT01586338|12349136|FG000|Overall Study|Other|1
7860691|NCT01586364|12349140|FG000|Overall Study|Withdrawal by Subject|40
7860692|NCT01586364|12349140|FG000|Overall Study|Adverse Event|37
7860693|NCT01586364|12349140|FG000|Overall Study|Lost to Follow-up|17
7860694|NCT01586364|12349140|FG000|Overall Study|Protocol Violation|16
7860695|NCT01586364|12349140|FG000|Overall Study|Lack of Efficacy|1
7860696|NCT01586364|12349140|FG000|Overall Study|Other-Did not feel better post-treatment|1
7860697|NCT01586364|12349140|FG000|Overall Study|Other-Subject wasn't getting much relief|1
7860698|NCT01586364|12349140|FG000|Overall Study|Other-Site closure due to PI illness|1
7860699|NCT01586364|12349140|FG000|Overall Study|Other-PI discretion, site closing|2
7860700|NCT01586364|12349140|FG000|Overall Study|Other-Not specified|1
7860701|NCT01586624|12349152|FG000|Overall Study|Adverse Event|3
7860702|NCT01586624|12349153|FG001|Overall Study|Adverse Event|0
7860703|NCT01586624|12349154|FG002|Overall Study|Adverse Event|2
7860704|NCT01586624|12349155|FG003|Overall Study|Adverse Event|1
7860705|NCT01586624|12349156|FG004|Overall Study|Adverse Event|3
7860706|NCT01586624|12349157|FG005|Overall Study|Adverse Event|3
7860707|NCT01586624|12349158|FG006|Overall Study|Adverse Event|2
7860708|NCT01586624|12349159|FG007|Overall Study|Adverse Event|3
7860709|NCT01586624|12349152|FG000|Overall Study|Physician Decision|0
7860710|NCT01586624|12349153|FG001|Overall Study|Physician Decision|1
7860711|NCT01586624|12349154|FG002|Overall Study|Physician Decision|1
7860712|NCT01586624|12349155|FG003|Overall Study|Physician Decision|0
7860713|NCT01586624|12349156|FG004|Overall Study|Physician Decision|2
7860714|NCT01586624|12349157|FG005|Overall Study|Physician Decision|0
7860715|NCT01586624|12349158|FG006|Overall Study|Physician Decision|1
7860716|NCT01586624|12349159|FG007|Overall Study|Physician Decision|1
7860717|NCT01586624|12349152|FG000|Overall Study|Withdrawal by Subject|0
7860718|NCT01586624|12349153|FG001|Overall Study|Withdrawal by Subject|0
7860719|NCT01586624|12349154|FG002|Overall Study|Withdrawal by Subject|0
7860720|NCT01586624|12349155|FG003|Overall Study|Withdrawal by Subject|1
7860721|NCT01586624|12349156|FG004|Overall Study|Withdrawal by Subject|0
7860722|NCT01586624|12349157|FG005|Overall Study|Withdrawal by Subject|0
7860723|NCT01586624|12349158|FG006|Overall Study|Withdrawal by Subject|0
7860724|NCT01586624|12349159|FG007|Overall Study|Withdrawal by Subject|0
7860725|NCT01586624|12349152|FG000|Overall Study|Evidence of disease progression|1
7860726|NCT01586624|12349153|FG001|Overall Study|Evidence of disease progression|3
7860727|NCT01586624|12349154|FG002|Overall Study|Evidence of disease progression|2
7860728|NCT01586624|12349155|FG003|Overall Study|Evidence of disease progression|5
7860729|NCT01586624|12349156|FG004|Overall Study|Evidence of disease progression|3
7860730|NCT01586624|12349157|FG005|Overall Study|Evidence of disease progression|5
7860731|NCT01586624|12349158|FG006|Overall Study|Evidence of disease progression|4
7860732|NCT01586624|12349159|FG007|Overall Study|Evidence of disease progression|6
7860733|NCT01586624|12349152|FG000|Overall Study|Screen failure (no treatment received)|0
7860734|NCT01586624|12349153|FG001|Overall Study|Screen failure (no treatment received)|0
7860735|NCT01586624|12349154|FG002|Overall Study|Screen failure (no treatment received)|0
7860736|NCT01586624|12349155|FG003|Overall Study|Screen failure (no treatment received)|0
7860737|NCT01586624|12349156|FG004|Overall Study|Screen failure (no treatment received)|0
7860738|NCT01586624|12349157|FG005|Overall Study|Screen failure (no treatment received)|0
7860739|NCT01586624|12349158|FG006|Overall Study|Screen failure (no treatment received)|1
7860740|NCT01586624|12349159|FG007|Overall Study|Screen failure (no treatment received)|0
7860741|NCT01586806|12349194|FG000|Overall Study|Protocol Violation|0
7860742|NCT01586806|12349195|FG001|Overall Study|Protocol Violation|1
7860743|NCT01586806|12349196|FG002|Overall Study|Protocol Violation|0
7860744|NCT01586806|12349194|FG000|Overall Study|Withdrawal by Subject|1
7860745|NCT01586806|12349195|FG001|Overall Study|Withdrawal by Subject|0
7860746|NCT01586806|12349196|FG002|Overall Study|Withdrawal by Subject|0
7860747|NCT01586806|12349194|FG000|Overall Study|Lost to Follow-up|2
7860748|NCT01586806|12349195|FG001|Overall Study|Lost to Follow-up|3
7860749|NCT01586806|12349196|FG002|Overall Study|Lost to Follow-up|2
7863926|NCT01609556|12353453|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7863927|NCT01609556|12353454|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7863928|NCT01609556|12353455|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
7863929|NCT01609556|12353456|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7863930|NCT01609556|12353457|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7863931|NCT01609556|12353458|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7863932|NCT01609556|12353459|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7863933|NCT01609556|12353444|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7863934|NCT01609556|12353445|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7863935|NCT01609556|12353446|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7863936|NCT01609556|12353447|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7863937|NCT01609556|12353448|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7863938|NCT01609556|12353449|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1
7863939|NCT01609556|12353450|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7863940|NCT01609556|12353451|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7863941|NCT01609556|12353452|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7863942|NCT01609556|12353453|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7863943|NCT01609556|12353454|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7863944|NCT01609556|12353455|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7863945|NCT01609556|12353456|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7863946|NCT01609556|12353457|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7863947|NCT01609556|12353458|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7863948|NCT01609556|12353459|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7863949|NCT01609556|12353444|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7863950|NCT01609556|12353445|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7863951|NCT01609556|12353446|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7863952|NCT01609556|12353447|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7863953|NCT01609556|12353448|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7863954|NCT01609556|12353449|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7863955|NCT01609556|12353450|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7863956|NCT01609556|12353451|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7863957|NCT01609556|12353452|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1
7863958|NCT01609556|12353453|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7863959|NCT01609556|12353454|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7860750|NCT01586819|12349206|FG000|Overall Study|Withdrawal by Subject|1
7860751|NCT01586819|12349207|FG001|Overall Study|Withdrawal by Subject|0
7860752|NCT01587001|12349256|FG000|Overall Study|Lost to Follow-up|2
7860753|NCT01587001|12349257|FG001|Overall Study|Lost to Follow-up|0
7860754|NCT01587001|12349256|FG000|Overall Study|Insufficient samples to complete testing|4
7860755|NCT01587001|12349257|FG001|Overall Study|Insufficient samples to complete testing|1
7860756|NCT01587014|12349264|FG000|Overall Study|Death|2
7860757|NCT01587079|12349277|FG000|Overall Study|Protocol-specified criteria|9
7860758|NCT01587079|12349277|FG000|Overall Study|Protocol Violation|5
7860759|NCT01587079|12349277|FG000|Overall Study|Lost to Follow-up|2
7860760|NCT01587079|12349277|FG000|Overall Study|Physician Decision|2
7860761|NCT01587079|12349277|FG000|Overall Study|Withdrawal by Subject|7
7860762|NCT01587079|12349277|FG000|Overall Study|Adverse Event|14
7860763|NCT01587118|12349320|FG000|Overall Study|Adverse Event|3
7860764|NCT01587118|12349320|FG000|Overall Study|Lost to Follow-up|2
7860765|NCT01587118|12349320|FG000|Overall Study|Relocation|1
7860766|NCT01587118|12349320|FG000|Overall Study|nonresponse|1
7860767|NCT01587274|12349327|FG000|Overall Study|Lost to Follow-up|4
7860768|NCT01587274|12349328|FG001|Overall Study|Lost to Follow-up|5
7860769|NCT01587274|12349329|FG002|Overall Study|Lost to Follow-up|3
7860770|NCT01587651|12349340|FG000|Overall Study|Adverse Event|0
7860771|NCT01587651|12349341|FG001|Overall Study|Adverse Event|1
7860772|NCT01587651|12349342|FG002|Overall Study|Adverse Event|0
7860773|NCT01587651|12349340|FG000|Overall Study|Protocol Violation|0
7860774|NCT01587651|12349341|FG001|Overall Study|Protocol Violation|1
7860775|NCT01587651|12349342|FG002|Overall Study|Protocol Violation|1
7860776|NCT01587651|12349340|FG000|Overall Study|Withdrawal by Subject|0
7860777|NCT01587651|12349341|FG001|Overall Study|Withdrawal by Subject|1
7860778|NCT01587651|12349342|FG002|Overall Study|Withdrawal by Subject|0
7860779|NCT01587703|12349369|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1
7860780|NCT01587703|12349370|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860781|NCT01587703|12349371|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860782|NCT01587703|12349372|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860783|NCT01587703|12349373|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860784|NCT01587703|12349374|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860785|NCT01587703|12349375|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860786|NCT01587703|12349376|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860787|NCT01587703|12349377|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860788|NCT01587703|12349378|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860789|NCT01587703|12349379|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860790|NCT01587703|12349380|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860791|NCT01587703|12349381|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860792|NCT01587703|12349382|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860793|NCT01587703|12349383|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860794|NCT01587703|12349384|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860795|NCT01587703|12349385|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860796|NCT01587703|12349386|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860797|NCT01587703|12349387|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7860798|NCT01587703|12349369|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860799|NCT01587703|12349370|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860800|NCT01587703|12349371|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860801|NCT01587703|12349372|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860802|NCT01587703|12349373|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860803|NCT01587703|12349374|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1
7860804|NCT01587703|12349375|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860805|NCT01587703|12349376|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2
7860806|NCT01587703|12349377|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860807|NCT01587703|12349378|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860808|NCT01587703|12349379|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860809|NCT01587703|12349380|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860810|NCT01587703|12349381|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860811|NCT01587703|12349382|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860812|NCT01587703|12349383|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860813|NCT01587703|12349384|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860814|NCT01587703|12349385|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860815|NCT01587703|12349386|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860816|NCT01587703|12349387|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7860817|NCT01587703|12349369|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860818|NCT01587703|12349370|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860819|NCT01587703|12349371|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860820|NCT01587703|12349372|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860821|NCT01587703|12349373|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860822|NCT01587703|12349374|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860823|NCT01587703|12349375|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2
7860824|NCT01587703|12349376|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860825|NCT01587703|12349377|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860826|NCT01587703|12349378|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860827|NCT01587703|12349379|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860828|NCT01587703|12349380|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860829|NCT01587703|12349381|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860830|NCT01587703|12349382|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860831|NCT01587703|12349383|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860832|NCT01587703|12349384|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860833|NCT01587703|12349385|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860834|NCT01587703|12349386|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860835|NCT01587703|12349387|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7860836|NCT01587703|12349369|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2
7860837|NCT01587703|12349370|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4
7860838|NCT01587703|12349371|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1
7860839|NCT01587703|12349372|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3
7860840|NCT01587703|12349373|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4
7860841|NCT01587703|12349374|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7
7860842|NCT01587703|12349375|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30
7860843|NCT01587703|12349376|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7
7860844|NCT01587703|12349377|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0
7860845|NCT01587703|12349378|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0
7860846|NCT01587703|12349379|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0
7860847|NCT01587703|12349380|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0
7860848|NCT01587703|12349381|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0
7860849|NCT01587703|12349382|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0
7860850|NCT01587703|12349383|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0
7860851|NCT01587703|12349384|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0
7860852|NCT01587703|12349385|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0
7860853|NCT01587703|12349386|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0
7860854|NCT01587703|12349387|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0
7860855|NCT01587703|12349369|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0
7860856|NCT01587703|12349370|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0
7860857|NCT01587703|12349371|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0
7860858|NCT01587703|12349372|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0
7860859|NCT01587703|12349373|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0
7860860|NCT01587703|12349374|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0
7860861|NCT01587703|12349375|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0
7860862|NCT01587703|12349376|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0
7860863|NCT01587703|12349377|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1
7860864|NCT01587703|12349378|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9
7860865|NCT01587703|12349379|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3
7860866|NCT01587703|12349380|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0
7860867|NCT01587703|12349381|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0
7860868|NCT01587703|12349382|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0
7860869|NCT01587703|12349383|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0
7860870|NCT01587703|12349384|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0
7860871|NCT01587703|12349385|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0
7860872|NCT01587703|12349386|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0
7860873|NCT01587703|12349387|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0
7860874|NCT01587703|12349369|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860875|NCT01587703|12349370|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860876|NCT01587703|12349371|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860877|NCT01587703|12349372|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860878|NCT01587703|12349373|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860879|NCT01587703|12349374|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860880|NCT01587703|12349375|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860881|NCT01587703|12349376|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860882|NCT01587703|12349377|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
7860883|NCT01587703|12349378|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860884|NCT01587703|12349379|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
7860885|NCT01587703|12349380|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860886|NCT01587703|12349381|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860887|NCT01587703|12349382|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860888|NCT01587703|12349383|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860889|NCT01587703|12349384|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860890|NCT01587703|12349385|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860891|NCT01587703|12349386|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860892|NCT01587703|12349387|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7860893|NCT01587703|12349369|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860894|NCT01587703|12349370|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860895|NCT01587703|12349371|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860896|NCT01587703|12349372|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860897|NCT01587703|12349373|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860898|NCT01587703|12349374|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860899|NCT01587703|12349375|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860900|NCT01587703|12349376|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860901|NCT01587703|12349377|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860902|NCT01587703|12349378|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1
7860903|NCT01587703|12349379|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1
7860904|NCT01587703|12349380|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860905|NCT01587703|12349381|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860906|NCT01587703|12349382|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860907|NCT01587703|12349383|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860908|NCT01587703|12349384|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860909|NCT01587703|12349385|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860910|NCT01587703|12349386|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860911|NCT01587703|12349387|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7860912|NCT01587703|12349369|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860913|NCT01587703|12349370|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860914|NCT01587703|12349371|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860915|NCT01587703|12349372|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860916|NCT01587703|12349373|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860917|NCT01587703|12349374|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860918|NCT01587703|12349375|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860919|NCT01587703|12349376|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860920|NCT01587703|12349377|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1
7860921|NCT01587703|12349378|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860922|NCT01587703|12349379|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860923|NCT01587703|12349380|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860924|NCT01587703|12349381|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860925|NCT01587703|12349382|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860926|NCT01587703|12349383|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860927|NCT01587703|12349384|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860928|NCT01587703|12349385|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860929|NCT01587703|12349386|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7860930|NCT01587703|12349387|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7883494|NCT01782378|12383176|FG001|First Series|Lost to Follow-up|8
7860931|NCT01587703|12349369|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860932|NCT01587703|12349370|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860933|NCT01587703|12349371|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860934|NCT01587703|12349372|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860935|NCT01587703|12349373|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860936|NCT01587703|12349374|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860937|NCT01587703|12349375|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860938|NCT01587703|12349376|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860939|NCT01587703|12349377|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860940|NCT01587703|12349378|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860941|NCT01587703|12349379|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860942|NCT01587703|12349380|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860943|NCT01587703|12349381|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860944|NCT01587703|12349382|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860945|NCT01587703|12349383|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860946|NCT01587703|12349384|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860947|NCT01587703|12349385|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860948|NCT01587703|12349386|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7860949|NCT01587703|12349387|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1
7860950|NCT01587703|12349369|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860951|NCT01587703|12349370|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860952|NCT01587703|12349371|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860953|NCT01587703|12349372|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860954|NCT01587703|12349373|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860955|NCT01587703|12349374|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860956|NCT01587703|12349375|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860957|NCT01587703|12349376|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860958|NCT01587703|12349377|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860959|NCT01587703|12349378|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860960|NCT01587703|12349379|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860961|NCT01587703|12349380|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860962|NCT01587703|12349381|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860963|NCT01587703|12349382|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860964|NCT01587703|12349383|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860965|NCT01587703|12349384|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860966|NCT01587703|12349385|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7860967|NCT01587703|12349386|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5
7860968|NCT01587703|12349387|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4
7860969|NCT01587703|12349369|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860970|NCT01587703|12349370|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860971|NCT01587703|12349371|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860972|NCT01587703|12349372|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860973|NCT01587703|12349373|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860974|NCT01587703|12349374|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860975|NCT01587703|12349375|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860976|NCT01587703|12349376|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860977|NCT01587703|12349377|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860978|NCT01587703|12349378|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860979|NCT01587703|12349379|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860980|NCT01587703|12349380|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860981|NCT01587703|12349381|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860982|NCT01587703|12349382|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860983|NCT01587703|12349383|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860984|NCT01587703|12349384|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1
7860985|NCT01587703|12349385|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860986|NCT01587703|12349386|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860987|NCT01587703|12349387|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7860988|NCT01587703|12349369|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7860989|NCT01587703|12349370|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7860990|NCT01587703|12349371|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7860991|NCT01587703|12349372|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7860992|NCT01587703|12349373|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7860993|NCT01587703|12349374|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7860994|NCT01587703|12349375|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7860995|NCT01587703|12349376|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7860996|NCT01587703|12349377|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7860997|NCT01587703|12349378|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7860998|NCT01587703|12349379|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7860999|NCT01587703|12349380|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1
7861000|NCT01587703|12349381|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7861001|NCT01587703|12349382|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7861002|NCT01587703|12349383|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2
7861003|NCT01587703|12349384|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7861004|NCT01587703|12349385|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7861005|NCT01587703|12349386|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7861006|NCT01587703|12349387|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7861007|NCT01587703|12349369|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0
7861008|NCT01587703|12349370|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0
7861009|NCT01587703|12349371|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0
7861010|NCT01587703|12349372|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0
7861011|NCT01587703|12349373|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0
7861012|NCT01587703|12349374|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0
7861013|NCT01587703|12349375|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0
7861014|NCT01587703|12349376|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0
7861015|NCT01587703|12349377|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0
7861016|NCT01587703|12349378|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0
7861017|NCT01587703|12349379|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0
7861018|NCT01587703|12349380|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2
7861019|NCT01587703|12349381|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2
7861020|NCT01587703|12349382|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1
7861021|NCT01587703|12349383|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1
7861022|NCT01587703|12349384|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3
7861023|NCT01587703|12349385|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8
7861024|NCT01587703|12349386|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0
7861025|NCT01587703|12349387|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0
7861026|NCT01587703|12349369|FG000|Part2(Median Exposure of 1.41 Months)|Death|0
7861027|NCT01587703|12349370|FG001|Part2(Median Exposure of 1.41 Months)|Death|0
7861028|NCT01587703|12349371|FG002|Part2(Median Exposure of 1.41 Months)|Death|0
7861029|NCT01587703|12349372|FG003|Part2(Median Exposure of 1.41 Months)|Death|0
7861030|NCT01587703|12349373|FG004|Part2(Median Exposure of 1.41 Months)|Death|0
7861031|NCT01587703|12349374|FG005|Part2(Median Exposure of 1.41 Months)|Death|0
7950054|NCT02546609|12496243|FG001|Overall Study|Adverse Event|6
7861032|NCT01587703|12349375|FG006|Part2(Median Exposure of 1.41 Months)|Death|0
7861033|NCT01587703|12349376|FG007|Part2(Median Exposure of 1.41 Months)|Death|0
7861034|NCT01587703|12349377|FG008|Part2(Median Exposure of 1.41 Months)|Death|0
7861035|NCT01587703|12349378|FG009|Part2(Median Exposure of 1.41 Months)|Death|0
7861036|NCT01587703|12349379|FG010|Part2(Median Exposure of 1.41 Months)|Death|0
7861037|NCT01587703|12349380|FG011|Part2(Median Exposure of 1.41 Months)|Death|8
7861038|NCT01587703|12349381|FG012|Part2(Median Exposure of 1.41 Months)|Death|12
7861039|NCT01587703|12349382|FG013|Part2(Median Exposure of 1.41 Months)|Death|21
7861040|NCT01587703|12349383|FG014|Part2(Median Exposure of 1.41 Months)|Death|16
7861041|NCT01587703|12349384|FG015|Part2(Median Exposure of 1.41 Months)|Death|17
7861042|NCT01587703|12349385|FG016|Part2(Median Exposure of 1.41 Months)|Death|5
7861043|NCT01587703|12349386|FG017|Part2(Median Exposure of 1.41 Months)|Death|0
7861044|NCT01587703|12349387|FG018|Part2(Median Exposure of 1.41 Months)|Death|0
7861045|NCT01587703|12349369|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861046|NCT01587703|12349370|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861047|NCT01587703|12349371|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861048|NCT01587703|12349372|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861049|NCT01587703|12349373|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861050|NCT01587703|12349374|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861051|NCT01587703|12349375|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861052|NCT01587703|12349376|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861053|NCT01587703|12349377|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861054|NCT01587703|12349378|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861055|NCT01587703|12349379|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861056|NCT01587703|12349380|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1
7861057|NCT01587703|12349381|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861058|NCT01587703|12349382|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861059|NCT01587703|12349383|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861060|NCT01587703|12349384|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861061|NCT01587703|12349385|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861062|NCT01587703|12349386|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861063|NCT01587703|12349387|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7861064|NCT01587885|12349446|FG000|Treatment Period 1|Failure to Return|0
7861065|NCT01587885|12349447|FG001|Treatment Period 1|Failure to Return|1
7861066|NCT01587885|12349446|FG000|Treatment Period 1|Protocol Violation|0
7861067|NCT01587885|12349447|FG001|Treatment Period 1|Protocol Violation|2
7861068|NCT01587898|12349458|FG000|Overall Study|Adverse Event|1
7861069|NCT01587898|12349459|FG001|Overall Study|Adverse Event|1
7861070|NCT01587898|12349460|FG002|Overall Study|Adverse Event|0
7861071|NCT01587898|12349461|FG003|Overall Study|Adverse Event|0
7861072|NCT01587898|12349458|FG000|Overall Study|Protocol Violation|0
7861073|NCT01587898|12349459|FG001|Overall Study|Protocol Violation|2
7861074|NCT01587898|12349460|FG002|Overall Study|Protocol Violation|1
7861075|NCT01587898|12349461|FG003|Overall Study|Protocol Violation|1
7861076|NCT01587898|12349458|FG000|Overall Study|Lost to Follow-up|0
7861077|NCT01587898|12349459|FG001|Overall Study|Lost to Follow-up|0
7861078|NCT01587898|12349460|FG002|Overall Study|Lost to Follow-up|0
7861079|NCT01587898|12349461|FG003|Overall Study|Lost to Follow-up|1
7861080|NCT01587898|12349458|FG000|Overall Study|Withdrawal by Subject|2
7861081|NCT01587898|12349459|FG001|Overall Study|Withdrawal by Subject|1
7861082|NCT01587898|12349460|FG002|Overall Study|Withdrawal by Subject|0
7861083|NCT01587898|12349461|FG003|Overall Study|Withdrawal by Subject|0
7861084|NCT01587898|12349458|FG000|Overall Study|Met haemoglobin stopping criteria|1
7861085|NCT01587898|12349459|FG001|Overall Study|Met haemoglobin stopping criteria|1
7861086|NCT01587898|12349460|FG002|Overall Study|Met haemoglobin stopping criteria|1
7861087|NCT01587898|12349461|FG003|Overall Study|Met haemoglobin stopping criteria|0
7861088|NCT01587924|12349478|FG000|Overall Study|Adverse Event|0
7861089|NCT01587924|12349479|FG001|Overall Study|Adverse Event|2
7861090|NCT01587924|12349480|FG002|Overall Study|Adverse Event|0
7861091|NCT01587924|12349481|FG003|Overall Study|Adverse Event|0
7861092|NCT01587924|12349478|FG000|Overall Study|Protocol Violation|2
7861093|NCT01587924|12349479|FG001|Overall Study|Protocol Violation|1
7861094|NCT01587924|12349480|FG002|Overall Study|Protocol Violation|2
7861095|NCT01587924|12349481|FG003|Overall Study|Protocol Violation|1
7861096|NCT01587924|12349478|FG000|Overall Study|Met Hemoglobin stopping criteria|2
7861097|NCT01587924|12349479|FG001|Overall Study|Met Hemoglobin stopping criteria|0
7861098|NCT01587924|12349480|FG002|Overall Study|Met Hemoglobin stopping criteria|1
7861099|NCT01587924|12349481|FG003|Overall Study|Met Hemoglobin stopping criteria|0
7861100|NCT01587924|12349478|FG000|Overall Study|Withdrawal by Subject|0
7861101|NCT01587924|12349479|FG001|Overall Study|Withdrawal by Subject|1
7861102|NCT01587924|12349480|FG002|Overall Study|Withdrawal by Subject|1
7861103|NCT01587924|12349481|FG003|Overall Study|Withdrawal by Subject|0
7861104|NCT01587989|12349506|FG000|12-Week Open-Label Run-In Period|Physician Decision|7
7861105|NCT01587989|12349507|FG001|12-Week Open-Label Run-In Period|Physician Decision|0
7861106|NCT01587989|12349508|FG002|12-Week Open-Label Run-In Period|Physician Decision|0
7861107|NCT01587989|12349506|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
7861108|NCT01587989|12349507|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
7861109|NCT01587989|12349508|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
7861110|NCT01587989|12349506|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4
7861111|NCT01587989|12349507|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0
7861112|NCT01587989|12349508|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0
7861113|NCT01587989|12349506|FG000|Randomized Study Treatment|Withdrawal by Subject|0
7861114|NCT01587989|12349507|FG001|Randomized Study Treatment|Withdrawal by Subject|1
7861115|NCT01587989|12349508|FG002|Randomized Study Treatment|Withdrawal by Subject|0
7861116|NCT01587989|12349506|FG000|Randomized Study Treatment|Screening failure|0
7861117|NCT01587989|12349507|FG001|Randomized Study Treatment|Screening failure|1
7861118|NCT01587989|12349508|FG002|Randomized Study Treatment|Screening failure|0
7861119|NCT01587989|12349506|FG000|Randomized Study Treatment|Physician Decision|0
7861120|NCT01587989|12349507|FG001|Randomized Study Treatment|Physician Decision|0
7861121|NCT01587989|12349508|FG002|Randomized Study Treatment|Physician Decision|1
7861122|NCT01588106|12349516|FG000|Overall Study|Withdrawal by Subject|5
7861123|NCT01588106|12349517|FG001|Overall Study|Withdrawal by Subject|4
7861124|NCT01588184|12349538|FG000|Overall Study|Death|1
7861125|NCT01588184|12349539|FG001|Overall Study|Death|0
7861126|NCT01588184|12349540|FG002|Overall Study|Death|0
7861127|NCT01588184|12349541|FG003|Overall Study|Death|1
7861128|NCT01588184|12349542|FG004|Overall Study|Death|1
7861129|NCT01588184|12349543|FG005|Overall Study|Death|1
7861130|NCT01588184|12349538|FG000|Overall Study|Withdrawal by Subject|2
7861131|NCT01588184|12349539|FG001|Overall Study|Withdrawal by Subject|4
7861132|NCT01588184|12349540|FG002|Overall Study|Withdrawal by Subject|0
7861133|NCT01588184|12349541|FG003|Overall Study|Withdrawal by Subject|1
7861134|NCT01588184|12349542|FG004|Overall Study|Withdrawal by Subject|0
7861135|NCT01588184|12349543|FG005|Overall Study|Withdrawal by Subject|0
7861136|NCT01588184|12349538|FG000|Overall Study|Bevacizumab treatment provision changed|0
7861137|NCT01588184|12349539|FG001|Overall Study|Bevacizumab treatment provision changed|6
7861138|NCT01588184|12349540|FG002|Overall Study|Bevacizumab treatment provision changed|2
7861139|NCT01588184|12349541|FG003|Overall Study|Bevacizumab treatment provision changed|0
7861140|NCT01588184|12349542|FG004|Overall Study|Bevacizumab treatment provision changed|1
7861141|NCT01588184|12349543|FG005|Overall Study|Bevacizumab treatment provision changed|3
7861142|NCT01588184|12349538|FG000|Overall Study|multiple reasons|0
7861143|NCT01588184|12349539|FG001|Overall Study|multiple reasons|3
7861144|NCT01588184|12349540|FG002|Overall Study|multiple reasons|0
7861145|NCT01588184|12349541|FG003|Overall Study|multiple reasons|1
7861146|NCT01588184|12349542|FG004|Overall Study|multiple reasons|0
7861147|NCT01588184|12349543|FG005|Overall Study|multiple reasons|0
7861148|NCT01588197|12349559|FG000|Overall Study|Lack of Efficacy|0
7861149|NCT01588197|12349560|FG001|Overall Study|Lack of Efficacy|1
7861150|NCT01588197|12349559|FG000|Overall Study|No MRI|1
7861151|NCT01588197|12349560|FG001|Overall Study|No MRI|0
7861152|NCT01588353|12349582|FG000|Step2|Withdrawal by Subject|0
7861153|NCT01588353|12349583|FG001|Step2|Withdrawal by Subject|1
7861154|NCT01588353|12349584|FG002|Step2|Withdrawal by Subject|0
7861155|NCT01588353|12349582|FG000|Step3|Adverse Event|0
7861156|NCT01588353|12349583|FG001|Step3|Adverse Event|0
7861157|NCT01588353|12349584|FG002|Step3|Adverse Event|2
7861158|NCT01588366|12349596|FG000|Overall Study|Adverse Event|0
7861159|NCT01588366|12349597|FG001|Overall Study|Adverse Event|1
7861160|NCT01588366|12349598|FG002|Overall Study|Adverse Event|0
7861161|NCT01588366|12349599|FG003|Overall Study|Adverse Event|1
7861162|NCT01588366|12349600|FG004|Overall Study|Adverse Event|0
7861163|NCT01588366|12349601|FG005|Overall Study|Adverse Event|2
7861164|NCT01588405|12349617|FG000|Overall Study|Adverse Event|1
7861165|NCT01588405|12349617|FG000|Overall Study|Clinical Worsening|1
7861166|NCT01588496|12349677|FG000|Overall Study|Withdrawal by Subject|0
7861167|NCT01588496|12349678|FG001|Overall Study|Withdrawal by Subject|1
7861168|NCT01588496|12349679|FG002|Overall Study|Withdrawal by Subject|0
7861169|NCT01588509|12349689|FG000|Overall Study|Lost to Follow-up|1
7861170|NCT01588509|12349690|FG001|Overall Study|Lost to Follow-up|0
7861171|NCT01588548|12349702|FG000|Overall Study|Withdrawal by Subject|0
7861172|NCT01588548|12349703|FG001|Overall Study|Withdrawal by Subject|1
7861173|NCT01588548|12349704|FG002|Overall Study|Withdrawal by Subject|1
7861174|NCT01588548|12349705|FG003|Overall Study|Withdrawal by Subject|1
7861175|NCT01588548|12349706|FG004|Overall Study|Withdrawal by Subject|2
7861176|NCT01588548|12349707|FG005|Overall Study|Withdrawal by Subject|3
7861177|NCT01588548|12349702|FG000|Overall Study|Adverse Event|0
7861178|NCT01588548|12349703|FG001|Overall Study|Adverse Event|0
7861179|NCT01588548|12349704|FG002|Overall Study|Adverse Event|1
7861180|NCT01588548|12349705|FG003|Overall Study|Adverse Event|2
7861181|NCT01588548|12349706|FG004|Overall Study|Adverse Event|1
7861182|NCT01588548|12349707|FG005|Overall Study|Adverse Event|0
7861183|NCT01588548|12349702|FG000|Overall Study|Condition Under Investigation Worsened|3
7861184|NCT01588548|12349703|FG001|Overall Study|Condition Under Investigation Worsened|6
7861185|NCT01588548|12349704|FG002|Overall Study|Condition Under Investigation Worsened|4
7861186|NCT01588548|12349705|FG003|Overall Study|Condition Under Investigation Worsened|4
7861187|NCT01588548|12349706|FG004|Overall Study|Condition Under Investigation Worsened|3
7861188|NCT01588548|12349707|FG005|Overall Study|Condition Under Investigation Worsened|3
7861189|NCT01588951|12349736|FG000|Overall Study|Ineligible in retrospect|0
7861190|NCT01588951|12349737|FG001|Overall Study|Ineligible in retrospect|0
7861191|NCT01588951|12349738|FG002|Overall Study|Ineligible in retrospect|1
7861192|NCT01588990|12349746|FG000|Phase A|Withdrawal by Subject|5
7861193|NCT01588990|12349746|FG000|Phase A|Physician Decision|11
7861194|NCT01588990|12349746|FG000|Phase A|Other|14
7861195|NCT01588990|12349746|FG000|Phase A|Lost to Follow-up|1
7861196|NCT01588990|12349746|FG000|Phase A|Death|5
7861197|NCT01588990|12349746|FG000|Phase A|Adverse Event|28
7861198|NCT01588990|12349746|FG000|Phase A|Still on therapy at end of study|6
7861199|NCT01588990|12349746|FG000|Phase B|Adverse Event|2
7861200|NCT01588990|12349746|FG000|Phase B|Still on therapy at end of study|5
7861201|NCT01588990|12349746|FG000|Phase B|Withdrawal by Subject|3
7861202|NCT01588990|12349746|FG000|Phase B|Physician Decision|4
7861203|NCT01588990|12349746|FG000|Phase B|Other|2
7861204|NCT01589094|12349754|FG000|Overall Study|Did not receive treatment|2
7861205|NCT01589185|12349763|FG000|Overall Study|Death|1
7861206|NCT01589185|12349764|FG001|Overall Study|Death|2
7861207|NCT01589185|12349765|FG002|Overall Study|Death|2
7861208|NCT01589185|12349766|FG003|Overall Study|Death|0
7861209|NCT01589185|12349767|FG004|Overall Study|Death|1
7861210|NCT01589185|12349763|FG000|Overall Study|Lost to Follow-up|1
7861211|NCT01589185|12349764|FG001|Overall Study|Lost to Follow-up|0
7861212|NCT01589185|12349765|FG002|Overall Study|Lost to Follow-up|2
7861213|NCT01589185|12349766|FG003|Overall Study|Lost to Follow-up|3
7861214|NCT01589185|12349767|FG004|Overall Study|Lost to Follow-up|0
7861215|NCT01589237|12349784|FG000|Part A (52 Weeks)|Subject/guardian decision|2
7861216|NCT01589237|12349785|FG001|Part A (52 Weeks)|Subject/guardian decision|3
7861217|NCT01589237|12349786|FG002|Part A (52 Weeks)|Subject/guardian decision|2
7861218|NCT01589237|12349787|FG003|Part A (52 Weeks)|Subject/guardian decision|0
7861219|NCT01589237|12349784|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
7861220|NCT01589237|12349785|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
7861221|NCT01589237|12349786|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
7861222|NCT01589237|12349787|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
7861223|NCT01589237|12349784|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
7861224|NCT01589237|12349785|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
7861225|NCT01589237|12349786|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
7861226|NCT01589237|12349787|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
7861227|NCT01589237|12349784|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0
7861228|NCT01589237|12349785|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0
7861229|NCT01589237|12349786|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0
7861230|NCT01589237|12349787|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1
7861231|NCT01589445|12349814|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1
7861232|NCT01589445|12349814|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
7861233|NCT01589445|12349814|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
7861234|NCT01589445|12349814|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
7861235|NCT01589445|12349814|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
7861236|NCT01589445|12349814|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1
7861237|NCT01589445|12349814|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2
7861238|NCT01589445|12349814|FG000|002 (Metformin)-3 Months|Protocol Violation|2
7861239|NCT01589445|12349814|FG000|002 (Metformin)-3 Months|Adverse Event|2
7861240|NCT01589445|12349814|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2
7861241|NCT01589497|12349831|FG000|Overall Study|Withdrawal by Subject|0
7861242|NCT01589497|12349832|FG001|Overall Study|Withdrawal by Subject|1
7861243|NCT01589497|12349833|FG002|Overall Study|Withdrawal by Subject|0
7861244|NCT01589497|12349834|FG003|Overall Study|Withdrawal by Subject|1
7861245|NCT01589497|12349831|FG000|Overall Study|Death|1
7861246|NCT01589497|12349832|FG001|Overall Study|Death|0
7861247|NCT01589497|12349833|FG002|Overall Study|Death|0
7861248|NCT01589497|12349834|FG003|Overall Study|Death|0
7861249|NCT01589497|12349831|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0
7950055|NCT02546609|12496244|FG002|Overall Study|Adverse Event|1
7950056|NCT02546609|12496242|FG000|Overall Study|Protocol Violation|0
7950057|NCT02546609|12496243|FG001|Overall Study|Protocol Violation|1
7950058|NCT02546609|12496244|FG002|Overall Study|Protocol Violation|1
7950059|NCT02546609|12496242|FG000|Overall Study|Lost to Follow-up|2
7950060|NCT02546609|12496243|FG001|Overall Study|Lost to Follow-up|3
7950061|NCT02546609|12496244|FG002|Overall Study|Lost to Follow-up|1
7950062|NCT02546609|12496242|FG000|Overall Study|travel or work schedule restriction|0
7950063|NCT02546609|12496243|FG001|Overall Study|travel or work schedule restriction|0
7950064|NCT02546609|12496244|FG002|Overall Study|travel or work schedule restriction|2
7950065|NCT02546765|12496256|FG000|Overall Study|Withdrawal by Subject|0
7950066|NCT02546765|12496257|FG001|Overall Study|Withdrawal by Subject|1
7950067|NCT02546765|12496258|FG002|Overall Study|Withdrawal by Subject|0
7950068|NCT02546765|12496259|FG003|Overall Study|Withdrawal by Subject|0
7950069|NCT02546856|12496282|FG000|4 Months Evaluation|Death|2
7950070|NCT02546856|12496283|FG001|4 Months Evaluation|Death|3
7950071|NCT02546856|12496282|FG000|4 Months Evaluation|Withdrawal by Subject|2
7950072|NCT02546856|12496283|FG001|4 Months Evaluation|Withdrawal by Subject|3
7950073|NCT02546856|12496282|FG000|4 Months Evaluation|Lost to Follow-up|3
7950074|NCT02546856|12496283|FG001|4 Months Evaluation|Lost to Follow-up|3
7950075|NCT02546856|12496282|FG000|4 Months Evaluation|Physician Decision|3
7950076|NCT02546856|12496283|FG001|4 Months Evaluation|Physician Decision|0
7950077|NCT02546856|12496282|FG000|4 Months Evaluation|Working or living abroad|5
7950078|NCT02546856|12496283|FG001|4 Months Evaluation|Working or living abroad|1
7950079|NCT02546856|12496282|FG000|4 Months Evaluation|reasons not due to titration|4
7950080|NCT02546856|12496283|FG001|4 Months Evaluation|reasons not due to titration|1
7950081|NCT02546856|12496282|FG000|4 Months Evaluation|HF Unit not active in summer|1
7950082|NCT02546856|12496283|FG001|4 Months Evaluation|HF Unit not active in summer|0
7950083|NCT02546856|12496282|FG000|6 Months Evaluation|Death|1
7950084|NCT02546856|12496283|FG001|6 Months Evaluation|Death|1
7950085|NCT02546856|12496282|FG000|6 Months Evaluation|Lost to Follow-up|1
7950086|NCT02546856|12496283|FG001|6 Months Evaluation|Lost to Follow-up|1
7950087|NCT02546856|12496282|FG000|6 Months Evaluation|Working or living abroad|6
7950088|NCT02546856|12496283|FG001|6 Months Evaluation|Working or living abroad|4
7950089|NCT02546856|12496282|FG000|6 Months Evaluation|reasons not due to titration|0
7950090|NCT02546856|12496283|FG001|6 Months Evaluation|reasons not due to titration|1
7950091|NCT02547038|12496312|FG000|Overall Study|Lost to Follow-up|3
7950092|NCT02547038|12496313|FG001|Overall Study|Lost to Follow-up|2
7950093|NCT02547220|12496330|FG000|Overall Study|Withdrawal by Subject|1
7950094|NCT02547220|12496331|FG001|Overall Study|Withdrawal by Subject|0
7950095|NCT02547220|12496330|FG000|Overall Study|Study terminated by sponsor|18
7950096|NCT02547220|12496331|FG001|Overall Study|Study terminated by sponsor|20
7950097|NCT02547233|12496339|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1
7950098|NCT02547233|12496340|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0
7950099|NCT02547233|12496339|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
7950100|NCT02547233|12496340|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
7950101|NCT02547233|12496339|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
7950102|NCT02547233|12496340|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
7950103|NCT02547233|12496339|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
7950104|NCT02547233|12496340|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
7950105|NCT02547233|12496339|FG000|12-month Follow-up|Withdrawal by Subject|10
7950106|NCT02547233|12496340|FG001|12-month Follow-up|Withdrawal by Subject|10
7950107|NCT02547233|12496339|FG000|12-month Follow-up|Lost to Follow-up|3
7950108|NCT02547233|12496340|FG001|12-month Follow-up|Lost to Follow-up|3
7950109|NCT02547233|12496339|FG000|12-month Follow-up|Lack of Efficacy|1
7950110|NCT02547233|12496340|FG001|12-month Follow-up|Lack of Efficacy|2
7950111|NCT02547233|12496339|FG000|12-month Follow-up|Protocol Violation|0
7950112|NCT02547233|12496340|FG001|12-month Follow-up|Protocol Violation|1
7950113|NCT02547233|12496339|FG000|12-month Follow-up|Other|0
7950114|NCT02547233|12496340|FG001|12-month Follow-up|Other|1
7950115|NCT02547363|12496350|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0
7950116|NCT02547363|12496351|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1
7950117|NCT02547363|12496350|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
7950118|NCT02547363|12496351|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
7950119|NCT02547363|12496350|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
7950120|NCT02547363|12496351|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
7861250|NCT01589497|12349832|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0
7861251|NCT01589497|12349833|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1
7861252|NCT01589497|12349834|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0
7861253|NCT01589653|12349864|FG000|Overall Study|Protocol Violation|3
7861254|NCT01589653|12349865|FG001|Overall Study|Protocol Violation|1
7861255|NCT01589653|12349864|FG000|Overall Study|Withdrawal criteria|4
7861256|NCT01589653|12349865|FG001|Overall Study|Withdrawal criteria|7
7861257|NCT01589653|12349864|FG000|Overall Study|Unclassified|0
7861258|NCT01589653|12349865|FG001|Overall Study|Unclassified|3
7861259|NCT01589770|12349873|FG000|Overall Study|EGFR <60ml/min|6
7861260|NCT01589770|12349874|FG001|Overall Study|EGFR <60ml/min|4
7861261|NCT01589770|12349873|FG000|Overall Study|claustrophobic when entering cardiac MRI|2
7861262|NCT01589770|12349874|FG001|Overall Study|claustrophobic when entering cardiac MRI|1
7861263|NCT01589822|12349883|FG000|Overall Study|Withdrawal by Subject|1
7861264|NCT01589822|12349884|FG001|Overall Study|Withdrawal by Subject|2
7861265|NCT01589822|12349885|FG002|Overall Study|Withdrawal by Subject|0
7861266|NCT01589822|12349883|FG000|Overall Study|Death|1
7861267|NCT01589822|12349884|FG001|Overall Study|Death|0
7861268|NCT01589822|12349885|FG002|Overall Study|Death|0
7861269|NCT01589822|12349883|FG000|Overall Study|Missed 90 day visit|2
7861270|NCT01589822|12349884|FG001|Overall Study|Missed 90 day visit|1
7861271|NCT01589822|12349885|FG002|Overall Study|Missed 90 day visit|1
7950121|NCT02547363|12496350|FG000|3-day Treatment and 8-week Follow-up|Other|1
7950122|NCT02547363|12496351|FG001|3-day Treatment and 8-week Follow-up|Other|1
7950123|NCT02547363|12496350|FG000|12-month Follow-up|Withdrawal by Subject|4
7950124|NCT02547363|12496351|FG001|12-month Follow-up|Withdrawal by Subject|3
7950125|NCT02547363|12496350|FG000|12-month Follow-up|Lost to Follow-up|4
7950126|NCT02547363|12496351|FG001|12-month Follow-up|Lost to Follow-up|1
7950127|NCT02547363|12496350|FG000|12-month Follow-up|Lack of Efficacy|1
7950128|NCT02547363|12496351|FG001|12-month Follow-up|Lack of Efficacy|1
7950129|NCT02547363|12496350|FG000|12-month Follow-up|Other|1
7950130|NCT02547363|12496351|FG001|12-month Follow-up|Other|0
7950131|NCT02547428|12496361|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8
7950132|NCT02547428|12496362|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1
7950133|NCT02547428|12496361|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1
7950134|NCT02547428|12496362|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1
7950135|NCT02547428|12496361|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1
7950136|NCT02547428|12496362|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1
7950137|NCT02547428|12496361|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1
7950138|NCT02547428|12496362|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3
7950139|NCT02547428|12496361|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0
7950140|NCT02547428|12496362|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3
7950141|NCT02547428|12496361|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0
7950142|NCT02547428|12496362|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3
7950143|NCT02547428|12496361|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0
7950144|NCT02547428|12496362|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1
7950145|NCT02547428|12496361|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1
7950146|NCT02547428|12496362|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0
7950147|NCT02547454|12496375|FG000|Overall Study|Due to hemodialysis|53
7950148|NCT02547454|12496375|FG000|Overall Study|Due to transplantation|1
7950149|NCT02547454|12496375|FG000|Overall Study|Due to no further need to treat|4
7950150|NCT02547454|12496375|FG000|Overall Study|Death|38
7950151|NCT02547454|12496375|FG000|Overall Study|Lost to Follow-up|26
7950152|NCT02547454|12496375|FG000|Overall Study|Other|39
7950153|NCT02547454|12496375|FG000|Overall Study|No data|11
7950154|NCT02547649|12496391|FG000|Overall Study|Lost to Follow-up|3
7950155|NCT02547649|12496392|FG001|Overall Study|Lost to Follow-up|1
7950156|NCT02547649|12496393|FG002|Overall Study|Lost to Follow-up|1
7950157|NCT02547649|12496391|FG000|Overall Study|Not vaccinated|0
7950158|NCT02547649|12496392|FG001|Overall Study|Not vaccinated|0
7950159|NCT02547649|12496393|FG002|Overall Study|Not vaccinated|1
7950160|NCT02547649|12496391|FG000|Overall Study|Withdrawal by Subject|0
7950161|NCT02547649|12496392|FG001|Overall Study|Withdrawal by Subject|4
7950162|NCT02547649|12496393|FG002|Overall Study|Withdrawal by Subject|2
7950163|NCT02547766|12496406|FG000|Overall Study|Withdrawal by Subject|1
7950164|NCT02547922|12496422|FG000|Overall Study|Withdrawal by Subject|9
7950165|NCT02547922|12496423|FG001|Overall Study|Withdrawal by Subject|6
7950166|NCT02547922|12496424|FG002|Overall Study|Withdrawal by Subject|10
7950167|NCT02547922|12496422|FG000|Overall Study|Adverse Event|3
7950168|NCT02547922|12496423|FG001|Overall Study|Adverse Event|1
7950169|NCT02547922|12496424|FG002|Overall Study|Adverse Event|2
7950170|NCT02547922|12496422|FG000|Overall Study|Lost to Follow-up|1
7950171|NCT02547922|12496423|FG001|Overall Study|Lost to Follow-up|0
7950172|NCT02547922|12496424|FG002|Overall Study|Lost to Follow-up|0
7950173|NCT02547922|12496422|FG000|Overall Study|Lack of Efficacy|5
7950174|NCT02547922|12496423|FG001|Overall Study|Lack of Efficacy|7
7950175|NCT02547922|12496424|FG002|Overall Study|Lack of Efficacy|4
7950176|NCT02547922|12496422|FG000|Overall Study|Death|1
7950177|NCT02547922|12496423|FG001|Overall Study|Death|0
7950178|NCT02547922|12496424|FG002|Overall Study|Death|0
7950179|NCT02547922|12496422|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4
7950180|NCT02547922|12496423|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8
7950181|NCT02547922|12496424|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9
7950182|NCT02547922|12496422|FG000|Overall Study|TECHNICAL PROBLEMS|1
7950183|NCT02547922|12496423|FG001|Overall Study|TECHNICAL PROBLEMS|0
7950184|NCT02547922|12496424|FG002|Overall Study|TECHNICAL PROBLEMS|0
7950185|NCT02547922|12496422|FG000|Overall Study|PROGRESSIVE DISEASE|1
7950186|NCT02547922|12496423|FG001|Overall Study|PROGRESSIVE DISEASE|0
7950187|NCT02547922|12496424|FG002|Overall Study|PROGRESSIVE DISEASE|2
7950188|NCT02547922|12496422|FG000|Overall Study|Physician Decision|2
7950189|NCT02547922|12496423|FG001|Overall Study|Physician Decision|1
7950190|NCT02547922|12496424|FG002|Overall Study|Physician Decision|2
7950191|NCT02547922|12496422|FG000|Overall Study|Patients did not receive IP|1
7950192|NCT02547922|12496423|FG001|Overall Study|Patients did not receive IP|1
7950193|NCT02547922|12496424|FG002|Overall Study|Patients did not receive IP|0
7950194|NCT02547935|12496441|FG000|Overall Study|Other|0
7950195|NCT02547935|12496442|FG001|Overall Study|Other|1
7950196|NCT02547935|12496443|FG002|Overall Study|Other|0
7950197|NCT02547935|12496441|FG000|Overall Study|Withdrawal by Subject|2
7950198|NCT02547935|12496442|FG001|Overall Study|Withdrawal by Subject|3
7950199|NCT02547935|12496443|FG002|Overall Study|Withdrawal by Subject|4
7950200|NCT02547935|12496441|FG000|Overall Study|Screen Failure|2
7950201|NCT02547935|12496442|FG001|Overall Study|Screen Failure|0
7950202|NCT02547935|12496443|FG002|Overall Study|Screen Failure|0
7950203|NCT02547935|12496441|FG000|Overall Study|Physician Decision|0
7950204|NCT02547935|12496442|FG001|Overall Study|Physician Decision|1
7950205|NCT02547935|12496443|FG002|Overall Study|Physician Decision|0
7950206|NCT02547935|12496441|FG000|Overall Study|Lost to Follow-up|0
7950207|NCT02547935|12496442|FG001|Overall Study|Lost to Follow-up|2
7950208|NCT02547935|12496443|FG002|Overall Study|Lost to Follow-up|1
7950209|NCT02547935|12496441|FG000|Overall Study|Death|1
7950210|NCT02547935|12496442|FG001|Overall Study|Death|1
7950211|NCT02547935|12496443|FG002|Overall Study|Death|0
7950212|NCT02547974|12496457|FG000|Overall Study|Withdrawal by Subject|1
7950213|NCT02547974|12496458|FG001|Overall Study|Withdrawal by Subject|0
7950214|NCT02547974|12496459|FG002|Overall Study|Withdrawal by Subject|0
7950215|NCT02547974|12496460|FG003|Overall Study|Withdrawal by Subject|0
7950216|NCT02547987|12496473|FG000|Overall Study|Withdrawal by Subject|1
7950217|NCT02547987|12496473|FG000|Overall Study|Adverse Event|2
7950218|NCT02548078|12496479|FG000|Overall Study|Serious adverse event/Adverse event|1
7950219|NCT02548078|12496480|FG001|Overall Study|Serious adverse event/Adverse event|0
7950220|NCT02548078|12496479|FG000|Overall Study|Moved from study area|3
7950221|NCT02548078|12496480|FG001|Overall Study|Moved from study area|3
7950222|NCT02548078|12496479|FG000|Overall Study|Lost to Follow-up|1
7950223|NCT02548078|12496480|FG001|Overall Study|Lost to Follow-up|3
7950224|NCT02548156|12496493|FG000|Washout Period 1|Lost to Follow-up|0
7950225|NCT02548156|12496494|FG001|Washout Period 1|Lost to Follow-up|0
7950226|NCT02548156|12496495|FG002|Washout Period 1|Lost to Follow-up|0
7950227|NCT02548156|12496496|FG003|Washout Period 1|Lost to Follow-up|0
7950228|NCT02548156|12496497|FG004|Washout Period 1|Lost to Follow-up|1
7950229|NCT02548156|12496498|FG005|Washout Period 1|Lost to Follow-up|0
7950230|NCT02548455|12496539|FG000|Overall Study|Withdrawal by Subject|27
7950231|NCT02548455|12496539|FG000|Overall Study|Death|26
7950232|NCT02548455|12496539|FG000|Overall Study|Lost to Follow-up|14
7950233|NCT02548455|12496539|FG000|Overall Study|Visit not completed|173
7950234|NCT02548585|12496550|FG000|Overall Study|Withdrawal by Subject|0
7950235|NCT02548585|12496551|FG001|Overall Study|Withdrawal by Subject|0
7950236|NCT02548585|12496552|FG002|Overall Study|Withdrawal by Subject|0
7950237|NCT02548585|12496553|FG003|Overall Study|Withdrawal by Subject|0
7950238|NCT02548585|12496554|FG004|Overall Study|Withdrawal by Subject|0
7950239|NCT02548585|12496555|FG005|Overall Study|Withdrawal by Subject|1
7950240|NCT02548585|12496556|FG006|Overall Study|Withdrawal by Subject|0
7950241|NCT02548585|12496550|FG000|Overall Study|Lost to Follow-up|1
7950242|NCT02548585|12496551|FG001|Overall Study|Lost to Follow-up|0
7950243|NCT02548585|12496552|FG002|Overall Study|Lost to Follow-up|0
7950244|NCT02548585|12496553|FG003|Overall Study|Lost to Follow-up|0
7950245|NCT02548585|12496554|FG004|Overall Study|Lost to Follow-up|0
7950246|NCT02548585|12496555|FG005|Overall Study|Lost to Follow-up|0
7950247|NCT02548585|12496556|FG006|Overall Study|Lost to Follow-up|0
7950248|NCT02548585|12496550|FG000|Overall Study|Other|1
7950249|NCT02548585|12496551|FG001|Overall Study|Other|0
7950250|NCT02548585|12496552|FG002|Overall Study|Other|0
7950251|NCT02548585|12496553|FG003|Overall Study|Other|2
7950252|NCT02548585|12496554|FG004|Overall Study|Other|3
7950253|NCT02548585|12496555|FG005|Overall Study|Other|0
7950254|NCT02548585|12496556|FG006|Overall Study|Other|1
7950255|NCT02548585|12496550|FG000|Overall Study|Randomized but not treated|0
7950256|NCT02548585|12496551|FG001|Overall Study|Randomized but not treated|0
7950257|NCT02548585|12496552|FG002|Overall Study|Randomized but not treated|0
7950258|NCT02548585|12496553|FG003|Overall Study|Randomized but not treated|0
7950259|NCT02548585|12496554|FG004|Overall Study|Randomized but not treated|0
7950260|NCT02548585|12496555|FG005|Overall Study|Randomized but not treated|1
7950261|NCT02548585|12496556|FG006|Overall Study|Randomized but not treated|0
7950262|NCT02548650|12496599|FG000|Triple Therapy|Adverse Event|1
7950263|NCT02548650|12496600|FG001|Triple Therapy|Adverse Event|0
7950264|NCT02548650|12496599|FG000|Triple Therapy|Withdrawal by Subject|0
7950265|NCT02548650|12496600|FG001|Triple Therapy|Withdrawal by Subject|4
7950266|NCT02548650|12496599|FG000|Double Therapy|Adverse Event|1
7950267|NCT02548650|12496600|FG001|Double Therapy|Adverse Event|1
7950268|NCT02548650|12496599|FG000|Double Therapy|Withdrawal by Subject|0
7950269|NCT02548650|12496600|FG001|Double Therapy|Withdrawal by Subject|1
7950270|NCT02548962|12496639|FG000|Overall Study|Withdrawal by Subject|1
7950271|NCT02548962|12496640|FG001|Overall Study|Withdrawal by Subject|0
7950272|NCT02549027|12496675|FG000|Washout After Period 4|Withdrawal by Subject|0
7950273|NCT02549027|12496676|FG001|Washout After Period 4|Withdrawal by Subject|1
7950274|NCT02549027|12496677|FG002|Washout After Period 4|Withdrawal by Subject|1
7950275|NCT02549027|12496678|FG003|Washout After Period 4|Withdrawal by Subject|1
7950276|NCT02549027|12496679|FG004|Washout After Period 4|Withdrawal by Subject|0
7950277|NCT02549027|12496680|FG005|Washout After Period 4|Withdrawal by Subject|0
7950278|NCT02549027|12496675|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7950279|NCT02549027|12496676|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7950280|NCT02549027|12496677|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7950281|NCT02549027|12496678|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7950282|NCT02549027|12496679|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2
7950283|NCT02549027|12496680|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7950284|NCT02549196|12496711|FG000|Overall Study|Protocol Violation|0
7950285|NCT02549196|12496712|FG001|Overall Study|Protocol Violation|0
7950286|NCT02549196|12496713|FG002|Overall Study|Protocol Violation|0
7950287|NCT02549196|12496714|FG003|Overall Study|Protocol Violation|1
7950288|NCT02549196|12496711|FG000|Overall Study|Withdrawal by Subject|1
7950289|NCT02549196|12496712|FG001|Overall Study|Withdrawal by Subject|0
7950290|NCT02549196|12496713|FG002|Overall Study|Withdrawal by Subject|1
7950291|NCT02549196|12496714|FG003|Overall Study|Withdrawal by Subject|0
7950292|NCT02549287|12496726|FG000|Overall Study|Lost to Follow-up|65
7950293|NCT02549287|12496727|FG001|Overall Study|Lost to Follow-up|26
7950294|NCT02549287|12496726|FG000|Overall Study|Withdrawal by Subject|15
7950295|NCT02549287|12496727|FG001|Overall Study|Withdrawal by Subject|6
7950296|NCT02549339|12496735|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2
7950297|NCT02549339|12496736|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0
7950298|NCT02549339|12496735|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
7950299|NCT02549339|12496736|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
7950300|NCT02549339|12496735|FG000|3-day Treatment and 8-week Follow-up|Other|1
7950301|NCT02549339|12496736|FG001|3-day Treatment and 8-week Follow-up|Other|0
7950302|NCT02549339|12496735|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
7950303|NCT02549339|12496736|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
7950304|NCT02549339|12496735|FG000|12-month Follow-up|Lack of Efficacy|0
7950305|NCT02549339|12496736|FG001|12-month Follow-up|Lack of Efficacy|2
7950306|NCT02549339|12496735|FG000|12-month Follow-up|Withdrawal by Subject|8
7950307|NCT02549339|12496736|FG001|12-month Follow-up|Withdrawal by Subject|3
7950308|NCT02549339|12496735|FG000|12-month Follow-up|Lost to Follow-up|1
7950309|NCT02549339|12496736|FG001|12-month Follow-up|Lost to Follow-up|3
7950310|NCT02549339|12496735|FG000|12-month Follow-up|Other|0
7950311|NCT02549339|12496736|FG001|12-month Follow-up|Other|3
7950312|NCT02549352|12496746|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0
7950313|NCT02549352|12496747|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1
7950314|NCT02549352|12496746|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
7950315|NCT02549352|12496747|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
7950316|NCT02549352|12496746|FG000|3-day Treatment and 8-week Follow-up|Other|0
7950317|NCT02549352|12496747|FG001|3-day Treatment and 8-week Follow-up|Other|2
7950318|NCT02549352|12496746|FG000|12-month Follow-up|Withdrawal by Subject|4
7950319|NCT02549352|12496747|FG001|12-month Follow-up|Withdrawal by Subject|5
7950320|NCT02549352|12496746|FG000|12-month Follow-up|Lost to Follow-up|3
7950321|NCT02549352|12496747|FG001|12-month Follow-up|Lost to Follow-up|2
7950322|NCT02549352|12496746|FG000|12-month Follow-up|Death|0
7950323|NCT02549352|12496747|FG001|12-month Follow-up|Death|1
7950324|NCT02549352|12496746|FG000|12-month Follow-up|Protocol Violation|0
7950325|NCT02549352|12496747|FG001|12-month Follow-up|Protocol Violation|1
7950326|NCT02549352|12496746|FG000|12-month Follow-up|Other|1
7950327|NCT02549352|12496747|FG001|12-month Follow-up|Other|3
7965880|NCT02739984|12521280|FG000|Overall Study|Withdrawal by Subject|1
7965881|NCT02739984|12521281|FG001|Overall Study|Withdrawal by Subject|1
7965882|NCT02739984|12521280|FG000|Overall Study|Death|0
7965883|NCT02739984|12521281|FG001|Overall Study|Death|1
7965884|NCT02739984|12521280|FG000|Overall Study|Lost to Follow-up|3
7965885|NCT02739984|12521281|FG001|Overall Study|Lost to Follow-up|0
7965886|NCT02739997|12521287|FG000|Overall Study|Death|1
7965887|NCT02739997|12521287|FG000|Overall Study|Withdrawal by Subject|1
7965888|NCT02740049|12521291|FG000|Overall Study|Isolated cells did not grow sufficiently|1
7965889|NCT02740478|12521323|FG000|Overall Study|Withdrawal by Subject|1
7965890|NCT02741076|12521379|FG000|Overall Study|Adverse Event|0
7965891|NCT02741076|12521380|FG001|Overall Study|Adverse Event|1
7965892|NCT02741076|12521381|FG002|Overall Study|Adverse Event|1
7965893|NCT02741076|12521382|FG003|Overall Study|Adverse Event|0
7965894|NCT02741076|12521379|FG000|Overall Study|Lack of Efficacy|1
7965895|NCT02741076|12521380|FG001|Overall Study|Lack of Efficacy|0
7965896|NCT02741076|12521381|FG002|Overall Study|Lack of Efficacy|0
7965897|NCT02741076|12521382|FG003|Overall Study|Lack of Efficacy|0
7965898|NCT02741076|12521379|FG000|Overall Study|Withdrawal by Subject|0
7965899|NCT02741076|12521380|FG001|Overall Study|Withdrawal by Subject|1
7965900|NCT02741076|12521381|FG002|Overall Study|Withdrawal by Subject|0
7965901|NCT02741076|12521382|FG003|Overall Study|Withdrawal by Subject|0
7965902|NCT02741076|12521379|FG000|Overall Study|Sponsor Request|2
7965903|NCT02741076|12521380|FG001|Overall Study|Sponsor Request|3
7965904|NCT02741076|12521381|FG002|Overall Study|Sponsor Request|0
7965905|NCT02741076|12521382|FG003|Overall Study|Sponsor Request|1
7965906|NCT02741076|12521379|FG000|Overall Study|No additional information available|0
7965907|NCT02741076|12521380|FG001|Overall Study|No additional information available|0
7965908|NCT02741076|12521381|FG002|Overall Study|No additional information available|1
7965909|NCT02741076|12521382|FG003|Overall Study|No additional information available|1
7965910|NCT02741310|12521410|FG000|Overall Study|Sponsor Decision|2
7965911|NCT02741310|12521411|FG001|Overall Study|Sponsor Decision|2
7950328|NCT02549573|12496777|FG000|Overall Study|Withdrawal by Subject|0
7950329|NCT02549573|12496778|FG001|Overall Study|Withdrawal by Subject|2
7950330|NCT02549573|12496777|FG000|Overall Study|Protocol Violation|0
7950331|NCT02549573|12496778|FG001|Overall Study|Protocol Violation|1
7950332|NCT02549859|12496784|FG000|Long-term 60 Hz DBS|Study Closed|1
7950333|NCT02550106|12496792|FG000|Overall Study|Adverse Event|1
7950334|NCT02550106|12496792|FG000|Overall Study|Lack of Efficacy|3
7950335|NCT02550106|12496792|FG000|Overall Study|Protocol Violation|6
7950336|NCT02550106|12496792|FG000|Overall Study|Withdrawal by Subject|2
7950337|NCT02550795|12496827|FG000|Overall Study|Physician Decision|0
7950338|NCT02550795|12496828|FG001|Overall Study|Physician Decision|1
7950339|NCT02550795|12496829|FG002|Overall Study|Physician Decision|0
7950340|NCT02550938|12496841|FG000|Overall Study|Lost to Follow-up|8
7950341|NCT02550938|12496842|FG001|Overall Study|Lost to Follow-up|7
7950342|NCT02550938|12496843|FG002|Overall Study|Lost to Follow-up|12
7950343|NCT02550938|12496844|FG003|Overall Study|Lost to Follow-up|11
7950344|NCT02551055|12496861|FG000|Overall Study|Death|2
7950345|NCT02551055|12496862|FG001|Overall Study|Death|4
7950346|NCT02551055|12496863|FG002|Overall Study|Death|2
7950347|NCT02551055|12496864|FG003|Overall Study|Death|2
7950348|NCT02551055|12496865|FG004|Overall Study|Death|2
7950349|NCT02551055|12496866|FG005|Overall Study|Death|1
7950350|NCT02551055|12496867|FG006|Overall Study|Death|2
7950351|NCT02551055|12496868|FG007|Overall Study|Death|0
7950352|NCT02551055|12496861|FG000|Overall Study|Study Terminated by Sponsor|1
7950353|NCT02551055|12496862|FG001|Overall Study|Study Terminated by Sponsor|1
7950354|NCT02551055|12496863|FG002|Overall Study|Study Terminated by Sponsor|0
7950355|NCT02551055|12496864|FG003|Overall Study|Study Terminated by Sponsor|2
7950356|NCT02551055|12496865|FG004|Overall Study|Study Terminated by Sponsor|2
7950357|NCT02551055|12496866|FG005|Overall Study|Study Terminated by Sponsor|0
7950358|NCT02551055|12496867|FG006|Overall Study|Study Terminated by Sponsor|0
7950359|NCT02551055|12496868|FG007|Overall Study|Study Terminated by Sponsor|0
7950360|NCT02551055|12496861|FG000|Overall Study|Withdrawal by Subject|1
7950361|NCT02551055|12496862|FG001|Overall Study|Withdrawal by Subject|1
7950362|NCT02551055|12496863|FG002|Overall Study|Withdrawal by Subject|0
7950363|NCT02551055|12496864|FG003|Overall Study|Withdrawal by Subject|1
7950364|NCT02551055|12496865|FG004|Overall Study|Withdrawal by Subject|2
7950365|NCT02551055|12496866|FG005|Overall Study|Withdrawal by Subject|0
7950366|NCT02551055|12496867|FG006|Overall Study|Withdrawal by Subject|0
7950367|NCT02551055|12496868|FG007|Overall Study|Withdrawal by Subject|0
7950368|NCT02551055|12496861|FG000|Overall Study|Reason not specified|0
7950369|NCT02551055|12496862|FG001|Overall Study|Reason not specified|0
7950370|NCT02551055|12496863|FG002|Overall Study|Reason not specified|0
7950371|NCT02551055|12496864|FG003|Overall Study|Reason not specified|0
7950372|NCT02551055|12496865|FG004|Overall Study|Reason not specified|1
7950373|NCT02551055|12496866|FG005|Overall Study|Reason not specified|0
7950374|NCT02551055|12496867|FG006|Overall Study|Reason not specified|1
7950375|NCT02551055|12496868|FG007|Overall Study|Reason not specified|0
7950376|NCT02551159|12496898|FG000|Overall Study|Death|352
7950377|NCT02551159|12496899|FG001|Overall Study|Death|174
7950378|NCT02551159|12496900|FG002|Overall Study|Death|161
7950379|NCT02551159|12496898|FG000|Overall Study|Withdrawal by Subject|8
7950380|NCT02551159|12496899|FG001|Overall Study|Withdrawal by Subject|5
7950381|NCT02551159|12496900|FG002|Overall Study|Withdrawal by Subject|16
7950382|NCT02551159|12496898|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53
7950383|NCT02551159|12496899|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25
7950384|NCT02551159|12496900|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29
7950385|NCT02551666|12496930|FG000|Overall Study|Withdrawal by Subject|1
7950386|NCT02551666|12496931|FG001|Overall Study|Withdrawal by Subject|3
7950387|NCT02551692|12496940|FG000|Overall Study|Lost to Follow-up|0
7950388|NCT02551692|12496941|FG001|Overall Study|Lost to Follow-up|1
7950389|NCT02551692|12496942|FG002|Overall Study|Lost to Follow-up|4
7950390|NCT02551692|12496940|FG000|Overall Study|Withdrawal by Subject|1
7950391|NCT02551692|12496941|FG001|Overall Study|Withdrawal by Subject|0
7950392|NCT02551692|12496942|FG002|Overall Study|Withdrawal by Subject|1
7950393|NCT02551731|12496950|FG000|Overall Study|Withdrawal by Subject|2
7950394|NCT02551874|12497006|FG000|Overall Study|Lost to Follow-up|0
7950395|NCT02551874|12497007|FG001|Overall Study|Lost to Follow-up|2
7950396|NCT02551874|12497006|FG000|Overall Study|Pregnancy|0
7950397|NCT02551874|12497007|FG001|Overall Study|Pregnancy|1
7950398|NCT02551874|12497006|FG000|Overall Study|Reason not reported|10
7950399|NCT02551874|12497007|FG001|Overall Study|Reason not reported|4
7950400|NCT02551874|12497006|FG000|Overall Study|Did not receive randomized treatment|0
7950401|NCT02551874|12497007|FG001|Overall Study|Did not receive randomized treatment|7
7950402|NCT02551874|12497006|FG000|Overall Study|Did not enter long-term study|18
7950403|NCT02551874|12497007|FG001|Overall Study|Did not enter long-term study|25
7950404|NCT02552121|12497034|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2
7950405|NCT02552121|12497035|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7950406|NCT02552121|12497036|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7950407|NCT02552121|12497037|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7950408|NCT02552121|12497038|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7950409|NCT02552121|12497039|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7950410|NCT02552121|12497040|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7950411|NCT02552121|12497041|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7950412|NCT02552121|12497034|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1
7950413|NCT02552121|12497035|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7950414|NCT02552121|12497036|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7950415|NCT02552121|12497037|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7950416|NCT02552121|12497038|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7950417|NCT02552121|12497039|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7950418|NCT02552121|12497040|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7950419|NCT02552121|12497041|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7950420|NCT02552121|12497034|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7950421|NCT02552121|12497035|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1
7950422|NCT02552121|12497036|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7950423|NCT02552121|12497037|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7950424|NCT02552121|12497038|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7950425|NCT02552121|12497039|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7950426|NCT02552121|12497040|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7950427|NCT02552121|12497041|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7950428|NCT02552121|12497034|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7950429|NCT02552121|12497035|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2
7950430|NCT02552121|12497036|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7950431|NCT02552121|12497037|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7950432|NCT02552121|12497038|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7950433|NCT02552121|12497039|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7950434|NCT02552121|12497040|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7950435|NCT02552121|12497041|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7950436|NCT02552121|12497034|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7950437|NCT02552121|12497035|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2
7950438|NCT02552121|12497036|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7950439|NCT02552121|12497037|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7950440|NCT02552121|12497038|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7950441|NCT02552121|12497039|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7950442|NCT02552121|12497040|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7950443|NCT02552121|12497041|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7950444|NCT02552121|12497034|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7950445|NCT02552121|12497035|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1
7950446|NCT02552121|12497036|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7950447|NCT02552121|12497037|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7950448|NCT02552121|12497038|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7950449|NCT02552121|12497039|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7950450|NCT02552121|12497040|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7950451|NCT02552121|12497041|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7950452|NCT02552121|12497034|FG000|Part 2: Cohort Expansion|Patient Choice|0
7950453|NCT02552121|12497035|FG001|Part 2: Cohort Expansion|Patient Choice|0
7950454|NCT02552121|12497036|FG002|Part 2: Cohort Expansion|Patient Choice|1
7950455|NCT02552121|12497037|FG003|Part 2: Cohort Expansion|Patient Choice|0
7950456|NCT02552121|12497038|FG004|Part 2: Cohort Expansion|Patient Choice|0
7950457|NCT02552121|12497039|FG005|Part 2: Cohort Expansion|Patient Choice|0
7950458|NCT02552121|12497040|FG006|Part 2: Cohort Expansion|Patient Choice|1
7950459|NCT02552121|12497041|FG007|Part 2: Cohort Expansion|Patient Choice|0
7950460|NCT02552121|12497034|FG000|Part 2: Cohort Expansion|Disease Progression|0
7950461|NCT02552121|12497035|FG001|Part 2: Cohort Expansion|Disease Progression|0
7950462|NCT02552121|12497036|FG002|Part 2: Cohort Expansion|Disease Progression|3
7950463|NCT02552121|12497037|FG003|Part 2: Cohort Expansion|Disease Progression|2
7950464|NCT02552121|12497038|FG004|Part 2: Cohort Expansion|Disease Progression|1
7950465|NCT02552121|12497039|FG005|Part 2: Cohort Expansion|Disease Progression|4
7950466|NCT02552121|12497040|FG006|Part 2: Cohort Expansion|Disease Progression|0
7950467|NCT02552121|12497041|FG007|Part 2: Cohort Expansion|Disease Progression|3
7950468|NCT02552121|12497034|FG000|Part 2: Cohort Expansion|Adverse Event|0
7950469|NCT02552121|12497035|FG001|Part 2: Cohort Expansion|Adverse Event|0
7950470|NCT02552121|12497036|FG002|Part 2: Cohort Expansion|Adverse Event|6
7950471|NCT02552121|12497037|FG003|Part 2: Cohort Expansion|Adverse Event|1
7950472|NCT02552121|12497038|FG004|Part 2: Cohort Expansion|Adverse Event|0
7950473|NCT02552121|12497039|FG005|Part 2: Cohort Expansion|Adverse Event|0
7950474|NCT02552121|12497040|FG006|Part 2: Cohort Expansion|Adverse Event|0
7950475|NCT02552121|12497041|FG007|Part 2: Cohort Expansion|Adverse Event|0
7950476|NCT02552121|12497034|FG000|Part 2: Cohort Expansion|Death|0
7950477|NCT02552121|12497035|FG001|Part 2: Cohort Expansion|Death|0
7950478|NCT02552121|12497036|FG002|Part 2: Cohort Expansion|Death|1
7950479|NCT02552121|12497037|FG003|Part 2: Cohort Expansion|Death|0
7950480|NCT02552121|12497038|FG004|Part 2: Cohort Expansion|Death|0
7950481|NCT02552121|12497039|FG005|Part 2: Cohort Expansion|Death|0
7950482|NCT02552121|12497040|FG006|Part 2: Cohort Expansion|Death|0
7950483|NCT02552121|12497041|FG007|Part 2: Cohort Expansion|Death|0
7950484|NCT02552147|12497073|FG000|First Intervention (7 Days)|Protocol Violation|1
7950485|NCT02552147|12497074|FG001|First Intervention (7 Days)|Protocol Violation|0
7950486|NCT02552147|12497073|FG000|Second Intervention (7 Days)|Protocol Violation|2
7950487|NCT02552147|12497074|FG001|Second Intervention (7 Days)|Protocol Violation|0
7950488|NCT02552225|12497082|FG000|Overall Study|Withdrawal by Subject|1
7950489|NCT02552225|12497083|FG001|Overall Study|Withdrawal by Subject|0
7950490|NCT02552238|12497089|FG000|Overall Study|Withdrawal by Subject|2
7950491|NCT02552238|12497089|FG000|Overall Study|Adverse Event|2
7950492|NCT02552303|12497104|FG000|Allocation|Withdrawal by Subject|2
7950493|NCT02552303|12497105|FG001|Allocation|Withdrawal by Subject|1
7950494|NCT02552303|12497106|FG002|Allocation|Withdrawal by Subject|1
7950495|NCT02552303|12497107|FG003|Allocation|Withdrawal by Subject|1
7950496|NCT02552303|12497104|FG000|Allocation|ineligible|1
7950497|NCT02552303|12497105|FG001|Allocation|ineligible|1
7950498|NCT02552303|12497106|FG002|Allocation|ineligible|0
7950499|NCT02552303|12497107|FG003|Allocation|ineligible|0
7950500|NCT02552303|12497104|FG000|Follow-Up|Lost to Follow-up|0
7950501|NCT02552303|12497105|FG001|Follow-Up|Lost to Follow-up|0
7950502|NCT02552303|12497106|FG002|Follow-Up|Lost to Follow-up|1
7950503|NCT02552303|12497107|FG003|Follow-Up|Lost to Follow-up|0
7950504|NCT02552303|12497104|FG000|Follow-Up|ineligible|0
7950505|NCT02552303|12497105|FG001|Follow-Up|ineligible|2
7950506|NCT02552303|12497106|FG002|Follow-Up|ineligible|0
7950507|NCT02552303|12497107|FG003|Follow-Up|ineligible|0
7950508|NCT02552316|12497117|FG000|Overall Study|Withdrawal by Subject|1
7950509|NCT02552316|12497117|FG000|Overall Study|Withdrawal due to non-compliance|1
7950510|NCT02552355|12497169|FG000|Overall Study|Adverse Event|0
7950511|NCT02552355|12497170|FG001|Overall Study|Adverse Event|2
7950512|NCT02552355|12497171|FG002|Overall Study|Adverse Event|2
7950513|NCT02552355|12497172|FG003|Overall Study|Adverse Event|0
7950514|NCT02552355|12497169|FG000|Overall Study|Withdrawal by Subject|0
7950515|NCT02552355|12497170|FG001|Overall Study|Withdrawal by Subject|0
7950516|NCT02552355|12497171|FG002|Overall Study|Withdrawal by Subject|0
7950517|NCT02552355|12497172|FG003|Overall Study|Withdrawal by Subject|1
7950518|NCT02552732|12497187|FG000|Overall Study|Lost to Follow-up|2
7950519|NCT02552732|12497187|FG000|Overall Study|Physician Decision|1
7950520|NCT02552732|12497187|FG000|Overall Study|Day 1 SpO2 > 96%|1
7950521|NCT02552732|12497187|FG000|Overall Study|Withdrawal by Subject|6
7950522|NCT02552888|12497203|FG000|Overall Study|Lost to Follow-up|1
7950523|NCT02552888|12497204|FG001|Overall Study|Lost to Follow-up|1
7950524|NCT02552966|12497214|FG000|Overall Study|Lost to Follow-up|2
7950525|NCT02552966|12497214|FG000|Overall Study|Withdrawal by Subject|3
7950526|NCT02553317|12497224|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0
7950527|NCT02553317|12497225|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1
7950528|NCT02553317|12497224|FG000|Overall Treatment Period + Follow-up|Physician Decision|2
7950529|NCT02553317|12497225|FG001|Overall Treatment Period + Follow-up|Physician Decision|4
7950530|NCT02553317|12497224|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0
7950531|NCT02553317|12497225|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1
7950532|NCT02553317|12497224|FG000|Overall Treatment Period + Follow-up|Death|1
7950533|NCT02553317|12497225|FG001|Overall Treatment Period + Follow-up|Death|3
7950534|NCT02553317|12497224|FG000|Overall Treatment Period + Follow-up|Adverse Event|6
7950535|NCT02553317|12497225|FG001|Overall Treatment Period + Follow-up|Adverse Event|5
7950536|NCT02553317|12497224|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4
7950537|NCT02553317|12497225|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5
7950538|NCT02553317|12497224|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0
7950539|NCT02553317|12497225|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1
7950540|NCT02553317|12497224|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
7950541|NCT02553317|12497225|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
7950542|NCT02553317|12497224|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0
7950543|NCT02553317|12497225|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1
7950544|NCT02553317|12497224|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0
7950545|NCT02553317|12497225|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1
7950546|NCT02553330|12497235|FG000|Overall Study|Study Terminated by Sponsor|2
7950547|NCT02553330|12497236|FG001|Overall Study|Study Terminated by Sponsor|13
7950548|NCT02553330|12497237|FG002|Overall Study|Study Terminated by Sponsor|12
7950549|NCT02553330|12497235|FG000|Overall Study|Withdrawal by Subject|3
7950550|NCT02553330|12497236|FG001|Overall Study|Withdrawal by Subject|19
7950551|NCT02553330|12497237|FG002|Overall Study|Withdrawal by Subject|21
7950552|NCT02553330|12497235|FG000|Overall Study|Other|0
7950553|NCT02553330|12497236|FG001|Overall Study|Other|1
7950554|NCT02553330|12497237|FG002|Overall Study|Other|0
7950555|NCT02553330|12497235|FG000|Overall Study|Non compliance to study treatment|0
7950556|NCT02553330|12497236|FG001|Overall Study|Non compliance to study treatment|1
7950557|NCT02553330|12497237|FG002|Overall Study|Non compliance to study treatment|0
7950558|NCT02553330|12497235|FG000|Overall Study|Adverse Event|0
7950559|NCT02553330|12497236|FG001|Overall Study|Adverse Event|1
7950560|NCT02553330|12497237|FG002|Overall Study|Adverse Event|0
7950561|NCT02553330|12497235|FG000|Overall Study|Lost to Follow-up|0
7950562|NCT02553330|12497236|FG001|Overall Study|Lost to Follow-up|4
7950563|NCT02553330|12497237|FG002|Overall Study|Lost to Follow-up|4
7950564|NCT02553421|12497258|FG000|Overall Study|Lost to Follow-up|21
7950565|NCT02553421|12497259|FG001|Overall Study|Lost to Follow-up|1
7950566|NCT02553421|12497258|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5
7950567|NCT02553421|12497259|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0
7950568|NCT02553421|12497258|FG000|Overall Study|Improper Device Placement|3
7950569|NCT02553421|12497259|FG001|Overall Study|Improper Device Placement|0
7950570|NCT02553499|12497280|FG000|Overall Study|Adverse Event|0
7950571|NCT02553499|12497281|FG001|Overall Study|Adverse Event|0
7950572|NCT02553499|12497282|FG002|Overall Study|Adverse Event|0
7950573|NCT02553499|12497283|FG003|Overall Study|Adverse Event|0
7950574|NCT02553499|12497284|FG004|Overall Study|Adverse Event|0
7950575|NCT02553499|12497285|FG005|Overall Study|Adverse Event|0
7950576|NCT02553499|12497286|FG006|Overall Study|Adverse Event|1
7950577|NCT02553499|12497287|FG007|Overall Study|Adverse Event|1
7950578|NCT02553499|12497288|FG008|Overall Study|Adverse Event|0
7950579|NCT02553499|12497289|FG009|Overall Study|Adverse Event|0
7950580|NCT02553499|12497290|FG010|Overall Study|Adverse Event|0
7950581|NCT02553499|12497291|FG011|Overall Study|Adverse Event|0
7950582|NCT02553499|12497292|FG012|Overall Study|Adverse Event|0
7950583|NCT02553499|12497293|FG013|Overall Study|Adverse Event|1
7950584|NCT02553499|12497280|FG000|Overall Study|Death|0
7950585|NCT02553499|12497281|FG001|Overall Study|Death|1
7950586|NCT02553499|12497282|FG002|Overall Study|Death|1
7950587|NCT02553499|12497283|FG003|Overall Study|Death|0
7950588|NCT02553499|12497284|FG004|Overall Study|Death|1
7950589|NCT02553499|12497285|FG005|Overall Study|Death|2
7950590|NCT02553499|12497286|FG006|Overall Study|Death|0
7950591|NCT02553499|12497287|FG007|Overall Study|Death|0
7950592|NCT02553499|12497288|FG008|Overall Study|Death|0
7950593|NCT02553499|12497289|FG009|Overall Study|Death|0
7950594|NCT02553499|12497290|FG010|Overall Study|Death|1
7950595|NCT02553499|12497291|FG011|Overall Study|Death|0
7950596|NCT02553499|12497292|FG012|Overall Study|Death|0
7950597|NCT02553499|12497293|FG013|Overall Study|Death|0
7950598|NCT02553499|12497280|FG000|Overall Study|Lost to Follow-up|0
7950599|NCT02553499|12497281|FG001|Overall Study|Lost to Follow-up|0
7950600|NCT02553499|12497282|FG002|Overall Study|Lost to Follow-up|0
7950601|NCT02553499|12497283|FG003|Overall Study|Lost to Follow-up|0
7950602|NCT02553499|12497284|FG004|Overall Study|Lost to Follow-up|0
7950603|NCT02553499|12497285|FG005|Overall Study|Lost to Follow-up|0
7950604|NCT02553499|12497286|FG006|Overall Study|Lost to Follow-up|1
7950605|NCT02553499|12497287|FG007|Overall Study|Lost to Follow-up|0
7950606|NCT02553499|12497288|FG008|Overall Study|Lost to Follow-up|0
7950607|NCT02553499|12497289|FG009|Overall Study|Lost to Follow-up|0
7950608|NCT02553499|12497290|FG010|Overall Study|Lost to Follow-up|0
7950609|NCT02553499|12497291|FG011|Overall Study|Lost to Follow-up|0
7950610|NCT02553499|12497292|FG012|Overall Study|Lost to Follow-up|0
7950611|NCT02553499|12497293|FG013|Overall Study|Lost to Follow-up|0
7950612|NCT02553499|12497280|FG000|Overall Study|Physician Decision|0
7950613|NCT02553499|12497281|FG001|Overall Study|Physician Decision|1
7950614|NCT02553499|12497282|FG002|Overall Study|Physician Decision|1
7950615|NCT02553499|12497283|FG003|Overall Study|Physician Decision|0
7950616|NCT02553499|12497284|FG004|Overall Study|Physician Decision|1
7950617|NCT02553499|12497285|FG005|Overall Study|Physician Decision|0
7950618|NCT02553499|12497286|FG006|Overall Study|Physician Decision|0
7950619|NCT02553499|12497287|FG007|Overall Study|Physician Decision|1
7950620|NCT02553499|12497288|FG008|Overall Study|Physician Decision|1
7950621|NCT02553499|12497289|FG009|Overall Study|Physician Decision|2
7950622|NCT02553499|12497290|FG010|Overall Study|Physician Decision|1
7950623|NCT02553499|12497291|FG011|Overall Study|Physician Decision|3
7950624|NCT02553499|12497292|FG012|Overall Study|Physician Decision|1
7950625|NCT02553499|12497293|FG013|Overall Study|Physician Decision|0
7950626|NCT02553499|12497280|FG000|Overall Study|Progressive Disease|0
7950627|NCT02553499|12497281|FG001|Overall Study|Progressive Disease|0
7950628|NCT02553499|12497282|FG002|Overall Study|Progressive Disease|0
7950629|NCT02553499|12497283|FG003|Overall Study|Progressive Disease|2
7950630|NCT02553499|12497284|FG004|Overall Study|Progressive Disease|1
7950631|NCT02553499|12497285|FG005|Overall Study|Progressive Disease|1
7950632|NCT02553499|12497286|FG006|Overall Study|Progressive Disease|1
7950633|NCT02553499|12497287|FG007|Overall Study|Progressive Disease|0
7950634|NCT02553499|12497288|FG008|Overall Study|Progressive Disease|0
7950635|NCT02553499|12497289|FG009|Overall Study|Progressive Disease|1
7950636|NCT02553499|12497290|FG010|Overall Study|Progressive Disease|0
7950637|NCT02553499|12497291|FG011|Overall Study|Progressive Disease|0
7950638|NCT02553499|12497292|FG012|Overall Study|Progressive Disease|2
7950639|NCT02553499|12497293|FG013|Overall Study|Progressive Disease|1
7950640|NCT02553499|12497280|FG000|Overall Study|Study Terminated by Sponsor|0
7950641|NCT02553499|12497281|FG001|Overall Study|Study Terminated by Sponsor|0
7950642|NCT02553499|12497282|FG002|Overall Study|Study Terminated by Sponsor|0
7950643|NCT02553499|12497283|FG003|Overall Study|Study Terminated by Sponsor|0
7950644|NCT02553499|12497284|FG004|Overall Study|Study Terminated by Sponsor|0
7950645|NCT02553499|12497285|FG005|Overall Study|Study Terminated by Sponsor|0
7950646|NCT02553499|12497286|FG006|Overall Study|Study Terminated by Sponsor|0
7950647|NCT02553499|12497287|FG007|Overall Study|Study Terminated by Sponsor|0
7950648|NCT02553499|12497288|FG008|Overall Study|Study Terminated by Sponsor|1
7950649|NCT02553499|12497289|FG009|Overall Study|Study Terminated by Sponsor|0
7950650|NCT02553499|12497290|FG010|Overall Study|Study Terminated by Sponsor|0
7950651|NCT02553499|12497291|FG011|Overall Study|Study Terminated by Sponsor|0
7950652|NCT02553499|12497292|FG012|Overall Study|Study Terminated by Sponsor|0
7950653|NCT02553499|12497293|FG013|Overall Study|Study Terminated by Sponsor|0
7950654|NCT02553499|12497280|FG000|Overall Study|Withdrawal by Subject|2
7950655|NCT02553499|12497281|FG001|Overall Study|Withdrawal by Subject|0
7950656|NCT02553499|12497282|FG002|Overall Study|Withdrawal by Subject|0
7950657|NCT02553499|12497283|FG003|Overall Study|Withdrawal by Subject|0
7950658|NCT02553499|12497284|FG004|Overall Study|Withdrawal by Subject|0
7950659|NCT02553499|12497285|FG005|Overall Study|Withdrawal by Subject|0
7950660|NCT02553499|12497286|FG006|Overall Study|Withdrawal by Subject|0
7950661|NCT02553499|12497287|FG007|Overall Study|Withdrawal by Subject|1
7950662|NCT02553499|12497288|FG008|Overall Study|Withdrawal by Subject|1
7950663|NCT02553499|12497289|FG009|Overall Study|Withdrawal by Subject|0
7950664|NCT02553499|12497290|FG010|Overall Study|Withdrawal by Subject|1
7950665|NCT02553499|12497291|FG011|Overall Study|Withdrawal by Subject|0
7950666|NCT02553499|12497292|FG012|Overall Study|Withdrawal by Subject|0
7950667|NCT02553499|12497293|FG013|Overall Study|Withdrawal by Subject|0
7950668|NCT02553538|12497330|FG000|Overall Study|Could Not Reach by Telephone|133
7950669|NCT02553538|12497331|FG001|Overall Study|Could Not Reach by Telephone|0
7950670|NCT02553538|12497330|FG000|Overall Study|Died or Left Network|54
7950671|NCT02553538|12497331|FG001|Overall Study|Died or Left Network|56
7950672|NCT02553629|12497339|FG000|Overall Study|Logistic reasons|3
7950673|NCT02553629|12497340|FG001|Overall Study|Logistic reasons|6
7950674|NCT02553772|12497357|FG000|Overall Study|Adverse Event|2
7950675|NCT02553772|12497358|FG001|Overall Study|Adverse Event|3
7950676|NCT02553772|12497357|FG000|Overall Study|Lost to Follow-up|2
7950677|NCT02553772|12497358|FG001|Overall Study|Lost to Follow-up|1
7950678|NCT02553772|12497357|FG000|Overall Study|Withdrawal of Consent|1
7950679|NCT02553772|12497358|FG001|Overall Study|Withdrawal of Consent|1
7950680|NCT02553772|12497357|FG000|Overall Study|Lack of Efficacy|1
7950681|NCT02553772|12497358|FG001|Overall Study|Lack of Efficacy|0
7950682|NCT02553772|12497357|FG000|Overall Study|Other Miscellaneous Reasons|0
7950683|NCT02553772|12497358|FG001|Overall Study|Other Miscellaneous Reasons|1
7950684|NCT02553928|12497370|FG000|Overall Study|Adverse Event|2
7950685|NCT02553928|12497371|FG001|Overall Study|Adverse Event|1
7950686|NCT02553928|12497370|FG000|Overall Study|Lost to Follow-up|0
7950687|NCT02553928|12497371|FG001|Overall Study|Lost to Follow-up|1
7950688|NCT02553928|12497370|FG000|Overall Study|Administrative reason(s)|0
7950689|NCT02553928|12497371|FG001|Overall Study|Administrative reason(s)|1
7950690|NCT02554019|12497381|FG000|Overall Study|Withdrawal by Subject|1
7950691|NCT02554019|12497382|FG001|Overall Study|Withdrawal by Subject|0
7950692|NCT02554019|12497383|FG002|Overall Study|Withdrawal by Subject|2
7950693|NCT02554019|12497381|FG000|Overall Study|Adverse Event|1
7950694|NCT02554019|12497382|FG001|Overall Study|Adverse Event|0
7950695|NCT02554019|12497383|FG002|Overall Study|Adverse Event|0
7950696|NCT02554279|12497393|FG000|Overall Study|Adverse Event|2
7950697|NCT02554279|12497394|FG001|Overall Study|Adverse Event|5
7950698|NCT02554279|12497393|FG000|Overall Study|Lost to Follow-up|3
7950699|NCT02554279|12497394|FG001|Overall Study|Lost to Follow-up|2
7950700|NCT02554279|12497393|FG000|Overall Study|Withdrawal by Subject|6
7950701|NCT02554279|12497394|FG001|Overall Study|Withdrawal by Subject|4
7950702|NCT02554279|12497393|FG000|Overall Study|Protocol Violation|2
7950703|NCT02554279|12497394|FG001|Overall Study|Protocol Violation|1
7950704|NCT02554279|12497393|FG000|Overall Study|Other reason|19
7950705|NCT02554279|12497394|FG001|Overall Study|Other reason|6
7950706|NCT02554513|12497417|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0
7950707|NCT02554513|12497418|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1
7950708|NCT02554656|12497430|FG000|Overall Study|Protocol Violation|3
7950709|NCT02554682|12497444|FG000|Overall Study|Lost to Follow-up|11
7950710|NCT02554682|12497445|FG001|Overall Study|Lost to Follow-up|9
7950711|NCT02554682|12497446|FG002|Overall Study|Lost to Follow-up|4
7950712|NCT02554682|12497447|FG003|Overall Study|Lost to Follow-up|3
7950713|NCT02554682|12497448|FG004|Overall Study|Lost to Follow-up|2
7950714|NCT02554682|12497449|FG005|Overall Study|Lost to Follow-up|1
7950715|NCT02554682|12497450|FG006|Overall Study|Lost to Follow-up|6
7950716|NCT02554682|12497451|FG007|Overall Study|Lost to Follow-up|6
7950717|NCT02554682|12497452|FG008|Overall Study|Lost to Follow-up|2
7950718|NCT02554682|12497453|FG009|Overall Study|Lost to Follow-up|2
7950719|NCT02554682|12497444|FG000|Overall Study|Withdrawal by Subject|2
7950720|NCT02554682|12497445|FG001|Overall Study|Withdrawal by Subject|1
7950721|NCT02554682|12497446|FG002|Overall Study|Withdrawal by Subject|0
7950722|NCT02554682|12497447|FG003|Overall Study|Withdrawal by Subject|0
7950723|NCT02554682|12497448|FG004|Overall Study|Withdrawal by Subject|0
7950724|NCT02554682|12497449|FG005|Overall Study|Withdrawal by Subject|0
7950725|NCT02554682|12497450|FG006|Overall Study|Withdrawal by Subject|0
7950726|NCT02554682|12497451|FG007|Overall Study|Withdrawal by Subject|0
7950727|NCT02554682|12497452|FG008|Overall Study|Withdrawal by Subject|0
7950728|NCT02554682|12497453|FG009|Overall Study|Withdrawal by Subject|0
7950729|NCT02554682|12497444|FG000|Overall Study|Physician Decision|2
7950730|NCT02554682|12497445|FG001|Overall Study|Physician Decision|2
7950731|NCT02554682|12497446|FG002|Overall Study|Physician Decision|0
7950732|NCT02554682|12497447|FG003|Overall Study|Physician Decision|0
7950733|NCT02554682|12497448|FG004|Overall Study|Physician Decision|0
7950734|NCT02554682|12497449|FG005|Overall Study|Physician Decision|0
7950735|NCT02554682|12497450|FG006|Overall Study|Physician Decision|0
7950736|NCT02554682|12497451|FG007|Overall Study|Physician Decision|0
7950737|NCT02554682|12497452|FG008|Overall Study|Physician Decision|0
7950738|NCT02554682|12497453|FG009|Overall Study|Physician Decision|0
7950739|NCT02554721|12497483|FG000|Overall Study|Adverse Event|1
7950740|NCT02554721|12497484|FG001|Overall Study|Adverse Event|0
7950741|NCT02554721|12497485|FG002|Overall Study|Adverse Event|0
7950742|NCT02554721|12497486|FG003|Overall Study|Adverse Event|0
7950743|NCT02554721|12497487|FG004|Overall Study|Adverse Event|1
7950744|NCT02554721|12497483|FG000|Overall Study|Noncompliance|0
7950745|NCT02554721|12497484|FG001|Overall Study|Noncompliance|0
7950746|NCT02554721|12497485|FG002|Overall Study|Noncompliance|0
7950747|NCT02554721|12497486|FG003|Overall Study|Noncompliance|0
7950748|NCT02554721|12497487|FG004|Overall Study|Noncompliance|1
7950749|NCT02554786|12497511|FG000|Overall Study|Subject/guardian decision|29
7950750|NCT02554786|12497512|FG001|Overall Study|Subject/guardian decision|17
7950751|NCT02554786|12497513|FG002|Overall Study|Subject/guardian decision|18
7950752|NCT02554786|12497514|FG003|Overall Study|Subject/guardian decision|30
7950753|NCT02554786|12497515|FG004|Overall Study|Subject/guardian decision|20
7950754|NCT02554786|12497511|FG000|Overall Study|Lost to Follow-up|4
7950755|NCT02554786|12497512|FG001|Overall Study|Lost to Follow-up|3
7950756|NCT02554786|12497513|FG002|Overall Study|Lost to Follow-up|4
7950757|NCT02554786|12497514|FG003|Overall Study|Lost to Follow-up|2
7950758|NCT02554786|12497515|FG004|Overall Study|Lost to Follow-up|2
7950759|NCT02554786|12497511|FG000|Overall Study|Protocol deviation|1
7950760|NCT02554786|12497512|FG001|Overall Study|Protocol deviation|3
7950761|NCT02554786|12497513|FG002|Overall Study|Protocol deviation|3
7950762|NCT02554786|12497514|FG003|Overall Study|Protocol deviation|4
7950763|NCT02554786|12497515|FG004|Overall Study|Protocol deviation|2
7950764|NCT02554786|12497511|FG000|Overall Study|Technical problems|1
7950765|NCT02554786|12497512|FG001|Overall Study|Technical problems|1
7950766|NCT02554786|12497513|FG002|Overall Study|Technical problems|0
7950767|NCT02554786|12497514|FG003|Overall Study|Technical problems|2
7950768|NCT02554786|12497515|FG004|Overall Study|Technical problems|1
7950769|NCT02554786|12497511|FG000|Overall Study|Adverse Event|0
7950770|NCT02554786|12497512|FG001|Overall Study|Adverse Event|0
7950771|NCT02554786|12497513|FG002|Overall Study|Adverse Event|0
7950772|NCT02554786|12497514|FG003|Overall Study|Adverse Event|0
7950773|NCT02554786|12497515|FG004|Overall Study|Adverse Event|2
7950774|NCT02554786|12497511|FG000|Overall Study|Death|0
7950775|NCT02554786|12497512|FG001|Overall Study|Death|0
7950776|NCT02554786|12497513|FG002|Overall Study|Death|0
7950777|NCT02554786|12497514|FG003|Overall Study|Death|1
7950778|NCT02554786|12497515|FG004|Overall Study|Death|0
7950779|NCT02554786|12497511|FG000|Overall Study|Non-compliance with study treatment|0
7950780|NCT02554786|12497512|FG001|Overall Study|Non-compliance with study treatment|1
7950781|NCT02554786|12497513|FG002|Overall Study|Non-compliance with study treatment|1
7950782|NCT02554786|12497514|FG003|Overall Study|Non-compliance with study treatment|0
7950783|NCT02554786|12497515|FG004|Overall Study|Non-compliance with study treatment|1
7950784|NCT02554786|12497511|FG000|Overall Study|Physician Decision|0
7950785|NCT02554786|12497512|FG001|Overall Study|Physician Decision|1
7950786|NCT02554786|12497513|FG002|Overall Study|Physician Decision|4
7950787|NCT02554786|12497514|FG003|Overall Study|Physician Decision|1
7950788|NCT02554786|12497515|FG004|Overall Study|Physician Decision|1
7950789|NCT02554786|12497511|FG000|Overall Study|Pregnancy|0
7950790|NCT02554786|12497512|FG001|Overall Study|Pregnancy|0
7950791|NCT02554786|12497513|FG002|Overall Study|Pregnancy|0
7950792|NCT02554786|12497514|FG003|Overall Study|Pregnancy|1
7950793|NCT02554786|12497515|FG004|Overall Study|Pregnancy|1
7950794|NCT02554877|12497544|FG000|Overall Study|Adverse Event|2
7950795|NCT02554877|12497545|FG001|Overall Study|Adverse Event|0
7950796|NCT02554877|12497546|FG002|Overall Study|Adverse Event|0
7950797|NCT02554877|12497547|FG003|Overall Study|Adverse Event|1
7950798|NCT02554877|12497544|FG000|Overall Study|Lost to Follow-up|1
7950799|NCT02554877|12497545|FG001|Overall Study|Lost to Follow-up|1
7950800|NCT02554877|12497546|FG002|Overall Study|Lost to Follow-up|1
7950801|NCT02554877|12497547|FG003|Overall Study|Lost to Follow-up|2
7950802|NCT02554877|12497544|FG000|Overall Study|Did not meet entrance criteria|0
7950803|NCT02554877|12497545|FG001|Overall Study|Did not meet entrance criteria|0
7950804|NCT02554877|12497546|FG002|Overall Study|Did not meet entrance criteria|1
7950805|NCT02554877|12497547|FG003|Overall Study|Did not meet entrance criteria|0
7950806|NCT02554877|12497544|FG000|Overall Study|No longer met eligibility criteria|1
7950807|NCT02554877|12497545|FG001|Overall Study|No longer met eligibility criteria|0
7950808|NCT02554877|12497546|FG002|Overall Study|No longer met eligibility criteria|1
7950809|NCT02554877|12497547|FG003|Overall Study|No longer met eligibility criteria|1
7950810|NCT02554877|12497544|FG000|Overall Study|Protocol Violation|3
7950811|NCT02554877|12497545|FG001|Overall Study|Protocol Violation|1
7950812|NCT02554877|12497546|FG002|Overall Study|Protocol Violation|1
7950813|NCT02554877|12497547|FG003|Overall Study|Protocol Violation|0
7950814|NCT02554877|12497544|FG000|Overall Study|Other|1
7950815|NCT02554877|12497545|FG001|Overall Study|Other|3
7950816|NCT02554877|12497546|FG002|Overall Study|Other|0
7950817|NCT02554877|12497547|FG003|Overall Study|Other|3
7950818|NCT02554877|12497544|FG000|Overall Study|Insufficient clinical response|4
7950819|NCT02554877|12497545|FG001|Overall Study|Insufficient clinical response|0
7950820|NCT02554877|12497546|FG002|Overall Study|Insufficient clinical response|0
7950821|NCT02554877|12497547|FG003|Overall Study|Insufficient clinical response|0
7950822|NCT02554877|12497544|FG000|Overall Study|No longer willing to participate|0
7950823|NCT02554877|12497545|FG001|Overall Study|No longer willing to participate|2
7950824|NCT02554877|12497546|FG002|Overall Study|No longer willing to participate|2
7950825|NCT02554877|12497547|FG003|Overall Study|No longer willing to participate|0
7950826|NCT02554890|12497559|FG000|Double-blind|Adverse Event|45
7950827|NCT02554890|12497560|FG001|Double-blind|Adverse Event|51
7950828|NCT02554890|12497559|FG000|Double-blind|Death|6
7950829|NCT02554890|12497560|FG001|Double-blind|Death|4
7950830|NCT02554890|12497559|FG000|Double-blind|Protocol Violation|1
7950831|NCT02554890|12497560|FG001|Double-blind|Protocol Violation|1
7950832|NCT02554890|12497559|FG000|Double-blind|Physician Decision|4
7950833|NCT02554890|12497560|FG001|Double-blind|Physician Decision|3
7950834|NCT02554890|12497559|FG000|Double-blind|Subject/Guardian decision|21
7950835|NCT02554890|12497560|FG001|Double-blind|Subject/Guardian decision|16
7950836|NCT02554890|12497559|FG000|Double-blind|Lost to Follow-up|7
7950837|NCT02554890|12497560|FG001|Double-blind|Lost to Follow-up|5
7950838|NCT02554890|12497559|FG000|Double-blind|Technical problems|1
7950839|NCT02554890|12497560|FG001|Double-blind|Technical problems|0
7950840|NCT02554890|12497559|FG000|Double-blind|Withdrawal by Subject|5
7950841|NCT02554890|12497560|FG001|Double-blind|Withdrawal by Subject|6
7950842|NCT02554890|12497559|FG000|Double-blind|Noncompliance with study treatment|6
7950843|NCT02554890|12497560|FG001|Double-blind|Noncompliance with study treatment|5
7950844|NCT02554890|12497559|FG000|Open-label|Adverse Event|0
7950845|NCT02554890|12497560|FG001|Open-label|Adverse Event|30
7950846|NCT02554890|12497559|FG000|Open-label|Death|0
7950847|NCT02554890|12497560|FG001|Open-label|Death|1
7950848|NCT02554890|12497559|FG000|Open-label|Physician Decision|0
7950849|NCT02554890|12497560|FG001|Open-label|Physician Decision|1
7950850|NCT02554890|12497559|FG000|Open-label|Subject/Guardian decision|0
7950851|NCT02554890|12497560|FG001|Open-label|Subject/Guardian decision|11
7950852|NCT02554890|12497559|FG000|Open-label|Lost to Follow-up|0
7950853|NCT02554890|12497560|FG001|Open-label|Lost to Follow-up|7
7950854|NCT02554890|12497559|FG000|Open-label|Technical problems|0
7950855|NCT02554890|12497560|FG001|Open-label|Technical problems|1
7950856|NCT02554890|12497559|FG000|Open-label|Withdrawal by Subject|0
7950857|NCT02554890|12497560|FG001|Open-label|Withdrawal by Subject|1
7950858|NCT02554903|12497570|FG000|Overall Study|Death|1
7950859|NCT02554903|12497571|FG001|Overall Study|Death|1
7950860|NCT02554903|12497570|FG000|Overall Study|Physician Decision|2
7950861|NCT02554903|12497571|FG001|Overall Study|Physician Decision|2
7950862|NCT02554903|12497570|FG000|Overall Study|Heart Transplant|1
7950863|NCT02554903|12497571|FG001|Overall Study|Heart Transplant|2
7950864|NCT02554929|12497580|FG000|Overall Study|Lost to Follow-up|4
7950865|NCT02554929|12497581|FG001|Overall Study|Lost to Follow-up|4
7950866|NCT02554929|12497580|FG000|Overall Study|Withdrawal by Subject|2
7950867|NCT02554929|12497581|FG001|Overall Study|Withdrawal by Subject|8
7950868|NCT02554981|12497587|FG000|Overall Study|Adverse Event|1
7950869|NCT02554981|12497587|FG000|Overall Study|Administrative Reasons|1
7950870|NCT02554981|12497587|FG000|Overall Study|Other Miscellaneous Reasons|3
7950871|NCT02555215|12497602|FG000|Overall Study|Other|1
7950872|NCT02555215|12497602|FG000|Overall Study|Investigator Decision|2
7950873|NCT02555371|12497632|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1
7950874|NCT02555371|12497633|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7950875|NCT02555371|12497634|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7950876|NCT02555371|12497635|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7950877|NCT02555371|12497636|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7950878|NCT02555371|12497632|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2
7950879|NCT02555371|12497633|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7950880|NCT02555371|12497634|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7950881|NCT02555371|12497635|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7950882|NCT02555371|12497636|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7950883|NCT02555371|12497632|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5
7950884|NCT02555371|12497633|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7950885|NCT02555371|12497634|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7950886|NCT02555371|12497635|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7950887|NCT02555371|12497636|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7950888|NCT02555371|12497632|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1
7950889|NCT02555371|12497633|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7950890|NCT02555371|12497634|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7950891|NCT02555371|12497635|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7950892|NCT02555371|12497636|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7950893|NCT02555371|12497632|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2
7950894|NCT02555371|12497633|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7950895|NCT02555371|12497634|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7950896|NCT02555371|12497635|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7950897|NCT02555371|12497636|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7950898|NCT02555371|12497632|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
7950899|NCT02555371|12497633|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84
7950900|NCT02555371|12497634|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45
7950901|NCT02555371|12497635|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
7950902|NCT02555371|12497636|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
7950903|NCT02555371|12497632|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
7950904|NCT02555371|12497633|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
7950905|NCT02555371|12497634|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
7950906|NCT02555371|12497635|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
7950907|NCT02555371|12497636|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
7950908|NCT02555371|12497632|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7950909|NCT02555371|12497633|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1
7950910|NCT02555371|12497634|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7950911|NCT02555371|12497635|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7950912|NCT02555371|12497636|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7950913|NCT02555371|12497632|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0
7950914|NCT02555371|12497633|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2
7950915|NCT02555371|12497634|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1
7950916|NCT02555371|12497635|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0
7950917|NCT02555371|12497636|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0
7950918|NCT02555371|12497632|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7950919|NCT02555371|12497633|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7950920|NCT02555371|12497634|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7950921|NCT02555371|12497635|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1
7950922|NCT02555371|12497636|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7950923|NCT02555371|12497632|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7950924|NCT02555371|12497633|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7950925|NCT02555371|12497634|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7950926|NCT02555371|12497635|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2
7950927|NCT02555371|12497636|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7950928|NCT02555371|12497632|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7950929|NCT02555371|12497633|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7950930|NCT02555371|12497634|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7950931|NCT02555371|12497635|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7950932|NCT02555371|12497636|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2
7950933|NCT02555371|12497632|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7950934|NCT02555371|12497633|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7950935|NCT02555371|12497634|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7950936|NCT02555371|12497635|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7950937|NCT02555371|12497636|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1
7950938|NCT02555371|12497632|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7950939|NCT02555371|12497633|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7950940|NCT02555371|12497634|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7950941|NCT02555371|12497635|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1
7950942|NCT02555371|12497636|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7950943|NCT02555618|12497651|FG000|Overall Study|Sponsor's Circumstances|1
7950944|NCT02555618|12497652|FG001|Overall Study|Sponsor's Circumstances|0
7950945|NCT02555683|12497665|FG000|Overall Study|Physician Decision|1
7950946|NCT02555683|12497666|FG001|Overall Study|Physician Decision|0
7950947|NCT02555683|12497667|FG002|Overall Study|Physician Decision|2
7950948|NCT02555683|12497665|FG000|Overall Study|Lost to Follow-up|2
7950949|NCT02555683|12497666|FG001|Overall Study|Lost to Follow-up|1
7950950|NCT02555683|12497667|FG002|Overall Study|Lost to Follow-up|2
7950951|NCT02555683|12497665|FG000|Overall Study|Technical Problems|1
7950952|NCT02555683|12497666|FG001|Overall Study|Technical Problems|1
7950953|NCT02555683|12497667|FG002|Overall Study|Technical Problems|0
7950954|NCT02555683|12497665|FG000|Overall Study|Protocol deviation|0
7950955|NCT02555683|12497666|FG001|Overall Study|Protocol deviation|1
7950956|NCT02555683|12497667|FG002|Overall Study|Protocol deviation|0
7950957|NCT02555683|12497665|FG000|Overall Study|Lack of Efficacy|2
7950958|NCT02555683|12497666|FG001|Overall Study|Lack of Efficacy|0
7950959|NCT02555683|12497667|FG002|Overall Study|Lack of Efficacy|0
7950960|NCT02555683|12497665|FG000|Overall Study|Death|0
7950961|NCT02555683|12497666|FG001|Overall Study|Death|1
7950962|NCT02555683|12497667|FG002|Overall Study|Death|2
7950963|NCT02555683|12497665|FG000|Overall Study|Adverse Event|1
7950964|NCT02555683|12497666|FG001|Overall Study|Adverse Event|0
7950965|NCT02555683|12497667|FG002|Overall Study|Adverse Event|1
7950966|NCT02555683|12497665|FG000|Overall Study|Subject/guardian decision|12
7950967|NCT02555683|12497666|FG001|Overall Study|Subject/guardian decision|12
7950968|NCT02555683|12497667|FG002|Overall Study|Subject/guardian decision|22
7950969|NCT02555683|12497665|FG000|Overall Study|Death post Treatment/safety period|0
7950970|NCT02555683|12497666|FG001|Overall Study|Death post Treatment/safety period|1
7950971|NCT02555683|12497667|FG002|Overall Study|Death post Treatment/safety period|0
7950972|NCT02555722|12497677|FG000|Week 2|Adverse Event|0
7950973|NCT02555722|12497678|FG001|Week 2|Adverse Event|1
7950974|NCT02555722|12497677|FG000|Week 2|Withdrawal by Subject|1
7950975|NCT02555722|12497678|FG001|Week 2|Withdrawal by Subject|0
7950976|NCT02555722|12497677|FG000|Month 1|Lens Discomfort|1
7950977|NCT02555722|12497678|FG001|Month 1|Lens Discomfort|0
7950978|NCT02555722|12497677|FG000|Month 2|Withdrawal by Subject|3
7950979|NCT02555722|12497678|FG001|Month 2|Withdrawal by Subject|0
7950980|NCT02555722|12497677|FG000|Month 2|Lost to Follow-up|1
7950981|NCT02555722|12497678|FG001|Month 2|Lost to Follow-up|0
7950982|NCT02555878|12497709|FG000|Overall Study|Lost to Follow-up|2
7950983|NCT02555878|12497710|FG001|Overall Study|Lost to Follow-up|3
7950984|NCT02555878|12497709|FG000|Overall Study|Withdrawal by Subject|48
7950985|NCT02555878|12497710|FG001|Overall Study|Withdrawal by Subject|48
7950986|NCT02555878|12497709|FG000|Overall Study|Adverse Event|12
7950987|NCT02555878|12497710|FG001|Overall Study|Adverse Event|8
7950988|NCT02555878|12497709|FG000|Overall Study|Death|74
7950989|NCT02555878|12497710|FG001|Overall Study|Death|59
7950990|NCT02555878|12497709|FG000|Overall Study|Protocol Violation|1
7950991|NCT02555878|12497710|FG001|Overall Study|Protocol Violation|2
7950992|NCT02555878|12497709|FG000|Overall Study|Physician Decision|12
7950993|NCT02555878|12497710|FG001|Overall Study|Physician Decision|13
7950994|NCT02555878|12497709|FG000|Overall Study|Other|17
7950995|NCT02555878|12497710|FG001|Overall Study|Other|17
7950996|NCT02556138|12497735|FG000|Overall Study|Withdrawal by Subject|1
7950997|NCT02556177|12497741|FG000|Overall Study|Subjects did not complete all 4 visits|283
7950998|NCT02556177|12497742|FG001|Overall Study|Subjects did not complete all 4 visits|61
7950999|NCT02556203|12497750|FG000|Overall Study|Withdrawal by Subject|21
7951000|NCT02556203|12497751|FG001|Overall Study|Withdrawal by Subject|21
7951001|NCT02556203|12497750|FG000|Overall Study|Lost to Follow-up|5
7951002|NCT02556203|12497751|FG001|Overall Study|Lost to Follow-up|5
7951003|NCT02556203|12497750|FG000|Overall Study|Adverse Event|1
7951004|NCT02556203|12497751|FG001|Overall Study|Adverse Event|0
7951005|NCT02556255|12497757|FG000|Overall Study|Lost to Follow-up|4
7951006|NCT02556307|12497761|FG000|Overall Study|Premature treatment interruption|11
7951007|NCT02556307|12497761|FG000|Overall Study|Lost to Follow-up|36
7951008|NCT02556307|12497761|FG000|Overall Study|Change to triple therapy|4
7951009|NCT02556307|12497761|FG000|Overall Study|Enrolled but not treated|2
7951010|NCT02556632|12497790|FG000|Overall Study|Lost to Follow-up|1
7951011|NCT02556632|12497791|FG001|Overall Study|Lost to Follow-up|0
7951012|NCT02556632|12497792|FG002|Overall Study|Lost to Follow-up|0
7951013|NCT02556632|12497790|FG000|Overall Study|Disliked Intervention|1
7951014|NCT02556632|12497791|FG001|Overall Study|Disliked Intervention|1
7951015|NCT02556632|12497792|FG002|Overall Study|Disliked Intervention|1
7951016|NCT02556632|12497790|FG000|Overall Study|No Reason|1
7951017|NCT02556632|12497791|FG001|Overall Study|No Reason|0
7951018|NCT02556632|12497792|FG002|Overall Study|No Reason|1
7951019|NCT02556632|12497790|FG000|Overall Study|Personal Issues|0
7951020|NCT02556632|12497791|FG001|Overall Study|Personal Issues|1
7951021|NCT02556632|12497792|FG002|Overall Study|Personal Issues|1
7951022|NCT02556632|12497790|FG000|Overall Study|Changed Mind|0
7951023|NCT02556632|12497791|FG001|Overall Study|Changed Mind|1
7951024|NCT02556632|12497792|FG002|Overall Study|Changed Mind|0
7951025|NCT02556632|12497790|FG000|Overall Study|Withdrew (Unrelated Medical)|1
7951026|NCT02556632|12497791|FG001|Overall Study|Withdrew (Unrelated Medical)|0
7951027|NCT02556632|12497792|FG002|Overall Study|Withdrew (Unrelated Medical)|0
7951028|NCT02556632|12497790|FG000|Overall Study|Unrelated Adverse Event|1
7951029|NCT02556632|12497791|FG001|Overall Study|Unrelated Adverse Event|0
7951030|NCT02556632|12497792|FG002|Overall Study|Unrelated Adverse Event|3
7951031|NCT02556632|12497790|FG000|Overall Study|Related Adverse Event|0
7951032|NCT02556632|12497791|FG001|Overall Study|Related Adverse Event|1
7951033|NCT02556632|12497792|FG002|Overall Study|Related Adverse Event|0
7951034|NCT02556632|12497790|FG000|Overall Study|Possibly Related Adverse Event|0
7951035|NCT02556632|12497791|FG001|Overall Study|Possibly Related Adverse Event|0
7951036|NCT02556632|12497792|FG002|Overall Study|Possibly Related Adverse Event|1
7951037|NCT02556632|12497790|FG000|Overall Study|Did Not Start RT|0
7951038|NCT02556632|12497791|FG001|Overall Study|Did Not Start RT|1
7951039|NCT02556632|12497792|FG002|Overall Study|Did Not Start RT|0
7951040|NCT02556632|12497790|FG000|Overall Study|Ineligible|0
7951041|NCT02556632|12497791|FG001|Overall Study|Ineligible|1
7951042|NCT02556632|12497792|FG002|Overall Study|Ineligible|0
7951043|NCT02556632|12497790|FG000|Overall Study|Disliked Study Procedures|0
7951044|NCT02556632|12497791|FG001|Overall Study|Disliked Study Procedures|0
7951045|NCT02556632|12497792|FG002|Overall Study|Disliked Study Procedures|1
7951046|NCT02556632|12497790|FG000|Overall Study|Treatment or Change Delay|0
7951047|NCT02556632|12497791|FG001|Overall Study|Treatment or Change Delay|0
7951048|NCT02556632|12497792|FG002|Overall Study|Treatment or Change Delay|1
7951049|NCT02556775|12497804|FG000|Overall Study|Withdrawal by Subject|1
7951050|NCT02556775|12497805|FG001|Overall Study|Withdrawal by Subject|0
7951051|NCT02556775|12497806|FG002|Overall Study|Withdrawal by Subject|1
7951052|NCT02556775|12497807|FG003|Overall Study|Withdrawal by Subject|0
7951053|NCT02556775|12497804|FG000|Overall Study|Lost to Follow-up|1
7951054|NCT02556775|12497805|FG001|Overall Study|Lost to Follow-up|0
7951055|NCT02556775|12497806|FG002|Overall Study|Lost to Follow-up|0
7951056|NCT02556775|12497807|FG003|Overall Study|Lost to Follow-up|0
7951057|NCT02556801|12497832|FG000|Overall Study|Lost to Follow-up|1
7951058|NCT02556801|12497833|FG001|Overall Study|Lost to Follow-up|0
7951059|NCT02556801|12497834|FG002|Overall Study|Lost to Follow-up|2
7951060|NCT02556801|12497835|FG003|Overall Study|Lost to Follow-up|0
7951061|NCT02556801|12497832|FG000|Overall Study|Withdrawal by Subject|1
7951062|NCT02556801|12497833|FG001|Overall Study|Withdrawal by Subject|1
7951063|NCT02556801|12497834|FG002|Overall Study|Withdrawal by Subject|1
7951064|NCT02556801|12497835|FG003|Overall Study|Withdrawal by Subject|0
7951065|NCT02556801|12497832|FG000|Overall Study|Protocol Violation|0
7951066|NCT02556801|12497833|FG001|Overall Study|Protocol Violation|3
7951067|NCT02556801|12497834|FG002|Overall Study|Protocol Violation|1
7951068|NCT02556801|12497835|FG003|Overall Study|Protocol Violation|1
7951069|NCT02556801|12497832|FG000|Overall Study|Adverse Event|0
7951070|NCT02556801|12497833|FG001|Overall Study|Adverse Event|2
7951071|NCT02556801|12497834|FG002|Overall Study|Adverse Event|0
7951072|NCT02556801|12497835|FG003|Overall Study|Adverse Event|3
7951073|NCT02556801|12497832|FG000|Overall Study|Pregnancy|0
7951074|NCT02556801|12497833|FG001|Overall Study|Pregnancy|1
7951075|NCT02556801|12497834|FG002|Overall Study|Pregnancy|0
7951076|NCT02556801|12497835|FG003|Overall Study|Pregnancy|0
7951077|NCT02556801|12497832|FG000|Overall Study|Personal reasons patient|0
7951078|NCT02556801|12497833|FG001|Overall Study|Personal reasons patient|0
7951079|NCT02556801|12497834|FG002|Overall Study|Personal reasons patient|0
7951080|NCT02556801|12497835|FG003|Overall Study|Personal reasons patient|1
7951081|NCT02556918|12497847|FG000|Overall Study|Protocol Violation|5
7951082|NCT02556918|12497848|FG001|Overall Study|Protocol Violation|6
7951083|NCT02556918|12497847|FG000|Overall Study|Withdrawal by Subject|4
7951084|NCT02556918|12497848|FG001|Overall Study|Withdrawal by Subject|4
7951085|NCT02557100|12497867|FG000|Single Blind Treatment Period|Lost to Follow-up|0
7951086|NCT02557100|12497868|FG001|Single Blind Treatment Period|Lost to Follow-up|1
7951087|NCT02557100|12497869|FG002|Single Blind Treatment Period|Lost to Follow-up|0
7951088|NCT02557100|12497867|FG000|Single Blind Treatment Period|Death|0
7951089|NCT02557100|12497868|FG001|Single Blind Treatment Period|Death|1
7951090|NCT02557100|12497869|FG002|Single Blind Treatment Period|Death|0
7951091|NCT02557100|12497867|FG000|Single Blind Treatment Period|Request to Discontinue|0
7951092|NCT02557100|12497868|FG001|Single Blind Treatment Period|Request to Discontinue|1
7951093|NCT02557100|12497869|FG002|Single Blind Treatment Period|Request to Discontinue|0
7951094|NCT02557100|12497867|FG000|Single Blind Treatment Period|Adverse Event|0
7951095|NCT02557100|12497868|FG001|Single Blind Treatment Period|Adverse Event|1
7951096|NCT02557100|12497869|FG002|Single Blind Treatment Period|Adverse Event|0
7951097|NCT02557100|12497867|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40
7951098|NCT02557100|12497868|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36
7951099|NCT02557100|12497869|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0
7951100|NCT02557100|12497867|FG000|Cumulative Abatacept Period|Other Reasons|0
7951101|NCT02557100|12497868|FG001|Cumulative Abatacept Period|Other Reasons|0
7951102|NCT02557100|12497869|FG002|Cumulative Abatacept Period|Other Reasons|1
7951103|NCT02557100|12497867|FG000|Cumulative Abatacept Period|Lost to Follow-up|0
7951104|NCT02557100|12497868|FG001|Cumulative Abatacept Period|Lost to Follow-up|0
7951105|NCT02557100|12497869|FG002|Cumulative Abatacept Period|Lost to Follow-up|2
7951106|NCT02557100|12497867|FG000|Cumulative Abatacept Period|Request to Discontinue|0
7951107|NCT02557100|12497868|FG001|Cumulative Abatacept Period|Request to Discontinue|0
7951108|NCT02557100|12497869|FG002|Cumulative Abatacept Period|Request to Discontinue|1
7951109|NCT02557399|12497888|FG000|Overall Study|Adverse Event|6
7951110|NCT02557399|12497889|FG001|Overall Study|Adverse Event|5
7951111|NCT02557399|12497888|FG000|Overall Study|Protocol Violation|0
7951112|NCT02557399|12497889|FG001|Overall Study|Protocol Violation|1
7951113|NCT02557399|12497888|FG000|Overall Study|Protocol-defined stopping criteria|0
7951114|NCT02557399|12497889|FG001|Overall Study|Protocol-defined stopping criteria|1
7951115|NCT02557399|12497888|FG000|Overall Study|Withdrawal by Subject|1
7951116|NCT02557399|12497889|FG001|Overall Study|Withdrawal by Subject|1
7951117|NCT02557516|12497902|FG000|Overall Study|Adverse Event|1
7951118|NCT02557516|12497903|FG001|Overall Study|Adverse Event|0
7951119|NCT02557516|12497904|FG002|Overall Study|Adverse Event|2
7951120|NCT02557516|12497905|FG003|Overall Study|Adverse Event|1
7951121|NCT02557516|12497902|FG000|Overall Study|Disease progression|0
7951122|NCT02557516|12497903|FG001|Overall Study|Disease progression|2
7951123|NCT02557516|12497904|FG002|Overall Study|Disease progression|0
7951124|NCT02557516|12497905|FG003|Overall Study|Disease progression|0
7951125|NCT02557516|12497902|FG000|Overall Study|Physician Decision|0
7951126|NCT02557516|12497903|FG001|Overall Study|Physician Decision|2
7951127|NCT02557516|12497904|FG002|Overall Study|Physician Decision|0
7951128|NCT02557516|12497905|FG003|Overall Study|Physician Decision|0
7951129|NCT02557516|12497902|FG000|Overall Study|Sponsor decision|0
7951130|NCT02557516|12497903|FG001|Overall Study|Sponsor decision|1
7951131|NCT02557516|12497904|FG002|Overall Study|Sponsor decision|2
7951132|NCT02557516|12497905|FG003|Overall Study|Sponsor decision|8
7951133|NCT02557646|12497929|FG000|Overall Study|Adverse Event|40
7951134|NCT02557646|12497929|FG000|Overall Study|Death|1
7951135|NCT02557646|12497929|FG000|Overall Study|Lack of Efficacy|186
7951136|NCT02557646|12497929|FG000|Overall Study|Withdrawal by Subject|18
7951137|NCT02557646|12497929|FG000|Overall Study|Lost to Follow-up|17
7951138|NCT02557646|12497929|FG000|Overall Study|Other|14
7951139|NCT02558231|12497944|FG000|Overall Study|Death|4
7951140|NCT02558231|12497945|FG001|Overall Study|Death|12
7951141|NCT02558231|12497944|FG000|Overall Study|Lost to Follow-up|7
7951142|NCT02558231|12497945|FG001|Overall Study|Lost to Follow-up|4
7951143|NCT02558231|12497944|FG000|Overall Study|Withdrawal by Subject|7
7951144|NCT02558231|12497945|FG001|Overall Study|Withdrawal by Subject|4
7951145|NCT02558231|12497944|FG000|Overall Study|Physician Decision|7
7951146|NCT02558231|12497945|FG001|Overall Study|Physician Decision|5
7951147|NCT02558231|12497944|FG000|Overall Study|Sponsor Decision|0
7951148|NCT02558231|12497945|FG001|Overall Study|Sponsor Decision|1
7965912|NCT02741518|12521427|FG000|Overall Study|Withdrawal by Subject|1
7965913|NCT02741518|12521428|FG001|Overall Study|Withdrawal by Subject|1
7965914|NCT02741596|12521436|FG000|Overall Study|Adverse Event|1
7965915|NCT02741596|12521437|FG001|Overall Study|Adverse Event|5
7965916|NCT02741596|12521436|FG000|Overall Study|Lost to Follow-up|1
7965917|NCT02741596|12521437|FG001|Overall Study|Lost to Follow-up|1
7965918|NCT02741596|12521436|FG000|Overall Study|Physician Decision|2
7965919|NCT02741596|12521437|FG001|Overall Study|Physician Decision|1
7965920|NCT02741596|12521436|FG000|Overall Study|Pregnancy|3
7965921|NCT02741596|12521437|FG001|Overall Study|Pregnancy|1
7965922|NCT02741596|12521436|FG000|Overall Study|Other (Unspecified)|0
7965923|NCT02741596|12521437|FG001|Overall Study|Other (Unspecified)|3
7965924|NCT02741596|12521436|FG000|Overall Study|Subject withdrawn-Other|17
7965925|NCT02741596|12521437|FG001|Overall Study|Subject withdrawn-Other|4
7965926|NCT02741596|12521436|FG000|Overall Study|Subject withdrawn-to commercial product|54
7965927|NCT02741596|12521437|FG001|Overall Study|Subject withdrawn-to commercial product|63
7965928|NCT02741635|12521443|FG000|Overall Study|Withdrawal by Subject|1
7965929|NCT02741713|12521459|FG000|Overall Study|Surgery type changed intra-operatively|2
7965930|NCT02741713|12521460|FG001|Overall Study|Surgery type changed intra-operatively|1
7965931|NCT02742103|12521473|FG000|Overall Study|Protocol Violation|1
7965932|NCT02742103|12521474|FG001|Overall Study|Protocol Violation|0
7965933|NCT02742103|12521473|FG000|Overall Study|Death|2
7965934|NCT02742103|12521474|FG001|Overall Study|Death|2
7965935|NCT02742103|12521473|FG000|Overall Study|Adverse Event|1
7965936|NCT02742103|12521474|FG001|Overall Study|Adverse Event|0
7965937|NCT02742103|12521473|FG000|Overall Study|Moved to another town|0
7965938|NCT02742103|12521474|FG001|Overall Study|Moved to another town|1
7965939|NCT02742103|12521473|FG000|Overall Study|Withdrawal by Subject|5
7965940|NCT02742103|12521474|FG001|Overall Study|Withdrawal by Subject|2
7965941|NCT02742441|12521494|FG000|Overall Study|Lost to Follow-up|4
7965942|NCT02742441|12521495|FG001|Overall Study|Lost to Follow-up|4
7965943|NCT02742441|12521494|FG000|Overall Study|Withdrawal by Subject|2
7965944|NCT02742441|12521495|FG001|Overall Study|Withdrawal by Subject|2
7965945|NCT02742441|12521494|FG000|Overall Study|Adverse Event|0
7965946|NCT02742441|12521495|FG001|Overall Study|Adverse Event|2
7965947|NCT02742519|12521503|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
7965948|NCT02742519|12521504|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
7965949|NCT02742519|12521505|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
7965950|NCT02742519|12521503|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
7965951|NCT02742519|12521504|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
7965952|NCT02742519|12521505|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
7965953|NCT02742519|12521503|FG000|Part 2 Open Label Period (32 Weeks)|Other|0
7965954|NCT02742519|12521504|FG001|Part 2 Open Label Period (32 Weeks)|Other|0
7965955|NCT02742519|12521505|FG002|Part 2 Open Label Period (32 Weeks)|Other|1
7965956|NCT02742649|12521525|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5
7965957|NCT02742649|12521526|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7965958|NCT02742649|12521527|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7965959|NCT02742649|12521528|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7965960|NCT02742649|12521529|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7965961|NCT02742649|12521525|FG000|Double-Blind Treatment Period|Adverse Event|0
7965962|NCT02742649|12521526|FG001|Double-Blind Treatment Period|Adverse Event|1
7965963|NCT02742649|12521527|FG002|Double-Blind Treatment Period|Adverse Event|0
7965964|NCT02742649|12521528|FG003|Double-Blind Treatment Period|Adverse Event|0
7965965|NCT02742649|12521529|FG004|Double-Blind Treatment Period|Adverse Event|0
7965966|NCT02742649|12521525|FG000|Open-Label Period|Lost to Follow-up|0
7965967|NCT02742649|12521526|FG001|Open-Label Period|Lost to Follow-up|0
7965968|NCT02742649|12521527|FG002|Open-Label Period|Lost to Follow-up|0
7965969|NCT02742649|12521528|FG003|Open-Label Period|Lost to Follow-up|0
7965970|NCT02742649|12521529|FG004|Open-Label Period|Lost to Follow-up|1
7965971|NCT02742766|12521559|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965972|NCT02742766|12521560|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965973|NCT02742766|12521561|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965974|NCT02742766|12521562|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965975|NCT02742766|12521563|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965976|NCT02742766|12521564|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7951149|NCT02558296|12497953|FG000|Completed the Study Through Week 24|Adverse Event|9
7951150|NCT02558296|12497954|FG001|Completed the Study Through Week 24|Adverse Event|3
7951151|NCT02558296|12497953|FG000|Completed the Study Through Week 24|Death|7
7951152|NCT02558296|12497954|FG001|Completed the Study Through Week 24|Death|7
7951153|NCT02558296|12497953|FG000|Completed the Study Through Week 24|Lost to Follow-up|8
7951154|NCT02558296|12497954|FG001|Completed the Study Through Week 24|Lost to Follow-up|1
7951155|NCT02558296|12497953|FG000|Completed the Study Through Week 24|Physician Decision|1
7951156|NCT02558296|12497954|FG001|Completed the Study Through Week 24|Physician Decision|0
7951157|NCT02558296|12497953|FG000|Completed the Study Through Week 24|Protocol Violation|1
7951158|NCT02558296|12497954|FG001|Completed the Study Through Week 24|Protocol Violation|1
7951159|NCT02558296|12497953|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17
7951160|NCT02558296|12497954|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13
7951161|NCT02558296|12497953|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1
7951162|NCT02558296|12497954|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0
7951163|NCT02558296|12497953|FG000|Completed the Study|Adverse Event|14
7951164|NCT02558296|12497954|FG001|Completed the Study|Adverse Event|5
7951165|NCT02558296|12497953|FG000|Completed the Study|Death|39
7951166|NCT02558296|12497954|FG001|Completed the Study|Death|25
7951167|NCT02558296|12497953|FG000|Completed the Study|Lost to Follow-up|31
7951168|NCT02558296|12497954|FG001|Completed the Study|Lost to Follow-up|23
7951169|NCT02558296|12497953|FG000|Completed the Study|Physician Decision|6
7951170|NCT02558296|12497954|FG001|Completed the Study|Physician Decision|0
7951171|NCT02558296|12497953|FG000|Completed the Study|Protocol Violation|2
7951172|NCT02558296|12497954|FG001|Completed the Study|Protocol Violation|1
7951173|NCT02558296|12497953|FG000|Completed the Study|Withdrawal by Subject|53
7951174|NCT02558296|12497954|FG001|Completed the Study|Withdrawal by Subject|31
7951175|NCT02558296|12497953|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1
7951176|NCT02558296|12497954|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0
7951177|NCT02558400|12497976|FG000|Overall Study|Adverse Event|47
7951178|NCT02558400|12497977|FG001|Overall Study|Adverse Event|53
7951179|NCT02558400|12497978|FG002|Overall Study|Adverse Event|4
7951180|NCT02558400|12497976|FG000|Overall Study|Withdrawal by Subject|13
7951181|NCT02558400|12497977|FG001|Overall Study|Withdrawal by Subject|9
7951182|NCT02558400|12497978|FG002|Overall Study|Withdrawal by Subject|8
7951183|NCT02558400|12497976|FG000|Overall Study|Non-Compliant|0
7951184|NCT02558400|12497977|FG001|Overall Study|Non-Compliant|1
7951185|NCT02558400|12497978|FG002|Overall Study|Non-Compliant|3
7951186|NCT02558400|12497976|FG000|Overall Study|Lost to Follow-up|5
7951187|NCT02558400|12497977|FG001|Overall Study|Lost to Follow-up|5
7951188|NCT02558400|12497978|FG002|Overall Study|Lost to Follow-up|4
7951189|NCT02558400|12497976|FG000|Overall Study|Lack of Efficacy|0
7951190|NCT02558400|12497977|FG001|Overall Study|Lack of Efficacy|13
7951191|NCT02558400|12497978|FG002|Overall Study|Lack of Efficacy|1
7951192|NCT02558400|12497976|FG000|Overall Study|Disallowed Concurrent Medication|6
7951193|NCT02558400|12497977|FG001|Overall Study|Disallowed Concurrent Medication|7
7951194|NCT02558400|12497978|FG002|Overall Study|Disallowed Concurrent Medication|5
7951195|NCT02558400|12497976|FG000|Overall Study|Physician Decision|2
7951196|NCT02558400|12497977|FG001|Overall Study|Physician Decision|2
7951197|NCT02558400|12497978|FG002|Overall Study|Physician Decision|0
7951198|NCT02558400|12497976|FG000|Overall Study|Protocol Violation|6
7951199|NCT02558400|12497977|FG001|Overall Study|Protocol Violation|3
7951200|NCT02558400|12497978|FG002|Overall Study|Protocol Violation|8
7951201|NCT02558400|12497976|FG000|Overall Study|Death|0
7951202|NCT02558400|12497977|FG001|Overall Study|Death|1
7951203|NCT02558400|12497978|FG002|Overall Study|Death|0
7951204|NCT02558400|12497976|FG000|Overall Study|Ineligible for the study|0
7951205|NCT02558400|12497977|FG001|Overall Study|Ineligible for the study|2
7951206|NCT02558400|12497978|FG002|Overall Study|Ineligible for the study|0
7951207|NCT02558790|12497989|FG000|Overall Study|Lost to Follow-up|2
7951208|NCT02558790|12497989|FG000|Overall Study|Physician Decision|1
7951209|NCT02558790|12497989|FG000|Overall Study|Withdrawal by Subject|1
7951210|NCT02558790|12497989|FG000|Overall Study|Screen Fail|3
7951211|NCT02558894|12498028|FG000|Overall Study|Death; any cause, entire study duration|28
7951212|NCT02558894|12498029|FG001|Overall Study|Death; any cause, entire study duration|31
7951213|NCT02558894|12498028|FG000|Overall Study|Withdrawal by Subject|2
7951214|NCT02558894|12498029|FG001|Overall Study|Withdrawal by Subject|1
7951215|NCT02558894|12498028|FG000|Overall Study|Closure of Part A|2
7951216|NCT02558894|12498029|FG001|Overall Study|Closure of Part A|1
7951217|NCT02559115|12498035|FG000|Overall Study|Withdrawal by Subject|3
7951218|NCT02559206|12498047|FG000|Overall Study|Adverse Event|0
7951219|NCT02559206|12498048|FG001|Overall Study|Adverse Event|4
7951220|NCT02559206|12498049|FG002|Overall Study|Adverse Event|1
7951221|NCT02559206|12498050|FG003|Overall Study|Adverse Event|5
7951222|NCT02559206|12498051|FG004|Overall Study|Adverse Event|3
7951223|NCT02559206|12498052|FG005|Overall Study|Adverse Event|0
7951224|NCT02559206|12498053|FG006|Overall Study|Adverse Event|1
7951225|NCT02559206|12498054|FG007|Overall Study|Adverse Event|0
7951226|NCT02559206|12498047|FG000|Overall Study|Protocol Violation|1
7951227|NCT02559206|12498048|FG001|Overall Study|Protocol Violation|0
7951228|NCT02559206|12498049|FG002|Overall Study|Protocol Violation|1
7951229|NCT02559206|12498050|FG003|Overall Study|Protocol Violation|0
7951230|NCT02559206|12498051|FG004|Overall Study|Protocol Violation|0
7951231|NCT02559206|12498052|FG005|Overall Study|Protocol Violation|2
7951232|NCT02559206|12498053|FG006|Overall Study|Protocol Violation|0
7951233|NCT02559206|12498054|FG007|Overall Study|Protocol Violation|0
7951234|NCT02559206|12498047|FG000|Overall Study|Withdrawal by Subject|3
7951235|NCT02559206|12498048|FG001|Overall Study|Withdrawal by Subject|3
7951236|NCT02559206|12498049|FG002|Overall Study|Withdrawal by Subject|1
7951237|NCT02559206|12498050|FG003|Overall Study|Withdrawal by Subject|3
7951238|NCT02559206|12498051|FG004|Overall Study|Withdrawal by Subject|5
7951239|NCT02559206|12498052|FG005|Overall Study|Withdrawal by Subject|4
7951240|NCT02559206|12498053|FG006|Overall Study|Withdrawal by Subject|1
7951241|NCT02559206|12498054|FG007|Overall Study|Withdrawal by Subject|2
7951242|NCT02559206|12498047|FG000|Overall Study|Lost to Follow-up|3
7951243|NCT02559206|12498048|FG001|Overall Study|Lost to Follow-up|5
7951244|NCT02559206|12498049|FG002|Overall Study|Lost to Follow-up|3
7951245|NCT02559206|12498050|FG003|Overall Study|Lost to Follow-up|3
7951246|NCT02559206|12498051|FG004|Overall Study|Lost to Follow-up|2
7951247|NCT02559206|12498052|FG005|Overall Study|Lost to Follow-up|5
7951248|NCT02559206|12498053|FG006|Overall Study|Lost to Follow-up|1
7951249|NCT02559206|12498054|FG007|Overall Study|Lost to Follow-up|4
7951250|NCT02559206|12498047|FG000|Overall Study|Lack of Efficacy|1
7951251|NCT02559206|12498048|FG001|Overall Study|Lack of Efficacy|0
7951252|NCT02559206|12498049|FG002|Overall Study|Lack of Efficacy|3
7951253|NCT02559206|12498050|FG003|Overall Study|Lack of Efficacy|2
7951254|NCT02559206|12498051|FG004|Overall Study|Lack of Efficacy|2
7951255|NCT02559206|12498052|FG005|Overall Study|Lack of Efficacy|3
7951256|NCT02559206|12498053|FG006|Overall Study|Lack of Efficacy|3
7951257|NCT02559206|12498054|FG007|Overall Study|Lack of Efficacy|3
7951258|NCT02559206|12498047|FG000|Overall Study|Other Not Specified|0
7951259|NCT02559206|12498048|FG001|Overall Study|Other Not Specified|0
7951260|NCT02559206|12498049|FG002|Overall Study|Other Not Specified|0
7951261|NCT02559206|12498050|FG003|Overall Study|Other Not Specified|1
7951262|NCT02559206|12498051|FG004|Overall Study|Other Not Specified|0
7951263|NCT02559206|12498052|FG005|Overall Study|Other Not Specified|0
7951264|NCT02559206|12498053|FG006|Overall Study|Other Not Specified|0
7951265|NCT02559206|12498054|FG007|Overall Study|Other Not Specified|0
7951266|NCT02559310|12498074|FG000|Overall Study|Death|4
7951267|NCT02559310|12498075|FG001|Overall Study|Death|3
7951268|NCT02559310|12498074|FG000|Overall Study|Lost to Follow-up|5
7951269|NCT02559310|12498075|FG001|Overall Study|Lost to Follow-up|3
7951270|NCT02559310|12498074|FG000|Overall Study|Physician Decision|2
7951271|NCT02559310|12498075|FG001|Overall Study|Physician Decision|1
7951272|NCT02559310|12498074|FG000|Overall Study|Withdrawal by Subject|13
7951273|NCT02559310|12498075|FG001|Overall Study|Withdrawal by Subject|9
7951274|NCT02559310|12498074|FG000|Overall Study|Sponsor Decision|0
7951275|NCT02559310|12498075|FG001|Overall Study|Sponsor Decision|1
7951276|NCT02559310|12498074|FG000|Overall Study|Randomized but not treated|3
7951277|NCT02559310|12498075|FG001|Overall Study|Randomized but not treated|2
7951278|NCT02559414|12498084|FG000|Overall Study|Lost to Follow-up|0
7951279|NCT02559414|12498085|FG001|Overall Study|Lost to Follow-up|1
7951280|NCT02559414|12498086|FG002|Overall Study|Lost to Follow-up|0
7951281|NCT02559414|12498084|FG000|Overall Study|Withdrawal by Subject|1
7951282|NCT02559414|12498085|FG001|Overall Study|Withdrawal by Subject|0
7951283|NCT02559414|12498086|FG002|Overall Study|Withdrawal by Subject|1
7951284|NCT02559414|12498084|FG000|Overall Study|Other|0
7951285|NCT02559414|12498085|FG001|Overall Study|Other|1
7951286|NCT02559414|12498086|FG002|Overall Study|Other|1
7951287|NCT02559505|12498111|FG000|Overall Study|Lost to Follow-up|23
7951288|NCT02559505|12498112|FG001|Overall Study|Lost to Follow-up|20
7951289|NCT02559505|12498111|FG000|Overall Study|Withdrawal by Subject|4
7951290|NCT02559505|12498112|FG001|Overall Study|Withdrawal by Subject|2
7951291|NCT02559570|12498135|FG000|Overall Study|Adverse Event|0
7951292|NCT02559570|12498136|FG001|Overall Study|Adverse Event|2
7951293|NCT02559570|12498137|FG002|Overall Study|Adverse Event|0
7951294|NCT02559570|12498138|FG003|Overall Study|Adverse Event|1
7951295|NCT02559570|12498139|FG004|Overall Study|Adverse Event|0
7951296|NCT02559570|12498135|FG000|Overall Study|Withdrawal of Consent|0
7951297|NCT02559570|12498136|FG001|Overall Study|Withdrawal of Consent|0
7951298|NCT02559570|12498137|FG002|Overall Study|Withdrawal of Consent|1
7951299|NCT02559570|12498138|FG003|Overall Study|Withdrawal of Consent|2
7951300|NCT02559570|12498139|FG004|Overall Study|Withdrawal of Consent|1
7951301|NCT02559570|12498135|FG000|Overall Study|Lost to Follow-up|1
7951302|NCT02559570|12498136|FG001|Overall Study|Lost to Follow-up|0
7951303|NCT02559570|12498137|FG002|Overall Study|Lost to Follow-up|0
7951304|NCT02559570|12498138|FG003|Overall Study|Lost to Follow-up|0
7951305|NCT02559570|12498139|FG004|Overall Study|Lost to Follow-up|0
7951306|NCT02559570|12498135|FG000|Overall Study|Protocol Violation|1
7951307|NCT02559570|12498136|FG001|Overall Study|Protocol Violation|0
7951308|NCT02559570|12498137|FG002|Overall Study|Protocol Violation|0
7951309|NCT02559570|12498138|FG003|Overall Study|Protocol Violation|0
7951310|NCT02559570|12498139|FG004|Overall Study|Protocol Violation|1
7951311|NCT02559570|12498135|FG000|Overall Study|Other Miscellaneous Reasons|0
7951312|NCT02559570|12498136|FG001|Overall Study|Other Miscellaneous Reasons|0
7951313|NCT02559570|12498137|FG002|Overall Study|Other Miscellaneous Reasons|1
7951314|NCT02559570|12498138|FG003|Overall Study|Other Miscellaneous Reasons|0
7951315|NCT02559570|12498139|FG004|Overall Study|Other Miscellaneous Reasons|0
7951316|NCT02559622|12498154|FG000|Overall Study|Progressive disease|0
7951317|NCT02559622|12498155|FG001|Overall Study|Progressive disease|1
7951318|NCT02559622|12498156|FG002|Overall Study|Progressive disease|0
7951319|NCT02559622|12498157|FG003|Overall Study|Progressive disease|0
7951320|NCT02559622|12498154|FG000|Overall Study|Adverse Event|0
7951321|NCT02559622|12498155|FG001|Overall Study|Adverse Event|2
7951322|NCT02559622|12498156|FG002|Overall Study|Adverse Event|2
7951323|NCT02559622|12498157|FG003|Overall Study|Adverse Event|2
7951324|NCT02559622|12498154|FG000|Overall Study|Patient/guardian decision|1
7951325|NCT02559622|12498155|FG001|Overall Study|Patient/guardian decision|2
7951326|NCT02559622|12498156|FG002|Overall Study|Patient/guardian decision|0
7951327|NCT02559622|12498157|FG003|Overall Study|Patient/guardian decision|1
7951328|NCT02559713|12498171|FG000|Overall Study|Pretreatment Event/ Adverse Event|1
7951329|NCT02559817|12498180|FG000|Treatment Period|Adverse Event|1
7951330|NCT02559817|12498181|FG001|Treatment Period|Adverse Event|0
7951331|NCT02559817|12498182|FG002|Treatment Period|Adverse Event|1
7951332|NCT02559817|12498183|FG003|Treatment Period|Adverse Event|0
7951333|NCT02559817|12498184|FG004|Treatment Period|Adverse Event|0
7951334|NCT02559817|12498180|FG000|Treatment Period|Lack of Efficacy|0
7951335|NCT02559817|12498181|FG001|Treatment Period|Lack of Efficacy|1
7951336|NCT02559817|12498182|FG002|Treatment Period|Lack of Efficacy|0
7951337|NCT02559817|12498183|FG003|Treatment Period|Lack of Efficacy|0
7951338|NCT02559817|12498184|FG004|Treatment Period|Lack of Efficacy|0
7951339|NCT02559817|12498180|FG000|Treatment Period|Lost to Follow-up|0
7951340|NCT02559817|12498181|FG001|Treatment Period|Lost to Follow-up|1
7951341|NCT02559817|12498182|FG002|Treatment Period|Lost to Follow-up|0
7951342|NCT02559817|12498183|FG003|Treatment Period|Lost to Follow-up|1
7951343|NCT02559817|12498184|FG004|Treatment Period|Lost to Follow-up|0
7951344|NCT02559817|12498180|FG000|Treatment Period|Non-Compliance With Study Drug|0
7951345|NCT02559817|12498181|FG001|Treatment Period|Non-Compliance With Study Drug|0
7951346|NCT02559817|12498182|FG002|Treatment Period|Non-Compliance With Study Drug|1
7951347|NCT02559817|12498183|FG003|Treatment Period|Non-Compliance With Study Drug|0
7951348|NCT02559817|12498184|FG004|Treatment Period|Non-Compliance With Study Drug|0
7951349|NCT02559817|12498180|FG000|Treatment Period|Protocol Violation|0
7951350|NCT02559817|12498181|FG001|Treatment Period|Protocol Violation|0
7951351|NCT02559817|12498182|FG002|Treatment Period|Protocol Violation|0
7951352|NCT02559817|12498183|FG003|Treatment Period|Protocol Violation|1
7951353|NCT02559817|12498184|FG004|Treatment Period|Protocol Violation|0
7951354|NCT02559895|12498200|FG000|Overall Study|Adverse Event|3
7951355|NCT02559895|12498201|FG001|Overall Study|Adverse Event|3
7951356|NCT02559895|12498202|FG002|Overall Study|Adverse Event|2
7951357|NCT02559895|12498203|FG003|Overall Study|Adverse Event|1
7951358|NCT02559895|12498200|FG000|Overall Study|Lack of Efficacy|2
7951359|NCT02559895|12498201|FG001|Overall Study|Lack of Efficacy|3
7951360|NCT02559895|12498202|FG002|Overall Study|Lack of Efficacy|2
7951361|NCT02559895|12498203|FG003|Overall Study|Lack of Efficacy|8
7951362|NCT02559895|12498200|FG000|Overall Study|Lost to Follow-up|22
7951363|NCT02559895|12498201|FG001|Overall Study|Lost to Follow-up|16
7951364|NCT02559895|12498202|FG002|Overall Study|Lost to Follow-up|12
7951365|NCT02559895|12498203|FG003|Overall Study|Lost to Follow-up|17
7951366|NCT02559895|12498200|FG000|Overall Study|Physician Decision|1
7951367|NCT02559895|12498201|FG001|Overall Study|Physician Decision|1
7951368|NCT02559895|12498202|FG002|Overall Study|Physician Decision|3
7951369|NCT02559895|12498203|FG003|Overall Study|Physician Decision|0
7951370|NCT02559895|12498200|FG000|Overall Study|Withdrawal by Subject|16
7951371|NCT02559895|12498201|FG001|Overall Study|Withdrawal by Subject|9
7951372|NCT02559895|12498202|FG002|Overall Study|Withdrawal by Subject|20
7951373|NCT02559895|12498203|FG003|Overall Study|Withdrawal by Subject|9
7951374|NCT02559895|12498200|FG000|Overall Study|Study Burden|10
7951375|NCT02559895|12498201|FG001|Overall Study|Study Burden|16
7951376|NCT02559895|12498202|FG002|Overall Study|Study Burden|12
7951377|NCT02559895|12498203|FG003|Overall Study|Study Burden|22
7951378|NCT02559895|12498200|FG000|Overall Study|Other|1
7951379|NCT02559895|12498201|FG001|Overall Study|Other|5
7951380|NCT02559895|12498202|FG002|Overall Study|Other|3
7951381|NCT02559895|12498203|FG003|Overall Study|Other|3
7951382|NCT02560012|12498213|FG000|Overall Study|Study Terminated|2
7951383|NCT02560025|12498217|FG000|Overall Study|Ineligible after consent/ registration|3
7951384|NCT02560389|12498254|FG000|Overall Study|Lost to Follow-up|1
7951385|NCT02560389|12498255|FG001|Overall Study|Lost to Follow-up|2
7951386|NCT02560389|12498256|FG002|Overall Study|Lost to Follow-up|2
7951387|NCT02560389|12498254|FG000|Overall Study|Tested positive for illicit substance|0
7951388|NCT02560389|12498255|FG001|Overall Study|Tested positive for illicit substance|1
7951389|NCT02560389|12498256|FG002|Overall Study|Tested positive for illicit substance|0
7951390|NCT02560558|12498275|FG000|Overall Study|Adverse Event|1
7951391|NCT02560558|12498276|FG001|Overall Study|Adverse Event|0
7951392|NCT02560558|12498275|FG000|Overall Study|Death|0
7951393|NCT02560558|12498276|FG001|Overall Study|Death|2
7951394|NCT02560558|12498275|FG000|Overall Study|Lost to Follow-up|0
7951395|NCT02560558|12498276|FG001|Overall Study|Lost to Follow-up|4
7951396|NCT02560558|12498275|FG000|Overall Study|Protocol Violation|3
7951397|NCT02560558|12498276|FG001|Overall Study|Protocol Violation|0
7951398|NCT02560558|12498275|FG000|Overall Study|Withdrawal by Subject|3
7951399|NCT02560558|12498276|FG001|Overall Study|Withdrawal by Subject|0
7951400|NCT02561000|12498335|FG000|Overall Study|Withdrawal by Subject|2
7951401|NCT02561000|12498336|FG001|Overall Study|Withdrawal by Subject|3
7951402|NCT02561000|12498337|FG002|Overall Study|Withdrawal by Subject|0
7951403|NCT02561000|12498335|FG000|Overall Study|Adverse Event|0
7951404|NCT02561000|12498336|FG001|Overall Study|Adverse Event|1
7951405|NCT02561000|12498337|FG002|Overall Study|Adverse Event|0
7951406|NCT02561078|12498347|FG000|Overall Study|Adverse Event|5
7951407|NCT02561078|12498348|FG001|Overall Study|Adverse Event|2
7951408|NCT02561078|12498347|FG000|Overall Study|Death|2
7951409|NCT02561078|12498348|FG001|Overall Study|Death|1
7951410|NCT02561078|12498347|FG000|Overall Study|Lost to Follow-up|2
7951411|NCT02561078|12498348|FG001|Overall Study|Lost to Follow-up|6
7951412|NCT02561078|12498347|FG000|Overall Study|Non-Compliance with Study Drug|6
7951413|NCT02561078|12498348|FG001|Overall Study|Non-Compliance with Study Drug|3
7951414|NCT02561078|12498347|FG000|Overall Study|Physician Decision|2
7951415|NCT02561078|12498348|FG001|Overall Study|Physician Decision|3
7951416|NCT02561078|12498347|FG000|Overall Study|Withdrawal by Subject|13
7951417|NCT02561078|12498348|FG001|Overall Study|Withdrawal by Subject|10
7951418|NCT02561156|12498376|FG000|Part 2|Adverse Event|0
7951419|NCT02561156|12498377|FG001|Part 2|Adverse Event|0
7951420|NCT02561156|12498378|FG002|Part 2|Adverse Event|0
7951421|NCT02561156|12498379|FG003|Part 2|Adverse Event|0
7951422|NCT02561156|12498380|FG004|Part 2|Adverse Event|0
7951423|NCT02561156|12498381|FG005|Part 2|Adverse Event|0
7951424|NCT02561156|12498382|FG006|Part 2|Adverse Event|0
7951425|NCT02561156|12498383|FG007|Part 2|Adverse Event|0
7951426|NCT02561156|12498384|FG008|Part 2|Adverse Event|0
7951427|NCT02561156|12498385|FG009|Part 2|Adverse Event|0
7951428|NCT02561156|12498386|FG010|Part 2|Adverse Event|0
7951429|NCT02561156|12498387|FG011|Part 2|Adverse Event|1
7951430|NCT02561156|12498388|FG012|Part 2|Adverse Event|0
7951431|NCT02561195|12498438|FG000|Vaccination 1 to 3|Adverse Event|4
7951432|NCT02561195|12498439|FG001|Vaccination 1 to 3|Adverse Event|5
7951433|NCT02561195|12498440|FG002|Vaccination 1 to 3|Adverse Event|0
7951434|NCT02561195|12498441|FG003|Vaccination 1 to 3|Adverse Event|3
7951435|NCT02561195|12498442|FG004|Vaccination 1 to 3|Adverse Event|4
7951436|NCT02561195|12498443|FG005|Vaccination 1 to 3|Adverse Event|0
7951437|NCT02561195|12498444|FG006|Vaccination 1 to 3|Adverse Event|0
7951438|NCT02561195|12498445|FG007|Vaccination 1 to 3|Adverse Event|0
7951439|NCT02561195|12498446|FG008|Vaccination 1 to 3|Adverse Event|0
7951440|NCT02561195|12498447|FG009|Vaccination 1 to 3|Adverse Event|0
7951441|NCT02561195|12498448|FG010|Vaccination 1 to 3|Adverse Event|0
7951442|NCT02561195|12498449|FG011|Vaccination 1 to 3|Adverse Event|0
7951443|NCT02561195|12498450|FG012|Vaccination 1 to 3|Adverse Event|0
7951444|NCT02561195|12498451|FG013|Vaccination 1 to 3|Adverse Event|0
7951445|NCT02561195|12498438|FG000|Vaccination 1 to 3|Lost to Follow-up|3
7951446|NCT02561195|12498439|FG001|Vaccination 1 to 3|Lost to Follow-up|4
7951447|NCT02561195|12498440|FG002|Vaccination 1 to 3|Lost to Follow-up|0
7951448|NCT02561195|12498441|FG003|Vaccination 1 to 3|Lost to Follow-up|2
7951449|NCT02561195|12498442|FG004|Vaccination 1 to 3|Lost to Follow-up|3
7951450|NCT02561195|12498443|FG005|Vaccination 1 to 3|Lost to Follow-up|3
7951451|NCT02561195|12498444|FG006|Vaccination 1 to 3|Lost to Follow-up|0
7951452|NCT02561195|12498445|FG007|Vaccination 1 to 3|Lost to Follow-up|0
7951453|NCT02561195|12498446|FG008|Vaccination 1 to 3|Lost to Follow-up|0
7951454|NCT02561195|12498447|FG009|Vaccination 1 to 3|Lost to Follow-up|0
7951455|NCT02561195|12498448|FG010|Vaccination 1 to 3|Lost to Follow-up|0
7951456|NCT02561195|12498449|FG011|Vaccination 1 to 3|Lost to Follow-up|0
7951457|NCT02561195|12498450|FG012|Vaccination 1 to 3|Lost to Follow-up|0
7951458|NCT02561195|12498451|FG013|Vaccination 1 to 3|Lost to Follow-up|0
7951459|NCT02561195|12498438|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0
7951460|NCT02561195|12498439|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1
7951461|NCT02561195|12498440|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0
7951462|NCT02561195|12498441|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4
7951463|NCT02561195|12498442|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4
7951464|NCT02561195|12498443|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1
7951465|NCT02561195|12498444|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0
7951466|NCT02561195|12498445|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0
7951467|NCT02561195|12498446|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0
7951468|NCT02561195|12498447|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0
7951469|NCT02561195|12498448|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0
7951470|NCT02561195|12498449|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0
7951471|NCT02561195|12498450|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0
7951472|NCT02561195|12498451|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0
7951473|NCT02561195|12498438|FG000|Vaccination 1 to 3|No longer willing to participate|2
7951474|NCT02561195|12498439|FG001|Vaccination 1 to 3|No longer willing to participate|4
7951475|NCT02561195|12498440|FG002|Vaccination 1 to 3|No longer willing to participate|0
7951476|NCT02561195|12498441|FG003|Vaccination 1 to 3|No longer willing to participate|4
7951477|NCT02561195|12498442|FG004|Vaccination 1 to 3|No longer willing to participate|1
7951478|NCT02561195|12498443|FG005|Vaccination 1 to 3|No longer willing to participate|3
7951479|NCT02561195|12498444|FG006|Vaccination 1 to 3|No longer willing to participate|0
7951480|NCT02561195|12498445|FG007|Vaccination 1 to 3|No longer willing to participate|0
7951481|NCT02561195|12498446|FG008|Vaccination 1 to 3|No longer willing to participate|0
7951482|NCT02561195|12498447|FG009|Vaccination 1 to 3|No longer willing to participate|0
7951483|NCT02561195|12498448|FG010|Vaccination 1 to 3|No longer willing to participate|0
7951484|NCT02561195|12498449|FG011|Vaccination 1 to 3|No longer willing to participate|0
7951485|NCT02561195|12498450|FG012|Vaccination 1 to 3|No longer willing to participate|0
7951486|NCT02561195|12498451|FG013|Vaccination 1 to 3|No longer willing to participate|0
7951487|NCT02561195|12498438|FG000|Vaccination 1 to 3|Other|7
7951488|NCT02561195|12498439|FG001|Vaccination 1 to 3|Other|3
7951489|NCT02561195|12498440|FG002|Vaccination 1 to 3|Other|1
7951490|NCT02561195|12498441|FG003|Vaccination 1 to 3|Other|7
7951491|NCT02561195|12498442|FG004|Vaccination 1 to 3|Other|5
7951492|NCT02561195|12498443|FG005|Vaccination 1 to 3|Other|1
7951493|NCT02561195|12498444|FG006|Vaccination 1 to 3|Other|0
7951494|NCT02561195|12498445|FG007|Vaccination 1 to 3|Other|0
7951495|NCT02561195|12498446|FG008|Vaccination 1 to 3|Other|0
7951496|NCT02561195|12498447|FG009|Vaccination 1 to 3|Other|0
7951497|NCT02561195|12498448|FG010|Vaccination 1 to 3|Other|0
7951498|NCT02561195|12498449|FG011|Vaccination 1 to 3|Other|0
7951499|NCT02561195|12498450|FG012|Vaccination 1 to 3|Other|0
7951500|NCT02561195|12498451|FG013|Vaccination 1 to 3|Other|0
7951501|NCT02561195|12498438|FG000|Vaccination 1 to 3|Protocol Violation|1
7951502|NCT02561195|12498439|FG001|Vaccination 1 to 3|Protocol Violation|0
7951503|NCT02561195|12498440|FG002|Vaccination 1 to 3|Protocol Violation|1
7951504|NCT02561195|12498441|FG003|Vaccination 1 to 3|Protocol Violation|2
7951505|NCT02561195|12498442|FG004|Vaccination 1 to 3|Protocol Violation|5
7951506|NCT02561195|12498443|FG005|Vaccination 1 to 3|Protocol Violation|2
7951507|NCT02561195|12498444|FG006|Vaccination 1 to 3|Protocol Violation|0
7951508|NCT02561195|12498445|FG007|Vaccination 1 to 3|Protocol Violation|0
7951509|NCT02561195|12498446|FG008|Vaccination 1 to 3|Protocol Violation|0
7951510|NCT02561195|12498447|FG009|Vaccination 1 to 3|Protocol Violation|0
7951511|NCT02561195|12498448|FG010|Vaccination 1 to 3|Protocol Violation|0
7951512|NCT02561195|12498449|FG011|Vaccination 1 to 3|Protocol Violation|0
7951513|NCT02561195|12498450|FG012|Vaccination 1 to 3|Protocol Violation|0
7951514|NCT02561195|12498451|FG013|Vaccination 1 to 3|Protocol Violation|0
7951515|NCT02561195|12498438|FG000|Vaccination 1 to 3|Death|2
7951516|NCT02561195|12498439|FG001|Vaccination 1 to 3|Death|1
7951517|NCT02561195|12498440|FG002|Vaccination 1 to 3|Death|0
7951518|NCT02561195|12498441|FG003|Vaccination 1 to 3|Death|2
7951519|NCT02561195|12498442|FG004|Vaccination 1 to 3|Death|0
7951520|NCT02561195|12498443|FG005|Vaccination 1 to 3|Death|0
7951521|NCT02561195|12498444|FG006|Vaccination 1 to 3|Death|0
7951522|NCT02561195|12498445|FG007|Vaccination 1 to 3|Death|0
7951523|NCT02561195|12498446|FG008|Vaccination 1 to 3|Death|0
7951524|NCT02561195|12498447|FG009|Vaccination 1 to 3|Death|0
7951525|NCT02561195|12498448|FG010|Vaccination 1 to 3|Death|0
7951526|NCT02561195|12498449|FG011|Vaccination 1 to 3|Death|0
7951527|NCT02561195|12498450|FG012|Vaccination 1 to 3|Death|0
7951528|NCT02561195|12498451|FG013|Vaccination 1 to 3|Death|0
7951529|NCT02561195|12498438|FG000|Vaccination 1 to 3|Withdrawal by Subject|3
7951530|NCT02561195|12498439|FG001|Vaccination 1 to 3|Withdrawal by Subject|4
7951531|NCT02561195|12498440|FG002|Vaccination 1 to 3|Withdrawal by Subject|4
7951532|NCT02561195|12498441|FG003|Vaccination 1 to 3|Withdrawal by Subject|2
7951533|NCT02561195|12498442|FG004|Vaccination 1 to 3|Withdrawal by Subject|6
7951534|NCT02561195|12498443|FG005|Vaccination 1 to 3|Withdrawal by Subject|0
7951535|NCT02561195|12498444|FG006|Vaccination 1 to 3|Withdrawal by Subject|0
7951536|NCT02561195|12498445|FG007|Vaccination 1 to 3|Withdrawal by Subject|0
7951537|NCT02561195|12498446|FG008|Vaccination 1 to 3|Withdrawal by Subject|0
7951538|NCT02561195|12498447|FG009|Vaccination 1 to 3|Withdrawal by Subject|0
7951539|NCT02561195|12498448|FG010|Vaccination 1 to 3|Withdrawal by Subject|0
7951540|NCT02561195|12498449|FG011|Vaccination 1 to 3|Withdrawal by Subject|0
7951541|NCT02561195|12498450|FG012|Vaccination 1 to 3|Withdrawal by Subject|0
7951542|NCT02561195|12498451|FG013|Vaccination 1 to 3|Withdrawal by Subject|0
7951543|NCT02561195|12498438|FG000|Vaccination 1 to 3|Randomized but not treated|1
7951544|NCT02561195|12498439|FG001|Vaccination 1 to 3|Randomized but not treated|0
7951545|NCT02561195|12498440|FG002|Vaccination 1 to 3|Randomized but not treated|0
7951546|NCT02561195|12498441|FG003|Vaccination 1 to 3|Randomized but not treated|0
7951547|NCT02561195|12498442|FG004|Vaccination 1 to 3|Randomized but not treated|0
7951548|NCT02561195|12498443|FG005|Vaccination 1 to 3|Randomized but not treated|0
7951549|NCT02561195|12498444|FG006|Vaccination 1 to 3|Randomized but not treated|0
7951550|NCT02561195|12498445|FG007|Vaccination 1 to 3|Randomized but not treated|0
7951551|NCT02561195|12498446|FG008|Vaccination 1 to 3|Randomized but not treated|0
7951552|NCT02561195|12498447|FG009|Vaccination 1 to 3|Randomized but not treated|0
7951553|NCT02561195|12498448|FG010|Vaccination 1 to 3|Randomized but not treated|0
7951554|NCT02561195|12498449|FG011|Vaccination 1 to 3|Randomized but not treated|0
7951555|NCT02561195|12498450|FG012|Vaccination 1 to 3|Randomized but not treated|0
7951556|NCT02561195|12498451|FG013|Vaccination 1 to 3|Randomized but not treated|0
7951557|NCT02561195|12498438|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0
7951558|NCT02561195|12498439|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0
7951559|NCT02561195|12498440|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0
7951560|NCT02561195|12498441|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0
7951561|NCT02561195|12498442|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0
7951562|NCT02561195|12498443|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0
7951563|NCT02561195|12498444|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0
7951564|NCT02561195|12498445|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0
7951565|NCT02561195|12498446|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3
7951566|NCT02561195|12498447|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1
7951567|NCT02561195|12498448|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2
7951568|NCT02561195|12498449|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2
7951569|NCT02561195|12498450|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3
7951570|NCT02561195|12498451|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0
7951571|NCT02561195|12498438|FG000|Extension Stage (Vaccination 4)|Adverse Event|0
7951572|NCT02561195|12498439|FG001|Extension Stage (Vaccination 4)|Adverse Event|0
7951573|NCT02561195|12498440|FG002|Extension Stage (Vaccination 4)|Adverse Event|0
7951574|NCT02561195|12498441|FG003|Extension Stage (Vaccination 4)|Adverse Event|0
7951575|NCT02561195|12498442|FG004|Extension Stage (Vaccination 4)|Adverse Event|0
7951576|NCT02561195|12498443|FG005|Extension Stage (Vaccination 4)|Adverse Event|0
7951577|NCT02561195|12498444|FG006|Extension Stage (Vaccination 4)|Adverse Event|0
7951578|NCT02561195|12498445|FG007|Extension Stage (Vaccination 4)|Adverse Event|0
7951579|NCT02561195|12498446|FG008|Extension Stage (Vaccination 4)|Adverse Event|0
7951580|NCT02561195|12498447|FG009|Extension Stage (Vaccination 4)|Adverse Event|0
7951581|NCT02561195|12498448|FG010|Extension Stage (Vaccination 4)|Adverse Event|0
7951582|NCT02561195|12498449|FG011|Extension Stage (Vaccination 4)|Adverse Event|0
7951583|NCT02561195|12498450|FG012|Extension Stage (Vaccination 4)|Adverse Event|0
7951584|NCT02561195|12498451|FG013|Extension Stage (Vaccination 4)|Adverse Event|2
7951585|NCT02561195|12498438|FG000|Extension Stage (Vaccination 4)|Death|0
7951586|NCT02561195|12498439|FG001|Extension Stage (Vaccination 4)|Death|0
7951587|NCT02561195|12498440|FG002|Extension Stage (Vaccination 4)|Death|0
7951588|NCT02561195|12498441|FG003|Extension Stage (Vaccination 4)|Death|0
7951589|NCT02561195|12498442|FG004|Extension Stage (Vaccination 4)|Death|0
7951590|NCT02561195|12498443|FG005|Extension Stage (Vaccination 4)|Death|0
7951591|NCT02561195|12498444|FG006|Extension Stage (Vaccination 4)|Death|0
7951592|NCT02561195|12498445|FG007|Extension Stage (Vaccination 4)|Death|0
7951593|NCT02561195|12498446|FG008|Extension Stage (Vaccination 4)|Death|0
7951594|NCT02561195|12498447|FG009|Extension Stage (Vaccination 4)|Death|1
7951595|NCT02561195|12498448|FG010|Extension Stage (Vaccination 4)|Death|0
7951596|NCT02561195|12498449|FG011|Extension Stage (Vaccination 4)|Death|0
7951597|NCT02561195|12498450|FG012|Extension Stage (Vaccination 4)|Death|0
7951598|NCT02561195|12498451|FG013|Extension Stage (Vaccination 4)|Death|0
7951599|NCT02561195|12498438|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7951600|NCT02561195|12498439|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7951601|NCT02561195|12498440|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7951602|NCT02561195|12498441|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7951603|NCT02561195|12498442|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7951604|NCT02561195|12498443|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7951605|NCT02561195|12498444|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7951606|NCT02561195|12498445|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7951607|NCT02561195|12498446|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7951608|NCT02561195|12498447|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7951609|NCT02561195|12498448|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2
7951610|NCT02561195|12498449|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7951611|NCT02561195|12498450|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2
7951612|NCT02561195|12498451|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7951613|NCT02561195|12498438|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7951614|NCT02561195|12498439|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7951615|NCT02561195|12498440|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7951616|NCT02561195|12498441|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7951617|NCT02561195|12498442|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7951618|NCT02561195|12498443|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7951619|NCT02561195|12498444|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7951620|NCT02561195|12498445|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7951621|NCT02561195|12498446|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7951622|NCT02561195|12498447|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7951623|NCT02561195|12498448|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7951624|NCT02561195|12498449|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
7951625|NCT02561195|12498450|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
7951626|NCT02561195|12498451|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
7951627|NCT02561195|12498438|FG000|Extension Stage (Vaccination 4)|Other|0
7951628|NCT02561195|12498439|FG001|Extension Stage (Vaccination 4)|Other|0
7951629|NCT02561195|12498440|FG002|Extension Stage (Vaccination 4)|Other|0
7951630|NCT02561195|12498441|FG003|Extension Stage (Vaccination 4)|Other|0
7951631|NCT02561195|12498442|FG004|Extension Stage (Vaccination 4)|Other|0
7951632|NCT02561195|12498443|FG005|Extension Stage (Vaccination 4)|Other|0
7951633|NCT02561195|12498444|FG006|Extension Stage (Vaccination 4)|Other|0
7951634|NCT02561195|12498445|FG007|Extension Stage (Vaccination 4)|Other|0
7951635|NCT02561195|12498446|FG008|Extension Stage (Vaccination 4)|Other|0
7951636|NCT02561195|12498447|FG009|Extension Stage (Vaccination 4)|Other|0
7951637|NCT02561195|12498448|FG010|Extension Stage (Vaccination 4)|Other|2
7951638|NCT02561195|12498449|FG011|Extension Stage (Vaccination 4)|Other|2
7951639|NCT02561195|12498450|FG012|Extension Stage (Vaccination 4)|Other|1
7951640|NCT02561195|12498451|FG013|Extension Stage (Vaccination 4)|Other|0
7951641|NCT02561195|12498438|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0
7951642|NCT02561195|12498439|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0
7951643|NCT02561195|12498440|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0
7951644|NCT02561195|12498441|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0
7951645|NCT02561195|12498442|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0
7951646|NCT02561195|12498443|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0
7951647|NCT02561195|12498444|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1
7951648|NCT02561195|12498445|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0
7951649|NCT02561195|12498446|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0
7951650|NCT02561195|12498447|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0
7951651|NCT02561195|12498448|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2
7951652|NCT02561195|12498449|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1
7951653|NCT02561195|12498450|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0
7951654|NCT02561195|12498451|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1
7951655|NCT02561247|12498483|FG000|Overall Study|Protocol Violation|1
7951656|NCT02561247|12498483|FG000|Overall Study|Withdrawal by Subject|1
7951657|NCT02561247|12498483|FG000|Overall Study|Two filter changes required within the first 24 hours.|4
7951658|NCT02561273|12498489|FG000|Overall Study|Protocol Violation|1
7951659|NCT02561273|12498490|FG001|Overall Study|Protocol Violation|0
7951660|NCT02561455|12498525|FG000|Overall Study|Participant Transitioned to Commercial Drug|1
7951661|NCT02561455|12498526|FG001|Overall Study|Participant Transitioned to Commercial Drug|1
7951662|NCT02561455|12498527|FG002|Overall Study|Participant Transitioned to Commercial Drug|2
7951663|NCT02561455|12498528|FG003|Overall Study|Participant Transitioned to Commercial Drug|1
7951664|NCT02561455|12498525|FG000|Overall Study|Withdrawal by Subject|1
7951665|NCT02561455|12498526|FG001|Overall Study|Withdrawal by Subject|0
7951666|NCT02561455|12498527|FG002|Overall Study|Withdrawal by Subject|1
7951667|NCT02561455|12498528|FG003|Overall Study|Withdrawal by Subject|0
7951668|NCT02561455|12498525|FG000|Overall Study|Disease Progression|0
7951669|NCT02561455|12498526|FG001|Overall Study|Disease Progression|1
7951670|NCT02561455|12498527|FG002|Overall Study|Disease Progression|0
7951671|NCT02561455|12498528|FG003|Overall Study|Disease Progression|0
7951672|NCT02561572|12498552|FG000|Overall Study|Inadequate time before surgery|2
7951673|NCT02561572|12498553|FG001|Overall Study|Inadequate time before surgery|1
7951674|NCT02561572|12498552|FG000|Overall Study|Protocol Violation|0
7951675|NCT02561572|12498553|FG001|Overall Study|Protocol Violation|1
7951676|NCT02561806|12498581|FG000|Induction Period|Adverse Event|0
7951677|NCT02561806|12498582|FG001|Induction Period|Adverse Event|2
7951678|NCT02561806|12498581|FG000|Induction Period|Lack of Efficacy|1
7951679|NCT02561806|12498582|FG001|Induction Period|Lack of Efficacy|0
7951680|NCT02561806|12498581|FG000|Induction Period|Withdrawal by Subject|0
7951681|NCT02561806|12498582|FG001|Induction Period|Withdrawal by Subject|2
7951682|NCT02561806|12498581|FG000|Induction Period|Site staff became unblinded|1
7951683|NCT02561806|12498582|FG001|Induction Period|Site staff became unblinded|0
7951684|NCT02561806|12498581|FG000|Induction Period|Randomized but not treated|0
7951685|NCT02561806|12498582|FG001|Induction Period|Randomized but not treated|1
7951686|NCT02561806|12498581|FG000|Maintenance Period|Adverse Event|2
7951687|NCT02561806|12498582|FG001|Maintenance Period|Adverse Event|1
7951688|NCT02561806|12498581|FG000|Maintenance Period|Lack of Efficacy|3
7951689|NCT02561806|12498582|FG001|Maintenance Period|Lack of Efficacy|1
7951690|NCT02561806|12498581|FG000|Maintenance Period|Lost to Follow-up|2
7951691|NCT02561806|12498582|FG001|Maintenance Period|Lost to Follow-up|2
7951692|NCT02561806|12498581|FG000|Maintenance Period|Protocol Violation|1
7951693|NCT02561806|12498582|FG001|Maintenance Period|Protocol Violation|0
7951694|NCT02561806|12498581|FG000|Maintenance Period|Withdrawal by Subject|5
7951695|NCT02561806|12498582|FG001|Maintenance Period|Withdrawal by Subject|3
7951696|NCT02561806|12498581|FG000|Maintenance Period|Site staff became unblinded|0
7951697|NCT02561806|12498582|FG001|Maintenance Period|Site staff became unblinded|1
7951698|NCT02561806|12498581|FG000|Post-Treatment Follow-up|Lost to Follow-up|1
7951699|NCT02561806|12498582|FG001|Post-Treatment Follow-up|Lost to Follow-up|1
7951700|NCT02561806|12498581|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1
7951701|NCT02561806|12498582|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0
7951702|NCT02561832|12498605|FG000|Overall Study|Withdrawal by Subject|1
7951703|NCT02561832|12498606|FG001|Overall Study|Withdrawal by Subject|1
7951704|NCT02561832|12498605|FG000|Overall Study|Adverse Event|3
7951705|NCT02561832|12498606|FG001|Overall Study|Adverse Event|0
7951706|NCT02561832|12498605|FG000|Overall Study|Disease progression|3
7951707|NCT02561832|12498606|FG001|Overall Study|Disease progression|3
7951708|NCT02562482|12498635|FG000|Overall Study|Enrolled, but did not receive product|4
7951709|NCT02562482|12498636|FG001|Overall Study|Enrolled, but did not receive product|0
7951710|NCT02562482|12498635|FG000|Overall Study|Lost to Follow-up|9
7951711|NCT02562482|12498636|FG001|Overall Study|Lost to Follow-up|6
7951712|NCT02562482|12498635|FG000|Overall Study|Moved from area|2
7951713|NCT02562482|12498636|FG001|Overall Study|Moved from area|3
7951714|NCT02562482|12498635|FG000|Overall Study|Withdrawal by Subject|5
7951715|NCT02562482|12498636|FG001|Overall Study|Withdrawal by Subject|3
7951716|NCT02562482|12498635|FG000|Overall Study|Physician Decision|1
7951717|NCT02562482|12498636|FG001|Overall Study|Physician Decision|3
7951718|NCT02562482|12498635|FG000|Overall Study|Illness/Injury unrelated to product|0
7951719|NCT02562482|12498636|FG001|Overall Study|Illness/Injury unrelated to product|1
7951720|NCT02563067|12498701|FG000|Overall Study|Subject/guardian decision|14
7951721|NCT02563067|12498702|FG001|Overall Study|Subject/guardian decision|20
7951722|NCT02563067|12498703|FG002|Overall Study|Subject/guardian decision|16
7951723|NCT02563067|12498701|FG000|Overall Study|Physician Decision|0
7951724|NCT02563067|12498702|FG001|Overall Study|Physician Decision|1
7951725|NCT02563067|12498703|FG002|Overall Study|Physician Decision|3
7951726|NCT02563067|12498701|FG000|Overall Study|Lost to Follow-up|1
7951727|NCT02563067|12498702|FG001|Overall Study|Lost to Follow-up|2
7951728|NCT02563067|12498703|FG002|Overall Study|Lost to Follow-up|0
7951729|NCT02563067|12498701|FG000|Overall Study|Technical problems|0
7951730|NCT02563067|12498702|FG001|Overall Study|Technical problems|1
7951731|NCT02563067|12498703|FG002|Overall Study|Technical problems|0
7951732|NCT02563067|12498701|FG000|Overall Study|Lack of Efficacy|1
7951733|NCT02563067|12498702|FG001|Overall Study|Lack of Efficacy|0
7951734|NCT02563067|12498703|FG002|Overall Study|Lack of Efficacy|0
7951735|NCT02563067|12498701|FG000|Overall Study|Death|0
7951736|NCT02563067|12498702|FG001|Overall Study|Death|1
7951737|NCT02563067|12498703|FG002|Overall Study|Death|1
7951738|NCT02563067|12498701|FG000|Overall Study|Adverse Event|2
7951739|NCT02563067|12498702|FG001|Overall Study|Adverse Event|1
7951740|NCT02563067|12498703|FG002|Overall Study|Adverse Event|0
7951741|NCT02563067|12498701|FG000|Overall Study|Death post Treatment/safety period|1
7951742|NCT02563067|12498702|FG001|Overall Study|Death post Treatment/safety period|0
7951743|NCT02563067|12498703|FG002|Overall Study|Death post Treatment/safety period|0
7951744|NCT02563106|12498731|FG000|Overall Study|Withdrawal by Subject|7
7951745|NCT02563106|12498732|FG001|Overall Study|Withdrawal by Subject|8
7951746|NCT02563106|12498731|FG000|Overall Study|Adverse Event|17
7951747|NCT02563106|12498732|FG001|Overall Study|Adverse Event|15
7951748|NCT02563106|12498731|FG000|Overall Study|Protocol Violation|1
7951749|NCT02563106|12498732|FG001|Overall Study|Protocol Violation|0
7951750|NCT02563106|12498731|FG000|Overall Study|Use of non-permitted concurrent therapy|1
7951751|NCT02563106|12498732|FG001|Overall Study|Use of non-permitted concurrent therapy|2
7951752|NCT02563106|12498731|FG000|Overall Study|Lost to Follow-up|3
7951753|NCT02563106|12498732|FG001|Overall Study|Lost to Follow-up|2
7951754|NCT02563106|12498731|FG000|Overall Study|Physician Decision|3
7951755|NCT02563106|12498732|FG001|Overall Study|Physician Decision|1
7951756|NCT02563106|12498731|FG000|Overall Study|Other reason - not specified|2
7951757|NCT02563106|12498732|FG001|Overall Study|Other reason - not specified|1
7951758|NCT02563548|12498761|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2
7951759|NCT02563548|12498762|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7951760|NCT02563548|12498763|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7951761|NCT02563548|12498764|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1
7951762|NCT02563548|12498765|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7951763|NCT02563548|12498766|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7951764|NCT02563548|12498761|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1
7951765|NCT02563548|12498762|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
7951766|NCT02563548|12498763|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
7951767|NCT02563548|12498764|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
7951768|NCT02563548|12498765|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
7951769|NCT02563548|12498766|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
7951770|NCT02563548|12498761|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7951771|NCT02563548|12498762|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7951772|NCT02563548|12498763|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3
7951773|NCT02563548|12498764|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7951774|NCT02563548|12498765|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7951775|NCT02563548|12498766|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7951776|NCT02563548|12498761|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7951777|NCT02563548|12498762|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7951778|NCT02563548|12498763|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2
7951779|NCT02563548|12498764|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1
7951780|NCT02563548|12498765|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7951781|NCT02563548|12498766|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7951782|NCT02563548|12498761|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7951783|NCT02563548|12498762|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7951784|NCT02563548|12498763|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7951785|NCT02563548|12498764|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7951786|NCT02563548|12498765|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1
7951787|NCT02563548|12498766|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8
7951788|NCT02563548|12498761|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7951789|NCT02563548|12498762|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7951790|NCT02563548|12498763|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7951791|NCT02563548|12498764|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7951792|NCT02563548|12498765|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15
7951793|NCT02563548|12498766|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3
7951794|NCT02563548|12498761|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7951795|NCT02563548|12498762|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7951796|NCT02563548|12498763|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7951797|NCT02563548|12498764|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7951798|NCT02563548|12498765|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6
7951799|NCT02563548|12498766|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7951800|NCT02563548|12498761|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7951801|NCT02563548|12498762|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7951802|NCT02563548|12498763|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7951803|NCT02563548|12498764|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7951804|NCT02563548|12498765|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2
7951805|NCT02563548|12498766|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1
7951806|NCT02563548|12498761|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7951807|NCT02563548|12498762|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7951808|NCT02563548|12498763|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7951809|NCT02563548|12498764|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7951810|NCT02563548|12498765|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7951811|NCT02563548|12498766|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2
7951812|NCT02563548|12498761|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7951813|NCT02563548|12498762|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7951814|NCT02563548|12498763|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7951815|NCT02563548|12498764|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7951816|NCT02563548|12498765|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7951817|NCT02563548|12498766|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2
7951818|NCT02563548|12498761|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7951819|NCT02563548|12498762|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7951820|NCT02563548|12498763|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7951821|NCT02563548|12498764|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7951822|NCT02563548|12498765|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7951823|NCT02563548|12498766|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1
7951824|NCT02563548|12498761|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7951825|NCT02563548|12498762|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7951826|NCT02563548|12498763|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7951827|NCT02563548|12498764|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7951828|NCT02563548|12498765|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1
7951829|NCT02563548|12498766|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7951830|NCT02563561|12498789|FG000|Overall Study|Histology Other than Ta, G1-G2|3
7951831|NCT02563561|12498790|FG001|Overall Study|Histology Other than Ta, G1-G2|6
7951832|NCT02563561|12498791|FG002|Overall Study|Histology Other than Ta, G1-G2|6
7951833|NCT02563561|12498789|FG000|Overall Study|Withdrew of Consent|1
7951834|NCT02563561|12498790|FG001|Overall Study|Withdrew of Consent|1
7951835|NCT02563561|12498791|FG002|Overall Study|Withdrew of Consent|2
7951836|NCT02563561|12498789|FG000|Overall Study|Lost to Follow-up|1
7951837|NCT02563561|12498790|FG001|Overall Study|Lost to Follow-up|1
7951838|NCT02563561|12498791|FG002|Overall Study|Lost to Follow-up|0
7951839|NCT02563561|12498789|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4
7951840|NCT02563561|12498790|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2
7951841|NCT02563561|12498791|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1
7951842|NCT02563561|12498789|FG000|Overall Study|Investigator Decision|3
7951843|NCT02563561|12498790|FG001|Overall Study|Investigator Decision|4
7951844|NCT02563561|12498791|FG002|Overall Study|Investigator Decision|2
7951845|NCT02563561|12498789|FG000|Overall Study|Sponsor Decision|5
7951846|NCT02563561|12498790|FG001|Overall Study|Sponsor Decision|2
7951847|NCT02563561|12498791|FG002|Overall Study|Sponsor Decision|4
7951848|NCT02563561|12498789|FG000|Overall Study|Other|1
7951849|NCT02563561|12498790|FG001|Overall Study|Other|5
7951850|NCT02563561|12498791|FG002|Overall Study|Other|2
7951851|NCT02563899|12498827|FG000|Overall Study|Protocol Violation|1
7951852|NCT02563899|12498828|FG001|Overall Study|Protocol Violation|0
7951853|NCT02563899|12498829|FG002|Overall Study|Protocol Violation|0
7951854|NCT02563899|12498830|FG003|Overall Study|Protocol Violation|0
7951855|NCT02563899|12498827|FG000|Overall Study|Withdrawal by Subject|0
7951856|NCT02563899|12498828|FG001|Overall Study|Withdrawal by Subject|0
7951857|NCT02563899|12498829|FG002|Overall Study|Withdrawal by Subject|1
7951858|NCT02563899|12498830|FG003|Overall Study|Withdrawal by Subject|0
7951859|NCT02564042|12498878|FG000|Overall Study|Adverse Event|4
7951860|NCT02564042|12498879|FG001|Overall Study|Adverse Event|4
7951861|NCT02564042|12498880|FG002|Overall Study|Adverse Event|3
7951862|NCT02564042|12498881|FG003|Overall Study|Adverse Event|0
7951863|NCT02564042|12498882|FG004|Overall Study|Adverse Event|0
7951864|NCT02564042|12498883|FG005|Overall Study|Adverse Event|1
7951865|NCT02564042|12498878|FG000|Overall Study|Lost to Follow-up|1
7951866|NCT02564042|12498879|FG001|Overall Study|Lost to Follow-up|1
7951867|NCT02564042|12498880|FG002|Overall Study|Lost to Follow-up|1
7951868|NCT02564042|12498881|FG003|Overall Study|Lost to Follow-up|0
7951869|NCT02564042|12498882|FG004|Overall Study|Lost to Follow-up|1
7951870|NCT02564042|12498883|FG005|Overall Study|Lost to Follow-up|1
7951871|NCT02564042|12498878|FG000|Overall Study|Physician Decision|1
7951872|NCT02564042|12498879|FG001|Overall Study|Physician Decision|0
7951873|NCT02564042|12498880|FG002|Overall Study|Physician Decision|0
7951874|NCT02564042|12498881|FG003|Overall Study|Physician Decision|1
7951875|NCT02564042|12498882|FG004|Overall Study|Physician Decision|0
7951876|NCT02564042|12498883|FG005|Overall Study|Physician Decision|0
7951877|NCT02564042|12498878|FG000|Overall Study|Withdrawal by Subject|5
7951878|NCT02564042|12498879|FG001|Overall Study|Withdrawal by Subject|3
7951879|NCT02564042|12498880|FG002|Overall Study|Withdrawal by Subject|2
7951880|NCT02564042|12498881|FG003|Overall Study|Withdrawal by Subject|2
7951881|NCT02564042|12498882|FG004|Overall Study|Withdrawal by Subject|10
7951882|NCT02564042|12498883|FG005|Overall Study|Withdrawal by Subject|12
7951883|NCT02564055|12498903|FG000|Overall Study|Adverse Event|1
7951884|NCT02564055|12498904|FG001|Overall Study|Adverse Event|0
7951885|NCT02564055|12498905|FG002|Overall Study|Adverse Event|4
7951886|NCT02564055|12498906|FG003|Overall Study|Adverse Event|1
7951887|NCT02564055|12498907|FG004|Overall Study|Adverse Event|4
7951888|NCT02564055|12498908|FG005|Overall Study|Adverse Event|1
7951889|NCT02564055|12498903|FG000|Overall Study|Protocol Violation|1
7951890|NCT02564055|12498904|FG001|Overall Study|Protocol Violation|0
7951891|NCT02564055|12498905|FG002|Overall Study|Protocol Violation|0
7951892|NCT02564055|12498906|FG003|Overall Study|Protocol Violation|0
7951893|NCT02564055|12498907|FG004|Overall Study|Protocol Violation|0
7951894|NCT02564055|12498908|FG005|Overall Study|Protocol Violation|0
7951895|NCT02564055|12498903|FG000|Overall Study|Reached stopping criteria|0
7951896|NCT02564055|12498904|FG001|Overall Study|Reached stopping criteria|0
7951897|NCT02564055|12498905|FG002|Overall Study|Reached stopping criteria|0
7951898|NCT02564055|12498906|FG003|Overall Study|Reached stopping criteria|0
7951899|NCT02564055|12498907|FG004|Overall Study|Reached stopping criteria|0
7951900|NCT02564055|12498908|FG005|Overall Study|Reached stopping criteria|1
7951901|NCT02564055|12498903|FG000|Overall Study|Lost to Follow-up|0
7951902|NCT02564055|12498904|FG001|Overall Study|Lost to Follow-up|1
7951903|NCT02564055|12498905|FG002|Overall Study|Lost to Follow-up|4
7951904|NCT02564055|12498906|FG003|Overall Study|Lost to Follow-up|2
7951905|NCT02564055|12498907|FG004|Overall Study|Lost to Follow-up|1
7951906|NCT02564055|12498908|FG005|Overall Study|Lost to Follow-up|0
7951907|NCT02564055|12498903|FG000|Overall Study|Physician Decision|0
7951908|NCT02564055|12498904|FG001|Overall Study|Physician Decision|0
7951909|NCT02564055|12498905|FG002|Overall Study|Physician Decision|1
7951910|NCT02564055|12498906|FG003|Overall Study|Physician Decision|0
7951911|NCT02564055|12498907|FG004|Overall Study|Physician Decision|0
7951912|NCT02564055|12498908|FG005|Overall Study|Physician Decision|0
7951913|NCT02564055|12498903|FG000|Overall Study|Withdrawal by Subject|4
7951914|NCT02564055|12498904|FG001|Overall Study|Withdrawal by Subject|4
7951915|NCT02564055|12498905|FG002|Overall Study|Withdrawal by Subject|3
7951916|NCT02564055|12498906|FG003|Overall Study|Withdrawal by Subject|3
7951917|NCT02564055|12498907|FG004|Overall Study|Withdrawal by Subject|10
7951918|NCT02564055|12498908|FG005|Overall Study|Withdrawal by Subject|10
7951919|NCT02564120|12498927|FG000|Overall Study|Did not return release forms|160
7951920|NCT02564120|12498927|FG000|Overall Study|Death|58
7951921|NCT02564120|12498927|FG000|Overall Study|Withdrawal by Subject|204
7951922|NCT02564120|12498927|FG000|Overall Study|Other medical condition|24
7951923|NCT02564198|12498944|FG000|Overall Study|Withdrawal by Subject|2
7951924|NCT02564198|12498945|FG001|Overall Study|Withdrawal by Subject|4
7951925|NCT02564198|12498946|FG002|Overall Study|Withdrawal by Subject|0
7951926|NCT02564198|12498944|FG000|Overall Study|Adverse Event|0
7951927|NCT02564198|12498945|FG001|Overall Study|Adverse Event|1
7951928|NCT02564198|12498946|FG002|Overall Study|Adverse Event|0
7951929|NCT02564211|12498956|FG000|Overall Study|Adverse Event|4
7951930|NCT02564471|12498979|FG000|Overall Study|Adverse Event|1
7951931|NCT02564471|12498980|FG001|Overall Study|Adverse Event|0
7951932|NCT02564471|12498981|FG002|Overall Study|Adverse Event|0
7951933|NCT02564471|12498982|FG003|Overall Study|Adverse Event|0
7951934|NCT02564471|12498979|FG000|Overall Study|Withdrawal by Subject|2
7951935|NCT02564471|12498980|FG001|Overall Study|Withdrawal by Subject|1
7951936|NCT02564471|12498981|FG002|Overall Study|Withdrawal by Subject|3
7951937|NCT02564471|12498982|FG003|Overall Study|Withdrawal by Subject|0
7951938|NCT02564471|12498979|FG000|Overall Study|Lost to Follow-up|0
7951939|NCT02564471|12498980|FG001|Overall Study|Lost to Follow-up|2
7951940|NCT02564471|12498981|FG002|Overall Study|Lost to Follow-up|0
7951941|NCT02564471|12498982|FG003|Overall Study|Lost to Follow-up|0
7951942|NCT02564718|12499003|FG000|Overall Study|Withdrew from treatment|0
7951943|NCT02564718|12499004|FG001|Overall Study|Withdrew from treatment|1
7951944|NCT02564887|12499012|FG000|Overall Study|Lost to Follow-up|6
7951945|NCT02564887|12499013|FG001|Overall Study|Lost to Follow-up|0
7951946|NCT02565147|12499032|FG000|Overall Study|Withdrawal by Subject|5
7951947|NCT02565147|12499033|FG001|Overall Study|Withdrawal by Subject|1
7951948|NCT02565147|12499032|FG000|Overall Study|Lost to Follow-up|0
7951949|NCT02565147|12499033|FG001|Overall Study|Lost to Follow-up|1
7951950|NCT02565147|12499032|FG000|Overall Study|Death|1
7951951|NCT02565147|12499033|FG001|Overall Study|Death|1
7951952|NCT02565186|12499041|FG000|Overall Study|Adverse Event|113
7951953|NCT02565186|12499042|FG001|Overall Study|Adverse Event|148
7951954|NCT02565186|12499041|FG000|Overall Study|Lost to Follow-up|102
7951955|NCT02565186|12499042|FG001|Overall Study|Lost to Follow-up|93
7951956|NCT02565186|12499041|FG000|Overall Study|Non-Compliance|57
7951957|NCT02565186|12499042|FG001|Overall Study|Non-Compliance|55
7951958|NCT02565186|12499041|FG000|Overall Study|Withdrawal by Subject|229
7951959|NCT02565186|12499042|FG001|Overall Study|Withdrawal by Subject|214
7951960|NCT02565186|12499041|FG000|Overall Study|Physician Decision|18
7951961|NCT02565186|12499042|FG001|Overall Study|Physician Decision|16
7951962|NCT02565186|12499041|FG000|Overall Study|Sponsor Request|5
7951963|NCT02565186|12499042|FG001|Overall Study|Sponsor Request|9
7951964|NCT02565186|12499041|FG000|Overall Study|Missing|1
7951965|NCT02565186|12499042|FG001|Overall Study|Missing|0
7951966|NCT02565186|12499041|FG000|Overall Study|Did Not Receive Study Drug|55
7951967|NCT02565186|12499042|FG001|Overall Study|Did Not Receive Study Drug|86
7951968|NCT02565381|12499051|FG000|Overall Study|Lost to Follow-up|1
7951969|NCT02565381|12499052|FG001|Overall Study|Lost to Follow-up|0
7951970|NCT02565381|12499053|FG002|Overall Study|Lost to Follow-up|1
7951971|NCT02565511|12499074|FG000|Overall Study|Study terminated by Sponsor|35
7951972|NCT02565511|12499075|FG001|Overall Study|Study terminated by Sponsor|22
7951973|NCT02565511|12499076|FG002|Overall Study|Study terminated by Sponsor|235
7951974|NCT02565511|12499077|FG003|Overall Study|Study terminated by Sponsor|156
7951975|NCT02565511|12499074|FG000|Overall Study|Withdrawal by Subject|3
7951976|NCT02565511|12499075|FG001|Overall Study|Withdrawal by Subject|0
7951977|NCT02565511|12499076|FG002|Overall Study|Withdrawal by Subject|12
7951978|NCT02565511|12499077|FG003|Overall Study|Withdrawal by Subject|5
7951979|NCT02565511|12499074|FG000|Overall Study|Adverse Event|0
7951980|NCT02565511|12499075|FG001|Overall Study|Adverse Event|0
7951981|NCT02565511|12499076|FG002|Overall Study|Adverse Event|1
7951982|NCT02565511|12499077|FG003|Overall Study|Adverse Event|1
7951983|NCT02565511|12499074|FG000|Overall Study|Lost to Follow-up|4
7951984|NCT02565511|12499075|FG001|Overall Study|Lost to Follow-up|1
7951985|NCT02565511|12499076|FG002|Overall Study|Lost to Follow-up|0
7951986|NCT02565511|12499077|FG003|Overall Study|Lost to Follow-up|1
7951987|NCT02565511|12499074|FG000|Overall Study|Physician Decision|0
7951988|NCT02565511|12499075|FG001|Overall Study|Physician Decision|0
7951989|NCT02565511|12499076|FG002|Overall Study|Physician Decision|0
7951990|NCT02565511|12499077|FG003|Overall Study|Physician Decision|1
7951991|NCT02565511|12499074|FG000|Overall Study|Protocol deviation|0
7951992|NCT02565511|12499075|FG001|Overall Study|Protocol deviation|0
7951993|NCT02565511|12499076|FG002|Overall Study|Protocol deviation|3
7951994|NCT02565511|12499077|FG003|Overall Study|Protocol deviation|0
7951995|NCT02565576|12499089|FG000|Overall Study|abnormal lab value|2
7951996|NCT02565576|12499090|FG001|Overall Study|abnormal lab value|0
7951997|NCT02565576|12499089|FG000|Overall Study|subject / guardian decision|1
7951998|NCT02565576|12499090|FG001|Overall Study|subject / guardian decision|3
7951999|NCT02565576|12499089|FG000|Overall Study|Lost to Follow-up|1
7952000|NCT02565576|12499090|FG001|Overall Study|Lost to Follow-up|0
7952001|NCT02565576|12499089|FG000|Overall Study|Death|0
7952002|NCT02565576|12499090|FG001|Overall Study|Death|2
7952003|NCT02565576|12499089|FG000|Overall Study|Adverse Event|1
7952004|NCT02565576|12499090|FG001|Overall Study|Adverse Event|0
7952005|NCT02565615|12499101|FG000|Overall Study|Death|0
7952006|NCT02565615|12499102|FG001|Overall Study|Death|1
7952007|NCT02565615|12499103|FG002|Overall Study|Death|0
7952008|NCT02565615|12499104|FG003|Overall Study|Death|0
7952009|NCT02565615|12499105|FG004|Overall Study|Death|4
7952010|NCT02565615|12499101|FG000|Overall Study|Not willing to participate in study|2
7952011|NCT02565615|12499102|FG001|Overall Study|Not willing to participate in study|21
7952012|NCT02565615|12499103|FG002|Overall Study|Not willing to participate in study|0
7952013|NCT02565615|12499104|FG003|Overall Study|Not willing to participate in study|1
7952014|NCT02565615|12499105|FG004|Overall Study|Not willing to participate in study|169
7952015|NCT02565615|12499101|FG000|Overall Study|Lost to Follow-up|0
7952016|NCT02565615|12499102|FG001|Overall Study|Lost to Follow-up|4
7952017|NCT02565615|12499103|FG002|Overall Study|Lost to Follow-up|0
7952018|NCT02565615|12499104|FG003|Overall Study|Lost to Follow-up|1
7952019|NCT02565615|12499105|FG004|Overall Study|Lost to Follow-up|765
7952020|NCT02565615|12499101|FG000|Overall Study|Not meeting eligibility criteria|0
7952021|NCT02565615|12499102|FG001|Overall Study|Not meeting eligibility criteria|7
7952022|NCT02565615|12499103|FG002|Overall Study|Not meeting eligibility criteria|0
7952023|NCT02565615|12499104|FG003|Overall Study|Not meeting eligibility criteria|0
7952024|NCT02565615|12499105|FG004|Overall Study|Not meeting eligibility criteria|25
7952025|NCT02565615|12499101|FG000|Overall Study|Reason not defined|0
7952026|NCT02565615|12499102|FG001|Overall Study|Reason not defined|2
7952027|NCT02565615|12499103|FG002|Overall Study|Reason not defined|0
7952028|NCT02565615|12499104|FG003|Overall Study|Reason not defined|1
7952029|NCT02565615|12499105|FG004|Overall Study|Reason not defined|62
7952030|NCT02565615|12499101|FG000|Overall Study|Adverse Event|1
7952031|NCT02565615|12499102|FG001|Overall Study|Adverse Event|1
7952032|NCT02565615|12499103|FG002|Overall Study|Adverse Event|0
7952033|NCT02565615|12499104|FG003|Overall Study|Adverse Event|0
7952034|NCT02565615|12499105|FG004|Overall Study|Adverse Event|9
7952035|NCT02565615|12499101|FG000|Overall Study|Untreated|0
7952036|NCT02565615|12499102|FG001|Overall Study|Untreated|0
7952037|NCT02565615|12499103|FG002|Overall Study|Untreated|0
7952038|NCT02565615|12499104|FG003|Overall Study|Untreated|0
7952039|NCT02565615|12499105|FG004|Overall Study|Untreated|567
7952040|NCT02565706|12499130|FG000|Overall Study|Withdrawal by Subject|5
7952041|NCT02565706|12499131|FG001|Overall Study|Withdrawal by Subject|7
7952042|NCT02565706|12499132|FG002|Overall Study|Withdrawal by Subject|7
7952043|NCT02565706|12499133|FG003|Overall Study|Withdrawal by Subject|11
7952044|NCT02565706|12499130|FG000|Overall Study|Lost to Follow-up|72
7952045|NCT02565706|12499131|FG001|Overall Study|Lost to Follow-up|75
7952046|NCT02565706|12499132|FG002|Overall Study|Lost to Follow-up|82
7952047|NCT02565706|12499133|FG003|Overall Study|Lost to Follow-up|74
7952048|NCT02565810|12499148|FG000|Overall Study|Withdrawal by Subject|1
7952049|NCT02566005|12499173|FG000|Overall Study|vaginal bleeding|0
7952050|NCT02566005|12499174|FG001|Overall Study|vaginal bleeding|1
7952051|NCT02566005|12499173|FG000|Overall Study|received foley|8
7952052|NCT02566005|12499174|FG001|Overall Study|received foley|0
7952053|NCT02566005|12499173|FG000|Overall Study|did not receive foley|0
7952054|NCT02566005|12499174|FG001|Overall Study|did not receive foley|1
7952055|NCT02566005|12499173|FG000|Overall Study|labor after randomization|0
7952056|NCT02566005|12499174|FG001|Overall Study|labor after randomization|4
7952057|NCT02566031|12499182|FG000|Overall Study|Patient/guardian decision|14
7952058|NCT02566031|12499183|FG001|Overall Study|Patient/guardian decision|7
7952059|NCT02566031|12499182|FG000|Overall Study|Protocol deviation|2
7952060|NCT02566031|12499183|FG001|Overall Study|Protocol deviation|3
7952061|NCT02566031|12499182|FG000|Overall Study|Adverse Event|3
7952062|NCT02566031|12499183|FG001|Overall Study|Adverse Event|1
7952063|NCT02566031|12499182|FG000|Overall Study|Lost to Follow-up|1
7952064|NCT02566031|12499183|FG001|Overall Study|Lost to Follow-up|1
7952065|NCT02566109|12499217|FG000|Overall Study|Withdrawal by Subject|1
7952066|NCT02566525|12499268|FG000|Overall Study|Protocol Violation|3
7952067|NCT02566525|12499269|FG001|Overall Study|Protocol Violation|5
7952068|NCT02566577|12499279|FG000|Overall Study|Withdrawal by Subject|1
7952069|NCT02566577|12499280|FG001|Overall Study|Withdrawal by Subject|1
7952070|NCT02566577|12499279|FG000|Overall Study|Equipment failure|1
7952071|NCT02566577|12499280|FG001|Overall Study|Equipment failure|1
7952072|NCT02566577|12499279|FG000|Overall Study|Physical limitation|1
7952073|NCT02566577|12499280|FG001|Overall Study|Physical limitation|0
7965977|NCT02742766|12521565|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965978|NCT02742766|12521566|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965979|NCT02742766|12521567|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965980|NCT02742766|12521568|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965981|NCT02742766|12521569|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965982|NCT02742766|12521570|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965983|NCT02742766|12521571|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965984|NCT02742766|12521572|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1
7965985|NCT02742766|12521573|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965986|NCT02742766|12521574|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965987|NCT02742766|12521575|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965988|NCT02742766|12521576|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965989|NCT02742766|12521577|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7965990|NCT02742766|12521559|FG000|Part 2 (Up to 22 Days)|Physician Decision|0
7965991|NCT02742766|12521560|FG001|Part 2 (Up to 22 Days)|Physician Decision|0
7965992|NCT02742766|12521561|FG002|Part 2 (Up to 22 Days)|Physician Decision|0
7965993|NCT02742766|12521562|FG003|Part 2 (Up to 22 Days)|Physician Decision|0
7965994|NCT02742766|12521563|FG004|Part 2 (Up to 22 Days)|Physician Decision|0
7965995|NCT02742766|12521564|FG005|Part 2 (Up to 22 Days)|Physician Decision|0
7965996|NCT02742766|12521565|FG006|Part 2 (Up to 22 Days)|Physician Decision|0
7965997|NCT02742766|12521566|FG007|Part 2 (Up to 22 Days)|Physician Decision|0
7965998|NCT02742766|12521567|FG008|Part 2 (Up to 22 Days)|Physician Decision|0
7965999|NCT02742766|12521568|FG009|Part 2 (Up to 22 Days)|Physician Decision|0
7966000|NCT02742766|12521569|FG010|Part 2 (Up to 22 Days)|Physician Decision|0
7966001|NCT02742766|12521570|FG011|Part 2 (Up to 22 Days)|Physician Decision|0
7966002|NCT02742766|12521571|FG012|Part 2 (Up to 22 Days)|Physician Decision|2
7966003|NCT02742766|12521572|FG013|Part 2 (Up to 22 Days)|Physician Decision|5
7966004|NCT02742766|12521573|FG014|Part 2 (Up to 22 Days)|Physician Decision|0
7966005|NCT02742766|12521574|FG015|Part 2 (Up to 22 Days)|Physician Decision|1
7966006|NCT02742766|12521575|FG016|Part 2 (Up to 22 Days)|Physician Decision|0
7966007|NCT02742766|12521576|FG017|Part 2 (Up to 22 Days)|Physician Decision|0
7966008|NCT02742766|12521577|FG018|Part 2 (Up to 22 Days)|Physician Decision|0
7966009|NCT02742818|12521639|FG000|Overall Study|Adverse Event|0
7966010|NCT02742818|12521640|FG001|Overall Study|Adverse Event|1
7966011|NCT02742818|12521639|FG000|Overall Study|Protocol Violation|0
7966012|NCT02742818|12521640|FG001|Overall Study|Protocol Violation|1
7966013|NCT02743117|12521663|FG000|Overall Study|Lost to Follow-up|0
7966014|NCT02743117|12521664|FG001|Overall Study|Lost to Follow-up|1
7966015|NCT02743117|12521663|FG000|Overall Study|Other|1
7966016|NCT02743117|12521664|FG001|Overall Study|Other|0
7966017|NCT02743221|12521672|FG000|Overall Study|Progressive disease|29
7966018|NCT02743221|12521673|FG001|Overall Study|Progressive disease|38
7966019|NCT02743221|12521672|FG000|Overall Study|Adverse Event|17
7966020|NCT02743221|12521673|FG001|Overall Study|Adverse Event|14
7952074|NCT02566759|12499314|FG000|All Parts|Withdrawal by Subject|0
7952075|NCT02566759|12499315|FG001|All Parts|Withdrawal by Subject|1
7952076|NCT02566759|12499316|FG002|All Parts|Withdrawal by Subject|0
7952077|NCT02566759|12499317|FG003|All Parts|Withdrawal by Subject|0
7952078|NCT02566759|12499318|FG004|All Parts|Withdrawal by Subject|0
7952079|NCT02566759|12499319|FG005|All Parts|Withdrawal by Subject|0
7952080|NCT02566759|12499320|FG006|All Parts|Withdrawal by Subject|0
7952081|NCT02566759|12499321|FG007|All Parts|Withdrawal by Subject|0
7952082|NCT02566759|12499322|FG008|All Parts|Withdrawal by Subject|0
7952083|NCT02566759|12499323|FG009|All Parts|Withdrawal by Subject|0
7952084|NCT02566759|12499324|FG010|All Parts|Withdrawal by Subject|0
7952085|NCT02566759|12499325|FG011|All Parts|Withdrawal by Subject|0
7952086|NCT02566759|12499326|FG012|All Parts|Withdrawal by Subject|0
7952087|NCT02566759|12499327|FG013|All Parts|Withdrawal by Subject|0
7952088|NCT02566759|12499328|FG014|All Parts|Withdrawal by Subject|0
7952089|NCT02566759|12499329|FG015|All Parts|Withdrawal by Subject|0
7952090|NCT02566759|12499330|FG016|All Parts|Withdrawal by Subject|0
7952091|NCT02566759|12499314|FG000|All Parts|Adverse Event|0
7952092|NCT02566759|12499315|FG001|All Parts|Adverse Event|0
7952093|NCT02566759|12499316|FG002|All Parts|Adverse Event|0
7952094|NCT02566759|12499317|FG003|All Parts|Adverse Event|0
7952095|NCT02566759|12499318|FG004|All Parts|Adverse Event|0
7952096|NCT02566759|12499319|FG005|All Parts|Adverse Event|0
7952097|NCT02566759|12499320|FG006|All Parts|Adverse Event|0
7952098|NCT02566759|12499321|FG007|All Parts|Adverse Event|0
7952099|NCT02566759|12499322|FG008|All Parts|Adverse Event|0
7952100|NCT02566759|12499323|FG009|All Parts|Adverse Event|0
7952101|NCT02566759|12499324|FG010|All Parts|Adverse Event|0
7952102|NCT02566759|12499325|FG011|All Parts|Adverse Event|0
7952103|NCT02566759|12499326|FG012|All Parts|Adverse Event|1
7952104|NCT02566759|12499327|FG013|All Parts|Adverse Event|3
7952105|NCT02566759|12499328|FG014|All Parts|Adverse Event|0
7952106|NCT02566759|12499329|FG015|All Parts|Adverse Event|0
7952107|NCT02566759|12499330|FG016|All Parts|Adverse Event|0
7952108|NCT02566759|12499314|FG000|All Parts|Other|0
7952109|NCT02566759|12499315|FG001|All Parts|Other|0
7952110|NCT02566759|12499316|FG002|All Parts|Other|0
7952111|NCT02566759|12499317|FG003|All Parts|Other|0
7952112|NCT02566759|12499318|FG004|All Parts|Other|0
7952113|NCT02566759|12499319|FG005|All Parts|Other|0
7952114|NCT02566759|12499320|FG006|All Parts|Other|0
7952115|NCT02566759|12499321|FG007|All Parts|Other|0
7952116|NCT02566759|12499322|FG008|All Parts|Other|0
7952117|NCT02566759|12499323|FG009|All Parts|Other|0
7952118|NCT02566759|12499324|FG010|All Parts|Other|0
7952119|NCT02566759|12499325|FG011|All Parts|Other|0
7952120|NCT02566759|12499326|FG012|All Parts|Other|0
7952121|NCT02566759|12499327|FG013|All Parts|Other|2
7952122|NCT02566759|12499328|FG014|All Parts|Other|0
7952123|NCT02566759|12499329|FG015|All Parts|Other|0
7952124|NCT02566759|12499330|FG016|All Parts|Other|0
7952125|NCT02566759|12499314|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952126|NCT02566759|12499315|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952127|NCT02566759|12499316|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952128|NCT02566759|12499317|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952129|NCT02566759|12499318|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952130|NCT02566759|12499319|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952131|NCT02566759|12499320|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952132|NCT02566759|12499321|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952133|NCT02566759|12499322|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952134|NCT02566759|12499323|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952135|NCT02566759|12499324|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952136|NCT02566759|12499325|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952137|NCT02566759|12499326|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952138|NCT02566759|12499327|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952139|NCT02566759|12499328|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952140|NCT02566759|12499329|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7952141|NCT02566759|12499330|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
7952142|NCT02566785|12499391|FG000|Overall Study|Lost to Follow-up|0
7952143|NCT02566785|12499392|FG001|Overall Study|Lost to Follow-up|2
7952144|NCT02566785|12499391|FG000|Overall Study|Worsening condition|1
7952145|NCT02566785|12499392|FG001|Overall Study|Worsening condition|1
7952146|NCT02566889|12499400|FG000|Overall Study|Withdrawal by Subject|3
7952147|NCT02566889|12499401|FG001|Overall Study|Withdrawal by Subject|1
7952148|NCT02566889|12499400|FG000|Overall Study|Adverse Event|4
7952149|NCT02566889|12499401|FG001|Overall Study|Adverse Event|2
7952150|NCT02566889|12499400|FG000|Overall Study|Other|6
7952151|NCT02566889|12499401|FG001|Overall Study|Other|2
7952152|NCT02566902|12499408|FG000|Overall Study|Protocol Violation|2
7952153|NCT02566902|12499409|FG001|Overall Study|Protocol Violation|1
7952154|NCT02566993|12499417|FG000|Overall Study|Randomized but not treated|5
7952155|NCT02566993|12499418|FG001|Overall Study|Randomized but not treated|16
7952156|NCT02566993|12499417|FG000|Overall Study|Progressive disease|213
7952157|NCT02566993|12499418|FG001|Overall Study|Progressive disease|152
7952158|NCT02566993|12499417|FG000|Overall Study|Withdrawal by Subject|12
7952159|NCT02566993|12499418|FG001|Overall Study|Withdrawal by Subject|28
7952160|NCT02566993|12499417|FG000|Overall Study|Death|17
7952161|NCT02566993|12499418|FG001|Overall Study|Death|23
7952162|NCT02566993|12499417|FG000|Overall Study|Physician Decision|10
7952163|NCT02566993|12499418|FG001|Overall Study|Physician Decision|17
7952164|NCT02566993|12499417|FG000|Overall Study|Study drug-related adverse event|20
7952165|NCT02566993|12499418|FG001|Overall Study|Study drug-related adverse event|41
7952166|NCT02566993|12499417|FG000|Overall Study|Non study drug-related adverse event|9
7952167|NCT02566993|12499418|FG001|Overall Study|Non study drug-related adverse event|9
7952168|NCT02566993|12499417|FG000|Overall Study|Symptomatic deterioration|9
7952169|NCT02566993|12499418|FG001|Overall Study|Symptomatic deterioration|16
7952170|NCT02566993|12499417|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9
7952171|NCT02566993|12499418|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1
7952172|NCT02566993|12499417|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1
7952173|NCT02566993|12499418|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1
7952174|NCT02566993|12499417|FG000|Overall Study|Screening failure|2
7952175|NCT02566993|12499418|FG001|Overall Study|Screening failure|0
7952176|NCT02566993|12499417|FG000|Overall Study|Lost to Follow-up|0
7952177|NCT02566993|12499418|FG001|Overall Study|Lost to Follow-up|1
7952178|NCT02566993|12499417|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0
7952179|NCT02566993|12499418|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1
7952180|NCT02567188|12499426|FG000|Overall Study|Death|10
7952181|NCT02567188|12499426|FG000|Overall Study|Terminated Mircera Treatment|9
7952182|NCT02567188|12499426|FG000|Overall Study|Lost to Follow-up|5
7952183|NCT02567188|12499426|FG000|Overall Study|Adverse Event|1
7952184|NCT02567188|12499426|FG000|Overall Study|Withdrawal by Subject|1
7952185|NCT02567188|12499426|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1
7952186|NCT02567188|12499426|FG000|Overall Study|Moved and Changed Clinic|1
7952187|NCT02567188|12499426|FG000|Overall Study|Started Hemodialysis|2
7952188|NCT02567188|12499426|FG000|Overall Study|Protocol Violation|5
7952189|NCT02567227|12499433|FG000|9 Weeks|Adverse Event|5
7952190|NCT02567227|12499434|FG001|9 Weeks|Adverse Event|5
7952191|NCT02567227|12499433|FG000|9 Weeks|Withdrawal by Subject|18
7952192|NCT02567227|12499434|FG001|9 Weeks|Withdrawal by Subject|8
7952193|NCT02567227|12499433|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11
7952194|NCT02567227|12499434|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11
7952195|NCT02567227|12499433|FG000|6 Month|Death|2
7952196|NCT02567227|12499434|FG001|6 Month|Death|0
7952197|NCT02567227|12499433|FG000|6 Month|Lost to Follow-up|43
7952198|NCT02567227|12499434|FG001|6 Month|Lost to Follow-up|40
7952199|NCT02567227|12499433|FG000|12 Months|Lost to Follow-up|31
7952200|NCT02567227|12499434|FG001|12 Months|Lost to Follow-up|32
7952201|NCT02567227|12499433|FG000|12 Months|Death|0
7952202|NCT02567227|12499434|FG001|12 Months|Death|2
7952203|NCT02567266|12499443|FG000|Overall Study|Withdrawal by Subject|10
7952204|NCT02567266|12499444|FG001|Overall Study|Withdrawal by Subject|7
7952205|NCT02567266|12499445|FG002|Overall Study|Withdrawal by Subject|6
7952206|NCT02567266|12499443|FG000|Overall Study|Lost to Follow-up|13
7952207|NCT02567266|12499444|FG001|Overall Study|Lost to Follow-up|8
7952208|NCT02567266|12499445|FG002|Overall Study|Lost to Follow-up|10
7952209|NCT02567552|12499455|FG000|Overall Study|Adverse Event|0
7952210|NCT02567552|12499456|FG001|Overall Study|Adverse Event|1
7952211|NCT02567656|12499468|FG000|Overall Study|Premature discontinuation due to PD|1
7952212|NCT02567656|12499469|FG001|Overall Study|Premature discontinuation due to PD|1
7952213|NCT02567656|12499470|FG002|Overall Study|Premature discontinuation due to PD|2
7952214|NCT02567656|12499471|FG003|Overall Study|Premature discontinuation due to PD|0
7952215|NCT02567656|12499472|FG004|Overall Study|Premature discontinuation due to PD|0
7952216|NCT02567656|12499473|FG005|Overall Study|Premature discontinuation due to PD|0
7952217|NCT02567708|12499487|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
7952218|NCT02567708|12499488|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
7952219|NCT02567708|12499487|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
7952220|NCT02567708|12499488|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
7952221|NCT02567708|12499487|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
7952222|NCT02567708|12499488|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
7952223|NCT02567708|12499487|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
7952224|NCT02567708|12499488|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
7952225|NCT02568046|12499504|FG000|Overall Study|Adverse Event|0
7952226|NCT02568046|12499505|FG001|Overall Study|Adverse Event|1
7952227|NCT02568046|12499504|FG000|Overall Study|Death|2
7952228|NCT02568046|12499505|FG001|Overall Study|Death|0
7952229|NCT02568046|12499504|FG000|Overall Study|Progressive Disease|1
7952230|NCT02568046|12499505|FG001|Overall Study|Progressive Disease|0
7952231|NCT02568046|12499504|FG000|Overall Study|Withdrawal by Subject|2
7952232|NCT02568046|12499505|FG001|Overall Study|Withdrawal by Subject|1
7952233|NCT02568046|12499504|FG000|Overall Study|Other Events|0
7952234|NCT02568046|12499505|FG001|Overall Study|Other Events|1
7952235|NCT02568072|12499511|FG000|Overall Study|Unavailable for appointment|23
7952236|NCT02568072|12499511|FG000|Overall Study|Unable to contact|3
7952237|NCT02568072|12499511|FG000|Overall Study|Diagnosis of Long QT Syndrome|1
7952238|NCT02568072|12499511|FG000|Overall Study|Withdrawal by Subject|1
7952239|NCT02568072|12499511|FG000|Overall Study|Sustained injury, marathon not run|24
7952240|NCT02568254|12499516|FG000|Period 2|Adverse Event|0
7952241|NCT02568254|12499517|FG001|Period 2|Adverse Event|0
7952242|NCT02568254|12499518|FG002|Period 2|Adverse Event|1
7952243|NCT02568254|12499519|FG003|Period 2|Adverse Event|0
7952244|NCT02568254|12499520|FG004|Period 2|Adverse Event|0
7952245|NCT02568254|12499521|FG005|Period 2|Adverse Event|0
7952246|NCT02568254|12499516|FG000|Period 3|Unstatisfactory Lens fitting|0
7952247|NCT02568254|12499517|FG001|Period 3|Unstatisfactory Lens fitting|0
7952248|NCT02568254|12499518|FG002|Period 3|Unstatisfactory Lens fitting|0
7952249|NCT02568254|12499519|FG003|Period 3|Unstatisfactory Lens fitting|0
7952250|NCT02568254|12499520|FG004|Period 3|Unstatisfactory Lens fitting|1
7952251|NCT02568254|12499521|FG005|Period 3|Unstatisfactory Lens fitting|0
7952252|NCT02568384|12499533|FG000|Overall Study|Mobile devices incompatible with App|2
7952253|NCT02568397|12499537|FG000|Period 2|Withdrawal by Subject|0
7952254|NCT02568397|12499538|FG001|Period 2|Withdrawal by Subject|1
7952255|NCT02568397|12499537|FG000|Period 2|Physician Decision|0
7952256|NCT02568397|12499538|FG001|Period 2|Physician Decision|1
7952257|NCT02568475|12499555|FG000|Overall Study|Lost to Follow-up|40
7952258|NCT02568475|12499556|FG001|Overall Study|Lost to Follow-up|39
7952259|NCT02568475|12499555|FG000|Overall Study|Withdrawal by Subject|2
7952260|NCT02568475|12499556|FG001|Overall Study|Withdrawal by Subject|0
7952261|NCT02568475|12499555|FG000|Overall Study|Discharged home|4
7952262|NCT02568475|12499556|FG001|Overall Study|Discharged home|4
7952263|NCT02568475|12499555|FG000|Overall Study|Short-term: Discharge location unknown|4
7952264|NCT02568475|12499556|FG001|Overall Study|Short-term: Discharge location unknown|0
7952265|NCT02568475|12499555|FG000|Overall Study|Transferred to another facility|1
7952266|NCT02568475|12499556|FG001|Overall Study|Transferred to another facility|0
7952267|NCT02568683|12499575|FG000|Overall Study|Death|0
7952268|NCT02568683|12499576|FG001|Overall Study|Death|2
7952269|NCT02568683|12499575|FG000|Overall Study|Withdrew Consent|1
7952270|NCT02568683|12499576|FG001|Overall Study|Withdrew Consent|0
7952271|NCT02568683|12499575|FG000|Overall Study|Study Terminated By Sponsor|5
7952272|NCT02568683|12499576|FG001|Overall Study|Study Terminated By Sponsor|2
7952273|NCT02569398|12499604|FG000|Overall Study|Adverse Event|0
7952274|NCT02569398|12499605|FG001|Overall Study|Adverse Event|1
7952275|NCT02569398|12499606|FG002|Overall Study|Adverse Event|6
7952276|NCT02569398|12499604|FG000|Overall Study|Withdrawal by Subject|43
7952277|NCT02569398|12499605|FG001|Overall Study|Withdrawal by Subject|43
7952278|NCT02569398|12499606|FG002|Overall Study|Withdrawal by Subject|30
7952279|NCT02569398|12499604|FG000|Overall Study|Study terminated by sponsor|130
7952280|NCT02569398|12499605|FG001|Overall Study|Study terminated by sponsor|131
7952281|NCT02569398|12499606|FG002|Overall Study|Study terminated by sponsor|134
7952282|NCT02569398|12499604|FG000|Overall Study|Other|12
7952283|NCT02569398|12499605|FG001|Overall Study|Other|14
7952284|NCT02569398|12499606|FG002|Overall Study|Other|13
7952285|NCT02569437|12499625|FG000|Overall Study|Lost to Follow-up|12
7952286|NCT02569437|12499626|FG001|Overall Study|Lost to Follow-up|14
7952287|NCT02569710|12499659|FG000|Overall Study|Adverse Event|1
7952288|NCT02569710|12499660|FG001|Overall Study|Adverse Event|0
7952289|NCT02569710|12499661|FG002|Overall Study|Adverse Event|0
7952290|NCT02569710|12499662|FG003|Overall Study|Adverse Event|0
7952291|NCT02569710|12499663|FG004|Overall Study|Adverse Event|0
7952292|NCT02569710|12499664|FG005|Overall Study|Adverse Event|0
7952293|NCT02569710|12499665|FG006|Overall Study|Adverse Event|0
7952294|NCT02569710|12499666|FG007|Overall Study|Adverse Event|0
7952295|NCT02569710|12499667|FG008|Overall Study|Adverse Event|0
7952296|NCT02569710|12499668|FG009|Overall Study|Adverse Event|0
7952297|NCT02569710|12499659|FG000|Overall Study|Lost to Follow-up|0
7952298|NCT02569710|12499660|FG001|Overall Study|Lost to Follow-up|0
7952299|NCT02569710|12499661|FG002|Overall Study|Lost to Follow-up|0
7952300|NCT02569710|12499662|FG003|Overall Study|Lost to Follow-up|0
7952301|NCT02569710|12499663|FG004|Overall Study|Lost to Follow-up|0
7952302|NCT02569710|12499664|FG005|Overall Study|Lost to Follow-up|0
7952303|NCT02569710|12499665|FG006|Overall Study|Lost to Follow-up|1
7952304|NCT02569710|12499666|FG007|Overall Study|Lost to Follow-up|0
7952305|NCT02569710|12499667|FG008|Overall Study|Lost to Follow-up|1
7952306|NCT02569710|12499668|FG009|Overall Study|Lost to Follow-up|0
7952307|NCT02569710|12499659|FG000|Overall Study|Virologic failure|0
7952308|NCT02569710|12499660|FG001|Overall Study|Virologic failure|0
7952309|NCT02569710|12499661|FG002|Overall Study|Virologic failure|0
7952310|NCT02569710|12499662|FG003|Overall Study|Virologic failure|0
7952311|NCT02569710|12499663|FG004|Overall Study|Virologic failure|1
7952312|NCT02569710|12499664|FG005|Overall Study|Virologic failure|0
7952313|NCT02569710|12499665|FG006|Overall Study|Virologic failure|1
7952314|NCT02569710|12499666|FG007|Overall Study|Virologic failure|0
7952315|NCT02569710|12499667|FG008|Overall Study|Virologic failure|0
7952316|NCT02569710|12499668|FG009|Overall Study|Virologic failure|0
7952317|NCT02569710|12499659|FG000|Overall Study|Withdrawal by Subject|0
7952318|NCT02569710|12499660|FG001|Overall Study|Withdrawal by Subject|0
7952319|NCT02569710|12499661|FG002|Overall Study|Withdrawal by Subject|0
7952320|NCT02569710|12499662|FG003|Overall Study|Withdrawal by Subject|0
7952321|NCT02569710|12499663|FG004|Overall Study|Withdrawal by Subject|0
7952322|NCT02569710|12499664|FG005|Overall Study|Withdrawal by Subject|1
7952323|NCT02569710|12499665|FG006|Overall Study|Withdrawal by Subject|0
7952324|NCT02569710|12499666|FG007|Overall Study|Withdrawal by Subject|0
7952325|NCT02569710|12499667|FG008|Overall Study|Withdrawal by Subject|0
7952326|NCT02569710|12499668|FG009|Overall Study|Withdrawal by Subject|0
7952327|NCT02569801|12499707|FG000|Overall Study|Withdrawal by Subject|9
7952328|NCT02569801|12499708|FG001|Overall Study|Withdrawal by Subject|9
7952329|NCT02569801|12499707|FG000|Overall Study|Sponsor Decision|13
7952330|NCT02569801|12499708|FG001|Overall Study|Sponsor Decision|14
7952331|NCT02569801|12499707|FG000|Overall Study|Progressive Disease|2
7952332|NCT02569801|12499708|FG001|Overall Study|Progressive Disease|7
7952333|NCT02569801|12499707|FG000|Overall Study|Lost to Follow-up|0
7952334|NCT02569801|12499708|FG001|Overall Study|Lost to Follow-up|1
7952335|NCT02569801|12499707|FG000|Overall Study|Death|12
7952336|NCT02569801|12499708|FG001|Overall Study|Death|4
7952337|NCT02569853|12499716|FG000|Overall Study|Adverse Event|2
7952338|NCT02569853|12499717|FG001|Overall Study|Adverse Event|0
7952339|NCT02569853|12499716|FG000|Overall Study|Withdrawal by Subject|3
7952340|NCT02569853|12499717|FG001|Overall Study|Withdrawal by Subject|2
7952341|NCT02569853|12499716|FG000|Overall Study|Lost to Follow-up|3
7952342|NCT02569853|12499717|FG001|Overall Study|Lost to Follow-up|3
7952343|NCT02569853|12499716|FG000|Overall Study|Protocol Violation|1
7952344|NCT02569853|12499717|FG001|Overall Study|Protocol Violation|1
7952345|NCT02569853|12499716|FG000|Overall Study|Did not experience migraine attack|10
7952346|NCT02569853|12499717|FG001|Overall Study|Did not experience migraine attack|7
7952347|NCT02569853|12499716|FG000|Overall Study|Physician Decision|1
7952348|NCT02569853|12499717|FG001|Overall Study|Physician Decision|1
7952349|NCT02569996|12499732|FG000|Overall Study|Adverse Event|6
7952350|NCT02569996|12499732|FG000|Overall Study|Physician Decision|3
7952351|NCT02569996|12499732|FG000|Overall Study|Progression of the disease|18
7952352|NCT02569996|12499732|FG000|Overall Study|New anti-lymphoma treatment|1
7952353|NCT02569996|12499732|FG000|Overall Study|Non-compliance|9
7952354|NCT02569996|12499732|FG000|Overall Study|Withdrawal by Subject|5
7952355|NCT02569996|12499732|FG000|Overall Study|Lost to Follow-up|5
7952356|NCT02569996|12499732|FG000|Overall Study|Complete remission|7
7952357|NCT02569996|12499732|FG000|Overall Study|Unknown reason|1
7952358|NCT02570074|12499747|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1
7952359|NCT02570074|12499748|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0
7952360|NCT02570126|12499768|FG000|Overall Study|Lost to Follow-up|2
7952361|NCT02570126|12499769|FG001|Overall Study|Lost to Follow-up|0
7952362|NCT02570126|12499768|FG000|Overall Study|Unable To Arrange Visit 3|1
7952363|NCT02570126|12499769|FG001|Overall Study|Unable To Arrange Visit 3|0
7952364|NCT02570126|12499768|FG000|Overall Study|Violation Of Procedures GSK|0
7952365|NCT02570126|12499769|FG001|Overall Study|Violation Of Procedures GSK|1
7952366|NCT02570126|12499768|FG000|Overall Study|Protocol Violation|0
7952367|NCT02570126|12499769|FG001|Overall Study|Protocol Violation|1
7952368|NCT02570126|12499768|FG000|Overall Study|Withdrawal by Subject|3
7952369|NCT02570126|12499769|FG001|Overall Study|Withdrawal by Subject|7
7952370|NCT02570152|12499784|FG000|Overall Study|Protocol Violation|2
7952371|NCT02570152|12499784|FG000|Overall Study|Migrated/moved from study area|13
7952372|NCT02570165|12499795|FG000|Overall Study|Adverse Event|1
7952373|NCT02570165|12499796|FG001|Overall Study|Adverse Event|0
7952374|NCT02570165|12499797|FG002|Overall Study|Adverse Event|2
7952375|NCT02570165|12499798|FG003|Overall Study|Adverse Event|0
7952376|NCT02570165|12499799|FG004|Overall Study|Adverse Event|0
7952377|NCT02570165|12499800|FG005|Overall Study|Adverse Event|0
7952378|NCT02570165|12499801|FG006|Overall Study|Adverse Event|0
7952379|NCT02570165|12499795|FG000|Overall Study|Lack of Efficacy|0
7952380|NCT02570165|12499796|FG001|Overall Study|Lack of Efficacy|1
7952381|NCT02570165|12499797|FG002|Overall Study|Lack of Efficacy|0
7952382|NCT02570165|12499798|FG003|Overall Study|Lack of Efficacy|0
7952383|NCT02570165|12499799|FG004|Overall Study|Lack of Efficacy|4
7952384|NCT02570165|12499800|FG005|Overall Study|Lack of Efficacy|0
7952385|NCT02570165|12499801|FG006|Overall Study|Lack of Efficacy|0
7952386|NCT02570165|12499795|FG000|Overall Study|Par. Reached Stopping Criteria|1
7952387|NCT02570165|12499796|FG001|Overall Study|Par. Reached Stopping Criteria|1
7952388|NCT02570165|12499797|FG002|Overall Study|Par. Reached Stopping Criteria|0
7952389|NCT02570165|12499798|FG003|Overall Study|Par. Reached Stopping Criteria|2
7952390|NCT02570165|12499799|FG004|Overall Study|Par. Reached Stopping Criteria|1
7952391|NCT02570165|12499800|FG005|Overall Study|Par. Reached Stopping Criteria|1
7952392|NCT02570165|12499801|FG006|Overall Study|Par. Reached Stopping Criteria|0
7952393|NCT02570165|12499795|FG000|Overall Study|Lost to Follow-up|0
7952394|NCT02570165|12499796|FG001|Overall Study|Lost to Follow-up|0
7952395|NCT02570165|12499797|FG002|Overall Study|Lost to Follow-up|1
7952396|NCT02570165|12499798|FG003|Overall Study|Lost to Follow-up|1
7952397|NCT02570165|12499799|FG004|Overall Study|Lost to Follow-up|0
7952398|NCT02570165|12499800|FG005|Overall Study|Lost to Follow-up|0
7952399|NCT02570165|12499801|FG006|Overall Study|Lost to Follow-up|0
7952400|NCT02570165|12499795|FG000|Overall Study|Physician Decision|0
7952401|NCT02570165|12499796|FG001|Overall Study|Physician Decision|1
7952402|NCT02570165|12499797|FG002|Overall Study|Physician Decision|0
7952403|NCT02570165|12499798|FG003|Overall Study|Physician Decision|0
7952404|NCT02570165|12499799|FG004|Overall Study|Physician Decision|0
7952405|NCT02570165|12499800|FG005|Overall Study|Physician Decision|0
7952406|NCT02570165|12499801|FG006|Overall Study|Physician Decision|0
7952407|NCT02570165|12499795|FG000|Overall Study|Withdrawal by Subject|0
7952408|NCT02570165|12499796|FG001|Overall Study|Withdrawal by Subject|0
7952409|NCT02570165|12499797|FG002|Overall Study|Withdrawal by Subject|0
7952410|NCT02570165|12499798|FG003|Overall Study|Withdrawal by Subject|2
7952411|NCT02570165|12499799|FG004|Overall Study|Withdrawal by Subject|1
7952412|NCT02570165|12499800|FG005|Overall Study|Withdrawal by Subject|0
7952413|NCT02570165|12499801|FG006|Overall Study|Withdrawal by Subject|0
7952414|NCT02570165|12499795|FG000|Overall Study|Par. did not Meet Continuation Criteria|0
7952415|NCT02570165|12499796|FG001|Overall Study|Par. did not Meet Continuation Criteria|0
7952416|NCT02570165|12499797|FG002|Overall Study|Par. did not Meet Continuation Criteria|0
7952417|NCT02570165|12499798|FG003|Overall Study|Par. did not Meet Continuation Criteria|0
7952418|NCT02570165|12499799|FG004|Overall Study|Par. did not Meet Continuation Criteria|0
7952419|NCT02570165|12499800|FG005|Overall Study|Par. did not Meet Continuation Criteria|1
7952420|NCT02570165|12499801|FG006|Overall Study|Par. did not Meet Continuation Criteria|0
7952421|NCT02570165|12499795|FG000|Overall Study|Withdrawal Request by GSK|0
7952422|NCT02570165|12499796|FG001|Overall Study|Withdrawal Request by GSK|0
7952423|NCT02570165|12499797|FG002|Overall Study|Withdrawal Request by GSK|2
7952424|NCT02570165|12499798|FG003|Overall Study|Withdrawal Request by GSK|0
7952425|NCT02570165|12499799|FG004|Overall Study|Withdrawal Request by GSK|0
7952426|NCT02570165|12499800|FG005|Overall Study|Withdrawal Request by GSK|0
7952427|NCT02570165|12499801|FG006|Overall Study|Withdrawal Request by GSK|0
7952428|NCT02570711|12499840|FG000|Overall Study|Death|1
7952429|NCT02570711|12499841|FG001|Overall Study|Death|0
7952430|NCT02570711|12499840|FG000|Overall Study|Early Termination of Study by Sponsor|0
7952431|NCT02570711|12499841|FG001|Overall Study|Early Termination of Study by Sponsor|2
7952432|NCT02570750|12499849|FG000|Overall Study|Inclusion/exclusion criteria deviation|1
7952433|NCT02570750|12499850|FG001|Overall Study|Inclusion/exclusion criteria deviation|0
7952434|NCT02570750|12499849|FG000|Overall Study|Protocol deviation|4
7952435|NCT02570750|12499850|FG001|Overall Study|Protocol deviation|2
7952436|NCT02570750|12499849|FG000|Overall Study|Withdrawal by Subject|5
7952437|NCT02570750|12499850|FG001|Overall Study|Withdrawal by Subject|0
7952438|NCT02570750|12499849|FG000|Overall Study|Lost to Follow-up|2
7952439|NCT02570750|12499850|FG001|Overall Study|Lost to Follow-up|2
7952440|NCT02570750|12499849|FG000|Overall Study|Adverse Event|2
7952441|NCT02570750|12499850|FG001|Overall Study|Adverse Event|1
7952442|NCT02571049|12499856|FG000|Screening|Did not meet entry criteria|2
7952443|NCT02571049|12499857|FG001|Screening|Did not meet entry criteria|2
7952444|NCT02571049|12499856|FG000|Randomization|No migraine attack|0
7952445|NCT02571049|12499857|FG001|Randomization|No migraine attack|1
7952446|NCT02571049|12499856|FG000|Randomization|Adverse Event|0
7952447|NCT02571049|12499857|FG001|Randomization|Adverse Event|1
7952448|NCT02571075|12499865|FG000|Overall Study|Lost to Follow-up|20
7952449|NCT02571075|12499866|FG001|Overall Study|Lost to Follow-up|24
7952450|NCT02571244|12499896|FG000|Overall Study|Lost to Follow-up|0
7952451|NCT02571244|12499897|FG001|Overall Study|Lost to Follow-up|1
7952452|NCT02571244|12499896|FG000|Overall Study|Unable to reach out post discharge|3
7952453|NCT02571244|12499897|FG001|Overall Study|Unable to reach out post discharge|0
7952454|NCT02571452|12499917|FG000|Overall Study Treatment|Protocol Violation|0
7952455|NCT02571452|12499918|FG001|Overall Study Treatment|Protocol Violation|1
7952456|NCT02571452|12499917|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4
7952457|NCT02571452|12499918|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0
7952458|NCT02571452|12499917|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1
7952459|NCT02571452|12499918|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0
7952460|NCT02571777|12499934|FG000|Overall Study|Subject/guardian decision|34
7952461|NCT02571777|12499935|FG001|Overall Study|Subject/guardian decision|26
7952462|NCT02571777|12499936|FG002|Overall Study|Subject/guardian decision|26
7952463|NCT02571777|12499937|FG003|Overall Study|Subject/guardian decision|25
7952464|NCT02571777|12499938|FG004|Overall Study|Subject/guardian decision|27
7952465|NCT02571777|12499934|FG000|Overall Study|Protocol Deviation|2
7952466|NCT02571777|12499935|FG001|Overall Study|Protocol Deviation|3
7952467|NCT02571777|12499936|FG002|Overall Study|Protocol Deviation|4
7952468|NCT02571777|12499937|FG003|Overall Study|Protocol Deviation|8
7952469|NCT02571777|12499938|FG004|Overall Study|Protocol Deviation|4
7952470|NCT02571777|12499934|FG000|Overall Study|Death|1
7952471|NCT02571777|12499935|FG001|Overall Study|Death|1
7952472|NCT02571777|12499936|FG002|Overall Study|Death|4
7952473|NCT02571777|12499937|FG003|Overall Study|Death|0
7952474|NCT02571777|12499938|FG004|Overall Study|Death|0
7952475|NCT02571777|12499934|FG000|Overall Study|Lost to Follow-up|1
7952476|NCT02571777|12499935|FG001|Overall Study|Lost to Follow-up|1
7952477|NCT02571777|12499936|FG002|Overall Study|Lost to Follow-up|2
7952478|NCT02571777|12499937|FG003|Overall Study|Lost to Follow-up|0
7952479|NCT02571777|12499938|FG004|Overall Study|Lost to Follow-up|1
7952480|NCT02571777|12499934|FG000|Overall Study|Physician Decision|1
7952481|NCT02571777|12499935|FG001|Overall Study|Physician Decision|7
7952482|NCT02571777|12499936|FG002|Overall Study|Physician Decision|5
7952483|NCT02571777|12499937|FG003|Overall Study|Physician Decision|2
7952484|NCT02571777|12499938|FG004|Overall Study|Physician Decision|4
7952485|NCT02571777|12499934|FG000|Overall Study|Pregnancy|0
7952486|NCT02571777|12499935|FG001|Overall Study|Pregnancy|0
7952487|NCT02571777|12499936|FG002|Overall Study|Pregnancy|0
7952488|NCT02571777|12499937|FG003|Overall Study|Pregnancy|2
7952489|NCT02571777|12499938|FG004|Overall Study|Pregnancy|0
7952490|NCT02571972|12499950|FG000|Overall Study|Protocol Violation|2
7952491|NCT02571972|12499950|FG000|Overall Study|Withdrawal by Subject|2
7952492|NCT02572076|12499954|FG000|Overall Study|Protocol Violation|1
7952493|NCT02572167|12499961|FG000|Overall Study|In follow up|6
7952494|NCT02572167|12499962|FG001|Overall Study|In follow up|48
7952495|NCT02572167|12499963|FG002|Overall Study|In follow up|27
7952496|NCT02572167|12499961|FG000|Overall Study|Withdrawal by Subject|0
7952497|NCT02572167|12499962|FG001|Overall Study|Withdrawal by Subject|3
7952498|NCT02572167|12499963|FG002|Overall Study|Withdrawal by Subject|1
7952499|NCT02572167|12499961|FG000|Overall Study|Lost to Follow-up|0
7952500|NCT02572167|12499962|FG001|Overall Study|Lost to Follow-up|2
7952501|NCT02572167|12499963|FG002|Overall Study|Lost to Follow-up|1
7952502|NCT02572167|12499961|FG000|Overall Study|Death|0
7952503|NCT02572167|12499962|FG001|Overall Study|Death|3
7952504|NCT02572167|12499963|FG002|Overall Study|Death|1
7952505|NCT02572167|12499961|FG000|Overall Study|Did not meet inclusion criteria|0
7952506|NCT02572167|12499962|FG001|Overall Study|Did not meet inclusion criteria|0
7952507|NCT02572167|12499963|FG002|Overall Study|Did not meet inclusion criteria|1
7952508|NCT02572388|12499975|FG000|Overall Study|Withdrawal by Subject|1
7952509|NCT02572388|12499976|FG001|Overall Study|Withdrawal by Subject|1
7952510|NCT02572388|12499977|FG002|Overall Study|Withdrawal by Subject|2
7952511|NCT02572388|12499978|FG003|Overall Study|Withdrawal by Subject|2
7952512|NCT02572401|12499992|FG000|Overall Study|Lost to Follow-up|5
7952513|NCT02572401|12499993|FG001|Overall Study|Lost to Follow-up|8
7952514|NCT02572401|12499994|FG002|Overall Study|Lost to Follow-up|9
7952515|NCT02572401|12499995|FG003|Overall Study|Lost to Follow-up|9
7952516|NCT02572401|12499992|FG000|Overall Study|Death|0
7952517|NCT02572401|12499993|FG001|Overall Study|Death|0
7952518|NCT02572401|12499994|FG002|Overall Study|Death|0
7952519|NCT02572401|12499995|FG003|Overall Study|Death|1
7952520|NCT02572570|12500014|FG000|Overall Study|Study Terminated|27
7952521|NCT02572817|12500044|FG000|Overall Study|Death|6
7952522|NCT02572817|12500045|FG001|Overall Study|Death|3
7952523|NCT02572817|12500044|FG000|Overall Study|Lost to Follow-up|3
7952524|NCT02572817|12500045|FG001|Overall Study|Lost to Follow-up|3
7952525|NCT02573012|12500053|FG000|Overall Study|Adverse Event|5
7952526|NCT02573012|12500054|FG001|Overall Study|Adverse Event|5
7952527|NCT02573012|12500053|FG000|Overall Study|Lack of Efficacy|5
7952528|NCT02573012|12500054|FG001|Overall Study|Lack of Efficacy|4
7952529|NCT02573012|12500053|FG000|Overall Study|Non-compliance|1
7952530|NCT02573012|12500054|FG001|Overall Study|Non-compliance|2
7952531|NCT02573012|12500053|FG000|Overall Study|Withdrawal by Subject|2
7952532|NCT02573012|12500054|FG001|Overall Study|Withdrawal by Subject|2
7952533|NCT02573012|12500053|FG000|Overall Study|Study Ended per Protocol|1
7952534|NCT02573012|12500054|FG001|Overall Study|Study Ended per Protocol|0
7952535|NCT02573012|12500053|FG000|Overall Study|Physician Decision|1
7952536|NCT02573012|12500054|FG001|Overall Study|Physician Decision|2
7952537|NCT02573155|12500062|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0
7952538|NCT02573155|12500063|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1
7952539|NCT02573155|12500062|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
7952540|NCT02573155|12500063|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
7952541|NCT02573155|12500062|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0
7952542|NCT02573155|12500063|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3
7952543|NCT02573155|12500062|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
7952544|NCT02573155|12500063|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
7952545|NCT02573155|12500062|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0
7952546|NCT02573155|12500063|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2
7952547|NCT02573155|12500062|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
7952548|NCT02573155|12500063|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
7952549|NCT02573155|12500062|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0
7952550|NCT02573155|12500063|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1
7952551|NCT02573155|12500062|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0
7952552|NCT02573155|12500063|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1
7952553|NCT02573246|12500103|FG000|Overall Study|Lost to Follow-up|2
7952554|NCT02573246|12500104|FG001|Overall Study|Lost to Follow-up|0
7952555|NCT02573246|12500105|FG002|Overall Study|Lost to Follow-up|0
7952556|NCT02573246|12500106|FG003|Overall Study|Lost to Follow-up|0
7952557|NCT02573246|12500107|FG004|Overall Study|Lost to Follow-up|1
7952558|NCT02573246|12500103|FG000|Overall Study|Withdrawal by Subject|0
7952559|NCT02573246|12500104|FG001|Overall Study|Withdrawal by Subject|0
7952560|NCT02573246|12500105|FG002|Overall Study|Withdrawal by Subject|0
7952561|NCT02573246|12500106|FG003|Overall Study|Withdrawal by Subject|0
7952562|NCT02573246|12500107|FG004|Overall Study|Withdrawal by Subject|1
7952563|NCT02573246|12500103|FG000|Overall Study|Physician Decision|1
7952564|NCT02573246|12500104|FG001|Overall Study|Physician Decision|1
7952565|NCT02573246|12500105|FG002|Overall Study|Physician Decision|3
7952566|NCT02573246|12500106|FG003|Overall Study|Physician Decision|2
7952567|NCT02573246|12500107|FG004|Overall Study|Physician Decision|2
7952568|NCT02573311|12500126|FG000|Disposition for Part 1|Withdrawal by Subject|7
7952569|NCT02573311|12500127|FG001|Disposition for Part 1|Withdrawal by Subject|3
7952570|NCT02573311|12500126|FG000|Disposition for Part 2|Physician Decision|25
7952571|NCT02573311|12500127|FG001|Disposition for Part 2|Physician Decision|7
7952572|NCT02573311|12500126|FG000|Disposition for Part 2|Adverse Event|36
7952573|NCT02573311|12500127|FG001|Disposition for Part 2|Adverse Event|5
7952574|NCT02573311|12500126|FG000|Disposition for Part 2|Lost to Follow-up|76
7952575|NCT02573311|12500127|FG001|Disposition for Part 2|Lost to Follow-up|7
7952576|NCT02573311|12500126|FG000|Disposition for Part 2|Withdrawal by Subject|60
7952577|NCT02573311|12500127|FG001|Disposition for Part 2|Withdrawal by Subject|3
7952578|NCT02573311|12500126|FG000|Disposition for Part 2|Investigator decision|0
7952579|NCT02573311|12500127|FG001|Disposition for Part 2|Investigator decision|1
7952580|NCT02573311|12500126|FG000|Disposition for Part 2|Other than specified above|13
7952581|NCT02573311|12500127|FG001|Disposition for Part 2|Other than specified above|3
7952582|NCT02573350|12500135|FG000|Overall Study|Lost to Follow-up|2
7952583|NCT02573350|12500136|FG001|Overall Study|Lost to Follow-up|1
7952584|NCT02573350|12500135|FG000|Overall Study|Adverse Event|3
7952585|NCT02573350|12500136|FG001|Overall Study|Adverse Event|4
7952586|NCT02573350|12500135|FG000|Overall Study|Subject met Withdrawal Criteria|1
7952587|NCT02573350|12500136|FG001|Overall Study|Subject met Withdrawal Criteria|1
7952588|NCT02573350|12500135|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3
7952589|NCT02573350|12500136|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1
7952590|NCT02573350|12500135|FG000|Overall Study|Subject withdrew consent to participate|6
7952591|NCT02573350|12500136|FG001|Overall Study|Subject withdrew consent to participate|1
7952592|NCT02573350|12500135|FG000|Overall Study|Protocol Deviation|1
7952593|NCT02573350|12500136|FG001|Overall Study|Protocol Deviation|1
7952594|NCT02573467|12500158|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0
7952595|NCT02573467|12500159|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0
7952596|NCT02573467|12500160|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1
7952597|NCT02573467|12500161|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0
7952598|NCT02573467|12500158|FG000|Double-blind Treatment Epoch|Adverse Event|1
7952599|NCT02573467|12500159|FG001|Double-blind Treatment Epoch|Adverse Event|0
7952600|NCT02573467|12500160|FG002|Double-blind Treatment Epoch|Adverse Event|1
7952601|NCT02573467|12500161|FG003|Double-blind Treatment Epoch|Adverse Event|0
7952602|NCT02573467|12500158|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2
7952603|NCT02573467|12500159|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1
7952604|NCT02573467|12500160|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1
7952605|NCT02573467|12500161|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0
7952606|NCT02573467|12500158|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50
7952607|NCT02573467|12500159|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51
7952608|NCT02573467|12500160|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48
7952609|NCT02573467|12500161|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55
7952610|NCT02573467|12500158|FG000|Post-treatment Follow up Epoch|Death|1
7952611|NCT02573467|12500159|FG001|Post-treatment Follow up Epoch|Death|1
7952612|NCT02573467|12500160|FG002|Post-treatment Follow up Epoch|Death|0
7952613|NCT02573467|12500161|FG003|Post-treatment Follow up Epoch|Death|1
7952614|NCT02573467|12500158|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5
7952615|NCT02573467|12500159|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4
7952616|NCT02573467|12500160|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9
7952617|NCT02573467|12500161|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2
7952618|NCT02573467|12500158|FG000|Post-treatment Follow up Epoch|Technical problems|0
7952619|NCT02573467|12500159|FG001|Post-treatment Follow up Epoch|Technical problems|0
7952620|NCT02573467|12500160|FG002|Post-treatment Follow up Epoch|Technical problems|1
7952621|NCT02573467|12500161|FG003|Post-treatment Follow up Epoch|Technical problems|0
7952622|NCT02573870|12500183|FG000|Overall Study|Adverse Event|0
7952623|NCT02573870|12500184|FG001|Overall Study|Adverse Event|2
7952624|NCT02573870|12500183|FG000|Overall Study|Lack of Efficacy|0
7952625|NCT02573870|12500184|FG001|Overall Study|Lack of Efficacy|1
7952626|NCT02573870|12500183|FG000|Overall Study|Other: Reached defined stopping criteria|0
7952627|NCT02573870|12500184|FG001|Overall Study|Other: Reached defined stopping criteria|1
7952628|NCT02573870|12500183|FG000|Overall Study|Lost to Follow-up|0
7952629|NCT02573870|12500184|FG001|Overall Study|Lost to Follow-up|1
7952630|NCT02573870|12500183|FG000|Overall Study|Other: Fail to Meet Visit|0
7952631|NCT02573870|12500184|FG001|Overall Study|Other: Fail to Meet Visit|2
7952632|NCT02573883|12500192|FG000|Six Month Follow Up|Lost to Follow-up|1
7952633|NCT02573883|12500193|FG001|Six Month Follow Up|Lost to Follow-up|0
7952634|NCT02573883|12500194|FG002|Six Month Follow Up|Lost to Follow-up|0
7952635|NCT02573883|12500195|FG003|Six Month Follow Up|Lost to Follow-up|0
7952636|NCT02573883|12500192|FG000|One Year Follow Up|Lost to Follow-up|2
7952637|NCT02573883|12500193|FG001|One Year Follow Up|Lost to Follow-up|1
7952638|NCT02573883|12500194|FG002|One Year Follow Up|Lost to Follow-up|0
7952639|NCT02573883|12500195|FG003|One Year Follow Up|Lost to Follow-up|0
7952640|NCT02573948|12500210|FG000|Longitudinal Cohort|Death|9
7952641|NCT02573948|12500210|FG000|Longitudinal Cohort|Lost to Follow-up|22
7952642|NCT02573948|12500210|FG000|Longitudinal Cohort|Incarcerated|25
7952643|NCT02574078|12500230|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0
7952644|NCT02574078|12500231|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0
7952645|NCT02574078|12500232|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0
7952646|NCT02574078|12500233|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0
7952647|NCT02574078|12500234|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0
7952648|NCT02574078|12500235|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1
7952649|NCT02574078|12500236|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2
7952650|NCT02574078|12500237|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0
7952651|NCT02574078|12500238|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1
7952652|NCT02574078|12500239|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0
7952653|NCT02574078|12500240|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0
7952654|NCT02574078|12500241|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0
7952655|NCT02574078|12500242|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0
7952656|NCT02574078|12500230|FG000|Pre-Treatment Period|Participant withdrew consent|0
7952657|NCT02574078|12500231|FG001|Pre-Treatment Period|Participant withdrew consent|0
7952658|NCT02574078|12500232|FG002|Pre-Treatment Period|Participant withdrew consent|0
7952659|NCT02574078|12500233|FG003|Pre-Treatment Period|Participant withdrew consent|0
7952660|NCT02574078|12500234|FG004|Pre-Treatment Period|Participant withdrew consent|0
7952661|NCT02574078|12500235|FG005|Pre-Treatment Period|Participant withdrew consent|0
7952662|NCT02574078|12500236|FG006|Pre-Treatment Period|Participant withdrew consent|0
7952663|NCT02574078|12500237|FG007|Pre-Treatment Period|Participant withdrew consent|3
7952664|NCT02574078|12500238|FG008|Pre-Treatment Period|Participant withdrew consent|0
7952665|NCT02574078|12500239|FG009|Pre-Treatment Period|Participant withdrew consent|0
7952666|NCT02574078|12500240|FG010|Pre-Treatment Period|Participant withdrew consent|2
7952667|NCT02574078|12500241|FG011|Pre-Treatment Period|Participant withdrew consent|0
7952668|NCT02574078|12500242|FG012|Pre-Treatment Period|Participant withdrew consent|0
7952669|NCT02574078|12500230|FG000|Pre-Treatment Period|Other reasons|0
7952670|NCT02574078|12500231|FG001|Pre-Treatment Period|Other reasons|0
7952671|NCT02574078|12500232|FG002|Pre-Treatment Period|Other reasons|0
7952672|NCT02574078|12500233|FG003|Pre-Treatment Period|Other reasons|0
7952673|NCT02574078|12500234|FG004|Pre-Treatment Period|Other reasons|0
7952674|NCT02574078|12500235|FG005|Pre-Treatment Period|Other reasons|0
7952675|NCT02574078|12500236|FG006|Pre-Treatment Period|Other reasons|2
7952676|NCT02574078|12500237|FG007|Pre-Treatment Period|Other reasons|0
7952677|NCT02574078|12500238|FG008|Pre-Treatment Period|Other reasons|0
7952678|NCT02574078|12500239|FG009|Pre-Treatment Period|Other reasons|0
7952679|NCT02574078|12500240|FG010|Pre-Treatment Period|Other reasons|2
7952680|NCT02574078|12500241|FG011|Pre-Treatment Period|Other reasons|0
7952681|NCT02574078|12500242|FG012|Pre-Treatment Period|Other reasons|0
7952682|NCT02574078|12500230|FG000|Pre-Treatment Period|Poor/non-compliance|0
7952683|NCT02574078|12500231|FG001|Pre-Treatment Period|Poor/non-compliance|0
7952684|NCT02574078|12500232|FG002|Pre-Treatment Period|Poor/non-compliance|0
7952685|NCT02574078|12500233|FG003|Pre-Treatment Period|Poor/non-compliance|0
7952686|NCT02574078|12500234|FG004|Pre-Treatment Period|Poor/non-compliance|0
7952687|NCT02574078|12500235|FG005|Pre-Treatment Period|Poor/non-compliance|0
7952688|NCT02574078|12500236|FG006|Pre-Treatment Period|Poor/non-compliance|0
7952689|NCT02574078|12500237|FG007|Pre-Treatment Period|Poor/non-compliance|0
7952690|NCT02574078|12500238|FG008|Pre-Treatment Period|Poor/non-compliance|0
7952691|NCT02574078|12500239|FG009|Pre-Treatment Period|Poor/non-compliance|0
7952692|NCT02574078|12500240|FG010|Pre-Treatment Period|Poor/non-compliance|0
7952693|NCT02574078|12500241|FG011|Pre-Treatment Period|Poor/non-compliance|1
7952694|NCT02574078|12500242|FG012|Pre-Treatment Period|Poor/non-compliance|0
7952695|NCT02574078|12500230|FG000|Treatment Period|Disease progression|6
7952696|NCT02574078|12500231|FG001|Treatment Period|Disease progression|4
7952697|NCT02574078|12500232|FG002|Treatment Period|Disease progression|7
7952698|NCT02574078|12500233|FG003|Treatment Period|Disease progression|18
7952699|NCT02574078|12500234|FG004|Treatment Period|Disease progression|16
7952700|NCT02574078|12500235|FG005|Treatment Period|Disease progression|26
7952701|NCT02574078|12500236|FG006|Treatment Period|Disease progression|5
7952702|NCT02574078|12500237|FG007|Treatment Period|Disease progression|9
7952703|NCT02574078|12500238|FG008|Treatment Period|Disease progression|8
7952704|NCT02574078|12500239|FG009|Treatment Period|Disease progression|5
7952705|NCT02574078|12500240|FG010|Treatment Period|Disease progression|20
7952706|NCT02574078|12500241|FG011|Treatment Period|Disease progression|29
7952707|NCT02574078|12500242|FG012|Treatment Period|Disease progression|2
7952708|NCT02574078|12500230|FG000|Treatment Period|Study drug toxicity|1
7952709|NCT02574078|12500231|FG001|Treatment Period|Study drug toxicity|1
7952710|NCT02574078|12500232|FG002|Treatment Period|Study drug toxicity|0
7952711|NCT02574078|12500233|FG003|Treatment Period|Study drug toxicity|5
7952712|NCT02574078|12500234|FG004|Treatment Period|Study drug toxicity|3
7952713|NCT02574078|12500235|FG005|Treatment Period|Study drug toxicity|1
7952714|NCT02574078|12500236|FG006|Treatment Period|Study drug toxicity|2
7952715|NCT02574078|12500237|FG007|Treatment Period|Study drug toxicity|0
7952716|NCT02574078|12500238|FG008|Treatment Period|Study drug toxicity|2
7952717|NCT02574078|12500239|FG009|Treatment Period|Study drug toxicity|1
7952718|NCT02574078|12500240|FG010|Treatment Period|Study drug toxicity|16
7952719|NCT02574078|12500241|FG011|Treatment Period|Study drug toxicity|2
7952720|NCT02574078|12500242|FG012|Treatment Period|Study drug toxicity|4
7952721|NCT02574078|12500230|FG000|Treatment Period|Death|2
7952722|NCT02574078|12500231|FG001|Treatment Period|Death|0
7952723|NCT02574078|12500232|FG002|Treatment Period|Death|0
7952724|NCT02574078|12500233|FG003|Treatment Period|Death|0
7952725|NCT02574078|12500234|FG004|Treatment Period|Death|1
7952726|NCT02574078|12500235|FG005|Treatment Period|Death|1
7952727|NCT02574078|12500236|FG006|Treatment Period|Death|1
7952728|NCT02574078|12500237|FG007|Treatment Period|Death|1
7952729|NCT02574078|12500238|FG008|Treatment Period|Death|7
7952730|NCT02574078|12500239|FG009|Treatment Period|Death|1
7952731|NCT02574078|12500240|FG010|Treatment Period|Death|0
7952732|NCT02574078|12500241|FG011|Treatment Period|Death|2
7952733|NCT02574078|12500242|FG012|Treatment Period|Death|1
7952734|NCT02574078|12500230|FG000|Treatment Period|Adverse event unrelated to drug|0
7952735|NCT02574078|12500231|FG001|Treatment Period|Adverse event unrelated to drug|0
7952736|NCT02574078|12500232|FG002|Treatment Period|Adverse event unrelated to drug|1
7952737|NCT02574078|12500233|FG003|Treatment Period|Adverse event unrelated to drug|0
7952738|NCT02574078|12500234|FG004|Treatment Period|Adverse event unrelated to drug|2
7952739|NCT02574078|12500235|FG005|Treatment Period|Adverse event unrelated to drug|3
7952740|NCT02574078|12500236|FG006|Treatment Period|Adverse event unrelated to drug|0
7952741|NCT02574078|12500237|FG007|Treatment Period|Adverse event unrelated to drug|0
7952742|NCT02574078|12500238|FG008|Treatment Period|Adverse event unrelated to drug|1
7952743|NCT02574078|12500239|FG009|Treatment Period|Adverse event unrelated to drug|2
7952744|NCT02574078|12500240|FG010|Treatment Period|Adverse event unrelated to drug|4
7952745|NCT02574078|12500241|FG011|Treatment Period|Adverse event unrelated to drug|1
7952746|NCT02574078|12500242|FG012|Treatment Period|Adverse event unrelated to drug|0
7952747|NCT02574078|12500230|FG000|Treatment Period|Administrative reason by Sponsor|0
7952748|NCT02574078|12500231|FG001|Treatment Period|Administrative reason by Sponsor|1
7952749|NCT02574078|12500232|FG002|Treatment Period|Administrative reason by Sponsor|0
7952750|NCT02574078|12500233|FG003|Treatment Period|Administrative reason by Sponsor|0
7952751|NCT02574078|12500234|FG004|Treatment Period|Administrative reason by Sponsor|0
7952752|NCT02574078|12500235|FG005|Treatment Period|Administrative reason by Sponsor|0
7952753|NCT02574078|12500236|FG006|Treatment Period|Administrative reason by Sponsor|1
7952754|NCT02574078|12500237|FG007|Treatment Period|Administrative reason by Sponsor|0
7952755|NCT02574078|12500238|FG008|Treatment Period|Administrative reason by Sponsor|0
7952756|NCT02574078|12500239|FG009|Treatment Period|Administrative reason by Sponsor|0
7952757|NCT02574078|12500240|FG010|Treatment Period|Administrative reason by Sponsor|0
7952758|NCT02574078|12500241|FG011|Treatment Period|Administrative reason by Sponsor|0
7952759|NCT02574078|12500242|FG012|Treatment Period|Administrative reason by Sponsor|3
7952760|NCT02574078|12500230|FG000|Treatment Period|Other reasons|1
7952761|NCT02574078|12500231|FG001|Treatment Period|Other reasons|0
7952762|NCT02574078|12500232|FG002|Treatment Period|Other reasons|1
7952763|NCT02574078|12500233|FG003|Treatment Period|Other reasons|3
7952764|NCT02574078|12500234|FG004|Treatment Period|Other reasons|3
7952765|NCT02574078|12500235|FG005|Treatment Period|Other reasons|1
7952766|NCT02574078|12500236|FG006|Treatment Period|Other reasons|2
7952767|NCT02574078|12500237|FG007|Treatment Period|Other reasons|1
7952768|NCT02574078|12500238|FG008|Treatment Period|Other reasons|3
7952769|NCT02574078|12500239|FG009|Treatment Period|Other reasons|1
7952770|NCT02574078|12500240|FG010|Treatment Period|Other reasons|1
7952771|NCT02574078|12500241|FG011|Treatment Period|Other reasons|3
7952772|NCT02574078|12500242|FG012|Treatment Period|Other reasons|1
7952773|NCT02574078|12500230|FG000|Treatment Period|Participant request to stop drug|0
7952774|NCT02574078|12500231|FG001|Treatment Period|Participant request to stop drug|0
7952775|NCT02574078|12500232|FG002|Treatment Period|Participant request to stop drug|0
7952776|NCT02574078|12500233|FG003|Treatment Period|Participant request to stop drug|2
7952777|NCT02574078|12500234|FG004|Treatment Period|Participant request to stop drug|4
7952778|NCT02574078|12500235|FG005|Treatment Period|Participant request to stop drug|0
7952779|NCT02574078|12500236|FG006|Treatment Period|Participant request to stop drug|1
7952780|NCT02574078|12500237|FG007|Treatment Period|Participant request to stop drug|0
7952781|NCT02574078|12500238|FG008|Treatment Period|Participant request to stop drug|3
7952782|NCT02574078|12500239|FG009|Treatment Period|Participant request to stop drug|2
7952783|NCT02574078|12500240|FG010|Treatment Period|Participant request to stop drug|2
7952784|NCT02574078|12500241|FG011|Treatment Period|Participant request to stop drug|4
7952785|NCT02574078|12500242|FG012|Treatment Period|Participant request to stop drug|1
7952786|NCT02574078|12500230|FG000|Treatment Period|Participant withdrew consent|0
7952787|NCT02574078|12500231|FG001|Treatment Period|Participant withdrew consent|0
7952788|NCT02574078|12500232|FG002|Treatment Period|Participant withdrew consent|0
7952789|NCT02574078|12500233|FG003|Treatment Period|Participant withdrew consent|0
7952790|NCT02574078|12500234|FG004|Treatment Period|Participant withdrew consent|1
7952791|NCT02574078|12500235|FG005|Treatment Period|Participant withdrew consent|1
7952792|NCT02574078|12500236|FG006|Treatment Period|Participant withdrew consent|0
7952793|NCT02574078|12500237|FG007|Treatment Period|Participant withdrew consent|1
7952794|NCT02574078|12500238|FG008|Treatment Period|Participant withdrew consent|0
7952795|NCT02574078|12500239|FG009|Treatment Period|Participant withdrew consent|2
7952796|NCT02574078|12500240|FG010|Treatment Period|Participant withdrew consent|1
7952797|NCT02574078|12500241|FG011|Treatment Period|Participant withdrew consent|4
7952798|NCT02574078|12500242|FG012|Treatment Period|Participant withdrew consent|1
7952799|NCT02574078|12500230|FG000|Treatment Period|Participant no longer meets criteria|0
7952800|NCT02574078|12500231|FG001|Treatment Period|Participant no longer meets criteria|0
7952801|NCT02574078|12500232|FG002|Treatment Period|Participant no longer meets criteria|0
7952802|NCT02574078|12500233|FG003|Treatment Period|Participant no longer meets criteria|0
7952803|NCT02574078|12500234|FG004|Treatment Period|Participant no longer meets criteria|1
7952804|NCT02574078|12500235|FG005|Treatment Period|Participant no longer meets criteria|0
7952805|NCT02574078|12500236|FG006|Treatment Period|Participant no longer meets criteria|0
7952806|NCT02574078|12500237|FG007|Treatment Period|Participant no longer meets criteria|0
7952807|NCT02574078|12500238|FG008|Treatment Period|Participant no longer meets criteria|0
7952808|NCT02574078|12500239|FG009|Treatment Period|Participant no longer meets criteria|1
7952809|NCT02574078|12500240|FG010|Treatment Period|Participant no longer meets criteria|1
7952810|NCT02574078|12500241|FG011|Treatment Period|Participant no longer meets criteria|1
7952811|NCT02574078|12500242|FG012|Treatment Period|Participant no longer meets criteria|0
7952812|NCT02574078|12500230|FG000|Treatment Period|Lost to Follow-up|0
7952813|NCT02574078|12500231|FG001|Treatment Period|Lost to Follow-up|0
7952814|NCT02574078|12500232|FG002|Treatment Period|Lost to Follow-up|0
7952815|NCT02574078|12500233|FG003|Treatment Period|Lost to Follow-up|0
7952816|NCT02574078|12500234|FG004|Treatment Period|Lost to Follow-up|0
7952817|NCT02574078|12500235|FG005|Treatment Period|Lost to Follow-up|0
7952818|NCT02574078|12500236|FG006|Treatment Period|Lost to Follow-up|0
7952819|NCT02574078|12500237|FG007|Treatment Period|Lost to Follow-up|0
7952820|NCT02574078|12500238|FG008|Treatment Period|Lost to Follow-up|0
7952821|NCT02574078|12500239|FG009|Treatment Period|Lost to Follow-up|1
7952822|NCT02574078|12500240|FG010|Treatment Period|Lost to Follow-up|0
7952823|NCT02574078|12500241|FG011|Treatment Period|Lost to Follow-up|1
7952824|NCT02574078|12500242|FG012|Treatment Period|Lost to Follow-up|0
7952825|NCT02574078|12500230|FG000|Treatment Period|Maximum clinical benefit|0
7952826|NCT02574078|12500231|FG001|Treatment Period|Maximum clinical benefit|0
7952827|NCT02574078|12500232|FG002|Treatment Period|Maximum clinical benefit|0
7952828|NCT02574078|12500233|FG003|Treatment Period|Maximum clinical benefit|0
7952829|NCT02574078|12500234|FG004|Treatment Period|Maximum clinical benefit|0
7952830|NCT02574078|12500235|FG005|Treatment Period|Maximum clinical benefit|0
7952831|NCT02574078|12500236|FG006|Treatment Period|Maximum clinical benefit|0
7952832|NCT02574078|12500237|FG007|Treatment Period|Maximum clinical benefit|0
7952833|NCT02574078|12500238|FG008|Treatment Period|Maximum clinical benefit|0
7952834|NCT02574078|12500239|FG009|Treatment Period|Maximum clinical benefit|1
7952835|NCT02574078|12500240|FG010|Treatment Period|Maximum clinical benefit|0
7952836|NCT02574078|12500241|FG011|Treatment Period|Maximum clinical benefit|0
7952837|NCT02574078|12500242|FG012|Treatment Period|Maximum clinical benefit|0
7952838|NCT02574247|12500276|FG000|Overall Study|Withdrawal by Subject|1
7952839|NCT02574247|12500277|FG001|Overall Study|Withdrawal by Subject|0
7952840|NCT02574247|12500278|FG002|Overall Study|Withdrawal by Subject|0
7952841|NCT02574247|12500276|FG000|Overall Study|Did not meet inclusion criteria|4
7952842|NCT02574247|12500277|FG001|Overall Study|Did not meet inclusion criteria|3
7952843|NCT02574247|12500278|FG002|Overall Study|Did not meet inclusion criteria|5
7952844|NCT02574260|12500288|FG000|Overall Study|Disease Progression|1
7952845|NCT02574312|12500294|FG000|3 Months Follow-up|Withdrawal by Subject|1
7952846|NCT02574312|12500295|FG001|3 Months Follow-up|Withdrawal by Subject|0
7952847|NCT02574520|12500305|FG000|Overall Study|Not dosed|2
7952848|NCT02574520|12500306|FG001|Overall Study|Not dosed|0
7952849|NCT02574520|12500307|FG002|Overall Study|Not dosed|5
7952850|NCT02574520|12500308|FG003|Overall Study|Not dosed|4
7952851|NCT02574520|12500305|FG000|Overall Study|Adverse Event|0
7952852|NCT02574520|12500306|FG001|Overall Study|Adverse Event|0
7952853|NCT02574520|12500307|FG002|Overall Study|Adverse Event|0
7952854|NCT02574520|12500308|FG003|Overall Study|Adverse Event|1
7952855|NCT02574520|12500305|FG000|Overall Study|Withdrawal by Subject|0
7952856|NCT02574520|12500306|FG001|Overall Study|Withdrawal by Subject|0
7952857|NCT02574520|12500307|FG002|Overall Study|Withdrawal by Subject|0
7952858|NCT02574520|12500308|FG003|Overall Study|Withdrawal by Subject|1
7952859|NCT02574520|12500305|FG000|Overall Study|Other|0
7952860|NCT02574520|12500306|FG001|Overall Study|Other|0
7952861|NCT02574520|12500307|FG002|Overall Study|Other|0
7952862|NCT02574520|12500308|FG003|Overall Study|Other|2
7952863|NCT02574637|12500332|FG000|Double-blind Period|Adverse Event|1
7952864|NCT02574637|12500333|FG001|Double-blind Period|Adverse Event|0
7952865|NCT02574637|12500334|FG002|Double-blind Period|Adverse Event|0
7952866|NCT02574637|12500335|FG003|Double-blind Period|Adverse Event|0
7952867|NCT02574637|12500336|FG004|Double-blind Period|Adverse Event|0
7952868|NCT02574637|12500337|FG005|Double-blind Period|Adverse Event|0
7952869|NCT02574637|12500338|FG006|Double-blind Period|Adverse Event|0
7952870|NCT02574637|12500339|FG007|Double-blind Period|Adverse Event|0
7952871|NCT02574637|12500340|FG008|Double-blind Period|Adverse Event|0
7952872|NCT02574637|12500341|FG009|Double-blind Period|Adverse Event|0
7952873|NCT02574637|12500332|FG000|Double-blind Period|Lack of Efficacy|0
7952874|NCT02574637|12500333|FG001|Double-blind Period|Lack of Efficacy|0
7952875|NCT02574637|12500334|FG002|Double-blind Period|Lack of Efficacy|2
7952876|NCT02574637|12500335|FG003|Double-blind Period|Lack of Efficacy|0
7952877|NCT02574637|12500336|FG004|Double-blind Period|Lack of Efficacy|0
7952878|NCT02574637|12500337|FG005|Double-blind Period|Lack of Efficacy|0
7952879|NCT02574637|12500338|FG006|Double-blind Period|Lack of Efficacy|0
7952880|NCT02574637|12500339|FG007|Double-blind Period|Lack of Efficacy|0
7952881|NCT02574637|12500340|FG008|Double-blind Period|Lack of Efficacy|0
7952882|NCT02574637|12500341|FG009|Double-blind Period|Lack of Efficacy|0
7952883|NCT02574637|12500332|FG000|Double-blind Period|Protocol Deviation|1
7952884|NCT02574637|12500333|FG001|Double-blind Period|Protocol Deviation|0
7952885|NCT02574637|12500334|FG002|Double-blind Period|Protocol Deviation|0
7952886|NCT02574637|12500335|FG003|Double-blind Period|Protocol Deviation|0
7952887|NCT02574637|12500336|FG004|Double-blind Period|Protocol Deviation|0
7952888|NCT02574637|12500337|FG005|Double-blind Period|Protocol Deviation|0
7952889|NCT02574637|12500338|FG006|Double-blind Period|Protocol Deviation|0
7952890|NCT02574637|12500339|FG007|Double-blind Period|Protocol Deviation|0
7952891|NCT02574637|12500340|FG008|Double-blind Period|Protocol Deviation|0
7952892|NCT02574637|12500341|FG009|Double-blind Period|Protocol Deviation|0
7952893|NCT02574637|12500332|FG000|Double-blind Period|Non-Compliance With Study Drug|0
7952894|NCT02574637|12500333|FG001|Double-blind Period|Non-Compliance With Study Drug|0
7952895|NCT02574637|12500334|FG002|Double-blind Period|Non-Compliance With Study Drug|0
7952896|NCT02574637|12500335|FG003|Double-blind Period|Non-Compliance With Study Drug|1
7952897|NCT02574637|12500336|FG004|Double-blind Period|Non-Compliance With Study Drug|0
7952898|NCT02574637|12500337|FG005|Double-blind Period|Non-Compliance With Study Drug|0
7952899|NCT02574637|12500338|FG006|Double-blind Period|Non-Compliance With Study Drug|0
7952900|NCT02574637|12500339|FG007|Double-blind Period|Non-Compliance With Study Drug|0
7952901|NCT02574637|12500340|FG008|Double-blind Period|Non-Compliance With Study Drug|0
7952902|NCT02574637|12500341|FG009|Double-blind Period|Non-Compliance With Study Drug|0
7952903|NCT02574637|12500332|FG000|Double-blind Period|Study Terminated By Sponsor|1
7952904|NCT02574637|12500333|FG001|Double-blind Period|Study Terminated By Sponsor|1
7952905|NCT02574637|12500334|FG002|Double-blind Period|Study Terminated By Sponsor|5
7952906|NCT02574637|12500335|FG003|Double-blind Period|Study Terminated By Sponsor|2
7952907|NCT02574637|12500336|FG004|Double-blind Period|Study Terminated By Sponsor|2
7952908|NCT02574637|12500337|FG005|Double-blind Period|Study Terminated By Sponsor|0
7952909|NCT02574637|12500338|FG006|Double-blind Period|Study Terminated By Sponsor|0
7952910|NCT02574637|12500339|FG007|Double-blind Period|Study Terminated By Sponsor|0
7952911|NCT02574637|12500340|FG008|Double-blind Period|Study Terminated By Sponsor|0
7952912|NCT02574637|12500341|FG009|Double-blind Period|Study Terminated By Sponsor|0
7952913|NCT02574637|12500332|FG000|Double-blind Period|Reason Not Specified|0
7952914|NCT02574637|12500333|FG001|Double-blind Period|Reason Not Specified|0
7952915|NCT02574637|12500334|FG002|Double-blind Period|Reason Not Specified|0
7952916|NCT02574637|12500335|FG003|Double-blind Period|Reason Not Specified|1
7952917|NCT02574637|12500336|FG004|Double-blind Period|Reason Not Specified|0
7952918|NCT02574637|12500337|FG005|Double-blind Period|Reason Not Specified|0
7952919|NCT02574637|12500338|FG006|Double-blind Period|Reason Not Specified|0
7952920|NCT02574637|12500339|FG007|Double-blind Period|Reason Not Specified|0
7952921|NCT02574637|12500340|FG008|Double-blind Period|Reason Not Specified|0
7952922|NCT02574637|12500341|FG009|Double-blind Period|Reason Not Specified|0
7952923|NCT02574637|12500332|FG000|Open-label (OL) Period|Adverse Event|0
7952924|NCT02574637|12500333|FG001|Open-label (OL) Period|Adverse Event|0
7952925|NCT02574637|12500334|FG002|Open-label (OL) Period|Adverse Event|0
7952926|NCT02574637|12500335|FG003|Open-label (OL) Period|Adverse Event|0
7952927|NCT02574637|12500336|FG004|Open-label (OL) Period|Adverse Event|0
7952928|NCT02574637|12500337|FG005|Open-label (OL) Period|Adverse Event|0
7952929|NCT02574637|12500338|FG006|Open-label (OL) Period|Adverse Event|0
7952930|NCT02574637|12500339|FG007|Open-label (OL) Period|Adverse Event|0
7952931|NCT02574637|12500340|FG008|Open-label (OL) Period|Adverse Event|1
7952932|NCT02574637|12500341|FG009|Open-label (OL) Period|Adverse Event|0
7952933|NCT02574637|12500332|FG000|Open-label (OL) Period|Withdrawal by Subject|0
7952934|NCT02574637|12500333|FG001|Open-label (OL) Period|Withdrawal by Subject|0
7952935|NCT02574637|12500334|FG002|Open-label (OL) Period|Withdrawal by Subject|0
7952936|NCT02574637|12500335|FG003|Open-label (OL) Period|Withdrawal by Subject|0
7952937|NCT02574637|12500336|FG004|Open-label (OL) Period|Withdrawal by Subject|0
7952938|NCT02574637|12500337|FG005|Open-label (OL) Period|Withdrawal by Subject|1
7952939|NCT02574637|12500338|FG006|Open-label (OL) Period|Withdrawal by Subject|0
7952940|NCT02574637|12500339|FG007|Open-label (OL) Period|Withdrawal by Subject|0
7952941|NCT02574637|12500340|FG008|Open-label (OL) Period|Withdrawal by Subject|0
7952942|NCT02574637|12500341|FG009|Open-label (OL) Period|Withdrawal by Subject|1
7952943|NCT02574637|12500332|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0
7952944|NCT02574637|12500333|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0
7952945|NCT02574637|12500334|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0
7952946|NCT02574637|12500335|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0
7952947|NCT02574637|12500336|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0
7952948|NCT02574637|12500337|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1
7952949|NCT02574637|12500338|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2
7952950|NCT02574637|12500339|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1
7952951|NCT02574637|12500340|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1
7952952|NCT02574637|12500341|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0
7952953|NCT02574845|12500372|FG000|Overall Study|Consent withdrawn further participation|0
7952954|NCT02574845|12500373|FG001|Overall Study|Consent withdrawn further participation|0
7952955|NCT02574845|12500374|FG002|Overall Study|Consent withdrawn further participation|0
7952956|NCT02574845|12500375|FG003|Overall Study|Consent withdrawn further participation|0
7952957|NCT02574845|12500376|FG004|Overall Study|Consent withdrawn further participation|1
7952958|NCT02574845|12500377|FG005|Overall Study|Consent withdrawn further participation|0
7952959|NCT02574845|12500372|FG000|Overall Study|Adverse Event|0
7952960|NCT02574845|12500373|FG001|Overall Study|Adverse Event|1
7952961|NCT02574845|12500374|FG002|Overall Study|Adverse Event|0
7952962|NCT02574845|12500375|FG003|Overall Study|Adverse Event|0
7952963|NCT02574845|12500376|FG004|Overall Study|Adverse Event|0
7952964|NCT02574845|12500377|FG005|Overall Study|Adverse Event|1
7952965|NCT02575079|12500397|FG000|Overall Study|Death|3
7952966|NCT02575079|12500398|FG001|Overall Study|Death|0
7952967|NCT02575079|12500397|FG000|Overall Study|Withdrawal by Subject|3
7952968|NCT02575079|12500398|FG001|Overall Study|Withdrawal by Subject|0
7952969|NCT02575807|12500412|FG000|Overall Study|Death|8
7952970|NCT02575807|12500413|FG001|Overall Study|Death|3
7952971|NCT02575807|12500414|FG002|Overall Study|Death|7
7952972|NCT02575807|12500415|FG003|Overall Study|Death|0
7952973|NCT02575807|12500416|FG004|Overall Study|Death|1
7952974|NCT02575807|12500412|FG000|Overall Study|Study terminated by Sponsor|0
7952975|NCT02575807|12500413|FG001|Overall Study|Study terminated by Sponsor|1
7952976|NCT02575807|12500414|FG002|Overall Study|Study terminated by Sponsor|7
7952977|NCT02575807|12500415|FG003|Overall Study|Study terminated by Sponsor|0
7952978|NCT02575807|12500416|FG004|Overall Study|Study terminated by Sponsor|1
7952979|NCT02575807|12500412|FG000|Overall Study|Terminated due to FDA clinical hold|1
7952980|NCT02575807|12500413|FG001|Overall Study|Terminated due to FDA clinical hold|0
7952981|NCT02575807|12500414|FG002|Overall Study|Terminated due to FDA clinical hold|0
7952982|NCT02575807|12500415|FG003|Overall Study|Terminated due to FDA clinical hold|0
7952983|NCT02575807|12500416|FG004|Overall Study|Terminated due to FDA clinical hold|0
7952984|NCT02575807|12500412|FG000|Overall Study|Terminated due to physician decision|0
7952985|NCT02575807|12500413|FG001|Overall Study|Terminated due to physician decision|0
7952986|NCT02575807|12500414|FG002|Overall Study|Terminated due to physician decision|1
7952987|NCT02575807|12500415|FG003|Overall Study|Terminated due to physician decision|0
7952988|NCT02575807|12500416|FG004|Overall Study|Terminated due to physician decision|0
7952989|NCT02575807|12500412|FG000|Overall Study|Subject ineligible - medical implant|0
7952990|NCT02575807|12500413|FG001|Overall Study|Subject ineligible - medical implant|0
7952991|NCT02575807|12500414|FG002|Overall Study|Subject ineligible - medical implant|0
7952992|NCT02575807|12500415|FG003|Overall Study|Subject ineligible - medical implant|1
7952993|NCT02575807|12500416|FG004|Overall Study|Subject ineligible - medical implant|0
7952994|NCT02575807|12500412|FG000|Overall Study|Withdrawal by Subject|0
7952995|NCT02575807|12500413|FG001|Overall Study|Withdrawal by Subject|0
7952996|NCT02575807|12500414|FG002|Overall Study|Withdrawal by Subject|1
7952997|NCT02575807|12500415|FG003|Overall Study|Withdrawal by Subject|1
7952998|NCT02575807|12500416|FG004|Overall Study|Withdrawal by Subject|2
7952999|NCT02575833|12500432|FG000|Overall Study|Withdrawal by Subject|0
7953000|NCT02575833|12500433|FG001|Overall Study|Withdrawal by Subject|1
7953001|NCT02575833|12500432|FG000|Overall Study|Lost to Follow-up|1
7953002|NCT02575833|12500433|FG001|Overall Study|Lost to Follow-up|0
7953003|NCT02575911|12500439|FG000|Overall Study|Lost to Follow-up|1
7953004|NCT02575950|12500451|FG000|Overall Study|Withdrawal by Subject|0
7953005|NCT02575950|12500452|FG001|Overall Study|Withdrawal by Subject|0
7953006|NCT02575950|12500453|FG002|Overall Study|Withdrawal by Subject|0
7953007|NCT02575950|12500454|FG003|Overall Study|Withdrawal by Subject|2
7953008|NCT02575950|12500451|FG000|Overall Study|Lost to Follow-up|0
7953009|NCT02575950|12500452|FG001|Overall Study|Lost to Follow-up|1
7953010|NCT02575950|12500453|FG002|Overall Study|Lost to Follow-up|0
7953011|NCT02575950|12500454|FG003|Overall Study|Lost to Follow-up|3
7953012|NCT02576054|12500466|FG000|Overall Study|Withdrawal by Subject|1
7953013|NCT02576067|12500474|FG000|Overall Study|Death|0
7953014|NCT02576067|12500475|FG001|Overall Study|Death|1
7953015|NCT02576067|12500474|FG000|Overall Study|Lack of Efficacy|1
7953016|NCT02576067|12500475|FG001|Overall Study|Lack of Efficacy|0
7953017|NCT02576067|12500474|FG000|Overall Study|Lost to Follow-up|11
7953018|NCT02576067|12500475|FG001|Overall Study|Lost to Follow-up|0
7953019|NCT02576067|12500474|FG000|Overall Study|Withdrawal by Subject|11
7953020|NCT02576067|12500475|FG001|Overall Study|Withdrawal by Subject|2
7953021|NCT02576067|12500474|FG000|Overall Study|study closure of main CIRT trial)|0
7953022|NCT02576067|12500475|FG001|Overall Study|study closure of main CIRT trial)|8
7953023|NCT02576067|12500474|FG000|Overall Study|not randomized, failed run-in|7
7953024|NCT02576067|12500475|FG001|Overall Study|not randomized, failed run-in|0
7953025|NCT02576067|12500474|FG000|Overall Study|screen failure/ re-enrolled|0
7953026|NCT02576067|12500475|FG001|Overall Study|screen failure/ re-enrolled|25
7953027|NCT02576067|12500474|FG000|Overall Study|Physician Decision|4
7953028|NCT02576067|12500475|FG001|Overall Study|Physician Decision|0
7953029|NCT02576145|12500483|FG000|Overall Study|Adverse Event|1
7953030|NCT02576145|12500484|FG001|Overall Study|Adverse Event|0
7953031|NCT02576145|12500483|FG000|Overall Study|Withdrawal by Subject|1
7953032|NCT02576145|12500484|FG001|Overall Study|Withdrawal by Subject|0
7953033|NCT02576145|12500483|FG000|Overall Study|Acute rejection|1
7953034|NCT02576145|12500484|FG001|Overall Study|Acute rejection|0
7953035|NCT02576145|12500483|FG000|Overall Study|Tetanus Titers Decreased|0
7953036|NCT02576145|12500484|FG001|Overall Study|Tetanus Titers Decreased|1
7953037|NCT02576535|12500499|FG000|Overall Study|Withdrawal by Subject|2
7966021|NCT02743221|12521672|FG000|Overall Study|non medical reason|8
7966022|NCT02743221|12521673|FG001|Overall Study|non medical reason|2
7966023|NCT02743221|12521672|FG000|Overall Study|Physician Decision|2
7966024|NCT02743221|12521673|FG001|Overall Study|Physician Decision|5
7966025|NCT02743221|12521672|FG000|Overall Study|Patient not eligible, not treated|0
7966026|NCT02743221|12521673|FG001|Overall Study|Patient not eligible, not treated|1
7966027|NCT02743520|12521711|FG000|Overall Study|Withdrawal by Subject|1
7966028|NCT02743780|12521729|FG000|Part 3 (7 Days)|Adverse Event|0
7966029|NCT02743780|12521730|FG001|Part 3 (7 Days)|Adverse Event|0
7966030|NCT02743780|12521731|FG002|Part 3 (7 Days)|Adverse Event|1
7966031|NCT02743780|12521732|FG003|Part 3 (7 Days)|Adverse Event|0
7966032|NCT02743780|12521733|FG004|Part 3 (7 Days)|Adverse Event|0
7966033|NCT02743793|12521755|FG000|Overall Study|Death|1
7966034|NCT02743793|12521756|FG001|Overall Study|Death|1
7966035|NCT02743793|12521755|FG000|Overall Study|Withdrawal by Subject|0
7966036|NCT02743793|12521756|FG001|Overall Study|Withdrawal by Subject|1
7966037|NCT02743793|12521755|FG000|Overall Study|Screen Failure|4
7966038|NCT02743793|12521756|FG001|Overall Study|Screen Failure|0
7966039|NCT02743793|12521755|FG000|Overall Study|No Primary Care Physician|0
7966040|NCT02743793|12521756|FG001|Overall Study|No Primary Care Physician|1
7966041|NCT02743793|12521755|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0
7966042|NCT02743793|12521756|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1
7966043|NCT02743793|12521755|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0
7966044|NCT02743793|12521756|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32
7966045|NCT02743949|12521773|FG000|Overall Study|Adverse Event|0
7966046|NCT02743949|12521774|FG001|Overall Study|Adverse Event|0
7966047|NCT02743949|12521775|FG002|Overall Study|Adverse Event|2
7966048|NCT02743949|12521773|FG000|Overall Study|Significant Protocol Deviation|2
7966049|NCT02743949|12521774|FG001|Overall Study|Significant Protocol Deviation|0
7966050|NCT02743949|12521775|FG002|Overall Study|Significant Protocol Deviation|1
7966051|NCT02743949|12521773|FG000|Overall Study|Voluntary Withdrawal|2
7953038|NCT02576587|12500505|FG000|Baseline|Equipment failure|0
7953039|NCT02576587|12500506|FG001|Baseline|Equipment failure|1
7953040|NCT02576587|12500505|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25
7953041|NCT02576587|12500506|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0
7953042|NCT02576587|12500505|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
7953043|NCT02576587|12500506|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
7953044|NCT02576587|12500505|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0
7953045|NCT02576587|12500506|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155
7953046|NCT02576639|12500519|FG000|Overall Study|Withdrawal by Subject|1
7953047|NCT02576639|12500520|FG001|Overall Study|Withdrawal by Subject|2
7953048|NCT02576639|12500521|FG002|Overall Study|Withdrawal by Subject|1
7953049|NCT02576639|12500522|FG003|Overall Study|Withdrawal by Subject|0
7953050|NCT02576639|12500523|FG004|Overall Study|Withdrawal by Subject|1
7953051|NCT02576639|12500519|FG000|Overall Study|Adverse Event|1
7953052|NCT02576639|12500520|FG001|Overall Study|Adverse Event|0
7953053|NCT02576639|12500521|FG002|Overall Study|Adverse Event|1
7953054|NCT02576639|12500522|FG003|Overall Study|Adverse Event|1
7953055|NCT02576639|12500523|FG004|Overall Study|Adverse Event|2
7953056|NCT02576639|12500519|FG000|Overall Study|Physician Decision|0
7953057|NCT02576639|12500520|FG001|Overall Study|Physician Decision|0
7953058|NCT02576639|12500521|FG002|Overall Study|Physician Decision|0
7953059|NCT02576639|12500522|FG003|Overall Study|Physician Decision|0
7953060|NCT02576639|12500523|FG004|Overall Study|Physician Decision|1
7953061|NCT02576652|12500539|FG000|Overall Study|Withdrawal by Subject|2
7953062|NCT02576678|12500546|FG000|Overall Study|Adverse Event|0
7953063|NCT02576678|12500547|FG001|Overall Study|Adverse Event|0
7953064|NCT02576678|12500548|FG002|Overall Study|Adverse Event|2
7953065|NCT02576678|12500546|FG000|Overall Study|Withdrawal by Subject|3
7953066|NCT02576678|12500547|FG001|Overall Study|Withdrawal by Subject|1
7953067|NCT02576678|12500548|FG002|Overall Study|Withdrawal by Subject|2
7953068|NCT02576678|12500546|FG000|Overall Study|Lost to Follow-up|0
7953069|NCT02576678|12500547|FG001|Overall Study|Lost to Follow-up|0
7953070|NCT02576678|12500548|FG002|Overall Study|Lost to Follow-up|1
7953071|NCT02576678|12500546|FG000|Overall Study|Miscellaneous|2
7953072|NCT02576678|12500547|FG001|Overall Study|Miscellaneous|0
7953073|NCT02576678|12500548|FG002|Overall Study|Miscellaneous|0
7953074|NCT02576938|12500569|FG000|Overall Study|Adverse Event|5
7953075|NCT02576938|12500570|FG001|Overall Study|Adverse Event|3
7953076|NCT02576938|12500571|FG002|Overall Study|Adverse Event|6
7953077|NCT02576938|12500569|FG000|Overall Study|Protocol Violation|1
7953078|NCT02576938|12500570|FG001|Overall Study|Protocol Violation|1
7953079|NCT02576938|12500571|FG002|Overall Study|Protocol Violation|1
7953080|NCT02576938|12500569|FG000|Overall Study|Withdrawal by Subject|3
7953081|NCT02576938|12500570|FG001|Overall Study|Withdrawal by Subject|2
7953082|NCT02576938|12500571|FG002|Overall Study|Withdrawal by Subject|4
7953083|NCT02576938|12500569|FG000|Overall Study|Lack of Efficacy|9
7953084|NCT02576938|12500570|FG001|Overall Study|Lack of Efficacy|4
7953085|NCT02576938|12500571|FG002|Overall Study|Lack of Efficacy|0
7953086|NCT02576938|12500569|FG000|Overall Study|Lost to Follow-up|2
7953087|NCT02576938|12500570|FG001|Overall Study|Lost to Follow-up|0
7953088|NCT02576938|12500571|FG002|Overall Study|Lost to Follow-up|1
7953089|NCT02576938|12500569|FG000|Overall Study|Physician Decision|0
7953090|NCT02576938|12500570|FG001|Overall Study|Physician Decision|1
7953091|NCT02576938|12500571|FG002|Overall Study|Physician Decision|0
7953092|NCT02576938|12500569|FG000|Overall Study|Met Exclusion Criteria|0
7953093|NCT02576938|12500570|FG001|Overall Study|Met Exclusion Criteria|1
7953094|NCT02576938|12500571|FG002|Overall Study|Met Exclusion Criteria|0
7953095|NCT02576951|12500585|FG000|Overall Study|Lost to Follow-up|0
7953096|NCT02576951|12500586|FG001|Overall Study|Lost to Follow-up|0
7953097|NCT02576951|12500587|FG002|Overall Study|Lost to Follow-up|2
7953098|NCT02576951|12500588|FG003|Overall Study|Lost to Follow-up|2
7953099|NCT02576951|12500585|FG000|Overall Study|Withdrawal by Subject|1
7953100|NCT02576951|12500586|FG001|Overall Study|Withdrawal by Subject|0
7953101|NCT02576951|12500587|FG002|Overall Study|Withdrawal by Subject|0
7953102|NCT02576951|12500588|FG003|Overall Study|Withdrawal by Subject|2
7953103|NCT02576951|12500585|FG000|Overall Study|Protocol Violation|0
7953104|NCT02576951|12500586|FG001|Overall Study|Protocol Violation|0
7953105|NCT02576951|12500587|FG002|Overall Study|Protocol Violation|0
7953106|NCT02576951|12500588|FG003|Overall Study|Protocol Violation|1
7953107|NCT02576977|12500602|FG000|Overall Study|Adverse Event|13
7953108|NCT02576977|12500603|FG001|Overall Study|Adverse Event|2
7953109|NCT02576977|12500602|FG000|Overall Study|Death|73
7953110|NCT02576977|12500603|FG001|Overall Study|Death|60
7953111|NCT02576977|12500602|FG000|Overall Study|Screen failure|1
7953112|NCT02576977|12500603|FG001|Overall Study|Screen failure|0
7953113|NCT02576977|12500602|FG000|Overall Study|Study Terminated at Selected Sites|27
7953114|NCT02576977|12500603|FG001|Overall Study|Study Terminated at Selected Sites|50
7953115|NCT02576977|12500602|FG000|Overall Study|Withdrawal by Subject|11
7953116|NCT02576977|12500603|FG001|Overall Study|Withdrawal by Subject|11
7953117|NCT02576977|12500602|FG000|Overall Study|Final Disposition Unknown|0
7953118|NCT02576977|12500603|FG001|Overall Study|Final Disposition Unknown|1
7953119|NCT02576977|12500602|FG000|Overall Study|Lost to Follow-up|1
7953120|NCT02576977|12500603|FG001|Overall Study|Lost to Follow-up|0
7953121|NCT02576977|12500602|FG000|Overall Study|Progressive Disease|0
7953122|NCT02576977|12500603|FG001|Overall Study|Progressive Disease|1
7953123|NCT02576990|12500611|FG000|Overall Study|Death|29
7953124|NCT02576990|12500612|FG001|Overall Study|Death|18
7953125|NCT02576990|12500611|FG000|Overall Study|Physician Decision|1
7953126|NCT02576990|12500612|FG001|Overall Study|Physician Decision|0
7953127|NCT02576990|12500611|FG000|Overall Study|Screen failure|2
7953128|NCT02576990|12500612|FG001|Overall Study|Screen failure|0
7953129|NCT02576990|12500611|FG000|Overall Study|Sponsor's decision|24
7953130|NCT02576990|12500612|FG001|Overall Study|Sponsor's decision|4
7953131|NCT02576990|12500611|FG000|Overall Study|Withdrawal by Subject|0
7953132|NCT02576990|12500612|FG001|Overall Study|Withdrawal by Subject|2
7953133|NCT02577003|12500620|FG000|Overall Study|Adverse Event|2
7953134|NCT02577003|12500621|FG001|Overall Study|Adverse Event|4
7953135|NCT02577003|12500620|FG000|Overall Study|Withdrawal by Subject|0
7953136|NCT02577003|12500621|FG001|Overall Study|Withdrawal by Subject|1
7953137|NCT02577016|12500629|FG000|Overall Study|Adverse Event|2
7953138|NCT02577016|12500630|FG001|Overall Study|Adverse Event|1
7953139|NCT02577016|12500629|FG000|Overall Study|Physician Decision|0
7953140|NCT02577016|12500630|FG001|Overall Study|Physician Decision|1
7953141|NCT02577029|12500644|FG000|Overall Study|Adverse Event|1
7953142|NCT02577029|12500645|FG001|Overall Study|Adverse Event|0
7953143|NCT02577029|12500646|FG002|Overall Study|Adverse Event|2
7953144|NCT02577029|12500647|FG003|Overall Study|Adverse Event|0
7953145|NCT02577029|12500648|FG004|Overall Study|Adverse Event|1
7953146|NCT02577029|12500649|FG005|Overall Study|Adverse Event|0
7953147|NCT02577029|12500650|FG006|Overall Study|Adverse Event|0
7953148|NCT02577029|12500651|FG007|Overall Study|Adverse Event|0
7953149|NCT02577029|12500644|FG000|Overall Study|Withdrawal by Subject|0
7953150|NCT02577029|12500645|FG001|Overall Study|Withdrawal by Subject|0
7953151|NCT02577029|12500646|FG002|Overall Study|Withdrawal by Subject|0
7953152|NCT02577029|12500647|FG003|Overall Study|Withdrawal by Subject|0
7953153|NCT02577029|12500648|FG004|Overall Study|Withdrawal by Subject|0
7953154|NCT02577029|12500649|FG005|Overall Study|Withdrawal by Subject|1
7953155|NCT02577029|12500650|FG006|Overall Study|Withdrawal by Subject|0
7953156|NCT02577029|12500651|FG007|Overall Study|Withdrawal by Subject|0
7953157|NCT02577029|12500644|FG000|Overall Study|Sponsor Termination of the Study|9
7953158|NCT02577029|12500645|FG001|Overall Study|Sponsor Termination of the Study|2
7953159|NCT02577029|12500646|FG002|Overall Study|Sponsor Termination of the Study|5
7953160|NCT02577029|12500647|FG003|Overall Study|Sponsor Termination of the Study|12
7953161|NCT02577029|12500648|FG004|Overall Study|Sponsor Termination of the Study|10
7953162|NCT02577029|12500649|FG005|Overall Study|Sponsor Termination of the Study|12
7953163|NCT02577029|12500650|FG006|Overall Study|Sponsor Termination of the Study|12
7953164|NCT02577029|12500651|FG007|Overall Study|Sponsor Termination of the Study|12
7953165|NCT02577107|12500681|FG000|Overall Study|Protocol deviation|0
7953166|NCT02577107|12500682|FG001|Overall Study|Protocol deviation|1
7953167|NCT02577146|12500688|FG000|Overall Study|Lost to Follow-up|8
7953168|NCT02577146|12500688|FG000|Overall Study|Physician Decision|3
7953169|NCT02577146|12500688|FG000|Overall Study|Screen Failure|17
7953170|NCT02577315|12500694|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7953171|NCT02577315|12500695|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
7953172|NCT02577718|12500747|FG000|Overall Study|Death|6
7953173|NCT02577718|12500747|FG000|Overall Study|Withdrawal by Subject|2
7953174|NCT02577887|12500762|FG000|Overall Study|Death|93
7953175|NCT02577887|12500762|FG000|Overall Study|Protocol Violation|125
7953176|NCT02577887|12500762|FG000|Overall Study|Withdrawal by Subject|80
7953177|NCT02578186|12500801|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
7953178|NCT02578186|12500802|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
7953179|NCT02578186|12500801|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1
7953180|NCT02578186|12500802|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1
7953181|NCT02578316|12500816|FG000|Extension Phase|Progression of disease|6
7953182|NCT02578706|12500827|FG000|Overall Study|Withdrawal by Subject|1
7953183|NCT02578706|12500828|FG001|Overall Study|Withdrawal by Subject|0
7953184|NCT02578706|12500829|FG002|Overall Study|Withdrawal by Subject|0
7953185|NCT02578706|12500827|FG000|Overall Study|Lost to Follow-up|0
7953186|NCT02578706|12500828|FG001|Overall Study|Lost to Follow-up|4
7953187|NCT02578706|12500829|FG002|Overall Study|Lost to Follow-up|0
7953188|NCT02578706|12500827|FG000|Overall Study|Physician Decision|0
7953189|NCT02578706|12500828|FG001|Overall Study|Physician Decision|1
7953190|NCT02578706|12500829|FG002|Overall Study|Physician Decision|0
7953191|NCT02578862|12500849|FG000|Overall Study|Withdrawal by Subject|0
7953192|NCT02578862|12500850|FG001|Overall Study|Withdrawal by Subject|1
7953193|NCT02578862|12500849|FG000|Overall Study|Unplanned unilateral procedure|0
7953194|NCT02578862|12500850|FG001|Overall Study|Unplanned unilateral procedure|1
7953195|NCT02578940|12500865|FG000|Overall Study|Screening failure|5
7953196|NCT02578940|12500865|FG000|Overall Study|Lost to Follow-up|1
7953197|NCT02578992|12500873|FG000|Overall Study|equipment not available or malfunction|3
7953198|NCT02578992|12500874|FG001|Overall Study|equipment not available or malfunction|3
7953199|NCT02579382|12500917|FG000|Main Study Phase|Lost to Follow-up|0
7953200|NCT02579382|12500918|FG001|Main Study Phase|Lost to Follow-up|0
7953201|NCT02579382|12500919|FG002|Main Study Phase|Lost to Follow-up|2
7953202|NCT02579382|12500920|FG003|Main Study Phase|Lost to Follow-up|0
7953203|NCT02579382|12500917|FG000|Main Study Phase|Withdrew Consent|0
7953204|NCT02579382|12500918|FG001|Main Study Phase|Withdrew Consent|0
7953205|NCT02579382|12500919|FG002|Main Study Phase|Withdrew Consent|0
7953206|NCT02579382|12500920|FG003|Main Study Phase|Withdrew Consent|2
7953207|NCT02579382|12500917|FG000|Main Study Phase|Lack of Efficacy|0
7953208|NCT02579382|12500918|FG001|Main Study Phase|Lack of Efficacy|0
7953209|NCT02579382|12500919|FG002|Main Study Phase|Lack of Efficacy|0
7953210|NCT02579382|12500920|FG003|Main Study Phase|Lack of Efficacy|1
7953211|NCT02579382|12500917|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0
7953212|NCT02579382|12500918|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3
7953213|NCT02579382|12500919|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1
7953214|NCT02579382|12500920|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4
7953215|NCT02579382|12500917|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1
7953216|NCT02579382|12500918|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
7953217|NCT02579382|12500919|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2
7953218|NCT02579382|12500920|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
7953219|NCT02579382|12500917|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0
7953220|NCT02579382|12500918|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
7953221|NCT02579382|12500919|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
7953222|NCT02579382|12500920|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
7953223|NCT02579382|12500917|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
7953224|NCT02579382|12500918|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1
7953225|NCT02579382|12500919|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
7953226|NCT02579382|12500920|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
7953227|NCT02579382|12500917|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
7953228|NCT02579382|12500918|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1
7953229|NCT02579382|12500919|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
7953230|NCT02579382|12500920|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
7953231|NCT02579382|12500917|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
7953232|NCT02579382|12500918|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1
7953233|NCT02579382|12500919|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
7953234|NCT02579382|12500920|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
7953235|NCT02579603|12500957|FG000|Overall Study|Not treated|1
7953236|NCT02579603|12500958|FG001|Overall Study|Not treated|0
7953237|NCT02579603|12500957|FG000|Overall Study|Adverse Event|2
7953238|NCT02579603|12500958|FG001|Overall Study|Adverse Event|2
7953239|NCT02579603|12500957|FG000|Overall Study|Other than stated|1
7953240|NCT02579603|12500958|FG001|Overall Study|Other than stated|0
7953241|NCT02579616|12500965|FG000|Overall Study|Participants did not receive treatment|3
7953242|NCT02579629|12500972|FG000|Overall Study|Withdrawal by Subject|0
7953243|NCT02579629|12500973|FG001|Overall Study|Withdrawal by Subject|1
7953244|NCT02579629|12500974|FG002|Overall Study|Withdrawal by Subject|0
7953245|NCT02579629|12500972|FG000|Overall Study|Screen Failure|2
7953246|NCT02579629|12500973|FG001|Overall Study|Screen Failure|0
7953247|NCT02579629|12500974|FG002|Overall Study|Screen Failure|2
7953248|NCT02579759|12500985|FG000|Overall Study|Protocol Violation|2
7953249|NCT02579759|12500986|FG001|Overall Study|Protocol Violation|0
7953250|NCT02579759|12500987|FG002|Overall Study|Protocol Violation|0
7953251|NCT02579759|12500985|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0
7953252|NCT02579759|12500986|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1
7953253|NCT02579759|12500987|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0
7953254|NCT02579759|12500985|FG000|Overall Study|BfArM hold|13
7953255|NCT02579759|12500986|FG001|Overall Study|BfArM hold|12
7953256|NCT02579759|12500987|FG002|Overall Study|BfArM hold|12
7953257|NCT02579759|12500985|FG000|Overall Study|Sponsor stopped Dose 2|0
7953258|NCT02579759|12500986|FG001|Overall Study|Sponsor stopped Dose 2|41
7953259|NCT02579759|12500987|FG002|Overall Study|Sponsor stopped Dose 2|0
7953260|NCT02579759|12500985|FG000|Overall Study|Non compliance|0
7953261|NCT02579759|12500986|FG001|Overall Study|Non compliance|1
7953262|NCT02579759|12500987|FG002|Overall Study|Non compliance|0
7953263|NCT02579759|12500985|FG000|Overall Study|Pregnancy|0
7953264|NCT02579759|12500986|FG001|Overall Study|Pregnancy|1
7953265|NCT02579759|12500987|FG002|Overall Study|Pregnancy|0
7953266|NCT02579759|12500985|FG000|Overall Study|Inclusion/exclusion criteria|0
7953267|NCT02579759|12500986|FG001|Overall Study|Inclusion/exclusion criteria|0
7953268|NCT02579759|12500987|FG002|Overall Study|Inclusion/exclusion criteria|1
7953269|NCT02579759|12500985|FG000|Overall Study|Adverse Event|4
7953270|NCT02579759|12500986|FG001|Overall Study|Adverse Event|3
7953271|NCT02579759|12500987|FG002|Overall Study|Adverse Event|1
7953272|NCT02579759|12500985|FG000|Overall Study|Withdrawal by Subject|3
7953273|NCT02579759|12500986|FG001|Overall Study|Withdrawal by Subject|3
7953274|NCT02579759|12500987|FG002|Overall Study|Withdrawal by Subject|5
7953275|NCT02579759|12500985|FG000|Overall Study|Lost to Follow-up|2
7953276|NCT02579759|12500986|FG001|Overall Study|Lost to Follow-up|2
7953277|NCT02579759|12500987|FG002|Overall Study|Lost to Follow-up|2
7953278|NCT02579772|12500997|FG000|Overall Study|Withdrawal by Subject|0
7953279|NCT02579772|12500998|FG001|Overall Study|Withdrawal by Subject|1
7953280|NCT02579772|12500997|FG000|Overall Study|Usage of additional antioxidants|1
7953281|NCT02579772|12500998|FG001|Overall Study|Usage of additional antioxidants|0
7953282|NCT02579772|12500997|FG000|Overall Study|flu-like illness, orthopedic trauma|1
7953283|NCT02579772|12500998|FG001|Overall Study|flu-like illness, orthopedic trauma|1
7953284|NCT02579863|12501006|FG000|Overall Study|Final Disposition Unknown|2
7953285|NCT02579863|12501007|FG001|Overall Study|Final Disposition Unknown|1
7953286|NCT02579863|12501006|FG000|Overall Study|Adverse Event|18
7953287|NCT02579863|12501007|FG001|Overall Study|Adverse Event|11
7953288|NCT02579863|12501006|FG000|Overall Study|Death|31
7953289|NCT02579863|12501007|FG001|Overall Study|Death|29
7953290|NCT02579863|12501006|FG000|Overall Study|Lost to Follow-up|2
7953291|NCT02579863|12501007|FG001|Overall Study|Lost to Follow-up|1
7953292|NCT02579863|12501006|FG000|Overall Study|Physician Decision|1
7953293|NCT02579863|12501007|FG001|Overall Study|Physician Decision|2
7953294|NCT02579863|12501006|FG000|Overall Study|Screen Failure|0
7953295|NCT02579863|12501007|FG001|Overall Study|Screen Failure|2
7953296|NCT02579863|12501006|FG000|Overall Study|Study Terminated at Selected Sites|82
7953297|NCT02579863|12501007|FG001|Overall Study|Study Terminated at Selected Sites|88
7953298|NCT02579863|12501006|FG000|Overall Study|Withdrawal by Subject|20
7953299|NCT02579863|12501007|FG001|Overall Study|Withdrawal by Subject|20
7953300|NCT02579928|12501033|FG000|Overall Study|Withdrawal by Subject|1
7953301|NCT02579928|12501034|FG001|Overall Study|Withdrawal by Subject|0
7953302|NCT02580240|12501062|FG000|Overall Study|Physician Decision|2
7953303|NCT02580240|12501063|FG001|Overall Study|Physician Decision|0
7953304|NCT02580357|12501076|FG000|Overall Study|Lost to Follow-up|2
7953305|NCT02580357|12501077|FG001|Overall Study|Lost to Follow-up|0
7953306|NCT02580357|12501078|FG002|Overall Study|Lost to Follow-up|0
7953307|NCT02580357|12501076|FG000|Overall Study|Protocol Violation|1
7953308|NCT02580357|12501077|FG001|Overall Study|Protocol Violation|0
7953309|NCT02580357|12501078|FG002|Overall Study|Protocol Violation|0
7953310|NCT02580591|12501090|FG000|Overall Study|Adverse Event|0
7953311|NCT02580591|12501091|FG001|Overall Study|Adverse Event|1
7953312|NCT02580591|12501092|FG002|Overall Study|Adverse Event|2
7953313|NCT02580591|12501093|FG003|Overall Study|Adverse Event|5
7953314|NCT02580591|12501090|FG000|Overall Study|Protocol Violation|3
7953315|NCT02580591|12501091|FG001|Overall Study|Protocol Violation|2
7953316|NCT02580591|12501092|FG002|Overall Study|Protocol Violation|1
7953317|NCT02580591|12501093|FG003|Overall Study|Protocol Violation|1
7953318|NCT02580591|12501090|FG000|Overall Study|Lost to Follow-up|5
7953319|NCT02580591|12501091|FG001|Overall Study|Lost to Follow-up|3
7953320|NCT02580591|12501092|FG002|Overall Study|Lost to Follow-up|3
7953321|NCT02580591|12501093|FG003|Overall Study|Lost to Follow-up|1
7953322|NCT02580591|12501090|FG000|Overall Study|Withdrawal by Subject|6
7953323|NCT02580591|12501091|FG001|Overall Study|Withdrawal by Subject|1
7953324|NCT02580591|12501092|FG002|Overall Study|Withdrawal by Subject|2
7953325|NCT02580591|12501093|FG003|Overall Study|Withdrawal by Subject|3
7953326|NCT02580591|12501090|FG000|Overall Study|Not treated|1
7953327|NCT02580591|12501091|FG001|Overall Study|Not treated|1
7953328|NCT02580591|12501092|FG002|Overall Study|Not treated|0
7953329|NCT02580591|12501093|FG003|Overall Study|Not treated|0
7953330|NCT02580591|12501090|FG000|Overall Study|Other than specified|3
7953331|NCT02580591|12501091|FG001|Overall Study|Other than specified|2
7953332|NCT02580591|12501092|FG002|Overall Study|Other than specified|5
7953333|NCT02580591|12501093|FG003|Overall Study|Other than specified|2
7953334|NCT02580877|12501109|FG000|Overall Study|Withdrawal by Subject|1
7953335|NCT02580877|12501110|FG001|Overall Study|Withdrawal by Subject|3
7953336|NCT02580877|12501109|FG000|Overall Study|Adverse Event|0
7953337|NCT02580877|12501110|FG001|Overall Study|Adverse Event|1
7953338|NCT02581163|12501126|FG000|Overall Study|Failure to return|15
7953339|NCT02581163|12501126|FG000|Overall Study|Insufficient virological response|3
7953340|NCT02581163|12501126|FG000|Overall Study|Withdrew consent|1
7953341|NCT02581163|12501126|FG000|Overall Study|Death|1
7953342|NCT02581163|12501126|FG000|Overall Study|Other, not specified|9
7953343|NCT02581189|12501133|FG000|Overall Study|Failure to return|36
7953344|NCT02581189|12501133|FG000|Overall Study|Withdrew consent|5
7953345|NCT02581189|12501133|FG000|Overall Study|Death|3
7953346|NCT02581189|12501133|FG000|Overall Study|Insufficient virological response|2
7953347|NCT02581189|12501133|FG000|Overall Study|Other, not specified|7
7953348|NCT02581202|12501140|FG000|Overall Study|Lack of Efficacy|2
7953349|NCT02581202|12501140|FG000|Overall Study|Withdrawal by Subject|4
7953350|NCT02581202|12501140|FG000|Overall Study|Lost to Follow-up|5
7953351|NCT02581202|12501140|FG000|Overall Study|Pregnancy|3
7953352|NCT02581345|12501147|FG000|Part 1: up to Week 16|Adverse Event|3
7953353|NCT02581345|12501148|FG001|Part 1: up to Week 16|Adverse Event|8
7953354|NCT02581345|12501149|FG002|Part 1: up to Week 16|Adverse Event|0
7953355|NCT02581345|12501150|FG003|Part 1: up to Week 16|Adverse Event|0
7953356|NCT02581345|12501147|FG000|Part 1: up to Week 16|Physician Decision|2
7953357|NCT02581345|12501148|FG001|Part 1: up to Week 16|Physician Decision|4
7953358|NCT02581345|12501149|FG002|Part 1: up to Week 16|Physician Decision|0
7953359|NCT02581345|12501150|FG003|Part 1: up to Week 16|Physician Decision|0
7953360|NCT02581345|12501147|FG000|Part 1: up to Week 16|Withdrawal by Subject|4
7953361|NCT02581345|12501148|FG001|Part 1: up to Week 16|Withdrawal by Subject|7
7953362|NCT02581345|12501149|FG002|Part 1: up to Week 16|Withdrawal by Subject|0
7953363|NCT02581345|12501150|FG003|Part 1: up to Week 16|Withdrawal by Subject|0
7953364|NCT02581345|12501147|FG000|Part 1: up to Week 16|Lost to Follow-up|2
7953365|NCT02581345|12501148|FG001|Part 1: up to Week 16|Lost to Follow-up|0
7953366|NCT02581345|12501149|FG002|Part 1: up to Week 16|Lost to Follow-up|0
7953367|NCT02581345|12501150|FG003|Part 1: up to Week 16|Lost to Follow-up|0
7953368|NCT02581345|12501147|FG000|Part 1: up to Week 16|Unspecified Reason|3
7953369|NCT02581345|12501148|FG001|Part 1: up to Week 16|Unspecified Reason|3
7953370|NCT02581345|12501149|FG002|Part 1: up to Week 16|Unspecified Reason|0
7953371|NCT02581345|12501150|FG003|Part 1: up to Week 16|Unspecified Reason|0
7953372|NCT02581345|12501147|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1
7953373|NCT02581345|12501148|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1
7953374|NCT02581345|12501149|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0
7953375|NCT02581345|12501150|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0
7953376|NCT02581345|12501147|FG000|Part 2: Week 17 to Week 47|Adverse Event|5
7953377|NCT02581345|12501148|FG001|Part 2: Week 17 to Week 47|Adverse Event|0
7953378|NCT02581345|12501149|FG002|Part 2: Week 17 to Week 47|Adverse Event|2
7953379|NCT02581345|12501150|FG003|Part 2: Week 17 to Week 47|Adverse Event|2
7953380|NCT02581345|12501147|FG000|Part 2: Week 17 to Week 47|Physician Decision|3
7953381|NCT02581345|12501148|FG001|Part 2: Week 17 to Week 47|Physician Decision|0
7953382|NCT02581345|12501149|FG002|Part 2: Week 17 to Week 47|Physician Decision|2
7953383|NCT02581345|12501150|FG003|Part 2: Week 17 to Week 47|Physician Decision|1
7953384|NCT02581345|12501147|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
7953385|NCT02581345|12501148|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
7953386|NCT02581345|12501149|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
7953387|NCT02581345|12501150|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
7953388|NCT02581345|12501147|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
7953389|NCT02581345|12501148|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
7953390|NCT02581345|12501149|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
7953391|NCT02581345|12501150|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
7953392|NCT02581345|12501147|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2
7953393|NCT02581345|12501148|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0
7953394|NCT02581345|12501149|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0
7953395|NCT02581345|12501150|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1
7953396|NCT02581345|12501147|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2
7953397|NCT02581345|12501148|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0
7953398|NCT02581345|12501149|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1
7953399|NCT02581345|12501150|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1
7953400|NCT02581410|12501178|FG000|Vaccination Phase|Adverse Event|2
7953401|NCT02581410|12501179|FG001|Vaccination Phase|Adverse Event|1
7953402|NCT02581410|12501178|FG000|Vaccination Phase|Withdrawal by Subject|0
7953403|NCT02581410|12501179|FG001|Vaccination Phase|Withdrawal by Subject|1
7953404|NCT02581410|12501178|FG000|Vaccination Phase|Migrated/moved from study area|0
7953405|NCT02581410|12501179|FG001|Vaccination Phase|Migrated/moved from study area|1
7953406|NCT02581410|12501178|FG000|End of Study Phase|Adverse Event|4
7953407|NCT02581410|12501179|FG001|End of Study Phase|Adverse Event|3
7953408|NCT02581410|12501178|FG000|End of Study Phase|Withdrawal by Subject|1
7953409|NCT02581410|12501179|FG001|End of Study Phase|Withdrawal by Subject|2
7953410|NCT02581410|12501178|FG000|End of Study Phase|Migrated/moved from study area|0
7953411|NCT02581410|12501179|FG001|End of Study Phase|Migrated/moved from study area|3
7953412|NCT02581410|12501178|FG000|End of Study Phase|Lost to Follow-up|0
7953413|NCT02581410|12501179|FG001|End of Study Phase|Lost to Follow-up|2
7953414|NCT02581410|12501178|FG000|End of Study Phase|Other-transfer of subject not completed|0
7953415|NCT02581410|12501179|FG001|End of Study Phase|Other-transfer of subject not completed|1
7953416|NCT02581488|12501197|FG000|Overall Study|Adverse Event|6
7953417|NCT02581488|12501198|FG001|Overall Study|Adverse Event|7
7953418|NCT02581488|12501197|FG000|Overall Study|Lost to Follow-up|1
7953419|NCT02581488|12501198|FG001|Overall Study|Lost to Follow-up|0
7953420|NCT02581488|12501197|FG000|Overall Study|Withdrawal by Subject|1
7953421|NCT02581488|12501198|FG001|Overall Study|Withdrawal by Subject|0
7953422|NCT02581488|12501197|FG000|Overall Study|Non-Compliance|1
7953423|NCT02581488|12501198|FG001|Overall Study|Non-Compliance|0
7953424|NCT02581488|12501197|FG000|Overall Study|Protocol Violation|0
7953425|NCT02581488|12501198|FG001|Overall Study|Protocol Violation|4
7953426|NCT02581891|12501226|FG000|Overall Study|Adverse Event|4
7953427|NCT02581891|12501227|FG001|Overall Study|Adverse Event|6
7953428|NCT02581891|12501226|FG000|Overall Study|Death|3
7953429|NCT02581891|12501227|FG001|Overall Study|Death|4
7953430|NCT02581891|12501226|FG000|Overall Study|Lost to Follow-up|1
7953431|NCT02581891|12501227|FG001|Overall Study|Lost to Follow-up|2
7953432|NCT02581891|12501226|FG000|Overall Study|Physician Decision|0
7953433|NCT02581891|12501227|FG001|Overall Study|Physician Decision|1
7953434|NCT02581891|12501226|FG000|Overall Study|Withdrawal by Subject|4
7953435|NCT02581891|12501227|FG001|Overall Study|Withdrawal by Subject|5
7953436|NCT02581891|12501226|FG000|Overall Study|Other Reasons|3
7953437|NCT02581891|12501227|FG001|Overall Study|Other Reasons|1
7953438|NCT02581891|12501226|FG000|Overall Study|Discontinued during followup|1
7953439|NCT02581891|12501227|FG001|Overall Study|Discontinued during followup|0
7953440|NCT02581995|12501234|FG000|Overall Study|Unspecified other|3
7953441|NCT02581995|12501234|FG000|Overall Study|Adverse Event|6
7953442|NCT02581995|12501234|FG000|Overall Study|Lost to Follow-up|5
7953443|NCT02581995|12501234|FG000|Overall Study|Withdrawal by participant|12
7953444|NCT02581995|12501234|FG000|Overall Study|Physician Decision|1
7953445|NCT02581995|12501234|FG000|Overall Study|Death|4
7953446|NCT02582242|12501254|FG000|Overall Study|Adverse Event|4
7953447|NCT02582242|12501255|FG001|Overall Study|Adverse Event|3
7953448|NCT02582242|12501254|FG000|Overall Study|Protocol Violation|3
7953449|NCT02582242|12501255|FG001|Overall Study|Protocol Violation|1
7953450|NCT02582242|12501254|FG000|Overall Study|Lost to Follow-up|0
7953451|NCT02582242|12501255|FG001|Overall Study|Lost to Follow-up|1
7953452|NCT02582242|12501254|FG000|Overall Study|Withdrawal by Subject|11
7953453|NCT02582242|12501255|FG001|Overall Study|Withdrawal by Subject|11
7953454|NCT02582242|12501254|FG000|Overall Study|Unclassified|2
7953455|NCT02582242|12501255|FG001|Overall Study|Unclassified|1
7953456|NCT02582255|12501263|FG000|Overall Study|Protocol Violation|0
7953457|NCT02582255|12501264|FG001|Overall Study|Protocol Violation|3
7953458|NCT02582515|12501273|FG000|Overall Study|Withdrawal by Subject|0
7953459|NCT02582515|12501274|FG001|Overall Study|Withdrawal by Subject|1
7953460|NCT02582632|12501280|FG000|Overall Study|Other|1
7953461|NCT02582658|12501284|FG000|Overall Study|Failure to Return|10
7953462|NCT02582658|12501284|FG000|Overall Study|Insufficient Virological Response|2
7953463|NCT02582658|12501284|FG000|Overall Study|Withdrawn Consent|1
7953464|NCT02582658|12501284|FG000|Overall Study|Death|1
7953465|NCT02582658|12501284|FG000|Overall Study|Not further specified|11
7953466|NCT02582671|12501288|FG000|Overall Study|Failure to return|1
7953467|NCT02582671|12501288|FG000|Overall Study|Other, not specified|1
7953468|NCT02582684|12501293|FG000|Overall Study|Unable to contact subject/parent|4
7953469|NCT02582684|12501293|FG000|Overall Study|Subject not able to get to clinic|10
7953470|NCT02582684|12501293|FG000|Overall Study|Subject withdrew consent|1
7953471|NCT02582684|12501293|FG000|Overall Study|Found to be ineligible after enrollment|2
7953472|NCT02582814|12501299|FG000|Overall Study|Study-specific withdrawal criteria|1
7953473|NCT02582814|12501300|FG001|Overall Study|Study-specific withdrawal criteria|0
7953474|NCT02582814|12501299|FG000|Overall Study|Withdrawal by Subject|4
7953475|NCT02582814|12501300|FG001|Overall Study|Withdrawal by Subject|3
7953476|NCT02582814|12501299|FG000|Overall Study|Adverse Event|4
7953477|NCT02582814|12501300|FG001|Overall Study|Adverse Event|4
7953478|NCT02582866|12501321|FG000|Overall Study|Death|1
7953479|NCT02582866|12501321|FG000|Overall Study|Lack of Efficacy|2
7953480|NCT02582866|12501321|FG000|Overall Study|Lost to Follow-up|2
7953481|NCT02582866|12501321|FG000|Overall Study|Withdrawal by Subject|7
7953482|NCT02582866|12501321|FG000|Overall Study|Investigator decision|5
7953483|NCT02582866|12501321|FG000|Overall Study|Participant wants to get pregnant|1
7953484|NCT02582866|12501321|FG000|Overall Study|Pregnancy|2
7953485|NCT02582866|12501321|FG000|Overall Study|Sponsor decision|1
7953486|NCT02582866|12501321|FG000|Overall Study|Withdrawal due to personal reasons|1
7953487|NCT02582983|12501329|FG000|Overall Study|Death|3
7953488|NCT02582983|12501329|FG000|Overall Study|Withdrawal by Subject|2
7953489|NCT02582983|12501329|FG000|Overall Study|Adverse Event|1
7953490|NCT02583256|12501341|FG000|Overall Study|Withdrawal by Subject|0
7953491|NCT02583256|12501342|FG001|Overall Study|Withdrawal by Subject|1
7953492|NCT02583256|12501343|FG002|Overall Study|Withdrawal by Subject|1
7953493|NCT02583256|12501344|FG003|Overall Study|Withdrawal by Subject|0
7953494|NCT02583256|12501341|FG000|Overall Study|Lost to Follow-up|1
7953495|NCT02583256|12501342|FG001|Overall Study|Lost to Follow-up|1
7953496|NCT02583256|12501343|FG002|Overall Study|Lost to Follow-up|0
7953497|NCT02583256|12501344|FG003|Overall Study|Lost to Follow-up|1
7953498|NCT02583256|12501341|FG000|Overall Study|Administrative/Other|2
7953499|NCT02583256|12501342|FG001|Overall Study|Administrative/Other|0
7953500|NCT02583256|12501343|FG002|Overall Study|Administrative/Other|1
7953501|NCT02583256|12501344|FG003|Overall Study|Administrative/Other|2
7953502|NCT02583399|12501365|FG000|Overall Study|Able to be discharged|3
7953503|NCT02583399|12501365|FG000|Overall Study|Wanted to use a restricted medication|3
7953504|NCT02583425|12501369|FG000|Screening|Did not meet entry criteria|12
7953505|NCT02583425|12501369|FG000|Baseline|Did not meet continued criteria|5
7953506|NCT02583425|12501369|FG000|Treatment Period|Adverse Event|1
7953507|NCT02583477|12501376|FG000|Overall Study|Adverse Event|0
7953508|NCT02583477|12501377|FG001|Overall Study|Adverse Event|2
7953509|NCT02583477|12501376|FG000|Overall Study|Death|1
7953510|NCT02583477|12501377|FG001|Overall Study|Death|16
7953511|NCT02583477|12501376|FG000|Overall Study|Study terminated|2
7953512|NCT02583477|12501377|FG001|Overall Study|Study terminated|2
7953513|NCT02583711|12501387|FG000|Overall Study|Withdrawal by Subject|0
7953514|NCT02583711|12501388|FG001|Overall Study|Withdrawal by Subject|10
7953515|NCT02583711|12501389|FG002|Overall Study|Withdrawal by Subject|0
7953516|NCT02584257|12501403|FG000|Period 1|Withdrawal by Subject|0
7953517|NCT02584257|12501404|FG001|Period 1|Withdrawal by Subject|0
7953518|NCT02584257|12501405|FG002|Period 1|Withdrawal by Subject|0
7953519|NCT02584257|12501406|FG003|Period 1|Withdrawal by Subject|0
7953520|NCT02584257|12501407|FG004|Period 1|Withdrawal by Subject|0
7953521|NCT02584257|12501408|FG005|Period 1|Withdrawal by Subject|0
7953522|NCT02584257|12501409|FG006|Period 1|Withdrawal by Subject|1
7953523|NCT02584257|12501410|FG007|Period 1|Withdrawal by Subject|0
7953524|NCT02584257|12501411|FG008|Period 1|Withdrawal by Subject|0
7953525|NCT02584257|12501403|FG000|Period 2|Physician Decision|1
7953526|NCT02584257|12501404|FG001|Period 2|Physician Decision|0
7953527|NCT02584257|12501405|FG002|Period 2|Physician Decision|0
7953528|NCT02584257|12501406|FG003|Period 2|Physician Decision|0
7953529|NCT02584257|12501407|FG004|Period 2|Physician Decision|0
7953530|NCT02584257|12501408|FG005|Period 2|Physician Decision|0
7953531|NCT02584257|12501409|FG006|Period 2|Physician Decision|0
7953532|NCT02584257|12501410|FG007|Period 2|Physician Decision|0
7953533|NCT02584257|12501411|FG008|Period 2|Physician Decision|0
7953534|NCT02584257|12501403|FG000|Period 2|Adverse Event|0
7953535|NCT02584257|12501404|FG001|Period 2|Adverse Event|1
7953536|NCT02584257|12501405|FG002|Period 2|Adverse Event|0
7953537|NCT02584257|12501406|FG003|Period 2|Adverse Event|0
7953538|NCT02584257|12501407|FG004|Period 2|Adverse Event|0
7953539|NCT02584257|12501408|FG005|Period 2|Adverse Event|0
7953540|NCT02584257|12501409|FG006|Period 2|Adverse Event|0
7953541|NCT02584257|12501410|FG007|Period 2|Adverse Event|0
7953542|NCT02584257|12501411|FG008|Period 2|Adverse Event|0
7953543|NCT02584452|12501425|FG000|Overall Study|Physician Decision|1
7953544|NCT02584452|12501426|FG001|Overall Study|Physician Decision|1
7953545|NCT02584452|12501425|FG000|Overall Study|Lost to Follow-up|1
7953546|NCT02584452|12501426|FG001|Overall Study|Lost to Follow-up|1
7953547|NCT02584504|12501436|FG000|Double-blind Treatment|Participant withdrew consent|0
7953548|NCT02584504|12501437|FG001|Double-blind Treatment|Participant withdrew consent|0
7953549|NCT02584504|12501438|FG002|Double-blind Treatment|Participant withdrew consent|1
7953550|NCT02584504|12501436|FG000|Double-blind Treatment|Adverse Event|0
7953551|NCT02584504|12501437|FG001|Double-blind Treatment|Adverse Event|1
7953552|NCT02584504|12501438|FG002|Double-blind Treatment|Adverse Event|0
7953553|NCT02584504|12501436|FG000|Double-blind Treatment|Family Matter|0
7953554|NCT02584504|12501437|FG001|Double-blind Treatment|Family Matter|1
7953555|NCT02584504|12501438|FG002|Double-blind Treatment|Family Matter|0
7953556|NCT02584504|12501436|FG000|Open-label Treatment|Participant withdrew consent|0
7953557|NCT02584504|12501437|FG001|Open-label Treatment|Participant withdrew consent|0
7953558|NCT02584504|12501438|FG002|Open-label Treatment|Participant withdrew consent|4
7953559|NCT02584504|12501436|FG000|Open-label Treatment|Adverse Event|2
7953560|NCT02584504|12501437|FG001|Open-label Treatment|Adverse Event|2
7953561|NCT02584504|12501438|FG002|Open-label Treatment|Adverse Event|3
7953562|NCT02584504|12501436|FG000|Open-label Treatment|Physician Decision|0
7953563|NCT02584504|12501437|FG001|Open-label Treatment|Physician Decision|1
7953564|NCT02584504|12501438|FG002|Open-label Treatment|Physician Decision|0
7953565|NCT02584504|12501436|FG000|Open-label Treatment|Entered but not treated|0
7953566|NCT02584504|12501437|FG001|Open-label Treatment|Entered but not treated|1
7953567|NCT02584504|12501438|FG002|Open-label Treatment|Entered but not treated|1
7953568|NCT02584660|12501456|FG000|Overall Study|Adverse Event|4
7953569|NCT02584660|12501457|FG001|Overall Study|Adverse Event|0
7953570|NCT02584660|12501456|FG000|Overall Study|Lost to Follow-up|3
7953571|NCT02584660|12501457|FG001|Overall Study|Lost to Follow-up|4
7953572|NCT02584660|12501456|FG000|Overall Study|Protocol Violation|0
7953573|NCT02584660|12501457|FG001|Overall Study|Protocol Violation|1
7953574|NCT02584660|12501456|FG000|Overall Study|Withdrawal by Subject|0
7953575|NCT02584660|12501457|FG001|Overall Study|Withdrawal by Subject|2
7953576|NCT02584660|12501456|FG000|Overall Study|Other|0
7953577|NCT02584660|12501457|FG001|Overall Study|Other|1
7966052|NCT02743949|12521774|FG001|Overall Study|Voluntary Withdrawal|1
7966053|NCT02743949|12521775|FG002|Overall Study|Voluntary Withdrawal|0
7966054|NCT02743962|12521785|FG000|Overall Study|Atrophic vaginitis diagnosed|1
7966055|NCT02743962|12521786|FG001|Overall Study|Atrophic vaginitis diagnosed|0
7966056|NCT02744066|12521797|FG000|Overall Study|Withdrawal by parent|0
7966057|NCT02744066|12521798|FG001|Overall Study|Withdrawal by parent|1
7966058|NCT02744066|12521797|FG000|Overall Study|Discharged from NICU prior to completion|0
7966059|NCT02744066|12521798|FG001|Overall Study|Discharged from NICU prior to completion|4
7966060|NCT02744391|12521806|FG000|Overall Study|Lost to Follow-up|9
7966061|NCT02744391|12521806|FG000|Overall Study|Physician Decision|2
7966062|NCT02744391|12521806|FG000|Overall Study|Withdrawal by Subject|3
7966063|NCT02744755|12521818|FG000|Study Period 1|Protocol Violation|2
7966064|NCT02744755|12521819|FG001|Study Period 1|Protocol Violation|1
7966065|NCT02744755|12521818|FG000|Study Period 1|not defined|0
7966066|NCT02744755|12521819|FG001|Study Period 1|not defined|1
7966067|NCT02744755|12521818|FG000|Study Period 1|Pregnancy|1
7966068|NCT02744755|12521819|FG001|Study Period 1|Pregnancy|0
7966069|NCT02744755|12521818|FG000|Study Period 1|Adverse Event|1
7966070|NCT02744755|12521819|FG001|Study Period 1|Adverse Event|1
7966071|NCT02744755|12521818|FG000|Study Period 1|Lost to Follow-up|1
7966072|NCT02744755|12521819|FG001|Study Period 1|Lost to Follow-up|1
7966073|NCT02744755|12521818|FG000|Study Period 1|Lack of Efficacy|1
7966074|NCT02744755|12521819|FG001|Study Period 1|Lack of Efficacy|0
7966075|NCT02744755|12521818|FG000|Study Period 1|Withdrawal by Subject|8
7966076|NCT02744755|12521819|FG001|Study Period 1|Withdrawal by Subject|4
7966077|NCT02744755|12521818|FG000|Study Period 2|Adverse Event|5
7966078|NCT02744755|12521819|FG001|Study Period 2|Adverse Event|0
7966079|NCT02744755|12521818|FG000|Study Period 2|Protocol Violation|1
7966080|NCT02744755|12521819|FG001|Study Period 2|Protocol Violation|0
7966081|NCT02744755|12521818|FG000|Study Period 2|not defined|3
7966082|NCT02744755|12521819|FG001|Study Period 2|not defined|2
7966083|NCT02744755|12521818|FG000|Study Period 2|Lost to Follow-up|0
7966084|NCT02744755|12521819|FG001|Study Period 2|Lost to Follow-up|2
7966085|NCT02744755|12521818|FG000|Study Period 2|Withdrawal by Subject|2
7966086|NCT02744755|12521819|FG001|Study Period 2|Withdrawal by Subject|2
7966087|NCT02744755|12521818|FG000|Study Period 2|Lack of Efficacy|3
7966088|NCT02744755|12521819|FG001|Study Period 2|Lack of Efficacy|2
7966089|NCT02744898|12521837|FG000|Overall Study|Progressive Disease|2
7966090|NCT02744898|12521837|FG000|Overall Study|Physician Decision|1
7966091|NCT02744898|12521837|FG000|Overall Study|Toxicity|1
7966092|NCT02745080|12521843|FG000|Overall Study|Adverse Event|13
7966093|NCT02745080|12521844|FG001|Overall Study|Adverse Event|21
7966094|NCT02745080|12521843|FG000|Overall Study|Lack of Efficacy|11
7966095|NCT02745080|12521844|FG001|Overall Study|Lack of Efficacy|23
7966096|NCT02745080|12521843|FG000|Overall Study|Lost to Follow-up|3
7966097|NCT02745080|12521844|FG001|Overall Study|Lost to Follow-up|3
7966098|NCT02745080|12521843|FG000|Overall Study|Physician Decision|3
7966099|NCT02745080|12521844|FG001|Overall Study|Physician Decision|0
7966100|NCT02745080|12521843|FG000|Overall Study|Protocol Violation|3
7966101|NCT02745080|12521844|FG001|Overall Study|Protocol Violation|1
7966102|NCT02745080|12521843|FG000|Overall Study|Withdrawal by Subject|22
7966103|NCT02745080|12521844|FG001|Overall Study|Withdrawal by Subject|41
7966104|NCT02745119|12521855|FG000|Overall Study|Adverse Event|1
7966105|NCT02745119|12521856|FG001|Overall Study|Adverse Event|0
7966106|NCT02745119|12521857|FG002|Overall Study|Adverse Event|1
7966107|NCT02745119|12521858|FG003|Overall Study|Adverse Event|3
7966108|NCT02745119|12521855|FG000|Overall Study|Death|3
7966109|NCT02745119|12521856|FG001|Overall Study|Death|3
7953578|NCT02584855|12501499|FG000|Open-Label Treatment Period|Lack of Efficacy|61
7953579|NCT02584855|12501500|FG001|Open-Label Treatment Period|Lack of Efficacy|0
7953580|NCT02584855|12501501|FG002|Open-Label Treatment Period|Lack of Efficacy|0
7953581|NCT02584855|12501502|FG003|Open-Label Treatment Period|Lack of Efficacy|0
7953582|NCT02584855|12501503|FG004|Open-Label Treatment Period|Lack of Efficacy|0
7953583|NCT02584855|12501504|FG005|Open-Label Treatment Period|Lack of Efficacy|0
7953584|NCT02584855|12501499|FG000|Open-Label Treatment Period|Withdrawal by Subject|21
7953585|NCT02584855|12501500|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
7953586|NCT02584855|12501501|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
7953587|NCT02584855|12501502|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
7953588|NCT02584855|12501503|FG004|Open-Label Treatment Period|Withdrawal by Subject|0
7953589|NCT02584855|12501504|FG005|Open-Label Treatment Period|Withdrawal by Subject|0
7953590|NCT02584855|12501499|FG000|Open-Label Treatment Period|Adverse Event|14
7953591|NCT02584855|12501500|FG001|Open-Label Treatment Period|Adverse Event|0
7953592|NCT02584855|12501501|FG002|Open-Label Treatment Period|Adverse Event|0
7953593|NCT02584855|12501502|FG003|Open-Label Treatment Period|Adverse Event|0
7953594|NCT02584855|12501503|FG004|Open-Label Treatment Period|Adverse Event|0
7953595|NCT02584855|12501504|FG005|Open-Label Treatment Period|Adverse Event|0
7953596|NCT02584855|12501499|FG000|Open-Label Treatment Period|Death|2
7953597|NCT02584855|12501500|FG001|Open-Label Treatment Period|Death|0
7953598|NCT02584855|12501501|FG002|Open-Label Treatment Period|Death|0
7953599|NCT02584855|12501502|FG003|Open-Label Treatment Period|Death|0
7953600|NCT02584855|12501503|FG004|Open-Label Treatment Period|Death|0
7953601|NCT02584855|12501504|FG005|Open-Label Treatment Period|Death|0
7953602|NCT02584855|12501499|FG000|Open-Label Treatment Period|Lost to Follow-up|1
7953603|NCT02584855|12501500|FG001|Open-Label Treatment Period|Lost to Follow-up|0
7953604|NCT02584855|12501501|FG002|Open-Label Treatment Period|Lost to Follow-up|0
7953605|NCT02584855|12501502|FG003|Open-Label Treatment Period|Lost to Follow-up|0
7953606|NCT02584855|12501503|FG004|Open-Label Treatment Period|Lost to Follow-up|0
7953607|NCT02584855|12501504|FG005|Open-Label Treatment Period|Lost to Follow-up|0
7953608|NCT02584855|12501499|FG000|Open-Label Treatment Period|Protocol Violation|1
7953609|NCT02584855|12501500|FG001|Open-Label Treatment Period|Protocol Violation|0
7953610|NCT02584855|12501501|FG002|Open-Label Treatment Period|Protocol Violation|0
7953611|NCT02584855|12501502|FG003|Open-Label Treatment Period|Protocol Violation|0
7953612|NCT02584855|12501503|FG004|Open-Label Treatment Period|Protocol Violation|0
7953613|NCT02584855|12501504|FG005|Open-Label Treatment Period|Protocol Violation|0
7953614|NCT02584855|12501499|FG000|Open-Label Treatment Period|No PI Available|2
7953615|NCT02584855|12501500|FG001|Open-Label Treatment Period|No PI Available|0
7953616|NCT02584855|12501501|FG002|Open-Label Treatment Period|No PI Available|0
7953617|NCT02584855|12501502|FG003|Open-Label Treatment Period|No PI Available|0
7953618|NCT02584855|12501503|FG004|Open-Label Treatment Period|No PI Available|0
7953619|NCT02584855|12501504|FG005|Open-Label Treatment Period|No PI Available|0
7953620|NCT02584855|12501499|FG000|Open-Label Treatment Period|Sponsor Decision|1
7953621|NCT02584855|12501500|FG001|Open-Label Treatment Period|Sponsor Decision|0
7953622|NCT02584855|12501501|FG002|Open-Label Treatment Period|Sponsor Decision|0
7953623|NCT02584855|12501502|FG003|Open-Label Treatment Period|Sponsor Decision|0
7953624|NCT02584855|12501503|FG004|Open-Label Treatment Period|Sponsor Decision|0
7953625|NCT02584855|12501504|FG005|Open-Label Treatment Period|Sponsor Decision|0
7953626|NCT02584855|12501499|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7953627|NCT02584855|12501500|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7953628|NCT02584855|12501501|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2
7953629|NCT02584855|12501502|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7953630|NCT02584855|12501503|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7953631|NCT02584855|12501504|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7953632|NCT02584855|12501499|FG000|Double-Blind Withdrawal Period|Adverse Event|0
7953633|NCT02584855|12501500|FG001|Double-Blind Withdrawal Period|Adverse Event|4
7953634|NCT02584855|12501501|FG002|Double-Blind Withdrawal Period|Adverse Event|0
7953635|NCT02584855|12501502|FG003|Double-Blind Withdrawal Period|Adverse Event|1
7953636|NCT02584855|12501503|FG004|Double-Blind Withdrawal Period|Adverse Event|0
7953637|NCT02584855|12501504|FG005|Double-Blind Withdrawal Period|Adverse Event|0
7953638|NCT02584855|12501499|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0
7953639|NCT02584855|12501500|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10
7953640|NCT02584855|12501501|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0
7953641|NCT02584855|12501502|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0
7953642|NCT02584855|12501503|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0
7953643|NCT02584855|12501504|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0
7953644|NCT02584855|12501499|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7966110|NCT02745119|12521857|FG002|Overall Study|Death|0
7953645|NCT02584855|12501500|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1
7953646|NCT02584855|12501501|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7953647|NCT02584855|12501502|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7953648|NCT02584855|12501503|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7953649|NCT02584855|12501504|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7953650|NCT02584855|12501499|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0
7953651|NCT02584855|12501500|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0
7953652|NCT02584855|12501501|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0
7953653|NCT02584855|12501502|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0
7953654|NCT02584855|12501503|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7
7953655|NCT02584855|12501504|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0
7953656|NCT02584855|12501499|FG000|Post Treatment Follow-up Period|Protocol Violation|0
7953657|NCT02584855|12501500|FG001|Post Treatment Follow-up Period|Protocol Violation|0
7953658|NCT02584855|12501501|FG002|Post Treatment Follow-up Period|Protocol Violation|0
7953659|NCT02584855|12501502|FG003|Post Treatment Follow-up Period|Protocol Violation|0
7953660|NCT02584855|12501503|FG004|Post Treatment Follow-up Period|Protocol Violation|1
7953661|NCT02584855|12501504|FG005|Post Treatment Follow-up Period|Protocol Violation|0
7953662|NCT02584959|12501529|FG000|Period 1|Withdrawn from study|3
7953663|NCT02584959|12501530|FG001|Period 1|Withdrawn from study|4
7953664|NCT02584959|12501531|FG002|Period 1|Withdrawn from study|0
7953665|NCT02584959|12501529|FG000|Period 2|Withdrawn from study|6
7953666|NCT02584959|12501530|FG001|Period 2|Withdrawn from study|1
7953667|NCT02584959|12501531|FG002|Period 2|Withdrawn from study|2
7953668|NCT02585713|12501577|FG000|Overall Study|Withdrew prior to treatment|2
7953669|NCT02585713|12501578|FG001|Overall Study|Withdrew prior to treatment|7
7953670|NCT02585713|12501577|FG000|Overall Study|Other|3
7953671|NCT02585713|12501578|FG001|Overall Study|Other|1
7953672|NCT02585778|12501588|FG000|Overall Study|Adverse Event|17
7953673|NCT02585778|12501589|FG001|Overall Study|Adverse Event|4
7953674|NCT02585778|12501588|FG000|Overall Study|Participant did not wish to continue|9
7953675|NCT02585778|12501589|FG001|Overall Study|Participant did not wish to continue|4
7953676|NCT02585778|12501588|FG000|Overall Study|Poor compliance to study protocol|0
7953677|NCT02585778|12501589|FG001|Overall Study|Poor compliance to study protocol|2
7953678|NCT02585778|12501588|FG000|Overall Study|Death|0
7953679|NCT02585778|12501589|FG001|Overall Study|Death|1
7953680|NCT02585778|12501588|FG000|Overall Study|Randomized but not treated|1
7953681|NCT02585778|12501589|FG001|Overall Study|Randomized but not treated|2
7953682|NCT02585778|12501588|FG000|Overall Study|Other than specified above|6
7953683|NCT02585778|12501589|FG001|Overall Study|Other than specified above|2
7953684|NCT02585830|12501599|FG000|Overall Study|Withdrawal by Subject|3
7953685|NCT02585934|12501626|FG000|Overall Study|Lost to Follow-up|2
7953686|NCT02585934|12501627|FG001|Overall Study|Lost to Follow-up|2
7953687|NCT02585934|12501626|FG000|Overall Study|Protocol Violation|14
7953688|NCT02585934|12501627|FG001|Overall Study|Protocol Violation|11
7953689|NCT02585934|12501626|FG000|Overall Study|Adverse Event|21
7953690|NCT02585934|12501627|FG001|Overall Study|Adverse Event|22
7953691|NCT02585934|12501626|FG000|Overall Study|Physician Decision|3
7953692|NCT02585934|12501627|FG001|Overall Study|Physician Decision|2
7953693|NCT02585934|12501626|FG000|Overall Study|Withdrawal by Subject|7
7953694|NCT02585934|12501627|FG001|Overall Study|Withdrawal by Subject|21
7953695|NCT02585934|12501626|FG000|Overall Study|Lack of Efficacy|2
7953696|NCT02585934|12501627|FG001|Overall Study|Lack of Efficacy|1
7953697|NCT02585934|12501626|FG000|Overall Study|Death|2
7953698|NCT02585934|12501627|FG001|Overall Study|Death|0
7953699|NCT02585934|12501626|FG000|Overall Study|Caregiver Withdrew Consent|7
7953700|NCT02585934|12501627|FG001|Overall Study|Caregiver Withdrew Consent|7
7953701|NCT02585934|12501626|FG000|Overall Study|Sponsor Termination|1
7953702|NCT02585934|12501627|FG001|Overall Study|Sponsor Termination|2
7953703|NCT02585934|12501626|FG000|Overall Study|Another Reason|10
7953704|NCT02585934|12501627|FG001|Overall Study|Another Reason|5
7953705|NCT02585960|12501641|FG000|PK/Safety Assessment Period|Physician Decision|0
7953706|NCT02585960|12501642|FG001|PK/Safety Assessment Period|Physician Decision|1
7953707|NCT02585960|12501643|FG002|PK/Safety Assessment Period|Physician Decision|0
7953708|NCT02585960|12501641|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1
7953709|NCT02585960|12501642|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2
7953710|NCT02585960|12501643|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5
7953711|NCT02585960|12501641|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0
7953712|NCT02585960|12501642|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2
7953713|NCT02585960|12501643|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0
7953714|NCT02585960|12501641|FG000|PK/Safety Assessment Period|Other|4
7953715|NCT02585960|12501642|FG001|PK/Safety Assessment Period|Other|4
7953716|NCT02585960|12501643|FG002|PK/Safety Assessment Period|Other|0
7953717|NCT02585960|12501641|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0
7953718|NCT02585960|12501642|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1
7953719|NCT02585960|12501643|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0
7953720|NCT02585960|12501641|FG000|PK/Safety Assessment Period|Screen Failure|0
7953721|NCT02585960|12501642|FG001|PK/Safety Assessment Period|Screen Failure|0
7953722|NCT02585960|12501643|FG002|PK/Safety Assessment Period|Screen Failure|1
7953723|NCT02585960|12501641|FG000|Prophylactic Treatment Period|Major protocol deviation|0
7953724|NCT02585960|12501642|FG001|Prophylactic Treatment Period|Major protocol deviation|4
7953725|NCT02585960|12501643|FG002|Prophylactic Treatment Period|Major protocol deviation|0
7953726|NCT02585960|12501641|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
7953727|NCT02585960|12501642|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1
7953728|NCT02585960|12501643|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
7953729|NCT02585999|12501654|FG000|Overall Study|Lost to Follow-up|1
7953730|NCT02585999|12501654|FG000|Overall Study|Protocol Violation|1
7953731|NCT02586012|12501659|FG000|Overall Study|Withdrawal by Subject|1
7953732|NCT02586012|12501660|FG001|Overall Study|Withdrawal by Subject|1
7953733|NCT02586012|12501661|FG002|Overall Study|Withdrawal by Subject|0
7953734|NCT02586012|12501662|FG003|Overall Study|Withdrawal by Subject|1
7953735|NCT02586012|12501663|FG004|Overall Study|Withdrawal by Subject|0
7953736|NCT02586012|12501664|FG005|Overall Study|Withdrawal by Subject|2
7953737|NCT02586012|12501659|FG000|Overall Study|Protocol Violation|0
7953738|NCT02586012|12501660|FG001|Overall Study|Protocol Violation|0
7953739|NCT02586012|12501661|FG002|Overall Study|Protocol Violation|0
7953740|NCT02586012|12501662|FG003|Overall Study|Protocol Violation|0
7953741|NCT02586012|12501663|FG004|Overall Study|Protocol Violation|0
7953742|NCT02586012|12501664|FG005|Overall Study|Protocol Violation|1
7953743|NCT02586012|12501659|FG000|Overall Study|study terminated|0
7953744|NCT02586012|12501660|FG001|Overall Study|study terminated|2
7953745|NCT02586012|12501661|FG002|Overall Study|study terminated|1
7953746|NCT02586012|12501662|FG003|Overall Study|study terminated|1
7953747|NCT02586012|12501663|FG004|Overall Study|study terminated|1
7953748|NCT02586012|12501664|FG005|Overall Study|study terminated|0
7953749|NCT02586064|12501675|FG000|Overall Study|Other Obligations|6
7953750|NCT02586064|12501676|FG001|Overall Study|Other Obligations|6
7953751|NCT02586064|12501675|FG000|Overall Study|Other|3
7953752|NCT02586064|12501676|FG001|Overall Study|Other|7
7953753|NCT02586064|12501675|FG000|Overall Study|Never Started|3
7953754|NCT02586064|12501676|FG001|Overall Study|Never Started|3
7953755|NCT02586064|12501675|FG000|Overall Study|Lost Interest|1
7953756|NCT02586064|12501676|FG001|Overall Study|Lost Interest|4
7953757|NCT02586064|12501675|FG000|Overall Study|Miscellaneous Life Issues|0
7953758|NCT02586064|12501676|FG001|Overall Study|Miscellaneous Life Issues|5
7953759|NCT02586064|12501675|FG000|Overall Study|Infrequent Attendance|2
7953760|NCT02586064|12501676|FG001|Overall Study|Infrequent Attendance|1
7953761|NCT02586064|12501675|FG000|Overall Study|Timed Out|2
7953762|NCT02586064|12501676|FG001|Overall Study|Timed Out|0
7953763|NCT02586064|12501675|FG000|Overall Study|AUD relapse|0
7953764|NCT02586064|12501676|FG001|Overall Study|AUD relapse|2
7953765|NCT02586064|12501675|FG000|Overall Study|Legal Issue|1
7953766|NCT02586064|12501676|FG001|Overall Study|Legal Issue|0
7953767|NCT02586077|12501685|FG000|Overall Study|Withdrawal by Subject|1
7953768|NCT02586077|12501685|FG000|Overall Study|Physician Decision|4
7953769|NCT02586077|12501685|FG000|Overall Study|Lost to Follow-up|3
7953770|NCT02586155|12501692|FG000|Overall Study|Adverse Event|2
7953771|NCT02586155|12501693|FG001|Overall Study|Adverse Event|3
7953772|NCT02586155|12501692|FG000|Overall Study|Withdrawal by Subject|31
7953773|NCT02586155|12501693|FG001|Overall Study|Withdrawal by Subject|24
7953774|NCT02586155|12501692|FG000|Overall Study|Lost to Follow-up|7
7953775|NCT02586155|12501693|FG001|Overall Study|Lost to Follow-up|13
7953776|NCT02586155|12501692|FG000|Overall Study|Death|61
7953777|NCT02586155|12501693|FG001|Overall Study|Death|72
7953778|NCT02586155|12501692|FG000|Overall Study|Other reasons|26
7953779|NCT02586155|12501693|FG001|Overall Study|Other reasons|15
7953780|NCT02586233|12501706|FG000|Overall Study|Randomized but did not receive treatment|0
7953781|NCT02586233|12501707|FG001|Overall Study|Randomized but did not receive treatment|1
7953782|NCT02586233|12501708|FG002|Overall Study|Randomized but did not receive treatment|0
7953783|NCT02586233|12501709|FG003|Overall Study|Randomized but did not receive treatment|0
7953784|NCT02586233|12501710|FG004|Overall Study|Randomized but did not receive treatment|0
7953785|NCT02586233|12501711|FG005|Overall Study|Randomized but did not receive treatment|2
7953786|NCT02586233|12501712|FG006|Overall Study|Randomized but did not receive treatment|2
7953787|NCT02586233|12501706|FG000|Overall Study|Death|0
7953788|NCT02586233|12501707|FG001|Overall Study|Death|1
7953789|NCT02586233|12501708|FG002|Overall Study|Death|0
7953790|NCT02586233|12501709|FG003|Overall Study|Death|0
7953791|NCT02586233|12501710|FG004|Overall Study|Death|2
7953792|NCT02586233|12501711|FG005|Overall Study|Death|0
7953793|NCT02586233|12501712|FG006|Overall Study|Death|0
7953794|NCT02586415|12501734|FG000|Overall Study|Death|13
7953795|NCT02586415|12501735|FG001|Overall Study|Death|23
7953796|NCT02586415|12501734|FG000|Overall Study|Lost to Follow-up|1
7953797|NCT02586415|12501735|FG001|Overall Study|Lost to Follow-up|2
7953798|NCT02586493|12501742|FG000|Overall Study|Adverse Event|4
7953799|NCT02586493|12501742|FG000|Overall Study|Protocol Violation|6
7953800|NCT02586493|12501742|FG000|Overall Study|Lost to Follow-up|1
7953801|NCT02586493|12501742|FG000|Overall Study|Withdrawal by Subject|1
7953802|NCT02586506|12501746|FG000|Overall Study|Protocol Violation|6
7953803|NCT02586506|12501746|FG000|Overall Study|Lost to Follow-up|1
7953804|NCT02586506|12501746|FG000|Overall Study|Other Reason|2
7953805|NCT02586727|12501752|FG000|Overall Study|Lost to Follow-up|1
7953806|NCT02586727|12501753|FG001|Overall Study|Lost to Follow-up|0
7953807|NCT02586805|12501763|FG000|Overall Study|Withdrawal by Subject|3
7953808|NCT02586805|12501764|FG001|Overall Study|Withdrawal by Subject|1
7953809|NCT02586805|12501765|FG002|Overall Study|Withdrawal by Subject|1
7953810|NCT02586805|12501766|FG003|Overall Study|Withdrawal by Subject|2
7953811|NCT02586805|12501763|FG000|Overall Study|Adverse Event|2
7953812|NCT02586805|12501764|FG001|Overall Study|Adverse Event|0
7953813|NCT02586805|12501765|FG002|Overall Study|Adverse Event|1
7953814|NCT02586805|12501766|FG003|Overall Study|Adverse Event|0
7953815|NCT02586805|12501763|FG000|Overall Study|Lost to Follow-up|0
7953816|NCT02586805|12501764|FG001|Overall Study|Lost to Follow-up|0
7953817|NCT02586805|12501765|FG002|Overall Study|Lost to Follow-up|1
7953818|NCT02586805|12501766|FG003|Overall Study|Lost to Follow-up|0
7953819|NCT02586805|12501763|FG000|Overall Study|Physician Decision|1
7953820|NCT02586805|12501764|FG001|Overall Study|Physician Decision|0
7953821|NCT02586805|12501765|FG002|Overall Study|Physician Decision|0
7953822|NCT02586805|12501766|FG003|Overall Study|Physician Decision|0
7953823|NCT02587065|12501800|FG000|Overall Study|Adverse Event|14
7953824|NCT02587065|12501800|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5
7953825|NCT02587065|12501800|FG000|Overall Study|Non-adherence to the Protocol|3
7953826|NCT02587065|12501800|FG000|Overall Study|Discontinuation of Study Medication|2
7953827|NCT02587065|12501800|FG000|Overall Study|Reason not Specified|3
7953828|NCT02587143|12501815|FG000|Overall Study|Adverse Event|1
7953829|NCT02587143|12501816|FG001|Overall Study|Adverse Event|0
7953830|NCT02587221|12501824|FG000|Overall Study|Adverse Event|3
7953831|NCT02587221|12501825|FG001|Overall Study|Adverse Event|3
7953832|NCT02587221|12501824|FG000|Overall Study|Death|33
7953833|NCT02587221|12501825|FG001|Overall Study|Death|34
7953834|NCT02587221|12501824|FG000|Overall Study|Withdrawal by Subject|66
7953835|NCT02587221|12501825|FG001|Overall Study|Withdrawal by Subject|61
7953836|NCT02587221|12501824|FG000|Overall Study|Lost to Follow-up|21
7953837|NCT02587221|12501825|FG001|Overall Study|Lost to Follow-up|19
7953838|NCT02587221|12501824|FG000|Overall Study|Protocol Violation|6
7953839|NCT02587221|12501825|FG001|Overall Study|Protocol Violation|5
7953840|NCT02587221|12501824|FG000|Overall Study|Other Reason or Unspecified|2
7953841|NCT02587221|12501825|FG001|Overall Study|Other Reason or Unspecified|1
7953842|NCT02587234|12501833|FG000|Overall Study|Withdrawal by Subject|1
7953843|NCT02587234|12501834|FG001|Overall Study|Withdrawal by Subject|1
7953844|NCT02587234|12501833|FG000|Overall Study|Lost to Follow-up|0
7953845|NCT02587234|12501834|FG001|Overall Study|Lost to Follow-up|2
7953846|NCT02587819|12501849|FG000|Overall Study|Adverse Event|1
7953847|NCT02587819|12501849|FG000|Overall Study|Lost to Follow-up|1
7953848|NCT02587962|12501859|FG000|Overall Study|Adverse Event|0
7953849|NCT02587962|12501860|FG001|Overall Study|Adverse Event|0
7953850|NCT02587962|12501861|FG002|Overall Study|Adverse Event|1
7953851|NCT02587962|12501862|FG003|Overall Study|Adverse Event|0
7953852|NCT02587962|12501863|FG004|Overall Study|Adverse Event|0
7953853|NCT02587962|12501859|FG000|Overall Study|Withdrawal by Subject|0
7953854|NCT02587962|12501860|FG001|Overall Study|Withdrawal by Subject|0
7953855|NCT02587962|12501861|FG002|Overall Study|Withdrawal by Subject|1
7953856|NCT02587962|12501862|FG003|Overall Study|Withdrawal by Subject|1
7953857|NCT02587962|12501863|FG004|Overall Study|Withdrawal by Subject|4
7953858|NCT02587962|12501859|FG000|Overall Study|Radiological progression|2
7953859|NCT02587962|12501860|FG001|Overall Study|Radiological progression|2
7953860|NCT02587962|12501861|FG002|Overall Study|Radiological progression|2
7953861|NCT02587962|12501862|FG003|Overall Study|Radiological progression|5
7953862|NCT02587962|12501863|FG004|Overall Study|Radiological progression|10
7953863|NCT02587962|12501859|FG000|Overall Study|Clinical progression|0
7953864|NCT02587962|12501860|FG001|Overall Study|Clinical progression|1
7953865|NCT02587962|12501861|FG002|Overall Study|Clinical progression|2
7953866|NCT02587962|12501862|FG003|Overall Study|Clinical progression|0
7953867|NCT02587962|12501863|FG004|Overall Study|Clinical progression|1
7953868|NCT02588092|12501888|FG000|Overall Study|Death|4
7953869|NCT02588092|12501889|FG001|Overall Study|Death|3
7953870|NCT02588092|12501890|FG002|Overall Study|Death|3
7953871|NCT02588092|12501891|FG003|Overall Study|Death|3
7953872|NCT02588092|12501892|FG004|Overall Study|Death|2
7953873|NCT02588092|12501893|FG005|Overall Study|Death|2
7953874|NCT02588092|12501894|FG006|Overall Study|Death|2
7953875|NCT02588092|12501895|FG007|Overall Study|Death|1
7953876|NCT02588092|12501896|FG008|Overall Study|Death|5
7953877|NCT02588092|12501897|FG009|Overall Study|Death|2
7953878|NCT02588092|12501888|FG000|Overall Study|Withdrawal by Subject|0
7953879|NCT02588092|12501889|FG001|Overall Study|Withdrawal by Subject|0
7953880|NCT02588092|12501890|FG002|Overall Study|Withdrawal by Subject|0
7953881|NCT02588092|12501891|FG003|Overall Study|Withdrawal by Subject|0
7953882|NCT02588092|12501892|FG004|Overall Study|Withdrawal by Subject|0
7953883|NCT02588092|12501893|FG005|Overall Study|Withdrawal by Subject|1
7953884|NCT02588092|12501894|FG006|Overall Study|Withdrawal by Subject|1
7953885|NCT02588092|12501895|FG007|Overall Study|Withdrawal by Subject|2
7953886|NCT02588092|12501896|FG008|Overall Study|Withdrawal by Subject|0
7953887|NCT02588092|12501897|FG009|Overall Study|Withdrawal by Subject|0
7953888|NCT02588092|12501888|FG000|Overall Study|Started Another Treatment|0
7953889|NCT02588092|12501889|FG001|Overall Study|Started Another Treatment|0
7953890|NCT02588092|12501890|FG002|Overall Study|Started Another Treatment|0
7953891|NCT02588092|12501891|FG003|Overall Study|Started Another Treatment|0
7953892|NCT02588092|12501892|FG004|Overall Study|Started Another Treatment|1
7953893|NCT02588092|12501893|FG005|Overall Study|Started Another Treatment|0
7953894|NCT02588092|12501894|FG006|Overall Study|Started Another Treatment|0
7953895|NCT02588092|12501895|FG007|Overall Study|Started Another Treatment|1
7953896|NCT02588092|12501896|FG008|Overall Study|Started Another Treatment|0
7953897|NCT02588092|12501897|FG009|Overall Study|Started Another Treatment|0
7953898|NCT02588092|12501888|FG000|Overall Study|Sponsor Decision|0
7953899|NCT02588092|12501889|FG001|Overall Study|Sponsor Decision|0
7953900|NCT02588092|12501890|FG002|Overall Study|Sponsor Decision|0
7953901|NCT02588092|12501891|FG003|Overall Study|Sponsor Decision|0
7953902|NCT02588092|12501892|FG004|Overall Study|Sponsor Decision|0
7953903|NCT02588092|12501893|FG005|Overall Study|Sponsor Decision|0
7953904|NCT02588092|12501894|FG006|Overall Study|Sponsor Decision|0
7953905|NCT02588092|12501895|FG007|Overall Study|Sponsor Decision|0
7953906|NCT02588092|12501896|FG008|Overall Study|Sponsor Decision|1
7953907|NCT02588092|12501897|FG009|Overall Study|Sponsor Decision|1
7966111|NCT02745119|12521858|FG003|Overall Study|Death|4
7966112|NCT02745119|12521855|FG000|Overall Study|Lost to Follow-up|0
7966113|NCT02745119|12521856|FG001|Overall Study|Lost to Follow-up|0
7966114|NCT02745119|12521857|FG002|Overall Study|Lost to Follow-up|0
7966115|NCT02745119|12521858|FG003|Overall Study|Lost to Follow-up|1
7966116|NCT02745119|12521855|FG000|Overall Study|Protocol Deviation|0
7966117|NCT02745119|12521856|FG001|Overall Study|Protocol Deviation|0
7966118|NCT02745119|12521857|FG002|Overall Study|Protocol Deviation|0
7966119|NCT02745119|12521858|FG003|Overall Study|Protocol Deviation|1
7966120|NCT02745119|12521855|FG000|Overall Study|Withdrawal by Subject|7
7966121|NCT02745119|12521856|FG001|Overall Study|Withdrawal by Subject|15
7966122|NCT02745119|12521857|FG002|Overall Study|Withdrawal by Subject|8
7966123|NCT02745119|12521858|FG003|Overall Study|Withdrawal by Subject|14
7966124|NCT02745119|12521855|FG000|Overall Study|Study Terminated by Sponsor|134
7966125|NCT02745119|12521856|FG001|Overall Study|Study Terminated by Sponsor|252
7966126|NCT02745119|12521857|FG002|Overall Study|Study Terminated by Sponsor|135
7966127|NCT02745119|12521858|FG003|Overall Study|Study Terminated by Sponsor|251
7966128|NCT02745119|12521855|FG000|Overall Study|Physician Decision|0
7966129|NCT02745119|12521856|FG001|Overall Study|Physician Decision|2
7966130|NCT02745119|12521857|FG002|Overall Study|Physician Decision|2
7966131|NCT02745119|12521858|FG003|Overall Study|Physician Decision|2
7966132|NCT02745119|12521855|FG000|Overall Study|Reason Not Specified|0
7966133|NCT02745119|12521856|FG001|Overall Study|Reason Not Specified|2
7966134|NCT02745119|12521857|FG002|Overall Study|Reason Not Specified|0
7966135|NCT02745119|12521858|FG003|Overall Study|Reason Not Specified|1
7966136|NCT02745145|12521873|FG000|Overall Study|Adverse Event|1
7966137|NCT02745145|12521874|FG001|Overall Study|Adverse Event|0
7966138|NCT02745145|12521875|FG002|Overall Study|Adverse Event|0
7966139|NCT02745145|12521873|FG000|Overall Study|Death|0
7966140|NCT02745145|12521874|FG001|Overall Study|Death|1
7966141|NCT02745145|12521875|FG002|Overall Study|Death|0
7966142|NCT02745145|12521873|FG000|Overall Study|Progressive disease|0
7966143|NCT02745145|12521874|FG001|Overall Study|Progressive disease|0
7966144|NCT02745145|12521875|FG002|Overall Study|Progressive disease|1
7966145|NCT02745145|12521873|FG000|Overall Study|Withdrew consent|1
7966146|NCT02745145|12521874|FG001|Overall Study|Withdrew consent|1
7966147|NCT02745145|12521875|FG002|Overall Study|Withdrew consent|1
7966148|NCT02745145|12521873|FG000|Overall Study|Study Termination|8
7966149|NCT02745145|12521874|FG001|Overall Study|Study Termination|3
7966150|NCT02745145|12521875|FG002|Overall Study|Study Termination|7
7966151|NCT02745392|12521896|FG000|Overall Study|Lost to Follow-up|0
7966152|NCT02745392|12521897|FG001|Overall Study|Lost to Follow-up|1
7966153|NCT02745392|12521898|FG002|Overall Study|Lost to Follow-up|0
7966154|NCT02745392|12521899|FG003|Overall Study|Lost to Follow-up|0
7966155|NCT02746575|12521941|FG000|Overall Study|Surgery cancelled or time chaned|13
7966156|NCT02746575|12521941|FG000|Overall Study|Received epidural|10
7966157|NCT02746575|12521941|FG000|Overall Study|Withdrawal by Subject|3
7966158|NCT02746575|12521941|FG000|Overall Study|Bradycardia/hypotension|9
7966159|NCT02746575|12521941|FG000|Overall Study|Study paused|8
7966160|NCT02746575|12521941|FG000|Overall Study|put on beta-blocker|3
7966161|NCT02746575|12521941|FG000|Overall Study|type of surgery|1
7966162|NCT02746575|12521941|FG000|Overall Study|typ of surgery|1
7953908|NCT04960228|12501925|FG000|Overall Study|Withdrawal by Subject|216
7953909|NCT04960228|12501926|FG001|Overall Study|Withdrawal by Subject|35
7953910|NCT04960228|12501925|FG000|Overall Study|Failed attention check|69
7953911|NCT04960228|12501926|FG001|Overall Study|Failed attention check|148
7953912|NCT04960228|12501925|FG000|Overall Study|Flagged for response quality by Dynata|3
7953913|NCT04960228|12501926|FG001|Overall Study|Flagged for response quality by Dynata|3
7966163|NCT02746575|12521941|FG000|Overall Study|PI unavailable|1
7966164|NCT02746575|12521941|FG000|Overall Study|Unknown history of CVA|1
7966165|NCT02746627|12521948|FG000|Overall Study|Withdrawal by Subject|1
7966166|NCT02746627|12521949|FG001|Overall Study|Withdrawal by Subject|1
7966167|NCT02746627|12521950|FG002|Overall Study|Withdrawal by Subject|1
7966168|NCT02746679|12521960|FG000|Overall Study|Lost to Follow-up|4
7966169|NCT02746679|12521961|FG001|Overall Study|Lost to Follow-up|6
7966170|NCT02746705|12521969|FG000|Overall Study|Physician Decision|1
7966171|NCT02746705|12521970|FG001|Overall Study|Physician Decision|1
7966172|NCT02746705|12521969|FG000|Overall Study|Lost to Follow-up|1
7966173|NCT02746705|12521970|FG001|Overall Study|Lost to Follow-up|0
7966174|NCT02746705|12521969|FG000|Overall Study|outlier scores deemed not valid|0
7966175|NCT02746705|12521970|FG001|Overall Study|outlier scores deemed not valid|1
7966176|NCT02746874|12521978|FG000|Overall Study|Withdrawal by Subject|0
7966177|NCT02746874|12521979|FG001|Overall Study|Withdrawal by Subject|1
7966178|NCT02746874|12521978|FG000|Overall Study|Surgery Date Changed|0
7966179|NCT02746874|12521979|FG001|Overall Study|Surgery Date Changed|2
7966180|NCT02747108|12521998|FG000|Overall Study|Death|2
7966181|NCT02747108|12521999|FG001|Overall Study|Death|2
7966182|NCT02747108|12521998|FG000|Overall Study|Withdrawal by Subject|1
7966183|NCT02747108|12521999|FG001|Overall Study|Withdrawal by Subject|0
7966184|NCT02747108|12521998|FG000|Overall Study|Protocol Violation|2
7966185|NCT02747108|12521999|FG001|Overall Study|Protocol Violation|0
7966186|NCT02747238|12522021|FG000|Overall Study|Lack of Efficacy|0
7966187|NCT02747238|12522022|FG001|Overall Study|Lack of Efficacy|1
7966188|NCT02747238|12522021|FG000|Overall Study|Data lost|3
7966189|NCT02747238|12522022|FG001|Overall Study|Data lost|5
7966190|NCT02747420|12522030|FG000|Overall Study|Lost to Follow-up|4
7966191|NCT02747420|12522031|FG001|Overall Study|Lost to Follow-up|2
7966192|NCT02747420|12522030|FG000|Overall Study|Withdrawal by Subject|3
7966193|NCT02747420|12522031|FG001|Overall Study|Withdrawal by Subject|2
7966194|NCT02747875|12522061|FG000|Overall Study|Physician Decision|1
7966195|NCT02747875|12522062|FG001|Overall Study|Physician Decision|0
7966196|NCT02747875|12522061|FG000|Overall Study|Adverse Event|0
7966197|NCT02747875|12522062|FG001|Overall Study|Adverse Event|1
7966198|NCT02748213|12522088|FG000|Overall Study|Withdrawal Prior to Treatment|1
7966199|NCT02748213|12522089|FG001|Overall Study|Withdrawal Prior to Treatment|2
7966200|NCT02748213|12522088|FG000|Overall Study|Abnormal Laboratory Test|1
7966201|NCT02748213|12522089|FG001|Overall Study|Abnormal Laboratory Test|0
7966202|NCT02748213|12522088|FG000|Overall Study|Adverse Event or Intercurrent Illness|5
7966203|NCT02748213|12522089|FG001|Overall Study|Adverse Event or Intercurrent Illness|11
7966204|NCT02748213|12522088|FG000|Overall Study|Death|5
7966205|NCT02748213|12522089|FG001|Overall Study|Death|3
7966206|NCT02748213|12522088|FG000|Overall Study|Insufficient Therapeutic Response|56
7966207|NCT02748213|12522089|FG001|Overall Study|Insufficient Therapeutic Response|57
7966208|NCT02748213|12522088|FG000|Overall Study|Violation of Selection Criteria|2
7966209|NCT02748213|12522089|FG001|Overall Study|Violation of Selection Criteria|0
7966210|NCT02748213|12522088|FG000|Overall Study|Protocol Violation|6
7966211|NCT02748213|12522089|FG001|Overall Study|Protocol Violation|4
7966212|NCT02748213|12522088|FG000|Overall Study|Refused Treatment*|6
7966213|NCT02748213|12522089|FG001|Overall Study|Refused Treatment*|6
7966214|NCT02748213|12522088|FG000|Overall Study|Failure to Return|1
7966215|NCT02748213|12522089|FG001|Overall Study|Failure to Return|0
7966216|NCT02748213|12522088|FG000|Overall Study|Other|30
7966217|NCT02748213|12522089|FG001|Overall Study|Other|29
7966218|NCT02748317|12522095|FG000|Overall Study|Withdrawal by Subject|14
7966219|NCT02748317|12522095|FG000|Overall Study|Lost to Follow-up|8
7966220|NCT02748317|12522095|FG000|Overall Study|Death|1
7966221|NCT02748356|12522099|FG000|Overall Study|Withdrawal by Subject|1
7953914|NCT03922477|12501932|FG000|Overall Study|Death|9
7953915|NCT03922477|12501932|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1
7953916|NCT03922477|12501932|FG000|Overall Study|Physician Decision|1
7953917|NCT03922477|12501932|FG000|Overall Study|Withdrawal by Subject|2
7953918|NCT03688074|12501938|FG000|Overall Study|Adverse Event|0
7953919|NCT03688074|12501939|FG001|Overall Study|Adverse Event|1
7953920|NCT03688074|12501938|FG000|Overall Study|Other|1
7953921|NCT03688074|12501939|FG001|Overall Study|Other|0
7966222|NCT02748512|12522105|FG000|Overall Study|Lost to Follow-up|1
7966223|NCT02748512|12522106|FG001|Overall Study|Lost to Follow-up|1
7966224|NCT02748694|12522131|FG000|Overall Study|Voluntary Withdrawal|0
7966225|NCT02748694|12522132|FG001|Overall Study|Voluntary Withdrawal|0
7966226|NCT02748694|12522133|FG002|Overall Study|Voluntary Withdrawal|0
7966227|NCT02748694|12522134|FG003|Overall Study|Voluntary Withdrawal|0
7966228|NCT02748694|12522135|FG004|Overall Study|Voluntary Withdrawal|0
7966229|NCT02748694|12522136|FG005|Overall Study|Voluntary Withdrawal|0
7966230|NCT02748694|12522137|FG006|Overall Study|Voluntary Withdrawal|0
7966231|NCT02748694|12522138|FG007|Overall Study|Voluntary Withdrawal|0
7966232|NCT02748694|12522139|FG008|Overall Study|Voluntary Withdrawal|0
7966233|NCT02748694|12522140|FG009|Overall Study|Voluntary Withdrawal|0
7966234|NCT02748694|12522141|FG010|Overall Study|Voluntary Withdrawal|0
7966235|NCT02748694|12522142|FG011|Overall Study|Voluntary Withdrawal|0
7966236|NCT02748694|12522143|FG012|Overall Study|Voluntary Withdrawal|0
7966237|NCT02748694|12522144|FG013|Overall Study|Voluntary Withdrawal|0
7966238|NCT02748694|12522145|FG014|Overall Study|Voluntary Withdrawal|2
7967248|NCT02762565|12523868|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11
7967249|NCT02762578|12523874|FG000|Overall Study|Adverse Event|1
7967250|NCT02762578|12523875|FG001|Overall Study|Adverse Event|6
7967251|NCT02762578|12523874|FG000|Overall Study|Protocol Violation|4
7967252|NCT02762578|12523875|FG001|Overall Study|Protocol Violation|2
7967253|NCT02762578|12523874|FG000|Overall Study|Withdrawal by Subject|4
7967254|NCT02762578|12523875|FG001|Overall Study|Withdrawal by Subject|2
7967255|NCT02762578|12523874|FG000|Overall Study|Unclassified|6
7967256|NCT02762578|12523875|FG001|Overall Study|Unclassified|0
7967257|NCT02762994|12523914|FG000|Overall Study|Withdrawal by Subject|0
7967258|NCT02762994|12523915|FG001|Overall Study|Withdrawal by Subject|1
7967259|NCT02762994|12523916|FG002|Overall Study|Withdrawal by Subject|2
7967260|NCT02762994|12523917|FG003|Overall Study|Withdrawal by Subject|0
7967261|NCT02762994|12523914|FG000|Overall Study|Protocol Violation|1
7967262|NCT02762994|12523915|FG001|Overall Study|Protocol Violation|0
7967263|NCT02762994|12523916|FG002|Overall Study|Protocol Violation|0
7967264|NCT02762994|12523917|FG003|Overall Study|Protocol Violation|2
7967265|NCT02763046|12523934|FG000|Overall Study|Adverse Event|5
7967266|NCT02763046|12523935|FG001|Overall Study|Adverse Event|4
7967267|NCT02763046|12523936|FG002|Overall Study|Adverse Event|0
7967268|NCT02763046|12523934|FG000|Overall Study|Lack of Efficacy|1
7967269|NCT02763046|12523935|FG001|Overall Study|Lack of Efficacy|1
7967270|NCT02763046|12523936|FG002|Overall Study|Lack of Efficacy|3
7967271|NCT02763046|12523934|FG000|Overall Study|Physician Decision|1
7967272|NCT02763046|12523935|FG001|Overall Study|Physician Decision|0
7967273|NCT02763046|12523936|FG002|Overall Study|Physician Decision|1
7967274|NCT02763046|12523934|FG000|Overall Study|Subject/guardian decision|2
7967275|NCT02763046|12523935|FG001|Overall Study|Subject/guardian decision|0
7967276|NCT02763046|12523936|FG002|Overall Study|Subject/guardian decision|4
7967277|NCT02763215|12523954|FG000|Overall Study|Participants withdrew from study|3
7967278|NCT02763215|12523954|FG000|Overall Study|Missed visit|1
7967279|NCT02763215|12523954|FG000|Overall Study|Visit outside visit-window|1
7967280|NCT02763215|12523954|FG000|Overall Study|Death|1
7967281|NCT02763215|12523954|FG000|Overall Study|Lost to Follow-up|1
7967282|NCT02763254|12523958|FG000|Overall Study|Adverse Event|1
7967283|NCT02763644|12523964|FG000|Overall Study|Patient/guardian decision|1
7967284|NCT02763644|12523965|FG001|Overall Study|Patient/guardian decision|0
7967285|NCT02763644|12523964|FG000|Overall Study|Death|1
7967286|NCT02763644|12523965|FG001|Overall Study|Death|1
7967287|NCT02763644|12523964|FG000|Overall Study|Adverse Event|1
7967288|NCT02763644|12523965|FG001|Overall Study|Adverse Event|1
7967289|NCT02764151|12524020|FG000|Overall Study|Subject refused further follow-up|0
7967290|NCT02764151|12524021|FG001|Overall Study|Subject refused further follow-up|0
7967291|NCT02764151|12524022|FG002|Overall Study|Subject refused further follow-up|0
7967292|NCT02764151|12524023|FG003|Overall Study|Subject refused further follow-up|1
7967293|NCT02764151|12524020|FG000|Overall Study|Other|0
7967294|NCT02764151|12524021|FG001|Overall Study|Other|0
7967295|NCT02764151|12524022|FG002|Overall Study|Other|0
7967296|NCT02764151|12524023|FG003|Overall Study|Other|2
7953922|NCT03342001|12501945|FG000|Overall Study|Adverse Event|1
7953923|NCT03342001|12501945|FG000|Overall Study|Lost to Follow-up|1
7953924|NCT02859558|12501963|FG000|Step 1|Not Eligible|0
7953925|NCT02859558|12501964|FG001|Step 1|Not Eligible|0
7953926|NCT02859558|12501965|FG002|Step 1|Not Eligible|0
7953927|NCT02859558|12501966|FG003|Step 1|Not Eligible|0
7953928|NCT02859558|12501967|FG004|Step 1|Not Eligible|3
7953929|NCT02859558|12501963|FG000|Step 1|Lost to Follow-up|1
7953930|NCT02859558|12501964|FG001|Step 1|Lost to Follow-up|3
7953931|NCT02859558|12501965|FG002|Step 1|Lost to Follow-up|3
7953932|NCT02859558|12501966|FG003|Step 1|Lost to Follow-up|0
7953933|NCT02859558|12501967|FG004|Step 1|Lost to Follow-up|0
7953934|NCT02859558|12501963|FG000|Step 1|Did Not Return to Clinic|2
7953935|NCT02859558|12501964|FG001|Step 1|Did Not Return to Clinic|3
7953936|NCT02859558|12501965|FG002|Step 1|Did Not Return to Clinic|4
7953937|NCT02859558|12501966|FG003|Step 1|Did Not Return to Clinic|0
7953938|NCT02859558|12501967|FG004|Step 1|Did Not Return to Clinic|0
7953939|NCT02859558|12501963|FG000|Step 1|Moved|0
7953940|NCT02859558|12501964|FG001|Step 1|Moved|1
7953941|NCT02859558|12501965|FG002|Step 1|Moved|1
7953942|NCT02859558|12501966|FG003|Step 1|Moved|0
7953943|NCT02859558|12501967|FG004|Step 1|Moved|0
7953944|NCT02859558|12501963|FG000|Step 1|Withdrawal By Participant|1
7953945|NCT02859558|12501964|FG001|Step 1|Withdrawal By Participant|2
7953946|NCT02859558|12501965|FG002|Step 1|Withdrawal By Participant|1
7953947|NCT02859558|12501966|FG003|Step 1|Withdrawal By Participant|0
7953948|NCT02859558|12501967|FG004|Step 1|Withdrawal By Participant|0
7953949|NCT02859558|12501963|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1
7953950|NCT02859558|12501964|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0
7953951|NCT02859558|12501965|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0
7953952|NCT02859558|12501966|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0
7953953|NCT02859558|12501967|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0
7953954|NCT02859558|12501963|FG000|Step 1|Incarceration|0
7953955|NCT02859558|12501964|FG001|Step 1|Incarceration|1
7953956|NCT02859558|12501965|FG002|Step 1|Incarceration|0
7953957|NCT02859558|12501966|FG003|Step 1|Incarceration|0
7953958|NCT02859558|12501967|FG004|Step 1|Incarceration|0
7953959|NCT02859558|12501963|FG000|Step 1|Non-Adherence to Study Drug|2
7953960|NCT02859558|12501964|FG001|Step 1|Non-Adherence to Study Drug|0
7953961|NCT02859558|12501965|FG002|Step 1|Non-Adherence to Study Drug|1
7953962|NCT02859558|12501966|FG003|Step 1|Non-Adherence to Study Drug|0
7953963|NCT02859558|12501967|FG004|Step 1|Non-Adherence to Study Drug|0
7953964|NCT02859558|12501963|FG000|Step 1|Non-Adherence to Study Requirements|3
7953965|NCT02859558|12501964|FG001|Step 1|Non-Adherence to Study Requirements|1
7953966|NCT02859558|12501965|FG002|Step 1|Non-Adherence to Study Requirements|0
7953967|NCT02859558|12501966|FG003|Step 1|Non-Adherence to Study Requirements|0
7953968|NCT02859558|12501967|FG004|Step 1|Non-Adherence to Study Requirements|0
7953969|NCT02859558|12501963|FG000|Step 1|Virologic Failure|2
7953970|NCT02859558|12501964|FG001|Step 1|Virologic Failure|1
7953971|NCT02859558|12501965|FG002|Step 1|Virologic Failure|1
7953972|NCT02859558|12501966|FG003|Step 1|Virologic Failure|0
7953973|NCT02859558|12501967|FG004|Step 1|Virologic Failure|0
7953974|NCT02859558|12501963|FG000|Step 2|Active On Study|23
7953975|NCT02859558|12501964|FG001|Step 2|Active On Study|38
7953976|NCT02859558|12501965|FG002|Step 2|Active On Study|20
7953977|NCT02859558|12501966|FG003|Step 2|Active On Study|0
7953978|NCT02859558|12501967|FG004|Step 2|Active On Study|0
7953979|NCT02859558|12501963|FG000|Step 2|Did Not Return to Clinic|2
7953980|NCT02859558|12501964|FG001|Step 2|Did Not Return to Clinic|0
7953981|NCT02859558|12501965|FG002|Step 2|Did Not Return to Clinic|0
7953982|NCT02859558|12501966|FG003|Step 2|Did Not Return to Clinic|0
7953983|NCT02859558|12501967|FG004|Step 2|Did Not Return to Clinic|0
7953984|NCT02859558|12501963|FG000|Step 2|Unexpected Closure of Site|0
7953985|NCT02859558|12501964|FG001|Step 2|Unexpected Closure of Site|1
7953986|NCT02859558|12501965|FG002|Step 2|Unexpected Closure of Site|1
7953987|NCT02859558|12501966|FG003|Step 2|Unexpected Closure of Site|0
7953988|NCT02859558|12501967|FG004|Step 2|Unexpected Closure of Site|0
7953989|NCT02818920|12501977|FG000|Overall Study|Unresectable|4
7953990|NCT02818920|12501977|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1
7953991|NCT02818920|12501977|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8
7953992|NCT02818920|12501977|FG000|Overall Study|Adverse Event|3
7953993|NCT02818920|12501977|FG000|Overall Study|Developed Other Disease|1
7953994|NCT02818920|12501977|FG000|Overall Study|Refused Further Treatment|1
7953995|NCT02481310|12501984|FG000|Follow up|Still in follow up|0
7953996|NCT02481310|12501985|FG001|Follow up|Still in follow up|3
7953997|NCT02481310|12501986|FG002|Follow up|Still in follow up|0
7953998|NCT02343952|12501990|FG000|Study Treatment|Disease Progression|23
7953999|NCT02343952|12501990|FG000|Study Treatment|Death|3
7954000|NCT02343952|12501990|FG000|Study Treatment|Adverse Event|19
7954001|NCT02343952|12501990|FG000|Study Treatment|Withdrawal by Subject|7
7954002|NCT02343952|12501990|FG000|Study Treatment|other complicating Diseases|1
7954003|NCT02343952|12501990|FG000|Follow up|Withdrawal by Subject|3
7954004|NCT02343952|12501990|FG000|Follow up|Death|33
7954005|NCT02343952|12501990|FG000|Follow up|Patient does not meet eligibility for study.|1
7954006|NCT02343952|12501990|FG000|Follow up|Research department closed by the practice.|5
7954007|NCT02343952|12501990|FG000|Follow up|Patient went home to Russia|1
7954008|NCT02343952|12501990|FG000|Follow up|Disease Progression|1
7954009|NCT02343952|12501990|FG000|Follow up|study terminated|1
7954010|NCT02326155|12501996|FG000|Overall Study|Adverse Event|21
7954011|NCT02326155|12501997|FG001|Overall Study|Adverse Event|5
7954012|NCT02326155|12501996|FG000|Overall Study|Death|3
7954013|NCT02326155|12501997|FG001|Overall Study|Death|0
7954014|NCT02326155|12501996|FG000|Overall Study|Lack of Efficacy|49
7954015|NCT02326155|12501997|FG001|Overall Study|Lack of Efficacy|5
7954016|NCT02326155|12501996|FG000|Overall Study|Lost to Follow-up|14
7954017|NCT02326155|12501997|FG001|Overall Study|Lost to Follow-up|3
7954018|NCT02326155|12501996|FG000|Overall Study|Protocol Violation|2
7954019|NCT02326155|12501997|FG001|Overall Study|Protocol Violation|0
7954020|NCT02326155|12501996|FG000|Overall Study|Withdrawal by Subject|34
7954021|NCT02326155|12501997|FG001|Overall Study|Withdrawal by Subject|11
7954022|NCT02326155|12501996|FG000|Overall Study|Disease progression|37
7954023|NCT02326155|12501997|FG001|Overall Study|Disease progression|4
7954024|NCT02326155|12501996|FG000|Overall Study|Study close|188
7954025|NCT02326155|12501997|FG001|Overall Study|Study close|21
7954026|NCT02326155|12501996|FG000|Overall Study|except for study close|46
7954027|NCT02326155|12501997|FG001|Overall Study|except for study close|13
7954028|NCT02304367|12502003|FG000|Overall Study|Lack of Response to Bruosumab|1
7954029|NCT02304367|12502003|FG000|Overall Study|Sponsor Decision|3
7954030|NCT02304367|12502003|FG000|Overall Study|Death|2
7954031|NCT02304367|12502003|FG000|Overall Study|Physician Decision|1
7954032|NCT02304367|12502003|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1
7954033|NCT02588261|12502025|FG000|Overall Study|Study Terminated by Sponsor|157
7954034|NCT02588261|12502026|FG001|Overall Study|Study Terminated by Sponsor|142
7954035|NCT02588261|12502025|FG000|Overall Study|Protocol Deviation|1
7954036|NCT02588261|12502026|FG001|Overall Study|Protocol Deviation|0
7954037|NCT02588261|12502025|FG000|Overall Study|Death|1
7954038|NCT02588261|12502026|FG001|Overall Study|Death|2
7954039|NCT02588261|12502025|FG000|Overall Study|Withdrawal by Subject|12
7954040|NCT02588261|12502026|FG001|Overall Study|Withdrawal by Subject|8
7954041|NCT02588261|12502025|FG000|Overall Study|Noncompliance with Study Drug|0
7954042|NCT02588261|12502026|FG001|Overall Study|Noncompliance with Study Drug|1
7954043|NCT02588261|12502025|FG000|Overall Study|Miscellaneous|5
7954044|NCT02588261|12502026|FG001|Overall Study|Miscellaneous|4
7954045|NCT02588261|12502025|FG000|Overall Study|Progressive Disease|61
7954046|NCT02588261|12502026|FG001|Overall Study|Progressive Disease|82
7954047|NCT02588261|12502025|FG000|Overall Study|Adverse Event|29
7954048|NCT02588261|12502026|FG001|Overall Study|Adverse Event|24
7954049|NCT02588261|12502025|FG000|Overall Study|Lost to Follow-up|1
7954050|NCT02588261|12502026|FG001|Overall Study|Lost to Follow-up|0
7954051|NCT02588339|12502032|FG000|Overall Study|Withdrawal by Subject|1
7954052|NCT02588339|12502032|FG000|Overall Study|GVHD Progression prior to treatment|2
7954053|NCT02588612|12502065|FG000|Overall Study|Physician Decision|1
7954054|NCT02588612|12502065|FG000|Overall Study|Leukapheresis did not yield enough cells|1
7954055|NCT02588612|12502065|FG000|Overall Study|Failed eligibility prior to chemotherapy|2
7954056|NCT02588612|12502065|FG000|Overall Study|Death prior to T-cell infusion|1
7954057|NCT02588664|12502071|FG000|Overall Study|Death|56
7954058|NCT02588664|12502072|FG001|Overall Study|Death|55
7954059|NCT02588664|12502071|FG000|Overall Study|Lost to Follow-up|1305
7954060|NCT02588664|12502072|FG001|Overall Study|Lost to Follow-up|990
7954061|NCT02588833|12502080|FG000|Part 1|Withdrawal by Subject|1
7954062|NCT02588833|12502081|FG001|Part 1|Withdrawal by Subject|0
7954063|NCT02588833|12502080|FG000|Part 2A|Physician Decision|0
7954064|NCT02588833|12502081|FG001|Part 2A|Physician Decision|1
7954065|NCT02588833|12502080|FG000|Part 2A|Withdrawal by Subject|0
7954066|NCT02588833|12502081|FG001|Part 2A|Withdrawal by Subject|1
7954067|NCT02588833|12502080|FG000|Part 2B|Adverse Event|0
7954068|NCT02588833|12502081|FG001|Part 2B|Adverse Event|1
7954069|NCT02588833|12502080|FG000|Part 2C|Adverse Event|0
7954070|NCT02588833|12502081|FG001|Part 2C|Adverse Event|1
7954071|NCT02588833|12502080|FG000|Part 2C|Withdrawal by Subject|0
7954072|NCT02588833|12502081|FG001|Part 2C|Withdrawal by Subject|1
7954073|NCT02588833|12502080|FG000|Part 3 (Safety Follow-up)|Other|0
7954074|NCT02588833|12502081|FG001|Part 3 (Safety Follow-up)|Other|2
7954075|NCT02589405|12502121|FG000|Overall Study|Adverse Event|3
7954076|NCT02589405|12502121|FG000|Overall Study|Withdrawal by Subject|1
7954077|NCT02589626|12502127|FG000|Overall Study|Other than the reason specified|1
7954078|NCT02589626|12502128|FG001|Overall Study|Other than the reason specified|0
7954079|NCT02589626|12502127|FG000|Overall Study|Withdrawal by Subject|1
7954080|NCT02589626|12502128|FG001|Overall Study|Withdrawal by Subject|1
7954081|NCT02589626|12502127|FG000|Overall Study|Adverse Event|1
7954082|NCT02589626|12502128|FG001|Overall Study|Adverse Event|1
7954083|NCT02589639|12502137|FG000|Overall Study|Lost to Follow-up|1
7954084|NCT02589639|12502138|FG001|Overall Study|Lost to Follow-up|0
7954085|NCT02589639|12502139|FG002|Overall Study|Lost to Follow-up|0
7954086|NCT02589639|12502137|FG000|Overall Study|Protocol Violation|1
7954087|NCT02589639|12502138|FG001|Overall Study|Protocol Violation|0
7954088|NCT02589639|12502139|FG002|Overall Study|Protocol Violation|0
7954089|NCT02589639|12502137|FG000|Overall Study|Patient withdrawal, not due to AE|3
7954090|NCT02589639|12502138|FG001|Overall Study|Patient withdrawal, not due to AE|0
7954091|NCT02589639|12502139|FG002|Overall Study|Patient withdrawal, not due to AE|0
7954092|NCT02589639|12502137|FG000|Overall Study|Adverse Event|4
7954093|NCT02589639|12502138|FG001|Overall Study|Adverse Event|5
7954094|NCT02589639|12502139|FG002|Overall Study|Adverse Event|3
7954095|NCT02589639|12502137|FG000|Overall Study|Other reason than specified above|1
7954096|NCT02589639|12502138|FG001|Overall Study|Other reason than specified above|2
7954097|NCT02589639|12502139|FG002|Overall Study|Other reason than specified above|1
7954098|NCT02589639|12502137|FG000|Overall Study|Not Treated|0
7954099|NCT02589639|12502138|FG001|Overall Study|Not Treated|3
7954100|NCT02589639|12502139|FG002|Overall Study|Not Treated|0
7954101|NCT02589665|12502151|FG000|Induction Period|Did not receive drug|0
7954102|NCT02589665|12502152|FG001|Induction Period|Did not receive drug|0
7954103|NCT02589665|12502153|FG002|Induction Period|Did not receive drug|0
7954104|NCT02589665|12502154|FG003|Induction Period|Did not receive drug|1
7954105|NCT02589665|12502155|FG004|Induction Period|Did not receive drug|0
7954106|NCT02589665|12502156|FG005|Induction Period|Did not receive drug|0
7954107|NCT02589665|12502157|FG006|Induction Period|Did not receive drug|0
7954108|NCT02589665|12502158|FG007|Induction Period|Did not receive drug|0
7954109|NCT02589665|12502159|FG008|Induction Period|Did not receive drug|0
7954110|NCT02589665|12502160|FG009|Induction Period|Did not receive drug|0
7954111|NCT02589665|12502151|FG000|Induction Period|Adverse Event|3
7954112|NCT02589665|12502152|FG001|Induction Period|Adverse Event|0
7954113|NCT02589665|12502153|FG002|Induction Period|Adverse Event|2
7954114|NCT02589665|12502154|FG003|Induction Period|Adverse Event|2
7954115|NCT02589665|12502155|FG004|Induction Period|Adverse Event|0
7954116|NCT02589665|12502156|FG005|Induction Period|Adverse Event|0
7954117|NCT02589665|12502157|FG006|Induction Period|Adverse Event|0
7954118|NCT02589665|12502158|FG007|Induction Period|Adverse Event|0
7954119|NCT02589665|12502159|FG008|Induction Period|Adverse Event|0
7954120|NCT02589665|12502160|FG009|Induction Period|Adverse Event|0
7954121|NCT02589665|12502151|FG000|Induction Period|Withdrawal by Subject|0
7954122|NCT02589665|12502152|FG001|Induction Period|Withdrawal by Subject|1
7954123|NCT02589665|12502153|FG002|Induction Period|Withdrawal by Subject|0
7954124|NCT02589665|12502154|FG003|Induction Period|Withdrawal by Subject|1
7954125|NCT02589665|12502155|FG004|Induction Period|Withdrawal by Subject|0
7954126|NCT02589665|12502156|FG005|Induction Period|Withdrawal by Subject|0
7954127|NCT02589665|12502157|FG006|Induction Period|Withdrawal by Subject|0
7954128|NCT02589665|12502158|FG007|Induction Period|Withdrawal by Subject|0
7954129|NCT02589665|12502159|FG008|Induction Period|Withdrawal by Subject|0
7954130|NCT02589665|12502160|FG009|Induction Period|Withdrawal by Subject|0
7954131|NCT02589665|12502151|FG000|Induction Period|Protocol Violation|0
7954132|NCT02589665|12502152|FG001|Induction Period|Protocol Violation|1
7954133|NCT02589665|12502153|FG002|Induction Period|Protocol Violation|0
7954134|NCT02589665|12502154|FG003|Induction Period|Protocol Violation|0
7954135|NCT02589665|12502155|FG004|Induction Period|Protocol Violation|0
7954136|NCT02589665|12502156|FG005|Induction Period|Protocol Violation|0
7954137|NCT02589665|12502157|FG006|Induction Period|Protocol Violation|0
7954138|NCT02589665|12502158|FG007|Induction Period|Protocol Violation|0
7954139|NCT02589665|12502159|FG008|Induction Period|Protocol Violation|0
7954140|NCT02589665|12502160|FG009|Induction Period|Protocol Violation|0
7954141|NCT02589665|12502151|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7954142|NCT02589665|12502152|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7954143|NCT02589665|12502153|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7954144|NCT02589665|12502154|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7954145|NCT02589665|12502155|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7
7954146|NCT02589665|12502156|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41
7954147|NCT02589665|12502157|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39
7954148|NCT02589665|12502158|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7954149|NCT02589665|12502159|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7954150|NCT02589665|12502160|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7954151|NCT02589665|12502151|FG000|Maintenance Period|Withdrawal by Subject|0
7954152|NCT02589665|12502152|FG001|Maintenance Period|Withdrawal by Subject|0
7954153|NCT02589665|12502153|FG002|Maintenance Period|Withdrawal by Subject|0
7954154|NCT02589665|12502154|FG003|Maintenance Period|Withdrawal by Subject|0
7954155|NCT02589665|12502155|FG004|Maintenance Period|Withdrawal by Subject|4
7954156|NCT02589665|12502156|FG005|Maintenance Period|Withdrawal by Subject|2
7954157|NCT02589665|12502157|FG006|Maintenance Period|Withdrawal by Subject|4
7954158|NCT02589665|12502158|FG007|Maintenance Period|Withdrawal by Subject|0
7954159|NCT02589665|12502159|FG008|Maintenance Period|Withdrawal by Subject|0
7954160|NCT02589665|12502160|FG009|Maintenance Period|Withdrawal by Subject|0
7954161|NCT02589665|12502151|FG000|Maintenance Period|Lack of Efficacy|0
7954162|NCT02589665|12502152|FG001|Maintenance Period|Lack of Efficacy|0
7954163|NCT02589665|12502153|FG002|Maintenance Period|Lack of Efficacy|0
7954164|NCT02589665|12502154|FG003|Maintenance Period|Lack of Efficacy|0
7954165|NCT02589665|12502155|FG004|Maintenance Period|Lack of Efficacy|2
7954166|NCT02589665|12502156|FG005|Maintenance Period|Lack of Efficacy|1
7954167|NCT02589665|12502157|FG006|Maintenance Period|Lack of Efficacy|0
7954168|NCT02589665|12502158|FG007|Maintenance Period|Lack of Efficacy|0
7954169|NCT02589665|12502159|FG008|Maintenance Period|Lack of Efficacy|0
7954170|NCT02589665|12502160|FG009|Maintenance Period|Lack of Efficacy|0
7954171|NCT02589665|12502151|FG000|Maintenance Period|Adverse Event|0
7954172|NCT02589665|12502152|FG001|Maintenance Period|Adverse Event|0
7954173|NCT02589665|12502153|FG002|Maintenance Period|Adverse Event|0
7954174|NCT02589665|12502154|FG003|Maintenance Period|Adverse Event|0
7954175|NCT02589665|12502155|FG004|Maintenance Period|Adverse Event|0
7954176|NCT02589665|12502156|FG005|Maintenance Period|Adverse Event|0
7954177|NCT02589665|12502157|FG006|Maintenance Period|Adverse Event|2
7954178|NCT02589665|12502158|FG007|Maintenance Period|Adverse Event|0
7954179|NCT02589665|12502159|FG008|Maintenance Period|Adverse Event|0
7954180|NCT02589665|12502160|FG009|Maintenance Period|Adverse Event|0
7954181|NCT02589665|12502151|FG000|Maintenance Period|Lost to Follow-up|0
7954182|NCT02589665|12502152|FG001|Maintenance Period|Lost to Follow-up|0
7954183|NCT02589665|12502153|FG002|Maintenance Period|Lost to Follow-up|0
7954184|NCT02589665|12502154|FG003|Maintenance Period|Lost to Follow-up|0
7954185|NCT02589665|12502155|FG004|Maintenance Period|Lost to Follow-up|0
7954186|NCT02589665|12502156|FG005|Maintenance Period|Lost to Follow-up|1
7954187|NCT02589665|12502157|FG006|Maintenance Period|Lost to Follow-up|0
7954188|NCT02589665|12502158|FG007|Maintenance Period|Lost to Follow-up|0
7954189|NCT02589665|12502159|FG008|Maintenance Period|Lost to Follow-up|0
7954190|NCT02589665|12502160|FG009|Maintenance Period|Lost to Follow-up|0
7954191|NCT02589665|12502151|FG000|Maintenance Period|Physician Decision|0
7954192|NCT02589665|12502152|FG001|Maintenance Period|Physician Decision|0
7954193|NCT02589665|12502153|FG002|Maintenance Period|Physician Decision|0
7954194|NCT02589665|12502154|FG003|Maintenance Period|Physician Decision|0
7954195|NCT02589665|12502155|FG004|Maintenance Period|Physician Decision|0
7954196|NCT02589665|12502156|FG005|Maintenance Period|Physician Decision|1
7954197|NCT02589665|12502157|FG006|Maintenance Period|Physician Decision|0
7954198|NCT02589665|12502158|FG007|Maintenance Period|Physician Decision|0
7954199|NCT02589665|12502159|FG008|Maintenance Period|Physician Decision|0
7954200|NCT02589665|12502160|FG009|Maintenance Period|Physician Decision|0
7954201|NCT02589665|12502151|FG000|Maintenance Period|Reason Not Collected|0
7954202|NCT02589665|12502152|FG001|Maintenance Period|Reason Not Collected|0
7954203|NCT02589665|12502153|FG002|Maintenance Period|Reason Not Collected|0
7954204|NCT02589665|12502154|FG003|Maintenance Period|Reason Not Collected|0
7954205|NCT02589665|12502155|FG004|Maintenance Period|Reason Not Collected|0
7954206|NCT02589665|12502156|FG005|Maintenance Period|Reason Not Collected|1
7954207|NCT02589665|12502157|FG006|Maintenance Period|Reason Not Collected|1
7954208|NCT02589665|12502158|FG007|Maintenance Period|Reason Not Collected|0
7954209|NCT02589665|12502159|FG008|Maintenance Period|Reason Not Collected|0
7954210|NCT02589665|12502160|FG009|Maintenance Period|Reason Not Collected|0
7954211|NCT02589665|12502151|FG000|Induction Extension Period|Adverse Event|0
7954212|NCT02589665|12502152|FG001|Induction Extension Period|Adverse Event|0
7954213|NCT02589665|12502153|FG002|Induction Extension Period|Adverse Event|0
7954214|NCT02589665|12502154|FG003|Induction Extension Period|Adverse Event|0
7954215|NCT02589665|12502155|FG004|Induction Extension Period|Adverse Event|0
7954216|NCT02589665|12502156|FG005|Induction Extension Period|Adverse Event|0
7954217|NCT02589665|12502157|FG006|Induction Extension Period|Adverse Event|0
7954218|NCT02589665|12502158|FG007|Induction Extension Period|Adverse Event|0
7954219|NCT02589665|12502159|FG008|Induction Extension Period|Adverse Event|4
7954220|NCT02589665|12502160|FG009|Induction Extension Period|Adverse Event|0
7954221|NCT02589665|12502151|FG000|Induction Extension Period|Lack of Efficacy|0
7954222|NCT02589665|12502152|FG001|Induction Extension Period|Lack of Efficacy|0
7954223|NCT02589665|12502153|FG002|Induction Extension Period|Lack of Efficacy|0
7954224|NCT02589665|12502154|FG003|Induction Extension Period|Lack of Efficacy|0
7954225|NCT02589665|12502155|FG004|Induction Extension Period|Lack of Efficacy|0
7954226|NCT02589665|12502156|FG005|Induction Extension Period|Lack of Efficacy|0
7954227|NCT02589665|12502157|FG006|Induction Extension Period|Lack of Efficacy|0
7954228|NCT02589665|12502158|FG007|Induction Extension Period|Lack of Efficacy|0
7954229|NCT02589665|12502159|FG008|Induction Extension Period|Lack of Efficacy|3
7954230|NCT02589665|12502160|FG009|Induction Extension Period|Lack of Efficacy|0
7954231|NCT02589665|12502151|FG000|Induction Extension Period|Withdrawal by Subject|0
7954232|NCT02589665|12502152|FG001|Induction Extension Period|Withdrawal by Subject|0
7954233|NCT02589665|12502153|FG002|Induction Extension Period|Withdrawal by Subject|0
7954234|NCT02589665|12502154|FG003|Induction Extension Period|Withdrawal by Subject|0
7954235|NCT02589665|12502155|FG004|Induction Extension Period|Withdrawal by Subject|0
7954236|NCT02589665|12502156|FG005|Induction Extension Period|Withdrawal by Subject|0
7954237|NCT02589665|12502157|FG006|Induction Extension Period|Withdrawal by Subject|0
7954238|NCT02589665|12502158|FG007|Induction Extension Period|Withdrawal by Subject|2
7954239|NCT02589665|12502159|FG008|Induction Extension Period|Withdrawal by Subject|3
7954240|NCT02589665|12502160|FG009|Induction Extension Period|Withdrawal by Subject|0
7954241|NCT02589665|12502151|FG000|Induction Extension Period|Physician Decision|0
7954242|NCT02589665|12502152|FG001|Induction Extension Period|Physician Decision|0
7954243|NCT02589665|12502153|FG002|Induction Extension Period|Physician Decision|0
7954244|NCT02589665|12502154|FG003|Induction Extension Period|Physician Decision|0
7954245|NCT02589665|12502155|FG004|Induction Extension Period|Physician Decision|0
7954246|NCT02589665|12502156|FG005|Induction Extension Period|Physician Decision|0
7954247|NCT02589665|12502157|FG006|Induction Extension Period|Physician Decision|0
7954248|NCT02589665|12502158|FG007|Induction Extension Period|Physician Decision|0
7954249|NCT02589665|12502159|FG008|Induction Extension Period|Physician Decision|1
7954250|NCT02589665|12502160|FG009|Induction Extension Period|Physician Decision|0
7954251|NCT02589665|12502151|FG000|Induction Extension Period|Reason Not Collected|0
7954252|NCT02589665|12502152|FG001|Induction Extension Period|Reason Not Collected|0
7954253|NCT02589665|12502153|FG002|Induction Extension Period|Reason Not Collected|0
7954254|NCT02589665|12502154|FG003|Induction Extension Period|Reason Not Collected|0
7954255|NCT02589665|12502155|FG004|Induction Extension Period|Reason Not Collected|0
7954256|NCT02589665|12502156|FG005|Induction Extension Period|Reason Not Collected|0
7954257|NCT02589665|12502157|FG006|Induction Extension Period|Reason Not Collected|0
7954258|NCT02589665|12502158|FG007|Induction Extension Period|Reason Not Collected|0
7954259|NCT02589665|12502159|FG008|Induction Extension Period|Reason Not Collected|1
7954260|NCT02589665|12502160|FG009|Induction Extension Period|Reason Not Collected|0
7954261|NCT02589665|12502151|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7954262|NCT02589665|12502152|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7954263|NCT02589665|12502153|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7954264|NCT02589665|12502154|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7954265|NCT02589665|12502155|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7954266|NCT02589665|12502156|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7954267|NCT02589665|12502157|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7954268|NCT02589665|12502158|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7954269|NCT02589665|12502159|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7954270|NCT02589665|12502160|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57
7954271|NCT02589665|12502151|FG000|Maintenance Extension Period|Withdrawal by Subject|0
7954272|NCT02589665|12502152|FG001|Maintenance Extension Period|Withdrawal by Subject|0
7954273|NCT02589665|12502153|FG002|Maintenance Extension Period|Withdrawal by Subject|0
7954274|NCT02589665|12502154|FG003|Maintenance Extension Period|Withdrawal by Subject|0
7954275|NCT02589665|12502155|FG004|Maintenance Extension Period|Withdrawal by Subject|0
7954276|NCT02589665|12502156|FG005|Maintenance Extension Period|Withdrawal by Subject|0
7954277|NCT02589665|12502157|FG006|Maintenance Extension Period|Withdrawal by Subject|0
7954278|NCT02589665|12502158|FG007|Maintenance Extension Period|Withdrawal by Subject|0
7954279|NCT02589665|12502159|FG008|Maintenance Extension Period|Withdrawal by Subject|0
7954280|NCT02589665|12502160|FG009|Maintenance Extension Period|Withdrawal by Subject|4
7954281|NCT02589665|12502151|FG000|Maintenance Extension Period|Lack of Efficacy|0
7954282|NCT02589665|12502152|FG001|Maintenance Extension Period|Lack of Efficacy|0
7954283|NCT02589665|12502153|FG002|Maintenance Extension Period|Lack of Efficacy|0
7954284|NCT02589665|12502154|FG003|Maintenance Extension Period|Lack of Efficacy|0
7954285|NCT02589665|12502155|FG004|Maintenance Extension Period|Lack of Efficacy|0
7954286|NCT02589665|12502156|FG005|Maintenance Extension Period|Lack of Efficacy|0
7954287|NCT02589665|12502157|FG006|Maintenance Extension Period|Lack of Efficacy|0
7954288|NCT02589665|12502158|FG007|Maintenance Extension Period|Lack of Efficacy|0
7954289|NCT02589665|12502159|FG008|Maintenance Extension Period|Lack of Efficacy|0
7954290|NCT02589665|12502160|FG009|Maintenance Extension Period|Lack of Efficacy|4
7954291|NCT02589665|12502151|FG000|Maintenance Extension Period|Adverse Event|0
7954292|NCT02589665|12502152|FG001|Maintenance Extension Period|Adverse Event|0
7954293|NCT02589665|12502153|FG002|Maintenance Extension Period|Adverse Event|0
7954294|NCT02589665|12502154|FG003|Maintenance Extension Period|Adverse Event|0
7954295|NCT02589665|12502155|FG004|Maintenance Extension Period|Adverse Event|0
7954296|NCT02589665|12502156|FG005|Maintenance Extension Period|Adverse Event|0
7954297|NCT02589665|12502157|FG006|Maintenance Extension Period|Adverse Event|0
7954298|NCT02589665|12502158|FG007|Maintenance Extension Period|Adverse Event|0
7954299|NCT02589665|12502159|FG008|Maintenance Extension Period|Adverse Event|0
7954300|NCT02589665|12502160|FG009|Maintenance Extension Period|Adverse Event|2
7954301|NCT02589665|12502151|FG000|Maintenance Extension Period|Non-responder|0
7954302|NCT02589665|12502152|FG001|Maintenance Extension Period|Non-responder|0
7954303|NCT02589665|12502153|FG002|Maintenance Extension Period|Non-responder|0
7954304|NCT02589665|12502154|FG003|Maintenance Extension Period|Non-responder|0
7954305|NCT02589665|12502155|FG004|Maintenance Extension Period|Non-responder|0
7954306|NCT02589665|12502156|FG005|Maintenance Extension Period|Non-responder|0
7954307|NCT02589665|12502157|FG006|Maintenance Extension Period|Non-responder|0
7954308|NCT02589665|12502158|FG007|Maintenance Extension Period|Non-responder|0
7954309|NCT02589665|12502159|FG008|Maintenance Extension Period|Non-responder|0
7954310|NCT02589665|12502160|FG009|Maintenance Extension Period|Non-responder|1
7954311|NCT02590003|12502213|FG000|Overall Study|Death|1
7954312|NCT02590003|12502214|FG001|Overall Study|Death|2
7954313|NCT02590354|12502220|FG000|Phase 1|Active hepatitis B or C infection|1
7954314|NCT02590354|12502220|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1
7954315|NCT02590354|12502220|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75
7954316|NCT02590354|12502220|FG000|Phase 1|Subject does not want to participate|20
7954317|NCT02590354|12502220|FG000|Phase 1|Lost to Follow-up|1
7954318|NCT02590354|12502220|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2
7954319|NCT02590406|12502227|FG000|Overall Study|Adverse Event|1
7954320|NCT02590406|12502228|FG001|Overall Study|Adverse Event|0
7954321|NCT02590406|12502227|FG000|Overall Study|Saturometer malfunction|0
7954322|NCT02590406|12502228|FG001|Overall Study|Saturometer malfunction|1
7954323|NCT02590432|12502236|FG000|Open-label Treatment Period|Adverse Event|97
7954324|NCT02590432|12502237|FG001|Open-label Treatment Period|Adverse Event|79
7954325|NCT02590432|12502238|FG002|Open-label Treatment Period|Adverse Event|0
7954326|NCT02590432|12502239|FG003|Open-label Treatment Period|Adverse Event|0
7954327|NCT02590432|12502240|FG004|Open-label Treatment Period|Adverse Event|0
7954328|NCT02590432|12502241|FG005|Open-label Treatment Period|Adverse Event|0
7954329|NCT02590432|12502242|FG006|Open-label Treatment Period|Adverse Event|0
7954330|NCT02590432|12502243|FG007|Open-label Treatment Period|Adverse Event|0
7954331|NCT02590432|12502244|FG008|Open-label Treatment Period|Adverse Event|0
7954332|NCT02590432|12502236|FG000|Open-label Treatment Period|Lack of Efficacy|14
7954333|NCT02590432|12502237|FG001|Open-label Treatment Period|Lack of Efficacy|5
7954334|NCT02590432|12502238|FG002|Open-label Treatment Period|Lack of Efficacy|0
7954335|NCT02590432|12502239|FG003|Open-label Treatment Period|Lack of Efficacy|0
7954336|NCT02590432|12502240|FG004|Open-label Treatment Period|Lack of Efficacy|0
7954337|NCT02590432|12502241|FG005|Open-label Treatment Period|Lack of Efficacy|0
7954338|NCT02590432|12502242|FG006|Open-label Treatment Period|Lack of Efficacy|0
7954339|NCT02590432|12502243|FG007|Open-label Treatment Period|Lack of Efficacy|0
7954340|NCT02590432|12502244|FG008|Open-label Treatment Period|Lack of Efficacy|0
7954341|NCT02590432|12502236|FG000|Open-label Treatment Period|Withdrawal of Consent|43
7954342|NCT02590432|12502237|FG001|Open-label Treatment Period|Withdrawal of Consent|28
7954343|NCT02590432|12502238|FG002|Open-label Treatment Period|Withdrawal of Consent|0
7954344|NCT02590432|12502239|FG003|Open-label Treatment Period|Withdrawal of Consent|0
7954345|NCT02590432|12502240|FG004|Open-label Treatment Period|Withdrawal of Consent|0
7954346|NCT02590432|12502241|FG005|Open-label Treatment Period|Withdrawal of Consent|0
7954347|NCT02590432|12502242|FG006|Open-label Treatment Period|Withdrawal of Consent|0
7954348|NCT02590432|12502243|FG007|Open-label Treatment Period|Withdrawal of Consent|0
7954349|NCT02590432|12502244|FG008|Open-label Treatment Period|Withdrawal of Consent|0
7954350|NCT02590432|12502236|FG000|Open-label Treatment Period|Lost to Follow-up|51
7954351|NCT02590432|12502237|FG001|Open-label Treatment Period|Lost to Follow-up|29
7954352|NCT02590432|12502238|FG002|Open-label Treatment Period|Lost to Follow-up|0
7954353|NCT02590432|12502239|FG003|Open-label Treatment Period|Lost to Follow-up|0
7954354|NCT02590432|12502240|FG004|Open-label Treatment Period|Lost to Follow-up|0
7954355|NCT02590432|12502241|FG005|Open-label Treatment Period|Lost to Follow-up|0
7954356|NCT02590432|12502242|FG006|Open-label Treatment Period|Lost to Follow-up|0
7954357|NCT02590432|12502243|FG007|Open-label Treatment Period|Lost to Follow-up|0
7954358|NCT02590432|12502244|FG008|Open-label Treatment Period|Lost to Follow-up|0
7954359|NCT02590432|12502236|FG000|Open-label Treatment Period|Protocol Violation|10
7954360|NCT02590432|12502237|FG001|Open-label Treatment Period|Protocol Violation|4
7954361|NCT02590432|12502238|FG002|Open-label Treatment Period|Protocol Violation|0
7954362|NCT02590432|12502239|FG003|Open-label Treatment Period|Protocol Violation|0
7954363|NCT02590432|12502240|FG004|Open-label Treatment Period|Protocol Violation|0
7954364|NCT02590432|12502241|FG005|Open-label Treatment Period|Protocol Violation|0
7954365|NCT02590432|12502242|FG006|Open-label Treatment Period|Protocol Violation|0
7954366|NCT02590432|12502243|FG007|Open-label Treatment Period|Protocol Violation|0
7954367|NCT02590432|12502244|FG008|Open-label Treatment Period|Protocol Violation|0
7954368|NCT02590432|12502236|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7
7954369|NCT02590432|12502237|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1
7954370|NCT02590432|12502238|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0
7954371|NCT02590432|12502239|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0
7954372|NCT02590432|12502240|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0
7954373|NCT02590432|12502241|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0
7954374|NCT02590432|12502242|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0
7954375|NCT02590432|12502243|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0
7954376|NCT02590432|12502244|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0
7954377|NCT02590432|12502236|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10
7954378|NCT02590432|12502237|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6
7954379|NCT02590432|12502238|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0
7954380|NCT02590432|12502239|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0
7954381|NCT02590432|12502240|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0
7954382|NCT02590432|12502241|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0
7954383|NCT02590432|12502242|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0
7954384|NCT02590432|12502243|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0
7954385|NCT02590432|12502244|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0
7954386|NCT02590432|12502236|FG000|Double-blind Treatment Period|Adverse Event|0
7954387|NCT02590432|12502237|FG001|Double-blind Treatment Period|Adverse Event|0
7954388|NCT02590432|12502238|FG002|Double-blind Treatment Period|Adverse Event|14
7954389|NCT02590432|12502239|FG003|Double-blind Treatment Period|Adverse Event|12
7954390|NCT02590432|12502240|FG004|Double-blind Treatment Period|Adverse Event|6
7954391|NCT02590432|12502241|FG005|Double-blind Treatment Period|Adverse Event|22
7954392|NCT02590432|12502242|FG006|Double-blind Treatment Period|Adverse Event|20
7954393|NCT02590432|12502243|FG007|Double-blind Treatment Period|Adverse Event|0
7954394|NCT02590432|12502244|FG008|Double-blind Treatment Period|Adverse Event|0
7954395|NCT02590432|12502236|FG000|Double-blind Treatment Period|Lack of Efficacy|0
7954396|NCT02590432|12502237|FG001|Double-blind Treatment Period|Lack of Efficacy|0
7954397|NCT02590432|12502238|FG002|Double-blind Treatment Period|Lack of Efficacy|1
7954398|NCT02590432|12502239|FG003|Double-blind Treatment Period|Lack of Efficacy|0
7954399|NCT02590432|12502240|FG004|Double-blind Treatment Period|Lack of Efficacy|0
7954400|NCT02590432|12502241|FG005|Double-blind Treatment Period|Lack of Efficacy|0
7954401|NCT02590432|12502242|FG006|Double-blind Treatment Period|Lack of Efficacy|0
7954402|NCT02590432|12502243|FG007|Double-blind Treatment Period|Lack of Efficacy|0
7954403|NCT02590432|12502244|FG008|Double-blind Treatment Period|Lack of Efficacy|0
7954404|NCT02590432|12502236|FG000|Double-blind Treatment Period|Withdrawal of Consent|0
7954405|NCT02590432|12502237|FG001|Double-blind Treatment Period|Withdrawal of Consent|0
7954406|NCT02590432|12502238|FG002|Double-blind Treatment Period|Withdrawal of Consent|1
7954407|NCT02590432|12502239|FG003|Double-blind Treatment Period|Withdrawal of Consent|3
7954408|NCT02590432|12502240|FG004|Double-blind Treatment Period|Withdrawal of Consent|3
7954409|NCT02590432|12502241|FG005|Double-blind Treatment Period|Withdrawal of Consent|1
7954410|NCT02590432|12502242|FG006|Double-blind Treatment Period|Withdrawal of Consent|1
7954411|NCT02590432|12502243|FG007|Double-blind Treatment Period|Withdrawal of Consent|0
7954412|NCT02590432|12502244|FG008|Double-blind Treatment Period|Withdrawal of Consent|0
7954413|NCT02590432|12502236|FG000|Double-blind Treatment Period|Lost to Follow-up|0
7954414|NCT02590432|12502237|FG001|Double-blind Treatment Period|Lost to Follow-up|0
7954415|NCT02590432|12502238|FG002|Double-blind Treatment Period|Lost to Follow-up|1
7954416|NCT02590432|12502239|FG003|Double-blind Treatment Period|Lost to Follow-up|0
7954417|NCT02590432|12502240|FG004|Double-blind Treatment Period|Lost to Follow-up|0
7954418|NCT02590432|12502241|FG005|Double-blind Treatment Period|Lost to Follow-up|2
7954419|NCT02590432|12502242|FG006|Double-blind Treatment Period|Lost to Follow-up|0
7954420|NCT02590432|12502243|FG007|Double-blind Treatment Period|Lost to Follow-up|0
7954421|NCT02590432|12502244|FG008|Double-blind Treatment Period|Lost to Follow-up|0
7954422|NCT02590432|12502236|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0
7954423|NCT02590432|12502237|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0
7954424|NCT02590432|12502238|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0
7954425|NCT02590432|12502239|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0
7954426|NCT02590432|12502240|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0
7954427|NCT02590432|12502241|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1
7954428|NCT02590432|12502242|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0
7954429|NCT02590432|12502243|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0
7954430|NCT02590432|12502244|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0
7954431|NCT02590432|12502236|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0
7954432|NCT02590432|12502237|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0
7954433|NCT02590432|12502238|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0
7954434|NCT02590432|12502239|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0
7954435|NCT02590432|12502240|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0
7954436|NCT02590432|12502241|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0
7954437|NCT02590432|12502242|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0
7954438|NCT02590432|12502243|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12
7954439|NCT02590432|12502244|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15
7954440|NCT02590432|12502236|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7954441|NCT02590432|12502237|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7954442|NCT02590432|12502238|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7954443|NCT02590432|12502239|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7954444|NCT02590432|12502240|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7954445|NCT02590432|12502241|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7954446|NCT02590432|12502242|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7954447|NCT02590432|12502243|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1
7954448|NCT02590432|12502244|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7954449|NCT02590432|12502236|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7954450|NCT02590432|12502237|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7954451|NCT02590432|12502238|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7954452|NCT02590432|12502239|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7954453|NCT02590432|12502240|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7954454|NCT02590432|12502241|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7954455|NCT02590432|12502242|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7954456|NCT02590432|12502243|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3
7954457|NCT02590432|12502244|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1
7954458|NCT02590432|12502236|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7954459|NCT02590432|12502237|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7954460|NCT02590432|12502238|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7954461|NCT02590432|12502239|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7954462|NCT02590432|12502240|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7954463|NCT02590432|12502241|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7954464|NCT02590432|12502242|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7954465|NCT02590432|12502243|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7954466|NCT02590432|12502244|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1
7954467|NCT02590432|12502236|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7954468|NCT02590432|12502237|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7954469|NCT02590432|12502238|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7954470|NCT02590432|12502239|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7954471|NCT02590432|12502240|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7954472|NCT02590432|12502241|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7954473|NCT02590432|12502242|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7954474|NCT02590432|12502243|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7954475|NCT02590432|12502244|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1
7954476|NCT02590432|12502236|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7954477|NCT02590432|12502237|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7954478|NCT02590432|12502238|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7954479|NCT02590432|12502239|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7954480|NCT02590432|12502240|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7954481|NCT02590432|12502241|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7954482|NCT02590432|12502242|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7954483|NCT02590432|12502243|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1
7954484|NCT02590432|12502244|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7954485|NCT02590432|12502236|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7954486|NCT02590432|12502237|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7954487|NCT02590432|12502238|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7954488|NCT02590432|12502239|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7954489|NCT02590432|12502240|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7954490|NCT02590432|12502241|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7954491|NCT02590432|12502242|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7954492|NCT02590432|12502243|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1
7954493|NCT02590432|12502244|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7954494|NCT02590562|12502256|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6
7954495|NCT02590588|12502266|FG000|Overall Study|Adverse Event|1
7954496|NCT02590939|12502272|FG000|Overall Study|Withdrawal by Subject|3
7954497|NCT02590939|12502273|FG001|Overall Study|Withdrawal by Subject|1
7954498|NCT02590939|12502272|FG000|Overall Study|Failed the nociceptive test|2
7954499|NCT02590939|12502273|FG001|Overall Study|Failed the nociceptive test|1
7966239|NCT02748863|12522221|FG000|Treatment Period 1|Adverse Event|0
7966240|NCT02748863|12522222|FG001|Treatment Period 1|Adverse Event|1
7966241|NCT02748863|12522223|FG002|Treatment Period 1|Adverse Event|0
7966242|NCT02748863|12522224|FG003|Treatment Period 1|Adverse Event|0
7966243|NCT02748863|12522225|FG004|Treatment Period 1|Adverse Event|0
7966244|NCT02748863|12522221|FG000|Treatment Period 1|Lack of Efficacy|0
7966245|NCT02748863|12522222|FG001|Treatment Period 1|Lack of Efficacy|0
7966246|NCT02748863|12522223|FG002|Treatment Period 1|Lack of Efficacy|1
7966247|NCT02748863|12522224|FG003|Treatment Period 1|Lack of Efficacy|0
7966248|NCT02748863|12522225|FG004|Treatment Period 1|Lack of Efficacy|0
7966249|NCT02748863|12522221|FG000|Treatment Period 1|Withdrawal by Subject|0
7966250|NCT02748863|12522222|FG001|Treatment Period 1|Withdrawal by Subject|1
7966251|NCT02748863|12522223|FG002|Treatment Period 1|Withdrawal by Subject|1
7966252|NCT02748863|12522224|FG003|Treatment Period 1|Withdrawal by Subject|0
7966253|NCT02748863|12522225|FG004|Treatment Period 1|Withdrawal by Subject|0
7966254|NCT02748863|12522221|FG000|Treatment Period 2|Lost to Follow-up|2
7966255|NCT02748863|12522222|FG001|Treatment Period 2|Lost to Follow-up|0
7966256|NCT02748863|12522223|FG002|Treatment Period 2|Lost to Follow-up|0
7966257|NCT02748863|12522224|FG003|Treatment Period 2|Lost to Follow-up|0
7966258|NCT02748863|12522225|FG004|Treatment Period 2|Lost to Follow-up|0
7966259|NCT02748863|12522221|FG000|Treatment Period 2|Adverse Event|3
7966260|NCT02748863|12522222|FG001|Treatment Period 2|Adverse Event|2
7966261|NCT02748863|12522223|FG002|Treatment Period 2|Adverse Event|0
7966262|NCT02748863|12522224|FG003|Treatment Period 2|Adverse Event|2
7966263|NCT02748863|12522225|FG004|Treatment Period 2|Adverse Event|0
7966264|NCT02748863|12522221|FG000|Treatment Period 2|Lack of Efficacy|0
7966265|NCT02748863|12522222|FG001|Treatment Period 2|Lack of Efficacy|1
7966266|NCT02748863|12522223|FG002|Treatment Period 2|Lack of Efficacy|0
7966267|NCT02748863|12522224|FG003|Treatment Period 2|Lack of Efficacy|0
7966268|NCT02748863|12522225|FG004|Treatment Period 2|Lack of Efficacy|0
7966269|NCT02748863|12522221|FG000|Treatment Period 2|Pregnancy|0
7966270|NCT02748863|12522222|FG001|Treatment Period 2|Pregnancy|0
7966271|NCT02748863|12522223|FG002|Treatment Period 2|Pregnancy|0
7966272|NCT02748863|12522224|FG003|Treatment Period 2|Pregnancy|0
7966273|NCT02748863|12522225|FG004|Treatment Period 2|Pregnancy|1
7966274|NCT02749370|12522256|FG000|Overall Study|Withdrawal by Subject|11
7966275|NCT02749370|12522256|FG000|Overall Study|Lost to Follow-up|3
7966276|NCT02749721|12522260|FG000|Screening|Withdrawal by Subject|1
7966277|NCT02749721|12522260|FG000|Screening|Lost to Follow-up|2
7966278|NCT02749721|12522260|FG000|Screening|Protocol Violation|3
7966279|NCT02749721|12522260|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2
7966280|NCT02749721|12522260|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1
7966281|NCT02749799|12522266|FG000|Overall Study|Adverse Event|2
7966282|NCT02749799|12522266|FG000|Overall Study|Lost to Follow-up|4
7966283|NCT02749799|12522266|FG000|Overall Study|Protocol Violation|1
7966284|NCT02749799|12522266|FG000|Overall Study|Withdrawal by Subject|1
7966285|NCT02750306|12522287|FG000|Overall Study|Withdrawal by Subject|5
7966286|NCT02750306|12522288|FG001|Overall Study|Withdrawal by Subject|2
7966287|NCT02750306|12522287|FG000|Overall Study|Protocol Violation|1
7966288|NCT02750306|12522288|FG001|Overall Study|Protocol Violation|0
7966289|NCT02750332|12522294|FG000|Treatment Period 1|Withdrawal by Subject|0
7966290|NCT02750332|12522295|FG001|Treatment Period 1|Withdrawal by Subject|1
7966291|NCT02750345|12522301|FG000|Intervention 1|Adverse Event|0
7966292|NCT02750345|12522302|FG001|Intervention 1|Adverse Event|0
7966293|NCT02750345|12522303|FG002|Intervention 1|Adverse Event|0
7966294|NCT02750345|12522304|FG003|Intervention 1|Adverse Event|0
7966295|NCT02750345|12522305|FG004|Intervention 1|Adverse Event|1
7966296|NCT02750345|12522306|FG005|Intervention 1|Adverse Event|0
7966297|NCT02750410|12522318|FG000|Double-Blind Treatment Period|Adverse Event|2
7966298|NCT02750410|12522319|FG001|Double-Blind Treatment Period|Adverse Event|2
7966299|NCT02750410|12522318|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7966300|NCT02750410|12522319|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
7966301|NCT02750410|12522318|FG000|Open-Label Extension Period|Adverse Event|5
7954500|NCT02591238|12502287|FG000|Overall Study|Pregnancy|1
7954501|NCT02591238|12502288|FG001|Overall Study|Pregnancy|0
7954502|NCT02591238|12502289|FG002|Overall Study|Pregnancy|0
7954503|NCT02591238|12502290|FG003|Overall Study|Pregnancy|0
7954504|NCT02591238|12502287|FG000|Overall Study|Withdrawal by Subject|0
7954505|NCT02591238|12502288|FG001|Overall Study|Withdrawal by Subject|0
7954506|NCT02591238|12502289|FG002|Overall Study|Withdrawal by Subject|0
7954507|NCT02591238|12502290|FG003|Overall Study|Withdrawal by Subject|1
7954508|NCT02591238|12502287|FG000|Overall Study|influenza|0
7954509|NCT02591238|12502288|FG001|Overall Study|influenza|0
7954510|NCT02591238|12502289|FG002|Overall Study|influenza|0
7954511|NCT02591238|12502290|FG003|Overall Study|influenza|1
7954512|NCT02591238|12502287|FG000|Overall Study|personal circumstances|0
7954513|NCT02591238|12502288|FG001|Overall Study|personal circumstances|0
7954514|NCT02591238|12502289|FG002|Overall Study|personal circumstances|0
7954515|NCT02591238|12502290|FG003|Overall Study|personal circumstances|1
7954516|NCT02591238|12502287|FG000|Overall Study|personal circumstances|0
7954517|NCT02591238|12502288|FG001|Overall Study|personal circumstances|1
7954518|NCT02591238|12502289|FG002|Overall Study|personal circumstances|0
7954519|NCT02591238|12502290|FG003|Overall Study|personal circumstances|0
7954520|NCT02591290|12502300|FG000|Overall Study|Withdrawal by Subject|2
7954521|NCT02592018|12502323|FG000|Overall Study|Adverse Event|1
7954522|NCT02592018|12502323|FG000|Overall Study|Lost to Follow-up|1
7954523|NCT02592434|12502336|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12
7954524|NCT02592434|12502337|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0
7954525|NCT02592434|12502338|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0
7954526|NCT02592434|12502336|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21
7954527|NCT02592434|12502337|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
7954528|NCT02592434|12502338|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
7954529|NCT02592434|12502336|FG000|Open-Label Phase (18 Weeks)|Other|3
7954530|NCT02592434|12502337|FG001|Open-Label Phase (18 Weeks)|Other|0
7954531|NCT02592434|12502338|FG002|Open-Label Phase (18 Weeks)|Other|0
7954532|NCT02592434|12502336|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4
7954533|NCT02592434|12502337|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0
7954534|NCT02592434|12502338|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0
7954535|NCT02592434|12502336|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0
7954536|NCT02592434|12502337|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2
7954537|NCT02592434|12502338|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2
7954538|NCT02592434|12502336|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0
7954539|NCT02592434|12502337|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22
7954540|NCT02592434|12502338|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44
7954541|NCT02592434|12502336|FG000|Double Blind Phase (26 Weeks)|Other|0
7954542|NCT02592434|12502337|FG001|Double Blind Phase (26 Weeks)|Other|1
7954543|NCT02592434|12502338|FG002|Double Blind Phase (26 Weeks)|Other|0
7954544|NCT02592434|12502336|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0
7954545|NCT02592434|12502337|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0
7954546|NCT02592434|12502338|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1
7954547|NCT02592434|12502336|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
7954548|NCT02592434|12502337|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1
7954549|NCT02592434|12502338|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
7954550|NCT02592434|12502336|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
7954551|NCT02592434|12502337|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1
7954552|NCT02592434|12502338|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
7954553|NCT02592447|12502348|FG000|Overall Study|Lost to Follow-up|1
7954554|NCT02592447|12502349|FG001|Overall Study|Lost to Follow-up|0
7954555|NCT02592447|12502348|FG000|Overall Study|Ineligible after randomization|1
7954556|NCT02592447|12502349|FG001|Overall Study|Ineligible after randomization|0
7954557|NCT02592447|12502348|FG000|Overall Study|Withdrawal by Subject|0
7954558|NCT02592447|12502349|FG001|Overall Study|Withdrawal by Subject|1
7954559|NCT02592798|12502396|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1
7954560|NCT02592798|12502397|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0
7954561|NCT02592798|12502396|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0
7954562|NCT02592798|12502397|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1
7954563|NCT02592798|12502396|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1
7954564|NCT02592798|12502397|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3
7954565|NCT02592798|12502396|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1
7954566|NCT02592798|12502397|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2
7954567|NCT02592798|12502396|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3
7954568|NCT02592798|12502397|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2
7954569|NCT02592798|12502396|FG000|Double-Blind Period 2 (DB2)|Other reasons|1
7954570|NCT02592798|12502397|FG001|Double-Blind Period 2 (DB2)|Other reasons|0
7954571|NCT02592798|12502396|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1
7954572|NCT02592798|12502397|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0
7954573|NCT02592798|12502396|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1
7954574|NCT02592798|12502397|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0
7954575|NCT02592798|12502396|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1
7954576|NCT02592798|12502397|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2
7954577|NCT02592798|12502396|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1
7954578|NCT02592798|12502397|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0
7954579|NCT02592798|12502396|FG000|Transition From DB2 to OLE|Other reasons|1
7954580|NCT02592798|12502397|FG001|Transition From DB2 to OLE|Other reasons|0
7954581|NCT02592798|12502396|FG000|Open Label Period (OLE)|Other reasons|0
7954582|NCT02592798|12502397|FG001|Open Label Period (OLE)|Other reasons|2
7954583|NCT02592798|12502396|FG000|Open Label Period (OLE)|Participant request to discontinue|1
7954584|NCT02592798|12502397|FG001|Open Label Period (OLE)|Participant request to discontinue|0
7954585|NCT02592798|12502396|FG000|Open Label Period (OLE)|Lost to Follow-up|0
7954586|NCT02592798|12502397|FG001|Open Label Period (OLE)|Lost to Follow-up|1
7954587|NCT02592798|12502396|FG000|Open Label Period (OLE)|Lack of Efficacy|3
7954588|NCT02592798|12502397|FG001|Open Label Period (OLE)|Lack of Efficacy|5
7954589|NCT02592798|12502396|FG000|Open Label Period (OLE)|Adverse Event|0
7954590|NCT02592798|12502397|FG001|Open Label Period (OLE)|Adverse Event|1
7954591|NCT02592876|12502412|FG000|Overall Study|Withdrawal by Subject|3
7954592|NCT02592876|12502413|FG001|Overall Study|Withdrawal by Subject|3
7954593|NCT02592876|12502412|FG000|Overall Study|Study Termination by Sponsor|32
7954594|NCT02592876|12502413|FG001|Overall Study|Study Termination by Sponsor|27
7954595|NCT02592876|12502412|FG000|Overall Study|Lost to Follow-up|0
7954596|NCT02592876|12502413|FG001|Overall Study|Lost to Follow-up|1
7954597|NCT02592876|12502412|FG000|Overall Study|Death|6
7954598|NCT02592876|12502413|FG001|Overall Study|Death|9
7954599|NCT02593097|12502444|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1
7954600|NCT02593097|12502445|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2
7954601|NCT02593097|12502444|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
7954602|NCT02593097|12502445|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2
7954603|NCT02593097|12502444|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1
7954604|NCT02593097|12502445|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1
7954605|NCT02593097|12502444|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1
7954606|NCT02593097|12502445|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0
7954607|NCT02593097|12502444|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1
7954608|NCT02593097|12502445|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0
7954609|NCT02593149|12502453|FG000|Run-In|Didn't use CVC for at least 21 days|36
7954610|NCT02593149|12502454|FG001|Run-In|Didn't use CVC for at least 21 days|38
7954611|NCT02593149|12502453|FG000|Intervention|Didn't use CVC for at least 21 day|116
7954612|NCT02593149|12502454|FG001|Intervention|Didn't use CVC for at least 21 day|115
7954613|NCT02593305|12502463|FG000|Post 1|Comparison only group. No intervention.|0
7954614|NCT02593305|12502464|FG001|Post 1|Comparison only group. No intervention.|0
7954615|NCT02593305|12502465|FG002|Post 1|Comparison only group. No intervention.|10
7954616|NCT02593318|12502476|FG000|Overall Study|Withdrawal by Subject|1
7954617|NCT02593318|12502477|FG001|Overall Study|Withdrawal by Subject|1
7954618|NCT02593539|12502498|FG000|Overall Study|Adverse Event|1
7954619|NCT02593773|12502510|FG000|Overall Study|Voluntary Withdrawal|3
7954620|NCT02593773|12502510|FG000|Overall Study|Study Terminated by Sponsor|31
7954621|NCT02593773|12502510|FG000|Overall Study|Death|1
7954622|NCT02593825|12502516|FG000|Intervention|Lost to Follow-up|10
7954623|NCT02593825|12502517|FG001|Intervention|Lost to Follow-up|12
7954624|NCT02593864|12502525|FG000|Overall Study|Withdrawal by Subject|3
7954625|NCT02593864|12502525|FG000|Overall Study|Lost to Follow-up|3
7966302|NCT02750410|12522319|FG001|Open-Label Extension Period|Adverse Event|3
7966303|NCT02750410|12522318|FG000|Open-Label Extension Period|Protocol Violation|0
7966304|NCT02750410|12522319|FG001|Open-Label Extension Period|Protocol Violation|1
7966305|NCT02750410|12522318|FG000|Open-Label Extension Period|Withdrawal by Subject|1
7966306|NCT02750410|12522319|FG001|Open-Label Extension Period|Withdrawal by Subject|2
7966307|NCT02750501|12522329|FG000|Overall Study|Adverse Event|4
7966308|NCT02750501|12522329|FG000|Overall Study|Physician Decision|1
7966309|NCT02750501|12522329|FG000|Overall Study|Protocol Violation|1
7966310|NCT02750501|12522329|FG000|Overall Study|G-tube came out|1
7966311|NCT02750501|12522329|FG000|Overall Study|Non-compliant use of PERT|1
7966312|NCT02750514|12522342|FG000|Track 1|Disease progression|20
7966313|NCT02750514|12522343|FG001|Track 1|Disease progression|1
7966314|NCT02750514|12522344|FG002|Track 1|Disease progression|0
7966315|NCT02750514|12522345|FG003|Track 1|Disease progression|1
7966316|NCT02750514|12522346|FG004|Track 1|Disease progression|0
7966317|NCT02750514|12522342|FG000|Track 1|Adverse event unrelated to study drug|1
7966318|NCT02750514|12522343|FG001|Track 1|Adverse event unrelated to study drug|0
7966319|NCT02750514|12522344|FG002|Track 1|Adverse event unrelated to study drug|0
7966320|NCT02750514|12522345|FG003|Track 1|Adverse event unrelated to study drug|0
7966321|NCT02750514|12522346|FG004|Track 1|Adverse event unrelated to study drug|0
7966322|NCT02750514|12522342|FG000|Track 1|Study drug toxicity|4
7966323|NCT02750514|12522343|FG001|Track 1|Study drug toxicity|1
7966324|NCT02750514|12522344|FG002|Track 1|Study drug toxicity|0
7966325|NCT02750514|12522345|FG003|Track 1|Study drug toxicity|1
7966326|NCT02750514|12522346|FG004|Track 1|Study drug toxicity|0
7966327|NCT02750514|12522342|FG000|Track 1|Participant request to discontinue|1
7966328|NCT02750514|12522343|FG001|Track 1|Participant request to discontinue|0
7966329|NCT02750514|12522344|FG002|Track 1|Participant request to discontinue|0
7966330|NCT02750514|12522345|FG003|Track 1|Participant request to discontinue|0
7966331|NCT02750514|12522346|FG004|Track 1|Participant request to discontinue|0
7954626|NCT04142242|12502535|FG000|Overall Study|Non-compliance with the protocol|1
7954627|NCT04142242|12502536|FG001|Overall Study|Non-compliance with the protocol|0
7954628|NCT04142242|12502537|FG002|Overall Study|Non-compliance with the protocol|0
7954629|NCT04142242|12502538|FG003|Overall Study|Non-compliance with the protocol|0
7954630|NCT04142242|12502539|FG004|Overall Study|Non-compliance with the protocol|0
7954631|NCT04142242|12502540|FG005|Overall Study|Non-compliance with the protocol|1
7954632|NCT04142242|12502535|FG000|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7954633|NCT04142242|12502536|FG001|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|1
7954634|NCT04142242|12502537|FG002|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7954635|NCT04142242|12502538|FG003|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7954636|NCT04142242|12502539|FG004|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7954637|NCT04142242|12502540|FG005|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7954638|NCT04142242|12502535|FG000|Overall Study|Ongoing|0
7954639|NCT04142242|12502536|FG001|Overall Study|Ongoing|0
7954640|NCT04142242|12502537|FG002|Overall Study|Ongoing|31
7954641|NCT04142242|12502538|FG003|Overall Study|Ongoing|39
7954642|NCT04142242|12502539|FG004|Overall Study|Ongoing|0
7954643|NCT04142242|12502540|FG005|Overall Study|Ongoing|0
7954644|NCT03990389|12502561|FG000|Overall Study|Lost to Follow-up|3
7954645|NCT03990389|12502562|FG001|Overall Study|Lost to Follow-up|0
7954646|NCT03939312|12502568|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43
7954647|NCT03939312|12502568|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25
7954648|NCT03939312|12502568|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4
7954649|NCT03939312|12502568|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35
7954650|NCT03939312|12502568|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19
7954651|NCT03939312|12502568|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3
7954652|NCT03939312|12502568|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16
7954653|NCT03939312|12502568|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4
7954654|NCT03939312|12502568|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3
7954655|NCT03939312|12502568|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22
7954656|NCT03939312|12502568|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12
7954657|NCT03939312|12502568|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4
7954658|NCT03934541|12502578|FG000|Overall Study|Study Terminated by Sponsor|0
7954659|NCT03934541|12502579|FG001|Overall Study|Study Terminated by Sponsor|1
7954660|NCT03934541|12502580|FG002|Overall Study|Study Terminated by Sponsor|0
7954661|NCT03934541|12502581|FG003|Overall Study|Study Terminated by Sponsor|0
7966332|NCT02750514|12522342|FG000|Track 1|Other reasons|1
7966333|NCT02750514|12522343|FG001|Track 1|Other reasons|0
7966334|NCT02750514|12522344|FG002|Track 1|Other reasons|0
7966335|NCT02750514|12522345|FG003|Track 1|Other reasons|0
7966336|NCT02750514|12522346|FG004|Track 1|Other reasons|0
7966337|NCT02750514|12522342|FG000|Track 2|Disease progression|4
7966338|NCT02750514|12522343|FG001|Track 2|Disease progression|5
7966339|NCT02750514|12522344|FG002|Track 2|Disease progression|2
7966340|NCT02750514|12522345|FG003|Track 2|Disease progression|5
7966341|NCT02750514|12522346|FG004|Track 2|Disease progression|0
7966342|NCT02750514|12522342|FG000|Track 2|Adverse event unrelated to study drug|1
7966343|NCT02750514|12522343|FG001|Track 2|Adverse event unrelated to study drug|0
7966344|NCT02750514|12522344|FG002|Track 2|Adverse event unrelated to study drug|0
7966345|NCT02750514|12522345|FG003|Track 2|Adverse event unrelated to study drug|0
7966346|NCT02750514|12522346|FG004|Track 2|Adverse event unrelated to study drug|0
7966347|NCT02750514|12522342|FG000|Track 2|Study drug toxicity|1
7966348|NCT02750514|12522343|FG001|Track 2|Study drug toxicity|2
7966349|NCT02750514|12522344|FG002|Track 2|Study drug toxicity|0
7966350|NCT02750514|12522345|FG003|Track 2|Study drug toxicity|2
7966351|NCT02750514|12522346|FG004|Track 2|Study drug toxicity|0
7966352|NCT02750514|12522342|FG000|Track 2|Participant withdrew consent|0
7966353|NCT02750514|12522343|FG001|Track 2|Participant withdrew consent|1
7966354|NCT02750514|12522344|FG002|Track 2|Participant withdrew consent|0
7966355|NCT02750514|12522345|FG003|Track 2|Participant withdrew consent|0
7966356|NCT02750514|12522346|FG004|Track 2|Participant withdrew consent|0
7966357|NCT02750514|12522342|FG000|Track 3|Disease progression|0
7966358|NCT02750514|12522343|FG001|Track 3|Disease progression|24
7966359|NCT02750514|12522344|FG002|Track 3|Disease progression|13
7966360|NCT02750514|12522345|FG003|Track 3|Disease progression|14
7966361|NCT02750514|12522346|FG004|Track 3|Disease progression|0
7966362|NCT02750514|12522342|FG000|Track 3|Adverse event unrelated to study drug|0
7966363|NCT02750514|12522343|FG001|Track 3|Adverse event unrelated to study drug|1
7966364|NCT02750514|12522344|FG002|Track 3|Adverse event unrelated to study drug|1
7966365|NCT02750514|12522345|FG003|Track 3|Adverse event unrelated to study drug|1
7966366|NCT02750514|12522346|FG004|Track 3|Adverse event unrelated to study drug|0
7966367|NCT02750514|12522342|FG000|Track 3|Study drug toxicity|0
7966368|NCT02750514|12522343|FG001|Track 3|Study drug toxicity|3
7966369|NCT02750514|12522344|FG002|Track 3|Study drug toxicity|0
7966370|NCT02750514|12522345|FG003|Track 3|Study drug toxicity|1
7966371|NCT02750514|12522346|FG004|Track 3|Study drug toxicity|0
7966372|NCT02750514|12522342|FG000|Track 3|Participant request to discontinue|0
7966373|NCT02750514|12522343|FG001|Track 3|Participant request to discontinue|2
7966374|NCT02750514|12522344|FG002|Track 3|Participant request to discontinue|0
7954662|NCT03895034|12502591|FG000|Overall Study|Lost to Follow-up|2
7954663|NCT03870477|12502595|FG000|Overall Study|Early Study Termination|1
7954664|NCT03351244|12502602|FG000|Overall Study|Adverse Event|7
7954665|NCT03351244|12502603|FG001|Overall Study|Adverse Event|11
7954666|NCT03351244|12502604|FG002|Overall Study|Adverse Event|12
7954667|NCT03351244|12502602|FG000|Overall Study|Investigator's decision|0
7954668|NCT03351244|12502603|FG001|Overall Study|Investigator's decision|0
7954669|NCT03351244|12502604|FG002|Overall Study|Investigator's decision|2
7954670|NCT03351244|12502602|FG000|Overall Study|System error|0
7954671|NCT03351244|12502603|FG001|Overall Study|System error|0
7954672|NCT03351244|12502604|FG002|Overall Study|System error|2
7954673|NCT03351244|12502602|FG000|Overall Study|COVID-19 restrictions|3
7954674|NCT03351244|12502603|FG001|Overall Study|COVID-19 restrictions|0
7954675|NCT03351244|12502604|FG002|Overall Study|COVID-19 restrictions|1
7954676|NCT03351244|12502602|FG000|Overall Study|Non-compliance|2
7954677|NCT03351244|12502603|FG001|Overall Study|Non-compliance|5
7954678|NCT03351244|12502604|FG002|Overall Study|Non-compliance|0
7954679|NCT03351244|12502602|FG000|Overall Study|Withdrawal by Subject|11
7954680|NCT03351244|12502603|FG001|Overall Study|Withdrawal by Subject|16
7954681|NCT03351244|12502604|FG002|Overall Study|Withdrawal by Subject|13
7954682|NCT03351244|12502602|FG000|Overall Study|Lost to Follow-up|2
7954683|NCT03351244|12502603|FG001|Overall Study|Lost to Follow-up|6
7721006|NCT00542425|12145525|FG002|Initial 24 Weeks|Administrative reasons|1
7721007|NCT00542425|12145526|FG003|Initial 24 Weeks|Administrative reasons|1
7721008|NCT00542425|12145527|FG004|Initial 24 Weeks|Administrative reasons|0
7721009|NCT00542425|12145523|FG000|Initial 24 Weeks|Adverse Event|0
7721010|NCT00542425|12145524|FG001|Initial 24 Weeks|Adverse Event|1
7721011|NCT00542425|12145525|FG002|Initial 24 Weeks|Adverse Event|1
7954684|NCT03351244|12502604|FG002|Overall Study|Lost to Follow-up|4
7954685|NCT03351244|12502602|FG000|Overall Study|Protocol Violation|2
7954686|NCT03351244|12502603|FG001|Overall Study|Protocol Violation|2
7954687|NCT03351244|12502604|FG002|Overall Study|Protocol Violation|0
7954688|NCT02982954|12502627|FG000|Treatment Period|Disease progression|62
7954689|NCT02982954|12502628|FG001|Treatment Period|Disease progression|26
7954690|NCT02982954|12502629|FG002|Treatment Period|Disease progression|12
7954691|NCT02982954|12502630|FG003|Treatment Period|Disease progression|10
7954692|NCT02982954|12502627|FG000|Treatment Period|study drug toxicity|20
7954693|NCT02982954|12502628|FG001|Treatment Period|study drug toxicity|10
7954694|NCT02982954|12502629|FG002|Treatment Period|study drug toxicity|8
7954695|NCT02982954|12502630|FG003|Treatment Period|study drug toxicity|0
7954696|NCT02982954|12502627|FG000|Treatment Period|Death|1
7954697|NCT02982954|12502628|FG001|Treatment Period|Death|3
7954698|NCT02982954|12502629|FG002|Treatment Period|Death|2
7954699|NCT02982954|12502630|FG003|Treatment Period|Death|4
7954700|NCT02982954|12502627|FG000|Treatment Period|Adverse events unrelated to study drug|4
7954701|NCT02982954|12502628|FG001|Treatment Period|Adverse events unrelated to study drug|1
7954702|NCT02982954|12502629|FG002|Treatment Period|Adverse events unrelated to study drug|1
7954703|NCT02982954|12502630|FG003|Treatment Period|Adverse events unrelated to study drug|3
7954704|NCT02982954|12502627|FG000|Treatment Period|participant request to discontinue|2
7954705|NCT02982954|12502628|FG001|Treatment Period|participant request to discontinue|2
7954706|NCT02982954|12502629|FG002|Treatment Period|participant request to discontinue|1
7954707|NCT02982954|12502630|FG003|Treatment Period|participant request to discontinue|2
7954708|NCT02982954|12502627|FG000|Treatment Period|participant withdrew consent|1
7954709|NCT02982954|12502628|FG001|Treatment Period|participant withdrew consent|1
7954710|NCT02982954|12502629|FG002|Treatment Period|participant withdrew consent|0
7954711|NCT02982954|12502630|FG003|Treatment Period|participant withdrew consent|1
7954712|NCT02982954|12502627|FG000|Treatment Period|maximum clinical benefit|1
7954713|NCT02982954|12502628|FG001|Treatment Period|maximum clinical benefit|0
7954714|NCT02982954|12502629|FG002|Treatment Period|maximum clinical benefit|0
7954715|NCT02982954|12502630|FG003|Treatment Period|maximum clinical benefit|0
7954716|NCT02982954|12502627|FG000|Treatment Period|no longer meets study criteria|0
7954717|NCT02982954|12502628|FG001|Treatment Period|no longer meets study criteria|1
7954718|NCT02982954|12502629|FG002|Treatment Period|no longer meets study criteria|0
7954719|NCT02982954|12502630|FG003|Treatment Period|no longer meets study criteria|0
7954720|NCT02982954|12502627|FG000|Treatment Period|Admin reason by sponsor|3
7954721|NCT02982954|12502628|FG001|Treatment Period|Admin reason by sponsor|0
7954722|NCT02982954|12502629|FG002|Treatment Period|Admin reason by sponsor|0
7954723|NCT02982954|12502630|FG003|Treatment Period|Admin reason by sponsor|0
7954724|NCT02982954|12502627|FG000|Treatment Period|other reasons|12
7954725|NCT02982954|12502628|FG001|Treatment Period|other reasons|8
7954726|NCT02982954|12502629|FG002|Treatment Period|other reasons|4
7954727|NCT02982954|12502630|FG003|Treatment Period|other reasons|5
7954728|NCT02982954|12502627|FG000|Continuing in Study|Death|44
7954729|NCT02982954|12502628|FG001|Continuing in Study|Death|27
7954730|NCT02982954|12502629|FG002|Continuing in Study|Death|10
7954731|NCT02982954|12502630|FG003|Continuing in Study|Death|17
7954732|NCT02982954|12502627|FG000|Continuing in Study|participant withdrew consent|9
7954733|NCT02982954|12502628|FG001|Continuing in Study|participant withdrew consent|5
7954734|NCT02982954|12502629|FG002|Continuing in Study|participant withdrew consent|1
7954735|NCT02982954|12502630|FG003|Continuing in Study|participant withdrew consent|1
7954736|NCT02982954|12502627|FG000|Continuing in Study|Lost to Follow-up|1
7954737|NCT02982954|12502628|FG001|Continuing in Study|Lost to Follow-up|0
7954738|NCT02982954|12502629|FG002|Continuing in Study|Lost to Follow-up|0
7954739|NCT02982954|12502630|FG003|Continuing in Study|Lost to Follow-up|0
7954740|NCT02982954|12502627|FG000|Continuing in Study|other reasons|0
7954741|NCT02982954|12502628|FG001|Continuing in Study|other reasons|1
7954742|NCT02982954|12502629|FG002|Continuing in Study|other reasons|0
7954743|NCT02982954|12502630|FG003|Continuing in Study|other reasons|0
7954744|NCT02727699|12502642|FG000|Overall Study|Adverse Event|2
7954745|NCT02727699|12502643|FG001|Overall Study|Adverse Event|0
7954746|NCT02727699|12502642|FG000|Overall Study|Withdrawal by Subject|5
7954747|NCT02727699|12502643|FG001|Overall Study|Withdrawal by Subject|3
7954748|NCT02727699|12502642|FG000|Overall Study|Protocol Violation|0
7954749|NCT02727699|12502643|FG001|Overall Study|Protocol Violation|1
7954750|NCT02727699|12502642|FG000|Overall Study|Physician Decision|0
7954751|NCT02727699|12502643|FG001|Overall Study|Physician Decision|1
7954752|NCT02727699|12502642|FG000|Overall Study|Lost to Follow-up|1
7954753|NCT02727699|12502643|FG001|Overall Study|Lost to Follow-up|0
7954754|NCT02727699|12502642|FG000|Overall Study|Sponsor Decision|1
7954755|NCT02727699|12502643|FG001|Overall Study|Sponsor Decision|0
7966375|NCT02750514|12522345|FG003|Track 3|Participant request to discontinue|0
7966376|NCT02750514|12522346|FG004|Track 3|Participant request to discontinue|0
7966377|NCT02750514|12522342|FG000|Track 3|Participant withdrew consent|0
7966378|NCT02750514|12522343|FG001|Track 3|Participant withdrew consent|3
7966379|NCT02750514|12522344|FG002|Track 3|Participant withdrew consent|1
7966380|NCT02750514|12522345|FG003|Track 3|Participant withdrew consent|0
7966381|NCT02750514|12522346|FG004|Track 3|Participant withdrew consent|0
7966382|NCT02750514|12522342|FG000|Track 3|Other reasons|0
7966383|NCT02750514|12522343|FG001|Track 3|Other reasons|3
7966384|NCT02750514|12522344|FG002|Track 3|Other reasons|0
7966385|NCT02750514|12522345|FG003|Track 3|Other reasons|0
7966386|NCT02750514|12522346|FG004|Track 3|Other reasons|0
7966387|NCT02750514|12522342|FG000|Track 4|Study drug toxicity|0
7966388|NCT02750514|12522343|FG001|Track 4|Study drug toxicity|6
7966389|NCT02750514|12522344|FG002|Track 4|Study drug toxicity|0
7966390|NCT02750514|12522345|FG003|Track 4|Study drug toxicity|5
7966391|NCT02750514|12522346|FG004|Track 4|Study drug toxicity|0
7966392|NCT02750514|12522342|FG000|Track 4|Participant request to discontinue|0
7966393|NCT02750514|12522343|FG001|Track 4|Participant request to discontinue|1
7966394|NCT02750514|12522344|FG002|Track 4|Participant request to discontinue|0
7966395|NCT02750514|12522345|FG003|Track 4|Participant request to discontinue|1
7966396|NCT02750514|12522346|FG004|Track 4|Participant request to discontinue|0
7966397|NCT02750514|12522342|FG000|Track 4|Participant withdrew consent|0
7966398|NCT02750514|12522343|FG001|Track 4|Participant withdrew consent|1
7966399|NCT02750514|12522344|FG002|Track 4|Participant withdrew consent|0
7966400|NCT02750514|12522345|FG003|Track 4|Participant withdrew consent|0
7966401|NCT02750514|12522346|FG004|Track 4|Participant withdrew consent|0
7966402|NCT02750514|12522342|FG000|Track 4|Other reasons|0
7966403|NCT02750514|12522343|FG001|Track 4|Other reasons|5
7966404|NCT02750514|12522344|FG002|Track 4|Other reasons|0
7966405|NCT02750514|12522345|FG003|Track 4|Other reasons|3
7966406|NCT02750514|12522346|FG004|Track 4|Other reasons|0
7966407|NCT02750514|12522342|FG000|Track 4|Disease progression|0
7966408|NCT02750514|12522343|FG001|Track 4|Disease progression|33
7966409|NCT02750514|12522344|FG002|Track 4|Disease progression|0
7966410|NCT02750514|12522345|FG003|Track 4|Disease progression|32
7966411|NCT02750514|12522346|FG004|Track 4|Disease progression|0
7966412|NCT02750514|12522342|FG000|Track 4|Adverse event unrelated to study drug|0
7966413|NCT02750514|12522343|FG001|Track 4|Adverse event unrelated to study drug|5
7966414|NCT02750514|12522344|FG002|Track 4|Adverse event unrelated to study drug|0
7966415|NCT02750514|12522345|FG003|Track 4|Adverse event unrelated to study drug|0
7966416|NCT02750514|12522346|FG004|Track 4|Adverse event unrelated to study drug|0
7966417|NCT02750514|12522342|FG000|Track 4|Death|0
7966418|NCT02750514|12522343|FG001|Track 4|Death|0
7966419|NCT02750514|12522344|FG002|Track 4|Death|0
7966420|NCT02750514|12522345|FG003|Track 4|Death|1
7966421|NCT02750514|12522346|FG004|Track 4|Death|0
7966422|NCT02750514|12522342|FG000|Track 5|Disease progression|0
7966423|NCT02750514|12522343|FG001|Track 5|Disease progression|0
7966424|NCT02750514|12522344|FG002|Track 5|Disease progression|0
7966425|NCT02750514|12522345|FG003|Track 5|Disease progression|0
7966426|NCT02750514|12522346|FG004|Track 5|Disease progression|34
7966427|NCT02750514|12522342|FG000|Track 5|Adverse event unrelated to study drug|0
7966428|NCT02750514|12522343|FG001|Track 5|Adverse event unrelated to study drug|0
7966429|NCT02750514|12522344|FG002|Track 5|Adverse event unrelated to study drug|0
7966430|NCT02750514|12522345|FG003|Track 5|Adverse event unrelated to study drug|0
7966431|NCT02750514|12522346|FG004|Track 5|Adverse event unrelated to study drug|2
7966432|NCT02750514|12522342|FG000|Track 5|Study drug toxicity|0
7966433|NCT02750514|12522343|FG001|Track 5|Study drug toxicity|0
7966434|NCT02750514|12522344|FG002|Track 5|Study drug toxicity|0
7966435|NCT02750514|12522345|FG003|Track 5|Study drug toxicity|0
7966436|NCT02750514|12522346|FG004|Track 5|Study drug toxicity|2
7966437|NCT02750514|12522342|FG000|Track 5|Participant request to discontinue|0
7966438|NCT02750514|12522343|FG001|Track 5|Participant request to discontinue|0
7966439|NCT02750514|12522344|FG002|Track 5|Participant request to discontinue|0
7966440|NCT02750514|12522345|FG003|Track 5|Participant request to discontinue|0
7966441|NCT02750514|12522346|FG004|Track 5|Participant request to discontinue|3
7954756|NCT02230254|12502663|FG000|Overall Study|Lost to Follow-up|3
7954757|NCT01891396|12502670|FG000|Overall Study|Withdrawal by Subject|4
7954758|NCT01891396|12502671|FG001|Overall Study|Withdrawal by Subject|4
7954759|NCT01891396|12502672|FG002|Overall Study|Withdrawal by Subject|3
7954760|NCT01891396|12502670|FG000|Overall Study|Lost to Follow-up|0
7954761|NCT01891396|12502671|FG001|Overall Study|Lost to Follow-up|1
7954762|NCT01891396|12502672|FG002|Overall Study|Lost to Follow-up|0
7954763|NCT01525901|12502688|FG000|Period 2: 12 Weeks|Adverse Event|0
7954764|NCT01525901|12502689|FG001|Period 2: 12 Weeks|Adverse Event|1
7954765|NCT01525901|12502690|FG002|Period 2: 12 Weeks|Adverse Event|0
7954766|NCT01525901|12502691|FG003|Period 2: 12 Weeks|Adverse Event|0
7954767|NCT01354431|12502704|FG000|Pre-Treatment Period|Not reported|1
7954768|NCT01354431|12502705|FG001|Pre-Treatment Period|Not reported|0
7954769|NCT01354431|12502706|FG002|Pre-Treatment Period|Not reported|0
7954770|NCT01354431|12502704|FG000|Treatment Period|Disease Progression|50
7954771|NCT01354431|12502705|FG001|Treatment Period|Disease Progression|40
7954772|NCT01354431|12502706|FG002|Treatment Period|Disease Progression|44
7954773|NCT01354431|12502704|FG000|Treatment Period|Study Drug Toxicity|5
7954774|NCT01354431|12502705|FG001|Treatment Period|Study Drug Toxicity|8
7954775|NCT01354431|12502706|FG002|Treatment Period|Study Drug Toxicity|4
7954776|NCT01354431|12502704|FG000|Treatment Period|Death|0
7954777|NCT01354431|12502705|FG001|Treatment Period|Death|1
7954778|NCT01354431|12502706|FG002|Treatment Period|Death|0
7954779|NCT01354431|12502704|FG000|Treatment Period|AE unrelated to study drug|1
7954780|NCT01354431|12502705|FG001|Treatment Period|AE unrelated to study drug|2
7954781|NCT01354431|12502706|FG002|Treatment Period|AE unrelated to study drug|5
7954782|NCT01354431|12502704|FG000|Treatment Period|Participant request to discontinue|2
7954783|NCT01354431|12502705|FG001|Treatment Period|Participant request to discontinue|2
7954784|NCT01354431|12502706|FG002|Treatment Period|Participant request to discontinue|1
7954785|NCT01354431|12502704|FG000|Treatment Period|Participant withdrew consent|0
7954786|NCT01354431|12502705|FG001|Treatment Period|Participant withdrew consent|1
7954787|NCT01354431|12502706|FG002|Treatment Period|Participant withdrew consent|0
7954788|NCT01354431|12502704|FG000|Treatment Period|Participant no longer meeting study criteria|1
7954789|NCT01354431|12502705|FG001|Treatment Period|Participant no longer meeting study criteria|0
7954790|NCT01354431|12502706|FG002|Treatment Period|Participant no longer meeting study criteria|0
7954791|NCT01003691|12502718|FG000|Overall Study|Adverse Event|0
7954792|NCT01003691|12502719|FG001|Overall Study|Adverse Event|0
7954793|NCT01003691|12502720|FG002|Overall Study|Adverse Event|0
7954794|NCT01003691|12502721|FG003|Overall Study|Adverse Event|1
7954795|NCT02594098|12502743|FG000|Overall Study|Lack of Efficacy|17
7954796|NCT02594098|12502744|FG001|Overall Study|Lack of Efficacy|6
7954797|NCT02594098|12502743|FG000|Overall Study|Withdrawal by Subject|1
7954798|NCT02594098|12502744|FG001|Overall Study|Withdrawal by Subject|3
7954799|NCT02594098|12502743|FG000|Overall Study|Terminated participation|6
7954800|NCT02594098|12502744|FG001|Overall Study|Terminated participation|2
7954801|NCT02594098|12502743|FG000|Overall Study|Seek alternative treatment|2
7954802|NCT02594098|12502744|FG001|Overall Study|Seek alternative treatment|1
7954803|NCT02594098|12502743|FG000|Overall Study|Other|0
7954804|NCT02594098|12502744|FG001|Overall Study|Other|1
7954805|NCT02594163|12502754|FG000|Treatment Period|Progressive disease|2
7954806|NCT02594163|12502755|FG001|Treatment Period|Progressive disease|3
7954807|NCT02594163|12502754|FG000|Treatment Period|Adverse Event|1
7954808|NCT02594163|12502755|FG001|Treatment Period|Adverse Event|5
7954809|NCT02594163|12502754|FG000|Treatment Period|Physician Decision|1
7954810|NCT02594163|12502755|FG001|Treatment Period|Physician Decision|3
7954811|NCT02594163|12502754|FG000|Treatment Period|Study termination by sponsor|2
7954812|NCT02594163|12502755|FG001|Treatment Period|Study termination by sponsor|1
7954813|NCT02594163|12502754|FG000|Treatment Period|Other, Non-AE|1
7954814|NCT02594163|12502755|FG001|Treatment Period|Other, Non-AE|0
7954815|NCT02594163|12502754|FG000|Follow-up Period|Withdrawal by Subject|0
7954816|NCT02594163|12502755|FG001|Follow-up Period|Withdrawal by Subject|1
7954817|NCT02594163|12502754|FG000|Follow-up Period|Study Termination by Sponsor|6
7954818|NCT02594163|12502755|FG001|Follow-up Period|Study Termination by Sponsor|4
7954819|NCT02594163|12502754|FG000|Follow-up Period|Lost to Follow-up|1
7954820|NCT02594163|12502755|FG001|Follow-up Period|Lost to Follow-up|0
7954821|NCT02594163|12502754|FG000|Follow-up Period|Death|2
7954822|NCT02594163|12502755|FG001|Follow-up Period|Death|5
7954823|NCT02594163|12502754|FG000|Follow-up Period|Adverse Event|0
7954824|NCT02594163|12502755|FG001|Follow-up Period|Adverse Event|1
7954825|NCT02594163|12502754|FG000|Follow-up Period|Progressive Disease|2
7954826|NCT02594163|12502755|FG001|Follow-up Period|Progressive Disease|0
7954827|NCT02594163|12502754|FG000|Follow-up Period|Physician Decision|0
7954828|NCT02594163|12502755|FG001|Follow-up Period|Physician Decision|1
7954829|NCT02595008|12502791|FG000|Overall Study|Enrolled In Error|1
7954830|NCT02595008|12502792|FG001|Overall Study|Enrolled In Error|0
7954831|NCT02595073|12502800|FG000|Overall Study|Progressive Disease|0
7954832|NCT02595073|12502801|FG001|Overall Study|Progressive Disease|1
7954833|NCT02595073|12502800|FG000|Overall Study|Protocol Violation|2
7954834|NCT02595073|12502801|FG001|Overall Study|Protocol Violation|0
7954835|NCT02595398|12502809|FG000|Overall Study|Non-compliance|1
7954836|NCT02595398|12502810|FG001|Overall Study|Non-compliance|0
7954837|NCT02595398|12502809|FG000|Overall Study|Withdrawal by Subject|2
7954838|NCT02595398|12502810|FG001|Overall Study|Withdrawal by Subject|1
7954839|NCT02595398|12502809|FG000|Overall Study|Lost to Follow-up|1
7954840|NCT02595398|12502810|FG001|Overall Study|Lost to Follow-up|0
7954841|NCT02595437|12502816|FG000|Triferic Via IV|Withdrawal by Subject|1
7954842|NCT02595450|12502828|FG000|Overall Study|Unspecified (only completed 1 cycle)|73
7954843|NCT02595450|12502828|FG000|Overall Study|Enrolled, but not treated|8
7954844|NCT02595502|12502832|FG000|Period 1|Adverse Event|0
7954845|NCT02595502|12502833|FG001|Period 1|Adverse Event|1
7954846|NCT02595502|12502832|FG000|Period 1|Withdrawal by Subject|1
7954847|NCT02595502|12502833|FG001|Period 1|Withdrawal by Subject|0
7954848|NCT02595502|12502832|FG000|Period 1|Lost to Follow-up|0
7954849|NCT02595502|12502833|FG001|Period 1|Lost to Follow-up|1
7954850|NCT02595502|12502832|FG000|Period 2|Adverse Event|1
7954851|NCT02595502|12502833|FG001|Period 2|Adverse Event|1
7954852|NCT02595502|12502832|FG000|Period 2|Received incorrect lens at Period 1|0
7954853|NCT02595502|12502833|FG001|Period 2|Received incorrect lens at Period 1|1
7954854|NCT02595502|12502832|FG000|Period 3|Protocol Violation|0
7954855|NCT02595502|12502833|FG001|Period 3|Protocol Violation|1
7954856|NCT02595502|12502832|FG000|Period 3|Lost to Follow-up|1
7954857|NCT02595502|12502833|FG001|Period 3|Lost to Follow-up|0
7954858|NCT02595502|12502832|FG000|Period 3|Received Incorrect Treatment at period 3|0
7954859|NCT02595502|12502833|FG001|Period 3|Received Incorrect Treatment at period 3|1
7954860|NCT02595528|12502843|FG000|Overall Study|Withdrawal by Subject|1
7954861|NCT02595528|12502844|FG001|Overall Study|Withdrawal by Subject|2
7954862|NCT02595528|12502845|FG002|Overall Study|Withdrawal by Subject|1
7954863|NCT02595528|12502846|FG003|Overall Study|Withdrawal by Subject|3
7954864|NCT02595528|12502843|FG000|Overall Study|Lost to Follow-up|1
7954865|NCT02595528|12502844|FG001|Overall Study|Lost to Follow-up|1
7954866|NCT02595528|12502845|FG002|Overall Study|Lost to Follow-up|0
7954867|NCT02595528|12502846|FG003|Overall Study|Lost to Follow-up|1
7954868|NCT02595723|12502872|FG000|First Washout (21 Days)|Withdrawal by Subject|1
7954869|NCT02595723|12502873|FG001|First Washout (21 Days)|Withdrawal by Subject|0
7954870|NCT02595723|12502874|FG002|First Washout (21 Days)|Withdrawal by Subject|0
7954871|NCT02595723|12502872|FG000|First Washout (21 Days)|Lost to Follow-up|1
7954872|NCT02595723|12502873|FG001|First Washout (21 Days)|Lost to Follow-up|0
7954873|NCT02595723|12502874|FG002|First Washout (21 Days)|Lost to Follow-up|0
7954874|NCT02595749|12502884|FG000|Overall Study|Withdrawal by Subject|12
7954875|NCT02595749|12502885|FG001|Overall Study|Withdrawal by Subject|7
7954876|NCT02595970|12502891|FG000|Overall Study|Withdrawal by Subject|2
7954877|NCT02595970|12502891|FG000|Overall Study|Physician Decision|2
7954878|NCT02595970|12502891|FG000|Overall Study|Protocol Violation|4
7954879|NCT02595970|12502891|FG000|Overall Study|Adverse Event|5
7954880|NCT02595970|12502891|FG000|Overall Study|Lack of Efficacy|7
7954881|NCT02596009|12502900|FG000|Overall Study|Administrative problems|0
7954882|NCT02596009|12502901|FG001|Overall Study|Administrative problems|1
7954883|NCT02596009|12502902|FG002|Overall Study|Administrative problems|0
7954884|NCT02596009|12502903|FG003|Overall Study|Administrative problems|0
7954885|NCT02596009|12502904|FG004|Overall Study|Administrative problems|0
7954886|NCT02596009|12502905|FG005|Overall Study|Administrative problems|0
7954887|NCT02596230|12502925|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714
7954888|NCT02596230|12502926|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228
7954889|NCT02596230|12502927|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0
7954890|NCT02596230|12502928|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846
7954891|NCT02596230|12502929|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0
7954892|NCT02596230|12502925|FG000|Objective 2, One Year|Lost to Follow-up|0
7954893|NCT02596230|12502926|FG001|Objective 2, One Year|Lost to Follow-up|41
7954894|NCT02596230|12502927|FG002|Objective 2, One Year|Lost to Follow-up|41
7954895|NCT02596230|12502928|FG003|Objective 2, One Year|Lost to Follow-up|32
7954896|NCT02596230|12502929|FG004|Objective 2, One Year|Lost to Follow-up|46
7954897|NCT02596230|12502925|FG000|Objective 2, One Year|Withdrawal by Subject|0
7954898|NCT02596230|12502926|FG001|Objective 2, One Year|Withdrawal by Subject|11
7954899|NCT02596230|12502927|FG002|Objective 2, One Year|Withdrawal by Subject|14
7954900|NCT02596230|12502928|FG003|Objective 2, One Year|Withdrawal by Subject|5
7954901|NCT02596230|12502929|FG004|Objective 2, One Year|Withdrawal by Subject|2
7954902|NCT02596230|12502925|FG000|Objective 2, One Year|Adverse drug reaction|0
7954903|NCT02596230|12502926|FG001|Objective 2, One Year|Adverse drug reaction|1
7954904|NCT02596230|12502927|FG002|Objective 2, One Year|Adverse drug reaction|0
7954905|NCT02596230|12502928|FG003|Objective 2, One Year|Adverse drug reaction|0
7954906|NCT02596230|12502929|FG004|Objective 2, One Year|Adverse drug reaction|0
7954907|NCT02596230|12502925|FG000|Objective 2, One Year|Death|0
7954908|NCT02596230|12502926|FG001|Objective 2, One Year|Death|12
7954909|NCT02596230|12502927|FG002|Objective 2, One Year|Death|41
7954910|NCT02596230|12502928|FG003|Objective 2, One Year|Death|21
7954911|NCT02596230|12502929|FG004|Objective 2, One Year|Death|30
7954912|NCT02596230|12502925|FG000|Objective 2, One Year|Other|0
7954913|NCT02596230|12502926|FG001|Objective 2, One Year|Other|3
7954914|NCT02596230|12502927|FG002|Objective 2, One Year|Other|2
7954915|NCT02596230|12502928|FG003|Objective 2, One Year|Other|0
7954916|NCT02596230|12502929|FG004|Objective 2, One Year|Other|0
7954917|NCT02596620|12502962|FG000|Overall Study|Lost to Follow-up|1
7954918|NCT02596620|12502963|FG001|Overall Study|Lost to Follow-up|1
7954919|NCT02596711|12502972|FG000|Overall Study|Lost to Follow-up|1
7954920|NCT02596711|12502973|FG001|Overall Study|Lost to Follow-up|2
7954921|NCT02596711|12502974|FG002|Overall Study|Lost to Follow-up|3
7954922|NCT02596854|12502992|FG000|Overall Study|Withdrawn|8
7954923|NCT02596893|12503005|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61
7954924|NCT02596893|12503006|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56
7954925|NCT02596893|12503007|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48
7954926|NCT02596893|12503008|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58
7954927|NCT02596893|12503005|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11
7954928|NCT02596893|12503006|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
7954929|NCT02596893|12503007|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
7954930|NCT02596893|12503008|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12
7954931|NCT02596893|12503005|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
7954932|NCT02596893|12503006|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
7954933|NCT02596893|12503007|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
7954934|NCT02596893|12503008|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1
7954935|NCT02596893|12503005|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15
7954936|NCT02596893|12503006|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
7954937|NCT02596893|12503007|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
7954938|NCT02596893|12503008|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13
7954939|NCT02596893|12503005|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10
7954940|NCT02596893|12503006|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4
7954941|NCT02596893|12503007|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13
7954942|NCT02596893|12503008|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5
7954943|NCT02596893|12503005|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1
7954944|NCT02596893|12503006|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
7954945|NCT02596893|12503007|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0
7954946|NCT02596893|12503008|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
7954947|NCT02596893|12503005|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0
7954948|NCT02596893|12503006|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
7954949|NCT02596893|12503007|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
7954950|NCT02596893|12503008|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
7954951|NCT02596893|12503005|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
7954952|NCT02596893|12503006|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
7954953|NCT02596893|12503007|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1
7954954|NCT02596893|12503008|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2
7954955|NCT02596893|12503005|FG000|Overall Double-Blind Period Weeks 0-52|Death|0
7954956|NCT02596893|12503006|FG001|Overall Double-Blind Period Weeks 0-52|Death|0
7954957|NCT02596893|12503007|FG002|Overall Double-Blind Period Weeks 0-52|Death|1
7954958|NCT02596893|12503008|FG003|Overall Double-Blind Period Weeks 0-52|Death|0
7954959|NCT02596893|12503005|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
7954960|NCT02596893|12503006|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
7954961|NCT02596893|12503007|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
7954962|NCT02596893|12503008|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2
7954963|NCT02596893|12503005|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66
7954964|NCT02596893|12503006|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76
7954965|NCT02596893|12503007|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69
7954966|NCT02596893|12503008|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70
7954967|NCT02596945|12503027|FG000|Overall Study|No documentation of study drug dosing|3
7954968|NCT02596945|12503027|FG000|Overall Study|Other|32
7954969|NCT02596945|12503027|FG000|Overall Study|Change to hemodialysis|15
7954970|NCT02596945|12503027|FG000|Overall Study|Other Erythropoietin stimulating agent|4
7954971|NCT02596945|12503027|FG000|Overall Study|Withdrawal by Subject|1
7954972|NCT02596945|12503027|FG000|Overall Study|Missing|1
7954973|NCT02596958|12503031|FG000|Overall Study|Serious Adverse Drug Reactions|44
7954974|NCT02596958|12503031|FG000|Overall Study|Cancer Progression|441
7954975|NCT02596958|12503031|FG000|Overall Study|Death From Cancer|112
7954976|NCT02596958|12503031|FG000|Overall Study|Death From Other Cause|33
7954977|NCT02596958|12503031|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61
7954978|NCT02596958|12503031|FG000|Overall Study|Administrative Reasons/Other|231
7954979|NCT02596958|12503031|FG000|Overall Study|Lost to Follow-up|33
7954980|NCT02596958|12503031|FG000|Overall Study|Missing|32
7954981|NCT02596958|12503031|FG000|Overall Study|Excluded Due to Second Line Treatment|9
7954982|NCT02596971|12503038|FG000|Overall Study|Death|5
7954983|NCT02596971|12503039|FG001|Overall Study|Death|1
7954984|NCT02596971|12503040|FG002|Overall Study|Death|5
7954985|NCT02596971|12503038|FG000|Overall Study|Withdrawal by Subject|5
7954986|NCT02596971|12503039|FG001|Overall Study|Withdrawal by Subject|1
7954987|NCT02596971|12503040|FG002|Overall Study|Withdrawal by Subject|4
7954988|NCT02597049|12503054|FG000|Overall Study|Lost to Follow-up|0
7954989|NCT02597049|12503055|FG001|Overall Study|Lost to Follow-up|3
7954990|NCT02597049|12503056|FG002|Overall Study|Lost to Follow-up|2
7954991|NCT02597049|12503054|FG000|Overall Study|Withdrawal by Subject|2
7954992|NCT02597049|12503055|FG001|Overall Study|Withdrawal by Subject|2
7954993|NCT02597049|12503056|FG002|Overall Study|Withdrawal by Subject|1
7954994|NCT02597049|12503054|FG000|Overall Study|Adverse Event|2
7954995|NCT02597049|12503055|FG001|Overall Study|Adverse Event|0
7954996|NCT02597049|12503056|FG002|Overall Study|Adverse Event|0
7954997|NCT02597049|12503054|FG000|Overall Study|Death|2
7954998|NCT02597049|12503055|FG001|Overall Study|Death|0
7954999|NCT02597049|12503056|FG002|Overall Study|Death|0
7955000|NCT02597049|12503054|FG000|Overall Study|Noncompliant with Study Visits|1
7955001|NCT02597049|12503055|FG001|Overall Study|Noncompliant with Study Visits|0
7955002|NCT02597049|12503056|FG002|Overall Study|Noncompliant with Study Visits|0
7955003|NCT02597452|12503127|FG000|Overall Study|testing incomplete|30
7955004|NCT02597478|12503133|FG000|Overall Study|Withdrawal by Subject|2
7955005|NCT02597478|12503134|FG001|Overall Study|Withdrawal by Subject|0
7955006|NCT02597478|12503133|FG000|Overall Study|Change of opioid dose|1
7955007|NCT02597478|12503134|FG001|Overall Study|Change of opioid dose|0
7955008|NCT02597478|12503133|FG000|Overall Study|Insufficient exertional dyspnea|0
7955009|NCT02597478|12503134|FG001|Overall Study|Insufficient exertional dyspnea|1
7955010|NCT02597712|12503180|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2
7955011|NCT02597712|12503181|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0
7955012|NCT02597712|12503180|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1
7955013|NCT02597712|12503181|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0
7955014|NCT02597712|12503180|FG000|Overall Study|Recurrent metastatic prostate cancer|0
7955015|NCT02597712|12503181|FG001|Overall Study|Recurrent metastatic prostate cancer|1
7955016|NCT02597855|12503189|FG000|Overall Study|Lost to Follow-up|2
7955017|NCT02597855|12503190|FG001|Overall Study|Lost to Follow-up|1
7955018|NCT02597920|12503208|FG000|Overall Study|Worsening of other pre-existing disease|0
7955019|NCT02597920|12503209|FG001|Overall Study|Worsening of other pre-existing disease|1
7955020|NCT02597920|12503210|FG002|Overall Study|Worsening of other pre-existing disease|0
7955021|NCT02597920|12503208|FG000|Overall Study|Other adverse event|20
7955022|NCT02597920|12503209|FG001|Overall Study|Other adverse event|30
7955023|NCT02597920|12503210|FG002|Overall Study|Other adverse event|0
7955024|NCT02597920|12503208|FG000|Overall Study|Lost to Follow-up|7
7955025|NCT02597920|12503209|FG001|Overall Study|Lost to Follow-up|9
7955026|NCT02597920|12503210|FG002|Overall Study|Lost to Follow-up|0
7955027|NCT02597920|12503208|FG000|Overall Study|Refuse to continue in the study|3
7955028|NCT02597920|12503209|FG001|Overall Study|Refuse to continue in the study|13
7955029|NCT02597920|12503210|FG002|Overall Study|Refuse to continue in the study|1
7955030|NCT02597920|12503208|FG000|Overall Study|Other than specified|10
7955031|NCT02597920|12503209|FG001|Overall Study|Other than specified|31
7955032|NCT02597920|12503210|FG002|Overall Study|Other than specified|5
7955033|NCT02597920|12503208|FG000|Overall Study|Other|1
7955034|NCT02597920|12503209|FG001|Overall Study|Other|0
7955035|NCT02597920|12503210|FG002|Overall Study|Other|0
7955036|NCT02597933|12503222|FG000|Overall Study|Withdrawal by Subject|7
7955037|NCT02597933|12503223|FG001|Overall Study|Withdrawal by Subject|5
7955038|NCT02597933|12503222|FG000|Overall Study|Protocol Violation|2
7955039|NCT02597933|12503223|FG001|Overall Study|Protocol Violation|2
7955040|NCT02597933|12503222|FG000|Overall Study|Adverse Event|20
7955041|NCT02597933|12503223|FG001|Overall Study|Adverse Event|28
7955042|NCT02597933|12503222|FG000|Overall Study|Not treated|2
7955043|NCT02597933|12503223|FG001|Overall Study|Not treated|2
7955044|NCT02597933|12503222|FG000|Overall Study|Other than stated above|7
7955045|NCT02597933|12503223|FG001|Overall Study|Other than stated above|14
7955046|NCT02597946|12503229|FG000|Overall Study|Withdrawal by Subject|1
7955047|NCT02597946|12503229|FG000|Overall Study|Progressive disease|16
7955048|NCT02597946|12503229|FG000|Overall Study|Other than above|1
7955049|NCT02598076|12503235|FG000|Overall Study|Lost to Follow-up|2
7955050|NCT02598076|12503236|FG001|Overall Study|Lost to Follow-up|3
7955051|NCT02598128|12503258|FG000|Period A: Days -7 to -1|Adverse Event|1
7955052|NCT02598128|12503259|FG001|Period A: Days -7 to -1|Adverse Event|0
7955053|NCT02598128|12503260|FG002|Period A: Days -7 to -1|Adverse Event|0
7955054|NCT02598128|12503261|FG003|Period A: Days -7 to -1|Adverse Event|0
7955055|NCT02598193|12503273|FG000|Overall Study|Adverse Event|13
7955056|NCT02598193|12503273|FG000|Overall Study|Withdrawal by Subject|1
7955057|NCT02598193|12503273|FG000|Overall Study|Listed in active lung transplant list|1
7955058|NCT02598193|12503273|FG000|Overall Study|Does not want to take Nintedanib|1
7955059|NCT02598297|12503279|FG000|Overall Study|Study terminated by Sponsor|21
7955060|NCT02598297|12503280|FG001|Overall Study|Study terminated by Sponsor|23
7955061|NCT02598297|12503279|FG000|Overall Study|Adverse Event|1
7955062|NCT02598297|12503280|FG001|Overall Study|Adverse Event|1
7955063|NCT02598297|12503279|FG000|Overall Study|Physician Decision|1
7955064|NCT02598297|12503280|FG001|Overall Study|Physician Decision|0
7955065|NCT02598297|12503279|FG000|Overall Study|Subject/guardian decision|1
7955066|NCT02598297|12503280|FG001|Overall Study|Subject/guardian decision|0
7955067|NCT02598297|12503279|FG000|Overall Study|Followed for survival|1
7955068|NCT02598297|12503280|FG001|Overall Study|Followed for survival|0
7955069|NCT02598934|12503288|FG000|Overall Study|Adverse Event|11
7955070|NCT02598934|12503289|FG001|Overall Study|Adverse Event|13
7955071|NCT02598934|12503288|FG000|Overall Study|Failure to Return|3
7955072|NCT02598934|12503289|FG001|Overall Study|Failure to Return|3
7955073|NCT02598934|12503288|FG000|Overall Study|Withdrawal by Subject|2
7955074|NCT02598934|12503289|FG001|Overall Study|Withdrawal by Subject|3
7955075|NCT02598934|12503288|FG000|Overall Study|Administrative|2
7955076|NCT02598934|12503289|FG001|Overall Study|Administrative|1
7955077|NCT02598934|12503288|FG000|Overall Study|Protocol Violation|1
7955078|NCT02598934|12503289|FG001|Overall Study|Protocol Violation|2
7955079|NCT02599129|12503297|FG000|Overall Study|Lack of Efficacy|2
7955080|NCT02599129|12503298|FG001|Overall Study|Lack of Efficacy|2
7955081|NCT02599129|12503297|FG000|Overall Study|Lost to Follow-up|1
7955082|NCT02599129|12503298|FG001|Overall Study|Lost to Follow-up|0
7955083|NCT02599129|12503297|FG000|Overall Study|Withdrawal by Subject|2
7955084|NCT02599129|12503298|FG001|Overall Study|Withdrawal by Subject|1
7955085|NCT02599402|12503310|FG000|Overall Study|Disease progression|153
7955086|NCT02599402|12503310|FG000|Overall Study|Study drug toxicity|201
7955087|NCT02599402|12503310|FG000|Overall Study|Death|26
7955088|NCT02599402|12503310|FG000|Overall Study|Adverse Event unrelated to study drug|23
7955089|NCT02599402|12503310|FG000|Overall Study|Participant request to discontinue study treatment|13
7955090|NCT02599402|12503310|FG000|Overall Study|Participant withdrew consent|5
7955091|NCT02599402|12503310|FG000|Overall Study|Lost to Follow-up|1
7955092|NCT02599402|12503310|FG000|Overall Study|Maximum Clinical Benefit|7
7955093|NCT02599402|12503310|FG000|Overall Study|Poor/non-compliance|1
7955094|NCT02599402|12503310|FG000|Overall Study|Pregnancy|1
7955095|NCT02599402|12503310|FG000|Overall Study|Participant no longer met study criteria|7
7955096|NCT02599402|12503310|FG000|Overall Study|Other Reasons|95
7955097|NCT02599688|12503361|FG000|Overall Study|Lack of Efficacy|1
7955098|NCT02599688|12503361|FG000|Overall Study|Withdrawal by Subject|1
7955099|NCT02599688|12503361|FG000|Overall Study|Termination by Sponsor|2
7955100|NCT02599961|12503373|FG000|Overall Study|Withdrawal by Subject|1
7955101|NCT02599961|12503373|FG000|Overall Study|Subject Non-Compliance|2
7955102|NCT02599961|12503373|FG000|Overall Study|Discontinuation of Study by Sponsor|9
7955103|NCT02599961|12503373|FG000|Overall Study|Other, Not Specified|3
7955104|NCT02600351|12503385|FG000|Overall Study|Lack of Efficacy|3
7955105|NCT02600351|12503386|FG001|Overall Study|Lack of Efficacy|0
7955106|NCT02600351|12503387|FG002|Overall Study|Lack of Efficacy|5
7955107|NCT02600351|12503388|FG003|Overall Study|Lack of Efficacy|2
7955108|NCT02600351|12503385|FG000|Overall Study|Lost to Follow-up|1
7955109|NCT02600351|12503386|FG001|Overall Study|Lost to Follow-up|0
7955110|NCT02600351|12503387|FG002|Overall Study|Lost to Follow-up|0
7955111|NCT02600351|12503388|FG003|Overall Study|Lost to Follow-up|0
7955112|NCT02600351|12503385|FG000|Overall Study|Randomized but Not Treated|1
7955113|NCT02600351|12503386|FG001|Overall Study|Randomized but Not Treated|0
7955114|NCT02600351|12503387|FG002|Overall Study|Randomized but Not Treated|1
7955115|NCT02600351|12503388|FG003|Overall Study|Randomized but Not Treated|3
7955116|NCT02600559|12503416|FG000|Overall Study|Withdrawal by Subject|3
7955117|NCT02600559|12503416|FG000|Overall Study|Lost to Follow-up|20
7955118|NCT02600819|12503454|FG000|GEN Phase|Adverse Event|2
7955119|NCT02600819|12503455|FG001|GEN Phase|Adverse Event|0
7955120|NCT02600819|12503454|FG000|GEN Phase|Death|2
7955121|NCT02600819|12503455|FG001|GEN Phase|Death|0
7955122|NCT02600819|12503454|FG000|GEN Phase|Investigator's Discretion|4
7955123|NCT02600819|12503455|FG001|GEN Phase|Investigator's Discretion|0
7955124|NCT02600819|12503454|FG000|GEN Phase|Non-Compliance with Study Drug|1
7955125|NCT02600819|12503455|FG001|GEN Phase|Non-Compliance with Study Drug|0
7955126|NCT02600819|12503454|FG000|GEN Phase|Withdrew Consent|5
7955127|NCT02600819|12503455|FG001|GEN Phase|Withdrew Consent|0
7955128|NCT02600819|12503454|FG000|GEN Phase|Lost to Follow-up|2
7955129|NCT02600819|12503455|FG001|GEN Phase|Lost to Follow-up|0
7955130|NCT02600845|12503461|FG000|Overall Study|Reason Not Specified|3
7955131|NCT02600845|12503461|FG000|Overall Study|Non-compliance with Study Procedures|10
7955132|NCT02600845|12503461|FG000|Overall Study|Consent Withdrawal|5
7955133|NCT02600871|12503467|FG000|Overall Study|Lost to Follow-up|13
7955134|NCT02600871|12503468|FG001|Overall Study|Lost to Follow-up|10
7955135|NCT02601001|12503478|FG000|Dosing Period 2|Adverse Event|0
7955136|NCT02601001|12503479|FG001|Dosing Period 2|Adverse Event|0
7955137|NCT02601001|12503480|FG002|Dosing Period 2|Adverse Event|0
7955138|NCT02601001|12503481|FG003|Dosing Period 2|Adverse Event|0
7955139|NCT02601001|12503482|FG004|Dosing Period 2|Adverse Event|0
7955140|NCT02601001|12503483|FG005|Dosing Period 2|Adverse Event|0
7955141|NCT02601001|12503484|FG006|Dosing Period 2|Adverse Event|1
7955142|NCT02601027|12503507|FG000|Registration to Surgery|Withdrawal by Subject|20
7955143|NCT02601027|12503508|FG001|Registration to Surgery|Withdrawal by Subject|10
7955144|NCT02601300|12503529|FG000|Induction Phase|Lack of Efficacy|2
7955145|NCT02601300|12503529|FG000|Induction Phase|Protocol Violation|1
7955146|NCT02601300|12503529|FG000|Extension Phase|Withdrawal by Subject|3
7955147|NCT02601300|12503529|FG000|Extension Phase|Adverse Event|4
7955148|NCT02601300|12503529|FG000|Extension Phase|Lack of Efficacy|10
7955149|NCT02601469|12503537|FG000|Overall Study|Enrolled in Error|1
7955150|NCT02601469|12503538|FG001|Overall Study|Enrolled in Error|0
7966442|NCT02750514|12522342|FG000|Track 5|Other reasons|0
7966443|NCT02750514|12522343|FG001|Track 5|Other reasons|0
7966444|NCT02750514|12522344|FG002|Track 5|Other reasons|0
7966445|NCT02750514|12522345|FG003|Track 5|Other reasons|0
7955151|NCT02601560|12503552|FG000|Overall Study|Other|0
7955152|NCT02601560|12503553|FG001|Overall Study|Other|0
7955153|NCT02601560|12503554|FG002|Overall Study|Other|0
7955154|NCT02601560|12503555|FG003|Overall Study|Other|0
7955155|NCT02601560|12503556|FG004|Overall Study|Other|0
7955156|NCT02601560|12503557|FG005|Overall Study|Other|0
7955157|NCT02601560|12503558|FG006|Overall Study|Other|1
7955158|NCT02601560|12503559|FG007|Overall Study|Other|0
7955159|NCT02601573|12503589|FG000|Overall Study|Lost to Follow-up|0
7955160|NCT02601573|12503590|FG001|Overall Study|Lost to Follow-up|3
7955161|NCT02601573|12503591|FG002|Overall Study|Lost to Follow-up|1
7955162|NCT02601573|12503592|FG003|Overall Study|Lost to Follow-up|0
7955163|NCT02601573|12503593|FG004|Overall Study|Lost to Follow-up|2
7955164|NCT02601573|12503589|FG000|Overall Study|Withdrawal by Subject|0
7955165|NCT02601573|12503590|FG001|Overall Study|Withdrawal by Subject|1
7955166|NCT02601573|12503591|FG002|Overall Study|Withdrawal by Subject|0
7955167|NCT02601573|12503592|FG003|Overall Study|Withdrawal by Subject|1
7955168|NCT02601573|12503593|FG004|Overall Study|Withdrawal by Subject|0
7955169|NCT02601625|12503609|FG000|Overall Study|Lost to Follow-up|0
7955170|NCT02601625|12503610|FG001|Overall Study|Lost to Follow-up|0
7955171|NCT02601625|12503611|FG002|Overall Study|Lost to Follow-up|1
7955172|NCT02601625|12503612|FG003|Overall Study|Lost to Follow-up|1
7955173|NCT02601820|12503636|FG000|Early On-Treatment (T2)|Missing T2 Record|51
7955174|NCT02601820|12503636|FG000|Late On-Treatment (T3)|missing T3 Record|49
7955175|NCT02601820|12503636|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3
7955176|NCT02601820|12503636|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88
7955177|NCT02602080|12503672|FG000|Overall Study|Protocol Violation|6
7955178|NCT02602080|12503673|FG001|Overall Study|Protocol Violation|1
7955179|NCT02602080|12503674|FG002|Overall Study|Protocol Violation|3
7955180|NCT02603107|12503703|FG000|Randomized Phase|Withdrew consent|8
7955181|NCT02603107|12503704|FG001|Randomized Phase|Withdrew consent|15
7955182|NCT02603107|12503703|FG000|Randomized Phase|Lost to Follow-up|1
7955183|NCT02603107|12503704|FG001|Randomized Phase|Lost to Follow-up|3
7955184|NCT02603107|12503703|FG000|Randomized Phase|Adverse Event|2
7955185|NCT02603107|12503704|FG001|Randomized Phase|Adverse Event|0
7955186|NCT02603107|12503703|FG000|Randomized Phase|Death|1
7955187|NCT02603107|12503704|FG001|Randomized Phase|Death|1
7955188|NCT02603107|12503703|FG000|Randomized Phase|Non-compliance with study drug|1
7955189|NCT02603107|12503704|FG001|Randomized Phase|Non-compliance with study drug|1
7955190|NCT02603107|12503703|FG000|Randomized Phase|Investigator's discretion|0
7955191|NCT02603107|12503704|FG001|Randomized Phase|Investigator's discretion|1
7955192|NCT02603107|12503703|FG000|Randomized Phase|Lack of Efficacy|1
7955193|NCT02603107|12503704|FG001|Randomized Phase|Lack of Efficacy|0
7955194|NCT02603107|12503703|FG000|Randomized Phase|Protocol Violation|1
7955195|NCT02603107|12503704|FG001|Randomized Phase|Protocol Violation|0
7955196|NCT02603107|12503703|FG000|Optional Extension Phase|Lost to Follow-up|3
7955197|NCT02603107|12503704|FG001|Optional Extension Phase|Lost to Follow-up|3
7955198|NCT02603107|12503703|FG000|Optional Extension Phase|Withdrew consent|3
7955199|NCT02603107|12503704|FG001|Optional Extension Phase|Withdrew consent|2
7955200|NCT02603107|12503703|FG000|Optional Extension Phase|Investigator's discretion|2
7955201|NCT02603107|12503704|FG001|Optional Extension Phase|Investigator's discretion|2
7955202|NCT02603107|12503703|FG000|Optional Extension Phase|Pregnancy|0
7955203|NCT02603107|12503704|FG001|Optional Extension Phase|Pregnancy|3
7955204|NCT02603107|12503703|FG000|Optional Extension Phase|Adverse Event|0
7955205|NCT02603107|12503704|FG001|Optional Extension Phase|Adverse Event|2
7955206|NCT02603107|12503703|FG000|Optional Extension Phase|Not treated in extension phase|0
7955207|NCT02603107|12503704|FG001|Optional Extension Phase|Not treated in extension phase|1
7955208|NCT02603107|12503703|FG000|Optional Extension Phase|Protocol Violation|1
7955209|NCT02603107|12503704|FG001|Optional Extension Phase|Protocol Violation|0
7955210|NCT02603120|12503714|FG000|Double-Blind Treatment Phase|Withdrew consent|4
7955211|NCT02603120|12503715|FG001|Double-Blind Treatment Phase|Withdrew consent|8
7955212|NCT02603120|12503714|FG000|Double-Blind Treatment Phase|Adverse Event|3
7955213|NCT02603120|12503715|FG001|Double-Blind Treatment Phase|Adverse Event|3
7955214|NCT02603120|12503714|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4
7955215|NCT02603120|12503715|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2
7955216|NCT02603120|12503714|FG000|Double-Blind Treatment Phase|Death|2
7955217|NCT02603120|12503715|FG001|Double-Blind Treatment Phase|Death|0
7955218|NCT02603120|12503714|FG000|Double-Blind Treatment Phase|Investigator's discretion|2
7955219|NCT02603120|12503715|FG001|Double-Blind Treatment Phase|Investigator's discretion|0
7955220|NCT02603120|12503714|FG000|Double-Blind Treatment Phase|Pregnancy|1
7955221|NCT02603120|12503715|FG001|Double-Blind Treatment Phase|Pregnancy|1
7955222|NCT02603120|12503714|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1
7955223|NCT02603120|12503715|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0
7955224|NCT02603120|12503714|FG000|Double-Blind Treatment Phase|Did not receive study drug|2
7955225|NCT02603120|12503715|FG001|Double-Blind Treatment Phase|Did not receive study drug|2
7955226|NCT02603120|12503714|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3
7955227|NCT02603120|12503715|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4
7955228|NCT02603120|12503714|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1
7955229|NCT02603120|12503715|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2
7955230|NCT02603120|12503714|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1
7955231|NCT02603120|12503715|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2
7955232|NCT02603120|12503714|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0
7955233|NCT02603120|12503715|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1
7955234|NCT02603120|12503714|FG000|OL Extension B/F/TAF Treatment Phase|Death|0
7955235|NCT02603120|12503715|FG001|OL Extension B/F/TAF Treatment Phase|Death|1
7955236|NCT02603120|12503714|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0
7955237|NCT02603120|12503715|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1
7955238|NCT02603172|12503731|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0
7955239|NCT02603172|12503732|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0
7955240|NCT02603172|12503733|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1
7955241|NCT02603172|12503734|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0
7955242|NCT02603172|12503735|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0
7955243|NCT02603172|12503736|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0
7955244|NCT02603172|12503737|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0
7955245|NCT02603172|12503738|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0
7955246|NCT02603393|12503761|FG000|Overall Study|Patient/guardian decision|32
7955247|NCT02603393|12503762|FG001|Overall Study|Patient/guardian decision|18
7955248|NCT02603393|12503761|FG000|Overall Study|Adverse Event|17
7955249|NCT02603393|12503762|FG001|Overall Study|Adverse Event|15
7955250|NCT02603393|12503761|FG000|Overall Study|Technical problems|4
7955251|NCT02603393|12503762|FG001|Overall Study|Technical problems|7
7955252|NCT02603393|12503761|FG000|Overall Study|Lack of Efficacy|7
7955253|NCT02603393|12503762|FG001|Overall Study|Lack of Efficacy|2
7955254|NCT02603393|12503761|FG000|Overall Study|Death|3
7955255|NCT02603393|12503762|FG001|Overall Study|Death|4
7955256|NCT02603393|12503761|FG000|Overall Study|Physician Decision|3
7955257|NCT02603393|12503762|FG001|Overall Study|Physician Decision|3
7955258|NCT02603393|12503761|FG000|Overall Study|Protocol deviation|2
7955259|NCT02603393|12503762|FG001|Overall Study|Protocol deviation|3
7955260|NCT02603393|12503761|FG000|Overall Study|Lost to Follow-up|1
7955261|NCT02603393|12503762|FG001|Overall Study|Lost to Follow-up|2
7955262|NCT02603393|12503761|FG000|Overall Study|Non-compliance with study treatment|1
7955263|NCT02603393|12503762|FG001|Overall Study|Non-compliance with study treatment|0
7955264|NCT02603393|12503761|FG000|Overall Study|Sponsor decision|1
7955265|NCT02603393|12503762|FG001|Overall Study|Sponsor decision|0
7955266|NCT02603419|12503774|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7955267|NCT02603419|12503775|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1
7955268|NCT02603419|12503776|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7955269|NCT02603419|12503777|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7955270|NCT02603419|12503778|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7955271|NCT02603419|12503779|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7955272|NCT02603419|12503774|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
7955273|NCT02603419|12503775|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
7955274|NCT02603419|12503776|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
7955275|NCT02603419|12503777|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
7955276|NCT02603419|12503778|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3
7955277|NCT02603419|12503779|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0
7955278|NCT02603419|12503774|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2
7955279|NCT02603419|12503775|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
7955280|NCT02603419|12503776|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3
7955281|NCT02603419|12503777|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
7955282|NCT02603419|12503778|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1
7955283|NCT02603419|12503779|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
7955284|NCT02603419|12503774|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7955285|NCT02603419|12503775|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7955286|NCT02603419|12503776|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7955287|NCT02603419|12503777|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7955288|NCT02603419|12503778|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1
7955289|NCT02603419|12503779|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7955290|NCT02603419|12503774|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7955291|NCT02603419|12503775|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1
7955292|NCT02603419|12503776|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7955293|NCT02603419|12503777|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7955294|NCT02603419|12503778|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7955295|NCT02603419|12503779|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7955296|NCT02603419|12503774|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2
7955297|NCT02603419|12503775|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
7955298|NCT02603419|12503776|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
7955299|NCT02603419|12503777|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
7955300|NCT02603419|12503778|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
7955301|NCT02603419|12503779|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
7955302|NCT02603419|12503774|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7955303|NCT02603419|12503775|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7955304|NCT02603419|12503776|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7955305|NCT02603419|12503777|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2
7955306|NCT02603419|12503778|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7955307|NCT02603419|12503779|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7955308|NCT02603419|12503774|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7955309|NCT02603419|12503775|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7955310|NCT02603419|12503776|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7955311|NCT02603419|12503777|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7955312|NCT02603419|12503778|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7955313|NCT02603419|12503779|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1
7955314|NCT02603419|12503774|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7955315|NCT02603419|12503775|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7955316|NCT02603419|12503776|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7955317|NCT02603419|12503777|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7955318|NCT02603419|12503778|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7955319|NCT02603419|12503779|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1
7955320|NCT02603419|12503774|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7955321|NCT02603419|12503775|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7955322|NCT02603419|12503776|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7955323|NCT02603419|12503777|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7955324|NCT02603419|12503778|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7955325|NCT02603419|12503779|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1
7955326|NCT02603809|12503804|FG000|Overall Study|Withdrawal by Subject|4
7955327|NCT02603809|12503805|FG001|Overall Study|Withdrawal by Subject|1
7955328|NCT02603809|12503806|FG002|Overall Study|Withdrawal by Subject|2
7955329|NCT02603809|12503807|FG003|Overall Study|Withdrawal by Subject|3
7955330|NCT02603809|12503808|FG004|Overall Study|Withdrawal by Subject|3
7955331|NCT02603809|12503809|FG005|Overall Study|Withdrawal by Subject|4
7955332|NCT02603809|12503804|FG000|Overall Study|Lost to Follow-up|2
7955333|NCT02603809|12503805|FG001|Overall Study|Lost to Follow-up|3
7955334|NCT02603809|12503806|FG002|Overall Study|Lost to Follow-up|1
7955335|NCT02603809|12503807|FG003|Overall Study|Lost to Follow-up|4
7955336|NCT02603809|12503808|FG004|Overall Study|Lost to Follow-up|2
7955337|NCT02603809|12503809|FG005|Overall Study|Lost to Follow-up|2
7955338|NCT02603809|12503804|FG000|Overall Study|Pre-specified discontinuation criteria|3
7955339|NCT02603809|12503805|FG001|Overall Study|Pre-specified discontinuation criteria|3
7955340|NCT02603809|12503806|FG002|Overall Study|Pre-specified discontinuation criteria|2
7955341|NCT02603809|12503807|FG003|Overall Study|Pre-specified discontinuation criteria|2
7955342|NCT02603809|12503808|FG004|Overall Study|Pre-specified discontinuation criteria|3
7955343|NCT02603809|12503809|FG005|Overall Study|Pre-specified discontinuation criteria|1
7955344|NCT02603809|12503804|FG000|Overall Study|Physician Decision|0
7955345|NCT02603809|12503805|FG001|Overall Study|Physician Decision|0
7955346|NCT02603809|12503806|FG002|Overall Study|Physician Decision|0
7955347|NCT02603809|12503807|FG003|Overall Study|Physician Decision|1
7955348|NCT02603809|12503808|FG004|Overall Study|Physician Decision|2
7955349|NCT02603809|12503809|FG005|Overall Study|Physician Decision|1
7955350|NCT02603809|12503804|FG000|Overall Study|Adverse Event|3
7955351|NCT02603809|12503805|FG001|Overall Study|Adverse Event|0
7955352|NCT02603809|12503806|FG002|Overall Study|Adverse Event|2
7955353|NCT02603809|12503807|FG003|Overall Study|Adverse Event|2
7955354|NCT02603809|12503808|FG004|Overall Study|Adverse Event|1
7955355|NCT02603809|12503809|FG005|Overall Study|Adverse Event|1
7955356|NCT02603809|12503804|FG000|Overall Study|Lack of Efficacy|0
7955357|NCT02603809|12503805|FG001|Overall Study|Lack of Efficacy|1
7955358|NCT02603809|12503806|FG002|Overall Study|Lack of Efficacy|0
7955359|NCT02603809|12503807|FG003|Overall Study|Lack of Efficacy|0
7955360|NCT02603809|12503808|FG004|Overall Study|Lack of Efficacy|0
7955361|NCT02603809|12503809|FG005|Overall Study|Lack of Efficacy|1
7955362|NCT02603952|12503834|FG000|Overall Study|Withdrawal by Subject|1
7955363|NCT02603952|12503835|FG001|Overall Study|Withdrawal by Subject|0
7955364|NCT02603952|12503836|FG002|Overall Study|Withdrawal by Subject|0
7955365|NCT02603952|12503837|FG003|Overall Study|Withdrawal by Subject|0
7955366|NCT02603952|12503834|FG000|Overall Study|Received oseltamivir by error|0
7955367|NCT02603952|12503835|FG001|Overall Study|Received oseltamivir by error|0
7955368|NCT02603952|12503836|FG002|Overall Study|Received oseltamivir by error|0
7955369|NCT02603952|12503837|FG003|Overall Study|Received oseltamivir by error|1
7955370|NCT02604017|12503852|FG000|Overall Study|Withdrew Consent|0
7955371|NCT02604017|12503853|FG001|Overall Study|Withdrew Consent|2
7955372|NCT02604017|12503852|FG000|Overall Study|Lost to Follow-up|5
7955373|NCT02604017|12503853|FG001|Overall Study|Lost to Follow-up|6
7955374|NCT02604017|12503852|FG000|Overall Study|Other|1
7955375|NCT02604017|12503853|FG001|Overall Study|Other|0
7955376|NCT02604160|12503861|FG000|Overall Study|Protocol Violation|0
7955377|NCT02604160|12503862|FG001|Overall Study|Protocol Violation|1
7955378|NCT02604160|12503861|FG000|Overall Study|Physician Decision|0
7955379|NCT02604160|12503862|FG001|Overall Study|Physician Decision|1
7955380|NCT02604199|12503887|FG000|Overall Study|Pregnancy|0
7955381|NCT02604199|12503888|FG001|Overall Study|Pregnancy|0
7955382|NCT02604199|12503889|FG002|Overall Study|Pregnancy|0
7955383|NCT02604199|12503890|FG003|Overall Study|Pregnancy|1
7955384|NCT02604199|12503887|FG000|Overall Study|Study terminated by sponsor|0
7955385|NCT02604199|12503888|FG001|Overall Study|Study terminated by sponsor|2
7955386|NCT02604199|12503889|FG002|Overall Study|Study terminated by sponsor|0
7955387|NCT02604199|12503890|FG003|Overall Study|Study terminated by sponsor|2
7955388|NCT02604199|12503887|FG000|Overall Study|Withdrawal by Subject|0
7955389|NCT02604199|12503888|FG001|Overall Study|Withdrawal by Subject|1
7955390|NCT02604199|12503889|FG002|Overall Study|Withdrawal by Subject|0
7955391|NCT02604199|12503890|FG003|Overall Study|Withdrawal by Subject|0
7955392|NCT02604212|12503907|FG000|Overall Study|Study Terminated by Sponsor|2
7955393|NCT02604212|12503908|FG001|Overall Study|Study Terminated by Sponsor|1
7955394|NCT02604212|12503909|FG002|Overall Study|Study Terminated by Sponsor|3
7955395|NCT02604212|12503910|FG003|Overall Study|Study Terminated by Sponsor|3
7955396|NCT02604212|12503907|FG000|Overall Study|Withdrawal by Subject|0
7955397|NCT02604212|12503908|FG001|Overall Study|Withdrawal by Subject|0
7955398|NCT02604212|12503909|FG002|Overall Study|Withdrawal by Subject|1
7955399|NCT02604212|12503910|FG003|Overall Study|Withdrawal by Subject|0
7955400|NCT02604264|12503927|FG000|Intervention|Didn't use CVC for at least 21 days|200
7955401|NCT02604264|12503928|FG001|Intervention|Didn't use CVC for at least 21 days|242
7955402|NCT02604342|12503936|FG000|Overall Study|Death|32
7955403|NCT02604342|12503937|FG001|Overall Study|Death|16
7955404|NCT02604342|12503936|FG000|Overall Study|Progression of disease|1
7955405|NCT02604342|12503937|FG001|Overall Study|Progression of disease|0
7955406|NCT02604342|12503936|FG000|Overall Study|Withdrawal by Subject|5
7955407|NCT02604342|12503937|FG001|Overall Study|Withdrawal by Subject|6
7955408|NCT02604342|12503936|FG000|Overall Study|Other|1
7955409|NCT02604342|12503937|FG001|Overall Study|Other|0
7955410|NCT02604342|12503936|FG000|Overall Study|Study Termination by Sponsor|1
7955411|NCT02604342|12503937|FG001|Overall Study|Study Termination by Sponsor|0
7955412|NCT02604342|12503936|FG000|Overall Study|Lost to Follow-up|1
7955413|NCT02604342|12503937|FG001|Overall Study|Lost to Follow-up|1
7955414|NCT02604342|12503936|FG000|Overall Study|Physician Decision|2
7955415|NCT02604342|12503937|FG001|Overall Study|Physician Decision|0
7955416|NCT02604407|12503946|FG000|Overall Study|Adverse Event|0
7955417|NCT02604407|12503947|FG001|Overall Study|Adverse Event|7
7955418|NCT02604407|12503948|FG002|Overall Study|Adverse Event|5
7955419|NCT02604407|12503946|FG000|Overall Study|Protocol Violation|2
7955420|NCT02604407|12503947|FG001|Overall Study|Protocol Violation|0
7955421|NCT02604407|12503948|FG002|Overall Study|Protocol Violation|0
7955422|NCT02604407|12503946|FG000|Overall Study|Withdrawal by Subject|3
7955423|NCT02604407|12503947|FG001|Overall Study|Withdrawal by Subject|3
7955424|NCT02604407|12503948|FG002|Overall Study|Withdrawal by Subject|5
7955425|NCT02604407|12503946|FG000|Overall Study|Lost to Follow-up|2
7955426|NCT02604407|12503947|FG001|Overall Study|Lost to Follow-up|1
7955427|NCT02604407|12503948|FG002|Overall Study|Lost to Follow-up|2
7955428|NCT02604407|12503946|FG000|Overall Study|Lack of Efficacy|1
7955429|NCT02604407|12503947|FG001|Overall Study|Lack of Efficacy|0
7955430|NCT02604407|12503948|FG002|Overall Study|Lack of Efficacy|0
7955431|NCT02604407|12503946|FG000|Overall Study|Other|3
7955432|NCT02604407|12503947|FG001|Overall Study|Other|1
7955433|NCT02604407|12503948|FG002|Overall Study|Other|4
7955434|NCT02604550|12503958|FG000|Overall Study|Lost to Follow-up|7
7955435|NCT02604550|12503959|FG001|Overall Study|Lost to Follow-up|6
7955436|NCT02604550|12503958|FG000|Overall Study|Withdrawal by Subject|0
7955437|NCT02604550|12503959|FG001|Overall Study|Withdrawal by Subject|1
7955438|NCT02604550|12503958|FG000|Overall Study|Incomplete data using paper journal|18
7955439|NCT02604550|12503959|FG001|Overall Study|Incomplete data using paper journal|19
7955440|NCT02604589|12503968|FG000|Overall Study|catheter dislodgement|0
7955441|NCT02604589|12503969|FG001|Overall Study|catheter dislodgement|0
7955442|NCT02604589|12503970|FG002|Overall Study|catheter dislodgement|1
7955443|NCT02605122|12503986|FG000|Overall Study|Withdrawal by Subject|4
7955444|NCT02605122|12503987|FG001|Overall Study|Withdrawal by Subject|1
7955445|NCT02605122|12503986|FG000|Overall Study|Lost to Follow-up|1
7955446|NCT02605122|12503987|FG001|Overall Study|Lost to Follow-up|1
7955447|NCT02605174|12503997|FG000|Overall Study|Adverse Event|0
7955448|NCT02605174|12503998|FG001|Overall Study|Adverse Event|0
7955449|NCT02605174|12503999|FG002|Overall Study|Adverse Event|1
7955450|NCT02605174|12504000|FG003|Overall Study|Adverse Event|0
7955451|NCT02605174|12504001|FG004|Overall Study|Adverse Event|4
7955452|NCT02605174|12504002|FG005|Overall Study|Adverse Event|0
7955453|NCT02605174|12504003|FG006|Overall Study|Adverse Event|0
7955454|NCT02605174|12503997|FG000|Overall Study|Lost to Follow-up|20
7955455|NCT02605174|12503998|FG001|Overall Study|Lost to Follow-up|7
7955456|NCT02605174|12503999|FG002|Overall Study|Lost to Follow-up|27
7955457|NCT02605174|12504000|FG003|Overall Study|Lost to Follow-up|10
7955458|NCT02605174|12504001|FG004|Overall Study|Lost to Follow-up|20
7955459|NCT02605174|12504002|FG005|Overall Study|Lost to Follow-up|10
7955460|NCT02605174|12504003|FG006|Overall Study|Lost to Follow-up|29
7955461|NCT02605174|12503997|FG000|Overall Study|Protocol Violation|10
7955462|NCT02605174|12503998|FG001|Overall Study|Protocol Violation|4
7955463|NCT02605174|12503999|FG002|Overall Study|Protocol Violation|14
7955464|NCT02605174|12504000|FG003|Overall Study|Protocol Violation|6
7955465|NCT02605174|12504001|FG004|Overall Study|Protocol Violation|7
7955466|NCT02605174|12504002|FG005|Overall Study|Protocol Violation|7
7955467|NCT02605174|12504003|FG006|Overall Study|Protocol Violation|12
7955468|NCT02605174|12503997|FG000|Overall Study|Pregnancy|1
7955469|NCT02605174|12503998|FG001|Overall Study|Pregnancy|0
7955470|NCT02605174|12503999|FG002|Overall Study|Pregnancy|0
7955471|NCT02605174|12504000|FG003|Overall Study|Pregnancy|2
7955472|NCT02605174|12504001|FG004|Overall Study|Pregnancy|0
7955473|NCT02605174|12504002|FG005|Overall Study|Pregnancy|0
7955474|NCT02605174|12504003|FG006|Overall Study|Pregnancy|0
7955475|NCT02605174|12503997|FG000|Overall Study|Withdrawal by Subject|9
7955476|NCT02605174|12503998|FG001|Overall Study|Withdrawal by Subject|6
7955477|NCT02605174|12503999|FG002|Overall Study|Withdrawal by Subject|14
7955478|NCT02605174|12504000|FG003|Overall Study|Withdrawal by Subject|11
7955479|NCT02605174|12504001|FG004|Overall Study|Withdrawal by Subject|6
7955480|NCT02605174|12504002|FG005|Overall Study|Withdrawal by Subject|4
7955481|NCT02605174|12504003|FG006|Overall Study|Withdrawal by Subject|15
7955482|NCT02605174|12503997|FG000|Overall Study|Physician Decision|2
7955483|NCT02605174|12503998|FG001|Overall Study|Physician Decision|0
7955484|NCT02605174|12503999|FG002|Overall Study|Physician Decision|0
7955485|NCT02605174|12504000|FG003|Overall Study|Physician Decision|0
7955486|NCT02605174|12504001|FG004|Overall Study|Physician Decision|0
7955487|NCT02605174|12504002|FG005|Overall Study|Physician Decision|0
7955488|NCT02605174|12504003|FG006|Overall Study|Physician Decision|3
7955489|NCT02605174|12503997|FG000|Overall Study|Randomization Failure|22
7955490|NCT02605174|12503998|FG001|Overall Study|Randomization Failure|6
7955491|NCT02605174|12503999|FG002|Overall Study|Randomization Failure|20
7955492|NCT02605174|12504000|FG003|Overall Study|Randomization Failure|7
7955493|NCT02605174|12504001|FG004|Overall Study|Randomization Failure|16
7955494|NCT02605174|12504002|FG005|Overall Study|Randomization Failure|11
7955495|NCT02605174|12504003|FG006|Overall Study|Randomization Failure|30
7955496|NCT02605447|12504062|FG000|Overall Study|Death|66
7955497|NCT02605447|12504062|FG000|Overall Study|Physician Decision|1
7955498|NCT02605447|12504062|FG000|Overall Study|Lost to Follow-up|24
7955499|NCT02605447|12504062|FG000|Overall Study|Withdrawal by Subject|10
7955500|NCT02605447|12504062|FG000|Overall Study|Not disclosed|1
7955501|NCT02605642|12504069|FG000|Overall Study|Other|11
7955502|NCT02605642|12504070|FG001|Overall Study|Other|1
7955503|NCT02605642|12504069|FG000|Overall Study|Participant non-compliance|2
7955504|NCT02605642|12504070|FG001|Overall Study|Participant non-compliance|4
7955505|NCT02605642|12504069|FG000|Overall Study|Physician Decision|10
7955506|NCT02605642|12504070|FG001|Overall Study|Physician Decision|0
7955507|NCT02605642|12504069|FG000|Overall Study|Lost to Follow-up|12
7955508|NCT02605642|12504070|FG001|Overall Study|Lost to Follow-up|1
7955509|NCT02605642|12504069|FG000|Overall Study|Adverse Event|14
7955510|NCT02605642|12504070|FG001|Overall Study|Adverse Event|2
7955511|NCT02605642|12504069|FG000|Overall Study|Withdrawal by Subject|23
7955512|NCT02605642|12504070|FG001|Overall Study|Withdrawal by Subject|2
7955513|NCT02605642|12504069|FG000|Overall Study|Lack of response|24
7955514|NCT02605642|12504070|FG001|Overall Study|Lack of response|11
7955515|NCT02605837|12504078|FG000|Overall Study|Adverse Event|3
7955516|NCT02605837|12504079|FG001|Overall Study|Adverse Event|1
7955517|NCT02605837|12504078|FG000|Overall Study|Non-Compliance with Study Drug|0
7955518|NCT02605837|12504079|FG001|Overall Study|Non-Compliance with Study Drug|1
7955519|NCT02605837|12504078|FG000|Overall Study|Withdrawal by Subject|8
7955520|NCT02605837|12504079|FG001|Overall Study|Withdrawal by Subject|8
7955521|NCT02605837|12504078|FG000|Overall Study|Physician Decision|0
7955522|NCT02605837|12504079|FG001|Overall Study|Physician Decision|1
7955523|NCT02605928|12504108|FG000|Overall Study|Model tuning phase|28
7955524|NCT02605928|12504108|FG000|Overall Study|Lack of Efficacy|5
7955525|NCT02605954|12504114|FG000|Overall Study|Adverse Event|5
7955526|NCT02605954|12504115|FG001|Overall Study|Adverse Event|1
7955527|NCT02605954|12504114|FG000|Overall Study|Investigator's Discretion|1
7955528|NCT02605954|12504115|FG001|Overall Study|Investigator's Discretion|0
7955529|NCT02605954|12504114|FG000|Overall Study|Non-Compliance with Study Drug|1
7955530|NCT02605954|12504115|FG001|Overall Study|Non-Compliance with Study Drug|0
7955531|NCT02605954|12504114|FG000|Overall Study|Withdrew Consent|2
7955532|NCT02605954|12504115|FG001|Overall Study|Withdrew Consent|2
7955533|NCT02605954|12504114|FG000|Overall Study|Lost to Follow-up|3
7955534|NCT02605954|12504115|FG001|Overall Study|Lost to Follow-up|0
7955535|NCT02605954|12504114|FG000|Overall Study|Randomized but not treated|0
7955536|NCT02605954|12504115|FG001|Overall Study|Randomized but not treated|1
7955537|NCT02606253|12504127|FG000|Overall Study|Adverse Event|2
7955538|NCT02606253|12504128|FG001|Overall Study|Adverse Event|0
7955539|NCT02606253|12504129|FG002|Overall Study|Adverse Event|0
7955540|NCT02606253|12504127|FG000|Overall Study|Protocol Violation|2
7955541|NCT02606253|12504128|FG001|Overall Study|Protocol Violation|1
7955542|NCT02606253|12504129|FG002|Overall Study|Protocol Violation|0
7955543|NCT02606253|12504127|FG000|Overall Study|Physician Decision|1
7955544|NCT02606253|12504128|FG001|Overall Study|Physician Decision|1
7955545|NCT02606253|12504129|FG002|Overall Study|Physician Decision|0
7955546|NCT02606643|12504159|FG000|Overall Study|did not meet inclusion criteria|1
7955547|NCT02606643|12504160|FG001|Overall Study|did not meet inclusion criteria|3
7955548|NCT02606877|12504188|FG000|Overall Study|Adverse Event|3
7955549|NCT02606877|12504189|FG001|Overall Study|Adverse Event|0
7955550|NCT02606877|12504188|FG000|Overall Study|Non-compliance with protocol|0
7955551|NCT02606877|12504189|FG001|Overall Study|Non-compliance with protocol|1
7955552|NCT02606877|12504188|FG000|Overall Study|Other than listed above|1
7955553|NCT02606877|12504189|FG001|Overall Study|Other than listed above|0
7955554|NCT02607228|12504218|FG000|Overall Study|Progressive Disease|4
7955555|NCT02607228|12504219|FG001|Overall Study|Progressive Disease|3
7955556|NCT02607228|12504220|FG002|Overall Study|Progressive Disease|1
7955557|NCT02607228|12504221|FG003|Overall Study|Progressive Disease|5
7955558|NCT02607228|12504222|FG004|Overall Study|Progressive Disease|4
7955559|NCT02607228|12504223|FG005|Overall Study|Progressive Disease|3
7955560|NCT02607228|12504224|FG006|Overall Study|Progressive Disease|1
7955561|NCT02607228|12504218|FG000|Overall Study|Adverse Event|1
7955562|NCT02607228|12504219|FG001|Overall Study|Adverse Event|0
7955563|NCT02607228|12504220|FG002|Overall Study|Adverse Event|1
7955564|NCT02607228|12504221|FG003|Overall Study|Adverse Event|0
7955565|NCT02607228|12504222|FG004|Overall Study|Adverse Event|1
7955566|NCT02607228|12504223|FG005|Overall Study|Adverse Event|1
7955567|NCT02607228|12504224|FG006|Overall Study|Adverse Event|1
7955568|NCT02607228|12504218|FG000|Overall Study|Investigator's Discretion|0
7955569|NCT02607228|12504219|FG001|Overall Study|Investigator's Discretion|0
7955570|NCT02607228|12504220|FG002|Overall Study|Investigator's Discretion|1
7955571|NCT02607228|12504221|FG003|Overall Study|Investigator's Discretion|0
7955572|NCT02607228|12504222|FG004|Overall Study|Investigator's Discretion|0
7955573|NCT02607228|12504223|FG005|Overall Study|Investigator's Discretion|1
7955574|NCT02607228|12504224|FG006|Overall Study|Investigator's Discretion|0
7955575|NCT02607228|12504218|FG000|Overall Study|Withdrew Consent|0
7955576|NCT02607228|12504219|FG001|Overall Study|Withdrew Consent|1
7955577|NCT02607228|12504220|FG002|Overall Study|Withdrew Consent|0
7955578|NCT02607228|12504221|FG003|Overall Study|Withdrew Consent|0
7955579|NCT02607228|12504222|FG004|Overall Study|Withdrew Consent|0
7955580|NCT02607228|12504223|FG005|Overall Study|Withdrew Consent|1
7955581|NCT02607228|12504224|FG006|Overall Study|Withdrew Consent|0
7955582|NCT02607228|12504218|FG000|Overall Study|Study Terminated by Sponsor|0
7955583|NCT02607228|12504219|FG001|Overall Study|Study Terminated by Sponsor|0
7955584|NCT02607228|12504220|FG002|Overall Study|Study Terminated by Sponsor|0
7955585|NCT02607228|12504221|FG003|Overall Study|Study Terminated by Sponsor|1
7955586|NCT02607228|12504222|FG004|Overall Study|Study Terminated by Sponsor|0
7955587|NCT02607228|12504223|FG005|Overall Study|Study Terminated by Sponsor|0
7955588|NCT02607228|12504224|FG006|Overall Study|Study Terminated by Sponsor|0
7955589|NCT02607280|12504262|FG000|Overall Study|Adverse Event|4
7955590|NCT02607280|12504263|FG001|Overall Study|Adverse Event|0
7955591|NCT02607280|12504262|FG000|Overall Study|Decrease in CrCl <15|0
7955592|NCT02607280|12504263|FG001|Overall Study|Decrease in CrCl <15|1
7955593|NCT02607306|12504272|FG000|Overall Study|Adverse Event|8
7955594|NCT02607306|12504273|FG001|Overall Study|Adverse Event|6
7955595|NCT02607306|12504274|FG002|Overall Study|Adverse Event|6
7955596|NCT02607306|12504272|FG000|Overall Study|Unclassified|1
7955597|NCT02607306|12504273|FG001|Overall Study|Unclassified|4
7955598|NCT02607306|12504274|FG002|Overall Study|Unclassified|0
7955599|NCT02607306|12504272|FG000|Overall Study|Withdrawal by Subject|8
7955600|NCT02607306|12504273|FG001|Overall Study|Withdrawal by Subject|10
7955601|NCT02607306|12504274|FG002|Overall Study|Withdrawal by Subject|2
7955602|NCT02607306|12504272|FG000|Overall Study|Lack of Efficacy|0
7955603|NCT02607306|12504273|FG001|Overall Study|Lack of Efficacy|1
7861272|NCT01590082|12349902|FG000|Overall Study|Withdrawal by Subject|1
7861273|NCT01590082|12349903|FG001|Overall Study|Withdrawal by Subject|0
7861274|NCT01590082|12349902|FG000|Overall Study|Ineligible|1
7861275|NCT01590082|12349903|FG001|Overall Study|Ineligible|0
7861276|NCT01590212|12349912|FG000|Overall Study|Withdrawal by Subject|2
7861277|NCT01590212|12349913|FG001|Overall Study|Withdrawal by Subject|2
7861278|NCT01590212|12349914|FG002|Overall Study|Withdrawal by Subject|2
7861279|NCT01590212|12349912|FG000|Overall Study|Lost to Follow-up|1
7861280|NCT01590212|12349913|FG001|Overall Study|Lost to Follow-up|2
7861281|NCT01590212|12349914|FG002|Overall Study|Lost to Follow-up|3
7861282|NCT01590433|12349933|FG000|Overall Study|Lost to Follow-up|20
7861283|NCT01590433|12349934|FG001|Overall Study|Lost to Follow-up|8
7861284|NCT01590433|12349933|FG000|Overall Study|Withdrawal by Subject|21
7861285|NCT01590433|12349934|FG001|Overall Study|Withdrawal by Subject|11
7861286|NCT01590433|12349933|FG000|Overall Study|Adverse Event|11
7861287|NCT01590433|12349934|FG001|Overall Study|Adverse Event|3
7861288|NCT01590563|12349945|FG000|Overall Study|simple uterine hyperplasia - not related|1
7861289|NCT01590758|12349952|FG000|Overall Study|Withdrawal by Subject|0
7861290|NCT01590758|12349953|FG001|Overall Study|Withdrawal by Subject|3
7861291|NCT01590758|12349952|FG000|Overall Study|Physician Decision|1
7955604|NCT02607306|12504274|FG002|Overall Study|Lack of Efficacy|1
7955605|NCT02607306|12504272|FG000|Overall Study|Protocol Violation|4
7955606|NCT02607306|12504273|FG001|Overall Study|Protocol Violation|2
7955607|NCT02607306|12504274|FG002|Overall Study|Protocol Violation|1
7955608|NCT02607735|12504294|FG000|Primary Study|Randomized but Never Treated|1
7955609|NCT02607735|12504295|FG001|Primary Study|Randomized but Never Treated|0
7955610|NCT02607735|12504296|FG002|Primary Study|Randomized but Never Treated|0
7955611|NCT02607735|12504294|FG000|Primary Study|Lost to Follow-up|4
7955612|NCT02607735|12504295|FG001|Primary Study|Lost to Follow-up|0
7955613|NCT02607735|12504296|FG002|Primary Study|Lost to Follow-up|0
7955614|NCT02607735|12504294|FG000|Primary Study|Withdrew Consent|2
7955615|NCT02607735|12504295|FG001|Primary Study|Withdrew Consent|0
7955616|NCT02607735|12504296|FG002|Primary Study|Withdrew Consent|0
7955617|NCT02607735|12504294|FG000|Deferred Treatment Substudy|Lost to Follow-up|0
7955618|NCT02607735|12504295|FG001|Deferred Treatment Substudy|Lost to Follow-up|0
7955619|NCT02607735|12504296|FG002|Deferred Treatment Substudy|Lost to Follow-up|4
7955620|NCT02607735|12504294|FG000|Deferred Treatment Substudy|Withdrew Consent|0
7955621|NCT02607735|12504295|FG001|Deferred Treatment Substudy|Withdrew Consent|0
7955622|NCT02607735|12504296|FG002|Deferred Treatment Substudy|Withdrew Consent|1
7955623|NCT02607800|12504306|FG000|Overall Study|Lost to Follow-up|7
7955624|NCT02607800|12504307|FG001|Overall Study|Lost to Follow-up|10
7955625|NCT02607800|12504306|FG000|Overall Study|Withdrew Consent|2
7955626|NCT02607800|12504307|FG001|Overall Study|Withdrew Consent|0
7955627|NCT02607800|12504306|FG000|Overall Study|Randomized/Enrolled but Not Treated|1
7955628|NCT02607800|12504307|FG001|Overall Study|Randomized/Enrolled but Not Treated|1
7955629|NCT02608099|12504316|FG000|Overall Study|Ablation procedure not initiated|3
7955630|NCT02608099|12504317|FG001|Overall Study|Ablation procedure not initiated|2
7955631|NCT02608450|12504347|FG000|Overall Study|Lost to Follow-up|39
7955632|NCT02608450|12504348|FG001|Overall Study|Lost to Follow-up|32
7955633|NCT02608450|12504347|FG000|Overall Study|Withdrawal by Subject|21
7955634|NCT02608450|12504348|FG001|Overall Study|Withdrawal by Subject|15
7955635|NCT02608450|12504347|FG000|Overall Study|Adverse Event|3
7955636|NCT02608450|12504348|FG001|Overall Study|Adverse Event|6
7955637|NCT02608450|12504347|FG000|Overall Study|Withdrawal by parent|2
7955638|NCT02608450|12504348|FG001|Overall Study|Withdrawal by parent|3
7955639|NCT02608450|12504347|FG000|Overall Study|Lack of Efficacy|0
7955640|NCT02608450|12504348|FG001|Overall Study|Lack of Efficacy|3
7955641|NCT02608450|12504347|FG000|Overall Study|Noncompliance with study drug|0
7955642|NCT02608450|12504348|FG001|Overall Study|Noncompliance with study drug|2
7955643|NCT02608450|12504347|FG000|Overall Study|Physician Decision|0
7955644|NCT02608450|12504348|FG001|Overall Study|Physician Decision|1
7955645|NCT02608450|12504347|FG000|Overall Study|Pregnancy|0
7955646|NCT02608450|12504348|FG001|Overall Study|Pregnancy|1
7955647|NCT02608450|12504347|FG000|Overall Study|Progressive disease|1
7955648|NCT02608450|12504348|FG001|Overall Study|Progressive disease|0
7955649|NCT02608450|12504347|FG000|Overall Study|Multiple reasons|0
7955650|NCT02608450|12504348|FG001|Overall Study|Multiple reasons|2
7955651|NCT02608476|12504370|FG000|Overall Study|Withdrawal by Subject|30
7955652|NCT02608476|12504371|FG001|Overall Study|Withdrawal by Subject|37
7955653|NCT02608476|12504370|FG000|Overall Study|Lost to Follow-up|24
7955654|NCT02608476|12504371|FG001|Overall Study|Lost to Follow-up|24
7955655|NCT02608476|12504370|FG000|Overall Study|Adverse Event|2
7955656|NCT02608476|12504371|FG001|Overall Study|Adverse Event|8
7955657|NCT02608476|12504370|FG000|Overall Study|Withdrawal by Parent/Guardian|5
7955658|NCT02608476|12504371|FG001|Overall Study|Withdrawal by Parent/Guardian|4
7955659|NCT02608476|12504370|FG000|Overall Study|Noncompliance with treatment|1
7955660|NCT02608476|12504371|FG001|Overall Study|Noncompliance with treatment|5
7955661|NCT02608476|12504370|FG000|Overall Study|Lack of Efficacy|3
7955662|NCT02608476|12504371|FG001|Overall Study|Lack of Efficacy|1
7955663|NCT02608476|12504370|FG000|Overall Study|Other|0
7955664|NCT02608476|12504371|FG001|Overall Study|Other|1
7955665|NCT02608476|12504370|FG000|Overall Study|Physician Decision|1
7955666|NCT02608476|12504371|FG001|Overall Study|Physician Decision|0
7955667|NCT02608476|12504370|FG000|Overall Study|Pregnancy|0
7955668|NCT02608476|12504371|FG001|Overall Study|Pregnancy|1
7955669|NCT02608476|12504370|FG000|Overall Study|Progressive disease|1
7955670|NCT02608476|12504371|FG001|Overall Study|Progressive disease|0
7955671|NCT02608879|12504389|FG000|Overall Study|Lost to Follow-up|1
7955672|NCT02608879|12504390|FG001|Overall Study|Lost to Follow-up|0
7955673|NCT02608879|12504391|FG002|Overall Study|Lost to Follow-up|0
7955674|NCT02608879|12504389|FG000|Overall Study|Did not meet continuation criteria|0
7955675|NCT02608879|12504390|FG001|Overall Study|Did not meet continuation criteria|0
7955676|NCT02608879|12504391|FG002|Overall Study|Did not meet continuation criteria|3
7955677|NCT02608892|12504401|FG000|Overall Study|Lost to Follow-up|1
7955678|NCT02608892|12504402|FG001|Overall Study|Lost to Follow-up|0
7955679|NCT02609178|12504429|FG000|First Crown|Withdrawal by Subject|0
7955680|NCT02609178|12504430|FG001|First Crown|Withdrawal by Subject|0
7955681|NCT02609178|12504431|FG002|First Crown|Withdrawal by Subject|1
7955682|NCT02609178|12504432|FG003|First Crown|Withdrawal by Subject|1
7955683|NCT02609178|12504433|FG004|First Crown|Withdrawal by Subject|0
7955684|NCT02609178|12504434|FG005|First Crown|Withdrawal by Subject|0
7955685|NCT02609399|12504456|FG000|Influenza Season 2015-2016|Lost to Follow-up|3
7955686|NCT02609399|12504457|FG001|Influenza Season 2015-2016|Lost to Follow-up|2
7955687|NCT02609399|12504456|FG000|Influenza Season 2016-2017|Lost to Follow-up|8
7955688|NCT02609399|12504457|FG001|Influenza Season 2016-2017|Lost to Follow-up|5
7955689|NCT02609399|12504456|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1
7955690|NCT02609399|12504457|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0
7955691|NCT02609607|12504467|FG000|Overall Study|Lost to Follow-up|0
7955692|NCT02609607|12504468|FG001|Overall Study|Lost to Follow-up|1
7955693|NCT02609633|12504476|FG000|Overall Study|Consent Withdrawn|0
7955694|NCT02609633|12504477|FG001|Overall Study|Consent Withdrawn|1
7955695|NCT02609633|12504476|FG000|Overall Study|Protocol Deviation|1
7955696|NCT02609633|12504477|FG001|Overall Study|Protocol Deviation|0
7955697|NCT02609633|12504476|FG000|Overall Study|Non-Compliant with Study Procedures|2
7955698|NCT02609633|12504477|FG001|Overall Study|Non-Compliant with Study Procedures|0
7955699|NCT02609633|12504476|FG000|Overall Study|Reason not Specified|2
7955700|NCT02609633|12504477|FG001|Overall Study|Reason not Specified|1
7955701|NCT02609659|12504484|FG000|Overall Study|Adverse Event|1
7955702|NCT02609659|12504484|FG000|Overall Study|Lost to Follow-up|6
7955703|NCT02609659|12504484|FG000|Overall Study|Other|1
7955704|NCT02609672|12504490|FG000|Overall Study|Lost to Follow-up|3
7955705|NCT02609672|12504491|FG001|Overall Study|Lost to Follow-up|1
7955706|NCT02609984|12504507|FG000|Overall Study|Death|29
7955707|NCT02609984|12504508|FG001|Overall Study|Death|26
7955708|NCT02609984|12504507|FG000|Overall Study|Participation Discontinued by Sponsor|12
7955709|NCT02609984|12504508|FG001|Overall Study|Participation Discontinued by Sponsor|10
7955710|NCT02609984|12504507|FG000|Overall Study|Lost to Follow-up|1
7721012|NCT00542425|12145526|FG003|Initial 24 Weeks|Adverse Event|3
7721013|NCT00542425|12145527|FG004|Initial 24 Weeks|Adverse Event|2
7955711|NCT02609984|12504508|FG001|Overall Study|Lost to Follow-up|2
7955712|NCT02609984|12504507|FG000|Overall Study|Withdrawal by Subject|0
7955713|NCT02609984|12504508|FG001|Overall Study|Withdrawal by Subject|1
7955714|NCT02609984|12504507|FG000|Overall Study|Disease Progression|2
7955715|NCT02609984|12504508|FG001|Overall Study|Disease Progression|0
7955716|NCT02610140|12504516|FG000|Randomization and Treatment Period|Radiological progression|23
7955717|NCT02610140|12504517|FG001|Randomization and Treatment Period|Radiological progression|15
7955718|NCT02610140|12504516|FG000|Randomization and Treatment Period|Progressive disease - radiological|54
7955719|NCT02610140|12504517|FG001|Randomization and Treatment Period|Progressive disease - radiological|23
7955720|NCT02610140|12504516|FG000|Randomization and Treatment Period|Protocol Violation|1
7955721|NCT02610140|12504517|FG001|Randomization and Treatment Period|Protocol Violation|0
7955722|NCT02610140|12504516|FG000|Randomization and Treatment Period|Physician Decision|0
7955723|NCT02610140|12504517|FG001|Randomization and Treatment Period|Physician Decision|1
7955724|NCT02610140|12504516|FG000|Randomization and Treatment Period|Lack of Efficacy|1
7955725|NCT02610140|12504517|FG001|Randomization and Treatment Period|Lack of Efficacy|0
7955726|NCT02610140|12504516|FG000|Randomization and Treatment Period|Death|7
7955727|NCT02610140|12504517|FG001|Randomization and Treatment Period|Death|1
7955728|NCT02610140|12504516|FG000|Randomization and Treatment Period|Withdrawal by Subject|12
7955729|NCT02610140|12504517|FG001|Randomization and Treatment Period|Withdrawal by Subject|12
7955730|NCT02610140|12504516|FG000|Randomization and Treatment Period|Adverse Event|44
7955731|NCT02610140|12504517|FG001|Randomization and Treatment Period|Adverse Event|13
7955732|NCT02610140|12504516|FG000|Randomization and Treatment Period|Progressive disease - clinical|12
7955733|NCT02610140|12504517|FG001|Randomization and Treatment Period|Progressive disease - clinical|5
7955734|NCT02610140|12504516|FG000|Randomization and Treatment Period|Ongoing but not completed|9
7955735|NCT02610140|12504517|FG001|Randomization and Treatment Period|Ongoing but not completed|2
7955736|NCT02610140|12504516|FG000|Randomization and Treatment Period|Not treated|3
7955737|NCT02610140|12504517|FG001|Randomization and Treatment Period|Not treated|10
7955738|NCT02610140|12504516|FG000|Safety Follow-up|Other|0
7955739|NCT02610140|12504517|FG001|Safety Follow-up|Other|2
7955740|NCT02610140|12504516|FG000|Safety Follow-up|Lost to Follow-up|1
7955741|NCT02610140|12504517|FG001|Safety Follow-up|Lost to Follow-up|0
7955742|NCT02610140|12504516|FG000|Safety Follow-up|No follow-up|5
7955743|NCT02610140|12504517|FG001|Safety Follow-up|No follow-up|3
7955744|NCT02610140|12504516|FG000|Safety Follow-up|Death|12
7955745|NCT02610140|12504517|FG001|Safety Follow-up|Death|2
7955746|NCT02610140|12504516|FG000|Safety Follow-up|Deterioration of general conditions|15
7955747|NCT02610140|12504517|FG001|Safety Follow-up|Deterioration of general conditions|5
7955748|NCT02610140|12504516|FG000|Safety Follow-up|Withdrawal by Subject|12
7955749|NCT02610140|12504517|FG001|Safety Follow-up|Withdrawal by Subject|12
7955750|NCT02610140|12504516|FG000|Active Follow-up|Progressive disease - radiological|30
7955751|NCT02610140|12504517|FG001|Active Follow-up|Progressive disease - radiological|22
7955752|NCT02610140|12504516|FG000|Active Follow-up|Death|8
7955753|NCT02610140|12504517|FG001|Active Follow-up|Death|1
7955754|NCT02610140|12504516|FG000|Active Follow-up|Withdrawal by Subject|4
7955755|NCT02610140|12504517|FG001|Active Follow-up|Withdrawal by Subject|0
7721014|NCT00542425|12145523|FG000|Initial 24 Weeks|Inability to complete procedures|0
7955756|NCT02610140|12504516|FG000|Active Follow-up|Progressive disease - clinical|1
7955757|NCT02610140|12504517|FG001|Active Follow-up|Progressive disease - clinical|2
7955758|NCT02610140|12504516|FG000|Active Follow-up|Deterioration of general conditions|1
7955759|NCT02610140|12504517|FG001|Active Follow-up|Deterioration of general conditions|0
7955760|NCT02610140|12504516|FG000|Active Follow-up|Ongoing but not completed|4
7955761|NCT02610140|12504517|FG001|Active Follow-up|Ongoing but not completed|1
7955762|NCT02610140|12504516|FG000|Long-term Follow-up|Death|86
7955763|NCT02610140|12504517|FG001|Long-term Follow-up|Death|44
7955764|NCT02610140|12504516|FG000|Long-term Follow-up|Withdrawal by Subject|6
7955765|NCT02610140|12504517|FG001|Long-term Follow-up|Withdrawal by Subject|3
7955766|NCT02610140|12504516|FG000|Long-term Follow-up|Lost to Follow-up|1
7955767|NCT02610140|12504517|FG001|Long-term Follow-up|Lost to Follow-up|2
7955768|NCT02610140|12504516|FG000|Long-term Follow-up|Ongoing but not completed|30
7955769|NCT02610140|12504517|FG001|Long-term Follow-up|Ongoing but not completed|17
7955770|NCT02610192|12504523|FG000|Overall Study|Received other treatment|8
7955771|NCT02610192|12504523|FG000|Overall Study|Physician Decision|1
7955772|NCT02610231|12504527|FG000|Overall Study|Withdrawal by Subject|27
7955773|NCT02610231|12504527|FG000|Overall Study|Adverse Event|20
7955774|NCT02610231|12504527|FG000|Overall Study|Death|5
7955775|NCT02610231|12504527|FG000|Overall Study|Surgery|2
7955776|NCT02610231|12504527|FG000|Overall Study|Physician Decision|1
7955777|NCT02610231|12504527|FG000|Overall Study|Non Compliance|2
7955778|NCT02610231|12504527|FG000|Overall Study|Other|3
7955779|NCT02610725|12504543|FG000|Overall Study|Lost to Follow-up|197
7955780|NCT02610725|12504543|FG000|Overall Study|self-reported contraindication|9
7955781|NCT02610816|12504549|FG000|Phase 1|Withdrawal by Subject|2
7955782|NCT02610816|12504550|FG001|Phase 1|Withdrawal by Subject|6
7955783|NCT02610816|12504551|FG002|Phase 1|Withdrawal by Subject|0
7955784|NCT02610816|12504552|FG003|Phase 1|Withdrawal by Subject|0
7955785|NCT02610816|12504549|FG000|Phase 1|Lost to Follow-up|2
7955786|NCT02610816|12504550|FG001|Phase 1|Lost to Follow-up|1
7955787|NCT02610816|12504551|FG002|Phase 1|Lost to Follow-up|0
7955788|NCT02610816|12504552|FG003|Phase 1|Lost to Follow-up|0
7955789|NCT02610816|12504549|FG000|Phase 1|Physician Decision|0
7955790|NCT02610816|12504550|FG001|Phase 1|Physician Decision|1
7955791|NCT02610816|12504551|FG002|Phase 1|Physician Decision|0
7955792|NCT02610816|12504552|FG003|Phase 1|Physician Decision|0
7955793|NCT02610816|12504549|FG000|Phase 2|Withdrawal by Subject|0
7955794|NCT02610816|12504550|FG001|Phase 2|Withdrawal by Subject|0
7955795|NCT02610816|12504551|FG002|Phase 2|Withdrawal by Subject|9
7955796|NCT02610816|12504552|FG003|Phase 2|Withdrawal by Subject|3
7955797|NCT02610816|12504549|FG000|Phase 2|Lost to Follow-up|0
7955798|NCT02610816|12504550|FG001|Phase 2|Lost to Follow-up|0
7955799|NCT02610816|12504551|FG002|Phase 2|Lost to Follow-up|2
7955800|NCT02610816|12504552|FG003|Phase 2|Lost to Follow-up|0
7955801|NCT02610816|12504549|FG000|Phase 2|Physician Decision|0
7955802|NCT02610816|12504550|FG001|Phase 2|Physician Decision|0
7955803|NCT02610816|12504551|FG002|Phase 2|Physician Decision|0
7955804|NCT02610816|12504552|FG003|Phase 2|Physician Decision|2
7955805|NCT02610816|12504549|FG000|Phase 2|Pregnancy|0
7955806|NCT02610816|12504550|FG001|Phase 2|Pregnancy|0
7955807|NCT02610816|12504551|FG002|Phase 2|Pregnancy|0
7955808|NCT02610816|12504552|FG003|Phase 2|Pregnancy|1
7955809|NCT02610842|12504562|FG000|Overall Study|Lost to Follow-up|5
7955810|NCT02611362|12504618|FG000|Overall Study|Withdrawal by Subject|7
7955811|NCT02611362|12504619|FG001|Overall Study|Withdrawal by Subject|2
7955812|NCT02611362|12504618|FG000|Overall Study|Lost to Follow-up|2
7955813|NCT02611362|12504619|FG001|Overall Study|Lost to Follow-up|4
7955814|NCT02611479|12504626|FG000|Baseline Enrollment|Exited study|13
7955815|NCT02611479|12504626|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2
7955816|NCT02611479|12504626|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18
7955817|NCT02611479|12504626|FG000|Data Cleaning|No baseline function or pain metrics|2
7955818|NCT02611752|12504632|FG000|Overall Study|Adverse Event|0
7955819|NCT02611752|12504633|FG001|Overall Study|Adverse Event|1
7955820|NCT02611778|12504663|FG000|Overall Study|Withdrawal by Subject|2
7955821|NCT02611778|12504664|FG001|Overall Study|Withdrawal by Subject|8
7955822|NCT02611778|12504663|FG000|Overall Study|Adverse Event|1
7955823|NCT02611778|12504664|FG001|Overall Study|Adverse Event|2
7955824|NCT02611778|12504663|FG000|Overall Study|Death|2
7955825|NCT02611778|12504664|FG001|Overall Study|Death|1
7955826|NCT02611778|12504663|FG000|Overall Study|Protocol Violation|1
7955827|NCT02611778|12504664|FG001|Overall Study|Protocol Violation|0
7955828|NCT02611778|12504663|FG000|Overall Study|Lost to Follow-up|3
7955829|NCT02611778|12504664|FG001|Overall Study|Lost to Follow-up|1
7955830|NCT02611778|12504663|FG000|Overall Study|Need for alternative treatment|1
7955831|NCT02611778|12504664|FG001|Overall Study|Need for alternative treatment|0
7955832|NCT02611778|12504663|FG000|Overall Study|Other Reason|2
7721015|NCT00542425|12145524|FG001|Initial 24 Weeks|Inability to complete procedures|3
7721016|NCT00542425|12145525|FG002|Initial 24 Weeks|Inability to complete procedures|2
7721017|NCT00542425|12145526|FG003|Initial 24 Weeks|Inability to complete procedures|1
7721018|NCT00542425|12145527|FG004|Initial 24 Weeks|Inability to complete procedures|2
7955833|NCT02611778|12504664|FG001|Overall Study|Other Reason|1
7955834|NCT02611882|12504674|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33
7955835|NCT02611882|12504675|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0
7955836|NCT02611882|12504676|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0
7955837|NCT02612064|12504685|FG000|Overall Study|Withdrawal by Subject|1
7955838|NCT02612064|12504686|FG001|Overall Study|Withdrawal by Subject|1
7955839|NCT02612064|12504685|FG000|Overall Study|Other|0
7955840|NCT02612064|12504686|FG001|Overall Study|Other|2
7955841|NCT02612077|12504692|FG000|Overall Study|Adverse Event|3
7955842|NCT02612077|12504692|FG000|Overall Study|Withdrawal by Subject|9
7955843|NCT02612077|12504692|FG000|Overall Study|Protocol Violation|28
7955844|NCT02612077|12504692|FG000|Overall Study|Lost to Follow-up|20
7955845|NCT02612077|12504692|FG000|Overall Study|Death|377
7955846|NCT02612077|12504692|FG000|Overall Study|Moved or Changed Medical Team|23
7955847|NCT02612077|12504692|FG000|Overall Study|Enrollment in a Clinical Trial|1
7955848|NCT02612077|12504692|FG000|Overall Study|Disease Progression|3
7955849|NCT02612077|12504692|FG000|Overall Study|Unknown reason|2
7955850|NCT02612155|12504701|FG000|Overall Study|Death|1
7955851|NCT02612155|12504702|FG001|Overall Study|Death|1
7955852|NCT02612155|12504701|FG000|Overall Study|Lost to Follow-up|2
7955853|NCT02612155|12504702|FG001|Overall Study|Lost to Follow-up|2
7955854|NCT02612428|12504710|FG000|VTL-308|Death|14
7955855|NCT02612428|12504711|FG001|VTL-308|Death|16
7955856|NCT02612428|12504710|FG000|VTL-308|Withdrawal by Subject|0
7955857|NCT02612428|12504711|FG001|VTL-308|Withdrawal by Subject|1
7955858|NCT02612428|12504710|FG000|VTL-308E|Death|9
7955859|NCT02612428|12504711|FG001|VTL-308E|Death|7
7955860|NCT02612428|12504710|FG000|VTL-308E|Lost to Follow-up|2
7955861|NCT02612428|12504711|FG001|VTL-308E|Lost to Follow-up|0
7966446|NCT02750514|12522346|FG004|Track 5|Other reasons|2
7966447|NCT02750592|12522366|FG000|Overall Study|Adverse Event|3
7966448|NCT02750592|12522366|FG000|Overall Study|Lack of Efficacy|2
7966449|NCT02750618|12522370|FG000|Overall Study|Withdrawal by Subject|1
7966450|NCT02750709|12522374|FG000|Treatment Period 1|Adverse Event|0
7966451|NCT02750709|12522375|FG001|Treatment Period 1|Adverse Event|0
7966452|NCT02750709|12522376|FG002|Treatment Period 1|Adverse Event|0
7966453|NCT02750709|12522377|FG003|Treatment Period 1|Adverse Event|0
7966454|NCT02750709|12522378|FG004|Treatment Period 1|Adverse Event|0
7966455|NCT02750709|12522379|FG005|Treatment Period 1|Adverse Event|1
7966456|NCT02750761|12522393|FG000|Overall Study|Lost to Follow-up|0
7966457|NCT02750761|12522394|FG001|Overall Study|Lost to Follow-up|0
7966458|NCT02750761|12522395|FG002|Overall Study|Lost to Follow-up|1
7966459|NCT02750761|12522396|FG003|Overall Study|Lost to Follow-up|0
7966460|NCT02750761|12522397|FG004|Overall Study|Lost to Follow-up|0
7966461|NCT02750761|12522398|FG005|Overall Study|Lost to Follow-up|0
7966462|NCT02750800|12522422|FG000|Overall Study|Adverse Event|18
7966463|NCT02750800|12522422|FG000|Overall Study|Lost to Follow-up|12
7966464|NCT02750800|12522422|FG000|Overall Study|Investigator decision|53
7966465|NCT02750800|12522422|FG000|Overall Study|Patient request|12
7966466|NCT02750800|12522422|FG000|Overall Study|Other, not specified|3
7966467|NCT02750813|12522440|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
7966468|NCT02750813|12522441|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
7966469|NCT02750813|12522440|FG000|Period 1, First 14 Days of Wear|Reason not given|0
7966470|NCT02750813|12522441|FG001|Period 1, First 14 Days of Wear|Reason not given|1
7966471|NCT02750930|12522448|FG000|Overall Study|Study closed/terminated|8
7966472|NCT02750943|12522454|FG000|Overall Study|Lost to Follow-up|1
7966473|NCT02750943|12522455|FG001|Overall Study|Lost to Follow-up|2
7966474|NCT02750943|12522454|FG000|Overall Study|Withdrawal by Subject|5
7966475|NCT02750943|12522455|FG001|Overall Study|Withdrawal by Subject|7
7966476|NCT02751320|12522461|FG000|Overall Study|Adverse Event|2
7966477|NCT02751320|12522461|FG000|Overall Study|Withdrawal by Subject|1
7966478|NCT02751359|12522486|FG000|Overall Study|Lost to Follow-up|1
7966479|NCT02751424|12522514|FG000|Part 2|Adverse Event|0
7966480|NCT02751424|12522515|FG001|Part 2|Adverse Event|0
7966481|NCT02751424|12522516|FG002|Part 2|Adverse Event|0
7721019|NCT00542425|12145523|FG000|Initial 24 Weeks|Lost to Follow-up|2
7966482|NCT02751424|12522517|FG003|Part 2|Adverse Event|0
7966483|NCT02751424|12522518|FG004|Part 2|Adverse Event|0
7966484|NCT02751424|12522519|FG005|Part 2|Adverse Event|0
7966485|NCT02751424|12522520|FG006|Part 2|Adverse Event|0
7966486|NCT02751424|12522521|FG007|Part 2|Adverse Event|5
7966487|NCT02751424|12522522|FG008|Part 2|Adverse Event|0
7955862|NCT02612610|12504721|FG000|Overall Study|Withdrawal by Subject|1
7955863|NCT02612610|12504722|FG001|Overall Study|Withdrawal by Subject|1
7955864|NCT02612610|12504723|FG002|Overall Study|Withdrawal by Subject|0
7955865|NCT02612610|12504724|FG003|Overall Study|Withdrawal by Subject|2
7955866|NCT02612610|12504721|FG000|Overall Study|Adverse Event|2
7955867|NCT02612610|12504722|FG001|Overall Study|Adverse Event|2
7955868|NCT02612610|12504723|FG002|Overall Study|Adverse Event|3
7955869|NCT02612610|12504724|FG003|Overall Study|Adverse Event|10
7955870|NCT02612610|12504721|FG000|Overall Study|Lost to Follow-up|0
7955871|NCT02612610|12504722|FG001|Overall Study|Lost to Follow-up|1
7955872|NCT02612610|12504723|FG002|Overall Study|Lost to Follow-up|0
7955873|NCT02612610|12504724|FG003|Overall Study|Lost to Follow-up|0
7955874|NCT02612610|12504721|FG000|Overall Study|Protocol Violation|0
7955875|NCT02612610|12504722|FG001|Overall Study|Protocol Violation|1
7955876|NCT02612610|12504723|FG002|Overall Study|Protocol Violation|1
7955877|NCT02612610|12504724|FG003|Overall Study|Protocol Violation|0
7955878|NCT02612610|12504721|FG000|Overall Study|Lack of Efficacy|1
7955879|NCT02612610|12504722|FG001|Overall Study|Lack of Efficacy|2
7955880|NCT02612610|12504723|FG002|Overall Study|Lack of Efficacy|0
7955881|NCT02612610|12504724|FG003|Overall Study|Lack of Efficacy|1
7955882|NCT02612610|12504721|FG000|Overall Study|Physician Decision|0
7955883|NCT02612610|12504722|FG001|Overall Study|Physician Decision|1
7955884|NCT02612610|12504723|FG002|Overall Study|Physician Decision|0
7955885|NCT02612610|12504724|FG003|Overall Study|Physician Decision|0
7955886|NCT02612610|12504721|FG000|Overall Study|Noncompliance|1
7955887|NCT02612610|12504722|FG001|Overall Study|Noncompliance|0
7955888|NCT02612610|12504723|FG002|Overall Study|Noncompliance|0
7955889|NCT02612610|12504724|FG003|Overall Study|Noncompliance|0
7955890|NCT02612610|12504721|FG000|Overall Study|Cough Improvement|0
7955891|NCT02612610|12504722|FG001|Overall Study|Cough Improvement|0
7955892|NCT02612610|12504723|FG002|Overall Study|Cough Improvement|1
7955893|NCT02612610|12504724|FG003|Overall Study|Cough Improvement|0
7955894|NCT02612623|12504738|FG000|Overall Study|Withdrawal by Subject|0
7955895|NCT02612623|12504739|FG001|Overall Study|Withdrawal by Subject|1
7955896|NCT02612623|12504740|FG002|Overall Study|Withdrawal by Subject|0
7955897|NCT02612623|12504741|FG003|Overall Study|Withdrawal by Subject|0
7955898|NCT02612623|12504738|FG000|Overall Study|Adverse Event|1
7955899|NCT02612623|12504739|FG001|Overall Study|Adverse Event|0
7955900|NCT02612623|12504740|FG002|Overall Study|Adverse Event|1
7955901|NCT02612623|12504741|FG003|Overall Study|Adverse Event|0
7955902|NCT02612727|12504764|FG000|Overall Study|Parent request|4
7955903|NCT02612727|12504765|FG001|Overall Study|Parent request|1
7955904|NCT02612727|12504764|FG000|Overall Study|Needed treatment incompatible with PT|1
7955905|NCT02612727|12504765|FG001|Overall Study|Needed treatment incompatible with PT|1
7955906|NCT02612727|12504764|FG000|Overall Study|Direct hyperbilirubinemia|0
7955907|NCT02612727|12504765|FG001|Overall Study|Direct hyperbilirubinemia|2
7955908|NCT02612779|12504773|FG000|Overall Study|Administrative reason by sponsor|4
7955909|NCT02612779|12504774|FG001|Overall Study|Administrative reason by sponsor|1
7955910|NCT02612779|12504773|FG000|Overall Study|No longer meet study criteria|0
7955911|NCT02612779|12504774|FG001|Overall Study|No longer meet study criteria|1
7955912|NCT02612779|12504773|FG000|Overall Study|Disease progression|29
7955913|NCT02612779|12504774|FG001|Overall Study|Disease progression|2
7955914|NCT02612779|12504773|FG000|Overall Study|Study drug toxicity|10
7955915|NCT02612779|12504774|FG001|Overall Study|Study drug toxicity|1
7955916|NCT02612779|12504773|FG000|Overall Study|Death|1
7955917|NCT02612779|12504774|FG001|Overall Study|Death|0
7955918|NCT02612779|12504773|FG000|Overall Study|Adverse event unrelated to study drug|5
7955919|NCT02612779|12504774|FG001|Overall Study|Adverse event unrelated to study drug|0
7955920|NCT02612779|12504773|FG000|Overall Study|Participant withdrew consent|4
7955921|NCT02612779|12504774|FG001|Overall Study|Participant withdrew consent|0
7955922|NCT02612779|12504773|FG000|Overall Study|Lost to Follow-up|1
7955923|NCT02612779|12504774|FG001|Overall Study|Lost to Follow-up|0
7955924|NCT02612779|12504773|FG000|Overall Study|Maximum clinical benefit|10
7955925|NCT02612779|12504774|FG001|Overall Study|Maximum clinical benefit|1
7955926|NCT02612779|12504773|FG000|Overall Study|Other reasons|4
7955927|NCT02612779|12504774|FG001|Overall Study|Other reasons|0
7955928|NCT02612909|12504799|FG000|Phase 2|Withdrawal by Subject|2
7955929|NCT02612909|12504800|FG001|Phase 2|Withdrawal by Subject|5
7955930|NCT02612909|12504801|FG002|Phase 2|Withdrawal by Subject|0
7955931|NCT02612909|12504802|FG003|Phase 2|Withdrawal by Subject|0
7955932|NCT02612909|12504803|FG004|Phase 2|Withdrawal by Subject|0
7955933|NCT02612909|12504799|FG000|Phase 2|Pregnancy|0
7955934|NCT02612909|12504800|FG001|Phase 2|Pregnancy|0
7955935|NCT02612909|12504801|FG002|Phase 2|Pregnancy|1
7955936|NCT02612909|12504802|FG003|Phase 2|Pregnancy|0
7955937|NCT02612909|12504803|FG004|Phase 2|Pregnancy|0
7955938|NCT02612909|12504799|FG000|Phase 3|Withdrawal by Subject|0
7955939|NCT02612909|12504800|FG001|Phase 3|Withdrawal by Subject|0
7955940|NCT02612909|12504801|FG002|Phase 3|Withdrawal by Subject|0
7955941|NCT02612909|12504802|FG003|Phase 3|Withdrawal by Subject|1
7955942|NCT02612909|12504803|FG004|Phase 3|Withdrawal by Subject|0
7955943|NCT02613169|12504828|FG000|Overall Study|Withdrawal by Subject|4
7955944|NCT02613169|12504829|FG001|Overall Study|Withdrawal by Subject|1
7955945|NCT02613169|12504828|FG000|Overall Study|Lost to Follow-up|0
7955946|NCT02613169|12504829|FG001|Overall Study|Lost to Follow-up|5
7955947|NCT02613169|12504828|FG000|Overall Study|HIV|0
7955948|NCT02613169|12504829|FG001|Overall Study|HIV|2
7955949|NCT02613169|12504828|FG000|Overall Study|No TB infection endpoint|14
7955950|NCT02613169|12504829|FG001|Overall Study|No TB infection endpoint|9
7955951|NCT02613182|12504835|FG000|Overall Study|Death|6
7955952|NCT02613182|12504835|FG000|Overall Study|Physician Decision|1
7955953|NCT02613182|12504835|FG000|Overall Study|Study Terminated by Sponsor|21
7955954|NCT02613182|12504835|FG000|Overall Study|Withdrawal by Subject|6
7955955|NCT02613208|12504839|FG000|Overall Study|Withdrawal by Subject|1
7955956|NCT02613208|12504839|FG000|Overall Study|Change of address|2
7955957|NCT02613208|12504839|FG000|Overall Study|Physician Decision|2
7955958|NCT02613208|12504839|FG000|Overall Study|Lost to Follow-up|5
7955959|NCT02613208|12504839|FG000|Overall Study|Death|37
7955960|NCT02613221|12504843|FG000|Overall Study|Lack of efficacy (exacerbation)|50
7955961|NCT02613221|12504843|FG000|Overall Study|Adverse Event|2
7955962|NCT02613221|12504843|FG000|Overall Study|Voluntary Discontinuation|1
7955963|NCT02613221|12504843|FG000|Overall Study|Delayed Treatment|1
7955964|NCT02613221|12504843|FG000|Overall Study|Enrolled but Not Treated|1
7955965|NCT02613364|12504854|FG000|Overall Study|Other|19
7955966|NCT02613364|12504855|FG001|Overall Study|Other|29
7955967|NCT02613364|12504856|FG002|Overall Study|Other|17
7955968|NCT02613364|12504854|FG000|Overall Study|Too time consuming|21
7955969|NCT02613364|12504855|FG001|Overall Study|Too time consuming|26
7955970|NCT02613364|12504856|FG002|Overall Study|Too time consuming|26
7955971|NCT02613364|12504854|FG000|Overall Study|Withdrawal by Subject|13
7955972|NCT02613364|12504855|FG001|Overall Study|Withdrawal by Subject|18
7955973|NCT02613364|12504856|FG002|Overall Study|Withdrawal by Subject|17
7955974|NCT02613364|12504854|FG000|Overall Study|Medical|12
7955975|NCT02613364|12504855|FG001|Overall Study|Medical|13
7955976|NCT02613364|12504856|FG002|Overall Study|Medical|9
7955977|NCT02613364|12504854|FG000|Overall Study|Disliked Study Procedure|1
7955978|NCT02613364|12504855|FG001|Overall Study|Disliked Study Procedure|1
7955979|NCT02613364|12504856|FG002|Overall Study|Disliked Study Procedure|4
7955980|NCT02613364|12504854|FG000|Overall Study|Disliked Intervention|0
7955981|NCT02613364|12504855|FG001|Overall Study|Disliked Intervention|3
7955982|NCT02613364|12504856|FG002|Overall Study|Disliked Intervention|3
7955983|NCT02613403|12504868|FG000|Overall Study|Lost to Follow-up|0
7955984|NCT02613403|12504869|FG001|Overall Study|Lost to Follow-up|1
7955985|NCT02613403|12504870|FG002|Overall Study|Lost to Follow-up|0
7955986|NCT02613403|12504871|FG003|Overall Study|Lost to Follow-up|0
7955987|NCT02613403|12504872|FG004|Overall Study|Lost to Follow-up|0
7955988|NCT02613403|12504868|FG000|Overall Study|Withdrawal by Subject|2
7955989|NCT02613403|12504869|FG001|Overall Study|Withdrawal by Subject|0
7955990|NCT02613403|12504870|FG002|Overall Study|Withdrawal by Subject|0
7955991|NCT02613403|12504871|FG003|Overall Study|Withdrawal by Subject|0
7955992|NCT02613403|12504872|FG004|Overall Study|Withdrawal by Subject|0
7955993|NCT02613481|12504882|FG000|Overall Study|Lost to Follow-up|7
7955994|NCT02613481|12504882|FG000|Overall Study|Withdrawal by Subject|2
7955995|NCT02613572|12504889|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1
7955996|NCT02613572|12504890|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
7955997|NCT02613572|12504891|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
7955998|NCT02613572|12504889|FG000|Phase II: Double-Blind Rand Plac Control|Death|0
7955999|NCT02613572|12504890|FG001|Phase II: Double-Blind Rand Plac Control|Death|1
7956000|NCT02613572|12504891|FG002|Phase II: Double-Blind Rand Plac Control|Death|0
7956001|NCT02613871|12504903|FG000|Overall Study|Death|2
7956002|NCT02613871|12504903|FG000|Overall Study|Withdrew Consent|1
7956003|NCT02613884|12504907|FG000|Overall Study|Death|1
7956004|NCT02613884|12504907|FG000|Overall Study|Lost to Follow-up|1
7956005|NCT02613910|12504926|FG000|Overall Study|Termination of study|1
7956006|NCT02614079|12504930|FG000|Overall Study|Withdrawal by Subject|1
7956007|NCT02614131|12504941|FG000|Overall Study|Withdrawal by Subject|1
7956008|NCT02614131|12504942|FG001|Overall Study|Withdrawal by Subject|0
7956009|NCT02614131|12504943|FG002|Overall Study|Withdrawal by Subject|0
7956010|NCT02614131|12504944|FG003|Overall Study|Withdrawal by Subject|0
7956011|NCT02614131|12504945|FG004|Overall Study|Withdrawal by Subject|0
7956012|NCT02614131|12504946|FG005|Overall Study|Withdrawal by Subject|0
7956013|NCT02614131|12504947|FG006|Overall Study|Withdrawal by Subject|0
7956014|NCT02614131|12504941|FG000|Overall Study|Adverse Event|0
7956015|NCT02614131|12504942|FG001|Overall Study|Adverse Event|0
7956016|NCT02614131|12504943|FG002|Overall Study|Adverse Event|0
7956017|NCT02614131|12504944|FG003|Overall Study|Adverse Event|0
7956018|NCT02614131|12504945|FG004|Overall Study|Adverse Event|0
7956019|NCT02614131|12504946|FG005|Overall Study|Adverse Event|0
7956020|NCT02614131|12504947|FG006|Overall Study|Adverse Event|1
7956021|NCT02614183|12504972|FG000|Double Blind Treatment Phase|Adverse Event|10
7956022|NCT02614183|12504973|FG001|Double Blind Treatment Phase|Adverse Event|9
7956023|NCT02614183|12504974|FG002|Double Blind Treatment Phase|Adverse Event|7
7956024|NCT02614183|12504972|FG000|Double Blind Treatment Phase|Lack of Efficacy|10
7956025|NCT02614183|12504973|FG001|Double Blind Treatment Phase|Lack of Efficacy|1
7956026|NCT02614183|12504974|FG002|Double Blind Treatment Phase|Lack of Efficacy|2
7956027|NCT02614183|12504972|FG000|Double Blind Treatment Phase|Lost to Follow-up|18
7956028|NCT02614183|12504973|FG001|Double Blind Treatment Phase|Lost to Follow-up|9
7956029|NCT02614183|12504974|FG002|Double Blind Treatment Phase|Lost to Follow-up|5
7956030|NCT02614183|12504972|FG000|Double Blind Treatment Phase|Physician Decision|7
7956031|NCT02614183|12504973|FG001|Double Blind Treatment Phase|Physician Decision|3
7956032|NCT02614183|12504974|FG002|Double Blind Treatment Phase|Physician Decision|2
7956033|NCT02614183|12504972|FG000|Double Blind Treatment Phase|Pregnancy|2
7956034|NCT02614183|12504973|FG001|Double Blind Treatment Phase|Pregnancy|1
7956035|NCT02614183|12504974|FG002|Double Blind Treatment Phase|Pregnancy|3
7956036|NCT02614183|12504972|FG000|Double Blind Treatment Phase|Protocol Violation|2
7956037|NCT02614183|12504973|FG001|Double Blind Treatment Phase|Protocol Violation|2
7956038|NCT02614183|12504974|FG002|Double Blind Treatment Phase|Protocol Violation|2
7956039|NCT02614183|12504972|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33
7956040|NCT02614183|12504973|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11
7956041|NCT02614183|12504974|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16
7956042|NCT02614183|12504972|FG000|Double Blind Treatment Phase|Did not receive study drug|1
7956043|NCT02614183|12504973|FG001|Double Blind Treatment Phase|Did not receive study drug|1
7956044|NCT02614183|12504974|FG002|Double Blind Treatment Phase|Did not receive study drug|2
7956045|NCT02614183|12504972|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5
7956046|NCT02614183|12504973|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3
7956047|NCT02614183|12504974|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5
7956048|NCT02614183|12504972|FG000|Post Treatment Follow-up Phase|Physician Decision|5
7956049|NCT02614183|12504973|FG001|Post Treatment Follow-up Phase|Physician Decision|1
7956050|NCT02614183|12504974|FG002|Post Treatment Follow-up Phase|Physician Decision|2
7956051|NCT02614183|12504972|FG000|Post Treatment Follow-up Phase|Protocol Violation|1
7956052|NCT02614183|12504973|FG001|Post Treatment Follow-up Phase|Protocol Violation|0
7956053|NCT02614183|12504974|FG002|Post Treatment Follow-up Phase|Protocol Violation|0
7956054|NCT02614183|12504972|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7
7956055|NCT02614183|12504973|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2
7956056|NCT02614183|12504974|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5
7956057|NCT02614196|12504994|FG000|Double Blind Treatment Phase|Adverse Event|8
7956058|NCT02614196|12504995|FG001|Double Blind Treatment Phase|Adverse Event|5
7956059|NCT02614196|12504996|FG002|Double Blind Treatment Phase|Adverse Event|9
7956060|NCT02614196|12504997|FG003|Double Blind Treatment Phase|Adverse Event|0
7956061|NCT02614196|12504998|FG004|Double Blind Treatment Phase|Adverse Event|0
7956062|NCT02614196|12504999|FG005|Double Blind Treatment Phase|Adverse Event|0
7956063|NCT02614196|12504994|FG000|Double Blind Treatment Phase|Lack of Efficacy|6
7956064|NCT02614196|12504995|FG001|Double Blind Treatment Phase|Lack of Efficacy|1
7956065|NCT02614196|12504996|FG002|Double Blind Treatment Phase|Lack of Efficacy|1
7956066|NCT02614196|12504997|FG003|Double Blind Treatment Phase|Lack of Efficacy|0
7956067|NCT02614196|12504998|FG004|Double Blind Treatment Phase|Lack of Efficacy|0
7956068|NCT02614196|12504999|FG005|Double Blind Treatment Phase|Lack of Efficacy|0
7721020|NCT00542425|12145524|FG001|Initial 24 Weeks|Lost to Follow-up|2
7721021|NCT00542425|12145525|FG002|Initial 24 Weeks|Lost to Follow-up|1
7721022|NCT00542425|12145526|FG003|Initial 24 Weeks|Lost to Follow-up|0
7721023|NCT00542425|12145527|FG004|Initial 24 Weeks|Lost to Follow-up|0
7721024|NCT00542425|12145523|FG000|Initial 24 Weeks|Non-compliance|0
7721025|NCT00542425|12145524|FG001|Initial 24 Weeks|Non-compliance|0
7956069|NCT02614196|12504994|FG000|Double Blind Treatment Phase|Lost to Follow-up|10
7956070|NCT02614196|12504995|FG001|Double Blind Treatment Phase|Lost to Follow-up|7
7956071|NCT02614196|12504996|FG002|Double Blind Treatment Phase|Lost to Follow-up|1
7956072|NCT02614196|12504997|FG003|Double Blind Treatment Phase|Lost to Follow-up|0
7956073|NCT02614196|12504998|FG004|Double Blind Treatment Phase|Lost to Follow-up|0
7956074|NCT02614196|12504999|FG005|Double Blind Treatment Phase|Lost to Follow-up|0
7956075|NCT02614196|12504994|FG000|Double Blind Treatment Phase|Physician Decision|4
7956076|NCT02614196|12504995|FG001|Double Blind Treatment Phase|Physician Decision|0
7956077|NCT02614196|12504996|FG002|Double Blind Treatment Phase|Physician Decision|2
7956078|NCT02614196|12504997|FG003|Double Blind Treatment Phase|Physician Decision|0
7956079|NCT02614196|12504998|FG004|Double Blind Treatment Phase|Physician Decision|0
7956080|NCT02614196|12504999|FG005|Double Blind Treatment Phase|Physician Decision|0
7956081|NCT02614196|12504994|FG000|Double Blind Treatment Phase|Pregnancy|1
7956082|NCT02614196|12504995|FG001|Double Blind Treatment Phase|Pregnancy|2
7956083|NCT02614196|12504996|FG002|Double Blind Treatment Phase|Pregnancy|0
7956084|NCT02614196|12504997|FG003|Double Blind Treatment Phase|Pregnancy|0
7956085|NCT02614196|12504998|FG004|Double Blind Treatment Phase|Pregnancy|0
7956086|NCT02614196|12504999|FG005|Double Blind Treatment Phase|Pregnancy|0
7956087|NCT02614196|12504994|FG000|Double Blind Treatment Phase|Protocol Violation|5
7956088|NCT02614196|12504995|FG001|Double Blind Treatment Phase|Protocol Violation|2
7956089|NCT02614196|12504996|FG002|Double Blind Treatment Phase|Protocol Violation|1
7956090|NCT02614196|12504997|FG003|Double Blind Treatment Phase|Protocol Violation|0
7956091|NCT02614196|12504998|FG004|Double Blind Treatment Phase|Protocol Violation|1
7956092|NCT02614196|12504999|FG005|Double Blind Treatment Phase|Protocol Violation|0
7956093|NCT02614196|12504994|FG000|Double Blind Treatment Phase|Terminated by sponsor|1
7956094|NCT02614196|12504995|FG001|Double Blind Treatment Phase|Terminated by sponsor|0
7956095|NCT02614196|12504996|FG002|Double Blind Treatment Phase|Terminated by sponsor|0
7956096|NCT02614196|12504997|FG003|Double Blind Treatment Phase|Terminated by sponsor|0
7956097|NCT02614196|12504998|FG004|Double Blind Treatment Phase|Terminated by sponsor|0
7956098|NCT02614196|12504999|FG005|Double Blind Treatment Phase|Terminated by sponsor|0
7956099|NCT02614196|12504994|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39
7956100|NCT02614196|12504995|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11
7956101|NCT02614196|12504996|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14
7956102|NCT02614196|12504997|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4
7956103|NCT02614196|12504998|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0
7956104|NCT02614196|12504999|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0
7956105|NCT02614196|12504994|FG000|Double Blind Treatment Phase|Did not receive study drug|2
7956106|NCT02614196|12504995|FG001|Double Blind Treatment Phase|Did not receive study drug|2
7956107|NCT02614196|12504996|FG002|Double Blind Treatment Phase|Did not receive study drug|3
7956108|NCT02614196|12504997|FG003|Double Blind Treatment Phase|Did not receive study drug|0
7956109|NCT02614196|12504998|FG004|Double Blind Treatment Phase|Did not receive study drug|0
7956110|NCT02614196|12504999|FG005|Double Blind Treatment Phase|Did not receive study drug|0
7956111|NCT02614196|12504994|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8
7956112|NCT02614196|12504995|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3
7956113|NCT02614196|12504996|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3
7956114|NCT02614196|12504997|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0
7956115|NCT02614196|12504998|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1
7956116|NCT02614196|12504999|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0
7956117|NCT02614196|12504994|FG000|Post Treatment Follow-up Phase|Pregnancy|2
7956118|NCT02614196|12504995|FG001|Post Treatment Follow-up Phase|Pregnancy|0
7956119|NCT02614196|12504996|FG002|Post Treatment Follow-up Phase|Pregnancy|0
7956120|NCT02614196|12504997|FG003|Post Treatment Follow-up Phase|Pregnancy|0
7956121|NCT02614196|12504998|FG004|Post Treatment Follow-up Phase|Pregnancy|0
7956122|NCT02614196|12504999|FG005|Post Treatment Follow-up Phase|Pregnancy|0
7956123|NCT02614196|12504994|FG000|Post Treatment Follow-up Phase|Protocol Violation|0
7956124|NCT02614196|12504995|FG001|Post Treatment Follow-up Phase|Protocol Violation|1
7956125|NCT02614196|12504996|FG002|Post Treatment Follow-up Phase|Protocol Violation|0
7956126|NCT02614196|12504997|FG003|Post Treatment Follow-up Phase|Protocol Violation|0
7956127|NCT02614196|12504998|FG004|Post Treatment Follow-up Phase|Protocol Violation|1
7956128|NCT02614196|12504999|FG005|Post Treatment Follow-up Phase|Protocol Violation|0
7956129|NCT02614196|12504994|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10
7956130|NCT02614196|12504995|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1
7956131|NCT02614196|12504996|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5
7956132|NCT02614196|12504997|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1
7956133|NCT02614196|12504998|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0
7956134|NCT02614196|12504999|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0
7956135|NCT02614287|12505042|FG000|Open Label (OL) Treatment Phase|Adverse Event|7
7956136|NCT02614287|12505043|FG001|Open Label (OL) Treatment Phase|Adverse Event|6
7956137|NCT02614287|12505042|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13
7956138|NCT02614287|12505043|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5
7956139|NCT02614287|12505042|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7
7956140|NCT02614287|12505043|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4
7956141|NCT02614287|12505042|FG000|Open Label (OL) Treatment Phase|Physician Decision|1
7956142|NCT02614287|12505043|FG001|Open Label (OL) Treatment Phase|Physician Decision|0
7956143|NCT02614287|12505042|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10
7956144|NCT02614287|12505043|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7
7956145|NCT02614287|12505042|FG000|Post Treatment Follow-up Phase|Adverse Event|1
7956146|NCT02614287|12505043|FG001|Post Treatment Follow-up Phase|Adverse Event|0
7956147|NCT02614287|12505042|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2
7956148|NCT02614287|12505043|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2
7956149|NCT02614287|12505042|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6
7956150|NCT02614287|12505043|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3
7956151|NCT02614560|12505065|FG000|Overall Study|Death|6
7956152|NCT02614560|12505066|FG001|Overall Study|Death|2
7956153|NCT02614703|12505074|FG000|Overall Study|Withdrawal by Subject|7
7956154|NCT02614703|12505075|FG001|Overall Study|Withdrawal by Subject|1
7956155|NCT02614729|12505083|FG000|Overall Study|Withdrawal by Subject|1
7956156|NCT02614729|12505084|FG001|Overall Study|Withdrawal by Subject|0
7956157|NCT02615145|12505105|FG000|Overall Study|Did Not Start Treatment|0
7956158|NCT02615145|12505106|FG001|Overall Study|Did Not Start Treatment|0
7956159|NCT02615145|12505107|FG002|Overall Study|Did Not Start Treatment|1
7956160|NCT02615145|12505108|FG003|Overall Study|Did Not Start Treatment|1
7956161|NCT02615145|12505105|FG000|Overall Study|Failure to Return|20
7956162|NCT02615145|12505106|FG001|Overall Study|Failure to Return|10
7956163|NCT02615145|12505107|FG002|Overall Study|Failure to Return|7
7956164|NCT02615145|12505108|FG003|Overall Study|Failure to Return|0
7956165|NCT02615145|12505105|FG000|Overall Study|Death|2
7956166|NCT02615145|12505106|FG001|Overall Study|Death|3
7956167|NCT02615145|12505107|FG002|Overall Study|Death|0
7956168|NCT02615145|12505108|FG003|Overall Study|Death|0
7956169|NCT02615145|12505105|FG000|Overall Study|Other, Not Specified|5
7956170|NCT02615145|12505106|FG001|Overall Study|Other, Not Specified|2
7956171|NCT02615145|12505107|FG002|Overall Study|Other, Not Specified|0
7956172|NCT02615145|12505108|FG003|Overall Study|Other, Not Specified|0
7956173|NCT02615171|12505149|FG000|Overall Study|Lost to Follow-up|2
7956174|NCT02615171|12505150|FG001|Overall Study|Lost to Follow-up|1
7956175|NCT02615249|12505156|FG000|Overall Study|Withdrawal by Subject|1
7956176|NCT02615470|12505163|FG000|Overall Study|Lost to Follow-up|21
7956177|NCT02615470|12505164|FG001|Overall Study|Lost to Follow-up|32
7956178|NCT02615509|12505170|FG000|Overall Study|Lost to Follow-up|134
7956179|NCT02615509|12505170|FG000|Overall Study|Death|4
7956180|NCT02615509|12505170|FG000|Overall Study|Withdrawal by Subject|8
7956181|NCT02616029|12505203|FG000|Overall Study|Adverse Event|1
7956182|NCT02616029|12505204|FG001|Overall Study|Adverse Event|0
7956183|NCT02616029|12505203|FG000|Overall Study|Death|0
7956184|NCT02616029|12505204|FG001|Overall Study|Death|1
7956185|NCT02616029|12505203|FG000|Overall Study|Protocol Violation|1
7956186|NCT02616029|12505204|FG001|Overall Study|Protocol Violation|0
7956187|NCT02616029|12505203|FG000|Overall Study|Withdrew Consent|1
7956188|NCT02616029|12505204|FG001|Overall Study|Withdrew Consent|0
7956189|NCT02616029|12505203|FG000|Overall Study|Enrolled and Never Treated|1
7956190|NCT02616029|12505204|FG001|Overall Study|Enrolled and Never Treated|1
7956191|NCT02616380|12505219|FG000|Overall Study|Lost to Follow-up|1
7956192|NCT02616380|12505219|FG000|Overall Study|Other|2
7956193|NCT02616601|12505242|FG000|Overall Study|Withdrawal by Subject|4
7956194|NCT02616601|12505243|FG001|Overall Study|Withdrawal by Subject|4
7956195|NCT02616601|12505244|FG002|Overall Study|Withdrawal by Subject|3
7956196|NCT02616601|12505242|FG000|Overall Study|Adverse Event|2
7956197|NCT02616601|12505243|FG001|Overall Study|Adverse Event|0
7956198|NCT02616601|12505244|FG002|Overall Study|Adverse Event|2
7956199|NCT02616601|12505242|FG000|Overall Study|Death|1
7956200|NCT02616601|12505243|FG001|Overall Study|Death|0
7956201|NCT02616601|12505244|FG002|Overall Study|Death|0
7956202|NCT02616601|12505242|FG000|Overall Study|Lost to Follow-up|1
7956203|NCT02616601|12505243|FG001|Overall Study|Lost to Follow-up|0
7956204|NCT02616601|12505244|FG002|Overall Study|Lost to Follow-up|1
7956205|NCT02616601|12505242|FG000|Overall Study|Non-Compliance with Test Article|1
7956206|NCT02616601|12505243|FG001|Overall Study|Non-Compliance with Test Article|0
7956207|NCT02616601|12505244|FG002|Overall Study|Non-Compliance with Test Article|1
7956208|NCT02616614|12505255|FG000|Overall Study|Withdrawal by Subject|10
7956209|NCT02616614|12505256|FG001|Overall Study|Withdrawal by Subject|5
7956210|NCT02616614|12505257|FG002|Overall Study|Withdrawal by Subject|6
7956211|NCT02616614|12505255|FG000|Overall Study|Physician Decision|2
7956212|NCT02616614|12505256|FG001|Overall Study|Physician Decision|1
7956213|NCT02616614|12505257|FG002|Overall Study|Physician Decision|0
7956214|NCT02616614|12505255|FG000|Overall Study|Adverse Event|1
7956215|NCT02616614|12505256|FG001|Overall Study|Adverse Event|4
7956216|NCT02616614|12505257|FG002|Overall Study|Adverse Event|1
7956217|NCT02616614|12505255|FG000|Overall Study|Protocol Violation|0
7956218|NCT02616614|12505256|FG001|Overall Study|Protocol Violation|3
7956219|NCT02616614|12505257|FG002|Overall Study|Protocol Violation|1
7956220|NCT02616614|12505255|FG000|Overall Study|Prohibited Medication|12
7956221|NCT02616614|12505256|FG001|Overall Study|Prohibited Medication|9
7956222|NCT02616614|12505257|FG002|Overall Study|Prohibited Medication|5
7956223|NCT02616614|12505255|FG000|Overall Study|More than 3 applications missed|6
7956224|NCT02616614|12505256|FG001|Overall Study|More than 3 applications missed|8
7956225|NCT02616614|12505257|FG002|Overall Study|More than 3 applications missed|1
7956226|NCT02616614|12505255|FG000|Overall Study|Lost to Follow-up|31
7956227|NCT02616614|12505256|FG001|Overall Study|Lost to Follow-up|28
7956228|NCT02616614|12505257|FG002|Overall Study|Lost to Follow-up|13
7956229|NCT02616614|12505255|FG000|Overall Study|Pregnancy|2
7956230|NCT02616614|12505256|FG001|Overall Study|Pregnancy|0
7956231|NCT02616614|12505257|FG002|Overall Study|Pregnancy|1
7956232|NCT02616614|12505255|FG000|Overall Study|Other|1
7956233|NCT02616614|12505256|FG001|Overall Study|Other|2
7956234|NCT02616614|12505257|FG002|Overall Study|Other|1
7956235|NCT02616783|12505268|FG000|Overall Study|Randomized but Not Treated|1
7956236|NCT02616783|12505269|FG001|Overall Study|Randomized but Not Treated|0
7956237|NCT02616783|12505268|FG000|Overall Study|Adverse Event|1
7956238|NCT02616783|12505269|FG001|Overall Study|Adverse Event|0
7956239|NCT02616783|12505268|FG000|Overall Study|Death|1
7956240|NCT02616783|12505269|FG001|Overall Study|Death|0
7956241|NCT02616783|12505268|FG000|Overall Study|Non-Compliance with Study Drug|1
7956242|NCT02616783|12505269|FG001|Overall Study|Non-Compliance with Study Drug|0
7956243|NCT02616783|12505268|FG000|Overall Study|Protocol Violation|1
7956244|NCT02616783|12505269|FG001|Overall Study|Protocol Violation|1
7956245|NCT02616783|12505268|FG000|Overall Study|Withdrew Consent|1
7956246|NCT02616783|12505269|FG001|Overall Study|Withdrew Consent|1
7956247|NCT02616900|12505275|FG000|Overall Study|Lack of Efficacy|7
7956248|NCT02616900|12505275|FG000|Overall Study|Lost to Follow-up|2
7956249|NCT02616900|12505275|FG000|Overall Study|Protocol Violation|5
7956250|NCT02616900|12505275|FG000|Overall Study|Withdrawal by Subject|3
7956251|NCT02616900|12505275|FG000|Overall Study|Incomplete data|6
7956252|NCT02617628|12505281|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62
7956253|NCT02617628|12505282|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61
7956254|NCT02618382|12505370|FG000|Overall Study|Physician Decision|1
7956255|NCT02618382|12505370|FG000|Overall Study|Withdrawal by Subject|1
7956256|NCT02618382|12505370|FG000|Overall Study|Protocol Violation|1
7956257|NCT02618616|12505380|FG000|Overall Study|Lack of Efficacy|4
7956258|NCT02618616|12505381|FG001|Overall Study|Lack of Efficacy|0
7956259|NCT02618616|12505380|FG000|Overall Study|Pregnancy|0
7956260|NCT02618616|12505381|FG001|Overall Study|Pregnancy|1
7956261|NCT02618616|12505380|FG000|Overall Study|Adverse Event|8
7956262|NCT02618616|12505381|FG001|Overall Study|Adverse Event|0
7956263|NCT02618616|12505380|FG000|Overall Study|Failure to comply with dosing/evaluation|1
7956264|NCT02618616|12505381|FG001|Overall Study|Failure to comply with dosing/evaluation|0
7956265|NCT02618616|12505380|FG000|Overall Study|Consent withdrawn by subject|8
7956266|NCT02618616|12505381|FG001|Overall Study|Consent withdrawn by subject|5
7956267|NCT02618616|12505380|FG000|Overall Study|Lost to Follow-up|0
7956268|NCT02618616|12505381|FG001|Overall Study|Lost to Follow-up|1
7956269|NCT02618759|12505414|FG000|Overall Study|Lost to Follow-up|0
7956270|NCT02618759|12505415|FG001|Overall Study|Lost to Follow-up|1
7956271|NCT02618759|12505414|FG000|Overall Study|Withdrawal by Subject|1
7956272|NCT02618759|12505415|FG001|Overall Study|Withdrawal by Subject|0
7956273|NCT02618759|12505414|FG000|Overall Study|Other Reasons|1
7956274|NCT02618759|12505415|FG001|Overall Study|Other Reasons|4
7956275|NCT02618928|12505441|FG000|Overall Study|Failure to Return|28
7956276|NCT02618928|12505441|FG000|Overall Study|Insufficient Virological Response|1
7956277|NCT02618928|12505441|FG000|Overall Study|Withdrawal by Subject|2
7956278|NCT02618928|12505441|FG000|Overall Study|Death|3
7956279|NCT02618928|12505441|FG000|Overall Study|Other|11
7956280|NCT02618928|12505441|FG000|Overall Study|Missing|6
7956281|NCT02618928|12505441|FG000|Overall Study|Treatment Never Started|7
7956282|NCT02618967|12505456|FG000|Overall Study|Lost to Follow-up|0
7956283|NCT02618967|12505457|FG001|Overall Study|Lost to Follow-up|0
7956284|NCT02618967|12505458|FG002|Overall Study|Lost to Follow-up|1
7956285|NCT02618967|12505459|FG003|Overall Study|Lost to Follow-up|0
7956286|NCT02618967|12505460|FG004|Overall Study|Lost to Follow-up|2
7956287|NCT02618967|12505461|FG005|Overall Study|Lost to Follow-up|0
7956288|NCT02618967|12505462|FG006|Overall Study|Lost to Follow-up|0
7956289|NCT02618967|12505463|FG007|Overall Study|Lost to Follow-up|0
7956290|NCT02618967|12505456|FG000|Overall Study|Withdrawal by Subject|1
7956291|NCT02618967|12505457|FG001|Overall Study|Withdrawal by Subject|0
7956292|NCT02618967|12505458|FG002|Overall Study|Withdrawal by Subject|0
7956293|NCT02618967|12505459|FG003|Overall Study|Withdrawal by Subject|0
7956294|NCT02618967|12505460|FG004|Overall Study|Withdrawal by Subject|0
7956295|NCT02618967|12505461|FG005|Overall Study|Withdrawal by Subject|0
7956296|NCT02618967|12505462|FG006|Overall Study|Withdrawal by Subject|0
7956297|NCT02618967|12505463|FG007|Overall Study|Withdrawal by Subject|0
7956298|NCT02619175|12505483|FG000|Overall Study|Withdrawal by Subject|1
7956299|NCT02619175|12505484|FG001|Overall Study|Withdrawal by Subject|0
7956300|NCT02619175|12505483|FG000|Overall Study|foot pain|1
7956301|NCT02619175|12505484|FG001|Overall Study|foot pain|0
7956302|NCT02619617|12505542|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0
7956303|NCT02619617|12505543|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1
7956304|NCT02619617|12505542|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0
7956305|NCT02619617|12505543|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3
7956306|NCT02620020|12505564|FG000|Overall Study|Adverse Event|8
7956307|NCT02620020|12505565|FG001|Overall Study|Adverse Event|4
7956308|NCT02620020|12505566|FG002|Overall Study|Adverse Event|3
7956309|NCT02620020|12505567|FG003|Overall Study|Adverse Event|5
7956310|NCT02620020|12505564|FG000|Overall Study|Lost to Follow-up|4
7956311|NCT02620020|12505565|FG001|Overall Study|Lost to Follow-up|8
7956312|NCT02620020|12505566|FG002|Overall Study|Lost to Follow-up|1
7956313|NCT02620020|12505567|FG003|Overall Study|Lost to Follow-up|4
7956314|NCT02620020|12505564|FG000|Overall Study|Physician Decision|7
7956315|NCT02620020|12505565|FG001|Overall Study|Physician Decision|4
7956316|NCT02620020|12505566|FG002|Overall Study|Physician Decision|3
7956317|NCT02620020|12505567|FG003|Overall Study|Physician Decision|4
7956318|NCT02620020|12505564|FG000|Overall Study|Protocol Violation|5
7956319|NCT02620020|12505565|FG001|Overall Study|Protocol Violation|2
7956320|NCT02620020|12505566|FG002|Overall Study|Protocol Violation|1
7956321|NCT02620020|12505567|FG003|Overall Study|Protocol Violation|1
7956322|NCT02620020|12505564|FG000|Overall Study|Withdrawal by Subject|20
7956323|NCT02620020|12505565|FG001|Overall Study|Withdrawal by Subject|16
7956324|NCT02620020|12505566|FG002|Overall Study|Withdrawal by Subject|17
7956325|NCT02620020|12505567|FG003|Overall Study|Withdrawal by Subject|12
7956326|NCT02620020|12505564|FG000|Overall Study|Death|0
7956327|NCT02620020|12505565|FG001|Overall Study|Death|1
7956328|NCT02620020|12505566|FG002|Overall Study|Death|0
7956329|NCT02620020|12505567|FG003|Overall Study|Death|0
7956330|NCT02620384|12505579|FG000|Overall Study|Adverse Event|2
7956331|NCT02620384|12505580|FG001|Overall Study|Adverse Event|1
7956332|NCT02620384|12505579|FG000|Overall Study|Discharged prior to 2nd dose|2
7956333|NCT02620384|12505580|FG001|Overall Study|Discharged prior to 2nd dose|5
7956334|NCT02620384|12505579|FG000|Overall Study|Drug shortage prevented 2nd dose|0
7956335|NCT02620384|12505580|FG001|Overall Study|Drug shortage prevented 2nd dose|1
7956336|NCT02620787|12505603|FG000|Overall Study|Adverse Event|1
7956337|NCT02620787|12505604|FG001|Overall Study|Adverse Event|0
7956338|NCT02620787|12505603|FG000|Overall Study|Eligibility Criteria Not Met|1
7956339|NCT02620787|12505604|FG001|Overall Study|Eligibility Criteria Not Met|0
7956340|NCT02621034|12505635|FG000|Overall Study|Lost to Follow-up|3
7956341|NCT02621034|12505636|FG001|Overall Study|Lost to Follow-up|2
7956342|NCT02621034|12505637|FG002|Overall Study|Lost to Follow-up|5
7956343|NCT02621047|12505650|FG000|Overall Study|Adverse Event|0
7956344|NCT02621047|12505651|FG001|Overall Study|Adverse Event|0
7956345|NCT02621047|12505652|FG002|Overall Study|Adverse Event|1
7956346|NCT02621073|12505672|FG000|Overall Study|Lost to Follow-up|0
7956347|NCT02621073|12505673|FG001|Overall Study|Lost to Follow-up|1
7956348|NCT02621073|12505672|FG000|Overall Study|Physician Decision|3
7956349|NCT02621073|12505673|FG001|Overall Study|Physician Decision|2
7956350|NCT02621931|12505704|FG000|Overall Study|Death|0
7956351|NCT02621931|12505705|FG001|Overall Study|Death|1
7956352|NCT02621931|12505706|FG002|Overall Study|Death|0
7956353|NCT02621931|12505704|FG000|Overall Study|Adverse Event|8
7956354|NCT02621931|12505705|FG001|Overall Study|Adverse Event|5
7956355|NCT02621931|12505706|FG002|Overall Study|Adverse Event|7
7956356|NCT02621931|12505704|FG000|Overall Study|Withdrawal by Subject|12
7956357|NCT02621931|12505705|FG001|Overall Study|Withdrawal by Subject|10
7956358|NCT02621931|12505706|FG002|Overall Study|Withdrawal by Subject|11
7956359|NCT02621931|12505704|FG000|Overall Study|Protocol Violation|2
7956360|NCT02621931|12505705|FG001|Overall Study|Protocol Violation|2
7956361|NCT02621931|12505706|FG002|Overall Study|Protocol Violation|2
7956362|NCT02621931|12505704|FG000|Overall Study|Pregnancy|2
7956363|NCT02621931|12505705|FG001|Overall Study|Pregnancy|0
7956364|NCT02621931|12505706|FG002|Overall Study|Pregnancy|0
7956365|NCT02621931|12505704|FG000|Overall Study|Noncompliance to study procedures|0
7956366|NCT02621931|12505705|FG001|Overall Study|Noncompliance to study procedures|1
7956367|NCT02621931|12505706|FG002|Overall Study|Noncompliance to study procedures|2
7956368|NCT02621931|12505704|FG000|Overall Study|Lost to Follow-up|8
7956369|NCT02621931|12505705|FG001|Overall Study|Lost to Follow-up|7
7956370|NCT02621931|12505706|FG002|Overall Study|Lost to Follow-up|10
7956371|NCT02621931|12505704|FG000|Overall Study|Lack of Efficacy|0
7956372|NCT02621931|12505705|FG001|Overall Study|Lack of Efficacy|0
7956373|NCT02621931|12505706|FG002|Overall Study|Lack of Efficacy|1
7956374|NCT02621931|12505704|FG000|Overall Study|Other|1
7956375|NCT02621931|12505705|FG001|Overall Study|Other|1
7956376|NCT02621931|12505706|FG002|Overall Study|Other|3
7956377|NCT02622074|12505731|FG000|Overall Study|Death|4
7956378|NCT02622074|12505732|FG001|Overall Study|Death|0
7956379|NCT02622074|12505733|FG002|Overall Study|Death|0
7956380|NCT02622074|12505734|FG003|Overall Study|Death|1
7956381|NCT02622074|12505735|FG004|Overall Study|Death|1
7956382|NCT02622074|12505736|FG005|Overall Study|Death|0
7956383|NCT02622074|12505731|FG000|Overall Study|Withdrawal by Subject|0
7956384|NCT02622074|12505732|FG001|Overall Study|Withdrawal by Subject|1
7956385|NCT02622074|12505733|FG002|Overall Study|Withdrawal by Subject|0
7956386|NCT02622074|12505734|FG003|Overall Study|Withdrawal by Subject|0
7956387|NCT02622074|12505735|FG004|Overall Study|Withdrawal by Subject|0
7956388|NCT02622074|12505736|FG005|Overall Study|Withdrawal by Subject|0
7956389|NCT02622113|12505752|FG000|Overall Study|Adverse Event|4
7956390|NCT02622113|12505753|FG001|Overall Study|Adverse Event|4
7956391|NCT02622113|12505752|FG000|Overall Study|Physician Decision|0
7956392|NCT02622113|12505753|FG001|Overall Study|Physician Decision|1
7956393|NCT02622113|12505752|FG000|Overall Study|Withdrawal by Subject|0
7956394|NCT02622113|12505753|FG001|Overall Study|Withdrawal by Subject|2
7956395|NCT02622113|12505752|FG000|Overall Study|Stopping Criteria|1
7956396|NCT02622113|12505753|FG001|Overall Study|Stopping Criteria|3
7956397|NCT02622321|12505787|FG000|Overall Study|Withdrawal by Subject|2
7956398|NCT02622321|12505788|FG001|Overall Study|Withdrawal by Subject|0
7956399|NCT02622321|12505789|FG002|Overall Study|Withdrawal by Subject|0
7956400|NCT02622321|12505790|FG003|Overall Study|Withdrawal by Subject|0
7956401|NCT02622321|12505787|FG000|Overall Study|Death|0
7956402|NCT02622321|12505788|FG001|Overall Study|Death|0
7956403|NCT02622321|12505789|FG002|Overall Study|Death|1
7956404|NCT02622321|12505790|FG003|Overall Study|Death|0
7956405|NCT02622321|12505787|FG000|Overall Study|Physician Decision|1
7956406|NCT02622321|12505788|FG001|Overall Study|Physician Decision|0
7956407|NCT02622321|12505789|FG002|Overall Study|Physician Decision|0
7956408|NCT02622321|12505790|FG003|Overall Study|Physician Decision|0
7956409|NCT02622568|12505816|FG000|Overall Study|Lost to Follow-up|5
7956410|NCT02622568|12505817|FG001|Overall Study|Lost to Follow-up|5
7956411|NCT02622724|12505825|FG000|Overall Study|Death|51
7956412|NCT02622724|12505826|FG001|Overall Study|Death|53
7956413|NCT02622724|12505825|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4
7956414|NCT02622724|12505826|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7
7956415|NCT02622724|12505825|FG000|Overall Study|Early termination of study|38
7956416|NCT02622724|12505826|FG001|Overall Study|Early termination of study|43
7956417|NCT02623218|12505843|FG000|Overall Study|Lost to Follow-up|0
7956418|NCT02623218|12505844|FG001|Overall Study|Lost to Follow-up|1
7956419|NCT02623218|12505845|FG002|Overall Study|Lost to Follow-up|0
7956420|NCT02623218|12505846|FG003|Overall Study|Lost to Follow-up|0
7956421|NCT02623218|12505847|FG004|Overall Study|Lost to Follow-up|0
7956422|NCT02623322|12505862|FG000|Overall Study|Lost to Follow-up|2
7956423|NCT02623322|12505863|FG001|Overall Study|Lost to Follow-up|1
7956424|NCT02623322|12505864|FG002|Overall Study|Lost to Follow-up|0
7956425|NCT02623335|12505876|FG000|Overall Study|Death|8
7956426|NCT02623335|12505877|FG001|Overall Study|Death|7
7956427|NCT02623335|12505876|FG000|Overall Study|Lost to Follow-up|15
7956428|NCT02623335|12505877|FG001|Overall Study|Lost to Follow-up|23
7956429|NCT02623335|12505876|FG000|Overall Study|Withdrawal by Subject|2
7956430|NCT02623335|12505877|FG001|Overall Study|Withdrawal by Subject|5
7956431|NCT02623335|12505876|FG000|Overall Study|Protocol Violation|2
7956432|NCT02623335|12505877|FG001|Overall Study|Protocol Violation|1
7966488|NCT02751450|12522547|FG000|Overall Study|Adverse Event|1
7966489|NCT02751450|12522548|FG001|Overall Study|Adverse Event|0
7966490|NCT02751580|12522556|FG000|Overall Study|Lost to Follow-up|4
7966491|NCT02751580|12522556|FG000|Overall Study|Death|2
7966492|NCT02751827|12522563|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0
7966493|NCT02751827|12522564|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0
7966494|NCT02751827|12522565|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1
7966495|NCT02751931|12522587|FG000|Overall Study|Adverse Event|3
7966496|NCT02751931|12522588|FG001|Overall Study|Adverse Event|0
7966497|NCT02751931|12522587|FG000|Overall Study|Other: Miscelleneous|10
7966498|NCT02751931|12522588|FG001|Overall Study|Other: Miscelleneous|8
7966499|NCT02751983|12522602|FG000|Treatment|Stopped ACT, but Remained in study|2
7966500|NCT02751983|12522603|FG001|Treatment|Stopped ACT, but Remained in study|0
7966501|NCT02751983|12522602|FG000|Treatment|Discharged prior to beginning ACT|2
7966502|NCT02751983|12522603|FG001|Treatment|Discharged prior to beginning ACT|0
7966503|NCT02751983|12522602|FG000|Post-Treatment Assessment|Lost to Follow-up|5
7966504|NCT02751983|12522603|FG001|Post-Treatment Assessment|Lost to Follow-up|0
7966505|NCT02751983|12522602|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14
7966506|NCT02751983|12522603|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12
7966507|NCT02751983|12522602|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12
7966508|NCT02751983|12522603|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16
7966509|NCT02752048|12522612|FG000|Overall Study|Withdrawal by Subject|0
7966510|NCT02752048|12522613|FG001|Overall Study|Withdrawal by Subject|0
7966511|NCT02752048|12522614|FG002|Overall Study|Withdrawal by Subject|3
7966512|NCT02752074|12522624|FG000|Overall Study|Lost to Follow-up|1
7966513|NCT02752074|12522625|FG001|Overall Study|Lost to Follow-up|4
7966514|NCT02752074|12522624|FG000|Overall Study|Death|146
7966515|NCT02752074|12522625|FG001|Overall Study|Death|129
7966516|NCT02752074|12522624|FG000|Overall Study|Withdrawal by Subject|9
7966517|NCT02752074|12522625|FG001|Overall Study|Withdrawal by Subject|10
7966518|NCT02752087|12522631|FG000|Washout|Physician Decision|1
7966519|NCT02752087|12522632|FG001|Washout|Physician Decision|0
7966520|NCT02752633|12522656|FG000|Overall Study|Withdrawal by Subject|1
7966521|NCT02752776|12522663|FG000|Overall Study|Adverse Event|15
7966522|NCT02752776|12522664|FG001|Overall Study|Adverse Event|23
7966523|NCT02752776|12522665|FG002|Overall Study|Adverse Event|11
7966524|NCT02752776|12522663|FG000|Overall Study|Lack of Efficacy|2
7966525|NCT02752776|12522664|FG001|Overall Study|Lack of Efficacy|6
7956433|NCT02623361|12505894|FG000|Overall Study|Protocol Violation|0
7956434|NCT02623361|12505895|FG001|Overall Study|Protocol Violation|1
7956435|NCT02623361|12505894|FG000|Overall Study|Withdrawal by Subject|0
7956436|NCT02623361|12505895|FG001|Overall Study|Withdrawal by Subject|1
7956437|NCT02623829|12505912|FG000|Overall Study|Lost to Follow-up|1
7956438|NCT02623829|12505913|FG001|Overall Study|Lost to Follow-up|1
7956439|NCT02624050|12505930|FG000|Overall Study|Physician Decision|4
7956440|NCT02624050|12505931|FG001|Overall Study|Physician Decision|0
7956441|NCT02624050|12505930|FG000|Overall Study|Protocol Violation|2
7956442|NCT02624050|12505931|FG001|Overall Study|Protocol Violation|0
7956443|NCT02624284|12505949|FG000|Overall Study|Withdrawal by Subject|3
7956444|NCT02624284|12505950|FG001|Overall Study|Withdrawal by Subject|6
7956445|NCT02624284|12505951|FG002|Overall Study|Withdrawal by Subject|3
7956446|NCT02624284|12505949|FG000|Overall Study|Protocol Violation|9
7956447|NCT02624284|12505950|FG001|Overall Study|Protocol Violation|10
7956448|NCT02624284|12505951|FG002|Overall Study|Protocol Violation|7
7956449|NCT02624284|12505949|FG000|Overall Study|Revealed exclusionary condition|2
7956450|NCT02624284|12505950|FG001|Overall Study|Revealed exclusionary condition|2
7956451|NCT02624284|12505951|FG002|Overall Study|Revealed exclusionary condition|0
7956452|NCT02624284|12505949|FG000|Overall Study|Adverse Event|0
7956453|NCT02624284|12505950|FG001|Overall Study|Adverse Event|0
7956454|NCT02624284|12505951|FG002|Overall Study|Adverse Event|1
7956455|NCT02624492|12505966|FG000|Overall Study|Adverse Event|2
7956456|NCT02624492|12505967|FG001|Overall Study|Adverse Event|2
7956457|NCT02624492|12505968|FG002|Overall Study|Adverse Event|2
7956458|NCT02624492|12505966|FG000|Overall Study|Progressive disease|0
7956459|NCT02624492|12505967|FG001|Overall Study|Progressive disease|2
7956460|NCT02624492|12505968|FG002|Overall Study|Progressive disease|3
7956461|NCT02624687|12505978|FG000|Overall Study|Withdrawal by Subject|1
7956462|NCT02624687|12505979|FG001|Overall Study|Withdrawal by Subject|1
7956463|NCT02624687|12505978|FG000|Overall Study|medical leave from work|0
7956464|NCT02624687|12505979|FG001|Overall Study|medical leave from work|1
7956465|NCT02624713|12505998|FG000|Overall Study|Lost to Follow-up|14
7956466|NCT02624713|12505999|FG001|Overall Study|Lost to Follow-up|0
7956467|NCT02624791|12506006|FG000|Overall Study|Withdrawal by Subject|2
7956468|NCT02624791|12506007|FG001|Overall Study|Withdrawal by Subject|0
7956469|NCT02624791|12506008|FG002|Overall Study|Withdrawal by Subject|0
7956470|NCT02624791|12506009|FG003|Overall Study|Withdrawal by Subject|0
7956471|NCT02624791|12506010|FG004|Overall Study|Withdrawal by Subject|0
7956472|NCT02624791|12506011|FG005|Overall Study|Withdrawal by Subject|0
7956473|NCT02624986|12506036|FG000|Overall Study|Death|0
7956474|NCT02624986|12506037|FG001|Overall Study|Death|1
7956475|NCT02624986|12506038|FG002|Overall Study|Death|2
7956476|NCT02624986|12506039|FG003|Overall Study|Death|2
7956477|NCT02624986|12506040|FG004|Overall Study|Death|2
7956478|NCT02624986|12506041|FG005|Overall Study|Death|0
7956479|NCT02624986|12506042|FG006|Overall Study|Death|0
7956480|NCT02624986|12506043|FG007|Overall Study|Death|1
7956481|NCT02624986|12506036|FG000|Overall Study|Study Terminated by Sponsor|1
7956482|NCT02624986|12506037|FG001|Overall Study|Study Terminated by Sponsor|1
7956483|NCT02624986|12506038|FG002|Overall Study|Study Terminated by Sponsor|0
7956484|NCT02624986|12506039|FG003|Overall Study|Study Terminated by Sponsor|1
7956485|NCT02624986|12506040|FG004|Overall Study|Study Terminated by Sponsor|2
7956486|NCT02624986|12506041|FG005|Overall Study|Study Terminated by Sponsor|2
7956487|NCT02624986|12506042|FG006|Overall Study|Study Terminated by Sponsor|4
7956488|NCT02624986|12506043|FG007|Overall Study|Study Terminated by Sponsor|3
7956489|NCT02624986|12506036|FG000|Overall Study|Progressive Disease|0
7956490|NCT02624986|12506037|FG001|Overall Study|Progressive Disease|1
7956491|NCT02624986|12506038|FG002|Overall Study|Progressive Disease|0
7956492|NCT02624986|12506039|FG003|Overall Study|Progressive Disease|0
7956493|NCT02624986|12506040|FG004|Overall Study|Progressive Disease|0
7956494|NCT02624986|12506041|FG005|Overall Study|Progressive Disease|0
7956495|NCT02624986|12506042|FG006|Overall Study|Progressive Disease|0
7956496|NCT02624986|12506043|FG007|Overall Study|Progressive Disease|0
7956497|NCT02624986|12506036|FG000|Overall Study|Protocol Violation|1
7956498|NCT02624986|12506037|FG001|Overall Study|Protocol Violation|0
7956499|NCT02624986|12506038|FG002|Overall Study|Protocol Violation|0
7956500|NCT02624986|12506039|FG003|Overall Study|Protocol Violation|0
7956501|NCT02624986|12506040|FG004|Overall Study|Protocol Violation|0
7956502|NCT02624986|12506041|FG005|Overall Study|Protocol Violation|0
7956503|NCT02624986|12506042|FG006|Overall Study|Protocol Violation|0
7956504|NCT02624986|12506043|FG007|Overall Study|Protocol Violation|0
7956505|NCT02624986|12506036|FG000|Overall Study|Withdrawal by Subject|0
7956506|NCT02624986|12506037|FG001|Overall Study|Withdrawal by Subject|0
7956507|NCT02624986|12506038|FG002|Overall Study|Withdrawal by Subject|0
7956508|NCT02624986|12506039|FG003|Overall Study|Withdrawal by Subject|0
7956509|NCT02624986|12506040|FG004|Overall Study|Withdrawal by Subject|0
7956510|NCT02624986|12506041|FG005|Overall Study|Withdrawal by Subject|0
7956511|NCT02624986|12506042|FG006|Overall Study|Withdrawal by Subject|0
7956512|NCT02624986|12506043|FG007|Overall Study|Withdrawal by Subject|1
7956513|NCT02625220|12506099|FG000|Overall Study|Adverse Event|2
7956514|NCT02625220|12506099|FG000|Overall Study|Lost to Follow-up|2
7956515|NCT02625220|12506099|FG000|Overall Study|Protocol Violation|1
7956516|NCT02625220|12506099|FG000|Overall Study|Study discontinued at site|2
7956517|NCT02625233|12506105|FG000|Overall Study|Adverse Event|2
7956518|NCT02625233|12506106|FG001|Overall Study|Adverse Event|0
7956519|NCT02625259|12506117|FG000|First Intervention (Day 1)|Other|0
7956520|NCT02625259|12506118|FG001|First Intervention (Day 1)|Other|0
7956521|NCT02625259|12506119|FG002|First Intervention (Day 1)|Other|1
7956522|NCT02625259|12506120|FG003|First Intervention (Day 1)|Other|0
7956523|NCT02625259|12506121|FG004|First Intervention (Day 1)|Other|0
7956524|NCT02625259|12506117|FG000|First Intervention (Day 1)|Adverse Event|2
7956525|NCT02625259|12506118|FG001|First Intervention (Day 1)|Adverse Event|1
7956526|NCT02625259|12506119|FG002|First Intervention (Day 1)|Adverse Event|0
7956527|NCT02625259|12506120|FG003|First Intervention (Day 1)|Adverse Event|0
7956528|NCT02625259|12506121|FG004|First Intervention (Day 1)|Adverse Event|0
7956529|NCT02625259|12506117|FG000|First Intervention (Day 1)|Withdrawal by Subject|0
7956530|NCT02625259|12506118|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
7956531|NCT02625259|12506119|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
7956532|NCT02625259|12506120|FG003|First Intervention (Day 1)|Withdrawal by Subject|1
7956533|NCT02625259|12506121|FG004|First Intervention (Day 1)|Withdrawal by Subject|0
7956534|NCT02625623|12506175|FG000|Overall Study|Participants randomized but not treated|9
7956535|NCT02625623|12506176|FG001|Overall Study|Participants randomized but not treated|1
7956536|NCT02625909|12506190|FG000|Overall Study|Death|2
7956537|NCT02625909|12506191|FG001|Overall Study|Death|0
7956538|NCT02625909|12506190|FG000|Overall Study|Lost to Follow-up|3
7956539|NCT02625909|12506191|FG001|Overall Study|Lost to Follow-up|5
7956540|NCT02625909|12506190|FG000|Overall Study|Lack of Efficacy|9
7956541|NCT02625909|12506191|FG001|Overall Study|Lack of Efficacy|2
7956542|NCT02625909|12506190|FG000|Overall Study|Reinfection|3
7956543|NCT02625909|12506191|FG001|Overall Study|Reinfection|2
7956544|NCT02625922|12506199|FG000|Overall Study|Non-availability of IMP|1
7956545|NCT02625922|12506200|FG001|Overall Study|Non-availability of IMP|1
7956546|NCT02625922|12506199|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1
7956547|NCT02625922|12506200|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1
7956548|NCT02625974|12506211|FG000|Overall Study|Adverse Event|12
7956549|NCT02625974|12506212|FG001|Overall Study|Adverse Event|2
7956550|NCT02625974|12506211|FG000|Overall Study|Withdrawal by Subject|3
7956551|NCT02625974|12506212|FG001|Overall Study|Withdrawal by Subject|1
7956552|NCT02625974|12506211|FG000|Overall Study|positive parasitemia|1
7956553|NCT02625974|12506212|FG001|Overall Study|positive parasitemia|0
7956554|NCT02625974|12506211|FG000|Overall Study|non-compliance with study drug|0
7956555|NCT02625974|12506212|FG001|Overall Study|non-compliance with study drug|2
7956556|NCT02625974|12506211|FG000|Overall Study|Protocol Violation|0
7956557|NCT02625974|12506212|FG001|Overall Study|Protocol Violation|1
7956558|NCT02626000|12506254|FG000|Overall Study|Decision by Sponsor|1
7956559|NCT02626000|12506254|FG000|Overall Study|Death|29
7956560|NCT02626026|12506265|FG000|Overall Study|Randomized but Never Treated|0
7956561|NCT02626026|12506266|FG001|Overall Study|Randomized but Never Treated|0
7956562|NCT02626026|12506267|FG002|Overall Study|Randomized but Never Treated|0
7956563|NCT02626026|12506268|FG003|Overall Study|Randomized but Never Treated|0
7956564|NCT02626026|12506269|FG004|Overall Study|Randomized but Never Treated|1
7956565|NCT02626026|12506270|FG005|Overall Study|Randomized but Never Treated|0
7956566|NCT02626182|12506311|FG000|Overall Study|Adverse Event|2
7956567|NCT02626182|12506312|FG001|Overall Study|Adverse Event|0
7956568|NCT02626780|12506338|FG000|Overall Study|Withdrawal by Subject|3
7956569|NCT02626819|12506344|FG000|Overall Study|Lost to Follow-up|3
7956570|NCT02626819|12506345|FG001|Overall Study|Lost to Follow-up|2
7956571|NCT02626819|12506344|FG000|Overall Study|Withdrawal by Subject|1
7956572|NCT02626819|12506345|FG001|Overall Study|Withdrawal by Subject|0
7956573|NCT02626819|12506344|FG000|Overall Study|Diagnosed w/ catastrophic illness|0
7956574|NCT02626819|12506345|FG001|Overall Study|Diagnosed w/ catastrophic illness|1
7956575|NCT02627144|12506382|FG000|Overall Study|Serious adverse event|32
7956576|NCT02627144|12506382|FG000|Overall Study|Cancer progression|171
7956577|NCT02627144|12506382|FG000|Overall Study|Death from cancer|20
7956578|NCT02627144|12506382|FG000|Overall Study|Death from other cause|8
7956579|NCT02627144|12506382|FG000|Overall Study|Refusal of treatment / poor cooperation|38
7956580|NCT02627144|12506382|FG000|Overall Study|Administrative reasons|65
7956581|NCT02627144|12506382|FG000|Overall Study|Lost to Follow-up|8
7956582|NCT02627144|12506382|FG000|Overall Study|Enrolled, not treated|6
7956583|NCT02627144|12506382|FG000|Overall Study|Other|17
7956584|NCT02627495|12506386|FG000|Overall Study|Withdrawal by Subject|4
7956585|NCT02627677|12506393|FG000|Overall Study|Adverse event (not progressive disease)|1
7956586|NCT02627677|12506394|FG001|Overall Study|Adverse event (not progressive disease)|4
7956587|NCT02627677|12506395|FG002|Overall Study|Adverse event (not progressive disease)|1
7956588|NCT02627677|12506393|FG000|Overall Study|Progressive disease|1
7956589|NCT02627677|12506394|FG001|Overall Study|Progressive disease|3
7956590|NCT02627677|12506395|FG002|Overall Study|Progressive disease|0
7956591|NCT02627677|12506393|FG000|Overall Study|Lack of Efficacy|1
7956592|NCT02627677|12506394|FG001|Overall Study|Lack of Efficacy|2
7956593|NCT02627677|12506395|FG002|Overall Study|Lack of Efficacy|0
7956594|NCT02627677|12506393|FG000|Overall Study|Lost to Follow-up|0
7956595|NCT02627677|12506394|FG001|Overall Study|Lost to Follow-up|0
7956596|NCT02627677|12506395|FG002|Overall Study|Lost to Follow-up|1
7956597|NCT02627677|12506393|FG000|Overall Study|Pregnancy|0
7956598|NCT02627677|12506394|FG001|Overall Study|Pregnancy|1
7956599|NCT02627677|12506395|FG002|Overall Study|Pregnancy|0
7956600|NCT02627677|12506393|FG000|Overall Study|Study Terminated by Sponsor|5
7956601|NCT02627677|12506394|FG001|Overall Study|Study Terminated by Sponsor|10
7721026|NCT00542425|12145525|FG002|Initial 24 Weeks|Non-compliance|0
7956602|NCT02627677|12506395|FG002|Overall Study|Study Terminated by Sponsor|6
7956603|NCT02627677|12506393|FG000|Overall Study|Physician Decision|0
7956604|NCT02627677|12506394|FG001|Overall Study|Physician Decision|0
7956605|NCT02627677|12506395|FG002|Overall Study|Physician Decision|2
7956606|NCT02627677|12506393|FG000|Overall Study|Withdrawal by Subject|2
7956607|NCT02627677|12506394|FG001|Overall Study|Withdrawal by Subject|1
7956608|NCT02627677|12506395|FG002|Overall Study|Withdrawal by Subject|1
7956609|NCT02627677|12506393|FG000|Overall Study|Reason not Specified|0
7956610|NCT02627677|12506394|FG001|Overall Study|Reason not Specified|0
7956611|NCT02627677|12506395|FG002|Overall Study|Reason not Specified|1
7956612|NCT02627677|12506393|FG000|Overall Study|Randomized but not Treated|1
7956613|NCT02627677|12506394|FG001|Overall Study|Randomized but not Treated|0
7956614|NCT02627677|12506395|FG002|Overall Study|Randomized but not Treated|0
7956615|NCT02628028|12506426|FG000|Dosing Period|Withdrawal by Subject|0
7956616|NCT02628028|12506427|FG001|Dosing Period|Withdrawal by Subject|0
7956617|NCT02628028|12506428|FG002|Dosing Period|Withdrawal by Subject|1
7956618|NCT02628028|12506429|FG003|Dosing Period|Withdrawal by Subject|0
7956619|NCT02628028|12506430|FG004|Dosing Period|Withdrawal by Subject|2
7956620|NCT02628028|12506431|FG005|Dosing Period|Withdrawal by Subject|4
7956621|NCT02628028|12506432|FG006|Dosing Period|Withdrawal by Subject|1
7956622|NCT02628028|12506433|FG007|Dosing Period|Withdrawal by Subject|1
7956623|NCT02628028|12506426|FG000|Dosing Period|Adverse Event|0
7956624|NCT02628028|12506427|FG001|Dosing Period|Adverse Event|0
7956625|NCT02628028|12506428|FG002|Dosing Period|Adverse Event|0
7956626|NCT02628028|12506429|FG003|Dosing Period|Adverse Event|0
7956627|NCT02628028|12506430|FG004|Dosing Period|Adverse Event|2
7956628|NCT02628028|12506431|FG005|Dosing Period|Adverse Event|1
7956629|NCT02628028|12506432|FG006|Dosing Period|Adverse Event|3
7956630|NCT02628028|12506433|FG007|Dosing Period|Adverse Event|2
7956631|NCT02628028|12506426|FG000|Dosing Period|Death|0
7956632|NCT02628028|12506427|FG001|Dosing Period|Death|0
7956633|NCT02628028|12506428|FG002|Dosing Period|Death|0
7956634|NCT02628028|12506429|FG003|Dosing Period|Death|0
7956635|NCT02628028|12506430|FG004|Dosing Period|Death|0
7956636|NCT02628028|12506431|FG005|Dosing Period|Death|0
7956637|NCT02628028|12506432|FG006|Dosing Period|Death|0
7956638|NCT02628028|12506433|FG007|Dosing Period|Death|1
7956639|NCT02628028|12506426|FG000|Dosing Period|Lack of Efficacy|0
7956640|NCT02628028|12506427|FG001|Dosing Period|Lack of Efficacy|0
7956641|NCT02628028|12506428|FG002|Dosing Period|Lack of Efficacy|0
7956642|NCT02628028|12506429|FG003|Dosing Period|Lack of Efficacy|0
7956643|NCT02628028|12506430|FG004|Dosing Period|Lack of Efficacy|3
7956644|NCT02628028|12506431|FG005|Dosing Period|Lack of Efficacy|0
7956645|NCT02628028|12506432|FG006|Dosing Period|Lack of Efficacy|1
7956646|NCT02628028|12506433|FG007|Dosing Period|Lack of Efficacy|0
7956647|NCT02628028|12506426|FG000|Dosing Period|Study Terminated by Sponsor|0
7956648|NCT02628028|12506427|FG001|Dosing Period|Study Terminated by Sponsor|0
7956649|NCT02628028|12506428|FG002|Dosing Period|Study Terminated by Sponsor|0
7956650|NCT02628028|12506429|FG003|Dosing Period|Study Terminated by Sponsor|0
7956651|NCT02628028|12506430|FG004|Dosing Period|Study Terminated by Sponsor|7
7956652|NCT02628028|12506431|FG005|Dosing Period|Study Terminated by Sponsor|6
7956653|NCT02628028|12506432|FG006|Dosing Period|Study Terminated by Sponsor|7
7956654|NCT02628028|12506433|FG007|Dosing Period|Study Terminated by Sponsor|7
7956655|NCT02628028|12506426|FG000|Dosing Period|Physician Decision|0
7956656|NCT02628028|12506427|FG001|Dosing Period|Physician Decision|0
7956657|NCT02628028|12506428|FG002|Dosing Period|Physician Decision|0
7956658|NCT02628028|12506429|FG003|Dosing Period|Physician Decision|0
7956659|NCT02628028|12506430|FG004|Dosing Period|Physician Decision|0
7956660|NCT02628028|12506431|FG005|Dosing Period|Physician Decision|1
7956661|NCT02628028|12506432|FG006|Dosing Period|Physician Decision|0
7956662|NCT02628028|12506433|FG007|Dosing Period|Physician Decision|0
7956663|NCT02628028|12506426|FG000|Dosing Period|Site Terminated by Sponsor|0
7956664|NCT02628028|12506427|FG001|Dosing Period|Site Terminated by Sponsor|0
7956665|NCT02628028|12506428|FG002|Dosing Period|Site Terminated by Sponsor|0
7956666|NCT02628028|12506429|FG003|Dosing Period|Site Terminated by Sponsor|0
7956667|NCT02628028|12506430|FG004|Dosing Period|Site Terminated by Sponsor|0
7956668|NCT02628028|12506431|FG005|Dosing Period|Site Terminated by Sponsor|1
7956669|NCT02628028|12506432|FG006|Dosing Period|Site Terminated by Sponsor|1
7956670|NCT02628028|12506433|FG007|Dosing Period|Site Terminated by Sponsor|0
7956671|NCT02628028|12506426|FG000|Dosing Period|Lost to Follow-up|0
7956672|NCT02628028|12506427|FG001|Dosing Period|Lost to Follow-up|0
7956673|NCT02628028|12506428|FG002|Dosing Period|Lost to Follow-up|0
7956674|NCT02628028|12506429|FG003|Dosing Period|Lost to Follow-up|0
7956675|NCT02628028|12506430|FG004|Dosing Period|Lost to Follow-up|0
7956676|NCT02628028|12506431|FG005|Dosing Period|Lost to Follow-up|0
7956677|NCT02628028|12506432|FG006|Dosing Period|Lost to Follow-up|1
7956678|NCT02628028|12506433|FG007|Dosing Period|Lost to Follow-up|0
7956679|NCT02628028|12506426|FG000|Dosing Period|Other|0
7956680|NCT02628028|12506427|FG001|Dosing Period|Other|0
7956681|NCT02628028|12506428|FG002|Dosing Period|Other|0
7956682|NCT02628028|12506429|FG003|Dosing Period|Other|0
7956683|NCT02628028|12506430|FG004|Dosing Period|Other|2
7956684|NCT02628028|12506431|FG005|Dosing Period|Other|1
7956685|NCT02628028|12506432|FG006|Dosing Period|Other|2
7956686|NCT02628028|12506433|FG007|Dosing Period|Other|4
7956687|NCT02628028|12506426|FG000|Long-term Extension (LTE) Period|Adverse Event|0
7956688|NCT02628028|12506427|FG001|Long-term Extension (LTE) Period|Adverse Event|0
7956689|NCT02628028|12506428|FG002|Long-term Extension (LTE) Period|Adverse Event|0
7956690|NCT02628028|12506429|FG003|Long-term Extension (LTE) Period|Adverse Event|0
7956691|NCT02628028|12506430|FG004|Long-term Extension (LTE) Period|Adverse Event|0
7956692|NCT02628028|12506431|FG005|Long-term Extension (LTE) Period|Adverse Event|1
7956693|NCT02628028|12506432|FG006|Long-term Extension (LTE) Period|Adverse Event|0
7956694|NCT02628028|12506433|FG007|Long-term Extension (LTE) Period|Adverse Event|3
7956695|NCT02628028|12506426|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0
7956696|NCT02628028|12506427|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0
7956697|NCT02628028|12506428|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0
7956698|NCT02628028|12506429|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0
7956699|NCT02628028|12506430|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0
7956700|NCT02628028|12506431|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2
7956701|NCT02628028|12506432|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0
7956702|NCT02628028|12506433|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1
7956703|NCT02628028|12506426|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7956704|NCT02628028|12506427|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7956705|NCT02628028|12506428|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7956706|NCT02628028|12506429|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7956707|NCT02628028|12506430|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7956708|NCT02628028|12506431|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52
7956709|NCT02628028|12506432|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
7956710|NCT02628028|12506433|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
7956711|NCT02628028|12506426|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7956712|NCT02628028|12506427|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7956713|NCT02628028|12506428|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7956714|NCT02628028|12506429|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7956715|NCT02628028|12506430|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7956716|NCT02628028|12506431|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2
7956717|NCT02628028|12506432|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3
7956718|NCT02628028|12506433|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3
7956719|NCT02628028|12506426|FG000|Long-term Extension (LTE) Period|Other|0
7956720|NCT02628028|12506427|FG001|Long-term Extension (LTE) Period|Other|0
7956721|NCT02628028|12506428|FG002|Long-term Extension (LTE) Period|Other|0
7956722|NCT02628028|12506429|FG003|Long-term Extension (LTE) Period|Other|0
7956723|NCT02628028|12506430|FG004|Long-term Extension (LTE) Period|Other|0
7956724|NCT02628028|12506431|FG005|Long-term Extension (LTE) Period|Other|3
7956725|NCT02628028|12506432|FG006|Long-term Extension (LTE) Period|Other|4
7956726|NCT02628028|12506433|FG007|Long-term Extension (LTE) Period|Other|3
7956727|NCT02628418|12506483|FG000|Overall Study|Lost to Follow-up|1
7956728|NCT02628418|12506484|FG001|Overall Study|Lost to Follow-up|2
7956729|NCT02628600|12506498|FG000|Overall Study|Death|2
7956730|NCT02628600|12506499|FG001|Overall Study|Death|1
7956731|NCT02628600|12506498|FG000|Overall Study|Adverse Event|3
7956732|NCT02628600|12506499|FG001|Overall Study|Adverse Event|20
7956733|NCT02628600|12506498|FG000|Overall Study|Protocol Violation|0
7956734|NCT02628600|12506499|FG001|Overall Study|Protocol Violation|1
7956735|NCT02628600|12506498|FG000|Overall Study|Lack of Efficacy|2
7956736|NCT02628600|12506499|FG001|Overall Study|Lack of Efficacy|0
7956737|NCT02628600|12506498|FG000|Overall Study|Withdrawal by Subject|13
7956738|NCT02628600|12506499|FG001|Overall Study|Withdrawal by Subject|8
7956739|NCT02628600|12506498|FG000|Overall Study|Lost to Follow-up|1
7956740|NCT02628600|12506499|FG001|Overall Study|Lost to Follow-up|0
7956741|NCT02628600|12506498|FG000|Overall Study|Physician Decision|2
7956742|NCT02628600|12506499|FG001|Overall Study|Physician Decision|2
7956743|NCT02628600|12506498|FG000|Overall Study|Other not specified|1
7956744|NCT02628600|12506499|FG001|Overall Study|Other not specified|0
7956745|NCT02628743|12506505|FG000|Overall Study|Other|3
7956746|NCT02628743|12506505|FG000|Overall Study|Withdrawal by Subject|50
7956747|NCT02628743|12506505|FG000|Overall Study|Study Terminated by Sponsor|76
7956748|NCT02628743|12506505|FG000|Overall Study|Physician Decision|2
7956749|NCT02628769|12506509|FG000|First Intervention|Adverse Event|1
7956750|NCT02628769|12506510|FG001|First Intervention|Adverse Event|0
7956751|NCT02628769|12506509|FG000|First Intervention|Withdrawal by Subject|0
7956752|NCT02628769|12506510|FG001|First Intervention|Withdrawal by Subject|1
7956753|NCT02628769|12506509|FG000|Second Intervention|Adverse Event|2
7956754|NCT02628769|12506510|FG001|Second Intervention|Adverse Event|0
7956755|NCT02628769|12506509|FG000|Second Intervention|Physician Decision|0
7956756|NCT02628769|12506510|FG001|Second Intervention|Physician Decision|1
7956757|NCT02628873|12506518|FG000|Break (1 Hour)|Withdrawal by Subject|0
7956758|NCT02628873|12506519|FG001|Break (1 Hour)|Withdrawal by Subject|1
7956759|NCT02628873|12506518|FG000|Second Test (1 Hour)|Physician Decision|1
7956760|NCT02628873|12506519|FG001|Second Test (1 Hour)|Physician Decision|0
7956761|NCT02628938|12506528|FG000|Overall Study|Did not attend the follow up recall|2
7956762|NCT02628938|12506529|FG001|Overall Study|Did not attend the follow up recall|2
7956763|NCT02628938|12506530|FG002|Overall Study|Did not attend the follow up recall|1
7956764|NCT02628938|12506528|FG000|Overall Study|Failure to comply with the instructions|3
7956765|NCT02628938|12506529|FG001|Overall Study|Failure to comply with the instructions|0
7956766|NCT02628938|12506530|FG002|Overall Study|Failure to comply with the instructions|3
7956767|NCT02629133|12506553|FG000|Overall Study|Lost to Follow-up|3
7956768|NCT02629133|12506554|FG001|Overall Study|Lost to Follow-up|1
7956769|NCT02629133|12506553|FG000|Overall Study|Withdrawal by Subject|1
7956770|NCT02629133|12506554|FG001|Overall Study|Withdrawal by Subject|1
7956771|NCT02629822|12506569|FG000|Base Study|Lost to Follow-up|2
7956772|NCT02629822|12506569|FG000|Base Study|Non-Compliance With Study Drug|1
7956773|NCT02629822|12506569|FG000|Extension Study|Adverse Event|1
7956774|NCT02629822|12506569|FG000|Extension Study|Lost to Follow-up|1
7956775|NCT02629861|12506577|FG000|Overall Study|Adverse Event|7
7956776|NCT02629861|12506578|FG001|Overall Study|Adverse Event|5
7956777|NCT02629861|12506579|FG002|Overall Study|Adverse Event|4
7956778|NCT02629861|12506577|FG000|Overall Study|Withdrawal by Subject|5
7956779|NCT02629861|12506578|FG001|Overall Study|Withdrawal by Subject|8
7956780|NCT02629861|12506579|FG002|Overall Study|Withdrawal by Subject|13
7956781|NCT02629861|12506577|FG000|Overall Study|Protocol Violation|2
7956782|NCT02629861|12506578|FG001|Overall Study|Protocol Violation|3
7956783|NCT02629861|12506579|FG002|Overall Study|Protocol Violation|7
7956784|NCT02629861|12506577|FG000|Overall Study|Lost to Follow-up|12
7956785|NCT02629861|12506578|FG001|Overall Study|Lost to Follow-up|9
7956786|NCT02629861|12506579|FG002|Overall Study|Lost to Follow-up|4
7956787|NCT02629861|12506577|FG000|Overall Study|Other|1
7956788|NCT02629861|12506578|FG001|Overall Study|Other|1
7956789|NCT02629861|12506579|FG002|Overall Study|Other|0
7956790|NCT02629861|12506577|FG000|Overall Study|Pregnancy|2
7956791|NCT02629861|12506578|FG001|Overall Study|Pregnancy|1
7956792|NCT02629861|12506579|FG002|Overall Study|Pregnancy|0
7956793|NCT02629965|12506587|FG000|Period 1|Adverse Event|1
7956794|NCT02629965|12506588|FG001|Period 1|Adverse Event|0
7956795|NCT02629965|12506587|FG000|Period 1|Unexpected worsening of disease|2
7956796|NCT02629965|12506588|FG001|Period 1|Unexpected worsening of disease|0
7956797|NCT02629965|12506587|FG000|Period 1|Other than listed above|1
7956798|NCT02629965|12506588|FG001|Period 1|Other than listed above|2
7956799|NCT02629965|12506587|FG000|Period 2|Adverse Event|1
7956800|NCT02629965|12506588|FG001|Period 2|Adverse Event|0
7956801|NCT02630186|12506625|FG000|Overall Study|Withdrawal by Subject|1
7956802|NCT02630251|12506633|FG000|Overall Study|Physician Decision|0
7956803|NCT02630251|12506634|FG001|Overall Study|Physician Decision|0
7956804|NCT02630251|12506635|FG002|Overall Study|Physician Decision|1
7956805|NCT02630251|12506636|FG003|Overall Study|Physician Decision|0
7956806|NCT02630563|12506646|FG000|Overall Study|Administrative|1
7956807|NCT02630693|12506653|FG000|Overall Study|No receive treatment|0
7956808|NCT02630693|12506654|FG001|Overall Study|No receive treatment|1
7956809|NCT02630706|12506663|FG000|Overall Study|Adverse Event|2
7956810|NCT02630706|12506664|FG001|Overall Study|Adverse Event|1
7956811|NCT02630706|12506665|FG002|Overall Study|Adverse Event|1
7956812|NCT02630706|12506663|FG000|Overall Study|Lost to Follow-up|0
7956813|NCT02630706|12506664|FG001|Overall Study|Lost to Follow-up|1
7956814|NCT02630706|12506665|FG002|Overall Study|Lost to Follow-up|2
7956815|NCT02630706|12506663|FG000|Overall Study|Physician Decision|1
7956816|NCT02630706|12506664|FG001|Overall Study|Physician Decision|1
7956817|NCT02630706|12506665|FG002|Overall Study|Physician Decision|0
7956818|NCT02630706|12506663|FG000|Overall Study|Pregnancy|0
7956819|NCT02630706|12506664|FG001|Overall Study|Pregnancy|1
7956820|NCT02630706|12506665|FG002|Overall Study|Pregnancy|0
7956821|NCT02630706|12506663|FG000|Overall Study|Withdrawal by Subject|4
7956822|NCT02630706|12506664|FG001|Overall Study|Withdrawal by Subject|5
7956823|NCT02630706|12506665|FG002|Overall Study|Withdrawal by Subject|7
7956824|NCT02630966|12506693|FG000|Overall Study|Adverse Event|1
7956825|NCT02630966|12506694|FG001|Overall Study|Adverse Event|3
7956826|NCT02630966|12506693|FG000|Overall Study|Significant Protocol Deviation|0
7956827|NCT02630966|12506694|FG001|Overall Study|Significant Protocol Deviation|2
7956828|NCT02630966|12506693|FG000|Overall Study|Voluntary Withdrawal|1
7956829|NCT02630966|12506694|FG001|Overall Study|Voluntary Withdrawal|1
7956830|NCT02630966|12506693|FG000|Overall Study|Lack of Efficacy|0
7956831|NCT02630966|12506694|FG001|Overall Study|Lack of Efficacy|2
7956832|NCT02631538|12506726|FG000|Treatment Period (Up to Week 52)|Adverse Event|1
7956833|NCT02631538|12506727|FG001|Treatment Period (Up to Week 52)|Adverse Event|5
7956834|NCT02631538|12506728|FG002|Treatment Period (Up to Week 52)|Adverse Event|2
7956835|NCT02631538|12506729|FG003|Treatment Period (Up to Week 52)|Adverse Event|2
7956836|NCT02631538|12506726|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1
7956837|NCT02631538|12506727|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1
7956838|NCT02631538|12506728|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2
7956839|NCT02631538|12506729|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5
7956840|NCT02631538|12506726|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1
7956841|NCT02631538|12506727|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1
7956842|NCT02631538|12506728|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0
7956843|NCT02631538|12506729|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0
7956844|NCT02631538|12506726|FG000|Treatment Period (Up to Week 52)|Physician Decision|1
7956845|NCT02631538|12506727|FG001|Treatment Period (Up to Week 52)|Physician Decision|0
7956846|NCT02631538|12506728|FG002|Treatment Period (Up to Week 52)|Physician Decision|0
7956847|NCT02631538|12506729|FG003|Treatment Period (Up to Week 52)|Physician Decision|1
7956848|NCT02631538|12506726|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0
7956849|NCT02631538|12506727|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0
7956850|NCT02631538|12506728|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1
7956851|NCT02631538|12506729|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0
7956852|NCT02631538|12506726|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1
7956853|NCT02631538|12506727|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0
7956854|NCT02631538|12506728|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0
7956855|NCT02631538|12506729|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1
7956856|NCT02631551|12506743|FG000|Overall Study|Adverse Event|1
7956857|NCT02631551|12506744|FG001|Overall Study|Adverse Event|2
7956858|NCT02631551|12506745|FG002|Overall Study|Adverse Event|4
7956859|NCT02631551|12506746|FG003|Overall Study|Adverse Event|0
7956860|NCT02631551|12506743|FG000|Overall Study|Lack of Efficacy|0
7956861|NCT02631551|12506744|FG001|Overall Study|Lack of Efficacy|0
7956862|NCT02631551|12506745|FG002|Overall Study|Lack of Efficacy|1
7956863|NCT02631551|12506746|FG003|Overall Study|Lack of Efficacy|0
7956864|NCT02631551|12506743|FG000|Overall Study|Lost to Follow-up|1
7956865|NCT02631551|12506744|FG001|Overall Study|Lost to Follow-up|2
7956866|NCT02631551|12506745|FG002|Overall Study|Lost to Follow-up|0
7956867|NCT02631551|12506746|FG003|Overall Study|Lost to Follow-up|3
7956868|NCT02631551|12506743|FG000|Overall Study|Withdrawal by Subject|2
7956869|NCT02631551|12506744|FG001|Overall Study|Withdrawal by Subject|2
7956870|NCT02631551|12506745|FG002|Overall Study|Withdrawal by Subject|0
7956871|NCT02631551|12506746|FG003|Overall Study|Withdrawal by Subject|5
7956872|NCT02631551|12506743|FG000|Overall Study|Protocol deviation|3
7956873|NCT02631551|12506744|FG001|Overall Study|Protocol deviation|6
7956874|NCT02631551|12506745|FG002|Overall Study|Protocol deviation|3
7956875|NCT02631551|12506746|FG003|Overall Study|Protocol deviation|0
7956876|NCT02631551|12506743|FG000|Overall Study|Non-compliance with study procedures|0
7956877|NCT02631551|12506744|FG001|Overall Study|Non-compliance with study procedures|0
7956878|NCT02631551|12506745|FG002|Overall Study|Non-compliance with study procedures|1
7956879|NCT02631551|12506746|FG003|Overall Study|Non-compliance with study procedures|1
7956880|NCT02631551|12506743|FG000|Overall Study|Non-compliance with study drug|1
7956881|NCT02631551|12506744|FG001|Overall Study|Non-compliance with study drug|0
7956882|NCT02631551|12506745|FG002|Overall Study|Non-compliance with study drug|0
7956883|NCT02631551|12506746|FG003|Overall Study|Non-compliance with study drug|0
7956884|NCT02631551|12506743|FG000|Overall Study|Other, specific reasons not collected|5
7956885|NCT02631551|12506744|FG001|Overall Study|Other, specific reasons not collected|7
7956886|NCT02631551|12506745|FG002|Overall Study|Other, specific reasons not collected|2
7956887|NCT02631551|12506746|FG003|Overall Study|Other, specific reasons not collected|2
7956888|NCT02631746|12506760|FG000|Overall Study|Lack of Efficacy|3
7956889|NCT02631850|12506777|FG000|Treatment Period|Lost to Follow-up|0
7956890|NCT02631850|12506778|FG001|Treatment Period|Lost to Follow-up|1
7956891|NCT02631850|12506779|FG002|Treatment Period|Lost to Follow-up|0
7956892|NCT02631850|12506780|FG003|Treatment Period|Lost to Follow-up|0
7956893|NCT02631850|12506777|FG000|Treatment Period|Protocol Violation|1
7956894|NCT02631850|12506778|FG001|Treatment Period|Protocol Violation|0
7956895|NCT02631850|12506779|FG002|Treatment Period|Protocol Violation|0
7956896|NCT02631850|12506780|FG003|Treatment Period|Protocol Violation|0
7956897|NCT02631850|12506777|FG000|Treatment Period|Withdrawal by Subject|0
7956898|NCT02631850|12506778|FG001|Treatment Period|Withdrawal by Subject|5
7956899|NCT02631850|12506779|FG002|Treatment Period|Withdrawal by Subject|2
7956900|NCT02631850|12506780|FG003|Treatment Period|Withdrawal by Subject|2
7956901|NCT02631850|12506777|FG000|Treatment Period|Adverse Event|1
7956902|NCT02631850|12506778|FG001|Treatment Period|Adverse Event|0
7956903|NCT02631850|12506779|FG002|Treatment Period|Adverse Event|2
7956904|NCT02631850|12506780|FG003|Treatment Period|Adverse Event|3
7956905|NCT02631850|12506777|FG000|Treatment Period|Family medical issue|1
7956906|NCT02631850|12506778|FG001|Treatment Period|Family medical issue|0
7956907|NCT02631850|12506779|FG002|Treatment Period|Family medical issue|0
7956908|NCT02631850|12506780|FG003|Treatment Period|Family medical issue|0
7956909|NCT02631850|12506777|FG000|6 Month Follow up|Lost to Follow-up|5
7956910|NCT02631850|12506778|FG001|6 Month Follow up|Lost to Follow-up|8
7956911|NCT02631850|12506779|FG002|6 Month Follow up|Lost to Follow-up|3
7956912|NCT02631850|12506780|FG003|6 Month Follow up|Lost to Follow-up|5
7956913|NCT02631850|12506777|FG000|6 Month Follow up|Withdrawal by Subject|1
7956914|NCT02631850|12506778|FG001|6 Month Follow up|Withdrawal by Subject|0
7956915|NCT02631850|12506779|FG002|6 Month Follow up|Withdrawal by Subject|0
7956916|NCT02631850|12506780|FG003|6 Month Follow up|Withdrawal by Subject|2
7956917|NCT02631850|12506777|FG000|6 Month Follow up|Adverse Event|1
7956918|NCT02631850|12506778|FG001|6 Month Follow up|Adverse Event|4
7956919|NCT02631850|12506779|FG002|6 Month Follow up|Adverse Event|1
7956920|NCT02631850|12506780|FG003|6 Month Follow up|Adverse Event|3
7956921|NCT02631850|12506777|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0
7956922|NCT02631850|12506778|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1
7956923|NCT02631850|12506779|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2
7956924|NCT02631850|12506780|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1
7956925|NCT02631876|12506793|FG000|Overall Study|Death|96
7956926|NCT02631876|12506794|FG001|Overall Study|Death|50
7956927|NCT02631876|12506793|FG000|Overall Study|Investigator's discretion|1
7956928|NCT02631876|12506794|FG001|Overall Study|Investigator's discretion|0
7956929|NCT02631876|12506793|FG000|Overall Study|Lost to Follow-up|2
7956930|NCT02631876|12506794|FG001|Overall Study|Lost to Follow-up|0
7956931|NCT02631876|12506793|FG000|Overall Study|Withdrawal by Subject|16
7956932|NCT02631876|12506794|FG001|Overall Study|Withdrawal by Subject|9
7956933|NCT02631876|12506793|FG000|Overall Study|Other than specified|4
7956934|NCT02631876|12506794|FG001|Overall Study|Other than specified|4
7956935|NCT02632110|12506815|FG000|Overall Study|Withdrawal by Subject|1
7956936|NCT02632110|12506816|FG001|Overall Study|Withdrawal by Subject|1
7956937|NCT02632110|12506817|FG002|Overall Study|Withdrawal by Subject|0
7956938|NCT02632110|12506818|FG003|Overall Study|Withdrawal by Subject|0
7956939|NCT02632110|12506819|FG004|Overall Study|Withdrawal by Subject|1
7956940|NCT02632110|12506820|FG005|Overall Study|Withdrawal by Subject|1
7956941|NCT02632110|12506821|FG006|Overall Study|Withdrawal by Subject|3
7956942|NCT02632110|12506822|FG007|Overall Study|Withdrawal by Subject|3
7956943|NCT02632110|12506823|FG008|Overall Study|Withdrawal by Subject|1
7956944|NCT02632110|12506824|FG009|Overall Study|Withdrawal by Subject|1
7956945|NCT02632552|12506899|FG000|Overall Study|Lost to Follow-up|14
7956946|NCT02632552|12506900|FG001|Overall Study|Lost to Follow-up|8
7956947|NCT02632552|12506899|FG000|Overall Study|Withdrawal by Subject|2
7956948|NCT02632552|12506900|FG001|Overall Study|Withdrawal by Subject|0
7956949|NCT02632552|12506899|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7
7956950|NCT02632552|12506900|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2
7956951|NCT02632747|12506909|FG000|Wash-out Period|Adverse Event|1
7956952|NCT02632747|12506910|FG001|Wash-out Period|Adverse Event|0
7956953|NCT02632786|12506918|FG000|Overall Study|Adverse Event|2
7956954|NCT02632786|12506919|FG001|Overall Study|Adverse Event|1
7956955|NCT02632786|12506918|FG000|Overall Study|Death|3
7956956|NCT02632786|12506919|FG001|Overall Study|Death|2
7956957|NCT02632786|12506918|FG000|Overall Study|Physician Decision|5
7956958|NCT02632786|12506919|FG001|Overall Study|Physician Decision|4
7956959|NCT02632786|12506918|FG000|Overall Study|Withdrawal by Subject|1
7956960|NCT02632786|12506919|FG001|Overall Study|Withdrawal by Subject|0
7956961|NCT02632838|12506937|FG000|Overall Study|Withdrawal by Subject|3
7956962|NCT02632838|12506938|FG001|Overall Study|Withdrawal by Subject|0
7956963|NCT02632838|12506937|FG000|Overall Study|Lost to Follow-up|0
7956964|NCT02632838|12506938|FG001|Overall Study|Lost to Follow-up|2
7956965|NCT02633020|12506950|FG000|Overall Study|Adverse Event|1
7956966|NCT02633020|12506951|FG001|Overall Study|Adverse Event|0
7956967|NCT02633046|12506957|FG000|Overall Study|Adverse Event|8
7956968|NCT02633046|12506957|FG000|Overall Study|Physician Decision|7
7956969|NCT02633046|12506957|FG000|Overall Study|Withdrawal by Subject|8
7956970|NCT02633046|12506957|FG000|Overall Study|Increased proteinuria|2
7956971|NCT02633046|12506957|FG000|Overall Study|Participant decided not to continue with open label extension|1
7956972|NCT02633046|12506957|FG000|Overall Study|Mutual decision patient and physician|1
7956973|NCT02633215|12506963|FG000|Overall Study|Lost to Follow-up|2
7956974|NCT02633215|12506964|FG001|Overall Study|Lost to Follow-up|3
7956975|NCT02633306|12506970|FG000|Overall Study|Withdrawal by Subject|3
7966526|NCT02752776|12522665|FG002|Overall Study|Lack of Efficacy|14
7966527|NCT02752776|12522663|FG000|Overall Study|Lost to Follow-up|11
7966528|NCT02752776|12522664|FG001|Overall Study|Lost to Follow-up|12
7966529|NCT02752776|12522665|FG002|Overall Study|Lost to Follow-up|4
7966530|NCT02752776|12522663|FG000|Overall Study|Non-compliance with study treatment|0
7966531|NCT02752776|12522664|FG001|Overall Study|Non-compliance with study treatment|0
7966532|NCT02752776|12522665|FG002|Overall Study|Non-compliance with study treatment|1
7966533|NCT02752776|12522663|FG000|Overall Study|Physician Decision|2
7966534|NCT02752776|12522664|FG001|Overall Study|Physician Decision|6
7966535|NCT02752776|12522665|FG002|Overall Study|Physician Decision|2
7966536|NCT02752776|12522663|FG000|Overall Study|Pregnancy|1
7966537|NCT02752776|12522664|FG001|Overall Study|Pregnancy|6
7966538|NCT02752776|12522665|FG002|Overall Study|Pregnancy|3
7966539|NCT02752776|12522663|FG000|Overall Study|Protocol Violation|10
7966540|NCT02752776|12522664|FG001|Overall Study|Protocol Violation|13
7966541|NCT02752776|12522665|FG002|Overall Study|Protocol Violation|6
7966542|NCT02752776|12522663|FG000|Overall Study|Subject/guardian decision|8
7966543|NCT02752776|12522664|FG001|Overall Study|Subject/guardian decision|6
7966544|NCT02752776|12522665|FG002|Overall Study|Subject/guardian decision|4
7966545|NCT02752776|12522663|FG000|Overall Study|Death|0
7966546|NCT02752776|12522664|FG001|Overall Study|Death|0
7966547|NCT02752776|12522665|FG002|Overall Study|Death|1
7956976|NCT02633501|12507004|FG000|Overall Study|Adverse Event|0
7956977|NCT02633501|12507005|FG001|Overall Study|Adverse Event|0
7956978|NCT02633501|12507006|FG002|Overall Study|Adverse Event|1
7956979|NCT02633501|12507007|FG003|Overall Study|Adverse Event|0
7956980|NCT02633501|12507008|FG004|Overall Study|Adverse Event|1
7956981|NCT02633501|12507009|FG005|Overall Study|Adverse Event|1
7956982|NCT02633501|12507004|FG000|Overall Study|Withdrawal by Subject|2
7956983|NCT02633501|12507005|FG001|Overall Study|Withdrawal by Subject|1
7956984|NCT02633501|12507006|FG002|Overall Study|Withdrawal by Subject|2
7956985|NCT02633501|12507007|FG003|Overall Study|Withdrawal by Subject|2
7956986|NCT02633501|12507008|FG004|Overall Study|Withdrawal by Subject|1
7956987|NCT02633501|12507009|FG005|Overall Study|Withdrawal by Subject|3
7956988|NCT02633501|12507004|FG000|Overall Study|Various other reasons|0
7956989|NCT02633501|12507005|FG001|Overall Study|Various other reasons|2
7956990|NCT02633501|12507006|FG002|Overall Study|Various other reasons|4
7956991|NCT02633501|12507007|FG003|Overall Study|Various other reasons|1
7956992|NCT02633501|12507008|FG004|Overall Study|Various other reasons|7
7956993|NCT02633501|12507009|FG005|Overall Study|Various other reasons|11
7956994|NCT02633501|12507004|FG000|Overall Study|Lost to Follow-up|0
7956995|NCT02633501|12507005|FG001|Overall Study|Lost to Follow-up|0
7956996|NCT02633501|12507006|FG002|Overall Study|Lost to Follow-up|0
7956997|NCT02633501|12507007|FG003|Overall Study|Lost to Follow-up|1
7956998|NCT02633501|12507008|FG004|Overall Study|Lost to Follow-up|2
7956999|NCT02633501|12507009|FG005|Overall Study|Lost to Follow-up|0
7957000|NCT02633527|12507033|FG000|Overall Study|Failed to meet eligibility|0
7957001|NCT02633527|12507034|FG001|Overall Study|Failed to meet eligibility|1
7957002|NCT02633527|12507035|FG002|Overall Study|Failed to meet eligibility|1
7957003|NCT02633527|12507036|FG003|Overall Study|Failed to meet eligibility|0
7957004|NCT02633527|12507037|FG004|Overall Study|Failed to meet eligibility|1
7957005|NCT02633527|12507033|FG000|Overall Study|Adverse Event|0
7957006|NCT02633527|12507034|FG001|Overall Study|Adverse Event|4
7957007|NCT02633527|12507035|FG002|Overall Study|Adverse Event|3
7957008|NCT02633527|12507036|FG003|Overall Study|Adverse Event|1
7957009|NCT02633527|12507037|FG004|Overall Study|Adverse Event|5
7957010|NCT02633527|12507033|FG000|Overall Study|Lost to Follow-up|1
7957011|NCT02633527|12507034|FG001|Overall Study|Lost to Follow-up|2
7957012|NCT02633527|12507035|FG002|Overall Study|Lost to Follow-up|5
7957013|NCT02633527|12507036|FG003|Overall Study|Lost to Follow-up|5
7957014|NCT02633527|12507037|FG004|Overall Study|Lost to Follow-up|4
7957015|NCT02633527|12507033|FG000|Overall Study|Withdrawal by Subject|0
7957016|NCT02633527|12507034|FG001|Overall Study|Withdrawal by Subject|3
7957017|NCT02633527|12507035|FG002|Overall Study|Withdrawal by Subject|5
7957018|NCT02633527|12507036|FG003|Overall Study|Withdrawal by Subject|4
7957019|NCT02633527|12507037|FG004|Overall Study|Withdrawal by Subject|4
7957020|NCT02633527|12507033|FG000|Overall Study|Protocol Violation|0
7957021|NCT02633527|12507034|FG001|Overall Study|Protocol Violation|1
7957022|NCT02633527|12507035|FG002|Overall Study|Protocol Violation|1
7957023|NCT02633527|12507036|FG003|Overall Study|Protocol Violation|1
7957024|NCT02633527|12507037|FG004|Overall Study|Protocol Violation|1
7957025|NCT02633527|12507033|FG000|Overall Study|Physician Decision|0
7957026|NCT02633527|12507034|FG001|Overall Study|Physician Decision|0
7957027|NCT02633527|12507035|FG002|Overall Study|Physician Decision|0
7957028|NCT02633527|12507036|FG003|Overall Study|Physician Decision|0
7957029|NCT02633527|12507037|FG004|Overall Study|Physician Decision|1
7957030|NCT02633527|12507033|FG000|Overall Study|Administrative reason|1
7957031|NCT02633527|12507034|FG001|Overall Study|Administrative reason|0
7957032|NCT02633527|12507035|FG002|Overall Study|Administrative reason|0
7957033|NCT02633527|12507036|FG003|Overall Study|Administrative reason|1
7957034|NCT02633527|12507037|FG004|Overall Study|Administrative reason|0
7957035|NCT02633527|12507033|FG000|Overall Study|Multiple reasons|1
7957036|NCT02633527|12507034|FG001|Overall Study|Multiple reasons|0
7957037|NCT02633527|12507035|FG002|Overall Study|Multiple reasons|2
7957038|NCT02633527|12507036|FG003|Overall Study|Multiple reasons|2
7957039|NCT02633527|12507037|FG004|Overall Study|Multiple reasons|1
7957040|NCT02633787|12507058|FG000|Overall Study|Withdrawal by Subject|1
7957041|NCT02633800|12507064|FG000|Overall Study|Death|3
7957042|NCT02633800|12507065|FG001|Overall Study|Death|3
7957043|NCT02633800|12507064|FG000|Overall Study|Reason not provided|1
7957044|NCT02633800|12507065|FG001|Overall Study|Reason not provided|0
7957045|NCT02633800|12507064|FG000|Overall Study|Radiologic(al) progression|23
7957046|NCT02633800|12507065|FG001|Overall Study|Radiologic(al) progression|23
7957047|NCT02633800|12507064|FG000|Overall Study|Clinical progression|3
7957048|NCT02633800|12507065|FG001|Overall Study|Clinical progression|6
7957049|NCT02633800|12507064|FG000|Overall Study|Study terminated by sponsor|6
7957050|NCT02633800|12507065|FG001|Overall Study|Study terminated by sponsor|5
7957051|NCT02633800|12507064|FG000|Overall Study|Adverse event, non-fatal|7
7957052|NCT02633800|12507065|FG001|Overall Study|Adverse event, non-fatal|2
7957053|NCT02633800|12507064|FG000|Overall Study|Withdrawal by Subject|0
7957054|NCT02633800|12507065|FG001|Overall Study|Withdrawal by Subject|3
7957055|NCT02633800|12507064|FG000|Overall Study|Patient Request|1
7957056|NCT02633800|12507065|FG001|Overall Study|Patient Request|1
7957057|NCT02634151|12507107|FG000|Overall Study|Withdrawal by Subject|1
7957058|NCT02634151|12507108|FG001|Overall Study|Withdrawal by Subject|0
7957059|NCT02634151|12507107|FG000|Overall Study|Non-Compliance|0
7957060|NCT02634151|12507108|FG001|Overall Study|Non-Compliance|1
7957061|NCT02634151|12507107|FG000|Overall Study|Other|0
7957062|NCT02634151|12507108|FG001|Overall Study|Other|1
7957063|NCT02634320|12507123|FG000|Overall Study|Adverse Event|2
7957064|NCT02634320|12507123|FG000|Overall Study|Lost to Follow-up|3
7957065|NCT02634320|12507123|FG000|Overall Study|Moved out of area|2
7957066|NCT02634320|12507123|FG000|Overall Study|Out of window for study visits|1
7957067|NCT02634320|12507123|FG000|Overall Study|Protocol Violation|1
7957068|NCT02634320|12507123|FG000|Overall Study|Withdrawal by Subject|5
7957069|NCT02634320|12507123|FG000|Overall Study|Lack of Efficacy|2
7957070|NCT02634346|12507130|FG000|Overall Study|Withdrawal by Subject|8
7957071|NCT02634346|12507131|FG001|Overall Study|Withdrawal by Subject|9
7957072|NCT02634346|12507132|FG002|Overall Study|Withdrawal by Subject|8
7957073|NCT02634346|12507130|FG000|Overall Study|Adverse Event|2
7957074|NCT02634346|12507131|FG001|Overall Study|Adverse Event|2
7957075|NCT02634346|12507132|FG002|Overall Study|Adverse Event|7
7957076|NCT02634346|12507130|FG000|Overall Study|Lack of Efficacy|1
7957077|NCT02634346|12507131|FG001|Overall Study|Lack of Efficacy|2
7957078|NCT02634346|12507132|FG002|Overall Study|Lack of Efficacy|8
7957079|NCT02634346|12507130|FG000|Overall Study|Lost to Follow-up|1
7957080|NCT02634346|12507131|FG001|Overall Study|Lost to Follow-up|0
7957081|NCT02634346|12507132|FG002|Overall Study|Lost to Follow-up|0
7957082|NCT02634346|12507130|FG000|Overall Study|Protocol Violation|0
7957083|NCT02634346|12507131|FG001|Overall Study|Protocol Violation|1
7957084|NCT02634346|12507132|FG002|Overall Study|Protocol Violation|0
7957085|NCT02634580|12507144|FG000|Double-blind Treatment Period|Subject Request|1
7957086|NCT02634580|12507145|FG001|Double-blind Treatment Period|Subject Request|0
7957087|NCT02634580|12507146|FG002|Double-blind Treatment Period|Subject Request|1
7957088|NCT02634580|12507147|FG003|Double-blind Treatment Period|Subject Request|1
7957089|NCT02634580|12507144|FG000|Open-label Extension Period|Withdrawal by Subject|0
7957090|NCT02634580|12507145|FG001|Open-label Extension Period|Withdrawal by Subject|1
7957091|NCT02634580|12507146|FG002|Open-label Extension Period|Withdrawal by Subject|0
7957092|NCT02634580|12507147|FG003|Open-label Extension Period|Withdrawal by Subject|1
7957093|NCT02634788|12507177|FG000|Overall Study|Adverse Event|0
7957094|NCT02634788|12507178|FG001|Overall Study|Adverse Event|8
7957095|NCT02634788|12507179|FG002|Overall Study|Adverse Event|3
7957096|NCT02634788|12507180|FG003|Overall Study|Adverse Event|1
7957097|NCT02634788|12507177|FG000|Overall Study|Lack of Efficacy|4
7957098|NCT02634788|12507178|FG001|Overall Study|Lack of Efficacy|0
7957099|NCT02634788|12507179|FG002|Overall Study|Lack of Efficacy|1
7957100|NCT02634788|12507180|FG003|Overall Study|Lack of Efficacy|4
7957101|NCT02634788|12507177|FG000|Overall Study|Lost to Follow-up|0
7957102|NCT02634788|12507178|FG001|Overall Study|Lost to Follow-up|1
7957103|NCT02634788|12507179|FG002|Overall Study|Lost to Follow-up|0
7957104|NCT02634788|12507180|FG003|Overall Study|Lost to Follow-up|0
7957105|NCT02634788|12507177|FG000|Overall Study|Withdrawal by Subject|0
7957106|NCT02634788|12507178|FG001|Overall Study|Withdrawal by Subject|1
7957107|NCT02634788|12507179|FG002|Overall Study|Withdrawal by Subject|1
7957108|NCT02634788|12507180|FG003|Overall Study|Withdrawal by Subject|0
7957109|NCT02634801|12507193|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2
7957110|NCT02634801|12507194|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20
7957111|NCT02634801|12507195|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0
7957112|NCT02634801|12507193|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
7957113|NCT02634801|12507194|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
7957114|NCT02634801|12507195|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
7957115|NCT02634801|12507193|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
7957116|NCT02634801|12507194|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
7957117|NCT02634801|12507195|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
7957118|NCT02634801|12507193|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
7957119|NCT02634801|12507194|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
7957120|NCT02634801|12507195|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
7957121|NCT02634801|12507193|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
7957122|NCT02634801|12507194|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
7957123|NCT02634801|12507195|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
7957124|NCT02634801|12507193|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0
7957125|NCT02634801|12507194|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0
7957126|NCT02634801|12507195|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1
7957127|NCT02634801|12507193|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
7957128|NCT02634801|12507194|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
7957129|NCT02634801|12507195|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
7957130|NCT02634801|12507193|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
7957131|NCT02634801|12507194|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
7957132|NCT02634801|12507195|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
7957133|NCT02634801|12507193|FG000|Extension Period (Weeks 24 to 36)|Missing|1
7957134|NCT02634801|12507194|FG001|Extension Period (Weeks 24 to 36)|Missing|0
7957135|NCT02634801|12507195|FG002|Extension Period (Weeks 24 to 36)|Missing|0
7957136|NCT02634801|12507193|FG000|Follow-up Period|Lost to Follow-up|3
7957137|NCT02634801|12507194|FG001|Follow-up Period|Lost to Follow-up|1
7957138|NCT02634801|12507195|FG002|Follow-up Period|Lost to Follow-up|2
7957139|NCT02634801|12507193|FG000|Follow-up Period|Physician Decision|0
7957140|NCT02634801|12507194|FG001|Follow-up Period|Physician Decision|0
7957141|NCT02634801|12507195|FG002|Follow-up Period|Physician Decision|1
7957142|NCT02634801|12507193|FG000|Follow-up Period|Withdrawal by Subject|1
7957143|NCT02634801|12507194|FG001|Follow-up Period|Withdrawal by Subject|2
7957144|NCT02634801|12507195|FG002|Follow-up Period|Withdrawal by Subject|5
7957145|NCT02634801|12507193|FG000|Follow-up Period|Adverse Event|1
7957146|NCT02634801|12507194|FG001|Follow-up Period|Adverse Event|5
7957147|NCT02634801|12507195|FG002|Follow-up Period|Adverse Event|0
7957148|NCT02634983|12507220|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2
7957149|NCT02634983|12507221|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0
7957150|NCT02635204|12507238|FG000|Overall Study|Adverse Event|1
7957151|NCT02635204|12507239|FG001|Overall Study|Adverse Event|0
7957152|NCT02635204|12507238|FG000|Overall Study|Lost to Follow-up|1
7957153|NCT02635204|12507239|FG001|Overall Study|Lost to Follow-up|1
7957154|NCT02635347|12507247|FG000|Overall Study|Failed screening|20
7957155|NCT02635347|12507248|FG001|Overall Study|Failed screening|7
7957156|NCT02635386|12507260|FG000|Overall Study|Pregnancy|2
7957157|NCT02635386|12507261|FG001|Overall Study|Pregnancy|0
7957158|NCT02635386|12507262|FG002|Overall Study|Pregnancy|0
7957159|NCT02635386|12507263|FG003|Overall Study|Pregnancy|0
7957160|NCT02635386|12507264|FG004|Overall Study|Pregnancy|2
7957161|NCT02635386|12507260|FG000|Overall Study|Withdrawal by Subject|1
7957162|NCT02635386|12507261|FG001|Overall Study|Withdrawal by Subject|1
7957163|NCT02635386|12507262|FG002|Overall Study|Withdrawal by Subject|0
7957164|NCT02635386|12507263|FG003|Overall Study|Withdrawal by Subject|1
7957165|NCT02635386|12507264|FG004|Overall Study|Withdrawal by Subject|0
7957166|NCT02635386|12507260|FG000|Overall Study|Physician Decision|0
7957167|NCT02635386|12507261|FG001|Overall Study|Physician Decision|1
7957168|NCT02635386|12507262|FG002|Overall Study|Physician Decision|0
7957169|NCT02635386|12507263|FG003|Overall Study|Physician Decision|0
7957170|NCT02635386|12507264|FG004|Overall Study|Physician Decision|0
7957171|NCT02635386|12507260|FG000|Overall Study|Moved Out of State|0
7957172|NCT02635386|12507261|FG001|Overall Study|Moved Out of State|1
7957173|NCT02635386|12507262|FG002|Overall Study|Moved Out of State|0
7957174|NCT02635386|12507263|FG003|Overall Study|Moved Out of State|0
7957175|NCT02635386|12507264|FG004|Overall Study|Moved Out of State|0
7957176|NCT02635386|12507260|FG000|Overall Study|Noncompliant|0
7957177|NCT02635386|12507261|FG001|Overall Study|Noncompliant|2
7957178|NCT02635386|12507262|FG002|Overall Study|Noncompliant|1
7957179|NCT02635386|12507263|FG003|Overall Study|Noncompliant|1
7957180|NCT02635386|12507264|FG004|Overall Study|Noncompliant|1
7957181|NCT02635386|12507260|FG000|Overall Study|side effects|0
7957182|NCT02635386|12507261|FG001|Overall Study|side effects|0
7957183|NCT02635386|12507262|FG002|Overall Study|side effects|1
7957184|NCT02635386|12507263|FG003|Overall Study|side effects|4
7957185|NCT02635386|12507264|FG004|Overall Study|side effects|6
7957186|NCT02635386|12507260|FG000|Overall Study|needed other major surgery|0
7957187|NCT02635386|12507261|FG001|Overall Study|needed other major surgery|1
7957188|NCT02635386|12507262|FG002|Overall Study|needed other major surgery|0
7957189|NCT02635386|12507263|FG003|Overall Study|needed other major surgery|0
7957190|NCT02635386|12507264|FG004|Overall Study|needed other major surgery|0
7957191|NCT02635386|12507260|FG000|Overall Study|Other medical problems not drug related|0
7957192|NCT02635386|12507261|FG001|Overall Study|Other medical problems not drug related|0
7957193|NCT02635386|12507262|FG002|Overall Study|Other medical problems not drug related|0
7957194|NCT02635386|12507263|FG003|Overall Study|Other medical problems not drug related|1
7957195|NCT02635386|12507264|FG004|Overall Study|Other medical problems not drug related|0
7957196|NCT02635646|12507301|FG000|Overall Study|Lost to Follow-up|24
7957197|NCT02635646|12507302|FG001|Overall Study|Lost to Follow-up|25
7957198|NCT02635646|12507301|FG000|Overall Study|Pregnancy|1
7957199|NCT02635646|12507302|FG001|Overall Study|Pregnancy|1
7957200|NCT02635724|12507317|FG000|Overall Study|Withdrawal by Subject|0
7957201|NCT02635724|12507318|FG001|Overall Study|Withdrawal by Subject|1
7957202|NCT02635724|12507319|FG002|Overall Study|Withdrawal by Subject|0
7957203|NCT02635737|12507327|FG000|Overall Study|Protocol Violation|1
7957204|NCT02635984|12507341|FG000|Overall Study|Lost to Follow-up|2
7957205|NCT02635984|12507342|FG001|Overall Study|Lost to Follow-up|4
7957206|NCT02635984|12507341|FG000|Overall Study|Study Arm Closed|1
7957207|NCT02635984|12507342|FG001|Overall Study|Study Arm Closed|0
7957208|NCT02636361|12507354|FG000|Period 4|Physician Decision|0
7957209|NCT02636361|12507355|FG001|Period 4|Physician Decision|0
7957210|NCT02636361|12507356|FG002|Period 4|Physician Decision|0
7957211|NCT02636361|12507357|FG003|Period 4|Physician Decision|1
7957212|NCT02636361|12507358|FG004|Period 4|Physician Decision|0
7957213|NCT02636595|12507372|FG000|Overall Study|Lost to Follow-up|1
7957214|NCT02636595|12507372|FG000|Overall Study|Other|1
7957215|NCT02636608|12507376|FG000|Overall Study|Failure to Return|4
7957216|NCT02636608|12507376|FG000|Overall Study|Insufficient Virological Response|1
7957217|NCT02636608|12507376|FG000|Overall Study|Death|3
7957218|NCT02636608|12507376|FG000|Overall Study|Other|2
7957219|NCT02636608|12507376|FG000|Overall Study|Did Not Receive Treatment|1
7957220|NCT02636699|12507385|FG000|Overall Study|Adverse Event|4
7957221|NCT02636699|12507386|FG001|Overall Study|Adverse Event|0
7957222|NCT02636699|12507385|FG000|Overall Study|Lost to Follow-up|3
7957223|NCT02636699|12507386|FG001|Overall Study|Lost to Follow-up|3
7957224|NCT02636699|12507385|FG000|Overall Study|Non-compliance with the investigational product (IP)|2
7957225|NCT02636699|12507386|FG001|Overall Study|Non-compliance with the investigational product (IP)|0
7957226|NCT02636699|12507385|FG000|Overall Study|Physician Decision|0
7957227|NCT02636699|12507386|FG001|Overall Study|Physician Decision|1
7957228|NCT02636699|12507385|FG000|Overall Study|Withdrawal by Subject|13
7957229|NCT02636699|12507386|FG001|Overall Study|Withdrawal by Subject|6
7957230|NCT02636699|12507385|FG000|Overall Study|Other|3
7957231|NCT02636699|12507386|FG001|Overall Study|Other|1
7957232|NCT02636725|12507397|FG000|Baseline|Adverse Event|1
7957233|NCT02636725|12507397|FG000|Baseline|Lack of Efficacy|2
7957234|NCT02636868|12507404|FG000|Overall Study|Death|0
7957235|NCT02636868|12507405|FG001|Overall Study|Death|1
7957236|NCT02636868|12507406|FG002|Overall Study|Death|2
7957237|NCT02636907|12507414|FG000|Autoinjector Assessment Period|Adverse Event|2
7957238|NCT02636907|12507414|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2
7957239|NCT02636907|12507414|FG000|Extension Phase|Adverse Event|2
7957240|NCT02636907|12507414|FG000|Extension Phase|Withdrawal by Subject|4
7957241|NCT02636907|12507414|FG000|Extension Phase|Physician Decision|1
7957242|NCT02636907|12507414|FG000|Extension Phase|Lost to Follow-up|2
7957243|NCT02636907|12507414|FG000|Extension Phase|Lack of Efficacy|1
7957244|NCT02637037|12507420|FG000|Overall Study|Positive drug screen at admission|1
7957245|NCT02637037|12507421|FG001|Overall Study|Positive drug screen at admission|0
7957246|NCT02637037|12507420|FG000|Overall Study|Withdrawal by Subject|2
7957247|NCT02637037|12507421|FG001|Overall Study|Withdrawal by Subject|1
7957248|NCT02637037|12507420|FG000|Overall Study|Adverse Event|1
7957249|NCT02637037|12507421|FG001|Overall Study|Adverse Event|0
7957250|NCT02637063|12507442|FG000|Overall Study|Lost to Follow-up|3
7957251|NCT02637063|12507443|FG001|Overall Study|Lost to Follow-up|2
7957252|NCT02637063|12507444|FG002|Overall Study|Lost to Follow-up|3
7957253|NCT02637063|12507442|FG000|Overall Study|Withdrawal by Subject|2
7957254|NCT02637063|12507443|FG001|Overall Study|Withdrawal by Subject|2
7957255|NCT02637063|12507444|FG002|Overall Study|Withdrawal by Subject|3
7957256|NCT02637076|12507454|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1
7957257|NCT02637076|12507455|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1
7957258|NCT02637076|12507454|FG000|Overall Study|Withdrawal by Subject|0
7957259|NCT02637076|12507455|FG001|Overall Study|Withdrawal by Subject|4
7957260|NCT02637141|12507464|FG000|Overall Study|Adverse Event|1
7957261|NCT02637141|12507465|FG001|Overall Study|Adverse Event|1
7957262|NCT02637141|12507466|FG002|Overall Study|Adverse Event|0
7957263|NCT02637141|12507464|FG000|Overall Study|Withdrawal by Subject|1
7957264|NCT02637141|12507465|FG001|Overall Study|Withdrawal by Subject|1
7957265|NCT02637141|12507466|FG002|Overall Study|Withdrawal by Subject|1
7957266|NCT02637232|12507474|FG000|Overall Study|Lost to Follow-up|42
7957267|NCT02637232|12507474|FG000|Overall Study|Adverse Event|11
7957268|NCT02637232|12507474|FG000|Overall Study|patient 's decision|2
7957269|NCT02637323|12507480|FG000|Overall Study|Lost to Follow-up|2
7957270|NCT02637323|12507481|FG001|Overall Study|Lost to Follow-up|0
7957271|NCT02637323|12507480|FG000|Overall Study|Protocol Violation|0
7957272|NCT02637323|12507481|FG001|Overall Study|Protocol Violation|1
7957273|NCT02637557|12507501|FG000|Overall Study|Adverse Event|3
7957274|NCT02637557|12507502|FG001|Overall Study|Adverse Event|1
7957275|NCT02637557|12507503|FG002|Overall Study|Adverse Event|3
7957276|NCT02637557|12507504|FG003|Overall Study|Adverse Event|3
7957277|NCT02637557|12507501|FG000|Overall Study|Lost to Follow-up|1
7957278|NCT02637557|12507502|FG001|Overall Study|Lost to Follow-up|1
7957279|NCT02637557|12507503|FG002|Overall Study|Lost to Follow-up|0
7957280|NCT02637557|12507504|FG003|Overall Study|Lost to Follow-up|1
7957281|NCT02637557|12507501|FG000|Overall Study|Physician Decision|1
7957282|NCT02637557|12507502|FG001|Overall Study|Physician Decision|0
7957283|NCT02637557|12507503|FG002|Overall Study|Physician Decision|0
7957284|NCT02637557|12507504|FG003|Overall Study|Physician Decision|0
7957285|NCT02637557|12507501|FG000|Overall Study|Protocol Violation|2
7957286|NCT02637557|12507502|FG001|Overall Study|Protocol Violation|0
7957287|NCT02637557|12507503|FG002|Overall Study|Protocol Violation|2
7957288|NCT02637557|12507504|FG003|Overall Study|Protocol Violation|1
7957289|NCT02637557|12507501|FG000|Overall Study|Withdrawal by Subject|1
7957290|NCT02637557|12507502|FG001|Overall Study|Withdrawal by Subject|3
7957291|NCT02637557|12507503|FG002|Overall Study|Withdrawal by Subject|4
7957292|NCT02637557|12507504|FG003|Overall Study|Withdrawal by Subject|2
7957293|NCT02637856|12507536|FG000|Main Study (Baseline to Week 100)|Adverse Event|9
7957294|NCT02637856|12507537|FG001|Main Study (Baseline to Week 100)|Adverse Event|0
7957295|NCT02637856|12507536|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5
7957296|NCT02637856|12507537|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0
7957297|NCT02637856|12507536|FG000|Main Study (Baseline to Week 100)|Physician Decision|2
7957298|NCT02637856|12507537|FG001|Main Study (Baseline to Week 100)|Physician Decision|0
7957299|NCT02637856|12507536|FG000|Main Study (Baseline to Week 100)|Pregnancy|7
7957300|NCT02637856|12507537|FG001|Main Study (Baseline to Week 100)|Pregnancy|0
7957301|NCT02637856|12507536|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20
7957302|NCT02637856|12507537|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0
7957303|NCT02637856|12507536|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2
7957304|NCT02637856|12507537|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0
7957305|NCT02637856|12507536|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164
7957306|NCT02637856|12507537|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0
7957307|NCT02637856|12507536|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1
7957308|NCT02637856|12507537|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0
7957309|NCT02637856|12507536|FG000|Main Study (Baseline to Week 100)|Incarceration|1
7957310|NCT02637856|12507537|FG001|Main Study (Baseline to Week 100)|Incarceration|0
7957311|NCT02637856|12507536|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2
7957312|NCT02637856|12507537|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0
7957313|NCT02637856|12507536|FG000|Main Study (Baseline to Week 100)|Site Closing|6
7957314|NCT02637856|12507537|FG001|Main Study (Baseline to Week 100)|Site Closing|0
7957315|NCT02637856|12507536|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0
7957316|NCT02637856|12507537|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1
7957317|NCT02637856|12507536|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0
7957318|NCT02637856|12507537|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3
7957319|NCT02637895|12507545|FG000|Overall Study|Lost to Follow-up|4
7957320|NCT02637895|12507546|FG001|Overall Study|Lost to Follow-up|0
7957321|NCT02637895|12507545|FG000|Overall Study|Protocol Violation|0
7957322|NCT02637895|12507546|FG001|Overall Study|Protocol Violation|1
7957323|NCT02637895|12507545|FG000|Overall Study|Lack of Efficacy|1
7957324|NCT02637895|12507546|FG001|Overall Study|Lack of Efficacy|0
7957325|NCT02637895|12507545|FG000|Overall Study|Withdrawal by Subject|1
7957326|NCT02637895|12507546|FG001|Overall Study|Withdrawal by Subject|1
7957327|NCT02637895|12507545|FG000|Overall Study|Abnormal baseline lab|0
7957328|NCT02637895|12507546|FG001|Overall Study|Abnormal baseline lab|1
7957329|NCT02638012|12507566|FG000|Overall Study|Lost to Follow-up|1
7957330|NCT02638103|12507583|FG000|Overall Study|Adverse Event|13
7957331|NCT02638103|12507584|FG001|Overall Study|Adverse Event|12
7957332|NCT02638103|12507585|FG002|Overall Study|Adverse Event|19
7957333|NCT02638103|12507586|FG003|Overall Study|Adverse Event|12
7957334|NCT02638103|12507583|FG000|Overall Study|Withdrawal by Subject|43
7957335|NCT02638103|12507584|FG001|Overall Study|Withdrawal by Subject|53
7957336|NCT02638103|12507585|FG002|Overall Study|Withdrawal by Subject|30
7957337|NCT02638103|12507586|FG003|Overall Study|Withdrawal by Subject|61
7957338|NCT02638103|12507583|FG000|Overall Study|Protocol Violation|1
7957339|NCT02638103|12507584|FG001|Overall Study|Protocol Violation|2
7957340|NCT02638103|12507585|FG002|Overall Study|Protocol Violation|1
7957341|NCT02638103|12507586|FG003|Overall Study|Protocol Violation|4
7957342|NCT02638103|12507583|FG000|Overall Study|Pregnancy|2
7957343|NCT02638103|12507584|FG001|Overall Study|Pregnancy|3
7957344|NCT02638103|12507585|FG002|Overall Study|Pregnancy|0
7957345|NCT02638103|12507586|FG003|Overall Study|Pregnancy|1
7957346|NCT02638103|12507583|FG000|Overall Study|Non-compliance to Study Procedures|2
7957347|NCT02638103|12507584|FG001|Overall Study|Non-compliance to Study Procedures|1
7957348|NCT02638103|12507585|FG002|Overall Study|Non-compliance to Study Procedures|1
7957349|NCT02638103|12507586|FG003|Overall Study|Non-compliance to Study Procedures|1
7957350|NCT02638103|12507583|FG000|Overall Study|Lost to Follow-up|26
7957351|NCT02638103|12507584|FG001|Overall Study|Lost to Follow-up|33
7957352|NCT02638103|12507585|FG002|Overall Study|Lost to Follow-up|20
7957353|NCT02638103|12507586|FG003|Overall Study|Lost to Follow-up|37
7957354|NCT02638103|12507583|FG000|Overall Study|Lack of Efficacy|14
7957355|NCT02638103|12507584|FG001|Overall Study|Lack of Efficacy|10
7957356|NCT02638103|12507585|FG002|Overall Study|Lack of Efficacy|12
7957357|NCT02638103|12507586|FG003|Overall Study|Lack of Efficacy|22
7957358|NCT02638103|12507583|FG000|Overall Study|Other than specified|5
7957359|NCT02638103|12507584|FG001|Overall Study|Other than specified|4
7957360|NCT02638103|12507585|FG002|Overall Study|Other than specified|2
7957361|NCT02638103|12507586|FG003|Overall Study|Other than specified|4
7957362|NCT02638259|12507626|FG000|Treatment Period 1|Adverse Event|1
7957363|NCT02638259|12507627|FG001|Treatment Period 1|Adverse Event|5
7957364|NCT02638259|12507626|FG000|Treatment Period 1|Death|0
7957365|NCT02638259|12507627|FG001|Treatment Period 1|Death|1
7957366|NCT02638259|12507626|FG000|Treatment Period 1|Lack of Efficacy|0
7957367|NCT02638259|12507627|FG001|Treatment Period 1|Lack of Efficacy|1
7957368|NCT02638259|12507626|FG000|Treatment Period 1|Protocol Violation|0
7957369|NCT02638259|12507627|FG001|Treatment Period 1|Protocol Violation|3
7957370|NCT02638259|12507626|FG000|Treatment Period 1|Withdrawal by Subject|4
7957371|NCT02638259|12507627|FG001|Treatment Period 1|Withdrawal by Subject|6
7957372|NCT02638259|12507626|FG000|Treatment Period 1|Withdrawn per sponsor decision|0
7957373|NCT02638259|12507627|FG001|Treatment Period 1|Withdrawn per sponsor decision|2
7957374|NCT02638259|12507626|FG000|Treatment Period 2|Adverse Event|5
7957375|NCT02638259|12507627|FG001|Treatment Period 2|Adverse Event|4
7957376|NCT02638259|12507626|FG000|Treatment Period 2|Withdrawal by Subject|1
7957377|NCT02638259|12507627|FG001|Treatment Period 2|Withdrawal by Subject|7
7957378|NCT02638337|12507639|FG000|Overall Study|Adverse Event|6
7957379|NCT02638337|12507640|FG001|Overall Study|Adverse Event|10
7957380|NCT02638337|12507639|FG000|Overall Study|Protocol Violation|3
7957381|NCT02638337|12507640|FG001|Overall Study|Protocol Violation|0
7957382|NCT02638337|12507639|FG000|Overall Study|Withdrawal by Subject|13
7957383|NCT02638337|12507640|FG001|Overall Study|Withdrawal by Subject|16
7957384|NCT02638337|12507639|FG000|Overall Study|Lost to Follow-up|7
7957385|NCT02638337|12507640|FG001|Overall Study|Lost to Follow-up|7
7957386|NCT02638337|12507639|FG000|Overall Study|Other - Miscellaneous|4
7957387|NCT02638337|12507640|FG001|Overall Study|Other - Miscellaneous|3
7957388|NCT02638493|12507649|FG000|Overall Study|Inability to provide semen samples|2
7957389|NCT02638493|12507650|FG001|Overall Study|Inability to provide semen samples|0
7957390|NCT02638493|12507651|FG002|Overall Study|Inability to provide semen samples|0
7957391|NCT02638623|12507672|FG000|Overall Study|Surgery timing|5
7957392|NCT02638623|12507673|FG001|Overall Study|Surgery timing|6
7957393|NCT02638623|12507672|FG000|Overall Study|Not given intervention|2
7957394|NCT02638623|12507673|FG001|Overall Study|Not given intervention|0
7957395|NCT02638948|12507683|FG000|Overall Study|Withdrawal by Subject|4
7957396|NCT02638948|12507684|FG001|Overall Study|Withdrawal by Subject|5
7957397|NCT02638948|12507685|FG002|Overall Study|Withdrawal by Subject|3
7957398|NCT02638948|12507686|FG003|Overall Study|Withdrawal by Subject|1
7957399|NCT02638948|12507683|FG000|Overall Study|Administrative Reason by Sponsor|0
7957400|NCT02638948|12507684|FG001|Overall Study|Administrative Reason by Sponsor|1
7957401|NCT02638948|12507685|FG002|Overall Study|Administrative Reason by Sponsor|0
7957402|NCT02638948|12507686|FG003|Overall Study|Administrative Reason by Sponsor|4
7957403|NCT02638948|12507683|FG000|Overall Study|Adverse Event|0
7957404|NCT02638948|12507684|FG001|Overall Study|Adverse Event|0
7957405|NCT02638948|12507685|FG002|Overall Study|Adverse Event|1
7957406|NCT02638948|12507686|FG003|Overall Study|Adverse Event|1
7957407|NCT02638948|12507683|FG000|Overall Study|Lack of Efficacy|1
7957408|NCT02638948|12507684|FG001|Overall Study|Lack of Efficacy|1
7957409|NCT02638948|12507685|FG002|Overall Study|Lack of Efficacy|0
7957410|NCT02638948|12507686|FG003|Overall Study|Lack of Efficacy|0
7957411|NCT02638948|12507683|FG000|Overall Study|Lost to Follow-up|0
7957412|NCT02638948|12507684|FG001|Overall Study|Lost to Follow-up|0
7957413|NCT02638948|12507685|FG002|Overall Study|Lost to Follow-up|1
7957414|NCT02638948|12507686|FG003|Overall Study|Lost to Follow-up|1
7957415|NCT02638948|12507683|FG000|Overall Study|Poor/Non-Compliance|0
7957416|NCT02638948|12507684|FG001|Overall Study|Poor/Non-Compliance|2
7957417|NCT02638948|12507685|FG002|Overall Study|Poor/Non-Compliance|1
7957418|NCT02638948|12507686|FG003|Overall Study|Poor/Non-Compliance|0
7957419|NCT02638948|12507683|FG000|Overall Study|Participant no longer met study criteria|0
7957420|NCT02638948|12507684|FG001|Overall Study|Participant no longer met study criteria|1
7957421|NCT02638948|12507685|FG002|Overall Study|Participant no longer met study criteria|0
7957422|NCT02638948|12507686|FG003|Overall Study|Participant no longer met study criteria|0
7957423|NCT02638948|12507683|FG000|Overall Study|Other than specified above|4
7957424|NCT02638948|12507684|FG001|Overall Study|Other than specified above|1
7957425|NCT02638948|12507685|FG002|Overall Study|Other than specified above|1
7957426|NCT02638948|12507686|FG003|Overall Study|Other than specified above|1
7957427|NCT02639052|12507708|FG000|Overall Study|Lost to Follow-up|1
7957428|NCT02639182|12507716|FG000|Overall Study|Disease Progression|50
7957429|NCT02639182|12507717|FG001|Overall Study|Disease Progression|49
7957430|NCT02639182|12507716|FG000|Overall Study|Adverse Event|7
7957431|NCT02639182|12507717|FG001|Overall Study|Adverse Event|5
7957432|NCT02639182|12507716|FG000|Overall Study|Physician Decision|3
7957433|NCT02639182|12507717|FG001|Overall Study|Physician Decision|3
7957434|NCT02639182|12507716|FG000|Overall Study|Withdrew Consent|5
7957435|NCT02639182|12507717|FG001|Overall Study|Withdrew Consent|4
7957436|NCT02639182|12507716|FG000|Overall Study|Lost to Follow-up|0
7957437|NCT02639182|12507717|FG001|Overall Study|Lost to Follow-up|1
7957438|NCT02639182|12507716|FG000|Overall Study|Study Closure|1
7957439|NCT02639182|12507717|FG001|Overall Study|Study Closure|2
7957440|NCT02639182|12507716|FG000|Overall Study|Sponsor Ended Study|0
7957441|NCT02639182|12507717|FG001|Overall Study|Sponsor Ended Study|1
7957442|NCT02639182|12507716|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1
7957443|NCT02639182|12507717|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1
7957444|NCT02639247|12507725|FG000|Overall Study|Lost to Follow-up|2
7957445|NCT02639247|12507726|FG001|Overall Study|Lost to Follow-up|1
7957446|NCT02639247|12507725|FG000|Overall Study|Death|2
7957447|NCT02639247|12507726|FG001|Overall Study|Death|0
7957448|NCT02639247|12507725|FG000|Overall Study|Withdrew Consent|0
7957449|NCT02639247|12507726|FG001|Overall Study|Withdrew Consent|1
7957450|NCT02639247|12507725|FG000|Overall Study|Protocol Violation|1
7957451|NCT02639247|12507726|FG001|Overall Study|Protocol Violation|0
7957452|NCT02639338|12507743|FG000|Overall Study|Lost to Follow-up|2
7957453|NCT02639338|12507744|FG001|Overall Study|Lost to Follow-up|2
7957454|NCT02639338|12507743|FG000|Overall Study|Withdrew Consent|1
7957455|NCT02639338|12507744|FG001|Overall Study|Withdrew Consent|2
7957456|NCT02639338|12507743|FG000|Overall Study|Death|1
7957457|NCT02639338|12507744|FG001|Overall Study|Death|0
7957458|NCT02639338|12507743|FG000|Overall Study|Randomized but Not Treated|0
7957459|NCT02639338|12507744|FG001|Overall Study|Randomized but Not Treated|1
7957460|NCT02640053|12507815|FG000|Overall Study|Withdrawal by Subject|2
7957461|NCT02640053|12507816|FG001|Overall Study|Withdrawal by Subject|1
7957462|NCT02640053|12507815|FG000|Overall Study|Adverse Event|1
7957463|NCT02640053|12507816|FG001|Overall Study|Adverse Event|1
7957464|NCT02640053|12507815|FG000|Overall Study|Alternative Therapy|1
7957465|NCT02640053|12507816|FG001|Overall Study|Alternative Therapy|1
7957466|NCT02640053|12507815|FG000|Overall Study|Chemo regimen changed after 1st Rx|0
7957467|NCT02640053|12507816|FG001|Overall Study|Chemo regimen changed after 1st Rx|1
7957468|NCT02640157|12507825|FG000|Overall Study|Adverse Event|2
7957469|NCT02640157|12507826|FG001|Overall Study|Adverse Event|2
7957470|NCT02640157|12507827|FG002|Overall Study|Adverse Event|1
7957471|NCT02640157|12507825|FG000|Overall Study|Withdrew consent|2
7957472|NCT02640157|12507826|FG001|Overall Study|Withdrew consent|0
7957473|NCT02640157|12507827|FG002|Overall Study|Withdrew consent|2
7957474|NCT02640157|12507825|FG000|Overall Study|Lost to Follow-up|9
7957475|NCT02640157|12507826|FG001|Overall Study|Lost to Follow-up|2
7957476|NCT02640157|12507827|FG002|Overall Study|Lost to Follow-up|7
7957477|NCT02640157|12507825|FG000|Overall Study|Randomized in error; did not receive Tx|0
7957478|NCT02640157|12507826|FG001|Overall Study|Randomized in error; did not receive Tx|1
7957479|NCT02640157|12507827|FG002|Overall Study|Randomized in error; did not receive Tx|0
7957480|NCT02640235|12507838|FG000|Overall Study|Withdrawal by Subject|7
7957481|NCT02640235|12507839|FG001|Overall Study|Withdrawal by Subject|6
7957482|NCT02640235|12507838|FG000|Overall Study|Lost to Follow-up|4
7957483|NCT02640235|12507839|FG001|Overall Study|Lost to Follow-up|3
7957484|NCT02640235|12507838|FG000|Overall Study|Death|2
7957485|NCT02640235|12507839|FG001|Overall Study|Death|3
7957486|NCT02640235|12507838|FG000|Overall Study|Other|1
7957487|NCT02640235|12507839|FG001|Overall Study|Other|2
7957488|NCT02640404|12507847|FG000|Overall Study|Protocol Violation|1
7957489|NCT02640404|12507848|FG001|Overall Study|Protocol Violation|0
7957490|NCT02640404|12507847|FG000|Overall Study|Withdrawal by Subject|1
7957491|NCT02640404|12507848|FG001|Overall Study|Withdrawal by Subject|0
7957492|NCT02640482|12507856|FG000|Overall Study|Lost to Follow-up|3
7957493|NCT02640482|12507857|FG001|Overall Study|Lost to Follow-up|0
7957494|NCT02640547|12507863|FG000|Overall Study|Failure to Return|1
7957495|NCT02640547|12507863|FG000|Overall Study|Withdrawal by Subject|1
7957496|NCT02640547|12507863|FG000|Overall Study|Death|6
7957497|NCT02640547|12507863|FG000|Overall Study|Miscellaneous|3
7957498|NCT02640612|12507878|FG000|Overall Study|Adverse Event|6
7957499|NCT02640612|12507879|FG001|Overall Study|Adverse Event|7
7957500|NCT02640612|12507880|FG002|Overall Study|Adverse Event|2
7957501|NCT02640612|12507878|FG000|Overall Study|Death|1
7957502|NCT02640612|12507879|FG001|Overall Study|Death|0
7957503|NCT02640612|12507880|FG002|Overall Study|Death|0
7957504|NCT02640612|12507878|FG000|Overall Study|Withdrawal by Subject|10
7957505|NCT02640612|12507879|FG001|Overall Study|Withdrawal by Subject|3
7957506|NCT02640612|12507880|FG002|Overall Study|Withdrawal by Subject|3
7957507|NCT02640612|12507878|FG000|Overall Study|Lost to Follow-up|4
7957508|NCT02640612|12507879|FG001|Overall Study|Lost to Follow-up|1
7957509|NCT02640612|12507880|FG002|Overall Study|Lost to Follow-up|1
7957510|NCT02640612|12507878|FG000|Overall Study|Protocol Violation|0
7957511|NCT02640612|12507879|FG001|Overall Study|Protocol Violation|2
7957512|NCT02640612|12507880|FG002|Overall Study|Protocol Violation|0
7957513|NCT02640612|12507878|FG000|Overall Study|Lack of Efficacy|1
7957514|NCT02640612|12507879|FG001|Overall Study|Lack of Efficacy|1
7957515|NCT02640612|12507880|FG002|Overall Study|Lack of Efficacy|0
7957516|NCT02640755|12507899|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0
7957517|NCT02640755|12507900|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1
7957518|NCT02640755|12507899|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1
7957519|NCT02640755|12507900|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0
7957520|NCT02640755|12507899|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1
7957521|NCT02640755|12507900|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0
7957522|NCT02641080|12507931|FG000|Overall Study|Physician Decision|2
7957523|NCT02641080|12507932|FG001|Overall Study|Physician Decision|0
7957524|NCT02641080|12507931|FG000|Overall Study|Withdrawal by Subject|0
7957525|NCT02641080|12507932|FG001|Overall Study|Withdrawal by Subject|1
7957526|NCT02641080|12507931|FG000|Overall Study|Rehab Center denied use of pumps|0
7957527|NCT02641080|12507932|FG001|Overall Study|Rehab Center denied use of pumps|3
7957528|NCT02641080|12507931|FG000|Overall Study|Lost to Follow-up|0
7957529|NCT02641080|12507932|FG001|Overall Study|Lost to Follow-up|3
7957530|NCT02641379|12507970|FG000|Overall Study|Exclusion criterion during screening|1
7957531|NCT02641379|12507971|FG001|Overall Study|Exclusion criterion during screening|0
7957532|NCT02641379|12507972|FG002|Overall Study|Exclusion criterion during screening|0
7957533|NCT02641379|12507973|FG003|Overall Study|Exclusion criterion during screening|1
7957534|NCT02641379|12507974|FG004|Overall Study|Exclusion criterion during screening|2
7957535|NCT02641379|12507975|FG005|Overall Study|Exclusion criterion during screening|0
7957536|NCT02641379|12507976|FG006|Overall Study|Exclusion criterion during screening|0
7957537|NCT02641379|12507977|FG007|Overall Study|Exclusion criterion during screening|0
7957538|NCT02641379|12507978|FG008|Overall Study|Exclusion criterion during screening|0
7957539|NCT02641379|12507979|FG009|Overall Study|Exclusion criterion during screening|0
7957540|NCT02641379|12507980|FG010|Overall Study|Exclusion criterion during screening|0
7957541|NCT02641379|12507970|FG000|Overall Study|Withdrawal of informed consent|0
7957542|NCT02641379|12507971|FG001|Overall Study|Withdrawal of informed consent|1
7957543|NCT02641379|12507972|FG002|Overall Study|Withdrawal of informed consent|0
7957544|NCT02641379|12507973|FG003|Overall Study|Withdrawal of informed consent|0
7957545|NCT02641379|12507974|FG004|Overall Study|Withdrawal of informed consent|0
7957546|NCT02641379|12507975|FG005|Overall Study|Withdrawal of informed consent|0
7957547|NCT02641379|12507976|FG006|Overall Study|Withdrawal of informed consent|0
7957548|NCT02641379|12507977|FG007|Overall Study|Withdrawal of informed consent|1
7957549|NCT02641379|12507978|FG008|Overall Study|Withdrawal of informed consent|0
7957550|NCT02641379|12507979|FG009|Overall Study|Withdrawal of informed consent|0
7957551|NCT02641379|12507980|FG010|Overall Study|Withdrawal of informed consent|0
7957552|NCT02641379|12507970|FG000|Overall Study|Adverse Event|7
7957553|NCT02641379|12507971|FG001|Overall Study|Adverse Event|8
7957554|NCT02641379|12507972|FG002|Overall Study|Adverse Event|2
7957555|NCT02641379|12507973|FG003|Overall Study|Adverse Event|2
7957556|NCT02641379|12507974|FG004|Overall Study|Adverse Event|5
7957557|NCT02641379|12507975|FG005|Overall Study|Adverse Event|1
7957558|NCT02641379|12507976|FG006|Overall Study|Adverse Event|5
7957559|NCT02641379|12507977|FG007|Overall Study|Adverse Event|0
7957560|NCT02641379|12507978|FG008|Overall Study|Adverse Event|1
7957561|NCT02641379|12507979|FG009|Overall Study|Adverse Event|1
7957562|NCT02641379|12507980|FG010|Overall Study|Adverse Event|5
7957563|NCT02641379|12507970|FG000|Overall Study|Lack of Efficacy|0
7957564|NCT02641379|12507971|FG001|Overall Study|Lack of Efficacy|0
7957565|NCT02641379|12507972|FG002|Overall Study|Lack of Efficacy|2
7957566|NCT02641379|12507973|FG003|Overall Study|Lack of Efficacy|0
7957567|NCT02641379|12507974|FG004|Overall Study|Lack of Efficacy|0
7957568|NCT02641379|12507975|FG005|Overall Study|Lack of Efficacy|2
7957569|NCT02641379|12507976|FG006|Overall Study|Lack of Efficacy|0
7957570|NCT02641379|12507977|FG007|Overall Study|Lack of Efficacy|5
7957571|NCT02641379|12507978|FG008|Overall Study|Lack of Efficacy|0
7957572|NCT02641379|12507979|FG009|Overall Study|Lack of Efficacy|0
7957573|NCT02641379|12507980|FG010|Overall Study|Lack of Efficacy|0
7957574|NCT02641379|12507970|FG000|Overall Study|Participant unable to attend study visit|4
7957575|NCT02641379|12507971|FG001|Overall Study|Participant unable to attend study visit|10
7957576|NCT02641379|12507972|FG002|Overall Study|Participant unable to attend study visit|1
7957577|NCT02641379|12507973|FG003|Overall Study|Participant unable to attend study visit|2
7957578|NCT02641379|12507974|FG004|Overall Study|Participant unable to attend study visit|5
7957579|NCT02641379|12507975|FG005|Overall Study|Participant unable to attend study visit|1
7957580|NCT02641379|12507976|FG006|Overall Study|Participant unable to attend study visit|1
7957581|NCT02641379|12507977|FG007|Overall Study|Participant unable to attend study visit|1
7957582|NCT02641379|12507978|FG008|Overall Study|Participant unable to attend study visit|0
7957583|NCT02641379|12507979|FG009|Overall Study|Participant unable to attend study visit|2
7957584|NCT02641379|12507980|FG010|Overall Study|Participant unable to attend study visit|0
7957585|NCT02641379|12507970|FG000|Overall Study|Participant's compliance|0
7957586|NCT02641379|12507971|FG001|Overall Study|Participant's compliance|1
7957587|NCT02641379|12507972|FG002|Overall Study|Participant's compliance|0
7957588|NCT02641379|12507973|FG003|Overall Study|Participant's compliance|1
7957589|NCT02641379|12507974|FG004|Overall Study|Participant's compliance|0
7957590|NCT02641379|12507975|FG005|Overall Study|Participant's compliance|2
7957591|NCT02641379|12507976|FG006|Overall Study|Participant's compliance|0
7957592|NCT02641379|12507977|FG007|Overall Study|Participant's compliance|0
7957593|NCT02641379|12507978|FG008|Overall Study|Participant's compliance|1
7957594|NCT02641379|12507979|FG009|Overall Study|Participant's compliance|1
7957595|NCT02641379|12507980|FG010|Overall Study|Participant's compliance|1
7957596|NCT02641379|12507970|FG000|Overall Study|Participant cannot be reached|4
7957597|NCT02641379|12507971|FG001|Overall Study|Participant cannot be reached|4
7957598|NCT02641379|12507972|FG002|Overall Study|Participant cannot be reached|0
7957599|NCT02641379|12507973|FG003|Overall Study|Participant cannot be reached|8
7957600|NCT02641379|12507974|FG004|Overall Study|Participant cannot be reached|2
7957601|NCT02641379|12507975|FG005|Overall Study|Participant cannot be reached|1
7957602|NCT02641379|12507976|FG006|Overall Study|Participant cannot be reached|0
7957603|NCT02641379|12507977|FG007|Overall Study|Participant cannot be reached|1
7957604|NCT02641379|12507978|FG008|Overall Study|Participant cannot be reached|0
7957605|NCT02641379|12507979|FG009|Overall Study|Participant cannot be reached|2
7957606|NCT02641379|12507980|FG010|Overall Study|Participant cannot be reached|1
7957607|NCT02641379|12507970|FG000|Overall Study|PCR positive at Week 24|15
7957608|NCT02641379|12507971|FG001|Overall Study|PCR positive at Week 24|21
7957609|NCT02641379|12507972|FG002|Overall Study|PCR positive at Week 24|62
7957610|NCT02641379|12507973|FG003|Overall Study|PCR positive at Week 24|0
7957611|NCT02641379|12507974|FG004|Overall Study|PCR positive at Week 24|0
7957612|NCT02641379|12507975|FG005|Overall Study|PCR positive at Week 24|6
7957613|NCT02641379|12507976|FG006|Overall Study|PCR positive at Week 24|3
7957614|NCT02641379|12507977|FG007|Overall Study|PCR positive at Week 24|8
7957615|NCT02641379|12507978|FG008|Overall Study|PCR positive at Week 24|0
7957616|NCT02641379|12507979|FG009|Overall Study|PCR positive at Week 24|1
7957617|NCT02641379|12507980|FG010|Overall Study|PCR positive at Week 24|0
7957618|NCT02641379|12507970|FG000|Overall Study|PCR positive at follow up 2|1
7957619|NCT02641379|12507971|FG001|Overall Study|PCR positive at follow up 2|0
7957620|NCT02641379|12507972|FG002|Overall Study|PCR positive at follow up 2|0
7957621|NCT02641379|12507973|FG003|Overall Study|PCR positive at follow up 2|0
7957622|NCT02641379|12507974|FG004|Overall Study|PCR positive at follow up 2|0
7957623|NCT02641379|12507975|FG005|Overall Study|PCR positive at follow up 2|0
7957624|NCT02641379|12507976|FG006|Overall Study|PCR positive at follow up 2|0
7957625|NCT02641379|12507977|FG007|Overall Study|PCR positive at follow up 2|0
7957626|NCT02641379|12507978|FG008|Overall Study|PCR positive at follow up 2|0
7957627|NCT02641379|12507979|FG009|Overall Study|PCR positive at follow up 2|0
7957628|NCT02641379|12507980|FG010|Overall Study|PCR positive at follow up 2|0
7957629|NCT02641379|12507970|FG000|Overall Study|Participant showed relapse|1
7957630|NCT02641379|12507971|FG001|Overall Study|Participant showed relapse|0
7957631|NCT02641379|12507972|FG002|Overall Study|Participant showed relapse|0
7957632|NCT02641379|12507973|FG003|Overall Study|Participant showed relapse|0
7957633|NCT02641379|12507974|FG004|Overall Study|Participant showed relapse|0
7957634|NCT02641379|12507975|FG005|Overall Study|Participant showed relapse|0
7957635|NCT02641379|12507976|FG006|Overall Study|Participant showed relapse|1
7957636|NCT02641379|12507977|FG007|Overall Study|Participant showed relapse|0
7957637|NCT02641379|12507978|FG008|Overall Study|Participant showed relapse|0
7957638|NCT02641379|12507979|FG009|Overall Study|Participant showed relapse|0
7957639|NCT02641379|12507980|FG010|Overall Study|Participant showed relapse|0
7957640|NCT02641379|12507970|FG000|Overall Study|Participant stopped study/treatment|1
7957641|NCT02641379|12507971|FG001|Overall Study|Participant stopped study/treatment|3
7957642|NCT02641379|12507972|FG002|Overall Study|Participant stopped study/treatment|1
7957643|NCT02641379|12507973|FG003|Overall Study|Participant stopped study/treatment|0
7957644|NCT02641379|12507974|FG004|Overall Study|Participant stopped study/treatment|0
7957645|NCT02641379|12507975|FG005|Overall Study|Participant stopped study/treatment|1
7957646|NCT02641379|12507976|FG006|Overall Study|Participant stopped study/treatment|2
7957647|NCT02641379|12507977|FG007|Overall Study|Participant stopped study/treatment|0
7957648|NCT02641379|12507978|FG008|Overall Study|Participant stopped study/treatment|1
7957649|NCT02641379|12507979|FG009|Overall Study|Participant stopped study/treatment|0
7957650|NCT02641379|12507980|FG010|Overall Study|Participant stopped study/treatment|0
7957651|NCT02641379|12507970|FG000|Overall Study|Therapy stopped due to misunderstanding|1
7957652|NCT02641379|12507971|FG001|Overall Study|Therapy stopped due to misunderstanding|0
7957653|NCT02641379|12507972|FG002|Overall Study|Therapy stopped due to misunderstanding|0
7957654|NCT02641379|12507973|FG003|Overall Study|Therapy stopped due to misunderstanding|0
7957655|NCT02641379|12507974|FG004|Overall Study|Therapy stopped due to misunderstanding|0
7957656|NCT02641379|12507975|FG005|Overall Study|Therapy stopped due to misunderstanding|0
7957657|NCT02641379|12507976|FG006|Overall Study|Therapy stopped due to misunderstanding|0
7957658|NCT02641379|12507977|FG007|Overall Study|Therapy stopped due to misunderstanding|0
7957659|NCT02641379|12507978|FG008|Overall Study|Therapy stopped due to misunderstanding|0
7957660|NCT02641379|12507979|FG009|Overall Study|Therapy stopped due to misunderstanding|0
7966548|NCT02752776|12522663|FG000|Overall Study|Withdrawal by Subject|3
7957661|NCT02641379|12507980|FG010|Overall Study|Therapy stopped due to misunderstanding|0
7957662|NCT02641379|12507970|FG000|Overall Study|Financial problems|0
7957663|NCT02641379|12507971|FG001|Overall Study|Financial problems|1
7957664|NCT02641379|12507972|FG002|Overall Study|Financial problems|0
7957665|NCT02641379|12507973|FG003|Overall Study|Financial problems|0
7957666|NCT02641379|12507974|FG004|Overall Study|Financial problems|0
7957667|NCT02641379|12507975|FG005|Overall Study|Financial problems|0
7957668|NCT02641379|12507976|FG006|Overall Study|Financial problems|0
7957669|NCT02641379|12507977|FG007|Overall Study|Financial problems|0
7957670|NCT02641379|12507978|FG008|Overall Study|Financial problems|0
7957671|NCT02641379|12507979|FG009|Overall Study|Financial problems|0
7957672|NCT02641379|12507980|FG010|Overall Study|Financial problems|0
7957673|NCT02641379|12507970|FG000|Overall Study|PCR positive at Week 68|0
7957674|NCT02641379|12507971|FG001|Overall Study|PCR positive at Week 68|1
7957675|NCT02641379|12507972|FG002|Overall Study|PCR positive at Week 68|0
7957676|NCT02641379|12507973|FG003|Overall Study|PCR positive at Week 68|0
7957677|NCT02641379|12507974|FG004|Overall Study|PCR positive at Week 68|0
7957678|NCT02641379|12507975|FG005|Overall Study|PCR positive at Week 68|0
7957679|NCT02641379|12507976|FG006|Overall Study|PCR positive at Week 68|0
7957680|NCT02641379|12507977|FG007|Overall Study|PCR positive at Week 68|0
7957681|NCT02641379|12507978|FG008|Overall Study|PCR positive at Week 68|0
7957682|NCT02641379|12507979|FG009|Overall Study|PCR positive at Week 68|0
7957683|NCT02641379|12507980|FG010|Overall Study|PCR positive at Week 68|0
7957684|NCT02641379|12507970|FG000|Overall Study|PCR positive at Week 48|0
7957685|NCT02641379|12507971|FG001|Overall Study|PCR positive at Week 48|1
7957686|NCT02641379|12507972|FG002|Overall Study|PCR positive at Week 48|0
7957687|NCT02641379|12507973|FG003|Overall Study|PCR positive at Week 48|0
7957688|NCT02641379|12507974|FG004|Overall Study|PCR positive at Week 48|0
7957689|NCT02641379|12507975|FG005|Overall Study|PCR positive at Week 48|0
7957690|NCT02641379|12507976|FG006|Overall Study|PCR positive at Week 48|0
7957691|NCT02641379|12507977|FG007|Overall Study|PCR positive at Week 48|0
7957692|NCT02641379|12507978|FG008|Overall Study|PCR positive at Week 48|0
7957693|NCT02641379|12507979|FG009|Overall Study|PCR positive at Week 48|0
7957694|NCT02641379|12507980|FG010|Overall Study|PCR positive at Week 48|0
7957695|NCT02641379|12507970|FG000|Overall Study|PCR not performed at Week 12|0
7957696|NCT02641379|12507971|FG001|Overall Study|PCR not performed at Week 12|0
7957697|NCT02641379|12507972|FG002|Overall Study|PCR not performed at Week 12|1
7957698|NCT02641379|12507973|FG003|Overall Study|PCR not performed at Week 12|0
7957699|NCT02641379|12507974|FG004|Overall Study|PCR not performed at Week 12|0
7957700|NCT02641379|12507975|FG005|Overall Study|PCR not performed at Week 12|0
7957701|NCT02641379|12507976|FG006|Overall Study|PCR not performed at Week 12|0
7957702|NCT02641379|12507977|FG007|Overall Study|PCR not performed at Week 12|0
7957703|NCT02641379|12507978|FG008|Overall Study|PCR not performed at Week 12|0
7957704|NCT02641379|12507979|FG009|Overall Study|PCR not performed at Week 12|0
7957705|NCT02641379|12507980|FG010|Overall Study|PCR not performed at Week 12|0
7957706|NCT02641379|12507970|FG000|Overall Study|No PCR at baseline|0
7957707|NCT02641379|12507971|FG001|Overall Study|No PCR at baseline|0
7957708|NCT02641379|12507972|FG002|Overall Study|No PCR at baseline|1
7957709|NCT02641379|12507973|FG003|Overall Study|No PCR at baseline|0
7957710|NCT02641379|12507974|FG004|Overall Study|No PCR at baseline|0
7957711|NCT02641379|12507975|FG005|Overall Study|No PCR at baseline|0
7957712|NCT02641379|12507976|FG006|Overall Study|No PCR at baseline|0
7957713|NCT02641379|12507977|FG007|Overall Study|No PCR at baseline|0
7957714|NCT02641379|12507978|FG008|Overall Study|No PCR at baseline|0
7957715|NCT02641379|12507979|FG009|Overall Study|No PCR at baseline|0
7957716|NCT02641379|12507980|FG010|Overall Study|No PCR at baseline|0
7957717|NCT02641379|12507970|FG000|Overall Study|PCR positive at Week 28|0
7957718|NCT02641379|12507971|FG001|Overall Study|PCR positive at Week 28|0
7957719|NCT02641379|12507972|FG002|Overall Study|PCR positive at Week 28|1
7957720|NCT02641379|12507973|FG003|Overall Study|PCR positive at Week 28|0
7957721|NCT02641379|12507974|FG004|Overall Study|PCR positive at Week 28|0
7957722|NCT02641379|12507975|FG005|Overall Study|PCR positive at Week 28|0
7957723|NCT02641379|12507976|FG006|Overall Study|PCR positive at Week 28|0
7957724|NCT02641379|12507977|FG007|Overall Study|PCR positive at Week 28|0
7957725|NCT02641379|12507978|FG008|Overall Study|PCR positive at Week 28|0
7957726|NCT02641379|12507979|FG009|Overall Study|PCR positive at Week 28|0
7957727|NCT02641379|12507980|FG010|Overall Study|PCR positive at Week 28|0
7957728|NCT02641379|12507970|FG000|Overall Study|PCR sample for Week 4 not drawn|0
7957729|NCT02641379|12507971|FG001|Overall Study|PCR sample for Week 4 not drawn|0
7957730|NCT02641379|12507972|FG002|Overall Study|PCR sample for Week 4 not drawn|0
7957731|NCT02641379|12507973|FG003|Overall Study|PCR sample for Week 4 not drawn|1
7957732|NCT02641379|12507974|FG004|Overall Study|PCR sample for Week 4 not drawn|0
7957733|NCT02641379|12507975|FG005|Overall Study|PCR sample for Week 4 not drawn|0
7957734|NCT02641379|12507976|FG006|Overall Study|PCR sample for Week 4 not drawn|0
7957735|NCT02641379|12507977|FG007|Overall Study|PCR sample for Week 4 not drawn|0
7957736|NCT02641379|12507978|FG008|Overall Study|PCR sample for Week 4 not drawn|0
7957737|NCT02641379|12507979|FG009|Overall Study|PCR sample for Week 4 not drawn|0
7957738|NCT02641379|12507980|FG010|Overall Study|PCR sample for Week 4 not drawn|0
7957739|NCT02641379|12507970|FG000|Overall Study|Inclusion criteria not fulfilled|0
7957740|NCT02641379|12507971|FG001|Overall Study|Inclusion criteria not fulfilled|0
7957741|NCT02641379|12507972|FG002|Overall Study|Inclusion criteria not fulfilled|0
7957742|NCT02641379|12507973|FG003|Overall Study|Inclusion criteria not fulfilled|1
7957743|NCT02641379|12507974|FG004|Overall Study|Inclusion criteria not fulfilled|0
7957744|NCT02641379|12507975|FG005|Overall Study|Inclusion criteria not fulfilled|0
7957745|NCT02641379|12507976|FG006|Overall Study|Inclusion criteria not fulfilled|0
7957746|NCT02641379|12507977|FG007|Overall Study|Inclusion criteria not fulfilled|0
7957747|NCT02641379|12507978|FG008|Overall Study|Inclusion criteria not fulfilled|0
7957748|NCT02641379|12507979|FG009|Overall Study|Inclusion criteria not fulfilled|0
7957749|NCT02641379|12507980|FG010|Overall Study|Inclusion criteria not fulfilled|0
7957750|NCT02641379|12507970|FG000|Overall Study|Baseline viral load unavailable|0
7957751|NCT02641379|12507971|FG001|Overall Study|Baseline viral load unavailable|0
7957752|NCT02641379|12507972|FG002|Overall Study|Baseline viral load unavailable|0
7957753|NCT02641379|12507973|FG003|Overall Study|Baseline viral load unavailable|1
7957754|NCT02641379|12507974|FG004|Overall Study|Baseline viral load unavailable|0
7957755|NCT02641379|12507975|FG005|Overall Study|Baseline viral load unavailable|0
7957756|NCT02641379|12507976|FG006|Overall Study|Baseline viral load unavailable|0
7957757|NCT02641379|12507977|FG007|Overall Study|Baseline viral load unavailable|0
7957758|NCT02641379|12507978|FG008|Overall Study|Baseline viral load unavailable|0
7957759|NCT02641379|12507979|FG009|Overall Study|Baseline viral load unavailable|0
7957760|NCT02641379|12507980|FG010|Overall Study|Baseline viral load unavailable|0
7957761|NCT02641379|12507970|FG000|Overall Study|Blood could not be drawn|0
7957762|NCT02641379|12507971|FG001|Overall Study|Blood could not be drawn|0
7957763|NCT02641379|12507972|FG002|Overall Study|Blood could not be drawn|0
7957764|NCT02641379|12507973|FG003|Overall Study|Blood could not be drawn|0
7957765|NCT02641379|12507974|FG004|Overall Study|Blood could not be drawn|1
7957766|NCT02641379|12507975|FG005|Overall Study|Blood could not be drawn|0
7957767|NCT02641379|12507976|FG006|Overall Study|Blood could not be drawn|0
7957768|NCT02641379|12507977|FG007|Overall Study|Blood could not be drawn|0
7957769|NCT02641379|12507978|FG008|Overall Study|Blood could not be drawn|0
7957770|NCT02641379|12507979|FG009|Overall Study|Blood could not be drawn|0
7957771|NCT02641379|12507980|FG010|Overall Study|Blood could not be drawn|0
7957772|NCT02641379|12507970|FG000|Overall Study|Protocol Violation|0
7957773|NCT02641379|12507971|FG001|Overall Study|Protocol Violation|0
7957774|NCT02641379|12507972|FG002|Overall Study|Protocol Violation|0
7957775|NCT02641379|12507973|FG003|Overall Study|Protocol Violation|0
7957776|NCT02641379|12507974|FG004|Overall Study|Protocol Violation|2
7957777|NCT02641379|12507975|FG005|Overall Study|Protocol Violation|0
7957778|NCT02641379|12507976|FG006|Overall Study|Protocol Violation|0
7957779|NCT02641379|12507977|FG007|Overall Study|Protocol Violation|0
7957780|NCT02641379|12507978|FG008|Overall Study|Protocol Violation|1
7957781|NCT02641379|12507979|FG009|Overall Study|Protocol Violation|0
7957782|NCT02641379|12507980|FG010|Overall Study|Protocol Violation|0
7957783|NCT02641379|12507970|FG000|Overall Study|Participation in sili rescue study|0
7957784|NCT02641379|12507971|FG001|Overall Study|Participation in sili rescue study|0
7957785|NCT02641379|12507972|FG002|Overall Study|Participation in sili rescue study|0
7957786|NCT02641379|12507973|FG003|Overall Study|Participation in sili rescue study|0
7957787|NCT02641379|12507974|FG004|Overall Study|Participation in sili rescue study|0
7957788|NCT02641379|12507975|FG005|Overall Study|Participation in sili rescue study|1
7957789|NCT02641379|12507976|FG006|Overall Study|Participation in sili rescue study|0
7957790|NCT02641379|12507977|FG007|Overall Study|Participation in sili rescue study|0
7957791|NCT02641379|12507978|FG008|Overall Study|Participation in sili rescue study|0
7957792|NCT02641379|12507979|FG009|Overall Study|Participation in sili rescue study|0
7957793|NCT02641379|12507980|FG010|Overall Study|Participation in sili rescue study|0
7957794|NCT02641379|12507970|FG000|Overall Study|Lost to Follow-up|0
7957795|NCT02641379|12507971|FG001|Overall Study|Lost to Follow-up|0
7957796|NCT02641379|12507972|FG002|Overall Study|Lost to Follow-up|0
7957797|NCT02641379|12507973|FG003|Overall Study|Lost to Follow-up|0
7957798|NCT02641379|12507974|FG004|Overall Study|Lost to Follow-up|0
7957799|NCT02641379|12507975|FG005|Overall Study|Lost to Follow-up|0
7957800|NCT02641379|12507976|FG006|Overall Study|Lost to Follow-up|0
7957801|NCT02641379|12507977|FG007|Overall Study|Lost to Follow-up|0
7957802|NCT02641379|12507978|FG008|Overall Study|Lost to Follow-up|1
7957803|NCT02641379|12507979|FG009|Overall Study|Lost to Follow-up|0
7957804|NCT02641379|12507980|FG010|Overall Study|Lost to Follow-up|0
7957805|NCT02641379|12507970|FG000|Overall Study|Source data not found|0
7957806|NCT02641379|12507971|FG001|Overall Study|Source data not found|0
7957807|NCT02641379|12507972|FG002|Overall Study|Source data not found|0
7957808|NCT02641379|12507973|FG003|Overall Study|Source data not found|0
7957809|NCT02641379|12507974|FG004|Overall Study|Source data not found|0
7957810|NCT02641379|12507975|FG005|Overall Study|Source data not found|1
7957811|NCT02641379|12507976|FG006|Overall Study|Source data not found|0
7957812|NCT02641379|12507977|FG007|Overall Study|Source data not found|0
7957813|NCT02641379|12507978|FG008|Overall Study|Source data not found|0
7957814|NCT02641379|12507979|FG009|Overall Study|Source data not found|0
7957815|NCT02641379|12507980|FG010|Overall Study|Source data not found|0
7957816|NCT02641379|12507970|FG000|Overall Study|Participant showed weight reduction|0
7957817|NCT02641379|12507971|FG001|Overall Study|Participant showed weight reduction|0
7957818|NCT02641379|12507972|FG002|Overall Study|Participant showed weight reduction|0
7957819|NCT02641379|12507973|FG003|Overall Study|Participant showed weight reduction|0
7957820|NCT02641379|12507974|FG004|Overall Study|Participant showed weight reduction|0
7957821|NCT02641379|12507975|FG005|Overall Study|Participant showed weight reduction|0
7957822|NCT02641379|12507976|FG006|Overall Study|Participant showed weight reduction|0
7957823|NCT02641379|12507977|FG007|Overall Study|Participant showed weight reduction|1
7957824|NCT02641379|12507978|FG008|Overall Study|Participant showed weight reduction|0
7957825|NCT02641379|12507979|FG009|Overall Study|Participant showed weight reduction|0
7957826|NCT02641379|12507980|FG010|Overall Study|Participant showed weight reduction|0
7957827|NCT02641379|12507970|FG000|Overall Study|Non-response Week 12|0
7957828|NCT02641379|12507971|FG001|Overall Study|Non-response Week 12|0
7957829|NCT02641379|12507972|FG002|Overall Study|Non-response Week 12|0
7957830|NCT02641379|12507973|FG003|Overall Study|Non-response Week 12|0
7957831|NCT02641379|12507974|FG004|Overall Study|Non-response Week 12|0
7957832|NCT02641379|12507975|FG005|Overall Study|Non-response Week 12|0
7957833|NCT02641379|12507976|FG006|Overall Study|Non-response Week 12|0
7957834|NCT02641379|12507977|FG007|Overall Study|Non-response Week 12|1
7957835|NCT02641379|12507978|FG008|Overall Study|Non-response Week 12|0
7957836|NCT02641379|12507979|FG009|Overall Study|Non-response Week 12|0
7957837|NCT02641379|12507980|FG010|Overall Study|Non-response Week 12|0
7957838|NCT02641379|12507970|FG000|Overall Study|No 2 Log drop at Week 12|0
7957839|NCT02641379|12507971|FG001|Overall Study|No 2 Log drop at Week 12|0
7957840|NCT02641379|12507972|FG002|Overall Study|No 2 Log drop at Week 12|0
7957841|NCT02641379|12507973|FG003|Overall Study|No 2 Log drop at Week 12|0
7957842|NCT02641379|12507974|FG004|Overall Study|No 2 Log drop at Week 12|0
7957843|NCT02641379|12507975|FG005|Overall Study|No 2 Log drop at Week 12|0
7957844|NCT02641379|12507976|FG006|Overall Study|No 2 Log drop at Week 12|0
7957845|NCT02641379|12507977|FG007|Overall Study|No 2 Log drop at Week 12|0
7957846|NCT02641379|12507978|FG008|Overall Study|No 2 Log drop at Week 12|0
7957847|NCT02641379|12507979|FG009|Overall Study|No 2 Log drop at Week 12|0
7957848|NCT02641379|12507980|FG010|Overall Study|No 2 Log drop at Week 12|1
7957849|NCT02641379|12507970|FG000|Overall Study|Negative PCR result|0
7957850|NCT02641379|12507971|FG001|Overall Study|Negative PCR result|0
7957851|NCT02641379|12507972|FG002|Overall Study|Negative PCR result|0
7957852|NCT02641379|12507973|FG003|Overall Study|Negative PCR result|0
7957853|NCT02641379|12507974|FG004|Overall Study|Negative PCR result|0
7957854|NCT02641379|12507975|FG005|Overall Study|Negative PCR result|0
7957855|NCT02641379|12507976|FG006|Overall Study|Negative PCR result|0
7957856|NCT02641379|12507977|FG007|Overall Study|Negative PCR result|0
7957857|NCT02641379|12507978|FG008|Overall Study|Negative PCR result|0
7957858|NCT02641379|12507979|FG009|Overall Study|Negative PCR result|1
7957859|NCT02641379|12507980|FG010|Overall Study|Negative PCR result|0
7957860|NCT02641379|12507970|FG000|Overall Study|Participant's PCR high|0
7957861|NCT02641379|12507971|FG001|Overall Study|Participant's PCR high|0
7957862|NCT02641379|12507972|FG002|Overall Study|Participant's PCR high|0
7957863|NCT02641379|12507973|FG003|Overall Study|Participant's PCR high|0
7957864|NCT02641379|12507974|FG004|Overall Study|Participant's PCR high|0
7957865|NCT02641379|12507975|FG005|Overall Study|Participant's PCR high|0
7957866|NCT02641379|12507976|FG006|Overall Study|Participant's PCR high|0
7957867|NCT02641379|12507977|FG007|Overall Study|Participant's PCR high|1
7957868|NCT02641379|12507978|FG008|Overall Study|Participant's PCR high|0
7957869|NCT02641379|12507979|FG009|Overall Study|Participant's PCR high|0
7957870|NCT02641379|12507980|FG010|Overall Study|Participant's PCR high|0
7957871|NCT02641379|12507970|FG000|Overall Study|Participant treated after Week 24|0
7957872|NCT02641379|12507971|FG001|Overall Study|Participant treated after Week 24|0
7957873|NCT02641379|12507972|FG002|Overall Study|Participant treated after Week 24|0
7957874|NCT02641379|12507973|FG003|Overall Study|Participant treated after Week 24|0
7957875|NCT02641379|12507974|FG004|Overall Study|Participant treated after Week 24|0
7957876|NCT02641379|12507975|FG005|Overall Study|Participant treated after Week 24|0
7957877|NCT02641379|12507976|FG006|Overall Study|Participant treated after Week 24|0
7957878|NCT02641379|12507977|FG007|Overall Study|Participant treated after Week 24|0
7957879|NCT02641379|12507978|FG008|Overall Study|Participant treated after Week 24|1
7957880|NCT02641379|12507979|FG009|Overall Study|Participant treated after Week 24|0
7957881|NCT02641379|12507980|FG010|Overall Study|Participant treated after Week 24|0
7957882|NCT02641379|12507970|FG000|Overall Study|Missing PCR result at Week 8|0
7957883|NCT02641379|12507971|FG001|Overall Study|Missing PCR result at Week 8|0
7957884|NCT02641379|12507972|FG002|Overall Study|Missing PCR result at Week 8|0
7957885|NCT02641379|12507973|FG003|Overall Study|Missing PCR result at Week 8|0
7957886|NCT02641379|12507974|FG004|Overall Study|Missing PCR result at Week 8|0
7957887|NCT02641379|12507975|FG005|Overall Study|Missing PCR result at Week 8|0
7957888|NCT02641379|12507976|FG006|Overall Study|Missing PCR result at Week 8|0
7957889|NCT02641379|12507977|FG007|Overall Study|Missing PCR result at Week 8|0
7957890|NCT02641379|12507978|FG008|Overall Study|Missing PCR result at Week 8|0
7966549|NCT02752776|12522664|FG001|Overall Study|Withdrawal by Subject|4
7957891|NCT02641379|12507979|FG009|Overall Study|Missing PCR result at Week 8|1
7957892|NCT02641379|12507980|FG010|Overall Study|Missing PCR result at Week 8|0
7957893|NCT02641379|12507970|FG000|Overall Study|PCR positive|0
7957894|NCT02641379|12507971|FG001|Overall Study|PCR positive|0
7957895|NCT02641379|12507972|FG002|Overall Study|PCR positive|0
7957896|NCT02641379|12507973|FG003|Overall Study|PCR positive|0
7957897|NCT02641379|12507974|FG004|Overall Study|PCR positive|0
7957898|NCT02641379|12507975|FG005|Overall Study|PCR positive|0
7957899|NCT02641379|12507976|FG006|Overall Study|PCR positive|1
7957900|NCT02641379|12507977|FG007|Overall Study|PCR positive|0
7957901|NCT02641379|12507978|FG008|Overall Study|PCR positive|0
7957902|NCT02641379|12507979|FG009|Overall Study|PCR positive|0
7957903|NCT02641379|12507980|FG010|Overall Study|PCR positive|0
7957904|NCT02641392|12508012|FG000|Overall Study|Lost to Follow-up|0
7957905|NCT02641392|12508013|FG001|Overall Study|Lost to Follow-up|0
7957906|NCT02641392|12508014|FG002|Overall Study|Lost to Follow-up|2
7957907|NCT02641392|12508012|FG000|Overall Study|Withdrawal by Subject|0
7957908|NCT02641392|12508013|FG001|Overall Study|Withdrawal by Subject|0
7957909|NCT02641392|12508014|FG002|Overall Study|Withdrawal by Subject|17
7957910|NCT02641392|12508012|FG000|Overall Study|Adverse Event|0
7957911|NCT02641392|12508013|FG001|Overall Study|Adverse Event|1
7957912|NCT02641392|12508014|FG002|Overall Study|Adverse Event|25
7957913|NCT02641392|12508012|FG000|Overall Study|Study Terminated by Sponsor|4
7957914|NCT02641392|12508013|FG001|Overall Study|Study Terminated by Sponsor|12
7957915|NCT02641392|12508014|FG002|Overall Study|Study Terminated by Sponsor|144
7957916|NCT02641392|12508012|FG000|Overall Study|Lack of Efficacy|0
7957917|NCT02641392|12508013|FG001|Overall Study|Lack of Efficacy|0
7957918|NCT02641392|12508014|FG002|Overall Study|Lack of Efficacy|101
7957919|NCT02641392|12508012|FG000|Overall Study|Miscellaneous|0
7957920|NCT02641392|12508013|FG001|Overall Study|Miscellaneous|0
7957921|NCT02641392|12508014|FG002|Overall Study|Miscellaneous|3
7957922|NCT02641392|12508012|FG000|Overall Study|Death|0
7957923|NCT02641392|12508013|FG001|Overall Study|Death|0
7957924|NCT02641392|12508014|FG002|Overall Study|Death|1
7957925|NCT02641587|12508046|FG000|Confinement Period|Adverse Event|1
7957926|NCT02641587|12508047|FG001|Confinement Period|Adverse Event|0
7957927|NCT02641587|12508046|FG000|Confinement Period|Withdrawal by Subject|2
7957928|NCT02641587|12508047|FG001|Confinement Period|Withdrawal by Subject|1
7957929|NCT02641587|12508046|FG000|Ambulatory Period|Withdrawal by Subject|1
7957930|NCT02641587|12508047|FG001|Ambulatory Period|Withdrawal by Subject|0
7957931|NCT02641730|12508073|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
7957932|NCT02641730|12508074|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7957933|NCT02641730|12508075|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7957934|NCT02641730|12508076|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
7957935|NCT02641730|12508077|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
7957936|NCT02641730|12508073|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0
7957937|NCT02641730|12508074|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1
7957938|NCT02641730|12508075|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1
7957939|NCT02641730|12508076|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5
7957940|NCT02641730|12508077|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4
7957941|NCT02641730|12508073|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
7957942|NCT02641730|12508074|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
7957943|NCT02641730|12508075|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
7957944|NCT02641730|12508076|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
7957945|NCT02641730|12508077|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
7957946|NCT02641730|12508073|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0
7957947|NCT02641730|12508074|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0
7957948|NCT02641730|12508075|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0
7957949|NCT02641730|12508076|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1
7957950|NCT02641730|12508077|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1
7957951|NCT02641730|12508073|FG000|After Controlled Period (Week 16 - 52)|Other|0
7957952|NCT02641730|12508074|FG001|After Controlled Period (Week 16 - 52)|Other|1
7957953|NCT02641730|12508075|FG002|After Controlled Period (Week 16 - 52)|Other|1
7957954|NCT02641730|12508076|FG003|After Controlled Period (Week 16 - 52)|Other|0
7957955|NCT02641730|12508077|FG004|After Controlled Period (Week 16 - 52)|Other|1
7957956|NCT02641730|12508073|FG000|Observational Period (Week 60 - Week 84)|Other|0
7957957|NCT02641730|12508074|FG001|Observational Period (Week 60 - Week 84)|Other|0
7957958|NCT02641730|12508075|FG002|Observational Period (Week 60 - Week 84)|Other|0
7957959|NCT02641730|12508076|FG003|Observational Period (Week 60 - Week 84)|Other|0
7957960|NCT02641730|12508077|FG004|Observational Period (Week 60 - Week 84)|Other|1
7957961|NCT02642159|12508116|FG000|Overall Study|Randomized but not treated|1
7957962|NCT02642159|12508117|FG001|Overall Study|Randomized but not treated|0
7957963|NCT02642159|12508116|FG000|Overall Study|Adverse Event|10
7957964|NCT02642159|12508117|FG001|Overall Study|Adverse Event|4
7957965|NCT02642159|12508116|FG000|Overall Study|Withdrawal by Subject|9
7957966|NCT02642159|12508117|FG001|Overall Study|Withdrawal by Subject|1
7957967|NCT02642159|12508116|FG000|Overall Study|Poor compliance to study protocol|1
7957968|NCT02642159|12508117|FG001|Overall Study|Poor compliance to study protocol|0
7957969|NCT02642159|12508116|FG000|Overall Study|Other than specified above|10
7957970|NCT02642159|12508117|FG001|Overall Study|Other than specified above|3
7957971|NCT02642432|12508142|FG000|Overall Study|Adverse Event|2
7957972|NCT02642432|12508142|FG000|Overall Study|Withdrew Consent|1
7957973|NCT02642432|12508142|FG000|Overall Study|Lost to Follow-up|2
7957974|NCT02642432|12508142|FG000|Overall Study|Other|3
7966550|NCT02752776|12522665|FG002|Overall Study|Withdrawal by Subject|2
7966551|NCT02752802|12522677|FG000|Overall Study|Contrast Volume Not Collected|1
7966552|NCT02752802|12522678|FG001|Overall Study|Contrast Volume Not Collected|0
7966553|NCT02752958|12522696|FG000|Overall Study|Adverse Event|3
7966554|NCT02752958|12522696|FG000|Overall Study|Lost to Follow-up|1
7966555|NCT02752958|12522696|FG000|Overall Study|Protocol Violation|1
7966556|NCT02752958|12522696|FG000|Overall Study|Withdrawal by Subject|2
7966557|NCT02752958|12522696|FG000|Overall Study|Other (Reason not specified)|2
7966558|NCT02753075|12522705|FG000|Overall Study|Adverse Event|2
7966559|NCT02753075|12522706|FG001|Overall Study|Adverse Event|1
7966560|NCT02753075|12522707|FG002|Overall Study|Adverse Event|0
7966561|NCT02753075|12522705|FG000|Overall Study|Lost to Follow-up|2
7966562|NCT02753075|12522706|FG001|Overall Study|Lost to Follow-up|0
7966563|NCT02753075|12522707|FG002|Overall Study|Lost to Follow-up|0
7966564|NCT02753075|12522705|FG000|Overall Study|Withdrawal of Consent|1
7966565|NCT02753075|12522706|FG001|Overall Study|Withdrawal of Consent|1
7966566|NCT02753075|12522707|FG002|Overall Study|Withdrawal of Consent|3
7966567|NCT02753075|12522705|FG000|Overall Study|Physician Decision|3
7966568|NCT02753075|12522706|FG001|Overall Study|Physician Decision|1
7966569|NCT02753075|12522707|FG002|Overall Study|Physician Decision|0
7966570|NCT02753400|12522718|FG000|Overall Study|Adverse Event|3
7966571|NCT02753400|12522719|FG001|Overall Study|Adverse Event|0
7966572|NCT02753400|12522718|FG000|Overall Study|Withdrawal by Subject|2
7966573|NCT02753400|12522719|FG001|Overall Study|Withdrawal by Subject|1
7966574|NCT02753595|12522736|FG000|Overall Study|Sponsor termination|2
7966575|NCT02753595|12522737|FG001|Overall Study|Sponsor termination|2
7966576|NCT02753816|12522760|FG000|Overall Study|Protocol Violation|0
7966577|NCT02753816|12522761|FG001|Overall Study|Protocol Violation|1
7966578|NCT02753816|12522762|FG002|Overall Study|Protocol Violation|0
7966579|NCT02753946|12522821|FG000|Overall Study|Adverse Event|7
7966580|NCT02753946|12522822|FG001|Overall Study|Adverse Event|6
7966581|NCT02753946|12522821|FG000|Overall Study|Withdrawal by Subject|6
7966582|NCT02753946|12522822|FG001|Overall Study|Withdrawal by Subject|1
7966583|NCT02753946|12522821|FG000|Overall Study|Lack of Efficacy|1
7966584|NCT02753946|12522822|FG001|Overall Study|Lack of Efficacy|0
7966585|NCT02753946|12522821|FG000|Overall Study|Physician Decision|0
7966586|NCT02753946|12522822|FG001|Overall Study|Physician Decision|2
7966587|NCT02754440|12522850|FG000|Overall Study|Protocol Violation|3
7966588|NCT02754440|12522851|FG001|Overall Study|Protocol Violation|2
7966589|NCT02754440|12522852|FG002|Overall Study|Protocol Violation|2
7966590|NCT02754440|12522853|FG003|Overall Study|Protocol Violation|6
7966591|NCT02754440|12522850|FG000|Overall Study|Adverse Event|3
7966592|NCT02754440|12522851|FG001|Overall Study|Adverse Event|1
7966593|NCT02754440|12522852|FG002|Overall Study|Adverse Event|0
7966594|NCT02754440|12522853|FG003|Overall Study|Adverse Event|9
7966595|NCT02754440|12522850|FG000|Overall Study|Withdrawal by Subject|0
7966596|NCT02754440|12522851|FG001|Overall Study|Withdrawal by Subject|0
7966597|NCT02754440|12522852|FG002|Overall Study|Withdrawal by Subject|0
7966598|NCT02754440|12522853|FG003|Overall Study|Withdrawal by Subject|1
7966599|NCT02754440|12522850|FG000|Overall Study|Equipment failure|0
7966600|NCT02754440|12522851|FG001|Overall Study|Equipment failure|5
7966601|NCT02754440|12522852|FG002|Overall Study|Equipment failure|5
7966602|NCT02754440|12522853|FG003|Overall Study|Equipment failure|7
7966603|NCT02754440|12522850|FG000|Overall Study|Subject issues not resulting in AE|0
7966604|NCT02754440|12522851|FG001|Overall Study|Subject issues not resulting in AE|0
7966605|NCT02754440|12522852|FG002|Overall Study|Subject issues not resulting in AE|0
7966606|NCT02754440|12522853|FG003|Overall Study|Subject issues not resulting in AE|12
7966607|NCT02754492|12522866|FG000|Overall Study|Protocol Violation|2
7966608|NCT02754492|12522867|FG001|Overall Study|Protocol Violation|2
7966609|NCT02754492|12522868|FG002|Overall Study|Protocol Violation|0
7966610|NCT02754492|12522869|FG003|Overall Study|Protocol Violation|1
7966611|NCT02754492|12522866|FG000|Overall Study|Withdrawal by Subject|2
7966612|NCT02754492|12522867|FG001|Overall Study|Withdrawal by Subject|0
7966613|NCT02754492|12522868|FG002|Overall Study|Withdrawal by Subject|0
7966614|NCT02754492|12522869|FG003|Overall Study|Withdrawal by Subject|0
7966615|NCT02754492|12522866|FG000|Overall Study|Equipment malfuntion|0
7966616|NCT02754492|12522867|FG001|Overall Study|Equipment malfuntion|0
7966617|NCT02754492|12522868|FG002|Overall Study|Equipment malfuntion|2
7966618|NCT02754492|12522869|FG003|Overall Study|Equipment malfuntion|5
7957975|NCT02642614|12508163|FG000|Overall Study|Adverse Event|1
7957976|NCT02642614|12508164|FG001|Overall Study|Adverse Event|1
7957977|NCT02642614|12508165|FG002|Overall Study|Adverse Event|2
7957978|NCT02642614|12508166|FG003|Overall Study|Adverse Event|2
7957979|NCT02642614|12508163|FG000|Overall Study|Lost to Follow-up|1
7957980|NCT02642614|12508164|FG001|Overall Study|Lost to Follow-up|0
7957981|NCT02642614|12508165|FG002|Overall Study|Lost to Follow-up|0
7957982|NCT02642614|12508166|FG003|Overall Study|Lost to Follow-up|0
7957983|NCT02642614|12508163|FG000|Overall Study|Withdrawal by Subject|1
7957984|NCT02642614|12508164|FG001|Overall Study|Withdrawal by Subject|1
7957985|NCT02642614|12508165|FG002|Overall Study|Withdrawal by Subject|0
7957986|NCT02642614|12508166|FG003|Overall Study|Withdrawal by Subject|0
7957987|NCT02642653|12508186|FG000|Overall Study|Adverse Event|2
7957988|NCT02642653|12508187|FG001|Overall Study|Adverse Event|0
7957989|NCT02642679|12508193|FG000|Overall Study|Withdrawal by Subject|1
7957990|NCT02642679|12508193|FG000|Overall Study|Physician Decision|1
7957991|NCT02642679|12508193|FG000|Overall Study|Physician Decision|1
7957992|NCT02643082|12508227|FG000|Period 1|Adverse Event|1
7957993|NCT02643082|12508228|FG001|Period 1|Adverse Event|0
7957994|NCT02643251|12508255|FG000|Overall Study|Adverse Event|3
7957995|NCT02643251|12508256|FG001|Overall Study|Adverse Event|1
7957996|NCT02643251|12508255|FG000|Overall Study|Withdrawal by Subject|2
7957997|NCT02643251|12508256|FG001|Overall Study|Withdrawal by Subject|0
7957998|NCT02643251|12508255|FG000|Overall Study|Lost to Follow-up|4
7957999|NCT02643251|12508256|FG001|Overall Study|Lost to Follow-up|1
7958000|NCT02643251|12508255|FG000|Overall Study|Protocol Violation|1
7958001|NCT02643251|12508256|FG001|Overall Study|Protocol Violation|0
7958002|NCT02643251|12508255|FG000|Overall Study|PI Decision to terminate patient|1
7958003|NCT02643251|12508256|FG001|Overall Study|PI Decision to terminate patient|0
7958004|NCT02643355|12508264|FG000|Overall Study|Withdrawal by Subject|1
7958005|NCT02643355|12508265|FG001|Overall Study|Withdrawal by Subject|3
7958006|NCT02643355|12508264|FG000|Overall Study|Protocol Violation|0
7958007|NCT02643355|12508265|FG001|Overall Study|Protocol Violation|2
7958008|NCT02643394|12508273|FG000|Overall Study|Protocol Violation|4
7958009|NCT02643394|12508274|FG001|Overall Study|Protocol Violation|5
7958010|NCT02643472|12508292|FG000|Overall Study|Death|2
7958011|NCT02643472|12508293|FG001|Overall Study|Death|5
7958012|NCT02643472|12508292|FG000|Overall Study|Withdrawal by Subject|3
7958013|NCT02643472|12508293|FG001|Overall Study|Withdrawal by Subject|2
7958014|NCT02643472|12508292|FG000|Overall Study|Protocol Violation|0
7958015|NCT02643472|12508293|FG001|Overall Study|Protocol Violation|1
7958016|NCT02643472|12508292|FG000|Overall Study|Lost to Follow-up|22
7958017|NCT02643472|12508293|FG001|Overall Study|Lost to Follow-up|26
7958018|NCT02643628|12508313|FG000|Overall Study|Lost to Follow-up|1
7958019|NCT02643628|12508314|FG001|Overall Study|Lost to Follow-up|4
7958020|NCT02643628|12508313|FG000|Overall Study|Withdrawal by Subject|0
7958021|NCT02643628|12508314|FG001|Overall Study|Withdrawal by Subject|1
7958022|NCT02643628|12508313|FG000|Overall Study|Relocated out of state|0
7958023|NCT02643628|12508314|FG001|Overall Study|Relocated out of state|1
7958024|NCT02643693|12508322|FG000|Overall Study|Physician Decision|0
7958025|NCT02643693|12508323|FG001|Overall Study|Physician Decision|1
7958026|NCT02643693|12508324|FG002|Overall Study|Physician Decision|0
7958027|NCT02643693|12508325|FG003|Overall Study|Physician Decision|0
7958028|NCT02643693|12508326|FG004|Overall Study|Physician Decision|0
7958029|NCT02643693|12508327|FG005|Overall Study|Physician Decision|0
7958030|NCT02643693|12508322|FG000|Overall Study|Withdrawal by Subject|0
7958031|NCT02643693|12508323|FG001|Overall Study|Withdrawal by Subject|1
7958032|NCT02643693|12508324|FG002|Overall Study|Withdrawal by Subject|0
7958033|NCT02643693|12508325|FG003|Overall Study|Withdrawal by Subject|0
7958034|NCT02643693|12508326|FG004|Overall Study|Withdrawal by Subject|0
7958035|NCT02643693|12508327|FG005|Overall Study|Withdrawal by Subject|0
7958036|NCT02643693|12508322|FG000|Overall Study|Protocol Adherence Issues|2
7958037|NCT02643693|12508323|FG001|Overall Study|Protocol Adherence Issues|0
7958038|NCT02643693|12508324|FG002|Overall Study|Protocol Adherence Issues|1
7958039|NCT02643693|12508325|FG003|Overall Study|Protocol Adherence Issues|0
7958040|NCT02643693|12508326|FG004|Overall Study|Protocol Adherence Issues|0
7958041|NCT02643693|12508327|FG005|Overall Study|Protocol Adherence Issues|1
7958042|NCT02644096|12508364|FG000|Overall Study|Withdrawal by Subject|28
7958043|NCT02644096|12508365|FG001|Overall Study|Withdrawal by Subject|25
7958044|NCT02644109|12508373|FG000|Overall Study|Adverse Event|0
7958045|NCT02644109|12508374|FG001|Overall Study|Adverse Event|4
7958046|NCT02644122|12508380|FG000|Overall Study|Withdrawal by Subject|1
7958047|NCT02644343|12508402|FG000|Overall Study|Withdrawal by Subject|1
7958048|NCT02644356|12508406|FG000|Overall Study|Withdrawal by Subject|2
7958049|NCT02644668|12508413|FG000|Overall Study|Adverse Event|2
7958050|NCT02644668|12508414|FG001|Overall Study|Adverse Event|0
7958051|NCT02644668|12508415|FG002|Overall Study|Adverse Event|1
7958052|NCT02644668|12508413|FG000|Overall Study|Protocol Violation|0
7958053|NCT02644668|12508414|FG001|Overall Study|Protocol Violation|0
7958054|NCT02644668|12508415|FG002|Overall Study|Protocol Violation|1
7958055|NCT02644668|12508413|FG000|Overall Study|Withdrawal by Subject|0
7958056|NCT02644668|12508414|FG001|Overall Study|Withdrawal by Subject|0
7958057|NCT02644668|12508415|FG002|Overall Study|Withdrawal by Subject|1
7958058|NCT02645409|12508483|FG000|Overall Study|Withdrawal by Subject|3
7958059|NCT02645409|12508484|FG001|Overall Study|Withdrawal by Subject|0
7958060|NCT02645409|12508483|FG000|Overall Study|Physician Decision|1
7958061|NCT02645409|12508484|FG001|Overall Study|Physician Decision|0
7958062|NCT02646124|12508505|FG000|Overall Study|Lost to Follow-up|0
7958063|NCT02646124|12508506|FG001|Overall Study|Lost to Follow-up|2
7958064|NCT02646332|12508514|FG000|Overall Study|Lost to Follow-up|0
7958065|NCT02646332|12508515|FG001|Overall Study|Lost to Follow-up|3
7958066|NCT02646423|12508532|FG000|Overall Study|Adverse Event|5
7958067|NCT02646423|12508533|FG001|Overall Study|Adverse Event|7
7958068|NCT02646423|12508532|FG000|Overall Study|Ineligible|2
7958069|NCT02646423|12508533|FG001|Overall Study|Ineligible|1
7958070|NCT02646566|12508551|FG000|Overall Study|Lost to Follow-up|5
7958071|NCT02646566|12508552|FG001|Overall Study|Lost to Follow-up|4
7958072|NCT02646566|12508553|FG002|Overall Study|Lost to Follow-up|5
7958073|NCT02646566|12508551|FG000|Overall Study|Treatment failure|1
7958074|NCT02646566|12508552|FG001|Overall Study|Treatment failure|0
7958075|NCT02646566|12508553|FG002|Overall Study|Treatment failure|0
7958076|NCT02646618|12508563|FG000|Overall Study|Lost to Follow-up|10
7958077|NCT02646618|12508564|FG001|Overall Study|Lost to Follow-up|14
7958078|NCT02646891|12508608|FG000|Overall Study|Adverse Event|0
7958079|NCT02646891|12508609|FG001|Overall Study|Adverse Event|1
7958080|NCT02646891|12508610|FG002|Overall Study|Adverse Event|0
7958081|NCT02646891|12508611|FG003|Overall Study|Adverse Event|0
7958082|NCT02646891|12508612|FG004|Overall Study|Adverse Event|0
7958083|NCT02646891|12508613|FG005|Overall Study|Adverse Event|0
7958084|NCT02646891|12508614|FG006|Overall Study|Adverse Event|0
7958085|NCT02646891|12508615|FG007|Overall Study|Adverse Event|0
7958086|NCT02646891|12508616|FG008|Overall Study|Adverse Event|0
7958087|NCT02646891|12508617|FG009|Overall Study|Adverse Event|0
7958088|NCT02646891|12508608|FG000|Overall Study|Lost to Follow-up|0
7958089|NCT02646891|12508609|FG001|Overall Study|Lost to Follow-up|0
7958090|NCT02646891|12508610|FG002|Overall Study|Lost to Follow-up|0
7958091|NCT02646891|12508611|FG003|Overall Study|Lost to Follow-up|0
7958092|NCT02646891|12508612|FG004|Overall Study|Lost to Follow-up|0
7958093|NCT02646891|12508613|FG005|Overall Study|Lost to Follow-up|0
7958094|NCT02646891|12508614|FG006|Overall Study|Lost to Follow-up|2
7958095|NCT02646891|12508615|FG007|Overall Study|Lost to Follow-up|2
7958096|NCT02646891|12508616|FG008|Overall Study|Lost to Follow-up|2
7958097|NCT02646891|12508617|FG009|Overall Study|Lost to Follow-up|2
7958098|NCT02646891|12508608|FG000|Overall Study|Protocol Violation|0
7958099|NCT02646891|12508609|FG001|Overall Study|Protocol Violation|0
7958100|NCT02646891|12508610|FG002|Overall Study|Protocol Violation|0
7958101|NCT02646891|12508611|FG003|Overall Study|Protocol Violation|0
7958102|NCT02646891|12508612|FG004|Overall Study|Protocol Violation|0
7958103|NCT02646891|12508613|FG005|Overall Study|Protocol Violation|0
7958104|NCT02646891|12508614|FG006|Overall Study|Protocol Violation|1
7958105|NCT02646891|12508615|FG007|Overall Study|Protocol Violation|1
7958106|NCT02646891|12508616|FG008|Overall Study|Protocol Violation|0
7958107|NCT02646891|12508617|FG009|Overall Study|Protocol Violation|0
7958108|NCT02646891|12508608|FG000|Overall Study|Withdrawal by Subject|2
7958109|NCT02646891|12508609|FG001|Overall Study|Withdrawal by Subject|0
7958110|NCT02646891|12508610|FG002|Overall Study|Withdrawal by Subject|1
7958111|NCT02646891|12508611|FG003|Overall Study|Withdrawal by Subject|0
7958112|NCT02646891|12508612|FG004|Overall Study|Withdrawal by Subject|0
7958113|NCT02646891|12508613|FG005|Overall Study|Withdrawal by Subject|0
7958114|NCT02646891|12508614|FG006|Overall Study|Withdrawal by Subject|5
7958115|NCT02646891|12508615|FG007|Overall Study|Withdrawal by Subject|9
7958116|NCT02646891|12508616|FG008|Overall Study|Withdrawal by Subject|7
7958117|NCT02646891|12508617|FG009|Overall Study|Withdrawal by Subject|3
7958118|NCT02646891|12508608|FG000|Overall Study|Death|0
7958119|NCT02646891|12508609|FG001|Overall Study|Death|0
7958120|NCT02646891|12508610|FG002|Overall Study|Death|0
7958121|NCT02646891|12508611|FG003|Overall Study|Death|0
7958122|NCT02646891|12508612|FG004|Overall Study|Death|0
7958123|NCT02646891|12508613|FG005|Overall Study|Death|0
7958124|NCT02646891|12508614|FG006|Overall Study|Death|1
7958125|NCT02646891|12508615|FG007|Overall Study|Death|1
7958126|NCT02646891|12508616|FG008|Overall Study|Death|1
7958127|NCT02646891|12508617|FG009|Overall Study|Death|0
7958128|NCT02647281|12508683|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7958129|NCT02647281|12508684|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7958130|NCT02647281|12508685|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7958131|NCT02647281|12508686|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7958132|NCT02647281|12508687|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7958133|NCT02647281|12508688|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7958134|NCT02647281|12508689|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7958135|NCT02647281|12508690|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7958136|NCT02647281|12508691|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
7958137|NCT02647320|12508725|FG000|Overall Study|Adverse Event|0
7958138|NCT02647320|12508726|FG001|Overall Study|Adverse Event|1
7958139|NCT02647320|12508727|FG002|Overall Study|Adverse Event|3
7958140|NCT02647320|12508728|FG003|Overall Study|Adverse Event|2
7958141|NCT02647320|12508729|FG004|Overall Study|Adverse Event|1
7958142|NCT02647320|12508725|FG000|Overall Study|Protocol Violation|0
7958143|NCT02647320|12508726|FG001|Overall Study|Protocol Violation|0
7958144|NCT02647320|12508727|FG002|Overall Study|Protocol Violation|3
7958145|NCT02647320|12508728|FG003|Overall Study|Protocol Violation|0
7958146|NCT02647320|12508729|FG004|Overall Study|Protocol Violation|0
7958147|NCT02647320|12508725|FG000|Overall Study|Withdrawal by Subject|7
7958148|NCT02647320|12508726|FG001|Overall Study|Withdrawal by Subject|4
7958149|NCT02647320|12508727|FG002|Overall Study|Withdrawal by Subject|2
7958150|NCT02647320|12508728|FG003|Overall Study|Withdrawal by Subject|2
7958151|NCT02647320|12508729|FG004|Overall Study|Withdrawal by Subject|7
7958152|NCT02647320|12508725|FG000|Overall Study|Persistent hyperglycemia|0
7958153|NCT02647320|12508726|FG001|Overall Study|Persistent hyperglycemia|1
7958154|NCT02647320|12508727|FG002|Overall Study|Persistent hyperglycemia|1
7958155|NCT02647320|12508728|FG003|Overall Study|Persistent hyperglycemia|1
7958156|NCT02647320|12508729|FG004|Overall Study|Persistent hyperglycemia|1
7958157|NCT02647320|12508725|FG000|Overall Study|Study terminated by sponsor|1
7958158|NCT02647320|12508726|FG001|Overall Study|Study terminated by sponsor|1
7958159|NCT02647320|12508727|FG002|Overall Study|Study terminated by sponsor|1
7958160|NCT02647320|12508728|FG003|Overall Study|Study terminated by sponsor|1
7958161|NCT02647320|12508729|FG004|Overall Study|Study terminated by sponsor|2
7958162|NCT02647320|12508725|FG000|Overall Study|Reason not provided|0
7958163|NCT02647320|12508726|FG001|Overall Study|Reason not provided|0
7958164|NCT02647320|12508727|FG002|Overall Study|Reason not provided|1
7958165|NCT02647320|12508728|FG003|Overall Study|Reason not provided|0
7958166|NCT02647320|12508729|FG004|Overall Study|Reason not provided|2
7958167|NCT02647320|12508725|FG000|Overall Study|Lost to Follow-up|1
7958168|NCT02647320|12508726|FG001|Overall Study|Lost to Follow-up|1
7958169|NCT02647320|12508727|FG002|Overall Study|Lost to Follow-up|0
7958170|NCT02647320|12508728|FG003|Overall Study|Lost to Follow-up|0
7958171|NCT02647320|12508729|FG004|Overall Study|Lost to Follow-up|0
7958172|NCT02647320|12508725|FG000|Overall Study|Develop anemia|1
7958173|NCT02647320|12508726|FG001|Overall Study|Develop anemia|0
7958174|NCT02647320|12508727|FG002|Overall Study|Develop anemia|0
7958175|NCT02647320|12508728|FG003|Overall Study|Develop anemia|0
7958176|NCT02647320|12508729|FG004|Overall Study|Develop anemia|0
7958177|NCT02647320|12508725|FG000|Overall Study|Lack of Efficacy|0
7958178|NCT02647320|12508726|FG001|Overall Study|Lack of Efficacy|0
7958179|NCT02647320|12508727|FG002|Overall Study|Lack of Efficacy|0
7958180|NCT02647320|12508728|FG003|Overall Study|Lack of Efficacy|1
7958181|NCT02647320|12508729|FG004|Overall Study|Lack of Efficacy|0
7958182|NCT02647320|12508725|FG000|Overall Study|Disposition Missing Due to Fire at Site|2
7958183|NCT02647320|12508726|FG001|Overall Study|Disposition Missing Due to Fire at Site|3
7958184|NCT02647320|12508727|FG002|Overall Study|Disposition Missing Due to Fire at Site|4
7958185|NCT02647320|12508728|FG003|Overall Study|Disposition Missing Due to Fire at Site|3
7958186|NCT02647320|12508729|FG004|Overall Study|Disposition Missing Due to Fire at Site|4
7958187|NCT02647645|12508749|FG000|Overall Study|Lost to Follow-up|2
7958188|NCT02647645|12508750|FG001|Overall Study|Lost to Follow-up|1
7958189|NCT02647658|12508758|FG000|Overall Study|Consent refusal|15
7958190|NCT02647658|12508759|FG001|Overall Study|Consent refusal|24
7958191|NCT02647788|12508767|FG000|Overall Study|Lost to Follow-up|13
7958192|NCT02647788|12508768|FG001|Overall Study|Lost to Follow-up|11
7958193|NCT02647788|12508767|FG000|Overall Study|Did not want opiate|0
7958194|NCT02647788|12508768|FG001|Overall Study|Did not want opiate|1
7958195|NCT02647788|12508767|FG000|Overall Study|Withdrawal by Subject|1
7958196|NCT02647788|12508768|FG001|Overall Study|Withdrawal by Subject|0
7958197|NCT02647788|12508767|FG000|Overall Study|Felt itchy with assigned medication|1
7958198|NCT02647788|12508768|FG001|Overall Study|Felt itchy with assigned medication|0
7958199|NCT02647788|12508767|FG000|Overall Study|Felt nauseous with assigned medication|1
7958200|NCT02647788|12508768|FG001|Overall Study|Felt nauseous with assigned medication|1
7958201|NCT02647866|12508779|FG000|Overall Study|Adverse Event|0
7958202|NCT02647866|12508780|FG001|Overall Study|Adverse Event|0
7958203|NCT02647866|12508781|FG002|Overall Study|Adverse Event|2
7958204|NCT02647866|12508782|FG003|Overall Study|Adverse Event|2
7958205|NCT02647866|12508783|FG004|Overall Study|Adverse Event|1
7958206|NCT02647866|12508779|FG000|Overall Study|Disease Worsening|3
7958207|NCT02647866|12508780|FG001|Overall Study|Disease Worsening|1
7958208|NCT02647866|12508781|FG002|Overall Study|Disease Worsening|0
7958209|NCT02647866|12508782|FG003|Overall Study|Disease Worsening|0
7958210|NCT02647866|12508783|FG004|Overall Study|Disease Worsening|1
7958211|NCT02647866|12508779|FG000|Overall Study|Withdrawal by Subject|1
7958212|NCT02647866|12508780|FG001|Overall Study|Withdrawal by Subject|1
7958213|NCT02647866|12508781|FG002|Overall Study|Withdrawal by Subject|2
7958214|NCT02647866|12508782|FG003|Overall Study|Withdrawal by Subject|4
7958215|NCT02647866|12508783|FG004|Overall Study|Withdrawal by Subject|4
7958216|NCT02647866|12508779|FG000|Overall Study|Physician Decision|0
7958217|NCT02647866|12508780|FG001|Overall Study|Physician Decision|1
7958218|NCT02647866|12508781|FG002|Overall Study|Physician Decision|1
7958219|NCT02647866|12508782|FG003|Overall Study|Physician Decision|0
7958220|NCT02647866|12508783|FG004|Overall Study|Physician Decision|2
7958221|NCT02647866|12508779|FG000|Overall Study|Death|0
7958222|NCT02647866|12508780|FG001|Overall Study|Death|1
7958223|NCT02647866|12508781|FG002|Overall Study|Death|0
7958224|NCT02647866|12508782|FG003|Overall Study|Death|0
7958225|NCT02647866|12508783|FG004|Overall Study|Death|0
7958226|NCT02647866|12508779|FG000|Overall Study|Subject moved to different country|1
7958227|NCT02647866|12508780|FG001|Overall Study|Subject moved to different country|0
7958228|NCT02647866|12508781|FG002|Overall Study|Subject moved to different country|0
7958229|NCT02647866|12508782|FG003|Overall Study|Subject moved to different country|0
7958230|NCT02647866|12508783|FG004|Overall Study|Subject moved to different country|0
7958231|NCT02647905|12508803|FG000|Overall Study|Lost to Follow-up|1
7958232|NCT02647905|12508803|FG000|Overall Study|Withdrawal by Subject|2
7958233|NCT02647944|12508809|FG000|Overall Study|Withdrawal by Subject|0
7958234|NCT02647944|12508810|FG001|Overall Study|Withdrawal by Subject|3
7958235|NCT02647944|12508809|FG000|Overall Study|Adverse Event|2
7958236|NCT02647944|12508810|FG001|Overall Study|Adverse Event|0
7958237|NCT02648204|12508833|FG000|Overall Study|Withdrawal by Subject|12
7958238|NCT02648204|12508834|FG001|Overall Study|Withdrawal by Subject|8
7958239|NCT02648204|12508835|FG002|Overall Study|Withdrawal by Subject|2
7958240|NCT02648204|12508836|FG003|Overall Study|Withdrawal by Subject|6
7958241|NCT02648204|12508833|FG000|Overall Study|Lost to Follow-up|5
7958242|NCT02648204|12508834|FG001|Overall Study|Lost to Follow-up|8
7958243|NCT02648204|12508835|FG002|Overall Study|Lost to Follow-up|4
7958244|NCT02648204|12508836|FG003|Overall Study|Lost to Follow-up|6
7958245|NCT02648204|12508833|FG000|Overall Study|Missing follow-up information|4
7958246|NCT02648204|12508834|FG001|Overall Study|Missing follow-up information|4
7958247|NCT02648204|12508835|FG002|Overall Study|Missing follow-up information|4
7958248|NCT02648204|12508836|FG003|Overall Study|Missing follow-up information|2
7958249|NCT02648204|12508833|FG000|Overall Study|Death|1
7958250|NCT02648204|12508834|FG001|Overall Study|Death|1
7958251|NCT02648204|12508835|FG002|Overall Study|Death|2
7958252|NCT02648204|12508836|FG003|Overall Study|Death|2
7958253|NCT02648204|12508833|FG000|Overall Study|Adverse Event|0
7958254|NCT02648204|12508834|FG001|Overall Study|Adverse Event|0
7958255|NCT02648204|12508835|FG002|Overall Study|Adverse Event|1
7958256|NCT02648204|12508836|FG003|Overall Study|Adverse Event|0
7958257|NCT02648217|12508848|FG000|Overall Study|Adverse Event|0
7958258|NCT02648217|12508849|FG001|Overall Study|Adverse Event|1
7958259|NCT02648217|12508848|FG000|Overall Study|Lost to Follow-up|1
7958260|NCT02648217|12508849|FG001|Overall Study|Lost to Follow-up|1
7958261|NCT02648217|12508848|FG000|Overall Study|Withdrawal by Subject|4
7958262|NCT02648217|12508849|FG001|Overall Study|Withdrawal by Subject|3
7958263|NCT02648217|12508848|FG000|Overall Study|Unclassified|5
7958264|NCT02648217|12508849|FG001|Overall Study|Unclassified|0
7958265|NCT02648438|12508862|FG000|Overall Study|Eligibility criteria not fulfilled|0
7958266|NCT02648438|12508863|FG001|Overall Study|Eligibility criteria not fulfilled|2
7958267|NCT02648438|12508864|FG002|Overall Study|Eligibility criteria not fulfilled|0
7958268|NCT02648438|12508862|FG000|Overall Study|Protocol Violation|2
7958269|NCT02648438|12508863|FG001|Overall Study|Protocol Violation|0
7958270|NCT02648438|12508864|FG002|Overall Study|Protocol Violation|0
7958271|NCT02648438|12508862|FG000|Overall Study|Withdrawal by Subject|1
7958272|NCT02648438|12508863|FG001|Overall Study|Withdrawal by Subject|1
7958273|NCT02648438|12508864|FG002|Overall Study|Withdrawal by Subject|0
7958274|NCT02648932|12508895|FG000|Overall Study|No transplant|3
7958275|NCT02648932|12508896|FG001|Overall Study|No transplant|1
7958276|NCT02649218|12508949|FG000|Overall Study|Adverse Event|8
7958277|NCT02649218|12508949|FG000|Overall Study|Lack of Efficacy|8
7958278|NCT02649218|12508949|FG000|Overall Study|Pregnancy|3
7958279|NCT02649218|12508949|FG000|Overall Study|Protocol Violation|3
7958280|NCT02649218|12508949|FG000|Overall Study|Physician Decision|1
7958281|NCT02649218|12508949|FG000|Overall Study|Withdrawal by Subject|2
7958282|NCT02649231|12508958|FG000|Overall Study|Adverse Event|0
7958283|NCT02649231|12508959|FG001|Overall Study|Adverse Event|0
7958284|NCT02649231|12508960|FG002|Overall Study|Adverse Event|0
7958285|NCT02649231|12508961|FG003|Overall Study|Adverse Event|1
7958286|NCT02649231|12508958|FG000|Overall Study|Lost to Follow-up|2
7958287|NCT02649231|12508959|FG001|Overall Study|Lost to Follow-up|1
7958288|NCT02649231|12508960|FG002|Overall Study|Lost to Follow-up|1
7958289|NCT02649231|12508961|FG003|Overall Study|Lost to Follow-up|0
7958290|NCT02649231|12508958|FG000|Overall Study|Withdrawal by Subject|0
7958291|NCT02649231|12508959|FG001|Overall Study|Withdrawal by Subject|1
7958292|NCT02649231|12508960|FG002|Overall Study|Withdrawal by Subject|0
7958293|NCT02649231|12508961|FG003|Overall Study|Withdrawal by Subject|1
7958294|NCT02649231|12508958|FG000|Overall Study|Protocol Violation|2
7958295|NCT02649231|12508959|FG001|Overall Study|Protocol Violation|1
7958296|NCT02649231|12508960|FG002|Overall Study|Protocol Violation|1
7958297|NCT02649231|12508961|FG003|Overall Study|Protocol Violation|0
7958298|NCT02649634|12509034|FG000|Overall Study|Withdrawal by Subject|3
7958299|NCT02649634|12509035|FG001|Overall Study|Withdrawal by Subject|5
7958300|NCT02649634|12509034|FG000|Overall Study|Lost to Follow-up|0
7958301|NCT02649634|12509035|FG001|Overall Study|Lost to Follow-up|1
7958302|NCT02649894|12509049|FG000|Overall Study|Adverse Event|1
7958303|NCT02649894|12509050|FG001|Overall Study|Adverse Event|0
7958304|NCT02649894|12509049|FG000|Overall Study|Physician Decision|0
7958305|NCT02649894|12509050|FG001|Overall Study|Physician Decision|1
7958306|NCT02649894|12509049|FG000|Overall Study|Withdrawal by Subject|5
7958307|NCT02649894|12509050|FG001|Overall Study|Withdrawal by Subject|2
7958308|NCT02649894|12509049|FG000|Overall Study|Lost to Follow-up|2
7958309|NCT02649894|12509050|FG001|Overall Study|Lost to Follow-up|1
7958310|NCT02649894|12509049|FG000|Overall Study|Death|30
7958311|NCT02649894|12509050|FG001|Overall Study|Death|7
7958312|NCT02649894|12509049|FG000|Overall Study|Other, not specified|6
7958313|NCT02649894|12509050|FG001|Overall Study|Other, not specified|0
7958314|NCT02650128|12509056|FG000|Overall Study|Death|2
7958315|NCT02650466|12509093|FG000|Overall Study|Physician Decision|1
7958316|NCT02650466|12509093|FG000|Overall Study|Withdrawal by Subject|5
7958317|NCT02650466|12509093|FG000|Overall Study|Lost to Follow-up|1
7958318|NCT02650895|12509114|FG000|Overall Study|Withdrawal by Subject|0
7958319|NCT02650895|12509115|FG001|Overall Study|Withdrawal by Subject|1
7958320|NCT02650895|12509116|FG002|Overall Study|Withdrawal by Subject|0
7958321|NCT02650895|12509117|FG003|Overall Study|Withdrawal by Subject|0
7958322|NCT02650895|12509118|FG004|Overall Study|Withdrawal by Subject|0
7958323|NCT02650895|12509119|FG005|Overall Study|Withdrawal by Subject|0
7958324|NCT02651116|12509148|FG000|Overall Study|Adverse Event|0
7958325|NCT02651116|12509149|FG001|Overall Study|Adverse Event|1
7958326|NCT02651116|12509148|FG000|Overall Study|No Longer Willing To Participate In Study|1
7958327|NCT02651116|12509149|FG001|Overall Study|No Longer Willing To Participate In Study|0
7958328|NCT02651155|12509157|FG000|Overall Study|Pretreatment Event/Adverse Event|1
7958329|NCT02651155|12509158|FG001|Overall Study|Pretreatment Event/Adverse Event|2
7958330|NCT02651155|12509157|FG000|Overall Study|Voluntary Withdrawal|5
7958331|NCT02651155|12509158|FG001|Overall Study|Voluntary Withdrawal|0
7958332|NCT02651194|12509164|FG000|Overall Study|Lost to Follow-up|3
7958333|NCT02651194|12509164|FG000|Overall Study|Other|2
7958334|NCT02651220|12509171|FG000|Overall Study|Adverse Event|1
7958335|NCT02651220|12509172|FG001|Overall Study|Adverse Event|5
7958336|NCT02651220|12509173|FG002|Overall Study|Adverse Event|1
7958337|NCT02651220|12509171|FG000|Overall Study|Lost to Follow-up|8
7958338|NCT02651220|12509172|FG001|Overall Study|Lost to Follow-up|14
7958339|NCT02651220|12509173|FG002|Overall Study|Lost to Follow-up|14
7958340|NCT02651220|12509171|FG000|Overall Study|Non-Compliance with Study Drug|4
7958341|NCT02651220|12509172|FG001|Overall Study|Non-Compliance with Study Drug|0
7958342|NCT02651220|12509173|FG002|Overall Study|Non-Compliance with Study Drug|1
7958343|NCT02651220|12509171|FG000|Overall Study|Pregnancy|1
7958344|NCT02651220|12509172|FG001|Overall Study|Pregnancy|0
7958345|NCT02651220|12509173|FG002|Overall Study|Pregnancy|1
7958346|NCT02651220|12509171|FG000|Overall Study|Protocol Violation|0
7958347|NCT02651220|12509172|FG001|Overall Study|Protocol Violation|0
7958348|NCT02651220|12509173|FG002|Overall Study|Protocol Violation|1
7958349|NCT02651220|12509171|FG000|Overall Study|Withdrawal by Subject|5
7958350|NCT02651220|12509172|FG001|Overall Study|Withdrawal by Subject|6
7958351|NCT02651220|12509173|FG002|Overall Study|Withdrawal by Subject|8
7958352|NCT02651220|12509171|FG000|Overall Study|Miscellaneous|4
7958353|NCT02651220|12509172|FG001|Overall Study|Miscellaneous|1
7958354|NCT02651220|12509173|FG002|Overall Study|Miscellaneous|2
7958355|NCT02651220|12509171|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7958356|NCT02651220|12509172|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7958357|NCT02651220|12509173|FG002|Overall Study|Withdrawal by Parent/Guardian|1
7958358|NCT02651467|12509222|FG000|Overall Study|Withdrawal by Subject|0
7958359|NCT02651467|12509223|FG001|Overall Study|Withdrawal by Subject|0
7958360|NCT02651467|12509224|FG002|Overall Study|Withdrawal by Subject|2
7958361|NCT02651467|12509222|FG000|Overall Study|Other (Not specified)|1
7958362|NCT02651467|12509223|FG001|Overall Study|Other (Not specified)|0
7958363|NCT02651467|12509224|FG002|Overall Study|Other (Not specified)|2
7966619|NCT02754492|12522866|FG000|Overall Study|Adverse Event|0
7966620|NCT02754492|12522867|FG001|Overall Study|Adverse Event|0
7966621|NCT02754492|12522868|FG002|Overall Study|Adverse Event|0
7966622|NCT02754492|12522869|FG003|Overall Study|Adverse Event|13
7966623|NCT02754492|12522866|FG000|Overall Study|Venous access issues not resulting in AE|0
7966624|NCT02754492|12522867|FG001|Overall Study|Venous access issues not resulting in AE|0
7966625|NCT02754492|12522868|FG002|Overall Study|Venous access issues not resulting in AE|0
7966626|NCT02754492|12522869|FG003|Overall Study|Venous access issues not resulting in AE|4
7966627|NCT02755090|12522910|FG000|Overall Study|equipment malfunction|1
7966628|NCT02755090|12522911|FG001|Overall Study|equipment malfunction|0
7966629|NCT02755116|12522919|FG000|Overall Study|surgery converted to open, pt admitted|3
7966630|NCT02755116|12522920|FG001|Overall Study|surgery converted to open, pt admitted|1
7966631|NCT02755649|12522940|FG000|Overall Study|Transitioned into OLE study|99
7966632|NCT02755649|12522941|FG001|Overall Study|Transitioned into OLE study|98
7958364|NCT02651688|12509257|FG000|Overall Study|Non-compliance|0
7958365|NCT02651688|12509258|FG001|Overall Study|Non-compliance|0
7958366|NCT02651688|12509259|FG002|Overall Study|Non-compliance|1
7958367|NCT02651688|12509257|FG000|Overall Study|Principal Investigator (PI) decision|0
7958368|NCT02651688|12509258|FG001|Overall Study|Principal Investigator (PI) decision|2
7958369|NCT02651688|12509259|FG002|Overall Study|Principal Investigator (PI) decision|0
7958370|NCT02651688|12509257|FG000|Overall Study|Lost to Follow-up|1
7958371|NCT02651688|12509258|FG001|Overall Study|Lost to Follow-up|3
7958372|NCT02651688|12509259|FG002|Overall Study|Lost to Follow-up|0
7958373|NCT02651688|12509257|FG000|Overall Study|Withdrawal by Subject|1
7958374|NCT02651688|12509258|FG001|Overall Study|Withdrawal by Subject|0
7958375|NCT02651688|12509259|FG002|Overall Study|Withdrawal by Subject|2
7958376|NCT02651922|12509267|FG000|Overall Study|due to exclusion criteria|2
7958377|NCT02651987|12509273|FG000|Overall Study|Adverse Event|2
7958378|NCT02651987|12509274|FG001|Overall Study|Adverse Event|2
7958379|NCT02651987|12509273|FG000|Overall Study|Consent Withdrawn|2
7958380|NCT02651987|12509274|FG001|Overall Study|Consent Withdrawn|0
7958381|NCT02651987|12509273|FG000|Overall Study|Local PD|0
7958382|NCT02651987|12509274|FG001|Overall Study|Local PD|2
7958383|NCT02651987|12509273|FG000|Overall Study|Investigator Decision|1
7958384|NCT02651987|12509274|FG001|Overall Study|Investigator Decision|1
7958385|NCT02652156|12509286|FG000|Overall Study|Physician Decision|1
7958386|NCT02652156|12509287|FG001|Overall Study|Physician Decision|0
7958387|NCT02652156|12509288|FG002|Overall Study|Physician Decision|0
7958388|NCT02652442|12509346|FG000|Centrifugation - Distance|Lost to Follow-up|1
7958389|NCT02652624|12509364|FG000|Randomized Phase|Pregnancy|3
7958390|NCT02652624|12509365|FG001|Randomized Phase|Pregnancy|1
7958391|NCT02652624|12509364|FG000|Randomized Phase|Investigator's Discretion|0
7958392|NCT02652624|12509365|FG001|Randomized Phase|Investigator's Discretion|2
7958393|NCT02652624|12509364|FG000|Randomized Phase|Death|0
7958394|NCT02652624|12509365|FG001|Randomized Phase|Death|1
7958395|NCT02652624|12509364|FG000|Randomized Phase|Lost to Follow-up|0
7958396|NCT02652624|12509365|FG001|Randomized Phase|Lost to Follow-up|1
7958397|NCT02652624|12509364|FG000|Extension Phase|Lost to Follow-up|3
7958398|NCT02652624|12509365|FG001|Extension Phase|Lost to Follow-up|1
7958399|NCT02652624|12509364|FG000|Extension Phase|Pregnancy|1
7958400|NCT02652624|12509365|FG001|Extension Phase|Pregnancy|1
7958401|NCT02652624|12509364|FG000|Extension Phase|Adverse Event|0
7958402|NCT02652624|12509365|FG001|Extension Phase|Adverse Event|1
7958403|NCT02652624|12509364|FG000|Extension Phase|Withdrew Consent|0
7958404|NCT02652624|12509365|FG001|Extension Phase|Withdrew Consent|1
7958405|NCT02653170|12509396|FG000|Overall Study|Withdrawal by Subject|3
7958406|NCT02653170|12509397|FG001|Overall Study|Withdrawal by Subject|8
7958407|NCT02653170|12509398|FG002|Overall Study|Withdrawal by Subject|3
7958408|NCT02653170|12509396|FG000|Overall Study|withdrawn by study team|2
7958409|NCT02653170|12509397|FG001|Overall Study|withdrawn by study team|4
7958410|NCT02653170|12509398|FG002|Overall Study|withdrawn by study team|5
7958411|NCT02653170|12509396|FG000|Overall Study|Lost to Follow-up|12
7958412|NCT02653170|12509397|FG001|Overall Study|Lost to Follow-up|4
7958413|NCT02653170|12509398|FG002|Overall Study|Lost to Follow-up|10
7958414|NCT02653300|12509415|FG000|Overall Study|Withdrawal by Subject|2
7958415|NCT02653326|12509421|FG000|Overall Study|Lost to Follow-up|10
7958416|NCT02653326|12509422|FG001|Overall Study|Lost to Follow-up|7
7958417|NCT02653625|12509516|FG000|Overall Study|Adverse Event|1
7958418|NCT02653625|12509516|FG000|Overall Study|Non-compliance with Study Drug|1
7958419|NCT02653625|12509516|FG000|Overall Study|Protocol Violation|1
7958420|NCT02653625|12509516|FG000|Overall Study|Suspected Drug Induced Liver Injury|1
7958421|NCT02653664|12509523|FG000|Post-Treatment|Withdrawal by Subject|6
7958422|NCT02653664|12509524|FG001|Post-Treatment|Withdrawal by Subject|5
7958423|NCT02653664|12509525|FG002|Post-Treatment|Withdrawal by Subject|7
7958424|NCT02653664|12509523|FG000|Post-Treatment|Lost to Follow-up|8
7958425|NCT02653664|12509524|FG001|Post-Treatment|Lost to Follow-up|1
7958426|NCT02653664|12509525|FG002|Post-Treatment|Lost to Follow-up|7
7958427|NCT02653664|12509523|FG000|3 Month Follow-Up|Withdrawal by Subject|9
7958428|NCT02653664|12509524|FG001|3 Month Follow-Up|Withdrawal by Subject|5
7958429|NCT02653664|12509525|FG002|3 Month Follow-Up|Withdrawal by Subject|9
7958430|NCT02653664|12509523|FG000|3 Month Follow-Up|Lost to Follow-up|9
7958431|NCT02653664|12509524|FG001|3 Month Follow-Up|Lost to Follow-up|8
7958432|NCT02653664|12509525|FG002|3 Month Follow-Up|Lost to Follow-up|16
7958433|NCT02653664|12509523|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7958434|NCT02653664|12509524|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2
7958435|NCT02653664|12509525|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7958436|NCT02653664|12509523|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3
7958437|NCT02653664|12509524|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0
7958438|NCT02653664|12509525|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0
7958439|NCT02653664|12509523|FG000|6 Month Follow-Up|Withdrawal by Subject|13
7958440|NCT02653664|12509524|FG001|6 Month Follow-Up|Withdrawal by Subject|7
7958441|NCT02653664|12509525|FG002|6 Month Follow-Up|Withdrawal by Subject|14
7958442|NCT02653664|12509523|FG000|6 Month Follow-Up|Lost to Follow-up|10
7958443|NCT02653664|12509524|FG001|6 Month Follow-Up|Lost to Follow-up|11
7958444|NCT02653664|12509525|FG002|6 Month Follow-Up|Lost to Follow-up|9
7958445|NCT02653664|12509523|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7958446|NCT02653664|12509524|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2
7958447|NCT02653664|12509525|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7958448|NCT02653664|12509523|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0
7958449|NCT02653664|12509524|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1
7958450|NCT02653664|12509525|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0
7958451|NCT02654002|12509568|FG000|Overall Study|Adverse Event|0
7958452|NCT02654002|12509569|FG001|Overall Study|Adverse Event|0
7958453|NCT02654002|12509570|FG002|Overall Study|Adverse Event|0
7958454|NCT02654002|12509571|FG003|Overall Study|Adverse Event|0
7958455|NCT02654002|12509572|FG004|Overall Study|Adverse Event|0
7958456|NCT02654002|12509573|FG005|Overall Study|Adverse Event|0
7958457|NCT02654002|12509574|FG006|Overall Study|Adverse Event|1
7958458|NCT02654002|12509575|FG007|Overall Study|Adverse Event|0
7958459|NCT02654002|12509576|FG008|Overall Study|Adverse Event|0
7958460|NCT02654002|12509568|FG000|Overall Study|Withdrew Consent|0
7958461|NCT02654002|12509569|FG001|Overall Study|Withdrew Consent|0
7958462|NCT02654002|12509570|FG002|Overall Study|Withdrew Consent|0
7958463|NCT02654002|12509571|FG003|Overall Study|Withdrew Consent|0
7958464|NCT02654002|12509572|FG004|Overall Study|Withdrew Consent|0
7958465|NCT02654002|12509573|FG005|Overall Study|Withdrew Consent|1
7958466|NCT02654002|12509574|FG006|Overall Study|Withdrew Consent|0
7958467|NCT02654002|12509575|FG007|Overall Study|Withdrew Consent|1
7958468|NCT02654002|12509576|FG008|Overall Study|Withdrew Consent|0
7958469|NCT02654054|12509614|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
7958470|NCT02654054|12509615|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
7958471|NCT02654054|12509616|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
7958472|NCT02654054|12509614|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7958473|NCT02654054|12509615|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7958474|NCT02654054|12509616|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13
7958475|NCT02654054|12509614|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
7958476|NCT02654054|12509615|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
7958477|NCT02654054|12509616|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
7958478|NCT02654054|12509614|FG000|Post-Treatment Follow-Up Period|Other|1
7958479|NCT02654054|12509615|FG001|Post-Treatment Follow-Up Period|Other|0
7958480|NCT02654054|12509616|FG002|Post-Treatment Follow-Up Period|Other|4
7958481|NCT02654054|12509614|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
7958482|NCT02654054|12509615|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0
7958483|NCT02654054|12509616|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4
7958484|NCT02654145|12509625|FG000|Overall Study|Lack of Efficacy|1
7958485|NCT02654145|12509625|FG000|Overall Study|Protocol Violation|1
7958486|NCT02654145|12509625|FG000|Overall Study|Withdrawal by Subject|5
7958487|NCT02654717|12509659|FG000|Overall Study|Adverse Event|2
7958488|NCT02654717|12509660|FG001|Overall Study|Adverse Event|2
7958489|NCT02654717|12509659|FG000|Overall Study|Protocol Violation|1
7958490|NCT02654717|12509660|FG001|Overall Study|Protocol Violation|2
7958491|NCT02654717|12509659|FG000|Overall Study|Withdrawal by Subject|0
7958492|NCT02654717|12509660|FG001|Overall Study|Withdrawal by Subject|1
7958493|NCT02654717|12509659|FG000|Overall Study|Non-permitted medication|3
7958494|NCT02654717|12509660|FG001|Overall Study|Non-permitted medication|0
7958495|NCT02654977|12509717|FG000|Overall Study|Death|1
7958496|NCT02654977|12509717|FG000|Overall Study|Lost to Follow-up|1
7958497|NCT02654977|12509717|FG000|Overall Study|Adverse Event|1
7958498|NCT02654977|12509717|FG000|Overall Study|Withdrawal by Subject|1
7958499|NCT02654977|12509717|FG000|Overall Study|Lack of Efficacy|3
7958500|NCT02655224|12509723|FG000|Overall Study|Adverse Event|1
7958501|NCT02655224|12509724|FG001|Overall Study|Adverse Event|1
7958502|NCT02655237|12509732|FG000|Overall Study|Adverse Event|10
7958503|NCT02655237|12509733|FG001|Overall Study|Adverse Event|7
7958504|NCT02655237|12509732|FG000|Overall Study|Protocol Deviation|2
7958505|NCT02655237|12509733|FG001|Overall Study|Protocol Deviation|0
7958506|NCT02655237|12509732|FG000|Overall Study|Withdrawal by Participant|1
7958507|NCT02655237|12509733|FG001|Overall Study|Withdrawal by Participant|2
7958508|NCT02655237|12509732|FG000|Overall Study|Lack of Efficacy|0
7958509|NCT02655237|12509733|FG001|Overall Study|Lack of Efficacy|1
7958510|NCT02655237|12509732|FG000|Overall Study|Recovery Leading to Surgery|2
7958511|NCT02655237|12509733|FG001|Overall Study|Recovery Leading to Surgery|1
7958512|NCT02655237|12509732|FG000|Overall Study|Reduction of Hemoglobin Concentration|1
7958513|NCT02655237|12509733|FG001|Overall Study|Reduction of Hemoglobin Concentration|0
7958514|NCT02655237|12509732|FG000|Overall Study|Randomized but Not Treated|1
7958515|NCT02655237|12509733|FG001|Overall Study|Randomized but Not Treated|0
7958516|NCT02655419|12509750|FG000|Overall Study|Enrolled but not treated|1
7958517|NCT02655419|12509751|FG001|Overall Study|Enrolled but not treated|5
7958518|NCT02655419|12509750|FG000|Overall Study|Withdrawal by Subject|4
7958519|NCT02655419|12509751|FG001|Overall Study|Withdrawal by Subject|1
7958520|NCT02655419|12509750|FG000|Overall Study|Other|0
7958521|NCT02655419|12509751|FG001|Overall Study|Other|1
7958522|NCT02655666|12509789|FG000|Overall Study|Sponsor stopped this clinical research.|12
7958523|NCT02655679|12509798|FG000|Overall Study|Adverse Event|0
7958524|NCT02655679|12509799|FG001|Overall Study|Adverse Event|1
7958525|NCT02655679|12509800|FG002|Overall Study|Adverse Event|0
7958526|NCT02655679|12509801|FG003|Overall Study|Adverse Event|0
7958527|NCT02655679|12509802|FG004|Overall Study|Adverse Event|0
7958528|NCT02655679|12509798|FG000|Overall Study|Withdrawal by Subject|1
7958529|NCT02655679|12509799|FG001|Overall Study|Withdrawal by Subject|1
7958530|NCT02655679|12509800|FG002|Overall Study|Withdrawal by Subject|0
7958531|NCT02655679|12509801|FG003|Overall Study|Withdrawal by Subject|3
7958532|NCT02655679|12509802|FG004|Overall Study|Withdrawal by Subject|1
7958533|NCT02655679|12509798|FG000|Overall Study|Inability to Comply with the Protocol|1
7958534|NCT02655679|12509799|FG001|Overall Study|Inability to Comply with the Protocol|0
7958535|NCT02655679|12509800|FG002|Overall Study|Inability to Comply with the Protocol|0
7958536|NCT02655679|12509801|FG003|Overall Study|Inability to Comply with the Protocol|0
7958537|NCT02655679|12509802|FG004|Overall Study|Inability to Comply with the Protocol|0
7958538|NCT02655679|12509798|FG000|Overall Study|Lost to Follow-up|0
7958539|NCT02655679|12509799|FG001|Overall Study|Lost to Follow-up|1
7958540|NCT02655679|12509800|FG002|Overall Study|Lost to Follow-up|1
7958541|NCT02655679|12509801|FG003|Overall Study|Lost to Follow-up|1
7958542|NCT02655679|12509802|FG004|Overall Study|Lost to Follow-up|0
7958543|NCT02655679|12509798|FG000|Overall Study|Other Miscellaneous Reasons|1
7958544|NCT02655679|12509799|FG001|Overall Study|Other Miscellaneous Reasons|0
7958545|NCT02655679|12509800|FG002|Overall Study|Other Miscellaneous Reasons|0
7958546|NCT02655679|12509801|FG003|Overall Study|Other Miscellaneous Reasons|0
7958547|NCT02655679|12509802|FG004|Overall Study|Other Miscellaneous Reasons|0
7958548|NCT02655887|12509815|FG000|Overall Study|Lost to Follow-up|3
7958549|NCT02655887|12509815|FG000|Overall Study|Death|4
7958550|NCT02655887|12509815|FG000|Overall Study|Withdrawal by Subject|3
7958551|NCT02655887|12509815|FG000|Overall Study|Missed 12-month follow-up visit|4
7958552|NCT02656173|12509837|FG000|Overall Study|Deviation from the Eligible Criteria|3
7958553|NCT02656173|12509838|FG001|Overall Study|Deviation from the Eligible Criteria|2
7958554|NCT02656173|12509837|FG000|Overall Study|Adverse Event|7
7958555|NCT02656173|12509838|FG001|Overall Study|Adverse Event|5
7958556|NCT02656173|12509837|FG000|Overall Study|Withdrawal by Subject|1
7958557|NCT02656173|12509838|FG001|Overall Study|Withdrawal by Subject|3
7958558|NCT02656173|12509837|FG000|Overall Study|Protocol Violation|0
7958559|NCT02656173|12509838|FG001|Overall Study|Protocol Violation|1
7958560|NCT02656173|12509837|FG000|Overall Study|Miscellaneous|2
7958561|NCT02656173|12509838|FG001|Overall Study|Miscellaneous|0
7958562|NCT02656329|12509848|FG000|Overall Study|Lost to Follow-up|2
7958563|NCT02656329|12509849|FG001|Overall Study|Lost to Follow-up|3
7958564|NCT02656329|12509848|FG000|Overall Study|Withdrawal by Subject|7
7958565|NCT02656329|12509849|FG001|Overall Study|Withdrawal by Subject|6
7958566|NCT02656329|12509848|FG000|Overall Study|Study termination by Sponsor|150
7958567|NCT02656329|12509849|FG001|Overall Study|Study termination by Sponsor|142
7958568|NCT02656329|12509848|FG000|Overall Study|Other than specified above|5
7958569|NCT02656329|12509849|FG001|Overall Study|Other than specified above|6
7958570|NCT02656680|12509896|FG000|Overall Study|Lost to Follow-up|0
7958571|NCT02656680|12509897|FG001|Overall Study|Lost to Follow-up|1
7958572|NCT02656693|12509908|FG000|Overall Study|Pregnancy|1
7958573|NCT02656693|12509909|FG001|Overall Study|Pregnancy|1
7958574|NCT02656693|12509910|FG002|Overall Study|Pregnancy|1
7958575|NCT02656693|12509908|FG000|Overall Study|Bariatric surgery|0
7958576|NCT02656693|12509909|FG001|Overall Study|Bariatric surgery|1
7958577|NCT02656693|12509910|FG002|Overall Study|Bariatric surgery|2
7958578|NCT02657031|12509935|FG000|Overall Study|Adverse Event|1
7958579|NCT02657031|12509936|FG001|Overall Study|Adverse Event|2
7958580|NCT02657369|12509958|FG000|Overall Study|Death|27
7958581|NCT02657369|12509958|FG000|Overall Study|Study terminated by sponsor|7
7958582|NCT02657408|12509964|FG000|Overall Study|Adverse Event|3
7958583|NCT02657408|12509965|FG001|Overall Study|Adverse Event|7
7958584|NCT02657889|12509996|FG000|Overall Study|Death|5
7958585|NCT02657889|12509997|FG001|Overall Study|Death|2
7958586|NCT02657889|12509998|FG002|Overall Study|Death|20
7958587|NCT02657889|12509999|FG003|Overall Study|Death|34
7958588|NCT02657889|12509996|FG000|Overall Study|Lost to Follow-up|2
7958589|NCT02657889|12509997|FG001|Overall Study|Lost to Follow-up|0
7958590|NCT02657889|12509998|FG002|Overall Study|Lost to Follow-up|1
7958591|NCT02657889|12509999|FG003|Overall Study|Lost to Follow-up|2
7958592|NCT02657889|12509996|FG000|Overall Study|Withdrawal by Subject|0
7958593|NCT02657889|12509997|FG001|Overall Study|Withdrawal by Subject|0
7958594|NCT02657889|12509998|FG002|Overall Study|Withdrawal by Subject|8
7958595|NCT02657889|12509999|FG003|Overall Study|Withdrawal by Subject|0
7958596|NCT02657889|12509996|FG000|Overall Study|Ongoing in Study|0
7958597|NCT02657889|12509997|FG001|Overall Study|Ongoing in Study|5
7958598|NCT02657889|12509998|FG002|Overall Study|Ongoing in Study|24
7958599|NCT02657889|12509999|FG003|Overall Study|Ongoing in Study|19
7958600|NCT02658019|12510030|FG000|Overall Study|Adverse Event|1
7958601|NCT02658084|12510036|FG000|Overall Study|Withdrawal by Subject|1
7958602|NCT02658084|12510037|FG001|Overall Study|Withdrawal by Subject|0
7958603|NCT02658084|12510036|FG000|Overall Study|Study Termination|1
7958604|NCT02658084|12510037|FG001|Overall Study|Study Termination|0
7958605|NCT02658149|12510044|FG000|Overall Study|Physician Decision|1
7958606|NCT02658149|12510045|FG001|Overall Study|Physician Decision|0
7958607|NCT02658175|12510054|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1
7958608|NCT02658175|12510055|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0
7958609|NCT02658175|12510056|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0
7958610|NCT02658175|12510054|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6
7958611|NCT02658175|12510055|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2
7958612|NCT02658175|12510056|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0
7958613|NCT02658175|12510054|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8
7958614|NCT02658175|12510055|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5
7958615|NCT02658175|12510056|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0
7958616|NCT02658175|12510054|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1
7958617|NCT02658175|12510055|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0
7958618|NCT02658175|12510056|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0
7958619|NCT02658175|12510054|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4
7958620|NCT02658175|12510055|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0
7958621|NCT02658175|12510056|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1
7958622|NCT02658175|12510054|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7
7958623|NCT02658175|12510055|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0
7958624|NCT02658175|12510056|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0
7958625|NCT02658175|12510054|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1
7958626|NCT02658175|12510055|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0
7958627|NCT02658175|12510056|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1
7958628|NCT02658175|12510054|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8
7958629|NCT02658175|12510055|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2
7958630|NCT02658175|12510056|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0
7958631|NCT02658175|12510054|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0
7958632|NCT02658175|12510055|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0
7958633|NCT02658175|12510056|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1
7958634|NCT02658175|12510054|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1
7958635|NCT02658175|12510055|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0
7958636|NCT02658175|12510056|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0
7958637|NCT02658448|12510073|FG000|Overall Study|Lost to Follow-up|1
7958638|NCT02658487|12510092|FG000|Overall Study|Death|2
7958639|NCT02658487|12510092|FG000|Overall Study|Disease progression|10
7958640|NCT02658487|12510092|FG000|Overall Study|Alternative therapy|1
7958641|NCT02658487|12510092|FG000|Overall Study|Adverse Event|1
7958642|NCT02658487|12510092|FG000|Overall Study|Treatment Failure, circulating blasts|1
7958643|NCT02658487|12510092|FG000|Overall Study|Refractory AML|1
7958644|NCT02658630|12510097|FG000|Overall Study|Withdrawal by Subject|4
7958645|NCT02658734|12510101|FG000|Overall Study|Adverse Event|2
7958646|NCT02658734|12510101|FG000|Overall Study|Death|4
7958647|NCT02658734|12510101|FG000|Overall Study|Lost to Follow-up|7
7958648|NCT02658734|12510101|FG000|Overall Study|Withdrawal of Consent|16
7958649|NCT02658734|12510101|FG000|Overall Study|Disease Progression|28
7958650|NCT02659098|12510123|FG000|Overall Study|Withdrawal by Subject|7
7958651|NCT02659150|12510127|FG000|Subject Enrollment|Physician Decision|3
7958652|NCT02659150|12510127|FG000|Subject Enrollment|Withdrawal by Subject|2
7958653|NCT02659150|12510127|FG000|Baseline Imaging|Withdrawal by Subject|1
7958654|NCT02659150|12510127|FG000|Baseline Imaging|Physician Decision|1
7958655|NCT02659150|12510127|FG000|Study Drug Dosing|Adverse Event|1
7958656|NCT02659540|12510143|FG000|Overall Study|Adverse Event|3
7958657|NCT02659540|12510144|FG001|Overall Study|Adverse Event|2
7958658|NCT02659540|12510143|FG000|Overall Study|Death|1
7958659|NCT02659540|12510144|FG001|Overall Study|Death|0
7958660|NCT02659540|12510143|FG000|Overall Study|Progressive disease|2
7958661|NCT02659540|12510144|FG001|Overall Study|Progressive disease|6
7958662|NCT02659631|12510160|FG000|Overall Study|Lost to Follow-up|0
7958663|NCT02659631|12510161|FG001|Overall Study|Lost to Follow-up|0
7958664|NCT02659631|12510162|FG002|Overall Study|Lost to Follow-up|2
7958665|NCT02659631|12510163|FG003|Overall Study|Lost to Follow-up|0
7958666|NCT02659631|12510164|FG004|Overall Study|Lost to Follow-up|0
7958667|NCT02659631|12510165|FG005|Overall Study|Lost to Follow-up|1
7958668|NCT02659631|12510166|FG006|Overall Study|Lost to Follow-up|0
7958669|NCT02659631|12510167|FG007|Overall Study|Lost to Follow-up|0
7958670|NCT02659631|12510168|FG008|Overall Study|Lost to Follow-up|0
7958671|NCT02659631|12510169|FG009|Overall Study|Lost to Follow-up|0
7958672|NCT02659631|12510160|FG000|Overall Study|Withdrawal prior to treatment|0
7958673|NCT02659631|12510161|FG001|Overall Study|Withdrawal prior to treatment|0
7958674|NCT02659631|12510162|FG002|Overall Study|Withdrawal prior to treatment|0
7958675|NCT02659631|12510163|FG003|Overall Study|Withdrawal prior to treatment|0
7958676|NCT02659631|12510164|FG004|Overall Study|Withdrawal prior to treatment|1
7958677|NCT02659631|12510165|FG005|Overall Study|Withdrawal prior to treatment|0
7958678|NCT02659631|12510166|FG006|Overall Study|Withdrawal prior to treatment|0
7958679|NCT02659631|12510167|FG007|Overall Study|Withdrawal prior to treatment|0
7958680|NCT02659631|12510168|FG008|Overall Study|Withdrawal prior to treatment|0
7958681|NCT02659631|12510169|FG009|Overall Study|Withdrawal prior to treatment|0
7958682|NCT02659631|12510160|FG000|Overall Study|Participant refused further follow-up|0
7958683|NCT02659631|12510161|FG001|Overall Study|Participant refused further follow-up|0
7958684|NCT02659631|12510162|FG002|Overall Study|Participant refused further follow-up|0
7958685|NCT02659631|12510163|FG003|Overall Study|Participant refused further follow-up|1
7958686|NCT02659631|12510164|FG004|Overall Study|Participant refused further follow-up|0
7958687|NCT02659631|12510165|FG005|Overall Study|Participant refused further follow-up|0
7958688|NCT02659631|12510166|FG006|Overall Study|Participant refused further follow-up|0
7958689|NCT02659631|12510167|FG007|Overall Study|Participant refused further follow-up|0
7958690|NCT02659631|12510168|FG008|Overall Study|Participant refused further follow-up|1
7958691|NCT02659631|12510169|FG009|Overall Study|Participant refused further follow-up|0
7958692|NCT02659631|12510160|FG000|Overall Study|Death (follow-up phase)|1
7958693|NCT02659631|12510161|FG001|Overall Study|Death (follow-up phase)|2
7958694|NCT02659631|12510162|FG002|Overall Study|Death (follow-up phase)|1
7958695|NCT02659631|12510163|FG003|Overall Study|Death (follow-up phase)|1
7958696|NCT02659631|12510164|FG004|Overall Study|Death (follow-up phase)|3
7958697|NCT02659631|12510165|FG005|Overall Study|Death (follow-up phase)|2
7958698|NCT02659631|12510166|FG006|Overall Study|Death (follow-up phase)|0
7958699|NCT02659631|12510167|FG007|Overall Study|Death (follow-up phase)|3
7958700|NCT02659631|12510168|FG008|Overall Study|Death (follow-up phase)|1
7958701|NCT02659631|12510169|FG009|Overall Study|Death (follow-up phase)|0
7958702|NCT02659631|12510160|FG000|Overall Study|Death (treatment phase)|0
7958703|NCT02659631|12510161|FG001|Overall Study|Death (treatment phase)|0
7958704|NCT02659631|12510162|FG002|Overall Study|Death (treatment phase)|0
7958705|NCT02659631|12510163|FG003|Overall Study|Death (treatment phase)|0
7958706|NCT02659631|12510164|FG004|Overall Study|Death (treatment phase)|1
7958707|NCT02659631|12510165|FG005|Overall Study|Death (treatment phase)|0
7958708|NCT02659631|12510166|FG006|Overall Study|Death (treatment phase)|1
7958709|NCT02659631|12510167|FG007|Overall Study|Death (treatment phase)|0
7958710|NCT02659631|12510168|FG008|Overall Study|Death (treatment phase)|0
7958711|NCT02659631|12510169|FG009|Overall Study|Death (treatment phase)|0
7958712|NCT02659943|12510211|FG000|Overall Study|Switched to alternative treatment|1
7958713|NCT02659943|12510212|FG001|Overall Study|Switched to alternative treatment|1
7958714|NCT02659943|12510213|FG002|Overall Study|Switched to alternative treatment|0
7958715|NCT02659943|12510214|FG003|Overall Study|Switched to alternative treatment|2
7958716|NCT02659943|12510215|FG004|Overall Study|Switched to alternative treatment|1
7958717|NCT02659943|12510216|FG005|Overall Study|Switched to alternative treatment|0
7958718|NCT02659943|12510217|FG006|Overall Study|Switched to alternative treatment|1
7958719|NCT02659943|12510211|FG000|Overall Study|Disease progression on study|0
7958720|NCT02659943|12510212|FG001|Overall Study|Disease progression on study|1
7958721|NCT02659943|12510213|FG002|Overall Study|Disease progression on study|1
7958722|NCT02659943|12510214|FG003|Overall Study|Disease progression on study|1
7958723|NCT02659943|12510215|FG004|Overall Study|Disease progression on study|1
7958724|NCT02659943|12510216|FG005|Overall Study|Disease progression on study|4
7958725|NCT02659943|12510217|FG006|Overall Study|Disease progression on study|0
7958726|NCT02659943|12510211|FG000|Overall Study|Patient's condition per principal investigator|0
7958727|NCT02659943|12510212|FG001|Overall Study|Patient's condition per principal investigator|0
7958728|NCT02659943|12510213|FG002|Overall Study|Patient's condition per principal investigator|0
7958729|NCT02659943|12510214|FG003|Overall Study|Patient's condition per principal investigator|0
7958730|NCT02659943|12510215|FG004|Overall Study|Patient's condition per principal investigator|0
7958731|NCT02659943|12510216|FG005|Overall Study|Patient's condition per principal investigator|1
7958732|NCT02659943|12510217|FG006|Overall Study|Patient's condition per principal investigator|0
7958733|NCT02659943|12510211|FG000|Overall Study|Ineligible|0
7958734|NCT02659943|12510212|FG001|Overall Study|Ineligible|0
7958735|NCT02659943|12510213|FG002|Overall Study|Ineligible|0
7958736|NCT02659943|12510214|FG003|Overall Study|Ineligible|0
7958737|NCT02659943|12510215|FG004|Overall Study|Ineligible|0
7958738|NCT02659943|12510216|FG005|Overall Study|Ineligible|0
7958739|NCT02659943|12510217|FG006|Overall Study|Ineligible|1
7958740|NCT02659943|12510211|FG000|Overall Study|No longer meets eligibility|0
7958741|NCT02659943|12510212|FG001|Overall Study|No longer meets eligibility|0
7958742|NCT02659943|12510213|FG002|Overall Study|No longer meets eligibility|0
7958743|NCT02659943|12510214|FG003|Overall Study|No longer meets eligibility|0
7958744|NCT02659943|12510215|FG004|Overall Study|No longer meets eligibility|0
7958745|NCT02659943|12510216|FG005|Overall Study|No longer meets eligibility|0
7958746|NCT02659943|12510217|FG006|Overall Study|No longer meets eligibility|1
7958747|NCT02659943|12510211|FG000|Overall Study|No treatment, per protocol|0
7958748|NCT02659943|12510212|FG001|Overall Study|No treatment, per protocol|0
7958749|NCT02659943|12510213|FG002|Overall Study|No treatment, per protocol|0
7958750|NCT02659943|12510214|FG003|Overall Study|No treatment, per protocol|0
7958751|NCT02659943|12510215|FG004|Overall Study|No treatment, per protocol|0
7958752|NCT02659943|12510216|FG005|Overall Study|No treatment, per protocol|0
7958753|NCT02659943|12510217|FG006|Overall Study|No treatment, per protocol|3
7958754|NCT02660229|12510244|FG000|Overall Study|Adverse Event|2
7958755|NCT02660229|12510245|FG001|Overall Study|Adverse Event|0
7958756|NCT02660229|12510244|FG000|Overall Study|Withdrawal by Subject|0
7958757|NCT02660229|12510245|FG001|Overall Study|Withdrawal by Subject|1
7958758|NCT02660242|12510251|FG000|Glucose Tabs|Lost to Follow-up|1
7958759|NCT02660242|12510251|FG000|Glucagon Injection|Lost to Follow-up|1
7958760|NCT02660489|12510266|FG000|Overall Study|Lost to Follow-up|1
7958761|NCT02660489|12510267|FG001|Overall Study|Lost to Follow-up|1
7958762|NCT02660489|12510266|FG000|Overall Study|Adverse Event|1
7958763|NCT02660489|12510267|FG001|Overall Study|Adverse Event|3
7958764|NCT02660489|12510266|FG000|Overall Study|no rhinovirus infection|4
7958765|NCT02660489|12510267|FG001|Overall Study|no rhinovirus infection|4
7958766|NCT02660580|12510275|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
7958767|NCT02660580|12510276|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
7958768|NCT02660580|12510277|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
7958769|NCT02660580|12510278|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
7958770|NCT02660580|12510279|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
7958771|NCT02660580|12510275|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3
7958772|NCT02660580|12510276|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1
7958773|NCT02660580|12510277|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
7958774|NCT02660580|12510278|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
7958775|NCT02660580|12510279|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
7958776|NCT02660580|12510275|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1
7958777|NCT02660580|12510276|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7958778|NCT02660580|12510277|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7958779|NCT02660580|12510278|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7958780|NCT02660580|12510279|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7958781|NCT02660580|12510275|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7958782|NCT02660580|12510276|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2
7958783|NCT02660580|12510277|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7958784|NCT02660580|12510278|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7958785|NCT02660580|12510279|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7958786|NCT02660580|12510275|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2
7958787|NCT02660580|12510276|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9
7958788|NCT02660580|12510277|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0
7958789|NCT02660580|12510278|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0
7958790|NCT02660580|12510279|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0
7958791|NCT02660580|12510275|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1
7958792|NCT02660580|12510276|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4
7958793|NCT02660580|12510277|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
7958794|NCT02660580|12510278|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
7958795|NCT02660580|12510279|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
7958796|NCT02660580|12510275|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1
7958797|NCT02660580|12510276|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2
7958798|NCT02660580|12510277|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
7958799|NCT02660580|12510278|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
7958800|NCT02660580|12510279|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
7958801|NCT02660580|12510275|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
7958802|NCT02660580|12510276|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
7958803|NCT02660580|12510277|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2
7958804|NCT02660580|12510278|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
7958805|NCT02660580|12510279|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1
7958806|NCT02660580|12510275|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
7958807|NCT02660580|12510276|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
7958808|NCT02660580|12510277|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
7958809|NCT02660580|12510278|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
7958810|NCT02660580|12510279|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
7958811|NCT02660580|12510275|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
7958812|NCT02660580|12510276|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
7958813|NCT02660580|12510277|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4
7958814|NCT02660580|12510278|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
7958815|NCT02660580|12510279|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
7958816|NCT02660580|12510275|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
7958817|NCT02660580|12510276|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
7958818|NCT02660580|12510277|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8
7958819|NCT02660580|12510278|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6
7958820|NCT02660580|12510279|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4
7958821|NCT02660580|12510275|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
7958822|NCT02660580|12510276|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
7958823|NCT02660580|12510277|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3
7958824|NCT02660580|12510278|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
7958825|NCT02660580|12510279|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
7958826|NCT02660580|12510275|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
7958827|NCT02660580|12510276|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
7958828|NCT02660580|12510277|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
7958829|NCT02660580|12510278|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
7958830|NCT02660580|12510279|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
7958831|NCT02660944|12510330|FG000|Overall Study|Adverse Event|3
7958832|NCT02660944|12510331|FG001|Overall Study|Adverse Event|4
7958833|NCT02660944|12510330|FG000|Overall Study|Physician Decision|3
7958834|NCT02660944|12510331|FG001|Overall Study|Physician Decision|1
7958835|NCT02660944|12510330|FG000|Overall Study|Withdrawal by Subject|5
7958836|NCT02660944|12510331|FG001|Overall Study|Withdrawal by Subject|3
7958837|NCT02660944|12510330|FG000|Overall Study|Lost to Follow-up|4
7958838|NCT02660944|12510331|FG001|Overall Study|Lost to Follow-up|1
7958839|NCT02660944|12510330|FG000|Overall Study|Subject schedule|0
7958840|NCT02660944|12510331|FG001|Overall Study|Subject schedule|1
7958841|NCT02660944|12510330|FG000|Overall Study|Exclusion criteria met|2
7958842|NCT02660944|12510331|FG001|Overall Study|Exclusion criteria met|0
7958843|NCT02660983|12510339|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1
7958844|NCT02660983|12510340|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5
7958845|NCT02660983|12510339|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15
7958846|NCT02660983|12510340|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12
7958847|NCT02660983|12510339|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8
7958848|NCT02660983|12510340|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9
7958849|NCT02660983|12510339|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
7958850|NCT02660983|12510340|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
7958851|NCT02660983|12510339|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1
7958852|NCT02660983|12510340|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4
7958853|NCT02660983|12510339|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1
7958854|NCT02660983|12510340|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3
7958855|NCT02660983|12510339|FG000|Open Label Extension Phase (24 Weeks)|Other|0
7958856|NCT02660983|12510340|FG001|Open Label Extension Phase (24 Weeks)|Other|1
7958857|NCT02661061|12510349|FG000|Overall Study|Lack of Efficacy|1
7958858|NCT02661061|12510350|FG001|Overall Study|Lack of Efficacy|1
7958859|NCT02661061|12510349|FG000|Overall Study|Withdrawal by Subject|1
7958860|NCT02661061|12510350|FG001|Overall Study|Withdrawal by Subject|1
7966633|NCT02755649|12522942|FG002|Overall Study|Transitioned into OLE study|100
7966634|NCT02755649|12522940|FG000|Overall Study|Did Not Complete Follow-up Visits|1
7966635|NCT02755649|12522941|FG001|Overall Study|Did Not Complete Follow-up Visits|0
7966636|NCT02755649|12522942|FG002|Overall Study|Did Not Complete Follow-up Visits|0
7966637|NCT02755649|12522940|FG000|Overall Study|Physician Decision|0
7966638|NCT02755649|12522941|FG001|Overall Study|Physician Decision|0
7966639|NCT02755649|12522942|FG002|Overall Study|Physician Decision|2
7966640|NCT02755649|12522940|FG000|Overall Study|Withdrawal by Subject|0
7966641|NCT02755649|12522941|FG001|Overall Study|Withdrawal by Subject|1
7966642|NCT02755649|12522942|FG002|Overall Study|Withdrawal by Subject|0
7966643|NCT02755649|12522940|FG000|Overall Study|Undecided|1
7966644|NCT02755649|12522941|FG001|Overall Study|Undecided|0
7966645|NCT02755649|12522942|FG002|Overall Study|Undecided|0
7966646|NCT02755805|12522952|FG000|Overall Study|Lost to Follow-up|1
7966647|NCT02755805|12522953|FG001|Overall Study|Lost to Follow-up|2
7966648|NCT02755805|12522952|FG000|Overall Study|Refused assessments|1
7966649|NCT02755805|12522953|FG001|Overall Study|Refused assessments|0
7966650|NCT02755805|12522952|FG000|Overall Study|Withdrawal by Subject|0
7966651|NCT02755805|12522953|FG001|Overall Study|Withdrawal by Subject|2
7966652|NCT02755818|12522963|FG000|Overall Study|Withdrawal by Subject|0
7966653|NCT02755818|12522964|FG001|Overall Study|Withdrawal by Subject|0
7966654|NCT02755818|12522965|FG002|Overall Study|Withdrawal by Subject|0
7966655|NCT02755818|12522966|FG003|Overall Study|Withdrawal by Subject|2
7966656|NCT02755818|12522963|FG000|Overall Study|withdrawal by PI|0
7966657|NCT02755818|12522964|FG001|Overall Study|withdrawal by PI|0
7966658|NCT02755818|12522965|FG002|Overall Study|withdrawal by PI|1
7958861|NCT02661178|12510380|FG000|Part 1|Protocol Violation|1
7958862|NCT02661178|12510381|FG001|Part 1|Protocol Violation|0
7958863|NCT02661178|12510382|FG002|Part 1|Protocol Violation|0
7958864|NCT02661178|12510383|FG003|Part 1|Protocol Violation|0
7958865|NCT02661178|12510384|FG004|Part 1|Protocol Violation|0
7958866|NCT02661178|12510385|FG005|Part 1|Protocol Violation|0
7958867|NCT02661178|12510386|FG006|Part 1|Protocol Violation|0
7958868|NCT02661178|12510387|FG007|Part 1|Protocol Violation|0
7958869|NCT02661178|12510388|FG008|Part 1|Protocol Violation|0
7958870|NCT02661178|12510389|FG009|Part 1|Protocol Violation|0
7958871|NCT02661178|12510390|FG010|Part 1|Protocol Violation|0
7958872|NCT02661178|12510391|FG011|Part 1|Protocol Violation|0
7958873|NCT02661178|12510392|FG012|Part 1|Protocol Violation|0
7958874|NCT02661178|12510393|FG013|Part 1|Protocol Violation|0
7958875|NCT02661178|12510394|FG014|Part 1|Protocol Violation|0
7958876|NCT02661217|12510446|FG000|Overall Study|Physician Decision|12
7958877|NCT02661217|12510447|FG001|Overall Study|Physician Decision|15
7958878|NCT02661217|12510446|FG000|Overall Study|Lost to Follow-up|1
7958879|NCT02661217|12510447|FG001|Overall Study|Lost to Follow-up|4
7958880|NCT02661217|12510446|FG000|Overall Study|Protocol Deviation|0
7958881|NCT02661217|12510447|FG001|Overall Study|Protocol Deviation|4
7958882|NCT02661217|12510446|FG000|Overall Study|Non-compliance with study treatment|5
7958883|NCT02661217|12510447|FG001|Overall Study|Non-compliance with study treatment|5
7958884|NCT02661217|12510446|FG000|Overall Study|Death|21
7958885|NCT02661217|12510447|FG001|Overall Study|Death|15
7958886|NCT02661217|12510446|FG000|Overall Study|Adverse Event|10
7958887|NCT02661217|12510447|FG001|Overall Study|Adverse Event|8
7958888|NCT02661217|12510446|FG000|Overall Study|Withdrawal by Subject|15
7958889|NCT02661217|12510447|FG001|Overall Study|Withdrawal by Subject|19
7958890|NCT02661217|12510446|FG000|Overall Study|Did not enter follow-up epoch|7
7958891|NCT02661217|12510447|FG001|Overall Study|Did not enter follow-up epoch|10
7958892|NCT02661217|12510446|FG000|Overall Study|Death - no study drug received|1
7958893|NCT02661217|12510447|FG001|Overall Study|Death - no study drug received|2
7958894|NCT02661217|12510446|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3
7958895|NCT02661217|12510447|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1
7958896|NCT02661490|12510465|FG000|Overall Study|Lost to Follow-up|0
7958897|NCT02661490|12510466|FG001|Overall Study|Lost to Follow-up|1
7958898|NCT02661490|12510467|FG002|Overall Study|Lost to Follow-up|0
7958899|NCT02661490|12510468|FG003|Overall Study|Lost to Follow-up|0
7958900|NCT02661490|12510469|FG004|Overall Study|Lost to Follow-up|2
7958901|NCT02661490|12510465|FG000|Overall Study|Withdrawal by Subject|2
7958902|NCT02661490|12510466|FG001|Overall Study|Withdrawal by Subject|0
7958903|NCT02661490|12510467|FG002|Overall Study|Withdrawal by Subject|2
7958904|NCT02661490|12510468|FG003|Overall Study|Withdrawal by Subject|0
7958905|NCT02661490|12510469|FG004|Overall Study|Withdrawal by Subject|0
7958906|NCT02661490|12510465|FG000|Overall Study|Death|1
7958907|NCT02661490|12510466|FG001|Overall Study|Death|1
7958908|NCT02661490|12510467|FG002|Overall Study|Death|0
7958909|NCT02661490|12510468|FG003|Overall Study|Death|1
7958910|NCT02661490|12510469|FG004|Overall Study|Death|0
7958911|NCT02661490|12510465|FG000|Overall Study|Reason not Specified|0
7958912|NCT02661490|12510466|FG001|Overall Study|Reason not Specified|0
7958913|NCT02661490|12510467|FG002|Overall Study|Reason not Specified|0
7958914|NCT02661490|12510468|FG003|Overall Study|Reason not Specified|0
7958915|NCT02661490|12510469|FG004|Overall Study|Reason not Specified|1
7958916|NCT02661594|12510485|FG000|Overall Study|Protocol Violation|1
7958917|NCT02661594|12510486|FG001|Overall Study|Protocol Violation|0
7958918|NCT02661594|12510487|FG002|Overall Study|Protocol Violation|1
7958919|NCT02661594|12510488|FG003|Overall Study|Protocol Violation|0
7958920|NCT02661815|12510506|FG000|Overall Study|Withdrawal by Subject|1
7958921|NCT02661815|12510507|FG001|Overall Study|Withdrawal by Subject|0
7958922|NCT02661815|12510508|FG002|Overall Study|Withdrawal by Subject|0
7958923|NCT02661815|12510509|FG003|Overall Study|Withdrawal by Subject|0
7958924|NCT02662556|12510566|FG000|Overall Study|Adverse Event|4
7958925|NCT02662556|12510566|FG000|Overall Study|Lack of Efficacy|4
7958926|NCT02662569|12510575|FG000|Overall Study|Withdrawal by Subject|6
7958927|NCT02662569|12510576|FG001|Overall Study|Withdrawal by Subject|1
7958928|NCT02662569|12510577|FG002|Overall Study|Withdrawal by Subject|6
7958929|NCT02662569|12510578|FG003|Overall Study|Withdrawal by Subject|4
7958930|NCT02662569|12510575|FG000|Overall Study|Lost to Follow-up|1
7958931|NCT02662569|12510576|FG001|Overall Study|Lost to Follow-up|0
7958932|NCT02662569|12510577|FG002|Overall Study|Lost to Follow-up|0
7958933|NCT02662569|12510578|FG003|Overall Study|Lost to Follow-up|0
7958934|NCT02662582|12510590|FG000|Treatment Period 1 (14 Days)|Adverse Event|3
7958935|NCT02662582|12510591|FG001|Treatment Period 1 (14 Days)|Adverse Event|2
7958936|NCT02662582|12510590|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0
7958937|NCT02662582|12510591|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1
7958938|NCT02662582|12510590|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1
7958939|NCT02662582|12510591|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0
7958940|NCT02662582|12510590|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7958941|NCT02662582|12510591|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7958942|NCT02662764|12510602|FG000|Overall Study|Adverse Event|6
7958943|NCT02662764|12510602|FG000|Overall Study|Lack of Efficacy|8
7958944|NCT02662764|12510602|FG000|Overall Study|Protocol Violation|1
7958945|NCT02662764|12510602|FG000|Overall Study|Withdrawal by Subject|5
7958946|NCT02662764|12510602|FG000|Overall Study|Device failure|4
7958947|NCT02662764|12510602|FG000|Overall Study|Patient changed treatment|1
7958948|NCT02662764|12510602|FG000|Overall Study|Patient discharged prior to 24 hrs|5
7958949|NCT02663128|12510613|FG000|Period 2|Physician Decision|0
7958950|NCT02663128|12510614|FG001|Period 2|Physician Decision|0
7958951|NCT02663128|12510615|FG002|Period 2|Physician Decision|0
7958952|NCT02663128|12510616|FG003|Period 2|Physician Decision|0
7958953|NCT02663128|12510617|FG004|Period 2|Physician Decision|1
7958954|NCT02663128|12510618|FG005|Period 2|Physician Decision|0
7958955|NCT02663453|12510633|FG000|Overall Study|Death|4
7958956|NCT02663453|12510634|FG001|Overall Study|Death|4
7958957|NCT02663453|12510633|FG000|Overall Study|Withdrawal by Subject|1
7958958|NCT02663453|12510634|FG001|Overall Study|Withdrawal by Subject|0
7958959|NCT02663674|12510642|FG000|Overall Study|Lost to Follow-up|5
7958960|NCT02663674|12510643|FG001|Overall Study|Lost to Follow-up|4
7958961|NCT02663674|12510642|FG000|Overall Study|Withdrawal by Subject|1
7958962|NCT02663674|12510643|FG001|Overall Study|Withdrawal by Subject|4
7958963|NCT02663674|12510642|FG000|Overall Study|Physician Decision|1
7958964|NCT02663674|12510643|FG001|Overall Study|Physician Decision|1
7958965|NCT02663674|12510642|FG000|Overall Study|Other Event (Health Related)|0
7958966|NCT02663674|12510643|FG001|Overall Study|Other Event (Health Related)|1
7958967|NCT02663687|12510654|FG000|Overall Study|Adverse Event|1
7958968|NCT02663687|12510655|FG001|Overall Study|Adverse Event|0
7958969|NCT02663687|12510656|FG002|Overall Study|Adverse Event|0
7958970|NCT02663687|12510657|FG003|Overall Study|Adverse Event|0
7958971|NCT02663687|12510658|FG004|Overall Study|Adverse Event|0
7958972|NCT02663687|12510654|FG000|Overall Study|Other|1
7958973|NCT02663687|12510655|FG001|Overall Study|Other|0
7958974|NCT02663687|12510656|FG002|Overall Study|Other|1
7958975|NCT02663687|12510657|FG003|Overall Study|Other|0
7958976|NCT02663687|12510658|FG004|Overall Study|Other|0
7958977|NCT02663817|12510683|FG000|Overall Study|Screen failure|2
7958978|NCT02663882|12510691|FG000|Overall Study|Lost to Follow-up|4
7958979|NCT02663882|12510692|FG001|Overall Study|Lost to Follow-up|2
7958980|NCT02663895|12510698|FG000|Overall Study|Adverse Event|3
7958981|NCT02663895|12510698|FG000|Overall Study|Physician Decision|2
7958982|NCT02663895|12510698|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1
7958983|NCT02663895|12510698|FG000|Overall Study|Withdrawal by Subject|1
7958984|NCT02664272|12510712|FG000|Overall Study|Fluoroscopic images not made available|2
7958985|NCT02664415|12510731|FG000|Overall Study|Adverse Event|1
7958986|NCT02664415|12510732|FG001|Overall Study|Adverse Event|0
7958987|NCT02665052|12510794|FG000|Overall Study|Lost to Follow-up|1
7958988|NCT02665052|12510795|FG001|Overall Study|Lost to Follow-up|0
7958989|NCT02665052|12510796|FG002|Overall Study|Lost to Follow-up|0
7958990|NCT02665052|12510797|FG003|Overall Study|Lost to Follow-up|0
7958991|NCT02665052|12510794|FG000|Overall Study|Withdrawal by Subject|1
7958992|NCT02665052|12510795|FG001|Overall Study|Withdrawal by Subject|1
7958993|NCT02665052|12510796|FG002|Overall Study|Withdrawal by Subject|0
7958994|NCT02665052|12510797|FG003|Overall Study|Withdrawal by Subject|5
7958995|NCT02665052|12510794|FG000|Overall Study|Adverse Event|1
7958996|NCT02665052|12510795|FG001|Overall Study|Adverse Event|1
7958997|NCT02665052|12510796|FG002|Overall Study|Adverse Event|0
7958998|NCT02665052|12510797|FG003|Overall Study|Adverse Event|0
7958999|NCT02665286|12510841|FG000|Overall Study|Lost to Follow-up|3
7959000|NCT02665286|12510842|FG001|Overall Study|Lost to Follow-up|2
7959001|NCT02665286|12510843|FG002|Overall Study|Lost to Follow-up|1
7959002|NCT02665455|12510860|FG000|Overall Study|Withdrawal by Subject|6
7959003|NCT02665455|12510860|FG000|Overall Study|Lost to Follow-up|1
7959004|NCT02665455|12510860|FG000|Overall Study|Adverse Event|1
7959005|NCT02665455|12510860|FG000|Overall Study|Protocol Violation|1
7959006|NCT02665689|12510875|FG000|Overall Study|Adverse Event|1
7959007|NCT02665689|12510876|FG001|Overall Study|Adverse Event|0
7959008|NCT02665689|12510875|FG000|Overall Study|Trial termination|1
7959009|NCT02665689|12510876|FG001|Overall Study|Trial termination|1
7959010|NCT02665689|12510875|FG000|Overall Study|Lost to Follow-up|0
7959011|NCT02665689|12510876|FG001|Overall Study|Lost to Follow-up|1
7959012|NCT02666222|12510908|FG000|Overall Study|Death|2
7959013|NCT02666664|12510948|FG000|Overall Study|Physician Decision|0
7959014|NCT02666664|12510949|FG001|Overall Study|Physician Decision|1
7959015|NCT02666664|12510948|FG000|Overall Study|Protocol Violation|0
7959016|NCT02666664|12510949|FG001|Overall Study|Protocol Violation|2
7959017|NCT02666664|12510948|FG000|Overall Study|Other|0
7959018|NCT02666664|12510949|FG001|Overall Study|Other|1
7959019|NCT02666664|12510948|FG000|Overall Study|Adverse Event|12
7959020|NCT02666664|12510949|FG001|Overall Study|Adverse Event|37
7959021|NCT02666664|12510948|FG000|Overall Study|Withdrawal by participant|23
7959022|NCT02666664|12510949|FG001|Overall Study|Withdrawal by participant|40
7959023|NCT02666664|12510948|FG000|Overall Study|Sponsor decision|0
7959024|NCT02666664|12510949|FG001|Overall Study|Sponsor decision|1
7959025|NCT02666664|12510948|FG000|Overall Study|Lost to Follow-up|1
7959026|NCT02666664|12510949|FG001|Overall Study|Lost to Follow-up|2
7959027|NCT02667236|12510996|FG000|Overall Study|Adverse Event|1
7959028|NCT02667236|12510997|FG001|Overall Study|Adverse Event|1
7959029|NCT02667236|12510996|FG000|Overall Study|Withdrawal by Subject|2
7959030|NCT02667236|12510997|FG001|Overall Study|Withdrawal by Subject|0
7959031|NCT02667275|12511005|FG000|Overall Study|Protocol Violation|11
7959032|NCT02667275|12511006|FG001|Overall Study|Protocol Violation|7
7959033|NCT02667275|12511005|FG000|Overall Study|Lost to Follow-up|0
7959034|NCT02667275|12511006|FG001|Overall Study|Lost to Follow-up|2
7959035|NCT02667275|12511005|FG000|Overall Study|Withdrawal by Subject|0
7959036|NCT02667275|12511006|FG001|Overall Study|Withdrawal by Subject|5
7959037|NCT02667275|12511005|FG000|Overall Study|Discontinued early without completing|0
7959038|NCT02667275|12511006|FG001|Overall Study|Discontinued early without completing|1
7959039|NCT02667288|12511012|FG000|Overall Study|Protocol Violation|5
7959040|NCT02667288|12511012|FG000|Overall Study|Lost to Follow-up|3
7959041|NCT02667288|12511012|FG000|Overall Study|Withdrawal by Subject|5
7959042|NCT02667301|12511016|FG000|Overall Study|Adverse Event|1
7959043|NCT02667301|12511016|FG000|Overall Study|Lack of Efficacy|1
7959044|NCT02667457|12511028|FG000|Overall Study|Withdrawal by Subject|1
7959045|NCT02667457|12511029|FG001|Overall Study|Withdrawal by Subject|0
7959046|NCT02667457|12511028|FG000|Overall Study|Other Reason|0
7959047|NCT02667457|12511029|FG001|Overall Study|Other Reason|2
7959048|NCT02667626|12511038|FG000|Overall Study|Withdrawal by Subject|0
7959049|NCT02667626|12511039|FG001|Overall Study|Withdrawal by Subject|1
7959050|NCT02667912|12511062|FG000|Overall Study|Death|3
7959051|NCT02667912|12511063|FG001|Overall Study|Death|1
7959052|NCT02667912|12511062|FG000|Overall Study|Withdrawal by Subject|1
7959053|NCT02667912|12511063|FG001|Overall Study|Withdrawal by Subject|2
7959054|NCT02667912|12511062|FG000|Overall Study|Withdrawal by Subject|1
7959055|NCT02667912|12511063|FG001|Overall Study|Withdrawal by Subject|0
7959056|NCT02668185|12511087|FG000|First Intervention (4 Weeks)|Physician Decision|2
7959057|NCT02668185|12511088|FG001|First Intervention (4 Weeks)|Physician Decision|0
7959058|NCT02668185|12511087|FG000|Washout Period (2 Weeks)|Adverse Event|1
7959059|NCT02668185|12511088|FG001|Washout Period (2 Weeks)|Adverse Event|0
7959060|NCT02668185|12511087|FG000|Washout Period (2 Weeks)|Physician Decision|0
7959061|NCT02668185|12511088|FG001|Washout Period (2 Weeks)|Physician Decision|2
7959062|NCT02668185|12511087|FG000|Second Intervention (4 Weeks)|Physician Decision|1
7959063|NCT02668185|12511088|FG001|Second Intervention (4 Weeks)|Physician Decision|3
7959064|NCT02668302|12511101|FG000|Overall Study|Withdrawal by Subject|1
7959065|NCT02668302|12511102|FG001|Overall Study|Withdrawal by Subject|0
7959066|NCT02668393|12511110|FG000|Overall Study|Progressive disease|6
7959067|NCT02668393|12511111|FG001|Overall Study|Progressive disease|3
7959068|NCT02668393|12511110|FG000|Overall Study|Adverse Event|0
7959069|NCT02668393|12511111|FG001|Overall Study|Adverse Event|2
7959070|NCT02668393|12511110|FG000|Overall Study|Withdrawal from the trial|0
7959071|NCT02668393|12511111|FG001|Overall Study|Withdrawal from the trial|1
7959072|NCT02668393|12511110|FG000|Overall Study|Lack of benefit and side effects|1
7959073|NCT02668393|12511111|FG001|Overall Study|Lack of benefit and side effects|0
7959074|NCT02668640|12511127|FG000|Overall Study|Lost to Follow-up|13
7959075|NCT02668640|12511127|FG000|Overall Study|Other, not specified|1
7959076|NCT02668692|12511133|FG000|Overall Study|Adverse Event|1
7959077|NCT02668692|12511134|FG001|Overall Study|Adverse Event|0
7959078|NCT02669017|12511158|FG000|Overall Study|Death|1
7959079|NCT02669017|12511159|FG001|Overall Study|Death|2
7959080|NCT02669017|12511160|FG002|Overall Study|Death|2
7959081|NCT02669017|12511161|FG003|Overall Study|Death|3
7959082|NCT02669017|12511162|FG004|Overall Study|Death|8
7959083|NCT02669017|12511163|FG005|Overall Study|Death|18
7959084|NCT02669017|12511164|FG006|Overall Study|Death|10
7959085|NCT02669017|12511165|FG007|Overall Study|Death|47
7959086|NCT02669017|12511166|FG008|Overall Study|Death|20
7959087|NCT02669017|12511158|FG000|Overall Study|Withdrawal by Subject|0
7959088|NCT02669017|12511159|FG001|Overall Study|Withdrawal by Subject|0
7959089|NCT02669017|12511160|FG002|Overall Study|Withdrawal by Subject|0
7959090|NCT02669017|12511161|FG003|Overall Study|Withdrawal by Subject|1
7959091|NCT02669017|12511162|FG004|Overall Study|Withdrawal by Subject|2
7959092|NCT02669017|12511163|FG005|Overall Study|Withdrawal by Subject|0
7959093|NCT02669017|12511164|FG006|Overall Study|Withdrawal by Subject|0
7959094|NCT02669017|12511165|FG007|Overall Study|Withdrawal by Subject|2
7959095|NCT02669017|12511166|FG008|Overall Study|Withdrawal by Subject|2
7959096|NCT02669017|12511158|FG000|Overall Study|Lost to Follow-up|0
7959097|NCT02669017|12511159|FG001|Overall Study|Lost to Follow-up|0
7959098|NCT02669017|12511160|FG002|Overall Study|Lost to Follow-up|0
7959099|NCT02669017|12511161|FG003|Overall Study|Lost to Follow-up|0
7959100|NCT02669017|12511162|FG004|Overall Study|Lost to Follow-up|0
7959101|NCT02669017|12511163|FG005|Overall Study|Lost to Follow-up|0
7959102|NCT02669017|12511164|FG006|Overall Study|Lost to Follow-up|0
7959103|NCT02669017|12511165|FG007|Overall Study|Lost to Follow-up|0
7959104|NCT02669017|12511166|FG008|Overall Study|Lost to Follow-up|1
7959105|NCT02669017|12511158|FG000|Overall Study|Miscellaneous|0
7959106|NCT02669017|12511159|FG001|Overall Study|Miscellaneous|0
7959107|NCT02669017|12511160|FG002|Overall Study|Miscellaneous|0
7959108|NCT02669017|12511161|FG003|Overall Study|Miscellaneous|0
7959109|NCT02669017|12511162|FG004|Overall Study|Miscellaneous|2
7959110|NCT02669017|12511163|FG005|Overall Study|Miscellaneous|1
7959111|NCT02669017|12511164|FG006|Overall Study|Miscellaneous|1
7959112|NCT02669017|12511165|FG007|Overall Study|Miscellaneous|13
7959113|NCT02669017|12511166|FG008|Overall Study|Miscellaneous|2
7959114|NCT02669043|12511194|FG000|Overall Study|Didn't meet I/E criteria|4
7959115|NCT02669082|12511198|FG000|Overall Study|Adverse Event|1
7959116|NCT02669095|12511204|FG000|Overall Study|Adverse Event|1
7959117|NCT02669095|12511205|FG001|Overall Study|Adverse Event|0
7959118|NCT02669095|12511204|FG000|Overall Study|Unsatisfactory Lens Fitting|0
7959119|NCT02669095|12511205|FG001|Overall Study|Unsatisfactory Lens Fitting|1
7959120|NCT02669095|12511204|FG000|Overall Study|Torn Lens|0
7959121|NCT02669095|12511205|FG001|Overall Study|Torn Lens|1
7959122|NCT02669095|12511204|FG000|Overall Study|Visit 5 assessments not completed|0
7959123|NCT02669095|12511205|FG001|Overall Study|Visit 5 assessments not completed|1
7959124|NCT02669121|12511213|FG000|Overall Study|Adverse Event|4
7959125|NCT02669121|12511214|FG001|Overall Study|Adverse Event|5
7959126|NCT02669121|12511213|FG000|Overall Study|Lost to Follow-up|15
7959127|NCT02669121|12511214|FG001|Overall Study|Lost to Follow-up|27
7959128|NCT02669121|12511213|FG000|Overall Study|Withdrawal by Subject|132
7959129|NCT02669121|12511214|FG001|Overall Study|Withdrawal by Subject|140
7959130|NCT02669121|12511213|FG000|Overall Study|Pregnancy|0
7959131|NCT02669121|12511214|FG001|Overall Study|Pregnancy|1
7959132|NCT02669121|12511213|FG000|Overall Study|Discharged from US Military Active Service|117
7959133|NCT02669121|12511214|FG001|Overall Study|Discharged from US Military Active Service|91
7959134|NCT02669121|12511213|FG000|Overall Study|Reason not Specified|22
7959135|NCT02669121|12511214|FG001|Overall Study|Reason not Specified|18
7959136|NCT02669264|12511227|FG000|Overall Study|Death|5
7959137|NCT02669264|12511228|FG001|Overall Study|Death|5
7959138|NCT02669264|12511229|FG002|Overall Study|Death|3
7959139|NCT02669264|12511230|FG003|Overall Study|Death|3
7959140|NCT02669264|12511231|FG004|Overall Study|Death|3
7959141|NCT02669264|12511232|FG005|Overall Study|Death|6
7959142|NCT02669264|12511233|FG006|Overall Study|Death|3
7959143|NCT02669264|12511227|FG000|Overall Study|Withdrawal by Subject|0
7959144|NCT02669264|12511228|FG001|Overall Study|Withdrawal by Subject|1
7959145|NCT02669264|12511229|FG002|Overall Study|Withdrawal by Subject|0
7959146|NCT02669264|12511230|FG003|Overall Study|Withdrawal by Subject|0
7959147|NCT02669264|12511231|FG004|Overall Study|Withdrawal by Subject|1
7959148|NCT02669264|12511232|FG005|Overall Study|Withdrawal by Subject|0
7959149|NCT02669264|12511233|FG006|Overall Study|Withdrawal by Subject|0
7959150|NCT02669264|12511227|FG000|Overall Study|Lost to Follow-up|0
7959151|NCT02669264|12511228|FG001|Overall Study|Lost to Follow-up|0
7959152|NCT02669264|12511229|FG002|Overall Study|Lost to Follow-up|0
7959153|NCT02669264|12511230|FG003|Overall Study|Lost to Follow-up|0
7959154|NCT02669264|12511231|FG004|Overall Study|Lost to Follow-up|1
7959155|NCT02669264|12511232|FG005|Overall Study|Lost to Follow-up|0
7959156|NCT02669264|12511233|FG006|Overall Study|Lost to Follow-up|0
7959157|NCT02669264|12511227|FG000|Overall Study|Miscellaneous|0
7959158|NCT02669264|12511228|FG001|Overall Study|Miscellaneous|0
7959159|NCT02669264|12511229|FG002|Overall Study|Miscellaneous|0
7959160|NCT02669264|12511230|FG003|Overall Study|Miscellaneous|0
7959161|NCT02669264|12511231|FG004|Overall Study|Miscellaneous|0
7959162|NCT02669264|12511232|FG005|Overall Study|Miscellaneous|0
7959163|NCT02669264|12511233|FG006|Overall Study|Miscellaneous|2
7959164|NCT02669407|12511255|FG000|Overall Study|Physician Decision|3
7959165|NCT02669433|12511262|FG000|Overall Study|Protocol Violation|0
7959166|NCT02669433|12511263|FG001|Overall Study|Protocol Violation|4
7959167|NCT02669433|12511264|FG002|Overall Study|Protocol Violation|1
7959168|NCT02669433|12511262|FG000|Overall Study|Disease Progression|1
7959169|NCT02669433|12511263|FG001|Overall Study|Disease Progression|0
7959170|NCT02669433|12511264|FG002|Overall Study|Disease Progression|0
7959171|NCT02669433|12511262|FG000|Overall Study|Physician Decision|1
7959172|NCT02669433|12511263|FG001|Overall Study|Physician Decision|1
7959173|NCT02669433|12511264|FG002|Overall Study|Physician Decision|0
7959174|NCT02669433|12511262|FG000|Overall Study|Adverse Event|6
7959175|NCT02669433|12511263|FG001|Overall Study|Adverse Event|7
7959176|NCT02669433|12511264|FG002|Overall Study|Adverse Event|10
7959177|NCT02669433|12511262|FG000|Overall Study|Sponsor Termination|1
7959178|NCT02669433|12511263|FG001|Overall Study|Sponsor Termination|0
7959179|NCT02669433|12511264|FG002|Overall Study|Sponsor Termination|1
7959180|NCT02669433|12511262|FG000|Overall Study|Withdrawal by Subject|5
7959181|NCT02669433|12511263|FG001|Overall Study|Withdrawal by Subject|1
7959182|NCT02669433|12511264|FG002|Overall Study|Withdrawal by Subject|0
7959183|NCT02669433|12511262|FG000|Overall Study|Withdrawal by Caregiver|1
7959184|NCT02669433|12511263|FG001|Overall Study|Withdrawal by Caregiver|0
7959185|NCT02669433|12511264|FG002|Overall Study|Withdrawal by Caregiver|2
7959186|NCT02669433|12511262|FG000|Overall Study|Death|0
7959187|NCT02669433|12511263|FG001|Overall Study|Death|1
7959188|NCT02669433|12511264|FG002|Overall Study|Death|1
7959189|NCT02669667|12511283|FG000|Overall Study|Lost to Follow-up|0
7959190|NCT02669667|12511284|FG001|Overall Study|Lost to Follow-up|0
7959191|NCT02669667|12511285|FG002|Overall Study|Lost to Follow-up|0
7959192|NCT02669667|12511286|FG003|Overall Study|Lost to Follow-up|0
7959193|NCT02669667|12511287|FG004|Overall Study|Lost to Follow-up|0
7959194|NCT02669667|12511288|FG005|Overall Study|Lost to Follow-up|1
7959195|NCT02669667|12511289|FG006|Overall Study|Lost to Follow-up|0
7959196|NCT02669758|12511311|FG000|Overall Study|Withdrawal by Subject|43
7959197|NCT02669758|12511311|FG000|Overall Study|Lost to Follow-up|19
7959198|NCT02669758|12511311|FG000|Overall Study|Adverse Event|16
7959199|NCT02669758|12511311|FG000|Overall Study|Non-Compliance with Study Drug|8
7959200|NCT02669758|12511311|FG000|Overall Study|Lack of Efficacy|5
7959201|NCT02669758|12511311|FG000|Overall Study|Pregnancy|1
7959202|NCT02669758|12511311|FG000|Overall Study|Study noncompliance|1
7959203|NCT02669758|12511311|FG000|Overall Study|Protocol Violation|1
7959204|NCT02669849|12511327|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
7959205|NCT02669849|12511328|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0
7959206|NCT02669849|12511329|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3
7959207|NCT02669849|12511327|FG000|Overall Study|Lost to Follow-up|1
7959208|NCT02669849|12511328|FG001|Overall Study|Lost to Follow-up|0
7959209|NCT02669849|12511329|FG002|Overall Study|Lost to Follow-up|3
7959210|NCT02669849|12511327|FG000|Overall Study|Death|1
7959211|NCT02669849|12511328|FG001|Overall Study|Death|1
7959212|NCT02669849|12511329|FG002|Overall Study|Death|2
7959213|NCT02669849|12511327|FG000|Overall Study|Study terminated by sponsor|16
7959214|NCT02669849|12511328|FG001|Overall Study|Study terminated by sponsor|1
7959215|NCT02669849|12511329|FG002|Overall Study|Study terminated by sponsor|14
7959216|NCT02669849|12511327|FG000|Overall Study|Other|0
7959217|NCT02669849|12511328|FG001|Overall Study|Other|0
7959218|NCT02669849|12511329|FG002|Overall Study|Other|2
7959219|NCT02669862|12511340|FG000|Overall Study|Lost to Follow-up|0
7959220|NCT02669862|12511341|FG001|Overall Study|Lost to Follow-up|2
7959221|NCT02669862|12511342|FG002|Overall Study|Lost to Follow-up|1
7959222|NCT02669862|12511340|FG000|Overall Study|Withdrawal by Subject|2
7959223|NCT02669862|12511341|FG001|Overall Study|Withdrawal by Subject|2
7959224|NCT02669862|12511342|FG002|Overall Study|Withdrawal by Subject|3
7959225|NCT02669862|12511340|FG000|Overall Study|moved|0
7959226|NCT02669862|12511341|FG001|Overall Study|moved|1
7959227|NCT02669862|12511342|FG002|Overall Study|moved|0
7959228|NCT02669862|12511340|FG000|Overall Study|Protocol Violation|0
7959229|NCT02669862|12511341|FG001|Overall Study|Protocol Violation|0
7959230|NCT02669862|12511342|FG002|Overall Study|Protocol Violation|1
7959231|NCT02669940|12511368|FG000|Overall Study|Failure to return|0
7959232|NCT02669940|12511369|FG001|Overall Study|Failure to return|3
7959233|NCT02669940|12511368|FG000|Overall Study|Insufficient follow-up data|1
7959234|NCT02669940|12511369|FG001|Overall Study|Insufficient follow-up data|0
7959235|NCT02670083|12511384|FG000|Overall Study|Adverse Event|16
7959236|NCT02670083|12511385|FG001|Overall Study|Adverse Event|13
7959237|NCT02670083|12511384|FG000|Overall Study|Death|4
7959238|NCT02670083|12511385|FG001|Overall Study|Death|6
7959239|NCT02670083|12511384|FG000|Overall Study|Lost to Follow-up|2
7959240|NCT02670083|12511385|FG001|Overall Study|Lost to Follow-up|2
7959241|NCT02670083|12511384|FG000|Overall Study|Multiple Reasons|9
7959242|NCT02670083|12511385|FG001|Overall Study|Multiple Reasons|9
7959243|NCT02670083|12511384|FG000|Overall Study|Physician Decision|0
7959244|NCT02670083|12511385|FG001|Overall Study|Physician Decision|2
7959245|NCT02670083|12511384|FG000|Overall Study|Study Terminated By Sponsor|257
7959246|NCT02670083|12511385|FG001|Overall Study|Study Terminated By Sponsor|254
7959247|NCT02670083|12511384|FG000|Overall Study|Symptomatic Deterioration|0
7959248|NCT02670083|12511385|FG001|Overall Study|Symptomatic Deterioration|2
7959249|NCT02670083|12511384|FG000|Overall Study|Withdrawal by Subject|32
7959250|NCT02670083|12511385|FG001|Overall Study|Withdrawal by Subject|31
7959251|NCT02670083|12511384|FG000|Overall Study|Non-Compliance With Study Drug|1
7959252|NCT02670083|12511385|FG001|Overall Study|Non-Compliance With Study Drug|0
7959253|NCT02670122|12511392|FG000|Overall Study|Lost to Follow-up|4
7959254|NCT02670330|12511405|FG000|Overall Study|Protocol Deviation|1
7959255|NCT02670330|12511406|FG001|Overall Study|Protocol Deviation|0
7959256|NCT02670330|12511405|FG000|Overall Study|Study Terminated By Sponsor|36
7959257|NCT02670330|12511406|FG001|Overall Study|Study Terminated By Sponsor|43
7959258|NCT02670330|12511405|FG000|Overall Study|Adverse Event|1
7959259|NCT02670330|12511406|FG001|Overall Study|Adverse Event|3
7959260|NCT02670330|12511405|FG000|Overall Study|Withdrawal by Subject|34
7959261|NCT02670330|12511406|FG001|Overall Study|Withdrawal by Subject|29
7959262|NCT02670330|12511405|FG000|Overall Study|Lost to Follow-up|3
7959263|NCT02670330|12511406|FG001|Overall Study|Lost to Follow-up|2
7959264|NCT02670382|12511416|FG000|Placebo lead-in Phase|Withdrawal by Subject|2
7959265|NCT02670382|12511417|FG001|Placebo lead-in Phase|Withdrawal by Subject|1
7959266|NCT02670473|12511425|FG000|Overall Study|Withdrawal by Subject|1
7959267|NCT02670538|12511441|FG000|Overall Study|Withdrawal of Consent|8
7959268|NCT02670538|12511442|FG001|Overall Study|Withdrawal of Consent|6
7959269|NCT02670538|12511443|FG002|Overall Study|Withdrawal of Consent|5
7959270|NCT02670538|12511441|FG000|Overall Study|Lost to Follow-up|8
7959271|NCT02670538|12511442|FG001|Overall Study|Lost to Follow-up|12
7959272|NCT02670538|12511443|FG002|Overall Study|Lost to Follow-up|7
7959273|NCT02670538|12511441|FG000|Overall Study|Adverse Event|5
7959274|NCT02670538|12511442|FG001|Overall Study|Adverse Event|5
7959275|NCT02670538|12511443|FG002|Overall Study|Adverse Event|11
7959276|NCT02670538|12511441|FG000|Overall Study|Lack of Efficacy|7
7959277|NCT02670538|12511442|FG001|Overall Study|Lack of Efficacy|1
7959278|NCT02670538|12511443|FG002|Overall Study|Lack of Efficacy|2
7959279|NCT02670538|12511441|FG000|Overall Study|Protocol Violation|3
7959280|NCT02670538|12511442|FG001|Overall Study|Protocol Violation|4
7959281|NCT02670538|12511443|FG002|Overall Study|Protocol Violation|1
7959282|NCT02670538|12511441|FG000|Overall Study|Noncompliance with Study Drug|1
7959283|NCT02670538|12511442|FG001|Overall Study|Noncompliance with Study Drug|3
7959284|NCT02670538|12511443|FG002|Overall Study|Noncompliance with Study Drug|2
7959285|NCT02670538|12511441|FG000|Overall Study|Other Miscellaneous Reasons|0
7959286|NCT02670538|12511442|FG001|Overall Study|Other Miscellaneous Reasons|1
7959287|NCT02670538|12511443|FG002|Overall Study|Other Miscellaneous Reasons|2
7959288|NCT02670551|12511454|FG000|Overall Study|Adverse Event|4
7959289|NCT02670551|12511455|FG001|Overall Study|Adverse Event|7
7959290|NCT02670551|12511456|FG002|Overall Study|Adverse Event|9
7959291|NCT02670551|12511454|FG000|Overall Study|Lack of Efficacy|2
7959292|NCT02670551|12511455|FG001|Overall Study|Lack of Efficacy|0
7959293|NCT02670551|12511456|FG002|Overall Study|Lack of Efficacy|3
7959294|NCT02670551|12511454|FG000|Overall Study|Withdrawal of Consent|6
7959295|NCT02670551|12511455|FG001|Overall Study|Withdrawal of Consent|3
7959296|NCT02670551|12511456|FG002|Overall Study|Withdrawal of Consent|8
7959297|NCT02670551|12511454|FG000|Overall Study|Lost to Follow-up|5
7959298|NCT02670551|12511455|FG001|Overall Study|Lost to Follow-up|7
7959299|NCT02670551|12511456|FG002|Overall Study|Lost to Follow-up|6
7959300|NCT02670551|12511454|FG000|Overall Study|Protocol Violation|1
7959301|NCT02670551|12511455|FG001|Overall Study|Protocol Violation|0
7959302|NCT02670551|12511456|FG002|Overall Study|Protocol Violation|0
7959303|NCT02670551|12511454|FG000|Overall Study|Noncompliance with study drug|3
7959304|NCT02670551|12511455|FG001|Overall Study|Noncompliance with study drug|3
7959305|NCT02670551|12511456|FG002|Overall Study|Noncompliance with study drug|2
7959306|NCT02670551|12511454|FG000|Overall Study|Other Miscellaneous Reasons|2
7959307|NCT02670551|12511455|FG001|Overall Study|Other Miscellaneous Reasons|3
7959308|NCT02670551|12511456|FG002|Overall Study|Other Miscellaneous Reasons|3
7959309|NCT02670551|12511454|FG000|Overall Study|Did Not Receive Treatment|5
7959310|NCT02670551|12511455|FG001|Overall Study|Did Not Receive Treatment|3
7959311|NCT02670551|12511456|FG002|Overall Study|Did Not Receive Treatment|0
7966659|NCT02755818|12522966|FG003|Overall Study|withdrawal by PI|1
7966660|NCT02755831|12522980|FG000|Overall Study|Lost to Follow-up|3
7966661|NCT02755831|12522981|FG001|Overall Study|Lost to Follow-up|3
7966662|NCT02756078|12522991|FG000|Period 1|Unsatisfactory Lens Fitting|0
7966663|NCT02756078|12522992|FG001|Period 1|Unsatisfactory Lens Fitting|1
7966664|NCT02756078|12522991|FG000|Period 1|Lost to Follow-up|0
7966665|NCT02756078|12522992|FG001|Period 1|Lost to Follow-up|2
7966666|NCT02756078|12522991|FG000|Period 1|Protocol Violation|0
7966667|NCT02756078|12522992|FG001|Period 1|Protocol Violation|1
7966668|NCT02756078|12522991|FG000|Period 1|Adverse Event|1
7966669|NCT02756078|12522992|FG001|Period 1|Adverse Event|10
7966670|NCT02756078|12522991|FG000|Period 1|Withdrawal by Subject|6
7966671|NCT02756078|12522992|FG001|Period 1|Withdrawal by Subject|6
7966672|NCT02756078|12522991|FG000|Period 1|Lens Discomfort|2
7966673|NCT02756078|12522992|FG001|Period 1|Lens Discomfort|2
7966674|NCT02756078|12522991|FG000|Period 2|Adverse Event|3
7966675|NCT02756078|12522992|FG001|Period 2|Adverse Event|5
7966676|NCT02756078|12522991|FG000|Period 2|Unsatisfactory Lens Fitting|0
7966677|NCT02756078|12522992|FG001|Period 2|Unsatisfactory Lens Fitting|1
7966678|NCT02756078|12522991|FG000|Period 2|Withdrawal by Subject|3
7966679|NCT02756078|12522992|FG001|Period 2|Withdrawal by Subject|1
7966680|NCT02756182|12522998|FG000|Overall Study|StudyTechnical Difficulties|4
7966681|NCT02756338|12523004|FG000|Overall Study|Withdrawn by Investigator|1
7966682|NCT02756338|12523004|FG000|Overall Study|Device Replaced with Pacemaker|4
7966683|NCT02756364|12523020|FG000|Overall Study|Site Terminated by Sponsor|24
7966684|NCT02756364|12523021|FG001|Overall Study|Site Terminated by Sponsor|30
7966685|NCT02756364|12523022|FG002|Overall Study|Site Terminated by Sponsor|21
7966686|NCT02756364|12523020|FG000|Overall Study|Death|20
7966687|NCT02756364|12523021|FG001|Overall Study|Death|15
7966688|NCT02756364|12523022|FG002|Overall Study|Death|18
7966689|NCT02756364|12523020|FG000|Overall Study|Withdrawal by Patient|2
7966690|NCT02756364|12523021|FG001|Overall Study|Withdrawal by Patient|1
7966691|NCT02756364|12523022|FG002|Overall Study|Withdrawal by Patient|8
7966692|NCT02756364|12523020|FG000|Overall Study|Lost to Follow-up|0
7966693|NCT02756364|12523021|FG001|Overall Study|Lost to Follow-up|1
7959312|NCT02670915|12511485|FG000|Overall Study|Withdrawal by Subject|0
7959313|NCT02670915|12511486|FG001|Overall Study|Withdrawal by Subject|1
7959314|NCT02670915|12511487|FG002|Overall Study|Withdrawal by Subject|4
7959315|NCT02670915|12511485|FG000|Overall Study|Withdrawal by parent/guardian|4
7959316|NCT02670915|12511486|FG001|Overall Study|Withdrawal by parent/guardian|4
7959317|NCT02670915|12511487|FG002|Overall Study|Withdrawal by parent/guardian|1
7959318|NCT02670915|12511485|FG000|Overall Study|Unclassified|0
7959319|NCT02670915|12511486|FG001|Overall Study|Unclassified|3
7959320|NCT02670915|12511487|FG002|Overall Study|Unclassified|0
7959321|NCT02670928|12511497|FG000|Overall Study|Adverse Event|3
7959322|NCT02670928|12511498|FG001|Overall Study|Adverse Event|1
7959323|NCT02670928|12511497|FG000|Overall Study|Withdrawal by Subject|4
7959324|NCT02670928|12511498|FG001|Overall Study|Withdrawal by Subject|0
7959325|NCT02670928|12511497|FG000|Overall Study|Lost to Follow-up|1
7959326|NCT02670928|12511498|FG001|Overall Study|Lost to Follow-up|0
7959327|NCT02670928|12511497|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2
7959328|NCT02670928|12511498|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0
7959329|NCT02671266|12511510|FG000|Overall Study|Withdrawal by Subject|1
7959330|NCT02671266|12511511|FG001|Overall Study|Withdrawal by Subject|1
7959331|NCT02671422|12511517|FG000|Overall Study|Lost to Follow-up|1
7959332|NCT02671422|12511517|FG000|Overall Study|Adverse Event|68
7959333|NCT02671422|12511517|FG000|Overall Study|Lack of Efficacy|1
7959334|NCT02671422|12511517|FG000|Overall Study|Lost to Follow-up|4
7959335|NCT02671422|12511517|FG000|Overall Study|Withdrawal by Subject|7
7959336|NCT02671422|12511517|FG000|Overall Study|Progressive Disease|156
7959337|NCT02671422|12511517|FG000|Overall Study|Worsening of Disease|4
7959338|NCT02671422|12511517|FG000|Overall Study|Sponsor decision|5
7959339|NCT02671422|12511517|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8
7959340|NCT02671422|12511517|FG000|Overall Study|Not treated with Vargatef®|3
7959341|NCT02671422|12511517|FG000|Overall Study|Other not defined above|3
7959342|NCT02671500|12511521|FG000|Overall Study|Lack of Efficacy|12
7959343|NCT02671500|12511521|FG000|Overall Study|Lost to Follow-up|2
7959344|NCT02671760|12511529|FG000|Overall Study|Lost to Follow-up|0
7959345|NCT02671760|12511530|FG001|Overall Study|Lost to Follow-up|1
7959346|NCT02671760|12511531|FG002|Overall Study|Lost to Follow-up|0
7959347|NCT02672423|12511564|FG000|Period 1|Adverse Event|0
7959348|NCT02672423|12511565|FG001|Period 1|Adverse Event|0
7959349|NCT02672423|12511566|FG002|Period 1|Adverse Event|0
7959350|NCT02672423|12511567|FG003|Period 1|Adverse Event|0
7959351|NCT02672423|12511568|FG004|Period 1|Adverse Event|1
7959352|NCT02672423|12511569|FG005|Period 1|Adverse Event|0
7959353|NCT02672423|12511570|FG006|Period 1|Adverse Event|0
7959354|NCT02672423|12511571|FG007|Period 1|Adverse Event|0
7959355|NCT02672423|12511572|FG008|Period 1|Adverse Event|0
7959356|NCT02672423|12511573|FG009|Period 1|Adverse Event|0
7959357|NCT02672423|12511564|FG000|Period 2|Withdrawal by Subject|0
7959358|NCT02672423|12511565|FG001|Period 2|Withdrawal by Subject|0
7959359|NCT02672423|12511566|FG002|Period 2|Withdrawal by Subject|1
7959360|NCT02672423|12511567|FG003|Period 2|Withdrawal by Subject|0
7959361|NCT02672423|12511568|FG004|Period 2|Withdrawal by Subject|0
7959362|NCT02672423|12511569|FG005|Period 2|Withdrawal by Subject|0
7959363|NCT02672423|12511570|FG006|Period 2|Withdrawal by Subject|0
7959364|NCT02672423|12511571|FG007|Period 2|Withdrawal by Subject|0
7959365|NCT02672423|12511572|FG008|Period 2|Withdrawal by Subject|0
7959366|NCT02672423|12511573|FG009|Period 2|Withdrawal by Subject|0
7959367|NCT02672423|12511564|FG000|Period 3|Withdrawal by Subject|0
7959368|NCT02672423|12511565|FG001|Period 3|Withdrawal by Subject|0
7959369|NCT02672423|12511566|FG002|Period 3|Withdrawal by Subject|0
7959370|NCT02672423|12511567|FG003|Period 3|Withdrawal by Subject|0
7959371|NCT02672423|12511568|FG004|Period 3|Withdrawal by Subject|0
7959372|NCT02672423|12511569|FG005|Period 3|Withdrawal by Subject|0
7959373|NCT02672423|12511570|FG006|Period 3|Withdrawal by Subject|0
7959374|NCT02672423|12511571|FG007|Period 3|Withdrawal by Subject|1
7959375|NCT02672423|12511572|FG008|Period 3|Withdrawal by Subject|0
7959376|NCT02672423|12511573|FG009|Period 3|Withdrawal by Subject|0
7959377|NCT02672423|12511564|FG000|Period 3|Physician Decision|0
7959378|NCT02672423|12511565|FG001|Period 3|Physician Decision|0
7959379|NCT02672423|12511566|FG002|Period 3|Physician Decision|0
7959380|NCT02672423|12511567|FG003|Period 3|Physician Decision|0
7959381|NCT02672423|12511568|FG004|Period 3|Physician Decision|0
7959382|NCT02672423|12511569|FG005|Period 3|Physician Decision|1
7959383|NCT02672423|12511570|FG006|Period 3|Physician Decision|0
7959384|NCT02672423|12511571|FG007|Period 3|Physician Decision|0
7959385|NCT02672423|12511572|FG008|Period 3|Physician Decision|0
7959386|NCT02672423|12511573|FG009|Period 3|Physician Decision|0
7959387|NCT02672553|12511605|FG000|Overall Study|Death|3
7959388|NCT02672553|12511606|FG001|Overall Study|Death|5
7959389|NCT02672553|12511605|FG000|Overall Study|Valve Explant|1
7959390|NCT02672553|12511606|FG001|Overall Study|Valve Explant|0
7959391|NCT02672553|12511605|FG000|Overall Study|Conversion to Commercial Valve|3
7959392|NCT02672553|12511606|FG001|Overall Study|Conversion to Commercial Valve|0
7959393|NCT02672553|12511605|FG000|Overall Study|Withdrawal by Subject|3
7959394|NCT02672553|12511606|FG001|Overall Study|Withdrawal by Subject|3
7959395|NCT02672553|12511605|FG000|Overall Study|Intraoperative screen failure|2
7959396|NCT02672553|12511606|FG001|Overall Study|Intraoperative screen failure|0
7959397|NCT02672852|12511615|FG000|Part A1|Disease Worsening|1
7959398|NCT02672852|12511616|FG001|Part A1|Disease Worsening|0
7959399|NCT02672852|12511617|FG002|Part A1|Disease Worsening|0
7959400|NCT02672852|12511618|FG003|Part A1|Disease Worsening|0
7959401|NCT02672852|12511619|FG004|Part A1|Disease Worsening|0
7959402|NCT02672852|12511620|FG005|Part A1|Disease Worsening|0
7959403|NCT02672852|12511621|FG006|Part A1|Disease Worsening|0
7959404|NCT02672852|12511615|FG000|Part A1|Adverse Event|0
7959405|NCT02672852|12511616|FG001|Part A1|Adverse Event|1
7959406|NCT02672852|12511617|FG002|Part A1|Adverse Event|0
7959407|NCT02672852|12511618|FG003|Part A1|Adverse Event|0
7959408|NCT02672852|12511619|FG004|Part A1|Adverse Event|0
7959409|NCT02672852|12511620|FG005|Part A1|Adverse Event|0
7959410|NCT02672852|12511621|FG006|Part A1|Adverse Event|0
7959411|NCT02672852|12511615|FG000|Part A1|Lost to Follow-up|1
7959412|NCT02672852|12511616|FG001|Part A1|Lost to Follow-up|2
7959413|NCT02672852|12511617|FG002|Part A1|Lost to Follow-up|0
7959414|NCT02672852|12511618|FG003|Part A1|Lost to Follow-up|0
7959415|NCT02672852|12511619|FG004|Part A1|Lost to Follow-up|0
7959416|NCT02672852|12511620|FG005|Part A1|Lost to Follow-up|0
7959417|NCT02672852|12511621|FG006|Part A1|Lost to Follow-up|0
7959418|NCT02672852|12511615|FG000|Part A1|Withdrawal by Subject|1
7959419|NCT02672852|12511616|FG001|Part A1|Withdrawal by Subject|1
7959420|NCT02672852|12511617|FG002|Part A1|Withdrawal by Subject|0
7959421|NCT02672852|12511618|FG003|Part A1|Withdrawal by Subject|0
7959422|NCT02672852|12511619|FG004|Part A1|Withdrawal by Subject|0
7959423|NCT02672852|12511620|FG005|Part A1|Withdrawal by Subject|0
7959424|NCT02672852|12511621|FG006|Part A1|Withdrawal by Subject|0
7959425|NCT02672852|12511615|FG000|Part A2|Disease worsening|0
7959426|NCT02672852|12511616|FG001|Part A2|Disease worsening|0
7959427|NCT02672852|12511617|FG002|Part A2|Disease worsening|1
7959428|NCT02672852|12511618|FG003|Part A2|Disease worsening|0
7959429|NCT02672852|12511619|FG004|Part A2|Disease worsening|0
7959430|NCT02672852|12511620|FG005|Part A2|Disease worsening|0
7959431|NCT02672852|12511621|FG006|Part A2|Disease worsening|0
7959432|NCT02672852|12511615|FG000|Part A2|Adverse Event|0
7959433|NCT02672852|12511616|FG001|Part A2|Adverse Event|0
7959434|NCT02672852|12511617|FG002|Part A2|Adverse Event|3
7959435|NCT02672852|12511618|FG003|Part A2|Adverse Event|0
7959436|NCT02672852|12511619|FG004|Part A2|Adverse Event|0
7959437|NCT02672852|12511620|FG005|Part A2|Adverse Event|0
7959438|NCT02672852|12511621|FG006|Part A2|Adverse Event|0
7959439|NCT02672852|12511615|FG000|Part A2|Lost to Follow-up|0
7959440|NCT02672852|12511616|FG001|Part A2|Lost to Follow-up|0
7959441|NCT02672852|12511617|FG002|Part A2|Lost to Follow-up|2
7959442|NCT02672852|12511618|FG003|Part A2|Lost to Follow-up|0
7959443|NCT02672852|12511619|FG004|Part A2|Lost to Follow-up|0
7959444|NCT02672852|12511620|FG005|Part A2|Lost to Follow-up|0
7959445|NCT02672852|12511621|FG006|Part A2|Lost to Follow-up|0
7959446|NCT02672852|12511615|FG000|Part A2|Withdrawal by Subject|0
7959447|NCT02672852|12511616|FG001|Part A2|Withdrawal by Subject|0
7959448|NCT02672852|12511617|FG002|Part A2|Withdrawal by Subject|1
7959449|NCT02672852|12511618|FG003|Part A2|Withdrawal by Subject|0
7959450|NCT02672852|12511619|FG004|Part A2|Withdrawal by Subject|0
7959451|NCT02672852|12511620|FG005|Part A2|Withdrawal by Subject|0
7959452|NCT02672852|12511621|FG006|Part A2|Withdrawal by Subject|0
7959453|NCT02672852|12511615|FG000|Part A2|Other|0
7959454|NCT02672852|12511616|FG001|Part A2|Other|0
7959455|NCT02672852|12511617|FG002|Part A2|Other|3
7959456|NCT02672852|12511618|FG003|Part A2|Other|0
7959457|NCT02672852|12511619|FG004|Part A2|Other|0
7959458|NCT02672852|12511620|FG005|Part A2|Other|0
7959459|NCT02672852|12511621|FG006|Part A2|Other|0
7959460|NCT02672852|12511615|FG000|Part A2|Not entered in Part B|0
7959461|NCT02672852|12511616|FG001|Part A2|Not entered in Part B|0
7959462|NCT02672852|12511617|FG002|Part A2|Not entered in Part B|0
7959463|NCT02672852|12511618|FG003|Part A2|Not entered in Part B|4
7959464|NCT02672852|12511619|FG004|Part A2|Not entered in Part B|0
7959465|NCT02672852|12511620|FG005|Part A2|Not entered in Part B|0
7959466|NCT02672852|12511621|FG006|Part A2|Not entered in Part B|0
7959467|NCT02672852|12511615|FG000|Part B|Disease worsening|0
7959468|NCT02672852|12511616|FG001|Part B|Disease worsening|0
7959469|NCT02672852|12511617|FG002|Part B|Disease worsening|0
7959470|NCT02672852|12511618|FG003|Part B|Disease worsening|0
7959471|NCT02672852|12511619|FG004|Part B|Disease worsening|1
7959472|NCT02672852|12511620|FG005|Part B|Disease worsening|0
7959473|NCT02672852|12511621|FG006|Part B|Disease worsening|1
7959474|NCT02672852|12511615|FG000|Part B|Worsening pre-existing condition|0
7959475|NCT02672852|12511616|FG001|Part B|Worsening pre-existing condition|0
7959476|NCT02672852|12511617|FG002|Part B|Worsening pre-existing condition|0
7959477|NCT02672852|12511618|FG003|Part B|Worsening pre-existing condition|0
7959478|NCT02672852|12511619|FG004|Part B|Worsening pre-existing condition|0
7959479|NCT02672852|12511620|FG005|Part B|Worsening pre-existing condition|1
7959480|NCT02672852|12511621|FG006|Part B|Worsening pre-existing condition|0
7959481|NCT02672852|12511615|FG000|Part B|Other adverse event|0
7959482|NCT02672852|12511616|FG001|Part B|Other adverse event|0
7959483|NCT02672852|12511617|FG002|Part B|Other adverse event|0
7959484|NCT02672852|12511618|FG003|Part B|Other adverse event|0
7959485|NCT02672852|12511619|FG004|Part B|Other adverse event|3
7959486|NCT02672852|12511620|FG005|Part B|Other adverse event|5
7959487|NCT02672852|12511621|FG006|Part B|Other adverse event|1
7959488|NCT02672852|12511615|FG000|Part B|Lost to Follow-up|0
7959489|NCT02672852|12511616|FG001|Part B|Lost to Follow-up|0
7959490|NCT02672852|12511617|FG002|Part B|Lost to Follow-up|0
7959491|NCT02672852|12511618|FG003|Part B|Lost to Follow-up|0
7959492|NCT02672852|12511619|FG004|Part B|Lost to Follow-up|3
7959493|NCT02672852|12511620|FG005|Part B|Lost to Follow-up|4
7959494|NCT02672852|12511621|FG006|Part B|Lost to Follow-up|1
7959495|NCT02672852|12511615|FG000|Part B|Withdrawal by Subject|0
7959496|NCT02672852|12511616|FG001|Part B|Withdrawal by Subject|0
7959497|NCT02672852|12511617|FG002|Part B|Withdrawal by Subject|0
7959498|NCT02672852|12511618|FG003|Part B|Withdrawal by Subject|0
7959499|NCT02672852|12511619|FG004|Part B|Withdrawal by Subject|5
7959500|NCT02672852|12511620|FG005|Part B|Withdrawal by Subject|0
7959501|NCT02672852|12511621|FG006|Part B|Withdrawal by Subject|7
7959502|NCT02672852|12511615|FG000|Part B|Other|0
7959503|NCT02672852|12511616|FG001|Part B|Other|0
7959504|NCT02672852|12511617|FG002|Part B|Other|0
7959505|NCT02672852|12511618|FG003|Part B|Other|0
7959506|NCT02672852|12511619|FG004|Part B|Other|4
7959507|NCT02672852|12511620|FG005|Part B|Other|1
7959508|NCT02672852|12511621|FG006|Part B|Other|2
7959509|NCT02673489|12511649|FG000|Treatment Period|Lost to Follow-up|3
7959510|NCT02673489|12511650|FG001|Treatment Period|Lost to Follow-up|0
7959511|NCT02673489|12511649|FG000|Treatment Period|Participant request to discontinue|1
7959512|NCT02673489|12511650|FG001|Treatment Period|Participant request to discontinue|1
7959513|NCT02673489|12511649|FG000|Treatment Period|Participant moved to another province|1
7959514|NCT02673489|12511650|FG001|Treatment Period|Participant moved to another province|0
7959515|NCT02673489|12511649|FG000|Treatment Period|Participant was incarcerated|0
7959516|NCT02673489|12511650|FG001|Treatment Period|Participant was incarcerated|1
7959517|NCT02673489|12511649|FG000|Treatment Period|Adverse Event|0
7959518|NCT02673489|12511650|FG001|Treatment Period|Adverse Event|1
7959519|NCT02673489|12511649|FG000|Follow Up Period|Unable to return for week 24 follow-up|0
7959520|NCT02673489|12511650|FG001|Follow Up Period|Unable to return for week 24 follow-up|1
7959521|NCT02673489|12511649|FG000|Follow Up Period|Unable to return for follow-up|0
7959522|NCT02673489|12511650|FG001|Follow Up Period|Unable to return for follow-up|1
7959523|NCT02673515|12511659|FG000|Overall Study|Lack of motivation|2
7959524|NCT02673515|12511660|FG001|Overall Study|Lack of motivation|1
7959525|NCT02673619|12511679|FG000|Overall Study|Lost to Follow-up|1
7959526|NCT02673619|12511680|FG001|Overall Study|Lost to Follow-up|0
7959527|NCT02673619|12511681|FG002|Overall Study|Lost to Follow-up|0
7959528|NCT02673619|12511682|FG003|Overall Study|Lost to Follow-up|0
7959529|NCT02673619|12511679|FG000|Overall Study|Withdrawal by Subject|1
7959530|NCT02673619|12511680|FG001|Overall Study|Withdrawal by Subject|1
7959531|NCT02673619|12511681|FG002|Overall Study|Withdrawal by Subject|1
7959532|NCT02673619|12511682|FG003|Overall Study|Withdrawal by Subject|0
7959533|NCT02673619|12511679|FG000|Overall Study|Adverse Event|0
7959534|NCT02673619|12511680|FG001|Overall Study|Adverse Event|0
7959535|NCT02673619|12511681|FG002|Overall Study|Adverse Event|1
7959536|NCT02673619|12511682|FG003|Overall Study|Adverse Event|0
7959537|NCT02673619|12511679|FG000|Overall Study|Lack of Efficacy|0
7959538|NCT02673619|12511680|FG001|Overall Study|Lack of Efficacy|0
7959539|NCT02673619|12511681|FG002|Overall Study|Lack of Efficacy|1
7959540|NCT02673619|12511682|FG003|Overall Study|Lack of Efficacy|0
7959541|NCT02674334|12511711|FG000|Overall Study|Lost to Follow-up|5
7959542|NCT02674334|12511712|FG001|Overall Study|Lost to Follow-up|3
7959543|NCT02674334|12511711|FG000|Overall Study|participant difficulty breathing|1
7959544|NCT02674334|12511712|FG001|Overall Study|participant difficulty breathing|0
7959545|NCT02674334|12511711|FG000|Overall Study|NIRS not recording|1
7959546|NCT02674334|12511712|FG001|Overall Study|NIRS not recording|0
7959547|NCT02674386|12511721|FG000|Overall Study|Lost to Follow-up|0
7959548|NCT02674386|12511722|FG001|Overall Study|Lost to Follow-up|1
7959549|NCT02674386|12511723|FG002|Overall Study|Lost to Follow-up|1
7959550|NCT02674386|12511721|FG000|Overall Study|Withdrawal by Subject|0
7959551|NCT02674386|12511722|FG001|Overall Study|Withdrawal by Subject|4
7959552|NCT02674386|12511723|FG002|Overall Study|Withdrawal by Subject|0
7959553|NCT02674386|12511721|FG000|Overall Study|Other|0
7959554|NCT02674386|12511722|FG001|Overall Study|Other|1
7959555|NCT02674386|12511723|FG002|Overall Study|Other|0
7959556|NCT02674386|12511721|FG000|Overall Study|Enrolled but not evaluated|0
7959557|NCT02674386|12511722|FG001|Overall Study|Enrolled but not evaluated|4
7959558|NCT02674386|12511723|FG002|Overall Study|Enrolled but not evaluated|0
7959559|NCT02674399|12511738|FG000|Overall Study|Lost to Follow-up|2
7959560|NCT02674399|12511739|FG001|Overall Study|Lost to Follow-up|0
7959561|NCT02674477|12511755|FG000|Overall Study|Protocol Violation|8
7959562|NCT02674477|12511756|FG001|Overall Study|Protocol Violation|2
7959563|NCT02674568|12511762|FG000|Overall Study|Withdrawal by Subject|5
7959564|NCT02674568|12511762|FG000|Overall Study|Death|303
7959565|NCT02674568|12511762|FG000|Overall Study|Physician Decision|2
7959566|NCT02674568|12511762|FG000|Overall Study|Lost to Follow-up|9
7959567|NCT02674568|12511762|FG000|Overall Study|Other, Not Specified|20
7959568|NCT02674633|12511773|FG000|Overall Study|Lost to Follow-up|3
7959569|NCT02674633|12511774|FG001|Overall Study|Lost to Follow-up|2
7959570|NCT02674633|12511773|FG000|Overall Study|Physician Decision|1
7959571|NCT02674633|12511774|FG001|Overall Study|Physician Decision|0
7959572|NCT02674633|12511773|FG000|Overall Study|Withdrawal by Parent/Guardian|1
7959573|NCT02674633|12511774|FG001|Overall Study|Withdrawal by Parent/Guardian|2
7959574|NCT02674685|12511789|FG000|Overall Study|Protocol Violation|4
7959575|NCT02674854|12511796|FG000|Overall Study|Adverse Event|17
7959576|NCT02674854|12511797|FG001|Overall Study|Adverse Event|15
7959577|NCT02674854|12511798|FG002|Overall Study|Adverse Event|5
7959578|NCT02674854|12511796|FG000|Overall Study|Withdrawal by Subject|1
7959579|NCT02674854|12511797|FG001|Overall Study|Withdrawal by Subject|5
7959580|NCT02674854|12511798|FG002|Overall Study|Withdrawal by Subject|4
7959581|NCT02674854|12511796|FG000|Overall Study|No-compliant subject|1
7959582|NCT02674854|12511797|FG001|Overall Study|No-compliant subject|0
7959583|NCT02674854|12511798|FG002|Overall Study|No-compliant subject|1
7959584|NCT02674854|12511796|FG000|Overall Study|Lost to Follow-up|1
7959585|NCT02674854|12511797|FG001|Overall Study|Lost to Follow-up|0
7959586|NCT02674854|12511798|FG002|Overall Study|Lost to Follow-up|2
7959587|NCT02674854|12511796|FG000|Overall Study|Lack of Efficacy|0
7959588|NCT02674854|12511797|FG001|Overall Study|Lack of Efficacy|3
7959589|NCT02674854|12511798|FG002|Overall Study|Lack of Efficacy|0
7959590|NCT02674854|12511796|FG000|Overall Study|Disallowed Concurrent Medication|2
7959591|NCT02674854|12511797|FG001|Overall Study|Disallowed Concurrent Medication|2
7959592|NCT02674854|12511798|FG002|Overall Study|Disallowed Concurrent Medication|0
7959593|NCT02674854|12511796|FG000|Overall Study|Protocol Violation|1
7959594|NCT02674854|12511797|FG001|Overall Study|Protocol Violation|1
7959595|NCT02674854|12511798|FG002|Overall Study|Protocol Violation|2
7959596|NCT02674854|12511796|FG000|Overall Study|Death|0
7959597|NCT02674854|12511797|FG001|Overall Study|Death|1
7959598|NCT02674854|12511798|FG002|Overall Study|Death|0
7959599|NCT02674854|12511796|FG000|Overall Study|Subject missed V6.2|1
7959600|NCT02674854|12511797|FG001|Overall Study|Subject missed V6.2|0
7959601|NCT02674854|12511798|FG002|Overall Study|Subject missed V6.2|0
7959602|NCT02675075|12511808|FG000|Overall Study|Lost to Follow-up|3
7959603|NCT02675075|12511809|FG001|Overall Study|Lost to Follow-up|0
7959604|NCT02675517|12511817|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8
7959605|NCT02675517|12511817|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151
7959606|NCT02675634|12511830|FG000|Test Period 1|Adverse Event|0
7959607|NCT02675634|12511831|FG001|Test Period 1|Adverse Event|1
7959608|NCT02675634|12511832|FG002|Test Period 1|Adverse Event|0
7959609|NCT02675634|12511833|FG003|Test Period 1|Adverse Event|1
7959610|NCT02675634|12511834|FG004|Test Period 1|Adverse Event|0
7959611|NCT02675634|12511835|FG005|Test Period 1|Adverse Event|0
7959612|NCT02675634|12511830|FG000|Test Period 1|Device deficiency that did not lead to A|0
7959613|NCT02675634|12511831|FG001|Test Period 1|Device deficiency that did not lead to A|0
7959614|NCT02675634|12511832|FG002|Test Period 1|Device deficiency that did not lead to A|1
7959615|NCT02675634|12511833|FG003|Test Period 1|Device deficiency that did not lead to A|0
7959616|NCT02675634|12511834|FG004|Test Period 1|Device deficiency that did not lead to A|0
7959617|NCT02675634|12511835|FG005|Test Period 1|Device deficiency that did not lead to A|0
7959618|NCT02675634|12511830|FG000|Test Period 2|Lack of Efficacy|1
7959619|NCT02675634|12511831|FG001|Test Period 2|Lack of Efficacy|0
7959620|NCT02675634|12511832|FG002|Test Period 2|Lack of Efficacy|0
7959621|NCT02675634|12511833|FG003|Test Period 2|Lack of Efficacy|0
7959622|NCT02675634|12511834|FG004|Test Period 2|Lack of Efficacy|0
7959623|NCT02675634|12511835|FG005|Test Period 2|Lack of Efficacy|0
7959624|NCT02675634|12511830|FG000|Test Period 2|Adverse Event|0
7959625|NCT02675634|12511831|FG001|Test Period 2|Adverse Event|0
7959626|NCT02675634|12511832|FG002|Test Period 2|Adverse Event|0
7959627|NCT02675634|12511833|FG003|Test Period 2|Adverse Event|0
7959628|NCT02675634|12511834|FG004|Test Period 2|Adverse Event|0
7959629|NCT02675634|12511835|FG005|Test Period 2|Adverse Event|1
7959630|NCT02675907|12511854|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
7959631|NCT02675907|12511855|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
7959632|NCT02675907|12511854|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
7959633|NCT02675907|12511855|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
7959634|NCT02675907|12511854|FG000|Study Overall|Lack of Efficacy|1
7959635|NCT02675907|12511855|FG001|Study Overall|Lack of Efficacy|0
7959636|NCT02675907|12511854|FG000|Study Overall|Withdrawal by Subject|2
7959637|NCT02675907|12511855|FG001|Study Overall|Withdrawal by Subject|2
7959638|NCT02675907|12511854|FG000|Study Overall|Lost to Follow-up|0
7959639|NCT02675907|12511855|FG001|Study Overall|Lost to Follow-up|2
7959640|NCT02675998|12511865|FG000|8-Week Treatment Period|Adverse Event|6
7959641|NCT02675998|12511866|FG001|8-Week Treatment Period|Adverse Event|5
7959642|NCT02675998|12511867|FG002|8-Week Treatment Period|Adverse Event|6
7959643|NCT02675998|12511868|FG003|8-Week Treatment Period|Adverse Event|0
7959644|NCT02675998|12511865|FG000|8-Week Treatment Period|Withdrawal by Subject|3
7959645|NCT02675998|12511866|FG001|8-Week Treatment Period|Withdrawal by Subject|3
7959646|NCT02675998|12511867|FG002|8-Week Treatment Period|Withdrawal by Subject|3
7959647|NCT02675998|12511868|FG003|8-Week Treatment Period|Withdrawal by Subject|0
7959648|NCT02675998|12511865|FG000|8-Week Treatment Period|Lack of Efficacy|2
7959649|NCT02675998|12511866|FG001|8-Week Treatment Period|Lack of Efficacy|5
7959650|NCT02675998|12511867|FG002|8-Week Treatment Period|Lack of Efficacy|3
7959651|NCT02675998|12511868|FG003|8-Week Treatment Period|Lack of Efficacy|0
7959652|NCT02675998|12511865|FG000|8-Week Treatment Period|Physician Decision|1
7959653|NCT02675998|12511866|FG001|8-Week Treatment Period|Physician Decision|0
7959654|NCT02675998|12511867|FG002|8-Week Treatment Period|Physician Decision|2
7959655|NCT02675998|12511868|FG003|8-Week Treatment Period|Physician Decision|0
7959656|NCT02675998|12511865|FG000|8-Week Treatment Period|GI side Effects|1
7959657|NCT02675998|12511866|FG001|8-Week Treatment Period|GI side Effects|4
7959658|NCT02675998|12511867|FG002|8-Week Treatment Period|GI side Effects|2
7959659|NCT02675998|12511868|FG003|8-Week Treatment Period|GI side Effects|0
7959660|NCT02675998|12511865|FG000|8-Week Treatment Period|Protocol Violation|1
7959661|NCT02675998|12511866|FG001|8-Week Treatment Period|Protocol Violation|1
7959662|NCT02675998|12511867|FG002|8-Week Treatment Period|Protocol Violation|1
7959663|NCT02675998|12511868|FG003|8-Week Treatment Period|Protocol Violation|0
7959664|NCT02675998|12511865|FG000|8-Week Treatment Period|Other|3
7959665|NCT02675998|12511866|FG001|8-Week Treatment Period|Other|1
7959666|NCT02675998|12511867|FG002|8-Week Treatment Period|Other|2
7959667|NCT02675998|12511868|FG003|8-Week Treatment Period|Other|0
7959668|NCT02675998|12511865|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0
7959669|NCT02675998|12511866|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
7959670|NCT02675998|12511867|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
7959671|NCT02675998|12511868|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3
7959672|NCT02675998|12511865|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0
7959673|NCT02675998|12511866|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0
7959674|NCT02675998|12511867|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1
7959675|NCT02675998|12511868|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3
7959676|NCT02675998|12511865|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0
7959677|NCT02675998|12511866|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0
7959678|NCT02675998|12511867|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0
7959679|NCT02675998|12511868|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1
7959680|NCT02675998|12511865|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1
7959681|NCT02675998|12511866|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0
7959682|NCT02675998|12511867|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0
7959683|NCT02675998|12511868|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0
7959684|NCT02675998|12511865|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
7959685|NCT02675998|12511866|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
7959686|NCT02675998|12511867|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
7959687|NCT02675998|12511868|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1
7959688|NCT02676466|12511899|FG000|Overall Study|Death|0
7959689|NCT02676466|12511900|FG001|Overall Study|Death|2
7959690|NCT02676466|12511901|FG002|Overall Study|Death|1
7959691|NCT02676466|12511902|FG003|Overall Study|Death|0
7959692|NCT02676466|12511903|FG004|Overall Study|Death|0
7959693|NCT02676466|12511904|FG005|Overall Study|Death|0
7959694|NCT02676466|12511905|FG006|Overall Study|Death|0
7959695|NCT02676466|12511906|FG007|Overall Study|Death|0
7959696|NCT02676466|12511899|FG000|Overall Study|Withdrawal by Subject|4
7959697|NCT02676466|12511900|FG001|Overall Study|Withdrawal by Subject|3
7959698|NCT02676466|12511901|FG002|Overall Study|Withdrawal by Subject|1
7959699|NCT02676466|12511902|FG003|Overall Study|Withdrawal by Subject|0
7959700|NCT02676466|12511903|FG004|Overall Study|Withdrawal by Subject|3
7959701|NCT02676466|12511904|FG005|Overall Study|Withdrawal by Subject|1
7959702|NCT02676466|12511905|FG006|Overall Study|Withdrawal by Subject|1
7959703|NCT02676466|12511906|FG007|Overall Study|Withdrawal by Subject|1
7959704|NCT02676778|12511931|FG000|Overall Study|Disease Progression|7
7959705|NCT02676778|12511932|FG001|Overall Study|Disease Progression|3
7959706|NCT02676778|12511933|FG002|Overall Study|Disease Progression|1
7959707|NCT02676778|12511931|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1
7959708|NCT02676778|12511932|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1
7959709|NCT02676778|12511933|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0
7959710|NCT02676778|12511931|FG000|Overall Study|Withdrawal by Subject|3
7959711|NCT02676778|12511932|FG001|Overall Study|Withdrawal by Subject|2
7959712|NCT02676778|12511933|FG002|Overall Study|Withdrawal by Subject|0
7959713|NCT02676778|12511931|FG000|Overall Study|Other|4
7959714|NCT02676778|12511932|FG001|Overall Study|Other|3
7959715|NCT02676778|12511933|FG002|Overall Study|Other|0
7959716|NCT02676778|12511931|FG000|Overall Study|Adverse Event|2
7959717|NCT02676778|12511932|FG001|Overall Study|Adverse Event|3
7959718|NCT02676778|12511933|FG002|Overall Study|Adverse Event|0
7959719|NCT02676882|12511949|FG000|Overall Study|Adverse Event|1
7959720|NCT02676882|12511950|FG001|Overall Study|Adverse Event|0
7959721|NCT02676882|12511949|FG000|Overall Study|Lost to Follow-up|1
7959722|NCT02676882|12511950|FG001|Overall Study|Lost to Follow-up|0
7959723|NCT02676882|12511949|FG000|Overall Study|Withdrawal by Subject|1
7959724|NCT02676882|12511950|FG001|Overall Study|Withdrawal by Subject|2
7959725|NCT02676895|12511959|FG000|Overall Study|Administrative reason|1
7959726|NCT02676895|12511960|FG001|Overall Study|Administrative reason|0
7959727|NCT02676895|12511961|FG002|Overall Study|Administrative reason|0
7959728|NCT02676895|12511959|FG000|Overall Study|Protocol Violation|1
7959729|NCT02676895|12511960|FG001|Overall Study|Protocol Violation|0
7959730|NCT02676895|12511961|FG002|Overall Study|Protocol Violation|0
7959731|NCT02676895|12511959|FG000|Overall Study|Adverse Event|0
7959732|NCT02676895|12511960|FG001|Overall Study|Adverse Event|3
7959733|NCT02676895|12511961|FG002|Overall Study|Adverse Event|1
7959734|NCT02676895|12511959|FG000|Overall Study|Lost to Follow-up|0
7959735|NCT02676895|12511960|FG001|Overall Study|Lost to Follow-up|0
7959736|NCT02676895|12511961|FG002|Overall Study|Lost to Follow-up|1
7959737|NCT02676895|12511959|FG000|Overall Study|Withdrawal by Subject|0
7959738|NCT02676895|12511960|FG001|Overall Study|Withdrawal by Subject|0
7959739|NCT02676895|12511961|FG002|Overall Study|Withdrawal by Subject|1
7959740|NCT02677116|12511979|FG000|Overall Study|Adverse Event|0
7959741|NCT02677116|12511980|FG001|Overall Study|Adverse Event|1
7959742|NCT02677116|12511981|FG002|Overall Study|Adverse Event|0
7959743|NCT02677116|12511982|FG003|Overall Study|Adverse Event|0
7959744|NCT02677116|12511983|FG004|Overall Study|Adverse Event|0
7959745|NCT02677116|12511984|FG005|Overall Study|Adverse Event|1
7959746|NCT02677116|12511985|FG006|Overall Study|Adverse Event|1
7959747|NCT02677116|12511986|FG007|Overall Study|Adverse Event|0
7959748|NCT02677116|12511987|FG008|Overall Study|Adverse Event|0
7959749|NCT02677116|12511979|FG000|Overall Study|Physician Decision|0
7959750|NCT02677116|12511980|FG001|Overall Study|Physician Decision|2
7959751|NCT02677116|12511981|FG002|Overall Study|Physician Decision|3
7959752|NCT02677116|12511982|FG003|Overall Study|Physician Decision|2
7959753|NCT02677116|12511983|FG004|Overall Study|Physician Decision|1
7959754|NCT02677116|12511984|FG005|Overall Study|Physician Decision|3
7959755|NCT02677116|12511985|FG006|Overall Study|Physician Decision|1
7959756|NCT02677116|12511986|FG007|Overall Study|Physician Decision|1
7959757|NCT02677116|12511987|FG008|Overall Study|Physician Decision|2
7959758|NCT02677116|12511979|FG000|Overall Study|Withdrawal by parent or guardian|2
7959759|NCT02677116|12511980|FG001|Overall Study|Withdrawal by parent or guardian|1
7959760|NCT02677116|12511981|FG002|Overall Study|Withdrawal by parent or guardian|0
7959761|NCT02677116|12511982|FG003|Overall Study|Withdrawal by parent or guardian|1
7959762|NCT02677116|12511983|FG004|Overall Study|Withdrawal by parent or guardian|0
7959763|NCT02677116|12511984|FG005|Overall Study|Withdrawal by parent or guardian|0
7959764|NCT02677116|12511985|FG006|Overall Study|Withdrawal by parent or guardian|2
7959765|NCT02677116|12511986|FG007|Overall Study|Withdrawal by parent or guardian|1
7959766|NCT02677116|12511987|FG008|Overall Study|Withdrawal by parent or guardian|0
7959767|NCT02677116|12511979|FG000|Overall Study|Withdrawal by Subject|1
7959768|NCT02677116|12511980|FG001|Overall Study|Withdrawal by Subject|0
7959769|NCT02677116|12511981|FG002|Overall Study|Withdrawal by Subject|0
7959770|NCT02677116|12511982|FG003|Overall Study|Withdrawal by Subject|0
7959771|NCT02677116|12511983|FG004|Overall Study|Withdrawal by Subject|0
7959772|NCT02677116|12511984|FG005|Overall Study|Withdrawal by Subject|0
7959773|NCT02677116|12511985|FG006|Overall Study|Withdrawal by Subject|0
7959774|NCT02677116|12511986|FG007|Overall Study|Withdrawal by Subject|0
7959775|NCT02677116|12511987|FG008|Overall Study|Withdrawal by Subject|0
7959776|NCT02677220|12512030|FG000|Overall Study|Adverse Event|1
7959777|NCT02677714|12512088|FG000|Overall Study|Withdrawal by Subject|2
7959778|NCT02677714|12512089|FG001|Overall Study|Withdrawal by Subject|0
7959779|NCT02677844|12512133|FG000|Period 3|Withdrawal by Subject|0
7959780|NCT02677844|12512134|FG001|Period 3|Withdrawal by Subject|0
7959781|NCT02677844|12512135|FG002|Period 3|Withdrawal by Subject|0
7959782|NCT02677844|12512136|FG003|Period 3|Withdrawal by Subject|1
7959783|NCT02677844|12512137|FG004|Period 3|Withdrawal by Subject|0
7959784|NCT02677844|12512138|FG005|Period 3|Withdrawal by Subject|0
7959785|NCT02677844|12512139|FG006|Period 3|Withdrawal by Subject|0
7959786|NCT02678000|12512163|FG000|PART 2|Adverse Event|0
7959787|NCT02678000|12512164|FG001|PART 2|Adverse Event|0
7959788|NCT02678000|12512165|FG002|PART 2|Adverse Event|2
7959789|NCT02678000|12512166|FG003|PART 2|Adverse Event|1
7959790|NCT02678000|12512167|FG004|PART 2|Adverse Event|0
7959791|NCT02678000|12512163|FG000|PART 2|Withdrawal by Subject|0
7959792|NCT02678000|12512164|FG001|PART 2|Withdrawal by Subject|0
7959793|NCT02678000|12512165|FG002|PART 2|Withdrawal by Subject|1
7959794|NCT02678000|12512166|FG003|PART 2|Withdrawal by Subject|0
7959795|NCT02678000|12512167|FG004|PART 2|Withdrawal by Subject|0
7959796|NCT02678247|12512203|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0
7959797|NCT02678247|12512204|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2
7959798|NCT02678247|12512203|FG000|First Intervention (7 Weeks)|Adverse Event|1
7959799|NCT02678247|12512204|FG001|First Intervention (7 Weeks)|Adverse Event|2
7959800|NCT02678247|12512203|FG000|First Intervention (7 Weeks)|Physician Decision|1
7959801|NCT02678247|12512204|FG001|First Intervention (7 Weeks)|Physician Decision|0
7959802|NCT02678247|12512203|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1
7959803|NCT02678247|12512204|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1
7959804|NCT02678247|12512203|FG000|Second Intervention (7 Weeks)|Adverse Event|2
7959805|NCT02678247|12512204|FG001|Second Intervention (7 Weeks)|Adverse Event|1
7959806|NCT02678247|12512203|FG000|Second Intervention (7 Weeks)|Physician Decision|1
7959807|NCT02678247|12512204|FG001|Second Intervention (7 Weeks)|Physician Decision|0
7959808|NCT02678286|12512217|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
7959809|NCT02678286|12512218|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
7959810|NCT02678286|12512217|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
7959811|NCT02678286|12512218|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
7959812|NCT02678286|12512217|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
7959813|NCT02678286|12512218|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
7959814|NCT02678286|12512217|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
7959815|NCT02678286|12512218|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
7959816|NCT02678286|12512217|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
7959817|NCT02678286|12512218|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
7959818|NCT02678390|12512226|FG000|AE (1 Day)|Withdrawal by Subject|0
7959819|NCT02678390|12512227|FG001|AE (1 Day)|Withdrawal by Subject|1
7959820|NCT02678416|12512235|FG000|Part 1|Withdrawal by Subject|1
7959821|NCT02678416|12512235|FG000|Part 2|Adverse Event|2
7959822|NCT02678416|12512235|FG000|Part 2|Withdrawal by Subject|1
7959823|NCT02678676|12512264|FG000|Overall Study|Death|619
7959824|NCT02678676|12512265|FG001|Overall Study|Death|649
7959825|NCT02678676|12512264|FG000|Overall Study|Withdrawal by Subject|13
7959826|NCT02678676|12512265|FG001|Overall Study|Withdrawal by Subject|5
7959827|NCT02678676|12512264|FG000|Overall Study|Lost to Follow-up|171
7959828|NCT02678676|12512265|FG001|Overall Study|Lost to Follow-up|151
7959829|NCT02678676|12512264|FG000|Overall Study|Unconfirmed for lost to follow-up|85
7959830|NCT02678676|12512265|FG001|Overall Study|Unconfirmed for lost to follow-up|67
7959831|NCT02678923|12512273|FG000|Overall Study|Protocol Deviation (Not Dosed)|1
7959832|NCT02678923|12512274|FG001|Overall Study|Protocol Deviation (Not Dosed)|3
7959833|NCT02678923|12512273|FG000|Overall Study|Withdrawal by Subject|3
7959834|NCT02678923|12512274|FG001|Overall Study|Withdrawal by Subject|2
7959835|NCT02678923|12512273|FG000|Overall Study|Lost to Follow-up|1
7959836|NCT02678923|12512274|FG001|Overall Study|Lost to Follow-up|0
7959837|NCT02678923|12512273|FG000|Overall Study|Did Not Return for Study Visits|1
7959838|NCT02678923|12512274|FG001|Overall Study|Did Not Return for Study Visits|0
7959839|NCT02679079|12512283|FG000|Overall Study|Adverse Event|2
7959840|NCT02679079|12512284|FG001|Overall Study|Adverse Event|0
7959841|NCT02679079|12512285|FG002|Overall Study|Adverse Event|2
7959842|NCT02679079|12512283|FG000|Overall Study|Protocol Violation|0
7959843|NCT02679079|12512284|FG001|Overall Study|Protocol Violation|1
7959844|NCT02679079|12512285|FG002|Overall Study|Protocol Violation|0
7959845|NCT02679079|12512283|FG000|Overall Study|Withdrawal by Subject|2
7959846|NCT02679079|12512284|FG001|Overall Study|Withdrawal by Subject|1
7959847|NCT02679079|12512285|FG002|Overall Study|Withdrawal by Subject|0
7959848|NCT02679222|12512293|FG000|Overall Study|No time for project|1
7959849|NCT02679235|12512305|FG000|Overall Study|Withdrawal by Subject|3
7959850|NCT02679235|12512305|FG000|Overall Study|Adverse Event|1
7959851|NCT02679274|12512311|FG000|Overall Study|Withdrawal by Subject|1
7959852|NCT02679274|12512312|FG001|Overall Study|Withdrawal by Subject|0
7959853|NCT02679287|12512320|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2
7959854|NCT02679287|12512321|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1
7959855|NCT02679287|12512320|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2
7959856|NCT02679287|12512321|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3
7959857|NCT02679287|12512320|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0
7959858|NCT02679287|12512321|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1
7959859|NCT02679287|12512320|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0
7959860|NCT02679287|12512321|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1
7959861|NCT02679287|12512320|FG000|Period 2|Work/Scheduling Conflict|1
7959862|NCT02679287|12512321|FG001|Period 2|Work/Scheduling Conflict|0
7959863|NCT02679287|12512320|FG000|Period 2|Disliked Mobile System|2
7959864|NCT02679287|12512321|FG001|Period 2|Disliked Mobile System|0
7959865|NCT02679287|12512320|FG000|Period 3|Work/Scheduling Conflict|0
7959866|NCT02679287|12512321|FG001|Period 3|Work/Scheduling Conflict|1
7959867|NCT02679573|12512339|FG000|Overall Study|Adverse Event|13
7959868|NCT02679573|12512340|FG001|Overall Study|Adverse Event|6
7959869|NCT02679573|12512339|FG000|Overall Study|Lack of Efficacy|12
7959870|NCT02679573|12512340|FG001|Overall Study|Lack of Efficacy|15
7959871|NCT02679573|12512339|FG000|Overall Study|Could not complete required study visits|6
7959872|NCT02679573|12512340|FG001|Overall Study|Could not complete required study visits|2
7959873|NCT02679573|12512339|FG000|Overall Study|Withdrawal by Subject|2
7959874|NCT02679573|12512340|FG001|Overall Study|Withdrawal by Subject|9
7959875|NCT02679573|12512339|FG000|Overall Study|Death|2
7959876|NCT02679573|12512340|FG001|Overall Study|Death|0
7959877|NCT02679573|12512339|FG000|Overall Study|Physician Decision|2
7959878|NCT02679573|12512340|FG001|Overall Study|Physician Decision|4
7959879|NCT02679573|12512339|FG000|Overall Study|Lost to Follow-up|0
7959880|NCT02679573|12512340|FG001|Overall Study|Lost to Follow-up|3
7959881|NCT02679729|12512361|FG000|Overall Study|Lost to Follow-up|0
7959882|NCT02679729|12512362|FG001|Overall Study|Lost to Follow-up|1
7959883|NCT02679729|12512363|FG002|Overall Study|Lost to Follow-up|0
7959884|NCT02679729|12512364|FG003|Overall Study|Lost to Follow-up|0
7959885|NCT02679729|12512365|FG004|Overall Study|Lost to Follow-up|1
7959886|NCT02679729|12512366|FG005|Overall Study|Lost to Follow-up|0
7959887|NCT02679729|12512367|FG006|Overall Study|Lost to Follow-up|0
7959888|NCT02679729|12512368|FG007|Overall Study|Lost to Follow-up|0
7959889|NCT02679729|12512369|FG008|Overall Study|Lost to Follow-up|0
7959890|NCT02679729|12512361|FG000|Overall Study|Participant decision|0
7959891|NCT02679729|12512362|FG001|Overall Study|Participant decision|1
7959892|NCT02679729|12512363|FG002|Overall Study|Participant decision|0
7959893|NCT02679729|12512364|FG003|Overall Study|Participant decision|0
7959894|NCT02679729|12512365|FG004|Overall Study|Participant decision|0
7959895|NCT02679729|12512366|FG005|Overall Study|Participant decision|0
7959896|NCT02679729|12512367|FG006|Overall Study|Participant decision|1
7959897|NCT02679729|12512368|FG007|Overall Study|Participant decision|0
7959898|NCT02679729|12512369|FG008|Overall Study|Participant decision|0
7959899|NCT02680002|12512426|FG000|Overall Study|Lost to Follow-up|5
7959900|NCT02680002|12512427|FG001|Overall Study|Lost to Follow-up|1
7959901|NCT02680002|12512428|FG002|Overall Study|Lost to Follow-up|4
7959902|NCT02680002|12512429|FG003|Overall Study|Lost to Follow-up|2
7959903|NCT02680002|12512430|FG004|Overall Study|Lost to Follow-up|0
7959904|NCT02680002|12512431|FG005|Overall Study|Lost to Follow-up|2
7959905|NCT02680002|12512426|FG000|Overall Study|Physician Decision|5
7959906|NCT02680002|12512427|FG001|Overall Study|Physician Decision|1
7959907|NCT02680002|12512428|FG002|Overall Study|Physician Decision|1
7959908|NCT02680002|12512429|FG003|Overall Study|Physician Decision|1
7959909|NCT02680002|12512430|FG004|Overall Study|Physician Decision|1
7959910|NCT02680002|12512431|FG005|Overall Study|Physician Decision|1
7959911|NCT02680002|12512426|FG000|Overall Study|Protocol Violation|1
7959912|NCT02680002|12512427|FG001|Overall Study|Protocol Violation|0
7959913|NCT02680002|12512428|FG002|Overall Study|Protocol Violation|1
7959914|NCT02680002|12512429|FG003|Overall Study|Protocol Violation|0
7959915|NCT02680002|12512430|FG004|Overall Study|Protocol Violation|1
7959916|NCT02680002|12512431|FG005|Overall Study|Protocol Violation|2
7959917|NCT02680002|12512426|FG000|Overall Study|Withdrawal by Subject|0
7959918|NCT02680002|12512427|FG001|Overall Study|Withdrawal by Subject|0
7959919|NCT02680002|12512428|FG002|Overall Study|Withdrawal by Subject|1
7959920|NCT02680002|12512429|FG003|Overall Study|Withdrawal by Subject|0
7959921|NCT02680002|12512430|FG004|Overall Study|Withdrawal by Subject|2
7959922|NCT02680002|12512431|FG005|Overall Study|Withdrawal by Subject|2
7959923|NCT02680002|12512426|FG000|Overall Study|Missed Visit 8 (Day 201)|2
7959924|NCT02680002|12512427|FG001|Overall Study|Missed Visit 8 (Day 201)|1
7959925|NCT02680002|12512428|FG002|Overall Study|Missed Visit 8 (Day 201)|3
7959926|NCT02680002|12512429|FG003|Overall Study|Missed Visit 8 (Day 201)|1
7959927|NCT02680002|12512430|FG004|Overall Study|Missed Visit 8 (Day 201)|5
7959928|NCT02680002|12512431|FG005|Overall Study|Missed Visit 8 (Day 201)|0
7959929|NCT02680002|12512426|FG000|Overall Study|Other|0
7959930|NCT02680002|12512427|FG001|Overall Study|Other|1
7959931|NCT02680002|12512428|FG002|Overall Study|Other|0
7959932|NCT02680002|12512429|FG003|Overall Study|Other|0
7959933|NCT02680002|12512430|FG004|Overall Study|Other|1
7959934|NCT02680002|12512431|FG005|Overall Study|Other|0
7959935|NCT02680002|12512426|FG000|Overall Study|Adverse Event|0
7959936|NCT02680002|12512427|FG001|Overall Study|Adverse Event|0
7959937|NCT02680002|12512428|FG002|Overall Study|Adverse Event|0
7959938|NCT02680002|12512429|FG003|Overall Study|Adverse Event|0
7959939|NCT02680002|12512430|FG004|Overall Study|Adverse Event|1
7959940|NCT02680002|12512431|FG005|Overall Study|Adverse Event|2
7959941|NCT02680041|12512448|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8
7959942|NCT02680041|12512448|FG000|Overall Study|Lost to Follow-up|2
7959943|NCT02680639|12512496|FG000|Screening Period|Screen Failure|7
7959944|NCT02680639|12512497|FG001|Screening Period|Screen Failure|0
7959945|NCT02680639|12512498|FG002|Screening Period|Screen Failure|0
7959946|NCT02680665|12512508|FG000|Overall Study|No visit after the first prescription|5
7959947|NCT02680756|12512514|FG000|Overall Study|Adverse Event|10
7959948|NCT02680756|12512515|FG001|Overall Study|Adverse Event|2
7959949|NCT02680756|12512514|FG000|Overall Study|Lost to Follow-up|7
7959950|NCT02680756|12512515|FG001|Overall Study|Lost to Follow-up|6
7959951|NCT02680756|12512514|FG000|Overall Study|Withdrawal by Subject|5
7959952|NCT02680756|12512515|FG001|Overall Study|Withdrawal by Subject|5
7959953|NCT02680756|12512514|FG000|Overall Study|Physician Decision|4
7959954|NCT02680756|12512515|FG001|Overall Study|Physician Decision|1
7959955|NCT02680756|12512514|FG000|Overall Study|Hb ≤7.5 g/dL|0
7959956|NCT02680756|12512515|FG001|Overall Study|Hb ≤7.5 g/dL|2
7959957|NCT02680756|12512514|FG000|Overall Study|Blood transfusion for any reason|0
7959958|NCT02680756|12512515|FG001|Overall Study|Blood transfusion for any reason|1
7959959|NCT02680756|12512514|FG000|Overall Study|Death|1
7959960|NCT02680756|12512515|FG001|Overall Study|Death|0
7959961|NCT02680756|12512514|FG000|Overall Study|Protocol Violation|1
7959962|NCT02680756|12512515|FG001|Overall Study|Protocol Violation|0
7959963|NCT02680756|12512514|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1
7959964|NCT02680756|12512515|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0
7959965|NCT02680756|12512514|FG000|Overall Study|None of above or not recorded|3
7959966|NCT02680756|12512515|FG001|Overall Study|None of above or not recorded|2
7959967|NCT02680834|12512523|FG000|Overall Study|Physician Decision|5
7959968|NCT02680834|12512524|FG001|Overall Study|Physician Decision|2
7959969|NCT02680834|12512523|FG000|Overall Study|Withdrawal by Subject|6
7959970|NCT02680834|12512524|FG001|Overall Study|Withdrawal by Subject|0
7959971|NCT02680834|12512523|FG000|Overall Study|Lost to Follow-up|0
7959972|NCT02680834|12512524|FG001|Overall Study|Lost to Follow-up|1
7959973|NCT02680847|12512533|FG000|Overall Study|Other|2
7959974|NCT02680847|12512534|FG001|Overall Study|Other|0
7959975|NCT02680847|12512535|FG002|Overall Study|Other|0
7959976|NCT02680847|12512533|FG000|Overall Study|No longer met eligibility criteria|2
7959977|NCT02680847|12512534|FG001|Overall Study|No longer met eligibility criteria|2
7959978|NCT02680847|12512535|FG002|Overall Study|No longer met eligibility criteria|0
7959979|NCT02680847|12512533|FG000|Overall Study|Unwilling to participate in study|1
7959980|NCT02680847|12512534|FG001|Overall Study|Unwilling to participate in study|1
7959981|NCT02680847|12512535|FG002|Overall Study|Unwilling to participate in study|0
7959982|NCT02680847|12512533|FG000|Overall Study|Lack of Efficacy|0
7959983|NCT02680847|12512534|FG001|Overall Study|Lack of Efficacy|0
7959984|NCT02680847|12512535|FG002|Overall Study|Lack of Efficacy|2
7959985|NCT02680847|12512533|FG000|Overall Study|Adverse Event|0
7959986|NCT02680847|12512534|FG001|Overall Study|Adverse Event|0
7959987|NCT02680847|12512535|FG002|Overall Study|Adverse Event|1
7959988|NCT02681094|12512546|FG000|1 -Modified Enrolled Participants Set|Participant decision|7
7959989|NCT02681094|12512547|FG001|1 -Modified Enrolled Participants Set|Participant decision|10
7959990|NCT02681094|12512548|FG002|1 -Modified Enrolled Participants Set|Participant decision|9
7959991|NCT02681094|12512546|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10
7959992|NCT02681094|12512547|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4
7959993|NCT02681094|12512548|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1
7959994|NCT02681094|12512546|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
7959995|NCT02681094|12512547|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
7959996|NCT02681094|12512548|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
7959997|NCT02681094|12512546|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
7959998|NCT02681094|12512547|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
7959999|NCT02681094|12512548|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
7960000|NCT02681094|12512546|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
7960001|NCT02681094|12512547|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
7960002|NCT02681094|12512548|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
7960003|NCT02681094|12512546|FG000|1 -Modified Enrolled Participants Set|Other|6
7960004|NCT02681094|12512547|FG001|1 -Modified Enrolled Participants Set|Other|6
7960005|NCT02681094|12512548|FG002|1 -Modified Enrolled Participants Set|Other|7
7960006|NCT02681094|12512546|FG000|1 -Modified Enrolled Participants Set|No treatment given|0
7960007|NCT02681094|12512547|FG001|1 -Modified Enrolled Participants Set|No treatment given|1
7960008|NCT02681094|12512548|FG002|1 -Modified Enrolled Participants Set|No treatment given|1
7960009|NCT02681094|12512546|FG000|2 - Enrolled Participants Set|Participant decision|7
7960010|NCT02681094|12512547|FG001|2 - Enrolled Participants Set|Participant decision|10
7960011|NCT02681094|12512548|FG002|2 - Enrolled Participants Set|Participant decision|9
7960012|NCT02681094|12512546|FG000|2 - Enrolled Participants Set|Adverse Event|10
7960013|NCT02681094|12512547|FG001|2 - Enrolled Participants Set|Adverse Event|4
7960014|NCT02681094|12512548|FG002|2 - Enrolled Participants Set|Adverse Event|1
7960015|NCT02681094|12512546|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
7960016|NCT02681094|12512547|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
7960017|NCT02681094|12512548|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
7960018|NCT02681094|12512546|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1
7960019|NCT02681094|12512547|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5
7960020|NCT02681094|12512548|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14
7960021|NCT02681094|12512546|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
7960022|NCT02681094|12512547|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
7960023|NCT02681094|12512548|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
7960024|NCT02681094|12512546|FG000|2 - Enrolled Participants Set|Other|6
7960025|NCT02681094|12512547|FG001|2 - Enrolled Participants Set|Other|6
7960026|NCT02681094|12512548|FG002|2 - Enrolled Participants Set|Other|7
7960027|NCT02681094|12512546|FG000|2 - Enrolled Participants Set|No treatment given|0
7960028|NCT02681094|12512547|FG001|2 - Enrolled Participants Set|No treatment given|1
7960029|NCT02681094|12512548|FG002|2 - Enrolled Participants Set|No treatment given|1
7960030|NCT02681510|12512570|FG000|Overall Study|Withdrawal by Subject|1
7960031|NCT02681510|12512570|FG000|Overall Study|Lost to Follow-up|9
7960032|NCT02681523|12512574|FG000|Overall Study|Adverse Event|1
7960033|NCT02681523|12512574|FG000|Overall Study|Patient Non-compliance|1
7966694|NCT02756364|12523022|FG002|Overall Study|Lost to Follow-up|1
7966695|NCT02756637|12523050|FG000|Overall Study|Not eligible for initial SWOG study|10
7966696|NCT02756637|12523051|FG001|Overall Study|Not eligible for initial SWOG study|10
7966697|NCT02756637|12523050|FG000|Overall Study|No available NLR value|44
7966698|NCT02756637|12523051|FG001|Overall Study|No available NLR value|44
7966699|NCT02756637|12523050|FG000|Overall Study|Did not complete curative therapy|33
7966700|NCT02756637|12523051|FG001|Overall Study|Did not complete curative therapy|0
7966701|NCT02756650|12523057|FG000|Overall Study|Physician Decision|1
7966702|NCT02756650|12523057|FG000|Overall Study|Adverse Event|1
7966703|NCT02756819|12523104|FG000|Overall Study|Lost for observation|23
7966704|NCT02756819|12523104|FG000|Overall Study|Patient's unwillingness|16
7966705|NCT02756819|12523104|FG000|Overall Study|Insufficient efficacy|2
7966706|NCT02756819|12523104|FG000|Overall Study|Adverse Event|2
7966707|NCT02756819|12523104|FG000|Overall Study|Reason not Specified|9
7966708|NCT02756832|12523108|FG000|Overall Study|Lost for Observation after Baseline|6
7966709|NCT02756832|12523108|FG000|Overall Study|Lost for Observation|13
7966710|NCT02756832|12523108|FG000|Overall Study|Patient's Unwillingness|12
7966711|NCT02756832|12523108|FG000|Overall Study|Insufficient Efficacy|2
7966712|NCT02756832|12523108|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1
7966713|NCT02756832|12523108|FG000|Overall Study|Reason not Specified|9
7966714|NCT02756832|12523108|FG000|Overall Study|Protocol Deviation|10
7966715|NCT02757352|12523222|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2
7966716|NCT02757352|12523223|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7966717|NCT02757352|12523224|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1
7966718|NCT02757352|12523225|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7966719|NCT02757352|12523226|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7966720|NCT02757352|12523227|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7966721|NCT02757352|12523228|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7966722|NCT02757352|12523229|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7966723|NCT02757352|12523230|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7966724|NCT02757352|12523231|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7966725|NCT02757352|12523222|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7966726|NCT02757352|12523223|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7966727|NCT02757352|12523224|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1
7966728|NCT02757352|12523225|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7966729|NCT02757352|12523226|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7966730|NCT02757352|12523227|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7966731|NCT02757352|12523228|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7966732|NCT02757352|12523229|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7966733|NCT02757352|12523230|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7966734|NCT02757352|12523231|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7966735|NCT02757352|12523222|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6
7966736|NCT02757352|12523223|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1
7966737|NCT02757352|12523224|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2
7966738|NCT02757352|12523225|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7966739|NCT02757352|12523226|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7966740|NCT02757352|12523227|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7966741|NCT02757352|12523228|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7966742|NCT02757352|12523229|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7966743|NCT02757352|12523230|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7966744|NCT02757352|12523231|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7966745|NCT02757352|12523222|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7966746|NCT02757352|12523223|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1
7966747|NCT02757352|12523224|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7966748|NCT02757352|12523225|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7966749|NCT02757352|12523226|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7966750|NCT02757352|12523227|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7960034|NCT02682264|12512624|FG000|Overall Study|Withdrawal by Subject|56
7960035|NCT02682264|12512625|FG001|Overall Study|Withdrawal by Subject|45
7960036|NCT02682264|12512624|FG000|Overall Study|Lost to Follow-up|49
7960037|NCT02682264|12512625|FG001|Overall Study|Lost to Follow-up|41
7960038|NCT02682264|12512624|FG000|Overall Study|Lack of Efficacy|14
7960039|NCT02682264|12512625|FG001|Overall Study|Lack of Efficacy|16
7960040|NCT02682264|12512624|FG000|Overall Study|Withdrawal by Parent|6
7960041|NCT02682264|12512625|FG001|Overall Study|Withdrawal by Parent|7
7960042|NCT02682264|12512624|FG000|Overall Study|Adverse Event|9
7960043|NCT02682264|12512625|FG001|Overall Study|Adverse Event|0
7960044|NCT02682264|12512624|FG000|Overall Study|Noncompliance with study drug|1
7960045|NCT02682264|12512625|FG001|Overall Study|Noncompliance with study drug|4
7960046|NCT02682264|12512624|FG000|Overall Study|Pregnancy|1
7960047|NCT02682264|12512625|FG001|Overall Study|Pregnancy|2
7960048|NCT02682264|12512624|FG000|Overall Study|Recovery|1
7960049|NCT02682264|12512625|FG001|Overall Study|Recovery|2
7960050|NCT02682264|12512624|FG000|Overall Study|Progressive Disease|1
7960051|NCT02682264|12512625|FG001|Overall Study|Progressive Disease|0
7960052|NCT02682264|12512624|FG000|Overall Study|Technical Problems|0
7960053|NCT02682264|12512625|FG001|Overall Study|Technical Problems|1
7960054|NCT02682264|12512624|FG000|Overall Study|Moved abroad and unable to continue|0
7960055|NCT02682264|12512625|FG001|Overall Study|Moved abroad and unable to continue|3
7960056|NCT02682264|12512624|FG000|Overall Study|Stopped test article application|0
7960057|NCT02682264|12512625|FG001|Overall Study|Stopped test article application|1
7960058|NCT02682602|12512676|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1
7960059|NCT02682602|12512677|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0
7960060|NCT02682602|12512676|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3
7960061|NCT02682602|12512677|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0
7960062|NCT02682784|12512691|FG000|Overall Study|Withdrawal by Subject|0
7960063|NCT02682784|12512692|FG001|Overall Study|Withdrawal by Subject|2
7960064|NCT02682784|12512693|FG002|Overall Study|Withdrawal by Subject|1
7960065|NCT02682784|12512694|FG003|Overall Study|Withdrawal by Subject|2
7960066|NCT02682784|12512691|FG000|Overall Study|Physician Decision|1
7960067|NCT02682784|12512692|FG001|Overall Study|Physician Decision|0
7960068|NCT02682784|12512693|FG002|Overall Study|Physician Decision|1
7960069|NCT02682784|12512694|FG003|Overall Study|Physician Decision|1
7960070|NCT02682823|12512709|FG000|Overall Study|Withdrawal by Subject|0
7960071|NCT02682823|12512710|FG001|Overall Study|Withdrawal by Subject|0
7960072|NCT02682823|12512711|FG002|Overall Study|Withdrawal by Subject|1
7960073|NCT02682823|12512712|FG003|Overall Study|Withdrawal by Subject|0
7960074|NCT02682823|12512713|FG004|Overall Study|Withdrawal by Subject|1
7960075|NCT02682823|12512709|FG000|Overall Study|Protocol Deviation|0
7960076|NCT02682823|12512710|FG001|Overall Study|Protocol Deviation|1
7960077|NCT02682823|12512711|FG002|Overall Study|Protocol Deviation|0
7960078|NCT02682823|12512712|FG003|Overall Study|Protocol Deviation|0
7960079|NCT02682823|12512713|FG004|Overall Study|Protocol Deviation|0
7960080|NCT02682823|12512709|FG000|Overall Study|Adverse Event|0
7960081|NCT02682823|12512710|FG001|Overall Study|Adverse Event|0
7960082|NCT02682823|12512711|FG002|Overall Study|Adverse Event|0
7960083|NCT02682823|12512712|FG003|Overall Study|Adverse Event|1
7960084|NCT02682823|12512713|FG004|Overall Study|Adverse Event|0
7960085|NCT02683109|12512731|FG000|Overall Study|Adverse Event|1
7960086|NCT02683109|12512732|FG001|Overall Study|Adverse Event|0
7960087|NCT02683187|12512748|FG000|Overall Study|Failed IV access|3
7960088|NCT02683187|12512748|FG000|Overall Study|Withdrawal by Subject|5
7960089|NCT02683525|12512773|FG000|Overall Study|Lost to Follow-up|1
7960090|NCT02683525|12512773|FG000|Overall Study|Physician Decision|1
7960091|NCT02683525|12512773|FG000|Overall Study|Disease Progression|6
7960092|NCT02683668|12512792|FG000|Period 2|Withdrawal by Subject|0
7960093|NCT02683668|12512793|FG001|Period 2|Withdrawal by Subject|1
7960094|NCT02683668|12512794|FG002|Period 2|Withdrawal by Subject|0
7960095|NCT02683746|12512811|FG000|Overall Study|Adverse Event|3
7960096|NCT02683746|12512812|FG001|Overall Study|Adverse Event|2
7960097|NCT02683746|12512811|FG000|Overall Study|Lost to Follow-up|5
7960098|NCT02683746|12512812|FG001|Overall Study|Lost to Follow-up|6
7960099|NCT02683746|12512811|FG000|Overall Study|Withdrawal by Subject|6
7960100|NCT02683746|12512812|FG001|Overall Study|Withdrawal by Subject|5
7960101|NCT02683746|12512811|FG000|Overall Study|Physician Decision|2
7960102|NCT02683746|12512812|FG001|Overall Study|Physician Decision|1
7960103|NCT02683785|12512831|FG000|Overall Study|Withdrawal by Subject|1
7960104|NCT02683785|12512832|FG001|Overall Study|Withdrawal by Subject|1
7960105|NCT02683785|12512831|FG000|Overall Study|Lost to Follow-up|0
7960106|NCT02683785|12512832|FG001|Overall Study|Lost to Follow-up|1
7960107|NCT02683785|12512831|FG000|Overall Study|Adverse Event|0
7960108|NCT02683785|12512832|FG001|Overall Study|Adverse Event|2
7960109|NCT02683876|12512842|FG000|Overall Study|samples damaged during shipping|2
7960110|NCT02683876|12512843|FG001|Overall Study|samples damaged during shipping|0
7960111|NCT02683941|12512862|FG000|Double-blind Phase|Adverse Event|0
7960112|NCT02683941|12512863|FG001|Double-blind Phase|Adverse Event|1
7960113|NCT02683941|12512862|FG000|Double-blind Phase|Withdrawal by Subject|4
7960114|NCT02683941|12512863|FG001|Double-blind Phase|Withdrawal by Subject|2
7960115|NCT02683941|12512862|FG000|Double-blind Phase|Lost to Follow-up|1
7960116|NCT02683941|12512863|FG001|Double-blind Phase|Lost to Follow-up|0
7960117|NCT02683941|12512862|FG000|Double-blind Phase|Disease Progression|5
7960118|NCT02683941|12512863|FG001|Double-blind Phase|Disease Progression|2
7960119|NCT02683941|12512862|FG000|Open-label Treatment Phase|Withdrawal by Subject|0
7960120|NCT02683941|12512863|FG001|Open-label Treatment Phase|Withdrawal by Subject|2
7960121|NCT02683941|12512862|FG000|Open-label Treatment Phase|Disease Progression|1
7960122|NCT02683941|12512863|FG001|Open-label Treatment Phase|Disease Progression|2
7960123|NCT02683941|12512862|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18
7960124|NCT02683941|12512863|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9
7960125|NCT02683941|12512862|FG000|Open-label Treatment Phase|Other|1
7960126|NCT02683941|12512863|FG001|Open-label Treatment Phase|Other|0
7960127|NCT02683941|12512862|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3
7960128|NCT02683941|12512863|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3
7960129|NCT02683941|12512862|FG000|Open-label Follow-up Phase|Lost to Follow-up|1
7960130|NCT02683941|12512863|FG001|Open-label Follow-up Phase|Lost to Follow-up|0
7960131|NCT02683941|12512862|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6
7960132|NCT02683941|12512863|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4
7960133|NCT02683941|12512862|FG000|Open-label Follow-up Phase|Other|8
7960134|NCT02683941|12512863|FG001|Open-label Follow-up Phase|Other|1
7960135|NCT02684097|12512884|FG000|Overall Study|Lack of Efficacy|13
7960136|NCT02684097|12512885|FG001|Overall Study|Lack of Efficacy|6
7960137|NCT02684279|12512910|FG000|Overall Study|Adverse Event|87
7960138|NCT02684279|12512910|FG000|Overall Study|Lack of Efficacy|4
7960139|NCT02684279|12512910|FG000|Overall Study|Lost to Follow-up|61
7960140|NCT02684279|12512910|FG000|Overall Study|Protocol Violation|6
7960141|NCT02684279|12512910|FG000|Overall Study|Pregnancy|8
7960142|NCT02684279|12512910|FG000|Overall Study|Withdrawal by Subject|92
7960143|NCT02684279|12512910|FG000|Overall Study|non-compliance with study drug|9
7960144|NCT02684279|12512910|FG000|Overall Study|non compliance with study visits|2
7960145|NCT02684279|12512910|FG000|Overall Study|subject to have surgery|1
7960146|NCT02684279|12512910|FG000|Overall Study|family emergency|1
7960147|NCT02684279|12512910|FG000|Overall Study|Site closures|7
7960148|NCT02684279|12512910|FG000|Overall Study|Physician Decision|1
7960149|NCT02684344|12512916|FG000|Overall Study|Withdrawal by Subject|0
7960150|NCT02684344|12512917|FG001|Overall Study|Withdrawal by Subject|1
7960151|NCT02684357|12512926|FG000|Part A|Adverse Event (Worsening of Disease)|1
7960152|NCT02684357|12512927|FG001|Part A|Adverse Event (Worsening of Disease)|0
7960153|NCT02684357|12512928|FG002|Part A|Adverse Event (Worsening of Disease)|0
7960154|NCT02684357|12512929|FG003|Part A|Adverse Event (Worsening of Disease)|0
7960155|NCT02684357|12512930|FG004|Part A|Adverse Event (Worsening of Disease)|0
7960156|NCT02684357|12512931|FG005|Part A|Adverse Event (Worsening of Disease)|0
7960157|NCT02684357|12512926|FG000|Part A|Lost to Follow-up|0
7960158|NCT02684357|12512927|FG001|Part A|Lost to Follow-up|2
7960159|NCT02684357|12512928|FG002|Part A|Lost to Follow-up|2
7960160|NCT02684357|12512929|FG003|Part A|Lost to Follow-up|0
7960161|NCT02684357|12512930|FG004|Part A|Lost to Follow-up|0
7960162|NCT02684357|12512931|FG005|Part A|Lost to Follow-up|0
7960163|NCT02684357|12512926|FG000|Part A|Withdrawal by Subject|3
7960164|NCT02684357|12512927|FG001|Part A|Withdrawal by Subject|0
7960165|NCT02684357|12512928|FG002|Part A|Withdrawal by Subject|0
7960166|NCT02684357|12512929|FG003|Part A|Withdrawal by Subject|0
7960167|NCT02684357|12512930|FG004|Part A|Withdrawal by Subject|0
7960168|NCT02684357|12512931|FG005|Part A|Withdrawal by Subject|0
7960169|NCT02684357|12512926|FG000|Part A|Other|0
7960170|NCT02684357|12512927|FG001|Part A|Other|1
7960171|NCT02684357|12512928|FG002|Part A|Other|0
7960172|NCT02684357|12512929|FG003|Part A|Other|0
7960173|NCT02684357|12512930|FG004|Part A|Other|0
7960174|NCT02684357|12512931|FG005|Part A|Other|0
7960175|NCT02684357|12512926|FG000|Part B|Adverse Event (Other)|0
7960176|NCT02684357|12512927|FG001|Part B|Adverse Event (Other)|0
7960177|NCT02684357|12512928|FG002|Part B|Adverse Event (Other)|0
7960178|NCT02684357|12512929|FG003|Part B|Adverse Event (Other)|1
7960179|NCT02684357|12512930|FG004|Part B|Adverse Event (Other)|1
7960180|NCT02684357|12512931|FG005|Part B|Adverse Event (Other)|1
7960181|NCT02684357|12512926|FG000|Part B|Lost to Follow-up|0
7960182|NCT02684357|12512927|FG001|Part B|Lost to Follow-up|0
7960183|NCT02684357|12512928|FG002|Part B|Lost to Follow-up|0
7960184|NCT02684357|12512929|FG003|Part B|Lost to Follow-up|1
7960185|NCT02684357|12512930|FG004|Part B|Lost to Follow-up|1
7960186|NCT02684357|12512931|FG005|Part B|Lost to Follow-up|7
7960187|NCT02684357|12512926|FG000|Part B|Withdrawal by Subject|0
7960188|NCT02684357|12512927|FG001|Part B|Withdrawal by Subject|0
7960189|NCT02684357|12512928|FG002|Part B|Withdrawal by Subject|0
7960190|NCT02684357|12512929|FG003|Part B|Withdrawal by Subject|0
7960191|NCT02684357|12512930|FG004|Part B|Withdrawal by Subject|2
7960192|NCT02684357|12512931|FG005|Part B|Withdrawal by Subject|4
7960193|NCT02684357|12512926|FG000|Part B|Other|0
7960194|NCT02684357|12512927|FG001|Part B|Other|0
7960195|NCT02684357|12512928|FG002|Part B|Other|0
7960196|NCT02684357|12512929|FG003|Part B|Other|1
7960197|NCT02684357|12512930|FG004|Part B|Other|0
7960198|NCT02684357|12512931|FG005|Part B|Other|1
7960199|NCT02684370|12512947|FG000|Part A|Adverse Event|2
7960200|NCT02684370|12512948|FG001|Part A|Adverse Event|0
7960201|NCT02684370|12512949|FG002|Part A|Adverse Event|1
7960202|NCT02684370|12512950|FG003|Part A|Adverse Event|0
7960203|NCT02684370|12512951|FG004|Part A|Adverse Event|0
7960204|NCT02684370|12512952|FG005|Part A|Adverse Event|0
7960205|NCT02684370|12512947|FG000|Part A|Lost to Follow-up|1
7960206|NCT02684370|12512948|FG001|Part A|Lost to Follow-up|1
7960207|NCT02684370|12512949|FG002|Part A|Lost to Follow-up|0
7960208|NCT02684370|12512950|FG003|Part A|Lost to Follow-up|0
7960209|NCT02684370|12512951|FG004|Part A|Lost to Follow-up|0
7960210|NCT02684370|12512952|FG005|Part A|Lost to Follow-up|0
7960211|NCT02684370|12512947|FG000|Part A|Subject Withdrawal|1
7960212|NCT02684370|12512948|FG001|Part A|Subject Withdrawal|0
7960213|NCT02684370|12512949|FG002|Part A|Subject Withdrawal|3
7960214|NCT02684370|12512950|FG003|Part A|Subject Withdrawal|0
7960215|NCT02684370|12512951|FG004|Part A|Subject Withdrawal|0
7960216|NCT02684370|12512952|FG005|Part A|Subject Withdrawal|0
7960217|NCT02684370|12512947|FG000|Part A|Other|0
7960218|NCT02684370|12512948|FG001|Part A|Other|0
7960219|NCT02684370|12512949|FG002|Part A|Other|1
7960220|NCT02684370|12512950|FG003|Part A|Other|0
7960221|NCT02684370|12512951|FG004|Part A|Other|0
7960222|NCT02684370|12512952|FG005|Part A|Other|0
7960223|NCT02684370|12512947|FG000|Part B|Adverse Event|0
7960224|NCT02684370|12512948|FG001|Part B|Adverse Event|0
7960225|NCT02684370|12512949|FG002|Part B|Adverse Event|0
7960226|NCT02684370|12512950|FG003|Part B|Adverse Event|0
7960227|NCT02684370|12512951|FG004|Part B|Adverse Event|2
7960228|NCT02684370|12512952|FG005|Part B|Adverse Event|1
7960229|NCT02684370|12512947|FG000|Part B|Lost to Follow-up|0
7960230|NCT02684370|12512948|FG001|Part B|Lost to Follow-up|0
7960231|NCT02684370|12512949|FG002|Part B|Lost to Follow-up|0
7960232|NCT02684370|12512950|FG003|Part B|Lost to Follow-up|1
7960233|NCT02684370|12512951|FG004|Part B|Lost to Follow-up|2
7960234|NCT02684370|12512952|FG005|Part B|Lost to Follow-up|5
7960235|NCT02684370|12512947|FG000|Part B|Subject Withdrawal|0
7960236|NCT02684370|12512948|FG001|Part B|Subject Withdrawal|0
7960237|NCT02684370|12512949|FG002|Part B|Subject Withdrawal|0
7960238|NCT02684370|12512950|FG003|Part B|Subject Withdrawal|1
7960239|NCT02684370|12512951|FG004|Part B|Subject Withdrawal|1
7960240|NCT02684370|12512952|FG005|Part B|Subject Withdrawal|2
7960241|NCT02684617|12513016|FG000|Overall Study|Adverse Event|1
7960242|NCT02684617|12513017|FG001|Overall Study|Adverse Event|0
7960243|NCT02684617|12513018|FG002|Overall Study|Adverse Event|1
7960244|NCT02684617|12513016|FG000|Overall Study|Death|8
7960245|NCT02684617|12513017|FG001|Overall Study|Death|16
7960246|NCT02684617|12513018|FG002|Overall Study|Death|28
7960247|NCT02684617|12513016|FG000|Overall Study|Withdrawal by Subject|2
7960248|NCT02684617|12513017|FG001|Overall Study|Withdrawal by Subject|0
7960249|NCT02684617|12513018|FG002|Overall Study|Withdrawal by Subject|4
7960250|NCT02684617|12513016|FG000|Overall Study|Screen Failure|1
7960251|NCT02684617|12513017|FG001|Overall Study|Screen Failure|0
7960252|NCT02684617|12513018|FG002|Overall Study|Screen Failure|2
7960253|NCT02684617|12513016|FG000|Overall Study|Study Terminated by Sponsor|6
7960254|NCT02684617|12513017|FG001|Overall Study|Study Terminated by Sponsor|1
7960255|NCT02684617|12513018|FG002|Overall Study|Study Terminated by Sponsor|5
7960256|NCT02684981|12513056|FG000|Overall Study|Permanently discontinued the treatment|157
7960257|NCT02684981|12513057|FG001|Overall Study|Permanently discontinued the treatment|161
7960258|NCT02684981|12513058|FG002|Overall Study|Permanently discontinued the treatment|110
7960259|NCT02684981|12513056|FG000|Overall Study|Other|83
7960260|NCT02684981|12513057|FG001|Overall Study|Other|49
7960261|NCT02684981|12513058|FG002|Overall Study|Other|17
7960262|NCT02685033|12513078|FG000|Overall Study|Withdrawal of Consent|0
7960263|NCT02685033|12513079|FG001|Overall Study|Withdrawal of Consent|1
7960264|NCT02685033|12513078|FG000|Overall Study|Lost to Follow-up|2
7960265|NCT02685033|12513079|FG001|Overall Study|Lost to Follow-up|1
7960266|NCT02685033|12513078|FG000|Overall Study|Adverse Event|1
7960267|NCT02685033|12513079|FG001|Overall Study|Adverse Event|0
7960268|NCT02685072|12513087|FG000|Treatment Period|Lost to Follow-up|12
7960269|NCT02685072|12513088|FG001|Treatment Period|Lost to Follow-up|6
7960270|NCT02685072|12513087|FG000|Treatment Period|Withdrawal by Subject|1
7960271|NCT02685072|12513088|FG001|Treatment Period|Withdrawal by Subject|3
7960272|NCT02685072|12513087|FG000|1-Month Follow-Up|Withdrawal by Subject|1
7960273|NCT02685072|12513088|FG001|1-Month Follow-Up|Withdrawal by Subject|0
7960274|NCT02685488|12513117|FG000|Overall Study|Withdrawal by Subject|0
7960275|NCT02685488|12513118|FG001|Overall Study|Withdrawal by Subject|1
7960276|NCT02685995|12513146|FG000|Overall Study|Insertion of immediately puncturable graft.|1
7960277|NCT02685995|12513147|FG001|Overall Study|Insertion of immediately puncturable graft.|1
7960278|NCT02686034|12513155|FG000|Run-In Period 1|Eligibility|12
7960279|NCT02686034|12513156|FG001|Run-In Period 1|Eligibility|10
7960280|NCT02686034|12513155|FG000|Run-In Period 1|Withdrawal by Subject|4
7960281|NCT02686034|12513156|FG001|Run-In Period 1|Withdrawal by Subject|3
7960282|NCT02686034|12513155|FG000|Run-In Period 1|Lost to Follow-up|4
7960283|NCT02686034|12513156|FG001|Run-In Period 1|Lost to Follow-up|4
7960284|NCT02686034|12513155|FG000|Randomized Controlled Period 2|Lost to Follow-up|1
7960285|NCT02686034|12513156|FG001|Randomized Controlled Period 2|Lost to Follow-up|2
7960286|NCT02686034|12513155|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3
7960287|NCT02686034|12513156|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0
7960288|NCT02686034|12513155|FG000|Randomized Controlled Period 2|Adverse Event|0
7960289|NCT02686034|12513156|FG001|Randomized Controlled Period 2|Adverse Event|2
7960290|NCT02686034|12513155|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1
7960291|NCT02686034|12513156|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0
7960292|NCT02686034|12513155|FG000|Open Label Period 3|Lost to Follow-up|0
7960293|NCT02686034|12513156|FG001|Open Label Period 3|Lost to Follow-up|1
7960294|NCT02686164|12513171|FG000|Overall Study|Adverse Event|1
7960295|NCT02686164|12513171|FG000|Overall Study|Withdrawal of consent|1
7960296|NCT02686164|12513171|FG000|Overall Study|Clinical progression|1
7960297|NCT02687035|12513187|FG000|Overall Study|Withdrawal by Subject|1
7960298|NCT02687035|12513187|FG000|Overall Study|Death|87
7960299|NCT02687035|12513187|FG000|Overall Study|Lost to Follow-up|1
7960300|NCT02687035|12513187|FG000|Overall Study|Missed Visit|87
7960301|NCT02687035|12513187|FG000|Overall Study|Did not receive Study Device|8
7960302|NCT02687191|12513208|FG000|Overall Study|Death|0
7960303|NCT02687191|12513209|FG001|Overall Study|Death|1
7960304|NCT02687191|12513210|FG002|Overall Study|Death|1
7960305|NCT02687191|12513211|FG003|Overall Study|Death|0
7960306|NCT02687191|12513212|FG004|Overall Study|Death|1
7960307|NCT02687191|12513213|FG005|Overall Study|Death|1
7960308|NCT02687191|12513208|FG000|Overall Study|Withdrawal by Subject|0
7960309|NCT02687191|12513209|FG001|Overall Study|Withdrawal by Subject|0
7960310|NCT02687191|12513210|FG002|Overall Study|Withdrawal by Subject|0
7960311|NCT02687191|12513211|FG003|Overall Study|Withdrawal by Subject|1
7960312|NCT02687191|12513212|FG004|Overall Study|Withdrawal by Subject|0
7960313|NCT02687191|12513213|FG005|Overall Study|Withdrawal by Subject|0
7960314|NCT02687451|12513251|FG000|Overall Study|Withdrawal by Subject|1
7960315|NCT02687451|12513252|FG001|Overall Study|Withdrawal by Subject|0
7960316|NCT02687451|12513253|FG002|Overall Study|Withdrawal by Subject|0
7960317|NCT02687451|12513254|FG003|Overall Study|Withdrawal by Subject|0
7960318|NCT02687451|12513255|FG004|Overall Study|Withdrawal by Subject|0
7960319|NCT02687451|12513256|FG005|Overall Study|Withdrawal by Subject|1
7960320|NCT02687542|12513286|FG000|Overall Study|Medication error without associated AEs|0
7960321|NCT02687542|12513287|FG001|Overall Study|Medication error without associated AEs|0
7960322|NCT02687542|12513288|FG002|Overall Study|Medication error without associated AEs|0
7960323|NCT02687542|12513289|FG003|Overall Study|Medication error without associated AEs|0
7960324|NCT02687542|12513290|FG004|Overall Study|Medication error without associated AEs|1
7960325|NCT02687542|12513286|FG000|Overall Study|Lost to Follow-up|0
7960326|NCT02687542|12513287|FG001|Overall Study|Lost to Follow-up|0
7960327|NCT02687542|12513288|FG002|Overall Study|Lost to Follow-up|0
7960328|NCT02687542|12513289|FG003|Overall Study|Lost to Follow-up|0
7960329|NCT02687542|12513290|FG004|Overall Study|Lost to Follow-up|1
7960330|NCT02687542|12513286|FG000|Overall Study|Protocol Violation|0
7960331|NCT02687542|12513287|FG001|Overall Study|Protocol Violation|1
7960332|NCT02687542|12513288|FG002|Overall Study|Protocol Violation|0
7960333|NCT02687542|12513289|FG003|Overall Study|Protocol Violation|0
7960334|NCT02687542|12513290|FG004|Overall Study|Protocol Violation|0
7960335|NCT02687542|12513286|FG000|Overall Study|Other|5
7960336|NCT02687542|12513287|FG001|Overall Study|Other|9
7960337|NCT02687542|12513288|FG002|Overall Study|Other|10
7960338|NCT02687542|12513289|FG003|Overall Study|Other|6
7960339|NCT02687542|12513290|FG004|Overall Study|Other|5
7960340|NCT02687542|12513286|FG000|Overall Study|Adverse Event|3
7960341|NCT02687542|12513287|FG001|Overall Study|Adverse Event|1
7960342|NCT02687542|12513288|FG002|Overall Study|Adverse Event|3
7960343|NCT02687542|12513289|FG003|Overall Study|Adverse Event|2
7960344|NCT02687542|12513290|FG004|Overall Study|Adverse Event|9
7960345|NCT02687542|12513286|FG000|Overall Study|Withdrawal by Subject|0
7960346|NCT02687542|12513287|FG001|Overall Study|Withdrawal by Subject|1
7960347|NCT02687542|12513288|FG002|Overall Study|Withdrawal by Subject|1
7960348|NCT02687542|12513289|FG003|Overall Study|Withdrawal by Subject|2
7960349|NCT02687542|12513290|FG004|Overall Study|Withdrawal by Subject|4
7960350|NCT02687711|12513302|FG000|Overall Study|Adverse Event|89
7960351|NCT02687711|12513302|FG000|Overall Study|Lack of Efficacy|70
7960352|NCT02687711|12513302|FG000|Overall Study|Lost to Follow-up|20
7960353|NCT02687711|12513302|FG000|Overall Study|Consent withdrawn|15
7960354|NCT02687711|12513302|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1
7960355|NCT02687711|12513302|FG000|Overall Study|Too expensive|4
7960356|NCT02687711|12513302|FG000|Overall Study|Participant moved abroad|1
7960357|NCT02687711|12513302|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1
7960358|NCT02687711|12513302|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1
7960359|NCT02687711|12513302|FG000|Overall Study|Disliked taste|1
7960360|NCT02687711|12513302|FG000|Overall Study|Low mood|1
7960361|NCT02687711|12513302|FG000|Overall Study|Side effects|1
7960362|NCT02687711|12513302|FG000|Overall Study|Change of Hospital|1
7960363|NCT02687711|12513302|FG000|Overall Study|Liver Encephalopathy|1
7960364|NCT02687711|12513302|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1
7960365|NCT02687711|12513302|FG000|Overall Study|Withdrawn due to intake interruption|1
7960366|NCT02687711|12513302|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1
7960367|NCT02687711|12513302|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1
7960368|NCT02687711|12513302|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1
7960369|NCT02687815|12513308|FG000|Overall Study|Lost to Follow-up|2
7960370|NCT02687815|12513309|FG001|Overall Study|Lost to Follow-up|4
7960371|NCT02687815|12513308|FG000|Overall Study|Withdrawal by Subject|2
7960372|NCT02687815|12513309|FG001|Overall Study|Withdrawal by Subject|4
7960373|NCT02687919|12513317|FG000|Overall Study|Withdrawal by Subject|6
7960374|NCT02687919|12513318|FG001|Overall Study|Withdrawal by Subject|6
7960375|NCT02687919|12513317|FG000|Overall Study|Protocol Violation|2
7960376|NCT02687919|12513318|FG001|Overall Study|Protocol Violation|0
7960377|NCT02688153|12513326|FG000|Overall Study|Death|7
7960378|NCT02688153|12513327|FG001|Overall Study|Death|5
7960379|NCT02688153|12513326|FG000|Overall Study|Withdrawal by Subject|4
7960380|NCT02688153|12513327|FG001|Overall Study|Withdrawal by Subject|2
7960381|NCT02688153|12513326|FG000|Overall Study|Valve Explant|1
7960382|NCT02688153|12513327|FG001|Overall Study|Valve Explant|0
7960383|NCT02688153|12513326|FG000|Overall Study|Conversion to Commercial Valve|3
7960384|NCT02688153|12513327|FG001|Overall Study|Conversion to Commercial Valve|0
7960385|NCT02688192|12513336|FG000|Overall Study|Lost to Follow-up|11
7960386|NCT02688192|12513337|FG001|Overall Study|Lost to Follow-up|5
7960387|NCT02688192|12513336|FG000|Overall Study|Physician Decision|1
7960388|NCT02688192|12513337|FG001|Overall Study|Physician Decision|0
7960389|NCT02688387|12513357|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960390|NCT02688387|12513358|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960391|NCT02688387|12513359|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1
7960392|NCT02688387|12513360|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960393|NCT02688387|12513361|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960394|NCT02688387|12513362|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960395|NCT02688387|12513363|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960396|NCT02688387|12513364|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960397|NCT02688387|12513365|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960398|NCT02688387|12513366|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960399|NCT02688387|12513367|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960400|NCT02688387|12513368|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960401|NCT02688387|12513369|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960402|NCT02688387|12513370|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960403|NCT02688387|12513371|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960404|NCT02688387|12513372|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960405|NCT02688387|12513373|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960406|NCT02688387|12513374|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960407|NCT02688387|12513375|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960408|NCT02688387|12513376|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960409|NCT02688387|12513377|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960410|NCT02688387|12513378|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7960411|NCT02688387|12513357|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960412|NCT02688387|12513358|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960413|NCT02688387|12513359|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960414|NCT02688387|12513360|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1
7960415|NCT02688387|12513361|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960416|NCT02688387|12513362|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960417|NCT02688387|12513363|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960418|NCT02688387|12513364|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960419|NCT02688387|12513365|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960420|NCT02688387|12513366|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960421|NCT02688387|12513367|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960422|NCT02688387|12513368|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960423|NCT02688387|12513369|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960424|NCT02688387|12513370|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960425|NCT02688387|12513371|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960426|NCT02688387|12513372|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960427|NCT02688387|12513373|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960428|NCT02688387|12513374|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960429|NCT02688387|12513375|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960430|NCT02688387|12513376|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960431|NCT02688387|12513377|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960432|NCT02688387|12513378|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960433|NCT02688387|12513357|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960434|NCT02688387|12513358|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1
7960435|NCT02688387|12513359|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960436|NCT02688387|12513360|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960437|NCT02688387|12513361|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960438|NCT02688387|12513362|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960439|NCT02688387|12513363|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960440|NCT02688387|12513364|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960441|NCT02688387|12513365|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960442|NCT02688387|12513366|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960443|NCT02688387|12513367|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960444|NCT02688387|12513368|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960445|NCT02688387|12513369|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960446|NCT02688387|12513370|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960447|NCT02688387|12513371|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960448|NCT02688387|12513372|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960449|NCT02688387|12513373|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960450|NCT02688387|12513374|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960451|NCT02688387|12513375|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960452|NCT02688387|12513376|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960453|NCT02688387|12513377|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960454|NCT02688387|12513378|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7960455|NCT02688387|12513357|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960456|NCT02688387|12513358|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960457|NCT02688387|12513359|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
7960458|NCT02688387|12513360|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960459|NCT02688387|12513361|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
7960460|NCT02688387|12513362|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960461|NCT02688387|12513363|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960462|NCT02688387|12513364|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960463|NCT02688387|12513365|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960464|NCT02688387|12513366|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960465|NCT02688387|12513367|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960466|NCT02688387|12513368|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960467|NCT02688387|12513369|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960468|NCT02688387|12513370|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960469|NCT02688387|12513371|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960470|NCT02688387|12513372|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960471|NCT02688387|12513373|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960472|NCT02688387|12513374|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960473|NCT02688387|12513375|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960474|NCT02688387|12513376|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960475|NCT02688387|12513377|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960476|NCT02688387|12513378|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7960477|NCT02688387|12513357|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1
7960478|NCT02688387|12513358|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960479|NCT02688387|12513359|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960480|NCT02688387|12513360|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960481|NCT02688387|12513361|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960482|NCT02688387|12513362|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960483|NCT02688387|12513363|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960484|NCT02688387|12513364|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960485|NCT02688387|12513365|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960486|NCT02688387|12513366|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960487|NCT02688387|12513367|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960488|NCT02688387|12513368|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960489|NCT02688387|12513369|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960490|NCT02688387|12513370|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960491|NCT02688387|12513371|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960492|NCT02688387|12513372|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960493|NCT02688387|12513373|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960494|NCT02688387|12513374|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960495|NCT02688387|12513375|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960496|NCT02688387|12513376|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960497|NCT02688387|12513377|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960498|NCT02688387|12513378|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7960499|NCT02688387|12513357|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960500|NCT02688387|12513358|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960501|NCT02688387|12513359|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960502|NCT02688387|12513360|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960503|NCT02688387|12513361|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960504|NCT02688387|12513362|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960505|NCT02688387|12513363|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960506|NCT02688387|12513364|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960507|NCT02688387|12513365|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960508|NCT02688387|12513366|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960509|NCT02688387|12513367|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1
7960510|NCT02688387|12513368|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960511|NCT02688387|12513369|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960512|NCT02688387|12513370|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960513|NCT02688387|12513371|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960514|NCT02688387|12513372|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960515|NCT02688387|12513373|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960516|NCT02688387|12513374|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960517|NCT02688387|12513375|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960518|NCT02688387|12513376|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960519|NCT02688387|12513377|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960520|NCT02688387|12513378|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7960521|NCT02688387|12513357|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960522|NCT02688387|12513358|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960523|NCT02688387|12513359|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960524|NCT02688387|12513360|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960525|NCT02688387|12513361|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960526|NCT02688387|12513362|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960527|NCT02688387|12513363|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960528|NCT02688387|12513364|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960529|NCT02688387|12513365|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960530|NCT02688387|12513366|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960531|NCT02688387|12513367|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960532|NCT02688387|12513368|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960533|NCT02688387|12513369|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960534|NCT02688387|12513370|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960535|NCT02688387|12513371|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1
7960536|NCT02688387|12513372|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960537|NCT02688387|12513373|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960538|NCT02688387|12513374|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960539|NCT02688387|12513375|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960540|NCT02688387|12513376|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960541|NCT02688387|12513377|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960542|NCT02688387|12513378|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7960543|NCT02688387|12513357|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960544|NCT02688387|12513358|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960545|NCT02688387|12513359|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960546|NCT02688387|12513360|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960547|NCT02688387|12513361|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960548|NCT02688387|12513362|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960549|NCT02688387|12513363|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960550|NCT02688387|12513364|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960551|NCT02688387|12513365|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960552|NCT02688387|12513366|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960553|NCT02688387|12513367|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960554|NCT02688387|12513368|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960555|NCT02688387|12513369|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960556|NCT02688387|12513370|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960557|NCT02688387|12513371|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960558|NCT02688387|12513372|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960559|NCT02688387|12513373|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960560|NCT02688387|12513374|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960561|NCT02688387|12513375|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960562|NCT02688387|12513376|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960563|NCT02688387|12513377|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1
7960564|NCT02688387|12513378|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7960565|NCT02688387|12513357|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960566|NCT02688387|12513358|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960567|NCT02688387|12513359|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960568|NCT02688387|12513360|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960569|NCT02688387|12513361|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960570|NCT02688387|12513362|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960571|NCT02688387|12513363|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960572|NCT02688387|12513364|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960573|NCT02688387|12513365|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960574|NCT02688387|12513366|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960575|NCT02688387|12513367|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960576|NCT02688387|12513368|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960577|NCT02688387|12513369|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960578|NCT02688387|12513370|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960579|NCT02688387|12513371|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960580|NCT02688387|12513372|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960581|NCT02688387|12513373|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960582|NCT02688387|12513374|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960583|NCT02688387|12513375|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
7960584|NCT02688387|12513376|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960585|NCT02688387|12513377|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
7960586|NCT02688387|12513378|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7960587|NCT02688387|12513357|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960588|NCT02688387|12513358|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960589|NCT02688387|12513359|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960590|NCT02688387|12513360|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960591|NCT02688387|12513361|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960592|NCT02688387|12513362|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960593|NCT02688387|12513363|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960594|NCT02688387|12513364|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960595|NCT02688387|12513365|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960596|NCT02688387|12513366|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960597|NCT02688387|12513367|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960598|NCT02688387|12513368|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960599|NCT02688387|12513369|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960600|NCT02688387|12513370|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960601|NCT02688387|12513371|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960602|NCT02688387|12513372|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960603|NCT02688387|12513373|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960604|NCT02688387|12513374|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960605|NCT02688387|12513375|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960606|NCT02688387|12513376|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1
7960607|NCT02688387|12513377|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960608|NCT02688387|12513378|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7960609|NCT02688621|12513426|FG000|Overall Study|Pregnancy|1
7960610|NCT02688621|12513427|FG001|Overall Study|Pregnancy|3
7960611|NCT02688621|12513426|FG000|Overall Study|Lost to Follow-up|38
7960612|NCT02688621|12513427|FG001|Overall Study|Lost to Follow-up|15
7960613|NCT02688621|12513426|FG000|Overall Study|Withdrawal by Subject|1
7960614|NCT02688621|12513427|FG001|Overall Study|Withdrawal by Subject|0
7960615|NCT02688764|12513438|FG000|Overall Study|Adverse Event|3
7960616|NCT02688764|12513439|FG001|Overall Study|Adverse Event|3
7960617|NCT02688764|12513438|FG000|Overall Study|AE/Kidney transplant|1
7960618|NCT02688764|12513439|FG001|Overall Study|AE/Kidney transplant|0
7960619|NCT02688764|12513438|FG000|Overall Study|AE/Lack of efficacy|1
7960620|NCT02688764|12513439|FG001|Overall Study|AE/Lack of efficacy|0
7960621|NCT02688764|12513438|FG000|Overall Study|AE/Non-compl.|1
7960622|NCT02688764|12513439|FG001|Overall Study|AE/Non-compl.|0
7960623|NCT02688764|12513438|FG000|Overall Study|AE/Non-compl./Withd. parent|0
7960624|NCT02688764|12513439|FG001|Overall Study|AE/Non-compl./Withd. parent|1
7960625|NCT02688764|12513438|FG000|Overall Study|AE/Other|0
7960626|NCT02688764|12513439|FG001|Overall Study|AE/Other|1
7960627|NCT02688764|12513438|FG000|Overall Study|AE/Physician decision|1
7960628|NCT02688764|12513439|FG001|Overall Study|AE/Physician decision|0
7960629|NCT02688764|12513438|FG000|Overall Study|AE/Withd. parent|3
7960630|NCT02688764|12513439|FG001|Overall Study|AE/Withd. parent|0
7960631|NCT02688764|12513438|FG000|Overall Study|AE/Withd. parent/Withd. subject|1
7960632|NCT02688764|12513439|FG001|Overall Study|AE/Withd. parent/Withd. subject|1
7960633|NCT02688764|12513438|FG000|Overall Study|AE/Withd. subject|1
7960634|NCT02688764|12513439|FG001|Overall Study|AE/Withd. subject|0
7960635|NCT02688764|12513438|FG000|Overall Study|Kidney transplant|10
7960636|NCT02688764|12513439|FG001|Overall Study|Kidney transplant|4
7960637|NCT02688764|12513438|FG000|Overall Study|Lack of Efficacy|3
7960638|NCT02688764|12513439|FG001|Overall Study|Lack of Efficacy|2
7960639|NCT02688764|12513438|FG000|Overall Study|Lack of efficacy/Physician decision|0
7960640|NCT02688764|12513439|FG001|Overall Study|Lack of efficacy/Physician decision|1
7960641|NCT02688764|12513438|FG000|Overall Study|Non-compliance with study drug|4
7960642|NCT02688764|12513439|FG001|Overall Study|Non-compliance with study drug|0
7960643|NCT02688764|12513438|FG000|Overall Study|Non-compl./Physician decision|2
7960644|NCT02688764|12513439|FG001|Overall Study|Non-compl./Physician decision|0
7960645|NCT02688764|12513438|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1
7960646|NCT02688764|12513439|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1
7960647|NCT02688764|12513438|FG000|Overall Study|Non-compl./Withd. subject|0
7960648|NCT02688764|12513439|FG001|Overall Study|Non-compl./Withd. subject|2
7960649|NCT02688764|12513438|FG000|Overall Study|Phosphorus level outside safe range|0
7960650|NCT02688764|12513439|FG001|Overall Study|Phosphorus level outside safe range|1
7960651|NCT02688764|12513438|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1
7960652|NCT02688764|12513439|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0
7960653|NCT02688764|12513438|FG000|Overall Study|Study drug taste/Withd. parent|1
7960654|NCT02688764|12513439|FG001|Overall Study|Study drug taste/Withd. parent|0
7960655|NCT02688764|12513438|FG000|Overall Study|Subject moving out|2
7960656|NCT02688764|12513439|FG001|Overall Study|Subject moving out|0
7960657|NCT02688764|12513438|FG000|Overall Study|Subject taken off dialysis|1
7960658|NCT02688764|12513439|FG001|Overall Study|Subject taken off dialysis|0
7960659|NCT02688764|12513438|FG000|Overall Study|Withdrawal by parent|3
7960660|NCT02688764|12513439|FG001|Overall Study|Withdrawal by parent|0
7960661|NCT02689076|12513480|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172
7960662|NCT02689076|12513481|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213
7960663|NCT02689076|12513482|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0
7960664|NCT02689076|12513480|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3
7960665|NCT02689076|12513481|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1
7960666|NCT02689076|12513482|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0
7960667|NCT02689076|12513480|FG000|Overall Study|Did not have an HIE match|2
7960668|NCT02689076|12513481|FG001|Overall Study|Did not have an HIE match|0
7960669|NCT02689076|12513482|FG002|Overall Study|Did not have an HIE match|0
7960670|NCT02689076|12513480|FG000|Overall Study|Death during non-VA encounter|2
7960671|NCT02689076|12513481|FG001|Overall Study|Death during non-VA encounter|5
7960672|NCT02689076|12513482|FG002|Overall Study|Death during non-VA encounter|0
7960673|NCT02689076|12513480|FG000|Overall Study|Provider declined to participate after participant assignment|1
7960674|NCT02689076|12513481|FG001|Overall Study|Provider declined to participate after participant assignment|1
7960675|NCT02689076|12513482|FG002|Overall Study|Provider declined to participate after participant assignment|0
7960676|NCT02689076|12513480|FG000|Overall Study|Participant no longer active in VA system|1
7960677|NCT02689076|12513481|FG001|Overall Study|Participant no longer active in VA system|0
7960678|NCT02689076|12513482|FG002|Overall Study|Participant no longer active in VA system|0
7960679|NCT02689076|12513480|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0
7960680|NCT02689076|12513481|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2
7960681|NCT02689076|12513482|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0
7960682|NCT02689206|12513499|FG000|Overall Study|Adverse Event|0
7960683|NCT02689206|12513500|FG001|Overall Study|Adverse Event|0
7960684|NCT02689206|12513501|FG002|Overall Study|Adverse Event|1
7960685|NCT02689206|12513502|FG003|Overall Study|Adverse Event|0
7960686|NCT02689206|12513503|FG004|Overall Study|Adverse Event|2
7960687|NCT02689206|12513499|FG000|Overall Study|Protocol Violation|1
7960688|NCT02689206|12513500|FG001|Overall Study|Protocol Violation|0
7960689|NCT02689206|12513501|FG002|Overall Study|Protocol Violation|0
7960690|NCT02689206|12513502|FG003|Overall Study|Protocol Violation|1
7960691|NCT02689206|12513503|FG004|Overall Study|Protocol Violation|2
7960692|NCT02689206|12513499|FG000|Overall Study|Other: Reached stopping criteria|0
7960693|NCT02689206|12513500|FG001|Overall Study|Other: Reached stopping criteria|1
7960694|NCT02689206|12513501|FG002|Overall Study|Other: Reached stopping criteria|2
7960695|NCT02689206|12513502|FG003|Overall Study|Other: Reached stopping criteria|3
7960696|NCT02689206|12513503|FG004|Overall Study|Other: Reached stopping criteria|4
7960697|NCT02689206|12513499|FG000|Overall Study|Physician Decision|1
7960698|NCT02689206|12513500|FG001|Overall Study|Physician Decision|0
7960699|NCT02689206|12513501|FG002|Overall Study|Physician Decision|0
7960700|NCT02689206|12513502|FG003|Overall Study|Physician Decision|0
7960701|NCT02689206|12513503|FG004|Overall Study|Physician Decision|0
7960702|NCT02689206|12513499|FG000|Overall Study|Withdrawal by Subject|1
7960703|NCT02689206|12513500|FG001|Overall Study|Withdrawal by Subject|0
7960704|NCT02689206|12513501|FG002|Overall Study|Withdrawal by Subject|1
7960705|NCT02689206|12513502|FG003|Overall Study|Withdrawal by Subject|0
7960706|NCT02689206|12513503|FG004|Overall Study|Withdrawal by Subject|0
7960707|NCT02689219|12513521|FG000|Overall Study|Death|1
7960708|NCT02689219|12513522|FG001|Overall Study|Death|1
7960709|NCT02689219|12513521|FG000|Overall Study|Disease Progression|10
7960710|NCT02689219|12513522|FG001|Overall Study|Disease Progression|6
7960711|NCT02689492|12513528|FG000|Overall Study|Lost to Follow-up|61
7960712|NCT02689492|12513528|FG000|Overall Study|Withdrawal by Subject|11
7960713|NCT02689492|12513528|FG000|Overall Study|Death|9
7960714|NCT02689492|12513528|FG000|Overall Study|Physician Decision|2
7960715|NCT02689492|12513528|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1
7960716|NCT02689492|12513528|FG000|Overall Study|Withdrawal/ Physician's Decision|1
7960717|NCT02689492|12513528|FG000|Overall Study|Other than listed|1
7960718|NCT02689804|12513537|FG000|Overall Study|Withdrawal by Subject|2
7960719|NCT02689804|12513538|FG001|Overall Study|Withdrawal by Subject|0
7960720|NCT02690194|12513598|FG000|Overall Study|Withdrawal by Subject|1
7960721|NCT02690194|12513599|FG001|Overall Study|Withdrawal by Subject|4
7960722|NCT02690194|12513600|FG002|Overall Study|Withdrawal by Subject|0
7960723|NCT02690207|12513608|FG000|Overall Study|Lost to Follow-up|48
7960724|NCT02690207|12513608|FG000|Overall Study|Withdrawal by Subject|46
7960725|NCT02690207|12513608|FG000|Overall Study|Protocol Violation|2
7960726|NCT02690207|12513608|FG000|Overall Study|Serious adverse event|110
7960727|NCT02690207|12513608|FG000|Overall Study|Non-serious Adverse Event|18
7960728|NCT02690207|12513608|FG000|Overall Study|Migrated/moved from study area|5
7960729|NCT02690207|12513608|FG000|Overall Study|Suspected HZ Episode|1
7960730|NCT02690207|12513608|FG000|Overall Study|Other reasons for withdrawal|23
7960731|NCT02690649|12513618|FG000|Overall Study|Withdrawal by Subject|1
7960732|NCT02690649|12513619|FG001|Overall Study|Withdrawal by Subject|1
7960733|NCT02690649|12513618|FG000|Overall Study|Protocol Violation|0
7960734|NCT02690649|12513619|FG001|Overall Study|Protocol Violation|3
7960735|NCT02690701|12513629|FG000|Treatment Period 1|Adverse Event|2
7960736|NCT02690701|12513630|FG001|Treatment Period 1|Adverse Event|2
7960737|NCT02690701|12513629|FG000|Treatment Period 1|Withdrawal by Subject|0
7960738|NCT02690701|12513630|FG001|Treatment Period 1|Withdrawal by Subject|1
7960739|NCT02690701|12513629|FG000|Treatment Period 2|Adverse Event|2
7960740|NCT02690701|12513630|FG001|Treatment Period 2|Adverse Event|0
7960741|NCT02690701|12513629|FG000|Treatment Period 2|Lack of Efficacy|1
7960742|NCT02690701|12513630|FG001|Treatment Period 2|Lack of Efficacy|0
7960743|NCT02690701|12513629|FG000|Treatment Period 2|Lost to Follow-up|0
7960744|NCT02690701|12513630|FG001|Treatment Period 2|Lost to Follow-up|2
7960745|NCT02690701|12513629|FG000|Treatment Period 2|Withdrawal by Subject|0
7960746|NCT02690701|12513630|FG001|Treatment Period 2|Withdrawal by Subject|2
7960747|NCT02690701|12513629|FG000|Treatment Period 2|Protocol Violation|0
7960748|NCT02690701|12513630|FG001|Treatment Period 2|Protocol Violation|1
7960749|NCT02690714|12513637|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1
7960750|NCT02690714|12513637|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1
7960751|NCT02690727|12513645|FG000|Overall Study|Adverse Event|2
7960752|NCT02690727|12513646|FG001|Overall Study|Adverse Event|2
7960753|NCT02690974|12513672|FG000|Overall Study|Adverse Event|16
7960754|NCT02690974|12513672|FG000|Overall Study|Death|9
7960755|NCT02690974|12513672|FG000|Overall Study|Subject/guardian decision|4
7960756|NCT02690974|12513672|FG000|Overall Study|Lost to Follow-up|3
7960757|NCT02690974|12513672|FG000|Overall Study|Withdrawal of Informed Consent|3
7960758|NCT02690974|12513672|FG000|Overall Study|Physician Decision|2
7960759|NCT02690974|12513672|FG000|Overall Study|Non-compliance with study treatment|1
7960760|NCT02690974|12513672|FG000|Overall Study|Protocol-defined stopping criteria|1
7960761|NCT02690974|12513672|FG000|Overall Study|Protocol Deviation|1
7960762|NCT02691247|12513688|FG000|Overall Study|Withdrawal by Subject|1
7960763|NCT02691247|12513689|FG001|Overall Study|Withdrawal by Subject|2
7960764|NCT02691247|12513690|FG002|Overall Study|Withdrawal by Subject|2
7960765|NCT02691247|12513688|FG000|Overall Study|Lost to Follow-up|2
7960766|NCT02691247|12513689|FG001|Overall Study|Lost to Follow-up|0
7960767|NCT02691247|12513690|FG002|Overall Study|Lost to Follow-up|1
7960768|NCT02691455|12513730|FG000|Overall Study|Withdrawal by Subject|1
7960769|NCT02691455|12513731|FG001|Overall Study|Withdrawal by Subject|2
7960770|NCT02691455|12513730|FG000|Overall Study|Lost to Follow-up|15
7960771|NCT02691455|12513731|FG001|Overall Study|Lost to Follow-up|15
7966751|NCT02757352|12523228|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7966752|NCT02757352|12523229|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7966753|NCT02757352|12523230|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7966754|NCT02757352|12523231|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7966755|NCT02757352|12523222|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7966756|NCT02757352|12523223|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1
7966757|NCT02757352|12523224|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7966758|NCT02757352|12523225|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7966759|NCT02757352|12523226|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7966760|NCT02757352|12523227|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7966761|NCT02757352|12523228|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7966762|NCT02757352|12523229|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7966763|NCT02757352|12523230|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7966764|NCT02757352|12523231|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7966765|NCT02757352|12523222|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
7966766|NCT02757352|12523223|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
7966767|NCT02757352|12523224|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4
7966768|NCT02757352|12523225|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7966769|NCT02757352|12523226|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7966770|NCT02757352|12523227|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7966771|NCT02757352|12523228|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7966772|NCT02757352|12523229|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7966773|NCT02757352|12523230|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7966774|NCT02757352|12523231|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7966775|NCT02757352|12523222|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62
7966776|NCT02757352|12523223|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40
7966777|NCT02757352|12523224|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42
7966778|NCT02757352|12523225|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7966779|NCT02757352|12523226|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7966780|NCT02757352|12523227|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7960772|NCT02691468|12513739|FG000|Overall Study|Bronchial blocker use|2
7960773|NCT02691468|12513740|FG001|Overall Study|Bronchial blocker use|1
7960774|NCT02691468|12513739|FG000|Overall Study|Lost to Follow-up|2
7960775|NCT02691468|12513740|FG001|Overall Study|Lost to Follow-up|1
7960776|NCT02691468|12513739|FG000|Overall Study|Failure to advance FOB|2
7960777|NCT02691468|12513740|FG001|Overall Study|Failure to advance FOB|0
7960778|NCT02691494|12513749|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
7960779|NCT02691494|12513750|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
7960780|NCT02691494|12513751|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
7960781|NCT02691494|12513749|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7960782|NCT02691494|12513750|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7960783|NCT02691494|12513751|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4
7960784|NCT02691494|12513749|FG000|Post-Treatment Follow-Up Period|Other|2
7960785|NCT02691494|12513750|FG001|Post-Treatment Follow-Up Period|Other|1
7960786|NCT02691494|12513751|FG002|Post-Treatment Follow-Up Period|Other|1
7960787|NCT02691494|12513749|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
7960788|NCT02691494|12513750|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
7960789|NCT02691494|12513751|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3
7960790|NCT02691494|12513749|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
7960791|NCT02691494|12513750|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1
7960792|NCT02691494|12513751|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1
7960793|NCT02691507|12513761|FG000|Overall Study|Missed Visit 3|0
7960794|NCT02691507|12513762|FG001|Overall Study|Missed Visit 3|1
7960795|NCT02691572|12513770|FG000|Overall Study|Withdrawal by Subject|1
7960796|NCT02691572|12513771|FG001|Overall Study|Withdrawal by Subject|0
7960797|NCT02691572|12513770|FG000|Overall Study|Protocol Violation|0
7960798|NCT02691572|12513771|FG001|Overall Study|Protocol Violation|1
7960799|NCT02691702|12513788|FG000|Overall Study|Adverse Event|1
7960800|NCT02691702|12513789|FG001|Overall Study|Adverse Event|0
7960801|NCT02691702|12513790|FG002|Overall Study|Adverse Event|0
7960802|NCT02691702|12513791|FG003|Overall Study|Adverse Event|0
7960803|NCT02691702|12513792|FG004|Overall Study|Adverse Event|0
7960804|NCT02691702|12513793|FG005|Overall Study|Adverse Event|0
7960805|NCT02691702|12513794|FG006|Overall Study|Adverse Event|0
7960806|NCT02691702|12513795|FG007|Overall Study|Adverse Event|0
7960807|NCT02691702|12513796|FG008|Overall Study|Adverse Event|1
7960808|NCT02691702|12513797|FG009|Overall Study|Adverse Event|0
7960809|NCT02691702|12513798|FG010|Overall Study|Adverse Event|1
7960810|NCT02691702|12513788|FG000|Overall Study|Lost to Follow-up|0
7960811|NCT02691702|12513789|FG001|Overall Study|Lost to Follow-up|0
7960812|NCT02691702|12513790|FG002|Overall Study|Lost to Follow-up|1
7960813|NCT02691702|12513791|FG003|Overall Study|Lost to Follow-up|0
7960814|NCT02691702|12513792|FG004|Overall Study|Lost to Follow-up|0
7960815|NCT02691702|12513793|FG005|Overall Study|Lost to Follow-up|2
7960816|NCT02691702|12513794|FG006|Overall Study|Lost to Follow-up|0
7960817|NCT02691702|12513795|FG007|Overall Study|Lost to Follow-up|0
7960818|NCT02691702|12513796|FG008|Overall Study|Lost to Follow-up|0
7960819|NCT02691702|12513797|FG009|Overall Study|Lost to Follow-up|0
7960820|NCT02691702|12513798|FG010|Overall Study|Lost to Follow-up|1
7960821|NCT02691702|12513788|FG000|Overall Study|Withdrawal by Subject|1
7960822|NCT02691702|12513789|FG001|Overall Study|Withdrawal by Subject|1
7960823|NCT02691702|12513790|FG002|Overall Study|Withdrawal by Subject|0
7960824|NCT02691702|12513791|FG003|Overall Study|Withdrawal by Subject|0
7960825|NCT02691702|12513792|FG004|Overall Study|Withdrawal by Subject|0
7960826|NCT02691702|12513793|FG005|Overall Study|Withdrawal by Subject|1
7960827|NCT02691702|12513794|FG006|Overall Study|Withdrawal by Subject|2
7960828|NCT02691702|12513795|FG007|Overall Study|Withdrawal by Subject|0
7960829|NCT02691702|12513796|FG008|Overall Study|Withdrawal by Subject|0
7960830|NCT02691702|12513797|FG009|Overall Study|Withdrawal by Subject|0
7960831|NCT02691702|12513798|FG010|Overall Study|Withdrawal by Subject|0
7960832|NCT02691702|12513788|FG000|Overall Study|Other|0
7960833|NCT02691702|12513789|FG001|Overall Study|Other|0
7960834|NCT02691702|12513790|FG002|Overall Study|Other|0
7960835|NCT02691702|12513791|FG003|Overall Study|Other|0
7960836|NCT02691702|12513792|FG004|Overall Study|Other|0
7960837|NCT02691702|12513793|FG005|Overall Study|Other|0
7960838|NCT02691702|12513794|FG006|Overall Study|Other|1
7960839|NCT02691702|12513795|FG007|Overall Study|Other|0
7960840|NCT02691702|12513796|FG008|Overall Study|Other|1
7960841|NCT02691702|12513797|FG009|Overall Study|Other|0
7960842|NCT02691702|12513798|FG010|Overall Study|Other|0
7960843|NCT02691702|12513788|FG000|Overall Study|Protocol Violation|0
7960844|NCT02691702|12513789|FG001|Overall Study|Protocol Violation|0
7960845|NCT02691702|12513790|FG002|Overall Study|Protocol Violation|0
7960846|NCT02691702|12513791|FG003|Overall Study|Protocol Violation|0
7960847|NCT02691702|12513792|FG004|Overall Study|Protocol Violation|0
7960848|NCT02691702|12513793|FG005|Overall Study|Protocol Violation|0
7960849|NCT02691702|12513794|FG006|Overall Study|Protocol Violation|0
7960850|NCT02691702|12513795|FG007|Overall Study|Protocol Violation|0
7960851|NCT02691702|12513796|FG008|Overall Study|Protocol Violation|0
7960852|NCT02691702|12513797|FG009|Overall Study|Protocol Violation|2
7960853|NCT02691702|12513798|FG010|Overall Study|Protocol Violation|0
7960854|NCT02691741|12513832|FG000|Overall Study|Adverse Event|0
7960855|NCT02691741|12513833|FG001|Overall Study|Adverse Event|2
7960856|NCT02691741|12513832|FG000|Overall Study|Lost to Follow-up|1
7960857|NCT02691741|12513833|FG001|Overall Study|Lost to Follow-up|0
7960858|NCT02691741|12513832|FG000|Overall Study|Physician Decision|0
7960859|NCT02691741|12513833|FG001|Overall Study|Physician Decision|1
7960860|NCT02691741|12513832|FG000|Overall Study|Withdrawal by Subject|0
7960861|NCT02691741|12513833|FG001|Overall Study|Withdrawal by Subject|4
7960862|NCT02691936|12513846|FG000|Overall Study|Withdrawal by Subject|2
7960863|NCT02691936|12513847|FG001|Overall Study|Withdrawal by Subject|5
7960864|NCT02692040|12513875|FG000|Overall Study|Protocol Violation|0
7960865|NCT02692040|12513876|FG001|Overall Study|Protocol Violation|0
7721027|NCT00542425|12145526|FG003|Initial 24 Weeks|Non-compliance|1
7721028|NCT00542425|12145527|FG004|Initial 24 Weeks|Non-compliance|1
7721029|NCT00542425|12145523|FG000|Initial 24 Weeks|Protocol Violation|0
7721030|NCT00542425|12145524|FG001|Initial 24 Weeks|Protocol Violation|0
7721031|NCT00542425|12145525|FG002|Initial 24 Weeks|Protocol Violation|0
7721032|NCT00542425|12145526|FG003|Initial 24 Weeks|Protocol Violation|1
7721033|NCT00542425|12145527|FG004|Initial 24 Weeks|Protocol Violation|0
7721034|NCT00542425|12145523|FG000|Initial 24 Weeks|Refusal of treatment|2
7721035|NCT00542425|12145524|FG001|Initial 24 Weeks|Refusal of treatment|2
7721036|NCT00542425|12145525|FG002|Initial 24 Weeks|Refusal of treatment|1
7721037|NCT00542425|12145526|FG003|Initial 24 Weeks|Refusal of treatment|4
7960866|NCT02692040|12513877|FG002|Overall Study|Protocol Violation|0
7960867|NCT02692040|12513878|FG003|Overall Study|Protocol Violation|0
7960868|NCT02692040|12513879|FG004|Overall Study|Protocol Violation|0
7960869|NCT02692040|12513880|FG005|Overall Study|Protocol Violation|0
7960870|NCT02692040|12513881|FG006|Overall Study|Protocol Violation|0
7960871|NCT02692040|12513882|FG007|Overall Study|Protocol Violation|0
7960872|NCT02692040|12513883|FG008|Overall Study|Protocol Violation|0
7960873|NCT02692040|12513884|FG009|Overall Study|Protocol Violation|0
7960874|NCT02692040|12513885|FG010|Overall Study|Protocol Violation|0
7960875|NCT02692040|12513886|FG011|Overall Study|Protocol Violation|0
7960876|NCT02692040|12513887|FG012|Overall Study|Protocol Violation|1
7960877|NCT02692040|12513888|FG013|Overall Study|Protocol Violation|0
7960878|NCT02692040|12513889|FG014|Overall Study|Protocol Violation|0
7960879|NCT02692040|12513890|FG015|Overall Study|Protocol Violation|0
7960880|NCT02692040|12513891|FG016|Overall Study|Protocol Violation|0
7960881|NCT02692040|12513875|FG000|Overall Study|Adverse Event|0
7960882|NCT02692040|12513876|FG001|Overall Study|Adverse Event|0
7960883|NCT02692040|12513877|FG002|Overall Study|Adverse Event|0
7960884|NCT02692040|12513878|FG003|Overall Study|Adverse Event|0
7960885|NCT02692040|12513879|FG004|Overall Study|Adverse Event|0
7960886|NCT02692040|12513880|FG005|Overall Study|Adverse Event|0
7960887|NCT02692040|12513881|FG006|Overall Study|Adverse Event|0
7960888|NCT02692040|12513882|FG007|Overall Study|Adverse Event|0
7960889|NCT02692040|12513883|FG008|Overall Study|Adverse Event|0
7960890|NCT02692040|12513884|FG009|Overall Study|Adverse Event|0
7960891|NCT02692040|12513885|FG010|Overall Study|Adverse Event|0
7960892|NCT02692040|12513886|FG011|Overall Study|Adverse Event|0
7960893|NCT02692040|12513887|FG012|Overall Study|Adverse Event|0
7960894|NCT02692040|12513888|FG013|Overall Study|Adverse Event|3
7960895|NCT02692040|12513889|FG014|Overall Study|Adverse Event|1
7960896|NCT02692040|12513890|FG015|Overall Study|Adverse Event|1
7960897|NCT02692040|12513891|FG016|Overall Study|Adverse Event|0
7960898|NCT02692235|12513976|FG000|Overall Study|Withdrawal by Subject|2
7960899|NCT02692235|12513977|FG001|Overall Study|Withdrawal by Subject|1
7960900|NCT02692235|12513976|FG000|Overall Study|Adverse Event|1
7960901|NCT02692235|12513977|FG001|Overall Study|Adverse Event|2
7960902|NCT02692417|12513994|FG000|Overall Study|Withdrawal by Subject|5
7960903|NCT02692417|12513995|FG001|Overall Study|Withdrawal by Subject|1
7960904|NCT02692417|12513994|FG000|Overall Study|Adverse Event|1
7960905|NCT02692417|12513995|FG001|Overall Study|Adverse Event|0
7960906|NCT02692482|12514003|FG000|Overall Study|Death|2
7960907|NCT02692482|12514004|FG001|Overall Study|Death|2
7960908|NCT02692482|12514003|FG000|Overall Study|Withdrawal by Subject|1
7960909|NCT02692482|12514004|FG001|Overall Study|Withdrawal by Subject|2
7960910|NCT02692560|12514026|FG000|Overall Study|Withdrawal by Subject|0
7960911|NCT02692560|12514027|FG001|Overall Study|Withdrawal by Subject|6
7960912|NCT02692586|12514033|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1
7960913|NCT02692586|12514033|FG000|Overall Study|Received adjunctive thrombolytics|2
7960914|NCT02692703|12514037|FG000|Overall Study|Lost to Follow-up|1
7960915|NCT02692703|12514037|FG000|Overall Study|Other|1
7960916|NCT02693106|12514055|FG000|Overall Study|No time|3
7960917|NCT02693119|12514067|FG000|Open-Label Period|Withdrawal by Subject|0
7960918|NCT02693119|12514068|FG001|Open-Label Period|Withdrawal by Subject|1
7960919|NCT02693418|12514129|FG000|Overall Study|Lost to Follow-up|1
7960920|NCT02693418|12514130|FG001|Overall Study|Lost to Follow-up|2
7960921|NCT02693418|12514131|FG002|Overall Study|Lost to Follow-up|0
7960922|NCT02693418|12514132|FG003|Overall Study|Lost to Follow-up|0
7960923|NCT02693418|12514133|FG004|Overall Study|Lost to Follow-up|0
7960924|NCT02693418|12514129|FG000|Overall Study|Menses during study period|0
7960925|NCT02693418|12514130|FG001|Overall Study|Menses during study period|0
7721038|NCT00542425|12145527|FG004|Initial 24 Weeks|Refusal of treatment|1
7721039|NCT00542425|12145523|FG000|Initial 24 Weeks|Other|0
7721040|NCT00542425|12145524|FG001|Initial 24 Weeks|Other|2
7721041|NCT00542425|12145525|FG002|Initial 24 Weeks|Other|1
7721042|NCT00542425|12145526|FG003|Initial 24 Weeks|Other|0
7721043|NCT00542425|12145527|FG004|Initial 24 Weeks|Other|0
7721044|NCT00542425|12145523|FG000|Extended 24 Weeks of Treatment|Adverse Event|0
7721045|NCT00542425|12145524|FG001|Extended 24 Weeks of Treatment|Adverse Event|0
7721046|NCT00542425|12145525|FG002|Extended 24 Weeks of Treatment|Adverse Event|1
7721047|NCT00542425|12145526|FG003|Extended 24 Weeks of Treatment|Adverse Event|1
7721048|NCT00542425|12145527|FG004|Extended 24 Weeks of Treatment|Adverse Event|0
7721049|NCT00542425|12145523|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0
7721050|NCT00542425|12145524|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0
7721051|NCT00542425|12145525|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1
7721052|NCT00542425|12145526|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0
7721053|NCT00542425|12145527|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0
7721054|NCT00542425|12145523|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0
7721055|NCT00542425|12145524|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1
7721056|NCT00542425|12145525|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0
7721057|NCT00542425|12145526|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0
7721058|NCT00542425|12145527|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0
7721059|NCT00542425|12145523|FG000|Extended 24 Weeks of Treatment|Other|1
7721060|NCT00542425|12145524|FG001|Extended 24 Weeks of Treatment|Other|1
7721061|NCT00542425|12145525|FG002|Extended 24 Weeks of Treatment|Other|0
7721062|NCT00542425|12145526|FG003|Extended 24 Weeks of Treatment|Other|0
7721063|NCT00542425|12145527|FG004|Extended 24 Weeks of Treatment|Other|1
7721064|NCT00542789|12145558|FG000|Overall Study|Adverse Event|18
7721065|NCT00542789|12145559|FG001|Overall Study|Adverse Event|17
7721066|NCT00542789|12145558|FG000|Overall Study|Withdrawal by Subject|7
7721067|NCT00542789|12145559|FG001|Overall Study|Withdrawal by Subject|3
7721068|NCT00542789|12145558|FG000|Overall Study|Protocol Violation|8
7721069|NCT00542789|12145559|FG001|Overall Study|Protocol Violation|1
7721070|NCT00542789|12145558|FG000|Overall Study|Recurrence of Gastric Ulcer|8
7721071|NCT00542789|12145559|FG001|Overall Study|Recurrence of Gastric Ulcer|57
7721072|NCT00542815|12145568|FG000|Overall Study|Adverse Event|19
7721073|NCT00542815|12145569|FG001|Overall Study|Adverse Event|6
7721074|NCT00542815|12145570|FG002|Overall Study|Adverse Event|9
7721075|NCT00542815|12145568|FG000|Overall Study|Death|10
7721076|NCT00542815|12145569|FG001|Overall Study|Death|7
7960926|NCT02693418|12514131|FG002|Overall Study|Menses during study period|2
7960927|NCT02693418|12514132|FG003|Overall Study|Menses during study period|0
7960928|NCT02693418|12514133|FG004|Overall Study|Menses during study period|0
7960929|NCT02693834|12514162|FG000|Baseline Measurement|Withdrawal by Subject|1
7960930|NCT02693834|12514163|FG001|Baseline Measurement|Withdrawal by Subject|0
7960931|NCT02693834|12514162|FG000|Baseline Measurement|Adverse Event|1
7960932|NCT02693834|12514163|FG001|Baseline Measurement|Adverse Event|0
7721077|NCT00542815|12145570|FG002|Overall Study|Death|3
7721078|NCT00542815|12145568|FG000|Overall Study|Lack of Efficacy|9
7721079|NCT00542815|12145569|FG001|Overall Study|Lack of Efficacy|2
7721080|NCT00542815|12145570|FG002|Overall Study|Lack of Efficacy|0
7960933|NCT02693834|12514162|FG000|Week 2 Practice|Adverse Event|0
7960934|NCT02693834|12514163|FG001|Week 2 Practice|Adverse Event|1
7960935|NCT02694328|12514192|FG000|Overall Study|Adverse Event|27
7960936|NCT02694328|12514193|FG001|Overall Study|Adverse Event|33
7960937|NCT02694328|12514192|FG000|Overall Study|Withdrawal by Subject|27
7960938|NCT02694328|12514193|FG001|Overall Study|Withdrawal by Subject|23
7960939|NCT02694328|12514192|FG000|Overall Study|Lost to Follow-up|26
7960940|NCT02694328|12514193|FG001|Overall Study|Lost to Follow-up|22
7960941|NCT02694328|12514192|FG000|Overall Study|Noncompliant with study drug|11
7960942|NCT02694328|12514193|FG001|Overall Study|Noncompliant with study drug|8
7960943|NCT02694328|12514192|FG000|Overall Study|Incarceration|1
7960944|NCT02694328|12514193|FG001|Overall Study|Incarceration|1
7960945|NCT02694328|12514192|FG000|Overall Study|Lack of Efficacy|1
7960946|NCT02694328|12514193|FG001|Overall Study|Lack of Efficacy|2
7960947|NCT02694328|12514192|FG000|Overall Study|Pregnancy|1
7960948|NCT02694328|12514193|FG001|Overall Study|Pregnancy|1
7960949|NCT02694328|12514192|FG000|Overall Study|Protocol Violation|6
7960950|NCT02694328|12514193|FG001|Overall Study|Protocol Violation|5
7960951|NCT02694328|12514192|FG000|Overall Study|Abnormal Laboratory Value|0
7960952|NCT02694328|12514193|FG001|Overall Study|Abnormal Laboratory Value|3
7960953|NCT02694523|12514205|FG000|Part A|Adverse Event|7
7721081|NCT00542815|12145568|FG000|Overall Study|Physician Decision|2
7721082|NCT00542815|12145569|FG001|Overall Study|Physician Decision|1
7721083|NCT00542815|12145570|FG002|Overall Study|Physician Decision|0
7721084|NCT00542815|12145568|FG000|Overall Study|Protocol Violation|1
7721085|NCT00542815|12145569|FG001|Overall Study|Protocol Violation|1
7721086|NCT00542815|12145570|FG002|Overall Study|Protocol Violation|2
7721087|NCT00542815|12145568|FG000|Overall Study|Withdrawal by Subject|41
7721088|NCT00542815|12145569|FG001|Overall Study|Withdrawal by Subject|5
7721089|NCT00542815|12145570|FG002|Overall Study|Withdrawal by Subject|8
7721090|NCT00542815|12145568|FG000|Overall Study|Other reasons|24
7721091|NCT00542815|12145569|FG001|Overall Study|Other reasons|10
7721092|NCT00542815|12145570|FG002|Overall Study|Other reasons|10
7721093|NCT00542828|12145578|FG000|Overall Study|Physician Decision|1
7721094|NCT00542828|12145578|FG000|Overall Study|Need for Prohibited Treatment|3
7721095|NCT00542828|12145578|FG000|Overall Study|Study Prematurely Discontinued|7
7721096|NCT00542828|12145578|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2
7721097|NCT00542880|12145584|FG000|Period 1|Eligibility criteria not fulfilled|2
7721098|NCT00542880|12145585|FG001|Period 1|Eligibility criteria not fulfilled|6
7721099|NCT00542880|12145584|FG000|Period 1|Adverse Event|2
7721100|NCT00542880|12145585|FG001|Period 1|Adverse Event|2
7721101|NCT00542880|12145584|FG000|Period 1|Development of study-specific criteria|1
7721102|NCT00542880|12145585|FG001|Period 1|Development of study-specific criteria|2
7721103|NCT00542880|12145584|FG000|Period 1|Withdrawal by Subject|1
7721104|NCT00542880|12145585|FG001|Period 1|Withdrawal by Subject|1
7721105|NCT00542880|12145584|FG000|Period 1|Protocol Violation|0
7721106|NCT00542880|12145585|FG001|Period 1|Protocol Violation|1
7721107|NCT00542880|12145584|FG000|Period 2|Adverse Event|5
7721108|NCT00542880|12145585|FG001|Period 2|Adverse Event|7
7721109|NCT00542880|12145584|FG000|Period 2|Eligibility not fulfilled|0
7721110|NCT00542880|12145585|FG001|Period 2|Eligibility not fulfilled|1
7721111|NCT00542880|12145584|FG000|Period 2|Discontinuation criteria|2
7721112|NCT00542880|12145585|FG001|Period 2|Discontinuation criteria|0
7721113|NCT00542880|12145584|FG000|Period 2|Severe non-compliance|0
7721114|NCT00542880|12145585|FG001|Period 2|Severe non-compliance|1
7721115|NCT00542880|12145584|FG000|Period 2|Other|0
7721116|NCT00542880|12145585|FG001|Period 2|Other|1
7721117|NCT00542880|12145584|FG000|Period 3|Adverse Event|0
7721118|NCT00542880|12145585|FG001|Period 3|Adverse Event|2
7721119|NCT00542919|12145595|FG000|Overall Study|Adverse Event|1
7721120|NCT00542919|12145596|FG001|Overall Study|Adverse Event|5
7721121|NCT00542919|12145597|FG002|Overall Study|Adverse Event|1
7721122|NCT00542919|12145595|FG000|Overall Study|Withdrawal by Subject|1
7721123|NCT00542919|12145596|FG001|Overall Study|Withdrawal by Subject|0
7721124|NCT00542919|12145597|FG002|Overall Study|Withdrawal by Subject|3
7721125|NCT00542919|12145595|FG000|Overall Study|Physician Decision|2
7721126|NCT00542919|12145596|FG001|Overall Study|Physician Decision|2
7721127|NCT00542919|12145597|FG002|Overall Study|Physician Decision|1
7721128|NCT00542919|12145595|FG000|Overall Study|Sponsor Decision|1
7721129|NCT00542919|12145596|FG001|Overall Study|Sponsor Decision|0
7721130|NCT00542919|12145597|FG002|Overall Study|Sponsor Decision|0
7721131|NCT00542919|12145595|FG000|Overall Study|Lost to Follow-up|2
7721132|NCT00542919|12145596|FG001|Overall Study|Lost to Follow-up|0
7721133|NCT00542919|12145597|FG002|Overall Study|Lost to Follow-up|1
7721134|NCT00542997|12145624|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2
7721135|NCT00542997|12145624|FG000|Wash in / Wash Out Period|Adverse Event|3
7721136|NCT00542997|12145624|FG000|Efficacy Period|Adverse Event|3
7960954|NCT02694523|12514206|FG001|Part A|Adverse Event|3
7960955|NCT02694523|12514207|FG002|Part A|Adverse Event|0
7960956|NCT02694523|12514208|FG003|Part A|Adverse Event|0
7960957|NCT02694523|12514209|FG004|Part A|Adverse Event|0
7960958|NCT02694523|12514210|FG005|Part A|Adverse Event|0
7721137|NCT00543062|12145631|FG000|Overall Study|Withdrawal by Subject|1
7721138|NCT00543062|12145632|FG001|Overall Study|Withdrawal by Subject|0
7721139|NCT00543062|12145633|FG002|Overall Study|Withdrawal by Subject|2
7721140|NCT00543062|12145634|FG003|Overall Study|Withdrawal by Subject|0
7721141|NCT00543062|12145631|FG000|Overall Study|Adverse Event|0
7721142|NCT00543062|12145632|FG001|Overall Study|Adverse Event|1
7721143|NCT00543062|12145633|FG002|Overall Study|Adverse Event|1
7721144|NCT00543062|12145634|FG003|Overall Study|Adverse Event|1
7721145|NCT00543062|12145631|FG000|Overall Study|Protocol Violation|1
7721146|NCT00543062|12145632|FG001|Overall Study|Protocol Violation|0
7721147|NCT00543062|12145633|FG002|Overall Study|Protocol Violation|0
7721148|NCT00543062|12145634|FG003|Overall Study|Protocol Violation|0
7721149|NCT00543140|12145671|FG000|Overall Study|Lost to Follow-up|33
7721150|NCT00543140|12145671|FG000|Overall Study|Withdrawal by Subject|13
7721151|NCT00543140|12145671|FG000|Overall Study|Protocol Violation|10
7721152|NCT00543140|12145671|FG000|Overall Study|Insufficient weight loss|10
7721153|NCT00543140|12145671|FG000|Overall Study|SAE leading to explant of SAGB|3
7721154|NCT00543140|12145671|FG000|Overall Study|Death|1
7721155|NCT00543140|12145671|FG000|Overall Study|Subject moved|1
7721156|NCT00543140|12145671|FG000|Overall Study|Conversion to different procedure|1
7721157|NCT00543296|12145675|FG000|Overall Study|Physician Decision|7
7721158|NCT00543309|12145682|FG000|Overall Study|Physician Decision|0
7721159|NCT00543309|12145683|FG001|Overall Study|Physician Decision|1
7721160|NCT00543309|12145684|FG002|Overall Study|Physician Decision|0
7721161|NCT00543387|12145702|FG000|Panel 1 + Panel 2|Adverse Event|0
7721162|NCT00543387|12145703|FG001|Panel 1 + Panel 2|Adverse Event|1
7721163|NCT00543387|12145704|FG002|Panel 1 + Panel 2|Adverse Event|0
7721164|NCT00543387|12145705|FG003|Panel 1 + Panel 2|Adverse Event|0
7721165|NCT00543387|12145706|FG004|Panel 1 + Panel 2|Adverse Event|0
7721166|NCT00543387|12145707|FG005|Panel 1 + Panel 2|Adverse Event|0
7721167|NCT00543387|12145708|FG006|Panel 1 + Panel 2|Adverse Event|0
7721168|NCT00543387|12145709|FG007|Panel 1 + Panel 2|Adverse Event|1
7721169|NCT00543387|12145710|FG008|Panel 1 + Panel 2|Adverse Event|1
7721170|NCT00543387|12145711|FG009|Panel 1 + Panel 2|Adverse Event|0
7721171|NCT00543387|12145712|FG010|Panel 1 + Panel 2|Adverse Event|0
7721172|NCT00543387|12145702|FG000|Panel 1 + Panel 2|Physician Decision|0
7721173|NCT00543387|12145703|FG001|Panel 1 + Panel 2|Physician Decision|0
7721174|NCT00543387|12145704|FG002|Panel 1 + Panel 2|Physician Decision|1
7721175|NCT00543387|12145705|FG003|Panel 1 + Panel 2|Physician Decision|0
7721176|NCT00543387|12145706|FG004|Panel 1 + Panel 2|Physician Decision|0
7721177|NCT00543387|12145707|FG005|Panel 1 + Panel 2|Physician Decision|0
7721178|NCT00543387|12145708|FG006|Panel 1 + Panel 2|Physician Decision|0
7721179|NCT00543387|12145709|FG007|Panel 1 + Panel 2|Physician Decision|1
7721180|NCT00543387|12145710|FG008|Panel 1 + Panel 2|Physician Decision|0
7721181|NCT00543387|12145711|FG009|Panel 1 + Panel 2|Physician Decision|0
7721182|NCT00543387|12145712|FG010|Panel 1 + Panel 2|Physician Decision|0
7721183|NCT00543387|12145702|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3
7721184|NCT00543387|12145703|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2
7960959|NCT02694523|12514211|FG006|Part A|Adverse Event|0
7960960|NCT02694523|12514205|FG000|Part A|Protocol Violation|1
7721185|NCT00543387|12145704|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2
7721186|NCT00543387|12145705|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3
7721187|NCT00543387|12145706|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3
7721188|NCT00543387|12145707|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3
7721189|NCT00543387|12145708|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5
7721190|NCT00543387|12145709|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4
7721191|NCT00543387|12145710|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4
7721192|NCT00543387|12145711|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0
7721193|NCT00543387|12145712|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0
7721194|NCT00543387|12145702|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0
7721195|NCT00543387|12145703|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0
7721196|NCT00543387|12145704|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0
7721197|NCT00543387|12145705|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0
7721198|NCT00543387|12145706|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0
7721199|NCT00543387|12145707|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0
7721200|NCT00543387|12145708|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1
7721201|NCT00543387|12145709|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0
7721202|NCT00543387|12145710|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0
7721203|NCT00543387|12145711|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0
7721204|NCT00543387|12145712|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0
7721205|NCT00543387|12145702|FG000|Crossover Participants|Progressive Disease|0
7721206|NCT00543387|12145703|FG001|Crossover Participants|Progressive Disease|0
7721207|NCT00543387|12145704|FG002|Crossover Participants|Progressive Disease|0
7721208|NCT00543387|12145705|FG003|Crossover Participants|Progressive Disease|0
7721209|NCT00543387|12145706|FG004|Crossover Participants|Progressive Disease|0
7721210|NCT00543387|12145707|FG005|Crossover Participants|Progressive Disease|0
7721211|NCT00543387|12145708|FG006|Crossover Participants|Progressive Disease|0
7721212|NCT00543387|12145709|FG007|Crossover Participants|Progressive Disease|0
7721213|NCT00543387|12145710|FG008|Crossover Participants|Progressive Disease|0
7721214|NCT00543387|12145711|FG009|Crossover Participants|Progressive Disease|1
7721215|NCT00543387|12145712|FG010|Crossover Participants|Progressive Disease|2
7721216|NCT00543387|12145702|FG000|Crossover Participants|Study Terminated by Sponsor|0
7721217|NCT00543387|12145703|FG001|Crossover Participants|Study Terminated by Sponsor|0
7721218|NCT00543387|12145704|FG002|Crossover Participants|Study Terminated by Sponsor|0
7721219|NCT00543387|12145705|FG003|Crossover Participants|Study Terminated by Sponsor|0
7721220|NCT00543387|12145706|FG004|Crossover Participants|Study Terminated by Sponsor|0
7721221|NCT00543387|12145707|FG005|Crossover Participants|Study Terminated by Sponsor|0
7721222|NCT00543387|12145708|FG006|Crossover Participants|Study Terminated by Sponsor|0
7721223|NCT00543387|12145709|FG007|Crossover Participants|Study Terminated by Sponsor|0
7721224|NCT00543387|12145710|FG008|Crossover Participants|Study Terminated by Sponsor|0
7721225|NCT00543387|12145711|FG009|Crossover Participants|Study Terminated by Sponsor|0
7721226|NCT00543387|12145712|FG010|Crossover Participants|Study Terminated by Sponsor|1
7721227|NCT00543439|12145756|FG000|Period 1|Adverse Event|0
7721228|NCT00543439|12145757|FG001|Period 1|Adverse Event|2
7721229|NCT00543439|12145758|FG002|Period 1|Adverse Event|1
7721230|NCT00543439|12145756|FG000|Period 1|Withdrawal by Subject|1
7721231|NCT00543439|12145757|FG001|Period 1|Withdrawal by Subject|1
7960961|NCT02694523|12514206|FG001|Part A|Protocol Violation|0
7960962|NCT02694523|12514207|FG002|Part A|Protocol Violation|0
7960963|NCT02694523|12514208|FG003|Part A|Protocol Violation|0
7960964|NCT02694523|12514209|FG004|Part A|Protocol Violation|0
7960965|NCT02694523|12514210|FG005|Part A|Protocol Violation|0
7960966|NCT02694523|12514211|FG006|Part A|Protocol Violation|0
7721232|NCT00543439|12145758|FG002|Period 1|Withdrawal by Subject|0
7721233|NCT00543439|12145756|FG000|Period 1|Physician Decision|0
7721234|NCT00543439|12145757|FG001|Period 1|Physician Decision|0
7721235|NCT00543439|12145758|FG002|Period 1|Physician Decision|1
7721236|NCT00543439|12145756|FG000|Period 2|Protocol Violation|1
7721237|NCT00543439|12145757|FG001|Period 2|Protocol Violation|0
7721238|NCT00543439|12145758|FG002|Period 2|Protocol Violation|1
7721239|NCT00543439|12145756|FG000|Period 2|Adverse Event|0
7721240|NCT00543439|12145757|FG001|Period 2|Adverse Event|1
7721241|NCT00543439|12145758|FG002|Period 2|Adverse Event|1
7721242|NCT00543543|12145779|FG000|Base Study|Adverse Event|1
7721243|NCT00543543|12145780|FG001|Base Study|Adverse Event|11
7721244|NCT00543543|12145781|FG002|Base Study|Adverse Event|0
7721245|NCT00543543|12145782|FG003|Base Study|Adverse Event|5
7721246|NCT00543543|12145779|FG000|Base Study|Lost to Follow-up|12
7721247|NCT00543543|12145780|FG001|Base Study|Lost to Follow-up|749
7721248|NCT00543543|12145781|FG002|Base Study|Lost to Follow-up|9
7721249|NCT00543543|12145782|FG003|Base Study|Lost to Follow-up|701
7721250|NCT00543543|12145779|FG000|Base Study|Physician Decision|0
7721251|NCT00543543|12145780|FG001|Base Study|Physician Decision|4
7721252|NCT00543543|12145781|FG002|Base Study|Physician Decision|0
7721253|NCT00543543|12145782|FG003|Base Study|Physician Decision|7
7721254|NCT00543543|12145779|FG000|Base Study|Protocol Violation|0
7721255|NCT00543543|12145780|FG001|Base Study|Protocol Violation|6
7721256|NCT00543543|12145781|FG002|Base Study|Protocol Violation|0
7960967|NCT02694523|12514205|FG000|Part A|Lost to Follow-up|1
7960968|NCT02694523|12514206|FG001|Part A|Lost to Follow-up|2
7721257|NCT00543543|12145782|FG003|Base Study|Protocol Violation|6
7721258|NCT00543543|12145779|FG000|Base Study|Withdrawal by Subject|7
7721259|NCT00543543|12145780|FG001|Base Study|Withdrawal by Subject|482
7721260|NCT00543543|12145781|FG002|Base Study|Withdrawal by Subject|5
7721261|NCT00543543|12145782|FG003|Base Study|Withdrawal by Subject|503
7721262|NCT00543543|12145779|FG000|Extension Study|Adverse Event|0
7721263|NCT00543543|12145780|FG001|Extension Study|Adverse Event|0
7721264|NCT00543543|12145781|FG002|Extension Study|Adverse Event|0
7721265|NCT00543543|12145782|FG003|Extension Study|Adverse Event|5
7721266|NCT00543543|12145779|FG000|Extension Study|Lost to Follow-up|0
7721267|NCT00543543|12145780|FG001|Extension Study|Lost to Follow-up|0
7721268|NCT00543543|12145781|FG002|Extension Study|Lost to Follow-up|0
7721269|NCT00543543|12145782|FG003|Extension Study|Lost to Follow-up|77
7721270|NCT00543543|12145779|FG000|Extension Study|Physician Decision|0
7721271|NCT00543543|12145780|FG001|Extension Study|Physician Decision|0
7721272|NCT00543543|12145781|FG002|Extension Study|Physician Decision|0
7721273|NCT00543543|12145782|FG003|Extension Study|Physician Decision|7
7721274|NCT00543543|12145779|FG000|Extension Study|Pregnancy|0
7721275|NCT00543543|12145780|FG001|Extension Study|Pregnancy|0
7721276|NCT00543543|12145781|FG002|Extension Study|Pregnancy|0
7960969|NCT02694523|12514207|FG002|Part A|Lost to Follow-up|0
7960970|NCT02694523|12514208|FG003|Part A|Lost to Follow-up|0
7960971|NCT02694523|12514209|FG004|Part A|Lost to Follow-up|0
7960972|NCT02694523|12514210|FG005|Part A|Lost to Follow-up|0
7960973|NCT02694523|12514211|FG006|Part A|Lost to Follow-up|0
7960974|NCT02694523|12514205|FG000|Part A|Withdrawal by Subject|3
7960975|NCT02694523|12514206|FG001|Part A|Withdrawal by Subject|1
7960976|NCT02694523|12514207|FG002|Part A|Withdrawal by Subject|0
7960977|NCT02694523|12514208|FG003|Part A|Withdrawal by Subject|0
7960978|NCT02694523|12514209|FG004|Part A|Withdrawal by Subject|0
7960979|NCT02694523|12514210|FG005|Part A|Withdrawal by Subject|0
7960980|NCT02694523|12514211|FG006|Part A|Withdrawal by Subject|0
7960981|NCT02694523|12514205|FG000|Part A|Other|1
7960982|NCT02694523|12514206|FG001|Part A|Other|1
7960983|NCT02694523|12514207|FG002|Part A|Other|0
7960984|NCT02694523|12514208|FG003|Part A|Other|0
7960985|NCT02694523|12514209|FG004|Part A|Other|0
7960986|NCT02694523|12514210|FG005|Part A|Other|0
7960987|NCT02694523|12514211|FG006|Part A|Other|0
7960988|NCT02694523|12514205|FG000|Part B|Adverse Event|0
7960989|NCT02694523|12514206|FG001|Part B|Adverse Event|0
7960990|NCT02694523|12514207|FG002|Part B|Adverse Event|7
7960991|NCT02694523|12514208|FG003|Part B|Adverse Event|1
7960992|NCT02694523|12514209|FG004|Part B|Adverse Event|1
7960993|NCT02694523|12514210|FG005|Part B|Adverse Event|2
7960994|NCT02694523|12514211|FG006|Part B|Adverse Event|0
7960995|NCT02694523|12514205|FG000|Part B|Protocol Violation|0
7960996|NCT02694523|12514206|FG001|Part B|Protocol Violation|0
7960997|NCT02694523|12514207|FG002|Part B|Protocol Violation|1
7960998|NCT02694523|12514208|FG003|Part B|Protocol Violation|0
7960999|NCT02694523|12514209|FG004|Part B|Protocol Violation|0
7961000|NCT02694523|12514210|FG005|Part B|Protocol Violation|0
7961001|NCT02694523|12514211|FG006|Part B|Protocol Violation|0
7961002|NCT02694523|12514205|FG000|Part B|Lost to Follow-up|0
7961003|NCT02694523|12514206|FG001|Part B|Lost to Follow-up|0
7961004|NCT02694523|12514207|FG002|Part B|Lost to Follow-up|2
7961005|NCT02694523|12514208|FG003|Part B|Lost to Follow-up|3
7961006|NCT02694523|12514209|FG004|Part B|Lost to Follow-up|2
7961007|NCT02694523|12514210|FG005|Part B|Lost to Follow-up|0
7961008|NCT02694523|12514211|FG006|Part B|Lost to Follow-up|1
7961009|NCT02694523|12514205|FG000|Part B|Withdrawal by Subject|0
7961010|NCT02694523|12514206|FG001|Part B|Withdrawal by Subject|0
7961011|NCT02694523|12514207|FG002|Part B|Withdrawal by Subject|9
7961012|NCT02694523|12514208|FG003|Part B|Withdrawal by Subject|0
7961013|NCT02694523|12514209|FG004|Part B|Withdrawal by Subject|1
7961014|NCT02694523|12514210|FG005|Part B|Withdrawal by Subject|3
7961015|NCT02694523|12514211|FG006|Part B|Withdrawal by Subject|0
7961016|NCT02694523|12514205|FG000|Part B|Other|0
7961017|NCT02694523|12514206|FG001|Part B|Other|0
7961018|NCT02694523|12514207|FG002|Part B|Other|1
7961019|NCT02694523|12514208|FG003|Part B|Other|0
7961020|NCT02694523|12514209|FG004|Part B|Other|0
7961021|NCT02694523|12514210|FG005|Part B|Other|0
7961022|NCT02694523|12514211|FG006|Part B|Other|1
7961023|NCT02694536|12514223|FG000|Overall Study|Progressive Disease|40
7961024|NCT02694536|12514223|FG000|Overall Study|Lost to Follow-up|1
7961025|NCT02694536|12514223|FG000|Overall Study|Study Drug-Related Adverse Event|1
7961026|NCT02694536|12514223|FG000|Overall Study|Withdrawal by Subject|8
7961027|NCT02694536|12514223|FG000|Overall Study|Death|8
7961028|NCT02694536|12514223|FG000|Overall Study|Other|22
7961029|NCT02694549|12514227|FG000|Overall Study|screen failures|2
7961030|NCT02694562|12514231|FG000|Overall Study|Death|8
7961031|NCT02694562|12514231|FG000|Overall Study|Protocol Violation|4
7961032|NCT02694562|12514231|FG000|Overall Study|Lost to Follow-up|3
7961033|NCT02694562|12514231|FG000|Overall Study|Screen Failure|2
7961034|NCT02694562|12514231|FG000|Overall Study|Physician Decision|1
7961035|NCT02694718|12514239|FG000|Overall Study|Death|1
7961036|NCT02694718|12514239|FG000|Overall Study|Withdrawal by Subject|1
7961037|NCT02694744|12514245|FG000|Overall Study|Adverse Event|2
7961038|NCT02694744|12514246|FG001|Overall Study|Adverse Event|1
7961039|NCT02694744|12514245|FG000|Overall Study|Withdrawal by Subject|2
7961040|NCT02694744|12514246|FG001|Overall Study|Withdrawal by Subject|1
7961041|NCT02694744|12514245|FG000|Overall Study|Physician Decision|1
7961042|NCT02694744|12514246|FG001|Overall Study|Physician Decision|2
7961043|NCT02694744|12514245|FG000|Overall Study|Lost to Follow-up|1
7961044|NCT02694744|12514246|FG001|Overall Study|Lost to Follow-up|0
7961045|NCT02694744|12514245|FG000|Overall Study|Taking potassium supplement: exclusion 6|0
7961046|NCT02694744|12514246|FG001|Overall Study|Taking potassium supplement: exclusion 6|1
7961047|NCT02694978|12514265|FG000|Overall Study|Adverse Event|10
7961048|NCT02694978|12514266|FG001|Overall Study|Adverse Event|9
7961049|NCT02694978|12514265|FG000|Overall Study|Withdrawal by Subject|22
7961050|NCT02694978|12514266|FG001|Overall Study|Withdrawal by Subject|19
7961051|NCT02694978|12514265|FG000|Overall Study|Lost to Follow-up|14
7961052|NCT02694978|12514266|FG001|Overall Study|Lost to Follow-up|17
7961053|NCT02694978|12514265|FG000|Overall Study|Death|4
7961054|NCT02694978|12514266|FG001|Overall Study|Death|1
7961055|NCT02694978|12514265|FG000|Overall Study|Other-Decision of Participant|6
7961056|NCT02694978|12514266|FG001|Overall Study|Other-Decision of Participant|1
7961057|NCT02694978|12514265|FG000|Overall Study|Other-Investigator's decision|1
7961058|NCT02694978|12514266|FG001|Overall Study|Other-Investigator's decision|0
7961059|NCT02694978|12514265|FG000|Overall Study|Other-Unable to be reached|0
7961060|NCT02694978|12514266|FG001|Overall Study|Other-Unable to be reached|1
7961061|NCT02694978|12514265|FG000|Overall Study|Other-Protocol noncompliant|2
7961062|NCT02694978|12514266|FG001|Overall Study|Other-Protocol noncompliant|1
7961063|NCT02694978|12514265|FG000|Overall Study|Other-Personal reasons|3
7961064|NCT02694978|12514266|FG001|Overall Study|Other-Personal reasons|3
7961065|NCT02694978|12514265|FG000|Overall Study|Other-Withdrew prior to dosing|9
7961066|NCT02694978|12514266|FG001|Overall Study|Other-Withdrew prior to dosing|8
7961067|NCT02695329|12514278|FG000|Overall Study|Adverse Event|1
7961068|NCT02695329|12514279|FG001|Overall Study|Adverse Event|0
7961069|NCT02695329|12514278|FG000|Overall Study|Poor X-ray quality for measurement|4
7961070|NCT02695329|12514279|FG001|Overall Study|Poor X-ray quality for measurement|5
7961071|NCT02695420|12514289|FG000|Overall Study|Death|0
7961072|NCT02695420|12514290|FG001|Overall Study|Death|1
7961073|NCT02695420|12514291|FG002|Overall Study|Death|0
7961074|NCT02695420|12514292|FG003|Overall Study|Death|0
7961075|NCT02695524|12514311|FG000|Overall Study|Lost to Follow-up|3
7961076|NCT02695524|12514312|FG001|Overall Study|Lost to Follow-up|2
7961077|NCT02695524|12514311|FG000|Overall Study|Death|0
7961078|NCT02695524|12514312|FG001|Overall Study|Death|1
7961079|NCT02695537|12514318|FG000|Overall Study|Adverse Event|3
7961080|NCT02695537|12514318|FG000|Overall Study|Lack of Efficacy|28
7961081|NCT02695537|12514318|FG000|Overall Study|Withdrawal by Subject|4
7961082|NCT02695537|12514318|FG000|Overall Study|Protocol Violation|3
7961083|NCT02695628|12514322|FG000|Overall Study|Withdrawal by Subject|1
7961084|NCT02695719|12514328|FG000|Overall Study|Pretreatment Event/Adverse Event|2
7961085|NCT02695719|12514329|FG001|Overall Study|Pretreatment Event/Adverse Event|9
7961086|NCT02695719|12514328|FG000|Overall Study|Significant Protocol Deviation|0
7961087|NCT02695719|12514329|FG001|Overall Study|Significant Protocol Deviation|1
7961088|NCT02695719|12514328|FG000|Overall Study|Voluntary Withdrawal|1
7961089|NCT02695719|12514329|FG001|Overall Study|Voluntary Withdrawal|0
7961090|NCT02696317|12514371|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2
7961091|NCT02696317|12514372|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4
7961092|NCT02696317|12514371|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1
7961093|NCT02696317|12514372|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0
7961094|NCT02696434|12514382|FG000|Overall Study|Adverse Event|3
7961095|NCT02696434|12514383|FG001|Overall Study|Adverse Event|1
7961096|NCT02696434|12514382|FG000|Overall Study|Lost to Follow-up|5
7961097|NCT02696434|12514383|FG001|Overall Study|Lost to Follow-up|4
7961098|NCT02696434|12514382|FG000|Overall Study|Withdrawal by Subject|14
7961099|NCT02696434|12514383|FG001|Overall Study|Withdrawal by Subject|12
7961100|NCT02696434|12514382|FG000|Overall Study|Physician Decision|0
7961101|NCT02696434|12514383|FG001|Overall Study|Physician Decision|1
7961102|NCT02696785|12514393|FG000|Blinded Treatment Period|Adverse Event|0
7961103|NCT02696785|12514394|FG001|Blinded Treatment Period|Adverse Event|1
7961104|NCT02696785|12514395|FG002|Blinded Treatment Period|Adverse Event|3
7961105|NCT02696785|12514396|FG003|Blinded Treatment Period|Adverse Event|0
7961106|NCT02696785|12514393|FG000|Blinded Treatment Period|Withdrawal by Subject|0
7961107|NCT02696785|12514394|FG001|Blinded Treatment Period|Withdrawal by Subject|1
7961108|NCT02696785|12514395|FG002|Blinded Treatment Period|Withdrawal by Subject|1
7961109|NCT02696785|12514396|FG003|Blinded Treatment Period|Withdrawal by Subject|2
7961110|NCT02696785|12514393|FG000|Blinded Treatment Period|Lack of Efficacy|0
7961111|NCT02696785|12514394|FG001|Blinded Treatment Period|Lack of Efficacy|0
7961112|NCT02696785|12514395|FG002|Blinded Treatment Period|Lack of Efficacy|0
7961113|NCT02696785|12514396|FG003|Blinded Treatment Period|Lack of Efficacy|1
7961114|NCT02696785|12514393|FG000|Blinded Treatment Period|Screen Failure|1
7961115|NCT02696785|12514394|FG001|Blinded Treatment Period|Screen Failure|0
7961116|NCT02696785|12514395|FG002|Blinded Treatment Period|Screen Failure|0
7961117|NCT02696785|12514396|FG003|Blinded Treatment Period|Screen Failure|0
7961118|NCT02696785|12514393|FG000|Washout Period|Withdrawal by Subject|0
7961119|NCT02696785|12514394|FG001|Washout Period|Withdrawal by Subject|1
7961120|NCT02696785|12514395|FG002|Washout Period|Withdrawal by Subject|0
7961121|NCT02696785|12514396|FG003|Washout Period|Withdrawal by Subject|0
7961122|NCT02696785|12514393|FG000|Washout Period|Lack of Efficacy|0
7961123|NCT02696785|12514394|FG001|Washout Period|Lack of Efficacy|1
7961124|NCT02696785|12514395|FG002|Washout Period|Lack of Efficacy|0
7961125|NCT02696785|12514396|FG003|Washout Period|Lack of Efficacy|0
7961126|NCT02696785|12514393|FG000|Extended Treatment Period|Adverse Event|2
7961127|NCT02696785|12514394|FG001|Extended Treatment Period|Adverse Event|3
7961128|NCT02696785|12514395|FG002|Extended Treatment Period|Adverse Event|2
7961129|NCT02696785|12514396|FG003|Extended Treatment Period|Adverse Event|1
7961130|NCT02696785|12514393|FG000|Extended Treatment Period|Lack of Efficacy|0
7961131|NCT02696785|12514394|FG001|Extended Treatment Period|Lack of Efficacy|1
7961132|NCT02696785|12514395|FG002|Extended Treatment Period|Lack of Efficacy|0
7961133|NCT02696785|12514396|FG003|Extended Treatment Period|Lack of Efficacy|0
7961134|NCT02696785|12514393|FG000|Extended Treatment Period|Withdrawal by Subject|1
7961135|NCT02696785|12514394|FG001|Extended Treatment Period|Withdrawal by Subject|2
7961136|NCT02696785|12514395|FG002|Extended Treatment Period|Withdrawal by Subject|3
7961137|NCT02696785|12514396|FG003|Extended Treatment Period|Withdrawal by Subject|5
7961138|NCT02696785|12514393|FG000|Follow-up Period|Adverse Event|0
7961139|NCT02696785|12514394|FG001|Follow-up Period|Adverse Event|0
7961140|NCT02696785|12514395|FG002|Follow-up Period|Adverse Event|8
7961141|NCT02696785|12514396|FG003|Follow-up Period|Adverse Event|2
7961142|NCT02696785|12514393|FG000|Follow-up Period|Lost to Follow-up|0
7961143|NCT02696785|12514394|FG001|Follow-up Period|Lost to Follow-up|0
7961144|NCT02696785|12514395|FG002|Follow-up Period|Lost to Follow-up|0
7961145|NCT02696785|12514396|FG003|Follow-up Period|Lost to Follow-up|1
7961146|NCT02696785|12514393|FG000|Follow-up Period|Lack of Efficacy|0
7961147|NCT02696785|12514394|FG001|Follow-up Period|Lack of Efficacy|0
7961148|NCT02696785|12514395|FG002|Follow-up Period|Lack of Efficacy|0
7961149|NCT02696785|12514396|FG003|Follow-up Period|Lack of Efficacy|1
7961150|NCT02696785|12514393|FG000|Follow-up Period|Withdrawal by Subject|1
7961151|NCT02696785|12514394|FG001|Follow-up Period|Withdrawal by Subject|0
7961152|NCT02696785|12514395|FG002|Follow-up Period|Withdrawal by Subject|5
7961153|NCT02696785|12514396|FG003|Follow-up Period|Withdrawal by Subject|4
7961154|NCT02696798|12514427|FG000|Blinded Treatment Dosing Period|Adverse Event|2
7961155|NCT02696798|12514428|FG001|Blinded Treatment Dosing Period|Adverse Event|9
7961156|NCT02696798|12514429|FG002|Blinded Treatment Dosing Period|Adverse Event|2
7961157|NCT02696798|12514427|FG000|Blinded Treatment Dosing Period|Death|0
7961158|NCT02696798|12514428|FG001|Blinded Treatment Dosing Period|Death|0
7961159|NCT02696798|12514429|FG002|Blinded Treatment Dosing Period|Death|1
7961160|NCT02696798|12514427|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2
7961161|NCT02696798|12514428|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1
7961162|NCT02696798|12514429|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1
7961163|NCT02696798|12514427|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0
7961164|NCT02696798|12514428|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1
7961165|NCT02696798|12514429|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0
7961166|NCT02696798|12514427|FG000|Blinded Treatment Dosing Period|Physician Decision|0
7961167|NCT02696798|12514428|FG001|Blinded Treatment Dosing Period|Physician Decision|1
7961168|NCT02696798|12514429|FG002|Blinded Treatment Dosing Period|Physician Decision|0
7961169|NCT02696798|12514427|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7
7961170|NCT02696798|12514428|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3
7961171|NCT02696798|12514429|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4
7961172|NCT02696798|12514427|FG000|Extended Treatment Period|Adverse Event|1
7961173|NCT02696798|12514428|FG001|Extended Treatment Period|Adverse Event|4
7961174|NCT02696798|12514429|FG002|Extended Treatment Period|Adverse Event|5
7961175|NCT02696798|12514427|FG000|Extended Treatment Period|Lack of Efficacy|7
7961176|NCT02696798|12514428|FG001|Extended Treatment Period|Lack of Efficacy|2
7961177|NCT02696798|12514429|FG002|Extended Treatment Period|Lack of Efficacy|2
7961178|NCT02696798|12514427|FG000|Extended Treatment Period|Lost to Follow-up|1
7961179|NCT02696798|12514428|FG001|Extended Treatment Period|Lost to Follow-up|0
7961180|NCT02696798|12514429|FG002|Extended Treatment Period|Lost to Follow-up|0
7961181|NCT02696798|12514427|FG000|Extended Treatment Period|Physician Decision|0
7961182|NCT02696798|12514428|FG001|Extended Treatment Period|Physician Decision|1
7961183|NCT02696798|12514429|FG002|Extended Treatment Period|Physician Decision|0
7961184|NCT02696798|12514427|FG000|Extended Treatment Period|Withdrawal by Subject|3
7961185|NCT02696798|12514428|FG001|Extended Treatment Period|Withdrawal by Subject|2
7961186|NCT02696798|12514429|FG002|Extended Treatment Period|Withdrawal by Subject|3
7961187|NCT02696798|12514427|FG000|Post-treatment Follow-up Period|Adverse Event|2
7961188|NCT02696798|12514428|FG001|Post-treatment Follow-up Period|Adverse Event|12
7961189|NCT02696798|12514429|FG002|Post-treatment Follow-up Period|Adverse Event|6
7961190|NCT02696798|12514427|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0
7961191|NCT02696798|12514428|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1
7961192|NCT02696798|12514429|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1
7961193|NCT02696798|12514427|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1
7961194|NCT02696798|12514428|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2
7961195|NCT02696798|12514429|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0
7961196|NCT02696798|12514427|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2
7961197|NCT02696798|12514428|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8
7961198|NCT02696798|12514429|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12
7961199|NCT02696798|12514427|FG000|Post-treatment Follow-up Period|Physician Decision|0
7961200|NCT02696798|12514428|FG001|Post-treatment Follow-up Period|Physician Decision|2
7961201|NCT02696798|12514429|FG002|Post-treatment Follow-up Period|Physician Decision|0
7961202|NCT02696798|12514427|FG000|Post-treatment Follow-up Period|No progressive improvement|0
7961203|NCT02696798|12514428|FG001|Post-treatment Follow-up Period|No progressive improvement|1
7961204|NCT02696798|12514429|FG002|Post-treatment Follow-up Period|No progressive improvement|0
7961205|NCT02696850|12514453|FG000|Overall Study|Withdrawal by Subject|3
7961206|NCT02696850|12514454|FG001|Overall Study|Withdrawal by Subject|3
7961207|NCT02696850|12514453|FG000|Overall Study|Lost to Follow-up|8
7961208|NCT02696850|12514454|FG001|Overall Study|Lost to Follow-up|5
7961209|NCT02696902|12514463|FG000|Overall Study|Lost to Follow-up|0
7961210|NCT02696902|12514464|FG001|Overall Study|Lost to Follow-up|1
7961211|NCT02696902|12514465|FG002|Overall Study|Lost to Follow-up|1
7961212|NCT02696902|12514463|FG000|Overall Study|Withdrawal by Subject|0
7961213|NCT02696902|12514464|FG001|Overall Study|Withdrawal by Subject|0
7961214|NCT02696902|12514465|FG002|Overall Study|Withdrawal by Subject|1
7961215|NCT02696902|12514463|FG000|Overall Study|Death|19
7961216|NCT02696902|12514464|FG001|Overall Study|Death|3
7961217|NCT02696902|12514465|FG002|Overall Study|Death|24
7961218|NCT02696902|12514463|FG000|Overall Study|Participant not fit post-randomization|0
7961219|NCT02696902|12514464|FG001|Overall Study|Participant not fit post-randomization|0
7961220|NCT02696902|12514465|FG002|Overall Study|Participant not fit post-randomization|1
7961221|NCT02696902|12514463|FG000|Overall Study|Participant not eligible (negative PCR)|0
7961222|NCT02696902|12514464|FG001|Overall Study|Participant not eligible (negative PCR)|0
7961223|NCT02696902|12514465|FG002|Overall Study|Participant not eligible (negative PCR)|1
7961224|NCT02696902|12514463|FG000|Overall Study|Principal investigator's decision|1
7961225|NCT02696902|12514464|FG001|Overall Study|Principal investigator's decision|0
7961226|NCT02696902|12514465|FG002|Overall Study|Principal investigator's decision|0
7961227|NCT02696902|12514463|FG000|Overall Study|Sponsor's decision|1
7961228|NCT02696902|12514464|FG001|Overall Study|Sponsor's decision|0
7961229|NCT02696902|12514465|FG002|Overall Study|Sponsor's decision|0
7961230|NCT02696902|12514463|FG000|Overall Study|Transferred to other hospital|1
7961231|NCT02696902|12514464|FG001|Overall Study|Transferred to other hospital|0
7961232|NCT02696902|12514465|FG002|Overall Study|Transferred to other hospital|0
7961233|NCT02697435|12514544|FG000|Overall Study|Withdrawal by Subject|1
7961234|NCT02697435|12514545|FG001|Overall Study|Withdrawal by Subject|0
7961235|NCT02697435|12514544|FG000|Overall Study|Physician Decision|0
7961236|NCT02697435|12514545|FG001|Overall Study|Physician Decision|4
7961237|NCT02697591|12514562|FG000|Overall Study|Lost to Follow-up|0
7961238|NCT02697591|12514563|FG001|Overall Study|Lost to Follow-up|0
7961239|NCT02697591|12514564|FG002|Overall Study|Lost to Follow-up|0
7961240|NCT02697591|12514565|FG003|Overall Study|Lost to Follow-up|0
7961241|NCT02697591|12514566|FG004|Overall Study|Lost to Follow-up|0
7961242|NCT02697591|12514567|FG005|Overall Study|Lost to Follow-up|1
7961243|NCT02697591|12514568|FG006|Overall Study|Lost to Follow-up|1
7961244|NCT02697591|12514569|FG007|Overall Study|Lost to Follow-up|0
7961245|NCT02697591|12514570|FG008|Overall Study|Lost to Follow-up|0
7961246|NCT02697591|12514571|FG009|Overall Study|Lost to Follow-up|1
7961247|NCT02697591|12514562|FG000|Overall Study|Withdrawal by Subject|1
7961248|NCT02697591|12514563|FG001|Overall Study|Withdrawal by Subject|1
7961249|NCT02697591|12514564|FG002|Overall Study|Withdrawal by Subject|2
7961250|NCT02697591|12514565|FG003|Overall Study|Withdrawal by Subject|1
7961251|NCT02697591|12514566|FG004|Overall Study|Withdrawal by Subject|7
7961252|NCT02697591|12514567|FG005|Overall Study|Withdrawal by Subject|6
7961253|NCT02697591|12514568|FG006|Overall Study|Withdrawal by Subject|9
7961254|NCT02697591|12514569|FG007|Overall Study|Withdrawal by Subject|1
7961255|NCT02697591|12514570|FG008|Overall Study|Withdrawal by Subject|6
7961256|NCT02697591|12514571|FG009|Overall Study|Withdrawal by Subject|10
7961257|NCT02697591|12514562|FG000|Overall Study|Physician Decision|1
7961258|NCT02697591|12514563|FG001|Overall Study|Physician Decision|0
7961259|NCT02697591|12514564|FG002|Overall Study|Physician Decision|0
7961260|NCT02697591|12514565|FG003|Overall Study|Physician Decision|0
7961261|NCT02697591|12514566|FG004|Overall Study|Physician Decision|1
7961262|NCT02697591|12514567|FG005|Overall Study|Physician Decision|2
7961263|NCT02697591|12514568|FG006|Overall Study|Physician Decision|0
7961264|NCT02697591|12514569|FG007|Overall Study|Physician Decision|0
7961265|NCT02697591|12514570|FG008|Overall Study|Physician Decision|1
7961266|NCT02697591|12514571|FG009|Overall Study|Physician Decision|1
7961267|NCT02697591|12514562|FG000|Overall Study|Death|2
7961268|NCT02697591|12514563|FG001|Overall Study|Death|3
7961269|NCT02697591|12514564|FG002|Overall Study|Death|1
7961270|NCT02697591|12514565|FG003|Overall Study|Death|1
7961271|NCT02697591|12514566|FG004|Overall Study|Death|4
7961272|NCT02697591|12514567|FG005|Overall Study|Death|5
7961273|NCT02697591|12514568|FG006|Overall Study|Death|3
7961274|NCT02697591|12514569|FG007|Overall Study|Death|1
7961275|NCT02697591|12514570|FG008|Overall Study|Death|1
7961276|NCT02697591|12514571|FG009|Overall Study|Death|5
7961277|NCT02697591|12514562|FG000|Overall Study|Reason not Specified|0
7961278|NCT02697591|12514563|FG001|Overall Study|Reason not Specified|0
7961279|NCT02697591|12514564|FG002|Overall Study|Reason not Specified|0
7961280|NCT02697591|12514565|FG003|Overall Study|Reason not Specified|1
7961281|NCT02697591|12514566|FG004|Overall Study|Reason not Specified|1
7961282|NCT02697591|12514567|FG005|Overall Study|Reason not Specified|2
7961283|NCT02697591|12514568|FG006|Overall Study|Reason not Specified|3
7961284|NCT02697591|12514569|FG007|Overall Study|Reason not Specified|1
7961285|NCT02697591|12514570|FG008|Overall Study|Reason not Specified|1
7961286|NCT02697591|12514571|FG009|Overall Study|Reason not Specified|3
7961287|NCT02697617|12514594|FG000|Overall Study|Withdrawal by Subject|0
7961288|NCT02697617|12514595|FG001|Overall Study|Withdrawal by Subject|2
7961289|NCT02697617|12514594|FG000|Overall Study|Pregnancy|1
7961290|NCT02697617|12514595|FG001|Overall Study|Pregnancy|0
7961291|NCT02697734|12514607|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4
7961292|NCT02697734|12514608|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0
7961293|NCT02697734|12514607|FG000|Core Phase - up to Week 48|Adverse Event|1
7961294|NCT02697734|12514608|FG001|Core Phase - up to Week 48|Adverse Event|2
7961295|NCT02697734|12514607|FG000|Core Phase - up to Week 48|Physician Decision|1
7961296|NCT02697734|12514608|FG001|Core Phase - up to Week 48|Physician Decision|0
7961297|NCT02697734|12514607|FG000|Optional Extension Phase|Adverse Event|5
7961298|NCT02697734|12514608|FG001|Optional Extension Phase|Adverse Event|1
7961299|NCT02697734|12514607|FG000|Optional Extension Phase|Physician Decision|0
7961300|NCT02697734|12514608|FG001|Optional Extension Phase|Physician Decision|1
7961301|NCT02697773|12514625|FG000|Overall Study|Adverse Event|2
7961302|NCT02697773|12514626|FG001|Overall Study|Adverse Event|1
7961303|NCT02697773|12514627|FG002|Overall Study|Adverse Event|2
7961304|NCT02697773|12514625|FG000|Overall Study|Death|0
7961305|NCT02697773|12514626|FG001|Overall Study|Death|0
7961306|NCT02697773|12514627|FG002|Overall Study|Death|2
7961307|NCT02697773|12514625|FG000|Overall Study|Lack of Efficacy|4
7961308|NCT02697773|12514626|FG001|Overall Study|Lack of Efficacy|6
7961309|NCT02697773|12514627|FG002|Overall Study|Lack of Efficacy|6
7721277|NCT00543543|12145782|FG003|Extension Study|Pregnancy|6
7721278|NCT00543543|12145779|FG000|Extension Study|Protocol Violation|0
7721279|NCT00543543|12145780|FG001|Extension Study|Protocol Violation|0
7721280|NCT00543543|12145781|FG002|Extension Study|Protocol Violation|0
7961310|NCT02697773|12514625|FG000|Overall Study|Lost to Follow-up|5
7961311|NCT02697773|12514626|FG001|Overall Study|Lost to Follow-up|5
7961312|NCT02697773|12514627|FG002|Overall Study|Lost to Follow-up|7
7961313|NCT02697773|12514625|FG000|Overall Study|Other|15
7961314|NCT02697773|12514626|FG001|Overall Study|Other|11
7961315|NCT02697773|12514627|FG002|Overall Study|Other|10
7961316|NCT02697773|12514625|FG000|Overall Study|Protocol Violation|1
7961317|NCT02697773|12514626|FG001|Overall Study|Protocol Violation|1
7961318|NCT02697773|12514627|FG002|Overall Study|Protocol Violation|0
7961319|NCT02697773|12514625|FG000|Overall Study|Withdrawal by Subject|10
7721281|NCT00543543|12145782|FG003|Extension Study|Protocol Violation|11
7961320|NCT02697773|12514626|FG001|Overall Study|Withdrawal by Subject|13
7961321|NCT02697773|12514627|FG002|Overall Study|Withdrawal by Subject|13
7961322|NCT02697773|12514625|FG000|Overall Study|Randomized but not treated|1
7961323|NCT02697773|12514626|FG001|Overall Study|Randomized but not treated|1
7961324|NCT02697773|12514627|FG002|Overall Study|Randomized but not treated|0
7961325|NCT02697916|12514646|FG000|Overall Study|Death|357
7961326|NCT02697916|12514647|FG001|Overall Study|Death|315
7961327|NCT02697916|12514646|FG000|Overall Study|Withdrawal by Subject|221
7961328|NCT02697916|12514647|FG001|Overall Study|Withdrawal by Subject|393
7961329|NCT02698176|12514660|FG000|Overall Study|Progressive disease|4
7961330|NCT02698176|12514661|FG001|Overall Study|Progressive disease|3
7961331|NCT02698176|12514662|FG002|Overall Study|Progressive disease|1
7961332|NCT02698176|12514663|FG003|Overall Study|Progressive disease|0
7961333|NCT02698176|12514660|FG000|Overall Study|Adverse Event|2
7961334|NCT02698176|12514661|FG001|Overall Study|Adverse Event|0
7961335|NCT02698176|12514662|FG002|Overall Study|Adverse Event|0
7961336|NCT02698176|12514663|FG003|Overall Study|Adverse Event|0
7961337|NCT02698176|12514660|FG000|Overall Study|Clinical progression|3
7961338|NCT02698176|12514661|FG001|Overall Study|Clinical progression|0
7961339|NCT02698176|12514662|FG002|Overall Study|Clinical progression|0
7961340|NCT02698176|12514663|FG003|Overall Study|Clinical progression|0
7961341|NCT02698241|12514683|FG000|Overall Study|Inclusion/exclusion criteria not met|4
7961342|NCT02698241|12514683|FG000|Overall Study|Screening not met|7
7961343|NCT02698241|12514683|FG000|Overall Study|Withdrawal by Subject|7
7961344|NCT02698241|12514683|FG000|Overall Study|Physician Decision|2
7961345|NCT02698241|12514683|FG000|Overall Study|Subject underwent system modification|2
7961346|NCT02698241|12514683|FG000|Overall Study|Lost to Follow-up|3
7961347|NCT02698241|12514683|FG000|Overall Study|Subject on inodrip not safe to continue|6
7961348|NCT02698241|12514683|FG000|Overall Study|geographic and licensing issue|1
7961349|NCT02698241|12514683|FG000|Overall Study|Death|2
7961350|NCT02698371|12514687|FG000|All Participants Flow|Lost to Follow-up|3
7961351|NCT02698371|12514687|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3
7961352|NCT02698371|12514687|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3
7961353|NCT02698371|12514687|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3
7961354|NCT02698371|12514687|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3
7961355|NCT02698371|12514687|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3
7961356|NCT02698371|12514687|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2
7961357|NCT02698410|12514703|FG000|Overall Study|Adverse Event|2
7961358|NCT02698410|12514703|FG000|Overall Study|Withdrawal by Subject|1
7961359|NCT02698410|12514703|FG000|Overall Study|Other|1
7961360|NCT02698423|12514709|FG000|Overall Study|Lost to Follow-up|19
7961361|NCT02698423|12514710|FG001|Overall Study|Lost to Follow-up|24
7961362|NCT02698436|12514720|FG000|Overall Study|Adverse Event|1
7961363|NCT02698436|12514721|FG001|Overall Study|Adverse Event|0
7961364|NCT02698436|12514720|FG000|Overall Study|Withdrawal by Subject|3
7961365|NCT02698436|12514721|FG001|Overall Study|Withdrawal by Subject|3
7961366|NCT02698436|12514720|FG000|Overall Study|Lost to Follow-up|2
7961367|NCT02698436|12514721|FG001|Overall Study|Lost to Follow-up|4
7961368|NCT02698436|12514720|FG000|Overall Study|Non-compliance with study regimen|1
7961369|NCT02698436|12514721|FG001|Overall Study|Non-compliance with study regimen|0
7961370|NCT02698475|12514727|FG000|Main Study Period|Lack of Efficacy|1
7961371|NCT02698475|12514727|FG000|Main Study Period|Protocol Violation|2
7961372|NCT02698475|12514727|FG000|Long-Term Extension Period|Lost to Follow-up|1
7961373|NCT02698475|12514727|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1
7961374|NCT02698475|12514727|FG000|Long-Term Extension Period|Withdrawal by Subject|3
7961375|NCT02698475|12514727|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22
7961376|NCT02698475|12514727|FG000|Long-Term Extension Period|Other|1
7961377|NCT02698787|12514751|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0
7961378|NCT02698787|12514752|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1
7961379|NCT02699099|12514769|FG000|Overall Study|Adverse Event|1
7961380|NCT02699099|12514770|FG001|Overall Study|Adverse Event|0
7961381|NCT02699099|12514771|FG002|Overall Study|Adverse Event|2
7961382|NCT02699099|12514769|FG000|Overall Study|Lost to Follow-up|0
7961383|NCT02699099|12514770|FG001|Overall Study|Lost to Follow-up|1
7961384|NCT02699099|12514771|FG002|Overall Study|Lost to Follow-up|0
7961385|NCT02699099|12514769|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7
7961386|NCT02699099|12514770|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7961387|NCT02699099|12514771|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4
7961388|NCT02699125|12514781|FG000|Placebo|Lost to Follow-up|2
7961389|NCT02699125|12514782|FG001|Placebo|Lost to Follow-up|0
7961390|NCT02699125|12514781|FG000|Placebo|Protocol Violation|1
7961391|NCT02699125|12514782|FG001|Placebo|Protocol Violation|0
7961392|NCT02699125|12514781|FG000|Placebo|Withdrawal by Subject|0
7721282|NCT00543543|12145779|FG000|Extension Study|Withdrawal by Subject|0
7961393|NCT02699125|12514782|FG001|Placebo|Withdrawal by Subject|4
7961394|NCT02699125|12514781|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7
7961395|NCT02699125|12514782|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2
7961396|NCT02699450|12514795|FG000|Overall Study|Death|2
7961397|NCT02699450|12514796|FG001|Overall Study|Death|1
7961398|NCT02699450|12514797|FG002|Overall Study|Death|2
7961399|NCT02699450|12514795|FG000|Overall Study|Met Criteria for Study Exit|0
7961400|NCT02699450|12514796|FG001|Overall Study|Met Criteria for Study Exit|0
7961401|NCT02699450|12514797|FG002|Overall Study|Met Criteria for Study Exit|1
7961402|NCT02699450|12514795|FG000|Overall Study|Protocol Violation|4
7961403|NCT02699450|12514796|FG001|Overall Study|Protocol Violation|3
7961404|NCT02699450|12514797|FG002|Overall Study|Protocol Violation|5
7961405|NCT02699450|12514795|FG000|Overall Study|Lost to Follow-up|3
7961406|NCT02699450|12514796|FG001|Overall Study|Lost to Follow-up|0
7961407|NCT02699450|12514797|FG002|Overall Study|Lost to Follow-up|5
7961408|NCT02699450|12514795|FG000|Overall Study|Physician Decision|2
7961409|NCT02699450|12514796|FG001|Overall Study|Physician Decision|0
7961410|NCT02699450|12514797|FG002|Overall Study|Physician Decision|0
7961411|NCT02699450|12514795|FG000|Overall Study|Withdrawal by Subject|3
7961412|NCT02699450|12514796|FG001|Overall Study|Withdrawal by Subject|1
7961413|NCT02699450|12514797|FG002|Overall Study|Withdrawal by Subject|2
7961414|NCT02699450|12514795|FG000|Overall Study|Adverse Event|1
7961415|NCT02699450|12514796|FG001|Overall Study|Adverse Event|0
7961416|NCT02699450|12514797|FG002|Overall Study|Adverse Event|0
7961417|NCT02699463|12514808|FG000|Overall Study|Lost to Follow-up|11
7961418|NCT02699463|12514809|FG001|Overall Study|Lost to Follow-up|8
7961419|NCT02699463|12514808|FG000|Overall Study|Withdrawal by Subject|4
7961420|NCT02699463|12514809|FG001|Overall Study|Withdrawal by Subject|1
7961421|NCT02699593|12514815|FG000|Period 1|Unsatisfactory Visual Response|0
7961422|NCT02699593|12514816|FG001|Period 1|Unsatisfactory Visual Response|1
7961423|NCT02699593|12514815|FG000|Period 1|Torn Contact Len|4
7961424|NCT02699593|12514816|FG001|Period 1|Torn Contact Len|3
7961425|NCT02699593|12514815|FG000|Period 1|Protocol Violation|0
7961426|NCT02699593|12514816|FG001|Period 1|Protocol Violation|1
7961427|NCT02699593|12514815|FG000|Period 1|Withdrawal by Subject|0
7961428|NCT02699593|12514816|FG001|Period 1|Withdrawal by Subject|1
7961429|NCT02699593|12514815|FG000|Period 1|Adverse Event|1
7961430|NCT02699593|12514816|FG001|Period 1|Adverse Event|1
7961431|NCT02699593|12514815|FG000|Period 2|Adverse Event|1
7961432|NCT02699593|12514816|FG001|Period 2|Adverse Event|1
7961433|NCT02699593|12514815|FG000|Period 2|Lost Contact Lens|0
7961434|NCT02699593|12514816|FG001|Period 2|Lost Contact Lens|1
7961435|NCT02699593|12514815|FG000|Period 2|Torn Contact Lens|1
7961436|NCT02699593|12514816|FG001|Period 2|Torn Contact Lens|0
7961437|NCT02699684|12514829|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1
7961438|NCT02699684|12514830|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0
7961439|NCT02699749|12514851|FG000|Overall Study|Other|0
7961440|NCT02699749|12514852|FG001|Overall Study|Other|0
7961441|NCT02699749|12514853|FG002|Overall Study|Other|2
7961442|NCT02699749|12514854|FG003|Overall Study|Other|0
7961443|NCT02699749|12514855|FG004|Overall Study|Other|0
7961444|NCT02699749|12514856|FG005|Overall Study|Other|1
7961445|NCT02699749|12514857|FG006|Overall Study|Other|1
7961446|NCT02699749|12514858|FG007|Overall Study|Other|0
7961447|NCT02699749|12514859|FG008|Overall Study|Other|0
7961448|NCT02699749|12514860|FG009|Overall Study|Other|0
7961449|NCT02699749|12514861|FG010|Overall Study|Other|1
7961450|NCT02699749|12514862|FG011|Overall Study|Other|0
7961451|NCT02699749|12514863|FG012|Overall Study|Other|0
7961452|NCT02699749|12514864|FG013|Overall Study|Other|0
7961453|NCT02699749|12514851|FG000|Overall Study|Progressive Disease|3
7961454|NCT02699749|12514852|FG001|Overall Study|Progressive Disease|3
7961455|NCT02699749|12514853|FG002|Overall Study|Progressive Disease|14
7961456|NCT02699749|12514854|FG003|Overall Study|Progressive Disease|3
7961457|NCT02699749|12514855|FG004|Overall Study|Progressive Disease|3
7961458|NCT02699749|12514856|FG005|Overall Study|Progressive Disease|7
7961459|NCT02699749|12514857|FG006|Overall Study|Progressive Disease|5
7961460|NCT02699749|12514858|FG007|Overall Study|Progressive Disease|5
7961461|NCT02699749|12514859|FG008|Overall Study|Progressive Disease|6
7961462|NCT02699749|12514860|FG009|Overall Study|Progressive Disease|6
7961463|NCT02699749|12514861|FG010|Overall Study|Progressive Disease|5
7961464|NCT02699749|12514862|FG011|Overall Study|Progressive Disease|4
7961465|NCT02699749|12514863|FG012|Overall Study|Progressive Disease|3
7961466|NCT02699749|12514864|FG013|Overall Study|Progressive Disease|5
7961467|NCT02699749|12514851|FG000|Overall Study|Death|0
7961468|NCT02699749|12514852|FG001|Overall Study|Death|0
7961469|NCT02699749|12514853|FG002|Overall Study|Death|0
7961470|NCT02699749|12514854|FG003|Overall Study|Death|0
7961471|NCT02699749|12514855|FG004|Overall Study|Death|0
7961472|NCT02699749|12514856|FG005|Overall Study|Death|0
7961473|NCT02699749|12514857|FG006|Overall Study|Death|0
7961474|NCT02699749|12514858|FG007|Overall Study|Death|0
7961475|NCT02699749|12514859|FG008|Overall Study|Death|0
7961476|NCT02699749|12514860|FG009|Overall Study|Death|0
7961477|NCT02699749|12514861|FG010|Overall Study|Death|0
7961478|NCT02699749|12514862|FG011|Overall Study|Death|0
7961479|NCT02699749|12514863|FG012|Overall Study|Death|0
7961480|NCT02699749|12514864|FG013|Overall Study|Death|1
7961481|NCT02699749|12514851|FG000|Overall Study|Lost to Follow-up|0
7961482|NCT02699749|12514852|FG001|Overall Study|Lost to Follow-up|0
7961483|NCT02699749|12514853|FG002|Overall Study|Lost to Follow-up|0
7961484|NCT02699749|12514854|FG003|Overall Study|Lost to Follow-up|0
7961485|NCT02699749|12514855|FG004|Overall Study|Lost to Follow-up|0
7961486|NCT02699749|12514856|FG005|Overall Study|Lost to Follow-up|1
7961487|NCT02699749|12514857|FG006|Overall Study|Lost to Follow-up|0
7961488|NCT02699749|12514858|FG007|Overall Study|Lost to Follow-up|1
7961489|NCT02699749|12514859|FG008|Overall Study|Lost to Follow-up|0
7961490|NCT02699749|12514860|FG009|Overall Study|Lost to Follow-up|0
7961491|NCT02699749|12514861|FG010|Overall Study|Lost to Follow-up|0
7961492|NCT02699749|12514862|FG011|Overall Study|Lost to Follow-up|0
7961493|NCT02699749|12514863|FG012|Overall Study|Lost to Follow-up|0
7961494|NCT02699749|12514864|FG013|Overall Study|Lost to Follow-up|0
7961495|NCT02699866|12514894|FG000|Overall Study|Withdrawal by Subject|3
7961496|NCT02699866|12514894|FG000|Overall Study|Physician Decision|2
7961497|NCT02699866|12514894|FG000|Overall Study|Adverse Event|3
7961498|NCT02699892|12514898|FG000|Overall Study|Other|36
7961499|NCT02699983|12514909|FG000|Overall Study|Withdrawal by Subject|1
7961500|NCT02699983|12514910|FG001|Overall Study|Withdrawal by Subject|0
7961501|NCT02699996|12514922|FG000|Overall Study|Withdrawal by Subject|5
7961502|NCT02699996|12514923|FG001|Overall Study|Withdrawal by Subject|2
7966781|NCT02757352|12523228|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7966782|NCT02757352|12523229|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7961503|NCT02700412|12514944|FG000|Overall Study|Adverse Event|6
7961504|NCT02700412|12514944|FG000|Overall Study|Death|1
7961505|NCT02700412|12514944|FG000|Overall Study|Lack of Efficacy|19
7961506|NCT02700412|12514944|FG000|Overall Study|Protocol Violation|5
7961507|NCT02700412|12514944|FG000|Overall Study|Withdrawal by Subject|2
7961508|NCT02700815|12514961|FG000|Overall Study|Adverse Event|0
7961509|NCT02700815|12514962|FG001|Overall Study|Adverse Event|6
7961510|NCT02700815|12514963|FG002|Overall Study|Adverse Event|2
7961511|NCT02700815|12514964|FG003|Overall Study|Adverse Event|3
7961512|NCT02700815|12514961|FG000|Overall Study|Lack of Efficacy|0
7961513|NCT02700815|12514962|FG001|Overall Study|Lack of Efficacy|0
7721283|NCT00543543|12145780|FG001|Extension Study|Withdrawal by Subject|0
7961514|NCT02700815|12514963|FG002|Overall Study|Lack of Efficacy|1
7961515|NCT02700815|12514964|FG003|Overall Study|Lack of Efficacy|2
7961516|NCT02700815|12514961|FG000|Overall Study|Lost to Follow-up|1
7961517|NCT02700815|12514962|FG001|Overall Study|Lost to Follow-up|0
7961518|NCT02700815|12514963|FG002|Overall Study|Lost to Follow-up|0
7961519|NCT02700815|12514964|FG003|Overall Study|Lost to Follow-up|1
7961520|NCT02700815|12514961|FG000|Overall Study|Refusal to continue medication|0
7961521|NCT02700815|12514962|FG001|Overall Study|Refusal to continue medication|1
7961522|NCT02700815|12514963|FG002|Overall Study|Refusal to continue medication|0
7961523|NCT02700815|12514964|FG003|Overall Study|Refusal to continue medication|1
7961524|NCT02700815|12514961|FG000|Overall Study|Withdrawal by Subject|0
7961525|NCT02700815|12514962|FG001|Overall Study|Withdrawal by Subject|0
7961526|NCT02700815|12514963|FG002|Overall Study|Withdrawal by Subject|1
7961527|NCT02700815|12514964|FG003|Overall Study|Withdrawal by Subject|0
7961528|NCT02700919|12514977|FG000|Overall Study|Physician Decision|1
7961529|NCT02700919|12514978|FG001|Overall Study|Physician Decision|0
7961530|NCT02700919|12514979|FG002|Overall Study|Physician Decision|0
7961531|NCT02700919|12514977|FG000|Overall Study|Protocol Violation|1
7961532|NCT02700919|12514978|FG001|Overall Study|Protocol Violation|0
7961533|NCT02700919|12514979|FG002|Overall Study|Protocol Violation|0
7961534|NCT02700919|12514977|FG000|Overall Study|Adverse Event|1
7961535|NCT02700919|12514978|FG001|Overall Study|Adverse Event|3
7961536|NCT02700919|12514979|FG002|Overall Study|Adverse Event|1
7721284|NCT00543543|12145781|FG002|Extension Study|Withdrawal by Subject|0
7721285|NCT00543543|12145782|FG003|Extension Study|Withdrawal by Subject|120
7721286|NCT00543569|12145801|FG000|Overall Study|Death|2
7721287|NCT00543569|12145802|FG001|Overall Study|Death|2
7721288|NCT00543569|12145803|FG002|Overall Study|Death|3
7721289|NCT00543569|12145804|FG003|Overall Study|Death|1
7721290|NCT00543569|12145801|FG000|Overall Study|Lost to Follow-up|0
7721291|NCT00543569|12145802|FG001|Overall Study|Lost to Follow-up|0
7721292|NCT00543569|12145803|FG002|Overall Study|Lost to Follow-up|1
7721293|NCT00543569|12145804|FG003|Overall Study|Lost to Follow-up|1
7721294|NCT00543569|12145801|FG000|Overall Study|Miscellaneous Reasons|7
7721295|NCT00543569|12145802|FG001|Overall Study|Miscellaneous Reasons|3
7721296|NCT00543569|12145803|FG002|Overall Study|Miscellaneous Reasons|11
7961537|NCT02700919|12514977|FG000|Overall Study|Withdrawal by Subject|5
7961538|NCT02700919|12514978|FG001|Overall Study|Withdrawal by Subject|8
7961539|NCT02700919|12514979|FG002|Overall Study|Withdrawal by Subject|2
7961540|NCT02700919|12514977|FG000|Overall Study|Lost to Follow-up|2
7961541|NCT02700919|12514978|FG001|Overall Study|Lost to Follow-up|0
7961542|NCT02700919|12514979|FG002|Overall Study|Lost to Follow-up|0
7961543|NCT02700919|12514977|FG000|Overall Study|Other|2
7961544|NCT02700919|12514978|FG001|Overall Study|Other|1
7961545|NCT02700919|12514979|FG002|Overall Study|Other|1
7961546|NCT02700984|12514989|FG000|Overall Study|Death|2
7961547|NCT02700984|12514990|FG001|Overall Study|Death|1
7961548|NCT02700984|12514989|FG000|Overall Study|Lost to Follow-up|2
7721297|NCT00543569|12145804|FG003|Overall Study|Miscellaneous Reasons|4
7721298|NCT00543569|12145801|FG000|Overall Study|Randomized but never received study drug|3
7721299|NCT00543569|12145802|FG001|Overall Study|Randomized but never received study drug|3
7721300|NCT00543569|12145803|FG002|Overall Study|Randomized but never received study drug|5
7721301|NCT00543569|12145804|FG003|Overall Study|Randomized but never received study drug|3
7721302|NCT00543725|12145816|FG000|Overall Study|Adverse Event|18
7721303|NCT00543725|12145817|FG001|Overall Study|Adverse Event|27
7721304|NCT00543725|12145816|FG000|Overall Study|Sponsor's Decision|0
7721305|NCT00543725|12145817|FG001|Overall Study|Sponsor's Decision|1
7721306|NCT00543725|12145816|FG000|Overall Study|Subject Non-Compliant|4
7721307|NCT00543725|12145817|FG001|Overall Study|Subject Non-Compliant|4
7721308|NCT00543725|12145816|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
7721309|NCT00543725|12145817|FG001|Overall Study|Subject Ineligible To Continue The Trial|0
7721310|NCT00543725|12145816|FG000|Overall Study|Subject Reached A Virologic Endpoint|22
7721311|NCT00543725|12145817|FG001|Overall Study|Subject Reached A Virologic Endpoint|14
7721312|NCT00543725|12145816|FG000|Overall Study|Protocol Violation|0
7721313|NCT00543725|12145817|FG001|Overall Study|Protocol Violation|1
7721314|NCT00543725|12145816|FG000|Overall Study|Withdrawal by Subject|4
7961549|NCT02700984|12514990|FG001|Overall Study|Lost to Follow-up|1
7961550|NCT02700984|12514989|FG000|Overall Study|Physician Decision|0
7961551|NCT02700984|12514990|FG001|Overall Study|Physician Decision|1
7961552|NCT02700984|12514989|FG000|Overall Study|Withdrawal by Subject|8
7961553|NCT02700984|12514990|FG001|Overall Study|Withdrawal by Subject|9
7961554|NCT02700984|12514989|FG000|Overall Study|Reason not specified|3
7961555|NCT02700984|12514990|FG001|Overall Study|Reason not specified|2
7961556|NCT02700997|12515006|FG000|Overall Study|Did not undergo CT imaging|1
7961557|NCT02700997|12515006|FG000|Overall Study|No CT measurement - pelvic calcification|1
7961558|NCT02701296|12515090|FG000|Overall Study|Incomplete Data|0
7961559|NCT02701296|12515091|FG001|Overall Study|Incomplete Data|2
7721315|NCT00543725|12145817|FG001|Overall Study|Withdrawal by Subject|13
7721316|NCT00543725|12145816|FG000|Overall Study|Lost to Follow-up|15
7721317|NCT00543725|12145817|FG001|Overall Study|Lost to Follow-up|11
7721318|NCT00543725|12145816|FG000|Overall Study|Other|3
7721319|NCT00543725|12145817|FG001|Overall Study|Other|3
7721320|NCT00543803|12145836|FG000|Overall Study|Adverse Event|14
7721321|NCT00543803|12145836|FG000|Overall Study|Lack of Efficacy|22
7721322|NCT00543803|12145836|FG000|Overall Study|Lost to Follow-up|20
7721323|NCT00543803|12145836|FG000|Overall Study|Other|86
7721324|NCT00543855|12145846|FG000|Overall Study|Adverse Event|3
7721325|NCT00543855|12145847|FG001|Overall Study|Adverse Event|1
7721326|NCT00543855|12145848|FG002|Overall Study|Adverse Event|3
7721327|NCT00543855|12145849|FG003|Overall Study|Adverse Event|4
7721328|NCT00543855|12145846|FG000|Overall Study|Lost to Follow-up|0
7721329|NCT00543855|12145847|FG001|Overall Study|Lost to Follow-up|0
7721330|NCT00543855|12145848|FG002|Overall Study|Lost to Follow-up|1
7721331|NCT00543855|12145849|FG003|Overall Study|Lost to Follow-up|0
7721332|NCT00543855|12145846|FG000|Overall Study|Withdrawal by Subject|0
7721333|NCT00543855|12145847|FG001|Overall Study|Withdrawal by Subject|1
7721334|NCT00543855|12145848|FG002|Overall Study|Withdrawal by Subject|2
7721335|NCT00543855|12145849|FG003|Overall Study|Withdrawal by Subject|0
7721336|NCT00543855|12145846|FG000|Overall Study|Protocol Violation|1
7721337|NCT00543855|12145847|FG001|Overall Study|Protocol Violation|0
7721338|NCT00543855|12145848|FG002|Overall Study|Protocol Violation|0
7721339|NCT00543855|12145849|FG003|Overall Study|Protocol Violation|0
7721340|NCT00543985|12145859|FG000|Overall Study|Withdrawal by Subject|4
7721341|NCT00544167|12145880|FG000|Overall Study|Adverse Event|21
7721342|NCT00544167|12145880|FG000|Overall Study|Physician Decision|8
7721343|NCT00544440|12145884|FG000|Overall Study|Other|1
7721344|NCT00544440|12145884|FG000|Overall Study|Adverse Event|1
7721345|NCT00544440|12145884|FG000|Overall Study|Withdrawal by Subject|2
7721346|NCT00544440|12145884|FG000|Overall Study|Subject Non-compliance|1
7721347|NCT00544440|12145884|FG000|Overall Study|Progressive Disease|47
7721348|NCT00544440|12145884|FG000|Overall Study|Other|5
7721349|NCT00544544|12145888|FG000|Overall Study|Withdrawal by Subject|1
7721350|NCT00544544|12145888|FG000|Overall Study|Adverse Event|1
7721351|NCT00544544|12145888|FG000|Overall Study|Lost to Follow-up|1
7721352|NCT00544557|12145892|FG000|Overall Study|Adverse Event|140
7721353|NCT00544557|12145892|FG000|Overall Study|Lack of Efficacy|196
7721354|NCT00544557|12145892|FG000|Overall Study|Other|98
7721355|NCT00544648|12145898|FG000|Overall Study|Withdrawal by Subject|1
7721356|NCT00544648|12145899|FG001|Overall Study|Withdrawal by Subject|0
7721357|NCT00544648|12145898|FG000|Overall Study|Adverse Event|1
7721358|NCT00544648|12145899|FG001|Overall Study|Adverse Event|1
7721359|NCT00544648|12145898|FG000|Overall Study|progression of disease|1
7721360|NCT00544648|12145899|FG001|Overall Study|progression of disease|0
7721361|NCT00544817|12145924|FG000|Combined Modality|Lack of Efficacy|2
7721362|NCT00544817|12145924|FG000|Combined Modality|Worsening Neurologic Symptoms|2
7961560|NCT02701361|12515100|FG000|Overall Study|Lost to Follow-up|5
7961561|NCT02701361|12515101|FG001|Overall Study|Lost to Follow-up|2
7961562|NCT02701361|12515102|FG002|Overall Study|Lost to Follow-up|1
7961563|NCT02701361|12515100|FG000|Overall Study|Withdrawal by Subject|4
7961564|NCT02701361|12515101|FG001|Overall Study|Withdrawal by Subject|0
7961565|NCT02701361|12515102|FG002|Overall Study|Withdrawal by Subject|0
7961566|NCT02701361|12515100|FG000|Overall Study|timed out in rehab center|0
7961567|NCT02701361|12515101|FG001|Overall Study|timed out in rehab center|1
7961568|NCT02701361|12515102|FG002|Overall Study|timed out in rehab center|0
7961569|NCT02701361|12515100|FG000|Overall Study|incarceration|0
7961570|NCT02701361|12515101|FG001|Overall Study|incarceration|0
7721363|NCT00544817|12145924|FG000|Combined Modality|Adverse Event|2
7721364|NCT00544817|12145924|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1
7721365|NCT00544817|12145924|FG000|No Treatment Interval|Lack of Efficacy|8
7721366|NCT00544817|12145924|FG000|No Treatment Interval|Physician Decision|3
7721367|NCT00544817|12145924|FG000|No Treatment Interval|Adverse Event|1
7721368|NCT00544817|12145924|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15
7721369|NCT00544817|12145924|FG000|Follow-up Systemic Therapy|Physician Decision|3
7721370|NCT00544817|12145924|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
7721371|NCT00544869|12145931|FG000|Overall Study|Rsolution of congenitive symptoms|3
7721372|NCT00544869|12145932|FG001|Overall Study|Rsolution of congenitive symptoms|0
7721373|NCT00544869|12145933|FG002|Overall Study|Rsolution of congenitive symptoms|0
7721374|NCT00544869|12145931|FG000|Overall Study|Adverse Event|6
7721375|NCT00544869|12145932|FG001|Overall Study|Adverse Event|1
7721376|NCT00544869|12145933|FG002|Overall Study|Adverse Event|0
7721377|NCT00544869|12145931|FG000|Overall Study|Lack of Efficacy|1
7721378|NCT00544869|12145932|FG001|Overall Study|Lack of Efficacy|1
7721379|NCT00544869|12145933|FG002|Overall Study|Lack of Efficacy|0
7721380|NCT00544869|12145931|FG000|Overall Study|Physician Decision|2
7721381|NCT00544869|12145932|FG001|Overall Study|Physician Decision|0
7721382|NCT00544869|12145933|FG002|Overall Study|Physician Decision|0
7721383|NCT00544882|12145943|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
7721384|NCT00544882|12145944|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
7721385|NCT00544882|12145945|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
7721386|NCT00544882|12145943|FG000|Cycle 1: Run-in Cycle|Adverse Event|1
7721387|NCT00544882|12145944|FG001|Cycle 1: Run-in Cycle|Adverse Event|0
7721388|NCT00544882|12145945|FG002|Cycle 1: Run-in Cycle|Adverse Event|0
7721389|NCT00544882|12145943|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
7721390|NCT00544882|12145944|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
7721391|NCT00544882|12145945|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
7721392|NCT00544882|12145943|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
7721393|NCT00544882|12145944|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
7721394|NCT00544882|12145945|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
7721395|NCT00544882|12145943|FG000|Cycle 3: Follow-up|Noncompliance|0
7721396|NCT00544882|12145944|FG001|Cycle 3: Follow-up|Noncompliance|1
7721397|NCT00544882|12145945|FG002|Cycle 3: Follow-up|Noncompliance|0
7721398|NCT00544882|12145943|FG000|Cycle 3: Follow-up|Pregnancy|0
7721399|NCT00544882|12145944|FG001|Cycle 3: Follow-up|Pregnancy|1
7721400|NCT00544882|12145945|FG002|Cycle 3: Follow-up|Pregnancy|0
7721401|NCT00545051|12145966|FG000|Overall Study|Adverse Event|7
7721402|NCT00545051|12145967|FG001|Overall Study|Adverse Event|3
7721403|NCT00545051|12145966|FG000|Overall Study|Death|1
7721404|NCT00545051|12145967|FG001|Overall Study|Death|0
7721405|NCT00545051|12145966|FG000|Overall Study|Violation of inclusion/exclusion|0
7721406|NCT00545051|12145967|FG001|Overall Study|Violation of inclusion/exclusion|2
7721407|NCT00545051|12145966|FG000|Overall Study|Protocol Violation|1
7721408|NCT00545051|12145967|FG001|Overall Study|Protocol Violation|0
7721409|NCT00545051|12145966|FG000|Overall Study|Withdrawal by Subject|0
7721410|NCT00545051|12145967|FG001|Overall Study|Withdrawal by Subject|1
7721411|NCT00545051|12145966|FG000|Overall Study|Administrative reasons|0
7721412|NCT00545051|12145967|FG001|Overall Study|Administrative reasons|1
7721413|NCT00545064|12145973|FG000|Overall Study|Lost to Follow-up|3
7721414|NCT00545064|12145973|FG000|Overall Study|Withdrawal by Subject|2
7721415|NCT00545064|12145973|FG000|Overall Study|did not complete course of treatment|1
7721416|NCT00545064|12145973|FG000|Overall Study|cancel all appointments, no rebooking|1
7721417|NCT00545064|12145973|FG000|Overall Study|inclement weather|1
7721418|NCT00545077|12145981|FG000|Overall Study|Treatment not received|5
7721419|NCT00545077|12145982|FG001|Overall Study|Treatment not received|1
7721420|NCT00545077|12145981|FG000|Overall Study|Disease Progression|131
7721421|NCT00545077|12145982|FG001|Overall Study|Disease Progression|98
7721422|NCT00545077|12145981|FG000|Overall Study|Withdrawal by Subject|3
7721423|NCT00545077|12145982|FG001|Overall Study|Withdrawal by Subject|14
7721424|NCT00545077|12145981|FG000|Overall Study|Physician Decision|6
7721425|NCT00545077|12145982|FG001|Overall Study|Physician Decision|3
7721426|NCT00545077|12145981|FG000|Overall Study|Lost to Follow-up|2
7961571|NCT02701361|12515102|FG002|Overall Study|incarceration|1
7961572|NCT02701413|12515129|FG000|Overall Study|Withdrawal by Subject|7
7961573|NCT02701413|12515130|FG001|Overall Study|Withdrawal by Subject|11
7961574|NCT02701634|12515149|FG000|Overall Study|Adverse Event|2
7961575|NCT02701634|12515150|FG001|Overall Study|Adverse Event|3
7961576|NCT02701634|12515149|FG000|Overall Study|Death|1
7961577|NCT02701634|12515150|FG001|Overall Study|Death|0
7961578|NCT02701634|12515149|FG000|Overall Study|Investigator's Discretion|7
7961579|NCT02701634|12515150|FG001|Overall Study|Investigator's Discretion|4
7961580|NCT02701634|12515149|FG000|Overall Study|Study terminated by Sponsor|15
7961581|NCT02701634|12515150|FG001|Overall Study|Study terminated by Sponsor|17
7961582|NCT02701634|12515149|FG000|Overall Study|Withdrew Consent|6
7961583|NCT02701634|12515150|FG001|Overall Study|Withdrew Consent|7
7961584|NCT02701634|12515149|FG000|Overall Study|Randomized but not treated|1
7961585|NCT02701634|12515150|FG001|Overall Study|Randomized but not treated|0
7961586|NCT02701764|12515178|FG000|Overall Study|Lost to Follow-up|0
7961587|NCT02701764|12515179|FG001|Overall Study|Lost to Follow-up|1
7961588|NCT02701985|12515201|FG000|Overall Study|Withdrawal by Subject|1
7961589|NCT02701985|12515202|FG001|Overall Study|Withdrawal by Subject|1
7961590|NCT02701985|12515201|FG000|Overall Study|Lost to Follow-up|1
7961591|NCT02701985|12515202|FG001|Overall Study|Lost to Follow-up|0
7961592|NCT02701985|12515201|FG000|Overall Study|Death|1
7961593|NCT02701985|12515202|FG001|Overall Study|Death|0
7961594|NCT02701985|12515201|FG000|Overall Study|Adverse Event|0
7961595|NCT02701985|12515202|FG001|Overall Study|Adverse Event|5
7961596|NCT02702011|12515213|FG000|Overall Study|Withdrawal by Subject|0
7961597|NCT02702011|12515214|FG001|Overall Study|Withdrawal by Subject|1
7961598|NCT02702011|12515215|FG002|Overall Study|Withdrawal by Subject|0
7961599|NCT02702011|12515216|FG003|Overall Study|Withdrawal by Subject|0
7961600|NCT02702193|12515228|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1
7961601|NCT02702193|12515229|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0
7961602|NCT02702193|12515228|FG000|4 Month Follow up|Withdrawal by Subject|1
7961603|NCT02702193|12515229|FG001|4 Month Follow up|Withdrawal by Subject|0
7961604|NCT02702193|12515228|FG000|4 Month Follow up|Lost to Follow-up|17
7961605|NCT02702193|12515229|FG001|4 Month Follow up|Lost to Follow-up|18
7961606|NCT02702193|12515228|FG000|8 Month Follow up|Withdrawal by Subject|1
7961607|NCT02702193|12515229|FG001|8 Month Follow up|Withdrawal by Subject|0
7961608|NCT02702193|12515228|FG000|8 Month Follow up|Lost to Follow-up|14
7961609|NCT02702193|12515229|FG001|8 Month Follow up|Lost to Follow-up|18
7961610|NCT02702193|12515228|FG000|12 Month Follow up|Withdrawal by Subject|1
7961611|NCT02702193|12515229|FG001|12 Month Follow up|Withdrawal by Subject|0
7961612|NCT02702193|12515228|FG000|12 Month Follow up|Lost to Follow-up|16
7721427|NCT00545077|12145982|FG001|Overall Study|Lost to Follow-up|0
7721428|NCT00545077|12145981|FG000|Overall Study|Protocol Violation|1
7721429|NCT00545077|12145982|FG001|Overall Study|Protocol Violation|0
7721430|NCT00545077|12145981|FG000|Overall Study|Adverse Event|0
7721431|NCT00545077|12145982|FG001|Overall Study|Adverse Event|31
7721432|NCT00545077|12145981|FG000|Overall Study|Death|0
7721433|NCT00545077|12145982|FG001|Overall Study|Death|8
7721434|NCT00545103|12145992|FG000|Overall Study|Lack of Efficacy|48
7721435|NCT00545103|12145993|FG001|Overall Study|Lack of Efficacy|45
7721436|NCT00545103|12145994|FG002|Overall Study|Lack of Efficacy|31
7721437|NCT00545103|12145995|FG003|Overall Study|Lack of Efficacy|27
7721438|NCT00545103|12145992|FG000|Overall Study|Withdrawal by Subject|6
7721439|NCT00545103|12145993|FG001|Overall Study|Withdrawal by Subject|10
7721440|NCT00545103|12145994|FG002|Overall Study|Withdrawal by Subject|18
7721441|NCT00545103|12145995|FG003|Overall Study|Withdrawal by Subject|22
7721442|NCT00545103|12145992|FG000|Overall Study|Adverse Event|11
7721443|NCT00545103|12145993|FG001|Overall Study|Adverse Event|12
7721444|NCT00545103|12145994|FG002|Overall Study|Adverse Event|17
7721445|NCT00545103|12145995|FG003|Overall Study|Adverse Event|10
7721446|NCT00545103|12145992|FG000|Overall Study|Lost to Follow-up|4
7721447|NCT00545103|12145993|FG001|Overall Study|Lost to Follow-up|6
7721448|NCT00545103|12145994|FG002|Overall Study|Lost to Follow-up|3
7721449|NCT00545103|12145995|FG003|Overall Study|Lost to Follow-up|4
7721450|NCT00545103|12145992|FG000|Overall Study|Protocol Violation|1
7721451|NCT00545103|12145993|FG001|Overall Study|Protocol Violation|2
7721452|NCT00545103|12145994|FG002|Overall Study|Protocol Violation|3
7721453|NCT00545103|12145995|FG003|Overall Study|Protocol Violation|0
7721454|NCT00545103|12145992|FG000|Overall Study|Suspected recurrence of diverticulitis|1
7721455|NCT00545103|12145993|FG001|Overall Study|Suspected recurrence of diverticulitis|0
7721456|NCT00545103|12145994|FG002|Overall Study|Suspected recurrence of diverticulitis|0
7721457|NCT00545103|12145995|FG003|Overall Study|Suspected recurrence of diverticulitis|3
7721458|NCT00545103|12145992|FG000|Overall Study|Difficult to open package|0
7721459|NCT00545103|12145993|FG001|Overall Study|Difficult to open package|0
7721460|NCT00545103|12145994|FG002|Overall Study|Difficult to open package|0
7721461|NCT00545103|12145995|FG003|Overall Study|Difficult to open package|1
7721462|NCT00545103|12145992|FG000|Overall Study|Investigational product not taken|1
7721463|NCT00545103|12145993|FG001|Overall Study|Investigational product not taken|0
7721464|NCT00545103|12145994|FG002|Overall Study|Investigational product not taken|0
7721465|NCT00545103|12145995|FG003|Overall Study|Investigational product not taken|1
7721466|NCT00545103|12145992|FG000|Overall Study|Wish to start a family|0
7721467|NCT00545103|12145993|FG001|Overall Study|Wish to start a family|0
7721468|NCT00545103|12145994|FG002|Overall Study|Wish to start a family|0
7721469|NCT00545103|12145995|FG003|Overall Study|Wish to start a family|1
7721470|NCT00545103|12145992|FG000|Overall Study|Diverticulitis crisis|0
7721471|NCT00545103|12145993|FG001|Overall Study|Diverticulitis crisis|0
7721472|NCT00545103|12145994|FG002|Overall Study|Diverticulitis crisis|0
7721473|NCT00545103|12145995|FG003|Overall Study|Diverticulitis crisis|1
7721474|NCT00545103|12145992|FG000|Overall Study|Personal reasons|1
7721475|NCT00545103|12145993|FG001|Overall Study|Personal reasons|0
7721476|NCT00545103|12145994|FG002|Overall Study|Personal reasons|0
7721477|NCT00545103|12145995|FG003|Overall Study|Personal reasons|0
7721478|NCT00545103|12145992|FG000|Overall Study|Subject's decision|1
7721479|NCT00545103|12145993|FG001|Overall Study|Subject's decision|0
7721480|NCT00545103|12145994|FG002|Overall Study|Subject's decision|0
7721481|NCT00545103|12145995|FG003|Overall Study|Subject's decision|0
7961613|NCT02702193|12515229|FG001|12 Month Follow up|Lost to Follow-up|18
7961614|NCT02702388|12515237|FG000|Overall Study|Disease Progression|18
7961615|NCT02702388|12515238|FG001|Overall Study|Disease Progression|25
7961616|NCT02702388|12515237|FG000|Overall Study|Withdrawal by Subject|9
7961617|NCT02702388|12515238|FG001|Overall Study|Withdrawal by Subject|7
7961618|NCT02702388|12515237|FG000|Overall Study|Adverse Event|11
7961619|NCT02702388|12515238|FG001|Overall Study|Adverse Event|15
7961620|NCT02702388|12515237|FG000|Overall Study|Other|2
7961621|NCT02702388|12515238|FG001|Overall Study|Other|4
7961622|NCT02702518|12515255|FG000|Overall Study|Lost to Follow-up|3
7961623|NCT02702518|12515256|FG001|Overall Study|Lost to Follow-up|4
7961624|NCT02702609|12515264|FG000|Overall Study|Lost to Follow-up|8
7961625|NCT02702609|12515265|FG001|Overall Study|Lost to Follow-up|4
7961626|NCT02702609|12515264|FG000|Overall Study|Physician Decision|1
7961627|NCT02702609|12515265|FG001|Overall Study|Physician Decision|0
7961628|NCT02703259|12515291|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1
7961629|NCT02703259|12515292|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4
7961630|NCT02703259|12515291|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1
7961631|NCT02703259|12515292|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2
7961632|NCT02703259|12515291|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10
7961633|NCT02703259|12515292|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10
7961634|NCT02703311|12515298|FG000|Overall Study|Death|5
7961635|NCT02703311|12515298|FG000|Overall Study|Withdrawal by Subject|3
7961636|NCT02703324|12515302|FG000|Period Two|Withdrawal by Subject|0
7961637|NCT02703324|12515303|FG001|Period Two|Withdrawal by Subject|0
7961638|NCT02703324|12515304|FG002|Period Two|Withdrawal by Subject|1
7961639|NCT02703324|12515305|FG003|Period Two|Withdrawal by Subject|0
7961640|NCT02703324|12515306|FG004|Period Two|Withdrawal by Subject|0
7961641|NCT02703324|12515307|FG005|Period Two|Withdrawal by Subject|0
7961642|NCT02703337|12515316|FG000|Period One (Part A)|Withdrawal by Subject|0
7721482|NCT00545103|12145992|FG000|Overall Study|Noncompliance|0
7721483|NCT00545103|12145993|FG001|Overall Study|Noncompliance|1
7721484|NCT00545103|12145994|FG002|Overall Study|Noncompliance|0
7721485|NCT00545103|12145995|FG003|Overall Study|Noncompliance|0
7721486|NCT00545103|12145992|FG000|Overall Study|Investigator decision|0
7721487|NCT00545103|12145993|FG001|Overall Study|Investigator decision|0
7721488|NCT00545103|12145994|FG002|Overall Study|Investigator decision|1
7721489|NCT00545103|12145995|FG003|Overall Study|Investigator decision|0
7721490|NCT00545103|12145992|FG000|Overall Study|Subject moved|0
7721491|NCT00545103|12145993|FG001|Overall Study|Subject moved|1
7721492|NCT00545103|12145994|FG002|Overall Study|Subject moved|0
7721493|NCT00545103|12145995|FG003|Overall Study|Subject moved|0
7721494|NCT00545103|12145992|FG000|Overall Study|Use of prohibited medication|0
7721495|NCT00545103|12145993|FG001|Overall Study|Use of prohibited medication|0
7721496|NCT00545103|12145994|FG002|Overall Study|Use of prohibited medication|1
7721497|NCT00545103|12145995|FG003|Overall Study|Use of prohibited medication|0
7721498|NCT00545103|12145992|FG000|Overall Study|Does not want to take study drug anymore|1
7721499|NCT00545103|12145993|FG001|Overall Study|Does not want to take study drug anymore|0
7721500|NCT00545103|12145994|FG002|Overall Study|Does not want to take study drug anymore|1
7721501|NCT00545103|12145995|FG003|Overall Study|Does not want to take study drug anymore|0
7721502|NCT00545103|12145992|FG000|Overall Study|Subject met endpoint under protocol v. 1|0
7721503|NCT00545103|12145993|FG001|Overall Study|Subject met endpoint under protocol v. 1|0
7721504|NCT00545103|12145994|FG002|Overall Study|Subject met endpoint under protocol v. 1|1
7721505|NCT00545103|12145995|FG003|Overall Study|Subject met endpoint under protocol v. 1|0
7721506|NCT00545103|12145992|FG000|Overall Study|Death|0
7721507|NCT00545103|12145993|FG001|Overall Study|Death|1
7721508|NCT00545103|12145994|FG002|Overall Study|Death|0
7721509|NCT00545103|12145995|FG003|Overall Study|Death|0
7721510|NCT00545168|12146012|FG000|Overall Study|Lost to Follow-up|5
7721511|NCT00545168|12146013|FG001|Overall Study|Lost to Follow-up|5
7721512|NCT00545168|12146014|FG002|Overall Study|Lost to Follow-up|5
7721513|NCT00545168|12146012|FG000|Overall Study|Withdrawal by Subject|9
7721514|NCT00545168|12146013|FG001|Overall Study|Withdrawal by Subject|0
7721515|NCT00545168|12146014|FG002|Overall Study|Withdrawal by Subject|13
7721516|NCT00545168|12146012|FG000|Overall Study|Protocol Violation|1
7721517|NCT00545168|12146013|FG001|Overall Study|Protocol Violation|0
7721518|NCT00545168|12146014|FG002|Overall Study|Protocol Violation|1
7721519|NCT00545168|12146012|FG000|Overall Study|Visit for Day 21 was not done in error|1
7721520|NCT00545168|12146013|FG001|Overall Study|Visit for Day 21 was not done in error|0
7961643|NCT02703337|12515317|FG001|Period One (Part A)|Withdrawal by Subject|0
7961644|NCT02703337|12515318|FG002|Period One (Part A)|Withdrawal by Subject|0
7961645|NCT02703337|12515319|FG003|Period One (Part A)|Withdrawal by Subject|0
7961646|NCT02703337|12515320|FG004|Period One (Part A)|Withdrawal by Subject|1
7961647|NCT02703337|12515321|FG005|Period One (Part A)|Withdrawal by Subject|0
7961648|NCT02703337|12515322|FG006|Period One (Part A)|Withdrawal by Subject|0
7961649|NCT02703337|12515323|FG007|Period One (Part A)|Withdrawal by Subject|0
7961650|NCT02703454|12515368|FG000|Overall Study|Not treated|1
7961651|NCT02703454|12515369|FG001|Overall Study|Not treated|3
7961652|NCT02703454|12515368|FG000|Overall Study|Withdrawal by Subject|4
7961653|NCT02703454|12515369|FG001|Overall Study|Withdrawal by Subject|3
7961654|NCT02703454|12515368|FG000|Overall Study|Lost to Follow-up|1
7961655|NCT02703454|12515369|FG001|Overall Study|Lost to Follow-up|2
7961656|NCT02703454|12515368|FG000|Overall Study|Study discontinuation|5
7961657|NCT02703454|12515369|FG001|Overall Study|Study discontinuation|8
7961658|NCT02703532|12515396|FG000|Overall Study|Withdrawal by Subject|0
7961659|NCT02703532|12515397|FG001|Overall Study|Withdrawal by Subject|1
7961660|NCT02703532|12515398|FG002|Overall Study|Withdrawal by Subject|0
7961661|NCT02703532|12515399|FG003|Overall Study|Withdrawal by Subject|1
7961662|NCT02703532|12515396|FG000|Overall Study|Lost to Follow-up|2
7961663|NCT02703532|12515397|FG001|Overall Study|Lost to Follow-up|0
7961664|NCT02703532|12515398|FG002|Overall Study|Lost to Follow-up|2
7961665|NCT02703532|12515399|FG003|Overall Study|Lost to Follow-up|0
7961666|NCT02703636|12515409|FG000|Overall Study|Adverse Event|14
7961667|NCT02703636|12515409|FG000|Overall Study|Study stopped by sponsor|1
7961668|NCT02703636|12515409|FG000|Overall Study|Withdrawal by Subject|1
7961669|NCT02704091|12515452|FG000|Overall Study|Adverse Event|4
7961670|NCT02704091|12515453|FG001|Overall Study|Adverse Event|3
7961671|NCT02704091|12515452|FG000|Overall Study|Protocol Violation|5
7961672|NCT02704091|12515453|FG001|Overall Study|Protocol Violation|3
7961673|NCT02704091|12515452|FG000|Overall Study|Consent withdrawn|4
7961674|NCT02704091|12515453|FG001|Overall Study|Consent withdrawn|4
7961675|NCT02704091|12515452|FG000|Overall Study|Lost to Follow-up|13
7961676|NCT02704091|12515453|FG001|Overall Study|Lost to Follow-up|5
7961677|NCT02704091|12515452|FG000|Overall Study|Other|2
7961678|NCT02704091|12515453|FG001|Overall Study|Other|8
7961679|NCT02704143|12515467|FG000|Overall Study|disease progression|10
7961680|NCT02704689|12515471|FG000|Overall Study|Physician Decision|1
7961681|NCT02704689|12515471|FG000|Overall Study|Study device not implanted|2
7961682|NCT02705586|12515522|FG000|Overall Study|Health Issues|2
7961683|NCT02705586|12515522|FG000|Overall Study|Transportation Difficulties|5
7961684|NCT02705586|12515522|FG000|Overall Study|Vacation/Planned Absence|1
7961685|NCT02705625|12515529|FG000|Overall Study|Protocol Violation|1
7961686|NCT02705625|12515530|FG001|Overall Study|Protocol Violation|0
7961687|NCT02705625|12515531|FG002|Overall Study|Protocol Violation|0
7961688|NCT02705625|12515529|FG000|Overall Study|Adverse Event|6
7961689|NCT02705625|12515530|FG001|Overall Study|Adverse Event|5
7961690|NCT02705625|12515531|FG002|Overall Study|Adverse Event|2
7961691|NCT02705625|12515529|FG000|Overall Study|Death|0
7961692|NCT02705625|12515530|FG001|Overall Study|Death|0
7961693|NCT02705625|12515531|FG002|Overall Study|Death|1
7961694|NCT02705625|12515529|FG000|Overall Study|Withdrawal by Subject|1
7961695|NCT02705625|12515530|FG001|Overall Study|Withdrawal by Subject|4
7961696|NCT02705625|12515531|FG002|Overall Study|Withdrawal by Subject|5
7961697|NCT02705625|12515529|FG000|Overall Study|Lost to Follow-up|0
7961698|NCT02705625|12515530|FG001|Overall Study|Lost to Follow-up|0
7961699|NCT02705625|12515531|FG002|Overall Study|Lost to Follow-up|1
7961700|NCT02705625|12515529|FG000|Overall Study|Non-compliance|0
7961701|NCT02705625|12515530|FG001|Overall Study|Non-compliance|1
7961702|NCT02705625|12515531|FG002|Overall Study|Non-compliance|1
7961703|NCT02705625|12515529|FG000|Overall Study|Overdosing|0
7961704|NCT02705625|12515530|FG001|Overall Study|Overdosing|0
7961705|NCT02705625|12515531|FG002|Overall Study|Overdosing|1
7961706|NCT02705716|12515541|FG000|Overall Study|Adverse Event|0
7961707|NCT02705716|12515542|FG001|Overall Study|Adverse Event|1
7767886|NCT00856544|12210720|FG001|Overall Study|Randomized but not treated|0
7961708|NCT02705716|12515541|FG000|Overall Study|Protocol Violation|3
7961709|NCT02705716|12515542|FG001|Overall Study|Protocol Violation|0
7961710|NCT02705716|12515541|FG000|Overall Study|Withdrawal of Consent|1
7961711|NCT02705716|12515542|FG001|Overall Study|Withdrawal of Consent|1
7961712|NCT02706327|12515575|FG000|Overall Study|Lost to Follow-up|1
7961713|NCT02706327|12515576|FG001|Overall Study|Lost to Follow-up|1
7961714|NCT02706327|12515577|FG002|Overall Study|Lost to Follow-up|2
7961715|NCT02706483|12515585|FG000|Overall Study|Adverse Event|97
7961716|NCT02706483|12515585|FG000|Overall Study|Death|1
7961717|NCT02706483|12515585|FG000|Overall Study|Lack of Efficacy|39
7961718|NCT02706483|12515585|FG000|Overall Study|Lost to Follow-up|101
7961719|NCT02706483|12515585|FG000|Overall Study|Non-compliance with study drug|15
7961720|NCT02706483|12515585|FG000|Overall Study|Physician Decision|6
7961721|NCT02706483|12515585|FG000|Overall Study|Pregnancy|6
7961722|NCT02706483|12515585|FG000|Overall Study|Protocol Violation|18
7961723|NCT02706483|12515585|FG000|Overall Study|Withdrawal by Subject|136
7961724|NCT02706483|12515585|FG000|Overall Study|Non-compliance with visits|6
7961725|NCT02706483|12515585|FG000|Overall Study|Site closure|4
7961726|NCT02706483|12515585|FG000|Overall Study|Subject moved|1
7961727|NCT02706717|12515591|FG000|Overall Study|Withdrawal by Subject|1
7961728|NCT02706717|12515592|FG001|Overall Study|Withdrawal by Subject|8
7961729|NCT02706717|12515591|FG000|Overall Study|Lost to Follow-up|0
7961730|NCT02706717|12515592|FG001|Overall Study|Lost to Follow-up|1
7961731|NCT02706717|12515591|FG000|Overall Study|Physician Decision|0
7961732|NCT02706717|12515592|FG001|Overall Study|Physician Decision|1
7961733|NCT02706717|12515591|FG000|Overall Study|Death|0
7961734|NCT02706717|12515592|FG001|Overall Study|Death|1
7961735|NCT02706834|12515609|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7961736|NCT02706834|12515610|FG001|Overall Study|Pretreatment Event/Adverse Event|1
7961737|NCT02706834|12515611|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7961738|NCT02706834|12515612|FG003|Overall Study|Pretreatment Event/Adverse Event|0
7961739|NCT02706834|12515613|FG004|Overall Study|Pretreatment Event/Adverse Event|0
7961740|NCT02706834|12515614|FG005|Overall Study|Pretreatment Event/Adverse Event|0
7961741|NCT02706834|12515615|FG006|Overall Study|Pretreatment Event/Adverse Event|0
7961742|NCT02706834|12515616|FG007|Overall Study|Pretreatment Event/Adverse Event|0
7961743|NCT02706834|12515617|FG008|Overall Study|Pretreatment Event/Adverse Event|0
7961744|NCT02706834|12515618|FG009|Overall Study|Pretreatment Event/Adverse Event|0
7961745|NCT02706834|12515619|FG010|Overall Study|Pretreatment Event/Adverse Event|1
7961746|NCT02706834|12515609|FG000|Overall Study|Lost to Follow-up|0
7961747|NCT02706834|12515610|FG001|Overall Study|Lost to Follow-up|0
7961748|NCT02706834|12515611|FG002|Overall Study|Lost to Follow-up|1
7961749|NCT02706834|12515612|FG003|Overall Study|Lost to Follow-up|0
7961750|NCT02706834|12515613|FG004|Overall Study|Lost to Follow-up|0
7961751|NCT02706834|12515614|FG005|Overall Study|Lost to Follow-up|0
7961752|NCT02706834|12515615|FG006|Overall Study|Lost to Follow-up|0
7961753|NCT02706834|12515616|FG007|Overall Study|Lost to Follow-up|0
7961754|NCT02706834|12515617|FG008|Overall Study|Lost to Follow-up|0
7961755|NCT02706834|12515618|FG009|Overall Study|Lost to Follow-up|0
7961756|NCT02706834|12515619|FG010|Overall Study|Lost to Follow-up|0
7961757|NCT02706834|12515609|FG000|Overall Study|Voluntary Withdrawal|1
7961758|NCT02706834|12515610|FG001|Overall Study|Voluntary Withdrawal|0
7961759|NCT02706834|12515611|FG002|Overall Study|Voluntary Withdrawal|0
7961760|NCT02706834|12515612|FG003|Overall Study|Voluntary Withdrawal|0
7961761|NCT02706834|12515613|FG004|Overall Study|Voluntary Withdrawal|0
7961762|NCT02706834|12515614|FG005|Overall Study|Voluntary Withdrawal|0
7961763|NCT02706834|12515615|FG006|Overall Study|Voluntary Withdrawal|0
7961764|NCT02706834|12515616|FG007|Overall Study|Voluntary Withdrawal|0
7961765|NCT02706834|12515617|FG008|Overall Study|Voluntary Withdrawal|0
7961766|NCT02706834|12515618|FG009|Overall Study|Voluntary Withdrawal|1
7961767|NCT02706834|12515619|FG010|Overall Study|Voluntary Withdrawal|0
7961768|NCT02706834|12515609|FG000|Overall Study|Other Reason Not Specified|1
7961769|NCT02706834|12515610|FG001|Overall Study|Other Reason Not Specified|0
7961770|NCT02706834|12515611|FG002|Overall Study|Other Reason Not Specified|0
7961771|NCT02706834|12515612|FG003|Overall Study|Other Reason Not Specified|0
7961772|NCT02706834|12515613|FG004|Overall Study|Other Reason Not Specified|1
7961773|NCT02706834|12515614|FG005|Overall Study|Other Reason Not Specified|0
7961774|NCT02706834|12515615|FG006|Overall Study|Other Reason Not Specified|0
7961775|NCT02706834|12515616|FG007|Overall Study|Other Reason Not Specified|0
7961776|NCT02706834|12515617|FG008|Overall Study|Other Reason Not Specified|0
7961777|NCT02706834|12515618|FG009|Overall Study|Other Reason Not Specified|0
7961778|NCT02706834|12515619|FG010|Overall Study|Other Reason Not Specified|0
7961779|NCT02706886|12515673|FG000|Part A: SAD Period|Withdrawal by Subject|0
7961780|NCT02706886|12515674|FG001|Part A: SAD Period|Withdrawal by Subject|0
7961781|NCT02706886|12515675|FG002|Part A: SAD Period|Withdrawal by Subject|0
7961782|NCT02706886|12515676|FG003|Part A: SAD Period|Withdrawal by Subject|2
7961783|NCT02706886|12515677|FG004|Part A: SAD Period|Withdrawal by Subject|0
7961784|NCT02706886|12515678|FG005|Part A: SAD Period|Withdrawal by Subject|0
7961785|NCT02706886|12515679|FG006|Part A: SAD Period|Withdrawal by Subject|0
7961786|NCT02706886|12515680|FG007|Part A: SAD Period|Withdrawal by Subject|0
7961787|NCT02706886|12515681|FG008|Part A: SAD Period|Withdrawal by Subject|0
7961788|NCT02706899|12515726|FG000|Overall Study|Withdrawal by Subject|1
7961789|NCT02706899|12515727|FG001|Overall Study|Withdrawal by Subject|0
7961790|NCT02706899|12515726|FG000|Overall Study|Death|8
7961791|NCT02706899|12515727|FG001|Overall Study|Death|0
7961792|NCT02706899|12515726|FG000|Overall Study|Study Termination by Sponsor|4
7961793|NCT02706899|12515727|FG001|Overall Study|Study Termination by Sponsor|6
7961794|NCT02706938|12515780|FG000|First Period, 6 Weeks|Adverse Event|8
7961795|NCT02706938|12515781|FG001|First Period, 6 Weeks|Adverse Event|0
7961796|NCT02706938|12515780|FG000|First Period, 6 Weeks|Lost to Follow-up|2
7961797|NCT02706938|12515781|FG001|First Period, 6 Weeks|Lost to Follow-up|2
7961798|NCT02706938|12515780|FG000|First Period, 6 Weeks|Withdrawal by Subject|1
7961799|NCT02706938|12515781|FG001|First Period, 6 Weeks|Withdrawal by Subject|0
7961800|NCT02706938|12515780|FG000|Second Period, 6 Weeks|Adverse Event|0
7961801|NCT02706938|12515781|FG001|Second Period, 6 Weeks|Adverse Event|7
7961802|NCT02706938|12515780|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0
7961803|NCT02706938|12515781|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3
7961804|NCT02707601|12515826|FG000|Overall Study|Death|0
7961805|NCT02707601|12515827|FG001|Overall Study|Death|1
7961806|NCT02707601|12515826|FG000|Overall Study|Lack of Efficacy|0
7961807|NCT02707601|12515827|FG001|Overall Study|Lack of Efficacy|1
7961808|NCT02707601|12515826|FG000|Overall Study|Investigator's Discretion|1
7961809|NCT02707601|12515827|FG001|Overall Study|Investigator's Discretion|0
7961810|NCT02707601|12515826|FG000|Overall Study|Withdrew Consent|0
7961811|NCT02707601|12515827|FG001|Overall Study|Withdrew Consent|1
7961812|NCT02707601|12515826|FG000|Overall Study|Lost to Follow-up|1
7961813|NCT02707601|12515827|FG001|Overall Study|Lost to Follow-up|1
7961814|NCT02707601|12515826|FG000|Overall Study|Participants Randomized but Not Treated|2
7961815|NCT02707601|12515827|FG001|Overall Study|Participants Randomized but Not Treated|0
7961816|NCT02707640|12515839|FG000|Overall Study|Adverse Event|4
7961817|NCT02707640|12515840|FG001|Overall Study|Adverse Event|2
7961818|NCT02707640|12515839|FG000|Overall Study|Death|1
7961819|NCT02707640|12515840|FG001|Overall Study|Death|2
7961820|NCT02707640|12515839|FG000|Overall Study|Physician Decision|2
7961821|NCT02707640|12515840|FG001|Overall Study|Physician Decision|0
7961822|NCT02707640|12515839|FG000|Overall Study|Withdrawal by Subject|0
7961823|NCT02707640|12515840|FG001|Overall Study|Withdrawal by Subject|1
7961824|NCT02707640|12515839|FG000|Overall Study|Participant's Personal Decision|1
7961825|NCT02707640|12515840|FG001|Overall Study|Participant's Personal Decision|2
7961826|NCT02707640|12515839|FG000|Overall Study|Sponsor Discretion|1
7961827|NCT02707640|12515840|FG001|Overall Study|Sponsor Discretion|0
7961828|NCT02707757|12515848|FG000|Overall Study|Protocol Violation|3
7961829|NCT02707757|12515849|FG001|Overall Study|Protocol Violation|2
7961830|NCT02707757|12515848|FG000|Overall Study|Withdrawal by Subject|2
7961831|NCT02707757|12515849|FG001|Overall Study|Withdrawal by Subject|0
7961832|NCT02707757|12515848|FG000|Overall Study|Death|0
7961833|NCT02707757|12515849|FG001|Overall Study|Death|1
7961834|NCT02707757|12515848|FG000|Overall Study|Adverse Event|6
7961835|NCT02707757|12515849|FG001|Overall Study|Adverse Event|4
7961836|NCT02707757|12515848|FG000|Overall Study|Renal transplant/elective operation|1
7961837|NCT02707757|12515849|FG001|Overall Study|Renal transplant/elective operation|5
7961838|NCT02707861|12515868|FG000|Overall Study|Went onto commercial drug|30
7961839|NCT02707861|12515869|FG001|Overall Study|Went onto commercial drug|23
7961840|NCT02707861|12515868|FG000|Overall Study|Adverse Event|2
7961841|NCT02707861|12515869|FG001|Overall Study|Adverse Event|3
7961842|NCT02707861|12515868|FG000|Overall Study|Death|5
7961843|NCT02707861|12515869|FG001|Overall Study|Death|2
7961844|NCT02707861|12515868|FG000|Overall Study|Lack of Efficacy|0
7961845|NCT02707861|12515869|FG001|Overall Study|Lack of Efficacy|2
7961846|NCT02707861|12515868|FG000|Overall Study|Physician Decision|1
7961847|NCT02707861|12515869|FG001|Overall Study|Physician Decision|4
7961848|NCT02707861|12515868|FG000|Overall Study|Withdrawal by Subject|2
7961849|NCT02707861|12515869|FG001|Overall Study|Withdrawal by Subject|1
7961850|NCT02707861|12515868|FG000|Overall Study|Lost to Follow-up|1
7961851|NCT02707861|12515869|FG001|Overall Study|Lost to Follow-up|3
7961852|NCT02707952|12515879|FG000|Overall Study|Adverse Event|1
7961853|NCT02707952|12515880|FG001|Overall Study|Adverse Event|0
7961854|NCT02707952|12515881|FG002|Overall Study|Adverse Event|0
7961855|NCT02707952|12515882|FG003|Overall Study|Adverse Event|0
7961856|NCT02707952|12515879|FG000|Overall Study|Lost to Follow-up|1
7961857|NCT02707952|12515880|FG001|Overall Study|Lost to Follow-up|0
7961858|NCT02707952|12515881|FG002|Overall Study|Lost to Follow-up|0
7961859|NCT02707952|12515882|FG003|Overall Study|Lost to Follow-up|0
7961860|NCT02707952|12515879|FG000|Overall Study|Withdrawal by Subject|0
7961861|NCT02707952|12515880|FG001|Overall Study|Withdrawal by Subject|1
7961862|NCT02707952|12515881|FG002|Overall Study|Withdrawal by Subject|2
7961863|NCT02707952|12515882|FG003|Overall Study|Withdrawal by Subject|0
7961864|NCT02707965|12515903|FG000|Overall Study|Withdrawal by Subject|0
7961865|NCT02707965|12515904|FG001|Overall Study|Withdrawal by Subject|0
7961866|NCT02707965|12515905|FG002|Overall Study|Withdrawal by Subject|1
7961867|NCT02707965|12515906|FG003|Overall Study|Withdrawal by Subject|0
7961868|NCT02707965|12515907|FG004|Overall Study|Withdrawal by Subject|0
7961869|NCT02707965|12515908|FG005|Overall Study|Withdrawal by Subject|0
7961870|NCT02707965|12515909|FG006|Overall Study|Withdrawal by Subject|0
7961871|NCT02707965|12515910|FG007|Overall Study|Withdrawal by Subject|2
7961872|NCT02707965|12515911|FG008|Overall Study|Withdrawal by Subject|0
7961873|NCT02707965|12515912|FG009|Overall Study|Withdrawal by Subject|0
7961874|NCT02707965|12515913|FG010|Overall Study|Withdrawal by Subject|0
7961875|NCT02707965|12515914|FG011|Overall Study|Withdrawal by Subject|0
7961876|NCT02707965|12515915|FG012|Overall Study|Withdrawal by Subject|0
7961877|NCT02707965|12515916|FG013|Overall Study|Withdrawal by Subject|0
7961878|NCT02707965|12515917|FG014|Overall Study|Withdrawal by Subject|0
7961879|NCT02707965|12515918|FG015|Overall Study|Withdrawal by Subject|0
7961880|NCT02707965|12515903|FG000|Overall Study|PI decisions|0
7961881|NCT02707965|12515904|FG001|Overall Study|PI decisions|0
7961882|NCT02707965|12515905|FG002|Overall Study|PI decisions|0
7961883|NCT02707965|12515906|FG003|Overall Study|PI decisions|0
7961884|NCT02707965|12515907|FG004|Overall Study|PI decisions|0
7961885|NCT02707965|12515908|FG005|Overall Study|PI decisions|0
7961886|NCT02707965|12515909|FG006|Overall Study|PI decisions|0
7961887|NCT02707965|12515910|FG007|Overall Study|PI decisions|0
7961888|NCT02707965|12515911|FG008|Overall Study|PI decisions|0
7961889|NCT02707965|12515912|FG009|Overall Study|PI decisions|0
7961890|NCT02707965|12515913|FG010|Overall Study|PI decisions|0
7961891|NCT02707965|12515914|FG011|Overall Study|PI decisions|0
7961892|NCT02707965|12515915|FG012|Overall Study|PI decisions|0
7961893|NCT02707965|12515916|FG013|Overall Study|PI decisions|0
7961894|NCT02707965|12515917|FG014|Overall Study|PI decisions|2
7961895|NCT02707965|12515918|FG015|Overall Study|PI decisions|0
7961896|NCT02707965|12515903|FG000|Overall Study|Protocol deviation|1
7961897|NCT02707965|12515904|FG001|Overall Study|Protocol deviation|1
7961898|NCT02707965|12515905|FG002|Overall Study|Protocol deviation|0
7961899|NCT02707965|12515906|FG003|Overall Study|Protocol deviation|0
7961900|NCT02707965|12515907|FG004|Overall Study|Protocol deviation|0
7961901|NCT02707965|12515908|FG005|Overall Study|Protocol deviation|0
7961902|NCT02707965|12515909|FG006|Overall Study|Protocol deviation|0
7961903|NCT02707965|12515910|FG007|Overall Study|Protocol deviation|1
7961904|NCT02707965|12515911|FG008|Overall Study|Protocol deviation|0
7961905|NCT02707965|12515912|FG009|Overall Study|Protocol deviation|0
7961906|NCT02707965|12515913|FG010|Overall Study|Protocol deviation|0
7961907|NCT02707965|12515914|FG011|Overall Study|Protocol deviation|0
7961908|NCT02707965|12515915|FG012|Overall Study|Protocol deviation|0
7961909|NCT02707965|12515916|FG013|Overall Study|Protocol deviation|0
7961910|NCT02707965|12515917|FG014|Overall Study|Protocol deviation|0
7961911|NCT02707965|12515918|FG015|Overall Study|Protocol deviation|0
7961912|NCT02707991|12515953|FG000|Overall Study|Protocol Violation|1
7961913|NCT02707991|12515954|FG001|Overall Study|Protocol Violation|0
7961914|NCT02707991|12515953|FG000|Overall Study|Became ineligible|0
7961915|NCT02707991|12515954|FG001|Overall Study|Became ineligible|1
7961916|NCT02708095|12515963|FG000|Overall Study|Adverse Event|4
7961917|NCT02708095|12515964|FG001|Overall Study|Adverse Event|10
7961918|NCT02708095|12515965|FG002|Overall Study|Adverse Event|11
7961919|NCT02708095|12515963|FG000|Overall Study|Lack of Efficacy|9
7961920|NCT02708095|12515964|FG001|Overall Study|Lack of Efficacy|3
7961921|NCT02708095|12515965|FG002|Overall Study|Lack of Efficacy|0
7961922|NCT02708095|12515963|FG000|Overall Study|Lost to Follow-up|2
7961923|NCT02708095|12515964|FG001|Overall Study|Lost to Follow-up|0
7961924|NCT02708095|12515965|FG002|Overall Study|Lost to Follow-up|0
7961925|NCT02708095|12515963|FG000|Overall Study|Physician Decision|2
7961926|NCT02708095|12515964|FG001|Overall Study|Physician Decision|3
7961927|NCT02708095|12515965|FG002|Overall Study|Physician Decision|2
7961928|NCT02708095|12515963|FG000|Overall Study|Protocol Violation|0
7961929|NCT02708095|12515964|FG001|Overall Study|Protocol Violation|0
7961930|NCT02708095|12515965|FG002|Overall Study|Protocol Violation|1
7961931|NCT02708095|12515963|FG000|Overall Study|Withdrawal by Subject|5
7961932|NCT02708095|12515964|FG001|Overall Study|Withdrawal by Subject|3
7961933|NCT02708095|12515965|FG002|Overall Study|Withdrawal by Subject|4
7961934|NCT02708121|12515977|FG000|Overall Study|Withdrawn by Study Team|1
7961935|NCT02708121|12515978|FG001|Overall Study|Withdrawn by Study Team|1
7961936|NCT02708121|12515977|FG000|Overall Study|Withdrawal by Subject|0
7961937|NCT02708121|12515978|FG001|Overall Study|Withdrawal by Subject|4
7961938|NCT02708277|12516021|FG000|Overall Study|Lost to Follow-up|7
7961939|NCT02708277|12516022|FG001|Overall Study|Lost to Follow-up|4
7961940|NCT02708355|12516040|FG000|Overall Study|Adverse Event|1
7961941|NCT02708355|12516041|FG001|Overall Study|Adverse Event|0
7961942|NCT02708355|12516042|FG002|Overall Study|Adverse Event|0
7961943|NCT02708485|12516059|FG000|Overall Study|Withdrawal by Subject|3
7961944|NCT02708485|12516060|FG001|Overall Study|Withdrawal by Subject|2
7961945|NCT02708498|12516074|FG000|Overall Study|Death|20
7961946|NCT02708498|12516075|FG001|Overall Study|Death|19
7961947|NCT02708498|12516076|FG002|Overall Study|Death|0
7961948|NCT02708498|12516077|FG003|Overall Study|Death|0
7961949|NCT02708498|12516078|FG004|Overall Study|Death|1
7961950|NCT02708498|12516079|FG005|Overall Study|Death|0
7961951|NCT02708498|12516080|FG006|Overall Study|Death|0
7961952|NCT02708498|12516081|FG007|Overall Study|Death|0
7961953|NCT02708498|12516074|FG000|Overall Study|Unknown reason, missing data|0
7961954|NCT02708498|12516075|FG001|Overall Study|Unknown reason, missing data|0
7961955|NCT02708498|12516076|FG002|Overall Study|Unknown reason, missing data|62
7961956|NCT02708498|12516077|FG003|Overall Study|Unknown reason, missing data|51
7961957|NCT02708498|12516078|FG004|Overall Study|Unknown reason, missing data|195
7961958|NCT02708498|12516079|FG005|Overall Study|Unknown reason, missing data|132
7961959|NCT02708498|12516080|FG006|Overall Study|Unknown reason, missing data|0
7961960|NCT02708498|12516081|FG007|Overall Study|Unknown reason, missing data|0
7961961|NCT02708524|12516101|FG000|Overall Study|Adverse Event|0
7961962|NCT02708524|12516102|FG001|Overall Study|Adverse Event|1
7961963|NCT02708524|12516103|FG002|Overall Study|Adverse Event|0
7961964|NCT02708524|12516104|FG003|Overall Study|Adverse Event|0
7961965|NCT02708524|12516101|FG000|Overall Study|Lens Discomfort|1
7961966|NCT02708524|12516102|FG001|Overall Study|Lens Discomfort|0
7961967|NCT02708524|12516103|FG002|Overall Study|Lens Discomfort|1
7961968|NCT02708524|12516104|FG003|Overall Study|Lens Discomfort|0
7961969|NCT02708524|12516101|FG000|Overall Study|Lost to Follow-up|1
7961970|NCT02708524|12516102|FG001|Overall Study|Lost to Follow-up|1
7961971|NCT02708524|12516103|FG002|Overall Study|Lost to Follow-up|1
7961972|NCT02708524|12516104|FG003|Overall Study|Lost to Follow-up|0
7961973|NCT02708524|12516101|FG000|Overall Study|Protocol Violation|0
7961974|NCT02708524|12516102|FG001|Overall Study|Protocol Violation|1
7961975|NCT02708524|12516103|FG002|Overall Study|Protocol Violation|0
7961976|NCT02708524|12516104|FG003|Overall Study|Protocol Violation|0
7961977|NCT02708524|12516101|FG000|Overall Study|Withdrawal by Subject|1
7961978|NCT02708524|12516102|FG001|Overall Study|Withdrawal by Subject|1
7961979|NCT02708524|12516103|FG002|Overall Study|Withdrawal by Subject|0
7961980|NCT02708524|12516104|FG003|Overall Study|Withdrawal by Subject|0
7961981|NCT02708524|12516101|FG000|Overall Study|Dispensed incorrect study lens|0
7961982|NCT02708524|12516102|FG001|Overall Study|Dispensed incorrect study lens|1
7961983|NCT02708524|12516103|FG002|Overall Study|Dispensed incorrect study lens|1
7961984|NCT02708524|12516104|FG003|Overall Study|Dispensed incorrect study lens|0
7961985|NCT02708524|12516101|FG000|Overall Study|Did not wear lens at final visit|0
7961986|NCT02708524|12516102|FG001|Overall Study|Did not wear lens at final visit|1
7961987|NCT02708524|12516103|FG002|Overall Study|Did not wear lens at final visit|0
7961988|NCT02708524|12516104|FG003|Overall Study|Did not wear lens at final visit|0
7961989|NCT02708524|12516101|FG000|Overall Study|Subject lost study lens|1
7961990|NCT02708524|12516102|FG001|Overall Study|Subject lost study lens|0
7961991|NCT02708524|12516103|FG002|Overall Study|Subject lost study lens|0
7961992|NCT02708524|12516104|FG003|Overall Study|Subject lost study lens|0
7961993|NCT02708966|12516146|FG000|Overall Study|Lost to Follow-up|2
7961994|NCT02708966|12516147|FG001|Overall Study|Lost to Follow-up|2
7961995|NCT02709005|12516155|FG000|Overall Study|Lost to Follow-up|1
7961996|NCT02709005|12516156|FG001|Overall Study|Lost to Follow-up|1
7961997|NCT02709005|12516155|FG000|Overall Study|Withdrawal by Subject|3
7961998|NCT02709005|12516156|FG001|Overall Study|Withdrawal by Subject|0
7961999|NCT02709096|12516175|FG000|Overall Study|non-compliance|1
7962000|NCT02709096|12516176|FG001|Overall Study|non-compliance|1
7962001|NCT02709109|12516186|FG000|Treatment Period 1 (28 Days)|Adverse Event|3
7962002|NCT02709109|12516187|FG001|Treatment Period 1 (28 Days)|Adverse Event|3
7962003|NCT02709109|12516188|FG002|Treatment Period 1 (28 Days)|Adverse Event|1
7962004|NCT02709109|12516189|FG003|Treatment Period 1 (28 Days)|Adverse Event|0
7962005|NCT02709109|12516186|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0
7962006|NCT02709109|12516187|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2
7962007|NCT02709109|12516188|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0
7962008|NCT02709109|12516189|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0
7962009|NCT02709109|12516186|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1
7962010|NCT02709109|12516187|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
7962011|NCT02709109|12516188|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
7962012|NCT02709109|12516189|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
7962013|NCT02709109|12516186|FG000|Washout Period (28 Days)|Other|2
7962014|NCT02709109|12516187|FG001|Washout Period (28 Days)|Other|2
7962015|NCT02709109|12516188|FG002|Washout Period (28 Days)|Other|3
7962016|NCT02709109|12516189|FG003|Washout Period (28 Days)|Other|0
7962017|NCT02709109|12516186|FG000|Treatment Period 2 (28 Days)|Adverse Event|2
7962018|NCT02709109|12516187|FG001|Treatment Period 2 (28 Days)|Adverse Event|3
7962019|NCT02709109|12516188|FG002|Treatment Period 2 (28 Days)|Adverse Event|0
7962020|NCT02709109|12516189|FG003|Treatment Period 2 (28 Days)|Adverse Event|0
7962021|NCT02709109|12516186|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0
7962022|NCT02709109|12516187|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1
7962023|NCT02709109|12516188|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1
7962024|NCT02709109|12516189|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0
7962025|NCT02709109|12516186|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0
7962026|NCT02709109|12516187|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0
7962027|NCT02709109|12516188|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1
7962028|NCT02709109|12516189|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0
7962029|NCT02709109|12516186|FG000|Treatment Period 2 (28 Days)|Other|0
7962030|NCT02709109|12516187|FG001|Treatment Period 2 (28 Days)|Other|0
7962031|NCT02709109|12516188|FG002|Treatment Period 2 (28 Days)|Other|1
7962032|NCT02709109|12516189|FG003|Treatment Period 2 (28 Days)|Other|0
7962033|NCT02709330|12516200|FG000|Overall Study|Death|5
7962034|NCT02709330|12516201|FG001|Overall Study|Death|0
7962035|NCT02709330|12516200|FG000|Overall Study|Lost to Follow-up|2
7962036|NCT02709330|12516201|FG001|Overall Study|Lost to Follow-up|0
7962037|NCT02709330|12516200|FG000|Overall Study|Physician Decision|2
7962038|NCT02709330|12516201|FG001|Overall Study|Physician Decision|0
7962039|NCT02709330|12516200|FG000|Overall Study|Withdrawal by Subject|4
7962040|NCT02709330|12516201|FG001|Overall Study|Withdrawal by Subject|0
7962041|NCT02709369|12516207|FG000|Overall Study|Lost to Follow-up|15
7962042|NCT02709369|12516207|FG000|Overall Study|Withdrawal by Subject|10
7962043|NCT02709369|12516207|FG000|Overall Study|Did not received intervention|2
7962044|NCT02709486|12516214|FG000|Overall Study|Adverse Event|2
7962045|NCT02709486|12516215|FG001|Overall Study|Adverse Event|5
7962046|NCT02709486|12516216|FG002|Overall Study|Adverse Event|3
7962047|NCT02709486|12516214|FG000|Overall Study|Death|0
7962048|NCT02709486|12516215|FG001|Overall Study|Death|0
7962049|NCT02709486|12516216|FG002|Overall Study|Death|2
7962050|NCT02709486|12516214|FG000|Overall Study|Insufficient clinical response|7
7962051|NCT02709486|12516215|FG001|Overall Study|Insufficient clinical response|3
7962052|NCT02709486|12516216|FG002|Overall Study|Insufficient clinical response|3
7962053|NCT02709486|12516214|FG000|Overall Study|Lost to Follow-up|3
7962054|NCT02709486|12516215|FG001|Overall Study|Lost to Follow-up|2
7962055|NCT02709486|12516216|FG002|Overall Study|Lost to Follow-up|2
7962056|NCT02709486|12516214|FG000|Overall Study|Other|0
7962057|NCT02709486|12516215|FG001|Overall Study|Other|2
7962058|NCT02709486|12516216|FG002|Overall Study|Other|3
7962059|NCT02709486|12516214|FG000|Overall Study|Withdrawal by Subject|32
7962060|NCT02709486|12516215|FG001|Overall Study|Withdrawal by Subject|22
7962061|NCT02709486|12516216|FG002|Overall Study|Withdrawal by Subject|32
7962062|NCT02709538|12516227|FG000|Overall Study|Adverse Event|13
7962063|NCT02709538|12516228|FG001|Overall Study|Adverse Event|2
7962064|NCT02709538|12516229|FG002|Overall Study|Adverse Event|3
7962065|NCT02709538|12516227|FG000|Overall Study|Lack of Efficacy|1
7962066|NCT02709538|12516228|FG001|Overall Study|Lack of Efficacy|0
7962067|NCT02709538|12516229|FG002|Overall Study|Lack of Efficacy|0
7962068|NCT02709538|12516227|FG000|Overall Study|Lost to Follow-up|24
7962069|NCT02709538|12516228|FG001|Overall Study|Lost to Follow-up|8
7962070|NCT02709538|12516229|FG002|Overall Study|Lost to Follow-up|4
7962071|NCT02709538|12516227|FG000|Overall Study|Physician Decision|1
7962072|NCT02709538|12516228|FG001|Overall Study|Physician Decision|0
7962073|NCT02709538|12516229|FG002|Overall Study|Physician Decision|0
7962074|NCT02709538|12516227|FG000|Overall Study|Withdrawal by Subject|40
7962075|NCT02709538|12516228|FG001|Overall Study|Withdrawal by Subject|7
7962076|NCT02709538|12516229|FG002|Overall Study|Withdrawal by Subject|4
7962077|NCT02709538|12516227|FG000|Overall Study|Non-compliance with study procedures|5
7962078|NCT02709538|12516228|FG001|Overall Study|Non-compliance with study procedures|0
7962079|NCT02709538|12516229|FG002|Overall Study|Non-compliance with study procedures|0
7962080|NCT02709538|12516227|FG000|Overall Study|Non-compliance with study drug|2
7962081|NCT02709538|12516228|FG001|Overall Study|Non-compliance with study drug|0
7962082|NCT02709538|12516229|FG002|Overall Study|Non-compliance with study drug|0
7962083|NCT02709538|12516227|FG000|Overall Study|Protocol deviation|10
7962084|NCT02709538|12516228|FG001|Overall Study|Protocol deviation|4
7962085|NCT02709538|12516229|FG002|Overall Study|Protocol deviation|4
7962086|NCT02709538|12516227|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1
7962087|NCT02709538|12516228|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0
7962088|NCT02709538|12516229|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0
7962089|NCT02709538|12516227|FG000|Overall Study|Other|16
7962090|NCT02709538|12516228|FG001|Overall Study|Other|7
7962091|NCT02709538|12516229|FG002|Overall Study|Other|5
7962092|NCT02709577|12516239|FG000|Overall Study|non-accommodating anatomy|0
7962093|NCT02709577|12516240|FG001|Overall Study|non-accommodating anatomy|1
7962094|NCT02709577|12516241|FG002|Overall Study|non-accommodating anatomy|0
7962095|NCT02709577|12516242|FG003|Overall Study|non-accommodating anatomy|0
7962096|NCT02709577|12516239|FG000|Overall Study|procedural complication|0
7962097|NCT02709577|12516240|FG001|Overall Study|procedural complication|1
7962098|NCT02709577|12516241|FG002|Overall Study|procedural complication|0
7962099|NCT02709577|12516242|FG003|Overall Study|procedural complication|0
7962100|NCT02709577|12516239|FG000|Overall Study|Withdrawal by Subject|2
7962101|NCT02709577|12516240|FG001|Overall Study|Withdrawal by Subject|3
7962102|NCT02709577|12516241|FG002|Overall Study|Withdrawal by Subject|2
7962103|NCT02709577|12516242|FG003|Overall Study|Withdrawal by Subject|0
7966783|NCT02757352|12523230|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7966784|NCT02757352|12523231|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7966785|NCT02757352|12523222|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7966786|NCT02757352|12523223|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7966787|NCT02757352|12523224|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7721521|NCT00545168|12146014|FG002|Overall Study|Visit for Day 21 was not done in error|2
7721522|NCT00545233|12146034|FG000|Overall Study|Adverse Event|10
7721523|NCT00545233|12146035|FG001|Overall Study|Adverse Event|5
7721524|NCT00545233|12146034|FG000|Overall Study|Violation of Selection Criteria at Entry|5
7721525|NCT00545233|12146035|FG001|Overall Study|Violation of Selection Criteria at Entry|1
7721526|NCT00545233|12146034|FG000|Overall Study|Protocol Violation|2
7721527|NCT00545233|12146035|FG001|Overall Study|Protocol Violation|0
7721528|NCT00545233|12146034|FG000|Overall Study|Refused Treatment|9
7721529|NCT00545233|12146035|FG001|Overall Study|Refused Treatment|7
7721530|NCT00545233|12146034|FG000|Overall Study|Failure to Return|4
7721531|NCT00545233|12146035|FG001|Overall Study|Failure to Return|6
7721532|NCT00545233|12146034|FG000|Overall Study|Insufficient response|14
7721533|NCT00545233|12146035|FG001|Overall Study|Insufficient response|15
7721534|NCT00545233|12146034|FG000|Overall Study|Physician Decision|2
7721535|NCT00545233|12146035|FG001|Overall Study|Physician Decision|1
7966788|NCT02757352|12523225|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3
7966789|NCT02757352|12523226|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7966790|NCT02757352|12523227|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1
7966791|NCT02757352|12523228|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7966792|NCT02757352|12523229|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7966793|NCT02757352|12523230|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7966794|NCT02757352|12523231|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7966795|NCT02757352|12523222|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7966796|NCT02757352|12523223|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7966797|NCT02757352|12523224|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7966798|NCT02757352|12523225|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2
7966799|NCT02757352|12523226|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1
7966800|NCT02757352|12523227|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4
7966801|NCT02757352|12523228|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7966802|NCT02757352|12523229|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7966803|NCT02757352|12523230|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7966804|NCT02757352|12523231|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7966805|NCT02757352|12523222|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7966806|NCT02757352|12523223|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7966807|NCT02757352|12523224|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7966808|NCT02757352|12523225|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7962104|NCT02709746|12516272|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4
7962105|NCT02709746|12516273|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7962106|NCT02709746|12516274|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7962107|NCT02709746|12516275|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7962108|NCT02709746|12516276|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7962109|NCT02709746|12516272|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14
7962110|NCT02709746|12516273|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0
7962111|NCT02709746|12516274|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0
7721536|NCT00545272|12146048|FG000|Overall Study|Protocol deviation|0
7721537|NCT00545272|12146049|FG001|Overall Study|Protocol deviation|1
7721538|NCT00545272|12146050|FG002|Overall Study|Protocol deviation|0
7721539|NCT00545272|12146051|FG003|Overall Study|Protocol deviation|1
7721540|NCT00545272|12146052|FG004|Overall Study|Protocol deviation|0
7721541|NCT00545272|12146053|FG005|Overall Study|Protocol deviation|1
7721542|NCT00545272|12146048|FG000|Overall Study|Adverse Event|0
7721543|NCT00545272|12146049|FG001|Overall Study|Adverse Event|0
7721544|NCT00545272|12146050|FG002|Overall Study|Adverse Event|1
7721545|NCT00545272|12146051|FG003|Overall Study|Adverse Event|0
7721546|NCT00545272|12146052|FG004|Overall Study|Adverse Event|0
7962112|NCT02709746|12516275|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0
7721547|NCT00545272|12146053|FG005|Overall Study|Adverse Event|1
7962113|NCT02709746|12516276|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0
7721548|NCT00545272|12146048|FG000|Overall Study|Abnormal laboratory value(s)|0
7721549|NCT00545272|12146049|FG001|Overall Study|Abnormal laboratory value(s)|0
7721550|NCT00545272|12146050|FG002|Overall Study|Abnormal laboratory value(s)|0
7721551|NCT00545272|12146051|FG003|Overall Study|Abnormal laboratory value(s)|0
7721552|NCT00545272|12146052|FG004|Overall Study|Abnormal laboratory value(s)|0
7721553|NCT00545272|12146053|FG005|Overall Study|Abnormal laboratory value(s)|1
7721554|NCT00545272|12146048|FG000|Overall Study|Abnormal test procedure result(s)|0
7721555|NCT00545272|12146049|FG001|Overall Study|Abnormal test procedure result(s)|0
7721556|NCT00545272|12146050|FG002|Overall Study|Abnormal test procedure result(s)|0
7721557|NCT00545272|12146051|FG003|Overall Study|Abnormal test procedure result(s)|0
7721558|NCT00545272|12146052|FG004|Overall Study|Abnormal test procedure result(s)|1
7721559|NCT00545272|12146053|FG005|Overall Study|Abnormal test procedure result(s)|0
7721560|NCT00545272|12146048|FG000|Overall Study|Lost to Follow-up|0
7962114|NCT02709746|12516272|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12
7962115|NCT02709746|12516273|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7962116|NCT02709746|12516274|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7962117|NCT02709746|12516275|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7962118|NCT02709746|12516276|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7962119|NCT02709746|12516272|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7
7962120|NCT02709746|12516273|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7962121|NCT02709746|12516274|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7962122|NCT02709746|12516275|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7962123|NCT02709746|12516276|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7962124|NCT02709746|12516272|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2
7962125|NCT02709746|12516273|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0
7962126|NCT02709746|12516274|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0
7962127|NCT02709746|12516275|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0
7962128|NCT02709746|12516276|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0
7962129|NCT02709746|12516272|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12
7962130|NCT02709746|12516273|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7962131|NCT02709746|12516274|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7962132|NCT02709746|12516275|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7962133|NCT02709746|12516276|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7962134|NCT02709746|12516272|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7
7962135|NCT02709746|12516273|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7962136|NCT02709746|12516274|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7962137|NCT02709746|12516275|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7962138|NCT02709746|12516276|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7962139|NCT02709746|12516272|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7
7962140|NCT02709746|12516273|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7962141|NCT02709746|12516274|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7962142|NCT02709746|12516275|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7962143|NCT02709746|12516276|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7962144|NCT02709746|12516272|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103
7962145|NCT02709746|12516273|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7962146|NCT02709746|12516274|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7962147|NCT02709746|12516275|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7962148|NCT02709746|12516276|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7962149|NCT02709746|12516272|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0
7962150|NCT02709746|12516273|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1
7962151|NCT02709746|12516274|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0
7962152|NCT02709746|12516275|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0
7962153|NCT02709746|12516276|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2
7721561|NCT00545272|12146049|FG001|Overall Study|Lost to Follow-up|0
7721562|NCT00545272|12146050|FG002|Overall Study|Lost to Follow-up|0
7721563|NCT00545272|12146051|FG003|Overall Study|Lost to Follow-up|0
7721564|NCT00545272|12146052|FG004|Overall Study|Lost to Follow-up|1
7721565|NCT00545272|12146053|FG005|Overall Study|Lost to Follow-up|0
7721566|NCT00545298|12146070|FG000|Overall Study|Issues with Standard of Care|2
7721567|NCT00545298|12146071|FG001|Overall Study|Issues with Standard of Care|0
7721568|NCT00545298|12146072|FG002|Overall Study|Issues with Standard of Care|1
7721569|NCT00545363|12146085|FG000|Overall Study|Adverse Event|6
7721570|NCT00545363|12146086|FG001|Overall Study|Adverse Event|7
7721571|NCT00545363|12146085|FG000|Overall Study|Withdrawal by Subject|6
7721572|NCT00545363|12146086|FG001|Overall Study|Withdrawal by Subject|5
7721573|NCT00545363|12146085|FG000|Overall Study|Non-compliance|3
7721574|NCT00545363|12146086|FG001|Overall Study|Non-compliance|1
7721575|NCT00545363|12146085|FG000|Overall Study|Did not meet entry criteria|1
7721576|NCT00545363|12146086|FG001|Overall Study|Did not meet entry criteria|1
7721577|NCT00545363|12146085|FG000|Overall Study|Lost to Follow-up|2
7721578|NCT00545363|12146086|FG001|Overall Study|Lost to Follow-up|0
7721579|NCT00545363|12146085|FG000|Overall Study|Other|1
7721580|NCT00545363|12146086|FG001|Overall Study|Other|1
7721581|NCT00545402|12146094|FG000|Overall Study|Discontinuation of treatment|17
7721582|NCT00545402|12146095|FG001|Overall Study|Discontinuation of treatment|9
7721583|NCT00545402|12146094|FG000|Overall Study|Use of unauthorized immunosuppressant|8
7721584|NCT00545402|12146095|FG001|Overall Study|Use of unauthorized immunosuppressant|7
7721585|NCT00545402|12146094|FG000|Overall Study|Death|5
7721586|NCT00545402|12146095|FG001|Overall Study|Death|7
7721587|NCT00545402|12146094|FG000|Overall Study|Graft loss|2
7721588|NCT00545402|12146095|FG001|Overall Study|Graft loss|4
7721589|NCT00545402|12146094|FG000|Overall Study|Withdrawal by Subject|0
7721590|NCT00545402|12146095|FG001|Overall Study|Withdrawal by Subject|1
7721591|NCT00545402|12146094|FG000|Overall Study|Protocol Violation|1
7721592|NCT00545402|12146095|FG001|Overall Study|Protocol Violation|0
7721593|NCT00545402|12146094|FG000|Overall Study|Reason not specified|1
7721594|NCT00545402|12146095|FG001|Overall Study|Reason not specified|1
7721595|NCT00545441|12146103|FG000|Overall Study|Fistula draining at 6 months|2
7721596|NCT00545441|12146104|FG001|Overall Study|Fistula draining at 6 months|4
7721597|NCT00545441|12146103|FG000|Overall Study|Lost to Follow-up|9
7721598|NCT00545441|12146104|FG001|Overall Study|Lost to Follow-up|5
7721599|NCT00545441|12146103|FG000|Overall Study|Technical failure|0
7721600|NCT00545441|12146104|FG001|Overall Study|Technical failure|1
7721601|NCT00545441|12146103|FG000|Overall Study|Withdrawal by Subject|1
7721602|NCT00545441|12146104|FG001|Overall Study|Withdrawal by Subject|1
7721603|NCT00545441|12146103|FG000|Overall Study|Persistence or recurrence of fistula|5
7721604|NCT00545441|12146104|FG001|Overall Study|Persistence or recurrence of fistula|2
7721605|NCT00545441|12146103|FG000|Overall Study|Patients were not treated|1
7721606|NCT00545441|12146104|FG001|Overall Study|Patients were not treated|3
7721607|NCT00545532|12146112|FG000|Overall Study|Withdrawal by Subject|1
7721608|NCT00545532|12146113|FG001|Overall Study|Withdrawal by Subject|3
7721609|NCT00545532|12146112|FG000|Overall Study|Lost to Follow-up|5
7721610|NCT00545532|12146113|FG001|Overall Study|Lost to Follow-up|6
7721611|NCT00545532|12146112|FG000|Overall Study|Death|0
7721612|NCT00545532|12146113|FG001|Overall Study|Death|1
7721613|NCT00545571|12146121|FG000|Overall Study|Administrative Reasons|1
7721614|NCT00545571|12146121|FG000|Overall Study|Adverse Event|2
7721615|NCT00545571|12146121|FG000|Overall Study|Death|5
7721616|NCT00545571|12146121|FG000|Overall Study|Lack of Efficacy|1
7721617|NCT00545571|12146121|FG000|Overall Study|Protocol Violation|2
7721618|NCT00545571|12146121|FG000|Overall Study|Refused Treatment|1
7721619|NCT00545571|12146121|FG000|Overall Study|Screen Failure|16
7721620|NCT00545571|12146121|FG000|Overall Study|Transfusion|12
7721621|NCT00545571|12146121|FG000|Overall Study|Early Termination of Study|24
7721622|NCT00545571|12146121|FG000|Overall Study|Kidney Transplantation|3
7721623|NCT00545584|12146128|FG000|Overall Study|Only one reason for discontinuation|62
7721624|NCT00545584|12146129|FG001|Overall Study|Only one reason for discontinuation|61
7721625|NCT00545584|12146130|FG002|Overall Study|Only one reason for discontinuation|48
7721626|NCT00545584|12146128|FG000|Overall Study|Two or more reasons for discontinuation|17
7721627|NCT00545584|12146129|FG001|Overall Study|Two or more reasons for discontinuation|19
7721628|NCT00545584|12146130|FG002|Overall Study|Two or more reasons for discontinuation|8
7721629|NCT00545688|12146168|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1
7721630|NCT00545688|12146169|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2
7721631|NCT00545688|12146170|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1
7721632|NCT00545688|12146171|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1
7721633|NCT00545688|12146168|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1
7721634|NCT00545688|12146169|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1
7721635|NCT00545688|12146170|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4
7721636|NCT00545688|12146171|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1
7721637|NCT00545688|12146168|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
7721638|NCT00545688|12146169|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
7721639|NCT00545688|12146170|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
7721640|NCT00545688|12146171|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
7721641|NCT00545688|12146168|FG000|Neo-Adjuvant Treatment Period|Death|0
7721642|NCT00545688|12146169|FG001|Neo-Adjuvant Treatment Period|Death|1
7721643|NCT00545688|12146170|FG002|Neo-Adjuvant Treatment Period|Death|0
7721644|NCT00545688|12146171|FG003|Neo-Adjuvant Treatment Period|Death|0
7721645|NCT00545688|12146168|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0
7721646|NCT00545688|12146169|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1
7721647|NCT00545688|12146170|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7
7721648|NCT00545688|12146171|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2
7721649|NCT00545688|12146168|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1
7721650|NCT00545688|12146169|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0
7721651|NCT00545688|12146170|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0
7721652|NCT00545688|12146171|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0
7721653|NCT00545688|12146168|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0
7721654|NCT00545688|12146169|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0
7767887|NCT00856544|12210721|FG002|Overall Study|Randomized but not treated|0
7721655|NCT00545688|12146170|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2
7721656|NCT00545688|12146171|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2
7721657|NCT00545688|12146168|FG000|Adjuvant Treatment Period|Disease Progression|3
7721658|NCT00545688|12146169|FG001|Adjuvant Treatment Period|Disease Progression|3
7721659|NCT00545688|12146170|FG002|Adjuvant Treatment Period|Disease Progression|0
7721660|NCT00545688|12146171|FG003|Adjuvant Treatment Period|Disease Progression|7
7721661|NCT00545688|12146168|FG000|Adjuvant Treatment Period|Refused Treatment|1
7721662|NCT00545688|12146169|FG001|Adjuvant Treatment Period|Refused Treatment|1
7721663|NCT00545688|12146170|FG002|Adjuvant Treatment Period|Refused Treatment|1
7721664|NCT00545688|12146171|FG003|Adjuvant Treatment Period|Refused Treatment|5
7721665|NCT00545688|12146168|FG000|Adjuvant Treatment Period|Lost to Follow-up|1
7721666|NCT00545688|12146169|FG001|Adjuvant Treatment Period|Lost to Follow-up|0
7721667|NCT00545688|12146170|FG002|Adjuvant Treatment Period|Lost to Follow-up|1
7721668|NCT00545688|12146171|FG003|Adjuvant Treatment Period|Lost to Follow-up|0
7721669|NCT00545688|12146168|FG000|Adjuvant Treatment Period|Adverse Event|0
7721670|NCT00545688|12146169|FG001|Adjuvant Treatment Period|Adverse Event|3
7721671|NCT00545688|12146170|FG002|Adjuvant Treatment Period|Adverse Event|2
7721672|NCT00545688|12146171|FG003|Adjuvant Treatment Period|Adverse Event|2
7721673|NCT00545688|12146168|FG000|Adjuvant Treatment Period|Unknown Reason|0
7721674|NCT00545688|12146169|FG001|Adjuvant Treatment Period|Unknown Reason|1
7721675|NCT00545688|12146170|FG002|Adjuvant Treatment Period|Unknown Reason|0
7721676|NCT00545688|12146171|FG003|Adjuvant Treatment Period|Unknown Reason|0
7721677|NCT00545688|12146168|FG000|Follow-Up Period|Death|4
7721678|NCT00545688|12146169|FG001|Follow-Up Period|Death|2
7721679|NCT00545688|12146170|FG002|Follow-Up Period|Death|2
7721680|NCT00545688|12146171|FG003|Follow-Up Period|Death|6
7721681|NCT00545688|12146168|FG000|Follow-Up Period|Disease Progression|6
7721682|NCT00545688|12146169|FG001|Follow-Up Period|Disease Progression|5
7721683|NCT00545688|12146170|FG002|Follow-Up Period|Disease Progression|9
7721684|NCT00545688|12146171|FG003|Follow-Up Period|Disease Progression|9
7721685|NCT00545688|12146168|FG000|Follow-Up Period|Refused Treatment|6
7721686|NCT00545688|12146169|FG001|Follow-Up Period|Refused Treatment|2
7721687|NCT00545688|12146170|FG002|Follow-Up Period|Refused Treatment|0
7721688|NCT00545688|12146171|FG003|Follow-Up Period|Refused Treatment|2
7721689|NCT00545688|12146168|FG000|Follow-Up Period|Lost to Follow-up|3
7721690|NCT00545688|12146169|FG001|Follow-Up Period|Lost to Follow-up|3
7721691|NCT00545688|12146170|FG002|Follow-Up Period|Lost to Follow-up|3
7721692|NCT00545688|12146171|FG003|Follow-Up Period|Lost to Follow-up|1
7721693|NCT00545688|12146168|FG000|Follow-Up Period|Unspecified Reason|2
7721694|NCT00545688|12146169|FG001|Follow-Up Period|Unspecified Reason|5
7721695|NCT00545688|12146170|FG002|Follow-Up Period|Unspecified Reason|6
7721696|NCT00545688|12146171|FG003|Follow-Up Period|Unspecified Reason|8
7721697|NCT00545688|12146168|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0
7721698|NCT00545688|12146169|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2
7721699|NCT00545688|12146170|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0
7721700|NCT00545688|12146171|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1
7721701|NCT00545714|12146184|FG000|Induction Phase (6 Months)|Physician Decision|3
7721702|NCT00545714|12146184|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6
7721703|NCT00545714|12146184|FG000|Induction Phase (6 Months)|Disease Progression|1
7721704|NCT00545714|12146184|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2
7721705|NCT00545714|12146184|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16
7721706|NCT00545714|12146184|FG000|Maintenance Phase (36 Months)|Disease Progression|9
7721707|NCT00545714|12146184|FG000|Maintenance Phase (36 Months)|Physician Decision|1
7721708|NCT00545714|12146184|FG000|Maintenance Phase (36 Months)|Protocol Violation|1
7721709|NCT00545714|12146184|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3
7721710|NCT00545714|12146184|FG000|Maintenance Phase (36 Months)|Death|2
7721711|NCT00545740|12146192|FG000|Overall Study|Lack of Efficacy|34
7721712|NCT00545740|12146193|FG001|Overall Study|Lack of Efficacy|35
7721713|NCT00545740|12146194|FG002|Overall Study|Lack of Efficacy|47
7721714|NCT00545740|12146195|FG003|Overall Study|Lack of Efficacy|36
7721715|NCT00545740|12146192|FG000|Overall Study|Withdrawal by Subject|17
7721716|NCT00545740|12146193|FG001|Overall Study|Withdrawal by Subject|15
7721717|NCT00545740|12146194|FG002|Overall Study|Withdrawal by Subject|16
7721718|NCT00545740|12146195|FG003|Overall Study|Withdrawal by Subject|18
7721719|NCT00545740|12146192|FG000|Overall Study|Adverse Event|10
7721720|NCT00545740|12146193|FG001|Overall Study|Adverse Event|18
7721721|NCT00545740|12146194|FG002|Overall Study|Adverse Event|19
7721722|NCT00545740|12146195|FG003|Overall Study|Adverse Event|9
7721723|NCT00545740|12146192|FG000|Overall Study|Lost to Follow-up|7
7721724|NCT00545740|12146193|FG001|Overall Study|Lost to Follow-up|5
7721725|NCT00545740|12146194|FG002|Overall Study|Lost to Follow-up|5
7721726|NCT00545740|12146195|FG003|Overall Study|Lost to Follow-up|6
7721727|NCT00545740|12146192|FG000|Overall Study|Protocol Violation|1
7721728|NCT00545740|12146193|FG001|Overall Study|Protocol Violation|3
7721729|NCT00545740|12146194|FG002|Overall Study|Protocol Violation|1
7721730|NCT00545740|12146195|FG003|Overall Study|Protocol Violation|0
7721731|NCT00545740|12146192|FG000|Overall Study|Non-compliance|0
7721732|NCT00545740|12146193|FG001|Overall Study|Non-compliance|2
7721733|NCT00545740|12146194|FG002|Overall Study|Non-compliance|1
7721734|NCT00545740|12146195|FG003|Overall Study|Non-compliance|0
7721735|NCT00545740|12146192|FG000|Overall Study|Moved|2
7721736|NCT00545740|12146193|FG001|Overall Study|Moved|0
7721737|NCT00545740|12146194|FG002|Overall Study|Moved|1
7721738|NCT00545740|12146195|FG003|Overall Study|Moved|0
7721739|NCT00545740|12146192|FG000|Overall Study|Diverticulitis attack|0
7721740|NCT00545740|12146193|FG001|Overall Study|Diverticulitis attack|0
7721741|NCT00545740|12146194|FG002|Overall Study|Diverticulitis attack|1
7721742|NCT00545740|12146195|FG003|Overall Study|Diverticulitis attack|1
7721743|NCT00545740|12146192|FG000|Overall Study|Suspected Diverticulitis Recurrence|1
7721744|NCT00545740|12146193|FG001|Overall Study|Suspected Diverticulitis Recurrence|1
7721745|NCT00545740|12146194|FG002|Overall Study|Suspected Diverticulitis Recurrence|1
7721746|NCT00545740|12146195|FG003|Overall Study|Suspected Diverticulitis Recurrence|1
7721747|NCT00545740|12146192|FG000|Overall Study|Site closure|1
7721748|NCT00545740|12146193|FG001|Overall Study|Site closure|0
7721749|NCT00545740|12146194|FG002|Overall Study|Site closure|0
7721750|NCT00545740|12146195|FG003|Overall Study|Site closure|0
7721751|NCT00545740|12146192|FG000|Overall Study|Missed visit|1
7721752|NCT00545740|12146193|FG001|Overall Study|Missed visit|0
7721753|NCT00545740|12146194|FG002|Overall Study|Missed visit|0
7721754|NCT00545740|12146195|FG003|Overall Study|Missed visit|0
7721755|NCT00545740|12146192|FG000|Overall Study|Physician Decision|0
7721756|NCT00545740|12146193|FG001|Overall Study|Physician Decision|0
7721757|NCT00545740|12146194|FG002|Overall Study|Physician Decision|3
7721758|NCT00545740|12146195|FG003|Overall Study|Physician Decision|0
7721759|NCT00545740|12146192|FG000|Overall Study|Accepted only monthly telephone calls|1
7721760|NCT00545740|12146193|FG001|Overall Study|Accepted only monthly telephone calls|0
7721761|NCT00545740|12146194|FG002|Overall Study|Accepted only monthly telephone calls|0
7721762|NCT00545740|12146195|FG003|Overall Study|Accepted only monthly telephone calls|0
7721763|NCT00545740|12146192|FG000|Overall Study|Sponsor decision|0
7721764|NCT00545740|12146193|FG001|Overall Study|Sponsor decision|1
7721765|NCT00545740|12146194|FG002|Overall Study|Sponsor decision|0
7721766|NCT00545740|12146195|FG003|Overall Study|Sponsor decision|0
7721767|NCT00545740|12146192|FG000|Overall Study|Lack of time|0
7721768|NCT00545740|12146193|FG001|Overall Study|Lack of time|1
7721769|NCT00545740|12146194|FG002|Overall Study|Lack of time|0
7721770|NCT00545740|12146195|FG003|Overall Study|Lack of time|0
7721771|NCT00545740|12146192|FG000|Overall Study|Non-adherence to visits|0
7721772|NCT00545740|12146193|FG001|Overall Study|Non-adherence to visits|1
7721773|NCT00545740|12146194|FG002|Overall Study|Non-adherence to visits|0
7721774|NCT00545740|12146195|FG003|Overall Study|Non-adherence to visits|0
7721775|NCT00545740|12146192|FG000|Overall Study|Patient difficulties|0
7721776|NCT00545740|12146193|FG001|Overall Study|Patient difficulties|1
7721777|NCT00545740|12146194|FG002|Overall Study|Patient difficulties|0
7721778|NCT00545740|12146195|FG003|Overall Study|Patient difficulties|0
7721779|NCT00545740|12146192|FG000|Overall Study|Husband against study|0
7721780|NCT00545740|12146193|FG001|Overall Study|Husband against study|0
7721781|NCT00545740|12146194|FG002|Overall Study|Husband against study|1
7721782|NCT00545740|12146195|FG003|Overall Study|Husband against study|0
7721783|NCT00545753|12146208|FG000|Overall Study|Withdrawal by Subject|0
7721784|NCT00545753|12146209|FG001|Overall Study|Withdrawal by Subject|1
7721785|NCT00545753|12146210|FG002|Overall Study|Withdrawal by Subject|10
7721786|NCT00545753|12146208|FG000|Overall Study|Lost to Follow-up|13
7721787|NCT00545753|12146209|FG001|Overall Study|Lost to Follow-up|3
7721788|NCT00545753|12146210|FG002|Overall Study|Lost to Follow-up|12
7721789|NCT00545753|12146208|FG000|Overall Study|Protocol Violation|3
7721790|NCT00545753|12146209|FG001|Overall Study|Protocol Violation|1
7721791|NCT00545753|12146210|FG002|Overall Study|Protocol Violation|4
7721792|NCT00545779|12146219|FG000|Overall Study|Violation of selection criteria at entry|8
7721793|NCT00545779|12146219|FG000|Overall Study|Other protocol violation|1
7721794|NCT00545779|12146219|FG000|Overall Study|Did not cooperate|7
7721795|NCT00545779|12146219|FG000|Overall Study|Withdrawal by Subject|20
7721796|NCT00545779|12146219|FG000|Overall Study|Adverse Event/intercurrent illness|5
7721797|NCT00545779|12146219|FG000|Overall Study|Failure to return|3
7721798|NCT00545792|12146223|FG000|Overall Study|Withdrawal by Subject|1
7721799|NCT00545818|12146229|FG000|Overall Study|Protocol Violation|1
7721800|NCT00545818|12146230|FG001|Overall Study|Protocol Violation|0
7721801|NCT00545818|12146229|FG000|Overall Study|Adverse Event|1
7721802|NCT00545818|12146230|FG001|Overall Study|Adverse Event|1
7721803|NCT00545818|12146229|FG000|Overall Study|Lost to Follow-up|1
7721804|NCT00545818|12146230|FG001|Overall Study|Lost to Follow-up|6
7721805|NCT00545948|12146239|FG000|Overall Study|Not Treated|1
7721806|NCT00545948|12146240|FG001|Overall Study|Not Treated|1
7721807|NCT00545948|12146241|FG002|Overall Study|Not Treated|7
7721808|NCT00546000|12146259|FG000|Overall Study|Adverse Event|1
7721809|NCT00546000|12146259|FG000|Overall Study|Lost to Follow-up|1
7721810|NCT00546000|12146259|FG000|Overall Study|Baseline HPA Axis Supression|2
7721811|NCT00546078|12146265|FG000|Overall Study|Lost to Follow-up|1
7721812|NCT00546078|12146266|FG001|Overall Study|Lost to Follow-up|3
7721813|NCT00546078|12146265|FG000|Overall Study|Withdrawal by Subject|2
7721814|NCT00546078|12146266|FG001|Overall Study|Withdrawal by Subject|3
7721815|NCT00546078|12146265|FG000|Overall Study|Other reason|1
7721816|NCT00546078|12146266|FG001|Overall Study|Other reason|1
7721817|NCT00546117|12146278|FG000|Overall Study|Withdrawal by Subject|3
7721818|NCT00546117|12146279|FG001|Overall Study|Withdrawal by Subject|0
7721819|NCT00546117|12146278|FG000|Overall Study|Inability to schedule follow-up visit|1
7721820|NCT00546117|12146279|FG001|Overall Study|Inability to schedule follow-up visit|0
7721821|NCT00546260|12146297|FG000|Overall Study|Drug not given pre diagnostic angiogr|8
7721822|NCT00546260|12146298|FG001|Overall Study|Drug not given pre diagnostic angiogr|2
7721823|NCT00546351|12146304|FG000|Overall Study|Adverse Event|76
7721824|NCT00546351|12146304|FG000|Overall Study|Lack of Efficacy|15
7721825|NCT00546351|12146304|FG000|Overall Study|Withdrawal by Subject|109
7721826|NCT00546351|12146304|FG000|Overall Study|Lost to Follow-up|9
7721827|NCT00546351|12146304|FG000|Overall Study|Protocol Deviation|1
7721828|NCT00546351|12146304|FG000|Overall Study|Unsatisfactory compliance|9
7721829|NCT00546351|12146304|FG000|Overall Study|Other reasons for premature termination|17
7721830|NCT00546364|12146311|FG000|Overall Study|Disease progression|5
7721831|NCT00546364|12146312|FG001|Overall Study|Disease progression|11
7721832|NCT00546364|12146313|FG002|Overall Study|Disease progression|8
7721833|NCT00546364|12146311|FG000|Overall Study|Completed and off treatment|1
7721834|NCT00546364|12146312|FG001|Overall Study|Completed and off treatment|0
7721835|NCT00546364|12146313|FG002|Overall Study|Completed and off treatment|2
7721836|NCT00546364|12146311|FG000|Overall Study|Administrative reason by sponsor|1
7721837|NCT00546364|12146312|FG001|Overall Study|Administrative reason by sponsor|0
7721838|NCT00546364|12146313|FG002|Overall Study|Administrative reason by sponsor|0
7721839|NCT00546364|12146311|FG000|Overall Study|Poor compliance/noncompliance|0
7721840|NCT00546364|12146312|FG001|Overall Study|Poor compliance/noncompliance|0
7721841|NCT00546364|12146313|FG002|Overall Study|Poor compliance/noncompliance|1
7721842|NCT00546364|12146311|FG000|Overall Study|No longer meets study criteria|1
7721843|NCT00546364|12146312|FG001|Overall Study|No longer meets study criteria|1
7721844|NCT00546364|12146313|FG002|Overall Study|No longer meets study criteria|0
7721845|NCT00546364|12146311|FG000|Overall Study|Withdrawal by Subject|5
7721846|NCT00546364|12146312|FG001|Overall Study|Withdrawal by Subject|6
7721847|NCT00546364|12146313|FG002|Overall Study|Withdrawal by Subject|3
7721848|NCT00546364|12146311|FG000|Overall Study|Prior taxotere|1
7721849|NCT00546364|12146312|FG001|Overall Study|Prior taxotere|0
7721850|NCT00546364|12146313|FG002|Overall Study|Prior taxotere|0
7721851|NCT00546364|12146311|FG000|Overall Study|Mixed response|1
7721852|NCT00546364|12146312|FG001|Overall Study|Mixed response|0
7721853|NCT00546364|12146313|FG002|Overall Study|Mixed response|0
7721854|NCT00546364|12146311|FG000|Overall Study|Palliative treatment|1
7721855|NCT00546364|12146312|FG001|Overall Study|Palliative treatment|0
7721856|NCT00546364|12146313|FG002|Overall Study|Palliative treatment|1
7721857|NCT00546364|12146311|FG000|Overall Study|Target lesions resected|1
7721858|NCT00546364|12146312|FG001|Overall Study|Target lesions resected|0
7721859|NCT00546364|12146313|FG002|Overall Study|Target lesions resected|0
7721860|NCT00546364|12146311|FG000|Overall Study|Physician Decision|0
7721861|NCT00546364|12146312|FG001|Overall Study|Physician Decision|0
7721862|NCT00546364|12146313|FG002|Overall Study|Physician Decision|1
7721863|NCT00546364|12146311|FG000|Overall Study|Sponsor decision|0
7721864|NCT00546364|12146312|FG001|Overall Study|Sponsor decision|0
7721865|NCT00546364|12146313|FG002|Overall Study|Sponsor decision|1
7721866|NCT00546377|12146321|FG000|Overall Study|Deemed ineligible|1
7721867|NCT00546377|12146321|FG000|Overall Study|Adverse Event|6
7721868|NCT00546481|12146341|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
7721869|NCT00546481|12146342|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
7721870|NCT00546481|12146343|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
7721871|NCT00546481|12146341|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
7721872|NCT00546481|12146342|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
7721873|NCT00546481|12146343|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
7721874|NCT00546481|12146341|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
7721875|NCT00546481|12146342|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
7721876|NCT00546481|12146343|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
7721877|NCT00546481|12146341|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
7721878|NCT00546481|12146342|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
7721879|NCT00546481|12146343|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
7721880|NCT00546481|12146341|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
7721881|NCT00546481|12146342|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
7721882|NCT00546481|12146343|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
7721883|NCT00546481|12146341|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
7721884|NCT00546481|12146342|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
7721885|NCT00546481|12146343|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
7721886|NCT00546481|12146341|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0
7721887|NCT00546481|12146342|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0
7721888|NCT00546481|12146343|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2
7721889|NCT00546481|12146341|FG000|Maintenance Phase (CERA)|Kidney transplantation|0
7721890|NCT00546481|12146342|FG001|Maintenance Phase (CERA)|Kidney transplantation|0
7721891|NCT00546481|12146343|FG002|Maintenance Phase (CERA)|Kidney transplantation|1
7721892|NCT00546481|12146341|FG000|Maintenance Phase (CERA)|Other Reason|0
7721893|NCT00546481|12146342|FG001|Maintenance Phase (CERA)|Other Reason|0
7721894|NCT00546481|12146343|FG002|Maintenance Phase (CERA)|Other Reason|1
7721895|NCT00546572|12146353|FG000|Vax 1 / Year 0|Randomized, not treated|1
7721896|NCT00546572|12146354|FG001|Vax 1 / Year 0|Randomized, not treated|1
7721897|NCT00546572|12146353|FG000|Vax 1 / Year 0|Withdrawal by Subject|3
7721898|NCT00546572|12146354|FG001|Vax 1 / Year 0|Withdrawal by Subject|2
7721899|NCT00546572|12146353|FG000|Vax 1 / Year 0|Protocol Violation|3
7721900|NCT00546572|12146354|FG001|Vax 1 / Year 0|Protocol Violation|4
7721901|NCT00546572|12146353|FG000|Vax 1 / Year 0|Death|2
7721902|NCT00546572|12146354|FG001|Vax 1 / Year 0|Death|2
7721903|NCT00546572|12146353|FG000|Vax 1 / Year 0|Adverse Event|0
7721904|NCT00546572|12146354|FG001|Vax 1 / Year 0|Adverse Event|1
7721905|NCT00546572|12146353|FG000|Vax 1 / Year 0|Lost to Follow-up|0
7721906|NCT00546572|12146354|FG001|Vax 1 / Year 0|Lost to Follow-up|1
7721907|NCT00546572|12146353|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
7721908|NCT00546572|12146354|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
7721909|NCT00546572|12146353|FG000|Vax 2 / Year 1|Other|1
7721910|NCT00546572|12146354|FG001|Vax 2 / Year 1|Other|1
7721911|NCT00546572|12146353|FG000|Vax 2 / Year 1|Adverse Event|1
7721912|NCT00546572|12146354|FG001|Vax 2 / Year 1|Adverse Event|0
7721913|NCT00546572|12146353|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
7721914|NCT00546572|12146354|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
7721915|NCT00546637|12146373|FG000|Overall Study|Adverse Event|46
7721916|NCT00546637|12146374|FG001|Overall Study|Adverse Event|20
7721917|NCT00546637|12146373|FG000|Overall Study|Lack of Efficacy|5
7721918|NCT00546637|12146374|FG001|Overall Study|Lack of Efficacy|5
7721919|NCT00546637|12146373|FG000|Overall Study|Lost to Follow-up|2
7721920|NCT00546637|12146374|FG001|Overall Study|Lost to Follow-up|2
7721921|NCT00546637|12146373|FG000|Overall Study|Other|10
7721922|NCT00546637|12146374|FG001|Overall Study|Other|12
7721923|NCT00546637|12146373|FG000|Overall Study|Withdrawal by Subject|7
7721924|NCT00546637|12146374|FG001|Overall Study|Withdrawal by Subject|9
7721925|NCT00546637|12146373|FG000|Overall Study|Randomized, but not treated|3
7721926|NCT00546637|12146374|FG001|Overall Study|Randomized, but not treated|1
7721927|NCT00546715|12146384|FG000|Overall Study|Withdrawal by Subject|0
7721928|NCT00546715|12146385|FG001|Overall Study|Withdrawal by Subject|1
7721929|NCT00546715|12146386|FG002|Overall Study|Withdrawal by Subject|0
7721930|NCT00546715|12146387|FG003|Overall Study|Withdrawal by Subject|0
7721931|NCT00546819|12146408|FG000|Overall Study|Adverse Event|2
7721932|NCT00546819|12146409|FG001|Overall Study|Adverse Event|3
7721933|NCT00546819|12146408|FG000|Overall Study|Lost to Follow-up|2
7721934|NCT00546819|12146409|FG001|Overall Study|Lost to Follow-up|1
7721935|NCT00546819|12146408|FG000|Overall Study|Withdrawal by Subject|4
7721936|NCT00546819|12146409|FG001|Overall Study|Withdrawal by Subject|2
7721937|NCT00546871|12146415|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
7721938|NCT00546871|12146416|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
7721939|NCT00546871|12146415|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
7721940|NCT00546871|12146416|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
7721941|NCT00546871|12146415|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
7721942|NCT00546871|12146416|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
7721943|NCT00546871|12146415|FG000|Study Extension Period|Protocol Violation|1
7721944|NCT00546871|12146416|FG001|Study Extension Period|Protocol Violation|0
7721945|NCT00546871|12146415|FG000|Study Extension Period|Withdrawal by Subject|0
7721946|NCT00546871|12146416|FG001|Study Extension Period|Withdrawal by Subject|1
7721947|NCT00546910|12146465|FG000|Overall Study|Adverse Event|2
7721948|NCT00546910|12146466|FG001|Overall Study|Adverse Event|3
7721949|NCT00546910|12146465|FG000|Overall Study|Lack of Efficacy|5
7721950|NCT00546910|12146466|FG001|Overall Study|Lack of Efficacy|7
7721951|NCT00546910|12146465|FG000|Overall Study|Physician Decision|0
7721952|NCT00546910|12146466|FG001|Overall Study|Physician Decision|1
7721953|NCT00546910|12146465|FG000|Overall Study|Withdrawal by Subject|2
7721954|NCT00546910|12146466|FG001|Overall Study|Withdrawal by Subject|0
7721955|NCT00547118|12146478|FG000|Overall Study|Did not qualify prior to starting drug|1
7721956|NCT00547118|12146479|FG001|Overall Study|Did not qualify prior to starting drug|1
7721957|NCT00547118|12146478|FG000|Overall Study|Study suspended|7
7721958|NCT00547118|12146479|FG001|Overall Study|Study suspended|8
7721959|NCT00547157|12146489|FG000|Overall Study|Other|1
7721960|NCT00547157|12146490|FG001|Overall Study|Other|0
7721961|NCT00547157|12146489|FG000|Overall Study|Death|38
7721962|NCT00547157|12146490|FG001|Overall Study|Death|18
7721963|NCT00547157|12146489|FG000|Overall Study|Withdrawal by Subject|3
7721964|NCT00547157|12146490|FG001|Overall Study|Withdrawal by Subject|1
7721965|NCT00547157|12146489|FG000|Overall Study|Administrative decision|3
7721966|NCT00547157|12146490|FG001|Overall Study|Administrative decision|2
7721967|NCT00547157|12146489|FG000|Overall Study|Lost to Follow-up|4
7721968|NCT00547157|12146490|FG001|Overall Study|Lost to Follow-up|2
7721969|NCT00547248|12146500|FG000|Overall Study|Protocol Violation|0
7721970|NCT00547248|12146501|FG001|Overall Study|Protocol Violation|0
7721971|NCT00547248|12146502|FG002|Overall Study|Protocol Violation|1
7721972|NCT00547248|12146503|FG003|Overall Study|Protocol Violation|1
7721973|NCT00547248|12146500|FG000|Overall Study|Migrated/moved from study area|0
7721974|NCT00547248|12146501|FG001|Overall Study|Migrated/moved from study area|0
7721975|NCT00547248|12146502|FG002|Overall Study|Migrated/moved from study area|2
7721976|NCT00547248|12146503|FG003|Overall Study|Migrated/moved from study area|0
7721977|NCT00547248|12146500|FG000|Overall Study|Withdrawal by Subject|0
7721978|NCT00547248|12146501|FG001|Overall Study|Withdrawal by Subject|0
7721979|NCT00547248|12146502|FG002|Overall Study|Withdrawal by Subject|7
7721980|NCT00547248|12146503|FG003|Overall Study|Withdrawal by Subject|1
7721981|NCT00547365|12146516|FG000|Overall Study|Physician Decision|1
7721982|NCT00547365|12146516|FG000|Overall Study|Lost to Follow-up|1
7721983|NCT00547365|12146516|FG000|Overall Study|Protocol Violation|2
7721984|NCT00547365|12146516|FG000|Overall Study|death (not related to study)|4
7721985|NCT00547378|12146524|FG000|Randomized Cohort|Withdrawal by Subject|7
7721986|NCT00547378|12146525|FG001|Randomized Cohort|Withdrawal by Subject|5
7721987|NCT00547378|12146526|FG002|Randomized Cohort|Withdrawal by Subject|0
7721988|NCT00547378|12146524|FG000|Randomized Cohort|Death|0
7721989|NCT00547378|12146525|FG001|Randomized Cohort|Death|1
7721990|NCT00547378|12146526|FG002|Randomized Cohort|Death|0
7721991|NCT00547378|12146524|FG000|Randomized Cohort|Lost to Follow-up|1
7721992|NCT00547378|12146525|FG001|Randomized Cohort|Lost to Follow-up|0
7721993|NCT00547378|12146526|FG002|Randomized Cohort|Lost to Follow-up|0
7721994|NCT00547378|12146524|FG000|Randomized Cohort|Adverse Event|1
7721995|NCT00547378|12146525|FG001|Randomized Cohort|Adverse Event|0
7721996|NCT00547378|12146526|FG002|Randomized Cohort|Adverse Event|0
7721997|NCT00547378|12146524|FG000|Randomized Cohort|Other reasons|2
7721998|NCT00547378|12146525|FG001|Randomized Cohort|Other reasons|0
7721999|NCT00547378|12146526|FG002|Randomized Cohort|Other reasons|0
7722000|NCT00547378|12146524|FG000|All Implanted Cohort|Withdrawal by Subject|5
7722001|NCT00547378|12146525|FG001|All Implanted Cohort|Withdrawal by Subject|4
7722002|NCT00547378|12146526|FG002|All Implanted Cohort|Withdrawal by Subject|27
7722003|NCT00547378|12146524|FG000|All Implanted Cohort|Adverse Event|4
7722004|NCT00547378|12146525|FG001|All Implanted Cohort|Adverse Event|10
7722005|NCT00547378|12146526|FG002|All Implanted Cohort|Adverse Event|17
7722006|NCT00547378|12146524|FG000|All Implanted Cohort|Lost to Follow-up|0
7722007|NCT00547378|12146525|FG001|All Implanted Cohort|Lost to Follow-up|1
7722008|NCT00547378|12146526|FG002|All Implanted Cohort|Lost to Follow-up|14
7722009|NCT00547378|12146524|FG000|All Implanted Cohort|Death|3
7722010|NCT00547378|12146525|FG001|All Implanted Cohort|Death|1
7722011|NCT00547378|12146526|FG002|All Implanted Cohort|Death|4
7722012|NCT00547378|12146524|FG000|All Implanted Cohort|Physician Decision|0
7722013|NCT00547378|12146525|FG001|All Implanted Cohort|Physician Decision|2
7722014|NCT00547378|12146526|FG002|All Implanted Cohort|Physician Decision|6
7722015|NCT00547378|12146524|FG000|All Implanted Cohort|Site closure|2
7722016|NCT00547378|12146525|FG001|All Implanted Cohort|Site closure|0
7722017|NCT00547378|12146526|FG002|All Implanted Cohort|Site closure|1
7722018|NCT00547378|12146524|FG000|All Implanted Cohort|Other reasons|1
7722019|NCT00547378|12146525|FG001|All Implanted Cohort|Other reasons|0
7722020|NCT00547378|12146526|FG002|All Implanted Cohort|Other reasons|1
7767888|NCT00856544|12210722|FG003|Overall Study|Randomized but not treated|0
7767889|NCT00856544|12210719|FG000|Overall Study|Death|0
7767890|NCT00856544|12210720|FG001|Overall Study|Death|2
7767891|NCT00856544|12210721|FG002|Overall Study|Death|0
7767892|NCT00856544|12210722|FG003|Overall Study|Death|0
7767893|NCT00856544|12210719|FG000|Overall Study|Adverse Event|20
7767894|NCT00856544|12210720|FG001|Overall Study|Adverse Event|29
7767895|NCT00856544|12210721|FG002|Overall Study|Adverse Event|2
7767896|NCT00856544|12210722|FG003|Overall Study|Adverse Event|3
7767897|NCT00856544|12210719|FG000|Overall Study|Lack of Efficacy|16
7767898|NCT00856544|12210720|FG001|Overall Study|Lack of Efficacy|12
7767899|NCT00856544|12210721|FG002|Overall Study|Lack of Efficacy|3
7767900|NCT00856544|12210722|FG003|Overall Study|Lack of Efficacy|3
7767901|NCT00856544|12210719|FG000|Overall Study|Other|9
7767902|NCT00856544|12210720|FG001|Overall Study|Other|16
7767903|NCT00856544|12210721|FG002|Overall Study|Other|1
7767904|NCT00856544|12210722|FG003|Overall Study|Other|6
7767905|NCT00856544|12210719|FG000|Overall Study|Lost to Follow-up|1
7767906|NCT00856544|12210720|FG001|Overall Study|Lost to Follow-up|2
7767907|NCT00856544|12210721|FG002|Overall Study|Lost to Follow-up|2
7767908|NCT00856544|12210722|FG003|Overall Study|Lost to Follow-up|0
7767909|NCT00856544|12210719|FG000|Overall Study|Withdrawal by Subject|8
7767910|NCT00856544|12210720|FG001|Overall Study|Withdrawal by Subject|5
7767911|NCT00856544|12210721|FG002|Overall Study|Withdrawal by Subject|0
7767912|NCT00856544|12210722|FG003|Overall Study|Withdrawal by Subject|1
7767913|NCT00856557|12210746|FG000|Overall Study|No patients with contextual flags|12
7767914|NCT00856557|12210747|FG001|Overall Study|No patients with contextual flags|16
7767915|NCT00856583|12210755|FG000|Overall Study|Lack of Efficacy|389
7767916|NCT00856583|12210756|FG001|Overall Study|Lack of Efficacy|377
7767917|NCT00856583|12210755|FG000|Overall Study|Serious Adverse Event (SAE)|99
7767918|NCT00856583|12210756|FG001|Overall Study|Serious Adverse Event (SAE)|65
7767919|NCT00856583|12210755|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
7767920|NCT00856583|12210756|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
7767921|NCT00856583|12210755|FG000|Overall Study|Non-compliance|305
7767922|NCT00856583|12210756|FG001|Overall Study|Non-compliance|262
7767923|NCT00856583|12210755|FG000|Overall Study|Withdrawal by Subject|1092
7722021|NCT00547521|12146536|FG000|Short Term Study (4 Months)|Adverse Event|1
7722022|NCT00547521|12146537|FG001|Short Term Study (4 Months)|Adverse Event|0
7722023|NCT00547521|12146536|FG000|Short Term Study (4 Months)|Lack of Efficacy|0
7722024|NCT00547521|12146537|FG001|Short Term Study (4 Months)|Lack of Efficacy|2
7722025|NCT00547521|12146536|FG000|Short Term Study (4 Months)|Withdrawal of consent|0
7722026|NCT00547521|12146537|FG001|Short Term Study (4 Months)|Withdrawal of consent|1
7722027|NCT00547521|12146536|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
7722028|NCT00547521|12146537|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
7722029|NCT00547521|12146536|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0
7722030|NCT00547521|12146537|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14
7722031|NCT00547521|12146536|FG000|Long Term Extension (LTE) Study|Adverse Event|0
7722032|NCT00547521|12146537|FG001|Long Term Extension (LTE) Study|Adverse Event|9
7722033|NCT00547521|12146536|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0
7722034|NCT00547521|12146537|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3
7722035|NCT00547521|12146536|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0
7722036|NCT00547521|12146537|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2
7722037|NCT00547521|12146536|FG000|Long Term Extension (LTE) Study|Other|0
7722038|NCT00547521|12146537|FG001|Long Term Extension (LTE) Study|Other|2
7722039|NCT00547521|12146536|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
7722040|NCT00547521|12146537|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
7722041|NCT00547534|12146550|FG000|Overall Study|Adverse Event|7
7722042|NCT00547534|12146550|FG000|Overall Study|Disease Progression|4
7722043|NCT00547703|12146587|FG000|Overall Study|Lost to Follow-up|1
7722044|NCT00547703|12146588|FG001|Overall Study|Lost to Follow-up|0
7722045|NCT00547911|12146621|FG000|Overall Study|Adverse Event|0
7722046|NCT00547911|12146622|FG001|Overall Study|Adverse Event|0
7722047|NCT00547911|12146623|FG002|Overall Study|Adverse Event|0
7722048|NCT00547911|12146624|FG003|Overall Study|Adverse Event|1
7722049|NCT00547911|12146625|FG004|Overall Study|Adverse Event|0
7722050|NCT00547911|12146626|FG005|Overall Study|Adverse Event|0
7722051|NCT00548145|12146656|FG000|Overall Study|Death|0
7722052|NCT00548145|12146657|FG001|Overall Study|Death|1
7722053|NCT00548145|12146656|FG000|Overall Study|Withdrawal by Subject|0
7722054|NCT00548145|12146657|FG001|Overall Study|Withdrawal by Subject|2
7722055|NCT00548145|12146656|FG000|Overall Study|Physician Decision|1
7722056|NCT00548145|12146657|FG001|Overall Study|Physician Decision|1
7722057|NCT00548184|12146672|FG000|Overall Study|Adverse Event|3
7722058|NCT00548184|12146672|FG000|Overall Study|took other drug|1
7722059|NCT00548184|12146672|FG000|Overall Study|Found Her2 negative|1
7722060|NCT00548249|12146692|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
7722061|NCT00548249|12146693|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
7722062|NCT00548249|12146694|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
7722063|NCT00548249|12146695|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
7722064|NCT00548249|12146696|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
7722065|NCT00548249|12146692|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5
7722066|NCT00548249|12146693|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1
7722067|NCT00548249|12146694|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3
7722068|NCT00548249|12146695|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1
7722069|NCT00548249|12146696|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2
7722070|NCT00548249|12146692|FG000|Overall Study|Protocol Violation|1
7722071|NCT00548249|12146693|FG001|Overall Study|Protocol Violation|1
7722072|NCT00548249|12146694|FG002|Overall Study|Protocol Violation|4
7722073|NCT00548249|12146695|FG003|Overall Study|Protocol Violation|0
7722074|NCT00548249|12146696|FG004|Overall Study|Protocol Violation|3
7722075|NCT00548249|12146692|FG000|Overall Study|Miscellaneous|2
7722076|NCT00548249|12146693|FG001|Overall Study|Miscellaneous|3
7722077|NCT00548249|12146694|FG002|Overall Study|Miscellaneous|2
7722078|NCT00548249|12146695|FG003|Overall Study|Miscellaneous|0
7722079|NCT00548249|12146696|FG004|Overall Study|Miscellaneous|2
7722080|NCT00548249|12146692|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
7722081|NCT00548249|12146693|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
7722082|NCT00548249|12146694|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
7722083|NCT00548249|12146695|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
7722084|NCT00548249|12146696|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
7722085|NCT00548249|12146692|FG000|Overall Study|Adverse Event|2
7722086|NCT00548249|12146693|FG001|Overall Study|Adverse Event|2
7722087|NCT00548249|12146694|FG002|Overall Study|Adverse Event|0
7722088|NCT00548249|12146695|FG003|Overall Study|Adverse Event|1
7722089|NCT00548249|12146696|FG004|Overall Study|Adverse Event|1
7722090|NCT00548249|12146692|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0
7722091|NCT00548249|12146693|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0
7722092|NCT00548249|12146694|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1
7722093|NCT00548249|12146695|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3
7722094|NCT00548249|12146696|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2
7722095|NCT00548249|12146692|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0
7722096|NCT00548249|12146693|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0
7722097|NCT00548249|12146694|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1
7722098|NCT00548249|12146695|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2
7722099|NCT00548249|12146696|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2
7722100|NCT00548249|12146692|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
7722101|NCT00548249|12146693|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
7722102|NCT00548249|12146694|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
7722103|NCT00548249|12146695|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
7722104|NCT00548249|12146696|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
7722105|NCT00548249|12146692|FG000|Overall Study|Prolonged hospitalization|0
7722106|NCT00548249|12146693|FG001|Overall Study|Prolonged hospitalization|0
7722107|NCT00548249|12146694|FG002|Overall Study|Prolonged hospitalization|2
7722108|NCT00548249|12146695|FG003|Overall Study|Prolonged hospitalization|1
7722109|NCT00548249|12146696|FG004|Overall Study|Prolonged hospitalization|0
7722110|NCT00548249|12146692|FG000|Overall Study|Withdrawal by Subject|2
7722111|NCT00548249|12146693|FG001|Overall Study|Withdrawal by Subject|0
7722112|NCT00548249|12146694|FG002|Overall Study|Withdrawal by Subject|0
7722113|NCT00548249|12146695|FG003|Overall Study|Withdrawal by Subject|0
7722114|NCT00548249|12146696|FG004|Overall Study|Withdrawal by Subject|0
7722115|NCT00548249|12146692|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
7722116|NCT00548249|12146693|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
7722117|NCT00548249|12146694|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
7722118|NCT00548249|12146695|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
7722119|NCT00548249|12146696|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
7722120|NCT00548249|12146692|FG000|Overall Study|Sponsor's request|0
7722121|NCT00548249|12146693|FG001|Overall Study|Sponsor's request|0
7722122|NCT00548249|12146694|FG002|Overall Study|Sponsor's request|0
7722123|NCT00548249|12146695|FG003|Overall Study|Sponsor's request|1
7722124|NCT00548249|12146696|FG004|Overall Study|Sponsor's request|0
7722125|NCT00548262|12146708|FG000|Overall Study|Death|21
7722126|NCT00548262|12146708|FG000|Overall Study|Adverse Event|2
7722127|NCT00548262|12146708|FG000|Overall Study|Lack of Efficacy|4
7722128|NCT00548262|12146708|FG000|Overall Study|Lost to Follow-up|1
7722129|NCT00548262|12146708|FG000|Overall Study|Other|3
7722130|NCT00548262|12146708|FG000|Overall Study|Withdrawal by Subject|1
7722131|NCT00548340|12146715|FG000|Overall Study|Protocol Violation|2
7722132|NCT00548340|12146716|FG001|Overall Study|Protocol Violation|3
7722133|NCT00548340|12146717|FG002|Overall Study|Protocol Violation|3
7722134|NCT00548340|12146715|FG000|Overall Study|Adverse Event|2
7722135|NCT00548340|12146716|FG001|Overall Study|Adverse Event|2
7722136|NCT00548340|12146717|FG002|Overall Study|Adverse Event|2
7722137|NCT00548340|12146715|FG000|Overall Study|Lost to Follow-up|1
7722138|NCT00548340|12146716|FG001|Overall Study|Lost to Follow-up|1
7722139|NCT00548340|12146717|FG002|Overall Study|Lost to Follow-up|0
7722140|NCT00548340|12146715|FG000|Overall Study|Withdrawal by Subject|2
7722141|NCT00548340|12146716|FG001|Overall Study|Withdrawal by Subject|4
7722142|NCT00548340|12146717|FG002|Overall Study|Withdrawal by Subject|3
7722143|NCT00548340|12146715|FG000|Overall Study|Other|1
7722144|NCT00548340|12146716|FG001|Overall Study|Other|1
7722145|NCT00548340|12146717|FG002|Overall Study|Other|1
7722146|NCT00548405|12146728|FG000|Overall Study|Adverse Event|6
7722147|NCT00548405|12146729|FG001|Overall Study|Adverse Event|2
7722148|NCT00548405|12146730|FG002|Overall Study|Adverse Event|0
7722149|NCT00548405|12146728|FG000|Overall Study|Lack of Efficacy|6
7722150|NCT00548405|12146729|FG001|Overall Study|Lack of Efficacy|0
7722151|NCT00548405|12146730|FG002|Overall Study|Lack of Efficacy|0
7722152|NCT00548405|12146728|FG000|Overall Study|Physician Decision|3
7722153|NCT00548405|12146729|FG001|Overall Study|Physician Decision|4
7722154|NCT00548405|12146730|FG002|Overall Study|Physician Decision|1
7722155|NCT00548405|12146728|FG000|Overall Study|Pregnancy|1
7722156|NCT00548405|12146729|FG001|Overall Study|Pregnancy|0
7722157|NCT00548405|12146730|FG002|Overall Study|Pregnancy|0
7722158|NCT00548405|12146728|FG000|Overall Study|Protocol Violation|1
7722159|NCT00548405|12146729|FG001|Overall Study|Protocol Violation|0
7722160|NCT00548405|12146730|FG002|Overall Study|Protocol Violation|0
7722161|NCT00548405|12146728|FG000|Overall Study|Withdrawal by Subject|36
7722162|NCT00548405|12146729|FG001|Overall Study|Withdrawal by Subject|12
7722163|NCT00548405|12146730|FG002|Overall Study|Withdrawal by Subject|5
7722164|NCT00548405|12146728|FG000|Overall Study|Lost to Follow-up|1
7722165|NCT00548405|12146729|FG001|Overall Study|Lost to Follow-up|1
7722166|NCT00548405|12146730|FG002|Overall Study|Lost to Follow-up|2
7722167|NCT00548405|12146728|FG000|Overall Study|Death|0
7722168|NCT00548405|12146729|FG001|Overall Study|Death|1
7722169|NCT00548405|12146730|FG002|Overall Study|Death|1
7722170|NCT00548405|12146728|FG000|Overall Study|Sponsor decision|1
7722171|NCT00548405|12146729|FG001|Overall Study|Sponsor decision|0
7722172|NCT00548405|12146730|FG002|Overall Study|Sponsor decision|0
7722173|NCT00548405|12146728|FG000|Overall Study|Randomized but not treated|1
7722174|NCT00548405|12146729|FG001|Overall Study|Randomized but not treated|0
7722175|NCT00548405|12146730|FG002|Overall Study|Randomized but not treated|0
7722176|NCT00548548|12146753|FG000|Overall Study|Death|345
7722177|NCT00548548|12146754|FG001|Overall Study|Death|348
7722178|NCT00548548|12146753|FG000|Overall Study|Lost to Follow-up|17
7722179|NCT00548548|12146754|FG001|Overall Study|Lost to Follow-up|18
7722180|NCT00548717|12146784|FG000|Overall Study|Death|5
7722181|NCT00548717|12146785|FG001|Overall Study|Death|2
7722182|NCT00548717|12146784|FG000|Overall Study|Relapse|3
7722183|NCT00548717|12146785|FG001|Overall Study|Relapse|0
7722184|NCT00548717|12146784|FG000|Overall Study|Alternative treatment for GVHD|1
7722185|NCT00548717|12146785|FG001|Overall Study|Alternative treatment for GVHD|0
7722186|NCT00548808|12146796|FG000|Overall Study|Lost to Follow-up|9
7722187|NCT00548808|12146797|FG001|Overall Study|Lost to Follow-up|3
7722188|NCT00548808|12146796|FG000|Overall Study|Protocol Violation|8
7722189|NCT00548808|12146797|FG001|Overall Study|Protocol Violation|8
7722190|NCT00548808|12146796|FG000|Overall Study|Withdrawal by Subject|8
7722191|NCT00548808|12146797|FG001|Overall Study|Withdrawal by Subject|4
7722192|NCT00548808|12146796|FG000|Overall Study|Physician Decision|6
7722193|NCT00548808|12146797|FG001|Overall Study|Physician Decision|3
7722194|NCT00548808|12146796|FG000|Overall Study|Adverse Event|4
7722195|NCT00548808|12146797|FG001|Overall Study|Adverse Event|5
7722196|NCT00548808|12146796|FG000|Overall Study|Death|2
7722197|NCT00548808|12146797|FG001|Overall Study|Death|0
7722198|NCT00548808|12146796|FG000|Overall Study|Entry Criteria Not Met|2
7722199|NCT00548808|12146797|FG001|Overall Study|Entry Criteria Not Met|2
7722200|NCT00548808|12146796|FG000|Overall Study|Lack of Efficacy|2
7722201|NCT00548808|12146797|FG001|Overall Study|Lack of Efficacy|0
7722202|NCT00548808|12146796|FG000|Overall Study|Sponsor Decision|1
7722203|NCT00548808|12146797|FG001|Overall Study|Sponsor Decision|1
7722204|NCT00548847|12146803|FG000|Overall Study|Disease progression|7
7722205|NCT00549055|12146826|FG000|Overall Study|Adverse Event|4
7722206|NCT00549055|12146826|FG000|Overall Study|Lack of Efficacy|18
7722207|NCT00549055|12146826|FG000|Overall Study|Stabilization|5
7722208|NCT00549055|12146826|FG000|Overall Study|Progression to fibrosis|2
7722209|NCT00549055|12146826|FG000|Overall Study|Decrease of size|1
7722210|NCT00549055|12146826|FG000|Overall Study|Active choroidal neovascula increased|1
7722211|NCT00549055|12146826|FG000|Overall Study|Vitreous hemorrhage|1
7722212|NCT00549055|12146826|FG000|Overall Study|Growth choroidal neovascularisation|1
7722213|NCT00549055|12146826|FG000|Overall Study|Choroidal neovascularization|1
7722214|NCT00549055|12146826|FG000|Overall Study|Very low visual acuity (VA)|1
7722215|NCT00549198|12146841|FG000|Overall Study|Adverse Event|28
7722216|NCT00549198|12146842|FG001|Overall Study|Adverse Event|26
7722217|NCT00549198|12146841|FG000|Overall Study|Insufficient Viral Load Response|4
7722218|NCT00549198|12146842|FG001|Overall Study|Insufficient Viral Load Response|2
7722219|NCT00549198|12146841|FG000|Overall Study|Protocol-defined Virological Failure|7
7722220|NCT00549198|12146842|FG001|Overall Study|Protocol-defined Virological Failure|0
7722221|NCT00549198|12146841|FG000|Overall Study|Non-compliance|2
7722222|NCT00549198|12146842|FG001|Overall Study|Non-compliance|4
7722223|NCT00549198|12146841|FG000|Overall Study|Lost to Follow-up|7
7722224|NCT00549198|12146842|FG001|Overall Study|Lost to Follow-up|8
7722225|NCT00549198|12146841|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3
7722226|NCT00549198|12146842|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0
7722227|NCT00549198|12146841|FG000|Overall Study|Protocol Violation|7
7722228|NCT00549198|12146842|FG001|Overall Study|Protocol Violation|2
7722229|NCT00549198|12146841|FG000|Overall Study|Investigator Decision|4
7722230|NCT00549198|12146842|FG001|Overall Study|Investigator Decision|3
7722231|NCT00549198|12146841|FG000|Overall Study|Withdrawal by Subject|7
7722232|NCT00549198|12146842|FG001|Overall Study|Withdrawal by Subject|7
7722233|NCT00549198|12146841|FG000|Overall Study|Disease Progression|1
7722234|NCT00549198|12146842|FG001|Overall Study|Disease Progression|0
7722235|NCT00549198|12146841|FG000|Overall Study|Participant Moved|2
7722236|NCT00549198|12146842|FG001|Overall Study|Participant Moved|0
7722237|NCT00549198|12146841|FG000|Overall Study|Participant not able to perform Week 96|1
7722238|NCT00549198|12146842|FG001|Overall Study|Participant not able to perform Week 96|0
7722239|NCT00549198|12146841|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1
7722240|NCT00549198|12146842|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0
7722241|NCT00549198|12146841|FG000|Overall Study|Prohibited Medication|1
7722242|NCT00549198|12146842|FG001|Overall Study|Prohibited Medication|2
7722243|NCT00549198|12146841|FG000|Overall Study|Participant planning pregnancy|1
7722244|NCT00549198|12146842|FG001|Overall Study|Participant planning pregnancy|0
7722245|NCT00549198|12146841|FG000|Overall Study|Participant overweight, no scan possible|1
7722246|NCT00549198|12146842|FG001|Overall Study|Participant overweight, no scan possible|0
7722247|NCT00549198|12146841|FG000|Overall Study|No scan facilities|0
7722248|NCT00549198|12146842|FG001|Overall Study|No scan facilities|2
7722249|NCT00549198|12146841|FG000|Overall Study|Pregnancy|0
7722250|NCT00549198|12146842|FG001|Overall Study|Pregnancy|3
7722251|NCT00549198|12146841|FG000|Overall Study|Not Exposed to Study Drug|3
7722252|NCT00549198|12146842|FG001|Overall Study|Not Exposed to Study Drug|4
7722253|NCT00549302|12146850|FG000|Double-Blind|Death|2
7722254|NCT00549302|12146851|FG001|Double-Blind|Death|9
7722255|NCT00549302|12146852|FG002|Double-Blind|Death|0
7722256|NCT00549302|12146850|FG000|Double-Blind|Adverse Event|3
7722257|NCT00549302|12146851|FG001|Double-Blind|Adverse Event|16
7722258|NCT00549302|12146852|FG002|Double-Blind|Adverse Event|0
7722259|NCT00549302|12146850|FG000|Double-Blind|Withdrawal by Subject|3
7722260|NCT00549302|12146851|FG001|Double-Blind|Withdrawal by Subject|8
7722261|NCT00549302|12146852|FG002|Double-Blind|Withdrawal by Subject|0
7722262|NCT00549302|12146850|FG000|Double-Blind|Investigator Decision|1
7722263|NCT00549302|12146851|FG001|Double-Blind|Investigator Decision|5
7722264|NCT00549302|12146852|FG002|Double-Blind|Investigator Decision|0
7722265|NCT00549302|12146850|FG000|Double-Blind|Sponsor Decision|0
7722266|NCT00549302|12146851|FG001|Double-Blind|Sponsor Decision|1
7722267|NCT00549302|12146852|FG002|Double-Blind|Sponsor Decision|0
7722268|NCT00549302|12146850|FG000|Double-Blind|Lost to Follow-up|1
7722269|NCT00549302|12146851|FG001|Double-Blind|Lost to Follow-up|2
7722270|NCT00549302|12146852|FG002|Double-Blind|Lost to Follow-up|0
7722271|NCT00549302|12146850|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
7722272|NCT00549302|12146851|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
7722273|NCT00549302|12146852|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
7722274|NCT00549302|12146850|FG000|Double-Blind|New condition or starts new therapy|0
7722275|NCT00549302|12146851|FG001|Double-Blind|New condition or starts new therapy|2
7722276|NCT00549302|12146852|FG002|Double-Blind|New condition or starts new therapy|0
7722277|NCT00549302|12146850|FG000|Open-Label|Adverse Event|0
7722278|NCT00549302|12146851|FG001|Open-Label|Adverse Event|0
7722279|NCT00549302|12146852|FG002|Open-Label|Adverse Event|11
7722280|NCT00549302|12146850|FG000|Open-Label|Death|0
7722281|NCT00549302|12146851|FG001|Open-Label|Death|0
7722282|NCT00549302|12146852|FG002|Open-Label|Death|40
7722283|NCT00549302|12146850|FG000|Open-Label|Investigator Decision|0
7722284|NCT00549302|12146851|FG001|Open-Label|Investigator Decision|0
7722285|NCT00549302|12146852|FG002|Open-Label|Investigator Decision|5
7722286|NCT00549302|12146850|FG000|Open-Label|Lost to Follow-up|0
7722287|NCT00549302|12146851|FG001|Open-Label|Lost to Follow-up|0
7722288|NCT00549302|12146852|FG002|Open-Label|Lost to Follow-up|2
7722289|NCT00549302|12146850|FG000|Open-Label|Other|0
7722290|NCT00549302|12146851|FG001|Open-Label|Other|0
7722291|NCT00549302|12146852|FG002|Open-Label|Other|3
7722292|NCT00549302|12146850|FG000|Open-Label|New drug pulmonary atrial hypertension|0
7722293|NCT00549302|12146851|FG001|Open-Label|New drug pulmonary atrial hypertension|0
7722294|NCT00549302|12146852|FG002|Open-Label|New drug pulmonary atrial hypertension|2
7722295|NCT00549302|12146850|FG000|Open-Label|Withdrawal by Subject|0
7722296|NCT00549302|12146851|FG001|Open-Label|Withdrawal by Subject|0
7722297|NCT00549302|12146852|FG002|Open-Label|Withdrawal by Subject|6
7722298|NCT00549445|12146873|FG000|Overall Study|Sputum & Blood Samples Not Available|15
7722299|NCT00549445|12146874|FG001|Overall Study|Sputum & Blood Samples Not Available|17
7722300|NCT00549549|12146884|FG000|Overall Study|Adverse Event|5
7722301|NCT00549549|12146885|FG001|Overall Study|Adverse Event|3
7722302|NCT00549549|12146886|FG002|Overall Study|Adverse Event|1
7722303|NCT00549549|12146887|FG003|Overall Study|Adverse Event|9
7722304|NCT00549549|12146884|FG000|Overall Study|Lack of Efficacy|9
7722305|NCT00549549|12146885|FG001|Overall Study|Lack of Efficacy|6
7722306|NCT00549549|12146886|FG002|Overall Study|Lack of Efficacy|4
7722307|NCT00549549|12146887|FG003|Overall Study|Lack of Efficacy|2
7722308|NCT00549549|12146884|FG000|Overall Study|Lost to Follow-up|1
7722309|NCT00549549|12146885|FG001|Overall Study|Lost to Follow-up|0
7722310|NCT00549549|12146886|FG002|Overall Study|Lost to Follow-up|1
7722311|NCT00549549|12146887|FG003|Overall Study|Lost to Follow-up|2
7722312|NCT00549549|12146884|FG000|Overall Study|Withdrawal by Subject|0
7722313|NCT00549549|12146885|FG001|Overall Study|Withdrawal by Subject|4
7722314|NCT00549549|12146886|FG002|Overall Study|Withdrawal by Subject|1
7722315|NCT00549549|12146887|FG003|Overall Study|Withdrawal by Subject|0
7722316|NCT00549549|12146884|FG000|Overall Study|Other|9
7722317|NCT00549549|12146885|FG001|Overall Study|Other|9
7722318|NCT00549549|12146886|FG002|Overall Study|Other|9
7722319|NCT00549549|12146887|FG003|Overall Study|Other|11
7722320|NCT00549549|12146884|FG000|Overall Study|Randomized but not treated|0
7722321|NCT00549549|12146885|FG001|Overall Study|Randomized but not treated|0
7722322|NCT00549549|12146886|FG002|Overall Study|Randomized but not treated|1
7722323|NCT00549549|12146887|FG003|Overall Study|Randomized but not treated|1
7722324|NCT00549562|12146897|FG000|Overall Study|Adverse Event|1
7722325|NCT00549562|12146897|FG000|Overall Study|Lack of Efficacy|1
7722326|NCT00549601|12146904|FG000|Randomized|Protocol Violation|0
7722327|NCT00549601|12146905|FG001|Randomized|Protocol Violation|0
7722328|NCT00549601|12146906|FG002|Randomized|Protocol Violation|1
7722329|NCT00549601|12146904|FG000|Randomized|Withdrawal by Subject|0
7722330|NCT00549601|12146905|FG001|Randomized|Withdrawal by Subject|1
7722331|NCT00549601|12146906|FG002|Randomized|Withdrawal by Subject|1
7722332|NCT00549601|12146904|FG000|Received Study Drug|Adverse Event|2
7722333|NCT00549601|12146905|FG001|Received Study Drug|Adverse Event|5
7722334|NCT00549601|12146906|FG002|Received Study Drug|Adverse Event|1
7722335|NCT00549601|12146904|FG000|Received Study Drug|Death|0
7722336|NCT00549601|12146905|FG001|Received Study Drug|Death|1
7722337|NCT00549601|12146906|FG002|Received Study Drug|Death|0
7722338|NCT00549601|12146904|FG000|Received Study Drug|Lost to Follow-up|0
7722339|NCT00549601|12146905|FG001|Received Study Drug|Lost to Follow-up|1
7722340|NCT00549601|12146906|FG002|Received Study Drug|Lost to Follow-up|1
7722341|NCT00549601|12146904|FG000|Received Study Drug|Protocol Violation|3
7722342|NCT00549601|12146905|FG001|Received Study Drug|Protocol Violation|4
7722343|NCT00549601|12146906|FG002|Received Study Drug|Protocol Violation|1
7722344|NCT00549601|12146904|FG000|Received Study Drug|Withdrawal by Subject|2
7722345|NCT00549601|12146905|FG001|Received Study Drug|Withdrawal by Subject|0
7722346|NCT00549601|12146906|FG002|Received Study Drug|Withdrawal by Subject|1
7722347|NCT00549640|12146918|FG000|Overall Study|Withdrawal by Subject|6
7722348|NCT00549640|12146919|FG001|Overall Study|Withdrawal by Subject|12
7722349|NCT00549640|12146918|FG000|Overall Study|Adverse Event|5
7722350|NCT00549640|12146919|FG001|Overall Study|Adverse Event|0
7722351|NCT00549640|12146918|FG000|Overall Study|Lost to Follow-up|7
7722352|NCT00549640|12146919|FG001|Overall Study|Lost to Follow-up|4
7722353|NCT00549718|12146929|FG000|Overall Study|Insufficient clinical response|20
7722354|NCT00549718|12146930|FG001|Overall Study|Insufficient clinical response|7
7722355|NCT00549718|12146931|FG002|Overall Study|Insufficient clinical response|18
7722356|NCT00549718|12146932|FG003|Overall Study|Insufficient clinical response|32
7722357|NCT00549718|12146929|FG000|Overall Study|Adverse Event|6
7722358|NCT00549718|12146930|FG001|Overall Study|Adverse Event|8
7722359|NCT00549718|12146931|FG002|Overall Study|Adverse Event|7
7722360|NCT00549718|12146932|FG003|Overall Study|Adverse Event|3
7722361|NCT00549718|12146929|FG000|Overall Study|Lost to Follow-up|4
7722362|NCT00549718|12146930|FG001|Overall Study|Lost to Follow-up|2
7722363|NCT00549718|12146931|FG002|Overall Study|Lost to Follow-up|0
7722364|NCT00549718|12146932|FG003|Overall Study|Lost to Follow-up|6
7722365|NCT00549718|12146929|FG000|Overall Study|Withdrawal by Subject|9
7722366|NCT00549718|12146930|FG001|Overall Study|Withdrawal by Subject|18
7722367|NCT00549718|12146931|FG002|Overall Study|Withdrawal by Subject|12
7722368|NCT00549718|12146932|FG003|Overall Study|Withdrawal by Subject|13
7722369|NCT00549718|12146929|FG000|Overall Study|Administrative|2
7722370|NCT00549718|12146930|FG001|Overall Study|Administrative|2
7722371|NCT00549718|12146931|FG002|Overall Study|Administrative|2
7722372|NCT00549718|12146932|FG003|Overall Study|Administrative|1
7722373|NCT00549757|12146944|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590
7722374|NCT00549757|12146945|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462
7722375|NCT00549757|12146944|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
7722376|NCT00549757|12146945|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
7722377|NCT00549757|12146944|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
7722378|NCT00549757|12146945|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
7722379|NCT00549757|12146944|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
7722380|NCT00549757|12146945|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
7722381|NCT00549757|12146944|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
7722382|NCT00549757|12146945|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
7722383|NCT00549757|12146944|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
7722384|NCT00549757|12146945|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
7722385|NCT00549757|12146944|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
7722386|NCT00549757|12146945|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
7722387|NCT00549757|12146944|FG000|Active Treatment Phase: Max. 50 Months|Death|188
7722388|NCT00549757|12146945|FG001|Active Treatment Phase: Max. 50 Months|Death|200
7722389|NCT00549757|12146944|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353
7722390|NCT00549757|12146945|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380
7722391|NCT00549757|12146944|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
7722392|NCT00549757|12146945|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
7722393|NCT00549757|12146944|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8
7722394|NCT00549757|12146945|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9
7722395|NCT00549757|12146944|FG000|Extension Period (in Average 9 Months)|Death|143
7722396|NCT00549757|12146945|FG001|Extension Period (in Average 9 Months)|Death|136
7722397|NCT00549757|12146944|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52
7722398|NCT00549757|12146945|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47
7722399|NCT00549757|12146944|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
7722400|NCT00549757|12146945|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
7722401|NCT00549757|12146944|FG000|Extension Period (in Average 9 Months)|Patient's request|421
7722402|NCT00549757|12146945|FG001|Extension Period (in Average 9 Months)|Patient's request|436
7722403|NCT00549770|12146965|FG000|Overall Study|Protocol deviation|1
7722404|NCT00549770|12146966|FG001|Overall Study|Protocol deviation|1
7722405|NCT00549770|12146967|FG002|Overall Study|Protocol deviation|1
7722406|NCT00549770|12146968|FG003|Overall Study|Protocol deviation|2
7722407|NCT00549770|12146969|FG004|Overall Study|Protocol deviation|2
7722408|NCT00549770|12146970|FG005|Overall Study|Protocol deviation|2
7722409|NCT00549770|12146971|FG006|Overall Study|Protocol deviation|1
7722410|NCT00549770|12146972|FG007|Overall Study|Protocol deviation|2
7722411|NCT00549770|12146965|FG000|Overall Study|Administrative problems|0
7722412|NCT00549770|12146966|FG001|Overall Study|Administrative problems|1
7722413|NCT00549770|12146967|FG002|Overall Study|Administrative problems|0
7722414|NCT00549770|12146968|FG003|Overall Study|Administrative problems|0
7722415|NCT00549770|12146969|FG004|Overall Study|Administrative problems|0
7722416|NCT00549770|12146970|FG005|Overall Study|Administrative problems|0
7722417|NCT00549770|12146971|FG006|Overall Study|Administrative problems|0
7722418|NCT00549770|12146972|FG007|Overall Study|Administrative problems|1
7722419|NCT00549770|12146965|FG000|Overall Study|Lost to Follow-up|0
7722420|NCT00549770|12146966|FG001|Overall Study|Lost to Follow-up|0
7722421|NCT00549770|12146967|FG002|Overall Study|Lost to Follow-up|2
7722422|NCT00549770|12146968|FG003|Overall Study|Lost to Follow-up|2
7722423|NCT00549770|12146969|FG004|Overall Study|Lost to Follow-up|3
7722424|NCT00549770|12146970|FG005|Overall Study|Lost to Follow-up|2
7722425|NCT00549770|12146971|FG006|Overall Study|Lost to Follow-up|0
7722426|NCT00549770|12146972|FG007|Overall Study|Lost to Follow-up|0
7722427|NCT00549770|12146965|FG000|Overall Study|Withdrawal by Subject|4
7722428|NCT00549770|12146966|FG001|Overall Study|Withdrawal by Subject|6
7722429|NCT00549770|12146967|FG002|Overall Study|Withdrawal by Subject|4
7722430|NCT00549770|12146968|FG003|Overall Study|Withdrawal by Subject|5
7722431|NCT00549770|12146969|FG004|Overall Study|Withdrawal by Subject|6
7722432|NCT00549770|12146970|FG005|Overall Study|Withdrawal by Subject|6
7722433|NCT00549770|12146971|FG006|Overall Study|Withdrawal by Subject|4
7722434|NCT00549770|12146972|FG007|Overall Study|Withdrawal by Subject|9
7722435|NCT00549770|12146965|FG000|Overall Study|Lack of Efficacy|1
7722436|NCT00549770|12146966|FG001|Overall Study|Lack of Efficacy|0
7722437|NCT00549770|12146967|FG002|Overall Study|Lack of Efficacy|2
7722438|NCT00549770|12146968|FG003|Overall Study|Lack of Efficacy|3
7722439|NCT00549770|12146969|FG004|Overall Study|Lack of Efficacy|5
7722440|NCT00549770|12146970|FG005|Overall Study|Lack of Efficacy|1
7722441|NCT00549770|12146971|FG006|Overall Study|Lack of Efficacy|3
7722442|NCT00549770|12146972|FG007|Overall Study|Lack of Efficacy|8
7722443|NCT00549770|12146965|FG000|Overall Study|Abnormal test procedure results|0
7722444|NCT00549770|12146966|FG001|Overall Study|Abnormal test procedure results|0
7722445|NCT00549770|12146967|FG002|Overall Study|Abnormal test procedure results|0
7722446|NCT00549770|12146968|FG003|Overall Study|Abnormal test procedure results|2
7722447|NCT00549770|12146969|FG004|Overall Study|Abnormal test procedure results|0
7722448|NCT00549770|12146970|FG005|Overall Study|Abnormal test procedure results|1
7722449|NCT00549770|12146971|FG006|Overall Study|Abnormal test procedure results|1
7722450|NCT00549770|12146972|FG007|Overall Study|Abnormal test procedure results|1
7722451|NCT00549770|12146965|FG000|Overall Study|Abnormal laboratory values|0
7722452|NCT00549770|12146966|FG001|Overall Study|Abnormal laboratory values|0
7722453|NCT00549770|12146967|FG002|Overall Study|Abnormal laboratory values|0
7722454|NCT00549770|12146968|FG003|Overall Study|Abnormal laboratory values|0
7722455|NCT00549770|12146969|FG004|Overall Study|Abnormal laboratory values|0
7722456|NCT00549770|12146970|FG005|Overall Study|Abnormal laboratory values|1
7722457|NCT00549770|12146971|FG006|Overall Study|Abnormal laboratory values|0
7722458|NCT00549770|12146972|FG007|Overall Study|Abnormal laboratory values|0
7722459|NCT00549770|12146965|FG000|Overall Study|Adverse Event|1
7722460|NCT00549770|12146966|FG001|Overall Study|Adverse Event|3
7722461|NCT00549770|12146967|FG002|Overall Study|Adverse Event|1
7722462|NCT00549770|12146968|FG003|Overall Study|Adverse Event|2
7722463|NCT00549770|12146969|FG004|Overall Study|Adverse Event|1
7722464|NCT00549770|12146970|FG005|Overall Study|Adverse Event|0
7722465|NCT00549770|12146971|FG006|Overall Study|Adverse Event|5
7722466|NCT00549770|12146972|FG007|Overall Study|Adverse Event|4
7722467|NCT00549900|12147003|FG000|Overall Study|Adverse Event|1
7722468|NCT00549939|12147010|FG000|12-week Double Blind Treatment Period|Adverse Event|1
7722469|NCT00549939|12147011|FG001|12-week Double Blind Treatment Period|Adverse Event|1
7722470|NCT00549939|12147012|FG002|12-week Double Blind Treatment Period|Adverse Event|2
7722471|NCT00549939|12147010|FG000|12-week Double Blind Treatment Period|Too many blood draws|0
7722472|NCT00549939|12147011|FG001|12-week Double Blind Treatment Period|Too many blood draws|1
7722473|NCT00549939|12147012|FG002|12-week Double Blind Treatment Period|Too many blood draws|0
7722474|NCT00549939|12147010|FG000|40-week Open Label Treatment Period|Adverse Event|0
7722475|NCT00549939|12147011|FG001|40-week Open Label Treatment Period|Adverse Event|2
7722476|NCT00549939|12147012|FG002|40-week Open Label Treatment Period|Adverse Event|1
7722477|NCT00549939|12147010|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0
7722478|NCT00549939|12147011|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1
7722479|NCT00549939|12147012|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0
7722480|NCT00549939|12147010|FG000|40-week Open Label Treatment Period|Protocol Violation|0
7722481|NCT00549939|12147011|FG001|40-week Open Label Treatment Period|Protocol Violation|1
7722482|NCT00549939|12147012|FG002|40-week Open Label Treatment Period|Protocol Violation|0
7722483|NCT00549939|12147010|FG000|40-week Open Label Treatment Period|Other|0
7722484|NCT00549939|12147011|FG001|40-week Open Label Treatment Period|Other|1
7722485|NCT00549939|12147012|FG002|40-week Open Label Treatment Period|Other|4
7722486|NCT00550043|12147027|FG000|Overall Study|Adverse Event|0
7722487|NCT00550043|12147028|FG001|Overall Study|Adverse Event|0
7722488|NCT00550043|12147029|FG002|Overall Study|Adverse Event|0
7722489|NCT00550043|12147030|FG003|Overall Study|Adverse Event|1
7722490|NCT00550043|12147031|FG004|Overall Study|Adverse Event|1
7722491|NCT00550043|12147027|FG000|Overall Study|Subject Withdrew Consent|0
7722492|NCT00550043|12147028|FG001|Overall Study|Subject Withdrew Consent|2
7722493|NCT00550043|12147029|FG002|Overall Study|Subject Withdrew Consent|1
7722494|NCT00550043|12147030|FG003|Overall Study|Subject Withdrew Consent|0
7722495|NCT00550043|12147031|FG004|Overall Study|Subject Withdrew Consent|0
7722496|NCT00550043|12147027|FG000|Overall Study|Other Reasons- Unspecified|0
7722497|NCT00550043|12147028|FG001|Overall Study|Other Reasons- Unspecified|1
7722498|NCT00550043|12147029|FG002|Overall Study|Other Reasons- Unspecified|0
7722499|NCT00550043|12147030|FG003|Overall Study|Other Reasons- Unspecified|1
7722500|NCT00550043|12147031|FG004|Overall Study|Other Reasons- Unspecified|0
7722501|NCT00550147|12147043|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
7722502|NCT00550147|12147043|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
7722503|NCT00550147|12147043|FG000|Quetiapine Addition Treatment Period|Adverse Event|3
7722504|NCT00550147|12147043|FG000|Quetiapine Addition Treatment Period|Noncompliance|2
7722505|NCT00550147|12147043|FG000|Quetiapine Addition Treatment Period|Moved out of state|1
7722506|NCT00550173|12147059|FG000|Overall Study|Death|45
7722507|NCT00550173|12147060|FG001|Overall Study|Death|38
7722508|NCT00550173|12147061|FG002|Overall Study|Death|50
7722509|NCT00550173|12147059|FG000|Overall Study|Physician Decision|1
7722510|NCT00550173|12147060|FG001|Overall Study|Physician Decision|2
7722511|NCT00550173|12147061|FG002|Overall Study|Physician Decision|2
7722512|NCT00550173|12147059|FG000|Overall Study|Withdrawal by Subject|9
7722513|NCT00550173|12147060|FG001|Overall Study|Withdrawal by Subject|12
7722514|NCT00550173|12147061|FG002|Overall Study|Withdrawal by Subject|17
7722515|NCT00550173|12147059|FG000|Overall Study|Sponsor Decision|13
7722516|NCT00550173|12147060|FG001|Overall Study|Sponsor Decision|7
7722517|NCT00550173|12147061|FG002|Overall Study|Sponsor Decision|1
7722518|NCT00550173|12147059|FG000|Overall Study|Lost to Follow-up|4
7722519|NCT00550173|12147060|FG001|Overall Study|Lost to Follow-up|4
7722520|NCT00550173|12147061|FG002|Overall Study|Lost to Follow-up|3
7722521|NCT00550238|12147070|FG000|Overall Study|Adverse Event|88
7722522|NCT00550238|12147070|FG000|Overall Study|Death|34
7722523|NCT00550238|12147070|FG000|Overall Study|Disease progression|46
7722524|NCT00550238|12147070|FG000|Overall Study|Withdrawal by Subject|167
7722525|NCT00550238|12147070|FG000|Overall Study|Physician Decision|31
7722526|NCT00550238|12147070|FG000|Overall Study|Patient noncompliance|25
7722527|NCT00550238|12147070|FG000|Overall Study|Lost to Follow-up|13
7722528|NCT00550238|12147070|FG000|Overall Study|Sponsor decision|55
7722529|NCT00550407|12147109|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
7722530|NCT00550407|12147110|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
7722531|NCT00550407|12147111|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
7722532|NCT00550407|12147109|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
7722533|NCT00550407|12147110|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
7722534|NCT00550407|12147111|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
7722535|NCT00550407|12147109|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
7722536|NCT00550407|12147110|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
7722537|NCT00550407|12147111|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
7722538|NCT00550407|12147109|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
7722539|NCT00550407|12147110|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
7722540|NCT00550407|12147111|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
7722541|NCT00550407|12147109|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
7722542|NCT00550407|12147110|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
7722543|NCT00550407|12147111|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
7722544|NCT00550407|12147109|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
7722545|NCT00550407|12147110|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
7722546|NCT00550407|12147111|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
7722547|NCT00550407|12147109|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
7722548|NCT00550407|12147110|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
7722549|NCT00550407|12147111|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
7722550|NCT00550407|12147109|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
7722551|NCT00550407|12147110|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
7722552|NCT00550407|12147111|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
7722553|NCT00550407|12147109|FG000|26-Week Randomized Phase|Adverse Event|0
7722554|NCT00550407|12147110|FG001|26-Week Randomized Phase|Adverse Event|5
7722555|NCT00550407|12147111|FG002|26-Week Randomized Phase|Adverse Event|2
7722556|NCT00550407|12147109|FG000|26-Week Randomized Phase|Lack of Efficacy|0
7722557|NCT00550407|12147110|FG001|26-Week Randomized Phase|Lack of Efficacy|36
7722558|NCT00550407|12147111|FG002|26-Week Randomized Phase|Lack of Efficacy|19
7722559|NCT00550407|12147109|FG000|26-Week Randomized Phase|Investigator Discretion|0
7722560|NCT00550407|12147110|FG001|26-Week Randomized Phase|Investigator Discretion|1
7722561|NCT00550407|12147111|FG002|26-Week Randomized Phase|Investigator Discretion|0
7722562|NCT00550407|12147109|FG000|26-Week Randomized Phase|Withdrawal by Subject|0
7722563|NCT00550407|12147110|FG001|26-Week Randomized Phase|Withdrawal by Subject|1
7722564|NCT00550407|12147111|FG002|26-Week Randomized Phase|Withdrawal by Subject|3
7722565|NCT00550420|12147119|FG000|Overall Study|Adverse Event|28
7722566|NCT00550420|12147119|FG000|Overall Study|Lost to Follow-up|8
7722567|NCT00550420|12147119|FG000|Overall Study|Protocol Violation|11
7722568|NCT00550420|12147119|FG000|Overall Study|Withdrawal by Subject|30
7722569|NCT00550420|12147119|FG000|Overall Study|Still in study at termination|206
7722570|NCT00550420|12147119|FG000|Overall Study|Missing|2
7722571|NCT00550420|12147119|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12
7722572|NCT00550420|12147119|FG000|Overall Study|Investigators opinion|1
7722573|NCT00550420|12147119|FG000|Overall Study|Lack of curative effect|1
7722574|NCT00550420|12147119|FG000|Overall Study|Unethical stop of enrollment|2
7722575|NCT00550420|12147119|FG000|Overall Study|Caregiver's decision to withdraw|1
7722576|NCT00550420|12147119|FG000|Overall Study|Out of Electrocardiogram criteria|1
7722577|NCT00550420|12147119|FG000|Overall Study|Exclusion criteria|1
7722578|NCT00550420|12147119|FG000|Overall Study|Prohibited medicine|1
7722579|NCT00550446|12147132|FG000|Up To Week 12|Adverse Event|2
7722580|NCT00550446|12147133|FG001|Up To Week 12|Adverse Event|2
7722581|NCT00550446|12147134|FG002|Up To Week 12|Adverse Event|0
7722582|NCT00550446|12147135|FG003|Up To Week 12|Adverse Event|0
7722583|NCT00550446|12147136|FG004|Up To Week 12|Adverse Event|2
7722584|NCT00550446|12147137|FG005|Up To Week 12|Adverse Event|2
7722585|NCT00550446|12147138|FG006|Up To Week 12|Adverse Event|1
7722586|NCT00550446|12147139|FG007|Up To Week 12|Adverse Event|0
7722587|NCT00550446|12147140|FG008|Up To Week 12|Adverse Event|0
7722588|NCT00550446|12147141|FG009|Up To Week 12|Adverse Event|0
7722589|NCT00550446|12147142|FG010|Up To Week 12|Adverse Event|0
7722590|NCT00550446|12147132|FG000|Up To Week 12|Lack of Efficacy|3
7722591|NCT00550446|12147133|FG001|Up To Week 12|Lack of Efficacy|1
7722592|NCT00550446|12147134|FG002|Up To Week 12|Lack of Efficacy|0
7722593|NCT00550446|12147135|FG003|Up To Week 12|Lack of Efficacy|1
7722594|NCT00550446|12147136|FG004|Up To Week 12|Lack of Efficacy|0
7722595|NCT00550446|12147137|FG005|Up To Week 12|Lack of Efficacy|3
7722596|NCT00550446|12147138|FG006|Up To Week 12|Lack of Efficacy|3
7722597|NCT00550446|12147139|FG007|Up To Week 12|Lack of Efficacy|0
7722598|NCT00550446|12147140|FG008|Up To Week 12|Lack of Efficacy|0
7722599|NCT00550446|12147141|FG009|Up To Week 12|Lack of Efficacy|0
7722600|NCT00550446|12147142|FG010|Up To Week 12|Lack of Efficacy|0
7722601|NCT00550446|12147132|FG000|Up To Week 12|Lost to Follow-up|0
7722602|NCT00550446|12147133|FG001|Up To Week 12|Lost to Follow-up|1
7722603|NCT00550446|12147134|FG002|Up To Week 12|Lost to Follow-up|0
7722604|NCT00550446|12147135|FG003|Up To Week 12|Lost to Follow-up|0
7722605|NCT00550446|12147136|FG004|Up To Week 12|Lost to Follow-up|1
7722606|NCT00550446|12147137|FG005|Up To Week 12|Lost to Follow-up|1
7722607|NCT00550446|12147138|FG006|Up To Week 12|Lost to Follow-up|2
7722608|NCT00550446|12147139|FG007|Up To Week 12|Lost to Follow-up|0
7722609|NCT00550446|12147140|FG008|Up To Week 12|Lost to Follow-up|0
7722610|NCT00550446|12147141|FG009|Up To Week 12|Lost to Follow-up|0
7722611|NCT00550446|12147142|FG010|Up To Week 12|Lost to Follow-up|0
7722612|NCT00550446|12147132|FG000|Up To Week 12|Withdrawal by Subject|2
7722613|NCT00550446|12147133|FG001|Up To Week 12|Withdrawal by Subject|0
7722614|NCT00550446|12147134|FG002|Up To Week 12|Withdrawal by Subject|3
7722615|NCT00550446|12147135|FG003|Up To Week 12|Withdrawal by Subject|2
7722616|NCT00550446|12147136|FG004|Up To Week 12|Withdrawal by Subject|0
7722617|NCT00550446|12147137|FG005|Up To Week 12|Withdrawal by Subject|1
7722618|NCT00550446|12147138|FG006|Up To Week 12|Withdrawal by Subject|3
7722619|NCT00550446|12147139|FG007|Up To Week 12|Withdrawal by Subject|0
7722620|NCT00550446|12147140|FG008|Up To Week 12|Withdrawal by Subject|0
7722621|NCT00550446|12147141|FG009|Up To Week 12|Withdrawal by Subject|0
7722622|NCT00550446|12147142|FG010|Up To Week 12|Withdrawal by Subject|0
7722623|NCT00550446|12147132|FG000|Up To Week 12|Other|3
7722624|NCT00550446|12147133|FG001|Up To Week 12|Other|0
7722625|NCT00550446|12147134|FG002|Up To Week 12|Other|0
7722626|NCT00550446|12147135|FG003|Up To Week 12|Other|0
7722627|NCT00550446|12147136|FG004|Up To Week 12|Other|0
7722628|NCT00550446|12147137|FG005|Up To Week 12|Other|1
7722629|NCT00550446|12147138|FG006|Up To Week 12|Other|4
7722630|NCT00550446|12147139|FG007|Up To Week 12|Other|0
7722631|NCT00550446|12147140|FG008|Up To Week 12|Other|0
7722632|NCT00550446|12147141|FG009|Up To Week 12|Other|0
7722633|NCT00550446|12147142|FG010|Up To Week 12|Other|0
7722634|NCT00550446|12147132|FG000|Up To Week 12|Randomized not treated|0
7722635|NCT00550446|12147133|FG001|Up To Week 12|Randomized not treated|1
7722636|NCT00550446|12147134|FG002|Up To Week 12|Randomized not treated|1
7722637|NCT00550446|12147135|FG003|Up To Week 12|Randomized not treated|0
7722638|NCT00550446|12147136|FG004|Up To Week 12|Randomized not treated|0
7722639|NCT00550446|12147137|FG005|Up To Week 12|Randomized not treated|0
7722640|NCT00550446|12147138|FG006|Up To Week 12|Randomized not treated|0
7722641|NCT00550446|12147139|FG007|Up To Week 12|Randomized not treated|0
7722642|NCT00550446|12147140|FG008|Up To Week 12|Randomized not treated|0
7722643|NCT00550446|12147141|FG009|Up To Week 12|Randomized not treated|0
7722644|NCT00550446|12147142|FG010|Up To Week 12|Randomized not treated|0
7722645|NCT00550446|12147132|FG000|Post Week 12|Adverse Event|2
7722646|NCT00550446|12147133|FG001|Post Week 12|Adverse Event|1
7722647|NCT00550446|12147134|FG002|Post Week 12|Adverse Event|1
7722648|NCT00550446|12147135|FG003|Post Week 12|Adverse Event|1
7722649|NCT00550446|12147136|FG004|Post Week 12|Adverse Event|1
7722650|NCT00550446|12147137|FG005|Post Week 12|Adverse Event|1
7722651|NCT00550446|12147138|FG006|Post Week 12|Adverse Event|0
7722652|NCT00550446|12147139|FG007|Post Week 12|Adverse Event|0
7722653|NCT00550446|12147140|FG008|Post Week 12|Adverse Event|0
7722654|NCT00550446|12147141|FG009|Post Week 12|Adverse Event|4
7722655|NCT00550446|12147142|FG010|Post Week 12|Adverse Event|0
7722656|NCT00550446|12147132|FG000|Post Week 12|Lack of Efficacy|0
7722657|NCT00550446|12147133|FG001|Post Week 12|Lack of Efficacy|0
7722658|NCT00550446|12147134|FG002|Post Week 12|Lack of Efficacy|1
7722659|NCT00550446|12147135|FG003|Post Week 12|Lack of Efficacy|0
7722660|NCT00550446|12147136|FG004|Post Week 12|Lack of Efficacy|0
7722661|NCT00550446|12147137|FG005|Post Week 12|Lack of Efficacy|0
7722662|NCT00550446|12147138|FG006|Post Week 12|Lack of Efficacy|0
7722663|NCT00550446|12147139|FG007|Post Week 12|Lack of Efficacy|1
7722664|NCT00550446|12147140|FG008|Post Week 12|Lack of Efficacy|1
7722665|NCT00550446|12147141|FG009|Post Week 12|Lack of Efficacy|2
7722666|NCT00550446|12147142|FG010|Post Week 12|Lack of Efficacy|1
7722667|NCT00550446|12147132|FG000|Post Week 12|Lost to Follow-up|0
7722668|NCT00550446|12147133|FG001|Post Week 12|Lost to Follow-up|0
7722669|NCT00550446|12147134|FG002|Post Week 12|Lost to Follow-up|1
7722670|NCT00550446|12147135|FG003|Post Week 12|Lost to Follow-up|1
7722671|NCT00550446|12147136|FG004|Post Week 12|Lost to Follow-up|0
7722672|NCT00550446|12147137|FG005|Post Week 12|Lost to Follow-up|0
7722673|NCT00550446|12147138|FG006|Post Week 12|Lost to Follow-up|1
7722674|NCT00550446|12147139|FG007|Post Week 12|Lost to Follow-up|0
7722675|NCT00550446|12147140|FG008|Post Week 12|Lost to Follow-up|0
7722676|NCT00550446|12147141|FG009|Post Week 12|Lost to Follow-up|0
7722677|NCT00550446|12147142|FG010|Post Week 12|Lost to Follow-up|0
7722678|NCT00550446|12147132|FG000|Post Week 12|Withdrawal by Subject|0
7722679|NCT00550446|12147133|FG001|Post Week 12|Withdrawal by Subject|0
7722680|NCT00550446|12147134|FG002|Post Week 12|Withdrawal by Subject|0
7722681|NCT00550446|12147135|FG003|Post Week 12|Withdrawal by Subject|0
7722682|NCT00550446|12147136|FG004|Post Week 12|Withdrawal by Subject|1
7722683|NCT00550446|12147137|FG005|Post Week 12|Withdrawal by Subject|0
7722684|NCT00550446|12147138|FG006|Post Week 12|Withdrawal by Subject|0
7722685|NCT00550446|12147139|FG007|Post Week 12|Withdrawal by Subject|0
7722686|NCT00550446|12147140|FG008|Post Week 12|Withdrawal by Subject|0
7722687|NCT00550446|12147141|FG009|Post Week 12|Withdrawal by Subject|0
7722688|NCT00550446|12147142|FG010|Post Week 12|Withdrawal by Subject|0
7722689|NCT00550446|12147132|FG000|Post Week 12|Other|1
7722690|NCT00550446|12147133|FG001|Post Week 12|Other|1
7722691|NCT00550446|12147134|FG002|Post Week 12|Other|0
7722692|NCT00550446|12147135|FG003|Post Week 12|Other|1
7722693|NCT00550446|12147136|FG004|Post Week 12|Other|0
7722694|NCT00550446|12147137|FG005|Post Week 12|Other|0
7722695|NCT00550446|12147138|FG006|Post Week 12|Other|1
7722696|NCT00550446|12147139|FG007|Post Week 12|Other|0
7722697|NCT00550446|12147140|FG008|Post Week 12|Other|1
7722698|NCT00550446|12147141|FG009|Post Week 12|Other|1
7722699|NCT00550446|12147142|FG010|Post Week 12|Other|0
7722700|NCT00550459|12147182|FG000|Overall Study|Adverse Event|0
7722701|NCT00550459|12147183|FG001|Overall Study|Adverse Event|2
7722702|NCT00550459|12147182|FG000|Overall Study|Withdrawal by Subject|1
7722703|NCT00550459|12147183|FG001|Overall Study|Withdrawal by Subject|1
7722704|NCT00550537|12147189|FG000|Overall Study|Death|18
7722705|NCT00550537|12147189|FG000|Overall Study|Adverse Event|20
7722706|NCT00550537|12147189|FG000|Overall Study|Disease progression before|46
7722707|NCT00550537|12147189|FG000|Overall Study|Withdrawal by Subject|7
7722708|NCT00550537|12147189|FG000|Overall Study|Change in treatment plan|4
7722709|NCT00550537|12147189|FG000|Overall Study|Other complicating ilness|3
7722710|NCT00550537|12147189|FG000|Overall Study|Declining performance status|2
7722711|NCT00550537|12147189|FG000|Overall Study|Treated closer to home|4
7722712|NCT00550550|12147200|FG000|Overall Study|Adverse Event|13
7722713|NCT00550550|12147201|FG001|Overall Study|Adverse Event|5
7722714|NCT00550550|12147200|FG000|Overall Study|Treatment Failure|0
7722715|NCT00550550|12147201|FG001|Overall Study|Treatment Failure|1
7722716|NCT00550550|12147200|FG000|Overall Study|Lost to Follow-up|4
7722717|NCT00550550|12147201|FG001|Overall Study|Lost to Follow-up|0
7722718|NCT00550550|12147200|FG000|Overall Study|Withdrawal by Subject|10
7722719|NCT00550550|12147201|FG001|Overall Study|Withdrawal by Subject|8
7722720|NCT00550550|12147200|FG000|Overall Study|Protocol Violation|5
7722721|NCT00550550|12147201|FG001|Overall Study|Protocol Violation|14
7722722|NCT00550550|12147200|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
7722723|NCT00550550|12147201|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
7722724|NCT00550550|12147200|FG000|Overall Study|Randomized But Not Treated|1
7722725|NCT00550550|12147201|FG001|Overall Study|Randomized But Not Treated|0
7722726|NCT00550615|12147215|FG000|Overall Study|Withdrawal by Subject|0
7722727|NCT00550615|12147216|FG001|Overall Study|Withdrawal by Subject|0
7722728|NCT00550615|12147217|FG002|Overall Study|Withdrawal by Subject|2
7722729|NCT00550615|12147218|FG003|Overall Study|Withdrawal by Subject|3
7722730|NCT00550615|12147215|FG000|Overall Study|Not evaluable|0
7722731|NCT00550615|12147216|FG001|Overall Study|Not evaluable|0
7722732|NCT00550615|12147217|FG002|Overall Study|Not evaluable|2
7722733|NCT00550615|12147218|FG003|Overall Study|Not evaluable|7
7722734|NCT00550680|12147228|FG000|Overall Study|Administrative Reasons|1
7722735|NCT00550680|12147228|FG000|Overall Study|Adverse Event|5
7722736|NCT00550680|12147228|FG000|Overall Study|Death|3
7722737|NCT00550680|12147228|FG000|Overall Study|Early Improvement|1
7722738|NCT00550680|12147228|FG000|Overall Study|Lost to Follow-up|3
7722739|NCT00550680|12147228|FG000|Overall Study|Lack of Efficacy|1
7722740|NCT00550680|12147228|FG000|Overall Study|Other|10
7722741|NCT00550680|12147228|FG000|Overall Study|Protocol Violation|7
7722742|NCT00550680|12147228|FG000|Overall Study|Refused Treatment|19
7722743|NCT00550680|12147228|FG000|Overall Study|Screen Failure|6
7722744|NCT00550732|12147232|FG000|Overall Study|Death|4
7722745|NCT00550732|12147232|FG000|Overall Study|Withdrawal by Subject|2
7722746|NCT00550732|12147232|FG000|Overall Study|Physician Decision|2
7722747|NCT00550732|12147232|FG000|Overall Study|Lost to Follow-up|1
7722748|NCT00550732|12147232|FG000|Overall Study|Palliative care|1
7722749|NCT00550732|12147232|FG000|Overall Study|Adverse Event|1
7722750|NCT00550745|12147239|FG000|Overall Study|Death|20
7722751|NCT00550745|12147240|FG001|Overall Study|Death|16
7722752|NCT00550745|12147239|FG000|Overall Study|Lost to Follow-up|45
7722753|NCT00550745|12147240|FG001|Overall Study|Lost to Follow-up|30
7722754|NCT00550745|12147239|FG000|Overall Study|Physician Decision|0
7722755|NCT00550745|12147240|FG001|Overall Study|Physician Decision|2
7722756|NCT00550745|12147239|FG000|Overall Study|Protocol Violation|4
7722757|NCT00550745|12147240|FG001|Overall Study|Protocol Violation|2
7722758|NCT00550745|12147239|FG000|Overall Study|Withdrawal by Subject|17
7722759|NCT00550745|12147240|FG001|Overall Study|Withdrawal by Subject|10
7722760|NCT00550745|12147239|FG000|Overall Study|Screen failure|1
7722761|NCT00550745|12147240|FG001|Overall Study|Screen failure|0
7722762|NCT00550771|12147248|FG000|Overall Study|Adverse Event|11
7722763|NCT00550771|12147249|FG001|Overall Study|Adverse Event|3
7722764|NCT00550771|12147248|FG000|Overall Study|Discontinued for study-related reasons|0
7722765|NCT00550771|12147249|FG001|Overall Study|Discontinued for study-related reasons|1
7722766|NCT00550771|12147248|FG000|Overall Study|Physician Decision|2
7722767|NCT00550771|12147249|FG001|Overall Study|Physician Decision|0
7722768|NCT00550771|12147248|FG000|Overall Study|Withdrawal by Subject|0
7722769|NCT00550771|12147249|FG001|Overall Study|Withdrawal by Subject|1
7722770|NCT00550771|12147248|FG000|Overall Study|Protocol Violation|4
7722771|NCT00550771|12147249|FG001|Overall Study|Protocol Violation|5
7722772|NCT00550836|12147257|FG000|Overall Study|Withdrawal by Subject|3
7722773|NCT00550836|12147258|FG001|Overall Study|Withdrawal by Subject|9
7722774|NCT00550953|12147283|FG000|Overall Study|Adverse Event|4
7722775|NCT00550953|12147284|FG001|Overall Study|Adverse Event|3
7722776|NCT00550953|12147283|FG000|Overall Study|Not able to visit the site|2
7722777|NCT00550953|12147284|FG001|Overall Study|Not able to visit the site|3
7722778|NCT00551031|12147295|FG000|Overall Study|Adverse Event|0
7722779|NCT00551031|12147296|FG001|Overall Study|Adverse Event|1
7722780|NCT00551031|12147297|FG002|Overall Study|Adverse Event|0
7722781|NCT00551031|12147298|FG003|Overall Study|Adverse Event|0
7722782|NCT00551031|12147299|FG004|Overall Study|Adverse Event|0
7722783|NCT00551031|12147295|FG000|Overall Study|Protocol Violation|1
7722784|NCT00551031|12147296|FG001|Overall Study|Protocol Violation|1
7722785|NCT00551031|12147297|FG002|Overall Study|Protocol Violation|0
7722786|NCT00551031|12147298|FG003|Overall Study|Protocol Violation|0
7722787|NCT00551031|12147299|FG004|Overall Study|Protocol Violation|0
7722788|NCT00551031|12147295|FG000|Overall Study|Lost to Follow-up|0
7722789|NCT00551031|12147296|FG001|Overall Study|Lost to Follow-up|1
7722790|NCT00551031|12147297|FG002|Overall Study|Lost to Follow-up|0
7722791|NCT00551031|12147298|FG003|Overall Study|Lost to Follow-up|1
7722792|NCT00551031|12147299|FG004|Overall Study|Lost to Follow-up|1
7722793|NCT00551031|12147295|FG000|Overall Study|Withdrawal by Subject|0
7722794|NCT00551031|12147296|FG001|Overall Study|Withdrawal by Subject|4
7722795|NCT00551031|12147297|FG002|Overall Study|Withdrawal by Subject|1
7722796|NCT00551031|12147298|FG003|Overall Study|Withdrawal by Subject|2
7722797|NCT00551031|12147299|FG004|Overall Study|Withdrawal by Subject|0
7722798|NCT00551031|12147295|FG000|Overall Study|Serious Adverse Event|0
7722799|NCT00551031|12147296|FG001|Overall Study|Serious Adverse Event|2
7722800|NCT00551031|12147297|FG002|Overall Study|Serious Adverse Event|1
7722801|NCT00551031|12147298|FG003|Overall Study|Serious Adverse Event|0
7722802|NCT00551031|12147299|FG004|Overall Study|Serious Adverse Event|0
7722803|NCT00551031|12147295|FG000|Overall Study|Did not receive vaccine|1
7722804|NCT00551031|12147296|FG001|Overall Study|Did not receive vaccine|2
7722805|NCT00551031|12147297|FG002|Overall Study|Did not receive vaccine|0
7722806|NCT00551031|12147298|FG003|Overall Study|Did not receive vaccine|0
7722807|NCT00551031|12147299|FG004|Overall Study|Did not receive vaccine|0
7722808|NCT00551135|12147319|FG000|Overall Study|Adverse Event|1
7722809|NCT00551135|12147320|FG001|Overall Study|Adverse Event|0
7722810|NCT00551135|12147321|FG002|Overall Study|Adverse Event|1
7722811|NCT00551135|12147322|FG003|Overall Study|Adverse Event|1
7722812|NCT00551135|12147319|FG000|Overall Study|Lost to Follow-up|0
7722813|NCT00551135|12147320|FG001|Overall Study|Lost to Follow-up|0
7722814|NCT00551135|12147321|FG002|Overall Study|Lost to Follow-up|0
7722815|NCT00551135|12147322|FG003|Overall Study|Lost to Follow-up|1
7722816|NCT00551135|12147319|FG000|Overall Study|Other|3
7722817|NCT00551135|12147320|FG001|Overall Study|Other|2
7722818|NCT00551135|12147321|FG002|Overall Study|Other|1
7722819|NCT00551135|12147322|FG003|Overall Study|Other|2
7722820|NCT00551135|12147319|FG000|Overall Study|Withdrawal by Subject|1
7722821|NCT00551135|12147320|FG001|Overall Study|Withdrawal by Subject|0
7722822|NCT00551135|12147321|FG002|Overall Study|Withdrawal by Subject|3
7722823|NCT00551135|12147322|FG003|Overall Study|Withdrawal by Subject|1
7722824|NCT00551161|12147332|FG000|Overall Study|Withdrawal by Subject|1
7722825|NCT00551213|12147357|FG000|Overall Study|Adverse Event|6
7722826|NCT00551213|12147358|FG001|Overall Study|Adverse Event|3
7722827|NCT00551213|12147357|FG000|Overall Study|Progressive Disease|41
7722828|NCT00551213|12147358|FG001|Overall Study|Progressive Disease|12
7722829|NCT00551213|12147357|FG000|Overall Study|Withdrawal by Subject|2
7722830|NCT00551213|12147358|FG001|Overall Study|Withdrawal by Subject|0
7722831|NCT00551213|12147357|FG000|Overall Study|Not Treated|1
7722832|NCT00551213|12147358|FG001|Overall Study|Not Treated|2
7722833|NCT00551291|12147364|FG000|Overall Study|Physician Decision|1
7722834|NCT00551369|12147368|FG000|Overall Study|Protocol Violation|5
7722835|NCT00551369|12147368|FG000|Overall Study|Withdrawal by Subject|1
7722836|NCT00551369|12147368|FG000|Overall Study|Not treated per protocol and re|1
7722837|NCT00551421|12147372|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
7722838|NCT00551460|12147377|FG000|Overall Study|Adverse Event|1
7722839|NCT00551460|12147377|FG000|Overall Study|Withdrawal by Subject|1
7722840|NCT00551460|12147377|FG000|Overall Study|Physician Decision|1
7722841|NCT00551460|12147377|FG000|Overall Study|Death|7
7722842|NCT00551460|12147377|FG000|Overall Study|Ineligible|4
7722843|NCT00551460|12147377|FG000|Overall Study|Not analyzable (did not start treatment)|4
7722844|NCT00551525|12147381|FG000|Overall Study|Protocol Violation|5
7722845|NCT00551642|12147387|FG000|Treatment Period|Protocol Deviation|6
7722846|NCT00551642|12147388|FG001|Treatment Period|Protocol Deviation|11
7722847|NCT00551642|12147387|FG000|Treatment Period|Delivery device failure|1
7722848|NCT00551642|12147388|FG001|Treatment Period|Delivery device failure|3
7722849|NCT00551642|12147387|FG000|Treatment Period|Physician Decision|0
7722850|NCT00551642|12147388|FG001|Treatment Period|Physician Decision|1
7722851|NCT00551642|12147387|FG000|Treatment Period|Death|33
7722852|NCT00551642|12147388|FG001|Treatment Period|Death|31
7722853|NCT00551642|12147387|FG000|Treatment Period|Inclusion/Exclusion criteria|4
7722854|NCT00551642|12147388|FG001|Treatment Period|Inclusion/Exclusion criteria|4
7722855|NCT00551642|12147387|FG000|Treatment Period|Adverse Event|15
7722856|NCT00551642|12147388|FG001|Treatment Period|Adverse Event|12
7722857|NCT00551642|12147387|FG000|Treatment Period|Withdrawal by Subject|2
7722858|NCT00551642|12147388|FG001|Treatment Period|Withdrawal by Subject|1
7722859|NCT00551759|12147426|FG000|Overall Study|Adverse Event|7
7722860|NCT00551759|12147426|FG000|Overall Study|Death|5
7722861|NCT00551759|12147426|FG000|Overall Study|Ineligible|1
7722862|NCT00552058|12147432|FG000|Overall Study|Adverse Event|8
7722863|NCT00552058|12147433|FG001|Overall Study|Adverse Event|7
7722864|NCT00552058|12147432|FG000|Overall Study|Lack of Efficacy|1
7722865|NCT00552058|12147433|FG001|Overall Study|Lack of Efficacy|5
7722866|NCT00552058|12147432|FG000|Overall Study|Lost to Follow-up|1
7722867|NCT00552058|12147433|FG001|Overall Study|Lost to Follow-up|0
7722868|NCT00552058|12147432|FG000|Overall Study|Withdrawal by Subject|4
7722869|NCT00552058|12147433|FG001|Overall Study|Withdrawal by Subject|4
7722870|NCT00552058|12147432|FG000|Overall Study|Other: Protocol Violation|0
7722871|NCT00552058|12147433|FG001|Overall Study|Other: Protocol Violation|1
7722872|NCT00552058|12147432|FG000|Overall Study|Other: Non Compliance|1
7722873|NCT00552058|12147433|FG001|Overall Study|Other: Non Compliance|2
7722874|NCT00552058|12147432|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0
7722875|NCT00552058|12147433|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1
7722876|NCT00552058|12147432|FG000|Overall Study|Other: Low CDAI score, entry violation|0
7722877|NCT00552058|12147433|FG001|Overall Study|Other: Low CDAI score, entry violation|1
7722878|NCT00552058|12147432|FG000|Overall Study|Other: Positive Stool Result|0
7722879|NCT00552058|12147433|FG001|Overall Study|Other: Positive Stool Result|1
7722880|NCT00552058|12147432|FG000|Overall Study|Other: Randomized in error|0
7722881|NCT00552058|12147433|FG001|Overall Study|Other: Randomized in error|1
7722882|NCT00552058|12147432|FG000|Overall Study|Other: Sponsors Decision|0
7722883|NCT00552058|12147433|FG001|Overall Study|Other: Sponsors Decision|1
7722884|NCT00552058|12147432|FG000|Overall Study|Other: Early Roll Over|1
7722885|NCT00552058|12147433|FG001|Overall Study|Other: Early Roll Over|0
7722886|NCT00552071|12147441|FG000|Overall Study|Adverse Event|1
7722887|NCT00552071|12147442|FG001|Overall Study|Adverse Event|0
7722888|NCT00552071|12147441|FG000|Overall Study|Lack of Efficacy|1
7722889|NCT00552071|12147442|FG001|Overall Study|Lack of Efficacy|0
7722890|NCT00552071|12147441|FG000|Overall Study|Physician Decision|1
7722891|NCT00552071|12147442|FG001|Overall Study|Physician Decision|0
7722892|NCT00552071|12147441|FG000|Overall Study|Pregnancy|1
7722893|NCT00552071|12147442|FG001|Overall Study|Pregnancy|0
7722894|NCT00552071|12147441|FG000|Overall Study|Death|0
7722895|NCT00552071|12147442|FG001|Overall Study|Death|1
7722896|NCT00552071|12147441|FG000|Overall Study|Withdrawal by Subject|0
7722897|NCT00552071|12147442|FG001|Overall Study|Withdrawal by Subject|1
7722898|NCT00552084|12147452|FG000|Overall Study|Adverse Event|2
7722899|NCT00552084|12147453|FG001|Overall Study|Adverse Event|3
7722900|NCT00552084|12147452|FG000|Overall Study|Withdrawal by Subject|4
7722901|NCT00552084|12147453|FG001|Overall Study|Withdrawal by Subject|5
7722902|NCT00552084|12147452|FG000|Overall Study|Protocol Violation|1
7722903|NCT00552084|12147453|FG001|Overall Study|Protocol Violation|0
7722904|NCT00552084|12147452|FG000|Overall Study|change in anti-arrythmic drug|1
7722905|NCT00552084|12147453|FG001|Overall Study|change in anti-arrythmic drug|1
7722906|NCT00552110|12147464|FG000|Overall Study|Serious or Life-Threatening AE|0
7722907|NCT00552110|12147465|FG001|Overall Study|Serious or Life-Threatening AE|0
7722908|NCT00552110|12147466|FG002|Overall Study|Serious or Life-Threatening AE|1
7722909|NCT00552110|12147467|FG003|Overall Study|Serious or Life-Threatening AE|0
7722910|NCT00552110|12147468|FG004|Overall Study|Serious or Life-Threatening AE|0
7722911|NCT00552110|12147464|FG000|Overall Study|Lack of Efficacy|1
7722912|NCT00552110|12147465|FG001|Overall Study|Lack of Efficacy|0
7722913|NCT00552110|12147466|FG002|Overall Study|Lack of Efficacy|0
7722914|NCT00552110|12147467|FG003|Overall Study|Lack of Efficacy|1
7722915|NCT00552110|12147468|FG004|Overall Study|Lack of Efficacy|4
7722916|NCT00552110|12147464|FG000|Overall Study|Withdrawal by Subject|0
7722917|NCT00552110|12147465|FG001|Overall Study|Withdrawal by Subject|2
7722918|NCT00552110|12147466|FG002|Overall Study|Withdrawal by Subject|0
7722919|NCT00552110|12147467|FG003|Overall Study|Withdrawal by Subject|3
7722920|NCT00552110|12147468|FG004|Overall Study|Withdrawal by Subject|2
7722921|NCT00552110|12147464|FG000|Overall Study|Lost to Follow-up|0
7722922|NCT00552110|12147465|FG001|Overall Study|Lost to Follow-up|0
7722923|NCT00552110|12147466|FG002|Overall Study|Lost to Follow-up|0
7722924|NCT00552110|12147467|FG003|Overall Study|Lost to Follow-up|1
7722925|NCT00552110|12147468|FG004|Overall Study|Lost to Follow-up|1
7722926|NCT00552110|12147464|FG000|Overall Study|Failed to Comply With Study Requirements|1
7722927|NCT00552110|12147465|FG001|Overall Study|Failed to Comply With Study Requirements|1
7722928|NCT00552110|12147466|FG002|Overall Study|Failed to Comply With Study Requirements|1
7722929|NCT00552110|12147467|FG003|Overall Study|Failed to Comply With Study Requirements|0
7722930|NCT00552110|12147468|FG004|Overall Study|Failed to Comply With Study Requirements|1
7722931|NCT00552110|12147464|FG000|Overall Study|Withdrawn per Sponsor|0
7722932|NCT00552110|12147465|FG001|Overall Study|Withdrawn per Sponsor|1
7722933|NCT00552110|12147466|FG002|Overall Study|Withdrawn per Sponsor|0
7722934|NCT00552110|12147467|FG003|Overall Study|Withdrawn per Sponsor|0
7722935|NCT00552110|12147468|FG004|Overall Study|Withdrawn per Sponsor|1
7722936|NCT00552110|12147464|FG000|Overall Study|Use of Prohibited Medication|1
7722937|NCT00552110|12147465|FG001|Overall Study|Use of Prohibited Medication|1
7722938|NCT00552110|12147466|FG002|Overall Study|Use of Prohibited Medication|0
7722939|NCT00552110|12147467|FG003|Overall Study|Use of Prohibited Medication|0
7722940|NCT00552110|12147468|FG004|Overall Study|Use of Prohibited Medication|0
7722941|NCT00552110|12147464|FG000|Overall Study|Delay of Study due to Relabeling|0
7722942|NCT00552110|12147465|FG001|Overall Study|Delay of Study due to Relabeling|0
7722943|NCT00552110|12147466|FG002|Overall Study|Delay of Study due to Relabeling|0
7722944|NCT00552110|12147467|FG003|Overall Study|Delay of Study due to Relabeling|1
7722945|NCT00552110|12147468|FG004|Overall Study|Delay of Study due to Relabeling|0
7722946|NCT00552110|12147464|FG000|Overall Study|Increased Blood Pressure at Visit 2|0
7722947|NCT00552110|12147465|FG001|Overall Study|Increased Blood Pressure at Visit 2|0
7722948|NCT00552110|12147466|FG002|Overall Study|Increased Blood Pressure at Visit 2|0
7722949|NCT00552110|12147467|FG003|Overall Study|Increased Blood Pressure at Visit 2|1
7722950|NCT00552110|12147468|FG004|Overall Study|Increased Blood Pressure at Visit 2|0
7722951|NCT00552110|12147464|FG000|Overall Study|Nonserious Adverse Event (AE)|1
7722952|NCT00552110|12147465|FG001|Overall Study|Nonserious Adverse Event (AE)|0
7722953|NCT00552110|12147466|FG002|Overall Study|Nonserious Adverse Event (AE)|0
7722954|NCT00552110|12147467|FG003|Overall Study|Nonserious Adverse Event (AE)|1
7722955|NCT00552110|12147468|FG004|Overall Study|Nonserious Adverse Event (AE)|0
7722956|NCT00552175|12147483|FG000|Overall Study|Lack of Efficacy|2
7722957|NCT00552175|12147484|FG001|Overall Study|Lack of Efficacy|0
7722958|NCT00552175|12147485|FG002|Overall Study|Lack of Efficacy|1
7722959|NCT00552175|12147483|FG000|Overall Study|Adverse Event|9
7722960|NCT00552175|12147484|FG001|Overall Study|Adverse Event|9
7722961|NCT00552175|12147485|FG002|Overall Study|Adverse Event|10
7722962|NCT00552175|12147483|FG000|Overall Study|Withdrawal by Subject|2
7722963|NCT00552175|12147484|FG001|Overall Study|Withdrawal by Subject|2
7722964|NCT00552175|12147485|FG002|Overall Study|Withdrawal by Subject|1
7722965|NCT00552175|12147483|FG000|Overall Study|Lost to Follow-up|0
7722966|NCT00552175|12147484|FG001|Overall Study|Lost to Follow-up|0
7722967|NCT00552175|12147485|FG002|Overall Study|Lost to Follow-up|1
7722968|NCT00552175|12147483|FG000|Overall Study|Entry Criteria Not Met|1
7722969|NCT00552175|12147484|FG001|Overall Study|Entry Criteria Not Met|1
7722970|NCT00552175|12147485|FG002|Overall Study|Entry Criteria Not Met|0
7722971|NCT00552175|12147483|FG000|Overall Study|Reason Not Specified|3
7722972|NCT00552175|12147484|FG001|Overall Study|Reason Not Specified|1
7722973|NCT00552175|12147485|FG002|Overall Study|Reason Not Specified|1
7722974|NCT00552188|12147496|FG000|Overall Study|Adverse Event|0
7722975|NCT00552188|12147497|FG001|Overall Study|Adverse Event|2
7722976|NCT00552188|12147496|FG000|Overall Study|Lost to Follow-up|2
7722977|NCT00552188|12147497|FG001|Overall Study|Lost to Follow-up|1
7722978|NCT00552188|12147496|FG000|Overall Study|Withdrawal of consent|0
7722979|NCT00552188|12147497|FG001|Overall Study|Withdrawal of consent|1
7722980|NCT00552188|12147496|FG000|Overall Study|Subject returned to home country|0
7722981|NCT00552188|12147497|FG001|Overall Study|Subject returned to home country|1
7722982|NCT00552240|12147505|FG000|Overall Study|Adverse Event|9
7722983|NCT00552240|12147506|FG001|Overall Study|Adverse Event|9
7722984|NCT00552240|12147505|FG000|Overall Study|Protocol Violation|1
7722985|NCT00552240|12147506|FG001|Overall Study|Protocol Violation|1
7722986|NCT00552240|12147505|FG000|Overall Study|Lost to Follow-up|5
7722987|NCT00552240|12147506|FG001|Overall Study|Lost to Follow-up|6
7722988|NCT00552240|12147505|FG000|Overall Study|Withdrawal by Subject|2
7722989|NCT00552240|12147506|FG001|Overall Study|Withdrawal by Subject|2
7722990|NCT00552240|12147505|FG000|Overall Study|Lack of Efficacy|6
7722991|NCT00552240|12147506|FG001|Overall Study|Lack of Efficacy|0
7722992|NCT00552240|12147505|FG000|Overall Study|Other|1
7722993|NCT00552240|12147506|FG001|Overall Study|Other|0
7722994|NCT00552279|12147514|FG000|Overall Study|Adverse Event|0
7722995|NCT00552279|12147515|FG001|Overall Study|Adverse Event|1
7722996|NCT00552279|12147514|FG000|Overall Study|Withdrawal by Subject|12
7722997|NCT00552279|12147515|FG001|Overall Study|Withdrawal by Subject|1
7722998|NCT00552279|12147514|FG000|Overall Study|Lost to Follow-up|1
7722999|NCT00552279|12147515|FG001|Overall Study|Lost to Follow-up|0
7723000|NCT00552279|12147514|FG000|Overall Study|Other|1
7723001|NCT00552279|12147515|FG001|Overall Study|Other|1
7723002|NCT00552305|12147521|FG000|Overall Study|Adverse Event|43
7723003|NCT00552305|12147521|FG000|Overall Study|Lack of Efficacy|120
7723004|NCT00552305|12147521|FG000|Overall Study|Lost to Follow-up|4
7723005|NCT00552305|12147521|FG000|Overall Study|Protocol Violation|3
7723006|NCT00552305|12147521|FG000|Overall Study|Withdrawal by Subject|44
7723007|NCT00552305|12147521|FG000|Overall Study|Lack of efficacy/withdrew consent|1
7723008|NCT00552305|12147521|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3
7723009|NCT00552305|12147521|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
7723010|NCT00552305|12147521|FG000|Overall Study|Unsatisfactory compliance|11
7723011|NCT00552305|12147521|FG000|Overall Study|Poor compliance/lost to follow-up|1
7723012|NCT00552305|12147521|FG000|Overall Study|AE/Other: prohibited drug required|1
7723013|NCT00552305|12147521|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1
7723014|NCT00552305|12147521|FG000|Overall Study|Other: Site closed|4
7723015|NCT00552305|12147521|FG000|Overall Study|Other: Personal problems|1
7723016|NCT00552305|12147521|FG000|Overall Study|Other: Unable to attend visits|1
7723017|NCT00552305|12147521|FG000|Overall Study|Other: Subject underwent surgery|4
7723018|NCT00552305|12147521|FG000|Overall Study|Other: Subject became pregnant|1
7723019|NCT00552305|12147521|FG000|Overall Study|Other: Health problems, not drug related|1
7723020|NCT00552305|12147521|FG000|Overall Study|Other: Subject moved from area|2
7723021|NCT00552305|12147521|FG000|Overall Study|Other: Subject incarcerated|1
7723022|NCT00552305|12147521|FG000|Overall Study|Other: Subject went to rehab|1
7723023|NCT00552344|12147525|FG000|Overall Study|Lack of Efficacy|55
7723024|NCT00552344|12147525|FG000|Overall Study|Loss of efficacy|75
7723025|NCT00552344|12147525|FG000|Overall Study|Lost to Follow-up|8
7723026|NCT00552344|12147525|FG000|Overall Study|Withdrawal by Subject|48
7723027|NCT00552344|12147525|FG000|Overall Study|SAE, non-fatal|6
7723028|NCT00552344|12147525|FG000|Overall Study|AE, non-serious non-fatal|38
7723029|NCT00552344|12147525|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
7723030|NCT00552344|12147525|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
7723031|NCT00552344|12147525|FG000|Overall Study|Other Reason|22
7723032|NCT00552396|12147537|FG000|Overall Study|protocol withdrawal criteria|3
7723033|NCT00552396|12147538|FG001|Overall Study|protocol withdrawal criteria|3
7723034|NCT00552396|12147539|FG002|Overall Study|protocol withdrawal criteria|3
7723035|NCT00552396|12147540|FG003|Overall Study|protocol withdrawal criteria|6
7723036|NCT00552396|12147541|FG004|Overall Study|protocol withdrawal criteria|3
7723037|NCT00552396|12147542|FG005|Overall Study|protocol withdrawal criteria|3
7723038|NCT00552396|12147543|FG006|Overall Study|protocol withdrawal criteria|9
7767924|NCT00856583|12210756|FG001|Overall Study|Withdrawal by Subject|919
7767925|NCT00856583|12210755|FG000|Overall Study|Physician Decision|59
7767926|NCT00856583|12210756|FG001|Overall Study|Physician Decision|82
7767927|NCT00856583|12210755|FG000|Overall Study|Pregnancy|14
7767928|NCT00856583|12210756|FG001|Overall Study|Pregnancy|5
7767929|NCT00856583|12210755|FG000|Overall Study|Other|92
7767930|NCT00856583|12210756|FG001|Overall Study|Other|104
7767931|NCT00856583|12210755|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694
7767932|NCT00856583|12210756|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604
7767933|NCT00856609|12210764|FG000|Overall Study|Adverse Event|1
7767934|NCT00856609|12210765|FG001|Overall Study|Adverse Event|0
7767935|NCT00856635|12210773|FG000|Overall Study|Lost to Follow-up|2
7767936|NCT00856635|12210774|FG001|Overall Study|Lost to Follow-up|5
7767937|NCT00856635|12210773|FG000|Overall Study|Pregnancy|1
7767938|NCT00856635|12210774|FG001|Overall Study|Pregnancy|0
7767939|NCT00856635|12210773|FG000|Overall Study|Withdrawal by Subject|3
7767940|NCT00856635|12210774|FG001|Overall Study|Withdrawal by Subject|1
7767941|NCT00856635|12210773|FG000|Overall Study|Serious Adverse Event|1
7767942|NCT00856635|12210774|FG001|Overall Study|Serious Adverse Event|0
7767943|NCT00856635|12210773|FG000|Overall Study|Other|1
7767944|NCT00856635|12210774|FG001|Overall Study|Other|0
7723039|NCT00552578|12147601|FG000|Overall Study|Lost to Follow-up|1
7723040|NCT00552578|12147602|FG001|Overall Study|Lost to Follow-up|1
7723041|NCT00552617|12147618|FG000|Overall Study|Not Treated|0
7723042|NCT00552617|12147619|FG001|Overall Study|Not Treated|0
7723043|NCT00552617|12147620|FG002|Overall Study|Not Treated|1
7723044|NCT00552617|12147621|FG003|Overall Study|Not Treated|0
7723045|NCT00552617|12147622|FG004|Overall Study|Not Treated|0
7723046|NCT00552617|12147623|FG005|Overall Study|Not Treated|0
7723047|NCT00552617|12147624|FG006|Overall Study|Not Treated|0
7723048|NCT00552617|12147625|FG007|Overall Study|Not Treated|0
7723049|NCT00552617|12147626|FG008|Overall Study|Not Treated|0
7723050|NCT00552617|12147627|FG009|Overall Study|Not Treated|1
7723051|NCT00552617|12147618|FG000|Overall Study|Lost to Follow-up|0
7723052|NCT00552617|12147619|FG001|Overall Study|Lost to Follow-up|0
7723053|NCT00552617|12147620|FG002|Overall Study|Lost to Follow-up|0
7723054|NCT00552617|12147621|FG003|Overall Study|Lost to Follow-up|1
7723055|NCT00552617|12147622|FG004|Overall Study|Lost to Follow-up|0
7723056|NCT00552617|12147623|FG005|Overall Study|Lost to Follow-up|2
7723057|NCT00552617|12147624|FG006|Overall Study|Lost to Follow-up|0
7723058|NCT00552617|12147625|FG007|Overall Study|Lost to Follow-up|0
7723059|NCT00552617|12147626|FG008|Overall Study|Lost to Follow-up|2
7723060|NCT00552617|12147627|FG009|Overall Study|Lost to Follow-up|0
7723061|NCT00552669|12147651|FG000|Overall Study|Death|3
7723062|NCT00552669|12147652|FG001|Overall Study|Death|7
7723063|NCT00552760|12147669|FG000|Overall Study|Adverse Event|3
7723064|NCT00552760|12147670|FG001|Overall Study|Adverse Event|5
7723065|NCT00552760|12147669|FG000|Overall Study|Relapsed- Depressed Event|10
7723066|NCT00552760|12147670|FG001|Overall Study|Relapsed- Depressed Event|16
7723067|NCT00552760|12147669|FG000|Overall Study|Relapse- Manic Event|3
7723068|NCT00552760|12147670|FG001|Overall Study|Relapse- Manic Event|3
7723069|NCT00552760|12147669|FG000|Overall Study|Relapsed- Mixed Event|3
7723070|NCT00552760|12147670|FG001|Overall Study|Relapsed- Mixed Event|5
7723071|NCT00552760|12147669|FG000|Overall Study|Protocol Violation|0
7723072|NCT00552760|12147670|FG001|Overall Study|Protocol Violation|1
7723073|NCT00552760|12147669|FG000|Overall Study|Lost to Follow-up|1
7723074|NCT00552760|12147670|FG001|Overall Study|Lost to Follow-up|1
7723075|NCT00552760|12147669|FG000|Overall Study|Non-compliance|1
7723076|NCT00552760|12147670|FG001|Overall Study|Non-compliance|1
7723077|NCT00552760|12147669|FG000|Overall Study|Medical Condition|1
7723078|NCT00552760|12147670|FG001|Overall Study|Medical Condition|1
7723079|NCT00552760|12147669|FG000|Overall Study|Withdrawal by Subject|3
7723080|NCT00552760|12147670|FG001|Overall Study|Withdrawal by Subject|0
7723081|NCT00552760|12147669|FG000|Overall Study|Medication Change|1
7723082|NCT00552760|12147670|FG001|Overall Study|Medication Change|0
7723083|NCT00552929|12147699|FG000|Overall Study|Lost to Follow-up|0
7723084|NCT00552929|12147700|FG001|Overall Study|Lost to Follow-up|0
7723085|NCT00552929|12147701|FG002|Overall Study|Lost to Follow-up|0
7723086|NCT00552929|12147702|FG003|Overall Study|Lost to Follow-up|0
7723087|NCT00552929|12147703|FG004|Overall Study|Lost to Follow-up|0
7723088|NCT00552929|12147704|FG005|Overall Study|Lost to Follow-up|0
7723089|NCT00552929|12147705|FG006|Overall Study|Lost to Follow-up|0
7723090|NCT00552929|12147706|FG007|Overall Study|Lost to Follow-up|0
7723091|NCT00552929|12147707|FG008|Overall Study|Lost to Follow-up|1
7723092|NCT00552929|12147708|FG009|Overall Study|Lost to Follow-up|0
7723093|NCT00552929|12147699|FG000|Overall Study|Not Eligible|0
7723094|NCT00552929|12147700|FG001|Overall Study|Not Eligible|0
7723095|NCT00552929|12147701|FG002|Overall Study|Not Eligible|0
7723096|NCT00552929|12147702|FG003|Overall Study|Not Eligible|0
7723097|NCT00552929|12147703|FG004|Overall Study|Not Eligible|0
7723098|NCT00552929|12147704|FG005|Overall Study|Not Eligible|1
7723099|NCT00552929|12147705|FG006|Overall Study|Not Eligible|0
7723100|NCT00552929|12147706|FG007|Overall Study|Not Eligible|0
7723101|NCT00552929|12147707|FG008|Overall Study|Not Eligible|0
7723102|NCT00552929|12147708|FG009|Overall Study|Not Eligible|0
7723103|NCT00553059|12147732|FG000|Overall Study|Deemed ineligible|1
7723104|NCT00553059|12147733|FG001|Overall Study|Deemed ineligible|1
7723105|NCT00553059|12147732|FG000|Overall Study|Drug supply not available|0
7723106|NCT00553059|12147733|FG001|Overall Study|Drug supply not available|1
7723107|NCT00553150|12147749|FG000|Overall Study|Withdrawal by Subject|0
7723108|NCT00553150|12147750|FG001|Overall Study|Withdrawal by Subject|0
7723109|NCT00553150|12147751|FG002|Overall Study|Withdrawal by Subject|0
7723110|NCT00553150|12147752|FG003|Overall Study|Withdrawal by Subject|2
7723111|NCT00553150|12147749|FG000|Overall Study|Protocol Violation|0
7723112|NCT00553150|12147750|FG001|Overall Study|Protocol Violation|0
7723113|NCT00553150|12147751|FG002|Overall Study|Protocol Violation|0
7723114|NCT00553150|12147752|FG003|Overall Study|Protocol Violation|1
7723115|NCT00553150|12147749|FG000|Overall Study|Ineligible|0
7723116|NCT00553150|12147750|FG001|Overall Study|Ineligible|0
7723117|NCT00553150|12147751|FG002|Overall Study|Ineligible|0
7723118|NCT00553150|12147752|FG003|Overall Study|Ineligible|1
7723119|NCT00553202|12147774|FG000|Overall Study|Death|16
7723120|NCT00553202|12147774|FG000|Overall Study|Lost to Follow-up|1
7723121|NCT00553202|12147774|FG000|Overall Study|Physician Decision|28
7723122|NCT00553202|12147774|FG000|Overall Study|Withdrawal by Subject|1
7723123|NCT00553202|12147774|FG000|Overall Study|No donor identified|16
7723124|NCT00553202|12147774|FG000|Overall Study|Fails to meet organ function|6
7723125|NCT00553254|12147781|FG000|Overall Study|Death|3
7723126|NCT00553254|12147782|FG001|Overall Study|Death|6
7723127|NCT00553254|12147783|FG002|Overall Study|Death|25
7723128|NCT00553254|12147781|FG000|Overall Study|Lost to Follow-up|0
7723129|NCT00553254|12147782|FG001|Overall Study|Lost to Follow-up|0
7723130|NCT00553254|12147783|FG002|Overall Study|Lost to Follow-up|2
7723131|NCT00553254|12147781|FG000|Overall Study|Withdrawal by Subject|2
7723132|NCT00553254|12147782|FG001|Overall Study|Withdrawal by Subject|0
7723133|NCT00553254|12147783|FG002|Overall Study|Withdrawal by Subject|2
7723134|NCT00553254|12147781|FG000|Overall Study|Study terminated by Sponsor|0
7723135|NCT00553254|12147782|FG001|Overall Study|Study terminated by Sponsor|0
7723136|NCT00553254|12147783|FG002|Overall Study|Study terminated by Sponsor|1
7723137|NCT00553254|12147781|FG000|Overall Study|Other|1
7723138|NCT00553254|12147782|FG001|Overall Study|Other|0
7723139|NCT00553254|12147783|FG002|Overall Study|Other|13
7723140|NCT00553267|12147798|FG000|Overall Study|Adverse Event|8
7723141|NCT00553267|12147799|FG001|Overall Study|Adverse Event|10
7723142|NCT00553267|12147800|FG002|Overall Study|Adverse Event|5
7723143|NCT00553267|12147798|FG000|Overall Study|Non compliant with protocol|3
7723144|NCT00553267|12147799|FG001|Overall Study|Non compliant with protocol|3
7723145|NCT00553267|12147800|FG002|Overall Study|Non compliant with protocol|2
7723146|NCT00553267|12147798|FG000|Overall Study|Lost to Follow-up|0
7723147|NCT00553267|12147799|FG001|Overall Study|Lost to Follow-up|0
7723148|NCT00553267|12147800|FG002|Overall Study|Lost to Follow-up|1
7723149|NCT00553267|12147798|FG000|Overall Study|Consent withdrawn|2
7723150|NCT00553267|12147799|FG001|Overall Study|Consent withdrawn|3
7723151|NCT00553267|12147800|FG002|Overall Study|Consent withdrawn|1
7723152|NCT00553267|12147798|FG000|Overall Study|Specified category|1
7723153|NCT00553267|12147799|FG001|Overall Study|Specified category|2
7723154|NCT00553267|12147800|FG002|Overall Study|Specified category|1
7723155|NCT00553280|12147808|FG000|Overall Study|Adverse Event|19
7723156|NCT00553280|12147808|FG000|Overall Study|Lack of Efficacy|3
7723157|NCT00553280|12147808|FG000|Overall Study|Withdrawal by Subject|3
7723158|NCT00553280|12147808|FG000|Overall Study|Physician Decision|1
7723159|NCT00553319|12147815|FG000|Overall Study|Lost to Follow-up|10
7723160|NCT00553319|12147816|FG001|Overall Study|Lost to Follow-up|9
7723161|NCT00553319|12147817|FG002|Overall Study|Lost to Follow-up|5
7723162|NCT00553319|12147815|FG000|Overall Study|wanted treatment elsewhere|2
7723163|NCT00553319|12147816|FG001|Overall Study|wanted treatment elsewhere|1
7723164|NCT00553319|12147817|FG002|Overall Study|wanted treatment elsewhere|1
7723165|NCT00553319|12147815|FG000|Overall Study|non-compliance|0
7723166|NCT00553319|12147816|FG001|Overall Study|non-compliance|0
7723167|NCT00553319|12147817|FG002|Overall Study|non-compliance|2
7723168|NCT00553319|12147815|FG000|Overall Study|incarceration|1
7723169|NCT00553319|12147816|FG001|Overall Study|incarceration|0
7723170|NCT00553319|12147817|FG002|Overall Study|incarceration|0
7723171|NCT00553319|12147815|FG000|Overall Study|moved|1
7723172|NCT00553319|12147816|FG001|Overall Study|moved|0
7723173|NCT00553319|12147817|FG002|Overall Study|moved|1
7723174|NCT00553332|12147825|FG000|Overall Study|ineligible, incorrect diagnosis|1
7723175|NCT00553358|12147832|FG000|Overall Study|Randomized but did not receive treatment|3
7723176|NCT00553358|12147833|FG001|Overall Study|Randomized but did not receive treatment|3
7723177|NCT00553358|12147834|FG002|Overall Study|Randomized but did not receive treatment|1
7723178|NCT00553358|12147832|FG000|Overall Study|Lost to Follow-up|22
7723179|NCT00553358|12147833|FG001|Overall Study|Lost to Follow-up|26
7723180|NCT00553358|12147834|FG002|Overall Study|Lost to Follow-up|18
7723181|NCT00553358|12147832|FG000|Overall Study|Withdrew completely|23
7723182|NCT00553358|12147833|FG001|Overall Study|Withdrew completely|33
7723183|NCT00553358|12147834|FG002|Overall Study|Withdrew completely|34
7723184|NCT00553358|12147832|FG000|Overall Study|Died during clinical follow-up|25
7723185|NCT00553358|12147833|FG001|Overall Study|Died during clinical follow-up|29
7723186|NCT00553358|12147834|FG002|Overall Study|Died during clinical follow-up|32
7723187|NCT00553358|12147832|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4
7723188|NCT00553358|12147833|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
7723189|NCT00553358|12147834|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
7723190|NCT00553358|12147832|FG000|Overall Study|Died after clinical follow-up ended|1
7723191|NCT00553358|12147833|FG001|Overall Study|Died after clinical follow-up ended|2
7723192|NCT00553358|12147834|FG002|Overall Study|Died after clinical follow-up ended|0
7723193|NCT00553358|12147832|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
7723194|NCT00553358|12147833|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
7723195|NCT00553358|12147834|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
7723196|NCT00553436|12147857|FG000|Overall Study|Conversion to another procedure|1
7723197|NCT00553462|12147861|FG000|Overall Study|Adverse Event|4
7723198|NCT00553462|12147861|FG000|Overall Study|Progression|4
7723199|NCT00553462|12147861|FG000|Overall Study|Withdrawal by Subject|5
7723200|NCT00553462|12147861|FG000|Overall Study|Physician Decision|1
7723201|NCT00553475|12147868|FG000|Overall Study|Adverse Event|7
7723202|NCT00553475|12147869|FG001|Overall Study|Adverse Event|17
7723203|NCT00553475|12147870|FG002|Overall Study|Adverse Event|13
7723204|NCT00553475|12147868|FG000|Overall Study|Lack of Efficacy|7
7723205|NCT00553475|12147869|FG001|Overall Study|Lack of Efficacy|1
7723206|NCT00553475|12147870|FG002|Overall Study|Lack of Efficacy|0
7723207|NCT00553475|12147868|FG000|Overall Study|Withdrawal by Subject|1
7723208|NCT00553475|12147869|FG001|Overall Study|Withdrawal by Subject|1
7723209|NCT00553475|12147870|FG002|Overall Study|Withdrawal by Subject|0
7723210|NCT00553475|12147868|FG000|Overall Study|Physician Decision|1
7723211|NCT00553475|12147869|FG001|Overall Study|Physician Decision|0
7723212|NCT00553475|12147870|FG002|Overall Study|Physician Decision|0
7723213|NCT00553475|12147868|FG000|Overall Study|Due to moving|0
7723214|NCT00553475|12147869|FG001|Overall Study|Due to moving|1
7723215|NCT00553475|12147870|FG002|Overall Study|Due to moving|0
7723216|NCT00553501|12147880|FG000|Overall Study|Adverse Event|2
7723217|NCT00553501|12147880|FG000|Overall Study|Death|1
7723218|NCT00553501|12147880|FG000|Overall Study|Progression|1
7723219|NCT00553514|12147889|FG000|Overall Study|Protocol deviation|0
7723220|NCT00553514|12147890|FG001|Overall Study|Protocol deviation|0
7723221|NCT00553514|12147891|FG002|Overall Study|Protocol deviation|0
7723222|NCT00553514|12147892|FG003|Overall Study|Protocol deviation|1
7723223|NCT00553514|12147893|FG004|Overall Study|Protocol deviation|0
7723224|NCT00553514|12147889|FG000|Overall Study|Lack of ovarian response|4
7723225|NCT00553514|12147890|FG001|Overall Study|Lack of ovarian response|5
7723226|NCT00553514|12147891|FG002|Overall Study|Lack of ovarian response|5
7723227|NCT00553514|12147892|FG003|Overall Study|Lack of ovarian response|5
7723228|NCT00553514|12147893|FG004|Overall Study|Lack of ovarian response|6
7723229|NCT00553514|12147889|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3
7723230|NCT00553514|12147890|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0
7723231|NCT00553514|12147891|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1
7723232|NCT00553514|12147892|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0
7723233|NCT00553514|12147893|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0
7723234|NCT00553514|12147889|FG000|Overall Study|Risk of multiple pregnancy|0
7723235|NCT00553514|12147890|FG001|Overall Study|Risk of multiple pregnancy|2
7723236|NCT00553514|12147891|FG002|Overall Study|Risk of multiple pregnancy|0
7723237|NCT00553514|12147892|FG003|Overall Study|Risk of multiple pregnancy|1
7723238|NCT00553514|12147893|FG004|Overall Study|Risk of multiple pregnancy|0
7723239|NCT00553514|12147889|FG000|Overall Study|Other|1
7723240|NCT00553514|12147890|FG001|Overall Study|Other|1
7723241|NCT00553514|12147891|FG002|Overall Study|Other|0
7723242|NCT00553514|12147892|FG003|Overall Study|Other|0
7723243|NCT00553514|12147893|FG004|Overall Study|Other|1
7723244|NCT00553540|12147907|FG000|Overall Study|discharged after first visit|2
7723245|NCT00553540|12147908|FG001|Overall Study|discharged after first visit|5
7723246|NCT00553605|12147916|FG000|Overall Study|Did not meet entrance criteria|1
7723247|NCT00553605|12147917|FG001|Overall Study|Did not meet entrance criteria|3
7723248|NCT00553605|12147916|FG000|Overall Study|Did not receive full dose|1
7723249|NCT00553605|12147917|FG001|Overall Study|Did not receive full dose|0
7723250|NCT00553605|12147916|FG000|Overall Study|Randomized but not treated|2
7723251|NCT00553605|12147917|FG001|Overall Study|Randomized but not treated|0
7723252|NCT00553631|12147925|FG000|Overall Study|Withdrawal by Subject|0
7723253|NCT00553631|12147926|FG001|Overall Study|Withdrawal by Subject|1
7723254|NCT00553631|12147925|FG000|Overall Study|Lost to Follow-up|1
7723255|NCT00553631|12147926|FG001|Overall Study|Lost to Follow-up|0
7723256|NCT00553644|12147932|FG000|Overall Study|Adverse Event|17
7723257|NCT00553644|12147932|FG000|Overall Study|Withdrawal by Subject|4
7723258|NCT00553644|12147932|FG000|Overall Study|Physician Decision|1
7723259|NCT00553644|12147932|FG000|Overall Study|Alternative therapy|6
7723260|NCT00553696|12147940|FG000|Overall Study|Adverse Event|2
7723261|NCT00553696|12147941|FG001|Overall Study|Adverse Event|4
7723262|NCT00553696|12147942|FG002|Overall Study|Adverse Event|0
7723263|NCT00553696|12147943|FG003|Overall Study|Adverse Event|1
7723264|NCT00553696|12147940|FG000|Overall Study|Global deterioration of health status|0
7723265|NCT00553696|12147941|FG001|Overall Study|Global deterioration of health status|2
7723266|NCT00553696|12147942|FG002|Overall Study|Global deterioration of health status|0
7723267|NCT00553696|12147943|FG003|Overall Study|Global deterioration of health status|0
7723268|NCT00553696|12147940|FG000|Overall Study|Objective progression or relapse|2
7723269|NCT00553696|12147941|FG001|Overall Study|Objective progression or relapse|9
7723270|NCT00553696|12147942|FG002|Overall Study|Objective progression or relapse|6
7723271|NCT00553696|12147943|FG003|Overall Study|Objective progression or relapse|0
7723272|NCT00553696|12147940|FG000|Overall Study|Withdrawal by Subject|0
7723273|NCT00553696|12147941|FG001|Overall Study|Withdrawal by Subject|1
7723274|NCT00553696|12147942|FG002|Overall Study|Withdrawal by Subject|0
7723275|NCT00553696|12147943|FG003|Overall Study|Withdrawal by Subject|0
7723276|NCT00553787|12147966|FG000|Overall Study|Adverse Event|34
7723277|NCT00553787|12147967|FG001|Overall Study|Adverse Event|21
7723278|NCT00553787|12147968|FG002|Overall Study|Adverse Event|67
7723279|NCT00553787|12147966|FG000|Overall Study|Lost to Follow-up|132
7723280|NCT00553787|12147967|FG001|Overall Study|Lost to Follow-up|44
7723281|NCT00553787|12147968|FG002|Overall Study|Lost to Follow-up|78
7723282|NCT00553787|12147966|FG000|Overall Study|Withdrawal by Subject|151
7723283|NCT00553787|12147967|FG001|Overall Study|Withdrawal by Subject|40
7723284|NCT00553787|12147968|FG002|Overall Study|Withdrawal by Subject|83
7723285|NCT00553787|12147966|FG000|Overall Study|Lack of Efficacy|31
7723286|NCT00553787|12147967|FG001|Overall Study|Lack of Efficacy|1
7723287|NCT00553787|12147968|FG002|Overall Study|Lack of Efficacy|3
7723288|NCT00553787|12147966|FG000|Overall Study|Pregnancy|0
7723289|NCT00553787|12147967|FG001|Overall Study|Pregnancy|1
7723290|NCT00553787|12147968|FG002|Overall Study|Pregnancy|2
7723291|NCT00553787|12147966|FG000|Overall Study|non compliance|4
7723292|NCT00553787|12147967|FG001|Overall Study|non compliance|0
7723293|NCT00553787|12147968|FG002|Overall Study|non compliance|11
7723294|NCT00553787|12147966|FG000|Overall Study|Requirement for restricted medication|8
7723295|NCT00553787|12147967|FG001|Overall Study|Requirement for restricted medication|7
7723296|NCT00553787|12147968|FG002|Overall Study|Requirement for restricted medication|5
7723297|NCT00553787|12147966|FG000|Overall Study|Other|18
7723298|NCT00553787|12147967|FG001|Overall Study|Other|10
7723299|NCT00553787|12147968|FG002|Overall Study|Other|13
7723300|NCT00554099|12148000|FG000|Treatment Period (12 Weeks)|Adverse Event|3
7723301|NCT00554099|12148001|FG001|Treatment Period (12 Weeks)|Adverse Event|5
7723302|NCT00554099|12148002|FG002|Treatment Period (12 Weeks)|Adverse Event|1
7723303|NCT00554099|12148000|FG000|Treatment Period (12 Weeks)|Physician Decision|3
7723304|NCT00554099|12148001|FG001|Treatment Period (12 Weeks)|Physician Decision|0
7723305|NCT00554099|12148002|FG002|Treatment Period (12 Weeks)|Physician Decision|0
7723306|NCT00554099|12148000|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1
7723307|NCT00554099|12148001|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0
7723308|NCT00554099|12148002|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2
7723309|NCT00554099|12148000|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
7723310|NCT00554099|12148001|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
7723311|NCT00554099|12148002|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
7723312|NCT00554099|12148000|FG000|Treatment Period (12 Weeks)|Protocol Violation|0
7723313|NCT00554099|12148001|FG001|Treatment Period (12 Weeks)|Protocol Violation|0
7723314|NCT00554099|12148002|FG002|Treatment Period (12 Weeks)|Protocol Violation|2
7723315|NCT00554099|12148000|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4
7723316|NCT00554099|12148001|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1
7723317|NCT00554099|12148002|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4
7723318|NCT00554099|12148000|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
7723319|NCT00554099|12148001|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
7723320|NCT00554099|12148002|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
7723321|NCT00554099|12148000|FG000|Non-Treatment Phase (9 Months)|Relapse|2
7723322|NCT00554099|12148001|FG001|Non-Treatment Phase (9 Months)|Relapse|1
7723323|NCT00554099|12148002|FG002|Non-Treatment Phase (9 Months)|Relapse|1
7723324|NCT00554099|12148000|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
7723325|NCT00554099|12148001|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
7723326|NCT00554099|12148002|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
7723327|NCT00554216|12148013|FG000|Overall Study|Lost to Follow-up|92
7723328|NCT00554216|12148014|FG001|Overall Study|Lost to Follow-up|31
7723329|NCT00554216|12148015|FG002|Overall Study|Lost to Follow-up|63
7723330|NCT00554216|12148013|FG000|Overall Study|Adverse Event|16
7723331|NCT00554216|12148014|FG001|Overall Study|Adverse Event|16
7723332|NCT00554216|12148015|FG002|Overall Study|Adverse Event|36
7723333|NCT00554216|12148013|FG000|Overall Study|Withdrawal by Subject|92
7723334|NCT00554216|12148014|FG001|Overall Study|Withdrawal by Subject|31
7723335|NCT00554216|12148015|FG002|Overall Study|Withdrawal by Subject|43
7723336|NCT00554216|12148013|FG000|Overall Study|Non compliance|10
7723337|NCT00554216|12148014|FG001|Overall Study|Non compliance|4
7723338|NCT00554216|12148015|FG002|Overall Study|Non compliance|5
7723339|NCT00554216|12148013|FG000|Overall Study|Pregnancy|2
7723340|NCT00554216|12148014|FG001|Overall Study|Pregnancy|1
7723341|NCT00554216|12148015|FG002|Overall Study|Pregnancy|14
7723342|NCT00554216|12148013|FG000|Overall Study|Restricted med|3
7723343|NCT00554216|12148014|FG001|Overall Study|Restricted med|1
7723344|NCT00554216|12148015|FG002|Overall Study|Restricted med|1
7723345|NCT00554216|12148013|FG000|Overall Study|Other|12
7723346|NCT00554216|12148014|FG001|Overall Study|Other|7
7723347|NCT00554216|12148015|FG002|Overall Study|Other|10
7723348|NCT00554216|12148013|FG000|Overall Study|Lack of Efficacy|15
7723349|NCT00554216|12148014|FG001|Overall Study|Lack of Efficacy|3
7723350|NCT00554216|12148015|FG002|Overall Study|Lack of Efficacy|0
7723351|NCT00554229|12148025|FG000|Overall Study|Lost to Follow-up|3
7723352|NCT00554229|12148026|FG001|Overall Study|Lost to Follow-up|6
7723353|NCT00554229|12148025|FG000|Overall Study|Withdrawal by Subject|29
7723354|NCT00554229|12148026|FG001|Overall Study|Withdrawal by Subject|37
7723355|NCT00554229|12148025|FG000|Overall Study|Adverse Event|71
7723356|NCT00554229|12148026|FG001|Overall Study|Adverse Event|39
7723357|NCT00554229|12148025|FG000|Overall Study|Protocol Violation|3
7723358|NCT00554229|12148026|FG001|Overall Study|Protocol Violation|3
7723359|NCT00554229|12148025|FG000|Overall Study|Reason not otherwise captured, eg; death|119
7723360|NCT00554229|12148026|FG001|Overall Study|Reason not otherwise captured, eg; death|140
7723361|NCT00554229|12148025|FG000|Overall Study|Randomised but no treatment received|1
7723362|NCT00554229|12148026|FG001|Overall Study|Randomised but no treatment received|0
7723363|NCT00554619|12148047|FG000|Overall Study|Adverse Event|1
7723364|NCT00554619|12148047|FG000|Overall Study|Physician Decision|1
7723365|NCT00554619|12148047|FG000|Overall Study|Liver Function Test Abnormality|1
7723366|NCT00554801|12148067|FG000|Overall Study|left area before completion|5
7723367|NCT00554801|12148068|FG001|Overall Study|left area before completion|0
7723368|NCT00554801|12148067|FG000|Overall Study|Withdrawal by Subject|14
7723369|NCT00554801|12148068|FG001|Overall Study|Withdrawal by Subject|0
7723370|NCT00555061|12148116|FG000|Overall Study|Adverse Event|3
7723371|NCT00555061|12148116|FG000|Overall Study|Protocol Violation|1
7723372|NCT00555061|12148116|FG000|Overall Study|Lost to Follow-up|2
7723373|NCT00555061|12148116|FG000|Overall Study|Withdrawal by Subject|2
7723374|NCT00555061|12148116|FG000|Overall Study|Participant enrolled, but never treated|1
7723375|NCT00555217|12148139|FG000|Overall Study|Withdrawal by Subject|35
7723376|NCT00555217|12148140|FG001|Overall Study|Withdrawal by Subject|31
7723377|NCT00555217|12148139|FG000|Overall Study|Lost to Follow-up|19
7723378|NCT00555217|12148140|FG001|Overall Study|Lost to Follow-up|20
7723379|NCT00555217|12148139|FG000|Overall Study|close out sites|21
7723380|NCT00555217|12148140|FG001|Overall Study|close out sites|17
7723381|NCT00555321|12148151|FG000|Treatment Phase up to 12-months|Adverse Event|6
7723382|NCT00555321|12148152|FG001|Treatment Phase up to 12-months|Adverse Event|7
7723383|NCT00555321|12148153|FG002|Treatment Phase up to 12-months|Adverse Event|11
7723384|NCT00555321|12148154|FG003|Treatment Phase up to 12-months|Adverse Event|7
7723385|NCT00555321|12148155|FG004|Treatment Phase up to 12-months|Adverse Event|18
7723386|NCT00555321|12148151|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1
7723387|NCT00555321|12148152|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0
7723388|NCT00555321|12148153|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1
7723389|NCT00555321|12148154|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0
7723390|NCT00555321|12148155|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0
7723391|NCT00555321|12148151|FG000|Treatment Phase up to 12-months|Death|2
7723392|NCT00555321|12148152|FG001|Treatment Phase up to 12-months|Death|1
7723393|NCT00555321|12148153|FG002|Treatment Phase up to 12-months|Death|4
7723394|NCT00555321|12148154|FG003|Treatment Phase up to 12-months|Death|0
7723395|NCT00555321|12148155|FG004|Treatment Phase up to 12-months|Death|0
7723396|NCT00555321|12148151|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9
7723397|NCT00555321|12148152|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8
7723398|NCT00555321|12148153|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5
7723399|NCT00555321|12148154|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0
7723400|NCT00555321|12148155|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0
7723401|NCT00555321|12148151|FG000|Treatment Phase up to 12-months|Other Reason|1
7723402|NCT00555321|12148152|FG001|Treatment Phase up to 12-months|Other Reason|3
7723403|NCT00555321|12148153|FG002|Treatment Phase up to 12-months|Other Reason|2
7723404|NCT00555321|12148154|FG003|Treatment Phase up to 12-months|Other Reason|0
7723405|NCT00555321|12148155|FG004|Treatment Phase up to 12-months|Other Reason|0
7723406|NCT00555321|12148151|FG000|Treatment Phase up to 12-months|Never treated|2
7723407|NCT00555321|12148152|FG001|Treatment Phase up to 12-months|Never treated|3
7723408|NCT00555321|12148153|FG002|Treatment Phase up to 12-months|Never treated|1
7723409|NCT00555321|12148154|FG003|Treatment Phase up to 12-months|Never treated|0
7723410|NCT00555321|12148155|FG004|Treatment Phase up to 12-months|Never treated|4
7723411|NCT00555321|12148151|FG000|Long-term Extension Phase|Adverse Event|2
7723412|NCT00555321|12148152|FG001|Long-term Extension Phase|Adverse Event|5
7723413|NCT00555321|12148153|FG002|Long-term Extension Phase|Adverse Event|2
7723414|NCT00555321|12148154|FG003|Long-term Extension Phase|Adverse Event|1
7723415|NCT00555321|12148155|FG004|Long-term Extension Phase|Adverse Event|0
7723416|NCT00555321|12148151|FG000|Long-term Extension Phase|Withdrawal by Subject|2
7723417|NCT00555321|12148152|FG001|Long-term Extension Phase|Withdrawal by Subject|1
7723418|NCT00555321|12148153|FG002|Long-term Extension Phase|Withdrawal by Subject|2
7723419|NCT00555321|12148154|FG003|Long-term Extension Phase|Withdrawal by Subject|3
7723420|NCT00555321|12148155|FG004|Long-term Extension Phase|Withdrawal by Subject|2
7723421|NCT00555321|12148151|FG000|Long-term Extension Phase|Administrative reason by sponsor|23
7723422|NCT00555321|12148152|FG001|Long-term Extension Phase|Administrative reason by sponsor|21
7723423|NCT00555321|12148153|FG002|Long-term Extension Phase|Administrative reason by sponsor|18
7723424|NCT00555321|12148154|FG003|Long-term Extension Phase|Administrative reason by sponsor|31
7723425|NCT00555321|12148155|FG004|Long-term Extension Phase|Administrative reason by sponsor|23
7723426|NCT00555321|12148151|FG000|Long-term Extension Phase|Death|2
7723427|NCT00555321|12148152|FG001|Long-term Extension Phase|Death|0
7723428|NCT00555321|12148153|FG002|Long-term Extension Phase|Death|0
7723429|NCT00555321|12148154|FG003|Long-term Extension Phase|Death|3
7723430|NCT00555321|12148155|FG004|Long-term Extension Phase|Death|0
7723431|NCT00555321|12148151|FG000|Long-term Extension Phase|Participant did not meet study criteria|0
7723432|NCT00555321|12148152|FG001|Long-term Extension Phase|Participant did not meet study criteria|0
7723433|NCT00555321|12148153|FG002|Long-term Extension Phase|Participant did not meet study criteria|0
7723434|NCT00555321|12148154|FG003|Long-term Extension Phase|Participant did not meet study criteria|0
7723435|NCT00555321|12148155|FG004|Long-term Extension Phase|Participant did not meet study criteria|1
7723436|NCT00555321|12148151|FG000|Long-term Extension Phase|Other Reason|1
7723437|NCT00555321|12148152|FG001|Long-term Extension Phase|Other Reason|0
7723438|NCT00555321|12148153|FG002|Long-term Extension Phase|Other Reason|2
7723439|NCT00555321|12148154|FG003|Long-term Extension Phase|Other Reason|0
7723440|NCT00555321|12148155|FG004|Long-term Extension Phase|Other Reason|0
7723441|NCT00555425|12148184|FG000|Overall Study|Missed Medication > 1 wk|34
7723442|NCT00555425|12148185|FG001|Overall Study|Missed Medication > 1 wk|15
7723443|NCT00555425|12148184|FG000|Overall Study|Missed 3 physician management visits|1
7723444|NCT00555425|12148185|FG001|Overall Study|Missed 3 physician management visits|0
7723445|NCT00555425|12148184|FG000|Overall Study|Met criteria for protective transfer|16
7723446|NCT00555425|12148185|FG001|Overall Study|Met criteria for protective transfer|3
7723447|NCT00555425|12148184|FG000|Overall Study|Became pregnant and transferred care|0
7723448|NCT00555425|12148185|FG001|Overall Study|Became pregnant and transferred care|1
7723449|NCT00555438|12148191|FG000|10 Days Post-operative|Death|4
7723450|NCT00555438|12148191|FG000|Between 10 Days and 30 Days Postoperativ|Death|5
7723451|NCT00555477|12148206|FG000|Overall Study|Adverse Event|0
7723452|NCT00555477|12148207|FG001|Overall Study|Adverse Event|9
7723453|NCT00555477|12148206|FG000|Overall Study|Withdrawal by Subject|1
7723454|NCT00555477|12148207|FG001|Overall Study|Withdrawal by Subject|2
7723455|NCT00555477|12148206|FG000|Overall Study|Physician Decision|1
7723456|NCT00555477|12148207|FG001|Overall Study|Physician Decision|2
7723457|NCT00555568|12148215|FG000|Overall Study|Lost to Follow-up|26
7723458|NCT00555568|12148216|FG001|Overall Study|Lost to Follow-up|16
7723459|NCT00555568|12148217|FG002|Overall Study|Lost to Follow-up|16
7723460|NCT00555620|12148235|FG000|Overall Study|Death|0
7723461|NCT00555620|12148236|FG001|Overall Study|Death|1
7723462|NCT00555620|12148237|FG002|Overall Study|Death|0
7723463|NCT00555620|12148238|FG003|Overall Study|Death|0
7723464|NCT00555620|12148239|FG004|Overall Study|Death|0
7723465|NCT00555620|12148240|FG005|Overall Study|Death|1
7723466|NCT00555620|12148235|FG000|Overall Study|Study terminated by sponsor|0
7723467|NCT00555620|12148236|FG001|Overall Study|Study terminated by sponsor|0
7723468|NCT00555620|12148237|FG002|Overall Study|Study terminated by sponsor|1
7723469|NCT00555620|12148238|FG003|Overall Study|Study terminated by sponsor|0
7723470|NCT00555620|12148239|FG004|Overall Study|Study terminated by sponsor|0
7723471|NCT00555620|12148240|FG005|Overall Study|Study terminated by sponsor|0
7723472|NCT00555620|12148235|FG000|Overall Study|Adverse Event|0
7723473|NCT00555620|12148236|FG001|Overall Study|Adverse Event|0
7723474|NCT00555620|12148237|FG002|Overall Study|Adverse Event|1
7723475|NCT00555620|12148238|FG003|Overall Study|Adverse Event|5
7723476|NCT00555620|12148239|FG004|Overall Study|Adverse Event|0
7723477|NCT00555620|12148240|FG005|Overall Study|Adverse Event|1
7723478|NCT00555620|12148235|FG000|Overall Study|Objective progression or relapse|6
7723479|NCT00555620|12148236|FG001|Overall Study|Objective progression or relapse|5
7723480|NCT00555620|12148237|FG002|Overall Study|Objective progression or relapse|12
7723481|NCT00555620|12148238|FG003|Overall Study|Objective progression or relapse|17
7723482|NCT00555620|12148239|FG004|Overall Study|Objective progression or relapse|3
7723483|NCT00555620|12148240|FG005|Overall Study|Objective progression or relapse|16
7723484|NCT00555620|12148235|FG000|Overall Study|Participant refused treatment|0
7723485|NCT00555620|12148236|FG001|Overall Study|Participant refused treatment|1
7723486|NCT00555620|12148237|FG002|Overall Study|Participant refused treatment|1
7723487|NCT00555620|12148238|FG003|Overall Study|Participant refused treatment|0
7723488|NCT00555620|12148239|FG004|Overall Study|Participant refused treatment|0
7723489|NCT00555620|12148240|FG005|Overall Study|Participant refused treatment|1
7723490|NCT00555620|12148235|FG000|Overall Study|Other|0
7723491|NCT00555620|12148236|FG001|Overall Study|Other|0
7723492|NCT00555620|12148237|FG002|Overall Study|Other|0
7723493|NCT00555620|12148238|FG003|Overall Study|Other|1
7723494|NCT00555620|12148239|FG004|Overall Study|Other|0
7723495|NCT00555620|12148240|FG005|Overall Study|Other|3
7723496|NCT00555672|12148260|FG000|Overall Study|Death|0
7723497|NCT00555672|12148261|FG001|Overall Study|Death|2
7723498|NCT00555672|12148260|FG000|Overall Study|Adverse Event|8
7723499|NCT00555672|12148261|FG001|Overall Study|Adverse Event|2
7723500|NCT00555672|12148260|FG000|Overall Study|Objective progression or relapse|11
7723501|NCT00555672|12148261|FG001|Overall Study|Objective progression or relapse|5
7723502|NCT00555672|12148260|FG000|Overall Study|Other|3
7723503|NCT00555672|12148261|FG001|Overall Study|Other|1
7723504|NCT00555672|12148260|FG000|Overall Study|Participant refused|2
7723505|NCT00555672|12148261|FG001|Overall Study|Participant refused|0
7723506|NCT00555906|12148298|FG000|Phase 1|Objective Progression or Relapse|3
7723507|NCT00555906|12148299|FG001|Phase 1|Objective Progression or Relapse|5
7723508|NCT00555906|12148300|FG002|Phase 1|Objective Progression or Relapse|3
7723509|NCT00555906|12148301|FG003|Phase 1|Objective Progression or Relapse|1
7723510|NCT00555906|12148302|FG004|Phase 1|Objective Progression or Relapse|0
7723511|NCT00555906|12148298|FG000|Phase 1|Global Deterioration of Health Status|0
7723512|NCT00555906|12148299|FG001|Phase 1|Global Deterioration of Health Status|1
7723513|NCT00555906|12148300|FG002|Phase 1|Global Deterioration of Health Status|1
7723514|NCT00555906|12148301|FG003|Phase 1|Global Deterioration of Health Status|1
7723515|NCT00555906|12148302|FG004|Phase 1|Global Deterioration of Health Status|0
7723516|NCT00555906|12148298|FG000|Phase 1|Adverse Event|0
7723517|NCT00555906|12148299|FG001|Phase 1|Adverse Event|0
7723518|NCT00555906|12148300|FG002|Phase 1|Adverse Event|3
7723519|NCT00555906|12148301|FG003|Phase 1|Adverse Event|2
7723520|NCT00555906|12148302|FG004|Phase 1|Adverse Event|0
7723521|NCT00555906|12148298|FG000|Phase 1|Withdrawal by Subject|0
7723522|NCT00555906|12148299|FG001|Phase 1|Withdrawal by Subject|0
7723523|NCT00555906|12148300|FG002|Phase 1|Withdrawal by Subject|0
7723524|NCT00555906|12148301|FG003|Phase 1|Withdrawal by Subject|1
7723525|NCT00555906|12148302|FG004|Phase 1|Withdrawal by Subject|0
7723526|NCT00555906|12148298|FG000|Phase 2|Adverse Event|0
7723527|NCT00555906|12148299|FG001|Phase 2|Adverse Event|0
7723528|NCT00555906|12148300|FG002|Phase 2|Adverse Event|0
7723529|NCT00555906|12148301|FG003|Phase 2|Adverse Event|0
7723530|NCT00555906|12148302|FG004|Phase 2|Adverse Event|4
7723531|NCT00555906|12148298|FG000|Phase 2|Global Deterioration of Health Status|0
7723532|NCT00555906|12148299|FG001|Phase 2|Global Deterioration of Health Status|0
7723533|NCT00555906|12148300|FG002|Phase 2|Global Deterioration of Health Status|0
7723534|NCT00555906|12148301|FG003|Phase 2|Global Deterioration of Health Status|0
7723535|NCT00555906|12148302|FG004|Phase 2|Global Deterioration of Health Status|2
7723536|NCT00555906|12148298|FG000|Phase 2|Objective Progression or Relapse|0
7723537|NCT00555906|12148299|FG001|Phase 2|Objective Progression or Relapse|0
7723538|NCT00555906|12148300|FG002|Phase 2|Objective Progression or Relapse|0
7723539|NCT00555906|12148301|FG003|Phase 2|Objective Progression or Relapse|0
7723540|NCT00555906|12148302|FG004|Phase 2|Objective Progression or Relapse|16
7723541|NCT00555906|12148298|FG000|Phase 2|Withdrawal by Subject|0
7723542|NCT00555906|12148299|FG001|Phase 2|Withdrawal by Subject|0
7723543|NCT00555906|12148300|FG002|Phase 2|Withdrawal by Subject|0
7723544|NCT00555906|12148301|FG003|Phase 2|Withdrawal by Subject|0
7723545|NCT00555906|12148302|FG004|Phase 2|Withdrawal by Subject|2
7723546|NCT00555906|12148298|FG000|Phase 2|Other|0
7723547|NCT00555906|12148299|FG001|Phase 2|Other|0
7723548|NCT00555906|12148300|FG002|Phase 2|Other|0
7723549|NCT00555906|12148301|FG003|Phase 2|Other|0
7723550|NCT00555906|12148302|FG004|Phase 2|Other|6
7723551|NCT00555906|12148298|FG000|Phase 2|Randomized but not Treated|0
7723552|NCT00555906|12148299|FG001|Phase 2|Randomized but not Treated|0
7723553|NCT00555906|12148300|FG002|Phase 2|Randomized but not Treated|0
7723554|NCT00555906|12148301|FG003|Phase 2|Randomized but not Treated|0
7723555|NCT00555906|12148302|FG004|Phase 2|Randomized but not Treated|2
7723556|NCT00555971|12148319|FG000|Overall Study|Adverse Event|1
7723557|NCT00555971|12148320|FG001|Overall Study|Adverse Event|1
7723558|NCT00556322|12148354|FG000|Overall Study|Insufficient therapeutic response|158
7723559|NCT00556322|12148355|FG001|Overall Study|Insufficient therapeutic response|168
7723560|NCT00556322|12148354|FG000|Overall Study|Adverse Event|7
7723561|NCT00556322|12148355|FG001|Overall Study|Adverse Event|4
7723562|NCT00556322|12148354|FG000|Overall Study|Other|4
7723563|NCT00556322|12148355|FG001|Overall Study|Other|1
7723564|NCT00556322|12148354|FG000|Overall Study|Lost to Follow-up|5
7723565|NCT00556322|12148355|FG001|Overall Study|Lost to Follow-up|3
7723566|NCT00556322|12148354|FG000|Overall Study|Withdrawal by Subject|19
7723567|NCT00556322|12148355|FG001|Overall Study|Withdrawal by Subject|7
7723568|NCT00556322|12148354|FG000|Overall Study|Protocol Violation|5
7723569|NCT00556322|12148355|FG001|Overall Study|Protocol Violation|1
7723570|NCT00556322|12148354|FG000|Overall Study|Ongoing at data cutoff|3
7723571|NCT00556322|12148355|FG001|Overall Study|Ongoing at data cutoff|5
7723572|NCT00556322|12148354|FG000|Overall Study|Death|20
7723573|NCT00556322|12148355|FG001|Overall Study|Death|14
7723574|NCT00556426|12148364|FG000|Overall Study|Withdrawal by Subject|3
7723575|NCT00556426|12148364|FG000|Overall Study|Death|6
7723576|NCT00556439|12148373|FG000|Study Entry to Week 12|Lack of Efficacy|5
7723577|NCT00556439|12148374|FG001|Study Entry to Week 12|Lack of Efficacy|0
7723578|NCT00556439|12148375|FG002|Study Entry to Week 12|Lack of Efficacy|6
7723579|NCT00556439|12148376|FG003|Study Entry to Week 12|Lack of Efficacy|0
7723580|NCT00556439|12148373|FG000|Study Entry to Week 12|Physician Decision|1
7723581|NCT00556439|12148374|FG001|Study Entry to Week 12|Physician Decision|0
7723582|NCT00556439|12148375|FG002|Study Entry to Week 12|Physician Decision|0
7723583|NCT00556439|12148376|FG003|Study Entry to Week 12|Physician Decision|0
7723584|NCT00556439|12148373|FG000|Study Entry to Week 12|Withdrawal by Subject|1
7723585|NCT00556439|12148374|FG001|Study Entry to Week 12|Withdrawal by Subject|0
7723586|NCT00556439|12148375|FG002|Study Entry to Week 12|Withdrawal by Subject|1
7723587|NCT00556439|12148376|FG003|Study Entry to Week 12|Withdrawal by Subject|0
7723588|NCT00556439|12148373|FG000|Study Entry to Week 12|Recurrent infection|1
7723589|NCT00556439|12148374|FG001|Study Entry to Week 12|Recurrent infection|0
7723590|NCT00556439|12148375|FG002|Study Entry to Week 12|Recurrent infection|0
7723591|NCT00556439|12148376|FG003|Study Entry to Week 12|Recurrent infection|0
7723592|NCT00556439|12148373|FG000|Study Entry to Week 12|Malignancy|0
7723593|NCT00556439|12148374|FG001|Study Entry to Week 12|Malignancy|0
7723594|NCT00556439|12148375|FG002|Study Entry to Week 12|Malignancy|1
7723595|NCT00556439|12148376|FG003|Study Entry to Week 12|Malignancy|0
7723596|NCT00556439|12148373|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
7723597|NCT00556439|12148374|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
7723598|NCT00556439|12148375|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
7723599|NCT00556439|12148376|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
7723600|NCT00556439|12148373|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1
7723601|NCT00556439|12148374|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0
7723602|NCT00556439|12148375|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0
7723603|NCT00556439|12148376|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0
7723604|NCT00556439|12148373|FG000|After Week 12 (Randomized Study Period)|Malignancy|0
7723605|NCT00556439|12148374|FG001|After Week 12 (Randomized Study Period)|Malignancy|1
7723606|NCT00556439|12148375|FG002|After Week 12 (Randomized Study Period)|Malignancy|0
7770369|NCT00876343|12214384|FG001|Overall Study|Adverse Event|8
7723607|NCT00556439|12148376|FG003|After Week 12 (Randomized Study Period)|Malignancy|1
7723608|NCT00556439|12148373|FG000|After Week 12 (Randomized Study Period)|Severe infection|1
7723609|NCT00556439|12148374|FG001|After Week 12 (Randomized Study Period)|Severe infection|0
7723610|NCT00556439|12148375|FG002|After Week 12 (Randomized Study Period)|Severe infection|0
7723611|NCT00556439|12148376|FG003|After Week 12 (Randomized Study Period)|Severe infection|0
7723612|NCT00556673|12148445|FG000|Overall Study|Protocol deviation|3
7723613|NCT00556673|12148446|FG001|Overall Study|Protocol deviation|2
7723614|NCT00556712|12148456|FG000|Overall Study|Adverse Event|7
7723615|NCT00556712|12148457|FG001|Overall Study|Adverse Event|19
7723616|NCT00556712|12148456|FG000|Overall Study|Death|5
7723617|NCT00556712|12148457|FG001|Overall Study|Death|10
7723618|NCT00556712|12148456|FG000|Overall Study|Progressive Disease|383
7723619|NCT00556712|12148457|FG001|Overall Study|Progressive Disease|320
7723620|NCT00556712|12148456|FG000|Overall Study|Protocol Violation|3
7723621|NCT00556712|12148457|FG001|Overall Study|Protocol Violation|2
7723622|NCT00556712|12148456|FG000|Overall Study|Refused Treatment|17
7723623|NCT00556712|12148457|FG001|Overall Study|Refused Treatment|16
7723624|NCT00556712|12148456|FG000|Overall Study|Failure to Return|2
7723625|NCT00556712|12148457|FG001|Overall Study|Failure to Return|3
7723626|NCT00556712|12148456|FG000|Overall Study|Other|2
7723627|NCT00556712|12148457|FG001|Overall Study|Other|2
7723628|NCT00556712|12148456|FG000|Overall Study|Ongoing at Data Cutoff|32
7723629|NCT00556712|12148457|FG001|Overall Study|Ongoing at Data Cutoff|66
7723630|NCT00556894|12148483|FG000|Overall Study|Adverse Event|2
7723631|NCT00556894|12148484|FG001|Overall Study|Adverse Event|3
7723632|NCT00556894|12148485|FG002|Overall Study|Adverse Event|3
7723633|NCT00556894|12148483|FG000|Overall Study|Death|1
7723634|NCT00556894|12148484|FG001|Overall Study|Death|0
7723635|NCT00556894|12148485|FG002|Overall Study|Death|0
7723636|NCT00556894|12148483|FG000|Overall Study|regulatory decision in Bulgaria|10
7723637|NCT00556894|12148484|FG001|Overall Study|regulatory decision in Bulgaria|14
7723638|NCT00556894|12148485|FG002|Overall Study|regulatory decision in Bulgaria|13
7723639|NCT00556894|12148483|FG000|Overall Study|Change in therapy|2
7723640|NCT00556894|12148484|FG001|Overall Study|Change in therapy|1
7723641|NCT00556894|12148485|FG002|Overall Study|Change in therapy|2
7723642|NCT00556894|12148483|FG000|Overall Study|Withdrawal by Subject|1
7723643|NCT00556894|12148484|FG001|Overall Study|Withdrawal by Subject|1
7723644|NCT00556894|12148485|FG002|Overall Study|Withdrawal by Subject|1
7723645|NCT00556933|12148497|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2
7723646|NCT00556933|12148498|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3
7723647|NCT00556933|12148499|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3
7723648|NCT00556933|12148500|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0
7723649|NCT00556933|12148497|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
7723650|NCT00556933|12148498|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
7723651|NCT00556933|12148499|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
7723652|NCT00556933|12148500|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
7723653|NCT00556933|12148497|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
7723654|NCT00556933|12148498|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
7723655|NCT00556933|12148499|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
7723656|NCT00556933|12148500|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
7723657|NCT00556933|12148497|FG000|Single vs. Divided-dose rATG Induction|Death|0
7723658|NCT00556933|12148498|FG001|Single vs. Divided-dose rATG Induction|Death|1
7723659|NCT00556933|12148499|FG002|Single vs. Divided-dose rATG Induction|Death|0
7723660|NCT00556933|12148500|FG003|Single vs. Divided-dose rATG Induction|Death|0
7723661|NCT00556933|12148497|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
7723662|NCT00556933|12148498|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
7723663|NCT00556933|12148499|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
7723664|NCT00556933|12148500|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
7723665|NCT00556933|12148497|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
7723666|NCT00556933|12148498|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
7723667|NCT00556933|12148499|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
7723668|NCT00556933|12148500|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
7723669|NCT00556933|12148497|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
7723670|NCT00556933|12148498|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
7723671|NCT00556933|12148499|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
7723672|NCT00556933|12148500|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
7723673|NCT00556933|12148497|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
7723674|NCT00556933|12148498|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
7723675|NCT00556933|12148499|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
7723676|NCT00556933|12148500|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
7723677|NCT00556933|12148497|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
7723678|NCT00556933|12148498|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
7723679|NCT00556933|12148499|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
7723680|NCT00556933|12148500|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
7723681|NCT00556933|12148497|FG000|CNI Withdrawal vs. Minimization|Graft loss|0
7723682|NCT00556933|12148498|FG001|CNI Withdrawal vs. Minimization|Graft loss|1
7723683|NCT00556933|12148499|FG002|CNI Withdrawal vs. Minimization|Graft loss|2
7723684|NCT00556933|12148500|FG003|CNI Withdrawal vs. Minimization|Graft loss|0
7723685|NCT00556933|12148497|FG000|CNI Withdrawal vs. Minimization|Death|0
7723686|NCT00556933|12148498|FG001|CNI Withdrawal vs. Minimization|Death|0
7723687|NCT00556933|12148499|FG002|CNI Withdrawal vs. Minimization|Death|0
7723688|NCT00556933|12148500|FG003|CNI Withdrawal vs. Minimization|Death|1
7723689|NCT00556998|12148527|FG000|Voriconazole Intravenous (IV)|Adverse Event|1
7723690|NCT00556998|12148527|FG000|Voriconazole Intravenous (IV)|Other|4
7723691|NCT00556998|12148527|FG000|Voriconazole Oral|Adverse Event|1
7723692|NCT00556998|12148527|FG000|Voriconazole Oral|Intolerant of oral treatment|1
7723693|NCT00557076|12148537|FG000|Overall Study|Unblinding|0
7723694|NCT00557076|12148538|FG001|Overall Study|Unblinding|1
7723695|NCT00557245|12148547|FG000|Overall Study|Lost to Follow-up|7
7723696|NCT00557245|12148548|FG001|Overall Study|Lost to Follow-up|8
7723697|NCT00557245|12148549|FG002|Overall Study|Lost to Follow-up|10
7723698|NCT00557245|12148547|FG000|Overall Study|Ineligible|5
7723699|NCT00557245|12148548|FG001|Overall Study|Ineligible|4
7723700|NCT00557245|12148549|FG002|Overall Study|Ineligible|2
7723701|NCT00557310|12148569|FG000|Main Study (0 - 18 Months)|Adverse Event|4
7723702|NCT00557310|12148569|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1
7723703|NCT00557310|12148569|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1
7723704|NCT00557310|12148569|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
7723705|NCT00557310|12148569|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2
7723706|NCT00557310|12148569|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1
7723707|NCT00557323|12148573|FG000|Overall Study|Death|3
7723708|NCT00557323|12148573|FG000|Overall Study|Withdrawal by Subject|2
7723709|NCT00557323|12148573|FG000|Overall Study|Administrative change|2
7723710|NCT00557440|12148609|FG000|Treatment Period 1|Adverse Event|0
7723711|NCT00557440|12148610|FG001|Treatment Period 1|Adverse Event|0
7723712|NCT00557440|12148611|FG002|Treatment Period 1|Adverse Event|1
7723713|NCT00557466|12148625|FG000|Overall Study|Adverse Event|3
7723714|NCT00557466|12148626|FG001|Overall Study|Adverse Event|1
7723715|NCT00557466|12148627|FG002|Overall Study|Adverse Event|4
7723716|NCT00557466|12148628|FG003|Overall Study|Adverse Event|1
7723717|NCT00557466|12148629|FG004|Overall Study|Adverse Event|2
7723718|NCT00557466|12148630|FG005|Overall Study|Adverse Event|4
7723719|NCT00557466|12148625|FG000|Overall Study|Abnormal laboratory value(s)|1
7723720|NCT00557466|12148626|FG001|Overall Study|Abnormal laboratory value(s)|2
7723721|NCT00557466|12148627|FG002|Overall Study|Abnormal laboratory value(s)|0
7723722|NCT00557466|12148628|FG003|Overall Study|Abnormal laboratory value(s)|0
7723723|NCT00557466|12148629|FG004|Overall Study|Abnormal laboratory value(s)|0
7723724|NCT00557466|12148630|FG005|Overall Study|Abnormal laboratory value(s)|0
7723725|NCT00557466|12148625|FG000|Overall Study|Protocol deviation|0
7723726|NCT00557466|12148626|FG001|Overall Study|Protocol deviation|1
7723727|NCT00557466|12148627|FG002|Overall Study|Protocol deviation|0
7723728|NCT00557466|12148628|FG003|Overall Study|Protocol deviation|2
7723729|NCT00557466|12148629|FG004|Overall Study|Protocol deviation|0
7723730|NCT00557466|12148630|FG005|Overall Study|Protocol deviation|0
7723731|NCT00557466|12148625|FG000|Overall Study|Subject withdrew consent|0
7723732|NCT00557466|12148626|FG001|Overall Study|Subject withdrew consent|0
7723733|NCT00557466|12148627|FG002|Overall Study|Subject withdrew consent|0
7723734|NCT00557466|12148628|FG003|Overall Study|Subject withdrew consent|0
7723735|NCT00557466|12148629|FG004|Overall Study|Subject withdrew consent|1
7723736|NCT00557466|12148630|FG005|Overall Study|Subject withdrew consent|2
7723737|NCT00557466|12148625|FG000|Overall Study|Administrative problems|0
7723738|NCT00557466|12148626|FG001|Overall Study|Administrative problems|1
7723739|NCT00557466|12148627|FG002|Overall Study|Administrative problems|1
7723740|NCT00557466|12148628|FG003|Overall Study|Administrative problems|0
7723741|NCT00557466|12148629|FG004|Overall Study|Administrative problems|0
7723742|NCT00557466|12148630|FG005|Overall Study|Administrative problems|0
7723743|NCT00557466|12148625|FG000|Overall Study|Abnormal test procedure results|0
7723744|NCT00557466|12148626|FG001|Overall Study|Abnormal test procedure results|0
7723745|NCT00557466|12148627|FG002|Overall Study|Abnormal test procedure results|1
7723746|NCT00557466|12148628|FG003|Overall Study|Abnormal test procedure results|0
7723747|NCT00557466|12148629|FG004|Overall Study|Abnormal test procedure results|0
7723748|NCT00557466|12148630|FG005|Overall Study|Abnormal test procedure results|0
7723749|NCT00557466|12148625|FG000|Overall Study|Lost to Follow-up|0
7723750|NCT00557466|12148626|FG001|Overall Study|Lost to Follow-up|0
7723751|NCT00557466|12148627|FG002|Overall Study|Lost to Follow-up|0
7723752|NCT00557466|12148628|FG003|Overall Study|Lost to Follow-up|1
7723753|NCT00557466|12148629|FG004|Overall Study|Lost to Follow-up|0
7723754|NCT00557466|12148630|FG005|Overall Study|Lost to Follow-up|0
7723755|NCT00557492|12148644|FG000|Overall Study|Change in health insurance|1
7723756|NCT00557505|12148657|FG000|Overall Study|Death|0
7723757|NCT00557505|12148658|FG001|Overall Study|Death|0
7723758|NCT00557505|12148659|FG002|Overall Study|Death|0
7723759|NCT00557505|12148660|FG003|Overall Study|Death|0
7723760|NCT00557505|12148661|FG004|Overall Study|Death|0
7723761|NCT00557505|12148662|FG005|Overall Study|Death|0
7723762|NCT00557505|12148663|FG006|Overall Study|Death|0
7723763|NCT00557505|12148664|FG007|Overall Study|Death|0
7723764|NCT00557505|12148665|FG008|Overall Study|Death|1
7723765|NCT00557505|12148657|FG000|Overall Study|Adverse Event|0
7723766|NCT00557505|12148658|FG001|Overall Study|Adverse Event|0
7723767|NCT00557505|12148659|FG002|Overall Study|Adverse Event|1
7723768|NCT00557505|12148660|FG003|Overall Study|Adverse Event|0
7723769|NCT00557505|12148661|FG004|Overall Study|Adverse Event|0
7723770|NCT00557505|12148662|FG005|Overall Study|Adverse Event|0
7723771|NCT00557505|12148663|FG006|Overall Study|Adverse Event|1
7723772|NCT00557505|12148664|FG007|Overall Study|Adverse Event|0
7723773|NCT00557505|12148665|FG008|Overall Study|Adverse Event|0
7723774|NCT00557505|12148657|FG000|Overall Study|Global deterioration of health|1
7723775|NCT00557505|12148658|FG001|Overall Study|Global deterioration of health|0
7723776|NCT00557505|12148659|FG002|Overall Study|Global deterioration of health|0
7723777|NCT00557505|12148660|FG003|Overall Study|Global deterioration of health|0
7723778|NCT00557505|12148661|FG004|Overall Study|Global deterioration of health|0
7723779|NCT00557505|12148662|FG005|Overall Study|Global deterioration of health|0
7723780|NCT00557505|12148663|FG006|Overall Study|Global deterioration of health|0
7723781|NCT00557505|12148664|FG007|Overall Study|Global deterioration of health|0
7723782|NCT00557505|12148665|FG008|Overall Study|Global deterioration of health|0
7723783|NCT00557505|12148657|FG000|Overall Study|Objective progression or relapse|2
7723784|NCT00557505|12148658|FG001|Overall Study|Objective progression or relapse|3
7723785|NCT00557505|12148659|FG002|Overall Study|Objective progression or relapse|3
7723786|NCT00557505|12148660|FG003|Overall Study|Objective progression or relapse|2
7723787|NCT00557505|12148661|FG004|Overall Study|Objective progression or relapse|2
7723788|NCT00557505|12148662|FG005|Overall Study|Objective progression or relapse|3
7723789|NCT00557505|12148663|FG006|Overall Study|Objective progression or relapse|2
7723790|NCT00557505|12148664|FG007|Overall Study|Objective progression or relapse|5
7723791|NCT00557505|12148665|FG008|Overall Study|Objective progression or relapse|15
7723792|NCT00557505|12148657|FG000|Overall Study|Withdrawal by Subject|0
7723793|NCT00557505|12148658|FG001|Overall Study|Withdrawal by Subject|0
7723794|NCT00557505|12148659|FG002|Overall Study|Withdrawal by Subject|0
7723795|NCT00557505|12148660|FG003|Overall Study|Withdrawal by Subject|1
7723796|NCT00557505|12148661|FG004|Overall Study|Withdrawal by Subject|0
7723797|NCT00557505|12148662|FG005|Overall Study|Withdrawal by Subject|0
7723798|NCT00557505|12148663|FG006|Overall Study|Withdrawal by Subject|0
7723799|NCT00557505|12148664|FG007|Overall Study|Withdrawal by Subject|0
7723800|NCT00557505|12148665|FG008|Overall Study|Withdrawal by Subject|1
7723801|NCT00557622|12148690|FG000|4-Week Run-in Phase|Withdrawal by Subject|1
7723802|NCT00557622|12148691|FG001|4-Week Run-in Phase|Withdrawal by Subject|0
7723803|NCT00557622|12148690|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1
7723804|NCT00557622|12148691|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0
7723805|NCT00557622|12148690|FG000|12-Week Treatment Phase|Lost to Follow-up|0
7723806|NCT00557622|12148691|FG001|12-Week Treatment Phase|Lost to Follow-up|1
7723807|NCT00557830|12148700|FG000|Screening Treatment Phase|Withdrawal by Subject|1
7723808|NCT00557830|12148701|FG001|Screening Treatment Phase|Withdrawal by Subject|0
7723809|NCT00557830|12148702|FG002|Screening Treatment Phase|Withdrawal by Subject|0
7723810|NCT00557830|12148700|FG000|Screening Treatment Phase|Adverse Event|2
7723811|NCT00557830|12148701|FG001|Screening Treatment Phase|Adverse Event|0
7723812|NCT00557830|12148702|FG002|Screening Treatment Phase|Adverse Event|0
7723813|NCT00557830|12148700|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3
7723814|NCT00557830|12148701|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0
7723815|NCT00557830|12148702|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0
7723816|NCT00557856|12148710|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3
7723817|NCT00557856|12148711|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5
7723818|NCT00557856|12148712|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3
7723819|NCT00557856|12148713|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1
7723820|NCT00557856|12148714|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3
7723821|NCT00557856|12148715|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2
7723822|NCT00557856|12148716|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5
7723823|NCT00557856|12148717|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3
7723824|NCT00557856|12148718|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0
7723825|NCT00557856|12148710|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
7723826|NCT00557856|12148711|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7723827|NCT00557856|12148712|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
7723828|NCT00557856|12148713|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7723829|NCT00557856|12148714|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7723830|NCT00557856|12148715|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7723831|NCT00557856|12148716|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7723832|NCT00557856|12148717|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7723833|NCT00557856|12148718|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7723834|NCT00557856|12148710|FG000|Part 1: Dose Escalation Phase|Adverse Event|1
7723835|NCT00557856|12148711|FG001|Part 1: Dose Escalation Phase|Adverse Event|0
7723836|NCT00557856|12148712|FG002|Part 1: Dose Escalation Phase|Adverse Event|1
7723837|NCT00557856|12148713|FG003|Part 1: Dose Escalation Phase|Adverse Event|1
7723838|NCT00557856|12148714|FG004|Part 1: Dose Escalation Phase|Adverse Event|1
7723839|NCT00557856|12148715|FG005|Part 1: Dose Escalation Phase|Adverse Event|3
7723840|NCT00557856|12148716|FG006|Part 1: Dose Escalation Phase|Adverse Event|1
7723841|NCT00557856|12148717|FG007|Part 1: Dose Escalation Phase|Adverse Event|2
7723842|NCT00557856|12148718|FG008|Part 1: Dose Escalation Phase|Adverse Event|0
7723843|NCT00557856|12148710|FG000|Part 1: Dose Escalation Phase|Other|0
7723844|NCT00557856|12148711|FG001|Part 1: Dose Escalation Phase|Other|0
7723845|NCT00557856|12148712|FG002|Part 1: Dose Escalation Phase|Other|1
7723846|NCT00557856|12148713|FG003|Part 1: Dose Escalation Phase|Other|1
7723847|NCT00557856|12148714|FG004|Part 1: Dose Escalation Phase|Other|0
7723848|NCT00557856|12148715|FG005|Part 1: Dose Escalation Phase|Other|0
7723849|NCT00557856|12148716|FG006|Part 1: Dose Escalation Phase|Other|0
7723850|NCT00557856|12148717|FG007|Part 1: Dose Escalation Phase|Other|1
7723851|NCT00557856|12148718|FG008|Part 1: Dose Escalation Phase|Other|0
7723852|NCT00557856|12148710|FG000|Part 1: Dose Escalation Phase|Death|0
7723853|NCT00557856|12148711|FG001|Part 1: Dose Escalation Phase|Death|0
7723854|NCT00557856|12148712|FG002|Part 1: Dose Escalation Phase|Death|0
7723855|NCT00557856|12148713|FG003|Part 1: Dose Escalation Phase|Death|0
7723856|NCT00557856|12148714|FG004|Part 1: Dose Escalation Phase|Death|0
7723857|NCT00557856|12148715|FG005|Part 1: Dose Escalation Phase|Death|1
7723858|NCT00557856|12148716|FG006|Part 1: Dose Escalation Phase|Death|0
7723859|NCT00557856|12148717|FG007|Part 1: Dose Escalation Phase|Death|0
7723860|NCT00557856|12148718|FG008|Part 1: Dose Escalation Phase|Death|0
7723861|NCT00557856|12148710|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0
7723862|NCT00557856|12148711|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0
7723863|NCT00557856|12148712|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0
7723864|NCT00557856|12148713|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0
7723865|NCT00557856|12148714|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0
7723866|NCT00557856|12148715|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2
7723867|NCT00557856|12148716|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1
7723868|NCT00557856|12148717|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0
7723869|NCT00557856|12148718|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0
7723870|NCT00557856|12148710|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2
7723871|NCT00557856|12148711|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0
7723872|NCT00557856|12148712|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0
7723873|NCT00557856|12148713|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0
7723874|NCT00557856|12148714|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0
7723875|NCT00557856|12148715|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0
7723876|NCT00557856|12148716|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0
7723877|NCT00557856|12148717|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0
7723878|NCT00557856|12148718|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0
7723879|NCT00557856|12148710|FG000|Part 2: Exploratory Phase|objective progression or relapse|0
7723880|NCT00557856|12148711|FG001|Part 2: Exploratory Phase|objective progression or relapse|0
7723881|NCT00557856|12148712|FG002|Part 2: Exploratory Phase|objective progression or relapse|0
7723882|NCT00557856|12148713|FG003|Part 2: Exploratory Phase|objective progression or relapse|0
7723883|NCT00557856|12148714|FG004|Part 2: Exploratory Phase|objective progression or relapse|0
7723884|NCT00557856|12148715|FG005|Part 2: Exploratory Phase|objective progression or relapse|0
7723885|NCT00557856|12148716|FG006|Part 2: Exploratory Phase|objective progression or relapse|0
7723886|NCT00557856|12148717|FG007|Part 2: Exploratory Phase|objective progression or relapse|0
7723887|NCT00557856|12148718|FG008|Part 2: Exploratory Phase|objective progression or relapse|15
7723888|NCT00557856|12148710|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0
7723889|NCT00557856|12148711|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0
7723890|NCT00557856|12148712|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0
7723891|NCT00557856|12148713|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0
7723892|NCT00557856|12148714|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0
7723893|NCT00557856|12148715|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0
7723894|NCT00557856|12148716|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0
7723895|NCT00557856|12148717|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0
7723896|NCT00557856|12148718|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1
7723897|NCT00557856|12148710|FG000|Part 2: Exploratory Phase|Adverse Event|0
7723898|NCT00557856|12148711|FG001|Part 2: Exploratory Phase|Adverse Event|0
7723899|NCT00557856|12148712|FG002|Part 2: Exploratory Phase|Adverse Event|0
7723900|NCT00557856|12148713|FG003|Part 2: Exploratory Phase|Adverse Event|0
7723901|NCT00557856|12148714|FG004|Part 2: Exploratory Phase|Adverse Event|0
7723902|NCT00557856|12148715|FG005|Part 2: Exploratory Phase|Adverse Event|0
7723903|NCT00557856|12148716|FG006|Part 2: Exploratory Phase|Adverse Event|0
7723904|NCT00557856|12148717|FG007|Part 2: Exploratory Phase|Adverse Event|0
7723905|NCT00557856|12148718|FG008|Part 2: Exploratory Phase|Adverse Event|4
7723906|NCT00557856|12148710|FG000|Part 2: Exploratory Phase|Other|0
7723907|NCT00557856|12148711|FG001|Part 2: Exploratory Phase|Other|0
7723908|NCT00557856|12148712|FG002|Part 2: Exploratory Phase|Other|0
7723909|NCT00557856|12148713|FG003|Part 2: Exploratory Phase|Other|0
7723910|NCT00557856|12148714|FG004|Part 2: Exploratory Phase|Other|0
7723911|NCT00557856|12148715|FG005|Part 2: Exploratory Phase|Other|0
7723912|NCT00557856|12148716|FG006|Part 2: Exploratory Phase|Other|0
7723913|NCT00557856|12148717|FG007|Part 2: Exploratory Phase|Other|0
7723914|NCT00557856|12148718|FG008|Part 2: Exploratory Phase|Other|1
7723915|NCT00557856|12148710|FG000|Part 2: Exploratory Phase|Death|0
7723916|NCT00557856|12148711|FG001|Part 2: Exploratory Phase|Death|0
7723917|NCT00557856|12148712|FG002|Part 2: Exploratory Phase|Death|0
7723918|NCT00557856|12148713|FG003|Part 2: Exploratory Phase|Death|0
7723919|NCT00557856|12148714|FG004|Part 2: Exploratory Phase|Death|0
7723920|NCT00557856|12148715|FG005|Part 2: Exploratory Phase|Death|0
7723921|NCT00557856|12148716|FG006|Part 2: Exploratory Phase|Death|0
7723922|NCT00557856|12148717|FG007|Part 2: Exploratory Phase|Death|0
7723923|NCT00557856|12148718|FG008|Part 2: Exploratory Phase|Death|2
7723924|NCT00557856|12148710|FG000|Part 2: Exploratory Phase|global deterioration of health status|0
7723925|NCT00557856|12148711|FG001|Part 2: Exploratory Phase|global deterioration of health status|0
7723926|NCT00557856|12148712|FG002|Part 2: Exploratory Phase|global deterioration of health status|0
7723927|NCT00557856|12148713|FG003|Part 2: Exploratory Phase|global deterioration of health status|0
7723928|NCT00557856|12148714|FG004|Part 2: Exploratory Phase|global deterioration of health status|0
7723929|NCT00557856|12148715|FG005|Part 2: Exploratory Phase|global deterioration of health status|0
7723930|NCT00557856|12148716|FG006|Part 2: Exploratory Phase|global deterioration of health status|0
7723931|NCT00557856|12148717|FG007|Part 2: Exploratory Phase|global deterioration of health status|0
7723932|NCT00557856|12148718|FG008|Part 2: Exploratory Phase|global deterioration of health status|1
7767945|NCT00856635|12210773|FG000|Overall Study|Discontinued at Randomization|2
7767946|NCT00856635|12210774|FG001|Overall Study|Discontinued at Randomization|2
7767947|NCT00856661|12210784|FG000|Overall Study|Death|15
7767948|NCT00856661|12210785|FG001|Overall Study|Death|18
7767949|NCT00856661|12210784|FG000|Overall Study|Protocol Violation|2
7767950|NCT00856661|12210785|FG001|Overall Study|Protocol Violation|1
7767951|NCT00856661|12210784|FG000|Overall Study|Withdrawal by Subject|1
7767952|NCT00856661|12210785|FG001|Overall Study|Withdrawal by Subject|2
7767953|NCT00856661|12210784|FG000|Overall Study|Lost to Follow-up|1
7767954|NCT00856661|12210785|FG001|Overall Study|Lost to Follow-up|3
7767955|NCT00856661|12210784|FG000|Overall Study|Physician Judgement|8
7767956|NCT00856661|12210785|FG001|Overall Study|Physician Judgement|5
7767957|NCT00856778|12210811|FG000|Overall Study|Adverse Event|7
7767958|NCT00856778|12210811|FG000|Overall Study|Withdrawal by Subject|10
7767959|NCT00856778|12210811|FG000|Overall Study|Study deviation|2
7767960|NCT00856778|12210811|FG000|Overall Study|Lost to Follow-up|5
7767961|NCT00856830|12210823|FG000|Irinotecan & Bendamustine|Death|0
7767962|NCT00856830|12210824|FG001|Irinotecan & Bendamustine|Death|0
7767963|NCT00856830|12210825|FG002|Irinotecan & Bendamustine|Death|0
7767964|NCT00856830|12210826|FG003|Irinotecan & Bendamustine|Death|2
7767965|NCT00856830|12210823|FG000|Irinotecan & Bendamustine|Physician Decision|0
7767966|NCT00856830|12210824|FG001|Irinotecan & Bendamustine|Physician Decision|0
7767967|NCT00856830|12210825|FG002|Irinotecan & Bendamustine|Physician Decision|0
7767968|NCT00856830|12210826|FG003|Irinotecan & Bendamustine|Physician Decision|1
7767969|NCT00856843|12210833|FG000|Overall Study|Withdrawal by Subject|1
7767970|NCT00856843|12210834|FG001|Overall Study|Withdrawal by Subject|5
7767971|NCT00856843|12210833|FG000|Overall Study|Lack of Efficacy|1
7767972|NCT00856843|12210834|FG001|Overall Study|Lack of Efficacy|0
7767973|NCT00856856|12210840|FG000|2-year Clinical Follow-up|Lost to Follow-up|1
7767974|NCT00856856|12210840|FG000|4-year Clinical Follow-up|Missed visit|1
7767975|NCT00856908|12210851|FG000|Overall Study|Lost to Follow-up|1
7767976|NCT00856908|12210852|FG001|Overall Study|Lost to Follow-up|0
7767977|NCT00856973|12210861|FG000|Overall Study|Adverse Event|5
7767978|NCT00856973|12210862|FG001|Overall Study|Adverse Event|5
7767979|NCT00856973|12210863|FG002|Overall Study|Adverse Event|3
7767980|NCT00856973|12210861|FG000|Overall Study|Lost to Follow-up|6
7767981|NCT00856973|12210862|FG001|Overall Study|Lost to Follow-up|3
7767982|NCT00856973|12210863|FG002|Overall Study|Lost to Follow-up|5
7767983|NCT00856973|12210861|FG000|Overall Study|Physician Decision|0
7767984|NCT00856973|12210862|FG001|Overall Study|Physician Decision|3
7767985|NCT00856973|12210863|FG002|Overall Study|Physician Decision|1
7767986|NCT00856973|12210861|FG000|Overall Study|Protocol Violation|1
7767987|NCT00856973|12210862|FG001|Overall Study|Protocol Violation|2
7767988|NCT00856973|12210863|FG002|Overall Study|Protocol Violation|1
7767989|NCT00856973|12210861|FG000|Overall Study|Withdrawal by Subject|13
7767990|NCT00856973|12210862|FG001|Overall Study|Withdrawal by Subject|16
7767991|NCT00856973|12210863|FG002|Overall Study|Withdrawal by Subject|15
7767992|NCT00856973|12210861|FG000|Overall Study|Other|11
7767993|NCT00856973|12210862|FG001|Overall Study|Other|12
7767994|NCT00856973|12210863|FG002|Overall Study|Other|13
7767995|NCT00856986|12210880|FG000|Run-in Period, Weeks -12-0|Adverse Event|0
7767996|NCT00856986|12210881|FG001|Run-in Period, Weeks -12-0|Adverse Event|0
7767997|NCT00856986|12210882|FG002|Run-in Period, Weeks -12-0|Adverse Event|0
7767998|NCT00856986|12210883|FG003|Run-in Period, Weeks -12-0|Adverse Event|92
7767999|NCT00856986|12210884|FG004|Run-in Period, Weeks -12-0|Adverse Event|0
7768000|NCT00856986|12210880|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0
7768001|NCT00856986|12210881|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0
7768002|NCT00856986|12210882|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0
7768003|NCT00856986|12210883|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24
7768004|NCT00856986|12210884|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0
7768005|NCT00856986|12210880|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
7768006|NCT00856986|12210881|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
7768007|NCT00856986|12210882|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
7768008|NCT00856986|12210883|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
7723933|NCT00558025|12148761|FG000|Overall Study|Adverse Event|1
7723934|NCT00558025|12148762|FG001|Overall Study|Adverse Event|1
7723935|NCT00558025|12148761|FG000|Overall Study|Withdrawal by Subject|2
7723936|NCT00558025|12148762|FG001|Overall Study|Withdrawal by Subject|2
7723937|NCT00558025|12148761|FG000|Overall Study|Protocol Violation|1
7723938|NCT00558025|12148762|FG001|Overall Study|Protocol Violation|0
7723939|NCT00558064|12148770|FG000|Overall Study|Adverse Event|3
7723940|NCT00558064|12148771|FG001|Overall Study|Adverse Event|2
7723941|NCT00558064|12148770|FG000|Overall Study|Lack of Efficacy|0
7723942|NCT00558064|12148771|FG001|Overall Study|Lack of Efficacy|1
7723943|NCT00558064|12148770|FG000|Overall Study|Protocol Violation|1
7723944|NCT00558064|12148771|FG001|Overall Study|Protocol Violation|0
7723945|NCT00558064|12148770|FG000|Overall Study|Lost to Follow-up|0
7723946|NCT00558064|12148771|FG001|Overall Study|Lost to Follow-up|1
7723947|NCT00558064|12148770|FG000|Overall Study|Withdrawal by Subject|0
7723948|NCT00558064|12148771|FG001|Overall Study|Withdrawal by Subject|1
7723949|NCT00558064|12148770|FG000|Overall Study|No visit within allowance period|1
7723950|NCT00558064|12148771|FG001|Overall Study|No visit within allowance period|0
7723951|NCT00558103|12148782|FG000|Randomized Treatment Phase|Lost to Follow-up|2
7723952|NCT00558103|12148783|FG001|Randomized Treatment Phase|Lost to Follow-up|2
7723953|NCT00558103|12148784|FG002|Randomized Treatment Phase|Lost to Follow-up|2
7723954|NCT00558103|12148785|FG003|Randomized Treatment Phase|Lost to Follow-up|1
7723955|NCT00558103|12148786|FG004|Randomized Treatment Phase|Lost to Follow-up|3
7723956|NCT00558103|12148787|FG005|Randomized Treatment Phase|Lost to Follow-up|0
7723957|NCT00558103|12148782|FG000|Randomized Treatment Phase|Withdrawal by Subject|2
7723958|NCT00558103|12148783|FG001|Randomized Treatment Phase|Withdrawal by Subject|2
7723959|NCT00558103|12148784|FG002|Randomized Treatment Phase|Withdrawal by Subject|0
7723960|NCT00558103|12148785|FG003|Randomized Treatment Phase|Withdrawal by Subject|0
7723961|NCT00558103|12148786|FG004|Randomized Treatment Phase|Withdrawal by Subject|1
7723962|NCT00558103|12148787|FG005|Randomized Treatment Phase|Withdrawal by Subject|0
7723963|NCT00558103|12148782|FG000|Randomized Treatment Phase|Disease Progression|1
7723964|NCT00558103|12148783|FG001|Randomized Treatment Phase|Disease Progression|0
7723965|NCT00558103|12148784|FG002|Randomized Treatment Phase|Disease Progression|1
7723966|NCT00558103|12148785|FG003|Randomized Treatment Phase|Disease Progression|0
7723967|NCT00558103|12148786|FG004|Randomized Treatment Phase|Disease Progression|0
7723968|NCT00558103|12148787|FG005|Randomized Treatment Phase|Disease Progression|0
7723969|NCT00558103|12148782|FG000|Randomized Treatment Phase|Adverse Event|0
7723970|NCT00558103|12148783|FG001|Randomized Treatment Phase|Adverse Event|0
7723971|NCT00558103|12148784|FG002|Randomized Treatment Phase|Adverse Event|0
7723972|NCT00558103|12148785|FG003|Randomized Treatment Phase|Adverse Event|1
7723973|NCT00558103|12148786|FG004|Randomized Treatment Phase|Adverse Event|1
7723974|NCT00558103|12148787|FG005|Randomized Treatment Phase|Adverse Event|0
7723975|NCT00558103|12148782|FG000|Monotherapy Extension Phase|Protocol Violation|0
7723976|NCT00558103|12148783|FG001|Monotherapy Extension Phase|Protocol Violation|0
7723977|NCT00558103|12148784|FG002|Monotherapy Extension Phase|Protocol Violation|0
7723978|NCT00558103|12148785|FG003|Monotherapy Extension Phase|Protocol Violation|0
7723979|NCT00558103|12148786|FG004|Monotherapy Extension Phase|Protocol Violation|0
7723980|NCT00558103|12148787|FG005|Monotherapy Extension Phase|Protocol Violation|1
7723981|NCT00558103|12148782|FG000|Monotherapy Extension Phase|Disease Progression|0
7723982|NCT00558103|12148783|FG001|Monotherapy Extension Phase|Disease Progression|0
7723983|NCT00558103|12148784|FG002|Monotherapy Extension Phase|Disease Progression|0
7723984|NCT00558103|12148785|FG003|Monotherapy Extension Phase|Disease Progression|0
7723985|NCT00558103|12148786|FG004|Monotherapy Extension Phase|Disease Progression|0
7723986|NCT00558103|12148787|FG005|Monotherapy Extension Phase|Disease Progression|8
7723987|NCT00558259|12148809|FG000|Overall Study|Adverse Event|50
7723988|NCT00558259|12148810|FG001|Overall Study|Adverse Event|81
7723989|NCT00558259|12148809|FG000|Overall Study|Protocol Violation|9
7723990|NCT00558259|12148810|FG001|Overall Study|Protocol Violation|5
7723991|NCT00558259|12148809|FG000|Overall Study|Withdrawal by Subject|12
7723992|NCT00558259|12148810|FG001|Overall Study|Withdrawal by Subject|13
7723993|NCT00558272|12148818|FG000|Overall Study|Adverse Event|10
7723994|NCT00558272|12148819|FG001|Overall Study|Adverse Event|0
7723995|NCT00558272|12148818|FG000|Overall Study|Death|1
7723996|NCT00558272|12148819|FG001|Overall Study|Death|0
7723997|NCT00558272|12148818|FG000|Overall Study|Dev. of study specific discon. criteria|1
7723998|NCT00558272|12148819|FG001|Overall Study|Dev. of study specific discon. criteria|0
7723999|NCT00558272|12148818|FG000|Overall Study|AZ study team decision|0
7724000|NCT00558272|12148819|FG001|Overall Study|AZ study team decision|1
7724001|NCT00558272|12148818|FG000|Overall Study|Incorrectly enrolled|1
7724002|NCT00558272|12148819|FG001|Overall Study|Incorrectly enrolled|0
7724003|NCT00558272|12148818|FG000|Overall Study|Withdrawal by Subject|0
7724004|NCT00558272|12148819|FG001|Overall Study|Withdrawal by Subject|1
7724005|NCT00558285|12148830|FG000|Overall Study|Adverse Event|1
7724006|NCT00558285|12148831|FG001|Overall Study|Adverse Event|1
7724007|NCT00558285|12148832|FG002|Overall Study|Adverse Event|4
7724008|NCT00558285|12148833|FG003|Overall Study|Adverse Event|1
7724009|NCT00558285|12148834|FG004|Overall Study|Adverse Event|2
7724010|NCT00558285|12148830|FG000|Overall Study|Abnormal test procedure result(s)|1
7724011|NCT00558285|12148831|FG001|Overall Study|Abnormal test procedure result(s)|0
7724012|NCT00558285|12148832|FG002|Overall Study|Abnormal test procedure result(s)|0
7724013|NCT00558285|12148833|FG003|Overall Study|Abnormal test procedure result(s)|0
7724014|NCT00558285|12148834|FG004|Overall Study|Abnormal test procedure result(s)|0
7724015|NCT00558285|12148830|FG000|Overall Study|Subject withdrew consent|2
7724016|NCT00558285|12148831|FG001|Overall Study|Subject withdrew consent|0
7724017|NCT00558285|12148832|FG002|Overall Study|Subject withdrew consent|1
7724018|NCT00558285|12148833|FG003|Overall Study|Subject withdrew consent|1
7724019|NCT00558285|12148834|FG004|Overall Study|Subject withdrew consent|1
7724020|NCT00558285|12148830|FG000|Overall Study|Lost to Follow-up|1
7724021|NCT00558285|12148831|FG001|Overall Study|Lost to Follow-up|1
7724022|NCT00558285|12148832|FG002|Overall Study|Lost to Follow-up|0
7724023|NCT00558285|12148833|FG003|Overall Study|Lost to Follow-up|0
7724024|NCT00558285|12148834|FG004|Overall Study|Lost to Follow-up|0
7724025|NCT00558285|12148830|FG000|Overall Study|Administrative problems|0
7724026|NCT00558285|12148831|FG001|Overall Study|Administrative problems|0
7724027|NCT00558285|12148832|FG002|Overall Study|Administrative problems|0
7724028|NCT00558285|12148833|FG003|Overall Study|Administrative problems|1
7724029|NCT00558285|12148834|FG004|Overall Study|Administrative problems|1
7724030|NCT00558285|12148830|FG000|Overall Study|Protocol deviation|1
7724031|NCT00558285|12148831|FG001|Overall Study|Protocol deviation|1
7724032|NCT00558285|12148832|FG002|Overall Study|Protocol deviation|0
7724033|NCT00558285|12148833|FG003|Overall Study|Protocol deviation|1
7724034|NCT00558285|12148834|FG004|Overall Study|Protocol deviation|0
7724035|NCT00558363|12148848|FG000|Overall Study|Physician Decision|18
7724036|NCT00558363|12148849|FG001|Overall Study|Physician Decision|4
7724037|NCT00558363|12148848|FG000|Overall Study|Withdrawal by Subject|11
7724038|NCT00558363|12148849|FG001|Overall Study|Withdrawal by Subject|4
7724039|NCT00558363|12148848|FG000|Overall Study|Adverse Event|5
7724040|NCT00558363|12148849|FG001|Overall Study|Adverse Event|5
7724041|NCT00558363|12148848|FG000|Overall Study|Lack of Efficacy|2
7724042|NCT00558363|12148849|FG001|Overall Study|Lack of Efficacy|2
7724043|NCT00558363|12148848|FG000|Overall Study|Protocol Violation|2
7724044|NCT00558363|12148849|FG001|Overall Study|Protocol Violation|1
7724045|NCT00558363|12148848|FG000|Overall Study|Lost to Follow-up|0
7724046|NCT00558363|12148849|FG001|Overall Study|Lost to Follow-up|1
7724047|NCT00558363|12148848|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32
7724048|NCT00558363|12148849|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16
7724049|NCT00558363|12148848|FG000|Overall Study|Randomized in Error|1
7724050|NCT00558363|12148849|FG001|Overall Study|Randomized in Error|2
7724051|NCT00558363|12148848|FG000|Overall Study|Hospitalized; Unable to Continue|0
7724052|NCT00558363|12148849|FG001|Overall Study|Hospitalized; Unable to Continue|1
7724053|NCT00558428|12148859|FG000|Overall Study|Adverse Event|6
7724054|NCT00558428|12148860|FG001|Overall Study|Adverse Event|22
7724055|NCT00558428|12148861|FG002|Overall Study|Adverse Event|3
7724056|NCT00558428|12148862|FG003|Overall Study|Adverse Event|4
7724057|NCT00558428|12148859|FG000|Overall Study|Lost to Follow-up|0
7724058|NCT00558428|12148860|FG001|Overall Study|Lost to Follow-up|1
7724059|NCT00558428|12148861|FG002|Overall Study|Lost to Follow-up|0
7724060|NCT00558428|12148862|FG003|Overall Study|Lost to Follow-up|0
7724061|NCT00558428|12148859|FG000|Overall Study|Lack of Efficacy|0
7724062|NCT00558428|12148860|FG001|Overall Study|Lack of Efficacy|0
7724063|NCT00558428|12148861|FG002|Overall Study|Lack of Efficacy|1
7724064|NCT00558428|12148862|FG003|Overall Study|Lack of Efficacy|2
7724065|NCT00558428|12148859|FG000|Overall Study|Non compliant with protocol|1
7724066|NCT00558428|12148860|FG001|Overall Study|Non compliant with protocol|0
7724067|NCT00558428|12148861|FG002|Overall Study|Non compliant with protocol|0
7724068|NCT00558428|12148862|FG003|Overall Study|Non compliant with protocol|3
7724069|NCT00558428|12148859|FG000|Overall Study|Consent withdrawn|2
7724070|NCT00558428|12148860|FG001|Overall Study|Consent withdrawn|1
7724071|NCT00558428|12148861|FG002|Overall Study|Consent withdrawn|0
7724072|NCT00558428|12148862|FG003|Overall Study|Consent withdrawn|1
7724073|NCT00558428|12148859|FG000|Overall Study|Other|3
7724074|NCT00558428|12148860|FG001|Overall Study|Other|0
7724075|NCT00558428|12148861|FG002|Overall Study|Other|0
7724076|NCT00558428|12148862|FG003|Overall Study|Other|1
7724077|NCT00558467|12148874|FG000|Overall Study|Adverse Event|1
7724078|NCT00558467|12148875|FG001|Overall Study|Adverse Event|2
7724079|NCT00558467|12148874|FG000|Overall Study|Lack of Efficacy|0
7724080|NCT00558467|12148875|FG001|Overall Study|Lack of Efficacy|1
7724081|NCT00558467|12148874|FG000|Overall Study|Patient moving out of state|0
7724082|NCT00558467|12148875|FG001|Overall Study|Patient moving out of state|1
7724083|NCT00558519|12148881|FG000|Overall Study|Ph+|20
7724084|NCT00558519|12148881|FG000|Overall Study|Ineligible|1
7724085|NCT00558519|12148881|FG000|Overall Study|Insufficient data|1
7724086|NCT00558519|12148881|FG000|Overall Study|Never received treatment|1
7724087|NCT00558636|12148915|FG000|Treatment|Adverse Event|9
7724088|NCT00558636|12148916|FG001|Treatment|Adverse Event|2
7724089|NCT00558636|12148915|FG000|Treatment|Withdrawal by Subject|2
7724090|NCT00558636|12148916|FG001|Treatment|Withdrawal by Subject|0
7724091|NCT00558636|12148915|FG000|Treatment|Premature termination of the study|35
7724092|NCT00558636|12148916|FG001|Treatment|Premature termination of the study|37
7724093|NCT00558636|12148915|FG000|Treatment|Disease progression|1
7724094|NCT00558636|12148916|FG001|Treatment|Disease progression|5
7724095|NCT00558636|12148915|FG000|Follow-up|Premature termination of the study|12
7724096|NCT00558636|12148916|FG001|Follow-up|Premature termination of the study|7
7724097|NCT00558701|12148924|FG000|Overall Study|Protocol Deviations|1
7724098|NCT00558701|12148925|FG001|Overall Study|Protocol Deviations|4
7724099|NCT00558753|12148933|FG000|Overall Study|Lost to Follow-up|5
7724100|NCT00558753|12148934|FG001|Overall Study|Lost to Follow-up|7
7724101|NCT00558831|12148956|FG000|Overall Study|Lost to Follow-up|1
7724102|NCT00558896|12148991|FG000|Overall Study|Adverse Event|1
7724103|NCT00558896|12148992|FG001|Overall Study|Adverse Event|1
7724104|NCT00558896|12148993|FG002|Overall Study|Adverse Event|1
7724105|NCT00558896|12148994|FG003|Overall Study|Adverse Event|3
7724106|NCT00558896|12148995|FG004|Overall Study|Adverse Event|4
7724107|NCT00558896|12148996|FG005|Overall Study|Adverse Event|10
7724108|NCT00558896|12148997|FG006|Overall Study|Adverse Event|3
7724109|NCT00558896|12148991|FG000|Overall Study|Death|3
7724110|NCT00558896|12148992|FG001|Overall Study|Death|0
7724111|NCT00558896|12148993|FG002|Overall Study|Death|2
7724112|NCT00558896|12148994|FG003|Overall Study|Death|3
7724113|NCT00558896|12148995|FG004|Overall Study|Death|2
7724114|NCT00558896|12148996|FG005|Overall Study|Death|2
7724115|NCT00558896|12148997|FG006|Overall Study|Death|6
7724116|NCT00558896|12148991|FG000|Overall Study|Withdrawal by Subject|2
7724117|NCT00558896|12148992|FG001|Overall Study|Withdrawal by Subject|1
7724118|NCT00558896|12148993|FG002|Overall Study|Withdrawal by Subject|1
7724119|NCT00558896|12148994|FG003|Overall Study|Withdrawal by Subject|1
7724120|NCT00558896|12148995|FG004|Overall Study|Withdrawal by Subject|1
7724121|NCT00558896|12148996|FG005|Overall Study|Withdrawal by Subject|5
7724122|NCT00558896|12148997|FG006|Overall Study|Withdrawal by Subject|5
7724123|NCT00558896|12148991|FG000|Overall Study|Alternative Treatment|2
7724124|NCT00558896|12148992|FG001|Overall Study|Alternative Treatment|2
7724125|NCT00558896|12148993|FG002|Overall Study|Alternative Treatment|0
7724126|NCT00558896|12148994|FG003|Overall Study|Alternative Treatment|2
7724127|NCT00558896|12148995|FG004|Overall Study|Alternative Treatment|6
7724128|NCT00558896|12148996|FG005|Overall Study|Alternative Treatment|7
7724129|NCT00558896|12148997|FG006|Overall Study|Alternative Treatment|1
7724130|NCT00558896|12148991|FG000|Overall Study|Physician discretion|3
7724131|NCT00558896|12148992|FG001|Overall Study|Physician discretion|2
7724132|NCT00558896|12148993|FG002|Overall Study|Physician discretion|1
7724133|NCT00558896|12148994|FG003|Overall Study|Physician discretion|2
7724134|NCT00558896|12148995|FG004|Overall Study|Physician discretion|1
7724135|NCT00558896|12148996|FG005|Overall Study|Physician discretion|3
7724136|NCT00558896|12148997|FG006|Overall Study|Physician discretion|3
7724137|NCT00558896|12148991|FG000|Overall Study|Continues on treatment|10
7724138|NCT00558896|12148992|FG001|Overall Study|Continues on treatment|1
7724139|NCT00558896|12148993|FG002|Overall Study|Continues on treatment|0
7724140|NCT00558896|12148994|FG003|Overall Study|Continues on treatment|1
7724141|NCT00558896|12148995|FG004|Overall Study|Continues on treatment|9
7724142|NCT00558896|12148996|FG005|Overall Study|Continues on treatment|25
7724143|NCT00558896|12148997|FG006|Overall Study|Continues on treatment|6
7724144|NCT00559104|12149019|FG000|Overall Study|Lack of Efficacy|9
7724145|NCT00559104|12149020|FG001|Overall Study|Lack of Efficacy|0
7724146|NCT00559273|12149028|FG000|Correction Period (20 Weeks)|Death|3
7724147|NCT00559273|12149029|FG001|Correction Period (20 Weeks)|Death|4
7724148|NCT00559273|12149028|FG000|Correction Period (20 Weeks)|Adverse Event|2
7724149|NCT00559273|12149029|FG001|Correction Period (20 Weeks)|Adverse Event|1
7724150|NCT00559273|12149028|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2
7724151|NCT00559273|12149029|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6
7724152|NCT00559273|12149028|FG000|Correction Period (20 Weeks)|Participant treated by another center|0
7724153|NCT00559273|12149029|FG001|Correction Period (20 Weeks)|Participant treated by another center|1
7724154|NCT00559273|12149028|FG000|Correction Period (20 Weeks)|Did not received study treatment|2
7724155|NCT00559273|12149029|FG001|Correction Period (20 Weeks)|Did not received study treatment|0
7724156|NCT00559273|12149028|FG000|Evaluation Period (8 Weeks)|Death|1
7724157|NCT00559273|12149029|FG001|Evaluation Period (8 Weeks)|Death|3
7724158|NCT00559273|12149028|FG000|Evaluation Period (8 Weeks)|Adverse Event|0
7724159|NCT00559273|12149029|FG001|Evaluation Period (8 Weeks)|Adverse Event|1
7724160|NCT00559273|12149028|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
7724161|NCT00559273|12149029|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
7724162|NCT00559273|12149028|FG000|Evaluation Period (8 Weeks)|Physician Decision|0
7724163|NCT00559273|12149029|FG001|Evaluation Period (8 Weeks)|Physician Decision|1
7724164|NCT00559364|12149037|FG000|Overall Study|Inclusion/exclusion criteria failure|1
7724165|NCT00559364|12149038|FG001|Overall Study|Inclusion/exclusion criteria failure|0
7724166|NCT00559377|12149044|FG000|Overall Study|Withdrawal by Subject|9
7724167|NCT00559507|12149060|FG000|Overall Study|Not treated, patient ineligible|3
7724168|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|Adverse Event|17
7724169|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|Adverse Event|25
7724170|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11
7724171|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5
7724172|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0
7724173|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6
7724174|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
7724175|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
7724176|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|Death|1
7724177|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|Death|1
7724178|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
7724179|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
7724180|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6
7724181|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1
7724182|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3
7724183|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0
7724184|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|Missed Doses|0
7724185|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|Missed Doses|1
7724186|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0
7724187|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1
7724188|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
7724189|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
7724190|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|Early Discontinuation|0
7724191|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|Early Discontinuation|1
7724192|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1
7724193|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0
7724194|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
7724195|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
7724196|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|Investigator Decision|0
7724197|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|Investigator Decision|1
7724198|NCT00559585|12149066|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1
7724199|NCT00559585|12149067|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0
7724200|NCT00559585|12149066|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
7724201|NCT00559585|12149067|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
7724202|NCT00559585|12149066|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100
7724203|NCT00559585|12149067|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0
7724204|NCT00559585|12149066|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
7724205|NCT00559585|12149067|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
7724206|NCT00559585|12149066|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16
7724207|NCT00559585|12149067|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0
7724208|NCT00559585|12149066|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
7724209|NCT00559585|12149067|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
7724210|NCT00559585|12149066|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
7724211|NCT00559585|12149067|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
7724212|NCT00559585|12149066|FG000|Open Label LT Period Main + Sub-Study|Death|20
7724213|NCT00559585|12149067|FG001|Open Label LT Period Main + Sub-Study|Death|0
7724214|NCT00559585|12149066|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1
7724215|NCT00559585|12149067|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0
7724216|NCT00559585|12149066|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
7724217|NCT00559585|12149067|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
7724218|NCT00559585|12149066|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
7724219|NCT00559585|12149067|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
7724220|NCT00559585|12149066|FG000|Open Label LT Period Main + Sub-Study|non-specified|71
7724221|NCT00559585|12149067|FG001|Open Label LT Period Main + Sub-Study|non-specified|0
7724222|NCT00559585|12149066|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1
7724223|NCT00559585|12149067|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0
7724224|NCT00559637|12149084|FG000|Overall Study|Adverse Event|22
7724225|NCT00559637|12149084|FG000|Overall Study|Withdrawal by Subject|4
7724226|NCT00559637|12149084|FG000|Overall Study|Protocol Violation|6
7724227|NCT00559637|12149084|FG000|Overall Study|Withdrawal criteria fulfilled|4
7724228|NCT00559637|12149084|FG000|Overall Study|Failure to return|6
7724229|NCT00559637|12149084|FG000|Overall Study|Insufficient response|3
7724230|NCT00559637|12149084|FG000|Overall Study|Started requiring dialysis after month 7|2
7724231|NCT00559637|12149084|FG000|Overall Study|Suspected lung cancer|1
7724232|NCT00559637|12149084|FG000|Overall Study|Participation in another study|1
7724233|NCT00559637|12149084|FG000|Overall Study|Delayed administration of C.E.R.A|1
7724234|NCT00559637|12149084|FG000|Overall Study|Change of center|1
7724235|NCT00559637|12149084|FG000|Overall Study|Change of home|1
7724236|NCT00559637|12149084|FG000|Overall Study|Inclusion or exclusion criteria violated|2
7724237|NCT00559754|12149088|FG000|Overall Study|Disease progression|1
7724238|NCT00559754|12149088|FG000|Overall Study|Adverse Event|5
7724239|NCT00559754|12149088|FG000|Overall Study|Protocol Violation|1
7724240|NCT00559754|12149088|FG000|Overall Study|Investigator criteria|2
7724241|NCT00559754|12149088|FG000|Overall Study|Withdrawal by Subject|2
7724242|NCT00559845|12149092|FG000|Overall Study|Withdrew Consent|1
7724243|NCT00559845|12149092|FG000|Overall Study|Disease Progression|1
7724244|NCT00559845|12149092|FG000|Overall Study|Adverse Event|3
7724245|NCT00559845|12149092|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
7724246|NCT00559845|12149092|FG000|Overall Study|Premature Surgery-Investigator Decision|1
7724247|NCT00559949|12149096|FG000|Overall Study|Progressive Disease during cycle 1|1
7724248|NCT00559949|12149096|FG000|Overall Study|Adverse Event|1
7724249|NCT00559949|12149096|FG000|Overall Study|Withdrawal by Subject|4
7724250|NCT00559949|12149096|FG000|Overall Study|No disease evaluation per protocol|1
7724251|NCT00559962|12149108|FG000|Overall Study|Adverse Event|1
7724252|NCT00559962|12149109|FG001|Overall Study|Adverse Event|7
7724253|NCT00559962|12149110|FG002|Overall Study|Adverse Event|8
7724254|NCT00559962|12149111|FG003|Overall Study|Adverse Event|5
7724255|NCT00559962|12149112|FG004|Overall Study|Adverse Event|11
7724256|NCT00559962|12149113|FG005|Overall Study|Adverse Event|4
7724257|NCT00559962|12149114|FG006|Overall Study|Adverse Event|4
7724258|NCT00559962|12149115|FG007|Overall Study|Adverse Event|2
7724259|NCT00559962|12149108|FG000|Overall Study|Lost to Follow-up|0
7724260|NCT00559962|12149109|FG001|Overall Study|Lost to Follow-up|1
7724261|NCT00559962|12149110|FG002|Overall Study|Lost to Follow-up|0
7724262|NCT00559962|12149111|FG003|Overall Study|Lost to Follow-up|0
7724263|NCT00559962|12149112|FG004|Overall Study|Lost to Follow-up|0
7724264|NCT00559962|12149113|FG005|Overall Study|Lost to Follow-up|0
7724265|NCT00559962|12149114|FG006|Overall Study|Lost to Follow-up|0
7724266|NCT00559962|12149115|FG007|Overall Study|Lost to Follow-up|0
7724267|NCT00559962|12149108|FG000|Overall Study|Withdrawal by Subject|1
7724268|NCT00559962|12149109|FG001|Overall Study|Withdrawal by Subject|1
7724269|NCT00559962|12149110|FG002|Overall Study|Withdrawal by Subject|2
7724270|NCT00559962|12149111|FG003|Overall Study|Withdrawal by Subject|0
7724271|NCT00559962|12149112|FG004|Overall Study|Withdrawal by Subject|3
7724272|NCT00559962|12149113|FG005|Overall Study|Withdrawal by Subject|1
7724273|NCT00559962|12149114|FG006|Overall Study|Withdrawal by Subject|0
7724274|NCT00559962|12149115|FG007|Overall Study|Withdrawal by Subject|2
7724275|NCT00559962|12149108|FG000|Overall Study|Inclusion/exclusion criteria not met|0
7724276|NCT00559962|12149109|FG001|Overall Study|Inclusion/exclusion criteria not met|0
7724277|NCT00559962|12149110|FG002|Overall Study|Inclusion/exclusion criteria not met|0
7724278|NCT00559962|12149111|FG003|Overall Study|Inclusion/exclusion criteria not met|0
7724279|NCT00559962|12149112|FG004|Overall Study|Inclusion/exclusion criteria not met|0
7724280|NCT00559962|12149113|FG005|Overall Study|Inclusion/exclusion criteria not met|0
7724281|NCT00559962|12149114|FG006|Overall Study|Inclusion/exclusion criteria not met|1
7724282|NCT00559962|12149115|FG007|Overall Study|Inclusion/exclusion criteria not met|0
7724283|NCT00559988|12149136|FG000|Overall Study|Death|147
7724284|NCT00559988|12149137|FG001|Overall Study|Death|140
7724285|NCT00559988|12149136|FG000|Overall Study|Withdrawal by Subject|152
7724286|NCT00559988|12149137|FG001|Overall Study|Withdrawal by Subject|139
7724287|NCT00559988|12149136|FG000|Overall Study|Lost to Follow-up|42
7724288|NCT00559988|12149137|FG001|Overall Study|Lost to Follow-up|56
7724289|NCT00559988|12149136|FG000|Overall Study|ICD device explanted|10
7724290|NCT00559988|12149137|FG001|Overall Study|ICD device explanted|17
7724291|NCT00560066|12149145|FG000|Overall Study|Death|2
7724292|NCT00560066|12149146|FG001|Overall Study|Death|1
7724293|NCT00560066|12149145|FG000|Overall Study|Withdrawal by Subject|0
7724294|NCT00560066|12149146|FG001|Overall Study|Withdrawal by Subject|3
7724295|NCT00560066|12149145|FG000|Overall Study|Lost to Follow-up|4
7724296|NCT00560066|12149146|FG001|Overall Study|Lost to Follow-up|10
7724297|NCT00560066|12149145|FG000|Overall Study|Protocol Violation|0
7724298|NCT00560066|12149146|FG001|Overall Study|Protocol Violation|1
7724299|NCT00560066|12149145|FG000|Overall Study|Administrative reason|0
7724300|NCT00560066|12149146|FG001|Overall Study|Administrative reason|5
7724301|NCT00560066|12149145|FG000|Overall Study|Missing primary reason|0
7724302|NCT00560066|12149146|FG001|Overall Study|Missing primary reason|2
7724303|NCT00560105|12149159|FG000|Overall Study|musculoskeletal chest discomfort with us|1
7724304|NCT00560105|12149160|FG001|Overall Study|musculoskeletal chest discomfort with us|2
7724305|NCT00560235|12149169|FG000|Phase 1|Discontinued|8
7724306|NCT00560235|12149170|FG001|Phase 1|Discontinued|0
7724307|NCT00560235|12149171|FG002|Phase 1|Discontinued|0
7724308|NCT00560235|12149169|FG000|Phase 1B|Discontinued|0
7724309|NCT00560235|12149170|FG001|Phase 1B|Discontinued|19
7724310|NCT00560235|12149171|FG002|Phase 1B|Discontinued|0
7724311|NCT00560235|12149169|FG000|Phase 2|Discontinued|0
7724312|NCT00560235|12149170|FG001|Phase 2|Discontinued|0
7724313|NCT00560235|12149171|FG002|Phase 2|Discontinued|96
7724314|NCT00560235|12149169|FG000|Phase 2|Ongoing at Date of Cut-Off|0
7724315|NCT00560235|12149170|FG001|Phase 2|Ongoing at Date of Cut-Off|0
7724316|NCT00560235|12149171|FG002|Phase 2|Ongoing at Date of Cut-Off|1
7724317|NCT00560313|12149189|FG000|Overall Study|Adverse Events or Death|2
7724318|NCT00560313|12149189|FG000|Overall Study|Withdrawal by Subject|2
7724319|NCT00560313|12149189|FG000|Overall Study|Lost to Follow-up|1
7724320|NCT00560313|12149189|FG000|Overall Study|Protocol Violation|1
7724321|NCT00560352|12149211|FG000|Overall Study|Adverse event unrelated to study drug|2
7724322|NCT00560352|12149212|FG001|Overall Study|Adverse event unrelated to study drug|1
7724323|NCT00560352|12149213|FG002|Overall Study|Adverse event unrelated to study drug|1
7724324|NCT00560352|12149211|FG000|Overall Study|Study drug toxicity|3
7724325|NCT00560352|12149212|FG001|Overall Study|Study drug toxicity|0
7724326|NCT00560352|12149213|FG002|Overall Study|Study drug toxicity|1
7724327|NCT00560352|12149211|FG000|Overall Study|Disease progression|0
7724328|NCT00560352|12149212|FG001|Overall Study|Disease progression|1
7724329|NCT00560352|12149213|FG002|Overall Study|Disease progression|1
7724330|NCT00560352|12149211|FG000|Overall Study|Withdrawal by Subject|1
7724331|NCT00560352|12149212|FG001|Overall Study|Withdrawal by Subject|1
7724332|NCT00560352|12149213|FG002|Overall Study|Withdrawal by Subject|1
7724333|NCT00560352|12149211|FG000|Overall Study|Maximum clinical benefit|1
7724334|NCT00560352|12149212|FG001|Overall Study|Maximum clinical benefit|0
7724335|NCT00560352|12149213|FG002|Overall Study|Maximum clinical benefit|0
7724336|NCT00560391|12149230|FG000|Overall Study|Still on treatment|0
7724337|NCT00560391|12149231|FG001|Overall Study|Still on treatment|0
7724338|NCT00560391|12149232|FG002|Overall Study|Still on treatment|0
7724339|NCT00560391|12149233|FG003|Overall Study|Still on treatment|1
7724340|NCT00560391|12149234|FG004|Overall Study|Still on treatment|2
7724341|NCT00560404|12149249|FG000|Overall Study|Adverse Event|2
7724342|NCT00560404|12149250|FG001|Overall Study|Adverse Event|3
7724343|NCT00560404|12149249|FG000|Overall Study|Death|3
7724344|NCT00560404|12149250|FG001|Overall Study|Death|3
7724345|NCT00560404|12149249|FG000|Overall Study|Protocol Violation|12
7724346|NCT00560404|12149250|FG001|Overall Study|Protocol Violation|7
7724347|NCT00560404|12149249|FG000|Overall Study|Administrative Reasons|1
7724348|NCT00560404|12149250|FG001|Overall Study|Administrative Reasons|1
7724349|NCT00560404|12149249|FG000|Overall Study|Withdrew Consent|4
7724350|NCT00560404|12149250|FG001|Overall Study|Withdrew Consent|0
7724351|NCT00560404|12149249|FG000|Overall Study|Failure to return|1
7724352|NCT00560404|12149250|FG001|Overall Study|Failure to return|2
7724353|NCT00560404|12149249|FG000|Overall Study|Other withdrawal reason|13
7724354|NCT00560404|12149250|FG001|Overall Study|Other withdrawal reason|5
7724355|NCT00560417|12149258|FG000|Overall Study|Adverse Event|3
7724356|NCT00560417|12149259|FG001|Overall Study|Adverse Event|2
7724357|NCT00560417|12149258|FG000|Overall Study|Entry Criteria Not Met|1
7724358|NCT00560417|12149259|FG001|Overall Study|Entry Criteria Not Met|0
7724359|NCT00560417|12149258|FG000|Overall Study|Lost to Follow-up|0
7724360|NCT00560417|12149259|FG001|Overall Study|Lost to Follow-up|1
7724361|NCT00560417|12149258|FG000|Overall Study|Physician Decision|2
7724362|NCT00560417|12149259|FG001|Overall Study|Physician Decision|6
7724363|NCT00560417|12149258|FG000|Overall Study|Protocol Violation|6
7724364|NCT00560417|12149259|FG001|Overall Study|Protocol Violation|5
7724365|NCT00560417|12149258|FG000|Overall Study|Sponsor Decision|2
7724366|NCT00560417|12149259|FG001|Overall Study|Sponsor Decision|0
7724367|NCT00560417|12149258|FG000|Overall Study|Withdrawal by Subject|3
7724368|NCT00560417|12149259|FG001|Overall Study|Withdrawal by Subject|3
7724369|NCT00560508|12149267|FG000|12 Week Double-blind Period|Adverse Event|3
7724370|NCT00560508|12149268|FG001|12 Week Double-blind Period|Adverse Event|2
7724371|NCT00560508|12149267|FG000|12 Week Double-blind Period|Protocol Violation|1
7724372|NCT00560508|12149268|FG001|12 Week Double-blind Period|Protocol Violation|0
7724373|NCT00560508|12149267|FG000|12 Week Double-blind Period|Withdrawal by Subject|1
7724374|NCT00560508|12149268|FG001|12 Week Double-blind Period|Withdrawal by Subject|1
7724375|NCT00560508|12149267|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6
7724376|NCT00560508|12149268|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6
7724377|NCT00560508|12149267|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
7724378|NCT00560508|12149268|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
7724379|NCT00560508|12149267|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
7724380|NCT00560508|12149268|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
7724381|NCT00560508|12149267|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
7724382|NCT00560508|12149268|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
7724383|NCT00560573|12149288|FG000|Overall Study|Death|4
7724384|NCT00560573|12149289|FG001|Overall Study|Death|1
7724385|NCT00560573|12149290|FG002|Overall Study|Death|4
7724386|NCT00560573|12149291|FG003|Overall Study|Death|5
7724387|NCT00560573|12149292|FG004|Overall Study|Death|1
7724388|NCT00560573|12149293|FG005|Overall Study|Death|10
7724389|NCT00560573|12149288|FG000|Overall Study|Lost to Follow-up|0
7724390|NCT00560573|12149289|FG001|Overall Study|Lost to Follow-up|0
7724391|NCT00560573|12149290|FG002|Overall Study|Lost to Follow-up|0
7724392|NCT00560573|12149291|FG003|Overall Study|Lost to Follow-up|1
7724393|NCT00560573|12149292|FG004|Overall Study|Lost to Follow-up|1
7724394|NCT00560573|12149293|FG005|Overall Study|Lost to Follow-up|0
7724395|NCT00560573|12149288|FG000|Overall Study|Withdrawal by Subject|0
7724396|NCT00560573|12149289|FG001|Overall Study|Withdrawal by Subject|0
7724397|NCT00560573|12149290|FG002|Overall Study|Withdrawal by Subject|0
7724398|NCT00560573|12149291|FG003|Overall Study|Withdrawal by Subject|1
7724399|NCT00560573|12149292|FG004|Overall Study|Withdrawal by Subject|1
7724400|NCT00560573|12149293|FG005|Overall Study|Withdrawal by Subject|0
7724401|NCT00560573|12149288|FG000|Overall Study|Other|2
7724402|NCT00560573|12149289|FG001|Overall Study|Other|2
7724403|NCT00560573|12149290|FG002|Overall Study|Other|2
7724404|NCT00560573|12149291|FG003|Overall Study|Other|3
7724405|NCT00560573|12149292|FG004|Overall Study|Other|3
7724406|NCT00560573|12149293|FG005|Overall Study|Other|3
7724407|NCT00560573|12149288|FG000|Overall Study|Enrolled, not treated|0
7724408|NCT00560573|12149289|FG001|Overall Study|Enrolled, not treated|0
7724409|NCT00560573|12149290|FG002|Overall Study|Enrolled, not treated|0
7724410|NCT00560573|12149291|FG003|Overall Study|Enrolled, not treated|0
7724411|NCT00560573|12149292|FG004|Overall Study|Enrolled, not treated|1
7724412|NCT00560573|12149293|FG005|Overall Study|Enrolled, not treated|0
7724413|NCT00560703|12149334|FG000|Overall Study|Adverse Event|0
7724414|NCT00560703|12149335|FG001|Overall Study|Adverse Event|2
7724415|NCT00560703|12149334|FG000|Overall Study|Protocol Violation|0
7724416|NCT00560703|12149335|FG001|Overall Study|Protocol Violation|2
7724417|NCT00560703|12149334|FG000|Overall Study|Withdrawal by Subject|0
7724418|NCT00560703|12149335|FG001|Overall Study|Withdrawal by Subject|1
7724419|NCT00560703|12149334|FG000|Overall Study|non-compliance|0
7724420|NCT00560703|12149335|FG001|Overall Study|non-compliance|1
7724421|NCT00560755|12149341|FG000|Overall Study|Protocol Violation|15
7724422|NCT00560755|12149341|FG000|Overall Study|Withdrawal by Subject|26
7724423|NCT00560755|12149341|FG000|Overall Study|Lost to Follow-up|9
7724424|NCT00560755|12149341|FG000|Overall Study|Adverse Event|8
7724425|NCT00560755|12149341|FG000|Overall Study|Physician Decision|2
7724426|NCT00560794|12149346|FG000|Overall Study|Adverse Event|2
7724427|NCT00560794|12149346|FG000|Overall Study|Patient was not Compliant|1
7724428|NCT00560794|12149346|FG000|Overall Study|Minimal Residual Disease Relapse|1
7724429|NCT00560794|12149346|FG000|Overall Study|Hematological Relapse|1
7724430|NCT00560794|12149346|FG000|Overall Study|Received Bone Marrow Transplant|6
7724431|NCT00560833|12149357|FG000|Overall Study|Adverse Event|16
7724432|NCT00560833|12149358|FG001|Overall Study|Adverse Event|10
7724433|NCT00560833|12149359|FG002|Overall Study|Adverse Event|25
7724434|NCT00560833|12149360|FG003|Overall Study|Adverse Event|23
7724435|NCT00560833|12149361|FG004|Overall Study|Adverse Event|35
7724436|NCT00560833|12149357|FG000|Overall Study|Lost to Follow-up|0
7724437|NCT00560833|12149358|FG001|Overall Study|Lost to Follow-up|0
7724438|NCT00560833|12149359|FG002|Overall Study|Lost to Follow-up|1
7724439|NCT00560833|12149360|FG003|Overall Study|Lost to Follow-up|0
7724440|NCT00560833|12149361|FG004|Overall Study|Lost to Follow-up|0
7724441|NCT00560833|12149357|FG000|Overall Study|Lack of Efficacy|22
7724442|NCT00560833|12149358|FG001|Overall Study|Lack of Efficacy|9
7724443|NCT00560833|12149359|FG002|Overall Study|Lack of Efficacy|6
7724444|NCT00560833|12149360|FG003|Overall Study|Lack of Efficacy|4
7724445|NCT00560833|12149361|FG004|Overall Study|Lack of Efficacy|4
7724446|NCT00560833|12149357|FG000|Overall Study|Participant uncooperative|5
7724447|NCT00560833|12149358|FG001|Overall Study|Participant uncooperative|5
7724448|NCT00560833|12149359|FG002|Overall Study|Participant uncooperative|4
7724449|NCT00560833|12149360|FG003|Overall Study|Participant uncooperative|4
7724450|NCT00560833|12149361|FG004|Overall Study|Participant uncooperative|2
7724451|NCT00560833|12149357|FG000|Overall Study|Other|1
7724452|NCT00560833|12149358|FG001|Overall Study|Other|1
7724453|NCT00560833|12149359|FG002|Overall Study|Other|3
7724454|NCT00560833|12149360|FG003|Overall Study|Other|0
7724455|NCT00560833|12149361|FG004|Overall Study|Other|0
7724456|NCT00560833|12149357|FG000|Overall Study|Never received drug|0
7724457|NCT00560833|12149358|FG001|Overall Study|Never received drug|1
7724458|NCT00560833|12149359|FG002|Overall Study|Never received drug|0
7724459|NCT00560833|12149360|FG003|Overall Study|Never received drug|0
7724460|NCT00560833|12149361|FG004|Overall Study|Never received drug|1
7724461|NCT00560885|12149383|FG000|Overall Study|Death|7
7724462|NCT00560885|12149383|FG000|Overall Study|Withdrawal by Subject|1
7724463|NCT00560937|12149389|FG000|Overall Study|Withdrawal by Subject|0
7724464|NCT00560937|12149390|FG001|Overall Study|Withdrawal by Subject|1
7724465|NCT00560937|12149389|FG000|Overall Study|Physician Decision|1
7724466|NCT00560937|12149390|FG001|Overall Study|Physician Decision|1
7724467|NCT00560950|12149398|FG000|Overall Study|Lost to Follow-up|1
7724468|NCT00560950|12149399|FG001|Overall Study|Lost to Follow-up|0
7724469|NCT00561015|12149422|FG000|Overall Study|Adverse Event|0
7724470|NCT00561015|12149423|FG001|Overall Study|Adverse Event|0
7724471|NCT00561015|12149424|FG002|Overall Study|Adverse Event|0
7724472|NCT00561015|12149425|FG003|Overall Study|Adverse Event|0
7724473|NCT00561015|12149426|FG004|Overall Study|Adverse Event|1
7724474|NCT00561015|12149427|FG005|Overall Study|Adverse Event|0
7724475|NCT00561015|12149422|FG000|Overall Study|Lost to Follow-up|2
7724476|NCT00561015|12149423|FG001|Overall Study|Lost to Follow-up|0
7724477|NCT00561015|12149424|FG002|Overall Study|Lost to Follow-up|0
7724478|NCT00561015|12149425|FG003|Overall Study|Lost to Follow-up|1
7724479|NCT00561015|12149426|FG004|Overall Study|Lost to Follow-up|0
7724480|NCT00561015|12149427|FG005|Overall Study|Lost to Follow-up|3
7724481|NCT00561015|12149422|FG000|Overall Study|Participant non-compliance|2
7724482|NCT00561015|12149423|FG001|Overall Study|Participant non-compliance|0
7724483|NCT00561015|12149424|FG002|Overall Study|Participant non-compliance|0
7724484|NCT00561015|12149425|FG003|Overall Study|Participant non-compliance|0
7724485|NCT00561015|12149426|FG004|Overall Study|Participant non-compliance|0
7724486|NCT00561015|12149427|FG005|Overall Study|Participant non-compliance|0
7724487|NCT00561080|12149448|FG000|Vaccination Period (up to Month 4)|Adverse Event|0
7724488|NCT00561080|12149449|FG001|Vaccination Period (up to Month 4)|Adverse Event|4
7724489|NCT00561080|12149450|FG002|Vaccination Period (up to Month 4)|Adverse Event|6
7724490|NCT00561080|12149448|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
7724491|NCT00561080|12149449|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
7724492|NCT00561080|12149450|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
7724493|NCT00561080|12149448|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0
7724494|NCT00561080|12149449|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1
7724495|NCT00561080|12149450|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3
7724496|NCT00561080|12149448|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
7724497|NCT00561080|12149449|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
7724498|NCT00561080|12149450|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
7724499|NCT00561080|12149448|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0
7724500|NCT00561080|12149449|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1
7724501|NCT00561080|12149450|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0
7724502|NCT00561080|12149448|FG000|Vaccination Period (up to Month 4)|Other|0
7724503|NCT00561080|12149449|FG001|Vaccination Period (up to Month 4)|Other|2
7724504|NCT00561080|12149450|FG002|Vaccination Period (up to Month 4)|Other|1
7724505|NCT00561080|12149448|FG000|12-month Post Last Dose Follow-up|Adverse Event|3
7724506|NCT00561080|12149449|FG001|12-month Post Last Dose Follow-up|Adverse Event|3
7724507|NCT00561080|12149450|FG002|12-month Post Last Dose Follow-up|Adverse Event|1
7724508|NCT00561080|12149448|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0
7724509|NCT00561080|12149449|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0
7724510|NCT00561080|12149450|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4
7724511|NCT00561080|12149448|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
7724512|NCT00561080|12149449|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
7724513|NCT00561080|12149450|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
7724514|NCT00561080|12149448|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2
7724515|NCT00561080|12149449|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0
7724516|NCT00561080|12149450|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0
7724517|NCT00561340|12149471|FG000|Overall Study|refused to drink pediasure|6
7724518|NCT00561340|12149472|FG001|Overall Study|refused to drink pediasure|0
7724519|NCT00561353|12149488|FG000|Overall Study|Subject reached a virologic endpoint|2
7724520|NCT00561353|12149489|FG001|Overall Study|Subject reached a virologic endpoint|1
7724521|NCT00561353|12149490|FG002|Overall Study|Subject reached a virologic endpoint|1
7724522|NCT00561353|12149491|FG003|Overall Study|Subject reached a virologic endpoint|4
7724523|NCT00561353|12149492|FG004|Overall Study|Subject reached a virologic endpoint|1
7724524|NCT00561353|12149493|FG005|Overall Study|Subject reached a virologic endpoint|3
7724525|NCT00561353|12149494|FG006|Overall Study|Subject reached a virologic endpoint|4
7724526|NCT00561353|12149495|FG007|Overall Study|Subject reached a virologic endpoint|4
7724527|NCT00561353|12149496|FG008|Overall Study|Subject reached a virologic endpoint|5
7724528|NCT00561353|12149497|FG009|Overall Study|Subject reached a virologic endpoint|0
7724529|NCT00561353|12149488|FG000|Overall Study|Subject ineligible to continue the trial|0
7724530|NCT00561353|12149489|FG001|Overall Study|Subject ineligible to continue the trial|0
7724531|NCT00561353|12149490|FG002|Overall Study|Subject ineligible to continue the trial|0
7724532|NCT00561353|12149491|FG003|Overall Study|Subject ineligible to continue the trial|0
7724533|NCT00561353|12149492|FG004|Overall Study|Subject ineligible to continue the trial|0
7724534|NCT00561353|12149493|FG005|Overall Study|Subject ineligible to continue the trial|1
7724535|NCT00561353|12149494|FG006|Overall Study|Subject ineligible to continue the trial|1
7724536|NCT00561353|12149495|FG007|Overall Study|Subject ineligible to continue the trial|0
7724537|NCT00561353|12149496|FG008|Overall Study|Subject ineligible to continue the trial|2
7724538|NCT00561353|12149497|FG009|Overall Study|Subject ineligible to continue the trial|1
7724539|NCT00561353|12149488|FG000|Overall Study|Other|1
7724540|NCT00561353|12149489|FG001|Overall Study|Other|0
7724541|NCT00561353|12149490|FG002|Overall Study|Other|1
7724542|NCT00561353|12149491|FG003|Overall Study|Other|0
7724543|NCT00561353|12149492|FG004|Overall Study|Other|0
7724544|NCT00561353|12149493|FG005|Overall Study|Other|2
7724545|NCT00561353|12149494|FG006|Overall Study|Other|0
7724546|NCT00561353|12149495|FG007|Overall Study|Other|0
7724547|NCT00561353|12149496|FG008|Overall Study|Other|0
7724548|NCT00561353|12149497|FG009|Overall Study|Other|0
7724549|NCT00561353|12149488|FG000|Overall Study|Adverse Event|0
7724550|NCT00561353|12149489|FG001|Overall Study|Adverse Event|0
7724551|NCT00561353|12149490|FG002|Overall Study|Adverse Event|0
7724552|NCT00561353|12149491|FG003|Overall Study|Adverse Event|2
7724553|NCT00561353|12149492|FG004|Overall Study|Adverse Event|0
7724554|NCT00561353|12149493|FG005|Overall Study|Adverse Event|0
7724555|NCT00561353|12149494|FG006|Overall Study|Adverse Event|1
7724556|NCT00561353|12149495|FG007|Overall Study|Adverse Event|0
7724557|NCT00561353|12149496|FG008|Overall Study|Adverse Event|0
7724558|NCT00561353|12149497|FG009|Overall Study|Adverse Event|1
7724559|NCT00561353|12149488|FG000|Overall Study|Lost to Follow-up|2
7724560|NCT00561353|12149489|FG001|Overall Study|Lost to Follow-up|0
7724561|NCT00561353|12149490|FG002|Overall Study|Lost to Follow-up|1
7724562|NCT00561353|12149491|FG003|Overall Study|Lost to Follow-up|0
7724563|NCT00561353|12149492|FG004|Overall Study|Lost to Follow-up|0
7724564|NCT00561353|12149493|FG005|Overall Study|Lost to Follow-up|0
7724565|NCT00561353|12149494|FG006|Overall Study|Lost to Follow-up|0
7724566|NCT00561353|12149495|FG007|Overall Study|Lost to Follow-up|0
7724567|NCT00561353|12149496|FG008|Overall Study|Lost to Follow-up|0
7724568|NCT00561353|12149497|FG009|Overall Study|Lost to Follow-up|0
7724569|NCT00561353|12149488|FG000|Overall Study|Withdrawal by Subject|0
7724570|NCT00561353|12149489|FG001|Overall Study|Withdrawal by Subject|2
7724571|NCT00561353|12149490|FG002|Overall Study|Withdrawal by Subject|0
7724572|NCT00561353|12149491|FG003|Overall Study|Withdrawal by Subject|0
7724573|NCT00561353|12149492|FG004|Overall Study|Withdrawal by Subject|0
7724574|NCT00561353|12149493|FG005|Overall Study|Withdrawal by Subject|0
7724575|NCT00561353|12149494|FG006|Overall Study|Withdrawal by Subject|0
7724576|NCT00561353|12149495|FG007|Overall Study|Withdrawal by Subject|0
7724577|NCT00561353|12149496|FG008|Overall Study|Withdrawal by Subject|0
7724578|NCT00561353|12149497|FG009|Overall Study|Withdrawal by Subject|0
7724579|NCT00561392|12149559|FG000|Overall Study|Adverse Event|38
7724580|NCT00561392|12149559|FG000|Overall Study|Lack of Efficacy|2
7724581|NCT00561392|12149559|FG000|Overall Study|Protocol Violation|1
7724582|NCT00561392|12149559|FG000|Overall Study|Withdrawal by Subject|8
7724583|NCT00561392|12149559|FG000|Overall Study|Administrative problems|4
7724584|NCT00561470|12149582|FG000|Overall Study|Adverse Event|74
7724585|NCT00561470|12149583|FG001|Overall Study|Adverse Event|163
7724586|NCT00561470|12149582|FG000|Overall Study|Disease progression|437
7724587|NCT00561470|12149583|FG001|Overall Study|Disease progression|305
7724588|NCT00561470|12149582|FG000|Overall Study|poor compliance to protocol|4
7724589|NCT00561470|12149583|FG001|Overall Study|poor compliance to protocol|4
7724590|NCT00561470|12149582|FG000|Overall Study|Lost to Follow-up|2
7724591|NCT00561470|12149583|FG001|Overall Study|Lost to Follow-up|0
7724592|NCT00561470|12149582|FG000|Overall Study|Physician Decision|21
7724593|NCT00561470|12149583|FG001|Overall Study|Physician Decision|20
7724594|NCT00561470|12149582|FG000|Overall Study|Consent Withdrawn|2
7724595|NCT00561470|12149583|FG001|Overall Study|Consent Withdrawn|6
7724596|NCT00561470|12149582|FG000|Overall Study|Subject request|43
7724597|NCT00561470|12149583|FG001|Overall Study|Subject request|77
7724598|NCT00561470|12149582|FG000|Overall Study|Metastatic surgery|10
7724599|NCT00561470|12149583|FG001|Overall Study|Metastatic surgery|12
7724600|NCT00561470|12149582|FG000|Overall Study|Unauthorized procedure|3
7724601|NCT00561470|12149583|FG001|Overall Study|Unauthorized procedure|1
7724602|NCT00561470|12149582|FG000|Overall Study|Randomized but not treated|5
7724603|NCT00561470|12149583|FG001|Overall Study|Randomized but not treated|5
7724604|NCT00561470|12149582|FG000|Overall Study|Missed visit window|1
7724605|NCT00561470|12149583|FG001|Overall Study|Missed visit window|4
7724606|NCT00561470|12149582|FG000|Overall Study|Planning surgery|1
7724607|NCT00561470|12149583|FG001|Overall Study|Planning surgery|1
7724608|NCT00561470|12149582|FG000|Overall Study|Ongoing Treatment|11
7724609|NCT00561470|12149583|FG001|Overall Study|Ongoing Treatment|14
7724610|NCT00561574|12149593|FG000|Overall Study|Adverse Event|21
7724611|NCT00561574|12149594|FG001|Overall Study|Adverse Event|24
7724612|NCT00561574|12149593|FG000|Overall Study|Lack of Efficacy|11
7724613|NCT00561574|12149594|FG001|Overall Study|Lack of Efficacy|21
7724614|NCT00561574|12149593|FG000|Overall Study|Withdrawal by Subject|4
7724615|NCT00561574|12149594|FG001|Overall Study|Withdrawal by Subject|4
7724616|NCT00561574|12149593|FG000|Overall Study|Reason Unrelated to Trial|6
7724617|NCT00561574|12149594|FG001|Overall Study|Reason Unrelated to Trial|2
7724618|NCT00561574|12149593|FG000|Overall Study|Lost to Follow-up|1
7724619|NCT00561574|12149594|FG001|Overall Study|Lost to Follow-up|0
7724620|NCT00561574|12149593|FG000|Overall Study|Other|5
7724621|NCT00561574|12149594|FG001|Overall Study|Other|7
7724622|NCT00561652|12149613|FG000|Overall Study|Withdrawal by Subject|0
7724623|NCT00561652|12149614|FG001|Overall Study|Withdrawal by Subject|1
7724624|NCT00561678|12149622|FG000|Overall Study|Withdrawal by Subject|4
7724625|NCT00561678|12149623|FG001|Overall Study|Withdrawal by Subject|3
7724626|NCT00561678|12149622|FG000|Overall Study|surgery cancelled|1
7724627|NCT00561678|12149623|FG001|Overall Study|surgery cancelled|1
7724628|NCT00561678|12149622|FG000|Overall Study|surgery rescheduled to different site|2
7724629|NCT00561678|12149623|FG001|Overall Study|surgery rescheduled to different site|2
7724630|NCT00561678|12149622|FG000|Overall Study|anesthesia provider refusal|1
7724631|NCT00561678|12149623|FG001|Overall Study|anesthesia provider refusal|0
7724632|NCT00561730|12149629|FG000|Overall Study|Adverse Event|2
7724633|NCT00561730|12149629|FG000|Overall Study|Handling of the drug|1
7724634|NCT00561730|12149629|FG000|Overall Study|Lost to Follow-up|5
7724635|NCT00561730|12149629|FG000|Overall Study|Not specified reasons|1
7724636|NCT00561821|12149639|FG000|Overall Study|Not treated|0
7724637|NCT00561821|12149640|FG001|Overall Study|Not treated|0
7724638|NCT00561821|12149641|FG002|Overall Study|Not treated|1
7724639|NCT00561821|12149642|FG003|Overall Study|Not treated|0
7724640|NCT00561821|12149639|FG000|Overall Study|Withdrawal by Subject|0
7724641|NCT00561821|12149640|FG001|Overall Study|Withdrawal by Subject|1
7724642|NCT00561821|12149641|FG002|Overall Study|Withdrawal by Subject|0
7724643|NCT00561821|12149642|FG003|Overall Study|Withdrawal by Subject|2
7724644|NCT00561821|12149639|FG000|Overall Study|Reasons not related to trial|2
7724645|NCT00561821|12149640|FG001|Overall Study|Reasons not related to trial|1
7724646|NCT00561821|12149641|FG002|Overall Study|Reasons not related to trial|0
7724647|NCT00561821|12149642|FG003|Overall Study|Reasons not related to trial|0
7724648|NCT00561821|12149639|FG000|Overall Study|Other (reason not specified)|1
7724649|NCT00561821|12149640|FG001|Overall Study|Other (reason not specified)|1
7724650|NCT00561821|12149641|FG002|Overall Study|Other (reason not specified)|0
7724651|NCT00561821|12149642|FG003|Overall Study|Other (reason not specified)|0
7724652|NCT00561821|12149639|FG000|Overall Study|Adverse Event|2
7724653|NCT00561821|12149640|FG001|Overall Study|Adverse Event|3
7724654|NCT00561821|12149641|FG002|Overall Study|Adverse Event|1
7724655|NCT00561821|12149642|FG003|Overall Study|Adverse Event|1
7724656|NCT00561925|12149659|FG000|14 Day Lead-In Period|Adverse Event|38
7724657|NCT00561925|12149660|FG001|14 Day Lead-In Period|Adverse Event|0
7724658|NCT00561925|12149661|FG002|14 Day Lead-In Period|Adverse Event|0
7724659|NCT00561925|12149662|FG003|14 Day Lead-In Period|Adverse Event|0
7724660|NCT00561925|12149663|FG004|14 Day Lead-In Period|Adverse Event|0
7724661|NCT00561925|12149659|FG000|14 Day Lead-In Period|In/Exclusion criteria|4
7724662|NCT00561925|12149660|FG001|14 Day Lead-In Period|In/Exclusion criteria|0
7724663|NCT00561925|12149661|FG002|14 Day Lead-In Period|In/Exclusion criteria|0
7724664|NCT00561925|12149662|FG003|14 Day Lead-In Period|In/Exclusion criteria|0
7724665|NCT00561925|12149663|FG004|14 Day Lead-In Period|In/Exclusion criteria|0
7724666|NCT00561925|12149659|FG000|14 Day Lead-In Period|Lost to Follow-up|4
7724667|NCT00561925|12149660|FG001|14 Day Lead-In Period|Lost to Follow-up|0
7724668|NCT00561925|12149661|FG002|14 Day Lead-In Period|Lost to Follow-up|0
7724669|NCT00561925|12149662|FG003|14 Day Lead-In Period|Lost to Follow-up|0
7724670|NCT00561925|12149663|FG004|14 Day Lead-In Period|Lost to Follow-up|0
7724671|NCT00561925|12149659|FG000|14 Day Lead-In Period|Withdrawal by Subject|4
7724672|NCT00561925|12149660|FG001|14 Day Lead-In Period|Withdrawal by Subject|0
7724673|NCT00561925|12149661|FG002|14 Day Lead-In Period|Withdrawal by Subject|0
7724674|NCT00561925|12149662|FG003|14 Day Lead-In Period|Withdrawal by Subject|0
7724675|NCT00561925|12149663|FG004|14 Day Lead-In Period|Withdrawal by Subject|0
7724676|NCT00561925|12149659|FG000|14 Day Lead-In Period|Other|5
7724677|NCT00561925|12149660|FG001|14 Day Lead-In Period|Other|0
7724678|NCT00561925|12149661|FG002|14 Day Lead-In Period|Other|0
7724679|NCT00561925|12149662|FG003|14 Day Lead-In Period|Other|0
7724680|NCT00561925|12149663|FG004|14 Day Lead-In Period|Other|0
7724681|NCT00561925|12149659|FG000|144-week Double-blind, Double-dummy|Adverse Event|0
7724682|NCT00561925|12149660|FG001|144-week Double-blind, Double-dummy|Adverse Event|48
7724683|NCT00561925|12149661|FG002|144-week Double-blind, Double-dummy|Adverse Event|43
7724684|NCT00561925|12149662|FG003|144-week Double-blind, Double-dummy|Adverse Event|0
7724685|NCT00561925|12149663|FG004|144-week Double-blind, Double-dummy|Adverse Event|0
7724686|NCT00561925|12149659|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0
7724687|NCT00561925|12149660|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15
7724688|NCT00561925|12149661|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9
7724689|NCT00561925|12149662|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0
7724690|NCT00561925|12149663|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0
7724691|NCT00561925|12149659|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0
7724692|NCT00561925|12149660|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15
7724693|NCT00561925|12149661|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12
7724694|NCT00561925|12149662|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0
7724695|NCT00561925|12149663|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0
7724696|NCT00561925|12149659|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
7724697|NCT00561925|12149660|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
7724698|NCT00561925|12149661|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
7724699|NCT00561925|12149662|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
7724700|NCT00561925|12149663|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
7724701|NCT00561925|12149659|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0
7724702|NCT00561925|12149660|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36
7724703|NCT00561925|12149661|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33
7724704|NCT00561925|12149662|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0
7724705|NCT00561925|12149663|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0
7724706|NCT00561925|12149659|FG000|144-week Double-blind, Double-dummy|Pregnancy|0
7724707|NCT00561925|12149660|FG001|144-week Double-blind, Double-dummy|Pregnancy|1
7724708|NCT00561925|12149661|FG002|144-week Double-blind, Double-dummy|Pregnancy|9
7724709|NCT00561925|12149662|FG003|144-week Double-blind, Double-dummy|Pregnancy|0
7724710|NCT00561925|12149663|FG004|144-week Double-blind, Double-dummy|Pregnancy|0
7724711|NCT00561925|12149659|FG000|144-week Double-blind, Double-dummy|Death|0
7724712|NCT00561925|12149660|FG001|144-week Double-blind, Double-dummy|Death|6
7724713|NCT00561925|12149661|FG002|144-week Double-blind, Double-dummy|Death|3
7724714|NCT00561925|12149662|FG003|144-week Double-blind, Double-dummy|Death|0
7724715|NCT00561925|12149663|FG004|144-week Double-blind, Double-dummy|Death|0
7724716|NCT00561925|12149659|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0
7724717|NCT00561925|12149660|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2
7724718|NCT00561925|12149661|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0
7724719|NCT00561925|12149662|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0
7724720|NCT00561925|12149663|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0
7724721|NCT00561925|12149659|FG000|144-week Double-blind, Double-dummy|Other|0
7724722|NCT00561925|12149660|FG001|144-week Double-blind, Double-dummy|Other|8
7724723|NCT00561925|12149661|FG002|144-week Double-blind, Double-dummy|Other|11
7724724|NCT00561925|12149662|FG003|144-week Double-blind, Double-dummy|Other|0
7724725|NCT00561925|12149663|FG004|144-week Double-blind, Double-dummy|Other|0
7724726|NCT00561925|12149659|FG000|Open-Label Extension Period|Declined entry into extension period|0
7724727|NCT00561925|12149660|FG001|Open-Label Extension Period|Declined entry into extension period|0
7724728|NCT00561925|12149661|FG002|Open-Label Extension Period|Declined entry into extension period|0
7724729|NCT00561925|12149662|FG003|Open-Label Extension Period|Declined entry into extension period|43
7724730|NCT00561925|12149663|FG004|Open-Label Extension Period|Declined entry into extension period|50
7724731|NCT00561951|12149684|FG000|Overall Study|Adverse Event|11
7724732|NCT00561951|12149685|FG001|Overall Study|Adverse Event|14
7724733|NCT00561951|12149686|FG002|Overall Study|Adverse Event|14
7724734|NCT00561951|12149684|FG000|Overall Study|Lack of Efficacy|5
7724735|NCT00561951|12149685|FG001|Overall Study|Lack of Efficacy|3
7724736|NCT00561951|12149686|FG002|Overall Study|Lack of Efficacy|2
7724737|NCT00561951|12149684|FG000|Overall Study|Lost to Follow-up|1
7724738|NCT00561951|12149685|FG001|Overall Study|Lost to Follow-up|1
7724739|NCT00561951|12149686|FG002|Overall Study|Lost to Follow-up|0
7724740|NCT00561951|12149684|FG000|Overall Study|Withdrawal by Subject|10
7724741|NCT00561951|12149685|FG001|Overall Study|Withdrawal by Subject|9
7724742|NCT00561951|12149686|FG002|Overall Study|Withdrawal by Subject|10
7724743|NCT00561951|12149684|FG000|Overall Study|Protocol Violation|4
7724744|NCT00561951|12149685|FG001|Overall Study|Protocol Violation|3
7724745|NCT00561951|12149686|FG002|Overall Study|Protocol Violation|4
7724746|NCT00561951|12149684|FG000|Overall Study|Physician Decision|1
7724747|NCT00561951|12149685|FG001|Overall Study|Physician Decision|0
7724748|NCT00561951|12149686|FG002|Overall Study|Physician Decision|0
7724749|NCT00561951|12149684|FG000|Overall Study|Pregnancy|0
7724750|NCT00561951|12149685|FG001|Overall Study|Pregnancy|1
7724751|NCT00561951|12149686|FG002|Overall Study|Pregnancy|0
7724752|NCT00561951|12149684|FG000|Overall Study|Meet Withdrawal Criterion|0
7724753|NCT00561951|12149685|FG001|Overall Study|Meet Withdrawal Criterion|1
7724754|NCT00561951|12149686|FG002|Overall Study|Meet Withdrawal Criterion|1
7724755|NCT00561951|12149684|FG000|Overall Study|Adverse Event Occured Before Treatment|1
7724756|NCT00561951|12149685|FG001|Overall Study|Adverse Event Occured Before Treatment|2
7724757|NCT00561951|12149686|FG002|Overall Study|Adverse Event Occured Before Treatment|1
7724758|NCT00561977|12149697|FG000|Overall Study|Withdrawal by Subject|0
7724759|NCT00561977|12149698|FG001|Overall Study|Withdrawal by Subject|2
7724760|NCT00561977|12149699|FG002|Overall Study|Withdrawal by Subject|1
7724761|NCT00561977|12149697|FG000|Overall Study|Pregnancy|0
7724762|NCT00561977|12149698|FG001|Overall Study|Pregnancy|1
7724763|NCT00561977|12149699|FG002|Overall Study|Pregnancy|1
7724764|NCT00562094|12149707|FG000|Overall Study|Lost to Follow-up|62
7724765|NCT00562120|12149715|FG000|First Intervention Period|Adverse Event|1
7724766|NCT00562120|12149716|FG001|First Intervention Period|Adverse Event|0
7724767|NCT00562120|12149717|FG002|First Intervention Period|Adverse Event|0
7724768|NCT00562120|12149718|FG003|First Intervention Period|Adverse Event|0
7724769|NCT00562120|12149715|FG000|First Intervention Period|Randomized but not Treated|1
7724770|NCT00562120|12149716|FG001|First Intervention Period|Randomized but not Treated|0
7724771|NCT00562120|12149717|FG002|First Intervention Period|Randomized but not Treated|0
7724772|NCT00562120|12149718|FG003|First Intervention Period|Randomized but not Treated|0
7724773|NCT00562159|12149730|FG000|Overall Study|Adverse Event|11
7724774|NCT00562159|12149731|FG001|Overall Study|Adverse Event|8
7724775|NCT00562159|12149730|FG000|Overall Study|Lost to Follow-up|5
7724776|NCT00562159|12149731|FG001|Overall Study|Lost to Follow-up|4
7724777|NCT00562159|12149730|FG000|Overall Study|Withdrawal by Subject|9
7724778|NCT00562159|12149731|FG001|Overall Study|Withdrawal by Subject|8
7724779|NCT00562159|12149730|FG000|Overall Study|Protocol Violation|12
7724780|NCT00562159|12149731|FG001|Overall Study|Protocol Violation|12
7724781|NCT00562159|12149730|FG000|Overall Study|Did not meet protocol eligibility|1
7724782|NCT00562159|12149731|FG001|Overall Study|Did not meet protocol eligibility|1
7724783|NCT00562302|12149740|FG000|Overall Study|Lost to Follow-up|3
7724784|NCT00562302|12149741|FG001|Overall Study|Lost to Follow-up|3
7724785|NCT00562302|12149740|FG000|Overall Study|Adverse Event|0
7724786|NCT00562302|12149741|FG001|Overall Study|Adverse Event|6
7724787|NCT00562302|12149740|FG000|Overall Study|Non-compliance|1
7724788|NCT00562302|12149741|FG001|Overall Study|Non-compliance|2
7724789|NCT00562302|12149740|FG000|Overall Study|Withdrawal by Subject|7
7724790|NCT00562302|12149741|FG001|Overall Study|Withdrawal by Subject|8
7724791|NCT00562302|12149740|FG000|Overall Study|Death|1
7724792|NCT00562302|12149741|FG001|Overall Study|Death|2
7724793|NCT00562302|12149740|FG000|Overall Study|Lung resection prior to study completion|7
7724794|NCT00562302|12149741|FG001|Overall Study|Lung resection prior to study completion|7
7724795|NCT00562302|12149740|FG000|Overall Study|Not stated|1
7724796|NCT00562302|12149741|FG001|Overall Study|Not stated|4
7724797|NCT00562354|12149759|FG000|Overall Study|Physician Decision|0
7724798|NCT00562354|12149760|FG001|Overall Study|Physician Decision|1
7724799|NCT00562354|12149759|FG000|Overall Study|Lost to Follow-up|0
7724800|NCT00562354|12149760|FG001|Overall Study|Lost to Follow-up|1
7724801|NCT00562484|12149770|FG000|Overall Study|Adverse Event|6
7724802|NCT00562484|12149771|FG001|Overall Study|Adverse Event|1
7724803|NCT00562484|12149770|FG000|Overall Study|Protocol Violation|11
7724804|NCT00562484|12149771|FG001|Overall Study|Protocol Violation|2
7724805|NCT00562484|12149770|FG000|Overall Study|Withdrawal by Subject|12
7724806|NCT00562484|12149771|FG001|Overall Study|Withdrawal by Subject|9
7724807|NCT00562484|12149770|FG000|Overall Study|Moved away from the study area|20
7724808|NCT00562484|12149771|FG001|Overall Study|Moved away from the study area|9
7724809|NCT00562484|12149770|FG000|Overall Study|Lost to Follow-up|132
7724810|NCT00562484|12149771|FG001|Overall Study|Lost to Follow-up|71
7724811|NCT00562484|12149770|FG000|Overall Study|Reason not provided or not specified|25
7724812|NCT00562484|12149771|FG001|Overall Study|Reason not provided or not specified|12
7724813|NCT00562588|12149779|FG000|Overall Study|Adverse Event|40
7724814|NCT00562588|12149780|FG001|Overall Study|Adverse Event|58
7724815|NCT00562588|12149779|FG000|Overall Study|Protocol Violation|30
7724816|NCT00562588|12149780|FG001|Overall Study|Protocol Violation|26
7724817|NCT00562588|12149779|FG000|Overall Study|Lost to Follow-up|12
7724818|NCT00562588|12149780|FG001|Overall Study|Lost to Follow-up|4
7724819|NCT00562588|12149779|FG000|Overall Study|Withdrawal by Subject|10
7724820|NCT00562588|12149780|FG001|Overall Study|Withdrawal by Subject|9
7724821|NCT00562588|12149779|FG000|Overall Study|Other|0
7724822|NCT00562588|12149780|FG001|Overall Study|Other|2
7724823|NCT00562627|12149789|FG000|Overall Study|Protocol Violation|1
7724824|NCT00562627|12149790|FG001|Overall Study|Protocol Violation|1
7724825|NCT00562627|12149791|FG002|Overall Study|Protocol Violation|1
7724826|NCT00562718|12149799|FG000|Overall Study|Death|1
7724827|NCT00562718|12149799|FG000|Overall Study|Withdrawal by Subject|3
7724828|NCT00562718|12149799|FG000|Overall Study|Adverse Event|4
7724829|NCT00562718|12149799|FG000|Overall Study|Lack of Efficacy|2
7724830|NCT00562718|12149799|FG000|Overall Study|not stated|1
7724831|NCT00562861|12149805|FG000|Overall Study|Adverse Event|1
7724832|NCT00562861|12149806|FG001|Overall Study|Adverse Event|1
7724833|NCT00562861|12149805|FG000|Overall Study|Lack of Efficacy|5
7724834|NCT00562861|12149806|FG001|Overall Study|Lack of Efficacy|5
7724835|NCT00562861|12149805|FG000|Overall Study|noncompliance, moved|7
7724836|NCT00562861|12149806|FG001|Overall Study|noncompliance, moved|2
7724837|NCT00562861|12149805|FG000|Overall Study|Lost to Follow-up|7
7724838|NCT00562861|12149806|FG001|Overall Study|Lost to Follow-up|3
7724839|NCT00562965|12149814|FG000|Overall Study|Withdrawal by Subject|0
7724840|NCT00562965|12149815|FG001|Overall Study|Withdrawal by Subject|1
7724841|NCT00562965|12149814|FG000|Overall Study|Death|2
7724842|NCT00562965|12149815|FG001|Overall Study|Death|4
7724843|NCT00562965|12149814|FG000|Overall Study|Lost to Follow-up|1
7724844|NCT00562965|12149815|FG001|Overall Study|Lost to Follow-up|0
7724845|NCT00562965|12149814|FG000|Overall Study|Other|0
7724846|NCT00562965|12149815|FG001|Overall Study|Other|1
7724847|NCT00562978|12149823|FG000|Overall Study|Patient had imaging dose only|1
7724848|NCT00562978|12149824|FG001|Overall Study|Patient had imaging dose only|11
7724849|NCT00563186|12149832|FG000|Overall Study|LOS<48 hours|97
7724850|NCT00563186|12149833|FG001|Overall Study|LOS<48 hours|74
7724851|NCT00563186|12149832|FG000|Overall Study|Incomplete data|1
7724852|NCT00563186|12149833|FG001|Overall Study|Incomplete data|1
7724853|NCT00563316|12149853|FG000|Overall Study|Adverse Event|2
7724854|NCT00563316|12149853|FG000|Overall Study|Physician Decision|1
7724855|NCT00563316|12149853|FG000|Overall Study|Lost to Follow-up|2
7724856|NCT00563316|12149853|FG000|Overall Study|Death|1
7724857|NCT00563316|12149853|FG000|Overall Study|On-going in study as of 16 July 2009.|5
7724858|NCT00563316|12149853|FG000|Overall Study|Other|1
7724859|NCT00563368|12149868|FG000|Overall Study|Lost to Follow-up|14
7724860|NCT00563368|12149869|FG001|Overall Study|Lost to Follow-up|14
7724861|NCT00563368|12149870|FG002|Overall Study|Lost to Follow-up|12
7724862|NCT00563368|12149871|FG003|Overall Study|Lost to Follow-up|6
7724863|NCT00563368|12149872|FG004|Overall Study|Lost to Follow-up|9
7724864|NCT00563368|12149873|FG005|Overall Study|Lost to Follow-up|8
7724865|NCT00563368|12149874|FG006|Overall Study|Lost to Follow-up|9
7724866|NCT00563368|12149868|FG000|Overall Study|Adverse Event|3
7724867|NCT00563368|12149869|FG001|Overall Study|Adverse Event|4
7724868|NCT00563368|12149870|FG002|Overall Study|Adverse Event|5
7724869|NCT00563368|12149871|FG003|Overall Study|Adverse Event|9
7724870|NCT00563368|12149872|FG004|Overall Study|Adverse Event|6
7724871|NCT00563368|12149873|FG005|Overall Study|Adverse Event|10
7724872|NCT00563368|12149874|FG006|Overall Study|Adverse Event|17
7724873|NCT00563368|12149868|FG000|Overall Study|Withdrawal by Subject|11
7724874|NCT00563368|12149869|FG001|Overall Study|Withdrawal by Subject|6
7724875|NCT00563368|12149870|FG002|Overall Study|Withdrawal by Subject|5
7724876|NCT00563368|12149871|FG003|Overall Study|Withdrawal by Subject|7
7724877|NCT00563368|12149872|FG004|Overall Study|Withdrawal by Subject|8
7724878|NCT00563368|12149873|FG005|Overall Study|Withdrawal by Subject|5
7724879|NCT00563368|12149874|FG006|Overall Study|Withdrawal by Subject|4
7724880|NCT00563368|12149868|FG000|Overall Study|protocol non-compliance|1
7724881|NCT00563368|12149869|FG001|Overall Study|protocol non-compliance|1
7724882|NCT00563368|12149870|FG002|Overall Study|protocol non-compliance|2
7724883|NCT00563368|12149871|FG003|Overall Study|protocol non-compliance|1
7724884|NCT00563368|12149872|FG004|Overall Study|protocol non-compliance|0
7724885|NCT00563368|12149873|FG005|Overall Study|protocol non-compliance|1
7724886|NCT00563368|12149874|FG006|Overall Study|protocol non-compliance|3
7724887|NCT00563368|12149868|FG000|Overall Study|Pregnancy|1
7724888|NCT00563368|12149869|FG001|Overall Study|Pregnancy|0
7724889|NCT00563368|12149870|FG002|Overall Study|Pregnancy|1
7724890|NCT00563368|12149871|FG003|Overall Study|Pregnancy|2
7724891|NCT00563368|12149872|FG004|Overall Study|Pregnancy|1
7724892|NCT00563368|12149873|FG005|Overall Study|Pregnancy|2
7724893|NCT00563368|12149874|FG006|Overall Study|Pregnancy|0
7724894|NCT00563368|12149868|FG000|Overall Study|requirement for restricted medication|0
7724895|NCT00563368|12149869|FG001|Overall Study|requirement for restricted medication|0
7724896|NCT00563368|12149870|FG002|Overall Study|requirement for restricted medication|2
7724897|NCT00563368|12149871|FG003|Overall Study|requirement for restricted medication|0
7724898|NCT00563368|12149872|FG004|Overall Study|requirement for restricted medication|0
7724899|NCT00563368|12149873|FG005|Overall Study|requirement for restricted medication|0
7724900|NCT00563368|12149874|FG006|Overall Study|requirement for restricted medication|0
7724901|NCT00563368|12149868|FG000|Overall Study|Other|5
7724902|NCT00563368|12149869|FG001|Overall Study|Other|5
7724903|NCT00563368|12149870|FG002|Overall Study|Other|3
7724904|NCT00563368|12149871|FG003|Overall Study|Other|4
7724905|NCT00563368|12149872|FG004|Overall Study|Other|4
7724906|NCT00563368|12149873|FG005|Overall Study|Other|4
7724907|NCT00563368|12149874|FG006|Overall Study|Other|0
7724908|NCT00563381|12149892|FG000|Overall Study|Adverse Event|264
7724909|NCT00563381|12149893|FG001|Overall Study|Adverse Event|292
7724910|NCT00563381|12149892|FG000|Overall Study|Protocol Violation|66
7724911|NCT00563381|12149893|FG001|Overall Study|Protocol Violation|74
7724912|NCT00563381|12149892|FG000|Overall Study|Lost to Follow-up|7
7724913|NCT00563381|12149893|FG001|Overall Study|Lost to Follow-up|15
7724914|NCT00563381|12149892|FG000|Overall Study|Withdrawal by Subject|192
7724915|NCT00563381|12149893|FG001|Overall Study|Withdrawal by Subject|209
7724916|NCT00563381|12149892|FG000|Overall Study|Lack of Efficacy|32
7724917|NCT00563381|12149893|FG001|Overall Study|Lack of Efficacy|24
7724918|NCT00563381|12149892|FG000|Overall Study|Individual different reasons|24
7724919|NCT00563381|12149893|FG001|Overall Study|Individual different reasons|34
7724920|NCT00563706|12149908|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
7724921|NCT00563706|12149909|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
7724922|NCT00563706|12149910|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
7724923|NCT00563706|12149911|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
7724924|NCT00563706|12149912|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
7724925|NCT00563706|12149913|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
7724926|NCT00563706|12149914|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
7724927|NCT00563706|12149915|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
7724928|NCT00563706|12149916|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
7724929|NCT00563706|12149908|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
7724930|NCT00563706|12149909|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
7724931|NCT00563706|12149910|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
7724932|NCT00563706|12149911|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
7724933|NCT00563706|12149912|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
7724934|NCT00563706|12149913|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
7724935|NCT00563706|12149914|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
7724936|NCT00563706|12149915|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
7724937|NCT00563706|12149916|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
7724938|NCT00563706|12149908|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
7724939|NCT00563706|12149909|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
7724940|NCT00563706|12149910|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
7724941|NCT00563706|12149911|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
7724942|NCT00563706|12149912|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
7724943|NCT00563706|12149913|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
7724944|NCT00563706|12149914|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
7724945|NCT00563706|12149915|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
7724946|NCT00563706|12149916|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
7724947|NCT00563706|12149908|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
7724948|NCT00563706|12149909|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7724949|NCT00563706|12149910|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7724950|NCT00563706|12149911|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7724951|NCT00563706|12149912|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7724952|NCT00563706|12149913|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7724953|NCT00563706|12149914|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7724954|NCT00563706|12149915|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
7724955|NCT00563706|12149916|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7724956|NCT00563706|12149908|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0
7724957|NCT00563706|12149909|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0
7724958|NCT00563706|12149910|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0
7724959|NCT00563706|12149911|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0
7724960|NCT00563706|12149912|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0
7724961|NCT00563706|12149913|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0
7724962|NCT00563706|12149914|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0
7724963|NCT00563706|12149915|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1
7724964|NCT00563706|12149916|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2
7724965|NCT00563784|12149936|FG000|Overall Study|Withdrawal by Subject|2
7724966|NCT00563784|12149936|FG000|Overall Study|Screen Failures|20
7724967|NCT00563797|12149942|FG000|Overall Study|Lost to Follow-up|7
7724968|NCT00563797|12149943|FG001|Overall Study|Lost to Follow-up|2
7724969|NCT00564018|12149954|FG000|Overall Study|Withdrawal by Subject|2
7724970|NCT00564018|12149955|FG001|Overall Study|Withdrawal by Subject|3
7724971|NCT00564018|12149956|FG002|Overall Study|Withdrawal by Subject|1
7724972|NCT00564070|12149966|FG000|Overall Study|Lost to Follow-up|9
7724973|NCT00564070|12149967|FG001|Overall Study|Lost to Follow-up|7
7724974|NCT00564070|12149966|FG000|Overall Study|Worsening depression, referred to care|3
7724975|NCT00564070|12149967|FG001|Overall Study|Worsening depression, referred to care|0
7768009|NCT00856986|12210884|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
7768010|NCT00856986|12210880|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0
7768011|NCT00856986|12210881|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0
7768012|NCT00856986|12210882|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0
7768013|NCT00856986|12210883|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11
7768014|NCT00856986|12210884|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0
7768015|NCT00856986|12210880|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0
7768016|NCT00856986|12210881|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0
7768017|NCT00856986|12210882|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0
7768018|NCT00856986|12210883|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6
7768019|NCT00856986|12210884|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0
7768020|NCT00856986|12210880|FG000|Run-in Period, Weeks -12-0|Unclassified|0
7768021|NCT00856986|12210881|FG001|Run-in Period, Weeks -12-0|Unclassified|0
7768022|NCT00856986|12210882|FG002|Run-in Period, Weeks -12-0|Unclassified|0
7768023|NCT00856986|12210883|FG003|Run-in Period, Weeks -12-0|Unclassified|24
7768024|NCT00856986|12210884|FG004|Run-in Period, Weeks -12-0|Unclassified|0
7768025|NCT00856986|12210880|FG000|Main Period, Weeks 0-26|Adverse Event|6
7768026|NCT00856986|12210881|FG001|Main Period, Weeks 0-26|Adverse Event|4
7768027|NCT00856986|12210882|FG002|Main Period, Weeks 0-26|Adverse Event|9
7768028|NCT00856986|12210883|FG003|Main Period, Weeks 0-26|Adverse Event|0
7768029|NCT00856986|12210884|FG004|Main Period, Weeks 0-26|Adverse Event|0
7768030|NCT00856986|12210880|FG000|Main Period, Weeks 0-26|Protocol Violation|4
7768031|NCT00856986|12210881|FG001|Main Period, Weeks 0-26|Protocol Violation|5
7768032|NCT00856986|12210882|FG002|Main Period, Weeks 0-26|Protocol Violation|7
7768033|NCT00856986|12210883|FG003|Main Period, Weeks 0-26|Protocol Violation|0
7768034|NCT00856986|12210884|FG004|Main Period, Weeks 0-26|Protocol Violation|0
7768035|NCT00856986|12210880|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11
7768036|NCT00856986|12210881|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0
7768037|NCT00856986|12210882|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3
7768038|NCT00856986|12210883|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0
7768039|NCT00856986|12210884|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0
7768040|NCT00856986|12210880|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1
7768041|NCT00856986|12210881|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1
7768042|NCT00856986|12210882|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2
7768043|NCT00856986|12210883|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0
7768044|NCT00856986|12210884|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0
7768045|NCT00856986|12210880|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5
7768046|NCT00856986|12210881|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2
7768047|NCT00856986|12210882|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0
7768048|NCT00856986|12210883|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0
7768049|NCT00856986|12210884|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0
7768050|NCT00856986|12210880|FG000|Main Period, Weeks 0-26|Unclassified|7
7768051|NCT00856986|12210881|FG001|Main Period, Weeks 0-26|Unclassified|6
7768052|NCT00856986|12210882|FG002|Main Period, Weeks 0-26|Unclassified|7
7768053|NCT00856986|12210883|FG003|Main Period, Weeks 0-26|Unclassified|0
7768054|NCT00856986|12210884|FG004|Main Period, Weeks 0-26|Unclassified|0
7768055|NCT00856986|12210880|FG000|Extension Period, Weeks 26-52|Adverse Event|3
7768056|NCT00856986|12210881|FG001|Extension Period, Weeks 26-52|Adverse Event|3
7768057|NCT00856986|12210882|FG002|Extension Period, Weeks 26-52|Adverse Event|10
7768058|NCT00856986|12210883|FG003|Extension Period, Weeks 26-52|Adverse Event|0
7768059|NCT00856986|12210884|FG004|Extension Period, Weeks 26-52|Adverse Event|0
7768060|NCT00856986|12210880|FG000|Extension Period, Weeks 26-52|Protocol Violation|6
7768061|NCT00856986|12210881|FG001|Extension Period, Weeks 26-52|Protocol Violation|2
7768062|NCT00856986|12210882|FG002|Extension Period, Weeks 26-52|Protocol Violation|5
7768063|NCT00856986|12210883|FG003|Extension Period, Weeks 26-52|Protocol Violation|0
7768064|NCT00856986|12210884|FG004|Extension Period, Weeks 26-52|Protocol Violation|0
7768065|NCT00856986|12210880|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2
7768066|NCT00856986|12210881|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0
7724976|NCT05085665|12149977|FG000|Overall Study|Physician Decision|2
7724977|NCT04080752|12150001|FG000|Overall Study|Adverse Event|2
7724978|NCT04080752|12150002|FG001|Overall Study|Adverse Event|3
7724979|NCT04080752|12150001|FG000|Overall Study|Lack of Efficacy|1
7724980|NCT04080752|12150002|FG001|Overall Study|Lack of Efficacy|0
7724981|NCT04080752|12150001|FG000|Overall Study|Lost to Follow-up|1
7724982|NCT04080752|12150002|FG001|Overall Study|Lost to Follow-up|0
7724983|NCT04080752|12150001|FG000|Overall Study|Pregnancy|0
7724984|NCT04080752|12150002|FG001|Overall Study|Pregnancy|1
7724985|NCT04080752|12150001|FG000|Overall Study|Withdrawal by Subject|7
7724986|NCT04080752|12150002|FG001|Overall Study|Withdrawal by Subject|0
7724987|NCT04080752|12150001|FG000|Overall Study|Non-Compliance with Study Drug|0
7724988|NCT04080752|12150002|FG001|Overall Study|Non-Compliance with Study Drug|1
7724989|NCT04080752|12150001|FG000|Overall Study|Other|2
7724990|NCT04080752|12150002|FG001|Overall Study|Other|1
7724991|NCT03799627|12150023|FG000|Overall Study|Adverse Event|1
7724992|NCT03799627|12150024|FG001|Overall Study|Adverse Event|2
7724993|NCT03799627|12150025|FG002|Overall Study|Adverse Event|0
7724994|NCT03799627|12150026|FG003|Overall Study|Adverse Event|0
7724995|NCT03799627|12150027|FG004|Overall Study|Adverse Event|2
7724996|NCT03799627|12150028|FG005|Overall Study|Adverse Event|5
7724997|NCT03799627|12150029|FG006|Overall Study|Adverse Event|0
7724998|NCT03799627|12150030|FG007|Overall Study|Adverse Event|2
7724999|NCT03799627|12150031|FG008|Overall Study|Adverse Event|0
7725000|NCT03799627|12150023|FG000|Overall Study|Physician Decision|2
7725001|NCT03799627|12150024|FG001|Overall Study|Physician Decision|2
7725002|NCT03799627|12150025|FG002|Overall Study|Physician Decision|0
7725003|NCT03799627|12150026|FG003|Overall Study|Physician Decision|0
7725004|NCT03799627|12150027|FG004|Overall Study|Physician Decision|2
7725005|NCT03799627|12150028|FG005|Overall Study|Physician Decision|2
7725006|NCT03799627|12150029|FG006|Overall Study|Physician Decision|0
7725007|NCT03799627|12150030|FG007|Overall Study|Physician Decision|0
7725008|NCT03799627|12150031|FG008|Overall Study|Physician Decision|0
7725009|NCT03799627|12150023|FG000|Overall Study|Withdrawal by Subject|1
7725010|NCT03799627|12150024|FG001|Overall Study|Withdrawal by Subject|1
7725011|NCT03799627|12150025|FG002|Overall Study|Withdrawal by Subject|0
7725012|NCT03799627|12150026|FG003|Overall Study|Withdrawal by Subject|2
7725013|NCT03799627|12150027|FG004|Overall Study|Withdrawal by Subject|0
7725014|NCT03799627|12150028|FG005|Overall Study|Withdrawal by Subject|3
7725015|NCT03799627|12150029|FG006|Overall Study|Withdrawal by Subject|0
7725016|NCT03799627|12150030|FG007|Overall Study|Withdrawal by Subject|0
7725017|NCT03799627|12150031|FG008|Overall Study|Withdrawal by Subject|0
7725018|NCT03799627|12150023|FG000|Overall Study|Lack of Efficacy|0
7725019|NCT03799627|12150024|FG001|Overall Study|Lack of Efficacy|0
7725020|NCT03799627|12150025|FG002|Overall Study|Lack of Efficacy|0
7725021|NCT03799627|12150026|FG003|Overall Study|Lack of Efficacy|1
7725022|NCT03799627|12150027|FG004|Overall Study|Lack of Efficacy|0
7725023|NCT03799627|12150028|FG005|Overall Study|Lack of Efficacy|0
7725024|NCT03799627|12150029|FG006|Overall Study|Lack of Efficacy|0
7725025|NCT03799627|12150030|FG007|Overall Study|Lack of Efficacy|0
7725026|NCT03799627|12150031|FG008|Overall Study|Lack of Efficacy|0
7725027|NCT03799627|12150023|FG000|Overall Study|Lost to Follow-up|0
7725028|NCT03799627|12150024|FG001|Overall Study|Lost to Follow-up|0
7725029|NCT03799627|12150025|FG002|Overall Study|Lost to Follow-up|0
7725030|NCT03799627|12150026|FG003|Overall Study|Lost to Follow-up|0
7725031|NCT03799627|12150027|FG004|Overall Study|Lost to Follow-up|0
7725032|NCT03799627|12150028|FG005|Overall Study|Lost to Follow-up|0
7725033|NCT03799627|12150029|FG006|Overall Study|Lost to Follow-up|1
7725034|NCT03799627|12150030|FG007|Overall Study|Lost to Follow-up|0
7725035|NCT03799627|12150031|FG008|Overall Study|Lost to Follow-up|1
7725036|NCT03799627|12150023|FG000|Overall Study|Death|0
7725037|NCT03799627|12150024|FG001|Overall Study|Death|0
7725038|NCT03799627|12150025|FG002|Overall Study|Death|0
7725039|NCT03799627|12150026|FG003|Overall Study|Death|1
7725040|NCT03799627|12150027|FG004|Overall Study|Death|0
7725041|NCT03799627|12150028|FG005|Overall Study|Death|0
7725042|NCT03799627|12150029|FG006|Overall Study|Death|0
7725043|NCT03799627|12150030|FG007|Overall Study|Death|0
7725044|NCT03799627|12150031|FG008|Overall Study|Death|0
7725045|NCT03799627|12150023|FG000|Overall Study|Study Drug Put on Hold|1
7725046|NCT03799627|12150024|FG001|Overall Study|Study Drug Put on Hold|0
7725047|NCT03799627|12150025|FG002|Overall Study|Study Drug Put on Hold|0
7725048|NCT03799627|12150026|FG003|Overall Study|Study Drug Put on Hold|0
7725049|NCT03799627|12150027|FG004|Overall Study|Study Drug Put on Hold|0
7725050|NCT03799627|12150028|FG005|Overall Study|Study Drug Put on Hold|0
7725051|NCT03799627|12150029|FG006|Overall Study|Study Drug Put on Hold|0
7725052|NCT03799627|12150030|FG007|Overall Study|Study Drug Put on Hold|0
7725053|NCT03799627|12150031|FG008|Overall Study|Study Drug Put on Hold|0
7725054|NCT03799627|12150023|FG000|Overall Study|Due to Urgent Safety Measures Letter|1
7725055|NCT03799627|12150024|FG001|Overall Study|Due to Urgent Safety Measures Letter|2
7725056|NCT03799627|12150025|FG002|Overall Study|Due to Urgent Safety Measures Letter|0
7725057|NCT03799627|12150026|FG003|Overall Study|Due to Urgent Safety Measures Letter|2
7725058|NCT03799627|12150027|FG004|Overall Study|Due to Urgent Safety Measures Letter|1
7725059|NCT03799627|12150028|FG005|Overall Study|Due to Urgent Safety Measures Letter|0
7725060|NCT03799627|12150029|FG006|Overall Study|Due to Urgent Safety Measures Letter|0
7725061|NCT03799627|12150030|FG007|Overall Study|Due to Urgent Safety Measures Letter|0
7725062|NCT03799627|12150031|FG008|Overall Study|Due to Urgent Safety Measures Letter|0
7725063|NCT03799627|12150023|FG000|Overall Study|Kidney Transplantation|1
7725064|NCT03799627|12150024|FG001|Overall Study|Kidney Transplantation|0
7725065|NCT03799627|12150025|FG002|Overall Study|Kidney Transplantation|0
7725066|NCT03799627|12150026|FG003|Overall Study|Kidney Transplantation|1
7725067|NCT03799627|12150027|FG004|Overall Study|Kidney Transplantation|1
7725068|NCT03799627|12150028|FG005|Overall Study|Kidney Transplantation|0
7725069|NCT03799627|12150029|FG006|Overall Study|Kidney Transplantation|0
7725070|NCT03799627|12150030|FG007|Overall Study|Kidney Transplantation|0
7725071|NCT03799627|12150031|FG008|Overall Study|Kidney Transplantation|0
7725072|NCT03799627|12150023|FG000|Overall Study|Participant Was on Rescue Epogen|0
7725073|NCT03799627|12150024|FG001|Overall Study|Participant Was on Rescue Epogen|1
7725074|NCT03799627|12150025|FG002|Overall Study|Participant Was on Rescue Epogen|0
7725075|NCT03799627|12150026|FG003|Overall Study|Participant Was on Rescue Epogen|0
7725076|NCT03799627|12150027|FG004|Overall Study|Participant Was on Rescue Epogen|0
7725077|NCT03799627|12150028|FG005|Overall Study|Participant Was on Rescue Epogen|0
7725078|NCT03799627|12150029|FG006|Overall Study|Participant Was on Rescue Epogen|1
7725079|NCT03799627|12150030|FG007|Overall Study|Participant Was on Rescue Epogen|0
7725080|NCT03799627|12150031|FG008|Overall Study|Participant Was on Rescue Epogen|1
7725081|NCT03799627|12150023|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0
7725082|NCT03799627|12150024|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1
7725083|NCT03799627|12150025|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0
7725084|NCT03799627|12150026|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0
7725085|NCT03799627|12150027|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0
7725086|NCT03799627|12150028|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0
7725087|NCT03799627|12150029|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0
7725088|NCT03799627|12150030|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0
7725089|NCT03799627|12150031|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0
7725090|NCT03799627|12150023|FG000|Overall Study|Met Exclusion Criteria|0
7725091|NCT03799627|12150024|FG001|Overall Study|Met Exclusion Criteria|0
7725092|NCT03799627|12150025|FG002|Overall Study|Met Exclusion Criteria|0
7725093|NCT03799627|12150026|FG003|Overall Study|Met Exclusion Criteria|1
7725094|NCT03799627|12150027|FG004|Overall Study|Met Exclusion Criteria|0
7725095|NCT03799627|12150028|FG005|Overall Study|Met Exclusion Criteria|0
7725096|NCT03799627|12150029|FG006|Overall Study|Met Exclusion Criteria|0
7725097|NCT03799627|12150030|FG007|Overall Study|Met Exclusion Criteria|0
7725098|NCT03799627|12150031|FG008|Overall Study|Met Exclusion Criteria|0
7725099|NCT03799627|12150023|FG000|Overall Study|Investigational Product Noncompliance|0
7725100|NCT03799627|12150024|FG001|Overall Study|Investigational Product Noncompliance|0
7725101|NCT03799627|12150025|FG002|Overall Study|Investigational Product Noncompliance|0
7725102|NCT03799627|12150026|FG003|Overall Study|Investigational Product Noncompliance|1
7725103|NCT03799627|12150027|FG004|Overall Study|Investigational Product Noncompliance|0
7725104|NCT03799627|12150028|FG005|Overall Study|Investigational Product Noncompliance|0
7725105|NCT03799627|12150029|FG006|Overall Study|Investigational Product Noncompliance|0
7725106|NCT03799627|12150030|FG007|Overall Study|Investigational Product Noncompliance|0
7725107|NCT03799627|12150031|FG008|Overall Study|Investigational Product Noncompliance|0
7725108|NCT03799627|12150023|FG000|Overall Study|Participant Relocation|0
7725109|NCT03799627|12150024|FG001|Overall Study|Participant Relocation|0
7725110|NCT03799627|12150025|FG002|Overall Study|Participant Relocation|0
7725111|NCT03799627|12150026|FG003|Overall Study|Participant Relocation|1
7725112|NCT03799627|12150027|FG004|Overall Study|Participant Relocation|0
7725113|NCT03799627|12150028|FG005|Overall Study|Participant Relocation|1
7725114|NCT03799627|12150029|FG006|Overall Study|Participant Relocation|0
7725115|NCT03799627|12150030|FG007|Overall Study|Participant Relocation|0
7725116|NCT03799627|12150031|FG008|Overall Study|Participant Relocation|0
7725117|NCT03799627|12150023|FG000|Overall Study|Eurofin Issue|0
7725118|NCT03799627|12150024|FG001|Overall Study|Eurofin Issue|0
7725119|NCT03799627|12150025|FG002|Overall Study|Eurofin Issue|0
7725120|NCT03799627|12150026|FG003|Overall Study|Eurofin Issue|0
7725121|NCT03799627|12150027|FG004|Overall Study|Eurofin Issue|1
7725122|NCT03799627|12150028|FG005|Overall Study|Eurofin Issue|0
7725123|NCT03799627|12150029|FG006|Overall Study|Eurofin Issue|0
7725124|NCT03799627|12150030|FG007|Overall Study|Eurofin Issue|0
7725125|NCT03799627|12150031|FG008|Overall Study|Eurofin Issue|0
7725126|NCT03799627|12150023|FG000|Overall Study|Noncompliance with Site Instructions|0
7725127|NCT03799627|12150024|FG001|Overall Study|Noncompliance with Site Instructions|0
7725128|NCT03799627|12150025|FG002|Overall Study|Noncompliance with Site Instructions|0
7725129|NCT03799627|12150026|FG003|Overall Study|Noncompliance with Site Instructions|0
7725130|NCT03799627|12150027|FG004|Overall Study|Noncompliance with Site Instructions|1
7725131|NCT03799627|12150028|FG005|Overall Study|Noncompliance with Site Instructions|0
7725132|NCT03799627|12150029|FG006|Overall Study|Noncompliance with Site Instructions|0
7725133|NCT03799627|12150030|FG007|Overall Study|Noncompliance with Site Instructions|0
7725134|NCT03799627|12150031|FG008|Overall Study|Noncompliance with Site Instructions|0
7725135|NCT03799627|12150023|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0
7725136|NCT03799627|12150024|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0
7725137|NCT03799627|12150025|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0
7725138|NCT03799627|12150026|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0
7725139|NCT03799627|12150027|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1
7725140|NCT03799627|12150028|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0
7725141|NCT03799627|12150029|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0
7725142|NCT03799627|12150030|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0
7725143|NCT03799627|12150031|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0
7725144|NCT03799627|12150023|FG000|Overall Study|Changes In Hemoglobin Values|1
7725145|NCT03799627|12150024|FG001|Overall Study|Changes In Hemoglobin Values|2
7725146|NCT03799627|12150025|FG002|Overall Study|Changes In Hemoglobin Values|1
7725147|NCT03799627|12150026|FG003|Overall Study|Changes In Hemoglobin Values|0
7725148|NCT03799627|12150027|FG004|Overall Study|Changes In Hemoglobin Values|0
7725149|NCT03799627|12150028|FG005|Overall Study|Changes In Hemoglobin Values|2
7725150|NCT03799627|12150029|FG006|Overall Study|Changes In Hemoglobin Values|1
7725151|NCT03799627|12150030|FG007|Overall Study|Changes In Hemoglobin Values|0
7725152|NCT03799627|12150031|FG008|Overall Study|Changes In Hemoglobin Values|1
7725153|NCT03735498|12150070|FG000|Overall Study|Withdrawal by Subject|5
7725154|NCT03735498|12150070|FG000|Overall Study|one participant only completed 5 of 6 sessions|1
7725155|NCT03734679|12150074|FG000|Overall Study|Missed Visit|1
7725156|NCT03707587|12150080|FG000|Overall Study|Death|0
7725157|NCT03707587|12150081|FG001|Overall Study|Death|1
7725158|NCT03659136|12150089|FG000|Overall Study|COVID-19 related|1
7725159|NCT03659136|12150090|FG001|Overall Study|COVID-19 related|1
7725160|NCT03659136|12150089|FG000|Overall Study|Withdrawal by Subject|0
7725161|NCT03659136|12150090|FG001|Overall Study|Withdrawal by Subject|6
7725162|NCT03659136|12150089|FG000|Overall Study|Adverse Event|4
7725163|NCT03659136|12150090|FG001|Overall Study|Adverse Event|7
7725164|NCT03659136|12150089|FG000|Overall Study|Progressive disease|34
7725165|NCT03659136|12150090|FG001|Overall Study|Progressive disease|24
7725166|NCT03659136|12150089|FG000|Overall Study|Not treated|2
7725167|NCT03659136|12150090|FG001|Overall Study|Not treated|0
7725168|NCT03659136|12150089|FG000|Overall Study|Not specified above|2
7725169|NCT03659136|12150090|FG001|Overall Study|Not specified above|1
7725170|NCT03595332|12150108|FG000|Overall Study|Lost to Follow-up|16
7725171|NCT03595332|12150109|FG001|Overall Study|Lost to Follow-up|22
7725172|NCT03595332|12150108|FG000|Overall Study|Unable to retrieve ID from school|0
7725173|NCT03595332|12150109|FG001|Overall Study|Unable to retrieve ID from school|2
7725174|NCT02928224|12150122|FG000|Overall Study|Randomized, Not Treated|0
7725175|NCT02928224|12150123|FG001|Overall Study|Randomized, Not Treated|2
7725176|NCT02928224|12150124|FG002|Overall Study|Randomized, Not Treated|4
7725177|NCT02928224|12150125|FG003|Overall Study|Randomized, Not Treated|28
7725178|NCT02928224|12150122|FG000|Overall Study|Treatment Ongoing|6
7725179|NCT02928224|12150123|FG001|Overall Study|Treatment Ongoing|78
7725180|NCT02928224|12150124|FG002|Overall Study|Treatment Ongoing|78
7725181|NCT02928224|12150125|FG003|Overall Study|Treatment Ongoing|37
7725182|NCT02928224|12150122|FG000|Overall Study|Progressive Disease|23
7725183|NCT02928224|12150123|FG001|Overall Study|Progressive Disease|104
7725184|NCT02928224|12150124|FG002|Overall Study|Progressive Disease|101
7725185|NCT02928224|12150125|FG003|Overall Study|Progressive Disease|103
7725186|NCT02928224|12150122|FG000|Overall Study|Adverse Event|2
7725187|NCT02928224|12150123|FG001|Overall Study|Adverse Event|11
7725188|NCT02928224|12150124|FG002|Overall Study|Adverse Event|11
7725189|NCT02928224|12150125|FG003|Overall Study|Adverse Event|10
7725190|NCT02928224|12150122|FG000|Overall Study|Changes in Patient's Condition|3
7725191|NCT02928224|12150123|FG001|Overall Study|Changes in Patient's Condition|9
7725192|NCT02928224|12150124|FG002|Overall Study|Changes in Patient's Condition|9
7725193|NCT02928224|12150125|FG003|Overall Study|Changes in Patient's Condition|13
7725194|NCT02928224|12150122|FG000|Overall Study|Death|1
7725195|NCT02928224|12150123|FG001|Overall Study|Death|7
7725196|NCT02928224|12150124|FG002|Overall Study|Death|5
7725197|NCT02928224|12150125|FG003|Overall Study|Death|11
7725198|NCT02928224|12150122|FG000|Overall Study|Withdrawal by Subject|1
7725199|NCT02928224|12150123|FG001|Overall Study|Withdrawal by Subject|4
7725200|NCT02928224|12150124|FG002|Overall Study|Withdrawal by Subject|3
7725201|NCT02928224|12150125|FG003|Overall Study|Withdrawal by Subject|9
7725202|NCT02928224|12150122|FG000|Overall Study|Dose Interruptions>28|1
7725203|NCT02928224|12150123|FG001|Overall Study|Dose Interruptions>28|2
7725204|NCT02928224|12150124|FG002|Overall Study|Dose Interruptions>28|2
7725205|NCT02928224|12150125|FG003|Overall Study|Dose Interruptions>28|4
7725206|NCT02928224|12150122|FG000|Overall Study|Patient Decision to Discontinue Drug|0
7725207|NCT02928224|12150123|FG001|Overall Study|Patient Decision to Discontinue Drug|2
7725208|NCT02928224|12150124|FG002|Overall Study|Patient Decision to Discontinue Drug|2
7725209|NCT02928224|12150125|FG003|Overall Study|Patient Decision to Discontinue Drug|4
7725210|NCT02928224|12150122|FG000|Overall Study|Physician Decision|0
7725211|NCT02928224|12150123|FG001|Overall Study|Physician Decision|2
7725212|NCT02928224|12150124|FG002|Overall Study|Physician Decision|4
7725213|NCT02928224|12150125|FG003|Overall Study|Physician Decision|2
7725214|NCT02928224|12150122|FG000|Overall Study|not listed|0
7725215|NCT02928224|12150123|FG001|Overall Study|not listed|3
7725216|NCT02928224|12150124|FG002|Overall Study|not listed|1
7725217|NCT02928224|12150125|FG003|Overall Study|not listed|0
7725218|NCT02702401|12150142|FG000|Overall Study|Death|242
7725219|NCT02702401|12150143|FG001|Overall Study|Death|125
7725220|NCT02702401|12150142|FG000|Overall Study|Withdrawal by Subject|15
7725221|NCT02702401|12150143|FG001|Overall Study|Withdrawal by Subject|5
7725222|NCT02702401|12150142|FG000|Overall Study|Sponsor Decision|19
7725223|NCT02702401|12150143|FG001|Overall Study|Sponsor Decision|3
7725224|NCT02702401|12150142|FG000|Overall Study|Physician Decision|1
7725225|NCT02702401|12150143|FG001|Overall Study|Physician Decision|2
7725226|NCT02702401|12150142|FG000|Overall Study|Lost to Follow-up|1
7725227|NCT02702401|12150143|FG001|Overall Study|Lost to Follow-up|0
7725228|NCT02646982|12150152|FG000|Overall Study|Adverse Event|1
7725229|NCT02646982|12150153|FG001|Overall Study|Adverse Event|1
7725230|NCT02646982|12150152|FG000|Overall Study|Withdrawal by Subject|2
7725231|NCT02646982|12150153|FG001|Overall Study|Withdrawal by Subject|1
7725232|NCT02592551|12150162|FG000|Overall Study|Not evaluable|1
7725233|NCT02592551|12150163|FG001|Overall Study|Not evaluable|3
7725234|NCT02592551|12150164|FG002|Overall Study|Not evaluable|0
7725235|NCT02481830|12150175|FG000|Overall Study|No longer meets Study Criteria|1
7725236|NCT02481830|12150176|FG001|Overall Study|No longer meets Study Criteria|4
7725237|NCT02481830|12150175|FG000|Overall Study|Withdrawal by Subject|0
7725238|NCT02481830|12150176|FG001|Overall Study|Withdrawal by Subject|14
7725239|NCT02481830|12150175|FG000|Overall Study|Disease Progression|1
7725240|NCT02481830|12150176|FG001|Overall Study|Disease Progression|1
7725241|NCT02481830|12150175|FG000|Overall Study|Participant not eligible for trial|0
7725242|NCT02481830|12150176|FG001|Overall Study|Participant not eligible for trial|1
7725243|NCT02425904|12150184|FG000|Overall Study|Lost to Follow-up|1
7725244|NCT02425904|12150185|FG001|Overall Study|Lost to Follow-up|0
7725245|NCT02425904|12150184|FG000|Overall Study|Withdrawal by Subject|2
7725246|NCT02425904|12150185|FG001|Overall Study|Withdrawal by Subject|0
7725247|NCT02425904|12150184|FG000|Overall Study|Death|0
7725248|NCT02425904|12150185|FG001|Overall Study|Death|3
7725249|NCT02367040|12150194|FG000|Overall Study|Lost to Follow-up|1
7725250|NCT02367040|12150195|FG001|Overall Study|Lost to Follow-up|1
7725251|NCT02367040|12150194|FG000|Overall Study|Lack of Efficacy|1
7725252|NCT02367040|12150195|FG001|Overall Study|Lack of Efficacy|0
7725253|NCT02367040|12150194|FG000|Overall Study|Additional primary malignancy|0
7725254|NCT02367040|12150195|FG001|Overall Study|Additional primary malignancy|1
7725255|NCT02367040|12150194|FG000|Overall Study|AE not associated with clinical disease progression|104
7725256|NCT02367040|12150195|FG001|Overall Study|AE not associated with clinical disease progression|9
7725257|NCT02367040|12150194|FG000|Overall Study|AE associated with clinical disease progression|1
7725258|NCT02367040|12150195|FG001|Overall Study|AE associated with clinical disease progression|3
7725259|NCT02367040|12150194|FG000|Overall Study|Physician Decision|2
7725260|NCT02367040|12150195|FG001|Overall Study|Physician Decision|8
7725261|NCT02367040|12150194|FG000|Overall Study|Non-compliance with study drug|1
7725262|NCT02367040|12150195|FG001|Overall Study|Non-compliance with study drug|0
7725263|NCT02367040|12150194|FG000|Overall Study|Failure to meet continuation criteria|1
7725264|NCT02367040|12150195|FG001|Overall Study|Failure to meet continuation criteria|0
7725265|NCT02367040|12150194|FG000|Overall Study|Switching to other therapy|2
7725266|NCT02367040|12150195|FG001|Overall Study|Switching to other therapy|0
7725267|NCT02367040|12150194|FG000|Overall Study|Withdrawal by Subject|41
7725268|NCT02367040|12150195|FG001|Overall Study|Withdrawal by Subject|14
7725269|NCT02367040|12150194|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1
7725270|NCT02367040|12150195|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0
7725271|NCT02367040|12150194|FG000|Overall Study|Patient decision|35
7725272|NCT02367040|12150195|FG001|Overall Study|Patient decision|11
7725273|NCT02367040|12150194|FG000|Overall Study|Required procedure failed|1
7725274|NCT02367040|12150195|FG001|Overall Study|Required procedure failed|0
7725275|NCT02367040|12150194|FG000|Overall Study|Randomized by mistake with study treatment|1
7725276|NCT02367040|12150195|FG001|Overall Study|Randomized by mistake with study treatment|0
7725277|NCT02367040|12150194|FG000|Overall Study|Protocol Violation|1
7725278|NCT02367040|12150195|FG001|Overall Study|Protocol Violation|0
7725279|NCT02367040|12150194|FG000|Overall Study|Progressive disease - radiological progression|39
7725280|NCT02367040|12150195|FG001|Overall Study|Progressive disease - radiological progression|67
7725281|NCT02367040|12150194|FG000|Overall Study|Progressive disease - clinical progression|2
7725282|NCT02367040|12150195|FG001|Overall Study|Progressive disease - clinical progression|6
7725283|NCT02367040|12150194|FG000|Overall Study|Drug not administered|3
7725284|NCT02367040|12150195|FG001|Overall Study|Drug not administered|2
7725285|NCT02230891|12150214|FG000|Baseline|Did not meet inclusion|0
7725286|NCT02230891|12150215|FG001|Baseline|Did not meet inclusion|1
7725287|NCT02230891|12150216|FG002|Baseline|Did not meet inclusion|1
7725288|NCT02230891|12150214|FG000|2 Week|Withdrawal by Subject|2
7725289|NCT02230891|12150215|FG001|2 Week|Withdrawal by Subject|2
7725290|NCT02230891|12150216|FG002|2 Week|Withdrawal by Subject|0
7725291|NCT02230891|12150214|FG000|2 Week|Consent withdrawn|1
7725292|NCT02230891|12150215|FG001|2 Week|Consent withdrawn|0
7725293|NCT02230891|12150216|FG002|2 Week|Consent withdrawn|0
7725294|NCT02230891|12150214|FG000|6 Month|Withdrawal by Subject|1
7725295|NCT02230891|12150215|FG001|6 Month|Withdrawal by Subject|1
7725296|NCT02230891|12150216|FG002|6 Month|Withdrawal by Subject|1
7725297|NCT02230891|12150214|FG000|6 Month|Physician Decision|0
7725298|NCT02230891|12150215|FG001|6 Month|Physician Decision|2
7725299|NCT02230891|12150216|FG002|6 Month|Physician Decision|0
7725300|NCT02230891|12150214|FG000|12 Month|Death|1
7725301|NCT02230891|12150215|FG001|12 Month|Death|0
7725302|NCT02230891|12150216|FG002|12 Month|Death|0
7725303|NCT02230891|12150214|FG000|12 Month|Lost to Follow-up|0
7725304|NCT02230891|12150215|FG001|12 Month|Lost to Follow-up|1
7725305|NCT02230891|12150216|FG002|12 Month|Lost to Follow-up|0
7725306|NCT02230891|12150214|FG000|12 Month|Withdrawal by Subject|0
7725307|NCT02230891|12150215|FG001|12 Month|Withdrawal by Subject|2
7725308|NCT02230891|12150216|FG002|12 Month|Withdrawal by Subject|0
7725309|NCT02230891|12150214|FG000|18 Month End of Study|Death|0
7725310|NCT02230891|12150215|FG001|18 Month End of Study|Death|0
7725311|NCT02230891|12150216|FG002|18 Month End of Study|Death|1
7725312|NCT02230891|12150214|FG000|18 Month End of Study|Hear failure, lost to follow up|1
7725313|NCT02230891|12150215|FG001|18 Month End of Study|Hear failure, lost to follow up|0
7725314|NCT02230891|12150216|FG002|18 Month End of Study|Hear failure, lost to follow up|0
7725315|NCT02148263|12150232|FG000|Overall Study|Withdrawal by Subject|3
7725316|NCT02148263|12150233|FG001|Overall Study|Withdrawal by Subject|2
7725317|NCT02123108|12150241|FG000|Overall Study|Death|2
7725318|NCT02123108|12150242|FG001|Overall Study|Death|3
7725319|NCT01962948|12150265|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3
7725320|NCT01962948|12150266|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3
7725321|NCT01962948|12150267|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6
7768067|NCT00856986|12210882|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8
7725322|NCT01962948|12150268|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0
7725323|NCT01910402|12150277|FG000|Randomized Phase|Adverse Event|10
7725324|NCT01910402|12150278|FG001|Randomized Phase|Adverse Event|18
7725325|NCT01910402|12150277|FG000|Randomized Phase|Physician Decision|1
7725326|NCT01910402|12150278|FG001|Randomized Phase|Physician Decision|0
7725327|NCT01910402|12150277|FG000|Randomized Phase|Lack of Efficacy|5
7725328|NCT01910402|12150278|FG001|Randomized Phase|Lack of Efficacy|4
7725329|NCT01910402|12150277|FG000|Randomized Phase|Lost to Follow-up|11
7725330|NCT01910402|12150278|FG001|Randomized Phase|Lost to Follow-up|13
7725331|NCT01910402|12150277|FG000|Randomized Phase|Protocol Violation|10
7725332|NCT01910402|12150278|FG001|Randomized Phase|Protocol Violation|13
7725333|NCT01910402|12150277|FG000|Randomized Phase|Withdrawal by Subject|5
7725334|NCT01910402|12150278|FG001|Randomized Phase|Withdrawal by Subject|7
7725335|NCT01910402|12150277|FG000|Continuation Phase|Ongoing|84
7725336|NCT01910402|12150278|FG001|Continuation Phase|Ongoing|0
7725337|NCT01910402|12150277|FG000|Continuation Phase|Adverse Event|1
7725338|NCT01910402|12150278|FG001|Continuation Phase|Adverse Event|0
7725339|NCT01910402|12150277|FG000|Continuation Phase|Protocol Violation|3
7725340|NCT01910402|12150278|FG001|Continuation Phase|Protocol Violation|0
7725341|NCT01910402|12150277|FG000|Continuation Phase|Withdrawal by Subject|2
7725342|NCT01910402|12150278|FG001|Continuation Phase|Withdrawal by Subject|0
7725343|NCT01815580|12150288|FG000|Overall Study|Lost to Follow-up|4
7725344|NCT01815580|12150289|FG001|Overall Study|Lost to Follow-up|7
7725345|NCT01815580|12150288|FG000|Overall Study|Withdrawal by Subject|3
7725346|NCT01815580|12150289|FG001|Overall Study|Withdrawal by Subject|4
7725347|NCT01815580|12150288|FG000|Overall Study|Excluded from analysis|5
7725348|NCT01815580|12150289|FG001|Overall Study|Excluded from analysis|4
7725349|NCT01696773|12150302|FG000|Days 15-27, Washout|Adverse Event|1
7725350|NCT01696773|12150303|FG001|Days 15-27, Washout|Adverse Event|0
7725351|NCT01659151|12150309|FG000|Overall Study|Inadequate TIL growth|1
7725352|NCT01137604|12150317|FG000|Overall Study|Adverse Event|3
7725353|NCT01137604|12150318|FG001|Overall Study|Adverse Event|6
7725354|NCT01137604|12150319|FG002|Overall Study|Adverse Event|9
7725355|NCT01137604|12150320|FG003|Overall Study|Adverse Event|9
7725356|NCT01137604|12150317|FG000|Overall Study|Participant Choice|0
7725357|NCT01137604|12150318|FG001|Overall Study|Participant Choice|2
7725358|NCT01137604|12150319|FG002|Overall Study|Participant Choice|2
7725359|NCT01137604|12150320|FG003|Overall Study|Participant Choice|0
7725360|NCT01137604|12150317|FG000|Overall Study|Withdrawal of consent|0
7725361|NCT01137604|12150318|FG001|Overall Study|Withdrawal of consent|0
7725362|NCT01137604|12150319|FG002|Overall Study|Withdrawal of consent|0
7725363|NCT01137604|12150320|FG003|Overall Study|Withdrawal of consent|2
7725364|NCT01137604|12150317|FG000|Overall Study|Clinical progression/deterioration|1
7725365|NCT01137604|12150318|FG001|Overall Study|Clinical progression/deterioration|2
7725366|NCT01137604|12150319|FG002|Overall Study|Clinical progression/deterioration|2
7725367|NCT01137604|12150320|FG003|Overall Study|Clinical progression/deterioration|0
7768068|NCT00856986|12210883|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0
7768069|NCT00856986|12210884|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0
7768070|NCT00856986|12210880|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0
7768071|NCT00856986|12210881|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5
7768072|NCT00856986|12210882|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2
7768073|NCT00856986|12210883|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0
7768074|NCT00856986|12210884|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0
7768075|NCT00856986|12210880|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4
7768076|NCT00856986|12210881|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2
7768077|NCT00856986|12210882|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2
7768078|NCT00856986|12210883|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0
7768079|NCT00856986|12210884|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0
7768080|NCT00856986|12210880|FG000|Extension Period, Weeks 26-52|Unclassified|4
7768081|NCT00856986|12210881|FG001|Extension Period, Weeks 26-52|Unclassified|2
7768082|NCT00856986|12210882|FG002|Extension Period, Weeks 26-52|Unclassified|11
7768083|NCT00856986|12210883|FG003|Extension Period, Weeks 26-52|Unclassified|0
7768084|NCT00856986|12210884|FG004|Extension Period, Weeks 26-52|Unclassified|0
7768085|NCT00856999|12210896|FG000|Overall Study|Withdrawal by Subject|5
7768086|NCT00857207|12210903|FG000|Overall Study|Withdrawal by Subject|13
7768087|NCT00857207|12210904|FG001|Overall Study|Withdrawal by Subject|0
7768088|NCT00857207|12210903|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18
7768089|NCT00857207|12210904|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0
7768090|NCT00857207|12210903|FG000|Overall Study|Subject chose not to participate after signing consent|3
7768091|NCT00857207|12210904|FG001|Overall Study|Subject chose not to participate after signing consent|0
7768092|NCT00857220|12210911|FG000|Overall Study|Adverse Event|35
7768093|NCT00857220|12210911|FG000|Overall Study|Death|1
7768094|NCT00857220|12210911|FG000|Overall Study|Lack of Efficacy|11
7768095|NCT00857220|12210911|FG000|Overall Study|Lost to Follow-up|30
7768096|NCT00857220|12210911|FG000|Overall Study|Physician Decision|4
7768097|NCT00857220|12210911|FG000|Overall Study|Protocol Violation|16
7768098|NCT00857220|12210911|FG000|Overall Study|Withdrawal by Subject|67
7768099|NCT00857220|12210911|FG000|Overall Study|Clinical Hold|6
7768100|NCT00857220|12210911|FG000|Overall Study|Site Closed|5
7768101|NCT00857220|12210911|FG000|Overall Study|Miscellaneous|8
7725368|NCT00564278|12150348|FG000|Overall Study|Lost to Follow-up|35
7725369|NCT00564278|12150349|FG001|Overall Study|Lost to Follow-up|33
7725370|NCT00564278|12150348|FG000|Overall Study|Physician Decision|1
7725371|NCT00564278|12150349|FG001|Overall Study|Physician Decision|2
7725372|NCT00564278|12150348|FG000|Overall Study|Withdrawal by Subject|11
7725373|NCT00564278|12150349|FG001|Overall Study|Withdrawal by Subject|7
7725374|NCT00564395|12150355|FG000|First Intervention (10 Days)|Withdrawal by Subject|1
7725375|NCT00564395|12150356|FG001|First Intervention (10 Days)|Withdrawal by Subject|0
7725376|NCT00564395|12150355|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1
7725377|NCT00564395|12150356|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2
7725378|NCT00564486|12150398|FG000|Overall Study|Adverse Event|0
7725379|NCT00564486|12150399|FG001|Overall Study|Adverse Event|1
7725380|NCT00564486|12150400|FG002|Overall Study|Adverse Event|0
7725381|NCT00564486|12150401|FG003|Overall Study|Adverse Event|0
7725382|NCT00564486|12150398|FG000|Overall Study|Withdrawal by Subject|4
7725383|NCT00564486|12150399|FG001|Overall Study|Withdrawal by Subject|0
7725384|NCT00564486|12150400|FG002|Overall Study|Withdrawal by Subject|0
7725385|NCT00564486|12150401|FG003|Overall Study|Withdrawal by Subject|5
7725386|NCT00564486|12150398|FG000|Overall Study|Subject refused to have blood drawn|0
7725387|NCT00564486|12150399|FG001|Overall Study|Subject refused to have blood drawn|0
7725388|NCT00564486|12150400|FG002|Overall Study|Subject refused to have blood drawn|1
7725389|NCT00564486|12150401|FG003|Overall Study|Subject refused to have blood drawn|0
7725390|NCT00564486|12150398|FG000|Overall Study|Lost to Follow-up|3
7725391|NCT00564486|12150399|FG001|Overall Study|Lost to Follow-up|0
7725392|NCT00564486|12150400|FG002|Overall Study|Lost to Follow-up|2
7725393|NCT00564486|12150401|FG003|Overall Study|Lost to Follow-up|2
7725394|NCT00564629|12150417|FG000|Overall Study|Vomited within 2 hours of receiving drug|15
7725395|NCT00564629|12150418|FG001|Overall Study|Vomited within 2 hours of receiving drug|9
7725396|NCT00564733|12150440|FG000|Overall Study|Withdrawal by Subject|4
7725397|NCT00564733|12150440|FG000|Overall Study|Ineligible|5
7725398|NCT00564850|12150444|FG000|Overall Study|Protocol Violation|2
7725399|NCT00564889|12150448|FG000|Overall Study|Death|7
7725400|NCT00564889|12150448|FG000|Overall Study|Adverse Event|12
7725401|NCT00564889|12150448|FG000|Overall Study|Alternative treatment|3
7725402|NCT00564889|12150448|FG000|Overall Study|Disease progression|3
7725403|NCT00564889|12150448|FG000|Overall Study|Other, not specified|4
7725404|NCT00564902|12150455|FG000|Overall Study|Withdrawal by Subject|0
7725405|NCT00564902|12150456|FG001|Overall Study|Withdrawal by Subject|3
7725406|NCT00564902|12150457|FG002|Overall Study|Withdrawal by Subject|4
7725407|NCT00564902|12150455|FG000|Overall Study|Death|1
7725408|NCT00564902|12150456|FG001|Overall Study|Death|1
7725409|NCT00564902|12150457|FG002|Overall Study|Death|0
7725410|NCT00565058|12150485|FG000|Overall Study|Adverse Event|1
7725411|NCT00565058|12150486|FG001|Overall Study|Adverse Event|0
7725412|NCT00565136|12150511|FG000|Overall Study|Lost to Follow-up|1
7725413|NCT00565136|12150511|FG000|Overall Study|Withdrawal by Subject|1
7725414|NCT00565136|12150511|FG000|Overall Study|Protocol Violation|1
7725415|NCT00565409|12150527|FG000|Period 1 Open Label|Adverse Event|17
7725416|NCT00565409|12150528|FG001|Period 1 Open Label|Adverse Event|0
7725417|NCT00565409|12150529|FG002|Period 1 Open Label|Adverse Event|0
7725418|NCT00565409|12150530|FG003|Period 1 Open Label|Adverse Event|0
7725419|NCT00565409|12150527|FG000|Period 1 Open Label|Death|2
7725420|NCT00565409|12150528|FG001|Period 1 Open Label|Death|0
7725421|NCT00565409|12150529|FG002|Period 1 Open Label|Death|0
7725422|NCT00565409|12150530|FG003|Period 1 Open Label|Death|0
7725423|NCT00565409|12150527|FG000|Period 1 Open Label|Lost to Follow-up|1
7725424|NCT00565409|12150528|FG001|Period 1 Open Label|Lost to Follow-up|0
7725425|NCT00565409|12150529|FG002|Period 1 Open Label|Lost to Follow-up|0
7725426|NCT00565409|12150530|FG003|Period 1 Open Label|Lost to Follow-up|0
7725427|NCT00565409|12150527|FG000|Period 1 Open Label|Other|21
7725428|NCT00565409|12150528|FG001|Period 1 Open Label|Other|0
7725429|NCT00565409|12150529|FG002|Period 1 Open Label|Other|0
7725430|NCT00565409|12150530|FG003|Period 1 Open Label|Other|0
7725431|NCT00565409|12150527|FG000|Period 1 Open Label|Protocol Violation|14
7725432|NCT00565409|12150528|FG001|Period 1 Open Label|Protocol Violation|0
7725433|NCT00565409|12150529|FG002|Period 1 Open Label|Protocol Violation|0
7725434|NCT00565409|12150530|FG003|Period 1 Open Label|Protocol Violation|0
7725435|NCT00565409|12150527|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
7725436|NCT00565409|12150528|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
7725437|NCT00565409|12150529|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
7725438|NCT00565409|12150530|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
7725439|NCT00565409|12150527|FG000|Period 1 Open Label|no conclusion of participation record|1
7725440|NCT00565409|12150528|FG001|Period 1 Open Label|no conclusion of participation record|0
7725441|NCT00565409|12150529|FG002|Period 1 Open Label|no conclusion of participation record|0
7725442|NCT00565409|12150530|FG003|Period 1 Open Label|no conclusion of participation record|0
7725443|NCT00565409|12150527|FG000|After Period 1, Prior to Period 2|did not meet criteria|152
7725444|NCT00565409|12150528|FG001|After Period 1, Prior to Period 2|did not meet criteria|0
7725445|NCT00565409|12150529|FG002|After Period 1, Prior to Period 2|did not meet criteria|0
7725446|NCT00565409|12150530|FG003|After Period 1, Prior to Period 2|did not meet criteria|0
7725447|NCT00565409|12150527|FG000|Period 2 Double-Blind|Adverse Event|0
7725448|NCT00565409|12150528|FG001|Period 2 Double-Blind|Adverse Event|7
7725449|NCT00565409|12150529|FG002|Period 2 Double-Blind|Adverse Event|4
7725450|NCT00565409|12150530|FG003|Period 2 Double-Blind|Adverse Event|5
7725451|NCT00565409|12150527|FG000|Period 2 Double-Blind|Death|0
7725452|NCT00565409|12150528|FG001|Period 2 Double-Blind|Death|2
7725453|NCT00565409|12150529|FG002|Period 2 Double-Blind|Death|0
7725454|NCT00565409|12150530|FG003|Period 2 Double-Blind|Death|0
7725455|NCT00565409|12150527|FG000|Period 2 Double-Blind|Protocol Violation|0
7725456|NCT00565409|12150528|FG001|Period 2 Double-Blind|Protocol Violation|4
7725457|NCT00565409|12150529|FG002|Period 2 Double-Blind|Protocol Violation|6
7725458|NCT00565409|12150530|FG003|Period 2 Double-Blind|Protocol Violation|2
7725459|NCT00565409|12150527|FG000|Period 2 Double-Blind|Lost to Follow-up|0
7725460|NCT00565409|12150528|FG001|Period 2 Double-Blind|Lost to Follow-up|0
7725461|NCT00565409|12150529|FG002|Period 2 Double-Blind|Lost to Follow-up|1
7725462|NCT00565409|12150530|FG003|Period 2 Double-Blind|Lost to Follow-up|0
7725463|NCT00565409|12150527|FG000|Period 2 Double-Blind|Other|0
7725464|NCT00565409|12150528|FG001|Period 2 Double-Blind|Other|4
7725465|NCT00565409|12150529|FG002|Period 2 Double-Blind|Other|5
7725466|NCT00565409|12150530|FG003|Period 2 Double-Blind|Other|9
7725467|NCT00565409|12150527|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
7725468|NCT00565409|12150528|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
7725469|NCT00565409|12150529|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
7725470|NCT00565409|12150530|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
7725471|NCT00565448|12150542|FG000|Overall Study|Adverse Event|1
7725472|NCT00565448|12150543|FG001|Overall Study|Adverse Event|2
7725473|NCT00565448|12150542|FG000|Overall Study|Disease progression|1
7725474|NCT00565448|12150543|FG001|Overall Study|Disease progression|0
7725475|NCT00565448|12150542|FG000|Overall Study|Withdrawal by Subject|1
7725476|NCT00565448|12150543|FG001|Overall Study|Withdrawal by Subject|0
7725477|NCT00565604|12150552|FG000|Overall Study|Failure to treat|2
7725478|NCT00565604|12150552|FG000|Overall Study|Lost to Follow-up|2
7725479|NCT00565721|12150575|FG000|Overall Study|Screen Failure|2
7725480|NCT00565721|12150575|FG000|Overall Study|Lost to Follow-up|6
7725481|NCT00565721|12150575|FG000|Overall Study|Technical Problems|1
7725482|NCT00565721|12150575|FG000|Overall Study|Physician Decision|2
7725483|NCT00565721|12150575|FG000|Overall Study|Other reasons|6
7725484|NCT00565747|12150596|FG000|Overall Study|No embryo transfer|67
7725485|NCT00565747|12150597|FG001|Overall Study|No embryo transfer|73
7725486|NCT00565773|12150603|FG000|Overall Study|Withdrawal by Subject|1
7725487|NCT00565773|12150603|FG000|Overall Study|Physician Decision|1
7725488|NCT00565812|12150610|FG000|Overall Study|Death|2
7725489|NCT00565812|12150611|FG001|Overall Study|Death|1
7725490|NCT00565812|12150612|FG002|Overall Study|Death|3
7725491|NCT00565812|12150610|FG000|Overall Study|Did not Meet Entrance Criteria|1
7725492|NCT00565812|12150611|FG001|Overall Study|Did not Meet Entrance Criteria|0
7725493|NCT00565812|12150612|FG002|Overall Study|Did not Meet Entrance Criteria|1
7725494|NCT00565812|12150610|FG000|Overall Study|Lost to Follow-up|10
7725495|NCT00565812|12150611|FG001|Overall Study|Lost to Follow-up|8
7725496|NCT00565812|12150612|FG002|Overall Study|Lost to Follow-up|8
7725497|NCT00565812|12150610|FG000|Overall Study|Withdrawal by Subject|58
7725498|NCT00565812|12150611|FG001|Overall Study|Withdrawal by Subject|47
7725499|NCT00565812|12150612|FG002|Overall Study|Withdrawal by Subject|48
7725500|NCT00565812|12150610|FG000|Overall Study|Work Schedule|5
7725501|NCT00565812|12150611|FG001|Overall Study|Work Schedule|3
7725502|NCT00565812|12150612|FG002|Overall Study|Work Schedule|1
7725503|NCT00565812|12150610|FG000|Overall Study|Protocol Violation|2
7725504|NCT00565812|12150611|FG001|Overall Study|Protocol Violation|6
7725505|NCT00565812|12150612|FG002|Overall Study|Protocol Violation|4
7725506|NCT00565812|12150610|FG000|Overall Study|Adverse Event|41
7725507|NCT00565812|12150611|FG001|Overall Study|Adverse Event|54
7725508|NCT00565812|12150612|FG002|Overall Study|Adverse Event|40
7725509|NCT00565812|12150610|FG000|Overall Study|Jury Duty|1
7725510|NCT00565812|12150611|FG001|Overall Study|Jury Duty|0
7725511|NCT00565812|12150612|FG002|Overall Study|Jury Duty|0
7725512|NCT00565812|12150610|FG000|Overall Study|Relocated Out of Area|5
7725513|NCT00565812|12150611|FG001|Overall Study|Relocated Out of Area|8
7725514|NCT00565812|12150612|FG002|Overall Study|Relocated Out of Area|9
7725515|NCT00565812|12150610|FG000|Overall Study|Sponsor Decision|1
7725516|NCT00565812|12150611|FG001|Overall Study|Sponsor Decision|5
7725517|NCT00565812|12150612|FG002|Overall Study|Sponsor Decision|1
7725518|NCT00565812|12150610|FG000|Overall Study|Domestic Reasons|7
7725519|NCT00565812|12150611|FG001|Overall Study|Domestic Reasons|1
7725520|NCT00565812|12150612|FG002|Overall Study|Domestic Reasons|3
7725521|NCT00565812|12150610|FG000|Overall Study|Research Site Closure|6
7725522|NCT00565812|12150611|FG001|Overall Study|Research Site Closure|1
7725523|NCT00565812|12150612|FG002|Overall Study|Research Site Closure|8
7725524|NCT00565812|12150610|FG000|Overall Study|Surgical Intervention|0
7725525|NCT00565812|12150611|FG001|Overall Study|Surgical Intervention|1
7725526|NCT00565812|12150612|FG002|Overall Study|Surgical Intervention|2
7725527|NCT00565812|12150610|FG000|Overall Study|Low Compliance|1
7725528|NCT00565812|12150611|FG001|Overall Study|Low Compliance|0
7725529|NCT00565812|12150612|FG002|Overall Study|Low Compliance|1
7725530|NCT00565812|12150610|FG000|Overall Study|Follow-up Visit Not Completed|2
7725531|NCT00565812|12150611|FG001|Overall Study|Follow-up Visit Not Completed|0
7725532|NCT00565812|12150612|FG002|Overall Study|Follow-up Visit Not Completed|1
7725533|NCT00565812|12150610|FG000|Overall Study|Physician Decision|2
7725534|NCT00565812|12150611|FG001|Overall Study|Physician Decision|0
7725535|NCT00565812|12150612|FG002|Overall Study|Physician Decision|0
7725536|NCT00566020|12150644|FG000|6-week Dosage Adjustment Phase|Adverse Event|5
7725537|NCT00566020|12150645|FG001|6-week Dosage Adjustment Phase|Adverse Event|0
7725538|NCT00566020|12150644|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2
7725539|NCT00566020|12150645|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0
7725540|NCT00566020|12150644|FG000|46-week Long-term Administration Phase|Adverse Event|0
7725541|NCT00566020|12150645|FG001|46-week Long-term Administration Phase|Adverse Event|7
7725542|NCT00566020|12150644|FG000|46-week Long-term Administration Phase|Physician Decision|0
7725543|NCT00566020|12150645|FG001|46-week Long-term Administration Phase|Physician Decision|7
7725544|NCT00566020|12150644|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0
7725545|NCT00566020|12150645|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2
7725546|NCT00566020|12150644|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
7725547|NCT00566020|12150645|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
7725548|NCT00566098|12150650|FG000|Collection of MILs|Withdrawal by Subject|1
7725549|NCT00566098|12150650|FG000|Collection of MILs|Relapsed|1
7725550|NCT00566098|12150650|FG000|Generation of MILs Product|Relapsed|1
7725551|NCT00566098|12150650|FG000|Administration of ASCT+MILs|Death|10
7725552|NCT00566098|12150650|FG000|Administration of ASCT+MILs|Lack of Efficacy|8
7725553|NCT00566111|12150657|FG000|Overall Study|Adverse Event|0
7725554|NCT00566111|12150658|FG001|Overall Study|Adverse Event|2
7725555|NCT00566228|12150675|FG000|Overall Study|Withdrawal by Subject|1
7725556|NCT00566228|12150676|FG001|Overall Study|Withdrawal by Subject|0
7725557|NCT00566228|12150675|FG000|Overall Study|Attempt to mobilize stem cells failed|2
7725558|NCT00566228|12150676|FG001|Overall Study|Attempt to mobilize stem cells failed|2
7725559|NCT00566228|12150675|FG000|Overall Study|Unable to collect sufficient CD34 cells|3
7725560|NCT00566228|12150676|FG001|Overall Study|Unable to collect sufficient CD34 cells|2
7725561|NCT00566228|12150675|FG000|Overall Study|progressed before infusion could occur|0
7725562|NCT00566228|12150676|FG001|Overall Study|progressed before infusion could occur|1
7725563|NCT00566254|12150684|FG000|Overall Study|Adverse Event|3
7725564|NCT00566254|12150685|FG001|Overall Study|Adverse Event|1
7725565|NCT00566254|12150684|FG000|Overall Study|Protocol Violation|1
7725566|NCT00566254|12150685|FG001|Overall Study|Protocol Violation|3
7725567|NCT00566254|12150684|FG000|Overall Study|Withdrawal by Subject|1
7725568|NCT00566254|12150685|FG001|Overall Study|Withdrawal by Subject|2
7725569|NCT00566254|12150684|FG000|Overall Study|Lack of Efficacy|5
7725570|NCT00566254|12150685|FG001|Overall Study|Lack of Efficacy|6
7725571|NCT00566254|12150684|FG000|Overall Study|Other|0
7725572|NCT00566254|12150685|FG001|Overall Study|Other|2
7725573|NCT00566501|12150693|FG000|Overall Study|Adverse Event|68
7725574|NCT00566501|12150694|FG001|Overall Study|Adverse Event|59
7725575|NCT00566501|12150693|FG000|Overall Study|Medication Non-compliance|5
7725576|NCT00566501|12150694|FG001|Overall Study|Medication Non-compliance|0
7725577|NCT00566501|12150693|FG000|Overall Study|Protocol Violation|2
7725578|NCT00566501|12150694|FG001|Overall Study|Protocol Violation|2
7725579|NCT00566501|12150693|FG000|Overall Study|Request of Investigator or Sponsor|6
7725580|NCT00566501|12150694|FG001|Overall Study|Request of Investigator or Sponsor|7
7725581|NCT00566501|12150693|FG000|Overall Study|Withdrawal by Subject|33
7725582|NCT00566501|12150694|FG001|Overall Study|Withdrawal by Subject|30
7725583|NCT00566501|12150693|FG000|Overall Study|Lack of Efficacy|8
7725584|NCT00566501|12150694|FG001|Overall Study|Lack of Efficacy|3
7725585|NCT00566501|12150693|FG000|Overall Study|Other|25
7725586|NCT00566501|12150694|FG001|Overall Study|Other|21
7725587|NCT00566527|12150703|FG000|Overall Study|Reason not provided|3
7725588|NCT00566527|12150704|FG001|Overall Study|Reason not provided|11
7725589|NCT00566527|12150705|FG002|Overall Study|Reason not provided|10
7725590|NCT00566527|12150703|FG000|Overall Study|Adverse Event|2
7725591|NCT00566527|12150704|FG001|Overall Study|Adverse Event|0
7725592|NCT00566527|12150705|FG002|Overall Study|Adverse Event|1
7725593|NCT00566527|12150703|FG000|Overall Study|Physician Decision|3
7725594|NCT00566527|12150704|FG001|Overall Study|Physician Decision|8
7725595|NCT00566527|12150705|FG002|Overall Study|Physician Decision|20
7725596|NCT00566527|12150703|FG000|Overall Study|Lost to Follow-up|3
7725597|NCT00566527|12150704|FG001|Overall Study|Lost to Follow-up|4
7725598|NCT00566527|12150705|FG002|Overall Study|Lost to Follow-up|4
7725599|NCT00566527|12150703|FG000|Overall Study|Withdrawal by Subject|6
7725600|NCT00566527|12150704|FG001|Overall Study|Withdrawal by Subject|43
7725601|NCT00566527|12150705|FG002|Overall Study|Withdrawal by Subject|43
7725602|NCT00566631|12150728|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18
7725603|NCT00566631|12150728|FG000|Part 1: Core Treatment Phase|Physician Decision|1
7725604|NCT00566631|12150728|FG000|Part 1: Core Treatment Phase|Adverse Event|9
7725605|NCT00566631|12150728|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4
7725606|NCT00566631|12150728|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26
7725607|NCT00566631|12150728|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
7725608|NCT00566631|12150728|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1
7725609|NCT00566631|12150728|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95
7725610|NCT00566631|12150728|FG000|Part 2: Extension Phase|Lack of Efficacy|25
7725611|NCT00566631|12150728|FG000|Part 2: Extension Phase|Withdrawal by Subject|34
7725612|NCT00566631|12150728|FG000|Part 2: Extension Phase|Adverse Event|11
7725613|NCT00566631|12150728|FG000|Part 2: Extension Phase|Lost to Follow-up|6
7725614|NCT00566631|12150728|FG000|Part 2: Extension Phase|Death|1
7725615|NCT00566631|12150728|FG000|Part 2: Extension Phase|Other|5
7725616|NCT00566696|12150732|FG000|Overall Study|Met Exclusion Criteria|2
7725617|NCT00566696|12150732|FG000|Overall Study|Muromonab not available|1
7725618|NCT00566696|12150732|FG000|Overall Study|Health Status Change|1
7725619|NCT00566696|12150732|FG000|Overall Study|Physician Decision|1
7725620|NCT00566696|12150732|FG000|Overall Study|Non-Patient Donors|37
7725621|NCT00566709|12150738|FG000|Overall Study|Protocol Violation|5
7725622|NCT00566709|12150739|FG001|Overall Study|Protocol Violation|0
7725623|NCT00566722|12150748|FG000|Overall Study|Adverse Event|0
7725624|NCT00566722|12150749|FG001|Overall Study|Adverse Event|1
7725625|NCT00566722|12150750|FG002|Overall Study|Adverse Event|0
7725626|NCT00566722|12150748|FG000|Overall Study|Withdrawal by Subject|0
7725627|NCT00566722|12150749|FG001|Overall Study|Withdrawal by Subject|0
7725628|NCT00566722|12150750|FG002|Overall Study|Withdrawal by Subject|1
7725629|NCT00566722|12150748|FG000|Overall Study|Lost to Follow-up|1
7725630|NCT00566722|12150749|FG001|Overall Study|Lost to Follow-up|1
7725631|NCT00566722|12150750|FG002|Overall Study|Lost to Follow-up|1
7725632|NCT00566722|12150748|FG000|Overall Study|Lack of Efficacy|1
7725633|NCT00566722|12150749|FG001|Overall Study|Lack of Efficacy|2
7725634|NCT00566722|12150750|FG002|Overall Study|Lack of Efficacy|4
7725635|NCT00566722|12150748|FG000|Overall Study|Did not meet exclusion criteria|0
7725636|NCT00566722|12150749|FG001|Overall Study|Did not meet exclusion criteria|0
7725637|NCT00566722|12150750|FG002|Overall Study|Did not meet exclusion criteria|2
7725638|NCT00566722|12150748|FG000|Overall Study|Serious adverse event|0
7725639|NCT00566722|12150749|FG001|Overall Study|Serious adverse event|1
7725640|NCT00566722|12150750|FG002|Overall Study|Serious adverse event|0
7725641|NCT00566722|12150748|FG000|Overall Study|Noncompliant with drug administration|0
7725642|NCT00566722|12150749|FG001|Overall Study|Noncompliant with drug administration|0
7725643|NCT00566722|12150750|FG002|Overall Study|Noncompliant with drug administration|1
7725644|NCT00566735|12150763|FG000|Overall Study|Withdrawal by Subject|0
7725645|NCT00566735|12150764|FG001|Overall Study|Withdrawal by Subject|1
7725646|NCT00566735|12150763|FG000|Overall Study|Refused neuropsychological testing|2
7725647|NCT00566735|12150764|FG001|Overall Study|Refused neuropsychological testing|5
7725648|NCT00566735|12150763|FG000|Overall Study|Switched into a manic episode|0
7725649|NCT00566735|12150764|FG001|Overall Study|Switched into a manic episode|1
7725650|NCT00566852|12150781|FG000|Overall Study|Protocol Violation|22
7725651|NCT00566852|12150782|FG001|Overall Study|Protocol Violation|24
7725652|NCT00566852|12150781|FG000|Overall Study|Death|95
7725653|NCT00566852|12150782|FG001|Overall Study|Death|78
7725654|NCT00566852|12150781|FG000|Overall Study|Withdrawal by Subject|30
7725655|NCT00566852|12150782|FG001|Overall Study|Withdrawal by Subject|25
7725656|NCT00566852|12150781|FG000|Overall Study|Patient refusal|37
7725657|NCT00566852|12150782|FG001|Overall Study|Patient refusal|37
7725658|NCT00566852|12150781|FG000|Overall Study|Not tested due to disability|6
7725659|NCT00566852|12150782|FG001|Overall Study|Not tested due to disability|12
7725660|NCT00566852|12150781|FG000|Overall Study|Missing reason not specified|1
7725661|NCT00566852|12150782|FG001|Overall Study|Missing reason not specified|2
7725662|NCT00566852|12150781|FG000|Overall Study|Missing reason not reported|16
7725663|NCT00566852|12150782|FG001|Overall Study|Missing reason not reported|20
7725664|NCT00566982|12150831|FG000|Overall Study|Adverse Event|6
7725665|NCT00566982|12150832|FG001|Overall Study|Adverse Event|48
7725666|NCT00566982|12150831|FG000|Overall Study|Withdrawal by Subject|1
7725667|NCT00566982|12150832|FG001|Overall Study|Withdrawal by Subject|14
7725668|NCT00566982|12150831|FG000|Overall Study|Protocol Violation|1
7725669|NCT00566982|12150832|FG001|Overall Study|Protocol Violation|4
7725670|NCT00566982|12150831|FG000|Overall Study|Lost to Follow-up|0
7725671|NCT00566982|12150832|FG001|Overall Study|Lost to Follow-up|1
7725672|NCT00566982|12150831|FG000|Overall Study|Other-family problems & doctor's request|0
7725673|NCT00566982|12150832|FG001|Overall Study|Other-family problems & doctor's request|2
7725674|NCT00567112|12150850|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0
7725675|NCT00567112|12150851|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1
7725676|NCT00567112|12150852|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0
7725677|NCT00567112|12150850|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2
7725678|NCT00567112|12150851|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0
7725679|NCT00567112|12150852|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0
7725680|NCT00567112|12150850|FG000|Washout Period 3 (3 Days)|Protocol Violation|1
7725681|NCT00567112|12150851|FG001|Washout Period 3 (3 Days)|Protocol Violation|0
7725682|NCT00567112|12150852|FG002|Washout Period 3 (3 Days)|Protocol Violation|0
7725683|NCT00567164|12150864|FG000|Overall Study|Withdrawal by Subject|171
7725684|NCT00567164|12150865|FG001|Overall Study|Withdrawal by Subject|21
7725685|NCT00567164|12150866|FG002|Overall Study|Withdrawal by Subject|17
7725686|NCT00567164|12150864|FG000|Overall Study|Protocol Violation|23
7725687|NCT00567164|12150865|FG001|Overall Study|Protocol Violation|4
7725688|NCT00567164|12150866|FG002|Overall Study|Protocol Violation|2
7725689|NCT00567164|12150864|FG000|Overall Study|Adverse Event|92
7725690|NCT00567164|12150865|FG001|Overall Study|Adverse Event|13
7725691|NCT00567164|12150866|FG002|Overall Study|Adverse Event|9
7725692|NCT00567164|12150864|FG000|Overall Study|Death|0
7725693|NCT00567164|12150865|FG001|Overall Study|Death|0
7725694|NCT00567164|12150866|FG002|Overall Study|Death|1
7725695|NCT00567164|12150864|FG000|Overall Study|Lost to Follow-up|202
7725696|NCT00567164|12150865|FG001|Overall Study|Lost to Follow-up|23
7725697|NCT00567164|12150866|FG002|Overall Study|Lost to Follow-up|21
7725698|NCT00567164|12150864|FG000|Overall Study|Pregnancy|20
7725699|NCT00567164|12150865|FG001|Overall Study|Pregnancy|4
7725700|NCT00567164|12150866|FG002|Overall Study|Pregnancy|6
7725701|NCT00567164|12150864|FG000|Overall Study|Primary Reason coded as 'Other'|37
7725702|NCT00567164|12150865|FG001|Overall Study|Primary Reason coded as 'Other'|8
7725703|NCT00567164|12150866|FG002|Overall Study|Primary Reason coded as 'Other'|16
7725704|NCT00567164|12150864|FG000|Overall Study|Missing|1
7725705|NCT00567164|12150865|FG001|Overall Study|Missing|0
7725706|NCT00567164|12150866|FG002|Overall Study|Missing|0
7725707|NCT00567190|12150880|FG000|Overall Study|Death|235
7725708|NCT00567190|12150881|FG001|Overall Study|Death|280
7725709|NCT00567190|12150880|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48
7725710|NCT00567190|12150881|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53
7725711|NCT00567255|12150907|FG000|Overall Study|Adverse Event|241
7725712|NCT00567255|12150908|FG001|Overall Study|Adverse Event|68
7725713|NCT00567255|12150907|FG000|Overall Study|Lost to Follow-up|77
7725714|NCT00567255|12150908|FG001|Overall Study|Lost to Follow-up|48
7725715|NCT00567255|12150907|FG000|Overall Study|Withdrawal by Subject|75
7725716|NCT00567255|12150908|FG001|Overall Study|Withdrawal by Subject|56
7725717|NCT00567255|12150907|FG000|Overall Study|Lack of Efficacy|19
7725718|NCT00567255|12150908|FG001|Overall Study|Lack of Efficacy|33
7725719|NCT00567255|12150907|FG000|Overall Study|Protocol Violation|20
7725720|NCT00567255|12150908|FG001|Overall Study|Protocol Violation|8
7725721|NCT00567255|12150907|FG000|Overall Study|Pregnancy|6
7725722|NCT00567255|12150908|FG001|Overall Study|Pregnancy|0
7725723|NCT00567255|12150907|FG000|Overall Study|Drug noncompliance,moved,other|25
7725724|NCT00567255|12150908|FG001|Overall Study|Drug noncompliance,moved,other|15
7725725|NCT00567268|12150914|FG000|Overall Study|Protocol Violation|7
7725726|NCT00567268|12150914|FG000|Overall Study|Lost to Follow-up|36
7725727|NCT00567268|12150914|FG000|Overall Study|No Visit After First Day of Treatment|2
7725728|NCT00567268|12150914|FG000|Overall Study|No Drug Administration|4
7725729|NCT00567268|12150914|FG000|Overall Study|"Safety Evaluation Not Assessable"|1
7725730|NCT00567359|12150971|FG000|Overall Study|Withdrawal by Subject|1
7725731|NCT00567398|12150977|FG000|Overall Study|Adverse Event|6
7725732|NCT00567398|12150978|FG001|Overall Study|Adverse Event|14
7725733|NCT00567398|12150977|FG000|Overall Study|Physician Decision|0
7725734|NCT00567398|12150978|FG001|Overall Study|Physician Decision|4
7725735|NCT00567398|12150977|FG000|Overall Study|Withdrawal by Subject|0
7725736|NCT00567398|12150978|FG001|Overall Study|Withdrawal by Subject|2
7725737|NCT00567398|12150977|FG000|Overall Study|Renal Transplantation|0
7725738|NCT00567398|12150978|FG001|Overall Study|Renal Transplantation|3
7725739|NCT00567398|12150977|FG000|Overall Study|Other|1
7725740|NCT00567398|12150978|FG001|Overall Study|Other|0
7725741|NCT00567476|12150986|FG000|Overall Study|Adverse Event|2
7725742|NCT00567476|12150987|FG001|Overall Study|Adverse Event|0
7725743|NCT00567476|12150986|FG000|Overall Study|Pregnancy|1
7725744|NCT00567476|12150987|FG001|Overall Study|Pregnancy|0
7725745|NCT00567476|12150986|FG000|Overall Study|Protocol Violation|4
7725746|NCT00567476|12150987|FG001|Overall Study|Protocol Violation|1
7725747|NCT00567476|12150986|FG000|Overall Study|Lost to Follow-up|0
7725748|NCT00567476|12150987|FG001|Overall Study|Lost to Follow-up|1
7725749|NCT00567476|12150986|FG000|Overall Study|Administrative issues|1
7725750|NCT00567476|12150987|FG001|Overall Study|Administrative issues|0
7725751|NCT00567476|12150986|FG000|Overall Study|Medical Decision|0
7725752|NCT00567476|12150987|FG001|Overall Study|Medical Decision|1
7725753|NCT00567476|12150986|FG000|Overall Study|Non-adherence to protocol|0
7725754|NCT00567476|12150987|FG001|Overall Study|Non-adherence to protocol|1
7725755|NCT00567489|12150995|FG000|Overall Study|Adverse Event|6
7725756|NCT00567489|12150996|FG001|Overall Study|Adverse Event|14
7725757|NCT00567489|12150995|FG000|Overall Study|Physician Decision|0
7725758|NCT00567489|12150996|FG001|Overall Study|Physician Decision|4
7725759|NCT00567489|12150995|FG000|Overall Study|Withdrawal by Subject|0
7725760|NCT00567489|12150996|FG001|Overall Study|Withdrawal by Subject|2
7725761|NCT00567489|12150995|FG000|Overall Study|Renal Transplantation|0
7725762|NCT00567489|12150996|FG001|Overall Study|Renal Transplantation|3
7725763|NCT00567489|12150995|FG000|Overall Study|Other|1
7725764|NCT00567489|12150996|FG001|Overall Study|Other|0
7725765|NCT00567502|12151006|FG000|Overall Study|Lost to Follow-up|91
7725766|NCT00567502|12151007|FG001|Overall Study|Lost to Follow-up|14
7725767|NCT00567502|12151008|FG002|Overall Study|Lost to Follow-up|351
7725768|NCT00567502|12151009|FG003|Overall Study|Lost to Follow-up|2
7725769|NCT00567502|12151006|FG000|Overall Study|Death|65
7725770|NCT00567502|12151007|FG001|Overall Study|Death|16
7725771|NCT00567502|12151008|FG002|Overall Study|Death|360
7725772|NCT00567502|12151009|FG003|Overall Study|Death|5
7725773|NCT00567502|12151006|FG000|Overall Study|Other|64
7725774|NCT00567502|12151007|FG001|Overall Study|Other|2
7725775|NCT00567502|12151008|FG002|Overall Study|Other|134
7725776|NCT00567502|12151009|FG003|Overall Study|Other|6
7725777|NCT00567502|12151006|FG000|Overall Study|Participant request|12
7725778|NCT00567502|12151007|FG001|Overall Study|Participant request|1
7725779|NCT00567502|12151008|FG002|Overall Study|Participant request|33
7725780|NCT00567502|12151009|FG003|Overall Study|Participant request|1
7725781|NCT00567502|12151006|FG000|Overall Study|Sponsor request|9
7725782|NCT00567502|12151007|FG001|Overall Study|Sponsor request|0
7725783|NCT00567502|12151008|FG002|Overall Study|Sponsor request|30
7725784|NCT00567502|12151009|FG003|Overall Study|Sponsor request|1
7725785|NCT00567502|12151006|FG000|Overall Study|Never Initiated Treatment|0
7725786|NCT00567502|12151007|FG001|Overall Study|Never Initiated Treatment|0
7725787|NCT00567502|12151008|FG002|Overall Study|Never Initiated Treatment|0
7725788|NCT00567502|12151009|FG003|Overall Study|Never Initiated Treatment|72
7725789|NCT00567541|12151032|FG000|Overall Study|Adverse Event|0
7725790|NCT00567541|12151033|FG001|Overall Study|Adverse Event|1
7725791|NCT00567593|12151039|FG000|Overall Study|Adverse Event|1
7725792|NCT00567593|12151039|FG000|Overall Study|Physician Decision|1
7725793|NCT00567879|12151070|FG000|Overall Study|Adverse Event|2
7725794|NCT00567879|12151071|FG001|Overall Study|Adverse Event|0
7725795|NCT00567879|12151072|FG002|Overall Study|Adverse Event|1
7725796|NCT00567879|12151073|FG003|Overall Study|Adverse Event|0
7725797|NCT00567879|12151074|FG004|Overall Study|Adverse Event|1
7725798|NCT00567879|12151075|FG005|Overall Study|Adverse Event|0
7725799|NCT00567879|12151070|FG000|Overall Study|Abnormal test procedure(s)|0
7725800|NCT00567879|12151071|FG001|Overall Study|Abnormal test procedure(s)|0
7725801|NCT00567879|12151072|FG002|Overall Study|Abnormal test procedure(s)|1
7725802|NCT00567879|12151073|FG003|Overall Study|Abnormal test procedure(s)|0
7725803|NCT00567879|12151074|FG004|Overall Study|Abnormal test procedure(s)|0
7725804|NCT00567879|12151075|FG005|Overall Study|Abnormal test procedure(s)|0
7725805|NCT00567879|12151070|FG000|Overall Study|Withdrawal by Subject|0
7725806|NCT00567879|12151071|FG001|Overall Study|Withdrawal by Subject|0
7725807|NCT00567879|12151072|FG002|Overall Study|Withdrawal by Subject|3
7725808|NCT00567879|12151073|FG003|Overall Study|Withdrawal by Subject|1
7725809|NCT00567879|12151074|FG004|Overall Study|Withdrawal by Subject|0
7725810|NCT00567879|12151075|FG005|Overall Study|Withdrawal by Subject|0
7725811|NCT00567879|12151070|FG000|Overall Study|New cancer therapy|0
7725812|NCT00567879|12151071|FG001|Overall Study|New cancer therapy|0
7725813|NCT00567879|12151072|FG002|Overall Study|New cancer therapy|1
7725814|NCT00567879|12151073|FG003|Overall Study|New cancer therapy|0
7725815|NCT00567879|12151074|FG004|Overall Study|New cancer therapy|0
7725816|NCT00567879|12151075|FG005|Overall Study|New cancer therapy|0
7725817|NCT00567879|12151070|FG000|Overall Study|Disease progression|5
7725818|NCT00567879|12151071|FG001|Overall Study|Disease progression|7
7725819|NCT00567879|12151072|FG002|Overall Study|Disease progression|15
7725820|NCT00567879|12151073|FG003|Overall Study|Disease progression|5
7725821|NCT00567879|12151074|FG004|Overall Study|Disease progression|11
7725822|NCT00567879|12151075|FG005|Overall Study|Disease progression|3
7725823|NCT00567892|12151095|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
7725824|NCT00567892|12151096|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
7725825|NCT00567892|12151097|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
7725826|NCT00567892|12151098|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
7725827|NCT00567892|12151095|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
7725828|NCT00567892|12151096|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
7725829|NCT00567892|12151097|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
7725830|NCT00567892|12151098|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
7725831|NCT00567996|12151113|FG000|Overall Study|Adverse Event|18
7725832|NCT00567996|12151114|FG001|Overall Study|Adverse Event|16
7725833|NCT00567996|12151115|FG002|Overall Study|Adverse Event|13
7725834|NCT00567996|12151113|FG000|Overall Study|Protocol Deviation|9
7725835|NCT00567996|12151114|FG001|Overall Study|Protocol Deviation|11
7725836|NCT00567996|12151115|FG002|Overall Study|Protocol Deviation|13
7725837|NCT00567996|12151113|FG000|Overall Study|Withdrawal by Subject|8
7725838|NCT00567996|12151114|FG001|Overall Study|Withdrawal by Subject|12
7725839|NCT00567996|12151115|FG002|Overall Study|Withdrawal by Subject|22
7725840|NCT00567996|12151113|FG000|Overall Study|Abnormal Lab value(s)|2
7725841|NCT00567996|12151114|FG001|Overall Study|Abnormal Lab value(s)|1
7725842|NCT00567996|12151115|FG002|Overall Study|Abnormal Lab value(s)|2
7725843|NCT00567996|12151113|FG000|Overall Study|Abnormal test procedure result(s)|2
7725844|NCT00567996|12151114|FG001|Overall Study|Abnormal test procedure result(s)|1
7725845|NCT00567996|12151115|FG002|Overall Study|Abnormal test procedure result(s)|1
7725846|NCT00567996|12151113|FG000|Overall Study|Lost to Follow-up|2
7725847|NCT00567996|12151114|FG001|Overall Study|Lost to Follow-up|5
7725848|NCT00567996|12151115|FG002|Overall Study|Lost to Follow-up|2
7725849|NCT00567996|12151113|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7725850|NCT00567996|12151114|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7725851|NCT00567996|12151115|FG002|Overall Study|Unsatisfactory therapeutic effect|15
7725852|NCT00567996|12151113|FG000|Overall Study|Administrative problems|1
7725853|NCT00567996|12151114|FG001|Overall Study|Administrative problems|1
7725854|NCT00567996|12151115|FG002|Overall Study|Administrative problems|0
7725855|NCT00567996|12151113|FG000|Overall Study|Death|1
7725856|NCT00567996|12151114|FG001|Overall Study|Death|0
7725857|NCT00567996|12151115|FG002|Overall Study|Death|2
7725858|NCT00567996|12151113|FG000|Overall Study|Patient's inability to use the device|0
7725859|NCT00567996|12151114|FG001|Overall Study|Patient's inability to use the device|1
7725860|NCT00567996|12151115|FG002|Overall Study|Patient's inability to use the device|0
7725861|NCT00568061|12151139|FG000|Overall Study|Inclusion / exclusion criteria|5
7725862|NCT00568061|12151140|FG001|Overall Study|Inclusion / exclusion criteria|1
7725863|NCT00568061|12151139|FG000|Overall Study|Adverse Event|0
7725864|NCT00568061|12151140|FG001|Overall Study|Adverse Event|1
7725865|NCT00568126|12151158|FG000|Overall Study|Adverse Event|3
7725866|NCT00568126|12151159|FG001|Overall Study|Adverse Event|0
7725867|NCT00568126|12151158|FG000|Overall Study|Withdrawal by Subject|2
7725868|NCT00568126|12151159|FG001|Overall Study|Withdrawal by Subject|3
7725869|NCT00568126|12151158|FG000|Overall Study|Lost to Follow-up|4
7725870|NCT00568126|12151159|FG001|Overall Study|Lost to Follow-up|3
7725871|NCT00568126|12151158|FG000|Overall Study|Lack of Efficacy|0
7725872|NCT00568126|12151159|FG001|Overall Study|Lack of Efficacy|1
7725873|NCT00568126|12151158|FG000|Overall Study|Physician Decision|2
7725874|NCT00568126|12151159|FG001|Overall Study|Physician Decision|2
7725875|NCT00568321|12151168|FG000|Overall Study|Adverse Event|1
7725876|NCT00568321|12151169|FG001|Overall Study|Adverse Event|0
7725877|NCT00568321|12151170|FG002|Overall Study|Adverse Event|0
7725878|NCT00568321|12151168|FG000|Overall Study|Lack of Efficacy|8
7725879|NCT00568321|12151169|FG001|Overall Study|Lack of Efficacy|5
7725880|NCT00568321|12151170|FG002|Overall Study|Lack of Efficacy|6
7725881|NCT00568321|12151168|FG000|Overall Study|Lost to Follow-up|0
7725882|NCT00568321|12151169|FG001|Overall Study|Lost to Follow-up|0
7725883|NCT00568321|12151170|FG002|Overall Study|Lost to Follow-up|1
7725884|NCT00568321|12151168|FG000|Overall Study|Withdrawal by Subject|2
7725885|NCT00568321|12151169|FG001|Overall Study|Withdrawal by Subject|0
7725886|NCT00568321|12151170|FG002|Overall Study|Withdrawal by Subject|0
7725887|NCT00568321|12151168|FG000|Overall Study|Protocol Violation|0
7725888|NCT00568321|12151169|FG001|Overall Study|Protocol Violation|0
7725889|NCT00568321|12151170|FG002|Overall Study|Protocol Violation|1
7725890|NCT00568321|12151168|FG000|Overall Study|Randomized, not treated|2
7725891|NCT00568321|12151169|FG001|Overall Study|Randomized, not treated|0
7725892|NCT00568321|12151170|FG002|Overall Study|Randomized, not treated|1
7725893|NCT00568334|12151182|FG000|Overall Study|Withdrawal by Subject|0
7725894|NCT00568334|12151183|FG001|Overall Study|Withdrawal by Subject|1
7725895|NCT00568334|12151182|FG000|Overall Study|Lost to Follow-up|1
7725896|NCT00568334|12151183|FG001|Overall Study|Lost to Follow-up|0
7725897|NCT00568399|12151198|FG000|Overall Study|Death|2
7725898|NCT00568399|12151198|FG000|Overall Study|Adverse Event|5
7725899|NCT00568399|12151198|FG000|Overall Study|Withdrawal by Subject|8
7725900|NCT00568451|12151206|FG000|Overall Study|Disease Progression|0
7725901|NCT00568451|12151207|FG001|Overall Study|Disease Progression|0
7725902|NCT00568451|12151208|FG002|Overall Study|Disease Progression|2
7725903|NCT00568451|12151209|FG003|Overall Study|Disease Progression|7
7725904|NCT00568555|12151222|FG000|Overall Study|Withdrawal by Subject|1
7725905|NCT00568555|12151223|FG001|Overall Study|Withdrawal by Subject|1
7725906|NCT00568685|12151243|FG000|Overall Study|Adverse Event|2
7725907|NCT00568685|12151244|FG001|Overall Study|Adverse Event|3
7725908|NCT00568685|12151245|FG002|Overall Study|Adverse Event|3
7725909|NCT00568685|12151243|FG000|Overall Study|Withdrawal by Subject|7
7725910|NCT00568685|12151244|FG001|Overall Study|Withdrawal by Subject|2
7725911|NCT00568685|12151245|FG002|Overall Study|Withdrawal by Subject|2
7725912|NCT00568685|12151243|FG000|Overall Study|Protocol Violation|1
7725913|NCT00568685|12151244|FG001|Overall Study|Protocol Violation|0
7725914|NCT00568685|12151245|FG002|Overall Study|Protocol Violation|0
7725915|NCT00568776|12151261|FG000|Overall Study|Adverse Event|8
7725916|NCT00568776|12151262|FG001|Overall Study|Adverse Event|8
7725917|NCT00568776|12151263|FG002|Overall Study|Adverse Event|10
7725918|NCT00568776|12151264|FG003|Overall Study|Adverse Event|8
7725919|NCT00568776|12151261|FG000|Overall Study|Death|0
7725920|NCT00568776|12151262|FG001|Overall Study|Death|1
7725921|NCT00568776|12151263|FG002|Overall Study|Death|4
7725922|NCT00568776|12151264|FG003|Overall Study|Death|3
7725923|NCT00568776|12151261|FG000|Overall Study|Physician Decision|0
7725924|NCT00568776|12151262|FG001|Overall Study|Physician Decision|2
7725925|NCT00568776|12151263|FG002|Overall Study|Physician Decision|0
7725926|NCT00568776|12151264|FG003|Overall Study|Physician Decision|0
7725927|NCT00568776|12151261|FG000|Overall Study|Lack of Efficacy|2
7725928|NCT00568776|12151262|FG001|Overall Study|Lack of Efficacy|2
7725929|NCT00568776|12151263|FG002|Overall Study|Lack of Efficacy|2
7725930|NCT00568776|12151264|FG003|Overall Study|Lack of Efficacy|4
7725931|NCT00568776|12151261|FG000|Overall Study|Lost to Follow-up|1
7725932|NCT00568776|12151262|FG001|Overall Study|Lost to Follow-up|1
7725933|NCT00568776|12151263|FG002|Overall Study|Lost to Follow-up|1
7725934|NCT00568776|12151264|FG003|Overall Study|Lost to Follow-up|1
7725935|NCT00568776|12151261|FG000|Overall Study|Protocol Violation|1
7725936|NCT00568776|12151262|FG001|Overall Study|Protocol Violation|0
7725937|NCT00568776|12151263|FG002|Overall Study|Protocol Violation|1
7725938|NCT00568776|12151264|FG003|Overall Study|Protocol Violation|1
7725939|NCT00568776|12151261|FG000|Overall Study|Withdrawal by Subject|13
7725940|NCT00568776|12151262|FG001|Overall Study|Withdrawal by Subject|15
7725941|NCT00568776|12151263|FG002|Overall Study|Withdrawal by Subject|13
7725942|NCT00568776|12151264|FG003|Overall Study|Withdrawal by Subject|7
7725943|NCT00568776|12151261|FG000|Overall Study|Loss of Caregiver|0
7725944|NCT00568776|12151262|FG001|Overall Study|Loss of Caregiver|2
7725945|NCT00568776|12151263|FG002|Overall Study|Loss of Caregiver|1
7725946|NCT00568776|12151264|FG003|Overall Study|Loss of Caregiver|2
7725947|NCT00568776|12151261|FG000|Overall Study|Sponsor Decision|2
7725948|NCT00568776|12151262|FG001|Overall Study|Sponsor Decision|2
7725949|NCT00568776|12151263|FG002|Overall Study|Sponsor Decision|41
7725950|NCT00568776|12151264|FG003|Overall Study|Sponsor Decision|42
7725951|NCT00568776|12151261|FG000|Overall Study|Miscellaeneous|3
7725952|NCT00568776|12151262|FG001|Overall Study|Miscellaeneous|3
7725953|NCT00568776|12151263|FG002|Overall Study|Miscellaeneous|1
7725954|NCT00568776|12151264|FG003|Overall Study|Miscellaeneous|4
7768102|NCT00857233|12210915|FG000|Overall Study|Adverse Event|24
7768103|NCT00857233|12210915|FG000|Overall Study|Lack of Efficacy|1
7768104|NCT00857233|12210915|FG000|Overall Study|Non-compliance|1
7768105|NCT00857233|12210915|FG000|Overall Study|Withdrawal of Consent|9
7768106|NCT00857233|12210915|FG000|Overall Study|Lost to Follow-up|4
7768107|NCT00857233|12210915|FG000|Overall Study|Nursing Home Placement|14
7768108|NCT00857233|12210915|FG000|Overall Study|Other Reasons|2
7768109|NCT00857246|12210919|FG000|Induction Regimen|Adverse Event|1
7768110|NCT00857246|12210919|FG000|Induction Regimen|disease-related complications|1
7768111|NCT00857246|12210919|FG000|Induction Regimen|Withdrawal by Subject|1
7768112|NCT00857246|12210919|FG000|Surgery (Curative)|disease progression|6
7768113|NCT00857246|12210919|FG000|ChemoRT|Withdrawal by Subject|1
7768114|NCT00857246|12210919|FG000|ChemoRT|Adverse Event|2
7768115|NCT00857259|12210929|FG000|Overall Study|Protocol Violation|1
7768116|NCT00857259|12210930|FG001|Overall Study|Protocol Violation|0
7768117|NCT00857259|12210931|FG002|Overall Study|Protocol Violation|1
7768118|NCT00857311|12210954|FG000|Overall Study|Lost to Follow-up|1
7768119|NCT00857311|12210955|FG001|Overall Study|Lost to Follow-up|0
7768120|NCT00857311|12210956|FG002|Overall Study|Lost to Follow-up|0
7768121|NCT00857311|12210957|FG003|Overall Study|Lost to Follow-up|0
7768122|NCT00857389|12210963|FG000|Overall Study|Did not proceed to transplant|2
7768123|NCT00857415|12210969|FG000|Overall Study|Image acquisition failure|2
7768124|NCT00857415|12210970|FG001|Overall Study|Image acquisition failure|0
7768125|NCT00857415|12210969|FG000|Overall Study|Invalid image or not imaged|3
7768126|NCT00857415|12210970|FG001|Overall Study|Invalid image or not imaged|0
7768127|NCT00857415|12210969|FG000|Overall Study|Subject still living at end of study|110
7768128|NCT00857415|12210970|FG001|Overall Study|Subject still living at end of study|0
7768129|NCT00857415|12210969|FG000|Overall Study|Deceased with no autopsy|2
7768130|NCT00857415|12210970|FG001|Overall Study|Deceased with no autopsy|0
7768131|NCT00857454|12210976|FG000|Overall Study|Withdrawal by Subject|2
7768132|NCT00857454|12210976|FG000|Overall Study|Lost to Follow-up|1
7768133|NCT00857454|12210976|FG000|Overall Study|Adverse Event|2
7768134|NCT00857454|12210976|FG000|Overall Study|Total Testosterone >1050 ng/dL|1
7768135|NCT00857454|12210976|FG000|Overall Study|Total Testosterone <300 ng/dL|8
7768136|NCT00857454|12210976|FG000|Overall Study|MTE09 enrollment criteria not met|6
7768137|NCT00857584|12211032|FG000|Overall Study|Lack of Efficacy|1
7768138|NCT00857584|12211033|FG001|Overall Study|Lack of Efficacy|2
7768139|NCT00857584|12211032|FG000|Overall Study|Adverse Event|2
7768140|NCT00857584|12211033|FG001|Overall Study|Adverse Event|2
7768141|NCT00857584|12211032|FG000|Overall Study|Physician Decision|1
7768142|NCT00857584|12211033|FG001|Overall Study|Physician Decision|1
7768143|NCT00857623|12211041|FG000|Overall Study|Adverse Event|5
7725955|NCT04274192|12151276|FG000|Overall Study|Protocol Violation|1
7725956|NCT04274192|12151277|FG001|Overall Study|Protocol Violation|0
7725957|NCT04110314|12151295|FG000|Overall Study|Did not meet inclusion criteria|35255
7725958|NCT04110314|12151296|FG001|Overall Study|Did not meet inclusion criteria|35104
7725959|NCT04110314|12151297|FG002|Overall Study|Did not meet inclusion criteria|35636
7725960|NCT04110314|12151298|FG003|Overall Study|Did not meet inclusion criteria|35135
7725961|NCT04110314|12151299|FG004|Overall Study|Did not meet inclusion criteria|35247
7725962|NCT04110314|12151300|FG005|Overall Study|Did not meet inclusion criteria|35727
7725963|NCT03961204|12151321|FG000|Overall Study|Withdrawal by Subject|2
7725964|NCT03961204|12151321|FG000|Overall Study|Lost to Follow-up|3
7725965|NCT03961204|12151321|FG000|Overall Study|Other|1
7725966|NCT03961204|12151321|FG000|Overall Study|Missing|1
7725967|NCT03895840|12151325|FG000|Overall Study|Withdrawal by Subject|21
7768144|NCT00857623|12211042|FG001|Overall Study|Adverse Event|2
7768145|NCT00857623|12211041|FG000|Overall Study|Study-specific discontinuation criteria|5
7768146|NCT00857623|12211042|FG001|Overall Study|Study-specific discontinuation criteria|3
7768147|NCT00857623|12211041|FG000|Overall Study|Withdrawal by Subject|2
7768148|NCT00857623|12211042|FG001|Overall Study|Withdrawal by Subject|1
7768149|NCT00857623|12211041|FG000|Overall Study|Lack of Efficacy|1
7768150|NCT00857623|12211042|FG001|Overall Study|Lack of Efficacy|1
7768151|NCT00857623|12211041|FG000|Overall Study|Severe non-compliance to protocol|1
7768152|NCT00857623|12211042|FG001|Overall Study|Severe non-compliance to protocol|1
7768153|NCT00857623|12211041|FG000|Overall Study|Intake of prohibited medication|0
7768154|NCT00857623|12211042|FG001|Overall Study|Intake of prohibited medication|1
7768155|NCT00857623|12211041|FG000|Overall Study|Positive for HEP C|0
7768156|NCT00857623|12211042|FG001|Overall Study|Positive for HEP C|1
7768157|NCT00857649|12211050|FG000|Overall Study|Adverse Event|15
7768158|NCT00857649|12211051|FG001|Overall Study|Adverse Event|10
7768159|NCT00857649|12211050|FG000|Overall Study|Non-compliance|1
7768160|NCT00857649|12211051|FG001|Overall Study|Non-compliance|1
7768161|NCT00857649|12211050|FG000|Overall Study|Protocol Violation|2
7768162|NCT00857649|12211051|FG001|Overall Study|Protocol Violation|2
7768163|NCT00857649|12211050|FG000|Overall Study|Withdrawal of Consent|10
7768164|NCT00857649|12211051|FG001|Overall Study|Withdrawal of Consent|7
7768165|NCT00857649|12211050|FG000|Overall Study|Nursing Home Placement|2
7768166|NCT00857649|12211051|FG001|Overall Study|Nursing Home Placement|9
7768167|NCT00857649|12211050|FG000|Overall Study|Other Reasons|1
7768168|NCT00857649|12211051|FG001|Overall Study|Other Reasons|3
7770370|NCT00876343|12214385|FG002|Overall Study|Adverse Event|2
7770371|NCT00876343|12214383|FG000|Overall Study|Withdrawal by Subject|4
7770372|NCT00876343|12214384|FG001|Overall Study|Withdrawal by Subject|4
7770373|NCT00876343|12214385|FG002|Overall Study|Withdrawal by Subject|3
7770374|NCT00876343|12214383|FG000|Overall Study|Lack of Efficacy|0
7770375|NCT00876343|12214384|FG001|Overall Study|Lack of Efficacy|0
7770376|NCT00876343|12214385|FG002|Overall Study|Lack of Efficacy|1
7770377|NCT00876343|12214383|FG000|Overall Study|Protocol Violation|4
7770378|NCT00876343|12214384|FG001|Overall Study|Protocol Violation|1
7770379|NCT00876343|12214385|FG002|Overall Study|Protocol Violation|1
7770380|NCT00876343|12214383|FG000|Overall Study|Physician Decision|0
7770381|NCT00876343|12214384|FG001|Overall Study|Physician Decision|1
7770382|NCT00876343|12214385|FG002|Overall Study|Physician Decision|1
7770383|NCT00876343|12214383|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
7770384|NCT00876343|12214384|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
7770385|NCT00876343|12214385|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
7770386|NCT00876343|12214383|FG000|Overall Study|Change of residence or other commitments|2
7770387|NCT00876343|12214384|FG001|Overall Study|Change of residence or other commitments|2
7770388|NCT00876343|12214385|FG002|Overall Study|Change of residence or other commitments|3
7770389|NCT00876395|12214395|FG000|Overall Study|Untreated|8
7770390|NCT00876395|12214396|FG001|Overall Study|Untreated|1
7770391|NCT00876395|12214395|FG000|Overall Study|Adverse Event|63
7770392|NCT00876395|12214396|FG001|Overall Study|Adverse Event|11
7770393|NCT00876395|12214395|FG000|Overall Study|Abnormal test procedure result(s)|1
7770394|NCT00876395|12214396|FG001|Overall Study|Abnormal test procedure result(s)|0
7770395|NCT00876395|12214395|FG000|Overall Study|Disease progression|259
7770396|NCT00876395|12214396|FG001|Overall Study|Disease progression|162
7725968|NCT03818399|12151329|FG000|Overall Study|Lost to Follow-up|11
7725969|NCT03818399|12151329|FG000|Overall Study|Withdrawal by Subject|1
7725970|NCT03818399|12151329|FG000|Overall Study|Protocol Violation|2
7725971|NCT03603496|12151335|FG000|Overall Study|Death|19
7725972|NCT03603496|12151336|FG001|Overall Study|Death|24
7725973|NCT03603496|12151335|FG000|Overall Study|Lost to Follow-up|141
7725974|NCT03603496|12151336|FG001|Overall Study|Lost to Follow-up|141
7725975|NCT03603496|12151335|FG000|Overall Study|Withdrawal by Subject|26
7725976|NCT03603496|12151336|FG001|Overall Study|Withdrawal by Subject|20
7725977|NCT03480802|12151344|FG000|Overall Study|Lost to Follow-up|5
7725978|NCT03480802|12151345|FG001|Overall Study|Lost to Follow-up|1
7725979|NCT03480802|12151344|FG000|Overall Study|Withdrawal by Subject|2
7725980|NCT03480802|12151345|FG001|Overall Study|Withdrawal by Subject|1
7725981|NCT03480802|12151344|FG000|Overall Study|Relocated|0
7725982|NCT03480802|12151345|FG001|Overall Study|Relocated|1
7725983|NCT03472521|12151355|FG000|Overall Study|Lost to Follow-up|3
7725984|NCT03472521|12151356|FG001|Overall Study|Lost to Follow-up|2
7725985|NCT03472521|12151355|FG000|Overall Study|Discontinued intervention|3
7725986|NCT03472521|12151356|FG001|Overall Study|Discontinued intervention|1
7768169|NCT00857766|12211072|FG000|Overall Study|Adverse Event|13
7768170|NCT00857766|12211073|FG001|Overall Study|Adverse Event|12
7768171|NCT00857766|12211072|FG000|Overall Study|Protocol Violation|11
7768172|NCT00857766|12211073|FG001|Overall Study|Protocol Violation|11
7768173|NCT00857766|12211072|FG000|Overall Study|Lost to Follow-up|1
7768174|NCT00857766|12211073|FG001|Overall Study|Lost to Follow-up|0
7768175|NCT00857766|12211072|FG000|Overall Study|Investigator Discretion|2
7768176|NCT00857766|12211073|FG001|Overall Study|Investigator Discretion|3
7768177|NCT00857766|12211072|FG000|Overall Study|Participant Withdrew Consent|4
7768178|NCT00857766|12211073|FG001|Overall Study|Participant Withdrew Consent|4
7768179|NCT00857792|12211079|FG000|Overall Study|inadequate image quality for analysis|12
7768180|NCT00857818|12211085|FG000|Overall Study|Lack of Efficacy|1
7768181|NCT00857818|12211086|FG001|Overall Study|Lack of Efficacy|0
7768182|NCT00857818|12211085|FG000|Overall Study|Adverse Event|3
7768183|NCT00857818|12211086|FG001|Overall Study|Adverse Event|0
7768184|NCT00857818|12211085|FG000|Overall Study|Withdrawal by Subject|0
7768185|NCT00857818|12211086|FG001|Overall Study|Withdrawal by Subject|4
7768186|NCT00857818|12211085|FG000|Overall Study|Sponsor terminated study|6
7768187|NCT00857818|12211086|FG001|Overall Study|Sponsor terminated study|4
7768188|NCT00857818|12211085|FG000|Overall Study|Investigator decision|1
7768189|NCT00857818|12211086|FG001|Overall Study|Investigator decision|0
7768190|NCT00857896|12211104|FG000|Baseline to Week 4|Withdrawal by Subject|1
7768191|NCT00857948|12211113|FG000|Overall Study|Withdrawal by Subject|2
7768192|NCT00857948|12211114|FG001|Overall Study|Withdrawal by Subject|0
7768193|NCT00857948|12211115|FG002|Overall Study|Withdrawal by Subject|0
7768194|NCT00857948|12211116|FG003|Overall Study|Withdrawal by Subject|0
7768195|NCT00857948|12211113|FG000|Overall Study|Protocol Violation|1
7768196|NCT00857948|12211114|FG001|Overall Study|Protocol Violation|0
7768197|NCT00857948|12211115|FG002|Overall Study|Protocol Violation|1
7768198|NCT00857948|12211116|FG003|Overall Study|Protocol Violation|0
7768199|NCT00858117|12211145|FG000|Treatment on Study|Adverse Event|2
7768200|NCT00858117|12211145|FG000|Follow up for 5 Years|Death|4
7768201|NCT00858117|12211145|FG000|Follow up for 5 Years|No further data collected for study|9
7768202|NCT00858143|12211154|FG000|Overall Study|Adverse Event|16
7768203|NCT00858143|12211154|FG000|Overall Study|Lack of Efficacy|4
7768204|NCT00858143|12211154|FG000|Overall Study|Death|7
7768205|NCT00858143|12211154|FG000|Overall Study|Other|23
7768206|NCT00858208|12211158|FG000|Overall Study|Adverse Event|3
7768207|NCT00858208|12211158|FG000|Overall Study|Lost to Follow-up|26
7768208|NCT00858208|12211158|FG000|Overall Study|Participant refused|40
7768209|NCT00858208|12211158|FG000|Overall Study|Other|10
7768210|NCT00858234|12211162|FG000|Overall Study|Adverse Event|6
7768211|NCT00858234|12211162|FG000|Overall Study|Progressive disease|2
7768212|NCT00858234|12211162|FG000|Overall Study|Status unknown|1
7768213|NCT00858247|12211168|FG000|Baseline Assessment|Withdrawal by Subject|1
7768214|NCT00858247|12211169|FG001|Baseline Assessment|Withdrawal by Subject|1
7768215|NCT00858247|12211168|FG000|Baseline Assessment|Poor IV access|1
7725987|NCT02664441|12151378|FG000|Randomization|Withdrawal by Subject|0
7725988|NCT02664441|12151379|FG001|Randomization|Withdrawal by Subject|1
7725989|NCT02664441|12151378|FG000|36-week Randomized Trial|Adverse Event|2
7725990|NCT02664441|12151379|FG001|36-week Randomized Trial|Adverse Event|0
7725991|NCT02664441|12151378|FG000|36-week Randomized Trial|Lost to Follow-up|1
7725992|NCT02664441|12151379|FG001|36-week Randomized Trial|Lost to Follow-up|0
7725993|NCT02664441|12151378|FG000|36-week Randomized Trial|Withdrawal by Subject|0
7725994|NCT02664441|12151379|FG001|36-week Randomized Trial|Withdrawal by Subject|3
7725995|NCT02664441|12151378|FG000|18-week Open Label Extension|Adverse Event|1
7725996|NCT02664441|12151379|FG001|18-week Open Label Extension|Adverse Event|0
7725997|NCT02664441|12151378|FG000|18-week Open Label Extension|Physician Decision|1
7725998|NCT02664441|12151379|FG001|18-week Open Label Extension|Physician Decision|0
7725999|NCT02664441|12151378|FG000|18-week Open Label Extension|Death|1
7726000|NCT02664441|12151379|FG001|18-week Open Label Extension|Death|0
7726001|NCT02664441|12151378|FG000|18-week Open Label Extension|Lost to Follow-up|0
7726002|NCT02664441|12151379|FG001|18-week Open Label Extension|Lost to Follow-up|1
7726003|NCT02513472|12151399|FG000|Overall Study|Radiological Disease Progression|45
7726004|NCT02513472|12151400|FG001|Overall Study|Radiological Disease Progression|57
7726005|NCT02513472|12151399|FG000|Overall Study|Clinical Disease Progression|5
7726006|NCT02513472|12151400|FG001|Overall Study|Clinical Disease Progression|13
7726007|NCT02513472|12151399|FG000|Overall Study|Adverse Event|8
7726008|NCT02513472|12151400|FG001|Overall Study|Adverse Event|11
7726009|NCT02513472|12151399|FG000|Overall Study|Withdrawal by Subject|0
7726010|NCT02513472|12151400|FG001|Overall Study|Withdrawal by Subject|4
7726011|NCT02513472|12151399|FG000|Overall Study|Subject Choice|2
7726012|NCT02513472|12151400|FG001|Overall Study|Subject Choice|7
7726013|NCT02513472|12151399|FG000|Overall Study|Treatment Completed as per Protocol|3
7726014|NCT02513472|12151400|FG001|Overall Study|Treatment Completed as per Protocol|3
7726015|NCT02513472|12151399|FG000|Overall Study|Other|3
7726016|NCT02513472|12151400|FG001|Overall Study|Other|6
7726017|NCT01559935|12151439|FG000|Car Phase|Toxicity|4
7726018|NCT01559935|12151439|FG000|Car Phase|Death|1
7726019|NCT01559935|12151439|FG000|Car Phase|Lack of Efficacy|2
7726020|NCT01559935|12151439|FG000|Car Phase|Lost to Follow-up|1
7726021|NCT01559935|12151439|FG000|Car Phase|Physician Decision|1
7726022|NCT01559935|12151439|FG000|Car Phase|Withdrawal by Subject|2
7726023|NCT01559935|12151439|FG000|Car Phase|Per protocol|1
7726024|NCT01559935|12151439|FG000|Car Phase|Insurance|1
7726025|NCT01559935|12151439|FG000|Car Phase|non-compliance|1
7726026|NCT01559935|12151439|FG000|BiRD Phase|Toxicity|1
7726027|NCT01559935|12151439|FG000|BiRD Phase|Lack of Efficacy|1
7726028|NCT01559935|12151439|FG000|BiRD Phase|Withdrawal by Subject|2
7726029|NCT01559935|12151439|FG000|Maintenance Phase|Remains on study|28
7726030|NCT01559935|12151439|FG000|Maintenance Phase|Toxicity|1
7726031|NCT01559935|12151439|FG000|Maintenance Phase|Lack of Efficacy|18
7726032|NCT01559935|12151439|FG000|Maintenance Phase|Withdrawal by Subject|5
7726033|NCT01559935|12151439|FG000|Maintenance Phase|Non-compliance|2
7726034|NCT01067144|12151454|FG000|Treatment|Did not receive allocated intervention|4
7726035|NCT01067144|12151455|FG001|Treatment|Did not receive allocated intervention|7
7726036|NCT01067144|12151454|FG000|Follow-up|Lost to Follow-up|22
7726037|NCT01067144|12151455|FG001|Follow-up|Lost to Follow-up|12
7726038|NCT01067144|12151454|FG000|Follow-up|Censored owing to second surgery|19
7726039|NCT01067144|12151455|FG001|Follow-up|Censored owing to second surgery|28
7726040|NCT01067144|12151454|FG000|Follow-up|Withdrawal by Subject|18
7726041|NCT01067144|12151455|FG001|Follow-up|Withdrawal by Subject|14
7726042|NCT01067144|12151454|FG000|Follow-up|Surgery cancelled|0
7726043|NCT01067144|12151455|FG001|Follow-up|Surgery cancelled|1
7726044|NCT01067144|12151454|FG000|Follow-up|Death|0
7726045|NCT01067144|12151455|FG001|Follow-up|Death|1
7726046|NCT00600483|12151463|FG000|Overall Study|Lost to Follow-up|26
7726047|NCT00600483|12151464|FG001|Overall Study|Lost to Follow-up|47
7726048|NCT00600483|12151463|FG000|Overall Study|Randomized but not treated|10
7726049|NCT00600483|12151464|FG001|Overall Study|Randomized but not treated|0
7768216|NCT00858247|12211169|FG001|Baseline Assessment|Poor IV access|0
7768217|NCT00858247|12211168|FG000|Baseline Assessment|Protocol Violation|0
7768218|NCT00858247|12211169|FG001|Baseline Assessment|Protocol Violation|1
7768219|NCT00858247|12211168|FG000|Week 12 Follow-up|Withdrawal by Subject|0
7768220|NCT00858247|12211169|FG001|Week 12 Follow-up|Withdrawal by Subject|1
7768221|NCT00858364|12211177|FG000|Overall Study|Administrative Decision|3
7768222|NCT00858364|12211178|FG001|Overall Study|Administrative Decision|2
7768223|NCT00858364|12211177|FG000|Overall Study|Adverse Event|5
7726050|NCT00568958|12151481|FG000|Allocation|Withdrawal by Subject|7
7726051|NCT00568958|12151482|FG001|Allocation|Withdrawal by Subject|3
7726052|NCT00568958|12151481|FG000|Allocation|Physician Decision|2
7726053|NCT00568958|12151482|FG001|Allocation|Physician Decision|0
7726054|NCT00568958|12151481|FG000|Follow-Up|Withdrawal by Subject|6
7726055|NCT00568958|12151482|FG001|Follow-Up|Withdrawal by Subject|6
7726056|NCT00568958|12151481|FG000|Follow-Up|Physician Decision|1
7726057|NCT00568958|12151482|FG001|Follow-Up|Physician Decision|1
7726058|NCT00568958|12151481|FG000|Follow-Up|Family Emergency|1
7726059|NCT00568958|12151482|FG001|Follow-Up|Family Emergency|0
7726060|NCT00568958|12151481|FG000|Follow-Up|Adverse Event|1
7726061|NCT00568958|12151482|FG001|Follow-Up|Adverse Event|0
7726062|NCT00569166|12151508|FG000|Overall Study|Withdrawal by Subject|7
7726063|NCT00569166|12151509|FG001|Overall Study|Withdrawal by Subject|5
7726064|NCT00569166|12151510|FG002|Overall Study|Withdrawal by Subject|3
7726065|NCT00569166|12151508|FG000|Overall Study|Lost to Follow-up|2
7726066|NCT00569166|12151509|FG001|Overall Study|Lost to Follow-up|1
7726067|NCT00569166|12151510|FG002|Overall Study|Lost to Follow-up|1
7726068|NCT00569231|12151531|FG000|Overall Study|Study unrelated surgery|1
7726069|NCT00569231|12151531|FG000|Overall Study|Airfare expense|2
7726070|NCT00569231|12151531|FG000|Overall Study|Withdrawal by Subject|1
7726071|NCT00569231|12151531|FG000|Overall Study|Car accident injury|1
7726072|NCT00569231|12151531|FG000|Overall Study|Non-compliance|2
7726073|NCT00569270|12151535|FG000|Period: First Intervention|Protocol Violation|0
7726074|NCT00569270|12151536|FG001|Period: First Intervention|Protocol Violation|1
7726075|NCT00569374|12151555|FG000|Overall Study|Withdrawal by Subject|4
7726076|NCT00569582|12151568|FG000|Overall Study|Withdrawal by Subject|5
7726077|NCT00569582|12151568|FG000|Overall Study|Death|2
7726078|NCT00569582|12151568|FG000|Overall Study|Adverse Event|7
7726079|NCT00569582|12151568|FG000|Overall Study|Subject was too ill to travel.|1
7726080|NCT00569582|12151568|FG000|Overall Study|Subject was non-compliant.|1
7726081|NCT00569777|12151582|FG000|Overall Study|Withdrawal by Subject|4
7726082|NCT00569777|12151583|FG001|Overall Study|Withdrawal by Subject|0
7726083|NCT00569777|12151582|FG000|Overall Study|Adverse Event|3
7726084|NCT00569777|12151583|FG001|Overall Study|Adverse Event|0
7726085|NCT00569777|12151582|FG000|Overall Study|Lost to Follow-up|1
7726086|NCT00569777|12151583|FG001|Overall Study|Lost to Follow-up|0
7726087|NCT00569777|12151582|FG000|Overall Study|scheduled eye surgery|0
7726088|NCT00569777|12151583|FG001|Overall Study|scheduled eye surgery|1
7726089|NCT00569777|12151582|FG000|Overall Study|did not meet exclusion criteria|1
7726090|NCT00569777|12151583|FG001|Overall Study|did not meet exclusion criteria|2
7726091|NCT00569777|12151582|FG000|Overall Study|pregnant|1
7726092|NCT00569777|12151583|FG001|Overall Study|pregnant|0
7726093|NCT00569803|12151597|FG000|Overall Study|Lost to Follow-up|1
7726094|NCT00569803|12151598|FG001|Overall Study|Lost to Follow-up|0
7726095|NCT00569803|12151599|FG002|Overall Study|Lost to Follow-up|0
7726096|NCT00569803|12151600|FG003|Overall Study|Lost to Follow-up|0
7726097|NCT00569803|12151601|FG004|Overall Study|Lost to Follow-up|0
7726098|NCT00569803|12151602|FG005|Overall Study|Lost to Follow-up|0
7726099|NCT00569803|12151603|FG006|Overall Study|Lost to Follow-up|0
7726100|NCT00569803|12151604|FG007|Overall Study|Lost to Follow-up|0
7726101|NCT00569803|12151597|FG000|Overall Study|injection syringe leaked during dosing|0
7726102|NCT00569803|12151598|FG001|Overall Study|injection syringe leaked during dosing|0
7726103|NCT00569803|12151599|FG002|Overall Study|injection syringe leaked during dosing|0
7726104|NCT00569803|12151600|FG003|Overall Study|injection syringe leaked during dosing|1
7726105|NCT00569803|12151601|FG004|Overall Study|injection syringe leaked during dosing|0
7726106|NCT00569803|12151602|FG005|Overall Study|injection syringe leaked during dosing|0
7726107|NCT00569803|12151603|FG006|Overall Study|injection syringe leaked during dosing|0
7726108|NCT00569803|12151604|FG007|Overall Study|injection syringe leaked during dosing|0
7726109|NCT00569803|12151597|FG000|Overall Study|Withdrawal by Subject|0
7726110|NCT00569803|12151598|FG001|Overall Study|Withdrawal by Subject|0
7726111|NCT00569803|12151599|FG002|Overall Study|Withdrawal by Subject|0
7726112|NCT00569803|12151600|FG003|Overall Study|Withdrawal by Subject|0
7726113|NCT00569803|12151601|FG004|Overall Study|Withdrawal by Subject|0
7726114|NCT00569803|12151602|FG005|Overall Study|Withdrawal by Subject|0
7726115|NCT00569803|12151603|FG006|Overall Study|Withdrawal by Subject|0
7726116|NCT00569803|12151604|FG007|Overall Study|Withdrawal by Subject|1
7726117|NCT00569946|12151630|FG000|Overall Study|Adverse Event|16
7726118|NCT00569946|12151630|FG000|Overall Study|Objective Progression or Relapse|42
7726119|NCT00569946|12151630|FG000|Overall Study|Global Deterioration of Health Status|1
7726120|NCT00570037|12151636|FG000|Overall Study|Could not reach for 6-8 week contact|44
7726121|NCT00570037|12151637|FG001|Overall Study|Could not reach for 6-8 week contact|69
7726122|NCT00570063|12151645|FG000|Overall Study|Adverse Event|4
7726123|NCT00570063|12151646|FG001|Overall Study|Adverse Event|1
7726124|NCT00570063|12151645|FG000|Overall Study|Lack of Efficacy|0
7726125|NCT00570063|12151646|FG001|Overall Study|Lack of Efficacy|1
7726126|NCT00570063|12151645|FG000|Overall Study|Withdrawal by Subject|4
7726127|NCT00570063|12151646|FG001|Overall Study|Withdrawal by Subject|3
7726128|NCT00570063|12151645|FG000|Overall Study|Sponsor's Decision|7
7726129|NCT00570063|12151646|FG001|Overall Study|Sponsor's Decision|3
7726130|NCT00570128|12151663|FG000|Overall Study|Adverse Event|1
7726131|NCT00570128|12151664|FG001|Overall Study|Adverse Event|0
7726132|NCT00570128|12151663|FG000|Overall Study|Lost to Follow-up|1
7726133|NCT00570128|12151664|FG001|Overall Study|Lost to Follow-up|0
7726134|NCT00570128|12151663|FG000|Overall Study|Withdrawal by Subject|2
7726135|NCT00570128|12151664|FG001|Overall Study|Withdrawal by Subject|0
7726136|NCT00570141|12151670|FG000|Overall Study|Adverse Event|1
7726137|NCT00570141|12151670|FG000|Overall Study|Missed visits|1
7726138|NCT00570141|12151670|FG000|Overall Study|Lost to Follow-up|1
7726139|NCT00570232|12151674|FG000|Overall Study|Adverse Event|10
7726140|NCT00570232|12151674|FG000|Overall Study|discontinued due to medical condition|3
7726141|NCT00570232|12151674|FG000|Overall Study|discontinued due to recurrence|8
7726142|NCT00570232|12151674|FG000|Overall Study|discontinued due to noncompliance|2
7726143|NCT00570310|12151680|FG000|Overall Study|Adverse Event|1
7726144|NCT00570310|12151681|FG001|Overall Study|Adverse Event|2
7726145|NCT00570310|12151680|FG000|Overall Study|Lack of Efficacy|1
7726146|NCT00570310|12151681|FG001|Overall Study|Lack of Efficacy|4
7726147|NCT00570323|12151689|FG000|Started Treatment After Randomization|Withdrawal by Subject|0
7726148|NCT00570323|12151690|FG001|Started Treatment After Randomization|Withdrawal by Subject|1
7726149|NCT00570323|12151689|FG000|Started Treatment After Randomization|Protocol Violation|1
7726150|NCT00570323|12151690|FG001|Started Treatment After Randomization|Protocol Violation|0
7726151|NCT00570323|12151689|FG000|Started Treatment After Randomization|Physician Decision|1
7726152|NCT00570323|12151690|FG001|Started Treatment After Randomization|Physician Decision|0
7726153|NCT00570323|12151689|FG000|Complete Study After Start|Lost to Follow-up|0
7726154|NCT00570323|12151690|FG001|Complete Study After Start|Lost to Follow-up|1
7726155|NCT00570323|12151689|FG000|Complete Study After Start|Withdrawal by Subject|2
7726156|NCT00570323|12151690|FG001|Complete Study After Start|Withdrawal by Subject|0
7726157|NCT00570323|12151689|FG000|Complete Study After Start|Physician Decision|1
7726158|NCT00570323|12151690|FG001|Complete Study After Start|Physician Decision|0
7726159|NCT00570401|12151720|FG000|Overall Study|Adverse Event|2
7726160|NCT00570492|12151726|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
7726161|NCT00570492|12151727|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
7726162|NCT00570492|12151728|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
7726163|NCT00570492|12151726|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
7726164|NCT00570492|12151727|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
7726165|NCT00570492|12151728|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
7726166|NCT00570492|12151726|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56
7726167|NCT00570492|12151727|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0
7726168|NCT00570492|12151728|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0
7726169|NCT00570492|12151726|FG000|16-week Single-blind Baseline Period|Protocol Violation|15
7726170|NCT00570492|12151727|FG001|16-week Single-blind Baseline Period|Protocol Violation|0
7726171|NCT00570492|12151728|FG002|16-week Single-blind Baseline Period|Protocol Violation|0
7726172|NCT00570492|12151726|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2
7726173|NCT00570492|12151727|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0
7726174|NCT00570492|12151728|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0
7726175|NCT00570492|12151726|FG000|16-week Single-blind Baseline Period|Adverse Event|1
7726176|NCT00570492|12151727|FG001|16-week Single-blind Baseline Period|Adverse Event|0
7726177|NCT00570492|12151728|FG002|16-week Single-blind Baseline Period|Adverse Event|0
7726178|NCT00570492|12151726|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
7726179|NCT00570492|12151727|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
7726180|NCT00570492|12151728|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
7726181|NCT00570492|12151726|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0
7726182|NCT00570492|12151727|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20
7726183|NCT00570492|12151728|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20
7726184|NCT00570492|12151726|FG000|52-week Double-blind Treatment Period|Protocol Violation|0
7726185|NCT00570492|12151727|FG001|52-week Double-blind Treatment Period|Protocol Violation|12
7726186|NCT00570492|12151728|FG002|52-week Double-blind Treatment Period|Protocol Violation|15
7726187|NCT00570492|12151726|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0
7726188|NCT00570492|12151727|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5
7726189|NCT00570492|12151728|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7
7726190|NCT00570492|12151726|FG000|52-week Double-blind Treatment Period|Adverse Event|0
7726191|NCT00570492|12151727|FG001|52-week Double-blind Treatment Period|Adverse Event|5
7726192|NCT00570492|12151728|FG002|52-week Double-blind Treatment Period|Adverse Event|5
7726193|NCT00570492|12151726|FG000|52-week Double-blind Treatment Period|Physician Decision|0
7726194|NCT00570492|12151727|FG001|52-week Double-blind Treatment Period|Physician Decision|2
7726195|NCT00570492|12151728|FG002|52-week Double-blind Treatment Period|Physician Decision|4
7726196|NCT00570492|12151726|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0
7726197|NCT00570492|12151727|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3
7726198|NCT00570492|12151728|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0
7726199|NCT00570492|12151726|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
7726200|NCT00570492|12151727|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
7726201|NCT00570492|12151728|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
7726202|NCT00570505|12151734|FG000|Overall Study|Adverse Event|7
7726203|NCT00570505|12151734|FG000|Overall Study|Withdrawal by Subject|7
7726204|NCT00570505|12151734|FG000|Overall Study|Lost to Follow-up|23
7726205|NCT00570505|12151734|FG000|Overall Study|Other loss to follow-up|4
7726206|NCT00570661|12151738|FG000|Overall Study|Disease worsening|5
7726207|NCT00570661|12151738|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1
7726208|NCT00570661|12151738|FG000|Overall Study|Adverse Event|1
7726209|NCT00570674|12151743|FG000|Overall Study|Withdrawal by Subject|0
7726210|NCT00570674|12151744|FG001|Overall Study|Withdrawal by Subject|0
7726211|NCT00570674|12151745|FG002|Overall Study|Withdrawal by Subject|1
7726212|NCT00570674|12151746|FG003|Overall Study|Withdrawal by Subject|0
7726213|NCT00570674|12151747|FG004|Overall Study|Withdrawal by Subject|0
7726214|NCT00570674|12151748|FG005|Overall Study|Withdrawal by Subject|0
7726215|NCT00570674|12151749|FG006|Overall Study|Withdrawal by Subject|0
7726216|NCT00570687|12151762|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726217|NCT00570687|12151763|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726218|NCT00570687|12151764|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726219|NCT00570687|12151765|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726220|NCT00570687|12151766|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
7726221|NCT00570687|12151767|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
7726222|NCT00570687|12151768|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
7726223|NCT00570687|12151769|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
7726224|NCT00570687|12151770|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
7726225|NCT00570687|12151771|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
7726226|NCT00570687|12151762|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726227|NCT00570687|12151763|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726228|NCT00570687|12151764|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726229|NCT00570687|12151765|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726230|NCT00570687|12151766|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726231|NCT00570687|12151767|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726232|NCT00570687|12151768|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726233|NCT00570687|12151769|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726234|NCT00570687|12151770|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
7726235|NCT00570687|12151771|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726236|NCT00570687|12151762|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726237|NCT00570687|12151763|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726238|NCT00570687|12151764|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726239|NCT00570687|12151765|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726240|NCT00570687|12151766|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726241|NCT00570687|12151767|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726242|NCT00570687|12151768|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
7726243|NCT00570687|12151769|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726244|NCT00570687|12151770|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726245|NCT00570687|12151771|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7726246|NCT00570713|12151791|FG000|Overall Study|Adverse Event|16
7726247|NCT00570713|12151792|FG001|Overall Study|Adverse Event|9
7726248|NCT00570713|12151791|FG000|Overall Study|Death|7
7726249|NCT00570713|12151792|FG001|Overall Study|Death|7
7726250|NCT00570713|12151791|FG000|Overall Study|Lack of Efficacy|40
7726251|NCT00570713|12151792|FG001|Overall Study|Lack of Efficacy|49
7726252|NCT00570713|12151791|FG000|Overall Study|Physician Decision|2
7726253|NCT00570713|12151792|FG001|Overall Study|Physician Decision|2
7726254|NCT00570713|12151791|FG000|Overall Study|Withdrawal by Subject|3
7726255|NCT00570713|12151792|FG001|Overall Study|Withdrawal by Subject|3
7726256|NCT00570713|12151791|FG000|Overall Study|Discontinuation of Study by the Sponsor|10
7726257|NCT00570713|12151792|FG001|Overall Study|Discontinuation of Study by the Sponsor|7
7726258|NCT00570739|12151802|FG000|Overall Study|Adverse Event|8
7726259|NCT00570739|12151803|FG001|Overall Study|Adverse Event|6
7726260|NCT00570739|12151804|FG002|Overall Study|Adverse Event|2
7726261|NCT00570739|12151805|FG003|Overall Study|Adverse Event|2
7726262|NCT00570739|12151802|FG000|Overall Study|Lost to Follow-up|4
7726263|NCT00570739|12151803|FG001|Overall Study|Lost to Follow-up|5
7726264|NCT00570739|12151804|FG002|Overall Study|Lost to Follow-up|4
7726265|NCT00570739|12151805|FG003|Overall Study|Lost to Follow-up|1
7726266|NCT00570739|12151802|FG000|Overall Study|Physician Decision|1
7726267|NCT00570739|12151803|FG001|Overall Study|Physician Decision|1
7726268|NCT00570739|12151804|FG002|Overall Study|Physician Decision|0
7726269|NCT00570739|12151805|FG003|Overall Study|Physician Decision|0
7726270|NCT00570739|12151802|FG000|Overall Study|Withdrawal by Subject|7
7726271|NCT00570739|12151803|FG001|Overall Study|Withdrawal by Subject|7
7726272|NCT00570739|12151804|FG002|Overall Study|Withdrawal by Subject|3
7726273|NCT00570739|12151805|FG003|Overall Study|Withdrawal by Subject|5
7768224|NCT00858364|12211178|FG001|Overall Study|Adverse Event|2
7726274|NCT00570739|12151802|FG000|Overall Study|Required restricted medication|0
7726275|NCT00570739|12151803|FG001|Overall Study|Required restricted medication|0
7726276|NCT00570739|12151804|FG002|Overall Study|Required restricted medication|1
7726277|NCT00570739|12151805|FG003|Overall Study|Required restricted medication|0
7726278|NCT00570739|12151802|FG000|Overall Study|Met discontinuation criteria|1
7726279|NCT00570739|12151803|FG001|Overall Study|Met discontinuation criteria|0
7726280|NCT00570739|12151804|FG002|Overall Study|Met discontinuation criteria|1
7726281|NCT00570739|12151805|FG003|Overall Study|Met discontinuation criteria|1
7726282|NCT00570739|12151802|FG000|Overall Study|Other|0
7726283|NCT00570739|12151803|FG001|Overall Study|Other|2
7726284|NCT00570739|12151804|FG002|Overall Study|Other|5
7726285|NCT00570739|12151805|FG003|Overall Study|Other|3
7726286|NCT00570765|12151838|FG000|DB Phase|Withdrawal by Subject|1
7726287|NCT00570765|12151839|FG001|DB Phase|Withdrawal by Subject|0
7726288|NCT00570765|12151840|FG002|DB Phase|Withdrawal by Subject|0
7726289|NCT00570765|12151841|FG003|DB Phase|Withdrawal by Subject|0
7726290|NCT00570765|12151838|FG000|DB Phase|Protocol Violation|0
7726291|NCT00570765|12151839|FG001|DB Phase|Protocol Violation|1
7726292|NCT00570765|12151840|FG002|DB Phase|Protocol Violation|0
7726293|NCT00570765|12151841|FG003|DB Phase|Protocol Violation|0
7726294|NCT00570765|12151838|FG000|DB Phase|Adverse Event|3
7726295|NCT00570765|12151839|FG001|DB Phase|Adverse Event|6
7726296|NCT00570765|12151840|FG002|DB Phase|Adverse Event|0
7726297|NCT00570765|12151841|FG003|DB Phase|Adverse Event|0
7726298|NCT00570765|12151838|FG000|DB Phase|Did Not Receive Study Drug|0
7726299|NCT00570765|12151839|FG001|DB Phase|Did Not Receive Study Drug|0
7726300|NCT00570765|12151840|FG002|DB Phase|Did Not Receive Study Drug|1
7726301|NCT00570765|12151841|FG003|DB Phase|Did Not Receive Study Drug|0
7726302|NCT00570765|12151838|FG000|LTSE Phase|Withdrawal by Subject|0
7726303|NCT00570765|12151839|FG001|LTSE Phase|Withdrawal by Subject|0
7726304|NCT00570765|12151840|FG002|LTSE Phase|Withdrawal by Subject|0
7726305|NCT00570765|12151841|FG003|LTSE Phase|Withdrawal by Subject|1
7726306|NCT00570765|12151838|FG000|LTSE Phase|Adverse Event|0
7726307|NCT00570765|12151839|FG001|LTSE Phase|Adverse Event|0
7726308|NCT00570765|12151840|FG002|LTSE Phase|Adverse Event|0
7726309|NCT00570765|12151841|FG003|LTSE Phase|Adverse Event|7
7726310|NCT00570765|12151838|FG000|LTSE Phase|Physician Decision|0
7726311|NCT00570765|12151839|FG001|LTSE Phase|Physician Decision|0
7726312|NCT00570765|12151840|FG002|LTSE Phase|Physician Decision|0
7726313|NCT00570765|12151841|FG003|LTSE Phase|Physician Decision|4
7726314|NCT00570778|12151852|FG000|Overall Study|Protocol deviation|2
7726315|NCT00570778|12151853|FG001|Overall Study|Protocol deviation|1
7726316|NCT00570778|12151854|FG002|Overall Study|Protocol deviation|2
7726317|NCT00570778|12151855|FG003|Overall Study|Protocol deviation|2
7726318|NCT00570778|12151852|FG000|Overall Study|Adverse Event|0
7726319|NCT00570778|12151853|FG001|Overall Study|Adverse Event|1
7726320|NCT00570778|12151854|FG002|Overall Study|Adverse Event|4
7726321|NCT00570778|12151855|FG003|Overall Study|Adverse Event|1
7726322|NCT00570778|12151852|FG000|Overall Study|Subject withdrew consent|0
7726323|NCT00570778|12151853|FG001|Overall Study|Subject withdrew consent|1
7726324|NCT00570778|12151854|FG002|Overall Study|Subject withdrew consent|0
7726325|NCT00570778|12151855|FG003|Overall Study|Subject withdrew consent|1
7726326|NCT00570778|12151852|FG000|Overall Study|Abnormal test procedure|1
7726327|NCT00570778|12151853|FG001|Overall Study|Abnormal test procedure|0
7726328|NCT00570778|12151854|FG002|Overall Study|Abnormal test procedure|0
7726329|NCT00570778|12151855|FG003|Overall Study|Abnormal test procedure|0
7726330|NCT00570778|12151852|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7726331|NCT00570778|12151853|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7726332|NCT00570778|12151854|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7726333|NCT00570778|12151855|FG003|Overall Study|Unsatisfactory therapeutic effect|0
7726334|NCT00570778|12151852|FG000|Overall Study|Lost to Follow-up|0
7726335|NCT00570778|12151853|FG001|Overall Study|Lost to Follow-up|0
7726336|NCT00570778|12151854|FG002|Overall Study|Lost to Follow-up|1
7726337|NCT00570778|12151855|FG003|Overall Study|Lost to Follow-up|0
7726338|NCT00570778|12151852|FG000|Overall Study|Subject no longer requires study drug|0
7726339|NCT00570778|12151853|FG001|Overall Study|Subject no longer requires study drug|1
7726340|NCT00570778|12151854|FG002|Overall Study|Subject no longer requires study drug|0
7726341|NCT00570778|12151855|FG003|Overall Study|Subject no longer requires study drug|0
7726342|NCT00570908|12151865|FG000|Overall Study|Adverse Event|5
7726343|NCT00570908|12151865|FG000|Overall Study|Withdrawal by Subject|2
7726344|NCT00570921|12151869|FG000|Overall Study|Protocol Violation|1
7726345|NCT00570921|12151869|FG000|Overall Study|Physician Decision|1
7726346|NCT00571038|12151884|FG000|Overall Study|Lost to Follow-up|1
7726347|NCT00571038|12151885|FG001|Overall Study|Lost to Follow-up|4
7726348|NCT00571038|12151884|FG000|Overall Study|Death|7
7726349|NCT00571038|12151885|FG001|Overall Study|Death|5
7726350|NCT00571038|12151884|FG000|Overall Study|Withdrawal by Subject|1
7726351|NCT00571038|12151885|FG001|Overall Study|Withdrawal by Subject|3
7726352|NCT00571038|12151884|FG000|Overall Study|Moved out of state|2
7726353|NCT00571038|12151885|FG001|Overall Study|Moved out of state|2
7726354|NCT00571064|12151891|FG000|Overall Study|Adverse Event|13
7726355|NCT00571064|12151891|FG000|Overall Study|Protocol Violation|4
7726356|NCT00571064|12151891|FG000|Overall Study|Withdrawal by Subject|2
7726357|NCT00571064|12151891|FG000|Overall Study|Other|2
7726358|NCT00571103|12151896|FG000|Overall Study|Withdrawal by Subject|1
7726359|NCT00571103|12151896|FG000|Overall Study|Lost to Follow-up|1
7726360|NCT00571519|12151948|FG000|Overall Study|Subject withdrew consent|0
7726361|NCT00571519|12151949|FG001|Overall Study|Subject withdrew consent|1
7726362|NCT00571519|12151950|FG002|Overall Study|Subject withdrew consent|0
7726363|NCT00571519|12151951|FG003|Overall Study|Subject withdrew consent|2
7726364|NCT00571519|12151952|FG004|Overall Study|Subject withdrew consent|1
7726365|NCT00571519|12151953|FG005|Overall Study|Subject withdrew consent|1
7726366|NCT00571519|12151954|FG006|Overall Study|Subject withdrew consent|2
7726367|NCT00571519|12151948|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1
7726368|NCT00571519|12151949|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0
7726369|NCT00571519|12151950|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1
7726370|NCT00571519|12151951|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1
7726371|NCT00571519|12151952|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0
7726372|NCT00571519|12151953|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0
7726373|NCT00571519|12151954|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0
7726374|NCT00571519|12151948|FG000|Overall Study|Therapeutic failure/lack of efficacy|0
7726375|NCT00571519|12151949|FG001|Overall Study|Therapeutic failure/lack of efficacy|1
7726376|NCT00571519|12151950|FG002|Overall Study|Therapeutic failure/lack of efficacy|0
7726377|NCT00571519|12151951|FG003|Overall Study|Therapeutic failure/lack of efficacy|0
7726378|NCT00571519|12151952|FG004|Overall Study|Therapeutic failure/lack of efficacy|0
7726379|NCT00571519|12151953|FG005|Overall Study|Therapeutic failure/lack of efficacy|0
7726380|NCT00571519|12151954|FG006|Overall Study|Therapeutic failure/lack of efficacy|0
7726381|NCT00571519|12151948|FG000|Overall Study|Termination of study by Sponsor|2
7726382|NCT00571519|12151949|FG001|Overall Study|Termination of study by Sponsor|7
7726383|NCT00571519|12151950|FG002|Overall Study|Termination of study by Sponsor|10
7726384|NCT00571519|12151951|FG003|Overall Study|Termination of study by Sponsor|24
7726385|NCT00571519|12151952|FG004|Overall Study|Termination of study by Sponsor|8
7726386|NCT00571519|12151953|FG005|Overall Study|Termination of study by Sponsor|9
7726387|NCT00571519|12151954|FG006|Overall Study|Termination of study by Sponsor|22
7726388|NCT00571519|12151948|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7726389|NCT00571519|12151949|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7726390|NCT00571519|12151950|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1
7726391|NCT00571519|12151951|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7726392|NCT00571519|12151952|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7726393|NCT00571519|12151953|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7726394|NCT00571519|12151954|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7726395|NCT00571649|12151972|FG000|Treatment Period|Adverse Event|438
7726396|NCT00571649|12151973|FG001|Treatment Period|Adverse Event|385
7726397|NCT00571649|12151972|FG000|Treatment Period|Clinical endpoint reached|50
7726398|NCT00571649|12151973|FG001|Treatment Period|Clinical endpoint reached|56
7726399|NCT00571649|12151972|FG000|Treatment Period|Withdrawal by Subject|285
7726400|NCT00571649|12151973|FG001|Treatment Period|Withdrawal by Subject|255
7726401|NCT00571649|12151972|FG000|Treatment Period|Death|76
7726402|NCT00571649|12151973|FG001|Treatment Period|Death|59
7726403|NCT00571649|12151972|FG000|Treatment Period|Physician Decision|8
7726404|NCT00571649|12151973|FG001|Treatment Period|Physician Decision|9
7726405|NCT00571649|12151972|FG000|Treatment Period|Lost to Follow-up|43
7726406|NCT00571649|12151973|FG001|Treatment Period|Lost to Follow-up|41
7726407|NCT00571649|12151972|FG000|Treatment Period|Non-compliant with study medication|88
7726408|NCT00571649|12151973|FG001|Treatment Period|Non-compliant with study medication|89
7726409|NCT00571649|12151972|FG000|Treatment Period|Patient convenience|11
7726410|NCT00571649|12151973|FG001|Treatment Period|Patient convenience|13
7726411|NCT00571649|12151972|FG000|Treatment Period|Protocol Violation|90
7726412|NCT00571649|12151973|FG001|Treatment Period|Protocol Violation|92
7726413|NCT00571649|12151972|FG000|Treatment Period|Technical problems|3
7726414|NCT00571649|12151973|FG001|Treatment Period|Technical problems|5
7726415|NCT00571649|12151972|FG000|Follow-up Period|Adverse Event|46
7726416|NCT00571649|12151973|FG001|Follow-up Period|Adverse Event|40
7726417|NCT00571649|12151972|FG000|Follow-up Period|Clinical endpoint reached|5
7726418|NCT00571649|12151973|FG001|Follow-up Period|Clinical endpoint reached|2
7726419|NCT00571649|12151972|FG000|Follow-up Period|Withdrawal by Subject|119
7726420|NCT00571649|12151973|FG001|Follow-up Period|Withdrawal by Subject|115
7726421|NCT00571649|12151972|FG000|Follow-up Period|Death|132
7726422|NCT00571649|12151973|FG001|Follow-up Period|Death|133
7726423|NCT00571649|12151972|FG000|Follow-up Period|Physician Decision|7
7726424|NCT00571649|12151973|FG001|Follow-up Period|Physician Decision|13
7726425|NCT00571649|12151972|FG000|Follow-up Period|Lost to Follow-up|95
7726426|NCT00571649|12151973|FG001|Follow-up Period|Lost to Follow-up|92
7726427|NCT00571649|12151972|FG000|Follow-up Period|Patient convenience|136
7726428|NCT00571649|12151973|FG001|Follow-up Period|Patient convenience|121
7726429|NCT00571649|12151972|FG000|Follow-up Period|Protocol Violation|5
7726430|NCT00571649|12151973|FG001|Follow-up Period|Protocol Violation|12
7726431|NCT00571662|12151979|FG000|Overall Study|Withdrawal by Subject|2
7726432|NCT00571662|12151979|FG000|Overall Study|psychiatric instability|1
7726433|NCT00571662|12151979|FG000|Overall Study|Adverse Event|5
7726434|NCT00571688|12151987|FG000|Overall Study|Lost to Follow-up|3
7726435|NCT00571688|12151988|FG001|Overall Study|Lost to Follow-up|6
7726436|NCT00571688|12151987|FG000|Overall Study|subject did not tolerate Consta|1
7726437|NCT00571688|12151988|FG001|Overall Study|subject did not tolerate Consta|0
7726438|NCT00571688|12151987|FG000|Overall Study|subject moved out of the area|1
7726439|NCT00571688|12151988|FG001|Overall Study|subject moved out of the area|0
7726440|NCT00571701|12151996|FG000|First Intervention 12 Months|Withdrawal by Subject|2
7726441|NCT00571701|12151997|FG001|First Intervention 12 Months|Withdrawal by Subject|1
7726442|NCT00571701|12151996|FG000|First Intervention 12 Months|Death|1
7726443|NCT00571701|12151997|FG001|First Intervention 12 Months|Death|0
7726444|NCT00571701|12151996|FG000|Second Intervention 12 Months|Adverse Event|0
7726445|NCT00571701|12151997|FG001|Second Intervention 12 Months|Adverse Event|1
7726446|NCT00571701|12151996|FG000|Second Intervention 12 Months|Withdrawal by Subject|3
7726447|NCT00571701|12151997|FG001|Second Intervention 12 Months|Withdrawal by Subject|0
7726448|NCT00571948|12152023|FG000|Overall Study|Lost to Follow-up|2
7726449|NCT00571948|12152024|FG001|Overall Study|Lost to Follow-up|0
7726450|NCT00571948|12152023|FG000|Overall Study|Withdrawal by Subject|1
7726451|NCT00571948|12152024|FG001|Overall Study|Withdrawal by Subject|2
7726452|NCT00571948|12152023|FG000|Overall Study|Protocol Violation|3
7726453|NCT00571948|12152024|FG001|Overall Study|Protocol Violation|3
7726454|NCT00571948|12152023|FG000|Overall Study|infant refused study meal|3
7726455|NCT00571948|12152024|FG001|Overall Study|infant refused study meal|4
7726456|NCT00571948|12152023|FG000|Overall Study|Parent were afraid of blood colection|2
7726457|NCT00571948|12152024|FG001|Overall Study|Parent were afraid of blood colection|5
7726458|NCT00572039|12152050|FG000|Overall Study|Withdrawal by Subject|9
7726459|NCT00572039|12152051|FG001|Overall Study|Withdrawal by Subject|6
7726460|NCT00572039|12152050|FG000|Overall Study|Death|2
7726461|NCT00572039|12152051|FG001|Overall Study|Death|3
7726462|NCT00572039|12152050|FG000|Overall Study|Ill|5
7726463|NCT00572039|12152051|FG001|Overall Study|Ill|1
7726464|NCT00572156|12152074|FG000|Overall Study|Adverse Event|3
7726465|NCT00572156|12152075|FG001|Overall Study|Adverse Event|1
7726466|NCT00572156|12152076|FG002|Overall Study|Adverse Event|5
7726467|NCT00572156|12152077|FG003|Overall Study|Adverse Event|1
7726468|NCT00572156|12152074|FG000|Overall Study|Lost to Follow-up|1
7726469|NCT00572156|12152075|FG001|Overall Study|Lost to Follow-up|1
7726470|NCT00572156|12152076|FG002|Overall Study|Lost to Follow-up|1
7726471|NCT00572156|12152077|FG003|Overall Study|Lost to Follow-up|0
7726472|NCT00572156|12152074|FG000|Overall Study|Protocol Violation|1
7726473|NCT00572156|12152075|FG001|Overall Study|Protocol Violation|2
7726474|NCT00572156|12152076|FG002|Overall Study|Protocol Violation|0
7726475|NCT00572156|12152077|FG003|Overall Study|Protocol Violation|2
7726476|NCT00572156|12152074|FG000|Overall Study|Patient/Parent Decision|1
7726477|NCT00572156|12152075|FG001|Overall Study|Patient/Parent Decision|6
7726478|NCT00572156|12152076|FG002|Overall Study|Patient/Parent Decision|4
7726479|NCT00572156|12152077|FG003|Overall Study|Patient/Parent Decision|3
7726480|NCT00572156|12152074|FG000|Overall Study|Sponsor Decision|20
7726481|NCT00572156|12152075|FG001|Overall Study|Sponsor Decision|16
7726482|NCT00572156|12152076|FG002|Overall Study|Sponsor Decision|17
7726483|NCT00572156|12152077|FG003|Overall Study|Sponsor Decision|19
7726484|NCT00572195|12152087|FG000|Overall Study|Withdrawal by Subject|50
7726485|NCT00572195|12152087|FG000|Overall Study|Death|9
7726486|NCT00572195|12152087|FG000|Overall Study|Adverse Event|4
7726487|NCT00572195|12152087|FG000|Overall Study|Lost to Follow-up|5
7726488|NCT00572455|12152114|FG000|Stage I (14 Days)|Adverse Event|0
7726489|NCT00572455|12152115|FG001|Stage I (14 Days)|Adverse Event|0
7726490|NCT00572455|12152116|FG002|Stage I (14 Days)|Adverse Event|0
7726491|NCT00572455|12152117|FG003|Stage I (14 Days)|Adverse Event|0
7726492|NCT00572455|12152118|FG004|Stage I (14 Days)|Adverse Event|0
7726493|NCT00572455|12152119|FG005|Stage I (14 Days)|Adverse Event|3
7726494|NCT00572455|12152120|FG006|Stage I (14 Days)|Adverse Event|0
7726495|NCT00572455|12152121|FG007|Stage I (14 Days)|Adverse Event|0
7726496|NCT00572455|12152122|FG008|Stage I (14 Days)|Adverse Event|0
7726497|NCT00572455|12152123|FG009|Stage I (14 Days)|Adverse Event|0
7726498|NCT00572455|12152124|FG010|Stage I (14 Days)|Adverse Event|0
7726499|NCT00572455|12152125|FG011|Stage I (14 Days)|Adverse Event|0
7726500|NCT00572455|12152126|FG012|Stage I (14 Days)|Adverse Event|0
7726501|NCT00572455|12152127|FG013|Stage I (14 Days)|Adverse Event|0
7726502|NCT00572455|12152114|FG000|Stage I (14 Days)|Other|0
7726503|NCT00572455|12152115|FG001|Stage I (14 Days)|Other|0
7726504|NCT00572455|12152116|FG002|Stage I (14 Days)|Other|0
7726505|NCT00572455|12152117|FG003|Stage I (14 Days)|Other|0
7726506|NCT00572455|12152118|FG004|Stage I (14 Days)|Other|1
7726507|NCT00572455|12152119|FG005|Stage I (14 Days)|Other|0
7726508|NCT00572455|12152120|FG006|Stage I (14 Days)|Other|0
7726509|NCT00572455|12152121|FG007|Stage I (14 Days)|Other|0
7726510|NCT00572455|12152122|FG008|Stage I (14 Days)|Other|0
7726511|NCT00572455|12152123|FG009|Stage I (14 Days)|Other|0
7726512|NCT00572455|12152124|FG010|Stage I (14 Days)|Other|0
7726513|NCT00572455|12152125|FG011|Stage I (14 Days)|Other|0
7726514|NCT00572455|12152126|FG012|Stage I (14 Days)|Other|0
7726515|NCT00572455|12152127|FG013|Stage I (14 Days)|Other|0
7726516|NCT00572455|12152114|FG000|Stage II (28 Days)|Adverse Event|0
7726517|NCT00572455|12152115|FG001|Stage II (28 Days)|Adverse Event|0
7726518|NCT00572455|12152116|FG002|Stage II (28 Days)|Adverse Event|0
7726519|NCT00572455|12152117|FG003|Stage II (28 Days)|Adverse Event|0
7726520|NCT00572455|12152118|FG004|Stage II (28 Days)|Adverse Event|0
7726521|NCT00572455|12152119|FG005|Stage II (28 Days)|Adverse Event|0
7726522|NCT00572455|12152120|FG006|Stage II (28 Days)|Adverse Event|0
7726523|NCT00572455|12152121|FG007|Stage II (28 Days)|Adverse Event|0
7726524|NCT00572455|12152122|FG008|Stage II (28 Days)|Adverse Event|1
7726525|NCT00572455|12152123|FG009|Stage II (28 Days)|Adverse Event|3
7726526|NCT00572455|12152124|FG010|Stage II (28 Days)|Adverse Event|3
7726527|NCT00572455|12152125|FG011|Stage II (28 Days)|Adverse Event|4
7726528|NCT00572455|12152126|FG012|Stage II (28 Days)|Adverse Event|5
7726529|NCT00572455|12152127|FG013|Stage II (28 Days)|Adverse Event|1
7726530|NCT00572455|12152114|FG000|Stage II (28 Days)|Death|0
7726531|NCT00572455|12152115|FG001|Stage II (28 Days)|Death|0
7726532|NCT00572455|12152116|FG002|Stage II (28 Days)|Death|0
7726533|NCT00572455|12152117|FG003|Stage II (28 Days)|Death|0
7726534|NCT00572455|12152118|FG004|Stage II (28 Days)|Death|0
7726535|NCT00572455|12152119|FG005|Stage II (28 Days)|Death|0
7726536|NCT00572455|12152120|FG006|Stage II (28 Days)|Death|0
7726537|NCT00572455|12152121|FG007|Stage II (28 Days)|Death|0
7726538|NCT00572455|12152122|FG008|Stage II (28 Days)|Death|1
7726539|NCT00572455|12152123|FG009|Stage II (28 Days)|Death|0
7726540|NCT00572455|12152124|FG010|Stage II (28 Days)|Death|0
7726541|NCT00572455|12152125|FG011|Stage II (28 Days)|Death|0
7726542|NCT00572455|12152126|FG012|Stage II (28 Days)|Death|0
7726543|NCT00572455|12152127|FG013|Stage II (28 Days)|Death|0
7726544|NCT00572455|12152114|FG000|Stage II (28 Days)|Withdrawal by Subject|0
7726545|NCT00572455|12152115|FG001|Stage II (28 Days)|Withdrawal by Subject|0
7726546|NCT00572455|12152116|FG002|Stage II (28 Days)|Withdrawal by Subject|0
7726547|NCT00572455|12152117|FG003|Stage II (28 Days)|Withdrawal by Subject|0
7726548|NCT00572455|12152118|FG004|Stage II (28 Days)|Withdrawal by Subject|0
7726549|NCT00572455|12152119|FG005|Stage II (28 Days)|Withdrawal by Subject|0
7726550|NCT00572455|12152120|FG006|Stage II (28 Days)|Withdrawal by Subject|0
7726551|NCT00572455|12152121|FG007|Stage II (28 Days)|Withdrawal by Subject|1
7726552|NCT00572455|12152122|FG008|Stage II (28 Days)|Withdrawal by Subject|0
7726553|NCT00572455|12152123|FG009|Stage II (28 Days)|Withdrawal by Subject|0
7726554|NCT00572455|12152124|FG010|Stage II (28 Days)|Withdrawal by Subject|2
7726555|NCT00572455|12152125|FG011|Stage II (28 Days)|Withdrawal by Subject|0
7726556|NCT00572455|12152126|FG012|Stage II (28 Days)|Withdrawal by Subject|0
7726557|NCT00572455|12152127|FG013|Stage II (28 Days)|Withdrawal by Subject|0
7726558|NCT00572455|12152114|FG000|Stage II (28 Days)|Other|0
7726559|NCT00572455|12152115|FG001|Stage II (28 Days)|Other|0
7726560|NCT00572455|12152116|FG002|Stage II (28 Days)|Other|0
7726561|NCT00572455|12152117|FG003|Stage II (28 Days)|Other|0
7726562|NCT00572455|12152118|FG004|Stage II (28 Days)|Other|0
7726563|NCT00572455|12152119|FG005|Stage II (28 Days)|Other|0
7726564|NCT00572455|12152120|FG006|Stage II (28 Days)|Other|0
7726565|NCT00572455|12152121|FG007|Stage II (28 Days)|Other|0
7726566|NCT00572455|12152122|FG008|Stage II (28 Days)|Other|1
7726567|NCT00572455|12152123|FG009|Stage II (28 Days)|Other|0
7726568|NCT00572455|12152124|FG010|Stage II (28 Days)|Other|0
7726569|NCT00572455|12152125|FG011|Stage II (28 Days)|Other|0
7726570|NCT00572455|12152126|FG012|Stage II (28 Days)|Other|0
7726571|NCT00572455|12152127|FG013|Stage II (28 Days)|Other|0
7726572|NCT00572455|12152114|FG000|Stage II (28 Days)|Randomized, but not treated|0
7726573|NCT00572455|12152115|FG001|Stage II (28 Days)|Randomized, but not treated|0
7726574|NCT00572455|12152116|FG002|Stage II (28 Days)|Randomized, but not treated|0
7726575|NCT00572455|12152117|FG003|Stage II (28 Days)|Randomized, but not treated|0
7726576|NCT00572455|12152118|FG004|Stage II (28 Days)|Randomized, but not treated|0
7726577|NCT00572455|12152119|FG005|Stage II (28 Days)|Randomized, but not treated|0
7726578|NCT00572455|12152120|FG006|Stage II (28 Days)|Randomized, but not treated|0
7726579|NCT00572455|12152121|FG007|Stage II (28 Days)|Randomized, but not treated|0
7726580|NCT00572455|12152122|FG008|Stage II (28 Days)|Randomized, but not treated|0
7726581|NCT00572455|12152123|FG009|Stage II (28 Days)|Randomized, but not treated|0
7726582|NCT00572455|12152124|FG010|Stage II (28 Days)|Randomized, but not treated|0
7726583|NCT00572455|12152125|FG011|Stage II (28 Days)|Randomized, but not treated|0
7726584|NCT00572455|12152126|FG012|Stage II (28 Days)|Randomized, but not treated|0
7726585|NCT00572455|12152127|FG013|Stage II (28 Days)|Randomized, but not treated|1
7726586|NCT00572533|12152168|FG000|Overall Study|Death|4
7726587|NCT00572533|12152169|FG001|Overall Study|Death|1
7726588|NCT00572533|12152168|FG000|Overall Study|Received Kidney Transplant|2
7726589|NCT00572533|12152169|FG001|Overall Study|Received Kidney Transplant|1
7726590|NCT00572533|12152168|FG000|Overall Study|Social Issues|1
7726591|NCT00572533|12152169|FG001|Overall Study|Social Issues|0
7726592|NCT00572533|12152168|FG000|Overall Study|Transfer out of Facility|0
7726593|NCT00572533|12152169|FG001|Overall Study|Transfer out of Facility|1
7726594|NCT00572572|12152177|FG000|Overall Study|Withdrawal by Subject|3
7726595|NCT00572572|12152178|FG001|Overall Study|Withdrawal by Subject|6
7726596|NCT00572624|12152186|FG000|Overall Study|Lost to Follow-up|10
7726597|NCT00572624|12152187|FG001|Overall Study|Lost to Follow-up|4
7726598|NCT00572624|12152186|FG000|Overall Study|Wanted to do a different diet program|1
7726599|NCT00572624|12152187|FG001|Overall Study|Wanted to do a different diet program|0
7726600|NCT00572624|12152186|FG000|Overall Study|Medication change|1
7726601|NCT00572624|12152187|FG001|Overall Study|Medication change|0
7726602|NCT00572624|12152186|FG000|Overall Study|Started a new job-- no time for study|1
7726603|NCT00572624|12152187|FG001|Overall Study|Started a new job-- no time for study|0
7726604|NCT00572624|12152186|FG000|Overall Study|Admitted to being a smoker|1
7726605|NCT00572624|12152187|FG001|Overall Study|Admitted to being a smoker|0
7726606|NCT00572624|12152186|FG000|Overall Study|Refused to do the stress test|1
7726607|NCT00572624|12152187|FG001|Overall Study|Refused to do the stress test|0
7726608|NCT00572624|12152186|FG000|Overall Study|Problem with vascular access|1
7726609|NCT00572624|12152187|FG001|Overall Study|Problem with vascular access|0
7726610|NCT00572624|12152186|FG000|Overall Study|Health issues unrelated to the study|1
7726611|NCT00572624|12152187|FG001|Overall Study|Health issues unrelated to the study|0
7726612|NCT00572728|12152193|FG000|Overall Study|Withdrawal by Subject|10
7726613|NCT00572728|12152193|FG000|Overall Study|Ineligible|3
7726614|NCT00572728|12152193|FG000|Overall Study|Enrolled under Amendment 4|5
7726615|NCT00572728|12152193|FG000|Overall Study|Offstudy due to complicating disease|1
7726616|NCT00572728|12152193|FG000|Overall Study|FLT1 not completed|4
7726617|NCT00572728|12152193|FG000|Overall Study|First Chemotherapy not initiated|2
7726618|NCT00572728|12152193|FG000|Overall Study|FLT2 not completed|5
7726619|NCT00572728|12152193|FG000|Overall Study|Second chemotherapy not initiated|1
7726620|NCT00572728|12152193|FG000|Overall Study|FLT2 after second chemotherapy initiated|7
7726621|NCT00572728|12152193|FG000|Overall Study|Pathology missing|1
7726622|NCT00572832|12152201|FG000|Overall Study|Lost to Follow-up|0
7726623|NCT00572832|12152202|FG001|Overall Study|Lost to Follow-up|11
7726624|NCT00572832|12152201|FG000|Overall Study|Pregnancy|0
7726625|NCT00572832|12152202|FG001|Overall Study|Pregnancy|1
7726626|NCT00572910|12152223|FG000|Overall Study|Adverse Event|1
7726627|NCT00572910|12152224|FG001|Overall Study|Adverse Event|2
7726628|NCT00572910|12152225|FG002|Overall Study|Adverse Event|0
7726629|NCT00572910|12152226|FG003|Overall Study|Adverse Event|2
7726630|NCT00572910|12152227|FG004|Overall Study|Adverse Event|0
7726631|NCT00572910|12152228|FG005|Overall Study|Adverse Event|0
7726632|NCT00572910|12152229|FG006|Overall Study|Adverse Event|4
7726633|NCT00572910|12152230|FG007|Overall Study|Adverse Event|2
7726634|NCT00572910|12152231|FG008|Overall Study|Adverse Event|1
7726635|NCT00572910|12152232|FG009|Overall Study|Adverse Event|3
7726636|NCT00572910|12152233|FG010|Overall Study|Adverse Event|2
7726637|NCT00572910|12152223|FG000|Overall Study|Lost to Follow-up|0
7726638|NCT00572910|12152224|FG001|Overall Study|Lost to Follow-up|1
7726639|NCT00572910|12152225|FG002|Overall Study|Lost to Follow-up|1
7726640|NCT00572910|12152226|FG003|Overall Study|Lost to Follow-up|2
7726641|NCT00572910|12152227|FG004|Overall Study|Lost to Follow-up|1
7726642|NCT00572910|12152228|FG005|Overall Study|Lost to Follow-up|0
7726643|NCT00572910|12152229|FG006|Overall Study|Lost to Follow-up|0
7726644|NCT00572910|12152230|FG007|Overall Study|Lost to Follow-up|0
7726645|NCT00572910|12152231|FG008|Overall Study|Lost to Follow-up|0
7726646|NCT00572910|12152232|FG009|Overall Study|Lost to Follow-up|1
7726647|NCT00572910|12152233|FG010|Overall Study|Lost to Follow-up|0
7726648|NCT00572910|12152223|FG000|Overall Study|Withdrawal by Subject|3
7726649|NCT00572910|12152224|FG001|Overall Study|Withdrawal by Subject|0
7726650|NCT00572910|12152225|FG002|Overall Study|Withdrawal by Subject|1
7726651|NCT00572910|12152226|FG003|Overall Study|Withdrawal by Subject|0
7726652|NCT00572910|12152227|FG004|Overall Study|Withdrawal by Subject|1
7726653|NCT00572910|12152228|FG005|Overall Study|Withdrawal by Subject|3
7726654|NCT00572910|12152229|FG006|Overall Study|Withdrawal by Subject|0
7726655|NCT00572910|12152230|FG007|Overall Study|Withdrawal by Subject|2
7726656|NCT00572910|12152231|FG008|Overall Study|Withdrawal by Subject|2
7726657|NCT00572910|12152232|FG009|Overall Study|Withdrawal by Subject|2
7726658|NCT00572910|12152233|FG010|Overall Study|Withdrawal by Subject|1
7726659|NCT00573066|12152281|FG000|Overall Study|Exclusion criteria|18
7726660|NCT00573066|12152281|FG000|Overall Study|IV malfunction|1
7726661|NCT00573066|12152281|FG000|Overall Study|Postoperative bleeding|1
7726662|NCT00573144|12152287|FG000|Overall Study|Withdrawal by Subject|2
7726663|NCT00573144|12152288|FG001|Overall Study|Withdrawal by Subject|3
7726664|NCT00573170|12152294|FG000|First Treatment Period|Did Not Treat Attack 1|0
7726665|NCT00573170|12152295|FG001|First Treatment Period|Did Not Treat Attack 1|0
7726666|NCT00573170|12152296|FG002|First Treatment Period|Did Not Treat Attack 1|0
7726667|NCT00573170|12152297|FG003|First Treatment Period|Did Not Treat Attack 1|0
7726668|NCT00573170|12152298|FG004|First Treatment Period|Did Not Treat Attack 1|1
7726669|NCT00573170|12152299|FG005|First Treatment Period|Did Not Treat Attack 1|0
7726670|NCT00573170|12152294|FG000|First Washout Period|Adverse Event|1
7726671|NCT00573170|12152295|FG001|First Washout Period|Adverse Event|1
7726672|NCT00573170|12152296|FG002|First Washout Period|Adverse Event|0
7726673|NCT00573170|12152297|FG003|First Washout Period|Adverse Event|0
7726674|NCT00573170|12152298|FG004|First Washout Period|Adverse Event|0
7726675|NCT00573170|12152299|FG005|First Washout Period|Adverse Event|1
7726676|NCT00573170|12152294|FG000|First Washout Period|Lack of Efficacy|0
7726677|NCT00573170|12152295|FG001|First Washout Period|Lack of Efficacy|0
7726678|NCT00573170|12152296|FG002|First Washout Period|Lack of Efficacy|0
7726679|NCT00573170|12152297|FG003|First Washout Period|Lack of Efficacy|0
7726680|NCT00573170|12152298|FG004|First Washout Period|Lack of Efficacy|0
7726681|NCT00573170|12152299|FG005|First Washout Period|Lack of Efficacy|1
7726682|NCT00573170|12152294|FG000|First Washout Period|Lost to Follow-up|1
7726683|NCT00573170|12152295|FG001|First Washout Period|Lost to Follow-up|1
7726684|NCT00573170|12152296|FG002|First Washout Period|Lost to Follow-up|0
7726685|NCT00573170|12152297|FG003|First Washout Period|Lost to Follow-up|2
7726686|NCT00573170|12152298|FG004|First Washout Period|Lost to Follow-up|0
7726687|NCT00573170|12152299|FG005|First Washout Period|Lost to Follow-up|2
7726688|NCT00573170|12152294|FG000|First Washout Period|Withdrawal by Subject|2
7726689|NCT00573170|12152295|FG001|First Washout Period|Withdrawal by Subject|0
7726690|NCT00573170|12152296|FG002|First Washout Period|Withdrawal by Subject|0
7726691|NCT00573170|12152297|FG003|First Washout Period|Withdrawal by Subject|2
7726692|NCT00573170|12152298|FG004|First Washout Period|Withdrawal by Subject|3
7726693|NCT00573170|12152299|FG005|First Washout Period|Withdrawal by Subject|3
7726694|NCT00573170|12152294|FG000|First Washout Period|Other|4
7726695|NCT00573170|12152295|FG001|First Washout Period|Other|0
7726696|NCT00573170|12152296|FG002|First Washout Period|Other|1
7726697|NCT00573170|12152297|FG003|First Washout Period|Other|1
7726698|NCT00573170|12152298|FG004|First Washout Period|Other|0
7726699|NCT00573170|12152299|FG005|First Washout Period|Other|0
7726700|NCT00573170|12152294|FG000|Second Washout Period|Adverse Event|1
7726701|NCT00573170|12152295|FG001|Second Washout Period|Adverse Event|0
7726702|NCT00573170|12152296|FG002|Second Washout Period|Adverse Event|0
7726703|NCT00573170|12152297|FG003|Second Washout Period|Adverse Event|0
7726704|NCT00573170|12152298|FG004|Second Washout Period|Adverse Event|1
7726705|NCT00573170|12152299|FG005|Second Washout Period|Adverse Event|0
7726706|NCT00573170|12152294|FG000|Second Washout Period|Protocol Violation|2
7726707|NCT00573170|12152295|FG001|Second Washout Period|Protocol Violation|1
7726708|NCT00573170|12152296|FG002|Second Washout Period|Protocol Violation|1
7726709|NCT00573170|12152297|FG003|Second Washout Period|Protocol Violation|0
7726710|NCT00573170|12152298|FG004|Second Washout Period|Protocol Violation|0
7726711|NCT00573170|12152299|FG005|Second Washout Period|Protocol Violation|0
7726712|NCT00573170|12152294|FG000|Second Washout Period|Withdrawal by Subject|1
7726713|NCT00573170|12152295|FG001|Second Washout Period|Withdrawal by Subject|1
7726714|NCT00573170|12152296|FG002|Second Washout Period|Withdrawal by Subject|2
7726715|NCT00573170|12152297|FG003|Second Washout Period|Withdrawal by Subject|0
7726716|NCT00573170|12152298|FG004|Second Washout Period|Withdrawal by Subject|1
7726717|NCT00573170|12152299|FG005|Second Washout Period|Withdrawal by Subject|0
7726718|NCT00573170|12152294|FG000|Second Washout Period|Lost to Follow-up|0
7726719|NCT00573170|12152295|FG001|Second Washout Period|Lost to Follow-up|0
7726720|NCT00573170|12152296|FG002|Second Washout Period|Lost to Follow-up|0
7726721|NCT00573170|12152297|FG003|Second Washout Period|Lost to Follow-up|1
7726722|NCT00573170|12152298|FG004|Second Washout Period|Lost to Follow-up|0
7726723|NCT00573170|12152299|FG005|Second Washout Period|Lost to Follow-up|0
7726724|NCT00573170|12152294|FG000|Second Washout Period|Other|1
7726725|NCT00573170|12152295|FG001|Second Washout Period|Other|2
7726726|NCT00573170|12152296|FG002|Second Washout Period|Other|1
7726727|NCT00573170|12152297|FG003|Second Washout Period|Other|4
7726728|NCT00573170|12152298|FG004|Second Washout Period|Other|6
7726729|NCT00573170|12152299|FG005|Second Washout Period|Other|2
7726730|NCT00573170|12152294|FG000|Third Treatment Period|Withdrawal by Subject|1
7726731|NCT00573170|12152295|FG001|Third Treatment Period|Withdrawal by Subject|0
7726732|NCT00573170|12152296|FG002|Third Treatment Period|Withdrawal by Subject|0
7726733|NCT00573170|12152297|FG003|Third Treatment Period|Withdrawal by Subject|0
7726734|NCT00573170|12152298|FG004|Third Treatment Period|Withdrawal by Subject|0
7726735|NCT00573170|12152299|FG005|Third Treatment Period|Withdrawal by Subject|0
7726736|NCT00573170|12152294|FG000|Third Treatment Period|Lost to Follow-up|0
7726737|NCT00573170|12152295|FG001|Third Treatment Period|Lost to Follow-up|0
7726738|NCT00573170|12152296|FG002|Third Treatment Period|Lost to Follow-up|0
7726739|NCT00573170|12152297|FG003|Third Treatment Period|Lost to Follow-up|0
7726740|NCT00573170|12152298|FG004|Third Treatment Period|Lost to Follow-up|0
7726741|NCT00573170|12152299|FG005|Third Treatment Period|Lost to Follow-up|2
7726742|NCT00573183|12152318|FG000|Overall Study|Lost to Follow-up|52
7726743|NCT00573183|12152319|FG001|Overall Study|Lost to Follow-up|50
7726744|NCT00573183|12152318|FG000|Overall Study|Withdrawal by Subject|8
7726745|NCT00573183|12152319|FG001|Overall Study|Withdrawal by Subject|2
7726746|NCT00573183|12152318|FG000|Overall Study|Death|0
7726747|NCT00573183|12152319|FG001|Overall Study|Death|1
7726748|NCT00573183|12152318|FG000|Overall Study|Adverse Event|2
7726749|NCT00573183|12152319|FG001|Overall Study|Adverse Event|0
7726750|NCT00573183|12152318|FG000|Overall Study|Incarceration|5
7726751|NCT00573183|12152319|FG001|Overall Study|Incarceration|8
7726752|NCT00573183|12152318|FG000|Overall Study|Other|5
7726753|NCT00573183|12152319|FG001|Overall Study|Other|2
7726754|NCT00573248|12152329|FG000|Overall Study|scheduling conflicts|15
7726755|NCT00573248|12152330|FG001|Overall Study|scheduling conflicts|11
7726756|NCT00573313|12152360|FG000|Overall Study|Protocol Violation|5
7726757|NCT00573313|12152361|FG001|Overall Study|Protocol Violation|0
7726758|NCT00573313|12152362|FG002|Overall Study|Protocol Violation|6
7726759|NCT00573313|12152363|FG003|Overall Study|Protocol Violation|0
7726760|NCT00573430|12152373|FG000|Overall Study|Incorrect enrollment of randomization|0
7726761|NCT00573430|12152374|FG001|Overall Study|Incorrect enrollment of randomization|4
7726762|NCT00573430|12152375|FG002|Overall Study|Incorrect enrollment of randomization|3
7726763|NCT00573430|12152373|FG000|Overall Study|Adverse Event|0
7726764|NCT00573430|12152374|FG001|Overall Study|Adverse Event|0
7726765|NCT00573430|12152375|FG002|Overall Study|Adverse Event|2
7726766|NCT00573430|12152373|FG000|Overall Study|Withdrawal by Subject|1
7726767|NCT00573430|12152374|FG001|Overall Study|Withdrawal by Subject|0
7726768|NCT00573430|12152375|FG002|Overall Study|Withdrawal by Subject|1
7726769|NCT00573430|12152373|FG000|Overall Study|Protocol Violation|0
7726770|NCT00573430|12152374|FG001|Overall Study|Protocol Violation|1
7726771|NCT00573430|12152375|FG002|Overall Study|Protocol Violation|1
7726772|NCT00573430|12152373|FG000|Overall Study|Eligibility criteria not fulfilled|0
7726773|NCT00573430|12152374|FG001|Overall Study|Eligibility criteria not fulfilled|0
7726774|NCT00573430|12152375|FG002|Overall Study|Eligibility criteria not fulfilled|3
7726775|NCT00573443|12152386|FG000|Double-Blind Phase|Lost to Follow-up|1
7726776|NCT00573443|12152387|FG001|Double-Blind Phase|Lost to Follow-up|3
7726777|NCT00573443|12152388|FG002|Double-Blind Phase|Lost to Follow-up|2
7726778|NCT00573443|12152386|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1
7726779|NCT00573443|12152387|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0
7726780|NCT00573443|12152388|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1
7726781|NCT00573443|12152386|FG000|Double-Blind Phase|Adverse Event|1
7726782|NCT00573443|12152387|FG001|Double-Blind Phase|Adverse Event|5
7726783|NCT00573443|12152388|FG002|Double-Blind Phase|Adverse Event|0
7726784|NCT00573443|12152386|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2
7726785|NCT00573443|12152387|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3
7726786|NCT00573443|12152388|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1
7726787|NCT00573443|12152386|FG000|Double-Blind Phase|Medication refusal due to AE|2
7726788|NCT00573443|12152387|FG001|Double-Blind Phase|Medication refusal due to AE|2
7726789|NCT00573443|12152388|FG002|Double-Blind Phase|Medication refusal due to AE|0
7726790|NCT00573443|12152386|FG000|Double-Blind Phase|Withdrawal by Subject|2
7726791|NCT00573443|12152387|FG001|Double-Blind Phase|Withdrawal by Subject|2
7726792|NCT00573443|12152388|FG002|Double-Blind Phase|Withdrawal by Subject|7
7726793|NCT00573443|12152386|FG000|Double-Blind Phase|Protocol Violation|0
7726794|NCT00573443|12152387|FG001|Double-Blind Phase|Protocol Violation|2
7726795|NCT00573443|12152388|FG002|Double-Blind Phase|Protocol Violation|1
7726796|NCT00573443|12152386|FG000|Double-Blind Phase|Other|0
7726797|NCT00573443|12152387|FG001|Double-Blind Phase|Other|2
7726798|NCT00573443|12152388|FG002|Double-Blind Phase|Other|3
7726799|NCT00573443|12152386|FG000|Open-Label Extension Phase|Lost to Follow-up|1
7726800|NCT00573443|12152387|FG001|Open-Label Extension Phase|Lost to Follow-up|0
7726801|NCT00573443|12152388|FG002|Open-Label Extension Phase|Lost to Follow-up|0
7726802|NCT00573443|12152386|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2
7726803|NCT00573443|12152387|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0
7726804|NCT00573443|12152388|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0
7726805|NCT00573443|12152386|FG000|Open-Label Extension Phase|Adverse Event|3
7726806|NCT00573443|12152387|FG001|Open-Label Extension Phase|Adverse Event|0
7726807|NCT00573443|12152388|FG002|Open-Label Extension Phase|Adverse Event|0
7726808|NCT00573443|12152386|FG000|Open-Label Extension Phase|Serious Adverse Event|5
7726809|NCT00573443|12152387|FG001|Open-Label Extension Phase|Serious Adverse Event|0
7726810|NCT00573443|12152388|FG002|Open-Label Extension Phase|Serious Adverse Event|0
7726811|NCT00573443|12152386|FG000|Open-Label Extension Phase|Withdrawal by Subject|3
7726812|NCT00573443|12152387|FG001|Open-Label Extension Phase|Withdrawal by Subject|0
7726813|NCT00573443|12152388|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
7726814|NCT00573443|12152386|FG000|Open-Label Extension Phase|Protocol Violation|2
7726815|NCT00573443|12152387|FG001|Open-Label Extension Phase|Protocol Violation|0
7726816|NCT00573443|12152388|FG002|Open-Label Extension Phase|Protocol Violation|0
7726817|NCT00573443|12152386|FG000|Open-Label Extension Phase|Other|2
7726818|NCT00573443|12152387|FG001|Open-Label Extension Phase|Other|0
7726819|NCT00573443|12152388|FG002|Open-Label Extension Phase|Other|0
7726820|NCT00573469|12152400|FG000|Overall Study|Adverse Event|1
7726821|NCT00573469|12152401|FG001|Overall Study|Adverse Event|1
7726822|NCT00573469|12152402|FG002|Overall Study|Adverse Event|1
7726823|NCT00573469|12152400|FG000|Overall Study|Withdrawal by Subject|0
7726824|NCT00573469|12152401|FG001|Overall Study|Withdrawal by Subject|2
7726825|NCT00573469|12152402|FG002|Overall Study|Withdrawal by Subject|0
7726826|NCT00573469|12152400|FG000|Overall Study|Other|5
7726827|NCT00573469|12152401|FG001|Overall Study|Other|1
7726828|NCT00573469|12152402|FG002|Overall Study|Other|3
7726829|NCT00573534|12152419|FG000|Overall Study|oppositional behavior|3
7726830|NCT00573755|12152426|FG000|Overall Study|Still receiving treatment|1
7726831|NCT00573755|12152427|FG001|Overall Study|Still receiving treatment|0
7726832|NCT00573768|12152436|FG000|Overall Study|Adverse Event|1
7726833|NCT00573768|12152437|FG001|Overall Study|Adverse Event|1
7726834|NCT00573768|12152438|FG002|Overall Study|Adverse Event|2
7726835|NCT00573768|12152436|FG000|Overall Study|Protocol Violation|1
7726836|NCT00573768|12152437|FG001|Overall Study|Protocol Violation|0
7726837|NCT00573768|12152438|FG002|Overall Study|Protocol Violation|1
7726838|NCT00573768|12152436|FG000|Overall Study|Withdrawal by Subject|0
7726839|NCT00573768|12152437|FG001|Overall Study|Withdrawal by Subject|1
7726840|NCT00573768|12152438|FG002|Overall Study|Withdrawal by Subject|0
7726841|NCT00573768|12152436|FG000|Overall Study|Lost to Follow-up|0
7726842|NCT00573768|12152437|FG001|Overall Study|Lost to Follow-up|0
7726843|NCT00573768|12152438|FG002|Overall Study|Lost to Follow-up|1
7726844|NCT00573794|12152446|FG000|Overall Study|Adverse Event|81
7726845|NCT00573794|12152446|FG000|Overall Study|Withdrew Consent|90
7726846|NCT00573794|12152446|FG000|Overall Study|Lost to Follow-up|13
7726847|NCT00573794|12152446|FG000|Overall Study|Protocol Violation|6
7726848|NCT00573794|12152446|FG000|Overall Study|Lack of Efficacy|94
7726849|NCT00573794|12152446|FG000|Overall Study|Other|46
7726850|NCT00573833|12152450|FG000|Overall Study|Not Treated|2
7726851|NCT00573859|12152454|FG000|Medication Versus Placebo|Scheduling conflicts|12
7726852|NCT00573859|12152454|FG000|Smoking Versus Abstinence|Scheduling conflicts|12
7726853|NCT00574119|12152493|FG000|Overall Study|Adverse Event|1
7726854|NCT00574119|12152493|FG000|Overall Study|Protocol Violation|1
7726855|NCT00574119|12152493|FG000|Overall Study|Withdrawal by Subject|1
7726856|NCT00574119|12152493|FG000|Overall Study|Physician Decision|1
7726857|NCT00574145|12152499|FG000|Overall Study|Withdrawal by Subject|2
7726858|NCT00574145|12152500|FG001|Overall Study|Withdrawal by Subject|1
7726859|NCT00574249|12152520|FG000|Overall Study|Adverse Event|6
7726860|NCT00574249|12152521|FG001|Overall Study|Adverse Event|18
7726861|NCT00574249|12152520|FG000|Overall Study|Lack of Efficacy|5
7726862|NCT00574249|12152521|FG001|Overall Study|Lack of Efficacy|3
7726863|NCT00574249|12152520|FG000|Overall Study|Lost to Follow-up|4
7726864|NCT00574249|12152521|FG001|Overall Study|Lost to Follow-up|3
7726865|NCT00574249|12152520|FG000|Overall Study|Protocol Violation|5
7726866|NCT00574249|12152521|FG001|Overall Study|Protocol Violation|2
7726867|NCT00574249|12152520|FG000|Overall Study|History of carcinoma|1
7726868|NCT00574249|12152521|FG001|Overall Study|History of carcinoma|0
7726869|NCT00574249|12152520|FG000|Overall Study|Withdrawal by Subject|3
7726870|NCT00574249|12152521|FG001|Overall Study|Withdrawal by Subject|0
7726871|NCT00574249|12152520|FG000|Overall Study|Physician Decision|1
7726872|NCT00574249|12152521|FG001|Overall Study|Physician Decision|0
7726873|NCT00574249|12152520|FG000|Overall Study|Pregnancy|1
7726874|NCT00574249|12152521|FG001|Overall Study|Pregnancy|0
7726875|NCT00574249|12152520|FG000|Overall Study|Excluded by company|0
7726876|NCT00574249|12152521|FG001|Overall Study|Excluded by company|1
7726877|NCT00574249|12152520|FG000|Overall Study|PPD test taken twice|0
7726878|NCT00574249|12152521|FG001|Overall Study|PPD test taken twice|1
7768225|NCT00858364|12211177|FG000|Overall Study|Withdrawal by Subject|44
7768226|NCT00858364|12211178|FG001|Overall Study|Withdrawal by Subject|118
7768227|NCT00858364|12211177|FG000|Overall Study|Ineligibility Determined|1
7768228|NCT00858364|12211178|FG001|Overall Study|Ineligibility Determined|10
7768229|NCT00858364|12211177|FG000|Overall Study|Lost to Follow-up|24
7768230|NCT00858364|12211178|FG001|Overall Study|Lost to Follow-up|54
7768231|NCT00858364|12211177|FG000|Overall Study|Noncompliance|3
7768232|NCT00858364|12211178|FG001|Overall Study|Noncompliance|4
7768233|NCT00858364|12211177|FG000|Overall Study|Protocol Deviation|0
7768234|NCT00858364|12211178|FG001|Overall Study|Protocol Deviation|2
7768235|NCT00858364|12211177|FG000|Overall Study|Other|9
7768236|NCT00858364|12211178|FG001|Overall Study|Other|17
7768237|NCT00858364|12211177|FG000|Overall Study|Missing|1
7768238|NCT00858364|12211178|FG001|Overall Study|Missing|1
7768239|NCT00858364|12211177|FG000|Overall Study|Still on-study|114
7768240|NCT00858364|12211178|FG001|Overall Study|Still on-study|247
7768241|NCT00858403|12211193|FG000|Overall Study|Withdrawal by Subject|1
7768242|NCT00858403|12211193|FG000|Overall Study|Death|3
7768243|NCT00858403|12211193|FG000|Overall Study|Disease Progression|1
7768244|NCT00858442|12211199|FG000|Compression:Start to Finish|Lost to Follow-up|1
7768245|NCT00858442|12211200|FG001|Compression:Start to Finish|Lost to Follow-up|3
7768246|NCT00858637|12211231|FG000|Active Comparison Phase|Adverse Event|14
7768247|NCT00858637|12211232|FG001|Active Comparison Phase|Adverse Event|0
7768248|NCT00858637|12211233|FG002|Active Comparison Phase|Adverse Event|0
7768249|NCT00858637|12211234|FG003|Active Comparison Phase|Adverse Event|9
7768250|NCT00858637|12211235|FG004|Active Comparison Phase|Adverse Event|0
7768251|NCT00858637|12211236|FG005|Active Comparison Phase|Adverse Event|0
7768252|NCT00858637|12211231|FG000|Active Comparison Phase|Death|1
7768253|NCT00858637|12211232|FG001|Active Comparison Phase|Death|0
7768254|NCT00858637|12211233|FG002|Active Comparison Phase|Death|0
7768255|NCT00858637|12211234|FG003|Active Comparison Phase|Death|1
7768256|NCT00858637|12211235|FG004|Active Comparison Phase|Death|0
7768257|NCT00858637|12211236|FG005|Active Comparison Phase|Death|0
7768258|NCT00858637|12211231|FG000|Active Comparison Phase|Physician Decision|1
7768259|NCT00858637|12211232|FG001|Active Comparison Phase|Physician Decision|0
7768260|NCT00858637|12211233|FG002|Active Comparison Phase|Physician Decision|0
7768261|NCT00858637|12211234|FG003|Active Comparison Phase|Physician Decision|1
7768262|NCT00858637|12211235|FG004|Active Comparison Phase|Physician Decision|0
7768263|NCT00858637|12211236|FG005|Active Comparison Phase|Physician Decision|0
7768264|NCT00858637|12211231|FG000|Active Comparison Phase|Withdrawal by Subject|7
7768265|NCT00858637|12211232|FG001|Active Comparison Phase|Withdrawal by Subject|0
7768266|NCT00858637|12211233|FG002|Active Comparison Phase|Withdrawal by Subject|0
7768267|NCT00858637|12211234|FG003|Active Comparison Phase|Withdrawal by Subject|6
7768268|NCT00858637|12211235|FG004|Active Comparison Phase|Withdrawal by Subject|0
7768269|NCT00858637|12211236|FG005|Active Comparison Phase|Withdrawal by Subject|0
7768270|NCT00858637|12211231|FG000|Active Comparison Phase|Other Reasons|1
7768271|NCT00858637|12211232|FG001|Active Comparison Phase|Other Reasons|0
7768272|NCT00858637|12211233|FG002|Active Comparison Phase|Other Reasons|0
7768273|NCT00858637|12211234|FG003|Active Comparison Phase|Other Reasons|1
7768274|NCT00858637|12211235|FG004|Active Comparison Phase|Other Reasons|0
7768275|NCT00858637|12211236|FG005|Active Comparison Phase|Other Reasons|0
7768276|NCT00858637|12211231|FG000|Placebo-controlled Withdrawal Phase|Death|0
7768277|NCT00858637|12211232|FG001|Placebo-controlled Withdrawal Phase|Death|0
7768278|NCT00858637|12211233|FG002|Placebo-controlled Withdrawal Phase|Death|1
7726879|NCT00574275|12152529|FG000|Overall Study|Randomized but not treated|2
7726880|NCT00574275|12152530|FG001|Overall Study|Randomized but not treated|3
7726881|NCT00574275|12152529|FG000|Overall Study|Adverse Event|32
7726882|NCT00574275|12152530|FG001|Overall Study|Adverse Event|76
7726883|NCT00574275|12152529|FG000|Overall Study|Disease progression|160
7726884|NCT00574275|12152530|FG001|Overall Study|Disease progression|146
7726885|NCT00574275|12152529|FG000|Overall Study|Lost to Follow-up|2
7726886|NCT00574275|12152530|FG001|Overall Study|Lost to Follow-up|1
7726887|NCT00574275|12152529|FG000|Overall Study|Study stopped based on DMC decision|62
7726888|NCT00574275|12152530|FG001|Overall Study|Study stopped based on DMC decision|23
7726889|NCT00574275|12152529|FG000|Overall Study|Withdrawal by Subject|15
7726890|NCT00574275|12152530|FG001|Overall Study|Withdrawal by Subject|17
7726891|NCT00574275|12152529|FG000|Overall Study|Error calculating tumor measurement|1
7726892|NCT00574275|12152530|FG001|Overall Study|Error calculating tumor measurement|0
7726893|NCT00574275|12152529|FG000|Overall Study|Physician Decision|1
7726894|NCT00574275|12152530|FG001|Overall Study|Physician Decision|1
7726895|NCT00574275|12152529|FG000|Overall Study|Protocol Violation|0
7726896|NCT00574275|12152530|FG001|Overall Study|Protocol Violation|1
7726897|NCT00574275|12152529|FG000|Overall Study|Patient and Investigator decision|0
7726898|NCT00574275|12152530|FG001|Overall Study|Patient and Investigator decision|1
7726899|NCT00574275|12152529|FG000|Overall Study|Insurance change|0
7726900|NCT00574275|12152530|FG001|Overall Study|Insurance change|1
7726901|NCT00574275|12152529|FG000|Overall Study|Operation for curative intent|0
7726902|NCT00574275|12152530|FG001|Overall Study|Operation for curative intent|1
7726903|NCT00574288|12152543|FG000|Overall Study|Adverse Event|2
7726904|NCT00574288|12152544|FG001|Overall Study|Adverse Event|0
7726905|NCT00574288|12152545|FG002|Overall Study|Adverse Event|0
7726906|NCT00574288|12152546|FG003|Overall Study|Adverse Event|0
7726907|NCT00574288|12152547|FG004|Overall Study|Adverse Event|1
7726908|NCT00574288|12152548|FG005|Overall Study|Adverse Event|0
7726909|NCT00574288|12152549|FG006|Overall Study|Adverse Event|0
7726910|NCT00574288|12152543|FG000|Overall Study|Death|0
7726911|NCT00574288|12152544|FG001|Overall Study|Death|0
7726912|NCT00574288|12152545|FG002|Overall Study|Death|0
7726913|NCT00574288|12152546|FG003|Overall Study|Death|0
7726914|NCT00574288|12152547|FG004|Overall Study|Death|0
7726915|NCT00574288|12152548|FG005|Overall Study|Death|25
7726916|NCT00574288|12152549|FG006|Overall Study|Death|21
7726917|NCT00574288|12152543|FG000|Overall Study|Lost to Follow-up|0
7726918|NCT00574288|12152544|FG001|Overall Study|Lost to Follow-up|0
7726919|NCT00574288|12152545|FG002|Overall Study|Lost to Follow-up|0
7726920|NCT00574288|12152546|FG003|Overall Study|Lost to Follow-up|0
7726921|NCT00574288|12152547|FG004|Overall Study|Lost to Follow-up|0
7726922|NCT00574288|12152548|FG005|Overall Study|Lost to Follow-up|1
7726923|NCT00574288|12152549|FG006|Overall Study|Lost to Follow-up|2
7726924|NCT00574288|12152543|FG000|Overall Study|Study Terminated By Sponsor|0
7726925|NCT00574288|12152544|FG001|Overall Study|Study Terminated By Sponsor|0
7726926|NCT00574288|12152545|FG002|Overall Study|Study Terminated By Sponsor|0
7726927|NCT00574288|12152546|FG003|Overall Study|Study Terminated By Sponsor|0
7726928|NCT00574288|12152547|FG004|Overall Study|Study Terminated By Sponsor|0
7726929|NCT00574288|12152548|FG005|Overall Study|Study Terminated By Sponsor|0
7726930|NCT00574288|12152549|FG006|Overall Study|Study Terminated By Sponsor|5
7726931|NCT00574288|12152543|FG000|Overall Study|Progressive Disease|17
7726932|NCT00574288|12152544|FG001|Overall Study|Progressive Disease|2
7726933|NCT00574288|12152545|FG002|Overall Study|Progressive Disease|3
7726934|NCT00574288|12152546|FG003|Overall Study|Progressive Disease|2
7726935|NCT00574288|12152547|FG004|Overall Study|Progressive Disease|1
7726936|NCT00574288|12152548|FG005|Overall Study|Progressive Disease|0
7726937|NCT00574288|12152549|FG006|Overall Study|Progressive Disease|0
7726938|NCT00574288|12152543|FG000|Overall Study|Other|1
7726939|NCT00574288|12152544|FG001|Overall Study|Other|1
7726940|NCT00574288|12152545|FG002|Overall Study|Other|0
7726941|NCT00574288|12152546|FG003|Overall Study|Other|0
7726942|NCT00574288|12152547|FG004|Overall Study|Other|0
7726943|NCT00574288|12152548|FG005|Overall Study|Other|0
7726944|NCT00574288|12152549|FG006|Overall Study|Other|0
7726945|NCT00574405|12152584|FG000|Overall Study|Withdrawal by Subject|3
7726946|NCT00574405|12152585|FG001|Overall Study|Withdrawal by Subject|2
7726947|NCT00574795|12152653|FG000|Infant Series|Withdrawal by Subject|2
7726948|NCT00574795|12152653|FG000|Infant Series|Protocol Violation|2
7726949|NCT00574795|12152653|FG000|Infant Series|Adverse Event|1
7726950|NCT00574795|12152653|FG000|After Infant Series|Withdrawal by Subject|1
7726951|NCT00574795|12152653|FG000|After Infant Series|Adverse Event|2
7726952|NCT00574795|12152653|FG000|Toddler Dose|Withdrawal by Subject|1
7726953|NCT00574847|12152683|FG000|Overall Study|Adverse Event|2
7726954|NCT00574847|12152684|FG001|Overall Study|Adverse Event|0
7726955|NCT00574847|12152683|FG000|Overall Study|Death|1
7726956|NCT00574847|12152684|FG001|Overall Study|Death|0
7726957|NCT00574847|12152683|FG000|Overall Study|Withdrawal by Subject|2
7726958|NCT00574847|12152684|FG001|Overall Study|Withdrawal by Subject|2
7726959|NCT00574847|12152683|FG000|Overall Study|Physician Decision|1
7726960|NCT00574847|12152684|FG001|Overall Study|Physician Decision|0
7726961|NCT00574847|12152683|FG000|Overall Study|Did not receive medication (declined)|2
7726962|NCT00574847|12152684|FG001|Overall Study|Did not receive medication (declined)|5
7726963|NCT00574873|12152692|FG000|Overall Study|Withdrawal by Subject|18
7726964|NCT00574873|12152693|FG001|Overall Study|Withdrawal by Subject|19
7726965|NCT00574873|12152692|FG000|Overall Study|Investigator request|18
7726966|NCT00574873|12152693|FG001|Overall Study|Investigator request|8
7726967|NCT00574873|12152692|FG000|Overall Study|Death|15
7726968|NCT00574873|12152693|FG001|Overall Study|Death|14
7726969|NCT00574873|12152692|FG000|Overall Study|Lost to Follow-up|14
7726970|NCT00574873|12152693|FG001|Overall Study|Lost to Follow-up|5
7726971|NCT00574873|12152692|FG000|Overall Study|Other|40
7726972|NCT00574873|12152693|FG001|Overall Study|Other|4
7726973|NCT00574873|12152692|FG000|Overall Study|Discontinuation of study by sponsor|5
7726974|NCT00574873|12152693|FG001|Overall Study|Discontinuation of study by sponsor|199
7726975|NCT00574873|12152692|FG000|Overall Study|Blank, site closed per local regulations|2
7726976|NCT00574873|12152693|FG001|Overall Study|Blank, site closed per local regulations|2
7726977|NCT00574873|12152692|FG000|Overall Study|Extension Study|126
7726978|NCT00574873|12152693|FG001|Overall Study|Extension Study|0
7726979|NCT00574912|12152699|FG000|Overall Study|Could not place IV lines.|3
7726980|NCT00574912|12152699|FG000|Overall Study|scheduling conflicts|3
7726981|NCT00574912|12152699|FG000|Overall Study|Physician Decision|2
7726982|NCT00574951|12152711|FG000|Overall Study|Ineligible - improper prior treatment|1
7726983|NCT00575042|12152752|FG000|Overall Study|Adverse Event|2
7726984|NCT00575042|12152752|FG000|Overall Study|Lost to Follow-up|1
7726985|NCT00575094|12152757|FG000|Overall Study|Adverse Event|2
7726986|NCT00575094|12152757|FG000|Overall Study|Withdrawal by Subject|1
7726987|NCT00575328|12152794|FG000|Overall Study|Adverse Event|1
7726988|NCT00575328|12152795|FG001|Overall Study|Adverse Event|1
7726989|NCT00575328|12152794|FG000|Overall Study|Lost to Follow-up|2
7726990|NCT00575328|12152795|FG001|Overall Study|Lost to Follow-up|1
7726991|NCT00575380|12152812|FG000|Overall Study|Withdrawal by Subject|1
7726992|NCT00575380|12152813|FG001|Overall Study|Withdrawal by Subject|0
7726993|NCT00575380|12152812|FG000|Overall Study|Adverse Event|0
7726994|NCT00575380|12152813|FG001|Overall Study|Adverse Event|1
7726995|NCT00575380|12152812|FG000|Overall Study|Various|0
7726996|NCT00575380|12152813|FG001|Overall Study|Various|2
7726997|NCT00575510|12152822|FG000|Overall Study|Lost to Follow-up|4
7726998|NCT00575510|12152823|FG001|Overall Study|Lost to Follow-up|6
7726999|NCT00575510|12152824|FG002|Overall Study|Lost to Follow-up|9
7727000|NCT00575510|12152822|FG000|Overall Study|Withdrawal by Subject|1
7727001|NCT00575510|12152823|FG001|Overall Study|Withdrawal by Subject|0
7727002|NCT00575510|12152824|FG002|Overall Study|Withdrawal by Subject|0
7727003|NCT00575510|12152822|FG000|Overall Study|Clinic Called Patient|7
7727004|NCT00575510|12152823|FG001|Overall Study|Clinic Called Patient|7
7727005|NCT00575510|12152824|FG002|Overall Study|Clinic Called Patient|7
7727006|NCT00575510|12152822|FG000|Overall Study|Pregnancy|0
7727007|NCT00575510|12152823|FG001|Overall Study|Pregnancy|0
7727008|NCT00575510|12152824|FG002|Overall Study|Pregnancy|1
7727009|NCT00575588|12152835|FG000|Overall Study|Adverse Event|11
7727010|NCT00575588|12152836|FG001|Overall Study|Adverse Event|13
7727011|NCT00575588|12152835|FG000|Overall Study|Withdrawal by Subject|27
7727012|NCT00575588|12152836|FG001|Overall Study|Withdrawal by Subject|31
7727013|NCT00575588|12152835|FG000|Overall Study|Lost to Follow-up|1
7727014|NCT00575588|12152836|FG001|Overall Study|Lost to Follow-up|3
7727015|NCT00575588|12152835|FG000|Overall Study|Death|4
7727016|NCT00575588|12152836|FG001|Overall Study|Death|2
7727017|NCT00575588|12152835|FG000|Overall Study|Incorrect enrollment|8
7727018|NCT00575588|12152836|FG001|Overall Study|Incorrect enrollment|4
7727019|NCT00575588|12152835|FG000|Overall Study|Study specific discontinuation criteria|203
7727020|NCT00575588|12152836|FG001|Overall Study|Study specific discontinuation criteria|218
7727021|NCT00575588|12152835|FG000|Overall Study|Severe non-compliance to protocol|5
7727022|NCT00575588|12152836|FG001|Overall Study|Severe non-compliance to protocol|7
7727023|NCT00575588|12152835|FG000|Overall Study|Safety reasons|2
7727024|NCT00575588|12152836|FG001|Overall Study|Safety reasons|1
7727025|NCT00575588|12152835|FG000|Overall Study|Elevated triglyceride|1
7727026|NCT00575588|12152836|FG001|Overall Study|Elevated triglyceride|0
7727027|NCT00575588|12152835|FG000|Overall Study|Patient moved|1
7727028|NCT00575588|12152836|FG001|Overall Study|Patient moved|3
7727029|NCT00575588|12152835|FG000|Overall Study|Impossible to determine HbA1c|0
7727030|NCT00575588|12152836|FG001|Overall Study|Impossible to determine HbA1c|1
7727031|NCT00575666|12152844|FG000|Overall Study|Withdrawal by Subject|3
7727032|NCT00575666|12152845|FG001|Overall Study|Withdrawal by Subject|2
7727033|NCT00575666|12152844|FG000|Overall Study|Physician Decision|1
7727034|NCT00575666|12152845|FG001|Overall Study|Physician Decision|1
7727035|NCT00576056|12152859|FG000|Overall Study|Adverse Event|1
7727036|NCT00576056|12152859|FG000|Overall Study|Death|1
7727037|NCT00576056|12152859|FG000|Overall Study|Lack of Efficacy|1
7727038|NCT00576056|12152859|FG000|Overall Study|Withdrawal by Subject|2
7727039|NCT00576056|12152859|FG000|Overall Study|did not meet eligibility criteria|8
7727040|NCT00576056|12152859|FG000|Overall Study|Physician Decision|1
7727041|NCT00576199|12152867|FG000|Overall Study|Adverse Event|12
7727042|NCT00576199|12152867|FG000|Overall Study|Insufficient Therapeutic Response|14
7727043|NCT00576199|12152867|FG000|Overall Study|Refused Treatment|2
7727044|NCT00576199|12152867|FG000|Overall Study|Reason Unspecified|2
7727045|NCT00576303|12152880|FG000|Dose Titration Period|Early withdrawal|17
7727046|NCT00576303|12152880|FG000|Efficacy Evaluation Period|Early withdrawal|5
7727047|NCT00576303|12152880|FG000|Long Term Safety Period|Early withdrawal|16
7727048|NCT00576316|12152884|FG000|Overall Study|Adverse Event|9
7727049|NCT00576316|12152884|FG000|Overall Study|Withdrawal by Subject|2
7727050|NCT00576316|12152884|FG000|Overall Study|Protocol Violation|9
7727051|NCT00576381|12152888|FG000|Overall Study|Reoperation|3
7727052|NCT00576381|12152888|FG000|Overall Study|Adverse Event|4
7727053|NCT00576420|12152895|FG000|Overall Study|Death|0
7727054|NCT00576420|12152896|FG001|Overall Study|Death|0
7727055|NCT00576420|12152897|FG002|Overall Study|Death|1
7727056|NCT00576472|12152961|FG000|MPH In-Lab Phase|Declined participation in medication pha|0
7727057|NCT00576472|12152962|FG001|MPH In-Lab Phase|Declined participation in medication pha|0
7727058|NCT00576472|12152963|FG002|MPH In-Lab Phase|Declined participation in medication pha|0
7727059|NCT00576472|12152964|FG003|MPH In-Lab Phase|Declined participation in medication pha|75
7727060|NCT00576472|12152965|FG004|MPH In-Lab Phase|Declined participation in medication pha|0
7727061|NCT00576472|12152966|FG005|MPH In-Lab Phase|Declined participation in medication pha|0
7727062|NCT00576472|12152967|FG006|MPH In-Lab Phase|Declined participation in medication pha|0
7727063|NCT00576472|12152968|FG007|MPH In-Lab Phase|Declined participation in medication pha|0
7727064|NCT00576472|12152969|FG008|MPH In-Lab Phase|Declined participation in medication pha|0
7727065|NCT00576472|12152970|FG009|MPH In-Lab Phase|Declined participation in medication pha|0
7727066|NCT00576472|12152971|FG010|MPH In-Lab Phase|Declined participation in medication pha|0
7727067|NCT00576472|12152972|FG011|MPH In-Lab Phase|Declined participation in medication pha|0
7727068|NCT00576472|12152973|FG012|MPH In-Lab Phase|Declined participation in medication pha|0
7727069|NCT00576472|12152974|FG013|MPH In-Lab Phase|Declined participation in medication pha|0
7727070|NCT00576472|12152975|FG014|MPH In-Lab Phase|Declined participation in medication pha|0
7727071|NCT00576472|12152961|FG000|MPH In-Lab Phase|Lost to Follow-up|0
7727072|NCT00576472|12152962|FG001|MPH In-Lab Phase|Lost to Follow-up|0
7727073|NCT00576472|12152963|FG002|MPH In-Lab Phase|Lost to Follow-up|0
7727074|NCT00576472|12152964|FG003|MPH In-Lab Phase|Lost to Follow-up|1
7727075|NCT00576472|12152965|FG004|MPH In-Lab Phase|Lost to Follow-up|0
7727076|NCT00576472|12152966|FG005|MPH In-Lab Phase|Lost to Follow-up|0
7727077|NCT00576472|12152967|FG006|MPH In-Lab Phase|Lost to Follow-up|0
7727078|NCT00576472|12152968|FG007|MPH In-Lab Phase|Lost to Follow-up|0
7727079|NCT00576472|12152969|FG008|MPH In-Lab Phase|Lost to Follow-up|0
7727080|NCT00576472|12152970|FG009|MPH In-Lab Phase|Lost to Follow-up|0
7727081|NCT00576472|12152971|FG010|MPH In-Lab Phase|Lost to Follow-up|0
7727082|NCT00576472|12152972|FG011|MPH In-Lab Phase|Lost to Follow-up|0
7727083|NCT00576472|12152973|FG012|MPH In-Lab Phase|Lost to Follow-up|0
7727084|NCT00576472|12152974|FG013|MPH In-Lab Phase|Lost to Follow-up|0
7727085|NCT00576472|12152975|FG014|MPH In-Lab Phase|Lost to Follow-up|0
7727086|NCT00576472|12152961|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7727087|NCT00576472|12152962|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7727088|NCT00576472|12152963|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7727089|NCT00576472|12152964|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
7727090|NCT00576472|12152965|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7727091|NCT00576472|12152966|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7727092|NCT00576472|12152967|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7727093|NCT00576472|12152968|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7727094|NCT00576472|12152969|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7727095|NCT00576472|12152970|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7727096|NCT00576472|12152971|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7727097|NCT00576472|12152972|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7727098|NCT00576472|12152973|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7727099|NCT00576472|12152974|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7727100|NCT00576472|12152975|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7727101|NCT00576472|12152961|FG000|MPH In-Lab Phase|No attention/academic problems|0
7727102|NCT00576472|12152962|FG001|MPH In-Lab Phase|No attention/academic problems|0
7727103|NCT00576472|12152963|FG002|MPH In-Lab Phase|No attention/academic problems|0
7727104|NCT00576472|12152964|FG003|MPH In-Lab Phase|No attention/academic problems|245
7727105|NCT00576472|12152965|FG004|MPH In-Lab Phase|No attention/academic problems|0
7727106|NCT00576472|12152966|FG005|MPH In-Lab Phase|No attention/academic problems|0
7727107|NCT00576472|12152967|FG006|MPH In-Lab Phase|No attention/academic problems|0
7727108|NCT00576472|12152968|FG007|MPH In-Lab Phase|No attention/academic problems|0
7727109|NCT00576472|12152969|FG008|MPH In-Lab Phase|No attention/academic problems|0
7727110|NCT00576472|12152970|FG009|MPH In-Lab Phase|No attention/academic problems|0
7727111|NCT00576472|12152971|FG010|MPH In-Lab Phase|No attention/academic problems|0
7727112|NCT00576472|12152972|FG011|MPH In-Lab Phase|No attention/academic problems|0
7727113|NCT00576472|12152973|FG012|MPH In-Lab Phase|No attention/academic problems|0
7727114|NCT00576472|12152974|FG013|MPH In-Lab Phase|No attention/academic problems|0
7727115|NCT00576472|12152975|FG014|MPH In-Lab Phase|No attention/academic problems|0
7727116|NCT00576472|12152961|FG000|MPH In-Lab Phase|Psychiatric exclusion|0
7727117|NCT00576472|12152962|FG001|MPH In-Lab Phase|Psychiatric exclusion|0
7727118|NCT00576472|12152963|FG002|MPH In-Lab Phase|Psychiatric exclusion|0
7727119|NCT00576472|12152964|FG003|MPH In-Lab Phase|Psychiatric exclusion|10
7727120|NCT00576472|12152965|FG004|MPH In-Lab Phase|Psychiatric exclusion|0
7727121|NCT00576472|12152966|FG005|MPH In-Lab Phase|Psychiatric exclusion|0
7727122|NCT00576472|12152967|FG006|MPH In-Lab Phase|Psychiatric exclusion|0
7727123|NCT00576472|12152968|FG007|MPH In-Lab Phase|Psychiatric exclusion|0
7727124|NCT00576472|12152969|FG008|MPH In-Lab Phase|Psychiatric exclusion|0
7727125|NCT00576472|12152970|FG009|MPH In-Lab Phase|Psychiatric exclusion|0
7727126|NCT00576472|12152971|FG010|MPH In-Lab Phase|Psychiatric exclusion|0
7727127|NCT00576472|12152972|FG011|MPH In-Lab Phase|Psychiatric exclusion|0
7727128|NCT00576472|12152973|FG012|MPH In-Lab Phase|Psychiatric exclusion|0
7727129|NCT00576472|12152974|FG013|MPH In-Lab Phase|Psychiatric exclusion|0
7727130|NCT00576472|12152975|FG014|MPH In-Lab Phase|Psychiatric exclusion|0
7727131|NCT00576472|12152961|FG000|MPH Cross Over Phase|Withdrawal by Subject|0
7727132|NCT00576472|12152962|FG001|MPH Cross Over Phase|Withdrawal by Subject|0
7727133|NCT00576472|12152963|FG002|MPH Cross Over Phase|Withdrawal by Subject|0
7727134|NCT00576472|12152964|FG003|MPH Cross Over Phase|Withdrawal by Subject|0
7727135|NCT00576472|12152965|FG004|MPH Cross Over Phase|Withdrawal by Subject|0
7727136|NCT00576472|12152966|FG005|MPH Cross Over Phase|Withdrawal by Subject|0
7727137|NCT00576472|12152967|FG006|MPH Cross Over Phase|Withdrawal by Subject|6
7727138|NCT00576472|12152968|FG007|MPH Cross Over Phase|Withdrawal by Subject|0
7727139|NCT00576472|12152969|FG008|MPH Cross Over Phase|Withdrawal by Subject|0
7727140|NCT00576472|12152970|FG009|MPH Cross Over Phase|Withdrawal by Subject|0
7727141|NCT00576472|12152971|FG010|MPH Cross Over Phase|Withdrawal by Subject|0
7727142|NCT00576472|12152972|FG011|MPH Cross Over Phase|Withdrawal by Subject|0
7727143|NCT00576472|12152973|FG012|MPH Cross Over Phase|Withdrawal by Subject|0
7727144|NCT00576472|12152974|FG013|MPH Cross Over Phase|Withdrawal by Subject|0
7727145|NCT00576472|12152975|FG014|MPH Cross Over Phase|Withdrawal by Subject|0
7727146|NCT00576472|12152961|FG000|MPH Cross Over Phase|Ineligible due to disease|0
7727147|NCT00576472|12152962|FG001|MPH Cross Over Phase|Ineligible due to disease|0
7727148|NCT00576472|12152963|FG002|MPH Cross Over Phase|Ineligible due to disease|0
7727149|NCT00576472|12152964|FG003|MPH Cross Over Phase|Ineligible due to disease|0
7727150|NCT00576472|12152965|FG004|MPH Cross Over Phase|Ineligible due to disease|0
7727151|NCT00576472|12152966|FG005|MPH Cross Over Phase|Ineligible due to disease|0
7727152|NCT00576472|12152967|FG006|MPH Cross Over Phase|Ineligible due to disease|2
7727153|NCT00576472|12152968|FG007|MPH Cross Over Phase|Ineligible due to disease|0
7727154|NCT00576472|12152969|FG008|MPH Cross Over Phase|Ineligible due to disease|0
7727155|NCT00576472|12152970|FG009|MPH Cross Over Phase|Ineligible due to disease|0
7727156|NCT00576472|12152971|FG010|MPH Cross Over Phase|Ineligible due to disease|0
7727157|NCT00576472|12152972|FG011|MPH Cross Over Phase|Ineligible due to disease|0
7727158|NCT00576472|12152973|FG012|MPH Cross Over Phase|Ineligible due to disease|0
7727159|NCT00576472|12152974|FG013|MPH Cross Over Phase|Ineligible due to disease|0
7727160|NCT00576472|12152975|FG014|MPH Cross Over Phase|Ineligible due to disease|0
7727161|NCT00576472|12152961|FG000|MPH Cross Over Phase|Physician Decision|0
7727162|NCT00576472|12152962|FG001|MPH Cross Over Phase|Physician Decision|0
7727163|NCT00576472|12152963|FG002|MPH Cross Over Phase|Physician Decision|0
7727164|NCT00576472|12152964|FG003|MPH Cross Over Phase|Physician Decision|0
7727165|NCT00576472|12152965|FG004|MPH Cross Over Phase|Physician Decision|0
7727166|NCT00576472|12152966|FG005|MPH Cross Over Phase|Physician Decision|0
7727167|NCT00576472|12152967|FG006|MPH Cross Over Phase|Physician Decision|4
7727168|NCT00576472|12152968|FG007|MPH Cross Over Phase|Physician Decision|0
7727169|NCT00576472|12152969|FG008|MPH Cross Over Phase|Physician Decision|0
7727170|NCT00576472|12152970|FG009|MPH Cross Over Phase|Physician Decision|0
7727171|NCT00576472|12152971|FG010|MPH Cross Over Phase|Physician Decision|0
7727172|NCT00576472|12152972|FG011|MPH Cross Over Phase|Physician Decision|0
7727173|NCT00576472|12152973|FG012|MPH Cross Over Phase|Physician Decision|0
7727174|NCT00576472|12152974|FG013|MPH Cross Over Phase|Physician Decision|0
7727175|NCT00576472|12152975|FG014|MPH Cross Over Phase|Physician Decision|0
7727176|NCT00576472|12152961|FG000|MPH Cross Over Phase|Did not complete cross over phase|0
7727177|NCT00576472|12152962|FG001|MPH Cross Over Phase|Did not complete cross over phase|0
7727178|NCT00576472|12152963|FG002|MPH Cross Over Phase|Did not complete cross over phase|0
7727179|NCT00576472|12152964|FG003|MPH Cross Over Phase|Did not complete cross over phase|0
7727180|NCT00576472|12152965|FG004|MPH Cross Over Phase|Did not complete cross over phase|0
7727181|NCT00576472|12152966|FG005|MPH Cross Over Phase|Did not complete cross over phase|0
7727182|NCT00576472|12152967|FG006|MPH Cross Over Phase|Did not complete cross over phase|0
7727183|NCT00576472|12152968|FG007|MPH Cross Over Phase|Did not complete cross over phase|0
7727184|NCT00576472|12152969|FG008|MPH Cross Over Phase|Did not complete cross over phase|2
7727185|NCT00576472|12152970|FG009|MPH Cross Over Phase|Did not complete cross over phase|0
7727186|NCT00576472|12152971|FG010|MPH Cross Over Phase|Did not complete cross over phase|1
7727187|NCT00576472|12152972|FG011|MPH Cross Over Phase|Did not complete cross over phase|1
7727188|NCT00576472|12152973|FG012|MPH Cross Over Phase|Did not complete cross over phase|0
7727189|NCT00576472|12152974|FG013|MPH Cross Over Phase|Did not complete cross over phase|0
7727190|NCT00576472|12152975|FG014|MPH Cross Over Phase|Did not complete cross over phase|0
7727191|NCT00576472|12152961|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0
7727192|NCT00576472|12152962|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0
7727193|NCT00576472|12152963|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0
7727194|NCT00576472|12152964|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0
7727195|NCT00576472|12152965|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0
7727196|NCT00576472|12152966|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0
7727197|NCT00576472|12152967|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0
7727198|NCT00576472|12152968|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0
7727199|NCT00576472|12152969|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0
7727200|NCT00576472|12152970|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0
7727201|NCT00576472|12152971|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0
7727202|NCT00576472|12152972|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0
7727203|NCT00576472|12152973|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0
7727204|NCT00576472|12152974|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16
7727205|NCT00576472|12152975|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0
7727206|NCT00576472|12152961|FG000|MPH Home Maintenance Phase|Declined to participate|0
7727207|NCT00576472|12152962|FG001|MPH Home Maintenance Phase|Declined to participate|0
7727208|NCT00576472|12152963|FG002|MPH Home Maintenance Phase|Declined to participate|0
7727209|NCT00576472|12152964|FG003|MPH Home Maintenance Phase|Declined to participate|0
7727210|NCT00576472|12152965|FG004|MPH Home Maintenance Phase|Declined to participate|0
7727211|NCT00576472|12152966|FG005|MPH Home Maintenance Phase|Declined to participate|0
7727212|NCT00576472|12152967|FG006|MPH Home Maintenance Phase|Declined to participate|0
7727213|NCT00576472|12152968|FG007|MPH Home Maintenance Phase|Declined to participate|0
7727214|NCT00576472|12152969|FG008|MPH Home Maintenance Phase|Declined to participate|0
7727215|NCT00576472|12152970|FG009|MPH Home Maintenance Phase|Declined to participate|0
7727216|NCT00576472|12152971|FG010|MPH Home Maintenance Phase|Declined to participate|0
7727217|NCT00576472|12152972|FG011|MPH Home Maintenance Phase|Declined to participate|0
7727218|NCT00576472|12152973|FG012|MPH Home Maintenance Phase|Declined to participate|0
7727219|NCT00576472|12152974|FG013|MPH Home Maintenance Phase|Declined to participate|7
7727220|NCT00576472|12152975|FG014|MPH Home Maintenance Phase|Declined to participate|0
7727221|NCT00576472|12152961|FG000|MPH Home Maintenance Phase|Insufficient data|0
7727222|NCT00576472|12152962|FG001|MPH Home Maintenance Phase|Insufficient data|0
7727223|NCT00576472|12152963|FG002|MPH Home Maintenance Phase|Insufficient data|0
7727224|NCT00576472|12152964|FG003|MPH Home Maintenance Phase|Insufficient data|0
7727225|NCT00576472|12152965|FG004|MPH Home Maintenance Phase|Insufficient data|0
7727226|NCT00576472|12152966|FG005|MPH Home Maintenance Phase|Insufficient data|0
7727227|NCT00576472|12152967|FG006|MPH Home Maintenance Phase|Insufficient data|0
7727228|NCT00576472|12152968|FG007|MPH Home Maintenance Phase|Insufficient data|0
7727229|NCT00576472|12152969|FG008|MPH Home Maintenance Phase|Insufficient data|0
7727230|NCT00576472|12152970|FG009|MPH Home Maintenance Phase|Insufficient data|0
7727231|NCT00576472|12152971|FG010|MPH Home Maintenance Phase|Insufficient data|0
7727232|NCT00576472|12152972|FG011|MPH Home Maintenance Phase|Insufficient data|0
7727233|NCT00576472|12152973|FG012|MPH Home Maintenance Phase|Insufficient data|0
7727234|NCT00576472|12152974|FG013|MPH Home Maintenance Phase|Insufficient data|4
7727235|NCT00576472|12152975|FG014|MPH Home Maintenance Phase|Insufficient data|0
7727236|NCT00576472|12152961|FG000|MPH Home Maintenance Phase|Side effects|0
7727237|NCT00576472|12152962|FG001|MPH Home Maintenance Phase|Side effects|0
7727238|NCT00576472|12152963|FG002|MPH Home Maintenance Phase|Side effects|0
7727239|NCT00576472|12152964|FG003|MPH Home Maintenance Phase|Side effects|0
7727240|NCT00576472|12152965|FG004|MPH Home Maintenance Phase|Side effects|0
7727241|NCT00576472|12152966|FG005|MPH Home Maintenance Phase|Side effects|0
7727242|NCT00576472|12152967|FG006|MPH Home Maintenance Phase|Side effects|0
7727243|NCT00576472|12152968|FG007|MPH Home Maintenance Phase|Side effects|0
7727244|NCT00576472|12152969|FG008|MPH Home Maintenance Phase|Side effects|0
7727245|NCT00576472|12152970|FG009|MPH Home Maintenance Phase|Side effects|0
7727246|NCT00576472|12152971|FG010|MPH Home Maintenance Phase|Side effects|0
7727247|NCT00576472|12152972|FG011|MPH Home Maintenance Phase|Side effects|0
7727248|NCT00576472|12152973|FG012|MPH Home Maintenance Phase|Side effects|0
7727249|NCT00576472|12152974|FG013|MPH Home Maintenance Phase|Side effects|0
7727250|NCT00576472|12152975|FG014|MPH Home Maintenance Phase|Side effects|8
7727251|NCT00576472|12152961|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0
7727252|NCT00576472|12152962|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0
7727253|NCT00576472|12152963|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0
7727254|NCT00576472|12152964|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0
7727255|NCT00576472|12152965|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0
7727256|NCT00576472|12152966|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0
7727257|NCT00576472|12152967|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0
7727258|NCT00576472|12152968|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0
7727259|NCT00576472|12152969|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0
7727260|NCT00576472|12152970|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0
7727261|NCT00576472|12152971|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0
7727262|NCT00576472|12152972|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0
7727263|NCT00576472|12152973|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0
7727264|NCT00576472|12152974|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0
7727265|NCT00576472|12152975|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6
7727266|NCT00576472|12152961|FG000|MPH Home Maintenance Phase|Medical reasons|0
7727267|NCT00576472|12152962|FG001|MPH Home Maintenance Phase|Medical reasons|0
7727268|NCT00576472|12152963|FG002|MPH Home Maintenance Phase|Medical reasons|0
7727269|NCT00576472|12152964|FG003|MPH Home Maintenance Phase|Medical reasons|0
7727270|NCT00576472|12152965|FG004|MPH Home Maintenance Phase|Medical reasons|0
7727271|NCT00576472|12152966|FG005|MPH Home Maintenance Phase|Medical reasons|0
7727272|NCT00576472|12152967|FG006|MPH Home Maintenance Phase|Medical reasons|0
7727273|NCT00576472|12152968|FG007|MPH Home Maintenance Phase|Medical reasons|0
7727274|NCT00576472|12152969|FG008|MPH Home Maintenance Phase|Medical reasons|0
7727275|NCT00576472|12152970|FG009|MPH Home Maintenance Phase|Medical reasons|0
7727276|NCT00576472|12152971|FG010|MPH Home Maintenance Phase|Medical reasons|0
7727277|NCT00576472|12152972|FG011|MPH Home Maintenance Phase|Medical reasons|0
7727278|NCT00576472|12152973|FG012|MPH Home Maintenance Phase|Medical reasons|0
7727279|NCT00576472|12152974|FG013|MPH Home Maintenance Phase|Medical reasons|0
7727280|NCT00576472|12152975|FG014|MPH Home Maintenance Phase|Medical reasons|6
7727281|NCT00576472|12152961|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0
7727282|NCT00576472|12152962|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0
7727283|NCT00576472|12152963|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0
7727284|NCT00576472|12152964|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0
7727285|NCT00576472|12152965|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0
7727286|NCT00576472|12152966|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0
7727287|NCT00576472|12152967|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0
7727288|NCT00576472|12152968|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0
7727289|NCT00576472|12152969|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0
7727290|NCT00576472|12152970|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0
7727291|NCT00576472|12152971|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0
7727292|NCT00576472|12152972|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0
7727293|NCT00576472|12152973|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0
7727294|NCT00576472|12152974|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0
7727295|NCT00576472|12152975|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3
7727296|NCT00576576|12153006|FG000|Overall Study|Lost to Follow-up|6
7727297|NCT00576576|12153006|FG000|Overall Study|Protocol Violation|1
7727298|NCT00576628|12153010|FG000|Overall Study|Adverse Event|11
7727299|NCT00576628|12153010|FG000|Overall Study|Death|2
7727300|NCT00576628|12153010|FG000|Overall Study|Failure to return|1
7727301|NCT00576628|12153010|FG000|Overall Study|Refused Treatment|8
7727302|NCT00576628|12153010|FG000|Overall Study|Pregnancy|1
7727303|NCT00576628|12153010|FG000|Overall Study|RBC transfusion|1
7727304|NCT00576628|12153010|FG000|Overall Study|Progression of Kidney Disease|1
7727305|NCT00576628|12153010|FG000|Overall Study|Progression of Renal Failure|1
7727306|NCT00576628|12153010|FG000|Overall Study|The patient move into other town|1
7727307|NCT00576628|12153010|FG000|Overall Study|Transplantation|1
7727308|NCT00576628|12153010|FG000|Overall Study|Dialysis|15
7727309|NCT00576693|12153021|FG000|Overall Study|Lost to Follow-up|7
7727310|NCT00576693|12153022|FG001|Overall Study|Lost to Follow-up|11
7727311|NCT00576693|12153021|FG000|Overall Study|Withdrawal by Subject|3
7727312|NCT00576693|12153022|FG001|Overall Study|Withdrawal by Subject|13
7727313|NCT00576732|12153031|FG000|DOUBLE BLIND|Adverse Event|0
7727314|NCT00576732|12153032|FG001|DOUBLE BLIND|Adverse Event|0
7727315|NCT00576732|12153033|FG002|DOUBLE BLIND|Adverse Event|1
7727316|NCT00576732|12153034|FG003|DOUBLE BLIND|Adverse Event|0
7727317|NCT00576732|12153035|FG004|DOUBLE BLIND|Adverse Event|0
7727318|NCT00576732|12153036|FG005|DOUBLE BLIND|Adverse Event|0
7727319|NCT00576732|12153031|FG000|DOUBLE BLIND|Lost to Follow-up|0
7727320|NCT00576732|12153032|FG001|DOUBLE BLIND|Lost to Follow-up|1
7727321|NCT00576732|12153033|FG002|DOUBLE BLIND|Lost to Follow-up|1
7727322|NCT00576732|12153034|FG003|DOUBLE BLIND|Lost to Follow-up|0
7727323|NCT00576732|12153035|FG004|DOUBLE BLIND|Lost to Follow-up|0
7727324|NCT00576732|12153036|FG005|DOUBLE BLIND|Lost to Follow-up|0
7727325|NCT00576732|12153031|FG000|DOUBLE BLIND|Withdrawal by Subject|1
7727326|NCT00576732|12153032|FG001|DOUBLE BLIND|Withdrawal by Subject|1
7727327|NCT00576732|12153033|FG002|DOUBLE BLIND|Withdrawal by Subject|3
7727328|NCT00576732|12153034|FG003|DOUBLE BLIND|Withdrawal by Subject|0
7727329|NCT00576732|12153035|FG004|DOUBLE BLIND|Withdrawal by Subject|0
7727330|NCT00576732|12153036|FG005|DOUBLE BLIND|Withdrawal by Subject|0
7727331|NCT00576732|12153031|FG000|DOUBLE BLIND|OTHER|0
7727332|NCT00576732|12153032|FG001|DOUBLE BLIND|OTHER|2
7727333|NCT00576732|12153033|FG002|DOUBLE BLIND|OTHER|1
7727334|NCT00576732|12153034|FG003|DOUBLE BLIND|OTHER|0
7727335|NCT00576732|12153035|FG004|DOUBLE BLIND|OTHER|0
7727336|NCT00576732|12153036|FG005|DOUBLE BLIND|OTHER|0
7727337|NCT00576732|12153031|FG000|DOUBLE BLIND|Lack of Efficacy|6
7727338|NCT00576732|12153032|FG001|DOUBLE BLIND|Lack of Efficacy|1
7727339|NCT00576732|12153033|FG002|DOUBLE BLIND|Lack of Efficacy|0
7727340|NCT00576732|12153034|FG003|DOUBLE BLIND|Lack of Efficacy|0
7727341|NCT00576732|12153035|FG004|DOUBLE BLIND|Lack of Efficacy|0
7727342|NCT00576732|12153036|FG005|DOUBLE BLIND|Lack of Efficacy|0
7727343|NCT00576732|12153031|FG000|DOUBLE BLIND|Protocol Violation|1
7727344|NCT00576732|12153032|FG001|DOUBLE BLIND|Protocol Violation|0
7727345|NCT00576732|12153033|FG002|DOUBLE BLIND|Protocol Violation|0
7727346|NCT00576732|12153034|FG003|DOUBLE BLIND|Protocol Violation|0
7727347|NCT00576732|12153035|FG004|DOUBLE BLIND|Protocol Violation|0
7727348|NCT00576732|12153036|FG005|DOUBLE BLIND|Protocol Violation|0
7727349|NCT00576732|12153031|FG000|OPEN LABEL|Adverse Event|0
7727350|NCT00576732|12153032|FG001|OPEN LABEL|Adverse Event|0
7727351|NCT00576732|12153033|FG002|OPEN LABEL|Adverse Event|0
7727352|NCT00576732|12153034|FG003|OPEN LABEL|Adverse Event|4
7727353|NCT00576732|12153035|FG004|OPEN LABEL|Adverse Event|0
7727354|NCT00576732|12153036|FG005|OPEN LABEL|Adverse Event|1
7727355|NCT00576732|12153031|FG000|OPEN LABEL|Lost to Follow-up|0
7727356|NCT00576732|12153032|FG001|OPEN LABEL|Lost to Follow-up|0
7727357|NCT00576732|12153033|FG002|OPEN LABEL|Lost to Follow-up|0
7727358|NCT00576732|12153034|FG003|OPEN LABEL|Lost to Follow-up|2
7727359|NCT00576732|12153035|FG004|OPEN LABEL|Lost to Follow-up|1
7727360|NCT00576732|12153036|FG005|OPEN LABEL|Lost to Follow-up|1
7727361|NCT00576732|12153031|FG000|OPEN LABEL|Withdrawal by Subject|0
7727362|NCT00576732|12153032|FG001|OPEN LABEL|Withdrawal by Subject|0
7727363|NCT00576732|12153033|FG002|OPEN LABEL|Withdrawal by Subject|0
7727364|NCT00576732|12153034|FG003|OPEN LABEL|Withdrawal by Subject|1
7727365|NCT00576732|12153035|FG004|OPEN LABEL|Withdrawal by Subject|0
7727366|NCT00576732|12153036|FG005|OPEN LABEL|Withdrawal by Subject|1
7727367|NCT00576732|12153031|FG000|OPEN LABEL|OTHER|0
7727368|NCT00576732|12153032|FG001|OPEN LABEL|OTHER|0
7727369|NCT00576732|12153033|FG002|OPEN LABEL|OTHER|0
7727370|NCT00576732|12153034|FG003|OPEN LABEL|OTHER|0
7727371|NCT00576732|12153035|FG004|OPEN LABEL|OTHER|0
7727372|NCT00576732|12153036|FG005|OPEN LABEL|OTHER|2
7727373|NCT00576732|12153031|FG000|OPEN LABEL|Lack of Efficacy|0
7727374|NCT00576732|12153032|FG001|OPEN LABEL|Lack of Efficacy|0
7727375|NCT00576732|12153033|FG002|OPEN LABEL|Lack of Efficacy|0
7727376|NCT00576732|12153034|FG003|OPEN LABEL|Lack of Efficacy|2
7727377|NCT00576732|12153035|FG004|OPEN LABEL|Lack of Efficacy|2
7727378|NCT00576732|12153036|FG005|OPEN LABEL|Lack of Efficacy|3
7727379|NCT00576732|12153031|FG000|OPEN LABEL|Protocol Violation|0
7727380|NCT00576732|12153032|FG001|OPEN LABEL|Protocol Violation|0
7727381|NCT00576732|12153033|FG002|OPEN LABEL|Protocol Violation|0
7727382|NCT00576732|12153034|FG003|OPEN LABEL|Protocol Violation|2
7727383|NCT00576732|12153035|FG004|OPEN LABEL|Protocol Violation|1
7727384|NCT00576732|12153036|FG005|OPEN LABEL|Protocol Violation|0
7727385|NCT00576758|12153050|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3
7727386|NCT00576758|12153051|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3
7727387|NCT00576758|12153050|FG000|Induction Treatment Period|Insufficient therapeutic response|2
7727388|NCT00576758|12153051|FG001|Induction Treatment Period|Insufficient therapeutic response|0
7727389|NCT00576758|12153050|FG000|Induction Treatment Period|Violation of selection criteria at entry|1
7727390|NCT00576758|12153051|FG001|Induction Treatment Period|Violation of selection criteria at entry|1
7727391|NCT00576758|12153050|FG000|Induction Treatment Period|Death|1
7727392|NCT00576758|12153051|FG001|Induction Treatment Period|Death|0
7727393|NCT00576758|12153050|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
7727394|NCT00576758|12153051|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
7727395|NCT00576758|12153050|FG000|Induction Treatment Period|Withdrew consent|1
7727396|NCT00576758|12153051|FG001|Induction Treatment Period|Withdrew consent|0
7727397|NCT00576758|12153050|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6
7727398|NCT00576758|12153051|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7
7727399|NCT00576758|12153050|FG000|Extension Treatment Period|Death|1
7727400|NCT00576758|12153051|FG001|Extension Treatment Period|Death|1
7727401|NCT00576758|12153050|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2
7727402|NCT00576758|12153051|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1
7727403|NCT00576758|12153050|FG000|Extension Treatment Period|Insufficient therapeutic response|30
7727404|NCT00576758|12153051|FG001|Extension Treatment Period|Insufficient therapeutic response|33
7727405|NCT00576758|12153050|FG000|Extension Treatment Period|Administrative/Other|3
7727406|NCT00576758|12153051|FG001|Extension Treatment Period|Administrative/Other|1
7727407|NCT00576758|12153050|FG000|Follow-up Period|Administrative/Other|6
7727408|NCT00576758|12153051|FG001|Follow-up Period|Administrative/Other|8
7727409|NCT00576758|12153050|FG000|Follow-up Period|Death|3
7727410|NCT00576758|12153051|FG001|Follow-up Period|Death|3
7727411|NCT00576758|12153050|FG000|Follow-up Period|Insufficient therapeutic response|16
7727412|NCT00576758|12153051|FG001|Follow-up Period|Insufficient therapeutic response|5
7727413|NCT00576758|12153050|FG000|Follow-up Period|Withdrew consent|2
7727414|NCT00576758|12153051|FG001|Follow-up Period|Withdrew consent|1
7727415|NCT00576823|12153061|FG000|12-week Efficacy Phase|Parent's schedule issue|1
7727416|NCT00576823|12153062|FG001|12-week Efficacy Phase|Parent's schedule issue|0
7727417|NCT00576823|12153063|FG002|12-week Efficacy Phase|Parent's schedule issue|0
7727418|NCT00576823|12153061|FG000|40-week Safety Extension Phase|Lack of Efficacy|1
7727419|NCT00576823|12153062|FG001|40-week Safety Extension Phase|Lack of Efficacy|0
7727420|NCT00576823|12153063|FG002|40-week Safety Extension Phase|Lack of Efficacy|0
7727421|NCT00576901|12153074|FG000|Overall Study|Withdrawal by Subject|1
7727422|NCT00576901|12153074|FG000|Overall Study|Disease course|1
7727423|NCT00576901|12153074|FG000|Overall Study|Protocol Violation|1
7727424|NCT00576927|12153080|FG000|Clinical Assessment|Lack of Efficacy|24
7727425|NCT00576927|12153080|FG000|Clinical Assessment|Death|1
7727426|NCT00576927|12153080|FG000|Clinical Assessment|Withdrawal by Subject|10
7727427|NCT00576927|12153080|FG000|Clinical Assessment|Physician Decision|1
7727428|NCT00576927|12153080|FG000|Baseline|Physician Decision|9
7727429|NCT00576927|12153080|FG000|Baseline|Medication Change by PCP of subject|1
7727430|NCT00576927|12153080|FG000|Baseline|Withdrawal by Subject|3
7727431|NCT00576927|12153080|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
7727432|NCT00576927|12153080|FG000|Sleep Hygiene Behavioral Intervention|Death|1
7727433|NCT00576927|12153080|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
7727434|NCT00576927|12153080|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
7727435|NCT00576927|12153080|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
7727436|NCT00577005|12153088|FG000|Overall Study|Lost to Follow-up|3
7727437|NCT00577005|12153089|FG001|Overall Study|Lost to Follow-up|2
7727438|NCT00577005|12153088|FG000|Overall Study|Withdrawal by Subject|2
7727439|NCT00577005|12153089|FG001|Overall Study|Withdrawal by Subject|1
7727440|NCT00577031|12153098|FG000|Overall Study|Adverse Event|52
7727441|NCT00577031|12153098|FG000|Overall Study|Progression of disease|93
7727442|NCT00577031|12153098|FG000|Overall Study|Protocol Violation|5
7727443|NCT00577031|12153098|FG000|Overall Study|Participant withdrew consent|13
7727444|NCT00577031|12153098|FG000|Overall Study|Participant non-compliance|5
7727445|NCT00577031|12153098|FG000|Overall Study|Need for surgery|17
7727446|NCT00577031|12153098|FG000|Overall Study|Medical decision|14
7727447|NCT00577031|12153098|FG000|Overall Study|Death|6
7727448|NCT00577096|12153122|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3
7727449|NCT00577096|12153123|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2
7727450|NCT00577096|12153122|FG000|Short Term Participation|Withdrawal by Subject|3
7727451|NCT00577096|12153123|FG001|Short Term Participation|Withdrawal by Subject|5
7727452|NCT00577096|12153122|FG000|Short Term Participation|Death|1
7727453|NCT00577096|12153123|FG001|Short Term Participation|Death|1
7727454|NCT00577122|12153131|FG000|Overall Study|Adverse Event|0
7727455|NCT00577122|12153132|FG001|Overall Study|Adverse Event|2
7727456|NCT00577122|12153131|FG000|Overall Study|Progression, relapse during active trt|6
7727457|NCT00577122|12153132|FG001|Overall Study|Progression, relapse during active trt|8
7727458|NCT00577122|12153131|FG000|Overall Study|Prog, refract disease during active trt|8
7727459|NCT00577122|12153132|FG001|Overall Study|Prog, refract disease during active trt|5
7727460|NCT00577122|12153131|FG000|Overall Study|Alternative Therapy|0
7727461|NCT00577122|12153132|FG001|Overall Study|Alternative Therapy|1
7727462|NCT00577382|12153158|FG000|Overall Study|Adverse Event|0
7727463|NCT00577382|12153159|FG001|Overall Study|Adverse Event|6
7727464|NCT00577382|12153158|FG000|Overall Study|Withdrawal by Subject|0
7727465|NCT00577382|12153159|FG001|Overall Study|Withdrawal by Subject|1
7727466|NCT00577382|12153158|FG000|Overall Study|Progressive Disease|17
7727467|NCT00577382|12153159|FG001|Overall Study|Progressive Disease|19
7727468|NCT00577382|12153158|FG000|Overall Study|Intercurrent Illness|1
7727469|NCT00577382|12153159|FG001|Overall Study|Intercurrent Illness|2
7727470|NCT00577382|12153158|FG000|Overall Study|Death|1
7727471|NCT00577382|12153159|FG001|Overall Study|Death|1
7727472|NCT00577382|12153158|FG000|Overall Study|Lost to Follow-up|2
7727473|NCT00577382|12153159|FG001|Overall Study|Lost to Follow-up|2
7727474|NCT00577408|12153167|FG000|Overall Study|Stopped attending study visits|9
7727475|NCT00577408|12153168|FG001|Overall Study|Stopped attending study visits|11
7727476|NCT00577408|12153167|FG000|Overall Study|Continued opioid use|3
7727477|NCT00577408|12153168|FG001|Overall Study|Continued opioid use|2
7727478|NCT00577408|12153167|FG000|Overall Study|Non-compliance with study meds|0
7727479|NCT00577408|12153168|FG001|Overall Study|Non-compliance with study meds|3
7727480|NCT00577408|12153167|FG000|Overall Study|Refused Oral Naltrexone|0
7727481|NCT00577408|12153168|FG001|Overall Study|Refused Oral Naltrexone|1
7727482|NCT00577408|12153167|FG000|Overall Study|Moved out of state|0
7727483|NCT00577408|12153168|FG001|Overall Study|Moved out of state|1
7727484|NCT00577408|12153167|FG000|Overall Study|Scheduling Issues|0
7727485|NCT00577408|12153168|FG001|Overall Study|Scheduling Issues|3
7727486|NCT00577408|12153167|FG000|Overall Study|Death|0
7727487|NCT00577408|12153168|FG001|Overall Study|Death|1
7727488|NCT00577408|12153167|FG000|Overall Study|Psychiatric hospitalization|0
7727489|NCT00577408|12153168|FG001|Overall Study|Psychiatric hospitalization|1
7727490|NCT00577460|12153177|FG000|Overall Study|Adverse Event|11
7727491|NCT00577460|12153178|FG001|Overall Study|Adverse Event|7
7727492|NCT00577460|12153179|FG002|Overall Study|Adverse Event|14
7727493|NCT00577460|12153177|FG000|Overall Study|Protocol Violation|0
7727494|NCT00577460|12153178|FG001|Overall Study|Protocol Violation|1
7727495|NCT00577460|12153179|FG002|Overall Study|Protocol Violation|1
7727496|NCT00577460|12153177|FG000|Overall Study|Lost to Follow-up|0
7727497|NCT00577460|12153178|FG001|Overall Study|Lost to Follow-up|3
7727498|NCT00577460|12153179|FG002|Overall Study|Lost to Follow-up|4
7727499|NCT00577460|12153177|FG000|Overall Study|Withdrawal by Subject|5
7727500|NCT00577460|12153178|FG001|Overall Study|Withdrawal by Subject|5
7727501|NCT00577460|12153179|FG002|Overall Study|Withdrawal by Subject|6
7727502|NCT00577460|12153177|FG000|Overall Study|Other|0
7727503|NCT00577460|12153178|FG001|Overall Study|Other|3
7727504|NCT00577460|12153179|FG002|Overall Study|Other|2
7727505|NCT00577473|12153196|FG000|Overall Study|Protocol Violation|1
7727506|NCT00577473|12153197|FG001|Overall Study|Protocol Violation|4
7727507|NCT00577473|12153196|FG000|Overall Study|Adverse Event|8
7727508|NCT00577473|12153197|FG001|Overall Study|Adverse Event|5
7727509|NCT00577473|12153196|FG000|Overall Study|Withdrawal by Subject|2
7727510|NCT00577473|12153197|FG001|Overall Study|Withdrawal by Subject|6
7727511|NCT00577473|12153196|FG000|Overall Study|Physician Decision|2
7727512|NCT00577473|12153197|FG001|Overall Study|Physician Decision|2
7727513|NCT00577473|12153196|FG000|Overall Study|Lack of Efficacy|8
7727514|NCT00577473|12153197|FG001|Overall Study|Lack of Efficacy|7
7727515|NCT00577629|12153220|FG000|Treatment Period|Death|1
7727516|NCT00577629|12153220|FG000|Long Term Follow-Up|Death|15
7727517|NCT00577629|12153220|FG000|Long Term Follow-Up|Lost to Follow-up|5
7727518|NCT00577629|12153220|FG000|Long Term Follow-Up|Withdrawal by Subject|4
7727519|NCT00577629|12153220|FG000|Long Term Follow-Up|Physician Decision|1
7727520|NCT00577642|12153226|FG000|Overall Study|Clinical Disease Progression|1
7727521|NCT00577655|12153232|FG000|Overall Study|Patient Request|0
7727522|NCT00577655|12153233|FG001|Overall Study|Patient Request|2
7727523|NCT00577655|12153232|FG000|Overall Study|Protocol Violation|0
7727524|NCT00577655|12153233|FG001|Overall Study|Protocol Violation|1
7727525|NCT00577655|12153232|FG000|Overall Study|Lost to Follow-up|1
7727526|NCT00577655|12153233|FG001|Overall Study|Lost to Follow-up|1
7727527|NCT00577707|12153240|FG000|Overall Study|Withdrawal by Subject|3
7727528|NCT00577720|12153248|FG000|Overall Study|Adverse Event|2
7727529|NCT00577720|12153249|FG001|Overall Study|Adverse Event|1
7727530|NCT00577720|12153250|FG002|Overall Study|Adverse Event|0
7727531|NCT00577720|12153251|FG003|Overall Study|Adverse Event|4
7727532|NCT00577720|12153248|FG000|Overall Study|Lost to Follow-up|0
7727533|NCT00577720|12153249|FG001|Overall Study|Lost to Follow-up|0
7727534|NCT00577720|12153250|FG002|Overall Study|Lost to Follow-up|1
7727535|NCT00577720|12153251|FG003|Overall Study|Lost to Follow-up|0
7727536|NCT00577720|12153248|FG000|Overall Study|Protocol Violation|0
7727537|NCT00577720|12153249|FG001|Overall Study|Protocol Violation|0
7727538|NCT00577720|12153250|FG002|Overall Study|Protocol Violation|0
7727539|NCT00577720|12153251|FG003|Overall Study|Protocol Violation|1
7727540|NCT00577720|12153248|FG000|Overall Study|Withdrawal by Subject|2
7727541|NCT00577720|12153249|FG001|Overall Study|Withdrawal by Subject|0
7727542|NCT00577720|12153250|FG002|Overall Study|Withdrawal by Subject|0
7727543|NCT00577720|12153251|FG003|Overall Study|Withdrawal by Subject|2
7727544|NCT00577824|12153264|FG000|Overall Study|Adverse Event|6
7727545|NCT00577824|12153265|FG001|Overall Study|Adverse Event|18
7727546|NCT00577824|12153266|FG002|Overall Study|Adverse Event|1
7727547|NCT00577824|12153264|FG000|Overall Study|Patient decision|0
7727548|NCT00577824|12153265|FG001|Overall Study|Patient decision|1
7727549|NCT00577824|12153266|FG002|Overall Study|Patient decision|1
7727550|NCT00577824|12153264|FG000|Overall Study|Protocol Violation|1
7727551|NCT00577824|12153265|FG001|Overall Study|Protocol Violation|1
7727552|NCT00577824|12153266|FG002|Overall Study|Protocol Violation|0
7727553|NCT00577863|12153276|FG000|Overall Study|Adverse Event|4
7727554|NCT00577863|12153277|FG001|Overall Study|Adverse Event|2
7727555|NCT00577863|12153276|FG000|Overall Study|Death|1
7727556|NCT00577863|12153277|FG001|Overall Study|Death|0
7727557|NCT00577863|12153276|FG000|Overall Study|Lost to Follow-up|2
7727558|NCT00577863|12153277|FG001|Overall Study|Lost to Follow-up|2
7727559|NCT00577863|12153276|FG000|Overall Study|Entry Criteria Exclusion|1
7727560|NCT00577863|12153277|FG001|Overall Study|Entry Criteria Exclusion|0
7727561|NCT00577863|12153276|FG000|Overall Study|Withdrawal by Subject|0
7727562|NCT00577863|12153277|FG001|Overall Study|Withdrawal by Subject|2
7727563|NCT00577863|12153276|FG000|Overall Study|Sponsor Decision|2
7727564|NCT00577863|12153277|FG001|Overall Study|Sponsor Decision|7
7727565|NCT00577863|12153276|FG000|Overall Study|Did Not Receive at Least One Injection|0
7727566|NCT00577863|12153277|FG001|Overall Study|Did Not Receive at Least One Injection|1
7727567|NCT00577889|12153286|FG000|Overall Study|Withdrawal by Subject|1
7727568|NCT00577889|12153287|FG001|Overall Study|Withdrawal by Subject|0
7727569|NCT00577889|12153288|FG002|Overall Study|Withdrawal by Subject|0
7727570|NCT00577993|12153299|FG000|Overall Study|Adverse Event|1
7727571|NCT00577993|12153300|FG001|Overall Study|Adverse Event|0
7727572|NCT00577993|12153301|FG002|Overall Study|Adverse Event|0
7727573|NCT00577993|12153299|FG000|Overall Study|Death|0
7727574|NCT00577993|12153300|FG001|Overall Study|Death|1
7727575|NCT00577993|12153301|FG002|Overall Study|Death|1
7727576|NCT00577993|12153299|FG000|Overall Study|Lack of Efficacy|0
7727577|NCT00577993|12153300|FG001|Overall Study|Lack of Efficacy|1
7727578|NCT00577993|12153301|FG002|Overall Study|Lack of Efficacy|0
7727579|NCT00577993|12153299|FG000|Overall Study|Protocol Violation|2
7727580|NCT00577993|12153300|FG001|Overall Study|Protocol Violation|3
7727581|NCT00577993|12153301|FG002|Overall Study|Protocol Violation|0
7727582|NCT00577993|12153299|FG000|Overall Study|Withdrawal by Subject|1
7727583|NCT00577993|12153300|FG001|Overall Study|Withdrawal by Subject|0
7727584|NCT00577993|12153301|FG002|Overall Study|Withdrawal by Subject|2
7727585|NCT00577993|12153299|FG000|Overall Study|Conversion|2
7727586|NCT00577993|12153300|FG001|Overall Study|Conversion|5
7727587|NCT00577993|12153301|FG002|Overall Study|Conversion|0
7727588|NCT00577993|12153299|FG000|Overall Study|Uninsured|1
7727589|NCT00577993|12153300|FG001|Overall Study|Uninsured|0
7727590|NCT00577993|12153301|FG002|Overall Study|Uninsured|0
7727591|NCT00578136|12153314|FG000|Overall Study|Not given intervention|1
7727592|NCT00578136|12153315|FG001|Overall Study|Not given intervention|1
7727593|NCT00578175|12153324|FG000|Overall Study|Adverse Event|0
7727594|NCT00578175|12153325|FG001|Overall Study|Adverse Event|1
7727595|NCT00578175|12153326|FG002|Overall Study|Adverse Event|1
7727596|NCT00578175|12153324|FG000|Overall Study|Other reasons|70
7727597|NCT00578175|12153325|FG001|Overall Study|Other reasons|42
7727598|NCT00578175|12153326|FG002|Overall Study|Other reasons|23
7727599|NCT00578227|12153352|FG000|Overall Study|Lost to Follow-up|0
7727600|NCT00578227|12153353|FG001|Overall Study|Lost to Follow-up|1
7727601|NCT00578227|12153354|FG002|Overall Study|Lost to Follow-up|1
7727602|NCT00578227|12153352|FG000|Overall Study|Withdrawal by Subject|5
7727603|NCT00578227|12153353|FG001|Overall Study|Withdrawal by Subject|1
7727604|NCT00578227|12153354|FG002|Overall Study|Withdrawal by Subject|3
7727605|NCT00578292|12153373|FG000|Overall Study|Death|1
7727606|NCT00578292|12153373|FG000|Overall Study|Graft failure|2
7727607|NCT00578318|12153398|FG000|Overall Study|Lost to Follow-up|2
7727608|NCT00578318|12153399|FG001|Overall Study|Lost to Follow-up|0
7727609|NCT00578318|12153398|FG000|Overall Study|Physician Decision|1
7727610|NCT00578318|12153399|FG001|Overall Study|Physician Decision|0
7727611|NCT00578344|12153414|FG000|Overall Study|Insurance problems|1
7727612|NCT00578344|12153414|FG000|Overall Study|Graft failure|1
7727613|NCT00578448|12153439|FG000|Day 1 up to 3 Years of Planned Study|Death|1
7727614|NCT00578448|12153439|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1
7727615|NCT00578448|12153439|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
7727616|NCT00578448|12153439|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1
7727617|NCT00578565|12153466|FG000|Overall Study|Adverse Event|3
7727618|NCT00578643|12153480|FG000|Overall Study|Death|1
7727619|NCT00578643|12153480|FG000|Overall Study|Lost to Follow-up|1
7727620|NCT00578786|12153505|FG000|Overall Study|Adverse Event|27
7727621|NCT00578786|12153506|FG001|Overall Study|Adverse Event|37
7727622|NCT00578786|12153507|FG002|Overall Study|Adverse Event|17
7727623|NCT00578786|12153505|FG000|Overall Study|Lack of Efficacy|2
7727624|NCT00578786|12153506|FG001|Overall Study|Lack of Efficacy|5
7727625|NCT00578786|12153507|FG002|Overall Study|Lack of Efficacy|2
7727626|NCT00578786|12153505|FG000|Overall Study|Early Escape from Prior Study|2
7727627|NCT00578786|12153506|FG001|Overall Study|Early Escape from Prior Study|1
7727628|NCT00578786|12153507|FG002|Overall Study|Early Escape from Prior Study|2
7727629|NCT00578786|12153505|FG000|Overall Study|Withdrawal by Subject|7
7727630|NCT00578786|12153506|FG001|Overall Study|Withdrawal by Subject|8
7727631|NCT00578786|12153507|FG002|Overall Study|Withdrawal by Subject|5
7727632|NCT00578786|12153505|FG000|Overall Study|Protocol Violation|0
7727633|NCT00578786|12153506|FG001|Overall Study|Protocol Violation|3
7727634|NCT00578786|12153507|FG002|Overall Study|Protocol Violation|1
7727635|NCT00578786|12153505|FG000|Overall Study|Physician Decision|1
7727636|NCT00578786|12153506|FG001|Overall Study|Physician Decision|0
7727637|NCT00578786|12153507|FG002|Overall Study|Physician Decision|1
7727638|NCT00578786|12153505|FG000|Overall Study|Sponsor Decision|0
7727639|NCT00578786|12153506|FG001|Overall Study|Sponsor Decision|0
7727640|NCT00578786|12153507|FG002|Overall Study|Sponsor Decision|1
7727641|NCT00578786|12153505|FG000|Overall Study|Lost to Follow-up|0
7727642|NCT00578786|12153506|FG001|Overall Study|Lost to Follow-up|4
7727643|NCT00578786|12153507|FG002|Overall Study|Lost to Follow-up|0
7727644|NCT00578786|12153505|FG000|Overall Study|Pregnancy|0
7727645|NCT00578786|12153506|FG001|Overall Study|Pregnancy|1
7727646|NCT00578786|12153507|FG002|Overall Study|Pregnancy|0
7727647|NCT00578786|12153505|FG000|Overall Study|Not Otherwise Specified|0
7727648|NCT00578786|12153506|FG001|Overall Study|Not Otherwise Specified|4
7727649|NCT00578786|12153507|FG002|Overall Study|Not Otherwise Specified|1
7727650|NCT00578786|12153505|FG000|Overall Study|Qualified but Not Enrolled in Extension|0
7727651|NCT00578786|12153506|FG001|Overall Study|Qualified but Not Enrolled in Extension|3
7727652|NCT00578786|12153507|FG002|Overall Study|Qualified but Not Enrolled in Extension|0
7727653|NCT00578812|12153527|FG000|Overall Study|Not treated|6
7727654|NCT00578812|12153528|FG001|Overall Study|Not treated|7
7727655|NCT00578864|12153537|FG000|Overall Study|Death|1
7727656|NCT00578864|12153538|FG001|Overall Study|Death|0
7727657|NCT00578877|12153546|FG000|Overall Study|Lost to Follow-up|8
7727658|NCT00578877|12153547|FG001|Overall Study|Lost to Follow-up|10
7727659|NCT00578877|12153546|FG000|Overall Study|early discontinue|61
7727660|NCT00578877|12153547|FG001|Overall Study|early discontinue|101
7727661|NCT00578877|12153546|FG000|Overall Study|did not provide follow-up data|12
7727662|NCT00578877|12153547|FG001|Overall Study|did not provide follow-up data|17
7727663|NCT00578942|12153575|FG000|Overall Study|Lost to Follow-up|1
7727664|NCT00579059|12153595|FG000|Overall Study|Study Canceled at 1 Year|21
7727665|NCT00579059|12153596|FG001|Overall Study|Study Canceled at 1 Year|10
7727666|NCT00579098|12153604|FG000|Overall Study|Lost to Follow-up|2
7727667|NCT00579098|12153605|FG001|Overall Study|Lost to Follow-up|0
7727668|NCT00579098|12153604|FG000|Overall Study|Adverse Event|2
7727669|NCT00579098|12153605|FG001|Overall Study|Adverse Event|3
7727670|NCT00579098|12153604|FG000|Overall Study|Withdrawal by Subject|2
7727671|NCT00579098|12153605|FG001|Overall Study|Withdrawal by Subject|3
7727672|NCT00579098|12153604|FG000|Overall Study|AF returned after ablation|3
7727673|NCT00579098|12153605|FG001|Overall Study|AF returned after ablation|2
7768279|NCT00858637|12211234|FG003|Placebo-controlled Withdrawal Phase|Death|0
7768280|NCT00858637|12211235|FG004|Placebo-controlled Withdrawal Phase|Death|1
7727674|NCT00579345|12153645|FG000|Overall Study|Withdrawal by Subject|2
7727675|NCT00579345|12153646|FG001|Overall Study|Withdrawal by Subject|0
7727676|NCT00579345|12153647|FG002|Overall Study|Withdrawal by Subject|0
7727677|NCT00579345|12153648|FG003|Overall Study|Withdrawal by Subject|0
7727678|NCT00579345|12153649|FG004|Overall Study|Withdrawal by Subject|0
7727679|NCT00579345|12153650|FG005|Overall Study|Withdrawal by Subject|0
7727680|NCT00579345|12153651|FG006|Overall Study|Withdrawal by Subject|0
7727681|NCT00579345|12153652|FG007|Overall Study|Withdrawal by Subject|1
7727682|NCT00579345|12153645|FG000|Overall Study|Lost to Follow-up|1
7727683|NCT00579345|12153646|FG001|Overall Study|Lost to Follow-up|0
7727684|NCT00579345|12153647|FG002|Overall Study|Lost to Follow-up|0
7727685|NCT00579345|12153648|FG003|Overall Study|Lost to Follow-up|0
7727686|NCT00579345|12153649|FG004|Overall Study|Lost to Follow-up|0
7727687|NCT00579345|12153650|FG005|Overall Study|Lost to Follow-up|0
7727688|NCT00579345|12153651|FG006|Overall Study|Lost to Follow-up|0
7727689|NCT00579345|12153652|FG007|Overall Study|Lost to Follow-up|0
7727690|NCT00579345|12153645|FG000|Overall Study|Adverse Event|0
7727691|NCT00579345|12153646|FG001|Overall Study|Adverse Event|0
7727692|NCT00579345|12153647|FG002|Overall Study|Adverse Event|1
7727693|NCT00579345|12153648|FG003|Overall Study|Adverse Event|0
7727694|NCT00579345|12153649|FG004|Overall Study|Adverse Event|0
7727695|NCT00579345|12153650|FG005|Overall Study|Adverse Event|0
7727696|NCT00579345|12153651|FG006|Overall Study|Adverse Event|0
7727697|NCT00579345|12153652|FG007|Overall Study|Adverse Event|0
7727698|NCT00579345|12153645|FG000|Overall Study|Protocol Violation|1
7727699|NCT00579345|12153646|FG001|Overall Study|Protocol Violation|0
7727700|NCT00579345|12153647|FG002|Overall Study|Protocol Violation|0
7727701|NCT00579345|12153648|FG003|Overall Study|Protocol Violation|0
7727702|NCT00579345|12153649|FG004|Overall Study|Protocol Violation|0
7727703|NCT00579345|12153650|FG005|Overall Study|Protocol Violation|0
7727704|NCT00579345|12153651|FG006|Overall Study|Protocol Violation|0
7727705|NCT00579345|12153652|FG007|Overall Study|Protocol Violation|1
7727706|NCT00579345|12153645|FG000|Overall Study|Death|1
7727707|NCT00579345|12153646|FG001|Overall Study|Death|1
7727708|NCT00579345|12153647|FG002|Overall Study|Death|1
7727709|NCT00579345|12153648|FG003|Overall Study|Death|1
7727710|NCT00579345|12153649|FG004|Overall Study|Death|0
7727711|NCT00579345|12153650|FG005|Overall Study|Death|0
7727712|NCT00579345|12153651|FG006|Overall Study|Death|0
7727713|NCT00579345|12153652|FG007|Overall Study|Death|0
7727714|NCT00579501|12153689|FG000|Overall Study|Death|1
7727715|NCT00579501|12153689|FG000|Overall Study|End of neoadjuvant therapy|25
7727716|NCT00579501|12153689|FG000|Overall Study|toxicity|1
7727717|NCT00579501|12153689|FG000|Overall Study|Secondary lesion|1
7727718|NCT00579501|12153689|FG000|Overall Study|Radiation therapy before surgery|1
7727719|NCT00579553|12153695|FG000|Overall Study|Lost to Follow-up|16
7727720|NCT00579553|12153696|FG001|Overall Study|Lost to Follow-up|13
7727721|NCT00579670|12153707|FG000|Overall Study|Death|1
7727722|NCT00579670|12153708|FG001|Overall Study|Death|0
7727723|NCT00579670|12153709|FG002|Overall Study|Death|0
7727724|NCT00579670|12153710|FG003|Overall Study|Death|0
7727725|NCT00579670|12153711|FG004|Overall Study|Death|0
7727726|NCT00579670|12153707|FG000|Overall Study|Adverse Event|1
7727727|NCT00579670|12153708|FG001|Overall Study|Adverse Event|0
7727728|NCT00579670|12153709|FG002|Overall Study|Adverse Event|1
7727729|NCT00579670|12153710|FG003|Overall Study|Adverse Event|2
7727730|NCT00579670|12153711|FG004|Overall Study|Adverse Event|0
7727731|NCT00579670|12153707|FG000|Overall Study|Lack of Efficacy|0
7727732|NCT00579670|12153708|FG001|Overall Study|Lack of Efficacy|0
7727733|NCT00579670|12153709|FG002|Overall Study|Lack of Efficacy|1
7727734|NCT00579670|12153710|FG003|Overall Study|Lack of Efficacy|14
7727735|NCT00579670|12153711|FG004|Overall Study|Lack of Efficacy|0
7727736|NCT00579670|12153707|FG000|Overall Study|Lost to Follow-up|0
7727737|NCT00579670|12153708|FG001|Overall Study|Lost to Follow-up|1
7727738|NCT00579670|12153709|FG002|Overall Study|Lost to Follow-up|0
7727739|NCT00579670|12153710|FG003|Overall Study|Lost to Follow-up|4
7727740|NCT00579670|12153711|FG004|Overall Study|Lost to Follow-up|0
7727741|NCT00579670|12153707|FG000|Overall Study|Other|0
7727742|NCT00579670|12153708|FG001|Overall Study|Other|0
7727743|NCT00579670|12153709|FG002|Overall Study|Other|1
7727744|NCT00579670|12153710|FG003|Overall Study|Other|2
7727745|NCT00579670|12153711|FG004|Overall Study|Other|0
7727746|NCT00579670|12153707|FG000|Overall Study|Withdrawal by Subject|0
7727747|NCT00579670|12153708|FG001|Overall Study|Withdrawal by Subject|0
7727748|NCT00579670|12153709|FG002|Overall Study|Withdrawal by Subject|1
7727749|NCT00579670|12153710|FG003|Overall Study|Withdrawal by Subject|0
7727750|NCT00579670|12153711|FG004|Overall Study|Withdrawal by Subject|0
7727751|NCT00579982|12153758|FG000|Overall Study|Adverse Event|4
7727752|NCT00579982|12153758|FG000|Overall Study|Protocol Violation|4
7727753|NCT00580034|12153762|FG000|Overall Study|Toxicity|10
7727754|NCT00580034|12153763|FG001|Overall Study|Toxicity|0
7727755|NCT00580047|12153770|FG000|Overall Study|Lost to Follow-up|1
7727756|NCT00580047|12153771|FG001|Overall Study|Lost to Follow-up|1
7727757|NCT00580047|12153772|FG002|Overall Study|Lost to Follow-up|0
7727758|NCT00580047|12153770|FG000|Overall Study|Withdrawal by Subject|1
7727759|NCT00580047|12153771|FG001|Overall Study|Withdrawal by Subject|1
7727760|NCT00580047|12153772|FG002|Overall Study|Withdrawal by Subject|2
7727761|NCT00580047|12153770|FG000|Overall Study|Withdrawal by Subject|1
7727762|NCT00580047|12153771|FG001|Overall Study|Withdrawal by Subject|0
7727763|NCT00580047|12153772|FG002|Overall Study|Withdrawal by Subject|0
7727764|NCT00580606|12153832|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
7727765|NCT00580606|12153833|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
7727766|NCT00580606|12153832|FG000|Open Label (OL)|Withdrawal by Subject|4
7727767|NCT00580606|12153833|FG001|Open Label (OL)|Withdrawal by Subject|6
7727768|NCT00580606|12153832|FG000|Open Label (OL)|Dosing Symptoms|0
7727769|NCT00580606|12153833|FG001|Open Label (OL)|Dosing Symptoms|1
7727770|NCT00580606|12153832|FG000|Open Label (OL)|Lost to Follow-up|0
7727771|NCT00580606|12153833|FG001|Open Label (OL)|Lost to Follow-up|1
7727772|NCT00580606|12153832|FG000|Open Label (OL)|Pregnancy|0
7727773|NCT00580606|12153833|FG001|Open Label (OL)|Pregnancy|1
7727774|NCT00580606|12153832|FG000|Open Label (OL)|Non-compliance|2
7727775|NCT00580606|12153833|FG001|Open Label (OL)|Non-compliance|0
7727776|NCT00580606|12153832|FG000|Open Label (OL)|Physician Decision|1
7727777|NCT00580606|12153833|FG001|Open Label (OL)|Physician Decision|1
7727778|NCT00580606|12153832|FG000|Open Label (OL)|Needed Prohibited Medication|0
7727779|NCT00580606|12153833|FG001|Open Label (OL)|Needed Prohibited Medication|1
7727780|NCT00580723|12153873|FG000|Overall Study|Did not want to participate in extension|3
7727781|NCT00580723|12153873|FG000|Overall Study|Lost to Follow-up|5
7727782|NCT00580788|12153881|FG000|Overall Study|Adverse Event|0
7727783|NCT00580788|12153882|FG001|Overall Study|Adverse Event|0
7727784|NCT00580788|12153883|FG002|Overall Study|Adverse Event|0
7727785|NCT00580788|12153884|FG003|Overall Study|Adverse Event|1
7727786|NCT00580801|12153904|FG000|Overall Study|Physician Decision|1
7727787|NCT00580801|12153905|FG001|Overall Study|Physician Decision|0
7727788|NCT00580801|12153906|FG002|Overall Study|Physician Decision|0
7727789|NCT00580801|12153904|FG000|Overall Study|Adverse Event|2
7727790|NCT00580801|12153905|FG001|Overall Study|Adverse Event|0
7727791|NCT00580801|12153906|FG002|Overall Study|Adverse Event|0
7727792|NCT00580801|12153904|FG000|Overall Study|Lost to Follow-up|2
7727793|NCT00580801|12153905|FG001|Overall Study|Lost to Follow-up|0
7727794|NCT00580801|12153906|FG002|Overall Study|Lost to Follow-up|0
7727795|NCT00580801|12153904|FG000|Overall Study|Reached a virologic endpoint|0
7727796|NCT00580801|12153905|FG001|Overall Study|Reached a virologic endpoint|1
7727797|NCT00580801|12153906|FG002|Overall Study|Reached a virologic endpoint|2
7727798|NCT00580801|12153904|FG000|Overall Study|Participant non-compliant|0
7727799|NCT00580801|12153905|FG001|Overall Study|Participant non-compliant|0
7727800|NCT00580801|12153906|FG002|Overall Study|Participant non-compliant|1
7727801|NCT00580801|12153904|FG000|Overall Study|Travel|1
7727802|NCT00580801|12153905|FG001|Overall Study|Travel|0
7727803|NCT00580801|12153906|FG002|Overall Study|Travel|0
7727804|NCT00580840|12153914|FG000|Run-in|Adverse Event|17
7727805|NCT00580840|12153915|FG001|Run-in|Adverse Event|0
7727806|NCT00580840|12153916|FG002|Run-in|Adverse Event|0
7727807|NCT00580840|12153917|FG003|Run-in|Adverse Event|0
7727808|NCT00580840|12153914|FG000|Run-in|Lack of Efficacy|93
7727809|NCT00580840|12153915|FG001|Run-in|Lack of Efficacy|0
7727810|NCT00580840|12153916|FG002|Run-in|Lack of Efficacy|0
7727811|NCT00580840|12153917|FG003|Run-in|Lack of Efficacy|0
7727812|NCT00580840|12153914|FG000|Run-in|Loss of Efficacy|1
7727813|NCT00580840|12153915|FG001|Run-in|Loss of Efficacy|0
7727814|NCT00580840|12153916|FG002|Run-in|Loss of Efficacy|0
7727815|NCT00580840|12153917|FG003|Run-in|Loss of Efficacy|0
7727816|NCT00580840|12153914|FG000|Run-in|Lost to Follow-up|4
7727817|NCT00580840|12153915|FG001|Run-in|Lost to Follow-up|0
7727818|NCT00580840|12153916|FG002|Run-in|Lost to Follow-up|0
7727819|NCT00580840|12153917|FG003|Run-in|Lost to Follow-up|0
7727820|NCT00580840|12153914|FG000|Run-in|Withdrawal by Subject|5
7727821|NCT00580840|12153915|FG001|Run-in|Withdrawal by Subject|0
7727822|NCT00580840|12153916|FG002|Run-in|Withdrawal by Subject|0
7727823|NCT00580840|12153917|FG003|Run-in|Withdrawal by Subject|0
7727824|NCT00580840|12153914|FG000|Run-in|Other: Per Sponsor Request|2
7727825|NCT00580840|12153915|FG001|Run-in|Other: Per Sponsor Request|0
7727826|NCT00580840|12153916|FG002|Run-in|Other: Per Sponsor Request|0
7727827|NCT00580840|12153917|FG003|Run-in|Other: Per Sponsor Request|0
7727828|NCT00580840|12153914|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1
7727829|NCT00580840|12153915|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0
7727830|NCT00580840|12153916|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0
7727831|NCT00580840|12153917|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0
7727832|NCT00580840|12153914|FG000|Run-in|Other: Exclusionary Lab Value|1
7727833|NCT00580840|12153915|FG001|Run-in|Other: Exclusionary Lab Value|0
7727834|NCT00580840|12153916|FG002|Run-in|Other: Exclusionary Lab Value|0
7727835|NCT00580840|12153917|FG003|Run-in|Other: Exclusionary Lab Value|0
7727836|NCT00580840|12153914|FG000|Double-Blind|Adverse Event|0
7727837|NCT00580840|12153915|FG001|Double-Blind|Adverse Event|3
7727838|NCT00580840|12153916|FG002|Double-Blind|Adverse Event|4
7727839|NCT00580840|12153917|FG003|Double-Blind|Adverse Event|1
7727840|NCT00580840|12153914|FG000|Double-Blind|Loss of Efficacy|0
7727841|NCT00580840|12153915|FG001|Double-Blind|Loss of Efficacy|1
7727842|NCT00580840|12153916|FG002|Double-Blind|Loss of Efficacy|2
7727843|NCT00580840|12153917|FG003|Double-Blind|Loss of Efficacy|10
7727844|NCT00580840|12153914|FG000|Double-Blind|Lost to Follow-up|0
7727845|NCT00580840|12153915|FG001|Double-Blind|Lost to Follow-up|1
7727846|NCT00580840|12153916|FG002|Double-Blind|Lost to Follow-up|0
7727847|NCT00580840|12153917|FG003|Double-Blind|Lost to Follow-up|2
7727848|NCT00580840|12153914|FG000|Double-Blind|Withdrawal by Subject|0
7727849|NCT00580840|12153915|FG001|Double-Blind|Withdrawal by Subject|1
7727850|NCT00580840|12153916|FG002|Double-Blind|Withdrawal by Subject|2
7727851|NCT00580840|12153917|FG003|Double-Blind|Withdrawal by Subject|2
7727852|NCT00580840|12153914|FG000|Double-Blind|Other: Discontinued Methotrexate|0
7727853|NCT00580840|12153915|FG001|Double-Blind|Other: Discontinued Methotrexate|1
7727854|NCT00580840|12153916|FG002|Double-Blind|Other: Discontinued Methotrexate|0
7727855|NCT00580840|12153917|FG003|Double-Blind|Other: Discontinued Methotrexate|0
7727856|NCT00580840|12153914|FG000|Double-Blind|Other: Forbidden Medication|0
7727857|NCT00580840|12153915|FG001|Double-Blind|Other: Forbidden Medication|0
7727858|NCT00580840|12153916|FG002|Double-Blind|Other: Forbidden Medication|1
7727859|NCT00580840|12153917|FG003|Double-Blind|Other: Forbidden Medication|0
7727860|NCT00580866|12153942|FG000|Overall Study|Lost to Follow-up|2
7727861|NCT00580866|12153943|FG001|Overall Study|Lost to Follow-up|2
7727862|NCT00580970|12153960|FG000|Pre-treatment|Non-compliance|1
7727863|NCT00580970|12153960|FG000|Treatment (Lovastatin)|Non-compliance|6
7727864|NCT00580970|12153960|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7
7727865|NCT00580970|12153960|FG000|Treatment (Lovastatin)|Physician Decision|4
7727866|NCT00580970|12153960|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1
7727867|NCT00580970|12153960|FG000|Treatment (Lovastatin)|Death|1
7727868|NCT00580983|12153964|FG000|Overall Study|Did not complete 12 mon post RT studies|7
7727869|NCT00581100|12153981|FG000|Overall Study|Death|1
7727870|NCT00581100|12153982|FG001|Overall Study|Death|0
7727871|NCT00581100|12153981|FG000|Overall Study|Adverse Event|2
7727872|NCT00581100|12153982|FG001|Overall Study|Adverse Event|1
7727873|NCT00581100|12153981|FG000|Overall Study|Withdrawal by Subject|1
7727874|NCT00581100|12153982|FG001|Overall Study|Withdrawal by Subject|4
7727875|NCT00581100|12153981|FG000|Overall Study|Other|3
7727876|NCT00581100|12153982|FG001|Overall Study|Other|0
7727877|NCT00581308|12154004|FG000|Pre Discharge|Lost to Follow-up|1
7727878|NCT00581308|12154004|FG000|Pre Discharge|Device Removed|1
7727879|NCT00581308|12154004|FG000|Month 1|Lost to Follow-up|3
7727880|NCT00581308|12154004|FG000|Month 1|Withdrawal by Subject|2
7727881|NCT00581308|12154004|FG000|Month 1|Device Removed|2
7727882|NCT00581308|12154004|FG000|Month 1|Uknown|1
7727883|NCT00581308|12154004|FG000|Month 6|Lost to Follow-up|1
7727884|NCT00581308|12154004|FG000|Month 6|Withdrawal by Subject|2
7727885|NCT00581308|12154004|FG000|Month 12|Death|1
7727886|NCT00581308|12154004|FG000|Month 12|Lost to Follow-up|14
7727887|NCT00581308|12154004|FG000|Month 12|Withdrawal by Subject|3
7727888|NCT00581308|12154004|FG000|Month 12|Device Removed|1
7727889|NCT00581308|12154004|FG000|Month 12|Other|1
7727890|NCT00581360|12154020|FG000|Overall Study|Withdrawal by Subject|1
7727891|NCT00581542|12154052|FG000|Overall Study|they met an exclusion criteria|2
7727892|NCT00581542|12154053|FG001|Overall Study|they met an exclusion criteria|2
7727893|NCT00581542|12154052|FG000|Overall Study|Lost to Follow-up|9
7727894|NCT00581542|12154053|FG001|Overall Study|Lost to Follow-up|21
7727895|NCT00581555|12154063|FG000|Overall Study|Adverse Event|4
7727896|NCT00581555|12154064|FG001|Overall Study|Adverse Event|3
7727897|NCT00581555|12154063|FG000|Overall Study|Physician Decision|3
7727898|NCT00581555|12154064|FG001|Overall Study|Physician Decision|2
7727899|NCT00581555|12154063|FG000|Overall Study|Withdrawal by Subject|18
7727900|NCT00581555|12154064|FG001|Overall Study|Withdrawal by Subject|9
7727901|NCT00581555|12154063|FG000|Overall Study|Lost to Follow-up|2
7727902|NCT00581555|12154064|FG001|Overall Study|Lost to Follow-up|2
7727903|NCT00581555|12154063|FG000|Overall Study|Other reasons|16
7727904|NCT00581555|12154064|FG001|Overall Study|Other reasons|4
7727905|NCT00581776|12154079|FG000|Overall Study|Disease progression or no response|3
7727906|NCT00581828|12154083|FG000|Overall Study|Protocol Violation|1
7727907|NCT00581893|12154098|FG000|Second Intervention (1 Month)|Lost to Follow-up|3
7727908|NCT00581893|12154099|FG001|Second Intervention (1 Month)|Lost to Follow-up|2
7727909|NCT00581919|12154105|FG000|Overall Study|Adverse Event|8
7727910|NCT00581919|12154105|FG000|Overall Study|Death|1
7727911|NCT00581919|12154105|FG000|Overall Study|Disease Progression|10
7727912|NCT00581919|12154105|FG000|Overall Study|Physician Decision|1
7727913|NCT00581919|12154105|FG000|Overall Study|Other Complicating Disease|1
7727914|NCT00581919|12154105|FG000|Overall Study|Started Non-Protocol Therapy|2
7727915|NCT00581919|12154105|FG000|Overall Study|Withdrawal by Subject|1
7727916|NCT00581945|12154112|FG000|Overall Study|Adverse Event|4
7727917|NCT00581945|12154113|FG001|Overall Study|Adverse Event|4
7727918|NCT00581945|12154112|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7727919|NCT00581945|12154113|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7727920|NCT00581945|12154112|FG000|Overall Study|Withdrawal by Subject|2
7727921|NCT00581945|12154113|FG001|Overall Study|Withdrawal by Subject|6
7727922|NCT00581945|12154112|FG000|Overall Study|Death|1
7727923|NCT00581945|12154113|FG001|Overall Study|Death|0
7727924|NCT00582010|12154126|FG000|Overall Study|Death|0
7727925|NCT00582010|12154127|FG001|Overall Study|Death|1
7727926|NCT00582114|12154139|FG000|Overall Study|Death|4
7727927|NCT00582114|12154140|FG001|Overall Study|Death|4
7727928|NCT00582114|12154139|FG000|Overall Study|Kidney Transplant|3
7727929|NCT00582114|12154140|FG001|Overall Study|Kidney Transplant|1
7727930|NCT00582114|12154139|FG000|Overall Study|Lost to Follow-up|7
7727931|NCT00582114|12154140|FG001|Overall Study|Lost to Follow-up|6
7727932|NCT00582114|12154139|FG000|Overall Study|Withdrawal by Subject|8
7727933|NCT00582114|12154140|FG001|Overall Study|Withdrawal by Subject|16
7727934|NCT00582114|12154139|FG000|Overall Study|Adverse Event|1
7727935|NCT00582114|12154140|FG001|Overall Study|Adverse Event|1
7727936|NCT00582114|12154139|FG000|Overall Study|Physician Decision|0
7727937|NCT00582114|12154140|FG001|Overall Study|Physician Decision|6
7727938|NCT00582114|12154139|FG000|Overall Study|Stopped by data safety monitoring board|19
7727939|NCT00582114|12154140|FG001|Overall Study|Stopped by data safety monitoring board|20
7727940|NCT00582166|12154146|FG000|Overall Study|Death|1
7727941|NCT00582166|12154146|FG000|Overall Study|Ineligible pathology|1
7727942|NCT00582309|12154157|FG000|Overall Study|Protocol Violation|0
7727943|NCT00582309|12154158|FG001|Overall Study|Protocol Violation|0
7727944|NCT00582309|12154159|FG002|Overall Study|Protocol Violation|2
7727945|NCT00582426|12154182|FG000|Overall Study|Lost to Follow-up|0
7727946|NCT00582426|12154183|FG001|Overall Study|Lost to Follow-up|2
7727947|NCT00582426|12154182|FG000|Overall Study|Adverse Event|4
7727948|NCT00582426|12154183|FG001|Overall Study|Adverse Event|2
7727949|NCT00582426|12154182|FG000|Overall Study|Protocol Violation|6
7727950|NCT00582426|12154183|FG001|Overall Study|Protocol Violation|2
7727951|NCT00582426|12154182|FG000|Overall Study|Death|4
7727952|NCT00582426|12154183|FG001|Overall Study|Death|3
7727953|NCT00582426|12154182|FG000|Overall Study|Withdrawal by Subject|3
7727954|NCT00582426|12154183|FG001|Overall Study|Withdrawal by Subject|2
7727955|NCT00582426|12154182|FG000|Overall Study|Disease Progression|2
7727956|NCT00582426|12154183|FG001|Overall Study|Disease Progression|2
7727957|NCT00582426|12154182|FG000|Overall Study|Use of illicit drugs|1
7727958|NCT00582426|12154183|FG001|Overall Study|Use of illicit drugs|0
7727959|NCT00582491|12154191|FG000|Overall Study|Withdrawal by Subject|1
7727960|NCT00582491|12154192|FG001|Overall Study|Withdrawal by Subject|0
7727961|NCT00582556|12154210|FG000|Overall Study|Withdrawal by Subject|0
7727962|NCT00582556|12154211|FG001|Overall Study|Withdrawal by Subject|1
7727963|NCT00582556|12154212|FG002|Overall Study|Withdrawal by Subject|1
7727964|NCT00582556|12154210|FG000|Overall Study|Physician Decision|0
7727965|NCT00582556|12154211|FG001|Overall Study|Physician Decision|0
7727966|NCT00582556|12154212|FG002|Overall Study|Physician Decision|1
7727967|NCT00582608|12154221|FG000|Overall Study|Not Treated|7
7727968|NCT00582608|12154221|FG000|Overall Study|Patient Ineligible|1
7727969|NCT00582608|12154221|FG000|Overall Study|Lack of accrual|4
7727970|NCT00582738|12154236|FG000|Overall Study|Administrative Problems|7
7727971|NCT00582738|12154237|FG001|Overall Study|Administrative Problems|8
7727972|NCT00582738|12154236|FG000|Overall Study|Adverse Event|0
7727973|NCT00582738|12154237|FG001|Overall Study|Adverse Event|5
7727974|NCT00582738|12154236|FG000|Overall Study|Graft Lost|0
7727975|NCT00582738|12154237|FG001|Overall Study|Graft Lost|1
7727976|NCT00582738|12154236|FG000|Overall Study|Other|1
7727977|NCT00582738|12154237|FG001|Overall Study|Other|0
7727978|NCT00582738|12154236|FG000|Overall Study|Protocol Violation|1
7727979|NCT00582738|12154237|FG001|Overall Study|Protocol Violation|1
7727980|NCT00582738|12154236|FG000|Overall Study|Withdrawal by Subject|0
7727981|NCT00582738|12154237|FG001|Overall Study|Withdrawal by Subject|3
7727982|NCT00582790|12154249|FG000|Overall Study|Rapid progression of disease|1
7727983|NCT00582816|12154254|FG000|Overall Study|Engraftment Failure|3
7727984|NCT00582907|12154262|FG000|1st Course|Withdrawal by Subject|1
7727985|NCT00582907|12154263|FG001|1st Course|Withdrawal by Subject|0
7727986|NCT00582907|12154264|FG002|1st Course|Withdrawal by Subject|0
7727987|NCT00582907|12154265|FG003|1st Course|Withdrawal by Subject|0
7727988|NCT00582907|12154262|FG000|1st Course|Lost to Follow-up|0
7727989|NCT00582907|12154263|FG001|1st Course|Lost to Follow-up|0
7727990|NCT00582907|12154264|FG002|1st Course|Lost to Follow-up|0
7727991|NCT00582907|12154265|FG003|1st Course|Lost to Follow-up|1
7727992|NCT00582907|12154262|FG000|2nd Course|Lack of Efficacy|1
7727993|NCT00582907|12154263|FG001|2nd Course|Lack of Efficacy|0
7727994|NCT00582907|12154264|FG002|2nd Course|Lack of Efficacy|0
7727995|NCT00582907|12154265|FG003|2nd Course|Lack of Efficacy|0
7727996|NCT00582933|12154271|FG000|Overall Study|Physician Decision|3
7727997|NCT00582972|12154279|FG000|Overall Study|Protocol Violation|2
7727998|NCT00583102|12154307|FG000|Overall Study|Adverse Event|3
7727999|NCT00583219|12154311|FG000|Phase 2|Withdrawal by Subject|1
7728000|NCT00583362|12154315|FG000|Overall Study|Adverse Event|44
7728001|NCT00583362|12154315|FG000|Overall Study|Lack of Efficacy|22
7728002|NCT00583362|12154315|FG000|Overall Study|Lost to Follow-up|4
7728003|NCT00583362|12154315|FG000|Overall Study|Non-compliance with study drug|28
7728004|NCT00583362|12154315|FG000|Overall Study|Pregnancy|7
7728005|NCT00583362|12154315|FG000|Overall Study|Miscommunication of visit window|5
7728006|NCT00583362|12154315|FG000|Overall Study|Current site closed|7
7728007|NCT00583362|12154315|FG000|Overall Study|Subject not dosed in LBSL99|1
7728008|NCT00583362|12154315|FG000|Overall Study|Subject moved out of the country/state|2
7728009|NCT00583362|12154315|FG000|Overall Study|Missed visits due to staff changes|1
7728010|NCT00583362|12154315|FG000|Overall Study|Misunderstanding of protocol|1
7728011|NCT00583362|12154315|FG000|Overall Study|Behavioral problems and non-compliance|1
7728012|NCT00583362|12154315|FG000|Overall Study|Sponsor request due to missed doses|1
7728013|NCT00583362|12154315|FG000|Overall Study|Physician Decision|19
7728014|NCT00583362|12154315|FG000|Overall Study|Protocol Violation|2
7728015|NCT00583362|12154315|FG000|Overall Study|Withdrawal by Subject|57
7728016|NCT00583453|12154334|FG000|Overall Study|discontinued intervention|0
7728017|NCT00583453|12154335|FG001|Overall Study|discontinued intervention|2
7728018|NCT00583557|12154352|FG000|Overall Study|Withdrawal by Subject|18
7728019|NCT00583557|12154352|FG000|Overall Study|Adverse Event|9
7728020|NCT00583557|12154352|FG000|Overall Study|Lack of Efficacy|31
7728021|NCT00583557|12154352|FG000|Overall Study|Lack of Compliance|5
7728022|NCT00583557|12154352|FG000|Overall Study|Other|5
7728023|NCT00583557|12154352|FG000|Overall Study|Did not receive belimumab in LBRA99|2
7728024|NCT00583596|12154356|FG000|Overall Study|Lost to Follow-up|110
7728025|NCT00583596|12154356|FG000|Overall Study|Excluded due to Hurricane Katrina|30
7728026|NCT00583596|12154356|FG000|Overall Study|Death|2
7728027|NCT00583596|12154356|FG000|Overall Study|Withdrawal by Subject|6
7728028|NCT00583596|12154356|FG000|Overall Study|Lost to Follow-up|94
7728029|NCT00583596|12154356|FG000|Overall Study|Data not complete|1
7728030|NCT00583596|12154356|FG000|Overall Study|Not consented|15
7728031|NCT00583596|12154356|FG000|Overall Study|Outside f-up window|26
7728032|NCT00583791|12154392|FG000|Overall Study|Other|67
7728033|NCT00583791|12154392|FG000|Overall Study|Death|6
7728034|NCT00583947|12154427|FG000|Cross-over Period|Adverse Event|2
7728035|NCT00583947|12154428|FG001|Cross-over Period|Adverse Event|0
7728036|NCT00583947|12154427|FG000|Cross-over Period|Withdrawal by Subject|2
7728037|NCT00583947|12154428|FG001|Cross-over Period|Withdrawal by Subject|0
7728038|NCT00583947|12154427|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0
7728039|NCT00583947|12154428|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1
7728040|NCT00583947|12154427|FG000|Cross-over Period|Other|1
7728041|NCT00583947|12154428|FG001|Cross-over Period|Other|1
7728042|NCT00584194|12154441|FG000|Overall Study|Other|135
7768281|NCT00858637|12211236|FG005|Placebo-controlled Withdrawal Phase|Death|0
7768282|NCT00858637|12211231|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
7768283|NCT00858637|12211232|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
7768284|NCT00858637|12211233|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
7768285|NCT00858637|12211234|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
7768286|NCT00858637|12211235|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
7768287|NCT00858637|12211236|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
7768288|NCT00858780|12211250|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
7768289|NCT00858780|12211251|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
7768290|NCT00858780|12211252|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
7768291|NCT00858780|12211253|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
7768292|NCT00858780|12211254|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
7768293|NCT00858780|12211250|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
7768294|NCT00858780|12211251|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
7768295|NCT00858780|12211252|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
7768296|NCT00858780|12211253|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
7768297|NCT00858780|12211254|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
7768298|NCT00858780|12211250|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
7768299|NCT00858780|12211251|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
7768300|NCT00858780|12211252|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
7768301|NCT00858780|12211253|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
7768302|NCT00858780|12211254|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
7768303|NCT00858780|12211250|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0
7768304|NCT00858780|12211251|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1
7768305|NCT00858780|12211252|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0
7768306|NCT00858780|12211253|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0
7768307|NCT00858780|12211254|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0
7768308|NCT00858780|12211250|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
7768309|NCT00858780|12211251|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
7768310|NCT00858780|12211252|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
7768311|NCT00858780|12211253|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
7768312|NCT00858780|12211254|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
7768313|NCT00858780|12211250|FG000|OL Re-Treatment (Failure to Week 48)|Other|0
7768314|NCT00858780|12211251|FG001|OL Re-Treatment (Failure to Week 48)|Other|0
7768315|NCT00858780|12211252|FG002|OL Re-Treatment (Failure to Week 48)|Other|0
7768316|NCT00858780|12211253|FG003|OL Re-Treatment (Failure to Week 48)|Other|0
7768317|NCT00858780|12211254|FG004|OL Re-Treatment (Failure to Week 48)|Other|1
7768318|NCT00858832|12211266|FG000|Overall Study|became ineligible: delivered vaginally|1
7768319|NCT00858832|12211267|FG001|Overall Study|became ineligible: delivered vaginally|0
7768320|NCT00858832|12211266|FG000|Overall Study|Adverse Event|0
7768321|NCT00858832|12211267|FG001|Overall Study|Adverse Event|1
7768322|NCT00858845|12211275|FG000|Overall Study|Patient underwent heart transplant.|0
7768323|NCT00858845|12211276|FG001|Overall Study|Patient underwent heart transplant.|1
7768324|NCT00858988|12211292|FG000|Analysis|Lactulose unable to be detected in urine|2
7768325|NCT00858988|12211293|FG001|Analysis|Lactulose unable to be detected in urine|1
7768326|NCT00859014|12211299|FG000|Overall Study|Death|4
7768327|NCT00859014|12211299|FG000|Overall Study|Lost to Follow-up|1
7768328|NCT00859222|12211350|FG000|Overall Study|Adverse Event|2
7768329|NCT00859222|12211351|FG001|Overall Study|Adverse Event|3
7768330|NCT00859222|12211352|FG002|Overall Study|Adverse Event|6
7768331|NCT00859222|12211353|FG003|Overall Study|Adverse Event|24
7768332|NCT00859222|12211354|FG004|Overall Study|Adverse Event|15
7728043|NCT00584415|12154460|FG000|Overall Study|Adverse Event|7
7728044|NCT00584454|12154465|FG000|Overall Study|Adverse Event|1
7728045|NCT00584454|12154465|FG000|Overall Study|Relocation|1
7728046|NCT00584454|12154465|FG000|Overall Study|Clinical Hold|2
7728047|NCT00584727|12154483|FG000|First Intervention|Discontinuation|0
7728048|NCT00584727|12154484|FG001|First Intervention|Discontinuation|0
7728049|NCT00584727|12154485|FG002|First Intervention|Discontinuation|1
7728050|NCT00584727|12154486|FG003|First Intervention|Discontinuation|0
7728051|NCT00584727|12154487|FG004|First Intervention|Discontinuation|0
7728052|NCT00584727|12154488|FG005|First Intervention|Discontinuation|0
7728053|NCT00584727|12154483|FG000|Third Intervention|Protocol Violation|0
7728054|NCT00584727|12154484|FG001|Third Intervention|Protocol Violation|0
7728055|NCT00584727|12154485|FG002|Third Intervention|Protocol Violation|1
7728056|NCT00584727|12154486|FG003|Third Intervention|Protocol Violation|0
7728057|NCT00584727|12154487|FG004|Third Intervention|Protocol Violation|4
7728058|NCT00584727|12154488|FG005|Third Intervention|Protocol Violation|2
7728059|NCT00584740|12154501|FG000|Overall Study|Adverse Event|1
7728060|NCT00584740|12154502|FG001|Overall Study|Adverse Event|1
7728061|NCT00584740|12154501|FG000|Overall Study|Lack of Efficacy|8
7728062|NCT00584740|12154502|FG001|Overall Study|Lack of Efficacy|2
7728063|NCT00584740|12154501|FG000|Overall Study|Withdrawal by Subject|3
7728064|NCT00584740|12154502|FG001|Overall Study|Withdrawal by Subject|2
7728065|NCT00584740|12154501|FG000|Overall Study|Lost to Follow-up|0
7728066|NCT00584740|12154502|FG001|Overall Study|Lost to Follow-up|1
7728067|NCT00584805|12154508|FG000|Overall Study|No longer at risk of exposure|39
7728068|NCT00584805|12154508|FG000|Overall Study|Relocation|36
7728069|NCT00584805|12154508|FG000|Overall Study|Withdrawal by Subject|18
7728070|NCT00584805|12154508|FG000|Overall Study|Non-compliance|1
7728071|NCT00584805|12154508|FG000|Overall Study|Lost to follow up|3
7728072|NCT00584805|12154508|FG000|Overall Study|Screen failures|2
7728073|NCT00584844|12154542|FG000|Overall Study|Withdrawal by Subject|59
7728074|NCT00584844|12154542|FG000|Overall Study|Screen Failure|20
7728075|NCT00584870|12154557|FG000|Overall Study|Adverse Event|4
7728076|NCT00584870|12154558|FG001|Overall Study|Adverse Event|3
7728077|NCT00584870|12154559|FG002|Overall Study|Adverse Event|2
7728078|NCT00584870|12154557|FG000|Overall Study|Lost to Follow-up|4
7728079|NCT00584870|12154558|FG001|Overall Study|Lost to Follow-up|1
7728080|NCT00584870|12154559|FG002|Overall Study|Lost to Follow-up|1
7728081|NCT00584870|12154557|FG000|Overall Study|Lack of Efficacy|7
7728082|NCT00584870|12154558|FG001|Overall Study|Lack of Efficacy|14
7728083|NCT00584870|12154559|FG002|Overall Study|Lack of Efficacy|8
7728084|NCT00584870|12154557|FG000|Overall Study|Withdrawal by Subject|10
7728085|NCT00584870|12154558|FG001|Overall Study|Withdrawal by Subject|5
7728086|NCT00584870|12154559|FG002|Overall Study|Withdrawal by Subject|3
7728087|NCT00584870|12154557|FG000|Overall Study|Protocol Violation|1
7728088|NCT00584870|12154558|FG001|Overall Study|Protocol Violation|1
7728089|NCT00584870|12154559|FG002|Overall Study|Protocol Violation|2
7728090|NCT00584870|12154557|FG000|Overall Study|Did not met entrance criteria|1
7728091|NCT00584870|12154558|FG001|Overall Study|Did not met entrance criteria|0
7728092|NCT00584870|12154559|FG002|Overall Study|Did not met entrance criteria|0
7728093|NCT00584870|12154557|FG000|Overall Study|Other|2
7728094|NCT00584870|12154558|FG001|Overall Study|Other|0
7728095|NCT00584870|12154559|FG002|Overall Study|Other|0
7728096|NCT00584870|12154557|FG000|Overall Study|Randomized but not treated|0
7728097|NCT00584870|12154558|FG001|Overall Study|Randomized but not treated|1
7728098|NCT00584870|12154559|FG002|Overall Study|Randomized but not treated|2
7728099|NCT00584909|12154567|FG000|Overall Study|Adverse Event|4
7728100|NCT00584987|12154588|FG000|Overall Study|Protocol Violation|1
7728101|NCT00584987|12154589|FG001|Overall Study|Protocol Violation|1
7728102|NCT00584987|12154590|FG002|Overall Study|Protocol Violation|1
7728103|NCT00584987|12154591|FG003|Overall Study|Protocol Violation|0
7728104|NCT00584987|12154588|FG000|Overall Study|Adverse Event|0
7728105|NCT00584987|12154589|FG001|Overall Study|Adverse Event|0
7728106|NCT00584987|12154590|FG002|Overall Study|Adverse Event|0
7728107|NCT00584987|12154591|FG003|Overall Study|Adverse Event|1
7728108|NCT00585039|12154614|FG000|Overall Study|medication spilled|2
7728109|NCT00585039|12154615|FG001|Overall Study|medication spilled|0
7728110|NCT00585052|12154623|FG000|Overall Study|Withdrawal by Subject|1
7728111|NCT00585078|12154627|FG000|Overall Study|Withdrawal by Subject|4
7728112|NCT00585078|12154627|FG000|Overall Study|Poor performance status|1
7728113|NCT00585078|12154627|FG000|Overall Study|Disease Progression|24
7728114|NCT00585078|12154627|FG000|Overall Study|Adverse Event|10
7728115|NCT00585078|12154627|FG000|Overall Study|Death|1
7728116|NCT00585169|12154635|FG000|Overall Study|Withdrawal by Subject|1
7728117|NCT00585286|12154654|FG000|Overall Study|Lost to Follow-up|1
7728118|NCT00585312|12154660|FG000|Overall Study|Adverse Event|3
7728119|NCT00585312|12154661|FG001|Overall Study|Adverse Event|0
7728120|NCT00585312|12154660|FG000|Overall Study|Lack of Efficacy|6
7728121|NCT00585312|12154661|FG001|Overall Study|Lack of Efficacy|11
7728122|NCT00585312|12154660|FG000|Overall Study|Lost to Follow-up|1
7728123|NCT00585312|12154661|FG001|Overall Study|Lost to Follow-up|1
7728124|NCT00585312|12154660|FG000|Overall Study|Reason not specified|2
7728125|NCT00585312|12154661|FG001|Overall Study|Reason not specified|0
7728126|NCT00585312|12154660|FG000|Overall Study|Withdrawal by Subject|5
7728127|NCT00585312|12154661|FG001|Overall Study|Withdrawal by Subject|1
7728128|NCT00585312|12154660|FG000|Overall Study|Study terminated by the sponsor|34
7728129|NCT00585312|12154661|FG001|Overall Study|Study terminated by the sponsor|31
7728130|NCT00585325|12154669|FG000|Overall Study|Withdrawal by Subject|1
7728131|NCT00585325|12154670|FG001|Overall Study|Withdrawal by Subject|1
7728132|NCT00585351|12154682|FG000|Notification Period (Informed Consent)|Physician Decision|0
7728133|NCT00585351|12154683|FG001|Notification Period (Informed Consent)|Physician Decision|2
7728134|NCT00585351|12154684|FG002|Notification Period (Informed Consent)|Physician Decision|0
7728135|NCT00585351|12154685|FG003|Notification Period (Informed Consent)|Physician Decision|0
7728136|NCT00585351|12154686|FG004|Notification Period (Informed Consent)|Physician Decision|0
7728137|NCT00585351|12154687|FG005|Notification Period (Informed Consent)|Physician Decision|0
7728138|NCT00585351|12154688|FG006|Notification Period (Informed Consent)|Physician Decision|0
7728139|NCT00585351|12154689|FG007|Notification Period (Informed Consent)|Physician Decision|0
7728140|NCT00585351|12154682|FG000|Notification Period (Informed Consent)|Flight aborted|2
7728141|NCT00585351|12154683|FG001|Notification Period (Informed Consent)|Flight aborted|1
7728142|NCT00585351|12154684|FG002|Notification Period (Informed Consent)|Flight aborted|0
7728143|NCT00585351|12154685|FG003|Notification Period (Informed Consent)|Flight aborted|0
7728144|NCT00585351|12154686|FG004|Notification Period (Informed Consent)|Flight aborted|0
7728145|NCT00585351|12154687|FG005|Notification Period (Informed Consent)|Flight aborted|0
7728146|NCT00585351|12154688|FG006|Notification Period (Informed Consent)|Flight aborted|0
7728147|NCT00585351|12154689|FG007|Notification Period (Informed Consent)|Flight aborted|0
7728148|NCT00585351|12154682|FG000|Notification Period (Informed Consent)|No study medication on flight|0
7728149|NCT00585351|12154683|FG001|Notification Period (Informed Consent)|No study medication on flight|1
7728150|NCT00585351|12154684|FG002|Notification Period (Informed Consent)|No study medication on flight|0
7728151|NCT00585351|12154685|FG003|Notification Period (Informed Consent)|No study medication on flight|0
7728152|NCT00585351|12154686|FG004|Notification Period (Informed Consent)|No study medication on flight|0
7728153|NCT00585351|12154687|FG005|Notification Period (Informed Consent)|No study medication on flight|0
7728154|NCT00585351|12154688|FG006|Notification Period (Informed Consent)|No study medication on flight|0
7728155|NCT00585351|12154689|FG007|Notification Period (Informed Consent)|No study medication on flight|0
7728156|NCT00585351|12154682|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
7728157|NCT00585351|12154683|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
7728158|NCT00585351|12154684|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7728159|NCT00585351|12154685|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7728160|NCT00585351|12154686|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7728161|NCT00585351|12154687|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7728162|NCT00585351|12154688|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7728163|NCT00585351|12154689|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7728164|NCT00585351|12154682|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0
7728165|NCT00585351|12154683|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0
7728166|NCT00585351|12154684|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0
7728167|NCT00585351|12154685|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0
7728168|NCT00585351|12154686|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0
7728169|NCT00585351|12154687|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0
7728170|NCT00585351|12154688|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1
7728171|NCT00585351|12154689|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1
7728172|NCT00585351|12154682|FG000|Enrollment Period (Intervention)|Death|0
7728173|NCT00585351|12154683|FG001|Enrollment Period (Intervention)|Death|0
7728174|NCT00585351|12154684|FG002|Enrollment Period (Intervention)|Death|0
7728175|NCT00585351|12154685|FG003|Enrollment Period (Intervention)|Death|0
7728176|NCT00585351|12154686|FG004|Enrollment Period (Intervention)|Death|1
7728177|NCT00585351|12154687|FG005|Enrollment Period (Intervention)|Death|0
7728178|NCT00585351|12154688|FG006|Enrollment Period (Intervention)|Death|1
7728179|NCT00585351|12154689|FG007|Enrollment Period (Intervention)|Death|0
7728180|NCT00585351|12154682|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7728181|NCT00585351|12154683|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7728182|NCT00585351|12154684|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7728183|NCT00585351|12154685|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7728184|NCT00585351|12154686|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1
7728185|NCT00585351|12154687|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2
7728186|NCT00585351|12154688|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7728187|NCT00585351|12154689|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7728188|NCT00585468|12154707|FG000|First Intervention|Withdrawal by Subject|1
7728189|NCT00585468|12154708|FG001|First Intervention|Withdrawal by Subject|1
7728190|NCT00585533|12154720|FG000|Overall Study|objective or symptomatic progression|9
7728191|NCT00585546|12154724|FG000|Clenbuterol Treatment - up to 12 Months|Death|1
7728192|NCT00585546|12154724|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
7728193|NCT00585689|12154754|FG000|Overall Study|Received different ABI-007 schedule|3
7728194|NCT00585689|12154754|FG000|Overall Study|Adverse Event|1
7728195|NCT00585689|12154754|FG000|Overall Study|Patient Declined Surgery|1
7728196|NCT00585689|12154754|FG000|Overall Study|Patient had unresectable disease|1
7728197|NCT00585689|12154754|FG000|Overall Study|Death|1
7728198|NCT00585923|12154795|FG000|Overall Study|Physician decided not to continue|31
7728199|NCT00585923|12154796|FG001|Overall Study|Physician decided not to continue|33
7728200|NCT00585975|12154804|FG000|Overall Study|Withdrawal by Subject|3
7728201|NCT00585975|12154805|FG001|Overall Study|Withdrawal by Subject|3
7728202|NCT00585975|12154804|FG000|Overall Study|Lost to Follow-up|2
7728203|NCT00585975|12154805|FG001|Overall Study|Lost to Follow-up|1
7728204|NCT00585975|12154804|FG000|Overall Study|Enrollment met/over-enrolled|10
7728205|NCT00585975|12154805|FG001|Overall Study|Enrollment met/over-enrolled|9
7728206|NCT00586066|12154823|FG000|Overall Study|Lost to Follow-up|6
7728207|NCT00586066|12154824|FG001|Overall Study|Lost to Follow-up|3
7728208|NCT00586066|12154823|FG000|Overall Study|Lack of Efficacy|5
7728209|NCT00586066|12154824|FG001|Overall Study|Lack of Efficacy|3
7728210|NCT00586066|12154823|FG000|Overall Study|Adverse Event|2
7728211|NCT00586066|12154824|FG001|Overall Study|Adverse Event|2
7728212|NCT00586066|12154823|FG000|Overall Study|Physician Decision|1
7728213|NCT00586066|12154824|FG001|Overall Study|Physician Decision|0
7728214|NCT00586066|12154823|FG000|Overall Study|Withdrawal of consent|4
7728215|NCT00586066|12154824|FG001|Overall Study|Withdrawal of consent|2
7728216|NCT00586105|12154830|FG000|Overall Study|Adverse Event|4
7728217|NCT00586105|12154830|FG000|Overall Study|Death|2
7728218|NCT00586105|12154830|FG000|Overall Study|Protocol Violation|1
7728219|NCT00586105|12154830|FG000|Overall Study|Withdrawal by Subject|3
7728220|NCT00586105|12154830|FG000|Overall Study|Disease progression|19
7728221|NCT00586105|12154830|FG000|Overall Study|Switched to commercial drug|9
7728222|NCT00586105|12154830|FG000|Overall Study|Reason not reported|1
7728223|NCT00586157|12154834|FG000|First Intervention|Worsening behavior|1
7728224|NCT00586157|12154835|FG001|First Intervention|Worsening behavior|0
7728225|NCT00586157|12154834|FG000|Second Intervention|Withdrawal by Subject|1
7728226|NCT00586157|12154835|FG001|Second Intervention|Withdrawal by Subject|0
7728227|NCT00586157|12154834|FG000|Second Intervention|Worsening behavior|1
7728228|NCT00586157|12154835|FG001|Second Intervention|Worsening behavior|0
7728229|NCT00586157|12154834|FG000|Second Intervention|Adverse Event|0
7728230|NCT00586157|12154835|FG001|Second Intervention|Adverse Event|1
7728231|NCT00586313|12154868|FG000|Overall Study|Lack of Efficacy|2
7728232|NCT00586326|12154872|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6
7728233|NCT00586326|12154872|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
7728234|NCT00586326|12154872|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2
7728235|NCT00586326|12154872|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1
7728236|NCT00586326|12154872|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
7728237|NCT00586326|12154872|FG000|Enrollment to Device Placement-Enrolled|Other|1
7728238|NCT00586326|12154872|FG000|Device Placed toTreatment-ITT|Skin Distance|7
7728239|NCT00586326|12154872|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6
7728240|NCT00586326|12154872|FG000|Device Placed toTreatment-ITT|Microinvasion|1
7728241|NCT00586326|12154872|FG000|Device Placed toTreatment-ITT|Positive Margins|3
7728242|NCT00586326|12154872|FG000|Device Placed toTreatment-ITT|Physician Decision|1
7728243|NCT00586326|12154872|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
7728244|NCT00586326|12154872|FG000|Treated Through 5-yr Follow Up-Treated|Death|2
7728245|NCT00586326|12154872|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
7728246|NCT00586326|12154872|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
7728247|NCT00586326|12154872|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
7728248|NCT00586326|12154872|FG000|Treated Through 5-yr Follow Up-Treated|Other|2
7728249|NCT00586339|12154883|FG000|Overall Study|Withdrawal by Subject|1
7728250|NCT00586339|12154884|FG001|Overall Study|Withdrawal by Subject|3
7728251|NCT00586339|12154885|FG002|Overall Study|Withdrawal by Subject|1
7728252|NCT00586339|12154883|FG000|Overall Study|Migrated/moved from study area|3
7728253|NCT00586339|12154884|FG001|Overall Study|Migrated/moved from study area|2
7728254|NCT00586339|12154885|FG002|Overall Study|Migrated/moved from study area|4
7728255|NCT00586339|12154883|FG000|Overall Study|Lost to Follow-up|3
7728256|NCT00586339|12154884|FG001|Overall Study|Lost to Follow-up|2
7728257|NCT00586339|12154885|FG002|Overall Study|Lost to Follow-up|1
7728258|NCT00586469|12154895|FG000|Overall Study|Adverse Event|0
7728259|NCT00586469|12154896|FG001|Overall Study|Adverse Event|1
7728260|NCT00586495|12154911|FG000|Treatment Period|Adverse Event|11
7728261|NCT00586495|12154911|FG000|Treatment Period|Death|1
7728262|NCT00586495|12154911|FG000|Treatment Period|Protocol Violation|1
7728263|NCT00586495|12154911|FG000|Treatment Period|Withdrawal by Subject|1
7728264|NCT00586495|12154911|FG000|Treatment Period|Disease progression, recurrence/relapse|71
7728265|NCT00586495|12154911|FG000|Treatment Period|Switch to commercial drug|10
7728266|NCT00586495|12154911|FG000|Follow-up|Death|40
7728267|NCT00586495|12154911|FG000|Follow-up|Lost to Follow-up|1
7728268|NCT00586495|12154911|FG000|Follow-up|Withdrawal by Subject|4
7728269|NCT00586495|12154911|FG000|Follow-up|Protocol driven decision point|37
7728270|NCT00586495|12154911|FG000|Follow-up|Switch to commercial drug|10
7728271|NCT00586508|12154917|FG000|Overall Study|Progressive disease|52
7728272|NCT00586508|12154918|FG001|Overall Study|Progressive disease|8
7728273|NCT00586508|12154917|FG000|Overall Study|Death|0
7728274|NCT00586508|12154918|FG001|Overall Study|Death|1
7728275|NCT00586508|12154917|FG000|Overall Study|Adverse Event|12
7728276|NCT00586508|12154918|FG001|Overall Study|Adverse Event|4
7728277|NCT00586508|12154917|FG000|Overall Study|Withdrawal by Subject|4
7728278|NCT00586508|12154918|FG001|Overall Study|Withdrawal by Subject|0
7728279|NCT00586521|12154924|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
7728280|NCT00586612|12154934|FG000|Primary Phase|Protocol Violation|1
7728281|NCT00586612|12154935|FG001|Primary Phase|Protocol Violation|0
7728282|NCT00586612|12154934|FG000|Primary Phase|Lost to Follow-up|0
7728283|NCT00586612|12154935|FG001|Primary Phase|Lost to Follow-up|1
7728284|NCT00586612|12154934|FG000|Primary Phase|Withdrawal by Subject|0
7728285|NCT00586612|12154935|FG001|Primary Phase|Withdrawal by Subject|2
7728286|NCT00586612|12154934|FG000|Booster Phase|Lost to Follow-up|3
7728287|NCT00586612|12154935|FG001|Booster Phase|Lost to Follow-up|1
7728288|NCT00586625|12154943|FG000|Overall Study|Adverse Event|6
7728289|NCT00586625|12154944|FG001|Overall Study|Adverse Event|6
7728290|NCT00586625|12154943|FG000|Overall Study|Protocol Violation|3
7728291|NCT00586625|12154944|FG001|Overall Study|Protocol Violation|0
7728292|NCT00586625|12154943|FG000|Overall Study|Withdrawal by Subject|32
7728293|NCT00586625|12154944|FG001|Overall Study|Withdrawal by Subject|10
7728294|NCT00586625|12154943|FG000|Overall Study|Subject non-compliance|0
7728295|NCT00586625|12154944|FG001|Overall Study|Subject non-compliance|1
7728296|NCT00586625|12154943|FG000|Overall Study|Subject unable to return for visit|2
7728297|NCT00586625|12154944|FG001|Overall Study|Subject unable to return for visit|0
7728298|NCT00586664|12154953|FG000|Overall Study|Withdrawal by Subject|3
7728299|NCT00586664|12154954|FG001|Overall Study|Withdrawal by Subject|7
7728300|NCT00586664|12154955|FG002|Overall Study|Withdrawal by Subject|1
7728301|NCT00586664|12154953|FG000|Overall Study|Exclusion criteria met|2
7728302|NCT00586664|12154954|FG001|Overall Study|Exclusion criteria met|0
7728303|NCT00586664|12154955|FG002|Overall Study|Exclusion criteria met|0
7728304|NCT00586690|12154965|FG000|Overall Study|Death|2
7728305|NCT00586690|12154966|FG001|Overall Study|Death|0
7728306|NCT00586690|12154965|FG000|Overall Study|Disease Progression|10
7728307|NCT00586690|12154966|FG001|Overall Study|Disease Progression|0
7728308|NCT00586690|12154965|FG000|Overall Study|Adverse Event|1
7728309|NCT00586690|12154966|FG001|Overall Study|Adverse Event|0
7728310|NCT00586690|12154965|FG000|Overall Study|Lack of Efficacy|2
7728311|NCT00586690|12154966|FG001|Overall Study|Lack of Efficacy|0
7728312|NCT00586690|12154965|FG000|Overall Study|Lab can't accommodate|1
7728313|NCT00586690|12154966|FG001|Overall Study|Lab can't accommodate|0
7728314|NCT00586703|12154971|FG000|Overall Study|Death|12
7728315|NCT00586820|12154986|FG000|Overall Study|Unsuccessful PCI|1
7728316|NCT00586820|12154987|FG001|Overall Study|Unsuccessful PCI|0
7728317|NCT00586846|12154993|FG000|Overall Study|Physician Decision|1
7728318|NCT00586846|12154993|FG000|Overall Study|Death|1
7728319|NCT00586846|12154993|FG000|Overall Study|Evaluable for Toxicity Only|4
7728320|NCT00586898|12154997|FG000|Overall Study|Adverse Event|1
7728321|NCT00586898|12154997|FG000|Overall Study|Patiemt Non-compliance|1
7728322|NCT00586898|12154997|FG000|Overall Study|Evaluable for Toxicity Only|5
7728323|NCT00587054|12155014|FG000|Overall Study|Patient not treated|9
7728324|NCT00587158|12155041|FG000|Overall Study|Did not want to do 24 hr urine collect.|4
7728325|NCT00587158|12155042|FG001|Overall Study|Did not want to do 24 hr urine collect.|3
7728326|NCT00587158|12155041|FG000|Overall Study|Physician Decision|0
7728327|NCT00587158|12155042|FG001|Overall Study|Physician Decision|1
7728328|NCT00587158|12155041|FG000|Overall Study|Lost to Follow-up|1
7728329|NCT00587158|12155042|FG001|Overall Study|Lost to Follow-up|2
7728330|NCT00587158|12155041|FG000|Overall Study|Death|0
7728331|NCT00587158|12155042|FG001|Overall Study|Death|1
7728332|NCT00587158|12155041|FG000|Overall Study|Subject did not want to take study med|0
7728333|NCT00587158|12155042|FG001|Overall Study|Subject did not want to take study med|1
7728334|NCT00587171|12155050|FG000|Overall Study|Lost to Follow-up|1
7728335|NCT00587171|12155051|FG001|Overall Study|Lost to Follow-up|1
7728336|NCT00587288|12155059|FG000|Overall Study|Adverse Event|0
7728337|NCT00587288|12155060|FG001|Overall Study|Adverse Event|1
7728338|NCT00587288|12155059|FG000|Overall Study|Lack of Efficacy|2
7728339|NCT00587288|12155060|FG001|Overall Study|Lack of Efficacy|8
7728340|NCT00587288|12155059|FG000|Overall Study|Protocol Violation|1
7728341|NCT00587288|12155060|FG001|Overall Study|Protocol Violation|0
7728342|NCT00587431|12155070|FG000|Overall Study|Adverse Event|1
7728343|NCT00587431|12155071|FG001|Overall Study|Adverse Event|0
7728344|NCT00587431|12155070|FG000|Overall Study|Withdrawal by Subject|0
7728345|NCT00587431|12155071|FG001|Overall Study|Withdrawal by Subject|1
7728346|NCT00587457|12155083|FG000|Overall Study|Adverse Event|1
7728347|NCT00587457|12155084|FG001|Overall Study|Adverse Event|2
7728348|NCT00587457|12155085|FG002|Overall Study|Adverse Event|1
7728349|NCT00587457|12155083|FG000|Overall Study|Disease progression|2
7728350|NCT00587457|12155084|FG001|Overall Study|Disease progression|0
7728351|NCT00587457|12155085|FG002|Overall Study|Disease progression|2
7728352|NCT00587457|12155083|FG000|Overall Study|Initiation of alternative therapy|0
7728353|NCT00587457|12155084|FG001|Overall Study|Initiation of alternative therapy|1
7728354|NCT00587457|12155085|FG002|Overall Study|Initiation of alternative therapy|0
7728355|NCT00587457|12155083|FG000|Overall Study|Undefined|0
7728356|NCT00587457|12155084|FG001|Overall Study|Undefined|0
7728357|NCT00587457|12155085|FG002|Overall Study|Undefined|1
7728358|NCT00587457|12155083|FG000|Overall Study|Development of neutralizing Abs|0
7728359|NCT00587457|12155084|FG001|Overall Study|Development of neutralizing Abs|0
7728360|NCT00587457|12155085|FG002|Overall Study|Development of neutralizing Abs|1
7728361|NCT00587587|12155108|FG000|Overall Study|Lost to Follow-up|6
7728362|NCT00587587|12155109|FG001|Overall Study|Lost to Follow-up|1
7728363|NCT00587639|12155117|FG000|Overall Study|Withdrawal by Subject|1
7728364|NCT00587847|12155153|FG000|Overall Study|Lack of Efficacy|5
7728365|NCT00587847|12155153|FG000|Overall Study|Adverse Event|2
7768333|NCT00859222|12211350|FG000|Overall Study|DLT|1
7768334|NCT00859222|12211351|FG001|Overall Study|DLT|0
7768335|NCT00859222|12211352|FG002|Overall Study|DLT|0
7768336|NCT00859222|12211353|FG003|Overall Study|DLT|0
7768337|NCT00859222|12211354|FG004|Overall Study|DLT|0
7768338|NCT00859313|12211369|FG000|Overall Study|Lack of Efficacy|2
7768339|NCT00859313|12211369|FG000|Overall Study|Adverse Event|1
7768340|NCT00859313|12211369|FG000|Overall Study|staff error|1
7768341|NCT00859456|12211377|FG000|Overall Study|Adverse Event|3
7768342|NCT00859456|12211377|FG000|Overall Study|Progressive disease|2
7768343|NCT00859456|12211377|FG000|Overall Study|Non-compliance|3
7768344|NCT00859469|12211381|FG000|Overall Study|Adverse Event|2
7768345|NCT00859469|12211381|FG000|Overall Study|Lack of Efficacy|9
7768346|NCT00859469|12211381|FG000|Overall Study|Withdrawal by Subject|1
7768347|NCT00859469|12211381|FG000|Overall Study|Death|16
7768348|NCT00859547|12211398|FG000|Overall Study|Lost to Follow-up|1
7768349|NCT00859547|12211398|FG000|Overall Study|Parent withdrew consent|1
7768350|NCT00859573|12211404|FG000|Overall Study|Withdrawal by Subject|4
7768351|NCT00859573|12211405|FG001|Overall Study|Withdrawal by Subject|1
7768352|NCT00859573|12211404|FG000|Overall Study|Physician Decision|1
7768353|NCT00859573|12211405|FG001|Overall Study|Physician Decision|1
7768354|NCT00859586|12211411|FG000|Overall Study|Donors|4
7768355|NCT00859638|12211417|FG000|Overall Study|Lost to Follow-up|6
7768356|NCT00859638|12211418|FG001|Overall Study|Lost to Follow-up|1
7768357|NCT00859638|12211417|FG000|Overall Study|Withdrawal by Subject|3
7768358|NCT00859638|12211418|FG001|Overall Study|Withdrawal by Subject|2
7768359|NCT00859638|12211417|FG000|Overall Study|Ill health|1
7768360|NCT00859638|12211418|FG001|Overall Study|Ill health|1
7768361|NCT00859898|12211441|FG000|Overall Study|Lack of Efficacy|0
7768362|NCT00859898|12211442|FG001|Overall Study|Lack of Efficacy|1
7768363|NCT00859898|12211443|FG002|Overall Study|Lack of Efficacy|1
7768364|NCT00859898|12211441|FG000|Overall Study|Adverse Event|4
7768365|NCT00859898|12211442|FG001|Overall Study|Adverse Event|9
7768366|NCT00859898|12211443|FG002|Overall Study|Adverse Event|8
7768367|NCT00859898|12211441|FG000|Overall Study|Withdrawal by Subject|11
7768368|NCT00859898|12211442|FG001|Overall Study|Withdrawal by Subject|8
7768369|NCT00859898|12211443|FG002|Overall Study|Withdrawal by Subject|11
7768370|NCT00859898|12211441|FG000|Overall Study|Death|0
7768371|NCT00859898|12211442|FG001|Overall Study|Death|0
7768372|NCT00859898|12211443|FG002|Overall Study|Death|1
7768373|NCT00859898|12211441|FG000|Overall Study|Lost to Follow-up|10
7768374|NCT00859898|12211442|FG001|Overall Study|Lost to Follow-up|11
7768375|NCT00859898|12211443|FG002|Overall Study|Lost to Follow-up|5
7768376|NCT00859898|12211441|FG000|Overall Study|poor/non-compliance|2
7768377|NCT00859898|12211442|FG001|Overall Study|poor/non-compliance|0
7768378|NCT00859898|12211443|FG002|Overall Study|poor/non-compliance|0
7768379|NCT00859898|12211441|FG000|Overall Study|No longer meets criteria|0
7768380|NCT00859898|12211442|FG001|Overall Study|No longer meets criteria|1
7768381|NCT00859898|12211443|FG002|Overall Study|No longer meets criteria|0
7768382|NCT00859898|12211441|FG000|Overall Study|non-specified|1
7768383|NCT00859898|12211442|FG001|Overall Study|non-specified|1
7768384|NCT00859898|12211443|FG002|Overall Study|non-specified|1
7768385|NCT00859937|12211454|FG000|Overall Study|Protocol Violation|1
7768386|NCT00859937|12211455|FG001|Overall Study|Protocol Violation|0
7768387|NCT00860028|12211485|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
7768388|NCT00860028|12211486|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
7768389|NCT00860067|12211497|FG000|Overall Study|Lost to Follow-up|46
7768390|NCT00860067|12211498|FG001|Overall Study|Lost to Follow-up|9
7768391|NCT00860067|12211499|FG002|Overall Study|Lost to Follow-up|9
7768392|NCT00860067|12211497|FG000|Overall Study|Withdrawal by Subject|4
7768393|NCT00860067|12211498|FG001|Overall Study|Withdrawal by Subject|0
7768394|NCT00860067|12211499|FG002|Overall Study|Withdrawal by Subject|0
7768395|NCT00860067|12211497|FG000|Overall Study|Pregnancy|1
7768396|NCT00860067|12211498|FG001|Overall Study|Pregnancy|0
7768397|NCT00860067|12211499|FG002|Overall Study|Pregnancy|0
7768398|NCT00860262|12211517|FG000|Overall Study|Adverse Event|9
7768399|NCT00860262|12211518|FG001|Overall Study|Adverse Event|6
7768400|NCT00860262|12211519|FG002|Overall Study|Adverse Event|7
7728366|NCT04411680|12155164|FG000|Treatment Period|Adverse Event|3
7728367|NCT04411680|12155165|FG001|Treatment Period|Adverse Event|0
7728368|NCT04411680|12155164|FG000|Treatment Period|Discharged from hospital|18
7728369|NCT04411680|12155165|FG001|Treatment Period|Discharged from hospital|7
7728370|NCT04411680|12155164|FG000|Treatment Period|Missed 1 or more doses|8
7728371|NCT04411680|12155165|FG001|Treatment Period|Missed 1 or more doses|0
7728372|NCT04411680|12155164|FG000|Treatment Period|Transferred to another hospital|0
7728373|NCT04411680|12155165|FG001|Treatment Period|Transferred to another hospital|1
7728374|NCT04411680|12155164|FG000|Follow up Period|Withdrawal by Subject|2
7728375|NCT04411680|12155165|FG001|Follow up Period|Withdrawal by Subject|0
7728376|NCT04411680|12155164|FG000|Follow up Period|Lost to Follow-up|5
7728377|NCT04411680|12155165|FG001|Follow up Period|Lost to Follow-up|6
7728378|NCT04411680|12155164|FG000|Follow up Period|Death|11
7728379|NCT04411680|12155165|FG001|Follow up Period|Death|8
7728380|NCT04364984|12155174|FG000|Overall Study|Death|2
7728381|NCT04364984|12155175|FG001|Overall Study|Death|2
7728382|NCT04364984|12155176|FG002|Overall Study|Death|0
7768401|NCT00860262|12211517|FG000|Overall Study|Protocol Violation|0
7768402|NCT00860262|12211518|FG001|Overall Study|Protocol Violation|1
7768403|NCT00860262|12211519|FG002|Overall Study|Protocol Violation|0
7768404|NCT00860262|12211517|FG000|Overall Study|Lost to Follow-up|2
7768405|NCT00860262|12211518|FG001|Overall Study|Lost to Follow-up|0
7768406|NCT00860262|12211519|FG002|Overall Study|Lost to Follow-up|1
7768407|NCT00860262|12211517|FG000|Overall Study|Withdrawal by Subject|4
7768408|NCT00860262|12211518|FG001|Overall Study|Withdrawal by Subject|8
7768409|NCT00860262|12211519|FG002|Overall Study|Withdrawal by Subject|6
7768410|NCT00860262|12211517|FG000|Overall Study|Lack of Efficacy|0
7768411|NCT00860262|12211518|FG001|Overall Study|Lack of Efficacy|4
7768412|NCT00860262|12211519|FG002|Overall Study|Lack of Efficacy|3
7768413|NCT00860262|12211517|FG000|Overall Study|Other|5
7768414|NCT00860262|12211518|FG001|Overall Study|Other|3
7768415|NCT00860262|12211519|FG002|Overall Study|Other|1
7768416|NCT00860405|12211553|FG000|Overall Study|Main reason: Follow-up data not complete|5
7768417|NCT00860405|12211554|FG001|Overall Study|Main reason: Follow-up data not complete|4
7768418|NCT00860470|12211566|FG000|Overall Study|Death|6
7768419|NCT00860470|12211567|FG001|Overall Study|Death|10
7768420|NCT00860470|12211566|FG000|Overall Study|Moved away|8
7768421|NCT00860470|12211567|FG001|Overall Study|Moved away|10
7768422|NCT00860470|12211566|FG000|Overall Study|Lost to Follow-up|34
7768423|NCT00860470|12211567|FG001|Overall Study|Lost to Follow-up|39
7768424|NCT00860574|12211577|FG000|Overall Study|Death|2
7768425|NCT00860574|12211577|FG000|Overall Study|Relapse|1
7768426|NCT00860743|12211587|FG000|Overall Study|Withdrawal by Subject|3
7768427|NCT00860743|12211588|FG001|Overall Study|Withdrawal by Subject|0
7768428|NCT00860951|12211621|FG000|Overall Study|Withdrawal by Subject|2
7768429|NCT00860951|12211621|FG000|Overall Study|Lost to Follow-up|5
7768430|NCT00861198|12211636|FG000|Overall Study|SpyGlass Failed|5
7768431|NCT00861341|12211644|FG000|Overall Study|Withdrawal by Subject|2
7768432|NCT00861380|12211655|FG000|Overall Study|Withdrawal Information not recorded|8427
7768433|NCT00861380|12211656|FG001|Overall Study|Withdrawal Information not recorded|9112
7768434|NCT00861380|12211657|FG002|Overall Study|Withdrawal Information not recorded|8872
7768435|NCT00861380|12211658|FG003|Overall Study|Withdrawal Information not recorded|3689
7768436|NCT00861380|12211659|FG004|Overall Study|Withdrawal Information not recorded|1812
7768437|NCT00861380|12211660|FG005|Overall Study|Withdrawal Information not recorded|6249
7768438|NCT00861380|12211661|FG006|Overall Study|Withdrawal Information not recorded|3020
7768439|NCT00861471|12211694|FG000|Overall Study|Withdrawal by Subject|1
7768440|NCT00861471|12211694|FG000|Overall Study|Adverse Event|2
7768441|NCT00861471|12211694|FG000|Overall Study|Lack of Efficacy|3
7768442|NCT00861471|12211694|FG000|Overall Study|treatment for lumbar laminectomy|1
7768443|NCT00861471|12211694|FG000|Overall Study|Physician Decision|2
7768444|NCT00861614|12211716|FG000|Overall Study|Disease Progression|182
7768445|NCT00861614|12211717|FG001|Overall Study|Disease Progression|263
7768446|NCT00861614|12211716|FG000|Overall Study|Study Drug Toxicity|79
7768447|NCT00861614|12211717|FG001|Overall Study|Study Drug Toxicity|6
7768448|NCT00861614|12211716|FG000|Overall Study|Death|32
7768449|NCT00861614|12211717|FG001|Overall Study|Death|19
7768450|NCT00861614|12211716|FG000|Overall Study|Adverse Event|27
7768451|NCT00861614|12211717|FG001|Overall Study|Adverse Event|23
7768452|NCT00861614|12211716|FG000|Overall Study|Withdrawal by Subject|34
7768453|NCT00861614|12211717|FG001|Overall Study|Withdrawal by Subject|35
7768454|NCT00861614|12211716|FG000|Overall Study|Other|17
7768455|NCT00861614|12211717|FG001|Overall Study|Other|22
7768456|NCT00861692|12211723|FG000|Overall Study|Death|6
7768457|NCT00861744|12211731|FG000|Overall Study|Adverse Event|0
7768458|NCT00861744|12211732|FG001|Overall Study|Adverse Event|0
7768459|NCT00861744|12211733|FG002|Overall Study|Adverse Event|0
7768460|NCT00861744|12211734|FG003|Overall Study|Adverse Event|1
7768461|NCT00861744|12211731|FG000|Overall Study|Lost to Follow-up|7
7768462|NCT00861744|12211732|FG001|Overall Study|Lost to Follow-up|19
7768463|NCT00861744|12211733|FG002|Overall Study|Lost to Follow-up|17
7768464|NCT00861744|12211734|FG003|Overall Study|Lost to Follow-up|12
7768465|NCT00861744|12211731|FG000|Overall Study|Withdrawal by Subject|10
7768466|NCT00861744|12211732|FG001|Overall Study|Withdrawal by Subject|6
7768467|NCT00861744|12211733|FG002|Overall Study|Withdrawal by Subject|6
7768468|NCT00861744|12211734|FG003|Overall Study|Withdrawal by Subject|19
7768469|NCT00861744|12211731|FG000|Overall Study|Protocol Violation|0
7728383|NCT03711266|12155216|FG000|Overall Study|Lost to Follow-up|10
7728384|NCT03630393|12155222|FG000|Overall Study|Death|1
7728385|NCT03630393|12155223|FG001|Overall Study|Death|0
7728386|NCT03359811|12155240|FG000|Overall Study|Protocol Violation|2
7728387|NCT03359811|12155241|FG001|Overall Study|Protocol Violation|0
7728388|NCT02954406|12155283|FG000|Overall Study|Adverse Event|0
7728389|NCT02954406|12155284|FG001|Overall Study|Adverse Event|1
7728390|NCT02954406|12155285|FG002|Overall Study|Adverse Event|0
7728391|NCT02954406|12155286|FG003|Overall Study|Adverse Event|0
7728392|NCT02954406|12155287|FG004|Overall Study|Adverse Event|1
7728393|NCT02954406|12155288|FG005|Overall Study|Adverse Event|0
7728394|NCT02954406|12155289|FG006|Overall Study|Adverse Event|0
7728395|NCT02954406|12155290|FG007|Overall Study|Adverse Event|0
7728396|NCT02954406|12155291|FG008|Overall Study|Adverse Event|1
7728397|NCT02954406|12155292|FG009|Overall Study|Adverse Event|1
7728398|NCT02954406|12155293|FG010|Overall Study|Adverse Event|0
7728399|NCT02954406|12155283|FG000|Overall Study|Progressive Disease|3
7728400|NCT02954406|12155284|FG001|Overall Study|Progressive Disease|4
7728401|NCT02954406|12155285|FG002|Overall Study|Progressive Disease|3
7728402|NCT02954406|12155286|FG003|Overall Study|Progressive Disease|4
7728403|NCT02954406|12155287|FG004|Overall Study|Progressive Disease|3
7728404|NCT02954406|12155288|FG005|Overall Study|Progressive Disease|3
7728405|NCT02954406|12155289|FG006|Overall Study|Progressive Disease|2
7728406|NCT02954406|12155290|FG007|Overall Study|Progressive Disease|2
7728407|NCT02954406|12155291|FG008|Overall Study|Progressive Disease|1
7728408|NCT02954406|12155292|FG009|Overall Study|Progressive Disease|1
7728409|NCT02954406|12155293|FG010|Overall Study|Progressive Disease|0
7728410|NCT02954406|12155283|FG000|Overall Study|Symptomatic Deterioration|0
7728411|NCT02954406|12155284|FG001|Overall Study|Symptomatic Deterioration|1
7728412|NCT02954406|12155285|FG002|Overall Study|Symptomatic Deterioration|0
7728413|NCT02954406|12155286|FG003|Overall Study|Symptomatic Deterioration|0
7728414|NCT02954406|12155287|FG004|Overall Study|Symptomatic Deterioration|0
7728415|NCT02954406|12155288|FG005|Overall Study|Symptomatic Deterioration|0
7728416|NCT02954406|12155289|FG006|Overall Study|Symptomatic Deterioration|0
7728417|NCT02954406|12155290|FG007|Overall Study|Symptomatic Deterioration|0
7728418|NCT02954406|12155291|FG008|Overall Study|Symptomatic Deterioration|0
7728419|NCT02954406|12155292|FG009|Overall Study|Symptomatic Deterioration|0
7728420|NCT02954406|12155293|FG010|Overall Study|Symptomatic Deterioration|0
7728421|NCT02954406|12155283|FG000|Overall Study|Death|0
7728422|NCT02954406|12155284|FG001|Overall Study|Death|0
7728423|NCT02954406|12155285|FG002|Overall Study|Death|0
7728424|NCT02954406|12155286|FG003|Overall Study|Death|0
7728425|NCT02954406|12155287|FG004|Overall Study|Death|1
7728426|NCT02954406|12155288|FG005|Overall Study|Death|0
7728427|NCT02954406|12155289|FG006|Overall Study|Death|0
7728428|NCT02954406|12155290|FG007|Overall Study|Death|0
7728429|NCT02954406|12155291|FG008|Overall Study|Death|1
7728430|NCT02954406|12155292|FG009|Overall Study|Death|1
7728431|NCT02954406|12155293|FG010|Overall Study|Death|0
7728432|NCT02954406|12155283|FG000|Overall Study|Reason Not Specified|0
7728433|NCT02954406|12155284|FG001|Overall Study|Reason Not Specified|0
7728434|NCT02954406|12155285|FG002|Overall Study|Reason Not Specified|3
7728435|NCT02954406|12155286|FG003|Overall Study|Reason Not Specified|2
7728436|NCT02954406|12155287|FG004|Overall Study|Reason Not Specified|2
7728437|NCT02954406|12155288|FG005|Overall Study|Reason Not Specified|0
7728438|NCT02954406|12155289|FG006|Overall Study|Reason Not Specified|1
7728439|NCT02954406|12155290|FG007|Overall Study|Reason Not Specified|0
7728440|NCT02954406|12155291|FG008|Overall Study|Reason Not Specified|1
7728441|NCT02954406|12155292|FG009|Overall Study|Reason Not Specified|0
7728442|NCT02954406|12155293|FG010|Overall Study|Reason Not Specified|0
7728443|NCT02927145|12155328|FG000|Initial Recruitment|Withdrawal by Subject|0
7728444|NCT02927145|12155329|FG001|Initial Recruitment|Withdrawal by Subject|1
7728445|NCT02927145|12155330|FG002|Initial Recruitment|Withdrawal by Subject|1
7728446|NCT02927145|12155331|FG003|Initial Recruitment|Withdrawal by Subject|4
7728447|NCT02927145|12155332|FG004|Initial Recruitment|Withdrawal by Subject|1
7728448|NCT02927145|12155333|FG005|Initial Recruitment|Withdrawal by Subject|1
7728449|NCT02927145|12155334|FG006|Initial Recruitment|Withdrawal by Subject|0
7728450|NCT02927145|12155335|FG007|Initial Recruitment|Withdrawal by Subject|0
7728451|NCT02927145|12155336|FG008|Initial Recruitment|Withdrawal by Subject|2
7728452|NCT02927145|12155328|FG000|Initial Recruitment|Adverse Event|0
7728453|NCT02927145|12155329|FG001|Initial Recruitment|Adverse Event|0
7728454|NCT02927145|12155330|FG002|Initial Recruitment|Adverse Event|0
7728455|NCT02927145|12155331|FG003|Initial Recruitment|Adverse Event|0
7728456|NCT02927145|12155332|FG004|Initial Recruitment|Adverse Event|2
7728457|NCT02927145|12155333|FG005|Initial Recruitment|Adverse Event|0
7728458|NCT02927145|12155334|FG006|Initial Recruitment|Adverse Event|0
7728459|NCT02927145|12155335|FG007|Initial Recruitment|Adverse Event|0
7728460|NCT02927145|12155336|FG008|Initial Recruitment|Adverse Event|0
7728461|NCT02927145|12155328|FG000|Invitation for Additional Challenge|Pregnancy|0
7728462|NCT02927145|12155329|FG001|Invitation for Additional Challenge|Pregnancy|0
7728463|NCT02927145|12155330|FG002|Invitation for Additional Challenge|Pregnancy|0
7728464|NCT02927145|12155331|FG003|Invitation for Additional Challenge|Pregnancy|0
7728465|NCT02927145|12155332|FG004|Invitation for Additional Challenge|Pregnancy|0
7728466|NCT02927145|12155333|FG005|Invitation for Additional Challenge|Pregnancy|0
7728467|NCT02927145|12155334|FG006|Invitation for Additional Challenge|Pregnancy|1
7728468|NCT02927145|12155335|FG007|Invitation for Additional Challenge|Pregnancy|0
7728469|NCT02927145|12155336|FG008|Invitation for Additional Challenge|Pregnancy|0
7728470|NCT02910583|12155359|FG000|Overall Study|Withdrawal by Subject|6
7728471|NCT02910583|12155360|FG001|Overall Study|Withdrawal by Subject|7
7728472|NCT02910583|12155359|FG000|Overall Study|Other, Not Specified|1
7728473|NCT02910583|12155360|FG001|Overall Study|Other, Not Specified|0
7768470|NCT00861744|12211732|FG001|Overall Study|Protocol Violation|1
7768471|NCT00861744|12211733|FG002|Overall Study|Protocol Violation|0
7768472|NCT00861744|12211734|FG003|Overall Study|Protocol Violation|0
7768473|NCT00861744|12211731|FG000|Overall Study|Migration from study area|0
7768474|NCT00861744|12211732|FG001|Overall Study|Migration from study area|3
7768475|NCT00861744|12211733|FG002|Overall Study|Migration from study area|1
7768476|NCT00861744|12211734|FG003|Overall Study|Migration from study area|0
7768477|NCT00861744|12211731|FG000|Overall Study|Blood draws|0
7768478|NCT00861744|12211732|FG001|Overall Study|Blood draws|0
7768479|NCT00861744|12211733|FG002|Overall Study|Blood draws|0
7768480|NCT00861744|12211734|FG003|Overall Study|Blood draws|1
7768481|NCT00861757|12211748|FG000|Overall Study|Adverse Event|1
7768482|NCT00861757|12211749|FG001|Overall Study|Adverse Event|5
7768483|NCT00861757|12211750|FG002|Overall Study|Adverse Event|7
7768484|NCT00861757|12211751|FG003|Overall Study|Adverse Event|2
7768485|NCT00861757|12211748|FG000|Overall Study|Entry Criteria Not Met|1
7768486|NCT00861757|12211749|FG001|Overall Study|Entry Criteria Not Met|2
7768487|NCT00861757|12211750|FG002|Overall Study|Entry Criteria Not Met|1
7768488|NCT00861757|12211751|FG003|Overall Study|Entry Criteria Not Met|1
7768489|NCT00861757|12211748|FG000|Overall Study|Lack of Efficacy|3
7768490|NCT00861757|12211749|FG001|Overall Study|Lack of Efficacy|1
7768491|NCT00861757|12211750|FG002|Overall Study|Lack of Efficacy|0
7768492|NCT00861757|12211751|FG003|Overall Study|Lack of Efficacy|1
7768493|NCT00861757|12211748|FG000|Overall Study|Lost to Follow-up|1
7768494|NCT00861757|12211749|FG001|Overall Study|Lost to Follow-up|0
7768495|NCT00861757|12211750|FG002|Overall Study|Lost to Follow-up|1
7768496|NCT00861757|12211751|FG003|Overall Study|Lost to Follow-up|1
7768497|NCT00861757|12211748|FG000|Overall Study|Physician Decision|0
7768498|NCT00861757|12211749|FG001|Overall Study|Physician Decision|0
7768499|NCT00861757|12211750|FG002|Overall Study|Physician Decision|0
7768500|NCT00861757|12211751|FG003|Overall Study|Physician Decision|1
7768501|NCT00861757|12211748|FG000|Overall Study|Protocol Violation|2
7768502|NCT00861757|12211749|FG001|Overall Study|Protocol Violation|2
7768503|NCT00861757|12211750|FG002|Overall Study|Protocol Violation|4
7768504|NCT00861757|12211751|FG003|Overall Study|Protocol Violation|1
7768505|NCT00861757|12211748|FG000|Overall Study|Withdrawal by Subject|1
7768506|NCT00861757|12211749|FG001|Overall Study|Withdrawal by Subject|5
7768507|NCT00861757|12211750|FG002|Overall Study|Withdrawal by Subject|5
7768508|NCT00861757|12211751|FG003|Overall Study|Withdrawal by Subject|2
7768509|NCT00862082|12211771|FG000|Overall Study|Sponsor decision to terminate the study|5
7768510|NCT00862082|12211772|FG001|Overall Study|Sponsor decision to terminate the study|0
7768511|NCT00862082|12211771|FG000|Overall Study|Withdrawal by Subject|0
7768512|NCT00862082|12211772|FG001|Overall Study|Withdrawal by Subject|1
7768513|NCT00862121|12211787|FG000|Overall Study|Adverse Event|1
7768514|NCT00862121|12211788|FG001|Overall Study|Adverse Event|2
7768515|NCT00862121|12211787|FG000|Overall Study|Lack of Efficacy|0
7768516|NCT00862121|12211788|FG001|Overall Study|Lack of Efficacy|3
7768517|NCT00862121|12211787|FG000|Overall Study|Protocol Violation|0
7768518|NCT00862121|12211788|FG001|Overall Study|Protocol Violation|1
7768519|NCT00862121|12211787|FG000|Overall Study|Exclusion criterion violation|0
7768520|NCT00862121|12211788|FG001|Overall Study|Exclusion criterion violation|1
7768521|NCT00862121|12211787|FG000|Overall Study|Incorrect randomisation|0
7768522|NCT00862121|12211788|FG001|Overall Study|Incorrect randomisation|1
7728474|NCT02598388|12155417|FG000|Overall Study|Lost to Follow-up|1
7728475|NCT02598388|12155418|FG001|Overall Study|Lost to Follow-up|0
7728476|NCT02598388|12155419|FG002|Overall Study|Lost to Follow-up|1
7728477|NCT02598388|12155420|FG003|Overall Study|Lost to Follow-up|0
7728478|NCT02598388|12155421|FG004|Overall Study|Lost to Follow-up|5
7728479|NCT02598388|12155422|FG005|Overall Study|Lost to Follow-up|1
7728480|NCT02598388|12155423|FG006|Overall Study|Lost to Follow-up|2
7728481|NCT02598388|12155424|FG007|Overall Study|Lost to Follow-up|1
7728482|NCT02598388|12155425|FG008|Overall Study|Lost to Follow-up|0
7728483|NCT02598388|12155426|FG009|Overall Study|Lost to Follow-up|0
7728484|NCT02598388|12155427|FG010|Overall Study|Lost to Follow-up|1
7728485|NCT02598388|12155428|FG011|Overall Study|Lost to Follow-up|0
7728486|NCT02598388|12155417|FG000|Overall Study|Withdrawal by Subject|0
7728487|NCT02598388|12155418|FG001|Overall Study|Withdrawal by Subject|0
7728488|NCT02598388|12155419|FG002|Overall Study|Withdrawal by Subject|0
7728489|NCT02598388|12155420|FG003|Overall Study|Withdrawal by Subject|0
7728490|NCT02598388|12155421|FG004|Overall Study|Withdrawal by Subject|2
7728491|NCT02598388|12155422|FG005|Overall Study|Withdrawal by Subject|0
7728492|NCT02598388|12155423|FG006|Overall Study|Withdrawal by Subject|2
7728493|NCT02598388|12155424|FG007|Overall Study|Withdrawal by Subject|0
7728494|NCT02598388|12155425|FG008|Overall Study|Withdrawal by Subject|0
7728495|NCT02598388|12155426|FG009|Overall Study|Withdrawal by Subject|1
7728496|NCT02598388|12155427|FG010|Overall Study|Withdrawal by Subject|0
7728497|NCT02598388|12155428|FG011|Overall Study|Withdrawal by Subject|0
7728498|NCT02598388|12155417|FG000|Overall Study|Other|0
7728499|NCT02598388|12155418|FG001|Overall Study|Other|0
7728500|NCT02598388|12155419|FG002|Overall Study|Other|1
7728501|NCT02598388|12155420|FG003|Overall Study|Other|0
7728502|NCT02598388|12155421|FG004|Overall Study|Other|3
7728503|NCT02598388|12155422|FG005|Overall Study|Other|0
7728504|NCT02598388|12155423|FG006|Overall Study|Other|1
7728505|NCT02598388|12155424|FG007|Overall Study|Other|0
7728506|NCT02598388|12155425|FG008|Overall Study|Other|0
7728507|NCT02598388|12155426|FG009|Overall Study|Other|0
7728508|NCT02598388|12155427|FG010|Overall Study|Other|0
7728509|NCT02598388|12155428|FG011|Overall Study|Other|0
7728510|NCT02493751|12155461|FG000|Overall Study|Withdrawal by Subject|2
7728511|NCT02493751|12155462|FG001|Overall Study|Withdrawal by Subject|8
7728512|NCT02493751|12155461|FG000|Overall Study|Death|6
7728513|NCT02493751|12155462|FG001|Overall Study|Death|13
7728514|NCT02493751|12155461|FG000|Overall Study|Lost to Follow-up|2
7728515|NCT02493751|12155462|FG001|Overall Study|Lost to Follow-up|3
7728516|NCT02493751|12155461|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6
7728517|NCT02493751|12155462|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15
7728518|NCT02285166|12155469|FG000|Overall Study|Case Report Forms Uncollected|564
7728519|NCT02285166|12155469|FG000|Overall Study|Protocol Deviation|402
7728520|NCT02075593|12155475|FG000|Overall Study|Withdrawal by Subject|1
7728521|NCT02075593|12155475|FG000|Overall Study|Treatment ongoing at the time of analysis|2
7728522|NCT00587860|12155483|FG000|Overall Study|Lost to Follow-up|2
7728523|NCT00587860|12155484|FG001|Overall Study|Lost to Follow-up|2
7728524|NCT00587860|12155483|FG000|Overall Study|Withdrawal by Subject|3
7728525|NCT00587860|12155484|FG001|Overall Study|Withdrawal by Subject|3
7728526|NCT00587964|12155490|FG000|Overall Study|Withdrawal by Subject|1
7728527|NCT00587964|12155490|FG000|Overall Study|Lost to Follow-up|1
7728528|NCT00587964|12155490|FG000|Overall Study|Patient found to be ineligible|1
7728529|NCT00587964|12155490|FG000|Overall Study|Patient did not receive intervention|5
7728530|NCT00587964|12155490|FG000|Overall Study|Progression of Disease|4
7728531|NCT00587990|12155497|FG000|Overall Study|Death|0
7728532|NCT00587990|12155498|FG001|Overall Study|Death|0
7728533|NCT00587990|12155499|FG002|Overall Study|Death|1
7728534|NCT00588094|12155507|FG000|Overall Study|Adverse Event|3
7728535|NCT00588094|12155507|FG000|Overall Study|Progression of Disease|2
7728536|NCT00588237|12155520|FG000|Overall Study|Evaluable for toxicity only|3
7728537|NCT00588237|12155520|FG000|Overall Study|Patien not treated|1
7728538|NCT00588341|12155524|FG000|Overall Study|Withdrawal by Subject|3
7728539|NCT00588341|12155524|FG000|Overall Study|Not treated due to metastatic disease|1
7728540|NCT00588341|12155524|FG000|Overall Study|Patient ineligible|1
7728541|NCT00588354|12155530|FG000|Baseline to 2 Weeks|Adverse Event|1
7728542|NCT00588354|12155531|FG001|Baseline to 2 Weeks|Adverse Event|0
7728543|NCT00588354|12155530|FG000|Baseline to 2 Weeks|Lack of Efficacy|1
7728544|NCT00588354|12155531|FG001|Baseline to 2 Weeks|Lack of Efficacy|0
7728545|NCT00588354|12155530|FG000|Baseline to 4 Weeks|Lost to Follow-up|0
7728546|NCT00588354|12155531|FG001|Baseline to 4 Weeks|Lost to Follow-up|1
7728547|NCT00588445|12155552|FG000|Overall Study|Protocol Violation|1
7728548|NCT00588445|12155552|FG000|Overall Study|Withdrawal by Subject|3
7728549|NCT00588445|12155552|FG000|Overall Study|Disease Progression|1
7728550|NCT00588445|12155552|FG000|Overall Study|Not Treated|10
7728551|NCT00588640|12155562|FG000|Overall Study|Physician Decision|1
7728552|NCT00588640|12155562|FG000|Overall Study|Ineligible Patient|1
7728553|NCT00588666|12155566|FG000|Overall Study|Adverse Event|4
7728554|NCT00588692|12155572|FG000|Overall Study|Withdrawal by Subject|4
7728555|NCT00588692|12155573|FG001|Overall Study|Withdrawal by Subject|2
7728556|NCT00588692|12155572|FG000|Overall Study|Hip Surgery|0
7728557|NCT00588692|12155573|FG001|Overall Study|Hip Surgery|1
7728558|NCT00588692|12155572|FG000|Overall Study|Severe Peptic Ulcer Disease|1
7728559|NCT00588692|12155573|FG001|Overall Study|Severe Peptic Ulcer Disease|0
7728560|NCT00588692|12155572|FG000|Overall Study|Cancer|1
7728561|NCT00588692|12155573|FG001|Overall Study|Cancer|0
7728562|NCT00588692|12155572|FG000|Overall Study|Death|1
7728563|NCT00588692|12155573|FG001|Overall Study|Death|0
7728564|NCT00588731|12155583|FG000|Overall Study|Withdrawal by Subject|3
7728565|NCT00588731|12155584|FG001|Overall Study|Withdrawal by Subject|2
7728566|NCT00588822|12155594|FG000|Overall Study|progression of disease|8
7728567|NCT00588848|12155600|FG000|Overall Study|Physician Decision|0
7728568|NCT00588848|12155601|FG001|Overall Study|Physician Decision|3
7728569|NCT00588952|12155615|FG000|Overall Study|Adverse Event|0
7728570|NCT00588952|12155616|FG001|Overall Study|Adverse Event|2
7728571|NCT00588952|12155615|FG000|Overall Study|Withdrawal by Subject|3
7728572|NCT00588952|12155616|FG001|Overall Study|Withdrawal by Subject|5
7728573|NCT00589108|12155635|FG000|Overall Study|Lost to Follow-up|1
7728574|NCT00589108|12155636|FG001|Overall Study|Lost to Follow-up|1
7728575|NCT00589108|12155637|FG002|Overall Study|Lost to Follow-up|1
7728576|NCT00589108|12155635|FG000|Overall Study|Death|3
7728577|NCT00589108|12155636|FG001|Overall Study|Death|3
7728578|NCT00589108|12155637|FG002|Overall Study|Death|4
7768523|NCT00862134|12211796|FG000|Overall Study|Death|1
7768524|NCT00862134|12211797|FG001|Overall Study|Death|0
7768525|NCT00862134|12211796|FG000|Overall Study|Physician Decision|0
7768526|NCT00862134|12211797|FG001|Overall Study|Physician Decision|1
7768527|NCT00862134|12211796|FG000|Overall Study|Withdrawal by Subject|1
7768528|NCT00862134|12211797|FG001|Overall Study|Withdrawal by Subject|2
7768529|NCT00862134|12211796|FG000|Overall Study|Sponsor terminated study|5
7768530|NCT00862134|12211797|FG001|Overall Study|Sponsor terminated study|7
7768531|NCT00862134|12211796|FG000|Overall Study|Adverse Event|2
7768532|NCT00862134|12211797|FG001|Overall Study|Adverse Event|2
7768533|NCT00862134|12211796|FG000|Overall Study|Withdrew prior to dosing|2
7768534|NCT00862134|12211797|FG001|Overall Study|Withdrew prior to dosing|0
7768535|NCT00862277|12211811|FG000|Overall Study|Protocol Violation|1
7768536|NCT00862277|12211812|FG001|Overall Study|Protocol Violation|2
7768537|NCT00862277|12211813|FG002|Overall Study|Protocol Violation|5
7768538|NCT00862459|12211828|FG000|Overall Study|Lost to Follow-up|1
7768539|NCT00862459|12211829|FG001|Overall Study|Lost to Follow-up|2
7768540|NCT00862459|12211830|FG002|Overall Study|Lost to Follow-up|2
7768541|NCT00862459|12211828|FG000|Overall Study|Protocol Violation|1
7768542|NCT00862459|12211829|FG001|Overall Study|Protocol Violation|0
7768543|NCT00862459|12211830|FG002|Overall Study|Protocol Violation|0
7768544|NCT00862459|12211828|FG000|Overall Study|Withdrawal by Subject|1
7768545|NCT00862459|12211829|FG001|Overall Study|Withdrawal by Subject|1
7768546|NCT00862459|12211830|FG002|Overall Study|Withdrawal by Subject|3
7768547|NCT00862459|12211828|FG000|Overall Study|Adverse Event|0
7768548|NCT00862459|12211829|FG001|Overall Study|Adverse Event|1
7768549|NCT00862459|12211830|FG002|Overall Study|Adverse Event|0
7768550|NCT00862459|12211828|FG000|Overall Study|Personal reasons|1
7768551|NCT00862459|12211829|FG001|Overall Study|Personal reasons|0
7768552|NCT00862459|12211830|FG002|Overall Study|Personal reasons|0
7768553|NCT00862459|12211828|FG000|Overall Study|Operation|1
7768554|NCT00862459|12211829|FG001|Overall Study|Operation|1
7768555|NCT00862459|12211830|FG002|Overall Study|Operation|0
7768556|NCT00862459|12211828|FG000|Overall Study|Intravenous (IV) site problems|1
7768557|NCT00862459|12211829|FG001|Overall Study|Intravenous (IV) site problems|0
7768558|NCT00862459|12211830|FG002|Overall Study|Intravenous (IV) site problems|1
7768559|NCT00862459|12211828|FG000|Overall Study|Unable to hold still for imaging|0
7768560|NCT00862459|12211829|FG001|Overall Study|Unable to hold still for imaging|1
7768561|NCT00862459|12211830|FG002|Overall Study|Unable to hold still for imaging|0
7768562|NCT00862459|12211828|FG000|Overall Study|Inclusion/exclusion criteria not met|0
7768563|NCT00862459|12211829|FG001|Overall Study|Inclusion/exclusion criteria not met|1
7768564|NCT00862459|12211830|FG002|Overall Study|Inclusion/exclusion criteria not met|0
7768565|NCT00862459|12211828|FG000|Overall Study|Administrative problems|0
7768566|NCT00862459|12211829|FG001|Overall Study|Administrative problems|1
7768567|NCT00862459|12211830|FG002|Overall Study|Administrative problems|0
7768568|NCT00862641|12211873|FG000|Overall Study|Randomized, but drug not received|1
7768569|NCT00862641|12211874|FG001|Overall Study|Randomized, but drug not received|4
7768570|NCT00862641|12211875|FG002|Overall Study|Randomized, but drug not received|1
7768571|NCT00862641|12211876|FG003|Overall Study|Randomized, but drug not received|4
7768572|NCT00862654|12211890|FG000|Overall Study|Lack of Efficacy|1
7728579|NCT00589121|12155647|FG000|Overall Study|Protocol Violation|2
7728580|NCT00589121|12155648|FG001|Overall Study|Protocol Violation|6
7728581|NCT00589121|12155647|FG000|Overall Study|No protocol treatment received|0
7728582|NCT00589121|12155648|FG001|Overall Study|No protocol treatment received|1
7728583|NCT00589290|12155666|FG000|Overall Study|Withdrawal by Subject|1
7728584|NCT00589303|12155674|FG000|Overall Study|Withdrawal by Subject|2
7728585|NCT00589303|12155675|FG001|Overall Study|Withdrawal by Subject|1
7728586|NCT00589472|12155691|FG000|Overall Study|Adverse Event|1
7728587|NCT00589602|12155699|FG000|Overall Study|Did not collect enough CD34+ cells|1
7728588|NCT00589628|12155707|FG000|Overall Study|Lost to Follow-up|0
7728589|NCT00589628|12155708|FG001|Overall Study|Lost to Follow-up|1
7728590|NCT00589667|12155714|FG000|Overall Study|Adverse Event|2
7728591|NCT00589667|12155714|FG000|Overall Study|Withdrawal by Subject|1
7728592|NCT00589693|12155720|FG000|Overall Study|randomized in error|12
7728593|NCT00589693|12155721|FG001|Overall Study|randomized in error|6
7728594|NCT00589693|12155720|FG000|Overall Study|Adverse Event|4
7728595|NCT00589693|12155721|FG001|Overall Study|Adverse Event|4
7728596|NCT00589693|12155720|FG000|Overall Study|Death|26
7728597|NCT00589693|12155721|FG001|Overall Study|Death|16
7728598|NCT00589693|12155720|FG000|Overall Study|Lack of Efficacy|0
7728599|NCT00589693|12155721|FG001|Overall Study|Lack of Efficacy|1
7728600|NCT00589693|12155720|FG000|Overall Study|Lost to Follow-up|1
7728601|NCT00589693|12155721|FG001|Overall Study|Lost to Follow-up|0
7728602|NCT00589693|12155720|FG000|Overall Study|Physician Decision|0
7728603|NCT00589693|12155721|FG001|Overall Study|Physician Decision|1
7728604|NCT00589693|12155720|FG000|Overall Study|Protocol Violation|1
7728605|NCT00589693|12155721|FG001|Overall Study|Protocol Violation|1
7728606|NCT00589784|12155729|FG000|Overall Study|Withdrawal by Subject|0
7728607|NCT00589784|12155730|FG001|Overall Study|Withdrawal by Subject|6
7728608|NCT00589784|12155729|FG000|Overall Study|Patient inevaluable|1
7728609|NCT00589784|12155730|FG001|Overall Study|Patient inevaluable|0
7728610|NCT00589784|12155729|FG000|Overall Study|Adverse Event|0
7728611|NCT00589784|12155730|FG001|Overall Study|Adverse Event|4
7728612|NCT00589797|12155737|FG000|Overall Study|Death|1
7728613|NCT00589797|12155738|FG001|Overall Study|Death|0
7728614|NCT00589797|12155737|FG000|Overall Study|Lost to Follow-up|12
7728615|NCT00589797|12155738|FG001|Overall Study|Lost to Follow-up|9
7728616|NCT00589797|12155737|FG000|Overall Study|Physician Decision|8
7728617|NCT00589797|12155738|FG001|Overall Study|Physician Decision|3
7728618|NCT00589797|12155737|FG000|Overall Study|Withdrawal by Subject|6
7728619|NCT00589797|12155738|FG001|Overall Study|Withdrawal by Subject|5
7728620|NCT00589797|12155737|FG000|Overall Study|Non-Randomized Training Subjects|46
7728621|NCT00589797|12155738|FG001|Overall Study|Non-Randomized Training Subjects|6
7728622|NCT00589914|12155775|FG000|Overall Study|Adverse Event|19
7728623|NCT00589914|12155776|FG001|Overall Study|Adverse Event|10
7728624|NCT00589914|12155775|FG000|Overall Study|Death|2
7728625|NCT00589914|12155776|FG001|Overall Study|Death|0
7728626|NCT00589914|12155775|FG000|Overall Study|Lack of Efficacy|40
7728627|NCT00589914|12155776|FG001|Overall Study|Lack of Efficacy|43
7728628|NCT00589914|12155775|FG000|Overall Study|Lost to Follow-up|11
7728629|NCT00589914|12155776|FG001|Overall Study|Lost to Follow-up|18
7728630|NCT00589914|12155775|FG000|Overall Study|Pregnancy|1
7728631|NCT00589914|12155776|FG001|Overall Study|Pregnancy|0
7728632|NCT00589914|12155775|FG000|Overall Study|Withdrawal by Subject|55
7728633|NCT00589914|12155776|FG001|Overall Study|Withdrawal by Subject|49
7728634|NCT00589914|12155775|FG000|Overall Study|Other|22
7728635|NCT00589914|12155776|FG001|Overall Study|Other|17
7728636|NCT00589979|12155784|FG000|Run-In Period|Adverse Event|5
7728637|NCT00589979|12155785|FG001|Run-In Period|Adverse Event|0
7728638|NCT00589979|12155786|FG002|Run-In Period|Adverse Event|0
7728639|NCT00589979|12155784|FG000|Run-In Period|Protocol Violation|3
7728640|NCT00589979|12155785|FG001|Run-In Period|Protocol Violation|0
7728641|NCT00589979|12155786|FG002|Run-In Period|Protocol Violation|0
7728642|NCT00589979|12155784|FG000|Run-In Period|Did not qualify for randomization|54
7728643|NCT00589979|12155785|FG001|Run-In Period|Did not qualify for randomization|0
7728644|NCT00589979|12155786|FG002|Run-In Period|Did not qualify for randomization|0
7728645|NCT00589979|12155784|FG000|Run-In Period|Withdrawal by Subject|10
7728646|NCT00589979|12155785|FG001|Run-In Period|Withdrawal by Subject|0
7728647|NCT00589979|12155786|FG002|Run-In Period|Withdrawal by Subject|0
7728648|NCT00589979|12155784|FG000|Run-In Period|Informed Consent Withdrawn|4
7728649|NCT00589979|12155785|FG001|Run-In Period|Informed Consent Withdrawn|0
7728650|NCT00589979|12155786|FG002|Run-In Period|Informed Consent Withdrawn|0
7728651|NCT00589979|12155784|FG000|Double-Blind Treatment Period 1|Adverse Event|0
7728652|NCT00589979|12155785|FG001|Double-Blind Treatment Period 1|Adverse Event|1
7728653|NCT00589979|12155786|FG002|Double-Blind Treatment Period 1|Adverse Event|0
7728654|NCT00589979|12155784|FG000|Double-Blind Treatment Period 1|Protocol Violation|0
7728655|NCT00589979|12155785|FG001|Double-Blind Treatment Period 1|Protocol Violation|1
7728656|NCT00589979|12155786|FG002|Double-Blind Treatment Period 1|Protocol Violation|1
7728657|NCT00589979|12155784|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0
7728658|NCT00589979|12155785|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0
7728659|NCT00589979|12155786|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1
7728660|NCT00589979|12155784|FG000|Double-Blind Treatment Period 2|Adverse Event|0
7728661|NCT00589979|12155785|FG001|Double-Blind Treatment Period 2|Adverse Event|1
7728662|NCT00589979|12155786|FG002|Double-Blind Treatment Period 2|Adverse Event|0
7728663|NCT00589979|12155784|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0
7728664|NCT00589979|12155785|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0
7728665|NCT00589979|12155786|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1
7728666|NCT00589979|12155784|FG000|Double-Blind Treatment Period 2|Other|0
7728667|NCT00589979|12155785|FG001|Double-Blind Treatment Period 2|Other|0
7728668|NCT00589979|12155786|FG002|Double-Blind Treatment Period 2|Other|1
7728669|NCT00589979|12155784|FG000|Double-Blind Treatment Period 3|Protocol Violation|0
7728670|NCT00589979|12155785|FG001|Double-Blind Treatment Period 3|Protocol Violation|1
7728671|NCT00589979|12155786|FG002|Double-Blind Treatment Period 3|Protocol Violation|0
7728672|NCT00589979|12155784|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0
7728673|NCT00589979|12155785|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0
7728674|NCT00589979|12155786|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1
7728675|NCT00590031|12155814|FG000|Overall Study|Adverse Event|3
7728676|NCT00590031|12155814|FG000|Overall Study|Withdrawal by Subject|1
7728677|NCT00590031|12155814|FG000|Overall Study|Metastatic Disease|1
7728678|NCT00590031|12155814|FG000|Overall Study|Admin Hold|1
7728679|NCT00590044|12155820|FG000|Overall Study|Withdrawal by Subject|2
7728680|NCT00590044|12155821|FG001|Overall Study|Withdrawal by Subject|2
7728681|NCT00590044|12155820|FG000|Overall Study|wrong insulin arm assigned|1
7728682|NCT00590044|12155821|FG001|Overall Study|wrong insulin arm assigned|0
7728683|NCT00590044|12155820|FG000|Overall Study|Protocol Violation|1
7728684|NCT00590044|12155821|FG001|Overall Study|Protocol Violation|0
7728685|NCT00590317|12155850|FG000|Overall Study|Lack of Efficacy|1
7728686|NCT00590317|12155851|FG001|Overall Study|Lack of Efficacy|5
7728687|NCT00590564|12155879|FG000|Overall Study|Withdrawal by Subject|4
7728688|NCT00590564|12155879|FG000|Overall Study|Lost to Follow-up|6
7728689|NCT00590564|12155879|FG000|Overall Study|Protocol Violation|1
7728690|NCT00590564|12155879|FG000|Overall Study|Patient Found to be Ineligible|1
7728691|NCT00590564|12155879|FG000|Overall Study|Patient Non-compliance|6
7728692|NCT00590577|12155887|FG000|Overall Study|Lack of Efficacy|31
7728693|NCT00590577|12155888|FG001|Overall Study|Lack of Efficacy|28
7728694|NCT00590577|12155889|FG002|Overall Study|Lack of Efficacy|23
7728695|NCT00590577|12155890|FG003|Overall Study|Lack of Efficacy|45
7728696|NCT00590577|12155887|FG000|Overall Study|Withdrawal by Subject|23
7728697|NCT00590577|12155888|FG001|Overall Study|Withdrawal by Subject|28
7728698|NCT00590577|12155889|FG002|Overall Study|Withdrawal by Subject|30
7728699|NCT00590577|12155890|FG003|Overall Study|Withdrawal by Subject|26
7728700|NCT00590577|12155887|FG000|Overall Study|Adverse Event|10
7728701|NCT00590577|12155888|FG001|Overall Study|Adverse Event|10
7728702|NCT00590577|12155889|FG002|Overall Study|Adverse Event|13
7728703|NCT00590577|12155890|FG003|Overall Study|Adverse Event|11
7728704|NCT00590577|12155887|FG000|Overall Study|Lost to Follow-up|12
7728705|NCT00590577|12155888|FG001|Overall Study|Lost to Follow-up|6
7728706|NCT00590577|12155889|FG002|Overall Study|Lost to Follow-up|6
7728707|NCT00590577|12155890|FG003|Overall Study|Lost to Follow-up|9
7728708|NCT00590577|12155887|FG000|Overall Study|Pregnancy|0
7728709|NCT00590577|12155888|FG001|Overall Study|Pregnancy|1
7728710|NCT00590577|12155889|FG002|Overall Study|Pregnancy|0
7728711|NCT00590577|12155890|FG003|Overall Study|Pregnancy|0
7728712|NCT00590577|12155887|FG000|Overall Study|Various reasons|1
7728713|NCT00590577|12155888|FG001|Overall Study|Various reasons|3
7728714|NCT00590577|12155889|FG002|Overall Study|Various reasons|1
7728715|NCT00590577|12155890|FG003|Overall Study|Various reasons|2
7728716|NCT00590590|12155903|FG000|Overall Study|Lack of Efficacy|1
7728717|NCT00590590|12155904|FG001|Overall Study|Lack of Efficacy|2
7728718|NCT00590590|12155905|FG002|Overall Study|Lack of Efficacy|0
7728719|NCT00590590|12155903|FG000|Overall Study|Adverse Event|1
7728720|NCT00590590|12155904|FG001|Overall Study|Adverse Event|0
7728721|NCT00590590|12155905|FG002|Overall Study|Adverse Event|0
7728722|NCT00590590|12155903|FG000|Overall Study|Protocol Violation|0
7728723|NCT00590590|12155904|FG001|Overall Study|Protocol Violation|0
7728724|NCT00590590|12155905|FG002|Overall Study|Protocol Violation|2
7728725|NCT00590590|12155903|FG000|Overall Study|Lost to Follow-up|4
7728726|NCT00590590|12155904|FG001|Overall Study|Lost to Follow-up|1
7728727|NCT00590590|12155905|FG002|Overall Study|Lost to Follow-up|2
7728728|NCT00590590|12155903|FG000|Overall Study|Withdrawal by Subject|0
7728729|NCT00590590|12155904|FG001|Overall Study|Withdrawal by Subject|1
7728730|NCT00590590|12155905|FG002|Overall Study|Withdrawal by Subject|1
7728731|NCT00590590|12155903|FG000|Overall Study|Did not complete due to study closure|1
7728732|NCT00590590|12155904|FG001|Overall Study|Did not complete due to study closure|1
7728733|NCT00590590|12155905|FG002|Overall Study|Did not complete due to study closure|1
7728734|NCT00590590|12155903|FG000|Overall Study|Did not complete study|0
7728735|NCT00590590|12155904|FG001|Overall Study|Did not complete study|1
7728736|NCT00590590|12155905|FG002|Overall Study|Did not complete study|0
7728737|NCT00590681|12155913|FG000|Overall Study|Withdrawal by Subject|7
7728738|NCT00590681|12155913|FG000|Overall Study|Adverse Event|8
7728739|NCT00590681|12155913|FG000|Overall Study|Death|3
7728740|NCT00590681|12155913|FG000|Overall Study|Lost to Follow-up|1
7728741|NCT00590681|12155913|FG000|Overall Study|disease progression|1
7728742|NCT00590720|12155928|FG000|Overall Study|Lost to Follow-up|1
7728743|NCT00590720|12155929|FG001|Overall Study|Lost to Follow-up|0
7728744|NCT00590720|12155928|FG000|Overall Study|Withdrawal by Subject|0
7728745|NCT00590720|12155929|FG001|Overall Study|Withdrawal by Subject|1
7728746|NCT00590759|12155935|FG000|Overall Study|Death|52
7728747|NCT00590759|12155935|FG000|Overall Study|Lost to Follow-up|28
7728748|NCT00590824|12155949|FG000|Overall Study|Disease could not be resected|0
7728749|NCT00590824|12155950|FG001|Overall Study|Disease could not be resected|2
7728750|NCT00590824|12155951|FG002|Overall Study|Disease could not be resected|1
7728751|NCT00590824|12155952|FG003|Overall Study|Disease could not be resected|0
7728752|NCT00590824|12155949|FG000|Overall Study|Adverse Event|0
7728753|NCT00590824|12155950|FG001|Overall Study|Adverse Event|0
7728754|NCT00590824|12155951|FG002|Overall Study|Adverse Event|0
7728755|NCT00590824|12155952|FG003|Overall Study|Adverse Event|1
7728756|NCT00590902|12155985|FG000|Overall Study|Death|1
7728757|NCT00590954|12155989|FG000|Overall Study|Inevaluable|2
7728758|NCT00590967|12155997|FG000|Overall Study|Withdrawal by Subject|1
7728759|NCT00590967|12155998|FG001|Overall Study|Withdrawal by Subject|1
7728760|NCT00590967|12155997|FG000|Overall Study|Ineligible|1
7728761|NCT00590967|12155998|FG001|Overall Study|Ineligible|0
7728762|NCT00590967|12155997|FG000|Overall Study|Poor performance status|0
7728763|NCT00590967|12155998|FG001|Overall Study|Poor performance status|1
7728764|NCT00590967|12155997|FG000|Overall Study|Non-compliant|0
7728765|NCT00590967|12155998|FG001|Overall Study|Non-compliant|2
7728766|NCT00590967|12155997|FG000|Overall Study|Did not sign consent form|0
7728767|NCT00590967|12155998|FG001|Overall Study|Did not sign consent form|1
7728768|NCT00590967|12155997|FG000|Overall Study|Did not receive chemo per protocol|1
7728769|NCT00590967|12155998|FG001|Overall Study|Did not receive chemo per protocol|0
7728770|NCT00590980|12156004|FG000|Overall Study|Did not meet all inclusion criteria|10
7728771|NCT00591006|12156008|FG000|Overall Study|Withdrawal by Subject|0
7728772|NCT00591006|12156009|FG001|Overall Study|Withdrawal by Subject|0
7728773|NCT00591006|12156010|FG002|Overall Study|Withdrawal by Subject|0
7728774|NCT00591006|12156011|FG003|Overall Study|Withdrawal by Subject|0
7728775|NCT00591006|12156012|FG004|Overall Study|Withdrawal by Subject|0
7728776|NCT00591006|12156013|FG005|Overall Study|Withdrawal by Subject|0
7728777|NCT00591006|12156014|FG006|Overall Study|Withdrawal by Subject|0
7728778|NCT00591006|12156015|FG007|Overall Study|Withdrawal by Subject|0
7728779|NCT00591006|12156016|FG008|Overall Study|Withdrawal by Subject|0
7728780|NCT00591006|12156017|FG009|Overall Study|Withdrawal by Subject|0
7728781|NCT00591006|12156018|FG010|Overall Study|Withdrawal by Subject|0
7728782|NCT00591006|12156019|FG011|Overall Study|Withdrawal by Subject|0
7728783|NCT00591006|12156020|FG012|Overall Study|Withdrawal by Subject|0
7728784|NCT00591006|12156021|FG013|Overall Study|Withdrawal by Subject|0
7728785|NCT00591006|12156022|FG014|Overall Study|Withdrawal by Subject|0
7728786|NCT00591006|12156023|FG015|Overall Study|Withdrawal by Subject|1
7728787|NCT00591006|12156024|FG016|Overall Study|Withdrawal by Subject|0
7728788|NCT00591006|12156025|FG017|Overall Study|Withdrawal by Subject|0
7728789|NCT00591006|12156026|FG018|Overall Study|Withdrawal by Subject|0
7728790|NCT00591006|12156027|FG019|Overall Study|Withdrawal by Subject|0
7728791|NCT00591006|12156028|FG020|Overall Study|Withdrawal by Subject|0
7728792|NCT00591006|12156029|FG021|Overall Study|Withdrawal by Subject|0
7728793|NCT00591006|12156030|FG022|Overall Study|Withdrawal by Subject|0
7728794|NCT00591006|12156031|FG023|Overall Study|Withdrawal by Subject|1
7728795|NCT00591006|12156008|FG000|Overall Study|Adverse Event|0
7728796|NCT00591006|12156009|FG001|Overall Study|Adverse Event|0
7728797|NCT00591006|12156010|FG002|Overall Study|Adverse Event|0
7728798|NCT00591006|12156011|FG003|Overall Study|Adverse Event|0
7728799|NCT00591006|12156012|FG004|Overall Study|Adverse Event|0
7728800|NCT00591006|12156013|FG005|Overall Study|Adverse Event|0
7728801|NCT00591006|12156014|FG006|Overall Study|Adverse Event|0
7728802|NCT00591006|12156015|FG007|Overall Study|Adverse Event|0
7728803|NCT00591006|12156016|FG008|Overall Study|Adverse Event|0
7728804|NCT00591006|12156017|FG009|Overall Study|Adverse Event|0
7728805|NCT00591006|12156018|FG010|Overall Study|Adverse Event|0
7728806|NCT00591006|12156019|FG011|Overall Study|Adverse Event|0
7728807|NCT00591006|12156020|FG012|Overall Study|Adverse Event|0
7728808|NCT00591006|12156021|FG013|Overall Study|Adverse Event|0
7728809|NCT00591006|12156022|FG014|Overall Study|Adverse Event|0
7728810|NCT00591006|12156023|FG015|Overall Study|Adverse Event|0
7728811|NCT00591006|12156024|FG016|Overall Study|Adverse Event|0
7728812|NCT00591006|12156025|FG017|Overall Study|Adverse Event|0
7728813|NCT00591006|12156026|FG018|Overall Study|Adverse Event|0
7728814|NCT00591006|12156027|FG019|Overall Study|Adverse Event|0
7728815|NCT00591006|12156028|FG020|Overall Study|Adverse Event|0
7728816|NCT00591006|12156029|FG021|Overall Study|Adverse Event|0
7728817|NCT00591006|12156030|FG022|Overall Study|Adverse Event|1
7728818|NCT00591006|12156031|FG023|Overall Study|Adverse Event|0
7728819|NCT00591149|12156061|FG000|Overall Study|Adverse Event|4
7728820|NCT00591149|12156061|FG000|Overall Study|Withdrawal by Subject|1
7728821|NCT00591214|12156065|FG000|Overall Study|Physician Decision|7
7728822|NCT00591214|12156065|FG000|Overall Study|Withdrawal by Subject|1
7728823|NCT00591253|12156081|FG000|Overall Study|Adverse Event|3
7728824|NCT00591253|12156082|FG001|Overall Study|Adverse Event|3
7728825|NCT00591253|12156083|FG002|Overall Study|Adverse Event|1
7728826|NCT00591253|12156081|FG000|Overall Study|Protocol Violation|2
7728827|NCT00591253|12156082|FG001|Overall Study|Protocol Violation|2
7728828|NCT00591253|12156083|FG002|Overall Study|Protocol Violation|2
7728829|NCT00591253|12156081|FG000|Overall Study|Lost to Follow-up|2
7728830|NCT00591253|12156082|FG001|Overall Study|Lost to Follow-up|4
7728831|NCT00591253|12156083|FG002|Overall Study|Lost to Follow-up|0
7728832|NCT00591253|12156081|FG000|Overall Study|Withdrawal by Subject|1
7728833|NCT00591253|12156082|FG001|Overall Study|Withdrawal by Subject|7
7728834|NCT00591253|12156083|FG002|Overall Study|Withdrawal by Subject|6
7728835|NCT00591253|12156081|FG000|Overall Study|Lack of Efficacy|1
7728836|NCT00591253|12156082|FG001|Overall Study|Lack of Efficacy|0
7728837|NCT00591253|12156083|FG002|Overall Study|Lack of Efficacy|3
7728838|NCT00591253|12156081|FG000|Overall Study|Other|5
7728839|NCT00591253|12156082|FG001|Overall Study|Other|5
7728840|NCT00591253|12156083|FG002|Overall Study|Other|3
7728841|NCT00591266|12156094|FG000|Overall Study|Adverse Event|2
7728842|NCT00591266|12156095|FG001|Overall Study|Adverse Event|2
7728843|NCT00591266|12156096|FG002|Overall Study|Adverse Event|3
7728844|NCT00591266|12156094|FG000|Overall Study|Lost to Follow-up|0
7728845|NCT00591266|12156095|FG001|Overall Study|Lost to Follow-up|1
7728846|NCT00591266|12156096|FG002|Overall Study|Lost to Follow-up|0
7728847|NCT00591266|12156094|FG000|Overall Study|Protocol Violation|0
7728848|NCT00591266|12156095|FG001|Overall Study|Protocol Violation|0
7728849|NCT00591266|12156096|FG002|Overall Study|Protocol Violation|1
7728850|NCT00591266|12156094|FG000|Overall Study|Withdrawal by Subject|6
7728851|NCT00591266|12156095|FG001|Overall Study|Withdrawal by Subject|2
7728852|NCT00591266|12156096|FG002|Overall Study|Withdrawal by Subject|5
7728853|NCT00591266|12156094|FG000|Overall Study|Lack of Efficacy|0
7728854|NCT00591266|12156095|FG001|Overall Study|Lack of Efficacy|2
7728855|NCT00591266|12156096|FG002|Overall Study|Lack of Efficacy|0
7728856|NCT00591266|12156094|FG000|Overall Study|Other|1
7728857|NCT00591266|12156095|FG001|Overall Study|Other|4
7728858|NCT00591266|12156096|FG002|Overall Study|Other|5
7728859|NCT00591344|12156116|FG000|Overall Study|Transportation issues|1
7728860|NCT00591344|12156117|FG001|Overall Study|Transportation issues|0
7728861|NCT00591344|12156116|FG000|Overall Study|Moved out of state|1
7728862|NCT00591344|12156117|FG001|Overall Study|Moved out of state|0
7728863|NCT00591344|12156116|FG000|Overall Study|Medical complications|1
7728864|NCT00591344|12156117|FG001|Overall Study|Medical complications|3
7728865|NCT00591344|12156116|FG000|Overall Study|Underwent DBS|2
7728866|NCT00591344|12156117|FG001|Overall Study|Underwent DBS|2
7728867|NCT00591344|12156116|FG000|Overall Study|Death|0
7728868|NCT00591344|12156117|FG001|Overall Study|Death|1
7728869|NCT00591344|12156116|FG000|Overall Study|Lost to Follow-up|0
7728870|NCT00591344|12156117|FG001|Overall Study|Lost to Follow-up|1
7728871|NCT00591344|12156116|FG000|Overall Study|Did not want to come off medication|0
7728872|NCT00591344|12156117|FG001|Overall Study|Did not want to come off medication|1
7728873|NCT00591370|12156127|FG000|Overall Study|Not Treated|2
7728874|NCT00591409|12156141|FG000|Overall Study|Not Treated|0
7728875|NCT00591409|12156142|FG001|Overall Study|Not Treated|0
7728876|NCT00591409|12156143|FG002|Overall Study|Not Treated|0
7728877|NCT00591409|12156144|FG003|Overall Study|Not Treated|0
7728878|NCT00591409|12156145|FG004|Overall Study|Not Treated|1
7728879|NCT00591409|12156146|FG005|Overall Study|Not Treated|0
7728880|NCT00591409|12156147|FG006|Overall Study|Not Treated|0
7728881|NCT00591409|12156148|FG007|Overall Study|Not Treated|0
7728882|NCT00591409|12156149|FG008|Overall Study|Not Treated|0
7728883|NCT00591409|12156150|FG009|Overall Study|Not Treated|1
7728884|NCT00591565|12156172|FG000|Overall Study|lost follow up, withdrawn|5
7728885|NCT00591578|12156179|FG000|Double-Blind Treatment Phase|Adverse Event|20
7728886|NCT00591578|12156180|FG001|Double-Blind Treatment Phase|Adverse Event|26
7728887|NCT00591578|12156181|FG002|Double-Blind Treatment Phase|Adverse Event|19
7728888|NCT00591578|12156179|FG000|Double-Blind Treatment Phase|Protocol Violation|3
7728889|NCT00591578|12156180|FG001|Double-Blind Treatment Phase|Protocol Violation|2
7728890|NCT00591578|12156181|FG002|Double-Blind Treatment Phase|Protocol Violation|3
7728891|NCT00591578|12156179|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12
7728892|NCT00591578|12156180|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12
7728893|NCT00591578|12156181|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11
7728894|NCT00591578|12156179|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22
7728895|NCT00591578|12156180|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22
7728896|NCT00591578|12156181|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22
7728897|NCT00591578|12156179|FG000|Double-Blind Treatment Phase|Pregnancy|1
7728898|NCT00591578|12156180|FG001|Double-Blind Treatment Phase|Pregnancy|0
7728899|NCT00591578|12156181|FG002|Double-Blind Treatment Phase|Pregnancy|0
7728900|NCT00591578|12156179|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16
7728901|NCT00591578|12156180|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9
7728902|NCT00591578|12156181|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25
7728903|NCT00591578|12156179|FG000|Double-Blind Treatment Phase|Other|4
7728904|NCT00591578|12156180|FG001|Double-Blind Treatment Phase|Other|9
7728905|NCT00591578|12156181|FG002|Double-Blind Treatment Phase|Other|4
7728906|NCT00591578|12156179|FG000|Open-Label Extension Phase|Adverse Event|3
7728907|NCT00591578|12156180|FG001|Open-Label Extension Phase|Adverse Event|5
7728908|NCT00591578|12156181|FG002|Open-Label Extension Phase|Adverse Event|0
7728909|NCT00591578|12156179|FG000|Open-Label Extension Phase|Lost to Follow-up|1
7728910|NCT00591578|12156180|FG001|Open-Label Extension Phase|Lost to Follow-up|4
7728911|NCT00591578|12156181|FG002|Open-Label Extension Phase|Lost to Follow-up|0
7728912|NCT00591578|12156179|FG000|Open-Label Extension Phase|Withdrawal by Subject|1
7728913|NCT00591578|12156180|FG001|Open-Label Extension Phase|Withdrawal by Subject|1
7728914|NCT00591578|12156181|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
7728915|NCT00591578|12156179|FG000|Open-Label Extension Phase|Other|1
7728916|NCT00591578|12156180|FG001|Open-Label Extension Phase|Other|0
7728917|NCT00591578|12156181|FG002|Open-Label Extension Phase|Other|0
7728918|NCT00591591|12156192|FG000|Overall Study|Withdrawal by Subject|1
7728919|NCT00591591|12156193|FG001|Overall Study|Withdrawal by Subject|37
7728920|NCT00591591|12156192|FG000|Overall Study|Lack of Efficacy|10
7728921|NCT00591591|12156193|FG001|Overall Study|Lack of Efficacy|2
7728922|NCT00591630|12156203|FG000|Overall Study|Death|0
7728923|NCT00591630|12156204|FG001|Overall Study|Death|0
7728924|NCT00591630|12156205|FG002|Overall Study|Death|1
7728925|NCT00591630|12156206|FG003|Overall Study|Death|0
7728926|NCT00591721|12156218|FG000|Overall Study|Withdrawal by Subject|10
7728927|NCT00591721|12156219|FG001|Overall Study|Withdrawal by Subject|10
7728928|NCT00591721|12156218|FG000|Overall Study|Lost to Follow-up|1
7728929|NCT00591721|12156219|FG001|Overall Study|Lost to Follow-up|4
7728930|NCT00591721|12156218|FG000|Overall Study|Intervention not received|10
7728931|NCT00591721|12156219|FG001|Overall Study|Intervention not received|8
7728932|NCT00591734|12156225|FG000|Overall Study|Lack of Efficacy|35
7728933|NCT00591734|12156225|FG000|Overall Study|Adverse Event|5
7728934|NCT00591734|12156225|FG000|Overall Study|Physician Decision|5
7728935|NCT00591734|12156225|FG000|Overall Study|Intercurrent Illness|8
7728936|NCT00591773|12156241|FG000|Overall Study|Adverse Event|9
7728937|NCT00591773|12156242|FG001|Overall Study|Adverse Event|9
7728938|NCT00591773|12156243|FG002|Overall Study|Adverse Event|6
7728939|NCT00591773|12156241|FG000|Overall Study|Protocol Violation|2
7728940|NCT00591773|12156242|FG001|Overall Study|Protocol Violation|3
7728941|NCT00591773|12156243|FG002|Overall Study|Protocol Violation|0
7728942|NCT00591773|12156241|FG000|Overall Study|Lost to Follow-up|1
7728943|NCT00591773|12156242|FG001|Overall Study|Lost to Follow-up|4
7728944|NCT00591773|12156243|FG002|Overall Study|Lost to Follow-up|1
7728945|NCT00591773|12156241|FG000|Overall Study|Withdrawal by Subject|2
7728946|NCT00591773|12156242|FG001|Overall Study|Withdrawal by Subject|5
7728947|NCT00591773|12156243|FG002|Overall Study|Withdrawal by Subject|3
7728948|NCT00591773|12156241|FG000|Overall Study|Lack of Efficacy|1
7728949|NCT00591773|12156242|FG001|Overall Study|Lack of Efficacy|2
7728950|NCT00591773|12156243|FG002|Overall Study|Lack of Efficacy|2
7728951|NCT00591773|12156241|FG000|Overall Study|Other|1
7728952|NCT00591773|12156242|FG001|Overall Study|Other|1
7728953|NCT00591773|12156243|FG002|Overall Study|Other|4
7728954|NCT00591786|12156261|FG000|Overall Study|Withdrawal of Informed Consent|0
7728955|NCT00591786|12156262|FG001|Overall Study|Withdrawal of Informed Consent|0
7728956|NCT00591786|12156263|FG002|Overall Study|Withdrawal of Informed Consent|1
7728957|NCT00591786|12156264|FG003|Overall Study|Withdrawal of Informed Consent|0
7728958|NCT00591786|12156265|FG004|Overall Study|Withdrawal of Informed Consent|0
7728959|NCT00591786|12156266|FG005|Overall Study|Withdrawal of Informed Consent|0
7728960|NCT00591786|12156267|FG006|Overall Study|Withdrawal of Informed Consent|0
7728961|NCT00591786|12156268|FG007|Overall Study|Withdrawal of Informed Consent|0
7728962|NCT00591786|12156269|FG008|Overall Study|Withdrawal of Informed Consent|0
7728963|NCT00591786|12156270|FG009|Overall Study|Withdrawal of Informed Consent|0
7728964|NCT00591838|12156324|FG000|Overall Study|Withdrawal by Subject|0
7728965|NCT00591838|12156325|FG001|Overall Study|Withdrawal by Subject|0
7728966|NCT00591838|12156326|FG002|Overall Study|Withdrawal by Subject|0
7728967|NCT00591838|12156327|FG003|Overall Study|Withdrawal by Subject|1
7728968|NCT00591838|12156328|FG004|Overall Study|Withdrawal by Subject|0
7728969|NCT00591851|12156341|FG000|Overall Study|Withdrawal by Subject|3
7728970|NCT00591851|12156341|FG000|Overall Study|Adverse Event|2
7728971|NCT00591851|12156341|FG000|Overall Study|Progressive Disease|1
7728972|NCT00591864|12156345|FG000|Overall Study|Incomplete Imaging|5
7728973|NCT00592072|12156357|FG000|Wash Out Period|Lost to Follow-up|1
7728974|NCT00592072|12156358|FG001|Wash Out Period|Lost to Follow-up|1
7728975|NCT00592319|12156391|FG000|Overall Study|Lost to Follow-up|0
7728976|NCT00592319|12156392|FG001|Overall Study|Lost to Follow-up|3
7728977|NCT00592358|12156400|FG000|Overall Study|Withdrawal by Subject|2
7728978|NCT00592358|12156400|FG000|Overall Study|Adverse Event|1
7728979|NCT00592358|12156400|FG000|Overall Study|Lack of Efficacy|2
7728980|NCT00592358|12156400|FG000|Overall Study|Inability to swallow pills|1
7728981|NCT00592384|12156406|FG000|Overall Study|Withdrawal by Subject|5
7728982|NCT00592384|12156407|FG001|Overall Study|Withdrawal by Subject|6
7728983|NCT00592501|12156437|FG000|Overall Study|Withdrawal by Subject|1
7728984|NCT00592501|12156437|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1
7728985|NCT00592553|12156444|FG000|Overall Study|Protocol Noncompliance|1
7728986|NCT00592553|12156445|FG001|Overall Study|Protocol Noncompliance|0
7728987|NCT00592553|12156446|FG002|Overall Study|Protocol Noncompliance|0
7728988|NCT00592631|12156456|FG000|Overall Study|Lost to Follow-up|0
7728989|NCT00592631|12156457|FG001|Overall Study|Lost to Follow-up|2
7728990|NCT00592683|12156465|FG000|Overall Study|Found ineligible|0
7728991|NCT00592683|12156466|FG001|Overall Study|Found ineligible|1
7728992|NCT00592683|12156465|FG000|Overall Study|Withdrawal by Subject|1
7728993|NCT00592683|12156466|FG001|Overall Study|Withdrawal by Subject|0
7728994|NCT00592683|12156465|FG000|Overall Study|Adverse Event|0
7728995|NCT00592683|12156466|FG001|Overall Study|Adverse Event|2
7728996|NCT00592683|12156465|FG000|Overall Study|Protocol Violation|1
7728997|NCT00592683|12156466|FG001|Overall Study|Protocol Violation|0
7728998|NCT00592683|12156465|FG000|Overall Study|Study drug expired|1
7728999|NCT00592683|12156466|FG001|Overall Study|Study drug expired|0
7729000|NCT00592683|12156465|FG000|Overall Study|Other|1
7729001|NCT00592683|12156466|FG001|Overall Study|Other|0
7729002|NCT00592683|12156465|FG000|Overall Study|Lost to Follow-up|0
7729003|NCT00592683|12156466|FG001|Overall Study|Lost to Follow-up|1
7729004|NCT00592774|12156484|FG000|Overall Study|Adverse Event|5
7729005|NCT00592774|12156485|FG001|Overall Study|Adverse Event|19
7729006|NCT00592774|12156486|FG002|Overall Study|Adverse Event|2
7729007|NCT00592774|12156487|FG003|Overall Study|Adverse Event|14
7729008|NCT00592774|12156488|FG004|Overall Study|Adverse Event|8
7729009|NCT00592774|12156484|FG000|Overall Study|Protocol Violation|0
7729010|NCT00592774|12156485|FG001|Overall Study|Protocol Violation|1
7729011|NCT00592774|12156486|FG002|Overall Study|Protocol Violation|0
7729012|NCT00592774|12156487|FG003|Overall Study|Protocol Violation|0
7729013|NCT00592774|12156488|FG004|Overall Study|Protocol Violation|1
7729014|NCT00592774|12156484|FG000|Overall Study|Withdrawal by Subject|3
7729015|NCT00592774|12156485|FG001|Overall Study|Withdrawal by Subject|7
7729016|NCT00592774|12156486|FG002|Overall Study|Withdrawal by Subject|0
7729017|NCT00592774|12156487|FG003|Overall Study|Withdrawal by Subject|0
7729018|NCT00592774|12156488|FG004|Overall Study|Withdrawal by Subject|0
7729019|NCT00592774|12156484|FG000|Overall Study|Lack of Efficacy|3
7729020|NCT00592774|12156485|FG001|Overall Study|Lack of Efficacy|3
7729021|NCT00592774|12156486|FG002|Overall Study|Lack of Efficacy|0
7729022|NCT00592774|12156487|FG003|Overall Study|Lack of Efficacy|0
7729023|NCT00592774|12156488|FG004|Overall Study|Lack of Efficacy|2
7729024|NCT00592774|12156484|FG000|Overall Study|Physician Decision|0
7729025|NCT00592774|12156485|FG001|Overall Study|Physician Decision|1
7729026|NCT00592774|12156486|FG002|Overall Study|Physician Decision|1
7729027|NCT00592774|12156487|FG003|Overall Study|Physician Decision|0
7729028|NCT00592774|12156488|FG004|Overall Study|Physician Decision|1
7729029|NCT00592774|12156484|FG000|Overall Study|Other|0
7729030|NCT00592774|12156485|FG001|Overall Study|Other|1
7729031|NCT00592774|12156486|FG002|Overall Study|Other|1
7729032|NCT00592774|12156487|FG003|Overall Study|Other|0
7729033|NCT00592774|12156488|FG004|Overall Study|Other|2
7729034|NCT00592839|12156503|FG000|Overall Study|Withdrawal by Subject|1
7729035|NCT00592839|12156504|FG001|Overall Study|Withdrawal by Subject|1
7729036|NCT00592839|12156505|FG002|Overall Study|Withdrawal by Subject|3
7729037|NCT00592839|12156503|FG000|Overall Study|Protocol Violation|1
7729038|NCT00592839|12156504|FG001|Overall Study|Protocol Violation|1
7729039|NCT00592839|12156505|FG002|Overall Study|Protocol Violation|2
7729040|NCT00592839|12156503|FG000|Overall Study|Adverse Event|0
7729041|NCT00592839|12156504|FG001|Overall Study|Adverse Event|1
7729042|NCT00592839|12156505|FG002|Overall Study|Adverse Event|0
7729043|NCT00592839|12156503|FG000|Overall Study|Lost to Follow-up|0
7729044|NCT00592839|12156504|FG001|Overall Study|Lost to Follow-up|1
7729045|NCT00592839|12156505|FG002|Overall Study|Lost to Follow-up|1
7729046|NCT00592852|12156513|FG000|Overall Study|Non-compliance|1
7729047|NCT00592852|12156513|FG000|Overall Study|Adverse Event|3
7729048|NCT00592852|12156513|FG000|Overall Study|Found ineligible|1
7729049|NCT00592852|12156513|FG000|Overall Study|Withdrawal by Subject|1
7729050|NCT00592904|12156521|FG000|Overall Study|Adverse Event|15
7729051|NCT00592904|12156522|FG001|Overall Study|Adverse Event|25
7729052|NCT00592904|12156523|FG002|Overall Study|Adverse Event|13
7729053|NCT00592904|12156524|FG003|Overall Study|Adverse Event|5
7729054|NCT00592904|12156521|FG000|Overall Study|Protocol Violation|1
7729055|NCT00592904|12156522|FG001|Overall Study|Protocol Violation|1
7729056|NCT00592904|12156523|FG002|Overall Study|Protocol Violation|0
7729057|NCT00592904|12156524|FG003|Overall Study|Protocol Violation|1
7729058|NCT00592904|12156521|FG000|Overall Study|Withdrawal by Subject|4
7729059|NCT00592904|12156522|FG001|Overall Study|Withdrawal by Subject|16
7729060|NCT00592904|12156523|FG002|Overall Study|Withdrawal by Subject|1
7729061|NCT00592904|12156524|FG003|Overall Study|Withdrawal by Subject|2
7729062|NCT00592904|12156521|FG000|Overall Study|Lack of Efficacy|2
7729063|NCT00592904|12156522|FG001|Overall Study|Lack of Efficacy|7
7729064|NCT00592904|12156523|FG002|Overall Study|Lack of Efficacy|2
7729065|NCT00592904|12156524|FG003|Overall Study|Lack of Efficacy|3
7729066|NCT00592904|12156521|FG000|Overall Study|Physician Decision|0
7729067|NCT00592904|12156522|FG001|Overall Study|Physician Decision|3
7729068|NCT00592904|12156523|FG002|Overall Study|Physician Decision|1
7729069|NCT00592904|12156524|FG003|Overall Study|Physician Decision|0
7729070|NCT00592904|12156521|FG000|Overall Study|Other|3
7729071|NCT00592904|12156522|FG001|Overall Study|Other|3
7729072|NCT00592904|12156523|FG002|Overall Study|Other|0
7729073|NCT00592904|12156524|FG003|Overall Study|Other|0
7729074|NCT00593112|12156545|FG000|Overall Study|Scan Anxiety|3
7729075|NCT00593112|12156546|FG001|Overall Study|Scan Anxiety|0
7729076|NCT00593112|12156545|FG000|Overall Study|Abnormal Scan|1
7729077|NCT00593112|12156546|FG001|Overall Study|Abnormal Scan|0
7729078|NCT00593112|12156545|FG000|Overall Study|Unreadable Scan|1
7729079|NCT00593112|12156546|FG001|Overall Study|Unreadable Scan|0
7729080|NCT00593112|12156545|FG000|Overall Study|Withdrawal by Subject|5
7729081|NCT00593112|12156546|FG001|Overall Study|Withdrawal by Subject|0
7729082|NCT00593333|12156554|FG000|Overall Study|Lost to Follow-up|10
7729083|NCT00593333|12156555|FG001|Overall Study|Lost to Follow-up|11
7729084|NCT00593385|12156575|FG000|Overall Study|Death|14
7729085|NCT00593385|12156575|FG000|Overall Study|Lost to Follow-up|17
7729086|NCT00593385|12156575|FG000|Overall Study|Withdrawal by Subject|9
7729087|NCT00593489|12156600|FG000|Allocation|did not attend workshop; allocation not|2
7729088|NCT00593489|12156601|FG001|Allocation|did not attend workshop; allocation not|1
7729089|NCT00593554|12156611|FG000|Overall Study|Death|1
7729090|NCT00593554|12156612|FG001|Overall Study|Death|2
7729091|NCT00593554|12156611|FG000|Overall Study|Physician Decision|0
7729092|NCT00593554|12156612|FG001|Overall Study|Physician Decision|1
7729093|NCT00593554|12156611|FG000|Overall Study|Withdrawal by Subject|1
7729094|NCT00593554|12156612|FG001|Overall Study|Withdrawal by Subject|0
7729095|NCT00593554|12156611|FG000|Overall Study|Disease Progression|1
7729096|NCT00593554|12156612|FG001|Overall Study|Disease Progression|2
7729097|NCT00593606|12156618|FG000|Overall Study|Adverse Event|13
7729098|NCT00593606|12156618|FG000|Overall Study|Withdrawal by Subject|1
7729099|NCT00593606|12156618|FG000|Overall Study|Protocol Violation|3
7729100|NCT00593606|12156618|FG000|Overall Study|Lost to Follow-up|2
7729101|NCT00593606|12156618|FG000|Overall Study|Run-In Failure|5
7729102|NCT00593606|12156618|FG000|Overall Study|Screen Failure|3
7729103|NCT00593684|12156628|FG000|Overall Study|Death|2
7729104|NCT00593684|12156629|FG001|Overall Study|Death|1
7729105|NCT00593736|12156639|FG000|Screening Period and Placebo Run-in|Adverse Event|0
7729106|NCT00593736|12156640|FG001|Screening Period and Placebo Run-in|Adverse Event|0
7729107|NCT00593736|12156641|FG002|Screening Period and Placebo Run-in|Adverse Event|0
7729108|NCT00593736|12156642|FG003|Screening Period and Placebo Run-in|Adverse Event|3
7729109|NCT00593736|12156639|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0
7729110|NCT00593736|12156640|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0
7729111|NCT00593736|12156641|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0
7729112|NCT00593736|12156642|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9
7729113|NCT00593736|12156639|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0
7729114|NCT00593736|12156640|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0
7729115|NCT00593736|12156641|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0
7729116|NCT00593736|12156642|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43
7729117|NCT00593736|12156639|FG000|Screening Period and Placebo Run-in|Study Termination|0
7729118|NCT00593736|12156640|FG001|Screening Period and Placebo Run-in|Study Termination|0
7729119|NCT00593736|12156641|FG002|Screening Period and Placebo Run-in|Study Termination|0
7729120|NCT00593736|12156642|FG003|Screening Period and Placebo Run-in|Study Termination|15
7729121|NCT00593736|12156639|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
7729122|NCT00593736|12156640|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
7729123|NCT00593736|12156641|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
7729124|NCT00593736|12156642|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
7729125|NCT00593736|12156639|FG000|Screening Period and Placebo Run-in|Various|0
7729126|NCT00593736|12156640|FG001|Screening Period and Placebo Run-in|Various|0
7729127|NCT00593736|12156641|FG002|Screening Period and Placebo Run-in|Various|0
7729128|NCT00593736|12156642|FG003|Screening Period and Placebo Run-in|Various|25
7729129|NCT00593736|12156639|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2
7729130|NCT00593736|12156640|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1
7729131|NCT00593736|12156641|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2
7729132|NCT00593736|12156642|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0
7729133|NCT00593736|12156639|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0
7729134|NCT00593736|12156640|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0
7729135|NCT00593736|12156641|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1
7729136|NCT00593736|12156642|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1
7729137|NCT00593736|12156639|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
7729138|NCT00593736|12156640|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
7729139|NCT00593736|12156641|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
7729140|NCT00593736|12156642|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
7729141|NCT00593736|12156639|FG000|Treatment Period and Placebo Run-out|Various|1
7729142|NCT00593736|12156640|FG001|Treatment Period and Placebo Run-out|Various|1
7729143|NCT00593736|12156641|FG002|Treatment Period and Placebo Run-out|Various|1
7729144|NCT00593736|12156642|FG003|Treatment Period and Placebo Run-out|Various|0
7729145|NCT00593814|12156654|FG000|Overall Study|Death|7
7729146|NCT00593814|12156655|FG001|Overall Study|Death|0
7729147|NCT00593814|12156654|FG000|Overall Study|Withdrawal by Subject|7
7729148|NCT00593814|12156655|FG001|Overall Study|Withdrawal by Subject|0
7729149|NCT00593814|12156654|FG000|Overall Study|Lost to Follow-up|7
7729150|NCT00593814|12156655|FG001|Overall Study|Lost to Follow-up|0
7729151|NCT00593814|12156654|FG000|Overall Study|Physician Decision|3
7729152|NCT00593814|12156655|FG001|Overall Study|Physician Decision|0
7768573|NCT00862654|12211891|FG001|Overall Study|Lack of Efficacy|0
7768574|NCT00862654|12211892|FG002|Overall Study|Lack of Efficacy|1
7768575|NCT00862654|12211893|FG003|Overall Study|Lack of Efficacy|0
7768576|NCT00862654|12211890|FG000|Overall Study|Lost to Follow-up|1
7768577|NCT00862654|12211891|FG001|Overall Study|Lost to Follow-up|2
7768578|NCT00862654|12211892|FG002|Overall Study|Lost to Follow-up|1
7768579|NCT00862654|12211893|FG003|Overall Study|Lost to Follow-up|3
7729153|NCT00593827|12156663|FG000|Overall Study|On Active Treatment/Pending|0
7729154|NCT00593827|12156664|FG001|Overall Study|On Active Treatment/Pending|2
7729155|NCT00593918|12156676|FG000|Overall Study|Withdrawal by Subject|5
7729156|NCT00593918|12156677|FG001|Overall Study|Withdrawal by Subject|24
7729157|NCT00593957|12156686|FG000|Overall Study|Physician Decision|0
7729158|NCT00593957|12156687|FG001|Overall Study|Physician Decision|1
7729159|NCT00593957|12156688|FG002|Overall Study|Physician Decision|2
7729160|NCT00594035|12156725|FG000|Overall Study|Lost to Follow-up|1
7729161|NCT00594035|12156726|FG001|Overall Study|Lost to Follow-up|1
7729162|NCT00594035|12156725|FG000|Overall Study|Withdrawal by Subject|1
7729163|NCT00594035|12156726|FG001|Overall Study|Withdrawal by Subject|0
7729164|NCT00594035|12156725|FG000|Overall Study|Subject transferred to nursing home|0
7729165|NCT00594035|12156726|FG001|Overall Study|Subject transferred to nursing home|1
7729166|NCT00594035|12156725|FG000|Overall Study|Subject couldn't return due to job|0
7729167|NCT00594035|12156726|FG001|Overall Study|Subject couldn't return due to job|1
7729168|NCT00594100|12156736|FG000|Procedure|Technical Failure|9
7729169|NCT00594100|12156736|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
7729170|NCT00594100|12156736|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
7729171|NCT00594100|12156736|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
7729172|NCT00594165|12156740|FG000|Overall Study|Major protocol violation|1
7729173|NCT00594165|12156740|FG000|Overall Study|Lack of Efficacy|12
7729174|NCT00594165|12156740|FG000|Overall Study|Adverse Event|52
7729175|NCT00594165|12156740|FG000|Overall Study|Unsatisfactory compliance of subject|6
7729176|NCT00594165|12156740|FG000|Overall Study|Subject withdrew consent|27
7729177|NCT00594165|12156740|FG000|Overall Study|Study ended per sponsor|102
7729178|NCT00594165|12156740|FG000|Overall Study|Lost to Follow-up|4
7729179|NCT00594165|12156740|FG000|Overall Study|Other: PI discretion|5
7729180|NCT00594165|12156740|FG000|Overall Study|Other: Subject moving|3
7729181|NCT00594165|12156740|FG000|Overall Study|Other: Brain surgery controlled symptoms|1
7729182|NCT00594165|12156740|FG000|Overall Study|Other: House bound; can't get to clinic|1
7729183|NCT00594165|12156740|FG000|Overall Study|Other: Subject enrolled in other trial|1
7729184|NCT00594165|12156740|FG000|Overall Study|Other: Site terminated participation|2
7729185|NCT00594178|12156744|FG000|Overall Study|Physician Decision|5
7729186|NCT00594204|12156750|FG000|Overall Study|Adverse Event|15
7729187|NCT00594204|12156751|FG001|Overall Study|Adverse Event|3
7729188|NCT00594204|12156750|FG000|Overall Study|Lost to Follow-up|9
7729189|NCT00594204|12156751|FG001|Overall Study|Lost to Follow-up|5
7729190|NCT00594204|12156750|FG000|Overall Study|Withdrawal by Subject|23
7729191|NCT00594204|12156751|FG001|Overall Study|Withdrawal by Subject|29
7729192|NCT00594204|12156750|FG000|Overall Study|Other|4
7729193|NCT00594204|12156751|FG001|Overall Study|Other|3
7729194|NCT00594204|12156750|FG000|Overall Study|Lack of Efficacy|3
7729195|NCT00594204|12156751|FG001|Overall Study|Lack of Efficacy|4
7729196|NCT00594204|12156750|FG000|Overall Study|Randomized but not treated|4
7729197|NCT00594204|12156751|FG001|Overall Study|Randomized but not treated|1
7729198|NCT00594399|12156777|FG000|Initial 3 Month Counseling|Not ready to exercise|1
7729199|NCT00594399|12156778|FG001|Initial 3 Month Counseling|Not ready to exercise|0
7729200|NCT00594399|12156779|FG002|Initial 3 Month Counseling|Not ready to exercise|0
7729201|NCT00594399|12156777|FG000|Initial 3 Month Counseling|Lack of Interest|3
7729202|NCT00594399|12156778|FG001|Initial 3 Month Counseling|Lack of Interest|3
7729203|NCT00594399|12156779|FG002|Initial 3 Month Counseling|Lack of Interest|0
7729204|NCT00594399|12156777|FG000|Initial 3 Month Counseling|Personal issues|2
7729205|NCT00594399|12156778|FG001|Initial 3 Month Counseling|Personal issues|0
7729206|NCT00594399|12156779|FG002|Initial 3 Month Counseling|Personal issues|0
7729207|NCT00594399|12156777|FG000|Initial 3 Month Counseling|Too busy|7
7729208|NCT00594399|12156778|FG001|Initial 3 Month Counseling|Too busy|1
7729209|NCT00594399|12156779|FG002|Initial 3 Month Counseling|Too busy|0
7729210|NCT00594399|12156777|FG000|Initial 3 Month Counseling|Pain|2
7729211|NCT00594399|12156778|FG001|Initial 3 Month Counseling|Pain|0
7729212|NCT00594399|12156779|FG002|Initial 3 Month Counseling|Pain|0
7729213|NCT00594399|12156777|FG000|Initial 3 Month Counseling|Moved|1
7729214|NCT00594399|12156778|FG001|Initial 3 Month Counseling|Moved|0
7729215|NCT00594399|12156779|FG002|Initial 3 Month Counseling|Moved|0
7729216|NCT00594399|12156777|FG000|Initial 3 Month Counseling|Family illness|1
7729217|NCT00594399|12156778|FG001|Initial 3 Month Counseling|Family illness|0
7729218|NCT00594399|12156779|FG002|Initial 3 Month Counseling|Family illness|0
7729219|NCT00594399|12156777|FG000|Rerandomization Arm 1 Only|Death|2
7729220|NCT00594399|12156778|FG001|Rerandomization Arm 1 Only|Death|1
7729221|NCT00594399|12156779|FG002|Rerandomization Arm 1 Only|Death|0
7729222|NCT00594399|12156777|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0
7729223|NCT00594399|12156778|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3
7729224|NCT00594399|12156779|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0
7729225|NCT00594464|12156798|FG000|Overall Study|Withdrawal by Subject|1
7729226|NCT00594464|12156798|FG000|Overall Study|Delay in operation|2
7729227|NCT00594516|12156808|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
7729228|NCT00594516|12156809|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
7729229|NCT00594516|12156810|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
7729230|NCT00594516|12156808|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
7729231|NCT00594516|12156809|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
7729232|NCT00594516|12156810|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
7729233|NCT00594516|12156808|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16
7729234|NCT00594516|12156809|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0
7729235|NCT00594516|12156810|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0
7729236|NCT00594516|12156808|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
7729237|NCT00594516|12156809|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
7729238|NCT00594516|12156810|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
7729239|NCT00594516|12156808|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
7729240|NCT00594516|12156809|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
7729241|NCT00594516|12156810|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
7729242|NCT00594516|12156808|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
7729243|NCT00594516|12156809|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
7729244|NCT00594516|12156810|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
7729245|NCT00594516|12156808|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
7729246|NCT00594516|12156809|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
7729247|NCT00594516|12156810|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
7729248|NCT00594516|12156808|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
7729249|NCT00594516|12156809|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
7729250|NCT00594516|12156810|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
7729251|NCT00594516|12156808|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
7729252|NCT00594516|12156809|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
7729253|NCT00594516|12156810|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
7729254|NCT00594568|12156817|FG000|Initial Treatment|Adverse Event|51
7729255|NCT00594568|12156818|FG001|Initial Treatment|Adverse Event|121
7729256|NCT00594568|12156819|FG002|Initial Treatment|Adverse Event|144
7729257|NCT00594568|12156817|FG000|Initial Treatment|Death|6
7729258|NCT00594568|12156818|FG001|Initial Treatment|Death|11
7729259|NCT00594568|12156819|FG002|Initial Treatment|Death|15
7729260|NCT00594568|12156817|FG000|Initial Treatment|Lost to Follow-up|4
7729261|NCT00594568|12156818|FG001|Initial Treatment|Lost to Follow-up|1
7729262|NCT00594568|12156819|FG002|Initial Treatment|Lost to Follow-up|4
7729263|NCT00594568|12156817|FG000|Initial Treatment|Physician Decision|3
7729264|NCT00594568|12156818|FG001|Initial Treatment|Physician Decision|2
7729265|NCT00594568|12156819|FG002|Initial Treatment|Physician Decision|4
7729266|NCT00594568|12156817|FG000|Initial Treatment|Protocol Violation|2
7729267|NCT00594568|12156818|FG001|Initial Treatment|Protocol Violation|2
7729268|NCT00594568|12156819|FG002|Initial Treatment|Protocol Violation|5
7729269|NCT00594568|12156817|FG000|Initial Treatment|Withdrawal by Subject|25
7729270|NCT00594568|12156818|FG001|Initial Treatment|Withdrawal by Subject|31
7729271|NCT00594568|12156819|FG002|Initial Treatment|Withdrawal by Subject|46
7729272|NCT00594568|12156817|FG000|Initial Treatment|Sponsor decision|193
7729273|NCT00594568|12156818|FG001|Initial Treatment|Sponsor decision|142
7729274|NCT00594568|12156819|FG002|Initial Treatment|Sponsor decision|147
7729275|NCT00594568|12156817|FG000|Initial Treatment|Caregiver decision|21
7729276|NCT00594568|12156818|FG001|Initial Treatment|Caregiver decision|36
7729277|NCT00594568|12156819|FG002|Initial Treatment|Caregiver decision|36
7729278|NCT00594568|12156817|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
7729279|NCT00594568|12156818|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
7729280|NCT00594568|12156819|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
7729281|NCT00594568|12156817|FG000|Initial Treatment|Entry criteria exclusion|0
7729282|NCT00594568|12156818|FG001|Initial Treatment|Entry criteria exclusion|1
7729283|NCT00594568|12156819|FG002|Initial Treatment|Entry criteria exclusion|1
7729284|NCT00594568|12156817|FG000|Delayed Start|Death|0
7729285|NCT00594568|12156818|FG001|Delayed Start|Death|0
7729286|NCT00594568|12156819|FG002|Delayed Start|Death|1
7729287|NCT00594568|12156817|FG000|Delayed Start|Adverse Event|12
7729288|NCT00594568|12156818|FG001|Delayed Start|Adverse Event|2
7729289|NCT00594568|12156819|FG002|Delayed Start|Adverse Event|2
7729290|NCT00594568|12156817|FG000|Delayed Start|Withdrawal by Subject|4
7729291|NCT00594568|12156818|FG001|Delayed Start|Withdrawal by Subject|3
7729292|NCT00594568|12156819|FG002|Delayed Start|Withdrawal by Subject|0
7729293|NCT00594568|12156817|FG000|Delayed Start|Physician Decision|0
7729294|NCT00594568|12156818|FG001|Delayed Start|Physician Decision|0
7729295|NCT00594568|12156819|FG002|Delayed Start|Physician Decision|1
7729296|NCT00594568|12156817|FG000|Delayed Start|Lost to Follow-up|0
7729297|NCT00594568|12156818|FG001|Delayed Start|Lost to Follow-up|0
7729298|NCT00594568|12156819|FG002|Delayed Start|Lost to Follow-up|1
7729299|NCT00594568|12156817|FG000|Delayed Start|Caregiver Decision|5
7729300|NCT00594568|12156818|FG001|Delayed Start|Caregiver Decision|6
7729301|NCT00594568|12156819|FG002|Delayed Start|Caregiver Decision|2
7729302|NCT00594568|12156817|FG000|Delayed Start|Sponsor Decision|77
7729303|NCT00594568|12156818|FG001|Delayed Start|Sponsor Decision|66
7729304|NCT00594568|12156819|FG002|Delayed Start|Sponsor Decision|59
7729305|NCT00594568|12156817|FG000|Safety Follow Up (SFU)-Optional|Death|0
7729306|NCT00594568|12156818|FG001|Safety Follow Up (SFU)-Optional|Death|1
7729307|NCT00594568|12156819|FG002|Safety Follow Up (SFU)-Optional|Death|0
7729308|NCT00594568|12156817|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5
7729309|NCT00594568|12156818|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0
7729310|NCT00594568|12156819|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0
7729311|NCT00594568|12156817|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
7729312|NCT00594568|12156818|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
7729313|NCT00594568|12156819|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
7729314|NCT00594568|12156817|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
7729315|NCT00594568|12156818|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
7729316|NCT00594568|12156819|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
7729317|NCT00594568|12156817|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
7729318|NCT00594568|12156818|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
7729319|NCT00594568|12156819|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
7729320|NCT00594568|12156817|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
7729321|NCT00594568|12156818|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
7729322|NCT00594568|12156819|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
7729323|NCT00594646|12156835|FG000|Overall Study|Withdrawal by Subject|1
7729324|NCT00594646|12156835|FG000|Overall Study|Lost to Follow-up|15
7729325|NCT00594659|12156843|FG000|Overall Study|Lost to Follow-up|13
7729326|NCT00594659|12156844|FG001|Overall Study|Lost to Follow-up|9
7729327|NCT00594659|12156845|FG002|Overall Study|Lost to Follow-up|7
7729328|NCT00594815|12156857|FG000|Overall Study|Never Treated|3
7729329|NCT00594815|12156857|FG000|Overall Study|Withdrawal by Subject|2
7729330|NCT00594815|12156857|FG000|Overall Study|Toxicity|4
7729331|NCT00594854|12156863|FG000|Overall Study|Study terminated|7
7729332|NCT00594854|12156864|FG001|Overall Study|Study terminated|10
7729333|NCT00594880|12156872|FG000|Overall Study|Withdrawal by Subject|1
7729334|NCT00594880|12156873|FG001|Overall Study|Withdrawal by Subject|1
7729335|NCT00594880|12156872|FG000|Overall Study|Lost to Follow-up|1
7729336|NCT00594880|12156873|FG001|Overall Study|Lost to Follow-up|0
7729337|NCT00594906|12156885|FG000|Overall Study|Physician Decision|1
7729338|NCT00594906|12156886|FG001|Overall Study|Physician Decision|0
7729339|NCT00594906|12156885|FG000|Overall Study|Physician Decision|0
7729340|NCT00594906|12156886|FG001|Overall Study|Physician Decision|1
7729341|NCT00594906|12156885|FG000|Overall Study|Death|0
7729342|NCT00594906|12156886|FG001|Overall Study|Death|1
7729343|NCT00594932|12156894|FG000|First 3 Months|Withdrawal by Subject|1
7729344|NCT00594932|12156895|FG001|First 3 Months|Withdrawal by Subject|3
7729345|NCT00594932|12156894|FG000|Final 3 Months|Withdrawal by Subject|4
7729346|NCT00594932|12156895|FG001|Final 3 Months|Withdrawal by Subject|3
7729347|NCT00594958|12156915|FG000|Overall Study|Withdrawal by Subject|1
7729348|NCT00594958|12156916|FG001|Overall Study|Withdrawal by Subject|0
7729349|NCT00594958|12156917|FG002|Overall Study|Withdrawal by Subject|1
7729350|NCT00594958|12156915|FG000|Overall Study|Adverse Event|4
7729351|NCT00594958|12156916|FG001|Overall Study|Adverse Event|1
7729352|NCT00594958|12156917|FG002|Overall Study|Adverse Event|2
7729353|NCT00594958|12156915|FG000|Overall Study|Pregnancy|0
7729354|NCT00594958|12156916|FG001|Overall Study|Pregnancy|2
7729355|NCT00594958|12156917|FG002|Overall Study|Pregnancy|0
7729356|NCT00594958|12156915|FG000|Overall Study|Protocol Violation|1
7729357|NCT00594958|12156916|FG001|Overall Study|Protocol Violation|0
7729358|NCT00594958|12156917|FG002|Overall Study|Protocol Violation|2
7729359|NCT00594958|12156915|FG000|Overall Study|Lost to Follow-up|5
7729360|NCT00594958|12156916|FG001|Overall Study|Lost to Follow-up|0
7729361|NCT00594958|12156917|FG002|Overall Study|Lost to Follow-up|3
7729362|NCT00594958|12156915|FG000|Overall Study|administrative|3
7729363|NCT00594958|12156916|FG001|Overall Study|administrative|0
7729364|NCT00594958|12156917|FG002|Overall Study|administrative|2
7729365|NCT00595075|12156938|FG000|Overall Study|Withdrawal by Subject|1
7729366|NCT00595075|12156939|FG001|Overall Study|Withdrawal by Subject|0
7729367|NCT00595127|12156975|FG000|Overall Study|Death|6
7729368|NCT00595127|12156975|FG000|Overall Study|Relapsed|3
7729369|NCT00595127|12156975|FG000|Overall Study|joined another trial|1
7729370|NCT00595309|12157014|FG000|Overall Study|Lost to Follow-up|1
7729371|NCT00595309|12157014|FG000|Overall Study|planned vaccination against yellow fever|1
7729372|NCT00595309|12157014|FG000|Overall Study|acute infection after V0|1
7729373|NCT00595309|12157014|FG000|Overall Study|personal reason|1
7729374|NCT00595335|12157020|FG000|Baseline to Six Months|Withdrawal by Subject|0
7729375|NCT00595335|12157021|FG001|Baseline to Six Months|Withdrawal by Subject|1
7729376|NCT00595335|12157020|FG000|Baseline to Six Months|Disease Progression|1
7729377|NCT00595335|12157021|FG001|Baseline to Six Months|Disease Progression|1
7729378|NCT00595335|12157020|FG000|Baseline to Six Months|Adverse Event|1
7729379|NCT00595335|12157021|FG001|Baseline to Six Months|Adverse Event|0
7729380|NCT00595335|12157020|FG000|Six Months to Twelve Months|Withdrawal by Subject|0
7729381|NCT00595335|12157021|FG001|Six Months to Twelve Months|Withdrawal by Subject|1
7729382|NCT00595335|12157020|FG000|Six Months to Twelve Months|Disease Progression|1
7768580|NCT00862654|12211890|FG000|Overall Study|Adverse Event|0
7729383|NCT00595335|12157021|FG001|Six Months to Twelve Months|Disease Progression|0
7729384|NCT00595413|12157044|FG000|Overall Study|Adverse Event|0
7729385|NCT00595413|12157045|FG001|Overall Study|Adverse Event|2
7729386|NCT00595413|12157046|FG002|Overall Study|Adverse Event|1
7729387|NCT00595413|12157047|FG003|Overall Study|Adverse Event|1
7729388|NCT00595413|12157044|FG000|Overall Study|Lost to Follow-up|2
7729389|NCT00595413|12157045|FG001|Overall Study|Lost to Follow-up|2
7729390|NCT00595413|12157046|FG002|Overall Study|Lost to Follow-up|1
7729391|NCT00595413|12157047|FG003|Overall Study|Lost to Follow-up|3
7729392|NCT00595413|12157044|FG000|Overall Study|Death|0
7729393|NCT00595413|12157045|FG001|Overall Study|Death|0
7729394|NCT00595413|12157046|FG002|Overall Study|Death|1
7729395|NCT00595413|12157047|FG003|Overall Study|Death|0
7729396|NCT00595413|12157044|FG000|Overall Study|Other|5
7729397|NCT00595413|12157045|FG001|Overall Study|Other|1
7729398|NCT00595413|12157046|FG002|Overall Study|Other|5
7729399|NCT00595413|12157047|FG003|Overall Study|Other|0
7729400|NCT00595465|12157060|FG000|Overall Study|Adverse Event|4
7729401|NCT00595465|12157061|FG001|Overall Study|Adverse Event|3
7729402|NCT00595465|12157062|FG002|Overall Study|Adverse Event|3
7729403|NCT00595465|12157060|FG000|Overall Study|Pregnancy|0
7729404|NCT00595465|12157061|FG001|Overall Study|Pregnancy|0
7729405|NCT00595465|12157062|FG002|Overall Study|Pregnancy|1
7729406|NCT00595465|12157060|FG000|Overall Study|Protocol Violation|2
7729407|NCT00595465|12157061|FG001|Overall Study|Protocol Violation|1
7729408|NCT00595465|12157062|FG002|Overall Study|Protocol Violation|0
7729409|NCT00595465|12157060|FG000|Overall Study|Lost to Follow-up|0
7729410|NCT00595465|12157061|FG001|Overall Study|Lost to Follow-up|0
7729411|NCT00595465|12157062|FG002|Overall Study|Lost to Follow-up|2
7729412|NCT00595465|12157060|FG000|Overall Study|administrative reason|0
7729413|NCT00595465|12157061|FG001|Overall Study|administrative reason|0
7729414|NCT00595465|12157062|FG002|Overall Study|administrative reason|1
7729415|NCT00595478|12157072|FG000|36-week Follow-up Period|Lost to Follow-up|5
7729416|NCT00595478|12157073|FG001|36-week Follow-up Period|Lost to Follow-up|4
7729417|NCT00595478|12157072|FG000|36-week Follow-up Period|Withdrawal by Subject|4
7729418|NCT00595478|12157073|FG001|36-week Follow-up Period|Withdrawal by Subject|4
7729419|NCT00595504|12157081|FG000|Overall Study|Withdrawal by Subject|1
7729420|NCT00595504|12157082|FG001|Overall Study|Withdrawal by Subject|3
7729421|NCT00595504|12157081|FG000|Overall Study|Physician Decision|1
7729422|NCT00595504|12157082|FG001|Overall Study|Physician Decision|0
7729423|NCT00595517|12157088|FG000|Overall Study|Adverse Event|6
7729424|NCT00595517|12157088|FG000|Overall Study|Withdrawal by Subject|4
7729425|NCT00595517|12157088|FG000|Overall Study|Protocol Violation|2
7729426|NCT00595517|12157088|FG000|Overall Study|Recurrence of ulcer|5
7729427|NCT00595517|12157088|FG000|Overall Study|usage of prohibited treatment|1
7729428|NCT00595517|12157088|FG000|Overall Study|No intention to attend regularly|1
7729429|NCT00595621|12157108|FG000|Open Label Run in|Adverse Event|1
7729430|NCT00595621|12157109|FG001|Open Label Run in|Adverse Event|0
7729431|NCT00595621|12157108|FG000|Open Label Run in|Physician Decision|1
7729432|NCT00595621|12157109|FG001|Open Label Run in|Physician Decision|0
7729433|NCT00595621|12157108|FG000|Open Label Run in|Withdrawal by Subject|1
7729434|NCT00595621|12157109|FG001|Open Label Run in|Withdrawal by Subject|0
7729435|NCT00595621|12157108|FG000|Randomization and Study|Adverse Event|2
7729436|NCT00595621|12157109|FG001|Randomization and Study|Adverse Event|0
7729437|NCT00595621|12157108|FG000|Randomization and Study|Withdrawal by Subject|0
7729438|NCT00595621|12157109|FG001|Randomization and Study|Withdrawal by Subject|1
7729439|NCT00595764|12157118|FG000|Overall Study|Protocol Violation|24
7729440|NCT00595764|12157119|FG001|Overall Study|Protocol Violation|19
7729441|NCT00595764|12157118|FG000|Overall Study|Missed Medication >1 week|10
7729442|NCT00595764|12157119|FG001|Overall Study|Missed Medication >1 week|17
7729443|NCT00595764|12157118|FG000|Overall Study|Missed 3 PM visits|1
7729444|NCT00595764|12157119|FG001|Overall Study|Missed 3 PM visits|7
7729445|NCT00595764|12157118|FG000|Overall Study|Withdrawal by Subject|4
7729446|NCT00595764|12157119|FG001|Overall Study|Withdrawal by Subject|0
7729447|NCT00595868|12157140|FG000|Overall Study|Lost to Follow-up|45
7729448|NCT00595868|12157141|FG001|Overall Study|Lost to Follow-up|50
7729449|NCT00595959|12157161|FG000|Overall Study|Withdrawal by Subject|1
7729450|NCT00595959|12157161|FG000|Overall Study|Lost to Follow-up|1
7729451|NCT00596011|12157167|FG000|Overall Study|Withdrawal by Subject|2
7729452|NCT00596011|12157168|FG001|Overall Study|Withdrawal by Subject|3
7729453|NCT00596011|12157167|FG000|Overall Study|Adverse Event|11
7729454|NCT00596011|12157168|FG001|Overall Study|Adverse Event|7
7729455|NCT00596362|12157204|FG000|Overall Study|Progressive Disease|1
7729456|NCT00596427|12157210|FG000|Overall Study|Withdrawal by Subject|2
7729457|NCT00596427|12157211|FG001|Overall Study|Withdrawal by Subject|2
7729458|NCT00596427|12157210|FG000|Overall Study|Increased Fasting Triacylglycerol level|1
7729459|NCT00596427|12157211|FG001|Overall Study|Increased Fasting Triacylglycerol level|0
7729460|NCT00596427|12157210|FG000|Overall Study|Protocol Violation|1
7729461|NCT00596427|12157211|FG001|Overall Study|Protocol Violation|0
7729462|NCT00596466|12157236|FG000|Overall Study|Lack of Efficacy|5
7729463|NCT00596466|12157236|FG000|Overall Study|Adverse Event|4
7729464|NCT00596466|12157236|FG000|Overall Study|Withdrawal by Subject|2
7729465|NCT00596466|12157236|FG000|Overall Study|Protocol Violation|2
7729466|NCT00596466|12157236|FG000|Overall Study|Unpecified|2
7729467|NCT00596466|12157236|FG000|Overall Study|Enrolled, not treated|2
7729468|NCT00596635|12157255|FG000|Overall Study|Lost to Follow-up|0
7729469|NCT00596635|12157256|FG001|Overall Study|Lost to Follow-up|2
7729470|NCT00596635|12157257|FG002|Overall Study|Lost to Follow-up|0
7729471|NCT00596635|12157255|FG000|Overall Study|Treatment for symptomatic UTI|4
7729472|NCT00596635|12157256|FG001|Overall Study|Treatment for symptomatic UTI|6
7729473|NCT00596635|12157257|FG002|Overall Study|Treatment for symptomatic UTI|3
7729474|NCT00596635|12157255|FG000|Overall Study|Hip fracture|2
7729475|NCT00596635|12157256|FG001|Overall Study|Hip fracture|3
7729476|NCT00596635|12157257|FG002|Overall Study|Hip fracture|3
7729477|NCT00596635|12157255|FG000|Overall Study|Could not provide urine specimen|1
7729478|NCT00596635|12157256|FG001|Overall Study|Could not provide urine specimen|2
7729479|NCT00596635|12157257|FG002|Overall Study|Could not provide urine specimen|2
7729480|NCT00596687|12157267|FG000|Overall Study|< 24 hours of insulin treatment|8
7729481|NCT00596687|12157268|FG001|Overall Study|< 24 hours of insulin treatment|6
7729482|NCT00596687|12157267|FG000|Overall Study|continuous insulin infusion during TPN|2
7729483|NCT00596687|12157268|FG001|Overall Study|continuous insulin infusion during TPN|1
7729484|NCT00596687|12157267|FG000|Overall Study|Withdrawal by Subject|3
7729485|NCT00596687|12157268|FG001|Overall Study|Withdrawal by Subject|1
7729486|NCT00596687|12157267|FG000|Overall Study|cancelled surgery|1
7729487|NCT00596687|12157268|FG001|Overall Study|cancelled surgery|1
7729488|NCT00596752|12157276|FG000|Overall Study|Other Reason|44
7729489|NCT00596752|12157277|FG001|Overall Study|Other Reason|49
7729490|NCT00596752|12157276|FG000|Overall Study|Adverse Event|34
7729491|NCT00596752|12157277|FG001|Overall Study|Adverse Event|34
7729492|NCT00596752|12157276|FG000|Overall Study|Lost to Follow-up|22
7729493|NCT00596752|12157277|FG001|Overall Study|Lost to Follow-up|38
7729494|NCT00596752|12157276|FG000|Overall Study|Withdrawal by Subject|12
7729495|NCT00596752|12157277|FG001|Overall Study|Withdrawal by Subject|9
7729496|NCT00596752|12157276|FG000|Overall Study|Unsatisfactory Compliance|9
7729497|NCT00596752|12157277|FG001|Overall Study|Unsatisfactory Compliance|6
7729498|NCT00596752|12157276|FG000|Overall Study|Lack of Efficacy|4
7729499|NCT00596752|12157277|FG001|Overall Study|Lack of Efficacy|7
7729500|NCT00596752|12157276|FG000|Overall Study|Protocol Violation|1
7729501|NCT00596752|12157277|FG001|Overall Study|Protocol Violation|0
7729502|NCT00594386|12157283|FG000|Overall Study|Major protocol violation|2
7729503|NCT00594386|12157283|FG000|Overall Study|Lack of Efficacy|12
7729504|NCT00594386|12157283|FG000|Overall Study|Adverse Event|68
7729505|NCT00594386|12157283|FG000|Overall Study|Unsatisfactory compliance of subject|11
7729506|NCT00594386|12157283|FG000|Overall Study|Subject withdrew consent|35
7729507|NCT00594386|12157283|FG000|Overall Study|Study ended per sponsor|115
7729508|NCT00594386|12157283|FG000|Overall Study|Lost to Follow-up|6
7729509|NCT00594386|12157283|FG000|Overall Study|Other: Patient went off patch (hospital)|1
7729510|NCT00594386|12157283|FG000|Overall Study|Other: Subject moved to Seattle|1
7729511|NCT00594386|12157283|FG000|Overall Study|Other: Subject admitted to nursing home|1
7768581|NCT00862654|12211891|FG001|Overall Study|Adverse Event|1
7729512|NCT00594386|12157283|FG000|Overall Study|Other: Study terminated per investigator|2
7729513|NCT00594386|12157283|FG000|Overall Study|Other: Sponsor closure of study|1
7729514|NCT00594386|12157283|FG000|Overall Study|Other: Site terminated participation|1
7729515|NCT00594386|12157283|FG000|Overall Study|Other: Patient wants prescription Neupro|1
7729516|NCT00594386|12157283|FG000|Overall Study|Other: Loss of drivers license|1
7729517|NCT00596817|12157290|FG000|Open-label Period|Adverse Event|0
7729518|NCT00596817|12157291|FG001|Open-label Period|Adverse Event|49
7729519|NCT00596817|12157290|FG000|Open-label Period|Lack of Efficacy|0
7729520|NCT00596817|12157291|FG001|Open-label Period|Lack of Efficacy|33
7729521|NCT00596817|12157290|FG000|Open-label Period|Other Reasons|0
7729522|NCT00596817|12157291|FG001|Open-label Period|Other Reasons|65
7729523|NCT00596817|12157290|FG000|Open-label Period to Double-blind Period|Adverse Event|0
7729524|NCT00596817|12157291|FG001|Open-label Period to Double-blind Period|Adverse Event|5
7729525|NCT00596817|12157290|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0
7729526|NCT00596817|12157291|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24
7729527|NCT00596817|12157290|FG000|Open-label Period to Double-blind Period|Not Eligible|0
7729528|NCT00596817|12157291|FG001|Open-label Period to Double-blind Period|Not Eligible|49
7729529|NCT00596817|12157290|FG000|Open-label Period to Double-blind Period|Other Reasons|0
7729530|NCT00596817|12157291|FG001|Open-label Period to Double-blind Period|Other Reasons|14
7729531|NCT00596817|12157290|FG000|Double-blind Period|Adverse Event|5
7729532|NCT00596817|12157291|FG001|Double-blind Period|Adverse Event|16
7729533|NCT00596817|12157290|FG000|Double-blind Period|Lack of Efficacy|52
7729534|NCT00596817|12157291|FG001|Double-blind Period|Lack of Efficacy|28
7729535|NCT00596817|12157290|FG000|Double-blind Period|Non-compliance With Study Product|3
7729536|NCT00596817|12157291|FG001|Double-blind Period|Non-compliance With Study Product|4
7729537|NCT00596817|12157290|FG000|Double-blind Period|Protocol Violation|11
7729538|NCT00596817|12157291|FG001|Double-blind Period|Protocol Violation|8
7729539|NCT00596817|12157290|FG000|Double-blind Period|Withdrawal of Consent|7
7729540|NCT00596817|12157291|FG001|Double-blind Period|Withdrawal of Consent|3
7729541|NCT00596817|12157290|FG000|Double-blind Period|Lost to Follow-up|0
7729542|NCT00596817|12157291|FG001|Double-blind Period|Lost to Follow-up|2
7729543|NCT00596817|12157290|FG000|Double-blind Period|Other Reasons|10
7729544|NCT00596817|12157291|FG001|Double-blind Period|Other Reasons|18
7729545|NCT00596830|12157300|FG000|Overall Study|Death|258
7729546|NCT00596830|12157301|FG001|Overall Study|Death|247
7729547|NCT00596830|12157300|FG000|Overall Study|Lost to Follow-up|7
7729548|NCT00596830|12157301|FG001|Overall Study|Lost to Follow-up|11
7729549|NCT00596830|12157300|FG000|Overall Study|Withdrawal by Subject|22
7729550|NCT00596830|12157301|FG001|Overall Study|Withdrawal by Subject|12
7729551|NCT00596830|12157300|FG000|Overall Study|Study terminated by sponsor|51
7729552|NCT00596830|12157301|FG001|Overall Study|Study terminated by sponsor|62
7729553|NCT00596830|12157300|FG000|Overall Study|Follow-up was discontinued|1
7729554|NCT00596830|12157301|FG001|Overall Study|Follow-up was discontinued|0
7729555|NCT00596830|12157300|FG000|Overall Study|Randomized but not treated|3
7729556|NCT00596830|12157301|FG001|Overall Study|Randomized but not treated|7
7729557|NCT00596934|12157307|FG000|Overall Study|Protocol Violation|1
7729558|NCT00596934|12157307|FG000|Overall Study|Withdrawal by Subject|1
7729559|NCT00596960|12157315|FG000|Overall Study|Death|1
7729560|NCT00596960|12157316|FG001|Overall Study|Death|2
7729561|NCT00596960|12157315|FG000|Overall Study|Lost to Follow-up|6
7729562|NCT00596960|12157316|FG001|Overall Study|Lost to Follow-up|5
7729563|NCT00596960|12157315|FG000|Overall Study|Withdrawal by Subject|1
7729564|NCT00596960|12157316|FG001|Overall Study|Withdrawal by Subject|0
7729565|NCT00596960|12157315|FG000|Overall Study|Incarcerated|2
7729566|NCT00596960|12157316|FG001|Overall Study|Incarcerated|0
7729567|NCT00596960|12157315|FG000|Overall Study|Physician Decision|1
7729568|NCT00596960|12157316|FG001|Overall Study|Physician Decision|0
7729569|NCT00596960|12157315|FG000|Overall Study|Protocol Violation|0
7729570|NCT00596960|12157316|FG001|Overall Study|Protocol Violation|1
7729571|NCT00596960|12157315|FG000|Overall Study|No alcohol use data|0
7729572|NCT00596960|12157316|FG001|Overall Study|No alcohol use data|1
7729573|NCT00597116|12157335|FG000|Overall Study|Adverse Event|2
7729574|NCT00597116|12157336|FG001|Overall Study|Adverse Event|1
7729575|NCT00597116|12157335|FG000|Overall Study|Withdrawal by Subject|0
7729576|NCT00597116|12157336|FG001|Overall Study|Withdrawal by Subject|2
7729577|NCT00597116|12157335|FG000|Overall Study|Physician Decision|0
7729578|NCT00597116|12157336|FG001|Overall Study|Physician Decision|1
7729579|NCT00597116|12157335|FG000|Overall Study|Death|0
7729580|NCT00597116|12157336|FG001|Overall Study|Death|1
7729581|NCT00597116|12157335|FG000|Overall Study|Lost to Follow-up|1
7729582|NCT00597116|12157336|FG001|Overall Study|Lost to Follow-up|0
7729583|NCT00597116|12157335|FG000|Overall Study|Progressive disease|11
7729584|NCT00597116|12157336|FG001|Overall Study|Progressive disease|6
7729585|NCT00597207|12157344|FG000|Overall Study|Lost to Follow-up|5
7729586|NCT00597207|12157345|FG001|Overall Study|Lost to Follow-up|7
7729587|NCT00597376|12157386|FG000|Overall Study|Withdrawal by Subject|4
7729588|NCT00597376|12157387|FG001|Overall Study|Withdrawal by Subject|3
7729589|NCT00597376|12157386|FG000|Overall Study|Adverse Event|4
7729590|NCT00597376|12157387|FG001|Overall Study|Adverse Event|1
7729591|NCT00597506|12157414|FG000|Overall Study|Subject is being followed for survival|1
7729592|NCT00597519|12157418|FG000|Overall Study|Death|1
7729593|NCT00597584|12157437|FG000|Overall Study|Adverse Event|4
7729594|NCT00597584|12157438|FG001|Overall Study|Adverse Event|2
7729595|NCT00597584|12157437|FG000|Overall Study|Death|53
7729596|NCT00597584|12157438|FG001|Overall Study|Death|30
7729597|NCT00597584|12157437|FG000|Overall Study|Lack of Efficacy|1
7729598|NCT00597584|12157438|FG001|Overall Study|Lack of Efficacy|0
7729599|NCT00597584|12157437|FG000|Overall Study|Lost to Follow-up|2
7729600|NCT00597584|12157438|FG001|Overall Study|Lost to Follow-up|4
7729601|NCT00597584|12157437|FG000|Overall Study|Physician Decision|3
7729602|NCT00597584|12157438|FG001|Overall Study|Physician Decision|0
7729603|NCT00597584|12157437|FG000|Overall Study|Pregnancy|2
7729604|NCT00597584|12157438|FG001|Overall Study|Pregnancy|0
7729605|NCT00597584|12157437|FG000|Overall Study|Withdrawal by Subject|44
7729606|NCT00597584|12157438|FG001|Overall Study|Withdrawal by Subject|12
7729607|NCT00597584|12157437|FG000|Overall Study|Discontinued Dialysis|0
7729608|NCT00597584|12157438|FG001|Overall Study|Discontinued Dialysis|1
7729609|NCT00597584|12157437|FG000|Overall Study|Lost ability to consent|1
7729610|NCT00597584|12157438|FG001|Overall Study|Lost ability to consent|1
7729611|NCT00597584|12157437|FG000|Overall Study|Never dosed|1
7729612|NCT00597584|12157438|FG001|Overall Study|Never dosed|0
7729613|NCT00597584|12157437|FG000|Overall Study|Relocation|8
7729614|NCT00597584|12157438|FG001|Overall Study|Relocation|6
7729615|NCT00597584|12157437|FG000|Overall Study|Renal transplant|9
7729616|NCT00597584|12157438|FG001|Overall Study|Renal transplant|7
7729617|NCT00597701|12157457|FG000|Overall Study|Withdrawal by Subject|5
7729618|NCT00597701|12157458|FG001|Overall Study|Withdrawal by Subject|5
7729619|NCT00597701|12157457|FG000|Overall Study|Death|0
7729620|NCT00597701|12157458|FG001|Overall Study|Death|1
7729621|NCT00597701|12157457|FG000|Overall Study|Physician Decision|2
7729622|NCT00597701|12157458|FG001|Overall Study|Physician Decision|0
7729623|NCT00597701|12157457|FG000|Overall Study|Did not start intervention (pharmacy er)|0
7729624|NCT00597701|12157458|FG001|Overall Study|Did not start intervention (pharmacy er)|2
7729625|NCT00597714|12157466|FG000|Overall Study|Death|56
7729626|NCT00597714|12157467|FG001|Overall Study|Death|46
7729627|NCT00597714|12157468|FG002|Overall Study|Death|0
7729628|NCT00597714|12157466|FG000|Overall Study|Recipient death|0
7729629|NCT00597714|12157467|FG001|Overall Study|Recipient death|0
7729630|NCT00597714|12157468|FG002|Overall Study|Recipient death|10
7729631|NCT00597753|12157501|FG000|Overall Study|Adverse Event|6
7729632|NCT00597753|12157502|FG001|Overall Study|Adverse Event|2
7729633|NCT00597753|12157501|FG000|Overall Study|Death|55
7729634|NCT00597753|12157502|FG001|Overall Study|Death|29
7729635|NCT00597753|12157501|FG000|Overall Study|Lack of Efficacy|2
7729636|NCT00597753|12157502|FG001|Overall Study|Lack of Efficacy|0
7729637|NCT00597753|12157501|FG000|Overall Study|Lost to Follow-up|10
7729638|NCT00597753|12157502|FG001|Overall Study|Lost to Follow-up|3
7729639|NCT00597753|12157501|FG000|Overall Study|Physician Decision|5
7729640|NCT00597753|12157502|FG001|Overall Study|Physician Decision|1
7729641|NCT00597753|12157501|FG000|Overall Study|Pregnancy|1
7729642|NCT00597753|12157502|FG001|Overall Study|Pregnancy|0
7729643|NCT00597753|12157501|FG000|Overall Study|Withdrawal by Subject|35
7729644|NCT00597753|12157502|FG001|Overall Study|Withdrawal by Subject|12
7729645|NCT00597753|12157501|FG000|Overall Study|Discontinued Dialysis|0
7729646|NCT00597753|12157502|FG001|Overall Study|Discontinued Dialysis|1
7729647|NCT00597753|12157501|FG000|Overall Study|Never dosed|2
7729648|NCT00597753|12157502|FG001|Overall Study|Never dosed|0
7729649|NCT00597753|12157501|FG000|Overall Study|Noncompliance|2
7729650|NCT00597753|12157502|FG001|Overall Study|Noncompliance|1
7729651|NCT00597753|12157501|FG000|Overall Study|Relocation|17
7729652|NCT00597753|12157502|FG001|Overall Study|Relocation|6
7729653|NCT00597753|12157501|FG000|Overall Study|Renal transplant|10
7729654|NCT00597753|12157502|FG001|Overall Study|Renal transplant|3
7729655|NCT00597753|12157501|FG000|Overall Study|Site closed by sponsor|19
7729656|NCT00597753|12157502|FG001|Overall Study|Site closed by sponsor|7
7729657|NCT00597753|12157501|FG000|Overall Study|Site elected to close|2
7729658|NCT00597753|12157502|FG001|Overall Study|Site elected to close|4
7729659|NCT00597766|12157511|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1
7729660|NCT00597766|12157512|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0
7729661|NCT00597766|12157513|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0
7729662|NCT00597766|12157511|FG000|Follow-up 2, Week 8|Lost to Follow-up|0
7729663|NCT00597766|12157512|FG001|Follow-up 2, Week 8|Lost to Follow-up|0
7729664|NCT00597766|12157513|FG002|Follow-up 2, Week 8|Lost to Follow-up|1
7729665|NCT00598078|12157565|FG000|Period 2 (Day 2)|Adverse Event|1
7729666|NCT00598078|12157566|FG001|Period 2 (Day 2)|Adverse Event|0
7729667|NCT00598273|12157577|FG000|Overall Study|Adverse Event|4
7729668|NCT00598273|12157578|FG001|Overall Study|Adverse Event|5
7729669|NCT00598273|12157579|FG002|Overall Study|Adverse Event|2
7729670|NCT00598273|12157577|FG000|Overall Study|Death|6
7729671|NCT00598273|12157578|FG001|Overall Study|Death|12
7729672|NCT00598273|12157579|FG002|Overall Study|Death|8
7729673|NCT00598273|12157577|FG000|Overall Study|Lost to Follow-up|8
7729674|NCT00598273|12157578|FG001|Overall Study|Lost to Follow-up|3
7729675|NCT00598273|12157579|FG002|Overall Study|Lost to Follow-up|5
7729676|NCT00598273|12157577|FG000|Overall Study|Physician Decision|0
7729677|NCT00598273|12157578|FG001|Overall Study|Physician Decision|0
7729678|NCT00598273|12157579|FG002|Overall Study|Physician Decision|1
7729679|NCT00598273|12157577|FG000|Overall Study|Withdrawal by Subject|12
7729680|NCT00598273|12157578|FG001|Overall Study|Withdrawal by Subject|10
7729681|NCT00598273|12157579|FG002|Overall Study|Withdrawal by Subject|10
7729682|NCT00598273|12157577|FG000|Overall Study|Noncompliance|3
7729683|NCT00598273|12157578|FG001|Overall Study|Noncompliance|2
7729684|NCT00598273|12157579|FG002|Overall Study|Noncompliance|3
7729685|NCT00598273|12157577|FG000|Overall Study|Relocation|0
7729686|NCT00598273|12157578|FG001|Overall Study|Relocation|2
7729687|NCT00598273|12157579|FG002|Overall Study|Relocation|4
7729688|NCT00598273|12157577|FG000|Overall Study|Renal transplant|1
7729689|NCT00598273|12157578|FG001|Overall Study|Renal transplant|0
7729690|NCT00598273|12157579|FG002|Overall Study|Renal transplant|1
7729691|NCT00598273|12157577|FG000|Overall Study|Site elected to close|1
7729692|NCT00598273|12157578|FG001|Overall Study|Site elected to close|0
7729693|NCT00598273|12157579|FG002|Overall Study|Site elected to close|0
7729694|NCT00598273|12157577|FG000|Overall Study|Started dialysis|6
7729695|NCT00598273|12157578|FG001|Overall Study|Started dialysis|4
7729696|NCT00598273|12157579|FG002|Overall Study|Started dialysis|5
7729697|NCT00598442|12157590|FG000|Overall Study|Adverse Event|3
7729698|NCT00598442|12157591|FG001|Overall Study|Adverse Event|0
7729699|NCT00598442|12157592|FG002|Overall Study|Adverse Event|0
7729700|NCT00598442|12157590|FG000|Overall Study|Death|19
7729701|NCT00598442|12157591|FG001|Overall Study|Death|11
7729702|NCT00598442|12157592|FG002|Overall Study|Death|11
7729703|NCT00598442|12157590|FG000|Overall Study|Lost to Follow-up|4
7729704|NCT00598442|12157591|FG001|Overall Study|Lost to Follow-up|3
7729705|NCT00598442|12157592|FG002|Overall Study|Lost to Follow-up|3
7729706|NCT00598442|12157590|FG000|Overall Study|Physician Decision|2
7729707|NCT00598442|12157591|FG001|Overall Study|Physician Decision|1
7729708|NCT00598442|12157592|FG002|Overall Study|Physician Decision|1
7729709|NCT00598442|12157590|FG000|Overall Study|Withdrawal by Subject|8
7729710|NCT00598442|12157591|FG001|Overall Study|Withdrawal by Subject|16
7729711|NCT00598442|12157592|FG002|Overall Study|Withdrawal by Subject|6
7729712|NCT00598442|12157590|FG000|Overall Study|Noncompliance|0
7729713|NCT00598442|12157591|FG001|Overall Study|Noncompliance|2
7729714|NCT00598442|12157592|FG002|Overall Study|Noncompliance|1
7729715|NCT00598442|12157590|FG000|Overall Study|Relocation|1
7729716|NCT00598442|12157591|FG001|Overall Study|Relocation|4
7729717|NCT00598442|12157592|FG002|Overall Study|Relocation|0
7729718|NCT00598442|12157590|FG000|Overall Study|Renal transplant|0
7729719|NCT00598442|12157591|FG001|Overall Study|Renal transplant|0
7729720|NCT00598442|12157592|FG002|Overall Study|Renal transplant|1
7729721|NCT00598442|12157590|FG000|Overall Study|Site closed by sponsor|5
7729722|NCT00598442|12157591|FG001|Overall Study|Site closed by sponsor|2
7729723|NCT00598442|12157592|FG002|Overall Study|Site closed by sponsor|1
7729724|NCT00598442|12157590|FG000|Overall Study|Started dialysis|1
7729725|NCT00598442|12157591|FG001|Overall Study|Started dialysis|0
7729726|NCT00598442|12157592|FG002|Overall Study|Started dialysis|0
7768582|NCT00862654|12211892|FG002|Overall Study|Adverse Event|1
7768583|NCT00862654|12211893|FG003|Overall Study|Adverse Event|0
7768584|NCT00862654|12211890|FG000|Overall Study|Pregnancy|1
7768585|NCT00862654|12211891|FG001|Overall Study|Pregnancy|1
7768586|NCT00862654|12211892|FG002|Overall Study|Pregnancy|0
7768587|NCT00862654|12211893|FG003|Overall Study|Pregnancy|0
7768588|NCT00862654|12211890|FG000|Overall Study|Withdrawal by Subject|2
7768589|NCT00862654|12211891|FG001|Overall Study|Withdrawal by Subject|2
7768590|NCT00862654|12211892|FG002|Overall Study|Withdrawal by Subject|2
7768591|NCT00862654|12211893|FG003|Overall Study|Withdrawal by Subject|3
7768592|NCT00862654|12211890|FG000|Overall Study|Subject mistake|0
7768593|NCT00862654|12211891|FG001|Overall Study|Subject mistake|1
7768594|NCT00862654|12211892|FG002|Overall Study|Subject mistake|0
7768595|NCT00862654|12211893|FG003|Overall Study|Subject mistake|0
7768596|NCT00862654|12211890|FG000|Overall Study|Familly constraint|0
7768597|NCT00862654|12211891|FG001|Overall Study|Familly constraint|1
7768598|NCT00862654|12211892|FG002|Overall Study|Familly constraint|0
7768599|NCT00862654|12211893|FG003|Overall Study|Familly constraint|0
7768600|NCT00862654|12211890|FG000|Overall Study|Never used study drugs|1
7768601|NCT00862654|12211891|FG001|Overall Study|Never used study drugs|0
7768602|NCT00862654|12211892|FG002|Overall Study|Never used study drugs|0
7768603|NCT00862654|12211893|FG003|Overall Study|Never used study drugs|0
7768604|NCT00862654|12211890|FG000|Overall Study|Included after end of inclusions|0
7768605|NCT00862654|12211891|FG001|Overall Study|Included after end of inclusions|0
7768606|NCT00862654|12211892|FG002|Overall Study|Included after end of inclusions|1
7768607|NCT00862654|12211893|FG003|Overall Study|Included after end of inclusions|0
7768608|NCT00862719|12211907|FG000|Overall Study|Disease Progression|5
7768609|NCT00862719|12211908|FG001|Overall Study|Disease Progression|0
7729727|NCT00598481|12157600|FG000|Treatment|Physician Decision|1
7729728|NCT00598559|12157614|FG000|Overall Study|Adverse Event|11
7729729|NCT00598559|12157615|FG001|Overall Study|Adverse Event|7
7729730|NCT00598559|12157616|FG002|Overall Study|Adverse Event|0
7729731|NCT00598559|12157614|FG000|Overall Study|Withdrawal by Subject|2
7729732|NCT00598559|12157615|FG001|Overall Study|Withdrawal by Subject|2
7729733|NCT00598559|12157616|FG002|Overall Study|Withdrawal by Subject|0
7729734|NCT00598559|12157614|FG000|Overall Study|Protocol Non-compliance|1
7729735|NCT00598559|12157615|FG001|Overall Study|Protocol Non-compliance|0
7729736|NCT00598559|12157616|FG002|Overall Study|Protocol Non-compliance|0
7729737|NCT00598559|12157614|FG000|Overall Study|Early discharge from hospital|9
7729738|NCT00598559|12157615|FG001|Overall Study|Early discharge from hospital|12
7729739|NCT00598559|12157616|FG002|Overall Study|Early discharge from hospital|3
7729740|NCT00598559|12157614|FG000|Overall Study|Subject unable/unwilling to attend visit|4
7729741|NCT00598559|12157615|FG001|Overall Study|Subject unable/unwilling to attend visit|7
7729742|NCT00598559|12157616|FG002|Overall Study|Subject unable/unwilling to attend visit|0
7729743|NCT00598585|12157626|FG000|Overall Study|Lost to Follow-up|1
7729744|NCT00598585|12157627|FG001|Overall Study|Lost to Follow-up|0
7729745|NCT00598650|12157633|FG000|Overall Study|Withdrawal by Subject|3
7729746|NCT00598650|12157633|FG000|Overall Study|Adverse Event|18
7729747|NCT00598650|12157633|FG000|Overall Study|No treatment for 3 weeks|1
7729748|NCT00598650|12157633|FG000|Overall Study|Not eligible|1
7729749|NCT00598650|12157633|FG000|Overall Study|Prohibited Concomitant Medication|2
7729750|NCT00598650|12157633|FG000|Overall Study|Physician Decision|2
7729751|NCT00598702|12157667|FG000|Overall Study|Other|0
7729752|NCT00598702|12157668|FG001|Overall Study|Other|2
7729753|NCT00598702|12157669|FG002|Overall Study|Other|0
7729754|NCT00598702|12157670|FG003|Overall Study|Other|0
7729755|NCT00598702|12157671|FG004|Overall Study|Other|0
7729756|NCT00598702|12157672|FG005|Overall Study|Other|1
7729757|NCT00598702|12157673|FG006|Overall Study|Other|0
7729758|NCT00598702|12157674|FG007|Overall Study|Other|0
7729759|NCT00598702|12157667|FG000|Overall Study|Early discharge from hospital|0
7729760|NCT00598702|12157668|FG001|Overall Study|Early discharge from hospital|0
7729761|NCT00598702|12157669|FG002|Overall Study|Early discharge from hospital|2
7729762|NCT00598702|12157670|FG003|Overall Study|Early discharge from hospital|5
7729763|NCT00598702|12157671|FG004|Overall Study|Early discharge from hospital|0
7729764|NCT00598702|12157672|FG005|Overall Study|Early discharge from hospital|10
7729765|NCT00598702|12157673|FG006|Overall Study|Early discharge from hospital|1
7729766|NCT00598702|12157674|FG007|Overall Study|Early discharge from hospital|0
7729767|NCT00598702|12157667|FG000|Overall Study|Adverse Event|0
7729768|NCT00598702|12157668|FG001|Overall Study|Adverse Event|0
7729769|NCT00598702|12157669|FG002|Overall Study|Adverse Event|0
7729770|NCT00598702|12157670|FG003|Overall Study|Adverse Event|1
7729771|NCT00598702|12157671|FG004|Overall Study|Adverse Event|0
7729772|NCT00598702|12157672|FG005|Overall Study|Adverse Event|0
7729773|NCT00598702|12157673|FG006|Overall Study|Adverse Event|0
7729774|NCT00598702|12157674|FG007|Overall Study|Adverse Event|0
7729775|NCT00598702|12157667|FG000|Overall Study|Withdrawal by Subject|0
7729776|NCT00598702|12157668|FG001|Overall Study|Withdrawal by Subject|0
7729777|NCT00598702|12157669|FG002|Overall Study|Withdrawal by Subject|0
7729778|NCT00598702|12157670|FG003|Overall Study|Withdrawal by Subject|1
7729779|NCT00598702|12157671|FG004|Overall Study|Withdrawal by Subject|1
7729780|NCT00598702|12157672|FG005|Overall Study|Withdrawal by Subject|0
7729781|NCT00598702|12157673|FG006|Overall Study|Withdrawal by Subject|0
7729782|NCT00598702|12157674|FG007|Overall Study|Withdrawal by Subject|0
7729783|NCT00598702|12157667|FG000|Overall Study|Physician Decision|0
7729784|NCT00598702|12157668|FG001|Overall Study|Physician Decision|0
7729785|NCT00598702|12157669|FG002|Overall Study|Physician Decision|0
7729786|NCT00598702|12157670|FG003|Overall Study|Physician Decision|0
7729787|NCT00598702|12157671|FG004|Overall Study|Physician Decision|1
7729788|NCT00598702|12157672|FG005|Overall Study|Physician Decision|0
7729789|NCT00598702|12157673|FG006|Overall Study|Physician Decision|0
7729790|NCT00598702|12157674|FG007|Overall Study|Physician Decision|0
7729791|NCT00598702|12157667|FG000|Overall Study|Dose limiting toxicity|0
7729792|NCT00598702|12157668|FG001|Overall Study|Dose limiting toxicity|0
7729793|NCT00598702|12157669|FG002|Overall Study|Dose limiting toxicity|0
7729794|NCT00598702|12157670|FG003|Overall Study|Dose limiting toxicity|1
7729795|NCT00598702|12157671|FG004|Overall Study|Dose limiting toxicity|1
7729796|NCT00598702|12157672|FG005|Overall Study|Dose limiting toxicity|1
7729797|NCT00598702|12157673|FG006|Overall Study|Dose limiting toxicity|0
7729798|NCT00598702|12157674|FG007|Overall Study|Dose limiting toxicity|0
7729799|NCT00598832|12157707|FG000|Overall Study|Lack of Efficacy|3
7729800|NCT00598832|12157708|FG001|Overall Study|Lack of Efficacy|7
7729801|NCT00598832|12157707|FG000|Overall Study|Adverse Event|6
7729802|NCT00598832|12157708|FG001|Overall Study|Adverse Event|2
7729803|NCT00598832|12157707|FG000|Overall Study|Withdrawal by Subject|25
7729804|NCT00598832|12157708|FG001|Overall Study|Withdrawal by Subject|36
7729805|NCT00598832|12157707|FG000|Overall Study|Protocol Violation|0
7729806|NCT00598832|12157708|FG001|Overall Study|Protocol Violation|2
7729807|NCT00598832|12157707|FG000|Overall Study|Lost to Follow-up|24
7729808|NCT00598832|12157708|FG001|Overall Study|Lost to Follow-up|29
7729809|NCT00598832|12157707|FG000|Overall Study|Pregnancy|2
7729810|NCT00598832|12157708|FG001|Overall Study|Pregnancy|2
7729811|NCT00598832|12157707|FG000|Overall Study|Physician Decision|1
7729812|NCT00598832|12157708|FG001|Overall Study|Physician Decision|4
7729813|NCT00598832|12157707|FG000|Overall Study|Non compliance|1
7729814|NCT00598832|12157708|FG001|Overall Study|Non compliance|0
7729815|NCT00598871|12157716|FG000|Overall Study|Adverse Event|0
7729816|NCT00598871|12157717|FG001|Overall Study|Adverse Event|1
7729817|NCT00598975|12157725|FG000|Overall Study|Adverse Event|1
7729818|NCT00598975|12157726|FG001|Overall Study|Adverse Event|1
7729819|NCT00598975|12157725|FG000|Overall Study|Brain metastases|1
7729820|NCT00598975|12157726|FG001|Overall Study|Brain metastases|0
7729821|NCT00598975|12157725|FG000|Overall Study|Withdrawal by Subject|1
7729822|NCT00598975|12157726|FG001|Overall Study|Withdrawal by Subject|1
7729823|NCT00598975|12157725|FG000|Overall Study|Withdrawal of consent|0
7729824|NCT00598975|12157726|FG001|Overall Study|Withdrawal of consent|1
7729825|NCT00598975|12157725|FG000|Overall Study|Disease progression|8
7729826|NCT00598975|12157726|FG001|Overall Study|Disease progression|3
7729827|NCT00598975|12157725|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1
7729828|NCT00598975|12157726|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0
7729829|NCT00599196|12157747|FG000|Overall Study|Lack of Efficacy|22
7729830|NCT00599196|12157747|FG000|Overall Study|Adverse Event|93
7729831|NCT00599196|12157747|FG000|Overall Study|Unsatisfactory compliance of subject|3
7729832|NCT00599196|12157747|FG000|Overall Study|Subject withdrew consent|43
7729833|NCT00599196|12157747|FG000|Overall Study|Study ended per sponsor|197
7729834|NCT00599196|12157747|FG000|Overall Study|Lost to Follow-up|17
7729835|NCT00599196|12157747|FG000|Overall Study|Other: Patient Leaving For Israel|1
7729836|NCT00599196|12157747|FG000|Overall Study|Other: Spouse Withdrew Consent|1
7729837|NCT00599196|12157747|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
7729838|NCT00599196|12157747|FG000|Overall Study|Other: Pt Moved To Australia|1
7729839|NCT00599196|12157747|FG000|Overall Study|Other: Patient Stopped Due To Moving|1
7729840|NCT00599196|12157747|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1
7729841|NCT00599313|12157765|FG000|Overall Study|Adverse Event|19
7729842|NCT00599313|12157765|FG000|Overall Study|Disease Progression|12
7729843|NCT00599313|12157765|FG000|Overall Study|Patient Request|4
7729844|NCT00599313|12157765|FG000|Overall Study|Ineligible|1
7729845|NCT00599326|12157769|FG000|Overall Study|Lost to Follow-up|1
7729846|NCT00599326|12157769|FG000|Overall Study|Noncompliant|1
7729847|NCT00599339|12157773|FG000|Overall Study|Adverse Event|79
7729848|NCT00599339|12157773|FG000|Overall Study|Withdrawal by Subject|137
7729849|NCT00599339|12157773|FG000|Overall Study|Other Reason|179
7729850|NCT00599339|12157773|FG000|Overall Study|Lost to Follow-up|221
7729851|NCT00599339|12157773|FG000|Overall Study|No valid data consent|36
7729852|NCT00599339|12157773|FG000|Overall Study|Study Termination Status Unknown|12
7729853|NCT00599521|12157797|FG000|Overall Study|Lack of Efficacy|4
7729854|NCT00599521|12157798|FG001|Overall Study|Lack of Efficacy|8
7729855|NCT00599521|12157797|FG000|Overall Study|Adverse Event|4
7729856|NCT00599521|12157798|FG001|Overall Study|Adverse Event|1
7729857|NCT00599521|12157797|FG000|Overall Study|Withdrawal by Subject|28
7729858|NCT00599521|12157798|FG001|Overall Study|Withdrawal by Subject|34
7729859|NCT00599521|12157797|FG000|Overall Study|Protocol Violation|1
7729860|NCT00599521|12157798|FG001|Overall Study|Protocol Violation|1
7729861|NCT00599521|12157797|FG000|Overall Study|Lost to Follow-up|23
7729862|NCT00599521|12157798|FG001|Overall Study|Lost to Follow-up|23
7729863|NCT00599521|12157797|FG000|Overall Study|Pregnancy|0
7729864|NCT00599521|12157798|FG001|Overall Study|Pregnancy|2
7729865|NCT00599638|12157808|FG000|First Intervention Period (2 Weeks)|Adverse Event|1
7729866|NCT00599638|12157809|FG001|First Intervention Period (2 Weeks)|Adverse Event|0
7729867|NCT00599638|12157810|FG002|First Intervention Period (2 Weeks)|Adverse Event|3
7729868|NCT00599638|12157811|FG003|First Intervention Period (2 Weeks)|Adverse Event|2
7729869|NCT00599638|12157808|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1
7729870|NCT00599638|12157809|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0
7729871|NCT00599638|12157810|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0
7729872|NCT00599638|12157811|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1
7729873|NCT00599638|12157808|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0
7729874|NCT00599638|12157809|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1
7729875|NCT00599638|12157810|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0
7729876|NCT00599638|12157811|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1
7729877|NCT00599638|12157808|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0
7729878|NCT00599638|12157809|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1
7729879|NCT00599638|12157810|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0
7729880|NCT00599638|12157811|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1
7729881|NCT00599638|12157808|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1
7729882|NCT00599638|12157809|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0
7729883|NCT00599638|12157810|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0
7729884|NCT00599638|12157811|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1
7729885|NCT00599638|12157808|FG000|Washout Period (2 Weeks)|Adverse Event|0
7729886|NCT00599638|12157809|FG001|Washout Period (2 Weeks)|Adverse Event|0
7729887|NCT00599638|12157810|FG002|Washout Period (2 Weeks)|Adverse Event|0
7729888|NCT00599638|12157811|FG003|Washout Period (2 Weeks)|Adverse Event|1
7729889|NCT00599638|12157808|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0
7729890|NCT00599638|12157809|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0
7729891|NCT00599638|12157810|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0
7729892|NCT00599638|12157811|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1
7729893|NCT00599638|12157808|FG000|Washout Period (2 Weeks)|Protocol Violation|0
7729894|NCT00599638|12157809|FG001|Washout Period (2 Weeks)|Protocol Violation|1
7729895|NCT00599638|12157810|FG002|Washout Period (2 Weeks)|Protocol Violation|0
7729896|NCT00599638|12157811|FG003|Washout Period (2 Weeks)|Protocol Violation|0
7729897|NCT00599638|12157808|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1
7729898|NCT00599638|12157809|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0
7729899|NCT00599638|12157810|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0
7729900|NCT00599638|12157811|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0
7729901|NCT00599755|12157819|FG000|Overall Study|Adverse Event|11
7729902|NCT00599755|12157819|FG000|Overall Study|Withdrawal by Subject|2
7729903|NCT00599755|12157819|FG000|Overall Study|Progression of Disease|3
7729904|NCT00599755|12157819|FG000|Overall Study|Other Reason|2
7729905|NCT00599755|12157819|FG000|Overall Study|No data available|1
7729906|NCT00599924|12157843|FG000|Overall Study|Lack of Efficacy|3
7729907|NCT00599924|12157844|FG001|Overall Study|Lack of Efficacy|5
7729908|NCT00599924|12157845|FG002|Overall Study|Lack of Efficacy|1
7729909|NCT00599924|12157846|FG003|Overall Study|Lack of Efficacy|2
7729910|NCT00599924|12157847|FG004|Overall Study|Lack of Efficacy|3
7729911|NCT00599924|12157848|FG005|Overall Study|Lack of Efficacy|2
7729912|NCT00599924|12157849|FG006|Overall Study|Lack of Efficacy|0
7729913|NCT00599924|12157843|FG000|Overall Study|Adverse Event|0
7729914|NCT00599924|12157844|FG001|Overall Study|Adverse Event|0
7729915|NCT00599924|12157845|FG002|Overall Study|Adverse Event|0
7729916|NCT00599924|12157846|FG003|Overall Study|Adverse Event|2
7729917|NCT00599924|12157847|FG004|Overall Study|Adverse Event|0
7729918|NCT00599924|12157848|FG005|Overall Study|Adverse Event|0
7729919|NCT00599924|12157849|FG006|Overall Study|Adverse Event|2
7729920|NCT00599924|12157843|FG000|Overall Study|Death|0
7729921|NCT00599924|12157844|FG001|Overall Study|Death|0
7729922|NCT00599924|12157845|FG002|Overall Study|Death|0
7729923|NCT00599924|12157846|FG003|Overall Study|Death|2
7729924|NCT00599924|12157847|FG004|Overall Study|Death|0
7729925|NCT00599924|12157848|FG005|Overall Study|Death|2
7729926|NCT00599924|12157849|FG006|Overall Study|Death|1
7729927|NCT00599924|12157843|FG000|Overall Study|Protocol Violation|0
7729928|NCT00599924|12157844|FG001|Overall Study|Protocol Violation|0
7729929|NCT00599924|12157845|FG002|Overall Study|Protocol Violation|0
7729930|NCT00599924|12157846|FG003|Overall Study|Protocol Violation|1
7729931|NCT00599924|12157847|FG004|Overall Study|Protocol Violation|0
7729932|NCT00599924|12157848|FG005|Overall Study|Protocol Violation|0
7729933|NCT00599924|12157849|FG006|Overall Study|Protocol Violation|0
7729934|NCT00599924|12157843|FG000|Overall Study|Withdrawal by Subject|0
7729935|NCT00599924|12157844|FG001|Overall Study|Withdrawal by Subject|0
7729936|NCT00599924|12157845|FG002|Overall Study|Withdrawal by Subject|1
7729937|NCT00599924|12157846|FG003|Overall Study|Withdrawal by Subject|0
7729938|NCT00599924|12157847|FG004|Overall Study|Withdrawal by Subject|1
7729939|NCT00599924|12157848|FG005|Overall Study|Withdrawal by Subject|0
7729940|NCT00599924|12157849|FG006|Overall Study|Withdrawal by Subject|0
7729941|NCT00599924|12157843|FG000|Overall Study|Other|0
7729942|NCT00599924|12157844|FG001|Overall Study|Other|0
7729943|NCT00599924|12157845|FG002|Overall Study|Other|0
7729944|NCT00599924|12157846|FG003|Overall Study|Other|1
7729945|NCT00599924|12157847|FG004|Overall Study|Other|2
7729946|NCT00599924|12157848|FG005|Overall Study|Other|0
7729947|NCT00599924|12157849|FG006|Overall Study|Other|2
7729948|NCT00600028|12157872|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
7729949|NCT00600028|12157873|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0
7729950|NCT00600028|12157872|FG000|First Intervention (12 Weeks)|Adverse Event|0
7729951|NCT00600028|12157873|FG001|First Intervention (12 Weeks)|Adverse Event|1
7729952|NCT00600028|12157872|FG000|Second Intervention (12 Weeks)|Adverse Event|0
7729953|NCT00600028|12157873|FG001|Second Intervention (12 Weeks)|Adverse Event|2
7729954|NCT00600067|12157884|FG000|Overall Study|Adverse Event|0
7729955|NCT00600067|12157885|FG001|Overall Study|Adverse Event|1
7729956|NCT00600067|12157884|FG000|Overall Study|Lost to Follow-up|2
7729957|NCT00600067|12157885|FG001|Overall Study|Lost to Follow-up|3
7729958|NCT00600067|12157884|FG000|Overall Study|protocol non-compliance|0
7729959|NCT00600067|12157885|FG001|Overall Study|protocol non-compliance|3
7729960|NCT00600067|12157884|FG000|Overall Study|Lack of Efficacy|1
7729961|NCT00600067|12157885|FG001|Overall Study|Lack of Efficacy|0
7729962|NCT00600106|12157901|FG000|Overall Study|Withdrawal by Subject|1
7729963|NCT00600106|12157902|FG001|Overall Study|Withdrawal by Subject|1
7729964|NCT00600119|12157914|FG000|Single-blind Placebo run-in Period|Other - Not specified|1
7729965|NCT00600119|12157915|FG001|Single-blind Placebo run-in Period|Other - Not specified|0
7729966|NCT00600119|12157916|FG002|Single-blind Placebo run-in Period|Other - Not specified|0
7729967|NCT00600119|12157917|FG003|Single-blind Placebo run-in Period|Other - Not specified|0
7729968|NCT00600119|12157918|FG004|Single-blind Placebo run-in Period|Other - Not specified|1
7729969|NCT00600119|12157919|FG005|Single-blind Placebo run-in Period|Other - Not specified|1
7729970|NCT00600119|12157914|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
7729971|NCT00600119|12157915|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
7729972|NCT00600119|12157916|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
7729973|NCT00600119|12157917|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
7729974|NCT00600119|12157918|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
7729975|NCT00600119|12157919|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
7729976|NCT00600119|12157914|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0
7729977|NCT00600119|12157915|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0
7729978|NCT00600119|12157916|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1
7729979|NCT00600119|12157917|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0
7729980|NCT00600119|12157918|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1
7729981|NCT00600119|12157919|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0
7729982|NCT00600119|12157914|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1
7729983|NCT00600119|12157915|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0
7729984|NCT00600119|12157916|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0
7729985|NCT00600119|12157917|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0
7729986|NCT00600119|12157918|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0
7729987|NCT00600119|12157919|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0
7729988|NCT00600119|12157914|FG000|Single-blind Placebo run-in Period|Adverse Event|0
7729989|NCT00600119|12157915|FG001|Single-blind Placebo run-in Period|Adverse Event|0
7729990|NCT00600119|12157916|FG002|Single-blind Placebo run-in Period|Adverse Event|0
7729991|NCT00600119|12157917|FG003|Single-blind Placebo run-in Period|Adverse Event|1
7729992|NCT00600119|12157918|FG004|Single-blind Placebo run-in Period|Adverse Event|0
7729993|NCT00600119|12157919|FG005|Single-blind Placebo run-in Period|Adverse Event|1
7729994|NCT00600119|12157914|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2
7729995|NCT00600119|12157915|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1
7729996|NCT00600119|12157916|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0
7729997|NCT00600119|12157917|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0
7729998|NCT00600119|12157918|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0
7729999|NCT00600119|12157919|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0
7730000|NCT00600119|12157914|FG000|Double-blind Treatment Period|Withdrawal by Subject|2
7730001|NCT00600119|12157915|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
7730002|NCT00600119|12157916|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7730003|NCT00600119|12157917|FG003|Double-blind Treatment Period|Withdrawal by Subject|1
7730004|NCT00600119|12157918|FG004|Double-blind Treatment Period|Withdrawal by Subject|0
7730005|NCT00600119|12157919|FG005|Double-blind Treatment Period|Withdrawal by Subject|3
7730006|NCT00600119|12157914|FG000|Double-blind Treatment Period|Other|0
7730007|NCT00600119|12157915|FG001|Double-blind Treatment Period|Other|0
7730008|NCT00600119|12157916|FG002|Double-blind Treatment Period|Other|0
7730009|NCT00600119|12157917|FG003|Double-blind Treatment Period|Other|0
7730010|NCT00600119|12157918|FG004|Double-blind Treatment Period|Other|2
7730011|NCT00600119|12157919|FG005|Double-blind Treatment Period|Other|1
7730012|NCT00600119|12157914|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
7730013|NCT00600119|12157915|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
7730014|NCT00600119|12157916|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
7730015|NCT00600119|12157917|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
7730016|NCT00600119|12157918|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
7730017|NCT00600119|12157919|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
7730018|NCT00600119|12157914|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
7730019|NCT00600119|12157915|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
7730020|NCT00600119|12157916|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
7730021|NCT00600119|12157917|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
7730022|NCT00600119|12157918|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
7730023|NCT00600119|12157919|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
7730024|NCT00600119|12157914|FG000|Double-blind Treatment Period|Sponsor Decision|0
7730025|NCT00600119|12157915|FG001|Double-blind Treatment Period|Sponsor Decision|1
7730026|NCT00600119|12157916|FG002|Double-blind Treatment Period|Sponsor Decision|0
7730027|NCT00600119|12157917|FG003|Double-blind Treatment Period|Sponsor Decision|0
7730028|NCT00600119|12157918|FG004|Double-blind Treatment Period|Sponsor Decision|1
7730029|NCT00600119|12157919|FG005|Double-blind Treatment Period|Sponsor Decision|0
7730030|NCT00600119|12157914|FG000|Double-blind Treatment Period|Physician Decision|2
7730031|NCT00600119|12157915|FG001|Double-blind Treatment Period|Physician Decision|0
7730032|NCT00600119|12157916|FG002|Double-blind Treatment Period|Physician Decision|0
7730033|NCT00600119|12157917|FG003|Double-blind Treatment Period|Physician Decision|0
7730034|NCT00600119|12157918|FG004|Double-blind Treatment Period|Physician Decision|0
7730035|NCT00600119|12157919|FG005|Double-blind Treatment Period|Physician Decision|0
7730036|NCT00600119|12157914|FG000|Double-blind Treatment Period|Lost to Follow-up|0
7730037|NCT00600119|12157915|FG001|Double-blind Treatment Period|Lost to Follow-up|1
7730038|NCT00600119|12157916|FG002|Double-blind Treatment Period|Lost to Follow-up|0
7730039|NCT00600119|12157917|FG003|Double-blind Treatment Period|Lost to Follow-up|0
7730040|NCT00600119|12157918|FG004|Double-blind Treatment Period|Lost to Follow-up|0
7730041|NCT00600119|12157919|FG005|Double-blind Treatment Period|Lost to Follow-up|0
7730042|NCT00600119|12157914|FG000|Double-blind Treatment Period|Adverse Event|1
7730043|NCT00600119|12157915|FG001|Double-blind Treatment Period|Adverse Event|1
7730044|NCT00600119|12157916|FG002|Double-blind Treatment Period|Adverse Event|0
7730045|NCT00600119|12157917|FG003|Double-blind Treatment Period|Adverse Event|1
7730046|NCT00600119|12157918|FG004|Double-blind Treatment Period|Adverse Event|2
7730047|NCT00600119|12157919|FG005|Double-blind Treatment Period|Adverse Event|10
7730048|NCT00600119|12157914|FG000|Follow-up Period|Adverse Event|0
7730049|NCT00600119|12157915|FG001|Follow-up Period|Adverse Event|0
7730050|NCT00600119|12157916|FG002|Follow-up Period|Adverse Event|0
7730051|NCT00600119|12157917|FG003|Follow-up Period|Adverse Event|0
7730052|NCT00600119|12157918|FG004|Follow-up Period|Adverse Event|0
7730053|NCT00600119|12157919|FG005|Follow-up Period|Adverse Event|1
7730054|NCT00600119|12157914|FG000|Follow-up Period|Other|1
7730055|NCT00600119|12157915|FG001|Follow-up Period|Other|0
7730056|NCT00600119|12157916|FG002|Follow-up Period|Other|0
7730057|NCT00600119|12157917|FG003|Follow-up Period|Other|0
7730058|NCT00600119|12157918|FG004|Follow-up Period|Other|0
7730059|NCT00600119|12157919|FG005|Follow-up Period|Other|0
7730060|NCT00600171|12157939|FG000|Overall Study|Adverse Event|0
7730061|NCT00600171|12157940|FG001|Overall Study|Adverse Event|1
7730062|NCT00600171|12157941|FG002|Overall Study|Adverse Event|0
7730063|NCT00600171|12157942|FG003|Overall Study|Adverse Event|0
7730064|NCT00600171|12157943|FG004|Overall Study|Adverse Event|1
7730065|NCT00600171|12157944|FG005|Overall Study|Adverse Event|0
7730066|NCT00600171|12157939|FG000|Overall Study|Lack of Efficacy|9
7730067|NCT00600171|12157940|FG001|Overall Study|Lack of Efficacy|12
7730068|NCT00600171|12157941|FG002|Overall Study|Lack of Efficacy|3
7730069|NCT00600171|12157942|FG003|Overall Study|Lack of Efficacy|5
7730070|NCT00600171|12157943|FG004|Overall Study|Lack of Efficacy|4
7730071|NCT00600171|12157944|FG005|Overall Study|Lack of Efficacy|0
7730072|NCT00600171|12157939|FG000|Overall Study|Protocol Violation|1
7730073|NCT00600171|12157940|FG001|Overall Study|Protocol Violation|2
7730074|NCT00600171|12157941|FG002|Overall Study|Protocol Violation|0
7730075|NCT00600171|12157942|FG003|Overall Study|Protocol Violation|1
7730076|NCT00600171|12157943|FG004|Overall Study|Protocol Violation|0
7730077|NCT00600171|12157944|FG005|Overall Study|Protocol Violation|0
7730078|NCT00600171|12157939|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3
7730079|NCT00600171|12157940|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
7730080|NCT00600171|12157941|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7
7730081|NCT00600171|12157942|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3
7730082|NCT00600171|12157943|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2
7730083|NCT00600171|12157944|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2
7730084|NCT00600171|12157939|FG000|Overall Study|Withdrawal by Subject|3
7730085|NCT00600171|12157940|FG001|Overall Study|Withdrawal by Subject|0
7730086|NCT00600171|12157941|FG002|Overall Study|Withdrawal by Subject|0
7730087|NCT00600171|12157942|FG003|Overall Study|Withdrawal by Subject|1
7730088|NCT00600171|12157943|FG004|Overall Study|Withdrawal by Subject|1
7730089|NCT00600171|12157944|FG005|Overall Study|Withdrawal by Subject|1
7730090|NCT00600171|12157939|FG000|Overall Study|Physician Decision|0
7730091|NCT00600171|12157940|FG001|Overall Study|Physician Decision|1
7730092|NCT00600171|12157941|FG002|Overall Study|Physician Decision|0
7730093|NCT00600171|12157942|FG003|Overall Study|Physician Decision|1
7730094|NCT00600171|12157943|FG004|Overall Study|Physician Decision|0
7730095|NCT00600171|12157944|FG005|Overall Study|Physician Decision|2
7730096|NCT00600171|12157939|FG000|Overall Study|Lost to Follow-up|0
7730097|NCT00600171|12157940|FG001|Overall Study|Lost to Follow-up|0
7730098|NCT00600171|12157941|FG002|Overall Study|Lost to Follow-up|0
7730099|NCT00600171|12157942|FG003|Overall Study|Lost to Follow-up|1
7730100|NCT00600171|12157943|FG004|Overall Study|Lost to Follow-up|0
7730101|NCT00600171|12157944|FG005|Overall Study|Lost to Follow-up|0
7730102|NCT00600353|12157971|FG000|Overall Study|history of malignancy within 5 years|1
7730103|NCT00600353|12157972|FG001|Overall Study|history of malignancy within 5 years|0
7730104|NCT00600353|12157971|FG000|Overall Study|History of prepartive regimen|0
7730105|NCT00600353|12157972|FG001|Overall Study|History of prepartive regimen|1
7730106|NCT00600613|12157978|FG000|Overall Study|Protocol Deviation|1
7730107|NCT00600756|12158019|FG000|Analysis After 6 Months|Adverse Event|43
7730108|NCT00600756|12158020|FG001|Analysis After 6 Months|Adverse Event|33
7730109|NCT00600756|12158019|FG000|Analysis After 6 Months|Withdrawal by Subject|38
7730110|NCT00600756|12158020|FG001|Analysis After 6 Months|Withdrawal by Subject|30
7730111|NCT00600756|12158019|FG000|Analysis After 6 Months|Incorrect Enrollment|12
7730112|NCT00600756|12158020|FG001|Analysis After 6 Months|Incorrect Enrollment|21
7730113|NCT00600756|12158019|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11
7730114|NCT00600756|12158020|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14
7730115|NCT00600756|12158019|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11
7730116|NCT00600756|12158020|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11
7730117|NCT00600756|12158019|FG000|Analysis After 6 Months|Lost to Follow-up|10
7730118|NCT00600756|12158020|FG001|Analysis After 6 Months|Lost to Follow-up|8
7730119|NCT00600756|12158019|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6
7730120|NCT00600756|12158020|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3
7730121|NCT00600756|12158019|FG000|Overall Study Analysis After 12 Months|Adverse Event|53
7730122|NCT00600756|12158020|FG001|Overall Study Analysis After 12 Months|Adverse Event|44
7730123|NCT00600756|12158019|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
7730124|NCT00600756|12158020|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
7730125|NCT00600756|12158019|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21
7730126|NCT00600756|12158020|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29
7730127|NCT00600756|12158019|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
7730128|NCT00600756|12158020|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
7730129|NCT00600756|12158019|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
7730130|NCT00600756|12158020|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
7730131|NCT00600756|12158019|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16
7730132|NCT00600756|12158020|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13
7730133|NCT00600756|12158019|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
7730134|NCT00600756|12158020|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
7730135|NCT00600821|12158028|FG000|Overall Study|Death|45
7730136|NCT00600821|12158029|FG001|Overall Study|Death|46
7730137|NCT00600821|12158028|FG000|Overall Study|Lost to Follow-up|2
7730138|NCT00600821|12158029|FG001|Overall Study|Lost to Follow-up|2
7730139|NCT00600821|12158028|FG000|Overall Study|Withdrawal by Subject|1
7730140|NCT00600821|12158029|FG001|Overall Study|Withdrawal by Subject|1
7730141|NCT00600821|12158028|FG000|Overall Study|Terminated by sponsor|8
7730142|NCT00600821|12158029|FG001|Overall Study|Terminated by sponsor|6
7730143|NCT00600821|12158028|FG000|Overall Study|Objective progression or relapse|0
7730144|NCT00600821|12158029|FG001|Overall Study|Objective progression or relapse|1
7730145|NCT00600821|12158028|FG000|Overall Study|Randomized but not treated|0
7730146|NCT00600821|12158029|FG001|Overall Study|Randomized but not treated|1
7730147|NCT00600821|12158028|FG000|Overall Study|Other|2
7730148|NCT00600821|12158029|FG001|Overall Study|Other|3
7730149|NCT00600886|12158039|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
7730150|NCT00600886|12158040|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
7730151|NCT00600886|12158039|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
7730152|NCT00600886|12158040|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
7730153|NCT00600886|12158039|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
7730154|NCT00600886|12158040|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
7730155|NCT00600886|12158039|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
7730156|NCT00600886|12158040|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
7730157|NCT00600886|12158039|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
7730158|NCT00600886|12158040|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
7730159|NCT00600886|12158039|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
7730160|NCT00600886|12158040|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
7730161|NCT00600886|12158039|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
7730162|NCT00600886|12158040|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
7730163|NCT00600886|12158039|FG000|Core Phase - Full Analysis Set (FAS)|Death|0
7730164|NCT00600886|12158040|FG001|Core Phase - Full Analysis Set (FAS)|Death|1
7730165|NCT00600886|12158039|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
7730166|NCT00600886|12158040|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
7730167|NCT00600886|12158039|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3
7730168|NCT00600886|12158040|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3
7730169|NCT00600886|12158039|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9
7730170|NCT00600886|12158040|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3
7730171|NCT00600886|12158039|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3
7730172|NCT00600886|12158040|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1
7730173|NCT00600886|12158039|FG000|Extension - Same Treatment (FAS)|Adverse Event|4
7730174|NCT00600886|12158040|FG001|Extension - Same Treatment (FAS)|Adverse Event|1
7730175|NCT00600886|12158039|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
7730176|NCT00600886|12158040|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
7730177|NCT00600886|12158039|FG000|Extension - Same Treatment (FAS)|Death|1
7730178|NCT00600886|12158040|FG001|Extension - Same Treatment (FAS)|Death|1
7730179|NCT00600886|12158039|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
7730180|NCT00600886|12158040|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
7730181|NCT00600886|12158039|FG000|Extension - After Crossover (CAS)|Adverse Event|19
7730182|NCT00600886|12158040|FG001|Extension - After Crossover (CAS)|Adverse Event|1
7730183|NCT00600886|12158039|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19
7730184|NCT00600886|12158040|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4
7730185|NCT00600886|12158039|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13
7730186|NCT00600886|12158040|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4
7730187|NCT00600886|12158039|FG000|Extension - After Crossover (CAS)|Administrative Problems|4
7730188|NCT00600886|12158040|FG001|Extension - After Crossover (CAS)|Administrative Problems|4
7730189|NCT00600886|12158039|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
7730190|NCT00600886|12158040|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
7730191|NCT00600886|12158039|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
7730192|NCT00600886|12158040|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
7730193|NCT00600886|12158039|FG000|Extension - After Crossover (CAS)|Death|1
7730194|NCT00600886|12158040|FG001|Extension - After Crossover (CAS)|Death|0
7730195|NCT00600938|12158071|FG000|Core Study|Abnormal test procedure result(s)|3
7730196|NCT00600938|12158072|FG001|Core Study|Abnormal test procedure result(s)|2
7730197|NCT00600938|12158073|FG002|Core Study|Abnormal test procedure result(s)|0
7730198|NCT00600938|12158074|FG003|Core Study|Abnormal test procedure result(s)|0
7730199|NCT00600938|12158071|FG000|Core Study|Unsatisfactory therapeutic effect|1
7730200|NCT00600938|12158072|FG001|Core Study|Unsatisfactory therapeutic effect|2
7730201|NCT00600938|12158073|FG002|Core Study|Unsatisfactory therapeutic effect|0
7730202|NCT00600938|12158074|FG003|Core Study|Unsatisfactory therapeutic effect|0
7730203|NCT00600938|12158071|FG000|Core Study|Patient withdrew consent|7
7730204|NCT00600938|12158072|FG001|Core Study|Patient withdrew consent|12
7730205|NCT00600938|12158073|FG002|Core Study|Patient withdrew consent|0
7730206|NCT00600938|12158074|FG003|Core Study|Patient withdrew consent|0
7730207|NCT00600938|12158071|FG000|Core Study|Lost to Follow-up|3
7730208|NCT00600938|12158072|FG001|Core Study|Lost to Follow-up|2
7730209|NCT00600938|12158073|FG002|Core Study|Lost to Follow-up|0
7730210|NCT00600938|12158074|FG003|Core Study|Lost to Follow-up|0
7730211|NCT00600938|12158071|FG000|Core Study|Death|1
7730212|NCT00600938|12158072|FG001|Core Study|Death|1
7730213|NCT00600938|12158073|FG002|Core Study|Death|0
7730214|NCT00600938|12158074|FG003|Core Study|Death|0
7730215|NCT00600938|12158071|FG000|Core Study|Protocol Violation|1
7730216|NCT00600938|12158072|FG001|Core Study|Protocol Violation|2
7730217|NCT00600938|12158073|FG002|Core Study|Protocol Violation|0
7730218|NCT00600938|12158074|FG003|Core Study|Protocol Violation|0
7730219|NCT00600938|12158071|FG000|Extension Study|Adverse Event|1
7730220|NCT00600938|12158072|FG001|Extension Study|Adverse Event|0
7730221|NCT00600938|12158073|FG002|Extension Study|Adverse Event|2
7730222|NCT00600938|12158074|FG003|Extension Study|Adverse Event|0
7730223|NCT00600938|12158071|FG000|Extension Study|Abnormal test procedure results|0
7730224|NCT00600938|12158072|FG001|Extension Study|Abnormal test procedure results|1
7730225|NCT00600938|12158073|FG002|Extension Study|Abnormal test procedure results|1
7730226|NCT00600938|12158074|FG003|Extension Study|Abnormal test procedure results|1
7730227|NCT00600938|12158071|FG000|Extension Study|Unsatisfactory therapeutic effect|4
7730228|NCT00600938|12158072|FG001|Extension Study|Unsatisfactory therapeutic effect|1
7730229|NCT00600938|12158073|FG002|Extension Study|Unsatisfactory therapeutic effect|1
7730230|NCT00600938|12158074|FG003|Extension Study|Unsatisfactory therapeutic effect|0
7730231|NCT00600938|12158071|FG000|Extension Study|Withdrawal by Subject|2
7730232|NCT00600938|12158072|FG001|Extension Study|Withdrawal by Subject|2
7730233|NCT00600938|12158073|FG002|Extension Study|Withdrawal by Subject|3
7730234|NCT00600938|12158074|FG003|Extension Study|Withdrawal by Subject|0
7730235|NCT00600938|12158071|FG000|Extension Study|Lost to Follow-up|1
7730236|NCT00600938|12158072|FG001|Extension Study|Lost to Follow-up|1
7730237|NCT00600938|12158073|FG002|Extension Study|Lost to Follow-up|2
7730238|NCT00600938|12158074|FG003|Extension Study|Lost to Follow-up|0
7730239|NCT00600938|12158071|FG000|Extension Study|Death|1
7730240|NCT00600938|12158072|FG001|Extension Study|Death|0
7730241|NCT00600938|12158073|FG002|Extension Study|Death|0
7730242|NCT00600938|12158074|FG003|Extension Study|Death|0
7730243|NCT00601107|12158103|FG000|Overall Study|Adverse Event|0
7730244|NCT00601107|12158104|FG001|Overall Study|Adverse Event|1
7730245|NCT00601107|12158105|FG002|Overall Study|Adverse Event|3
7730246|NCT00601107|12158106|FG003|Overall Study|Adverse Event|0
7730247|NCT00601107|12158103|FG000|Overall Study|Withdrawal by Subject|5
7730248|NCT00601107|12158104|FG001|Overall Study|Withdrawal by Subject|4
7730249|NCT00601107|12158105|FG002|Overall Study|Withdrawal by Subject|7
7730250|NCT00601107|12158106|FG003|Overall Study|Withdrawal by Subject|4
7730251|NCT00601107|12158103|FG000|Overall Study|Lost to Follow-up|3
7730252|NCT00601107|12158104|FG001|Overall Study|Lost to Follow-up|3
7730253|NCT00601107|12158105|FG002|Overall Study|Lost to Follow-up|0
7730254|NCT00601107|12158106|FG003|Overall Study|Lost to Follow-up|3
7730255|NCT00601107|12158103|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
7730256|NCT00601107|12158104|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
7730257|NCT00601107|12158105|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
7730258|NCT00601107|12158106|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
7730259|NCT00601107|12158103|FG000|Overall Study|Worsening of Psoriasis|4
7730260|NCT00601107|12158104|FG001|Overall Study|Worsening of Psoriasis|1
7730261|NCT00601107|12158105|FG002|Overall Study|Worsening of Psoriasis|1
7730262|NCT00601107|12158106|FG003|Overall Study|Worsening of Psoriasis|4
7730263|NCT00601107|12158103|FG000|Overall Study|Undefined|1
7730264|NCT00601107|12158104|FG001|Overall Study|Undefined|0
7730265|NCT00601107|12158105|FG002|Overall Study|Undefined|1
7730266|NCT00601107|12158106|FG003|Overall Study|Undefined|0
7730267|NCT00601172|12158122|FG000|Overall Study|Adverse Event|43
7730268|NCT00601172|12158123|FG001|Overall Study|Adverse Event|32
7730269|NCT00601172|12158122|FG000|Overall Study|Lack of Efficacy|11
7730270|NCT00601172|12158123|FG001|Overall Study|Lack of Efficacy|12
7730271|NCT00601172|12158122|FG000|Overall Study|Protocol Violation|2
7730272|NCT00601172|12158123|FG001|Overall Study|Protocol Violation|5
7730273|NCT00601172|12158122|FG000|Overall Study|Lost to Follow-up|4
7730274|NCT00601172|12158123|FG001|Overall Study|Lost to Follow-up|3
7730275|NCT00601172|12158122|FG000|Overall Study|Physician Decision|27
7730276|NCT00601172|12158123|FG001|Overall Study|Physician Decision|28
7730277|NCT00601172|12158122|FG000|Overall Study|Withdrawal by Subject|35
7730278|NCT00601172|12158123|FG001|Overall Study|Withdrawal by Subject|27
7730279|NCT00601172|12158122|FG000|Overall Study|Did not meet continuation criteria|19
7730280|NCT00601172|12158123|FG001|Overall Study|Did not meet continuation criteria|20
7730281|NCT00601250|12158132|FG000|Overall Study|Adverse Event|3
7730282|NCT00601250|12158133|FG001|Overall Study|Adverse Event|9
7730283|NCT00601250|12158132|FG000|Overall Study|Protocol Violation|3
7730284|NCT00601250|12158133|FG001|Overall Study|Protocol Violation|2
7730285|NCT00601250|12158132|FG000|Overall Study|Lost to Follow-up|2
7730286|NCT00601250|12158133|FG001|Overall Study|Lost to Follow-up|6
7730287|NCT00601250|12158132|FG000|Overall Study|Withdrawal by Subject|4
7730288|NCT00601250|12158133|FG001|Overall Study|Withdrawal by Subject|13
7730289|NCT00601250|12158132|FG000|Overall Study|Other incl. lack of efficacy|2
7730290|NCT00601250|12158133|FG001|Overall Study|Other incl. lack of efficacy|9
7730291|NCT00601354|12158141|FG000|Overall Study|Lost to Follow-up|4
7730292|NCT00601354|12158142|FG001|Overall Study|Lost to Follow-up|5
7730293|NCT00601419|12158152|FG000|Overall Study|Lost to Follow-up|3
7730294|NCT00601419|12158152|FG000|Overall Study|Missed Visits|1
7730295|NCT00601458|12158175|FG000|Overall Study|Dosing Error|1
7730296|NCT00601458|12158176|FG001|Overall Study|Dosing Error|0
7730297|NCT00601458|12158177|FG002|Overall Study|Dosing Error|0
7730298|NCT00601458|12158175|FG000|Overall Study|Incomplete Data|0
7730299|NCT00601458|12158176|FG001|Overall Study|Incomplete Data|2
7730300|NCT00601458|12158177|FG002|Overall Study|Incomplete Data|0
7730301|NCT00601458|12158175|FG000|Overall Study|Protocol Violation|3
7730302|NCT00601458|12158176|FG001|Overall Study|Protocol Violation|2
7730303|NCT00601458|12158177|FG002|Overall Study|Protocol Violation|1
7730304|NCT00601458|12158175|FG000|Overall Study|Early Termination|0
7730305|NCT00601458|12158176|FG001|Overall Study|Early Termination|1
7730306|NCT00601458|12158177|FG002|Overall Study|Early Termination|1
7730307|NCT00601484|12158187|FG000|Overall Study|Adverse Event|0
7730308|NCT00601484|12158188|FG001|Overall Study|Adverse Event|1
7730309|NCT00601484|12158187|FG000|Overall Study|Lost to Follow-up|4
7730310|NCT00601484|12158188|FG001|Overall Study|Lost to Follow-up|3
7730311|NCT00601484|12158187|FG000|Overall Study|Lack of Efficacy|0
7730312|NCT00601484|12158188|FG001|Overall Study|Lack of Efficacy|2
7730313|NCT00601484|12158187|FG000|Overall Study|Withdrawal by Subject|1
7730314|NCT00601484|12158188|FG001|Overall Study|Withdrawal by Subject|1
7730315|NCT00601484|12158187|FG000|Overall Study|Randomized, but not treated|0
7730316|NCT00601484|12158188|FG001|Overall Study|Randomized, but not treated|1
7730317|NCT00601523|12158196|FG000|Overall Study|Adverse Event|42
7730318|NCT00601523|12158197|FG001|Overall Study|Adverse Event|14
7730319|NCT00601523|12158196|FG000|Overall Study|Lack of Efficacy|3
7730320|NCT00601523|12158197|FG001|Overall Study|Lack of Efficacy|0
7730321|NCT00601523|12158196|FG000|Overall Study|Protocol Violation|5
7730322|NCT00601523|12158197|FG001|Overall Study|Protocol Violation|1
7730323|NCT00601523|12158196|FG000|Overall Study|Lost to Follow-up|0
7730324|NCT00601523|12158197|FG001|Overall Study|Lost to Follow-up|1
7730325|NCT00601523|12158196|FG000|Overall Study|Withdrawal by Subject|18
7730326|NCT00601523|12158197|FG001|Overall Study|Withdrawal by Subject|9
7730327|NCT00601523|12158196|FG000|Overall Study|Other|9
7730328|NCT00601523|12158197|FG001|Overall Study|Other|1
7730329|NCT00601640|12158210|FG000|Overall Study|Withdrawal by Subject|3
7730330|NCT00601640|12158211|FG001|Overall Study|Withdrawal by Subject|0
7730331|NCT00601640|12158212|FG002|Overall Study|Withdrawal by Subject|7
7730332|NCT00601640|12158210|FG000|Overall Study|Death|1
7730333|NCT00601640|12158211|FG001|Overall Study|Death|0
7730334|NCT00601640|12158212|FG002|Overall Study|Death|0
7730335|NCT00601640|12158210|FG000|Overall Study|Adverse Event|0
7730336|NCT00601640|12158211|FG001|Overall Study|Adverse Event|4
7730337|NCT00601640|12158212|FG002|Overall Study|Adverse Event|2
7730338|NCT00601640|12158210|FG000|Overall Study|intercurrent illness|1
7730339|NCT00601640|12158211|FG001|Overall Study|intercurrent illness|0
7730340|NCT00601640|12158212|FG002|Overall Study|intercurrent illness|0
7730341|NCT00601640|12158210|FG000|Overall Study|change in eligibility status|0
7730342|NCT00601640|12158211|FG001|Overall Study|change in eligibility status|1
7730343|NCT00601640|12158212|FG002|Overall Study|change in eligibility status|1
7730344|NCT00601705|12158222|FG000|Overall Study|Withdrawal by Subject|1
7730345|NCT00601835|12158278|FG000|Overall Study|Withdrawal by Subject|9
7730346|NCT00601835|12158279|FG001|Overall Study|Withdrawal by Subject|6
7730347|NCT00601835|12158278|FG000|Overall Study|Physician Decision|1
7730348|NCT00601835|12158279|FG001|Overall Study|Physician Decision|0
7730349|NCT00601835|12158278|FG000|Overall Study|Lost to Follow-up|37
7730350|NCT00601835|12158279|FG001|Overall Study|Lost to Follow-up|5
7730351|NCT00601835|12158278|FG000|Overall Study|Adverse Event|1
7730352|NCT00601835|12158279|FG001|Overall Study|Adverse Event|1
7730353|NCT00601835|12158278|FG000|Overall Study|Relocate|12
7730354|NCT00601835|12158279|FG001|Overall Study|Relocate|2
7730355|NCT00602420|12158355|FG000|Overall Study|Death|1
7730356|NCT00602420|12158356|FG001|Overall Study|Death|4
7730357|NCT00602420|12158355|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
7730358|NCT00602420|12158356|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
7730359|NCT00602420|12158355|FG000|Overall Study|Withdrawal by Subject|18
7730360|NCT00602420|12158356|FG001|Overall Study|Withdrawal by Subject|17
7730361|NCT00602420|12158355|FG000|Overall Study|Adverse Event|1
7730362|NCT00602420|12158356|FG001|Overall Study|Adverse Event|0
7730363|NCT00602472|12158368|FG000|Overall Study|Adverse Event|5
7730364|NCT00602472|12158369|FG001|Overall Study|Adverse Event|23
7730365|NCT00602472|12158368|FG000|Overall Study|Protocol Violation|4
7730366|NCT00602472|12158369|FG001|Overall Study|Protocol Violation|19
7730367|NCT00602472|12158368|FG000|Overall Study|Withdrawal by Subject|8
7730368|NCT00602472|12158369|FG001|Overall Study|Withdrawal by Subject|14
7730369|NCT00602472|12158368|FG000|Overall Study|Other incl. lack of efficacy|4
7730370|NCT00602472|12158369|FG001|Overall Study|Other incl. lack of efficacy|2
7730371|NCT00602537|12158377|FG000|12 Week Double Blind Comparison|Adverse Event|2
7730372|NCT00602537|12158378|FG001|12 Week Double Blind Comparison|Adverse Event|5
7730373|NCT00602537|12158377|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13
7730374|NCT00602537|12158378|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23
7730375|NCT00602537|12158377|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5
7730376|NCT00602537|12158378|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6
7730377|NCT00602537|12158377|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3
7730378|NCT00602537|12158378|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13
7730379|NCT00602537|12158377|FG000|Follow Up Study Comparison|Adverse Event|1
7730380|NCT00602537|12158378|FG001|Follow Up Study Comparison|Adverse Event|0
7730381|NCT00602537|12158377|FG000|Follow Up Study Comparison|Lost to Follow-up|8
7730382|NCT00602537|12158378|FG001|Follow Up Study Comparison|Lost to Follow-up|1
7730383|NCT00602537|12158377|FG000|Follow Up Study Comparison|Withdrawal by Subject|2
7730384|NCT00602537|12158378|FG001|Follow Up Study Comparison|Withdrawal by Subject|2
7730385|NCT00602797|12158393|FG000|Overall Study|Adverse Event|1
7730386|NCT00602927|12158404|FG000|Period 1: 13 Days|Protocol Violation|2
7730387|NCT00602927|12158405|FG001|Period 1: 13 Days|Protocol Violation|4
7730388|NCT00602927|12158404|FG000|Period 1: 13 Days|MRI scanner technical issue|1
7730389|NCT00602927|12158405|FG001|Period 1: 13 Days|MRI scanner technical issue|0
7730390|NCT00602927|12158404|FG000|Period 1: 13 Days|Time|1
7730391|NCT00602927|12158405|FG001|Period 1: 13 Days|Time|0
7730392|NCT00602927|12158404|FG000|Period 1: 13 Days|Claustrophobia|0
7730393|NCT00602927|12158405|FG001|Period 1: 13 Days|Claustrophobia|1
7730394|NCT00602927|12158404|FG000|Period 2: 14 Days|Protocol Violation|0
7730395|NCT00602927|12158405|FG001|Period 2: 14 Days|Protocol Violation|2
7730396|NCT00602927|12158404|FG000|Period 3: 13 Days|Protocol Violation|0
7730397|NCT00602927|12158405|FG001|Period 3: 13 Days|Protocol Violation|1
7730398|NCT00602927|12158404|FG000|Period 3: 13 Days|MRI data quality|2
7730399|NCT00602927|12158405|FG001|Period 3: 13 Days|MRI data quality|2
7730400|NCT00602979|12158437|FG000|Overall Study|Lost to Follow-up|3
7730401|NCT00602979|12158438|FG001|Overall Study|Lost to Follow-up|2
7730402|NCT00602979|12158439|FG002|Overall Study|Lost to Follow-up|3
7730403|NCT00602979|12158440|FG003|Overall Study|Lost to Follow-up|2
7730404|NCT00602979|12158441|FG004|Overall Study|Lost to Follow-up|3
7730405|NCT00602979|12158437|FG000|Overall Study|Failed Intubation|0
7730406|NCT00602979|12158438|FG001|Overall Study|Failed Intubation|1
7730407|NCT00602979|12158439|FG002|Overall Study|Failed Intubation|0
7730408|NCT00602979|12158440|FG003|Overall Study|Failed Intubation|1
7730409|NCT00602979|12158441|FG004|Overall Study|Failed Intubation|0
7730410|NCT00603239|12158473|FG000|Overall Study|Adverse Event|4
7730411|NCT00603239|12158474|FG001|Overall Study|Adverse Event|1
7730412|NCT00603239|12158473|FG000|Overall Study|Entry criteria not met|0
7730413|NCT00603239|12158474|FG001|Overall Study|Entry criteria not met|1
7730414|NCT00603239|12158473|FG000|Overall Study|Loss of glucose control|3
7730415|NCT00603239|12158474|FG001|Overall Study|Loss of glucose control|0
7730416|NCT00603239|12158473|FG000|Overall Study|Lost to Follow-up|2
7730417|NCT00603239|12158474|FG001|Overall Study|Lost to Follow-up|1
7730418|NCT00603239|12158473|FG000|Overall Study|Physician Decision|2
7730419|NCT00603239|12158474|FG001|Overall Study|Physician Decision|0
7730420|NCT00603239|12158473|FG000|Overall Study|Protocol Violation|2
7730421|NCT00603239|12158474|FG001|Overall Study|Protocol Violation|0
7730422|NCT00603239|12158473|FG000|Overall Study|Subject decision|2
7730423|NCT00603239|12158474|FG001|Overall Study|Subject decision|1
7730424|NCT00603265|12158483|FG000|Overall Study|Adverse Event|2
7730425|NCT00603265|12158484|FG001|Overall Study|Adverse Event|11
7730426|NCT00603265|12158485|FG002|Overall Study|Adverse Event|1
7730427|NCT00603265|12158483|FG000|Overall Study|Withdrawal by Subject|1
7730428|NCT00603265|12158484|FG001|Overall Study|Withdrawal by Subject|2
7730429|NCT00603265|12158485|FG002|Overall Study|Withdrawal by Subject|1
7730430|NCT00603265|12158483|FG000|Overall Study|Lack of Efficacy|3
7730431|NCT00603265|12158484|FG001|Overall Study|Lack of Efficacy|0
7730432|NCT00603265|12158485|FG002|Overall Study|Lack of Efficacy|3
7730433|NCT00603265|12158483|FG000|Overall Study|Lost to Follow-up|0
7730434|NCT00603265|12158484|FG001|Overall Study|Lost to Follow-up|1
7730435|NCT00603265|12158485|FG002|Overall Study|Lost to Follow-up|0
7730436|NCT00603265|12158483|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0
7730437|NCT00603265|12158484|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1
7730438|NCT00603265|12158485|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0
7730439|NCT00603265|12158483|FG000|Overall Study|Participant Left Country, No Responses|0
7730440|NCT00603265|12158484|FG001|Overall Study|Participant Left Country, No Responses|1
7730441|NCT00603265|12158485|FG002|Overall Study|Participant Left Country, No Responses|0
7730442|NCT00603265|12158483|FG000|Overall Study|Protocol Violation|1
7730443|NCT00603265|12158484|FG001|Overall Study|Protocol Violation|0
7730444|NCT00603265|12158485|FG002|Overall Study|Protocol Violation|0
7730445|NCT00603278|12158499|FG000|Overall Study|Lack of Efficacy|35
7730446|NCT00603278|12158500|FG001|Overall Study|Lack of Efficacy|10
7730447|NCT00603278|12158501|FG002|Overall Study|Lack of Efficacy|11
7730448|NCT00603278|12158502|FG003|Overall Study|Lack of Efficacy|8
7730449|NCT00603278|12158503|FG004|Overall Study|Lack of Efficacy|7
7730450|NCT00603278|12158504|FG005|Overall Study|Lack of Efficacy|14
7730451|NCT00603278|12158499|FG000|Overall Study|Adverse Event|0
7730452|NCT00603278|12158500|FG001|Overall Study|Adverse Event|3
7730453|NCT00603278|12158501|FG002|Overall Study|Adverse Event|1
7730454|NCT00603278|12158502|FG003|Overall Study|Adverse Event|0
7730455|NCT00603278|12158503|FG004|Overall Study|Adverse Event|2
7730456|NCT00603278|12158504|FG005|Overall Study|Adverse Event|1
7730457|NCT00603278|12158499|FG000|Overall Study|Withdrawal by Subject|2
7730458|NCT00603278|12158500|FG001|Overall Study|Withdrawal by Subject|3
7730459|NCT00603278|12158501|FG002|Overall Study|Withdrawal by Subject|1
7730460|NCT00603278|12158502|FG003|Overall Study|Withdrawal by Subject|2
7730461|NCT00603278|12158503|FG004|Overall Study|Withdrawal by Subject|1
7730462|NCT00603278|12158504|FG005|Overall Study|Withdrawal by Subject|2
7730463|NCT00603278|12158499|FG000|Overall Study|Protocol Violation|3
7730464|NCT00603278|12158500|FG001|Overall Study|Protocol Violation|0
7730465|NCT00603278|12158501|FG002|Overall Study|Protocol Violation|1
7730466|NCT00603278|12158502|FG003|Overall Study|Protocol Violation|1
7730467|NCT00603278|12158503|FG004|Overall Study|Protocol Violation|0
7730468|NCT00603278|12158504|FG005|Overall Study|Protocol Violation|1
7730469|NCT00603278|12158499|FG000|Overall Study|Physician Decision|0
7730470|NCT00603278|12158500|FG001|Overall Study|Physician Decision|1
7730471|NCT00603278|12158501|FG002|Overall Study|Physician Decision|0
7730472|NCT00603278|12158502|FG003|Overall Study|Physician Decision|0
7730473|NCT00603278|12158503|FG004|Overall Study|Physician Decision|2
7730474|NCT00603278|12158504|FG005|Overall Study|Physician Decision|1
7730475|NCT00603278|12158499|FG000|Overall Study|Lost to Follow-up|1
7730476|NCT00603278|12158500|FG001|Overall Study|Lost to Follow-up|0
7730477|NCT00603278|12158501|FG002|Overall Study|Lost to Follow-up|0
7730478|NCT00603278|12158502|FG003|Overall Study|Lost to Follow-up|0
7730479|NCT00603278|12158503|FG004|Overall Study|Lost to Follow-up|1
7730480|NCT00603278|12158504|FG005|Overall Study|Lost to Follow-up|0
7730481|NCT00603304|12158533|FG000|Overall Study|Lost to Follow-up|5
7730482|NCT00603304|12158534|FG001|Overall Study|Lost to Follow-up|7
7730483|NCT00603304|12158533|FG000|Overall Study|Withdrawal by Subject|8
7730484|NCT00603304|12158534|FG001|Overall Study|Withdrawal by Subject|5
7730485|NCT00603304|12158533|FG000|Overall Study|Protocol Violation|1
7730486|NCT00603304|12158534|FG001|Overall Study|Protocol Violation|0
7730487|NCT00603304|12158533|FG000|Overall Study|Adverse Event|4
7730488|NCT00603304|12158534|FG001|Overall Study|Adverse Event|2
7730489|NCT00603304|12158533|FG000|Overall Study|Unacceptable Treatment Toxicity|5
7730490|NCT00603304|12158534|FG001|Overall Study|Unacceptable Treatment Toxicity|8
7730491|NCT00603304|12158533|FG000|Overall Study|Crossed Over to Open Label Therapy|3
7730492|NCT00603304|12158534|FG001|Overall Study|Crossed Over to Open Label Therapy|3
7730493|NCT00603304|12158533|FG000|Overall Study|Exclusionary Medication|2
7730494|NCT00603304|12158534|FG001|Overall Study|Exclusionary Medication|3
7730495|NCT00603304|12158533|FG000|Overall Study|Non-Compliant|0
7730496|NCT00603304|12158534|FG001|Overall Study|Non-Compliant|1
7730497|NCT00603304|12158533|FG000|Overall Study|Moved Away|0
7730498|NCT00603304|12158534|FG001|Overall Study|Moved Away|2
7730499|NCT00603304|12158533|FG000|Overall Study|Other|2
7730500|NCT00603304|12158534|FG001|Overall Study|Other|0
7730501|NCT00603304|12158533|FG000|Overall Study|Patient Decision|2
7730502|NCT00603304|12158534|FG001|Overall Study|Patient Decision|0
7730503|NCT00603382|12158548|FG000|Overall Study|Adverse Event|0
7730504|NCT00603382|12158549|FG001|Overall Study|Adverse Event|1
7730505|NCT00603382|12158550|FG002|Overall Study|Adverse Event|1
7730506|NCT00603382|12158551|FG003|Overall Study|Adverse Event|2
7730507|NCT00603382|12158552|FG004|Overall Study|Adverse Event|1
7730508|NCT00603382|12158553|FG005|Overall Study|Adverse Event|2
7730509|NCT00603382|12158548|FG000|Overall Study|Lack of Efficacy|14
7730510|NCT00603382|12158549|FG001|Overall Study|Lack of Efficacy|9
7730511|NCT00603382|12158550|FG002|Overall Study|Lack of Efficacy|3
7730512|NCT00603382|12158551|FG003|Overall Study|Lack of Efficacy|6
7730513|NCT00603382|12158552|FG004|Overall Study|Lack of Efficacy|6
7730514|NCT00603382|12158553|FG005|Overall Study|Lack of Efficacy|11
7730515|NCT00603382|12158548|FG000|Overall Study|Protocol Violation|1
7730516|NCT00603382|12158549|FG001|Overall Study|Protocol Violation|0
7730517|NCT00603382|12158550|FG002|Overall Study|Protocol Violation|1
7730518|NCT00603382|12158551|FG003|Overall Study|Protocol Violation|2
7730519|NCT00603382|12158552|FG004|Overall Study|Protocol Violation|1
7730520|NCT00603382|12158553|FG005|Overall Study|Protocol Violation|0
7730521|NCT00603382|12158548|FG000|Overall Study|Lost to Follow-up|0
7730522|NCT00603382|12158549|FG001|Overall Study|Lost to Follow-up|1
7730523|NCT00603382|12158550|FG002|Overall Study|Lost to Follow-up|1
7730524|NCT00603382|12158551|FG003|Overall Study|Lost to Follow-up|1
7730525|NCT00603382|12158552|FG004|Overall Study|Lost to Follow-up|0
7730526|NCT00603382|12158553|FG005|Overall Study|Lost to Follow-up|1
7730527|NCT00603382|12158548|FG000|Overall Study|Physician Decision|0
7730528|NCT00603382|12158549|FG001|Overall Study|Physician Decision|0
7730529|NCT00603382|12158550|FG002|Overall Study|Physician Decision|2
7730530|NCT00603382|12158551|FG003|Overall Study|Physician Decision|0
7730531|NCT00603382|12158552|FG004|Overall Study|Physician Decision|1
7730532|NCT00603382|12158553|FG005|Overall Study|Physician Decision|3
7730533|NCT00603382|12158548|FG000|Overall Study|Withdrawal by Subject|3
7730534|NCT00603382|12158549|FG001|Overall Study|Withdrawal by Subject|3
7730535|NCT00603382|12158550|FG002|Overall Study|Withdrawal by Subject|1
7730536|NCT00603382|12158551|FG003|Overall Study|Withdrawal by Subject|1
7730537|NCT00603382|12158552|FG004|Overall Study|Withdrawal by Subject|0
7730538|NCT00603382|12158553|FG005|Overall Study|Withdrawal by Subject|1
7730539|NCT00603447|12158579|FG000|Overall Study|Adverse Event|0
7730540|NCT00603447|12158580|FG001|Overall Study|Adverse Event|1
7730541|NCT00603447|12158581|FG002|Overall Study|Adverse Event|1
7730542|NCT00603447|12158582|FG003|Overall Study|Adverse Event|2
7730543|NCT00603447|12158583|FG004|Overall Study|Adverse Event|1
7730544|NCT00603447|12158584|FG005|Overall Study|Adverse Event|2
7730545|NCT00603447|12158585|FG006|Overall Study|Adverse Event|10
7730546|NCT00603447|12158579|FG000|Overall Study|Other|0
7730547|NCT00603447|12158580|FG001|Overall Study|Other|0
7730548|NCT00603447|12158581|FG002|Overall Study|Other|1
7730549|NCT00603447|12158582|FG003|Overall Study|Other|0
7730550|NCT00603447|12158583|FG004|Overall Study|Other|3
7730551|NCT00603447|12158584|FG005|Overall Study|Other|0
7730552|NCT00603447|12158585|FG006|Overall Study|Other|13
7730553|NCT00603447|12158579|FG000|Overall Study|Withdrew Consent|0
7730554|NCT00603447|12158580|FG001|Overall Study|Withdrew Consent|2
7730555|NCT00603447|12158581|FG002|Overall Study|Withdrew Consent|0
7730556|NCT00603447|12158582|FG003|Overall Study|Withdrew Consent|0
7730557|NCT00603447|12158583|FG004|Overall Study|Withdrew Consent|1
7730558|NCT00603447|12158584|FG005|Overall Study|Withdrew Consent|0
7730559|NCT00603447|12158585|FG006|Overall Study|Withdrew Consent|1
7730560|NCT00603473|12158601|FG000|Overall Study|Adverse Event|4
7730561|NCT00603473|12158601|FG000|Overall Study|Lack of Efficacy|4
7730562|NCT00603473|12158601|FG000|Overall Study|Protocol Violation|1
7730563|NCT00603512|12158610|FG000|Overall Study|Adverse Event|0
7730564|NCT00603512|12158611|FG001|Overall Study|Adverse Event|2
7730565|NCT00603512|12158612|FG002|Overall Study|Adverse Event|4
7730566|NCT00603512|12158613|FG003|Overall Study|Adverse Event|4
7730567|NCT00603512|12158614|FG004|Overall Study|Adverse Event|2
7730568|NCT00603512|12158610|FG000|Overall Study|Lack of Efficacy|0
7730569|NCT00603512|12158611|FG001|Overall Study|Lack of Efficacy|1
7730570|NCT00603512|12158612|FG002|Overall Study|Lack of Efficacy|0
7730571|NCT00603512|12158613|FG003|Overall Study|Lack of Efficacy|0
7730572|NCT00603512|12158614|FG004|Overall Study|Lack of Efficacy|1
7730573|NCT00603512|12158610|FG000|Overall Study|Other|2
7730574|NCT00603512|12158611|FG001|Overall Study|Other|1
7730575|NCT00603512|12158612|FG002|Overall Study|Other|0
7730576|NCT00603512|12158613|FG003|Overall Study|Other|1
7730577|NCT00603512|12158614|FG004|Overall Study|Other|1
7730578|NCT00603512|12158610|FG000|Overall Study|Withdrawal by Subject|0
7730579|NCT00603512|12158611|FG001|Overall Study|Withdrawal by Subject|0
7730580|NCT00603512|12158612|FG002|Overall Study|Withdrawal by Subject|0
7730581|NCT00603512|12158613|FG003|Overall Study|Withdrawal by Subject|0
7730582|NCT00603512|12158614|FG004|Overall Study|Withdrawal by Subject|1
7730583|NCT00603512|12158610|FG000|Overall Study|Randomized but not treated|0
7730584|NCT00603512|12158611|FG001|Overall Study|Randomized but not treated|1
7730585|NCT00603512|12158612|FG002|Overall Study|Randomized but not treated|1
7730586|NCT00603512|12158613|FG003|Overall Study|Randomized but not treated|2
7730587|NCT00603512|12158614|FG004|Overall Study|Randomized but not treated|0
7730588|NCT00603525|12158628|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3
7730589|NCT00603525|12158629|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9
7730590|NCT00603525|12158630|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0
7730591|NCT00603525|12158628|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
7730592|NCT00603525|12158629|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
7730593|NCT00603525|12158630|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
7730594|NCT00603525|12158628|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1
7730595|NCT00603525|12158629|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2
7730596|NCT00603525|12158630|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0
7730597|NCT00603525|12158628|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
7730598|NCT00603525|12158629|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
7730599|NCT00603525|12158630|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
7730600|NCT00603525|12158628|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
7730601|NCT00603525|12158629|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
7730602|NCT00603525|12158630|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
7730603|NCT00603525|12158628|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0
7730604|NCT00603525|12158629|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1
7730605|NCT00603525|12158630|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0
7730606|NCT00603525|12158628|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
7730607|NCT00603525|12158629|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
7730608|NCT00603525|12158630|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
7730609|NCT00603525|12158628|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0
7730610|NCT00603525|12158629|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12
7730611|NCT00603525|12158630|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0
7730612|NCT00603525|12158628|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
7730613|NCT00603525|12158629|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
7730614|NCT00603525|12158630|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
7730615|NCT00603525|12158628|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0
7730616|NCT00603525|12158629|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1
7730617|NCT00603525|12158630|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0
7730618|NCT00603525|12158628|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
7730619|NCT00603525|12158629|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
7730620|NCT00603525|12158630|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
7730621|NCT00603525|12158628|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
7730622|NCT00603525|12158629|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
7730623|NCT00603525|12158630|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
7730624|NCT00603525|12158628|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0
7730625|NCT00603525|12158629|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2
7730626|NCT00603525|12158630|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0
7730627|NCT00603525|12158628|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
7730628|NCT00603525|12158629|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
7730629|NCT00603525|12158630|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
7730630|NCT00603525|12158628|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
7730631|NCT00603525|12158629|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
7730632|NCT00603525|12158630|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
7730633|NCT00603538|12158644|FG000|Overall Study|Adverse Event|0
7730634|NCT00603538|12158645|FG001|Overall Study|Adverse Event|4
7730635|NCT00603538|12158646|FG002|Overall Study|Adverse Event|2
7730636|NCT00603538|12158644|FG000|Overall Study|Objective progression or relapse|3
7730637|NCT00603538|12158645|FG001|Overall Study|Objective progression or relapse|0
7730638|NCT00603538|12158646|FG002|Overall Study|Objective progression or relapse|0
7730639|NCT00603590|12158668|FG000|Overall Study|Did not attend study clinic|39
7730640|NCT00603590|12158669|FG001|Overall Study|Did not attend study clinic|30
7730641|NCT00603590|12158668|FG000|Overall Study|Refused blood test|5
7730642|NCT00603590|12158669|FG001|Overall Study|Refused blood test|1
7730643|NCT00603590|12158668|FG000|Overall Study|Patient discontinued study drug|22
7730644|NCT00603590|12158669|FG001|Overall Study|Patient discontinued study drug|15
7730645|NCT00603590|12158668|FG000|Overall Study|Adverse Event|2
7730646|NCT00603590|12158669|FG001|Overall Study|Adverse Event|0
7730647|NCT00603590|12158668|FG000|Overall Study|Lost to Follow-up|8
7730648|NCT00603590|12158669|FG001|Overall Study|Lost to Follow-up|4
7730649|NCT00603590|12158668|FG000|Overall Study|Cardiovascular event|0
7730650|NCT00603590|12158669|FG001|Overall Study|Cardiovascular event|1
7730651|NCT00603733|12158707|FG000|Active Phase ITT|Adverse Event|8
7730652|NCT00603733|12158708|FG001|Active Phase ITT|Adverse Event|7
7730653|NCT00603733|12158707|FG000|Active Phase ITT|Withdrawal by Subject|0
7730654|NCT00603733|12158708|FG001|Active Phase ITT|Withdrawal by Subject|3
7730655|NCT00603733|12158707|FG000|Active Phase ITT|Lost to Follow-up|0
7730656|NCT00603733|12158708|FG001|Active Phase ITT|Lost to Follow-up|1
7730657|NCT00603733|12158707|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1
7730658|NCT00603733|12158708|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3
7730659|NCT00603733|12158707|FG000|Active Phase ITT|Lack of Efficacy|1
7730660|NCT00603733|12158708|FG001|Active Phase ITT|Lack of Efficacy|2
7730661|NCT00603733|12158707|FG000|Active Phase ITT|Subject moved, site closed|1
7730662|NCT00603733|12158708|FG001|Active Phase ITT|Subject moved, site closed|1
7730663|NCT00603733|12158707|FG000|Run-In Phase - 4 Weeks|Adverse Event|2
7730664|NCT00603733|12158708|FG001|Run-In Phase - 4 Weeks|Adverse Event|1
7730665|NCT00603733|12158707|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
7730666|NCT00603733|12158708|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
7730667|NCT00603733|12158707|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1
7730668|NCT00603733|12158708|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0
7730669|NCT00603733|12158707|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
7730670|NCT00603733|12158708|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
7730671|NCT00603733|12158707|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2
7730672|NCT00603733|12158708|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1
7730673|NCT00603733|12158707|FG000|Maintenance Phase ITT|Adverse Event|3
7730674|NCT00603733|12158708|FG001|Maintenance Phase ITT|Adverse Event|6
7730675|NCT00603733|12158707|FG000|Maintenance Phase ITT|Withdrawal by Subject|1
7730676|NCT00603733|12158708|FG001|Maintenance Phase ITT|Withdrawal by Subject|0
7730677|NCT00603733|12158707|FG000|Maintenance Phase ITT|Protocol Violation|1
7730678|NCT00603733|12158708|FG001|Maintenance Phase ITT|Protocol Violation|1
7730679|NCT00603733|12158707|FG000|Maintenance Phase ITT|Lost to Follow-up|0
7730680|NCT00603733|12158708|FG001|Maintenance Phase ITT|Lost to Follow-up|1
7730681|NCT00603733|12158707|FG000|Maintenance Phase ITT|Lack of Efficacy|2
7730682|NCT00603733|12158708|FG001|Maintenance Phase ITT|Lack of Efficacy|2
7730683|NCT00603733|12158707|FG000|Maintenance Phase ITT|Physician Decision|0
7730684|NCT00603733|12158708|FG001|Maintenance Phase ITT|Physician Decision|1
7730685|NCT00603733|12158707|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
7730686|NCT00603733|12158708|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
7730687|NCT00603746|12158720|FG000|Overall Study|Adverse Event|2
7730688|NCT00603746|12158721|FG001|Overall Study|Adverse Event|3
7730689|NCT00603746|12158722|FG002|Overall Study|Adverse Event|0
7730690|NCT00603746|12158723|FG003|Overall Study|Adverse Event|1
7730691|NCT00603746|12158724|FG004|Overall Study|Adverse Event|0
7730692|NCT00603746|12158725|FG005|Overall Study|Adverse Event|4
7730693|NCT00603746|12158720|FG000|Overall Study|Lack of Efficacy|34
7730694|NCT00603746|12158721|FG001|Overall Study|Lack of Efficacy|11
7730695|NCT00603746|12158722|FG002|Overall Study|Lack of Efficacy|6
7730696|NCT00603746|12158723|FG003|Overall Study|Lack of Efficacy|11
7730697|NCT00603746|12158724|FG004|Overall Study|Lack of Efficacy|12
7730698|NCT00603746|12158725|FG005|Overall Study|Lack of Efficacy|8
7730699|NCT00603746|12158720|FG000|Overall Study|Protocol Violation|0
7730700|NCT00603746|12158721|FG001|Overall Study|Protocol Violation|3
7730701|NCT00603746|12158722|FG002|Overall Study|Protocol Violation|1
7730702|NCT00603746|12158723|FG003|Overall Study|Protocol Violation|0
7730703|NCT00603746|12158724|FG004|Overall Study|Protocol Violation|1
7730704|NCT00603746|12158725|FG005|Overall Study|Protocol Violation|0
7730705|NCT00603746|12158720|FG000|Overall Study|Lost to Follow-up|0
7730706|NCT00603746|12158721|FG001|Overall Study|Lost to Follow-up|1
7730707|NCT00603746|12158722|FG002|Overall Study|Lost to Follow-up|1
7730708|NCT00603746|12158723|FG003|Overall Study|Lost to Follow-up|0
7730709|NCT00603746|12158724|FG004|Overall Study|Lost to Follow-up|0
7730710|NCT00603746|12158725|FG005|Overall Study|Lost to Follow-up|0
7730711|NCT00603746|12158720|FG000|Overall Study|Physician Decision|1
7730712|NCT00603746|12158721|FG001|Overall Study|Physician Decision|0
7730713|NCT00603746|12158722|FG002|Overall Study|Physician Decision|0
7730714|NCT00603746|12158723|FG003|Overall Study|Physician Decision|0
7730715|NCT00603746|12158724|FG004|Overall Study|Physician Decision|1
7730716|NCT00603746|12158725|FG005|Overall Study|Physician Decision|0
7730717|NCT00603746|12158720|FG000|Overall Study|Withdrawal by Subject|1
7730718|NCT00603746|12158721|FG001|Overall Study|Withdrawal by Subject|0
7730719|NCT00603746|12158722|FG002|Overall Study|Withdrawal by Subject|0
7730720|NCT00603746|12158723|FG003|Overall Study|Withdrawal by Subject|1
7730721|NCT00603746|12158724|FG004|Overall Study|Withdrawal by Subject|3
7730722|NCT00603746|12158725|FG005|Overall Study|Withdrawal by Subject|1
7730723|NCT00603798|12158742|FG000|Overall Study|Adverse Event|4
7730724|NCT00603798|12158743|FG001|Overall Study|Adverse Event|2
7730725|NCT00603798|12158744|FG002|Overall Study|Adverse Event|1
7730726|NCT00603798|12158742|FG000|Overall Study|Withdrawal by Subject|4
7730727|NCT00603798|12158743|FG001|Overall Study|Withdrawal by Subject|3
7730728|NCT00603798|12158744|FG002|Overall Study|Withdrawal by Subject|4
7730729|NCT00603798|12158742|FG000|Overall Study|Lost to Follow-up|1
7730730|NCT00603798|12158743|FG001|Overall Study|Lost to Follow-up|0
7730731|NCT00603798|12158744|FG002|Overall Study|Lost to Follow-up|1
7730732|NCT00603798|12158742|FG000|Overall Study|Non-compliance with study procedures|0
7730733|NCT00603798|12158743|FG001|Overall Study|Non-compliance with study procedures|1
7730734|NCT00603798|12158744|FG002|Overall Study|Non-compliance with study procedures|0
7730735|NCT00603798|12158742|FG000|Overall Study|Not due to AE|1
7730736|NCT00603798|12158743|FG001|Overall Study|Not due to AE|1
7730737|NCT00603798|12158744|FG002|Overall Study|Not due to AE|4
7730738|NCT00603837|12158754|FG000|Overall Study|Physician Decision|3
7730739|NCT00603837|12158755|FG001|Overall Study|Physician Decision|0
7768610|NCT00862719|12211909|FG002|Overall Study|Disease Progression|1
7768611|NCT00862719|12211910|FG003|Overall Study|Disease Progression|0
7768612|NCT00862719|12211907|FG000|Overall Study|Death|5
7768613|NCT00862719|12211908|FG001|Overall Study|Death|6
7768614|NCT00862719|12211909|FG002|Overall Study|Death|1
7768615|NCT00862719|12211910|FG003|Overall Study|Death|1
7768616|NCT00862719|12211907|FG000|Overall Study|Engraftment failure|0
7768617|NCT00862719|12211908|FG001|Overall Study|Engraftment failure|0
7768618|NCT00862719|12211909|FG002|Overall Study|Engraftment failure|1
7768619|NCT00862719|12211910|FG003|Overall Study|Engraftment failure|0
7768620|NCT00862719|12211907|FG000|Overall Study|Veno-Occlusive Disease|0
7768621|NCT00862719|12211908|FG001|Overall Study|Veno-Occlusive Disease|0
7768622|NCT00862719|12211909|FG002|Overall Study|Veno-Occlusive Disease|1
7768623|NCT00862719|12211910|FG003|Overall Study|Veno-Occlusive Disease|0
7768624|NCT00862823|12211942|FG000|First Intervention|Withdrawal by Subject|1
7768625|NCT00862823|12211943|FG001|First Intervention|Withdrawal by Subject|1
7768626|NCT00862836|12211948|FG000|Overall Study|Withdrawal by Subject|1
7768627|NCT00862849|12211952|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
7768628|NCT00862849|12211953|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
7768629|NCT00862849|12211954|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
7768630|NCT00862849|12211955|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
7768631|NCT00862849|12211956|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
7768632|NCT00862849|12211957|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
7768633|NCT00862849|12211952|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0
7768634|NCT00862849|12211953|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1
7768635|NCT00862849|12211954|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0
7768636|NCT00862849|12211955|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0
7768637|NCT00862849|12211956|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0
7768638|NCT00862849|12211957|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0
7770397|NCT00876395|12214395|FG000|Overall Study|New cancer therapy|25
7770398|NCT00876395|12214396|FG001|Overall Study|New cancer therapy|7
7770399|NCT00876395|12214395|FG000|Overall Study|Protocol Violation|5
7770400|NCT00876395|12214396|FG001|Overall Study|Protocol Violation|2
7770401|NCT00876395|12214395|FG000|Overall Study|Withdrawal by Subject|66
7770402|NCT00876395|12214396|FG001|Overall Study|Withdrawal by Subject|33
7770403|NCT00876395|12214395|FG000|Overall Study|Lost to Follow-up|2
7770404|NCT00876395|12214396|FG001|Overall Study|Lost to Follow-up|0
7770405|NCT00876395|12214395|FG000|Overall Study|Administrative problems|39
7770406|NCT00876395|12214396|FG001|Overall Study|Administrative problems|23
7770407|NCT00876395|12214395|FG000|Overall Study|Death|12
7770408|NCT00876395|12214396|FG001|Overall Study|Death|0
7770409|NCT00876447|12214409|FG000|Overall Study|Other miscellaneous reasons|3
7770410|NCT00876447|12214410|FG001|Overall Study|Other miscellaneous reasons|8
7770411|NCT00876447|12214409|FG000|Overall Study|Site closure|19
7770412|NCT00876447|12214410|FG001|Overall Study|Site closure|14
7770413|NCT00876447|12214409|FG000|Overall Study|Protocol Violation|9
7770414|NCT00876447|12214410|FG001|Overall Study|Protocol Violation|3
7770415|NCT00876447|12214409|FG000|Overall Study|Personal reasons|30
7770416|NCT00876447|12214410|FG001|Overall Study|Personal reasons|28
7770417|NCT00876447|12214409|FG000|Overall Study|Lost to Follow-up|6
7770418|NCT00876447|12214410|FG001|Overall Study|Lost to Follow-up|15
7770419|NCT00876447|12214409|FG000|Overall Study|Pregnancy|4
7770420|NCT00876447|12214410|FG001|Overall Study|Pregnancy|2
7770421|NCT00876447|12214409|FG000|Overall Study|Lack of Efficacy|5
7770422|NCT00876447|12214410|FG001|Overall Study|Lack of Efficacy|3
7770423|NCT00876447|12214409|FG000|Overall Study|Adverse Event|4
7770424|NCT00876447|12214410|FG001|Overall Study|Adverse Event|8
7770425|NCT00876460|12214448|FG000|Combination Therapy Phase|Progressive disease|2
7770426|NCT00876460|12214449|FG001|Combination Therapy Phase|Progressive disease|3
7770427|NCT00876460|12214450|FG002|Combination Therapy Phase|Progressive disease|3
7770428|NCT00876460|12214451|FG003|Combination Therapy Phase|Progressive disease|3
7770429|NCT00876460|12214452|FG004|Combination Therapy Phase|Progressive disease|3
7770430|NCT00876460|12214453|FG005|Combination Therapy Phase|Progressive disease|1
7770431|NCT00876460|12214454|FG006|Combination Therapy Phase|Progressive disease|1
7770432|NCT00876460|12214455|FG007|Combination Therapy Phase|Progressive disease|1
7770433|NCT00876460|12214448|FG000|Combination Therapy Phase|Dose limiting toxicity|0
7770434|NCT00876460|12214449|FG001|Combination Therapy Phase|Dose limiting toxicity|1
7770435|NCT00876460|12214450|FG002|Combination Therapy Phase|Dose limiting toxicity|0
7770436|NCT00876460|12214451|FG003|Combination Therapy Phase|Dose limiting toxicity|1
7770437|NCT00876460|12214452|FG004|Combination Therapy Phase|Dose limiting toxicity|1
7770438|NCT00876460|12214453|FG005|Combination Therapy Phase|Dose limiting toxicity|2
7770439|NCT00876460|12214454|FG006|Combination Therapy Phase|Dose limiting toxicity|2
7730740|NCT00603915|12158778|FG000|Overall Study|Physician Decision|1
7730741|NCT00603941|12158785|FG000|Overall Study|Disease progression|6
7730742|NCT00603941|12158786|FG001|Overall Study|Disease progression|7
7730743|NCT00603941|12158787|FG002|Overall Study|Disease progression|1
7730744|NCT00603941|12158785|FG000|Overall Study|Adverse Event|1
7730745|NCT00603941|12158786|FG001|Overall Study|Adverse Event|0
7730746|NCT00603941|12158787|FG002|Overall Study|Adverse Event|1
7730747|NCT00603941|12158785|FG000|Overall Study|Physician Decision|0
7730748|NCT00603941|12158786|FG001|Overall Study|Physician Decision|1
7730749|NCT00603941|12158787|FG002|Overall Study|Physician Decision|0
7730750|NCT00603941|12158785|FG000|Overall Study|Withdrawal by Subject|0
7730751|NCT00603941|12158786|FG001|Overall Study|Withdrawal by Subject|2
7730752|NCT00603941|12158787|FG002|Overall Study|Withdrawal by Subject|0
7730753|NCT00603980|12158796|FG000|Study Qualification|Protocol Violation|3
7730754|NCT00603980|12158796|FG000|Study Qualification|Inconsistent data reporting|13
7730755|NCT00603980|12158796|FG000|Main Study|14th subject completed trial|1
7730756|NCT00604162|12158838|FG000|Overall Study|Physician Decision|3
7730757|NCT00604162|12158838|FG000|Overall Study|Withdrawal by Subject|1
7730758|NCT00604175|12158848|FG000|Entry Through Week 28|Death|2
7730759|NCT00604175|12158849|FG001|Entry Through Week 28|Death|0
7730760|NCT00604175|12158850|FG002|Entry Through Week 28|Death|0
7730761|NCT00604175|12158848|FG000|Entry Through Week 28|Withdrawal by Subject|1
7730762|NCT00604175|12158849|FG001|Entry Through Week 28|Withdrawal by Subject|0
7730763|NCT00604175|12158850|FG002|Entry Through Week 28|Withdrawal by Subject|0
7730764|NCT00604175|12158848|FG000|Entry Through Week 28|Lost to Follow-up|4
7730765|NCT00604175|12158849|FG001|Entry Through Week 28|Lost to Follow-up|3
7730766|NCT00604175|12158850|FG002|Entry Through Week 28|Lost to Follow-up|0
7730767|NCT00604175|12158848|FG000|Entry Through Week 28|Ineligible|1
7730768|NCT00604175|12158849|FG001|Entry Through Week 28|Ineligible|0
7730769|NCT00604175|12158850|FG002|Entry Through Week 28|Ineligible|0
7730770|NCT00604175|12158848|FG000|Entry Through Week 28|Did not start intervention|2
7730771|NCT00604175|12158849|FG001|Entry Through Week 28|Did not start intervention|0
7730772|NCT00604175|12158850|FG002|Entry Through Week 28|Did not start intervention|1
7730773|NCT00604175|12158848|FG000|Week 29 Through Week 72|Death|0
7730774|NCT00604175|12158849|FG001|Week 29 Through Week 72|Death|0
7730775|NCT00604175|12158850|FG002|Week 29 Through Week 72|Death|1
7730776|NCT00604175|12158848|FG000|Week 29 Through Week 72|Lost to Follow-up|12
7730777|NCT00604175|12158849|FG001|Week 29 Through Week 72|Lost to Follow-up|6
7730778|NCT00604175|12158850|FG002|Week 29 Through Week 72|Lost to Follow-up|2
7730779|NCT00604175|12158848|FG000|Week 29 Through Week 72|Site closure|0
7730780|NCT00604175|12158849|FG001|Week 29 Through Week 72|Site closure|1
7730781|NCT00604175|12158850|FG002|Week 29 Through Week 72|Site closure|0
7730782|NCT00604175|12158848|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0
7730783|NCT00604175|12158849|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0
7730784|NCT00604175|12158850|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1
7730785|NCT00604188|12158884|FG000|Overall Study|Adverse Event|1
7730786|NCT00604188|12158885|FG001|Overall Study|Adverse Event|4
7730787|NCT00604188|12158884|FG000|Overall Study|Lost to Follow-up|17
7730788|NCT00604188|12158885|FG001|Overall Study|Lost to Follow-up|15
7730789|NCT00604188|12158884|FG000|Overall Study|Withdrawal by Subject|5
7730790|NCT00604188|12158885|FG001|Overall Study|Withdrawal by Subject|1
7730791|NCT00604188|12158884|FG000|Overall Study|Non-compliance with protocol|4
7730792|NCT00604188|12158885|FG001|Overall Study|Non-compliance with protocol|4
7730793|NCT00604188|12158884|FG000|Overall Study|Did not receive study drug|0
7730794|NCT00604188|12158885|FG001|Overall Study|Did not receive study drug|1
7730795|NCT00604214|12158893|FG000|Baseline to Day 28|Death|223
7730796|NCT00604214|12158894|FG001|Baseline to Day 28|Death|202
7730797|NCT00604214|12158893|FG000|Baseline to Day 28|Lost to Follow-up|2
7730798|NCT00604214|12158894|FG001|Baseline to Day 28|Lost to Follow-up|4
7730799|NCT00604214|12158893|FG000|Baseline to Day 28|Withdrawal by Subject|3
7730800|NCT00604214|12158894|FG001|Baseline to Day 28|Withdrawal by Subject|7
7730801|NCT00604214|12158893|FG000|Day 29 to Day 90|Death|64
7730802|NCT00604214|12158894|FG001|Day 29 to Day 90|Death|67
7730803|NCT00604214|12158893|FG000|Day 29 to Day 90|Lost to Follow-up|4
7730804|NCT00604214|12158894|FG001|Day 29 to Day 90|Lost to Follow-up|6
7730805|NCT00604214|12158893|FG000|Day 29 to Day 90|Withdrawal by Subject|0
7730806|NCT00604214|12158894|FG001|Day 29 to Day 90|Withdrawal by Subject|6
7730807|NCT00604214|12158893|FG000|Day 91 to Day 180|Death|19
7730808|NCT00604214|12158894|FG001|Day 91 to Day 180|Death|23
7730809|NCT00604214|12158893|FG000|Day 91 to Day 180|Lost to Follow-up|6
7730810|NCT00604214|12158894|FG001|Day 91 to Day 180|Lost to Follow-up|8
7730811|NCT00604214|12158893|FG000|Day 91 to Day 180|Withdrawal by Subject|1
7730812|NCT00604214|12158894|FG001|Day 91 to Day 180|Withdrawal by Subject|1
7730813|NCT00604279|12158902|FG000|Overall Study|Lack of Efficacy|22
7730814|NCT00604279|12158903|FG001|Overall Study|Lack of Efficacy|9
7730815|NCT00604279|12158902|FG000|Overall Study|Lost to Follow-up|9
7730816|NCT00604279|12158903|FG001|Overall Study|Lost to Follow-up|14
7730817|NCT00604279|12158902|FG000|Overall Study|Pregnancy|2
7730818|NCT00604279|12158903|FG001|Overall Study|Pregnancy|0
7730819|NCT00604279|12158902|FG000|Overall Study|Protocol Violation|3
7730820|NCT00604279|12158903|FG001|Overall Study|Protocol Violation|1
7730821|NCT00604279|12158902|FG000|Overall Study|Withdrawal by Subject|16
7730822|NCT00604279|12158903|FG001|Overall Study|Withdrawal by Subject|5
7730823|NCT00604279|12158902|FG000|Overall Study|Adverse Event|4
7730824|NCT00604279|12158903|FG001|Overall Study|Adverse Event|5
7730825|NCT00604279|12158902|FG000|Overall Study|Other|8
7730826|NCT00604279|12158903|FG001|Overall Study|Other|4
7730827|NCT00604383|12158911|FG000|Overall Study|Withdrawal by Subject|33
7730828|NCT00604383|12158912|FG001|Overall Study|Withdrawal by Subject|31
7730829|NCT00604383|12158911|FG000|Overall Study|Lost to Follow-up|24
7730830|NCT00604383|12158912|FG001|Overall Study|Lost to Follow-up|19
7730831|NCT00604383|12158911|FG000|Overall Study|Death|14
7730832|NCT00604383|12158912|FG001|Overall Study|Death|22
7730833|NCT00604383|12158911|FG000|Overall Study|Adverse Event|16
7730834|NCT00604383|12158912|FG001|Overall Study|Adverse Event|9
7730835|NCT00604383|12158911|FG000|Overall Study|Physician Decision|0
7730836|NCT00604383|12158912|FG001|Overall Study|Physician Decision|3
7730837|NCT00604565|12158935|FG000|Overall Study|Study terminated|0
7730838|NCT00604565|12158936|FG001|Overall Study|Study terminated|3
7730839|NCT00604669|12158942|FG000|Overall Study|lack of information in chart|7
7730840|NCT00604695|12158948|FG000|Overall Study|Did not receive first bolus.|0
7730841|NCT00604695|12158949|FG001|Overall Study|Did not receive first bolus.|4
7730842|NCT00604708|12158957|FG000|Overall Study|Withdrawal by Subject|9
7730843|NCT00604708|12158958|FG001|Overall Study|Withdrawal by Subject|10
7730844|NCT00604708|12158957|FG000|Overall Study|Protocol Violation|2
7730845|NCT00604708|12158958|FG001|Overall Study|Protocol Violation|8
7730846|NCT00604708|12158957|FG000|Overall Study|Lost to Follow-up|5
7730847|NCT00604708|12158958|FG001|Overall Study|Lost to Follow-up|5
7730848|NCT00604708|12158957|FG000|Overall Study|administrative reasons|9
7730849|NCT00604708|12158958|FG001|Overall Study|administrative reasons|11
7730850|NCT00604708|12158957|FG000|Overall Study|Adverse Event|6
7730851|NCT00604708|12158958|FG001|Overall Study|Adverse Event|6
7730852|NCT00604721|12158964|FG000|Overall Study|Physician Decision|1
7730853|NCT00604721|12158964|FG000|Overall Study|Withdrawal by Subject|1
7730854|NCT00604786|12158971|FG000|Overall Study|Lost to Follow-up|2
7730855|NCT00604786|12158972|FG001|Overall Study|Lost to Follow-up|0
7730856|NCT00604825|12158982|FG000|Overall Study|Adverse Event|2
7730857|NCT00604825|12158983|FG001|Overall Study|Adverse Event|6
7730858|NCT00604825|12158984|FG002|Overall Study|Adverse Event|7
7730859|NCT00604825|12158985|FG003|Overall Study|Adverse Event|4
7730860|NCT00604825|12158982|FG000|Overall Study|Lost to Follow-up|0
7730861|NCT00604825|12158983|FG001|Overall Study|Lost to Follow-up|3
7730862|NCT00604825|12158984|FG002|Overall Study|Lost to Follow-up|1
7730863|NCT00604825|12158985|FG003|Overall Study|Lost to Follow-up|0
7730864|NCT00604825|12158982|FG000|Overall Study|Protocol Violation|0
7730865|NCT00604825|12158983|FG001|Overall Study|Protocol Violation|1
7730866|NCT00604825|12158984|FG002|Overall Study|Protocol Violation|0
7730867|NCT00604825|12158985|FG003|Overall Study|Protocol Violation|0
7730868|NCT00604825|12158982|FG000|Overall Study|Withdrawal by Subject|4
7730869|NCT00604825|12158983|FG001|Overall Study|Withdrawal by Subject|3
7730870|NCT00604825|12158984|FG002|Overall Study|Withdrawal by Subject|5
7730871|NCT00604825|12158985|FG003|Overall Study|Withdrawal by Subject|5
7730872|NCT00604825|12158982|FG000|Overall Study|Lack of Efficacy|3
7730873|NCT00604825|12158983|FG001|Overall Study|Lack of Efficacy|2
7730874|NCT00604825|12158984|FG002|Overall Study|Lack of Efficacy|1
7730875|NCT00604825|12158985|FG003|Overall Study|Lack of Efficacy|0
7730876|NCT00604825|12158982|FG000|Overall Study|Did not meet eligibility criteria|0
7730877|NCT00604825|12158983|FG001|Overall Study|Did not meet eligibility criteria|0
7730878|NCT00604825|12158984|FG002|Overall Study|Did not meet eligibility criteria|2
7730879|NCT00604825|12158985|FG003|Overall Study|Did not meet eligibility criteria|0
7730880|NCT00604825|12158982|FG000|Overall Study|Physician Decision|0
7730881|NCT00604825|12158983|FG001|Overall Study|Physician Decision|0
7730882|NCT00604825|12158984|FG002|Overall Study|Physician Decision|0
7730883|NCT00604825|12158985|FG003|Overall Study|Physician Decision|1
7730884|NCT00604825|12158982|FG000|Overall Study|Exclusion criterion met|0
7730885|NCT00604825|12158983|FG001|Overall Study|Exclusion criterion met|0
7730886|NCT00604825|12158984|FG002|Overall Study|Exclusion criterion met|0
7730887|NCT00604825|12158985|FG003|Overall Study|Exclusion criterion met|1
7730888|NCT00605033|12159019|FG000|Overall Study|Adverse Event|2
7730889|NCT00605033|12159020|FG001|Overall Study|Adverse Event|2
7730890|NCT00605033|12159019|FG000|Overall Study|Lost to Follow-up|1
7730891|NCT00605033|12159020|FG001|Overall Study|Lost to Follow-up|1
7730892|NCT00605033|12159019|FG000|Overall Study|Withdrawal by Subject|3
7730893|NCT00605033|12159020|FG001|Overall Study|Withdrawal by Subject|4
7730894|NCT00605033|12159019|FG000|Overall Study|Protocol Violation|1
7730895|NCT00605033|12159020|FG001|Overall Study|Protocol Violation|1
7730896|NCT00605085|12159041|FG000|Overall Study|Withdrawal by Subject|8
7730897|NCT00605085|12159042|FG001|Overall Study|Withdrawal by Subject|5
7730898|NCT00605085|12159041|FG000|Overall Study|Adverse Event|9
7730899|NCT00605085|12159042|FG001|Overall Study|Adverse Event|5
7730900|NCT00605085|12159041|FG000|Overall Study|Pregnancy|2
7730901|NCT00605085|12159042|FG001|Overall Study|Pregnancy|0
7730902|NCT00605085|12159041|FG000|Overall Study|Protocol Violation|3
7730903|NCT00605085|12159042|FG001|Overall Study|Protocol Violation|2
7730904|NCT00605085|12159041|FG000|Overall Study|Lost to Follow-up|10
7730905|NCT00605085|12159042|FG001|Overall Study|Lost to Follow-up|5
7730906|NCT00605085|12159041|FG000|Overall Study|administrative reasons|18
7730907|NCT00605085|12159042|FG001|Overall Study|administrative reasons|8
7730908|NCT00605176|12159051|FG000|Overall Study|Adverse Event|2
7730909|NCT00605176|12159052|FG001|Overall Study|Adverse Event|1
7730910|NCT00605176|12159053|FG002|Overall Study|Adverse Event|3
7730911|NCT00605176|12159051|FG000|Overall Study|Withdrawal by Subject|4
7730912|NCT00605176|12159052|FG001|Overall Study|Withdrawal by Subject|2
7730913|NCT00605176|12159053|FG002|Overall Study|Withdrawal by Subject|4
7730914|NCT00605176|12159051|FG000|Overall Study|Lost to Follow-up|2
7730915|NCT00605176|12159052|FG001|Overall Study|Lost to Follow-up|2
7730916|NCT00605176|12159053|FG002|Overall Study|Lost to Follow-up|1
7730917|NCT00605176|12159051|FG000|Overall Study|Non-complicance with study procedures|1
7730918|NCT00605176|12159052|FG001|Overall Study|Non-complicance with study procedures|0
7730919|NCT00605176|12159053|FG002|Overall Study|Non-complicance with study procedures|0
7730920|NCT00605176|12159051|FG000|Overall Study|Use of concomitant therapy|1
7730921|NCT00605176|12159052|FG001|Overall Study|Use of concomitant therapy|0
7730922|NCT00605176|12159053|FG002|Overall Study|Use of concomitant therapy|1
7730923|NCT00605176|12159051|FG000|Overall Study|Other (not due to AE)|1
7730924|NCT00605176|12159052|FG001|Overall Study|Other (not due to AE)|1
7730925|NCT00605176|12159053|FG002|Overall Study|Other (not due to AE)|0
7730926|NCT00605267|12159070|FG000|Overall Study|Adverse Event|0
7730927|NCT00605267|12159071|FG001|Overall Study|Adverse Event|1
7730928|NCT00605267|12159070|FG000|Overall Study|Lack of Efficacy|1
7730929|NCT00605267|12159071|FG001|Overall Study|Lack of Efficacy|5
7730930|NCT00605267|12159070|FG000|Overall Study|Withdrawal by Subject|2
7730931|NCT00605267|12159071|FG001|Overall Study|Withdrawal by Subject|3
7730932|NCT00605280|12159081|FG000|Year 1|Protocol Violation|0
7730933|NCT00605280|12159082|FG001|Year 1|Protocol Violation|0
7730934|NCT00605280|12159083|FG002|Year 1|Protocol Violation|0
7730935|NCT00605280|12159084|FG003|Year 1|Protocol Violation|1
7730936|NCT00605280|12159081|FG000|Year 1|Adverse Event|3
7730937|NCT00605280|12159082|FG001|Year 1|Adverse Event|1
7730938|NCT00605280|12159083|FG002|Year 1|Adverse Event|1
7730939|NCT00605280|12159084|FG003|Year 1|Adverse Event|5
7730940|NCT00605280|12159081|FG000|Year 1|Physician Decision|7
7730941|NCT00605280|12159082|FG001|Year 1|Physician Decision|4
7730942|NCT00605280|12159083|FG002|Year 1|Physician Decision|0
7730943|NCT00605280|12159084|FG003|Year 1|Physician Decision|6
7730944|NCT00605280|12159081|FG000|Year 1|Withdrawal by Subject|2
7730945|NCT00605280|12159082|FG001|Year 1|Withdrawal by Subject|4
7730946|NCT00605280|12159083|FG002|Year 1|Withdrawal by Subject|0
7730947|NCT00605280|12159084|FG003|Year 1|Withdrawal by Subject|4
7730948|NCT00605280|12159081|FG000|Year 1|Other|2
7730949|NCT00605280|12159082|FG001|Year 1|Other|1
7730950|NCT00605280|12159083|FG002|Year 1|Other|0
7730951|NCT00605280|12159084|FG003|Year 1|Other|1
7730952|NCT00605280|12159081|FG000|Year 1|Lost to Follow-up or Patient non-comply|5
7730953|NCT00605280|12159082|FG001|Year 1|Lost to Follow-up or Patient non-comply|1
7730954|NCT00605280|12159083|FG002|Year 1|Lost to Follow-up or Patient non-comply|0
7730955|NCT00605280|12159084|FG003|Year 1|Lost to Follow-up or Patient non-comply|2
7730956|NCT00605280|12159081|FG000|Year 2|Adverse Event|4
7730957|NCT00605280|12159082|FG001|Year 2|Adverse Event|0
7730958|NCT00605280|12159083|FG002|Year 2|Adverse Event|2
7730959|NCT00605280|12159084|FG003|Year 2|Adverse Event|4
7730960|NCT00605280|12159081|FG000|Year 2|Physician Decision|11
7730961|NCT00605280|12159082|FG001|Year 2|Physician Decision|6
7730962|NCT00605280|12159083|FG002|Year 2|Physician Decision|4
7730963|NCT00605280|12159084|FG003|Year 2|Physician Decision|11
7730964|NCT00605280|12159081|FG000|Year 2|Withdrawal by Subject|4
7730965|NCT00605280|12159082|FG001|Year 2|Withdrawal by Subject|0
7730966|NCT00605280|12159083|FG002|Year 2|Withdrawal by Subject|0
7730967|NCT00605280|12159084|FG003|Year 2|Withdrawal by Subject|4
7730968|NCT00605280|12159081|FG000|Year 2|Other|1
7730969|NCT00605280|12159082|FG001|Year 2|Other|0
7730970|NCT00605280|12159083|FG002|Year 2|Other|0
7730971|NCT00605280|12159084|FG003|Year 2|Other|1
7730972|NCT00605280|12159081|FG000|Year 2|Lost to Follow-up or Patient non-comply|4
7730973|NCT00605280|12159082|FG001|Year 2|Lost to Follow-up or Patient non-comply|0
7730974|NCT00605280|12159083|FG002|Year 2|Lost to Follow-up or Patient non-comply|0
7730975|NCT00605280|12159084|FG003|Year 2|Lost to Follow-up or Patient non-comply|2
7730976|NCT00605280|12159081|FG000|Year 3 Extension|Adverse Event|2
7730977|NCT00605280|12159082|FG001|Year 3 Extension|Adverse Event|0
7730978|NCT00605280|12159083|FG002|Year 3 Extension|Adverse Event|0
7730979|NCT00605280|12159084|FG003|Year 3 Extension|Adverse Event|2
7730980|NCT00605280|12159081|FG000|Year 3 Extension|Physician Decision|0
7730981|NCT00605280|12159082|FG001|Year 3 Extension|Physician Decision|0
7730982|NCT00605280|12159083|FG002|Year 3 Extension|Physician Decision|0
7730983|NCT00605280|12159084|FG003|Year 3 Extension|Physician Decision|2
7730984|NCT00605280|12159081|FG000|Year 3 Extension|Withdrawal by Subject|2
7730985|NCT00605280|12159082|FG001|Year 3 Extension|Withdrawal by Subject|0
7730986|NCT00605280|12159083|FG002|Year 3 Extension|Withdrawal by Subject|0
7730987|NCT00605280|12159084|FG003|Year 3 Extension|Withdrawal by Subject|5
7730988|NCT00605280|12159081|FG000|Year 3 Extension|Other|2
7730989|NCT00605280|12159082|FG001|Year 3 Extension|Other|0
7730990|NCT00605280|12159083|FG002|Year 3 Extension|Other|0
7730991|NCT00605280|12159084|FG003|Year 3 Extension|Other|0
7730992|NCT00605280|12159081|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
7730993|NCT00605280|12159082|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
7730994|NCT00605280|12159083|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
7730995|NCT00605280|12159084|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
7730996|NCT00605293|12159096|FG000|Overall Study|Death|2
7730997|NCT00605293|12159097|FG001|Overall Study|Death|1
7730998|NCT00605293|12159096|FG000|Overall Study|Insufficient Therapeutic Response|2
7730999|NCT00605293|12159097|FG001|Overall Study|Insufficient Therapeutic Response|0
7731000|NCT00605293|12159096|FG000|Overall Study|Adverse Event|1
7731001|NCT00605293|12159097|FG001|Overall Study|Adverse Event|0
7731002|NCT00605293|12159096|FG000|Overall Study|Holidays Dialysis Out|1
7731003|NCT00605293|12159097|FG001|Overall Study|Holidays Dialysis Out|0
7731004|NCT00605293|12159096|FG000|Overall Study|Blood Transfusion|7
7731005|NCT00605293|12159097|FG001|Overall Study|Blood Transfusion|1
7731006|NCT00605293|12159096|FG000|Overall Study|Renal Transplantation|3
7731007|NCT00605293|12159097|FG001|Overall Study|Renal Transplantation|1
7731008|NCT00605293|12159096|FG000|Overall Study|Incorrect Epoetin Beta Administration|1
7731009|NCT00605293|12159097|FG001|Overall Study|Incorrect Epoetin Beta Administration|0
7731010|NCT00605293|12159096|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0
7731011|NCT00605293|12159097|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1
7731012|NCT00605293|12159096|FG000|Overall Study|Principal Investigator Decision|0
7731013|NCT00605293|12159097|FG001|Overall Study|Principal Investigator Decision|1
7731014|NCT00605306|12159105|FG000|Overall Study|Adverse Event|0
7731015|NCT00605306|12159106|FG001|Overall Study|Adverse Event|1
7731016|NCT00605319|12159112|FG000|Overall Study|Adverse Event|6
7731017|NCT00605345|12159124|FG000|Overall Study|Withdrawal by Subject|1
7731018|NCT00605345|12159125|FG001|Overall Study|Withdrawal by Subject|0
7731019|NCT00605345|12159124|FG000|Overall Study|Adverse Event|0
7731020|NCT00605345|12159125|FG001|Overall Study|Adverse Event|1
7731021|NCT00605345|12159124|FG000|Overall Study|Protocol Violation|0
7731022|NCT00605345|12159125|FG001|Overall Study|Protocol Violation|2
7731023|NCT00605475|12159168|FG000|Overall Study|Abnormal Laboratory Values|0
7731024|NCT00605475|12159169|FG001|Overall Study|Abnormal Laboratory Values|0
7731025|NCT00605475|12159170|FG002|Overall Study|Abnormal Laboratory Values|0
7731026|NCT00605475|12159171|FG003|Overall Study|Abnormal Laboratory Values|0
7731027|NCT00605475|12159172|FG004|Overall Study|Abnormal Laboratory Values|0
7731028|NCT00605475|12159173|FG005|Overall Study|Abnormal Laboratory Values|0
7731029|NCT00605475|12159174|FG006|Overall Study|Abnormal Laboratory Values|0
7731030|NCT00605475|12159175|FG007|Overall Study|Abnormal Laboratory Values|0
7731031|NCT00605475|12159176|FG008|Overall Study|Abnormal Laboratory Values|1
7731032|NCT00605475|12159177|FG009|Overall Study|Abnormal Laboratory Values|0
7731033|NCT00605475|12159168|FG000|Overall Study|Administrative problems|0
7731034|NCT00605475|12159169|FG001|Overall Study|Administrative problems|0
7731035|NCT00605475|12159170|FG002|Overall Study|Administrative problems|0
7731036|NCT00605475|12159171|FG003|Overall Study|Administrative problems|0
7731037|NCT00605475|12159172|FG004|Overall Study|Administrative problems|0
7731038|NCT00605475|12159173|FG005|Overall Study|Administrative problems|0
7731039|NCT00605475|12159174|FG006|Overall Study|Administrative problems|1
7731040|NCT00605475|12159175|FG007|Overall Study|Administrative problems|0
7731041|NCT00605475|12159176|FG008|Overall Study|Administrative problems|0
7731042|NCT00605475|12159177|FG009|Overall Study|Administrative problems|0
7731043|NCT00605475|12159168|FG000|Overall Study|Lost to Follow-up|0
7731044|NCT00605475|12159169|FG001|Overall Study|Lost to Follow-up|0
7731045|NCT00605475|12159170|FG002|Overall Study|Lost to Follow-up|0
7731046|NCT00605475|12159171|FG003|Overall Study|Lost to Follow-up|0
7731047|NCT00605475|12159172|FG004|Overall Study|Lost to Follow-up|0
7731048|NCT00605475|12159173|FG005|Overall Study|Lost to Follow-up|0
7731049|NCT00605475|12159174|FG006|Overall Study|Lost to Follow-up|0
7731050|NCT00605475|12159175|FG007|Overall Study|Lost to Follow-up|0
7731051|NCT00605475|12159176|FG008|Overall Study|Lost to Follow-up|1
7731052|NCT00605475|12159177|FG009|Overall Study|Lost to Follow-up|1
7731053|NCT00605475|12159168|FG000|Overall Study|Protocol Violation|0
7731054|NCT00605475|12159169|FG001|Overall Study|Protocol Violation|0
7731055|NCT00605475|12159170|FG002|Overall Study|Protocol Violation|0
7731056|NCT00605475|12159171|FG003|Overall Study|Protocol Violation|0
7731057|NCT00605475|12159172|FG004|Overall Study|Protocol Violation|1
7731058|NCT00605475|12159173|FG005|Overall Study|Protocol Violation|0
7731059|NCT00605475|12159174|FG006|Overall Study|Protocol Violation|0
7731060|NCT00605475|12159175|FG007|Overall Study|Protocol Violation|0
7731061|NCT00605475|12159176|FG008|Overall Study|Protocol Violation|0
7731062|NCT00605475|12159177|FG009|Overall Study|Protocol Violation|0
7731063|NCT00605475|12159168|FG000|Overall Study|Withdrawal by Subject|0
7731064|NCT00605475|12159169|FG001|Overall Study|Withdrawal by Subject|0
7731065|NCT00605475|12159170|FG002|Overall Study|Withdrawal by Subject|0
7731066|NCT00605475|12159171|FG003|Overall Study|Withdrawal by Subject|0
7731067|NCT00605475|12159172|FG004|Overall Study|Withdrawal by Subject|0
7731068|NCT00605475|12159173|FG005|Overall Study|Withdrawal by Subject|2
7731069|NCT00605475|12159174|FG006|Overall Study|Withdrawal by Subject|0
7731070|NCT00605475|12159175|FG007|Overall Study|Withdrawal by Subject|0
7731071|NCT00605475|12159176|FG008|Overall Study|Withdrawal by Subject|0
7731072|NCT00605475|12159177|FG009|Overall Study|Withdrawal by Subject|1
7731073|NCT00605540|12159220|FG000|Overall Study|Death|15
7731074|NCT00605540|12159220|FG000|Overall Study|Lost to Follow-up|23
7731075|NCT00605566|12159224|FG000|Overall Study|Adverse Event|1
7731076|NCT00605566|12159224|FG000|Overall Study|Clinical deterioration|1
7731077|NCT00605566|12159224|FG000|Overall Study|Poor compliance in run-in period|1
7731078|NCT00605657|12159249|FG000|Overall Study|Adverse Event|1
7731079|NCT00605657|12159249|FG000|Overall Study|Protocol Violation|1
7731080|NCT00605722|12159262|FG000|Overall Study|Adverse Event|6
7731081|NCT00605722|12159262|FG000|Overall Study|Insufficient therapeutic response|44
7731082|NCT00605722|12159262|FG000|Overall Study|Failure to return|1
7731083|NCT00605813|12159266|FG000|Overall Study|Protocol Violation|25
7731084|NCT00605839|12159291|FG000|Overall Study|Protocol Violation|1
7731085|NCT00605839|12159292|FG001|Overall Study|Protocol Violation|0
7731086|NCT00605839|12159293|FG002|Overall Study|Protocol Violation|0
7731087|NCT00605865|12159301|FG000|Overall Study|Protocol Violation|115
7731088|NCT00605917|12159342|FG000|Overall Study|Protocol Violation|79
7731089|NCT00606008|12159377|FG000|Overall Study|Adverse Event|1
7731090|NCT00606008|12159377|FG000|Overall Study|Withdrawal by Subject|4
7731091|NCT00606021|12159387|FG000|Induction Phase|Death|73
7731092|NCT00606021|12159388|FG001|Induction Phase|Death|0
7731093|NCT00606021|12159389|FG002|Induction Phase|Death|0
7731094|NCT00606021|12159387|FG000|Induction Phase|Physician Decision|2
7731095|NCT00606021|12159388|FG001|Induction Phase|Physician Decision|0
7731096|NCT00606021|12159389|FG002|Induction Phase|Physician Decision|0
7731097|NCT00606021|12159387|FG000|Induction Phase|Withdrawal by Subject|2
7731098|NCT00606021|12159388|FG001|Induction Phase|Withdrawal by Subject|0
7731099|NCT00606021|12159389|FG002|Induction Phase|Withdrawal by Subject|0
7731100|NCT00606021|12159387|FG000|Induction Phase|Lost to Follow-up|10
7731101|NCT00606021|12159388|FG001|Induction Phase|Lost to Follow-up|0
7731102|NCT00606021|12159389|FG002|Induction Phase|Lost to Follow-up|0
7731103|NCT00606021|12159387|FG000|Maintenance Phase|Death|0
7731104|NCT00606021|12159388|FG001|Maintenance Phase|Death|17
7731105|NCT00606021|12159389|FG002|Maintenance Phase|Death|15
7731106|NCT00606021|12159387|FG000|Maintenance Phase|Physician Decision|0
7731107|NCT00606021|12159388|FG001|Maintenance Phase|Physician Decision|1
7731108|NCT00606021|12159389|FG002|Maintenance Phase|Physician Decision|0
7731109|NCT00606021|12159387|FG000|Maintenance Phase|Lost to Follow-up|0
7731110|NCT00606021|12159388|FG001|Maintenance Phase|Lost to Follow-up|5
7731111|NCT00606021|12159389|FG002|Maintenance Phase|Lost to Follow-up|2
7731112|NCT00606034|12159397|FG000|Overall Study|incarceration|1
7731113|NCT00606086|12159409|FG000|Overall Study|Adverse Event|1
7731114|NCT00606086|12159410|FG001|Overall Study|Adverse Event|1
7731115|NCT00606086|12159409|FG000|Overall Study|Lost to Follow-up|4
7731116|NCT00606086|12159410|FG001|Overall Study|Lost to Follow-up|8
7731117|NCT00606086|12159409|FG000|Overall Study|Protocol Violation|1
7731118|NCT00606086|12159410|FG001|Overall Study|Protocol Violation|0
7731119|NCT00606086|12159409|FG000|Overall Study|Withdrawal by Subject|5
7731120|NCT00606086|12159410|FG001|Overall Study|Withdrawal by Subject|3
7731121|NCT00606086|12159409|FG000|Overall Study|Non-compliance|0
7731122|NCT00606086|12159410|FG001|Overall Study|Non-compliance|1
7731123|NCT00606086|12159409|FG000|Overall Study|Randomized, not treated|1
7731124|NCT00606086|12159410|FG001|Overall Study|Randomized, not treated|2
7731125|NCT00606177|12159427|FG000|Overall Study|Adverse Event|9
7731126|NCT00606177|12159428|FG001|Overall Study|Adverse Event|5
7731127|NCT00606177|12159427|FG000|Overall Study|Lack of Efficacy|3
7731128|NCT00606177|12159428|FG001|Overall Study|Lack of Efficacy|7
7731129|NCT00606177|12159427|FG000|Overall Study|Physician Decision|1
7731130|NCT00606177|12159428|FG001|Overall Study|Physician Decision|0
7731131|NCT00606177|12159427|FG000|Overall Study|Protocol Violation|1
7731132|NCT00606177|12159428|FG001|Overall Study|Protocol Violation|4
7731133|NCT00606177|12159427|FG000|Overall Study|Withdrawal by Subject|5
7731134|NCT00606177|12159428|FG001|Overall Study|Withdrawal by Subject|6
7731135|NCT00606177|12159427|FG000|Overall Study|Progression to depressive phase|6
7731136|NCT00606177|12159428|FG001|Overall Study|Progression to depressive phase|1
7731137|NCT00606177|12159427|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1
7731138|NCT00606177|12159428|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1
7731139|NCT00606177|12159427|FG000|Overall Study|Change of residence or other commitments|1
7731140|NCT00606177|12159428|FG001|Overall Study|Change of residence or other commitments|1
7731141|NCT00606229|12159434|FG000|Overall Study|Adverse Event|11
7731142|NCT00606229|12159434|FG000|Overall Study|Lack of Efficacy|1
7731143|NCT00606229|12159434|FG000|Overall Study|Withdrawal by Subject|4
7731144|NCT00606229|12159434|FG000|Overall Study|does not meet inclusion criterion 1-3|4
7731145|NCT00606229|12159434|FG000|Overall Study|change of residence or other commitments|2
7731146|NCT00606281|12159440|FG000|Overall Study|Adverse Event|11
7731147|NCT00606281|12159441|FG001|Overall Study|Adverse Event|12
7731148|NCT00606281|12159440|FG000|Overall Study|Death|1
7731149|NCT00606281|12159441|FG001|Overall Study|Death|0
7731150|NCT00606281|12159440|FG000|Overall Study|Lack of Efficacy|28
7731151|NCT00606281|12159441|FG001|Overall Study|Lack of Efficacy|35
7731152|NCT00606281|12159440|FG000|Overall Study|Physician Decision|0
7731153|NCT00606281|12159441|FG001|Overall Study|Physician Decision|1
7731154|NCT00606281|12159440|FG000|Overall Study|Protocol Violation|3
7731155|NCT00606281|12159441|FG001|Overall Study|Protocol Violation|3
7731156|NCT00606281|12159440|FG000|Overall Study|Withdrawal by Subject|11
7731157|NCT00606281|12159441|FG001|Overall Study|Withdrawal by Subject|13
7731158|NCT00606281|12159440|FG000|Overall Study|Progression to depressive phase|1
7731159|NCT00606281|12159441|FG001|Overall Study|Progression to depressive phase|1
7731160|NCT00606281|12159440|FG000|Overall Study|Change of residence or other commitments|1
7731161|NCT00606281|12159441|FG001|Overall Study|Change of residence or other commitments|1
7731162|NCT00606307|12159447|FG000|Overall Study|Adverse Event|2
7731163|NCT00606307|12159447|FG000|Overall Study|Withdrawal by Subject|2
7731164|NCT00606307|12159447|FG000|Overall Study|Disease progression|6
7731165|NCT00606307|12159447|FG000|Overall Study|QTc prolongation|1
7731166|NCT00606320|12159451|FG000|Overall Study|Adverse Event|3
7731167|NCT00606320|12159451|FG000|Overall Study|Lack of Efficacy|5
7731168|NCT00606320|12159451|FG000|Overall Study|Physician Decision|7
7731169|NCT00606320|12159451|FG000|Overall Study|Protocol Violation|8
7731170|NCT00606320|12159451|FG000|Overall Study|Withdrawal by Subject|10
7731171|NCT00606320|12159451|FG000|Overall Study|Progression to depressive phase|4
7731172|NCT00606502|12159466|FG000|Randomization|Randomized but not treated|3
7731173|NCT00606502|12159467|FG001|Randomization|Randomized but not treated|0
7731174|NCT00606502|12159466|FG000|Treatment|Treatment ongoing at time of data cutoff|0
7731175|NCT00606502|12159467|FG001|Treatment|Treatment ongoing at time of data cutoff|3
7731176|NCT00606580|12159489|FG000|Overall Study|Lost to Follow-up|1
7731177|NCT00606580|12159490|FG001|Overall Study|Lost to Follow-up|1
7731178|NCT00606580|12159491|FG002|Overall Study|Lost to Follow-up|4
7731179|NCT00606580|12159489|FG000|Overall Study|Clinical failures|1
7731180|NCT00606580|12159490|FG001|Overall Study|Clinical failures|0
7731181|NCT00606580|12159491|FG002|Overall Study|Clinical failures|12
7731182|NCT00606580|12159489|FG000|Overall Study|Withdrawal by investigator|0
7731183|NCT00606580|12159490|FG001|Overall Study|Withdrawal by investigator|1
7731184|NCT00606580|12159491|FG002|Overall Study|Withdrawal by investigator|6
7731185|NCT00606580|12159489|FG000|Overall Study|Withdrawal by Subject|0
7731186|NCT00606580|12159490|FG001|Overall Study|Withdrawal by Subject|1
7731187|NCT00606580|12159491|FG002|Overall Study|Withdrawal by Subject|0
7731188|NCT00606593|12159499|FG000|Overall Study|Adverse Event|0
7731189|NCT00606593|12159500|FG001|Overall Study|Adverse Event|0
7731190|NCT00606593|12159501|FG002|Overall Study|Adverse Event|0
7731191|NCT00606593|12159502|FG003|Overall Study|Adverse Event|1
7731192|NCT00606593|12159503|FG004|Overall Study|Adverse Event|1
7731193|NCT00606593|12159504|FG005|Overall Study|Adverse Event|0
7731194|NCT00606593|12159505|FG006|Overall Study|Adverse Event|1
7731195|NCT00606593|12159506|FG007|Overall Study|Adverse Event|2
7731196|NCT00606593|12159507|FG008|Overall Study|Adverse Event|1
7731197|NCT00606593|12159508|FG009|Overall Study|Adverse Event|0
7731198|NCT00606593|12159499|FG000|Overall Study|Withdrawal of consent|1
7731199|NCT00606593|12159500|FG001|Overall Study|Withdrawal of consent|0
7731200|NCT00606593|12159501|FG002|Overall Study|Withdrawal of consent|1
7731201|NCT00606593|12159502|FG003|Overall Study|Withdrawal of consent|0
7731202|NCT00606593|12159503|FG004|Overall Study|Withdrawal of consent|0
7731203|NCT00606593|12159504|FG005|Overall Study|Withdrawal of consent|0
7731204|NCT00606593|12159505|FG006|Overall Study|Withdrawal of consent|0
7731205|NCT00606593|12159506|FG007|Overall Study|Withdrawal of consent|0
7731206|NCT00606593|12159507|FG008|Overall Study|Withdrawal of consent|0
7731207|NCT00606593|12159508|FG009|Overall Study|Withdrawal of consent|0
7731208|NCT00606593|12159499|FG000|Overall Study|Administrative/Other|0
7731209|NCT00606593|12159500|FG001|Overall Study|Administrative/Other|0
7731210|NCT00606593|12159501|FG002|Overall Study|Administrative/Other|1
7731211|NCT00606593|12159502|FG003|Overall Study|Administrative/Other|0
7731212|NCT00606593|12159503|FG004|Overall Study|Administrative/Other|0
7731213|NCT00606593|12159504|FG005|Overall Study|Administrative/Other|0
7731214|NCT00606593|12159505|FG006|Overall Study|Administrative/Other|0
7731215|NCT00606593|12159506|FG007|Overall Study|Administrative/Other|0
7731216|NCT00606593|12159507|FG008|Overall Study|Administrative/Other|0
7731217|NCT00606593|12159508|FG009|Overall Study|Administrative/Other|0
7731218|NCT00606632|12159521|FG000|Overall Study|Withdrawal by Subject|13
7731219|NCT00606632|12159521|FG000|Overall Study|Miscellaneous reasons|9
7731220|NCT00606684|12159536|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
7731221|NCT00606684|12159537|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7731222|NCT00606684|12159538|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7731223|NCT00606684|12159539|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7731224|NCT00606684|12159540|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7731225|NCT00606684|12159541|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7731226|NCT00606684|12159542|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7731227|NCT00606684|12159536|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
7731228|NCT00606684|12159537|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7731229|NCT00606684|12159538|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7731230|NCT00606684|12159539|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7731231|NCT00606684|12159540|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7731232|NCT00606684|12159541|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7731233|NCT00606684|12159542|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7731234|NCT00606684|12159536|FG000|2-week Single-Blind Run-in Period|Physician Decision|18
7731235|NCT00606684|12159537|FG001|2-week Single-Blind Run-in Period|Physician Decision|0
7731236|NCT00606684|12159538|FG002|2-week Single-Blind Run-in Period|Physician Decision|0
7731237|NCT00606684|12159539|FG003|2-week Single-Blind Run-in Period|Physician Decision|0
7731238|NCT00606684|12159540|FG004|2-week Single-Blind Run-in Period|Physician Decision|0
7731239|NCT00606684|12159541|FG005|2-week Single-Blind Run-in Period|Physician Decision|0
7731240|NCT00606684|12159542|FG006|2-week Single-Blind Run-in Period|Physician Decision|0
7731241|NCT00606684|12159536|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
7731242|NCT00606684|12159537|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7731243|NCT00606684|12159538|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7731244|NCT00606684|12159539|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7731245|NCT00606684|12159540|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7731246|NCT00606684|12159541|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7731247|NCT00606684|12159542|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7731248|NCT00606684|12159536|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5
7731249|NCT00606684|12159537|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7731250|NCT00606684|12159538|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7731251|NCT00606684|12159539|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7731252|NCT00606684|12159540|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7731253|NCT00606684|12159541|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7731254|NCT00606684|12159542|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7731255|NCT00606684|12159536|FG000|2-week Single-Blind Run-in Period|Adverse Event|2
7731256|NCT00606684|12159537|FG001|2-week Single-Blind Run-in Period|Adverse Event|0
7731257|NCT00606684|12159538|FG002|2-week Single-Blind Run-in Period|Adverse Event|0
7731258|NCT00606684|12159539|FG003|2-week Single-Blind Run-in Period|Adverse Event|0
7731259|NCT00606684|12159540|FG004|2-week Single-Blind Run-in Period|Adverse Event|0
7731260|NCT00606684|12159541|FG005|2-week Single-Blind Run-in Period|Adverse Event|0
7731261|NCT00606684|12159542|FG006|2-week Single-Blind Run-in Period|Adverse Event|0
7731262|NCT00606684|12159536|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
7731263|NCT00606684|12159537|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7731264|NCT00606684|12159538|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7731265|NCT00606684|12159539|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7731266|NCT00606684|12159540|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7731267|NCT00606684|12159541|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7731268|NCT00606684|12159542|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7731269|NCT00606684|12159536|FG000|Double-Blind Treatment Period|Adverse Event|0
7731270|NCT00606684|12159537|FG001|Double-Blind Treatment Period|Adverse Event|3
7731271|NCT00606684|12159538|FG002|Double-Blind Treatment Period|Adverse Event|2
7731272|NCT00606684|12159539|FG003|Double-Blind Treatment Period|Adverse Event|4
7731273|NCT00606684|12159540|FG004|Double-Blind Treatment Period|Adverse Event|2
7731274|NCT00606684|12159541|FG005|Double-Blind Treatment Period|Adverse Event|0
7731275|NCT00606684|12159542|FG006|Double-Blind Treatment Period|Adverse Event|1
7731276|NCT00606684|12159536|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
7731277|NCT00606684|12159537|FG001|Double-Blind Treatment Period|Lack of Efficacy|1
7731278|NCT00606684|12159538|FG002|Double-Blind Treatment Period|Lack of Efficacy|0
7731279|NCT00606684|12159539|FG003|Double-Blind Treatment Period|Lack of Efficacy|0
7731280|NCT00606684|12159540|FG004|Double-Blind Treatment Period|Lack of Efficacy|1
7731281|NCT00606684|12159541|FG005|Double-Blind Treatment Period|Lack of Efficacy|0
7731282|NCT00606684|12159542|FG006|Double-Blind Treatment Period|Lack of Efficacy|0
7731283|NCT00606684|12159536|FG000|Double-Blind Treatment Period|Protocol Violation|0
7731284|NCT00606684|12159537|FG001|Double-Blind Treatment Period|Protocol Violation|5
7731285|NCT00606684|12159538|FG002|Double-Blind Treatment Period|Protocol Violation|5
7731286|NCT00606684|12159539|FG003|Double-Blind Treatment Period|Protocol Violation|3
7731287|NCT00606684|12159540|FG004|Double-Blind Treatment Period|Protocol Violation|0
7731288|NCT00606684|12159541|FG005|Double-Blind Treatment Period|Protocol Violation|3
7731289|NCT00606684|12159542|FG006|Double-Blind Treatment Period|Protocol Violation|4
7731290|NCT00606684|12159536|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
7731291|NCT00606684|12159537|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
7731292|NCT00606684|12159538|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
7731293|NCT00606684|12159539|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
7731294|NCT00606684|12159540|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
7731295|NCT00606684|12159541|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
7731296|NCT00606684|12159542|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
7731297|NCT00606684|12159536|FG000|Double-Blind Treatment Period|Physician Decision|0
7731298|NCT00606684|12159537|FG001|Double-Blind Treatment Period|Physician Decision|5
7731299|NCT00606684|12159538|FG002|Double-Blind Treatment Period|Physician Decision|1
7731300|NCT00606684|12159539|FG003|Double-Blind Treatment Period|Physician Decision|0
7731301|NCT00606684|12159540|FG004|Double-Blind Treatment Period|Physician Decision|3
7731302|NCT00606684|12159541|FG005|Double-Blind Treatment Period|Physician Decision|1
7731303|NCT00606684|12159542|FG006|Double-Blind Treatment Period|Physician Decision|2
7731304|NCT00606684|12159536|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7731305|NCT00606684|12159537|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
7731306|NCT00606684|12159538|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1
7731307|NCT00606684|12159539|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2
7731308|NCT00606684|12159540|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1
7731309|NCT00606684|12159541|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2
7731310|NCT00606684|12159542|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0
7731311|NCT00606801|12159558|FG000|Intervention|Protocol Violation|3
7731312|NCT00606801|12159559|FG001|Intervention|Protocol Violation|3
7731313|NCT00606892|12159569|FG000|First Intervention|Protocol Violation|1
7731314|NCT00606892|12159570|FG001|First Intervention|Protocol Violation|4
7731315|NCT00606905|12159604|FG000|Overall Study|No Pregnancy|9
7731316|NCT00606905|12159605|FG001|Overall Study|No Pregnancy|6
7731317|NCT00606905|12159604|FG000|Overall Study|Non-Index Pregnancy|1
7731318|NCT00606905|12159605|FG001|Overall Study|Non-Index Pregnancy|4
7731319|NCT00606905|12159604|FG000|Overall Study|Withdrew|5
7731320|NCT00606905|12159605|FG001|Overall Study|Withdrew|5
7731321|NCT00606931|12159611|FG000|Overall Study|Withdrawal by Subject|3
7731322|NCT00607022|12159627|FG000|Overall Study|Withdrawal by Subject|1
7731323|NCT00607022|12159628|FG001|Overall Study|Withdrawal by Subject|0
7731324|NCT00607022|12159629|FG002|Overall Study|Withdrawal by Subject|0
7731325|NCT00607048|12159639|FG000|Overall Study|Adverse Event|0
7731326|NCT00607048|12159640|FG001|Overall Study|Adverse Event|1
7731327|NCT00607048|12159641|FG002|Overall Study|Adverse Event|0
7731328|NCT00607048|12159642|FG003|Overall Study|Adverse Event|0
7731329|NCT00607048|12159643|FG004|Overall Study|Adverse Event|4
7731330|NCT00607048|12159644|FG005|Overall Study|Adverse Event|0
7731331|NCT00607048|12159639|FG000|Overall Study|Global deterioration of health|1
7731332|NCT00607048|12159640|FG001|Overall Study|Global deterioration of health|0
7731333|NCT00607048|12159641|FG002|Overall Study|Global deterioration of health|0
7731334|NCT00607048|12159642|FG003|Overall Study|Global deterioration of health|0
7731335|NCT00607048|12159643|FG004|Overall Study|Global deterioration of health|0
7731336|NCT00607048|12159644|FG005|Overall Study|Global deterioration of health|0
7731337|NCT00607048|12159639|FG000|Overall Study|Objective disease progression - relapse|1
7731338|NCT00607048|12159640|FG001|Overall Study|Objective disease progression - relapse|2
7731339|NCT00607048|12159641|FG002|Overall Study|Objective disease progression - relapse|4
7731340|NCT00607048|12159642|FG003|Overall Study|Objective disease progression - relapse|2
7731341|NCT00607048|12159643|FG004|Overall Study|Objective disease progression - relapse|2
7731342|NCT00607048|12159644|FG005|Overall Study|Objective disease progression - relapse|2
7731343|NCT00607048|12159639|FG000|Overall Study|Withdrawal by Subject|0
7731344|NCT00607048|12159640|FG001|Overall Study|Withdrawal by Subject|0
7731345|NCT00607048|12159641|FG002|Overall Study|Withdrawal by Subject|0
7731346|NCT00607048|12159642|FG003|Overall Study|Withdrawal by Subject|1
7731347|NCT00607048|12159643|FG004|Overall Study|Withdrawal by Subject|0
7731348|NCT00607048|12159644|FG005|Overall Study|Withdrawal by Subject|2
7731349|NCT00607048|12159639|FG000|Overall Study|Other|1
7731350|NCT00607048|12159640|FG001|Overall Study|Other|1
7731351|NCT00607048|12159641|FG002|Overall Study|Other|0
7731352|NCT00607048|12159642|FG003|Overall Study|Other|0
7731353|NCT00607048|12159643|FG004|Overall Study|Other|0
7731354|NCT00607048|12159644|FG005|Overall Study|Other|1
7731355|NCT00607087|12159663|FG000|Overall Study|Withdrawal by Subject|9
7731356|NCT00607087|12159664|FG001|Overall Study|Withdrawal by Subject|4
7731357|NCT00607087|12159665|FG002|Overall Study|Withdrawal by Subject|4
7731358|NCT00607087|12159663|FG000|Overall Study|Adverse Event|3
7731359|NCT00607087|12159664|FG001|Overall Study|Adverse Event|2
7731360|NCT00607087|12159665|FG002|Overall Study|Adverse Event|3
7731361|NCT00607087|12159663|FG000|Overall Study|Other reason|1
7731362|NCT00607087|12159664|FG001|Overall Study|Other reason|5
7731363|NCT00607087|12159665|FG002|Overall Study|Other reason|2
7731364|NCT00607087|12159663|FG000|Overall Study|Poor compliance to protocol|1
7731365|NCT00607087|12159664|FG001|Overall Study|Poor compliance to protocol|0
7731366|NCT00607087|12159665|FG002|Overall Study|Poor compliance to protocol|1
7731367|NCT00607087|12159663|FG000|Overall Study|Lost to Follow-up|1
7731368|NCT00607087|12159664|FG001|Overall Study|Lost to Follow-up|0
7731369|NCT00607087|12159665|FG002|Overall Study|Lost to Follow-up|0
7731370|NCT00607087|12159663|FG000|Period 1|Withdrawal by Subject|7
7731371|NCT00607087|12159664|FG001|Period 1|Withdrawal by Subject|2
7731372|NCT00607087|12159665|FG002|Period 1|Withdrawal by Subject|3
7731373|NCT00607087|12159663|FG000|Period 1|Adverse Event|3
7731374|NCT00607087|12159664|FG001|Period 1|Adverse Event|0
7731375|NCT00607087|12159665|FG002|Period 1|Adverse Event|0
7731376|NCT00607087|12159663|FG000|Period 1|Poor compliance to protocol|1
7731377|NCT00607087|12159664|FG001|Period 1|Poor compliance to protocol|0
7731378|NCT00607087|12159665|FG002|Period 1|Poor compliance to protocol|0
7731379|NCT00607087|12159663|FG000|Period 1|Lost to Follow-up|1
7731380|NCT00607087|12159664|FG001|Period 1|Lost to Follow-up|0
7731381|NCT00607087|12159665|FG002|Period 1|Lost to Follow-up|0
7731382|NCT00607087|12159663|FG000|Period 1|Other reason|0
7731383|NCT00607087|12159664|FG001|Period 1|Other reason|4
7731384|NCT00607087|12159665|FG002|Period 1|Other reason|2
7731385|NCT00607087|12159663|FG000|Period 2|Withdrawal by Subject|0
7731386|NCT00607087|12159664|FG001|Period 2|Withdrawal by Subject|1
7731387|NCT00607087|12159665|FG002|Period 2|Withdrawal by Subject|1
7731388|NCT00607087|12159663|FG000|Period 2|Other reason|1
7731389|NCT00607087|12159664|FG001|Period 2|Other reason|1
7731390|NCT00607087|12159665|FG002|Period 2|Other reason|0
7731391|NCT00607087|12159663|FG000|Period 2|Adverse Event|0
7731392|NCT00607087|12159664|FG001|Period 2|Adverse Event|1
7731393|NCT00607087|12159665|FG002|Period 2|Adverse Event|3
7731394|NCT00607087|12159663|FG000|Period 2|Poor compliance to protocol|0
7731395|NCT00607087|12159664|FG001|Period 2|Poor compliance to protocol|0
7731396|NCT00607087|12159665|FG002|Period 2|Poor compliance to protocol|1
7731397|NCT00607087|12159663|FG000|Period 3|Withdrawal by Subject|2
7731398|NCT00607087|12159664|FG001|Period 3|Withdrawal by Subject|1
7731399|NCT00607087|12159665|FG002|Period 3|Withdrawal by Subject|0
7731400|NCT00607087|12159663|FG000|Period 3|Adverse Event|0
7731401|NCT00607087|12159664|FG001|Period 3|Adverse Event|1
7731402|NCT00607087|12159665|FG002|Period 3|Adverse Event|0
7731403|NCT00607373|12159716|FG000|Treatment Period|Adverse Event|0
7731404|NCT00607373|12159717|FG001|Treatment Period|Adverse Event|4
7731405|NCT00607373|12159716|FG000|Treatment Period|Physician Decision|0
7731406|NCT00607373|12159717|FG001|Treatment Period|Physician Decision|1
7731407|NCT00607373|12159716|FG000|Treatment Period|Withdrawal by Subject|0
7731408|NCT00607373|12159717|FG001|Treatment Period|Withdrawal by Subject|1
7731409|NCT00607373|12159716|FG000|Follow-up Period|Other|0
7731410|NCT00607373|12159717|FG001|Follow-up Period|Other|1
7731411|NCT00607373|12159716|FG000|Follow-up Period|Protocol Violation|0
7731412|NCT00607373|12159717|FG001|Follow-up Period|Protocol Violation|1
7731413|NCT00607373|12159716|FG000|Follow-up Period|Withdrawal by Subject|1
7731414|NCT00607373|12159717|FG001|Follow-up Period|Withdrawal by Subject|3
7731415|NCT00607386|12159723|FG000|Overall Study|Physician Decision|1
7731416|NCT00607724|12159765|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7
7731417|NCT00607724|12159766|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8
7731418|NCT00607724|12159767|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4
7731419|NCT00607724|12159768|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
7731420|NCT00607724|12159769|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
7731421|NCT00607724|12159770|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
7731422|NCT00607724|12159771|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
7731423|NCT00607724|12159765|FG000|Stage 2: Expanded Cohort|Adverse Event|0
7731424|NCT00607724|12159766|FG001|Stage 2: Expanded Cohort|Adverse Event|0
7731425|NCT00607724|12159767|FG002|Stage 2: Expanded Cohort|Adverse Event|0
7731426|NCT00607724|12159768|FG003|Stage 2: Expanded Cohort|Adverse Event|0
7731427|NCT00607724|12159769|FG004|Stage 2: Expanded Cohort|Adverse Event|0
7731428|NCT00607724|12159770|FG005|Stage 2: Expanded Cohort|Adverse Event|0
7731429|NCT00607724|12159771|FG006|Stage 2: Expanded Cohort|Adverse Event|1
7731430|NCT00607724|12159765|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
7731431|NCT00607724|12159766|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
7731432|NCT00607724|12159767|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
7731433|NCT00607724|12159768|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4
7731434|NCT00607724|12159769|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8
7731435|NCT00607724|12159770|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11
7731436|NCT00607724|12159771|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10
7731437|NCT00607724|12159765|FG000|Stage 2: Expanded Cohort|Physician Decision|0
7731438|NCT00607724|12159766|FG001|Stage 2: Expanded Cohort|Physician Decision|0
7731439|NCT00607724|12159767|FG002|Stage 2: Expanded Cohort|Physician Decision|0
7731440|NCT00607724|12159768|FG003|Stage 2: Expanded Cohort|Physician Decision|0
7731441|NCT00607724|12159769|FG004|Stage 2: Expanded Cohort|Physician Decision|1
7731442|NCT00607724|12159770|FG005|Stage 2: Expanded Cohort|Physician Decision|1
7731443|NCT00607724|12159771|FG006|Stage 2: Expanded Cohort|Physician Decision|0
7731444|NCT00607724|12159765|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7731445|NCT00607724|12159766|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7731446|NCT00607724|12159767|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7731447|NCT00607724|12159768|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1
7731448|NCT00607724|12159769|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7731449|NCT00607724|12159770|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7731450|NCT00607724|12159771|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7731451|NCT00607789|12159797|FG000|Overall Study|Adverse Event|3
7731452|NCT00607789|12159798|FG001|Overall Study|Adverse Event|0
7731453|NCT00607789|12159797|FG000|Overall Study|Lack of Efficacy|0
7731454|NCT00607789|12159798|FG001|Overall Study|Lack of Efficacy|1
7731455|NCT00607789|12159797|FG000|Overall Study|Inadequate adherence|3
7731456|NCT00607789|12159798|FG001|Overall Study|Inadequate adherence|0
7731457|NCT00607789|12159797|FG000|Overall Study|Lost to Follow-up|0
7731458|NCT00607789|12159798|FG001|Overall Study|Lost to Follow-up|5
7731459|NCT00607789|12159797|FG000|Overall Study|Withdrawal by Subject|1
7731460|NCT00607789|12159798|FG001|Overall Study|Withdrawal by Subject|0
7731461|NCT00607880|12159826|FG000|Overall Study|Unable to place port due to occlusion|1
7731462|NCT00607880|12159827|FG001|Overall Study|Unable to place port due to occlusion|0
7731463|NCT00607893|12159835|FG000|Overall Study|Lost to Follow-up|4
7731464|NCT00607893|12159836|FG001|Overall Study|Lost to Follow-up|0
7731465|NCT00607893|12159835|FG000|Overall Study|withdrew due to loss of interest|0
7731466|NCT00607893|12159836|FG001|Overall Study|withdrew due to loss of interest|1
7731467|NCT00607893|12159835|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0
7731468|NCT00607893|12159836|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1
7731469|NCT00607893|12159835|FG000|Overall Study|withdrew could not tolerate CPAP|0
7731470|NCT00607893|12159836|FG001|Overall Study|withdrew could not tolerate CPAP|1
7731471|NCT00607893|12159835|FG000|Overall Study|Declined to be treated|1
7731472|NCT00607893|12159836|FG001|Overall Study|Declined to be treated|0
7731473|NCT00607893|12159835|FG000|Overall Study|Withdrew due to hypertensive urgency|1
7731474|NCT00607893|12159836|FG001|Overall Study|Withdrew due to hypertensive urgency|1
7731475|NCT00607919|12159846|FG000|Acute Phase|Adverse Event|9
7731476|NCT00607919|12159847|FG001|Acute Phase|Adverse Event|2
7731477|NCT00607919|12159846|FG000|Acute Phase|Entry Criteria Not Met|1
7731478|NCT00607919|12159847|FG001|Acute Phase|Entry Criteria Not Met|1
7731479|NCT00607919|12159846|FG000|Acute Phase|Lack of Efficacy|1
7731480|NCT00607919|12159847|FG001|Acute Phase|Lack of Efficacy|2
7731481|NCT00607919|12159846|FG000|Acute Phase|Lost to Follow-up|9
7731482|NCT00607919|12159847|FG001|Acute Phase|Lost to Follow-up|3
7731483|NCT00607919|12159846|FG000|Acute Phase|Parent/Caregiver Decision|6
7731484|NCT00607919|12159847|FG001|Acute Phase|Parent/Caregiver Decision|4
7731485|NCT00607919|12159846|FG000|Acute Phase|Protocol Violation|5
7731486|NCT00607919|12159847|FG001|Acute Phase|Protocol Violation|1
7731487|NCT00607919|12159846|FG000|Acute Phase|Withdrawal by Subject|3
7731488|NCT00607919|12159847|FG001|Acute Phase|Withdrawal by Subject|3
7731489|NCT00607919|12159846|FG000|Open-Label Phase|Adverse Event|1
7731490|NCT00607919|12159847|FG001|Open-Label Phase|Adverse Event|5
7731491|NCT00607919|12159846|FG000|Open-Label Phase|Lost to Follow-up|4
7731492|NCT00607919|12159847|FG001|Open-Label Phase|Lost to Follow-up|1
7731493|NCT00607919|12159846|FG000|Open-Label Phase|Protocol Violation|2
7731494|NCT00607919|12159847|FG001|Open-Label Phase|Protocol Violation|2
7731495|NCT00607919|12159846|FG000|Open-Label Phase|Withdrawal by Subject|2
7731496|NCT00607919|12159847|FG001|Open-Label Phase|Withdrawal by Subject|2
7731497|NCT00607919|12159846|FG000|Open-Label Phase|Parent/Caregiver Decision|1
7731498|NCT00607919|12159847|FG001|Open-Label Phase|Parent/Caregiver Decision|2
7731499|NCT00607997|12159859|FG000|Overall Study|Lack of Efficacy|6
7731500|NCT00607997|12159860|FG001|Overall Study|Lack of Efficacy|20
7731501|NCT00607997|12159861|FG002|Overall Study|Lack of Efficacy|14
7731502|NCT00607997|12159862|FG003|Overall Study|Lack of Efficacy|10
7731503|NCT00607997|12159859|FG000|Overall Study|Death|8
7731504|NCT00607997|12159860|FG001|Overall Study|Death|5
7731505|NCT00607997|12159861|FG002|Overall Study|Death|2
7731506|NCT00607997|12159862|FG003|Overall Study|Death|5
7731507|NCT00607997|12159859|FG000|Overall Study|Adverse Event|3
7731508|NCT00607997|12159860|FG001|Overall Study|Adverse Event|1
7731509|NCT00607997|12159861|FG002|Overall Study|Adverse Event|2
7731510|NCT00607997|12159862|FG003|Overall Study|Adverse Event|0
7731511|NCT00607997|12159859|FG000|Overall Study|Physician Decision|4
7731512|NCT00607997|12159860|FG001|Overall Study|Physician Decision|1
7731513|NCT00607997|12159861|FG002|Overall Study|Physician Decision|0
7731514|NCT00607997|12159862|FG003|Overall Study|Physician Decision|0
7731515|NCT00607997|12159859|FG000|Overall Study|Relapse, recurrent illness|4
7731516|NCT00607997|12159860|FG001|Overall Study|Relapse, recurrent illness|0
7731517|NCT00607997|12159861|FG002|Overall Study|Relapse, recurrent illness|2
7731518|NCT00607997|12159862|FG003|Overall Study|Relapse, recurrent illness|0
7731519|NCT00607997|12159859|FG000|Overall Study|Other without explanation|2
7731520|NCT00607997|12159860|FG001|Overall Study|Other without explanation|0
7731521|NCT00607997|12159861|FG002|Overall Study|Other without explanation|4
7731522|NCT00607997|12159862|FG003|Overall Study|Other without explanation|1
7731523|NCT00608205|12159924|FG000|Overall Study|Adverse Event|3
7731524|NCT00608205|12159925|FG001|Overall Study|Adverse Event|2
7731525|NCT00608205|12159924|FG000|Overall Study|Patient non-compliant|0
7731526|NCT00608205|12159925|FG001|Overall Study|Patient non-compliant|1
7731527|NCT00608244|12159933|FG000|Overall Study|Adverse Event|1
7731528|NCT00608244|12159933|FG000|Overall Study|Low trough levels|1
7731529|NCT00608322|12159941|FG000|Overall Study|Death|2
7731530|NCT00608322|12159942|FG001|Overall Study|Death|1
7731531|NCT00608426|12159950|FG000|Overall Study|Death|32
7731532|NCT00608426|12159951|FG001|Overall Study|Death|36
7731533|NCT00608426|12159950|FG000|Overall Study|Lost to Follow-up|485
7731534|NCT00608426|12159951|FG001|Overall Study|Lost to Follow-up|521
7731535|NCT00608426|12159950|FG000|Overall Study|refused, health issues, wrong address|319
7731536|NCT00608426|12159951|FG001|Overall Study|refused, health issues, wrong address|348
7768639|NCT00862940|12211967|FG000|Overall Study|Adverse Event|15
7768640|NCT00862940|12211968|FG001|Overall Study|Adverse Event|12
7768641|NCT00862940|12211967|FG000|Overall Study|Lack of Efficacy|1
7768642|NCT00862940|12211968|FG001|Overall Study|Lack of Efficacy|3
7768643|NCT00862940|12211967|FG000|Overall Study|Protocol Violation|2
7768644|NCT00862940|12211968|FG001|Overall Study|Protocol Violation|5
7768645|NCT00862940|12211967|FG000|Overall Study|Withdrawal by Subject|4
7768646|NCT00862940|12211968|FG001|Overall Study|Withdrawal by Subject|6
7768647|NCT00862940|12211967|FG000|Overall Study|Non-compliance|4
7768648|NCT00862940|12211968|FG001|Overall Study|Non-compliance|0
7768649|NCT00862940|12211967|FG000|Overall Study|Lost to Follow-up|0
7768650|NCT00862940|12211968|FG001|Overall Study|Lost to Follow-up|1
7768651|NCT00862940|12211967|FG000|Overall Study|Administrative or other reason(s)|4
7768652|NCT00862940|12211968|FG001|Overall Study|Administrative or other reason(s)|3
7768653|NCT00862979|12211976|FG000|Overall Study|Adverse Event|6
7768654|NCT00862979|12211977|FG001|Overall Study|Adverse Event|3
7768655|NCT00862979|12211976|FG000|Overall Study|Protocol Violation|0
7768656|NCT00862979|12211977|FG001|Overall Study|Protocol Violation|1
7731537|NCT00608517|12159969|FG000|Overall Study|Death|1
7731538|NCT00608517|12159970|FG001|Overall Study|Death|0
7731539|NCT00608517|12159971|FG002|Overall Study|Death|0
7731540|NCT00608530|12159984|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
7731541|NCT00608530|12159985|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
7731542|NCT00608530|12159986|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
7731543|NCT00608530|12159987|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
7731544|NCT00608530|12159984|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
7731545|NCT00608530|12159985|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
7731546|NCT00608530|12159986|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
7731547|NCT00608530|12159987|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
7731548|NCT00608530|12159984|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
7731549|NCT00608530|12159985|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
7731550|NCT00608530|12159986|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
7731551|NCT00608530|12159987|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
7731552|NCT00608530|12159984|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0
7731553|NCT00608530|12159985|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0
7731554|NCT00608530|12159986|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2
7731555|NCT00608530|12159987|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0
7731556|NCT00608530|12159984|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0
7731557|NCT00608530|12159985|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0
7731558|NCT00608530|12159986|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4
7731559|NCT00608530|12159987|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1
7731560|NCT00608530|12159984|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
7731561|NCT00608530|12159985|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
7731562|NCT00608530|12159986|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
7731563|NCT00608530|12159987|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
7731564|NCT00608543|12160002|FG000|Overall Study|Adverse Event|4
7731565|NCT00608569|12160009|FG000|Overall Study|Death|4
7731566|NCT00608569|12160010|FG001|Overall Study|Death|3
7731567|NCT00608569|12160009|FG000|Overall Study|Lost to Follow-up|4
7731568|NCT00608569|12160010|FG001|Overall Study|Lost to Follow-up|5
7731569|NCT00608569|12160009|FG000|Overall Study|Withdrawal by Subject|1
7731570|NCT00608569|12160010|FG001|Overall Study|Withdrawal by Subject|0
7731571|NCT00608569|12160009|FG000|Overall Study|Adverse Event|1
7731572|NCT00608569|12160010|FG001|Overall Study|Adverse Event|0
7731573|NCT00608569|12160009|FG000|Overall Study|Unable to adhere with study requirements|0
7731574|NCT00608569|12160010|FG001|Overall Study|Unable to adhere with study requirements|1
7731575|NCT00608582|12160018|FG000|Overall Study|Lost to Follow-up|2
7731576|NCT00608582|12160019|FG001|Overall Study|Lost to Follow-up|0
7731577|NCT00608582|12160018|FG000|Overall Study|No Best Response in Phase 1 located|1
7731578|NCT00608582|12160019|FG001|Overall Study|No Best Response in Phase 1 located|1
7731579|NCT00608582|12160018|FG000|Overall Study|Illicit Drug Use|1
7731580|NCT00608582|12160019|FG001|Overall Study|Illicit Drug Use|0
7731581|NCT00608582|12160018|FG000|Overall Study|Early stage Design Change|0
7731582|NCT00608582|12160019|FG001|Overall Study|Early stage Design Change|3
7731583|NCT00608829|12160042|FG000|Overall Study|Death|6
7731584|NCT00608829|12160042|FG000|Overall Study|Withdrawal by Subject|4
7731585|NCT00608829|12160042|FG000|Overall Study|Subject refuses to follow up or return.|5
7731586|NCT00608842|12160050|FG000|Overall Study|Participant's Request|0
7731587|NCT00608842|12160051|FG001|Overall Study|Participant's Request|1
7731588|NCT00608842|12160052|FG002|Overall Study|Participant's Request|2
7731589|NCT00608842|12160053|FG003|Overall Study|Participant's Request|1
7731590|NCT00608842|12160050|FG000|Overall Study|Lost to Follow-up|1
7731591|NCT00608842|12160051|FG001|Overall Study|Lost to Follow-up|0
7731592|NCT00608842|12160052|FG002|Overall Study|Lost to Follow-up|0
7731593|NCT00608842|12160053|FG003|Overall Study|Lost to Follow-up|0
7731594|NCT00608868|12160063|FG000|Overall Study|Withdrawal by Subject|7
7731595|NCT00608868|12160063|FG000|Overall Study|Protocol Violation|3
7731596|NCT00608868|12160063|FG000|Overall Study|Lost to Follow-up|2
7731597|NCT00608868|12160063|FG000|Overall Study|Adverse Event|1
7731598|NCT00608868|12160063|FG000|Overall Study|Physician Decision|2
7731599|NCT00608881|12160069|FG000|Overall Study|Death|22
7731600|NCT00608881|12160070|FG001|Overall Study|Death|13
7731601|NCT00608881|12160069|FG000|Overall Study|Adverse Event|5
7731602|NCT00608881|12160070|FG001|Overall Study|Adverse Event|3
7731603|NCT00608881|12160069|FG000|Overall Study|Lost to Follow-up|28
7731604|NCT00608881|12160070|FG001|Overall Study|Lost to Follow-up|14
7731605|NCT00608881|12160069|FG000|Overall Study|Withdrawal by Subject|18
7731606|NCT00608881|12160070|FG001|Overall Study|Withdrawal by Subject|29
7731607|NCT00608881|12160069|FG000|Overall Study|Physician Decision|5
7731608|NCT00608881|12160070|FG001|Overall Study|Physician Decision|5
7731609|NCT00608881|12160069|FG000|Overall Study|Institutionalized|1
7731610|NCT00608881|12160070|FG001|Overall Study|Institutionalized|2
7731611|NCT00608894|12160078|FG000|Overall Study|Withdrawal by Subject|0
7731612|NCT00608894|12160079|FG001|Overall Study|Withdrawal by Subject|2
7731613|NCT00608907|12160090|FG000|Overall Study|Adverse Event|6
7731614|NCT00608907|12160091|FG001|Overall Study|Adverse Event|0
7731615|NCT00608907|12160092|FG002|Overall Study|Adverse Event|1
7731616|NCT00608907|12160090|FG000|Overall Study|Death|1
7731617|NCT00608907|12160091|FG001|Overall Study|Death|0
7731618|NCT00608907|12160092|FG002|Overall Study|Death|0
7731619|NCT00608907|12160090|FG000|Overall Study|Withdrawal by Subject|4
7731620|NCT00608907|12160091|FG001|Overall Study|Withdrawal by Subject|0
7731621|NCT00608907|12160092|FG002|Overall Study|Withdrawal by Subject|0
7731622|NCT00608907|12160090|FG000|Overall Study|Progressive Disease|1
7731623|NCT00608907|12160091|FG001|Overall Study|Progressive Disease|0
7731624|NCT00608907|12160092|FG002|Overall Study|Progressive Disease|0
7731625|NCT00608959|12160102|FG000|Part 1|Did not meet eligibility criteria|1
7731626|NCT00608985|12160116|FG000|Overall Study|Adverse Event|2
7731627|NCT00608985|12160117|FG001|Overall Study|Adverse Event|7
7731628|NCT00608985|12160118|FG002|Overall Study|Adverse Event|4
7731629|NCT00608985|12160119|FG003|Overall Study|Adverse Event|6
7731630|NCT00608985|12160116|FG000|Overall Study|Administrative/Other|7
7731631|NCT00608985|12160117|FG001|Overall Study|Administrative/Other|4
7731632|NCT00608985|12160118|FG002|Overall Study|Administrative/Other|1
7731633|NCT00608985|12160119|FG003|Overall Study|Administrative/Other|2
7731634|NCT00608985|12160116|FG000|Overall Study|Withdrawal of Consent|5
7731635|NCT00608985|12160117|FG001|Overall Study|Withdrawal of Consent|1
7731636|NCT00608985|12160118|FG002|Overall Study|Withdrawal of Consent|1
7731637|NCT00608985|12160119|FG003|Overall Study|Withdrawal of Consent|1
7731638|NCT00608985|12160116|FG000|Overall Study|Lost to Follow-up|2
7731639|NCT00608985|12160117|FG001|Overall Study|Lost to Follow-up|1
7731640|NCT00608985|12160118|FG002|Overall Study|Lost to Follow-up|0
7731641|NCT00608985|12160119|FG003|Overall Study|Lost to Follow-up|0
7731642|NCT00609167|12160136|FG000|Overall Study|Withdrawal by Subject|1
7731643|NCT00609167|12160137|FG001|Overall Study|Withdrawal by Subject|0
7731644|NCT00609167|12160136|FG000|Overall Study|Lack of Efficacy|1
7731645|NCT00609167|12160137|FG001|Overall Study|Lack of Efficacy|0
7731646|NCT00609167|12160136|FG000|Overall Study|Adverse Event|5
7731647|NCT00609167|12160137|FG001|Overall Study|Adverse Event|1
7731648|NCT00609167|12160136|FG000|Overall Study|Disease Progression|1
7731649|NCT00609167|12160137|FG001|Overall Study|Disease Progression|0
7731650|NCT00609167|12160136|FG000|Overall Study|Stem Cell Transplant|0
7731651|NCT00609167|12160137|FG001|Overall Study|Stem Cell Transplant|6
7731652|NCT00609245|12160143|FG000|Overall Study|Adverse Event|1
7731653|NCT00609336|12160158|FG000|Overall Study|Protocol Violation|3
7731654|NCT00609336|12160158|FG000|Overall Study|Death|1
7731655|NCT00609336|12160158|FG000|Overall Study|LA or Met at Surgery|9
7731656|NCT00609362|12160165|FG000|Overall Study|Withdrawal by Subject|2
7731657|NCT00609362|12160166|FG001|Overall Study|Withdrawal by Subject|1
7731658|NCT00609362|12160165|FG000|Overall Study|Adverse Event|1
7731659|NCT00609362|12160166|FG001|Overall Study|Adverse Event|0
7731660|NCT00609466|12160175|FG000|Overall Study|Withdrawal by Subject|0
7731661|NCT00609466|12160176|FG001|Overall Study|Withdrawal by Subject|1
7731662|NCT00609466|12160177|FG002|Overall Study|Withdrawal by Subject|1
7731663|NCT00609466|12160175|FG000|Overall Study|Adverse Event|2
7731664|NCT00609466|12160176|FG001|Overall Study|Adverse Event|3
7731665|NCT00609466|12160177|FG002|Overall Study|Adverse Event|1
7731666|NCT00609466|12160175|FG000|Overall Study|Lack of Efficacy|0
7731667|NCT00609466|12160176|FG001|Overall Study|Lack of Efficacy|2
7731668|NCT00609466|12160177|FG002|Overall Study|Lack of Efficacy|2
7731669|NCT00609492|12160188|FG000|Overall Study|Withdrawal by Subject|0
7731670|NCT00609492|12160189|FG001|Overall Study|Withdrawal by Subject|2
7731671|NCT00609492|12160190|FG002|Overall Study|Withdrawal by Subject|3
7731672|NCT00609492|12160188|FG000|Overall Study|Lost to Follow-up|1
7731673|NCT00609492|12160189|FG001|Overall Study|Lost to Follow-up|1
7731674|NCT00609492|12160190|FG002|Overall Study|Lost to Follow-up|4
7731675|NCT00609518|12160202|FG000|Overall Study|Death from Study Disease|32
7731676|NCT00609518|12160203|FG001|Overall Study|Death from Study Disease|32
7731677|NCT00609518|12160202|FG000|Overall Study|Withdrawal by Subject|5
7731678|NCT00609518|12160203|FG001|Overall Study|Withdrawal by Subject|3
7731679|NCT00609518|12160202|FG000|Overall Study|Lost to Follow-up|3
7731680|NCT00609518|12160203|FG001|Overall Study|Lost to Follow-up|0
7731681|NCT00609518|12160202|FG000|Overall Study|Physician Decision|1
7731682|NCT00609518|12160203|FG001|Overall Study|Physician Decision|3
7731683|NCT00609518|12160202|FG000|Overall Study|Death from Adverse Event|2
7731684|NCT00609518|12160203|FG001|Overall Study|Death from Adverse Event|2
7731685|NCT00609609|12160211|FG000|Overall Study|Withdrawal by Subject|2
7731686|NCT00609609|12160212|FG001|Overall Study|Withdrawal by Subject|0
7731687|NCT00609609|12160211|FG000|Overall Study|Progression|4
7731688|NCT00609609|12160212|FG001|Overall Study|Progression|2
7731689|NCT00609622|12160220|FG000|Overall Study|Adverse Event|14
7731690|NCT00609622|12160221|FG001|Overall Study|Adverse Event|10
7731691|NCT00609622|12160220|FG000|Overall Study|Withdrawal by Subject|4
7731692|NCT00609622|12160221|FG001|Overall Study|Withdrawal by Subject|20
7731693|NCT00609622|12160220|FG000|Overall Study|Death|1
7731694|NCT00609622|12160221|FG001|Overall Study|Death|4
7731695|NCT00609622|12160220|FG000|Overall Study|Protocol Violation|1
7731696|NCT00609622|12160221|FG001|Overall Study|Protocol Violation|1
7731697|NCT00609622|12160220|FG000|Overall Study|Objective progression or relapse|47
7731698|NCT00609622|12160221|FG001|Overall Study|Objective progression or relapse|41
7731699|NCT00609622|12160220|FG000|Overall Study|Study terminated by sponsor|16
7731700|NCT00609622|12160221|FG001|Overall Study|Study terminated by sponsor|3
7731701|NCT00609622|12160220|FG000|Overall Study|Other|7
7731702|NCT00609622|12160221|FG001|Overall Study|Other|14
7731703|NCT00609622|12160220|FG000|Overall Study|Global deterioration of health status|6
7731704|NCT00609622|12160221|FG001|Overall Study|Global deterioration of health status|2
7731705|NCT00609674|12160229|FG000|Overall Study|Adverse Event|1
7731706|NCT00609674|12160230|FG001|Overall Study|Adverse Event|1
7731707|NCT00609674|12160229|FG000|Overall Study|Protocol Violation|3
7731708|NCT00609674|12160230|FG001|Overall Study|Protocol Violation|5
7731709|NCT00609674|12160229|FG000|Overall Study|Lost to Follow-up|1
7731710|NCT00609674|12160230|FG001|Overall Study|Lost to Follow-up|0
7731711|NCT00609674|12160229|FG000|Overall Study|Withdrew consent|2
7731712|NCT00609674|12160230|FG001|Overall Study|Withdrew consent|1
7731713|NCT00609869|12160252|FG000|Overall Study|Withdrawn, ischemic stroke|1
7731714|NCT00609869|12160252|FG000|Overall Study|Severe hematologic toxicity|1
7731715|NCT00609869|12160252|FG000|Overall Study|Withdrawal by Subject|1
7731716|NCT00609869|12160252|FG000|Overall Study|Seizures|1
7731717|NCT00609869|12160252|FG000|Overall Study|Severe tumor flare reaction|1
7731718|NCT00609869|12160252|FG000|Overall Study|Hepatitis B infection|1
7731719|NCT00609869|12160252|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1
7731720|NCT00609869|12160252|FG000|Overall Study|Mantle cell: not evaluable|4
7731721|NCT00609947|12160256|FG000|Overall Study|Death|1
7731722|NCT00609973|12160263|FG000|Overall Study|Adverse Event|2
7731723|NCT00609973|12160264|FG001|Overall Study|Adverse Event|1
7731724|NCT00609973|12160263|FG000|Overall Study|Protocol Violation|4
7731725|NCT00609973|12160264|FG001|Overall Study|Protocol Violation|3
7731726|NCT00609973|12160263|FG000|Overall Study|Lost to Follow-up|2
7731727|NCT00609973|12160264|FG001|Overall Study|Lost to Follow-up|1
7731728|NCT00609973|12160263|FG000|Overall Study|Withdrawal by Subject|0
7731729|NCT00609973|12160264|FG001|Overall Study|Withdrawal by Subject|1
7731730|NCT00609986|12160272|FG000|Overall Study|Did not receive transplant or treatment|8
7731731|NCT00609986|12160273|FG001|Overall Study|Did not receive transplant or treatment|3
7731732|NCT00610129|12160283|FG000|Overall Study|Not treated since patients ineligible|3
7731733|NCT00610155|12160287|FG000|Period 1|Withdrawal by Subject|0
7731734|NCT00610155|12160288|FG001|Period 1|Withdrawal by Subject|0
7731735|NCT00610155|12160289|FG002|Period 1|Withdrawal by Subject|1
7731736|NCT00610155|12160290|FG003|Period 1|Withdrawal by Subject|0
7731737|NCT00610155|12160291|FG004|Period 1|Withdrawal by Subject|0
7731738|NCT00610155|12160292|FG005|Period 1|Withdrawal by Subject|0
7731739|NCT00610155|12160287|FG000|Period 3|Adverse Event|1
7731740|NCT00610155|12160288|FG001|Period 3|Adverse Event|0
7731741|NCT00610155|12160289|FG002|Period 3|Adverse Event|0
7731742|NCT00610155|12160290|FG003|Period 3|Adverse Event|0
7731743|NCT00610155|12160291|FG004|Period 3|Adverse Event|0
7731744|NCT00610155|12160292|FG005|Period 3|Adverse Event|0
7731745|NCT00610168|12160302|FG000|Overall Study|Withdrawal by Subject|2
7731746|NCT00610168|12160303|FG001|Overall Study|Withdrawal by Subject|0
7731747|NCT00610207|12160309|FG000|Overall Study|Lost to Follow-up|3
7731748|NCT00610363|12160319|FG000|Overall Study|Non-compliance with protocol|0
7731749|NCT00610363|12160320|FG001|Overall Study|Non-compliance with protocol|1
7731750|NCT00610363|12160319|FG000|Overall Study|Adverse Event|3
7731751|NCT00610363|12160320|FG001|Overall Study|Adverse Event|1
7731752|NCT00610363|12160319|FG000|Overall Study|Lack of Efficacy|2
7731753|NCT00610363|12160320|FG001|Overall Study|Lack of Efficacy|0
7731754|NCT00610363|12160319|FG000|Overall Study|Lost to Follow-up|4
7731755|NCT00610363|12160320|FG001|Overall Study|Lost to Follow-up|0
7731756|NCT00610363|12160319|FG000|Overall Study|Withdrawal by Subject|1
7731757|NCT00610363|12160320|FG001|Overall Study|Withdrawal by Subject|0
7731758|NCT00610363|12160319|FG000|Overall Study|Other than specified above|1
7731759|NCT00610363|12160320|FG001|Overall Study|Other than specified above|1
7731760|NCT00610441|12160344|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1
7731761|NCT00610441|12160345|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1
7731762|NCT00610441|12160346|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4
7731763|NCT00610441|12160347|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1
7731764|NCT00610441|12160344|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
7731765|NCT00610441|12160345|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
7731766|NCT00610441|12160346|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
7731767|NCT00610441|12160347|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
7731768|NCT00610441|12160344|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
7731769|NCT00610441|12160345|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
7731770|NCT00610441|12160346|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
7731771|NCT00610441|12160347|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
7731772|NCT00610441|12160344|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
7731773|NCT00610441|12160345|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
7731774|NCT00610441|12160346|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
7731775|NCT00610441|12160347|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
7731776|NCT00610441|12160344|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0
7731777|NCT00610441|12160345|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0
7731778|NCT00610441|12160346|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2
7731779|NCT00610441|12160347|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0
7731780|NCT00610441|12160344|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
7731781|NCT00610441|12160345|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
7731782|NCT00610441|12160346|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
7731783|NCT00610441|12160347|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
7731784|NCT00610441|12160344|FG000|Treatment Period 2 - 3 Weeks|Other|1
7731785|NCT00610441|12160345|FG001|Treatment Period 2 - 3 Weeks|Other|1
7731786|NCT00610441|12160346|FG002|Treatment Period 2 - 3 Weeks|Other|0
7731787|NCT00610441|12160347|FG003|Treatment Period 2 - 3 Weeks|Other|1
7731788|NCT00610441|12160344|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0
7731789|NCT00610441|12160345|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0
7731790|NCT00610441|12160346|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0
7731791|NCT00610441|12160347|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1
7731792|NCT00610441|12160344|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
7731793|NCT00610441|12160345|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
7731794|NCT00610441|12160346|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
7731795|NCT00610441|12160347|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
7731796|NCT00610649|12160379|FG000|Overall Study|Adverse Event|1
7731797|NCT00610649|12160380|FG001|Overall Study|Adverse Event|0
7731798|NCT00610649|12160381|FG002|Overall Study|Adverse Event|0
7731799|NCT00610649|12160382|FG003|Overall Study|Adverse Event|0
7731800|NCT00610649|12160383|FG004|Overall Study|Adverse Event|0
7731801|NCT00610649|12160384|FG005|Overall Study|Adverse Event|0
7731802|NCT00610649|12160385|FG006|Overall Study|Adverse Event|0
7731803|NCT00610649|12160386|FG007|Overall Study|Adverse Event|0
7731804|NCT00610649|12160387|FG008|Overall Study|Adverse Event|0
7731805|NCT00610649|12160388|FG009|Overall Study|Adverse Event|0
7731806|NCT00610649|12160389|FG010|Overall Study|Adverse Event|1
7731807|NCT00610649|12160379|FG000|Overall Study|Family Emergency|0
7731808|NCT00610649|12160380|FG001|Overall Study|Family Emergency|1
7731809|NCT00610649|12160381|FG002|Overall Study|Family Emergency|0
7731810|NCT00610649|12160382|FG003|Overall Study|Family Emergency|0
7731811|NCT00610649|12160383|FG004|Overall Study|Family Emergency|0
7731812|NCT00610649|12160384|FG005|Overall Study|Family Emergency|0
7731813|NCT00610649|12160385|FG006|Overall Study|Family Emergency|0
7731814|NCT00610649|12160386|FG007|Overall Study|Family Emergency|0
7731815|NCT00610649|12160387|FG008|Overall Study|Family Emergency|0
7731816|NCT00610649|12160388|FG009|Overall Study|Family Emergency|0
7731817|NCT00610649|12160389|FG010|Overall Study|Family Emergency|0
7731818|NCT00610649|12160379|FG000|Overall Study|Withdrawal by Subject|0
7731819|NCT00610649|12160380|FG001|Overall Study|Withdrawal by Subject|0
7731820|NCT00610649|12160381|FG002|Overall Study|Withdrawal by Subject|0
7731821|NCT00610649|12160382|FG003|Overall Study|Withdrawal by Subject|0
7731822|NCT00610649|12160383|FG004|Overall Study|Withdrawal by Subject|0
7731823|NCT00610649|12160384|FG005|Overall Study|Withdrawal by Subject|0
7731824|NCT00610649|12160385|FG006|Overall Study|Withdrawal by Subject|0
7731825|NCT00610649|12160386|FG007|Overall Study|Withdrawal by Subject|0
7731826|NCT00610649|12160387|FG008|Overall Study|Withdrawal by Subject|0
7731827|NCT00610649|12160388|FG009|Overall Study|Withdrawal by Subject|1
7731828|NCT00610649|12160389|FG010|Overall Study|Withdrawal by Subject|0
7731829|NCT00610675|12160413|FG000|Overall Study|Untreated|4
7731830|NCT00610675|12160413|FG000|Overall Study|Adverse Event|67
7731831|NCT00610675|12160413|FG000|Overall Study|Insufficient Effect|31
7731832|NCT00610675|12160413|FG000|Overall Study|Withdrawal by Subject|28
7731833|NCT00610675|12160413|FG000|Overall Study|Reasons unrelated to trial|27
7731834|NCT00610675|12160413|FG000|Overall Study|Lack of Compliance|7
7731835|NCT00610675|12160413|FG000|Overall Study|Lost to Follow-up|31
7731836|NCT00610675|12160413|FG000|Overall Study|Other reason (not specified)|25
7731837|NCT00610714|12160441|FG000|Overall Study|Adverse Event|3
7731838|NCT00610714|12160442|FG001|Overall Study|Adverse Event|1
7731839|NCT00610714|12160441|FG000|Overall Study|Death|12
7731840|NCT00610714|12160442|FG001|Overall Study|Death|18
7731841|NCT00610714|12160441|FG000|Overall Study|Withdrawal by Subject|9
7731842|NCT00610714|12160442|FG001|Overall Study|Withdrawal by Subject|3
7731843|NCT00610714|12160441|FG000|Overall Study|Study completion at 120 PFS events|2
7731844|NCT00610714|12160442|FG001|Overall Study|Study completion at 120 PFS events|2
7731845|NCT00610857|12160481|FG000|Overall Study|Not evaluable for response|2
7731846|NCT00610935|12160491|FG000|Overall Study|Lost to Follow-up|0
7731847|NCT00610935|12160492|FG001|Overall Study|Lost to Follow-up|1
7731848|NCT00610935|12160491|FG000|Overall Study|Withdrawal by Subject|0
7731849|NCT00610935|12160492|FG001|Overall Study|Withdrawal by Subject|2
7731850|NCT00610935|12160491|FG000|Overall Study|Sponsor Discontinuation|1
7731851|NCT00610935|12160492|FG001|Overall Study|Sponsor Discontinuation|0
7731852|NCT00611026|12160510|FG000|Randomized to Double-blind Treatment|Not treated|2
7731853|NCT00611026|12160511|FG001|Randomized to Double-blind Treatment|Not treated|1
7731854|NCT00611026|12160512|FG002|Randomized to Double-blind Treatment|Not treated|3
7731855|NCT00611026|12160510|FG000|Double-blind Treatment Period|Death|1
7731856|NCT00611026|12160511|FG001|Double-blind Treatment Period|Death|0
7731857|NCT00611026|12160512|FG002|Double-blind Treatment Period|Death|0
7731858|NCT00611026|12160510|FG000|Double-blind Treatment Period|Adverse Event|9
7731859|NCT00611026|12160511|FG001|Double-blind Treatment Period|Adverse Event|28
7731860|NCT00611026|12160512|FG002|Double-blind Treatment Period|Adverse Event|46
7731861|NCT00611026|12160510|FG000|Double-blind Treatment Period|Lack of Efficacy|11
7731862|NCT00611026|12160511|FG001|Double-blind Treatment Period|Lack of Efficacy|10
7731863|NCT00611026|12160512|FG002|Double-blind Treatment Period|Lack of Efficacy|4
7731864|NCT00611026|12160510|FG000|Double-blind Treatment Period|Lost to Follow-up|6
7731865|NCT00611026|12160511|FG001|Double-blind Treatment Period|Lost to Follow-up|11
7731866|NCT00611026|12160512|FG002|Double-blind Treatment Period|Lost to Follow-up|14
7731867|NCT00611026|12160510|FG000|Double-blind Treatment Period|Withdrawal by Subject|7
7731868|NCT00611026|12160511|FG001|Double-blind Treatment Period|Withdrawal by Subject|19
7731869|NCT00611026|12160512|FG002|Double-blind Treatment Period|Withdrawal by Subject|16
7731870|NCT00611026|12160510|FG000|Double-blind Treatment Period|Other|13
7731871|NCT00611026|12160511|FG001|Double-blind Treatment Period|Other|20
7731872|NCT00611026|12160512|FG002|Double-blind Treatment Period|Other|18
7731873|NCT00611130|12160524|FG000|Overall Study|Lost to Follow-up|25
7731874|NCT00611130|12160525|FG001|Overall Study|Lost to Follow-up|29
7731875|NCT00611130|12160524|FG000|Overall Study|Protocol noncompliance|7
7731876|NCT00611130|12160525|FG001|Overall Study|Protocol noncompliance|6
7731877|NCT00611130|12160524|FG000|Overall Study|Withdrawal by Subject|6
7731878|NCT00611130|12160525|FG001|Overall Study|Withdrawal by Subject|5
7731879|NCT00611130|12160524|FG000|Overall Study|Other|5
7731880|NCT00611130|12160525|FG001|Overall Study|Other|4
7731881|NCT00611130|12160524|FG000|Overall Study|Incarceration|3
7731882|NCT00611130|12160525|FG001|Overall Study|Incarceration|2
7731883|NCT00611130|12160524|FG000|Overall Study|Administrative|1
7731884|NCT00611130|12160525|FG001|Overall Study|Administrative|1
7731885|NCT00611130|12160524|FG000|Overall Study|Adverse Event|1
7731886|NCT00611130|12160525|FG001|Overall Study|Adverse Event|0
7731887|NCT00611130|12160524|FG000|Overall Study|Death|1
7731888|NCT00611130|12160525|FG001|Overall Study|Death|0
7731889|NCT00611247|12160534|FG000|Overall Study|Death|1
7731890|NCT00611247|12160535|FG001|Overall Study|Death|5
7731891|NCT00611247|12160534|FG000|Overall Study|Lack of Efficacy|1
7731892|NCT00611247|12160535|FG001|Overall Study|Lack of Efficacy|16
7731893|NCT00611455|12160575|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2
7731894|NCT00611455|12160576|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8
7731895|NCT00611455|12160577|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0
7731896|NCT00611455|12160575|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
7731897|NCT00611455|12160576|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
7731898|NCT00611455|12160577|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
7731899|NCT00611455|12160575|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4
7731900|NCT00611455|12160576|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1
7731901|NCT00611455|12160577|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0
7731902|NCT00611455|12160575|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
7731903|NCT00611455|12160576|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
7731904|NCT00611455|12160577|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
7731905|NCT00611455|12160575|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
7731906|NCT00611455|12160576|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
7731907|NCT00611455|12160577|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
7731908|NCT00611455|12160575|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
7731909|NCT00611455|12160576|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
7731910|NCT00611455|12160577|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
7731911|NCT00611455|12160575|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0
7731912|NCT00611455|12160576|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17
7731913|NCT00611455|12160577|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0
7731914|NCT00611455|12160575|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
7731915|NCT00611455|12160576|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
7731916|NCT00611455|12160577|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
7731917|NCT00611455|12160575|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0
7731918|NCT00611455|12160576|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3
7731919|NCT00611455|12160577|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0
7731920|NCT00611455|12160575|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
7731921|NCT00611455|12160576|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
7731922|NCT00611455|12160577|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
7731923|NCT00611455|12160575|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
7731924|NCT00611455|12160576|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
7731925|NCT00611455|12160577|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
7731926|NCT00611455|12160575|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
7731927|NCT00611455|12160576|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
7731928|NCT00611455|12160577|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
7731929|NCT00611455|12160575|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0
7731930|NCT00611455|12160576|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5
7731931|NCT00611455|12160577|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0
7731932|NCT00611455|12160575|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
7731933|NCT00611455|12160576|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
7731934|NCT00611455|12160577|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
7731935|NCT00611455|12160575|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0
7731936|NCT00611455|12160576|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0
7731937|NCT00611455|12160577|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30
7731938|NCT00611455|12160575|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
7731939|NCT00611455|12160576|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
7731940|NCT00611455|12160577|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
7731941|NCT00611455|12160575|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
7731942|NCT00611455|12160576|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
7731943|NCT00611455|12160577|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
7731944|NCT00611455|12160575|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
7731945|NCT00611455|12160576|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
7731946|NCT00611455|12160577|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
7731947|NCT00611455|12160575|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
7731948|NCT00611455|12160576|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
7731949|NCT00611455|12160577|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
7731950|NCT00611455|12160575|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
7731951|NCT00611455|12160576|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
7731952|NCT00611455|12160577|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
7731953|NCT00611455|12160575|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
7731954|NCT00611455|12160576|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
7731955|NCT00611455|12160577|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
7731956|NCT00611533|12160594|FG000|First Intervention (6 Weeks)|Never started study|0
7731957|NCT00611533|12160595|FG001|First Intervention (6 Weeks)|Never started study|1
7731958|NCT00611533|12160594|FG000|First Intervention (6 Weeks)|Adverse Event|0
7731959|NCT00611533|12160595|FG001|First Intervention (6 Weeks)|Adverse Event|1
7731960|NCT00611533|12160594|FG000|Second Intervention (6 Weeks)|Adverse Event|0
7731961|NCT00611533|12160595|FG001|Second Intervention (6 Weeks)|Adverse Event|2
7731962|NCT00611559|12160605|FG000|Overall Study|Lost to Follow-up|0
7731963|NCT00611559|12160606|FG001|Overall Study|Lost to Follow-up|1
7731964|NCT00611559|12160607|FG002|Overall Study|Lost to Follow-up|0
7731965|NCT00611559|12160605|FG000|Overall Study|Protocol Violation|1
7731966|NCT00611559|12160606|FG001|Overall Study|Protocol Violation|0
7731967|NCT00611559|12160607|FG002|Overall Study|Protocol Violation|1
7731968|NCT00611715|12160622|FG000|Overall Study|Disease Progression|24
7731969|NCT00611715|12160623|FG001|Overall Study|Disease Progression|4
7731970|NCT00611715|12160622|FG000|Overall Study|Withdrawal by Subject|5
7731971|NCT00611715|12160623|FG001|Overall Study|Withdrawal by Subject|1
7731972|NCT00611715|12160622|FG000|Overall Study|Adverse Event|9
7731973|NCT00611715|12160623|FG001|Overall Study|Adverse Event|1
7731974|NCT00611715|12160622|FG000|Overall Study|Death|1
7731975|NCT00611715|12160623|FG001|Overall Study|Death|0
7731976|NCT00611715|12160622|FG000|Overall Study|two patients are still on treatment|2
7731977|NCT00611715|12160623|FG001|Overall Study|two patients are still on treatment|0
7731978|NCT00611767|12160637|FG000|Overall Study|Withdrawal by Subject|4
7731979|NCT00611767|12160638|FG001|Overall Study|Withdrawal by Subject|1
7731980|NCT00611767|12160637|FG000|Overall Study|Thiopental not available|3
7731981|NCT00611767|12160638|FG001|Overall Study|Thiopental not available|0
7731982|NCT00611767|12160637|FG000|Overall Study|didn't like the medication|1
7731983|NCT00611767|12160638|FG001|Overall Study|didn't like the medication|1
7731984|NCT00611767|12160637|FG000|Overall Study|Physician Decision|1
7731985|NCT00611767|12160638|FG001|Overall Study|Physician Decision|0
7731986|NCT00611806|12160646|FG000|Overall Study|Withdrawal by Subject|8
7731987|NCT00611806|12160647|FG001|Overall Study|Withdrawal by Subject|2
7731988|NCT00611806|12160646|FG000|Overall Study|Adverse Event|2
7731989|NCT00611806|12160647|FG001|Overall Study|Adverse Event|1
7731990|NCT00611806|12160646|FG000|Overall Study|Lost to Follow-up|6
7731991|NCT00611806|12160647|FG001|Overall Study|Lost to Follow-up|0
7731992|NCT00611858|12160653|FG000|Overall Study|Adverse Event|2
7731993|NCT00611858|12160653|FG000|Overall Study|Withdrawal by Subject|2
7731994|NCT00611884|12160663|FG000|Overall Study|Adverse Event|1
7731995|NCT00611884|12160664|FG001|Overall Study|Adverse Event|0
7731996|NCT00611884|12160665|FG002|Overall Study|Adverse Event|0
7731997|NCT00611884|12160666|FG003|Overall Study|Adverse Event|1
7731998|NCT00611884|12160663|FG000|Overall Study|Non-Compliance|1
7731999|NCT00611884|12160664|FG001|Overall Study|Non-Compliance|4
7732000|NCT00611884|12160665|FG002|Overall Study|Non-Compliance|2
7732001|NCT00611884|12160666|FG003|Overall Study|Non-Compliance|2
7732002|NCT00611884|12160663|FG000|Overall Study|Lack of Efficacy|0
7732003|NCT00611884|12160664|FG001|Overall Study|Lack of Efficacy|1
7732004|NCT00611884|12160665|FG002|Overall Study|Lack of Efficacy|0
7732005|NCT00611884|12160666|FG003|Overall Study|Lack of Efficacy|0
7732006|NCT00611884|12160663|FG000|Overall Study|Unclassified|7
7732007|NCT00611884|12160664|FG001|Overall Study|Unclassified|4
7732008|NCT00611884|12160665|FG002|Overall Study|Unclassified|2
7732009|NCT00611884|12160666|FG003|Overall Study|Unclassified|3
7732010|NCT00611923|12160687|FG000|Overall Study|Withdrawal by Subject|2
7732011|NCT00611923|12160688|FG001|Overall Study|Withdrawal by Subject|2
7732012|NCT00611975|12160698|FG000|Overall Study|Withdrawal by Subject|3
7732013|NCT00611975|12160699|FG001|Overall Study|Withdrawal by Subject|7
7732014|NCT00611975|12160698|FG000|Overall Study|Pregnancy|2
7732015|NCT00611975|12160699|FG001|Overall Study|Pregnancy|1
7732016|NCT00612040|12160708|FG000|Overall Study|Adverse Event|0
7732017|NCT00612040|12160709|FG001|Overall Study|Adverse Event|2
7732018|NCT00612040|12160710|FG002|Overall Study|Adverse Event|1
7732019|NCT00612040|12160708|FG000|Overall Study|Protocol Violation|1
7732020|NCT00612040|12160709|FG001|Overall Study|Protocol Violation|2
7732021|NCT00612040|12160710|FG002|Overall Study|Protocol Violation|1
7732022|NCT00612040|12160708|FG000|Overall Study|Lack of Efficacy|2
7732023|NCT00612040|12160709|FG001|Overall Study|Lack of Efficacy|1
7732024|NCT00612040|12160710|FG002|Overall Study|Lack of Efficacy|0
7732025|NCT00612040|12160708|FG000|Overall Study|Unclassified|2
7732026|NCT00612040|12160709|FG001|Overall Study|Unclassified|2
7732027|NCT00612040|12160710|FG002|Overall Study|Unclassified|5
7732028|NCT00612066|12160718|FG000|Overall Study|Adverse Event|1
7732029|NCT00612105|12160724|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18
7732030|NCT00612105|12160725|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1
7732031|NCT00612105|12160724|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
7732032|NCT00612105|12160725|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
7732033|NCT00612105|12160724|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
7732034|NCT00612105|12160725|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
7732035|NCT00612105|12160724|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1
7732036|NCT00612105|12160725|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1
7732037|NCT00612105|12160724|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
7732038|NCT00612105|12160725|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
7732039|NCT00612105|12160724|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
7732040|NCT00612105|12160725|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
7732041|NCT00612105|12160724|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
7732042|NCT00612105|12160725|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
7732043|NCT00612105|12160724|FG000|Period Title 1: 6-Week Titration Phase|Other|0
7732044|NCT00612105|12160725|FG001|Period Title 1: 6-Week Titration Phase|Other|1
7732045|NCT00612105|12160724|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
7732046|NCT00612105|12160725|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
7732047|NCT00612105|12160724|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
7732048|NCT00612105|12160725|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
7732049|NCT00612105|12160724|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
7732050|NCT00612105|12160725|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
7732051|NCT00612105|12160724|FG000|Period Title 3: 3-Week Taper Phase|Other|1
7732052|NCT00612105|12160725|FG001|Period Title 3: 3-Week Taper Phase|Other|0
7732053|NCT00612313|12160755|FG000|Overall Study|Withdrawal by Subject|6
7732054|NCT00612313|12160756|FG001|Overall Study|Withdrawal by Subject|9
7732055|NCT00612313|12160755|FG000|Overall Study|Lost to Follow-up|11
7732056|NCT00612313|12160756|FG001|Overall Study|Lost to Follow-up|4
7732057|NCT00612352|12160774|FG000|Overall Study|Adverse Event|1
7732058|NCT00612352|12160775|FG001|Overall Study|Adverse Event|0
7732059|NCT00612352|12160774|FG000|Overall Study|Withdrawal by Subject|3
7732060|NCT00612352|12160775|FG001|Overall Study|Withdrawal by Subject|5
7732061|NCT00612352|12160774|FG000|Overall Study|moved out of state|1
7732062|NCT00612352|12160775|FG001|Overall Study|moved out of state|0
7732063|NCT00612352|12160774|FG000|Overall Study|didn't return calls/show up on test date|4
7732064|NCT00612352|12160775|FG001|Overall Study|didn't return calls/show up on test date|1
7732065|NCT00612456|12160795|FG000|Overall Study|Adverse Event|1
7732066|NCT00612456|12160796|FG001|Overall Study|Adverse Event|0
7732067|NCT00612456|12160797|FG002|Overall Study|Adverse Event|0
7732068|NCT00612456|12160795|FG000|Overall Study|Lack of Efficacy|1
7732069|NCT00612456|12160796|FG001|Overall Study|Lack of Efficacy|1
7732070|NCT00612456|12160797|FG002|Overall Study|Lack of Efficacy|0
7732071|NCT00612456|12160795|FG000|Overall Study|Withdrawal by Subject|0
7732072|NCT00612456|12160796|FG001|Overall Study|Withdrawal by Subject|1
7732073|NCT00612456|12160797|FG002|Overall Study|Withdrawal by Subject|0
7732074|NCT00612508|12160809|FG000|Overall Study|Withdrawal by Subject|3
7732075|NCT00612508|12160810|FG001|Overall Study|Withdrawal by Subject|4
7732076|NCT00612534|12160822|FG000|Overall Study|Adverse Event|0
7732077|NCT00612534|12160823|FG001|Overall Study|Adverse Event|4
7732078|NCT00612534|12160824|FG002|Overall Study|Adverse Event|2
7732079|NCT00612534|12160825|FG003|Overall Study|Adverse Event|1
7732080|NCT00612534|12160822|FG000|Overall Study|Lack of Efficacy|13
7732081|NCT00612534|12160823|FG001|Overall Study|Lack of Efficacy|12
7732082|NCT00612534|12160824|FG002|Overall Study|Lack of Efficacy|5
7732083|NCT00612534|12160825|FG003|Overall Study|Lack of Efficacy|16
7732084|NCT00612534|12160822|FG000|Overall Study|Other Reason|0
7732085|NCT00612534|12160823|FG001|Overall Study|Other Reason|1
7732086|NCT00612534|12160824|FG002|Overall Study|Other Reason|0
7732087|NCT00612534|12160825|FG003|Overall Study|Other Reason|0
7732088|NCT00612586|12160871|FG000|Overall Study|Adverse Event|6
7732089|NCT00612586|12160872|FG001|Overall Study|Adverse Event|2
7732090|NCT00612586|12160871|FG000|Overall Study|Death|1
7732091|NCT00612586|12160872|FG001|Overall Study|Death|0
7732092|NCT00612586|12160871|FG000|Overall Study|Entry Criteria Not Met|0
7732093|NCT00612586|12160872|FG001|Overall Study|Entry Criteria Not Met|2
7732094|NCT00612586|12160871|FG000|Overall Study|Withdrawal by Subject|7
7732095|NCT00612586|12160872|FG001|Overall Study|Withdrawal by Subject|9
7732096|NCT00612586|12160871|FG000|Overall Study|Physician Decision|1
7732097|NCT00612586|12160872|FG001|Overall Study|Physician Decision|2
7732098|NCT00612586|12160871|FG000|Overall Study|Sponsor Decision|1
7732099|NCT00612586|12160872|FG001|Overall Study|Sponsor Decision|1
7732100|NCT00612586|12160871|FG000|Overall Study|Progressive Disease|26
7732101|NCT00612586|12160872|FG001|Overall Study|Progressive Disease|24
7732102|NCT00612586|12160871|FG000|Overall Study|Randomized and Not Treated|1
7732103|NCT00612586|12160872|FG001|Overall Study|Randomized and Not Treated|1
7732104|NCT00612690|12160881|FG000|Overall Study|Lost to Follow-up|72
7732105|NCT00612690|12160882|FG001|Overall Study|Lost to Follow-up|98
7732106|NCT00612690|12160881|FG000|Overall Study|Withdrawal by Subject|32
7732107|NCT00612690|12160882|FG001|Overall Study|Withdrawal by Subject|20
7732108|NCT00612690|12160881|FG000|Overall Study|Withdrawal by Site|11
7732109|NCT00612690|12160882|FG001|Overall Study|Withdrawal by Site|0
7732110|NCT00612807|12160921|FG000|Overall Study|Withdrawal by Subject|2
7732111|NCT00612807|12160922|FG001|Overall Study|Withdrawal by Subject|0
7732112|NCT00613015|12160944|FG000|Overall Study|Lost to Follow-up|0
7732113|NCT00613015|12160945|FG001|Overall Study|Lost to Follow-up|1
7732114|NCT00613015|12160946|FG002|Overall Study|Lost to Follow-up|3
7732115|NCT00613015|12160947|FG003|Overall Study|Lost to Follow-up|3
7732116|NCT00613015|12160948|FG004|Overall Study|Lost to Follow-up|2
7732117|NCT00613015|12160949|FG005|Overall Study|Lost to Follow-up|3
7732118|NCT00613080|12160972|FG000|Overall Study|Ineligible / no protocol treatment|11
7732119|NCT00613106|12160978|FG000|Overall Study|Adverse Event|3
7732120|NCT00613106|12160979|FG001|Overall Study|Adverse Event|1
7732121|NCT00613106|12160978|FG000|Overall Study|Withdrawal by Subject|6
7732122|NCT00613106|12160979|FG001|Overall Study|Withdrawal by Subject|3
7732123|NCT00613106|12160978|FG000|Overall Study|Lost to Follow-up|7
7732124|NCT00613106|12160979|FG001|Overall Study|Lost to Follow-up|2
7732125|NCT00613106|12160978|FG000|Overall Study|misc|4
7732126|NCT00613106|12160979|FG001|Overall Study|misc|3
7732127|NCT00613171|12160985|FG000|Overall Study|Adverse Event|7
7732128|NCT00613171|12160985|FG000|Overall Study|Withdrawal by Subject|3
7732129|NCT00613171|12160985|FG000|Overall Study|Reason not Specified|4
7732130|NCT00613301|12160990|FG000|Overall Study|Adverse Event|49
7732131|NCT00613301|12160990|FG000|Overall Study|Lost to Follow-up|88
7732132|NCT00613301|12160990|FG000|Overall Study|Withdrawal by Subject|5
7732133|NCT00613301|12160990|FG000|Overall Study|Death|6
7732134|NCT00613301|12160990|FG000|Overall Study|Lack of Efficacy|13
7732135|NCT00613301|12160990|FG000|Overall Study|Physician Decision|2
7732136|NCT00613301|12160990|FG000|Overall Study|No data was collected|53
7732137|NCT00613301|12160990|FG000|Overall Study|Irregularly enrolled patients|12
7768657|NCT00862979|12211976|FG000|Overall Study|Patient withdrew consent|2
7768658|NCT00862979|12211977|FG001|Overall Study|Patient withdrew consent|1
7768659|NCT00862979|12211976|FG000|Overall Study|Administrative problems|0
7768660|NCT00862979|12211977|FG001|Overall Study|Administrative problems|1
7768661|NCT00862979|12211976|FG000|Overall Study|Death|0
7768662|NCT00862979|12211977|FG001|Overall Study|Death|1
7768663|NCT00862992|12211986|FG000|Overall Study|Adverse Event|2
7768664|NCT00862992|12211987|FG001|Overall Study|Adverse Event|1
7768665|NCT00862992|12211988|FG002|Overall Study|Adverse Event|1
7768666|NCT00862992|12211986|FG000|Overall Study|Physician Decision|1
7768667|NCT00862992|12211987|FG001|Overall Study|Physician Decision|0
7768668|NCT00862992|12211988|FG002|Overall Study|Physician Decision|0
7768669|NCT00862992|12211986|FG000|Overall Study|Withdrawal by Subject|0
7768670|NCT00862992|12211987|FG001|Overall Study|Withdrawal by Subject|0
7768671|NCT00862992|12211988|FG002|Overall Study|Withdrawal by Subject|2
7768672|NCT00863057|12212000|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
7768673|NCT00863057|12212001|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
7768674|NCT00863057|12212002|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
7768675|NCT00863057|12212003|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
7768676|NCT00863057|12212000|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
7768677|NCT00863057|12212001|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
7768678|NCT00863057|12212002|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
7768679|NCT00863057|12212003|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
7768680|NCT00863057|12212000|FG000|Period 2 (Weeks 6-10)|Adverse Event|0
7732138|NCT00613314|12160995|FG000|Overall Study|Adverse Event|5
7732139|NCT00613314|12160995|FG000|Overall Study|Protocol Violation|14
7732140|NCT00613314|12160995|FG000|Overall Study|Lost to Follow-up|46
7732141|NCT00613314|12160995|FG000|Overall Study|Other reason not defined above|90
7732142|NCT00613327|12160999|FG000|Overall Study|Adverse Event|38
7732143|NCT00613327|12160999|FG000|Overall Study|Lost to Follow-up|8
7732144|NCT00613327|12160999|FG000|Overall Study|Withdrawal by Subject|6
7732145|NCT00613327|12160999|FG000|Overall Study|Protocol Violation|2
7732146|NCT00613327|12160999|FG000|Overall Study|Other|47
7732147|NCT00613366|12161005|FG000|Overall Study|Withdrawal by Subject|3
7732148|NCT00613366|12161006|FG001|Overall Study|Withdrawal by Subject|2
7732149|NCT00613509|12161036|FG000|Cycle 1|Adverse Event|2
7732150|NCT00613509|12161037|FG001|Cycle 1|Adverse Event|1
7732151|NCT00613509|12161036|FG000|Cycle 1|Disease Progression|2
7732152|NCT00613509|12161037|FG001|Cycle 1|Disease Progression|6
7732153|NCT00613509|12161036|FG000|Cycle 1|Unacceptable Toxicity|1
7732154|NCT00613509|12161037|FG001|Cycle 1|Unacceptable Toxicity|0
7732155|NCT00613509|12161036|FG000|Cycle 1|Other administrative reason|0
7732156|NCT00613509|12161037|FG001|Cycle 1|Other administrative reason|1
7732157|NCT00613574|12161043|FG000|Overall Study|Adverse Event|3
7732158|NCT00613574|12161043|FG000|Overall Study|Lost to Follow-up|2
7732159|NCT00613574|12161043|FG000|Overall Study|Other|1
7732160|NCT00613626|12161050|FG000|Overall Study|Ineligible|0
7732161|NCT00613626|12161051|FG001|Overall Study|Ineligible|1
7732162|NCT00613626|12161052|FG002|Overall Study|Ineligible|0
7732163|NCT00613821|12161061|FG000|Overall Study|Withdrawal by Subject|1
7732164|NCT00613821|12161062|FG001|Overall Study|Withdrawal by Subject|0
7732165|NCT00613821|12161061|FG000|Overall Study|Physician Decision|1
7732166|NCT00613821|12161062|FG001|Overall Study|Physician Decision|1
7732167|NCT00613834|12161070|FG000|Overall Study|Withdrawal by Subject|0
7732168|NCT00613834|12161071|FG001|Overall Study|Withdrawal by Subject|3
7732169|NCT00613925|12161081|FG000|Overall Study|1 did not tolerate outpatient biopsy|0
7732170|NCT00613925|12161082|FG001|Overall Study|1 did not tolerate outpatient biopsy|1
7732171|NCT00613938|12161092|FG000|Overall Study|Withdrawal by Subject|2
7732172|NCT00613938|12161093|FG001|Overall Study|Withdrawal by Subject|4
7732173|NCT00613938|12161094|FG002|Overall Study|Withdrawal by Subject|9
7732174|NCT00613938|12161095|FG003|Overall Study|Withdrawal by Subject|9
7732175|NCT00613938|12161092|FG000|Overall Study|Adverse Event|1
7732176|NCT00613938|12161093|FG001|Overall Study|Adverse Event|4
7732177|NCT00613938|12161094|FG002|Overall Study|Adverse Event|8
7732178|NCT00613938|12161095|FG003|Overall Study|Adverse Event|5
7732179|NCT00613938|12161092|FG000|Overall Study|Lack of Efficacy|16
7732180|NCT00613938|12161093|FG001|Overall Study|Lack of Efficacy|18
7732181|NCT00613938|12161094|FG002|Overall Study|Lack of Efficacy|5
7732182|NCT00613938|12161095|FG003|Overall Study|Lack of Efficacy|9
7732183|NCT00613938|12161092|FG000|Overall Study|Other|1
7732184|NCT00613938|12161093|FG001|Overall Study|Other|2
7732185|NCT00613938|12161094|FG002|Overall Study|Other|1
7732186|NCT00613938|12161095|FG003|Overall Study|Other|3
7732187|NCT00613951|12161108|FG000|Overall Study|Adverse Event|1
7732188|NCT00613951|12161109|FG001|Overall Study|Adverse Event|0
7732189|NCT00613951|12161110|FG002|Overall Study|Adverse Event|1
7732190|NCT00613951|12161108|FG000|Overall Study|Lack of Efficacy|0
7732191|NCT00613951|12161109|FG001|Overall Study|Lack of Efficacy|1
7732192|NCT00613951|12161110|FG002|Overall Study|Lack of Efficacy|1
7732193|NCT00613951|12161108|FG000|Overall Study|Protocol Violation|1
7732194|NCT00613951|12161109|FG001|Overall Study|Protocol Violation|1
7732195|NCT00613951|12161110|FG002|Overall Study|Protocol Violation|1
7732196|NCT00613951|12161108|FG000|Overall Study|Unclassified|5
7732197|NCT00613951|12161109|FG001|Overall Study|Unclassified|3
7732198|NCT00613951|12161110|FG002|Overall Study|Unclassified|2
7732199|NCT00614055|12161124|FG000|Overall Study|Adverse Event|1
7732200|NCT00614055|12161125|FG001|Overall Study|Adverse Event|0
7732201|NCT00614055|12161126|FG002|Overall Study|Adverse Event|0
7732202|NCT00614055|12161124|FG000|Overall Study|Protocol Violation|2
7732203|NCT00614055|12161125|FG001|Overall Study|Protocol Violation|2
7732204|NCT00614055|12161126|FG002|Overall Study|Protocol Violation|1
7732205|NCT00614055|12161124|FG000|Overall Study|Lack of Efficacy|0
7732206|NCT00614055|12161125|FG001|Overall Study|Lack of Efficacy|0
7732207|NCT00614055|12161126|FG002|Overall Study|Lack of Efficacy|2
7732208|NCT00614055|12161124|FG000|Overall Study|Unclassified|1
7732209|NCT00614055|12161125|FG001|Overall Study|Unclassified|4
7732210|NCT00614055|12161126|FG002|Overall Study|Unclassified|2
7732211|NCT00614120|12161141|FG000|Overall Study|Adverse Event|9
7732212|NCT00614120|12161142|FG001|Overall Study|Adverse Event|22
7732213|NCT00614120|12161143|FG002|Overall Study|Adverse Event|30
7732214|NCT00614120|12161144|FG003|Overall Study|Adverse Event|3
7732215|NCT00614120|12161141|FG000|Overall Study|Lack of Efficacy|3
7732216|NCT00614120|12161142|FG001|Overall Study|Lack of Efficacy|3
7732217|NCT00614120|12161143|FG002|Overall Study|Lack of Efficacy|2
7732218|NCT00614120|12161144|FG003|Overall Study|Lack of Efficacy|2
7732219|NCT00614120|12161141|FG000|Overall Study|Protocol Violation|2
7732220|NCT00614120|12161142|FG001|Overall Study|Protocol Violation|5
7732221|NCT00614120|12161143|FG002|Overall Study|Protocol Violation|3
7732222|NCT00614120|12161144|FG003|Overall Study|Protocol Violation|1
7732223|NCT00614120|12161141|FG000|Overall Study|Withdrawal criteria|1
7732224|NCT00614120|12161142|FG001|Overall Study|Withdrawal criteria|0
7732225|NCT00614120|12161143|FG002|Overall Study|Withdrawal criteria|0
7732226|NCT00614120|12161144|FG003|Overall Study|Withdrawal criteria|0
7732227|NCT00614120|12161141|FG000|Overall Study|Withdrawal by Subject|9
7732228|NCT00614120|12161142|FG001|Overall Study|Withdrawal by Subject|10
7732229|NCT00614120|12161143|FG002|Overall Study|Withdrawal by Subject|16
7732230|NCT00614120|12161144|FG003|Overall Study|Withdrawal by Subject|3
7732231|NCT00614120|12161141|FG000|Overall Study|Did not meet trial criteria|0
7732232|NCT00614120|12161142|FG001|Overall Study|Did not meet trial criteria|1
7732233|NCT00614120|12161143|FG002|Overall Study|Did not meet trial criteria|1
7732234|NCT00614120|12161144|FG003|Overall Study|Did not meet trial criteria|1
7732235|NCT00614120|12161141|FG000|Overall Study|hCG positive (not pregnant)|0
7732236|NCT00614120|12161142|FG001|Overall Study|hCG positive (not pregnant)|0
7732237|NCT00614120|12161143|FG002|Overall Study|hCG positive (not pregnant)|1
7732238|NCT00614120|12161144|FG003|Overall Study|hCG positive (not pregnant)|0
7732239|NCT00614120|12161141|FG000|Overall Study|Hypoglycaemia|0
7732240|NCT00614120|12161142|FG001|Overall Study|Hypoglycaemia|0
7732241|NCT00614120|12161143|FG002|Overall Study|Hypoglycaemia|0
7732242|NCT00614120|12161144|FG003|Overall Study|Hypoglycaemia|1
7732243|NCT00614120|12161141|FG000|Overall Study|Lack of trial product|3
7732244|NCT00614120|12161142|FG001|Overall Study|Lack of trial product|3
7732245|NCT00614120|12161143|FG002|Overall Study|Lack of trial product|2
7732246|NCT00614120|12161144|FG003|Overall Study|Lack of trial product|0
7732247|NCT00614120|12161141|FG000|Overall Study|Late syphilis, latent|1
7732248|NCT00614120|12161142|FG001|Overall Study|Late syphilis, latent|0
7732249|NCT00614120|12161143|FG002|Overall Study|Late syphilis, latent|0
7732250|NCT00614120|12161144|FG003|Overall Study|Late syphilis, latent|0
7732251|NCT00614120|12161141|FG000|Overall Study|Taken inhibition medication eg Prandin|0
7732252|NCT00614120|12161142|FG001|Overall Study|Taken inhibition medication eg Prandin|0
7732253|NCT00614120|12161143|FG002|Overall Study|Taken inhibition medication eg Prandin|1
7732254|NCT00614120|12161144|FG003|Overall Study|Taken inhibition medication eg Prandin|1
7732255|NCT00614120|12161141|FG000|Overall Study|Lost to Follow-up|1
7732256|NCT00614120|12161142|FG001|Overall Study|Lost to Follow-up|2
7732257|NCT00614120|12161143|FG002|Overall Study|Lost to Follow-up|3
7732258|NCT00614120|12161144|FG003|Overall Study|Lost to Follow-up|4
7732259|NCT00614380|12161171|FG000|Overall Study|Adverse Event|14
7732260|NCT00614380|12161172|FG001|Overall Study|Adverse Event|4
7732261|NCT00614380|12161173|FG002|Overall Study|Adverse Event|0
7732262|NCT00614380|12161174|FG003|Overall Study|Adverse Event|0
7732263|NCT00614380|12161171|FG000|Overall Study|Lost to Follow-up|6
7732264|NCT00614380|12161172|FG001|Overall Study|Lost to Follow-up|1
7732265|NCT00614380|12161173|FG002|Overall Study|Lost to Follow-up|0
7732266|NCT00614380|12161174|FG003|Overall Study|Lost to Follow-up|0
7732267|NCT00614380|12161171|FG000|Overall Study|Non compliant with the protocol|12
7732268|NCT00614380|12161172|FG001|Overall Study|Non compliant with the protocol|2
7732269|NCT00614380|12161173|FG002|Overall Study|Non compliant with the protocol|1
7732270|NCT00614380|12161174|FG003|Overall Study|Non compliant with the protocol|2
7732271|NCT00614380|12161171|FG000|Overall Study|Consent withdrawn|3
7732272|NCT00614380|12161172|FG001|Overall Study|Consent withdrawn|1
7732273|NCT00614380|12161173|FG002|Overall Study|Consent withdrawn|0
7732274|NCT00614380|12161174|FG003|Overall Study|Consent withdrawn|0
7732275|NCT00614393|12161194|FG000|Overall Study|Adverse Event|20
7732276|NCT00614393|12161195|FG001|Overall Study|Adverse Event|2
7732277|NCT00614393|12161196|FG002|Overall Study|Adverse Event|3
7732278|NCT00614393|12161197|FG003|Overall Study|Adverse Event|13
7732279|NCT00614393|12161198|FG004|Overall Study|Adverse Event|21
7732280|NCT00614393|12161194|FG000|Overall Study|Lost to Follow-up|0
7732281|NCT00614393|12161195|FG001|Overall Study|Lost to Follow-up|0
7732282|NCT00614393|12161196|FG002|Overall Study|Lost to Follow-up|0
7732283|NCT00614393|12161197|FG003|Overall Study|Lost to Follow-up|1
7732284|NCT00614393|12161198|FG004|Overall Study|Lost to Follow-up|2
7732285|NCT00614393|12161194|FG000|Overall Study|Physician Decision|17
7732286|NCT00614393|12161195|FG001|Overall Study|Physician Decision|0
7732287|NCT00614393|12161196|FG002|Overall Study|Physician Decision|1
7732288|NCT00614393|12161197|FG003|Overall Study|Physician Decision|8
7732289|NCT00614393|12161198|FG004|Overall Study|Physician Decision|9
7732290|NCT00614393|12161194|FG000|Overall Study|Progressive Disease|118
7732291|NCT00614393|12161195|FG001|Overall Study|Progressive Disease|5
7732292|NCT00614393|12161196|FG002|Overall Study|Progressive Disease|5
7732293|NCT00614393|12161197|FG003|Overall Study|Progressive Disease|138
7732294|NCT00614393|12161198|FG004|Overall Study|Progressive Disease|130
7732295|NCT00614393|12161194|FG000|Overall Study|Protocol Violation|1
7732296|NCT00614393|12161195|FG001|Overall Study|Protocol Violation|0
7732297|NCT00614393|12161196|FG002|Overall Study|Protocol Violation|0
7732298|NCT00614393|12161197|FG003|Overall Study|Protocol Violation|0
7732299|NCT00614393|12161198|FG004|Overall Study|Protocol Violation|0
7732300|NCT00614393|12161194|FG000|Overall Study|Terminated by Sponsor|0
7732301|NCT00614393|12161195|FG001|Overall Study|Terminated by Sponsor|0
7732302|NCT00614393|12161196|FG002|Overall Study|Terminated by Sponsor|0
7732303|NCT00614393|12161197|FG003|Overall Study|Terminated by Sponsor|0
7732304|NCT00614393|12161198|FG004|Overall Study|Terminated by Sponsor|1
7732305|NCT00614393|12161194|FG000|Overall Study|Withdrawal by Subject|20
7732306|NCT00614393|12161195|FG001|Overall Study|Withdrawal by Subject|1
7732307|NCT00614393|12161196|FG002|Overall Study|Withdrawal by Subject|1
7732308|NCT00614393|12161197|FG003|Overall Study|Withdrawal by Subject|16
7732309|NCT00614393|12161198|FG004|Overall Study|Withdrawal by Subject|13
7732310|NCT00614393|12161194|FG000|Overall Study|Other|4
7732311|NCT00614393|12161195|FG001|Overall Study|Other|0
7732312|NCT00614393|12161196|FG002|Overall Study|Other|0
7732313|NCT00614393|12161197|FG003|Overall Study|Other|4
7732314|NCT00614393|12161198|FG004|Overall Study|Other|2
7732315|NCT00614393|12161194|FG000|Overall Study|Not Treated|0
7732316|NCT00614393|12161195|FG001|Overall Study|Not Treated|0
7732317|NCT00614393|12161196|FG002|Overall Study|Not Treated|0
7732318|NCT00614393|12161197|FG003|Overall Study|Not Treated|0
7732319|NCT00614393|12161198|FG004|Overall Study|Not Treated|2
7732320|NCT00614523|12161239|FG000|Overall Study|Adverse Event|4
7732321|NCT00614523|12161240|FG001|Overall Study|Adverse Event|20
7732322|NCT00614523|12161239|FG000|Overall Study|Death|5
7732323|NCT00614523|12161240|FG001|Overall Study|Death|8
7732324|NCT00614523|12161239|FG000|Overall Study|Lack of Efficacy|9
7732325|NCT00614523|12161240|FG001|Overall Study|Lack of Efficacy|11
7732326|NCT00614523|12161239|FG000|Overall Study|Lost to Follow-up|0
7732327|NCT00614523|12161240|FG001|Overall Study|Lost to Follow-up|1
7732328|NCT00614523|12161239|FG000|Overall Study|Protocol Violation|3
7732329|NCT00614523|12161240|FG001|Overall Study|Protocol Violation|2
7732330|NCT00614523|12161239|FG000|Overall Study|Withdrawal by Subject|12
7732331|NCT00614523|12161240|FG001|Overall Study|Withdrawal by Subject|22
7732332|NCT00614523|12161239|FG000|Overall Study|Other|6
7732333|NCT00614523|12161240|FG001|Overall Study|Other|11
7732334|NCT00614523|12161239|FG000|Overall Study|Ineligibility Determined|1
7732335|NCT00614523|12161240|FG001|Overall Study|Ineligibility Determined|2
7732336|NCT00614523|12161239|FG000|Overall Study|Disease Progression|0
7732337|NCT00614523|12161240|FG001|Overall Study|Disease Progression|8
7732338|NCT00614523|12161239|FG000|Overall Study|Administrative Decision|23
7732339|NCT00614523|12161240|FG001|Overall Study|Administrative Decision|46
7732340|NCT00614575|12161246|FG000|Overall Study|Adverse Event|106
7732341|NCT00614575|12161246|FG000|Overall Study|Lost to Follow-up|55
7732342|NCT00614575|12161246|FG000|Overall Study|Lack of Efficacy|14
7732343|NCT00614575|12161246|FG000|Overall Study|Withdrawal by Subject|6
7732344|NCT00614575|12161246|FG000|Overall Study|Death|3
7732345|NCT00614575|12161246|FG000|Overall Study|Physician Decision|2
7732346|NCT00614575|12161246|FG000|Overall Study|No data were collected.|18
7732347|NCT00614575|12161246|FG000|Overall Study|Irregularly enrolled patients|23
7732348|NCT00614575|12161246|FG000|Overall Study|No treatment|1
7732349|NCT00614614|12161252|FG000|Primary Vaccination Phase|Adverse Event|6
7732350|NCT00614614|12161253|FG001|Primary Vaccination Phase|Adverse Event|0
7732351|NCT00614614|12161254|FG002|Primary Vaccination Phase|Adverse Event|0
7732352|NCT00614614|12161255|FG003|Primary Vaccination Phase|Adverse Event|0
7732353|NCT00614614|12161256|FG004|Primary Vaccination Phase|Adverse Event|0
7732354|NCT00614614|12161252|FG000|Primary Vaccination Phase|Withdrawal by Subject|45
7732355|NCT00614614|12161253|FG001|Primary Vaccination Phase|Withdrawal by Subject|6
7732356|NCT00614614|12161254|FG002|Primary Vaccination Phase|Withdrawal by Subject|0
7732357|NCT00614614|12161255|FG003|Primary Vaccination Phase|Withdrawal by Subject|0
7732358|NCT00614614|12161256|FG004|Primary Vaccination Phase|Withdrawal by Subject|0
7732359|NCT00614614|12161252|FG000|Primary Vaccination Phase|Lost to Follow-up|26
7732360|NCT00614614|12161253|FG001|Primary Vaccination Phase|Lost to Follow-up|8
7732361|NCT00614614|12161254|FG002|Primary Vaccination Phase|Lost to Follow-up|0
7732362|NCT00614614|12161255|FG003|Primary Vaccination Phase|Lost to Follow-up|0
7732363|NCT00614614|12161256|FG004|Primary Vaccination Phase|Lost to Follow-up|0
7732364|NCT00614614|12161252|FG000|Primary Vaccination Phase|Protocol Violation|9
7732365|NCT00614614|12161253|FG001|Primary Vaccination Phase|Protocol Violation|3
7732366|NCT00614614|12161254|FG002|Primary Vaccination Phase|Protocol Violation|0
7732367|NCT00614614|12161255|FG003|Primary Vaccination Phase|Protocol Violation|0
7732368|NCT00614614|12161256|FG004|Primary Vaccination Phase|Protocol Violation|0
7732369|NCT00614614|12161252|FG000|Primary Vaccination Phase|Other|4
7732370|NCT00614614|12161253|FG001|Primary Vaccination Phase|Other|0
7732371|NCT00614614|12161254|FG002|Primary Vaccination Phase|Other|0
7732372|NCT00614614|12161255|FG003|Primary Vaccination Phase|Other|0
7732373|NCT00614614|12161256|FG004|Primary Vaccination Phase|Other|0
7732374|NCT00614614|12161252|FG000|Booster Vaccination Phase|Adverse Event|0
7732375|NCT00614614|12161253|FG001|Booster Vaccination Phase|Adverse Event|0
7732376|NCT00614614|12161254|FG002|Booster Vaccination Phase|Adverse Event|1
7732377|NCT00614614|12161255|FG003|Booster Vaccination Phase|Adverse Event|1
7732378|NCT00614614|12161256|FG004|Booster Vaccination Phase|Adverse Event|0
7732379|NCT00614614|12161252|FG000|Booster Vaccination Phase|Withdrawal by Subject|0
7732380|NCT00614614|12161253|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
7732381|NCT00614614|12161254|FG002|Booster Vaccination Phase|Withdrawal by Subject|4
7732382|NCT00614614|12161255|FG003|Booster Vaccination Phase|Withdrawal by Subject|3
7732383|NCT00614614|12161256|FG004|Booster Vaccination Phase|Withdrawal by Subject|4
7732384|NCT00614614|12161252|FG000|Booster Vaccination Phase|Lost to Follow-up|0
7732385|NCT00614614|12161253|FG001|Booster Vaccination Phase|Lost to Follow-up|5
7732386|NCT00614614|12161254|FG002|Booster Vaccination Phase|Lost to Follow-up|17
7732387|NCT00614614|12161255|FG003|Booster Vaccination Phase|Lost to Follow-up|10
7732388|NCT00614614|12161256|FG004|Booster Vaccination Phase|Lost to Follow-up|8
7732389|NCT00614614|12161252|FG000|Booster Vaccination Phase|Protocol Violation|0
7732390|NCT00614614|12161253|FG001|Booster Vaccination Phase|Protocol Violation|0
7732391|NCT00614614|12161254|FG002|Booster Vaccination Phase|Protocol Violation|2
7732392|NCT00614614|12161255|FG003|Booster Vaccination Phase|Protocol Violation|3
7732393|NCT00614614|12161256|FG004|Booster Vaccination Phase|Protocol Violation|0
7732394|NCT00614614|12161252|FG000|Booster Vaccination Phase|Other|0
7732395|NCT00614614|12161253|FG001|Booster Vaccination Phase|Other|1
7732396|NCT00614614|12161254|FG002|Booster Vaccination Phase|Other|3
7732397|NCT00614614|12161255|FG003|Booster Vaccination Phase|Other|2
7732398|NCT00614614|12161256|FG004|Booster Vaccination Phase|Other|1
7732399|NCT00614744|12161273|FG000|Overall Study|Lost to Follow-up|5
7732400|NCT00614744|12161274|FG001|Overall Study|Lost to Follow-up|4
7732401|NCT00614744|12161273|FG000|Overall Study|Incomplete for Behavior Issues|0
7732402|NCT00614744|12161274|FG001|Overall Study|Incomplete for Behavior Issues|2
7732403|NCT00614822|12161280|FG000|Overall Study|Adverse Event|3
7732404|NCT00614874|12161285|FG000|Overall Study|Protocol Violation|1
7732405|NCT00614874|12161285|FG000|Overall Study|Withdrawal by Subject|1
7732406|NCT00614926|12161295|FG000|Overall Study|Burden of travel|1
7732407|NCT00614926|12161296|FG001|Overall Study|Burden of travel|0
7732408|NCT00614926|12161295|FG000|Overall Study|Adverse Event|3
7732409|NCT00614926|12161296|FG001|Overall Study|Adverse Event|0
7732410|NCT00614939|12161304|FG000|Overall Study|Withdrawal by Subject|10
7732411|NCT00614939|12161305|FG001|Overall Study|Withdrawal by Subject|17
7732412|NCT00614939|12161304|FG000|Overall Study|Study specific discontinuation criteris|13
7732413|NCT00614939|12161305|FG001|Overall Study|Study specific discontinuation criteris|16
7732414|NCT00614939|12161304|FG000|Overall Study|Adverse Event|2
7732415|NCT00614939|12161305|FG001|Overall Study|Adverse Event|5
7732416|NCT00614939|12161304|FG000|Overall Study|Incorrect enrollment|1
7732417|NCT00614939|12161305|FG001|Overall Study|Incorrect enrollment|2
7732418|NCT00614939|12161304|FG000|Overall Study|Death|4
7732419|NCT00614939|12161305|FG001|Overall Study|Death|3
7732420|NCT00614939|12161304|FG000|Overall Study|Poor/non-compliance|4
7732421|NCT00614939|12161305|FG001|Overall Study|Poor/non-compliance|0
7732422|NCT00614939|12161304|FG000|Overall Study|Hospitalized due to kidney transplant|1
7732423|NCT00614939|12161305|FG001|Overall Study|Hospitalized due to kidney transplant|0
7732424|NCT00614991|12161317|FG000|Overall Study|Adverse Event|3
7732425|NCT00614991|12161318|FG001|Overall Study|Adverse Event|3
7732426|NCT00614991|12161319|FG002|Overall Study|Adverse Event|0
7732427|NCT00614991|12161320|FG003|Overall Study|Adverse Event|0
7732428|NCT00614991|12161321|FG004|Overall Study|Adverse Event|1
7732429|NCT00614991|12161322|FG005|Overall Study|Adverse Event|0
7732430|NCT00615017|12161347|FG000|Overall Study|Adverse Event|0
7732431|NCT00615017|12161348|FG001|Overall Study|Adverse Event|1
7732432|NCT00615017|12161349|FG002|Overall Study|Adverse Event|2
7732433|NCT00615017|12161350|FG003|Overall Study|Adverse Event|0
7732434|NCT00615017|12161351|FG004|Overall Study|Adverse Event|0
7732435|NCT00615017|12161352|FG005|Overall Study|Adverse Event|1
7732436|NCT00615017|12161347|FG000|Overall Study|Death|0
7732437|NCT00615017|12161348|FG001|Overall Study|Death|0
7732438|NCT00615017|12161349|FG002|Overall Study|Death|2
7732439|NCT00615017|12161350|FG003|Overall Study|Death|0
7732440|NCT00615017|12161351|FG004|Overall Study|Death|1
7732441|NCT00615017|12161352|FG005|Overall Study|Death|1
7732442|NCT00615017|12161347|FG000|Overall Study|Sepsis resolved|0
7732443|NCT00615017|12161348|FG001|Overall Study|Sepsis resolved|0
7732444|NCT00615017|12161349|FG002|Overall Study|Sepsis resolved|1
7732445|NCT00615017|12161350|FG003|Overall Study|Sepsis resolved|0
7732446|NCT00615017|12161351|FG004|Overall Study|Sepsis resolved|0
7732447|NCT00615017|12161352|FG005|Overall Study|Sepsis resolved|0
7732448|NCT00615017|12161347|FG000|Overall Study|Transferred out of Intensive Care Unit|0
7732449|NCT00615017|12161348|FG001|Overall Study|Transferred out of Intensive Care Unit|0
7732450|NCT00615017|12161349|FG002|Overall Study|Transferred out of Intensive Care Unit|0
7732451|NCT00615017|12161350|FG003|Overall Study|Transferred out of Intensive Care Unit|1
7732452|NCT00615017|12161351|FG004|Overall Study|Transferred out of Intensive Care Unit|0
7732453|NCT00615017|12161352|FG005|Overall Study|Transferred out of Intensive Care Unit|0
7732454|NCT00615017|12161347|FG000|Overall Study|Physician discontinued drug|0
7732455|NCT00615017|12161348|FG001|Overall Study|Physician discontinued drug|0
7732456|NCT00615017|12161349|FG002|Overall Study|Physician discontinued drug|0
7732457|NCT00615017|12161350|FG003|Overall Study|Physician discontinued drug|0
7732458|NCT00615017|12161351|FG004|Overall Study|Physician discontinued drug|0
7732459|NCT00615017|12161352|FG005|Overall Study|Physician discontinued drug|1
7732460|NCT00615030|12161366|FG000|Period I|Administrative problem|0
7732461|NCT00615030|12161367|FG001|Period I|Administrative problem|0
7732462|NCT00615030|12161368|FG002|Period I|Administrative problem|0
7732463|NCT00615030|12161369|FG003|Period I|Administrative problem|0
7732464|NCT00615030|12161370|FG004|Period I|Administrative problem|1
7732465|NCT00615030|12161371|FG005|Period I|Administrative problem|0
7732466|NCT00615030|12161372|FG006|Period I|Administrative problem|0
7732467|NCT00615030|12161373|FG007|Period I|Administrative problem|0
7732468|NCT00615030|12161374|FG008|Period I|Administrative problem|0
7732469|NCT00615030|12161375|FG009|Period I|Administrative problem|0
7732470|NCT00615030|12161376|FG010|Period I|Administrative problem|0
7732471|NCT00615030|12161377|FG011|Period I|Administrative problem|0
7732472|NCT00615030|12161366|FG000|Period I|Protocol deviation|1
7732473|NCT00615030|12161367|FG001|Period I|Protocol deviation|0
7732474|NCT00615030|12161368|FG002|Period I|Protocol deviation|0
7732475|NCT00615030|12161369|FG003|Period I|Protocol deviation|0
7732476|NCT00615030|12161370|FG004|Period I|Protocol deviation|0
7732477|NCT00615030|12161371|FG005|Period I|Protocol deviation|0
7732478|NCT00615030|12161372|FG006|Period I|Protocol deviation|0
7732479|NCT00615030|12161373|FG007|Period I|Protocol deviation|0
7732480|NCT00615030|12161374|FG008|Period I|Protocol deviation|0
7732481|NCT00615030|12161375|FG009|Period I|Protocol deviation|0
7732482|NCT00615030|12161376|FG010|Period I|Protocol deviation|0
7732483|NCT00615030|12161377|FG011|Period I|Protocol deviation|0
7732484|NCT00615030|12161366|FG000|Period I|Subject withdrew consent|0
7732485|NCT00615030|12161367|FG001|Period I|Subject withdrew consent|0
7732486|NCT00615030|12161368|FG002|Period I|Subject withdrew consent|0
7732487|NCT00615030|12161369|FG003|Period I|Subject withdrew consent|0
7732488|NCT00615030|12161370|FG004|Period I|Subject withdrew consent|0
7732489|NCT00615030|12161371|FG005|Period I|Subject withdrew consent|0
7732490|NCT00615030|12161372|FG006|Period I|Subject withdrew consent|0
7732491|NCT00615030|12161373|FG007|Period I|Subject withdrew consent|0
7732492|NCT00615030|12161374|FG008|Period I|Subject withdrew consent|1
7732493|NCT00615030|12161375|FG009|Period I|Subject withdrew consent|0
7732494|NCT00615030|12161376|FG010|Period I|Subject withdrew consent|1
7732495|NCT00615030|12161377|FG011|Period I|Subject withdrew consent|1
7732496|NCT00615030|12161366|FG000|Period I|Abnormal laboratory value(s)|0
7732497|NCT00615030|12161367|FG001|Period I|Abnormal laboratory value(s)|0
7732498|NCT00615030|12161368|FG002|Period I|Abnormal laboratory value(s)|0
7732499|NCT00615030|12161369|FG003|Period I|Abnormal laboratory value(s)|0
7732500|NCT00615030|12161370|FG004|Period I|Abnormal laboratory value(s)|0
7732501|NCT00615030|12161371|FG005|Period I|Abnormal laboratory value(s)|1
7732502|NCT00615030|12161372|FG006|Period I|Abnormal laboratory value(s)|0
7732503|NCT00615030|12161373|FG007|Period I|Abnormal laboratory value(s)|0
7732504|NCT00615030|12161374|FG008|Period I|Abnormal laboratory value(s)|0
7732505|NCT00615030|12161375|FG009|Period I|Abnormal laboratory value(s)|0
7732506|NCT00615030|12161376|FG010|Period I|Abnormal laboratory value(s)|0
7732507|NCT00615030|12161377|FG011|Period I|Abnormal laboratory value(s)|0
7732508|NCT00615030|12161366|FG000|Period II|Adverse Event|0
7732509|NCT00615030|12161367|FG001|Period II|Adverse Event|0
7732510|NCT00615030|12161368|FG002|Period II|Adverse Event|1
7732511|NCT00615030|12161369|FG003|Period II|Adverse Event|0
7732512|NCT00615030|12161370|FG004|Period II|Adverse Event|0
7732513|NCT00615030|12161371|FG005|Period II|Adverse Event|0
7732514|NCT00615030|12161372|FG006|Period II|Adverse Event|0
7732515|NCT00615030|12161373|FG007|Period II|Adverse Event|0
7732516|NCT00615030|12161374|FG008|Period II|Adverse Event|1
7732517|NCT00615030|12161375|FG009|Period II|Adverse Event|0
7732518|NCT00615030|12161376|FG010|Period II|Adverse Event|0
7732519|NCT00615030|12161377|FG011|Period II|Adverse Event|0
7732520|NCT00615030|12161366|FG000|Period II|Subject withdrew consent|0
7732521|NCT00615030|12161367|FG001|Period II|Subject withdrew consent|0
7732522|NCT00615030|12161368|FG002|Period II|Subject withdrew consent|0
7732523|NCT00615030|12161369|FG003|Period II|Subject withdrew consent|1
7732524|NCT00615030|12161370|FG004|Period II|Subject withdrew consent|0
7732525|NCT00615030|12161371|FG005|Period II|Subject withdrew consent|0
7732526|NCT00615030|12161372|FG006|Period II|Subject withdrew consent|1
7732527|NCT00615030|12161373|FG007|Period II|Subject withdrew consent|0
7732528|NCT00615030|12161374|FG008|Period II|Subject withdrew consent|0
7732529|NCT00615030|12161375|FG009|Period II|Subject withdrew consent|0
7732530|NCT00615030|12161376|FG010|Period II|Subject withdrew consent|0
7732531|NCT00615030|12161377|FG011|Period II|Subject withdrew consent|0
7732532|NCT00615030|12161366|FG000|Period III|Administrative problems|1
7732533|NCT00615030|12161367|FG001|Period III|Administrative problems|0
7732534|NCT00615030|12161368|FG002|Period III|Administrative problems|0
7732535|NCT00615030|12161369|FG003|Period III|Administrative problems|1
7732536|NCT00615030|12161370|FG004|Period III|Administrative problems|0
7732537|NCT00615030|12161371|FG005|Period III|Administrative problems|0
7732538|NCT00615030|12161372|FG006|Period III|Administrative problems|0
7732539|NCT00615030|12161373|FG007|Period III|Administrative problems|0
7732540|NCT00615030|12161374|FG008|Period III|Administrative problems|0
7732541|NCT00615030|12161375|FG009|Period III|Administrative problems|0
7732542|NCT00615030|12161376|FG010|Period III|Administrative problems|0
7732543|NCT00615030|12161377|FG011|Period III|Administrative problems|0
7732544|NCT00615056|12161395|FG000|Overall Study|Death|31
7732545|NCT00615056|12161396|FG001|Overall Study|Death|31
7732546|NCT00615056|12161397|FG002|Overall Study|Death|21
7732547|NCT00615056|12161398|FG003|Overall Study|Death|23
7732548|NCT00615056|12161395|FG000|Overall Study|Lost to Follow-up|1
7732549|NCT00615056|12161396|FG001|Overall Study|Lost to Follow-up|2
7732550|NCT00615056|12161397|FG002|Overall Study|Lost to Follow-up|4
7732551|NCT00615056|12161398|FG003|Overall Study|Lost to Follow-up|5
7732552|NCT00615056|12161395|FG000|Overall Study|Other|13
7732553|NCT00615056|12161396|FG001|Overall Study|Other|15
7732554|NCT00615056|12161397|FG002|Overall Study|Other|10
7732555|NCT00615056|12161398|FG003|Overall Study|Other|7
7732556|NCT00615056|12161395|FG000|Overall Study|Objective progression or relapse|0
7732557|NCT00615056|12161396|FG001|Overall Study|Objective progression or relapse|2
7732558|NCT00615056|12161397|FG002|Overall Study|Objective progression or relapse|0
7732559|NCT00615056|12161398|FG003|Overall Study|Objective progression or relapse|0
7732560|NCT00615056|12161395|FG000|Overall Study|Withdrawal by Subject|0
7732561|NCT00615056|12161396|FG001|Overall Study|Withdrawal by Subject|1
7732562|NCT00615056|12161397|FG002|Overall Study|Withdrawal by Subject|1
7732563|NCT00615056|12161398|FG003|Overall Study|Withdrawal by Subject|0
7732564|NCT00615056|12161395|FG000|Overall Study|Discontinued by Sponsor|1
7732565|NCT00615056|12161396|FG001|Overall Study|Discontinued by Sponsor|0
7732566|NCT00615056|12161397|FG002|Overall Study|Discontinued by Sponsor|0
7732567|NCT00615056|12161398|FG003|Overall Study|Discontinued by Sponsor|0
7732568|NCT00615056|12161395|FG000|Overall Study|Randomized but not treated|3
7732569|NCT00615056|12161396|FG001|Overall Study|Randomized but not treated|0
7732570|NCT00615056|12161397|FG002|Overall Study|Randomized but not treated|0
7732571|NCT00615056|12161398|FG003|Overall Study|Randomized but not treated|0
7732572|NCT00615069|12161408|FG000|Overall Study|Death|10
7732573|NCT00615069|12161408|FG000|Overall Study|Physician Decision|2
7732574|NCT00615069|12161408|FG000|Overall Study|Withdrawal by Subject|4
7732575|NCT00615108|12161412|FG000|Overall Study|Adverse Event|122
7732576|NCT00615108|12161412|FG000|Overall Study|Other|370
7732577|NCT00615108|12161412|FG000|Overall Study|Lost to Follow-up|15
7732578|NCT00615199|12161422|FG000|Overall Study|Adverse Event|3
7732579|NCT00615199|12161423|FG001|Overall Study|Adverse Event|1
7732580|NCT00615199|12161424|FG002|Overall Study|Adverse Event|1
7732581|NCT00615199|12161425|FG003|Overall Study|Adverse Event|0
7732582|NCT00615199|12161422|FG000|Overall Study|Lack of Efficacy|2
7732583|NCT00615199|12161423|FG001|Overall Study|Lack of Efficacy|0
7732584|NCT00615199|12161424|FG002|Overall Study|Lack of Efficacy|0
7732585|NCT00615199|12161425|FG003|Overall Study|Lack of Efficacy|1
7732586|NCT00615199|12161422|FG000|Overall Study|Lost to Follow-up|1
7732587|NCT00615199|12161423|FG001|Overall Study|Lost to Follow-up|0
7732588|NCT00615199|12161424|FG002|Overall Study|Lost to Follow-up|0
7732589|NCT00615199|12161425|FG003|Overall Study|Lost to Follow-up|0
7732590|NCT00615199|12161422|FG000|Overall Study|Other|0
7732591|NCT00615199|12161423|FG001|Overall Study|Other|0
7732592|NCT00615199|12161424|FG002|Overall Study|Other|0
7732593|NCT00615199|12161425|FG003|Overall Study|Other|1
7732594|NCT00615199|12161422|FG000|Overall Study|Withdrawal by Subject|2
7732595|NCT00615199|12161423|FG001|Overall Study|Withdrawal by Subject|1
7732596|NCT00615199|12161424|FG002|Overall Study|Withdrawal by Subject|0
7732597|NCT00615199|12161425|FG003|Overall Study|Withdrawal by Subject|0
7732598|NCT00615264|12161437|FG000|Overall Study|Withdrawal by Subject|17
7732599|NCT00615264|12161438|FG001|Overall Study|Withdrawal by Subject|19
7732600|NCT00615264|12161437|FG000|Overall Study|Lost to Follow-up|6
7732601|NCT00615264|12161438|FG001|Overall Study|Lost to Follow-up|13
7732602|NCT00615264|12161437|FG000|Overall Study|Adverse Event|8
7732603|NCT00615264|12161438|FG001|Overall Study|Adverse Event|5
7732604|NCT00615264|12161437|FG000|Overall Study|Death|1
7732605|NCT00615264|12161438|FG001|Overall Study|Death|1
7732606|NCT00615264|12161437|FG000|Overall Study|Protocol Violation|11
7732607|NCT00615264|12161438|FG001|Overall Study|Protocol Violation|7
7732608|NCT00615264|12161437|FG000|Overall Study|Not defined|7
7732609|NCT00615264|12161438|FG001|Overall Study|Not defined|4
7732610|NCT00615264|12161437|FG000|Overall Study|Dermal Hypersensitivity|0
7732611|NCT00615264|12161438|FG001|Overall Study|Dermal Hypersensitivity|3
7732612|NCT00615290|12161444|FG000|Overall Study|Adverse Event|2
7732613|NCT00615290|12161444|FG000|Overall Study|Lost to Follow-up|3
7732614|NCT00615290|12161444|FG000|Overall Study|Withdrawal by Subject|1
7732615|NCT00615290|12161444|FG000|Overall Study|Other|2
7732616|NCT00615459|12161475|FG000|Period I|Adverse Event|2
7732617|NCT00615459|12161476|FG001|Period I|Adverse Event|0
7732618|NCT00615459|12161477|FG002|Period I|Adverse Event|1
7732619|NCT00615459|12161478|FG003|Period I|Adverse Event|0
7732620|NCT00615459|12161475|FG000|Period I|Subject withdrew consent|1
7732621|NCT00615459|12161476|FG001|Period I|Subject withdrew consent|0
7732622|NCT00615459|12161477|FG002|Period I|Subject withdrew consent|0
7732623|NCT00615459|12161478|FG003|Period I|Subject withdrew consent|1
7732624|NCT00615459|12161475|FG000|Period I|Abnormal test procedure results|1
7732625|NCT00615459|12161476|FG001|Period I|Abnormal test procedure results|1
7732626|NCT00615459|12161477|FG002|Period I|Abnormal test procedure results|1
7732627|NCT00615459|12161478|FG003|Period I|Abnormal test procedure results|0
7732628|NCT00615459|12161475|FG000|Period II|Adverse Event|1
7732629|NCT00615459|12161476|FG001|Period II|Adverse Event|0
7732630|NCT00615459|12161477|FG002|Period II|Adverse Event|0
7732631|NCT00615459|12161478|FG003|Period II|Adverse Event|0
7732632|NCT00615459|12161475|FG000|Period II|Lost to Follow-up|0
7732633|NCT00615459|12161476|FG001|Period II|Lost to Follow-up|0
7732634|NCT00615459|12161477|FG002|Period II|Lost to Follow-up|0
7732635|NCT00615459|12161478|FG003|Period II|Lost to Follow-up|1
7732636|NCT00615459|12161475|FG000|Period III|Adverse Event|0
7732637|NCT00615459|12161476|FG001|Period III|Adverse Event|1
7732638|NCT00615459|12161477|FG002|Period III|Adverse Event|0
7732639|NCT00615459|12161478|FG003|Period III|Adverse Event|0
7732640|NCT00615459|12161475|FG000|Period III|Administrative problems|0
7732641|NCT00615459|12161476|FG001|Period III|Administrative problems|1
7732642|NCT00615459|12161477|FG002|Period III|Administrative problems|1
7732643|NCT00615459|12161478|FG003|Period III|Administrative problems|0
7732644|NCT00615459|12161475|FG000|Period III|Unsatisfactory therapeutic effect|0
7732645|NCT00615459|12161476|FG001|Period III|Unsatisfactory therapeutic effect|1
7732646|NCT00615459|12161477|FG002|Period III|Unsatisfactory therapeutic effect|0
7732647|NCT00615459|12161478|FG003|Period III|Unsatisfactory therapeutic effect|0
7732648|NCT00615550|12161499|FG000|Overall Study|Lost to Follow-up|6
7732649|NCT00615550|12161500|FG001|Overall Study|Lost to Follow-up|1
7732650|NCT00615719|12161511|FG000|Overall Study|Physician Decision|5
7732651|NCT00615836|12161523|FG000|Extension Study (FE992026 CS31)|Adverse Event|7
7732652|NCT00615836|12161524|FG001|Extension Study (FE992026 CS31)|Adverse Event|12
7732653|NCT00615836|12161525|FG002|Extension Study (FE992026 CS31)|Adverse Event|15
7732654|NCT00615836|12161526|FG003|Extension Study (FE992026 CS31)|Adverse Event|13
7732655|NCT00615836|12161527|FG004|Extension Study (FE992026 CS31)|Adverse Event|0
7732656|NCT00615836|12161523|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
7732657|NCT00615836|12161524|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
7732658|NCT00615836|12161525|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
7732659|NCT00615836|12161526|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
7732660|NCT00615836|12161527|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
7732661|NCT00615836|12161523|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
7732662|NCT00615836|12161524|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
7732663|NCT00615836|12161525|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
7732664|NCT00615836|12161526|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
7732665|NCT00615836|12161527|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
7732666|NCT00615836|12161523|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4
7732667|NCT00615836|12161524|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5
7732668|NCT00615836|12161525|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2
7732669|NCT00615836|12161526|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3
7732670|NCT00615836|12161527|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0
7732671|NCT00615836|12161523|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
7732672|NCT00615836|12161524|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
7732673|NCT00615836|12161525|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
7732674|NCT00615836|12161526|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
7732675|NCT00615836|12161527|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
7732676|NCT00615836|12161523|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10
7732677|NCT00615836|12161524|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14
7732678|NCT00615836|12161525|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5
7732679|NCT00615836|12161526|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10
7732680|NCT00615836|12161527|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0
7732681|NCT00615836|12161523|FG000|Extension Study (FE992026 CS31)|Other|10
7732682|NCT00615836|12161524|FG001|Extension Study (FE992026 CS31)|Other|7
7732683|NCT00615836|12161525|FG002|Extension Study (FE992026 CS31)|Other|8
7732684|NCT00615836|12161526|FG003|Extension Study (FE992026 CS31)|Other|8
7732685|NCT00615836|12161527|FG004|Extension Study (FE992026 CS31)|Other|0
7732686|NCT00615836|12161523|FG000|Extension Study (FE992026 CS31)|Not reported|6
7732687|NCT00615836|12161524|FG001|Extension Study (FE992026 CS31)|Not reported|4
7732688|NCT00615836|12161525|FG002|Extension Study (FE992026 CS31)|Not reported|1
7732689|NCT00615836|12161526|FG003|Extension Study (FE992026 CS31)|Not reported|4
7732690|NCT00615836|12161527|FG004|Extension Study (FE992026 CS31)|Not reported|0
7732691|NCT00615836|12161523|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
7732692|NCT00615836|12161524|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
7732693|NCT00615836|12161525|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
7732694|NCT00615836|12161526|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
7732695|NCT00615836|12161527|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
7732696|NCT00615901|12161543|FG000|Overall Study|Withdrawal by Subject|2
7732697|NCT00615901|12161543|FG000|Overall Study|Adverse Event|7
7732698|NCT00615914|12161547|FG000|Overall Study|Adverse Event|274
7732699|NCT00615914|12161547|FG000|Overall Study|Death|20
7732700|NCT00615914|12161547|FG000|Overall Study|Lack of Efficacy|59
7732701|NCT00615914|12161547|FG000|Overall Study|Lost to Follow-up|187
7732702|NCT00615914|12161547|FG000|Overall Study|Withdrawal by Subject|16
7732703|NCT00615914|12161547|FG000|Overall Study|Physician Decision|4
7732704|NCT00615914|12161547|FG000|Overall Study|No data was collected.|65
7732705|NCT00615914|12161547|FG000|Overall Study|No treatment|2
7732706|NCT00615914|12161547|FG000|Overall Study|Irregularly enrolled patients|10
7732707|NCT00615992|12161561|FG000|Overall Study|Protocol Violation|67
7732708|NCT00616018|12161565|FG000|Overall Study|Protocol Violation|3
7732709|NCT00616239|12161589|FG000|Overall Study|Withdrawal by Subject|2
7732710|NCT00616421|12161596|FG000|Overall Study|Withdrawal by Subject|9
7732711|NCT00616421|12161597|FG001|Overall Study|Withdrawal by Subject|11
7732712|NCT00616421|12161598|FG002|Overall Study|Withdrawal by Subject|8
7732713|NCT00616421|12161596|FG000|Overall Study|Lost to Follow-up|12
7732714|NCT00616421|12161597|FG001|Overall Study|Lost to Follow-up|26
7732715|NCT00616421|12161598|FG002|Overall Study|Lost to Follow-up|30
7732716|NCT00616421|12161596|FG000|Overall Study|Inappropriate enrollment|3
7732717|NCT00616421|12161597|FG001|Overall Study|Inappropriate enrollment|0
7732718|NCT00616421|12161598|FG002|Overall Study|Inappropriate enrollment|1
7732719|NCT00616421|12161596|FG000|Overall Study|Administrative reason|1
7732720|NCT00616421|12161597|FG001|Overall Study|Administrative reason|0
7732721|NCT00616421|12161598|FG002|Overall Study|Administrative reason|0
7732722|NCT00616421|12161596|FG000|Overall Study|Protocol Violation|0
7732723|NCT00616421|12161597|FG001|Overall Study|Protocol Violation|1
7732724|NCT00616421|12161598|FG002|Overall Study|Protocol Violation|2
7732725|NCT00616421|12161596|FG000|Overall Study|Unable to classify|1
7732726|NCT00616421|12161597|FG001|Overall Study|Unable to classify|0
7732727|NCT00616421|12161598|FG002|Overall Study|Unable to classify|0
7732728|NCT00616434|12161622|FG000|Overall Study|Adverse Event|5
7732729|NCT00616434|12161623|FG001|Overall Study|Adverse Event|2
7732730|NCT00616434|12161622|FG000|Overall Study|Physician Decision|0
7732731|NCT00616434|12161623|FG001|Overall Study|Physician Decision|4
7732732|NCT00616434|12161622|FG000|Overall Study|Withdrawal by Subject|1
7732733|NCT00616434|12161623|FG001|Overall Study|Withdrawal by Subject|1
7732734|NCT00616434|12161622|FG000|Overall Study|Protocol deviation|0
7732735|NCT00616434|12161623|FG001|Overall Study|Protocol deviation|1
7732736|NCT00616629|12161634|FG000|Overall Study|Protocol Violation|1
7732737|NCT00616629|12161635|FG001|Overall Study|Protocol Violation|2
7732738|NCT00616629|12161636|FG002|Overall Study|Protocol Violation|1
7732739|NCT00616629|12161637|FG003|Overall Study|Protocol Violation|0
7732740|NCT00616629|12161638|FG004|Overall Study|Protocol Violation|0
7732741|NCT00616629|12161634|FG000|Overall Study|AV-block|1
7732742|NCT00616629|12161635|FG001|Overall Study|AV-block|0
7732743|NCT00616629|12161636|FG002|Overall Study|AV-block|0
7732744|NCT00616629|12161637|FG003|Overall Study|AV-block|0
7732745|NCT00616629|12161638|FG004|Overall Study|AV-block|0
7732746|NCT00616655|12161653|FG000|Overall Study|Adverse Event|10
7732747|NCT00616655|12161654|FG001|Overall Study|Adverse Event|7
7732748|NCT00616655|12161655|FG002|Overall Study|Adverse Event|12
7732749|NCT00616655|12161653|FG000|Overall Study|Lack of Efficacy|5
7732750|NCT00616655|12161654|FG001|Overall Study|Lack of Efficacy|5
7732751|NCT00616655|12161655|FG002|Overall Study|Lack of Efficacy|5
7732752|NCT00616655|12161653|FG000|Overall Study|Lost to Follow-up|3
7732753|NCT00616655|12161654|FG001|Overall Study|Lost to Follow-up|12
7732754|NCT00616655|12161655|FG002|Overall Study|Lost to Follow-up|10
7732755|NCT00616655|12161653|FG000|Overall Study|Protocol Violation|2
7732756|NCT00616655|12161654|FG001|Overall Study|Protocol Violation|4
7732757|NCT00616655|12161655|FG002|Overall Study|Protocol Violation|3
7732758|NCT00616655|12161653|FG000|Overall Study|Withdrawal by Subject|9
7732759|NCT00616655|12161654|FG001|Overall Study|Withdrawal by Subject|7
7732760|NCT00616655|12161655|FG002|Overall Study|Withdrawal by Subject|11
7732761|NCT00616655|12161653|FG000|Overall Study|Does not meet in/ex criteria|0
7732762|NCT00616655|12161654|FG001|Overall Study|Does not meet in/ex criteria|0
7732763|NCT00616655|12161655|FG002|Overall Study|Does not meet in/ex criteria|2
7732764|NCT00616655|12161653|FG000|Overall Study|Other|6
7732765|NCT00616655|12161654|FG001|Overall Study|Other|6
7732766|NCT00616655|12161655|FG002|Overall Study|Other|5
7732767|NCT00616902|12161674|FG000|Overall Study|Termination of study|6
7732768|NCT00616902|12161675|FG001|Overall Study|Termination of study|6
7732769|NCT00616928|12161685|FG000|Overall Study|Adverse Event|6
7732770|NCT00616928|12161686|FG001|Overall Study|Adverse Event|3
7732771|NCT00616928|12161687|FG002|Overall Study|Adverse Event|2
7732772|NCT00616928|12161688|FG003|Overall Study|Adverse Event|2
7732773|NCT00616928|12161685|FG000|Overall Study|Other|51
7732774|NCT00616928|12161686|FG001|Overall Study|Other|8
7732775|NCT00616928|12161687|FG002|Overall Study|Other|15
7732776|NCT00616928|12161688|FG003|Overall Study|Other|5
7732777|NCT00616928|12161685|FG000|Overall Study|Lost to Follow-up|5
7732778|NCT00616928|12161686|FG001|Overall Study|Lost to Follow-up|7
7732779|NCT00616928|12161687|FG002|Overall Study|Lost to Follow-up|0
7732780|NCT00616928|12161688|FG003|Overall Study|Lost to Follow-up|0
7732781|NCT00616941|12161713|FG000|Overall Study|Progressive Disease|1
7732782|NCT00616941|12161714|FG001|Overall Study|Progressive Disease|2
7732783|NCT00616941|12161715|FG002|Overall Study|Progressive Disease|1
7732784|NCT00616941|12161713|FG000|Overall Study|Adverse Event|0
7732785|NCT00616941|12161714|FG001|Overall Study|Adverse Event|1
7732786|NCT00616941|12161715|FG002|Overall Study|Adverse Event|1
7732787|NCT00616941|12161713|FG000|Overall Study|Subject Non-compliance|0
7732788|NCT00616941|12161714|FG001|Overall Study|Subject Non-compliance|0
7732789|NCT00616941|12161715|FG002|Overall Study|Subject Non-compliance|1
7732790|NCT00616941|12161713|FG000|Overall Study|Unrelated Medical Illness/Complication|0
7732791|NCT00616941|12161714|FG001|Overall Study|Unrelated Medical Illness/Complication|2
7732792|NCT00616941|12161715|FG002|Overall Study|Unrelated Medical Illness/Complication|0
7732793|NCT00616941|12161713|FG000|Overall Study|Vaccination Suspended|0
7732794|NCT00616941|12161714|FG001|Overall Study|Vaccination Suspended|0
7732795|NCT00616941|12161715|FG002|Overall Study|Vaccination Suspended|3
7732796|NCT00617084|12161738|FG000|Overall Study|Withdrawal by Subject|5
7732797|NCT00617084|12161739|FG001|Overall Study|Withdrawal by Subject|7
7732798|NCT00617084|12161738|FG000|Overall Study|Missed 12 Months visit|16
7732799|NCT00617084|12161739|FG001|Overall Study|Missed 12 Months visit|19
7732800|NCT00617123|12161758|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36
7732801|NCT00617123|12161759|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24
7732802|NCT00617123|12161758|FG000|Referral Screening Period|Did Not Wish To Continue|3
7732803|NCT00617123|12161759|FG001|Referral Screening Period|Did Not Wish To Continue|1
7732804|NCT00617123|12161758|FG000|Referral Screening Period|Adverse Event|0
7732805|NCT00617123|12161759|FG001|Referral Screening Period|Adverse Event|1
7732806|NCT00617123|12161758|FG000|Study Treatment Period|Withdrawal by Subject|8
7732807|NCT00617123|12161759|FG001|Study Treatment Period|Withdrawal by Subject|12
7732808|NCT00617123|12161758|FG000|Study Treatment Period|Adverse Event|7
7732809|NCT00617123|12161759|FG001|Study Treatment Period|Adverse Event|3
7732810|NCT00617123|12161758|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2
7732811|NCT00617123|12161759|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0
7732812|NCT00617123|12161758|FG000|Study Treatment Period|Noncompliance with Protocol|0
7732813|NCT00617123|12161759|FG001|Study Treatment Period|Noncompliance with Protocol|1
7732814|NCT00617201|12161780|FG000|Overall Study|Lost to Follow-up|9
7732815|NCT00617201|12161781|FG001|Overall Study|Lost to Follow-up|13
7732816|NCT00617240|12161791|FG000|Overall Study|Lack of Efficacy|1
7732817|NCT00617240|12161792|FG001|Overall Study|Lack of Efficacy|0
7732818|NCT00617279|12161800|FG000|Overall Study|Study terminated by Sponsor|10
7732819|NCT00617279|12161801|FG001|Overall Study|Study terminated by Sponsor|15
7732820|NCT00617279|12161800|FG000|Overall Study|Graft abandonment|2
7732821|NCT00617279|12161801|FG001|Overall Study|Graft abandonment|0
7732822|NCT00617279|12161800|FG000|Overall Study|Lost to Follow-up|1
7732823|NCT00617279|12161801|FG001|Overall Study|Lost to Follow-up|0
7732824|NCT00617279|12161800|FG000|Overall Study|Death|1
7732825|NCT00617279|12161801|FG001|Overall Study|Death|2
7732826|NCT00617305|12161810|FG000|Overall Study|Adverse Event|4
7732827|NCT00617305|12161811|FG001|Overall Study|Adverse Event|0
7732828|NCT00617305|12161812|FG002|Overall Study|Adverse Event|0
7732829|NCT00617305|12161810|FG000|Overall Study|Death|1
7732830|NCT00617305|12161811|FG001|Overall Study|Death|0
7732831|NCT00617305|12161812|FG002|Overall Study|Death|0
7732832|NCT00617305|12161810|FG000|Overall Study|Physician Decision|1
7732833|NCT00617305|12161811|FG001|Overall Study|Physician Decision|0
7732834|NCT00617305|12161812|FG002|Overall Study|Physician Decision|0
7732835|NCT00617305|12161810|FG000|Overall Study|Protocol Violation|1
7732836|NCT00617305|12161811|FG001|Overall Study|Protocol Violation|0
7732837|NCT00617305|12161812|FG002|Overall Study|Protocol Violation|1
7732838|NCT00617305|12161810|FG000|Overall Study|Withdrawal by Subject|1
7732839|NCT00617305|12161811|FG001|Overall Study|Withdrawal by Subject|0
7732840|NCT00617305|12161812|FG002|Overall Study|Withdrawal by Subject|0
7732841|NCT00617344|12161826|FG000|Overall Study|Serious adverse event|1
7732842|NCT00617344|12161827|FG001|Overall Study|Serious adverse event|0
7732843|NCT00617344|12161828|FG002|Overall Study|Serious adverse event|0
7732844|NCT00617344|12161826|FG000|Overall Study|Other Adverse Event|1
7732845|NCT00617344|12161827|FG001|Overall Study|Other Adverse Event|1
7732846|NCT00617344|12161828|FG002|Overall Study|Other Adverse Event|0
7732847|NCT00617344|12161826|FG000|Overall Study|Protocol Violation|10
7732848|NCT00617344|12161827|FG001|Overall Study|Protocol Violation|8
7732849|NCT00617344|12161828|FG002|Overall Study|Protocol Violation|5
7732850|NCT00617344|12161826|FG000|Overall Study|Lost to Follow-up|5
7732851|NCT00617344|12161827|FG001|Overall Study|Lost to Follow-up|4
7732852|NCT00617344|12161828|FG002|Overall Study|Lost to Follow-up|1
7732853|NCT00617344|12161826|FG000|Overall Study|Withdrawal by Subject|8
7732854|NCT00617344|12161827|FG001|Overall Study|Withdrawal by Subject|9
7732855|NCT00617344|12161828|FG002|Overall Study|Withdrawal by Subject|2
7732856|NCT00617357|12161836|FG000|Overall Study|Lost to Follow-up|7
7732857|NCT00617357|12161836|FG000|Overall Study|Death|5
7732858|NCT00617357|12161836|FG000|Overall Study|insurance concerns|2
7732859|NCT00617357|12161836|FG000|Overall Study|Withdrawal by Subject|1
7732860|NCT00617357|12161836|FG000|Overall Study|Physician Decision|1
7732861|NCT00617409|12161848|FG000|Overall Study|Withdrawal by Subject|4
7732862|NCT00617409|12161849|FG001|Overall Study|Withdrawal by Subject|1
7732863|NCT00617409|12161850|FG002|Overall Study|Withdrawal by Subject|2
7732864|NCT00617409|12161848|FG000|Overall Study|Adverse Event|0
7732865|NCT00617409|12161849|FG001|Overall Study|Adverse Event|2
7732866|NCT00617409|12161850|FG002|Overall Study|Adverse Event|3
7732867|NCT00617409|12161848|FG000|Overall Study|Disease Progression|8
7732868|NCT00617409|12161849|FG001|Overall Study|Disease Progression|8
7732869|NCT00617409|12161850|FG002|Overall Study|Disease Progression|18
7732870|NCT00617409|12161848|FG000|Overall Study|Death|3
7732871|NCT00617409|12161849|FG001|Overall Study|Death|5
7732872|NCT00617409|12161850|FG002|Overall Study|Death|4
7732873|NCT00617409|12161848|FG000|Overall Study|Alternative Therapy|1
7732874|NCT00617409|12161849|FG001|Overall Study|Alternative Therapy|2
7732875|NCT00617409|12161850|FG002|Overall Study|Alternative Therapy|0
7732876|NCT00617461|12161859|FG000|First Treatment Intervention Period|Adverse Event|2
7732877|NCT00617461|12161860|FG001|First Treatment Intervention Period|Adverse Event|0
7732878|NCT00617461|12161859|FG000|First Treatment Intervention Period|Lack of Efficacy|1
7732879|NCT00617461|12161860|FG001|First Treatment Intervention Period|Lack of Efficacy|0
7732880|NCT00617461|12161859|FG000|First Treatment Intervention Period|Protocol Violation|2
7732881|NCT00617461|12161860|FG001|First Treatment Intervention Period|Protocol Violation|1
7732882|NCT00617461|12161859|FG000|First Treatment Intervention Period|Lost to Follow-up|0
7732883|NCT00617461|12161860|FG001|First Treatment Intervention Period|Lost to Follow-up|1
7732884|NCT00617461|12161859|FG000|First Treatment Intervention Period|Investigator Discretion|1
7732885|NCT00617461|12161860|FG001|First Treatment Intervention Period|Investigator Discretion|1
7732886|NCT00617461|12161859|FG000|First Treatment Intervention Period|Withdrawal by Subject|4
7732887|NCT00617461|12161860|FG001|First Treatment Intervention Period|Withdrawal by Subject|0
7732888|NCT00617461|12161859|FG000|4-Day Crossover Period|Withdrawal by Subject|1
7732889|NCT00617461|12161860|FG001|4-Day Crossover Period|Withdrawal by Subject|0
7732890|NCT00617461|12161859|FG000|Second Treatment Intervention Period|Adverse Event|0
7732891|NCT00617461|12161860|FG001|Second Treatment Intervention Period|Adverse Event|1
7732892|NCT00617461|12161859|FG000|Second Treatment Intervention Period|Lack of Efficacy|0
7732893|NCT00617461|12161860|FG001|Second Treatment Intervention Period|Lack of Efficacy|3
7732894|NCT00617461|12161859|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1
7732895|NCT00617461|12161860|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0
7732896|NCT00617461|12161859|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
7732897|NCT00617461|12161860|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
7732898|NCT00617591|12161887|FG000|Overall Study|Withdrew consent during Induction|4
7732899|NCT00617591|12161887|FG000|Overall Study|Withdrew consent during Maintenance|6
7732900|NCT00617604|12161894|FG000|Overall Study|Death|2
7732901|NCT00617604|12161895|FG001|Overall Study|Death|1
7732902|NCT00617604|12161894|FG000|Overall Study|Lost to Follow-up|1
7732903|NCT00617604|12161895|FG001|Overall Study|Lost to Follow-up|0
7732904|NCT00617604|12161894|FG000|Overall Study|Miscellaneous Reasons|8
7732905|NCT00617604|12161895|FG001|Overall Study|Miscellaneous Reasons|10
7732906|NCT00617604|12161894|FG000|Overall Study|Withdrawal by Subject|4
7732907|NCT00617604|12161895|FG001|Overall Study|Withdrawal by Subject|6
7732908|NCT00617604|12161894|FG000|Overall Study|Randomized but Never Received Study Drug|3
7732909|NCT00617604|12161895|FG001|Overall Study|Randomized but Never Received Study Drug|3
7732910|NCT00617669|12161903|FG000|Overall Study|Withdrawal by Subject|71
7732911|NCT00617669|12161904|FG001|Overall Study|Withdrawal by Subject|77
7732912|NCT00617669|12161903|FG000|Overall Study|Lost to Follow-up|3
7732913|NCT00617669|12161904|FG001|Overall Study|Lost to Follow-up|2
7732914|NCT00617669|12161903|FG000|Overall Study|Adverse Event|87
7732915|NCT00617669|12161904|FG001|Overall Study|Adverse Event|76
7732916|NCT00617669|12161903|FG000|Overall Study|Protocol Violation|2
7732917|NCT00617669|12161904|FG001|Overall Study|Protocol Violation|3
7732918|NCT00617669|12161903|FG000|Overall Study|Reason not otherwise captured, eg; death|265
7732919|NCT00617669|12161904|FG001|Overall Study|Reason not otherwise captured, eg; death|290
7732920|NCT00617669|12161903|FG000|Overall Study|Patients randomized but not treated|2
7732921|NCT00617669|12161904|FG001|Overall Study|Patients randomized but not treated|3
7732922|NCT00617734|12161912|FG000|Overall Study|Withdrew Consent|2
7732923|NCT00617734|12161913|FG001|Overall Study|Withdrew Consent|0
7732924|NCT00617734|12161912|FG000|Overall Study|Adverse Event|4
7732925|NCT00617734|12161913|FG001|Overall Study|Adverse Event|1
7732926|NCT00617734|12161912|FG000|Overall Study|Protocol Violation|1
7732927|NCT00617734|12161913|FG001|Overall Study|Protocol Violation|0
7732928|NCT00617734|12161912|FG000|Overall Study|Found Ineligible After Randomization|1
7732929|NCT00617734|12161913|FG001|Overall Study|Found Ineligible After Randomization|4
7732930|NCT00617734|12161912|FG000|Overall Study|Lost to Follow-up|0
7732931|NCT00617734|12161913|FG001|Overall Study|Lost to Follow-up|1
7732932|NCT00617773|12161919|FG000|Overall Study|Physician Decision|1
7732933|NCT00617773|12161919|FG000|Overall Study|Lack of compliance with the protocol|1
7732934|NCT00617773|12161919|FG000|Overall Study|Withdrawal by Subject|1
7732935|NCT00617773|12161919|FG000|Overall Study|Death|1
7732936|NCT00617773|12161919|FG000|Overall Study|Progressive disease|19
7732937|NCT00617773|12161919|FG000|Overall Study|Protocol Violation|1
7732938|NCT00617851|12161927|FG000|Overall Study|Death|0
7732939|NCT00617851|12161928|FG001|Overall Study|Death|0
7732940|NCT00617851|12161929|FG002|Overall Study|Death|0
7732941|NCT00617851|12161930|FG003|Overall Study|Death|1
7732942|NCT00617851|12161927|FG000|Overall Study|Withdrawal by Subject|14
7732943|NCT00617851|12161928|FG001|Overall Study|Withdrawal by Subject|7
7732944|NCT00617851|12161929|FG002|Overall Study|Withdrawal by Subject|12
7732945|NCT00617851|12161930|FG003|Overall Study|Withdrawal by Subject|4
7732946|NCT00617851|12161927|FG000|Overall Study|Lost to Follow-up|27
7732947|NCT00617851|12161928|FG001|Overall Study|Lost to Follow-up|29
7732948|NCT00617851|12161929|FG002|Overall Study|Lost to Follow-up|31
7732949|NCT00617851|12161930|FG003|Overall Study|Lost to Follow-up|19
7732950|NCT00617851|12161927|FG000|Overall Study|Inappropriate Enrollment|5
7732951|NCT00617851|12161928|FG001|Overall Study|Inappropriate Enrollment|4
7732952|NCT00617851|12161929|FG002|Overall Study|Inappropriate Enrollment|1
7732953|NCT00617851|12161930|FG003|Overall Study|Inappropriate Enrollment|1
7732954|NCT00617851|12161927|FG000|Overall Study|Unable to classify|1
7732955|NCT00617851|12161928|FG001|Overall Study|Unable to classify|0
7732956|NCT00617851|12161929|FG002|Overall Study|Unable to classify|1
7732957|NCT00617851|12161930|FG003|Overall Study|Unable to classify|0
7732958|NCT00617890|12161954|FG000|Overall Study|Treatment ongoing at data cut-off|0
7732959|NCT00617890|12161955|FG001|Overall Study|Treatment ongoing at data cut-off|0
7732960|NCT00617890|12161956|FG002|Overall Study|Treatment ongoing at data cut-off|0
7732961|NCT00617890|12161957|FG003|Overall Study|Treatment ongoing at data cut-off|5
7732962|NCT00617890|12161954|FG000|Overall Study|Lack of Efficacy|23
7732963|NCT00617890|12161955|FG001|Overall Study|Lack of Efficacy|26
7732964|NCT00617890|12161956|FG002|Overall Study|Lack of Efficacy|30
7732965|NCT00617890|12161957|FG003|Overall Study|Lack of Efficacy|97
7732966|NCT00617890|12161954|FG000|Overall Study|Lost to Follow-up|0
7732967|NCT00617890|12161955|FG001|Overall Study|Lost to Follow-up|0
7732968|NCT00617890|12161956|FG002|Overall Study|Lost to Follow-up|1
7732969|NCT00617890|12161957|FG003|Overall Study|Lost to Follow-up|2
7732970|NCT00617890|12161954|FG000|Overall Study|Withdrawal by Subject|4
7732971|NCT00617890|12161955|FG001|Overall Study|Withdrawal by Subject|1
7732972|NCT00617890|12161956|FG002|Overall Study|Withdrawal by Subject|0
7732973|NCT00617890|12161957|FG003|Overall Study|Withdrawal by Subject|2
7732974|NCT00617890|12161954|FG000|Overall Study|Protocol Violation|2
7732975|NCT00617890|12161955|FG001|Overall Study|Protocol Violation|1
7732976|NCT00617890|12161956|FG002|Overall Study|Protocol Violation|0
7732977|NCT00617890|12161957|FG003|Overall Study|Protocol Violation|0
7732978|NCT00617890|12161954|FG000|Overall Study|Adverse Event|1
7732979|NCT00617890|12161955|FG001|Overall Study|Adverse Event|0
7732980|NCT00617890|12161956|FG002|Overall Study|Adverse Event|3
7732981|NCT00617890|12161957|FG003|Overall Study|Adverse Event|8
7732982|NCT00617890|12161954|FG000|Overall Study|Not treated|1
7732983|NCT00617890|12161955|FG001|Overall Study|Not treated|0
7732984|NCT00617890|12161956|FG002|Overall Study|Not treated|1
7732985|NCT00617890|12161957|FG003|Overall Study|Not treated|1
7732986|NCT00617903|12161972|FG000|Overall Study|Withdrawal by Subject|2
7732987|NCT00617903|12161973|FG001|Overall Study|Withdrawal by Subject|3
7732988|NCT00617903|12161972|FG000|Overall Study|Lost to Follow-up|1
7732989|NCT00617903|12161973|FG001|Overall Study|Lost to Follow-up|1
7732990|NCT00617903|12161972|FG000|Overall Study|Lack of Efficacy|0
7732991|NCT00617903|12161973|FG001|Overall Study|Lack of Efficacy|1
7732992|NCT00617903|12161972|FG000|Overall Study|Adverse Event|0
7732993|NCT00617903|12161973|FG001|Overall Study|Adverse Event|1
7732994|NCT00617903|12161972|FG000|Overall Study|noncompliance|0
7732995|NCT00617903|12161973|FG001|Overall Study|noncompliance|1
7732996|NCT00617929|12161979|FG000|Overall Study|Physician Decision|1
7732997|NCT00618072|12162010|FG000|Overall Study|Lost to Follow-up|2
7732998|NCT00618072|12162011|FG001|Overall Study|Lost to Follow-up|0
7732999|NCT00618072|12162012|FG002|Overall Study|Lost to Follow-up|3
7733000|NCT00618072|12162010|FG000|Overall Study|Physician Decision|0
7733001|NCT00618072|12162011|FG001|Overall Study|Physician Decision|1
7733002|NCT00618072|12162012|FG002|Overall Study|Physician Decision|1
7733003|NCT00618371|12162029|FG000|Overall Study|Withdrawal by Subject|2
7733004|NCT00618410|12162034|FG000|Washout Period (2 Weeks)|Physician Decision|0
7733005|NCT00618410|12162035|FG001|Washout Period (2 Weeks)|Physician Decision|1
7733006|NCT00618449|12162052|FG000|Overall Study|Lost to Follow-up|98
7733007|NCT00618449|12162053|FG001|Overall Study|Lost to Follow-up|110
7768681|NCT00863057|12212001|FG001|Period 2 (Weeks 6-10)|Adverse Event|1
7768682|NCT00863057|12212002|FG002|Period 2 (Weeks 6-10)|Adverse Event|1
7768683|NCT00863057|12212003|FG003|Period 2 (Weeks 6-10)|Adverse Event|0
7768684|NCT00863057|12212000|FG000|Period 2 (Weeks 6-10)|Physician Decision|0
7768685|NCT00863057|12212001|FG001|Period 2 (Weeks 6-10)|Physician Decision|0
7768686|NCT00863057|12212002|FG002|Period 2 (Weeks 6-10)|Physician Decision|0
7768687|NCT00863057|12212003|FG003|Period 2 (Weeks 6-10)|Physician Decision|1
7768688|NCT00863304|12212061|FG000|Overall Study|Adverse Event|10
7768689|NCT00863304|12212062|FG001|Overall Study|Adverse Event|4
7768690|NCT00863304|12212063|FG002|Overall Study|Adverse Event|14
7768691|NCT00863304|12212064|FG003|Overall Study|Adverse Event|16
7768692|NCT00863304|12212061|FG000|Overall Study|Lost to Follow-up|1
7768693|NCT00863304|12212062|FG001|Overall Study|Lost to Follow-up|5
7768694|NCT00863304|12212063|FG002|Overall Study|Lost to Follow-up|4
7768695|NCT00863304|12212064|FG003|Overall Study|Lost to Follow-up|2
7768696|NCT00863304|12212061|FG000|Overall Study|Lack of Efficacy|57
7768697|NCT00863304|12212062|FG001|Overall Study|Lack of Efficacy|26
7768698|NCT00863304|12212063|FG002|Overall Study|Lack of Efficacy|30
7768699|NCT00863304|12212064|FG003|Overall Study|Lack of Efficacy|28
7768700|NCT00863304|12212061|FG000|Overall Study|Withdrawal by Subject|19
7768701|NCT00863304|12212062|FG001|Overall Study|Withdrawal by Subject|14
7768702|NCT00863304|12212063|FG002|Overall Study|Withdrawal by Subject|20
7768703|NCT00863304|12212064|FG003|Overall Study|Withdrawal by Subject|18
7768704|NCT00863304|12212061|FG000|Overall Study|Other|1
7768705|NCT00863304|12212062|FG001|Overall Study|Other|0
7768706|NCT00863304|12212063|FG002|Overall Study|Other|0
7768707|NCT00863304|12212064|FG003|Overall Study|Other|1
7768708|NCT00863304|12212061|FG000|Overall Study|Protocol Violation|2
7768709|NCT00863304|12212062|FG001|Overall Study|Protocol Violation|6
7768710|NCT00863304|12212063|FG002|Overall Study|Protocol Violation|2
7768711|NCT00863304|12212064|FG003|Overall Study|Protocol Violation|0
7768712|NCT00863304|12212061|FG000|Overall Study|Randomized, but not Treated|3
7733008|NCT00618514|12162061|FG000|Overall Study|Lost to Follow-up|11
7733009|NCT00618514|12162062|FG001|Overall Study|Lost to Follow-up|12
7733010|NCT00618514|12162063|FG002|Overall Study|Lost to Follow-up|4
7733011|NCT00618618|12162078|FG000|Overall Study|Patient Request|0
7733012|NCT00618618|12162079|FG001|Overall Study|Patient Request|0
7733013|NCT00618618|12162080|FG002|Overall Study|Patient Request|2
7733014|NCT00618618|12162081|FG003|Overall Study|Patient Request|0
7733015|NCT00618618|12162078|FG000|Overall Study|Inability to Complete Study Procedures|0
7733016|NCT00618618|12162079|FG001|Overall Study|Inability to Complete Study Procedures|1
7733017|NCT00618618|12162080|FG002|Overall Study|Inability to Complete Study Procedures|0
7733018|NCT00618618|12162081|FG003|Overall Study|Inability to Complete Study Procedures|0
7733019|NCT00618618|12162078|FG000|Overall Study|Lost to Follow-up|3
7733020|NCT00618618|12162079|FG001|Overall Study|Lost to Follow-up|0
7733021|NCT00618618|12162080|FG002|Overall Study|Lost to Follow-up|0
7733022|NCT00618618|12162081|FG003|Overall Study|Lost to Follow-up|1
7733023|NCT00618618|12162078|FG000|Overall Study|Non-compliance|1
7733024|NCT00618618|12162079|FG001|Overall Study|Non-compliance|1
7733025|NCT00618618|12162080|FG002|Overall Study|Non-compliance|0
7733026|NCT00618618|12162081|FG003|Overall Study|Non-compliance|0
7733027|NCT00618618|12162078|FG000|Overall Study|Did Not Meet Entry Criteria|0
7733028|NCT00618618|12162079|FG001|Overall Study|Did Not Meet Entry Criteria|0
7733029|NCT00618618|12162080|FG002|Overall Study|Did Not Meet Entry Criteria|1
7733030|NCT00618618|12162081|FG003|Overall Study|Did Not Meet Entry Criteria|0
7733031|NCT00618618|12162078|FG000|Overall Study|Death|0
7733032|NCT00618618|12162079|FG001|Overall Study|Death|1
7733033|NCT00618618|12162080|FG002|Overall Study|Death|0
7733034|NCT00618618|12162081|FG003|Overall Study|Death|0
7733035|NCT00618722|12162096|FG000|Overall Study|Refusal of Treatment|0
7733036|NCT00618722|12162097|FG001|Overall Study|Refusal of Treatment|0
7733037|NCT00618722|12162098|FG002|Overall Study|Refusal of Treatment|1
7733038|NCT00618722|12162099|FG003|Overall Study|Refusal of Treatment|0
7733039|NCT00618722|12162096|FG000|Overall Study|Patient Request|1
7733040|NCT00618722|12162097|FG001|Overall Study|Patient Request|1
7733041|NCT00618722|12162098|FG002|Overall Study|Patient Request|1
7733042|NCT00618722|12162099|FG003|Overall Study|Patient Request|1
7733043|NCT00618722|12162096|FG000|Overall Study|Inability to Complete Study Procedure|0
7733044|NCT00618722|12162097|FG001|Overall Study|Inability to Complete Study Procedure|1
7733045|NCT00618722|12162098|FG002|Overall Study|Inability to Complete Study Procedure|0
7733046|NCT00618722|12162099|FG003|Overall Study|Inability to Complete Study Procedure|0
7733047|NCT00618722|12162096|FG000|Overall Study|Lost to Follow-up|2
7733048|NCT00618722|12162097|FG001|Overall Study|Lost to Follow-up|0
7733049|NCT00618722|12162098|FG002|Overall Study|Lost to Follow-up|0
7733050|NCT00618722|12162099|FG003|Overall Study|Lost to Follow-up|2
7733051|NCT00618722|12162096|FG000|Overall Study|Miscellaneous Reasons|0
7733052|NCT00618722|12162097|FG001|Overall Study|Miscellaneous Reasons|0
7733053|NCT00618722|12162098|FG002|Overall Study|Miscellaneous Reasons|1
7733054|NCT00618722|12162099|FG003|Overall Study|Miscellaneous Reasons|1
7733055|NCT00618748|12162112|FG000|Overall Study|Adverse Event|4
7733056|NCT00618748|12162113|FG001|Overall Study|Adverse Event|3
7733057|NCT00618748|12162114|FG002|Overall Study|Adverse Event|8
7733058|NCT00618748|12162112|FG000|Overall Study|Physician Decision|3
7733059|NCT00618748|12162113|FG001|Overall Study|Physician Decision|1
7733060|NCT00618748|12162114|FG002|Overall Study|Physician Decision|1
7733061|NCT00618748|12162112|FG000|Overall Study|Withdrawal by Subject|4
7733062|NCT00618748|12162113|FG001|Overall Study|Withdrawal by Subject|1
7733063|NCT00618748|12162114|FG002|Overall Study|Withdrawal by Subject|5
7733064|NCT00618774|12162124|FG000|Overall Study|Adverse Event|5
7733065|NCT00618774|12162125|FG001|Overall Study|Adverse Event|3
7733066|NCT00618774|12162124|FG000|Overall Study|Withdrawal by Subject|1
7733067|NCT00618774|12162125|FG001|Overall Study|Withdrawal by Subject|0
7733068|NCT00618787|12162133|FG000|Overall Study|Adverse Event|0
7733069|NCT00618787|12162134|FG001|Overall Study|Adverse Event|1
7733070|NCT00618787|12162133|FG000|Overall Study|Withdrawal by Subject|2
7733071|NCT00618787|12162134|FG001|Overall Study|Withdrawal by Subject|1
7733072|NCT00618787|12162133|FG000|Overall Study|Lost to Follow-up|1
7733073|NCT00618787|12162134|FG001|Overall Study|Lost to Follow-up|0
7733074|NCT00618813|12162140|FG000|Overall Study|Lack of Efficacy|1
7733075|NCT00618813|12162140|FG000|Overall Study|Physician Decision|2
7733076|NCT00618813|12162140|FG000|Overall Study|Withdrawal by Subject|1
7733077|NCT00618826|12162144|FG000|Overall Study|Adverse Event|1
7733078|NCT00618956|12162171|FG000|Overall Study|Adverse Event|10
7733079|NCT00618956|12162172|FG001|Overall Study|Adverse Event|34
7733080|NCT00618956|12162171|FG000|Overall Study|Lack of Efficacy|2
7733081|NCT00618956|12162172|FG001|Overall Study|Lack of Efficacy|1
7733082|NCT00618956|12162171|FG000|Overall Study|Withdrawal by Subject|5
7733083|NCT00618956|12162172|FG001|Overall Study|Withdrawal by Subject|7
7733084|NCT00618956|12162171|FG000|Overall Study|Lost to Follow-up|4
7733085|NCT00618956|12162172|FG001|Overall Study|Lost to Follow-up|5
7733086|NCT00618956|12162171|FG000|Overall Study|Protocol Violation|2
7733087|NCT00618956|12162172|FG001|Overall Study|Protocol Violation|2
7733088|NCT00618956|12162171|FG000|Overall Study|did not meet criteria, non-compliance|2
7733089|NCT00618956|12162172|FG001|Overall Study|did not meet criteria, non-compliance|1
7733090|NCT00618982|12162184|FG000|Overall Study|Adverse Event|23
7733091|NCT00618982|12162184|FG000|Overall Study|Withdrawal by Subject|1
7733092|NCT00618982|12162184|FG000|Overall Study|Protocol Violation|1
7733093|NCT00618982|12162184|FG000|Overall Study|ongoing, still treated with study med.|25
7733094|NCT00618995|12162191|FG000|Period 1|Adverse Event|0
7733095|NCT00618995|12162192|FG001|Period 1|Adverse Event|0
7733096|NCT00618995|12162193|FG002|Period 1|Adverse Event|1
7733097|NCT00618995|12162194|FG003|Period 1|Adverse Event|0
7733098|NCT00618995|12162191|FG000|Period 1|Protocol Violation|0
7733099|NCT00618995|12162192|FG001|Period 1|Protocol Violation|1
7733100|NCT00618995|12162193|FG002|Period 1|Protocol Violation|1
7733101|NCT00618995|12162194|FG003|Period 1|Protocol Violation|0
7733102|NCT00618995|12162191|FG000|Period 2|Protocol Violation|0
7733103|NCT00618995|12162192|FG001|Period 2|Protocol Violation|0
7733104|NCT00618995|12162193|FG002|Period 2|Protocol Violation|1
7733105|NCT00618995|12162194|FG003|Period 2|Protocol Violation|0
7733106|NCT00618995|12162191|FG000|Period 4|Adverse Event|1
7733107|NCT00618995|12162192|FG001|Period 4|Adverse Event|0
7733108|NCT00618995|12162193|FG002|Period 4|Adverse Event|0
7733109|NCT00618995|12162194|FG003|Period 4|Adverse Event|0
7733110|NCT00619099|12162222|FG000|Overall Study|Progressive Disease|7
7733111|NCT00619099|12162223|FG001|Overall Study|Progressive Disease|5
7733112|NCT00619099|12162222|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2
7733113|NCT00619099|12162223|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1
7733114|NCT00619099|12162222|FG000|Overall Study|Adverse Event|4
7733115|NCT00619099|12162223|FG001|Overall Study|Adverse Event|3
7733116|NCT00619099|12162222|FG000|Overall Study|Emergence of Clinically Significant Lab|1
7733117|NCT00619099|12162223|FG001|Overall Study|Emergence of Clinically Significant Lab|2
7733118|NCT00619099|12162222|FG000|Overall Study|Withdrawal by Subject|10
7733119|NCT00619099|12162223|FG001|Overall Study|Withdrawal by Subject|2
7733120|NCT00619099|12162222|FG000|Overall Study|Physician Decision|9
7733121|NCT00619099|12162223|FG001|Overall Study|Physician Decision|6
7733122|NCT00619112|12162231|FG000|Overall Study|Adverse Event|1
7733123|NCT00619112|12162232|FG001|Overall Study|Adverse Event|2
7733124|NCT00619177|12162241|FG000|Overall Study|Adverse Event|18
7733125|NCT00619177|12162241|FG000|Overall Study|Lost to Follow-up|2
7733126|NCT00619177|12162241|FG000|Overall Study|Lack of Efficacy|1
7733127|NCT00619177|12162241|FG000|Overall Study|Missing termination information|481
7733128|NCT00619177|12162241|FG000|Overall Study|Not specified reasons|6
7733129|NCT00619229|12162256|FG000|Overall Study|Withdrawal by Subject|1
7733130|NCT00619229|12162257|FG001|Overall Study|Withdrawal by Subject|1
7733131|NCT00619229|12162256|FG000|Overall Study|Lost to Follow-up|1
7733132|NCT00619229|12162257|FG001|Overall Study|Lost to Follow-up|0
7733133|NCT00619229|12162256|FG000|Overall Study|Termination of the Study by the Sponsor|1
7733134|NCT00619229|12162257|FG001|Overall Study|Termination of the Study by the Sponsor|1
7733135|NCT00619229|12162256|FG000|Overall Study|Investigator planned Cataract Operation|1
7733136|NCT00619229|12162257|FG001|Overall Study|Investigator planned Cataract Operation|0
7733137|NCT00619307|12162274|FG000|Overall Study|Adverse Event|0
7733138|NCT00619307|12162275|FG001|Overall Study|Adverse Event|1
7733139|NCT00619307|12162274|FG000|Overall Study|Lost to Follow-up|0
7733140|NCT00619307|12162275|FG001|Overall Study|Lost to Follow-up|1
7733141|NCT00619307|12162274|FG000|Overall Study|Protocol Violation|3
7733142|NCT00619307|12162275|FG001|Overall Study|Protocol Violation|0
7733143|NCT00619307|12162274|FG000|Overall Study|Withdrew consent|1
7733144|NCT00619307|12162275|FG001|Overall Study|Withdrew consent|0
7733145|NCT00619307|12162274|FG000|Overall Study|Severe migraine|0
7733146|NCT00619307|12162275|FG001|Overall Study|Severe migraine|1
7733147|NCT00619307|12162274|FG000|Overall Study|MS attack plus steroids|0
7733148|NCT00619307|12162275|FG001|Overall Study|MS attack plus steroids|1
7733149|NCT00619359|12162283|FG000|Overall Study|Adverse Event|32
7733150|NCT00619359|12162284|FG001|Overall Study|Adverse Event|36
7733151|NCT00619359|12162283|FG000|Overall Study|Lost to Follow-up|12
7733152|NCT00619359|12162284|FG001|Overall Study|Lost to Follow-up|16
7733153|NCT00619359|12162283|FG000|Overall Study|Physician Decision|0
7733154|NCT00619359|12162284|FG001|Overall Study|Physician Decision|7
7733155|NCT00619359|12162283|FG000|Overall Study|Protocol Violation|1
7733156|NCT00619359|12162284|FG001|Overall Study|Protocol Violation|1
7733157|NCT00619359|12162283|FG000|Overall Study|Withdrawal by Subject|19
7733158|NCT00619359|12162284|FG001|Overall Study|Withdrawal by Subject|20
7733159|NCT00619359|12162283|FG000|Overall Study|Progressive Disease|3
7733160|NCT00619359|12162284|FG001|Overall Study|Progressive Disease|1
7733161|NCT00619385|12162293|FG000|Overall Study|Adverse Event|0
7733162|NCT00619385|12162294|FG001|Overall Study|Adverse Event|0
7733163|NCT00619385|12162295|FG002|Overall Study|Adverse Event|3
7733164|NCT00619385|12162293|FG000|Overall Study|Other|1
7733165|NCT00619385|12162294|FG001|Overall Study|Other|2
7733166|NCT00619385|12162295|FG002|Overall Study|Other|1
7733167|NCT00619476|12162310|FG000|Overall Study|Adverse Event|12
7733168|NCT00619476|12162311|FG001|Overall Study|Adverse Event|6
7733169|NCT00619476|12162312|FG002|Overall Study|Adverse Event|12
7733170|NCT00619476|12162313|FG003|Overall Study|Adverse Event|16
7733171|NCT00619476|12162310|FG000|Overall Study|Lack of Efficacy|6
7733172|NCT00619476|12162311|FG001|Overall Study|Lack of Efficacy|1
7733173|NCT00619476|12162312|FG002|Overall Study|Lack of Efficacy|1
7733174|NCT00619476|12162313|FG003|Overall Study|Lack of Efficacy|4
7733175|NCT00619476|12162310|FG000|Overall Study|Protocol Violation|5
7733176|NCT00619476|12162311|FG001|Overall Study|Protocol Violation|4
7733177|NCT00619476|12162312|FG002|Overall Study|Protocol Violation|4
7733178|NCT00619476|12162313|FG003|Overall Study|Protocol Violation|9
7733179|NCT00619476|12162310|FG000|Overall Study|Lost to Follow-up|1
7733180|NCT00619476|12162311|FG001|Overall Study|Lost to Follow-up|2
7733181|NCT00619476|12162312|FG002|Overall Study|Lost to Follow-up|0
7733182|NCT00619476|12162313|FG003|Overall Study|Lost to Follow-up|1
7733183|NCT00619476|12162310|FG000|Overall Study|Investigator Discretion|2
7733184|NCT00619476|12162311|FG001|Overall Study|Investigator Discretion|2
7733185|NCT00619476|12162312|FG002|Overall Study|Investigator Discretion|2
7733186|NCT00619476|12162313|FG003|Overall Study|Investigator Discretion|0
7733187|NCT00619476|12162310|FG000|Overall Study|Withdrawal by Subject|5
7733188|NCT00619476|12162311|FG001|Overall Study|Withdrawal by Subject|7
7733189|NCT00619476|12162312|FG002|Overall Study|Withdrawal by Subject|5
7733190|NCT00619476|12162313|FG003|Overall Study|Withdrawal by Subject|4
7733191|NCT00619489|12162325|FG000|Overall Study|Adverse Event|0
7733192|NCT00619489|12162326|FG001|Overall Study|Adverse Event|7
7733193|NCT00619489|12162325|FG000|Overall Study|Withdrawal by Subject|1
7733194|NCT00619489|12162326|FG001|Overall Study|Withdrawal by Subject|1
7733195|NCT00619489|12162325|FG000|Overall Study|Lack of Efficacy|0
7733196|NCT00619489|12162326|FG001|Overall Study|Lack of Efficacy|11
7733197|NCT00619489|12162325|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22
7733198|NCT00619489|12162326|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15
7733199|NCT00619502|12162334|FG000|Overall Study|Lost to Follow-up|8
7733200|NCT00619502|12162335|FG001|Overall Study|Lost to Follow-up|10
7733201|NCT00619619|12162351|FG000|Overall Study|Physician Decision|0
7733202|NCT00619619|12162352|FG001|Overall Study|Physician Decision|0
7733203|NCT00619619|12162353|FG002|Overall Study|Physician Decision|1
7733204|NCT00619619|12162354|FG003|Overall Study|Physician Decision|0
7733205|NCT00619619|12162355|FG004|Overall Study|Physician Decision|0
7733206|NCT00619619|12162356|FG005|Overall Study|Physician Decision|0
7733207|NCT00619619|12162357|FG006|Overall Study|Physician Decision|0
7733208|NCT00619619|12162358|FG007|Overall Study|Physician Decision|0
7733209|NCT00619619|12162351|FG000|Overall Study|Protocol Violation|0
7733210|NCT00619619|12162352|FG001|Overall Study|Protocol Violation|0
7733211|NCT00619619|12162353|FG002|Overall Study|Protocol Violation|0
7733212|NCT00619619|12162354|FG003|Overall Study|Protocol Violation|1
7733213|NCT00619619|12162355|FG004|Overall Study|Protocol Violation|0
7733214|NCT00619619|12162356|FG005|Overall Study|Protocol Violation|0
7733215|NCT00619619|12162357|FG006|Overall Study|Protocol Violation|1
7733216|NCT00619619|12162358|FG007|Overall Study|Protocol Violation|1
7733217|NCT00619619|12162351|FG000|Overall Study|Adverse Event|0
7733218|NCT00619619|12162352|FG001|Overall Study|Adverse Event|0
7733219|NCT00619619|12162353|FG002|Overall Study|Adverse Event|0
7733220|NCT00619619|12162354|FG003|Overall Study|Adverse Event|0
7733221|NCT00619619|12162355|FG004|Overall Study|Adverse Event|2
7733222|NCT00619619|12162356|FG005|Overall Study|Adverse Event|0
7733223|NCT00619619|12162357|FG006|Overall Study|Adverse Event|0
7733224|NCT00619619|12162358|FG007|Overall Study|Adverse Event|2
7733225|NCT00619645|12162379|FG000|Overall Study|Adverse Event|1
7733226|NCT00619801|12162403|FG000|Overall Study|Lack of Efficacy|0
7733227|NCT00619801|12162404|FG001|Overall Study|Lack of Efficacy|1
7733228|NCT00619801|12162403|FG000|Overall Study|Withdrawal by Subject|1
7733229|NCT00619801|12162404|FG001|Overall Study|Withdrawal by Subject|1
7733230|NCT00619801|12162403|FG000|Overall Study|Loss of efficacy|0
7733231|NCT00619801|12162404|FG001|Overall Study|Loss of efficacy|1
7733232|NCT00619827|12162412|FG000|Overall Study|Adverse Event|1
7733233|NCT00619827|12162413|FG001|Overall Study|Adverse Event|2
7733234|NCT00619827|12162412|FG000|Overall Study|Withdrawal by Subject|2
7733235|NCT00619827|12162413|FG001|Overall Study|Withdrawal by Subject|2
7733236|NCT00619866|12162422|FG000|Weeks 1 - 12|Adverse Event|0
7733237|NCT00619866|12162423|FG001|Weeks 1 - 12|Adverse Event|1
7733238|NCT00619866|12162424|FG002|Weeks 1 - 12|Adverse Event|2
7733239|NCT00619866|12162425|FG003|Weeks 1 - 12|Adverse Event|0
7733240|NCT00619866|12162426|FG004|Weeks 1 - 12|Adverse Event|0
7733241|NCT00619866|12162422|FG000|Weeks 1 - 12|Non-compliance|0
7733242|NCT00619866|12162423|FG001|Weeks 1 - 12|Non-compliance|0
7733243|NCT00619866|12162424|FG002|Weeks 1 - 12|Non-compliance|1
7733244|NCT00619866|12162425|FG003|Weeks 1 - 12|Non-compliance|0
7733245|NCT00619866|12162426|FG004|Weeks 1 - 12|Non-compliance|0
7733246|NCT00619866|12162422|FG000|Weeks 1 - 12|Withdrawal by Subject|7
7733247|NCT00619866|12162423|FG001|Weeks 1 - 12|Withdrawal by Subject|2
7733248|NCT00619866|12162424|FG002|Weeks 1 - 12|Withdrawal by Subject|4
7733249|NCT00619866|12162425|FG003|Weeks 1 - 12|Withdrawal by Subject|0
7733250|NCT00619866|12162426|FG004|Weeks 1 - 12|Withdrawal by Subject|0
7733251|NCT00619866|12162422|FG000|Weeks 1 - 12|Lack of Efficacy|3
7733252|NCT00619866|12162423|FG001|Weeks 1 - 12|Lack of Efficacy|2
7733253|NCT00619866|12162424|FG002|Weeks 1 - 12|Lack of Efficacy|1
7733254|NCT00619866|12162425|FG003|Weeks 1 - 12|Lack of Efficacy|0
7733255|NCT00619866|12162426|FG004|Weeks 1 - 12|Lack of Efficacy|0
7733256|NCT00619866|12162422|FG000|Weeks 1 - 12|Lost to Follow-up|4
7733257|NCT00619866|12162423|FG001|Weeks 1 - 12|Lost to Follow-up|0
7733258|NCT00619866|12162424|FG002|Weeks 1 - 12|Lost to Follow-up|2
7733259|NCT00619866|12162425|FG003|Weeks 1 - 12|Lost to Follow-up|0
7733260|NCT00619866|12162426|FG004|Weeks 1 - 12|Lost to Follow-up|0
7733261|NCT00619866|12162422|FG000|Weeks 1 - 12|Sponsor Decision|0
7733262|NCT00619866|12162423|FG001|Weeks 1 - 12|Sponsor Decision|1
7733263|NCT00619866|12162424|FG002|Weeks 1 - 12|Sponsor Decision|0
7733264|NCT00619866|12162425|FG003|Weeks 1 - 12|Sponsor Decision|0
7733265|NCT00619866|12162426|FG004|Weeks 1 - 12|Sponsor Decision|0
7733266|NCT00619866|12162422|FG000|Weeks 13 - 24|Adverse Event|0
7733267|NCT00619866|12162423|FG001|Weeks 13 - 24|Adverse Event|0
7733268|NCT00619866|12162424|FG002|Weeks 13 - 24|Adverse Event|2
7733269|NCT00619866|12162425|FG003|Weeks 13 - 24|Adverse Event|1
7733270|NCT00619866|12162426|FG004|Weeks 13 - 24|Adverse Event|0
7733271|NCT00619866|12162422|FG000|Weeks 13 - 24|Protocol Deviation|0
7733272|NCT00619866|12162423|FG001|Weeks 13 - 24|Protocol Deviation|0
7733273|NCT00619866|12162424|FG002|Weeks 13 - 24|Protocol Deviation|0
7733274|NCT00619866|12162425|FG003|Weeks 13 - 24|Protocol Deviation|1
7733275|NCT00619866|12162426|FG004|Weeks 13 - 24|Protocol Deviation|0
7733276|NCT00619866|12162422|FG000|Weeks 13 - 24|Withdrawal by Subject|0
7733277|NCT00619866|12162423|FG001|Weeks 13 - 24|Withdrawal by Subject|3
7733278|NCT00619866|12162424|FG002|Weeks 13 - 24|Withdrawal by Subject|2
7733279|NCT00619866|12162425|FG003|Weeks 13 - 24|Withdrawal by Subject|2
7733280|NCT00619866|12162426|FG004|Weeks 13 - 24|Withdrawal by Subject|2
7733281|NCT00619866|12162422|FG000|Weeks 13 - 24|Non-compliance|0
7733282|NCT00619866|12162423|FG001|Weeks 13 - 24|Non-compliance|1
7733283|NCT00619866|12162424|FG002|Weeks 13 - 24|Non-compliance|1
7733284|NCT00619866|12162425|FG003|Weeks 13 - 24|Non-compliance|0
7733285|NCT00619866|12162426|FG004|Weeks 13 - 24|Non-compliance|0
7733286|NCT00619866|12162422|FG000|Weeks 13 - 24|Lost to Follow-up|0
7733287|NCT00619866|12162423|FG001|Weeks 13 - 24|Lost to Follow-up|3
7733288|NCT00619866|12162424|FG002|Weeks 13 - 24|Lost to Follow-up|0
7733289|NCT00619866|12162425|FG003|Weeks 13 - 24|Lost to Follow-up|0
7733290|NCT00619866|12162426|FG004|Weeks 13 - 24|Lost to Follow-up|0
7733291|NCT00619892|12162440|FG000|Overall Study|Adverse Event|3
7733292|NCT00619892|12162441|FG001|Overall Study|Adverse Event|0
7733293|NCT00619892|12162440|FG000|Overall Study|Lost to Follow-up|0
7733294|NCT00619892|12162441|FG001|Overall Study|Lost to Follow-up|1
7733295|NCT00619892|12162440|FG000|Overall Study|Intercurrent illness|0
7733296|NCT00619892|12162441|FG001|Overall Study|Intercurrent illness|1
7733297|NCT00619918|12162451|FG000|Overall Study|Withdrawal by Subject|4
7733298|NCT00619918|12162452|FG001|Overall Study|Withdrawal by Subject|3
7733299|NCT00619918|12162451|FG000|Overall Study|Physician Decision|8
7733300|NCT00619918|12162452|FG001|Overall Study|Physician Decision|8
7733301|NCT00619918|12162451|FG000|Overall Study|Transfer to outside facility|3
7733302|NCT00619918|12162452|FG001|Overall Study|Transfer to outside facility|3
7733303|NCT00619918|12162451|FG000|Overall Study|Left before receiving first dose|5
7733304|NCT00619918|12162452|FG001|Overall Study|Left before receiving first dose|8
7733305|NCT00619957|12162460|FG000|Month 24 Double-Blind|Adverse Event|9
7733306|NCT00619957|12162461|FG001|Month 24 Double-Blind|Adverse Event|7
7733307|NCT00619957|12162460|FG000|Month 24 Double-Blind|Protocol Violation|1
7733308|NCT00619957|12162461|FG001|Month 24 Double-Blind|Protocol Violation|0
7733309|NCT00619957|12162460|FG000|Month 24 Double-Blind|Withdrawal by Subject|7
7733310|NCT00619957|12162461|FG001|Month 24 Double-Blind|Withdrawal by Subject|9
7733311|NCT00619957|12162460|FG000|Month 24 Double-Blind|Lost to Follow-up|1
7733312|NCT00619957|12162461|FG001|Month 24 Double-Blind|Lost to Follow-up|0
7733313|NCT00619957|12162460|FG000|Month 24 Double-Blind|Did not take any study medication|0
7733314|NCT00619957|12162461|FG001|Month 24 Double-Blind|Did not take any study medication|1
7733315|NCT00619957|12162460|FG000|Month 48 Open-Label|Adverse Event|4
7733316|NCT00619957|12162461|FG001|Month 48 Open-Label|Adverse Event|4
7733317|NCT00619957|12162460|FG000|Month 48 Open-Label|Lost to Follow-up|2
7733318|NCT00619957|12162461|FG001|Month 48 Open-Label|Lost to Follow-up|4
7733319|NCT00619957|12162460|FG000|Month 48 Open-Label|Withdrawal by Subject|6
7733320|NCT00619957|12162461|FG001|Month 48 Open-Label|Withdrawal by Subject|9
7733321|NCT00619983|12162488|FG000|Test Drug Alone|Withdrawal by Subject|1
7733322|NCT00619983|12162489|FG001|Test Drug Alone|Withdrawal by Subject|0
7733323|NCT00619983|12162490|FG002|Test Drug Alone|Withdrawal by Subject|0
7733324|NCT00619983|12162491|FG003|Test Drug Alone|Withdrawal by Subject|1
7733325|NCT00619983|12162488|FG000|Test Drug Alone|Failure of daily diary device|1
7733326|NCT00619983|12162489|FG001|Test Drug Alone|Failure of daily diary device|1
7733327|NCT00619983|12162490|FG002|Test Drug Alone|Failure of daily diary device|2
7733328|NCT00619983|12162491|FG003|Test Drug Alone|Failure of daily diary device|2
7733329|NCT00620022|12162501|FG000|Treatment Period 1|Adverse Event|4
7733330|NCT00620022|12162502|FG001|Treatment Period 1|Adverse Event|6
7733331|NCT00620022|12162501|FG000|Treatment Period 1|Subject withdrew consent|1
7733332|NCT00620022|12162502|FG001|Treatment Period 1|Subject withdrew consent|0
7733333|NCT00620022|12162501|FG000|Treatment Period 2|Adverse Event|2
7733334|NCT00620022|12162502|FG001|Treatment Period 2|Adverse Event|2
7733335|NCT00620074|12162513|FG000|Overall Study|Adverse Event|1
7733336|NCT00620113|12162521|FG000|Overall Study|Adverse Event|3
7733337|NCT00620113|12162522|FG001|Overall Study|Adverse Event|2
7733338|NCT00620113|12162523|FG002|Overall Study|Adverse Event|2
7733339|NCT00620113|12162524|FG003|Overall Study|Adverse Event|1
7733340|NCT00620113|12162521|FG000|Overall Study|Lack of Efficacy|2
7733341|NCT00620113|12162522|FG001|Overall Study|Lack of Efficacy|3
7733342|NCT00620113|12162523|FG002|Overall Study|Lack of Efficacy|0
7733343|NCT00620113|12162524|FG003|Overall Study|Lack of Efficacy|2
7733344|NCT00620113|12162521|FG000|Overall Study|Physician Decision|1
7733345|NCT00620113|12162522|FG001|Overall Study|Physician Decision|0
7733346|NCT00620113|12162523|FG002|Overall Study|Physician Decision|0
7733347|NCT00620113|12162524|FG003|Overall Study|Physician Decision|2
7733348|NCT00620113|12162521|FG000|Overall Study|Protocol Violation|2
7733349|NCT00620113|12162522|FG001|Overall Study|Protocol Violation|1
7733350|NCT00620113|12162523|FG002|Overall Study|Protocol Violation|0
7733351|NCT00620113|12162524|FG003|Overall Study|Protocol Violation|0
7733352|NCT00620113|12162521|FG000|Overall Study|Withdrawal by Subject|5
7733353|NCT00620113|12162522|FG001|Overall Study|Withdrawal by Subject|1
7733354|NCT00620113|12162523|FG002|Overall Study|Withdrawal by Subject|3
7733355|NCT00620113|12162524|FG003|Overall Study|Withdrawal by Subject|5
7733356|NCT00620282|12162560|FG000|Overall Study|Adverse Event|0
7733357|NCT00620282|12162561|FG001|Overall Study|Adverse Event|1
7733358|NCT00620282|12162562|FG002|Overall Study|Adverse Event|0
7733359|NCT00620282|12162560|FG000|Overall Study|Arterial line unable to be placed|0
7733360|NCT00620282|12162561|FG001|Overall Study|Arterial line unable to be placed|0
7733361|NCT00620282|12162562|FG002|Overall Study|Arterial line unable to be placed|1
7733362|NCT00620282|12162560|FG000|Overall Study|Withdrawal by Subject|0
7733363|NCT00620282|12162561|FG001|Overall Study|Withdrawal by Subject|1
7733364|NCT00620282|12162562|FG002|Overall Study|Withdrawal by Subject|0
7733365|NCT00620321|12162572|FG000|Overall Study|Adverse Event|1
7733366|NCT00620321|12162573|FG001|Overall Study|Adverse Event|1
7733367|NCT00620321|12162572|FG000|Overall Study|Death|1
7733368|NCT00620321|12162573|FG001|Overall Study|Death|1
7733369|NCT00620321|12162572|FG000|Overall Study|Physician Decision|0
7733370|NCT00620321|12162573|FG001|Overall Study|Physician Decision|7
7733371|NCT00620321|12162572|FG000|Overall Study|Progressive Disease|5
7733372|NCT00620321|12162573|FG001|Overall Study|Progressive Disease|5
7733373|NCT00620321|12162572|FG000|Overall Study|Sponsor Decision|0
7733374|NCT00620321|12162573|FG001|Overall Study|Sponsor Decision|1
7733375|NCT00620321|12162572|FG000|Overall Study|Withdrawal by Subject|1
7733376|NCT00620321|12162573|FG001|Overall Study|Withdrawal by Subject|1
7733377|NCT00620373|12162579|FG000|Overall Study|Unverified cancer status|33
7733378|NCT00620542|12162612|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12
7733379|NCT00620542|12162613|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15
7733380|NCT00620542|12162614|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0
7733381|NCT00620542|12162615|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0
7733382|NCT00620542|12162612|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406
7733383|NCT00620542|12162613|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409
7733384|NCT00620542|12162614|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0
7733385|NCT00620542|12162615|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0
7733386|NCT00620542|12162612|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
7733387|NCT00620542|12162613|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
7733388|NCT00620542|12162614|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
7733389|NCT00620542|12162615|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
7733390|NCT00620542|12162612|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
7733391|NCT00620542|12162613|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
7733392|NCT00620542|12162614|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
7733393|NCT00620542|12162615|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
7733394|NCT00620542|12162612|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0
7733395|NCT00620542|12162613|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1
7733396|NCT00620542|12162614|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0
7733397|NCT00620542|12162615|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0
7733398|NCT00620542|12162612|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0
7733399|NCT00620542|12162613|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1
7733400|NCT00620542|12162614|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0
7733401|NCT00620542|12162615|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0
7733402|NCT00620542|12162612|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4
7733403|NCT00620542|12162613|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4
7733404|NCT00620542|12162614|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0
7733405|NCT00620542|12162615|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0
7733406|NCT00620542|12162612|FG000|Part B (2 Year Core Study)|Adverse Event|0
7733407|NCT00620542|12162613|FG001|Part B (2 Year Core Study)|Adverse Event|0
7733408|NCT00620542|12162614|FG002|Part B (2 Year Core Study)|Adverse Event|46
7733409|NCT00620542|12162615|FG003|Part B (2 Year Core Study)|Adverse Event|49
7733410|NCT00620542|12162612|FG000|Part B (2 Year Core Study)|Protocol Violation|0
7733411|NCT00620542|12162613|FG001|Part B (2 Year Core Study)|Protocol Violation|0
7733412|NCT00620542|12162614|FG002|Part B (2 Year Core Study)|Protocol Violation|3
7733413|NCT00620542|12162615|FG003|Part B (2 Year Core Study)|Protocol Violation|5
7733414|NCT00620542|12162612|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0
7733415|NCT00620542|12162613|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0
7733416|NCT00620542|12162614|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55
7733417|NCT00620542|12162615|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54
7733418|NCT00620542|12162612|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0
7733419|NCT00620542|12162613|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0
7733420|NCT00620542|12162614|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20
7733421|NCT00620542|12162615|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9
7733422|NCT00620542|12162612|FG000|Part B (2 Year Core Study)|Protocol Violation|0
7733423|NCT00620542|12162613|FG001|Part B (2 Year Core Study)|Protocol Violation|0
7733424|NCT00620542|12162614|FG002|Part B (2 Year Core Study)|Protocol Violation|13
7733425|NCT00620542|12162615|FG003|Part B (2 Year Core Study)|Protocol Violation|16
7733426|NCT00620542|12162612|FG000|Part B (2 Year Core Study)|Safety reasons|0
7733427|NCT00620542|12162613|FG001|Part B (2 Year Core Study)|Safety reasons|0
7733428|NCT00620542|12162614|FG002|Part B (2 Year Core Study)|Safety reasons|2
7733429|NCT00620542|12162615|FG003|Part B (2 Year Core Study)|Safety reasons|3
7733430|NCT00620542|12162612|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
7733431|NCT00620542|12162613|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
7733432|NCT00620542|12162614|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
7733433|NCT00620542|12162615|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
7733434|NCT00620542|12162612|FG000|Part B (2 Year Core Study)|IVUS not available|0
7733435|NCT00620542|12162613|FG001|Part B (2 Year Core Study)|IVUS not available|0
7733436|NCT00620542|12162614|FG002|Part B (2 Year Core Study)|IVUS not available|3
7733437|NCT00620542|12162615|FG003|Part B (2 Year Core Study)|IVUS not available|2
7733438|NCT00620555|12162623|FG000|Overall Study|Adverse Event|4
7733439|NCT00620555|12162623|FG000|Overall Study|Protocol Violation|2
7733440|NCT00620555|12162623|FG000|Overall Study|Lack of Efficacy|12
7733441|NCT00620555|12162623|FG000|Overall Study|Withdrawal by Subject|1
7733442|NCT00620555|12162623|FG000|Overall Study|Choice of other treatment|1
7733443|NCT00620555|12162623|FG000|Overall Study|Visit failure against planned|1
7733444|NCT00620659|12162627|FG000|Treatment Period 1|Adverse Event|1
7733445|NCT00620659|12162628|FG001|Treatment Period 1|Adverse Event|0
7733446|NCT00620659|12162629|FG002|Treatment Period 1|Adverse Event|0
7733447|NCT00620659|12162630|FG003|Treatment Period 1|Adverse Event|3
7733448|NCT00620659|12162631|FG004|Treatment Period 1|Adverse Event|0
7733449|NCT00620659|12162632|FG005|Treatment Period 1|Adverse Event|0
7733450|NCT00620659|12162627|FG000|Treatment Period 1|Protocol Violation|1
7733451|NCT00620659|12162628|FG001|Treatment Period 1|Protocol Violation|0
7733452|NCT00620659|12162629|FG002|Treatment Period 1|Protocol Violation|0
7733453|NCT00620659|12162630|FG003|Treatment Period 1|Protocol Violation|0
7733454|NCT00620659|12162631|FG004|Treatment Period 1|Protocol Violation|0
7733455|NCT00620659|12162632|FG005|Treatment Period 1|Protocol Violation|0
7733456|NCT00620659|12162627|FG000|Treatment Period 1|Withdrawal by Subject|1
7733457|NCT00620659|12162628|FG001|Treatment Period 1|Withdrawal by Subject|0
7733458|NCT00620659|12162629|FG002|Treatment Period 1|Withdrawal by Subject|1
7733459|NCT00620659|12162630|FG003|Treatment Period 1|Withdrawal by Subject|0
7733460|NCT00620659|12162631|FG004|Treatment Period 1|Withdrawal by Subject|1
7733461|NCT00620659|12162632|FG005|Treatment Period 1|Withdrawal by Subject|0
7733462|NCT00620659|12162627|FG000|Placebo Washout Period 1|Withdrawal by Subject|0
7733463|NCT00620659|12162628|FG001|Placebo Washout Period 1|Withdrawal by Subject|0
7733464|NCT00620659|12162629|FG002|Placebo Washout Period 1|Withdrawal by Subject|0
7733465|NCT00620659|12162630|FG003|Placebo Washout Period 1|Withdrawal by Subject|1
7733466|NCT00620659|12162631|FG004|Placebo Washout Period 1|Withdrawal by Subject|0
7733467|NCT00620659|12162632|FG005|Placebo Washout Period 1|Withdrawal by Subject|0
7733468|NCT00620659|12162627|FG000|Treatment Period 2|Adverse Event|0
7733469|NCT00620659|12162628|FG001|Treatment Period 2|Adverse Event|3
7733470|NCT00620659|12162629|FG002|Treatment Period 2|Adverse Event|0
7733471|NCT00620659|12162630|FG003|Treatment Period 2|Adverse Event|0
7733472|NCT00620659|12162631|FG004|Treatment Period 2|Adverse Event|2
7733473|NCT00620659|12162632|FG005|Treatment Period 2|Adverse Event|0
7733474|NCT00620659|12162627|FG000|Treatment Period 2|Withdrawal by Subject|0
7733475|NCT00620659|12162628|FG001|Treatment Period 2|Withdrawal by Subject|0
7733476|NCT00620659|12162629|FG002|Treatment Period 2|Withdrawal by Subject|1
7733477|NCT00620659|12162630|FG003|Treatment Period 2|Withdrawal by Subject|0
7733478|NCT00620659|12162631|FG004|Treatment Period 2|Withdrawal by Subject|3
7733479|NCT00620659|12162632|FG005|Treatment Period 2|Withdrawal by Subject|0
7733480|NCT00620659|12162627|FG000|Placebo Washout Period 2|Adverse Event|2
7733481|NCT00620659|12162628|FG001|Placebo Washout Period 2|Adverse Event|0
7733482|NCT00620659|12162629|FG002|Placebo Washout Period 2|Adverse Event|0
7733483|NCT00620659|12162630|FG003|Placebo Washout Period 2|Adverse Event|0
7733484|NCT00620659|12162631|FG004|Placebo Washout Period 2|Adverse Event|0
7733485|NCT00620659|12162632|FG005|Placebo Washout Period 2|Adverse Event|0
7733486|NCT00620659|12162627|FG000|Treatment Period 3|Adverse Event|0
7733487|NCT00620659|12162628|FG001|Treatment Period 3|Adverse Event|2
7733488|NCT00620659|12162629|FG002|Treatment Period 3|Adverse Event|0
7733489|NCT00620659|12162630|FG003|Treatment Period 3|Adverse Event|0
7733490|NCT00620659|12162631|FG004|Treatment Period 3|Adverse Event|0
7733491|NCT00620659|12162632|FG005|Treatment Period 3|Adverse Event|0
7733492|NCT00620659|12162627|FG000|Treatment Period 3|Withdrawal by Subject|0
7733493|NCT00620659|12162628|FG001|Treatment Period 3|Withdrawal by Subject|0
7733494|NCT00620659|12162629|FG002|Treatment Period 3|Withdrawal by Subject|0
7733495|NCT00620659|12162630|FG003|Treatment Period 3|Withdrawal by Subject|1
7733496|NCT00620659|12162631|FG004|Treatment Period 3|Withdrawal by Subject|0
7733497|NCT00620659|12162632|FG005|Treatment Period 3|Withdrawal by Subject|0
7733498|NCT00620750|12162653|FG000|Overall Study|Lost to Follow-up|25
7733499|NCT00620763|12162657|FG000|Period: First Intervention|Withdrawal by Subject|0
7733500|NCT00620763|12162658|FG001|Period: First Intervention|Withdrawal by Subject|2
7733501|NCT00620763|12162657|FG000|Period: First Intervention|Protocol Violation|0
7733502|NCT00620763|12162658|FG001|Period: First Intervention|Protocol Violation|3
7733503|NCT00620763|12162657|FG000|Period: Second Intervention|Withdrawal by Subject|1
7733504|NCT00620763|12162658|FG001|Period: Second Intervention|Withdrawal by Subject|0
7733505|NCT00620776|12162666|FG000|Overall Study|Did not receive treatment|3
7733506|NCT00620776|12162667|FG001|Overall Study|Did not receive treatment|5
7733507|NCT00620776|12162666|FG000|Overall Study|Adverse Event|2
7733508|NCT00620776|12162667|FG001|Overall Study|Adverse Event|3
7733509|NCT00620776|12162666|FG000|Overall Study|Lack of Efficacy|2
7733510|NCT00620776|12162667|FG001|Overall Study|Lack of Efficacy|1
7733511|NCT00620776|12162666|FG000|Overall Study|Lost to Follow-up|2
7733512|NCT00620776|12162667|FG001|Overall Study|Lost to Follow-up|5
7733513|NCT00620776|12162666|FG000|Overall Study|Withdrawal by Subject|3
7733514|NCT00620776|12162667|FG001|Overall Study|Withdrawal by Subject|2
7733515|NCT00620815|12162676|FG000|Overall Study|Adverse Event|1
7733516|NCT00620815|12162677|FG001|Overall Study|Adverse Event|1
7733517|NCT00620815|12162678|FG002|Overall Study|Adverse Event|2
7733518|NCT00620815|12162676|FG000|Overall Study|Withdrawal by Subject|1
7733519|NCT00620815|12162677|FG001|Overall Study|Withdrawal by Subject|2
7733520|NCT00620815|12162678|FG002|Overall Study|Withdrawal by Subject|0
7733521|NCT00620815|12162676|FG000|Overall Study|Lost to Follow-up|1
7733522|NCT00620815|12162677|FG001|Overall Study|Lost to Follow-up|6
7733523|NCT00620815|12162678|FG002|Overall Study|Lost to Follow-up|3
7733524|NCT00620815|12162676|FG000|Overall Study|Inappropriate enrolment|0
7733525|NCT00620815|12162677|FG001|Overall Study|Inappropriate enrolment|0
7733526|NCT00620815|12162678|FG002|Overall Study|Inappropriate enrolment|1
7733527|NCT00620815|12162676|FG000|Overall Study|Protocol Violation|1
7733528|NCT00620815|12162677|FG001|Overall Study|Protocol Violation|2
7733529|NCT00620815|12162678|FG002|Overall Study|Protocol Violation|1
7733530|NCT00620854|12162717|FG000|Washout 1|Withdrawal by Subject|0
7733531|NCT00620854|12162718|FG001|Washout 1|Withdrawal by Subject|0
7733532|NCT00620854|12162719|FG002|Washout 1|Withdrawal by Subject|1
7733533|NCT00620854|12162720|FG003|Washout 1|Withdrawal by Subject|1
7733534|NCT00620854|12162721|FG004|Washout 1|Withdrawal by Subject|0
7733535|NCT00620854|12162722|FG005|Washout 1|Withdrawal by Subject|0
7733536|NCT00621023|12162737|FG000|Overall Study|Death|5
7733537|NCT00621023|12162737|FG000|Overall Study|Follow up discontinued|1
7733538|NCT00621140|12162752|FG000|Overall Study|Adverse Event|4
7733539|NCT00621140|12162753|FG001|Overall Study|Adverse Event|5
7733540|NCT00621140|12162752|FG000|Overall Study|Lost to Follow-up|1
7733541|NCT00621140|12162753|FG001|Overall Study|Lost to Follow-up|2
7733542|NCT00621140|12162752|FG000|Overall Study|Withdrawal by Subject|4
7733543|NCT00621140|12162753|FG001|Overall Study|Withdrawal by Subject|6
7733544|NCT00621140|12162752|FG000|Overall Study|Other incl. lack of efficacy|6
7733545|NCT00621140|12162753|FG001|Overall Study|Other incl. lack of efficacy|5
7733546|NCT00621153|12162761|FG000|Overall Study|Safety Reason|8
7733547|NCT00621153|12162762|FG001|Overall Study|Safety Reason|7
7733548|NCT00621153|12162761|FG000|Overall Study|Adverse Event|3
7733549|NCT00621153|12162762|FG001|Overall Study|Adverse Event|2
7733550|NCT00621153|12162761|FG000|Overall Study|Lost to Follow-up|5
7733551|NCT00621153|12162762|FG001|Overall Study|Lost to Follow-up|1
7733552|NCT00621153|12162761|FG000|Overall Study|Withdrawal by Subject|4
7733553|NCT00621153|12162762|FG001|Overall Study|Withdrawal by Subject|5
7733554|NCT00621192|12162789|FG000|Overall Study|Withdrawal by Subject|0
7733555|NCT00621192|12162790|FG001|Overall Study|Withdrawal by Subject|0
7733556|NCT00621192|12162791|FG002|Overall Study|Withdrawal by Subject|2
7733557|NCT00621192|12162792|FG003|Overall Study|Withdrawal by Subject|0
7733558|NCT00621192|12162789|FG000|Overall Study|Physician Decision|1
7733559|NCT00621192|12162790|FG001|Overall Study|Physician Decision|3
7733560|NCT00621192|12162791|FG002|Overall Study|Physician Decision|0
7733561|NCT00621192|12162792|FG003|Overall Study|Physician Decision|0
7733562|NCT00621192|12162789|FG000|Overall Study|Protocol Violation|1
7733563|NCT00621192|12162790|FG001|Overall Study|Protocol Violation|0
7733564|NCT00621192|12162791|FG002|Overall Study|Protocol Violation|0
7733565|NCT00621192|12162792|FG003|Overall Study|Protocol Violation|1
7733566|NCT00621192|12162789|FG000|Overall Study|Adverse Event|0
7733567|NCT00621192|12162790|FG001|Overall Study|Adverse Event|1
7733568|NCT00621192|12162791|FG002|Overall Study|Adverse Event|0
7733569|NCT00621192|12162792|FG003|Overall Study|Adverse Event|1
7733570|NCT00621192|12162789|FG000|Overall Study|Death|2
7733571|NCT00621192|12162790|FG001|Overall Study|Death|5
7733572|NCT00621192|12162791|FG002|Overall Study|Death|0
7733573|NCT00621192|12162792|FG003|Overall Study|Death|0
7733574|NCT00621192|12162789|FG000|Overall Study|Final Assessments not Completed|0
7733575|NCT00621192|12162790|FG001|Overall Study|Final Assessments not Completed|0
7733576|NCT00621192|12162791|FG002|Overall Study|Final Assessments not Completed|3
7733577|NCT00621192|12162792|FG003|Overall Study|Final Assessments not Completed|1
7733578|NCT00621244|12162806|FG000|Overall Study|Withdrawal by Subject|7
7733579|NCT00621244|12162807|FG001|Overall Study|Withdrawal by Subject|3
7733580|NCT00621244|12162808|FG002|Overall Study|Withdrawal by Subject|3
7733581|NCT00621244|12162809|FG003|Overall Study|Withdrawal by Subject|3
7733582|NCT00621244|12162806|FG000|Overall Study|Disease progression|44
7733583|NCT00621244|12162807|FG001|Overall Study|Disease progression|20
7733584|NCT00621244|12162808|FG002|Overall Study|Disease progression|20
7733585|NCT00621244|12162809|FG003|Overall Study|Disease progression|15
7733586|NCT00621244|12162806|FG000|Overall Study|Death|3
7733587|NCT00621244|12162807|FG001|Overall Study|Death|3
7733588|NCT00621244|12162808|FG002|Overall Study|Death|1
7733589|NCT00621244|12162809|FG003|Overall Study|Death|1
7733590|NCT00621244|12162806|FG000|Overall Study|Adverse Event|27
7733591|NCT00621244|12162807|FG001|Overall Study|Adverse Event|7
7733592|NCT00621244|12162808|FG002|Overall Study|Adverse Event|9
7733593|NCT00621244|12162809|FG003|Overall Study|Adverse Event|2
7733594|NCT00621244|12162806|FG000|Overall Study|Administrative problems|5
7733595|NCT00621244|12162807|FG001|Overall Study|Administrative problems|1
7733596|NCT00621244|12162808|FG002|Overall Study|Administrative problems|0
7733597|NCT00621244|12162809|FG003|Overall Study|Administrative problems|2
7733598|NCT00621257|12162888|FG000|Overall Study|Lost to Follow-up|4
7733599|NCT00621257|12162889|FG001|Overall Study|Lost to Follow-up|0
7733600|NCT00621257|12162890|FG002|Overall Study|Lost to Follow-up|2
7733601|NCT00621257|12162891|FG003|Overall Study|Lost to Follow-up|4
7733602|NCT00621257|12162892|FG004|Overall Study|Lost to Follow-up|7
7733603|NCT00621257|12162888|FG000|Overall Study|Adverse Event|0
7733604|NCT00621257|12162889|FG001|Overall Study|Adverse Event|1
7733605|NCT00621257|12162890|FG002|Overall Study|Adverse Event|1
7733606|NCT00621257|12162891|FG003|Overall Study|Adverse Event|0
7733607|NCT00621257|12162892|FG004|Overall Study|Adverse Event|0
7733608|NCT00621257|12162888|FG000|Overall Study|Physician Decision|0
7733609|NCT00621257|12162889|FG001|Overall Study|Physician Decision|2
7733610|NCT00621257|12162890|FG002|Overall Study|Physician Decision|0
7733611|NCT00621257|12162891|FG003|Overall Study|Physician Decision|1
7733612|NCT00621257|12162892|FG004|Overall Study|Physician Decision|1
7733613|NCT00621257|12162888|FG000|Overall Study|Withdrawal by Subject|0
7733614|NCT00621257|12162889|FG001|Overall Study|Withdrawal by Subject|0
7733615|NCT00621257|12162890|FG002|Overall Study|Withdrawal by Subject|0
7733616|NCT00621257|12162891|FG003|Overall Study|Withdrawal by Subject|1
7733617|NCT00621257|12162892|FG004|Overall Study|Withdrawal by Subject|1
7733618|NCT00621296|12162904|FG000|Overall Study|Adverse Event|2
7733619|NCT00621296|12162904|FG000|Overall Study|Lack of Efficacy|1
7733620|NCT00621296|12162904|FG000|Overall Study|Physician Decision|7
7733621|NCT00621296|12162904|FG000|Overall Study|Unmatch Criteria|1
7733622|NCT00621296|12162904|FG000|Overall Study|Stopping Criteria|3
7733623|NCT00621309|12162908|FG000|Overall Study|Withdrawal by Subject|2
7733624|NCT00621309|12162909|FG001|Overall Study|Withdrawal by Subject|0
7733625|NCT00621309|12162910|FG002|Overall Study|Withdrawal by Subject|1
7733626|NCT00621309|12162911|FG003|Overall Study|Withdrawal by Subject|1
7733627|NCT00621309|12162912|FG004|Overall Study|Withdrawal by Subject|1
7733628|NCT00621309|12162913|FG005|Overall Study|Withdrawal by Subject|1
7733629|NCT00621322|12162925|FG000|Overall Study|Lost to Follow-up|0
7733630|NCT00621322|12162926|FG001|Overall Study|Lost to Follow-up|0
7733631|NCT00621322|12162927|FG002|Overall Study|Lost to Follow-up|0
7733632|NCT00621322|12162928|FG003|Overall Study|Lost to Follow-up|0
7733633|NCT00621322|12162929|FG004|Overall Study|Lost to Follow-up|1
7733634|NCT00621322|12162930|FG005|Overall Study|Lost to Follow-up|0
7733635|NCT00621322|12162925|FG000|Overall Study|Physician Decision|0
7733636|NCT00621322|12162926|FG001|Overall Study|Physician Decision|0
7733637|NCT00621322|12162927|FG002|Overall Study|Physician Decision|1
7733638|NCT00621322|12162928|FG003|Overall Study|Physician Decision|1
7733639|NCT00621322|12162929|FG004|Overall Study|Physician Decision|0
7733640|NCT00621322|12162930|FG005|Overall Study|Physician Decision|0
7733641|NCT00621322|12162925|FG000|Overall Study|Withdrawal by Subject|0
7733642|NCT00621322|12162926|FG001|Overall Study|Withdrawal by Subject|0
7733643|NCT00621322|12162927|FG002|Overall Study|Withdrawal by Subject|0
7733644|NCT00621322|12162928|FG003|Overall Study|Withdrawal by Subject|1
7733645|NCT00621322|12162929|FG004|Overall Study|Withdrawal by Subject|0
7733646|NCT00621322|12162930|FG005|Overall Study|Withdrawal by Subject|2
7733647|NCT00621322|12162925|FG000|Overall Study|Migrated/moved from study area|1
7733648|NCT00621322|12162926|FG001|Overall Study|Migrated/moved from study area|0
7733649|NCT00621322|12162927|FG002|Overall Study|Migrated/moved from study area|1
7733650|NCT00621322|12162928|FG003|Overall Study|Migrated/moved from study area|1
7733651|NCT00621322|12162929|FG004|Overall Study|Migrated/moved from study area|0
7733652|NCT00621322|12162930|FG005|Overall Study|Migrated/moved from study area|2
7733653|NCT00621504|12162959|FG000|Overall Study|Adverse Event|1
7733654|NCT00621504|12162960|FG001|Overall Study|Adverse Event|3
7733655|NCT00621504|12162959|FG000|Overall Study|At the request of sponsor/investigator|1
7733656|NCT00621504|12162960|FG001|Overall Study|At the request of sponsor/investigator|0
7733657|NCT00621504|12162959|FG000|Overall Study|Withdrew consent|9
7733658|NCT00621504|12162960|FG001|Overall Study|Withdrew consent|6
7733659|NCT00621504|12162959|FG000|Overall Study|Lost to Follow-up|8
7733660|NCT00621504|12162960|FG001|Overall Study|Lost to Follow-up|10
7733661|NCT00621504|12162959|FG000|Overall Study|Other|1
7733662|NCT00621504|12162960|FG001|Overall Study|Other|0
7733663|NCT00621504|12162959|FG000|Overall Study|Death|6
7733664|NCT00621504|12162960|FG001|Overall Study|Death|6
7733665|NCT00621517|12162968|FG000|Overall Study|Lost to Follow-up|3
7733666|NCT00621517|12162969|FG001|Overall Study|Lost to Follow-up|3
7733667|NCT00621517|12162968|FG000|Overall Study|Withdrawal by Subject|3
7733668|NCT00621517|12162969|FG001|Overall Study|Withdrawal by Subject|4
7733669|NCT00621517|12162968|FG000|Overall Study|Adverse Event|1
7733670|NCT00621517|12162969|FG001|Overall Study|Adverse Event|0
7733671|NCT00621543|12162987|FG000|Overall Study|Lost to Follow-up|23
7733672|NCT00621582|12162991|FG000|Overall Study|Adverse Event|7
7733673|NCT00621582|12162991|FG000|Overall Study|Protocol Violation|57
7733674|NCT00621582|12162991|FG000|Overall Study|Lost to Follow-up|24
7733675|NCT00621582|12162991|FG000|Overall Study|issues not identified by investigators|18
7733676|NCT00621621|12162998|FG000|Overall Study|Subjects were exited at EP study|30
7733677|NCT00621621|12162999|FG001|Overall Study|Subjects were exited at EP study|0
7733678|NCT00621764|12163021|FG000|Overall Study|Protocol Violation|0
7733679|NCT00621764|12163022|FG001|Overall Study|Protocol Violation|0
7733680|NCT00621764|12163023|FG002|Overall Study|Protocol Violation|0
7733681|NCT00621764|12163024|FG003|Overall Study|Protocol Violation|1
7733682|NCT00621777|12163037|FG000|Open Phase|Adverse Event|20
7733683|NCT00621777|12163038|FG001|Open Phase|Adverse Event|0
7733684|NCT00621777|12163037|FG000|Open Phase|Did not abstain during open phase|56
7733685|NCT00621777|12163038|FG001|Open Phase|Did not abstain during open phase|0
7733686|NCT00621777|12163037|FG000|Open Phase|Withdrawal by Subject|17
7733687|NCT00621777|12163038|FG001|Open Phase|Withdrawal by Subject|0
7733688|NCT00621777|12163037|FG000|Open Phase|administrative|13
7733689|NCT00621777|12163038|FG001|Open Phase|administrative|0
7733690|NCT00621777|12163037|FG000|Open Phase|Lost to Follow-up|10
7733691|NCT00621777|12163038|FG001|Open Phase|Lost to Follow-up|0
7733692|NCT00621777|12163037|FG000|Randomized Phase|Adverse Event|3
7733693|NCT00621777|12163038|FG001|Randomized Phase|Adverse Event|3
7733694|NCT00621777|12163037|FG000|Randomized Phase|Lost to Follow-up|3
7733695|NCT00621777|12163038|FG001|Randomized Phase|Lost to Follow-up|3
7733696|NCT00621777|12163037|FG000|Randomized Phase|Withdrawal by Subject|1
7733697|NCT00621777|12163038|FG001|Randomized Phase|Withdrawal by Subject|9
7733698|NCT00621777|12163037|FG000|Randomized Phase|administrative|0
7733699|NCT00621777|12163038|FG001|Randomized Phase|administrative|3
7733700|NCT00621777|12163037|FG000|Randomized Phase|Death|0
7733701|NCT00621777|12163038|FG001|Randomized Phase|Death|1
7733702|NCT00621842|12163046|FG000|Overall Study|Adverse Event|6
7733703|NCT00621842|12163046|FG000|Overall Study|Withdrawal by Subject|7
7733704|NCT00621842|12163046|FG000|Overall Study|Protocol Violation|4
7733705|NCT00621842|12163046|FG000|Overall Study|Lack of Efficacy|2
7733706|NCT00621855|12163055|FG000|Overall Study|Adverse Event|32
7733707|NCT00621855|12163056|FG001|Overall Study|Adverse Event|31
7733708|NCT00621855|12163057|FG002|Overall Study|Adverse Event|48
7733709|NCT00621855|12163058|FG003|Overall Study|Adverse Event|34
7733710|NCT00621855|12163059|FG004|Overall Study|Adverse Event|31
7733711|NCT00621855|12163055|FG000|Overall Study|Lost to Follow-up|0
7733712|NCT00621855|12163056|FG001|Overall Study|Lost to Follow-up|1
7733713|NCT00621855|12163057|FG002|Overall Study|Lost to Follow-up|3
7733714|NCT00621855|12163058|FG003|Overall Study|Lost to Follow-up|4
7733715|NCT00621855|12163059|FG004|Overall Study|Lost to Follow-up|1
7733716|NCT00621855|12163055|FG000|Overall Study|Protocol Violation|16
7733717|NCT00621855|12163056|FG001|Overall Study|Protocol Violation|8
7733718|NCT00621855|12163057|FG002|Overall Study|Protocol Violation|6
7733719|NCT00621855|12163058|FG003|Overall Study|Protocol Violation|7
7733720|NCT00621855|12163059|FG004|Overall Study|Protocol Violation|8
7733721|NCT00621855|12163055|FG000|Overall Study|Withdrawal by Subject|16
7733722|NCT00621855|12163056|FG001|Overall Study|Withdrawal by Subject|11
7733723|NCT00621855|12163057|FG002|Overall Study|Withdrawal by Subject|13
7733724|NCT00621855|12163058|FG003|Overall Study|Withdrawal by Subject|13
7733725|NCT00621855|12163059|FG004|Overall Study|Withdrawal by Subject|9
7733726|NCT00621855|12163055|FG000|Overall Study|Other|9
7733727|NCT00621855|12163056|FG001|Overall Study|Other|7
7733728|NCT00621855|12163057|FG002|Overall Study|Other|6
7733729|NCT00621855|12163058|FG003|Overall Study|Other|5
7733730|NCT00621855|12163059|FG004|Overall Study|Other|4
7733731|NCT00621855|12163055|FG000|Overall Study|Patients did not receive study drug|3
7733732|NCT00621855|12163056|FG001|Overall Study|Patients did not receive study drug|3
7733733|NCT00621855|12163057|FG002|Overall Study|Patients did not receive study drug|5
7733734|NCT00621855|12163058|FG003|Overall Study|Patients did not receive study drug|4
7733735|NCT00621855|12163059|FG004|Overall Study|Patients did not receive study drug|2
7733736|NCT00621959|12163087|FG000|Overall Study|Adverse Event|4
7733737|NCT00621959|12163088|FG001|Overall Study|Adverse Event|2
7733738|NCT00621959|12163087|FG000|Overall Study|Lack of Efficacy|1
7733739|NCT00621959|12163088|FG001|Overall Study|Lack of Efficacy|1
7733740|NCT00621959|12163087|FG000|Overall Study|Lost to Follow-up|0
7733741|NCT00621959|12163088|FG001|Overall Study|Lost to Follow-up|2
7733742|NCT00621959|12163087|FG000|Overall Study|Withdrawal by Subject|1
7733743|NCT00621959|12163088|FG001|Overall Study|Withdrawal by Subject|1
7733744|NCT00621959|12163087|FG000|Overall Study|Other|1
7733745|NCT00621959|12163088|FG001|Overall Study|Other|3
7733746|NCT00621985|12163094|FG000|Dexamethasone Admission|Adverse Event|1
7733747|NCT00622180|12163100|FG000|Overall Study|Lost to Follow-up|1
7733748|NCT00622180|12163101|FG001|Overall Study|Lost to Follow-up|2
7733749|NCT00622284|12163109|FG000|Overall Study|Lack of Efficacy|45
7733750|NCT00622284|12163110|FG001|Overall Study|Lack of Efficacy|15
7733751|NCT00622284|12163109|FG000|Overall Study|Adverse Event|61
7733752|NCT00622284|12163110|FG001|Overall Study|Adverse Event|90
7733753|NCT00622284|12163109|FG000|Overall Study|Protocol Violation|12
7733754|NCT00622284|12163110|FG001|Overall Study|Protocol Violation|5
7733755|NCT00622284|12163109|FG000|Overall Study|Lost to Follow-up|11
7733756|NCT00622284|12163110|FG001|Overall Study|Lost to Follow-up|13
7733757|NCT00622284|12163109|FG000|Overall Study|Withdrawal by Subject|27
7733758|NCT00622284|12163110|FG001|Overall Study|Withdrawal by Subject|24
7733759|NCT00622284|12163109|FG000|Overall Study|Other reason (not specified)|33
7733760|NCT00622284|12163110|FG001|Overall Study|Other reason (not specified)|24
7733761|NCT00622336|12163116|FG000|Treatment Phase|Progression of Disease|181
7733762|NCT00622336|12163116|FG000|Treatment Phase|Adverse Event|46
7733763|NCT00622336|12163116|FG000|Treatment Phase|Other|40
7733764|NCT00622336|12163116|FG000|Treatment Phase|Death|14
7733765|NCT00622336|12163116|FG000|Treatment Phase|Lack of therapeutic effect|13
7733766|NCT00622336|12163116|FG000|Treatment Phase|Withdrawal by Subject|13
7733767|NCT00622336|12163116|FG000|Treatment Phase|Lost to Follow-up|2
7733768|NCT00622336|12163116|FG000|Extension Phase|Adverse Event|2
7733769|NCT00622336|12163116|FG000|Extension Phase|Progressive Disease|6
7733770|NCT00622336|12163116|FG000|Extension Phase|Lack of therapeutic effect|2
7733771|NCT00622336|12163116|FG000|Extension Phase|Withdrawal by Subject|1
7733772|NCT00622336|12163116|FG000|Extension Phase|Lost to Follow-up|1
7733773|NCT00622336|12163116|FG000|Extension Phase|Other|9
7733774|NCT00622388|12163122|FG000|Overall Study|Disease Progression|47
7733775|NCT00622388|12163122|FG000|Overall Study|Adverse Event|6
7733776|NCT00622388|12163122|FG000|Overall Study|Protocol Violation|3
7733777|NCT00622388|12163122|FG000|Overall Study|Participant Refusal|1
7733778|NCT00622388|12163122|FG000|Overall Study|Death|3
7733779|NCT00622388|12163122|FG000|Overall Study|Received Alternate Anticancer Therapy|8
7733780|NCT00622388|12163122|FG000|Overall Study|Took Prohibited Medication|2
7733781|NCT00622388|12163122|FG000|Overall Study|Withdrew Consent|1
7733782|NCT00622388|12163122|FG000|Overall Study|Insurance Expired|1
7733783|NCT00622401|12163130|FG000|Overall Study|Disease progression prior to treatment|3
7733784|NCT00622401|12163131|FG001|Overall Study|Disease progression prior to treatment|2
7733785|NCT00622401|12163132|FG002|Overall Study|Disease progression prior to treatment|0
7733786|NCT00622440|12163152|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4
7733787|NCT00622440|12163153|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1
7733788|NCT00622440|12163152|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
7733789|NCT00622440|12163153|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
7733790|NCT00622440|12163152|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
7733791|NCT00622440|12163153|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
7733792|NCT00622440|12163152|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
7733793|NCT00622440|12163153|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
7733794|NCT00622466|12163159|FG000|Overall Study|Death|1
7733795|NCT00622466|12163159|FG000|Overall Study|Adverse Event|1
7733796|NCT00622466|12163159|FG000|Overall Study|Withdrawal by Subject|2
7733797|NCT00622505|12163165|FG000|Overall Study|Adverse Event|9
7733798|NCT00622505|12163166|FG001|Overall Study|Adverse Event|7
7733799|NCT00622505|12163165|FG000|Overall Study|Abnormal Laboratory Value(s)|3
7733800|NCT00622505|12163166|FG001|Overall Study|Abnormal Laboratory Value(s)|5
7733801|NCT00622505|12163165|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
7733802|NCT00622505|12163166|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
7733803|NCT00622505|12163165|FG000|Overall Study|Withdrawal by Subject|12
7733804|NCT00622505|12163166|FG001|Overall Study|Withdrawal by Subject|5
7733805|NCT00622505|12163165|FG000|Overall Study|Administrative Problems|2
7733806|NCT00622505|12163166|FG001|Overall Study|Administrative Problems|4
7733807|NCT00622505|12163165|FG000|Overall Study|Death|2
7733808|NCT00622505|12163166|FG001|Overall Study|Death|2
7768713|NCT00863304|12212062|FG001|Overall Study|Randomized, but not Treated|1
7768714|NCT00863304|12212063|FG002|Overall Study|Randomized, but not Treated|4
7768715|NCT00863304|12212064|FG003|Overall Study|Randomized, but not Treated|1
7768716|NCT00863304|12212061|FG000|Overall Study|Entered extension study|101
7768717|NCT00863304|12212062|FG001|Overall Study|Entered extension study|129
7768718|NCT00863304|12212063|FG002|Overall Study|Entered extension study|113
7768719|NCT00863304|12212064|FG003|Overall Study|Entered extension study|125
7768720|NCT00863317|12212078|FG000|Overall Study|Lost to Follow-up|8
7768721|NCT00863317|12212079|FG001|Overall Study|Lost to Follow-up|9
7768722|NCT00863655|12212110|FG000|Overall Study|Protocol Violation|4
7768723|NCT00863655|12212111|FG001|Overall Study|Protocol Violation|0
7768724|NCT00863655|12212110|FG000|Overall Study|Adverse Event|52
7768725|NCT00863655|12212111|FG001|Overall Study|Adverse Event|8
7768726|NCT00863655|12212110|FG000|Overall Study|Withdrawal by Subject|47
7768727|NCT00863655|12212111|FG001|Overall Study|Withdrawal by Subject|7
7768728|NCT00863655|12212110|FG000|Overall Study|Administrative problems|1
7768729|NCT00863655|12212111|FG001|Overall Study|Administrative problems|0
7768730|NCT00863655|12212110|FG000|Overall Study|Death|7
7768731|NCT00863655|12212111|FG001|Overall Study|Death|1
7768732|NCT00863655|12212110|FG000|Overall Study|New cancer therapy|5
7768733|NCT00863655|12212111|FG001|Overall Study|New cancer therapy|1
7768734|NCT00863655|12212110|FG000|Overall Study|Disease progression|364
7768735|NCT00863655|12212111|FG001|Overall Study|Disease progression|221
7768736|NCT00863655|12212110|FG000|Overall Study|Treatment completed as per protocol|5
7733809|NCT00622635|12163185|FG000|Treatment Period 1|Adverse Event|0
7733810|NCT00622635|12163186|FG001|Treatment Period 1|Adverse Event|0
7733811|NCT00622635|12163187|FG002|Treatment Period 1|Adverse Event|1
7733812|NCT00622635|12163188|FG003|Treatment Period 1|Adverse Event|0
7733813|NCT00622635|12163189|FG004|Treatment Period 1|Adverse Event|0
7733814|NCT00622635|12163190|FG005|Treatment Period 1|Adverse Event|0
7733815|NCT00622635|12163185|FG000|Treatment Period 1|Withdrawal by Subject|0
7733816|NCT00622635|12163186|FG001|Treatment Period 1|Withdrawal by Subject|1
7733817|NCT00622635|12163187|FG002|Treatment Period 1|Withdrawal by Subject|0
7733818|NCT00622635|12163188|FG003|Treatment Period 1|Withdrawal by Subject|0
7733819|NCT00622635|12163189|FG004|Treatment Period 1|Withdrawal by Subject|0
7733820|NCT00622635|12163190|FG005|Treatment Period 1|Withdrawal by Subject|0
7733821|NCT00622635|12163185|FG000|Treatment Period 1|Abnormal test procedure result(s)|0
7733822|NCT00622635|12163186|FG001|Treatment Period 1|Abnormal test procedure result(s)|0
7733823|NCT00622635|12163187|FG002|Treatment Period 1|Abnormal test procedure result(s)|0
7733824|NCT00622635|12163188|FG003|Treatment Period 1|Abnormal test procedure result(s)|0
7733825|NCT00622635|12163189|FG004|Treatment Period 1|Abnormal test procedure result(s)|1
7733826|NCT00622635|12163190|FG005|Treatment Period 1|Abnormal test procedure result(s)|0
7733827|NCT00622635|12163185|FG000|Treatment Period 2|Adverse Event|1
7733828|NCT00622635|12163186|FG001|Treatment Period 2|Adverse Event|0
7733829|NCT00622635|12163187|FG002|Treatment Period 2|Adverse Event|0
7733830|NCT00622635|12163188|FG003|Treatment Period 2|Adverse Event|0
7733831|NCT00622635|12163189|FG004|Treatment Period 2|Adverse Event|0
7733832|NCT00622635|12163190|FG005|Treatment Period 2|Adverse Event|0
7733833|NCT00622635|12163185|FG000|Treatment Period 3|Adverse Event|0
7733834|NCT00622635|12163186|FG001|Treatment Period 3|Adverse Event|0
7733835|NCT00622635|12163187|FG002|Treatment Period 3|Adverse Event|0
7733836|NCT00622635|12163188|FG003|Treatment Period 3|Adverse Event|2
7733837|NCT00622635|12163189|FG004|Treatment Period 3|Adverse Event|0
7733838|NCT00622635|12163190|FG005|Treatment Period 3|Adverse Event|0
7733839|NCT00622635|12163185|FG000|Treatment Period 3|Withdrawal by Subject|0
7733840|NCT00622635|12163186|FG001|Treatment Period 3|Withdrawal by Subject|0
7733841|NCT00622635|12163187|FG002|Treatment Period 3|Withdrawal by Subject|0
7733842|NCT00622635|12163188|FG003|Treatment Period 3|Withdrawal by Subject|1
7733843|NCT00622635|12163189|FG004|Treatment Period 3|Withdrawal by Subject|0
7733844|NCT00622635|12163190|FG005|Treatment Period 3|Withdrawal by Subject|0
7733845|NCT00622700|12163201|FG000|Core Treatment Period|Randomized but Not Treated|0
7733846|NCT00622700|12163202|FG001|Core Treatment Period|Randomized but Not Treated|2
7733847|NCT00622700|12163203|FG002|Core Treatment Period|Randomized but Not Treated|2
7733848|NCT00622700|12163204|FG003|Core Treatment Period|Randomized but Not Treated|0
7733849|NCT00622700|12163205|FG004|Core Treatment Period|Randomized but Not Treated|0
7733850|NCT00622700|12163206|FG005|Core Treatment Period|Randomized but Not Treated|0
7733851|NCT00622700|12163207|FG006|Core Treatment Period|Randomized but Not Treated|0
7733852|NCT00622700|12163201|FG000|Core Treatment Period|Adverse Event|18
7733853|NCT00622700|12163202|FG001|Core Treatment Period|Adverse Event|25
7733854|NCT00622700|12163203|FG002|Core Treatment Period|Adverse Event|18
7733855|NCT00622700|12163204|FG003|Core Treatment Period|Adverse Event|0
7733856|NCT00622700|12163205|FG004|Core Treatment Period|Adverse Event|0
7733857|NCT00622700|12163206|FG005|Core Treatment Period|Adverse Event|0
7733858|NCT00622700|12163207|FG006|Core Treatment Period|Adverse Event|0
7733859|NCT00622700|12163201|FG000|Core Treatment Period|Lack of Efficacy|19
7733860|NCT00622700|12163202|FG001|Core Treatment Period|Lack of Efficacy|6
7733861|NCT00622700|12163203|FG002|Core Treatment Period|Lack of Efficacy|12
7733862|NCT00622700|12163204|FG003|Core Treatment Period|Lack of Efficacy|0
7733863|NCT00622700|12163205|FG004|Core Treatment Period|Lack of Efficacy|0
7733864|NCT00622700|12163206|FG005|Core Treatment Period|Lack of Efficacy|0
7733865|NCT00622700|12163207|FG006|Core Treatment Period|Lack of Efficacy|0
7733866|NCT00622700|12163201|FG000|Core Treatment Period|Lost to Follow-up|1
7733867|NCT00622700|12163202|FG001|Core Treatment Period|Lost to Follow-up|1
7733868|NCT00622700|12163203|FG002|Core Treatment Period|Lost to Follow-up|1
7733869|NCT00622700|12163204|FG003|Core Treatment Period|Lost to Follow-up|0
7733870|NCT00622700|12163205|FG004|Core Treatment Period|Lost to Follow-up|0
7733871|NCT00622700|12163206|FG005|Core Treatment Period|Lost to Follow-up|0
7733872|NCT00622700|12163207|FG006|Core Treatment Period|Lost to Follow-up|0
7733873|NCT00622700|12163201|FG000|Core Treatment Period|Death|1
7733874|NCT00622700|12163202|FG001|Core Treatment Period|Death|0
7733875|NCT00622700|12163203|FG002|Core Treatment Period|Death|0
7733876|NCT00622700|12163204|FG003|Core Treatment Period|Death|0
7733877|NCT00622700|12163205|FG004|Core Treatment Period|Death|0
7733878|NCT00622700|12163206|FG005|Core Treatment Period|Death|0
7733879|NCT00622700|12163207|FG006|Core Treatment Period|Death|0
7733880|NCT00622700|12163201|FG000|Core Treatment Period|Progressive Disease|3
7733881|NCT00622700|12163202|FG001|Core Treatment Period|Progressive Disease|1
7733882|NCT00622700|12163203|FG002|Core Treatment Period|Progressive Disease|0
7733883|NCT00622700|12163204|FG003|Core Treatment Period|Progressive Disease|0
7733884|NCT00622700|12163205|FG004|Core Treatment Period|Progressive Disease|0
7733885|NCT00622700|12163206|FG005|Core Treatment Period|Progressive Disease|0
7733886|NCT00622700|12163207|FG006|Core Treatment Period|Progressive Disease|0
7733887|NCT00622700|12163201|FG000|Core Treatment Period|Withdrawal by Subject|12
7733888|NCT00622700|12163202|FG001|Core Treatment Period|Withdrawal by Subject|18
7733889|NCT00622700|12163203|FG002|Core Treatment Period|Withdrawal by Subject|15
7733890|NCT00622700|12163204|FG003|Core Treatment Period|Withdrawal by Subject|0
7733891|NCT00622700|12163205|FG004|Core Treatment Period|Withdrawal by Subject|0
7733892|NCT00622700|12163206|FG005|Core Treatment Period|Withdrawal by Subject|0
7733893|NCT00622700|12163207|FG006|Core Treatment Period|Withdrawal by Subject|0
7733894|NCT00622700|12163201|FG000|Core Treatment Period|Other than specified above|2
7733895|NCT00622700|12163202|FG001|Core Treatment Period|Other than specified above|2
7733896|NCT00622700|12163203|FG002|Core Treatment Period|Other than specified above|5
7733897|NCT00622700|12163204|FG003|Core Treatment Period|Other than specified above|0
7733898|NCT00622700|12163205|FG004|Core Treatment Period|Other than specified above|0
7733899|NCT00622700|12163206|FG005|Core Treatment Period|Other than specified above|0
7733900|NCT00622700|12163207|FG006|Core Treatment Period|Other than specified above|0
7733901|NCT00622700|12163201|FG000|Extension Treatment Period|Adverse Event|0
7733902|NCT00622700|12163202|FG001|Extension Treatment Period|Adverse Event|0
7733903|NCT00622700|12163203|FG002|Extension Treatment Period|Adverse Event|0
7733904|NCT00622700|12163204|FG003|Extension Treatment Period|Adverse Event|5
7733905|NCT00622700|12163205|FG004|Extension Treatment Period|Adverse Event|9
7733906|NCT00622700|12163206|FG005|Extension Treatment Period|Adverse Event|6
7733907|NCT00622700|12163207|FG006|Extension Treatment Period|Adverse Event|8
7733908|NCT00622700|12163201|FG000|Extension Treatment Period|Lack of Efficacy|0
7733909|NCT00622700|12163202|FG001|Extension Treatment Period|Lack of Efficacy|0
7733910|NCT00622700|12163203|FG002|Extension Treatment Period|Lack of Efficacy|0
7733911|NCT00622700|12163204|FG003|Extension Treatment Period|Lack of Efficacy|2
7733912|NCT00622700|12163205|FG004|Extension Treatment Period|Lack of Efficacy|8
7733913|NCT00622700|12163206|FG005|Extension Treatment Period|Lack of Efficacy|1
7733914|NCT00622700|12163207|FG006|Extension Treatment Period|Lack of Efficacy|9
7733915|NCT00622700|12163201|FG000|Extension Treatment Period|Protocol Violation|0
7733916|NCT00622700|12163202|FG001|Extension Treatment Period|Protocol Violation|0
7733917|NCT00622700|12163203|FG002|Extension Treatment Period|Protocol Violation|0
7733918|NCT00622700|12163204|FG003|Extension Treatment Period|Protocol Violation|0
7733919|NCT00622700|12163205|FG004|Extension Treatment Period|Protocol Violation|0
7733920|NCT00622700|12163206|FG005|Extension Treatment Period|Protocol Violation|2
7733921|NCT00622700|12163207|FG006|Extension Treatment Period|Protocol Violation|0
7733922|NCT00622700|12163201|FG000|Extension Treatment Period|Lost to Follow-up|0
7733923|NCT00622700|12163202|FG001|Extension Treatment Period|Lost to Follow-up|0
7733924|NCT00622700|12163203|FG002|Extension Treatment Period|Lost to Follow-up|0
7733925|NCT00622700|12163204|FG003|Extension Treatment Period|Lost to Follow-up|0
7733926|NCT00622700|12163205|FG004|Extension Treatment Period|Lost to Follow-up|1
7733927|NCT00622700|12163206|FG005|Extension Treatment Period|Lost to Follow-up|0
7733928|NCT00622700|12163207|FG006|Extension Treatment Period|Lost to Follow-up|0
7733929|NCT00622700|12163201|FG000|Extension Treatment Period|Progressive Disease|0
7733930|NCT00622700|12163202|FG001|Extension Treatment Period|Progressive Disease|0
7733931|NCT00622700|12163203|FG002|Extension Treatment Period|Progressive Disease|0
7733932|NCT00622700|12163204|FG003|Extension Treatment Period|Progressive Disease|1
7733933|NCT00622700|12163205|FG004|Extension Treatment Period|Progressive Disease|2
7733934|NCT00622700|12163206|FG005|Extension Treatment Period|Progressive Disease|0
7733935|NCT00622700|12163207|FG006|Extension Treatment Period|Progressive Disease|2
7733936|NCT00622700|12163201|FG000|Extension Treatment Period|Withdrawal by Subject|0
7733937|NCT00622700|12163202|FG001|Extension Treatment Period|Withdrawal by Subject|0
7733938|NCT00622700|12163203|FG002|Extension Treatment Period|Withdrawal by Subject|0
7733939|NCT00622700|12163204|FG003|Extension Treatment Period|Withdrawal by Subject|11
7733940|NCT00622700|12163205|FG004|Extension Treatment Period|Withdrawal by Subject|16
7733941|NCT00622700|12163206|FG005|Extension Treatment Period|Withdrawal by Subject|6
7733942|NCT00622700|12163207|FG006|Extension Treatment Period|Withdrawal by Subject|10
7733943|NCT00622700|12163201|FG000|Extension Treatment Period|Missing|0
7733944|NCT00622700|12163202|FG001|Extension Treatment Period|Missing|0
7733945|NCT00622700|12163203|FG002|Extension Treatment Period|Missing|0
7733946|NCT00622700|12163204|FG003|Extension Treatment Period|Missing|2
7733947|NCT00622700|12163205|FG004|Extension Treatment Period|Missing|3
7733948|NCT00622700|12163206|FG005|Extension Treatment Period|Missing|1
7733949|NCT00622700|12163207|FG006|Extension Treatment Period|Missing|0
7733950|NCT00622700|12163201|FG000|Extension Treatment Period|Other than specified above|0
7733951|NCT00622700|12163202|FG001|Extension Treatment Period|Other than specified above|0
7733952|NCT00622700|12163203|FG002|Extension Treatment Period|Other than specified above|0
7733953|NCT00622700|12163204|FG003|Extension Treatment Period|Other than specified above|0
7733954|NCT00622700|12163205|FG004|Extension Treatment Period|Other than specified above|0
7733955|NCT00622700|12163206|FG005|Extension Treatment Period|Other than specified above|1
7733956|NCT00622700|12163207|FG006|Extension Treatment Period|Other than specified above|1
7733957|NCT00622713|12163224|FG000|Overall Study|Adverse Event|35
7733958|NCT00622713|12163224|FG000|Overall Study|Administrative problems|4
7733959|NCT00622713|12163224|FG000|Overall Study|Withdrawal by Subject|11
7733960|NCT00622713|12163224|FG000|Overall Study|Lost to Follow-up|5
7733961|NCT00622713|12163224|FG000|Overall Study|Death|2
7733962|NCT00622713|12163224|FG000|Overall Study|Subject no longer required study drug|1
7733963|NCT00622713|12163224|FG000|Overall Study|Did not meet eligibility criteria|1
7733964|NCT00622726|12163230|FG000|March, 2008 to August, 2010|Death|5
7733965|NCT00622726|12163231|FG001|March, 2008 to August, 2010|Death|2
7733966|NCT00622726|12163230|FG000|August, 2010 to April, 2013|Death|1
7733967|NCT00622726|12163231|FG001|August, 2010 to April, 2013|Death|5
7733968|NCT00622739|12163243|FG000|Overall Study|Physician Decision|1
7733969|NCT00622739|12163244|FG001|Overall Study|Physician Decision|0
7733970|NCT00622739|12163243|FG000|Overall Study|Adverse Event|1
7733971|NCT00622739|12163244|FG001|Overall Study|Adverse Event|2
7733972|NCT00622739|12163243|FG000|Overall Study|Lack of Efficacy|0
7733973|NCT00622739|12163244|FG001|Overall Study|Lack of Efficacy|2
7733974|NCT00622739|12163243|FG000|Overall Study|Withdrawal by Subject|0
7733975|NCT00622739|12163244|FG001|Overall Study|Withdrawal by Subject|1
7733976|NCT00622739|12163243|FG000|Overall Study|Lost to Follow-up|0
7733977|NCT00622739|12163244|FG001|Overall Study|Lost to Follow-up|1
7733978|NCT00622869|12163255|FG000|Overall Study|Subject Withdrew Consent|13
7733979|NCT00622869|12163256|FG001|Overall Study|Subject Withdrew Consent|17
7733980|NCT00622869|12163257|FG002|Overall Study|Subject Withdrew Consent|11
7733981|NCT00622869|12163255|FG000|Overall Study|Administrative Problems|11
7733982|NCT00622869|12163256|FG001|Overall Study|Administrative Problems|17
7733983|NCT00622869|12163257|FG002|Overall Study|Administrative Problems|13
7733984|NCT00622869|12163255|FG000|Overall Study|Death|12
7733985|NCT00622869|12163256|FG001|Overall Study|Death|15
7733986|NCT00622869|12163257|FG002|Overall Study|Death|10
7733987|NCT00622869|12163255|FG000|Overall Study|Lost to Follow-up|2
7733988|NCT00622869|12163256|FG001|Overall Study|Lost to Follow-up|4
7733989|NCT00622869|12163257|FG002|Overall Study|Lost to Follow-up|2
7733990|NCT00622869|12163255|FG000|Overall Study|Graft Loss|5
7733991|NCT00622869|12163256|FG001|Overall Study|Graft Loss|3
7733992|NCT00622869|12163257|FG002|Overall Study|Graft Loss|2
7733993|NCT00622869|12163255|FG000|Overall Study|Missing|0
7733994|NCT00622869|12163256|FG001|Overall Study|Missing|1
7733995|NCT00622869|12163257|FG002|Overall Study|Missing|1
7733996|NCT00622908|12163274|FG000|Overall Study|Protocol Violation|1
7733997|NCT00622908|12163275|FG001|Overall Study|Protocol Violation|0
7733998|NCT00622908|12163274|FG000|Overall Study|Adverse Event|0
7733999|NCT00622908|12163275|FG001|Overall Study|Adverse Event|1
7734000|NCT00622908|12163274|FG000|Overall Study|Lack of Efficacy|1
7734001|NCT00622908|12163275|FG001|Overall Study|Lack of Efficacy|7
7734002|NCT00622908|12163274|FG000|Overall Study|Lost to Follow-up|1
7734003|NCT00622908|12163275|FG001|Overall Study|Lost to Follow-up|0
7734004|NCT00622908|12163274|FG000|Overall Study|Refusal|0
7734005|NCT00622908|12163275|FG001|Overall Study|Refusal|1
7734006|NCT00622908|12163274|FG000|Overall Study|Termination by study sponser|0
7734007|NCT00622908|12163275|FG001|Overall Study|Termination by study sponser|1
7734008|NCT00623103|12163287|FG000|Overall Study|Adverse Event|70
7734009|NCT00623103|12163288|FG001|Overall Study|Adverse Event|60
7734010|NCT00623103|12163287|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7734011|NCT00623103|12163288|FG001|Overall Study|Unsatisfactory therapeutic effect|12
7734012|NCT00623103|12163287|FG000|Overall Study|Withdrawal by Subject|18
7734013|NCT00623103|12163288|FG001|Overall Study|Withdrawal by Subject|24
7734014|NCT00623103|12163287|FG000|Overall Study|Lost to Follow-up|4
7734015|NCT00623103|12163288|FG001|Overall Study|Lost to Follow-up|1
7734016|NCT00623103|12163287|FG000|Overall Study|Administrative problems|2
7734017|NCT00623103|12163288|FG001|Overall Study|Administrative problems|4
7734018|NCT00623103|12163287|FG000|Overall Study|Death|11
7734019|NCT00623103|12163288|FG001|Overall Study|Death|11
7734020|NCT00623103|12163287|FG000|Overall Study|Protocol deviation|2
7734021|NCT00623103|12163288|FG001|Overall Study|Protocol deviation|1
7734022|NCT00623194|12163307|FG000|Overall Study|Lack of Efficacy|1
7734023|NCT00623194|12163307|FG000|Overall Study|Protocol Violation|3
7734024|NCT00623194|12163307|FG000|Overall Study|Unclassified|1
7734025|NCT00623233|12163311|FG000|Overall Study|Adverse Event|10
7734026|NCT00623233|12163311|FG000|Overall Study|Physician Decision|10
7734027|NCT00623233|12163311|FG000|Overall Study|Lost to Follow-up|1
7734028|NCT00623233|12163311|FG000|Overall Study|Withdrawal by Subject|3
7734029|NCT00623363|12163317|FG000|Overall Study|Adverse Event|2
7734030|NCT00623363|12163318|FG001|Overall Study|Adverse Event|2
7734031|NCT00623428|12163327|FG000|Treatment Period|Adverse event/intercurrent illness|0
7734032|NCT00623428|12163328|FG001|Treatment Period|Adverse event/intercurrent illness|9
7734033|NCT00623428|12163327|FG000|Treatment Period|Death|0
7734034|NCT00623428|12163328|FG001|Treatment Period|Death|1
7734035|NCT00623428|12163327|FG000|Treatment Period|Did not cooperate / refused treatment|0
7734036|NCT00623428|12163328|FG001|Treatment Period|Did not cooperate / refused treatment|13
7734037|NCT00623428|12163327|FG000|Treatment Period|Insufficient therapeutic response|0
7734038|NCT00623428|12163328|FG001|Treatment Period|Insufficient therapeutic response|2
7734039|NCT00623428|12163327|FG000|Treatment Period|Other|0
7734040|NCT00623428|12163328|FG001|Treatment Period|Other|1
7734041|NCT00623428|12163327|FG000|Treatment Period|Withdrawal by Subject|0
7734042|NCT00623428|12163328|FG001|Treatment Period|Withdrawal by Subject|1
7734043|NCT00623428|12163327|FG000|Follow-up Period|Relapse post-treatment|11
7734044|NCT00623428|12163328|FG001|Follow-up Period|Relapse post-treatment|3
7734045|NCT00623428|12163327|FG000|Follow-up Period|Failure to return|10
7734046|NCT00623428|12163328|FG001|Follow-up Period|Failure to return|2
7734047|NCT00623428|12163327|FG000|Follow-up Period|Patient withdrew consent|5
7734048|NCT00623428|12163328|FG001|Follow-up Period|Patient withdrew consent|4
7734049|NCT00623428|12163327|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2
7734050|NCT00623428|12163328|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1
7734051|NCT00623428|12163327|FG000|Follow-up Period|Did not cooperate|0
7734052|NCT00623428|12163328|FG001|Follow-up Period|Did not cooperate|3
7734053|NCT00623428|12163327|FG000|Follow-up Period|Reason not specified|1
7734054|NCT00623428|12163328|FG001|Follow-up Period|Reason not specified|1
7734055|NCT00623428|12163327|FG000|Follow-up Period|Death|0
7734056|NCT00623428|12163328|FG001|Follow-up Period|Death|1
7734057|NCT00623467|12163338|FG000|Overall Study|Lost to Follow-up|1
7734058|NCT00623467|12163338|FG000|Overall Study|Protocol Violation|4
7734059|NCT00623467|12163338|FG000|Overall Study|Withdrawal by Subject|2
7734060|NCT00623480|12163346|FG000|Overall Study|Lost to Follow-up|0
7734061|NCT00623480|12163347|FG001|Overall Study|Lost to Follow-up|1
7734062|NCT00623480|12163346|FG000|Overall Study|Withdrawal by Subject|2
7734063|NCT00623480|12163347|FG001|Overall Study|Withdrawal by Subject|4
7734064|NCT00623480|12163346|FG000|Overall Study|Lack of Efficacy|1
7734065|NCT00623480|12163347|FG001|Overall Study|Lack of Efficacy|0
7734066|NCT00623480|12163346|FG000|Overall Study|Non-compliant with study medication|4
7734067|NCT00623480|12163347|FG001|Overall Study|Non-compliant with study medication|0
7734068|NCT00623480|12163346|FG000|Overall Study|Protocol Violation|0
7734069|NCT00623480|12163347|FG001|Overall Study|Protocol Violation|1
7734070|NCT00623480|12163346|FG000|Overall Study|Site closed by sponsor|0
7734071|NCT00623480|12163347|FG001|Overall Study|Site closed by sponsor|1
7734072|NCT00623545|12163362|FG000|Overall Study|Adverse Event|6
7734073|NCT00623545|12163362|FG000|Overall Study|Withdrawal by Subject|4
7734074|NCT00623597|12163369|FG000|Overall Study|Failed to return|1
7734075|NCT00623597|12163370|FG001|Overall Study|Failed to return|0
7734076|NCT00623623|12163380|FG000|Overall Study|Previous enrolment into this study|1
7734077|NCT00623623|12163381|FG001|Overall Study|Previous enrolment into this study|1
7734078|NCT00623727|12163406|FG000|Double Blind (DB)|Adverse Event|1
7734079|NCT00623727|12163407|FG001|Double Blind (DB)|Adverse Event|3
7734080|NCT00623727|12163406|FG000|Double Blind (DB)|Physician Decision|0
7734081|NCT00623727|12163407|FG001|Double Blind (DB)|Physician Decision|1
7734082|NCT00623727|12163406|FG000|Double Blind (DB)|Withdrawal by Subject|8
7734083|NCT00623727|12163407|FG001|Double Blind (DB)|Withdrawal by Subject|2
7734084|NCT00623727|12163406|FG000|Double Blind (DB)|Lack of Efficacy|2
7734085|NCT00623727|12163407|FG001|Double Blind (DB)|Lack of Efficacy|2
7734086|NCT00623727|12163406|FG000|Double Blind (DB)|Termination of the double-blind period|22
7734087|NCT00623727|12163407|FG001|Double Blind (DB)|Termination of the double-blind period|21
7734088|NCT00623727|12163406|FG000|Double Blind (DB)|Lost to Follow-up|1
7734089|NCT00623727|12163407|FG001|Double Blind (DB)|Lost to Follow-up|1
7734090|NCT00623727|12163406|FG000|Double Blind (DB)|Protocol Violation|2
7734091|NCT00623727|12163407|FG001|Double Blind (DB)|Protocol Violation|2
7734092|NCT00623727|12163406|FG000|Open Label Follow-up|Withdrawal by Subject|0
7734093|NCT00623727|12163407|FG001|Open Label Follow-up|Withdrawal by Subject|1
7734094|NCT00623727|12163406|FG000|Open Label Follow-up|Study termination|0
7734095|NCT00623727|12163407|FG001|Open Label Follow-up|Study termination|6
7734096|NCT00623727|12163406|FG000|Open Label Follow-up|Participant convenience|0
7734097|NCT00623727|12163407|FG001|Open Label Follow-up|Participant convenience|1
7734098|NCT00623766|12163417|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36
7734099|NCT00623766|12163418|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16
7734100|NCT00623766|12163417|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
7734101|NCT00623766|12163418|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
7734102|NCT00623766|12163417|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
7734103|NCT00623766|12163418|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
7734104|NCT00623766|12163417|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
7734105|NCT00623766|12163418|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
7734106|NCT00623766|12163417|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
7734107|NCT00623766|12163418|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
7734108|NCT00623779|12163431|FG000|Overall Study|Adverse Event|1
7734109|NCT00623779|12163432|FG001|Overall Study|Adverse Event|3
7734110|NCT00623779|12163433|FG002|Overall Study|Adverse Event|0
7734111|NCT00623779|12163431|FG000|Overall Study|Criteria from CSR|2
7734112|NCT00623779|12163432|FG001|Overall Study|Criteria from CSR|0
7734113|NCT00623779|12163433|FG002|Overall Study|Criteria from CSR|1
7734114|NCT00623805|12163443|FG000|Overall Study|Adverse Event|9
7734115|NCT00623805|12163444|FG001|Overall Study|Adverse Event|6
7734116|NCT00623805|12163443|FG000|Overall Study|Death|2
7734117|NCT00623805|12163444|FG001|Overall Study|Death|0
7734118|NCT00623805|12163443|FG000|Overall Study|Lack of Efficacy|3
7734119|NCT00623805|12163444|FG001|Overall Study|Lack of Efficacy|7
7734120|NCT00623805|12163443|FG000|Overall Study|Lost to Follow-up|2
7734121|NCT00623805|12163444|FG001|Overall Study|Lost to Follow-up|2
7734122|NCT00623805|12163443|FG000|Overall Study|Protocol Violation|1
7734123|NCT00623805|12163444|FG001|Overall Study|Protocol Violation|1
7734124|NCT00623805|12163443|FG000|Overall Study|Reason not Specified|3
7734125|NCT00623805|12163444|FG001|Overall Study|Reason not Specified|6
7734126|NCT00623831|12163452|FG000|Overall Study|Withdrawal by Subject|1
7734127|NCT00623831|12163453|FG001|Overall Study|Withdrawal by Subject|0
7734128|NCT00623831|12163452|FG000|Overall Study|Progressive Disease|0
7734129|NCT00623831|12163453|FG001|Overall Study|Progressive Disease|1
7734130|NCT00623935|12163462|FG000|Overall Study|Death|1
7734131|NCT00623935|12163462|FG000|Overall Study|Patient Declined Transplant|1
7734132|NCT00624052|12163481|FG000|Overall Study|Adverse Event|7
7734133|NCT00624052|12163482|FG001|Overall Study|Adverse Event|6
7734134|NCT00624052|12163483|FG002|Overall Study|Adverse Event|0
7734135|NCT00624052|12163484|FG003|Overall Study|Adverse Event|3
7734136|NCT00624052|12163481|FG000|Overall Study|Lack of Efficacy|1
7734137|NCT00624052|12163482|FG001|Overall Study|Lack of Efficacy|1
7734138|NCT00624052|12163483|FG002|Overall Study|Lack of Efficacy|0
7734139|NCT00624052|12163484|FG003|Overall Study|Lack of Efficacy|0
7734140|NCT00624052|12163481|FG000|Overall Study|Lost to Follow-up|2
7734141|NCT00624052|12163482|FG001|Overall Study|Lost to Follow-up|3
7734142|NCT00624052|12163483|FG002|Overall Study|Lost to Follow-up|1
7734143|NCT00624052|12163484|FG003|Overall Study|Lost to Follow-up|0
7734144|NCT00624052|12163481|FG000|Overall Study|Non compliant with the protocol|2
7734145|NCT00624052|12163482|FG001|Overall Study|Non compliant with the protocol|1
7734146|NCT00624052|12163483|FG002|Overall Study|Non compliant with the protocol|1
7734147|NCT00624052|12163484|FG003|Overall Study|Non compliant with the protocol|1
7734148|NCT00624052|12163481|FG000|Overall Study|Consent withdrawn|3
7734149|NCT00624052|12163482|FG001|Overall Study|Consent withdrawn|1
7734150|NCT00624052|12163483|FG002|Overall Study|Consent withdrawn|1
7734151|NCT00624052|12163484|FG003|Overall Study|Consent withdrawn|0
7734152|NCT00624052|12163481|FG000|Overall Study|Changed job/ran out if meds|0
7734153|NCT00624052|12163482|FG001|Overall Study|Changed job/ran out if meds|2
7734154|NCT00624052|12163483|FG002|Overall Study|Changed job/ran out if meds|0
7734155|NCT00624052|12163484|FG003|Overall Study|Changed job/ran out if meds|0
7734156|NCT00624065|12163500|FG000|Overall Study|Adverse Event|5
7734157|NCT00624065|12163501|FG001|Overall Study|Adverse Event|6
7734158|NCT00624065|12163500|FG000|Overall Study|Lost to Follow-up|4
7734159|NCT00624065|12163501|FG001|Overall Study|Lost to Follow-up|1
7734160|NCT00624065|12163500|FG000|Overall Study|Consent withdrawn|6
7734161|NCT00624065|12163501|FG001|Overall Study|Consent withdrawn|5
7734162|NCT00624065|12163500|FG000|Overall Study|Lack of Efficacy|0
7734163|NCT00624065|12163501|FG001|Overall Study|Lack of Efficacy|3
7734164|NCT00624065|12163500|FG000|Overall Study|Met protocol-defined stopping criteria|4
7734165|NCT00624065|12163501|FG001|Overall Study|Met protocol-defined stopping criteria|9
7734166|NCT00624286|12163527|FG000|Overall Study|Protocol Deviation|7
7734167|NCT00624286|12163528|FG001|Overall Study|Protocol Deviation|9
7734168|NCT00624286|12163527|FG000|Overall Study|Adverse Event|6
7734169|NCT00624286|12163528|FG001|Overall Study|Adverse Event|3
7734170|NCT00624286|12163527|FG000|Overall Study|Withdrawal by Subject|5
7734171|NCT00624286|12163528|FG001|Overall Study|Withdrawal by Subject|4
7734172|NCT00624286|12163527|FG000|Overall Study|Lost to Follow-up|3
7734173|NCT00624286|12163528|FG001|Overall Study|Lost to Follow-up|2
7734174|NCT00624286|12163527|FG000|Overall Study|Administrative problems|3
7734175|NCT00624286|12163528|FG001|Overall Study|Administrative problems|0
7734176|NCT00624286|12163527|FG000|Overall Study|Lack of Efficacy|1
7734177|NCT00624286|12163528|FG001|Overall Study|Lack of Efficacy|6
7734178|NCT00624286|12163527|FG000|Overall Study|Not stated|0
7734179|NCT00624286|12163528|FG001|Overall Study|Not stated|1
7734180|NCT00624286|12163527|FG000|Overall Study|Abnormal test procedure result(s)|0
7734181|NCT00624286|12163528|FG001|Overall Study|Abnormal test procedure result(s)|1
7734182|NCT00624286|12163527|FG000|Overall Study|Death|0
7734183|NCT00624286|12163528|FG001|Overall Study|Death|1
7734184|NCT00624338|12163537|FG000|Overall Study|Adverse Event|14
7734185|NCT00624338|12163538|FG001|Overall Study|Adverse Event|14
7734186|NCT00624338|12163539|FG002|Overall Study|Adverse Event|18
7734187|NCT00624338|12163537|FG000|Overall Study|Lost to Follow-up|1
7734188|NCT00624338|12163538|FG001|Overall Study|Lost to Follow-up|0
7734189|NCT00624338|12163539|FG002|Overall Study|Lost to Follow-up|0
7734190|NCT00624338|12163537|FG000|Overall Study|Lack of Efficacy|11
7734191|NCT00624338|12163538|FG001|Overall Study|Lack of Efficacy|3
7734192|NCT00624338|12163539|FG002|Overall Study|Lack of Efficacy|14
7734193|NCT00624338|12163537|FG000|Overall Study|Protocol Violation|3
7734194|NCT00624338|12163538|FG001|Overall Study|Protocol Violation|3
7734195|NCT00624338|12163539|FG002|Overall Study|Protocol Violation|2
7734196|NCT00624338|12163537|FG000|Overall Study|Death|0
7734197|NCT00624338|12163538|FG001|Overall Study|Death|2
7734198|NCT00624338|12163539|FG002|Overall Study|Death|0
7734199|NCT00624338|12163537|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1
7734200|NCT00624338|12163538|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0
7734201|NCT00624338|12163539|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0
7734202|NCT00624338|12163537|FG000|Overall Study|Termination of 150 mg group by Sponsor|0
7734203|NCT00624338|12163538|FG001|Overall Study|Termination of 150 mg group by Sponsor|55
7734204|NCT00624338|12163539|FG002|Overall Study|Termination of 150 mg group by Sponsor|0
7734205|NCT00624338|12163537|FG000|Overall Study|Other|15
7734206|NCT00624338|12163538|FG001|Overall Study|Other|5
7734207|NCT00624338|12163539|FG002|Overall Study|Other|9
7734208|NCT00624338|12163537|FG000|Overall Study|Randomized but not treated|2
7734209|NCT00624338|12163538|FG001|Overall Study|Randomized but not treated|1
7734210|NCT00624338|12163539|FG002|Overall Study|Randomized but not treated|3
7734211|NCT00624377|12163547|FG000|Overall Study|Lost to Follow-up|355
7734212|NCT00624377|12163547|FG000|Overall Study|Withdrawal by Subject|100
7734213|NCT00624377|12163547|FG000|Overall Study|Adverse Event|14
7734214|NCT00624377|12163547|FG000|Overall Study|Other|91
7734215|NCT00624377|12163547|FG000|Overall Study|Non-evaluable population|84
7734216|NCT00624468|12163599|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13
7734217|NCT00624468|12163600|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12
7734218|NCT00624468|12163601|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0
7734219|NCT00624468|12163602|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0
7734220|NCT00624468|12163599|FG000|Double-blind Period|Withdrew Prematurely|1
7734221|NCT00624468|12163600|FG001|Double-blind Period|Withdrew Prematurely|1
7734222|NCT00624468|12163601|FG002|Double-blind Period|Withdrew Prematurely|0
7734223|NCT00624468|12163602|FG003|Double-blind Period|Withdrew Prematurely|0
7734224|NCT00624468|12163599|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0
7734225|NCT00624468|12163600|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0
7734226|NCT00624468|12163601|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1
7734227|NCT00624468|12163602|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2
7734228|NCT00624468|12163599|FG000|Safety Follow-up (SFU) Period|Other|0
7734229|NCT00624468|12163600|FG001|Safety Follow-up (SFU) Period|Other|0
7734230|NCT00624468|12163601|FG002|Safety Follow-up (SFU) Period|Other|1
7734231|NCT00624468|12163602|FG003|Safety Follow-up (SFU) Period|Other|1
7734232|NCT00624520|12163612|FG000|Overall Study|Withdrawal by Subject|12
7734233|NCT00624520|12163613|FG001|Overall Study|Withdrawal by Subject|7
7734234|NCT00624520|12163612|FG000|Overall Study|Death|0
7734235|NCT00624520|12163613|FG001|Overall Study|Death|1
7734236|NCT00624585|12163636|FG000|Overall Study|Death|3
7734237|NCT00624585|12163636|FG000|Overall Study|Disease Progression|6
7734238|NCT00624585|12163636|FG000|Overall Study|Adverse Event|3
7734239|NCT00624780|12163646|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7
7734240|NCT00624780|12163647|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5
7734241|NCT00624780|12163648|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15
7734242|NCT00624780|12163649|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3
7734243|NCT00624780|12163650|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9
7734244|NCT00624780|12163651|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5
7734245|NCT00624780|12163646|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
7734246|NCT00624780|12163647|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
7734247|NCT00624780|12163648|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
7734248|NCT00624780|12163649|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
7734249|NCT00624780|12163650|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
7734250|NCT00624780|12163651|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
7734251|NCT00624780|12163646|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
7734252|NCT00624780|12163647|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
7734253|NCT00624780|12163648|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
7734254|NCT00624780|12163649|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
7734255|NCT00624780|12163650|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
7734256|NCT00624780|12163651|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
7734257|NCT00624780|12163646|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
7734258|NCT00624780|12163647|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
7734259|NCT00624780|12163648|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
7734260|NCT00624780|12163649|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
7734261|NCT00624780|12163650|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
7734262|NCT00624780|12163651|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
7734263|NCT00624780|12163646|FG000|Treatment Optimization (Up to Week 12)|Other|10
7734264|NCT00624780|12163647|FG001|Treatment Optimization (Up to Week 12)|Other|4
7734265|NCT00624780|12163648|FG002|Treatment Optimization (Up to Week 12)|Other|8
7734266|NCT00624780|12163649|FG003|Treatment Optimization (Up to Week 12)|Other|2
7734267|NCT00624780|12163650|FG004|Treatment Optimization (Up to Week 12)|Other|9
7734268|NCT00624780|12163651|FG005|Treatment Optimization (Up to Week 12)|Other|0
7734269|NCT00624780|12163646|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
7734270|NCT00624780|12163647|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
7734271|NCT00624780|12163648|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
7734272|NCT00624780|12163649|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
7734273|NCT00624780|12163650|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
7734274|NCT00624780|12163651|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
7734275|NCT00624780|12163646|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
7734276|NCT00624780|12163647|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
7734277|NCT00624780|12163648|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
7734278|NCT00624780|12163649|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
7734279|NCT00624780|12163650|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
7734280|NCT00624780|12163651|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
7734281|NCT00624780|12163646|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
7734282|NCT00624780|12163647|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
7734283|NCT00624780|12163648|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
7734284|NCT00624780|12163649|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
7734285|NCT00624780|12163650|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
7734286|NCT00624780|12163651|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
7734287|NCT00624780|12163646|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
7734288|NCT00624780|12163647|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
7734289|NCT00624780|12163648|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
7734290|NCT00624780|12163649|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
7734291|NCT00624780|12163650|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
7734292|NCT00624780|12163651|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
7734293|NCT00624780|12163646|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5
7734294|NCT00624780|12163647|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3
7734295|NCT00624780|12163648|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4
7734296|NCT00624780|12163649|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1
7734297|NCT00624780|12163650|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4
7734298|NCT00624780|12163651|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3
7734299|NCT00624780|12163646|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1
7734300|NCT00624780|12163647|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0
7734301|NCT00624780|12163648|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2
7734302|NCT00624780|12163649|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1
7734303|NCT00624780|12163650|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0
7734304|NCT00624780|12163651|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1
7734305|NCT00624780|12163646|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
7734306|NCT00624780|12163647|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
7734307|NCT00624780|12163648|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
7734308|NCT00624780|12163649|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
7734309|NCT00624780|12163650|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
7734310|NCT00624780|12163651|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
7734311|NCT00624780|12163646|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
7734312|NCT00624780|12163647|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
7734313|NCT00624780|12163648|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
7734314|NCT00624780|12163649|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
7734315|NCT00624780|12163650|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
7734316|NCT00624780|12163651|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
7734317|NCT00624780|12163646|FG000|Follow-up (Week 26)|Death|0
7734318|NCT00624780|12163647|FG001|Follow-up (Week 26)|Death|0
7734319|NCT00624780|12163648|FG002|Follow-up (Week 26)|Death|1
7734320|NCT00624780|12163649|FG003|Follow-up (Week 26)|Death|0
7734321|NCT00624780|12163650|FG004|Follow-up (Week 26)|Death|0
7734322|NCT00624780|12163651|FG005|Follow-up (Week 26)|Death|0
7734323|NCT00624780|12163646|FG000|Follow-up (Week 26)|Adverse Event|0
7734324|NCT00624780|12163647|FG001|Follow-up (Week 26)|Adverse Event|0
7734325|NCT00624780|12163648|FG002|Follow-up (Week 26)|Adverse Event|0
7734326|NCT00624780|12163649|FG003|Follow-up (Week 26)|Adverse Event|0
7734327|NCT00624780|12163650|FG004|Follow-up (Week 26)|Adverse Event|1
7734328|NCT00624780|12163651|FG005|Follow-up (Week 26)|Adverse Event|0
7734329|NCT00624780|12163646|FG000|Follow-up (Week 26)|Lost to Follow-up|0
7734330|NCT00624780|12163647|FG001|Follow-up (Week 26)|Lost to Follow-up|0
7734331|NCT00624780|12163648|FG002|Follow-up (Week 26)|Lost to Follow-up|1
7734332|NCT00624780|12163649|FG003|Follow-up (Week 26)|Lost to Follow-up|0
7734333|NCT00624780|12163650|FG004|Follow-up (Week 26)|Lost to Follow-up|1
7734334|NCT00624780|12163651|FG005|Follow-up (Week 26)|Lost to Follow-up|0
7734335|NCT00624780|12163646|FG000|Follow-up (Week 26)|Withdrawal by Subject|1
7734336|NCT00624780|12163647|FG001|Follow-up (Week 26)|Withdrawal by Subject|0
7734337|NCT00624780|12163648|FG002|Follow-up (Week 26)|Withdrawal by Subject|0
7734338|NCT00624780|12163649|FG003|Follow-up (Week 26)|Withdrawal by Subject|0
7734339|NCT00624780|12163650|FG004|Follow-up (Week 26)|Withdrawal by Subject|0
7734340|NCT00624780|12163651|FG005|Follow-up (Week 26)|Withdrawal by Subject|0
7734341|NCT00624780|12163646|FG000|Follow-up (Week 26)|Other|1
7734342|NCT00624780|12163647|FG001|Follow-up (Week 26)|Other|1
7734343|NCT00624780|12163648|FG002|Follow-up (Week 26)|Other|0
7734344|NCT00624780|12163649|FG003|Follow-up (Week 26)|Other|0
7734345|NCT00624780|12163650|FG004|Follow-up (Week 26)|Other|0
7734346|NCT00624780|12163651|FG005|Follow-up (Week 26)|Other|0
7734347|NCT00624819|12163681|FG000|Follow-up Period: Year 4|Parents decision|0
7734348|NCT00624819|12163682|FG001|Follow-up Period: Year 4|Parents decision|0
7734349|NCT00624819|12163683|FG002|Follow-up Period: Year 4|Parents decision|1
7734350|NCT00624819|12163684|FG003|Follow-up Period: Year 4|Parents decision|0
7734351|NCT00624819|12163681|FG000|Follow-up Period: Year 4|Lost to Follow-up|1
7734352|NCT00624819|12163682|FG001|Follow-up Period: Year 4|Lost to Follow-up|1
7734353|NCT00624819|12163683|FG002|Follow-up Period: Year 4|Lost to Follow-up|0
7734354|NCT00624819|12163684|FG003|Follow-up Period: Year 4|Lost to Follow-up|0
7734355|NCT00624832|12163698|FG000|Overall Study|Adverse Event|0
7734356|NCT00624832|12163699|FG001|Overall Study|Adverse Event|1
7734357|NCT00624832|12163700|FG002|Overall Study|Adverse Event|0
7734358|NCT00624832|12163701|FG003|Overall Study|Adverse Event|1
7734359|NCT00624832|12163698|FG000|Overall Study|Abnormal Laboratory Value|2
7734360|NCT00624832|12163699|FG001|Overall Study|Abnormal Laboratory Value|0
7734361|NCT00624832|12163700|FG002|Overall Study|Abnormal Laboratory Value|0
7734362|NCT00624832|12163701|FG003|Overall Study|Abnormal Laboratory Value|0
7734363|NCT00625131|12163736|FG000|Overall Study|Lost to Follow-up|3
7734364|NCT00625131|12163737|FG001|Overall Study|Lost to Follow-up|2
7734365|NCT00625131|12163738|FG002|Overall Study|Lost to Follow-up|0
7734366|NCT00625131|12163736|FG000|Overall Study|Withdrawal by Subject|1
7734367|NCT00625131|12163737|FG001|Overall Study|Withdrawal by Subject|0
7734368|NCT00625131|12163738|FG002|Overall Study|Withdrawal by Subject|5
7734369|NCT00625183|12163744|FG000|Overall Study|Disease Progression|1
7734370|NCT00625365|12163750|FG000|Overall Study|Withdrawal by Subject|1
7734371|NCT00625365|12163750|FG000|Overall Study|No IV access|5
7734372|NCT00625365|12163750|FG000|Overall Study|VSD|1
7734373|NCT00625443|12163787|FG000|Overall Study|Adverse Event|1
7734374|NCT00625443|12163788|FG001|Overall Study|Adverse Event|4
7734375|NCT00625443|12163789|FG002|Overall Study|Adverse Event|0
7734376|NCT00625443|12163787|FG000|Overall Study|Non-compliance with protocol|0
7734377|NCT00625443|12163788|FG001|Overall Study|Non-compliance with protocol|1
7734378|NCT00625443|12163789|FG002|Overall Study|Non-compliance with protocol|0
7734379|NCT00625443|12163787|FG000|Overall Study|Platelet count increase >=500,000/mm3|1
7734380|NCT00625443|12163788|FG001|Overall Study|Platelet count increase >=500,000/mm3|0
7734381|NCT00625443|12163789|FG002|Overall Study|Platelet count increase >=500,000/mm3|0
7734382|NCT00625443|12163787|FG000|Overall Study|Withdrawal by Subject|0
7734383|NCT00625443|12163788|FG001|Overall Study|Withdrawal by Subject|1
7734384|NCT00625443|12163789|FG002|Overall Study|Withdrawal by Subject|2
7734385|NCT00625443|12163787|FG000|Overall Study|Physician Decision|0
7734386|NCT00625443|12163788|FG001|Overall Study|Physician Decision|4
7734387|NCT00625443|12163789|FG002|Overall Study|Physician Decision|2
7734388|NCT00625443|12163787|FG000|Overall Study|Other|0
7734389|NCT00625443|12163788|FG001|Overall Study|Other|1
7734390|NCT00625443|12163789|FG002|Overall Study|Other|1
7734391|NCT00625807|12163807|FG000|Overall Study|schedule conflict|2
7734392|NCT00625807|12163808|FG001|Overall Study|schedule conflict|8
7734393|NCT00625820|12163816|FG000|Overall Study|Withdrawal by Subject|1
7734394|NCT00625846|12163825|FG000|Overall Study|Withdrawal by Subject|2
7734395|NCT00625846|12163826|FG001|Overall Study|Withdrawal by Subject|0
7734396|NCT00625846|12163827|FG002|Overall Study|Withdrawal by Subject|1
7734397|NCT00625846|12163828|FG003|Overall Study|Withdrawal by Subject|2
7734398|NCT00625872|12163844|FG000|Overall Study|Withdrawal by Subject|1
7734399|NCT00625872|12163845|FG001|Overall Study|Withdrawal by Subject|0
7734400|NCT00625872|12163844|FG000|Overall Study|Does not meet inclusion criteria|1
7734401|NCT00625872|12163845|FG001|Overall Study|Does not meet inclusion criteria|0
7734402|NCT00625872|12163844|FG000|Overall Study|Terminated by sponsor|2
7734403|NCT00625872|12163845|FG001|Overall Study|Terminated by sponsor|5
7734404|NCT00625872|12163844|FG000|Overall Study|Randomized but not treated|0
7734405|NCT00625872|12163845|FG001|Overall Study|Randomized but not treated|1
7734406|NCT00626028|12163859|FG000|Overall Study|Adverse Event|1
7734407|NCT00626028|12163860|FG001|Overall Study|Adverse Event|1
7734408|NCT00626028|12163859|FG000|Overall Study|Device Failure|0
7734409|NCT00626028|12163860|FG001|Overall Study|Device Failure|1
7734410|NCT00626028|12163859|FG000|Overall Study|Physician Decision|2
7734411|NCT00626028|12163860|FG001|Overall Study|Physician Decision|1
7734412|NCT00626028|12163859|FG000|Overall Study|Inclusion/Exclusion Criteria|3
7734413|NCT00626028|12163860|FG001|Overall Study|Inclusion/Exclusion Criteria|6
7734414|NCT00626093|12163866|FG000|Overall Study|Lost to Follow-up|5
7734415|NCT00626093|12163866|FG000|Overall Study|Death|1
7734416|NCT00626093|12163866|FG000|Overall Study|Physician Decision|4
7734417|NCT00626093|12163866|FG000|Overall Study|Withdrawal by Subject|6
7734418|NCT00626093|12163866|FG000|Overall Study|Protocol Violation|1
7734419|NCT00626093|12163866|FG000|Overall Study|One of the required devices not implante|6
7734420|NCT00626197|12163873|FG000|Overall Study|Did not cooperate|2
7734421|NCT00626197|12163874|FG001|Overall Study|Did not cooperate|6
7734422|NCT00626197|12163875|FG002|Overall Study|Did not cooperate|1
7734423|NCT00626197|12163873|FG000|Overall Study|Failure to return|6
7734424|NCT00626197|12163874|FG001|Overall Study|Failure to return|5
7734425|NCT00626197|12163875|FG002|Overall Study|Failure to return|6
7734426|NCT00626197|12163873|FG000|Overall Study|Adverse event, serious fatal|3
7734427|NCT00626197|12163874|FG001|Overall Study|Adverse event, serious fatal|6
7734428|NCT00626197|12163875|FG002|Overall Study|Adverse event, serious fatal|6
7734429|NCT00626197|12163873|FG000|Overall Study|Adverse Event|1
7734430|NCT00626197|12163874|FG001|Overall Study|Adverse Event|1
7734431|NCT00626197|12163875|FG002|Overall Study|Adverse Event|2
7734432|NCT00626197|12163873|FG000|Overall Study|Withdrawal by Subject|17
7734433|NCT00626197|12163874|FG001|Overall Study|Withdrawal by Subject|17
7734434|NCT00626197|12163875|FG002|Overall Study|Withdrawal by Subject|7
7734435|NCT00626197|12163873|FG000|Overall Study|Administrative reasons|15
7734436|NCT00626197|12163874|FG001|Overall Study|Administrative reasons|19
7734437|NCT00626197|12163875|FG002|Overall Study|Administrative reasons|55
7734438|NCT00626275|12163893|FG000|Part A - Treatment Period 1|Adverse Event|1
7734439|NCT00626275|12163894|FG001|Part A - Treatment Period 1|Adverse Event|0
7734440|NCT00626275|12163895|FG002|Part A - Treatment Period 1|Adverse Event|0
7734441|NCT00626275|12163896|FG003|Part A - Treatment Period 1|Adverse Event|0
7734442|NCT00626275|12163897|FG004|Part A - Treatment Period 1|Adverse Event|0
7734443|NCT00626275|12163898|FG005|Part A - Treatment Period 1|Adverse Event|0
7734444|NCT00626275|12163899|FG006|Part A - Treatment Period 1|Adverse Event|0
7734445|NCT00626275|12163900|FG007|Part A - Treatment Period 1|Adverse Event|0
7734446|NCT00626275|12163893|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0
7734447|NCT00626275|12163894|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0
7734448|NCT00626275|12163895|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1
7734449|NCT00626275|12163896|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0
7734450|NCT00626275|12163897|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0
7734451|NCT00626275|12163898|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0
7734452|NCT00626275|12163899|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0
7734453|NCT00626275|12163900|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0
7734454|NCT00626275|12163893|FG000|Part B|Lost to Follow-up|0
7734455|NCT00626275|12163894|FG001|Part B|Lost to Follow-up|0
7734456|NCT00626275|12163895|FG002|Part B|Lost to Follow-up|0
7734457|NCT00626275|12163896|FG003|Part B|Lost to Follow-up|0
7734458|NCT00626275|12163897|FG004|Part B|Lost to Follow-up|0
7734459|NCT00626275|12163898|FG005|Part B|Lost to Follow-up|0
7734460|NCT00626275|12163899|FG006|Part B|Lost to Follow-up|1
7734461|NCT00626275|12163900|FG007|Part B|Lost to Follow-up|0
7734462|NCT00626275|12163893|FG000|Part B|Withdrawal by Subject|0
7734463|NCT00626275|12163894|FG001|Part B|Withdrawal by Subject|0
7734464|NCT00626275|12163895|FG002|Part B|Withdrawal by Subject|0
7734465|NCT00626275|12163896|FG003|Part B|Withdrawal by Subject|0
7734466|NCT00626275|12163897|FG004|Part B|Withdrawal by Subject|0
7734467|NCT00626275|12163898|FG005|Part B|Withdrawal by Subject|0
7734468|NCT00626275|12163899|FG006|Part B|Withdrawal by Subject|0
7734469|NCT00626275|12163900|FG007|Part B|Withdrawal by Subject|1
7734470|NCT00626327|12163917|FG000|Overall Study|Withdrawal by Subject|21
7734471|NCT00626327|12163918|FG001|Overall Study|Withdrawal by Subject|29
7734472|NCT00626327|12163919|FG002|Overall Study|Withdrawal by Subject|30
7734473|NCT00626327|12163917|FG000|Overall Study|Adverse Event|1
7734474|NCT00626327|12163918|FG001|Overall Study|Adverse Event|0
7734475|NCT00626327|12163919|FG002|Overall Study|Adverse Event|0
7734476|NCT00626327|12163917|FG000|Overall Study|Lost to Follow-up|24
7734477|NCT00626327|12163918|FG001|Overall Study|Lost to Follow-up|21
7734478|NCT00626327|12163919|FG002|Overall Study|Lost to Follow-up|23
7734479|NCT00626327|12163917|FG000|Overall Study|Inappropriate enrollment|4
7734480|NCT00626327|12163918|FG001|Overall Study|Inappropriate enrollment|5
7734481|NCT00626327|12163919|FG002|Overall Study|Inappropriate enrollment|3
7734482|NCT00626327|12163917|FG000|Overall Study|Administrative Reason|2
7734483|NCT00626327|12163918|FG001|Overall Study|Administrative Reason|0
7734484|NCT00626327|12163919|FG002|Overall Study|Administrative Reason|6
7734485|NCT00626327|12163917|FG000|Overall Study|Protocol Violation|26
7734486|NCT00626327|12163918|FG001|Overall Study|Protocol Violation|4
7734487|NCT00626327|12163919|FG002|Overall Study|Protocol Violation|26
7734488|NCT00626392|12163954|FG000|Run-in Period|Adverse Event|0
7734489|NCT00626392|12163955|FG001|Run-in Period|Adverse Event|0
7734490|NCT00626392|12163956|FG002|Run-in Period|Adverse Event|1
7734491|NCT00626392|12163957|FG003|Run-in Period|Adverse Event|0
7734492|NCT00626392|12163958|FG004|Run-in Period|Adverse Event|1
7734493|NCT00626392|12163959|FG005|Run-in Period|Adverse Event|0
7734494|NCT00626392|12163954|FG000|Run-in Period|Withdrawal by Subject|0
7734495|NCT00626392|12163955|FG001|Run-in Period|Withdrawal by Subject|1
7734496|NCT00626392|12163956|FG002|Run-in Period|Withdrawal by Subject|1
7734497|NCT00626392|12163957|FG003|Run-in Period|Withdrawal by Subject|1
7734498|NCT00626392|12163958|FG004|Run-in Period|Withdrawal by Subject|3
7734499|NCT00626392|12163959|FG005|Run-in Period|Withdrawal by Subject|1
7734500|NCT00626392|12163954|FG000|Run-in Period|Noncompliance|1
7734501|NCT00626392|12163955|FG001|Run-in Period|Noncompliance|0
7734502|NCT00626392|12163956|FG002|Run-in Period|Noncompliance|1
7734503|NCT00626392|12163957|FG003|Run-in Period|Noncompliance|0
7734504|NCT00626392|12163958|FG004|Run-in Period|Noncompliance|0
7734505|NCT00626392|12163959|FG005|Run-in Period|Noncompliance|0
7734506|NCT00626392|12163954|FG000|Coadministration Period|Adverse Event|3
7734507|NCT00626392|12163955|FG001|Coadministration Period|Adverse Event|1
7734508|NCT00626392|12163956|FG002|Coadministration Period|Adverse Event|7
7734509|NCT00626392|12163957|FG003|Coadministration Period|Adverse Event|4
7734510|NCT00626392|12163958|FG004|Coadministration Period|Adverse Event|3
7734511|NCT00626392|12163959|FG005|Coadministration Period|Adverse Event|4
7734512|NCT00626392|12163954|FG000|Coadministration Period|Withdrawal by Subject|1
7734513|NCT00626392|12163955|FG001|Coadministration Period|Withdrawal by Subject|1
7734514|NCT00626392|12163956|FG002|Coadministration Period|Withdrawal by Subject|0
7734515|NCT00626392|12163957|FG003|Coadministration Period|Withdrawal by Subject|1
7734516|NCT00626392|12163958|FG004|Coadministration Period|Withdrawal by Subject|0
7734517|NCT00626392|12163959|FG005|Coadministration Period|Withdrawal by Subject|1
7734518|NCT00626392|12163954|FG000|Coadministration Period|Protocol Violation|0
7734519|NCT00626392|12163955|FG001|Coadministration Period|Protocol Violation|1
7734520|NCT00626392|12163956|FG002|Coadministration Period|Protocol Violation|0
7734521|NCT00626392|12163957|FG003|Coadministration Period|Protocol Violation|1
7734522|NCT00626392|12163958|FG004|Coadministration Period|Protocol Violation|1
7734523|NCT00626392|12163959|FG005|Coadministration Period|Protocol Violation|0
7734524|NCT00626392|12163954|FG000|Coadministration Period|Other|0
7734525|NCT00626392|12163955|FG001|Coadministration Period|Other|2
7734526|NCT00626392|12163956|FG002|Coadministration Period|Other|3
7734527|NCT00626392|12163957|FG003|Coadministration Period|Other|1
7734528|NCT00626392|12163958|FG004|Coadministration Period|Other|1
7734529|NCT00626392|12163959|FG005|Coadministration Period|Other|1
7734530|NCT00626405|12163967|FG000|Overall Study|Deemed Ineligible|1
7734531|NCT00626405|12163968|FG001|Overall Study|Deemed Ineligible|0
7734532|NCT00626405|12163967|FG000|Overall Study|Withdrawal by Subject|0
7734533|NCT00626405|12163968|FG001|Overall Study|Withdrawal by Subject|1
7734534|NCT00626522|12163989|FG000|Overall Study|Protocol Violation|0
7734535|NCT00626522|12163990|FG001|Overall Study|Protocol Violation|0
7734536|NCT00626522|12163991|FG002|Overall Study|Protocol Violation|0
7734537|NCT00626522|12163992|FG003|Overall Study|Protocol Violation|0
7734538|NCT00626522|12163993|FG004|Overall Study|Protocol Violation|1
7734539|NCT00626522|12163994|FG005|Overall Study|Protocol Violation|0
7734540|NCT00626522|12163989|FG000|Overall Study|Adverse Event|2
7734541|NCT00626522|12163990|FG001|Overall Study|Adverse Event|1
7734542|NCT00626522|12163991|FG002|Overall Study|Adverse Event|2
7734543|NCT00626522|12163992|FG003|Overall Study|Adverse Event|0
7734544|NCT00626522|12163993|FG004|Overall Study|Adverse Event|1
7734545|NCT00626522|12163994|FG005|Overall Study|Adverse Event|1
7734546|NCT00626522|12163989|FG000|Overall Study|Withdrawal by Subject|2
7734547|NCT00626522|12163990|FG001|Overall Study|Withdrawal by Subject|5
7734548|NCT00626522|12163991|FG002|Overall Study|Withdrawal by Subject|5
7734549|NCT00626522|12163992|FG003|Overall Study|Withdrawal by Subject|0
7734550|NCT00626522|12163993|FG004|Overall Study|Withdrawal by Subject|4
7734551|NCT00626522|12163994|FG005|Overall Study|Withdrawal by Subject|1
7734552|NCT00626522|12163989|FG000|Overall Study|COPD exacerbation|0
7734553|NCT00626522|12163990|FG001|Overall Study|COPD exacerbation|0
7734554|NCT00626522|12163991|FG002|Overall Study|COPD exacerbation|0
7734555|NCT00626522|12163992|FG003|Overall Study|COPD exacerbation|1
7734556|NCT00626522|12163993|FG004|Overall Study|COPD exacerbation|1
7734557|NCT00626522|12163994|FG005|Overall Study|COPD exacerbation|0
7734558|NCT00626522|12163989|FG000|Overall Study|Lost to Follow-up|0
7734559|NCT00626522|12163990|FG001|Overall Study|Lost to Follow-up|1
7734560|NCT00626522|12163991|FG002|Overall Study|Lost to Follow-up|0
7734561|NCT00626522|12163992|FG003|Overall Study|Lost to Follow-up|0
7734562|NCT00626522|12163993|FG004|Overall Study|Lost to Follow-up|0
7734563|NCT00626522|12163994|FG005|Overall Study|Lost to Follow-up|0
7734564|NCT00626522|12163989|FG000|Overall Study|Inconsistent reason reported|1
7734565|NCT00626522|12163990|FG001|Overall Study|Inconsistent reason reported|0
7734566|NCT00626522|12163991|FG002|Overall Study|Inconsistent reason reported|0
7734567|NCT00626522|12163992|FG003|Overall Study|Inconsistent reason reported|0
7734568|NCT00626522|12163993|FG004|Overall Study|Inconsistent reason reported|0
7734569|NCT00626522|12163994|FG005|Overall Study|Inconsistent reason reported|0
7734570|NCT00626522|12163989|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1
7734571|NCT00626522|12163990|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0
7734572|NCT00626522|12163991|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1
7734573|NCT00626522|12163992|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1
7734574|NCT00626522|12163993|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0
7734575|NCT00626522|12163994|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0
7734576|NCT00626548|12164010|FG000|Overall Study|Adverse Event|164
7734577|NCT00626548|12164011|FG001|Overall Study|Adverse Event|44
7734578|NCT00626548|12164010|FG000|Overall Study|Withdrawal by Subject|42
7734579|NCT00626548|12164011|FG001|Overall Study|Withdrawal by Subject|46
7734580|NCT00626548|12164010|FG000|Overall Study|Protocol Violation|4
7734581|NCT00626548|12164011|FG001|Overall Study|Protocol Violation|11
7734582|NCT00626548|12164010|FG000|Overall Study|Lost to Follow-up|2
7734583|NCT00626548|12164011|FG001|Overall Study|Lost to Follow-up|2
7734584|NCT00626548|12164010|FG000|Overall Study|Other termination reason|493
7734585|NCT00626548|12164011|FG001|Overall Study|Other termination reason|613
7734586|NCT00626639|12164040|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2
7734587|NCT00626639|12164041|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2
7734588|NCT00626795|12164072|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0
7734589|NCT00626795|12164073|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1
7734590|NCT00626795|12164074|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0
7734591|NCT00626795|12164072|FG000|Blinded Treatment|Lack of Efficacy|2
7734592|NCT00626795|12164073|FG001|Blinded Treatment|Lack of Efficacy|0
7734593|NCT00626795|12164074|FG002|Blinded Treatment|Lack of Efficacy|0
7734594|NCT00626795|12164072|FG000|Blinded Treatment|Unacceptable adverse event|0
7734595|NCT00626795|12164073|FG001|Blinded Treatment|Unacceptable adverse event|0
7734596|NCT00626795|12164074|FG002|Blinded Treatment|Unacceptable adverse event|1
7734597|NCT00626795|12164072|FG000|Blinded Treatment|Protocol Violation|0
7734598|NCT00626795|12164073|FG001|Blinded Treatment|Protocol Violation|1
7734599|NCT00626795|12164074|FG002|Blinded Treatment|Protocol Violation|1
7734600|NCT00626795|12164072|FG000|Blinded Treatment|Withdrawal by Subject|1
7734601|NCT00626795|12164073|FG001|Blinded Treatment|Withdrawal by Subject|1
7734602|NCT00626795|12164074|FG002|Blinded Treatment|Withdrawal by Subject|0
7734603|NCT00626795|12164072|FG000|Blinded Treatment|Other reasons|2
7734604|NCT00626795|12164073|FG001|Blinded Treatment|Other reasons|0
7734605|NCT00626795|12164074|FG002|Blinded Treatment|Other reasons|2
7734606|NCT00626795|12164072|FG000|Blinded Treatment|Missing reason for withdrawal|5
7734607|NCT00626795|12164073|FG001|Blinded Treatment|Missing reason for withdrawal|3
7734608|NCT00626795|12164074|FG002|Blinded Treatment|Missing reason for withdrawal|5
7734609|NCT00626821|12164103|FG000|Overall Study|Adverse Event|44
7734610|NCT00626821|12164103|FG000|Overall Study|Protocol Violation|33
7734611|NCT00626821|12164103|FG000|Overall Study|Withdrawal by Subject|10
7734612|NCT00626821|12164103|FG000|Overall Study|Physician Decision|9
7734613|NCT00626821|12164103|FG000|Overall Study|Product dysfunction|21
7734614|NCT00626821|12164103|FG000|Overall Study|other/unknown reason|104
7734615|NCT00626925|12164127|FG000|Overall Study|Lost to Follow-up|1
7734616|NCT00626925|12164128|FG001|Overall Study|Lost to Follow-up|2
7734617|NCT00626925|12164127|FG000|Overall Study|relapse|1
7734618|NCT00626925|12164128|FG001|Overall Study|relapse|0
7734619|NCT00626925|12164127|FG000|Overall Study|Adverse effect|6
7734620|NCT00626925|12164128|FG001|Overall Study|Adverse effect|2
7734621|NCT00626925|12164127|FG000|Overall Study|Lack of Efficacy|1
7734622|NCT00626925|12164128|FG001|Overall Study|Lack of Efficacy|4
7734623|NCT00626925|12164127|FG000|Overall Study|Time constraints|3
7734624|NCT00626925|12164128|FG001|Overall Study|Time constraints|1
7734625|NCT00627016|12164150|FG000|Overall Study|Adverse Event|1
7734626|NCT00627016|12164151|FG001|Overall Study|Adverse Event|1
7734627|NCT00627016|12164150|FG000|Overall Study|Protocol Violation|0
7734628|NCT00627016|12164151|FG001|Overall Study|Protocol Violation|2
7734629|NCT00627016|12164150|FG000|Overall Study|Lost to Follow-up|0
7734630|NCT00627016|12164151|FG001|Overall Study|Lost to Follow-up|1
7734631|NCT00627016|12164150|FG000|Overall Study|Withdrawal by Subject|2
7734632|NCT00627016|12164151|FG001|Overall Study|Withdrawal by Subject|1
7734633|NCT00627016|12164150|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
7734634|NCT00627016|12164151|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1
7734635|NCT00627016|12164150|FG000|Overall Study|Lack of Efficacy|1
7734636|NCT00627016|12164151|FG001|Overall Study|Lack of Efficacy|0
7734637|NCT00627016|12164150|FG000|Overall Study|Placed on Excluded Drugs|1
7734638|NCT00627016|12164151|FG001|Overall Study|Placed on Excluded Drugs|0
7734639|NCT00627016|12164150|FG000|Overall Study|Pregnancy|1
7734640|NCT00627016|12164151|FG001|Overall Study|Pregnancy|0
7734641|NCT00627042|12164157|FG000|Overall Study|Withdrawal by Subject|2
7734642|NCT00627094|12164163|FG000|Overall Study|Adverse Event|8
7734643|NCT00627094|12164164|FG001|Overall Study|Adverse Event|7
7734644|NCT00627094|12164163|FG000|Overall Study|Lost to Follow-up|1
7734645|NCT00627094|12164164|FG001|Overall Study|Lost to Follow-up|0
7734646|NCT00627094|12164163|FG000|Overall Study|Withdrawal by Subject|1
7734647|NCT00627094|12164164|FG001|Overall Study|Withdrawal by Subject|1
7734648|NCT00627094|12164163|FG000|Overall Study|ulcer healed|1
7734649|NCT00627094|12164164|FG001|Overall Study|ulcer healed|7
7734650|NCT00627094|12164163|FG000|Overall Study|Other reason|1
7734651|NCT00627094|12164164|FG001|Overall Study|Other reason|0
7734652|NCT00627393|12164184|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5
7734653|NCT00627393|12164185|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3
7734654|NCT00627393|12164184|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
7734655|NCT00627393|12164185|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
7734656|NCT00627393|12164184|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
7734657|NCT00627393|12164185|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
7734658|NCT00627393|12164184|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
7734659|NCT00627393|12164185|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
7734660|NCT00627445|12164212|FG000|Overall Study|Adverse Event|3
7734661|NCT00627445|12164213|FG001|Overall Study|Adverse Event|3
7734662|NCT00627445|12164212|FG000|Overall Study|Lack of Efficacy|0
7734663|NCT00627445|12164213|FG001|Overall Study|Lack of Efficacy|1
7734664|NCT00627445|12164212|FG000|Overall Study|Other|6
7734665|NCT00627445|12164213|FG001|Overall Study|Other|8
7734666|NCT00627458|12164224|FG000|Overall Study|Migrated from study area|1
7734667|NCT00627458|12164225|FG001|Overall Study|Migrated from study area|0
7734668|NCT00627458|12164226|FG002|Overall Study|Migrated from study area|1
7734669|NCT00627458|12164224|FG000|Overall Study|Withdrawal by Subject|2
7734670|NCT00627458|12164225|FG001|Overall Study|Withdrawal by Subject|6
7734671|NCT00627458|12164226|FG002|Overall Study|Withdrawal by Subject|5
7734672|NCT00627458|12164224|FG000|Overall Study|Lost to Follow-up|1
7734673|NCT00627458|12164225|FG001|Overall Study|Lost to Follow-up|1
7734674|NCT00627458|12164226|FG002|Overall Study|Lost to Follow-up|0
7734675|NCT00627497|12164239|FG000|Overall Study|Lost to Follow-up|1
7734676|NCT00627497|12164240|FG001|Overall Study|Lost to Follow-up|1
7734677|NCT00627497|12164241|FG002|Overall Study|Lost to Follow-up|0
7734678|NCT00627497|12164242|FG003|Overall Study|Lost to Follow-up|0
7734679|NCT00627523|12164254|FG000|Overall Study|Lack of Efficacy|1
7734680|NCT00627523|12164255|FG001|Overall Study|Lack of Efficacy|0
7734681|NCT00627523|12164254|FG000|Overall Study|Withdrawal by Subject|0
7734682|NCT00627523|12164255|FG001|Overall Study|Withdrawal by Subject|2
7734683|NCT00627523|12164254|FG000|Overall Study|Other|1
7734684|NCT00627523|12164255|FG001|Overall Study|Other|0
7734685|NCT00627705|12164276|FG000|Overall Study|Unwilling to take the compound (taste)|1
7734686|NCT00627705|12164277|FG001|Overall Study|Unwilling to take the compound (taste)|3
7734687|NCT00627705|12164276|FG000|Overall Study|Adverse Event|1
7734688|NCT00627705|12164277|FG001|Overall Study|Adverse Event|0
7734689|NCT00627705|12164276|FG000|Overall Study|Withdrawal by Subject|0
7734690|NCT00627705|12164277|FG001|Overall Study|Withdrawal by Subject|2
7734691|NCT00627705|12164276|FG000|Overall Study|Lost to Follow-up|0
7734692|NCT00627705|12164277|FG001|Overall Study|Lost to Follow-up|1
7768737|NCT00863655|12212111|FG001|Overall Study|Treatment completed as per protocol|1
7768738|NCT00863681|12212120|FG000|Overall Study|Other|2
7768739|NCT00863681|12212121|FG001|Overall Study|Other|0
7768740|NCT00863681|12212122|FG002|Overall Study|Other|0
7768741|NCT00863681|12212120|FG000|Overall Study|Missing|1
7768742|NCT00863681|12212121|FG001|Overall Study|Missing|0
7768743|NCT00863681|12212122|FG002|Overall Study|Missing|0
7768744|NCT00863681|12212120|FG000|Overall Study|Death|40
7768745|NCT00863681|12212121|FG001|Overall Study|Death|23
7768746|NCT00863681|12212122|FG002|Overall Study|Death|6
7768747|NCT00863681|12212120|FG000|Overall Study|Withdrawal by Subject|12
7768748|NCT00863681|12212121|FG001|Overall Study|Withdrawal by Subject|5
7768749|NCT00863681|12212122|FG002|Overall Study|Withdrawal by Subject|2
7768750|NCT00863681|12212120|FG000|Overall Study|Protocol Violation|2
7768751|NCT00863681|12212121|FG001|Overall Study|Protocol Violation|0
7768752|NCT00863681|12212122|FG002|Overall Study|Protocol Violation|0
7768753|NCT00863681|12212120|FG000|Overall Study|Lost to Follow-up|3
7768754|NCT00863681|12212121|FG001|Overall Study|Lost to Follow-up|0
7768755|NCT00863681|12212122|FG002|Overall Study|Lost to Follow-up|3
7768756|NCT00863681|12212120|FG000|Overall Study|Adverse Event|28
7768757|NCT00863681|12212121|FG001|Overall Study|Adverse Event|10
7768758|NCT00863681|12212122|FG002|Overall Study|Adverse Event|6
7768759|NCT00863681|12212120|FG000|Overall Study|Lack of Efficacy|2
7768760|NCT00863681|12212121|FG001|Overall Study|Lack of Efficacy|2
7768761|NCT00863681|12212122|FG002|Overall Study|Lack of Efficacy|1
7768762|NCT00863681|12212120|FG000|Overall Study|Non-compliance with study drug|1
7768763|NCT00863681|12212121|FG001|Overall Study|Non-compliance with study drug|3
7768764|NCT00863681|12212122|FG002|Overall Study|Non-compliance with study drug|0
7768765|NCT00863707|12212132|FG000|Overall Study|Randomized, but drug not received|4
7768766|NCT00863707|12212133|FG001|Overall Study|Randomized, but drug not received|3
7768767|NCT00863746|12212141|FG000|Treatment|Not treated|4
7768768|NCT00863746|12212142|FG001|Treatment|Not treated|2
7768769|NCT00863746|12212141|FG000|Treatment|Adverse Event|41
7768770|NCT00863746|12212142|FG001|Treatment|Adverse Event|16
7768771|NCT00863746|12212141|FG000|Treatment|non-compliant with study medication|4
7768772|NCT00863746|12212142|FG001|Treatment|non-compliant with study medication|0
7768773|NCT00863746|12212141|FG000|Treatment|Consent withdrawn|15
7768774|NCT00863746|12212142|FG001|Treatment|Consent withdrawn|14
7768775|NCT00863746|12212141|FG000|Treatment|Lost to Follow-up|1
7768776|NCT00863746|12212142|FG001|Treatment|Lost to Follow-up|0
7768777|NCT00863746|12212141|FG000|Treatment|Protocol Violation|5
7768778|NCT00863746|12212142|FG001|Treatment|Protocol Violation|3
7768779|NCT00863746|12212141|FG000|Treatment|Other|1
7768780|NCT00863746|12212142|FG001|Treatment|Other|0
7768781|NCT00863746|12212141|FG000|Survival Follow up|Death|244
7768782|NCT00863746|12212142|FG001|Survival Follow up|Death|271
7768783|NCT00863746|12212141|FG000|Survival Follow up|Lost to Follow-up|2
7768784|NCT00863746|12212142|FG001|Survival Follow up|Lost to Follow-up|1
7768785|NCT00863746|12212141|FG000|Survival Follow up|Consent Withdrawn|7
7768786|NCT00863746|12212142|FG001|Survival Follow up|Consent Withdrawn|8
7768787|NCT00863772|12212151|FG000|Overall Study|Adverse Event|1
7768788|NCT00863772|12212152|FG001|Overall Study|Adverse Event|4
7768789|NCT00863772|12212153|FG002|Overall Study|Adverse Event|0
7768790|NCT00863772|12212151|FG000|Overall Study|Lack of Efficacy|4
7768791|NCT00863772|12212152|FG001|Overall Study|Lack of Efficacy|2
7768792|NCT00863772|12212153|FG002|Overall Study|Lack of Efficacy|4
7768793|NCT00863772|12212151|FG000|Overall Study|Lost to Follow-up|5
7768794|NCT00863772|12212152|FG001|Overall Study|Lost to Follow-up|1
7768795|NCT00863772|12212153|FG002|Overall Study|Lost to Follow-up|1
7734693|NCT00627926|12164292|FG000|Overall Study|Adverse Event|26
7734694|NCT00627926|12164293|FG001|Overall Study|Adverse Event|37
7734695|NCT00627926|12164294|FG002|Overall Study|Adverse Event|36
7734696|NCT00627926|12164292|FG000|Overall Study|Death|1
7734697|NCT00627926|12164293|FG001|Overall Study|Death|0
7734698|NCT00627926|12164294|FG002|Overall Study|Death|0
7734699|NCT00627926|12164292|FG000|Overall Study|Lost to Follow-up|4
7734700|NCT00627926|12164293|FG001|Overall Study|Lost to Follow-up|3
7734701|NCT00627926|12164294|FG002|Overall Study|Lost to Follow-up|4
7734702|NCT00627926|12164292|FG000|Overall Study|Withdrawal by Subject|2
7734703|NCT00627926|12164293|FG001|Overall Study|Withdrawal by Subject|1
7734704|NCT00627926|12164294|FG002|Overall Study|Withdrawal by Subject|0
7734705|NCT00627926|12164292|FG000|Overall Study|Lack of Efficacy|118
7734706|NCT00627926|12164293|FG001|Overall Study|Lack of Efficacy|40
7734707|NCT00627926|12164294|FG002|Overall Study|Lack of Efficacy|38
7734708|NCT00627926|12164292|FG000|Overall Study|Noncompliance/unspecified|8
7734709|NCT00627926|12164293|FG001|Overall Study|Noncompliance/unspecified|23
7734710|NCT00627926|12164294|FG002|Overall Study|Noncompliance/unspecified|17
7734711|NCT00628030|12164313|FG000|Baseline to Post-Assessment|Lost to Follow-up|28
7734712|NCT00628030|12164314|FG001|Baseline to Post-Assessment|Lost to Follow-up|29
7734713|NCT00628030|12164313|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5
7734714|NCT00628030|12164314|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0
7734715|NCT00628030|12164313|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32
7734716|NCT00628030|12164314|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30
7734717|NCT00628108|12164322|FG000|Overall Study|Adverse Event|0
7734718|NCT00628108|12164323|FG001|Overall Study|Adverse Event|3
7734719|NCT00628108|12164322|FG000|Overall Study|Withdrawal by Subject|1
7734720|NCT00628108|12164323|FG001|Overall Study|Withdrawal by Subject|0
7734721|NCT00628212|12164349|FG000|Overall Study|Adverse Event|2
7734722|NCT00628212|12164350|FG001|Overall Study|Adverse Event|0
7734723|NCT00628212|12164351|FG002|Overall Study|Adverse Event|1
7734724|NCT00628212|12164352|FG003|Overall Study|Adverse Event|2
7734725|NCT00628212|12164349|FG000|Overall Study|Physician Decision|1
7734726|NCT00628212|12164350|FG001|Overall Study|Physician Decision|1
7734727|NCT00628212|12164351|FG002|Overall Study|Physician Decision|2
7734728|NCT00628212|12164352|FG003|Overall Study|Physician Decision|3
7734729|NCT00628251|12164365|FG000|Randomised Part|Withdrawal by Subject|0
7734730|NCT00628251|12164366|FG001|Randomised Part|Withdrawal by Subject|0
7734731|NCT00628251|12164367|FG002|Randomised Part|Withdrawal by Subject|1
7734732|NCT00628251|12164365|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1
7734733|NCT00628251|12164366|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2
7734734|NCT00628251|12164367|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3
7734735|NCT00628251|12164365|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19
7734736|NCT00628251|12164366|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15
7734737|NCT00628251|12164367|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13
7734738|NCT00628251|12164365|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
7734739|NCT00628251|12164366|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2
7734740|NCT00628251|12164367|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
7734741|NCT00628251|12164365|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0
7734742|NCT00628251|12164366|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1
7734743|NCT00628251|12164367|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6
7734744|NCT00628251|12164365|FG000|Ongoing Initial Study Treatment at DCO|Other|1
7734745|NCT00628251|12164366|FG001|Ongoing Initial Study Treatment at DCO|Other|0
7734746|NCT00628251|12164367|FG002|Ongoing Initial Study Treatment at DCO|Other|2
7734747|NCT00628355|12164379|FG000|Overall Study|Withdrawal by Subject|1
7734748|NCT00628355|12164380|FG001|Overall Study|Withdrawal by Subject|1
7734749|NCT00628758|12164436|FG000|Overall Study|Adverse Event|2
7734750|NCT00628758|12164437|FG001|Overall Study|Adverse Event|3
7734751|NCT00628758|12164436|FG000|Overall Study|Withdrawal by Subject|6
7734752|NCT00628758|12164437|FG001|Overall Study|Withdrawal by Subject|3
7734753|NCT00628758|12164436|FG000|Overall Study|Death|1
7734754|NCT00628758|12164437|FG001|Overall Study|Death|0
7734755|NCT00628758|12164436|FG000|Overall Study|Protocol Violation|5
7734756|NCT00628758|12164437|FG001|Overall Study|Protocol Violation|1
7734757|NCT00628758|12164436|FG000|Overall Study|Lost to Follow-up|25
7734758|NCT00628758|12164437|FG001|Overall Study|Lost to Follow-up|31
7734759|NCT00628758|12164436|FG000|Overall Study|Pregnancy|2
7734760|NCT00628758|12164437|FG001|Overall Study|Pregnancy|2
7734761|NCT00628758|12164436|FG000|Overall Study|Investigator Moved|3
7734762|NCT00628758|12164437|FG001|Overall Study|Investigator Moved|0
7734763|NCT00628758|12164436|FG000|Overall Study|Treatment Failure|0
7734764|NCT00628758|12164437|FG001|Overall Study|Treatment Failure|2
7734765|NCT00628862|12164448|FG000|Overall Study|Adverse Event|6
7734766|NCT00628862|12164449|FG001|Overall Study|Adverse Event|8
7734767|NCT00628862|12164450|FG002|Overall Study|Adverse Event|10
7734768|NCT00628862|12164448|FG000|Overall Study|Withdrawal by Subject|4
7734769|NCT00628862|12164449|FG001|Overall Study|Withdrawal by Subject|6
7734770|NCT00628862|12164450|FG002|Overall Study|Withdrawal by Subject|11
7734771|NCT00628862|12164448|FG000|Overall Study|Lost to Follow-up|0
7734772|NCT00628862|12164449|FG001|Overall Study|Lost to Follow-up|2
7734773|NCT00628862|12164450|FG002|Overall Study|Lost to Follow-up|1
7734774|NCT00628862|12164448|FG000|Overall Study|Protocol Violation|1
7734775|NCT00628862|12164449|FG001|Overall Study|Protocol Violation|0
7734776|NCT00628862|12164450|FG002|Overall Study|Protocol Violation|0
7734777|NCT00628862|12164448|FG000|Overall Study|COPD Exacerbation|0
7734778|NCT00628862|12164449|FG001|Overall Study|COPD Exacerbation|1
7734779|NCT00628862|12164450|FG002|Overall Study|COPD Exacerbation|0
7734780|NCT00628927|12164469|FG000|Overall Study|Problems performing blood draw|6
7734781|NCT00628927|12164470|FG001|Overall Study|Problems performing blood draw|0
7734782|NCT00628927|12164469|FG000|Overall Study|Lost to Follow-up|1
7734783|NCT00628927|12164470|FG001|Overall Study|Lost to Follow-up|0
7734784|NCT00628927|12164469|FG000|Overall Study|Equipment failure|1
7734785|NCT00628927|12164470|FG001|Overall Study|Equipment failure|0
7734786|NCT00629083|12164492|FG000|Overall Study|Adverse Event|0
7734787|NCT00629083|12164493|FG001|Overall Study|Adverse Event|2
7734788|NCT00629083|12164492|FG000|Overall Study|Lack of Efficacy|3
7734789|NCT00629083|12164493|FG001|Overall Study|Lack of Efficacy|1
7734790|NCT00629083|12164492|FG000|Overall Study|Withdrawal by Subject|10
7734791|NCT00629083|12164493|FG001|Overall Study|Withdrawal by Subject|2
7734792|NCT00629083|12164492|FG000|Overall Study|Lost to Follow-up|12
7734793|NCT00629083|12164493|FG001|Overall Study|Lost to Follow-up|8
7734794|NCT00629083|12164492|FG000|Overall Study|Moved out of country/state|2
7734795|NCT00629083|12164493|FG001|Overall Study|Moved out of country/state|1
7734796|NCT00629083|12164492|FG000|Overall Study|Refused to return for 12 month visit|1
7734797|NCT00629083|12164493|FG001|Overall Study|Refused to return for 12 month visit|0
7734798|NCT00629239|12164512|FG000|Overall Study|Adverse Event|7
7734799|NCT00629239|12164513|FG001|Overall Study|Adverse Event|4
7734800|NCT00629239|12164512|FG000|Overall Study|Physician Decision|1
7734801|NCT00629239|12164513|FG001|Overall Study|Physician Decision|0
7734802|NCT00629265|12164521|FG000|Overall Study|Lost to Follow-up|4
7734803|NCT00629265|12164522|FG001|Overall Study|Lost to Follow-up|5
7734804|NCT00629265|12164521|FG000|Overall Study|Withdrawal by Subject|11
7734805|NCT00629265|12164522|FG001|Overall Study|Withdrawal by Subject|8
7734806|NCT00629265|12164521|FG000|Overall Study|Death|1
7734807|NCT00629265|12164522|FG001|Overall Study|Death|0
7734808|NCT00629265|12164521|FG000|Overall Study|Adverse Event|2
7734809|NCT00629265|12164522|FG001|Overall Study|Adverse Event|0
7734810|NCT00629265|12164521|FG000|Overall Study|HNC Recurrence|4
7734811|NCT00629265|12164522|FG001|Overall Study|HNC Recurrence|0
7734812|NCT00629265|12164521|FG000|Overall Study|Other CA Requiring Treatment|1
7734813|NCT00629265|12164522|FG001|Overall Study|Other CA Requiring Treatment|3
7734814|NCT00629265|12164521|FG000|Overall Study|Needed Esophageal Dilation|4
7734815|NCT00629265|12164522|FG001|Overall Study|Needed Esophageal Dilation|1
7734816|NCT00629265|12164521|FG000|Overall Study|Unrelated Medical Complications|3
7734817|NCT00629265|12164522|FG001|Overall Study|Unrelated Medical Complications|1
7734818|NCT00629265|12164521|FG000|Overall Study|Unknown Reason|2
7734819|NCT00629265|12164522|FG001|Overall Study|Unknown Reason|2
7734820|NCT00629707|12164538|FG000|Overall Study|Withdrawal by Subject|0
7734821|NCT00629707|12164539|FG001|Overall Study|Withdrawal by Subject|1
7734822|NCT00629707|12164538|FG000|Overall Study|Physician Decision|0
7734823|NCT00629707|12164539|FG001|Overall Study|Physician Decision|1
7734824|NCT00629772|12164547|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1
7734825|NCT00629772|12164548|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1
7734826|NCT00629772|12164547|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
7734827|NCT00629772|12164548|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
7734828|NCT00630032|12164557|FG000|Overall Study|Death|55
7734829|NCT00630032|12164558|FG001|Overall Study|Death|49
7734830|NCT00630032|12164557|FG000|Overall Study|Withdrawal by Subject|3
7734831|NCT00630032|12164558|FG001|Overall Study|Withdrawal by Subject|2
7734832|NCT00630032|12164557|FG000|Overall Study|Lost to Follow-up|18
7734833|NCT00630032|12164558|FG001|Overall Study|Lost to Follow-up|31
7734834|NCT00630032|12164557|FG000|Overall Study|Protocol Violation|1
7734835|NCT00630032|12164558|FG001|Overall Study|Protocol Violation|0
7734836|NCT00630032|12164557|FG000|Overall Study|Patient has moved|1
7734837|NCT00630032|12164558|FG001|Overall Study|Patient has moved|1
7734838|NCT00630032|12164557|FG000|Overall Study|Disease progression|1
7734839|NCT00630032|12164558|FG001|Overall Study|Disease progression|1
7734840|NCT00630032|12164557|FG000|Overall Study|End of monitoring in US centers|11
7734841|NCT00630032|12164558|FG001|Overall Study|End of monitoring in US centers|11
7734842|NCT00630058|12164566|FG000|Overall Study|Adverse Event|1
7734843|NCT00630058|12164567|FG001|Overall Study|Adverse Event|1
7734844|NCT00630058|12164566|FG000|Overall Study|Withdrawal by Subject|0
7734845|NCT00630058|12164567|FG001|Overall Study|Withdrawal by Subject|1
7734846|NCT00630058|12164566|FG000|Overall Study|stopping criteria|3
7734847|NCT00630058|12164567|FG001|Overall Study|stopping criteria|2
7734848|NCT00630305|12164586|FG000|Overall Study|Withdrawal by Subject|1
7734849|NCT00630305|12164586|FG000|Overall Study|Inability to insert contact lens|1
7734850|NCT00630331|12164602|FG000|Overall Study|Death|2
7734851|NCT00630331|12164603|FG001|Overall Study|Death|1
7734852|NCT00630331|12164604|FG002|Overall Study|Death|1
7734853|NCT00630331|12164602|FG000|Overall Study|Adverse Event|1
7734854|NCT00630331|12164603|FG001|Overall Study|Adverse Event|0
7734855|NCT00630331|12164604|FG002|Overall Study|Adverse Event|0
7734856|NCT00630331|12164602|FG000|Overall Study|Withdrawal by Subject|12
7734857|NCT00630331|12164603|FG001|Overall Study|Withdrawal by Subject|7
7734858|NCT00630331|12164604|FG002|Overall Study|Withdrawal by Subject|5
7734859|NCT00630331|12164602|FG000|Overall Study|Lost to Follow-up|175
7734860|NCT00630331|12164603|FG001|Overall Study|Lost to Follow-up|143
7734861|NCT00630331|12164604|FG002|Overall Study|Lost to Follow-up|170
7734862|NCT00630331|12164602|FG000|Overall Study|Inappropriate enrollment|3
7734863|NCT00630331|12164603|FG001|Overall Study|Inappropriate enrollment|6
7734864|NCT00630331|12164604|FG002|Overall Study|Inappropriate enrollment|3
7734865|NCT00630331|12164602|FG000|Overall Study|Unable to classify|9
7734866|NCT00630331|12164603|FG001|Overall Study|Unable to classify|4
7734867|NCT00630331|12164604|FG002|Overall Study|Unable to classify|3
7734868|NCT00630331|12164602|FG000|Overall Study|Protocol Violation|4
7734869|NCT00630331|12164603|FG001|Overall Study|Protocol Violation|5
7734870|NCT00630331|12164604|FG002|Overall Study|Protocol Violation|6
7734871|NCT00630344|12164612|FG000|Overall Study|Adverse Event|5
7734872|NCT00630344|12164612|FG000|Overall Study|Progressive Disease|19
7734873|NCT00630344|12164612|FG000|Overall Study|Physician Decision|9
7734874|NCT00630344|12164612|FG000|Overall Study|Withdrawal by Subject|1
7734875|NCT00630344|12164612|FG000|Overall Study|Intercurrent Illness|1
7734876|NCT00630344|12164612|FG000|Overall Study|Other|1
7734877|NCT00630396|12164617|FG000|Overall Study|Death|4
7734878|NCT00630396|12164617|FG000|Overall Study|Lost to Follow-up|3
7734879|NCT00630539|12164630|FG000|Overall Study|Adverse Event|1
7734880|NCT00630539|12164631|FG001|Overall Study|Adverse Event|3
7734881|NCT00630539|12164632|FG002|Overall Study|Adverse Event|1
7734882|NCT00630539|12164633|FG003|Overall Study|Adverse Event|2
7734883|NCT00630539|12164630|FG000|Overall Study|Withdrawal by Subject|0
7734884|NCT00630539|12164631|FG001|Overall Study|Withdrawal by Subject|1
7734885|NCT00630539|12164632|FG002|Overall Study|Withdrawal by Subject|0
7734886|NCT00630539|12164633|FG003|Overall Study|Withdrawal by Subject|1
7734887|NCT00630747|12164665|FG000|Overall Study|Death|1
7734888|NCT00630747|12164665|FG000|Overall Study|Transferred to Study TKT031NPU|7
7734889|NCT00630747|12164665|FG000|Overall Study|Returned to country of origin|1
7734890|NCT00630786|12164672|FG000|Overall Study|Physician Decision|0
7734891|NCT00630786|12164673|FG001|Overall Study|Physician Decision|0
7734892|NCT00630786|12164674|FG002|Overall Study|Physician Decision|1
7734893|NCT00630786|12164672|FG000|Overall Study|Withdrawal by Subject|0
7734894|NCT00630786|12164673|FG001|Overall Study|Withdrawal by Subject|1
7734895|NCT00630786|12164674|FG002|Overall Study|Withdrawal by Subject|1
7734896|NCT00630786|12164672|FG000|Overall Study|Lost to Follow-up|0
7734897|NCT00630786|12164673|FG001|Overall Study|Lost to Follow-up|1
7734898|NCT00630786|12164674|FG002|Overall Study|Lost to Follow-up|0
7734899|NCT00630786|12164672|FG000|Overall Study|Other|1
7734900|NCT00630786|12164673|FG001|Overall Study|Other|0
7734901|NCT00630786|12164674|FG002|Overall Study|Other|0
7734902|NCT00630812|12164682|FG000|Randomisation to First Dose|Adverse Event|1
7734903|NCT00630812|12164683|FG001|Randomisation to First Dose|Adverse Event|1
7734904|NCT00630812|12164682|FG000|Randomisation to First Dose|Withdrawal by Subject|2
7734905|NCT00630812|12164683|FG001|Randomisation to First Dose|Withdrawal by Subject|3
7734906|NCT00630812|12164682|FG000|Randomisation to First Dose|Lost to Follow-up|1
7734907|NCT00630812|12164683|FG001|Randomisation to First Dose|Lost to Follow-up|0
7734908|NCT00630812|12164682|FG000|Randomisation to First Dose|Protocol Violation|4
7734909|NCT00630812|12164683|FG001|Randomisation to First Dose|Protocol Violation|1
7734910|NCT00630812|12164682|FG000|Double Blind Treatment Period|Adverse Event|13
7734911|NCT00630812|12164683|FG001|Double Blind Treatment Period|Adverse Event|5
7734912|NCT00630812|12164682|FG000|Double Blind Treatment Period|Lost to Follow-up|1
7734913|NCT00630812|12164683|FG001|Double Blind Treatment Period|Lost to Follow-up|0
7734914|NCT00630812|12164682|FG000|Double Blind Treatment Period|Physician Decision|2
7734915|NCT00630812|12164683|FG001|Double Blind Treatment Period|Physician Decision|1
7734916|NCT00630812|12164682|FG000|Double Blind Treatment Period|Protocol Violation|1
7734917|NCT00630812|12164683|FG001|Double Blind Treatment Period|Protocol Violation|0
7734918|NCT00630812|12164682|FG000|Double Blind Treatment Period|Withdrawal by Subject|13
7734919|NCT00630812|12164683|FG001|Double Blind Treatment Period|Withdrawal by Subject|7
7734920|NCT00630812|12164682|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1
7734921|NCT00630812|12164683|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0
7734922|NCT00630812|12164682|FG000|Double Blind Treatment Period|Non-compliance|0
7734923|NCT00630812|12164683|FG001|Double Blind Treatment Period|Non-compliance|1
7734924|NCT00630825|12164693|FG000|Overall Study|Adverse Event|4
7734925|NCT00630825|12164694|FG001|Overall Study|Adverse Event|4
7734926|NCT00630825|12164695|FG002|Overall Study|Adverse Event|3
7734927|NCT00630825|12164696|FG003|Overall Study|Adverse Event|1
7734928|NCT00630825|12164693|FG000|Overall Study|Entry Criteria Not Met|1
7734929|NCT00630825|12164694|FG001|Overall Study|Entry Criteria Not Met|0
7734930|NCT00630825|12164695|FG002|Overall Study|Entry Criteria Not Met|2
7734931|NCT00630825|12164696|FG003|Overall Study|Entry Criteria Not Met|1
7734932|NCT00630825|12164693|FG000|Overall Study|Lost to Follow-up|1
7734933|NCT00630825|12164694|FG001|Overall Study|Lost to Follow-up|1
7734934|NCT00630825|12164695|FG002|Overall Study|Lost to Follow-up|1
7734935|NCT00630825|12164696|FG003|Overall Study|Lost to Follow-up|1
7734936|NCT00630825|12164693|FG000|Overall Study|Physician Decision|1
7734937|NCT00630825|12164694|FG001|Overall Study|Physician Decision|0
7734938|NCT00630825|12164695|FG002|Overall Study|Physician Decision|0
7734939|NCT00630825|12164696|FG003|Overall Study|Physician Decision|0
7734940|NCT00630825|12164693|FG000|Overall Study|Withdrawal by Subject|2
7734941|NCT00630825|12164694|FG001|Overall Study|Withdrawal by Subject|2
7734942|NCT00630825|12164695|FG002|Overall Study|Withdrawal by Subject|2
7734943|NCT00630825|12164696|FG003|Overall Study|Withdrawal by Subject|3
7734944|NCT00630838|12164708|FG000|Overall Study|Death|0
7734945|NCT00630838|12164709|FG001|Overall Study|Death|1
7734946|NCT00630838|12164708|FG000|Overall Study|Lost to Follow-up|0
7734947|NCT00630838|12164709|FG001|Overall Study|Lost to Follow-up|1
7734948|NCT00630864|12164717|FG000|Part 1 (up to Week 6)|Adverse Event|1
7734949|NCT00630864|12164717|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
7734950|NCT00630877|12164724|FG000|Overall Study|Adverse Event|11
7734951|NCT00630877|12164725|FG001|Overall Study|Adverse Event|8
7734952|NCT00630877|12164726|FG002|Overall Study|Adverse Event|7
7734953|NCT00630877|12164724|FG000|Overall Study|Withdrawal by Subject|3
7734954|NCT00630877|12164725|FG001|Overall Study|Withdrawal by Subject|4
7734955|NCT00630877|12164726|FG002|Overall Study|Withdrawal by Subject|0
7734956|NCT00630877|12164724|FG000|Overall Study|Lost to Follow-up|2
7734957|NCT00630877|12164725|FG001|Overall Study|Lost to Follow-up|0
7734958|NCT00630877|12164726|FG002|Overall Study|Lost to Follow-up|0
7734959|NCT00630877|12164724|FG000|Overall Study|Noncompliance|2
7734960|NCT00630877|12164725|FG001|Overall Study|Noncompliance|3
7734961|NCT00630877|12164726|FG002|Overall Study|Noncompliance|1
7734962|NCT00630877|12164724|FG000|Overall Study|Protocol violation|1
7734963|NCT00630877|12164725|FG001|Overall Study|Protocol violation|0
7734964|NCT00630877|12164726|FG002|Overall Study|Protocol violation|1
7734965|NCT00630877|12164724|FG000|Overall Study|Personal reasons|0
7734966|NCT00630877|12164725|FG001|Overall Study|Personal reasons|0
7734967|NCT00630877|12164726|FG002|Overall Study|Personal reasons|1
7734968|NCT00630916|12164738|FG000|Overall Study|Death|110
7734969|NCT00630916|12164738|FG000|Overall Study|Explant|8
7734970|NCT00630916|12164738|FG000|Overall Study|Lost to Follow-up|5
7734971|NCT00630916|12164738|FG000|Overall Study|Withdrawal by Subject|30
7734972|NCT00630916|12164738|FG000|Overall Study|Protocol Violation|7
7734973|NCT00630916|12164738|FG000|Overall Study|Physician Decision|47
7734974|NCT00630916|12164738|FG000|Overall Study|Lack of Efficacy|3
7734975|NCT00630994|12164755|FG000|Overall Study|Adverse Event|1
7734976|NCT00630994|12164755|FG000|Overall Study|Disease Progression|1
7734977|NCT00630994|12164755|FG000|Overall Study|Lack of Efficacy|1
7734978|NCT00630994|12164755|FG000|Overall Study|Other|1
7734979|NCT00631007|12164765|FG000|Overall Study|Adverse Event|0
7734980|NCT00631007|12164766|FG001|Overall Study|Adverse Event|2
7734981|NCT00631007|12164767|FG002|Overall Study|Adverse Event|0
7734982|NCT00631007|12164768|FG003|Overall Study|Adverse Event|2
7734983|NCT00631007|12164769|FG004|Overall Study|Adverse Event|3
7734984|NCT00631007|12164770|FG005|Overall Study|Adverse Event|2
7734985|NCT00631007|12164765|FG000|Overall Study|Lost to Follow-up|2
7734986|NCT00631007|12164766|FG001|Overall Study|Lost to Follow-up|1
7734987|NCT00631007|12164767|FG002|Overall Study|Lost to Follow-up|2
7734988|NCT00631007|12164768|FG003|Overall Study|Lost to Follow-up|4
7734989|NCT00631007|12164769|FG004|Overall Study|Lost to Follow-up|5
7734990|NCT00631007|12164770|FG005|Overall Study|Lost to Follow-up|3
7734991|NCT00631007|12164765|FG000|Overall Study|Physician Decision|1
7734992|NCT00631007|12164766|FG001|Overall Study|Physician Decision|0
7734993|NCT00631007|12164767|FG002|Overall Study|Physician Decision|1
7734994|NCT00631007|12164768|FG003|Overall Study|Physician Decision|0
7734995|NCT00631007|12164769|FG004|Overall Study|Physician Decision|0
7734996|NCT00631007|12164770|FG005|Overall Study|Physician Decision|2
7734997|NCT00631007|12164765|FG000|Overall Study|Persistent Hyperglycemia|2
7734998|NCT00631007|12164766|FG001|Overall Study|Persistent Hyperglycemia|2
7734999|NCT00631007|12164767|FG002|Overall Study|Persistent Hyperglycemia|5
7735000|NCT00631007|12164768|FG003|Overall Study|Persistent Hyperglycemia|1
7735001|NCT00631007|12164769|FG004|Overall Study|Persistent Hyperglycemia|2
7735002|NCT00631007|12164770|FG005|Overall Study|Persistent Hyperglycemia|5
7735003|NCT00631007|12164765|FG000|Overall Study|Withdrawal by Subject|4
7735004|NCT00631007|12164766|FG001|Overall Study|Withdrawal by Subject|5
7735005|NCT00631007|12164767|FG002|Overall Study|Withdrawal by Subject|2
7735006|NCT00631007|12164768|FG003|Overall Study|Withdrawal by Subject|2
7735007|NCT00631007|12164769|FG004|Overall Study|Withdrawal by Subject|1
7735008|NCT00631007|12164770|FG005|Overall Study|Withdrawal by Subject|3
7735009|NCT00631007|12164765|FG000|Overall Study|Other|2
7735010|NCT00631007|12164766|FG001|Overall Study|Other|1
7735011|NCT00631007|12164767|FG002|Overall Study|Other|0
7735012|NCT00631007|12164768|FG003|Overall Study|Other|0
7735013|NCT00631007|12164769|FG004|Overall Study|Other|1
7735014|NCT00631007|12164770|FG005|Overall Study|Other|0
7735015|NCT00631020|12164784|FG000|Overall Study|Lost to Follow-up|7
7735016|NCT00631020|12164784|FG000|Overall Study|Incarcerated|1
7735017|NCT00631163|12164788|FG000|Number of Participants in Year 1|Adverse Event|12
7735018|NCT00631163|12164788|FG000|Number of Participants in Year 1|Withdrawal by Subject|8
7735019|NCT00631163|12164788|FG000|Number of Participants in Year 1|Death|6
7735020|NCT00631163|12164788|FG000|Number of Participants in Year 1|Lost to Follow-up|1
7735021|NCT00631163|12164788|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1
7735022|NCT00631163|12164788|FG000|Number of Participants in Year 1|Administrative problems|6
7735023|NCT00631163|12164788|FG000|Number of Participants in Year 2|Withdrawal by Subject|2
7735024|NCT00631163|12164788|FG000|Number of Participants in Year 2|Adverse Event|1
7735025|NCT00631163|12164788|FG000|Number of Participants in Year 2|Protocol Violation|1
7735026|NCT00631163|12164788|FG000|Number of Participants in Year 2|Abnormal laboratory value|1
7735027|NCT00631189|12164803|FG000|Initial Phase|Protocol Violation|347
7735028|NCT00631189|12164804|FG001|Initial Phase|Protocol Violation|0
7735029|NCT00631189|12164805|FG002|Initial Phase|Protocol Violation|0
7735030|NCT00631189|12164806|FG003|Initial Phase|Protocol Violation|0
7735031|NCT00631189|12164803|FG000|Initial Phase|Withdrawal by Subject|4
7735032|NCT00631189|12164804|FG001|Initial Phase|Withdrawal by Subject|0
7735033|NCT00631189|12164805|FG002|Initial Phase|Withdrawal by Subject|0
7735034|NCT00631189|12164806|FG003|Initial Phase|Withdrawal by Subject|0
7735035|NCT00631189|12164803|FG000|Treatment Phase|Withdrawal by Subject|0
7735036|NCT00631189|12164804|FG001|Treatment Phase|Withdrawal by Subject|2
7735037|NCT00631189|12164805|FG002|Treatment Phase|Withdrawal by Subject|1
7735038|NCT00631189|12164806|FG003|Treatment Phase|Withdrawal by Subject|1
7735039|NCT00631189|12164803|FG000|Treatment Phase|Protocol Violation|0
7735040|NCT00631189|12164804|FG001|Treatment Phase|Protocol Violation|1
7735041|NCT00631189|12164805|FG002|Treatment Phase|Protocol Violation|6
7735042|NCT00631189|12164806|FG003|Treatment Phase|Protocol Violation|2
7735043|NCT00631189|12164803|FG000|Treatment Phase|Adverse Event|0
7735044|NCT00631189|12164804|FG001|Treatment Phase|Adverse Event|3
7735045|NCT00631189|12164805|FG002|Treatment Phase|Adverse Event|2
7735046|NCT00631189|12164806|FG003|Treatment Phase|Adverse Event|4
7735047|NCT00631189|12164803|FG000|Treatment Phase|Lost to Follow-up|0
7735048|NCT00631189|12164804|FG001|Treatment Phase|Lost to Follow-up|1
7735049|NCT00631189|12164805|FG002|Treatment Phase|Lost to Follow-up|0
7735050|NCT00631189|12164806|FG003|Treatment Phase|Lost to Follow-up|0
7735051|NCT00631189|12164803|FG000|Treatment Phase|Pregnancy|0
7735052|NCT00631189|12164804|FG001|Treatment Phase|Pregnancy|0
7735053|NCT00631189|12164805|FG002|Treatment Phase|Pregnancy|1
7735054|NCT00631189|12164806|FG003|Treatment Phase|Pregnancy|0
7735055|NCT00631189|12164803|FG000|Treatment Phase|patient did not take pravastatin|0
7735056|NCT00631189|12164804|FG001|Treatment Phase|patient did not take pravastatin|0
7735057|NCT00631189|12164805|FG002|Treatment Phase|patient did not take pravastatin|1
7735058|NCT00631189|12164806|FG003|Treatment Phase|patient did not take pravastatin|0
7735059|NCT00631371|12164837|FG000|Overall Study|Lost to Follow-up|24
7735060|NCT00631371|12164838|FG001|Overall Study|Lost to Follow-up|19
7735061|NCT00631371|12164837|FG000|Overall Study|Other reason|5
7735062|NCT00631371|12164838|FG001|Overall Study|Other reason|12
7735063|NCT00631371|12164837|FG000|Overall Study|subject request|38
7735064|NCT00631371|12164838|FG001|Overall Study|subject request|45
7735065|NCT00631371|12164837|FG000|Overall Study|Discontinuation of study by Sponsor|70
7735066|NCT00631371|12164838|FG001|Overall Study|Discontinuation of study by Sponsor|76
7735067|NCT00631371|12164837|FG000|Overall Study|Death|263
7735068|NCT00631371|12164838|FG001|Overall Study|Death|239
7735069|NCT00631410|12164846|FG000|Overall Study|Adverse Event|1
7735070|NCT00631410|12164847|FG001|Overall Study|Adverse Event|3
7735071|NCT00631410|12164846|FG000|Overall Study|Objective Progression or Relapse|4
7735072|NCT00631410|12164847|FG001|Overall Study|Objective Progression or Relapse|3
7735073|NCT00631410|12164846|FG000|Overall Study|Surgery|1
7735074|NCT00631410|12164847|FG001|Overall Study|Surgery|0
7735075|NCT00631475|12164867|FG000|Overall Study|Death|18
7735076|NCT00631475|12164867|FG000|Overall Study|Adverse Event|14
7735077|NCT00631475|12164867|FG000|Overall Study|Withdrew consent|5
7735078|NCT00631475|12164867|FG000|Overall Study|Preparation for lung transplant|8
7735079|NCT00631488|12164874|FG000|Overall Study|Adverse Event|1
7735080|NCT00631488|12164875|FG001|Overall Study|Adverse Event|0
7735081|NCT00631488|12164876|FG002|Overall Study|Adverse Event|0
7735082|NCT00631488|12164874|FG000|Overall Study|Lost to Follow-up|2
7735083|NCT00631488|12164875|FG001|Overall Study|Lost to Follow-up|2
7735084|NCT00631488|12164876|FG002|Overall Study|Lost to Follow-up|0
7735085|NCT00631488|12164874|FG000|Overall Study|Physician Decision|1
7735086|NCT00631488|12164875|FG001|Overall Study|Physician Decision|0
7735087|NCT00631488|12164876|FG002|Overall Study|Physician Decision|1
7735088|NCT00631488|12164874|FG000|Overall Study|Protocol Violation|0
7735089|NCT00631488|12164875|FG001|Overall Study|Protocol Violation|0
7735090|NCT00631488|12164876|FG002|Overall Study|Protocol Violation|1
7735091|NCT00631540|12164884|FG000|Overall Study|Withdrawal by Subject|5
7735092|NCT00631540|12164884|FG000|Overall Study|Death|4
7735093|NCT00631540|12164884|FG000|Overall Study|Lost to Follow-up|2
7735094|NCT00631540|12164884|FG000|Overall Study|Core Lab Data Unavailable|3
7735095|NCT00631657|12164903|FG000|6-Month Treatment Period|Adverse Event|47
7735096|NCT00631657|12164904|FG001|6-Month Treatment Period|Adverse Event|0
7735097|NCT00631657|12164905|FG002|6-Month Treatment Period|Adverse Event|7
7735098|NCT00631657|12164903|FG000|6-Month Treatment Period|Withdrawal by Subject|14
7735099|NCT00631657|12164904|FG001|6-Month Treatment Period|Withdrawal by Subject|0
7735100|NCT00631657|12164905|FG002|6-Month Treatment Period|Withdrawal by Subject|5
7735101|NCT00631657|12164903|FG000|6-Month Treatment Period|Lack of Efficacy|34
7735102|NCT00631657|12164904|FG001|6-Month Treatment Period|Lack of Efficacy|0
7735103|NCT00631657|12164905|FG002|6-Month Treatment Period|Lack of Efficacy|25
7735104|NCT00631657|12164903|FG000|6-Month Treatment Period|Lost to Follow-up|7
7735105|NCT00631657|12164904|FG001|6-Month Treatment Period|Lost to Follow-up|0
7735106|NCT00631657|12164905|FG002|6-Month Treatment Period|Lost to Follow-up|2
7735107|NCT00631657|12164903|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
7735108|NCT00631657|12164904|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
7735109|NCT00631657|12164905|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
7735110|NCT00631657|12164903|FG000|6-Month Treatment Period|Other|16
7735111|NCT00631657|12164904|FG001|6-Month Treatment Period|Other|0
7735112|NCT00631657|12164905|FG002|6-Month Treatment Period|Other|4
7735113|NCT00631657|12164903|FG000|6-Month Treatment Period|Not Treated|2
7735114|NCT00631657|12164904|FG001|6-Month Treatment Period|Not Treated|0
7735115|NCT00631657|12164905|FG002|6-Month Treatment Period|Not Treated|1
7735116|NCT00631657|12164903|FG000|7-Day Discontinuation Period|Not Treated|1
7735117|NCT00631657|12164904|FG001|7-Day Discontinuation Period|Not Treated|1
7735118|NCT00631657|12164905|FG002|7-Day Discontinuation Period|Not Treated|1
7735119|NCT00631657|12164903|FG000|7-Day Discontinuation Period|Other|1
7735120|NCT00631657|12164904|FG001|7-Day Discontinuation Period|Other|0
7735121|NCT00631657|12164905|FG002|7-Day Discontinuation Period|Other|0
7735122|NCT00631696|12164931|FG000|Overall Study|Entered, not randomized to treatment|1
7735123|NCT00631696|12164932|FG001|Overall Study|Entered, not randomized to treatment|1
7735124|NCT00631696|12164931|FG000|Overall Study|Discontinued after database release date|1
7735125|NCT00631696|12164932|FG001|Overall Study|Discontinued after database release date|0
7735126|NCT00631696|12164931|FG000|Overall Study|Follow up after database release date|1
7735127|NCT00631696|12164932|FG001|Overall Study|Follow up after database release date|0
7735128|NCT00631696|12164931|FG000|Overall Study|Lost to Follow-up|7
7735129|NCT00631696|12164932|FG001|Overall Study|Lost to Follow-up|10
7735130|NCT00631696|12164931|FG000|Overall Study|Withdrawal by Subject|2
7735131|NCT00631696|12164932|FG001|Overall Study|Withdrawal by Subject|9
7735132|NCT00631696|12164931|FG000|Overall Study|Other|8
7735133|NCT00631696|12164932|FG001|Overall Study|Other|8
7735134|NCT00631696|12164931|FG000|Overall Study|Protocol Violation|9
7735135|NCT00631696|12164932|FG001|Overall Study|Protocol Violation|9
7735136|NCT00631696|12164931|FG000|Overall Study|Study terminated by sponsor|3
7735137|NCT00631696|12164932|FG001|Overall Study|Study terminated by sponsor|3
7735138|NCT00631696|12164931|FG000|Overall Study|Adverse Event|5
7735139|NCT00631696|12164932|FG001|Overall Study|Adverse Event|0
7735140|NCT00631917|12164954|FG000|Overall Study|Adverse Event|34
7735141|NCT00631917|12164955|FG001|Overall Study|Adverse Event|45
7735142|NCT00631917|12164954|FG000|Overall Study|Abnormal laboratory value(s)|2
7735143|NCT00631917|12164955|FG001|Overall Study|Abnormal laboratory value(s)|1
7735144|NCT00631917|12164954|FG000|Overall Study|Abnormal test procedure result(s)|3
7735145|NCT00631917|12164955|FG001|Overall Study|Abnormal test procedure result(s)|2
7735146|NCT00631917|12164954|FG000|Overall Study|Unsatisfactory therapeutic effect|8
7735147|NCT00631917|12164955|FG001|Overall Study|Unsatisfactory therapeutic effect|14
7735148|NCT00631917|12164954|FG000|Overall Study|No longer required study drug|0
7735149|NCT00631917|12164955|FG001|Overall Study|No longer required study drug|1
7735150|NCT00631917|12164954|FG000|Overall Study|Protocol deviation|6
7735151|NCT00631917|12164955|FG001|Overall Study|Protocol deviation|5
7735152|NCT00631917|12164954|FG000|Overall Study|Subject withdrew consent|25
7735153|NCT00631917|12164955|FG001|Overall Study|Subject withdrew consent|33
7735154|NCT00631917|12164954|FG000|Overall Study|Lost to Follow-up|7
7735155|NCT00631917|12164955|FG001|Overall Study|Lost to Follow-up|7
7735156|NCT00631917|12164954|FG000|Overall Study|Administrative problems|2
7735157|NCT00631917|12164955|FG001|Overall Study|Administrative problems|0
7735158|NCT00631917|12164954|FG000|Overall Study|Death|1
7735159|NCT00631917|12164955|FG001|Overall Study|Death|0
7735160|NCT00631969|12164963|FG000|Overall Study|Adverse Event|3
7735161|NCT00631969|12164964|FG001|Overall Study|Adverse Event|1
7735162|NCT00631969|12164963|FG000|Overall Study|Lack of Efficacy|2
7735163|NCT00631969|12164964|FG001|Overall Study|Lack of Efficacy|8
7735164|NCT00631969|12164963|FG000|Overall Study|Lost to Follow-up|2
7735165|NCT00631969|12164964|FG001|Overall Study|Lost to Follow-up|1
7735166|NCT00631969|12164963|FG000|Overall Study|Protocol Violation|1
7735167|NCT00631969|12164964|FG001|Overall Study|Protocol Violation|1
7735168|NCT00631969|12164963|FG000|Overall Study|Consent Withdrawn|5
7735169|NCT00631969|12164964|FG001|Overall Study|Consent Withdrawn|7
7735170|NCT00631969|12164963|FG000|Overall Study|Noncompliant With Study Medication|0
7735171|NCT00631969|12164964|FG001|Overall Study|Noncompliant With Study Medication|1
7735172|NCT00631969|12164963|FG000|Overall Study|No Drug Exposure|2
7735173|NCT00631969|12164964|FG001|Overall Study|No Drug Exposure|2
7735174|NCT00632021|12164974|FG000|Overall Study|Withdrawal/death|4
7735175|NCT00632021|12164975|FG001|Overall Study|Withdrawal/death|7
7735176|NCT00632099|12164984|FG000|Overall Study|Lost to Follow-up|3
7735177|NCT00632099|12164985|FG001|Overall Study|Lost to Follow-up|3
7735178|NCT00632125|12164991|FG000|Overall Study|Death|82
7735179|NCT00632125|12164991|FG000|Overall Study|Withdrawal by Subject|44
7735180|NCT00632125|12164991|FG000|Overall Study|Adverse Event|36
7735181|NCT00632125|12164991|FG000|Overall Study|Renal transplantation|17
7735182|NCT00632125|12164991|FG000|Overall Study|Need for systemic immunosuppressive medi|8
7735183|NCT00632125|12164991|FG000|Overall Study|Non-compliance|8
7735184|NCT00632125|12164991|FG000|Overall Study|Development of uncontrolled hypertension|5
7735185|NCT00632125|12164991|FG000|Overall Study|Moved to other dialysis unit, etc.|102
7735186|NCT00632203|12164997|FG000|Overall Study|Did not start study treatment|1
7735187|NCT00632203|12164998|FG001|Overall Study|Did not start study treatment|0
7735188|NCT00632229|12165006|FG000|Overall Study|Adverse Event|6
7735189|NCT00632229|12165007|FG001|Overall Study|Adverse Event|0
7735190|NCT00632229|12165006|FG000|Overall Study|Lost to Follow-up|0
7735191|NCT00632229|12165007|FG001|Overall Study|Lost to Follow-up|3
7735192|NCT00632229|12165006|FG000|Overall Study|Lack of Efficacy|0
7735193|NCT00632229|12165007|FG001|Overall Study|Lack of Efficacy|2
7735194|NCT00632229|12165006|FG000|Overall Study|Undisclosed reasons within the first wee|0
7735195|NCT00632229|12165007|FG001|Overall Study|Undisclosed reasons within the first wee|1
7735196|NCT00632359|12165017|FG000|Overall Study|Withdrawal by Subject|2
7735197|NCT00632424|12165034|FG000|Overall Study|Disease Progression|17
7735198|NCT00632424|12165034|FG000|Overall Study|Study Drug Toxicity|1
7735199|NCT00632463|12165051|FG000|Overall Study|Adverse Event|0
7735200|NCT00632463|12165052|FG001|Overall Study|Adverse Event|1
7735201|NCT00632463|12165053|FG002|Overall Study|Adverse Event|0
7735202|NCT00632502|12165076|FG000|Overall Study|Adverse Event|0
7735203|NCT00632502|12165077|FG001|Overall Study|Adverse Event|1
7735204|NCT00632502|12165076|FG000|Overall Study|Randomized not treated|3
7735205|NCT00632502|12165077|FG001|Overall Study|Randomized not treated|0
7735206|NCT00632541|12165084|FG000|Overall Study|Adverse Event|7
7735207|NCT00632736|12165106|FG000|Overall Study|Adverse Event|104
7735208|NCT00632736|12165106|FG000|Overall Study|Lost to Follow-up|15
7735209|NCT00632736|12165106|FG000|Overall Study|Protocol Violation|14
7735210|NCT00632736|12165106|FG000|Overall Study|Withdrawal by Subject|99
7735211|NCT00632736|12165106|FG000|Overall Study|Lack of Efficacy|5
7735212|NCT00632736|12165106|FG000|Overall Study|Sponsor terminated study|5
7735213|NCT00632736|12165106|FG000|Overall Study|Non-compliance|10
7735214|NCT00632736|12165106|FG000|Overall Study|Other|16
7735215|NCT00632749|12165124|FG000|Overall Study|Progressive disease|3
7735216|NCT00632749|12165125|FG001|Overall Study|Progressive disease|2
7735217|NCT00632749|12165126|FG002|Overall Study|Progressive disease|2
7735218|NCT00632749|12165127|FG003|Overall Study|Progressive disease|2
7735219|NCT00632749|12165128|FG004|Overall Study|Progressive disease|4
7735220|NCT00632749|12165129|FG005|Overall Study|Progressive disease|4
7735221|NCT00632749|12165130|FG006|Overall Study|Progressive disease|3
7735222|NCT00632749|12165131|FG007|Overall Study|Progressive disease|2
7735223|NCT00632749|12165132|FG008|Overall Study|Progressive disease|3
7735224|NCT00632749|12165133|FG009|Overall Study|Progressive disease|2
7735225|NCT00632749|12165134|FG010|Overall Study|Progressive disease|4
7735226|NCT00632749|12165135|FG011|Overall Study|Progressive disease|3
7735227|NCT00632749|12165136|FG012|Overall Study|Progressive disease|2
7735228|NCT00632749|12165137|FG013|Overall Study|Progressive disease|4
7735229|NCT00632749|12165124|FG000|Overall Study|Other Adverse event|1
7735230|NCT00632749|12165125|FG001|Overall Study|Other Adverse event|1
7735231|NCT00632749|12165126|FG002|Overall Study|Other Adverse event|1
7735232|NCT00632749|12165127|FG003|Overall Study|Other Adverse event|1
7735233|NCT00632749|12165128|FG004|Overall Study|Other Adverse event|2
7735234|NCT00632749|12165129|FG005|Overall Study|Other Adverse event|4
7735235|NCT00632749|12165130|FG006|Overall Study|Other Adverse event|1
7735236|NCT00632749|12165131|FG007|Overall Study|Other Adverse event|2
7735237|NCT00632749|12165132|FG008|Overall Study|Other Adverse event|2
7735238|NCT00632749|12165133|FG009|Overall Study|Other Adverse event|0
7735239|NCT00632749|12165134|FG010|Overall Study|Other Adverse event|1
7735240|NCT00632749|12165135|FG011|Overall Study|Other Adverse event|0
7735241|NCT00632749|12165136|FG012|Overall Study|Other Adverse event|1
7735242|NCT00632749|12165137|FG013|Overall Study|Other Adverse event|0
7735243|NCT00632749|12165124|FG000|Overall Study|Refuse to continue medication|0
7735244|NCT00632749|12165125|FG001|Overall Study|Refuse to continue medication|0
7735245|NCT00632749|12165126|FG002|Overall Study|Refuse to continue medication|0
7735246|NCT00632749|12165127|FG003|Overall Study|Refuse to continue medication|1
7735247|NCT00632749|12165128|FG004|Overall Study|Refuse to continue medication|0
7735248|NCT00632749|12165129|FG005|Overall Study|Refuse to continue medication|0
7735249|NCT00632749|12165130|FG006|Overall Study|Refuse to continue medication|0
7735250|NCT00632749|12165131|FG007|Overall Study|Refuse to continue medication|0
7735251|NCT00632749|12165132|FG008|Overall Study|Refuse to continue medication|0
7735252|NCT00632749|12165133|FG009|Overall Study|Refuse to continue medication|1
7735253|NCT00632749|12165134|FG010|Overall Study|Refuse to continue medication|0
7735254|NCT00632749|12165135|FG011|Overall Study|Refuse to continue medication|0
7735255|NCT00632749|12165136|FG012|Overall Study|Refuse to continue medication|0
7735256|NCT00632749|12165137|FG013|Overall Study|Refuse to continue medication|0
7735257|NCT00632749|12165124|FG000|Overall Study|Reason other than those specified above|0
7735258|NCT00632749|12165125|FG001|Overall Study|Reason other than those specified above|2
7735259|NCT00632749|12165126|FG002|Overall Study|Reason other than those specified above|0
7735260|NCT00632749|12165127|FG003|Overall Study|Reason other than those specified above|0
7735261|NCT00632749|12165128|FG004|Overall Study|Reason other than those specified above|1
7735262|NCT00632749|12165129|FG005|Overall Study|Reason other than those specified above|0
7735263|NCT00632749|12165130|FG006|Overall Study|Reason other than those specified above|1
7735264|NCT00632749|12165131|FG007|Overall Study|Reason other than those specified above|0
7735265|NCT00632749|12165132|FG008|Overall Study|Reason other than those specified above|0
7735266|NCT00632749|12165133|FG009|Overall Study|Reason other than those specified above|0
7735267|NCT00632749|12165134|FG010|Overall Study|Reason other than those specified above|2
7735268|NCT00632749|12165135|FG011|Overall Study|Reason other than those specified above|1
7735269|NCT00632749|12165136|FG012|Overall Study|Reason other than those specified above|0
7735270|NCT00632749|12165137|FG013|Overall Study|Reason other than those specified above|2
7735271|NCT00632827|12165186|FG000|Overall Study|Excluded after GVD (Not evaluable)|2
7735272|NCT00632827|12165186|FG000|Overall Study|Death|2
7735273|NCT00632827|12165186|FG000|Overall Study|Adverse Event|5
7735274|NCT00632827|12165186|FG000|Overall Study|Lost to Follow-up|1
7735275|NCT00632931|12165191|FG000|Part 1, Period 1|Protocol Violation|1
7735276|NCT00632931|12165192|FG001|Part 1, Period 1|Protocol Violation|0
7735277|NCT00632931|12165193|FG002|Part 1, Period 1|Protocol Violation|0
7735278|NCT00632931|12165191|FG000|Part 1, Period 1|Withdrawal by Subject|1
7735279|NCT00632931|12165192|FG001|Part 1, Period 1|Withdrawal by Subject|0
7735280|NCT00632931|12165193|FG002|Part 1, Period 1|Withdrawal by Subject|0
7735281|NCT00632931|12165191|FG000|Part 2|Adverse Event|0
7735282|NCT00632931|12165192|FG001|Part 2|Adverse Event|0
7735283|NCT00632931|12165193|FG002|Part 2|Adverse Event|3
7735284|NCT00632931|12165191|FG000|Part 2|Death|0
7735285|NCT00632931|12165192|FG001|Part 2|Death|0
7735286|NCT00632931|12165193|FG002|Part 2|Death|1
7735287|NCT00632931|12165191|FG000|Part 2|Lack of Efficacy|0
7735288|NCT00632931|12165192|FG001|Part 2|Lack of Efficacy|0
7735289|NCT00632931|12165193|FG002|Part 2|Lack of Efficacy|17
7735290|NCT00632931|12165191|FG000|Part 2|Withdrawal by Subject|0
7735291|NCT00632931|12165192|FG001|Part 2|Withdrawal by Subject|0
7735292|NCT00632931|12165193|FG002|Part 2|Withdrawal by Subject|3
7735293|NCT00633022|12165226|FG000|Overall Study|Adverse Event|1
7735294|NCT00633022|12165227|FG001|Overall Study|Adverse Event|0
7735295|NCT00633022|12165228|FG002|Overall Study|Adverse Event|5
7735296|NCT00633022|12165226|FG000|Overall Study|Physician Decision|0
7735297|NCT00633022|12165227|FG001|Overall Study|Physician Decision|1
7735298|NCT00633022|12165228|FG002|Overall Study|Physician Decision|0
7735299|NCT00633074|12165238|FG000|Overall Study|Adverse Event|1
7735300|NCT00633074|12165239|FG001|Overall Study|Adverse Event|0
7735301|NCT00633126|12165245|FG000|Overall Study|Did not receive full dose|1
7735302|NCT00633139|12165252|FG000|Overall Study|Non compliance|0
7735303|NCT00633139|12165253|FG001|Overall Study|Non compliance|0
7735304|NCT00633139|12165254|FG002|Overall Study|Non compliance|1
7735305|NCT00633139|12165252|FG000|Overall Study|Withdrawal by Subject|0
7735306|NCT00633139|12165253|FG001|Overall Study|Withdrawal by Subject|1
7735307|NCT00633139|12165254|FG002|Overall Study|Withdrawal by Subject|0
7735308|NCT00633152|12165264|FG000|Overall Study|Adverse Event|1
7735309|NCT00633152|12165265|FG001|Overall Study|Adverse Event|0
7735310|NCT00633152|12165264|FG000|Overall Study|Randomized, did not receive study drug|5
7735311|NCT00633152|12165265|FG001|Overall Study|Randomized, did not receive study drug|2
7735312|NCT00633152|12165264|FG000|Overall Study|Withdrawal by Subject|1
7735313|NCT00633152|12165265|FG001|Overall Study|Withdrawal by Subject|1
7735314|NCT00633152|12165264|FG000|Overall Study|Lost to Follow-up|4
7735315|NCT00633152|12165265|FG001|Overall Study|Lost to Follow-up|1
7735316|NCT00633152|12165264|FG000|Overall Study|Miscellaneous Other|3
7735317|NCT00633152|12165265|FG001|Overall Study|Miscellaneous Other|2
7735318|NCT00633217|12165275|FG000|Overall Study|Adverse Event|5
7735319|NCT00633217|12165276|FG001|Overall Study|Adverse Event|9
7735320|NCT00633217|12165275|FG000|Overall Study|Lack of Efficacy|0
7735321|NCT00633217|12165276|FG001|Overall Study|Lack of Efficacy|2
7735322|NCT00633217|12165275|FG000|Overall Study|Protocol Violation|3
7735323|NCT00633217|12165276|FG001|Overall Study|Protocol Violation|7
7735324|NCT00633217|12165275|FG000|Overall Study|Lost to Follow-up|2
7735325|NCT00633217|12165276|FG001|Overall Study|Lost to Follow-up|2
7735326|NCT00633217|12165275|FG000|Overall Study|Investigator Discretion|2
7735327|NCT00633217|12165276|FG001|Overall Study|Investigator Discretion|0
7735328|NCT00633217|12165275|FG000|Overall Study|Withdrew Consent|3
7735329|NCT00633217|12165276|FG001|Overall Study|Withdrew Consent|3
7735330|NCT00633243|12165284|FG000|Overall Study|Withdrawal by Subject|0
7735331|NCT00633243|12165285|FG001|Overall Study|Withdrawal by Subject|1
7735332|NCT00633243|12165284|FG000|Overall Study|incarceration|0
7735333|NCT00633243|12165285|FG001|Overall Study|incarceration|2
7735334|NCT00633243|12165284|FG000|Overall Study|Homeless--no refrigeration for meds|0
7735335|NCT00633243|12165285|FG001|Overall Study|Homeless--no refrigeration for meds|1
7735336|NCT00633243|12165284|FG000|Overall Study|Not comfortable with self-injecting|0
7735337|NCT00633243|12165285|FG001|Overall Study|Not comfortable with self-injecting|1
7735338|NCT00633243|12165284|FG000|Overall Study|Mental Health--Depression|0
7735339|NCT00633243|12165285|FG001|Overall Study|Mental Health--Depression|1
7735340|NCT00633243|12165284|FG000|Overall Study|Couldn't tolerate side-effects|1
7735341|NCT00633243|12165285|FG001|Overall Study|Couldn't tolerate side-effects|1
7735342|NCT00633360|12165302|FG000|Overall Study|Lost to Follow-up|1
7735343|NCT00633360|12165303|FG001|Overall Study|Lost to Follow-up|1
7735344|NCT00633360|12165302|FG000|Overall Study|Adverse Event|3
7735345|NCT00633360|12165303|FG001|Overall Study|Adverse Event|1
7735346|NCT00633360|12165302|FG000|Overall Study|Protocol Violation|0
7735347|NCT00633360|12165303|FG001|Overall Study|Protocol Violation|1
7768796|NCT00863772|12212151|FG000|Overall Study|Protocol Violation|2
7768797|NCT00863772|12212152|FG001|Overall Study|Protocol Violation|0
7768798|NCT00863772|12212153|FG002|Overall Study|Protocol Violation|2
7768799|NCT00863772|12212151|FG000|Overall Study|Withdrawal by Subject|4
7768800|NCT00863772|12212152|FG001|Overall Study|Withdrawal by Subject|7
7768801|NCT00863772|12212153|FG002|Overall Study|Withdrawal by Subject|5
7768802|NCT00863772|12212151|FG000|Overall Study|Study terminated by sponsor|44
7768803|NCT00863772|12212152|FG001|Overall Study|Study terminated by sponsor|45
7768804|NCT00863772|12212153|FG002|Overall Study|Study terminated by sponsor|36
7768805|NCT00863772|12212151|FG000|Overall Study|Entered extension study|6
7768806|NCT00863772|12212152|FG001|Overall Study|Entered extension study|4
7768807|NCT00863772|12212153|FG002|Overall Study|Entered extension study|9
7768808|NCT00863772|12212151|FG000|Overall Study|Other|1
7768809|NCT00863772|12212152|FG001|Overall Study|Other|2
7768810|NCT00863772|12212153|FG002|Overall Study|Other|4
7768811|NCT00863772|12212151|FG000|Overall Study|Randomized but not Treated|1
7768812|NCT00863772|12212152|FG001|Overall Study|Randomized but not Treated|0
7768813|NCT00863772|12212153|FG002|Overall Study|Randomized but not Treated|0
7768814|NCT00863798|12212164|FG000|Overall Study|Adverse Event|5
7768815|NCT00863798|12212165|FG001|Overall Study|Adverse Event|2
7768816|NCT00863798|12212166|FG002|Overall Study|Adverse Event|4
7768817|NCT00863798|12212164|FG000|Overall Study|Participant failed to return|2
7768818|NCT00863798|12212165|FG001|Overall Study|Participant failed to return|1
7768819|NCT00863798|12212166|FG002|Overall Study|Participant failed to return|0
7768820|NCT00863798|12212164|FG000|Overall Study|Investigator request|1
7768821|NCT00863798|12212165|FG001|Overall Study|Investigator request|2
7768822|NCT00863798|12212166|FG002|Overall Study|Investigator request|1
7768823|NCT00863798|12212164|FG000|Overall Study|Lack of Efficacy|4
7768824|NCT00863798|12212165|FG001|Overall Study|Lack of Efficacy|3
7768825|NCT00863798|12212166|FG002|Overall Study|Lack of Efficacy|6
7768826|NCT00863798|12212164|FG000|Overall Study|Lost to Follow-up|6
7768827|NCT00863798|12212165|FG001|Overall Study|Lost to Follow-up|9
7768828|NCT00863798|12212166|FG002|Overall Study|Lost to Follow-up|5
7768829|NCT00863798|12212164|FG000|Overall Study|Other|2
7768830|NCT00863798|12212165|FG001|Overall Study|Other|3
7768831|NCT00863798|12212166|FG002|Overall Study|Other|1
7768832|NCT00863798|12212164|FG000|Overall Study|Protocol Violation|0
7768833|NCT00863798|12212165|FG001|Overall Study|Protocol Violation|1
7768834|NCT00863798|12212166|FG002|Overall Study|Protocol Violation|1
7735348|NCT00633464|12165322|FG000|Overall Study|Never Treated (Not met study criteria)|0
7735349|NCT00633464|12165323|FG001|Overall Study|Never Treated (Not met study criteria)|1
7735350|NCT00633464|12165322|FG000|Overall Study|Never Treated (Randomized in error)|0
7735351|NCT00633464|12165323|FG001|Overall Study|Never Treated (Randomized in error)|1
7735352|NCT00633477|12165331|FG000|Overall Study|Death|1
7735353|NCT00633477|12165332|FG001|Overall Study|Death|0
7735354|NCT00633477|12165331|FG000|Overall Study|Randomized but not treated|1
7735355|NCT00633477|12165332|FG001|Overall Study|Randomized but not treated|0
7735356|NCT00633594|12165341|FG000|Overall Study|Adverse Event|0
7735357|NCT00633594|12165342|FG001|Overall Study|Adverse Event|4
7735358|NCT00633594|12165343|FG002|Overall Study|Adverse Event|7
7735359|NCT00633594|12165341|FG000|Overall Study|Death|0
7735360|NCT00633594|12165342|FG001|Overall Study|Death|1
7735361|NCT00633594|12165343|FG002|Overall Study|Death|2
7735362|NCT00633594|12165341|FG000|Overall Study|Disease Progression|0
7735363|NCT00633594|12165342|FG001|Overall Study|Disease Progression|0
7735364|NCT00633594|12165343|FG002|Overall Study|Disease Progression|1
7735365|NCT00633750|12165354|FG000|Overall Study|Adverse Event|2
7735366|NCT00633750|12165354|FG000|Overall Study|Withdrawal by Subject|3
7735367|NCT00633880|12165372|FG000|Open Label Titration|Lack of Efficacy|1
7735368|NCT00633880|12165373|FG001|Open Label Titration|Lack of Efficacy|0
7735369|NCT00633880|12165374|FG002|Open Label Titration|Lack of Efficacy|0
7735370|NCT00633880|12165372|FG000|Open Label Titration|Adverse Event|13
7735371|NCT00633880|12165373|FG001|Open Label Titration|Adverse Event|0
7735372|NCT00633880|12165374|FG002|Open Label Titration|Adverse Event|0
7735373|NCT00633880|12165372|FG000|Open Label Titration|Treatment Failure|55
7735374|NCT00633880|12165373|FG001|Open Label Titration|Treatment Failure|0
7735375|NCT00633880|12165374|FG002|Open Label Titration|Treatment Failure|0
7735376|NCT00633880|12165372|FG000|Open Label Titration|Protocol Violation|6
7735377|NCT00633880|12165373|FG001|Open Label Titration|Protocol Violation|0
7735378|NCT00633880|12165374|FG002|Open Label Titration|Protocol Violation|0
7735379|NCT00633880|12165372|FG000|Open Label Titration|Physician Decision|1
7735380|NCT00633880|12165373|FG001|Open Label Titration|Physician Decision|0
7735381|NCT00633880|12165374|FG002|Open Label Titration|Physician Decision|0
7735382|NCT00633880|12165372|FG000|Open Label Titration|Withdrawal by Subject|4
7735383|NCT00633880|12165373|FG001|Open Label Titration|Withdrawal by Subject|0
7735384|NCT00633880|12165374|FG002|Open Label Titration|Withdrawal by Subject|0
7735385|NCT00633893|12165384|FG000|Overall Study|Death|1
7735386|NCT00633893|12165385|FG001|Overall Study|Death|3
7735387|NCT00633893|12165386|FG002|Overall Study|Death|9
7735388|NCT00633893|12165384|FG000|Overall Study|Adverse Event|65
7735389|NCT00633893|12165385|FG001|Overall Study|Adverse Event|58
7735390|NCT00633893|12165386|FG002|Overall Study|Adverse Event|126
7735391|NCT00633893|12165384|FG000|Overall Study|Withdrawal by Subject|7
7735392|NCT00633893|12165385|FG001|Overall Study|Withdrawal by Subject|12
7735393|NCT00633893|12165386|FG002|Overall Study|Withdrawal by Subject|6
7735394|NCT00633893|12165384|FG000|Overall Study|Lost to Follow-up|2
7735395|NCT00633893|12165385|FG001|Overall Study|Lost to Follow-up|4
7735396|NCT00633893|12165386|FG002|Overall Study|Lost to Follow-up|8
7735397|NCT00633893|12165384|FG000|Overall Study|Poor/non-compliance|5
7735398|NCT00633893|12165385|FG001|Overall Study|Poor/non-compliance|12
7735399|NCT00633893|12165386|FG002|Overall Study|Poor/non-compliance|3
7735400|NCT00633893|12165384|FG000|Overall Study|Pregnancy|2
7735401|NCT00633893|12165385|FG001|Overall Study|Pregnancy|1
7735402|NCT00633893|12165386|FG002|Overall Study|Pregnancy|1
7735403|NCT00633893|12165384|FG000|Overall Study|Not meet/no longer meets criteria|4
7735404|NCT00633893|12165385|FG001|Overall Study|Not meet/no longer meets criteria|6
7735405|NCT00633893|12165386|FG002|Overall Study|Not meet/no longer meets criteria|4
7735406|NCT00633893|12165384|FG000|Overall Study|Other|28
7735407|NCT00633893|12165385|FG001|Overall Study|Other|33
7735408|NCT00633893|12165386|FG002|Overall Study|Other|31
7735409|NCT00633932|12165406|FG000|Overall Study|Adverse Event|1
7735410|NCT00633932|12165407|FG001|Overall Study|Adverse Event|3
7735411|NCT00633932|12165408|FG002|Overall Study|Adverse Event|4
7735412|NCT00633932|12165406|FG000|Overall Study|Withdrawal by Subject|3
7735413|NCT00633932|12165407|FG001|Overall Study|Withdrawal by Subject|9
7735414|NCT00633932|12165408|FG002|Overall Study|Withdrawal by Subject|1
7735415|NCT00633932|12165406|FG000|Overall Study|Lost to Follow-up|1
7735416|NCT00633932|12165407|FG001|Overall Study|Lost to Follow-up|0
7735417|NCT00633932|12165408|FG002|Overall Study|Lost to Follow-up|2
7735418|NCT00633932|12165406|FG000|Overall Study|Protocol Violation|5
7735419|NCT00633932|12165407|FG001|Overall Study|Protocol Violation|2
7735420|NCT00633932|12165408|FG002|Overall Study|Protocol Violation|3
7735421|NCT00633932|12165406|FG000|Overall Study|Physician Decision|0
7735422|NCT00633932|12165407|FG001|Overall Study|Physician Decision|0
7735423|NCT00633932|12165408|FG002|Overall Study|Physician Decision|1
7735424|NCT00633932|12165406|FG000|Overall Study|Doctor's judgement|1
7735425|NCT00633932|12165407|FG001|Overall Study|Doctor's judgement|0
7735426|NCT00633932|12165408|FG002|Overall Study|Doctor's judgement|0
7735427|NCT00633932|12165406|FG000|Overall Study|Moved Away|1
7735428|NCT00633932|12165407|FG001|Overall Study|Moved Away|0
7735429|NCT00633932|12165408|FG002|Overall Study|Moved Away|0
7735430|NCT00633945|12165416|FG000|Overall Study|Physician Decision|2
7735431|NCT00633984|12165424|FG000|Overall Study|Lost to Follow-up|0
7735432|NCT00633984|12165425|FG001|Overall Study|Lost to Follow-up|6
7735433|NCT00633984|12165424|FG000|Overall Study|Withdrawal by Subject|8
7735434|NCT00633984|12165425|FG001|Overall Study|Withdrawal by Subject|7
7735435|NCT00633984|12165424|FG000|Overall Study|Hospitalized|1
7735436|NCT00633984|12165425|FG001|Overall Study|Hospitalized|0
7735437|NCT00634036|12165433|FG000|Overall Study|Lost to Follow-up|1
7735438|NCT00634036|12165434|FG001|Overall Study|Lost to Follow-up|1
7735439|NCT00634036|12165433|FG000|Overall Study|Withdrawal by Subject|1
7735440|NCT00634036|12165434|FG001|Overall Study|Withdrawal by Subject|1
7735441|NCT00634049|12165440|FG000|Overall Study|Never received study drug|1
7735442|NCT00634049|12165440|FG000|Overall Study|Died prior to receiving study drug|1
7735443|NCT00634049|12165440|FG000|Overall Study|Screening failure|1
7735444|NCT00634088|12165477|FG000|Time Period 1: Dose Level 1|Disease progression|2
7735445|NCT00634088|12165478|FG001|Time Period 1: Dose Level 1|Disease progression|0
7735446|NCT00634088|12165479|FG002|Time Period 1: Dose Level 1|Disease progression|0
7735447|NCT00634088|12165480|FG003|Time Period 1: Dose Level 1|Disease progression|0
7735448|NCT00634088|12165477|FG000|Time Period 1: Dose Level 1|Physician Decision|1
7735449|NCT00634088|12165478|FG001|Time Period 1: Dose Level 1|Physician Decision|0
7735450|NCT00634088|12165479|FG002|Time Period 1: Dose Level 1|Physician Decision|0
7735451|NCT00634088|12165480|FG003|Time Period 1: Dose Level 1|Physician Decision|0
7735452|NCT00634088|12165477|FG000|Time Period 1: Dose Level 1|Adverse Event|3
7735453|NCT00634088|12165478|FG001|Time Period 1: Dose Level 1|Adverse Event|0
7735454|NCT00634088|12165479|FG002|Time Period 1: Dose Level 1|Adverse Event|0
7735455|NCT00634088|12165480|FG003|Time Period 1: Dose Level 1|Adverse Event|0
7735456|NCT00634088|12165477|FG000|Time Period 2: Dose Level 2|Adverse Event|0
7735457|NCT00634088|12165478|FG001|Time Period 2: Dose Level 2|Adverse Event|2
7735458|NCT00634088|12165479|FG002|Time Period 2: Dose Level 2|Adverse Event|0
7735459|NCT00634088|12165480|FG003|Time Period 2: Dose Level 2|Adverse Event|0
7735460|NCT00634088|12165477|FG000|Time Period 2: Dose Level 2|Progressive disease|0
7735461|NCT00634088|12165478|FG001|Time Period 2: Dose Level 2|Progressive disease|1
7735462|NCT00634088|12165479|FG002|Time Period 2: Dose Level 2|Progressive disease|0
7735463|NCT00634088|12165480|FG003|Time Period 2: Dose Level 2|Progressive disease|0
7735464|NCT00634088|12165477|FG000|Time Period 3: Dose Level 3|Progressive disease|0
7735465|NCT00634088|12165478|FG001|Time Period 3: Dose Level 3|Progressive disease|0
7735466|NCT00634088|12165479|FG002|Time Period 3: Dose Level 3|Progressive disease|1
7735467|NCT00634088|12165480|FG003|Time Period 3: Dose Level 3|Progressive disease|0
7735468|NCT00634101|12165492|FG000|Overall Study|Study Terminated|3
7735469|NCT00634101|12165493|FG001|Overall Study|Study Terminated|3
7735470|NCT00634101|12165492|FG000|Overall Study|Lost to Follow-up|2
7735471|NCT00634101|12165493|FG001|Overall Study|Lost to Follow-up|0
7735472|NCT00634114|12165502|FG000|Overall Study|Adverse Event|6
7735473|NCT00634114|12165503|FG001|Overall Study|Adverse Event|8
7735474|NCT00634114|12165504|FG002|Overall Study|Adverse Event|3
7735475|NCT00634114|12165502|FG000|Overall Study|Withdrawal by Subject|9
7735476|NCT00634114|12165503|FG001|Overall Study|Withdrawal by Subject|6
7735477|NCT00634114|12165504|FG002|Overall Study|Withdrawal by Subject|11
7735478|NCT00634114|12165502|FG000|Overall Study|Lost to Follow-up|0
7735479|NCT00634114|12165503|FG001|Overall Study|Lost to Follow-up|0
7735480|NCT00634114|12165504|FG002|Overall Study|Lost to Follow-up|1
7735481|NCT00634114|12165502|FG000|Overall Study|Protocol Violation|3
7735482|NCT00634114|12165503|FG001|Overall Study|Protocol Violation|3
7735483|NCT00634114|12165504|FG002|Overall Study|Protocol Violation|1
7735484|NCT00634114|12165502|FG000|Overall Study|Pregnancy|1
7735485|NCT00634114|12165503|FG001|Overall Study|Pregnancy|0
7735486|NCT00634114|12165504|FG002|Overall Study|Pregnancy|0
7735487|NCT00634114|12165502|FG000|Overall Study|Incorrect enrolment|0
7735488|NCT00634114|12165503|FG001|Overall Study|Incorrect enrolment|1
7735489|NCT00634114|12165504|FG002|Overall Study|Incorrect enrolment|0
7735490|NCT00634114|12165502|FG000|Overall Study|Recurrence of reflux esophagitis|5
7735491|NCT00634114|12165503|FG001|Overall Study|Recurrence of reflux esophagitis|15
7735492|NCT00634114|12165504|FG002|Overall Study|Recurrence of reflux esophagitis|21
7735493|NCT00634114|12165502|FG000|Overall Study|Difficult to continue|3
7735494|NCT00634114|12165503|FG001|Overall Study|Difficult to continue|1
7735495|NCT00634114|12165504|FG002|Overall Study|Difficult to continue|1
7735496|NCT00634114|12165502|FG000|Overall Study|Other reason|1
7735497|NCT00634114|12165503|FG001|Overall Study|Other reason|1
7735498|NCT00634114|12165504|FG002|Overall Study|Other reason|1
7735499|NCT00634179|12165512|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1
7735500|NCT00634244|12165522|FG000|Overall Study|Never started treatment|0
7735501|NCT00634244|12165523|FG001|Overall Study|Never started treatment|1
7735502|NCT00634244|12165524|FG002|Overall Study|Never started treatment|0
7735503|NCT00634244|12165522|FG000|Overall Study|Death|1
7735504|NCT00634244|12165523|FG001|Overall Study|Death|6
7735505|NCT00634244|12165524|FG002|Overall Study|Death|0
7735506|NCT00634244|12165522|FG000|Overall Study|Adverse Event|0
7735507|NCT00634244|12165523|FG001|Overall Study|Adverse Event|2
7735508|NCT00634244|12165524|FG002|Overall Study|Adverse Event|0
7735509|NCT00634244|12165522|FG000|Overall Study|Withdrawal by Subject|0
7735510|NCT00634244|12165523|FG001|Overall Study|Withdrawal by Subject|1
7735511|NCT00634244|12165524|FG002|Overall Study|Withdrawal by Subject|0
7735512|NCT00634244|12165522|FG000|Overall Study|Physician Decision|0
7735513|NCT00634244|12165523|FG001|Overall Study|Physician Decision|1
7735514|NCT00634244|12165524|FG002|Overall Study|Physician Decision|0
7735515|NCT00634244|12165522|FG000|Overall Study|Disease progression/relapse|0
7735516|NCT00634244|12165523|FG001|Overall Study|Disease progression/relapse|1
7735517|NCT00634244|12165524|FG002|Overall Study|Disease progression/relapse|0
7735518|NCT00634244|12165522|FG000|Overall Study|Other complicating disease|0
7735519|NCT00634244|12165523|FG001|Overall Study|Other complicating disease|1
7735520|NCT00634244|12165524|FG002|Overall Study|Other complicating disease|0
7735521|NCT00634543|12165555|FG000|Overall Study|Other|1
7735522|NCT00634543|12165556|FG001|Overall Study|Other|2
7735523|NCT00634543|12165555|FG000|Overall Study|Protocol Violation|3
7735524|NCT00634543|12165556|FG001|Overall Study|Protocol Violation|3
7735525|NCT00634543|12165555|FG000|Overall Study|Adverse Event|11
7735526|NCT00634543|12165556|FG001|Overall Study|Adverse Event|11
7735527|NCT00634543|12165555|FG000|Overall Study|Withdrawal by Subject|4
7735528|NCT00634543|12165556|FG001|Overall Study|Withdrawal by Subject|4
7735529|NCT00634543|12165555|FG000|Overall Study|Lost to Follow-up|0
7735530|NCT00634543|12165556|FG001|Overall Study|Lost to Follow-up|1
7735531|NCT00634569|12165564|FG000|Overall Study|Withdrawal by Subject|0
7735532|NCT00634569|12165565|FG001|Overall Study|Withdrawal by Subject|4
7735533|NCT00634569|12165564|FG000|Overall Study|Physician Decision|0
7735534|NCT00634569|12165565|FG001|Overall Study|Physician Decision|1
7735535|NCT00634647|12165579|FG000|Overall Study|death on study|3
7735536|NCT00634647|12165579|FG000|Overall Study|refused further treatment|3
7735537|NCT00634647|12165579|FG000|Overall Study|declined to participate before treatment|1
7735538|NCT00634751|12165587|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1
7735539|NCT00634751|12165588|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0
7735540|NCT00634751|12165589|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0
7735541|NCT00634751|12165590|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0
7735542|NCT00634751|12165587|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0
7735543|NCT00634751|12165588|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1
7735544|NCT00634751|12165589|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0
7735545|NCT00634751|12165590|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0
7735546|NCT00634751|12165587|FG000|Pancreatic and Bilial Tract Cancer|Death|0
7735547|NCT00634751|12165588|FG001|Pancreatic and Bilial Tract Cancer|Death|0
7735548|NCT00634751|12165589|FG002|Pancreatic and Bilial Tract Cancer|Death|1
7735549|NCT00634751|12165590|FG003|Pancreatic and Bilial Tract Cancer|Death|1
7735550|NCT00634803|12165603|FG000|Overall Study|Lost to Follow-up|6
7735551|NCT00634803|12165604|FG001|Overall Study|Lost to Follow-up|7
7735552|NCT00634803|12165605|FG002|Overall Study|Lost to Follow-up|7
7735553|NCT00634842|12165615|FG000|Overall Study|Adverse Event|2
7735554|NCT00634842|12165616|FG001|Overall Study|Adverse Event|3
7735555|NCT00634842|12165615|FG000|Overall Study|Protocol Violation|8
7735556|NCT00634842|12165616|FG001|Overall Study|Protocol Violation|4
7735557|NCT00634842|12165615|FG000|Overall Study|Move to another state|1
7735558|NCT00634842|12165616|FG001|Overall Study|Move to another state|0
7735559|NCT00634842|12165615|FG000|Overall Study|Inclusion criteria were not met|1
7735560|NCT00634842|12165616|FG001|Overall Study|Inclusion criteria were not met|0
7735561|NCT00634842|12165615|FG000|Overall Study|Lost to Follow-up|1
7735562|NCT00634842|12165616|FG001|Overall Study|Lost to Follow-up|2
7735563|NCT00634842|12165615|FG000|Overall Study|Physician Decision|1
7735564|NCT00634842|12165616|FG001|Overall Study|Physician Decision|0
7735565|NCT00634842|12165615|FG000|Overall Study|Withdrawal by Subject|1
7735566|NCT00634842|12165616|FG001|Overall Study|Withdrawal by Subject|3
7735567|NCT00634842|12165615|FG000|Overall Study|Lack of time and intolerance to drug|0
7735568|NCT00634842|12165616|FG001|Overall Study|Lack of time and intolerance to drug|1
7735569|NCT00634842|12165615|FG000|Overall Study|Discontinued due to injection|0
7735570|NCT00634842|12165616|FG001|Overall Study|Discontinued due to injection|2
7735571|NCT00634842|12165615|FG000|Overall Study|No need of study drug to treat diabetes|0
7735572|NCT00634842|12165616|FG001|Overall Study|No need of study drug to treat diabetes|1
7735573|NCT00634842|12165615|FG000|Overall Study|No wish to keep taking Avandia|0
7735574|NCT00634842|12165616|FG001|Overall Study|No wish to keep taking Avandia|1
7735575|NCT00634842|12165615|FG000|Overall Study|Subject off study drug for too long|0
7735576|NCT00634842|12165616|FG001|Overall Study|Subject off study drug for too long|1
7735577|NCT00634907|12165624|FG000|Overall Study|Withdrawal by Subject|3
7735578|NCT00634907|12165625|FG001|Overall Study|Withdrawal by Subject|0
7735579|NCT00634907|12165624|FG000|Overall Study|Physician Decision|3
7735580|NCT00634907|12165625|FG001|Overall Study|Physician Decision|9
7735581|NCT00634907|12165624|FG000|Overall Study|Withdrawal by Subject|11
7735582|NCT00634907|12165625|FG001|Overall Study|Withdrawal by Subject|8
7735583|NCT00634920|12165634|FG000|Period 1 - Pre-Randomization|Adverse Event|0
7735584|NCT00634920|12165635|FG001|Period 1 - Pre-Randomization|Adverse Event|0
7735585|NCT00634920|12165636|FG002|Period 1 - Pre-Randomization|Adverse Event|36
7735586|NCT00634920|12165634|FG000|Period 1 - Pre-Randomization|Wound healing problems|0
7735587|NCT00634920|12165635|FG001|Period 1 - Pre-Randomization|Wound healing problems|0
7735588|NCT00634920|12165636|FG002|Period 1 - Pre-Randomization|Wound healing problems|16
7735589|NCT00634920|12165634|FG000|Period 1 - Pre-Randomization|Rejections|0
7735590|NCT00634920|12165635|FG001|Period 1 - Pre-Randomization|Rejections|0
7735591|NCT00634920|12165636|FG002|Period 1 - Pre-Randomization|Rejections|55
7735592|NCT00634920|12165634|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0
7735593|NCT00634920|12165635|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0
7735594|NCT00634920|12165636|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21
7735595|NCT00634920|12165634|FG000|Period 1 - Pre-Randomization|Non-Compliance|0
7735596|NCT00634920|12165635|FG001|Period 1 - Pre-Randomization|Non-Compliance|0
7735597|NCT00634920|12165636|FG002|Period 1 - Pre-Randomization|Non-Compliance|3
7735598|NCT00634920|12165634|FG000|Period 1 - Pre-Randomization|Other issues|0
7735599|NCT00634920|12165635|FG001|Period 1 - Pre-Randomization|Other issues|0
7735600|NCT00634920|12165636|FG002|Period 1 - Pre-Randomization|Other issues|6
7735601|NCT00634920|12165634|FG000|Period 2 - Post-Randomization|Adverse Event|37
7735602|NCT00634920|12165635|FG001|Period 2 - Post-Randomization|Adverse Event|9
7735603|NCT00634920|12165636|FG002|Period 2 - Post-Randomization|Adverse Event|0
7735604|NCT00634920|12165634|FG000|Period 2 - Post-Randomization|Rejection|11
7735605|NCT00634920|12165635|FG001|Period 2 - Post-Randomization|Rejection|5
7735606|NCT00634920|12165636|FG002|Period 2 - Post-Randomization|Rejection|0
7735607|NCT00634920|12165634|FG000|Period 2 - Post-Randomization|Death|2
7735608|NCT00634920|12165635|FG001|Period 2 - Post-Randomization|Death|5
7735609|NCT00634920|12165636|FG002|Period 2 - Post-Randomization|Death|0
7735610|NCT00634920|12165634|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
7735611|NCT00634920|12165635|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
7735612|NCT00634920|12165636|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
7735613|NCT00634920|12165634|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2
7735614|NCT00634920|12165635|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0
7735615|NCT00634920|12165636|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0
7735616|NCT00634933|12165645|FG000|Part A: Baseline to Week 24|Adverse Event|4
7735617|NCT00634933|12165646|FG001|Part A: Baseline to Week 24|Adverse Event|4
7735618|NCT00634933|12165647|FG002|Part A: Baseline to Week 24|Adverse Event|8
7735619|NCT00634933|12165648|FG003|Part A: Baseline to Week 24|Adverse Event|0
7735620|NCT00634933|12165649|FG004|Part A: Baseline to Week 24|Adverse Event|0
7735621|NCT00634933|12165645|FG000|Part A: Baseline to Week 24|Death|1
7735622|NCT00634933|12165646|FG001|Part A: Baseline to Week 24|Death|0
7735623|NCT00634933|12165647|FG002|Part A: Baseline to Week 24|Death|0
7735624|NCT00634933|12165648|FG003|Part A: Baseline to Week 24|Death|0
7735625|NCT00634933|12165649|FG004|Part A: Baseline to Week 24|Death|0
7735626|NCT00634933|12165645|FG000|Part A: Baseline to Week 24|Failed to Return|1
7735627|NCT00634933|12165646|FG001|Part A: Baseline to Week 24|Failed to Return|0
7735628|NCT00634933|12165647|FG002|Part A: Baseline to Week 24|Failed to Return|0
7735629|NCT00634933|12165648|FG003|Part A: Baseline to Week 24|Failed to Return|0
7735630|NCT00634933|12165649|FG004|Part A: Baseline to Week 24|Failed to Return|0
7735631|NCT00634933|12165645|FG000|Part A: Baseline to Week 24|Investigator Request|1
7735632|NCT00634933|12165646|FG001|Part A: Baseline to Week 24|Investigator Request|1
7735633|NCT00634933|12165647|FG002|Part A: Baseline to Week 24|Investigator Request|1
7735634|NCT00634933|12165648|FG003|Part A: Baseline to Week 24|Investigator Request|0
7735635|NCT00634933|12165649|FG004|Part A: Baseline to Week 24|Investigator Request|0
7735636|NCT00634933|12165645|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0
7735637|NCT00634933|12165646|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1
7735638|NCT00634933|12165647|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1
7735639|NCT00634933|12165648|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0
7735640|NCT00634933|12165649|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0
7735641|NCT00634933|12165645|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0
7735642|NCT00634933|12165646|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3
7735643|NCT00634933|12165647|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3
7735644|NCT00634933|12165648|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0
7735645|NCT00634933|12165649|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0
7735646|NCT00634933|12165645|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3
7735647|NCT00634933|12165646|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1
7735648|NCT00634933|12165647|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0
7735649|NCT00634933|12165648|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0
7735650|NCT00634933|12165649|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0
7735651|NCT00634933|12165645|FG000|Part A: Baseline to Week 24|Other|1
7735652|NCT00634933|12165646|FG001|Part A: Baseline to Week 24|Other|8
7962154|NCT02709746|12516272|FG000|Phase B (Double-blind Treatment Period)|Other|0
7735653|NCT00634933|12165647|FG002|Part A: Baseline to Week 24|Other|5
7735654|NCT00634933|12165648|FG003|Part A: Baseline to Week 24|Other|0
7735655|NCT00634933|12165649|FG004|Part A: Baseline to Week 24|Other|0
7735656|NCT00634933|12165645|FG000|Between Part A and Part B|Physician Decision|0
7735657|NCT00634933|12165646|FG001|Between Part A and Part B|Physician Decision|1
7735658|NCT00634933|12165647|FG002|Between Part A and Part B|Physician Decision|0
7735659|NCT00634933|12165648|FG003|Between Part A and Part B|Physician Decision|0
7735660|NCT00634933|12165649|FG004|Between Part A and Part B|Physician Decision|0
7735661|NCT00634933|12165645|FG000|Part B: Week 24 to Week 52|Adverse Event|0
7735662|NCT00634933|12165646|FG001|Part B: Week 24 to Week 52|Adverse Event|1
7735663|NCT00634933|12165647|FG002|Part B: Week 24 to Week 52|Adverse Event|1
7735664|NCT00634933|12165648|FG003|Part B: Week 24 to Week 52|Adverse Event|1
7735665|NCT00634933|12165649|FG004|Part B: Week 24 to Week 52|Adverse Event|0
7735666|NCT00634933|12165645|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
7735667|NCT00634933|12165646|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
7735668|NCT00634933|12165647|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
7735669|NCT00634933|12165648|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
7735670|NCT00634933|12165649|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
7735671|NCT00634933|12165645|FG000|Part B: Week 24 to Week 52|Physician Decision|0
7735672|NCT00634933|12165646|FG001|Part B: Week 24 to Week 52|Physician Decision|1
7735673|NCT00634933|12165647|FG002|Part B: Week 24 to Week 52|Physician Decision|1
7735674|NCT00634933|12165648|FG003|Part B: Week 24 to Week 52|Physician Decision|0
7735675|NCT00634933|12165649|FG004|Part B: Week 24 to Week 52|Physician Decision|0
7735676|NCT00634933|12165645|FG000|Part B: Week 24 to Week 52|Protocol Violation|0
7735677|NCT00634933|12165646|FG001|Part B: Week 24 to Week 52|Protocol Violation|0
7735678|NCT00634933|12165647|FG002|Part B: Week 24 to Week 52|Protocol Violation|0
7735679|NCT00634933|12165648|FG003|Part B: Week 24 to Week 52|Protocol Violation|0
7735680|NCT00634933|12165649|FG004|Part B: Week 24 to Week 52|Protocol Violation|1
7735681|NCT00634933|12165645|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0
7735682|NCT00634933|12165646|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0
7735683|NCT00634933|12165647|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0
7735684|NCT00634933|12165648|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2
7735685|NCT00634933|12165649|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1
7735686|NCT00634933|12165645|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0
7735687|NCT00634933|12165646|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1
7735688|NCT00634933|12165647|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1
7735689|NCT00634933|12165648|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0
7735690|NCT00634933|12165649|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0
7735691|NCT00634933|12165645|FG000|Part B: Week 24 to Week 52|Other|0
7735692|NCT00634933|12165646|FG001|Part B: Week 24 to Week 52|Other|0
7735693|NCT00634933|12165647|FG002|Part B: Week 24 to Week 52|Other|5
7735694|NCT00634933|12165648|FG003|Part B: Week 24 to Week 52|Other|0
7735695|NCT00634933|12165649|FG004|Part B: Week 24 to Week 52|Other|1
7735696|NCT00635024|12165661|FG000|Overall Study|Adverse Event|1
7735697|NCT00635050|12165665|FG000|Overall Study|Withdrawal by Subject|1
7735698|NCT00635089|12165672|FG000|Overall Study|Adverse Event|7
7735699|NCT00635089|12165672|FG000|Overall Study|Lack of Efficacy|28
7735700|NCT00635089|12165672|FG000|Overall Study|Protocol Deviation|4
7735701|NCT00635089|12165672|FG000|Overall Study|Lost to Follow-up|8
7735702|NCT00635089|12165672|FG000|Overall Study|Other|31
7735703|NCT00635102|12165691|FG000|Overall Study|Withdrawal by Subject|7
7735704|NCT00635102|12165692|FG001|Overall Study|Withdrawal by Subject|8
7735705|NCT00635154|12165709|FG000|Overall Study|Alternative Treatment|8
7735706|NCT00635154|12165709|FG000|Overall Study|Other|4
7735707|NCT00635154|12165709|FG000|Overall Study|Still on treatment|21
7735708|NCT00635219|12165720|FG000|Overall Study|Adverse Event|12
7735709|NCT00635219|12165721|FG001|Overall Study|Adverse Event|10
7735710|NCT00635219|12165722|FG002|Overall Study|Adverse Event|18
7735711|NCT00635219|12165723|FG003|Overall Study|Adverse Event|15
7735712|NCT00635219|12165724|FG004|Overall Study|Adverse Event|19
7735713|NCT00635219|12165720|FG000|Overall Study|Lack of Efficacy|5
7735714|NCT00635219|12165721|FG001|Overall Study|Lack of Efficacy|6
7735715|NCT00635219|12165722|FG002|Overall Study|Lack of Efficacy|3
7735716|NCT00635219|12165723|FG003|Overall Study|Lack of Efficacy|4
7735717|NCT00635219|12165724|FG004|Overall Study|Lack of Efficacy|6
7735718|NCT00635219|12165720|FG000|Overall Study|Non-compliance With Study Product|0
7735719|NCT00635219|12165721|FG001|Overall Study|Non-compliance With Study Product|0
7735720|NCT00635219|12165722|FG002|Overall Study|Non-compliance With Study Product|0
7735721|NCT00635219|12165723|FG003|Overall Study|Non-compliance With Study Product|2
7735722|NCT00635219|12165724|FG004|Overall Study|Non-compliance With Study Product|1
7735723|NCT00635219|12165720|FG000|Overall Study|Protocol Violation|0
7735724|NCT00635219|12165721|FG001|Overall Study|Protocol Violation|2
7735725|NCT00635219|12165722|FG002|Overall Study|Protocol Violation|3
7735726|NCT00635219|12165723|FG003|Overall Study|Protocol Violation|2
7735727|NCT00635219|12165724|FG004|Overall Study|Protocol Violation|4
7735728|NCT00635219|12165720|FG000|Overall Study|Withdrawal of Consent|8
7735729|NCT00635219|12165721|FG001|Overall Study|Withdrawal of Consent|6
7735730|NCT00635219|12165722|FG002|Overall Study|Withdrawal of Consent|8
7735731|NCT00635219|12165723|FG003|Overall Study|Withdrawal of Consent|11
7735732|NCT00635219|12165724|FG004|Overall Study|Withdrawal of Consent|8
7735733|NCT00635219|12165720|FG000|Overall Study|Lost to Follow-up|0
7735734|NCT00635219|12165721|FG001|Overall Study|Lost to Follow-up|0
7735735|NCT00635219|12165722|FG002|Overall Study|Lost to Follow-up|2
7735736|NCT00635219|12165723|FG003|Overall Study|Lost to Follow-up|0
7735737|NCT00635219|12165724|FG004|Overall Study|Lost to Follow-up|3
7735738|NCT00635219|12165720|FG000|Overall Study|Administrative or Other Reasons|0
7735739|NCT00635219|12165721|FG001|Overall Study|Administrative or Other Reasons|1
7735740|NCT00635219|12165722|FG002|Overall Study|Administrative or Other Reasons|1
7735741|NCT00635219|12165723|FG003|Overall Study|Administrative or Other Reasons|0
7735742|NCT00635219|12165724|FG004|Overall Study|Administrative or Other Reasons|1
7735743|NCT00635349|12165759|FG000|Overall Study|Other|8
7735744|NCT00635349|12165760|FG001|Overall Study|Other|6
7735745|NCT00635349|12165759|FG000|Overall Study|Protocol Violation|18
7735746|NCT00635349|12165760|FG001|Overall Study|Protocol Violation|22
7735747|NCT00635349|12165759|FG000|Overall Study|Withdrawal by Subject|3
7735748|NCT00635349|12165760|FG001|Overall Study|Withdrawal by Subject|8
7735749|NCT00635349|12165759|FG000|Overall Study|Lost to Follow-up|4
7735750|NCT00635349|12165760|FG001|Overall Study|Lost to Follow-up|3
7735751|NCT00635349|12165759|FG000|Overall Study|Adverse Event|11
7735752|NCT00635349|12165760|FG001|Overall Study|Adverse Event|9
7735753|NCT00635427|12165780|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0
7735754|NCT00635427|12165781|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0
7735755|NCT00635427|12165782|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1
7735756|NCT00635427|12165783|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0
7735757|NCT00635427|12165784|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0
7735758|NCT00635427|12165780|FG000|Overall Study|Death|0
7735759|NCT00635427|12165781|FG001|Overall Study|Death|0
7735760|NCT00635427|12165782|FG002|Overall Study|Death|0
7735761|NCT00635427|12165783|FG003|Overall Study|Death|1
7735762|NCT00635427|12165784|FG004|Overall Study|Death|0
7735763|NCT00635427|12165780|FG000|Overall Study|Termination Of Study By Sponsor|12
7735764|NCT00635427|12165781|FG001|Overall Study|Termination Of Study By Sponsor|6
7735765|NCT00635427|12165782|FG002|Overall Study|Termination Of Study By Sponsor|10
7735766|NCT00635427|12165783|FG003|Overall Study|Termination Of Study By Sponsor|6
7735767|NCT00635427|12165784|FG004|Overall Study|Termination Of Study By Sponsor|6
7735768|NCT00635427|12165780|FG000|Overall Study|Withdrawal Of Consent|0
7735769|NCT00635427|12165781|FG001|Overall Study|Withdrawal Of Consent|0
7735770|NCT00635427|12165782|FG002|Overall Study|Withdrawal Of Consent|0
7735771|NCT00635427|12165783|FG003|Overall Study|Withdrawal Of Consent|2
7735772|NCT00635427|12165784|FG004|Overall Study|Withdrawal Of Consent|2
7735773|NCT00635492|12165814|FG000|Overall Study|Death|12
7735774|NCT00635492|12165815|FG001|Overall Study|Death|40
7735775|NCT00635492|12165814|FG000|Overall Study|Lost to Follow-up|151
7735776|NCT00635492|12165815|FG001|Overall Study|Lost to Follow-up|172
7735777|NCT00635492|12165814|FG000|Overall Study|Physician Decision|32
7735778|NCT00635492|12165815|FG001|Overall Study|Physician Decision|22
7735779|NCT00635492|12165814|FG000|Overall Study|Sponsor decision|2
7735780|NCT00635492|12165815|FG001|Overall Study|Sponsor decision|3
7735781|NCT00635492|12165814|FG000|Overall Study|Withdrawal by Subject|82
7735782|NCT00635492|12165815|FG001|Overall Study|Withdrawal by Subject|45
7735783|NCT00635570|12165827|FG000|Overall Study|Lost to Follow-up|8
7735784|NCT00635570|12165828|FG001|Overall Study|Lost to Follow-up|8
7735785|NCT00635570|12165827|FG000|Overall Study|Withdrawal by Subject|1
7735786|NCT00635570|12165828|FG001|Overall Study|Withdrawal by Subject|1
7735787|NCT00635570|12165827|FG000|Overall Study|Adverse Event|2
7735788|NCT00635570|12165828|FG001|Overall Study|Adverse Event|0
7735789|NCT00635570|12165827|FG000|Overall Study|Physician Decision|1
7735790|NCT00635570|12165828|FG001|Overall Study|Physician Decision|0
7735791|NCT00635570|12165827|FG000|Overall Study|Did not complete survey|2
7735792|NCT00635570|12165828|FG001|Overall Study|Did not complete survey|1
7735793|NCT00635570|12165827|FG000|Overall Study|Early termination(No sexual activity)|1
7735794|NCT00635570|12165828|FG001|Overall Study|Early termination(No sexual activity)|1
7735795|NCT00635648|12165843|FG000|Overall Study|Adverse Event|12
7735796|NCT00635648|12165843|FG000|Overall Study|Withdrawal by Subject|9
7735797|NCT00635648|12165843|FG000|Overall Study|Physician Decision|4
7735798|NCT00635648|12165843|FG000|Overall Study|Rapid progression of baseline disease|4
7735799|NCT00635648|12165843|FG000|Overall Study|Use of other antifungal agent needed|1
7735800|NCT00635648|12165843|FG000|Overall Study|No improvement after 7-10 days treatment|4
7735801|NCT00635648|12165843|FG000|Overall Study|Noncompliance with protocol|1
7735802|NCT00635648|12165843|FG000|Overall Study|Other reason|2
7735803|NCT00635661|12165847|FG000|Overall Study|Withdrawal by Subject|4
7735804|NCT00635778|12165867|FG000|Overall Study|Adverse Event|1
7735805|NCT00635778|12165868|FG001|Overall Study|Adverse Event|0
7735806|NCT00635778|12165869|FG002|Overall Study|Adverse Event|0
7735807|NCT00635778|12165870|FG003|Overall Study|Adverse Event|3
7735808|NCT00635778|12165871|FG004|Overall Study|Adverse Event|3
7735809|NCT00635778|12165872|FG005|Overall Study|Adverse Event|6
7735810|NCT00635778|12165873|FG006|Overall Study|Adverse Event|1
7735811|NCT00635778|12165867|FG000|Overall Study|Withdrawal by Subject|0
7735812|NCT00635778|12165868|FG001|Overall Study|Withdrawal by Subject|0
7735813|NCT00635778|12165869|FG002|Overall Study|Withdrawal by Subject|0
7735814|NCT00635778|12165870|FG003|Overall Study|Withdrawal by Subject|1
7735815|NCT00635778|12165871|FG004|Overall Study|Withdrawal by Subject|0
7735816|NCT00635778|12165872|FG005|Overall Study|Withdrawal by Subject|1
7735817|NCT00635778|12165873|FG006|Overall Study|Withdrawal by Subject|1
7735818|NCT00635778|12165867|FG000|Overall Study|Progressive disease|0
7735819|NCT00635778|12165868|FG001|Overall Study|Progressive disease|3
7735820|NCT00635778|12165869|FG002|Overall Study|Progressive disease|3
7735821|NCT00635778|12165870|FG003|Overall Study|Progressive disease|4
7735822|NCT00635778|12165871|FG004|Overall Study|Progressive disease|5
7735823|NCT00635778|12165872|FG005|Overall Study|Progressive disease|14
7735824|NCT00635778|12165873|FG006|Overall Study|Progressive disease|4
7735825|NCT00635804|12165898|FG000|Overall Study|Adverse Event|0
7735826|NCT00635804|12165899|FG001|Overall Study|Adverse Event|0
7735827|NCT00635804|12165900|FG002|Overall Study|Adverse Event|0
7735828|NCT00635804|12165901|FG003|Overall Study|Adverse Event|0
7735829|NCT00635804|12165902|FG004|Overall Study|Adverse Event|0
7735830|NCT00635804|12165903|FG005|Overall Study|Adverse Event|1
7735831|NCT00635804|12165904|FG006|Overall Study|Adverse Event|0
7735832|NCT00635804|12165905|FG007|Overall Study|Adverse Event|0
7735833|NCT00635804|12165898|FG000|Overall Study|Withdrawal by Subject|1
7735834|NCT00635804|12165899|FG001|Overall Study|Withdrawal by Subject|0
7735835|NCT00635804|12165900|FG002|Overall Study|Withdrawal by Subject|0
7735836|NCT00635804|12165901|FG003|Overall Study|Withdrawal by Subject|0
7735837|NCT00635804|12165902|FG004|Overall Study|Withdrawal by Subject|0
7735838|NCT00635804|12165903|FG005|Overall Study|Withdrawal by Subject|0
7735839|NCT00635804|12165904|FG006|Overall Study|Withdrawal by Subject|0
7735840|NCT00635804|12165905|FG007|Overall Study|Withdrawal by Subject|0
7735841|NCT00635999|12165957|FG000|Overall Study|Withdrawal by Subject|4
7735842|NCT00635999|12165958|FG001|Overall Study|Withdrawal by Subject|2
7735843|NCT00635999|12165959|FG002|Overall Study|Withdrawal by Subject|1
7735844|NCT00636155|12165980|FG000|Overall Study|Adverse Event|8
7735845|NCT00636155|12165980|FG000|Overall Study|Lack of Efficacy|1
7735846|NCT00636155|12165980|FG000|Overall Study|Withdrawal by Subject|3
7735847|NCT00636155|12165980|FG000|Overall Study|Stem cell transplant|1
7735848|NCT00636155|12165980|FG000|Overall Study|Physician Decision|5
7735849|NCT00636168|12165986|FG000|Randomized to Study Drug|Withdrawal by Subject|2
7735850|NCT00636168|12165987|FG001|Randomized to Study Drug|Withdrawal by Subject|2
7735851|NCT00636168|12165986|FG000|Randomized to Study Drug|Adverse Event|1
7735852|NCT00636168|12165987|FG001|Randomized to Study Drug|Adverse Event|0
7735853|NCT00636168|12165986|FG000|Randomized to Study Drug|No longer meets study criteria|1
7735854|NCT00636168|12165987|FG001|Randomized to Study Drug|No longer meets study criteria|0
7735855|NCT00636168|12165986|FG000|Treated With Study Drug|Recurrence of disease|135
7735856|NCT00636168|12165987|FG001|Treated With Study Drug|Recurrence of disease|282
7735857|NCT00636168|12165986|FG000|Treated With Study Drug|Adverse Event|250
7735858|NCT00636168|12165987|FG001|Treated With Study Drug|Adverse Event|22
7735859|NCT00636168|12165986|FG000|Treated With Study Drug|Participant withdrew consent|16
7735860|NCT00636168|12165987|FG001|Treated With Study Drug|Participant withdrew consent|21
7735861|NCT00636168|12165986|FG000|Treated With Study Drug|Poor/non-compliance|1
7735862|NCT00636168|12165987|FG001|Treated With Study Drug|Poor/non-compliance|3
7735863|NCT00636168|12165986|FG000|Treated With Study Drug|Death|3
7735864|NCT00636168|12165987|FG001|Treated With Study Drug|Death|0
7735865|NCT00636168|12165986|FG000|Treated With Study Drug|Pregnancy|1
7735866|NCT00636168|12165987|FG001|Treated With Study Drug|Pregnancy|0
7735867|NCT00636168|12165986|FG000|Treated With Study Drug|No longer meets study criteria|1
7735868|NCT00636168|12165987|FG001|Treated With Study Drug|No longer meets study criteria|0
7735869|NCT00636168|12165986|FG000|Treated With Study Drug|Other reason|1
7735870|NCT00636168|12165987|FG001|Treated With Study Drug|Other reason|3
7735871|NCT00636168|12165986|FG000|Long Term Follow-Up|Lost to Follow-up|3
7735872|NCT00636168|12165987|FG001|Long Term Follow-Up|Lost to Follow-up|3
7735873|NCT00636168|12165986|FG000|Long Term Follow-Up|Participant withdrew consent|0
7735874|NCT00636168|12165987|FG001|Long Term Follow-Up|Participant withdrew consent|2
7735875|NCT00636168|12165986|FG000|Long Term Follow-Up|Death|8
7735876|NCT00636168|12165987|FG001|Long Term Follow-Up|Death|9
7735877|NCT00636181|12165996|FG000|Overall Study|Withdrawal by Subject|8
7735878|NCT00636181|12165997|FG001|Overall Study|Withdrawal by Subject|6
7735879|NCT00636181|12165998|FG002|Overall Study|Withdrawal by Subject|10
7735880|NCT00636194|12166008|FG000|Overall Study|Study related symptoms and complaints|1
7735881|NCT00636194|12166009|FG001|Overall Study|Study related symptoms and complaints|0
7735882|NCT00636194|12166008|FG000|Overall Study|Protocol Violation|2
7735883|NCT00636194|12166009|FG001|Overall Study|Protocol Violation|0
7735884|NCT00636207|12166018|FG000|Overall Study|Adverse Event|1
7735885|NCT00636207|12166019|FG001|Overall Study|Adverse Event|0
7735886|NCT00636207|12166020|FG002|Overall Study|Adverse Event|0
7735887|NCT00636207|12166021|FG003|Overall Study|Adverse Event|0
7735888|NCT00636207|12166022|FG004|Overall Study|Adverse Event|0
7735889|NCT00636207|12166023|FG005|Overall Study|Adverse Event|0
7735890|NCT00636207|12166024|FG006|Overall Study|Adverse Event|0
7735891|NCT00636207|12166018|FG000|Overall Study|Withdrawal by Subject|0
7735892|NCT00636207|12166019|FG001|Overall Study|Withdrawal by Subject|1
7735893|NCT00636207|12166020|FG002|Overall Study|Withdrawal by Subject|0
7735894|NCT00636207|12166021|FG003|Overall Study|Withdrawal by Subject|0
7735895|NCT00636207|12166022|FG004|Overall Study|Withdrawal by Subject|1
7735896|NCT00636207|12166023|FG005|Overall Study|Withdrawal by Subject|0
7735897|NCT00636207|12166024|FG006|Overall Study|Withdrawal by Subject|0
7735898|NCT00636363|12166052|FG000|Overall Study|Conjunctivitis|0
7735899|NCT00636363|12166053|FG001|Overall Study|Conjunctivitis|0
7735900|NCT00636363|12166054|FG002|Overall Study|Conjunctivitis|1
7735901|NCT00636363|12166052|FG000|Overall Study|Adverse Event|0
7735902|NCT00636363|12166053|FG001|Overall Study|Adverse Event|0
7735903|NCT00636363|12166054|FG002|Overall Study|Adverse Event|1
7735904|NCT00636363|12166052|FG000|Overall Study|Positive slit lamp finding|0
7735905|NCT00636363|12166053|FG001|Overall Study|Positive slit lamp finding|2
7735906|NCT00636363|12166054|FG002|Overall Study|Positive slit lamp finding|1
7735907|NCT00636363|12166052|FG000|Overall Study|Study related symptoms/complaints|8
7735908|NCT00636363|12166053|FG001|Overall Study|Study related symptoms/complaints|7
7735909|NCT00636363|12166054|FG002|Overall Study|Study related symptoms/complaints|4
7735910|NCT00636363|12166052|FG000|Overall Study|Met ineligibility criteria|0
7735911|NCT00636363|12166053|FG001|Overall Study|Met ineligibility criteria|0
7735912|NCT00636363|12166054|FG002|Overall Study|Met ineligibility criteria|3
7735913|NCT00636363|12166052|FG000|Overall Study|Missed > 1 visit|0
7735914|NCT00636363|12166053|FG001|Overall Study|Missed > 1 visit|1
7735915|NCT00636363|12166054|FG002|Overall Study|Missed > 1 visit|3
7735916|NCT00636363|12166052|FG000|Overall Study|Lack of motivation|1
7735917|NCT00636363|12166053|FG001|Overall Study|Lack of motivation|0
7735918|NCT00636363|12166054|FG002|Overall Study|Lack of motivation|1
7735919|NCT00636363|12166052|FG000|Overall Study|Protocol Violation|0
7735920|NCT00636363|12166053|FG001|Overall Study|Protocol Violation|3
7735921|NCT00636363|12166054|FG002|Overall Study|Protocol Violation|0
7735922|NCT00636363|12166052|FG000|Overall Study|Lost to Follow-up|3
7735923|NCT00636363|12166053|FG001|Overall Study|Lost to Follow-up|4
7735924|NCT00636363|12166054|FG002|Overall Study|Lost to Follow-up|2
7735925|NCT00636363|12166052|FG000|Overall Study|Withdrawal by Subject|1
7735926|NCT00636363|12166053|FG001|Overall Study|Withdrawal by Subject|3
7735927|NCT00636363|12166054|FG002|Overall Study|Withdrawal by Subject|2
7735928|NCT00636441|12166076|FG000|Overall Study|Adverse Event|0
7735929|NCT00636441|12166077|FG001|Overall Study|Adverse Event|1
7735930|NCT00636441|12166078|FG002|Overall Study|Adverse Event|1
7735931|NCT00636441|12166079|FG003|Overall Study|Adverse Event|0
7735932|NCT00636441|12166080|FG004|Overall Study|Adverse Event|0
7735933|NCT00636441|12166081|FG005|Overall Study|Adverse Event|1
7735934|NCT00636441|12166082|FG006|Overall Study|Adverse Event|0
7735935|NCT00636441|12166076|FG000|Overall Study|Late, ineligible|0
7735936|NCT00636441|12166077|FG001|Overall Study|Late, ineligible|0
7735937|NCT00636441|12166078|FG002|Overall Study|Late, ineligible|0
7735938|NCT00636441|12166079|FG003|Overall Study|Late, ineligible|0
7735939|NCT00636441|12166080|FG004|Overall Study|Late, ineligible|0
7735940|NCT00636441|12166081|FG005|Overall Study|Late, ineligible|0
7735941|NCT00636441|12166082|FG006|Overall Study|Late, ineligible|1
7735942|NCT00636441|12166076|FG000|Overall Study|Screen Failure|0
7735943|NCT00636441|12166077|FG001|Overall Study|Screen Failure|0
7735944|NCT00636441|12166078|FG002|Overall Study|Screen Failure|0
7735945|NCT00636441|12166079|FG003|Overall Study|Screen Failure|0
7735946|NCT00636441|12166080|FG004|Overall Study|Screen Failure|0
7735947|NCT00636441|12166081|FG005|Overall Study|Screen Failure|0
7735948|NCT00636441|12166082|FG006|Overall Study|Screen Failure|17
7735949|NCT00636506|12166093|FG000|Overall Study|Lost to Follow-up|8
7735950|NCT00636506|12166093|FG000|Overall Study|Explanted|1
7735951|NCT00636506|12166093|FG000|Overall Study|Withdrawal by Subject|6
7735952|NCT00636506|12166093|FG000|Overall Study|Procedure aborted|1
7735953|NCT00636610|12166117|FG000|Overall Study|Adverse Event|4
7735954|NCT00636610|12166118|FG001|Overall Study|Adverse Event|4
7735955|NCT00636610|12166117|FG000|Overall Study|Death|6
7735956|NCT00636610|12166118|FG001|Overall Study|Death|3
7735957|NCT00636610|12166117|FG000|Overall Study|Physician decision to withdraw patient|15
7735958|NCT00636610|12166118|FG001|Overall Study|Physician decision to withdraw patient|9
7735959|NCT00636610|12166117|FG000|Overall Study|Subject decision to withdraw|15
7735960|NCT00636610|12166118|FG001|Overall Study|Subject decision to withdraw|11
7735961|NCT00636610|12166117|FG000|Overall Study|Disease progression - radiographic|41
7735962|NCT00636610|12166118|FG001|Overall Study|Disease progression - radiographic|51
7735963|NCT00636610|12166117|FG000|Overall Study|Disease progression - clinical|8
7735964|NCT00636610|12166118|FG001|Overall Study|Disease progression - clinical|3
7735965|NCT00636610|12166117|FG000|Overall Study|Reason for discontinuation not available|3
7735966|NCT00636610|12166118|FG001|Overall Study|Reason for discontinuation not available|2
7735967|NCT00636636|12166128|FG000|Overall Study|Other reason|4
7735968|NCT00636636|12166129|FG001|Overall Study|Other reason|6
7735969|NCT00636636|12166128|FG000|Overall Study|Adverse Event|19
7735970|NCT00636636|12166129|FG001|Overall Study|Adverse Event|8
7735971|NCT00636636|12166128|FG000|Overall Study|Lack of Efficacy|7
7735972|NCT00636636|12166129|FG001|Overall Study|Lack of Efficacy|12
7735973|NCT00636636|12166128|FG000|Overall Study|Protocol Violation|2
7735974|NCT00636636|12166129|FG001|Overall Study|Protocol Violation|2
7735975|NCT00636636|12166128|FG000|Overall Study|Lost to Follow-up|0
7735976|NCT00636636|12166129|FG001|Overall Study|Lost to Follow-up|1
7735977|NCT00636636|12166128|FG000|Overall Study|Death|0
7735978|NCT00636636|12166129|FG001|Overall Study|Death|1
7735979|NCT00636636|12166128|FG000|Overall Study|Withdrawal by Subject|4
7735980|NCT00636636|12166129|FG001|Overall Study|Withdrawal by Subject|9
7735981|NCT00636675|12166150|FG000|Overall Study|Lost to Follow-up|121
7735982|NCT00636675|12166151|FG001|Overall Study|Lost to Follow-up|31
7735983|NCT00636675|12166150|FG000|Overall Study|Withdrawal by Subject|19
7735984|NCT00636675|12166151|FG001|Overall Study|Withdrawal by Subject|10
7735985|NCT00636792|12166166|FG000|Overall Study|Adverse Event|16
7735986|NCT00636792|12166166|FG000|Overall Study|Physician Decision|7
7735987|NCT00636792|12166166|FG000|Overall Study|Progressive Disease|4
7735988|NCT00636792|12166166|FG000|Overall Study|Withdrawal by Subject|3
7735989|NCT00636792|12166166|FG000|Overall Study|Other|3
7735990|NCT00636818|12166174|FG000|Overall Study|Adverse Event|1
7735991|NCT00636818|12166174|FG000|Overall Study|Lost to Follow-up|2
7735992|NCT00636818|12166174|FG000|Overall Study|Entry Criteria Exclusion|3
7735993|NCT00636818|12166174|FG000|Overall Study|Protocol Violation|1
7735994|NCT00636818|12166174|FG000|Overall Study|Withdrawal by Subject|4
7735995|NCT00636961|12166180|FG000|Period 1|Administrative problems|1
7735996|NCT00636961|12166181|FG001|Period 1|Administrative problems|1
7735997|NCT00636961|12166180|FG000|Period 2|Adverse Event|1
7735998|NCT00636961|12166181|FG001|Period 2|Adverse Event|0
7735999|NCT00636987|12166187|FG000|Overall Study|Death|44
7736000|NCT00636987|12166187|FG000|Overall Study|Explanted|13
7736001|NCT00636987|12166187|FG000|Overall Study|Lost to Follow-up|63
7736002|NCT00636987|12166187|FG000|Overall Study|5 year visit window not complete|69
7736003|NCT00637000|12166197|FG000|Overall Study|Withdrawal by Subject|4
7736004|NCT00637000|12166198|FG001|Overall Study|Withdrawal by Subject|3
7768835|NCT00863798|12212164|FG000|Overall Study|Withdrawal by Subject|8
7768836|NCT00863798|12212165|FG001|Overall Study|Withdrawal by Subject|7
7768837|NCT00863798|12212166|FG002|Overall Study|Withdrawal by Subject|4
7768838|NCT00863798|12212164|FG000|Overall Study|Randomized not treated|4
7768839|NCT00863798|12212165|FG001|Overall Study|Randomized not treated|2
7768840|NCT00863798|12212166|FG002|Overall Study|Randomized not treated|3
7768841|NCT00863928|12212176|FG000|Overall Study|Protocol Violation|26
7768842|NCT00863928|12212177|FG001|Overall Study|Protocol Violation|0
7768843|NCT00863928|12212176|FG000|Overall Study|Withdrawal by Subject|3
7768844|NCT00863928|12212177|FG001|Overall Study|Withdrawal by Subject|0
7768845|NCT00863928|12212176|FG000|Overall Study|surgery cancellation|4
7768846|NCT00863928|12212177|FG001|Overall Study|surgery cancellation|0
7768847|NCT00863928|12212176|FG000|Overall Study|medication allergy|3
7768848|NCT00863928|12212177|FG001|Overall Study|medication allergy|0
7768849|NCT00864097|12212204|FG000|Overall Study|Death|0
7768850|NCT00864097|12212205|FG001|Overall Study|Death|1
7768851|NCT00864097|12212206|FG002|Overall Study|Death|0
7768852|NCT00864097|12212207|FG003|Overall Study|Death|0
7768853|NCT00864097|12212204|FG000|Overall Study|Adverse Event|6
7768854|NCT00864097|12212205|FG001|Overall Study|Adverse Event|8
7768855|NCT00864097|12212206|FG002|Overall Study|Adverse Event|11
7768856|NCT00864097|12212207|FG003|Overall Study|Adverse Event|9
7768857|NCT00864097|12212204|FG000|Overall Study|Lack of Efficacy|9
7768858|NCT00864097|12212205|FG001|Overall Study|Lack of Efficacy|3
7768859|NCT00864097|12212206|FG002|Overall Study|Lack of Efficacy|7
7768860|NCT00864097|12212207|FG003|Overall Study|Lack of Efficacy|2
7768861|NCT00864097|12212204|FG000|Overall Study|Lost to Follow-up|0
7768862|NCT00864097|12212205|FG001|Overall Study|Lost to Follow-up|1
7768863|NCT00864097|12212206|FG002|Overall Study|Lost to Follow-up|0
7768864|NCT00864097|12212207|FG003|Overall Study|Lost to Follow-up|1
7768865|NCT00864097|12212204|FG000|Overall Study|Withdrawal by Subject|15
7768866|NCT00864097|12212205|FG001|Overall Study|Withdrawal by Subject|11
7768867|NCT00864097|12212206|FG002|Overall Study|Withdrawal by Subject|11
7768868|NCT00864097|12212207|FG003|Overall Study|Withdrawal by Subject|12
7736005|NCT00637156|12166206|FG000|Overall Study|Withdrawal by Subject|0
7736006|NCT00637156|12166207|FG001|Overall Study|Withdrawal by Subject|7
7736007|NCT00637156|12166206|FG000|Overall Study|Death|0
7736008|NCT00637156|12166207|FG001|Overall Study|Death|1
7736009|NCT00637156|12166206|FG000|Overall Study|Lost to Follow-up|10
7736010|NCT00637156|12166207|FG001|Overall Study|Lost to Follow-up|16
7736011|NCT00637195|12166215|FG000|Overall Study|Lost to Follow-up|1
7736012|NCT00637195|12166216|FG001|Overall Study|Lost to Follow-up|0
7736013|NCT00637195|12166215|FG000|Overall Study|Other|2
7736014|NCT00637195|12166216|FG001|Overall Study|Other|0
7736015|NCT00637195|12166215|FG000|Overall Study|Withdrawal by Subject|0
7736016|NCT00637195|12166216|FG001|Overall Study|Withdrawal by Subject|1
7736017|NCT00637273|12166236|FG000|Overall Study|Adverse Event|11
7736018|NCT00637273|12166237|FG001|Overall Study|Adverse Event|5
7736019|NCT00637273|12166238|FG002|Overall Study|Adverse Event|7
7736020|NCT00637273|12166236|FG000|Overall Study|Lost to Follow-up|8
7736021|NCT00637273|12166237|FG001|Overall Study|Lost to Follow-up|9
7736022|NCT00637273|12166238|FG002|Overall Study|Lost to Follow-up|13
7736023|NCT00637273|12166236|FG000|Overall Study|Protocol Violation|2
7736024|NCT00637273|12166237|FG001|Overall Study|Protocol Violation|4
7736025|NCT00637273|12166238|FG002|Overall Study|Protocol Violation|1
7736026|NCT00637273|12166236|FG000|Overall Study|Withdrawal of Consent|18
7736027|NCT00637273|12166237|FG001|Overall Study|Withdrawal of Consent|6
7736028|NCT00637273|12166238|FG002|Overall Study|Withdrawal of Consent|18
7736029|NCT00637273|12166236|FG000|Overall Study|Investigator Decision|1
7736030|NCT00637273|12166237|FG001|Overall Study|Investigator Decision|3
7736031|NCT00637273|12166238|FG002|Overall Study|Investigator Decision|1
7736032|NCT00637273|12166236|FG000|Overall Study|Administrative|2
7736033|NCT00637273|12166237|FG001|Overall Study|Administrative|0
7736034|NCT00637273|12166238|FG002|Overall Study|Administrative|0
7736035|NCT00637273|12166236|FG000|Overall Study|Loss of Glucose Control|1
7736036|NCT00637273|12166237|FG001|Overall Study|Loss of Glucose Control|1
7736037|NCT00637273|12166238|FG002|Overall Study|Loss of Glucose Control|1
7736038|NCT00637377|12166259|FG000|Overall Study|Adverse Event|2
7736039|NCT00637377|12166260|FG001|Overall Study|Adverse Event|6
7736040|NCT00637377|12166261|FG002|Overall Study|Adverse Event|8
7736041|NCT00637377|12166262|FG003|Overall Study|Adverse Event|9
7736042|NCT00637377|12166259|FG000|Overall Study|Death|1
7736043|NCT00637377|12166260|FG001|Overall Study|Death|3
7736044|NCT00637377|12166261|FG002|Overall Study|Death|2
7736045|NCT00637377|12166262|FG003|Overall Study|Death|1
7736046|NCT00637377|12166259|FG000|Overall Study|Lack of Efficacy|0
7736047|NCT00637377|12166260|FG001|Overall Study|Lack of Efficacy|0
7736048|NCT00637377|12166261|FG002|Overall Study|Lack of Efficacy|1
7736049|NCT00637377|12166262|FG003|Overall Study|Lack of Efficacy|1
7736050|NCT00637377|12166259|FG000|Overall Study|Lost to Follow-up|4
7736051|NCT00637377|12166260|FG001|Overall Study|Lost to Follow-up|1
7736052|NCT00637377|12166261|FG002|Overall Study|Lost to Follow-up|2
7736053|NCT00637377|12166262|FG003|Overall Study|Lost to Follow-up|2
7736054|NCT00637377|12166259|FG000|Overall Study|Protocol Violation|2
7736055|NCT00637377|12166260|FG001|Overall Study|Protocol Violation|1
7736056|NCT00637377|12166261|FG002|Overall Study|Protocol Violation|1
7736057|NCT00637377|12166262|FG003|Overall Study|Protocol Violation|0
7736058|NCT00637377|12166259|FG000|Overall Study|Withdrawal by Subject|11
7736059|NCT00637377|12166260|FG001|Overall Study|Withdrawal by Subject|15
7736060|NCT00637377|12166261|FG002|Overall Study|Withdrawal by Subject|13
7736061|NCT00637377|12166262|FG003|Overall Study|Withdrawal by Subject|11
7736062|NCT00637377|12166259|FG000|Overall Study|Other (no further information available)|7
7736063|NCT00637377|12166260|FG001|Overall Study|Other (no further information available)|6
7736064|NCT00637377|12166261|FG002|Overall Study|Other (no further information available)|10
7736065|NCT00637377|12166262|FG003|Overall Study|Other (no further information available)|5
7736066|NCT00637572|12166283|FG000|Overall Study|Adverse Event|1
7736067|NCT00637572|12166284|FG001|Overall Study|Adverse Event|2
7736068|NCT00637572|12166283|FG000|Overall Study|Death|0
7736069|NCT00637572|12166284|FG001|Overall Study|Death|1
7736070|NCT00637572|12166283|FG000|Overall Study|Lost to Follow-up|0
7736071|NCT00637572|12166284|FG001|Overall Study|Lost to Follow-up|1
7736072|NCT00637572|12166283|FG000|Overall Study|Physician Decision|1
7736073|NCT00637572|12166284|FG001|Overall Study|Physician Decision|1
7736074|NCT00637572|12166283|FG000|Overall Study|Withdrawal by Subject|0
7736075|NCT00637572|12166284|FG001|Overall Study|Withdrawal by Subject|2
7736076|NCT00637572|12166283|FG000|Overall Study|Illicit Drug Use|1
7736077|NCT00637572|12166284|FG001|Overall Study|Illicit Drug Use|0
7736078|NCT00638027|12166314|FG000|Overall Study|Adverse Event|0
7736079|NCT00638027|12166315|FG001|Overall Study|Adverse Event|2
7736080|NCT00638157|12166323|FG000|Overall Study|Adverse Event|0
7736081|NCT00638157|12166324|FG001|Overall Study|Adverse Event|1
7736082|NCT00638157|12166323|FG000|Overall Study|Clinical (symptomatic) failure|1
7736083|NCT00638157|12166324|FG001|Overall Study|Clinical (symptomatic) failure|1
7736084|NCT00638157|12166323|FG000|Overall Study|Microbiological failure|1
7736085|NCT00638157|12166324|FG001|Overall Study|Microbiological failure|0
7736086|NCT00638157|12166323|FG000|Overall Study|Lost to Follow-up|1
7736087|NCT00638157|12166324|FG001|Overall Study|Lost to Follow-up|0
7736088|NCT00638157|12166323|FG000|Overall Study|Physician Decision|1
7736089|NCT00638157|12166324|FG001|Overall Study|Physician Decision|0
7736090|NCT00638157|12166323|FG000|Overall Study|Other|1
7736091|NCT00638157|12166324|FG001|Overall Study|Other|2
7736092|NCT00638157|12166323|FG000|Overall Study|Randomized, not treated|2
7736093|NCT00638157|12166324|FG001|Overall Study|Randomized, not treated|0
7736094|NCT00638183|12166331|FG000|Overall Study|Adverse Event|23
7736095|NCT00638183|12166331|FG000|Overall Study|Lack of Efficacy|14
7736096|NCT00638183|12166331|FG000|Overall Study|Physician Decision|9
7736097|NCT00638183|12166331|FG000|Overall Study|Lost to Follow-up|46
7736098|NCT00638183|12166331|FG000|Overall Study|Other reason not defined above|27
7736099|NCT00638235|12166344|FG000|Overall Study|Lost to Follow-up|31
7736100|NCT00638235|12166345|FG001|Overall Study|Lost to Follow-up|3
7736101|NCT00638235|12166346|FG002|Overall Study|Lost to Follow-up|18
7736102|NCT00638235|12166347|FG003|Overall Study|Lost to Follow-up|10
7736103|NCT00638235|12166348|FG004|Overall Study|Lost to Follow-up|13
7736104|NCT00638235|12166349|FG005|Overall Study|Lost to Follow-up|26
7736105|NCT00638235|12166350|FG006|Overall Study|Lost to Follow-up|0
7736106|NCT00638235|12166351|FG007|Overall Study|Lost to Follow-up|1
7736107|NCT00638235|12166352|FG008|Overall Study|Lost to Follow-up|18
7736108|NCT00638378|12166401|FG000|Overall Study|Death|2
7736109|NCT00638378|12166401|FG000|Overall Study|Adverse Event|1
7736110|NCT00638378|12166401|FG000|Overall Study|Disease progression|15
7736111|NCT00638378|12166401|FG000|Overall Study|Physician Decision|4
7736112|NCT00638404|12166407|FG000|Overall Study|Physician Decision|8
7736113|NCT00638404|12166408|FG001|Overall Study|Physician Decision|0
7736114|NCT00638443|12166418|FG000|First Intervention|Adverse Event|2
7736115|NCT00638443|12166419|FG001|First Intervention|Adverse Event|1
7736116|NCT00638456|12166429|FG000|Overall Study|Withdrawal by Subject|6
7736117|NCT00638456|12166430|FG001|Overall Study|Withdrawal by Subject|2
7736118|NCT00638508|12166438|FG000|Overall Study|Physician Decision|5
7736119|NCT00638508|12166439|FG001|Overall Study|Physician Decision|2
7736120|NCT00638690|12166456|FG000|Overall Study|Death|655
7736121|NCT00638690|12166457|FG001|Overall Study|Death|335
7736122|NCT00638690|12166456|FG000|Overall Study|Withdrawal by Subject|22
7736123|NCT00638690|12166457|FG001|Overall Study|Withdrawal by Subject|5
7736124|NCT00638690|12166456|FG000|Overall Study|Lost to Follow-up|4
7736125|NCT00638690|12166457|FG001|Overall Study|Lost to Follow-up|2
7768869|NCT00864097|12212204|FG000|Overall Study|Protocol Violation|2
7768870|NCT00864097|12212205|FG001|Overall Study|Protocol Violation|1
7768871|NCT00864097|12212206|FG002|Overall Study|Protocol Violation|0
7768872|NCT00864097|12212207|FG003|Overall Study|Protocol Violation|1
7768873|NCT00864097|12212204|FG000|Overall Study|Terminated by sponsor|105
7768874|NCT00864097|12212205|FG001|Overall Study|Terminated by sponsor|112
7768875|NCT00864097|12212206|FG002|Overall Study|Terminated by sponsor|102
7768876|NCT00864097|12212207|FG003|Overall Study|Terminated by sponsor|99
7768877|NCT00864097|12212204|FG000|Overall Study|Randomized but not treated|2
7768878|NCT00864097|12212205|FG001|Overall Study|Randomized but not treated|0
7768879|NCT00864097|12212206|FG002|Overall Study|Randomized but not treated|1
7768880|NCT00864097|12212207|FG003|Overall Study|Randomized but not treated|0
7768881|NCT00864097|12212204|FG000|Overall Study|Other|0
7768882|NCT00864097|12212205|FG001|Overall Study|Other|0
7768883|NCT00864097|12212206|FG002|Overall Study|Other|0
7768884|NCT00864097|12212207|FG003|Overall Study|Other|1
7768885|NCT00864253|12212228|FG000|Overall Study|Adverse Event|56
7768886|NCT00864253|12212229|FG001|Overall Study|Adverse Event|11
7768887|NCT00864253|12212228|FG000|Overall Study|Unrelated Adverse Event|3
7768888|NCT00864253|12212229|FG001|Overall Study|Unrelated Adverse Event|1
7768889|NCT00864253|12212228|FG000|Overall Study|Physician Decision|11
7768890|NCT00864253|12212229|FG001|Overall Study|Physician Decision|15
7768891|NCT00864253|12212228|FG000|Overall Study|Protocol Violation|0
7768892|NCT00864253|12212229|FG001|Overall Study|Protocol Violation|2
7768893|NCT00864253|12212228|FG000|Overall Study|Lost to Follow-up|1
7768894|NCT00864253|12212229|FG001|Overall Study|Lost to Follow-up|1
7768895|NCT00864253|12212228|FG000|Overall Study|Withdrawal by Subject|18
7768896|NCT00864253|12212229|FG001|Overall Study|Withdrawal by Subject|18
7768897|NCT00864253|12212228|FG000|Overall Study|Death|1
7768898|NCT00864253|12212229|FG001|Overall Study|Death|0
7768899|NCT00864253|12212228|FG000|Overall Study|Ongoing|2
7768900|NCT00864253|12212229|FG001|Overall Study|Ongoing|3
7768901|NCT00864253|12212228|FG000|Overall Study|Untreated|7
7768902|NCT00864253|12212229|FG001|Overall Study|Untreated|7
7768903|NCT00864513|12212250|FG000|Overall Study|Withdrawal by Subject|3
7768904|NCT00864682|12212282|FG000|Overall Study|Protocol Violation|2
7768905|NCT00864682|12212283|FG001|Overall Study|Protocol Violation|1
7768906|NCT00864682|12212284|FG002|Overall Study|Protocol Violation|2
7768907|NCT00864721|12212298|FG000|Overall Study|Patient request|11
7768908|NCT00864721|12212298|FG000|Overall Study|Hospitalized|1
7768909|NCT00864721|12212298|FG000|Overall Study|Drug hold/delay more than 4 weeks|1
7768910|NCT00864721|12212298|FG000|Overall Study|Adverse Event|21
7768911|NCT00864851|12212305|FG000|Overall Study|Withdrawal by Subject|0
7768912|NCT00864851|12212306|FG001|Overall Study|Withdrawal by Subject|1
7768913|NCT00864851|12212307|FG002|Overall Study|Withdrawal by Subject|0
7768914|NCT00864851|12212305|FG000|Overall Study|Physician Decision|1
7768915|NCT00864851|12212306|FG001|Overall Study|Physician Decision|0
7768916|NCT00864851|12212307|FG002|Overall Study|Physician Decision|0
7768917|NCT00864851|12212305|FG000|Overall Study|Death|1
7768918|NCT00864851|12212306|FG001|Overall Study|Death|0
7768919|NCT00864851|12212307|FG002|Overall Study|Death|0
7768920|NCT00864851|12212305|FG000|Overall Study|Patient uncooperative|1
7768921|NCT00864851|12212306|FG001|Overall Study|Patient uncooperative|0
7768922|NCT00864851|12212307|FG002|Overall Study|Patient uncooperative|0
7768923|NCT00864916|12212319|FG000|Overall Study|Lost to Follow-up|4
7768924|NCT00864916|12212320|FG001|Overall Study|Lost to Follow-up|4
7768925|NCT00864916|12212319|FG000|Overall Study|Protocol Violation|1
7768926|NCT00864916|12212320|FG001|Overall Study|Protocol Violation|0
7768927|NCT00864916|12212319|FG000|Overall Study|Withdrawal by Subject|1
7768928|NCT00864916|12212320|FG001|Overall Study|Withdrawal by Subject|0
7768929|NCT00865020|12212328|FG000|Overall Study|Withdrawal by Subject|22
7768930|NCT00865020|12212329|FG001|Overall Study|Withdrawal by Subject|16
7768931|NCT00865020|12212328|FG000|Overall Study|Adverse Event|9
7768932|NCT00865020|12212329|FG001|Overall Study|Adverse Event|14
7768933|NCT00865020|12212328|FG000|Overall Study|Abnormal test procedure result(s)|6
7768934|NCT00865020|12212329|FG001|Overall Study|Abnormal test procedure result(s)|8
7768935|NCT00865020|12212328|FG000|Overall Study|Lost to Follow-up|6
7768936|NCT00865020|12212329|FG001|Overall Study|Lost to Follow-up|4
7768937|NCT00865020|12212328|FG000|Overall Study|Protocol deviation|4
7768938|NCT00865020|12212329|FG001|Overall Study|Protocol deviation|1
7768939|NCT00865020|12212328|FG000|Overall Study|Administrative problems|0
7768940|NCT00865020|12212329|FG001|Overall Study|Administrative problems|2
7768941|NCT00865020|12212328|FG000|Overall Study|Abnormal laboratory value(s)|0
7736126|NCT00638846|12166483|FG000|Overall Study|Adverse Event|0
7736127|NCT00638846|12166484|FG001|Overall Study|Adverse Event|1
7736128|NCT00638846|12166483|FG000|Overall Study|Lost to Follow-up|3
7736129|NCT00638846|12166484|FG001|Overall Study|Lost to Follow-up|2
7736130|NCT00638846|12166483|FG000|Overall Study|lens issue|1
7736131|NCT00638846|12166484|FG001|Overall Study|lens issue|3
7736132|NCT00638963|12166506|FG000|Overall Study|Withdrawal by Subject|1
7736133|NCT00638963|12166507|FG001|Overall Study|Withdrawal by Subject|0
7736134|NCT00638989|12166516|FG000|Overall Study|Lost to Follow-up|0
7736135|NCT00638989|12166517|FG001|Overall Study|Lost to Follow-up|0
7736136|NCT00638989|12166518|FG002|Overall Study|Lost to Follow-up|1
7736137|NCT00639002|12166528|FG000|Overall Study|Death|1
7736138|NCT00639002|12166528|FG000|Overall Study|Adverse Event|1
7736139|NCT00639002|12166528|FG000|Overall Study|Protocol Violation|1
7736140|NCT00639002|12166528|FG000|Overall Study|Disease progression|3
7736141|NCT00639002|12166528|FG000|Overall Study|Physician Decision|6
7736142|NCT00639002|12166528|FG000|Overall Study|Lack of Efficacy|1
7736143|NCT00639223|12166553|FG000|Overall Study|Lost to Follow-up|0
7736144|NCT00639223|12166554|FG001|Overall Study|Lost to Follow-up|2
7736145|NCT00639379|12166560|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2
7736146|NCT00639379|12166561|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0
7736147|NCT00639379|12166560|FG000|Period 1 - 2 Weeks|lens issue|3
7736148|NCT00639379|12166561|FG001|Period 1 - 2 Weeks|lens issue|0
7736149|NCT00639457|12166590|FG000|Overall Study|Withdrawal by Subject|2
7736150|NCT00639457|12166591|FG001|Overall Study|Withdrawal by Subject|3
7736151|NCT00639509|12166597|FG000|Overall Study|Death|1
7736152|NCT00639678|12166605|FG000|Overall Study|Withdrawal by Subject|3
7736153|NCT00639678|12166606|FG001|Overall Study|Withdrawal by Subject|0
7736154|NCT00639678|12166607|FG002|Overall Study|Withdrawal by Subject|4
7736155|NCT00639678|12166608|FG003|Overall Study|Withdrawal by Subject|0
7736156|NCT00639678|12166605|FG000|Overall Study|Lost to Follow-up|1
7736157|NCT00639678|12166606|FG001|Overall Study|Lost to Follow-up|0
7736158|NCT00639678|12166607|FG002|Overall Study|Lost to Follow-up|6
7736159|NCT00639678|12166608|FG003|Overall Study|Lost to Follow-up|0
7736160|NCT00639678|12166605|FG000|Overall Study|Adverse Event|0
7736161|NCT00639678|12166606|FG001|Overall Study|Adverse Event|1
7736162|NCT00639678|12166607|FG002|Overall Study|Adverse Event|0
7736163|NCT00639678|12166608|FG003|Overall Study|Adverse Event|0
7736164|NCT00639678|12166605|FG000|Overall Study|Lack of Compliance|0
7736165|NCT00639678|12166606|FG001|Overall Study|Lack of Compliance|0
7736166|NCT00639678|12166607|FG002|Overall Study|Lack of Compliance|1
7736167|NCT00639678|12166608|FG003|Overall Study|Lack of Compliance|0
7736168|NCT00639769|12166624|FG000|Overall Study|Death|2
7736169|NCT00639769|12166624|FG000|Overall Study|Adverse Event|7
7736170|NCT00639769|12166624|FG000|Overall Study|Lack of Efficacy|1
7736171|NCT00639769|12166624|FG000|Overall Study|Disease progression|26
7736172|NCT00639769|12166624|FG000|Overall Study|Withdrawal by Subject|4
7736173|NCT00640016|12166636|FG000|Overall Study|Withdrawal by Subject|0
7736174|NCT00640016|12166637|FG001|Overall Study|Withdrawal by Subject|1
7736175|NCT00640016|12166638|FG002|Overall Study|Withdrawal by Subject|0
7736176|NCT00640016|12166639|FG003|Overall Study|Withdrawal by Subject|0
7736177|NCT00640016|12166636|FG000|Overall Study|Study termination|2
7736178|NCT00640016|12166637|FG001|Overall Study|Study termination|1
7736179|NCT00640016|12166638|FG002|Overall Study|Study termination|3
7736180|NCT00640016|12166639|FG003|Overall Study|Study termination|2
7736181|NCT00640016|12166636|FG000|Overall Study|Adverse Event|0
7736182|NCT00640016|12166637|FG001|Overall Study|Adverse Event|0
7736183|NCT00640016|12166638|FG002|Overall Study|Adverse Event|0
7736184|NCT00640016|12166639|FG003|Overall Study|Adverse Event|1
7736185|NCT00640042|12166656|FG000|Enrollment|Did not receive study drug|83
7736186|NCT00640146|12166662|FG000|Overall Study|Adverse Event|2
7736187|NCT00640146|12166663|FG001|Overall Study|Adverse Event|0
7736188|NCT00640146|12166662|FG000|Overall Study|Lost to Follow-up|0
7736189|NCT00640146|12166663|FG001|Overall Study|Lost to Follow-up|1
7736190|NCT00640146|12166662|FG000|Overall Study|Lack of Efficacy|0
7736191|NCT00640146|12166663|FG001|Overall Study|Lack of Efficacy|1
7736192|NCT00640146|12166662|FG000|Overall Study|Withdrawal by Subject|1
7736193|NCT00640146|12166663|FG001|Overall Study|Withdrawal by Subject|1
7736194|NCT00640146|12166662|FG000|Overall Study|Randomized but not treated|1
7736195|NCT00640146|12166663|FG001|Overall Study|Randomized but not treated|3
7736196|NCT00640224|12166673|FG000|Overall Study|Lost to Follow-up|5
7736197|NCT00640224|12166674|FG001|Overall Study|Lost to Follow-up|2
7736198|NCT00640224|12166675|FG002|Overall Study|Lost to Follow-up|0
7736199|NCT00640224|12166676|FG003|Overall Study|Lost to Follow-up|0
7736200|NCT00640224|12166673|FG000|Overall Study|Withdrawal by Subject|1
7736201|NCT00640224|12166674|FG001|Overall Study|Withdrawal by Subject|0
7736202|NCT00640224|12166675|FG002|Overall Study|Withdrawal by Subject|0
7736203|NCT00640224|12166676|FG003|Overall Study|Withdrawal by Subject|0
7736204|NCT00640224|12166673|FG000|Overall Study|Headaches|0
7736205|NCT00640224|12166674|FG001|Overall Study|Headaches|1
7736206|NCT00640224|12166675|FG002|Overall Study|Headaches|0
7736207|NCT00640224|12166676|FG003|Overall Study|Headaches|0
7736208|NCT00640289|12166789|FG000|Overall Study|Death|3
7736209|NCT00640289|12166789|FG000|Overall Study|Withdrawal by Subject|1
7736210|NCT00640289|12166789|FG000|Overall Study|Lost to Follow-up|1
7736211|NCT00640289|12166789|FG000|Overall Study|Data collected under different amendment|2
7736212|NCT00640289|12166789|FG000|Overall Study|Transferred to another center|1
7736213|NCT00640289|12166789|FG000|Overall Study|Missing status|5
7736214|NCT00640315|12166795|FG000|Overall Study|Withdrawal by Subject|0
7736215|NCT00640315|12166796|FG001|Overall Study|Withdrawal by Subject|1
7736216|NCT00640328|12166808|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0
7736217|NCT00640328|12166809|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1
7736218|NCT00640328|12166810|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0
7736219|NCT00640328|12166811|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0
7736220|NCT00640328|12166812|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0
7736221|NCT00640328|12166813|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0
7736222|NCT00640328|12166808|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0
7736223|NCT00640328|12166809|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0
7736224|NCT00640328|12166810|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0
7736225|NCT00640328|12166811|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0
7736226|NCT00640328|12166812|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1
7736227|NCT00640328|12166813|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0
7736228|NCT00640328|12166808|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
7736229|NCT00640328|12166809|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
7736230|NCT00640328|12166810|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
7736231|NCT00640328|12166811|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
7736232|NCT00640328|12166812|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
7736233|NCT00640328|12166813|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
7736234|NCT00640328|12166808|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
7736235|NCT00640328|12166809|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
7736236|NCT00640328|12166810|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
7736237|NCT00640328|12166811|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
7736238|NCT00640328|12166812|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
7736239|NCT00640328|12166813|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
7736240|NCT00640341|12166837|FG000|Overall Study|Adverse Event|0
7736241|NCT00640341|12166838|FG001|Overall Study|Adverse Event|0
7736242|NCT00640341|12166839|FG002|Overall Study|Adverse Event|1
7736243|NCT00640341|12166837|FG000|Overall Study|Positive Slit Lamp Findings|0
7736244|NCT00640341|12166838|FG001|Overall Study|Positive Slit Lamp Findings|0
7736245|NCT00640341|12166839|FG002|Overall Study|Positive Slit Lamp Findings|1
7736246|NCT00640341|12166837|FG000|Overall Study|Study Related Symptoms/Complaints|2
7736247|NCT00640341|12166838|FG001|Overall Study|Study Related Symptoms/Complaints|1
7736248|NCT00640341|12166839|FG002|Overall Study|Study Related Symptoms/Complaints|2
7736249|NCT00640341|12166837|FG000|Overall Study|Inability to Maintain Wearing Schedule|1
7736250|NCT00640341|12166838|FG001|Overall Study|Inability to Maintain Wearing Schedule|1
7736251|NCT00640341|12166839|FG002|Overall Study|Inability to Maintain Wearing Schedule|0
7736252|NCT00640341|12166837|FG000|Overall Study|Failure to Follow Subject Instructions|1
7736253|NCT00640341|12166838|FG001|Overall Study|Failure to Follow Subject Instructions|0
7736254|NCT00640341|12166839|FG002|Overall Study|Failure to Follow Subject Instructions|0
7736255|NCT00640341|12166837|FG000|Overall Study|Lost to Follow-up|2
7736256|NCT00640341|12166838|FG001|Overall Study|Lost to Follow-up|0
7736257|NCT00640341|12166839|FG002|Overall Study|Lost to Follow-up|0
7736258|NCT00640341|12166837|FG000|Overall Study|Withdrawal by Subject|4
7736259|NCT00640341|12166838|FG001|Overall Study|Withdrawal by Subject|0
7736260|NCT00640341|12166839|FG002|Overall Study|Withdrawal by Subject|1
7736261|NCT00640341|12166837|FG000|Overall Study|Unacceptable Lens Movement|1
7736262|NCT00640341|12166838|FG001|Overall Study|Unacceptable Lens Movement|0
7736263|NCT00640341|12166839|FG002|Overall Study|Unacceptable Lens Movement|0
7736264|NCT00640341|12166837|FG000|Overall Study|Poor fit/Uncomfortable|4
7736265|NCT00640341|12166838|FG001|Overall Study|Poor fit/Uncomfortable|0
7736266|NCT00640341|12166839|FG002|Overall Study|Poor fit/Uncomfortable|0
7736267|NCT00640341|12166837|FG000|Overall Study|Ineligable at Baseline|5
7736268|NCT00640341|12166838|FG001|Overall Study|Ineligable at Baseline|3
7736269|NCT00640341|12166839|FG002|Overall Study|Ineligable at Baseline|2
7736270|NCT00640341|12166837|FG000|Overall Study|Adverse event and positive slit lamp|1
7736271|NCT00640341|12166838|FG001|Overall Study|Adverse event and positive slit lamp|0
7736272|NCT00640341|12166839|FG002|Overall Study|Adverse event and positive slit lamp|0
7736273|NCT00640393|12166847|FG000|Part 1|Lost to Follow-up|2
7736274|NCT00640393|12166848|FG001|Part 1|Lost to Follow-up|0
7736275|NCT00640393|12166849|FG002|Part 1|Lost to Follow-up|0
7736276|NCT00640393|12166847|FG000|Part 1|Withdrawal by Subject|3
7736277|NCT00640393|12166848|FG001|Part 1|Withdrawal by Subject|0
7736278|NCT00640393|12166849|FG002|Part 1|Withdrawal by Subject|0
7736279|NCT00640393|12166847|FG000|Randomization|Withdrawn per protocol|17
7736280|NCT00640393|12166848|FG001|Randomization|Withdrawn per protocol|0
7736281|NCT00640393|12166849|FG002|Randomization|Withdrawn per protocol|0
7736282|NCT00640393|12166847|FG000|Randomization|Never randomized by site|2
7736283|NCT00640393|12166848|FG001|Randomization|Never randomized by site|0
7736284|NCT00640393|12166849|FG002|Randomization|Never randomized by site|0
7736285|NCT00640393|12166847|FG000|Part 2|Lost to Follow-up|0
7736286|NCT00640393|12166848|FG001|Part 2|Lost to Follow-up|2
7736287|NCT00640393|12166849|FG002|Part 2|Lost to Follow-up|2
7736288|NCT00640393|12166847|FG000|Part 2|Withdrawal by Subject|0
7736289|NCT00640393|12166848|FG001|Part 2|Withdrawal by Subject|6
7736290|NCT00640393|12166849|FG002|Part 2|Withdrawal by Subject|1
7736291|NCT00640393|12166847|FG000|Part 2|Non-adherence|0
7736292|NCT00640393|12166848|FG001|Part 2|Non-adherence|1
7736293|NCT00640393|12166849|FG002|Part 2|Non-adherence|0
7736294|NCT00640393|12166847|FG000|Part 2|Adverse Event|0
7736295|NCT00640393|12166848|FG001|Part 2|Adverse Event|1
7736296|NCT00640393|12166849|FG002|Part 2|Adverse Event|0
7736297|NCT00640510|12166859|FG000|Overall Study|Lack of Efficacy|0
7736298|NCT00640510|12166860|FG001|Overall Study|Lack of Efficacy|1
7736299|NCT00640510|12166859|FG000|Overall Study|Protocol Violation|1
7736300|NCT00640510|12166860|FG001|Overall Study|Protocol Violation|0
7736301|NCT00640510|12166859|FG000|Overall Study|Physician Decision|0
7736302|NCT00640510|12166860|FG001|Overall Study|Physician Decision|1
7736303|NCT00640562|12166868|FG000|Overall Study|Adverse Event|8
7736304|NCT00640562|12166869|FG001|Overall Study|Adverse Event|5
7736305|NCT00640562|12166868|FG000|Overall Study|Lack of Efficacy|1
7736306|NCT00640562|12166869|FG001|Overall Study|Lack of Efficacy|4
7736307|NCT00640562|12166868|FG000|Overall Study|Protocol Violation|2
7736308|NCT00640562|12166869|FG001|Overall Study|Protocol Violation|4
7736309|NCT00640562|12166868|FG000|Overall Study|Withdrawal by Subject|6
7736310|NCT00640562|12166869|FG001|Overall Study|Withdrawal by Subject|10
7736311|NCT00640562|12166868|FG000|Overall Study|Known risperidone intolerance|0
7736312|NCT00640562|12166869|FG001|Overall Study|Known risperidone intolerance|1
7736313|NCT00640562|12166868|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0
7736314|NCT00640562|12166869|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1
7736315|NCT00640562|12166868|FG000|Overall Study|Low study drug dose|0
7736316|NCT00640562|12166869|FG001|Overall Study|Low study drug dose|1
7736317|NCT00640562|12166868|FG000|Overall Study|Glycosylated Hemoglobin >8|1
7736318|NCT00640562|12166869|FG001|Overall Study|Glycosylated Hemoglobin >8|0
7736319|NCT00640601|12166875|FG000|Overall Study|Adverse Event|43
7736320|NCT00640601|12166875|FG000|Overall Study|Withdrawal by Subject|20
7736321|NCT00640601|12166875|FG000|Overall Study|Protocol Violation|6
7736322|NCT00640601|12166875|FG000|Overall Study|Lack of Efficacy|16
7736323|NCT00640601|12166875|FG000|Overall Study|Lost to Follow-up|9
7736324|NCT00640601|12166875|FG000|Overall Study|Physician Decision|8
7736325|NCT00640601|12166875|FG000|Overall Study|treatment naive, combination therapy|10
7736326|NCT00640614|12166881|FG000|Overall Study|Lost to Follow-up|1
7736327|NCT00640614|12166882|FG001|Overall Study|Lost to Follow-up|0
7736328|NCT00640835|12166947|FG000|Overall Study|Adverse Event|5
7736329|NCT00640835|12166948|FG001|Overall Study|Adverse Event|3
7736330|NCT00640835|12166947|FG000|Overall Study|Withdrawal by Subject|12
7736331|NCT00640835|12166948|FG001|Overall Study|Withdrawal by Subject|14
7736332|NCT00640835|12166947|FG000|Overall Study|Physician Decision|10
7736333|NCT00640835|12166948|FG001|Overall Study|Physician Decision|14
7736334|NCT00640835|12166947|FG000|Overall Study|Sponsor's Decision|11
7736335|NCT00640835|12166948|FG001|Overall Study|Sponsor's Decision|7
7736336|NCT00640835|12166947|FG000|Overall Study|Protocol Violation|2
7736337|NCT00640835|12166948|FG001|Overall Study|Protocol Violation|2
7736338|NCT00640835|12166947|FG000|Overall Study|Lost to Follow-up|17
7736339|NCT00640835|12166948|FG001|Overall Study|Lost to Follow-up|13
7736340|NCT00640835|12166947|FG000|Overall Study|Other Reason|19
7736341|NCT00640835|12166948|FG001|Overall Study|Other Reason|4
7736342|NCT00640926|12166957|FG000|Overall Study|Adverse Event|2
7736343|NCT00640926|12166958|FG001|Overall Study|Adverse Event|3
7736344|NCT00640926|12166959|FG002|Overall Study|Adverse Event|2
7736345|NCT00640926|12166957|FG000|Overall Study|Lack of Efficacy|0
7736346|NCT00640926|12166958|FG001|Overall Study|Lack of Efficacy|2
7736347|NCT00640926|12166959|FG002|Overall Study|Lack of Efficacy|1
7736348|NCT00640926|12166957|FG000|Overall Study|Protocol Violation|2
7736349|NCT00640926|12166958|FG001|Overall Study|Protocol Violation|0
7736350|NCT00640926|12166959|FG002|Overall Study|Protocol Violation|2
7736351|NCT00640926|12166957|FG000|Overall Study|Lost to Follow-up|3
7736352|NCT00640926|12166958|FG001|Overall Study|Lost to Follow-up|1
7736353|NCT00640926|12166959|FG002|Overall Study|Lost to Follow-up|2
7736354|NCT00640926|12166957|FG000|Overall Study|Withdrawal by Subject|1
7736355|NCT00640926|12166958|FG001|Overall Study|Withdrawal by Subject|0
7736356|NCT00640926|12166959|FG002|Overall Study|Withdrawal by Subject|1
7736357|NCT00641043|12166973|FG000|Overall Study|Adverse Event|6
7736358|NCT00641043|12166974|FG001|Overall Study|Adverse Event|4
7736359|NCT00641043|12166973|FG000|Overall Study|Protocol Violation|2
7736360|NCT00641043|12166974|FG001|Overall Study|Protocol Violation|3
7736361|NCT00641043|12166973|FG000|Overall Study|Lost to Follow-up|3
7736362|NCT00641043|12166974|FG001|Overall Study|Lost to Follow-up|2
7736363|NCT00641043|12166973|FG000|Overall Study|Withdrawal by Subject|4
7736364|NCT00641043|12166974|FG001|Overall Study|Withdrawal by Subject|4
7736365|NCT00641043|12166973|FG000|Overall Study|Other incl. lack of efficacy|4
7736366|NCT00641043|12166974|FG001|Overall Study|Other incl. lack of efficacy|2
7736367|NCT00641056|12166982|FG000|Overall Study|Adverse Event|12
7736368|NCT00641056|12166983|FG001|Overall Study|Adverse Event|2
7736369|NCT00641056|12166982|FG000|Overall Study|Lost to Follow-up|2
7736370|NCT00641056|12166983|FG001|Overall Study|Lost to Follow-up|1
7736371|NCT00641056|12166982|FG000|Overall Study|Physician Decision|3
7736372|NCT00641056|12166983|FG001|Overall Study|Physician Decision|1
7736373|NCT00641056|12166982|FG000|Overall Study|Protocol Violation|2
7736374|NCT00641056|12166983|FG001|Overall Study|Protocol Violation|0
7736375|NCT00641056|12166982|FG000|Overall Study|Entry Criteria Not Met|3
7736376|NCT00641056|12166983|FG001|Overall Study|Entry Criteria Not Met|0
7736377|NCT00641056|12166982|FG000|Overall Study|Subject Decision|6
7736378|NCT00641056|12166983|FG001|Overall Study|Subject Decision|19
7736379|NCT00641056|12166982|FG000|Overall Study|Sponsor Decision|1
7736380|NCT00641056|12166983|FG001|Overall Study|Sponsor Decision|2
7736381|NCT00641147|12166995|FG000|Completed 4 Months.|Physician Decision|1
7736382|NCT00641147|12166996|FG001|Completed 4 Months.|Physician Decision|0
7736383|NCT00641147|12166995|FG000|Completed 4 Months.|Adverse Event|1
7736384|NCT00641147|12166996|FG001|Completed 4 Months.|Adverse Event|0
7736385|NCT00641147|12166995|FG000|Completed 8 Months.|Physician Decision|2
7736386|NCT00641147|12166996|FG001|Completed 8 Months.|Physician Decision|1
7736387|NCT00641147|12166995|FG000|Completed 8 Months.|non compliance|1
7736388|NCT00641147|12166996|FG001|Completed 8 Months.|non compliance|0
7736389|NCT00641147|12166995|FG000|Completed 8 Months.|Withdrawal by Subject|0
7736390|NCT00641147|12166996|FG001|Completed 8 Months.|Withdrawal by Subject|1
7736391|NCT00641147|12166995|FG000|Completed 12 Months.|Physician Decision|1
7736392|NCT00641147|12166996|FG001|Completed 12 Months.|Physician Decision|1
7736393|NCT00641147|12166995|FG000|Completed 12 Months.|Withdrawal by Subject|0
7736394|NCT00641147|12166996|FG001|Completed 12 Months.|Withdrawal by Subject|1
7736395|NCT00641147|12166995|FG000|Completed 16 Months.|Physician Decision|1
7736396|NCT00641147|12166996|FG001|Completed 16 Months.|Physician Decision|0
7736397|NCT00641147|12166995|FG000|Completed 16 Months.|Lost to Follow-up|1
7736398|NCT00641147|12166996|FG001|Completed 16 Months.|Lost to Follow-up|0
7736399|NCT00641667|12167017|FG000|Overall Study|Withdrawal by Subject|1
7736400|NCT00641667|12167017|FG000|Overall Study|Adverse Event|1
7736401|NCT00641667|12167017|FG000|Overall Study|Physician Decision|1
7736402|NCT00641667|12167017|FG000|Overall Study|Worsening of underlying disease|3
7736403|NCT00641706|12167023|FG000|Overall Study|Adverse Event|2
7736404|NCT00641706|12167024|FG001|Overall Study|Adverse Event|1
7736405|NCT00641706|12167023|FG000|Overall Study|Withdrawal by Subject|6
7736406|NCT00641706|12167024|FG001|Overall Study|Withdrawal by Subject|1
7736407|NCT00641706|12167023|FG000|Overall Study|Clinical Decline|1
7736408|NCT00641706|12167024|FG001|Overall Study|Clinical Decline|0
7736409|NCT00641706|12167023|FG000|Overall Study|Lead Investigator Decision|0
7736410|NCT00641706|12167024|FG001|Overall Study|Lead Investigator Decision|1
7736411|NCT00641719|12167032|FG000|Overall Study|Lack of Efficacy|1
7736412|NCT00641719|12167033|FG001|Overall Study|Lack of Efficacy|2
7736413|NCT00641719|12167032|FG000|Overall Study|Adverse Event|24
7736414|NCT00641719|12167033|FG001|Overall Study|Adverse Event|29
7736415|NCT00641719|12167032|FG000|Overall Study|Withdrawal by Subject|4
7736416|NCT00641719|12167033|FG001|Overall Study|Withdrawal by Subject|4
7736417|NCT00641719|12167032|FG000|Overall Study|Reason Not Specified|1
7736418|NCT00641719|12167033|FG001|Overall Study|Reason Not Specified|2
7736419|NCT00642018|12167068|FG000|Overall Study|Adverse Event|11
7736420|NCT00642018|12167069|FG001|Overall Study|Adverse Event|36
7736421|NCT00642018|12167068|FG000|Overall Study|Withdrawal by Subject|4
7736422|NCT00642018|12167069|FG001|Overall Study|Withdrawal by Subject|10
7736423|NCT00642018|12167068|FG000|Overall Study|Progressive Disease|13
7736424|NCT00642018|12167069|FG001|Overall Study|Progressive Disease|18
7736425|NCT00642018|12167068|FG000|Overall Study|Physician Decision|0
7736426|NCT00642018|12167069|FG001|Overall Study|Physician Decision|10
7736427|NCT00642018|12167068|FG000|Overall Study|Protocol Violation|0
7736428|NCT00642018|12167069|FG001|Overall Study|Protocol Violation|1
7736429|NCT00642018|12167068|FG000|Overall Study|Death|0
7736430|NCT00642018|12167069|FG001|Overall Study|Death|3
7736431|NCT00642018|12167068|FG000|Overall Study|Entry Criteria Not Met|0
7736432|NCT00642018|12167069|FG001|Overall Study|Entry Criteria Not Met|1
7736433|NCT00642174|12167078|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0
7736434|NCT00642174|12167079|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1
7736435|NCT00642278|12167092|FG000|Overall Study|Adverse Event|2
7736436|NCT00642278|12167093|FG001|Overall Study|Adverse Event|1
7736437|NCT00642278|12167094|FG002|Overall Study|Adverse Event|3
7736438|NCT00642278|12167095|FG003|Overall Study|Adverse Event|1
7736439|NCT00642278|12167096|FG004|Overall Study|Adverse Event|2
7736440|NCT00642278|12167097|FG005|Overall Study|Adverse Event|2
7736441|NCT00642278|12167098|FG006|Overall Study|Adverse Event|0
7736442|NCT00642278|12167092|FG000|Overall Study|Lack of Efficacy|0
7736443|NCT00642278|12167093|FG001|Overall Study|Lack of Efficacy|1
7736444|NCT00642278|12167094|FG002|Overall Study|Lack of Efficacy|0
7736445|NCT00642278|12167095|FG003|Overall Study|Lack of Efficacy|0
7736446|NCT00642278|12167096|FG004|Overall Study|Lack of Efficacy|0
7736447|NCT00642278|12167097|FG005|Overall Study|Lack of Efficacy|0
7736448|NCT00642278|12167098|FG006|Overall Study|Lack of Efficacy|0
7736449|NCT00642278|12167092|FG000|Overall Study|Lost to Follow-up|5
7736450|NCT00642278|12167093|FG001|Overall Study|Lost to Follow-up|1
7736451|NCT00642278|12167094|FG002|Overall Study|Lost to Follow-up|0
7736452|NCT00642278|12167095|FG003|Overall Study|Lost to Follow-up|1
7736453|NCT00642278|12167096|FG004|Overall Study|Lost to Follow-up|0
7736454|NCT00642278|12167097|FG005|Overall Study|Lost to Follow-up|1
7736455|NCT00642278|12167098|FG006|Overall Study|Lost to Follow-up|1
7736456|NCT00642278|12167092|FG000|Overall Study|Physician Decision|0
7736457|NCT00642278|12167093|FG001|Overall Study|Physician Decision|0
7736458|NCT00642278|12167094|FG002|Overall Study|Physician Decision|0
7736459|NCT00642278|12167095|FG003|Overall Study|Physician Decision|1
7736460|NCT00642278|12167096|FG004|Overall Study|Physician Decision|0
7736461|NCT00642278|12167097|FG005|Overall Study|Physician Decision|0
7736462|NCT00642278|12167098|FG006|Overall Study|Physician Decision|0
7736463|NCT00642278|12167092|FG000|Overall Study|Protocol Violation|0
7736464|NCT00642278|12167093|FG001|Overall Study|Protocol Violation|0
7736465|NCT00642278|12167094|FG002|Overall Study|Protocol Violation|1
7736466|NCT00642278|12167095|FG003|Overall Study|Protocol Violation|1
7736467|NCT00642278|12167096|FG004|Overall Study|Protocol Violation|0
7736468|NCT00642278|12167097|FG005|Overall Study|Protocol Violation|1
7736469|NCT00642278|12167098|FG006|Overall Study|Protocol Violation|2
7736470|NCT00642278|12167092|FG000|Overall Study|Withdrawal by Subject|1
7736471|NCT00642278|12167093|FG001|Overall Study|Withdrawal by Subject|1
7736472|NCT00642278|12167094|FG002|Overall Study|Withdrawal by Subject|1
7736473|NCT00642278|12167095|FG003|Overall Study|Withdrawal by Subject|3
7736474|NCT00642278|12167096|FG004|Overall Study|Withdrawal by Subject|6
7736475|NCT00642278|12167097|FG005|Overall Study|Withdrawal by Subject|2
7736476|NCT00642278|12167098|FG006|Overall Study|Withdrawal by Subject|2
7736477|NCT00642278|12167092|FG000|Overall Study|Noncompliance with study drug regimen|0
7736478|NCT00642278|12167093|FG001|Overall Study|Noncompliance with study drug regimen|0
7736479|NCT00642278|12167094|FG002|Overall Study|Noncompliance with study drug regimen|0
7736480|NCT00642278|12167095|FG003|Overall Study|Noncompliance with study drug regimen|1
7736481|NCT00642278|12167096|FG004|Overall Study|Noncompliance with study drug regimen|0
7736482|NCT00642278|12167097|FG005|Overall Study|Noncompliance with study drug regimen|0
7736483|NCT00642278|12167098|FG006|Overall Study|Noncompliance with study drug regimen|0
7736484|NCT00642278|12167092|FG000|Overall Study|Other|2
7736485|NCT00642278|12167093|FG001|Overall Study|Other|1
7736486|NCT00642278|12167094|FG002|Overall Study|Other|0
7736487|NCT00642278|12167095|FG003|Overall Study|Other|1
7736488|NCT00642278|12167096|FG004|Overall Study|Other|0
7736489|NCT00642278|12167097|FG005|Overall Study|Other|1
7736490|NCT00642278|12167098|FG006|Overall Study|Other|0
7736491|NCT00642304|12167114|FG000|Overall Study|Adverse Event|1
7736492|NCT00642304|12167114|FG000|Overall Study|Death|1
7736493|NCT00642304|12167114|FG000|Overall Study|Blood transfusion|2
7736494|NCT00642304|12167114|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1
7736495|NCT00642304|12167114|FG000|Overall Study|Transplantation|1
7736496|NCT00642356|12167120|FG000|Overall Study|Adverse Event|1
7736497|NCT00642356|12167121|FG001|Overall Study|Adverse Event|0
7736498|NCT00642356|12167120|FG000|Overall Study|Protocol Violation|0
7736499|NCT00642356|12167121|FG001|Overall Study|Protocol Violation|3
7736500|NCT00642356|12167120|FG000|Overall Study|Lack of Efficacy|1
7736501|NCT00642356|12167121|FG001|Overall Study|Lack of Efficacy|0
7736502|NCT00642369|12167129|FG000|Overall Study|Adverse Event|2
7736503|NCT00642369|12167130|FG001|Overall Study|Adverse Event|3
7736504|NCT00642369|12167129|FG000|Overall Study|Withdrawal by Subject|1
7736505|NCT00642369|12167130|FG001|Overall Study|Withdrawal by Subject|0
7736506|NCT00642369|12167129|FG000|Overall Study|misdiagnosis|0
7736507|NCT00642369|12167130|FG001|Overall Study|misdiagnosis|1
7736508|NCT00642369|12167129|FG000|Overall Study|Lack of Efficacy|2
7736509|NCT00642369|12167130|FG001|Overall Study|Lack of Efficacy|2
7736510|NCT00642460|12167140|FG000|Part I: 12 Week Double-Blind|Adverse Event|0
7736511|NCT00642460|12167141|FG001|Part I: 12 Week Double-Blind|Adverse Event|1
7736512|NCT00642460|12167142|FG002|Part I: 12 Week Double-Blind|Adverse Event|1
7736513|NCT00642460|12167143|FG003|Part I: 12 Week Double-Blind|Adverse Event|0
7736514|NCT00642460|12167144|FG004|Part I: 12 Week Double-Blind|Adverse Event|0
7736515|NCT00642460|12167145|FG005|Part I: 12 Week Double-Blind|Adverse Event|0
7736516|NCT00642460|12167140|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1
7736517|NCT00642460|12167141|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0
7736518|NCT00642460|12167142|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0
7736519|NCT00642460|12167143|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0
7736520|NCT00642460|12167144|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0
7736521|NCT00642460|12167145|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0
7736522|NCT00642460|12167140|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4
7736523|NCT00642460|12167141|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2
7736524|NCT00642460|12167142|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0
7736525|NCT00642460|12167143|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0
7736526|NCT00642460|12167144|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0
7736527|NCT00642460|12167145|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0
7736528|NCT00642460|12167140|FG000|Part II: Open-Label Up to Week 92|Death|0
7736529|NCT00642460|12167141|FG001|Part II: Open-Label Up to Week 92|Death|1
7736530|NCT00642460|12167142|FG002|Part II: Open-Label Up to Week 92|Death|0
7736531|NCT00642460|12167143|FG003|Part II: Open-Label Up to Week 92|Death|2
7736532|NCT00642460|12167144|FG004|Part II: Open-Label Up to Week 92|Death|0
7736533|NCT00642460|12167145|FG005|Part II: Open-Label Up to Week 92|Death|0
7736534|NCT00642460|12167140|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
7736535|NCT00642460|12167141|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
7736536|NCT00642460|12167142|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
7736537|NCT00642460|12167143|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
7736538|NCT00642460|12167144|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
7736539|NCT00642460|12167145|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
7736540|NCT00642460|12167140|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3
7736541|NCT00642460|12167141|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1
7736542|NCT00642460|12167142|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0
7736543|NCT00642460|12167143|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0
7736544|NCT00642460|12167144|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0
7736545|NCT00642460|12167145|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0
7736546|NCT00642460|12167140|FG000|Part II: Open-Label Up to Week 92|Failure to return|0
7736547|NCT00642460|12167141|FG001|Part II: Open-Label Up to Week 92|Failure to return|1
7736548|NCT00642460|12167142|FG002|Part II: Open-Label Up to Week 92|Failure to return|0
7736549|NCT00642460|12167143|FG003|Part II: Open-Label Up to Week 92|Failure to return|0
7736550|NCT00642460|12167144|FG004|Part II: Open-Label Up to Week 92|Failure to return|0
7736551|NCT00642460|12167145|FG005|Part II: Open-Label Up to Week 92|Failure to return|0
7736552|NCT00642460|12167140|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0
7736553|NCT00642460|12167141|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0
7736554|NCT00642460|12167142|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0
7736555|NCT00642460|12167143|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1
7736556|NCT00642460|12167144|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0
7736557|NCT00642460|12167145|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0
7736558|NCT00642460|12167140|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0
7736559|NCT00642460|12167141|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0
7736560|NCT00642460|12167142|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0
7736561|NCT00642460|12167143|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0
7736562|NCT00642460|12167144|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7
7736563|NCT00642460|12167145|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6
7736564|NCT00642460|12167140|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
7736565|NCT00642460|12167141|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
7736566|NCT00642460|12167142|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
7736567|NCT00642460|12167143|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
7736568|NCT00642460|12167144|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
7736569|NCT00642460|12167145|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
7736570|NCT00642460|12167140|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
7736571|NCT00642460|12167141|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
7736572|NCT00642460|12167142|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
7736573|NCT00642460|12167143|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
7736574|NCT00642460|12167144|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
7736575|NCT00642460|12167145|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
7736576|NCT00642460|12167140|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
7736577|NCT00642460|12167141|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
7736578|NCT00642460|12167142|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
7736579|NCT00642460|12167143|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
7736580|NCT00642460|12167144|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
7736581|NCT00642460|12167145|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
7736582|NCT00642460|12167140|FG000|Part III: Open-Label Up to Week 260|Other|0
7736583|NCT00642460|12167141|FG001|Part III: Open-Label Up to Week 260|Other|0
7736584|NCT00642460|12167142|FG002|Part III: Open-Label Up to Week 260|Other|0
7736585|NCT00642460|12167143|FG003|Part III: Open-Label Up to Week 260|Other|0
7736586|NCT00642460|12167144|FG004|Part III: Open-Label Up to Week 260|Other|2
7736587|NCT00642460|12167145|FG005|Part III: Open-Label Up to Week 260|Other|2
7736588|NCT00642460|12167140|FG000|Part III: Open-Label Up to Week 260|Death|0
7736589|NCT00642460|12167141|FG001|Part III: Open-Label Up to Week 260|Death|0
7736590|NCT00642460|12167142|FG002|Part III: Open-Label Up to Week 260|Death|0
7736591|NCT00642460|12167143|FG003|Part III: Open-Label Up to Week 260|Death|0
7736592|NCT00642460|12167144|FG004|Part III: Open-Label Up to Week 260|Death|0
7736593|NCT00642460|12167145|FG005|Part III: Open-Label Up to Week 260|Death|3
7736594|NCT00642460|12167140|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0
7736595|NCT00642460|12167141|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0
7736596|NCT00642460|12167142|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0
7736597|NCT00642460|12167143|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0
7736598|NCT00642460|12167144|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0
7736599|NCT00642460|12167145|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1
7736600|NCT00642460|12167140|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0
7736601|NCT00642460|12167141|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0
7736602|NCT00642460|12167142|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0
7736603|NCT00642460|12167143|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0
7736604|NCT00642460|12167144|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8
7736605|NCT00642460|12167145|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3
7736606|NCT00642473|12167157|FG000|Overall Study|Withdrawal by Subject|0
7736607|NCT00642473|12167158|FG001|Overall Study|Withdrawal by Subject|5
7736608|NCT00642473|12167157|FG000|Overall Study|Progression or death|2
7736609|NCT00642473|12167158|FG001|Overall Study|Progression or death|4
7736610|NCT00642473|12167157|FG000|Overall Study|Other|2
7736611|NCT00642473|12167158|FG001|Overall Study|Other|2
7736612|NCT00642616|12167171|FG000|Overall Study|Adverse Event|2
7736613|NCT00642616|12167172|FG001|Overall Study|Adverse Event|0
7736614|NCT00642616|12167173|FG002|Overall Study|Adverse Event|1
7736615|NCT00642616|12167174|FG003|Overall Study|Adverse Event|0
7736616|NCT00642616|12167171|FG000|Overall Study|Study Terminated by Sponsor|7
7736617|NCT00642616|12167172|FG001|Overall Study|Study Terminated by Sponsor|6
7736618|NCT00642616|12167173|FG002|Overall Study|Study Terminated by Sponsor|4
7736619|NCT00642616|12167174|FG003|Overall Study|Study Terminated by Sponsor|5
7736620|NCT00642616|12167171|FG000|Overall Study|Withdrawal by Subject|0
7736621|NCT00642616|12167172|FG001|Overall Study|Withdrawal by Subject|1
7736622|NCT00642616|12167173|FG002|Overall Study|Withdrawal by Subject|1
7736623|NCT00642616|12167174|FG003|Overall Study|Withdrawal by Subject|1
7736624|NCT00642616|12167171|FG000|Overall Study|Protocol Violation|0
7736625|NCT00642616|12167172|FG001|Overall Study|Protocol Violation|0
7736626|NCT00642616|12167173|FG002|Overall Study|Protocol Violation|2
7736627|NCT00642616|12167174|FG003|Overall Study|Protocol Violation|0
7736628|NCT00642616|12167171|FG000|Overall Study|Physician Decision|0
7736629|NCT00642616|12167172|FG001|Overall Study|Physician Decision|0
7736630|NCT00642616|12167173|FG002|Overall Study|Physician Decision|1
7736631|NCT00642616|12167174|FG003|Overall Study|Physician Decision|1
7736632|NCT00642642|12167186|FG000|Treatment & Follow Up|Adverse Event|2
7736633|NCT00642642|12167186|FG000|Treatment & Follow Up|Withdrawal by Subject|5
7736634|NCT00642642|12167186|FG000|Treatment & Follow Up|Lost to Follow-up|10
7736635|NCT00642668|12167196|FG000|Overall Study|Lost to Follow-up|1
7736636|NCT00642668|12167196|FG000|Overall Study|Adverse Event|2
7736637|NCT00642668|12167196|FG000|Overall Study|Death|2
7736638|NCT00642668|12167196|FG000|Overall Study|Insufficient Therapeutic Response|1
7736639|NCT00642668|12167196|FG000|Overall Study|Failure to Return|1
7736640|NCT00642668|12167196|FG000|Overall Study|Dialysis Initiation|5
7736641|NCT00642668|12167196|FG000|Overall Study|Blood Transfusion|2
7736642|NCT00642707|12167213|FG000|Overall Study|Adverse Event|0
7736643|NCT00642707|12167214|FG001|Overall Study|Adverse Event|0
7736644|NCT00642707|12167215|FG002|Overall Study|Adverse Event|0
7736645|NCT00642707|12167216|FG003|Overall Study|Adverse Event|2
7736646|NCT00642707|12167213|FG000|Overall Study|Withdrawal by Subject|1
7736647|NCT00642707|12167214|FG001|Overall Study|Withdrawal by Subject|0
7736648|NCT00642707|12167215|FG002|Overall Study|Withdrawal by Subject|0
7736649|NCT00642707|12167216|FG003|Overall Study|Withdrawal by Subject|0
7736650|NCT00642746|12167228|FG000|Overall Study|Patient unevaluable|1
7736651|NCT00642746|12167229|FG001|Overall Study|Patient unevaluable|0
7736652|NCT00642759|12167235|FG000|Overall Study|Protocol Violation|1
7736653|NCT00642772|12167240|FG000|Overall Study|Lost to Follow-up|3
7736654|NCT00642772|12167240|FG000|Overall Study|Withdrawal by Subject|7
7736655|NCT00642811|12167250|FG000|Overall Study|Adverse Event|2
7736656|NCT00642811|12167251|FG001|Overall Study|Adverse Event|3
7736657|NCT00642811|12167252|FG002|Overall Study|Adverse Event|0
7736658|NCT00642811|12167253|FG003|Overall Study|Adverse Event|0
7736659|NCT00642811|12167254|FG004|Overall Study|Adverse Event|0
7736660|NCT00642811|12167255|FG005|Overall Study|Adverse Event|1
7736661|NCT00642811|12167250|FG000|Overall Study|Developement of discontinuation criteria|0
7736662|NCT00642811|12167251|FG001|Overall Study|Developement of discontinuation criteria|0
7736663|NCT00642811|12167252|FG002|Overall Study|Developement of discontinuation criteria|0
7736664|NCT00642811|12167253|FG003|Overall Study|Developement of discontinuation criteria|0
7736665|NCT00642811|12167254|FG004|Overall Study|Developement of discontinuation criteria|1
7736666|NCT00642811|12167255|FG005|Overall Study|Developement of discontinuation criteria|0
7736667|NCT00642811|12167250|FG000|Overall Study|Severe Non-compliance to protocol|1
7736668|NCT00642811|12167251|FG001|Overall Study|Severe Non-compliance to protocol|0
7736669|NCT00642811|12167252|FG002|Overall Study|Severe Non-compliance to protocol|0
7736670|NCT00642811|12167253|FG003|Overall Study|Severe Non-compliance to protocol|0
7736671|NCT00642811|12167254|FG004|Overall Study|Severe Non-compliance to protocol|0
7736672|NCT00642811|12167255|FG005|Overall Study|Severe Non-compliance to protocol|0
7736673|NCT00642811|12167250|FG000|Overall Study|Other|0
7736674|NCT00642811|12167251|FG001|Overall Study|Other|1
7736675|NCT00642811|12167252|FG002|Overall Study|Other|0
7736676|NCT00642811|12167253|FG003|Overall Study|Other|1
7736677|NCT00642811|12167254|FG004|Overall Study|Other|0
7736678|NCT00642811|12167255|FG005|Overall Study|Other|0
7736679|NCT00642850|12167269|FG000|Overall Study|Death|7
7736680|NCT00642850|12167269|FG000|Overall Study|Adverse Event|2
7736681|NCT00642850|12167269|FG000|Overall Study|Lack of Efficacy|1
7736682|NCT00642850|12167269|FG000|Overall Study|Protocol Violation|2
7736683|NCT00642850|12167269|FG000|Overall Study|Kidney transplantation|8
7736684|NCT00642850|12167269|FG000|Overall Study|Blood transfusion|6
7736685|NCT00642850|12167269|FG000|Overall Study|Other reasons|7
7736686|NCT00642902|12167277|FG000|Overall Study|Adverse Event|0
7736687|NCT00642902|12167278|FG001|Overall Study|Adverse Event|1
7736688|NCT00642902|12167279|FG002|Overall Study|Adverse Event|3
7736689|NCT00642902|12167280|FG003|Overall Study|Adverse Event|1
7736690|NCT00642902|12167277|FG000|Overall Study|Lost to Follow-up|1
7736691|NCT00642902|12167278|FG001|Overall Study|Lost to Follow-up|1
7736692|NCT00642902|12167279|FG002|Overall Study|Lost to Follow-up|0
7736693|NCT00642902|12167280|FG003|Overall Study|Lost to Follow-up|0
7736694|NCT00642902|12167277|FG000|Overall Study|Lack of Efficacy|0
7736695|NCT00642902|12167278|FG001|Overall Study|Lack of Efficacy|3
7736696|NCT00642902|12167279|FG002|Overall Study|Lack of Efficacy|3
7736697|NCT00642902|12167280|FG003|Overall Study|Lack of Efficacy|0
7736698|NCT00642902|12167277|FG000|Overall Study|Death|1
7736699|NCT00642902|12167278|FG001|Overall Study|Death|0
7736700|NCT00642902|12167279|FG002|Overall Study|Death|0
7736701|NCT00642902|12167280|FG003|Overall Study|Death|0
7736702|NCT00642902|12167277|FG000|Overall Study|Premature termination of clinical trial|37
7736703|NCT00642902|12167278|FG001|Overall Study|Premature termination of clinical trial|32
7736704|NCT00642902|12167279|FG002|Overall Study|Premature termination of clinical trial|35
7736705|NCT00642902|12167280|FG003|Overall Study|Premature termination of clinical trial|35
7736706|NCT00642902|12167277|FG000|Overall Study|Randomized, but not treated|0
7736707|NCT00642902|12167278|FG001|Overall Study|Randomized, but not treated|0
7736708|NCT00642902|12167279|FG002|Overall Study|Randomized, but not treated|1
7736709|NCT00642902|12167280|FG003|Overall Study|Randomized, but not treated|0
7736710|NCT00642902|12167277|FG000|Overall Study|Other|1
7736711|NCT00642902|12167278|FG001|Overall Study|Other|5
7736712|NCT00642902|12167279|FG002|Overall Study|Other|1
7736713|NCT00642902|12167280|FG003|Overall Study|Other|4
7736714|NCT00642941|12167302|FG000|Overall Study|Physician Decision|3
7736715|NCT00642941|12167303|FG001|Overall Study|Physician Decision|1
7736716|NCT00642941|12167304|FG002|Overall Study|Physician Decision|0
7736717|NCT00642941|12167305|FG003|Overall Study|Physician Decision|0
7736718|NCT00642941|12167306|FG004|Overall Study|Physician Decision|0
7736719|NCT00642941|12167307|FG005|Overall Study|Physician Decision|0
7736720|NCT00642941|12167308|FG006|Overall Study|Physician Decision|1
7736721|NCT00642941|12167309|FG007|Overall Study|Physician Decision|0
7736722|NCT00642941|12167310|FG008|Overall Study|Physician Decision|0
7736723|NCT00642941|12167311|FG009|Overall Study|Physician Decision|1
7736724|NCT00642941|12167312|FG010|Overall Study|Physician Decision|0
7736725|NCT00642941|12167313|FG011|Overall Study|Physician Decision|1
7736726|NCT00642941|12167302|FG000|Overall Study|Death|4
7736727|NCT00642941|12167303|FG001|Overall Study|Death|0
7736728|NCT00642941|12167304|FG002|Overall Study|Death|1
7736729|NCT00642941|12167305|FG003|Overall Study|Death|1
7736730|NCT00642941|12167306|FG004|Overall Study|Death|2
7736731|NCT00642941|12167307|FG005|Overall Study|Death|1
7736732|NCT00642941|12167308|FG006|Overall Study|Death|0
7736733|NCT00642941|12167309|FG007|Overall Study|Death|0
7736734|NCT00642941|12167310|FG008|Overall Study|Death|0
7736735|NCT00642941|12167311|FG009|Overall Study|Death|0
7736736|NCT00642941|12167312|FG010|Overall Study|Death|0
7736737|NCT00642941|12167313|FG011|Overall Study|Death|1
7736738|NCT00642941|12167302|FG000|Overall Study|Study closed by Sponsor|0
7736739|NCT00642941|12167303|FG001|Overall Study|Study closed by Sponsor|1
7736740|NCT00642941|12167304|FG002|Overall Study|Study closed by Sponsor|0
7736741|NCT00642941|12167305|FG003|Overall Study|Study closed by Sponsor|0
7736742|NCT00642941|12167306|FG004|Overall Study|Study closed by Sponsor|0
7736743|NCT00642941|12167307|FG005|Overall Study|Study closed by Sponsor|0
7736744|NCT00642941|12167308|FG006|Overall Study|Study closed by Sponsor|0
7736745|NCT00642941|12167309|FG007|Overall Study|Study closed by Sponsor|0
7736746|NCT00642941|12167310|FG008|Overall Study|Study closed by Sponsor|0
7736747|NCT00642941|12167311|FG009|Overall Study|Study closed by Sponsor|0
7736748|NCT00642941|12167312|FG010|Overall Study|Study closed by Sponsor|0
7736749|NCT00642941|12167313|FG011|Overall Study|Study closed by Sponsor|0
7736750|NCT00642941|12167302|FG000|Overall Study|Withdrawal by Subject|1
7736751|NCT00642941|12167303|FG001|Overall Study|Withdrawal by Subject|0
7736752|NCT00642941|12167304|FG002|Overall Study|Withdrawal by Subject|0
7736753|NCT00642941|12167305|FG003|Overall Study|Withdrawal by Subject|2
7736754|NCT00642941|12167306|FG004|Overall Study|Withdrawal by Subject|0
7736755|NCT00642941|12167307|FG005|Overall Study|Withdrawal by Subject|0
7736756|NCT00642941|12167308|FG006|Overall Study|Withdrawal by Subject|2
7736757|NCT00642941|12167309|FG007|Overall Study|Withdrawal by Subject|0
7736758|NCT00642941|12167310|FG008|Overall Study|Withdrawal by Subject|1
7736759|NCT00642941|12167311|FG009|Overall Study|Withdrawal by Subject|0
7736760|NCT00642941|12167312|FG010|Overall Study|Withdrawal by Subject|0
7736761|NCT00642941|12167313|FG011|Overall Study|Withdrawal by Subject|1
7736762|NCT00642941|12167302|FG000|Overall Study|Protocol Violation|0
7736763|NCT00642941|12167303|FG001|Overall Study|Protocol Violation|0
7736764|NCT00642941|12167304|FG002|Overall Study|Protocol Violation|0
7736765|NCT00642941|12167305|FG003|Overall Study|Protocol Violation|0
7736766|NCT00642941|12167306|FG004|Overall Study|Protocol Violation|0
7736767|NCT00642941|12167307|FG005|Overall Study|Protocol Violation|0
7736768|NCT00642941|12167308|FG006|Overall Study|Protocol Violation|1
7736769|NCT00642941|12167309|FG007|Overall Study|Protocol Violation|0
7736770|NCT00642941|12167310|FG008|Overall Study|Protocol Violation|0
7736771|NCT00642941|12167311|FG009|Overall Study|Protocol Violation|0
7736772|NCT00642941|12167312|FG010|Overall Study|Protocol Violation|0
7736773|NCT00642941|12167313|FG011|Overall Study|Protocol Violation|0
7736774|NCT00642941|12167302|FG000|Overall Study|Adverse Event|1
7736775|NCT00642941|12167303|FG001|Overall Study|Adverse Event|1
7736776|NCT00642941|12167304|FG002|Overall Study|Adverse Event|0
7736777|NCT00642941|12167305|FG003|Overall Study|Adverse Event|0
7736778|NCT00642941|12167306|FG004|Overall Study|Adverse Event|0
7736779|NCT00642941|12167307|FG005|Overall Study|Adverse Event|0
7736780|NCT00642941|12167308|FG006|Overall Study|Adverse Event|1
7736781|NCT00642941|12167309|FG007|Overall Study|Adverse Event|1
7736782|NCT00642941|12167310|FG008|Overall Study|Adverse Event|0
7736783|NCT00642941|12167311|FG009|Overall Study|Adverse Event|1
7736784|NCT00642941|12167312|FG010|Overall Study|Adverse Event|0
7736785|NCT00642941|12167313|FG011|Overall Study|Adverse Event|0
7736786|NCT00642941|12167302|FG000|Overall Study|Other|1
7736787|NCT00642941|12167303|FG001|Overall Study|Other|1
7736788|NCT00642941|12167304|FG002|Overall Study|Other|1
7736789|NCT00642941|12167305|FG003|Overall Study|Other|1
7736790|NCT00642941|12167306|FG004|Overall Study|Other|0
7736791|NCT00642941|12167307|FG005|Overall Study|Other|1
7736792|NCT00642941|12167308|FG006|Overall Study|Other|0
7736793|NCT00642941|12167309|FG007|Overall Study|Other|1
7736794|NCT00642941|12167310|FG008|Overall Study|Other|0
7736795|NCT00642941|12167311|FG009|Overall Study|Other|0
7736796|NCT00642941|12167312|FG010|Overall Study|Other|0
7736797|NCT00642941|12167313|FG011|Overall Study|Other|1
7736798|NCT00642941|12167302|FG000|Overall Study|Disease progression|60
7736799|NCT00642941|12167303|FG001|Overall Study|Disease progression|50
7736800|NCT00642941|12167304|FG002|Overall Study|Disease progression|5
7736801|NCT00642941|12167305|FG003|Overall Study|Disease progression|36
7736802|NCT00642941|12167306|FG004|Overall Study|Disease progression|23
7736803|NCT00642941|12167307|FG005|Overall Study|Disease progression|39
7736804|NCT00642941|12167308|FG006|Overall Study|Disease progression|18
7736805|NCT00642941|12167309|FG007|Overall Study|Disease progression|12
7736806|NCT00642941|12167310|FG008|Overall Study|Disease progression|10
7736807|NCT00642941|12167311|FG009|Overall Study|Disease progression|7
7736808|NCT00642941|12167312|FG010|Overall Study|Disease progression|12
7736809|NCT00642941|12167313|FG011|Overall Study|Disease progression|7
7736810|NCT00642954|12167365|FG000|Overall Study|Progressive Disease|3
7736811|NCT00642954|12167366|FG001|Overall Study|Progressive Disease|3
7736812|NCT00642954|12167367|FG002|Overall Study|Progressive Disease|3
7736813|NCT00642954|12167368|FG003|Overall Study|Progressive Disease|3
7736814|NCT00642954|12167369|FG004|Overall Study|Progressive Disease|9
7736815|NCT00642954|12167365|FG000|Overall Study|Withdrawal by Subject|0
7736816|NCT00642954|12167366|FG001|Overall Study|Withdrawal by Subject|0
7736817|NCT00642954|12167367|FG002|Overall Study|Withdrawal by Subject|0
7736818|NCT00642954|12167368|FG003|Overall Study|Withdrawal by Subject|0
7736819|NCT00642954|12167369|FG004|Overall Study|Withdrawal by Subject|1
7736820|NCT00642954|12167365|FG000|Overall Study|Adverse Event|1
7736821|NCT00642954|12167366|FG001|Overall Study|Adverse Event|1
7736822|NCT00642954|12167367|FG002|Overall Study|Adverse Event|0
7736823|NCT00642954|12167368|FG003|Overall Study|Adverse Event|0
7736824|NCT00642954|12167369|FG004|Overall Study|Adverse Event|6
7736825|NCT00642993|12167383|FG000|Overall Study|Adverse Event|85
7736826|NCT00642993|12167384|FG001|Overall Study|Adverse Event|4
7736827|NCT00642993|12167383|FG000|Overall Study|Lost to Follow-up|8
7736828|NCT00642993|12167384|FG001|Overall Study|Lost to Follow-up|4
7736829|NCT00642993|12167383|FG000|Overall Study|Withdrew - reason unrelated to treatment|11
7736830|NCT00642993|12167384|FG001|Overall Study|Withdrew - reason unrelated to treatment|3
7736831|NCT00642993|12167383|FG000|Overall Study|Protocol Violation|1
7736832|NCT00642993|12167384|FG001|Overall Study|Protocol Violation|4
7736833|NCT00642993|12167383|FG000|Overall Study|Did not meet protocol eligibility|0
7736834|NCT00642993|12167384|FG001|Overall Study|Did not meet protocol eligibility|1
7736835|NCT00642993|12167383|FG000|Overall Study|Administrative|1
7736836|NCT00642993|12167384|FG001|Overall Study|Administrative|0
7736837|NCT00643006|12167392|FG000|Overall Study|Lost to Follow-up|5
7736838|NCT00643006|12167393|FG001|Overall Study|Lost to Follow-up|4
7736839|NCT00643123|12167416|FG000|Overall Study|Lost to Follow-up|4
7736840|NCT00643123|12167417|FG001|Overall Study|Lost to Follow-up|0
7736841|NCT00643123|12167416|FG000|Overall Study|Withdrawal by Subject|1
7736842|NCT00643123|12167417|FG001|Overall Study|Withdrawal by Subject|1
7736843|NCT00643162|12167425|FG000|Overall Study|Withdrawal by Subject|1
7736844|NCT00643162|12167426|FG001|Overall Study|Withdrawal by Subject|1
7736845|NCT00643201|12167434|FG000|Randomized, Completed 6 Months of Study|Death|20
7736846|NCT00643201|12167435|FG001|Randomized, Completed 6 Months of Study|Death|26
7736847|NCT00643201|12167434|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150
7736848|NCT00643201|12167435|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182
7736849|NCT00643201|12167434|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
7736850|NCT00643201|12167435|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
7736851|NCT00643201|12167434|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
7736852|NCT00643201|12167435|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
7736853|NCT00643201|12167434|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
7736854|NCT00643201|12167435|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
7736855|NCT00643201|12167434|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3
7736856|NCT00643201|12167435|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2
7736857|NCT00643201|12167434|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
7736858|NCT00643201|12167435|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
7736859|NCT00643201|12167434|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1
7736860|NCT00643201|12167435|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1
7736861|NCT00643201|12167434|FG000|Randomized, Completed 6 Months of Study|Other|107
7736862|NCT00643201|12167435|FG001|Randomized, Completed 6 Months of Study|Other|107
7736863|NCT00643201|12167434|FG000|Completed Study Follow Up|Death|28
7736864|NCT00643201|12167435|FG001|Completed Study Follow Up|Death|34
7736865|NCT00643201|12167434|FG000|Completed Study Follow Up|Withdrawal by Subject|23
7736866|NCT00643201|12167435|FG001|Completed Study Follow Up|Withdrawal by Subject|29
7736867|NCT00643201|12167434|FG000|Completed Study Follow Up|Lost to Follow-up|18
7736868|NCT00643201|12167435|FG001|Completed Study Follow Up|Lost to Follow-up|16
7736869|NCT00643201|12167434|FG000|Completed Study Follow Up|non-specified|1
7736870|NCT00643201|12167435|FG001|Completed Study Follow Up|non-specified|0
7736871|NCT00643279|12167445|FG000|Overall Study|Death|13
7736872|NCT00643279|12167446|FG001|Overall Study|Death|11
7736873|NCT00643279|12167445|FG000|Overall Study|Withdrawal by Subject|3
7736874|NCT00643279|12167446|FG001|Overall Study|Withdrawal by Subject|0
7736875|NCT00643279|12167445|FG000|Overall Study|Lost to Follow-up|0
7736876|NCT00643279|12167446|FG001|Overall Study|Lost to Follow-up|1
7736877|NCT00643279|12167445|FG000|Overall Study|Physician Decision|0
7736878|NCT00643279|12167446|FG001|Overall Study|Physician Decision|1
7736879|NCT00643448|12167457|FG000|Overall Study|Lack of Efficacy|2
7736880|NCT00643448|12167458|FG001|Overall Study|Lack of Efficacy|0
7736881|NCT00643448|12167459|FG002|Overall Study|Lack of Efficacy|4
7736882|NCT00643448|12167457|FG000|Overall Study|Adverse Event|2
7736883|NCT00643448|12167458|FG001|Overall Study|Adverse Event|2
7736884|NCT00643448|12167459|FG002|Overall Study|Adverse Event|2
7736885|NCT00643448|12167457|FG000|Overall Study|QTcF>550 ms|0
7736886|NCT00643448|12167458|FG001|Overall Study|QTcF>550 ms|3
7736887|NCT00643448|12167459|FG002|Overall Study|QTcF>550 ms|0
7736888|NCT00643487|12167469|FG000|Overall Study|Technical difficulty|3
7736889|NCT00643565|12167475|FG000|Overall Study|Death|12
7736890|NCT00643565|12167476|FG001|Overall Study|Death|11
7736891|NCT00643565|12167475|FG000|Overall Study|Withdrawal by Subject|4
7736892|NCT00643565|12167476|FG001|Overall Study|Withdrawal by Subject|1
7736893|NCT00643565|12167475|FG000|Overall Study|Lost to Follow-up|0
7736894|NCT00643565|12167476|FG001|Overall Study|Lost to Follow-up|6
7736895|NCT00643565|12167475|FG000|Overall Study|Other|7
7736896|NCT00643565|12167476|FG001|Overall Study|Other|8
7736897|NCT00643565|12167475|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0
7736898|NCT00643565|12167476|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1
7736899|NCT00643565|12167475|FG000|Overall Study|Recurrence of Disease|2
7736900|NCT00643565|12167476|FG001|Overall Study|Recurrence of Disease|1
7736901|NCT00643565|12167475|FG000|Overall Study|Progression of Disease|18
7736902|NCT00643565|12167476|FG001|Overall Study|Progression of Disease|14
7736903|NCT00643565|12167475|FG000|Overall Study|Protocol Violation|3
7736904|NCT00643565|12167476|FG001|Overall Study|Protocol Violation|0
7736905|NCT00643565|12167475|FG000|Overall Study|Did Not Cooperate|0
7736906|NCT00643565|12167476|FG001|Overall Study|Did Not Cooperate|1
7736907|NCT00643565|12167475|FG000|Overall Study|Administrative|22
7736908|NCT00643565|12167476|FG001|Overall Study|Administrative|16
7736909|NCT00643565|12167475|FG000|Overall Study|Adverse Event|5
7736910|NCT00643565|12167476|FG001|Overall Study|Adverse Event|8
7736911|NCT00643604|12167492|FG000|Overall Study|Death|1
7736912|NCT00643682|12167498|FG000|Overall Study|did not keep appointment|522
7736913|NCT00643682|12167499|FG001|Overall Study|did not keep appointment|509
7736914|NCT00643760|12167510|FG000|Overall Study|Adverse Event|11
7736915|NCT00643760|12167511|FG001|Overall Study|Adverse Event|5
7736916|NCT00643760|12167512|FG002|Overall Study|Adverse Event|12
7736917|NCT00643760|12167513|FG003|Overall Study|Adverse Event|21
7736918|NCT00643760|12167514|FG004|Overall Study|Adverse Event|6
7736919|NCT00643760|12167510|FG000|Overall Study|Lack of Efficacy|3
7736920|NCT00643760|12167511|FG001|Overall Study|Lack of Efficacy|1
7736921|NCT00643760|12167512|FG002|Overall Study|Lack of Efficacy|0
7736922|NCT00643760|12167513|FG003|Overall Study|Lack of Efficacy|4
7736923|NCT00643760|12167514|FG004|Overall Study|Lack of Efficacy|3
7736924|NCT00643760|12167510|FG000|Overall Study|Protocol Violation|7
7736925|NCT00643760|12167511|FG001|Overall Study|Protocol Violation|6
7736926|NCT00643760|12167512|FG002|Overall Study|Protocol Violation|4
7736927|NCT00643760|12167513|FG003|Overall Study|Protocol Violation|4
7736928|NCT00643760|12167514|FG004|Overall Study|Protocol Violation|6
7736929|NCT00643760|12167510|FG000|Overall Study|Lost to Follow-up|6
7736930|NCT00643760|12167511|FG001|Overall Study|Lost to Follow-up|2
7736931|NCT00643760|12167512|FG002|Overall Study|Lost to Follow-up|1
7736932|NCT00643760|12167513|FG003|Overall Study|Lost to Follow-up|3
7736933|NCT00643760|12167514|FG004|Overall Study|Lost to Follow-up|3
7736934|NCT00643760|12167510|FG000|Overall Study|Investigator Discretion|0
7736935|NCT00643760|12167511|FG001|Overall Study|Investigator Discretion|0
7736936|NCT00643760|12167512|FG002|Overall Study|Investigator Discretion|0
7736937|NCT00643760|12167513|FG003|Overall Study|Investigator Discretion|2
7736938|NCT00643760|12167514|FG004|Overall Study|Investigator Discretion|0
7736939|NCT00643760|12167510|FG000|Overall Study|Withdrawal by Subject|3
7736940|NCT00643760|12167511|FG001|Overall Study|Withdrawal by Subject|1
7736941|NCT00643760|12167512|FG002|Overall Study|Withdrawal by Subject|2
7736942|NCT00643760|12167513|FG003|Overall Study|Withdrawal by Subject|4
7736943|NCT00643760|12167514|FG004|Overall Study|Withdrawal by Subject|1
7736944|NCT00643851|12167529|FG000|Overall Study|Death|0
7736945|NCT00643851|12167530|FG001|Overall Study|Death|1
7736946|NCT00643851|12167531|FG002|Overall Study|Death|0
7736947|NCT00643851|12167529|FG000|Overall Study|Lack of Efficacy|0
7736948|NCT00643851|12167530|FG001|Overall Study|Lack of Efficacy|1
7736949|NCT00643851|12167531|FG002|Overall Study|Lack of Efficacy|0
7736950|NCT00643851|12167529|FG000|Overall Study|Adverse Event|2
7736951|NCT00643851|12167530|FG001|Overall Study|Adverse Event|6
7736952|NCT00643851|12167531|FG002|Overall Study|Adverse Event|6
7736953|NCT00643851|12167529|FG000|Overall Study|Lost to Follow-up|4
7736954|NCT00643851|12167530|FG001|Overall Study|Lost to Follow-up|6
7736955|NCT00643851|12167531|FG002|Overall Study|Lost to Follow-up|9
7736956|NCT00643851|12167529|FG000|Overall Study|Withdrawal by Subject|8
7736957|NCT00643851|12167530|FG001|Overall Study|Withdrawal by Subject|15
7736958|NCT00643851|12167531|FG002|Overall Study|Withdrawal by Subject|9
7736959|NCT00643851|12167529|FG000|Overall Study|Non-compl., not met criteria, etc.|3
7736960|NCT00643851|12167530|FG001|Overall Study|Non-compl., not met criteria, etc.|4
7736961|NCT00643851|12167531|FG002|Overall Study|Non-compl., not met criteria, etc.|6
7736962|NCT00643916|12167545|FG000|Overall Study|Protocol Violation|0
7736963|NCT00643916|12167546|FG001|Overall Study|Protocol Violation|1
7736964|NCT00643916|12167547|FG002|Overall Study|Protocol Violation|1
7736965|NCT00643916|12167548|FG003|Overall Study|Protocol Violation|1
7736966|NCT00643916|12167549|FG004|Overall Study|Protocol Violation|0
7736967|NCT00643916|12167550|FG005|Overall Study|Protocol Violation|0
7736968|NCT00643916|12167545|FG000|Overall Study|Lost to Follow-up|0
7736969|NCT00643916|12167546|FG001|Overall Study|Lost to Follow-up|1
7736970|NCT00643916|12167547|FG002|Overall Study|Lost to Follow-up|0
7736971|NCT00643916|12167548|FG003|Overall Study|Lost to Follow-up|0
7736972|NCT00643916|12167549|FG004|Overall Study|Lost to Follow-up|0
7736973|NCT00643916|12167550|FG005|Overall Study|Lost to Follow-up|0
7736974|NCT00643916|12167545|FG000|Overall Study|Withdrawal by Subject|2
7736975|NCT00643916|12167546|FG001|Overall Study|Withdrawal by Subject|2
7736976|NCT00643916|12167547|FG002|Overall Study|Withdrawal by Subject|2
7736977|NCT00643916|12167548|FG003|Overall Study|Withdrawal by Subject|1
7736978|NCT00643916|12167549|FG004|Overall Study|Withdrawal by Subject|0
7736979|NCT00643916|12167550|FG005|Overall Study|Withdrawal by Subject|1
7736980|NCT00643916|12167545|FG000|Overall Study|Not Vaccinated|2
7736981|NCT00643916|12167546|FG001|Overall Study|Not Vaccinated|2
7736982|NCT00643916|12167547|FG002|Overall Study|Not Vaccinated|3
7736983|NCT00643916|12167548|FG003|Overall Study|Not Vaccinated|0
7736984|NCT00643916|12167549|FG004|Overall Study|Not Vaccinated|2
7736985|NCT00643916|12167550|FG005|Overall Study|Not Vaccinated|0
7736986|NCT00644059|12167567|FG000|Overall Study|Lost to Follow-up|37
7736987|NCT00644059|12167568|FG001|Overall Study|Lost to Follow-up|34
7736988|NCT00644059|12167569|FG002|Overall Study|Lost to Follow-up|16
7736989|NCT00644059|12167567|FG000|Overall Study|Withdrawal by Subject|52
7736990|NCT00644059|12167568|FG001|Overall Study|Withdrawal by Subject|60
7736991|NCT00644059|12167569|FG002|Overall Study|Withdrawal by Subject|30
7736992|NCT00644059|12167567|FG000|Overall Study|Adverse Event|8
7736993|NCT00644059|12167568|FG001|Overall Study|Adverse Event|5
7736994|NCT00644059|12167569|FG002|Overall Study|Adverse Event|1
7736995|NCT00644059|12167567|FG000|Overall Study|Inappropriate Enrollment|1
7736996|NCT00644059|12167568|FG001|Overall Study|Inappropriate Enrollment|3
7736997|NCT00644059|12167569|FG002|Overall Study|Inappropriate Enrollment|0
7736998|NCT00644059|12167567|FG000|Overall Study|Protocol Deviation/violation|20
7736999|NCT00644059|12167568|FG001|Overall Study|Protocol Deviation/violation|19
7737000|NCT00644059|12167569|FG002|Overall Study|Protocol Deviation/violation|15
7737001|NCT00644059|12167567|FG000|Overall Study|Unable to classify|6
7737002|NCT00644059|12167568|FG001|Overall Study|Unable to classify|2
7737003|NCT00644059|12167569|FG002|Overall Study|Unable to classify|3
7737004|NCT00644332|12167627|FG000|Overall Study|Adverse Event|11
7737005|NCT00644332|12167627|FG000|Overall Study|Withdrawal by Subject|6
7737006|NCT00644332|12167627|FG000|Overall Study|Completion Status Unknown|2
7737007|NCT00644332|12167627|FG000|Overall Study|Did Not Meet Eligibility Requirements|1
7737008|NCT00644332|12167627|FG000|Overall Study|Could Not Attend Scheduled Visits|1
7737009|NCT00644358|12167631|FG000|Overall Study|Adverse Event|124
7737010|NCT00644358|12167631|FG000|Overall Study|Lost to Follow-up|105
7737011|NCT00644358|12167631|FG000|Overall Study|Consent Withdrawal|64
7737012|NCT00644358|12167631|FG000|Overall Study|Lack of Effectiveness|39
7737013|NCT00644358|12167631|FG000|Overall Study|Protocol Violation|5
7737014|NCT00644358|12167631|FG000|Overall Study|Noncompliance|14
7737015|NCT00644358|12167631|FG000|Overall Study|Other Unspecified|11
7737016|NCT00644423|12167637|FG000|Overall Study|Lost to Follow-up|1
7737017|NCT00644423|12167638|FG001|Overall Study|Lost to Follow-up|1
7737018|NCT00644787|12167657|FG000|Period 1: Titration Phase|Adverse Event|11
7737019|NCT00644787|12167658|FG001|Period 1: Titration Phase|Adverse Event|0
7737020|NCT00644787|12167659|FG002|Period 1: Titration Phase|Adverse Event|0
7737021|NCT00644787|12167657|FG000|Period 1: Titration Phase|Withdrawal by Subject|2
7737022|NCT00644787|12167658|FG001|Period 1: Titration Phase|Withdrawal by Subject|0
7737023|NCT00644787|12167659|FG002|Period 1: Titration Phase|Withdrawal by Subject|0
7737024|NCT00644787|12167657|FG000|Period 1: Titration Phase|Physician Decision|1
7737025|NCT00644787|12167658|FG001|Period 1: Titration Phase|Physician Decision|0
7737026|NCT00644787|12167659|FG002|Period 1: Titration Phase|Physician Decision|0
7737027|NCT00644787|12167657|FG000|Period 1: Titration Phase|Worsening of underlying disease|5
7737028|NCT00644787|12167658|FG001|Period 1: Titration Phase|Worsening of underlying disease|0
7737029|NCT00644787|12167659|FG002|Period 1: Titration Phase|Worsening of underlying disease|0
7737030|NCT00644787|12167657|FG000|Period 1: Titration Phase|Worsening of complications|1
7737031|NCT00644787|12167658|FG001|Period 1: Titration Phase|Worsening of complications|0
7737032|NCT00644787|12167659|FG002|Period 1: Titration Phase|Worsening of complications|0
7737033|NCT00644787|12167657|FG000|Period 1: Titration Phase|Worsening of symptoms|1
7737034|NCT00644787|12167658|FG001|Period 1: Titration Phase|Worsening of symptoms|0
7737035|NCT00644787|12167659|FG002|Period 1: Titration Phase|Worsening of symptoms|0
7737036|NCT00644787|12167657|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
7737037|NCT00644787|12167658|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
7737038|NCT00644787|12167659|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
7737039|NCT00644787|12167657|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3
7737040|NCT00644787|12167658|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0
7737041|NCT00644787|12167659|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0
7737042|NCT00644787|12167657|FG000|Period 2: Double Blind Phase|Adverse Event|0
7737043|NCT00644787|12167658|FG001|Period 2: Double Blind Phase|Adverse Event|2
7737044|NCT00644787|12167659|FG002|Period 2: Double Blind Phase|Adverse Event|4
7737045|NCT00644787|12167657|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0
7737046|NCT00644787|12167658|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1
7737047|NCT00644787|12167659|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0
7737048|NCT00644787|12167657|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0
7737049|NCT00644787|12167658|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6
7737050|NCT00644787|12167659|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2
7737051|NCT00644787|12167657|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0
7737052|NCT00644787|12167658|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0
7737053|NCT00644787|12167659|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1
7737054|NCT00644878|12167667|FG000|Overall Study|Adverse Event|2
7737055|NCT00644878|12167667|FG000|Overall Study|Abnormal laboratory value|3
7737056|NCT00644878|12167667|FG000|Overall Study|Protocol deviation|2
7737057|NCT00644878|12167667|FG000|Overall Study|Treatment duration completed as per protocol|11
7737058|NCT00644917|12167671|FG000|Overall Study|Withdrawal by Subject|2
7737059|NCT00644969|12167681|FG000|Treatment Phase|Randomized, not treated|1
7737060|NCT00644969|12167682|FG001|Treatment Phase|Randomized, not treated|0
7737061|NCT00644969|12167681|FG000|Treatment Phase|Adverse Event|3
7737062|NCT00644969|12167682|FG001|Treatment Phase|Adverse Event|0
7737063|NCT00644969|12167681|FG000|Treatment Phase|Withdrawal by Subject|4
7737064|NCT00644969|12167682|FG001|Treatment Phase|Withdrawal by Subject|0
7737065|NCT00644969|12167681|FG000|Treatment Phase|Lost to Follow-up|2
7737066|NCT00644969|12167682|FG001|Treatment Phase|Lost to Follow-up|2
7737067|NCT00644969|12167681|FG000|Treatment Phase|Other|4
7737068|NCT00644969|12167682|FG001|Treatment Phase|Other|1
7737069|NCT00644969|12167681|FG000|Post Treatment Phase|Death|1
7737070|NCT00644969|12167682|FG001|Post Treatment Phase|Death|0
7737071|NCT00644969|12167681|FG000|Post Treatment Phase|Withdrawal by Subject|4
7737072|NCT00644969|12167682|FG001|Post Treatment Phase|Withdrawal by Subject|2
7737073|NCT00644969|12167681|FG000|Post Treatment Phase|Lost to Follow-up|4
7737074|NCT00644969|12167682|FG001|Post Treatment Phase|Lost to Follow-up|1
7737075|NCT00644969|12167681|FG000|Post Treatment Phase|Other|1
7737076|NCT00644969|12167682|FG001|Post Treatment Phase|Other|0
7737077|NCT00644995|12167690|FG000|Overall Study|Lost to Follow-up|1
7737078|NCT00644995|12167691|FG001|Overall Study|Lost to Follow-up|4
7737079|NCT00644995|12167690|FG000|Overall Study|Refused|1
7737080|NCT00644995|12167691|FG001|Overall Study|Refused|0
7768942|NCT00865020|12212329|FG001|Overall Study|Abnormal laboratory value(s)|1
7768943|NCT00865020|12212328|FG000|Overall Study|Death|0
7768944|NCT00865020|12212329|FG001|Overall Study|Death|1
7768945|NCT00865020|12212328|FG000|Overall Study|Randomized but discontinued|2
7768946|NCT00865020|12212329|FG001|Overall Study|Randomized but discontinued|4
7768947|NCT00865046|12212338|FG000|Overall Study|Lost to Follow-up|1
7768948|NCT00865046|12212339|FG001|Overall Study|Lost to Follow-up|4
7768949|NCT00865046|12212340|FG002|Overall Study|Lost to Follow-up|0
7768950|NCT00865046|12212338|FG000|Overall Study|Death|0
7768951|NCT00865046|12212339|FG001|Overall Study|Death|1
7768952|NCT00865046|12212340|FG002|Overall Study|Death|1
7768953|NCT00865046|12212338|FG000|Overall Study|Withdrawal by Subject|5
7768954|NCT00865046|12212339|FG001|Overall Study|Withdrawal by Subject|0
7768955|NCT00865046|12212340|FG002|Overall Study|Withdrawal by Subject|0
7768956|NCT00865098|12212348|FG000|Overall Study|Progressive disease|1
7768957|NCT00865124|12212355|FG000|Overall Study|Physician Decision|2
7768958|NCT00865124|12212356|FG001|Overall Study|Physician Decision|1
7768959|NCT00865124|12212357|FG002|Overall Study|Physician Decision|0
7768960|NCT00865124|12212355|FG000|Overall Study|Withdrawn consent|2
7768961|NCT00865124|12212356|FG001|Overall Study|Withdrawn consent|0
7768962|NCT00865124|12212357|FG002|Overall Study|Withdrawn consent|0
7768963|NCT00865189|12212367|FG000|Overall Study|Other|1
7768964|NCT00865189|12212368|FG001|Overall Study|Other|2
7768965|NCT00865189|12212367|FG000|Overall Study|Death|4
7768966|NCT00865189|12212368|FG001|Overall Study|Death|11
7768967|NCT00865189|12212367|FG000|Overall Study|Lost to Follow-up|6
7768968|NCT00865189|12212368|FG001|Overall Study|Lost to Follow-up|6
7768969|NCT00865189|12212367|FG000|Overall Study|Withdrawal by Subject|1
7768970|NCT00865189|12212368|FG001|Overall Study|Withdrawal by Subject|0
7768971|NCT00865280|12212386|FG000|Overall Study|Withdrawal by Subject|4
7768972|NCT00865280|12212387|FG001|Overall Study|Withdrawal by Subject|1
7768973|NCT00865280|12212386|FG000|Overall Study|End of Treatment/Lost to Follow-up|0
7768974|NCT00865280|12212387|FG001|Overall Study|End of Treatment/Lost to Follow-up|1
7768975|NCT00865280|12212386|FG000|Overall Study|Adverse Event/Lost to Follow-up|1
7768976|NCT00865280|12212387|FG001|Overall Study|Adverse Event/Lost to Follow-up|0
7768977|NCT00865280|12212386|FG000|Overall Study|Exclusion Condition|1
7768978|NCT00865280|12212387|FG001|Overall Study|Exclusion Condition|0
7768979|NCT00865280|12212386|FG000|Overall Study|Adverse Event|0
7768980|NCT00865280|12212387|FG001|Overall Study|Adverse Event|1
7768981|NCT00865306|12212395|FG000|Controlled Trial|Lost to Follow-up|1
7768982|NCT00865306|12212396|FG001|Controlled Trial|Lost to Follow-up|1
7768983|NCT00865306|12212395|FG000|Controlled Trial|Difficulty commuting|2
7768984|NCT00865306|12212396|FG001|Controlled Trial|Difficulty commuting|0
7768985|NCT00865306|12212395|FG000|Controlled Trial|Improved btw baseline and first session|1
7768986|NCT00865306|12212396|FG001|Controlled Trial|Improved btw baseline and first session|0
7768987|NCT00865306|12212395|FG000|Controlled Trial|Sought treatment for conduct disorder|1
7768988|NCT00865306|12212396|FG001|Controlled Trial|Sought treatment for conduct disorder|0
7768989|NCT00865306|12212395|FG000|Controlled Trial|Withdrawal by Subject|0
7768990|NCT00865306|12212396|FG001|Controlled Trial|Withdrawal by Subject|1
7768991|NCT00865345|12212402|FG000|Overall Study|Withdrawal by Subject|2
7768992|NCT00865566|12212408|FG000|Overall Study|Death|1
7768993|NCT00865566|12212409|FG001|Overall Study|Death|11
7768994|NCT00865566|12212408|FG000|Overall Study|Lost to Follow-up|314
7768995|NCT00865566|12212409|FG001|Overall Study|Lost to Follow-up|315
7768996|NCT00865566|12212408|FG000|Overall Study|Withdrawal by Subject|45
7768997|NCT00865566|12212409|FG001|Overall Study|Withdrawal by Subject|65
7768998|NCT00865566|12212408|FG000|Overall Study|Physician Decision|0
7768999|NCT00865566|12212409|FG001|Overall Study|Physician Decision|1
7769000|NCT00865566|12212408|FG000|Overall Study|Participant relocated|78
7769001|NCT00865566|12212409|FG001|Overall Study|Participant relocated|107
7769002|NCT00865566|12212408|FG000|Overall Study|Participant unable to adhere|27
7769003|NCT00865566|12212409|FG001|Overall Study|Participant unable to adhere|42
7769004|NCT00865566|12212408|FG000|Overall Study|Other; N=245 due to early study closure|154
7769005|NCT00865566|12212409|FG001|Overall Study|Other; N=245 due to early study closure|139
7769006|NCT00865566|12212408|FG000|Overall Study|HIV infection|5
7769007|NCT00865566|12212409|FG001|Overall Study|HIV infection|7
7769008|NCT00865709|12212417|FG000|Treatment|Adverse Event|9
7769009|NCT00865709|12212418|FG001|Treatment|Adverse Event|6
7737081|NCT00645099|12167710|FG000|Overall Study|Lack of Efficacy|15
7737082|NCT00645099|12167711|FG001|Overall Study|Lack of Efficacy|6
7737083|NCT00645099|12167710|FG000|Overall Study|Withdrawal by Subject|30
7737084|NCT00645099|12167711|FG001|Overall Study|Withdrawal by Subject|22
7737085|NCT00645099|12167710|FG000|Overall Study|Lost to Follow-up|6
7737086|NCT00645099|12167711|FG001|Overall Study|Lost to Follow-up|4
7737087|NCT00645099|12167710|FG000|Overall Study|Adverse Event|11
7737088|NCT00645099|12167711|FG001|Overall Study|Adverse Event|5
7737089|NCT00645099|12167710|FG000|Overall Study|Other|9
7737090|NCT00645099|12167711|FG001|Overall Study|Other|5
7737091|NCT00645164|12167717|FG000|Overall Study|Lost to Follow-up|2
7737092|NCT00645164|12167717|FG000|Overall Study|Withdrawal by Subject|4
7737093|NCT00645164|12167717|FG000|Overall Study|Protocol Violation|1
7737094|NCT00645411|12167729|FG000|Overall Study|Adverse Event|0
7737095|NCT00645411|12167730|FG001|Overall Study|Adverse Event|0
7737096|NCT00645411|12167731|FG002|Overall Study|Adverse Event|0
7737097|NCT00645411|12167732|FG003|Overall Study|Adverse Event|2
7737098|NCT00645411|12167729|FG000|Overall Study|Withdrawal by Subject|2
7737099|NCT00645411|12167730|FG001|Overall Study|Withdrawal by Subject|1
7737100|NCT00645411|12167731|FG002|Overall Study|Withdrawal by Subject|19
7737101|NCT00645411|12167732|FG003|Overall Study|Withdrawal by Subject|21
7737102|NCT00645411|12167729|FG000|Overall Study|Lost to Follow-up|10
7737103|NCT00645411|12167730|FG001|Overall Study|Lost to Follow-up|5
7737104|NCT00645411|12167731|FG002|Overall Study|Lost to Follow-up|124
7737105|NCT00645411|12167732|FG003|Overall Study|Lost to Follow-up|75
7737106|NCT00645411|12167729|FG000|Overall Study|Protocol Violation|1
7737107|NCT00645411|12167730|FG001|Overall Study|Protocol Violation|0
7737108|NCT00645411|12167731|FG002|Overall Study|Protocol Violation|1
7737109|NCT00645411|12167732|FG003|Overall Study|Protocol Violation|0
7737110|NCT00645411|12167729|FG000|Overall Study|Inappropriate enrollment|0
7737111|NCT00645411|12167730|FG001|Overall Study|Inappropriate enrollment|0
7737112|NCT00645411|12167731|FG002|Overall Study|Inappropriate enrollment|4
7737113|NCT00645411|12167732|FG003|Overall Study|Inappropriate enrollment|1
7737114|NCT00645411|12167729|FG000|Overall Study|Unable to classify|0
7737115|NCT00645411|12167730|FG001|Overall Study|Unable to classify|0
7737116|NCT00645411|12167731|FG002|Overall Study|Unable to classify|3
7737117|NCT00645411|12167732|FG003|Overall Study|Unable to classify|4
7737118|NCT00645528|12167758|FG000|Overall Study|Did not show up for Visit 2|7
7737119|NCT00645593|12167764|FG000|Overall Study|Later found to be ineligible|1
7737120|NCT00645593|12167765|FG001|Overall Study|Later found to be ineligible|0
7737121|NCT00645671|12167773|FG000|Overall Study|Protocol Violation|1
7737122|NCT00645671|12167774|FG001|Overall Study|Protocol Violation|0
7737123|NCT00645671|12167773|FG000|Overall Study|Withdrawal by Subject|0
7737124|NCT00645671|12167774|FG001|Overall Study|Withdrawal by Subject|4
7737125|NCT00645671|12167773|FG000|Overall Study|Adverse Event|0
7737126|NCT00645671|12167774|FG001|Overall Study|Adverse Event|1
7737127|NCT00645671|12167773|FG000|Overall Study|Physician Decision|0
7737128|NCT00645671|12167774|FG001|Overall Study|Physician Decision|1
7737129|NCT00645788|12167804|FG000|Overall Study|Did not receive study drug|1
7737130|NCT00645788|12167805|FG001|Overall Study|Did not receive study drug|1
7737131|NCT00645788|12167806|FG002|Overall Study|Did not receive study drug|0
7737132|NCT00645788|12167807|FG003|Overall Study|Did not receive study drug|0
7737133|NCT00645788|12167804|FG000|Overall Study|Adverse Event|4
7737134|NCT00645788|12167805|FG001|Overall Study|Adverse Event|9
7737135|NCT00645788|12167806|FG002|Overall Study|Adverse Event|5
7737136|NCT00645788|12167807|FG003|Overall Study|Adverse Event|3
7737137|NCT00645788|12167804|FG000|Overall Study|Lost to Follow-up|1
7737138|NCT00645788|12167805|FG001|Overall Study|Lost to Follow-up|0
7737139|NCT00645788|12167806|FG002|Overall Study|Lost to Follow-up|0
7737140|NCT00645788|12167807|FG003|Overall Study|Lost to Follow-up|0
7737141|NCT00645788|12167804|FG000|Overall Study|Protocol Violation|1
7737142|NCT00645788|12167805|FG001|Overall Study|Protocol Violation|0
7737143|NCT00645788|12167806|FG002|Overall Study|Protocol Violation|2
7737144|NCT00645788|12167807|FG003|Overall Study|Protocol Violation|0
7737145|NCT00645788|12167804|FG000|Overall Study|Withdrawal by Subject|0
7737146|NCT00645788|12167805|FG001|Overall Study|Withdrawal by Subject|1
7737147|NCT00645788|12167806|FG002|Overall Study|Withdrawal by Subject|0
7737148|NCT00645788|12167807|FG003|Overall Study|Withdrawal by Subject|2
7737149|NCT00645788|12167804|FG000|Overall Study|Pulmonary exacerbation|13
7737150|NCT00645788|12167805|FG001|Overall Study|Pulmonary exacerbation|16
7737151|NCT00645788|12167806|FG002|Overall Study|Pulmonary exacerbation|11
7737152|NCT00645788|12167807|FG003|Overall Study|Pulmonary exacerbation|9
7737153|NCT00645840|12167826|FG000|Overall Study|Protocol Violation|3
7737154|NCT00645853|12167832|FG000|Overall Study|Adverse Event|18
7737155|NCT00645853|12167833|FG001|Overall Study|Adverse Event|7
7737156|NCT00645853|12167832|FG000|Overall Study|AZ study closure in Hungary|60
7737157|NCT00645853|12167833|FG001|Overall Study|AZ study closure in Hungary|40
7737158|NCT00645853|12167832|FG000|Overall Study|Withdrawal by Subject|5
7737159|NCT00645853|12167833|FG001|Overall Study|Withdrawal by Subject|2
7737160|NCT00645853|12167832|FG000|Overall Study|Protocol Violation|0
7737161|NCT00645853|12167833|FG001|Overall Study|Protocol Violation|2
7737162|NCT00645853|12167832|FG000|Overall Study|Discontinuation criteria|2
7737163|NCT00645853|12167833|FG001|Overall Study|Discontinuation criteria|2
7737164|NCT00645853|12167832|FG000|Overall Study|recall of ICF, planned operation, death|7
7737165|NCT00645853|12167833|FG001|Overall Study|recall of ICF, planned operation, death|4
7737166|NCT00645944|12167841|FG000|Randomized|Withdrawal by Subject|1
7737167|NCT00645944|12167842|FG001|Randomized|Withdrawal by Subject|2
7737168|NCT00645944|12167841|FG000|Received Medication|Adverse Event|2
7737169|NCT00645944|12167842|FG001|Received Medication|Adverse Event|1
7737170|NCT00645944|12167841|FG000|Received Medication|Withdrawal by Subject|1
7737171|NCT00645944|12167842|FG001|Received Medication|Withdrawal by Subject|1
7737172|NCT00645944|12167841|FG000|Received Medication|Lost to Follow-up|1
7737173|NCT00645944|12167842|FG001|Received Medication|Lost to Follow-up|0
7737174|NCT00645944|12167841|FG000|Received Medication|Protocol Violation|2
7737175|NCT00645944|12167842|FG001|Received Medication|Protocol Violation|1
7737176|NCT00646113|12167861|FG000|Overall Study|Lost to Follow-up|5
7737177|NCT00646113|12167861|FG000|Overall Study|Adverse Event|3
7737178|NCT00646399|12167867|FG000|Overall Study|Death|63
7737179|NCT00646399|12167868|FG001|Overall Study|Death|53
7737180|NCT00646399|12167867|FG000|Overall Study|Withdrawal by Subject|9
7737181|NCT00646399|12167868|FG001|Overall Study|Withdrawal by Subject|10
7737182|NCT00646399|12167867|FG000|Overall Study|Other Reason|11
7737183|NCT00646399|12167868|FG001|Overall Study|Other Reason|11
7737184|NCT00646451|12167874|FG000|Overall Study|Adverse Event|3
7737185|NCT00646451|12167875|FG001|Overall Study|Adverse Event|0
7737186|NCT00646451|12167874|FG000|Overall Study|Exacerbation of pre-existing condition|1
7737187|NCT00646451|12167875|FG001|Overall Study|Exacerbation of pre-existing condition|0
7737188|NCT00646776|12167920|FG000|Overall Study|Adverse Event|1
7737189|NCT00646776|12167921|FG001|Overall Study|Adverse Event|9
7737190|NCT00646776|12167920|FG000|Overall Study|Investigator discretion|0
7737191|NCT00646776|12167921|FG001|Overall Study|Investigator discretion|4
7737192|NCT00646906|12167934|FG000|Crossover Period 1|Withdrawal by Subject|1
7737193|NCT00646906|12167935|FG001|Crossover Period 1|Withdrawal by Subject|0
7737194|NCT00646906|12167936|FG002|Crossover Period 1|Withdrawal by Subject|0
7737195|NCT00646906|12167937|FG003|Crossover Period 1|Withdrawal by Subject|0
7737196|NCT00646906|12167938|FG004|Crossover Period 1|Withdrawal by Subject|0
7737197|NCT00646906|12167939|FG005|Crossover Period 1|Withdrawal by Subject|1
7737198|NCT00646906|12167940|FG006|Crossover Period 1|Withdrawal by Subject|0
7737199|NCT00646906|12167934|FG000|Crossover Period 2|Withdrawal by Subject|0
7737200|NCT00646906|12167935|FG001|Crossover Period 2|Withdrawal by Subject|1
7737201|NCT00646906|12167936|FG002|Crossover Period 2|Withdrawal by Subject|2
7737202|NCT00646906|12167937|FG003|Crossover Period 2|Withdrawal by Subject|1
7737203|NCT00646906|12167938|FG004|Crossover Period 2|Withdrawal by Subject|0
7737204|NCT00646906|12167939|FG005|Crossover Period 2|Withdrawal by Subject|0
7737205|NCT00646906|12167940|FG006|Crossover Period 2|Withdrawal by Subject|0
7737206|NCT00646906|12167934|FG000|Crossover Period 2|Physician Decision|0
7737207|NCT00646906|12167935|FG001|Crossover Period 2|Physician Decision|0
7737208|NCT00646906|12167936|FG002|Crossover Period 2|Physician Decision|0
7737209|NCT00646906|12167937|FG003|Crossover Period 2|Physician Decision|0
7737210|NCT00646906|12167938|FG004|Crossover Period 2|Physician Decision|0
7737211|NCT00646906|12167939|FG005|Crossover Period 2|Physician Decision|0
7737212|NCT00646906|12167940|FG006|Crossover Period 2|Physician Decision|1
7737213|NCT00646958|12167956|FG000|Overall Study|Lack of Efficacy|1
7737214|NCT00646958|12167957|FG001|Overall Study|Lack of Efficacy|0
7737215|NCT00646958|12167958|FG002|Overall Study|Lack of Efficacy|0
7737216|NCT00646958|12167956|FG000|Overall Study|Adverse Event|4
7737217|NCT00646958|12167957|FG001|Overall Study|Adverse Event|0
7737218|NCT00646958|12167958|FG002|Overall Study|Adverse Event|0
7737219|NCT00646958|12167956|FG000|Overall Study|Lost to Follow-up|1
7737220|NCT00646958|12167957|FG001|Overall Study|Lost to Follow-up|5
7737221|NCT00646958|12167958|FG002|Overall Study|Lost to Follow-up|7
7737222|NCT00646958|12167956|FG000|Overall Study|Protocol Violation|1
7737223|NCT00646958|12167957|FG001|Overall Study|Protocol Violation|1
7737224|NCT00646958|12167958|FG002|Overall Study|Protocol Violation|0
7737225|NCT00646958|12167956|FG000|Overall Study|Abnormal screening lab tests|1
7737226|NCT00646958|12167957|FG001|Overall Study|Abnormal screening lab tests|1
7737227|NCT00646958|12167958|FG002|Overall Study|Abnormal screening lab tests|0
7737228|NCT00646958|12167956|FG000|Overall Study|Withdrawal by Subject|1
7737229|NCT00646958|12167957|FG001|Overall Study|Withdrawal by Subject|2
7737230|NCT00646958|12167958|FG002|Overall Study|Withdrawal by Subject|0
7737231|NCT00646958|12167956|FG000|Overall Study|Did not receive study drug|2
7737232|NCT00646958|12167957|FG001|Overall Study|Did not receive study drug|0
7737233|NCT00646958|12167958|FG002|Overall Study|Did not receive study drug|2
7737234|NCT00647270|12167969|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
7737235|NCT00647270|12167970|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
7737236|NCT00647270|12167971|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
7737237|NCT00647270|12167969|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
7737238|NCT00647270|12167970|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
7737239|NCT00647270|12167971|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
7737240|NCT00647270|12167969|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
7737241|NCT00647270|12167970|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
7737242|NCT00647270|12167971|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
7737243|NCT00647270|12167969|FG000|Period 1, Placebo-control (12 Weeks)|Other|4
7737244|NCT00647270|12167970|FG001|Period 1, Placebo-control (12 Weeks)|Other|4
7737245|NCT00647270|12167971|FG002|Period 1, Placebo-control (12 Weeks)|Other|8
7737246|NCT00647270|12167969|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
7737247|NCT00647270|12167970|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
7737248|NCT00647270|12167971|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
7737249|NCT00647270|12167969|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
7737250|NCT00647270|12167970|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
7737251|NCT00647270|12167971|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
7737252|NCT00647270|12167969|FG000|Period 2, Placebo Switched to Adalimumab|Other|2
7737253|NCT00647270|12167970|FG001|Period 2, Placebo Switched to Adalimumab|Other|6
7737254|NCT00647270|12167971|FG002|Period 2, Placebo Switched to Adalimumab|Other|0
7737255|NCT00647296|12167986|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
7737256|NCT00647296|12167987|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
7737257|NCT00647296|12167988|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
7737258|NCT00647296|12167989|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1
7737259|NCT00647296|12167986|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1
7737260|NCT00647296|12167987|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0
7737261|NCT00647296|12167988|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0
7737262|NCT00647296|12167989|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1
7737263|NCT00647296|12167986|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
7737264|NCT00647296|12167987|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1
7737265|NCT00647296|12167988|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
7737266|NCT00647296|12167989|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
7737267|NCT00647296|12167986|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1
7737268|NCT00647296|12167987|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
7737269|NCT00647296|12167988|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
7737270|NCT00647296|12167989|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
7737271|NCT00647296|12167986|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1
7737272|NCT00647296|12167987|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
7737273|NCT00647296|12167988|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
7737274|NCT00647296|12167989|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
7737275|NCT00647296|12167986|FG000|Part 2: 4-week Placebo Washout|Death|3
7737276|NCT00647296|12167987|FG001|Part 2: 4-week Placebo Washout|Death|0
7737277|NCT00647296|12167988|FG002|Part 2: 4-week Placebo Washout|Death|0
7737278|NCT00647296|12167989|FG003|Part 2: 4-week Placebo Washout|Death|0
7737279|NCT00647296|12167986|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0
7737280|NCT00647296|12167987|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5
7737281|NCT00647296|12167988|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0
7737282|NCT00647296|12167989|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4
7737283|NCT00647296|12167986|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0
7737284|NCT00647296|12167987|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1
7737285|NCT00647296|12167988|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0
7737286|NCT00647296|12167989|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4
7737287|NCT00647296|12167986|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
7737288|NCT00647296|12167987|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1
7737289|NCT00647296|12167988|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
7737290|NCT00647296|12167989|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
7737291|NCT00647296|12167986|FG000|Part 2: 76-week Double-Blind Treatment|Death|0
7737292|NCT00647296|12167987|FG001|Part 2: 76-week Double-Blind Treatment|Death|7
7737293|NCT00647296|12167988|FG002|Part 2: 76-week Double-Blind Treatment|Death|0
7737294|NCT00647296|12167989|FG003|Part 2: 76-week Double-Blind Treatment|Death|5
7737295|NCT00647296|12167986|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0
7737296|NCT00647296|12167987|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1
7737297|NCT00647296|12167988|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0
7737298|NCT00647296|12167989|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1
7737299|NCT00647348|12168013|FG000|Overall Study|Lost to Follow-up|3
7737300|NCT00647348|12168014|FG001|Overall Study|Lost to Follow-up|6
7737301|NCT00647699|12168031|FG000|Overall Study|Lost to Follow-up|5
7737302|NCT00647699|12168032|FG001|Overall Study|Lost to Follow-up|4
7737303|NCT00647699|12168031|FG000|Overall Study|Withdrawal by Subject|3
7737304|NCT00647699|12168032|FG001|Overall Study|Withdrawal by Subject|8
7737305|NCT00648037|12168049|FG000|Overall Study|Not Treated|1
7737306|NCT00648037|12168049|FG000|Overall Study|Withdrawal by Subject|1
7737307|NCT00648037|12168049|FG000|Overall Study|Adverse Event|11
7737308|NCT00648037|12168049|FG000|Overall Study|Relapse|2
7737309|NCT00648037|12168049|FG000|Overall Study|Other|1
7737310|NCT00648167|12168066|FG000|Overall Study|Adverse Event|6
7737311|NCT00648167|12168066|FG000|Overall Study|unable to swallow tablets|1
7737312|NCT00648739|12168192|FG000|Overall Study|Adverse Event|1
7737313|NCT00648739|12168193|FG001|Overall Study|Adverse Event|0
7737314|NCT00648739|12168194|FG002|Overall Study|Adverse Event|1
7737315|NCT00648739|12168195|FG003|Overall Study|Adverse Event|2
7737316|NCT00648739|12168196|FG004|Overall Study|Adverse Event|1
7737317|NCT00648739|12168197|FG005|Overall Study|Adverse Event|0
7737318|NCT00648739|12168198|FG006|Overall Study|Adverse Event|0
7737319|NCT00648739|12168192|FG000|Overall Study|Withdrawal by Subject|1
7737320|NCT00648739|12168193|FG001|Overall Study|Withdrawal by Subject|0
7737321|NCT00648739|12168194|FG002|Overall Study|Withdrawal by Subject|1
7737322|NCT00648739|12168195|FG003|Overall Study|Withdrawal by Subject|0
7737323|NCT00648739|12168196|FG004|Overall Study|Withdrawal by Subject|0
7737324|NCT00648739|12168197|FG005|Overall Study|Withdrawal by Subject|2
7737325|NCT00648739|12168198|FG006|Overall Study|Withdrawal by Subject|0
7737326|NCT00648739|12168192|FG000|Overall Study|Lack of Efficacy|0
7737327|NCT00648739|12168193|FG001|Overall Study|Lack of Efficacy|0
7737328|NCT00648739|12168194|FG002|Overall Study|Lack of Efficacy|0
7737329|NCT00648739|12168195|FG003|Overall Study|Lack of Efficacy|0
7737330|NCT00648739|12168196|FG004|Overall Study|Lack of Efficacy|1
7737331|NCT00648739|12168197|FG005|Overall Study|Lack of Efficacy|2
7737332|NCT00648739|12168198|FG006|Overall Study|Lack of Efficacy|0
7737333|NCT00648739|12168192|FG000|Overall Study|Investigator Considered it Advisable|0
7737334|NCT00648739|12168193|FG001|Overall Study|Investigator Considered it Advisable|0
7737335|NCT00648739|12168194|FG002|Overall Study|Investigator Considered it Advisable|0
7737336|NCT00648739|12168195|FG003|Overall Study|Investigator Considered it Advisable|0
7737337|NCT00648739|12168196|FG004|Overall Study|Investigator Considered it Advisable|0
7737338|NCT00648739|12168197|FG005|Overall Study|Investigator Considered it Advisable|1
7737339|NCT00648739|12168198|FG006|Overall Study|Investigator Considered it Advisable|1
7737340|NCT00648739|12168192|FG000|Overall Study|Death|0
7737341|NCT00648739|12168193|FG001|Overall Study|Death|1
7737342|NCT00648739|12168194|FG002|Overall Study|Death|0
7737343|NCT00648739|12168195|FG003|Overall Study|Death|0
7737344|NCT00648739|12168196|FG004|Overall Study|Death|0
7737345|NCT00648739|12168197|FG005|Overall Study|Death|0
7737346|NCT00648739|12168198|FG006|Overall Study|Death|0
7737347|NCT00648739|12168192|FG000|Overall Study|Positive Human Anti-human Antibody|0
7737348|NCT00648739|12168193|FG001|Overall Study|Positive Human Anti-human Antibody|0
7737349|NCT00648739|12168194|FG002|Overall Study|Positive Human Anti-human Antibody|1
7737350|NCT00648739|12168195|FG003|Overall Study|Positive Human Anti-human Antibody|0
7737351|NCT00648739|12168196|FG004|Overall Study|Positive Human Anti-human Antibody|0
7737352|NCT00648739|12168197|FG005|Overall Study|Positive Human Anti-human Antibody|0
7737353|NCT00648739|12168198|FG006|Overall Study|Positive Human Anti-human Antibody|0
7737354|NCT00648739|12168192|FG000|Overall Study|Follow-up Visits Not Completed|0
7737355|NCT00648739|12168193|FG001|Overall Study|Follow-up Visits Not Completed|1
7737356|NCT00648739|12168194|FG002|Overall Study|Follow-up Visits Not Completed|0
7737357|NCT00648739|12168195|FG003|Overall Study|Follow-up Visits Not Completed|0
7737358|NCT00648739|12168196|FG004|Overall Study|Follow-up Visits Not Completed|0
7737359|NCT00648739|12168197|FG005|Overall Study|Follow-up Visits Not Completed|0
7737360|NCT00648739|12168198|FG006|Overall Study|Follow-up Visits Not Completed|0
7737361|NCT00649220|12168224|FG000|Overall Study|Adverse Event|2
7737362|NCT00649220|12168224|FG000|Overall Study|Withdrawal by Subject|1
7737363|NCT00649389|12168232|FG000|Overall Study|Adverse Event|22
7737364|NCT00649389|12168233|FG001|Overall Study|Adverse Event|46
7737365|NCT00649389|12168234|FG002|Overall Study|Adverse Event|38
7737366|NCT00649389|12168235|FG003|Overall Study|Adverse Event|48
7737367|NCT00649389|12168232|FG000|Overall Study|Lost to Follow-up|15
7737368|NCT00649389|12168233|FG001|Overall Study|Lost to Follow-up|17
7737369|NCT00649389|12168234|FG002|Overall Study|Lost to Follow-up|21
7737370|NCT00649389|12168235|FG003|Overall Study|Lost to Follow-up|26
7737371|NCT00649389|12168232|FG000|Overall Study|Protocol Violation|11
7737372|NCT00649389|12168233|FG001|Overall Study|Protocol Violation|13
7737373|NCT00649389|12168234|FG002|Overall Study|Protocol Violation|9
7737374|NCT00649389|12168235|FG003|Overall Study|Protocol Violation|8
7737375|NCT00649389|12168232|FG000|Overall Study|Withdrawal by Subject|20
7737376|NCT00649389|12168233|FG001|Overall Study|Withdrawal by Subject|21
7737377|NCT00649389|12168234|FG002|Overall Study|Withdrawal by Subject|19
7737378|NCT00649389|12168235|FG003|Overall Study|Withdrawal by Subject|23
7737379|NCT00649389|12168232|FG000|Overall Study|Other|3
7737380|NCT00649389|12168233|FG001|Overall Study|Other|9
7737381|NCT00649389|12168234|FG002|Overall Study|Other|1
7737382|NCT00649389|12168235|FG003|Overall Study|Other|6
7737383|NCT00649428|12168247|FG000|Overall Study|Adverse Event|2
7737384|NCT00649428|12168248|FG001|Overall Study|Adverse Event|2
7737385|NCT00649428|12168247|FG000|Overall Study|Withdrawal by Subject|6
7737386|NCT00649428|12168248|FG001|Overall Study|Withdrawal by Subject|6
7737387|NCT00649428|12168247|FG000|Overall Study|Lost to Follow-up|1
7737388|NCT00649428|12168248|FG001|Overall Study|Lost to Follow-up|3
7737389|NCT00649428|12168247|FG000|Overall Study|Insufficient manufacturing yield|5
7737390|NCT00649428|12168248|FG001|Overall Study|Insufficient manufacturing yield|1
7737391|NCT00649428|12168247|FG000|Overall Study|Protocol Violation|6
7737392|NCT00649428|12168248|FG001|Overall Study|Protocol Violation|2
7737393|NCT00649428|12168247|FG000|Overall Study|Physician Decision|0
7737394|NCT00649428|12168248|FG001|Overall Study|Physician Decision|1
7737395|NCT00650091|12168274|FG000|Amended Study Design|Withdrawal by Subject|12
7737396|NCT00650091|12168275|FG001|Amended Study Design|Withdrawal by Subject|11
7737397|NCT00650091|12168276|FG002|Amended Study Design|Withdrawal by Subject|0
7737398|NCT00650091|12168274|FG000|Amended Study Design|Physician Decision|5
7737399|NCT00650091|12168275|FG001|Amended Study Design|Physician Decision|0
7737400|NCT00650091|12168276|FG002|Amended Study Design|Physician Decision|0
7737401|NCT00650091|12168274|FG000|Amended Study Design|Adverse Event|1
7737402|NCT00650091|12168275|FG001|Amended Study Design|Adverse Event|4
7737403|NCT00650091|12168276|FG002|Amended Study Design|Adverse Event|0
7737404|NCT00650091|12168274|FG000|Amended Study Design|Lung transplantation|4
7737405|NCT00650091|12168275|FG001|Amended Study Design|Lung transplantation|2
7737406|NCT00650091|12168276|FG002|Amended Study Design|Lung transplantation|0
7737407|NCT00650091|12168274|FG000|Amended Study Design|Other|1
7737408|NCT00650091|12168275|FG001|Amended Study Design|Other|3
7737409|NCT00650091|12168276|FG002|Amended Study Design|Other|0
7737410|NCT00650104|12168284|FG000|Overall Study|Adverse Event|17
7737411|NCT00650104|12168284|FG000|Overall Study|Death|2
7737412|NCT00650104|12168284|FG000|Overall Study|Withdrawal by Subject|11
7737413|NCT00650104|12168284|FG000|Overall Study|Physician Decision|7
7737414|NCT00650104|12168284|FG000|Overall Study|Lost to Follow-up|1
7737415|NCT00650104|12168284|FG000|Overall Study|Non-compliance|2
7737416|NCT00650104|12168284|FG000|Overall Study|Sponsor Terminated Dosing|1
7737417|NCT00650585|12168304|FG000|Overall Study|Lost to Follow-up|505
7737418|NCT00650585|12168305|FG001|Overall Study|Lost to Follow-up|482
7737419|NCT00650585|12168304|FG000|Overall Study|No parental consent|935
7737420|NCT00650585|12168305|FG001|Overall Study|No parental consent|866
7737421|NCT00650585|12168304|FG000|Overall Study|Excluded/ruled ineligible|357
7737422|NCT00650585|12168305|FG001|Overall Study|Excluded/ruled ineligible|129
7737423|NCT00650767|12168315|FG000|Overall Study|Adverse Event|0
7737424|NCT00650767|12168316|FG001|Overall Study|Adverse Event|3
7737425|NCT00650767|12168317|FG002|Overall Study|Adverse Event|10
7737426|NCT00650767|12168318|FG003|Overall Study|Adverse Event|8
7737427|NCT00650767|12168315|FG000|Overall Study|Death|1
7737428|NCT00650767|12168316|FG001|Overall Study|Death|0
7737429|NCT00650767|12168317|FG002|Overall Study|Death|0
7737430|NCT00650767|12168318|FG003|Overall Study|Death|0
7737431|NCT00650767|12168315|FG000|Overall Study|Withdrawal by Subject|2
7737432|NCT00650767|12168316|FG001|Overall Study|Withdrawal by Subject|4
7737433|NCT00650767|12168317|FG002|Overall Study|Withdrawal by Subject|3
7737434|NCT00650767|12168318|FG003|Overall Study|Withdrawal by Subject|3
7737435|NCT00650767|12168315|FG000|Overall Study|Lost to Follow-up|1
7737436|NCT00650767|12168316|FG001|Overall Study|Lost to Follow-up|1
7737437|NCT00650767|12168317|FG002|Overall Study|Lost to Follow-up|1
7737438|NCT00650767|12168318|FG003|Overall Study|Lost to Follow-up|0
7737439|NCT00650767|12168315|FG000|Overall Study|Other|1
7737440|NCT00650767|12168316|FG001|Overall Study|Other|1
7737441|NCT00650767|12168317|FG002|Overall Study|Other|0
7737442|NCT00650767|12168318|FG003|Overall Study|Other|0
7737443|NCT00650806|12168332|FG000|Overall Study|Adverse Event|0
7737444|NCT00650806|12168333|FG001|Overall Study|Adverse Event|5
7737445|NCT00650806|12168334|FG002|Overall Study|Adverse Event|3
7737446|NCT00650806|12168335|FG003|Overall Study|Adverse Event|4
7737447|NCT00650806|12168332|FG000|Overall Study|Lost to Follow-up|7
7737448|NCT00650806|12168333|FG001|Overall Study|Lost to Follow-up|6
7737449|NCT00650806|12168334|FG002|Overall Study|Lost to Follow-up|11
7737450|NCT00650806|12168335|FG003|Overall Study|Lost to Follow-up|10
7737451|NCT00650806|12168332|FG000|Overall Study|Protocol Violation|0
7737452|NCT00650806|12168333|FG001|Overall Study|Protocol Violation|0
7737453|NCT00650806|12168334|FG002|Overall Study|Protocol Violation|0
7737454|NCT00650806|12168335|FG003|Overall Study|Protocol Violation|1
7737455|NCT00650806|12168332|FG000|Overall Study|Pregnancy|0
7737456|NCT00650806|12168333|FG001|Overall Study|Pregnancy|0
7737457|NCT00650806|12168334|FG002|Overall Study|Pregnancy|0
7737458|NCT00650806|12168335|FG003|Overall Study|Pregnancy|1
7737459|NCT00650806|12168332|FG000|Overall Study|Withdrawal by Subject|7
7737460|NCT00650806|12168333|FG001|Overall Study|Withdrawal by Subject|5
7737461|NCT00650806|12168334|FG002|Overall Study|Withdrawal by Subject|8
7737462|NCT00650806|12168335|FG003|Overall Study|Withdrawal by Subject|6
7737463|NCT00650806|12168332|FG000|Overall Study|Noncompliance with study drug regimen|1
7737464|NCT00650806|12168333|FG001|Overall Study|Noncompliance with study drug regimen|1
7737465|NCT00650806|12168334|FG002|Overall Study|Noncompliance with study drug regimen|0
7737466|NCT00650806|12168335|FG003|Overall Study|Noncompliance with study drug regimen|0
7737467|NCT00650806|12168332|FG000|Overall Study|Study terminated by sponsor|2
7737468|NCT00650806|12168333|FG001|Overall Study|Study terminated by sponsor|3
7737469|NCT00650806|12168334|FG002|Overall Study|Study terminated by sponsor|5
7737470|NCT00650806|12168335|FG003|Overall Study|Study terminated by sponsor|4
7737471|NCT00650806|12168332|FG000|Overall Study|Other|1
7737472|NCT00650806|12168333|FG001|Overall Study|Other|1
7737473|NCT00650806|12168334|FG002|Overall Study|Other|2
7737474|NCT00650806|12168335|FG003|Overall Study|Other|0
7737475|NCT00650845|12168349|FG000|Overall Study|Withdrawal by Subject|5
7737476|NCT00650845|12168350|FG001|Overall Study|Withdrawal by Subject|0
7737477|NCT00650845|12168349|FG000|Overall Study|Protocol Violation|0
7737478|NCT00650845|12168350|FG001|Overall Study|Protocol Violation|13
7737479|NCT00651118|12168387|FG000|Overall Study|Adverse Event|4
7737480|NCT00651118|12168388|FG001|Overall Study|Adverse Event|0
7737481|NCT00651118|12168389|FG002|Overall Study|Adverse Event|1
7737482|NCT00651118|12168390|FG003|Overall Study|Adverse Event|1
7737483|NCT00651118|12168387|FG000|Overall Study|Protocol Violation|2
7737484|NCT00651118|12168388|FG001|Overall Study|Protocol Violation|2
7737485|NCT00651118|12168389|FG002|Overall Study|Protocol Violation|6
7737486|NCT00651118|12168390|FG003|Overall Study|Protocol Violation|2
7737487|NCT00651118|12168387|FG000|Overall Study|Lost to Follow-up|2
7737488|NCT00651118|12168388|FG001|Overall Study|Lost to Follow-up|0
7737489|NCT00651118|12168389|FG002|Overall Study|Lost to Follow-up|1
7737490|NCT00651118|12168390|FG003|Overall Study|Lost to Follow-up|2
7737491|NCT00651118|12168387|FG000|Overall Study|administrative|1
7737492|NCT00651118|12168388|FG001|Overall Study|administrative|4
7737493|NCT00651118|12168389|FG002|Overall Study|administrative|2
7737494|NCT00651118|12168390|FG003|Overall Study|administrative|1
7737495|NCT00651118|12168387|FG000|Overall Study|Withdrawal by Subject|0
7737496|NCT00651118|12168388|FG001|Overall Study|Withdrawal by Subject|1
7737497|NCT00651118|12168389|FG002|Overall Study|Withdrawal by Subject|1
7737498|NCT00651118|12168390|FG003|Overall Study|Withdrawal by Subject|1
7737499|NCT00651157|12168403|FG000|Overall Study|Death|1
7737500|NCT00651157|12168403|FG000|Overall Study|Protocol Violation|1
7737501|NCT00651183|12168409|FG000|Overall Study|Lack of Efficacy|1
7737502|NCT00651183|12168410|FG001|Overall Study|Lack of Efficacy|0
7737503|NCT00651183|12168409|FG000|Overall Study|Efficacy insufficient + patients wish|0
7737504|NCT00651183|12168410|FG001|Overall Study|Efficacy insufficient + patients wish|1
7737505|NCT00651183|12168409|FG000|Overall Study|Tolerability insufficient|5
7737506|NCT00651183|12168410|FG001|Overall Study|Tolerability insufficient|2
7737507|NCT00651183|12168409|FG000|Overall Study|Tolerability insufficient +Patients wish|0
7737508|NCT00651183|12168410|FG001|Overall Study|Tolerability insufficient +Patients wish|1
7737509|NCT00651183|12168409|FG000|Overall Study|Withdrawal by Subject|6
7737510|NCT00651183|12168410|FG001|Overall Study|Withdrawal by Subject|3
7737511|NCT00651183|12168409|FG000|Overall Study|Lost to Follow-up|3
7737512|NCT00651183|12168410|FG001|Overall Study|Lost to Follow-up|1
7737513|NCT00651183|12168409|FG000|Overall Study|Other reasons|4
7737514|NCT00651183|12168410|FG001|Overall Study|Other reasons|2
7737515|NCT00651183|12168409|FG000|Overall Study|missing|1
7737516|NCT00651183|12168410|FG001|Overall Study|missing|0
7737517|NCT00651261|12168418|FG000|Overall Study|Adverse Event|32
7737518|NCT00651261|12168419|FG001|Overall Study|Adverse Event|22
7737519|NCT00651261|12168418|FG000|Overall Study|Death|18
7737520|NCT00651261|12168419|FG001|Overall Study|Death|18
7737521|NCT00651261|12168418|FG000|Overall Study|Withdrawal by Subject|22
7737522|NCT00651261|12168419|FG001|Overall Study|Withdrawal by Subject|40
7737523|NCT00651261|12168418|FG000|Overall Study|Induction failure|24
7737524|NCT00651261|12168419|FG001|Overall Study|Induction failure|35
7737525|NCT00651261|12168418|FG000|Overall Study|Disease progression|58
7737526|NCT00651261|12168419|FG001|Overall Study|Disease progression|58
7737527|NCT00651261|12168418|FG000|Overall Study|Alternative therapy|109
7737528|NCT00651261|12168419|FG001|Overall Study|Alternative therapy|107
7737529|NCT00651261|12168418|FG000|Overall Study|Other disease or participant decisions|23
7737530|NCT00651261|12168419|FG001|Overall Study|Other disease or participant decisions|23
7737531|NCT00651261|12168418|FG000|Overall Study|Never treated|5
7737532|NCT00651261|12168419|FG001|Overall Study|Never treated|3
7737533|NCT00651313|12168427|FG000|Overall Study|Adverse Event|0
7737534|NCT00651313|12168428|FG001|Overall Study|Adverse Event|1
7737535|NCT00651313|12168427|FG000|Overall Study|Withdrawal by Subject|3
7737536|NCT00651313|12168428|FG001|Overall Study|Withdrawal by Subject|1
7737537|NCT00651313|12168427|FG000|Overall Study|Lost to Follow-up|1
7737538|NCT00651313|12168428|FG001|Overall Study|Lost to Follow-up|1
7737539|NCT00651313|12168427|FG000|Overall Study|Adminstrative Discontinuation|2
7737540|NCT00651313|12168428|FG001|Overall Study|Adminstrative Discontinuation|3
7737541|NCT00651664|12168467|FG000|Overall Study|Occurrence of Adverse Event(s)|0
7737542|NCT00651664|12168468|FG001|Overall Study|Occurrence of Adverse Event(s)|0
7737543|NCT00651664|12168469|FG002|Overall Study|Occurrence of Adverse Event(s)|0
7737544|NCT00651664|12168470|FG003|Overall Study|Occurrence of Adverse Event(s)|0
7962155|NCT02709746|12516273|FG001|Phase B (Double-blind Treatment Period)|Other|6
7962156|NCT02709746|12516274|FG002|Phase B (Double-blind Treatment Period)|Other|5
7962157|NCT02709746|12516275|FG003|Phase B (Double-blind Treatment Period)|Other|6
7737545|NCT00651664|12168471|FG004|Overall Study|Occurrence of Adverse Event(s)|0
7737546|NCT00651664|12168472|FG005|Overall Study|Occurrence of Adverse Event(s)|0
7737547|NCT00651664|12168473|FG006|Overall Study|Occurrence of Adverse Event(s)|1
7737548|NCT00651664|12168474|FG007|Overall Study|Occurrence of Adverse Event(s)|0
7737549|NCT00651664|12168475|FG008|Overall Study|Occurrence of Adverse Event(s)|1
7737550|NCT00651664|12168476|FG009|Overall Study|Occurrence of Adverse Event(s)|0
7737551|NCT00651664|12168467|FG000|Overall Study|Unsatisfactory Therapeutic Response|0
7737552|NCT00651664|12168468|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
7737553|NCT00651664|12168469|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
7737554|NCT00651664|12168470|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
7737555|NCT00651664|12168471|FG004|Overall Study|Unsatisfactory Therapeutic Response|1
7737556|NCT00651664|12168472|FG005|Overall Study|Unsatisfactory Therapeutic Response|1
7737557|NCT00651664|12168473|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
7737558|NCT00651664|12168474|FG007|Overall Study|Unsatisfactory Therapeutic Response|1
7737559|NCT00651664|12168475|FG008|Overall Study|Unsatisfactory Therapeutic Response|0
7737560|NCT00651664|12168476|FG009|Overall Study|Unsatisfactory Therapeutic Response|1
7737561|NCT00651664|12168467|FG000|Overall Study|Progressive Disease|3
7737562|NCT00651664|12168468|FG001|Overall Study|Progressive Disease|3
7737563|NCT00651664|12168469|FG002|Overall Study|Progressive Disease|3
7737564|NCT00651664|12168470|FG003|Overall Study|Progressive Disease|12
7737565|NCT00651664|12168471|FG004|Overall Study|Progressive Disease|4
7737566|NCT00651664|12168472|FG005|Overall Study|Progressive Disease|1
7737567|NCT00651664|12168473|FG006|Overall Study|Progressive Disease|3
7737568|NCT00651664|12168474|FG007|Overall Study|Progressive Disease|6
7737569|NCT00651664|12168475|FG008|Overall Study|Progressive Disease|5
7737570|NCT00651664|12168476|FG009|Overall Study|Progressive Disease|5
7737571|NCT00651664|12168467|FG000|Overall Study|Patient Declined Further Treatment|0
7737572|NCT00651664|12168468|FG001|Overall Study|Patient Declined Further Treatment|0
7737573|NCT00651664|12168469|FG002|Overall Study|Patient Declined Further Treatment|0
7737574|NCT00651664|12168470|FG003|Overall Study|Patient Declined Further Treatment|1
7737575|NCT00651664|12168471|FG004|Overall Study|Patient Declined Further Treatment|1
7737576|NCT00651664|12168472|FG005|Overall Study|Patient Declined Further Treatment|1
7737577|NCT00651664|12168473|FG006|Overall Study|Patient Declined Further Treatment|0
7737578|NCT00651664|12168474|FG007|Overall Study|Patient Declined Further Treatment|0
7737579|NCT00651664|12168475|FG008|Overall Study|Patient Declined Further Treatment|0
7737580|NCT00651664|12168476|FG009|Overall Study|Patient Declined Further Treatment|1
7737581|NCT00651664|12168467|FG000|Overall Study|Symptomatic Deterioration|0
7737582|NCT00651664|12168468|FG001|Overall Study|Symptomatic Deterioration|0
7737583|NCT00651664|12168469|FG002|Overall Study|Symptomatic Deterioration|0
7737584|NCT00651664|12168470|FG003|Overall Study|Symptomatic Deterioration|1
7737585|NCT00651664|12168471|FG004|Overall Study|Symptomatic Deterioration|0
7737586|NCT00651664|12168472|FG005|Overall Study|Symptomatic Deterioration|0
7737587|NCT00651664|12168473|FG006|Overall Study|Symptomatic Deterioration|1
7737588|NCT00651664|12168474|FG007|Overall Study|Symptomatic Deterioration|0
7737589|NCT00651664|12168475|FG008|Overall Study|Symptomatic Deterioration|1
7737590|NCT00651664|12168476|FG009|Overall Study|Symptomatic Deterioration|0
7737591|NCT00651664|12168467|FG000|Overall Study|Reason not Specified|0
7737592|NCT00651664|12168468|FG001|Overall Study|Reason not Specified|0
7737593|NCT00651664|12168469|FG002|Overall Study|Reason not Specified|0
7737594|NCT00651664|12168470|FG003|Overall Study|Reason not Specified|0
7737595|NCT00651664|12168471|FG004|Overall Study|Reason not Specified|0
7737596|NCT00651664|12168472|FG005|Overall Study|Reason not Specified|0
7737597|NCT00651664|12168473|FG006|Overall Study|Reason not Specified|1
7737598|NCT00651664|12168474|FG007|Overall Study|Reason not Specified|0
7737599|NCT00651664|12168475|FG008|Overall Study|Reason not Specified|0
7737600|NCT00651664|12168476|FG009|Overall Study|Reason not Specified|0
7737601|NCT00651755|12168502|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
7737602|NCT00651755|12168503|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
7737603|NCT00651755|12168502|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0
7737604|NCT00651755|12168503|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1
7737605|NCT00651820|12168523|FG000|Overall Study|Lost to Follow-up|2
7737606|NCT00651924|12168531|FG000|Overall Study|Withdrawal by PI|0
7737607|NCT00651924|12168532|FG001|Overall Study|Withdrawal by PI|2
7737608|NCT00651924|12168531|FG000|Overall Study|Withdrawal by Subject|0
7737609|NCT00651924|12168532|FG001|Overall Study|Withdrawal by Subject|5
7737610|NCT00651937|12168540|FG000|Overall Study|Withdrawal by Subject|4
7737611|NCT00651937|12168541|FG001|Overall Study|Withdrawal by Subject|1
7737612|NCT00652028|12168551|FG000|Overall Study|Adverse Event|1
7737613|NCT00652028|12168552|FG001|Overall Study|Adverse Event|0
7737614|NCT00652028|12168553|FG002|Overall Study|Adverse Event|0
7737615|NCT00652028|12168554|FG003|Overall Study|Adverse Event|0
7737616|NCT00652028|12168551|FG000|Overall Study|No Longer Meets Entry Criteria|0
7737617|NCT00652028|12168552|FG001|Overall Study|No Longer Meets Entry Criteria|1
7737618|NCT00652028|12168553|FG002|Overall Study|No Longer Meets Entry Criteria|0
7737619|NCT00652028|12168554|FG003|Overall Study|No Longer Meets Entry Criteria|0
7737620|NCT00652028|12168551|FG000|Overall Study|Physician Decision|0
7737621|NCT00652028|12168552|FG001|Overall Study|Physician Decision|0
7737622|NCT00652028|12168553|FG002|Overall Study|Physician Decision|1
7737623|NCT00652028|12168554|FG003|Overall Study|Physician Decision|0
7737624|NCT00652093|12168576|FG000|Overall Study|Withdrawal by Subject|0
7737625|NCT00652093|12168577|FG001|Overall Study|Withdrawal by Subject|0
7737626|NCT00652093|12168578|FG002|Overall Study|Withdrawal by Subject|1
7737627|NCT00652093|12168579|FG003|Overall Study|Withdrawal by Subject|0
7737628|NCT00652093|12168580|FG004|Overall Study|Withdrawal by Subject|1
7737629|NCT00652093|12168581|FG005|Overall Study|Withdrawal by Subject|0
7737630|NCT00652093|12168576|FG000|Overall Study|Physician Decision|0
7737631|NCT00652093|12168577|FG001|Overall Study|Physician Decision|0
7737632|NCT00652093|12168578|FG002|Overall Study|Physician Decision|0
7737633|NCT00652093|12168579|FG003|Overall Study|Physician Decision|0
7737634|NCT00652093|12168580|FG004|Overall Study|Physician Decision|1
7737635|NCT00652093|12168581|FG005|Overall Study|Physician Decision|0
7737636|NCT00652340|12168617|FG000|Overall Study|Had not progressed.|4
7737637|NCT00652340|12168618|FG001|Overall Study|Had not progressed.|3
7737638|NCT00652366|12168629|FG000|Overall Study|Adverse Event|8
7737639|NCT00652366|12168630|FG001|Overall Study|Adverse Event|4
7737640|NCT00652366|12168631|FG002|Overall Study|Adverse Event|7
7737641|NCT00652366|12168632|FG003|Overall Study|Adverse Event|17
7737642|NCT00652366|12168633|FG004|Overall Study|Adverse Event|13
7737643|NCT00652366|12168629|FG000|Overall Study|Death|5
7737644|NCT00652366|12168630|FG001|Overall Study|Death|4
7737645|NCT00652366|12168631|FG002|Overall Study|Death|1
7737646|NCT00652366|12168632|FG003|Overall Study|Death|8
7737647|NCT00652366|12168633|FG004|Overall Study|Death|5
7737648|NCT00652366|12168629|FG000|Overall Study|Lack of Efficacy|84
7737649|NCT00652366|12168630|FG001|Overall Study|Lack of Efficacy|58
7737650|NCT00652366|12168631|FG002|Overall Study|Lack of Efficacy|53
7737651|NCT00652366|12168632|FG003|Overall Study|Lack of Efficacy|133
7737652|NCT00652366|12168633|FG004|Overall Study|Lack of Efficacy|13
7737653|NCT00652366|12168629|FG000|Overall Study|Violation of Selection Criteria|0
7737654|NCT00652366|12168630|FG001|Overall Study|Violation of Selection Criteria|0
7737655|NCT00652366|12168631|FG002|Overall Study|Violation of Selection Criteria|1
7737656|NCT00652366|12168632|FG003|Overall Study|Violation of Selection Criteria|0
7737657|NCT00652366|12168633|FG004|Overall Study|Violation of Selection Criteria|0
7737658|NCT00652366|12168629|FG000|Overall Study|Protocol Violation|1
7737659|NCT00652366|12168630|FG001|Overall Study|Protocol Violation|0
7737660|NCT00652366|12168631|FG002|Overall Study|Protocol Violation|0
7737661|NCT00652366|12168632|FG003|Overall Study|Protocol Violation|0
7737662|NCT00652366|12168633|FG004|Overall Study|Protocol Violation|0
7737663|NCT00652366|12168629|FG000|Overall Study|Refused treatment|3
7737664|NCT00652366|12168630|FG001|Overall Study|Refused treatment|7
7737665|NCT00652366|12168631|FG002|Overall Study|Refused treatment|6
7737666|NCT00652366|12168632|FG003|Overall Study|Refused treatment|17
7737667|NCT00652366|12168633|FG004|Overall Study|Refused treatment|5
7737668|NCT00652366|12168629|FG000|Overall Study|Other|5
7737669|NCT00652366|12168630|FG001|Overall Study|Other|2
7737670|NCT00652366|12168631|FG002|Overall Study|Other|3
7737671|NCT00652366|12168632|FG003|Overall Study|Other|4
7737672|NCT00652366|12168633|FG004|Overall Study|Other|0
7737673|NCT00652626|12168654|FG000|Initial Treatment Phase|Adverse Event|0
7737674|NCT00652626|12168655|FG001|Initial Treatment Phase|Adverse Event|0
7737675|NCT00652626|12168656|FG002|Initial Treatment Phase|Adverse Event|0
7737676|NCT00652626|12168657|FG003|Initial Treatment Phase|Adverse Event|0
7737677|NCT00652626|12168658|FG004|Initial Treatment Phase|Adverse Event|1
7737678|NCT00652626|12168659|FG005|Initial Treatment Phase|Adverse Event|0
7737679|NCT00652626|12168660|FG006|Initial Treatment Phase|Adverse Event|0
7737680|NCT00652626|12168654|FG000|Initial Treatment Phase|Protocol Violation|0
7737681|NCT00652626|12168655|FG001|Initial Treatment Phase|Protocol Violation|0
7737682|NCT00652626|12168656|FG002|Initial Treatment Phase|Protocol Violation|0
7737683|NCT00652626|12168657|FG003|Initial Treatment Phase|Protocol Violation|1
7737684|NCT00652626|12168658|FG004|Initial Treatment Phase|Protocol Violation|0
7737685|NCT00652626|12168659|FG005|Initial Treatment Phase|Protocol Violation|0
7769010|NCT00865709|12212417|FG000|Treatment|Withdrawal by Subject|10
7737686|NCT00652626|12168660|FG006|Initial Treatment Phase|Protocol Violation|0
7737687|NCT00652626|12168654|FG000|Initial Treatment Phase|Physician Decision|0
7737688|NCT00652626|12168655|FG001|Initial Treatment Phase|Physician Decision|0
7737689|NCT00652626|12168656|FG002|Initial Treatment Phase|Physician Decision|0
7737690|NCT00652626|12168657|FG003|Initial Treatment Phase|Physician Decision|0
7737691|NCT00652626|12168658|FG004|Initial Treatment Phase|Physician Decision|1
7737692|NCT00652626|12168659|FG005|Initial Treatment Phase|Physician Decision|0
7737693|NCT00652626|12168660|FG006|Initial Treatment Phase|Physician Decision|0
7737694|NCT00652626|12168654|FG000|Initial Treatment Phase|Sponsor Request|0
7737695|NCT00652626|12168655|FG001|Initial Treatment Phase|Sponsor Request|0
7737696|NCT00652626|12168656|FG002|Initial Treatment Phase|Sponsor Request|1
7737697|NCT00652626|12168657|FG003|Initial Treatment Phase|Sponsor Request|0
7737698|NCT00652626|12168658|FG004|Initial Treatment Phase|Sponsor Request|0
7737699|NCT00652626|12168659|FG005|Initial Treatment Phase|Sponsor Request|0
7737700|NCT00652626|12168660|FG006|Initial Treatment Phase|Sponsor Request|0
7737701|NCT00652626|12168654|FG000|Initial Treatment Phase|Lost to Follow-up|0
7737702|NCT00652626|12168655|FG001|Initial Treatment Phase|Lost to Follow-up|0
7737703|NCT00652626|12168656|FG002|Initial Treatment Phase|Lost to Follow-up|0
7737704|NCT00652626|12168657|FG003|Initial Treatment Phase|Lost to Follow-up|0
7737705|NCT00652626|12168658|FG004|Initial Treatment Phase|Lost to Follow-up|1
7737706|NCT00652626|12168659|FG005|Initial Treatment Phase|Lost to Follow-up|0
7737707|NCT00652626|12168660|FG006|Initial Treatment Phase|Lost to Follow-up|0
7737708|NCT00652626|12168654|FG000|Extension Phase|Withdrawal by Subject|0
7737709|NCT00652626|12168655|FG001|Extension Phase|Withdrawal by Subject|0
7737710|NCT00652626|12168656|FG002|Extension Phase|Withdrawal by Subject|0
7737711|NCT00652626|12168657|FG003|Extension Phase|Withdrawal by Subject|0
7737712|NCT00652626|12168658|FG004|Extension Phase|Withdrawal by Subject|0
7737713|NCT00652626|12168659|FG005|Extension Phase|Withdrawal by Subject|2
7737714|NCT00652626|12168660|FG006|Extension Phase|Withdrawal by Subject|0
7737715|NCT00652626|12168654|FG000|Extension Phase|Adverse Event|0
7737716|NCT00652626|12168655|FG001|Extension Phase|Adverse Event|0
7737717|NCT00652626|12168656|FG002|Extension Phase|Adverse Event|0
7737718|NCT00652626|12168657|FG003|Extension Phase|Adverse Event|0
7737719|NCT00652626|12168658|FG004|Extension Phase|Adverse Event|0
7737720|NCT00652626|12168659|FG005|Extension Phase|Adverse Event|2
7737721|NCT00652626|12168660|FG006|Extension Phase|Adverse Event|1
7737722|NCT00652626|12168654|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0
7737723|NCT00652626|12168655|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0
7737724|NCT00652626|12168656|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0
7737725|NCT00652626|12168657|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0
7737726|NCT00652626|12168658|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0
7737727|NCT00652626|12168659|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6
7737728|NCT00652626|12168660|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0
7737729|NCT00652626|12168654|FG000|Extension Phase|Physician Decision|0
7737730|NCT00652626|12168655|FG001|Extension Phase|Physician Decision|0
7737731|NCT00652626|12168656|FG002|Extension Phase|Physician Decision|0
7737732|NCT00652626|12168657|FG003|Extension Phase|Physician Decision|0
7737733|NCT00652626|12168658|FG004|Extension Phase|Physician Decision|0
7737734|NCT00652626|12168659|FG005|Extension Phase|Physician Decision|1
7737735|NCT00652626|12168660|FG006|Extension Phase|Physician Decision|1
7737736|NCT00652626|12168654|FG000|Extension Phase|Death|0
7737737|NCT00652626|12168655|FG001|Extension Phase|Death|0
7737738|NCT00652626|12168656|FG002|Extension Phase|Death|0
7737739|NCT00652626|12168657|FG003|Extension Phase|Death|0
7737740|NCT00652626|12168658|FG004|Extension Phase|Death|0
7737741|NCT00652626|12168659|FG005|Extension Phase|Death|1
7737742|NCT00652626|12168660|FG006|Extension Phase|Death|1
7737743|NCT00652743|12168681|FG000|Months 12-18|Lost to Follow-up|1
7737744|NCT00652743|12168682|FG001|Months 12-18|Lost to Follow-up|2
7737745|NCT00652743|12168683|FG002|Months 12-18|Lost to Follow-up|7
7737746|NCT00652743|12168681|FG000|Months 24-30|Other|5
7737747|NCT00652743|12168682|FG001|Months 24-30|Other|1
7737748|NCT00652743|12168683|FG002|Months 24-30|Other|11
7737749|NCT00652743|12168681|FG000|Months 36-42|Serious Adverse Events|0
7737750|NCT00652743|12168682|FG001|Months 36-42|Serious Adverse Events|1
7737751|NCT00652743|12168683|FG002|Months 36-42|Serious Adverse Events|1
7737752|NCT00652743|12168681|FG000|Months 36-42|Withdrawal by Subject|1
7737753|NCT00652743|12168682|FG001|Months 36-42|Withdrawal by Subject|1
7737754|NCT00652743|12168683|FG002|Months 36-42|Withdrawal by Subject|0
7737755|NCT00652743|12168681|FG000|Months 36-42|Lost to Follow-up|0
7737756|NCT00652743|12168682|FG001|Months 36-42|Lost to Follow-up|1
7737757|NCT00652743|12168683|FG002|Months 36-42|Lost to Follow-up|0
7737758|NCT00652743|12168681|FG000|Months 36-42|Migrated/moved from study area|1
7737759|NCT00652743|12168682|FG001|Months 36-42|Migrated/moved from study area|0
7737760|NCT00652743|12168683|FG002|Months 36-42|Migrated/moved from study area|0
7737761|NCT00652743|12168681|FG000|Months 36-42|Other|4
7737762|NCT00652743|12168682|FG001|Months 36-42|Other|2
7737763|NCT00652743|12168683|FG002|Months 36-42|Other|8
7737764|NCT00652834|12168694|FG000|Overall Study|Withdrawal by Subject|3
7737765|NCT00652834|12168694|FG000|Overall Study|Lost to Follow-up|2
7737766|NCT00652899|12168698|FG000|Overall Study|Death|1
7737767|NCT00652899|12168698|FG000|Overall Study|Treating physician decision|1
7737768|NCT00652938|12168709|FG000|Overall Study|Adverse Event|1
7737769|NCT00652938|12168710|FG001|Overall Study|Adverse Event|0
7737770|NCT00652938|12168711|FG002|Overall Study|Adverse Event|2
7737771|NCT00652938|12168709|FG000|Overall Study|Withdrawal by Subject|0
7737772|NCT00652938|12168710|FG001|Overall Study|Withdrawal by Subject|6
7737773|NCT00652938|12168711|FG002|Overall Study|Withdrawal by Subject|1
7737774|NCT00652938|12168709|FG000|Overall Study|Lost to Follow-up|0
7737775|NCT00652938|12168710|FG001|Overall Study|Lost to Follow-up|0
7737776|NCT00652938|12168711|FG002|Overall Study|Lost to Follow-up|2
7737777|NCT00652938|12168709|FG000|Overall Study|fear of blood sampling|0
7737778|NCT00652938|12168710|FG001|Overall Study|fear of blood sampling|1
7737779|NCT00652938|12168711|FG002|Overall Study|fear of blood sampling|0
7737780|NCT00652951|12168722|FG000|Booster Phase|Adverse event, non-fatal|0
7737781|NCT00652951|12168723|FG001|Booster Phase|Adverse event, non-fatal|1
7737782|NCT00652951|12168724|FG002|Booster Phase|Adverse event, non-fatal|0
7737783|NCT00652951|12168722|FG000|Booster Phase|Other|1
7737784|NCT00652951|12168723|FG001|Booster Phase|Other|0
7737785|NCT00652951|12168724|FG002|Booster Phase|Other|0
7737786|NCT00653159|12168743|FG000|Overall Study|Adverse Event|4
7737787|NCT00653159|12168744|FG001|Overall Study|Adverse Event|1
7737788|NCT00653159|12168743|FG000|Overall Study|Lost to Follow-up|1
7737789|NCT00653159|12168744|FG001|Overall Study|Lost to Follow-up|2
7737790|NCT00653224|12168752|FG000|Overall Study|Adverse Event|2
7737791|NCT00653224|12168753|FG001|Overall Study|Adverse Event|1
7737792|NCT00653224|12168752|FG000|Overall Study|Lack of Efficacy|1
7737793|NCT00653224|12168753|FG001|Overall Study|Lack of Efficacy|2
7737794|NCT00653224|12168752|FG000|Overall Study|Loss of efficacy|1
7737795|NCT00653224|12168753|FG001|Overall Study|Loss of efficacy|0
7737796|NCT00653224|12168752|FG000|Overall Study|Lost to Follow-up|1
7737797|NCT00653224|12168753|FG001|Overall Study|Lost to Follow-up|0
7737798|NCT00653224|12168752|FG000|Overall Study|Other|2
7737799|NCT00653224|12168753|FG001|Overall Study|Other|4
7737800|NCT00653263|12168759|FG000|Overall Study|Withdrawal by Subject|1
7737801|NCT00653263|12168759|FG000|Overall Study|Physician Decision|1
7737802|NCT00653328|12168763|FG000|Overall Study|Withdrawal by Subject|1
7737803|NCT00653328|12168763|FG000|Overall Study|Adverse Event|2
7737804|NCT00653328|12168763|FG000|Overall Study|Disease progression|10
7737805|NCT00653328|12168763|FG000|Overall Study|Drug manufacturer no longing making drug|2
7737806|NCT00653432|12168769|FG000|Overall Study|Adverse Event|4
7737807|NCT00653432|12168770|FG001|Overall Study|Adverse Event|1
7737808|NCT00653432|12168769|FG000|Overall Study|Withdrawal by Subject|4
7737809|NCT00653432|12168770|FG001|Overall Study|Withdrawal by Subject|5
7737810|NCT00653432|12168769|FG000|Overall Study|Lost to Follow-up|7
7737811|NCT00653432|12168770|FG001|Overall Study|Lost to Follow-up|6
7737812|NCT00653432|12168769|FG000|Overall Study|Use/Need of Con Therapy|2
7737813|NCT00653432|12168770|FG001|Overall Study|Use/Need of Con Therapy|1
7737814|NCT00653432|12168769|FG000|Overall Study|Other - Reason Not Provided|5
7737815|NCT00653432|12168770|FG001|Overall Study|Other - Reason Not Provided|3
7737816|NCT00653939|12168787|FG000|Overall Study|Adverse Event|1
7737817|NCT00653939|12168788|FG001|Overall Study|Adverse Event|3
7737818|NCT00653939|12168787|FG000|Overall Study|Withdrawal by Subject|3
7737819|NCT00653939|12168788|FG001|Overall Study|Withdrawal by Subject|3
7737820|NCT00653939|12168787|FG000|Overall Study|Physician Decision|4
7737821|NCT00653939|12168788|FG001|Overall Study|Physician Decision|0
7737822|NCT00653939|12168787|FG000|Overall Study|Disease Progression|2
7737823|NCT00653939|12168788|FG001|Overall Study|Disease Progression|3
7737824|NCT00653939|12168787|FG000|Overall Study|Other|2
7737825|NCT00653939|12168788|FG001|Overall Study|Other|6
7737826|NCT00653991|12168798|FG000|3 Month Follow-up|Participant would not respond|150
7737827|NCT00653991|12168799|FG001|3 Month Follow-up|Participant would not respond|157
7737828|NCT00653991|12168798|FG000|6 Month Follow-up|Participant would not respond|133
7737829|NCT00653991|12168799|FG001|6 Month Follow-up|Participant would not respond|141
7737830|NCT00654004|12168809|FG000|Overall Study|Lost to Follow-up|1
7737831|NCT00654004|12168810|FG001|Overall Study|Lost to Follow-up|0
7737832|NCT00654186|12168842|FG000|Overall Study|Withdrawal by Subject|5
7737833|NCT00654238|12168846|FG000|Overall Study|Screen Failures|4
7737834|NCT00654355|12168870|FG000|Overall Study|Lost to Follow-up|2
7737835|NCT00654355|12168871|FG001|Overall Study|Lost to Follow-up|2
7769011|NCT00865709|12212418|FG001|Treatment|Withdrawal by Subject|7
7737836|NCT00654368|12168880|FG000|Overall Study|Ineligibility determined|6
7737837|NCT00654368|12168881|FG001|Overall Study|Ineligibility determined|0
7737838|NCT00654368|12168882|FG002|Overall Study|Ineligibility determined|0
7737839|NCT00654368|12168880|FG000|Overall Study|Protocol deviation|3
7737840|NCT00654368|12168881|FG001|Overall Study|Protocol deviation|2
7737841|NCT00654368|12168882|FG002|Overall Study|Protocol deviation|1
7737842|NCT00654368|12168880|FG000|Overall Study|Non-compliance|2
7737843|NCT00654368|12168881|FG001|Overall Study|Non-compliance|1
7737844|NCT00654368|12168882|FG002|Overall Study|Non-compliance|2
7737845|NCT00654368|12168880|FG000|Overall Study|Withdrawal by Subject|5
7737846|NCT00654368|12168881|FG001|Overall Study|Withdrawal by Subject|2
7737847|NCT00654368|12168882|FG002|Overall Study|Withdrawal by Subject|2
7737848|NCT00654368|12168880|FG000|Overall Study|Disease progression|21
7737849|NCT00654368|12168881|FG001|Overall Study|Disease progression|31
7737850|NCT00654368|12168882|FG002|Overall Study|Disease progression|13
7737851|NCT00654368|12168880|FG000|Overall Study|Requirement for alternative therapy|1
7737852|NCT00654368|12168881|FG001|Overall Study|Requirement for alternative therapy|1
7737853|NCT00654368|12168882|FG002|Overall Study|Requirement for alternative therapy|1
7737854|NCT00654368|12168880|FG000|Overall Study|Physician Decision|0
7737855|NCT00654368|12168881|FG001|Overall Study|Physician Decision|0
7737856|NCT00654368|12168882|FG002|Overall Study|Physician Decision|2
7737857|NCT00654368|12168880|FG000|Overall Study|Death|1
7737858|NCT00654368|12168881|FG001|Overall Study|Death|0
7737859|NCT00654368|12168882|FG002|Overall Study|Death|0
7737860|NCT00654368|12168880|FG000|Overall Study|Pregnancy|0
7737861|NCT00654368|12168881|FG001|Overall Study|Pregnancy|0
7737862|NCT00654368|12168882|FG002|Overall Study|Pregnancy|2
7737863|NCT00654368|12168880|FG000|Overall Study|Other|0
7737864|NCT00654368|12168881|FG001|Overall Study|Other|2
7737865|NCT00654368|12168882|FG002|Overall Study|Other|3
7737866|NCT00654368|12168880|FG000|Overall Study|Adverse Event|14
7737867|NCT00654368|12168881|FG001|Overall Study|Adverse Event|9
7737868|NCT00654368|12168882|FG002|Overall Study|Adverse Event|6
7737869|NCT00654381|12168893|FG000|1st Stage|Adverse Event|3
7737870|NCT00654381|12168894|FG001|1st Stage|Adverse Event|3
7737871|NCT00654381|12168895|FG002|1st Stage|Adverse Event|3
7737872|NCT00654381|12168896|FG003|1st Stage|Adverse Event|3
7737873|NCT00654381|12168897|FG004|1st Stage|Adverse Event|2
7737874|NCT00654381|12168898|FG005|1st Stage|Adverse Event|1
7737875|NCT00654381|12168893|FG000|1st Stage|Withdrawal by Subject|0
7737876|NCT00654381|12168894|FG001|1st Stage|Withdrawal by Subject|0
7737877|NCT00654381|12168895|FG002|1st Stage|Withdrawal by Subject|0
7737878|NCT00654381|12168896|FG003|1st Stage|Withdrawal by Subject|1
7737879|NCT00654381|12168897|FG004|1st Stage|Withdrawal by Subject|0
7737880|NCT00654381|12168898|FG005|1st Stage|Withdrawal by Subject|1
7737881|NCT00654381|12168893|FG000|1st Stage|Investigator's decision|0
7737882|NCT00654381|12168894|FG001|1st Stage|Investigator's decision|0
7737883|NCT00654381|12168895|FG002|1st Stage|Investigator's decision|0
7737884|NCT00654381|12168896|FG003|1st Stage|Investigator's decision|1
7737885|NCT00654381|12168897|FG004|1st Stage|Investigator's decision|0
7737886|NCT00654381|12168898|FG005|1st Stage|Investigator's decision|0
7737887|NCT00654381|12168893|FG000|2nd Stage|Adverse Event|2
7737888|NCT00654381|12168894|FG001|2nd Stage|Adverse Event|0
7737889|NCT00654381|12168895|FG002|2nd Stage|Adverse Event|2
7737890|NCT00654381|12168896|FG003|2nd Stage|Adverse Event|3
7737891|NCT00654381|12168897|FG004|2nd Stage|Adverse Event|7
7737892|NCT00654381|12168898|FG005|2nd Stage|Adverse Event|2
7737893|NCT00654381|12168893|FG000|2nd Stage|Withdrawal by Subject|0
7737894|NCT00654381|12168894|FG001|2nd Stage|Withdrawal by Subject|0
7737895|NCT00654381|12168895|FG002|2nd Stage|Withdrawal by Subject|0
7737896|NCT00654381|12168896|FG003|2nd Stage|Withdrawal by Subject|0
7737897|NCT00654381|12168897|FG004|2nd Stage|Withdrawal by Subject|1
7737898|NCT00654381|12168898|FG005|2nd Stage|Withdrawal by Subject|1
7737899|NCT00654381|12168893|FG000|2nd Stage|Investigator's decision|0
7737900|NCT00654381|12168894|FG001|2nd Stage|Investigator's decision|0
7737901|NCT00654381|12168895|FG002|2nd Stage|Investigator's decision|1
7737902|NCT00654381|12168896|FG003|2nd Stage|Investigator's decision|1
7737903|NCT00654381|12168897|FG004|2nd Stage|Investigator's decision|0
7737904|NCT00654381|12168898|FG005|2nd Stage|Investigator's decision|0
7737905|NCT00654381|12168893|FG000|Extension Stage|Adverse Event|1
7737906|NCT00654381|12168894|FG001|Extension Stage|Adverse Event|2
7737907|NCT00654381|12168895|FG002|Extension Stage|Adverse Event|9
7737908|NCT00654381|12168896|FG003|Extension Stage|Adverse Event|7
7737909|NCT00654381|12168897|FG004|Extension Stage|Adverse Event|1
7737910|NCT00654381|12168898|FG005|Extension Stage|Adverse Event|1
7737911|NCT00654381|12168893|FG000|Extension Stage|Protocol Violation|0
7737912|NCT00654381|12168894|FG001|Extension Stage|Protocol Violation|0
7737913|NCT00654381|12168895|FG002|Extension Stage|Protocol Violation|0
7737914|NCT00654381|12168896|FG003|Extension Stage|Protocol Violation|1
7737915|NCT00654381|12168897|FG004|Extension Stage|Protocol Violation|0
7737916|NCT00654381|12168898|FG005|Extension Stage|Protocol Violation|0
7737917|NCT00654381|12168893|FG000|Extension Stage|Lack of Efficacy|0
7737918|NCT00654381|12168894|FG001|Extension Stage|Lack of Efficacy|0
7737919|NCT00654381|12168895|FG002|Extension Stage|Lack of Efficacy|1
7737920|NCT00654381|12168896|FG003|Extension Stage|Lack of Efficacy|0
7737921|NCT00654381|12168897|FG004|Extension Stage|Lack of Efficacy|0
7737922|NCT00654381|12168898|FG005|Extension Stage|Lack of Efficacy|0
7737923|NCT00654381|12168893|FG000|Extension Stage|Withdrawal by Subject|0
7737924|NCT00654381|12168894|FG001|Extension Stage|Withdrawal by Subject|0
7737925|NCT00654381|12168895|FG002|Extension Stage|Withdrawal by Subject|1
7737926|NCT00654381|12168896|FG003|Extension Stage|Withdrawal by Subject|1
7737927|NCT00654381|12168897|FG004|Extension Stage|Withdrawal by Subject|1
7737928|NCT00654381|12168898|FG005|Extension Stage|Withdrawal by Subject|1
7737929|NCT00654381|12168893|FG000|Extension Stage|Closure of the trial site|0
7737930|NCT00654381|12168894|FG001|Extension Stage|Closure of the trial site|0
7737931|NCT00654381|12168895|FG002|Extension Stage|Closure of the trial site|0
7737932|NCT00654381|12168896|FG003|Extension Stage|Closure of the trial site|0
7737933|NCT00654381|12168897|FG004|Extension Stage|Closure of the trial site|1
7737934|NCT00654381|12168898|FG005|Extension Stage|Closure of the trial site|1
7737935|NCT00654420|12168919|FG000|Phase I (Dose Escalation)|Adverse Event|0
7737936|NCT00654420|12168920|FG001|Phase I (Dose Escalation)|Adverse Event|1
7737937|NCT00654420|12168921|FG002|Phase I (Dose Escalation)|Adverse Event|0
7737938|NCT00654420|12168922|FG003|Phase I (Dose Escalation)|Adverse Event|0
7737939|NCT00654420|12168919|FG000|Phase I (Dose Escalation)|Progressive Disease|4
7737940|NCT00654420|12168920|FG001|Phase I (Dose Escalation)|Progressive Disease|15
7737941|NCT00654420|12168921|FG002|Phase I (Dose Escalation)|Progressive Disease|0
7737942|NCT00654420|12168922|FG003|Phase I (Dose Escalation)|Progressive Disease|0
7737943|NCT00654420|12168919|FG000|Phase II|Adverse Event|0
7737944|NCT00654420|12168920|FG001|Phase II|Adverse Event|0
7737945|NCT00654420|12168921|FG002|Phase II|Adverse Event|3
7737946|NCT00654420|12168922|FG003|Phase II|Adverse Event|3
7737947|NCT00654420|12168919|FG000|Phase II|Lost to Follow-up|0
7737948|NCT00654420|12168920|FG001|Phase II|Lost to Follow-up|0
7737949|NCT00654420|12168921|FG002|Phase II|Lost to Follow-up|0
7737950|NCT00654420|12168922|FG003|Phase II|Lost to Follow-up|1
7737951|NCT00654420|12168919|FG000|Phase II|Physician Decision|0
7737952|NCT00654420|12168920|FG001|Phase II|Physician Decision|0
7737953|NCT00654420|12168921|FG002|Phase II|Physician Decision|0
7737954|NCT00654420|12168922|FG003|Phase II|Physician Decision|4
7737955|NCT00654420|12168919|FG000|Phase II|Progressive Disease|0
7737956|NCT00654420|12168920|FG001|Phase II|Progressive Disease|0
7737957|NCT00654420|12168921|FG002|Phase II|Progressive Disease|29
7737958|NCT00654420|12168922|FG003|Phase II|Progressive Disease|29
7737959|NCT00654420|12168919|FG000|Phase II|Withdrawal by Subject|0
7737960|NCT00654420|12168920|FG001|Phase II|Withdrawal by Subject|0
7737961|NCT00654420|12168921|FG002|Phase II|Withdrawal by Subject|4
7737962|NCT00654420|12168922|FG003|Phase II|Withdrawal by Subject|1
7737963|NCT00654420|12168919|FG000|Phase II|Missing Disposition Record|0
7737964|NCT00654420|12168920|FG001|Phase II|Missing Disposition Record|0
7737965|NCT00654420|12168921|FG002|Phase II|Missing Disposition Record|1
7737966|NCT00654420|12168922|FG003|Phase II|Missing Disposition Record|0
7737967|NCT00654498|12168934|FG000|Overall Study|Not Treated|1
7737968|NCT00654498|12168935|FG001|Overall Study|Not Treated|0
7737969|NCT00654498|12168934|FG000|Overall Study|Adverse Event|6
7737970|NCT00654498|12168935|FG001|Overall Study|Adverse Event|1
7737971|NCT00654498|12168934|FG000|Overall Study|Protocol Violation|1
7737972|NCT00654498|12168935|FG001|Overall Study|Protocol Violation|1
7737973|NCT00654498|12168934|FG000|Overall Study|Lost to Follow-up|1
7737974|NCT00654498|12168935|FG001|Overall Study|Lost to Follow-up|5
7737975|NCT00654498|12168934|FG000|Overall Study|Withdrawal by Subject|1
7737976|NCT00654498|12168935|FG001|Overall Study|Withdrawal by Subject|0
7737977|NCT00654498|12168934|FG000|Overall Study|Other reason not defined above|4
7737978|NCT00654498|12168935|FG001|Overall Study|Other reason not defined above|5
7737979|NCT00654641|12168973|FG000|Overall Study|Lost to Follow-up|2
7737980|NCT00654641|12168974|FG001|Overall Study|Lost to Follow-up|3
7737981|NCT00654732|12168986|FG000|Overall Study|Adverse Event|4
7737982|NCT00654732|12168987|FG001|Overall Study|Adverse Event|6
7737983|NCT00654745|12168993|FG000|Overall Study|Adverse Event|12
7737984|NCT00654745|12168993|FG000|Overall Study|Lost to Follow-up|7
7737985|NCT00654745|12168993|FG000|Overall Study|Protocol Violation|11
7737986|NCT00654745|12168993|FG000|Overall Study|Withdrawal by Subject|10
7737987|NCT00654745|12168993|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3
7737988|NCT00654875|12169018|FG000|Overall Study|Adverse Event|5
7737989|NCT00654875|12169019|FG001|Overall Study|Adverse Event|5
7737990|NCT00654875|12169018|FG000|Overall Study|Withdrawal by Subject|4
7737991|NCT00654875|12169019|FG001|Overall Study|Withdrawal by Subject|4
7737992|NCT00654875|12169018|FG000|Overall Study|Protocol Violation|3
7737993|NCT00654875|12169019|FG001|Overall Study|Protocol Violation|3
7737994|NCT00654875|12169018|FG000|Overall Study|Lack of Efficacy|2
7737995|NCT00654875|12169019|FG001|Overall Study|Lack of Efficacy|2
7737996|NCT00654875|12169018|FG000|Overall Study|Lost to Follow-up|1
7737997|NCT00654875|12169019|FG001|Overall Study|Lost to Follow-up|3
7737998|NCT00654875|12169018|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
7737999|NCT00654875|12169019|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
7738000|NCT00654875|12169018|FG000|Overall Study|Administrative Problems|1
7738001|NCT00654875|12169019|FG001|Overall Study|Administrative Problems|0
7738002|NCT00654901|12169029|FG000|Overall Study|Lost to Follow-up|1
7738003|NCT00654901|12169030|FG001|Overall Study|Lost to Follow-up|0
7738004|NCT00654901|12169031|FG002|Overall Study|Lost to Follow-up|1
7738005|NCT00654901|12169032|FG003|Overall Study|Lost to Follow-up|0
7738006|NCT00654901|12169029|FG000|Overall Study|Withdrawal by Subject|3
7738007|NCT00654901|12169030|FG001|Overall Study|Withdrawal by Subject|0
7738008|NCT00654901|12169031|FG002|Overall Study|Withdrawal by Subject|1
7738009|NCT00654901|12169032|FG003|Overall Study|Withdrawal by Subject|0
7738010|NCT00654940|12169048|FG000|Period 1|Adverse Event|0
7738011|NCT00654940|12169049|FG001|Period 1|Adverse Event|1
7738012|NCT00654940|12169048|FG000|Period 1|Intolerable Pain Level|1
7738013|NCT00654940|12169049|FG001|Period 1|Intolerable Pain Level|0
7738014|NCT00655356|12169085|FG000|Overall Study|Withdrawal by Subject|3
7738015|NCT00655356|12169086|FG001|Overall Study|Withdrawal by Subject|4
7738016|NCT00655356|12169085|FG000|Overall Study|Sponsor Request|10
7738017|NCT00655356|12169086|FG001|Overall Study|Sponsor Request|4
7738018|NCT00655356|12169085|FG000|Overall Study|Adverse Event|1
7738019|NCT00655356|12169086|FG001|Overall Study|Adverse Event|1
7738020|NCT00655356|12169085|FG000|Overall Study|Protocol Violation|2
7738021|NCT00655356|12169086|FG001|Overall Study|Protocol Violation|1
7738022|NCT00655356|12169085|FG000|Overall Study|Other Reason|1
7738023|NCT00655356|12169086|FG001|Overall Study|Other Reason|0
7738024|NCT00655486|12169101|FG000|Overall Study|Adverse Event|10
7738025|NCT00655486|12169101|FG000|Overall Study|Lack of Efficacy|8
7738026|NCT00655486|12169101|FG000|Overall Study|Withdrawal by Subject|4
7738027|NCT00655486|12169101|FG000|Overall Study|Protocol Violation|1
7738028|NCT00655486|12169101|FG000|Overall Study|Unsatisfactory compliance|2
7738029|NCT00655486|12169101|FG000|Overall Study|Other: Pregnancy|1
7738030|NCT00655486|12169101|FG000|Overall Study|Other: Could not tolerate BID dosing|1
7738031|NCT00655486|12169101|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
7738032|NCT00655499|12169105|FG000|Overall Study|not eligible|4
7738033|NCT00655551|12169122|FG000|All Periods Combined|Adverse Event|0
7738034|NCT00655551|12169123|FG001|All Periods Combined|Adverse Event|3
7738035|NCT00655551|12169124|FG002|All Periods Combined|Adverse Event|4
7738036|NCT00655551|12169122|FG000|Period 2 (up to 7 Days)|Adverse Event|0
7738037|NCT00655551|12169123|FG001|Period 2 (up to 7 Days)|Adverse Event|1
7738038|NCT00655551|12169124|FG002|Period 2 (up to 7 Days)|Adverse Event|0
7738039|NCT00655551|12169122|FG000|Period 3 (up to 7 Days)|Adverse Event|0
7738040|NCT00655551|12169123|FG001|Period 3 (up to 7 Days)|Adverse Event|0
7738041|NCT00655551|12169124|FG002|Period 3 (up to 7 Days)|Adverse Event|4
7738042|NCT00655551|12169122|FG000|Period 4 (up to 7 Days)|Adverse Event|0
7738043|NCT00655551|12169123|FG001|Period 4 (up to 7 Days)|Adverse Event|2
7738044|NCT00655551|12169124|FG002|Period 4 (up to 7 Days)|Adverse Event|0
7738045|NCT00655564|12169132|FG000|Overall Study|Adverse Event|1
7738046|NCT00655564|12169132|FG000|Overall Study|Lost to Follow-up|1
7738047|NCT00655564|12169132|FG000|Overall Study|Desired Alternate Therapy|1
7738048|NCT00655629|12169139|FG000|Overall Study|Adverse Event|4
7738049|NCT00655629|12169140|FG001|Overall Study|Adverse Event|1
7738050|NCT00655629|12169139|FG000|Overall Study|Lack of Efficacy|2
7738051|NCT00655629|12169140|FG001|Overall Study|Lack of Efficacy|12
7738052|NCT00655629|12169139|FG000|Overall Study|Lost to Follow-up|4
7738053|NCT00655629|12169140|FG001|Overall Study|Lost to Follow-up|3
7738054|NCT00655629|12169139|FG000|Overall Study|Protocol Violation|5
7962158|NCT02709746|12516276|FG004|Phase B (Double-blind Treatment Period)|Other|7
7738055|NCT00655629|12169140|FG001|Overall Study|Protocol Violation|3
7738056|NCT00655629|12169139|FG000|Overall Study|consent withdrawn|6
7738057|NCT00655629|12169140|FG001|Overall Study|consent withdrawn|4
7738058|NCT00655668|12169163|FG000|Overall Study|Adverse Event|6
7738059|NCT00655668|12169163|FG000|Overall Study|Death|5
7738060|NCT00655668|12169163|FG000|Overall Study|Disease Progression|27
7738061|NCT00655668|12169163|FG000|Overall Study|Study Terminated|9
7738062|NCT00655668|12169163|FG000|Overall Study|Other|1
7738063|NCT00655668|12169163|FG000|Overall Study|New Lymphoma Treatment Started|4
7738064|NCT00655668|12169163|FG000|Overall Study|Withdrawal by Subject|2
7738065|NCT00655733|12169174|FG000|Overall Study|Lost to Follow-up|2
7738066|NCT00655733|12169175|FG001|Overall Study|Lost to Follow-up|2
7738067|NCT00655733|12169174|FG000|Overall Study|Adverse Event|2
7738068|NCT00655733|12169175|FG001|Overall Study|Adverse Event|2
7738069|NCT00655733|12169174|FG000|Overall Study|Withdrawal by Subject|3
7738070|NCT00655733|12169175|FG001|Overall Study|Withdrawal by Subject|3
7738071|NCT00655733|12169174|FG000|Overall Study|Physician Decision|0
7738072|NCT00655733|12169175|FG001|Overall Study|Physician Decision|1
7738073|NCT00655746|12169183|FG000|Overall Study|Withdrawal by Subject|1
7738074|NCT00655850|12169201|FG000|Overall Study|Death|2
7738075|NCT00655850|12169201|FG000|Overall Study|Withdrawal by Subject|1
7738076|NCT00655863|12169210|FG000|Overall Study|Lost to Follow-up|0
7738077|NCT00655863|12169211|FG001|Overall Study|Lost to Follow-up|0
7738078|NCT00655863|12169212|FG002|Overall Study|Lost to Follow-up|1
7738079|NCT00655889|12169220|FG000|Overall Study|Inadequate cell growth|1
7738080|NCT00655889|12169220|FG000|Overall Study|Protocol Violation|1
7738081|NCT00655928|12169226|FG000|Overall Study|Withdrawal by Subject|2
7738082|NCT00655928|12169227|FG001|Overall Study|Withdrawal by Subject|1
7738083|NCT00655928|12169226|FG000|Overall Study|Physician Decision|1
7738084|NCT00655928|12169227|FG001|Overall Study|Physician Decision|1
7738085|NCT00655980|12169236|FG000|Overall Study|surgery canceled; or subject or anesthes|26
7738086|NCT00655980|12169237|FG001|Overall Study|surgery canceled; or subject or anesthes|31
7738087|NCT00655980|12169238|FG002|Overall Study|surgery canceled; or subject or anesthes|5
7738088|NCT00656019|12169253|FG000|Overall Study|Not Eligible|10
7738089|NCT00656019|12169254|FG001|Overall Study|Not Eligible|0
7738090|NCT00656019|12169255|FG002|Overall Study|Not Eligible|0
7738091|NCT00656019|12169256|FG003|Overall Study|Not Eligible|0
7738092|NCT00656019|12169253|FG000|Overall Study|Withdrawal by Subject|2
7738093|NCT00656019|12169254|FG001|Overall Study|Withdrawal by Subject|0
7738094|NCT00656019|12169255|FG002|Overall Study|Withdrawal by Subject|0
7738095|NCT00656019|12169256|FG003|Overall Study|Withdrawal by Subject|0
7738096|NCT00656019|12169253|FG000|Overall Study|Lost to Follow-up|2
7738097|NCT00656019|12169254|FG001|Overall Study|Lost to Follow-up|1
7738098|NCT00656019|12169255|FG002|Overall Study|Lost to Follow-up|0
7738099|NCT00656019|12169256|FG003|Overall Study|Lost to Follow-up|0
7738100|NCT00656058|12169266|FG000|Overall Study|Withdrawal by Subject|2
7738101|NCT00656058|12169266|FG000|Overall Study|Withdrawal by Subject|4
7738102|NCT00656084|12169270|FG000|Overall Study|Adverse Event|4
7738103|NCT00656084|12169270|FG000|Overall Study|Withdrawal by Subject|1
7738104|NCT00656084|12169270|FG000|Overall Study|Patient Request|1
7738105|NCT00656084|12169270|FG000|Overall Study|Investigator Request|1
7738106|NCT00656136|12169276|FG000|Overall Study|Progressive disease|177
7738107|NCT00656136|12169277|FG001|Overall Study|Progressive disease|322
7738108|NCT00656136|12169276|FG000|Overall Study|Other Adverse Event|5
7738109|NCT00656136|12169277|FG001|Overall Study|Other Adverse Event|51
7738110|NCT00656136|12169276|FG000|Overall Study|Protocol Violation|2
7738111|NCT00656136|12169277|FG001|Overall Study|Protocol Violation|3
7738112|NCT00656136|12169276|FG000|Overall Study|Patient refused to take study medication|7
7738113|NCT00656136|12169277|FG001|Overall Study|Patient refused to take study medication|10
7738114|NCT00656136|12169276|FG000|Overall Study|Unknown and others|4
7738115|NCT00656136|12169277|FG001|Overall Study|Unknown and others|4
7738116|NCT00656175|12169285|FG000|Overall Study|Adverse Event|1
7738117|NCT00656175|12169286|FG001|Overall Study|Adverse Event|0
7738118|NCT00656175|12169285|FG000|Overall Study|Transportation issues|0
7738119|NCT00656175|12169286|FG001|Overall Study|Transportation issues|1
7738120|NCT00656292|12169303|FG000|Overall Study|Withdrawal by Subject|2
7738121|NCT00656292|12169304|FG001|Overall Study|Withdrawal by Subject|3
7738122|NCT00656292|12169303|FG000|Overall Study|Screen failure|1
7738123|NCT00656292|12169304|FG001|Overall Study|Screen failure|2
7738124|NCT00656370|12169319|FG000|Overall Study|Screen Failures|7
7738125|NCT00656370|12169319|FG000|Overall Study|Alternates|3
7738126|NCT00656474|12169335|FG000|Overall Study|Other Reason|1
7738127|NCT00656513|12169356|FG000|Overall Study|Protocol Violation|1
7738128|NCT00656513|12169357|FG001|Overall Study|Protocol Violation|0
7738129|NCT00656513|12169358|FG002|Overall Study|Protocol Violation|2
7738130|NCT00656513|12169356|FG000|Overall Study|Withdrawal by Subject|0
7738131|NCT00656513|12169357|FG001|Overall Study|Withdrawal by Subject|11
7738132|NCT00656513|12169358|FG002|Overall Study|Withdrawal by Subject|4
7738133|NCT00656513|12169356|FG000|Overall Study|Death|0
7738134|NCT00656513|12169357|FG001|Overall Study|Death|0
7738135|NCT00656513|12169358|FG002|Overall Study|Death|1
7738136|NCT00656513|12169356|FG000|Overall Study|Missing data|0
7738137|NCT00656513|12169357|FG001|Overall Study|Missing data|11
7738138|NCT00656513|12169358|FG002|Overall Study|Missing data|9
7738139|NCT00656513|12169356|FG000|Overall Study|Incomplete treatment|3
7738140|NCT00656513|12169357|FG001|Overall Study|Incomplete treatment|0
7738141|NCT00656513|12169358|FG002|Overall Study|Incomplete treatment|0
7738142|NCT00656513|12169356|FG000|Overall Study|Treatment completed outside of timeframe|0
7738143|NCT00656513|12169357|FG001|Overall Study|Treatment completed outside of timeframe|3
7738144|NCT00656513|12169358|FG002|Overall Study|Treatment completed outside of timeframe|1
7738145|NCT00656513|12169356|FG000|Overall Study|Missing baseline form|0
7738146|NCT00656513|12169357|FG001|Overall Study|Missing baseline form|5
7738147|NCT00656513|12169358|FG002|Overall Study|Missing baseline form|5
7738148|NCT00656617|12169366|FG000|Overall Study|Adverse Event|1
7738149|NCT00656617|12169366|FG000|Overall Study|Death|2
7738150|NCT00656617|12169366|FG000|Overall Study|Insurance Issues|2
7738151|NCT00656617|12169366|FG000|Overall Study|Move to different clinical trial|2
7738152|NCT00656669|12169388|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
7738153|NCT00656669|12169388|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
7738154|NCT00656669|12169388|FG000|AC (Cycles 6-9)|Adverse Event|1
7738155|NCT00656669|12169388|FG000|AC (Cycles 6-9)|Did not start segment 3|1
7738156|NCT00656799|12169397|FG000|Overall Study|Death|2
7738157|NCT00656851|12169403|FG000|Overall Study|Withdrawal by Subject|0
7738158|NCT00656851|12169404|FG001|Overall Study|Withdrawal by Subject|4
7738159|NCT00657020|12169419|FG000|PERIOD 1|Adverse Event|0
7738160|NCT00657020|12169420|FG001|PERIOD 1|Adverse Event|1
7738161|NCT00657046|12169435|FG000|Overall Study|Adverse Event|1
7738162|NCT00657046|12169436|FG001|Overall Study|Adverse Event|1
7738163|NCT00657046|12169437|FG002|Overall Study|Adverse Event|0
7738164|NCT00657046|12169435|FG000|Overall Study|Protocol Violation|2
7738165|NCT00657046|12169436|FG001|Overall Study|Protocol Violation|2
7738166|NCT00657046|12169437|FG002|Overall Study|Protocol Violation|0
7738167|NCT00657046|12169435|FG000|Overall Study|Withdrawal by Subject|1
7738168|NCT00657046|12169436|FG001|Overall Study|Withdrawal by Subject|0
7738169|NCT00657046|12169437|FG002|Overall Study|Withdrawal by Subject|0
7738170|NCT00657046|12169435|FG000|Overall Study|Death|0
7738171|NCT00657046|12169436|FG001|Overall Study|Death|0
7738172|NCT00657046|12169437|FG002|Overall Study|Death|1
7738173|NCT00657046|12169435|FG000|Overall Study|Surgery|0
7738174|NCT00657046|12169436|FG001|Overall Study|Surgery|0
7738175|NCT00657046|12169437|FG002|Overall Study|Surgery|1
7738176|NCT00657150|12169447|FG000|Overall Study|Adverse Event|19
7738177|NCT00657150|12169448|FG001|Overall Study|Adverse Event|10
7738178|NCT00657150|12169447|FG000|Overall Study|Non-compliant with protocol|5
7738179|NCT00657150|12169448|FG001|Overall Study|Non-compliant with protocol|9
7738180|NCT00657150|12169447|FG000|Overall Study|Lost to Follow-up|2
7738181|NCT00657150|12169448|FG001|Overall Study|Lost to Follow-up|0
7738182|NCT00657150|12169447|FG000|Overall Study|Withdrawal by Subject|51
7738183|NCT00657150|12169448|FG001|Overall Study|Withdrawal by Subject|36
7738184|NCT00657150|12169447|FG000|Overall Study|Other|38
7738185|NCT00657150|12169448|FG001|Overall Study|Other|38
7738186|NCT00657150|12169447|FG000|Treatment|Adverse Event|60
7738187|NCT00657150|12169448|FG001|Treatment|Adverse Event|53
7738188|NCT00657150|12169447|FG000|Treatment|Non-compliant with protocol|10
7738189|NCT00657150|12169448|FG001|Treatment|Non-compliant with protocol|9
7738190|NCT00657150|12169447|FG000|Treatment|Lost to Follow-up|1
7738191|NCT00657150|12169448|FG001|Treatment|Lost to Follow-up|0
7738192|NCT00657150|12169447|FG000|Treatment|Withdrawal by Subject|23
7738193|NCT00657150|12169448|FG001|Treatment|Withdrawal by Subject|20
7738194|NCT00657150|12169447|FG000|Treatment|Other|13
7738195|NCT00657150|12169448|FG001|Treatment|Other|15
7738196|NCT00657267|12169454|FG000|Overall Study|Progressive disease|45
7738197|NCT00657267|12169454|FG000|Overall Study|Adverse Event|9
7738198|NCT00657358|12169464|FG000|Overall Study|Lack of Efficacy|6
7738199|NCT00657371|12169469|FG000|Overall Study|Poor bowel preparation|15
7738200|NCT00657371|12169469|FG000|Overall Study|Unable to intubate the cecum|5
7738201|NCT00657371|12169469|FG000|Overall Study|Protocol Violation|2
7738202|NCT00657371|12169469|FG000|Overall Study|Device- related reasons|13
7738203|NCT00657371|12169469|FG000|Overall Study|Pre-existing medical condition|4
7738204|NCT00657540|12169475|FG000|Overall Study|Lost to Follow-up|1
7738205|NCT00657540|12169476|FG001|Overall Study|Lost to Follow-up|4
7738206|NCT00657618|12169486|FG000|Overall Study|Adverse Event|32
7738207|NCT00657618|12169486|FG000|Overall Study|Withdrawal by Subject|8
7738208|NCT00657618|12169486|FG000|Overall Study|negative for leishmaniasis|2
7738209|NCT00657618|12169486|FG000|Overall Study|didn't start due to schedule conflicts|1
7738210|NCT00657709|12169499|FG000|Overall Study|AE or Death|7
7738211|NCT00657709|12169500|FG001|Overall Study|AE or Death|7
7738212|NCT00657709|12169501|FG002|Overall Study|AE or Death|6
7738213|NCT00657709|12169502|FG003|Overall Study|AE or Death|7
7738214|NCT00657709|12169503|FG004|Overall Study|AE or Death|1
7738215|NCT00657709|12169499|FG000|Overall Study|Withdrawal by Subject|7
7738216|NCT00657709|12169500|FG001|Overall Study|Withdrawal by Subject|15
7738217|NCT00657709|12169501|FG002|Overall Study|Withdrawal by Subject|15
7738218|NCT00657709|12169502|FG003|Overall Study|Withdrawal by Subject|5
7738219|NCT00657709|12169503|FG004|Overall Study|Withdrawal by Subject|9
7738220|NCT00657709|12169499|FG000|Overall Study|Lost to Follow-up|9
7738221|NCT00657709|12169500|FG001|Overall Study|Lost to Follow-up|9
7738222|NCT00657709|12169501|FG002|Overall Study|Lost to Follow-up|7
7738223|NCT00657709|12169502|FG003|Overall Study|Lost to Follow-up|1
7738224|NCT00657709|12169503|FG004|Overall Study|Lost to Follow-up|21
7738225|NCT00657709|12169499|FG000|Overall Study|Protocol Violation|0
7738226|NCT00657709|12169500|FG001|Overall Study|Protocol Violation|2
7738227|NCT00657709|12169501|FG002|Overall Study|Protocol Violation|0
7738228|NCT00657709|12169502|FG003|Overall Study|Protocol Violation|1
7738229|NCT00657709|12169503|FG004|Overall Study|Protocol Violation|2
7738230|NCT00658021|12169532|FG000|28-Week Treatment Period|Adverse Event|3
7738231|NCT00658021|12169533|FG001|28-Week Treatment Period|Adverse Event|1
7738232|NCT00658021|12169534|FG002|28-Week Treatment Period|Adverse Event|0
7738233|NCT00658021|12169532|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0
7738234|NCT00658021|12169533|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2
7738235|NCT00658021|12169534|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0
7738236|NCT00658021|12169532|FG000|28-Week Treatment Period|Protocol Violation|0
7738237|NCT00658021|12169533|FG001|28-Week Treatment Period|Protocol Violation|2
7738238|NCT00658021|12169534|FG002|28-Week Treatment Period|Protocol Violation|1
7738239|NCT00658021|12169532|FG000|28-Week Treatment Period|Withdrawal by Subject|1
7738240|NCT00658021|12169533|FG001|28-Week Treatment Period|Withdrawal by Subject|1
7738241|NCT00658021|12169534|FG002|28-Week Treatment Period|Withdrawal by Subject|3
7738242|NCT00658021|12169532|FG000|28-Week Treatment Period|Physician Decision|1
7738243|NCT00658021|12169533|FG001|28-Week Treatment Period|Physician Decision|2
7738244|NCT00658021|12169534|FG002|28-Week Treatment Period|Physician Decision|1
7738245|NCT00658021|12169532|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1
7738246|NCT00658021|12169533|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1
7738247|NCT00658021|12169534|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1
7738248|NCT00658021|12169532|FG000|28-Week Treatment Period|Loss of glucose control|1
7738249|NCT00658021|12169533|FG001|28-Week Treatment Period|Loss of glucose control|1
7738250|NCT00658021|12169534|FG002|28-Week Treatment Period|Loss of glucose control|10
7738251|NCT00658021|12169532|FG000|28-Week Treatment Period|Other|2
7738252|NCT00658021|12169533|FG001|28-Week Treatment Period|Other|3
7738253|NCT00658021|12169534|FG002|28-Week Treatment Period|Other|1
7738254|NCT00658021|12169532|FG000|28-Week Treatment Period|Did not receive treatment|2
7738255|NCT00658021|12169533|FG001|28-Week Treatment Period|Did not receive treatment|0
7738256|NCT00658021|12169534|FG002|28-Week Treatment Period|Did not receive treatment|0
7738257|NCT00658021|12169532|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0
7738258|NCT00658021|12169533|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1
7738259|NCT00658021|12169534|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0
7738260|NCT00658021|12169532|FG000|Long-term Safety Follow-up Period|Physician Decision|0
7738261|NCT00658021|12169533|FG001|Long-term Safety Follow-up Period|Physician Decision|2
7738262|NCT00658021|12169534|FG002|Long-term Safety Follow-up Period|Physician Decision|0
7738263|NCT00658320|12169555|FG000|Core Study: 12 Months|Subject withdrew consent|5
7738264|NCT00658320|12169556|FG001|Core Study: 12 Months|Subject withdrew consent|3
7738265|NCT00658320|12169555|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
7738266|NCT00658320|12169556|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
7738267|NCT00658320|12169555|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
7738268|NCT00658320|12169556|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
7738269|NCT00658320|12169555|FG000|Extension Study: After Month 24|Subject withdrew consent|2
7738270|NCT00658320|12169556|FG001|Extension Study: After Month 24|Subject withdrew consent|0
7738271|NCT00658333|12169566|FG000|Overall Study|Adverse Event|2
7738272|NCT00658333|12169567|FG001|Overall Study|Adverse Event|1
7738273|NCT00658359|12169576|FG000|Overall Study|Death|3
7738274|NCT00658359|12169577|FG001|Overall Study|Death|1
7738275|NCT00658359|12169578|FG002|Overall Study|Death|2
7738276|NCT00658359|12169576|FG000|Overall Study|Adverse Event|13
7738277|NCT00658359|12169577|FG001|Overall Study|Adverse Event|6
7738278|NCT00658359|12169578|FG002|Overall Study|Adverse Event|9
7738279|NCT00658359|12169576|FG000|Overall Study|Protocol Violation|1
7738280|NCT00658359|12169577|FG001|Overall Study|Protocol Violation|0
7738281|NCT00658359|12169578|FG002|Overall Study|Protocol Violation|0
7738282|NCT00658359|12169576|FG000|Overall Study|Includes protocol Amendments 3 and 4|2
7738283|NCT00658359|12169577|FG001|Overall Study|Includes protocol Amendments 3 and 4|31
7738284|NCT00658359|12169578|FG002|Overall Study|Includes protocol Amendments 3 and 4|29
7738285|NCT00658359|12169576|FG000|Overall Study|Withdrawal by Subject|7
7738286|NCT00658359|12169577|FG001|Overall Study|Withdrawal by Subject|4
7738287|NCT00658359|12169578|FG002|Overall Study|Withdrawal by Subject|2
7738288|NCT00658359|12169576|FG000|Overall Study|Lost to Follow-up|2
7738289|NCT00658359|12169577|FG001|Overall Study|Lost to Follow-up|2
7738290|NCT00658359|12169578|FG002|Overall Study|Lost to Follow-up|4
7738291|NCT00658359|12169576|FG000|Overall Study|Lack of Efficacy|0
7738292|NCT00658359|12169577|FG001|Overall Study|Lack of Efficacy|1
7738293|NCT00658359|12169578|FG002|Overall Study|Lack of Efficacy|0
7738294|NCT00658528|12169611|FG000|Overall Study|Adverse Event|5
7738295|NCT00658528|12169612|FG001|Overall Study|Adverse Event|7
7738296|NCT00658528|12169611|FG000|Overall Study|Lost to Follow-up|14
7738297|NCT00658528|12169612|FG001|Overall Study|Lost to Follow-up|22
7738298|NCT00658528|12169611|FG000|Overall Study|Withdrawal by Subject|8
7738299|NCT00658528|12169612|FG001|Overall Study|Withdrawal by Subject|6
7738300|NCT00658528|12169611|FG000|Overall Study|Withdrawal of consent|5
7738301|NCT00658528|12169612|FG001|Overall Study|Withdrawal of consent|6
7738302|NCT00658528|12169611|FG000|Overall Study|Other|8
7738303|NCT00658528|12169612|FG001|Overall Study|Other|4
7738304|NCT00658541|12169618|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
7738305|NCT00658541|12169619|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7738306|NCT00658541|12169618|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
7738307|NCT00658541|12169619|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7738308|NCT00658567|12169628|FG000|Overall Study|Adverse Event|5
7738309|NCT00658567|12169629|FG001|Overall Study|Adverse Event|2
7738310|NCT00658567|12169630|FG002|Overall Study|Adverse Event|3
7738311|NCT00658567|12169628|FG000|Overall Study|Voluntary Withdrawal of Consent|2
7738312|NCT00658567|12169629|FG001|Overall Study|Voluntary Withdrawal of Consent|0
7738313|NCT00658567|12169630|FG002|Overall Study|Voluntary Withdrawal of Consent|2
7738314|NCT00658567|12169628|FG000|Overall Study|Physician Decision|0
7738315|NCT00658567|12169629|FG001|Overall Study|Physician Decision|1
7738316|NCT00658567|12169630|FG002|Overall Study|Physician Decision|0
7738317|NCT00658567|12169628|FG000|Overall Study|At Discretion of Sponsor|1
7738318|NCT00658567|12169629|FG001|Overall Study|At Discretion of Sponsor|1
7738319|NCT00658567|12169630|FG002|Overall Study|At Discretion of Sponsor|1
7738320|NCT00658606|12169640|FG000|Overall Study|Adverse Event|2
7738321|NCT00658606|12169641|FG001|Overall Study|Adverse Event|1
7738322|NCT00658606|12169640|FG000|Overall Study|Lack of Efficacy|6
7738323|NCT00658606|12169641|FG001|Overall Study|Lack of Efficacy|3
7738324|NCT00658606|12169640|FG000|Overall Study|Lost to Follow-up|1
7738325|NCT00658606|12169641|FG001|Overall Study|Lost to Follow-up|0
7738326|NCT00658606|12169640|FG000|Overall Study|Withdrawal by Subject|7
7738327|NCT00658606|12169641|FG001|Overall Study|Withdrawal by Subject|16
7738328|NCT00658606|12169640|FG000|Overall Study|Lack of Compliance|0
7738329|NCT00658606|12169641|FG001|Overall Study|Lack of Compliance|3
7738330|NCT00658632|12169667|FG000|Overall Study|Adverse Event|13
7738331|NCT00658632|12169668|FG001|Overall Study|Adverse Event|11
7738332|NCT00658632|12169667|FG000|Overall Study|Lost to Follow-up|25
7738333|NCT00658632|12169668|FG001|Overall Study|Lost to Follow-up|23
7738334|NCT00658632|12169667|FG000|Overall Study|Withdrawal by Subject|10
7738335|NCT00658632|12169668|FG001|Overall Study|Withdrawal by Subject|7
7738336|NCT00658632|12169667|FG000|Overall Study|Lack of Efficacy|0
7738337|NCT00658632|12169668|FG001|Overall Study|Lack of Efficacy|1
7738338|NCT00658632|12169667|FG000|Overall Study|Withdrawal of consent|8
7738339|NCT00658632|12169668|FG001|Overall Study|Withdrawal of consent|14
7738340|NCT00658632|12169667|FG000|Overall Study|Pregnancy|1
7738341|NCT00658632|12169668|FG001|Overall Study|Pregnancy|1
7738342|NCT00658632|12169667|FG000|Overall Study|Other|7
7738343|NCT00658632|12169668|FG001|Overall Study|Other|8
7738344|NCT00658658|12169679|FG000|Overall Study|Withdrawal by Subject|0
7738345|NCT00658658|12169680|FG001|Overall Study|Withdrawal by Subject|1
7738346|NCT00658658|12169681|FG002|Overall Study|Withdrawal by Subject|0
7738347|NCT00658658|12169682|FG003|Overall Study|Withdrawal by Subject|0
7738348|NCT00658658|12169683|FG004|Overall Study|Withdrawal by Subject|0
7738349|NCT00658658|12169679|FG000|Overall Study|Death|4
7738350|NCT00658658|12169680|FG001|Overall Study|Death|0
7738351|NCT00658658|12169681|FG002|Overall Study|Death|0
7738352|NCT00658658|12169682|FG003|Overall Study|Death|1
7738353|NCT00658658|12169683|FG004|Overall Study|Death|1
7738354|NCT00658658|12169679|FG000|Overall Study|Disease Progression|0
7738355|NCT00658658|12169680|FG001|Overall Study|Disease Progression|1
7738356|NCT00658658|12169681|FG002|Overall Study|Disease Progression|0
7738357|NCT00658658|12169682|FG003|Overall Study|Disease Progression|1
7738358|NCT00658658|12169683|FG004|Overall Study|Disease Progression|3
7738359|NCT00658658|12169679|FG000|Overall Study|Protocol-specified Criteria|1
7738360|NCT00658658|12169680|FG001|Overall Study|Protocol-specified Criteria|0
7738361|NCT00658658|12169681|FG002|Overall Study|Protocol-specified Criteria|0
7738362|NCT00658658|12169682|FG003|Overall Study|Protocol-specified Criteria|0
7738363|NCT00658658|12169683|FG004|Overall Study|Protocol-specified Criteria|0
7738364|NCT00658658|12169679|FG000|Overall Study|Other|0
7738365|NCT00658658|12169680|FG001|Overall Study|Other|0
7738366|NCT00658658|12169681|FG002|Overall Study|Other|0
7738367|NCT00658658|12169682|FG003|Overall Study|Other|0
7738368|NCT00658658|12169683|FG004|Overall Study|Other|1
7738369|NCT00658684|12169698|FG000|Overall Study|Adverse Event|10
7738370|NCT00658684|12169699|FG001|Overall Study|Adverse Event|8
7738371|NCT00658684|12169700|FG002|Overall Study|Adverse Event|2
7738372|NCT00658684|12169701|FG003|Overall Study|Adverse Event|0
7738373|NCT00658684|12169698|FG000|Overall Study|Withdrawal by Subject|6
7738374|NCT00658684|12169699|FG001|Overall Study|Withdrawal by Subject|4
7738375|NCT00658684|12169700|FG002|Overall Study|Withdrawal by Subject|1
7738376|NCT00658684|12169701|FG003|Overall Study|Withdrawal by Subject|1
7738377|NCT00658684|12169698|FG000|Overall Study|Lack of Efficacy|1
7738378|NCT00658684|12169699|FG001|Overall Study|Lack of Efficacy|1
7738379|NCT00658684|12169700|FG002|Overall Study|Lack of Efficacy|0
7738380|NCT00658684|12169701|FG003|Overall Study|Lack of Efficacy|0
7738381|NCT00658684|12169698|FG000|Overall Study|Protocol Violation|1
7738382|NCT00658684|12169699|FG001|Overall Study|Protocol Violation|1
7738383|NCT00658684|12169700|FG002|Overall Study|Protocol Violation|0
7738384|NCT00658684|12169701|FG003|Overall Study|Protocol Violation|0
7738385|NCT00658684|12169698|FG000|Overall Study|Pregnancy|1
7738386|NCT00658684|12169699|FG001|Overall Study|Pregnancy|1
7738387|NCT00658684|12169700|FG002|Overall Study|Pregnancy|0
7738388|NCT00658684|12169701|FG003|Overall Study|Pregnancy|0
7738389|NCT00658723|12169719|FG000|Overall Study|Lost to Follow-up|0
7738390|NCT00658723|12169720|FG001|Overall Study|Lost to Follow-up|2
7738391|NCT00658723|12169721|FG002|Overall Study|Lost to Follow-up|2
7738392|NCT00658723|12169719|FG000|Overall Study|Death|2
7738393|NCT00658723|12169720|FG001|Overall Study|Death|1
7738394|NCT00658723|12169721|FG002|Overall Study|Death|4
7738395|NCT00658723|12169719|FG000|Overall Study|Scheduling Issue|1
7738396|NCT00658723|12169720|FG001|Overall Study|Scheduling Issue|1
7738397|NCT00658723|12169721|FG002|Overall Study|Scheduling Issue|0
7738398|NCT00658723|12169719|FG000|Overall Study|Withdrawal by Subject|1
7738399|NCT00658723|12169720|FG001|Overall Study|Withdrawal by Subject|0
7738400|NCT00658723|12169721|FG002|Overall Study|Withdrawal by Subject|1
7738401|NCT00658775|12169743|FG000|Overall Study|Adverse Event|4
7738402|NCT00658775|12169744|FG001|Overall Study|Adverse Event|6
7738403|NCT00658775|12169743|FG000|Overall Study|Lost to Follow-up|17
7738404|NCT00658775|12169744|FG001|Overall Study|Lost to Follow-up|18
7738405|NCT00658775|12169743|FG000|Overall Study|Withdrawal by Subject|6
7738406|NCT00658775|12169744|FG001|Overall Study|Withdrawal by Subject|4
7738407|NCT00658775|12169743|FG000|Overall Study|Withdrawal of consent|8
7738408|NCT00658775|12169744|FG001|Overall Study|Withdrawal of consent|7
7738409|NCT00658775|12169743|FG000|Overall Study|Other|7
7738410|NCT00658775|12169744|FG001|Overall Study|Other|8
7738411|NCT00658879|12169750|FG000|Overall Study|Protocol Violation|1
7738412|NCT00658996|12169754|FG000|First Intervention|Positive slit lamp finding|1
7738413|NCT00658996|12169755|FG001|First Intervention|Positive slit lamp finding|0
7738414|NCT00658996|12169754|FG000|First Intervention|Lack of lenses|0
7738415|NCT00658996|12169755|FG001|First Intervention|Lack of lenses|1
7738416|NCT00658996|12169754|FG000|Crossover Period|Physician Decision|1
7738417|NCT00658996|12169755|FG001|Crossover Period|Physician Decision|0
7738418|NCT00658996|12169754|FG000|Crossover Period|Ineligible|1
7738419|NCT00658996|12169755|FG001|Crossover Period|Ineligible|1
7738420|NCT00658996|12169754|FG000|Second Intervention|Developed a stye on upper lid|1
7738421|NCT00658996|12169755|FG001|Second Intervention|Developed a stye on upper lid|0
7738422|NCT00658996|12169754|FG000|Second Intervention|Positive slit lamp finding|0
7738423|NCT00658996|12169755|FG001|Second Intervention|Positive slit lamp finding|1
7738424|NCT00659230|12169772|FG000|Overall Study|Lost to Follow-up|2
7738425|NCT00659230|12169773|FG001|Overall Study|Lost to Follow-up|5
7738426|NCT00659230|12169772|FG000|Overall Study|Lost source documentation|5
7738427|NCT00659230|12169773|FG001|Overall Study|Lost source documentation|4
7738428|NCT00659230|12169772|FG000|Overall Study|Did not return post-randomization|2
7738429|NCT00659230|12169773|FG001|Overall Study|Did not return post-randomization|3
7738430|NCT00659269|12169781|FG000|Overall Study|Physician Decision|1
7738431|NCT00659269|12169782|FG001|Overall Study|Physician Decision|1
7738432|NCT00659334|12169813|FG000|Overall Study|Screen Failure|8
7738433|NCT00659334|12169814|FG001|Overall Study|Screen Failure|5
7738434|NCT00659334|12169815|FG002|Overall Study|Screen Failure|0
7738435|NCT00659334|12169816|FG003|Overall Study|Screen Failure|0
7738436|NCT00659334|12169817|FG004|Overall Study|Screen Failure|0
7738437|NCT00659334|12169818|FG005|Overall Study|Screen Failure|0
7738438|NCT00659334|12169819|FG006|Overall Study|Screen Failure|1
7738439|NCT00659373|12169843|FG000|Overall Study|Withdrawal by Subject|3
7738440|NCT00659373|12169844|FG001|Overall Study|Withdrawal by Subject|5
7738441|NCT00659373|12169843|FG000|Overall Study|Assessment Missed|2
7738442|NCT00659373|12169844|FG001|Overall Study|Assessment Missed|2
7769012|NCT00865709|12212417|FG000|Treatment|Physician Decision|3
7769013|NCT00865709|12212418|FG001|Treatment|Physician Decision|2
7769014|NCT00865709|12212417|FG000|Treatment|Surgery|8
7769015|NCT00865709|12212418|FG001|Treatment|Surgery|3
7769016|NCT00865904|12212431|FG000|Overall Study|Randomized but not Treated|2
7769017|NCT00865904|12212432|FG001|Overall Study|Randomized but not Treated|0
7769018|NCT00865904|12212433|FG002|Overall Study|Randomized but not Treated|0
7769019|NCT00865904|12212434|FG003|Overall Study|Randomized but not Treated|1
7769020|NCT00865904|12212435|FG004|Overall Study|Randomized but not Treated|1
7769021|NCT00866047|12212464|FG000|Treatment Period|Progressive disease|13
7769022|NCT00866047|12212464|FG000|Treatment Period|Adverse Event|16
7769023|NCT00866047|12212464|FG000|Treatment Period|Physician Decision|14
7769024|NCT00866047|12212464|FG000|Treatment Period|Withdrawal by Subject|5
7769025|NCT00866047|12212464|FG000|Follow-up Period|Lost to Follow-up|5
7769026|NCT00866177|12212468|FG000|Overall Study|Withdrawal by Subject|1
7769027|NCT00866177|12212468|FG000|Overall Study|Not Treated|151
7769028|NCT00866281|12212474|FG000|Overall Study|Adverse Event|1
7769029|NCT00866281|12212475|FG001|Overall Study|Adverse Event|0
7769030|NCT00866281|12212474|FG000|Overall Study|Withdrawal by participants|3
7769031|NCT00866281|12212475|FG001|Overall Study|Withdrawal by participants|0
7769032|NCT00866281|12212474|FG000|Overall Study|Disease progression|3
7769033|NCT00866281|12212475|FG001|Overall Study|Disease progression|11
7769034|NCT00866281|12212474|FG000|Overall Study|New cancer therapy|0
7769035|NCT00866281|12212475|FG001|Overall Study|New cancer therapy|4
7769036|NCT00866294|12212487|FG000|Overall Study|Adverse Event|12
7769037|NCT00866294|12212488|FG001|Overall Study|Adverse Event|13
7769038|NCT00866294|12212489|FG002|Overall Study|Adverse Event|9
7769039|NCT00866294|12212487|FG000|Overall Study|Lack of Efficacy|7
7769040|NCT00866294|12212488|FG001|Overall Study|Lack of Efficacy|1
7769041|NCT00866294|12212489|FG002|Overall Study|Lack of Efficacy|0
7769042|NCT00866294|12212487|FG000|Overall Study|Protocol Violation|2
7769043|NCT00866294|12212488|FG001|Overall Study|Protocol Violation|0
7769044|NCT00866294|12212489|FG002|Overall Study|Protocol Violation|0
7769045|NCT00866294|12212487|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5
7769046|NCT00866294|12212488|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
7769047|NCT00866294|12212489|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1
7769048|NCT00866294|12212487|FG000|Overall Study|Lost to Follow-up|1
7769049|NCT00866294|12212488|FG001|Overall Study|Lost to Follow-up|3
7769050|NCT00866294|12212489|FG002|Overall Study|Lost to Follow-up|0
7738443|NCT00659425|12169860|FG000|Overall Study|Disease progression|1
7738444|NCT00659425|12169861|FG001|Overall Study|Disease progression|0
7738445|NCT00659425|12169862|FG002|Overall Study|Disease progression|0
7738446|NCT00659425|12169863|FG003|Overall Study|Disease progression|1
7738447|NCT00659425|12169864|FG004|Overall Study|Disease progression|0
7738448|NCT00659425|12169865|FG005|Overall Study|Disease progression|2
7738449|NCT00659425|12169866|FG006|Overall Study|Disease progression|4
7738450|NCT00659425|12169867|FG007|Overall Study|Disease progression|3
7738451|NCT00659425|12169868|FG008|Overall Study|Disease progression|5
7738452|NCT00659425|12169869|FG009|Overall Study|Disease progression|3
7738453|NCT00659425|12169860|FG000|Overall Study|Death|0
7738454|NCT00659425|12169861|FG001|Overall Study|Death|0
7738455|NCT00659425|12169862|FG002|Overall Study|Death|0
7738456|NCT00659425|12169863|FG003|Overall Study|Death|1
7738457|NCT00659425|12169864|FG004|Overall Study|Death|0
7738458|NCT00659425|12169865|FG005|Overall Study|Death|0
7738459|NCT00659425|12169866|FG006|Overall Study|Death|1
7738460|NCT00659425|12169867|FG007|Overall Study|Death|0
7738461|NCT00659425|12169868|FG008|Overall Study|Death|0
7738462|NCT00659425|12169869|FG009|Overall Study|Death|0
7738463|NCT00659425|12169860|FG000|Overall Study|Adverse Event|0
7738464|NCT00659425|12169861|FG001|Overall Study|Adverse Event|0
7738465|NCT00659425|12169862|FG002|Overall Study|Adverse Event|0
7738466|NCT00659425|12169863|FG003|Overall Study|Adverse Event|0
7738467|NCT00659425|12169864|FG004|Overall Study|Adverse Event|0
7738468|NCT00659425|12169865|FG005|Overall Study|Adverse Event|1
7738469|NCT00659425|12169866|FG006|Overall Study|Adverse Event|0
7738470|NCT00659425|12169867|FG007|Overall Study|Adverse Event|3
7738471|NCT00659425|12169868|FG008|Overall Study|Adverse Event|1
7738472|NCT00659425|12169869|FG009|Overall Study|Adverse Event|4
7738473|NCT00659425|12169860|FG000|Overall Study|Investigator Discretion|0
7738474|NCT00659425|12169861|FG001|Overall Study|Investigator Discretion|0
7738475|NCT00659425|12169862|FG002|Overall Study|Investigator Discretion|0
7738476|NCT00659425|12169863|FG003|Overall Study|Investigator Discretion|0
7738477|NCT00659425|12169864|FG004|Overall Study|Investigator Discretion|0
7738478|NCT00659425|12169865|FG005|Overall Study|Investigator Discretion|1
7738479|NCT00659425|12169866|FG006|Overall Study|Investigator Discretion|0
7738480|NCT00659425|12169867|FG007|Overall Study|Investigator Discretion|3
7738481|NCT00659425|12169868|FG008|Overall Study|Investigator Discretion|0
7738482|NCT00659425|12169869|FG009|Overall Study|Investigator Discretion|0
7738483|NCT00659425|12169860|FG000|Overall Study|Other|0
7738484|NCT00659425|12169861|FG001|Overall Study|Other|1
7738485|NCT00659425|12169862|FG002|Overall Study|Other|1
7738486|NCT00659425|12169863|FG003|Overall Study|Other|2
7738487|NCT00659425|12169864|FG004|Overall Study|Other|4
7738488|NCT00659425|12169865|FG005|Overall Study|Other|0
7738489|NCT00659425|12169866|FG006|Overall Study|Other|3
7738490|NCT00659425|12169867|FG007|Overall Study|Other|2
7738491|NCT00659425|12169868|FG008|Overall Study|Other|0
7738492|NCT00659425|12169869|FG009|Overall Study|Other|6
7738493|NCT00659438|12169906|FG000|Overall Study|Withdrawal by Subject|2
7738494|NCT00659438|12169907|FG001|Overall Study|Withdrawal by Subject|2
7738495|NCT00659438|12169906|FG000|Overall Study|Death|11
7738496|NCT00659438|12169907|FG001|Overall Study|Death|6
7738497|NCT00659438|12169906|FG000|Overall Study|Lost to Follow-up|1
7738498|NCT00659438|12169907|FG001|Overall Study|Lost to Follow-up|0
7738499|NCT00659490|12169916|FG000|Overall Study|Lost to Follow-up|2
7738500|NCT00659490|12169917|FG001|Overall Study|Lost to Follow-up|0
7738501|NCT00659490|12169918|FG002|Overall Study|Lost to Follow-up|1
7738502|NCT00659529|12169926|FG000|Overall Study|Withdrawal by Subject|4
7738503|NCT00659529|12169926|FG000|Overall Study|Protocol Violation|3
7738504|NCT00659529|12169926|FG000|Overall Study|Screen failure|9
7738505|NCT00659581|12169930|FG000|Overall Study|Adverse Event|1006
7738506|NCT00659581|12169930|FG000|Overall Study|Lack of Efficacy|1183
7738507|NCT00659581|12169930|FG000|Overall Study|Other|6393
7738508|NCT00659607|12169934|FG000|Overall Study|No blood pressure recorded|147
7738509|NCT00659607|12169934|FG000|Overall Study|Unknown measuring date of blood pressure|85
7738510|NCT00659607|12169934|FG000|Overall Study|'Unable to evaluate' for the final asses|67
7738511|NCT00659607|12169934|FG000|Overall Study|No recorded efficacy data|15
7738512|NCT00659607|12169934|FG000|Overall Study|Inconsistent BP measuring date|2
7738513|NCT00659815|12169983|FG000|Overall Study|Study related symptoms and complaints|2
7738514|NCT00659815|12169984|FG001|Overall Study|Study related symptoms and complaints|1
7738515|NCT00659815|12169983|FG000|Overall Study|Inability to maintain wearing schedule|1
7738516|NCT00659815|12169984|FG001|Overall Study|Inability to maintain wearing schedule|2
7738517|NCT00659815|12169983|FG000|Overall Study|Withdrawal by Subject|1
7738518|NCT00659815|12169984|FG001|Overall Study|Withdrawal by Subject|1
7738519|NCT00659880|12169994|FG000|Overall Study|Lost to Follow-up|5
7738520|NCT00659984|12170008|FG000|Overall Study|Adverse Event|1
7738521|NCT00660010|12170018|FG000|Overall Study|Withdrawal by Subject|2
7738522|NCT00660010|12170018|FG000|Overall Study|Lost to Follow-up|3
7738523|NCT00660010|12170018|FG000|Overall Study|Adverse Event|1
7738524|NCT00660010|12170018|FG000|Overall Study|Noncompliance with visit schedule|3
7738525|NCT00660023|12170022|FG000|Overall Study|Adverse Event|2
7738526|NCT00660023|12170022|FG000|Overall Study|Death|8
7738527|NCT00660023|12170022|FG000|Overall Study|Blood Transfusion|5
7738528|NCT00660023|12170022|FG000|Overall Study|Renal Transplantation|3
7738529|NCT00660023|12170022|FG000|Overall Study|Withdrawal by Subject|1
7738530|NCT00660023|12170022|FG000|Overall Study|Missed Pregnancy Test|1
7738531|NCT00660023|12170022|FG000|Overall Study|Other Screening Failure|9
7738532|NCT00660179|12170042|FG000|Overall Study|Death|44
7738533|NCT00660179|12170043|FG001|Overall Study|Death|47
7738534|NCT00660179|12170044|FG002|Overall Study|Death|34
7738535|NCT00660179|12170042|FG000|Overall Study|Withdrawal of consent|4
7738536|NCT00660179|12170043|FG001|Overall Study|Withdrawal of consent|6
7738537|NCT00660179|12170044|FG002|Overall Study|Withdrawal of consent|4
7738538|NCT00660179|12170042|FG000|Overall Study|Lost to Follow-up|7
7738539|NCT00660179|12170043|FG001|Overall Study|Lost to Follow-up|5
7738540|NCT00660179|12170044|FG002|Overall Study|Lost to Follow-up|2
7738541|NCT00660179|12170042|FG000|Overall Study|Administrative reason|0
7738542|NCT00660179|12170043|FG001|Overall Study|Administrative reason|0
7738543|NCT00660179|12170044|FG002|Overall Study|Administrative reason|1
7738544|NCT00660179|12170042|FG000|Overall Study|Incorrect randomization|1
7738545|NCT00660179|12170043|FG001|Overall Study|Incorrect randomization|0
7738546|NCT00660179|12170044|FG002|Overall Study|Incorrect randomization|0
7738547|NCT00660192|12170054|FG000|Overall Study|Lost to Follow-up|2
7738548|NCT00660192|12170055|FG001|Overall Study|Lost to Follow-up|3
7738549|NCT00660309|12170063|FG000|Overall Study|Adverse Event|2
7738550|NCT00660309|12170064|FG001|Overall Study|Adverse Event|0
7738551|NCT00660309|12170063|FG000|Overall Study|Withdrawal by Subject|0
7738552|NCT00660309|12170064|FG001|Overall Study|Withdrawal by Subject|3
7738553|NCT00660387|12170073|FG000|Overall Study|Adverse Event|1
7738554|NCT00660387|12170074|FG001|Overall Study|Adverse Event|2
7738555|NCT00660387|12170073|FG000|Overall Study|Lack of Efficacy|0
7738556|NCT00660387|12170074|FG001|Overall Study|Lack of Efficacy|1
7738557|NCT00660387|12170073|FG000|Overall Study|Protocol Violation|1
7738558|NCT00660387|12170074|FG001|Overall Study|Protocol Violation|0
7738559|NCT00660400|12170080|FG000|Overall Study|Lack of insurance approval|1
7738560|NCT00660400|12170080|FG000|Overall Study|Suboptimal organ function|1
7738561|NCT00660400|12170080|FG000|Overall Study|Intracranial hemorrhage|1
7738562|NCT00660400|12170080|FG000|Overall Study|Withdrawal by Subject|1
7738563|NCT00660660|12170128|FG000|Overall Study|Adverse Event|1
7738564|NCT00660660|12170129|FG001|Overall Study|Adverse Event|0
7738565|NCT00660660|12170128|FG000|Overall Study|Lost to Follow-up|0
7738566|NCT00660660|12170129|FG001|Overall Study|Lost to Follow-up|6
7738567|NCT00660660|12170128|FG000|Overall Study|Lack of Efficacy|0
7738568|NCT00660660|12170129|FG001|Overall Study|Lack of Efficacy|2
7738569|NCT00660660|12170128|FG000|Overall Study|Withdrawal by Subject|3
7738570|NCT00660660|12170129|FG001|Overall Study|Withdrawal by Subject|0
7738571|NCT00660660|12170128|FG000|Overall Study|Incorrect enrollment and other|0
7738572|NCT00660660|12170129|FG001|Overall Study|Incorrect enrollment and other|1
7738573|NCT00660660|12170128|FG000|Overall Study|New medication after randomization|1
7738574|NCT00660660|12170129|FG001|Overall Study|New medication after randomization|0
7738575|NCT00660699|12170135|FG000|Overall Study|Withdrawal by Subject|2
7738576|NCT00660790|12170139|FG000|Baseline to 3 Months|Death|1
7738577|NCT00660790|12170139|FG000|Baseline to 3 Months|Withdrawal by Subject|2
7738578|NCT00660790|12170139|FG000|3 Months to 2 Years|Withdrawal by Subject|17
7738579|NCT00660816|12170145|FG000|Overall Study|Adverse Event|1
7738580|NCT00660816|12170146|FG001|Overall Study|Adverse Event|2
7738581|NCT00660816|12170145|FG000|Overall Study|Withdrawal by Subject|1
7738582|NCT00660816|12170146|FG001|Overall Study|Withdrawal by Subject|0
7738583|NCT00660816|12170145|FG000|Overall Study|Death|0
7738584|NCT00660816|12170146|FG001|Overall Study|Death|2
7738585|NCT00660816|12170145|FG000|Overall Study|Lack of Efficacy|1
7738586|NCT00660816|12170146|FG001|Overall Study|Lack of Efficacy|0
7738587|NCT00660816|12170145|FG000|Overall Study|Physician Decision|0
7738588|NCT00660816|12170146|FG001|Overall Study|Physician Decision|2
7738589|NCT00660816|12170145|FG000|Overall Study|Protocol Violation|1
7738590|NCT00660816|12170146|FG001|Overall Study|Protocol Violation|0
7738591|NCT00660816|12170145|FG000|Overall Study|Disease Progression|16
7738592|NCT00660816|12170146|FG001|Overall Study|Disease Progression|12
7738593|NCT00660816|12170145|FG000|Overall Study|Complicating Disease|0
7738594|NCT00660816|12170146|FG001|Overall Study|Complicating Disease|1
7738595|NCT00660829|12170154|FG000|Overall Study|Adverse Event|3
7738596|NCT00660829|12170155|FG001|Overall Study|Adverse Event|4
7738597|NCT00660829|12170154|FG000|Overall Study|Lack of Efficacy|2
7738598|NCT00660829|12170155|FG001|Overall Study|Lack of Efficacy|3
7738599|NCT00660829|12170154|FG000|Overall Study|Non-Compliance|0
7738600|NCT00660829|12170155|FG001|Overall Study|Non-Compliance|4
7738601|NCT00660829|12170154|FG000|Overall Study|Withdrawal by Subject|1
7738602|NCT00660829|12170155|FG001|Overall Study|Withdrawal by Subject|2
7738603|NCT00660829|12170154|FG000|Overall Study|Lost to Follow-up|3
7738604|NCT00660829|12170155|FG001|Overall Study|Lost to Follow-up|2
7738605|NCT00660829|12170154|FG000|Overall Study|Other|9
7738606|NCT00660829|12170155|FG001|Overall Study|Other|4
7738607|NCT00660907|12170163|FG000|Overall Study|Incorrect Enrollment|1
7738608|NCT00660907|12170164|FG001|Overall Study|Incorrect Enrollment|1
7738609|NCT00660907|12170163|FG000|Overall Study|Adverse Event|33
7738610|NCT00660907|12170164|FG001|Overall Study|Adverse Event|19
7738611|NCT00660907|12170163|FG000|Overall Study|Subject No Longer Meets Study Criteria|6
7738612|NCT00660907|12170164|FG001|Overall Study|Subject No Longer Meets Study Criteria|27
7738613|NCT00660907|12170163|FG000|Overall Study|Withdrawal by Subject|23
7738614|NCT00660907|12170164|FG001|Overall Study|Withdrawal by Subject|32
7738615|NCT00660907|12170163|FG000|Overall Study|Lost to Follow-up|3
7738616|NCT00660907|12170164|FG001|Overall Study|Lost to Follow-up|3
7738617|NCT00660907|12170163|FG000|Overall Study|Poor/Non-Compliance|5
7738618|NCT00660907|12170164|FG001|Overall Study|Poor/Non-Compliance|1
7738619|NCT00660907|12170163|FG000|Overall Study|Safety|1
7738620|NCT00660907|12170164|FG001|Overall Study|Safety|0
7738621|NCT00660907|12170163|FG000|Overall Study|Death|1
7738622|NCT00660907|12170164|FG001|Overall Study|Death|3
7738623|NCT00660907|12170163|FG000|Overall Study|Various|11
7738624|NCT00660907|12170164|FG001|Overall Study|Various|8
7738625|NCT00661089|12170192|FG000|Overall Study|1 subject withdrawal|0
7738626|NCT00661089|12170193|FG001|Overall Study|1 subject withdrawal|1
7738627|NCT00661089|12170192|FG000|Overall Study|death at 8 weeks due to new stroke|0
7738628|NCT00661089|12170193|FG001|Overall Study|death at 8 weeks due to new stroke|1
7738629|NCT00661193|12170229|FG000|Overall Study|Adverse Event|2
7738630|NCT00661193|12170230|FG001|Overall Study|Adverse Event|1
7738631|NCT00661193|12170229|FG000|Overall Study|Withdrawal by Subject|3
7738632|NCT00661193|12170230|FG001|Overall Study|Withdrawal by Subject|1
7738633|NCT00661193|12170229|FG000|Overall Study|Progression|27
7738634|NCT00661193|12170230|FG001|Overall Study|Progression|24
7738635|NCT00661193|12170229|FG000|Overall Study|Not protocol specified|1
7738636|NCT00661193|12170230|FG001|Overall Study|Not protocol specified|0
7738637|NCT00661258|12170238|FG000|Overall Study|Death|1
7738638|NCT00661258|12170239|FG001|Overall Study|Death|0
7738639|NCT00661258|12170238|FG000|Overall Study|caught by police and in detox center|2
7738640|NCT00661258|12170239|FG001|Overall Study|caught by police and in detox center|1
7738641|NCT00661271|12170247|FG000|Overall Study|Lost to Follow-up|28
7738642|NCT00661271|12170248|FG001|Overall Study|Lost to Follow-up|25
7738643|NCT00661362|12170256|FG000|Overall Study|Adverse Event|5
7738644|NCT00661362|12170257|FG001|Overall Study|Adverse Event|4
7738645|NCT00661362|12170256|FG000|Overall Study|Incorrect enrollment|2
7738646|NCT00661362|12170257|FG001|Overall Study|Incorrect enrollment|0
7738647|NCT00661362|12170256|FG000|Overall Study|Study specific discontinuation criteria|4
7738648|NCT00661362|12170257|FG001|Overall Study|Study specific discontinuation criteria|11
7738649|NCT00661362|12170256|FG000|Overall Study|Withdrawal by Subject|13
7738650|NCT00661362|12170257|FG001|Overall Study|Withdrawal by Subject|23
7738651|NCT00661362|12170256|FG000|Overall Study|Lost to Follow-up|3
7738652|NCT00661362|12170257|FG001|Overall Study|Lost to Follow-up|1
7738653|NCT00661362|12170256|FG000|Overall Study|Severe non-compliance to protocol|0
7738654|NCT00661362|12170257|FG001|Overall Study|Severe non-compliance to protocol|1
7738655|NCT00661362|12170256|FG000|Overall Study|Safety reasons|1
7738656|NCT00661362|12170257|FG001|Overall Study|Safety reasons|0
7738657|NCT00661362|12170256|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
7738658|NCT00661362|12170257|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
7738659|NCT00661388|12170263|FG000|Overall Study|Adverse Event|14
7738660|NCT00661388|12170263|FG000|Overall Study|Protocol Violation|7
7738661|NCT00661388|12170263|FG000|Overall Study|Renal transplantation|1
7738662|NCT00661388|12170263|FG000|Overall Study|Dialysis initiation|1
7738663|NCT00661388|12170263|FG000|Overall Study|Administrative reasons|1
7738664|NCT00661427|12170269|FG000|Overall Study|Adverse Event|5
7738665|NCT00661427|12170270|FG001|Overall Study|Adverse Event|5
7738666|NCT00661427|12170269|FG000|Overall Study|Patient not treated|0
7738667|NCT00661427|12170270|FG001|Overall Study|Patient not treated|2
7738668|NCT00661492|12170298|FG000|Overall Study|Adverse Event|16
7738669|NCT00661492|12170299|FG001|Overall Study|Adverse Event|13
7738670|NCT00661492|12170298|FG000|Overall Study|Disease Progression|44
7738671|NCT00661492|12170299|FG001|Overall Study|Disease Progression|14
7738672|NCT00661492|12170298|FG000|Overall Study|Patient Request|6
7738673|NCT00661492|12170299|FG001|Overall Study|Patient Request|1
7738674|NCT00661492|12170298|FG000|Overall Study|Investigator Request|1
7738675|NCT00661492|12170299|FG001|Overall Study|Investigator Request|0
7738676|NCT00661492|12170298|FG000|Overall Study|Lost to Follow-up|0
7738677|NCT00661492|12170299|FG001|Overall Study|Lost to Follow-up|1
7738678|NCT00661492|12170298|FG000|Overall Study|Other|1
7738679|NCT00661492|12170299|FG001|Overall Study|Other|0
7738680|NCT00661505|12170305|FG000|Overall Study|Adverse Event|3
7738681|NCT00661505|12170305|FG000|Overall Study|Protocol Violation|14
7738682|NCT00661505|12170305|FG000|Overall Study|Withdrawal by Subject|8
7738683|NCT00661505|12170305|FG000|Overall Study|Lost to Follow-up|3
7738684|NCT00661505|12170305|FG000|Overall Study|Other|2
7738685|NCT00661531|12170310|FG000|Overall Study|Withdrawal by Subject|3
7738686|NCT00661609|12170344|FG000|Overall Study|Adverse Event|4
7738687|NCT00661609|12170344|FG000|Overall Study|Death|20
7738688|NCT00661609|12170344|FG000|Overall Study|Withdrawal by Subject|2
7738689|NCT00661609|12170344|FG000|Overall Study|PI Decision|1
7738690|NCT00661609|12170344|FG000|Overall Study|Survival follow up stage discontinued|11
7738691|NCT00661609|12170344|FG000|Overall Study|Disease progression|3
7738692|NCT00661622|12170350|FG000|Overall Study|Protocol Violation|1
7738693|NCT00661622|12170351|FG001|Overall Study|Protocol Violation|0
7738694|NCT00661661|12170360|FG000|Overall Study|Adverse Event|99
7738695|NCT00661661|12170361|FG001|Overall Study|Adverse Event|24
7738696|NCT00661661|12170360|FG000|Overall Study|Lack of Efficacy|3
7738697|NCT00661661|12170361|FG001|Overall Study|Lack of Efficacy|2
7738698|NCT00661661|12170360|FG000|Overall Study|Lost to Follow-up|0
7738699|NCT00661661|12170361|FG001|Overall Study|Lost to Follow-up|1
7738700|NCT00661661|12170360|FG000|Overall Study|Withdrawal by Subject|15
7738701|NCT00661661|12170361|FG001|Overall Study|Withdrawal by Subject|5
7738702|NCT00661661|12170360|FG000|Overall Study|Other|22
7738703|NCT00661661|12170361|FG001|Overall Study|Other|7
7738704|NCT00661661|12170360|FG000|Overall Study|Not assigned treatment|1
7738705|NCT00661661|12170361|FG001|Overall Study|Not assigned treatment|0
7738706|NCT00661687|12170382|FG000|Overall Study|Study related symptoms and complaints|5
7738707|NCT00661687|12170382|FG000|Overall Study|Positive slit lamp findings|4
7738708|NCT00661687|12170382|FG000|Overall Study|Inability to maintain wearing schedule|3
7738709|NCT00661687|12170382|FG000|Overall Study|Physician Decision|1
7738710|NCT00661687|12170382|FG000|Overall Study|Adverse Event|2
7738711|NCT00661713|12170396|FG000|Overall Study|Death|1
7738712|NCT00661713|12170397|FG001|Overall Study|Death|0
7738713|NCT00661713|12170398|FG002|Overall Study|Death|0
7738714|NCT00661713|12170399|FG003|Overall Study|Death|0
7738715|NCT00661713|12170400|FG004|Overall Study|Death|1
7738716|NCT00661713|12170401|FG005|Overall Study|Death|0
7738717|NCT00661713|12170402|FG006|Overall Study|Death|0
7738718|NCT00661713|12170403|FG007|Overall Study|Death|0
7738719|NCT00661713|12170396|FG000|Overall Study|Unable to Classify|1
7738720|NCT00661713|12170397|FG001|Overall Study|Unable to Classify|0
7738721|NCT00661713|12170398|FG002|Overall Study|Unable to Classify|0
7738722|NCT00661713|12170399|FG003|Overall Study|Unable to Classify|0
7738723|NCT00661713|12170400|FG004|Overall Study|Unable to Classify|0
7738724|NCT00661713|12170401|FG005|Overall Study|Unable to Classify|0
7738725|NCT00661713|12170402|FG006|Overall Study|Unable to Classify|0
7738726|NCT00661713|12170403|FG007|Overall Study|Unable to Classify|0
7738727|NCT00661713|12170396|FG000|Overall Study|Protocol Violation|1
7738728|NCT00661713|12170397|FG001|Overall Study|Protocol Violation|6
7738729|NCT00661713|12170398|FG002|Overall Study|Protocol Violation|3
7738730|NCT00661713|12170399|FG003|Overall Study|Protocol Violation|3
7738731|NCT00661713|12170400|FG004|Overall Study|Protocol Violation|0
7738732|NCT00661713|12170401|FG005|Overall Study|Protocol Violation|2
7738733|NCT00661713|12170402|FG006|Overall Study|Protocol Violation|2
7738734|NCT00661713|12170403|FG007|Overall Study|Protocol Violation|1
7738735|NCT00661713|12170396|FG000|Overall Study|Withdrawal by Subject|11
7738736|NCT00661713|12170397|FG001|Overall Study|Withdrawal by Subject|25
7738737|NCT00661713|12170398|FG002|Overall Study|Withdrawal by Subject|12
7738738|NCT00661713|12170399|FG003|Overall Study|Withdrawal by Subject|21
7738739|NCT00661713|12170400|FG004|Overall Study|Withdrawal by Subject|12
7738740|NCT00661713|12170401|FG005|Overall Study|Withdrawal by Subject|26
7738741|NCT00661713|12170402|FG006|Overall Study|Withdrawal by Subject|45
7738742|NCT00661713|12170403|FG007|Overall Study|Withdrawal by Subject|9
7738743|NCT00661713|12170396|FG000|Overall Study|Lost to Follow-up|2
7738744|NCT00661713|12170397|FG001|Overall Study|Lost to Follow-up|7
7738745|NCT00661713|12170398|FG002|Overall Study|Lost to Follow-up|2
7738746|NCT00661713|12170399|FG003|Overall Study|Lost to Follow-up|2
7738747|NCT00661713|12170400|FG004|Overall Study|Lost to Follow-up|5
7738748|NCT00661713|12170401|FG005|Overall Study|Lost to Follow-up|7
7738749|NCT00661713|12170402|FG006|Overall Study|Lost to Follow-up|14
7738750|NCT00661713|12170403|FG007|Overall Study|Lost to Follow-up|1
7738751|NCT00661713|12170396|FG000|Overall Study|Administrative Reason|0
7738752|NCT00661713|12170397|FG001|Overall Study|Administrative Reason|1
7738753|NCT00661713|12170398|FG002|Overall Study|Administrative Reason|0
7738754|NCT00661713|12170399|FG003|Overall Study|Administrative Reason|2
7738755|NCT00661713|12170400|FG004|Overall Study|Administrative Reason|2
7738756|NCT00661713|12170401|FG005|Overall Study|Administrative Reason|2
7738757|NCT00661713|12170402|FG006|Overall Study|Administrative Reason|1
7738758|NCT00661713|12170403|FG007|Overall Study|Administrative Reason|0
7738759|NCT00661713|12170396|FG000|Overall Study|Adverse Event|0
7738760|NCT00661713|12170397|FG001|Overall Study|Adverse Event|0
7738761|NCT00661713|12170398|FG002|Overall Study|Adverse Event|0
7738762|NCT00661713|12170399|FG003|Overall Study|Adverse Event|0
7738763|NCT00661713|12170400|FG004|Overall Study|Adverse Event|0
7738764|NCT00661713|12170401|FG005|Overall Study|Adverse Event|0
7738765|NCT00661713|12170402|FG006|Overall Study|Adverse Event|1
7738766|NCT00661713|12170403|FG007|Overall Study|Adverse Event|0
7738767|NCT00661713|12170396|FG000|Overall Study|Inappropriate Enrollment|0
7738768|NCT00661713|12170397|FG001|Overall Study|Inappropriate Enrollment|0
7738769|NCT00661713|12170398|FG002|Overall Study|Inappropriate Enrollment|0
7738770|NCT00661713|12170399|FG003|Overall Study|Inappropriate Enrollment|0
7738771|NCT00661713|12170400|FG004|Overall Study|Inappropriate Enrollment|0
7738772|NCT00661713|12170401|FG005|Overall Study|Inappropriate Enrollment|0
7738773|NCT00661713|12170402|FG006|Overall Study|Inappropriate Enrollment|1
7738774|NCT00661713|12170403|FG007|Overall Study|Inappropriate Enrollment|0
7738775|NCT00661726|12170423|FG000|Overall Study|Adverse Event|1
7738776|NCT00661778|12170427|FG000|Overall Study|Disease Progression|23
7738777|NCT00661778|12170427|FG000|Overall Study|Adverse Event|18
7738778|NCT00661778|12170427|FG000|Overall Study|Reason not Specified|6
7738779|NCT00661778|12170427|FG000|Overall Study|Protocol Violation|2
7738780|NCT00661778|12170427|FG000|Overall Study|Withdrawal of Consent|1
7738781|NCT00661830|12170433|FG000|Overall Study|Death|37
7738782|NCT00661830|12170434|FG001|Overall Study|Death|33
7738783|NCT00661830|12170433|FG000|Overall Study|Lost to Follow-up|1
7738784|NCT00661830|12170434|FG001|Overall Study|Lost to Follow-up|3
7738785|NCT00661830|12170433|FG000|Overall Study|Withdrawal by Subject|1
7738786|NCT00661830|12170434|FG001|Overall Study|Withdrawal by Subject|1
7738787|NCT00661830|12170433|FG000|Overall Study|Other reason|1
7738788|NCT00661830|12170434|FG001|Overall Study|Other reason|5
7738789|NCT00661999|12170465|FG000|Overall Study|Adverse Event|11
7738790|NCT00661999|12170466|FG001|Overall Study|Adverse Event|5
7738791|NCT00661999|12170467|FG002|Overall Study|Adverse Event|8
7738792|NCT00661999|12170465|FG000|Overall Study|Death|8
7738793|NCT00661999|12170466|FG001|Overall Study|Death|6
7738794|NCT00661999|12170467|FG002|Overall Study|Death|3
7738795|NCT00661999|12170465|FG000|Overall Study|Other Reasons|5
7738796|NCT00661999|12170466|FG001|Overall Study|Other Reasons|12
7738797|NCT00661999|12170467|FG002|Overall Study|Other Reasons|23
7738798|NCT00661999|12170465|FG000|Overall Study|Withdrawal by Subject|30
7738799|NCT00661999|12170466|FG001|Overall Study|Withdrawal by Subject|23
7738800|NCT00661999|12170467|FG002|Overall Study|Withdrawal by Subject|14
7738801|NCT00661999|12170465|FG000|Overall Study|Alternative Treatment|1
7738802|NCT00661999|12170466|FG001|Overall Study|Alternative Treatment|0
7738803|NCT00661999|12170467|FG002|Overall Study|Alternative Treatment|0
7738804|NCT00661999|12170465|FG000|Overall Study|Other Medical Problems|4
7738805|NCT00661999|12170466|FG001|Overall Study|Other Medical Problems|4
7738806|NCT00661999|12170467|FG002|Overall Study|Other Medical Problems|9
7738807|NCT00662012|12170475|FG000|Overall Study|Lost to Follow-up|85
7738808|NCT00662012|12170475|FG000|Overall Study|Death|1
7738809|NCT00662012|12170475|FG000|Overall Study|Withdrawal by Subject|1
7738810|NCT00662025|12170479|FG000|Overall Study|Objective progression or relapse|51
7738811|NCT00662025|12170479|FG000|Overall Study|Adverse Event|7
7738812|NCT00662025|12170479|FG000|Overall Study|Withdrawal by Subject|1
7738813|NCT00662025|12170479|FG000|Overall Study|Results of other clinical study|2
7738814|NCT00662025|12170479|FG000|Overall Study|Target lesion cannot be evaluated|1
7738815|NCT00662025|12170479|FG000|Overall Study|Domestic circumstances|1
7738816|NCT00662038|12170483|FG000|Overall Study|Reason not specified|3
7738817|NCT00662038|12170483|FG000|Overall Study|Withdrawn consent|22
7738818|NCT00662038|12170483|FG000|Overall Study|Withdrawal by Subject|83
7738819|NCT00662038|12170483|FG000|Overall Study|Sponsor decision|1
7738820|NCT00662038|12170483|FG000|Overall Study|Physician Decision|19
7738821|NCT00662038|12170483|FG000|Overall Study|Lung transplantation|44
7738822|NCT00662038|12170483|FG000|Overall Study|Lost to Follow-up|1
7738823|NCT00662038|12170483|FG000|Overall Study|Death|95
7738824|NCT00662038|12170483|FG000|Overall Study|Adverse Event|358
7738825|NCT00662038|12170483|FG000|Overall Study|Continued treatment|5
7738826|NCT00662129|12170487|FG000|Overall Study|Protocol Violation|1
7738827|NCT00662129|12170487|FG000|Overall Study|Cancel prior to beginning treatment|1
7738828|NCT00662129|12170487|FG000|Overall Study|Ineligible|1
7738829|NCT00662259|12170514|FG000|Overall Study|Adverse Event|2
7738830|NCT00662259|12170515|FG001|Overall Study|Adverse Event|0
7738831|NCT00662311|12170528|FG000|Overall Study|Respiratory Infection|1
7738832|NCT00662311|12170529|FG001|Overall Study|Respiratory Infection|0
7738833|NCT00662311|12170530|FG002|Overall Study|Respiratory Infection|0
7738834|NCT00662363|12170540|FG000|Overall Study|Withdrawal by Subject|6
7738835|NCT00662363|12170541|FG001|Overall Study|Withdrawal by Subject|5
7738836|NCT00662363|12170540|FG000|Overall Study|Adverse Event|0
7738837|NCT00662363|12170541|FG001|Overall Study|Adverse Event|3
7738838|NCT00662363|12170540|FG000|Overall Study|Discharged early from rehab|4
7738839|NCT00662363|12170541|FG001|Overall Study|Discharged early from rehab|1
7738840|NCT00662363|12170540|FG000|Overall Study|Protocol Violation|1
7738841|NCT00662363|12170541|FG001|Overall Study|Protocol Violation|1
7738842|NCT00662532|12170551|FG000|Overall Study|Adverse Event|0
7738843|NCT00662532|12170552|FG001|Overall Study|Adverse Event|1
7738844|NCT00662532|12170551|FG000|Overall Study|Lost to Follow-up|0
7738845|NCT00662532|12170552|FG001|Overall Study|Lost to Follow-up|1
7738846|NCT00662558|12170569|FG000|Overall Study|Adverse Event|21
7738847|NCT00662558|12170570|FG001|Overall Study|Adverse Event|59
7738848|NCT00662558|12170569|FG000|Overall Study|Lack of Efficacy|4
7738849|NCT00662558|12170570|FG001|Overall Study|Lack of Efficacy|7
7738850|NCT00662558|12170569|FG000|Overall Study|Lost to Follow-up|13
7738851|NCT00662558|12170570|FG001|Overall Study|Lost to Follow-up|10
7738852|NCT00662558|12170569|FG000|Overall Study|Other|9
7738853|NCT00662558|12170570|FG001|Overall Study|Other|14
7738854|NCT00662558|12170569|FG000|Overall Study|Withdrawal by Subject|7
7738855|NCT00662558|12170570|FG001|Overall Study|Withdrawal by Subject|12
7738856|NCT00662558|12170569|FG000|Overall Study|Randomized But Did Not Receive Treatment|2
7738857|NCT00662558|12170570|FG001|Overall Study|Randomized But Did Not Receive Treatment|8
7738858|NCT00662649|12170580|FG000|Core Study (24 Months)|Withdrawal by Subject|31
7738859|NCT00662649|12170581|FG001|Core Study (24 Months)|Withdrawal by Subject|17
7738860|NCT00662649|12170582|FG002|Core Study (24 Months)|Withdrawal by Subject|28
7738861|NCT00662649|12170583|FG003|Core Study (24 Months)|Withdrawal by Subject|0
7738862|NCT00662649|12170584|FG004|Core Study (24 Months)|Withdrawal by Subject|0
7738863|NCT00662649|12170580|FG000|Core Study (24 Months)|Adverse Event|22
7738864|NCT00662649|12170581|FG001|Core Study (24 Months)|Adverse Event|13
7738865|NCT00662649|12170582|FG002|Core Study (24 Months)|Adverse Event|18
7738866|NCT00662649|12170583|FG003|Core Study (24 Months)|Adverse Event|0
7738867|NCT00662649|12170584|FG004|Core Study (24 Months)|Adverse Event|0
7738868|NCT00662649|12170580|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
7738869|NCT00662649|12170581|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
7738870|NCT00662649|12170582|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
7738871|NCT00662649|12170583|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
7738872|NCT00662649|12170584|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
7738873|NCT00662649|12170580|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20
7738874|NCT00662649|12170581|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9
7738875|NCT00662649|12170582|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1
7738876|NCT00662649|12170583|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0
7738877|NCT00662649|12170584|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0
7738878|NCT00662649|12170580|FG000|Core Study (24 Months)|Lost to Follow-up|3
7738879|NCT00662649|12170581|FG001|Core Study (24 Months)|Lost to Follow-up|5
7738880|NCT00662649|12170582|FG002|Core Study (24 Months)|Lost to Follow-up|7
7738881|NCT00662649|12170583|FG003|Core Study (24 Months)|Lost to Follow-up|0
7738882|NCT00662649|12170584|FG004|Core Study (24 Months)|Lost to Follow-up|0
7738883|NCT00662649|12170580|FG000|Core Study (24 Months)|Protocol Violation|5
7738884|NCT00662649|12170581|FG001|Core Study (24 Months)|Protocol Violation|5
7738885|NCT00662649|12170582|FG002|Core Study (24 Months)|Protocol Violation|4
7738886|NCT00662649|12170583|FG003|Core Study (24 Months)|Protocol Violation|0
7738887|NCT00662649|12170584|FG004|Core Study (24 Months)|Protocol Violation|0
7738888|NCT00662649|12170580|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2
7738889|NCT00662649|12170581|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1
7738890|NCT00662649|12170582|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1
7738891|NCT00662649|12170583|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0
7738892|NCT00662649|12170584|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0
7738893|NCT00662649|12170580|FG000|Core Study (24 Months)|Death|1
7738894|NCT00662649|12170581|FG001|Core Study (24 Months)|Death|0
7738895|NCT00662649|12170582|FG002|Core Study (24 Months)|Death|2
7738896|NCT00662649|12170583|FG003|Core Study (24 Months)|Death|0
7738897|NCT00662649|12170584|FG004|Core Study (24 Months)|Death|0
7738898|NCT00662649|12170580|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
7738899|NCT00662649|12170581|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
7738900|NCT00662649|12170582|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
7738901|NCT00662649|12170583|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
7738902|NCT00662649|12170584|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
7738903|NCT00662649|12170580|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
7738904|NCT00662649|12170581|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
7738905|NCT00662649|12170582|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
7738906|NCT00662649|12170583|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
7738907|NCT00662649|12170584|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
7738908|NCT00662649|12170580|FG000|Extension Study (Month 24 to 60)|Administrative problems|0
7738909|NCT00662649|12170581|FG001|Extension Study (Month 24 to 60)|Administrative problems|0
7738910|NCT00662649|12170582|FG002|Extension Study (Month 24 to 60)|Administrative problems|0
7738911|NCT00662649|12170583|FG003|Extension Study (Month 24 to 60)|Administrative problems|1
7738912|NCT00662649|12170584|FG004|Extension Study (Month 24 to 60)|Administrative problems|0
7738913|NCT00662649|12170580|FG000|Extension Study (Month 24 to 60)|Adverse Event|6
7738914|NCT00662649|12170581|FG001|Extension Study (Month 24 to 60)|Adverse Event|9
7738915|NCT00662649|12170582|FG002|Extension Study (Month 24 to 60)|Adverse Event|0
7738916|NCT00662649|12170583|FG003|Extension Study (Month 24 to 60)|Adverse Event|6
7738917|NCT00662649|12170584|FG004|Extension Study (Month 24 to 60)|Adverse Event|10
7738918|NCT00662649|12170580|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2
7738919|NCT00662649|12170581|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0
7738920|NCT00662649|12170582|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0
7738921|NCT00662649|12170583|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1
7738922|NCT00662649|12170584|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1
7738923|NCT00662649|12170580|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1
7738924|NCT00662649|12170581|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1
7738925|NCT00662649|12170582|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0
7738926|NCT00662649|12170583|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0
7738927|NCT00662649|12170584|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0
7738928|NCT00662649|12170580|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19
7738929|NCT00662649|12170581|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23
7738930|NCT00662649|12170582|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0
7738931|NCT00662649|12170583|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15
7738932|NCT00662649|12170584|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9
7738933|NCT00662649|12170580|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
7738934|NCT00662649|12170581|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
7738935|NCT00662649|12170582|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
7738936|NCT00662649|12170583|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
7738937|NCT00662649|12170584|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
7738938|NCT00662649|12170580|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
7738939|NCT00662649|12170581|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
7738940|NCT00662649|12170582|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
7738941|NCT00662649|12170583|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
7738942|NCT00662649|12170584|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
7738943|NCT00662831|12170620|FG000|Overall Study|Death|4
7738944|NCT00662831|12170621|FG001|Overall Study|Death|1
7738945|NCT00662831|12170620|FG000|Overall Study|Lack of Efficacy|6
7738946|NCT00662831|12170621|FG001|Overall Study|Lack of Efficacy|6
7738947|NCT00662831|12170620|FG000|Overall Study|Lost to Follow-up|1
7738948|NCT00662831|12170621|FG001|Overall Study|Lost to Follow-up|0
7738949|NCT00662831|12170620|FG000|Overall Study|Withdrawal by Subject|2
7738950|NCT00662831|12170621|FG001|Overall Study|Withdrawal by Subject|1
7738951|NCT00662831|12170620|FG000|Overall Study|Other|62
7738952|NCT00662831|12170621|FG001|Overall Study|Other|31
7738953|NCT00662831|12170620|FG000|Overall Study|Protocol Violation|8
7738954|NCT00662831|12170621|FG001|Overall Study|Protocol Violation|4
7738955|NCT00662831|12170620|FG000|Overall Study|Adverse Event|23
7738956|NCT00662831|12170621|FG001|Overall Study|Adverse Event|16
7738957|NCT00662857|12170627|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0
7738958|NCT00662857|12170628|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1
7738959|NCT00662857|12170627|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
7738960|NCT00662857|12170628|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
7738961|NCT00662857|12170627|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
7738962|NCT00662857|12170628|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
7738963|NCT00662909|12170640|FG000|Overall Study|Adverse Event|17
7738964|NCT00662909|12170641|FG001|Overall Study|Adverse Event|18
7738965|NCT00662909|12170642|FG002|Overall Study|Adverse Event|19
7738966|NCT00662909|12170640|FG000|Overall Study|Lack of Efficacy|9
7738967|NCT00662909|12170641|FG001|Overall Study|Lack of Efficacy|1
7738968|NCT00662909|12170642|FG002|Overall Study|Lack of Efficacy|5
7738969|NCT00662909|12170640|FG000|Overall Study|Withdrawal by Subject|29
7738970|NCT00662909|12170641|FG001|Overall Study|Withdrawal by Subject|22
7738971|NCT00662909|12170642|FG002|Overall Study|Withdrawal by Subject|16
7738972|NCT00662909|12170640|FG000|Overall Study|Lost to Follow-up|2
7738973|NCT00662909|12170641|FG001|Overall Study|Lost to Follow-up|9
7738974|NCT00662909|12170642|FG002|Overall Study|Lost to Follow-up|3
7738975|NCT00662909|12170640|FG000|Overall Study|Protocol Violation|7
7738976|NCT00662909|12170641|FG001|Overall Study|Protocol Violation|4
7738977|NCT00662909|12170642|FG002|Overall Study|Protocol Violation|5
7738978|NCT00662909|12170640|FG000|Overall Study|Randomized- never received study drug|1
7738979|NCT00662909|12170641|FG001|Overall Study|Randomized- never received study drug|0
7738980|NCT00662909|12170642|FG002|Overall Study|Randomized- never received study drug|0
7738981|NCT00662909|12170640|FG000|Overall Study|Non-compliance with study procedures|3
7738982|NCT00662909|12170641|FG001|Overall Study|Non-compliance with study procedures|3
7738983|NCT00662909|12170642|FG002|Overall Study|Non-compliance with study procedures|2
7738984|NCT00662909|12170640|FG000|Overall Study|Physician Decision|1
7738985|NCT00662909|12170641|FG001|Overall Study|Physician Decision|1
7738986|NCT00662909|12170642|FG002|Overall Study|Physician Decision|2
7738987|NCT00662909|12170640|FG000|Overall Study|Eligibility criterion not met|0
7738988|NCT00662909|12170641|FG001|Overall Study|Eligibility criterion not met|1
7738989|NCT00662909|12170642|FG002|Overall Study|Eligibility criterion not met|1
7738990|NCT00663026|12170653|FG000|Overall Study|Lost to Follow-up|1
7738991|NCT00663026|12170654|FG001|Overall Study|Lost to Follow-up|0
7738992|NCT00663026|12170655|FG002|Overall Study|Lost to Follow-up|0
7738993|NCT00663026|12170653|FG000|Overall Study|Other|1
7738994|NCT00663026|12170654|FG001|Overall Study|Other|2
7738995|NCT00663026|12170655|FG002|Overall Study|Other|0
7738996|NCT00663026|12170653|FG000|Overall Study|Adverse Event|0
7738997|NCT00663026|12170654|FG001|Overall Study|Adverse Event|2
7738998|NCT00663026|12170655|FG002|Overall Study|Adverse Event|3
7738999|NCT00663026|12170653|FG000|Overall Study|Caregiver Request|0
7739000|NCT00663026|12170654|FG001|Overall Study|Caregiver Request|2
7739001|NCT00663026|12170655|FG002|Overall Study|Caregiver Request|0
7739002|NCT00663026|12170653|FG000|Overall Study|Withdrawal by Subject|0
7739003|NCT00663026|12170654|FG001|Overall Study|Withdrawal by Subject|0
7739004|NCT00663026|12170655|FG002|Overall Study|Withdrawal by Subject|1
7739005|NCT00663117|12170674|FG000|Overall Study|Lack of Efficacy|1
7739006|NCT00663117|12170675|FG001|Overall Study|Lack of Efficacy|0
7739007|NCT00663208|12170703|FG000|Treatment Period|Lost to Follow-up|0
7739008|NCT00663208|12170704|FG001|Treatment Period|Lost to Follow-up|1
7739009|NCT00663208|12170705|FG002|Treatment Period|Lost to Follow-up|0
7739010|NCT00663208|12170706|FG003|Treatment Period|Lost to Follow-up|0
7739011|NCT00663208|12170707|FG004|Treatment Period|Lost to Follow-up|0
7739012|NCT00663208|12170708|FG005|Treatment Period|Lost to Follow-up|0
7739013|NCT00663208|12170709|FG006|Treatment Period|Lost to Follow-up|0
7739014|NCT00663208|12170703|FG000|Follow-up Period|Lost to Follow-up|2
7739015|NCT00663208|12170704|FG001|Follow-up Period|Lost to Follow-up|0
7739016|NCT00663208|12170705|FG002|Follow-up Period|Lost to Follow-up|3
7739017|NCT00663208|12170706|FG003|Follow-up Period|Lost to Follow-up|2
7739018|NCT00663208|12170707|FG004|Follow-up Period|Lost to Follow-up|0
7739019|NCT00663208|12170708|FG005|Follow-up Period|Lost to Follow-up|0
7739020|NCT00663208|12170709|FG006|Follow-up Period|Lost to Follow-up|0
7739021|NCT00663208|12170703|FG000|Follow-up Period|Other reason|1
7739022|NCT00663208|12170704|FG001|Follow-up Period|Other reason|0
7739023|NCT00663208|12170705|FG002|Follow-up Period|Other reason|0
7739024|NCT00663208|12170706|FG003|Follow-up Period|Other reason|0
7739025|NCT00663208|12170707|FG004|Follow-up Period|Other reason|0
7739026|NCT00663208|12170708|FG005|Follow-up Period|Other reason|0
7739027|NCT00663208|12170709|FG006|Follow-up Period|Other reason|1
7739028|NCT00663234|12170727|FG000|Overall Study|Not willing to adhere to requirements|1
7739029|NCT00663260|12170738|FG000|Overall Study|Lack of Efficacy|2
7739030|NCT00663260|12170739|FG001|Overall Study|Lack of Efficacy|0
7739031|NCT00663260|12170740|FG002|Overall Study|Lack of Efficacy|0
7739032|NCT00663260|12170738|FG000|Overall Study|Adverse Event|12
7739033|NCT00663260|12170739|FG001|Overall Study|Adverse Event|7
7739034|NCT00663260|12170740|FG002|Overall Study|Adverse Event|6
7739035|NCT00663260|12170738|FG000|Overall Study|Withdrawal by Subject|3
7739036|NCT00663260|12170739|FG001|Overall Study|Withdrawal by Subject|1
7739037|NCT00663260|12170740|FG002|Overall Study|Withdrawal by Subject|6
7739038|NCT00663260|12170738|FG000|Overall Study|Death|1
7739039|NCT00663260|12170739|FG001|Overall Study|Death|0
7739040|NCT00663260|12170740|FG002|Overall Study|Death|1
7739041|NCT00663260|12170738|FG000|Overall Study|Lost to Follow-up|0
7739042|NCT00663260|12170739|FG001|Overall Study|Lost to Follow-up|1
7739043|NCT00663260|12170740|FG002|Overall Study|Lost to Follow-up|0
7739044|NCT00663260|12170738|FG000|Overall Study|non-compliance, not met criteria, etc.|3
7739045|NCT00663260|12170739|FG001|Overall Study|non-compliance, not met criteria, etc.|2
7739046|NCT00663260|12170740|FG002|Overall Study|non-compliance, not met criteria, etc.|3
7739047|NCT00663702|12170754|FG000|Overall Study|Adverse Event|8
7739048|NCT00663702|12170755|FG001|Overall Study|Adverse Event|4
7739049|NCT00663702|12170754|FG000|Overall Study|Withdrawal by Subject|3
7739050|NCT00663702|12170755|FG001|Overall Study|Withdrawal by Subject|1
7739051|NCT00663702|12170754|FG000|Overall Study|Pregnancy|0
7739052|NCT00663702|12170755|FG001|Overall Study|Pregnancy|1
7739053|NCT00663702|12170754|FG000|Overall Study|Lost to Follow-up|3
7739054|NCT00663702|12170755|FG001|Overall Study|Lost to Follow-up|0
7739055|NCT00663702|12170754|FG000|Overall Study|Death|1
7739056|NCT00663702|12170755|FG001|Overall Study|Death|1
7739057|NCT00663702|12170754|FG000|Overall Study|Lack of Efficacy|3
7739058|NCT00663702|12170755|FG001|Overall Study|Lack of Efficacy|3
7739059|NCT00663858|12170784|FG000|Overall Study|Adverse Event|9
7739060|NCT00663858|12170785|FG001|Overall Study|Adverse Event|1
7739061|NCT00663858|12170786|FG002|Overall Study|Adverse Event|6
7739062|NCT00663858|12170784|FG000|Overall Study|Lack of Efficacy|5
7739063|NCT00663858|12170785|FG001|Overall Study|Lack of Efficacy|1
7739064|NCT00663858|12170786|FG002|Overall Study|Lack of Efficacy|3
7739065|NCT00663858|12170784|FG000|Overall Study|Withdrawal by Subject|7
7739066|NCT00663858|12170785|FG001|Overall Study|Withdrawal by Subject|3
7739067|NCT00663858|12170786|FG002|Overall Study|Withdrawal by Subject|3
7739068|NCT00663858|12170784|FG000|Overall Study|Protocol Violation|5
7739069|NCT00663858|12170785|FG001|Overall Study|Protocol Violation|3
7739070|NCT00663858|12170786|FG002|Overall Study|Protocol Violation|4
7739071|NCT00663858|12170784|FG000|Overall Study|Other|8
7739072|NCT00663858|12170785|FG001|Overall Study|Other|2
7739073|NCT00663858|12170786|FG002|Overall Study|Other|4
7739074|NCT00663871|12170796|FG000|Overall Study|Lost to Follow-up|5
7739075|NCT00663871|12170797|FG001|Overall Study|Lost to Follow-up|5
7739076|NCT00663871|12170796|FG000|Overall Study|Withdrawal by Subject|5
7739077|NCT00663871|12170797|FG001|Overall Study|Withdrawal by Subject|2
7739078|NCT00663923|12170805|FG000|Overall Study|Lost to Follow-up|2
7739079|NCT00663962|12170813|FG000|Overall Study|somnolence|1
7739080|NCT00663962|12170814|FG001|Overall Study|somnolence|0
7769051|NCT00866294|12212487|FG000|Overall Study|Physician Decision|6
7769052|NCT00866294|12212488|FG001|Overall Study|Physician Decision|2
7769053|NCT00866294|12212489|FG002|Overall Study|Physician Decision|1
7769054|NCT00866307|12212505|FG000|Induction|Adverse Event|5
7769055|NCT00866307|12212506|FG001|Induction|Adverse Event|0
7769056|NCT00866307|12212507|FG002|Induction|Adverse Event|0
7769057|NCT00866307|12212505|FG000|Induction|Death|2
7769058|NCT00866307|12212506|FG001|Induction|Death|0
7769059|NCT00866307|12212507|FG002|Induction|Death|0
7769060|NCT00866307|12212505|FG000|Induction|Physician Decision|5
7769061|NCT00866307|12212506|FG001|Induction|Physician Decision|0
7739081|NCT00664105|12170820|FG000|Overall Study|Death|3
7739082|NCT00664105|12170820|FG000|Overall Study|Withdrawal by Subject|5
7739083|NCT00664105|12170820|FG000|Overall Study|Adverse Event|9
7739084|NCT00664105|12170820|FG000|Overall Study|Disease progression|7
7739085|NCT00664209|12170825|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7
7739086|NCT00664209|12170825|FG000|Study Treatment Period|Physician Decision|4
7739087|NCT00664209|12170825|FG000|Study Treatment Period|Withdrawal by Subject|2
7739088|NCT00664326|12170830|FG000|Overall Study|Adverse Event|14
7739089|NCT00664326|12170830|FG000|Overall Study|Noncompliance with study medication|3
7739090|NCT00664326|12170830|FG000|Overall Study|Withdrawal by Subject|1
7739091|NCT00664326|12170830|FG000|Overall Study|Physician Decision|1
7739092|NCT00664326|12170830|FG000|Overall Study|Other Reasons|3
7739093|NCT00664326|12170830|FG000|Overall Study|Death|2
7739094|NCT00664326|12170830|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24
7739095|NCT00664521|12170840|FG000|Overall Study|Adverse Event|4
7739096|NCT00664521|12170841|FG001|Overall Study|Adverse Event|1
7739097|NCT00664521|12170840|FG000|Overall Study|Lost to Follow-up|1
7739098|NCT00664521|12170841|FG001|Overall Study|Lost to Follow-up|0
7739099|NCT00664521|12170840|FG000|Overall Study|Other|1
7739100|NCT00664521|12170841|FG001|Overall Study|Other|0
7739101|NCT00664534|12170849|FG000|Overall Study|Adverse Event|2
7739102|NCT00664534|12170850|FG001|Overall Study|Adverse Event|3
7739103|NCT00664534|12170849|FG000|Overall Study|Lost to Follow-up|6
7739104|NCT00664534|12170850|FG001|Overall Study|Lost to Follow-up|10
7739105|NCT00664534|12170849|FG000|Overall Study|Protocol Violation|10
7739106|NCT00664534|12170850|FG001|Overall Study|Protocol Violation|8
7739107|NCT00664534|12170849|FG000|Overall Study|Withdrawal by Subject|7
7739108|NCT00664534|12170850|FG001|Overall Study|Withdrawal by Subject|6
7739109|NCT00664534|12170849|FG000|Overall Study|Physician Decision|8
7739110|NCT00664534|12170850|FG001|Overall Study|Physician Decision|0
7739111|NCT00664534|12170849|FG000|Overall Study|Sponsor decision|8
7739112|NCT00664534|12170850|FG001|Overall Study|Sponsor decision|6
7739113|NCT00664560|12170859|FG000|Overall Study|Adverse Event|19
7739114|NCT00664560|12170860|FG001|Overall Study|Adverse Event|16
7739115|NCT00664560|12170861|FG002|Overall Study|Adverse Event|7
7739116|NCT00664560|12170859|FG000|Overall Study|Withdrawal by Subject|9
7739117|NCT00664560|12170860|FG001|Overall Study|Withdrawal by Subject|13
7739118|NCT00664560|12170861|FG002|Overall Study|Withdrawal by Subject|7
7739119|NCT00664560|12170859|FG000|Overall Study|Lost to Follow-up|0
7739120|NCT00664560|12170860|FG001|Overall Study|Lost to Follow-up|2
7739121|NCT00664560|12170861|FG002|Overall Study|Lost to Follow-up|0
7739122|NCT00664560|12170859|FG000|Overall Study|Other|11
7739123|NCT00664560|12170860|FG001|Overall Study|Other|4
7739124|NCT00664560|12170861|FG002|Overall Study|Other|5
7739125|NCT00664742|12170869|FG000|Overall Study|Withdrawn due to adverse events|3
7739126|NCT00664742|12170869|FG000|Overall Study|Withdrawal by Subject|31
7739127|NCT00664742|12170869|FG000|Overall Study|Lost to Follow-up|92
7739128|NCT00664859|12170885|FG000|Overall Study|Adverse Event|2
7739129|NCT00664859|12170886|FG001|Overall Study|Adverse Event|1
7739130|NCT00664859|12170887|FG002|Overall Study|Adverse Event|3
7739131|NCT00664859|12170885|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6
7739132|NCT00664859|12170886|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
7739133|NCT00664859|12170887|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
7739134|NCT00664859|12170885|FG000|Overall Study|Noncompliance with protocol|1
7739135|NCT00664859|12170886|FG001|Overall Study|Noncompliance with protocol|0
7739136|NCT00664859|12170887|FG002|Overall Study|Noncompliance with protocol|4
7739137|NCT00664859|12170885|FG000|Overall Study|Laboratory abnormality|2
7739138|NCT00664859|12170886|FG001|Overall Study|Laboratory abnormality|1
7739139|NCT00664859|12170887|FG002|Overall Study|Laboratory abnormality|4
7739140|NCT00664859|12170885|FG000|Overall Study|Withdrawal by Subject|4
7739141|NCT00664859|12170886|FG001|Overall Study|Withdrawal by Subject|1
7739142|NCT00664859|12170887|FG002|Overall Study|Withdrawal by Subject|3
7739143|NCT00664859|12170885|FG000|Overall Study|Lost to Follow-up|2
7739144|NCT00664859|12170886|FG001|Overall Study|Lost to Follow-up|2
7739145|NCT00664859|12170887|FG002|Overall Study|Lost to Follow-up|1
7739146|NCT00664859|12170885|FG000|Overall Study|Other|0
7739147|NCT00664859|12170886|FG001|Overall Study|Other|1
7739148|NCT00664859|12170887|FG002|Overall Study|Other|2
7739149|NCT00665002|12170895|FG000|Overall Study|Progression/relapse during treatment|11
7739150|NCT00665002|12170895|FG000|Overall Study|Cytogenetic resistance|1
7739151|NCT00665353|12170903|FG000|Study Step 1|Adverse Event|1
7739152|NCT00665353|12170903|FG000|Study Step 1|Withdrawal by Subject|2
7739153|NCT00665353|12170903|FG000|Study Step 2|Lost to Follow-up|2
7739154|NCT00665353|12170903|FG000|Study Step 2|Lack of Efficacy|12
7739155|NCT00665366|12170909|FG000|Overall Study|Lack of Efficacy|11
7739156|NCT00665366|12170910|FG001|Overall Study|Lack of Efficacy|10
7739157|NCT00665366|12170909|FG000|Overall Study|Adverse Event|25
7739158|NCT00665366|12170910|FG001|Overall Study|Adverse Event|23
7739159|NCT00665366|12170909|FG000|Overall Study|Withdrawal by Subject|11
7739160|NCT00665366|12170910|FG001|Overall Study|Withdrawal by Subject|14
7739161|NCT00665366|12170909|FG000|Overall Study|Lost to Follow-up|3
7739162|NCT00665366|12170910|FG001|Overall Study|Lost to Follow-up|5
7739163|NCT00665366|12170909|FG000|Overall Study|Poor compliance/noncompliance|3
7739164|NCT00665366|12170910|FG001|Overall Study|Poor compliance/noncompliance|5
7739165|NCT00665366|12170909|FG000|Overall Study|Pregnancy|1
7739166|NCT00665366|12170910|FG001|Overall Study|Pregnancy|0
7739167|NCT00665366|12170909|FG000|Overall Study|No longer meets study criteria|0
7739168|NCT00665366|12170910|FG001|Overall Study|No longer meets study criteria|1
7739169|NCT00665366|12170909|FG000|Overall Study|Other reasons|4
7739170|NCT00665366|12170910|FG001|Overall Study|Other reasons|1
7739171|NCT00665392|12170916|FG000|Overall Study|not treated|1
7739172|NCT00665431|12170924|FG000|Overall Study|Adverse Event|16
7739173|NCT00665431|12170925|FG001|Overall Study|Adverse Event|22
7739174|NCT00665431|12170926|FG002|Overall Study|Adverse Event|6
7739175|NCT00665431|12170924|FG000|Overall Study|Withdrawal by Subject|17
7739176|NCT00665431|12170925|FG001|Overall Study|Withdrawal by Subject|25
7739177|NCT00665431|12170926|FG002|Overall Study|Withdrawal by Subject|15
7739178|NCT00665431|12170924|FG000|Overall Study|Lost to Follow-up|3
7739179|NCT00665431|12170925|FG001|Overall Study|Lost to Follow-up|3
7739180|NCT00665431|12170926|FG002|Overall Study|Lost to Follow-up|1
7739181|NCT00665431|12170924|FG000|Overall Study|Other|4
7739182|NCT00665431|12170925|FG001|Overall Study|Other|7
7739183|NCT00665431|12170926|FG002|Overall Study|Other|2
7739184|NCT00665561|12170949|FG000|Overall Study|Death recorded on subject summary pages|75
7739185|NCT00665561|12170950|FG001|Overall Study|Death recorded on subject summary pages|75
7739186|NCT00665561|12170949|FG000|Overall Study|Does not meet entrance criteria|19
7739187|NCT00665561|12170950|FG001|Overall Study|Does not meet entrance criteria|21
7739188|NCT00665561|12170949|FG000|Overall Study|Lost to Follow-up|203
7739189|NCT00665561|12170950|FG001|Overall Study|Lost to Follow-up|264
7739190|NCT00665561|12170949|FG000|Overall Study|Withdrawal by Subject|74
7739191|NCT00665561|12170950|FG001|Overall Study|Withdrawal by Subject|65
7739192|NCT00665561|12170949|FG000|Overall Study|Other|123
7739193|NCT00665561|12170950|FG001|Overall Study|Other|108
7739194|NCT00665561|12170949|FG000|Overall Study|Site closed|8
7739195|NCT00665561|12170950|FG001|Overall Study|Site closed|0
7739196|NCT00665561|12170949|FG000|Overall Study|Withdrawn due to pregnancy|0
7739197|NCT00665561|12170950|FG001|Overall Study|Withdrawn due to pregnancy|1
7739198|NCT00665626|12170958|FG000|Overall Study|Lack of Efficacy|8
7739199|NCT00665626|12170959|FG001|Overall Study|Lack of Efficacy|5
7739200|NCT00665626|12170958|FG000|Overall Study|Lost to Follow-up|0
7739201|NCT00665626|12170959|FG001|Overall Study|Lost to Follow-up|2
7739202|NCT00665626|12170958|FG000|Overall Study|Withdrawal by Subject|0
7739203|NCT00665626|12170959|FG001|Overall Study|Withdrawal by Subject|1
7739204|NCT00665626|12170958|FG000|Overall Study|Protocol Violation|0
7739205|NCT00665626|12170959|FG001|Overall Study|Protocol Violation|2
7739206|NCT00665626|12170958|FG000|Overall Study|Adverse Event|1
7739207|NCT00665626|12170959|FG001|Overall Study|Adverse Event|9
7739208|NCT00665626|12170958|FG000|Overall Study|Due to exclusion criteria|0
7739209|NCT00665626|12170959|FG001|Overall Study|Due to exclusion criteria|1
7739210|NCT00665626|12170958|FG000|Overall Study|Did not fulfil inclusion criteria|0
7739211|NCT00665626|12170959|FG001|Overall Study|Did not fulfil inclusion criteria|1
7739212|NCT00665626|12170958|FG000|Overall Study|Unably to comply with dosing regimen|0
7739213|NCT00665626|12170959|FG001|Overall Study|Unably to comply with dosing regimen|1
7739214|NCT00665626|12170958|FG000|Overall Study|Death|1
7739215|NCT00665626|12170959|FG001|Overall Study|Death|0
7739216|NCT00665652|12170965|FG000|Overall Study|Adverse Event|4
7739217|NCT00665652|12170965|FG000|Overall Study|Death|1
7739218|NCT00665652|12170965|FG000|Overall Study|No longer met inclusion criteria.|1
7739219|NCT00665847|12170973|FG000|Overall Study|Adverse Event|8
7739220|NCT00665847|12170973|FG000|Overall Study|Withdrawal by Subject|2
7739221|NCT00665847|12170973|FG000|Overall Study|Subject non-compliant|8
7739222|NCT00665847|12170973|FG000|Overall Study|Subject reached a virologic endpoint|4
7739223|NCT00665847|12170973|FG000|Overall Study|Resistance to TMC125|1
7739224|NCT00665847|12170973|FG000|Overall Study|Subject ineligible to continue the trial|1
7739225|NCT00665847|12170973|FG000|Overall Study|Switch to Commercial Medication|1
7739226|NCT00665925|12170981|FG000|Overall Study|Lack of Efficacy|10
7739227|NCT00665925|12170982|FG001|Overall Study|Lack of Efficacy|8
7739228|NCT00665925|12170983|FG002|Overall Study|Lack of Efficacy|9
7739229|NCT00665925|12170984|FG003|Overall Study|Lack of Efficacy|8
7739230|NCT00665925|12170981|FG000|Overall Study|Lost to Follow-up|1
7739231|NCT00665925|12170982|FG001|Overall Study|Lost to Follow-up|2
7739232|NCT00665925|12170983|FG002|Overall Study|Lost to Follow-up|2
7739233|NCT00665925|12170984|FG003|Overall Study|Lost to Follow-up|2
7739234|NCT00665925|12170981|FG000|Overall Study|Withdrawal by Subject|2
7739235|NCT00665925|12170982|FG001|Overall Study|Withdrawal by Subject|2
7739236|NCT00665925|12170983|FG002|Overall Study|Withdrawal by Subject|3
7739237|NCT00665925|12170984|FG003|Overall Study|Withdrawal by Subject|2
7739238|NCT00665925|12170981|FG000|Overall Study|Physician Decision|0
7739239|NCT00665925|12170982|FG001|Overall Study|Physician Decision|0
7739240|NCT00665925|12170983|FG002|Overall Study|Physician Decision|1
7739241|NCT00665925|12170984|FG003|Overall Study|Physician Decision|2
7739242|NCT00665925|12170981|FG000|Overall Study|Severe Non-Compliance to Protocol|0
7739243|NCT00665925|12170982|FG001|Overall Study|Severe Non-Compliance to Protocol|0
7739244|NCT00665925|12170983|FG002|Overall Study|Severe Non-Compliance to Protocol|1
7739245|NCT00665925|12170984|FG003|Overall Study|Severe Non-Compliance to Protocol|1
7739246|NCT00665925|12170981|FG000|Overall Study|Adverse Event|1
7739247|NCT00665925|12170982|FG001|Overall Study|Adverse Event|5
7739248|NCT00665925|12170983|FG002|Overall Study|Adverse Event|10
7739249|NCT00665925|12170984|FG003|Overall Study|Adverse Event|5
7739250|NCT00665925|12170981|FG000|Overall Study|Enrolled by mistake|0
7739251|NCT00665925|12170982|FG001|Overall Study|Enrolled by mistake|0
7739252|NCT00665925|12170983|FG002|Overall Study|Enrolled by mistake|0
7739253|NCT00665925|12170984|FG003|Overall Study|Enrolled by mistake|1
7739254|NCT00665925|12170981|FG000|Overall Study|Due to exclusion criteria|1
7739255|NCT00665925|12170982|FG001|Overall Study|Due to exclusion criteria|0
7739256|NCT00665925|12170983|FG002|Overall Study|Due to exclusion criteria|0
7739257|NCT00665925|12170984|FG003|Overall Study|Due to exclusion criteria|0
7739258|NCT00666198|12171005|FG000|Overall Study|Protocol Violation|10
7739259|NCT00666198|12171005|FG000|Overall Study|No Visit After First Day of Treatment|13
7739260|NCT00666198|12171005|FG000|Overall Study|Safety Not Assessable|6
7739261|NCT00666198|12171005|FG000|Overall Study|No Drug Administration|4
7739262|NCT00666211|12171011|FG000|Overall Study|Withdrawal by Subject|10
7739263|NCT00666211|12171012|FG001|Overall Study|Withdrawal by Subject|13
7739264|NCT00666211|12171011|FG000|Overall Study|went off medication, no more pain|1
7739265|NCT00666211|12171012|FG001|Overall Study|went off medication, no more pain|0
7739266|NCT00666211|12171011|FG000|Overall Study|patient non-compliant|6
7739267|NCT00666211|12171012|FG001|Overall Study|patient non-compliant|6
7739268|NCT00666211|12171011|FG000|Overall Study|disease progression|1
7739269|NCT00666211|12171012|FG001|Overall Study|disease progression|8
7739270|NCT00666211|12171011|FG000|Overall Study|Lost to Follow-up|2
7739271|NCT00666211|12171012|FG001|Overall Study|Lost to Follow-up|0
7739272|NCT00666211|12171011|FG000|Overall Study|toxicity|0
7739273|NCT00666211|12171012|FG001|Overall Study|toxicity|2
7739274|NCT00666211|12171011|FG000|Overall Study|hospital admission|0
7739275|NCT00666211|12171012|FG001|Overall Study|hospital admission|5
7739276|NCT00666211|12171011|FG000|Overall Study|Death|0
7739277|NCT00666211|12171012|FG001|Overall Study|Death|2
7739278|NCT00666211|12171011|FG000|Overall Study|off tx for other complicating disease|0
7739279|NCT00666211|12171012|FG001|Overall Study|off tx for other complicating disease|1
7739280|NCT00666211|12171011|FG000|Overall Study|Physician Decision|0
7739281|NCT00666211|12171012|FG001|Overall Study|Physician Decision|1
7739282|NCT00666224|12171020|FG000|Double-Blind|Adverse Event|15
7739283|NCT00666224|12171021|FG001|Double-Blind|Adverse Event|5
7739284|NCT00666224|12171020|FG000|Double-Blind|Lost to Follow-up|2
7739285|NCT00666224|12171021|FG001|Double-Blind|Lost to Follow-up|2
7739286|NCT00666224|12171020|FG000|Double-Blind|Withdrawal by Subject|18
7739287|NCT00666224|12171021|FG001|Double-Blind|Withdrawal by Subject|14
7739288|NCT00666224|12171020|FG000|Double-Blind|Physician Decision|0
7739289|NCT00666224|12171021|FG001|Double-Blind|Physician Decision|3
7739290|NCT00666224|12171020|FG000|Double-Blind|Sponsor decision|1
7739291|NCT00666224|12171021|FG001|Double-Blind|Sponsor decision|0
7739292|NCT00666224|12171020|FG000|Double-Blind|Pregnancy|3
7739293|NCT00666224|12171021|FG001|Double-Blind|Pregnancy|2
7739294|NCT00666224|12171020|FG000|Double-Blind|Noncompliance|1
7739295|NCT00666224|12171021|FG001|Double-Blind|Noncompliance|0
7739296|NCT00666224|12171020|FG000|Double-Blind|Death|1
7739297|NCT00666224|12171021|FG001|Double-Blind|Death|0
7739298|NCT00666224|12171020|FG000|Double-Blind|Undefined/Unknown|4
7739299|NCT00666224|12171021|FG001|Double-Blind|Undefined/Unknown|1
7739300|NCT00666224|12171020|FG000|Open-Label|Adverse Event|8
7739301|NCT00666224|12171021|FG001|Open-Label|Adverse Event|43
7739302|NCT00666224|12171020|FG000|Open-Label|Lost to Follow-up|4
7739303|NCT00666224|12171021|FG001|Open-Label|Lost to Follow-up|5
7739304|NCT00666224|12171020|FG000|Open-Label|Withdrawal by Subject|12
7739305|NCT00666224|12171021|FG001|Open-Label|Withdrawal by Subject|25
7739306|NCT00666224|12171020|FG000|Open-Label|Physician Decision|7
7739307|NCT00666224|12171021|FG001|Open-Label|Physician Decision|5
7739308|NCT00666224|12171020|FG000|Open-Label|Pregnancy|1
7739309|NCT00666224|12171021|FG001|Open-Label|Pregnancy|5
7739310|NCT00666224|12171020|FG000|Open-Label|Noncompliance|2
7739311|NCT00666224|12171021|FG001|Open-Label|Noncompliance|1
7739312|NCT00666224|12171020|FG000|Open-Label|Undefined/Unknown|1
7739313|NCT00666224|12171021|FG001|Open-Label|Undefined/Unknown|1
7739314|NCT00666263|12171028|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
7739315|NCT00666263|12171029|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
7739316|NCT00666263|12171028|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1
7739317|NCT00666263|12171029|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0
7739318|NCT00666263|12171028|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
7739319|NCT00666263|12171029|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
7739320|NCT00666276|12171074|FG000|Overall Study|Protocol Violation|34
7739321|NCT00666328|12171097|FG000|Overall Study|Death|2
7739322|NCT00666328|12171097|FG000|Overall Study|Lost to Follow-up|2
7739323|NCT00666328|12171097|FG000|Overall Study|No longer met eligibility criteria|1
7739324|NCT00666458|12171111|FG000|Overall Study|Adverse Event|8
7739325|NCT00666458|12171112|FG001|Overall Study|Adverse Event|7
7739326|NCT00666458|12171111|FG000|Overall Study|Withdrawal by Subject|5
7739327|NCT00666458|12171112|FG001|Overall Study|Withdrawal by Subject|4
7739328|NCT00666458|12171111|FG000|Overall Study|Lost to Follow-up|0
7739329|NCT00666458|12171112|FG001|Overall Study|Lost to Follow-up|3
7739330|NCT00666458|12171111|FG000|Overall Study|Administrative reason by sponsor|1
7739331|NCT00666458|12171112|FG001|Overall Study|Administrative reason by sponsor|1
7739332|NCT00666458|12171111|FG000|Overall Study|Incorrect enrollment|7
7739333|NCT00666458|12171112|FG001|Overall Study|Incorrect enrollment|1
7739334|NCT00666458|12171111|FG000|Overall Study|Study specific discontinuation criteria|14
7739335|NCT00666458|12171112|FG001|Overall Study|Study specific discontinuation criteria|7
7739336|NCT00666458|12171111|FG000|Overall Study|Severe non-compliance to the protocol|1
7739337|NCT00666458|12171112|FG001|Overall Study|Severe non-compliance to the protocol|1
7739338|NCT00666458|12171111|FG000|Overall Study|Safety reasons|1
7739339|NCT00666458|12171112|FG001|Overall Study|Safety reasons|0
7739340|NCT00666458|12171111|FG000|Overall Study|Medical history of anemia|1
7739341|NCT00666458|12171112|FG001|Overall Study|Medical history of anemia|0
7739342|NCT00666536|12171120|FG000|Overall Study|Adverse Event|9
7739343|NCT00666536|12171121|FG001|Overall Study|Adverse Event|19
7739344|NCT00666536|12171120|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7739345|NCT00666536|12171121|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7739346|NCT00666536|12171120|FG000|Overall Study|Protocol deviation(s)|8
7739347|NCT00666536|12171121|FG001|Overall Study|Protocol deviation(s)|6
7739348|NCT00666536|12171120|FG000|Overall Study|Withdrawal by Subject|10
7739349|NCT00666536|12171121|FG001|Overall Study|Withdrawal by Subject|9
7739350|NCT00666536|12171120|FG000|Overall Study|Lost to Follow-up|4
7739351|NCT00666536|12171121|FG001|Overall Study|Lost to Follow-up|3
7739352|NCT00666562|12171130|FG000|Overall Study|Withdrawal by Subject|0
7739353|NCT00666562|12171131|FG001|Overall Study|Withdrawal by Subject|1
7739354|NCT00666562|12171132|FG002|Overall Study|Withdrawal by Subject|0
7739355|NCT00666562|12171130|FG000|Overall Study|Concomitant Medication|0
7739356|NCT00666562|12171131|FG001|Overall Study|Concomitant Medication|1
7739357|NCT00666562|12171132|FG002|Overall Study|Concomitant Medication|0
7739358|NCT00666588|12171151|FG000|Overall Study|ineligible|2
7739359|NCT00666588|12171152|FG001|Overall Study|ineligible|0
7739360|NCT00666588|12171153|FG002|Overall Study|ineligible|0
7739361|NCT00666588|12171154|FG003|Overall Study|ineligible|2
7739362|NCT00666588|12171151|FG000|Overall Study|inevaluable|2
7739363|NCT00666588|12171152|FG001|Overall Study|inevaluable|0
7739364|NCT00666588|12171153|FG002|Overall Study|inevaluable|0
7739365|NCT00666588|12171154|FG003|Overall Study|inevaluable|0
7739366|NCT00666679|12171170|FG000|First Intervention|Lost to Follow-up|1
7739367|NCT00666679|12171171|FG001|First Intervention|Lost to Follow-up|0
7739368|NCT00666679|12171170|FG000|First Intervention|Protocol Violation|1
7739369|NCT00666679|12171171|FG001|First Intervention|Protocol Violation|0
7739370|NCT00666679|12171170|FG000|First Intervention|Withdrawal by Subject|1
7739371|NCT00666679|12171171|FG001|First Intervention|Withdrawal by Subject|0
7739372|NCT00666679|12171170|FG000|First Intervention|Randomized did not start treatment|1
7739373|NCT00666679|12171171|FG001|First Intervention|Randomized did not start treatment|1
7739374|NCT00666679|12171170|FG000|Washout Period of 1 Week|Lost to Follow-up|0
7739375|NCT00666679|12171171|FG001|Washout Period of 1 Week|Lost to Follow-up|1
7739376|NCT00666679|12171170|FG000|Washout Period of 1 Week|Protocol Violation|0
7739377|NCT00666679|12171171|FG001|Washout Period of 1 Week|Protocol Violation|1
7739378|NCT00666679|12171170|FG000|Second Intervention|Adverse Event|1
7739379|NCT00666679|12171171|FG001|Second Intervention|Adverse Event|0
7739380|NCT00666679|12171170|FG000|Second Intervention|Death|0
7739381|NCT00666679|12171171|FG001|Second Intervention|Death|1
7739382|NCT00666705|12171177|FG000|Overall Study|Withdrawal by Subject|1
7739383|NCT00666718|12171188|FG000|Overall Study|Adverse Event|0
7739384|NCT00666718|12171189|FG001|Overall Study|Adverse Event|1
7739385|NCT00666718|12171188|FG000|Overall Study|Death|1
7739386|NCT00666718|12171189|FG001|Overall Study|Death|0
7739387|NCT00666718|12171188|FG000|Overall Study|Lost to Follow-up|1
7739388|NCT00666718|12171189|FG001|Overall Study|Lost to Follow-up|0
7739389|NCT00666718|12171188|FG000|Overall Study|Entry Criteria Not Met|2
7739390|NCT00666718|12171189|FG001|Overall Study|Entry Criteria Not Met|0
7739391|NCT00666718|12171188|FG000|Overall Study|Protocol Violation|1
7739392|NCT00666718|12171189|FG001|Overall Study|Protocol Violation|3
7739393|NCT00666718|12171188|FG000|Overall Study|Withdrawal by Subject|7
7739394|NCT00666718|12171189|FG001|Overall Study|Withdrawal by Subject|12
7739395|NCT00666718|12171188|FG000|Overall Study|Physician Decision|0
7739396|NCT00666718|12171189|FG001|Overall Study|Physician Decision|2
7739397|NCT00666757|12171197|FG000|Overall Study|Lost to Follow-up|39
7739398|NCT00666757|12171198|FG001|Overall Study|Lost to Follow-up|35
7739399|NCT00666757|12171197|FG000|Overall Study|Protocol Violation|23
7739400|NCT00666757|12171198|FG001|Overall Study|Protocol Violation|24
7739401|NCT00666757|12171197|FG000|Overall Study|Adverse Event|22
7739402|NCT00666757|12171198|FG001|Overall Study|Adverse Event|12
7739403|NCT00666757|12171197|FG000|Overall Study|Withdrawal by Subject|13
7739404|NCT00666757|12171198|FG001|Overall Study|Withdrawal by Subject|17
7739405|NCT00666757|12171197|FG000|Overall Study|Lack of Efficacy|3
7739406|NCT00666757|12171198|FG001|Overall Study|Lack of Efficacy|6
7739407|NCT00666757|12171197|FG000|Overall Study|Physician Decision|0
7739408|NCT00666757|12171198|FG001|Overall Study|Physician Decision|2
7739409|NCT00666757|12171197|FG000|Overall Study|Sponsor decision|0
7739410|NCT00666757|12171198|FG001|Overall Study|Sponsor decision|1
7739411|NCT00666835|12171209|FG000|Overall Study|Withdrawal by Subject|5
7739412|NCT00666835|12171210|FG001|Overall Study|Withdrawal by Subject|2
7739413|NCT00666835|12171209|FG000|Overall Study|Lack of Efficacy|0
7739414|NCT00666835|12171210|FG001|Overall Study|Lack of Efficacy|1
7739415|NCT00666835|12171209|FG000|Overall Study|Incl./excl. not fulfilled|7
7739416|NCT00666835|12171210|FG001|Overall Study|Incl./excl. not fulfilled|2
7739417|NCT00666835|12171209|FG000|Overall Study|Adverse Event|7
7739418|NCT00666835|12171210|FG001|Overall Study|Adverse Event|6
7739419|NCT00666835|12171209|FG000|Overall Study|Protocol Violation|2
7739420|NCT00666835|12171210|FG001|Overall Study|Protocol Violation|0
7739421|NCT00666835|12171209|FG000|Overall Study|Death|15
7739422|NCT00666835|12171210|FG001|Overall Study|Death|4
7739423|NCT00666835|12171209|FG000|Overall Study|Kidney Transplantation (NTX)|10
7739424|NCT00666835|12171210|FG001|Overall Study|Kidney Transplantation (NTX)|2
7739425|NCT00666835|12171209|FG000|Overall Study|Hemoglobulin concentration|4
7739426|NCT00666835|12171210|FG001|Overall Study|Hemoglobulin concentration|3
7739427|NCT00666835|12171209|FG000|Overall Study|Planned operation|2
7739428|NCT00666835|12171210|FG001|Overall Study|Planned operation|0
7739429|NCT00666835|12171209|FG000|Overall Study|Physician Decision|1
7739430|NCT00666835|12171210|FG001|Overall Study|Physician Decision|2
7739431|NCT00666926|12171230|FG000|Overall Study|Adverse Event|0
7739432|NCT00666926|12171231|FG001|Overall Study|Adverse Event|0
7739433|NCT00666926|12171232|FG002|Overall Study|Adverse Event|0
7739434|NCT00666926|12171233|FG003|Overall Study|Adverse Event|0
7739435|NCT00666926|12171234|FG004|Overall Study|Adverse Event|0
7739436|NCT00666926|12171235|FG005|Overall Study|Adverse Event|0
7739437|NCT00666926|12171236|FG006|Overall Study|Adverse Event|0
7739438|NCT00666926|12171237|FG007|Overall Study|Adverse Event|0
7739439|NCT00666926|12171238|FG008|Overall Study|Adverse Event|0
7739440|NCT00666926|12171239|FG009|Overall Study|Adverse Event|2
7739441|NCT00666926|12171240|FG010|Overall Study|Adverse Event|2
7739442|NCT00666926|12171241|FG011|Overall Study|Adverse Event|2
7739443|NCT00666926|12171242|FG012|Overall Study|Adverse Event|0
7739444|NCT00666926|12171243|FG013|Overall Study|Adverse Event|1
7739445|NCT00666926|12171244|FG014|Overall Study|Adverse Event|0
7739446|NCT00666926|12171245|FG015|Overall Study|Adverse Event|0
7739447|NCT00666926|12171230|FG000|Overall Study|Laboratory abnormality|0
7739448|NCT00666926|12171231|FG001|Overall Study|Laboratory abnormality|0
7739449|NCT00666926|12171232|FG002|Overall Study|Laboratory abnormality|0
7739450|NCT00666926|12171233|FG003|Overall Study|Laboratory abnormality|0
7739451|NCT00666926|12171234|FG004|Overall Study|Laboratory abnormality|0
7739452|NCT00666926|12171235|FG005|Overall Study|Laboratory abnormality|0
7739453|NCT00666926|12171236|FG006|Overall Study|Laboratory abnormality|0
7739454|NCT00666926|12171237|FG007|Overall Study|Laboratory abnormality|0
7739455|NCT00666926|12171238|FG008|Overall Study|Laboratory abnormality|0
7739456|NCT00666926|12171239|FG009|Overall Study|Laboratory abnormality|0
7739457|NCT00666926|12171240|FG010|Overall Study|Laboratory abnormality|1
7739458|NCT00666926|12171241|FG011|Overall Study|Laboratory abnormality|0
7739459|NCT00666926|12171242|FG012|Overall Study|Laboratory abnormality|0
7739460|NCT00666926|12171243|FG013|Overall Study|Laboratory abnormality|0
7739461|NCT00666926|12171244|FG014|Overall Study|Laboratory abnormality|0
7739462|NCT00666926|12171245|FG015|Overall Study|Laboratory abnormality|1
7739463|NCT00666926|12171230|FG000|Overall Study|Lack of Efficacy|0
7739464|NCT00666926|12171231|FG001|Overall Study|Lack of Efficacy|0
7739465|NCT00666926|12171232|FG002|Overall Study|Lack of Efficacy|0
7739466|NCT00666926|12171233|FG003|Overall Study|Lack of Efficacy|0
7739467|NCT00666926|12171234|FG004|Overall Study|Lack of Efficacy|0
7739468|NCT00666926|12171235|FG005|Overall Study|Lack of Efficacy|1
7739469|NCT00666926|12171236|FG006|Overall Study|Lack of Efficacy|0
7739470|NCT00666926|12171237|FG007|Overall Study|Lack of Efficacy|0
7739471|NCT00666926|12171238|FG008|Overall Study|Lack of Efficacy|0
7739472|NCT00666926|12171239|FG009|Overall Study|Lack of Efficacy|0
7739473|NCT00666926|12171240|FG010|Overall Study|Lack of Efficacy|0
7739474|NCT00666926|12171241|FG011|Overall Study|Lack of Efficacy|1
7739475|NCT00666926|12171242|FG012|Overall Study|Lack of Efficacy|0
7739476|NCT00666926|12171243|FG013|Overall Study|Lack of Efficacy|0
7739477|NCT00666926|12171244|FG014|Overall Study|Lack of Efficacy|0
7739478|NCT00666926|12171245|FG015|Overall Study|Lack of Efficacy|0
7739479|NCT00666926|12171230|FG000|Overall Study|Lost to Follow-up|0
7962159|NCT02709746|12516272|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
7962160|NCT02709746|12516273|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
7962161|NCT02709746|12516274|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4
7962162|NCT02709746|12516275|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
7962163|NCT02709746|12516276|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
7962164|NCT02709746|12516272|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
7962165|NCT02709746|12516273|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3
7962166|NCT02709746|12516274|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
7739480|NCT00666926|12171231|FG001|Overall Study|Lost to Follow-up|0
7739481|NCT00666926|12171232|FG002|Overall Study|Lost to Follow-up|0
7739482|NCT00666926|12171233|FG003|Overall Study|Lost to Follow-up|1
7739483|NCT00666926|12171234|FG004|Overall Study|Lost to Follow-up|0
7739484|NCT00666926|12171235|FG005|Overall Study|Lost to Follow-up|0
7739485|NCT00666926|12171236|FG006|Overall Study|Lost to Follow-up|0
7739486|NCT00666926|12171237|FG007|Overall Study|Lost to Follow-up|0
7962167|NCT02709746|12516275|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1
7962168|NCT02709746|12516276|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2
7962169|NCT02709746|12516272|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0
7962170|NCT02709746|12516273|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4
7962171|NCT02709746|12516274|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8
7962172|NCT02709746|12516275|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5
7962173|NCT02709746|12516276|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2
7962174|NCT02709746|12516272|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0
7739487|NCT00666926|12171238|FG008|Overall Study|Lost to Follow-up|0
7739488|NCT00666926|12171239|FG009|Overall Study|Lost to Follow-up|0
7739489|NCT00666926|12171240|FG010|Overall Study|Lost to Follow-up|0
7739490|NCT00666926|12171241|FG011|Overall Study|Lost to Follow-up|0
7739491|NCT00666926|12171242|FG012|Overall Study|Lost to Follow-up|0
7739492|NCT00666926|12171243|FG013|Overall Study|Lost to Follow-up|0
7739493|NCT00666926|12171244|FG014|Overall Study|Lost to Follow-up|0
7739494|NCT00666926|12171245|FG015|Overall Study|Lost to Follow-up|0
7739495|NCT00666926|12171230|FG000|Overall Study|Other|2
7739496|NCT00666926|12171231|FG001|Overall Study|Other|4
7739497|NCT00666926|12171232|FG002|Overall Study|Other|3
7739498|NCT00666926|12171233|FG003|Overall Study|Other|3
7739499|NCT00666926|12171234|FG004|Overall Study|Other|3
7739500|NCT00666926|12171235|FG005|Overall Study|Other|3
7739501|NCT00666926|12171236|FG006|Overall Study|Other|4
7739502|NCT00666926|12171237|FG007|Overall Study|Other|0
7739503|NCT00666926|12171238|FG008|Overall Study|Other|3
7739504|NCT00666926|12171239|FG009|Overall Study|Other|5
7739505|NCT00666926|12171240|FG010|Overall Study|Other|3
7739506|NCT00666926|12171241|FG011|Overall Study|Other|26
7739507|NCT00666926|12171242|FG012|Overall Study|Other|3
7739508|NCT00666926|12171243|FG013|Overall Study|Other|2
7739509|NCT00666926|12171244|FG014|Overall Study|Other|4
7739510|NCT00666926|12171245|FG015|Overall Study|Other|4
7739511|NCT00666926|12171230|FG000|Overall Study|Withdrawal by Subject|0
7739512|NCT00666926|12171231|FG001|Overall Study|Withdrawal by Subject|0
7739513|NCT00666926|12171232|FG002|Overall Study|Withdrawal by Subject|0
7739514|NCT00666926|12171233|FG003|Overall Study|Withdrawal by Subject|0
7739515|NCT00666926|12171234|FG004|Overall Study|Withdrawal by Subject|0
7739516|NCT00666926|12171235|FG005|Overall Study|Withdrawal by Subject|0
7739517|NCT00666926|12171236|FG006|Overall Study|Withdrawal by Subject|0
7739518|NCT00666926|12171237|FG007|Overall Study|Withdrawal by Subject|1
7739519|NCT00666926|12171238|FG008|Overall Study|Withdrawal by Subject|0
7739520|NCT00666926|12171239|FG009|Overall Study|Withdrawal by Subject|3
7739521|NCT00666926|12171240|FG010|Overall Study|Withdrawal by Subject|0
7739522|NCT00666926|12171241|FG011|Overall Study|Withdrawal by Subject|3
7739523|NCT00666926|12171242|FG012|Overall Study|Withdrawal by Subject|0
7739524|NCT00666926|12171243|FG013|Overall Study|Withdrawal by Subject|1
7739525|NCT00666926|12171244|FG014|Overall Study|Withdrawal by Subject|3
7739526|NCT00666926|12171245|FG015|Overall Study|Withdrawal by Subject|3
7739527|NCT00666926|12171230|FG000|Overall Study|Death|0
7739528|NCT00666926|12171231|FG001|Overall Study|Death|0
7739529|NCT00666926|12171232|FG002|Overall Study|Death|0
7739530|NCT00666926|12171233|FG003|Overall Study|Death|0
7739531|NCT00666926|12171234|FG004|Overall Study|Death|0
7739532|NCT00666926|12171235|FG005|Overall Study|Death|0
7739533|NCT00666926|12171236|FG006|Overall Study|Death|0
7739534|NCT00666926|12171237|FG007|Overall Study|Death|0
7739535|NCT00666926|12171238|FG008|Overall Study|Death|0
7739536|NCT00666926|12171239|FG009|Overall Study|Death|0
7739537|NCT00666926|12171240|FG010|Overall Study|Death|0
7739538|NCT00666926|12171241|FG011|Overall Study|Death|1
7739539|NCT00666926|12171242|FG012|Overall Study|Death|0
7739540|NCT00666926|12171243|FG013|Overall Study|Death|0
7739541|NCT00666926|12171244|FG014|Overall Study|Death|0
7739542|NCT00666926|12171245|FG015|Overall Study|Death|0
7739543|NCT00666965|12171300|FG000|Overall Study|Adverse Event|0
7739544|NCT00666965|12171301|FG001|Overall Study|Adverse Event|2
7739545|NCT00666965|12171302|FG002|Overall Study|Adverse Event|1
7739546|NCT00666965|12171303|FG003|Overall Study|Adverse Event|9
7739547|NCT00666965|12171300|FG000|Overall Study|Lack of Efficacy|1
7739548|NCT00666965|12171301|FG001|Overall Study|Lack of Efficacy|1
7739549|NCT00666965|12171302|FG002|Overall Study|Lack of Efficacy|0
7739550|NCT00666965|12171303|FG003|Overall Study|Lack of Efficacy|0
7739551|NCT00666965|12171300|FG000|Overall Study|Protocol Violation|0
7739552|NCT00666965|12171301|FG001|Overall Study|Protocol Violation|0
7739553|NCT00666965|12171302|FG002|Overall Study|Protocol Violation|0
7739554|NCT00666965|12171303|FG003|Overall Study|Protocol Violation|2
7739555|NCT00666965|12171300|FG000|Overall Study|Discontinuation criteria|2
7739556|NCT00666965|12171301|FG001|Overall Study|Discontinuation criteria|1
7739557|NCT00666965|12171302|FG002|Overall Study|Discontinuation criteria|1
7739558|NCT00666965|12171303|FG003|Overall Study|Discontinuation criteria|2
7739559|NCT00666965|12171300|FG000|Overall Study|Withdrawal by Subject|0
7739560|NCT00666965|12171301|FG001|Overall Study|Withdrawal by Subject|0
7739561|NCT00666965|12171302|FG002|Overall Study|Withdrawal by Subject|0
7739562|NCT00666965|12171303|FG003|Overall Study|Withdrawal by Subject|2
7739563|NCT00667095|12171335|FG000|Overall Study|Withdrawal by Subject|0
7739564|NCT00667095|12171336|FG001|Overall Study|Withdrawal by Subject|1
7739565|NCT00667225|12171353|FG000|Overall Study|Subject had no more lesions to treat.|1
7739566|NCT00667225|12171354|FG001|Overall Study|Subject had no more lesions to treat.|0
7739567|NCT00667225|12171353|FG000|Overall Study|Lost to Follow-up|0
7739568|NCT00667225|12171354|FG001|Overall Study|Lost to Follow-up|1
7739569|NCT00667277|12171360|FG000|Overall Study|Withdrawal by Subject|2
7739570|NCT00667342|12171367|FG000|Overall Study|Protocol Violation|1
7739571|NCT00667342|12171368|FG001|Overall Study|Protocol Violation|0
7739572|NCT00667342|12171369|FG002|Overall Study|Protocol Violation|0
7739573|NCT00667342|12171367|FG000|Overall Study|Withdrawal by Subject|1
7739574|NCT00667342|12171368|FG001|Overall Study|Withdrawal by Subject|0
7739575|NCT00667342|12171369|FG002|Overall Study|Withdrawal by Subject|0
7739576|NCT00667342|12171367|FG000|Overall Study|Physician Decision|3
7739577|NCT00667342|12171368|FG001|Overall Study|Physician Decision|0
7739578|NCT00667342|12171369|FG002|Overall Study|Physician Decision|0
7739579|NCT00667342|12171367|FG000|Overall Study|Relapse or tumor progression|9
7739580|NCT00667342|12171368|FG001|Overall Study|Relapse or tumor progression|0
7739581|NCT00667342|12171369|FG002|Overall Study|Relapse or tumor progression|7
7739582|NCT00667342|12171367|FG000|Overall Study|Adverse Event|0
7739583|NCT00667342|12171368|FG001|Overall Study|Adverse Event|0
7739584|NCT00667342|12171369|FG002|Overall Study|Adverse Event|1
7739585|NCT00667342|12171367|FG000|Overall Study|Ineligible|0
7739586|NCT00667342|12171368|FG001|Overall Study|Ineligible|0
7739587|NCT00667342|12171369|FG002|Overall Study|Ineligible|1
7739588|NCT00667355|12171383|FG000|Overall Study|Adverse Event|5
7739589|NCT00667355|12171383|FG000|Overall Study|Lost to Follow-up|1
7739590|NCT00667355|12171383|FG000|Overall Study|Other reason was not specified|5
7739591|NCT00667368|12171389|FG000|Overall Study|Lost to Follow-up|176
7739592|NCT00667368|12171390|FG001|Overall Study|Lost to Follow-up|155
7739593|NCT00667368|12171389|FG000|Overall Study|Discontinued early|24
7739594|NCT00667368|12171390|FG001|Overall Study|Discontinued early|17
7739595|NCT00667394|12171407|FG000|Overall Study|Adverse Event|3
7739596|NCT00667394|12171408|FG001|Overall Study|Adverse Event|0
7739597|NCT00667394|12171407|FG000|Overall Study|Progressive disease|1
7739598|NCT00667394|12171408|FG001|Overall Study|Progressive disease|0
7739599|NCT00667420|12171414|FG000|Overall Study|Adverse Event|2
7739600|NCT00667420|12171414|FG000|Overall Study|Lack of Efficacy|5
7739601|NCT00667420|12171414|FG000|Overall Study|Physician Decision|1
7739602|NCT00667420|12171414|FG000|Overall Study|Withdrawal by Subject|2
7739603|NCT00667446|12171421|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13
7739604|NCT00667446|12171422|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15
7739605|NCT00667446|12171421|FG000|Treatment Period (36 Months)|Other|2
7739606|NCT00667446|12171422|FG001|Treatment Period (36 Months)|Other|2
7739607|NCT00667446|12171421|FG000|Treatment Period (36 Months)|Personal reasons|2
7739608|NCT00667446|12171422|FG001|Treatment Period (36 Months)|Personal reasons|2
7739609|NCT00667446|12171421|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0
7739610|NCT00667446|12171422|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4
7739611|NCT00667446|12171421|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
7739612|NCT00667446|12171422|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
7739613|NCT00667446|12171421|FG000|Treatment Period (36 Months)|Lost to Follow-up|1
7739614|NCT00667446|12171422|FG001|Treatment Period (36 Months)|Lost to Follow-up|0
7739615|NCT00667446|12171421|FG000|Treatment Period (36 Months)|Protocol Violation|1
7739616|NCT00667446|12171422|FG001|Treatment Period (36 Months)|Protocol Violation|1
7739617|NCT00667446|12171421|FG000|Treatment Period (36 Months)|Therapeutic Failure|1
7739618|NCT00667446|12171422|FG001|Treatment Period (36 Months)|Therapeutic Failure|1
7739619|NCT00667446|12171421|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
7739620|NCT00667446|12171422|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
7739621|NCT00667459|12171430|FG000|Overall Study|Death|0
7739622|NCT00667459|12171431|FG001|Overall Study|Death|2
7739623|NCT00667459|12171430|FG000|Overall Study|Lost to Follow-up|8
7739624|NCT00667459|12171431|FG001|Overall Study|Lost to Follow-up|43
7739625|NCT00667563|12171443|FG000|Overall Study|Protocol Violation|24
7739626|NCT00667576|12171452|FG000|Overall Study|Withdrawal by Subject|1
7739627|NCT00667576|12171453|FG001|Overall Study|Withdrawal by Subject|0
7739628|NCT00667576|12171454|FG002|Overall Study|Withdrawal by Subject|1
7739629|NCT00667576|12171455|FG003|Overall Study|Withdrawal by Subject|1
7739630|NCT00667576|12171456|FG004|Overall Study|Withdrawal by Subject|1
7739631|NCT00667576|12171452|FG000|Overall Study|Adverse Event|1
7739632|NCT00667576|12171453|FG001|Overall Study|Adverse Event|1
7739633|NCT00667576|12171454|FG002|Overall Study|Adverse Event|0
7739634|NCT00667576|12171455|FG003|Overall Study|Adverse Event|0
7739635|NCT00667576|12171456|FG004|Overall Study|Adverse Event|0
7739636|NCT00667576|12171452|FG000|Overall Study|Lost to Follow-up|0
7739637|NCT00667576|12171453|FG001|Overall Study|Lost to Follow-up|0
7739638|NCT00667576|12171454|FG002|Overall Study|Lost to Follow-up|1
7739639|NCT00667576|12171455|FG003|Overall Study|Lost to Follow-up|0
7739640|NCT00667576|12171456|FG004|Overall Study|Lost to Follow-up|0
7739641|NCT00667576|12171452|FG000|Overall Study|Protocol Violation|0
7739642|NCT00667576|12171453|FG001|Overall Study|Protocol Violation|0
7739643|NCT00667576|12171454|FG002|Overall Study|Protocol Violation|0
7739644|NCT00667576|12171455|FG003|Overall Study|Protocol Violation|1
7739645|NCT00667576|12171456|FG004|Overall Study|Protocol Violation|0
7739646|NCT00667576|12171452|FG000|Overall Study|Physician Decision|0
7739647|NCT00667576|12171453|FG001|Overall Study|Physician Decision|0
7739648|NCT00667576|12171454|FG002|Overall Study|Physician Decision|0
7739649|NCT00667576|12171455|FG003|Overall Study|Physician Decision|1
7739650|NCT00667576|12171456|FG004|Overall Study|Physician Decision|0
7739651|NCT00667576|12171452|FG000|Overall Study|Missed Visit|0
7739652|NCT00667576|12171453|FG001|Overall Study|Missed Visit|0
7739653|NCT00667576|12171454|FG002|Overall Study|Missed Visit|0
7739654|NCT00667576|12171455|FG003|Overall Study|Missed Visit|1
7739655|NCT00667576|12171456|FG004|Overall Study|Missed Visit|0
7739656|NCT00667602|12171488|FG000|Overall Study|Withdrawal by Subject|4
7739657|NCT00667602|12171489|FG001|Overall Study|Withdrawal by Subject|9
7739658|NCT00667602|12171490|FG002|Overall Study|Withdrawal by Subject|10
7739659|NCT00667602|12171488|FG000|Overall Study|Lost to Follow-up|4
7739660|NCT00667602|12171489|FG001|Overall Study|Lost to Follow-up|5
7739661|NCT00667602|12171490|FG002|Overall Study|Lost to Follow-up|6
7739662|NCT00667602|12171488|FG000|Overall Study|Administrative reason|0
7739663|NCT00667602|12171489|FG001|Overall Study|Administrative reason|0
7739664|NCT00667602|12171490|FG002|Overall Study|Administrative reason|2
7739665|NCT00667602|12171488|FG000|Overall Study|Protocol Violation|0
7739666|NCT00667602|12171489|FG001|Overall Study|Protocol Violation|1
7739667|NCT00667602|12171490|FG002|Overall Study|Protocol Violation|0
7739668|NCT00667719|12171516|FG000|Overall Study|Adverse Event|39
7739669|NCT00667719|12171516|FG000|Overall Study|Abnormal Test Procedure|1
7739670|NCT00667719|12171516|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
7739671|NCT00667719|12171516|FG000|Overall Study|Protocol Violation|3
7739672|NCT00667719|12171516|FG000|Overall Study|Withdrawal by Subject|17
7739673|NCT00667719|12171516|FG000|Overall Study|Lost to Follow-up|8
7739674|NCT00667732|12171527|FG000|Run -In (8 Weeks)|Adverse Event|4
7739675|NCT00667732|12171528|FG001|Run -In (8 Weeks)|Adverse Event|0
7739676|NCT00667732|12171529|FG002|Run -In (8 Weeks)|Adverse Event|0
7739677|NCT00667732|12171527|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3
7739678|NCT00667732|12171528|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0
7739679|NCT00667732|12171529|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0
7739680|NCT00667732|12171527|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0
7739681|NCT00667732|12171528|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1
7739682|NCT00667732|12171529|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0
7739683|NCT00667810|12171553|FG000|Overall Study|Adverse Event|13
7739684|NCT00667810|12171554|FG001|Overall Study|Adverse Event|14
7739685|NCT00667810|12171555|FG002|Overall Study|Adverse Event|19
7739686|NCT00667810|12171556|FG003|Overall Study|Adverse Event|1
7739687|NCT00667810|12171553|FG000|Overall Study|Death|1
7739688|NCT00667810|12171554|FG001|Overall Study|Death|1
7739689|NCT00667810|12171555|FG002|Overall Study|Death|3
7739690|NCT00667810|12171556|FG003|Overall Study|Death|0
7739691|NCT00667810|12171553|FG000|Overall Study|Lack of Efficacy|1
7739692|NCT00667810|12171554|FG001|Overall Study|Lack of Efficacy|0
7739693|NCT00667810|12171555|FG002|Overall Study|Lack of Efficacy|2
7739694|NCT00667810|12171556|FG003|Overall Study|Lack of Efficacy|0
7739695|NCT00667810|12171553|FG000|Overall Study|Lost to Follow-up|1
7739696|NCT00667810|12171554|FG001|Overall Study|Lost to Follow-up|4
7739697|NCT00667810|12171555|FG002|Overall Study|Lost to Follow-up|2
7739698|NCT00667810|12171556|FG003|Overall Study|Lost to Follow-up|0
7739699|NCT00667810|12171553|FG000|Overall Study|Physician Decision|1
7739700|NCT00667810|12171554|FG001|Overall Study|Physician Decision|1
7739701|NCT00667810|12171555|FG002|Overall Study|Physician Decision|2
7739702|NCT00667810|12171556|FG003|Overall Study|Physician Decision|0
7739703|NCT00667810|12171553|FG000|Overall Study|Protocol Violation|0
7739704|NCT00667810|12171554|FG001|Overall Study|Protocol Violation|2
7739705|NCT00667810|12171555|FG002|Overall Study|Protocol Violation|0
7739706|NCT00667810|12171556|FG003|Overall Study|Protocol Violation|0
7739707|NCT00667810|12171553|FG000|Overall Study|Withdrawal by Subject|14
7739708|NCT00667810|12171554|FG001|Overall Study|Withdrawal by Subject|20
7739709|NCT00667810|12171555|FG002|Overall Study|Withdrawal by Subject|29
7739710|NCT00667810|12171556|FG003|Overall Study|Withdrawal by Subject|1
7739711|NCT00667810|12171553|FG000|Overall Study|Discontinuation of Study by Sponsor|130
7739712|NCT00667810|12171554|FG001|Overall Study|Discontinuation of Study by Sponsor|118
7739713|NCT00667810|12171555|FG002|Overall Study|Discontinuation of Study by Sponsor|155
7739714|NCT00667810|12171556|FG003|Overall Study|Discontinuation of Study by Sponsor|0
7739715|NCT00667810|12171553|FG000|Overall Study|Failed to Return|0
7739716|NCT00667810|12171554|FG001|Overall Study|Failed to Return|0
7739717|NCT00667810|12171555|FG002|Overall Study|Failed to Return|2
7739718|NCT00667810|12171556|FG003|Overall Study|Failed to Return|0
7739719|NCT00667810|12171553|FG000|Overall Study|Loss of Caregiver|0
7739720|NCT00667810|12171554|FG001|Overall Study|Loss of Caregiver|1
7739721|NCT00667810|12171555|FG002|Overall Study|Loss of Caregiver|3
7739722|NCT00667810|12171556|FG003|Overall Study|Loss of Caregiver|0
7739723|NCT00667810|12171553|FG000|Overall Study|Vasogenic Edema Recurrence|0
7739724|NCT00667810|12171554|FG001|Overall Study|Vasogenic Edema Recurrence|3
7739725|NCT00667810|12171555|FG002|Overall Study|Vasogenic Edema Recurrence|0
7739726|NCT00667810|12171556|FG003|Overall Study|Vasogenic Edema Recurrence|0
7739727|NCT00667810|12171553|FG000|Overall Study|Other|6
7739728|NCT00667810|12171554|FG001|Overall Study|Other|6
7739729|NCT00667810|12171555|FG002|Overall Study|Other|5
7739730|NCT00667810|12171556|FG003|Overall Study|Other|0
7739731|NCT00667862|12171583|FG000|Overall Study|Adverse Event|9
7739732|NCT00667862|12171583|FG000|Overall Study|Death|1
7739733|NCT00667862|12171583|FG000|Overall Study|Disease Progression|22
7739734|NCT00667862|12171583|FG000|Overall Study|Withdrawal by Subject|3
7739735|NCT00667875|12171590|FG000|Overall Study|Adverse Event|0
7739736|NCT00667875|12171591|FG001|Overall Study|Adverse Event|2
7739737|NCT00667875|12171592|FG002|Overall Study|Adverse Event|6
7739738|NCT00667875|12171590|FG000|Overall Study|Withdrawal by Subject|10
7739739|NCT00667875|12171591|FG001|Overall Study|Withdrawal by Subject|9
7739740|NCT00667875|12171592|FG002|Overall Study|Withdrawal by Subject|7
7739741|NCT00667888|12171608|FG000|Overall Study|Death|1
7739742|NCT00667888|12171609|FG001|Overall Study|Death|1
7739743|NCT00667888|12171608|FG000|Overall Study|Withdrawal by Subject|6
7739744|NCT00667888|12171609|FG001|Overall Study|Withdrawal by Subject|3
7739745|NCT00667888|12171608|FG000|Overall Study|Proceed with other treatment|3
7739746|NCT00667888|12171609|FG001|Overall Study|Proceed with other treatment|3
7739747|NCT00667888|12171608|FG000|Overall Study|Ineligible after SIM|0
7739748|NCT00667888|12171609|FG001|Overall Study|Ineligible after SIM|2
7739749|NCT00667992|12171617|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
7739750|NCT00667992|12171618|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
7739751|NCT00667992|12171617|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
7739752|NCT00667992|12171618|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
7739753|NCT00667992|12171617|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0
7739754|NCT00667992|12171618|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1
7739755|NCT00667992|12171617|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1
7739756|NCT00667992|12171618|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0
7739757|NCT00667992|12171617|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0
7739758|NCT00667992|12171618|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1
7739759|NCT00667992|12171617|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
7739760|NCT00667992|12171618|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
7739761|NCT00667992|12171617|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
7739762|NCT00667992|12171618|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
7739763|NCT00667992|12171617|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
7739764|NCT00667992|12171618|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
7739765|NCT00667992|12171617|FG000|Wash-out|Not within one doubling dilution|4
7739766|NCT00667992|12171618|FG001|Wash-out|Not within one doubling dilution|3
7739767|NCT00667992|12171617|FG000|Wash-out|Failure to wash-out|2
7739768|NCT00667992|12171618|FG001|Wash-out|Failure to wash-out|2
7739769|NCT00667992|12171617|FG000|Wash-out|Withdrawal by Subject|1
7739770|NCT00667992|12171618|FG001|Wash-out|Withdrawal by Subject|0
7739771|NCT00667992|12171617|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
7739772|NCT00667992|12171618|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
7739773|NCT00667992|12171617|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
7739774|NCT00667992|12171618|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
7739775|NCT00668148|12171634|FG000|Overall Study|Adverse Event|5
7739776|NCT00668148|12171634|FG000|Overall Study|Subject Non-compliance|1
7739777|NCT00668148|12171634|FG000|Overall Study|Progressive Disease Before Treatment|2
7739778|NCT00668148|12171634|FG000|Overall Study|Withdrawal of Consent|2
7739779|NCT00668200|12171649|FG000|Overall Study|Withdrawal by Subject|2
7739780|NCT00668200|12171649|FG000|Overall Study|Lost to Follow-up|1
7739781|NCT00668317|12171653|FG000|Overall Study|Adverse Event|2
7739782|NCT00668395|12171664|FG000|Overall Study|Withdrawal by Subject|4
7739783|NCT00668395|12171665|FG001|Overall Study|Withdrawal by Subject|4
7739784|NCT00668395|12171666|FG002|Overall Study|Withdrawal by Subject|1
7739785|NCT00668395|12171664|FG000|Overall Study|Adverse Event|1
7739786|NCT00668395|12171665|FG001|Overall Study|Adverse Event|1
7739787|NCT00668395|12171666|FG002|Overall Study|Adverse Event|0
7739788|NCT00668395|12171664|FG000|Overall Study|Physician Decision|1
7739789|NCT00668395|12171665|FG001|Overall Study|Physician Decision|1
7739790|NCT00668395|12171666|FG002|Overall Study|Physician Decision|0
7739791|NCT00668707|12171702|FG000|Overall Study|Cancer Recurrence|58
7739792|NCT00668707|12171703|FG001|Overall Study|Cancer Recurrence|58
7739793|NCT00668707|12171702|FG000|Overall Study|Withdrawal by Subject|117
7739794|NCT00668707|12171703|FG001|Overall Study|Withdrawal by Subject|100
7739795|NCT00668707|12171702|FG000|Overall Study|Lost to Follow-up|3
7739796|NCT00668707|12171703|FG001|Overall Study|Lost to Follow-up|6
7739797|NCT00668707|12171702|FG000|Overall Study|Protocol Violation|10
7739798|NCT00668707|12171703|FG001|Overall Study|Protocol Violation|12
7739799|NCT00668707|12171702|FG000|Overall Study|Death|11
7739800|NCT00668707|12171703|FG001|Overall Study|Death|4
7739801|NCT00668733|12171716|FG000|Overall Study|Lost to Follow-up|2
7739802|NCT00668733|12171717|FG001|Overall Study|Lost to Follow-up|3
7739803|NCT00668733|12171716|FG000|Overall Study|Withdrawal by Subject|0
7739804|NCT00668733|12171717|FG001|Overall Study|Withdrawal by Subject|4
7739805|NCT00668746|12171725|FG000|Overall Study|Lost to Follow-up|2
7739806|NCT00668746|12171726|FG001|Overall Study|Lost to Follow-up|1
7739807|NCT00668863|12171746|FG000|Overall Study|Objective Progression or Relapse|42
7739808|NCT00668863|12171746|FG000|Overall Study|Adverse Event|13
7739809|NCT00668863|12171746|FG000|Overall Study|Study Terminated by Sponsor|8
7739810|NCT00668863|12171746|FG000|Overall Study|Global Deterioration of Health Status|4
7739811|NCT00668863|12171746|FG000|Overall Study|Withdrawal by Subject|1
7739812|NCT00668863|12171746|FG000|Overall Study|Surgery|1
7739813|NCT00668863|12171746|FG000|Overall Study|Subject's work scheduling problem|1
7739814|NCT00668863|12171746|FG000|Overall Study|Physician Decision|1
7739815|NCT00669032|12171769|FG000|Overall Study|Lost to Follow-up|6
7739816|NCT00669032|12171770|FG001|Overall Study|Lost to Follow-up|5
7739817|NCT00669032|12171769|FG000|Overall Study|Lack of Efficacy|8
7739818|NCT00669032|12171770|FG001|Overall Study|Lack of Efficacy|19
7739819|NCT00669032|12171769|FG000|Overall Study|Withdrawal by Subject|12
7739820|NCT00669032|12171770|FG001|Overall Study|Withdrawal by Subject|13
7739821|NCT00669032|12171769|FG000|Overall Study|Adverse Event|12
7739822|NCT00669032|12171770|FG001|Overall Study|Adverse Event|16
7739823|NCT00669032|12171769|FG000|Overall Study|Physician Decision|1
7739824|NCT00669032|12171770|FG001|Overall Study|Physician Decision|1
7739825|NCT00669032|12171769|FG000|Overall Study|No fulfilment of the selection criteria|5
7739826|NCT00669032|12171770|FG001|Overall Study|No fulfilment of the selection criteria|5
7739827|NCT00669110|12171778|FG000|Overall Study|Adverse Event|4
7739828|NCT00669110|12171779|FG001|Overall Study|Adverse Event|3
7739829|NCT00669110|12171778|FG000|Overall Study|Caregiver request|3
7739830|NCT00669110|12171779|FG001|Overall Study|Caregiver request|2
7739831|NCT00669110|12171778|FG000|Overall Study|Physician Decision|0
7739832|NCT00669110|12171779|FG001|Overall Study|Physician Decision|1
7739833|NCT00669110|12171778|FG000|Overall Study|Lost to Follow-up|1
7739834|NCT00669110|12171779|FG001|Overall Study|Lost to Follow-up|0
7739835|NCT00669110|12171778|FG000|Overall Study|Protocol Violation|0
7739836|NCT00669110|12171779|FG001|Overall Study|Protocol Violation|5
7739837|NCT00669110|12171778|FG000|Overall Study|Withdrawal by Subject|0
7739838|NCT00669110|12171779|FG001|Overall Study|Withdrawal by Subject|2
7739839|NCT00669162|12171785|FG000|Overall Study|Withdrawal by Subject|1
7739840|NCT00669240|12171802|FG000|Overall Study|Lack of Efficacy|33
7739841|NCT00669240|12171802|FG000|Overall Study|Withdrawal by Subject|42
7739842|NCT00669240|12171802|FG000|Overall Study|Lost to Follow-up|34
7739843|NCT00669240|12171802|FG000|Overall Study|Adverse Event|21
7739844|NCT00669240|12171802|FG000|Overall Study|Other|19
7739845|NCT00669240|12171802|FG000|Overall Study|Enrolled but not treated|15
7739846|NCT00669240|12171802|FG000|Overall Study|Enrolled but no dosing record|1
7739847|NCT00669318|12171815|FG000|Overall Study|Withdrawal by Subject|2
7739848|NCT00669331|12171821|FG000|Randomisation to First Dose|Adverse Event|1
7739849|NCT00669331|12171822|FG001|Randomisation to First Dose|Adverse Event|0
7739850|NCT00669331|12171821|FG000|Randomisation to First Dose|Protocol Violation|1
7739851|NCT00669331|12171822|FG001|Randomisation to First Dose|Protocol Violation|0
7739852|NCT00669331|12171821|FG000|Randomisation to First Dose|Withdrawal by Subject|3
7739853|NCT00669331|12171822|FG001|Randomisation to First Dose|Withdrawal by Subject|2
7739854|NCT00669331|12171821|FG000|Randomisation to First Dose|Lost to Follow-up|2
7739855|NCT00669331|12171822|FG001|Randomisation to First Dose|Lost to Follow-up|0
7739856|NCT00669331|12171821|FG000|Randomisation to First Dose|Death|1
7739857|NCT00669331|12171822|FG001|Randomisation to First Dose|Death|0
7739858|NCT00669331|12171821|FG000|Randomisation to First Dose|Sponsor decision|0
7739859|NCT00669331|12171822|FG001|Randomisation to First Dose|Sponsor decision|1
7739860|NCT00669331|12171821|FG000|Randomisation to First Dose|Randomised in error|3
7739861|NCT00669331|12171822|FG001|Randomisation to First Dose|Randomised in error|10
7739862|NCT00669331|12171821|FG000|Blinded Treatment Period|Adverse Event|16
7739863|NCT00669331|12171822|FG001|Blinded Treatment Period|Adverse Event|10
7739864|NCT00669331|12171821|FG000|Blinded Treatment Period|Protocol Violation|1
7739865|NCT00669331|12171822|FG001|Blinded Treatment Period|Protocol Violation|1
7739866|NCT00669331|12171821|FG000|Blinded Treatment Period|Withdrawal by Subject|17
7739867|NCT00669331|12171822|FG001|Blinded Treatment Period|Withdrawal by Subject|19
7739868|NCT00669331|12171821|FG000|Blinded Treatment Period|Lost to Follow-up|3
7739869|NCT00669331|12171822|FG001|Blinded Treatment Period|Lost to Follow-up|2
7739870|NCT00669331|12171821|FG000|Blinded Treatment Period|Death|0
7739871|NCT00669331|12171822|FG001|Blinded Treatment Period|Death|2
7739872|NCT00669331|12171821|FG000|Blinded Treatment Period|Physician Decision|3
7739873|NCT00669331|12171822|FG001|Blinded Treatment Period|Physician Decision|3
7739874|NCT00669331|12171821|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
7739875|NCT00669331|12171822|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
7739876|NCT00669396|12171841|FG000|Overall Study|Lost to Follow-up|10
7739877|NCT00669396|12171842|FG001|Overall Study|Lost to Follow-up|12
7769062|NCT00866307|12212507|FG002|Induction|Physician Decision|0
7769063|NCT00866307|12212505|FG000|Induction|Progressive Disease|1
7769064|NCT00866307|12212506|FG001|Induction|Progressive Disease|0
7769065|NCT00866307|12212507|FG002|Induction|Progressive Disease|0
7769066|NCT00866307|12212505|FG000|Induction|Identification of Patients with Day 29 M|3
7769067|NCT00866307|12212506|FG001|Induction|Identification of Patients with Day 29 M|0
7769068|NCT00866307|12212507|FG002|Induction|Identification of Patients with Day 29 M|0
7769069|NCT00866307|12212505|FG000|Induction|Inadequate cytognetic samples th|1
7769070|NCT00866307|12212506|FG001|Induction|Inadequate cytognetic samples th|0
7769071|NCT00866307|12212507|FG002|Induction|Inadequate cytognetic samples th|0
7769072|NCT00866307|12212505|FG000|Induction|Improper post-induction consent|2
7769073|NCT00866307|12212506|FG001|Induction|Improper post-induction consent|0
7739878|NCT00669409|12171854|FG000|Part 2|Withdrawal by Subject|0
7739879|NCT00669409|12171855|FG001|Part 2|Withdrawal by Subject|0
7739880|NCT00669409|12171856|FG002|Part 2|Withdrawal by Subject|0
7739881|NCT00669409|12171857|FG003|Part 2|Withdrawal by Subject|0
7739882|NCT00669409|12171858|FG004|Part 2|Withdrawal by Subject|0
7739883|NCT00669409|12171859|FG005|Part 2|Withdrawal by Subject|0
7739884|NCT00669409|12171860|FG006|Part 2|Withdrawal by Subject|0
7739885|NCT00669409|12171861|FG007|Part 2|Withdrawal by Subject|0
7739886|NCT00669409|12171862|FG008|Part 2|Withdrawal by Subject|0
7739887|NCT00669409|12171863|FG009|Part 2|Withdrawal by Subject|1
7739888|NCT00669409|12171864|FG010|Part 2|Withdrawal by Subject|0
7739889|NCT00669617|12171914|FG000|Period 1|Withdrawal by Subject|0
7739890|NCT00669617|12171915|FG001|Period 1|Withdrawal by Subject|0
7739891|NCT00669617|12171916|FG002|Period 1|Withdrawal by Subject|1
7739892|NCT00669617|12171917|FG003|Period 1|Withdrawal by Subject|0
7739893|NCT00669617|12171918|FG004|Period 1|Withdrawal by Subject|0
7739894|NCT00669617|12171914|FG000|Period 1|Protocol Deviation|0
7739895|NCT00669617|12171915|FG001|Period 1|Protocol Deviation|0
7739896|NCT00669617|12171916|FG002|Period 1|Protocol Deviation|0
7739897|NCT00669617|12171917|FG003|Period 1|Protocol Deviation|0
7739898|NCT00669617|12171918|FG004|Period 1|Protocol Deviation|1
7739899|NCT00669617|12171914|FG000|Period 3|Lost to Follow-up|1
7739900|NCT00669617|12171915|FG001|Period 3|Lost to Follow-up|0
7739901|NCT00669617|12171916|FG002|Period 3|Lost to Follow-up|0
7739902|NCT00669617|12171917|FG003|Period 3|Lost to Follow-up|0
7739903|NCT00669617|12171918|FG004|Period 3|Lost to Follow-up|0
7739904|NCT00669864|12171935|FG000|Overall Study|Lost to Follow-up|2
7739905|NCT00669864|12171935|FG000|Overall Study|Protocol Violation|2
7739906|NCT00669864|12171935|FG000|Overall Study|Withdrawal by Subject|3
7739907|NCT00669864|12171935|FG000|Overall Study|Other|2
7739908|NCT00669877|12171939|FG000|Overall Study|Disease Progression/Death|4
7739909|NCT00669903|12171947|FG000|Overall Study|Adverse Event|0
7739910|NCT00669903|12171948|FG001|Overall Study|Adverse Event|1
7739911|NCT00669903|12171949|FG002|Overall Study|Adverse Event|3
7739912|NCT00669903|12171950|FG003|Overall Study|Adverse Event|1
7739913|NCT00669903|12171947|FG000|Overall Study|Withdrawal by Subject|0
7739914|NCT00669903|12171948|FG001|Overall Study|Withdrawal by Subject|2
7739915|NCT00669903|12171949|FG002|Overall Study|Withdrawal by Subject|2
7739916|NCT00669903|12171950|FG003|Overall Study|Withdrawal by Subject|2
7739917|NCT00669903|12171947|FG000|Overall Study|Lost to Follow-up|1
7739918|NCT00669903|12171948|FG001|Overall Study|Lost to Follow-up|1
7739919|NCT00669903|12171949|FG002|Overall Study|Lost to Follow-up|0
7739920|NCT00669903|12171950|FG003|Overall Study|Lost to Follow-up|1
7739921|NCT00669903|12171947|FG000|Overall Study|Protocol Violation|0
7739922|NCT00669903|12171948|FG001|Overall Study|Protocol Violation|1
7739923|NCT00669903|12171949|FG002|Overall Study|Protocol Violation|0
7739924|NCT00669903|12171950|FG003|Overall Study|Protocol Violation|0
7739925|NCT00669942|12171981|FG000|Parts 2 and 3|Adverse Event|0
7739926|NCT00669942|12171982|FG001|Parts 2 and 3|Adverse Event|0
7739927|NCT00669942|12171983|FG002|Parts 2 and 3|Adverse Event|0
7739928|NCT00669942|12171984|FG003|Parts 2 and 3|Adverse Event|0
7739929|NCT00669942|12171985|FG004|Parts 2 and 3|Adverse Event|0
7739930|NCT00669942|12171986|FG005|Parts 2 and 3|Adverse Event|0
7739931|NCT00669942|12171987|FG006|Parts 2 and 3|Adverse Event|0
7739932|NCT00669942|12171988|FG007|Parts 2 and 3|Adverse Event|2
7739933|NCT00669942|12171989|FG008|Parts 2 and 3|Adverse Event|1
7739934|NCT00669942|12171990|FG009|Parts 2 and 3|Adverse Event|0
7739935|NCT00669942|12171991|FG010|Parts 2 and 3|Adverse Event|0
7739936|NCT00669942|12171992|FG011|Parts 2 and 3|Adverse Event|0
7739937|NCT00669942|12171981|FG000|Parts 2 and 3|Withdrawal by Subject|0
7739938|NCT00669942|12171982|FG001|Parts 2 and 3|Withdrawal by Subject|0
7739939|NCT00669942|12171983|FG002|Parts 2 and 3|Withdrawal by Subject|0
7739940|NCT00669942|12171984|FG003|Parts 2 and 3|Withdrawal by Subject|0
7739941|NCT00669942|12171985|FG004|Parts 2 and 3|Withdrawal by Subject|0
7739942|NCT00669942|12171986|FG005|Parts 2 and 3|Withdrawal by Subject|1
7739943|NCT00669942|12171987|FG006|Parts 2 and 3|Withdrawal by Subject|0
7739944|NCT00669942|12171988|FG007|Parts 2 and 3|Withdrawal by Subject|0
7739945|NCT00669942|12171989|FG008|Parts 2 and 3|Withdrawal by Subject|2
7739946|NCT00669942|12171990|FG009|Parts 2 and 3|Withdrawal by Subject|0
7739947|NCT00669942|12171991|FG010|Parts 2 and 3|Withdrawal by Subject|0
7739948|NCT00669942|12171992|FG011|Parts 2 and 3|Withdrawal by Subject|0
7739949|NCT00669942|12171981|FG000|Parts 2 and 3|Protocol Violation|0
7739950|NCT00669942|12171982|FG001|Parts 2 and 3|Protocol Violation|0
7739951|NCT00669942|12171983|FG002|Parts 2 and 3|Protocol Violation|0
7739952|NCT00669942|12171984|FG003|Parts 2 and 3|Protocol Violation|0
7739953|NCT00669942|12171985|FG004|Parts 2 and 3|Protocol Violation|0
7739954|NCT00669942|12171986|FG005|Parts 2 and 3|Protocol Violation|1
7739955|NCT00669942|12171987|FG006|Parts 2 and 3|Protocol Violation|0
7739956|NCT00669942|12171988|FG007|Parts 2 and 3|Protocol Violation|0
7739957|NCT00669942|12171989|FG008|Parts 2 and 3|Protocol Violation|0
7739958|NCT00669942|12171990|FG009|Parts 2 and 3|Protocol Violation|0
7739959|NCT00669942|12171991|FG010|Parts 2 and 3|Protocol Violation|0
7739960|NCT00669942|12171992|FG011|Parts 2 and 3|Protocol Violation|0
7739961|NCT00669955|12172017|FG000|Overall Study|Adverse Event|3
7739962|NCT00669955|12172018|FG001|Overall Study|Adverse Event|5
7739963|NCT00669955|12172017|FG000|Overall Study|Death|0
7739964|NCT00669955|12172018|FG001|Overall Study|Death|1
7739965|NCT00669955|12172017|FG000|Overall Study|Withdrawal by Subject|2
7739966|NCT00669955|12172018|FG001|Overall Study|Withdrawal by Subject|3
7739967|NCT00669955|12172017|FG000|Overall Study|Lost to Follow-up|5
7739968|NCT00669955|12172018|FG001|Overall Study|Lost to Follow-up|7
7739969|NCT00669955|12172017|FG000|Overall Study|Protocol Violation|2
7739970|NCT00669955|12172018|FG001|Overall Study|Protocol Violation|7
7739971|NCT00669955|12172017|FG000|Overall Study|Investigator Sponsor Judgement|0
7739972|NCT00669955|12172018|FG001|Overall Study|Investigator Sponsor Judgement|1
7739973|NCT00669955|12172017|FG000|Overall Study|not compliant with study drug/visit|2
7739974|NCT00669955|12172018|FG001|Overall Study|not compliant with study drug/visit|3
7739975|NCT00670007|12172024|FG000|Overall Study|Drug abuse|1
7739976|NCT00670007|12172024|FG000|Overall Study|Lung transplant|1
7739977|NCT00670007|12172024|FG000|Overall Study|Travel/Vacation|1
7739978|NCT00670007|12172024|FG000|Overall Study|Adverse event, serious fatal|1
7739979|NCT00670007|12172024|FG000|Overall Study|Adverse Event|1
7739980|NCT00670007|12172024|FG000|Overall Study|Withdrawal by Subject|4
7739981|NCT00670046|12172031|FG000|Overall Study|Lost to Follow-up|1
7739982|NCT00670046|12172032|FG001|Overall Study|Lost to Follow-up|1
7739983|NCT00670046|12172031|FG000|Overall Study|Withdrawal by Subject|0
7739984|NCT00670046|12172032|FG001|Overall Study|Withdrawal by Subject|1
7739985|NCT00670111|12172041|FG000|Enrollment to One Month|Testing Failure|0
7739986|NCT00670111|12172042|FG001|Enrollment to One Month|Testing Failure|0
7739987|NCT00670111|12172043|FG002|Enrollment to One Month|Testing Failure|13
7739988|NCT00670111|12172041|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0
7739989|NCT00670111|12172042|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0
7739990|NCT00670111|12172043|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6
7739991|NCT00670111|12172041|FG000|Enrollment to One Month|Physician Decision|1
7739992|NCT00670111|12172042|FG001|Enrollment to One Month|Physician Decision|0
7739993|NCT00670111|12172043|FG002|Enrollment to One Month|Physician Decision|0
7739994|NCT00670228|12172062|FG000|Overall Study|Adverse Event|1
7739995|NCT00670228|12172063|FG001|Overall Study|Adverse Event|0
7739996|NCT00670228|12172062|FG000|Overall Study|Death or MACE|0
7739997|NCT00670228|12172063|FG001|Overall Study|Death or MACE|1
7739998|NCT00670228|12172062|FG000|Overall Study|Not treated|2
7739999|NCT00670228|12172063|FG001|Overall Study|Not treated|2
7740000|NCT00670228|12172062|FG000|Overall Study|Not meeting the selection criteria|2
7740001|NCT00670228|12172063|FG001|Overall Study|Not meeting the selection criteria|0
7740002|NCT00670306|12172088|FG000|Overall Study|Adverse Event|8
7740003|NCT00670306|12172088|FG000|Overall Study|Lack of Efficacy|10
7740004|NCT00670306|12172088|FG000|Overall Study|Withdrawal by Subject|9
7740005|NCT00670306|12172088|FG000|Overall Study|Physician Decision|1
7740006|NCT00670306|12172088|FG000|Overall Study|Lost to Follow-up|8
7740007|NCT00670306|12172088|FG000|Overall Study|incl/excl criterias did not meet|19
7740008|NCT00670449|12172096|FG000|Overall Study|Adverse Event|6
7740009|NCT00670449|12172097|FG001|Overall Study|Adverse Event|2
7740010|NCT00670449|12172098|FG002|Overall Study|Adverse Event|8
7740011|NCT00670449|12172099|FG003|Overall Study|Adverse Event|5
7740012|NCT00670449|12172096|FG000|Overall Study|Protocol Deviation|1
7740013|NCT00670449|12172097|FG001|Overall Study|Protocol Deviation|2
7740014|NCT00670449|12172098|FG002|Overall Study|Protocol Deviation|0
7740015|NCT00670449|12172099|FG003|Overall Study|Protocol Deviation|1
7740016|NCT00670449|12172096|FG000|Overall Study|Administrative Problems|0
7740017|NCT00670449|12172097|FG001|Overall Study|Administrative Problems|2
7740018|NCT00670449|12172098|FG002|Overall Study|Administrative Problems|0
7740019|NCT00670449|12172099|FG003|Overall Study|Administrative Problems|1
7740020|NCT00670449|12172096|FG000|Overall Study|Subject Withdrew Consent|0
7740021|NCT00670449|12172097|FG001|Overall Study|Subject Withdrew Consent|2
7740022|NCT00670449|12172098|FG002|Overall Study|Subject Withdrew Consent|0
7740023|NCT00670449|12172099|FG003|Overall Study|Subject Withdrew Consent|1
7740024|NCT00670449|12172096|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2
7740025|NCT00670449|12172097|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
7740026|NCT00670449|12172098|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1
7740027|NCT00670449|12172099|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0
7740028|NCT00670449|12172096|FG000|Overall Study|Abnormal Laboratory Value(s)|0
7740029|NCT00670449|12172097|FG001|Overall Study|Abnormal Laboratory Value(s)|2
7740030|NCT00670449|12172098|FG002|Overall Study|Abnormal Laboratory Value(s)|0
7740031|NCT00670449|12172099|FG003|Overall Study|Abnormal Laboratory Value(s)|0
7740032|NCT00670488|12172129|FG000|Overall Study|Adverse Event|0
7740033|NCT00670488|12172130|FG001|Overall Study|Adverse Event|7
7740034|NCT00670488|12172131|FG002|Overall Study|Adverse Event|0
7740035|NCT00670488|12172132|FG003|Overall Study|Adverse Event|3
7740036|NCT00670488|12172133|FG004|Overall Study|Adverse Event|1
7740037|NCT00670488|12172134|FG005|Overall Study|Adverse Event|1
7740038|NCT00670488|12172135|FG006|Overall Study|Adverse Event|5
7740039|NCT00670488|12172136|FG007|Overall Study|Adverse Event|1
7740040|NCT00670488|12172137|FG008|Overall Study|Adverse Event|0
7740041|NCT00670488|12172138|FG009|Overall Study|Adverse Event|1
7740042|NCT00670488|12172129|FG000|Overall Study|Physician Decision|1
7740043|NCT00670488|12172130|FG001|Overall Study|Physician Decision|9
7740044|NCT00670488|12172131|FG002|Overall Study|Physician Decision|0
7740045|NCT00670488|12172132|FG003|Overall Study|Physician Decision|1
7740046|NCT00670488|12172133|FG004|Overall Study|Physician Decision|0
7740047|NCT00670488|12172134|FG005|Overall Study|Physician Decision|0
7740048|NCT00670488|12172135|FG006|Overall Study|Physician Decision|0
7740049|NCT00670488|12172136|FG007|Overall Study|Physician Decision|0
7740050|NCT00670488|12172137|FG008|Overall Study|Physician Decision|0
7740051|NCT00670488|12172138|FG009|Overall Study|Physician Decision|0
7740052|NCT00670488|12172129|FG000|Overall Study|Progressive Disease|2
7740053|NCT00670488|12172130|FG001|Overall Study|Progressive Disease|41
7740054|NCT00670488|12172131|FG002|Overall Study|Progressive Disease|3
7740055|NCT00670488|12172132|FG003|Overall Study|Progressive Disease|2
7740056|NCT00670488|12172133|FG004|Overall Study|Progressive Disease|2
7740057|NCT00670488|12172134|FG005|Overall Study|Progressive Disease|4
7740058|NCT00670488|12172135|FG006|Overall Study|Progressive Disease|11
7740059|NCT00670488|12172136|FG007|Overall Study|Progressive Disease|2
7740060|NCT00670488|12172137|FG008|Overall Study|Progressive Disease|2
7740061|NCT00670488|12172138|FG009|Overall Study|Progressive Disease|1
7740062|NCT00670488|12172129|FG000|Overall Study|Withdrawal by Subject|0
7740063|NCT00670488|12172130|FG001|Overall Study|Withdrawal by Subject|1
7740064|NCT00670488|12172131|FG002|Overall Study|Withdrawal by Subject|0
7740065|NCT00670488|12172132|FG003|Overall Study|Withdrawal by Subject|1
7740066|NCT00670488|12172133|FG004|Overall Study|Withdrawal by Subject|0
7740067|NCT00670488|12172134|FG005|Overall Study|Withdrawal by Subject|0
7740068|NCT00670488|12172135|FG006|Overall Study|Withdrawal by Subject|1
7740069|NCT00670488|12172136|FG007|Overall Study|Withdrawal by Subject|0
7740070|NCT00670488|12172137|FG008|Overall Study|Withdrawal by Subject|1
7740071|NCT00670488|12172138|FG009|Overall Study|Withdrawal by Subject|0
7740072|NCT00670540|12172160|FG000|Overall Study|ineligible|17
7740073|NCT00670540|12172160|FG000|Overall Study|not living in France|348
7740074|NCT00670540|12172160|FG000|Overall Study|refused to participate|189
7740075|NCT00670540|12172160|FG000|Overall Study|controls randomised for no follow up|2770
7740076|NCT00670540|12172160|FG000|Overall Study|missing information inclusion criteria|1
7740077|NCT00670748|12172177|FG000|Overall Study|Death during treatment|1
7740078|NCT00670748|12172178|FG001|Overall Study|Death during treatment|1
7740079|NCT00670748|12172179|FG002|Overall Study|Death during treatment|1
7740080|NCT00670748|12172180|FG003|Overall Study|Death during treatment|0
7740081|NCT00670748|12172177|FG000|Overall Study|Not off study|2
7740082|NCT00670748|12172178|FG001|Overall Study|Not off study|1
7740083|NCT00670748|12172179|FG002|Overall Study|Not off study|1
7740084|NCT00670748|12172180|FG003|Overall Study|Not off study|1
7740085|NCT00670800|12172196|FG000|Overall Study|2 controls were insulin resistant|0
7740086|NCT00670800|12172197|FG001|Overall Study|2 controls were insulin resistant|2
7740087|NCT00670930|12172207|FG000|Overall Study|Adminstrative Problem|0
7740088|NCT00670930|12172208|FG001|Overall Study|Adminstrative Problem|1
7740089|NCT00670930|12172207|FG000|Overall Study|Lost to Follow-up|1
7740090|NCT00670930|12172208|FG001|Overall Study|Lost to Follow-up|0
7740091|NCT00671034|12172229|FG000|Overall Study|Adverse Event|5
7740092|NCT00671034|12172230|FG001|Overall Study|Adverse Event|7
7740093|NCT00671034|12172231|FG002|Overall Study|Adverse Event|1
7740094|NCT00671034|12172229|FG000|Overall Study|Death|3
7740095|NCT00671034|12172230|FG001|Overall Study|Death|2
7740096|NCT00671034|12172231|FG002|Overall Study|Death|1
7740097|NCT00671034|12172229|FG000|Overall Study|Physician Decision|12
7740098|NCT00671034|12172230|FG001|Overall Study|Physician Decision|4
7740099|NCT00671034|12172231|FG002|Overall Study|Physician Decision|5
7740100|NCT00671034|12172229|FG000|Overall Study|VHR ALL feature|8
7740101|NCT00671034|12172230|FG001|Overall Study|VHR ALL feature|3
7740102|NCT00671034|12172231|FG002|Overall Study|VHR ALL feature|5
7740103|NCT00671034|12172229|FG000|Overall Study|Refusal|5
7740104|NCT00671034|12172230|FG001|Overall Study|Refusal|3
7740105|NCT00671034|12172231|FG002|Overall Study|Refusal|5
7740106|NCT00671034|12172229|FG000|Overall Study|includes Alternative therapy, etc.|6
7740107|NCT00671034|12172230|FG001|Overall Study|includes Alternative therapy, etc.|1
7740108|NCT00671034|12172231|FG002|Overall Study|includes Alternative therapy, etc.|7
7740109|NCT00671060|12172242|FG000|Overall Study|Protocol Violation|1
7740110|NCT00671060|12172243|FG001|Overall Study|Protocol Violation|0
7740111|NCT00671060|12172242|FG000|Overall Study|Physician Decision|0
7740112|NCT00671060|12172243|FG001|Overall Study|Physician Decision|1
7740113|NCT00671437|12172258|FG000|Overall Study|Progressive disease before C1 week 8|8
7740114|NCT00671437|12172258|FG000|Overall Study|Cutaneous SCC of head and neck|3
7740115|NCT00671437|12172258|FG000|Overall Study|Adverse Event|3
7740116|NCT00671437|12172258|FG000|Overall Study|Ineligible post-hoc|1
7740117|NCT00671554|12172287|FG000|Overall Study|Disease progression|3
7740118|NCT00671658|12172292|FG000|Overall Study|Physician Decision|5
7740119|NCT00671788|12172319|FG000|Overall Study|Adverse Event|8
7740120|NCT00671788|12172319|FG000|Overall Study|Refused further treatment|3
7740121|NCT00671788|12172319|FG000|Overall Study|Ineligible|1
7740122|NCT00671788|12172319|FG000|Overall Study|MD Decision|1
7740123|NCT00671788|12172319|FG000|Overall Study|Other|1
7740124|NCT00671853|12172325|FG000|Overall Study|Lack of Efficacy|3
7740125|NCT00671853|12172326|FG001|Overall Study|Lack of Efficacy|7
7740126|NCT00671853|12172325|FG000|Overall Study|Adverse Event|7
7740127|NCT00671853|12172326|FG001|Overall Study|Adverse Event|1
7740128|NCT00671853|12172325|FG000|Overall Study|Withdrawal by Subject|1
7740129|NCT00671853|12172326|FG001|Overall Study|Withdrawal by Subject|5
7740130|NCT00671853|12172325|FG000|Overall Study|Lost to Follow-up|8
7740131|NCT00671853|12172326|FG001|Overall Study|Lost to Follow-up|8
7740132|NCT00671853|12172325|FG000|Overall Study|Physician Decision|0
7740133|NCT00671853|12172326|FG001|Overall Study|Physician Decision|2
7740134|NCT00671853|12172325|FG000|Overall Study|Non-adherence with study procedures|1
7740135|NCT00671853|12172326|FG001|Overall Study|Non-adherence with study procedures|4
7740136|NCT00671879|12172337|FG000|Overall Study|Withdrawal by Subject|0
7740137|NCT00671879|12172338|FG001|Overall Study|Withdrawal by Subject|4
7740138|NCT00671879|12172339|FG002|Overall Study|Withdrawal by Subject|6
7740139|NCT00671931|12172358|FG000|Overall Study|Physician Decision|1
7740140|NCT00671931|12172359|FG001|Overall Study|Physician Decision|0
7740141|NCT00671931|12172360|FG002|Overall Study|Physician Decision|0
7740142|NCT00671931|12172361|FG003|Overall Study|Physician Decision|2
7740143|NCT00671931|12172362|FG004|Overall Study|Physician Decision|1
7740144|NCT00672139|12172414|FG000|Overall Study|Death|14
7740145|NCT00672139|12172415|FG001|Overall Study|Death|23
7740146|NCT00672139|12172414|FG000|Overall Study|Withdrawal by Subject|2
7740147|NCT00672139|12172415|FG001|Overall Study|Withdrawal by Subject|11
7740148|NCT00672139|12172414|FG000|Overall Study|Adverse Event|4
7740149|NCT00672139|12172415|FG001|Overall Study|Adverse Event|7
7740150|NCT00672139|12172414|FG000|Overall Study|Physician Decision|2
7740151|NCT00672139|12172415|FG001|Overall Study|Physician Decision|0
7740152|NCT00672139|12172414|FG000|Overall Study|Lack of Efficacy|4
7740153|NCT00672139|12172415|FG001|Overall Study|Lack of Efficacy|1
7740154|NCT00672139|12172414|FG000|Overall Study|Protocol Violation|1
7740155|NCT00672139|12172415|FG001|Overall Study|Protocol Violation|1
7740156|NCT00672139|12172414|FG000|Overall Study|hospice discharge, caregiver requests|3
7740157|NCT00672139|12172415|FG001|Overall Study|hospice discharge, caregiver requests|2
7740158|NCT00672256|12172430|FG000|Overall Study|PI dropped, bad data|44
7740159|NCT00672477|12172454|FG000|Overall Study|Adverse Event|10
7740160|NCT00672477|12172455|FG001|Overall Study|Adverse Event|7
7740161|NCT00672477|12172454|FG000|Overall Study|Death|7
7740162|NCT00672477|12172455|FG001|Overall Study|Death|11
7740163|NCT00672477|12172454|FG000|Overall Study|Physician Decision|2
7740164|NCT00672477|12172455|FG001|Overall Study|Physician Decision|0
7740165|NCT00672477|12172454|FG000|Overall Study|Protocol Violation|1
7740166|NCT00672477|12172455|FG001|Overall Study|Protocol Violation|1
7740167|NCT00672477|12172454|FG000|Overall Study|Withdrawal by Subject|5
7740168|NCT00672477|12172455|FG001|Overall Study|Withdrawal by Subject|3
7740169|NCT00672477|12172454|FG000|Overall Study|Lack of Efficacy|1
7740170|NCT00672477|12172455|FG001|Overall Study|Lack of Efficacy|1
7740171|NCT00672477|12172454|FG000|Overall Study|no study drug for low GFR, health cond.|1
7740172|NCT00672477|12172455|FG001|Overall Study|no study drug for low GFR, health cond.|3
7740173|NCT00672490|12172463|FG000|Overall Study|Withdrawal by Subject|8
7740174|NCT00672490|12172464|FG001|Overall Study|Withdrawal by Subject|8
7740175|NCT00672490|12172463|FG000|Overall Study|Lack of Compliance|2
7740176|NCT00672490|12172464|FG001|Overall Study|Lack of Compliance|7
7740177|NCT00672490|12172463|FG000|Overall Study|Mismatch Include/Exclude Criteria|1
7740178|NCT00672490|12172464|FG001|Overall Study|Mismatch Include/Exclude Criteria|0
7740179|NCT00672490|12172463|FG000|Overall Study|Adverse Event|5
7740180|NCT00672490|12172464|FG001|Overall Study|Adverse Event|8
7740181|NCT00672490|12172463|FG000|Overall Study|Violation of Concomitant Medicine|1
7740182|NCT00672490|12172464|FG001|Overall Study|Violation of Concomitant Medicine|0
7740183|NCT00672490|12172463|FG000|Overall Study|Intolerance|0
7740184|NCT00672490|12172464|FG001|Overall Study|Intolerance|2
7740185|NCT00672490|12172463|FG000|Overall Study|Lost to Follow-up|1
7740186|NCT00672490|12172464|FG001|Overall Study|Lost to Follow-up|5
7740187|NCT00672490|12172463|FG000|Overall Study|No reason was provided|6
7740188|NCT00672490|12172464|FG001|Overall Study|No reason was provided|2
7740189|NCT00672555|12172470|FG000|Overall Study|Lost to Follow-up|4
7740190|NCT00672555|12172470|FG000|Overall Study|Did not want to answer questionnaire|2
7740191|NCT00672620|12172482|FG000|Overall Study|Adverse Event|7
7740192|NCT00672620|12172483|FG001|Overall Study|Adverse Event|7
7740193|NCT00672620|12172484|FG002|Overall Study|Adverse Event|12
7740194|NCT00672620|12172485|FG003|Overall Study|Adverse Event|17
7740195|NCT00672620|12172482|FG000|Overall Study|Lack of Efficacy|1
7740196|NCT00672620|12172483|FG001|Overall Study|Lack of Efficacy|2
7740197|NCT00672620|12172484|FG002|Overall Study|Lack of Efficacy|2
7740198|NCT00672620|12172485|FG003|Overall Study|Lack of Efficacy|0
7740199|NCT00672620|12172482|FG000|Overall Study|Noncompliance with Study Drug|3
7740200|NCT00672620|12172483|FG001|Overall Study|Noncompliance with Study Drug|4
7740201|NCT00672620|12172484|FG002|Overall Study|Noncompliance with Study Drug|0
7740202|NCT00672620|12172485|FG003|Overall Study|Noncompliance with Study Drug|2
7740203|NCT00672620|12172482|FG000|Overall Study|Protocol Deviations|5
7740204|NCT00672620|12172483|FG001|Overall Study|Protocol Deviations|7
7740205|NCT00672620|12172484|FG002|Overall Study|Protocol Deviations|2
7740206|NCT00672620|12172485|FG003|Overall Study|Protocol Deviations|5
7740207|NCT00672620|12172482|FG000|Overall Study|Withdrawal of Consent|6
7740208|NCT00672620|12172483|FG001|Overall Study|Withdrawal of Consent|12
7740209|NCT00672620|12172484|FG002|Overall Study|Withdrawal of Consent|5
7740210|NCT00672620|12172485|FG003|Overall Study|Withdrawal of Consent|6
7740211|NCT00672620|12172482|FG000|Overall Study|Lost to Follow-up|8
7740212|NCT00672620|12172483|FG001|Overall Study|Lost to Follow-up|19
7740213|NCT00672620|12172484|FG002|Overall Study|Lost to Follow-up|8
7740214|NCT00672620|12172485|FG003|Overall Study|Lost to Follow-up|11
7740215|NCT00672620|12172482|FG000|Overall Study|Reason not Specified|3
7740216|NCT00672620|12172483|FG001|Overall Study|Reason not Specified|3
7740217|NCT00672620|12172484|FG002|Overall Study|Reason not Specified|2
7740218|NCT00672620|12172485|FG003|Overall Study|Reason not Specified|1
7740219|NCT00672633|12172497|FG000|Overall Study|Withdrawal by Subject|0
7740220|NCT00672633|12172498|FG001|Overall Study|Withdrawal by Subject|1
7740221|NCT00672646|12172507|FG000|Overall Study|Lost to Follow-up|0
7740222|NCT00672646|12172508|FG001|Overall Study|Lost to Follow-up|1
7740223|NCT00672646|12172509|FG002|Overall Study|Lost to Follow-up|2
7740224|NCT00672646|12172507|FG000|Overall Study|Withdrawal by Subject|0
7740225|NCT00672646|12172508|FG001|Overall Study|Withdrawal by Subject|0
7740226|NCT00672646|12172509|FG002|Overall Study|Withdrawal by Subject|1
7740227|NCT00672841|12172524|FG000|Overall Study|Comfort care|1
7740228|NCT00672841|12172525|FG001|Overall Study|Comfort care|4
7740229|NCT00672841|12172524|FG000|Overall Study|icteric specimens|0
7740230|NCT00672841|12172525|FG001|Overall Study|icteric specimens|3
7740231|NCT00672841|12172524|FG000|Overall Study|Antifungal therapy, negative glucan|0
7740232|NCT00672841|12172525|FG001|Overall Study|Antifungal therapy, negative glucan|4
7740233|NCT00672841|12172524|FG000|Overall Study|Adverse Event|0
7740234|NCT00672841|12172525|FG001|Overall Study|Adverse Event|3
7740235|NCT00672841|12172524|FG000|Overall Study|Pregnancy|0
7740236|NCT00672841|12172525|FG001|Overall Study|Pregnancy|1
7740237|NCT00672958|12172556|FG000|Overall Study|Adverse Event|11
7740238|NCT00672958|12172557|FG001|Overall Study|Adverse Event|9
7740239|NCT00672958|12172556|FG000|Overall Study|Lack of Efficacy|6
7740240|NCT00672958|12172557|FG001|Overall Study|Lack of Efficacy|11
7740241|NCT00672958|12172556|FG000|Overall Study|Non-compliance with study drug|2
7740242|NCT00672958|12172557|FG001|Overall Study|Non-compliance with study drug|3
7740243|NCT00672958|12172556|FG000|Overall Study|Protocol deviations|11
7740244|NCT00672958|12172557|FG001|Overall Study|Protocol deviations|5
7740245|NCT00672958|12172556|FG000|Overall Study|Voluntary withdrawal|12
7740246|NCT00672958|12172557|FG001|Overall Study|Voluntary withdrawal|8
7740247|NCT00672958|12172556|FG000|Overall Study|Lost to Follow-up|22
7740248|NCT00672958|12172557|FG001|Overall Study|Lost to Follow-up|17
7740249|NCT00672958|12172556|FG000|Overall Study|Reason not specified|0
7740250|NCT00672958|12172557|FG001|Overall Study|Reason not specified|3
7740251|NCT00672984|12172566|FG000|First Intervention|Adverse Event|5
7740252|NCT00672984|12172567|FG001|First Intervention|Adverse Event|0
7740253|NCT00672984|12172568|FG002|First Intervention|Adverse Event|0
7740254|NCT00672984|12172566|FG000|First Intervention|Withdrawal by Subject|1
7740255|NCT00672984|12172567|FG001|First Intervention|Withdrawal by Subject|2
7740256|NCT00672984|12172568|FG002|First Intervention|Withdrawal by Subject|2
7740257|NCT00672984|12172566|FG000|First Intervention|Sponsor decision|3
7740258|NCT00672984|12172567|FG001|First Intervention|Sponsor decision|0
7740259|NCT00672984|12172568|FG002|First Intervention|Sponsor decision|0
7740260|NCT00672984|12172566|FG000|Second Intervention|Non-compliance with facility policies|0
7740261|NCT00672984|12172567|FG001|Second Intervention|Non-compliance with facility policies|2
7740262|NCT00672984|12172568|FG002|Second Intervention|Non-compliance with facility policies|0
7740263|NCT00672984|12172566|FG000|Second Intervention|Withdrawal by Subject|0
7740264|NCT00672984|12172567|FG001|Second Intervention|Withdrawal by Subject|3
7740265|NCT00672984|12172568|FG002|Second Intervention|Withdrawal by Subject|0
7740266|NCT00672984|12172566|FG000|Second Intervention|Protocol Violation|0
7740267|NCT00672984|12172567|FG001|Second Intervention|Protocol Violation|1
7740268|NCT00672984|12172568|FG002|Second Intervention|Protocol Violation|1
7740269|NCT00672984|12172566|FG000|Third Intervention|Adverse Event|1
7740270|NCT00672984|12172567|FG001|Third Intervention|Adverse Event|0
7740271|NCT00672984|12172568|FG002|Third Intervention|Adverse Event|1
7740272|NCT00673049|12172580|FG000|Before Progression on Erlotinib|Randomized but not treated|3
7740273|NCT00673049|12172581|FG001|Before Progression on Erlotinib|Randomized but not treated|1
7740274|NCT00673049|12172582|FG002|Before Progression on Erlotinib|Randomized but not treated|0
7740275|NCT00673049|12172583|FG003|Before Progression on Erlotinib|Randomized but not treated|0
7740276|NCT00673049|12172580|FG000|Before Progression on Erlotinib|Death|235
7740277|NCT00673049|12172581|FG001|Before Progression on Erlotinib|Death|167
7740278|NCT00673049|12172582|FG002|Before Progression on Erlotinib|Death|1
7740279|NCT00673049|12172583|FG003|Before Progression on Erlotinib|Death|0
7740280|NCT00673049|12172580|FG000|Before Progression on Erlotinib|Lost to Follow-up|9
7740281|NCT00673049|12172581|FG001|Before Progression on Erlotinib|Lost to Follow-up|5
7740282|NCT00673049|12172582|FG002|Before Progression on Erlotinib|Lost to Follow-up|0
7740283|NCT00673049|12172583|FG003|Before Progression on Erlotinib|Lost to Follow-up|0
7740284|NCT00673049|12172580|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26
7740285|NCT00673049|12172581|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18
7740286|NCT00673049|12172582|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0
7740287|NCT00673049|12172583|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0
7740288|NCT00673049|12172580|FG000|Before Progression on Erlotinib|Other|1
7740289|NCT00673049|12172581|FG001|Before Progression on Erlotinib|Other|2
7740290|NCT00673049|12172582|FG002|Before Progression on Erlotinib|Other|0
7740291|NCT00673049|12172583|FG003|Before Progression on Erlotinib|Other|0
7740292|NCT00673049|12172580|FG000|Before Progression on Erlotinib|study terminated by sponsor|18
7740293|NCT00673049|12172581|FG001|Before Progression on Erlotinib|study terminated by sponsor|14
7740294|NCT00673049|12172582|FG002|Before Progression on Erlotinib|study terminated by sponsor|0
7740295|NCT00673049|12172583|FG003|Before Progression on Erlotinib|study terminated by sponsor|0
7740296|NCT00673049|12172580|FG000|Before Progression on Erlotinib|Switched to figitumumab|0
7740297|NCT00673049|12172581|FG001|Before Progression on Erlotinib|Switched to figitumumab|83
7740298|NCT00673049|12172582|FG002|Before Progression on Erlotinib|Switched to figitumumab|0
7740299|NCT00673049|12172583|FG003|Before Progression on Erlotinib|Switched to figitumumab|0
7740300|NCT00673049|12172580|FG000|After Progression on Erlotinib|Death|0
7740301|NCT00673049|12172581|FG001|After Progression on Erlotinib|Death|0
7740302|NCT00673049|12172582|FG002|After Progression on Erlotinib|Death|0
7740303|NCT00673049|12172583|FG003|After Progression on Erlotinib|Death|71
7740304|NCT00673049|12172580|FG000|After Progression on Erlotinib|Lost to Follow-up|0
7740305|NCT00673049|12172581|FG001|After Progression on Erlotinib|Lost to Follow-up|0
7740306|NCT00673049|12172582|FG002|After Progression on Erlotinib|Lost to Follow-up|0
7740307|NCT00673049|12172583|FG003|After Progression on Erlotinib|Lost to Follow-up|3
7740308|NCT00673049|12172580|FG000|After Progression on Erlotinib|Withdrawal by Subject|0
7740309|NCT00673049|12172581|FG001|After Progression on Erlotinib|Withdrawal by Subject|0
7740310|NCT00673049|12172582|FG002|After Progression on Erlotinib|Withdrawal by Subject|0
7740311|NCT00673049|12172583|FG003|After Progression on Erlotinib|Withdrawal by Subject|5
7740312|NCT00673049|12172580|FG000|After Progression on Erlotinib|study terminated by sponsor|0
7740313|NCT00673049|12172581|FG001|After Progression on Erlotinib|study terminated by sponsor|0
7740314|NCT00673049|12172582|FG002|After Progression on Erlotinib|study terminated by sponsor|0
7740315|NCT00673049|12172583|FG003|After Progression on Erlotinib|study terminated by sponsor|4
7740316|NCT00673231|12172619|FG000|Overall Study|Withdrawal by Subject|14
7740317|NCT00673231|12172620|FG001|Overall Study|Withdrawal by Subject|10
7740318|NCT00673231|12172621|FG002|Overall Study|Withdrawal by Subject|8
7740319|NCT00673231|12172622|FG003|Overall Study|Withdrawal by Subject|6
7740320|NCT00673231|12172619|FG000|Overall Study|Adverse Event|6
7740321|NCT00673231|12172620|FG001|Overall Study|Adverse Event|5
7740322|NCT00673231|12172621|FG002|Overall Study|Adverse Event|9
7740323|NCT00673231|12172622|FG003|Overall Study|Adverse Event|6
7740324|NCT00673231|12172619|FG000|Overall Study|Lost to Follow-up|1
7740325|NCT00673231|12172620|FG001|Overall Study|Lost to Follow-up|2
7740326|NCT00673231|12172621|FG002|Overall Study|Lost to Follow-up|1
7740327|NCT00673231|12172622|FG003|Overall Study|Lost to Follow-up|2
7740328|NCT00673231|12172619|FG000|Overall Study|Death|0
7740329|NCT00673231|12172620|FG001|Overall Study|Death|0
7740330|NCT00673231|12172621|FG002|Overall Study|Death|1
7740331|NCT00673231|12172622|FG003|Overall Study|Death|0
7740332|NCT00673231|12172619|FG000|Overall Study|Study criteria,compliance,safety, other|8
7740333|NCT00673231|12172620|FG001|Overall Study|Study criteria,compliance,safety, other|5
7740334|NCT00673231|12172621|FG002|Overall Study|Study criteria,compliance,safety, other|7
7740335|NCT00673231|12172622|FG003|Overall Study|Study criteria,compliance,safety, other|4
7740336|NCT00673257|12172641|FG000|Overall Study|Withdrawal by Subject|4
7740337|NCT00673257|12172641|FG000|Overall Study|Unable to obtain specimen|1
7740338|NCT00673387|12172653|FG000|Overall Study|Withdrawal by Subject|15
7740339|NCT00673387|12172654|FG001|Overall Study|Withdrawal by Subject|16
7740340|NCT00673387|12172655|FG002|Overall Study|Withdrawal by Subject|20
7740341|NCT00673387|12172656|FG003|Overall Study|Withdrawal by Subject|16
7740342|NCT00673387|12172657|FG004|Overall Study|Withdrawal by Subject|18
7740343|NCT00673387|12172658|FG005|Overall Study|Withdrawal by Subject|21
7740344|NCT00673387|12172659|FG006|Overall Study|Withdrawal by Subject|15
7740345|NCT00673387|12172660|FG007|Overall Study|Withdrawal by Subject|21
7740346|NCT00673387|12172653|FG000|Overall Study|Adverse Event|3
7740347|NCT00673387|12172654|FG001|Overall Study|Adverse Event|1
7740348|NCT00673387|12172655|FG002|Overall Study|Adverse Event|5
7740349|NCT00673387|12172656|FG003|Overall Study|Adverse Event|2
7740350|NCT00673387|12172657|FG004|Overall Study|Adverse Event|6
7740351|NCT00673387|12172658|FG005|Overall Study|Adverse Event|2
7740352|NCT00673387|12172659|FG006|Overall Study|Adverse Event|5
7740353|NCT00673387|12172660|FG007|Overall Study|Adverse Event|5
7740354|NCT00673387|12172653|FG000|Overall Study|Physician Decision|0
7740355|NCT00673387|12172654|FG001|Overall Study|Physician Decision|0
7740356|NCT00673387|12172655|FG002|Overall Study|Physician Decision|0
7740357|NCT00673387|12172656|FG003|Overall Study|Physician Decision|0
7740358|NCT00673387|12172657|FG004|Overall Study|Physician Decision|0
7740359|NCT00673387|12172658|FG005|Overall Study|Physician Decision|5
7740360|NCT00673387|12172659|FG006|Overall Study|Physician Decision|1
7740361|NCT00673387|12172660|FG007|Overall Study|Physician Decision|1
7740362|NCT00673387|12172653|FG000|Overall Study|Protocol Violation|3
7740363|NCT00673387|12172654|FG001|Overall Study|Protocol Violation|0
7740364|NCT00673387|12172655|FG002|Overall Study|Protocol Violation|1
7740365|NCT00673387|12172656|FG003|Overall Study|Protocol Violation|2
7740366|NCT00673387|12172657|FG004|Overall Study|Protocol Violation|0
7740367|NCT00673387|12172658|FG005|Overall Study|Protocol Violation|1
7740368|NCT00673387|12172659|FG006|Overall Study|Protocol Violation|1
7740369|NCT00673387|12172660|FG007|Overall Study|Protocol Violation|3
7740370|NCT00673387|12172653|FG000|Overall Study|Lost to Follow-up|8
7740371|NCT00673387|12172654|FG001|Overall Study|Lost to Follow-up|6
7740372|NCT00673387|12172655|FG002|Overall Study|Lost to Follow-up|5
7740373|NCT00673387|12172656|FG003|Overall Study|Lost to Follow-up|6
7740374|NCT00673387|12172657|FG004|Overall Study|Lost to Follow-up|6
7740375|NCT00673387|12172658|FG005|Overall Study|Lost to Follow-up|5
7740376|NCT00673387|12172659|FG006|Overall Study|Lost to Follow-up|8
7740377|NCT00673387|12172660|FG007|Overall Study|Lost to Follow-up|5
7740378|NCT00673452|12172705|FG000|Acute Double-Blind Phase|Adverse Event|41
7740379|NCT00673452|12172706|FG001|Acute Double-Blind Phase|Adverse Event|24
7740380|NCT00673452|12172705|FG000|Acute Double-Blind Phase|Lack of Efficacy|9
7740381|NCT00673452|12172706|FG001|Acute Double-Blind Phase|Lack of Efficacy|14
7740382|NCT00673452|12172705|FG000|Acute Double-Blind Phase|Lost to Follow-up|16
7740383|NCT00673452|12172706|FG001|Acute Double-Blind Phase|Lost to Follow-up|19
7740384|NCT00673452|12172705|FG000|Acute Double-Blind Phase|Physician Decision|0
7740385|NCT00673452|12172706|FG001|Acute Double-Blind Phase|Physician Decision|6
7740386|NCT00673452|12172705|FG000|Acute Double-Blind Phase|Protocol Violation|5
7740387|NCT00673452|12172706|FG001|Acute Double-Blind Phase|Protocol Violation|3
7740388|NCT00673452|12172705|FG000|Acute Double-Blind Phase|Sponsor Decision|0
7740389|NCT00673452|12172706|FG001|Acute Double-Blind Phase|Sponsor Decision|1
7740390|NCT00673452|12172705|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16
7740391|NCT00673452|12172706|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13
7740392|NCT00673452|12172705|FG000|Continuation Double-Blind Phase|Adverse Event|5
7740393|NCT00673452|12172706|FG001|Continuation Double-Blind Phase|Adverse Event|13
7740394|NCT00673452|12172705|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9
7740395|NCT00673452|12172706|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5
7740396|NCT00673452|12172705|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4
7740397|NCT00673452|12172706|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5
7740398|NCT00673452|12172705|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2
7740399|NCT00673452|12172706|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5
7740400|NCT00673452|12172705|FG000|Continuation Double-Blind Phase|Protocol Violation|2
7740401|NCT00673452|12172706|FG001|Continuation Double-Blind Phase|Protocol Violation|3
7740402|NCT00673452|12172705|FG000|Continuation Double-Blind Phase|Sponsor Decision|0
7740403|NCT00673452|12172706|FG001|Continuation Double-Blind Phase|Sponsor Decision|3
7740404|NCT00673452|12172705|FG000|Continuation Double-Blind Phase|Physician Decision|2
7740405|NCT00673452|12172706|FG001|Continuation Double-Blind Phase|Physician Decision|0
7740406|NCT00673452|12172705|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
7740407|NCT00673452|12172706|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
7740408|NCT00673465|12172712|FG000|Part 1/Period 1 (United States)|Protocol Violation|0
7740409|NCT00673465|12172713|FG001|Part 1/Period 1 (United States)|Protocol Violation|0
7740410|NCT00673465|12172714|FG002|Part 1/Period 1 (United States)|Protocol Violation|0
7740411|NCT00673465|12172715|FG003|Part 1/Period 1 (United States)|Protocol Violation|0
7740412|NCT00673465|12172716|FG004|Part 1/Period 1 (United States)|Protocol Violation|1
7740413|NCT00673465|12172717|FG005|Part 1/Period 1 (United States)|Protocol Violation|1
7740414|NCT00673465|12172718|FG006|Part 1/Period 1 (United States)|Protocol Violation|0
7740415|NCT00673465|12172719|FG007|Part 1/Period 1 (United States)|Protocol Violation|0
7740416|NCT00673465|12172720|FG008|Part 1/Period 1 (United States)|Protocol Violation|0
7740417|NCT00673465|12172721|FG009|Part 1/Period 1 (United States)|Protocol Violation|0
7740418|NCT00673465|12172722|FG010|Part 1/Period 1 (United States)|Protocol Violation|0
7740419|NCT00673465|12172723|FG011|Part 1/Period 1 (United States)|Protocol Violation|0
7740420|NCT00673465|12172712|FG000|Part 1/Period 2 (United States)|Protocol Violation|0
7740421|NCT00673465|12172713|FG001|Part 1/Period 2 (United States)|Protocol Violation|0
7740422|NCT00673465|12172714|FG002|Part 1/Period 2 (United States)|Protocol Violation|0
7740423|NCT00673465|12172715|FG003|Part 1/Period 2 (United States)|Protocol Violation|0
7740424|NCT00673465|12172716|FG004|Part 1/Period 2 (United States)|Protocol Violation|1
7740425|NCT00673465|12172717|FG005|Part 1/Period 2 (United States)|Protocol Violation|0
7740426|NCT00673465|12172718|FG006|Part 1/Period 2 (United States)|Protocol Violation|0
7740427|NCT00673465|12172719|FG007|Part 1/Period 2 (United States)|Protocol Violation|0
7740428|NCT00673465|12172720|FG008|Part 1/Period 2 (United States)|Protocol Violation|0
7740429|NCT00673465|12172721|FG009|Part 1/Period 2 (United States)|Protocol Violation|0
7740430|NCT00673465|12172722|FG010|Part 1/Period 2 (United States)|Protocol Violation|0
7740431|NCT00673465|12172723|FG011|Part 1/Period 2 (United States)|Protocol Violation|0
7740432|NCT00673660|12172731|FG000|Overall Study|Lost to Follow-up|107
7740433|NCT00673673|12172740|FG000|Overall Study|Progressive disease|27
7740434|NCT00673673|12172740|FG000|Overall Study|Adverse Event|4
7740435|NCT00673673|12172740|FG000|Overall Study|Withdrawal by Subject|3
7740436|NCT00673673|12172740|FG000|Overall Study|Investigators' discretion|2
7740437|NCT00673790|12172767|FG000|Overall Study|Adverse Event|23
7740438|NCT00673790|12172768|FG001|Overall Study|Adverse Event|14
7740439|NCT00673790|12172769|FG002|Overall Study|Adverse Event|2
7740440|NCT00673790|12172767|FG000|Overall Study|Lack of Efficacy|2
7740441|NCT00673790|12172768|FG001|Overall Study|Lack of Efficacy|2
7740442|NCT00673790|12172769|FG002|Overall Study|Lack of Efficacy|2
7740443|NCT00673790|12172767|FG000|Overall Study|Protocol Violation|6
7740444|NCT00673790|12172768|FG001|Overall Study|Protocol Violation|9
7740445|NCT00673790|12172769|FG002|Overall Study|Protocol Violation|1
7740446|NCT00673790|12172767|FG000|Overall Study|Withdrawal by Subject|7
7740447|NCT00673790|12172768|FG001|Overall Study|Withdrawal by Subject|4
7740448|NCT00673790|12172769|FG002|Overall Study|Withdrawal by Subject|1
7740449|NCT00673790|12172767|FG000|Overall Study|Lost to Follow-up|6
7740450|NCT00673790|12172768|FG001|Overall Study|Lost to Follow-up|6
7740451|NCT00673790|12172769|FG002|Overall Study|Lost to Follow-up|5
7740452|NCT00673790|12172767|FG000|Overall Study|Sponsor Terminated due to PI oversight|0
7740453|NCT00673790|12172768|FG001|Overall Study|Sponsor Terminated due to PI oversight|1
7740454|NCT00673790|12172769|FG002|Overall Study|Sponsor Terminated due to PI oversight|0
7740455|NCT00673790|12172767|FG000|Overall Study|Poor compliance|1
7740456|NCT00673790|12172768|FG001|Overall Study|Poor compliance|0
7740457|NCT00673790|12172769|FG002|Overall Study|Poor compliance|0
7740458|NCT00673790|12172767|FG000|Overall Study|Participated in two Nebivolol studies|0
7740459|NCT00673790|12172768|FG001|Overall Study|Participated in two Nebivolol studies|0
7740460|NCT00673790|12172769|FG002|Overall Study|Participated in two Nebivolol studies|1
7740461|NCT00673790|12172767|FG000|Overall Study|Unconfirmed pregnancy|0
7740462|NCT00673790|12172768|FG001|Overall Study|Unconfirmed pregnancy|1
7740463|NCT00673790|12172769|FG002|Overall Study|Unconfirmed pregnancy|0
7740464|NCT00673790|12172767|FG000|Overall Study|Randomization criteria not met|0
7740465|NCT00673790|12172768|FG001|Overall Study|Randomization criteria not met|1
7740466|NCT00673790|12172769|FG002|Overall Study|Randomization criteria not met|0
7740467|NCT00673816|12172778|FG000|Overall Study|Adverse Event|1
7740468|NCT00673816|12172778|FG000|Overall Study|Withdrawal by Subject|1
7740469|NCT00673881|12172790|FG000|Overall Study|Withdrawal by Subject|1
7740470|NCT00673894|12172796|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1
7740471|NCT00673894|12172797|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0
7740472|NCT00673894|12172796|FG000|First Intervention 4 Weeks|Adverse Event|1
7740473|NCT00673894|12172797|FG001|First Intervention 4 Weeks|Adverse Event|0
7740474|NCT00673920|12172811|FG000|Baseline up to Week 48|Withdrew consent|1
7740475|NCT00673920|12172812|FG001|Baseline up to Week 48|Withdrew consent|0
7740476|NCT00673920|12172813|FG002|Baseline up to Week 48|Withdrew consent|2
7740477|NCT00673920|12172814|FG003|Baseline up to Week 48|Withdrew consent|0
7740478|NCT00673920|12172815|FG004|Baseline up to Week 48|Withdrew consent|0
7740479|NCT00673920|12172816|FG005|Baseline up to Week 48|Withdrew consent|0
7740480|NCT00673920|12172817|FG006|Baseline up to Week 48|Withdrew consent|0
7740481|NCT00673920|12172818|FG007|Baseline up to Week 48|Withdrew consent|0
7740482|NCT00673920|12172811|FG000|Baseline up to Week 48|Refused treatment|1
7740483|NCT00673920|12172812|FG001|Baseline up to Week 48|Refused treatment|0
7740484|NCT00673920|12172813|FG002|Baseline up to Week 48|Refused treatment|0
7740485|NCT00673920|12172814|FG003|Baseline up to Week 48|Refused treatment|0
7740486|NCT00673920|12172815|FG004|Baseline up to Week 48|Refused treatment|0
7740487|NCT00673920|12172816|FG005|Baseline up to Week 48|Refused treatment|0
7740488|NCT00673920|12172817|FG006|Baseline up to Week 48|Refused treatment|0
7740489|NCT00673920|12172818|FG007|Baseline up to Week 48|Refused treatment|0
7740490|NCT00673920|12172811|FG000|Baseline up to Week 48|Insufficient therapeutic response|2
7740491|NCT00673920|12172812|FG001|Baseline up to Week 48|Insufficient therapeutic response|1
7740492|NCT00673920|12172813|FG002|Baseline up to Week 48|Insufficient therapeutic response|0
7740493|NCT00673920|12172814|FG003|Baseline up to Week 48|Insufficient therapeutic response|0
7740494|NCT00673920|12172815|FG004|Baseline up to Week 48|Insufficient therapeutic response|0
7740495|NCT00673920|12172816|FG005|Baseline up to Week 48|Insufficient therapeutic response|0
7740496|NCT00673920|12172817|FG006|Baseline up to Week 48|Insufficient therapeutic response|0
7740497|NCT00673920|12172818|FG007|Baseline up to Week 48|Insufficient therapeutic response|0
7740498|NCT00673920|12172811|FG000|Baseline up to Week 48|Protocol Violation|0
7740499|NCT00673920|12172812|FG001|Baseline up to Week 48|Protocol Violation|0
7740500|NCT00673920|12172813|FG002|Baseline up to Week 48|Protocol Violation|1
7740501|NCT00673920|12172814|FG003|Baseline up to Week 48|Protocol Violation|0
7740502|NCT00673920|12172815|FG004|Baseline up to Week 48|Protocol Violation|0
7740503|NCT00673920|12172816|FG005|Baseline up to Week 48|Protocol Violation|0
7740504|NCT00673920|12172817|FG006|Baseline up to Week 48|Protocol Violation|0
7740505|NCT00673920|12172818|FG007|Baseline up to Week 48|Protocol Violation|0
7740506|NCT00673920|12172811|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0
7740507|NCT00673920|12172812|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0
7740508|NCT00673920|12172813|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1
7740509|NCT00673920|12172814|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0
7740510|NCT00673920|12172815|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0
7740511|NCT00673920|12172816|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0
7740512|NCT00673920|12172817|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0
7740513|NCT00673920|12172818|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0
7740514|NCT00673920|12172811|FG000|Baseline up to Week 48|Administrative/Other|0
7740515|NCT00673920|12172812|FG001|Baseline up to Week 48|Administrative/Other|1
7740516|NCT00673920|12172813|FG002|Baseline up to Week 48|Administrative/Other|2
7740517|NCT00673920|12172814|FG003|Baseline up to Week 48|Administrative/Other|0
7740518|NCT00673920|12172815|FG004|Baseline up to Week 48|Administrative/Other|0
7740519|NCT00673920|12172816|FG005|Baseline up to Week 48|Administrative/Other|0
7740520|NCT00673920|12172817|FG006|Baseline up to Week 48|Administrative/Other|0
7740521|NCT00673920|12172818|FG007|Baseline up to Week 48|Administrative/Other|0
7740522|NCT00673920|12172811|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0
7740523|NCT00673920|12172812|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1
7740524|NCT00673920|12172813|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1
7740525|NCT00673920|12172814|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0
7740526|NCT00673920|12172815|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0
7740527|NCT00673920|12172816|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0
7740528|NCT00673920|12172817|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0
7740529|NCT00673920|12172818|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0
7740530|NCT00673920|12172811|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0
7740531|NCT00673920|12172812|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0
7740532|NCT00673920|12172813|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0
7740533|NCT00673920|12172814|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0
7740534|NCT00673920|12172815|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0
7740535|NCT00673920|12172816|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0
7740536|NCT00673920|12172817|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1
7740537|NCT00673920|12172818|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0
7740538|NCT00673920|12172811|FG000|Week 24 to Week 48|Failure to return|0
7740539|NCT00673920|12172812|FG001|Week 24 to Week 48|Failure to return|0
7740540|NCT00673920|12172813|FG002|Week 24 to Week 48|Failure to return|0
7740541|NCT00673920|12172814|FG003|Week 24 to Week 48|Failure to return|0
7740542|NCT00673920|12172815|FG004|Week 24 to Week 48|Failure to return|0
7740543|NCT00673920|12172816|FG005|Week 24 to Week 48|Failure to return|1
7740544|NCT00673920|12172817|FG006|Week 24 to Week 48|Failure to return|0
7740545|NCT00673920|12172818|FG007|Week 24 to Week 48|Failure to return|0
7740546|NCT00673920|12172811|FG000|Week 24 to Week 48|Insufficient therapeutic response|0
7740547|NCT00673920|12172812|FG001|Week 24 to Week 48|Insufficient therapeutic response|0
7740548|NCT00673920|12172813|FG002|Week 24 to Week 48|Insufficient therapeutic response|0
7740549|NCT00673920|12172814|FG003|Week 24 to Week 48|Insufficient therapeutic response|0
7740550|NCT00673920|12172815|FG004|Week 24 to Week 48|Insufficient therapeutic response|0
7740551|NCT00673920|12172816|FG005|Week 24 to Week 48|Insufficient therapeutic response|1
7740552|NCT00673920|12172817|FG006|Week 24 to Week 48|Insufficient therapeutic response|0
7740553|NCT00673920|12172818|FG007|Week 24 to Week 48|Insufficient therapeutic response|0
7740554|NCT00673920|12172811|FG000|Week 24 to Week 48|Death|0
7740555|NCT00673920|12172812|FG001|Week 24 to Week 48|Death|0
7740556|NCT00673920|12172813|FG002|Week 24 to Week 48|Death|0
7740557|NCT00673920|12172814|FG003|Week 24 to Week 48|Death|0
7740558|NCT00673920|12172815|FG004|Week 24 to Week 48|Death|0
7740559|NCT00673920|12172816|FG005|Week 24 to Week 48|Death|1
7740560|NCT00673920|12172817|FG006|Week 24 to Week 48|Death|0
7740561|NCT00673920|12172818|FG007|Week 24 to Week 48|Death|0
7740562|NCT00673920|12172811|FG000|Week 24 to Week 48|Adminstrative/Other|0
7740563|NCT00673920|12172812|FG001|Week 24 to Week 48|Adminstrative/Other|0
7740564|NCT00673920|12172813|FG002|Week 24 to Week 48|Adminstrative/Other|0
7740565|NCT00673920|12172814|FG003|Week 24 to Week 48|Adminstrative/Other|1
7740566|NCT00673920|12172815|FG004|Week 24 to Week 48|Adminstrative/Other|0
7740567|NCT00673920|12172816|FG005|Week 24 to Week 48|Adminstrative/Other|0
7740568|NCT00673920|12172817|FG006|Week 24 to Week 48|Adminstrative/Other|0
7740569|NCT00673920|12172818|FG007|Week 24 to Week 48|Adminstrative/Other|0
7740570|NCT00673933|12172840|FG000|Overall Study|Withdrawal by Subject|2
7740571|NCT00673933|12172840|FG000|Overall Study|Lost to Follow-up|1
7740572|NCT00674128|12172867|FG000|Overall Study|Withdrawal by Subject|25
7740573|NCT00674128|12172868|FG001|Overall Study|Withdrawal by Subject|23
7740574|NCT00674154|12172876|FG000|Overall Study|Withdrawal by Subject|3
7740575|NCT00674154|12172877|FG001|Overall Study|Withdrawal by Subject|1
7740576|NCT00674154|12172876|FG000|Overall Study|Did not want parathyroidectomy|0
7740577|NCT00674154|12172877|FG001|Overall Study|Did not want parathyroidectomy|2
7740578|NCT00674323|12172909|FG000|Overall Study|Adverse Event|0
7740579|NCT00674323|12172910|FG001|Overall Study|Adverse Event|1
7740580|NCT00674323|12172911|FG002|Overall Study|Adverse Event|0
7740581|NCT00674323|12172909|FG000|Overall Study|Protocol Violation|1
7740582|NCT00674323|12172910|FG001|Overall Study|Protocol Violation|0
7740583|NCT00674323|12172911|FG002|Overall Study|Protocol Violation|0
7769074|NCT00866307|12212507|FG002|Induction|Improper post-induction consent|0
7769075|NCT00866307|12212505|FG000|Induction|Study was closed at the time|1
7769076|NCT00866307|12212506|FG001|Induction|Study was closed at the time|0
7769077|NCT00866307|12212507|FG002|Induction|Study was closed at the time|0
7769078|NCT00866307|12212505|FG000|Consolidation/Maintenance|Adverse Event|0
7769079|NCT00866307|12212506|FG001|Consolidation/Maintenance|Adverse Event|0
7769080|NCT00866307|12212507|FG002|Consolidation/Maintenance|Adverse Event|8
7769081|NCT00866307|12212505|FG000|Consolidation/Maintenance|Death|0
7769082|NCT00866307|12212506|FG001|Consolidation/Maintenance|Death|0
7769083|NCT00866307|12212507|FG002|Consolidation/Maintenance|Death|1
7769084|NCT00866307|12212505|FG000|Consolidation/Maintenance|Physician Decision|0
7769085|NCT00866307|12212506|FG001|Consolidation/Maintenance|Physician Decision|3
7740584|NCT00674362|12172921|FG000|Double Blind|Adverse Event|6
7740585|NCT00674362|12172922|FG001|Double Blind|Adverse Event|6
7740586|NCT00674362|12172921|FG000|Double Blind|Lack of Efficacy|2
7740587|NCT00674362|12172922|FG001|Double Blind|Lack of Efficacy|6
7740588|NCT00674362|12172921|FG000|Double Blind|Loss of efficacy|0
7740589|NCT00674362|12172922|FG001|Double Blind|Loss of efficacy|1
7740590|NCT00674362|12172921|FG000|Double Blind|Withdrawal by Subject|4
7740591|NCT00674362|12172922|FG001|Double Blind|Withdrawal by Subject|3
7740592|NCT00674362|12172921|FG000|Double Blind|Other: Loss of Patient Compliance|0
7740593|NCT00674362|12172922|FG001|Double Blind|Other: Loss of Patient Compliance|1
7740594|NCT00674362|12172921|FG000|Double Blind|Other: Surgery|0
7740595|NCT00674362|12172922|FG001|Double Blind|Other: Surgery|1
7740596|NCT00674362|12172921|FG000|Open Label|Adverse Event|1
7740597|NCT00674362|12172922|FG001|Open Label|Adverse Event|0
7740598|NCT00674362|12172921|FG000|Open Label|Other: Subject moved to extension study|1
7740599|NCT00674362|12172922|FG001|Open Label|Other: Subject moved to extension study|0
7740600|NCT00674570|12172953|FG000|Overall Study|Withdrawal by Subject|0
7740601|NCT00674570|12172954|FG001|Overall Study|Withdrawal by Subject|2
7740602|NCT00674570|12172955|FG002|Overall Study|Withdrawal by Subject|0
7740603|NCT00674661|12173004|FG000|Overall Study|Other|5
7740604|NCT00674661|12173005|FG001|Overall Study|Other|7
7740605|NCT00674661|12173004|FG000|Overall Study|Lost to Follow-up|6
7740606|NCT00674661|12173005|FG001|Overall Study|Lost to Follow-up|3
7740607|NCT00674661|12173004|FG000|Overall Study|Withdrawal by Subject|0
7740608|NCT00674661|12173005|FG001|Overall Study|Withdrawal by Subject|5
7740609|NCT00674700|12173014|FG000|Year 1|Adverse Event|17
7740610|NCT00674700|12173015|FG001|Year 1|Adverse Event|20
7740611|NCT00674700|12173016|FG002|Year 1|Adverse Event|5
7740612|NCT00674700|12173014|FG000|Year 1|Withdrawal by Subject|7
7740613|NCT00674700|12173015|FG001|Year 1|Withdrawal by Subject|7
7740614|NCT00674700|12173016|FG002|Year 1|Withdrawal by Subject|6
7740615|NCT00674700|12173014|FG000|Year 1|Any other reason not above-mentioned|7
7740616|NCT00674700|12173015|FG001|Year 1|Any other reason not above-mentioned|7
7740617|NCT00674700|12173016|FG002|Year 1|Any other reason not above-mentioned|6
7740618|NCT00674700|12173014|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0
7740619|NCT00674700|12173015|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1
7740620|NCT00674700|12173016|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1
7740621|NCT00674700|12173014|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
7740622|NCT00674700|12173015|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
7740623|NCT00674700|12173016|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
7740624|NCT00674700|12173014|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
7740625|NCT00674700|12173015|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
7740626|NCT00674700|12173016|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
7740627|NCT00674817|12173046|FG000|Period 1|Withdrawal by Subject|2
7740628|NCT00674817|12173046|FG000|Period 1|Protocol Violation|1
7740629|NCT00674817|12173046|FG000|Period 3|Adverse Event|1
7740630|NCT00674817|12173046|FG000|Period 3|Protocol Violation|1
7740631|NCT00674817|12173046|FG000|Period 4|Adverse Event|1
7740632|NCT00674973|12173062|FG000|Overall Study|Insufficient Therapeutic Response|77
7740633|NCT00674973|12173063|FG001|Overall Study|Insufficient Therapeutic Response|72
7740634|NCT00674973|12173062|FG000|Overall Study|Refused Treatment|1
7740635|NCT00674973|12173063|FG001|Overall Study|Refused Treatment|5
7740636|NCT00674973|12173062|FG000|Overall Study|Failure to Return|1
7740637|NCT00674973|12173063|FG001|Overall Study|Failure to Return|0
7740638|NCT00674973|12173062|FG000|Overall Study|Adverse Event|2
7740639|NCT00674973|12173063|FG001|Overall Study|Adverse Event|9
7740640|NCT00674973|12173062|FG000|Overall Study|Death|19
7740641|NCT00674973|12173063|FG001|Overall Study|Death|15
7740642|NCT00674973|12173062|FG000|Overall Study|Protocol Violation|0
7740643|NCT00674973|12173063|FG001|Overall Study|Protocol Violation|1
7740644|NCT00674986|12173071|FG000|Overall Study|Adverse Event|2
7740645|NCT00674986|12173072|FG001|Overall Study|Adverse Event|1
7740646|NCT00674986|12173071|FG000|Overall Study|Subject withdrew consent|12
7740647|NCT00674986|12173072|FG001|Overall Study|Subject withdrew consent|19
7740648|NCT00674986|12173071|FG000|Overall Study|Lost to Follow-up|25
7740649|NCT00674986|12173072|FG001|Overall Study|Lost to Follow-up|53
7740650|NCT00674986|12173071|FG000|Overall Study|Other reasons|4
7740651|NCT00674986|12173072|FG001|Overall Study|Other reasons|8
7740652|NCT00675025|12173081|FG000|Overall Study|Study Terminated by Sponsor|38
7740653|NCT00675025|12173082|FG001|Overall Study|Study Terminated by Sponsor|42
7740654|NCT00675025|12173081|FG000|Overall Study|Adverse Event|6
7740655|NCT00675025|12173082|FG001|Overall Study|Adverse Event|11
7740656|NCT00675025|12173081|FG000|Overall Study|Lost to Follow-up|6
7740657|NCT00675025|12173082|FG001|Overall Study|Lost to Follow-up|4
7740658|NCT00675025|12173081|FG000|Overall Study|Withdrawal by Subject|4
7740659|NCT00675025|12173082|FG001|Overall Study|Withdrawal by Subject|6
7740660|NCT00675103|12173088|FG000|Overall Study|Lack of Efficacy|2
7740661|NCT00675103|12173088|FG000|Overall Study|Adverse Event|1
7740662|NCT00675428|12173111|FG000|Overall Study|Disease Progression|2
7740663|NCT00675428|12173112|FG001|Overall Study|Disease Progression|2
7740664|NCT00675428|12173111|FG000|Overall Study|No Disease Response After Cycle 6|0
7740665|NCT00675428|12173112|FG001|Overall Study|No Disease Response After Cycle 6|1
7740666|NCT00675428|12173111|FG000|Overall Study|Physician Decision|1
7740667|NCT00675428|12173112|FG001|Overall Study|Physician Decision|0
7740668|NCT00675441|12173118|FG000|Overall Study|Withdrawal by Subject|2
7740669|NCT00675441|12173118|FG000|Overall Study|Death|1
7740670|NCT00675506|12173124|FG000|Overall Study|Lost to Follow-up|1
7740671|NCT00675506|12173125|FG001|Overall Study|Lost to Follow-up|5
7740672|NCT00675506|12173124|FG000|Overall Study|Lost interest|3
7740673|NCT00675506|12173125|FG001|Overall Study|Lost interest|5
7740674|NCT00675506|12173124|FG000|Overall Study|Elevated fasting glucose|2
7740675|NCT00675506|12173125|FG001|Overall Study|Elevated fasting glucose|1
7740676|NCT00675506|12173124|FG000|Overall Study|Elevated IGF-1 prior to treatment|1
7740677|NCT00675506|12173125|FG001|Overall Study|Elevated IGF-1 prior to treatment|0
7740678|NCT00675506|12173124|FG000|Overall Study|Elevated IGF-1|2
7740679|NCT00675506|12173125|FG001|Overall Study|Elevated IGF-1|0
7740680|NCT00675506|12173124|FG000|Overall Study|Hypersensitivity Reaction|1
7740681|NCT00675506|12173125|FG001|Overall Study|Hypersensitivity Reaction|0
7740682|NCT00675506|12173124|FG000|Overall Study|Disclosed history of cancer|1
7740683|NCT00675506|12173125|FG001|Overall Study|Disclosed history of cancer|0
7740684|NCT00675506|12173124|FG000|Overall Study|Declined participation|1
7740685|NCT00675506|12173125|FG001|Overall Study|Declined participation|0
7740686|NCT00675506|12173124|FG000|Overall Study|Schedule conflict|0
7740687|NCT00675506|12173125|FG001|Overall Study|Schedule conflict|1
7740688|NCT00675597|12173154|FG000|Overall Study|Withdrawal by Subject|3
7740689|NCT00675766|12173162|FG000|Overall Study|Lost to Follow-up|6
7740690|NCT00675766|12173163|FG001|Overall Study|Lost to Follow-up|5
7740691|NCT00675766|12173164|FG002|Overall Study|Lost to Follow-up|21
7740692|NCT00675766|12173165|FG003|Overall Study|Lost to Follow-up|26
7740693|NCT00675948|12173204|FG000|Overall Study|Adverse Event|23
7740694|NCT00675948|12173205|FG001|Overall Study|Adverse Event|1
7740695|NCT00675948|12173204|FG000|Overall Study|Lack of Efficacy|3
7740696|NCT00675948|12173205|FG001|Overall Study|Lack of Efficacy|0
7740697|NCT00675948|12173204|FG000|Overall Study|Withdrawal by Subject|7
7740698|NCT00675948|12173205|FG001|Overall Study|Withdrawal by Subject|0
7740699|NCT00675948|12173204|FG000|Overall Study|Lost to Follow-up|2
7740700|NCT00675948|12173205|FG001|Overall Study|Lost to Follow-up|0
7740701|NCT00675948|12173204|FG000|Overall Study|Protocol Violation|1
7740702|NCT00675948|12173205|FG001|Overall Study|Protocol Violation|0
7740703|NCT00675948|12173204|FG000|Overall Study|Pain under control|1
7740704|NCT00675948|12173205|FG001|Overall Study|Pain under control|0
7740705|NCT00675948|12173204|FG000|Overall Study|Sponsor decision|0
7740706|NCT00675948|12173205|FG001|Overall Study|Sponsor decision|1
7740707|NCT00675948|12173204|FG000|Overall Study|Patient died|1
7740708|NCT00675948|12173205|FG001|Overall Study|Patient died|0
7740709|NCT00675948|12173204|FG000|Overall Study|Patient unable to comply with diaries|1
7740710|NCT00675948|12173205|FG001|Overall Study|Patient unable to comply with diaries|0
7740711|NCT00675948|12173204|FG000|Overall Study|Patient feels unable to take medication|0
7740712|NCT00675948|12173205|FG001|Overall Study|Patient feels unable to take medication|1
7740713|NCT00676052|12173236|FG000|Overall Study|Adverse Event|0
7740714|NCT00676052|12173237|FG001|Overall Study|Adverse Event|1
7740715|NCT00676052|12173238|FG002|Overall Study|Adverse Event|1
7740716|NCT00676052|12173239|FG003|Overall Study|Adverse Event|2
7740717|NCT00676052|12173240|FG004|Overall Study|Adverse Event|2
7740718|NCT00676052|12173241|FG005|Overall Study|Adverse Event|2
7740719|NCT00676052|12173236|FG000|Overall Study|Lack of Efficacy|2
7740720|NCT00676052|12173237|FG001|Overall Study|Lack of Efficacy|2
7740721|NCT00676052|12173238|FG002|Overall Study|Lack of Efficacy|1
7740722|NCT00676052|12173239|FG003|Overall Study|Lack of Efficacy|1
7740723|NCT00676052|12173240|FG004|Overall Study|Lack of Efficacy|2
7740724|NCT00676052|12173241|FG005|Overall Study|Lack of Efficacy|1
7740725|NCT00676052|12173236|FG000|Overall Study|Protocol Violation|5
7740726|NCT00676052|12173237|FG001|Overall Study|Protocol Violation|3
7740727|NCT00676052|12173238|FG002|Overall Study|Protocol Violation|2
7740728|NCT00676052|12173239|FG003|Overall Study|Protocol Violation|2
7740729|NCT00676052|12173240|FG004|Overall Study|Protocol Violation|1
7740730|NCT00676052|12173241|FG005|Overall Study|Protocol Violation|2
7740731|NCT00676052|12173236|FG000|Overall Study|Lost to Follow-up|0
7740732|NCT00676052|12173237|FG001|Overall Study|Lost to Follow-up|0
7740733|NCT00676052|12173238|FG002|Overall Study|Lost to Follow-up|0
7740734|NCT00676052|12173239|FG003|Overall Study|Lost to Follow-up|0
7740735|NCT00676052|12173240|FG004|Overall Study|Lost to Follow-up|1
7740736|NCT00676052|12173241|FG005|Overall Study|Lost to Follow-up|0
7740737|NCT00676052|12173236|FG000|Overall Study|Physician Decision|1
7740738|NCT00676052|12173237|FG001|Overall Study|Physician Decision|1
7740739|NCT00676052|12173238|FG002|Overall Study|Physician Decision|1
7740740|NCT00676052|12173239|FG003|Overall Study|Physician Decision|0
7740741|NCT00676052|12173240|FG004|Overall Study|Physician Decision|0
7740742|NCT00676052|12173241|FG005|Overall Study|Physician Decision|1
7740743|NCT00676052|12173236|FG000|Overall Study|Withdrawal by Subject|1
7740744|NCT00676052|12173237|FG001|Overall Study|Withdrawal by Subject|0
7740745|NCT00676052|12173238|FG002|Overall Study|Withdrawal by Subject|1
7740746|NCT00676052|12173239|FG003|Overall Study|Withdrawal by Subject|0
7740747|NCT00676052|12173240|FG004|Overall Study|Withdrawal by Subject|0
7740748|NCT00676052|12173241|FG005|Overall Study|Withdrawal by Subject|0
7740749|NCT00676091|12173270|FG000|Infant Series|Parent or legal guardian request|10
7740750|NCT00676091|12173271|FG001|Infant Series|Parent or legal guardian request|8
7740751|NCT00676091|12173270|FG000|Infant Series|Protocol Violation|6
7740752|NCT00676091|12173271|FG001|Infant Series|Protocol Violation|3
7740753|NCT00676091|12173270|FG000|Infant Series|Adverse Event|2
7740754|NCT00676091|12173271|FG001|Infant Series|Adverse Event|3
7740755|NCT00676091|12173270|FG000|Infant Series|Failed to return|1
7740756|NCT00676091|12173271|FG001|Infant Series|Failed to return|3
7740757|NCT00676091|12173270|FG000|Infant Series|Lost to Follow-up|1
7740758|NCT00676091|12173271|FG001|Infant Series|Lost to Follow-up|0
7740759|NCT00676091|12173270|FG000|Infant Series|Died prior to receiving 7vPnC|0
7740760|NCT00676091|12173271|FG001|Infant Series|Died prior to receiving 7vPnC|1
7740761|NCT00676091|12173270|FG000|After Infant Series|Adverse Event|0
7740762|NCT00676091|12173271|FG001|After Infant Series|Adverse Event|1
7740763|NCT00676091|12173270|FG000|After Infant Series|Protocol Violation|0
7740764|NCT00676091|12173271|FG001|After Infant Series|Protocol Violation|1
7740765|NCT00676091|12173270|FG000|After Infant Series|Failed to return|1
7740766|NCT00676091|12173271|FG001|After Infant Series|Failed to return|1
7740767|NCT00676091|12173270|FG000|Toddler Dose|Failed to return|2
7740768|NCT00676091|12173271|FG001|Toddler Dose|Failed to return|0
7740769|NCT00676091|12173270|FG000|Toddler Dose|Parent or legal guardian request|1
7740770|NCT00676091|12173271|FG001|Toddler Dose|Parent or legal guardian request|0
7740771|NCT00676130|12173283|FG000|Overall Study|Lost to Follow-up|0
7740772|NCT00676130|12173284|FG001|Overall Study|Lost to Follow-up|1
7740773|NCT00676130|12173283|FG000|Overall Study|Found ineligible|3
7740774|NCT00676130|12173284|FG001|Overall Study|Found ineligible|2
7740775|NCT00676130|12173283|FG000|Overall Study|Withdrawal by Subject|0
7740776|NCT00676130|12173284|FG001|Overall Study|Withdrawal by Subject|1
7740777|NCT00676143|12173292|FG000|Overall Study|Adverse Event|34
7740778|NCT00676143|12173293|FG001|Overall Study|Adverse Event|60
7740779|NCT00676143|12173292|FG000|Overall Study|Death|4
7740780|NCT00676143|12173293|FG001|Overall Study|Death|4
7740781|NCT00676143|12173292|FG000|Overall Study|Lack of Efficacy|0
7740782|NCT00676143|12173293|FG001|Overall Study|Lack of Efficacy|6
7740783|NCT00676143|12173292|FG000|Overall Study|Lost to Follow-up|0
7740784|NCT00676143|12173293|FG001|Overall Study|Lost to Follow-up|13
7740785|NCT00676143|12173292|FG000|Overall Study|Physician Decision|5
7740786|NCT00676143|12173293|FG001|Overall Study|Physician Decision|8
7740787|NCT00676143|12173292|FG000|Overall Study|Protocol Violation|4
7740788|NCT00676143|12173293|FG001|Overall Study|Protocol Violation|8
7740789|NCT00676143|12173292|FG000|Overall Study|Withdrawal by Subject|24
7740790|NCT00676143|12173293|FG001|Overall Study|Withdrawal by Subject|42
7740791|NCT00676143|12173292|FG000|Overall Study|Discontinuation of study by sponsor|65
7740792|NCT00676143|12173293|FG001|Overall Study|Discontinuation of study by sponsor|88
7740793|NCT00676143|12173292|FG000|Overall Study|Failed to return|2
7740794|NCT00676143|12173293|FG001|Overall Study|Failed to return|1
7740795|NCT00676143|12173292|FG000|Overall Study|Loss of caregiver|5
7740796|NCT00676143|12173293|FG001|Overall Study|Loss of caregiver|3
7740797|NCT00676143|12173292|FG000|Overall Study|Other|11
7740798|NCT00676143|12173293|FG001|Overall Study|Other|20
7740799|NCT00676143|12173292|FG000|Overall Study|Participant participation unknown|1
7740800|NCT00676143|12173293|FG001|Overall Study|Participant participation unknown|4
7740801|NCT00676143|12173292|FG000|Overall Study|Vasogenic edema recurrence|1
7740802|NCT00676143|12173293|FG001|Overall Study|Vasogenic edema recurrence|3
7740803|NCT00676195|12173312|FG000|Overall Study|Lost to Follow-up|1
7740804|NCT00676195|12173312|FG000|Overall Study|Adverse Event|1
7740805|NCT00676195|12173312|FG000|Overall Study|Physician Decision|1
7740806|NCT00676208|12173319|FG000|Overall Study|Lost to Follow-up|0
7740807|NCT00676208|12173320|FG001|Overall Study|Lost to Follow-up|2
7740808|NCT00676208|12173319|FG000|Overall Study|Incomplete data|2
7740809|NCT00676208|12173320|FG001|Overall Study|Incomplete data|4
7740810|NCT00676338|12173332|FG000|Overall Study|Adverse Event|6
7740811|NCT00676338|12173333|FG001|Overall Study|Adverse Event|6
7740812|NCT00676338|12173334|FG002|Overall Study|Adverse Event|5
7740813|NCT00676338|12173335|FG003|Overall Study|Adverse Event|1
7740814|NCT00676338|12173332|FG000|Overall Study|Lost to Follow-up|4
7740815|NCT00676338|12173333|FG001|Overall Study|Lost to Follow-up|1
7740816|NCT00676338|12173334|FG002|Overall Study|Lost to Follow-up|3
7740817|NCT00676338|12173335|FG003|Overall Study|Lost to Follow-up|4
7740818|NCT00676338|12173332|FG000|Overall Study|Physician Decision|3
7740819|NCT00676338|12173333|FG001|Overall Study|Physician Decision|3
7740820|NCT00676338|12173334|FG002|Overall Study|Physician Decision|2
7740821|NCT00676338|12173335|FG003|Overall Study|Physician Decision|3
7740822|NCT00676338|12173332|FG000|Overall Study|Protocol Violation|5
7740823|NCT00676338|12173333|FG001|Overall Study|Protocol Violation|9
7740824|NCT00676338|12173334|FG002|Overall Study|Protocol Violation|2
7740825|NCT00676338|12173335|FG003|Overall Study|Protocol Violation|5
7740826|NCT00676338|12173332|FG000|Overall Study|Withdrawal by Subject|17
7740827|NCT00676338|12173333|FG001|Overall Study|Withdrawal by Subject|9
7740828|NCT00676338|12173334|FG002|Overall Study|Withdrawal by Subject|12
7740829|NCT00676338|12173335|FG003|Overall Study|Withdrawal by Subject|6
7740830|NCT00676338|12173332|FG000|Overall Study|Entry Criteria Not Met|0
7740831|NCT00676338|12173333|FG001|Overall Study|Entry Criteria Not Met|2
7740832|NCT00676338|12173334|FG002|Overall Study|Entry Criteria Not Met|1
7740833|NCT00676338|12173335|FG003|Overall Study|Entry Criteria Not Met|1
7740834|NCT00676338|12173332|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
7740835|NCT00676338|12173333|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
7740836|NCT00676338|12173334|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
7740837|NCT00676338|12173335|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
7740838|NCT00676403|12173362|FG000|Overall Study|Adverse Event|1
7740839|NCT00676403|12173363|FG001|Overall Study|Adverse Event|2
7740840|NCT00676403|12173364|FG002|Overall Study|Adverse Event|0
7740841|NCT00676403|12173365|FG003|Overall Study|Adverse Event|5
7740842|NCT00676403|12173366|FG004|Overall Study|Adverse Event|1
7740843|NCT00676403|12173367|FG005|Overall Study|Adverse Event|2
7740844|NCT00676403|12173362|FG000|Overall Study|Lost to Follow-up|0
7740845|NCT00676403|12173363|FG001|Overall Study|Lost to Follow-up|0
7740846|NCT00676403|12173364|FG002|Overall Study|Lost to Follow-up|0
7740847|NCT00676403|12173365|FG003|Overall Study|Lost to Follow-up|0
7740848|NCT00676403|12173366|FG004|Overall Study|Lost to Follow-up|0
7740849|NCT00676403|12173367|FG005|Overall Study|Lost to Follow-up|1
7740850|NCT00676403|12173362|FG000|Overall Study|Reason Unspecified|1
7740851|NCT00676403|12173363|FG001|Overall Study|Reason Unspecified|0
7740852|NCT00676403|12173364|FG002|Overall Study|Reason Unspecified|1
7740853|NCT00676403|12173365|FG003|Overall Study|Reason Unspecified|0
7740854|NCT00676403|12173366|FG004|Overall Study|Reason Unspecified|0
7740855|NCT00676403|12173367|FG005|Overall Study|Reason Unspecified|1
7740856|NCT00676403|12173362|FG000|Overall Study|Withdrawal by Subject|0
7740857|NCT00676403|12173363|FG001|Overall Study|Withdrawal by Subject|0
7740858|NCT00676403|12173364|FG002|Overall Study|Withdrawal by Subject|0
7740859|NCT00676403|12173365|FG003|Overall Study|Withdrawal by Subject|0
7740860|NCT00676403|12173366|FG004|Overall Study|Withdrawal by Subject|0
7740861|NCT00676403|12173367|FG005|Overall Study|Withdrawal by Subject|1
7740862|NCT00676520|12173387|FG000|Overall Study|Withdrawal by Subject|163
7740863|NCT00676520|12173387|FG000|Overall Study|Lost to Follow-up|162
7740864|NCT00676520|12173387|FG000|Overall Study|Death|159
7740865|NCT00676520|12173387|FG000|Overall Study|Physician Decision|20
7740866|NCT00676520|12173387|FG000|Overall Study|Ineligible for Randomization to DAPT|209
7740867|NCT00676520|12173387|FG000|Overall Study|Other Reason|18
7740868|NCT00676650|12173416|FG000|Overall Study|Death|45
7740869|NCT00676650|12173417|FG001|Overall Study|Death|14
7740870|NCT00676650|12173416|FG000|Overall Study|Adverse Event|159
7740871|NCT00676650|12173417|FG001|Overall Study|Adverse Event|21
7740872|NCT00676650|12173416|FG000|Overall Study|Global deterioration of health status|66
7740873|NCT00676650|12173417|FG001|Overall Study|Global deterioration of health status|31
7740874|NCT00676650|12173416|FG000|Overall Study|Lost to Follow-up|0
7740875|NCT00676650|12173417|FG001|Overall Study|Lost to Follow-up|1
7740876|NCT00676650|12173416|FG000|Overall Study|Objective progression or relapse|189
7740877|NCT00676650|12173417|FG001|Overall Study|Objective progression or relapse|140
7740878|NCT00676650|12173416|FG000|Overall Study|Other|14
7740879|NCT00676650|12173417|FG001|Overall Study|Other|10
7740880|NCT00676650|12173416|FG000|Overall Study|Protocol Violation|3
7740881|NCT00676650|12173417|FG001|Overall Study|Protocol Violation|1
7740882|NCT00676650|12173416|FG000|Overall Study|Study terminated by sponsor|57
7740883|NCT00676650|12173417|FG001|Overall Study|Study terminated by sponsor|43
7740884|NCT00676650|12173416|FG000|Overall Study|Withdrawal by Subject|48
7740885|NCT00676650|12173417|FG001|Overall Study|Withdrawal by Subject|24
7740886|NCT00676650|12173416|FG000|Overall Study|Randomized but not treated|3
7740887|NCT00676650|12173417|FG001|Overall Study|Randomized but not treated|4
7740888|NCT00676689|12173427|FG000|Overall Study|Screen Failure|2
7740889|NCT00676689|12173427|FG000|Overall Study|Death|2
7740890|NCT00676689|12173427|FG000|Overall Study|Lost to Follow-up|4
7740891|NCT00676689|12173427|FG000|Overall Study|Physician Decision|1
7740892|NCT00676689|12173427|FG000|Overall Study|Withdrawal by Subject|3
7740893|NCT00676689|12173427|FG000|Overall Study|Continuing FU|49
7740894|NCT00677014|12173467|FG000|Overall Study|Lost to Follow-up|20
7740895|NCT00677014|12173468|FG001|Overall Study|Lost to Follow-up|12
7740896|NCT00677014|12173469|FG002|Overall Study|Lost to Follow-up|24
7740897|NCT00677014|12173467|FG000|Overall Study|Death|6
7740898|NCT00677014|12173468|FG001|Overall Study|Death|15
7740899|NCT00677014|12173469|FG002|Overall Study|Death|7
7740900|NCT00677014|12173467|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18
7740901|NCT00677014|12173468|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14
7740902|NCT00677014|12173469|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18
7740903|NCT00677092|12173482|FG000|Overall Study|Adverse Event|1
7740904|NCT00677092|12173482|FG000|Overall Study|Lost to Follow-up|1
7740905|NCT00677092|12173482|FG000|Overall Study|Withdrawal by Subject|3
7740906|NCT00677092|12173482|FG000|Overall Study|Death Prior to Receiving Treatment|1
7740907|NCT00677235|12173489|FG000|Overall Study|Withdrawal by Subject|1
7740908|NCT00677235|12173490|FG001|Overall Study|Withdrawal by Subject|1
7740909|NCT00677235|12173489|FG000|Overall Study|Lost to Follow-up|2
7740910|NCT00677235|12173490|FG001|Overall Study|Lost to Follow-up|1
7740911|NCT00677235|12173489|FG000|Overall Study|Death|37
7740912|NCT00677235|12173490|FG001|Overall Study|Death|36
7740913|NCT00677235|12173489|FG000|Overall Study|Adverse Experience|1
7740914|NCT00677235|12173490|FG001|Overall Study|Adverse Experience|0
7740915|NCT00677352|12173498|FG000|Treatment Phase|Adverse Event|14
7740916|NCT00677352|12173499|FG001|Treatment Phase|Adverse Event|22
7740917|NCT00677352|12173498|FG000|Treatment Phase|Lack of Efficacy|2
7740918|NCT00677352|12173499|FG001|Treatment Phase|Lack of Efficacy|3
7740919|NCT00677352|12173498|FG000|Treatment Phase|Lost to Follow-up|0
7740920|NCT00677352|12173499|FG001|Treatment Phase|Lost to Follow-up|1
7740921|NCT00677352|12173498|FG000|Treatment Phase|Withdrawal by Subject|7
7740922|NCT00677352|12173499|FG001|Treatment Phase|Withdrawal by Subject|7
7740923|NCT00677352|12173498|FG000|Treatment Phase|Physician Decision|1
7740924|NCT00677352|12173499|FG001|Treatment Phase|Physician Decision|0
7740925|NCT00677352|12173498|FG000|Treatment Phase|Pregnancy|0
7740926|NCT00677352|12173499|FG001|Treatment Phase|Pregnancy|1
7740927|NCT00677352|12173498|FG000|Treatment Phase|Protocol Violation|1
7740928|NCT00677352|12173499|FG001|Treatment Phase|Protocol Violation|1
7740929|NCT00677352|12173498|FG000|Treatment Phase|Transference or work related matter|0
7740930|NCT00677352|12173499|FG001|Treatment Phase|Transference or work related matter|5
7740931|NCT00677352|12173498|FG000|Treatment Phase|Not treated|0
7740932|NCT00677352|12173499|FG001|Treatment Phase|Not treated|2
7740933|NCT00677352|12173498|FG000|Tapering Phase|Adverse Event|1
7740934|NCT00677352|12173499|FG001|Tapering Phase|Adverse Event|5
7740935|NCT00677352|12173498|FG000|Tapering Phase|Withdrawal by Subject|5
7740936|NCT00677352|12173499|FG001|Tapering Phase|Withdrawal by Subject|3
7740937|NCT00677352|12173498|FG000|Tapering Phase|Pregnancy|0
7740938|NCT00677352|12173499|FG001|Tapering Phase|Pregnancy|1
7740939|NCT00677352|12173498|FG000|Tapering Phase|Job transfer|0
7740940|NCT00677352|12173499|FG001|Tapering Phase|Job transfer|1
7740941|NCT00677365|12173509|FG000|Overall Study|Adverse Event|2
7740942|NCT00677365|12173510|FG001|Overall Study|Adverse Event|1
7740943|NCT00677365|12173511|FG002|Overall Study|Adverse Event|1
7740944|NCT00677365|12173512|FG003|Overall Study|Adverse Event|2
7740945|NCT00677365|12173509|FG000|Overall Study|Withdrawal by Subject|0
7740946|NCT00677365|12173510|FG001|Overall Study|Withdrawal by Subject|0
7740947|NCT00677365|12173511|FG002|Overall Study|Withdrawal by Subject|1
7740948|NCT00677365|12173512|FG003|Overall Study|Withdrawal by Subject|0
7740949|NCT00677365|12173509|FG000|Overall Study|Other reason|0
7740950|NCT00677365|12173510|FG001|Overall Study|Other reason|0
7740951|NCT00677365|12173511|FG002|Overall Study|Other reason|0
7740952|NCT00677365|12173512|FG003|Overall Study|Other reason|1
7740953|NCT00677534|12173522|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1
7740954|NCT00677534|12173522|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1
7740955|NCT00677534|12173522|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1
7740956|NCT00677807|12173538|FG000|Overall Study|Adverse Event|4
7740957|NCT00677807|12173539|FG001|Overall Study|Adverse Event|1
7740958|NCT00677807|12173540|FG002|Overall Study|Adverse Event|6
7740959|NCT00677807|12173538|FG000|Overall Study|Lack of Efficacy|0
7740960|NCT00677807|12173539|FG001|Overall Study|Lack of Efficacy|0
7740961|NCT00677807|12173540|FG002|Overall Study|Lack of Efficacy|2
7740962|NCT00677807|12173538|FG000|Overall Study|Participant no longer needs study drug|0
7740963|NCT00677807|12173539|FG001|Overall Study|Participant no longer needs study drug|0
7740964|NCT00677807|12173540|FG002|Overall Study|Participant no longer needs study drug|1
7740965|NCT00677807|12173538|FG000|Overall Study|Withdrawal by Subject|10
7740966|NCT00677807|12173539|FG001|Overall Study|Withdrawal by Subject|3
7740967|NCT00677807|12173540|FG002|Overall Study|Withdrawal by Subject|6
7740968|NCT00677807|12173538|FG000|Overall Study|Lost to Follow-up|2
7740969|NCT00677807|12173539|FG001|Overall Study|Lost to Follow-up|2
7740970|NCT00677807|12173540|FG002|Overall Study|Lost to Follow-up|2
7740971|NCT00677807|12173538|FG000|Overall Study|Administrative problems|1
7740972|NCT00677807|12173539|FG001|Overall Study|Administrative problems|1
7740973|NCT00677807|12173540|FG002|Overall Study|Administrative problems|2
7740974|NCT00677807|12173538|FG000|Overall Study|Death|0
7740975|NCT00677807|12173539|FG001|Overall Study|Death|1
7740976|NCT00677807|12173540|FG002|Overall Study|Death|1
7740977|NCT00677807|12173538|FG000|Overall Study|Protocol Deviation|1
7740978|NCT00677807|12173539|FG001|Overall Study|Protocol Deviation|3
7740979|NCT00677807|12173540|FG002|Overall Study|Protocol Deviation|0
7740980|NCT00677820|12173550|FG000|Overall Study|Lost to Follow-up|1
7740981|NCT00677820|12173551|FG001|Overall Study|Lost to Follow-up|0
7740982|NCT00677833|12173561|FG000|Overall Study|Withdrawal by Subject|4
7740983|NCT00677833|12173562|FG001|Overall Study|Withdrawal by Subject|0
7740984|NCT00677833|12173563|FG002|Overall Study|Withdrawal by Subject|1
7740985|NCT00677833|12173564|FG003|Overall Study|Withdrawal by Subject|3
7740986|NCT00677833|12173561|FG000|Overall Study|Lost to Follow-up|0
7740987|NCT00677833|12173562|FG001|Overall Study|Lost to Follow-up|0
7740988|NCT00677833|12173563|FG002|Overall Study|Lost to Follow-up|1
7740989|NCT00677833|12173564|FG003|Overall Study|Lost to Follow-up|0
7740990|NCT00678080|12173596|FG000|Overall Study|Physician Decision|2
7740991|NCT00678080|12173597|FG001|Overall Study|Physician Decision|0
7740992|NCT00678080|12173596|FG000|Overall Study|Lost to Follow-up|1
7740993|NCT00678080|12173597|FG001|Overall Study|Lost to Follow-up|0
7740994|NCT00678080|12173596|FG000|Overall Study|Withdrawal by Subject|0
7740995|NCT00678080|12173597|FG001|Overall Study|Withdrawal by Subject|1
7740996|NCT00678210|12173607|FG000|Overall Study|Adverse Event|1
7740997|NCT00678210|12173608|FG001|Overall Study|Adverse Event|2
7740998|NCT00678210|12173609|FG002|Overall Study|Adverse Event|3
7740999|NCT00678210|12173610|FG003|Overall Study|Adverse Event|3
7741000|NCT00678210|12173607|FG000|Overall Study|Lack of Efficacy|2
7741001|NCT00678210|12173608|FG001|Overall Study|Lack of Efficacy|3
7741002|NCT00678210|12173609|FG002|Overall Study|Lack of Efficacy|1
7741003|NCT00678210|12173610|FG003|Overall Study|Lack of Efficacy|9
7741004|NCT00678210|12173607|FG000|Overall Study|Lost to Follow-up|4
7741005|NCT00678210|12173608|FG001|Overall Study|Lost to Follow-up|2
7741006|NCT00678210|12173609|FG002|Overall Study|Lost to Follow-up|0
7741007|NCT00678210|12173610|FG003|Overall Study|Lost to Follow-up|1
7741008|NCT00678210|12173607|FG000|Overall Study|Withdrawal by Subject|3
7741009|NCT00678210|12173608|FG001|Overall Study|Withdrawal by Subject|4
7741010|NCT00678210|12173609|FG002|Overall Study|Withdrawal by Subject|1
7741011|NCT00678210|12173610|FG003|Overall Study|Withdrawal by Subject|7
7741012|NCT00678210|12173607|FG000|Overall Study|Other|1
7741013|NCT00678210|12173608|FG001|Overall Study|Other|0
7741014|NCT00678210|12173609|FG002|Overall Study|Other|1
7741015|NCT00678210|12173610|FG003|Overall Study|Other|0
7741016|NCT00678301|12173635|FG000|Overall Study|Non-compliance with study procedures|0
7741017|NCT00678301|12173636|FG001|Overall Study|Non-compliance with study procedures|1
7741018|NCT00678301|12173635|FG000|Overall Study|Adverse Event|1
7741019|NCT00678301|12173636|FG001|Overall Study|Adverse Event|0
7741020|NCT00678301|12173635|FG000|Overall Study|Withdrawal by Subject|4
7741021|NCT00678301|12173636|FG001|Overall Study|Withdrawal by Subject|0
7741022|NCT00678301|12173635|FG000|Overall Study|Lost to Follow-up|3
7741023|NCT00678301|12173636|FG001|Overall Study|Lost to Follow-up|1
7741024|NCT00678379|12173645|FG000|Overall Study|Injection performed after tonsillectomy|2
7741025|NCT00678379|12173646|FG001|Overall Study|Injection performed after tonsillectomy|0
7741026|NCT00678379|12173647|FG002|Overall Study|Injection performed after tonsillectomy|1
7741027|NCT00678379|12173645|FG000|Overall Study|Incomplete Data|4
7741028|NCT00678379|12173646|FG001|Overall Study|Incomplete Data|3
7741029|NCT00678379|12173647|FG002|Overall Study|Incomplete Data|3
7741030|NCT00678392|12173657|FG000|Overall Study|Adverse Event|0
7741031|NCT00678392|12173658|FG001|Overall Study|Adverse Event|6
7741032|NCT00678392|12173657|FG000|Overall Study|Death|280
7741033|NCT00678392|12173658|FG001|Overall Study|Death|269
7741034|NCT00678392|12173657|FG000|Overall Study|Lost to Follow-up|15
7741035|NCT00678392|12173658|FG001|Overall Study|Lost to Follow-up|13
7741036|NCT00678392|12173657|FG000|Overall Study|Objective Progression or Relapse|3
7741037|NCT00678392|12173658|FG001|Overall Study|Objective Progression or Relapse|8
7741038|NCT00678392|12173657|FG000|Overall Study|Sponsor's Decision|1
7741039|NCT00678392|12173658|FG001|Overall Study|Sponsor's Decision|2
7741040|NCT00678392|12173657|FG000|Overall Study|Withdrawal by Subject|4
7741041|NCT00678392|12173658|FG001|Overall Study|Withdrawal by Subject|4
7741042|NCT00678392|12173657|FG000|Overall Study|Randomized But Not Treated|2
7741043|NCT00678392|12173658|FG001|Overall Study|Randomized But Not Treated|7
7741044|NCT00678392|12173657|FG000|Overall Study|Other|56
7741045|NCT00678392|12173658|FG001|Overall Study|Other|53
7741046|NCT00678561|12173714|FG000|Overall Study|Adverse Event|0
7741047|NCT00678561|12173715|FG001|Overall Study|Adverse Event|1
7741048|NCT00678561|12173716|FG002|Overall Study|Adverse Event|1
7741049|NCT00678561|12173717|FG003|Overall Study|Adverse Event|0
7741050|NCT00678561|12173718|FG004|Overall Study|Adverse Event|1
7741051|NCT00678561|12173719|FG005|Overall Study|Adverse Event|0
7741052|NCT00678561|12173720|FG006|Overall Study|Adverse Event|0
7741053|NCT00678561|12173721|FG007|Overall Study|Adverse Event|0
7741054|NCT00678561|12173714|FG000|Overall Study|Protocol Violation|0
7741055|NCT00678561|12173715|FG001|Overall Study|Protocol Violation|0
7741056|NCT00678561|12173716|FG002|Overall Study|Protocol Violation|0
7741057|NCT00678561|12173717|FG003|Overall Study|Protocol Violation|0
7741058|NCT00678561|12173718|FG004|Overall Study|Protocol Violation|1
7741059|NCT00678561|12173719|FG005|Overall Study|Protocol Violation|1
7741060|NCT00678561|12173720|FG006|Overall Study|Protocol Violation|0
7741061|NCT00678561|12173721|FG007|Overall Study|Protocol Violation|0
7741062|NCT00678561|12173714|FG000|Overall Study|Withdrawal by Subject|0
7741063|NCT00678561|12173715|FG001|Overall Study|Withdrawal by Subject|0
7741064|NCT00678561|12173716|FG002|Overall Study|Withdrawal by Subject|0
7741065|NCT00678561|12173717|FG003|Overall Study|Withdrawal by Subject|0
7741066|NCT00678561|12173718|FG004|Overall Study|Withdrawal by Subject|0
7741067|NCT00678561|12173719|FG005|Overall Study|Withdrawal by Subject|0
7741068|NCT00678561|12173720|FG006|Overall Study|Withdrawal by Subject|0
7741069|NCT00678561|12173721|FG007|Overall Study|Withdrawal by Subject|1
7741070|NCT00678587|12173748|FG000|Overall Study|Adverse Event|3
7741071|NCT00678587|12173749|FG001|Overall Study|Adverse Event|3
7741072|NCT00678587|12173748|FG000|Overall Study|Lack of Efficacy|1
7741073|NCT00678587|12173749|FG001|Overall Study|Lack of Efficacy|0
7741074|NCT00678587|12173748|FG000|Overall Study|Protocol Violation|2
7741075|NCT00678587|12173749|FG001|Overall Study|Protocol Violation|1
7741076|NCT00678587|12173748|FG000|Overall Study|Study Closed/Terminated|1
7741077|NCT00678587|12173749|FG001|Overall Study|Study Closed/Terminated|0
7741078|NCT00678587|12173748|FG000|Overall Study|Lost to Follow-up|3
7741079|NCT00678587|12173749|FG001|Overall Study|Lost to Follow-up|5
7741080|NCT00678587|12173748|FG000|Overall Study|Investigator Discretion|2
7741081|NCT00678587|12173749|FG001|Overall Study|Investigator Discretion|6
7741082|NCT00678587|12173748|FG000|Overall Study|Withdrew Consent|8
7741083|NCT00678587|12173749|FG001|Overall Study|Withdrew Consent|3
7741084|NCT00678639|12173758|FG000|Overall Study|Lost to Follow-up at 30 days|2
7741085|NCT00678639|12173759|FG001|Overall Study|Lost to Follow-up at 30 days|0
7741086|NCT00678652|12173770|FG000|Overall Study|Protocol Violation|2
7741087|NCT00678652|12173771|FG001|Overall Study|Protocol Violation|0
7741088|NCT00678652|12173772|FG002|Overall Study|Protocol Violation|0
7741089|NCT00678652|12173773|FG003|Overall Study|Protocol Violation|0
7741090|NCT00678652|12173770|FG000|Overall Study|Pregnancy|0
7741091|NCT00678652|12173771|FG001|Overall Study|Pregnancy|0
7741092|NCT00678652|12173772|FG002|Overall Study|Pregnancy|1
7741093|NCT00678652|12173773|FG003|Overall Study|Pregnancy|0
7741094|NCT00678652|12173770|FG000|Overall Study|Relocation|1
7741095|NCT00678652|12173771|FG001|Overall Study|Relocation|0
7741096|NCT00678652|12173772|FG002|Overall Study|Relocation|0
7741097|NCT00678652|12173773|FG003|Overall Study|Relocation|0
7741098|NCT00678691|12173785|FG000|Overall Study|Adverse Event|6
7741099|NCT00678691|12173786|FG001|Overall Study|Adverse Event|4
7741100|NCT00678795|12173794|FG000|Overall Study|Adverse Event|7
7741101|NCT00678795|12173795|FG001|Overall Study|Adverse Event|3
7741102|NCT00678795|12173794|FG000|Overall Study|Withdrawal by Subject|3
7741103|NCT00678795|12173795|FG001|Overall Study|Withdrawal by Subject|0
7741104|NCT00678795|12173794|FG000|Overall Study|Protocol Violation|0
7741105|NCT00678795|12173795|FG001|Overall Study|Protocol Violation|1
7741106|NCT00678795|12173794|FG000|Overall Study|Lost to Follow-up|0
7741107|NCT00678795|12173795|FG001|Overall Study|Lost to Follow-up|1
7741108|NCT00678795|12173794|FG000|Overall Study|Lack of Efficacy|1
7741109|NCT00678795|12173795|FG001|Overall Study|Lack of Efficacy|1
7741110|NCT00678886|12173826|FG000|Overall Study|Withdrawal by Subject|0
7741111|NCT00678886|12173827|FG001|Overall Study|Withdrawal by Subject|0
7741112|NCT00678886|12173828|FG002|Overall Study|Withdrawal by Subject|4
7741113|NCT00678886|12173829|FG003|Overall Study|Withdrawal by Subject|6
7741114|NCT00678886|12173826|FG000|Overall Study|Physician Decision|0
7741115|NCT00678886|12173827|FG001|Overall Study|Physician Decision|0
7741116|NCT00678886|12173828|FG002|Overall Study|Physician Decision|1
7741117|NCT00678886|12173829|FG003|Overall Study|Physician Decision|1
7741118|NCT00678886|12173826|FG000|Overall Study|Lost to Follow-up|0
7741119|NCT00678886|12173827|FG001|Overall Study|Lost to Follow-up|0
7741120|NCT00678886|12173828|FG002|Overall Study|Lost to Follow-up|3
7741121|NCT00678886|12173829|FG003|Overall Study|Lost to Follow-up|2
7741122|NCT00678886|12173826|FG000|Overall Study|Other|0
7741123|NCT00678886|12173827|FG001|Overall Study|Other|0
7741124|NCT00678886|12173828|FG002|Overall Study|Other|1
7741125|NCT00678886|12173829|FG003|Overall Study|Other|0
7741126|NCT00678899|12173838|FG000|Overall Study|Adverse Event|1
7741127|NCT00679029|12173843|FG000|Overall Study|Adverse Event|3
7741128|NCT00679029|12173843|FG000|Overall Study|Withdrawal by Subject|1
7741129|NCT00679029|12173843|FG000|Overall Study|Lost to Follow-up|1
7741130|NCT00679055|12173849|FG000|Overall Study|Adverse Event|0
7741131|NCT00679055|12173850|FG001|Overall Study|Adverse Event|1
7741132|NCT00679055|12173849|FG000|Overall Study|Other|0
7741133|NCT00679055|12173850|FG001|Overall Study|Other|3
7741134|NCT00679055|12173849|FG000|Overall Study|Study Terminated|2
7741135|NCT00679055|12173850|FG001|Overall Study|Study Terminated|1
7741136|NCT00679081|12173856|FG000|Overall Study|Lost to Follow-up|1
7741137|NCT00679172|12173869|FG000|Overall Study|Non-compliance|1
7741138|NCT00679172|12173870|FG001|Overall Study|Non-compliance|1
7741139|NCT00679172|12173871|FG002|Overall Study|Non-compliance|0
7741140|NCT00679172|12173872|FG003|Overall Study|Non-compliance|1
7741141|NCT00679172|12173873|FG004|Overall Study|Non-compliance|0
7741142|NCT00679172|12173869|FG000|Overall Study|Other not specified|0
7741143|NCT00679172|12173870|FG001|Overall Study|Other not specified|0
7741144|NCT00679172|12173871|FG002|Overall Study|Other not specified|1
7741145|NCT00679172|12173872|FG003|Overall Study|Other not specified|0
7741146|NCT00679172|12173873|FG004|Overall Study|Other not specified|0
7741147|NCT00679211|12173888|FG000|Overall Study|Progressive disease|82
7741148|NCT00679211|12173888|FG000|Overall Study|Adverse Event|7
7741149|NCT00679211|12173888|FG000|Overall Study|Withdrawal by Subject|2
7741150|NCT00679211|12173888|FG000|Overall Study|Physician Decision|5
7741151|NCT00679211|12173888|FG000|Overall Study|Refused to undergo protocol procedures|1
7741152|NCT00679211|12173888|FG000|Overall Study|Transferred to extension study TDM4529g|12
7741153|NCT00679211|12173888|FG000|Overall Study|Other|1
7741154|NCT00679263|12173897|FG000|Visit 2/Dose 1|Adverse Event|1
7741155|NCT00679263|12173898|FG001|Visit 2/Dose 1|Adverse Event|0
7741156|NCT00679263|12173899|FG002|Visit 2/Dose 1|Adverse Event|0
7741157|NCT00679263|12173897|FG000|Visit 2/Dose 1|subject not compliance|1
7741158|NCT00679263|12173898|FG001|Visit 2/Dose 1|subject not compliance|1
7741159|NCT00679263|12173899|FG002|Visit 2/Dose 1|subject not compliance|0
7741160|NCT00679289|12173910|FG000|Overall Study|Progressive disease|4
7741161|NCT00679289|12173911|FG001|Overall Study|Progressive disease|5
7741162|NCT00679289|12173912|FG002|Overall Study|Progressive disease|18
7741163|NCT00679289|12173910|FG000|Overall Study|Withdrawal by Subject|0
7741164|NCT00679289|12173911|FG001|Overall Study|Withdrawal by Subject|1
7741165|NCT00679289|12173912|FG002|Overall Study|Withdrawal by Subject|1
7741166|NCT00679289|12173910|FG000|Overall Study|Adverse Event|0
7741167|NCT00679289|12173911|FG001|Overall Study|Adverse Event|0
7741168|NCT00679289|12173912|FG002|Overall Study|Adverse Event|3
7741169|NCT00679289|12173910|FG000|Overall Study|Physician Decision|1
7741170|NCT00679289|12173911|FG001|Overall Study|Physician Decision|0
7741171|NCT00679289|12173912|FG002|Overall Study|Physician Decision|1
7741172|NCT00679302|12173924|FG000|Overall Study|Lost to Follow-up|8
7741173|NCT00679302|12173925|FG001|Overall Study|Lost to Follow-up|4
7741174|NCT00679341|12173933|FG000|Overall Study|Disease progression|42
7741175|NCT00679341|12173934|FG001|Overall Study|Disease progression|36
7741176|NCT00679341|12173933|FG000|Overall Study|Adverse Event|5
7741177|NCT00679341|12173934|FG001|Overall Study|Adverse Event|6
7741178|NCT00679341|12173933|FG000|Overall Study|Subject/guardian decision to discontinue|3
7741179|NCT00679341|12173934|FG001|Overall Study|Subject/guardian decision to discontinue|0
7741180|NCT00679341|12173933|FG000|Overall Study|Death|1
7741181|NCT00679341|12173934|FG001|Overall Study|Death|1
7741182|NCT00679341|12173933|FG000|Overall Study|Other|1
7741183|NCT00679341|12173934|FG001|Overall Study|Other|0
7741184|NCT00679341|12173933|FG000|Overall Study|Physician Decision|1
7741185|NCT00679341|12173934|FG001|Overall Study|Physician Decision|0
7741186|NCT00679341|12173933|FG000|Overall Study|Not treated|0
7741187|NCT00679341|12173934|FG001|Overall Study|Not treated|2
7741188|NCT00679341|12173933|FG000|Overall Study|Physician/patient decision to withdraw|0
7741189|NCT00679341|12173934|FG001|Overall Study|Physician/patient decision to withdraw|6
7741190|NCT00679354|12173941|FG000|Overall Study|Death|3
7741191|NCT00679354|12173941|FG000|Overall Study|Lack of Efficacy|22
7741192|NCT00679354|12173941|FG000|Overall Study|Physician Decision|4
7741193|NCT00679354|12173941|FG000|Overall Study|Ineligible|1
7741194|NCT00679367|12173946|FG000|Overall Study|Adverse Event|7
7741195|NCT00679367|12173946|FG000|Overall Study|inability to swallow oral drugs|1
7741196|NCT00679367|12173946|FG000|Overall Study|Lack of Efficacy|3
7741197|NCT00679367|12173946|FG000|Overall Study|Withdrawal by Subject|1
7741198|NCT00679432|12173972|FG000|Overall Study|Adverse Event|5
7741199|NCT00679432|12173973|FG001|Overall Study|Adverse Event|6
7741200|NCT00679432|12173974|FG002|Overall Study|Adverse Event|10
7741201|NCT00679432|12173975|FG003|Overall Study|Adverse Event|7
7741202|NCT00679432|12173972|FG000|Overall Study|Protocol Violation|1
7741203|NCT00679432|12173973|FG001|Overall Study|Protocol Violation|1
7741204|NCT00679432|12173974|FG002|Overall Study|Protocol Violation|2
7741205|NCT00679432|12173975|FG003|Overall Study|Protocol Violation|1
7741206|NCT00679432|12173972|FG000|Overall Study|Withdrawal by Subject|8
7741207|NCT00679432|12173973|FG001|Overall Study|Withdrawal by Subject|11
7741208|NCT00679432|12173974|FG002|Overall Study|Withdrawal by Subject|10
7741209|NCT00679432|12173975|FG003|Overall Study|Withdrawal by Subject|9
7741210|NCT00679432|12173972|FG000|Overall Study|Lost to Follow-up|1
7741211|NCT00679432|12173973|FG001|Overall Study|Lost to Follow-up|5
7741212|NCT00679432|12173974|FG002|Overall Study|Lost to Follow-up|4
7741213|NCT00679432|12173975|FG003|Overall Study|Lost to Follow-up|2
7741214|NCT00679432|12173972|FG000|Overall Study|Physician Decision|3
7741215|NCT00679432|12173973|FG001|Overall Study|Physician Decision|2
7741216|NCT00679432|12173974|FG002|Overall Study|Physician Decision|2
7741217|NCT00679432|12173975|FG003|Overall Study|Physician Decision|2
7741218|NCT00679432|12173972|FG000|Overall Study|Sponsor decision|1
7741219|NCT00679432|12173973|FG001|Overall Study|Sponsor decision|0
7741220|NCT00679432|12173974|FG002|Overall Study|Sponsor decision|0
7741221|NCT00679432|12173975|FG003|Overall Study|Sponsor decision|0
7741222|NCT00679432|12173972|FG000|Overall Study|Lack of Efficacy|13
7741223|NCT00679432|12173973|FG001|Overall Study|Lack of Efficacy|9
7741224|NCT00679432|12173974|FG002|Overall Study|Lack of Efficacy|14
7741225|NCT00679432|12173975|FG003|Overall Study|Lack of Efficacy|8
7741226|NCT00679432|12173972|FG000|Overall Study|Infectious colitis, normal histology|5
7741227|NCT00679432|12173973|FG001|Overall Study|Infectious colitis, normal histology|4
7741228|NCT00679432|12173974|FG002|Overall Study|Infectious colitis, normal histology|8
7741229|NCT00679432|12173975|FG003|Overall Study|Infectious colitis, normal histology|3
7741230|NCT00679432|12173972|FG000|Overall Study|Randomization error, return to prior Rx|0
7741231|NCT00679432|12173973|FG001|Overall Study|Randomization error, return to prior Rx|0
7741232|NCT00679432|12173974|FG002|Overall Study|Randomization error, return to prior Rx|3
7741233|NCT00679432|12173975|FG003|Overall Study|Randomization error, return to prior Rx|0
7769086|NCT00866307|12212507|FG002|Consolidation/Maintenance|Physician Decision|2
7769087|NCT00866307|12212505|FG000|Consolidation/Maintenance|Withdrawal by Subject|0
7769088|NCT00866307|12212506|FG001|Consolidation/Maintenance|Withdrawal by Subject|1
7769089|NCT00866307|12212507|FG002|Consolidation/Maintenance|Withdrawal by Subject|1
7769090|NCT00866307|12212505|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
7769091|NCT00866307|12212506|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
7769092|NCT00866307|12212507|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
7769093|NCT00866307|12212505|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0
7769094|NCT00866307|12212506|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3
7769095|NCT00866307|12212507|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1
7769096|NCT00866307|12212505|FG000|Consolidation/Maintenance|Therapy error|0
7769097|NCT00866307|12212506|FG001|Consolidation/Maintenance|Therapy error|1
7769098|NCT00866307|12212507|FG002|Consolidation/Maintenance|Therapy error|0
7769099|NCT00866307|12212505|FG000|Consolidation/Maintenance|Non-compliance|0
7769100|NCT00866307|12212506|FG001|Consolidation/Maintenance|Non-compliance|0
7769101|NCT00866307|12212507|FG002|Consolidation/Maintenance|Non-compliance|1
7769102|NCT00866307|12212505|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0
7741234|NCT00679549|12173987|FG000|Overall Study|dropout|2
7741235|NCT00679549|12173988|FG001|Overall Study|dropout|4
7741236|NCT00679549|12173987|FG000|Overall Study|missing outcome echocardiograms|4
7741237|NCT00679549|12173988|FG001|Overall Study|missing outcome echocardiograms|5
7741238|NCT00679627|12173996|FG000|Overall Study|Death|41
7741239|NCT00679627|12173997|FG001|Overall Study|Death|29
7741240|NCT00679627|12173996|FG000|Overall Study|Adverse Event|43
7741241|NCT00679627|12173997|FG001|Overall Study|Adverse Event|53
7741242|NCT00679627|12173996|FG000|Overall Study|Withdrawal by Subject|168
7741243|NCT00679627|12173997|FG001|Overall Study|Withdrawal by Subject|172
7741244|NCT00679627|12173996|FG000|Overall Study|Lost to Follow-up|22
7741245|NCT00679627|12173997|FG001|Overall Study|Lost to Follow-up|26
7741246|NCT00679627|12173996|FG000|Overall Study|Early Study Closure|425
7741247|NCT00679627|12173997|FG001|Overall Study|Early Study Closure|405
7741248|NCT00679913|12174005|FG000|Overall Study|Protocol Violation|18
7741249|NCT00679913|12174006|FG001|Overall Study|Protocol Violation|13
7741250|NCT00679939|12174015|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17
7741251|NCT00679939|12174016|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13
7741252|NCT00679939|12174015|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14
7741253|NCT00679939|12174016|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12
7741254|NCT00679939|12174015|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5
7741255|NCT00679939|12174016|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0
7741256|NCT00679939|12174015|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1
7741257|NCT00679939|12174016|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0
7741258|NCT00679939|12174015|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
7741259|NCT00679939|12174016|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
7741260|NCT00679939|12174015|FG000|24-Week Open-Label (OL) Period|Adverse Event|0
7741261|NCT00679939|12174016|FG001|24-Week Open-Label (OL) Period|Adverse Event|1
7741262|NCT00679939|12174015|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1
7741263|NCT00679939|12174016|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1
7741264|NCT00679939|12174015|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
7741265|NCT00679939|12174016|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
7741266|NCT00679939|12174015|FG000|24-Week Open-Label (OL) Period|Physician Decision|1
7741267|NCT00679939|12174016|FG001|24-Week Open-Label (OL) Period|Physician Decision|0
7741268|NCT00679939|12174015|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
7741269|NCT00679939|12174016|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
7741270|NCT00680017|12174037|FG000|Overall Study|Adverse Event|13
7741271|NCT00680017|12174038|FG001|Overall Study|Adverse Event|7
7741272|NCT00680017|12174037|FG000|Overall Study|Withdrawal by Subject|2
7741273|NCT00680017|12174038|FG001|Overall Study|Withdrawal by Subject|5
7741274|NCT00680017|12174037|FG000|Overall Study|Lost to Follow-up|2
7741275|NCT00680017|12174038|FG001|Overall Study|Lost to Follow-up|0
7741276|NCT00680043|12174047|FG000|Overall Study|Withdrawal by Subject|1
7741277|NCT00680043|12174048|FG001|Overall Study|Withdrawal by Subject|0
7741278|NCT00680043|12174049|FG002|Overall Study|Withdrawal by Subject|0
7741279|NCT00680043|12174047|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0
7741280|NCT00680043|12174048|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1
7741281|NCT00680043|12174049|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0
7741282|NCT00680043|12174047|FG000|Overall Study|Renal Transplant|1
7741283|NCT00680043|12174048|FG001|Overall Study|Renal Transplant|0
7741284|NCT00680043|12174049|FG002|Overall Study|Renal Transplant|4
7741285|NCT00680056|12174059|FG000|First Intervention|Mainly Exacerbation of COPD|1
7741286|NCT00680056|12174060|FG001|First Intervention|Mainly Exacerbation of COPD|2
7741287|NCT00680056|12174059|FG000|Second Intervention|Protocol Violation|3
7741288|NCT00680056|12174060|FG001|Second Intervention|Protocol Violation|1
7741289|NCT00680121|12174069|FG000|Overall Study|Lost to Follow-up|27
7741290|NCT00680121|12174070|FG001|Overall Study|Lost to Follow-up|23
7741291|NCT00680186|12174078|FG000|Overall Study|Adverse Event|47
7741292|NCT00680186|12174079|FG001|Overall Study|Adverse Event|44
7741293|NCT00680186|12174078|FG000|Overall Study|Protocol Violation|31
7741294|NCT00680186|12174079|FG001|Overall Study|Protocol Violation|26
7741295|NCT00680186|12174078|FG000|Overall Study|Lost to Follow-up|11
7741296|NCT00680186|12174079|FG001|Overall Study|Lost to Follow-up|6
7741297|NCT00680186|12174078|FG000|Overall Study|Withdrawal by Subject|32
7741298|NCT00680186|12174079|FG001|Overall Study|Withdrawal by Subject|39
7741299|NCT00680186|12174078|FG000|Overall Study|Other|4
7741300|NCT00680186|12174079|FG001|Overall Study|Other|1
7741301|NCT00680368|12174089|FG000|Overall Study|not supervised, not eligible|15
7741302|NCT00680407|12174098|FG000|Overall Study|Lost to Follow-up|3
7741303|NCT00680407|12174099|FG001|Overall Study|Lost to Follow-up|3
7741304|NCT00680407|12174100|FG002|Overall Study|Lost to Follow-up|1
7741305|NCT00680407|12174098|FG000|Overall Study|Withdrawal by Subject|5
7741306|NCT00680407|12174099|FG001|Overall Study|Withdrawal by Subject|2
7741307|NCT00680407|12174100|FG002|Overall Study|Withdrawal by Subject|2
7741308|NCT00680745|12174143|FG000|Overall Study|Withdrawal by Subject|8
7741309|NCT00680745|12174144|FG001|Overall Study|Withdrawal by Subject|3
7741310|NCT00680745|12174145|FG002|Overall Study|Withdrawal by Subject|2
7741311|NCT00680745|12174146|FG003|Overall Study|Withdrawal by Subject|8
7741312|NCT00680745|12174143|FG000|Overall Study|Lost to Follow-up|0
7741313|NCT00680745|12174144|FG001|Overall Study|Lost to Follow-up|1
7741314|NCT00680745|12174145|FG002|Overall Study|Lost to Follow-up|1
7741315|NCT00680745|12174146|FG003|Overall Study|Lost to Follow-up|0
7741316|NCT00680745|12174143|FG000|Overall Study|Death|1
7741317|NCT00680745|12174144|FG001|Overall Study|Death|0
7741318|NCT00680745|12174145|FG002|Overall Study|Death|1
7741319|NCT00680745|12174146|FG003|Overall Study|Death|0
7741320|NCT00680745|12174143|FG000|Overall Study|Adverse Event|5
7741321|NCT00680745|12174144|FG001|Overall Study|Adverse Event|3
7741322|NCT00680745|12174145|FG002|Overall Study|Adverse Event|3
7741323|NCT00680745|12174146|FG003|Overall Study|Adverse Event|3
7741324|NCT00680745|12174143|FG000|Overall Study|Poor/Non-compliance|0
7741325|NCT00680745|12174144|FG001|Overall Study|Poor/Non-compliance|3
7741326|NCT00680745|12174145|FG002|Overall Study|Poor/Non-compliance|0
7741327|NCT00680745|12174146|FG003|Overall Study|Poor/Non-compliance|0
7741328|NCT00680745|12174143|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
7741329|NCT00680745|12174144|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
7741330|NCT00680745|12174145|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
7741331|NCT00680745|12174146|FG003|Overall Study|Subject No Longer Meets Study Criteria|2
7741332|NCT00680745|12174143|FG000|Overall Study|False Treatment|0
7741333|NCT00680745|12174144|FG001|Overall Study|False Treatment|1
7741334|NCT00680745|12174145|FG002|Overall Study|False Treatment|3
7741335|NCT00680745|12174146|FG003|Overall Study|False Treatment|0
7741336|NCT00680771|12174159|FG000|Overall Study|Withdrawal by Subject|1
7741337|NCT00680771|12174160|FG001|Overall Study|Withdrawal by Subject|0
7741338|NCT00680771|12174159|FG000|Overall Study|Sleep Apnea suspected after PSG|1
7741339|NCT00680771|12174160|FG001|Overall Study|Sleep Apnea suspected after PSG|0
7741340|NCT00680771|12174159|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
7741341|NCT00680771|12174160|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
7741342|NCT00680836|12174198|FG000|Overall Study|Withdrawal by Subject|3
7741343|NCT00680836|12174199|FG001|Overall Study|Withdrawal by Subject|0
7741344|NCT00680836|12174198|FG000|Overall Study|Lost to Follow-up|3
7741345|NCT00680836|12174199|FG001|Overall Study|Lost to Follow-up|1
7741346|NCT00680836|12174198|FG000|Overall Study|Physician Decision|2
7741347|NCT00680836|12174199|FG001|Overall Study|Physician Decision|1
7741348|NCT00680914|12174212|FG000|Overall Study|Consent withdrawal|6
7741349|NCT00680914|12174213|FG001|Overall Study|Consent withdrawal|3
7741350|NCT00680914|12174212|FG000|Overall Study|Lost to Follow-up|4
7741351|NCT00680914|12174213|FG001|Overall Study|Lost to Follow-up|0
7741352|NCT00680914|12174212|FG000|Overall Study|serious adverse event (SAE)|0
7741353|NCT00680914|12174213|FG001|Overall Study|serious adverse event (SAE)|1
7741354|NCT00681109|12174246|FG000|Overall Study|Lost to Follow-up|2
7741355|NCT00681109|12174247|FG001|Overall Study|Lost to Follow-up|6
7741356|NCT00681109|12174248|FG002|Overall Study|Lost to Follow-up|0
7741357|NCT00681187|12174261|FG000|Overall Study|Withdrawal by Subject|1
7741358|NCT00681187|12174262|FG001|Overall Study|Withdrawal by Subject|0
7741359|NCT00681187|12174261|FG000|Overall Study|Death|0
7741360|NCT00681187|12174262|FG001|Overall Study|Death|1
7741361|NCT00681187|12174261|FG000|Overall Study|Adverse Event|0
7741362|NCT00681187|12174262|FG001|Overall Study|Adverse Event|1
7741363|NCT00681564|12174311|FG000|Overall Study|Lost to Follow-up|6
7741364|NCT00681564|12174312|FG001|Overall Study|Lost to Follow-up|6
7741365|NCT00681564|12174311|FG000|Overall Study|Withdrawal by Subject|0
7741366|NCT00681564|12174312|FG001|Overall Study|Withdrawal by Subject|1
7741367|NCT00681564|12174311|FG000|Overall Study|Death|0
7741368|NCT00681564|12174312|FG001|Overall Study|Death|1
7741369|NCT00681590|12174320|FG000|Overall Study|Withdrawal by Subject|2
7741370|NCT00681590|12174321|FG001|Overall Study|Withdrawal by Subject|12
7741371|NCT00681668|12174327|FG000|Overall Study|Protocol Violation|1
7741372|NCT00681668|12174327|FG000|Overall Study|Withdrawal by Subject|1
7741373|NCT00681811|12174333|FG000|Overall Study|Adverse Event|1
7741374|NCT00681811|12174334|FG001|Overall Study|Adverse Event|1
7741375|NCT00681811|12174333|FG000|Overall Study|Withdrawal by Subject|2
7741376|NCT00681811|12174334|FG001|Overall Study|Withdrawal by Subject|2
7741377|NCT00681811|12174333|FG000|Overall Study|Non-compliance|0
7741378|NCT00681811|12174334|FG001|Overall Study|Non-compliance|1
7741379|NCT00681824|12174354|FG000|Overall Study|withdrawn by investigator|0
7741380|NCT00681824|12174355|FG001|Overall Study|withdrawn by investigator|0
7741381|NCT00681824|12174356|FG002|Overall Study|withdrawn by investigator|1
7741382|NCT00681824|12174354|FG000|Overall Study|scheduling conflict|1
7741383|NCT00681824|12174355|FG001|Overall Study|scheduling conflict|0
7741384|NCT00681824|12174356|FG002|Overall Study|scheduling conflict|0
7741385|NCT00681824|12174354|FG000|Overall Study|Death|0
7741386|NCT00681824|12174355|FG001|Overall Study|Death|1
7741387|NCT00681824|12174356|FG002|Overall Study|Death|0
7741388|NCT00681863|12174364|FG000|Overall Study|Adverse Event|1
7741389|NCT00681863|12174364|FG000|Overall Study|Lost to Follow-up|2
7741390|NCT00681863|12174364|FG000|Overall Study|Lack of Efficacy|2
7741391|NCT00681863|12174364|FG000|Overall Study|Other|18
7741392|NCT00682435|12174385|FG000|Overall Study|Insufficient data|5
7741393|NCT00682435|12174385|FG000|Overall Study|Erroneously enrolled twice|2
7741394|NCT00682448|12174391|FG000|Overall Study|Adverse Event|1
7741395|NCT00682448|12174392|FG001|Overall Study|Adverse Event|2
7741396|NCT00682448|12174391|FG000|Overall Study|Lack of Efficacy|1
7741397|NCT00682448|12174392|FG001|Overall Study|Lack of Efficacy|0
7741398|NCT00682448|12174391|FG000|Overall Study|Lost to Follow-up|1
7741399|NCT00682448|12174392|FG001|Overall Study|Lost to Follow-up|3
7741400|NCT00682448|12174391|FG000|Overall Study|Pregnancy|0
7741401|NCT00682448|12174392|FG001|Overall Study|Pregnancy|1
7741402|NCT00682448|12174391|FG000|Overall Study|Withdrawal by Subject|2
7741403|NCT00682448|12174392|FG001|Overall Study|Withdrawal by Subject|0
7741404|NCT00682539|12174401|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
7741405|NCT00682539|12174402|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
7741406|NCT00682539|12174403|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
7741407|NCT00682539|12174401|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
7741408|NCT00682539|12174402|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
7741409|NCT00682539|12174403|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
7741410|NCT00682461|12174427|FG000|Overall Study|Adverse Event|5
7741411|NCT00682461|12174428|FG001|Overall Study|Adverse Event|7
7741412|NCT00682461|12174427|FG000|Overall Study|Lost to Follow-up|8
7741413|NCT00682461|12174428|FG001|Overall Study|Lost to Follow-up|5
7741414|NCT00682461|12174427|FG000|Overall Study|Withdrawal by Subject|12
7741415|NCT00682461|12174428|FG001|Overall Study|Withdrawal by Subject|19
7741416|NCT00682643|12174446|FG000|Overall Study|Adverse Event|12
7741417|NCT00682643|12174447|FG001|Overall Study|Adverse Event|23
7741418|NCT00682643|12174446|FG000|Overall Study|Lack of Efficacy|2
7741419|NCT00682643|12174447|FG001|Overall Study|Lack of Efficacy|0
7741420|NCT00682643|12174446|FG000|Overall Study|Protocol Violation|38
7741421|NCT00682643|12174447|FG001|Overall Study|Protocol Violation|76
7741422|NCT00682643|12174446|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3
7741423|NCT00682643|12174447|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4
7741424|NCT00682643|12174446|FG000|Overall Study|Lost to Follow-up|1
7741425|NCT00682643|12174447|FG001|Overall Study|Lost to Follow-up|6
7741426|NCT00682643|12174446|FG000|Overall Study|Physician Decision|2
7741427|NCT00682643|12174447|FG001|Overall Study|Physician Decision|6
7741428|NCT00682643|12174446|FG000|Overall Study|Withdrawal by Subject|19
7741429|NCT00682643|12174447|FG001|Overall Study|Withdrawal by Subject|53
7741430|NCT00682643|12174446|FG000|Overall Study|Did Not Receive Study Drug|1
7741431|NCT00682643|12174447|FG001|Overall Study|Did Not Receive Study Drug|1
7741432|NCT00682786|12174469|FG000|Overall Study|Withdrawal by Subject|2
7741433|NCT00682786|12174470|FG001|Overall Study|Withdrawal by Subject|2
7741434|NCT00682786|12174469|FG000|Overall Study|Did not receive irinotecan|0
7741435|NCT00682786|12174470|FG001|Overall Study|Did not receive irinotecan|1
7741436|NCT00682890|12174510|FG000|Overall Study|Lost to Follow-up|1
7741437|NCT00682890|12174511|FG001|Overall Study|Lost to Follow-up|1
7741438|NCT00682890|12174510|FG000|Overall Study|subject moved away|0
7741439|NCT00682890|12174511|FG001|Overall Study|subject moved away|1
7741440|NCT00682890|12174510|FG000|Overall Study|heavy menstrual bleeding|1
7741441|NCT00682890|12174511|FG001|Overall Study|heavy menstrual bleeding|0
7741442|NCT00682929|12174520|FG000|Overall Study|Adverse Event|4
7741443|NCT00682929|12174521|FG001|Overall Study|Adverse Event|1
7741444|NCT00682929|12174522|FG002|Overall Study|Adverse Event|1
7741445|NCT00682929|12174520|FG000|Overall Study|Withdrawal by Subject|1
7741446|NCT00682929|12174521|FG001|Overall Study|Withdrawal by Subject|2
7741447|NCT00682929|12174522|FG002|Overall Study|Withdrawal by Subject|1
7741448|NCT00682929|12174520|FG000|Overall Study|dosing compliance < 80%|0
7741449|NCT00682929|12174521|FG001|Overall Study|dosing compliance < 80%|2
7741450|NCT00682929|12174522|FG002|Overall Study|dosing compliance < 80%|0
7741451|NCT00682929|12174520|FG000|Overall Study|lag in DEA renewal|1
7741452|NCT00682929|12174521|FG001|Overall Study|lag in DEA renewal|0
7741453|NCT00682929|12174522|FG002|Overall Study|lag in DEA renewal|0
7741454|NCT00683293|12174558|FG000|Overall Study|Withdrawal by Subject|2
7741455|NCT00683293|12174559|FG001|Overall Study|Withdrawal by Subject|3
7741456|NCT00683384|12174569|FG000|Overall Study|Death|1
7741457|NCT00683384|12174569|FG000|Overall Study|Adverse Event|1
7741458|NCT00683449|12174582|FG000|Overall Study|Lost to Follow-up|0
7741459|NCT00683449|12174583|FG001|Overall Study|Lost to Follow-up|1
7741460|NCT00683449|12174584|FG002|Overall Study|Lost to Follow-up|0
7741461|NCT00683449|12174585|FG003|Overall Study|Lost to Follow-up|0
7741462|NCT00683449|12174586|FG004|Overall Study|Lost to Follow-up|0
7741463|NCT00683475|12174605|FG000|Overall Study|Withdrawal by Subject|1
7741464|NCT00683475|12174606|FG001|Overall Study|Withdrawal by Subject|0
7741465|NCT00683475|12174605|FG000|Overall Study|Never Treated: Adverse Event|2
7741466|NCT00683475|12174606|FG001|Overall Study|Never Treated: Adverse Event|3
7741467|NCT00683475|12174605|FG000|Overall Study|Never Treated: Progressive Disease|1
7741468|NCT00683475|12174606|FG001|Overall Study|Never Treated: Progressive Disease|0
7741469|NCT00683592|12174615|FG000|Overall Study|Adverse Event|12
7741470|NCT00683592|12174616|FG001|Overall Study|Adverse Event|4
7741471|NCT00683592|12174615|FG000|Overall Study|Withdrawal by Subject|11
7741472|NCT00683592|12174616|FG001|Overall Study|Withdrawal by Subject|11
7741473|NCT00683592|12174615|FG000|Overall Study|Lost to Follow-up|17
7741474|NCT00683592|12174616|FG001|Overall Study|Lost to Follow-up|17
7741475|NCT00683592|12174615|FG000|Overall Study|Lack of Efficacy|3
7741476|NCT00683592|12174616|FG001|Overall Study|Lack of Efficacy|7
7741477|NCT00683592|12174615|FG000|Overall Study|Physician Decision|0
7741478|NCT00683592|12174616|FG001|Overall Study|Physician Decision|1
7741479|NCT00683592|12174615|FG000|Overall Study|Non-compliance|3
7741480|NCT00683592|12174616|FG001|Overall Study|Non-compliance|5
7741481|NCT00683592|12174615|FG000|Overall Study|Other|1
7741482|NCT00683592|12174616|FG001|Overall Study|Other|1
7741483|NCT00683618|12174625|FG000|Randomised Treatment Period|Withdrawal by Subject|4
7741484|NCT00683618|12174626|FG001|Randomised Treatment Period|Withdrawal by Subject|1
7741485|NCT00683618|12174627|FG002|Randomised Treatment Period|Withdrawal by Subject|2
7741486|NCT00683618|12174625|FG000|Randomised Treatment Period|Protocol Violation|0
7741487|NCT00683618|12174626|FG001|Randomised Treatment Period|Protocol Violation|1
7741488|NCT00683618|12174627|FG002|Randomised Treatment Period|Protocol Violation|0
7741489|NCT00683618|12174625|FG000|Randomised Treatment Period|Adverse Event|2
7741490|NCT00683618|12174626|FG001|Randomised Treatment Period|Adverse Event|0
7741491|NCT00683618|12174627|FG002|Randomised Treatment Period|Adverse Event|2
7741492|NCT00683618|12174625|FG000|Randomised Treatment Period|Reason not provided|0
7741493|NCT00683618|12174626|FG001|Randomised Treatment Period|Reason not provided|0
7741494|NCT00683618|12174627|FG002|Randomised Treatment Period|Reason not provided|2
7741495|NCT00683618|12174625|FG000|Extension Treatment Period|Withdrawal by Subject|1
7741496|NCT00683618|12174626|FG001|Extension Treatment Period|Withdrawal by Subject|0
7741497|NCT00683618|12174627|FG002|Extension Treatment Period|Withdrawal by Subject|0
7741498|NCT00683618|12174625|FG000|Extension Treatment Period|Adverse Event|1
7741499|NCT00683618|12174626|FG001|Extension Treatment Period|Adverse Event|0
7741500|NCT00683618|12174627|FG002|Extension Treatment Period|Adverse Event|0
7741501|NCT00683618|12174625|FG000|Extension Treatment Period|Protocol Violation|1
7741502|NCT00683618|12174626|FG001|Extension Treatment Period|Protocol Violation|0
7741503|NCT00683618|12174627|FG002|Extension Treatment Period|Protocol Violation|0
7741504|NCT00683644|12174639|FG000|Overall Study|Withdrawal by Subject|4
7741505|NCT00683644|12174640|FG001|Overall Study|Withdrawal by Subject|2
7741506|NCT00683644|12174639|FG000|Overall Study|Lost to Follow-up|1
7741507|NCT00683644|12174640|FG001|Overall Study|Lost to Follow-up|4
7741508|NCT00683644|12174639|FG000|Overall Study|Adverse Event|1
7741509|NCT00683644|12174640|FG001|Overall Study|Adverse Event|2
7741510|NCT00683644|12174639|FG000|Overall Study|Low copper, other health problems,|7
7741511|NCT00683644|12174640|FG001|Overall Study|Low copper, other health problems,|6
7741512|NCT00683657|12174652|FG000|Overall Study|Adverse Event|0
7741513|NCT00683657|12174653|FG001|Overall Study|Adverse Event|1
7741514|NCT00683657|12174652|FG000|Overall Study|Subject Withdrew Consent|1
7741515|NCT00683657|12174653|FG001|Overall Study|Subject Withdrew Consent|0
7741516|NCT00683696|12174661|FG000|Overall Study|Withdrawn due to study closure|337
7741517|NCT00683696|12174662|FG001|Overall Study|Withdrawn due to study closure|338
7741518|NCT00683696|12174661|FG000|Overall Study|Withdrawn prior to study closure|13
7741519|NCT00683696|12174662|FG001|Overall Study|Withdrawn prior to study closure|28
7741520|NCT00683696|12174661|FG000|Overall Study|Lost to Follow-up|5
7741521|NCT00683696|12174662|FG001|Overall Study|Lost to Follow-up|6
7741522|NCT00683696|12174661|FG000|Overall Study|Vital status follow-up only|3
7741523|NCT00683696|12174662|FG001|Overall Study|Vital status follow-up only|3
7741524|NCT00683696|12174661|FG000|Overall Study|Death|46
7741525|NCT00683696|12174662|FG001|Overall Study|Death|30
7741526|NCT00683774|12174671|FG000|Overall Study|Withdrawal by Subject|0
7741527|NCT00683774|12174672|FG001|Overall Study|Withdrawal by Subject|1
7741528|NCT00683774|12174671|FG000|Overall Study|Physician Decision|3
7741529|NCT00683774|12174672|FG001|Overall Study|Physician Decision|0
7741530|NCT00683800|12174680|FG000|Overall Study|Adverse Event|195
7741531|NCT00683800|12174681|FG001|Overall Study|Adverse Event|102
7741532|NCT00683800|12174680|FG000|Overall Study|Death|0
7741533|NCT00683800|12174681|FG001|Overall Study|Death|1
7741534|NCT00683800|12174680|FG000|Overall Study|Lost to Follow-up|57
7741535|NCT00683800|12174681|FG001|Overall Study|Lost to Follow-up|44
7741536|NCT00683800|12174680|FG000|Overall Study|Other|5
7741537|NCT00683800|12174681|FG001|Overall Study|Other|2
7741538|NCT00683800|12174680|FG000|Overall Study|Protocol Violation|13
7741539|NCT00683800|12174681|FG001|Overall Study|Protocol Violation|16
7741540|NCT00683800|12174680|FG000|Overall Study|Withdrawal by Subject|66
7741541|NCT00683800|12174681|FG001|Overall Study|Withdrawal by Subject|64
7741542|NCT00683800|12174680|FG000|Overall Study|Lack of Efficacy|61
7741543|NCT00683800|12174681|FG001|Overall Study|Lack of Efficacy|104
7741544|NCT00683800|12174680|FG000|Overall Study|Randomized, not treated|35
7741545|NCT00683800|12174681|FG001|Overall Study|Randomized, not treated|33
7741546|NCT00683878|12174720|FG000|Overall Study|Lack of Efficacy|3
7741547|NCT00683878|12174721|FG001|Overall Study|Lack of Efficacy|0
7741548|NCT00683878|12174722|FG002|Overall Study|Lack of Efficacy|1
7741549|NCT00683878|12174720|FG000|Overall Study|Adverse Event|4
7741550|NCT00683878|12174721|FG001|Overall Study|Adverse Event|3
7741551|NCT00683878|12174722|FG002|Overall Study|Adverse Event|3
7741552|NCT00683878|12174720|FG000|Overall Study|Withdrawal by Subject|9
7741553|NCT00683878|12174721|FG001|Overall Study|Withdrawal by Subject|8
7741554|NCT00683878|12174722|FG002|Overall Study|Withdrawal by Subject|6
7741555|NCT00683878|12174720|FG000|Overall Study|Death|0
7741556|NCT00683878|12174721|FG001|Overall Study|Death|1
7741557|NCT00683878|12174722|FG002|Overall Study|Death|0
7741558|NCT00683878|12174720|FG000|Overall Study|Lost to Follow-up|4
7741559|NCT00683878|12174721|FG001|Overall Study|Lost to Follow-up|2
7741560|NCT00683878|12174722|FG002|Overall Study|Lost to Follow-up|4
7741561|NCT00683878|12174720|FG000|Overall Study|Non-compliance, not met criteria etc.|3
7741562|NCT00683878|12174721|FG001|Overall Study|Non-compliance, not met criteria etc.|2
7741563|NCT00683878|12174722|FG002|Overall Study|Non-compliance, not met criteria etc.|0
7741564|NCT00683904|12174732|FG000|Dose Level 1|Disease progression|2
7741565|NCT00683904|12174733|FG001|Dose Level 1|Disease progression|0
7741566|NCT00683904|12174732|FG000|Dose Level 1|Adverse Event|1
7741567|NCT00683904|12174733|FG001|Dose Level 1|Adverse Event|0
7741568|NCT00683904|12174732|FG000|Dose Level 2|Adverse Event|0
7741569|NCT00683904|12174733|FG001|Dose Level 2|Adverse Event|2
7741570|NCT00684021|12174763|FG000|Overall Study|MRI Contraindicated|1
7741571|NCT00684021|12174764|FG001|Overall Study|MRI Contraindicated|1
7741572|NCT00684021|12174765|FG002|Overall Study|MRI Contraindicated|1
7741573|NCT00684021|12174766|FG003|Overall Study|MRI Contraindicated|0
7741574|NCT00684021|12174763|FG000|Overall Study|MRI not performed|0
7741575|NCT00684021|12174764|FG001|Overall Study|MRI not performed|1
7741576|NCT00684021|12174765|FG002|Overall Study|MRI not performed|1
7741577|NCT00684021|12174766|FG003|Overall Study|MRI not performed|2
7741578|NCT00684021|12174763|FG000|Overall Study|Death|1
7741579|NCT00684021|12174764|FG001|Overall Study|Death|0
7741580|NCT00684021|12174765|FG002|Overall Study|Death|0
7741581|NCT00684021|12174766|FG003|Overall Study|Death|0
7741582|NCT00684060|12174791|FG000|Overall Study|Lost to Follow-up|1
7741583|NCT00684060|12174792|FG001|Overall Study|Lost to Follow-up|0
7741584|NCT00684060|12174791|FG000|Overall Study|New stenosis identified|1
7741585|NCT00684060|12174792|FG001|Overall Study|New stenosis identified|0
7741586|NCT00684060|12174791|FG000|Overall Study|Unable to collect MRI|1
7741587|NCT00684060|12174792|FG001|Overall Study|Unable to collect MRI|2
7741588|NCT00684060|12174791|FG000|Overall Study|Death|0
7741589|NCT00684060|12174792|FG001|Overall Study|Death|1
7741590|NCT00684073|12174798|FG000|Selection|Selection/non-selection criteria|3
7741591|NCT00684073|12174798|FG000|Selection|Death|1
7741592|NCT00684073|12174798|FG000|Selection|noncompliance|1
7741593|NCT00684073|12174798|FG000|Selection|Lost to Follow-up|1
7741594|NCT00684073|12174798|FG000|Selection|request of the sponsor|1
7741595|NCT00684073|12174798|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
7741596|NCT00684177|12174819|FG000|Overall Study|Adverse Event|4
7741597|NCT00684177|12174820|FG001|Overall Study|Adverse Event|3
7741598|NCT00684177|12174819|FG000|Overall Study|Lack of Efficacy|10
7741599|NCT00684177|12174820|FG001|Overall Study|Lack of Efficacy|15
7741600|NCT00684177|12174819|FG000|Overall Study|Protocol Violation|1
7741601|NCT00684177|12174820|FG001|Overall Study|Protocol Violation|0
7741602|NCT00684177|12174819|FG000|Overall Study|Lost to Follow-up|2
7741603|NCT00684177|12174820|FG001|Overall Study|Lost to Follow-up|1
7741604|NCT00684177|12174819|FG000|Overall Study|Physician Decision|2
7741605|NCT00684177|12174820|FG001|Overall Study|Physician Decision|0
7741606|NCT00684177|12174819|FG000|Overall Study|Withdrawal by Subject|1
7741607|NCT00684177|12174820|FG001|Overall Study|Withdrawal by Subject|2
7741608|NCT00684177|12174819|FG000|Overall Study|Other|1
7741609|NCT00684177|12174820|FG001|Overall Study|Other|2
7741610|NCT00684203|12174832|FG000|Overall Study|Adverse Event|6
7741611|NCT00684203|12174833|FG001|Overall Study|Adverse Event|4
7741612|NCT00684203|12174834|FG002|Overall Study|Adverse Event|8
7741613|NCT00684203|12174835|FG003|Overall Study|Adverse Event|0
7741614|NCT00684203|12174836|FG004|Overall Study|Adverse Event|0
7741615|NCT00684203|12174837|FG005|Overall Study|Adverse Event|0
7741616|NCT00684203|12174832|FG000|Overall Study|Protocol-defined clinical event|3
7741617|NCT00684203|12174833|FG001|Overall Study|Protocol-defined clinical event|1
7741618|NCT00684203|12174834|FG002|Overall Study|Protocol-defined clinical event|0
7741619|NCT00684203|12174835|FG003|Overall Study|Protocol-defined clinical event|0
7741620|NCT00684203|12174836|FG004|Overall Study|Protocol-defined clinical event|0
7741621|NCT00684203|12174837|FG005|Overall Study|Protocol-defined clinical event|0
7741622|NCT00684203|12174832|FG000|Overall Study|Withdrawal by Subject|0
7741623|NCT00684203|12174833|FG001|Overall Study|Withdrawal by Subject|2
7741624|NCT00684203|12174834|FG002|Overall Study|Withdrawal by Subject|1
7741625|NCT00684203|12174835|FG003|Overall Study|Withdrawal by Subject|0
7741626|NCT00684203|12174836|FG004|Overall Study|Withdrawal by Subject|0
7741627|NCT00684203|12174837|FG005|Overall Study|Withdrawal by Subject|0
7741628|NCT00684203|12174832|FG000|Overall Study|Did not meet protocol eligibility|0
7741629|NCT00684203|12174833|FG001|Overall Study|Did not meet protocol eligibility|1
7741630|NCT00684203|12174834|FG002|Overall Study|Did not meet protocol eligibility|0
7741631|NCT00684203|12174835|FG003|Overall Study|Did not meet protocol eligibility|0
7741632|NCT00684203|12174836|FG004|Overall Study|Did not meet protocol eligibility|0
7741633|NCT00684203|12174837|FG005|Overall Study|Did not meet protocol eligibility|0
7741634|NCT00684307|12174867|FG000|Overall Study|Adverse Event|11
7741635|NCT00684307|12174868|FG001|Overall Study|Adverse Event|6
7741636|NCT00684307|12174869|FG002|Overall Study|Adverse Event|15
7741637|NCT00684307|12174870|FG003|Overall Study|Adverse Event|16
7741638|NCT00684307|12174871|FG004|Overall Study|Adverse Event|8
7741639|NCT00684307|12174867|FG000|Overall Study|Development of increasing Liver Function|0
7741640|NCT00684307|12174868|FG001|Overall Study|Development of increasing Liver Function|2
7741641|NCT00684307|12174869|FG002|Overall Study|Development of increasing Liver Function|0
7741642|NCT00684307|12174870|FG003|Overall Study|Development of increasing Liver Function|1
7741643|NCT00684307|12174871|FG004|Overall Study|Development of increasing Liver Function|0
7741644|NCT00684307|12174867|FG000|Overall Study|Fullfillment of exclusion criteria|1
7741645|NCT00684307|12174868|FG001|Overall Study|Fullfillment of exclusion criteria|0
7741646|NCT00684307|12174869|FG002|Overall Study|Fullfillment of exclusion criteria|0
7741647|NCT00684307|12174870|FG003|Overall Study|Fullfillment of exclusion criteria|3
7741648|NCT00684307|12174871|FG004|Overall Study|Fullfillment of exclusion criteria|1
7741649|NCT00684307|12174867|FG000|Overall Study|Incorrect enrolment or randomization|4
7741650|NCT00684307|12174868|FG001|Overall Study|Incorrect enrolment or randomization|0
7741651|NCT00684307|12174869|FG002|Overall Study|Incorrect enrolment or randomization|0
7741652|NCT00684307|12174870|FG003|Overall Study|Incorrect enrolment or randomization|0
7741653|NCT00684307|12174871|FG004|Overall Study|Incorrect enrolment or randomization|0
7741654|NCT00684307|12174867|FG000|Overall Study|Interupted IP for more than 7 days|0
7741655|NCT00684307|12174868|FG001|Overall Study|Interupted IP for more than 7 days|4
7741656|NCT00684307|12174869|FG002|Overall Study|Interupted IP for more than 7 days|1
7741657|NCT00684307|12174870|FG003|Overall Study|Interupted IP for more than 7 days|3
7741658|NCT00684307|12174871|FG004|Overall Study|Interupted IP for more than 7 days|3
7741659|NCT00684307|12174867|FG000|Overall Study|Severe non compliance to protocol|1
7741660|NCT00684307|12174868|FG001|Overall Study|Severe non compliance to protocol|0
7741661|NCT00684307|12174869|FG002|Overall Study|Severe non compliance to protocol|0
7741662|NCT00684307|12174870|FG003|Overall Study|Severe non compliance to protocol|1
7741663|NCT00684307|12174871|FG004|Overall Study|Severe non compliance to protocol|2
7741664|NCT00684307|12174867|FG000|Overall Study|Participant not willing to continue|7
7741665|NCT00684307|12174868|FG001|Overall Study|Participant not willing to continue|10
7741666|NCT00684307|12174869|FG002|Overall Study|Participant not willing to continue|11
7741667|NCT00684307|12174870|FG003|Overall Study|Participant not willing to continue|5
7741668|NCT00684307|12174871|FG004|Overall Study|Participant not willing to continue|8
7741669|NCT00684307|12174867|FG000|Overall Study|Criteria from the CSR|0
7741670|NCT00684307|12174868|FG001|Overall Study|Criteria from the CSR|0
7741671|NCT00684307|12174869|FG002|Overall Study|Criteria from the CSR|1
7741672|NCT00684307|12174870|FG003|Overall Study|Criteria from the CSR|3
7741673|NCT00684307|12174871|FG004|Overall Study|Criteria from the CSR|3
7741674|NCT00684411|12174892|FG000|Overall Study|New Primary Cancer|1
7741675|NCT00684411|12174892|FG000|Overall Study|Disease Progression|10
7741676|NCT00684411|12174892|FG000|Overall Study|Adverse Event|1
7741677|NCT00684424|12174896|FG000|Overall Study|Adverse Event|1
7741678|NCT00684424|12174896|FG000|Overall Study|Lost to Follow-up|2
7741679|NCT00684424|12174896|FG000|Overall Study|Other|2
7741680|NCT00684515|12174904|FG000|Overall Study|Adverse Event|3
7741681|NCT00684515|12174905|FG001|Overall Study|Adverse Event|3
7741682|NCT00684515|12174906|FG002|Overall Study|Adverse Event|1
7741683|NCT00684515|12174904|FG000|Overall Study|Protocol-Defined Clinical Event|1
7741684|NCT00684515|12174905|FG001|Overall Study|Protocol-Defined Clinical Event|0
7741685|NCT00684515|12174906|FG002|Overall Study|Protocol-Defined Clinical Event|0
7741686|NCT00684567|12174933|FG000|Concomitant Radiotherapy Period|Adverse Event|2
7741687|NCT00684567|12174933|FG000|Monotherapy Period|Adverse Event|2
7741688|NCT00684567|12174933|FG000|Monotherapy Period|Death|1
7741689|NCT00684567|12174933|FG000|Monotherapy Period|Progression of primary disease|11
7741690|NCT00684593|12174939|FG000|Overall Study|Adverse Event|0
7741691|NCT00684593|12174940|FG001|Overall Study|Adverse Event|2
7741692|NCT00684645|12174946|FG000|Overall Study|Death|2
7741693|NCT00684645|12174946|FG000|Overall Study|Progressive disease|67
7741694|NCT00684645|12174946|FG000|Overall Study|Adverse Event|27
7741695|NCT00684645|12174946|FG000|Overall Study|Lost to Follow-up|3
7741696|NCT00684645|12174946|FG000|Overall Study|Other|15
7741697|NCT00684671|12174953|FG000|Overall Study|Adverse Event|1
7741698|NCT00684671|12174954|FG001|Overall Study|Adverse Event|0
7741699|NCT00684671|12174955|FG002|Overall Study|Adverse Event|0
7741700|NCT00684671|12174953|FG000|Overall Study|Lost to Follow-up|1
7741701|NCT00684671|12174954|FG001|Overall Study|Lost to Follow-up|0
7741702|NCT00684671|12174955|FG002|Overall Study|Lost to Follow-up|0
7741703|NCT00684671|12174953|FG000|Overall Study|Alcoholic dependance|1
7741704|NCT00684671|12174954|FG001|Overall Study|Alcoholic dependance|0
7741705|NCT00684671|12174955|FG002|Overall Study|Alcoholic dependance|0
7741706|NCT00684762|12174974|FG000|Washout Period of 7 Days|Withdrawal by Subject|2
7741707|NCT00684762|12174975|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
7769103|NCT00866307|12212506|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1
7769104|NCT00866307|12212507|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0
7769105|NCT00866320|12212513|FG000|Overall Study|Withdrawal by Subject|4
7769106|NCT00866320|12212513|FG000|Overall Study|Death|2
7769107|NCT00866333|12212522|FG000|Overall Study|Withdrawal of consent|0
7769108|NCT00866333|12212523|FG001|Overall Study|Withdrawal of consent|1
7769109|NCT00866333|12212524|FG002|Overall Study|Withdrawal of consent|2
7769110|NCT00866333|12212522|FG000|Overall Study|Reason not Specified|3
7769111|NCT00866333|12212523|FG001|Overall Study|Reason not Specified|1
7769112|NCT00866333|12212524|FG002|Overall Study|Reason not Specified|1
7769113|NCT00866333|12212522|FG000|Overall Study|Study Terminated by Sponsor|2
7769114|NCT00866333|12212523|FG001|Overall Study|Study Terminated by Sponsor|5
7769115|NCT00866333|12212524|FG002|Overall Study|Study Terminated by Sponsor|9
7769116|NCT00866359|12212534|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5
7741708|NCT00684814|12175013|FG000|Washout Period of 7 Days|Adverse Event|1
7741709|NCT00684814|12175014|FG001|Washout Period of 7 Days|Adverse Event|2
7741710|NCT00684814|12175013|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
7741711|NCT00684814|12175014|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
7741712|NCT00684814|12175013|FG000|Second Intervention|Adverse Event|1
7741713|NCT00684814|12175014|FG001|Second Intervention|Adverse Event|0
7741714|NCT00684996|12175031|FG000|Overall Study|Adverse Event|1
7741715|NCT00684996|12175031|FG000|Overall Study|Refusal unrelated to adverse event|1
7741716|NCT00684996|12175031|FG000|Overall Study|Progression/relapse|2
7741717|NCT00684996|12175031|FG000|Overall Study|Other reasons not protocol specified|1
7741718|NCT00685035|12175038|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
7741719|NCT00685035|12175039|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
7741720|NCT00685165|12175070|FG000|Washout Period of 14 Days|Adverse Event|1
7741721|NCT00685165|12175071|FG001|Washout Period of 14 Days|Adverse Event|0
7741722|NCT00685178|12175081|FG000|Overall Study|Adverse Event|1
7741723|NCT00685178|12175082|FG001|Overall Study|Adverse Event|5
7741724|NCT00685178|12175083|FG002|Overall Study|Adverse Event|2
7741725|NCT00685178|12175084|FG003|Overall Study|Adverse Event|4
7741726|NCT00685178|12175081|FG000|Overall Study|missed 3 consecutive methadone clin days|7
7741727|NCT00685178|12175082|FG001|Overall Study|missed 3 consecutive methadone clin days|5
7741728|NCT00685178|12175083|FG002|Overall Study|missed 3 consecutive methadone clin days|2
7741729|NCT00685178|12175084|FG003|Overall Study|missed 3 consecutive methadone clin days|6
7741730|NCT00685178|12175081|FG000|Overall Study|voluntary study discharge|4
7741731|NCT00685178|12175082|FG001|Overall Study|voluntary study discharge|5
7741732|NCT00685178|12175083|FG002|Overall Study|voluntary study discharge|1
7741733|NCT00685178|12175084|FG003|Overall Study|voluntary study discharge|1
7741734|NCT00685178|12175081|FG000|Overall Study|incarcerated|1
7741735|NCT00685178|12175082|FG001|Overall Study|incarcerated|3
7741736|NCT00685178|12175083|FG002|Overall Study|incarcerated|7
7741737|NCT00685178|12175084|FG003|Overall Study|incarcerated|0
7741738|NCT00685178|12175081|FG000|Overall Study|administrative (disciplinary) discharge|0
7741739|NCT00685178|12175082|FG001|Overall Study|administrative (disciplinary) discharge|1
7741740|NCT00685178|12175083|FG002|Overall Study|administrative (disciplinary) discharge|0
7741741|NCT00685178|12175084|FG003|Overall Study|administrative (disciplinary) discharge|2
7741742|NCT00685178|12175081|FG000|Overall Study|Pregnancy|0
7741743|NCT00685178|12175082|FG001|Overall Study|Pregnancy|0
7741744|NCT00685178|12175083|FG002|Overall Study|Pregnancy|0
7741745|NCT00685178|12175084|FG003|Overall Study|Pregnancy|1
7741746|NCT00685334|12175107|FG000|Overall Study|Withdrawal by Subject|5
7741747|NCT00685334|12175108|FG001|Overall Study|Withdrawal by Subject|6
7741748|NCT00685334|12175107|FG000|Overall Study|Lost to Follow-up|4
7741749|NCT00685334|12175108|FG001|Overall Study|Lost to Follow-up|0
7741750|NCT00685334|12175107|FG000|Overall Study|Chose to enter hospital|1
7741751|NCT00685334|12175108|FG001|Overall Study|Chose to enter hospital|1
7741752|NCT00685373|12175114|FG000|Overall Study|Adverse Event|3
7741753|NCT00685373|12175114|FG000|Overall Study|Withdrawal by Subject|5
7741754|NCT00685373|12175114|FG000|Overall Study|Lack of Efficacy|3
7741755|NCT00685373|12175114|FG000|Overall Study|Condition no longer requires study drug|1
7741756|NCT00685373|12175114|FG000|Overall Study|Lost to Follow-up|2
7741757|NCT00685373|12175114|FG000|Overall Study|Protocol Violation|1
7741758|NCT00685399|12175125|FG000|Treatment Period 1|Withdrawal by Subject|2
7741759|NCT00685399|12175126|FG001|Treatment Period 1|Withdrawal by Subject|0
7741760|NCT00685399|12175127|FG002|Treatment Period 1|Withdrawal by Subject|0
7741761|NCT00685399|12175128|FG003|Treatment Period 1|Withdrawal by Subject|0
7741762|NCT00685399|12175129|FG004|Treatment Period 1|Withdrawal by Subject|0
7741763|NCT00685399|12175130|FG005|Treatment Period 1|Withdrawal by Subject|0
7741764|NCT00685399|12175131|FG006|Treatment Period 1|Withdrawal by Subject|0
7741765|NCT00685399|12175132|FG007|Treatment Period 1|Withdrawal by Subject|0
7741766|NCT00685399|12175125|FG000|Treatment Period 1|Protocol Violation|1
7741767|NCT00685399|12175126|FG001|Treatment Period 1|Protocol Violation|0
7741768|NCT00685399|12175127|FG002|Treatment Period 1|Protocol Violation|0
7741769|NCT00685399|12175128|FG003|Treatment Period 1|Protocol Violation|0
7741770|NCT00685399|12175129|FG004|Treatment Period 1|Protocol Violation|0
7741771|NCT00685399|12175130|FG005|Treatment Period 1|Protocol Violation|0
7741772|NCT00685399|12175131|FG006|Treatment Period 1|Protocol Violation|0
7741773|NCT00685399|12175132|FG007|Treatment Period 1|Protocol Violation|0
7741774|NCT00685399|12175125|FG000|Treatment Period 1|Administrative|2
7741775|NCT00685399|12175126|FG001|Treatment Period 1|Administrative|0
7741776|NCT00685399|12175127|FG002|Treatment Period 1|Administrative|0
7741777|NCT00685399|12175128|FG003|Treatment Period 1|Administrative|0
7741778|NCT00685399|12175129|FG004|Treatment Period 1|Administrative|0
7741779|NCT00685399|12175130|FG005|Treatment Period 1|Administrative|0
7741780|NCT00685399|12175131|FG006|Treatment Period 1|Administrative|0
7741781|NCT00685399|12175132|FG007|Treatment Period 1|Administrative|0
7741782|NCT00685399|12175125|FG000|Treatment Period 1|Lack of Efficacy|1
7741783|NCT00685399|12175126|FG001|Treatment Period 1|Lack of Efficacy|0
7741784|NCT00685399|12175127|FG002|Treatment Period 1|Lack of Efficacy|0
7741785|NCT00685399|12175128|FG003|Treatment Period 1|Lack of Efficacy|0
7741786|NCT00685399|12175129|FG004|Treatment Period 1|Lack of Efficacy|0
7741787|NCT00685399|12175130|FG005|Treatment Period 1|Lack of Efficacy|0
7741788|NCT00685399|12175131|FG006|Treatment Period 1|Lack of Efficacy|0
7741789|NCT00685399|12175132|FG007|Treatment Period 1|Lack of Efficacy|0
7741790|NCT00685399|12175125|FG000|Treatment Period 2|Administrative Problems|0
7741791|NCT00685399|12175126|FG001|Treatment Period 2|Administrative Problems|2
7741792|NCT00685399|12175127|FG002|Treatment Period 2|Administrative Problems|1
7741793|NCT00685399|12175128|FG003|Treatment Period 2|Administrative Problems|0
7741794|NCT00685399|12175129|FG004|Treatment Period 2|Administrative Problems|0
7741795|NCT00685399|12175130|FG005|Treatment Period 2|Administrative Problems|0
7741796|NCT00685399|12175131|FG006|Treatment Period 2|Administrative Problems|0
7741797|NCT00685399|12175132|FG007|Treatment Period 2|Administrative Problems|0
7741798|NCT00685399|12175125|FG000|Treatment Period 2|Withdrawal by Subject|0
7741799|NCT00685399|12175126|FG001|Treatment Period 2|Withdrawal by Subject|0
7741800|NCT00685399|12175127|FG002|Treatment Period 2|Withdrawal by Subject|0
7741801|NCT00685399|12175128|FG003|Treatment Period 2|Withdrawal by Subject|0
7741802|NCT00685399|12175129|FG004|Treatment Period 2|Withdrawal by Subject|0
7741803|NCT00685399|12175130|FG005|Treatment Period 2|Withdrawal by Subject|0
7741804|NCT00685399|12175131|FG006|Treatment Period 2|Withdrawal by Subject|0
7741805|NCT00685399|12175132|FG007|Treatment Period 2|Withdrawal by Subject|2
7741806|NCT00685399|12175125|FG000|Treatment Period 2|Adverse Event|0
7741807|NCT00685399|12175126|FG001|Treatment Period 2|Adverse Event|0
7741808|NCT00685399|12175127|FG002|Treatment Period 2|Adverse Event|0
7741809|NCT00685399|12175128|FG003|Treatment Period 2|Adverse Event|0
7741810|NCT00685399|12175129|FG004|Treatment Period 2|Adverse Event|0
7741811|NCT00685399|12175130|FG005|Treatment Period 2|Adverse Event|1
7741812|NCT00685399|12175131|FG006|Treatment Period 2|Adverse Event|0
7741813|NCT00685399|12175132|FG007|Treatment Period 2|Adverse Event|0
7741814|NCT00685399|12175125|FG000|Treatment Period 2|Lack of Efficacy|0
7741815|NCT00685399|12175126|FG001|Treatment Period 2|Lack of Efficacy|10
7741816|NCT00685399|12175127|FG002|Treatment Period 2|Lack of Efficacy|2
7741817|NCT00685399|12175128|FG003|Treatment Period 2|Lack of Efficacy|0
7741818|NCT00685399|12175129|FG004|Treatment Period 2|Lack of Efficacy|0
7741819|NCT00685399|12175130|FG005|Treatment Period 2|Lack of Efficacy|1
7741820|NCT00685399|12175131|FG006|Treatment Period 2|Lack of Efficacy|0
7741821|NCT00685399|12175132|FG007|Treatment Period 2|Lack of Efficacy|0
7741822|NCT00685399|12175125|FG000|Extension|Administrative Issues|0
7741823|NCT00685399|12175126|FG001|Extension|Administrative Issues|0
7741824|NCT00685399|12175127|FG002|Extension|Administrative Issues|0
7741825|NCT00685399|12175128|FG003|Extension|Administrative Issues|1
7741826|NCT00685399|12175129|FG004|Extension|Administrative Issues|0
7741827|NCT00685399|12175130|FG005|Extension|Administrative Issues|0
7741828|NCT00685399|12175131|FG006|Extension|Administrative Issues|0
7741829|NCT00685399|12175132|FG007|Extension|Administrative Issues|0
7741830|NCT00685399|12175125|FG000|Extension|Withdrawal by Subject|0
7741831|NCT00685399|12175126|FG001|Extension|Withdrawal by Subject|0
7741832|NCT00685399|12175127|FG002|Extension|Withdrawal by Subject|0
7741833|NCT00685399|12175128|FG003|Extension|Withdrawal by Subject|1
7741834|NCT00685399|12175129|FG004|Extension|Withdrawal by Subject|0
7741835|NCT00685399|12175130|FG005|Extension|Withdrawal by Subject|0
7741836|NCT00685399|12175131|FG006|Extension|Withdrawal by Subject|0
7741837|NCT00685399|12175132|FG007|Extension|Withdrawal by Subject|0
7741838|NCT00685399|12175125|FG000|Extension|Protocol Violation|0
7741839|NCT00685399|12175126|FG001|Extension|Protocol Violation|0
7741840|NCT00685399|12175127|FG002|Extension|Protocol Violation|0
7741841|NCT00685399|12175128|FG003|Extension|Protocol Violation|1
7741842|NCT00685399|12175129|FG004|Extension|Protocol Violation|0
7741843|NCT00685399|12175130|FG005|Extension|Protocol Violation|0
7741844|NCT00685399|12175131|FG006|Extension|Protocol Violation|0
7741845|NCT00685399|12175132|FG007|Extension|Protocol Violation|0
7741846|NCT00685399|12175125|FG000|Extension|Lack of Efficacy|0
7741847|NCT00685399|12175126|FG001|Extension|Lack of Efficacy|0
7741848|NCT00685399|12175127|FG002|Extension|Lack of Efficacy|0
7741849|NCT00685399|12175128|FG003|Extension|Lack of Efficacy|2
7741850|NCT00685399|12175129|FG004|Extension|Lack of Efficacy|0
7741851|NCT00685399|12175130|FG005|Extension|Lack of Efficacy|0
7741852|NCT00685399|12175131|FG006|Extension|Lack of Efficacy|0
7741853|NCT00685399|12175132|FG007|Extension|Lack of Efficacy|0
7741854|NCT00685399|12175125|FG000|Extension|Adverse Event|0
7741855|NCT00685399|12175126|FG001|Extension|Adverse Event|0
7741856|NCT00685399|12175127|FG002|Extension|Adverse Event|0
7741857|NCT00685399|12175128|FG003|Extension|Adverse Event|2
7741858|NCT00685399|12175129|FG004|Extension|Adverse Event|0
7741859|NCT00685399|12175130|FG005|Extension|Adverse Event|0
7741860|NCT00685399|12175131|FG006|Extension|Adverse Event|0
7741861|NCT00685399|12175132|FG007|Extension|Adverse Event|0
7741862|NCT00685685|12175202|FG000|Washout Period of 7 Days|Adverse Event|2
7741863|NCT00685685|12175203|FG001|Washout Period of 7 Days|Adverse Event|0
7741864|NCT00685685|12175202|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
7741865|NCT00685685|12175203|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7741866|NCT00685698|12175209|FG000|Overall Study|Withdrawal by Subject|1
7741867|NCT00685698|12175209|FG000|Overall Study|Protocol Violation|6
7741868|NCT00685698|12175209|FG000|Overall Study|Adverse Event|3
7741869|NCT00685698|12175209|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1
7741870|NCT00685698|12175209|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1
7741871|NCT00685698|12175209|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
7741872|NCT00685750|12175232|FG000|Overall Study|Tumor sampling failure|0
7741873|NCT00685750|12175233|FG001|Overall Study|Tumor sampling failure|0
7741874|NCT00685750|12175234|FG002|Overall Study|Tumor sampling failure|1
7741875|NCT00685750|12175235|FG003|Overall Study|Tumor sampling failure|0
7741876|NCT00685750|12175236|FG004|Overall Study|Tumor sampling failure|0
7741877|NCT00685750|12175237|FG005|Overall Study|Tumor sampling failure|0
7741878|NCT00685750|12175238|FG006|Overall Study|Tumor sampling failure|0
7741879|NCT00685750|12175232|FG000|Overall Study|Patient didn't receive the treatment|0
7741880|NCT00685750|12175233|FG001|Overall Study|Patient didn't receive the treatment|0
7741881|NCT00685750|12175234|FG002|Overall Study|Patient didn't receive the treatment|0
7741882|NCT00685750|12175235|FG003|Overall Study|Patient didn't receive the treatment|0
7741883|NCT00685750|12175236|FG004|Overall Study|Patient didn't receive the treatment|0
7741884|NCT00685750|12175237|FG005|Overall Study|Patient didn't receive the treatment|0
7741885|NCT00685750|12175238|FG006|Overall Study|Patient didn't receive the treatment|1
7741886|NCT00685750|12175232|FG000|Overall Study|Eligibility criteria not fulfilled|0
7741887|NCT00685750|12175233|FG001|Overall Study|Eligibility criteria not fulfilled|0
7741888|NCT00685750|12175234|FG002|Overall Study|Eligibility criteria not fulfilled|1
7741889|NCT00685750|12175235|FG003|Overall Study|Eligibility criteria not fulfilled|0
7741890|NCT00685750|12175236|FG004|Overall Study|Eligibility criteria not fulfilled|0
7741891|NCT00685750|12175237|FG005|Overall Study|Eligibility criteria not fulfilled|0
7741892|NCT00685750|12175238|FG006|Overall Study|Eligibility criteria not fulfilled|0
7741893|NCT00685763|12175258|FG000|Overall Study|Intercurrent death-incomplete treatment|1
7741894|NCT00685763|12175258|FG000|Overall Study|Protocol Violation|1
7741895|NCT00685802|12175262|FG000|Washout Period of 7 Days|Protocol Violation|2
7741896|NCT00685802|12175263|FG001|Washout Period of 7 Days|Protocol Violation|0
7741897|NCT00685802|12175262|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
7741898|NCT00685802|12175263|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7741899|NCT00685945|12175278|FG000|L-NMMA + Bradykinin|Physician Decision|1
7741900|NCT00686075|12175298|FG000|Overall Study|Withdrawal by Subject|4
7741901|NCT00686075|12175299|FG001|Overall Study|Withdrawal by Subject|3
7741902|NCT00686075|12175300|FG002|Overall Study|Withdrawal by Subject|3
7741903|NCT00686075|12175301|FG003|Overall Study|Withdrawal by Subject|7
7741904|NCT00686075|12175302|FG004|Overall Study|Withdrawal by Subject|1
7741905|NCT00686075|12175303|FG005|Overall Study|Withdrawal by Subject|0
7741906|NCT00686075|12175304|FG006|Overall Study|Withdrawal by Subject|0
7741907|NCT00686075|12175305|FG007|Overall Study|Withdrawal by Subject|2
7741908|NCT00686075|12175306|FG008|Overall Study|Withdrawal by Subject|4
7741909|NCT00686075|12175307|FG009|Overall Study|Withdrawal by Subject|6
7741910|NCT00686075|12175298|FG000|Overall Study|Lost to Follow-up|3
7741911|NCT00686075|12175299|FG001|Overall Study|Lost to Follow-up|6
7741912|NCT00686075|12175300|FG002|Overall Study|Lost to Follow-up|3
7741913|NCT00686075|12175301|FG003|Overall Study|Lost to Follow-up|2
7741914|NCT00686075|12175302|FG004|Overall Study|Lost to Follow-up|3
7741915|NCT00686075|12175303|FG005|Overall Study|Lost to Follow-up|3
7741916|NCT00686075|12175304|FG006|Overall Study|Lost to Follow-up|0
7741917|NCT00686075|12175305|FG007|Overall Study|Lost to Follow-up|0
7741918|NCT00686075|12175306|FG008|Overall Study|Lost to Follow-up|2
7741919|NCT00686075|12175307|FG009|Overall Study|Lost to Follow-up|3
7741920|NCT00686075|12175298|FG000|Overall Study|Other|1
7741921|NCT00686075|12175299|FG001|Overall Study|Other|1
7741922|NCT00686075|12175300|FG002|Overall Study|Other|0
7741923|NCT00686075|12175301|FG003|Overall Study|Other|0
7741924|NCT00686075|12175302|FG004|Overall Study|Other|0
7741925|NCT00686075|12175303|FG005|Overall Study|Other|0
7741926|NCT00686075|12175304|FG006|Overall Study|Other|0
7741927|NCT00686075|12175305|FG007|Overall Study|Other|0
7741928|NCT00686075|12175306|FG008|Overall Study|Other|0
7741929|NCT00686075|12175307|FG009|Overall Study|Other|1
7741930|NCT00686127|12175331|FG000|Overall Study|Withdrawal by Subject|14
7741931|NCT00686127|12175332|FG001|Overall Study|Withdrawal by Subject|6
7741932|NCT00686166|12175338|FG000|Overall Study|Adverse Event|7
7741933|NCT00686166|12175338|FG000|Overall Study|Withdrawal by Subject|1
7741934|NCT00686166|12175338|FG000|Overall Study|Progression/Relapse|1
7741935|NCT00686166|12175338|FG000|Overall Study|Death|1
7741936|NCT00686166|12175338|FG000|Overall Study|Not Protocol Specified|1
7741937|NCT00686166|12175338|FG000|Overall Study|Ineligible|5
7741938|NCT00686166|12175338|FG000|Overall Study|Did not begin protocol therapy|4
7741939|NCT00686205|12175349|FG000|Overall Study|Protocol Violation|127
7741940|NCT00686205|12175350|FG001|Overall Study|Protocol Violation|0
7741941|NCT00686205|12175349|FG000|Overall Study|Withdrawal by Subject|2
7741942|NCT00686205|12175350|FG001|Overall Study|Withdrawal by Subject|0
7741943|NCT00686205|12175349|FG000|Overall Study|Specimen handling procedure altered|5878
7741944|NCT00686205|12175350|FG001|Overall Study|Specimen handling procedure altered|0
7741945|NCT00686205|12175349|FG000|Overall Study|Specimens not confirmed HIV positive|0
7741946|NCT00686205|12175350|FG001|Overall Study|Specimens not confirmed HIV positive|981
7741947|NCT00686335|12175380|FG000|Run-in Period|Adverse Event|1
7741948|NCT00686335|12175380|FG000|Run-in Period|asthma exacerbation|1
7741949|NCT00686335|12175380|FG000|Run-in Period|violation of inclusion/exclusion criteri|3
7741950|NCT00686517|12175389|FG000|Treatment|Serious Adverse Event|1
7741951|NCT00686517|12175390|FG001|Treatment|Serious Adverse Event|2
7741952|NCT00686517|12175391|FG002|Treatment|Serious Adverse Event|1
7741953|NCT00686517|12175389|FG000|Treatment|Adverse Event|2
7741954|NCT00686517|12175390|FG001|Treatment|Adverse Event|0
7741955|NCT00686517|12175391|FG002|Treatment|Adverse Event|0
7741956|NCT00686517|12175389|FG000|Treatment|Poor Protocol Compliance|1
7741957|NCT00686517|12175390|FG001|Treatment|Poor Protocol Compliance|0
7741958|NCT00686517|12175391|FG002|Treatment|Poor Protocol Compliance|0
7741959|NCT00686517|12175389|FG000|Treatment|Protocol Violation|2
7741960|NCT00686517|12175390|FG001|Treatment|Protocol Violation|1
7741961|NCT00686517|12175391|FG002|Treatment|Protocol Violation|0
7741962|NCT00686543|12175403|FG000|Overall Study|Adverse Event|9
7741963|NCT00686543|12175404|FG001|Overall Study|Adverse Event|1
7741964|NCT00686543|12175405|FG002|Overall Study|Adverse Event|3
7741965|NCT00686543|12175406|FG003|Overall Study|Adverse Event|2
7741966|NCT00686543|12175403|FG000|Overall Study|Withdrawal by Subject|2
7741967|NCT00686543|12175404|FG001|Overall Study|Withdrawal by Subject|0
7741968|NCT00686543|12175405|FG002|Overall Study|Withdrawal by Subject|0
7741969|NCT00686543|12175406|FG003|Overall Study|Withdrawal by Subject|0
7741970|NCT00686543|12175403|FG000|Overall Study|Protocol Violation|3
7741971|NCT00686543|12175404|FG001|Overall Study|Protocol Violation|0
7741972|NCT00686543|12175405|FG002|Overall Study|Protocol Violation|2
7741973|NCT00686543|12175406|FG003|Overall Study|Protocol Violation|1
7741974|NCT00686595|12175427|FG000|Overall Study|Adverse Event|3
7741975|NCT00686595|12175427|FG000|Overall Study|Protocol Violation|1
7741976|NCT00686595|12175427|FG000|Overall Study|Lost to Follow-up|1
7741977|NCT00686595|12175427|FG000|Overall Study|Lack of Efficacy|1
7741978|NCT00686595|12175427|FG000|Overall Study|Poor Compliance|1
7741979|NCT00686634|12175431|FG000|Overall Study|Protocol Violation|6
7741980|NCT00686647|12175436|FG000|Overall Study|Lost to Follow-up|1
7741981|NCT00686647|12175436|FG000|Overall Study|Death|1
7741982|NCT00686686|12175441|FG000|Overall Study|Non-compliance|1
7741983|NCT00686686|12175441|FG000|Overall Study|Adverse Event|2
7741984|NCT00686686|12175441|FG000|Overall Study|Lost to Follow-up|3
7741985|NCT00686699|12175447|FG000|Treatment Period 1|Adverse Event|0
7741986|NCT00686699|12175448|FG001|Treatment Period 1|Adverse Event|2
7741987|NCT00686712|12175457|FG000|Overall Study|Protocol Violation|8
7741988|NCT00686712|12175458|FG001|Overall Study|Protocol Violation|8
7741989|NCT00686712|12175459|FG002|Overall Study|Protocol Violation|10
7741990|NCT00686712|12175457|FG000|Overall Study|Lost to Follow-up|1
7741991|NCT00686712|12175458|FG001|Overall Study|Lost to Follow-up|2
7741992|NCT00686712|12175459|FG002|Overall Study|Lost to Follow-up|3
7741993|NCT00686712|12175457|FG000|Overall Study|Adverse Event|1
7741994|NCT00686712|12175458|FG001|Overall Study|Adverse Event|1
7741995|NCT00686712|12175459|FG002|Overall Study|Adverse Event|0
7741996|NCT00686725|12175472|FG000|Overall Study|Adverse Event|1
7741997|NCT00686725|12175473|FG001|Overall Study|Adverse Event|1
7741998|NCT00686725|12175472|FG000|Overall Study|Progressive Disease|17
7741999|NCT00686725|12175473|FG001|Overall Study|Progressive Disease|23
7742000|NCT00686725|12175472|FG000|Overall Study|Lost to Follow-up|7
7742001|NCT00686725|12175473|FG001|Overall Study|Lost to Follow-up|5
7742002|NCT00686725|12175472|FG000|Overall Study|Death|6
7742003|NCT00686725|12175473|FG001|Overall Study|Death|3
7742004|NCT00686725|12175472|FG000|Overall Study|Withdrawal by Subject|13
7742005|NCT00686725|12175473|FG001|Overall Study|Withdrawal by Subject|4
7742006|NCT00686725|12175472|FG000|Overall Study|Protocol Violation|1
7742007|NCT00686725|12175473|FG001|Overall Study|Protocol Violation|3
7742008|NCT00686725|12175472|FG000|Overall Study|Other|1
7742009|NCT00686725|12175473|FG001|Overall Study|Other|3
7742010|NCT00686777|12175479|FG000|Overall Study|Adverse Event|2
7742011|NCT00686777|12175479|FG000|Overall Study|Pregnancy|1
7742012|NCT00686777|12175479|FG000|Overall Study|Withdrawal by Subject|2
7742013|NCT00686777|12175479|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4
7742014|NCT00686777|12175479|FG000|Overall Study|No Visit|1
7742015|NCT00686790|12175483|FG000|Overall Study|Adverse Event|2
7742016|NCT00686790|12175483|FG000|Overall Study|Withdrawal by Subject|1
7742017|NCT00686790|12175483|FG000|Overall Study|Death|1
7742018|NCT00686790|12175483|FG000|Overall Study|Lost to Follow-up|12
7742019|NCT00686829|12175500|FG000|Overall Study|Adverse Event|5
7742020|NCT00686829|12175500|FG000|Overall Study|Lack of Efficacy|6
7742021|NCT00686829|12175500|FG000|Overall Study|Lost to Follow-up|4
7742022|NCT00686829|12175500|FG000|Overall Study|Withdrawal by Subject|14
7742023|NCT00686829|12175500|FG000|Overall Study|Protocol Violation|3
7742024|NCT00686829|12175500|FG000|Overall Study|Sponsor discontinued VCV|47
7742025|NCT00686855|12175510|FG000|Overall Study|Lost to Follow-up|1
7742026|NCT00686855|12175511|FG001|Overall Study|Lost to Follow-up|0
7742027|NCT00686855|12175510|FG000|Overall Study|Progressive GVHD|0
7742028|NCT00686855|12175511|FG001|Overall Study|Progressive GVHD|1
7742029|NCT00686881|12175519|FG000|Overall Study|Withdrawal by Subject|11
7742030|NCT00686881|12175520|FG001|Overall Study|Withdrawal by Subject|18
7742031|NCT00686881|12175519|FG000|Overall Study|Lost to Follow-up|0
7742032|NCT00686881|12175520|FG001|Overall Study|Lost to Follow-up|1
7742033|NCT00686881|12175519|FG000|Overall Study|Treatment-related adverse event|10
7742034|NCT00686881|12175520|FG001|Overall Study|Treatment-related adverse event|9
7742035|NCT00686881|12175519|FG000|Overall Study|Met discontinuation criteria|5
7742036|NCT00686881|12175520|FG001|Overall Study|Met discontinuation criteria|0
7742037|NCT00686881|12175519|FG000|Overall Study|Onset of malignant tumor|11
7742038|NCT00686881|12175520|FG001|Overall Study|Onset of malignant tumor|11
7742039|NCT00686881|12175519|FG000|Overall Study|Lack of Efficacy|4
7742040|NCT00686881|12175520|FG001|Overall Study|Lack of Efficacy|3
7742041|NCT00686881|12175519|FG000|Overall Study|Physician Decision|1
7742042|NCT00686881|12175520|FG001|Overall Study|Physician Decision|0
7742043|NCT00686881|12175519|FG000|Overall Study|Circumstances of site|1
7742044|NCT00686881|12175520|FG001|Overall Study|Circumstances of site|1
7742045|NCT00686881|12175519|FG000|Overall Study|Did not meet protocol eligibility|1
7742046|NCT00686881|12175520|FG001|Overall Study|Did not meet protocol eligibility|0
7742047|NCT00686881|12175519|FG000|Overall Study|Irregular visits|1
7742048|NCT00686881|12175520|FG001|Overall Study|Irregular visits|0
7742049|NCT00686881|12175519|FG000|Overall Study|Study discontinuation|35
7742050|NCT00686881|12175520|FG001|Overall Study|Study discontinuation|32
7742051|NCT00686881|12175519|FG000|Overall Study|Never received study drug|2
7742052|NCT00686881|12175520|FG001|Overall Study|Never received study drug|6
7742053|NCT00686894|12175528|FG000|Overall Study|Relapse|2
7742054|NCT00686894|12175528|FG000|Overall Study|Protocol Violation|4
7742055|NCT00686920|12175534|FG000|Overall Study|Death|45
7742056|NCT00686920|12175535|FG001|Overall Study|Death|14
7742057|NCT00686920|12175534|FG000|Overall Study|Liver Transplant|23
7742058|NCT00686920|12175535|FG001|Overall Study|Liver Transplant|8
7742059|NCT00686920|12175534|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1
7742060|NCT00686920|12175535|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2
7742061|NCT00686920|12175534|FG000|Overall Study|Withdrawal by Subject|23
7742062|NCT00686920|12175535|FG001|Overall Study|Withdrawal by Subject|5
7742063|NCT00686920|12175534|FG000|Overall Study|Protocol Violation|2
7742064|NCT00686920|12175535|FG001|Overall Study|Protocol Violation|1
7742065|NCT00686920|12175534|FG000|Overall Study|Adverse Event|10
7742066|NCT00686920|12175535|FG001|Overall Study|Adverse Event|2
7742067|NCT00686920|12175534|FG000|Overall Study|Personal Reason|0
7742068|NCT00686920|12175535|FG001|Overall Study|Personal Reason|1
7742069|NCT00686920|12175534|FG000|Overall Study|Lost to Follow-up|15
7742070|NCT00686920|12175535|FG001|Overall Study|Lost to Follow-up|3
7742071|NCT00686920|12175534|FG000|Overall Study|Moved to Another State|1
7742072|NCT00686920|12175535|FG001|Overall Study|Moved to Another State|0
7742073|NCT00686920|12175534|FG000|Overall Study|Transferred to Nursing Home|1
7742074|NCT00686920|12175535|FG001|Overall Study|Transferred to Nursing Home|0
7742075|NCT00686920|12175534|FG000|Overall Study|Noncompliance|9
7742076|NCT00686920|12175535|FG001|Overall Study|Noncompliance|0
7742077|NCT00686920|12175534|FG000|Overall Study|Principal Investigator Decision|2
7742078|NCT00686920|12175535|FG001|Overall Study|Principal Investigator Decision|0
7742079|NCT00686959|12175543|FG000|Overall Study|Participants censored (no death events)|124
7742080|NCT00686959|12175544|FG001|Overall Study|Participants censored (no death events)|117
7742081|NCT00686998|12175553|FG000|Overall Study|Adverse Event|3
7742082|NCT00686998|12175554|FG001|Overall Study|Adverse Event|2
7742083|NCT00686998|12175555|FG002|Overall Study|Adverse Event|1
7742084|NCT00686998|12175553|FG000|Overall Study|Withdrawal by Subject|2
7742085|NCT00686998|12175554|FG001|Overall Study|Withdrawal by Subject|1
7742086|NCT00686998|12175555|FG002|Overall Study|Withdrawal by Subject|2
7742087|NCT00686998|12175553|FG000|Overall Study|Lack of Efficacy|7
7742088|NCT00686998|12175554|FG001|Overall Study|Lack of Efficacy|5
7742089|NCT00686998|12175555|FG002|Overall Study|Lack of Efficacy|0
7742090|NCT00686998|12175553|FG000|Overall Study|Other|0
7742091|NCT00686998|12175554|FG001|Overall Study|Other|0
7742092|NCT00686998|12175555|FG002|Overall Study|Other|1
7742093|NCT00686998|12175553|FG000|Overall Study|Safety Reasons|1
7742094|NCT00686998|12175554|FG001|Overall Study|Safety Reasons|0
7742095|NCT00686998|12175555|FG002|Overall Study|Safety Reasons|0
7742096|NCT00687193|12175594|FG000|Overall Study|Adverse Event|0
7742097|NCT00687193|12175595|FG001|Overall Study|Adverse Event|1
7742098|NCT00687193|12175596|FG002|Overall Study|Adverse Event|2
7742099|NCT00687193|12175597|FG003|Overall Study|Adverse Event|3
7742100|NCT00687193|12175598|FG004|Overall Study|Adverse Event|0
7742101|NCT00687193|12175599|FG005|Overall Study|Adverse Event|2
7742102|NCT00687193|12175594|FG000|Overall Study|Lack of Efficacy|1
7742103|NCT00687193|12175595|FG001|Overall Study|Lack of Efficacy|1
7742104|NCT00687193|12175596|FG002|Overall Study|Lack of Efficacy|0
7742105|NCT00687193|12175597|FG003|Overall Study|Lack of Efficacy|0
7742106|NCT00687193|12175598|FG004|Overall Study|Lack of Efficacy|0
7742107|NCT00687193|12175599|FG005|Overall Study|Lack of Efficacy|2
7742108|NCT00687193|12175594|FG000|Overall Study|Protocol Violation|1
7742109|NCT00687193|12175595|FG001|Overall Study|Protocol Violation|2
7742110|NCT00687193|12175596|FG002|Overall Study|Protocol Violation|0
7742111|NCT00687193|12175597|FG003|Overall Study|Protocol Violation|1
7742112|NCT00687193|12175598|FG004|Overall Study|Protocol Violation|2
7742113|NCT00687193|12175599|FG005|Overall Study|Protocol Violation|0
7742114|NCT00687219|12175616|FG000|Overall Study|Adverse Event|8
7742115|NCT00687219|12175616|FG000|Overall Study|Discontinuance criteria met|7
7742116|NCT00687219|12175616|FG000|Overall Study|HCV-RNA positive conversion|34
7742117|NCT00687219|12175616|FG000|Overall Study|Withdrawal by Subject|1
7742118|NCT00687219|12175616|FG000|Overall Study|Lack of Efficacy|1
7742119|NCT00687271|12175624|FG000|Overall Study|Adverse Event|1
7742120|NCT00687271|12175625|FG001|Overall Study|Adverse Event|3
7742121|NCT00687271|12175626|FG002|Overall Study|Adverse Event|1
7742122|NCT00687271|12175627|FG003|Overall Study|Adverse Event|0
7742123|NCT00687271|12175624|FG000|Overall Study|Lost to Follow-up|0
7742124|NCT00687271|12175625|FG001|Overall Study|Lost to Follow-up|1
7742125|NCT00687271|12175626|FG002|Overall Study|Lost to Follow-up|0
7742126|NCT00687271|12175627|FG003|Overall Study|Lost to Follow-up|0
7742127|NCT00687271|12175624|FG000|Overall Study|Protocol Violation|2
7742128|NCT00687271|12175625|FG001|Overall Study|Protocol Violation|1
7742129|NCT00687271|12175626|FG002|Overall Study|Protocol Violation|1
7742130|NCT00687271|12175627|FG003|Overall Study|Protocol Violation|0
7742131|NCT00687271|12175624|FG000|Overall Study|Withdrawal by Subject|0
7742132|NCT00687271|12175625|FG001|Overall Study|Withdrawal by Subject|1
7742133|NCT00687271|12175626|FG002|Overall Study|Withdrawal by Subject|3
7742134|NCT00687271|12175627|FG003|Overall Study|Withdrawal by Subject|0
7742135|NCT00687297|12175639|FG000|Randomization|Withdrawal by Subject|2
7742136|NCT00687297|12175640|FG001|Randomization|Withdrawal by Subject|0
7742137|NCT00687297|12175639|FG000|Randomization|Withdrew before treatment, ineligible|1
7742138|NCT00687297|12175640|FG001|Randomization|Withdrew before treatment, ineligible|1
7742139|NCT00687297|12175639|FG000|Induction|Withdrawal by Subject|4
7742140|NCT00687297|12175640|FG001|Induction|Withdrawal by Subject|4
7742141|NCT00687297|12175639|FG000|Induction|Adverse Event|16
7742142|NCT00687297|12175640|FG001|Induction|Adverse Event|15
7742143|NCT00687297|12175639|FG000|Induction|Death|7
7742144|NCT00687297|12175640|FG001|Induction|Death|11
7742145|NCT00687297|12175639|FG000|Induction|Lack of Efficacy|17
7742146|NCT00687297|12175640|FG001|Induction|Lack of Efficacy|21
7742147|NCT00687297|12175639|FG000|Induction|Ineligible|0
7742148|NCT00687297|12175640|FG001|Induction|Ineligible|1
7742149|NCT00687297|12175639|FG000|Induction|Patient Noncompliance|1
7742150|NCT00687297|12175640|FG001|Induction|Patient Noncompliance|0
7742151|NCT00687297|12175639|FG000|Induction|Physician Decision|0
7742152|NCT00687297|12175640|FG001|Induction|Physician Decision|2
7742153|NCT00687297|12175639|FG000|Induction|Other|0
7742154|NCT00687297|12175640|FG001|Induction|Other|1
7742155|NCT00687323|12175648|FG000|Overall Study|Death|25
7742156|NCT00687323|12175648|FG000|Overall Study|Withdrawal by Subject|1
7742157|NCT00687323|12175648|FG000|Overall Study|Excluded from efficacy evaluations|6
7742158|NCT00687323|12175648|FG000|Overall Study|Screen failure|148
7742159|NCT00687362|12175652|FG000|Overall Study|Protocol Violation|2
7742160|NCT00687362|12175652|FG000|Overall Study|Withdrawal by Subject|1
7742161|NCT00687401|12175656|FG000|Overall Study|Protocol Violation|7
7742162|NCT00687401|12175656|FG000|Overall Study|Adverse Event|6
7742163|NCT00687401|12175656|FG000|Overall Study|Lack of Efficacy|6
7742164|NCT00687401|12175656|FG000|Overall Study|Withdrawal by Subject|4
7742165|NCT00687401|12175656|FG000|Overall Study|Did not return for visit|3
7742166|NCT00687401|12175656|FG000|Overall Study|For reasons different from those above|4
7742167|NCT00687440|12175661|FG000|Overall Study|Adverse Event|3
7742168|NCT00687440|12175661|FG000|Overall Study|Lost to Follow-up|3
7742169|NCT00687440|12175661|FG000|Overall Study|Lack of Efficacy|2
7742170|NCT00687440|12175661|FG000|Overall Study|Death|2
7742171|NCT00687440|12175661|FG000|Overall Study|Other|1
7742172|NCT00687440|12175661|FG000|Overall Study|Missing|1
7742173|NCT00687609|12175678|FG000|Overall Study|Physician Decision|1
7742174|NCT00687609|12175678|FG000|Overall Study|Withdrawal by Subject|2
7742175|NCT00687739|12175701|FG000|Overall Study|Lost to Follow-up|2
7742176|NCT00687739|12175702|FG001|Overall Study|Lost to Follow-up|2
7742177|NCT00687739|12175703|FG002|Overall Study|Lost to Follow-up|1
7742178|NCT00687739|12175704|FG003|Overall Study|Lost to Follow-up|2
7742179|NCT00687739|12175701|FG000|Overall Study|Adverse Event|0
7742180|NCT00687739|12175702|FG001|Overall Study|Adverse Event|1
7742181|NCT00687739|12175703|FG002|Overall Study|Adverse Event|1
7742182|NCT00687739|12175704|FG003|Overall Study|Adverse Event|0
7742183|NCT00687804|12175719|FG000|Core Study|Adverse Event|5
7742184|NCT00687804|12175720|FG001|Core Study|Adverse Event|3
7742185|NCT00687804|12175721|FG002|Core Study|Adverse Event|3
7742186|NCT00687804|12175719|FG000|Core Study|Abnormal laboratory value(s)|1
7742187|NCT00687804|12175720|FG001|Core Study|Abnormal laboratory value(s)|0
7742188|NCT00687804|12175721|FG002|Core Study|Abnormal laboratory value(s)|0
7742189|NCT00687804|12175719|FG000|Core Study|Lack of Efficacy|1
7742190|NCT00687804|12175720|FG001|Core Study|Lack of Efficacy|1
7742191|NCT00687804|12175721|FG002|Core Study|Lack of Efficacy|1
7742192|NCT00687804|12175719|FG000|Core Study|Withdrawal by Subject|4
7742193|NCT00687804|12175720|FG001|Core Study|Withdrawal by Subject|7
7742194|NCT00687804|12175721|FG002|Core Study|Withdrawal by Subject|7
7742195|NCT00687804|12175719|FG000|Core Study|Lost to Follow-up|0
7742196|NCT00687804|12175720|FG001|Core Study|Lost to Follow-up|1
7742197|NCT00687804|12175721|FG002|Core Study|Lost to Follow-up|0
7742198|NCT00687804|12175719|FG000|Core Study|Death|2
7742199|NCT00687804|12175720|FG001|Core Study|Death|2
7742200|NCT00687804|12175721|FG002|Core Study|Death|2
7742201|NCT00687804|12175719|FG000|Core Study|Protocol Violation|1
7742202|NCT00687804|12175720|FG001|Core Study|Protocol Violation|1
7742203|NCT00687804|12175721|FG002|Core Study|Protocol Violation|0
7742204|NCT00687804|12175719|FG000|Open-Label Extension Study|Adverse Event|2
7742205|NCT00687804|12175720|FG001|Open-Label Extension Study|Adverse Event|2
7742206|NCT00687804|12175721|FG002|Open-Label Extension Study|Adverse Event|2
7742207|NCT00687804|12175719|FG000|Open-Label Extension Study|Subject withdrew consent|3
7742208|NCT00687804|12175720|FG001|Open-Label Extension Study|Subject withdrew consent|4
7742209|NCT00687804|12175721|FG002|Open-Label Extension Study|Subject withdrew consent|4
7742210|NCT00687804|12175719|FG000|Open-Label Extension Study|Lost to Follow-up|2
7742211|NCT00687804|12175720|FG001|Open-Label Extension Study|Lost to Follow-up|1
7742212|NCT00687804|12175721|FG002|Open-Label Extension Study|Lost to Follow-up|2
7742213|NCT00687804|12175719|FG000|Open-Label Extension Study|Administrative problems|1
7742214|NCT00687804|12175720|FG001|Open-Label Extension Study|Administrative problems|1
7742215|NCT00687804|12175721|FG002|Open-Label Extension Study|Administrative problems|0
7742216|NCT00687804|12175719|FG000|Open-Label Extension Study|Death|2
7742217|NCT00687804|12175720|FG001|Open-Label Extension Study|Death|3
7742218|NCT00687804|12175721|FG002|Open-Label Extension Study|Death|3
7742219|NCT00687973|12175759|FG000|Overall Study|Adverse Event|18
7742220|NCT00687973|12175760|FG001|Overall Study|Adverse Event|28
7742221|NCT00687973|12175759|FG000|Overall Study|Lack of Efficacy|2
7742222|NCT00687973|12175760|FG001|Overall Study|Lack of Efficacy|3
7742223|NCT00687973|12175759|FG000|Overall Study|Protocol Violation|1
7742224|NCT00687973|12175760|FG001|Overall Study|Protocol Violation|2
7742225|NCT00687973|12175759|FG000|Overall Study|Administrative Reasons|0
7742226|NCT00687973|12175760|FG001|Overall Study|Administrative Reasons|2
7742227|NCT00687973|12175759|FG000|Overall Study|Withdrawal by Subject|3
7742228|NCT00687973|12175760|FG001|Overall Study|Withdrawal by Subject|3
7742229|NCT00688064|12175769|FG000|Overall Study|Protocol Violation|0
7742230|NCT00688064|12175770|FG001|Overall Study|Protocol Violation|1
7742231|NCT00688064|12175769|FG000|Overall Study|Adverse Event|2
7742232|NCT00688064|12175770|FG001|Overall Study|Adverse Event|4
7742233|NCT00688064|12175769|FG000|Overall Study|Withdrawal by Subject|7
7742234|NCT00688064|12175770|FG001|Overall Study|Withdrawal by Subject|7
7742235|NCT00688064|12175769|FG000|Overall Study|Lost to Follow-up|10
7742236|NCT00688064|12175770|FG001|Overall Study|Lost to Follow-up|10
7742237|NCT00688064|12175769|FG000|Overall Study|Lack of Efficacy|0
7742238|NCT00688064|12175770|FG001|Overall Study|Lack of Efficacy|1
7742239|NCT00688064|12175769|FG000|Overall Study|Pregnancy|1
7742240|NCT00688064|12175770|FG001|Overall Study|Pregnancy|0
7742241|NCT00688064|12175769|FG000|Overall Study|Any other reasons|1
7742242|NCT00688064|12175770|FG001|Overall Study|Any other reasons|3
7742243|NCT00688103|12175778|FG000|Overall Study|Adverse Event|4
7742244|NCT00688103|12175779|FG001|Overall Study|Adverse Event|1
7742245|NCT00688103|12175778|FG000|Overall Study|Lack of Efficacy|11
7742246|NCT00688103|12175779|FG001|Overall Study|Lack of Efficacy|1
7742247|NCT00688103|12175778|FG000|Overall Study|Withdrawal by Subject|4
7742248|NCT00688103|12175779|FG001|Overall Study|Withdrawal by Subject|2
7742249|NCT00688103|12175778|FG000|Overall Study|complex reasons|11
7742250|NCT00688103|12175779|FG001|Overall Study|complex reasons|9
7742251|NCT00688155|12175791|FG000|Overall Study|Withdrawal by Subject|2
7742252|NCT00688155|12175792|FG001|Overall Study|Withdrawal by Subject|2
7742253|NCT00688155|12175793|FG002|Overall Study|Withdrawal by Subject|1
7742254|NCT00688155|12175794|FG003|Overall Study|Withdrawal by Subject|1
7742255|NCT00688181|12175804|FG000|Overall Study|Lost to Follow-up|17
7742256|NCT00688181|12175804|FG000|Overall Study|Unknown Reason|4
7742257|NCT00688181|12175804|FG000|Overall Study|Non-clinical Reason|2
7742258|NCT00688259|12175812|FG000|Overall Study|Lost to Follow-up|2
7742259|NCT00688259|12175813|FG001|Overall Study|Lost to Follow-up|4
7742260|NCT00688259|12175812|FG000|Overall Study|Physician Decision|1
7742261|NCT00688259|12175813|FG001|Overall Study|Physician Decision|0
7742262|NCT00688259|12175812|FG000|Overall Study|Withdrawal by Subject|2
7742263|NCT00688259|12175813|FG001|Overall Study|Withdrawal by Subject|0
7742264|NCT00688259|12175812|FG000|Overall Study|Declined Interview|2
7742265|NCT00688259|12175813|FG001|Overall Study|Declined Interview|3
7742266|NCT00688259|12175812|FG000|Overall Study|Hospitalized at Follow-up|0
7742267|NCT00688259|12175813|FG001|Overall Study|Hospitalized at Follow-up|1
7742268|NCT00688324|12175819|FG000|Overall Study|Withdrawal by Subject|2
7742269|NCT00688324|12175819|FG000|Overall Study|Physician Decision|5
7742270|NCT00688324|12175819|FG000|Overall Study|Lost to Follow-up|1
7742271|NCT00688467|12175826|FG000|Treatment Period 1|Adverse Event|2
7742272|NCT00688467|12175827|FG001|Treatment Period 1|Adverse Event|1
7742273|NCT00688467|12175826|FG000|Treatment Period 1|Did not meet protocol eligibility|0
7742274|NCT00688467|12175827|FG001|Treatment Period 1|Did not meet protocol eligibility|1
7742275|NCT00688467|12175826|FG000|Treatment Period 2|Protocol Violation|0
7742276|NCT00688467|12175827|FG001|Treatment Period 2|Protocol Violation|1
7742277|NCT00688467|12175826|FG000|Treatment Period 2|Adverse Event|0
7742278|NCT00688467|12175827|FG001|Treatment Period 2|Adverse Event|1
7742279|NCT00688519|12175835|FG000|Overall Study|Adverse Event|2
7742280|NCT00688519|12175836|FG001|Overall Study|Adverse Event|3
7742281|NCT00688519|12175835|FG000|Overall Study|Lost to Follow-up|3
7742282|NCT00688519|12175836|FG001|Overall Study|Lost to Follow-up|3
7742283|NCT00688519|12175835|FG000|Overall Study|Lack of Efficacy|3
7742284|NCT00688519|12175836|FG001|Overall Study|Lack of Efficacy|1
7742285|NCT00688519|12175835|FG000|Overall Study|Withdrawal by Subject|7
7742286|NCT00688519|12175836|FG001|Overall Study|Withdrawal by Subject|6
7742287|NCT00688519|12175835|FG000|Overall Study|Prohibited medication|1
7742288|NCT00688519|12175836|FG001|Overall Study|Prohibited medication|0
7742289|NCT00688519|12175835|FG000|Overall Study|Non-compliance|0
7742290|NCT00688519|12175836|FG001|Overall Study|Non-compliance|1
7742291|NCT00688519|12175835|FG000|Overall Study|Subject moved out of state|1
7742292|NCT00688519|12175836|FG001|Overall Study|Subject moved out of state|0
7742293|NCT00688519|12175835|FG000|Overall Study|Investigator decision|1
7742294|NCT00688519|12175836|FG001|Overall Study|Investigator decision|0
7742295|NCT00688519|12175835|FG000|Overall Study|Subject moved out of area|1
7742296|NCT00688519|12175836|FG001|Overall Study|Subject moved out of area|0
7742297|NCT00688519|12175835|FG000|Overall Study|Pregnancy|0
7742298|NCT00688519|12175836|FG001|Overall Study|Pregnancy|1
7742299|NCT00688545|12175844|FG000|Overall Study|Lost to Follow-up|1
7742300|NCT00688545|12175845|FG001|Overall Study|Lost to Follow-up|4
7742301|NCT00688545|12175844|FG000|Overall Study|Insurance/cost of drug|0
7742302|NCT00688545|12175845|FG001|Overall Study|Insurance/cost of drug|1
7742303|NCT00688545|12175844|FG000|Overall Study|Withdrawal by Subject|2
7742304|NCT00688545|12175845|FG001|Overall Study|Withdrawal by Subject|3
7742305|NCT00688545|12175844|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2
7742306|NCT00688545|12175845|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7
7742307|NCT00688597|12175856|FG000|Overall Study|Adverse Event|2
7742308|NCT00688597|12175857|FG001|Overall Study|Adverse Event|0
7742309|NCT00688597|12175858|FG002|Overall Study|Adverse Event|0
7742310|NCT00688597|12175856|FG000|Overall Study|Physician Decision|1
7742311|NCT00688597|12175857|FG001|Overall Study|Physician Decision|0
7742312|NCT00688597|12175858|FG002|Overall Study|Physician Decision|0
7742313|NCT00688623|12175866|FG000|Overall Study|Adverse Event|22
7742314|NCT00688623|12175866|FG000|Overall Study|abnormal lab value|1
7742315|NCT00688623|12175866|FG000|Overall Study|Withdrawal by Subject|4
7742316|NCT00688623|12175866|FG000|Overall Study|Death|3
7742317|NCT00688623|12175866|FG000|Overall Study|disease progression|23
7742318|NCT00688623|12175866|FG000|Overall Study|Protocol Violation|2
7742319|NCT00688636|12175872|FG000|Overall Study|Adverse Event|2
7742320|NCT00688636|12175873|FG001|Overall Study|Adverse Event|1
7742321|NCT00688688|12175892|FG000|Overall Study|Eligibility criterion not met|7
7742322|NCT00688688|12175893|FG001|Overall Study|Eligibility criterion not met|7
7742323|NCT00688688|12175894|FG002|Overall Study|Eligibility criterion not met|10
7742324|NCT00688688|12175892|FG000|Overall Study|Adverse Event|52
7742325|NCT00688688|12175893|FG001|Overall Study|Adverse Event|51
7742326|NCT00688688|12175894|FG002|Overall Study|Adverse Event|50
7742327|NCT00688688|12175892|FG000|Overall Study|Lack of Efficacy|34
7742328|NCT00688688|12175893|FG001|Overall Study|Lack of Efficacy|25
7742329|NCT00688688|12175894|FG002|Overall Study|Lack of Efficacy|45
7742330|NCT00688688|12175892|FG000|Overall Study|Withdrawal by Subject|66
7742331|NCT00688688|12175893|FG001|Overall Study|Withdrawal by Subject|75
7742332|NCT00688688|12175894|FG002|Overall Study|Withdrawal by Subject|65
7742333|NCT00688688|12175892|FG000|Overall Study|Lost to Follow-up|14
7742334|NCT00688688|12175893|FG001|Overall Study|Lost to Follow-up|7
7742335|NCT00688688|12175894|FG002|Overall Study|Lost to Follow-up|7
7742336|NCT00688688|12175892|FG000|Overall Study|Protocol Violation|6
7742337|NCT00688688|12175893|FG001|Overall Study|Protocol Violation|9
7742338|NCT00688688|12175894|FG002|Overall Study|Protocol Violation|11
7742339|NCT00688688|12175892|FG000|Overall Study|Randomized but never received study drug|1
7742340|NCT00688688|12175893|FG001|Overall Study|Randomized but never received study drug|0
7742341|NCT00688688|12175894|FG002|Overall Study|Randomized but never received study drug|0
7742342|NCT00688688|12175892|FG000|Overall Study|Non-compliance with study procedures|5
7742343|NCT00688688|12175893|FG001|Overall Study|Non-compliance with study procedures|3
7742344|NCT00688688|12175894|FG002|Overall Study|Non-compliance with study procedures|4
7742345|NCT00688688|12175892|FG000|Overall Study|Taking exclusionary medications|1
7742346|NCT00688688|12175893|FG001|Overall Study|Taking exclusionary medications|0
7742347|NCT00688688|12175894|FG002|Overall Study|Taking exclusionary medications|0
7742348|NCT00688688|12175892|FG000|Overall Study|Site closure|0
7742349|NCT00688688|12175893|FG001|Overall Study|Site closure|1
7742350|NCT00688688|12175894|FG002|Overall Study|Site closure|0
7742351|NCT00688688|12175892|FG000|Overall Study|Violation of exclusion criterion|0
7742352|NCT00688688|12175893|FG001|Overall Study|Violation of exclusion criterion|1
7742353|NCT00688688|12175894|FG002|Overall Study|Violation of exclusion criterion|0
7742354|NCT00688701|12175905|FG000|Overall Study|Adverse Event|1
7742355|NCT00688701|12175906|FG001|Overall Study|Adverse Event|0
7742356|NCT00688701|12175907|FG002|Overall Study|Adverse Event|5
7742357|NCT00688701|12175908|FG003|Overall Study|Adverse Event|3
7742358|NCT00688701|12175905|FG000|Overall Study|Lack of Efficacy|0
7742359|NCT00688701|12175906|FG001|Overall Study|Lack of Efficacy|1
7742360|NCT00688701|12175907|FG002|Overall Study|Lack of Efficacy|0
7742361|NCT00688701|12175908|FG003|Overall Study|Lack of Efficacy|0
7742362|NCT00688701|12175905|FG000|Overall Study|Withdrawal by Subject|3
7742363|NCT00688701|12175906|FG001|Overall Study|Withdrawal by Subject|3
7742364|NCT00688701|12175907|FG002|Overall Study|Withdrawal by Subject|4
7742365|NCT00688701|12175908|FG003|Overall Study|Withdrawal by Subject|8
7742366|NCT00688701|12175905|FG000|Overall Study|Poor compliance to protocol|0
7742367|NCT00688701|12175906|FG001|Overall Study|Poor compliance to protocol|1
7742368|NCT00688701|12175907|FG002|Overall Study|Poor compliance to protocol|1
7742369|NCT00688701|12175908|FG003|Overall Study|Poor compliance to protocol|0
7742370|NCT00688740|12175921|FG000|Overall Study|Adverse Event|45
7742371|NCT00688740|12175922|FG001|Overall Study|Adverse Event|8
7742372|NCT00688740|12175921|FG000|Overall Study|Death|2
7742373|NCT00688740|12175922|FG001|Overall Study|Death|2
7742374|NCT00688740|12175921|FG000|Overall Study|Lost to Follow-up|0
7742375|NCT00688740|12175922|FG001|Overall Study|Lost to Follow-up|1
7742376|NCT00688740|12175921|FG000|Overall Study|Consent Withdrawn|17
7742377|NCT00688740|12175922|FG001|Overall Study|Consent Withdrawn|17
7742378|NCT00688740|12175921|FG000|Overall Study|Breast Cancer Relapse|1
7742379|NCT00688740|12175922|FG001|Overall Study|Breast Cancer Relapse|4
7742380|NCT00688740|12175921|FG000|Overall Study|Violation of Inclusion Criteria|1
7742381|NCT00688740|12175922|FG001|Overall Study|Violation of Inclusion Criteria|3
7742382|NCT00688753|12175928|FG000|Overall Study|Disease progression|55
7742383|NCT00688753|12175928|FG000|Overall Study|Missing|1
7742384|NCT00688753|12175928|FG000|Overall Study|Death|9
7742385|NCT00688753|12175928|FG000|Overall Study|Withdrawal by Subject|3
7742386|NCT00688753|12175928|FG000|Overall Study|Adverse Event|20
7742387|NCT00688753|12175928|FG000|Overall Study|Protocol Violation|1
7742388|NCT00688753|12175928|FG000|Overall Study|Lost to Follow-up|3
7742389|NCT00688844|12175932|FG000|Overall Study|Lost to Follow-up|10
7742390|NCT00688870|12175938|FG000|Infant Series|Parent or legal guardian request|4
7742391|NCT00688870|12175939|FG001|Infant Series|Parent or legal guardian request|0
7742392|NCT00688909|12175949|FG000|Overall Study|Adverse Event|28
7742393|NCT00688909|12175949|FG000|Overall Study|Patient withdrew consent|2
7742394|NCT00688909|12175949|FG000|Overall Study|Administrative problems|1
7742395|NCT00688909|12175949|FG000|Overall Study|Protocol Violation|2
7742396|NCT00689026|12175956|FG000|Overall Study|Withdrawal by Subject|13
7742397|NCT00689026|12175957|FG001|Overall Study|Withdrawal by Subject|6
7742398|NCT00689104|12175997|FG000|Overall Study|Eligibility criterion not met|5
7742399|NCT00689104|12175998|FG001|Overall Study|Eligibility criterion not met|8
7742400|NCT00689104|12175999|FG002|Overall Study|Eligibility criterion not met|0
7742401|NCT00689104|12176000|FG003|Overall Study|Eligibility criterion not met|4
7742402|NCT00689104|12175997|FG000|Overall Study|Adverse Event|13
7742403|NCT00689104|12175998|FG001|Overall Study|Adverse Event|25
7742404|NCT00689104|12175999|FG002|Overall Study|Adverse Event|16
7742405|NCT00689104|12176000|FG003|Overall Study|Adverse Event|24
7742406|NCT00689104|12175997|FG000|Overall Study|Lack of Efficacy|5
7742407|NCT00689104|12175998|FG001|Overall Study|Lack of Efficacy|6
7742408|NCT00689104|12175999|FG002|Overall Study|Lack of Efficacy|2
7742409|NCT00689104|12176000|FG003|Overall Study|Lack of Efficacy|3
7742410|NCT00689104|12175997|FG000|Overall Study|Withdrawal by Subject|12
7742411|NCT00689104|12175998|FG001|Overall Study|Withdrawal by Subject|11
7742412|NCT00689104|12175999|FG002|Overall Study|Withdrawal by Subject|18
7742413|NCT00689104|12176000|FG003|Overall Study|Withdrawal by Subject|11
7742414|NCT00689104|12175997|FG000|Overall Study|Lost to Follow-up|4
7742415|NCT00689104|12175998|FG001|Overall Study|Lost to Follow-up|3
7742416|NCT00689104|12175999|FG002|Overall Study|Lost to Follow-up|2
7742417|NCT00689104|12176000|FG003|Overall Study|Lost to Follow-up|5
7742418|NCT00689104|12175997|FG000|Overall Study|Protocol Violation|2
7742419|NCT00689104|12175998|FG001|Overall Study|Protocol Violation|3
7742420|NCT00689104|12175999|FG002|Overall Study|Protocol Violation|5
7742421|NCT00689104|12176000|FG003|Overall Study|Protocol Violation|3
7742422|NCT00689104|12175997|FG000|Overall Study|Randomized but never received study drug|2
7742423|NCT00689104|12175998|FG001|Overall Study|Randomized but never received study drug|1
7742424|NCT00689104|12175999|FG002|Overall Study|Randomized but never received study drug|1
7742425|NCT00689104|12176000|FG003|Overall Study|Randomized but never received study drug|0
7742426|NCT00689104|12175997|FG000|Overall Study|Physician Decision|1
7742427|NCT00689104|12175998|FG001|Overall Study|Physician Decision|0
7742428|NCT00689104|12175999|FG002|Overall Study|Physician Decision|0
7742429|NCT00689104|12176000|FG003|Overall Study|Physician Decision|0
7742430|NCT00689104|12175997|FG000|Overall Study|Non-compliance with study procedures|0
7742431|NCT00689104|12175998|FG001|Overall Study|Non-compliance with study procedures|0
7742432|NCT00689104|12175999|FG002|Overall Study|Non-compliance with study procedures|1
7742433|NCT00689104|12176000|FG003|Overall Study|Non-compliance with study procedures|0
7742434|NCT00689117|12176014|FG000|Overall Study|Adverse Event|6
7742435|NCT00689117|12176015|FG001|Overall Study|Adverse Event|0
7742436|NCT00689117|12176016|FG002|Overall Study|Adverse Event|5
7742437|NCT00689117|12176017|FG003|Overall Study|Adverse Event|0
7742438|NCT00689117|12176014|FG000|Overall Study|Lost to Follow-up|26
7742439|NCT00689117|12176015|FG001|Overall Study|Lost to Follow-up|19
7742440|NCT00689117|12176016|FG002|Overall Study|Lost to Follow-up|17
7742441|NCT00689117|12176017|FG003|Overall Study|Lost to Follow-up|11
7742442|NCT00689117|12176014|FG000|Overall Study|Lack of Efficacy|1
7742443|NCT00689117|12176015|FG001|Overall Study|Lack of Efficacy|2
7742444|NCT00689117|12176016|FG002|Overall Study|Lack of Efficacy|2
7742445|NCT00689117|12176017|FG003|Overall Study|Lack of Efficacy|2
7742446|NCT00689117|12176014|FG000|Overall Study|Non-Compliance with Study Treatment|3
7742447|NCT00689117|12176015|FG001|Overall Study|Non-Compliance with Study Treatment|3
7742448|NCT00689117|12176016|FG002|Overall Study|Non-Compliance with Study Treatment|3
7742449|NCT00689117|12176017|FG003|Overall Study|Non-Compliance with Study Treatment|1
7742450|NCT00689117|12176014|FG000|Overall Study|Withdrawal by Subject|19
7742451|NCT00689117|12176015|FG001|Overall Study|Withdrawal by Subject|18
7742452|NCT00689117|12176016|FG002|Overall Study|Withdrawal by Subject|26
7742453|NCT00689117|12176017|FG003|Overall Study|Withdrawal by Subject|13
7742454|NCT00689117|12176014|FG000|Overall Study|Unable to Comply with Visit Schedule|0
7742455|NCT00689117|12176015|FG001|Overall Study|Unable to Comply with Visit Schedule|0
7742456|NCT00689117|12176016|FG002|Overall Study|Unable to Comply with Visit Schedule|1
7742457|NCT00689117|12176017|FG003|Overall Study|Unable to Comply with Visit Schedule|1
7742458|NCT00689117|12176014|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7742459|NCT00689117|12176015|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2
7742460|NCT00689117|12176016|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7742461|NCT00689117|12176017|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7742462|NCT00689117|12176014|FG000|Overall Study|Non-compliance with Treatment Regimen|0
7742463|NCT00689117|12176015|FG001|Overall Study|Non-compliance with Treatment Regimen|1
7742464|NCT00689117|12176016|FG002|Overall Study|Non-compliance with Treatment Regimen|0
7742465|NCT00689117|12176017|FG003|Overall Study|Non-compliance with Treatment Regimen|0
7742466|NCT00689117|12176014|FG000|Overall Study|Change/Discontinuation of Birth Control|1
7742467|NCT00689117|12176015|FG001|Overall Study|Change/Discontinuation of Birth Control|1
7742468|NCT00689117|12176016|FG002|Overall Study|Change/Discontinuation of Birth Control|1
7742469|NCT00689117|12176017|FG003|Overall Study|Change/Discontinuation of Birth Control|0
7742470|NCT00689117|12176014|FG000|Overall Study|Use of Prohibitive Medication|2
7742471|NCT00689117|12176015|FG001|Overall Study|Use of Prohibitive Medication|1
7742472|NCT00689117|12176016|FG002|Overall Study|Use of Prohibitive Medication|3
7742473|NCT00689117|12176017|FG003|Overall Study|Use of Prohibitive Medication|0
7742474|NCT00689117|12176014|FG000|Overall Study|Pregnancy|0
7742475|NCT00689117|12176015|FG001|Overall Study|Pregnancy|2
7742476|NCT00689117|12176016|FG002|Overall Study|Pregnancy|0
7742477|NCT00689117|12176017|FG003|Overall Study|Pregnancy|2
7742478|NCT00689117|12176014|FG000|Overall Study|Incarceration|2
7742479|NCT00689117|12176015|FG001|Overall Study|Incarceration|0
7742480|NCT00689117|12176016|FG002|Overall Study|Incarceration|0
7742481|NCT00689117|12176017|FG003|Overall Study|Incarceration|0
7742482|NCT00689117|12176014|FG000|Overall Study|Fear of Birth Defects|0
7742483|NCT00689117|12176015|FG001|Overall Study|Fear of Birth Defects|0
7742484|NCT00689117|12176016|FG002|Overall Study|Fear of Birth Defects|1
7742485|NCT00689117|12176017|FG003|Overall Study|Fear of Birth Defects|0
7742486|NCT00689117|12176014|FG000|Overall Study|Transportation|1
7742487|NCT00689117|12176015|FG001|Overall Study|Transportation|0
7742488|NCT00689117|12176016|FG002|Overall Study|Transportation|0
7742489|NCT00689117|12176017|FG003|Overall Study|Transportation|0
7742490|NCT00689117|12176014|FG000|Overall Study|Patient Withdrew from Study|0
7742491|NCT00689117|12176015|FG001|Overall Study|Patient Withdrew from Study|0
7742492|NCT00689117|12176016|FG002|Overall Study|Patient Withdrew from Study|0
7742493|NCT00689117|12176017|FG003|Overall Study|Patient Withdrew from Study|1
7742494|NCT00689117|12176014|FG000|Overall Study|Personal Reason|0
7742495|NCT00689117|12176015|FG001|Overall Study|Personal Reason|1
7742496|NCT00689117|12176016|FG002|Overall Study|Personal Reason|0
7742497|NCT00689117|12176017|FG003|Overall Study|Personal Reason|0
7742498|NCT00689117|12176014|FG000|Overall Study|Dispensing Error|0
7742499|NCT00689117|12176015|FG001|Overall Study|Dispensing Error|1
7742500|NCT00689117|12176016|FG002|Overall Study|Dispensing Error|0
7742501|NCT00689117|12176017|FG003|Overall Study|Dispensing Error|0
7742502|NCT00689221|12176029|FG000|Overall Study|Ongoing at cut-off date|39
7742503|NCT00689221|12176030|FG001|Overall Study|Ongoing at cut-off date|36
7742504|NCT00689273|12176050|FG000|Overall Study|Adverse Event|3
7742505|NCT00689273|12176051|FG001|Overall Study|Adverse Event|1
7742506|NCT00689273|12176050|FG000|Overall Study|Lack of Efficacy|3
7742507|NCT00689273|12176051|FG001|Overall Study|Lack of Efficacy|0
7742508|NCT00689273|12176050|FG000|Overall Study|Lost to Follow-up|0
7742509|NCT00689273|12176051|FG001|Overall Study|Lost to Follow-up|2
7742510|NCT00689273|12176050|FG000|Overall Study|Other|6
7742511|NCT00689273|12176051|FG001|Overall Study|Other|2
7742512|NCT00689273|12176050|FG000|Overall Study|Randomized but not Treated|1
7742513|NCT00689273|12176051|FG001|Overall Study|Randomized but not Treated|0
7742514|NCT00689299|12176060|FG000|Overall Study|Adverse Event|2
7742515|NCT00689299|12176061|FG001|Overall Study|Adverse Event|1
7742516|NCT00689299|12176062|FG002|Overall Study|Adverse Event|1
7742517|NCT00689299|12176060|FG000|Overall Study|Lost to Follow-up|0
7742518|NCT00689299|12176061|FG001|Overall Study|Lost to Follow-up|1
7742519|NCT00689299|12176062|FG002|Overall Study|Lost to Follow-up|1
7742520|NCT00689299|12176060|FG000|Overall Study|Withdrawal by Subject|4
7742521|NCT00689299|12176061|FG001|Overall Study|Withdrawal by Subject|1
7742522|NCT00689299|12176062|FG002|Overall Study|Withdrawal by Subject|3
7742523|NCT00689299|12176060|FG000|Overall Study|Protocol Violation|1
7742524|NCT00689299|12176061|FG001|Overall Study|Protocol Violation|0
7742525|NCT00689299|12176062|FG002|Overall Study|Protocol Violation|0
7769117|NCT00866359|12212535|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4
7769118|NCT00866359|12212536|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0
7769119|NCT00866359|12212537|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0
7769120|NCT00866359|12212534|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
7769121|NCT00866359|12212535|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
7769122|NCT00866359|12212536|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
7769123|NCT00866359|12212537|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
7769124|NCT00866359|12212534|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
7769125|NCT00866359|12212535|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
7769126|NCT00866359|12212536|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
7769127|NCT00866359|12212537|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
7769128|NCT00866359|12212534|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1
7769129|NCT00866359|12212535|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1
7769130|NCT00866359|12212536|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0
7769131|NCT00866359|12212537|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0
7769132|NCT00866359|12212534|FG000|Treatment Phase (Days 1 to 85)|Other|1
7742526|NCT00689338|12176070|FG000|Overall Study|Death|65
7742527|NCT00689338|12176070|FG000|Overall Study|Adverse Event|13
7742528|NCT00689338|12176070|FG000|Overall Study|Insufficient Clinical Response|1
7742529|NCT00689338|12176070|FG000|Overall Study|Lack of Efficacy|6
7742530|NCT00689338|12176070|FG000|Overall Study|Other|8
7742531|NCT00689338|12176070|FG000|Overall Study|Did not Meet Entrance Criteria|27
7742532|NCT00689338|12176070|FG000|Overall Study|Lost to Follow-up|5
7742533|NCT00689338|12176070|FG000|Overall Study|Withdrawal by Subject|3
7742534|NCT00689338|12176070|FG000|Overall Study|Protocol Violation|15
7742535|NCT00689351|12176076|FG000|Infant Series of Dosing|Parent/legal guardian request|5
7742536|NCT00689351|12176077|FG001|Infant Series of Dosing|Parent/legal guardian request|0
7742537|NCT00689351|12176076|FG000|Infant Series of Dosing|Adverse Event|1
7742538|NCT00689351|12176077|FG001|Infant Series of Dosing|Adverse Event|0
7742539|NCT00689351|12176076|FG000|Infant Series of Dosing|Lost to Follow-up|0
7742540|NCT00689351|12176077|FG001|Infant Series of Dosing|Lost to Follow-up|1
7742541|NCT00689351|12176076|FG000|After Infant Series|Parent/legal guardian request|1
7742542|NCT00689351|12176077|FG001|After Infant Series|Parent/legal guardian request|0
7742543|NCT00689390|12176089|FG000|Overall Study|Adverse Event|19
7742544|NCT00689390|12176090|FG001|Overall Study|Adverse Event|0
7742545|NCT00689390|12176089|FG000|Overall Study|Lost to Follow-up|179
7742546|NCT00689390|12176090|FG001|Overall Study|Lost to Follow-up|7
7742547|NCT00689390|12176089|FG000|Overall Study|Withdrawal by Subject|117
7742548|NCT00689390|12176090|FG001|Overall Study|Withdrawal by Subject|3
7742549|NCT00689390|12176089|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52
7742550|NCT00689390|12176090|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0
7742551|NCT00689390|12176089|FG000|Overall Study|Non-Compliance With Protocol|21
7742552|NCT00689390|12176090|FG001|Overall Study|Non-Compliance With Protocol|0
7742553|NCT00689390|12176089|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
7742554|NCT00689390|12176090|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
7742555|NCT00689390|12176089|FG000|Overall Study|Administrative|37
7742556|NCT00689390|12176090|FG001|Overall Study|Administrative|0
7742557|NCT00689481|12176103|FG000|Overall Study|Adverse Event|7
7742558|NCT00689481|12176104|FG001|Overall Study|Adverse Event|1
7742559|NCT00689481|12176103|FG000|Overall Study|Lost to Follow-up|4
7742560|NCT00689481|12176104|FG001|Overall Study|Lost to Follow-up|3
7742561|NCT00689481|12176103|FG000|Overall Study|Lack of Efficacy|4
7742562|NCT00689481|12176104|FG001|Overall Study|Lack of Efficacy|3
7742563|NCT00689481|12176103|FG000|Overall Study|Non-compliance with study treatment|1
7742564|NCT00689481|12176104|FG001|Overall Study|Non-compliance with study treatment|1
7742565|NCT00689481|12176103|FG000|Overall Study|Withdrawal by Subject|8
7742566|NCT00689481|12176104|FG001|Overall Study|Withdrawal by Subject|4
7742567|NCT00689481|12176103|FG000|Overall Study|Excluded medication started during study|0
7742568|NCT00689481|12176104|FG001|Overall Study|Excluded medication started during study|1
7742569|NCT00689481|12176103|FG000|Overall Study|Subject early term, left on vacation|0
7742570|NCT00689481|12176104|FG001|Overall Study|Subject early term, left on vacation|1
7742571|NCT00689611|12176121|FG000|Overall Study|Death|6
7742572|NCT00689611|12176122|FG001|Overall Study|Death|9
7742573|NCT00689611|12176121|FG000|Overall Study|Withdrawal by Subject|8
7742574|NCT00689611|12176122|FG001|Overall Study|Withdrawal by Subject|9
7742575|NCT00689611|12176121|FG000|Overall Study|Lost to Follow-up|27
7742576|NCT00689611|12176122|FG001|Overall Study|Lost to Follow-up|28
7742577|NCT00689728|12176131|FG000|Double-Blind Treatment|Adverse Event|1
7742578|NCT00689728|12176132|FG001|Double-Blind Treatment|Adverse Event|0
7742579|NCT00689728|12176133|FG002|Double-Blind Treatment|Adverse Event|0
7742580|NCT00689728|12176131|FG000|Double-Blind Treatment|Protocol Violation|0
7742581|NCT00689728|12176132|FG001|Double-Blind Treatment|Protocol Violation|0
7742582|NCT00689728|12176133|FG002|Double-Blind Treatment|Protocol Violation|1
7742583|NCT00689728|12176131|FG000|Double-Blind Treatment|Withdrawal by Subject|3
7742584|NCT00689728|12176132|FG001|Double-Blind Treatment|Withdrawal by Subject|3
7742585|NCT00689728|12176133|FG002|Double-Blind Treatment|Withdrawal by Subject|2
7742586|NCT00689728|12176131|FG000|Double-Blind Treatment|Lack of Efficacy|0
7742587|NCT00689728|12176132|FG001|Double-Blind Treatment|Lack of Efficacy|1
7742588|NCT00689728|12176133|FG002|Double-Blind Treatment|Lack of Efficacy|2
7742589|NCT00689728|12176131|FG000|Rescue|Adverse Event|0
7742590|NCT00689728|12176132|FG001|Rescue|Adverse Event|1
7742591|NCT00689728|12176133|FG002|Rescue|Adverse Event|0
7742592|NCT00689728|12176131|FG000|Rescue|Withdrawal by Subject|1
7742593|NCT00689728|12176132|FG001|Rescue|Withdrawal by Subject|1
7742594|NCT00689728|12176133|FG002|Rescue|Withdrawal by Subject|1
7742595|NCT00689728|12176131|FG000|Optional Follow-Up|Adverse Event|1
7742596|NCT00689728|12176132|FG001|Optional Follow-Up|Adverse Event|0
7742597|NCT00689728|12176133|FG002|Optional Follow-Up|Adverse Event|0
7742598|NCT00689728|12176131|FG000|Optional Follow-Up|Lack of Efficacy|0
7742599|NCT00689728|12176132|FG001|Optional Follow-Up|Lack of Efficacy|1
7742600|NCT00689728|12176133|FG002|Optional Follow-Up|Lack of Efficacy|1
7742601|NCT00689728|12176131|FG000|Optional Follow-Up|Lost to Follow-up|0
7742602|NCT00689728|12176132|FG001|Optional Follow-Up|Lost to Follow-up|1
7742603|NCT00689728|12176133|FG002|Optional Follow-Up|Lost to Follow-up|1
7742604|NCT00689728|12176131|FG000|Optional Follow-Up|Protocol Violation|0
7742605|NCT00689728|12176132|FG001|Optional Follow-Up|Protocol Violation|0
7742606|NCT00689728|12176133|FG002|Optional Follow-Up|Protocol Violation|1
7742607|NCT00689728|12176131|FG000|Optional Follow-Up|Withdrawal by Subject|2
7742608|NCT00689728|12176132|FG001|Optional Follow-Up|Withdrawal by Subject|4
7742609|NCT00689728|12176133|FG002|Optional Follow-Up|Withdrawal by Subject|3
7742610|NCT00689793|12176164|FG000|Overall Study|Lost to Follow-up|4
7742611|NCT00689793|12176165|FG001|Overall Study|Lost to Follow-up|5
7742612|NCT00689871|12176186|FG000|Overall Study|Lost to Follow-up|123
7742613|NCT00689871|12176187|FG001|Overall Study|Lost to Follow-up|13
7742614|NCT00689871|12176188|FG002|Overall Study|Lost to Follow-up|37
7742615|NCT00689871|12176189|FG003|Overall Study|Lost to Follow-up|1
7742616|NCT00689871|12176186|FG000|Overall Study|Explanted of All Study Devices|36
7742617|NCT00689871|12176187|FG001|Overall Study|Explanted of All Study Devices|25
7742618|NCT00689871|12176188|FG002|Overall Study|Explanted of All Study Devices|29
7742619|NCT00689871|12176189|FG003|Overall Study|Explanted of All Study Devices|3
7742620|NCT00689871|12176186|FG000|Overall Study|Withdrawal by Subject|13
7742621|NCT00689871|12176187|FG001|Overall Study|Withdrawal by Subject|3
7742622|NCT00689871|12176188|FG002|Overall Study|Withdrawal by Subject|4
7742623|NCT00689871|12176189|FG003|Overall Study|Withdrawal by Subject|1
7742624|NCT00689871|12176186|FG000|Overall Study|Death|1
7742625|NCT00689871|12176187|FG001|Overall Study|Death|10
7742626|NCT00689871|12176188|FG002|Overall Study|Death|2
7742627|NCT00689871|12176189|FG003|Overall Study|Death|2
7742628|NCT00689871|12176186|FG000|Overall Study|Physician Decision|2
7742629|NCT00689871|12176187|FG001|Overall Study|Physician Decision|1
7742630|NCT00689871|12176188|FG002|Overall Study|Physician Decision|1
7742631|NCT00689871|12176189|FG003|Overall Study|Physician Decision|0
7742632|NCT00689936|12176202|FG000|Active Treatment Phase|Adverse Event|68
7742633|NCT00689936|12176203|FG001|Active Treatment Phase|Adverse Event|71
7742634|NCT00689936|12176204|FG002|Active Treatment Phase|Adverse Event|76
7742635|NCT00689936|12176202|FG000|Active Treatment Phase|Disease Progression|273
7742636|NCT00689936|12176203|FG001|Active Treatment Phase|Disease Progression|362
7742637|NCT00689936|12176204|FG002|Active Treatment Phase|Disease Progression|339
7742638|NCT00689936|12176202|FG000|Active Treatment Phase|Withdrawal by Subject|16
7742639|NCT00689936|12176203|FG001|Active Treatment Phase|Withdrawal by Subject|16
7742640|NCT00689936|12176204|FG002|Active Treatment Phase|Withdrawal by Subject|21
7742641|NCT00689936|12176202|FG000|Active Treatment Phase|Death|60
7742642|NCT00689936|12176203|FG001|Active Treatment Phase|Death|28
7742643|NCT00689936|12176204|FG002|Active Treatment Phase|Death|37
7742644|NCT00689936|12176202|FG000|Active Treatment Phase|Lost to Follow-up|0
7742645|NCT00689936|12176203|FG001|Active Treatment Phase|Lost to Follow-up|2
7742646|NCT00689936|12176204|FG002|Active Treatment Phase|Lost to Follow-up|2
7742647|NCT00689936|12176202|FG000|Active Treatment Phase|Protocol Violation|2
7742648|NCT00689936|12176203|FG001|Active Treatment Phase|Protocol Violation|2
7742649|NCT00689936|12176204|FG002|Active Treatment Phase|Protocol Violation|4
7742650|NCT00689936|12176202|FG000|Active Treatment Phase|Study Close Out|64
7742651|NCT00689936|12176203|FG001|Active Treatment Phase|Study Close Out|26
7742652|NCT00689936|12176204|FG002|Active Treatment Phase|Study Close Out|21
7742653|NCT00689936|12176202|FG000|Active Treatment Phase|Miscellaneous|52
7742654|NCT00689936|12176203|FG001|Active Treatment Phase|Miscellaneous|34
7742655|NCT00689936|12176204|FG002|Active Treatment Phase|Miscellaneous|47
7742656|NCT00689936|12176202|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
7742657|NCT00689936|12176203|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
7742658|NCT00689936|12176204|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
7742659|NCT00690378|12176258|FG000|Overall Study|Adverse Event|1
7742660|NCT00690378|12176259|FG001|Overall Study|Adverse Event|0
7742661|NCT00690378|12176258|FG000|Overall Study|Withdrawal by Subject|2
7742662|NCT00690378|12176259|FG001|Overall Study|Withdrawal by Subject|0
7742663|NCT00690378|12176258|FG000|Overall Study|Protocol Violation|1
7742664|NCT00690378|12176259|FG001|Overall Study|Protocol Violation|0
7742665|NCT00690378|12176258|FG000|Overall Study|Lost to Follow-up|2
7742666|NCT00690378|12176259|FG001|Overall Study|Lost to Follow-up|3
7742667|NCT00690378|12176258|FG000|Overall Study|Did not meet inc/exc criteria|13
7742668|NCT00690378|12176259|FG001|Overall Study|Did not meet inc/exc criteria|11
7742669|NCT00690378|12176258|FG000|Overall Study|Social problem|1
7742670|NCT00690378|12176259|FG001|Overall Study|Social problem|0
7742671|NCT00690430|12176267|FG000|Core Phase|Abnormal Laboratory value|0
7742672|NCT00690430|12176268|FG001|Core Phase|Abnormal Laboratory value|1
7742673|NCT00690430|12176269|FG002|Core Phase|Abnormal Laboratory value|0
7742674|NCT00690430|12176267|FG000|Core Phase|Adverse Event|5
7742675|NCT00690430|12176268|FG001|Core Phase|Adverse Event|1
7742676|NCT00690430|12176269|FG002|Core Phase|Adverse Event|0
7742677|NCT00690430|12176267|FG000|Core Phase|Death|0
7742678|NCT00690430|12176268|FG001|Core Phase|Death|2
7742679|NCT00690430|12176269|FG002|Core Phase|Death|0
7742680|NCT00690430|12176267|FG000|Core Phase|Protocol Violation|1
7742681|NCT00690430|12176268|FG001|Core Phase|Protocol Violation|0
7742682|NCT00690430|12176269|FG002|Core Phase|Protocol Violation|0
7742683|NCT00690430|12176267|FG000|Core Phase|Withdrawal by Subject|3
7742684|NCT00690430|12176268|FG001|Core Phase|Withdrawal by Subject|3
7742685|NCT00690430|12176269|FG002|Core Phase|Withdrawal by Subject|0
7742686|NCT00690430|12176267|FG000|Core Phase|Subject no longer requires study drug|1
7742687|NCT00690430|12176268|FG001|Core Phase|Subject no longer requires study drug|0
7742688|NCT00690430|12176269|FG002|Core Phase|Subject no longer requires study drug|0
7742689|NCT00690430|12176267|FG000|Core Phase|Lack of Efficacy|8
7742690|NCT00690430|12176268|FG001|Core Phase|Lack of Efficacy|10
7742691|NCT00690430|12176269|FG002|Core Phase|Lack of Efficacy|0
7742692|NCT00690430|12176267|FG000|Core Phase|Administrative Problems|0
7742693|NCT00690430|12176268|FG001|Core Phase|Administrative Problems|1
7742694|NCT00690430|12176269|FG002|Core Phase|Administrative Problems|0
7742695|NCT00690430|12176267|FG000|Core Phase|Early Termination|0
7742696|NCT00690430|12176268|FG001|Core Phase|Early Termination|5
7742697|NCT00690430|12176269|FG002|Core Phase|Early Termination|0
7742698|NCT00690430|12176267|FG000|Extension Phase|Lack of Efficacy|3
7742699|NCT00690430|12176268|FG001|Extension Phase|Lack of Efficacy|1
7742700|NCT00690430|12176269|FG002|Extension Phase|Lack of Efficacy|4
7742701|NCT00690430|12176267|FG000|Extension Phase|Abnormal Lab Values|1
7742702|NCT00690430|12176268|FG001|Extension Phase|Abnormal Lab Values|0
7742703|NCT00690430|12176269|FG002|Extension Phase|Abnormal Lab Values|0
7742704|NCT00690430|12176267|FG000|Extension Phase|Abnormal test procedure results|1
7742705|NCT00690430|12176268|FG001|Extension Phase|Abnormal test procedure results|0
7742706|NCT00690430|12176269|FG002|Extension Phase|Abnormal test procedure results|0
7742707|NCT00690430|12176267|FG000|Extension Phase|Administrative Problems|0
7742708|NCT00690430|12176268|FG001|Extension Phase|Administrative Problems|1
7742709|NCT00690430|12176269|FG002|Extension Phase|Administrative Problems|1
7742710|NCT00690430|12176267|FG000|Extension Phase|Adverse Event|2
7742711|NCT00690430|12176268|FG001|Extension Phase|Adverse Event|1
7742712|NCT00690430|12176269|FG002|Extension Phase|Adverse Event|2
7742713|NCT00690430|12176267|FG000|Extension Phase|Death|1
7742714|NCT00690430|12176268|FG001|Extension Phase|Death|1
7742715|NCT00690430|12176269|FG002|Extension Phase|Death|1
7742716|NCT00690430|12176267|FG000|Extension Phase|Withdrawal by Subject|0
7742717|NCT00690430|12176268|FG001|Extension Phase|Withdrawal by Subject|0
7742718|NCT00690430|12176269|FG002|Extension Phase|Withdrawal by Subject|2
7742719|NCT00690430|12176267|FG000|Extension Phase|Early Termination|10
7742720|NCT00690430|12176268|FG001|Extension Phase|Early Termination|1
7742721|NCT00690430|12176269|FG002|Extension Phase|Early Termination|3
7742722|NCT00690443|12176280|FG000|Overall Study|Adverse Event|1
7742723|NCT00690443|12176281|FG001|Overall Study|Adverse Event|2
7742724|NCT00690482|12176289|FG000|Overall Study|Adverse Event|2
7742725|NCT00690482|12176290|FG001|Overall Study|Adverse Event|1
7742726|NCT00690482|12176289|FG000|Overall Study|Incorrect enrolment|0
7742727|NCT00690482|12176290|FG001|Overall Study|Incorrect enrolment|1
7742728|NCT00690482|12176289|FG000|Overall Study|Study-specific discontinuation criteria|1
7742729|NCT00690482|12176290|FG001|Overall Study|Study-specific discontinuation criteria|0
7742730|NCT00690482|12176289|FG000|Overall Study|Intake of prohibited medicine|1
7742731|NCT00690482|12176290|FG001|Overall Study|Intake of prohibited medicine|0
7742732|NCT00690482|12176289|FG000|Overall Study|withdrew consent at rand.day|0
7742733|NCT00690482|12176290|FG001|Overall Study|withdrew consent at rand.day|1
7742734|NCT00690573|12176305|FG000|Overall Study|Lack of Efficacy|8
7742735|NCT00690573|12176305|FG000|Overall Study|Withdrawal by Subject|1
7742736|NCT00690612|12176309|FG000|Overall Study|Adverse Event|1
7742737|NCT00690612|12176309|FG000|Overall Study|Withdrawal by Subject|2
7742738|NCT00690755|12176320|FG000|Overall Study|Physician Decision|2
7742739|NCT00690755|12176321|FG001|Overall Study|Physician Decision|0
7742740|NCT00690755|12176322|FG002|Overall Study|Physician Decision|46
7742741|NCT00690755|12176323|FG003|Overall Study|Physician Decision|5
7742742|NCT00690755|12176324|FG004|Overall Study|Physician Decision|0
7742743|NCT00690755|12176325|FG005|Overall Study|Physician Decision|4
7742744|NCT00690755|12176326|FG006|Overall Study|Physician Decision|0
7742745|NCT00690794|12176344|FG000|Overall Study|Adverse Event|12
7742746|NCT00690794|12176345|FG001|Overall Study|Adverse Event|10
7742747|NCT00690794|12176344|FG000|Overall Study|Lost to Follow-up|1
7742748|NCT00690794|12176345|FG001|Overall Study|Lost to Follow-up|4
7742749|NCT00690794|12176344|FG000|Overall Study|Withdrawal by Subject|0
7742750|NCT00690794|12176345|FG001|Overall Study|Withdrawal by Subject|9
7742751|NCT00690794|12176344|FG000|Overall Study|Protocol Violation|6
7742752|NCT00690794|12176345|FG001|Overall Study|Protocol Violation|7
7742753|NCT00690794|12176344|FG000|Overall Study|Noncompliance|1
7742754|NCT00690794|12176345|FG001|Overall Study|Noncompliance|2
7742755|NCT00690794|12176344|FG000|Overall Study|Other not specified|1
7742756|NCT00690794|12176345|FG001|Overall Study|Other not specified|3
7742757|NCT00690820|12176353|FG000|Period 1|Withdrawal by Subject|0
7742758|NCT00690820|12176354|FG001|Period 1|Withdrawal by Subject|1
7742759|NCT00690898|12176364|FG000|SCREENING|Screen failure|18
7742760|NCT00690898|12176364|FG000|TREATMENT|Adverse Event|3
7742761|NCT00690898|12176364|FG000|TREATMENT|Lack of Efficacy|18
7742762|NCT00690898|12176364|FG000|TREATMENT|Withdrawal by Subject|4
7742763|NCT00690898|12176364|FG000|TREATMENT|Other (not otherwise specified)|1
7742764|NCT00691015|12176391|FG000|Overall Study|Refused further treatment|1
7742765|NCT00691028|12176398|FG000|Open-label Period|Adverse Event|0
7742766|NCT00691028|12176399|FG001|Open-label Period|Adverse Event|0
7742767|NCT00691028|12176400|FG002|Open-label Period|Adverse Event|0
7742768|NCT00691028|12176401|FG003|Open-label Period|Adverse Event|16
7742769|NCT00691028|12176398|FG000|Open-label Period|Withdrawal by Subject|0
7742770|NCT00691028|12176399|FG001|Open-label Period|Withdrawal by Subject|0
7742771|NCT00691028|12176400|FG002|Open-label Period|Withdrawal by Subject|0
7742772|NCT00691028|12176401|FG003|Open-label Period|Withdrawal by Subject|3
7742773|NCT00691028|12176398|FG000|Open-label Period|not come to a hospital|0
7742774|NCT00691028|12176399|FG001|Open-label Period|not come to a hospital|0
7742775|NCT00691028|12176400|FG002|Open-label Period|not come to a hospital|0
7742776|NCT00691028|12176401|FG003|Open-label Period|not come to a hospital|1
7742777|NCT00691028|12176398|FG000|Double-blind Period|Adverse Event|8
7742778|NCT00691028|12176399|FG001|Double-blind Period|Adverse Event|9
7742779|NCT00691028|12176400|FG002|Double-blind Period|Adverse Event|6
7742780|NCT00691028|12176401|FG003|Double-blind Period|Adverse Event|0
7742781|NCT00691028|12176398|FG000|Double-blind Period|Lack of Efficacy|4
7742782|NCT00691028|12176399|FG001|Double-blind Period|Lack of Efficacy|3
7742783|NCT00691028|12176400|FG002|Double-blind Period|Lack of Efficacy|2
7742784|NCT00691028|12176401|FG003|Double-blind Period|Lack of Efficacy|0
7742785|NCT00691028|12176398|FG000|Double-blind Period|Withdrawal by Subject|1
7742786|NCT00691028|12176399|FG001|Double-blind Period|Withdrawal by Subject|0
7742787|NCT00691028|12176400|FG002|Double-blind Period|Withdrawal by Subject|1
7742788|NCT00691028|12176401|FG003|Double-blind Period|Withdrawal by Subject|0
7742789|NCT00691028|12176398|FG000|Double-blind Period|not come to a hospital.|0
7742790|NCT00691028|12176399|FG001|Double-blind Period|not come to a hospital.|1
7742791|NCT00691028|12176400|FG002|Double-blind Period|not come to a hospital.|0
7742792|NCT00691028|12176401|FG003|Double-blind Period|not come to a hospital.|0
7742793|NCT00691054|12176413|FG000|Overall Study|Withdrawal by Subject|1
7742794|NCT00691093|12176419|FG000|Overall Study|Adverse Event|1
7742795|NCT00691093|12176419|FG000|Overall Study|Lost to Follow-up|1
7742796|NCT00691093|12176419|FG000|Overall Study|Lack of Efficacy|1
7742797|NCT00691093|12176419|FG000|Overall Study|Ongoing at Date of Cut-Off|4
7742798|NCT00691132|12176430|FG000|Overall Study|Adverse Event|2
7742799|NCT00691132|12176431|FG001|Overall Study|Adverse Event|3
7742800|NCT00691132|12176430|FG000|Overall Study|Withdrawal by Subject|10
7742801|NCT00691132|12176431|FG001|Overall Study|Withdrawal by Subject|10
7742802|NCT00691210|12176464|FG000|Overall Study|Progression of Disease|0
7742803|NCT00691210|12176465|FG001|Overall Study|Progression of Disease|0
7742804|NCT00691210|12176466|FG002|Overall Study|Progression of Disease|0
7742805|NCT00691210|12176467|FG003|Overall Study|Progression of Disease|2
7742806|NCT00691210|12176468|FG004|Overall Study|Progression of Disease|0
7742807|NCT00691210|12176469|FG005|Overall Study|Progression of Disease|0
7742808|NCT00691210|12176470|FG006|Overall Study|Progression of Disease|0
7742809|NCT00691210|12176471|FG007|Overall Study|Progression of Disease|0
7742810|NCT00691210|12176464|FG000|Overall Study|Lack of Efficacy|0
7742811|NCT00691210|12176465|FG001|Overall Study|Lack of Efficacy|0
7742812|NCT00691210|12176466|FG002|Overall Study|Lack of Efficacy|0
7742813|NCT00691210|12176467|FG003|Overall Study|Lack of Efficacy|1
7742814|NCT00691210|12176468|FG004|Overall Study|Lack of Efficacy|0
7742815|NCT00691210|12176469|FG005|Overall Study|Lack of Efficacy|1
7742816|NCT00691210|12176470|FG006|Overall Study|Lack of Efficacy|0
7742817|NCT00691210|12176471|FG007|Overall Study|Lack of Efficacy|0
7742818|NCT00691301|12176489|FG000|Overall Study|Adverse Event|10
7742819|NCT00691301|12176489|FG000|Overall Study|Death|2
7742820|NCT00691301|12176489|FG000|Overall Study|Lack of Efficacy|32
7742821|NCT00691301|12176489|FG000|Overall Study|Withdrawal by Subject|4
7742822|NCT00691301|12176489|FG000|Overall Study|Concurrent illness|2
7742823|NCT00691301|12176489|FG000|Overall Study|other reason|3
7742824|NCT00691301|12176489|FG000|Overall Study|Did not initiate study treatment|1
7742825|NCT00691483|12176510|FG000|Overall Study|Adverse Event|14
7742826|NCT00691483|12176511|FG001|Overall Study|Adverse Event|6
7742827|NCT00691483|12176510|FG000|Overall Study|Lost to Follow-up|17
7742828|NCT00691483|12176511|FG001|Overall Study|Lost to Follow-up|10
7742829|NCT00691483|12176510|FG000|Overall Study|Withdrawal by Subject|24
7742830|NCT00691483|12176511|FG001|Overall Study|Withdrawal by Subject|7
7742831|NCT00691483|12176510|FG000|Overall Study|Other known cause|6
7742832|NCT00691483|12176511|FG001|Overall Study|Other known cause|1
7742833|NCT00691483|12176510|FG000|Overall Study|Randomized by not treated|7
7742834|NCT00691483|12176511|FG001|Overall Study|Randomized by not treated|1
7742835|NCT00691704|12176535|FG000|Induction Therapy|Disease Progression|1
7742836|NCT00691704|12176535|FG000|Induction Therapy|Active Hepatitis|1
7742837|NCT00691704|12176535|FG000|Two Years of Maintenance Therapy|Disease Progression|8
7742838|NCT00691704|12176535|FG000|Two Years of Maintenance Therapy|Physician Decision|4
7742839|NCT00691704|12176535|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1
7742840|NCT00691938|12176559|FG000|Overall Study|QTc prolongation|1
7742841|NCT00691938|12176560|FG001|Overall Study|QTc prolongation|0
7742842|NCT00691938|12176561|FG002|Overall Study|QTc prolongation|0
7742843|NCT00691938|12176562|FG003|Overall Study|QTc prolongation|0
7742844|NCT00691938|12176563|FG004|Overall Study|QTc prolongation|0
7742845|NCT00691938|12176564|FG005|Overall Study|QTc prolongation|0
7742846|NCT00691938|12176565|FG006|Overall Study|QTc prolongation|0
7742847|NCT00692237|12176608|FG000|Overall Study|Withdrawal by Subject|1
7742848|NCT00692237|12176609|FG001|Overall Study|Withdrawal by Subject|3
7742849|NCT00692237|12176608|FG000|Overall Study|Adverse Event|0
7742850|NCT00692237|12176609|FG001|Overall Study|Adverse Event|1
7742851|NCT00692406|12176637|FG000|Overall Study|PI dropped, bad data|57
7742852|NCT00692770|12176663|FG000|Overall Study|Protocol Violation|2
7742853|NCT00692770|12176664|FG001|Overall Study|Protocol Violation|7
7742854|NCT00692770|12176663|FG000|Overall Study|Withdrawal by Subject|97
7742855|NCT00692770|12176664|FG001|Overall Study|Withdrawal by Subject|36
7742856|NCT00692770|12176663|FG000|Overall Study|Adverse Event|136
7742857|NCT00692770|12176664|FG001|Overall Study|Adverse Event|41
7742858|NCT00692770|12176663|FG000|Overall Study|Death|10
7742859|NCT00692770|12176664|FG001|Overall Study|Death|5
7742860|NCT00692770|12176663|FG000|Overall Study|Lost to Follow-up|7
7742861|NCT00692770|12176664|FG001|Overall Study|Lost to Follow-up|3
7742862|NCT00692770|12176663|FG000|Overall Study|Non-compliant with study medication|11
7742863|NCT00692770|12176664|FG001|Overall Study|Non-compliant with study medication|5
7742864|NCT00692770|12176663|FG000|Overall Study|Progression by clinical judgment|2
7742865|NCT00692770|12176664|FG001|Overall Study|Progression by clinical judgment|3
7742866|NCT00692770|12176663|FG000|Overall Study|Physician decision not protocol driven|10
7742867|NCT00692770|12176664|FG001|Overall Study|Physician decision not protocol driven|14
7742868|NCT00692770|12176663|FG000|Overall Study|Disease progression, recurrence/relapse|170
7742869|NCT00692770|12176664|FG001|Overall Study|Disease progression, recurrence/relapse|279
7742870|NCT00692770|12176663|FG000|Overall Study|Protocol driven decision point|3
7742871|NCT00692770|12176664|FG001|Overall Study|Protocol driven decision point|7
7742872|NCT00692770|12176663|FG000|Overall Study|Completed all planned assessments|79
7742873|NCT00692770|12176664|FG001|Overall Study|Completed all planned assessments|101
7742874|NCT00692770|12176663|FG000|Overall Study|Radiological and clinical progression|8
7742875|NCT00692770|12176664|FG001|Overall Study|Radiological and clinical progression|8
7742876|NCT00692770|12176663|FG000|Overall Study|Clinical endpoint reached|16
7742877|NCT00692770|12176664|FG001|Overall Study|Clinical endpoint reached|43
7742878|NCT00692770|12176663|FG000|Overall Study|Study terminated by sponsor|2
7742879|NCT00692770|12176664|FG001|Overall Study|Study terminated by sponsor|2
7742880|NCT00692770|12176663|FG000|Overall Study|Randomized but not treated|3
7742881|NCT00692770|12176664|FG001|Overall Study|Randomized but not treated|4
7742882|NCT00693225|12176708|FG000|Overall Study|Lost to Follow-up|1
7742883|NCT00693225|12176709|FG001|Overall Study|Lost to Follow-up|2
7742884|NCT00693225|12176708|FG000|Overall Study|Adverse Event|1
7742885|NCT00693225|12176709|FG001|Overall Study|Adverse Event|3
7742886|NCT00693420|12176721|FG000|Overall Study|Adverse Event|4
7742887|NCT00693420|12176722|FG001|Overall Study|Adverse Event|4
7742888|NCT00693420|12176721|FG000|Overall Study|Lost to Follow-up|0
7742889|NCT00693420|12176722|FG001|Overall Study|Lost to Follow-up|3
7742890|NCT00693420|12176721|FG000|Overall Study|Withdrawal by Subject|1
7742891|NCT00693420|12176722|FG001|Overall Study|Withdrawal by Subject|0
7742892|NCT00693420|12176721|FG000|Overall Study|Protocol Violation|0
7742893|NCT00693420|12176722|FG001|Overall Study|Protocol Violation|2
7742894|NCT00693420|12176721|FG000|Overall Study|Sponsor Request - Conflict of Interest|0
7742895|NCT00693420|12176722|FG001|Overall Study|Sponsor Request - Conflict of Interest|2
7742896|NCT00693420|12176721|FG000|Overall Study|Personal Reasons|1
7742897|NCT00693420|12176722|FG001|Overall Study|Personal Reasons|4
7742898|NCT00693472|12176732|FG000|Part 1|Adverse Event|1
7742899|NCT00693472|12176733|FG001|Part 1|Adverse Event|1
7742900|NCT00693472|12176734|FG002|Part 1|Adverse Event|0
7742901|NCT00693472|12176735|FG003|Part 1|Adverse Event|0
7742902|NCT00693472|12176732|FG000|Part 1|Lost to Follow-up|0
7742903|NCT00693472|12176733|FG001|Part 1|Lost to Follow-up|1
7742904|NCT00693472|12176734|FG002|Part 1|Lost to Follow-up|0
7742905|NCT00693472|12176735|FG003|Part 1|Lost to Follow-up|0
7742906|NCT00693472|12176732|FG000|Part 1|Withdrew - reason unrelated to treatment|5
7742907|NCT00693472|12176733|FG001|Part 1|Withdrew - reason unrelated to treatment|2
7742908|NCT00693472|12176734|FG002|Part 1|Withdrew - reason unrelated to treatment|0
7742909|NCT00693472|12176735|FG003|Part 1|Withdrew - reason unrelated to treatment|0
7742910|NCT00693472|12176732|FG000|Part 2|Adverse Event|0
7742911|NCT00693472|12176733|FG001|Part 2|Adverse Event|0
7742912|NCT00693472|12176734|FG002|Part 2|Adverse Event|1
7742913|NCT00693472|12176735|FG003|Part 2|Adverse Event|0
7742914|NCT00693472|12176732|FG000|Part 2|Withdrew - reason unrelated to treatment|0
7742915|NCT00693472|12176733|FG001|Part 2|Withdrew - reason unrelated to treatment|0
7742916|NCT00693472|12176734|FG002|Part 2|Withdrew - reason unrelated to treatment|1
7742917|NCT00693472|12176735|FG003|Part 2|Withdrew - reason unrelated to treatment|2
7742918|NCT00693693|12176780|FG000|Overall Study|Lost to Follow-up|1
7742919|NCT00693693|12176781|FG001|Overall Study|Lost to Follow-up|1
7742920|NCT00693693|12176782|FG002|Overall Study|Lost to Follow-up|2
7742921|NCT00693706|12176792|FG000|Overall Study|Protocol Violation|0
7742922|NCT00693706|12176793|FG001|Overall Study|Protocol Violation|1
7742923|NCT00693784|12176803|FG000|Overall Study|Lost to Follow-up|2
7742924|NCT00693784|12176803|FG000|Overall Study|Withdrawal by Subject|2
7742925|NCT00694096|12176829|FG000|Overall Study|Withdrawal by Subject|5
7742926|NCT00694109|12176833|FG000|Overall Study|Physician Decision|3
7742927|NCT00694109|12176833|FG000|Overall Study|Adverse Event|74
7742928|NCT00694109|12176833|FG000|Overall Study|Not consent of more 2 years of treatment|18
7742929|NCT00694109|12176833|FG000|Overall Study|Lack of Efficacy|2
7742930|NCT00694109|12176833|FG000|Overall Study|Withdrawal by Subject|13
7742931|NCT00694109|12176833|FG000|Overall Study|Pregnancy|1
7742932|NCT00694109|12176833|FG000|Overall Study|Enrolled but not treated|1
7742933|NCT00694109|12176833|FG000|Overall Study|Other|2
7742934|NCT00694109|12176833|FG000|Overall Study|Consented but no additional treatment|3
7742935|NCT00694122|12176838|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
7742936|NCT00694122|12176839|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
7742937|NCT00694122|12176838|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1
7742938|NCT00694122|12176839|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1
7742939|NCT00694122|12176838|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
7742940|NCT00694122|12176839|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
7742941|NCT00694161|12176850|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
7742942|NCT00694161|12176850|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
7742943|NCT00694161|12176850|FG000|Part 2 (After Week 6 up to Month 12)|Death|1
7742944|NCT00694304|12176854|FG000|Overall Study|Adverse Event|42
7742945|NCT00694304|12176854|FG000|Overall Study|Lack of Efficacy|35
7742946|NCT00694304|12176854|FG000|Overall Study|Non-compliance With Study Product|16
7742947|NCT00694304|12176854|FG000|Overall Study|Protocol Violation|6
7742948|NCT00694304|12176854|FG000|Overall Study|Withdrawal of Consent|61
7742949|NCT00694304|12176854|FG000|Overall Study|Lost to Follow-up|15
7742950|NCT00694304|12176854|FG000|Overall Study|Administrative or Other Reasons|32
7742951|NCT00694356|12176861|FG000|Overall Study|Adverse Event|1
7742952|NCT00694356|12176862|FG001|Overall Study|Adverse Event|0
7742953|NCT00694356|12176863|FG002|Overall Study|Adverse Event|0
7742954|NCT00694356|12176861|FG000|Overall Study|Progressive Disease|2
7742955|NCT00694356|12176862|FG001|Overall Study|Progressive Disease|6
7742956|NCT00694356|12176863|FG002|Overall Study|Progressive Disease|6
7742957|NCT00694551|12176878|FG000|Overall Study|Disease Progression|1
7742958|NCT00694551|12176879|FG001|Overall Study|Disease Progression|0
7742959|NCT00694551|12176880|FG002|Overall Study|Disease Progression|1
7742960|NCT00694707|12176902|FG000|Overall Study|Did Not Receive Treatment|0
7742961|NCT00694707|12176903|FG001|Overall Study|Did Not Receive Treatment|0
7742962|NCT00694707|12176904|FG002|Overall Study|Did Not Receive Treatment|1
7742963|NCT00694707|12176905|FG003|Overall Study|Did Not Receive Treatment|1
7742964|NCT00694707|12176906|FG004|Overall Study|Did Not Receive Treatment|1
7742965|NCT00694707|12176902|FG000|Overall Study|Adverse Event|22
7742966|NCT00694707|12176903|FG001|Overall Study|Adverse Event|14
7742967|NCT00694707|12176904|FG002|Overall Study|Adverse Event|8
7742968|NCT00694707|12176905|FG003|Overall Study|Adverse Event|12
7742969|NCT00694707|12176906|FG004|Overall Study|Adverse Event|13
7742970|NCT00694707|12176902|FG000|Overall Study|Insufficient Therapeutic Response|33
7742971|NCT00694707|12176903|FG001|Overall Study|Insufficient Therapeutic Response|18
7742972|NCT00694707|12176904|FG002|Overall Study|Insufficient Therapeutic Response|17
7742973|NCT00694707|12176905|FG003|Overall Study|Insufficient Therapeutic Response|15
7742974|NCT00694707|12176906|FG004|Overall Study|Insufficient Therapeutic Response|10
7742975|NCT00694707|12176902|FG000|Overall Study|Protocol Violation|1
7742976|NCT00694707|12176903|FG001|Overall Study|Protocol Violation|2
7742977|NCT00694707|12176904|FG002|Overall Study|Protocol Violation|1
7742978|NCT00694707|12176905|FG003|Overall Study|Protocol Violation|3
7742979|NCT00694707|12176906|FG004|Overall Study|Protocol Violation|1
7742980|NCT00694707|12176902|FG000|Overall Study|Withdrawal of Consent|14
7742981|NCT00694707|12176903|FG001|Overall Study|Withdrawal of Consent|18
7742982|NCT00694707|12176904|FG002|Overall Study|Withdrawal of Consent|22
7742983|NCT00694707|12176905|FG003|Overall Study|Withdrawal of Consent|16
7742984|NCT00694707|12176906|FG004|Overall Study|Withdrawal of Consent|15
7742985|NCT00694707|12176902|FG000|Overall Study|Lost to Follow-up|0
7742986|NCT00694707|12176903|FG001|Overall Study|Lost to Follow-up|1
7742987|NCT00694707|12176904|FG002|Overall Study|Lost to Follow-up|2
7742988|NCT00694707|12176905|FG003|Overall Study|Lost to Follow-up|0
7742989|NCT00694707|12176906|FG004|Overall Study|Lost to Follow-up|0
7742990|NCT00694707|12176902|FG000|Overall Study|Jeopardizing Parole Status|1
7742991|NCT00694707|12176903|FG001|Overall Study|Jeopardizing Parole Status|0
7742992|NCT00694707|12176904|FG002|Overall Study|Jeopardizing Parole Status|0
7742993|NCT00694707|12176905|FG003|Overall Study|Jeopardizing Parole Status|0
7742994|NCT00694707|12176906|FG004|Overall Study|Jeopardizing Parole Status|0
7742995|NCT00694707|12176902|FG000|Overall Study|Death in the Family|1
7742996|NCT00694707|12176903|FG001|Overall Study|Death in the Family|0
7742997|NCT00694707|12176904|FG002|Overall Study|Death in the Family|0
7742998|NCT00694707|12176905|FG003|Overall Study|Death in the Family|0
7742999|NCT00694707|12176906|FG004|Overall Study|Death in the Family|0
7743000|NCT00694707|12176902|FG000|Overall Study|Arrest by Police|0
7743001|NCT00694707|12176903|FG001|Overall Study|Arrest by Police|1
7743002|NCT00694707|12176904|FG002|Overall Study|Arrest by Police|0
7743003|NCT00694707|12176905|FG003|Overall Study|Arrest by Police|0
7743004|NCT00694707|12176906|FG004|Overall Study|Arrest by Police|0
7743005|NCT00694707|12176902|FG000|Overall Study|Administrative Reasons|0
7743006|NCT00694707|12176903|FG001|Overall Study|Administrative Reasons|1
7743007|NCT00694707|12176904|FG002|Overall Study|Administrative Reasons|0
7743008|NCT00694707|12176905|FG003|Overall Study|Administrative Reasons|2
7743009|NCT00694707|12176906|FG004|Overall Study|Administrative Reasons|0
7743010|NCT00694707|12176902|FG000|Overall Study|Notification of Past Head Injury|0
7743011|NCT00694707|12176903|FG001|Overall Study|Notification of Past Head Injury|0
7743012|NCT00694707|12176904|FG002|Overall Study|Notification of Past Head Injury|0
7743013|NCT00694707|12176905|FG003|Overall Study|Notification of Past Head Injury|1
7743014|NCT00694707|12176906|FG004|Overall Study|Notification of Past Head Injury|0
7743015|NCT00695019|12176921|FG000|Overall Study|Withdrawal by Subject|8
7743016|NCT00695019|12176922|FG001|Overall Study|Withdrawal by Subject|6
7743017|NCT00695019|12176923|FG002|Overall Study|Withdrawal by Subject|4
7743018|NCT00695019|12176921|FG000|Overall Study|Protocol Violation|1
7743019|NCT00695019|12176922|FG001|Overall Study|Protocol Violation|3
7743020|NCT00695019|12176923|FG002|Overall Study|Protocol Violation|1
7743021|NCT00695019|12176921|FG000|Overall Study|Lack of Efficacy|0
7743022|NCT00695019|12176922|FG001|Overall Study|Lack of Efficacy|0
7743023|NCT00695019|12176923|FG002|Overall Study|Lack of Efficacy|1
7743024|NCT00695019|12176921|FG000|Overall Study|Various|4
7743025|NCT00695019|12176922|FG001|Overall Study|Various|5
7743026|NCT00695019|12176923|FG002|Overall Study|Various|4
7743027|NCT00695110|12176940|FG000|Treatment Period 1|Adverse Event|1
7743028|NCT00695110|12176940|FG000|Treatment Period 1|Withdrawal by Subject|2
7743029|NCT00695110|12176940|FG000|Treatment Period 3|Withdrawal by Subject|1
7743030|NCT00695110|12176940|FG000|Treatment Period 4|Adverse Event|1
7743031|NCT00695136|12176947|FG000|Overall Study|Withdrawal by Subject|1
7743032|NCT00695136|12176947|FG000|Overall Study|unrelated adverse event|1
7743033|NCT00695318|12176971|FG000|Overall Study|Lost to Follow-up|1
7743034|NCT00695318|12176972|FG001|Overall Study|Lost to Follow-up|0
7743035|NCT00695318|12176971|FG000|Overall Study|Withdrawal by Subject|2
7743036|NCT00695318|12176972|FG001|Overall Study|Withdrawal by Subject|0
7743037|NCT00695318|12176971|FG000|Overall Study|Death|1
7743038|NCT00695318|12176972|FG001|Overall Study|Death|1
7743039|NCT00695318|12176971|FG000|Overall Study|Study Terminated|1
7743040|NCT00695318|12176972|FG001|Overall Study|Study Terminated|0
7743041|NCT00695396|12176986|FG000|Overall Study|Study Closed Prematurely|5
7743042|NCT00695396|12176987|FG001|Overall Study|Study Closed Prematurely|6
7743043|NCT00695396|12176988|FG002|Overall Study|Study Closed Prematurely|8
7743044|NCT00695396|12176986|FG000|Overall Study|Withdrawal by Subject|2
7743045|NCT00695396|12176987|FG001|Overall Study|Withdrawal by Subject|2
7743046|NCT00695396|12176988|FG002|Overall Study|Withdrawal by Subject|0
7743047|NCT00695565|12177022|FG000|Overall Study|Lost to Follow-up|4
7743048|NCT00695565|12177023|FG001|Overall Study|Lost to Follow-up|4
7743049|NCT00695565|12177022|FG000|Overall Study|Adverse Event|3
7743050|NCT00695565|12177023|FG001|Overall Study|Adverse Event|1
7743051|NCT00695565|12177022|FG000|Overall Study|Protocol Violation|3
7743052|NCT00695565|12177023|FG001|Overall Study|Protocol Violation|1
7743053|NCT00695565|12177022|FG000|Overall Study|Withdrawal by Subject|1
7743054|NCT00695565|12177023|FG001|Overall Study|Withdrawal by Subject|1
7743055|NCT00695565|12177022|FG000|Overall Study|Lack of Efficacy|1
7743056|NCT00695565|12177023|FG001|Overall Study|Lack of Efficacy|1
7743057|NCT00695565|12177022|FG000|Overall Study|Subject did not follow instructions|1
7743058|NCT00695565|12177023|FG001|Overall Study|Subject did not follow instructions|1
7743059|NCT00695669|12177042|FG000|Overall Study|Adverse Event|0
7743060|NCT00695669|12177043|FG001|Overall Study|Adverse Event|0
7743061|NCT00695669|12177044|FG002|Overall Study|Adverse Event|2
7743062|NCT00695669|12177045|FG003|Overall Study|Adverse Event|0
7743063|NCT00695669|12177042|FG000|Overall Study|Lost to Follow-up|4
7743064|NCT00695669|12177043|FG001|Overall Study|Lost to Follow-up|4
7743065|NCT00695669|12177044|FG002|Overall Study|Lost to Follow-up|1
7743066|NCT00695669|12177045|FG003|Overall Study|Lost to Follow-up|4
7743067|NCT00695786|12177062|FG000|Overall Study|Adverse Event|0
7743068|NCT00695786|12177063|FG001|Overall Study|Adverse Event|3
7743069|NCT00695786|12177064|FG002|Overall Study|Adverse Event|4
7743070|NCT00695786|12177065|FG003|Overall Study|Adverse Event|2
7743071|NCT00695786|12177062|FG000|Overall Study|Lost to Follow-up|0
7743072|NCT00695786|12177063|FG001|Overall Study|Lost to Follow-up|5
7743073|NCT00695786|12177064|FG002|Overall Study|Lost to Follow-up|1
7743074|NCT00695786|12177065|FG003|Overall Study|Lost to Follow-up|1
7743075|NCT00695786|12177062|FG000|Overall Study|Withdrawal by Subject|0
7743076|NCT00695786|12177063|FG001|Overall Study|Withdrawal by Subject|4
7743077|NCT00695786|12177064|FG002|Overall Study|Withdrawal by Subject|3
7743078|NCT00695786|12177065|FG003|Overall Study|Withdrawal by Subject|1
7743079|NCT00695786|12177062|FG000|Overall Study|Deemed Ineligible|1
7743080|NCT00695786|12177063|FG001|Overall Study|Deemed Ineligible|0
7743081|NCT00695786|12177064|FG002|Overall Study|Deemed Ineligible|0
7743082|NCT00695786|12177065|FG003|Overall Study|Deemed Ineligible|0
7743083|NCT00695786|12177062|FG000|Overall Study|Lack of Efficacy|0
7743084|NCT00695786|12177063|FG001|Overall Study|Lack of Efficacy|0
7743085|NCT00695786|12177064|FG002|Overall Study|Lack of Efficacy|0
7743086|NCT00695786|12177065|FG003|Overall Study|Lack of Efficacy|4
7743087|NCT00695864|12177075|FG000|Placebo|Withdrawal by Subject|1
7743088|NCT00695864|12177075|FG000|Placebo|Physician Decision|4
7743089|NCT00695903|12177083|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0
7743090|NCT00695903|12177084|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2
7743091|NCT00695903|12177083|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
7743092|NCT00695903|12177084|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
7743093|NCT00695903|12177083|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1
7743094|NCT00695903|12177084|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0
7743095|NCT00695903|12177083|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
7743096|NCT00695903|12177084|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
7743097|NCT00695903|12177083|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0
7743098|NCT00695903|12177084|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1
7743099|NCT00695903|12177083|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1
7743100|NCT00695903|12177084|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2
7743101|NCT00695903|12177083|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
7743102|NCT00695903|12177084|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
7743103|NCT00695903|12177083|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
7743104|NCT00695903|12177084|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
7743105|NCT00695903|12177083|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0
7743106|NCT00695903|12177084|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1
7743107|NCT00695955|12177090|FG000|Cohort 1|Adverse Event|26
7743108|NCT00695955|12177090|FG000|Cohort 1|Protocol Violation|2
7743109|NCT00695955|12177090|FG000|Cohort 1|Lost to Follow-up|30
7743110|NCT00695955|12177090|FG000|Cohort 1|Withdrawal by Subject|25
7743111|NCT00695955|12177090|FG000|Cohort 1|Lack of Efficacy|3
7743112|NCT00695955|12177090|FG000|Cohort 1|Other|16
7743113|NCT00695955|12177090|FG000|Cohort 2|Adverse Event|24
7743114|NCT00695955|12177090|FG000|Cohort 2|Protocol Violation|5
7743115|NCT00695955|12177090|FG000|Cohort 2|Lost to Follow-up|38
7743116|NCT00695955|12177090|FG000|Cohort 2|Withdrawal by Subject|28
7743117|NCT00695955|12177090|FG000|Cohort 2|Lack of Efficacy|4
7743118|NCT00695955|12177090|FG000|Cohort 2|Other|5
7769133|NCT00866359|12212535|FG001|Treatment Phase (Days 1 to 85)|Other|0
7769134|NCT00866359|12212536|FG002|Treatment Phase (Days 1 to 85)|Other|0
7769135|NCT00866359|12212537|FG003|Treatment Phase (Days 1 to 85)|Other|0
7769136|NCT00866359|12212534|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0
7769137|NCT00866359|12212535|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0
7769138|NCT00866359|12212536|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1
7769139|NCT00866359|12212537|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3
7769140|NCT00866606|12212564|FG000|Overall Study|Lost to Follow-up|3
7769141|NCT00866606|12212564|FG000|Overall Study|Adverse Event|1
7769142|NCT00866619|12212572|FG000|Overall Study|Adverse Event|112
7769143|NCT00866619|12212573|FG001|Overall Study|Adverse Event|106
7769144|NCT00866619|12212574|FG002|Overall Study|Adverse Event|47
7769145|NCT00866619|12212575|FG003|Overall Study|Adverse Event|44
7769146|NCT00866619|12212572|FG000|Overall Study|Protocol Violation|2
7769147|NCT00866619|12212573|FG001|Overall Study|Protocol Violation|39
7769148|NCT00866619|12212574|FG002|Overall Study|Protocol Violation|2
7769149|NCT00866619|12212575|FG003|Overall Study|Protocol Violation|17
7769150|NCT00866619|12212572|FG000|Overall Study|Withdrawal by Subject|587
7769151|NCT00866619|12212573|FG001|Overall Study|Withdrawal by Subject|295
7769152|NCT00866619|12212574|FG002|Overall Study|Withdrawal by Subject|272
7769153|NCT00866619|12212575|FG003|Overall Study|Withdrawal by Subject|144
7769154|NCT00866619|12212572|FG000|Overall Study|Lost to Follow-up|1145
7769155|NCT00866619|12212573|FG001|Overall Study|Lost to Follow-up|830
7769156|NCT00866619|12212574|FG002|Overall Study|Lost to Follow-up|568
7769157|NCT00866619|12212575|FG003|Overall Study|Lost to Follow-up|425
7769158|NCT00866658|12212612|FG000|Overall Study|Adverse Event|5
7769159|NCT00866658|12212613|FG001|Overall Study|Adverse Event|14
7769160|NCT00866658|12212612|FG000|Overall Study|Lack of Efficacy|2
7769161|NCT00866658|12212613|FG001|Overall Study|Lack of Efficacy|1
7769162|NCT00866658|12212612|FG000|Overall Study|Withdrawal by Subject|1
7769163|NCT00866658|12212613|FG001|Overall Study|Withdrawal by Subject|0
7769164|NCT00866658|12212612|FG000|Overall Study|Protocol Violation|1
7769165|NCT00866658|12212613|FG001|Overall Study|Protocol Violation|1
7769166|NCT00866658|12212612|FG000|Overall Study|Familial and Personal Reasons|4
7769167|NCT00866658|12212613|FG001|Overall Study|Familial and Personal Reasons|5
7769168|NCT00866697|12212621|FG000|Overall Study|Study closed/terminated|156
7769169|NCT00866697|12212622|FG001|Overall Study|Study closed/terminated|138
7769170|NCT00866697|12212621|FG000|Overall Study|Lost to Follow-up|22
7769171|NCT00866697|12212622|FG001|Overall Study|Lost to Follow-up|28
7769172|NCT00866697|12212621|FG000|Overall Study|Physician Decision|3
7769173|NCT00866697|12212622|FG001|Overall Study|Physician Decision|5
7769174|NCT00866697|12212621|FG000|Overall Study|Withdrawal by Subject|33
7769175|NCT00866697|12212622|FG001|Overall Study|Withdrawal by Subject|57
7769176|NCT00866723|12212628|FG000|Overall Study|Withdrawal by Subject|1
7769177|NCT00866723|12212628|FG000|Overall Study|Disease Progression|4
7769178|NCT00866775|12212638|FG000|Overall Study|Adverse Event|5
7769179|NCT00866775|12212639|FG001|Overall Study|Adverse Event|19
7769180|NCT00866775|12212638|FG000|Overall Study|Death|1
7769181|NCT00866775|12212639|FG001|Overall Study|Death|0
7769182|NCT00866775|12212638|FG000|Overall Study|Lost to Follow-up|0
7769183|NCT00866775|12212639|FG001|Overall Study|Lost to Follow-up|4
7769184|NCT00866775|12212638|FG000|Overall Study|Physician Decision|0
7769185|NCT00866775|12212639|FG001|Overall Study|Physician Decision|3
7769186|NCT00866775|12212638|FG000|Overall Study|Protocol Violation|3
7769187|NCT00866775|12212639|FG001|Overall Study|Protocol Violation|4
7769188|NCT00866775|12212638|FG000|Overall Study|Withdrawal by Subject|4
7769189|NCT00866775|12212639|FG001|Overall Study|Withdrawal by Subject|4
7769190|NCT00866775|12212638|FG000|Overall Study|met exit criteria|23
7769191|NCT00866775|12212639|FG001|Overall Study|met exit criteria|17
7769192|NCT00866775|12212638|FG000|Overall Study|discontinued due to communication error|0
7769193|NCT00866775|12212639|FG001|Overall Study|discontinued due to communication error|1
7769194|NCT00866788|12212651|FG000|Overall Study|Adverse Event|0
7769195|NCT00866788|12212652|FG001|Overall Study|Adverse Event|2
7769196|NCT00866788|12212653|FG002|Overall Study|Adverse Event|0
7769197|NCT00866788|12212654|FG003|Overall Study|Adverse Event|1
7769198|NCT00866788|12212651|FG000|Overall Study|Lost to Follow-up|1
7769199|NCT00866788|12212652|FG001|Overall Study|Lost to Follow-up|1
7769200|NCT00866788|12212653|FG002|Overall Study|Lost to Follow-up|0
7769201|NCT00866788|12212654|FG003|Overall Study|Lost to Follow-up|2
7769202|NCT00866788|12212651|FG000|Overall Study|Withdrawal by Subject|2
7769203|NCT00866788|12212652|FG001|Overall Study|Withdrawal by Subject|1
7769204|NCT00866788|12212653|FG002|Overall Study|Withdrawal by Subject|0
7769205|NCT00866788|12212654|FG003|Overall Study|Withdrawal by Subject|1
7769206|NCT00866788|12212651|FG000|Overall Study|Pregnancy|0
7769207|NCT00866788|12212652|FG001|Overall Study|Pregnancy|1
7743119|NCT00696020|12177100|FG000|Overall Study|Adverse Event|3
7743120|NCT00696020|12177101|FG001|Overall Study|Adverse Event|1
7743121|NCT00696020|12177102|FG002|Overall Study|Adverse Event|2
7743122|NCT00696020|12177103|FG003|Overall Study|Adverse Event|1
7743123|NCT00696020|12177100|FG000|Overall Study|Lack of Efficacy|1
7743124|NCT00696020|12177101|FG001|Overall Study|Lack of Efficacy|0
7743125|NCT00696020|12177102|FG002|Overall Study|Lack of Efficacy|0
7743126|NCT00696020|12177103|FG003|Overall Study|Lack of Efficacy|0
7743127|NCT00696020|12177100|FG000|Overall Study|Protocol Violation|0
7743128|NCT00696020|12177101|FG001|Overall Study|Protocol Violation|0
7743129|NCT00696020|12177102|FG002|Overall Study|Protocol Violation|0
7743130|NCT00696020|12177103|FG003|Overall Study|Protocol Violation|1
7743131|NCT00696020|12177100|FG000|Overall Study|Withdrawal by Subject|0
7743132|NCT00696020|12177101|FG001|Overall Study|Withdrawal by Subject|1
7743133|NCT00696020|12177102|FG002|Overall Study|Withdrawal by Subject|0
7743134|NCT00696020|12177103|FG003|Overall Study|Withdrawal by Subject|1
7743135|NCT00696020|12177100|FG000|Overall Study|Other not stated above|0
7743136|NCT00696020|12177101|FG001|Overall Study|Other not stated above|0
7743137|NCT00696020|12177102|FG002|Overall Study|Other not stated above|1
7743138|NCT00696020|12177103|FG003|Overall Study|Other not stated above|1
7743139|NCT00696072|12177117|FG000|Overall Study|continuing active treatment|10
7743140|NCT00696072|12177118|FG001|Overall Study|continuing active treatment|13
7743141|NCT00696072|12177117|FG000|Overall Study|Adverse Event|10
7743142|NCT00696072|12177118|FG001|Overall Study|Adverse Event|6
7743143|NCT00696072|12177117|FG000|Overall Study|Patient Request|3
7743144|NCT00696072|12177118|FG001|Overall Study|Patient Request|7
7743145|NCT00696072|12177117|FG000|Overall Study|Investigator Request|1
7743146|NCT00696072|12177118|FG001|Overall Study|Investigator Request|4
7743147|NCT00696072|12177117|FG000|Overall Study|Sponsor Request|0
7743148|NCT00696072|12177118|FG001|Overall Study|Sponsor Request|1
7743149|NCT00696072|12177117|FG000|Overall Study|Disease Progression|32
7743150|NCT00696072|12177118|FG001|Overall Study|Disease Progression|30
7743151|NCT00696072|12177117|FG000|Overall Study|Non-specified|1
7743152|NCT00696072|12177118|FG001|Overall Study|Non-specified|2
7743153|NCT00696137|12177125|FG000|Overall Study|Withdrawal by Subject|2
7743154|NCT00696241|12177134|FG000|Overall Study|Adverse Event|11
7743155|NCT00696241|12177135|FG001|Overall Study|Adverse Event|3
7743156|NCT00696241|12177136|FG002|Overall Study|Adverse Event|6
7743157|NCT00696241|12177137|FG003|Overall Study|Adverse Event|4
7743158|NCT00696241|12177138|FG004|Overall Study|Adverse Event|5
7743159|NCT00696241|12177134|FG000|Overall Study|Protocol Violation|1
7743160|NCT00696241|12177135|FG001|Overall Study|Protocol Violation|1
7743161|NCT00696241|12177136|FG002|Overall Study|Protocol Violation|2
7743162|NCT00696241|12177137|FG003|Overall Study|Protocol Violation|0
7743163|NCT00696241|12177138|FG004|Overall Study|Protocol Violation|3
7743164|NCT00696241|12177134|FG000|Overall Study|Lost to Follow-up|1
7743165|NCT00696241|12177135|FG001|Overall Study|Lost to Follow-up|4
7743166|NCT00696241|12177136|FG002|Overall Study|Lost to Follow-up|1
7743167|NCT00696241|12177137|FG003|Overall Study|Lost to Follow-up|2
7743168|NCT00696241|12177138|FG004|Overall Study|Lost to Follow-up|0
7743169|NCT00696241|12177134|FG000|Overall Study|Withdrawal by Subject|4
7743170|NCT00696241|12177135|FG001|Overall Study|Withdrawal by Subject|8
7743171|NCT00696241|12177136|FG002|Overall Study|Withdrawal by Subject|6
7743172|NCT00696241|12177137|FG003|Overall Study|Withdrawal by Subject|1
7743173|NCT00696241|12177138|FG004|Overall Study|Withdrawal by Subject|0
7743174|NCT00696241|12177134|FG000|Overall Study|Lack of Efficacy|1
7743175|NCT00696241|12177135|FG001|Overall Study|Lack of Efficacy|5
7743176|NCT00696241|12177136|FG002|Overall Study|Lack of Efficacy|4
7743177|NCT00696241|12177137|FG003|Overall Study|Lack of Efficacy|5
7743178|NCT00696241|12177138|FG004|Overall Study|Lack of Efficacy|3
7743179|NCT00696241|12177134|FG000|Overall Study|Other|6
7743180|NCT00696241|12177135|FG001|Overall Study|Other|1
7743181|NCT00696241|12177136|FG002|Overall Study|Other|5
7743182|NCT00696241|12177137|FG003|Overall Study|Other|2
7743183|NCT00696241|12177138|FG004|Overall Study|Other|1
7743184|NCT00696384|12177155|FG000|Open Label Phase|Adverse Event|27
7743185|NCT00696384|12177156|FG001|Open Label Phase|Adverse Event|0
7743186|NCT00696384|12177157|FG002|Open Label Phase|Adverse Event|0
7743187|NCT00696384|12177155|FG000|Open Label Phase|Protocol Violation|18
7743188|NCT00696384|12177156|FG001|Open Label Phase|Protocol Violation|0
7743189|NCT00696384|12177157|FG002|Open Label Phase|Protocol Violation|0
7743190|NCT00696384|12177155|FG000|Open Label Phase|Lost to Follow-up|24
7743191|NCT00696384|12177156|FG001|Open Label Phase|Lost to Follow-up|0
7743192|NCT00696384|12177157|FG002|Open Label Phase|Lost to Follow-up|0
7743193|NCT00696384|12177155|FG000|Open Label Phase|Withdrawal by Subject|37
7743194|NCT00696384|12177156|FG001|Open Label Phase|Withdrawal by Subject|0
7743195|NCT00696384|12177157|FG002|Open Label Phase|Withdrawal by Subject|0
7743196|NCT00696384|12177155|FG000|Open Label Phase|Other|6
7743197|NCT00696384|12177156|FG001|Open Label Phase|Other|0
7743198|NCT00696384|12177157|FG002|Open Label Phase|Other|0
7743199|NCT00696384|12177155|FG000|Open Label Phase|Lack of Efficacy|3
7743200|NCT00696384|12177156|FG001|Open Label Phase|Lack of Efficacy|0
7743201|NCT00696384|12177157|FG002|Open Label Phase|Lack of Efficacy|0
7743202|NCT00696384|12177155|FG000|Open Label Phase|Physician Decision|4
7743203|NCT00696384|12177156|FG001|Open Label Phase|Physician Decision|0
7743204|NCT00696384|12177157|FG002|Open Label Phase|Physician Decision|0
7743205|NCT00696384|12177155|FG000|Double Blind Phase|Adverse Event|0
7743206|NCT00696384|12177156|FG001|Double Blind Phase|Adverse Event|2
7743207|NCT00696384|12177157|FG002|Double Blind Phase|Adverse Event|2
7743208|NCT00696384|12177155|FG000|Double Blind Phase|Lost to Follow-up|0
7743209|NCT00696384|12177156|FG001|Double Blind Phase|Lost to Follow-up|2
7743210|NCT00696384|12177157|FG002|Double Blind Phase|Lost to Follow-up|1
7743211|NCT00696384|12177155|FG000|Double Blind Phase|Withdrawal by Subject|0
7743212|NCT00696384|12177156|FG001|Double Blind Phase|Withdrawal by Subject|4
7743213|NCT00696384|12177157|FG002|Double Blind Phase|Withdrawal by Subject|3
7743214|NCT00696384|12177155|FG000|Double Blind Phase|Lack of Efficacy|0
7743215|NCT00696384|12177156|FG001|Double Blind Phase|Lack of Efficacy|1
7743216|NCT00696384|12177157|FG002|Double Blind Phase|Lack of Efficacy|0
7743217|NCT00696384|12177155|FG000|Double Blind Phase|Physician Decision|0
7743218|NCT00696384|12177156|FG001|Double Blind Phase|Physician Decision|2
7743219|NCT00696384|12177157|FG002|Double Blind Phase|Physician Decision|0
7743220|NCT00696410|12177168|FG000|Overall Study|Lost to Follow-up|2
7743221|NCT00696410|12177169|FG001|Overall Study|Lost to Follow-up|0
7743222|NCT00696410|12177168|FG000|Overall Study|Withdrawal by Subject|8
7743223|NCT00696410|12177169|FG001|Overall Study|Withdrawal by Subject|0
7743224|NCT00696410|12177168|FG000|Overall Study|Physician Decision|3
7743225|NCT00696410|12177169|FG001|Overall Study|Physician Decision|0
7743226|NCT00696423|12177182|FG000|Overall Study|Lost to Follow-up|0
7743227|NCT00696423|12177183|FG001|Overall Study|Lost to Follow-up|5
7743228|NCT00696436|12177194|FG000|Overall Study|Adverse Event|7
7743229|NCT00696436|12177195|FG001|Overall Study|Adverse Event|9
7743230|NCT00696436|12177196|FG002|Overall Study|Adverse Event|8
7743231|NCT00696436|12177197|FG003|Overall Study|Adverse Event|6
7743232|NCT00696436|12177198|FG004|Overall Study|Adverse Event|4
7743233|NCT00696436|12177194|FG000|Overall Study|Protocol Violation|3
7743234|NCT00696436|12177195|FG001|Overall Study|Protocol Violation|2
7743235|NCT00696436|12177196|FG002|Overall Study|Protocol Violation|2
7743236|NCT00696436|12177197|FG003|Overall Study|Protocol Violation|0
7743237|NCT00696436|12177198|FG004|Overall Study|Protocol Violation|1
7743238|NCT00696436|12177194|FG000|Overall Study|Lost to Follow-up|1
7743239|NCT00696436|12177195|FG001|Overall Study|Lost to Follow-up|6
7743240|NCT00696436|12177196|FG002|Overall Study|Lost to Follow-up|2
7743241|NCT00696436|12177197|FG003|Overall Study|Lost to Follow-up|4
7743242|NCT00696436|12177198|FG004|Overall Study|Lost to Follow-up|3
7743243|NCT00696436|12177194|FG000|Overall Study|Withdrawal by Subject|4
7743244|NCT00696436|12177195|FG001|Overall Study|Withdrawal by Subject|11
7743245|NCT00696436|12177196|FG002|Overall Study|Withdrawal by Subject|5
7743246|NCT00696436|12177197|FG003|Overall Study|Withdrawal by Subject|7
7743247|NCT00696436|12177198|FG004|Overall Study|Withdrawal by Subject|1
7743248|NCT00696436|12177194|FG000|Overall Study|Lack of Efficacy|3
7743249|NCT00696436|12177195|FG001|Overall Study|Lack of Efficacy|1
7743250|NCT00696436|12177196|FG002|Overall Study|Lack of Efficacy|5
7743251|NCT00696436|12177197|FG003|Overall Study|Lack of Efficacy|2
7743252|NCT00696436|12177198|FG004|Overall Study|Lack of Efficacy|4
7743253|NCT00696436|12177194|FG000|Overall Study|Participant Unavailability|2
7743254|NCT00696436|12177195|FG001|Overall Study|Participant Unavailability|0
7743255|NCT00696436|12177196|FG002|Overall Study|Participant Unavailability|2
7743256|NCT00696436|12177197|FG003|Overall Study|Participant Unavailability|1
7743257|NCT00696436|12177198|FG004|Overall Study|Participant Unavailability|0
7743258|NCT00696436|12177194|FG000|Overall Study|Administrative Error|2
7743259|NCT00696436|12177195|FG001|Overall Study|Administrative Error|0
7743260|NCT00696436|12177196|FG002|Overall Study|Administrative Error|2
7743261|NCT00696436|12177197|FG003|Overall Study|Administrative Error|0
7743262|NCT00696436|12177198|FG004|Overall Study|Administrative Error|0
7743263|NCT00696436|12177194|FG000|Overall Study|Participant Non-compliance|0
7743264|NCT00696436|12177195|FG001|Overall Study|Participant Non-compliance|0
7743265|NCT00696436|12177196|FG002|Overall Study|Participant Non-compliance|1
7743266|NCT00696436|12177197|FG003|Overall Study|Participant Non-compliance|2
7743267|NCT00696436|12177198|FG004|Overall Study|Participant Non-compliance|0
7743268|NCT00696436|12177194|FG000|Overall Study|Administrative Decision|1
7743269|NCT00696436|12177195|FG001|Overall Study|Administrative Decision|0
7743270|NCT00696436|12177196|FG002|Overall Study|Administrative Decision|0
7743271|NCT00696436|12177197|FG003|Overall Study|Administrative Decision|0
7743272|NCT00696436|12177198|FG004|Overall Study|Administrative Decision|0
7743273|NCT00696436|12177194|FG000|Overall Study|Missing|0
7743274|NCT00696436|12177195|FG001|Overall Study|Missing|1
7743275|NCT00696436|12177196|FG002|Overall Study|Missing|1
7743276|NCT00696436|12177197|FG003|Overall Study|Missing|0
7743277|NCT00696436|12177198|FG004|Overall Study|Missing|0
7743278|NCT00696657|12177253|FG000|Overall Study|Protocol Violation|0
7743279|NCT00696657|12177254|FG001|Overall Study|Protocol Violation|0
7743280|NCT00696657|12177255|FG002|Overall Study|Protocol Violation|0
7743281|NCT00696657|12177256|FG003|Overall Study|Protocol Violation|0
7743282|NCT00696657|12177257|FG004|Overall Study|Protocol Violation|0
7743283|NCT00696657|12177258|FG005|Overall Study|Protocol Violation|1
7743284|NCT00696657|12177259|FG006|Overall Study|Protocol Violation|0
7743285|NCT00696657|12177260|FG007|Overall Study|Protocol Violation|0
7743286|NCT00696657|12177261|FG008|Overall Study|Protocol Violation|1
7743287|NCT00696657|12177253|FG000|Overall Study|Lack of Efficacy|0
7743288|NCT00696657|12177254|FG001|Overall Study|Lack of Efficacy|1
7743289|NCT00696657|12177255|FG002|Overall Study|Lack of Efficacy|0
7743290|NCT00696657|12177256|FG003|Overall Study|Lack of Efficacy|0
7743291|NCT00696657|12177257|FG004|Overall Study|Lack of Efficacy|0
7743292|NCT00696657|12177258|FG005|Overall Study|Lack of Efficacy|0
7743293|NCT00696657|12177259|FG006|Overall Study|Lack of Efficacy|0
7743294|NCT00696657|12177260|FG007|Overall Study|Lack of Efficacy|0
7743295|NCT00696657|12177261|FG008|Overall Study|Lack of Efficacy|0
7743296|NCT00696657|12177253|FG000|Overall Study|Withdrawal criteria|1
7743297|NCT00696657|12177254|FG001|Overall Study|Withdrawal criteria|3
7743298|NCT00696657|12177255|FG002|Overall Study|Withdrawal criteria|2
7743299|NCT00696657|12177256|FG003|Overall Study|Withdrawal criteria|2
7743300|NCT00696657|12177257|FG004|Overall Study|Withdrawal criteria|0
7743301|NCT00696657|12177258|FG005|Overall Study|Withdrawal criteria|0
7743302|NCT00696657|12177259|FG006|Overall Study|Withdrawal criteria|1
7743303|NCT00696657|12177260|FG007|Overall Study|Withdrawal criteria|1
7743304|NCT00696657|12177261|FG008|Overall Study|Withdrawal criteria|2
7743305|NCT00696657|12177253|FG000|Overall Study|Unclassified|0
7743306|NCT00696657|12177254|FG001|Overall Study|Unclassified|1
7743307|NCT00696657|12177255|FG002|Overall Study|Unclassified|3
7743308|NCT00696657|12177256|FG003|Overall Study|Unclassified|2
7743309|NCT00696657|12177257|FG004|Overall Study|Unclassified|4
7743310|NCT00696657|12177258|FG005|Overall Study|Unclassified|2
7743311|NCT00696657|12177259|FG006|Overall Study|Unclassified|0
7743312|NCT00696657|12177260|FG007|Overall Study|Unclassified|0
7743313|NCT00696657|12177261|FG008|Overall Study|Unclassified|1
7743314|NCT00696657|12177253|FG000|Overall Study|Adverse Event|0
7743315|NCT00696657|12177254|FG001|Overall Study|Adverse Event|0
7743316|NCT00696657|12177255|FG002|Overall Study|Adverse Event|3
7743317|NCT00696657|12177256|FG003|Overall Study|Adverse Event|7
7743318|NCT00696657|12177257|FG004|Overall Study|Adverse Event|6
7743319|NCT00696657|12177258|FG005|Overall Study|Adverse Event|9
7743320|NCT00696657|12177259|FG006|Overall Study|Adverse Event|14
7743321|NCT00696657|12177260|FG007|Overall Study|Adverse Event|2
7743322|NCT00696657|12177261|FG008|Overall Study|Adverse Event|5
7743323|NCT00696696|12177281|FG000|Overall Study|Adverse Event|5
7743324|NCT00696696|12177281|FG000|Overall Study|Withdrawal by Subject|8
7743325|NCT00696696|12177281|FG000|Overall Study|Physician Decision|2
7743326|NCT00696696|12177281|FG000|Overall Study|Death|3
7743327|NCT00696709|12177290|FG000|Overall Study|Withdrawal by Subject|1
7743328|NCT00696709|12177291|FG001|Overall Study|Withdrawal by Subject|2
7743329|NCT00696709|12177292|FG002|Overall Study|Withdrawal by Subject|1
7743330|NCT00696709|12177293|FG003|Overall Study|Withdrawal by Subject|4
7743331|NCT00696709|12177294|FG004|Overall Study|Withdrawal by Subject|3
7743332|NCT00696709|12177290|FG000|Overall Study|Protocol Violation|1
7743333|NCT00696709|12177291|FG001|Overall Study|Protocol Violation|0
7743334|NCT00696709|12177292|FG002|Overall Study|Protocol Violation|0
7743335|NCT00696709|12177293|FG003|Overall Study|Protocol Violation|0
7743336|NCT00696709|12177294|FG004|Overall Study|Protocol Violation|0
7743337|NCT00696709|12177290|FG000|Overall Study|Lost to Follow-up|1
7743338|NCT00696709|12177291|FG001|Overall Study|Lost to Follow-up|1
7743339|NCT00696709|12177292|FG002|Overall Study|Lost to Follow-up|0
7743340|NCT00696709|12177293|FG003|Overall Study|Lost to Follow-up|0
7743341|NCT00696709|12177294|FG004|Overall Study|Lost to Follow-up|0
7743342|NCT00696709|12177290|FG000|Overall Study|Adverse Event|0
7743343|NCT00696709|12177291|FG001|Overall Study|Adverse Event|0
7743344|NCT00696709|12177292|FG002|Overall Study|Adverse Event|0
7743345|NCT00696709|12177293|FG003|Overall Study|Adverse Event|1
7743346|NCT00696709|12177294|FG004|Overall Study|Adverse Event|0
7743347|NCT00696774|12177338|FG000|Period II|Adverse Event|0
7743348|NCT00696774|12177339|FG001|Period II|Adverse Event|0
7743349|NCT00696774|12177340|FG002|Period II|Adverse Event|15
7743350|NCT00696774|12177338|FG000|Period II|Lost to Follow-up|0
7743351|NCT00696774|12177339|FG001|Period II|Lost to Follow-up|0
7743352|NCT00696774|12177340|FG002|Period II|Lost to Follow-up|4
7743353|NCT00696774|12177338|FG000|Period II|Protocol Violation|0
7743354|NCT00696774|12177339|FG001|Period II|Protocol Violation|0
7743355|NCT00696774|12177340|FG002|Period II|Protocol Violation|11
7743356|NCT00696774|12177338|FG000|Period II|Withdrawal by Subject|0
7743357|NCT00696774|12177339|FG001|Period II|Withdrawal by Subject|0
7743358|NCT00696774|12177340|FG002|Period II|Withdrawal by Subject|4
7743359|NCT00696774|12177338|FG000|Period II|Sponsor Decision|0
7743360|NCT00696774|12177339|FG001|Period II|Sponsor Decision|0
7743361|NCT00696774|12177340|FG002|Period II|Sponsor Decision|0
7743362|NCT00696774|12177338|FG000|Period II|Lack of Efficacy|0
7743363|NCT00696774|12177339|FG001|Period II|Lack of Efficacy|0
7743364|NCT00696774|12177340|FG002|Period II|Lack of Efficacy|2
7743365|NCT00696774|12177338|FG000|Period III|Adverse Event|1
7743366|NCT00696774|12177339|FG001|Period III|Adverse Event|1
7743367|NCT00696774|12177340|FG002|Period III|Adverse Event|0
7743368|NCT00696774|12177338|FG000|Period III|Lost to Follow-up|2
7743369|NCT00696774|12177339|FG001|Period III|Lost to Follow-up|1
7743370|NCT00696774|12177340|FG002|Period III|Lost to Follow-up|0
7743371|NCT00696774|12177338|FG000|Period III|Protocol Violation|1
7743372|NCT00696774|12177339|FG001|Period III|Protocol Violation|1
7743373|NCT00696774|12177340|FG002|Period III|Protocol Violation|0
7743374|NCT00696774|12177338|FG000|Period III|Withdrawal by Subject|1
7743375|NCT00696774|12177339|FG001|Period III|Withdrawal by Subject|2
7743376|NCT00696774|12177340|FG002|Period III|Withdrawal by Subject|0
7743377|NCT00696774|12177338|FG000|Period III|Sponsor Decision|2
7743378|NCT00696774|12177339|FG001|Period III|Sponsor Decision|0
7743379|NCT00696774|12177340|FG002|Period III|Sponsor Decision|0
7743380|NCT00696774|12177338|FG000|Period III|Lack of Efficacy|0
7743381|NCT00696774|12177339|FG001|Period III|Lack of Efficacy|2
7743382|NCT00696774|12177340|FG002|Period III|Lack of Efficacy|0
7743383|NCT00696787|12177351|FG000|Overall Study|Adverse Event|1
7743384|NCT00696787|12177352|FG001|Overall Study|Adverse Event|0
7743385|NCT00696787|12177353|FG002|Overall Study|Adverse Event|6
7743386|NCT00696787|12177351|FG000|Overall Study|Discontinuation by Sponsor|9
7743387|NCT00696787|12177352|FG001|Overall Study|Discontinuation by Sponsor|13
7743388|NCT00696787|12177353|FG002|Overall Study|Discontinuation by Sponsor|14
7743389|NCT00696787|12177351|FG000|Overall Study|Lack of Efficacy|0
7743390|NCT00696787|12177352|FG001|Overall Study|Lack of Efficacy|1
7743391|NCT00696787|12177353|FG002|Overall Study|Lack of Efficacy|0
7743392|NCT00696787|12177351|FG000|Overall Study|Lost to Follow-up|4
7743393|NCT00696787|12177352|FG001|Overall Study|Lost to Follow-up|0
7743394|NCT00696787|12177353|FG002|Overall Study|Lost to Follow-up|3
7743395|NCT00696787|12177351|FG000|Overall Study|Withdrawal by Subject|0
7743396|NCT00696787|12177352|FG001|Overall Study|Withdrawal by Subject|3
7743397|NCT00696787|12177353|FG002|Overall Study|Withdrawal by Subject|2
7743398|NCT00696787|12177351|FG000|Overall Study|Failed to return|1
7743399|NCT00696787|12177352|FG001|Overall Study|Failed to return|3
7743400|NCT00696787|12177353|FG002|Overall Study|Failed to return|1
7743401|NCT00697073|12177361|FG000|Overall Study|Withdrawal by Subject|2
7743402|NCT00697073|12177361|FG000|Overall Study|Pregnancy|1
7743403|NCT00697073|12177361|FG000|Overall Study|non compliance and other|6
7743404|NCT00697112|12177365|FG000|Overall Study|Adverse Event|8
7743405|NCT00697112|12177365|FG000|Overall Study|Lost to Follow-up|1
7743406|NCT00697112|12177365|FG000|Overall Study|Did not meet inclusion criteria|1
7743407|NCT00697346|12177400|FG000|Overall Study|Adverse Event|4
7743408|NCT00697346|12177401|FG001|Overall Study|Adverse Event|5
7743409|NCT00697346|12177402|FG002|Overall Study|Adverse Event|0
7743410|NCT00697346|12177400|FG000|Overall Study|Progressive Disease|19
7743411|NCT00697346|12177401|FG001|Overall Study|Progressive Disease|18
7743412|NCT00697346|12177402|FG002|Overall Study|Progressive Disease|0
7743413|NCT00697346|12177400|FG000|Overall Study|Symptomatic Deterioration|0
7743414|NCT00697346|12177401|FG001|Overall Study|Symptomatic Deterioration|1
7743415|NCT00697346|12177402|FG002|Overall Study|Symptomatic Deterioration|0
7743416|NCT00697346|12177400|FG000|Overall Study|Withdrawal by Subject|2
7743417|NCT00697346|12177401|FG001|Overall Study|Withdrawal by Subject|2
7743418|NCT00697346|12177402|FG002|Overall Study|Withdrawal by Subject|0
7743419|NCT00697346|12177400|FG000|Overall Study|Reason not Specified|3
7743420|NCT00697346|12177401|FG001|Overall Study|Reason not Specified|0
7743421|NCT00697346|12177402|FG002|Overall Study|Reason not Specified|1
7743422|NCT00697463|12177429|FG000|Overall Study|Withdrawal by Subject|1
7743423|NCT00697515|12177433|FG000|Dose Optimization Period|Adverse Event|4
7743424|NCT00697515|12177434|FG001|Dose Optimization Period|Adverse Event|0
7743425|NCT00697515|12177433|FG000|Dose Optimization Period|Withdrawal by Subject|5
7743426|NCT00697515|12177434|FG001|Dose Optimization Period|Withdrawal by Subject|0
7743427|NCT00697515|12177433|FG000|Dose Optimization Period|Lost to Follow-up|2
7743428|NCT00697515|12177434|FG001|Dose Optimization Period|Lost to Follow-up|0
7743429|NCT00697515|12177433|FG000|Dose Optimization Period|sponsor request|2
7743430|NCT00697515|12177434|FG001|Dose Optimization Period|sponsor request|0
7743431|NCT00697515|12177433|FG000|Dose Optimization Period|called to active duty|1
7743432|NCT00697515|12177434|FG001|Dose Optimization Period|called to active duty|0
7743433|NCT00697515|12177433|FG000|Dose Optimization Period|elevated QTc|1
7743434|NCT00697515|12177434|FG001|Dose Optimization Period|elevated QTc|0
7743435|NCT00697515|12177433|FG000|First Intervention (Crossover Period)|Natural disaster|8
7743436|NCT00697515|12177434|FG001|First Intervention (Crossover Period)|Natural disaster|9
7743437|NCT00697515|12177433|FG000|First Intervention (Crossover Period)|Adverse Event|0
7743438|NCT00697515|12177434|FG001|First Intervention (Crossover Period)|Adverse Event|2
7743439|NCT00697515|12177433|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2
7743440|NCT00697515|12177434|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1
7743441|NCT00697515|12177433|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1
7743442|NCT00697515|12177434|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1
7743443|NCT00697593|12177450|FG000|Overall Study|Adverse Event|3
7743444|NCT00697593|12177450|FG000|Overall Study|Protocol Violation|1
7743445|NCT00697593|12177450|FG000|Overall Study|Lack of Efficacy|3
7743446|NCT00697593|12177450|FG000|Overall Study|Suspension of the study by sponsor|12
7743447|NCT00697619|12177456|FG000|Overall Study|Lack of Efficacy|2
7743448|NCT00697619|12177457|FG001|Overall Study|Lack of Efficacy|2
7743449|NCT00697619|12177456|FG000|Overall Study|Adverse Event|4
7743450|NCT00697619|12177457|FG001|Overall Study|Adverse Event|6
7743451|NCT00697788|12177472|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7743452|NCT00697788|12177473|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
7743453|NCT00697788|12177474|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7743454|NCT00697788|12177475|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7743455|NCT00697788|12177476|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7743456|NCT00697788|12177477|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7743457|NCT00697788|12177478|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7769208|NCT00866788|12212653|FG002|Overall Study|Pregnancy|0
7743458|NCT00697788|12177479|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7743459|NCT00697788|12177472|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7743460|NCT00697788|12177473|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7743461|NCT00697788|12177474|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7743462|NCT00697788|12177475|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7743463|NCT00697788|12177476|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
7743464|NCT00697788|12177477|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7743465|NCT00697788|12177478|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7743466|NCT00697788|12177479|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7743467|NCT00697827|12177521|FG000|Overall Study|enrolled but not treated|2
7743468|NCT00697827|12177522|FG001|Overall Study|enrolled but not treated|1
7743469|NCT00698204|12177555|FG000|Overall Study|Withdrawal by Subject|1
7743470|NCT00698204|12177556|FG001|Overall Study|Withdrawal by Subject|0
7743471|NCT00698451|12177564|FG000|Overall Study|Adverse Event|22
7743472|NCT00698451|12177564|FG000|Overall Study|Physician Decision|2
7743473|NCT00698451|12177564|FG000|Overall Study|Protocol Violation|6
7743474|NCT00698451|12177564|FG000|Overall Study|Withdrawal by Subject|6
7743475|NCT00698451|12177564|FG000|Overall Study|Disease progression|3
7743476|NCT00698516|12177568|FG000|Overall Study|Study Termination|2
7743477|NCT00698516|12177568|FG000|Overall Study|Withdrawal by Subject|3
7743478|NCT00698581|12177578|FG000|Overall Study|Lack of Efficacy|23
7743479|NCT00698581|12177579|FG001|Overall Study|Lack of Efficacy|11
7743480|NCT00698581|12177578|FG000|Overall Study|Withdrawal by Subject|6
7743481|NCT00698581|12177579|FG001|Overall Study|Withdrawal by Subject|0
7743482|NCT00698581|12177578|FG000|Overall Study|Other reason|9
7743483|NCT00698581|12177579|FG001|Overall Study|Other reason|1
7743484|NCT00698581|12177578|FG000|Overall Study|SAE, non-fatal|1
7743485|NCT00698581|12177579|FG001|Overall Study|SAE, non-fatal|0
7743486|NCT00698581|12177578|FG000|Overall Study|AE, non-serious non-fatal|4
7743487|NCT00698581|12177579|FG001|Overall Study|AE, non-serious non-fatal|0
7743488|NCT00698581|12177578|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7743489|NCT00698581|12177579|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7743490|NCT00698581|12177578|FG000|Overall Study|AE of unknown type|1
7743491|NCT00698581|12177579|FG001|Overall Study|AE of unknown type|0
7743492|NCT00698646|12177589|FG000|Overall Study|Adverse Event|8
7743493|NCT00698646|12177590|FG001|Overall Study|Adverse Event|7
7743494|NCT00698646|12177591|FG002|Overall Study|Adverse Event|8
7743495|NCT00698646|12177589|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11
7743496|NCT00698646|12177590|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11
7743497|NCT00698646|12177591|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7
7743498|NCT00698646|12177589|FG000|Overall Study|Protocol Deviation|6
7743499|NCT00698646|12177590|FG001|Overall Study|Protocol Deviation|2
7743500|NCT00698646|12177591|FG002|Overall Study|Protocol Deviation|3
7743501|NCT00698646|12177589|FG000|Overall Study|Withdrawal by Subject|10
7743502|NCT00698646|12177590|FG001|Overall Study|Withdrawal by Subject|11
7743503|NCT00698646|12177591|FG002|Overall Study|Withdrawal by Subject|8
7743504|NCT00698646|12177589|FG000|Overall Study|Lost to Follow-up|0
7743505|NCT00698646|12177590|FG001|Overall Study|Lost to Follow-up|0
7743506|NCT00698646|12177591|FG002|Overall Study|Lost to Follow-up|2
7743507|NCT00698646|12177589|FG000|Overall Study|Administrative problems|1
7743508|NCT00698646|12177590|FG001|Overall Study|Administrative problems|0
7743509|NCT00698646|12177591|FG002|Overall Study|Administrative problems|1
7743510|NCT00698685|12177599|FG000|Overall Study|Sister withdrew as donor|1
7743511|NCT00698685|12177599|FG000|Overall Study|Off study pre transplant by clinic MD|1
7743512|NCT00698841|12177603|FG000|Overall Study|Withdrawal by Subject|2
7743513|NCT00698841|12177603|FG000|Overall Study|Adverse Event|3
7743514|NCT00698841|12177603|FG000|Overall Study|Disease progression|7
7743515|NCT00698841|12177603|FG000|Overall Study|Failure to meet eligibility criteria|2
7743516|NCT00698841|12177603|FG000|Overall Study|Study drug toxicity|2
7743517|NCT00698841|12177603|FG000|Overall Study|Other|2
7743518|NCT00698932|12177613|FG000|Overall Study|Adverse Event|0
7743519|NCT00698932|12177614|FG001|Overall Study|Adverse Event|2
7743520|NCT00698932|12177613|FG000|Overall Study|Incorrect enrollment|0
7743521|NCT00698932|12177614|FG001|Overall Study|Incorrect enrollment|2
7743522|NCT00698932|12177613|FG000|Overall Study|Study specific discontinuation criteria|3
7743523|NCT00698932|12177614|FG001|Overall Study|Study specific discontinuation criteria|4
7743524|NCT00698932|12177613|FG000|Overall Study|Withdrawal by Subject|11
7743525|NCT00698932|12177614|FG001|Overall Study|Withdrawal by Subject|23
7743526|NCT00698932|12177613|FG000|Overall Study|Lost to Follow-up|6
7743527|NCT00698932|12177614|FG001|Overall Study|Lost to Follow-up|1
7743528|NCT00698932|12177613|FG000|Overall Study|Severe non-compliance to protocol|1
7743529|NCT00698932|12177614|FG001|Overall Study|Severe non-compliance to protocol|2
7743530|NCT00698932|12177613|FG000|Overall Study|Safety reasons|0
7743531|NCT00698932|12177614|FG001|Overall Study|Safety reasons|2
7743532|NCT00698932|12177613|FG000|Overall Study|Death|1
7743533|NCT00698932|12177614|FG001|Overall Study|Death|0
7743534|NCT00698997|12177622|FG000|Overall Study|Lost to Follow-up|3
7743535|NCT00698997|12177623|FG001|Overall Study|Lost to Follow-up|0
7743536|NCT00698997|12177622|FG000|Overall Study|Withdrawal by Subject|7
7743537|NCT00698997|12177623|FG001|Overall Study|Withdrawal by Subject|27
7743538|NCT00699153|12177649|FG000|Overall Study|Lost to Follow-up|1
7743539|NCT00699153|12177650|FG001|Overall Study|Lost to Follow-up|0
7743540|NCT00699153|12177649|FG000|Overall Study|Adverse Event|0
7743541|NCT00699153|12177650|FG001|Overall Study|Adverse Event|2
7743542|NCT00699153|12177649|FG000|Overall Study|Protocol Violation|1
7743543|NCT00699153|12177650|FG001|Overall Study|Protocol Violation|0
7743544|NCT00699153|12177649|FG000|Overall Study|Travel Problem|1
7743545|NCT00699153|12177650|FG001|Overall Study|Travel Problem|0
7743546|NCT00699192|12177659|FG000|Overall Study|Missing|1
7743547|NCT00699192|12177660|FG001|Overall Study|Missing|1
7743548|NCT00699192|12177661|FG002|Overall Study|Missing|1
7743549|NCT00699192|12177659|FG000|Overall Study|Adverse Event|9
7743550|NCT00699192|12177660|FG001|Overall Study|Adverse Event|4
7743551|NCT00699192|12177661|FG002|Overall Study|Adverse Event|3
7743552|NCT00699192|12177659|FG000|Overall Study|Abnormal test procedure result(s)|0
7743553|NCT00699192|12177660|FG001|Overall Study|Abnormal test procedure result(s)|0
7962175|NCT02709746|12516273|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
7962176|NCT02709746|12516274|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
7962177|NCT02709746|12516275|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
7962178|NCT02709746|12516276|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1
7962179|NCT02709746|12516272|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7962180|NCT02709746|12516273|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7962181|NCT02709746|12516274|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1
7962182|NCT02709746|12516275|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7962183|NCT02709746|12516276|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7962184|NCT02709746|12516272|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
7962185|NCT02709746|12516273|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4
7962186|NCT02709746|12516274|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
7962187|NCT02709746|12516275|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
7962188|NCT02709746|12516276|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
7962189|NCT02709785|12516291|FG000|Overall Study|Withdrawal by Subject|1
7962190|NCT02709785|12516292|FG001|Overall Study|Withdrawal by Subject|2
7962191|NCT02709785|12516293|FG002|Overall Study|Withdrawal by Subject|1
7962192|NCT02709889|12516309|FG000|Overall Study|Withdrawal by Subject|11
7962193|NCT02709889|12516310|FG001|Overall Study|Withdrawal by Subject|10
7962194|NCT02709889|12516311|FG002|Overall Study|Withdrawal by Subject|2
7962195|NCT02709889|12516312|FG003|Overall Study|Withdrawal by Subject|12
7962196|NCT02709889|12516309|FG000|Overall Study|Death|25
7962197|NCT02709889|12516310|FG001|Overall Study|Death|38
7962198|NCT02709889|12516311|FG002|Overall Study|Death|4
7962199|NCT02709889|12516312|FG003|Overall Study|Death|44
7962200|NCT02709889|12516309|FG000|Overall Study|Physician Decision|1
7962201|NCT02709889|12516310|FG001|Overall Study|Physician Decision|2
7962202|NCT02709889|12516311|FG002|Overall Study|Physician Decision|3
7962203|NCT02709889|12516312|FG003|Overall Study|Physician Decision|5
7962204|NCT02709889|12516309|FG000|Overall Study|Lost to Follow-up|2
7962205|NCT02709889|12516310|FG001|Overall Study|Lost to Follow-up|0
7962206|NCT02709889|12516311|FG002|Overall Study|Lost to Follow-up|0
7962207|NCT02709889|12516312|FG003|Overall Study|Lost to Follow-up|4
7962208|NCT02709889|12516309|FG000|Overall Study|Study Terminated by Sponsor|4
7962209|NCT02709889|12516310|FG001|Overall Study|Study Terminated by Sponsor|6
7743554|NCT00699192|12177661|FG002|Overall Study|Abnormal test procedure result(s)|1
7743555|NCT00699192|12177659|FG000|Overall Study|Lack of Efficacy|0
7743556|NCT00699192|12177660|FG001|Overall Study|Lack of Efficacy|0
7743557|NCT00699192|12177661|FG002|Overall Study|Lack of Efficacy|1
7743558|NCT00699192|12177659|FG000|Overall Study|Withdrawal by Subject|3
7743559|NCT00699192|12177660|FG001|Overall Study|Withdrawal by Subject|2
7743560|NCT00699192|12177661|FG002|Overall Study|Withdrawal by Subject|4
7743561|NCT00699192|12177659|FG000|Overall Study|Administrative problems|1
7743562|NCT00699192|12177660|FG001|Overall Study|Administrative problems|3
7743563|NCT00699192|12177661|FG002|Overall Study|Administrative problems|1
7743564|NCT00699192|12177659|FG000|Overall Study|Protocol Violation|2
7743565|NCT00699192|12177660|FG001|Overall Study|Protocol Violation|2
7743566|NCT00699192|12177661|FG002|Overall Study|Protocol Violation|0
7743567|NCT00699283|12177675|FG000|Overall Study|Lack of Efficacy|15
7743568|NCT00699283|12177676|FG001|Overall Study|Lack of Efficacy|5
7743569|NCT00699283|12177675|FG000|Overall Study|Lost to Follow-up|2
7743570|NCT00699283|12177676|FG001|Overall Study|Lost to Follow-up|0
7743571|NCT00699283|12177675|FG000|Overall Study|Withdrawal by Subject|1
7743572|NCT00699283|12177676|FG001|Overall Study|Withdrawal by Subject|0
7962210|NCT02709889|12516311|FG002|Overall Study|Study Terminated by Sponsor|2
7962211|NCT02709889|12516312|FG003|Overall Study|Study Terminated by Sponsor|17
7743573|NCT00699283|12177675|FG000|Overall Study|Other Reason|5
7743574|NCT00699283|12177676|FG001|Overall Study|Other Reason|1
7962212|NCT02709889|12516309|FG000|Overall Study|Other, Not Specified|0
7962213|NCT02709889|12516310|FG001|Overall Study|Other, Not Specified|1
7962214|NCT02709889|12516311|FG002|Overall Study|Other, Not Specified|1
7962215|NCT02709889|12516312|FG003|Overall Study|Other, Not Specified|6
7962216|NCT02710045|12516360|FG000|Overall Study|Death|1
7962217|NCT02710045|12516361|FG001|Overall Study|Death|2
7962218|NCT02710045|12516362|FG002|Overall Study|Death|0
7743575|NCT00699283|12177675|FG000|Overall Study|SAE, non-fatal|1
7743576|NCT00699283|12177676|FG001|Overall Study|SAE, non-fatal|1
7743577|NCT00699283|12177675|FG000|Overall Study|AE, non-serious non-fatal|8
7743578|NCT00699283|12177676|FG001|Overall Study|AE, non-serious non-fatal|1
7743579|NCT00699283|12177675|FG000|Overall Study|AE of unknown type|1
7743580|NCT00699283|12177676|FG001|Overall Study|AE of unknown type|0
7743581|NCT00699335|12177681|FG000|Overall Study|Combination of multiple reasons|176
7743582|NCT00699335|12177681|FG000|Overall Study|Missing data|52
7743583|NCT00699348|12177688|FG000|Overall Study|Death|6
7743584|NCT00699348|12177688|FG000|Overall Study|Adverse Event|15
7743585|NCT00699348|12177688|FG000|Overall Study|Withdrawal by Subject|11
7743586|NCT00699348|12177688|FG000|Overall Study|Protocol Violation|10
7743587|NCT00699348|12177688|FG000|Overall Study|Lack of Efficacy|8
7743588|NCT00699348|12177688|FG000|Overall Study|Failure to return|1
7743589|NCT00699348|12177688|FG000|Overall Study|Blood transfusion|24
7743590|NCT00699348|12177688|FG000|Overall Study|Renal transplantation|10
7743591|NCT00699348|12177688|FG000|Overall Study|Other|5
7743592|NCT00699374|12177694|FG000|Overall Study|Death|93
7743593|NCT00699374|12177695|FG001|Overall Study|Death|83
7743594|NCT00699374|12177694|FG000|Overall Study|Adverse Event|70
7743595|NCT00699374|12177695|FG001|Overall Study|Adverse Event|67
7743596|NCT00699374|12177694|FG000|Overall Study|Global deterioration of health status|7
7743597|NCT00699374|12177695|FG001|Overall Study|Global deterioration of health status|8
7743598|NCT00699374|12177694|FG000|Overall Study|Lost to Follow-up|3
7743599|NCT00699374|12177695|FG001|Overall Study|Lost to Follow-up|5
7743600|NCT00699374|12177694|FG000|Overall Study|Withdrawal by Subject|34
7743601|NCT00699374|12177695|FG001|Overall Study|Withdrawal by Subject|44
7743602|NCT00699374|12177694|FG000|Overall Study|Objective progression or relapse|281
7743603|NCT00699374|12177695|FG001|Overall Study|Objective progression or relapse|277
7743604|NCT00699374|12177694|FG000|Overall Study|Other|18
7743605|NCT00699374|12177695|FG001|Overall Study|Other|15
7743606|NCT00699374|12177694|FG000|Overall Study|Protocol Violation|2
7743607|NCT00699374|12177695|FG001|Overall Study|Protocol Violation|6
7743608|NCT00699374|12177694|FG000|Overall Study|Study terminated by sponsor|13
7743609|NCT00699374|12177695|FG001|Overall Study|Study terminated by sponsor|28
7743610|NCT00699374|12177694|FG000|Overall Study|Randomized but not treated|4
7743611|NCT00699374|12177695|FG001|Overall Study|Randomized but not treated|2
7743612|NCT00699374|12177694|FG000|Overall Study|Died 28 days after last dose|5
7743613|NCT00699374|12177695|FG001|Overall Study|Died 28 days after last dose|9
7743614|NCT00699582|12177753|FG000|Overall Study|Adverse Event|4
7743615|NCT00699582|12177754|FG001|Overall Study|Adverse Event|11
7743616|NCT00699582|12177755|FG002|Overall Study|Adverse Event|23
7743617|NCT00699582|12177753|FG000|Overall Study|Withdrawal by Subject|6
7743618|NCT00699582|12177754|FG001|Overall Study|Withdrawal by Subject|7
7743619|NCT00699582|12177755|FG002|Overall Study|Withdrawal by Subject|4
7743620|NCT00699582|12177753|FG000|Overall Study|Lack of Efficacy|1
7743621|NCT00699582|12177754|FG001|Overall Study|Lack of Efficacy|0
7743622|NCT00699582|12177755|FG002|Overall Study|Lack of Efficacy|1
7743623|NCT00699582|12177753|FG000|Overall Study|Progressive Disease|1
7743624|NCT00699582|12177754|FG001|Overall Study|Progressive Disease|0
7743625|NCT00699582|12177755|FG002|Overall Study|Progressive Disease|0
7743626|NCT00699582|12177753|FG000|Overall Study|Administrative/Other|4
7743627|NCT00699582|12177754|FG001|Overall Study|Administrative/Other|3
7743628|NCT00699582|12177755|FG002|Overall Study|Administrative/Other|0
7743629|NCT00699582|12177753|FG000|Overall Study|Randomized, Not Treated|2
7743630|NCT00699582|12177754|FG001|Overall Study|Randomized, Not Treated|1
7743631|NCT00699582|12177755|FG002|Overall Study|Randomized, Not Treated|0
7743632|NCT00699608|12177763|FG000|First Intervention|Withdrawal by Subject|0
7743633|NCT00699608|12177764|FG001|First Intervention|Withdrawal by Subject|0
7743634|NCT00699608|12177765|FG002|First Intervention|Withdrawal by Subject|1
7743635|NCT00699608|12177766|FG003|First Intervention|Withdrawal by Subject|0
7743636|NCT00699608|12177767|FG004|First Intervention|Withdrawal by Subject|0
7743637|NCT00699608|12177768|FG005|First Intervention|Withdrawal by Subject|0
7743638|NCT00699608|12177763|FG000|First Intervention|Protocol Violation|0
7743639|NCT00699608|12177764|FG001|First Intervention|Protocol Violation|0
7743640|NCT00699608|12177765|FG002|First Intervention|Protocol Violation|0
7743641|NCT00699608|12177766|FG003|First Intervention|Protocol Violation|0
7743642|NCT00699608|12177767|FG004|First Intervention|Protocol Violation|1
7743643|NCT00699608|12177768|FG005|First Intervention|Protocol Violation|0
7743644|NCT00699608|12177763|FG000|Second Intervention|Adverse Event|0
7743645|NCT00699608|12177764|FG001|Second Intervention|Adverse Event|0
7743646|NCT00699608|12177765|FG002|Second Intervention|Adverse Event|1
7743647|NCT00699608|12177766|FG003|Second Intervention|Adverse Event|0
7743648|NCT00699608|12177767|FG004|Second Intervention|Adverse Event|0
7743649|NCT00699608|12177768|FG005|Second Intervention|Adverse Event|0
7743650|NCT00699608|12177763|FG000|Second Intervention|Withdrawal by Subject|0
7743651|NCT00699608|12177764|FG001|Second Intervention|Withdrawal by Subject|0
7743652|NCT00699608|12177765|FG002|Second Intervention|Withdrawal by Subject|0
7743653|NCT00699608|12177766|FG003|Second Intervention|Withdrawal by Subject|1
7743654|NCT00699608|12177767|FG004|Second Intervention|Withdrawal by Subject|0
7743655|NCT00699608|12177768|FG005|Second Intervention|Withdrawal by Subject|0
7743656|NCT00699660|12177778|FG000|Overall Study|Lost to Follow-up|4
7743657|NCT00699660|12177779|FG001|Overall Study|Lost to Follow-up|2
7743658|NCT00699660|12177778|FG000|Overall Study|missing reports and recording failures|10
7743659|NCT00699660|12177779|FG001|Overall Study|missing reports and recording failures|6
7743660|NCT00699699|12177785|FG000|Overall Study|Adverse Event|36
7743661|NCT00699699|12177785|FG000|Overall Study|Individual different reasons|21
7743662|NCT00699751|12177791|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27
7743663|NCT00699751|12177792|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27
7743664|NCT00699751|12177791|FG000|Period 1: Without/Before Drug Switch|Death|28
7743665|NCT00699751|12177792|FG001|Period 1: Without/Before Drug Switch|Death|29
7743666|NCT00699751|12177791|FG000|Period 1: Without/Before Drug Switch|Subject Request|43
7743667|NCT00699751|12177792|FG001|Period 1: Without/Before Drug Switch|Subject Request|23
7743668|NCT00699751|12177791|FG000|Period 1: Without/Before Drug Switch|Other|30
7743669|NCT00699751|12177792|FG001|Period 1: Without/Before Drug Switch|Other|20
7743670|NCT00699751|12177791|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97
7743671|NCT00699751|12177792|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63
7743672|NCT00699751|12177791|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
7743673|NCT00699751|12177792|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
7743674|NCT00699751|12177791|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
7743675|NCT00699751|12177792|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
7743676|NCT00699751|12177791|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
7743677|NCT00699751|12177792|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
7743678|NCT00699816|12177810|FG000|Overall Study|Protocol Violation|1
7743679|NCT00699816|12177811|FG001|Overall Study|Protocol Violation|3
7743680|NCT00699907|12177820|FG000|Overall Study|Withdrawal by Subject|2
7743681|NCT00699907|12177821|FG001|Overall Study|Withdrawal by Subject|1
7743682|NCT00699907|12177822|FG002|Overall Study|Withdrawal by Subject|0
7743683|NCT00699907|12177820|FG000|Overall Study|No usable sample|0
7743684|NCT00699907|12177821|FG001|Overall Study|No usable sample|9
7743685|NCT00699907|12177822|FG002|Overall Study|No usable sample|8
7743686|NCT00699972|12177833|FG000|Overall Study|Adverse Event|7
7743687|NCT00699972|12177834|FG001|Overall Study|Adverse Event|9
7743688|NCT00699972|12177835|FG002|Overall Study|Adverse Event|24
7743689|NCT00699972|12177833|FG000|Overall Study|Lost to Follow-up|0
7743690|NCT00699972|12177834|FG001|Overall Study|Lost to Follow-up|2
7743691|NCT00699972|12177835|FG002|Overall Study|Lost to Follow-up|0
7743692|NCT00699972|12177833|FG000|Overall Study|Withdrawal by Subject|3
7743693|NCT00699972|12177834|FG001|Overall Study|Withdrawal by Subject|7
7743694|NCT00699972|12177835|FG002|Overall Study|Withdrawal by Subject|4
7743695|NCT00699972|12177833|FG000|Overall Study|Lack of Efficacy|2
7743696|NCT00699972|12177834|FG001|Overall Study|Lack of Efficacy|0
7743697|NCT00699972|12177835|FG002|Overall Study|Lack of Efficacy|2
7743698|NCT00699972|12177833|FG000|Overall Study|Administrative/Other|3
7743699|NCT00699972|12177834|FG001|Overall Study|Administrative/Other|1
7743700|NCT00699972|12177835|FG002|Overall Study|Administrative/Other|4
7743701|NCT00699972|12177833|FG000|Overall Study|Randomized, Not Treated|1
7743702|NCT00699972|12177834|FG001|Overall Study|Randomized, Not Treated|0
7743703|NCT00699972|12177835|FG002|Overall Study|Randomized, Not Treated|1
7743704|NCT00699998|12177847|FG000|Overall Study|Withdrawal by Subject|194
7743705|NCT00699998|12177848|FG001|Overall Study|Withdrawal by Subject|83
7743706|NCT00699998|12177849|FG002|Overall Study|Withdrawal by Subject|202
7743707|NCT00699998|12177850|FG003|Overall Study|Withdrawal by Subject|80
7743708|NCT00699998|12177847|FG000|Overall Study|Physician Decision|3
7743709|NCT00699998|12177848|FG001|Overall Study|Physician Decision|2
7743710|NCT00699998|12177849|FG002|Overall Study|Physician Decision|1
7743711|NCT00699998|12177850|FG003|Overall Study|Physician Decision|1
7743712|NCT00699998|12177847|FG000|Overall Study|Lost to Follow-up|2
7743713|NCT00699998|12177848|FG001|Overall Study|Lost to Follow-up|1
7743714|NCT00699998|12177849|FG002|Overall Study|Lost to Follow-up|3
7743715|NCT00699998|12177850|FG003|Overall Study|Lost to Follow-up|1
7743716|NCT00700011|12177867|FG000|Overall Study|Death|0
7743717|NCT00700011|12177868|FG001|Overall Study|Death|1
7743718|NCT00700102|12177909|FG000|Overall Study|Died|394
7743719|NCT00700102|12177910|FG001|Overall Study|Died|385
7743720|NCT00700102|12177909|FG000|Overall Study|Lost to Follow-up|8
7743721|NCT00700102|12177910|FG001|Overall Study|Lost to Follow-up|10
7743722|NCT00700115|12177918|FG000|Overall Study|Withdrawal by Subject|1
7743723|NCT00700115|12177919|FG001|Overall Study|Withdrawal by Subject|0
7743724|NCT00700115|12177918|FG000|Overall Study|Lost to Follow-up|0
7743725|NCT00700115|12177919|FG001|Overall Study|Lost to Follow-up|1
7743726|NCT00700180|12177931|FG000|Overall Study|Death|99
7743727|NCT00700180|12177932|FG001|Overall Study|Death|114
7743728|NCT00700180|12177931|FG000|Overall Study|Alive on treatment|5
7743729|NCT00700180|12177932|FG001|Overall Study|Alive on treatment|3
7743730|NCT00700180|12177931|FG000|Overall Study|Alive in follow-up|46
7743731|NCT00700180|12177932|FG001|Overall Study|Alive in follow-up|27
7743732|NCT00700180|12177931|FG000|Overall Study|Lost to Follow-up|4
7743733|NCT00700180|12177932|FG001|Overall Study|Lost to Follow-up|5
7743734|NCT00700271|12177940|FG000|Overall Study|Adverse Event|4
7743735|NCT00700271|12177941|FG001|Overall Study|Adverse Event|6
7743736|NCT00700271|12177940|FG000|Overall Study|Protocol Violation|1
7743737|NCT00700271|12177941|FG001|Overall Study|Protocol Violation|0
7743738|NCT00700271|12177940|FG000|Overall Study|Administrative Reasons|1
7743739|NCT00700271|12177941|FG001|Overall Study|Administrative Reasons|0
7743740|NCT00700271|12177940|FG000|Overall Study|Withdrawal by Subject|6
7743741|NCT00700271|12177941|FG001|Overall Study|Withdrawal by Subject|4
7743742|NCT00700271|12177940|FG000|Overall Study|Lost to Follow-up|2
7743743|NCT00700271|12177941|FG001|Overall Study|Lost to Follow-up|2
7743744|NCT00700310|12177951|FG000|Overall Study|Adverse Event|6
7743745|NCT00700310|12177952|FG001|Overall Study|Adverse Event|10
7743746|NCT00700310|12177953|FG002|Overall Study|Adverse Event|5
7743747|NCT00700310|12177954|FG003|Overall Study|Adverse Event|11
7743748|NCT00700310|12177951|FG000|Overall Study|Lost to Follow-up|4
7743749|NCT00700310|12177952|FG001|Overall Study|Lost to Follow-up|1
7743750|NCT00700310|12177953|FG002|Overall Study|Lost to Follow-up|0
7743751|NCT00700310|12177954|FG003|Overall Study|Lost to Follow-up|1
7743752|NCT00700310|12177951|FG000|Overall Study|Withdrawal by Subject|8
7743753|NCT00700310|12177952|FG001|Overall Study|Withdrawal by Subject|9
7743754|NCT00700310|12177953|FG002|Overall Study|Withdrawal by Subject|8
7743755|NCT00700310|12177954|FG003|Overall Study|Withdrawal by Subject|8
7743756|NCT00700310|12177951|FG000|Overall Study|Lack of Efficacy|0
7743757|NCT00700310|12177952|FG001|Overall Study|Lack of Efficacy|3
7743758|NCT00700310|12177953|FG002|Overall Study|Lack of Efficacy|0
7743759|NCT00700310|12177954|FG003|Overall Study|Lack of Efficacy|1
7743760|NCT00700310|12177951|FG000|Overall Study|Administrative/Other|1
7743761|NCT00700310|12177952|FG001|Overall Study|Administrative/Other|3
7743762|NCT00700310|12177953|FG002|Overall Study|Administrative/Other|1
7743763|NCT00700310|12177954|FG003|Overall Study|Administrative/Other|3
7743764|NCT00700310|12177951|FG000|Overall Study|Randomized, Not Treated|2
7743765|NCT00700310|12177952|FG001|Overall Study|Randomized, Not Treated|0
7743766|NCT00700310|12177953|FG002|Overall Study|Randomized, Not Treated|2
7743767|NCT00700310|12177954|FG003|Overall Study|Randomized, Not Treated|2
7743768|NCT00700401|12177985|FG000|Overall Study|Detectable HCV RNA after Week 4|82
7743769|NCT00700401|12177985|FG000|Overall Study|Adverse Event|5
7743770|NCT00700401|12177985|FG000|Overall Study|Refused Treatment|2
7743771|NCT00700401|12177985|FG000|Overall Study|Lost to Follow-up|1
7743772|NCT00700401|12177985|FG000|Overall Study|Treatment never started|1
7743773|NCT00700401|12177985|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1
7743774|NCT00700401|12177985|FG000|Overall Study|Withdrawal by Subject|2
7743775|NCT00700427|12177989|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
7743776|NCT00700427|12177990|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
7743777|NCT00700427|12177991|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
7743778|NCT00700427|12177992|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
7743779|NCT00700427|12177993|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
7743780|NCT00700427|12177989|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
7743781|NCT00700427|12177990|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
7743782|NCT00700427|12177991|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
7743783|NCT00700427|12177992|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
7743784|NCT00700427|12177993|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
7743785|NCT00700427|12177989|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
7743786|NCT00700427|12177990|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
7743787|NCT00700427|12177991|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
7743788|NCT00700427|12177992|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
7743789|NCT00700427|12177993|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
7743790|NCT00700427|12177989|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
7743791|NCT00700427|12177990|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
7743792|NCT00700427|12177991|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
7743793|NCT00700427|12177992|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
7743794|NCT00700427|12177993|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
7743795|NCT00700427|12177989|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
7743796|NCT00700427|12177990|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
7743797|NCT00700427|12177991|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
7743798|NCT00700427|12177992|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
7743799|NCT00700427|12177993|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
7743800|NCT00700427|12177989|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
7743801|NCT00700427|12177990|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
7743802|NCT00700427|12177991|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
7743803|NCT00700427|12177992|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
7743804|NCT00700427|12177993|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
7743805|NCT00700427|12177989|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
7743806|NCT00700427|12177990|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
7743807|NCT00700427|12177991|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
7743808|NCT00700427|12177992|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
7743809|NCT00700427|12177993|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
7743810|NCT00700427|12177989|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
7743811|NCT00700427|12177990|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
7743812|NCT00700427|12177991|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
7743813|NCT00700427|12177992|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
7743814|NCT00700427|12177993|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
7743815|NCT00700427|12177989|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
7743816|NCT00700427|12177990|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
7743817|NCT00700427|12177991|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
7743818|NCT00700427|12177992|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
7743819|NCT00700427|12177993|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
7743820|NCT00700427|12177989|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0
7743821|NCT00700427|12177990|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50
7743822|NCT00700427|12177991|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0
7743823|NCT00700427|12177992|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0
7743824|NCT00700427|12177993|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0
7743825|NCT00700427|12177989|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
7743826|NCT00700427|12177990|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
7743827|NCT00700427|12177991|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
7743828|NCT00700427|12177992|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
7743829|NCT00700427|12177993|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
7743830|NCT00700427|12177989|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
7743831|NCT00700427|12177990|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
7743832|NCT00700427|12177991|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
7743833|NCT00700427|12177992|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
7743834|NCT00700427|12177993|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
7743835|NCT00700427|12177989|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
7743836|NCT00700427|12177990|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
7743837|NCT00700427|12177991|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
7743838|NCT00700427|12177992|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
7743839|NCT00700427|12177993|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
7743840|NCT00700427|12177989|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
7743841|NCT00700427|12177990|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
7743842|NCT00700427|12177991|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
7743843|NCT00700427|12177992|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
7743844|NCT00700427|12177993|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
7743845|NCT00700427|12177989|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
7743846|NCT00700427|12177990|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
7743847|NCT00700427|12177991|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
7743848|NCT00700427|12177992|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
7743849|NCT00700427|12177993|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
7743850|NCT00700427|12177989|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
7743851|NCT00700427|12177990|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
7743852|NCT00700427|12177991|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
7743853|NCT00700427|12177992|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
7743854|NCT00700427|12177993|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
7743855|NCT00700427|12177989|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
7743856|NCT00700427|12177990|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
7743857|NCT00700427|12177991|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
7743858|NCT00700427|12177992|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
7743859|NCT00700427|12177993|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
7743860|NCT00700427|12177989|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0
7743861|NCT00700427|12177990|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2
7743862|NCT00700427|12177991|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0
7743863|NCT00700427|12177992|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0
7743864|NCT00700427|12177993|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0
7743865|NCT00700427|12177989|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
7743866|NCT00700427|12177990|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
7743867|NCT00700427|12177991|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
7743868|NCT00700427|12177992|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
7743869|NCT00700427|12177993|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
7743870|NCT00700427|12177989|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
7743871|NCT00700427|12177990|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
7743872|NCT00700427|12177991|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
7743873|NCT00700427|12177992|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
7743874|NCT00700427|12177993|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
7743875|NCT00700427|12177989|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
7743876|NCT00700427|12177990|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
7743877|NCT00700427|12177991|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
7743878|NCT00700427|12177992|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
7743879|NCT00700427|12177993|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
7743880|NCT00700427|12177989|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
7743881|NCT00700427|12177990|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
7743882|NCT00700427|12177991|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
7743883|NCT00700427|12177992|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
7743884|NCT00700427|12177993|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
7743885|NCT00700427|12177989|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
7743886|NCT00700427|12177990|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
7743887|NCT00700427|12177991|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
7743888|NCT00700427|12177992|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
7743889|NCT00700427|12177993|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
7743890|NCT00700427|12177989|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
7743891|NCT00700427|12177990|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
7743892|NCT00700427|12177991|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
7743893|NCT00700427|12177992|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
7743894|NCT00700427|12177993|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
7743895|NCT00700427|12177989|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
7743896|NCT00700427|12177990|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
7743897|NCT00700427|12177991|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
7743898|NCT00700427|12177992|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
7743899|NCT00700427|12177993|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
7743900|NCT00700427|12177989|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
7743901|NCT00700427|12177990|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
7743902|NCT00700427|12177991|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
7743903|NCT00700427|12177992|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
7743904|NCT00700427|12177993|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
7743905|NCT00700427|12177989|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0
7743906|NCT00700427|12177990|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0
7743907|NCT00700427|12177991|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1
7743908|NCT00700427|12177992|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1
7743909|NCT00700427|12177993|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0
7743910|NCT00700427|12177989|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
7743911|NCT00700427|12177990|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
7743912|NCT00700427|12177991|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
7743913|NCT00700427|12177992|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
7743914|NCT00700427|12177993|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
7743915|NCT00700427|12177989|FG000|Study Period 3B (Randomized Withdrawal)|Death|0
7743916|NCT00700427|12177990|FG001|Study Period 3B (Randomized Withdrawal)|Death|0
7743917|NCT00700427|12177991|FG002|Study Period 3B (Randomized Withdrawal)|Death|1
7743918|NCT00700427|12177992|FG003|Study Period 3B (Randomized Withdrawal)|Death|0
7743919|NCT00700427|12177993|FG004|Study Period 3B (Randomized Withdrawal)|Death|0
7743920|NCT00700427|12177989|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0
7743921|NCT00700427|12177990|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0
7743922|NCT00700427|12177991|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0
7743923|NCT00700427|12177992|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0
7743924|NCT00700427|12177993|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16
7743925|NCT00700427|12177989|FG000|Study Period 4 (Open-Label Extension)|Death|0
7743926|NCT00700427|12177990|FG001|Study Period 4 (Open-Label Extension)|Death|0
7743927|NCT00700427|12177991|FG002|Study Period 4 (Open-Label Extension)|Death|0
7743928|NCT00700427|12177992|FG003|Study Period 4 (Open-Label Extension)|Death|0
7743929|NCT00700427|12177993|FG004|Study Period 4 (Open-Label Extension)|Death|1
7743930|NCT00700427|12177989|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0
7743931|NCT00700427|12177990|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0
7743932|NCT00700427|12177991|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0
7743933|NCT00700427|12177992|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0
7743934|NCT00700427|12177993|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12
7743935|NCT00700427|12177989|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
7743936|NCT00700427|12177990|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
7743937|NCT00700427|12177991|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
7743938|NCT00700427|12177992|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
7743939|NCT00700427|12177993|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
7743940|NCT00700427|12177989|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0
7743941|NCT00700427|12177990|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0
7743942|NCT00700427|12177991|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0
7743943|NCT00700427|12177992|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0
7743944|NCT00700427|12177993|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2
7743945|NCT00700427|12177989|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
7743946|NCT00700427|12177990|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
7743947|NCT00700427|12177991|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
7743948|NCT00700427|12177992|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
7743949|NCT00700427|12177993|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
7743950|NCT00700427|12177989|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
7743951|NCT00700427|12177990|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
7743952|NCT00700427|12177991|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
7743953|NCT00700427|12177992|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
7743954|NCT00700427|12177993|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
7743955|NCT00700427|12177989|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
7743956|NCT00700427|12177990|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
7743957|NCT00700427|12177991|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
7743958|NCT00700427|12177992|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
7743959|NCT00700427|12177993|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
7743960|NCT00700427|12177989|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
7743961|NCT00700427|12177990|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
7743962|NCT00700427|12177991|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
7743963|NCT00700427|12177992|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
7743964|NCT00700427|12177993|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
7743965|NCT00700570|12178007|FG000|Overall Study|Adverse Event|2
7743966|NCT00700570|12178008|FG001|Overall Study|Adverse Event|6
7743967|NCT00700570|12178007|FG000|Overall Study|Discretion of Investigator or Sponsor|0
7743968|NCT00700570|12178008|FG001|Overall Study|Discretion of Investigator or Sponsor|3
7743969|NCT00700570|12178007|FG000|Overall Study|Disease Progression|8
7743970|NCT00700570|12178008|FG001|Overall Study|Disease Progression|11
7743971|NCT00700570|12178007|FG000|Overall Study|Withdrawal by Subject|1
7743972|NCT00700570|12178008|FG001|Overall Study|Withdrawal by Subject|6
7962219|NCT02710045|12516360|FG000|Overall Study|Withdrawal by Subject|6
7962220|NCT02710045|12516361|FG001|Overall Study|Withdrawal by Subject|6
7962221|NCT02710045|12516362|FG002|Overall Study|Withdrawal by Subject|2
7743973|NCT00700622|12178016|FG000|Overall Study|Adverse Event|4
7743974|NCT00700622|12178017|FG001|Overall Study|Adverse Event|0
7743975|NCT00700622|12178016|FG000|Overall Study|Lost to Follow-up|0
7743976|NCT00700622|12178017|FG001|Overall Study|Lost to Follow-up|1
7743977|NCT00700622|12178016|FG000|Overall Study|Physician Decision|2
7743978|NCT00700622|12178017|FG001|Overall Study|Physician Decision|1
7743979|NCT00700622|12178016|FG000|Overall Study|Protocol Violation|0
7743980|NCT00700622|12178017|FG001|Overall Study|Protocol Violation|1
7743981|NCT00700622|12178016|FG000|Overall Study|Withdrawal by Subject|4
7743982|NCT00700622|12178017|FG001|Overall Study|Withdrawal by Subject|1
7743983|NCT00700622|12178016|FG000|Overall Study|Other|3
7743984|NCT00700622|12178017|FG001|Overall Study|Other|1
7743985|NCT00700635|12178026|FG000|Overall Study|Adverse Event|1
7743986|NCT00700635|12178027|FG001|Overall Study|Adverse Event|0
7743987|NCT00700635|12178028|FG002|Overall Study|Adverse Event|0
7743988|NCT00700635|12178026|FG000|Overall Study|Lost to Follow-up|1
7743989|NCT00700635|12178027|FG001|Overall Study|Lost to Follow-up|3
7743990|NCT00700635|12178028|FG002|Overall Study|Lost to Follow-up|0
7743991|NCT00700635|12178026|FG000|Overall Study|Protocol Violation|2
7743992|NCT00700635|12178027|FG001|Overall Study|Protocol Violation|2
7743993|NCT00700635|12178028|FG002|Overall Study|Protocol Violation|0
7743994|NCT00700635|12178026|FG000|Overall Study|Withdrawal by Subject|7
7743995|NCT00700635|12178027|FG001|Overall Study|Withdrawal by Subject|3
7743996|NCT00700635|12178028|FG002|Overall Study|Withdrawal by Subject|1
7743997|NCT00700713|12178039|FG000|Overall Study|Protocol Violation|1
7743998|NCT00700713|12178040|FG001|Overall Study|Protocol Violation|0
7743999|NCT00700713|12178041|FG002|Overall Study|Protocol Violation|1
7744000|NCT00700713|12178039|FG000|Overall Study|Withdrawal by Subject|0
7744001|NCT00700713|12178040|FG001|Overall Study|Withdrawal by Subject|0
7744002|NCT00700713|12178041|FG002|Overall Study|Withdrawal by Subject|1
7744003|NCT00700739|12178051|FG000|Overall Study|Lost to Follow-up|4
7744004|NCT00700739|12178052|FG001|Overall Study|Lost to Follow-up|4
7744005|NCT00700752|12178059|FG000|First Intervention|Withdrawal by Subject|0
7744006|NCT00700752|12178060|FG001|First Intervention|Withdrawal by Subject|2
7744007|NCT00700804|12178068|FG000|Overall Study|Withdrawal by Subject|1
7744008|NCT00700804|12178069|FG001|Overall Study|Withdrawal by Subject|2
7744009|NCT00700804|12178068|FG000|Overall Study|Protocol Violation|1
7744010|NCT00700804|12178069|FG001|Overall Study|Protocol Violation|1
7744011|NCT00700804|12178068|FG000|Overall Study|Loose Stools|1
7744012|NCT00700804|12178069|FG001|Overall Study|Loose Stools|1
7744013|NCT00700817|12178080|FG000|Week 0-26 (Main Period)|Adverse Event|14
7744014|NCT00700817|12178081|FG001|Week 0-26 (Main Period)|Adverse Event|15
7744015|NCT00700817|12178082|FG002|Week 0-26 (Main Period)|Adverse Event|4
7744016|NCT00700817|12178083|FG003|Week 0-26 (Main Period)|Adverse Event|0
7744017|NCT00700817|12178084|FG004|Week 0-26 (Main Period)|Adverse Event|0
7744018|NCT00700817|12178080|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4
7744019|NCT00700817|12178081|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0
7744020|NCT00700817|12178082|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4
7744021|NCT00700817|12178083|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0
7962222|NCT02710045|12516360|FG000|Overall Study|Protocol Violation|1
7744022|NCT00700817|12178084|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0
7744023|NCT00700817|12178080|FG000|Week 0-26 (Main Period)|Protocol Violation|14
7744024|NCT00700817|12178081|FG001|Week 0-26 (Main Period)|Protocol Violation|4
7744025|NCT00700817|12178082|FG002|Week 0-26 (Main Period)|Protocol Violation|4
7744026|NCT00700817|12178083|FG003|Week 0-26 (Main Period)|Protocol Violation|0
7744027|NCT00700817|12178084|FG004|Week 0-26 (Main Period)|Protocol Violation|0
7744028|NCT00700817|12178080|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10
7744029|NCT00700817|12178081|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7
7744030|NCT00700817|12178082|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5
7744031|NCT00700817|12178083|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0
7744032|NCT00700817|12178084|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0
7744033|NCT00700817|12178080|FG000|Week 0-26 (Main Period)|Unclassified|14
7744034|NCT00700817|12178081|FG001|Week 0-26 (Main Period)|Unclassified|4
7744035|NCT00700817|12178082|FG002|Week 0-26 (Main Period)|Unclassified|8
7744036|NCT00700817|12178083|FG003|Week 0-26 (Main Period)|Unclassified|0
7744037|NCT00700817|12178084|FG004|Week 0-26 (Main Period)|Unclassified|0
7744038|NCT00700817|12178080|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5
7744039|NCT00700817|12178081|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10
7744040|NCT00700817|12178082|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3
7744041|NCT00700817|12178083|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0
7744042|NCT00700817|12178084|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0
7744043|NCT00700817|12178080|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3
7744044|NCT00700817|12178081|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2
7744045|NCT00700817|12178082|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2
7744046|NCT00700817|12178083|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0
7744047|NCT00700817|12178084|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0
7744048|NCT00700817|12178080|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
7744049|NCT00700817|12178081|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
7744050|NCT00700817|12178082|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
7744051|NCT00700817|12178083|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
7744052|NCT00700817|12178084|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
7744053|NCT00700817|12178080|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
7744054|NCT00700817|12178081|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
7744055|NCT00700817|12178082|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
7744056|NCT00700817|12178083|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
7744057|NCT00700817|12178084|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
7744058|NCT00700817|12178080|FG000|Week 26-52 (Extension Period 1)|Unclassified|4
7744059|NCT00700817|12178081|FG001|Week 26-52 (Extension Period 1)|Unclassified|3
7744060|NCT00700817|12178082|FG002|Week 26-52 (Extension Period 1)|Unclassified|1
7744061|NCT00700817|12178083|FG003|Week 26-52 (Extension Period 1)|Unclassified|0
7744062|NCT00700817|12178084|FG004|Week 26-52 (Extension Period 1)|Unclassified|0
7744063|NCT00700817|12178080|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0
7744064|NCT00700817|12178081|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3
7744065|NCT00700817|12178082|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0
7744066|NCT00700817|12178083|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6
7744067|NCT00700817|12178084|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0
7744068|NCT00700817|12178080|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1
7744069|NCT00700817|12178081|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2
7744070|NCT00700817|12178082|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0
7744071|NCT00700817|12178083|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1
7744072|NCT00700817|12178084|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1
7744073|NCT00700817|12178080|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
7744074|NCT00700817|12178081|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
7744075|NCT00700817|12178082|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
7744076|NCT00700817|12178083|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
7744077|NCT00700817|12178084|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
7744078|NCT00700817|12178080|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
7744079|NCT00700817|12178081|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
7744080|NCT00700817|12178082|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
7744081|NCT00700817|12178083|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
7744082|NCT00700817|12178084|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
7744083|NCT00700817|12178080|FG000|Week 52-78 (Extension Period 2)|Unclassified|2
7744084|NCT00700817|12178081|FG001|Week 52-78 (Extension Period 2)|Unclassified|4
7744085|NCT00700817|12178082|FG002|Week 52-78 (Extension Period 2)|Unclassified|0
7744086|NCT00700817|12178083|FG003|Week 52-78 (Extension Period 2)|Unclassified|0
7744087|NCT00700817|12178084|FG004|Week 52-78 (Extension Period 2)|Unclassified|1
7744088|NCT00700999|12178105|FG000|Overall Study|Lost to Follow-up|7
7744089|NCT00700999|12178106|FG001|Overall Study|Lost to Follow-up|7
7744090|NCT00700999|12178105|FG000|Overall Study|Excluded - did not meet study criteria|0
7744091|NCT00700999|12178106|FG001|Overall Study|Excluded - did not meet study criteria|1
7744092|NCT00700999|12178105|FG000|Overall Study|Withdrawal by Subject|8
7744093|NCT00700999|12178106|FG001|Overall Study|Withdrawal by Subject|1
7744094|NCT00701038|12178114|FG000|Overall Study|study amended pilot group of patients|4
7744095|NCT00701038|12178115|FG001|Overall Study|study amended pilot group of patients|4
7744096|NCT00701051|12178123|FG000|Screening|Failed Screening|40
7744097|NCT00701051|12178124|FG001|Screening|Failed Screening|0
7744098|NCT00701051|12178125|FG002|Screening|Failed Screening|0
7744099|NCT00701051|12178123|FG000|Screening|Time conflicts|19
7744100|NCT00701051|12178124|FG001|Screening|Time conflicts|0
7744101|NCT00701051|12178125|FG002|Screening|Time conflicts|0
7744102|NCT00701051|12178123|FG000|Exercise Intervention|time conflict; non-study related illness|0
7744103|NCT00701051|12178124|FG001|Exercise Intervention|time conflict; non-study related illness|5
7744104|NCT00701051|12178125|FG002|Exercise Intervention|time conflict; non-study related illness|3
7744105|NCT00701064|12178133|FG000|Overall Study|Protocol Violation|1
7744106|NCT00701064|12178134|FG001|Overall Study|Protocol Violation|1
7744107|NCT00701064|12178133|FG000|Overall Study|Withdrawal by Subject|1
7744108|NCT00701064|12178134|FG001|Overall Study|Withdrawal by Subject|1
7744109|NCT00701064|12178133|FG000|Overall Study|initiated other PTSD treatment|2
7744110|NCT00701064|12178134|FG001|Overall Study|initiated other PTSD treatment|2
7744111|NCT00701090|12178142|FG000|Overall Study|Adverse Event|11
7744112|NCT00701090|12178143|FG001|Overall Study|Adverse Event|2
7744113|NCT00701090|12178142|FG000|Overall Study|Death|0
7744114|NCT00701090|12178143|FG001|Overall Study|Death|1
7744115|NCT00701090|12178142|FG000|Overall Study|Lack of Efficacy|5
7744116|NCT00701090|12178143|FG001|Overall Study|Lack of Efficacy|4
7744117|NCT00701090|12178142|FG000|Overall Study|Lost to Follow-up|9
7744118|NCT00701090|12178143|FG001|Overall Study|Lost to Follow-up|9
7744119|NCT00701090|12178142|FG000|Overall Study|Physician Decision|3
7744120|NCT00701090|12178143|FG001|Overall Study|Physician Decision|4
7744121|NCT00701090|12178142|FG000|Overall Study|Protocol Violation|2
7744122|NCT00701090|12178143|FG001|Overall Study|Protocol Violation|3
7744123|NCT00701090|12178142|FG000|Overall Study|Withdrawal by Subject|11
7744124|NCT00701090|12178143|FG001|Overall Study|Withdrawal by Subject|16
7744125|NCT00701090|12178142|FG000|Overall Study|Other|7
7744126|NCT00701090|12178143|FG001|Overall Study|Other|12
7744127|NCT00701103|12178160|FG000|Overall Study|Adverse Event|0
7744128|NCT00701103|12178161|FG001|Overall Study|Adverse Event|0
7744129|NCT00701103|12178162|FG002|Overall Study|Adverse Event|1
7744130|NCT00701103|12178163|FG003|Overall Study|Adverse Event|1
7744131|NCT00701103|12178164|FG004|Overall Study|Adverse Event|0
7744132|NCT00701103|12178165|FG005|Overall Study|Adverse Event|1
7744133|NCT00701103|12178166|FG006|Overall Study|Adverse Event|1
7744134|NCT00701103|12178167|FG007|Overall Study|Adverse Event|0
7744135|NCT00701103|12178168|FG008|Overall Study|Adverse Event|0
7744136|NCT00701103|12178169|FG009|Overall Study|Adverse Event|2
7744137|NCT00701103|12178170|FG010|Overall Study|Adverse Event|0
7744138|NCT00701103|12178160|FG000|Overall Study|Progressive Disease|5
7744139|NCT00701103|12178161|FG001|Overall Study|Progressive Disease|2
7744140|NCT00701103|12178162|FG002|Overall Study|Progressive Disease|6
7744141|NCT00701103|12178163|FG003|Overall Study|Progressive Disease|5
7744142|NCT00701103|12178164|FG004|Overall Study|Progressive Disease|6
7744143|NCT00701103|12178165|FG005|Overall Study|Progressive Disease|5
7744144|NCT00701103|12178166|FG006|Overall Study|Progressive Disease|7
7744145|NCT00701103|12178167|FG007|Overall Study|Progressive Disease|7
7744146|NCT00701103|12178168|FG008|Overall Study|Progressive Disease|8
7744147|NCT00701103|12178169|FG009|Overall Study|Progressive Disease|8
7744148|NCT00701103|12178170|FG010|Overall Study|Progressive Disease|11
7744149|NCT00701103|12178160|FG000|Overall Study|Withdrawal by Subject|0
7744150|NCT00701103|12178161|FG001|Overall Study|Withdrawal by Subject|1
7744151|NCT00701103|12178162|FG002|Overall Study|Withdrawal by Subject|1
7744152|NCT00701103|12178163|FG003|Overall Study|Withdrawal by Subject|0
7744153|NCT00701103|12178164|FG004|Overall Study|Withdrawal by Subject|0
7744154|NCT00701103|12178165|FG005|Overall Study|Withdrawal by Subject|0
7744155|NCT00701103|12178166|FG006|Overall Study|Withdrawal by Subject|0
7744156|NCT00701103|12178167|FG007|Overall Study|Withdrawal by Subject|0
7744157|NCT00701103|12178168|FG008|Overall Study|Withdrawal by Subject|0
7744158|NCT00701103|12178169|FG009|Overall Study|Withdrawal by Subject|0
7744159|NCT00701103|12178170|FG010|Overall Study|Withdrawal by Subject|0
7744160|NCT00701103|12178160|FG000|Overall Study|Other|0
7744161|NCT00701103|12178161|FG001|Overall Study|Other|0
7744162|NCT00701103|12178162|FG002|Overall Study|Other|0
7744163|NCT00701103|12178163|FG003|Overall Study|Other|0
7744164|NCT00701103|12178164|FG004|Overall Study|Other|0
7744165|NCT00701103|12178165|FG005|Overall Study|Other|0
7744166|NCT00701103|12178166|FG006|Overall Study|Other|0
7744167|NCT00701103|12178167|FG007|Overall Study|Other|0
7744168|NCT00701103|12178168|FG008|Overall Study|Other|1
7744169|NCT00701103|12178169|FG009|Overall Study|Other|1
7744170|NCT00701103|12178170|FG010|Overall Study|Other|0
7744171|NCT00701129|12178198|FG000|Overall Study|Death|2
7744172|NCT00701311|12178202|FG000|Overall Study|Lack of Efficacy|3
7744173|NCT00701311|12178202|FG000|Overall Study|Adverse Event|3
7744174|NCT00701311|12178202|FG000|Overall Study|Withdrawal by Subject|2
7744175|NCT00701363|12178210|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
7744176|NCT00701363|12178211|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
7744177|NCT00701363|12178212|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
7744178|NCT00701363|12178213|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
7744179|NCT00701363|12178210|FG000|Treatment Phase 1|Does not meet entry Criteria|1
7744180|NCT00701363|12178211|FG001|Treatment Phase 1|Does not meet entry Criteria|0
7744181|NCT00701363|12178212|FG002|Treatment Phase 1|Does not meet entry Criteria|0
7744182|NCT00701363|12178213|FG003|Treatment Phase 1|Does not meet entry Criteria|0
7744183|NCT00701363|12178210|FG000|Treatment Phase 1|Adverse Event|7
7744184|NCT00701363|12178211|FG001|Treatment Phase 1|Adverse Event|0
7744185|NCT00701363|12178212|FG002|Treatment Phase 1|Adverse Event|0
7744186|NCT00701363|12178213|FG003|Treatment Phase 1|Adverse Event|0
7744187|NCT00701363|12178210|FG000|Treatment Phase 1|Protocol Violation|1
7744188|NCT00701363|12178211|FG001|Treatment Phase 1|Protocol Violation|0
7744189|NCT00701363|12178212|FG002|Treatment Phase 1|Protocol Violation|0
7744190|NCT00701363|12178213|FG003|Treatment Phase 1|Protocol Violation|0
7744191|NCT00701363|12178210|FG000|Treatment Phase 1|Withdrawal by Subject|5
7744192|NCT00701363|12178211|FG001|Treatment Phase 1|Withdrawal by Subject|0
7744193|NCT00701363|12178212|FG002|Treatment Phase 1|Withdrawal by Subject|0
7744194|NCT00701363|12178213|FG003|Treatment Phase 1|Withdrawal by Subject|0
7744195|NCT00701363|12178210|FG000|Treatment Phase 1|Lack of Efficacy|1
7744196|NCT00701363|12178211|FG001|Treatment Phase 1|Lack of Efficacy|0
7744197|NCT00701363|12178212|FG002|Treatment Phase 1|Lack of Efficacy|0
7744198|NCT00701363|12178213|FG003|Treatment Phase 1|Lack of Efficacy|0
7744199|NCT00701363|12178210|FG000|Treatment Phase 2|Adverse Event|0
7744200|NCT00701363|12178211|FG001|Treatment Phase 2|Adverse Event|0
7744201|NCT00701363|12178212|FG002|Treatment Phase 2|Adverse Event|1
7744202|NCT00701363|12178213|FG003|Treatment Phase 2|Adverse Event|0
7744203|NCT00701363|12178210|FG000|Treatment Phase 2|Withdrawal by Subject|0
7744204|NCT00701363|12178211|FG001|Treatment Phase 2|Withdrawal by Subject|0
7744205|NCT00701363|12178212|FG002|Treatment Phase 2|Withdrawal by Subject|1
7744206|NCT00701363|12178213|FG003|Treatment Phase 2|Withdrawal by Subject|0
7744207|NCT00701415|12178257|FG000|Overall Study|Adverse Event|0
7744208|NCT00701415|12178258|FG001|Overall Study|Adverse Event|1
7744209|NCT00701415|12178257|FG000|Overall Study|Social/family issues and needle phobia|1
7744210|NCT00701415|12178258|FG001|Overall Study|Social/family issues and needle phobia|0
7769209|NCT00866788|12212654|FG003|Overall Study|Pregnancy|0
7769210|NCT00866788|12212651|FG000|Overall Study|Disease progression|3
7769211|NCT00866788|12212652|FG001|Overall Study|Disease progression|1
7769212|NCT00866788|12212653|FG002|Overall Study|Disease progression|1
7769213|NCT00866788|12212654|FG003|Overall Study|Disease progression|0
7769214|NCT00866788|12212651|FG000|Overall Study|Physician Decision|0
7769215|NCT00866788|12212652|FG001|Overall Study|Physician Decision|0
7769216|NCT00866788|12212653|FG002|Overall Study|Physician Decision|1
7769217|NCT00866788|12212654|FG003|Overall Study|Physician Decision|1
7769218|NCT00866814|12212667|FG000|Overall Study|Lost to Follow-up|12
7769219|NCT00866814|12212667|FG000|Overall Study|Adverse Event|2
7769220|NCT00866814|12212667|FG000|Overall Study|Physician Decision|1
7769221|NCT00866814|12212667|FG000|Overall Study|Death|1
7769222|NCT00866814|12212667|FG000|Overall Study|No longer wished to participate|1
7769223|NCT00866814|12212667|FG000|Overall Study|Unable to meet follow-up requirements|2
7769224|NCT00866814|12212667|FG000|Overall Study|Moved to area without study site|1
7769225|NCT00867009|12212686|FG000|Induction Period|Nonserious Adverse Event|5
7769226|NCT00867009|12212686|FG000|Induction Period|Serious Adverse Event|10
7769227|NCT00867009|12212686|FG000|Induction Period|Death due to serious adverse event|6
7769228|NCT00867009|12212686|FG000|Induction Period|Death due to Study Disease|4
7769229|NCT00867009|12212686|FG000|Induction Period|Protocol Violation|1
7769230|NCT00867009|12212686|FG000|Induction Period|Withdrawal by Subject|8
7769231|NCT00867009|12212686|FG000|Induction Period|Physician Decision|3
7769232|NCT00867009|12212686|FG000|Induction Period|Progressive Disease (PD)|25
7769233|NCT00867009|12212686|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4
7769234|NCT00867035|12212692|FG000|Baseline to 1 Hour|Withdrawal by Subject|1
7769235|NCT00867035|12212693|FG001|Baseline to 1 Hour|Withdrawal by Subject|1
7769236|NCT00867035|12212692|FG000|Baseline to 1 Week|Withdrawal by Subject|1
7769237|NCT00867035|12212693|FG001|Baseline to 1 Week|Withdrawal by Subject|0
7769238|NCT00867087|12212699|FG000|Overall Study|Other|1
7769239|NCT00867087|12212699|FG000|Overall Study|Withdrawal by Subject|4
7769240|NCT00867087|12212699|FG000|Overall Study|Death|37
7769241|NCT00867113|12212760|FG000|Treatment Period|Adverse Event|15
7769242|NCT00867113|12212760|FG000|Treatment Period|Death|2
7769243|NCT00867113|12212760|FG000|Treatment Period|Withdrawal by Subject|19
7769244|NCT00867113|12212760|FG000|Treatment Period|Lost to Follow-up|3
7769245|NCT00867113|12212760|FG000|Treatment Period|Administrative problems|1
7769246|NCT00867113|12212760|FG000|Treatment Period|Disease progression/relapse|1
7769247|NCT00867113|12212760|FG000|Treatment Period|Protocol Violation|4
7769248|NCT00867113|12212760|FG000|Post Treatment After Survival Follow-up|Death|1
7769249|NCT00867113|12212760|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
7769250|NCT00867113|12212760|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5
7769251|NCT00867113|12212760|FG000|Post Treatment After Survival Follow-up|Administrative problems|4
7769252|NCT00867308|12212796|FG000|Overall Study|Death|1
7769253|NCT00867308|12212797|FG001|Overall Study|Death|0
7769254|NCT00867308|12212796|FG000|Overall Study|Adverse Event|1
7769255|NCT00867308|12212797|FG001|Overall Study|Adverse Event|4
7769256|NCT00867308|12212796|FG000|Overall Study|Lack of Efficacy|6
7769257|NCT00867308|12212797|FG001|Overall Study|Lack of Efficacy|12
7769258|NCT00867308|12212796|FG000|Overall Study|Withdrawal by Subject|1
7769259|NCT00867308|12212797|FG001|Overall Study|Withdrawal by Subject|2
7769260|NCT00867334|12212805|FG000|Overall Study|Withdrawal by Subject|0
7769261|NCT00867334|12212806|FG001|Overall Study|Withdrawal by Subject|1
7769262|NCT00867334|12212805|FG000|Overall Study|Withdrawal by Subject|1
7769263|NCT00867334|12212806|FG001|Overall Study|Withdrawal by Subject|0
7769264|NCT00867334|12212805|FG000|Overall Study|Withdrawal by Subject|1
7769265|NCT00867334|12212806|FG001|Overall Study|Withdrawal by Subject|0
7769266|NCT00867360|12212814|FG000|Overall Study|Withdrawal by Subject|1
7769267|NCT00867360|12212815|FG001|Overall Study|Withdrawal by Subject|0
7744211|NCT00701441|12178266|FG000|Overall Study|failure in cpap compliance|0
7744212|NCT00701441|12178267|FG001|Overall Study|failure in cpap compliance|4
7744213|NCT00701558|12178277|FG000|Overall Study|Death|7
7744214|NCT00701558|12178277|FG000|Overall Study|Lost to Follow-up|8
7744215|NCT00701662|12178289|FG000|Overall Study|Lack of Efficacy|1
7744216|NCT00701701|12178308|FG000|Overall Study|Withdrawal by Subject|0
7744217|NCT00701701|12178309|FG001|Overall Study|Withdrawal by Subject|1
7744218|NCT00701701|12178308|FG000|Overall Study|Adverse Event|0
7744219|NCT00701701|12178309|FG001|Overall Study|Adverse Event|1
7744220|NCT00701727|12178329|FG000|First Treatment Period|Adverse Event|0
7744221|NCT00701727|12178330|FG001|First Treatment Period|Adverse Event|0
7744222|NCT00701727|12178329|FG000|First Treatment Period|Withdrawal by Subject|1
7744223|NCT00701727|12178330|FG001|First Treatment Period|Withdrawal by Subject|0
7744224|NCT00701727|12178329|FG000|First Treatment Period|sponsor decision|0
7744225|NCT00701727|12178330|FG001|First Treatment Period|sponsor decision|1
7744226|NCT00701727|12178329|FG000|First Treatment Period|Lost to Follow-up|0
7744227|NCT00701727|12178330|FG001|First Treatment Period|Lost to Follow-up|1
7744228|NCT00701727|12178329|FG000|Second Treatment Period|Withdrawal by Subject|2
7744229|NCT00701727|12178330|FG001|Second Treatment Period|Withdrawal by Subject|0
7744230|NCT00701779|12178336|FG000|Overall Study|Adverse Event|6
7744231|NCT00701779|12178336|FG000|Overall Study|Lost to Follow-up|1
7744232|NCT00701779|12178336|FG000|Overall Study|Withdrawal by Subject|2
7744233|NCT00701805|12178344|FG000|Overall Study|Withdrawal by Subject|3
7744234|NCT00701805|12178345|FG001|Overall Study|Withdrawal by Subject|1
7744235|NCT00701805|12178346|FG002|Overall Study|Withdrawal by Subject|4
7744236|NCT00701805|12178347|FG003|Overall Study|Withdrawal by Subject|3
7744237|NCT00701805|12178344|FG000|Overall Study|Adverse Event|0
7744238|NCT00701805|12178345|FG001|Overall Study|Adverse Event|1
7744239|NCT00701805|12178346|FG002|Overall Study|Adverse Event|1
7744240|NCT00701805|12178347|FG003|Overall Study|Adverse Event|0
7744241|NCT00701805|12178344|FG000|Overall Study|Missed 7 consecutive doses|0
7744242|NCT00701805|12178345|FG001|Overall Study|Missed 7 consecutive doses|1
7744243|NCT00701805|12178346|FG002|Overall Study|Missed 7 consecutive doses|0
7744244|NCT00701805|12178347|FG003|Overall Study|Missed 7 consecutive doses|0
7744245|NCT00701805|12178344|FG000|Overall Study|Admitted to hospital for 2 weeks|0
7744246|NCT00701805|12178345|FG001|Overall Study|Admitted to hospital for 2 weeks|0
7744247|NCT00701805|12178346|FG002|Overall Study|Admitted to hospital for 2 weeks|1
7744248|NCT00701805|12178347|FG003|Overall Study|Admitted to hospital for 2 weeks|0
7744249|NCT00701805|12178344|FG000|Overall Study|Physician decision, change of therapy|0
7744250|NCT00701805|12178345|FG001|Overall Study|Physician decision, change of therapy|0
7744251|NCT00701805|12178346|FG002|Overall Study|Physician decision, change of therapy|0
7744252|NCT00701805|12178347|FG003|Overall Study|Physician decision, change of therapy|1
7744253|NCT00701805|12178344|FG000|Overall Study|Difficult to travel to dialysis site|0
7744254|NCT00701805|12178345|FG001|Overall Study|Difficult to travel to dialysis site|0
7744255|NCT00701805|12178346|FG002|Overall Study|Difficult to travel to dialysis site|1
7744256|NCT00701805|12178347|FG003|Overall Study|Difficult to travel to dialysis site|0
7744257|NCT00701805|12178344|FG000|Overall Study|Resumption criteria were not met|0
7962223|NCT02710045|12516361|FG001|Overall Study|Protocol Violation|2
7962224|NCT02710045|12516362|FG002|Overall Study|Protocol Violation|3
7962225|NCT02710045|12516360|FG000|Overall Study|Lost to Follow-up|3
7962226|NCT02710045|12516361|FG001|Overall Study|Lost to Follow-up|6
7962227|NCT02710045|12516362|FG002|Overall Study|Lost to Follow-up|7
7962228|NCT02710045|12516360|FG000|Overall Study|Physician Decision|0
7962229|NCT02710045|12516361|FG001|Overall Study|Physician Decision|0
7962230|NCT02710045|12516362|FG002|Overall Study|Physician Decision|1
7962231|NCT02710045|12516360|FG000|Overall Study|Poor Attendance|0
7962232|NCT02710045|12516361|FG001|Overall Study|Poor Attendance|1
7962233|NCT02710045|12516362|FG002|Overall Study|Poor Attendance|0
7962234|NCT02710071|12516372|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3
7962235|NCT02710071|12516373|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4
7962236|NCT02710071|12516372|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1
7962237|NCT02710071|12516373|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2
7962238|NCT02710136|12516382|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
7962239|NCT02710136|12516383|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
7962240|NCT02710214|12516392|FG000|Overall Study|Lost to Follow-up|1
7962241|NCT02710214|12516393|FG001|Overall Study|Lost to Follow-up|0
7962242|NCT02710214|12516392|FG000|Overall Study|Lack of Efficacy|0
7962243|NCT02710214|12516393|FG001|Overall Study|Lack of Efficacy|1
7962244|NCT02710214|12516392|FG000|Overall Study|Death|0
7962245|NCT02710214|12516393|FG001|Overall Study|Death|1
7962246|NCT02710292|12516403|FG000|Period 1, First 10 Days of Wear|Adverse Event|0
7962247|NCT02710292|12516404|FG001|Period 1, First 10 Days of Wear|Adverse Event|1
7962248|NCT02710292|12516403|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
7962249|NCT02710292|12516404|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
7962250|NCT02710422|12516413|FG000|Overall Study|Termination of study|9
7962251|NCT02710422|12516414|FG001|Overall Study|Termination of study|9
7962252|NCT02711306|12516505|FG000|Overall Study|Withdrawal by Subject|2
7962253|NCT02711306|12516506|FG001|Overall Study|Withdrawal by Subject|2
7962254|NCT02711345|12516522|FG000|Overall Study|Adverse Event|0
7962255|NCT02711345|12516523|FG001|Overall Study|Adverse Event|0
7962256|NCT02711345|12516524|FG002|Overall Study|Adverse Event|0
7744258|NCT00701805|12178345|FG001|Overall Study|Resumption criteria were not met|1
7744259|NCT00701805|12178346|FG002|Overall Study|Resumption criteria were not met|0
7744260|NCT00701805|12178347|FG003|Overall Study|Resumption criteria were not met|0
7744261|NCT00702052|12178375|FG000|Overall Study|Adverse Event|23
7744262|NCT00702052|12178375|FG000|Overall Study|Disease Progression|30
7744263|NCT00702052|12178375|FG000|Overall Study|Withdrawal by Subject|5
7744264|NCT00702143|12178382|FG000|Overall Study|Lost to Follow-up|0
7744265|NCT00702143|12178383|FG001|Overall Study|Lost to Follow-up|0
7744266|NCT00702143|12178384|FG002|Overall Study|Lost to Follow-up|1
7744267|NCT00702208|12178390|FG000|Overall Study|Lost to Follow-up|28
7744268|NCT00702208|12178390|FG000|Overall Study|Did not self-lavage|1
7744269|NCT00702208|12178390|FG000|Overall Study|Unsatisfactory colposcopy|2
7744270|NCT00702221|12178397|FG000|Overall Study|Adverse Event|4
7744271|NCT00702221|12178398|FG001|Overall Study|Adverse Event|3
7744272|NCT00702325|12178413|FG000|Overall Study|Adverse Event|1
7744273|NCT00702325|12178414|FG001|Overall Study|Adverse Event|0
7744274|NCT00702325|12178413|FG000|Overall Study|Withdrawal by Subject|7
7744275|NCT00702325|12178414|FG001|Overall Study|Withdrawal by Subject|7
7744276|NCT00702325|12178413|FG000|Overall Study|Lost to Follow-up|3
7744277|NCT00702325|12178414|FG001|Overall Study|Lost to Follow-up|4
7744278|NCT00702325|12178413|FG000|Overall Study|Incorrect enrollment|5
7744279|NCT00702325|12178414|FG001|Overall Study|Incorrect enrollment|7
7744280|NCT00702325|12178413|FG000|Overall Study|Developed study discontinuation criteria|18
7744281|NCT00702325|12178414|FG001|Overall Study|Developed study discontinuation criteria|28
7744282|NCT00702325|12178413|FG000|Overall Study|Severe noncompliance to protocol|3
7744283|NCT00702325|12178414|FG001|Overall Study|Severe noncompliance to protocol|3
7744284|NCT00702325|12178413|FG000|Overall Study|Termination due to lab results|1
7744285|NCT00702325|12178414|FG001|Overall Study|Termination due to lab results|0
7744286|NCT00702325|12178413|FG000|Overall Study|Didn't follow study medication dosage|0
7744287|NCT00702325|12178414|FG001|Overall Study|Didn't follow study medication dosage|2
7744288|NCT00702325|12178413|FG000|Overall Study|Withdrew consent|0
7744289|NCT00702325|12178414|FG001|Overall Study|Withdrew consent|1
7744290|NCT00702325|12178413|FG000|Overall Study|Incorrectly Discontinued|0
7744291|NCT00702325|12178414|FG001|Overall Study|Incorrectly Discontinued|1
7744292|NCT00702403|12178438|FG000|From Consent to Engraftment|Progressive leukemia|6
7744293|NCT00702403|12178438|FG000|From Consent to Engraftment|Critically ill|2
7744294|NCT00702403|12178438|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
7744295|NCT00702403|12178438|FG000|From Consent to Engraftment|Myocardial infarction|1
7744296|NCT00702403|12178438|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
7744297|NCT00702403|12178438|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
7744298|NCT00702403|12178438|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
7744299|NCT00702403|12178438|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
7744300|NCT00702403|12178438|FG000|From Engraftment to Study Completion|Non-compliance|2
7744301|NCT00702403|12178438|FG000|From Engraftment to Study Completion|Adenocarcinoma|1
7744302|NCT00702403|12178438|FG000|From Engraftment to Study Completion|Liver GVHD|1
7744303|NCT00702403|12178438|FG000|From Engraftment to Study Completion|Suicide|1
7744304|NCT00702403|12178438|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
7744305|NCT00702403|12178438|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
7744306|NCT00702403|12178438|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
7744307|NCT00702507|12178454|FG000|Initial Treatment Phase|Adverse Event|2
7744308|NCT00702507|12178454|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
7744309|NCT00702507|12178454|FG000|Initial Treatment Phase|Lost to Follow-up|2
7744310|NCT00702507|12178454|FG000|Initial Treatment Phase|Negative Candida Culture|34
7744311|NCT00702507|12178454|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
7744312|NCT00702507|12178454|FG000|Follow-up Phase|Protocol Violation|2
7744313|NCT00702507|12178454|FG000|Follow-up Phase|Lost to Follow-up|23
7744314|NCT00702507|12178454|FG000|Follow-up Phase|Late Enrollment|1
7744315|NCT00702650|12178459|FG000|Overall Study|Withdrawal by Subject|9
7744316|NCT00702650|12178459|FG000|Overall Study|Non-Compliance of Study Drug|3
7744317|NCT00702650|12178459|FG000|Overall Study|Lost to Follow-up|2
7744318|NCT00702650|12178459|FG000|Overall Study|Non-Compliance with Site Directives|1
7744319|NCT00702650|12178459|FG000|Overall Study|Sponsor Request|1
7744320|NCT00702650|12178459|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1
7744321|NCT00702650|12178459|FG000|Overall Study|Adverse Event|3
7744322|NCT00702689|12178463|FG000|Overall Study|Withdrawal by Subject|4
7744323|NCT00702689|12178463|FG000|Overall Study|Recurrent malignancy|1
7744324|NCT00702689|12178463|FG000|Overall Study|Adverse Event|1
7744325|NCT00702715|12178469|FG000|Overall Study|Lost to Follow-up|1
7744326|NCT00702715|12178470|FG001|Overall Study|Lost to Follow-up|0
7744327|NCT00702923|12178496|FG000|Overall Study|Adverse Event|1
7744328|NCT00702949|12178504|FG000|Overall Study|Refusal|3
7744329|NCT00702949|12178505|FG001|Overall Study|Refusal|2
7744330|NCT00702949|12178506|FG002|Overall Study|Refusal|2
7744331|NCT00702949|12178504|FG000|Overall Study|Adverse Event|1
7744332|NCT00702949|12178505|FG001|Overall Study|Adverse Event|6
7744333|NCT00702949|12178506|FG002|Overall Study|Adverse Event|3
7744334|NCT00702949|12178504|FG000|Overall Study|Other Medical Reason/unknown|1
7962257|NCT02711345|12516525|FG003|Overall Study|Adverse Event|1
7744335|NCT00702949|12178505|FG001|Overall Study|Other Medical Reason/unknown|1
7744336|NCT00702949|12178506|FG002|Overall Study|Other Medical Reason/unknown|3
7744337|NCT00703118|12178558|FG000|Overall Study|Adverse Event|1
7744338|NCT00703118|12178559|FG001|Overall Study|Adverse Event|2
7744339|NCT00703118|12178560|FG002|Overall Study|Adverse Event|2
7744340|NCT00703118|12178558|FG000|Overall Study|Subject Ineligible To Continue The Trial|6
7744341|NCT00703118|12178559|FG001|Overall Study|Subject Ineligible To Continue The Trial|3
7744342|NCT00703118|12178560|FG002|Overall Study|Subject Ineligible To Continue The Trial|2
7744343|NCT00703118|12178558|FG000|Overall Study|Lost to Follow-up|6
7744344|NCT00703118|12178559|FG001|Overall Study|Lost to Follow-up|4
7744345|NCT00703118|12178560|FG002|Overall Study|Lost to Follow-up|4
7744346|NCT00703118|12178558|FG000|Overall Study|Withdrawal by Subject|8
7744347|NCT00703118|12178559|FG001|Overall Study|Withdrawal by Subject|7
7744348|NCT00703118|12178560|FG002|Overall Study|Withdrawal by Subject|13
7744349|NCT00703118|12178558|FG000|Overall Study|Other|0
7744350|NCT00703118|12178559|FG001|Overall Study|Other|0
7744351|NCT00703118|12178560|FG002|Overall Study|Other|1
7744352|NCT00703157|12178573|FG000|Overall Study|Lost to Follow-up|0
7744353|NCT00703157|12178574|FG001|Overall Study|Lost to Follow-up|1
7744354|NCT00703157|12178573|FG000|Overall Study|source data permanently lost/ other|4
7744355|NCT00703157|12178574|FG001|Overall Study|source data permanently lost/ other|1
7744356|NCT00703677|12178620|FG000|Overall Study|Dropout-withdrawal not related to drug|3
7744357|NCT00703781|12178635|FG000|Overall Study|Withdrawal by Subject|1
7744358|NCT00703781|12178636|FG001|Overall Study|Withdrawal by Subject|2
7744359|NCT00703781|12178635|FG000|Overall Study|Cancelled surgery|1
7744360|NCT00703781|12178636|FG001|Overall Study|Cancelled surgery|0
7744361|NCT00703820|12178644|FG000|Overall Study|Adverse Event|12
7744362|NCT00703820|12178645|FG001|Overall Study|Adverse Event|17
7744363|NCT00703820|12178644|FG000|Overall Study|Death|5
7744364|NCT00703820|12178645|FG001|Overall Study|Death|0
7744365|NCT00703820|12178644|FG000|Overall Study|Lack of Efficacy|11
7744366|NCT00703820|12178645|FG001|Overall Study|Lack of Efficacy|11
7744367|NCT00703820|12178644|FG000|Overall Study|Received non-protocol therapy|1
7744368|NCT00703820|12178645|FG001|Overall Study|Received non-protocol therapy|0
7744369|NCT00703820|12178644|FG000|Overall Study|Physician Decision|4
7744370|NCT00703820|12178645|FG001|Overall Study|Physician Decision|5
7744371|NCT00703820|12178644|FG000|Overall Study|Withdrawal by Subject|2
7744372|NCT00703820|12178645|FG001|Overall Study|Withdrawal by Subject|1
7744373|NCT00703846|12178653|FG000|Overall Study|Adverse Event|8
7744374|NCT00703846|12178653|FG000|Overall Study|Lost to Follow-up|55
7744375|NCT00703846|12178653|FG000|Overall Study|Lack of Efficacy|15
7744376|NCT00703846|12178653|FG000|Overall Study|Noncompliance with Study Treatment|2
7744377|NCT00703846|12178653|FG000|Overall Study|Withdrawal by Subject|40
7744378|NCT00703846|12178653|FG000|Overall Study|Death|1
7744379|NCT00703846|12178653|FG000|Overall Study|Other|14
7744380|NCT00703846|12178653|FG000|Overall Study|Did Not Receive Study Drug|2
7744381|NCT00703911|12178657|FG000|Overall Study|Death|1
7744382|NCT00703911|12178657|FG000|Overall Study|Physician Decision|6
7744383|NCT00703911|12178657|FG000|Overall Study|Lost to Follow-up|1
7744384|NCT00703911|12178657|FG000|Overall Study|Withdrawal by Subject|2
7744385|NCT00703924|12178663|FG000|Overall Study|Withdrawal by Subject|1
7744386|NCT00703924|12178664|FG001|Overall Study|Withdrawal by Subject|1
7744387|NCT00703963|12178685|FG000|Overall Study|Withdrawal by Subject|7
7744388|NCT00703963|12178686|FG001|Overall Study|Withdrawal by Subject|13
7744389|NCT00703963|12178685|FG000|Overall Study|Physician Decision|0
7744390|NCT00703963|12178686|FG001|Overall Study|Physician Decision|1
7744391|NCT00704132|12178714|FG000|Overall Study|Clinical Adverse Experience|1
7744392|NCT00704132|12178715|FG001|Overall Study|Clinical Adverse Experience|0
7744393|NCT00704132|12178714|FG000|Overall Study|Lack of Efficacy|0
7744394|NCT00704132|12178715|FG001|Overall Study|Lack of Efficacy|1
7744395|NCT00704132|12178714|FG000|Overall Study|Withdrawal by Subject|0
7744396|NCT00704132|12178715|FG001|Overall Study|Withdrawal by Subject|1
7962258|NCT02711345|12516526|FG004|Overall Study|Adverse Event|1
7744397|NCT00704171|12178723|FG000|Overall Study|Withdrawal by Subject|1
7744398|NCT00704171|12178724|FG001|Overall Study|Withdrawal by Subject|0
7744399|NCT00704184|12178735|FG000|Double-Blind Treatment|Withdrawal by Subject|1
7744400|NCT00704184|12178736|FG001|Double-Blind Treatment|Withdrawal by Subject|0
7744401|NCT00704184|12178737|FG002|Double-Blind Treatment|Withdrawal by Subject|0
7744402|NCT00704184|12178738|FG003|Double-Blind Treatment|Withdrawal by Subject|0
7744403|NCT00704184|12178739|FG004|Double-Blind Treatment|Withdrawal by Subject|0
7744404|NCT00704184|12178735|FG000|Open-Label Treatment|Adverse Event|0
7744405|NCT00704184|12178736|FG001|Open-Label Treatment|Adverse Event|0
7744406|NCT00704184|12178737|FG002|Open-Label Treatment|Adverse Event|2
7744407|NCT00704184|12178738|FG003|Open-Label Treatment|Adverse Event|0
7744408|NCT00704184|12178739|FG004|Open-Label Treatment|Adverse Event|1
7744409|NCT00704184|12178735|FG000|Open-Label Treatment|Lack of Efficacy|0
7744410|NCT00704184|12178736|FG001|Open-Label Treatment|Lack of Efficacy|2
7744411|NCT00704184|12178737|FG002|Open-Label Treatment|Lack of Efficacy|2
7744412|NCT00704184|12178738|FG003|Open-Label Treatment|Lack of Efficacy|2
7744413|NCT00704184|12178739|FG004|Open-Label Treatment|Lack of Efficacy|1
7744414|NCT00704184|12178735|FG000|Open-Label Treatment|Physician Decision|0
7744415|NCT00704184|12178736|FG001|Open-Label Treatment|Physician Decision|0
7744416|NCT00704184|12178737|FG002|Open-Label Treatment|Physician Decision|0
7744417|NCT00704184|12178738|FG003|Open-Label Treatment|Physician Decision|0
7744418|NCT00704184|12178739|FG004|Open-Label Treatment|Physician Decision|1
7744419|NCT00704184|12178735|FG000|Open-Label Treatment|Withdrawal by Subject|1
7744420|NCT00704184|12178736|FG001|Open-Label Treatment|Withdrawal by Subject|0
7744421|NCT00704184|12178737|FG002|Open-Label Treatment|Withdrawal by Subject|0
7744422|NCT00704184|12178738|FG003|Open-Label Treatment|Withdrawal by Subject|3
7744423|NCT00704184|12178739|FG004|Open-Label Treatment|Withdrawal by Subject|0
7744424|NCT00704340|12178757|FG000|Overall Study|Lost to Follow-up|2
7744425|NCT00704340|12178758|FG001|Overall Study|Lost to Follow-up|1
7744426|NCT00704340|12178757|FG000|Overall Study|Death|0
7744427|NCT00704340|12178758|FG001|Overall Study|Death|1
7744428|NCT00704405|12178789|FG000|Overall Study (NC Population)|Adverse Event|1
7744429|NCT00704405|12178790|FG001|Overall Study (NC Population)|Adverse Event|0
7744430|NCT00704405|12178791|FG002|Overall Study (NC Population)|Adverse Event|0
7744431|NCT00704405|12178792|FG003|Overall Study (NC Population)|Adverse Event|0
7744432|NCT00704405|12178793|FG004|Overall Study (NC Population)|Adverse Event|0
7744433|NCT00704405|12178789|FG000|Overall Study (NC Population)|Lost to Follow-up|2
7744434|NCT00704405|12178790|FG001|Overall Study (NC Population)|Lost to Follow-up|1
7744435|NCT00704405|12178791|FG002|Overall Study (NC Population)|Lost to Follow-up|1
7744436|NCT00704405|12178792|FG003|Overall Study (NC Population)|Lost to Follow-up|2
7744437|NCT00704405|12178793|FG004|Overall Study (NC Population)|Lost to Follow-up|2
7744438|NCT00704405|12178789|FG000|Overall Study (NC Population)|Withdrawal by Subject|2
7744439|NCT00704405|12178790|FG001|Overall Study (NC Population)|Withdrawal by Subject|3
7744440|NCT00704405|12178791|FG002|Overall Study (NC Population)|Withdrawal by Subject|2
7744441|NCT00704405|12178792|FG003|Overall Study (NC Population)|Withdrawal by Subject|2
7744442|NCT00704405|12178793|FG004|Overall Study (NC Population)|Withdrawal by Subject|2
7744443|NCT00704405|12178789|FG000|Overall Study (NC Population)|Other|0
7744444|NCT00704405|12178790|FG001|Overall Study (NC Population)|Other|0
7744445|NCT00704405|12178791|FG002|Overall Study (NC Population)|Other|0
7744446|NCT00704405|12178792|FG003|Overall Study (NC Population)|Other|0
7744447|NCT00704405|12178793|FG004|Overall Study (NC Population)|Other|1
7744448|NCT00704405|12178789|FG000|Overall Study (C Population)|Withdrawal by Subject|1
7744449|NCT00704405|12178790|FG001|Overall Study (C Population)|Withdrawal by Subject|1
7744450|NCT00704405|12178791|FG002|Overall Study (C Population)|Withdrawal by Subject|1
7744451|NCT00704405|12178792|FG003|Overall Study (C Population)|Withdrawal by Subject|1
7744452|NCT00704405|12178793|FG004|Overall Study (C Population)|Withdrawal by Subject|0
7744453|NCT00704405|12178789|FG000|Overall Study (C Population)|Lost to Follow-up|0
7744454|NCT00704405|12178790|FG001|Overall Study (C Population)|Lost to Follow-up|2
7744455|NCT00704405|12178791|FG002|Overall Study (C Population)|Lost to Follow-up|0
7744456|NCT00704405|12178792|FG003|Overall Study (C Population)|Lost to Follow-up|0
7744457|NCT00704405|12178793|FG004|Overall Study (C Population)|Lost to Follow-up|0
7744458|NCT00704418|12178813|FG000|Overall Study|Withdrawal by Subject|2
7744459|NCT00704418|12178814|FG001|Overall Study|Withdrawal by Subject|0
7744460|NCT00704418|12178813|FG000|Overall Study|Over-enrolled/surgery postponed|3
7744461|NCT00704418|12178814|FG001|Overall Study|Over-enrolled/surgery postponed|6
7744462|NCT00704522|12178822|FG000|Overall Study|Lack of Efficacy|65
7744463|NCT00704522|12178823|FG001|Overall Study|Lack of Efficacy|17
7744464|NCT00704522|12178822|FG000|Overall Study|Failure to appear again at hospital|56
7744465|NCT00704522|12178823|FG001|Overall Study|Failure to appear again at hospital|10
7744466|NCT00704522|12178822|FG000|Overall Study|Withdrawal by Subject|17
7744467|NCT00704522|12178823|FG001|Overall Study|Withdrawal by Subject|8
7744468|NCT00704522|12178822|FG000|Overall Study|Adverse Event|9
7744469|NCT00704522|12178823|FG001|Overall Study|Adverse Event|1
7744470|NCT00704522|12178822|FG000|Overall Study|Undefined causes|9
7744471|NCT00704522|12178823|FG001|Overall Study|Undefined causes|7
7744472|NCT00704522|12178822|FG000|Overall Study|No information on therapy end|27
7744473|NCT00704522|12178823|FG001|Overall Study|No information on therapy end|2
7744474|NCT00704730|12178834|FG000|Overall Study|Adverse Event|35
7744475|NCT00704730|12178835|FG001|Overall Study|Adverse Event|9
7744476|NCT00704730|12178834|FG000|Overall Study|Death|11
7744477|NCT00704730|12178835|FG001|Overall Study|Death|5
7744478|NCT00704730|12178834|FG000|Overall Study|Physician Decision|2
7744479|NCT00704730|12178835|FG001|Overall Study|Physician Decision|0
7744480|NCT00704730|12178834|FG000|Overall Study|Did not receive drug|5
7744481|NCT00704730|12178835|FG001|Overall Study|Did not receive drug|2
7744482|NCT00704730|12178834|FG000|Overall Study|Disease progression per PI|58
7744483|NCT00704730|12178835|FG001|Overall Study|Disease progression per PI|67
7744484|NCT00704730|12178834|FG000|Overall Study|data unavailable|1
7744485|NCT00704730|12178835|FG001|Overall Study|data unavailable|0
7744486|NCT00704730|12178834|FG000|Overall Study|Withdrawal by Subject|9
7744487|NCT00704730|12178835|FG001|Overall Study|Withdrawal by Subject|13
7744488|NCT00704808|12178842|FG000|Overall Study|Discontinued prior to starting treatment|14
7744489|NCT00704808|12178842|FG000|Overall Study|Death|7
7744490|NCT00704808|12178842|FG000|Overall Study|Tumor progression|80
7744491|NCT00704808|12178842|FG000|Overall Study|Patient's decision|11
7744492|NCT00704808|12178842|FG000|Overall Study|Early therapy discontinuation|16
7744493|NCT00704808|12178842|FG000|Overall Study|Adverse Event|1
7744494|NCT00704808|12178842|FG000|Overall Study|Lost to Follow-up|1
7744495|NCT00704808|12178842|FG000|Overall Study|Treatment change|1
7744496|NCT00704964|12178877|FG000|Overall Study|Not completed on time|328
7744497|NCT00705016|12178898|FG000|Overall Study|Adverse Event|6
7744498|NCT00705016|12178899|FG001|Overall Study|Adverse Event|11
7744499|NCT00705016|12178900|FG002|Overall Study|Adverse Event|10
7744500|NCT00705016|12178898|FG000|Overall Study|Death|5
7744501|NCT00705016|12178899|FG001|Overall Study|Death|7
7744502|NCT00705016|12178900|FG002|Overall Study|Death|5
7744503|NCT00705016|12178898|FG000|Overall Study|Protocol Violation|0
7744504|NCT00705016|12178899|FG001|Overall Study|Protocol Violation|1
7744505|NCT00705016|12178900|FG002|Overall Study|Protocol Violation|1
7744506|NCT00705016|12178898|FG000|Overall Study|Withdrawal by Subject|4
7744507|NCT00705016|12178899|FG001|Overall Study|Withdrawal by Subject|3
7744508|NCT00705016|12178900|FG002|Overall Study|Withdrawal by Subject|2
7744509|NCT00705016|12178898|FG000|Overall Study|Progressive Disease|33
7744510|NCT00705016|12178899|FG001|Overall Study|Progressive Disease|29
7744511|NCT00705016|12178900|FG002|Overall Study|Progressive Disease|33
7744512|NCT00705016|12178898|FG000|Overall Study|Symptomatic Deterioration|3
7744513|NCT00705016|12178899|FG001|Overall Study|Symptomatic Deterioration|1
7744514|NCT00705016|12178900|FG002|Overall Study|Symptomatic Deterioration|1
7744515|NCT00705016|12178898|FG000|Overall Study|Other|9
7744516|NCT00705016|12178899|FG001|Overall Study|Other|6
7744517|NCT00705016|12178900|FG002|Overall Study|Other|6
7744518|NCT00705146|12178918|FG000|Overall Study|Lost to Follow-up|1
7744519|NCT00705146|12178919|FG001|Overall Study|Lost to Follow-up|1
7744520|NCT00705159|12178929|FG000|Overall Study|Withdrawal by Subject|0
7744521|NCT00705159|12178930|FG001|Overall Study|Withdrawal by Subject|1
7744522|NCT00705159|12178931|FG002|Overall Study|Withdrawal by Subject|1
7744523|NCT00705159|12178932|FG003|Overall Study|Withdrawal by Subject|1
7744524|NCT00705159|12178929|FG000|Overall Study|Protocol Violation|0
7744525|NCT00705159|12178930|FG001|Overall Study|Protocol Violation|1
7744526|NCT00705159|12178931|FG002|Overall Study|Protocol Violation|0
7744527|NCT00705159|12178932|FG003|Overall Study|Protocol Violation|0
7744528|NCT00705159|12178929|FG000|Overall Study|Adverse Event|0
7744529|NCT00705159|12178930|FG001|Overall Study|Adverse Event|0
7744530|NCT00705159|12178931|FG002|Overall Study|Adverse Event|1
7744531|NCT00705159|12178932|FG003|Overall Study|Adverse Event|0
7744532|NCT00705159|12178929|FG000|Overall Study|Lost to Follow-up|0
7744533|NCT00705159|12178930|FG001|Overall Study|Lost to Follow-up|0
7744534|NCT00705159|12178931|FG002|Overall Study|Lost to Follow-up|3
7744535|NCT00705159|12178932|FG003|Overall Study|Lost to Follow-up|2
7744536|NCT00705159|12178929|FG000|Overall Study|Screen Failure|0
7744537|NCT00705159|12178930|FG001|Overall Study|Screen Failure|0
7744538|NCT00705159|12178931|FG002|Overall Study|Screen Failure|0
7744539|NCT00705159|12178932|FG003|Overall Study|Screen Failure|1
7744540|NCT00705224|12178942|FG000|Overall Study|Adverse Event|1
7744541|NCT00705224|12178942|FG000|Overall Study|Lack of Efficacy|2
7744542|NCT00705224|12178942|FG000|Overall Study|Withdrawal by Subject|3
7744543|NCT00705224|12178942|FG000|Overall Study|Lost to Follow-up|5
7744544|NCT00705250|12178949|FG000|Overall Study|Withdrawal by Subject|1
7744545|NCT00705250|12178949|FG000|Overall Study|Patient died in car accident|1
7744546|NCT00705263|12178953|FG000|Overall Study|Withdrawal by Subject|2
7744547|NCT00705289|12178957|FG000|Overall Study|Subject or treating physician's choice|131
7744548|NCT00705341|12178980|FG000|Phase 2: Trial|Withdrawal by Subject|0
7744549|NCT00705341|12178981|FG001|Phase 2: Trial|Withdrawal by Subject|0
7744550|NCT00705341|12178982|FG002|Phase 2: Trial|Withdrawal by Subject|6
7744551|NCT00705341|12178983|FG003|Phase 2: Trial|Withdrawal by Subject|4
7744552|NCT00705341|12178980|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0
7744553|NCT00705341|12178981|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0
7744554|NCT00705341|12178982|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1
7744555|NCT00705341|12178983|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0
7744556|NCT00705367|12178993|FG000|Long-term Extension Period|Adverse Event|2
7744557|NCT00705367|12178994|FG001|Long-term Extension Period|Adverse Event|0
7744558|NCT00705367|12178993|FG000|Long-term Extension Period|Withdrawal by Subject|2
7744559|NCT00705367|12178994|FG001|Long-term Extension Period|Withdrawal by Subject|0
7744560|NCT00705367|12178993|FG000|Long-term Extension Period|Lack of Efficacy|1
7744561|NCT00705367|12178994|FG001|Long-term Extension Period|Lack of Efficacy|0
7744562|NCT00705367|12178993|FG000|Long-term Extension Period|No longer met study criteria|1
7744563|NCT00705367|12178994|FG001|Long-term Extension Period|No longer met study criteria|0
7744564|NCT00705367|12178993|FG000|Long-term Extension Period|Administrative reason by sponsor|3
7744565|NCT00705367|12178994|FG001|Long-term Extension Period|Administrative reason by sponsor|0
7744566|NCT00705406|12179004|FG000|Overall Study|Lost to Follow-up|3
7744567|NCT00705406|12179005|FG001|Overall Study|Lost to Follow-up|3
7744568|NCT00705406|12179004|FG000|Overall Study|Did not receive study drug|1
7744569|NCT00705406|12179005|FG001|Overall Study|Did not receive study drug|2
7744570|NCT00705432|12179018|FG000|Treatment Period|Adverse Event|45
7744571|NCT00705432|12179019|FG001|Treatment Period|Adverse Event|37
7744572|NCT00705432|12179020|FG002|Treatment Period|Adverse Event|51
7744573|NCT00705432|12179021|FG003|Treatment Period|Adverse Event|12
7744574|NCT00705432|12179022|FG004|Treatment Period|Adverse Event|8
7744575|NCT00705432|12179023|FG005|Treatment Period|Adverse Event|9
7744576|NCT00705432|12179018|FG000|Treatment Period|Treatment failure|92
7744577|NCT00705432|12179019|FG001|Treatment Period|Treatment failure|42
7744578|NCT00705432|12179020|FG002|Treatment Period|Treatment failure|33
7744579|NCT00705432|12179021|FG003|Treatment Period|Treatment failure|25
7744580|NCT00705432|12179022|FG004|Treatment Period|Treatment failure|13
7744581|NCT00705432|12179023|FG005|Treatment Period|Treatment failure|14
7744582|NCT00705432|12179018|FG000|Treatment Period|Non medical reason|26
7744583|NCT00705432|12179019|FG001|Treatment Period|Non medical reason|32
7744584|NCT00705432|12179020|FG002|Treatment Period|Non medical reason|37
7744585|NCT00705432|12179021|FG003|Treatment Period|Non medical reason|4
7744586|NCT00705432|12179022|FG004|Treatment Period|Non medical reason|7
7744587|NCT00705432|12179023|FG005|Treatment Period|Non medical reason|7
7744588|NCT00705432|12179018|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2
7744589|NCT00705432|12179019|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1
7744590|NCT00705432|12179020|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1
7744591|NCT00705432|12179021|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0
7744592|NCT00705432|12179022|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0
7744593|NCT00705432|12179023|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0
7744594|NCT00705432|12179018|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69
7744595|NCT00705432|12179019|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42
7744596|NCT00705432|12179020|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24
7744597|NCT00705432|12179021|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14
7744598|NCT00705432|12179022|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6
7744599|NCT00705432|12179023|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7
7744600|NCT00705484|12179036|FG000|Overall Study|Adverse Event|28
7744601|NCT00705484|12179037|FG001|Overall Study|Adverse Event|27
7744602|NCT00705484|12179036|FG000|Overall Study|Lost to Follow-up|169
7744603|NCT00705484|12179037|FG001|Overall Study|Lost to Follow-up|250
7744604|NCT00705484|12179036|FG000|Overall Study|Withdrawal by Subject|96
7744605|NCT00705484|12179037|FG001|Overall Study|Withdrawal by Subject|72
7744606|NCT00705484|12179036|FG000|Overall Study|Administrative|89
7744607|NCT00705484|12179037|FG001|Overall Study|Administrative|59
7744608|NCT00705523|12179047|FG000|Overall Study|Lost to Follow-up|2
7744609|NCT00705523|12179048|FG001|Overall Study|Lost to Follow-up|3
7744610|NCT00705536|12179056|FG000|Start Period 1|Withdrawal by Subject|0
7744611|NCT00705536|12179057|FG001|Start Period 1|Withdrawal by Subject|0
7744612|NCT00705536|12179058|FG002|Start Period 1|Withdrawal by Subject|0
7744613|NCT00705536|12179059|FG003|Start Period 1|Withdrawal by Subject|1
7744614|NCT00705575|12179080|FG000|Overall Study|Abnormal laboratory value(s)|0
7744615|NCT00705575|12179081|FG001|Overall Study|Abnormal laboratory value(s)|3
7744616|NCT00705575|12179080|FG000|Overall Study|Abnormal test procedure result(s)|2
7744617|NCT00705575|12179081|FG001|Overall Study|Abnormal test procedure result(s)|12
7744618|NCT00705575|12179080|FG000|Overall Study|Adverse Event|11
7744619|NCT00705575|12179081|FG001|Overall Study|Adverse Event|15
7744620|NCT00705575|12179080|FG000|Overall Study|Lost to Follow-up|3
7744621|NCT00705575|12179081|FG001|Overall Study|Lost to Follow-up|4
7744622|NCT00705575|12179080|FG000|Overall Study|Protocol Violation|2
7744623|NCT00705575|12179081|FG001|Overall Study|Protocol Violation|2
7744624|NCT00705575|12179080|FG000|Overall Study|Withdrawal by Subject|5
7744625|NCT00705575|12179081|FG001|Overall Study|Withdrawal by Subject|10
7744626|NCT00705614|12179089|FG000|Initial Intervention|Adverse Event|40
7744627|NCT00705614|12179090|FG001|Initial Intervention|Adverse Event|21
7744628|NCT00705614|12179089|FG000|Initial Intervention|Lost to Follow-up|310
7744629|NCT00705614|12179090|FG001|Initial Intervention|Lost to Follow-up|191
7744630|NCT00705614|12179089|FG000|Initial Intervention|Withdrawal by Subject|114
7744631|NCT00705614|12179090|FG001|Initial Intervention|Withdrawal by Subject|71
7744632|NCT00705614|12179089|FG000|Initial Intervention|Administrative Reason|51
7744633|NCT00705614|12179090|FG001|Initial Intervention|Administrative Reason|38
7744634|NCT00705614|12179089|FG000|Initial Intervention|Status completion unknown|3
7744635|NCT00705614|12179090|FG001|Initial Intervention|Status completion unknown|0
7744636|NCT00705614|12179089|FG000|Switch to Remicade|Adverse Event|0
7744637|NCT00705614|12179090|FG001|Switch to Remicade|Adverse Event|5
7744638|NCT00705614|12179089|FG000|Switch to Remicade|Lost to Follow-up|0
7744639|NCT00705614|12179090|FG001|Switch to Remicade|Lost to Follow-up|23
7744640|NCT00705614|12179089|FG000|Switch to Remicade|Withdrawal by Subject|0
7744641|NCT00705614|12179090|FG001|Switch to Remicade|Withdrawal by Subject|12
7744642|NCT00705614|12179089|FG000|Switch to Remicade|Administrative Reason|0
7744643|NCT00705614|12179090|FG001|Switch to Remicade|Administrative Reason|9
7744644|NCT00705666|12179102|FG000|Overall Study|No post-treatment questionnaire|279
7744645|NCT00705666|12179102|FG000|Overall Study|Withdrawal by Subject|21
7744646|NCT00705666|12179102|FG000|Overall Study|Physician Decision|7
7744647|NCT00705666|12179102|FG000|Overall Study|Lost to Follow-up|5
7744648|NCT00705666|12179102|FG000|Overall Study|Death|1
7744649|NCT00705666|12179102|FG000|Overall Study|Adverse Event|4
7744650|NCT00705666|12179102|FG000|Overall Study|Other|12
7744651|NCT00705666|12179102|FG000|Overall Study|Other|2
7744652|NCT00705666|12179102|FG000|Overall Study|Lack of data|3
7744653|NCT00705666|12179102|FG000|Overall Study|Untreated|5
7744654|NCT00705679|12179111|FG000|Overall Study|Adverse Event|1
7744655|NCT00705679|12179112|FG001|Overall Study|Adverse Event|1
7744656|NCT00705679|12179113|FG002|Overall Study|Adverse Event|0
7744657|NCT00705679|12179114|FG003|Overall Study|Adverse Event|0
7744658|NCT00705679|12179115|FG004|Overall Study|Adverse Event|0
7744659|NCT00705679|12179111|FG000|Overall Study|Death|0
7744660|NCT00705679|12179112|FG001|Overall Study|Death|0
7744661|NCT00705679|12179113|FG002|Overall Study|Death|3
7744662|NCT00705679|12179114|FG003|Overall Study|Death|2
7744663|NCT00705679|12179115|FG004|Overall Study|Death|1
7744664|NCT00705679|12179111|FG000|Overall Study|Lost to Follow-up|32
7744665|NCT00705679|12179112|FG001|Overall Study|Lost to Follow-up|60
7744666|NCT00705679|12179113|FG002|Overall Study|Lost to Follow-up|44
7744667|NCT00705679|12179114|FG003|Overall Study|Lost to Follow-up|30
7744668|NCT00705679|12179115|FG004|Overall Study|Lost to Follow-up|35
7744669|NCT00705679|12179111|FG000|Overall Study|Physician Decision|0
7744670|NCT00705679|12179112|FG001|Overall Study|Physician Decision|1
7744671|NCT00705679|12179113|FG002|Overall Study|Physician Decision|0
7744672|NCT00705679|12179114|FG003|Overall Study|Physician Decision|1
7744673|NCT00705679|12179115|FG004|Overall Study|Physician Decision|0
7744674|NCT00705679|12179111|FG000|Overall Study|Withdrawal by Subject|32
7744675|NCT00705679|12179112|FG001|Overall Study|Withdrawal by Subject|77
7744676|NCT00705679|12179113|FG002|Overall Study|Withdrawal by Subject|68
7744677|NCT00705679|12179114|FG003|Overall Study|Withdrawal by Subject|47
7744678|NCT00705679|12179115|FG004|Overall Study|Withdrawal by Subject|33
7744679|NCT00705718|12179134|FG000|Overall Study|Death|6
7744680|NCT00705718|12179135|FG001|Overall Study|Death|6
7744681|NCT00705718|12179134|FG000|Overall Study|Not due for Visit|0
7744682|NCT00705718|12179135|FG001|Overall Study|Not due for Visit|12
7744683|NCT00705718|12179134|FG000|Overall Study|Follow up not done|1
7744684|NCT00705718|12179135|FG001|Overall Study|Follow up not done|4
7744685|NCT00705757|12179144|FG000|Overall Study|Lack of Efficacy|5
7744686|NCT00705757|12179145|FG001|Overall Study|Lack of Efficacy|1
7744687|NCT00705757|12179146|FG002|Overall Study|Lack of Efficacy|3
7744688|NCT00705757|12179144|FG000|Overall Study|Lost to Follow-up|7
7744689|NCT00705757|12179145|FG001|Overall Study|Lost to Follow-up|6
7744690|NCT00705757|12179146|FG002|Overall Study|Lost to Follow-up|6
7744691|NCT00705757|12179144|FG000|Overall Study|Withdrawal by Subject|1
7744692|NCT00705757|12179145|FG001|Overall Study|Withdrawal by Subject|1
7744693|NCT00705757|12179146|FG002|Overall Study|Withdrawal by Subject|2
7744694|NCT00705783|12179156|FG000|Conversion Phase|Sponsor Discontinued Study|54
7744695|NCT00705783|12179157|FG001|Conversion Phase|Sponsor Discontinued Study|0
7744696|NCT00705783|12179158|FG002|Conversion Phase|Sponsor Discontinued Study|0
7744697|NCT00705783|12179156|FG000|Conversion Phase|Lost to Follow-up|13
7962259|NCT02711345|12516527|FG005|Overall Study|Adverse Event|2
7962260|NCT02711345|12516528|FG006|Overall Study|Adverse Event|1
7962261|NCT02711345|12516529|FG007|Overall Study|Adverse Event|0
7744698|NCT00705783|12179157|FG001|Conversion Phase|Lost to Follow-up|0
7744699|NCT00705783|12179158|FG002|Conversion Phase|Lost to Follow-up|0
7744700|NCT00705783|12179156|FG000|Conversion Phase|Met Withdrawal Criteria|4
7744701|NCT00705783|12179157|FG001|Conversion Phase|Met Withdrawal Criteria|0
7744702|NCT00705783|12179158|FG002|Conversion Phase|Met Withdrawal Criteria|0
7744703|NCT00705783|12179156|FG000|Conversion Phase|Withdrawn by Investigator|4
7744704|NCT00705783|12179157|FG001|Conversion Phase|Withdrawn by Investigator|0
7744705|NCT00705783|12179158|FG002|Conversion Phase|Withdrawn by Investigator|0
7744706|NCT00705783|12179156|FG000|Conversion Phase|Withdrew Consent|24
7744707|NCT00705783|12179157|FG001|Conversion Phase|Withdrew Consent|0
7744708|NCT00705783|12179158|FG002|Conversion Phase|Withdrew Consent|0
7744709|NCT00705783|12179156|FG000|Conversion Phase|Protocol Deviation|2
7744710|NCT00705783|12179157|FG001|Conversion Phase|Protocol Deviation|0
7744711|NCT00705783|12179158|FG002|Conversion Phase|Protocol Deviation|0
7744712|NCT00705783|12179156|FG000|Conversion Phase|Adverse Event|11
7744713|NCT00705783|12179157|FG001|Conversion Phase|Adverse Event|0
7744714|NCT00705783|12179158|FG002|Conversion Phase|Adverse Event|0
7744715|NCT00705783|12179156|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13
7744716|NCT00705783|12179157|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0
7744717|NCT00705783|12179158|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0
7744718|NCT00705783|12179156|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8
7744719|NCT00705783|12179157|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0
7962262|NCT02711345|12516530|FG008|Overall Study|Adverse Event|0
7962263|NCT02711345|12516531|FG009|Overall Study|Adverse Event|2
7744720|NCT00705783|12179158|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0
7744721|NCT00705783|12179156|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42
7744722|NCT00705783|12179157|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0
7744723|NCT00705783|12179158|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0
7744724|NCT00705783|12179156|FG000|Oral Stabilization Phase|Lost to Follow-up|7
7744725|NCT00705783|12179157|FG001|Oral Stabilization Phase|Lost to Follow-up|0
7744726|NCT00705783|12179158|FG002|Oral Stabilization Phase|Lost to Follow-up|0
7744727|NCT00705783|12179156|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19
7744728|NCT00705783|12179157|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0
7744729|NCT00705783|12179158|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0
7744730|NCT00705783|12179156|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12
7744731|NCT00705783|12179157|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0
7744732|NCT00705783|12179158|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0
7744733|NCT00705783|12179156|FG000|Oral Stabilization Phase|Withdrew Consent|29
7744734|NCT00705783|12179157|FG001|Oral Stabilization Phase|Withdrew Consent|0
7744735|NCT00705783|12179158|FG002|Oral Stabilization Phase|Withdrew Consent|0
7962264|NCT02711345|12516522|FG000|Overall Study|Physician Decision|0
7744736|NCT00705783|12179156|FG000|Oral Stabilization Phase|Adverse Event|14
7744737|NCT00705783|12179157|FG001|Oral Stabilization Phase|Adverse Event|0
7744738|NCT00705783|12179158|FG002|Oral Stabilization Phase|Adverse Event|0
7744739|NCT00705783|12179156|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
7744740|NCT00705783|12179157|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
7744741|NCT00705783|12179158|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
7744742|NCT00705783|12179156|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
7744743|NCT00705783|12179157|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
7744744|NCT00705783|12179158|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
7744745|NCT00705783|12179156|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86
7744746|NCT00705783|12179157|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0
7744747|NCT00705783|12179158|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0
7744748|NCT00705783|12179156|FG000|Depot Stabilization Phase|Lost to Follow-up|11
7744749|NCT00705783|12179157|FG001|Depot Stabilization Phase|Lost to Follow-up|0
7744750|NCT00705783|12179158|FG002|Depot Stabilization Phase|Lost to Follow-up|0
7744751|NCT00705783|12179156|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8
7744752|NCT00705783|12179157|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0
7744753|NCT00705783|12179158|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0
7744754|NCT00705783|12179156|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9
7744755|NCT00705783|12179157|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0
7744756|NCT00705783|12179158|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0
7744757|NCT00705783|12179156|FG000|Depot Stabilization Phase|Withdrew Consent|29
7744758|NCT00705783|12179157|FG001|Depot Stabilization Phase|Withdrew Consent|0
7744759|NCT00705783|12179158|FG002|Depot Stabilization Phase|Withdrew Consent|0
7744760|NCT00705783|12179156|FG000|Depot Stabilization Phase|Adverse Event|17
7744761|NCT00705783|12179157|FG001|Depot Stabilization Phase|Adverse Event|0
7744762|NCT00705783|12179158|FG002|Depot Stabilization Phase|Adverse Event|0
7744763|NCT00705783|12179156|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
7744764|NCT00705783|12179157|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
7744765|NCT00705783|12179158|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
7744766|NCT00705783|12179156|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
7744767|NCT00705783|12179157|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
7744768|NCT00705783|12179158|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
7744769|NCT00705783|12179156|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0
7744770|NCT00705783|12179157|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179
7744771|NCT00705783|12179158|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58
7744772|NCT00705783|12179156|FG000|Depot Maintenance Phase|Lost to Follow-up|0
7744773|NCT00705783|12179157|FG001|Depot Maintenance Phase|Lost to Follow-up|5
7744774|NCT00705783|12179158|FG002|Depot Maintenance Phase|Lost to Follow-up|3
7744775|NCT00705783|12179156|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0
7744776|NCT00705783|12179157|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2
7744777|NCT00705783|12179158|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2
7744778|NCT00705783|12179156|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0
7744779|NCT00705783|12179157|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8
7744780|NCT00705783|12179158|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6
7744781|NCT00705783|12179156|FG000|Depot Maintenance Phase|Withdrew Consent|0
7744782|NCT00705783|12179157|FG001|Depot Maintenance Phase|Withdrew Consent|14
7744783|NCT00705783|12179158|FG002|Depot Maintenance Phase|Withdrew Consent|4
7744784|NCT00705783|12179156|FG000|Depot Maintenance Phase|Protocol Deviation|0
7744785|NCT00705783|12179157|FG001|Depot Maintenance Phase|Protocol Deviation|2
7744786|NCT00705783|12179158|FG002|Depot Maintenance Phase|Protocol Deviation|0
7744787|NCT00705783|12179156|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
7744788|NCT00705783|12179157|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
7744789|NCT00705783|12179158|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
7744790|NCT00705783|12179156|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
7744791|NCT00705783|12179157|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
7744792|NCT00705783|12179158|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
7744793|NCT00705783|12179156|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
7744794|NCT00705783|12179157|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
7744795|NCT00705783|12179158|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
7744796|NCT00705939|12179199|FG000|Overall Study|Protocol Violation|0
7744797|NCT00705939|12179200|FG001|Overall Study|Protocol Violation|0
7744798|NCT00705939|12179201|FG002|Overall Study|Protocol Violation|1
7744799|NCT00705939|12179199|FG000|Overall Study|Withdrawal by Subject|0
7744800|NCT00705939|12179200|FG001|Overall Study|Withdrawal by Subject|1
7744801|NCT00705939|12179201|FG002|Overall Study|Withdrawal by Subject|3
7744802|NCT00705939|12179199|FG000|Overall Study|Physician Decision|0
7744803|NCT00705939|12179200|FG001|Overall Study|Physician Decision|1
7744804|NCT00705939|12179201|FG002|Overall Study|Physician Decision|0
7744805|NCT00706004|12179210|FG000|Overall Study|Did not meet eligibility criteria|2
7744806|NCT00706030|12179219|FG000|Overall Study|Disease Progression|4
7744807|NCT00706030|12179220|FG001|Overall Study|Disease Progression|6
7744808|NCT00706030|12179221|FG002|Overall Study|Disease Progression|46
7744809|NCT00706030|12179222|FG003|Overall Study|Disease Progression|12
7744810|NCT00706030|12179219|FG000|Overall Study|Adverse Event|1
7744811|NCT00706030|12179220|FG001|Overall Study|Adverse Event|0
7744812|NCT00706030|12179221|FG002|Overall Study|Adverse Event|4
7744813|NCT00706030|12179222|FG003|Overall Study|Adverse Event|2
7744814|NCT00706030|12179219|FG000|Overall Study|Withdrawal by Subject|1
7744815|NCT00706030|12179220|FG001|Overall Study|Withdrawal by Subject|0
7744816|NCT00706030|12179221|FG002|Overall Study|Withdrawal by Subject|2
7744817|NCT00706030|12179222|FG003|Overall Study|Withdrawal by Subject|0
7744818|NCT00706030|12179219|FG000|Overall Study|Physician Decision|0
7744819|NCT00706030|12179220|FG001|Overall Study|Physician Decision|0
7744820|NCT00706030|12179221|FG002|Overall Study|Physician Decision|2
7744821|NCT00706030|12179222|FG003|Overall Study|Physician Decision|0
7744822|NCT00706030|12179219|FG000|Overall Study|Not recorded|0
7744823|NCT00706030|12179220|FG001|Overall Study|Not recorded|0
7744824|NCT00706030|12179221|FG002|Overall Study|Not recorded|2
7744825|NCT00706030|12179222|FG003|Overall Study|Not recorded|0
7744826|NCT00706030|12179219|FG000|Overall Study|Protocol Violation|0
7744827|NCT00706030|12179220|FG001|Overall Study|Protocol Violation|0
7744828|NCT00706030|12179221|FG002|Overall Study|Protocol Violation|1
7744829|NCT00706030|12179222|FG003|Overall Study|Protocol Violation|1
7744830|NCT00706030|12179219|FG000|Overall Study|Failed to return|0
7744831|NCT00706030|12179220|FG001|Overall Study|Failed to return|0
7744832|NCT00706030|12179221|FG002|Overall Study|Failed to return|1
7744833|NCT00706030|12179222|FG003|Overall Study|Failed to return|0
7744834|NCT00706030|12179219|FG000|Overall Study|Symptomatic Deterioration|0
7744835|NCT00706030|12179220|FG001|Overall Study|Symptomatic Deterioration|0
7744836|NCT00706030|12179221|FG002|Overall Study|Symptomatic Deterioration|1
7744837|NCT00706030|12179222|FG003|Overall Study|Symptomatic Deterioration|0
7744838|NCT00706030|12179219|FG000|Overall Study|No treatment received|0
7744839|NCT00706030|12179220|FG001|Overall Study|No treatment received|0
7744840|NCT00706030|12179221|FG002|Overall Study|No treatment received|0
7744841|NCT00706030|12179222|FG003|Overall Study|No treatment received|1
7744842|NCT00706030|12179219|FG000|Overall Study|Death|0
7744843|NCT00706030|12179220|FG001|Overall Study|Death|0
7744844|NCT00706030|12179221|FG002|Overall Study|Death|1
7744845|NCT00706030|12179222|FG003|Overall Study|Death|0
7744846|NCT00706095|12179236|FG000|Overall Study|Progressive Disease|4
7744847|NCT00706095|12179237|FG001|Overall Study|Progressive Disease|5
7744848|NCT00706095|12179238|FG002|Overall Study|Progressive Disease|3
7744849|NCT00706095|12179236|FG000|Overall Study|Clinical Progression|1
7744850|NCT00706095|12179237|FG001|Overall Study|Clinical Progression|2
7744851|NCT00706095|12179238|FG002|Overall Study|Clinical Progression|2
7744852|NCT00706095|12179236|FG000|Overall Study|Withdrawal by Subject|1
7744853|NCT00706095|12179237|FG001|Overall Study|Withdrawal by Subject|0
7744854|NCT00706095|12179238|FG002|Overall Study|Withdrawal by Subject|0
7744855|NCT00706134|12179275|FG000|Overall Study|Adverse Event|8
7744856|NCT00706134|12179276|FG001|Overall Study|Adverse Event|7
7744857|NCT00706134|12179277|FG002|Overall Study|Adverse Event|2
7744858|NCT00706134|12179278|FG003|Overall Study|Adverse Event|3
7744859|NCT00706134|12179275|FG000|Overall Study|Lost to Follow-up|0
7744860|NCT00706134|12179276|FG001|Overall Study|Lost to Follow-up|1
7744861|NCT00706134|12179277|FG002|Overall Study|Lost to Follow-up|0
7744862|NCT00706134|12179278|FG003|Overall Study|Lost to Follow-up|0
7744863|NCT00706134|12179275|FG000|Overall Study|Protocol Violation|0
7744864|NCT00706134|12179276|FG001|Overall Study|Protocol Violation|6
7744865|NCT00706134|12179277|FG002|Overall Study|Protocol Violation|0
7744866|NCT00706134|12179278|FG003|Overall Study|Protocol Violation|3
7744867|NCT00706134|12179275|FG000|Overall Study|Withdrawal by Subject|1
7744868|NCT00706134|12179276|FG001|Overall Study|Withdrawal by Subject|2
7744869|NCT00706134|12179277|FG002|Overall Study|Withdrawal by Subject|1
7744870|NCT00706134|12179278|FG003|Overall Study|Withdrawal by Subject|0
7744871|NCT00706134|12179275|FG000|Overall Study|Unsatisfactory therapeutic effect|9
7744872|NCT00706134|12179276|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7744873|NCT00706134|12179277|FG002|Overall Study|Unsatisfactory therapeutic effect|3
7744874|NCT00706134|12179278|FG003|Overall Study|Unsatisfactory therapeutic effect|5
7744875|NCT00706134|12179275|FG000|Overall Study|Did not meet study criteria|2
7744876|NCT00706134|12179276|FG001|Overall Study|Did not meet study criteria|0
7744877|NCT00706134|12179277|FG002|Overall Study|Did not meet study criteria|0
7744878|NCT00706134|12179278|FG003|Overall Study|Did not meet study criteria|0
7744879|NCT00706238|12179288|FG000|Overall Study|Disease progression|4
7744880|NCT00706238|12179288|FG000|Overall Study|Other|1
7769268|NCT00867360|12212814|FG000|Overall Study|Physician Decision|0
7769269|NCT00867360|12212815|FG001|Overall Study|Physician Decision|1
7769270|NCT00867490|12212835|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5
7769271|NCT00867490|12212835|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
7769272|NCT00867490|12212835|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
7769273|NCT00867490|12212835|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
7769274|NCT00867490|12212835|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
7769275|NCT00867503|12212842|FG000|Overall Study|Withdrawal by Subject|1
7769276|NCT00867815|12212866|FG000|Overall Study|Lost to Follow-up|1
7769277|NCT00868166|12212898|FG000|Overall Study|Death|58
7769278|NCT00868166|12212899|FG001|Overall Study|Death|65
7769279|NCT00868166|12212898|FG000|Overall Study|Withdrawal by Subject|33
7769280|NCT00868166|12212899|FG001|Overall Study|Withdrawal by Subject|25
7769281|NCT00868166|12212898|FG000|Overall Study|Protocol Violation|1
7769282|NCT00868166|12212899|FG001|Overall Study|Protocol Violation|0
7769283|NCT00868166|12212898|FG000|Overall Study|Lost to Follow-up|1
7769284|NCT00868166|12212899|FG001|Overall Study|Lost to Follow-up|3
7769285|NCT00868166|12212898|FG000|Overall Study|Adverse Event|9
7769286|NCT00868166|12212899|FG001|Overall Study|Adverse Event|10
7769287|NCT00868166|12212898|FG000|Overall Study|Lack of efficacy, logistics, unwell|9
7769288|NCT00868166|12212899|FG001|Overall Study|Lack of efficacy, logistics, unwell|10
7769289|NCT00868166|12212898|FG000|Overall Study|Non-compliance with IMP|1
7769290|NCT00868166|12212899|FG001|Overall Study|Non-compliance with IMP|1
7769291|NCT00868192|12212905|FG000|Overall Study|Ineligible|4
7769292|NCT00868231|12212930|FG000|Treatment Period 1|Adverse Event|0
7769293|NCT00868231|12212931|FG001|Treatment Period 1|Adverse Event|0
7769294|NCT00868231|12212932|FG002|Treatment Period 1|Adverse Event|0
7769295|NCT00868231|12212933|FG003|Treatment Period 1|Adverse Event|0
7769296|NCT00868231|12212934|FG004|Treatment Period 1|Adverse Event|1
7769297|NCT00868231|12212935|FG005|Treatment Period 1|Adverse Event|0
7769298|NCT00868231|12212930|FG000|Treatment Period 2|Adverse Event|1
7769299|NCT00868231|12212931|FG001|Treatment Period 2|Adverse Event|0
7769300|NCT00868231|12212932|FG002|Treatment Period 2|Adverse Event|0
7769301|NCT00868231|12212933|FG003|Treatment Period 2|Adverse Event|0
7769302|NCT00868231|12212934|FG004|Treatment Period 2|Adverse Event|0
7769303|NCT00868231|12212935|FG005|Treatment Period 2|Adverse Event|0
7769304|NCT00868231|12212930|FG000|Treatment Period 3|Adverse Event|0
7769305|NCT00868231|12212931|FG001|Treatment Period 3|Adverse Event|0
7769306|NCT00868231|12212932|FG002|Treatment Period 3|Adverse Event|1
7769307|NCT00868231|12212933|FG003|Treatment Period 3|Adverse Event|0
7769308|NCT00868231|12212934|FG004|Treatment Period 3|Adverse Event|0
7769309|NCT00868231|12212935|FG005|Treatment Period 3|Adverse Event|0
7769310|NCT00868296|12212945|FG000|Overall Study|Adverse Event|0
7769311|NCT00868296|12212946|FG001|Overall Study|Adverse Event|2
7769312|NCT00868296|12212945|FG000|Overall Study|Withdrawal by Subject|0
7769313|NCT00868296|12212946|FG001|Overall Study|Withdrawal by Subject|1
7769314|NCT00868439|12212981|FG000|Overall Study|Adverse Event|4
7769315|NCT00868439|12212982|FG001|Overall Study|Adverse Event|3
7769316|NCT00868439|12212981|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
7769317|NCT00868439|12212982|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
7769318|NCT00868439|12212981|FG000|Overall Study|Death|0
7769319|NCT00868439|12212982|FG001|Overall Study|Death|1
7769320|NCT00868439|12212981|FG000|Overall Study|Protocol Violation|1
7769321|NCT00868439|12212982|FG001|Overall Study|Protocol Violation|1
7769322|NCT00868439|12212981|FG000|Overall Study|Physician Decision|1
7769323|NCT00868439|12212982|FG001|Overall Study|Physician Decision|0
7769324|NCT00868439|12212981|FG000|Overall Study|Withdrawal by Subject|0
7769325|NCT00868439|12212982|FG001|Overall Study|Withdrawal by Subject|1
7769326|NCT00868517|12213001|FG000|Overall Study|Withdrawal by Subject|3
7769327|NCT00868517|12213002|FG001|Overall Study|Withdrawal by Subject|3
7769328|NCT00868517|12213003|FG002|Overall Study|Withdrawal by Subject|2
7769329|NCT00868517|12213001|FG000|Overall Study|Protocol Violation|1
7769330|NCT00868517|12213002|FG001|Overall Study|Protocol Violation|1
7769331|NCT00868517|12213003|FG002|Overall Study|Protocol Violation|0
7769332|NCT00868530|12213011|FG000|Overall Study|Adverse Event|3
7769333|NCT00868530|12213011|FG000|Overall Study|Lost to Follow-up|1
7769334|NCT00868608|12213018|FG000|Overall Study|Withdrawal by Subject|3
7769335|NCT00868608|12213019|FG001|Overall Study|Withdrawal by Subject|1
7769336|NCT00868608|12213020|FG002|Overall Study|Withdrawal by Subject|0
7769337|NCT00868608|12213018|FG000|Overall Study|Lost to Follow-up|3
7769338|NCT00868608|12213019|FG001|Overall Study|Lost to Follow-up|0
7769339|NCT00868608|12213020|FG002|Overall Study|Lost to Follow-up|1
7769340|NCT00868608|12213018|FG000|Overall Study|Death|16
7769341|NCT00868608|12213019|FG001|Overall Study|Death|2
7769342|NCT00868608|12213020|FG002|Overall Study|Death|4
7769343|NCT00868608|12213018|FG000|Overall Study|Other - Unspecified|1
7769344|NCT00868608|12213019|FG001|Overall Study|Other - Unspecified|0
7769345|NCT00868608|12213020|FG002|Overall Study|Other - Unspecified|0
7770440|NCT00876460|12214455|FG007|Combination Therapy Phase|Dose limiting toxicity|1
7770441|NCT00876460|12214448|FG000|Combination Therapy Phase|Adverse Event|0
7770442|NCT00876460|12214449|FG001|Combination Therapy Phase|Adverse Event|2
7770443|NCT00876460|12214450|FG002|Combination Therapy Phase|Adverse Event|0
7744881|NCT00706342|12179303|FG000|Overall Study|Adverse Event|3
7744882|NCT00706342|12179303|FG000|Overall Study|Not responding to treatment|2
7744883|NCT00706342|12179303|FG000|Overall Study|Withdrawn due to failure to respond|1
7744884|NCT00706342|12179303|FG000|Overall Study|Death|1
7744885|NCT00706342|12179303|FG000|Overall Study|Withdrew from the study on his own.|1
7744886|NCT00706342|12179303|FG000|Overall Study|Investigator discretion|2
7744887|NCT00706342|12179303|FG000|Overall Study|Non-responder Week 12|1
7744888|NCT00706342|12179303|FG000|Overall Study|Ongoing|6
7744889|NCT00706342|12179303|FG000|Overall Study|WIthdrawal of consent|1
7744890|NCT00706355|12179311|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
7744891|NCT00706355|12179312|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
7744892|NCT00706355|12179313|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
7744893|NCT00706355|12179314|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
7744894|NCT00706355|12179311|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
7744895|NCT00706355|12179312|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
7744896|NCT00706355|12179313|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
7744897|NCT00706355|12179314|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
7744898|NCT00706355|12179311|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
7744899|NCT00706355|12179312|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
7744900|NCT00706355|12179313|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
7744901|NCT00706355|12179314|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
7744902|NCT00706355|12179311|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
7744903|NCT00706355|12179312|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
7744904|NCT00706355|12179313|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
7744905|NCT00706355|12179314|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
7744906|NCT00706355|12179311|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
7744907|NCT00706355|12179312|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
7744908|NCT00706355|12179313|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
7744909|NCT00706355|12179314|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
7744910|NCT00706355|12179311|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0
7744911|NCT00706355|12179312|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0
7744912|NCT00706355|12179313|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1
7744913|NCT00706355|12179314|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0
7744914|NCT00706355|12179311|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
7744915|NCT00706355|12179312|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
7744916|NCT00706355|12179313|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
7744917|NCT00706355|12179314|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
7744918|NCT00706355|12179311|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0
7744919|NCT00706355|12179312|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0
7744920|NCT00706355|12179313|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0
7744921|NCT00706355|12179314|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2
7744922|NCT00706355|12179311|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
7744923|NCT00706355|12179312|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
7744924|NCT00706355|12179313|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
7744925|NCT00706355|12179314|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
7744926|NCT00706381|12179330|FG000|Overall Study|Lost to Follow-up|0
7744927|NCT00706381|12179331|FG001|Overall Study|Lost to Follow-up|1
7744928|NCT00706381|12179332|FG002|Overall Study|Lost to Follow-up|1
7744929|NCT00706381|12179333|FG003|Overall Study|Lost to Follow-up|0
7744930|NCT00706433|12179363|FG000|Overall Study|Lost to Follow-up|3
7744931|NCT00706433|12179364|FG001|Overall Study|Lost to Follow-up|1
7744932|NCT00706433|12179365|FG002|Overall Study|Lost to Follow-up|6
7744933|NCT00706433|12179366|FG003|Overall Study|Lost to Follow-up|0
7744934|NCT00706433|12179363|FG000|Overall Study|Withdrawal by Subject|1
7744935|NCT00706433|12179364|FG001|Overall Study|Withdrawal by Subject|2
7744936|NCT00706433|12179365|FG002|Overall Study|Withdrawal by Subject|3
7744937|NCT00706433|12179366|FG003|Overall Study|Withdrawal by Subject|1
7744938|NCT00706433|12179363|FG000|Overall Study|Adverse Event|0
7744939|NCT00706433|12179364|FG001|Overall Study|Adverse Event|0
7744940|NCT00706433|12179365|FG002|Overall Study|Adverse Event|1
7744941|NCT00706433|12179366|FG003|Overall Study|Adverse Event|0
7744942|NCT00706433|12179363|FG000|Overall Study|Protocol Violation|1
7744943|NCT00706433|12179364|FG001|Overall Study|Protocol Violation|0
7744944|NCT00706433|12179365|FG002|Overall Study|Protocol Violation|0
7744945|NCT00706433|12179366|FG003|Overall Study|Protocol Violation|0
7744946|NCT00706433|12179363|FG000|Overall Study|new job|0
7744947|NCT00706433|12179364|FG001|Overall Study|new job|0
7744948|NCT00706433|12179365|FG002|Overall Study|new job|0
7744949|NCT00706433|12179366|FG003|Overall Study|new job|1
7744950|NCT00706511|12179409|FG000|Overall Study|Withdrawal by Subject|1
7744951|NCT00706511|12179410|FG001|Overall Study|Withdrawal by Subject|0
7744952|NCT00706511|12179411|FG002|Overall Study|Withdrawal by Subject|0
7744953|NCT00706511|12179412|FG003|Overall Study|Withdrawal by Subject|0
7744954|NCT00706628|12179452|FG000|Overall Study|Other Adverse Event|16
7744955|NCT00706628|12179453|FG001|Overall Study|Other Adverse Event|5
7744956|NCT00706628|12179454|FG002|Overall Study|Other Adverse Event|5
7744957|NCT00706628|12179455|FG003|Overall Study|Other Adverse Event|2
7744958|NCT00706628|12179452|FG000|Overall Study|Non compliant with protocol|0
7744959|NCT00706628|12179453|FG001|Overall Study|Non compliant with protocol|1
7744960|NCT00706628|12179454|FG002|Overall Study|Non compliant with protocol|0
7744961|NCT00706628|12179455|FG003|Overall Study|Non compliant with protocol|0
7744962|NCT00706628|12179452|FG000|Overall Study|Consent withdrawn|6
7744963|NCT00706628|12179453|FG001|Overall Study|Consent withdrawn|1
7744964|NCT00706628|12179454|FG002|Overall Study|Consent withdrawn|3
7744965|NCT00706628|12179455|FG003|Overall Study|Consent withdrawn|0
7744966|NCT00706628|12179452|FG000|Overall Study|Progressive disease|20
7744967|NCT00706628|12179453|FG001|Overall Study|Progressive disease|13
7744968|NCT00706628|12179454|FG002|Overall Study|Progressive disease|8
7744969|NCT00706628|12179455|FG003|Overall Study|Progressive disease|1
7744970|NCT00706628|12179452|FG000|Overall Study|Other than those stated above|4
7744971|NCT00706628|12179453|FG001|Overall Study|Other than those stated above|0
7744972|NCT00706628|12179454|FG002|Overall Study|Other than those stated above|0
7744973|NCT00706628|12179455|FG003|Overall Study|Other than those stated above|0
7744974|NCT00706628|12179452|FG000|Overall Study|Not treated|1
7744975|NCT00706628|12179453|FG001|Overall Study|Not treated|1
7744976|NCT00706628|12179454|FG002|Overall Study|Not treated|0
7744977|NCT00706628|12179455|FG003|Overall Study|Not treated|0
7744978|NCT00706641|12179468|FG000|Dasatinib Administration|Withdrawal by Subject|1
7744979|NCT00706641|12179468|FG000|Dasatinib Administration|Ineligible after start of therapy|1
7744980|NCT00706641|12179468|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1
7744981|NCT00706654|12179475|FG000|Conversion Phase|Lost to Follow-up|4
7744982|NCT00706654|12179476|FG001|Conversion Phase|Lost to Follow-up|0
7744983|NCT00706654|12179477|FG002|Conversion Phase|Lost to Follow-up|0
7744984|NCT00706654|12179478|FG003|Conversion Phase|Lost to Follow-up|0
7744985|NCT00706654|12179475|FG000|Conversion Phase|Sponsor Discontinued Trial|8
7744986|NCT00706654|12179476|FG001|Conversion Phase|Sponsor Discontinued Trial|0
7744987|NCT00706654|12179477|FG002|Conversion Phase|Sponsor Discontinued Trial|0
7744988|NCT00706654|12179478|FG003|Conversion Phase|Sponsor Discontinued Trial|0
7744989|NCT00706654|12179475|FG000|Conversion Phase|Met Withdrawal Criteria|2
7744990|NCT00706654|12179476|FG001|Conversion Phase|Met Withdrawal Criteria|0
7744991|NCT00706654|12179477|FG002|Conversion Phase|Met Withdrawal Criteria|0
7744992|NCT00706654|12179478|FG003|Conversion Phase|Met Withdrawal Criteria|0
7744993|NCT00706654|12179475|FG000|Conversion Phase|Withdrawn by Investigator|14
7744994|NCT00706654|12179476|FG001|Conversion Phase|Withdrawn by Investigator|0
7744995|NCT00706654|12179477|FG002|Conversion Phase|Withdrawn by Investigator|0
7744996|NCT00706654|12179478|FG003|Conversion Phase|Withdrawn by Investigator|0
7744997|NCT00706654|12179475|FG000|Conversion Phase|Withdrew Consent|38
7744998|NCT00706654|12179476|FG001|Conversion Phase|Withdrew Consent|0
7744999|NCT00706654|12179477|FG002|Conversion Phase|Withdrew Consent|0
7745000|NCT00706654|12179478|FG003|Conversion Phase|Withdrew Consent|0
7745001|NCT00706654|12179475|FG000|Conversion Phase|Adverse Event|18
7745002|NCT00706654|12179476|FG001|Conversion Phase|Adverse Event|0
7745003|NCT00706654|12179477|FG002|Conversion Phase|Adverse Event|0
7745004|NCT00706654|12179478|FG003|Conversion Phase|Adverse Event|0
7745005|NCT00706654|12179475|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9
7745006|NCT00706654|12179476|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0
7745007|NCT00706654|12179477|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0
7745008|NCT00706654|12179478|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0
7745009|NCT00706654|12179475|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2
7745010|NCT00706654|12179476|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0
7745011|NCT00706654|12179477|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0
7745012|NCT00706654|12179478|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0
7745013|NCT00706654|12179475|FG000|Oral Stabilization Phase|Lost to Follow-up|17
7745014|NCT00706654|12179476|FG001|Oral Stabilization Phase|Lost to Follow-up|0
7745015|NCT00706654|12179477|FG002|Oral Stabilization Phase|Lost to Follow-up|0
7745016|NCT00706654|12179478|FG003|Oral Stabilization Phase|Lost to Follow-up|0
7745017|NCT00706654|12179475|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19
7745018|NCT00706654|12179476|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0
7745019|NCT00706654|12179477|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0
7745020|NCT00706654|12179478|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0
7745021|NCT00706654|12179475|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15
7745022|NCT00706654|12179476|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0
7745023|NCT00706654|12179477|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0
7745024|NCT00706654|12179478|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0
7745025|NCT00706654|12179475|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21
7745026|NCT00706654|12179476|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0
7745027|NCT00706654|12179477|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0
7745028|NCT00706654|12179478|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0
7745029|NCT00706654|12179475|FG000|Oral Stabilization Phase|Withdrew consent|55
7745030|NCT00706654|12179476|FG001|Oral Stabilization Phase|Withdrew consent|0
7745031|NCT00706654|12179477|FG002|Oral Stabilization Phase|Withdrew consent|0
7745032|NCT00706654|12179478|FG003|Oral Stabilization Phase|Withdrew consent|0
7745033|NCT00706654|12179475|FG000|Oral Stabilization Phase|Protocol Deviation|2
7745034|NCT00706654|12179476|FG001|Oral Stabilization Phase|Protocol Deviation|0
7745035|NCT00706654|12179477|FG002|Oral Stabilization Phase|Protocol Deviation|0
7745036|NCT00706654|12179478|FG003|Oral Stabilization Phase|Protocol Deviation|0
7745037|NCT00706654|12179475|FG000|Oral Stabilization Phase|Adverse Event|21
7745038|NCT00706654|12179476|FG001|Oral Stabilization Phase|Adverse Event|0
7745039|NCT00706654|12179477|FG002|Oral Stabilization Phase|Adverse Event|0
7745040|NCT00706654|12179478|FG003|Oral Stabilization Phase|Adverse Event|0
7745041|NCT00706654|12179475|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
7745042|NCT00706654|12179476|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
7745043|NCT00706654|12179477|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
7745044|NCT00706654|12179478|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
7745045|NCT00706654|12179475|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
7745046|NCT00706654|12179476|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
7745047|NCT00706654|12179477|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
7745048|NCT00706654|12179478|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
7745049|NCT00706654|12179475|FG000|Depot Maintenance Phase|Lost to Follow-up|0
7745050|NCT00706654|12179476|FG001|Depot Maintenance Phase|Lost to Follow-up|4
7745051|NCT00706654|12179477|FG002|Depot Maintenance Phase|Lost to Follow-up|10
7745052|NCT00706654|12179478|FG003|Depot Maintenance Phase|Lost to Follow-up|6
7745053|NCT00706654|12179475|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0
7745054|NCT00706654|12179476|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4
7745055|NCT00706654|12179477|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6
7745056|NCT00706654|12179478|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5
7745057|NCT00706654|12179475|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0
7745058|NCT00706654|12179476|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8
7745059|NCT00706654|12179477|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12
7745060|NCT00706654|12179478|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8
7745061|NCT00706654|12179475|FG000|Depot Maintenance Phase|Withdrew Consent|0
7745062|NCT00706654|12179476|FG001|Depot Maintenance Phase|Withdrew Consent|21
7745063|NCT00706654|12179477|FG002|Depot Maintenance Phase|Withdrew Consent|29
7745064|NCT00706654|12179478|FG003|Depot Maintenance Phase|Withdrew Consent|14
7745065|NCT00706654|12179475|FG000|Depot Maintenance Phase|Protocol Deviation|0
7745066|NCT00706654|12179476|FG001|Depot Maintenance Phase|Protocol Deviation|2
7745067|NCT00706654|12179477|FG002|Depot Maintenance Phase|Protocol Deviation|3
7745068|NCT00706654|12179478|FG003|Depot Maintenance Phase|Protocol Deviation|1
7745069|NCT00706654|12179475|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
7745070|NCT00706654|12179476|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
7745071|NCT00706654|12179477|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
7745072|NCT00706654|12179478|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
7745073|NCT00706654|12179475|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
7745074|NCT00706654|12179476|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
7745075|NCT00706654|12179477|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
7745076|NCT00706654|12179478|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
7745077|NCT00706654|12179475|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
7745078|NCT00706654|12179476|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
7745079|NCT00706654|12179477|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
7745080|NCT00706654|12179478|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
7745081|NCT00706706|12179488|FG000|Overall Study|Death|53
7745082|NCT00706706|12179488|FG000|Overall Study|Lost to Follow-up|7
7745083|NCT00706706|12179488|FG000|Overall Study|Study endpoint had reached|45
7745084|NCT00706849|12179537|FG000|Treatment Period|Adverse Event|0
7745085|NCT00706849|12179538|FG001|Treatment Period|Adverse Event|9
7745086|NCT00706849|12179537|FG000|Treatment Period|Other|0
7745087|NCT00706849|12179538|FG001|Treatment Period|Other|1
7745088|NCT00706849|12179537|FG000|Follow-up Period|Withdrawal by Subject|0
7745089|NCT00706849|12179538|FG001|Follow-up Period|Withdrawal by Subject|2
7745090|NCT00706849|12179537|FG000|Follow-up Period|Protocol non-compliance|0
7745091|NCT00706849|12179538|FG001|Follow-up Period|Protocol non-compliance|1
7745092|NCT00706901|12179547|FG000|Overall Study|Lost to Follow-up|2
7745093|NCT00706901|12179548|FG001|Overall Study|Lost to Follow-up|3
7745094|NCT00706901|12179549|FG002|Overall Study|Lost to Follow-up|2
7745095|NCT00706901|12179547|FG000|Overall Study|Withdrawal by Subject|4
7745096|NCT00706901|12179548|FG001|Overall Study|Withdrawal by Subject|2
7745097|NCT00706901|12179549|FG002|Overall Study|Withdrawal by Subject|5
7745098|NCT00706901|12179547|FG000|Overall Study|In Jail|1
7745099|NCT00706901|12179548|FG001|Overall Study|In Jail|0
7745100|NCT00706901|12179549|FG002|Overall Study|In Jail|1
7745101|NCT00706901|12179547|FG000|Overall Study|Death|1
7745102|NCT00706901|12179548|FG001|Overall Study|Death|0
7745103|NCT00706901|12179549|FG002|Overall Study|Death|0
7745104|NCT00706914|12179561|FG000|Overall Study|Lack of Efficacy|0
7745105|NCT00706914|12179562|FG001|Overall Study|Lack of Efficacy|1
7745106|NCT00706914|12179563|FG002|Overall Study|Lack of Efficacy|0
7745107|NCT00706914|12179561|FG000|Overall Study|Lost to Follow-up|1
7745108|NCT00706914|12179562|FG001|Overall Study|Lost to Follow-up|0
7745109|NCT00706914|12179563|FG002|Overall Study|Lost to Follow-up|0
7745110|NCT00706914|12179561|FG000|Overall Study|Adverse Event|2
7745111|NCT00706914|12179562|FG001|Overall Study|Adverse Event|2
7745112|NCT00706914|12179563|FG002|Overall Study|Adverse Event|0
7745113|NCT00706914|12179561|FG000|Overall Study|Protocol Violation|3
7745114|NCT00706914|12179562|FG001|Overall Study|Protocol Violation|1
7745115|NCT00706914|12179563|FG002|Overall Study|Protocol Violation|1
7745116|NCT00706966|12179571|FG000|Overall Study|Adverse Event|1
7745117|NCT00706992|12179619|FG000|Overall Study|Study termination|5
7745118|NCT00706992|12179620|FG001|Overall Study|Study termination|5
7745119|NCT00706992|12179621|FG002|Overall Study|Study termination|6
7745120|NCT00706992|12179622|FG003|Overall Study|Study termination|2
7745121|NCT00706992|12179623|FG004|Overall Study|Study termination|3
7745122|NCT00706992|12179624|FG005|Overall Study|Study termination|2
7745123|NCT00706992|12179625|FG006|Overall Study|Study termination|3
7745124|NCT00706992|12179619|FG000|Overall Study|Disease progression before treatment|0
7745125|NCT00706992|12179620|FG001|Overall Study|Disease progression before treatment|0
7745126|NCT00706992|12179621|FG002|Overall Study|Disease progression before treatment|0
7745127|NCT00706992|12179622|FG003|Overall Study|Disease progression before treatment|0
7745128|NCT00706992|12179623|FG004|Overall Study|Disease progression before treatment|1
7745129|NCT00706992|12179624|FG005|Overall Study|Disease progression before treatment|0
7745130|NCT00706992|12179625|FG006|Overall Study|Disease progression before treatment|0
7745131|NCT00707031|12179644|FG000|Overall Study|Adverse Event|45
7745132|NCT00707031|12179645|FG001|Overall Study|Adverse Event|45
7745133|NCT00707031|12179644|FG000|Overall Study|Lack of Efficacy|19
7745134|NCT00707031|12179645|FG001|Overall Study|Lack of Efficacy|6
7745135|NCT00707031|12179644|FG000|Overall Study|Lost to Follow-up|2
7745136|NCT00707031|12179645|FG001|Overall Study|Lost to Follow-up|1
7745137|NCT00707031|12179644|FG000|Overall Study|Protocol Violation|1
7745138|NCT00707031|12179645|FG001|Overall Study|Protocol Violation|0
7745139|NCT00707031|12179644|FG000|Overall Study|Withdrawal by Subject|7
7745140|NCT00707031|12179645|FG001|Overall Study|Withdrawal by Subject|8
7745141|NCT00707031|12179644|FG000|Overall Study|Poor Compliance to Protocol|7
7745142|NCT00707031|12179645|FG001|Overall Study|Poor Compliance to Protocol|13
7745143|NCT00707031|12179644|FG000|Overall Study|Familial or Personal Reasons|12
7745144|NCT00707031|12179645|FG001|Overall Study|Familial or Personal Reasons|15
7745145|NCT00707031|12179644|FG000|Overall Study|Serious Noncompliance|2
7745146|NCT00707031|12179645|FG001|Overall Study|Serious Noncompliance|3
7745147|NCT00707031|12179644|FG000|Overall Study|Sponsor Decision|9
7745148|NCT00707031|12179645|FG001|Overall Study|Sponsor Decision|8
7745149|NCT00707057|12179654|FG000|Overall Study|Withdrawal by Subject|8
7745150|NCT00707057|12179655|FG001|Overall Study|Withdrawal by Subject|3
7745151|NCT00707057|12179654|FG000|Overall Study|Dosed incorrectly|0
7745152|NCT00707057|12179655|FG001|Overall Study|Dosed incorrectly|1
7745153|NCT00707174|12179663|FG000|Overall Study|Adverse Event|1
7745154|NCT00707174|12179664|FG001|Overall Study|Adverse Event|6
7745155|NCT00707174|12179663|FG000|Overall Study|Withdrawal by Subject|4
7745156|NCT00707174|12179664|FG001|Overall Study|Withdrawal by Subject|1
7745157|NCT00707239|12179673|FG000|Overall Study|Adverse Event|5
7745158|NCT00707239|12179674|FG001|Overall Study|Adverse Event|3
7745159|NCT00707239|12179675|FG002|Overall Study|Adverse Event|2
7745160|NCT00707239|12179673|FG000|Overall Study|Death|3
7745161|NCT00707239|12179674|FG001|Overall Study|Death|1
7745162|NCT00707239|12179675|FG002|Overall Study|Death|3
7745163|NCT00707239|12179673|FG000|Overall Study|Physician Decision|1
7745164|NCT00707239|12179674|FG001|Overall Study|Physician Decision|1
7745165|NCT00707239|12179675|FG002|Overall Study|Physician Decision|2
7745166|NCT00707239|12179673|FG000|Overall Study|Protocol Violation|0
7745167|NCT00707239|12179674|FG001|Overall Study|Protocol Violation|0
7745168|NCT00707239|12179675|FG002|Overall Study|Protocol Violation|1
7745169|NCT00707239|12179673|FG000|Overall Study|Lack of Efficacy|1
7745170|NCT00707239|12179674|FG001|Overall Study|Lack of Efficacy|2
7745171|NCT00707239|12179675|FG002|Overall Study|Lack of Efficacy|0
7745172|NCT00707239|12179673|FG000|Overall Study|Randomized, but not treated|1
7745173|NCT00707239|12179674|FG001|Overall Study|Randomized, but not treated|1
7745174|NCT00707239|12179675|FG002|Overall Study|Randomized, but not treated|1
7745175|NCT00707239|12179673|FG000|Overall Study|Other|8
7745176|NCT00707239|12179674|FG001|Overall Study|Other|3
7745177|NCT00707239|12179675|FG002|Overall Study|Other|5
7745178|NCT00707486|12179699|FG000|Overall Study|Withdrawal by Subject|1
7745179|NCT00707577|12179707|FG000|Overall Study|Withdrawal by Subject|3
7745180|NCT00707577|12179708|FG001|Overall Study|Withdrawal by Subject|2
7745181|NCT00707577|12179707|FG000|Overall Study|Lost to Follow-up|34
7745182|NCT00707577|12179708|FG001|Overall Study|Lost to Follow-up|25
7745183|NCT00707577|12179707|FG000|Overall Study|Left employment|13
7745184|NCT00707577|12179708|FG001|Overall Study|Left employment|10
7745185|NCT00707577|12179707|FG000|Overall Study|Pregnancy|4
7745186|NCT00707577|12179708|FG001|Overall Study|Pregnancy|1
7745187|NCT00707746|12179727|FG000|Treatment Period|Adverse Event|2
7745188|NCT00707746|12179728|FG001|Treatment Period|Adverse Event|4
7745189|NCT00707746|12179727|FG000|Treatment Period|Ineligibility|0
7745190|NCT00707746|12179728|FG001|Treatment Period|Ineligibility|1
7745191|NCT00707954|12179761|FG000|Overall Study|Physician Decision|0
7745192|NCT00707954|12179762|FG001|Overall Study|Physician Decision|0
7745193|NCT00707954|12179763|FG002|Overall Study|Physician Decision|0
7745194|NCT00707954|12179764|FG003|Overall Study|Physician Decision|0
7745195|NCT00707954|12179765|FG004|Overall Study|Physician Decision|1
7745196|NCT00707980|12179790|FG000|Overall Study|Adverse Event|49
7745197|NCT00707980|12179790|FG000|Overall Study|Lack of Efficacy|35
7745198|NCT00707980|12179790|FG000|Overall Study|Non-Compliance with Study Drug|28
7745199|NCT00707980|12179790|FG000|Overall Study|Protocol Deviations|19
7745200|NCT00707980|12179790|FG000|Overall Study|Withdrawal of Consent|81
7745201|NCT00707980|12179790|FG000|Overall Study|Lost to Follow-up|59
7745202|NCT00707980|12179790|FG000|Overall Study|Other|39
7745203|NCT00707993|12179796|FG000|Overall Study|Adverse Event|16
7745204|NCT00707993|12179797|FG001|Overall Study|Adverse Event|20
7745205|NCT00707993|12179796|FG000|Overall Study|Protocol Violation|4
7745206|NCT00707993|12179797|FG001|Overall Study|Protocol Violation|7
7745207|NCT00707993|12179796|FG000|Overall Study|Lost to Follow-up|0
7745208|NCT00707993|12179797|FG001|Overall Study|Lost to Follow-up|4
7745209|NCT00707993|12179796|FG000|Overall Study|Withdrawal by Subject|12
7745210|NCT00707993|12179797|FG001|Overall Study|Withdrawal by Subject|16
7745211|NCT00707993|12179796|FG000|Overall Study|Hyperglycemic Rescue|55
7745212|NCT00707993|12179797|FG001|Overall Study|Hyperglycemic Rescue|47
7745213|NCT00707993|12179796|FG000|Overall Study|Other|2
7745214|NCT00707993|12179797|FG001|Overall Study|Other|0
7745215|NCT00708032|12179814|FG000|Overall Study|Adverse Event|0
7745216|NCT00708032|12179815|FG001|Overall Study|Adverse Event|2
7745217|NCT00708032|12179814|FG000|Overall Study|Lost to Follow-up|1
7745218|NCT00708032|12179815|FG001|Overall Study|Lost to Follow-up|2
7745219|NCT00708032|12179814|FG000|Overall Study|Pregnancy|0
7745220|NCT00708032|12179815|FG001|Overall Study|Pregnancy|1
7745221|NCT00708032|12179814|FG000|Overall Study|Poor vision|0
7745222|NCT00708032|12179815|FG001|Overall Study|Poor vision|6
7745223|NCT00708032|12179814|FG000|Overall Study|Visit out of range at month 12|4
7745224|NCT00708032|12179815|FG001|Overall Study|Visit out of range at month 12|1
7745225|NCT00708032|12179814|FG000|Overall Study|Did not meet protocol criteria|1
7745226|NCT00708032|12179815|FG001|Overall Study|Did not meet protocol criteria|2
7745227|NCT00708032|12179814|FG000|Overall Study|Protocol Violation|4
7745228|NCT00708032|12179815|FG001|Overall Study|Protocol Violation|1
7745229|NCT00708032|12179814|FG000|Overall Study|Withdrawal by Subject|0
7745230|NCT00708032|12179815|FG001|Overall Study|Withdrawal by Subject|1
7745231|NCT00708097|12179855|FG000|Period 1|Protocol Violation|0
7745232|NCT00708097|12179856|FG001|Period 1|Protocol Violation|1
7745233|NCT00708097|12179857|FG002|Period 1|Protocol Violation|0
7745234|NCT00708097|12179858|FG003|Period 1|Protocol Violation|2
7745235|NCT00708097|12179859|FG004|Period 1|Protocol Violation|0
7745236|NCT00708097|12179855|FG000|Period 1|Other Reason|0
7745237|NCT00708097|12179856|FG001|Period 1|Other Reason|0
7745238|NCT00708097|12179857|FG002|Period 1|Other Reason|0
7745239|NCT00708097|12179858|FG003|Period 1|Other Reason|0
7745240|NCT00708097|12179859|FG004|Period 1|Other Reason|1
7745241|NCT00708097|12179855|FG000|Period 2|Protocol Violation|0
7745242|NCT00708097|12179856|FG001|Period 2|Protocol Violation|1
7745243|NCT00708097|12179857|FG002|Period 2|Protocol Violation|1
7745244|NCT00708097|12179858|FG003|Period 2|Protocol Violation|1
7745245|NCT00708097|12179859|FG004|Period 2|Protocol Violation|0
7745246|NCT00708123|12179893|FG000|Period 1|Protocol Violation|0
7745247|NCT00708123|12179894|FG001|Period 1|Protocol Violation|1
7745248|NCT00708123|12179895|FG002|Period 1|Protocol Violation|0
7745249|NCT00708123|12179896|FG003|Period 1|Protocol Violation|1
7745250|NCT00708123|12179897|FG004|Period 1|Protocol Violation|0
7745251|NCT00708123|12179893|FG000|Period 1|Adverse Event|0
7745252|NCT00708123|12179894|FG001|Period 1|Adverse Event|0
7745253|NCT00708123|12179895|FG002|Period 1|Adverse Event|1
7745254|NCT00708123|12179896|FG003|Period 1|Adverse Event|0
7745255|NCT00708123|12179897|FG004|Period 1|Adverse Event|0
7745256|NCT00708123|12179893|FG000|Period 2|Protocol Violation|0
7745257|NCT00708123|12179894|FG001|Period 2|Protocol Violation|0
7745258|NCT00708123|12179895|FG002|Period 2|Protocol Violation|0
7745259|NCT00708123|12179896|FG003|Period 2|Protocol Violation|1
7745260|NCT00708123|12179897|FG004|Period 2|Protocol Violation|0
7745261|NCT00708123|12179893|FG000|Period 2|Other Reason|1
7745262|NCT00708123|12179894|FG001|Period 2|Other Reason|0
7745263|NCT00708123|12179895|FG002|Period 2|Other Reason|0
7745264|NCT00708123|12179896|FG003|Period 2|Other Reason|0
7745265|NCT00708123|12179897|FG004|Period 2|Other Reason|0
7745266|NCT00708123|12179893|FG000|Period 3|Lost to Follow-up|0
7745267|NCT00708123|12179894|FG001|Period 3|Lost to Follow-up|0
7745268|NCT00708123|12179895|FG002|Period 3|Lost to Follow-up|1
7745269|NCT00708123|12179896|FG003|Period 3|Lost to Follow-up|1
7745270|NCT00708123|12179897|FG004|Period 3|Lost to Follow-up|0
7745271|NCT00708123|12179893|FG000|Period 4|Protocol Violation|0
7745272|NCT00708123|12179894|FG001|Period 4|Protocol Violation|1
7745273|NCT00708123|12179895|FG002|Period 4|Protocol Violation|0
7745274|NCT00708123|12179896|FG003|Period 4|Protocol Violation|0
7745275|NCT00708123|12179897|FG004|Period 4|Protocol Violation|0
7745276|NCT00708162|12179915|FG000|Randomized Phase|Randomized but Not Treated|7
7745277|NCT00708162|12179916|FG001|Randomized Phase|Randomized but Not Treated|5
7745278|NCT00708162|12179915|FG000|Randomized Phase|Participant Noncompliance|40
7745279|NCT00708162|12179916|FG001|Randomized Phase|Participant Noncompliance|32
7745280|NCT00708162|12179915|FG000|Randomized Phase|Lost to Follow-up|34
7745281|NCT00708162|12179916|FG001|Randomized Phase|Lost to Follow-up|34
7745282|NCT00708162|12179915|FG000|Randomized Phase|Withdrew Consent|31
7745283|NCT00708162|12179916|FG001|Randomized Phase|Withdrew Consent|22
7745284|NCT00708162|12179915|FG000|Randomized Phase|Lack of Efficacy|14
7745285|NCT00708162|12179916|FG001|Randomized Phase|Lack of Efficacy|19
7745286|NCT00708162|12179915|FG000|Randomized Phase|Protocol Violation|10
7745287|NCT00708162|12179916|FG001|Randomized Phase|Protocol Violation|11
7745288|NCT00708162|12179915|FG000|Randomized Phase|Adverse Event|8
7745289|NCT00708162|12179916|FG001|Randomized Phase|Adverse Event|12
7745290|NCT00708162|12179915|FG000|Randomized Phase|Investigator's Discretion|7
7745291|NCT00708162|12179916|FG001|Randomized Phase|Investigator's Discretion|10
7745292|NCT00708162|12179915|FG000|Randomized Phase|Death|2
7745293|NCT00708162|12179916|FG001|Randomized Phase|Death|9
7745294|NCT00708162|12179915|FG000|Randomized Phase|Pregnancy|3
7745295|NCT00708162|12179916|FG001|Randomized Phase|Pregnancy|0
7745296|NCT00708162|12179915|FG000|Open-Label Phase|Lost to Follow-up|10
7745297|NCT00708162|12179916|FG001|Open-Label Phase|Lost to Follow-up|8
7745298|NCT00708162|12179915|FG000|Open-Label Phase|Withdrew Consent|12
7962265|NCT02711345|12516523|FG001|Overall Study|Physician Decision|0
7962266|NCT02711345|12516524|FG002|Overall Study|Physician Decision|1
7745299|NCT00708162|12179916|FG001|Open-Label Phase|Withdrew Consent|6
7745300|NCT00708162|12179915|FG000|Open-Label Phase|Participant Noncompliance|7
7745301|NCT00708162|12179916|FG001|Open-Label Phase|Participant Noncompliance|7
7745302|NCT00708162|12179915|FG000|Open-Label Phase|Lack of Efficacy|7
7745303|NCT00708162|12179916|FG001|Open-Label Phase|Lack of Efficacy|4
7745304|NCT00708162|12179915|FG000|Open-Label Phase|Investigator's Discretion|3
7745305|NCT00708162|12179916|FG001|Open-Label Phase|Investigator's Discretion|2
7745306|NCT00708162|12179915|FG000|Open-Label Phase|Death|3
7745307|NCT00708162|12179916|FG001|Open-Label Phase|Death|1
7745308|NCT00708162|12179915|FG000|Open-Label Phase|Adverse Event|1
7745309|NCT00708162|12179916|FG001|Open-Label Phase|Adverse Event|2
7745310|NCT00708162|12179915|FG000|Open-Label Phase|Other|1
7745311|NCT00708162|12179916|FG001|Open-Label Phase|Other|0
7745312|NCT00708175|12179925|FG000|Overall Study|Adverse Event|4
7745313|NCT00708175|12179926|FG001|Overall Study|Adverse Event|5
7745314|NCT00708175|12179925|FG000|Overall Study|Protocol Violation|2
7745315|NCT00708175|12179926|FG001|Overall Study|Protocol Violation|3
7745316|NCT00708175|12179925|FG000|Overall Study|Lost to Follow-up|5
7745317|NCT00708175|12179926|FG001|Overall Study|Lost to Follow-up|3
7745318|NCT00708175|12179925|FG000|Overall Study|Withdrawal by Subject|5
7745319|NCT00708175|12179926|FG001|Overall Study|Withdrawal by Subject|7
7745320|NCT00708175|12179925|FG000|Overall Study|BMD loss >7%|2
7745321|NCT00708175|12179926|FG001|Overall Study|BMD loss >7%|3
7745322|NCT00708201|12179934|FG000|Overall Study|Adverse Event|4
7745323|NCT00708201|12179935|FG001|Overall Study|Adverse Event|4
7745324|NCT00708201|12179934|FG000|Overall Study|Withdrawal by Subject|1
7745325|NCT00708201|12179935|FG001|Overall Study|Withdrawal by Subject|1
7745326|NCT00708201|12179934|FG000|Overall Study|Lost to Follow-up|2
7745327|NCT00708201|12179935|FG001|Overall Study|Lost to Follow-up|0
7745328|NCT00708201|12179934|FG000|Overall Study|Protocol Violation|0
7745329|NCT00708201|12179935|FG001|Overall Study|Protocol Violation|1
7745330|NCT00708214|12179944|FG000|Overall Study|Other Adverse Event|3
7745331|NCT00708214|12179945|FG001|Overall Study|Other Adverse Event|6
7745332|NCT00708214|12179946|FG002|Overall Study|Other Adverse Event|2
7745333|NCT00708214|12179944|FG000|Overall Study|Other|0
7745334|NCT00708214|12179945|FG001|Overall Study|Other|1
7745335|NCT00708214|12179946|FG002|Overall Study|Other|1
7745336|NCT00708214|12179944|FG000|Overall Study|Progressive Disease|4
7745337|NCT00708214|12179945|FG001|Overall Study|Progressive Disease|6
7745338|NCT00708214|12179946|FG002|Overall Study|Progressive Disease|5
7745339|NCT00708227|12179963|FG000|Overall Study|Physician Decision|0
7745340|NCT00708227|12179964|FG001|Overall Study|Physician Decision|3
7745341|NCT00708227|12179965|FG002|Overall Study|Physician Decision|1
7745342|NCT00708227|12179966|FG003|Overall Study|Physician Decision|2
7745343|NCT00708227|12179963|FG000|Overall Study|Withdrawal by Subject|1
7745344|NCT00708227|12179964|FG001|Overall Study|Withdrawal by Subject|2
7745345|NCT00708227|12179965|FG002|Overall Study|Withdrawal by Subject|0
7745346|NCT00708227|12179966|FG003|Overall Study|Withdrawal by Subject|1
7745347|NCT00708305|12179996|FG000|Period 1|Protocol Violation|1
7745348|NCT00708305|12179997|FG001|Period 1|Protocol Violation|0
7745349|NCT00708305|12179998|FG002|Period 1|Protocol Violation|1
7745350|NCT00708305|12179999|FG003|Period 1|Protocol Violation|0
7745351|NCT00708305|12179996|FG000|Period 1|Other Reason|0
7745352|NCT00708305|12179997|FG001|Period 1|Other Reason|0
7745353|NCT00708305|12179998|FG002|Period 1|Other Reason|0
7745354|NCT00708305|12179999|FG003|Period 1|Other Reason|2
7745355|NCT00708305|12179996|FG000|Period 2|Lost to Follow-up|0
7745356|NCT00708305|12179997|FG001|Period 2|Lost to Follow-up|1
7745357|NCT00708305|12179998|FG002|Period 2|Lost to Follow-up|0
7745358|NCT00708305|12179999|FG003|Period 2|Lost to Follow-up|0
7745359|NCT00708305|12179996|FG000|Period 2|Protocol Violation|0
7745360|NCT00708305|12179997|FG001|Period 2|Protocol Violation|1
7745361|NCT00708305|12179998|FG002|Period 2|Protocol Violation|0
7745362|NCT00708305|12179999|FG003|Period 2|Protocol Violation|0
7745363|NCT00708305|12179996|FG000|Period 2|Other Reason|1
7745364|NCT00708305|12179997|FG001|Period 2|Other Reason|0
7745365|NCT00708305|12179998|FG002|Period 2|Other Reason|0
7745366|NCT00708305|12179999|FG003|Period 2|Other Reason|1
7745367|NCT00708305|12179996|FG000|Period 3|Protocol Violation|0
7745368|NCT00708305|12179997|FG001|Period 3|Protocol Violation|2
7745369|NCT00708305|12179998|FG002|Period 3|Protocol Violation|0
7745370|NCT00708305|12179999|FG003|Period 3|Protocol Violation|0
7745371|NCT00708305|12179996|FG000|Period 3|Other Reason|1
7745372|NCT00708305|12179997|FG001|Period 3|Other Reason|0
7745373|NCT00708305|12179998|FG002|Period 3|Other Reason|0
7745374|NCT00708305|12179999|FG003|Period 3|Other Reason|0
7745375|NCT00708422|12180014|FG000|Overall Study|Adverse Event|3
7745376|NCT00708422|12180015|FG001|Overall Study|Adverse Event|1
7745377|NCT00708422|12180014|FG000|Overall Study|Withdrawal by Subject|1
7745378|NCT00708422|12180015|FG001|Overall Study|Withdrawal by Subject|0
7745379|NCT00708435|12180023|FG000|Overall Study|Death / Serious Adverse Event|10
7745380|NCT00708435|12180024|FG001|Overall Study|Death / Serious Adverse Event|5
7745381|NCT00708435|12180023|FG000|Overall Study|Lost to Follow-up|9
7745382|NCT00708435|12180024|FG001|Overall Study|Lost to Follow-up|4
7745383|NCT00708435|12180023|FG000|Overall Study|Withdrawal by Subject|3
7745384|NCT00708435|12180024|FG001|Overall Study|Withdrawal by Subject|7
7745385|NCT00708435|12180023|FG000|Overall Study|Adverse Event|1
7745386|NCT00708435|12180024|FG001|Overall Study|Adverse Event|0
7745387|NCT00708435|12180023|FG000|Overall Study|Protocol Violation|0
7745388|NCT00708435|12180024|FG001|Overall Study|Protocol Violation|1
7745389|NCT00708435|12180023|FG000|Overall Study|Intervention by primary care physician|1
7745390|NCT00708435|12180024|FG001|Overall Study|Intervention by primary care physician|0
7745391|NCT00708435|12180023|FG000|Overall Study|Refused hospitalization|1
7745392|NCT00708435|12180024|FG001|Overall Study|Refused hospitalization|0
7745393|NCT00708461|12180034|FG000|Overall Study|Lost to Follow-up|18
7745394|NCT00708461|12180035|FG001|Overall Study|Lost to Follow-up|11
7745395|NCT00708461|12180034|FG000|Overall Study|Withdrawal by Subject|8
7745396|NCT00708461|12180035|FG001|Overall Study|Withdrawal by Subject|9
7745397|NCT00708461|12180034|FG000|Overall Study|left workforce|115
7745398|NCT00708461|12180035|FG001|Overall Study|left workforce|180
7745399|NCT00708500|12180044|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
7745400|NCT00708500|12180045|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
7745401|NCT00708500|12180046|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
7745402|NCT00708500|12180044|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
7745403|NCT00708500|12180045|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
7745404|NCT00708500|12180046|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
7745405|NCT00708500|12180044|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
7745406|NCT00708500|12180045|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
7745407|NCT00708500|12180046|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
7745408|NCT00708500|12180044|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
7745409|NCT00708500|12180045|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
7745410|NCT00708500|12180046|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
7745411|NCT00708500|12180044|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
7745412|NCT00708500|12180045|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
7745413|NCT00708500|12180046|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
7745414|NCT00708500|12180044|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
7745415|NCT00708500|12180045|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
7745416|NCT00708500|12180046|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
7745417|NCT00708500|12180044|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
7745418|NCT00708500|12180045|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
7745419|NCT00708500|12180046|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
7745420|NCT00708500|12180044|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
7745421|NCT00708500|12180045|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
7745422|NCT00708500|12180046|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
7745423|NCT00708500|12180044|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
7745424|NCT00708500|12180045|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
7745425|NCT00708500|12180046|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
7745426|NCT00708500|12180044|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
7745427|NCT00708500|12180045|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
7745428|NCT00708500|12180046|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
7745429|NCT00708500|12180044|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
7745430|NCT00708500|12180045|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
7745431|NCT00708500|12180046|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
7745432|NCT00708500|12180044|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
7745433|NCT00708500|12180045|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
7745434|NCT00708500|12180046|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
7745435|NCT00708500|12180044|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
7745436|NCT00708500|12180045|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
7745437|NCT00708500|12180046|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
7745438|NCT00708500|12180044|FG000|FOLLOWUP|Adverse Event|0
7745439|NCT00708500|12180045|FG001|FOLLOWUP|Adverse Event|1
7745440|NCT00708500|12180046|FG002|FOLLOWUP|Adverse Event|0
7745441|NCT00708500|12180044|FG000|FOLLOWUP|Lost to Follow-up|1
7745442|NCT00708500|12180045|FG001|FOLLOWUP|Lost to Follow-up|6
7745443|NCT00708500|12180046|FG002|FOLLOWUP|Lost to Follow-up|4
7745444|NCT00708500|12180044|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3
7745445|NCT00708500|12180045|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4
7745446|NCT00708500|12180046|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5
7745447|NCT00708500|12180044|FG000|FOLLOWUP|Subject withdrew consent|31
7745448|NCT00708500|12180045|FG001|FOLLOWUP|Subject withdrew consent|4
7745449|NCT00708500|12180046|FG002|FOLLOWUP|Subject withdrew consent|5
7745450|NCT00708500|12180044|FG000|FOLLOWUP|Non-compliance with protocol|5
7745451|NCT00708500|12180045|FG001|FOLLOWUP|Non-compliance with protocol|0
7745452|NCT00708500|12180046|FG002|FOLLOWUP|Non-compliance with protocol|1
7745453|NCT00708552|12180067|FG000|Overall Study|Adverse Event|10
7745454|NCT00708552|12180068|FG001|Overall Study|Adverse Event|3
7745455|NCT00708552|12180069|FG002|Overall Study|Adverse Event|4
7745456|NCT00708552|12180070|FG003|Overall Study|Adverse Event|6
7745457|NCT00708552|12180067|FG000|Overall Study|Lack of Efficacy|0
7745458|NCT00708552|12180068|FG001|Overall Study|Lack of Efficacy|4
7745459|NCT00708552|12180069|FG002|Overall Study|Lack of Efficacy|1
7745460|NCT00708552|12180070|FG003|Overall Study|Lack of Efficacy|0
7745461|NCT00708552|12180067|FG000|Overall Study|Protocol Violation|0
7745462|NCT00708552|12180068|FG001|Overall Study|Protocol Violation|0
7745463|NCT00708552|12180069|FG002|Overall Study|Protocol Violation|2
7745464|NCT00708552|12180070|FG003|Overall Study|Protocol Violation|4
7745465|NCT00708552|12180067|FG000|Overall Study|Lost to Follow-up|4
7745466|NCT00708552|12180068|FG001|Overall Study|Lost to Follow-up|2
7745467|NCT00708552|12180069|FG002|Overall Study|Lost to Follow-up|0
7745468|NCT00708552|12180070|FG003|Overall Study|Lost to Follow-up|1
7745469|NCT00708552|12180067|FG000|Overall Study|Physician Decision|1
7745470|NCT00708552|12180068|FG001|Overall Study|Physician Decision|2
7745471|NCT00708552|12180069|FG002|Overall Study|Physician Decision|0
7745472|NCT00708552|12180070|FG003|Overall Study|Physician Decision|0
7745473|NCT00708552|12180067|FG000|Overall Study|Withdrawal by Subject|12
7745474|NCT00708552|12180068|FG001|Overall Study|Withdrawal by Subject|7
7745475|NCT00708552|12180069|FG002|Overall Study|Withdrawal by Subject|8
7745476|NCT00708552|12180070|FG003|Overall Study|Withdrawal by Subject|10
7745477|NCT00708643|12180086|FG000|Overall Study|Adverse Event|0
7745478|NCT00708643|12180087|FG001|Overall Study|Adverse Event|1
7745479|NCT00708682|12180093|FG000|Infant Series|Adverse Event|1
7745480|NCT00708682|12180093|FG000|Infant Series|Lost to Follow-up|4
7745481|NCT00708682|12180093|FG000|Infant Series|Protocol Violation|1
7745482|NCT00708682|12180093|FG000|Infant Series|Parent/legal guardian request|6
7745483|NCT00708682|12180093|FG000|Infant Series|Failed to return|2
7745484|NCT00708682|12180093|FG000|Infant Series|Other|19
7745485|NCT00708682|12180093|FG000|After Infant Series|Parent/Legal Guardian Request|1
7745486|NCT00708682|12180093|FG000|Toddler Dose|Parent/Legal Guardian Request|1
7745487|NCT00708682|12180093|FG000|Toddler Dose|Lost to Follow-up|3
7745488|NCT00708682|12180093|FG000|Toddler Dose|Failed to Return|4
7745489|NCT00708708|12180099|FG000|Overall Study|Another therapy instead of Enbrel|141
7745490|NCT00708708|12180099|FG000|Overall Study|Lost to Follow-up|52
7745491|NCT00708708|12180099|FG000|Overall Study|Withdrawal by Subject|51
7745492|NCT00708708|12180099|FG000|Overall Study|Intolerance|42
7745493|NCT00708708|12180099|FG000|Overall Study|Another therapy along with Enbrel|15
7745494|NCT00708708|12180099|FG000|Overall Study|Other unspecified|11
7745495|NCT00708708|12180099|FG000|Overall Study|Good effectiveness|9
7745496|NCT00708708|12180099|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9
7745497|NCT00708708|12180099|FG000|Overall Study|Administrative reasons|7
7745498|NCT00708708|12180099|FG000|Overall Study|Lack of effectiveness|4
7745499|NCT00708708|12180099|FG000|Overall Study|Lack of compliance|3
7745500|NCT00708708|12180099|FG000|Overall Study|Pregnancy|3
7745501|NCT00708708|12180099|FG000|Overall Study|Adverse Event|3
7745502|NCT00708708|12180099|FG000|Overall Study|Missing values|392
7745503|NCT00709059|12180151|FG000|Overall Study|Lost to Follow-up|34
7745504|NCT00709059|12180151|FG000|Overall Study|Withdrawal by Subject|19
7745505|NCT00709059|12180151|FG000|Overall Study|Physician Decision|7
7745506|NCT00709059|12180151|FG000|Overall Study|Disease complication|3
7745507|NCT00709059|12180151|FG000|Overall Study|Side effects|20
7745508|NCT00709059|12180151|FG000|Overall Study|Serious side effects|11
7745509|NCT00709098|12180158|FG000|Double-blind Period|Withdrawal of consent|3
7745510|NCT00709098|12180159|FG001|Double-blind Period|Withdrawal of consent|3
7745511|NCT00709098|12180160|FG002|Double-blind Period|Withdrawal of consent|0
7745512|NCT00709098|12180158|FG000|Double-blind Period|Administrative reason|1
7745513|NCT00709098|12180159|FG001|Double-blind Period|Administrative reason|3
7745514|NCT00709098|12180160|FG002|Double-blind Period|Administrative reason|0
7745515|NCT00709098|12180158|FG000|Double-blind Period|Death|1
7745516|NCT00709098|12180159|FG001|Double-blind Period|Death|1
7745517|NCT00709098|12180160|FG002|Double-blind Period|Death|0
7745518|NCT00709098|12180158|FG000|Double-blind Period|Lost to Follow-up|1
7745519|NCT00709098|12180159|FG001|Double-blind Period|Lost to Follow-up|1
7745520|NCT00709098|12180160|FG002|Double-blind Period|Lost to Follow-up|0
7745521|NCT00709098|12180158|FG000|Open-label Period|Withdrawal of consent|0
7745522|NCT00709098|12180159|FG001|Open-label Period|Withdrawal of consent|0
7745523|NCT00709098|12180160|FG002|Open-label Period|Withdrawal of consent|7
7745524|NCT00709098|12180158|FG000|Open-label Period|Administrative reason|0
7745525|NCT00709098|12180159|FG001|Open-label Period|Administrative reason|0
7745526|NCT00709098|12180160|FG002|Open-label Period|Administrative reason|5
7745527|NCT00709098|12180158|FG000|Open-label Period|Death|0
7745528|NCT00709098|12180159|FG001|Open-label Period|Death|0
7745529|NCT00709098|12180160|FG002|Open-label Period|Death|1
7745530|NCT00709098|12180158|FG000|Open-label Period|Lost to Follow-up|0
7745531|NCT00709098|12180159|FG001|Open-label Period|Lost to Follow-up|0
7745532|NCT00709098|12180160|FG002|Open-label Period|Lost to Follow-up|1
7745533|NCT00709111|12180169|FG000|Overall Study|Withdrawal by Subject|1
7745534|NCT00709111|12180169|FG000|Overall Study|Unable to attend clinic visits|1
7745535|NCT00709124|12180175|FG000|Overall Study|Death|3
7745536|NCT00709124|12180176|FG001|Overall Study|Death|1
7745537|NCT00709124|12180175|FG000|Overall Study|encephalopathy; can't do assessment|1
7745538|NCT00709124|12180176|FG001|Overall Study|encephalopathy; can't do assessment|0
7745539|NCT00709202|12180188|FG000|Overall Study|Withdrawal by Subject|6
7745540|NCT00709202|12180189|FG001|Overall Study|Withdrawal by Subject|6
7745541|NCT00709228|12180196|FG000|Overall Study|Not treated|14
7745542|NCT00709228|12180196|FG000|Overall Study|Eligibility criteria not met|281
7745543|NCT00709228|12180196|FG000|Overall Study|Adverse events|2
7745544|NCT00709228|12180196|FG000|Overall Study|Discontinued treatment|14
7745545|NCT00709228|12180196|FG000|Overall Study|Did not enter follow-up|4
7745546|NCT00709228|12180196|FG000|Overall Study|Discontinued follow-up|5
7745547|NCT00709228|12180196|FG000|Overall Study|Disease progression|1
7745548|NCT00709228|12180196|FG000|Overall Study|Lost to Follow-up|6
7745549|NCT00709228|12180196|FG000|Overall Study|Non-compliance|5
7745550|NCT00709319|12180217|FG000|Overall Study|Death|4
7745551|NCT00709319|12180217|FG000|Overall Study|Withdrawal by Subject|2
7745552|NCT00709592|12180223|FG000|Overall Study|Unable to proceed to transplant|0
7745553|NCT00709592|12180224|FG001|Overall Study|Unable to proceed to transplant|1
7745554|NCT00709618|12180230|FG000|Overall Study|Withdrawal by Subject|4
7745555|NCT00709618|12180230|FG000|Overall Study|Lost to Follow-up|1
7745556|NCT00709618|12180230|FG000|Overall Study|Study Closed/Terminated|25
7745557|NCT00709722|12180243|FG000|Overall Study|Adverse Event|1
7745558|NCT00709735|12180249|FG000|Overall Study|Lost to Follow-up|1
7745559|NCT00709735|12180250|FG001|Overall Study|Lost to Follow-up|1
7745560|NCT00709735|12180249|FG000|Overall Study|Relapse into Opioid Abuse|0
7745561|NCT00709735|12180250|FG001|Overall Study|Relapse into Opioid Abuse|1
7745562|NCT00709735|12180249|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2
7745563|NCT00709735|12180250|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0
7745564|NCT00709761|12180256|FG000|Overall Study|Withdrawal by Subject|8
7745565|NCT00709761|12180256|FG000|Overall Study|study closed/terminated|17
7745566|NCT00709761|12180256|FG000|Overall Study|Lost to Follow-up|2
7745567|NCT00709852|12180269|FG000|Period 1|Adverse Event|2
7745568|NCT00709852|12180270|FG001|Period 1|Adverse Event|0
7745569|NCT00709852|12180269|FG000|Period 1|Withdrawal by Subject|4
7745570|NCT00709852|12180270|FG001|Period 1|Withdrawal by Subject|2
7745571|NCT00709852|12180269|FG000|Period 1|Protocol Violation|1
7745572|NCT00709852|12180270|FG001|Period 1|Protocol Violation|0
7745573|NCT00709852|12180269|FG000|Period 1|Defective scanner|0
7745574|NCT00709852|12180270|FG001|Period 1|Defective scanner|1
7745575|NCT00709852|12180269|FG000|Period 1|Lost to Follow-up|1
7745576|NCT00709852|12180270|FG001|Period 1|Lost to Follow-up|0
7745577|NCT00709852|12180269|FG000|Period 2|Protocol Violation|4
7745578|NCT00709852|12180270|FG001|Period 2|Protocol Violation|1
7745579|NCT00709852|12180269|FG000|Period 2|Adverse Event|1
7745580|NCT00709852|12180270|FG001|Period 2|Adverse Event|1
7745581|NCT00709852|12180269|FG000|Period 2|Lost to Follow-up|1
7745582|NCT00709852|12180270|FG001|Period 2|Lost to Follow-up|0
7745583|NCT00709852|12180269|FG000|Period 2|No 72-hour follow-up|3
7745584|NCT00709852|12180270|FG001|Period 2|No 72-hour follow-up|0
7745585|NCT00709956|12180308|FG000|Overall Study|Withdrawal by Subject|1
7745586|NCT00709956|12180309|FG001|Overall Study|Withdrawal by Subject|1
7745587|NCT00709956|12180308|FG000|Overall Study|Inclusion/exclusion criteria violation|2
7745588|NCT00709956|12180309|FG001|Overall Study|Inclusion/exclusion criteria violation|3
7745589|NCT00709995|12180319|FG000|Overall Study|Adverse Event|4
7745590|NCT00709995|12180320|FG001|Overall Study|Adverse Event|2
7745591|NCT00709995|12180319|FG000|Overall Study|Withdrawal by Subject|1
7745592|NCT00709995|12180320|FG001|Overall Study|Withdrawal by Subject|3
7745593|NCT00710021|12180332|FG000|Overall Study|Lost to Follow-up|1
7745594|NCT00710021|12180333|FG001|Overall Study|Lost to Follow-up|0
7745595|NCT00710021|12180334|FG002|Overall Study|Lost to Follow-up|0
7745596|NCT00710021|12180332|FG000|Overall Study|Subject's Decision|0
7745597|NCT00710021|12180333|FG001|Overall Study|Subject's Decision|1
7745598|NCT00710021|12180334|FG002|Overall Study|Subject's Decision|0
7745599|NCT00710021|12180332|FG000|Overall Study|Subject misrandomized|0
7745600|NCT00710021|12180333|FG001|Overall Study|Subject misrandomized|1
7745601|NCT00710021|12180334|FG002|Overall Study|Subject misrandomized|1
7745602|NCT00710021|12180332|FG000|Overall Study|Physician Decision|0
7745603|NCT00710021|12180333|FG001|Overall Study|Physician Decision|1
7745604|NCT00710021|12180334|FG002|Overall Study|Physician Decision|0
7745605|NCT00710034|12180345|FG000|Completed 6 Weeks of Treatment|Adverse Event|5
7745606|NCT00710034|12180346|FG001|Completed 6 Weeks of Treatment|Adverse Event|12
7745607|NCT00710034|12180345|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12
7745608|NCT00710034|12180346|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8
7745609|NCT00710034|12180345|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15
7745610|NCT00710034|12180346|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17
7745611|NCT00710034|12180345|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2
7745612|NCT00710034|12180346|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6
7745613|NCT00710034|12180345|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
7745614|NCT00710034|12180346|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
7745615|NCT00710034|12180345|FG000|Completed 6 Weeks of Treatment|Physician Decision|1
7745616|NCT00710034|12180346|FG001|Completed 6 Weeks of Treatment|Physician Decision|0
7745617|NCT00710034|12180345|FG000|Completed 12 Weeks of Treatment|Adverse Event|0
7745618|NCT00710034|12180346|FG001|Completed 12 Weeks of Treatment|Adverse Event|1
7745619|NCT00710034|12180345|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0
7745620|NCT00710034|12180346|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2
7745621|NCT00710034|12180345|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5
7745622|NCT00710034|12180346|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5
7745623|NCT00710034|12180345|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
7745624|NCT00710034|12180346|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
7745625|NCT00710034|12180345|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
7745626|NCT00710034|12180346|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
7745627|NCT00710385|12180362|FG000|Overall Study|Did not qualify|1
7745628|NCT00710385|12180362|FG000|Overall Study|Withdrawal by Subject|1
7745629|NCT00710385|12180362|FG000|Overall Study|Undisclosed back pain|1
7745630|NCT00710385|12180362|FG000|Overall Study|Physician Decision|1
7745631|NCT00710385|12180362|FG000|Overall Study|Undisclosed excessive methadone use|1
7745632|NCT00710424|12180374|FG000|Overall Study|Adverse Event|30
7745633|NCT00710424|12180375|FG001|Overall Study|Adverse Event|12
7745634|NCT00710424|12180374|FG000|Overall Study|Lack of Efficacy|4
7745635|NCT00710424|12180375|FG001|Overall Study|Lack of Efficacy|5
7745636|NCT00710424|12180374|FG000|Overall Study|Withdrawal by Subject|5
7745637|NCT00710424|12180375|FG001|Overall Study|Withdrawal by Subject|3
7745638|NCT00710424|12180374|FG000|Overall Study|Lost to Follow-up|0
7745639|NCT00710424|12180375|FG001|Overall Study|Lost to Follow-up|1
7745640|NCT00710424|12180374|FG000|Overall Study|Refused medication, no side effects|1
7745641|NCT00710424|12180375|FG001|Overall Study|Refused medication, no side effects|0
7745642|NCT00710424|12180374|FG000|Overall Study|Non-compliance with stable analgesia|1
7745643|NCT00710424|12180375|FG001|Overall Study|Non-compliance with stable analgesia|0
7745644|NCT00710424|12180374|FG000|Overall Study|Did not meet entry criteria at visit 1|1
7745645|NCT00710424|12180375|FG001|Overall Study|Did not meet entry criteria at visit 1|0
7745646|NCT00710424|12180374|FG000|Overall Study|Subject thought medication changed|1
7745647|NCT00710424|12180375|FG001|Overall Study|Subject thought medication changed|0
7745648|NCT00710424|12180374|FG000|Overall Study|Ceased treatment due to travel|1
7745649|NCT00710424|12180375|FG001|Overall Study|Ceased treatment due to travel|0
7745650|NCT00710424|12180374|FG000|Overall Study|Subject preferred paracetamol|0
7745651|NCT00710424|12180375|FG001|Overall Study|Subject preferred paracetamol|1
7745652|NCT00710424|12180374|FG000|Overall Study|Felt good so stopped treatment|0
7745653|NCT00710424|12180375|FG001|Overall Study|Felt good so stopped treatment|1
7745654|NCT00710554|12180383|FG000|Overall Study|Adverse Event|24
7745655|NCT00710554|12180384|FG001|Overall Study|Adverse Event|7
7745656|NCT00710554|12180383|FG000|Overall Study|Withdrawal by Subject|7
7745657|NCT00710554|12180384|FG001|Overall Study|Withdrawal by Subject|3
7745658|NCT00710554|12180383|FG000|Overall Study|Lost to Follow-up|7
7745659|NCT00710554|12180384|FG001|Overall Study|Lost to Follow-up|1
7745660|NCT00710554|12180383|FG000|Overall Study|Lack of Efficacy|11
7745661|NCT00710554|12180384|FG001|Overall Study|Lack of Efficacy|12
7745662|NCT00710554|12180383|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0
7745663|NCT00710554|12180384|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1
7745664|NCT00710593|12180392|FG000|Overall Study|Incarceration|1
7745665|NCT00710593|12180393|FG001|Overall Study|Incarceration|0
7745666|NCT00710593|12180392|FG000|Overall Study|Unable to complete Wk 48 within window|2
7745667|NCT00710593|12180393|FG001|Overall Study|Unable to complete Wk 48 within window|0
7745668|NCT00710593|12180392|FG000|Overall Study|Lost to Follow-up|3
7745669|NCT00710593|12180393|FG001|Overall Study|Lost to Follow-up|1
7745670|NCT00710593|12180392|FG000|Overall Study|Moved out of area|1
7745671|NCT00710593|12180393|FG001|Overall Study|Moved out of area|0
7745672|NCT00710593|12180392|FG000|Overall Study|Failure to adhere or complete study eval|1
7745673|NCT00710593|12180393|FG001|Overall Study|Failure to adhere or complete study eval|1
7745674|NCT00710593|12180392|FG000|Overall Study|Protocol Violation|1
7745675|NCT00710593|12180393|FG001|Overall Study|Protocol Violation|1
7745676|NCT00710593|12180392|FG000|Overall Study|Prem disc vaccine, completed all visits|6
7745677|NCT00710593|12180393|FG001|Overall Study|Prem disc vaccine, completed all visits|2
7745678|NCT00710606|12180417|FG000|Overall Study|Adverse Event|0
7745679|NCT00710606|12180418|FG001|Overall Study|Adverse Event|2
7745680|NCT00710684|12180429|FG000|Overall Study|Adverse Event|11
7745681|NCT00710684|12180430|FG001|Overall Study|Adverse Event|19
7745682|NCT00710684|12180431|FG002|Overall Study|Adverse Event|16
7745683|NCT00710684|12180429|FG000|Overall Study|Lack of Efficacy|4
7745684|NCT00710684|12180430|FG001|Overall Study|Lack of Efficacy|3
7745685|NCT00710684|12180431|FG002|Overall Study|Lack of Efficacy|5
7745686|NCT00710684|12180429|FG000|Overall Study|Protocol Violation|5
7745687|NCT00710684|12180430|FG001|Overall Study|Protocol Violation|5
7745688|NCT00710684|12180431|FG002|Overall Study|Protocol Violation|5
7745689|NCT00710684|12180429|FG000|Overall Study|Lost to Follow-up|4
7745690|NCT00710684|12180430|FG001|Overall Study|Lost to Follow-up|6
7745691|NCT00710684|12180431|FG002|Overall Study|Lost to Follow-up|7
7745692|NCT00710684|12180429|FG000|Overall Study|Physician Decision|0
7745693|NCT00710684|12180430|FG001|Overall Study|Physician Decision|2
7745694|NCT00710684|12180431|FG002|Overall Study|Physician Decision|4
7745695|NCT00710684|12180429|FG000|Overall Study|Withdrawal by Subject|24
7745696|NCT00710684|12180430|FG001|Overall Study|Withdrawal by Subject|18
7745697|NCT00710684|12180431|FG002|Overall Study|Withdrawal by Subject|11
7745698|NCT00710684|12180429|FG000|Overall Study|Missing|1
7745699|NCT00710684|12180430|FG001|Overall Study|Missing|0
7745700|NCT00710684|12180431|FG002|Overall Study|Missing|0
7745701|NCT00710684|12180429|FG000|Overall Study|Did not continue after week 24|25
7745702|NCT00710684|12180430|FG001|Overall Study|Did not continue after week 24|21
7745703|NCT00710684|12180431|FG002|Overall Study|Did not continue after week 24|16
7745704|NCT00710749|12180445|FG000|First Intervention|Withdrawal by Subject|1
7745705|NCT00710749|12180446|FG001|First Intervention|Withdrawal by Subject|0
7745706|NCT00710762|12180456|FG000|Overall Study|Progressive disease|27
7745707|NCT00710762|12180457|FG001|Overall Study|Progressive disease|30
7745708|NCT00710762|12180456|FG000|Overall Study|Adverse Event other disease worsening|2
7745709|NCT00710762|12180457|FG001|Overall Study|Adverse Event other disease worsening|1
7745710|NCT00710762|12180456|FG000|Overall Study|Other Adverse Event|7
7745711|NCT00710762|12180457|FG001|Overall Study|Other Adverse Event|7
7745712|NCT00710762|12180456|FG000|Overall Study|Lost to Follow-up|1
7745713|NCT00710762|12180457|FG001|Overall Study|Lost to Follow-up|0
7745714|NCT00710762|12180456|FG000|Overall Study|Reason other than listed above|2
7745715|NCT00710762|12180457|FG001|Overall Study|Reason other than listed above|2
7769346|NCT00868790|12213058|FG000|Period 1|Adverse Event|1
7769347|NCT00868790|12213059|FG001|Period 1|Adverse Event|0
7769348|NCT00868790|12213060|FG002|Period 1|Adverse Event|0
7769349|NCT00868790|12213061|FG003|Period 1|Adverse Event|0
7769350|NCT00868790|12213062|FG004|Period 1|Adverse Event|0
7769351|NCT00868790|12213063|FG005|Period 1|Adverse Event|0
7769352|NCT00868790|12213064|FG006|Period 1|Adverse Event|0
7769353|NCT00868790|12213065|FG007|Period 1|Adverse Event|3
7769354|NCT00868790|12213066|FG008|Period 1|Adverse Event|1
7769355|NCT00868790|12213067|FG009|Period 1|Adverse Event|0
7769356|NCT00868790|12213068|FG010|Period 1|Adverse Event|0
7769357|NCT00868790|12213069|FG011|Period 1|Adverse Event|0
7769358|NCT00868790|12213070|FG012|Period 1|Adverse Event|0
7769359|NCT00868790|12213071|FG013|Period 1|Adverse Event|1
7769360|NCT00868790|12213058|FG000|Period 1|Protocol Violation|1
7769361|NCT00868790|12213059|FG001|Period 1|Protocol Violation|0
7769362|NCT00868790|12213060|FG002|Period 1|Protocol Violation|0
7769363|NCT00868790|12213061|FG003|Period 1|Protocol Violation|0
7769364|NCT00868790|12213062|FG004|Period 1|Protocol Violation|0
7769365|NCT00868790|12213063|FG005|Period 1|Protocol Violation|0
7769366|NCT00868790|12213064|FG006|Period 1|Protocol Violation|0
7769367|NCT00868790|12213065|FG007|Period 1|Protocol Violation|0
7769368|NCT00868790|12213066|FG008|Period 1|Protocol Violation|0
7769369|NCT00868790|12213067|FG009|Period 1|Protocol Violation|0
7769370|NCT00868790|12213068|FG010|Period 1|Protocol Violation|0
7769371|NCT00868790|12213069|FG011|Period 1|Protocol Violation|0
7769372|NCT00868790|12213070|FG012|Period 1|Protocol Violation|0
7769373|NCT00868790|12213071|FG013|Period 1|Protocol Violation|0
7769374|NCT00868790|12213058|FG000|Period 1|Withdrawal by Subject|0
7769375|NCT00868790|12213059|FG001|Period 1|Withdrawal by Subject|1
7769376|NCT00868790|12213060|FG002|Period 1|Withdrawal by Subject|0
7769377|NCT00868790|12213061|FG003|Period 1|Withdrawal by Subject|0
7769378|NCT00868790|12213062|FG004|Period 1|Withdrawal by Subject|0
7769379|NCT00868790|12213063|FG005|Period 1|Withdrawal by Subject|0
7769380|NCT00868790|12213064|FG006|Period 1|Withdrawal by Subject|0
7769381|NCT00868790|12213065|FG007|Period 1|Withdrawal by Subject|0
7769382|NCT00868790|12213066|FG008|Period 1|Withdrawal by Subject|0
7769383|NCT00868790|12213067|FG009|Period 1|Withdrawal by Subject|0
7769384|NCT00868790|12213068|FG010|Period 1|Withdrawal by Subject|0
7769385|NCT00868790|12213069|FG011|Period 1|Withdrawal by Subject|0
7769386|NCT00868790|12213070|FG012|Period 1|Withdrawal by Subject|0
7769387|NCT00868790|12213071|FG013|Period 1|Withdrawal by Subject|1
7769388|NCT00868790|12213058|FG000|Period 1|Abnormal Triglycerides|0
7769389|NCT00868790|12213059|FG001|Period 1|Abnormal Triglycerides|0
7769390|NCT00868790|12213060|FG002|Period 1|Abnormal Triglycerides|0
7769391|NCT00868790|12213061|FG003|Period 1|Abnormal Triglycerides|0
7769392|NCT00868790|12213062|FG004|Period 1|Abnormal Triglycerides|1
7769393|NCT00868790|12213063|FG005|Period 1|Abnormal Triglycerides|0
7769394|NCT00868790|12213064|FG006|Period 1|Abnormal Triglycerides|0
7769395|NCT00868790|12213065|FG007|Period 1|Abnormal Triglycerides|0
7769396|NCT00868790|12213066|FG008|Period 1|Abnormal Triglycerides|0
7769397|NCT00868790|12213067|FG009|Period 1|Abnormal Triglycerides|0
7769398|NCT00868790|12213068|FG010|Period 1|Abnormal Triglycerides|0
7769399|NCT00868790|12213069|FG011|Period 1|Abnormal Triglycerides|0
7769400|NCT00868790|12213070|FG012|Period 1|Abnormal Triglycerides|0
7769401|NCT00868790|12213071|FG013|Period 1|Abnormal Triglycerides|0
7769402|NCT00868790|12213058|FG000|Period 1|Lost to Follow-up|0
7769403|NCT00868790|12213059|FG001|Period 1|Lost to Follow-up|0
7769404|NCT00868790|12213060|FG002|Period 1|Lost to Follow-up|0
7769405|NCT00868790|12213061|FG003|Period 1|Lost to Follow-up|0
7769406|NCT00868790|12213062|FG004|Period 1|Lost to Follow-up|0
7769407|NCT00868790|12213063|FG005|Period 1|Lost to Follow-up|1
7769408|NCT00868790|12213064|FG006|Period 1|Lost to Follow-up|0
7769409|NCT00868790|12213065|FG007|Period 1|Lost to Follow-up|0
7769410|NCT00868790|12213066|FG008|Period 1|Lost to Follow-up|0
7745716|NCT00710866|12180483|FG000|Overall Study|Protocol Violation|5
7745717|NCT00710866|12180484|FG001|Overall Study|Protocol Violation|4
7745718|NCT00710866|12180483|FG000|Overall Study|Withdrawal by Subject|2
7745719|NCT00710866|12180484|FG001|Overall Study|Withdrawal by Subject|1
7745720|NCT00710866|12180483|FG000|Overall Study|Lost to Follow-up|1
7745721|NCT00710866|12180484|FG001|Overall Study|Lost to Follow-up|0
7745722|NCT00710866|12180483|FG000|Overall Study|Failed to meet eligibility|1
7745723|NCT00710866|12180484|FG001|Overall Study|Failed to meet eligibility|1
7745724|NCT00710879|12180492|FG000|Overall Study|Lost to Follow-up|2
7745725|NCT00710879|12180493|FG001|Overall Study|Lost to Follow-up|1
7745726|NCT00710879|12180492|FG000|Overall Study|Protocol Violation|0
7745727|NCT00710879|12180493|FG001|Overall Study|Protocol Violation|3
7745728|NCT00711009|12180535|FG000|Overall Study|Adverse Event/HIV-Related Event|4
7745729|NCT00711009|12180536|FG001|Overall Study|Adverse Event/HIV-Related Event|5
7745730|NCT00711009|12180535|FG000|Overall Study|Withdrawal by Subject|4
7745731|NCT00711009|12180536|FG001|Overall Study|Withdrawal by Subject|2
7745732|NCT00711009|12180535|FG000|Overall Study|Lost to Follow-up|3
7745733|NCT00711009|12180536|FG001|Overall Study|Lost to Follow-up|9
7745734|NCT00711009|12180535|FG000|Overall Study|Participant Noncompliant|0
7745735|NCT00711009|12180536|FG001|Overall Study|Participant Noncompliant|1
7745736|NCT00711009|12180535|FG000|Overall Study|Virologic Failure|2
7745737|NCT00711009|12180536|FG001|Overall Study|Virologic Failure|1
7745738|NCT00711009|12180535|FG000|Overall Study|Pregnancy|1
7745739|NCT00711009|12180536|FG001|Overall Study|Pregnancy|0
7745740|NCT00711009|12180535|FG000|Overall Study|Site closing|0
7745741|NCT00711009|12180536|FG001|Overall Study|Site closing|1
7745742|NCT00711009|12180535|FG000|Overall Study|Dose adjustment|1
7745743|NCT00711009|12180536|FG001|Overall Study|Dose adjustment|0
7745744|NCT00711100|12180546|FG000|Overall Study|Lack of Efficacy|5
7745745|NCT00711100|12180546|FG000|Overall Study|Withdrawal by Subject|8
7745746|NCT00711113|12180562|FG000|Overall Study|Lost to Follow-up|9
7745747|NCT00711113|12180562|FG000|Overall Study|Implant lost|2
7745748|NCT00711191|12180569|FG000|Overall Study|Adverse Event|1
7745749|NCT00711191|12180570|FG001|Overall Study|Adverse Event|1
7745750|NCT00711191|12180571|FG002|Overall Study|Adverse Event|2
7745751|NCT00711191|12180569|FG000|Overall Study|Objective progression or relapse|2
7745752|NCT00711191|12180570|FG001|Overall Study|Objective progression or relapse|3
7745753|NCT00711191|12180571|FG002|Overall Study|Objective progression or relapse|7
7745754|NCT00711191|12180569|FG000|Overall Study|Withdrawal by Subject|0
7745755|NCT00711191|12180570|FG001|Overall Study|Withdrawal by Subject|1
7745756|NCT00711191|12180571|FG002|Overall Study|Withdrawal by Subject|3
7745757|NCT00711243|12180588|FG000|Registed and Started Treatment|Withdrawal by Subject|0
7745758|NCT00711243|12180589|FG001|Registed and Started Treatment|Withdrawal by Subject|0
7745759|NCT00711243|12180590|FG002|Registed and Started Treatment|Withdrawal by Subject|0
7745760|NCT00711243|12180591|FG003|Registed and Started Treatment|Withdrawal by Subject|0
7745761|NCT00711243|12180592|FG004|Registed and Started Treatment|Withdrawal by Subject|0
7745762|NCT00711243|12180593|FG005|Registed and Started Treatment|Withdrawal by Subject|1
7745763|NCT00711243|12180588|FG000|Reached First Response/4 Cycles|Death|0
7745764|NCT00711243|12180589|FG001|Reached First Response/4 Cycles|Death|0
7745765|NCT00711243|12180590|FG002|Reached First Response/4 Cycles|Death|0
7745766|NCT00711243|12180591|FG003|Reached First Response/4 Cycles|Death|0
7745767|NCT00711243|12180592|FG004|Reached First Response/4 Cycles|Death|0
7745768|NCT00711243|12180593|FG005|Reached First Response/4 Cycles|Death|2
7745769|NCT00711243|12180588|FG000|Reached First Response/4 Cycles|Progressive disease|0
7745770|NCT00711243|12180589|FG001|Reached First Response/4 Cycles|Progressive disease|0
7745771|NCT00711243|12180590|FG002|Reached First Response/4 Cycles|Progressive disease|0
7745772|NCT00711243|12180591|FG003|Reached First Response/4 Cycles|Progressive disease|1
7745773|NCT00711243|12180592|FG004|Reached First Response/4 Cycles|Progressive disease|0
7745774|NCT00711243|12180593|FG005|Reached First Response/4 Cycles|Progressive disease|0
7745775|NCT00711243|12180588|FG000|Treated Cycle 5 After First Response|Progressive disease|1
7745776|NCT00711243|12180589|FG001|Treated Cycle 5 After First Response|Progressive disease|2
7745777|NCT00711243|12180590|FG002|Treated Cycle 5 After First Response|Progressive disease|0
7745778|NCT00711243|12180591|FG003|Treated Cycle 5 After First Response|Progressive disease|0
7745779|NCT00711243|12180592|FG004|Treated Cycle 5 After First Response|Progressive disease|1
7745780|NCT00711243|12180593|FG005|Treated Cycle 5 After First Response|Progressive disease|1
7745781|NCT00711243|12180588|FG000|Treated Cycle 5 After First Response|Death|0
7745782|NCT00711243|12180589|FG001|Treated Cycle 5 After First Response|Death|0
7745783|NCT00711243|12180590|FG002|Treated Cycle 5 After First Response|Death|0
7745784|NCT00711243|12180591|FG003|Treated Cycle 5 After First Response|Death|0
7745785|NCT00711243|12180592|FG004|Treated Cycle 5 After First Response|Death|0
7745786|NCT00711243|12180593|FG005|Treated Cycle 5 After First Response|Death|2
7745787|NCT00711243|12180588|FG000|Treated Cycle 5 After First Response|Decline in performance status|0
7745788|NCT00711243|12180589|FG001|Treated Cycle 5 After First Response|Decline in performance status|0
7745789|NCT00711243|12180590|FG002|Treated Cycle 5 After First Response|Decline in performance status|0
7745790|NCT00711243|12180591|FG003|Treated Cycle 5 After First Response|Decline in performance status|0
7745791|NCT00711243|12180592|FG004|Treated Cycle 5 After First Response|Decline in performance status|0
7745792|NCT00711243|12180593|FG005|Treated Cycle 5 After First Response|Decline in performance status|1
7745793|NCT00711243|12180588|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0
7745794|NCT00711243|12180589|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0
7745795|NCT00711243|12180590|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0
7745796|NCT00711243|12180591|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0
7745797|NCT00711243|12180592|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0
7745798|NCT00711243|12180593|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2
7745799|NCT00711412|12180618|FG000|Induction Treatment|Death|2
7745800|NCT00711412|12180618|FG000|Induction Treatment|Adverse Event|1
7745801|NCT00711412|12180618|FG000|Induction Treatment|Other|1
7745802|NCT00711412|12180618|FG000|Evaluated for Combination Treatment|Adverse Event|2
7745803|NCT00711412|12180618|FG000|Evaluated for Combination Treatment|Death|1
7745804|NCT00711412|12180618|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1
7745805|NCT00711412|12180618|FG000|Evaluated for Combination Treatment|Progressive disease|2
7745806|NCT00711412|12180618|FG000|Combination Treatment|Progressive Disease|1
7745807|NCT00711412|12180618|FG000|Evaluation for Response and Surgery|Progressive Disease|2
7745808|NCT00711412|12180618|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2
7745809|NCT00711412|12180618|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1
7745810|NCT00711412|12180618|FG000|Evaluation for Response and Surgery|Death|1
7745811|NCT00711412|12180618|FG000|Survival Follow up Until Death|Other|12
7745812|NCT00711425|12180623|FG000|Overall Study|Protocol Violation|1
7745813|NCT00711425|12180623|FG000|Overall Study|Death|2
7745814|NCT00711425|12180623|FG000|Overall Study|Lost to Follow-up|1
7745815|NCT00711477|12180639|FG000|Overall Study|Adverse Event|3
7745816|NCT00711477|12180640|FG001|Overall Study|Adverse Event|1
7745817|NCT00711477|12180639|FG000|Overall Study|Lost to Follow-up|0
7745818|NCT00711477|12180640|FG001|Overall Study|Lost to Follow-up|1
7745819|NCT00711477|12180639|FG000|Overall Study|Noncompliance|0
7745820|NCT00711477|12180640|FG001|Overall Study|Noncompliance|1
7745821|NCT00711516|12180655|FG000|Overall Study|Adverse Event|1
7745822|NCT00711516|12180656|FG001|Overall Study|Adverse Event|1
7745823|NCT00711516|12180655|FG000|Overall Study|Withdrawal by Subject|0
7745824|NCT00711516|12180656|FG001|Overall Study|Withdrawal by Subject|1
7745825|NCT00711516|12180655|FG000|Overall Study|Protocol Violation|0
7745826|NCT00711516|12180656|FG001|Overall Study|Protocol Violation|1
7745827|NCT00711529|12180664|FG000|Overall Study|Protocol Violation|2
7745828|NCT00711529|12180665|FG001|Overall Study|Protocol Violation|0
7745829|NCT00711529|12180664|FG000|Overall Study|Withdrawal by Subject|2
7745830|NCT00711529|12180665|FG001|Overall Study|Withdrawal by Subject|6
7745831|NCT00711594|12180675|FG000|Overall Study|Progressive disease|2
7745832|NCT00711594|12180676|FG001|Overall Study|Progressive disease|2
7745833|NCT00711594|12180677|FG002|Overall Study|Progressive disease|6
7745834|NCT00711594|12180678|FG003|Overall Study|Progressive disease|44
7745835|NCT00711594|12180675|FG000|Overall Study|Other Adverse Event|1
7745836|NCT00711594|12180676|FG001|Overall Study|Other Adverse Event|0
7745837|NCT00711594|12180677|FG002|Overall Study|Other Adverse Event|0
7745838|NCT00711594|12180678|FG003|Overall Study|Other Adverse Event|16
7745839|NCT00711594|12180675|FG000|Overall Study|Withdrawal by Subject|0
7745840|NCT00711594|12180676|FG001|Overall Study|Withdrawal by Subject|1
7745841|NCT00711594|12180677|FG002|Overall Study|Withdrawal by Subject|0
7745842|NCT00711594|12180678|FG003|Overall Study|Withdrawal by Subject|2
7745843|NCT00711646|12180692|FG000|Overall Study|Adverse Event|6
7745844|NCT00711646|12180693|FG001|Overall Study|Adverse Event|1
7745845|NCT00711646|12180692|FG000|Overall Study|Withdrawal by Subject|4
7745846|NCT00711646|12180693|FG001|Overall Study|Withdrawal by Subject|0
7745847|NCT00711646|12180692|FG000|Overall Study|Protocol Violation|0
7745848|NCT00711646|12180693|FG001|Overall Study|Protocol Violation|1
7745849|NCT00711646|12180692|FG000|Overall Study|Lost to Follow-up|1
7745850|NCT00711646|12180693|FG001|Overall Study|Lost to Follow-up|0
7745851|NCT00711646|12180692|FG000|Overall Study|administrative decision|0
7745852|NCT00711646|12180693|FG001|Overall Study|administrative decision|1
7745853|NCT00711646|12180692|FG000|Overall Study|patient non-compliance|1
7745854|NCT00711646|12180693|FG001|Overall Study|patient non-compliance|0
7745855|NCT00711802|12180718|FG000|Overall Study|Not treated (no further detail)|2
7745856|NCT00711802|12180719|FG001|Overall Study|Not treated (no further detail)|1
7745857|NCT00711802|12180720|FG002|Overall Study|Not treated (no further detail)|2
7745858|NCT00711802|12180721|FG003|Overall Study|Not treated (no further detail)|0
7745859|NCT00711802|12180722|FG004|Overall Study|Not treated (no further detail)|2
7745860|NCT00711802|12180723|FG005|Overall Study|Not treated (no further detail)|0
7745861|NCT00711802|12180724|FG006|Overall Study|Not treated (no further detail)|0
7745862|NCT00711802|12180725|FG007|Overall Study|Not treated (no further detail)|0
7745863|NCT00711802|12180718|FG000|Overall Study|Adverse Event|0
7745864|NCT00711802|12180719|FG001|Overall Study|Adverse Event|0
7745865|NCT00711802|12180720|FG002|Overall Study|Adverse Event|0
7745866|NCT00711802|12180721|FG003|Overall Study|Adverse Event|0
7745867|NCT00711802|12180722|FG004|Overall Study|Adverse Event|1
7745868|NCT00711802|12180723|FG005|Overall Study|Adverse Event|1
7745869|NCT00711802|12180724|FG006|Overall Study|Adverse Event|0
7745870|NCT00711802|12180725|FG007|Overall Study|Adverse Event|0
7745871|NCT00711802|12180718|FG000|Overall Study|Microbiological failure|0
7745872|NCT00711802|12180719|FG001|Overall Study|Microbiological failure|1
7745873|NCT00711802|12180720|FG002|Overall Study|Microbiological failure|0
7745874|NCT00711802|12180721|FG003|Overall Study|Microbiological failure|0
7745875|NCT00711802|12180722|FG004|Overall Study|Microbiological failure|0
7745876|NCT00711802|12180723|FG005|Overall Study|Microbiological failure|1
7745877|NCT00711802|12180724|FG006|Overall Study|Microbiological failure|0
7745878|NCT00711802|12180725|FG007|Overall Study|Microbiological failure|0
7745879|NCT00711802|12180718|FG000|Overall Study|Protocol Violation|0
7745880|NCT00711802|12180719|FG001|Overall Study|Protocol Violation|0
7745881|NCT00711802|12180720|FG002|Overall Study|Protocol Violation|0
7745882|NCT00711802|12180721|FG003|Overall Study|Protocol Violation|1
7745883|NCT00711802|12180722|FG004|Overall Study|Protocol Violation|0
7745884|NCT00711802|12180723|FG005|Overall Study|Protocol Violation|0
7745885|NCT00711802|12180724|FG006|Overall Study|Protocol Violation|0
7745886|NCT00711802|12180725|FG007|Overall Study|Protocol Violation|0
7745887|NCT00711802|12180718|FG000|Overall Study|Physician Decision|0
7745888|NCT00711802|12180719|FG001|Overall Study|Physician Decision|2
7745889|NCT00711802|12180720|FG002|Overall Study|Physician Decision|0
7745890|NCT00711802|12180721|FG003|Overall Study|Physician Decision|0
7745891|NCT00711802|12180722|FG004|Overall Study|Physician Decision|0
7745892|NCT00711802|12180723|FG005|Overall Study|Physician Decision|0
7745893|NCT00711802|12180724|FG006|Overall Study|Physician Decision|0
7745894|NCT00711802|12180725|FG007|Overall Study|Physician Decision|0
7745895|NCT00711802|12180718|FG000|Overall Study|Withdrawal by Subject|0
7745896|NCT00711802|12180719|FG001|Overall Study|Withdrawal by Subject|1
7745897|NCT00711802|12180720|FG002|Overall Study|Withdrawal by Subject|0
7745898|NCT00711802|12180721|FG003|Overall Study|Withdrawal by Subject|1
7745899|NCT00711802|12180722|FG004|Overall Study|Withdrawal by Subject|0
7745900|NCT00711802|12180723|FG005|Overall Study|Withdrawal by Subject|0
7745901|NCT00711802|12180724|FG006|Overall Study|Withdrawal by Subject|0
7745902|NCT00711802|12180725|FG007|Overall Study|Withdrawal by Subject|0
7745903|NCT00711802|12180718|FG000|Overall Study|Lost to Follow-up|0
7745904|NCT00711802|12180719|FG001|Overall Study|Lost to Follow-up|0
7745905|NCT00711802|12180720|FG002|Overall Study|Lost to Follow-up|3
7745906|NCT00711802|12180721|FG003|Overall Study|Lost to Follow-up|1
7745907|NCT00711802|12180722|FG004|Overall Study|Lost to Follow-up|10
7745908|NCT00711802|12180723|FG005|Overall Study|Lost to Follow-up|6
7745909|NCT00711802|12180724|FG006|Overall Study|Lost to Follow-up|4
7745910|NCT00711802|12180725|FG007|Overall Study|Lost to Follow-up|2
7745911|NCT00711802|12180718|FG000|Overall Study|Reason not reported|0
7745912|NCT00711802|12180719|FG001|Overall Study|Reason not reported|1
7745913|NCT00711802|12180720|FG002|Overall Study|Reason not reported|1
7745914|NCT00711802|12180721|FG003|Overall Study|Reason not reported|0
7745915|NCT00711802|12180722|FG004|Overall Study|Reason not reported|1
7745916|NCT00711802|12180723|FG005|Overall Study|Reason not reported|0
7745917|NCT00711802|12180724|FG006|Overall Study|Reason not reported|1
7745918|NCT00711802|12180725|FG007|Overall Study|Reason not reported|0
7745919|NCT00711880|12180761|FG000|Overall Study|Adverse Event|11
7745920|NCT00711880|12180762|FG001|Overall Study|Adverse Event|2
7745921|NCT00711880|12180761|FG000|Overall Study|Patient non-compliance|1
7745922|NCT00711880|12180762|FG001|Overall Study|Patient non-compliance|0
7745923|NCT00711880|12180761|FG000|Overall Study|Lack of Efficacy|1
7745924|NCT00711880|12180762|FG001|Overall Study|Lack of Efficacy|5
7745925|NCT00711958|12180770|FG000|Overall Study|Withdrawal by Subject|6
7745926|NCT00711958|12180771|FG001|Overall Study|Withdrawal by Subject|8
7745927|NCT00711958|12180770|FG000|Overall Study|Lack of Efficacy|3
7745928|NCT00711958|12180771|FG001|Overall Study|Lack of Efficacy|1
7745929|NCT00711958|12180770|FG000|Overall Study|Clinical deterioration|1
7745930|NCT00711958|12180771|FG001|Overall Study|Clinical deterioration|0
7745931|NCT00711958|12180770|FG000|Overall Study|Adverse Event|9
7745932|NCT00711958|12180771|FG001|Overall Study|Adverse Event|7
7745933|NCT00711958|12180770|FG000|Overall Study|Protocol Violation|1
7745934|NCT00711958|12180771|FG001|Overall Study|Protocol Violation|0
7745935|NCT00711958|12180770|FG000|Overall Study|Lost to Follow-up|2
7745936|NCT00711958|12180771|FG001|Overall Study|Lost to Follow-up|2
7745937|NCT00711958|12180770|FG000|Overall Study|Death|10
7745938|NCT00711958|12180771|FG001|Overall Study|Death|5
7745939|NCT00711958|12180770|FG000|Overall Study|Progression of disease|1
7745940|NCT00711958|12180771|FG001|Overall Study|Progression of disease|0
7745941|NCT00711971|12180780|FG000|Overall Study|Lost to Follow-up|3
7745942|NCT00711971|12180781|FG001|Overall Study|Lost to Follow-up|4
7745943|NCT00711971|12180782|FG002|Overall Study|Lost to Follow-up|1
7745944|NCT00712010|12180805|FG000|Washout (7 Days)|Withdrawal by Subject|1
7745945|NCT00712166|12180836|FG000|Overall Study|Noncompliance|0
7745946|NCT00712166|12180837|FG001|Overall Study|Noncompliance|1
7745947|NCT00712270|12180869|FG000|Overall Study|Withdrawal by Subject|11
7745948|NCT00712270|12180869|FG000|Overall Study|Screen Failure|3
7745949|NCT00712335|12180923|FG000|Overall Study|Withdrawal by Subject|0
7745950|NCT00712335|12180924|FG001|Overall Study|Withdrawal by Subject|7
7745951|NCT00712335|12180925|FG002|Overall Study|Withdrawal by Subject|2
7745952|NCT00712335|12180926|FG003|Overall Study|Withdrawal by Subject|3
7745953|NCT00712335|12180927|FG004|Overall Study|Withdrawal by Subject|0
7745954|NCT00712335|12180923|FG000|Overall Study|Lost to Follow-up|2
7745955|NCT00712335|12180924|FG001|Overall Study|Lost to Follow-up|5
7745956|NCT00712335|12180925|FG002|Overall Study|Lost to Follow-up|0
7745957|NCT00712335|12180926|FG003|Overall Study|Lost to Follow-up|1
7745958|NCT00712335|12180927|FG004|Overall Study|Lost to Follow-up|0
7745959|NCT00712335|12180923|FG000|Overall Study|Protocol Violation|1
7745960|NCT00712335|12180924|FG001|Overall Study|Protocol Violation|2
7745961|NCT00712335|12180925|FG002|Overall Study|Protocol Violation|1
7745962|NCT00712335|12180926|FG003|Overall Study|Protocol Violation|0
7745963|NCT00712335|12180927|FG004|Overall Study|Protocol Violation|0
7745964|NCT00712335|12180923|FG000|Overall Study|Lack of Efficacy|0
7745965|NCT00712335|12180924|FG001|Overall Study|Lack of Efficacy|0
7745966|NCT00712335|12180925|FG002|Overall Study|Lack of Efficacy|1
7745967|NCT00712335|12180926|FG003|Overall Study|Lack of Efficacy|1
7745968|NCT00712335|12180927|FG004|Overall Study|Lack of Efficacy|0
7745969|NCT00712335|12180923|FG000|Overall Study|Other Reason|0
7745970|NCT00712335|12180924|FG001|Overall Study|Other Reason|3
7745971|NCT00712335|12180925|FG002|Overall Study|Other Reason|1
7745972|NCT00712335|12180926|FG003|Overall Study|Other Reason|0
7745973|NCT00712335|12180927|FG004|Overall Study|Other Reason|0
7745974|NCT00712348|12180939|FG000|Overall Study|Withdrawal by Subject|1
7745975|NCT00712543|12180958|FG000|Day 8-14|Lost to Follow-up|0
7745976|NCT00712543|12180959|FG001|Day 8-14|Lost to Follow-up|2
7745977|NCT00712673|12180968|FG000|Overall Study|Adverse Event|3
7745978|NCT00712673|12180969|FG001|Overall Study|Adverse Event|3
7745979|NCT00712673|12180970|FG002|Overall Study|Adverse Event|21
7745980|NCT00712673|12180971|FG003|Overall Study|Adverse Event|26
7745981|NCT00712673|12180968|FG000|Overall Study|Lack of Efficacy|2
7745982|NCT00712673|12180969|FG001|Overall Study|Lack of Efficacy|8
7745983|NCT00712673|12180970|FG002|Overall Study|Lack of Efficacy|8
7745984|NCT00712673|12180971|FG003|Overall Study|Lack of Efficacy|6
7745985|NCT00712673|12180968|FG000|Overall Study|Poor Compliance to Protocol|3
7745986|NCT00712673|12180969|FG001|Overall Study|Poor Compliance to Protocol|3
7745987|NCT00712673|12180970|FG002|Overall Study|Poor Compliance to Protocol|4
7745988|NCT00712673|12180971|FG003|Overall Study|Poor Compliance to Protocol|16
7745989|NCT00712673|12180968|FG000|Overall Study|Lost to Follow-up|1
7745990|NCT00712673|12180969|FG001|Overall Study|Lost to Follow-up|0
7745991|NCT00712673|12180970|FG002|Overall Study|Lost to Follow-up|2
7745992|NCT00712673|12180971|FG003|Overall Study|Lost to Follow-up|0
7745993|NCT00712673|12180968|FG000|Overall Study|Withdrawal by Subject|6
7745994|NCT00712673|12180969|FG001|Overall Study|Withdrawal by Subject|7
7745995|NCT00712673|12180970|FG002|Overall Study|Withdrawal by Subject|15
7745996|NCT00712673|12180971|FG003|Overall Study|Withdrawal by Subject|20
7745997|NCT00712673|12180968|FG000|Overall Study|Familial and Personal Reasons|5
7745998|NCT00712673|12180969|FG001|Overall Study|Familial and Personal Reasons|0
7745999|NCT00712673|12180970|FG002|Overall Study|Familial and Personal Reasons|5
7746000|NCT00712673|12180971|FG003|Overall Study|Familial and Personal Reasons|2
7746001|NCT00712673|12180968|FG000|Overall Study|Investigator's Decision|1
7746002|NCT00712673|12180969|FG001|Overall Study|Investigator's Decision|0
7746003|NCT00712673|12180970|FG002|Overall Study|Investigator's Decision|0
7746004|NCT00712673|12180971|FG003|Overall Study|Investigator's Decision|0
7746005|NCT00712673|12180968|FG000|Overall Study|Protocol Violation|0
7746006|NCT00712673|12180969|FG001|Overall Study|Protocol Violation|0
7746007|NCT00712673|12180970|FG002|Overall Study|Protocol Violation|2
7746008|NCT00712673|12180971|FG003|Overall Study|Protocol Violation|0
7746009|NCT00712712|12180990|FG000|Overall Study|Protocol Violation|11
7746010|NCT00712712|12180990|FG000|Overall Study|Radiofrequency not done|3
7746011|NCT00712712|12180990|FG000|Overall Study|Death|8
7746012|NCT00712712|12180990|FG000|Overall Study|Withdrawal by Subject|1
7746013|NCT00712725|12181002|FG000|Overall Study|Adverse Event|1
7746014|NCT00712725|12181003|FG001|Overall Study|Adverse Event|0
7746015|NCT00712725|12181004|FG002|Overall Study|Adverse Event|0
7746016|NCT00712725|12181005|FG003|Overall Study|Adverse Event|1
7746017|NCT00712725|12181006|FG004|Overall Study|Adverse Event|0
7746018|NCT00712725|12181007|FG005|Overall Study|Adverse Event|0
7746019|NCT00712725|12181008|FG006|Overall Study|Adverse Event|0
7746020|NCT00712725|12181009|FG007|Overall Study|Adverse Event|0
7746021|NCT00712725|12181002|FG000|Overall Study|Lost to Follow-up|3
7746022|NCT00712725|12181003|FG001|Overall Study|Lost to Follow-up|2
7746023|NCT00712725|12181004|FG002|Overall Study|Lost to Follow-up|1
7746024|NCT00712725|12181005|FG003|Overall Study|Lost to Follow-up|1
7746025|NCT00712725|12181006|FG004|Overall Study|Lost to Follow-up|2
7746026|NCT00712725|12181007|FG005|Overall Study|Lost to Follow-up|2
7746027|NCT00712725|12181008|FG006|Overall Study|Lost to Follow-up|3
7746028|NCT00712725|12181009|FG007|Overall Study|Lost to Follow-up|1
7746029|NCT00712725|12181002|FG000|Overall Study|Physician Decision|2
7746030|NCT00712725|12181003|FG001|Overall Study|Physician Decision|0
7746031|NCT00712725|12181004|FG002|Overall Study|Physician Decision|0
7746032|NCT00712725|12181005|FG003|Overall Study|Physician Decision|0
7746033|NCT00712725|12181006|FG004|Overall Study|Physician Decision|1
7746034|NCT00712725|12181007|FG005|Overall Study|Physician Decision|0
7746035|NCT00712725|12181008|FG006|Overall Study|Physician Decision|2
7746036|NCT00712725|12181009|FG007|Overall Study|Physician Decision|0
7746037|NCT00712725|12181002|FG000|Overall Study|Pregnancy|0
7746038|NCT00712725|12181003|FG001|Overall Study|Pregnancy|1
7746039|NCT00712725|12181004|FG002|Overall Study|Pregnancy|0
7746040|NCT00712725|12181005|FG003|Overall Study|Pregnancy|0
7746041|NCT00712725|12181006|FG004|Overall Study|Pregnancy|1
7746042|NCT00712725|12181007|FG005|Overall Study|Pregnancy|0
7746043|NCT00712725|12181008|FG006|Overall Study|Pregnancy|2
7746044|NCT00712725|12181009|FG007|Overall Study|Pregnancy|0
7746045|NCT00712725|12181002|FG000|Overall Study|Protocol Violation|2
7746046|NCT00712725|12181003|FG001|Overall Study|Protocol Violation|0
7746047|NCT00712725|12181004|FG002|Overall Study|Protocol Violation|1
7746048|NCT00712725|12181005|FG003|Overall Study|Protocol Violation|3
7746049|NCT00712725|12181006|FG004|Overall Study|Protocol Violation|2
7746050|NCT00712725|12181007|FG005|Overall Study|Protocol Violation|0
7746051|NCT00712725|12181008|FG006|Overall Study|Protocol Violation|1
7746052|NCT00712725|12181009|FG007|Overall Study|Protocol Violation|1
7746053|NCT00712725|12181002|FG000|Overall Study|Withdrawal by Subject|2
7746054|NCT00712725|12181003|FG001|Overall Study|Withdrawal by Subject|1
7746055|NCT00712725|12181004|FG002|Overall Study|Withdrawal by Subject|1
7746056|NCT00712725|12181005|FG003|Overall Study|Withdrawal by Subject|2
7746057|NCT00712725|12181006|FG004|Overall Study|Withdrawal by Subject|1
7746058|NCT00712725|12181007|FG005|Overall Study|Withdrawal by Subject|1
7746059|NCT00712725|12181008|FG006|Overall Study|Withdrawal by Subject|1
7746060|NCT00712725|12181009|FG007|Overall Study|Withdrawal by Subject|2
7746061|NCT00712725|12181002|FG000|Overall Study|Lack of Qualifying Event|16
7746062|NCT00712725|12181003|FG001|Overall Study|Lack of Qualifying Event|2
7746063|NCT00712725|12181004|FG002|Overall Study|Lack of Qualifying Event|6
7746064|NCT00712725|12181005|FG003|Overall Study|Lack of Qualifying Event|8
7746065|NCT00712725|12181006|FG004|Overall Study|Lack of Qualifying Event|11
7746066|NCT00712725|12181007|FG005|Overall Study|Lack of Qualifying Event|13
7746067|NCT00712725|12181008|FG006|Overall Study|Lack of Qualifying Event|11
7746068|NCT00712725|12181009|FG007|Overall Study|Lack of Qualifying Event|6
7746069|NCT00712725|12181002|FG000|Overall Study|Protocol Specified Criteria|3
7746070|NCT00712725|12181003|FG001|Overall Study|Protocol Specified Criteria|0
7746071|NCT00712725|12181004|FG002|Overall Study|Protocol Specified Criteria|1
7746072|NCT00712725|12181005|FG003|Overall Study|Protocol Specified Criteria|2
7746073|NCT00712725|12181006|FG004|Overall Study|Protocol Specified Criteria|1
7746074|NCT00712725|12181007|FG005|Overall Study|Protocol Specified Criteria|0
7746075|NCT00712725|12181008|FG006|Overall Study|Protocol Specified Criteria|2
7746076|NCT00712725|12181009|FG007|Overall Study|Protocol Specified Criteria|1
7746077|NCT00712920|12181030|FG000|Overall Study|Adverse Event|3
7746078|NCT00712920|12181031|FG001|Overall Study|Adverse Event|4
7746079|NCT00712920|12181032|FG002|Overall Study|Adverse Event|7
7746080|NCT00712920|12181030|FG000|Overall Study|Withdrawal by Subject|4
7746081|NCT00712920|12181031|FG001|Overall Study|Withdrawal by Subject|2
7746082|NCT00712920|12181032|FG002|Overall Study|Withdrawal by Subject|1
7746083|NCT00712920|12181030|FG000|Overall Study|Lost to Follow-up|1
7746084|NCT00712920|12181031|FG001|Overall Study|Lost to Follow-up|4
7746085|NCT00712920|12181032|FG002|Overall Study|Lost to Follow-up|0
7746086|NCT00712920|12181030|FG000|Overall Study|Lack of Efficacy|1
7746087|NCT00712920|12181031|FG001|Overall Study|Lack of Efficacy|0
7746088|NCT00712920|12181032|FG002|Overall Study|Lack of Efficacy|1
7746089|NCT00712920|12181030|FG000|Overall Study|Other|5
7746090|NCT00712920|12181031|FG001|Overall Study|Other|7
7746091|NCT00712920|12181032|FG002|Overall Study|Other|3
7746092|NCT00712920|12181030|FG000|Overall Study|Non-compliance|3
7746093|NCT00712920|12181031|FG001|Overall Study|Non-compliance|0
7746094|NCT00712920|12181032|FG002|Overall Study|Non-compliance|0
7746095|NCT00712959|12181042|FG000|Overall Study|Protocol Violation|3
7746096|NCT00712959|12181043|FG001|Overall Study|Protocol Violation|1
7746097|NCT00712959|12181042|FG000|Overall Study|Lost to Follow-up|13
7746098|NCT00712959|12181043|FG001|Overall Study|Lost to Follow-up|2
7746099|NCT00712959|12181042|FG000|Overall Study|Withdrawal by Subject|3
7746100|NCT00712959|12181043|FG001|Overall Study|Withdrawal by Subject|0
7746101|NCT00712985|12181049|FG000|Overall Study|1 withdrew prior to start of drug|1
7746102|NCT00712985|12181049|FG000|Overall Study|1 patient moved out of state|1
7746103|NCT00712985|12181049|FG000|Overall Study|Lack of Efficacy|3
7746104|NCT00713219|12181053|FG000|Overall Study|Death|1
7746105|NCT00713219|12181053|FG000|Overall Study|Protocol Violation|1
7746106|NCT00713310|12181063|FG000|Overall Study|Adverse Event|5
7746107|NCT00713310|12181064|FG001|Overall Study|Adverse Event|2
7746108|NCT00713310|12181063|FG000|Overall Study|Lack of Efficacy|0
7746109|NCT00713310|12181064|FG001|Overall Study|Lack of Efficacy|2
7746110|NCT00713310|12181063|FG000|Overall Study|Withdrawal by Subject|0
7746111|NCT00713310|12181064|FG001|Overall Study|Withdrawal by Subject|2
7746112|NCT00713323|12181070|FG000|Overall Study|Adverse Event|75
7746113|NCT00713323|12181070|FG000|Overall Study|Withdrawal by Subject|15
7746114|NCT00713323|12181070|FG000|Overall Study|Lost to Follow-up|11
7746115|NCT00713323|12181070|FG000|Overall Study|Lack of Efficacy|36
7746116|NCT00713323|12181070|FG000|Overall Study|Low creatine clearance at screening|1
7746117|NCT00713323|12181070|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1
7746118|NCT00713323|12181070|FG000|Overall Study|Surgery cured allodynic pain|1
7746119|NCT00713323|12181070|FG000|Overall Study|Pain free|1
7746120|NCT00713323|12181070|FG000|Overall Study|Non-compliance|1
7746121|NCT00713323|12181070|FG000|Overall Study|Pain resolved|1
7746122|NCT00713323|12181070|FG000|Overall Study|Subject travelling to USA|1
7746123|NCT00713323|12181070|FG000|Overall Study|Subject travelling to Dominica Republic|1
7746124|NCT00713323|12181070|FG000|Overall Study|Treatment that may interact with Sativex|1
7746125|NCT00713349|12181074|FG000|Overall Study|Protocol Violation|1
7746126|NCT00713544|12181099|FG000|Overall Study|Adverse Event|5
7746127|NCT00713544|12181100|FG001|Overall Study|Adverse Event|3
7746128|NCT00713544|12181101|FG002|Overall Study|Adverse Event|7
7746129|NCT00713544|12181102|FG003|Overall Study|Adverse Event|7
7746130|NCT00713544|12181103|FG004|Overall Study|Adverse Event|3
7746131|NCT00713544|12181104|FG005|Overall Study|Adverse Event|5
7746132|NCT00713544|12181099|FG000|Overall Study|Withdrawal by Subject|2
7746133|NCT00713544|12181100|FG001|Overall Study|Withdrawal by Subject|0
7746134|NCT00713544|12181101|FG002|Overall Study|Withdrawal by Subject|3
7746135|NCT00713544|12181102|FG003|Overall Study|Withdrawal by Subject|2
7746136|NCT00713544|12181103|FG004|Overall Study|Withdrawal by Subject|3
7746137|NCT00713544|12181104|FG005|Overall Study|Withdrawal by Subject|1
7746138|NCT00713544|12181099|FG000|Overall Study|Protocol Violation|0
7746139|NCT00713544|12181100|FG001|Overall Study|Protocol Violation|0
7746140|NCT00713544|12181101|FG002|Overall Study|Protocol Violation|0
7746141|NCT00713544|12181102|FG003|Overall Study|Protocol Violation|0
7746142|NCT00713544|12181103|FG004|Overall Study|Protocol Violation|0
7746143|NCT00713544|12181104|FG005|Overall Study|Protocol Violation|1
7746144|NCT00713544|12181099|FG000|Overall Study|Physician Decision|0
7746145|NCT00713544|12181100|FG001|Overall Study|Physician Decision|0
7746146|NCT00713544|12181101|FG002|Overall Study|Physician Decision|0
7746147|NCT00713544|12181102|FG003|Overall Study|Physician Decision|0
7746148|NCT00713544|12181103|FG004|Overall Study|Physician Decision|0
7746149|NCT00713544|12181104|FG005|Overall Study|Physician Decision|2
7746150|NCT00713544|12181099|FG000|Overall Study|Lack of Efficacy|0
7746151|NCT00713544|12181100|FG001|Overall Study|Lack of Efficacy|1
7746152|NCT00713544|12181101|FG002|Overall Study|Lack of Efficacy|0
7746153|NCT00713544|12181102|FG003|Overall Study|Lack of Efficacy|1
7746154|NCT00713544|12181103|FG004|Overall Study|Lack of Efficacy|1
7746155|NCT00713544|12181104|FG005|Overall Study|Lack of Efficacy|0
7746156|NCT00713544|12181099|FG000|Overall Study|Lost to Follow-up|0
7746157|NCT00713544|12181100|FG001|Overall Study|Lost to Follow-up|0
7746158|NCT00713544|12181101|FG002|Overall Study|Lost to Follow-up|1
7746159|NCT00713544|12181102|FG003|Overall Study|Lost to Follow-up|0
7746160|NCT00713544|12181103|FG004|Overall Study|Lost to Follow-up|0
7746161|NCT00713544|12181104|FG005|Overall Study|Lost to Follow-up|0
7746162|NCT00713544|12181099|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0
7746163|NCT00713544|12181100|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1
7746164|NCT00713544|12181101|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0
7746165|NCT00713544|12181102|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0
7746166|NCT00713544|12181103|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0
7746167|NCT00713544|12181104|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0
7746168|NCT00713544|12181099|FG000|Overall Study|Incorrect enrollment|0
7746169|NCT00713544|12181100|FG001|Overall Study|Incorrect enrollment|1
7746170|NCT00713544|12181101|FG002|Overall Study|Incorrect enrollment|0
7746171|NCT00713544|12181102|FG003|Overall Study|Incorrect enrollment|0
7746172|NCT00713544|12181103|FG004|Overall Study|Incorrect enrollment|0
7746173|NCT00713544|12181104|FG005|Overall Study|Incorrect enrollment|0
7746174|NCT00713544|12181099|FG000|Overall Study|Hepatotoxicity - not an AE|0
7746175|NCT00713544|12181100|FG001|Overall Study|Hepatotoxicity - not an AE|0
7746176|NCT00713544|12181101|FG002|Overall Study|Hepatotoxicity - not an AE|0
7746177|NCT00713544|12181102|FG003|Overall Study|Hepatotoxicity - not an AE|0
7746178|NCT00713544|12181103|FG004|Overall Study|Hepatotoxicity - not an AE|1
7746179|NCT00713544|12181104|FG005|Overall Study|Hepatotoxicity - not an AE|0
7746180|NCT00713609|12181133|FG000|Overall Study|Adverse Event|2
7746181|NCT00713609|12181134|FG001|Overall Study|Adverse Event|0
7746182|NCT00713609|12181135|FG002|Overall Study|Adverse Event|2
7746183|NCT00713609|12181136|FG003|Overall Study|Adverse Event|2
7746184|NCT00713609|12181137|FG004|Overall Study|Adverse Event|3
7746185|NCT00713609|12181138|FG005|Overall Study|Adverse Event|1
7746186|NCT00713609|12181133|FG000|Overall Study|Lost to Follow-up|5
7746187|NCT00713609|12181134|FG001|Overall Study|Lost to Follow-up|7
7746188|NCT00713609|12181135|FG002|Overall Study|Lost to Follow-up|5
7746189|NCT00713609|12181136|FG003|Overall Study|Lost to Follow-up|5
7746190|NCT00713609|12181137|FG004|Overall Study|Lost to Follow-up|7
7746191|NCT00713609|12181138|FG005|Overall Study|Lost to Follow-up|0
7746192|NCT00713609|12181133|FG000|Overall Study|Lack of Efficacy|1
7746193|NCT00713609|12181134|FG001|Overall Study|Lack of Efficacy|3
7746194|NCT00713609|12181135|FG002|Overall Study|Lack of Efficacy|0
7746195|NCT00713609|12181136|FG003|Overall Study|Lack of Efficacy|0
7746196|NCT00713609|12181137|FG004|Overall Study|Lack of Efficacy|1
7746197|NCT00713609|12181138|FG005|Overall Study|Lack of Efficacy|0
7746198|NCT00713609|12181133|FG000|Overall Study|Non-Compliance with Study Treatment|1
7746199|NCT00713609|12181134|FG001|Overall Study|Non-Compliance with Study Treatment|1
7746200|NCT00713609|12181135|FG002|Overall Study|Non-Compliance with Study Treatment|2
7746201|NCT00713609|12181136|FG003|Overall Study|Non-Compliance with Study Treatment|0
7746202|NCT00713609|12181137|FG004|Overall Study|Non-Compliance with Study Treatment|1
7746203|NCT00713609|12181138|FG005|Overall Study|Non-Compliance with Study Treatment|0
7746204|NCT00713609|12181133|FG000|Overall Study|Withdrawal by Subject|6
7746205|NCT00713609|12181134|FG001|Overall Study|Withdrawal by Subject|1
7746206|NCT00713609|12181135|FG002|Overall Study|Withdrawal by Subject|5
7746207|NCT00713609|12181136|FG003|Overall Study|Withdrawal by Subject|1
7746208|NCT00713609|12181137|FG004|Overall Study|Withdrawal by Subject|5
7746209|NCT00713609|12181138|FG005|Overall Study|Withdrawal by Subject|7
7746210|NCT00713609|12181133|FG000|Overall Study|Protocol Violation|6
7746211|NCT00713609|12181134|FG001|Overall Study|Protocol Violation|3
7746212|NCT00713609|12181135|FG002|Overall Study|Protocol Violation|1
7746213|NCT00713609|12181136|FG003|Overall Study|Protocol Violation|1
7746214|NCT00713609|12181137|FG004|Overall Study|Protocol Violation|2
7746215|NCT00713609|12181138|FG005|Overall Study|Protocol Violation|0
7746216|NCT00713648|12181152|FG000|Overall Study|Adverse Event|1
7746217|NCT00713648|12181152|FG000|Overall Study|Unclassified|2
7746218|NCT00713648|12181152|FG000|Overall Study|According to Protocol|2
7746219|NCT00713648|12181152|FG000|Overall Study|Development of antibodies|3
7746220|NCT00713700|12181173|FG000|Overall Study|Lost to Follow-up|3
7746221|NCT00713700|12181173|FG000|Overall Study|Withdrawal by Subject|1
7746222|NCT00713830|12181188|FG000|Overall Study|Adverse Event|23
7746223|NCT00713830|12181189|FG001|Overall Study|Adverse Event|71
7746224|NCT00713830|12181188|FG000|Overall Study|Lack of Efficacy|24
7746225|NCT00713830|12181189|FG001|Overall Study|Lack of Efficacy|16
7746226|NCT00713830|12181188|FG000|Overall Study|Lost to Follow-up|2
7746227|NCT00713830|12181189|FG001|Overall Study|Lost to Follow-up|9
7746228|NCT00713830|12181188|FG000|Overall Study|Withdrawal by Subject|13
7746229|NCT00713830|12181189|FG001|Overall Study|Withdrawal by Subject|23
7746230|NCT00713830|12181188|FG000|Overall Study|Poor Compliance to Protocol|7
7746231|NCT00713830|12181189|FG001|Overall Study|Poor Compliance to Protocol|14
7746232|NCT00713830|12181188|FG000|Overall Study|Familial and Personal Reasons|9
7746233|NCT00713830|12181189|FG001|Overall Study|Familial and Personal Reasons|34
7746234|NCT00713830|12181188|FG000|Overall Study|Sponsor Decision|4
7746235|NCT00713830|12181189|FG001|Overall Study|Sponsor Decision|10
7746236|NCT00714051|12181197|FG000|Overall Study|Withdrawal by Subject|1
7746237|NCT00714051|12181198|FG001|Overall Study|Withdrawal by Subject|0
7746238|NCT00714051|12181197|FG000|Overall Study|Death|0
7746239|NCT00714051|12181198|FG001|Overall Study|Death|1
7746240|NCT00714168|12181206|FG000|Overall Study|Pregnancy|5
7746241|NCT00714168|12181207|FG001|Overall Study|Pregnancy|4
7746242|NCT00714168|12181206|FG000|Overall Study|Lost to Follow-up|32
7746243|NCT00714168|12181207|FG001|Overall Study|Lost to Follow-up|50
7746244|NCT00714168|12181206|FG000|Overall Study|Relocation|4
7746245|NCT00714168|12181207|FG001|Overall Study|Relocation|3
7746246|NCT00714168|12181206|FG000|Overall Study|Non-study medical condition|3
7746247|NCT00714168|12181207|FG001|Overall Study|Non-study medical condition|2
7746248|NCT00714259|12181235|FG000|Overall Study|Death|2
7746249|NCT00714285|12181252|FG000|Overall Study|Lost to Follow-up|0
7746250|NCT00714285|12181253|FG001|Overall Study|Lost to Follow-up|2
7746251|NCT00714285|12181254|FG002|Overall Study|Lost to Follow-up|0
7746252|NCT00714285|12181255|FG003|Overall Study|Lost to Follow-up|1
7746253|NCT00714285|12181252|FG000|Overall Study|Migrated/moved from study area|0
7746254|NCT00714285|12181253|FG001|Overall Study|Migrated/moved from study area|1
7746255|NCT00714285|12181254|FG002|Overall Study|Migrated/moved from study area|0
7746256|NCT00714285|12181255|FG003|Overall Study|Migrated/moved from study area|0
7746257|NCT00714415|12181282|FG000|Overall Study|Lack of Efficacy|1
7746258|NCT00714415|12181283|FG001|Overall Study|Lack of Efficacy|0
7746259|NCT00714415|12181282|FG000|Overall Study|Death|1
7746260|NCT00714415|12181283|FG001|Overall Study|Death|0
7746261|NCT00714493|12181289|FG000|Overall Study|Adverse Event|11
7746262|NCT00714493|12181289|FG000|Overall Study|Death|3
7746263|NCT00714493|12181289|FG000|Overall Study|Lack of Efficacy|10
7746264|NCT00714493|12181289|FG000|Overall Study|Lost to Follow-up|3
7746265|NCT00714493|12181289|FG000|Overall Study|Protocol Violation|12
7746266|NCT00714493|12181289|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
7746267|NCT00714493|12181289|FG000|Overall Study|OTHER|2
7746268|NCT00714688|12181321|FG000|Overall Study|Lack of Efficacy|14
7746269|NCT00714688|12181322|FG001|Overall Study|Lack of Efficacy|1
7746270|NCT00714688|12181323|FG002|Overall Study|Lack of Efficacy|4
7746271|NCT00714688|12181321|FG000|Overall Study|Withdrawal by Subject|4
7746272|NCT00714688|12181322|FG001|Overall Study|Withdrawal by Subject|3
7746273|NCT00714688|12181323|FG002|Overall Study|Withdrawal by Subject|3
7746274|NCT00714688|12181321|FG000|Overall Study|Lost to Follow-up|5
7746275|NCT00714688|12181322|FG001|Overall Study|Lost to Follow-up|2
7746276|NCT00714688|12181323|FG002|Overall Study|Lost to Follow-up|0
7746277|NCT00714688|12181321|FG000|Overall Study|Adverse Event|2
7746278|NCT00714688|12181322|FG001|Overall Study|Adverse Event|15
7746279|NCT00714688|12181323|FG002|Overall Study|Adverse Event|19
7746280|NCT00714688|12181321|FG000|Overall Study|Subject Non-compliant|3
7746281|NCT00714688|12181322|FG001|Overall Study|Subject Non-compliant|5
7746282|NCT00714688|12181323|FG002|Overall Study|Subject Non-compliant|5
7746283|NCT00714688|12181321|FG000|Overall Study|Ineligible to Continue the Study|0
7746284|NCT00714688|12181322|FG001|Overall Study|Ineligible to Continue the Study|1
7746285|NCT00714688|12181323|FG002|Overall Study|Ineligible to Continue the Study|1
7746286|NCT00714688|12181321|FG000|Overall Study|Sponsor's Decision|0
7746287|NCT00714688|12181322|FG001|Overall Study|Sponsor's Decision|2
7746288|NCT00714688|12181323|FG002|Overall Study|Sponsor's Decision|0
7746289|NCT00714688|12181321|FG000|Overall Study|Other|1
7746290|NCT00714688|12181322|FG001|Overall Study|Other|6
7746291|NCT00714688|12181323|FG002|Overall Study|Other|5
7746292|NCT00714714|12181331|FG000|Overall Study|Adverse Event|1
7746293|NCT00714870|12181352|FG000|Overall Study|Lost to Follow-up|22
7746294|NCT00714870|12181353|FG001|Overall Study|Lost to Follow-up|5
7746295|NCT00714870|12181352|FG000|Overall Study|patient unable to come b/c back pain|1
7746296|NCT00714870|12181353|FG001|Overall Study|patient unable to come b/c back pain|0
7746297|NCT00714870|12181352|FG000|Overall Study|did not attend minimum of 4 sessions|4
7746298|NCT00714870|12181353|FG001|Overall Study|did not attend minimum of 4 sessions|0
7746299|NCT00715026|12181359|FG000|Overall Study|Withdrawal by Subject|5
7746300|NCT00715026|12181359|FG000|Overall Study|Lost to Follow-up|3
7746301|NCT00715026|12181359|FG000|Overall Study|Protocol Violation|1
7746302|NCT00715026|12181359|FG000|Overall Study|Surgery done on non-study consented hip|1
7746303|NCT00715078|12181366|FG000|Overall Study|Death|29
7746304|NCT00715078|12181367|FG001|Overall Study|Death|36
7746305|NCT00715078|12181368|FG002|Overall Study|Death|36
7746306|NCT00715078|12181366|FG000|Overall Study|Withdrawal by Subject|1
7746307|NCT00715078|12181367|FG001|Overall Study|Withdrawal by Subject|0
7746308|NCT00715078|12181368|FG002|Overall Study|Withdrawal by Subject|1
7746309|NCT00715078|12181366|FG000|Overall Study|Unable to start due to disease prog.|0
7746310|NCT00715078|12181367|FG001|Overall Study|Unable to start due to disease prog.|0
7746311|NCT00715078|12181368|FG002|Overall Study|Unable to start due to disease prog.|1
7746312|NCT00715117|12181425|FG000|Overall Study|Crohn's flare and rescue with steroids|0
7746313|NCT00715117|12181426|FG001|Overall Study|Crohn's flare and rescue with steroids|1
7746314|NCT00715208|12181439|FG000|Overall Study|Withdrawal by Subject|1
7746315|NCT00715208|12181440|FG001|Overall Study|Withdrawal by Subject|1
7746316|NCT00715208|12181439|FG000|Overall Study|Adverse Event|0
7746317|NCT00715208|12181440|FG001|Overall Study|Adverse Event|6
7746318|NCT00715208|12181439|FG000|Overall Study|Lack of Efficacy|0
7746319|NCT00715208|12181440|FG001|Overall Study|Lack of Efficacy|2
7746320|NCT00715299|12181446|FG000|Overall Study|Withdrawal by Subject|1
7746321|NCT00715299|12181446|FG000|Overall Study|Adverse Event|3
7746322|NCT00715299|12181446|FG000|Overall Study|failed the pre-screen exercise test|2
7746323|NCT00715403|12181461|FG000|Overall Study|Progressive disease|0
7746324|NCT00715403|12181462|FG001|Overall Study|Progressive disease|1
7746325|NCT00715403|12181463|FG002|Overall Study|Progressive disease|3
7746326|NCT00715403|12181464|FG003|Overall Study|Progressive disease|9
7746327|NCT00715403|12181465|FG004|Overall Study|Progressive disease|5
7746328|NCT00715403|12181466|FG005|Overall Study|Progressive disease|14
7746329|NCT00715403|12181467|FG006|Overall Study|Progressive disease|1
7746330|NCT00715403|12181461|FG000|Overall Study|Dose limiting Toxicity (DLT)|0
7746331|NCT00715403|12181462|FG001|Overall Study|Dose limiting Toxicity (DLT)|0
7746332|NCT00715403|12181463|FG002|Overall Study|Dose limiting Toxicity (DLT)|0
7746333|NCT00715403|12181464|FG003|Overall Study|Dose limiting Toxicity (DLT)|0
7746334|NCT00715403|12181465|FG004|Overall Study|Dose limiting Toxicity (DLT)|0
7746335|NCT00715403|12181466|FG005|Overall Study|Dose limiting Toxicity (DLT)|1
7746336|NCT00715403|12181467|FG006|Overall Study|Dose limiting Toxicity (DLT)|0
7746337|NCT00715403|12181461|FG000|Overall Study|Other Adverse Event than DLT|1
7746338|NCT00715403|12181462|FG001|Overall Study|Other Adverse Event than DLT|0
7746339|NCT00715403|12181463|FG002|Overall Study|Other Adverse Event than DLT|0
7746340|NCT00715403|12181464|FG003|Overall Study|Other Adverse Event than DLT|0
7746341|NCT00715403|12181465|FG004|Overall Study|Other Adverse Event than DLT|0
7746342|NCT00715403|12181466|FG005|Overall Study|Other Adverse Event than DLT|2
7746343|NCT00715403|12181467|FG006|Overall Study|Other Adverse Event than DLT|0
7746344|NCT00715403|12181461|FG000|Overall Study|Protocol Violation|0
7746345|NCT00715403|12181462|FG001|Overall Study|Protocol Violation|0
7746346|NCT00715403|12181463|FG002|Overall Study|Protocol Violation|0
7746347|NCT00715403|12181464|FG003|Overall Study|Protocol Violation|0
7746348|NCT00715403|12181465|FG004|Overall Study|Protocol Violation|0
7746349|NCT00715403|12181466|FG005|Overall Study|Protocol Violation|1
7746350|NCT00715403|12181467|FG006|Overall Study|Protocol Violation|0
7746351|NCT00715403|12181461|FG000|Overall Study|Other reason not defined above|0
7746352|NCT00715403|12181462|FG001|Overall Study|Other reason not defined above|0
7746353|NCT00715403|12181463|FG002|Overall Study|Other reason not defined above|1
7746354|NCT00715403|12181464|FG003|Overall Study|Other reason not defined above|0
7746355|NCT00715403|12181465|FG004|Overall Study|Other reason not defined above|1
7746356|NCT00715403|12181466|FG005|Overall Study|Other reason not defined above|1
7746357|NCT00715403|12181467|FG006|Overall Study|Other reason not defined above|0
7746358|NCT00715429|12181485|FG000|Overall Study|Did not complete the study diary|0
7746359|NCT00715429|12181486|FG001|Overall Study|Did not complete the study diary|1
7746360|NCT00715520|12181495|FG000|Overall Study|Screen failure|8
7746361|NCT00715520|12181496|FG001|Overall Study|Screen failure|1
7746362|NCT00715520|12181497|FG002|Overall Study|Screen failure|1
7746363|NCT00715520|12181495|FG000|Overall Study|Withdrawal by Subject|2
7746364|NCT00715520|12181496|FG001|Overall Study|Withdrawal by Subject|0
7746365|NCT00715520|12181497|FG002|Overall Study|Withdrawal by Subject|1
7746366|NCT00715559|12181505|FG000|Overall Study|medication not tolerated - nausea|1
7746367|NCT00715624|12181511|FG000|Overall Study|Adverse Event|12
7746368|NCT00715624|12181512|FG001|Overall Study|Adverse Event|37
7746369|NCT00715624|12181511|FG000|Overall Study|Lack of Efficacy|11
7746370|NCT00715624|12181512|FG001|Overall Study|Lack of Efficacy|11
7746371|NCT00715624|12181511|FG000|Overall Study|Lost to Follow-up|1
7746372|NCT00715624|12181512|FG001|Overall Study|Lost to Follow-up|2
7746373|NCT00715624|12181511|FG000|Overall Study|Protocol Violation|1
7746374|NCT00715624|12181512|FG001|Overall Study|Protocol Violation|0
7746375|NCT00715624|12181511|FG000|Overall Study|Withdrawal by Subject|11
7746376|NCT00715624|12181512|FG001|Overall Study|Withdrawal by Subject|25
7746377|NCT00715624|12181511|FG000|Overall Study|Familial and personal reasons|10
7746378|NCT00715624|12181512|FG001|Overall Study|Familial and personal reasons|22
7746379|NCT00715624|12181511|FG000|Overall Study|Poor compliance|6
7746380|NCT00715624|12181512|FG001|Overall Study|Poor compliance|13
7746381|NCT00715624|12181511|FG000|Overall Study|Sponsor decision|0
7746382|NCT00715624|12181512|FG001|Overall Study|Sponsor decision|4
7746383|NCT00715624|12181511|FG000|Overall Study|Incorrect randomization (not treated)|0
7746384|NCT00715624|12181512|FG001|Overall Study|Incorrect randomization (not treated)|1
7746385|NCT00715624|12181511|FG000|Overall Study|Other|0
7746386|NCT00715624|12181512|FG001|Overall Study|Other|1
7746387|NCT00715676|12181530|FG000|Overall Study|Adverse Event|3
7746388|NCT00715676|12181531|FG001|Overall Study|Adverse Event|5
7746389|NCT00715676|12181532|FG002|Overall Study|Adverse Event|21
7746390|NCT00715676|12181530|FG000|Overall Study|Withdrawal by Subject|1
7746391|NCT00715676|12181531|FG001|Overall Study|Withdrawal by Subject|3
7746392|NCT00715676|12181532|FG002|Overall Study|Withdrawal by Subject|8
7746393|NCT00715676|12181530|FG000|Overall Study|Lost to Follow-up|1
7746394|NCT00715676|12181531|FG001|Overall Study|Lost to Follow-up|2
7746395|NCT00715676|12181532|FG002|Overall Study|Lost to Follow-up|1
7746396|NCT00715676|12181530|FG000|Overall Study|Terminated by Sponsor|1
7746397|NCT00715676|12181531|FG001|Overall Study|Terminated by Sponsor|0
7746398|NCT00715676|12181532|FG002|Overall Study|Terminated by Sponsor|0
7746399|NCT00715676|12181530|FG000|Overall Study|Did Not Meet Entry Criteria|0
7746400|NCT00715676|12181531|FG001|Overall Study|Did Not Meet Entry Criteria|0
7746401|NCT00715676|12181532|FG002|Overall Study|Did Not Meet Entry Criteria|1
7746402|NCT00715676|12181530|FG000|Overall Study|Use of Exclusionary Medication|0
7746403|NCT00715676|12181531|FG001|Overall Study|Use of Exclusionary Medication|0
7746404|NCT00715676|12181532|FG002|Overall Study|Use of Exclusionary Medication|1
7746405|NCT00715676|12181530|FG000|Overall Study|Elevated Blood Glucose|0
7746406|NCT00715676|12181531|FG001|Overall Study|Elevated Blood Glucose|1
7746407|NCT00715676|12181532|FG002|Overall Study|Elevated Blood Glucose|0
7746408|NCT00715793|12181572|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
7746409|NCT00715793|12181573|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
7746410|NCT00715793|12181572|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
7746411|NCT00715793|12181573|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
7746412|NCT00715910|12181593|FG000|Booster and ESFU Phase|Lost to Follow-up|0
7746413|NCT00715910|12181594|FG001|Booster and ESFU Phase|Lost to Follow-up|0
7746414|NCT00715910|12181595|FG002|Booster and ESFU Phase|Lost to Follow-up|0
7746415|NCT00715910|12181596|FG003|Booster and ESFU Phase|Lost to Follow-up|6
7746416|NCT00715910|12181597|FG004|Booster and ESFU Phase|Lost to Follow-up|1
7746417|NCT00715910|12181598|FG005|Booster and ESFU Phase|Lost to Follow-up|13
7746418|NCT00715910|12181593|FG000|Booster and ESFU Phase|Other|0
7746419|NCT00715910|12181594|FG001|Booster and ESFU Phase|Other|0
7746420|NCT00715910|12181595|FG002|Booster and ESFU Phase|Other|0
7746421|NCT00715910|12181596|FG003|Booster and ESFU Phase|Other|5
7746422|NCT00715910|12181597|FG004|Booster and ESFU Phase|Other|1
7746423|NCT00715910|12181598|FG005|Booster and ESFU Phase|Other|0
7769411|NCT00868790|12213067|FG009|Period 1|Lost to Follow-up|0
7769412|NCT00868790|12213068|FG010|Period 1|Lost to Follow-up|0
7769413|NCT00868790|12213069|FG011|Period 1|Lost to Follow-up|0
7769414|NCT00868790|12213070|FG012|Period 1|Lost to Follow-up|0
7769415|NCT00868790|12213071|FG013|Period 1|Lost to Follow-up|0
7769416|NCT00868790|12213058|FG000|Period 2|Adverse Event|0
7769417|NCT00868790|12213059|FG001|Period 2|Adverse Event|0
7769418|NCT00868790|12213060|FG002|Period 2|Adverse Event|0
7769419|NCT00868790|12213061|FG003|Period 2|Adverse Event|0
7769420|NCT00868790|12213062|FG004|Period 2|Adverse Event|0
7769421|NCT00868790|12213063|FG005|Period 2|Adverse Event|0
7769422|NCT00868790|12213064|FG006|Period 2|Adverse Event|0
7769423|NCT00868790|12213065|FG007|Period 2|Adverse Event|0
7769424|NCT00868790|12213066|FG008|Period 2|Adverse Event|1
7769425|NCT00868790|12213067|FG009|Period 2|Adverse Event|0
7769426|NCT00868790|12213068|FG010|Period 2|Adverse Event|0
7769427|NCT00868790|12213069|FG011|Period 2|Adverse Event|0
7769428|NCT00868790|12213070|FG012|Period 2|Adverse Event|0
7769429|NCT00868790|12213071|FG013|Period 2|Adverse Event|0
7769430|NCT00868790|12213058|FG000|Period 2|Lost to Follow-up|0
7769431|NCT00868790|12213059|FG001|Period 2|Lost to Follow-up|1
7769432|NCT00868790|12213060|FG002|Period 2|Lost to Follow-up|0
7746424|NCT00715949|12181614|FG000|Overall Study|could not finish first test|4
7746425|NCT00716092|12181640|FG000|Overall Study|Other incl. Lack of Efficacy|2
7746426|NCT00716092|12181641|FG001|Overall Study|Other incl. Lack of Efficacy|1
7746427|NCT00716092|12181642|FG002|Overall Study|Other incl. Lack of Efficacy|0
7746428|NCT00716144|12181654|FG000|Overall Study|Withdrawal by Subject|4
7746429|NCT00716144|12181655|FG001|Overall Study|Withdrawal by Subject|2
7746430|NCT00716144|12181656|FG002|Overall Study|Withdrawal by Subject|6
7746431|NCT00716144|12181657|FG003|Overall Study|Withdrawal by Subject|6
7746432|NCT00716144|12181654|FG000|Overall Study|Lost to Follow-up|2
7746433|NCT00716144|12181655|FG001|Overall Study|Lost to Follow-up|2
7746434|NCT00716144|12181656|FG002|Overall Study|Lost to Follow-up|1
7746435|NCT00716144|12181657|FG003|Overall Study|Lost to Follow-up|2
7746436|NCT00716144|12181654|FG000|Overall Study|Adverse Event|0
7746437|NCT00716144|12181655|FG001|Overall Study|Adverse Event|0
7746438|NCT00716144|12181656|FG002|Overall Study|Adverse Event|0
7746439|NCT00716144|12181657|FG003|Overall Study|Adverse Event|2
7746440|NCT00716144|12181654|FG000|Overall Study|Non-compliance|1
7746441|NCT00716144|12181655|FG001|Overall Study|Non-compliance|0
7746442|NCT00716144|12181656|FG002|Overall Study|Non-compliance|0
7746443|NCT00716144|12181657|FG003|Overall Study|Non-compliance|0
7746444|NCT00716144|12181654|FG000|Overall Study|Protocol Violation|2
7746445|NCT00716144|12181655|FG001|Overall Study|Protocol Violation|0
7746446|NCT00716144|12181656|FG002|Overall Study|Protocol Violation|1
7746447|NCT00716144|12181657|FG003|Overall Study|Protocol Violation|0
7746448|NCT00716144|12181654|FG000|Overall Study|Physician Decision|0
7746449|NCT00716144|12181655|FG001|Overall Study|Physician Decision|1
7746450|NCT00716144|12181656|FG002|Overall Study|Physician Decision|2
7746451|NCT00716144|12181657|FG003|Overall Study|Physician Decision|2
7746452|NCT00716144|12181654|FG000|Overall Study|Intercurrent illness|0
7746453|NCT00716144|12181655|FG001|Overall Study|Intercurrent illness|0
7746454|NCT00716144|12181656|FG002|Overall Study|Intercurrent illness|1
7746455|NCT00716144|12181657|FG003|Overall Study|Intercurrent illness|0
7746456|NCT00716144|12181654|FG000|Overall Study|Withdrew consent, allowed use of data|0
7746457|NCT00716144|12181655|FG001|Overall Study|Withdrew consent, allowed use of data|0
7746458|NCT00716144|12181656|FG002|Overall Study|Withdrew consent, allowed use of data|1
7746459|NCT00716144|12181657|FG003|Overall Study|Withdrew consent, allowed use of data|0
7746460|NCT00716144|12181654|FG000|Overall Study|Adverse event: left foot pain|0
7746461|NCT00716144|12181655|FG001|Overall Study|Adverse event: left foot pain|1
7746462|NCT00716144|12181656|FG002|Overall Study|Adverse event: left foot pain|0
7746463|NCT00716144|12181657|FG003|Overall Study|Adverse event: left foot pain|0
7746464|NCT00716144|12181654|FG000|Overall Study|Clinical Depression|0
7746465|NCT00716144|12181655|FG001|Overall Study|Clinical Depression|1
7746466|NCT00716144|12181656|FG002|Overall Study|Clinical Depression|0
7746467|NCT00716144|12181657|FG003|Overall Study|Clinical Depression|0
7746468|NCT00716274|12181670|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2
7746469|NCT00716274|12181671|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0
7746470|NCT00716274|12181672|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0
7746471|NCT00716274|12181673|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0
7746472|NCT00716274|12181674|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0
7746473|NCT00716274|12181675|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0
7746474|NCT00716274|12181670|FG000|Study Period II (16-Weeks)|Protocol Violation|0
7746475|NCT00716274|12181671|FG001|Study Period II (16-Weeks)|Protocol Violation|3
7746476|NCT00716274|12181672|FG002|Study Period II (16-Weeks)|Protocol Violation|0
7746477|NCT00716274|12181673|FG003|Study Period II (16-Weeks)|Protocol Violation|0
7746478|NCT00716274|12181674|FG004|Study Period II (16-Weeks)|Protocol Violation|0
7746479|NCT00716274|12181675|FG005|Study Period II (16-Weeks)|Protocol Violation|1
7746480|NCT00716274|12181670|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1
7746481|NCT00716274|12181671|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0
7746482|NCT00716274|12181672|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0
7746483|NCT00716274|12181673|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0
7746484|NCT00716274|12181674|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0
7746485|NCT00716274|12181675|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0
7746486|NCT00716274|12181670|FG000|Study Period II (16-Weeks)|Physician Decision|3
7746487|NCT00716274|12181671|FG001|Study Period II (16-Weeks)|Physician Decision|1
7746488|NCT00716274|12181672|FG002|Study Period II (16-Weeks)|Physician Decision|0
7746489|NCT00716274|12181673|FG003|Study Period II (16-Weeks)|Physician Decision|0
7746490|NCT00716274|12181674|FG004|Study Period II (16-Weeks)|Physician Decision|0
7746491|NCT00716274|12181675|FG005|Study Period II (16-Weeks)|Physician Decision|1
7746492|NCT00716274|12181670|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
7746493|NCT00716274|12181671|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
7746494|NCT00716274|12181672|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
7746495|NCT00716274|12181673|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
7746496|NCT00716274|12181674|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
7746497|NCT00716274|12181675|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
7746498|NCT00716274|12181670|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0
7746499|NCT00716274|12181671|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2
7746500|NCT00716274|12181672|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0
7746501|NCT00716274|12181673|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0
7746502|NCT00716274|12181674|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0
7746503|NCT00716274|12181675|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0
7746504|NCT00716274|12181670|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0
7746505|NCT00716274|12181671|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0
7746506|NCT00716274|12181672|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2
7746507|NCT00716274|12181673|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0
7746508|NCT00716274|12181674|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0
7746509|NCT00716274|12181675|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0
7746510|NCT00716274|12181670|FG000|Study Period III (16-Weeks)|Physician Decision|0
7746511|NCT00716274|12181671|FG001|Study Period III (16-Weeks)|Physician Decision|0
7746512|NCT00716274|12181672|FG002|Study Period III (16-Weeks)|Physician Decision|0
7746513|NCT00716274|12181673|FG003|Study Period III (16-Weeks)|Physician Decision|0
7746514|NCT00716274|12181674|FG004|Study Period III (16-Weeks)|Physician Decision|1
7746515|NCT00716274|12181675|FG005|Study Period III (16-Weeks)|Physician Decision|0
7746516|NCT00716274|12181670|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0
7746517|NCT00716274|12181671|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0
7746518|NCT00716274|12181672|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0
7746519|NCT00716274|12181673|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1
7746520|NCT00716274|12181674|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1
7746521|NCT00716274|12181675|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0
7746522|NCT00716274|12181670|FG000|Study Period III (16-Weeks)|Adverse Event|0
7746523|NCT00716274|12181671|FG001|Study Period III (16-Weeks)|Adverse Event|0
7746524|NCT00716274|12181672|FG002|Study Period III (16-Weeks)|Adverse Event|0
7746525|NCT00716274|12181673|FG003|Study Period III (16-Weeks)|Adverse Event|0
7746526|NCT00716274|12181674|FG004|Study Period III (16-Weeks)|Adverse Event|1
7746527|NCT00716274|12181675|FG005|Study Period III (16-Weeks)|Adverse Event|0
7746528|NCT00716417|12181702|FG000|Overall Study|Adverse Event|0
7746529|NCT00716417|12181703|FG001|Overall Study|Adverse Event|0
7746530|NCT00716417|12181704|FG002|Overall Study|Adverse Event|2
7746531|NCT00716417|12181705|FG003|Overall Study|Adverse Event|1
7746532|NCT00716417|12181706|FG004|Overall Study|Adverse Event|0
7746533|NCT00716417|12181707|FG005|Overall Study|Adverse Event|0
7746534|NCT00716417|12181708|FG006|Overall Study|Adverse Event|3
7746535|NCT00716417|12181709|FG007|Overall Study|Adverse Event|1
7746536|NCT00716417|12181710|FG008|Overall Study|Adverse Event|0
7746537|NCT00716417|12181711|FG009|Overall Study|Adverse Event|3
7746538|NCT00716417|12181702|FG000|Overall Study|Withdrawal by Subject|0
7746539|NCT00716417|12181703|FG001|Overall Study|Withdrawal by Subject|1
7746540|NCT00716417|12181704|FG002|Overall Study|Withdrawal by Subject|0
7746541|NCT00716417|12181705|FG003|Overall Study|Withdrawal by Subject|2
7746542|NCT00716417|12181706|FG004|Overall Study|Withdrawal by Subject|0
7746543|NCT00716417|12181707|FG005|Overall Study|Withdrawal by Subject|0
7746544|NCT00716417|12181708|FG006|Overall Study|Withdrawal by Subject|1
7746545|NCT00716417|12181709|FG007|Overall Study|Withdrawal by Subject|0
7746546|NCT00716417|12181710|FG008|Overall Study|Withdrawal by Subject|0
7746547|NCT00716417|12181711|FG009|Overall Study|Withdrawal by Subject|0
7746548|NCT00716417|12181702|FG000|Overall Study|Progressive disease|3
7746549|NCT00716417|12181703|FG001|Overall Study|Progressive disease|5
7746550|NCT00716417|12181704|FG002|Overall Study|Progressive disease|3
7746551|NCT00716417|12181705|FG003|Overall Study|Progressive disease|8
7746552|NCT00716417|12181706|FG004|Overall Study|Progressive disease|0
7746553|NCT00716417|12181707|FG005|Overall Study|Progressive disease|3
7746554|NCT00716417|12181708|FG006|Overall Study|Progressive disease|3
7746555|NCT00716417|12181709|FG007|Overall Study|Progressive disease|1
7746556|NCT00716417|12181710|FG008|Overall Study|Progressive disease|5
7746557|NCT00716417|12181711|FG009|Overall Study|Progressive disease|0
7746558|NCT00716417|12181702|FG000|Overall Study|Dose limiting toxicity (DLT)|0
7746559|NCT00716417|12181703|FG001|Overall Study|Dose limiting toxicity (DLT)|0
7746560|NCT00716417|12181704|FG002|Overall Study|Dose limiting toxicity (DLT)|0
7746561|NCT00716417|12181705|FG003|Overall Study|Dose limiting toxicity (DLT)|0
7746562|NCT00716417|12181706|FG004|Overall Study|Dose limiting toxicity (DLT)|1
7746563|NCT00716417|12181707|FG005|Overall Study|Dose limiting toxicity (DLT)|0
7746564|NCT00716417|12181708|FG006|Overall Study|Dose limiting toxicity (DLT)|0
7746565|NCT00716417|12181709|FG007|Overall Study|Dose limiting toxicity (DLT)|0
7746566|NCT00716417|12181710|FG008|Overall Study|Dose limiting toxicity (DLT)|0
7746567|NCT00716417|12181711|FG009|Overall Study|Dose limiting toxicity (DLT)|0
7746568|NCT00716417|12181702|FG000|Overall Study|On patient request due to toxicities|0
7746569|NCT00716417|12181703|FG001|Overall Study|On patient request due to toxicities|0
7746570|NCT00716417|12181704|FG002|Overall Study|On patient request due to toxicities|0
7746571|NCT00716417|12181705|FG003|Overall Study|On patient request due to toxicities|0
7746572|NCT00716417|12181706|FG004|Overall Study|On patient request due to toxicities|0
7746573|NCT00716417|12181707|FG005|Overall Study|On patient request due to toxicities|0
7746574|NCT00716417|12181708|FG006|Overall Study|On patient request due to toxicities|0
7746575|NCT00716417|12181709|FG007|Overall Study|On patient request due to toxicities|1
7746576|NCT00716417|12181710|FG008|Overall Study|On patient request due to toxicities|0
7746577|NCT00716417|12181711|FG009|Overall Study|On patient request due to toxicities|0
7746578|NCT00716456|12181738|FG000|Overall Study|Adverse Event|0
7746579|NCT00716456|12181739|FG001|Overall Study|Adverse Event|2
7746580|NCT00716456|12181740|FG002|Overall Study|Adverse Event|0
7746581|NCT00716482|12181748|FG000|Overall Study|Lost to Follow-up|6
7746582|NCT00716482|12181748|FG000|Overall Study|Inadequate acquisition or analysis|50
7746583|NCT00716482|12181748|FG000|Overall Study|no pathology obtained|10
7746584|NCT00716482|12181748|FG000|Overall Study|technical/machine error|28
7746585|NCT00716482|12181748|FG000|Overall Study|inclusion/exclusion criteria not met|25
7746586|NCT00716625|12181763|FG000|Overall Study|Safety was not Assessable|1
7746587|NCT00716859|12181821|FG000|Overall Study|Adverse Event|4
7746588|NCT00716859|12181822|FG001|Overall Study|Adverse Event|1
7746589|NCT00716859|12181821|FG000|Overall Study|Lack of Efficacy|3
7746590|NCT00716859|12181822|FG001|Overall Study|Lack of Efficacy|0
7746591|NCT00716859|12181821|FG000|Overall Study|Withdrawal by Subject|1
7746592|NCT00716859|12181822|FG001|Overall Study|Withdrawal by Subject|3
7746593|NCT00716859|12181821|FG000|Overall Study|Not treated|1
7746594|NCT00716859|12181822|FG001|Overall Study|Not treated|1
7746595|NCT00716976|12181843|FG000|Overall Study|Adverse Event|2
7746596|NCT00716976|12181844|FG001|Overall Study|Adverse Event|0
7746597|NCT00716976|12181843|FG000|Overall Study|Death|1
7746598|NCT00716976|12181844|FG001|Overall Study|Death|0
7746599|NCT00716976|12181843|FG000|Overall Study|Physician Decision|2
7746600|NCT00716976|12181844|FG001|Overall Study|Physician Decision|2
7746601|NCT00716976|12181843|FG000|Overall Study|Withdrawal by Subject|5
7746602|NCT00716976|12181844|FG001|Overall Study|Withdrawal by Subject|1
7746603|NCT00716976|12181843|FG000|Overall Study|Premature discontinuation cisplatin|5
7746604|NCT00716976|12181844|FG001|Overall Study|Premature discontinuation cisplatin|4
7746605|NCT00716976|12181843|FG000|Overall Study|Radiation during protocol|1
7746606|NCT00716976|12181844|FG001|Overall Study|Radiation during protocol|0
7746607|NCT00716976|12181843|FG000|Overall Study|Ineligibles|4
7746608|NCT00716976|12181844|FG001|Overall Study|Ineligibles|2
7746609|NCT00717067|12181873|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
7746610|NCT00717067|12181874|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
7746611|NCT00717067|12181875|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
7746612|NCT00717067|12181876|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
7746613|NCT00717067|12181877|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
7746614|NCT00717093|12181901|FG000|Overall Study|Adverse Event|19
7746615|NCT00717093|12181902|FG001|Overall Study|Adverse Event|9
7746616|NCT00717093|12181901|FG000|Overall Study|Lack of Efficacy|3
7746617|NCT00717093|12181902|FG001|Overall Study|Lack of Efficacy|13
7746618|NCT00717093|12181901|FG000|Overall Study|Lost to Follow-up|9
7746619|NCT00717093|12181902|FG001|Overall Study|Lost to Follow-up|6
7746620|NCT00717093|12181901|FG000|Overall Study|Withdrawal by Subject|12
7746621|NCT00717093|12181902|FG001|Overall Study|Withdrawal by Subject|19
7746622|NCT00717093|12181901|FG000|Overall Study|Other|0
7746623|NCT00717093|12181902|FG001|Overall Study|Other|1
7746624|NCT00717093|12181901|FG000|Overall Study|Randomized but not treated|1
7746625|NCT00717093|12181902|FG001|Overall Study|Randomized but not treated|0
7746626|NCT00717197|12181908|FG000|Overall Study|Unable to purchase study drug|5
7746627|NCT00717197|12181908|FG000|Overall Study|Tumor Progression|1
7746628|NCT00717197|12181908|FG000|Overall Study|Physician Decision|1
7746629|NCT00717236|12181914|FG000|Double-Blind Period|Adverse Event|33
7746630|NCT00717236|12181915|FG001|Double-Blind Period|Adverse Event|6
7746631|NCT00717236|12181914|FG000|Double-Blind Period|Lack of Efficacy|6
7746632|NCT00717236|12181915|FG001|Double-Blind Period|Lack of Efficacy|6
7746633|NCT00717236|12181914|FG000|Double-Blind Period|Lost to Follow-up|3
7746634|NCT00717236|12181915|FG001|Double-Blind Period|Lost to Follow-up|5
7746635|NCT00717236|12181914|FG000|Double-Blind Period|Withdrawal by Subject|10
7746636|NCT00717236|12181915|FG001|Double-Blind Period|Withdrawal by Subject|2
7746637|NCT00717236|12181914|FG000|Double-Blind Period|Loss of efficacy|3
7746638|NCT00717236|12181915|FG001|Double-Blind Period|Loss of efficacy|0
7746639|NCT00717236|12181914|FG000|Double-Blind Period|Other: Death|1
7746640|NCT00717236|12181915|FG001|Double-Blind Period|Other: Death|0
7746641|NCT00717236|12181914|FG000|Double-Blind Period|Other: Pregnancy|1
7746642|NCT00717236|12181915|FG001|Double-Blind Period|Other: Pregnancy|0
7746643|NCT00717236|12181914|FG000|Double-Blind Period|Other: Protocol Violation|2
7746644|NCT00717236|12181915|FG001|Double-Blind Period|Other: Protocol Violation|0
7746645|NCT00717236|12181914|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
7746646|NCT00717236|12181915|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
7746647|NCT00717236|12181914|FG000|Double-Blind Period|Other: Site withdrew|2
7746648|NCT00717236|12181915|FG001|Double-Blind Period|Other: Site withdrew|0
7746649|NCT00717236|12181914|FG000|Double-Blind Period|Other: Screening failure|1
7746650|NCT00717236|12181915|FG001|Double-Blind Period|Other: Screening failure|0
7746651|NCT00717236|12181914|FG000|Double-Blind Period|Other: subject withdrew consent|1
7746652|NCT00717236|12181915|FG001|Double-Blind Period|Other: subject withdrew consent|1
7746653|NCT00717236|12181914|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2
7746654|NCT00717236|12181915|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1
7746655|NCT00717236|12181914|FG000|Double-Blind Period|Other: History of adenoid grown|1
7746656|NCT00717236|12181915|FG001|Double-Blind Period|Other: History of adenoid grown|0
7746657|NCT00717236|12181914|FG000|Double-Blind Period|Other: History of cancer|1
7746658|NCT00717236|12181915|FG001|Double-Blind Period|Other: History of cancer|0
7746659|NCT00717236|12181914|FG000|Double-Blind Period|Other: Sponsor request|1
7746660|NCT00717236|12181915|FG001|Double-Blind Period|Other: Sponsor request|0
7746661|NCT00717236|12181914|FG000|Double-Blind Period|Other: Inappropriate randomization|1
7746662|NCT00717236|12181915|FG001|Double-Blind Period|Other: Inappropriate randomization|0
7746663|NCT00717236|12181914|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
7746664|NCT00717236|12181915|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
7746665|NCT00717236|12181914|FG000|Double-Blind Period|Other: Subject moved|1
7746666|NCT00717236|12181915|FG001|Double-Blind Period|Other: Subject moved|1
7746667|NCT00717236|12181914|FG000|Double-Blind Period|Other: Stopped taking DMARD|1
7746668|NCT00717236|12181915|FG001|Double-Blind Period|Other: Stopped taking DMARD|0
7746669|NCT00717236|12181914|FG000|Double-Blind Period|Other: Prohibited medication taken|2
7746670|NCT00717236|12181915|FG001|Double-Blind Period|Other: Prohibited medication taken|2
7746671|NCT00717236|12181914|FG000|Double-Blind Period|Other: Transportation problems|0
7746672|NCT00717236|12181915|FG001|Double-Blind Period|Other: Transportation problems|1
7746673|NCT00717236|12181914|FG000|Double-Blind Period|Other: Investigator Decision|0
7746674|NCT00717236|12181915|FG001|Double-Blind Period|Other: Investigator Decision|1
7746675|NCT00717236|12181914|FG000|Open-Label Period|Adverse Event|29
7746676|NCT00717236|12181915|FG001|Open-Label Period|Adverse Event|4
7746677|NCT00717236|12181914|FG000|Open-Label Period|Lack of Efficacy|30
7746678|NCT00717236|12181915|FG001|Open-Label Period|Lack of Efficacy|8
7746679|NCT00717236|12181914|FG000|Open-Label Period|Lost to Follow-up|28
7746680|NCT00717236|12181915|FG001|Open-Label Period|Lost to Follow-up|4
7746681|NCT00717236|12181914|FG000|Open-Label Period|Withdrawal by Subject|20
7746682|NCT00717236|12181915|FG001|Open-Label Period|Withdrawal by Subject|2
7746683|NCT00717236|12181914|FG000|Open-Label Period|Loss of Efficacy|6
7746684|NCT00717236|12181915|FG001|Open-Label Period|Loss of Efficacy|1
7746685|NCT00717236|12181914|FG000|Open-Label Period|Other: Peripheral Neuropathy|0
7746686|NCT00717236|12181915|FG001|Open-Label Period|Other: Peripheral Neuropathy|1
7746687|NCT00717236|12181914|FG000|Open-Label Period|Other: Lack of Compliance|1
7746688|NCT00717236|12181915|FG001|Open-Label Period|Other: Lack of Compliance|1
7746689|NCT00717236|12181914|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1
7746690|NCT00717236|12181915|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0
7746691|NCT00717236|12181914|FG000|Open-Label Period|Other: Moved|1
7746692|NCT00717236|12181915|FG001|Open-Label Period|Other: Moved|0
7746693|NCT00717236|12181914|FG000|Open-Label Period|Other: Investigator Decision|1
7746694|NCT00717236|12181915|FG001|Open-Label Period|Other: Investigator Decision|0
7746695|NCT00717236|12181914|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1
7746696|NCT00717236|12181915|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0
7746697|NCT00717236|12181914|FG000|Open-Label Period|Other: Sponsor Request|3
7746698|NCT00717236|12181915|FG001|Open-Label Period|Other: Sponsor Request|0
7746699|NCT00717236|12181914|FG000|Open-Label Period|Other: Cataract Surgery|1
7746700|NCT00717236|12181915|FG001|Open-Label Period|Other: Cataract Surgery|0
7746701|NCT00717236|12181914|FG000|Open-Label Period|Other: Administration of Golimumab|1
7746702|NCT00717236|12181915|FG001|Open-Label Period|Other: Administration of Golimumab|0
7746703|NCT00717236|12181914|FG000|Open-Label Period|Other: Completion Accidently Performed|1
7746704|NCT00717236|12181915|FG001|Open-Label Period|Other: Completion Accidently Performed|0
7746705|NCT00717236|12181914|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1
7746706|NCT00717236|12181915|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0
7746707|NCT00717249|12181925|FG000|Overall Study|Lens Discomfort|4
7746708|NCT00717249|12181926|FG001|Overall Study|Lens Discomfort|1
7746709|NCT00717249|12181925|FG000|Overall Study|Unsatisfactory visual Response|0
7746710|NCT00717249|12181926|FG001|Overall Study|Unsatisfactory visual Response|2
7746711|NCT00717249|12181925|FG000|Overall Study|Adverse Event|4
7746712|NCT00717249|12181926|FG001|Overall Study|Adverse Event|2
7746713|NCT00717249|12181925|FG000|Overall Study|Lost to Follow-up|2
7746714|NCT00717249|12181926|FG001|Overall Study|Lost to Follow-up|0
7746715|NCT00717249|12181925|FG000|Overall Study|Withdrawal by Subject|1
7746716|NCT00717249|12181926|FG001|Overall Study|Withdrawal by Subject|2
7746717|NCT00717249|12181925|FG000|Overall Study|Pregnancy|6
7746718|NCT00717249|12181926|FG001|Overall Study|Pregnancy|3
7746719|NCT00717249|12181925|FG000|Overall Study|Protocol Violation|0
7746720|NCT00717249|12181926|FG001|Overall Study|Protocol Violation|2
7746721|NCT00717249|12181925|FG000|Overall Study|Subject became Ineligible|1
7746722|NCT00717249|12181926|FG001|Overall Study|Subject became Ineligible|1
7746723|NCT00717249|12181925|FG000|Overall Study|Unsatisfactory Physiological Response|0
7746724|NCT00717249|12181926|FG001|Overall Study|Unsatisfactory Physiological Response|1
7746725|NCT00717249|12181925|FG000|Overall Study|Gastric Surgery|0
7746726|NCT00717249|12181926|FG001|Overall Study|Gastric Surgery|1
7746727|NCT00717249|12181925|FG000|Overall Study|Diagnosed with Diabetes|1
7746728|NCT00717249|12181926|FG001|Overall Study|Diagnosed with Diabetes|0
7746729|NCT00717249|12181925|FG000|Overall Study|Diagnosed with Multiple Scletosis|1
7746730|NCT00717249|12181926|FG001|Overall Study|Diagnosed with Multiple Scletosis|0
7746731|NCT00717249|12181925|FG000|Overall Study|Subject relocated|1
7746732|NCT00717249|12181926|FG001|Overall Study|Subject relocated|0
7746733|NCT00717249|12181925|FG000|Overall Study|Headaches|1
7746734|NCT00717249|12181926|FG001|Overall Study|Headaches|0
7746735|NCT00717314|12181953|FG000|Overall Study|Adverse Event|3
7746736|NCT00717314|12181954|FG001|Overall Study|Adverse Event|2
7746737|NCT00717314|12181953|FG000|Overall Study|Protocol Violation|1
7746738|NCT00717314|12181954|FG001|Overall Study|Protocol Violation|0
7746739|NCT00717314|12181953|FG000|Overall Study|Lost to Follow-up|1
7746740|NCT00717314|12181954|FG001|Overall Study|Lost to Follow-up|5
7746741|NCT00717314|12181953|FG000|Overall Study|Withdrawal by Subject|1
7746742|NCT00717314|12181954|FG001|Overall Study|Withdrawal by Subject|3
7746743|NCT00717366|12181962|FG000|Core Study Period (20 Weeks)|Renal transplant|4
7746744|NCT00717366|12181963|FG001|Core Study Period (20 Weeks)|Renal transplant|9
7746745|NCT00717366|12181962|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0
7746746|NCT00717366|12181963|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2
7746747|NCT00717366|12181962|FG000|Core Study Period (20 Weeks)|Death|0
7746748|NCT00717366|12181963|FG001|Core Study Period (20 Weeks)|Death|1
7746749|NCT00717366|12181962|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
7746750|NCT00717366|12181963|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
7746751|NCT00717366|12181962|FG000|Extension Period (52 Weeks)|Renal transplant|3
7746752|NCT00717366|12181963|FG001|Extension Period (52 Weeks)|Renal transplant|13
7746753|NCT00717366|12181962|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0
7746754|NCT00717366|12181963|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2
7746755|NCT00717366|12181962|FG000|Extension Period (52 Weeks)|Withdrew consent|1
7746756|NCT00717366|12181963|FG001|Extension Period (52 Weeks)|Withdrew consent|1
7746757|NCT00717522|12181984|FG000|Overall Study|Disease Progression|5
7746758|NCT00717522|12181984|FG000|Overall Study|Adverse Event|1
7746759|NCT00717522|12181984|FG000|Overall Study|Death|1
7746760|NCT00717756|12182001|FG000|Overall Study|Withdrawal by Subject|1
7746761|NCT00717769|12182008|FG000|Overall Study|Adverse Event|9
7746762|NCT00717769|12182009|FG001|Overall Study|Adverse Event|6
7746763|NCT00717769|12182010|FG002|Overall Study|Adverse Event|1
7746764|NCT00717769|12182008|FG000|Overall Study|Lack of compliance|0
7746765|NCT00717769|12182009|FG001|Overall Study|Lack of compliance|2
7746766|NCT00717769|12182010|FG002|Overall Study|Lack of compliance|0
7746767|NCT00717769|12182008|FG000|Overall Study|Lost to Follow-up|3
7746768|NCT00717769|12182009|FG001|Overall Study|Lost to Follow-up|4
7746769|NCT00717769|12182010|FG002|Overall Study|Lost to Follow-up|0
7746770|NCT00717769|12182008|FG000|Overall Study|Lack of Efficacy|1
7746771|NCT00717769|12182009|FG001|Overall Study|Lack of Efficacy|2
7746772|NCT00717769|12182010|FG002|Overall Study|Lack of Efficacy|0
7746773|NCT00717769|12182008|FG000|Overall Study|Protocol Violation|0
7746774|NCT00717769|12182009|FG001|Overall Study|Protocol Violation|2
7746775|NCT00717769|12182010|FG002|Overall Study|Protocol Violation|0
7746776|NCT00717769|12182008|FG000|Overall Study|Sponsor decision|1
7746777|NCT00717769|12182009|FG001|Overall Study|Sponsor decision|0
7746778|NCT00717769|12182010|FG002|Overall Study|Sponsor decision|10
7746779|NCT00717769|12182008|FG000|Overall Study|Withdrew consent|2
7746780|NCT00717769|12182009|FG001|Overall Study|Withdrew consent|2
7746781|NCT00717769|12182010|FG002|Overall Study|Withdrew consent|0
7746782|NCT00717860|12182022|FG000|Overall Study|Clinical adverse experience|5
7746783|NCT00717860|12182023|FG001|Overall Study|Clinical adverse experience|9
7746784|NCT00717860|12182022|FG000|Overall Study|Laboratory adverse experience|2
7746785|NCT00717860|12182023|FG001|Overall Study|Laboratory adverse experience|2
7746786|NCT00717860|12182022|FG000|Overall Study|Lack of Efficacy|7
7746787|NCT00717860|12182023|FG001|Overall Study|Lack of Efficacy|13
7746788|NCT00717860|12182022|FG000|Overall Study|Discontinued for other reason|6
7746789|NCT00717860|12182023|FG001|Overall Study|Discontinued for other reason|1
7746790|NCT00717860|12182022|FG000|Overall Study|Withdrew consent|7
7746791|NCT00717860|12182023|FG001|Overall Study|Withdrew consent|3
7746792|NCT00717886|12182038|FG000|Overall Study|Withdrawal by Subject|3
7746793|NCT00717886|12182038|FG000|Overall Study|Treatment Failure|1
7746794|NCT00718042|12182066|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
7746795|NCT00718042|12182067|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
7746796|NCT00718042|12182068|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
7746797|NCT00718042|12182069|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
7746798|NCT00718042|12182070|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
7746799|NCT00718042|12182071|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
7746800|NCT00718042|12182066|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64
7746801|NCT00718042|12182067|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0
7746802|NCT00718042|12182068|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0
7746803|NCT00718042|12182069|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0
7746804|NCT00718042|12182070|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36
7746805|NCT00718042|12182071|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0
7746806|NCT00718042|12182066|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0
7746807|NCT00718042|12182067|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1
7746808|NCT00718042|12182068|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1
7746809|NCT00718042|12182069|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0
7746810|NCT00718042|12182070|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0
7746811|NCT00718042|12182071|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0
7746812|NCT00718042|12182066|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
7746813|NCT00718042|12182067|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
7746814|NCT00718042|12182068|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
7746815|NCT00718042|12182069|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
7746816|NCT00718042|12182070|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
7746817|NCT00718042|12182071|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
7746818|NCT00718042|12182066|FG000|Donor Follow-up|Lost to Follow-up|13
7746819|NCT00718042|12182067|FG001|Donor Follow-up|Lost to Follow-up|0
7746820|NCT00718042|12182068|FG002|Donor Follow-up|Lost to Follow-up|0
7746821|NCT00718042|12182069|FG003|Donor Follow-up|Lost to Follow-up|0
7746822|NCT00718042|12182070|FG004|Donor Follow-up|Lost to Follow-up|19
7746823|NCT00718042|12182071|FG005|Donor Follow-up|Lost to Follow-up|0
7746824|NCT00718081|12182086|FG000|Overall Study|Adverse Event|0
7746825|NCT00718081|12182087|FG001|Overall Study|Adverse Event|1
7746826|NCT00718081|12182088|FG002|Overall Study|Adverse Event|0
7746827|NCT00718081|12182086|FG000|Overall Study|Lack of Efficacy|7
7746828|NCT00718081|12182087|FG001|Overall Study|Lack of Efficacy|3
7746829|NCT00718081|12182088|FG002|Overall Study|Lack of Efficacy|21
7746830|NCT00718159|12182121|FG000|Overall Study|Progressive Disease|3
7746831|NCT00718159|12182122|FG001|Overall Study|Progressive Disease|3
7746832|NCT00718159|12182123|FG002|Overall Study|Progressive Disease|2
7746833|NCT00718159|12182124|FG003|Overall Study|Progressive Disease|0
7746834|NCT00718159|12182125|FG004|Overall Study|Progressive Disease|6
7746835|NCT00718159|12182126|FG005|Overall Study|Progressive Disease|0
7746836|NCT00718159|12182127|FG006|Overall Study|Progressive Disease|0
7746837|NCT00718159|12182121|FG000|Overall Study|Death due to Adverse Event|0
7746838|NCT00718159|12182122|FG001|Overall Study|Death due to Adverse Event|0
7746839|NCT00718159|12182123|FG002|Overall Study|Death due to Adverse Event|0
7746840|NCT00718159|12182124|FG003|Overall Study|Death due to Adverse Event|2
7746841|NCT00718159|12182125|FG004|Overall Study|Death due to Adverse Event|2
7746842|NCT00718159|12182126|FG005|Overall Study|Death due to Adverse Event|0
7746843|NCT00718159|12182127|FG006|Overall Study|Death due to Adverse Event|0
7746844|NCT00718159|12182121|FG000|Overall Study|Death due to Study Drug Toxicity|0
7746845|NCT00718159|12182122|FG001|Overall Study|Death due to Study Drug Toxicity|0
7746846|NCT00718159|12182123|FG002|Overall Study|Death due to Study Drug Toxicity|1
7746847|NCT00718159|12182124|FG003|Overall Study|Death due to Study Drug Toxicity|2
7746848|NCT00718159|12182125|FG004|Overall Study|Death due to Study Drug Toxicity|0
7746849|NCT00718159|12182126|FG005|Overall Study|Death due to Study Drug Toxicity|0
7746850|NCT00718159|12182127|FG006|Overall Study|Death due to Study Drug Toxicity|0
7746851|NCT00718159|12182121|FG000|Overall Study|Investigator Decision|0
7746852|NCT00718159|12182122|FG001|Overall Study|Investigator Decision|0
7746853|NCT00718159|12182123|FG002|Overall Study|Investigator Decision|0
7746854|NCT00718159|12182124|FG003|Overall Study|Investigator Decision|0
7746855|NCT00718159|12182125|FG004|Overall Study|Investigator Decision|0
7746856|NCT00718159|12182126|FG005|Overall Study|Investigator Decision|1
7746857|NCT00718159|12182127|FG006|Overall Study|Investigator Decision|1
7746858|NCT00718237|12182145|FG000|Overall Study|Adverse Event|1
7746859|NCT00718237|12182146|FG001|Overall Study|Adverse Event|3
7746860|NCT00718237|12182145|FG000|Overall Study|Lost to Follow-up|2
7746861|NCT00718237|12182146|FG001|Overall Study|Lost to Follow-up|2
7746862|NCT00718237|12182145|FG000|Overall Study|Physician Decision|1
7746863|NCT00718237|12182146|FG001|Overall Study|Physician Decision|0
7746864|NCT00718237|12182145|FG000|Overall Study|Withdrawal by Subject|9
7746865|NCT00718237|12182146|FG001|Overall Study|Withdrawal by Subject|10
7746866|NCT00718315|12182168|FG000|Overall Study|Adverse Event|1
7746867|NCT00718315|12182169|FG001|Overall Study|Adverse Event|2
7746868|NCT00718315|12182170|FG002|Overall Study|Adverse Event|3
7746869|NCT00718315|12182168|FG000|Overall Study|Death|6
7746870|NCT00718315|12182169|FG001|Overall Study|Death|6
7746871|NCT00718315|12182170|FG002|Overall Study|Death|5
7746872|NCT00718315|12182168|FG000|Overall Study|Lost to Follow-up|2
7746873|NCT00718315|12182169|FG001|Overall Study|Lost to Follow-up|3
7746874|NCT00718315|12182170|FG002|Overall Study|Lost to Follow-up|4
7746875|NCT00718315|12182168|FG000|Overall Study|Protocol Violation|5
7746876|NCT00718315|12182169|FG001|Overall Study|Protocol Violation|5
7746877|NCT00718315|12182170|FG002|Overall Study|Protocol Violation|3
7746878|NCT00718315|12182168|FG000|Overall Study|Erlotinib dose decreased|4
7746879|NCT00718315|12182169|FG001|Overall Study|Erlotinib dose decreased|3
7746880|NCT00718315|12182170|FG002|Overall Study|Erlotinib dose decreased|1
7746881|NCT00718315|12182168|FG000|Overall Study|Use of Minocyclin|1
7746882|NCT00718315|12182169|FG001|Overall Study|Use of Minocyclin|1
7746883|NCT00718315|12182170|FG002|Overall Study|Use of Minocyclin|1
7746884|NCT00718315|12182168|FG000|Overall Study|Disease progression|0
7746885|NCT00718315|12182169|FG001|Overall Study|Disease progression|1
7746886|NCT00718315|12182170|FG002|Overall Study|Disease progression|1
7746887|NCT00718315|12182168|FG000|Overall Study|Other|0
7746888|NCT00718315|12182169|FG001|Overall Study|Other|0
7746889|NCT00718315|12182170|FG002|Overall Study|Other|1
7746890|NCT00718315|12182168|FG000|Overall Study|Use of ATB and Corticoids|0
7746891|NCT00718315|12182169|FG001|Overall Study|Use of ATB and Corticoids|1
7746892|NCT00718315|12182170|FG002|Overall Study|Use of ATB and Corticoids|2
7746893|NCT00718328|12182180|FG000|Overall Study|Lost to Follow-up|1
7746894|NCT00718328|12182181|FG001|Overall Study|Lost to Follow-up|0
7746895|NCT00718419|12182189|FG000|Overall Study|Adverse Event|2
7746896|NCT00718419|12182190|FG001|Overall Study|Adverse Event|1
7746897|NCT00718419|12182189|FG000|Overall Study|Physician Decision|1
7746898|NCT00718419|12182190|FG001|Overall Study|Physician Decision|6
7746899|NCT00718419|12182189|FG000|Overall Study|Sponsor decision|0
7746900|NCT00718419|12182190|FG001|Overall Study|Sponsor decision|1
7746901|NCT00718419|12182189|FG000|Overall Study|Withdrawal by Subject|0
7746902|NCT00718419|12182190|FG001|Overall Study|Withdrawal by Subject|5
7746903|NCT00718419|12182189|FG000|Overall Study|Progressive Disease|7
7746904|NCT00718419|12182190|FG001|Overall Study|Progressive Disease|25
7746905|NCT00718419|12182189|FG000|Overall Study|Death Due to Progressive Disease|2
7746906|NCT00718419|12182190|FG001|Overall Study|Death Due to Progressive Disease|0
7746907|NCT00718419|12182189|FG000|Overall Study|Death Due to Study Drug Related|0
7746908|NCT00718419|12182190|FG001|Overall Study|Death Due to Study Drug Related|1
7746909|NCT00718419|12182189|FG000|Overall Study|Death Due to Adverse Events|1
7746910|NCT00718419|12182190|FG001|Overall Study|Death Due to Adverse Events|0
7746911|NCT00718510|12182198|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0
7746912|NCT00718510|12182199|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
7746913|NCT00718510|12182198|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1
7746914|NCT00718510|12182199|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7746915|NCT00718523|12182207|FG000|Overall Study|Withdrawal by Subject|5
7746916|NCT00718523|12182208|FG001|Overall Study|Withdrawal by Subject|7
7746917|NCT00718523|12182207|FG000|Overall Study|Death|13
7746918|NCT00718523|12182208|FG001|Overall Study|Death|17
7746919|NCT00718549|12182214|FG000|Induction Phase|Disease Progression|1
7746920|NCT00718549|12182215|FG001|Induction Phase|Disease Progression|0
7746921|NCT00718549|12182216|FG002|Induction Phase|Disease Progression|0
7746922|NCT00718549|12182214|FG000|Induction Phase|Eligibility Criteria Violation|2
7746923|NCT00718549|12182215|FG001|Induction Phase|Eligibility Criteria Violation|0
7746924|NCT00718549|12182216|FG002|Induction Phase|Eligibility Criteria Violation|0
7746925|NCT00718549|12182214|FG000|Induction Phase|Early Termination - No Additional Info|59
7746926|NCT00718549|12182215|FG001|Induction Phase|Early Termination - No Additional Info|0
7746927|NCT00718549|12182216|FG002|Induction Phase|Early Termination - No Additional Info|0
7746928|NCT00718549|12182214|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
7746929|NCT00718549|12182215|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
7746930|NCT00718549|12182216|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
7746931|NCT00718549|12182214|FG000|Maintenance/ Observation Phase|Death|0
7746932|NCT00718549|12182215|FG001|Maintenance/ Observation Phase|Death|1
7746933|NCT00718549|12182216|FG002|Maintenance/ Observation Phase|Death|2
7746934|NCT00718549|12182214|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0
7746935|NCT00718549|12182215|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4
7746936|NCT00718549|12182216|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4
7746937|NCT00718549|12182214|FG000|Maintenance/ Observation Phase|Progression|0
7746938|NCT00718549|12182215|FG001|Maintenance/ Observation Phase|Progression|5
7746939|NCT00718549|12182216|FG002|Maintenance/ Observation Phase|Progression|14
7746940|NCT00718549|12182214|FG000|Maintenance/ Observation Phase|Relapse|0
7746941|NCT00718549|12182215|FG001|Maintenance/ Observation Phase|Relapse|3
7746942|NCT00718549|12182216|FG002|Maintenance/ Observation Phase|Relapse|2
7746943|NCT00718666|12182232|FG000|Booster Phase Year 5|No active participation request|0
7746944|NCT00718666|12182233|FG001|Booster Phase Year 5|No active participation request|0
7746945|NCT00718666|12182234|FG002|Booster Phase Year 5|No active participation request|1
7746946|NCT00718666|12182232|FG000|Booster Phase Year 5|Declined v-4 serology|1
7746947|NCT00718666|12182233|FG001|Booster Phase Year 5|Declined v-4 serology|0
7746948|NCT00718666|12182234|FG002|Booster Phase Year 5|Declined v-4 serology|0
7746949|NCT00718666|12182232|FG000|Booster Phase Year 5|Withdrawal by Subject|0
7746950|NCT00718666|12182233|FG001|Booster Phase Year 5|Withdrawal by Subject|0
7746951|NCT00718666|12182234|FG002|Booster Phase Year 5|Withdrawal by Subject|1
7746952|NCT00718666|12182232|FG000|Booster Phase Year 5|Lost to Follow-up|1
7746953|NCT00718666|12182233|FG001|Booster Phase Year 5|Lost to Follow-up|0
7746954|NCT00718666|12182234|FG002|Booster Phase Year 5|Lost to Follow-up|4
7746955|NCT00718718|12182259|FG000|Prior to Week 12|Adverse Event|0
7746956|NCT00718718|12182260|FG001|Prior to Week 12|Adverse Event|0
7746957|NCT00718718|12182261|FG002|Prior to Week 12|Adverse Event|0
7746958|NCT00718718|12182262|FG003|Prior to Week 12|Adverse Event|0
7746959|NCT00718718|12182263|FG004|Prior to Week 12|Adverse Event|0
7746960|NCT00718718|12182264|FG005|Prior to Week 12|Adverse Event|0
7746961|NCT00718718|12182265|FG006|Prior to Week 12|Adverse Event|0
7746962|NCT00718718|12182266|FG007|Prior to Week 12|Adverse Event|1
7746963|NCT00718718|12182267|FG008|Prior to Week 12|Adverse Event|1
7746964|NCT00718718|12182268|FG009|Prior to Week 12|Adverse Event|0
7746965|NCT00718718|12182259|FG000|Prior to Week 12|Withdrawal by Subject|0
7746966|NCT00718718|12182260|FG001|Prior to Week 12|Withdrawal by Subject|0
7746967|NCT00718718|12182261|FG002|Prior to Week 12|Withdrawal by Subject|0
7746968|NCT00718718|12182262|FG003|Prior to Week 12|Withdrawal by Subject|0
7746969|NCT00718718|12182263|FG004|Prior to Week 12|Withdrawal by Subject|3
7746970|NCT00718718|12182264|FG005|Prior to Week 12|Withdrawal by Subject|0
7746971|NCT00718718|12182265|FG006|Prior to Week 12|Withdrawal by Subject|1
7746972|NCT00718718|12182266|FG007|Prior to Week 12|Withdrawal by Subject|1
7746973|NCT00718718|12182267|FG008|Prior to Week 12|Withdrawal by Subject|1
7746974|NCT00718718|12182268|FG009|Prior to Week 12|Withdrawal by Subject|0
7746975|NCT00718718|12182259|FG000|Prior to Week 12|Other|1
7746976|NCT00718718|12182260|FG001|Prior to Week 12|Other|0
7746977|NCT00718718|12182261|FG002|Prior to Week 12|Other|1
7746978|NCT00718718|12182262|FG003|Prior to Week 12|Other|0
7746979|NCT00718718|12182263|FG004|Prior to Week 12|Other|0
7746980|NCT00718718|12182264|FG005|Prior to Week 12|Other|0
7746981|NCT00718718|12182265|FG006|Prior to Week 12|Other|0
7746982|NCT00718718|12182266|FG007|Prior to Week 12|Other|0
7746983|NCT00718718|12182267|FG008|Prior to Week 12|Other|0
7746984|NCT00718718|12182268|FG009|Prior to Week 12|Other|0
7746985|NCT00718718|12182259|FG000|Week 12 to End of Study|Adverse Event|0
7746986|NCT00718718|12182260|FG001|Week 12 to End of Study|Adverse Event|0
7746987|NCT00718718|12182261|FG002|Week 12 to End of Study|Adverse Event|0
7746988|NCT00718718|12182262|FG003|Week 12 to End of Study|Adverse Event|0
7746989|NCT00718718|12182263|FG004|Week 12 to End of Study|Adverse Event|0
7746990|NCT00718718|12182264|FG005|Week 12 to End of Study|Adverse Event|0
7746991|NCT00718718|12182265|FG006|Week 12 to End of Study|Adverse Event|0
7746992|NCT00718718|12182266|FG007|Week 12 to End of Study|Adverse Event|1
7746993|NCT00718718|12182267|FG008|Week 12 to End of Study|Adverse Event|0
7746994|NCT00718718|12182268|FG009|Week 12 to End of Study|Adverse Event|0
7746995|NCT00718718|12182259|FG000|Week 12 to End of Study|Death|0
7746996|NCT00718718|12182260|FG001|Week 12 to End of Study|Death|0
7746997|NCT00718718|12182261|FG002|Week 12 to End of Study|Death|0
7746998|NCT00718718|12182262|FG003|Week 12 to End of Study|Death|0
7746999|NCT00718718|12182263|FG004|Week 12 to End of Study|Death|0
7747000|NCT00718718|12182264|FG005|Week 12 to End of Study|Death|1
7747001|NCT00718718|12182265|FG006|Week 12 to End of Study|Death|0
7747002|NCT00718718|12182266|FG007|Week 12 to End of Study|Death|0
7747003|NCT00718718|12182267|FG008|Week 12 to End of Study|Death|0
7747004|NCT00718718|12182268|FG009|Week 12 to End of Study|Death|0
7747005|NCT00718718|12182259|FG000|Week 12 to End of Study|Withdrawal by Subject|0
7747006|NCT00718718|12182260|FG001|Week 12 to End of Study|Withdrawal by Subject|0
7747007|NCT00718718|12182261|FG002|Week 12 to End of Study|Withdrawal by Subject|0
7747008|NCT00718718|12182262|FG003|Week 12 to End of Study|Withdrawal by Subject|0
7747009|NCT00718718|12182263|FG004|Week 12 to End of Study|Withdrawal by Subject|0
7747010|NCT00718718|12182264|FG005|Week 12 to End of Study|Withdrawal by Subject|2
7747011|NCT00718718|12182265|FG006|Week 12 to End of Study|Withdrawal by Subject|1
7747012|NCT00718718|12182266|FG007|Week 12 to End of Study|Withdrawal by Subject|0
7747013|NCT00718718|12182267|FG008|Week 12 to End of Study|Withdrawal by Subject|0
7747014|NCT00718718|12182268|FG009|Week 12 to End of Study|Withdrawal by Subject|0
7747015|NCT00718718|12182259|FG000|Week 12 to End of Study|Lost to Follow-up|0
7747016|NCT00718718|12182260|FG001|Week 12 to End of Study|Lost to Follow-up|0
7747017|NCT00718718|12182261|FG002|Week 12 to End of Study|Lost to Follow-up|0
7747018|NCT00718718|12182262|FG003|Week 12 to End of Study|Lost to Follow-up|0
7747019|NCT00718718|12182263|FG004|Week 12 to End of Study|Lost to Follow-up|0
7747020|NCT00718718|12182264|FG005|Week 12 to End of Study|Lost to Follow-up|0
7747021|NCT00718718|12182265|FG006|Week 12 to End of Study|Lost to Follow-up|0
7747022|NCT00718718|12182266|FG007|Week 12 to End of Study|Lost to Follow-up|0
7747023|NCT00718718|12182267|FG008|Week 12 to End of Study|Lost to Follow-up|1
7747024|NCT00718718|12182268|FG009|Week 12 to End of Study|Lost to Follow-up|0
7747025|NCT00718718|12182259|FG000|Week 12 to End of Study|Other|0
7747026|NCT00718718|12182260|FG001|Week 12 to End of Study|Other|1
7747027|NCT00718718|12182261|FG002|Week 12 to End of Study|Other|0
7747028|NCT00718718|12182262|FG003|Week 12 to End of Study|Other|1
7747029|NCT00718718|12182263|FG004|Week 12 to End of Study|Other|0
7747030|NCT00718718|12182264|FG005|Week 12 to End of Study|Other|0
7747031|NCT00718718|12182265|FG006|Week 12 to End of Study|Other|1
7747032|NCT00718718|12182266|FG007|Week 12 to End of Study|Other|0
7747033|NCT00718718|12182267|FG008|Week 12 to End of Study|Other|0
7747034|NCT00718718|12182268|FG009|Week 12 to End of Study|Other|0
7747035|NCT00718770|12182294|FG000|Overall Study|Adverse Event|1
7747036|NCT00718770|12182294|FG000|Overall Study|Lack of Efficacy|1
7747037|NCT00718770|12182294|FG000|Overall Study|Lack of Efficacy|1
7747038|NCT00718770|12182294|FG000|Overall Study|Adverse Event|1
7747039|NCT00718770|12182294|FG000|Overall Study|Lack of Efficacy|1
7747040|NCT00718770|12182294|FG000|Overall Study|Adverse Event|1
7747041|NCT00718770|12182294|FG000|Overall Study|Lack of Efficacy|1
7747042|NCT00718770|12182294|FG000|Overall Study|Adverse Event|1
7747043|NCT00718809|12182300|FG000|Overall Study|Disease progression|9
7747044|NCT00718809|12182301|FG001|Overall Study|Disease progression|7
7747045|NCT00718809|12182300|FG000|Overall Study|Adverse Event|1
7747046|NCT00718809|12182301|FG001|Overall Study|Adverse Event|1
7747047|NCT00718809|12182300|FG000|Overall Study|Withdrawal by Subject|0
7747048|NCT00718809|12182301|FG001|Overall Study|Withdrawal by Subject|1
7747049|NCT00718809|12182300|FG000|Overall Study|Lost to Follow-up|1
7747050|NCT00718809|12182301|FG001|Overall Study|Lost to Follow-up|0
7747051|NCT00718809|12182300|FG000|Overall Study|Noncompliance|1
7747052|NCT00718809|12182301|FG001|Overall Study|Noncompliance|0
7747053|NCT00718861|12182309|FG000|Overall Study|Withdrawal by Subject|15
7747054|NCT00718861|12182310|FG001|Overall Study|Withdrawal by Subject|10
7747055|NCT00718861|12182309|FG000|Overall Study|Adverse Event|2
7747056|NCT00718861|12182310|FG001|Overall Study|Adverse Event|1
7747057|NCT00718861|12182309|FG000|Overall Study|Lost to Follow-up|2
7747058|NCT00718861|12182310|FG001|Overall Study|Lost to Follow-up|1
7747059|NCT00718861|12182309|FG000|Overall Study|Administrative Problems|1
7747060|NCT00718861|12182310|FG001|Overall Study|Administrative Problems|1
7747061|NCT00718861|12182309|FG000|Overall Study|Death|1
7747062|NCT00718861|12182310|FG001|Overall Study|Death|5
7747063|NCT00718887|12182318|FG000|Overall Study|Withdrawal by Subject|3
7747064|NCT00718887|12182319|FG001|Overall Study|Withdrawal by Subject|2
7747065|NCT00718887|12182318|FG000|Overall Study|Not identified|2
7747066|NCT00718887|12182319|FG001|Overall Study|Not identified|7
7747067|NCT00719043|12182338|FG000|Overall Study|Adverse Event|5
7747068|NCT00719043|12182339|FG001|Overall Study|Adverse Event|1
7747069|NCT00719043|12182340|FG002|Overall Study|Adverse Event|2
7747070|NCT00719043|12182341|FG003|Overall Study|Adverse Event|2
7747071|NCT00719043|12182342|FG004|Overall Study|Adverse Event|1
7747072|NCT00719043|12182343|FG005|Overall Study|Adverse Event|4
7747073|NCT00719043|12182344|FG006|Overall Study|Adverse Event|4
7747074|NCT00719043|12182338|FG000|Overall Study|Lost to Follow-up|14
7747075|NCT00719043|12182339|FG001|Overall Study|Lost to Follow-up|10
7747076|NCT00719043|12182340|FG002|Overall Study|Lost to Follow-up|8
7747077|NCT00719043|12182341|FG003|Overall Study|Lost to Follow-up|9
7747078|NCT00719043|12182342|FG004|Overall Study|Lost to Follow-up|10
7747079|NCT00719043|12182343|FG005|Overall Study|Lost to Follow-up|9
7747080|NCT00719043|12182344|FG006|Overall Study|Lost to Follow-up|9
7747081|NCT00719043|12182338|FG000|Overall Study|Protocol Violation|0
7747082|NCT00719043|12182339|FG001|Overall Study|Protocol Violation|0
7747083|NCT00719043|12182340|FG002|Overall Study|Protocol Violation|0
7747084|NCT00719043|12182341|FG003|Overall Study|Protocol Violation|0
7747085|NCT00719043|12182342|FG004|Overall Study|Protocol Violation|0
7747086|NCT00719043|12182343|FG005|Overall Study|Protocol Violation|1
7747087|NCT00719043|12182344|FG006|Overall Study|Protocol Violation|0
7747088|NCT00719043|12182338|FG000|Overall Study|Other|1
7747089|NCT00719043|12182339|FG001|Overall Study|Other|0
7747090|NCT00719043|12182340|FG002|Overall Study|Other|1
7747091|NCT00719043|12182341|FG003|Overall Study|Other|2
7747092|NCT00719043|12182342|FG004|Overall Study|Other|0
7747093|NCT00719043|12182343|FG005|Overall Study|Other|2
7747094|NCT00719043|12182344|FG006|Overall Study|Other|1
7747095|NCT00719043|12182338|FG000|Overall Study|Withdrawal by Subject|12
7747096|NCT00719043|12182339|FG001|Overall Study|Withdrawal by Subject|14
7747097|NCT00719043|12182340|FG002|Overall Study|Withdrawal by Subject|9
7747098|NCT00719043|12182341|FG003|Overall Study|Withdrawal by Subject|10
7747099|NCT00719043|12182342|FG004|Overall Study|Withdrawal by Subject|16
7747100|NCT00719043|12182343|FG005|Overall Study|Withdrawal by Subject|18
7747101|NCT00719043|12182344|FG006|Overall Study|Withdrawal by Subject|14
7747102|NCT00719212|12182394|FG000|Overall Study|Death|41
7747103|NCT00719212|12182394|FG000|Overall Study|Lost to Follow-up|2
7747104|NCT00719212|12182394|FG000|Overall Study|Withdrawal by Subject|1
7747105|NCT00719264|12182400|FG000|Overall Study|Adverse Event|41
7747106|NCT00719264|12182401|FG001|Overall Study|Adverse Event|49
7747107|NCT00719264|12182400|FG000|Overall Study|Death|13
7747108|NCT00719264|12182401|FG001|Overall Study|Death|10
7747109|NCT00719264|12182400|FG000|Overall Study|Administrative Problems|6
7747110|NCT00719264|12182401|FG001|Overall Study|Administrative Problems|4
7747111|NCT00719264|12182400|FG000|Overall Study|Lost to Follow-up|1
7747112|NCT00719264|12182401|FG001|Overall Study|Lost to Follow-up|1
7747113|NCT00719264|12182400|FG000|Overall Study|Withdrawal by Subject|12
7747114|NCT00719264|12182401|FG001|Overall Study|Withdrawal by Subject|7
7747115|NCT00719264|12182400|FG000|Overall Study|Protocol Deviation|1
7747116|NCT00719264|12182401|FG001|Overall Study|Protocol Deviation|3
7747117|NCT00719264|12182400|FG000|Overall Study|New Cancer Therapy|4
7747118|NCT00719264|12182401|FG001|Overall Study|New Cancer Therapy|2
7747119|NCT00719264|12182400|FG000|Overall Study|Disease Progression|104
7747120|NCT00719264|12182401|FG001|Overall Study|Disease Progression|107
7747121|NCT00719355|12182425|FG000|Overall Study|Death|0
7747122|NCT00719355|12182426|FG001|Overall Study|Death|1
7747123|NCT00719355|12182425|FG000|Overall Study|Medical|14
7747124|NCT00719355|12182426|FG001|Overall Study|Medical|5
7747125|NCT00719355|12182425|FG000|Overall Study|Compliance|4
7747126|NCT00719355|12182426|FG001|Overall Study|Compliance|6
7747127|NCT00719355|12182425|FG000|Overall Study|Moved|0
7747128|NCT00719355|12182426|FG001|Overall Study|Moved|1
7747129|NCT00719472|12182432|FG000|Enrolled in Study|Physician decision to withdraw patient|1
7747130|NCT00719472|12182432|FG000|Enrolled in Study|Subject decision to withdraw|8
7747131|NCT00719472|12182432|FG000|Enrolled in Study|Various Reasons|17
7747132|NCT00719472|12182432|FG000|Received Cycle 1 Treatment|Adverse Event|8
7747133|NCT00719472|12182432|FG000|Received Cycle 1 Treatment|Death|5
7769433|NCT00868790|12213061|FG003|Period 2|Lost to Follow-up|0
7747134|NCT00719472|12182432|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
7747135|NCT00719472|12182432|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
7747136|NCT00719472|12182432|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9
7747137|NCT00719472|12182432|FG000|Received Cycle 1 Treatment|Various Reasons|13
7747138|NCT00719472|12182432|FG000|Received Cycle 2 Treatment|Adverse Event|12
7747139|NCT00719472|12182432|FG000|Received Cycle 2 Treatment|Death|6
7747140|NCT00719472|12182432|FG000|Received Cycle 2 Treatment|Disease progression|3
7747141|NCT00719472|12182432|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3
7747142|NCT00719472|12182432|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
7747143|NCT00719472|12182432|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6
7747144|NCT00719472|12182432|FG000|Received Cycle 2 Treatment|Various Reasons|25
7747145|NCT00719537|12182438|FG000|Overall Study|Withdrawal by Subject|1
7747146|NCT00719537|12182439|FG001|Overall Study|Withdrawal by Subject|0
7747147|NCT00719537|12182438|FG000|Overall Study|Lost to Follow-up|0
7747148|NCT00719537|12182439|FG001|Overall Study|Lost to Follow-up|1
7747149|NCT00719563|12182447|FG000|Overall Study|Adverse Event|16
7747150|NCT00719563|12182448|FG001|Overall Study|Adverse Event|13
7747151|NCT00719563|12182447|FG000|Overall Study|Medical condition changed|3
7747152|NCT00719563|12182448|FG001|Overall Study|Medical condition changed|5
7747153|NCT00719563|12182447|FG000|Overall Study|Lack of Efficacy|3
7747154|NCT00719563|12182448|FG001|Overall Study|Lack of Efficacy|7
7747155|NCT00719563|12182447|FG000|Overall Study|Personal reasons|6
7747156|NCT00719563|12182448|FG001|Overall Study|Personal reasons|7
7747157|NCT00719563|12182447|FG000|Overall Study|Unknown reasons|4
7747158|NCT00719563|12182448|FG001|Overall Study|Unknown reasons|6
7747159|NCT00719563|12182447|FG000|Overall Study|Noncompliant|1
7747160|NCT00719563|12182448|FG001|Overall Study|Noncompliant|1
7747161|NCT00719563|12182447|FG000|Overall Study|Lost to Follow-up|5
7747162|NCT00719563|12182448|FG001|Overall Study|Lost to Follow-up|3
7747163|NCT00719680|12182479|FG000|Overall Study|Adverse Event|1
7747164|NCT00719680|12182479|FG000|Overall Study|Lost to Follow-up|1
7747165|NCT00719680|12182479|FG000|Overall Study|Withdrawal by Subject|3
7747166|NCT00719706|12182485|FG000|Overall Study|Adverse Event|5
7747167|NCT00719706|12182486|FG001|Overall Study|Adverse Event|4
7747168|NCT00719706|12182485|FG000|Overall Study|Withdrawal by Subject|1
7747169|NCT00719706|12182486|FG001|Overall Study|Withdrawal by Subject|2
7747170|NCT00719706|12182485|FG000|Overall Study|Protocol Violation|3
7747171|NCT00719706|12182486|FG001|Overall Study|Protocol Violation|0
7747172|NCT00719732|12182492|FG000|Overall Study|Lost to Follow-up|20
7747173|NCT00719732|12182492|FG000|Overall Study|Unilateral (not bilateral) implantation|1
7747174|NCT00719732|12182492|FG000|Overall Study|Illness not associated with device|1
7747175|NCT00719810|12182499|FG000|Overall Study|Adverse Event|0
7747176|NCT00719810|12182500|FG001|Overall Study|Adverse Event|2
7747177|NCT00719810|12182501|FG002|Overall Study|Adverse Event|3
7747178|NCT00719810|12182499|FG000|Overall Study|Lost to Follow-up|2
7747179|NCT00719810|12182500|FG001|Overall Study|Lost to Follow-up|0
7747180|NCT00719810|12182501|FG002|Overall Study|Lost to Follow-up|3
7747181|NCT00719810|12182499|FG000|Overall Study|Physician Decision|0
7747182|NCT00719810|12182500|FG001|Overall Study|Physician Decision|1
7747183|NCT00719810|12182501|FG002|Overall Study|Physician Decision|0
7747184|NCT00719810|12182499|FG000|Overall Study|Withdrawal by Subject|1
7747185|NCT00719810|12182500|FG001|Overall Study|Withdrawal by Subject|1
7747186|NCT00719810|12182501|FG002|Overall Study|Withdrawal by Subject|2
7747187|NCT00719849|12182511|FG000|Overall Study|Death|0
7747188|NCT00719849|12182512|FG001|Overall Study|Death|1
7747189|NCT00719862|12182520|FG000|Overall Study|Adverse Event|1
7747190|NCT00719862|12182521|FG001|Overall Study|Adverse Event|2
7747191|NCT00719862|12182520|FG000|Overall Study|Lack of Efficacy|3
7747192|NCT00719862|12182521|FG001|Overall Study|Lack of Efficacy|0
7747193|NCT00719862|12182520|FG000|Overall Study|Non-Compliance|1
7747194|NCT00719862|12182521|FG001|Overall Study|Non-Compliance|0
7747195|NCT00719862|12182520|FG000|Overall Study|Withdrawal by Subject|1
7747196|NCT00719862|12182521|FG001|Overall Study|Withdrawal by Subject|0
7747197|NCT00719862|12182520|FG000|Overall Study|Lost to Follow-up|0
7747198|NCT00719862|12182521|FG001|Overall Study|Lost to Follow-up|1
7747199|NCT00719862|12182520|FG000|Overall Study|Other|2
7747200|NCT00719862|12182521|FG001|Overall Study|Other|3
7747201|NCT00719901|12182527|FG000|Overall Study|Adverse Event|5
7747202|NCT00719901|12182527|FG000|Overall Study|Withdrawal by Subject|1
7747203|NCT00719901|12182527|FG000|Overall Study|Alternate Treatment|1
7747204|NCT00719901|12182527|FG000|Overall Study|Disease Progression|3
7747205|NCT00719901|12182527|FG000|Overall Study|Availability of Study Drug|1
7747206|NCT00719953|12182531|FG000|Overall Study|Adverse Event|4
7747207|NCT00720057|12182537|FG000|Overall Study|Lost to Follow-up|0
7747208|NCT00720057|12182538|FG001|Overall Study|Lost to Follow-up|2
7747209|NCT00720057|12182537|FG000|Overall Study|Protocol Violation|1
7747210|NCT00720057|12182538|FG001|Overall Study|Protocol Violation|0
7747211|NCT00720057|12182537|FG000|Overall Study|Withdrawal by Subject|0
7747212|NCT00720057|12182538|FG001|Overall Study|Withdrawal by Subject|1
7747213|NCT00720096|12182546|FG000|Overall Study|Withdrawal by Subject|0
7747214|NCT00720096|12182547|FG001|Overall Study|Withdrawal by Subject|2
7747215|NCT00720109|12182553|FG000|Induction Period|Did not meet eligibility criteria|3
7747216|NCT00720109|12182554|FG001|Induction Period|Did not meet eligibility criteria|0
7747217|NCT00720109|12182555|FG002|Induction Period|Did not meet eligibility criteria|0
7747218|NCT00720109|12182553|FG000|Induction Period|Bone Marrow Transplant|2
7747219|NCT00720109|12182554|FG001|Induction Period|Bone Marrow Transplant|0
7747220|NCT00720109|12182555|FG002|Induction Period|Bone Marrow Transplant|0
7747221|NCT00720109|12182553|FG000|Induction Period|Physician Decision|1
7747222|NCT00720109|12182554|FG001|Induction Period|Physician Decision|0
7747223|NCT00720109|12182555|FG002|Induction Period|Physician Decision|0
7747224|NCT00720109|12182553|FG000|Risk Stratification Period|Adverse Event|0
7747225|NCT00720109|12182554|FG001|Risk Stratification Period|Adverse Event|1
7747226|NCT00720109|12182555|FG002|Risk Stratification Period|Adverse Event|0
7747227|NCT00720109|12182553|FG000|Risk Stratification Period|Physician Decision|0
7747228|NCT00720109|12182554|FG001|Risk Stratification Period|Physician Decision|2
7747229|NCT00720109|12182555|FG002|Risk Stratification Period|Physician Decision|1
7747230|NCT00720109|12182553|FG000|Risk Stratification Period|Bone marrow transplant|0
7747231|NCT00720109|12182554|FG001|Risk Stratification Period|Bone marrow transplant|9
7747232|NCT00720109|12182555|FG002|Risk Stratification Period|Bone marrow transplant|7
7747233|NCT00720109|12182553|FG000|Risk Stratification Period|Disease progression or relapse|0
7747234|NCT00720109|12182554|FG001|Risk Stratification Period|Disease progression or relapse|2
7747235|NCT00720109|12182555|FG002|Risk Stratification Period|Disease progression or relapse|0
7747236|NCT00720109|12182553|FG000|Risk Stratification Period|Development of second malignant neoplasm|0
7747237|NCT00720109|12182554|FG001|Risk Stratification Period|Development of second malignant neoplasm|1
7747238|NCT00720109|12182555|FG002|Risk Stratification Period|Development of second malignant neoplasm|0
7747239|NCT00720122|12182564|FG000|Overall Study|Lost to Follow-up|1
7747240|NCT00720122|12182564|FG000|Overall Study|Physician Decision|1
7747241|NCT00720122|12182564|FG000|Overall Study|Withdrawal by Subject|7
7747242|NCT00720213|12182568|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7
7747243|NCT00720213|12182569|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0
7747244|NCT00720213|12182570|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0
7747245|NCT00720226|12182580|FG000|Overall Study|Withdrawal by Subject|7
7747246|NCT00720226|12182581|FG001|Overall Study|Withdrawal by Subject|4
7747247|NCT00720278|12182590|FG000|Overall Study|Adverse Event|5
7747248|NCT00720278|12182591|FG001|Overall Study|Adverse Event|3
7747249|NCT00720278|12182592|FG002|Overall Study|Adverse Event|4
7747250|NCT00720278|12182590|FG000|Overall Study|Withdrawal by Subject|0
7747251|NCT00720278|12182591|FG001|Overall Study|Withdrawal by Subject|1
7747252|NCT00720278|12182592|FG002|Overall Study|Withdrawal by Subject|0
7747253|NCT00720278|12182590|FG000|Overall Study|Lost to Follow-up|0
7747254|NCT00720278|12182591|FG001|Overall Study|Lost to Follow-up|0
7747255|NCT00720278|12182592|FG002|Overall Study|Lost to Follow-up|1
7747256|NCT00720278|12182590|FG000|Overall Study|Non-compliance|1
7747257|NCT00720278|12182591|FG001|Overall Study|Non-compliance|0
7747258|NCT00720278|12182592|FG002|Overall Study|Non-compliance|0
7747259|NCT00720278|12182590|FG000|Overall Study|eligibility criteria violation|1
7747260|NCT00720278|12182591|FG001|Overall Study|eligibility criteria violation|0
7747261|NCT00720278|12182592|FG002|Overall Study|eligibility criteria violation|1
7747262|NCT00720356|12182613|FG000|Registration to Study|Determined to have methylated MGMT|67
7747263|NCT00720356|12182613|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1
7747264|NCT00720356|12182613|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
7747265|NCT00720356|12182613|FG000|Went on to be Treated Cycle 3|Adverse Event|1
7747266|NCT00720356|12182613|FG000|Went on to be Treated Cycle 3|Physician Decision|1
7747267|NCT00720356|12182613|FG000|Follow up Until Death|Withdrawal by Subject|1
7747268|NCT00720356|12182613|FG000|Follow up Until Death|Alive at last data collection|4
7747269|NCT00720382|12182630|FG000|Overall Study|Adverse Event|54
7747270|NCT00720382|12182631|FG001|Overall Study|Adverse Event|17
7747271|NCT00720382|12182630|FG000|Overall Study|Lack of Efficacy|18
7747272|NCT00720382|12182631|FG001|Overall Study|Lack of Efficacy|7
7747273|NCT00720382|12182630|FG000|Overall Study|Non-Compliance|15
7747274|NCT00720382|12182631|FG001|Overall Study|Non-Compliance|5
7747275|NCT00720382|12182630|FG000|Overall Study|Withdrawal by Subject|47
7747276|NCT00720382|12182631|FG001|Overall Study|Withdrawal by Subject|11
7747277|NCT00720382|12182630|FG000|Overall Study|Lost to Follow-up|28
7747278|NCT00720382|12182631|FG001|Overall Study|Lost to Follow-up|14
7747279|NCT00720382|12182630|FG000|Overall Study|administrative|14
7747280|NCT00720382|12182631|FG001|Overall Study|administrative|5
7747281|NCT00720434|12182641|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
7747282|NCT00720434|12182642|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
7747283|NCT00720434|12182643|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
7747284|NCT00720434|12182644|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
7747285|NCT00720434|12182641|FG000|Open-Label Period (Week 5-72)|Adverse Event|0
7747286|NCT00720434|12182642|FG001|Open-Label Period (Week 5-72)|Adverse Event|0
7747287|NCT00720434|12182643|FG002|Open-Label Period (Week 5-72)|Adverse Event|0
7747288|NCT00720434|12182644|FG003|Open-Label Period (Week 5-72)|Adverse Event|2
7747289|NCT00720434|12182641|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1
7747290|NCT00720434|12182642|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0
7747291|NCT00720434|12182643|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0
7747292|NCT00720434|12182644|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0
7747293|NCT00720434|12182641|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
7747294|NCT00720434|12182642|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
7747295|NCT00720434|12182643|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
7747296|NCT00720434|12182644|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
7747297|NCT00720434|12182641|FG000|Open-Label Period (Week 5-72)|Other|4
7747298|NCT00720434|12182642|FG001|Open-Label Period (Week 5-72)|Other|3
7747299|NCT00720434|12182643|FG002|Open-Label Period (Week 5-72)|Other|3
7747300|NCT00720434|12182644|FG003|Open-Label Period (Week 5-72)|Other|2
7747301|NCT00720499|12182664|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2
7747302|NCT00720499|12182665|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0
7747303|NCT00720499|12182664|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1
7747304|NCT00720499|12182665|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2
7747305|NCT00720499|12182664|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2
7747306|NCT00720499|12182665|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3
7747307|NCT00720759|12182682|FG000|Overall Study|Lost to Follow-up|0
7747308|NCT00720759|12182683|FG001|Overall Study|Lost to Follow-up|1
7747309|NCT00720759|12182684|FG002|Overall Study|Lost to Follow-up|1
7747310|NCT00720759|12182685|FG003|Overall Study|Lost to Follow-up|0
7747311|NCT00720798|12182695|FG000|Overall Study|Adverse Event|304
7747312|NCT00720798|12182695|FG000|Overall Study|Death|39
7747313|NCT00720798|12182695|FG000|Overall Study|Insufficient Therapeutic Response|129
7747314|NCT00720798|12182695|FG000|Overall Study|Protocol Violation|4
7747315|NCT00720798|12182695|FG000|Overall Study|Refused Treatment|151
7747316|NCT00720798|12182695|FG000|Overall Study|Failure to Return|46
7747317|NCT00720798|12182695|FG000|Overall Study|Reason not Specified|83
7747318|NCT00720876|12182699|FG000|Overall Study|found to be ineligible after starting tx|2
7747319|NCT00720941|12182705|FG000|Overall Study|Death|334
7747320|NCT00720941|12182706|FG001|Overall Study|Death|335
7747321|NCT00720941|12182705|FG000|Overall Study|Protocol Violation|0
7747322|NCT00720941|12182706|FG001|Overall Study|Protocol Violation|2
7747323|NCT00720941|12182705|FG000|Overall Study|Lost to Follow-up|17
7747324|NCT00720941|12182706|FG001|Overall Study|Lost to Follow-up|15
7747325|NCT00720941|12182705|FG000|Overall Study|Physician Decision|1
7747326|NCT00720941|12182706|FG001|Overall Study|Physician Decision|5
7747327|NCT00720941|12182705|FG000|Overall Study|Withdrawal by Subject|27
7747328|NCT00720941|12182706|FG001|Overall Study|Withdrawal by Subject|35
7747329|NCT00720941|12182705|FG000|Overall Study|Ongoing|34
7747330|NCT00720941|12182706|FG001|Overall Study|Ongoing|23
7747331|NCT00721110|12182716|FG000|Overall Study|Ultram use|1
7747332|NCT00721110|12182717|FG001|Overall Study|Ultram use|0
7747333|NCT00721110|12182718|FG002|Overall Study|Ultram use|0
7747334|NCT00721110|12182719|FG003|Overall Study|Ultram use|0
7747335|NCT00721110|12182716|FG000|Overall Study|vertical incision|0
7747336|NCT00721110|12182717|FG001|Overall Study|vertical incision|0
7747337|NCT00721110|12182718|FG002|Overall Study|vertical incision|1
7747338|NCT00721110|12182719|FG003|Overall Study|vertical incision|0
7747339|NCT00721123|12182729|FG000|Overall Study|Adverse Event|96
7747340|NCT00721123|12182729|FG000|Overall Study|Death|10
7747341|NCT00721123|12182729|FG000|Overall Study|Insufficient Therapeutic Response|21
7747342|NCT00721123|12182729|FG000|Overall Study|Protocol Violation|1
7747343|NCT00721123|12182729|FG000|Overall Study|Refused Treatment|41
7747344|NCT00721123|12182729|FG000|Overall Study|Failure to Return|9
7747345|NCT00721123|12182729|FG000|Overall Study|Withdrawal by Subject|5
7769434|NCT00868790|12213062|FG004|Period 2|Lost to Follow-up|0
7769435|NCT00868790|12213063|FG005|Period 2|Lost to Follow-up|1
7769436|NCT00868790|12213064|FG006|Period 2|Lost to Follow-up|0
7769437|NCT00868790|12213065|FG007|Period 2|Lost to Follow-up|0
7769438|NCT00868790|12213066|FG008|Period 2|Lost to Follow-up|0
7769439|NCT00868790|12213067|FG009|Period 2|Lost to Follow-up|0
7769440|NCT00868790|12213068|FG010|Period 2|Lost to Follow-up|0
7769441|NCT00868790|12213069|FG011|Period 2|Lost to Follow-up|0
7769442|NCT00868790|12213070|FG012|Period 2|Lost to Follow-up|0
7769443|NCT00868790|12213071|FG013|Period 2|Lost to Follow-up|0
7769444|NCT00868790|12213058|FG000|Period 2|Withdrawal by Subject|0
7769445|NCT00868790|12213059|FG001|Period 2|Withdrawal by Subject|0
7769446|NCT00868790|12213060|FG002|Period 2|Withdrawal by Subject|0
7769447|NCT00868790|12213061|FG003|Period 2|Withdrawal by Subject|0
7769448|NCT00868790|12213062|FG004|Period 2|Withdrawal by Subject|0
7769449|NCT00868790|12213063|FG005|Period 2|Withdrawal by Subject|0
7769450|NCT00868790|12213064|FG006|Period 2|Withdrawal by Subject|0
7769451|NCT00868790|12213065|FG007|Period 2|Withdrawal by Subject|0
7769452|NCT00868790|12213066|FG008|Period 2|Withdrawal by Subject|1
7747346|NCT00721149|12182770|FG000|Overall Study|Physician Decision|1
7747347|NCT00721214|12182791|FG000|Overall Study|Chose another center for transplant|1
7747348|NCT00721214|12182791|FG000|Overall Study|Death|3
7747349|NCT00721227|12182797|FG000|Overall Study|Lost to Follow-up|3
7747350|NCT00721227|12182798|FG001|Overall Study|Lost to Follow-up|0
7747351|NCT00721227|12182797|FG000|Overall Study|Noncompliance with scheduled visits.|1
7747352|NCT00721227|12182798|FG001|Overall Study|Noncompliance with scheduled visits.|0
7747353|NCT00721279|12182816|FG000|Overall Study|Lack of Efficacy|6
7747354|NCT00721279|12182817|FG001|Overall Study|Lack of Efficacy|3
7747355|NCT00721279|12182816|FG000|Overall Study|Tolerability insufficient|5
7747356|NCT00721279|12182817|FG001|Overall Study|Tolerability insufficient|2
7747357|NCT00721279|12182816|FG000|Overall Study|Withdrawal by Subject|13
7747358|NCT00721279|12182817|FG001|Overall Study|Withdrawal by Subject|3
7747359|NCT00721279|12182816|FG000|Overall Study|Other|12
7747360|NCT00721279|12182817|FG001|Overall Study|Other|16
7747361|NCT00721396|12182839|FG000|Overall Study|Adverse Event|4
7747362|NCT00721396|12182840|FG001|Overall Study|Adverse Event|7
7747363|NCT00721396|12182841|FG002|Overall Study|Adverse Event|2
7747364|NCT00721396|12182842|FG003|Overall Study|Adverse Event|0
7747365|NCT00721396|12182839|FG000|Overall Study|Withdrawal by Subject|12
7747366|NCT00721396|12182840|FG001|Overall Study|Withdrawal by Subject|15
7747367|NCT00721396|12182841|FG002|Overall Study|Withdrawal by Subject|3
7747368|NCT00721396|12182842|FG003|Overall Study|Withdrawal by Subject|7
7747369|NCT00721396|12182839|FG000|Overall Study|Lost to Follow-up|7
7747370|NCT00721396|12182840|FG001|Overall Study|Lost to Follow-up|9
7747371|NCT00721396|12182841|FG002|Overall Study|Lost to Follow-up|3
7747372|NCT00721396|12182842|FG003|Overall Study|Lost to Follow-up|3
7747373|NCT00721396|12182839|FG000|Overall Study|Protocol Violation|4
7747374|NCT00721396|12182840|FG001|Overall Study|Protocol Violation|3
7747375|NCT00721396|12182841|FG002|Overall Study|Protocol Violation|1
7747376|NCT00721396|12182842|FG003|Overall Study|Protocol Violation|0
7747377|NCT00721396|12182839|FG000|Overall Study|Inappropriate enrollment|0
7747378|NCT00721396|12182840|FG001|Overall Study|Inappropriate enrollment|2
7747379|NCT00721396|12182841|FG002|Overall Study|Inappropriate enrollment|0
7747380|NCT00721396|12182842|FG003|Overall Study|Inappropriate enrollment|0
7747381|NCT00721396|12182839|FG000|Overall Study|Administrative reason|3
7747382|NCT00721396|12182840|FG001|Overall Study|Administrative reason|0
7747383|NCT00721396|12182841|FG002|Overall Study|Administrative reason|1
7747384|NCT00721396|12182842|FG003|Overall Study|Administrative reason|0
7747385|NCT00721409|12182860|FG000|Overall Study|Global deterioration of health status|2
7747386|NCT00721409|12182861|FG001|Overall Study|Global deterioration of health status|6
7747387|NCT00721409|12182862|FG002|Overall Study|Global deterioration of health status|3
7747388|NCT00721409|12182860|FG000|Overall Study|Death|0
7747389|NCT00721409|12182861|FG001|Overall Study|Death|1
7747390|NCT00721409|12182862|FG002|Overall Study|Death|0
7747391|NCT00721409|12182860|FG000|Overall Study|Randomized not Treated|0
7747392|NCT00721409|12182861|FG001|Overall Study|Randomized not Treated|1
7747393|NCT00721409|12182862|FG002|Overall Study|Randomized not Treated|4
7747394|NCT00721409|12182860|FG000|Overall Study|Reason not specified|1
7747395|NCT00721409|12182861|FG001|Overall Study|Reason not specified|0
7747396|NCT00721409|12182862|FG002|Overall Study|Reason not specified|2
7747397|NCT00721409|12182860|FG000|Overall Study|Adverse Event|0
7747398|NCT00721409|12182861|FG001|Overall Study|Adverse Event|13
7747399|NCT00721409|12182862|FG002|Overall Study|Adverse Event|2
7747400|NCT00721409|12182860|FG000|Overall Study|Lost to Follow-up|0
7747401|NCT00721409|12182861|FG001|Overall Study|Lost to Follow-up|0
7747402|NCT00721409|12182862|FG002|Overall Study|Lost to Follow-up|1
7747403|NCT00721409|12182860|FG000|Overall Study|Withdrawal by Subject|1
7747404|NCT00721409|12182861|FG001|Overall Study|Withdrawal by Subject|6
7747405|NCT00721409|12182862|FG002|Overall Study|Withdrawal by Subject|5
7747406|NCT00721409|12182860|FG000|Overall Study|Objective progression or relapse|8
7747407|NCT00721409|12182861|FG001|Overall Study|Objective progression or relapse|55
7747408|NCT00721409|12182862|FG002|Overall Study|Objective progression or relapse|62
7747409|NCT00721578|12182909|FG000|Overall Study|Death|1
7747410|NCT00721578|12182910|FG001|Overall Study|Death|1
7747411|NCT00721578|12182909|FG000|Overall Study|Withdrawal by Subject|1
7747412|NCT00721578|12182910|FG001|Overall Study|Withdrawal by Subject|1
7747413|NCT00721630|12182921|FG000|Overall Study|Participant found to be ineligible|1
7747414|NCT00721734|12182930|FG000|Overall Study|Progressive Disease|3
7747415|NCT00721734|12182931|FG001|Overall Study|Progressive Disease|10
7747416|NCT00721734|12182932|FG002|Overall Study|Progressive Disease|4
7747417|NCT00721734|12182933|FG003|Overall Study|Progressive Disease|5
7747418|NCT00721734|12182934|FG004|Overall Study|Progressive Disease|2
7747419|NCT00721734|12182930|FG000|Overall Study|Adverse Event|3
7747420|NCT00721734|12182931|FG001|Overall Study|Adverse Event|1
7747421|NCT00721734|12182932|FG002|Overall Study|Adverse Event|4
7747422|NCT00721734|12182933|FG003|Overall Study|Adverse Event|0
7747423|NCT00721734|12182934|FG004|Overall Study|Adverse Event|3
7747424|NCT00721734|12182930|FG000|Overall Study|Withdrawal by Subject|2
7747425|NCT00721734|12182931|FG001|Overall Study|Withdrawal by Subject|1
7747426|NCT00721734|12182932|FG002|Overall Study|Withdrawal by Subject|0
7747427|NCT00721734|12182933|FG003|Overall Study|Withdrawal by Subject|0
7747428|NCT00721734|12182934|FG004|Overall Study|Withdrawal by Subject|1
7747429|NCT00721734|12182930|FG000|Overall Study|Other|0
7747430|NCT00721734|12182931|FG001|Overall Study|Other|0
7747431|NCT00721734|12182932|FG002|Overall Study|Other|0
7747432|NCT00721734|12182933|FG003|Overall Study|Other|1
7747433|NCT00721734|12182934|FG004|Overall Study|Other|0
7747434|NCT00721799|12182946|FG000|Overall Study|Withdrawal by Subject|7
7747435|NCT00721799|12182946|FG000|Overall Study|withdraw by subject after scan 1|1
7747436|NCT00721955|12182953|FG000|Overall Study|Adverse Event|0
7747437|NCT00721955|12182954|FG001|Overall Study|Adverse Event|0
7747438|NCT00721955|12182955|FG002|Overall Study|Adverse Event|2
7747439|NCT00721968|12182965|FG000|Overall Study|Lost to Follow-up|2
7747440|NCT00721968|12182966|FG001|Overall Study|Lost to Follow-up|0
7747441|NCT00722137|12183016|FG000|Overall Study|Overt Disease Progression|5
7747442|NCT00722137|12183017|FG001|Overall Study|Overt Disease Progression|4
7747443|NCT00722137|12183016|FG000|Overall Study|Adverse Event|17
7747444|NCT00722137|12183017|FG001|Overall Study|Adverse Event|21
7747445|NCT00722137|12183016|FG000|Overall Study|Death|12
7747446|NCT00722137|12183017|FG001|Overall Study|Death|7
7747447|NCT00722137|12183016|FG000|Overall Study|Withdrawal by Subject|6
7747448|NCT00722137|12183017|FG001|Overall Study|Withdrawal by Subject|9
7747449|NCT00722137|12183016|FG000|Overall Study|Other Reason Unknown|3
7747450|NCT00722137|12183017|FG001|Overall Study|Other Reason Unknown|4
7747451|NCT00722137|12183016|FG000|Overall Study|Randomized But Not Treated|2
7747452|NCT00722137|12183017|FG001|Overall Study|Randomized But Not Treated|3
7747453|NCT00722371|12183030|FG000|Overall Study|Adverse Event|6
7747454|NCT00722371|12183031|FG001|Overall Study|Adverse Event|13
7747455|NCT00722371|12183032|FG002|Overall Study|Adverse Event|9
7747456|NCT00722371|12183033|FG003|Overall Study|Adverse Event|10
7747457|NCT00722371|12183034|FG004|Overall Study|Adverse Event|6
7747458|NCT00722371|12183035|FG005|Overall Study|Adverse Event|8
7747459|NCT00722371|12183036|FG006|Overall Study|Adverse Event|4
7747460|NCT00722371|12183030|FG000|Overall Study|Contraindication|0
7747461|NCT00722371|12183031|FG001|Overall Study|Contraindication|0
7747462|NCT00722371|12183032|FG002|Overall Study|Contraindication|1
7747463|NCT00722371|12183033|FG003|Overall Study|Contraindication|0
7747464|NCT00722371|12183034|FG004|Overall Study|Contraindication|0
7747465|NCT00722371|12183035|FG005|Overall Study|Contraindication|0
7747466|NCT00722371|12183036|FG006|Overall Study|Contraindication|0
7747467|NCT00722371|12183030|FG000|Overall Study|Creatinine / Creatinine clearance|2
7747468|NCT00722371|12183031|FG001|Overall Study|Creatinine / Creatinine clearance|1
7747469|NCT00722371|12183032|FG002|Overall Study|Creatinine / Creatinine clearance|2
7747470|NCT00722371|12183033|FG003|Overall Study|Creatinine / Creatinine clearance|3
7747471|NCT00722371|12183034|FG004|Overall Study|Creatinine / Creatinine clearance|2
7747472|NCT00722371|12183035|FG005|Overall Study|Creatinine / Creatinine clearance|1
7747473|NCT00722371|12183036|FG006|Overall Study|Creatinine / Creatinine clearance|1
7747474|NCT00722371|12183030|FG000|Overall Study|Excluded medication|0
7747475|NCT00722371|12183031|FG001|Overall Study|Excluded medication|1
7747476|NCT00722371|12183032|FG002|Overall Study|Excluded medication|1
7747477|NCT00722371|12183033|FG003|Overall Study|Excluded medication|0
7747478|NCT00722371|12183034|FG004|Overall Study|Excluded medication|0
7747479|NCT00722371|12183035|FG005|Overall Study|Excluded medication|0
7747480|NCT00722371|12183036|FG006|Overall Study|Excluded medication|1
7747481|NCT00722371|12183030|FG000|Overall Study|Hyperglycemia|2
7747482|NCT00722371|12183031|FG001|Overall Study|Hyperglycemia|6
7747483|NCT00722371|12183032|FG002|Overall Study|Hyperglycemia|4
7747484|NCT00722371|12183033|FG003|Overall Study|Hyperglycemia|2
7747485|NCT00722371|12183034|FG004|Overall Study|Hyperglycemia|5
7747486|NCT00722371|12183035|FG005|Overall Study|Hyperglycemia|1
7747487|NCT00722371|12183036|FG006|Overall Study|Hyperglycemia|1
7747488|NCT00722371|12183030|FG000|Overall Study|Hypoglycemia|1
7747489|NCT00722371|12183031|FG001|Overall Study|Hypoglycemia|0
7747490|NCT00722371|12183032|FG002|Overall Study|Hypoglycemia|0
7747491|NCT00722371|12183033|FG003|Overall Study|Hypoglycemia|0
7747492|NCT00722371|12183034|FG004|Overall Study|Hypoglycemia|0
7747493|NCT00722371|12183035|FG005|Overall Study|Hypoglycemia|0
7747494|NCT00722371|12183036|FG006|Overall Study|Hypoglycemia|0
7747495|NCT00722371|12183030|FG000|Overall Study|Lack of Efficacy|4
7747496|NCT00722371|12183031|FG001|Overall Study|Lack of Efficacy|6
7747497|NCT00722371|12183032|FG002|Overall Study|Lack of Efficacy|6
7747498|NCT00722371|12183033|FG003|Overall Study|Lack of Efficacy|6
7747499|NCT00722371|12183034|FG004|Overall Study|Lack of Efficacy|2
7747500|NCT00722371|12183035|FG005|Overall Study|Lack of Efficacy|3
7747501|NCT00722371|12183036|FG006|Overall Study|Lack of Efficacy|0
7747502|NCT00722371|12183030|FG000|Overall Study|Lost to Follow-up|11
7747503|NCT00722371|12183031|FG001|Overall Study|Lost to Follow-up|14
7747504|NCT00722371|12183032|FG002|Overall Study|Lost to Follow-up|21
7747505|NCT00722371|12183033|FG003|Overall Study|Lost to Follow-up|13
7747506|NCT00722371|12183034|FG004|Overall Study|Lost to Follow-up|8
7747507|NCT00722371|12183035|FG005|Overall Study|Lost to Follow-up|16
7747508|NCT00722371|12183036|FG006|Overall Study|Lost to Follow-up|13
7747509|NCT00722371|12183030|FG000|Overall Study|Physician Decision|5
7747510|NCT00722371|12183031|FG001|Overall Study|Physician Decision|2
7747511|NCT00722371|12183032|FG002|Overall Study|Physician Decision|2
7747512|NCT00722371|12183033|FG003|Overall Study|Physician Decision|5
7747513|NCT00722371|12183034|FG004|Overall Study|Physician Decision|2
7747514|NCT00722371|12183035|FG005|Overall Study|Physician Decision|3
7747515|NCT00722371|12183036|FG006|Overall Study|Physician Decision|4
7747516|NCT00722371|12183030|FG000|Overall Study|Pregnancy|1
7747517|NCT00722371|12183031|FG001|Overall Study|Pregnancy|1
7747518|NCT00722371|12183032|FG002|Overall Study|Pregnancy|0
7747519|NCT00722371|12183033|FG003|Overall Study|Pregnancy|0
7747520|NCT00722371|12183034|FG004|Overall Study|Pregnancy|0
7747521|NCT00722371|12183035|FG005|Overall Study|Pregnancy|1
7747522|NCT00722371|12183036|FG006|Overall Study|Pregnancy|0
7747523|NCT00722371|12183030|FG000|Overall Study|Protocol Violation|6
7747524|NCT00722371|12183031|FG001|Overall Study|Protocol Violation|1
7747525|NCT00722371|12183032|FG002|Overall Study|Protocol Violation|0
7747526|NCT00722371|12183033|FG003|Overall Study|Protocol Violation|1
7747527|NCT00722371|12183034|FG004|Overall Study|Protocol Violation|4
7747528|NCT00722371|12183035|FG005|Overall Study|Protocol Violation|2
7747529|NCT00722371|12183036|FG006|Overall Study|Protocol Violation|1
7747530|NCT00722371|12183030|FG000|Overall Study|Withdrawal by Subject|18
7747531|NCT00722371|12183031|FG001|Overall Study|Withdrawal by Subject|27
7747532|NCT00722371|12183032|FG002|Overall Study|Withdrawal by Subject|19
7747533|NCT00722371|12183033|FG003|Overall Study|Withdrawal by Subject|23
7747534|NCT00722371|12183034|FG004|Overall Study|Withdrawal by Subject|19
7747535|NCT00722371|12183035|FG005|Overall Study|Withdrawal by Subject|18
7747536|NCT00722371|12183036|FG006|Overall Study|Withdrawal by Subject|26
7747537|NCT00722423|12183054|FG000|Overall Study|Protocol Violation|0
7747538|NCT00722423|12183055|FG001|Overall Study|Protocol Violation|1
7747539|NCT00722761|12183104|FG000|Overall Study|Lost to Follow-up|1
7747540|NCT00722761|12183105|FG001|Overall Study|Lost to Follow-up|4
7747541|NCT00722761|12183104|FG000|Overall Study|Withdrawal by Subject|5
7747542|NCT00722761|12183105|FG001|Overall Study|Withdrawal by Subject|2
7747543|NCT00722800|12183113|FG000|Overall Study|Withdrawal by Subject|1
7747544|NCT00722800|12183114|FG001|Overall Study|Withdrawal by Subject|0
7747545|NCT00722800|12183113|FG000|Overall Study|Physician Decision|1
7747546|NCT00722800|12183114|FG001|Overall Study|Physician Decision|0
7747547|NCT00723008|12183126|FG000|Enrollment|Lost to Follow-up|1
7747548|NCT00723008|12183127|FG001|Enrollment|Lost to Follow-up|0
7747549|NCT00723008|12183126|FG000|4-Week Double Blinded|Lack of Efficacy|0
7747550|NCT00723008|12183127|FG001|4-Week Double Blinded|Lack of Efficacy|1
7747551|NCT00723008|12183126|FG000|4-Week Double Blinded|Withdrawal by Subject|1
7747552|NCT00723008|12183127|FG001|4-Week Double Blinded|Withdrawal by Subject|1
7747553|NCT00723008|12183126|FG000|4-Week Double Blinded|Lost to Follow-up|4
7747554|NCT00723008|12183127|FG001|4-Week Double Blinded|Lost to Follow-up|3
7747555|NCT00723008|12183126|FG000|4-Week Unblinded Treatment|Adverse Event|1
7747556|NCT00723008|12183127|FG001|4-Week Unblinded Treatment|Adverse Event|0
7747557|NCT00723008|12183126|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0
7747558|NCT00723008|12183127|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1
7747559|NCT00723021|12183141|FG000|Intervention Period 4|Adverse Event|0
7747560|NCT00723021|12183142|FG001|Intervention Period 4|Adverse Event|0
7747561|NCT00723021|12183143|FG002|Intervention Period 4|Adverse Event|0
7747562|NCT00723021|12183144|FG003|Intervention Period 4|Adverse Event|0
7747563|NCT00723021|12183145|FG004|Intervention Period 4|Adverse Event|1
7747564|NCT00723125|12183180|FG000|Overall Study|Met Dx|1
7747565|NCT00723125|12183181|FG001|Overall Study|Met Dx|0
7747566|NCT00723125|12183180|FG000|Overall Study|Withdrawal by Subject|15
7747567|NCT00723125|12183181|FG001|Overall Study|Withdrawal by Subject|6
7747568|NCT00723125|12183180|FG000|Overall Study|Adverse Event|2
7747569|NCT00723125|12183181|FG001|Overall Study|Adverse Event|0
7747570|NCT00723190|12183206|FG000|Overall Study|Withdrawal by Subject|45
7747571|NCT00723190|12183206|FG000|Overall Study|Lost to Follow-up|37
7747572|NCT00723190|12183206|FG000|Overall Study|Adverse Event|18
7747573|NCT00723190|12183206|FG000|Overall Study|Lack of Efficacy|16
7747574|NCT00723190|12183206|FG000|Overall Study|Protocol Violation|15
7747575|NCT00723190|12183206|FG000|Overall Study|Other-Premature Discontinuation|9
7747576|NCT00723190|12183206|FG000|Overall Study|Other-Not included in safety population|2
7747577|NCT00723203|12183210|FG000|Overall Study|Withdrawal by Subject|3
7747578|NCT00723229|12183216|FG000|First Intervention|Lost to Follow-up|7
7747579|NCT00723229|12183217|FG001|First Intervention|Lost to Follow-up|3
7747580|NCT00723255|12183223|FG000|Overall Study|Ineligible: Inadequate pathology|1
7747581|NCT00723255|12183223|FG000|Overall Study|Ineligible: Second primary|1
7747582|NCT00723255|12183223|FG000|Overall Study|Ineligible: Wrong Primary|2
7747583|NCT00723294|12183239|FG000|Overall Study|Lobular histology|2
7747584|NCT00723294|12183239|FG000|Overall Study|>25% intraductal component|1
7747585|NCT00723294|12183239|FG000|Overall Study|No MRI tumor enhancement|1
7747586|NCT00723294|12183239|FG000|Overall Study|1.0-Tesla MRI|1
7747587|NCT00723294|12183239|FG000|Overall Study|No cryoabalation|2
7747588|NCT00723294|12183239|FG000|Overall Study|Did not undergo surgery|1
7747589|NCT00723294|12183239|FG000|Overall Study|Treated prior to registration|1
7747590|NCT00723294|12183239|FG000|Overall Study|Treated by non-credentialed surgeon|1
7747591|NCT00723294|12183239|FG000|Overall Study|Benign lesion|1
7747592|NCT00723294|12183239|FG000|Overall Study|Withdrawal by Subject|1
7747593|NCT00723294|12183239|FG000|Overall Study|No treatment due to probe failure|1
7747594|NCT00723398|12183248|FG000|Overall Study|Withdrawal by Subject|2
7747595|NCT00723398|12183249|FG001|Overall Study|Withdrawal by Subject|6
7747596|NCT00723398|12183250|FG002|Overall Study|Withdrawal by Subject|4
7747597|NCT00723398|12183251|FG003|Overall Study|Withdrawal by Subject|4
7747598|NCT00723398|12183252|FG004|Overall Study|Withdrawal by Subject|4
7747599|NCT00723398|12183248|FG000|Overall Study|Protocol Violation|2
7747600|NCT00723398|12183249|FG001|Overall Study|Protocol Violation|1
7747601|NCT00723398|12183250|FG002|Overall Study|Protocol Violation|5
7747602|NCT00723398|12183251|FG003|Overall Study|Protocol Violation|0
7747603|NCT00723398|12183252|FG004|Overall Study|Protocol Violation|0
7747604|NCT00723398|12183248|FG000|Overall Study|Physician Decision|2
7747605|NCT00723398|12183249|FG001|Overall Study|Physician Decision|2
7747606|NCT00723398|12183250|FG002|Overall Study|Physician Decision|5
7747607|NCT00723398|12183251|FG003|Overall Study|Physician Decision|0
7747608|NCT00723398|12183252|FG004|Overall Study|Physician Decision|1
7747609|NCT00723398|12183248|FG000|Overall Study|Adverse Event|0
7747610|NCT00723398|12183249|FG001|Overall Study|Adverse Event|5
7747611|NCT00723398|12183250|FG002|Overall Study|Adverse Event|3
7747612|NCT00723398|12183251|FG003|Overall Study|Adverse Event|1
7747613|NCT00723398|12183252|FG004|Overall Study|Adverse Event|4
7747614|NCT00723398|12183248|FG000|Overall Study|Lost to Follow-up|0
7747615|NCT00723398|12183249|FG001|Overall Study|Lost to Follow-up|1
7747616|NCT00723398|12183250|FG002|Overall Study|Lost to Follow-up|0
7747617|NCT00723398|12183251|FG003|Overall Study|Lost to Follow-up|0
7747618|NCT00723398|12183252|FG004|Overall Study|Lost to Follow-up|0
7747619|NCT00723450|12183266|FG000|Open-Label Phase|Adverse Event|26
7747620|NCT00723450|12183267|FG001|Open-Label Phase|Adverse Event|0
7747621|NCT00723450|12183268|FG002|Open-Label Phase|Adverse Event|0
7747622|NCT00723450|12183266|FG000|Open-Label Phase|Lack of Efficacy|18
7747623|NCT00723450|12183267|FG001|Open-Label Phase|Lack of Efficacy|0
7747624|NCT00723450|12183268|FG002|Open-Label Phase|Lack of Efficacy|0
7747625|NCT00723450|12183266|FG000|Open-Label Phase|Protocol Violation|35
7747626|NCT00723450|12183267|FG001|Open-Label Phase|Protocol Violation|0
7747627|NCT00723450|12183268|FG002|Open-Label Phase|Protocol Violation|0
7747628|NCT00723450|12183266|FG000|Open-Label Phase|Lost to Follow-up|7
7747629|NCT00723450|12183267|FG001|Open-Label Phase|Lost to Follow-up|0
7747630|NCT00723450|12183268|FG002|Open-Label Phase|Lost to Follow-up|0
7747631|NCT00723450|12183266|FG000|Open-Label Phase|Physician Decision|2
7747632|NCT00723450|12183267|FG001|Open-Label Phase|Physician Decision|0
7747633|NCT00723450|12183268|FG002|Open-Label Phase|Physician Decision|0
7747634|NCT00723450|12183266|FG000|Open-Label Phase|Withdrawal by Subject|37
7747635|NCT00723450|12183267|FG001|Open-Label Phase|Withdrawal by Subject|0
7747636|NCT00723450|12183268|FG002|Open-Label Phase|Withdrawal by Subject|0
7747637|NCT00723450|12183266|FG000|Randomized Phase|Adverse Event|0
7747638|NCT00723450|12183267|FG001|Randomized Phase|Adverse Event|26
7747639|NCT00723450|12183268|FG002|Randomized Phase|Adverse Event|17
7747640|NCT00723450|12183266|FG000|Randomized Phase|Lack of Efficacy|0
7747641|NCT00723450|12183267|FG001|Randomized Phase|Lack of Efficacy|11
7747642|NCT00723450|12183268|FG002|Randomized Phase|Lack of Efficacy|11
7747643|NCT00723450|12183266|FG000|Randomized Phase|Protocol Violation|0
7747644|NCT00723450|12183267|FG001|Randomized Phase|Protocol Violation|9
7747645|NCT00723450|12183268|FG002|Randomized Phase|Protocol Violation|13
7747646|NCT00723450|12183266|FG000|Randomized Phase|Lost to Follow-up|0
7747647|NCT00723450|12183267|FG001|Randomized Phase|Lost to Follow-up|2
7747648|NCT00723450|12183268|FG002|Randomized Phase|Lost to Follow-up|3
7747649|NCT00723450|12183266|FG000|Randomized Phase|Physician Decision|0
7747650|NCT00723450|12183267|FG001|Randomized Phase|Physician Decision|3
7747651|NCT00723450|12183268|FG002|Randomized Phase|Physician Decision|1
7747652|NCT00723450|12183266|FG000|Randomized Phase|Withdrawal by Subject|0
7747653|NCT00723450|12183267|FG001|Randomized Phase|Withdrawal by Subject|14
7747654|NCT00723450|12183268|FG002|Randomized Phase|Withdrawal by Subject|22
7747655|NCT00723489|12183281|FG000|Overall Study|Physician Decision|0
7747656|NCT00723489|12183282|FG001|Overall Study|Physician Decision|1
7747657|NCT00723489|12183283|FG002|Overall Study|Physician Decision|0
7747658|NCT00723489|12183284|FG003|Overall Study|Physician Decision|0
7962267|NCT02711345|12516525|FG003|Overall Study|Physician Decision|0
7747659|NCT00723489|12183281|FG000|Overall Study|Pregnancy|0
7747660|NCT00723489|12183282|FG001|Overall Study|Pregnancy|0
7747661|NCT00723489|12183283|FG002|Overall Study|Pregnancy|0
7747662|NCT00723489|12183284|FG003|Overall Study|Pregnancy|1
7747663|NCT00723489|12183281|FG000|Overall Study|Withdrawal by Subject|0
7747664|NCT00723489|12183282|FG001|Overall Study|Withdrawal by Subject|0
7747665|NCT00723489|12183283|FG002|Overall Study|Withdrawal by Subject|0
7747666|NCT00723489|12183284|FG003|Overall Study|Withdrawal by Subject|1
7747667|NCT00723489|12183281|FG000|Overall Study|Seropositive at baseline|1
7747668|NCT00723489|12183282|FG001|Overall Study|Seropositive at baseline|0
7747669|NCT00723489|12183283|FG002|Overall Study|Seropositive at baseline|0
7747670|NCT00723489|12183284|FG003|Overall Study|Seropositive at baseline|0
7747671|NCT00723489|12183281|FG000|Overall Study|Prohibited Medication|0
7747672|NCT00723489|12183282|FG001|Overall Study|Prohibited Medication|0
7747673|NCT00723489|12183283|FG002|Overall Study|Prohibited Medication|0
7747674|NCT00723489|12183284|FG003|Overall Study|Prohibited Medication|1
7747675|NCT00723489|12183281|FG000|Overall Study|Samples Collected Out of Window|0
7747676|NCT00723489|12183282|FG001|Overall Study|Samples Collected Out of Window|3
7747677|NCT00723489|12183283|FG002|Overall Study|Samples Collected Out of Window|0
7747678|NCT00723489|12183284|FG003|Overall Study|Samples Collected Out of Window|0
7747679|NCT00723528|12183297|FG000|Period 1: Controlled Period (CP)|Adverse Event|0
7747680|NCT00723528|12183298|FG001|Period 1: Controlled Period (CP)|Adverse Event|0
7747681|NCT00723528|12183299|FG002|Period 1: Controlled Period (CP)|Adverse Event|1
7747682|NCT00723528|12183300|FG003|Period 1: Controlled Period (CP)|Adverse Event|0
7747683|NCT00723528|12183301|FG004|Period 1: Controlled Period (CP)|Adverse Event|0
7747684|NCT00723528|12183302|FG005|Period 1: Controlled Period (CP)|Adverse Event|0
7747685|NCT00723528|12183303|FG006|Period 1: Controlled Period (CP)|Adverse Event|0
7747686|NCT00723528|12183297|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
7747687|NCT00723528|12183298|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7747688|NCT00723528|12183299|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7747689|NCT00723528|12183300|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7747690|NCT00723528|12183301|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7747691|NCT00723528|12183302|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7747692|NCT00723528|12183303|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7747693|NCT00723528|12183297|FG000|Period 1: Controlled Period (CP)|Physician Decision|0
7747694|NCT00723528|12183298|FG001|Period 1: Controlled Period (CP)|Physician Decision|0
7747695|NCT00723528|12183299|FG002|Period 1: Controlled Period (CP)|Physician Decision|1
7747696|NCT00723528|12183300|FG003|Period 1: Controlled Period (CP)|Physician Decision|0
7747697|NCT00723528|12183301|FG004|Period 1: Controlled Period (CP)|Physician Decision|0
7747698|NCT00723528|12183302|FG005|Period 1: Controlled Period (CP)|Physician Decision|0
7747699|NCT00723528|12183303|FG006|Period 1: Controlled Period (CP)|Physician Decision|0
7747700|NCT00723528|12183297|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7747701|NCT00723528|12183298|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7747702|NCT00723528|12183299|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
7747703|NCT00723528|12183300|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7747704|NCT00723528|12183301|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7747705|NCT00723528|12183302|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7747706|NCT00723528|12183303|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7747707|NCT00723528|12183297|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
7747708|NCT00723528|12183298|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
7747709|NCT00723528|12183299|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
7747710|NCT00723528|12183300|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
7747711|NCT00723528|12183301|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
7747712|NCT00723528|12183302|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
7747713|NCT00723528|12183303|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
7747714|NCT00723528|12183297|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0
7747715|NCT00723528|12183298|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0
7747716|NCT00723528|12183299|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0
7747717|NCT00723528|12183300|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1
7747718|NCT00723528|12183301|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0
7747719|NCT00723528|12183302|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1
7747720|NCT00723528|12183303|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1
7747721|NCT00723528|12183297|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7747722|NCT00723528|12183298|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7747723|NCT00723528|12183299|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7747724|NCT00723528|12183300|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7747725|NCT00723528|12183301|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7747726|NCT00723528|12183302|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1
7747727|NCT00723528|12183303|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7747728|NCT00723528|12183297|FG000|Period 2: After Controlled Period|Other|0
7747729|NCT00723528|12183298|FG001|Period 2: After Controlled Period|Other|0
7747730|NCT00723528|12183299|FG002|Period 2: After Controlled Period|Other|0
7747731|NCT00723528|12183300|FG003|Period 2: After Controlled Period|Other|0
7747732|NCT00723528|12183301|FG004|Period 2: After Controlled Period|Other|1
7747733|NCT00723528|12183302|FG005|Period 2: After Controlled Period|Other|4
7747734|NCT00723528|12183303|FG006|Period 2: After Controlled Period|Other|0
7747735|NCT00723528|12183297|FG000|Period 2: After Controlled Period|Adverse Event|0
7747736|NCT00723528|12183298|FG001|Period 2: After Controlled Period|Adverse Event|0
7747737|NCT00723528|12183299|FG002|Period 2: After Controlled Period|Adverse Event|0
7747738|NCT00723528|12183300|FG003|Period 2: After Controlled Period|Adverse Event|0
7747739|NCT00723528|12183301|FG004|Period 2: After Controlled Period|Adverse Event|1
7747740|NCT00723528|12183302|FG005|Period 2: After Controlled Period|Adverse Event|0
7747741|NCT00723528|12183303|FG006|Period 2: After Controlled Period|Adverse Event|1
7747742|NCT00723528|12183297|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7747743|NCT00723528|12183298|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7747744|NCT00723528|12183299|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7747745|NCT00723528|12183300|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7747746|NCT00723528|12183301|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7747747|NCT00723528|12183302|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7747748|NCT00723528|12183303|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
7747749|NCT00723528|12183297|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7747750|NCT00723528|12183298|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7769453|NCT00868790|12213067|FG009|Period 2|Withdrawal by Subject|0
7747751|NCT00723528|12183299|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7747752|NCT00723528|12183300|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7747753|NCT00723528|12183301|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7747754|NCT00723528|12183302|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7747755|NCT00723528|12183303|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
7747756|NCT00723554|12183319|FG000|Overall Study|Adverse Event|12
7747757|NCT00723554|12183319|FG000|Overall Study|Investigator's judgement|5
7747758|NCT00723554|12183319|FG000|Overall Study|Inhaled medication other than iloprost|4
7747759|NCT00723554|12183319|FG000|Overall Study|Withdrawal of consent|3
7747760|NCT00723554|12183319|FG000|Overall Study|Other|3
7747761|NCT00723554|12183319|FG000|Overall Study|Lost to Follow-up|1
7747762|NCT00723554|12183319|FG000|Overall Study|Non-compliance|1
7747763|NCT00723606|12183331|FG000|Overall Study|Adverse Event|2
7747764|NCT00723606|12183332|FG001|Overall Study|Adverse Event|5
7747765|NCT00723606|12183331|FG000|Overall Study|Other|2
7747766|NCT00723606|12183332|FG001|Overall Study|Other|0
7747767|NCT00723606|12183331|FG000|Overall Study|Withdrawal by Subject|0
7747768|NCT00723606|12183332|FG001|Overall Study|Withdrawal by Subject|2
7747769|NCT00723697|12183346|FG000|Overall Study|Physician questionnaires not received|2
7747770|NCT00723697|12183346|FG000|Overall Study|Missing Informed Consent Form|10
7747771|NCT00723697|12183346|FG000|Overall Study|Other exclusion criteria applied|6
7747772|NCT00723710|12183353|FG000|Overall Study|Disease progression|48
7747773|NCT00723710|12183353|FG000|Overall Study|Adverse Event|88
7747774|NCT00723710|12183353|FG000|Overall Study|Withdrawal by Subject|36
7747775|NCT00723710|12183353|FG000|Overall Study|Physician Decision|2
7747776|NCT00723801|12183369|FG000|Overall Study|Lost to Follow-up|1
7747777|NCT00723801|12183370|FG001|Overall Study|Lost to Follow-up|2
7747778|NCT00723801|12183369|FG000|Overall Study|Protocol Violation|2
7747779|NCT00723801|12183370|FG001|Overall Study|Protocol Violation|1
7747780|NCT00723840|12183380|FG000|Overall Study|Lost to Follow-up|2
7747781|NCT00723840|12183380|FG000|Overall Study|Failure to return|18
7747782|NCT00723840|12183380|FG000|Overall Study|Withdrawal by Subject|55
7747783|NCT00723840|12183380|FG000|Overall Study|Serious Adverse Events|3
7747784|NCT00723840|12183380|FG000|Overall Study|Other Medical Event|2
7747785|NCT00723840|12183380|FG000|Overall Study|Unspecified reason|2
7747786|NCT00723892|12183393|FG000|Overall Study|Participant not tracked|33
7747787|NCT00723892|12183394|FG001|Overall Study|Participant not tracked|35
7747788|NCT00723892|12183393|FG000|Overall Study|Virological criterion|24
7747789|NCT00723892|12183394|FG001|Overall Study|Virological criterion|9
7747790|NCT00723892|12183393|FG000|Overall Study|Withdrawal by Subject|6
7747791|NCT00723892|12183394|FG001|Overall Study|Withdrawal by Subject|9
7747792|NCT00723892|12183393|FG000|Overall Study|End planned|11
7747793|NCT00723892|12183394|FG001|Overall Study|End planned|7
7747794|NCT00723892|12183393|FG000|Overall Study|Bad tolerance|5
7747795|NCT00723892|12183394|FG001|Overall Study|Bad tolerance|5
7747796|NCT00723892|12183393|FG000|Overall Study|Multiple reasons|17
7747797|NCT00723892|12183394|FG001|Overall Study|Multiple reasons|12
7747798|NCT00723892|12183393|FG000|Overall Study|Other|6
7747799|NCT00723892|12183394|FG001|Overall Study|Other|3
7747800|NCT00723892|12183393|FG000|Overall Study|Study end|1
7747801|NCT00723892|12183394|FG001|Overall Study|Study end|3
7747802|NCT00723892|12183393|FG000|Overall Study|Weight loss|1
7747803|NCT00723892|12183394|FG001|Overall Study|Weight loss|3
7747804|NCT00723892|12183393|FG000|Overall Study|Alcohol abuse|0
7747805|NCT00723892|12183394|FG001|Overall Study|Alcohol abuse|1
7747806|NCT00723892|12183393|FG000|Overall Study|Intercurrent infection|2
7747807|NCT00723892|12183394|FG001|Overall Study|Intercurrent infection|0
7747808|NCT00723892|12183393|FG000|Overall Study|Drug addiction|1
7747809|NCT00723892|12183394|FG001|Overall Study|Drug addiction|0
7747810|NCT00723957|12183406|FG000|Overall Study|Adverse event unrelated to study drug|1
7747811|NCT00723957|12183407|FG001|Overall Study|Adverse event unrelated to study drug|4
7747812|NCT00723957|12183406|FG000|Overall Study|Death|3
7747813|NCT00723957|12183407|FG001|Overall Study|Death|4
7747814|NCT00723957|12183406|FG000|Overall Study|Disease progression|27
7747815|NCT00723957|12183407|FG001|Overall Study|Disease progression|25
7747816|NCT00723957|12183406|FG000|Overall Study|Maximum clinical benefit|4
7747817|NCT00723957|12183407|FG001|Overall Study|Maximum clinical benefit|5
7747818|NCT00723957|12183406|FG000|Overall Study|Investigator decision|1
7747819|NCT00723957|12183407|FG001|Overall Study|Investigator decision|1
7747820|NCT00723957|12183406|FG000|Overall Study|Study drug toxicity|4
7747821|NCT00723957|12183407|FG001|Overall Study|Study drug toxicity|6
7747822|NCT00723957|12183406|FG000|Overall Study|Withdrawal by Subject|7
7747823|NCT00723957|12183407|FG001|Overall Study|Withdrawal by Subject|5
7747824|NCT00723957|12183406|FG000|Overall Study|Reason not analyzed|1
7747825|NCT00723957|12183407|FG001|Overall Study|Reason not analyzed|0
7747826|NCT00723957|12183406|FG000|Overall Study|Never received treatment|3
7747827|NCT00723957|12183407|FG001|Overall Study|Never received treatment|3
7747828|NCT00724061|12183417|FG000|Dose Escalation Phase|Adverse Event|2
7747829|NCT00724061|12183417|FG000|Dose Escalation Phase|Disease Progression|3
7747830|NCT00724126|12183423|FG000|Overall Study|Adverse Event|2
7747831|NCT00724126|12183424|FG001|Overall Study|Adverse Event|0
7747832|NCT00724126|12183423|FG000|Overall Study|Withdrawal by Subject|8
7747833|NCT00724126|12183424|FG001|Overall Study|Withdrawal by Subject|6
7747834|NCT00724126|12183423|FG000|Overall Study|Lost to Follow-up|6
7747835|NCT00724126|12183424|FG001|Overall Study|Lost to Follow-up|6
7747836|NCT00724126|12183423|FG000|Overall Study|Noncompliance|2
7747837|NCT00724126|12183424|FG001|Overall Study|Noncompliance|1
7747838|NCT00724126|12183423|FG000|Overall Study|Subject randomized although ineligible|1
7747839|NCT00724126|12183424|FG001|Overall Study|Subject randomized although ineligible|1
7747840|NCT00724126|12183423|FG000|Overall Study|Subject had to leave vicinity of site|0
7747841|NCT00724126|12183424|FG001|Overall Study|Subject had to leave vicinity of site|1
7747842|NCT00724152|12183435|FG000|Two-arm Study Period|Withdrawal by Subject|3
7747843|NCT00724152|12183436|FG001|Two-arm Study Period|Withdrawal by Subject|2
7747844|NCT00724152|12183437|FG002|Two-arm Study Period|Withdrawal by Subject|0
7747845|NCT00724152|12183435|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
7747846|NCT00724152|12183436|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
7747847|NCT00724152|12183437|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
7747848|NCT00724243|12183447|FG000|Overall Study|Lack of Efficacy|10
7747849|NCT00724243|12183447|FG000|Overall Study|Adverse Event|5
7747850|NCT00724373|12183464|FG000|Overall Study|Adverse Event|41
7747851|NCT00724373|12183464|FG000|Overall Study|Lack of Efficacy|82
7747852|NCT00724373|12183464|FG000|Overall Study|Lost to Follow-up|7
7747853|NCT00724373|12183464|FG000|Overall Study|Non-compliance|2
7747854|NCT00724373|12183464|FG000|Overall Study|HCV RNA negative after 4 weeks|9
7747855|NCT00724373|12183464|FG000|Overall Study|Participant moved away|1
7747856|NCT00724373|12183464|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
7747857|NCT00724373|12183464|FG000|Overall Study|Only to have 24 week regimen|1
7747858|NCT00724373|12183464|FG000|Overall Study|Viral Relapse|1
7747859|NCT00724373|12183464|FG000|Overall Study|Acute HCV infection|1
7747860|NCT00724373|12183464|FG000|Overall Study|Drug Relapse|1
7747861|NCT00724373|12183464|FG000|Overall Study|Tolerability|23
7747862|NCT00724451|12183468|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7
7747863|NCT00724451|12183468|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3
7747864|NCT00724451|12183468|FG000|Overall Study|Not Eligible for Treatment|431
7747865|NCT00724451|12183468|FG000|Overall Study|Participant Refused Treatment|89
7747866|NCT00724451|12183468|FG000|Overall Study|Never Started Treatment|89
7747867|NCT00724451|12183468|FG000|Overall Study|Unknown; No Data Sources Available|9
7747868|NCT00724451|12183468|FG000|Overall Study|Physician Decision|116
7747869|NCT00724451|12183468|FG000|Overall Study|Withdrawal by Subject|45
7747870|NCT00724451|12183468|FG000|Overall Study|Investigator + Participant Decision|13
7747871|NCT00724503|12183479|FG000|Overall Study|Lost to Follow-up|4
7747872|NCT00724503|12183480|FG001|Overall Study|Lost to Follow-up|8
7747873|NCT00724503|12183479|FG000|Overall Study|Withdrawal by Subject|11
7747874|NCT00724503|12183480|FG001|Overall Study|Withdrawal by Subject|23
7747875|NCT00724503|12183479|FG000|Overall Study|Death|190
7747876|NCT00724503|12183480|FG001|Overall Study|Death|182
7747877|NCT00724503|12183479|FG000|Overall Study|Adverse Event|1
7747878|NCT00724503|12183480|FG001|Overall Study|Adverse Event|0
7747879|NCT00724503|12183479|FG000|Overall Study|Not otherwise specified|4
7747880|NCT00724503|12183480|FG001|Overall Study|Not otherwise specified|7
7747881|NCT00724711|12183527|FG000|Overall Study|Adverse Event|7
7747882|NCT00724711|12183528|FG001|Overall Study|Adverse Event|3
7747883|NCT00724711|12183527|FG000|Overall Study|Pregnancy|0
7747884|NCT00724711|12183528|FG001|Overall Study|Pregnancy|1
7747885|NCT00724711|12183527|FG000|Overall Study|Lack of Efficacy|0
7747886|NCT00724711|12183528|FG001|Overall Study|Lack of Efficacy|1
7747887|NCT00724711|12183527|FG000|Overall Study|Physician Decision|0
7747888|NCT00724711|12183528|FG001|Overall Study|Physician Decision|3
7747889|NCT00724711|12183527|FG000|Overall Study|Withdrawal by Subject|5
7747890|NCT00724711|12183528|FG001|Overall Study|Withdrawal by Subject|4
7747891|NCT00724711|12183527|FG000|Overall Study|Lost to Follow-up|4
7747892|NCT00724711|12183528|FG001|Overall Study|Lost to Follow-up|5
7747893|NCT00724711|12183527|FG000|Overall Study|Protocol Violation|1
7747894|NCT00724711|12183528|FG001|Overall Study|Protocol Violation|0
7747895|NCT00724815|12183545|FG000|Overall Study|Randomized, not treated|31
7747896|NCT00724815|12183546|FG001|Overall Study|Randomized, not treated|30
7747897|NCT00724815|12183545|FG000|Overall Study|Adverse Event|5
7747898|NCT00724815|12183546|FG001|Overall Study|Adverse Event|3
7747899|NCT00724815|12183545|FG000|Overall Study|Lost to Follow-up|4
7747900|NCT00724815|12183546|FG001|Overall Study|Lost to Follow-up|1
7747901|NCT00724815|12183545|FG000|Overall Study|Other Various|3
7747902|NCT00724815|12183546|FG001|Overall Study|Other Various|5
7747903|NCT00724854|12183554|FG000|Overall Study|Lack of Efficacy|187
7747904|NCT00724854|12183555|FG001|Overall Study|Lack of Efficacy|13
7747905|NCT00724854|12183554|FG000|Overall Study|Lost to Follow-up|87
7747906|NCT00724854|12183555|FG001|Overall Study|Lost to Follow-up|10
7747907|NCT00724854|12183554|FG000|Overall Study|Adverse Event|62
7747908|NCT00724854|12183555|FG001|Overall Study|Adverse Event|4
7747909|NCT00724854|12183554|FG000|Overall Study|Other|42
7747910|NCT00724854|12183555|FG001|Overall Study|Other|3
7747911|NCT00724854|12183554|FG000|Overall Study|Death|11
7747912|NCT00724854|12183555|FG001|Overall Study|Death|0
7747913|NCT00724854|12183554|FG000|Overall Study|Change of treatment|7
7747914|NCT00724854|12183555|FG001|Overall Study|Change of treatment|0
7747915|NCT00724854|12183554|FG000|Overall Study|Withdrawal by Subject|5
7747916|NCT00724854|12183555|FG001|Overall Study|Withdrawal by Subject|0
7747917|NCT00724854|12183554|FG000|Overall Study|Adverse event + lack of efficacy|2
7747918|NCT00724854|12183555|FG001|Overall Study|Adverse event + lack of efficacy|1
7747919|NCT00724867|12183562|FG000|Overall Study|Adverse Event|25
7747920|NCT00724867|12183562|FG000|Overall Study|Lack of Efficacy|14
7747921|NCT00724867|12183562|FG000|Overall Study|Lost to Follow-up|12
7747922|NCT00724867|12183562|FG000|Overall Study|Non-compliance with study drug|6
7747923|NCT00724867|12183562|FG000|Overall Study|Physician Decision|17
7747924|NCT00724867|12183562|FG000|Overall Study|Protocol Violation|1
7747925|NCT00724867|12183562|FG000|Overall Study|Withdrawal by Subject|31
7747926|NCT00724867|12183562|FG000|Overall Study|Sponsor decision to end study|14
7747927|NCT00724867|12183562|FG000|Overall Study|Subject incarcerated|1
7747928|NCT00724867|12183562|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4
7747929|NCT00724867|12183562|FG000|Overall Study|Subject moved out of state|1
7747930|NCT00724867|12183562|FG000|Overall Study|Elected to exit due to site closure|2
7747931|NCT00724893|12183571|FG000|Overall Study|Adverse Event|76
7747932|NCT00724893|12183572|FG001|Overall Study|Adverse Event|142
7747933|NCT00724893|12183571|FG000|Overall Study|Withdrawal by Subject|0
7747934|NCT00724893|12183572|FG001|Overall Study|Withdrawal by Subject|1
7747935|NCT00724893|12183571|FG000|Overall Study|Lack of virologic response|94
7747936|NCT00724893|12183572|FG001|Overall Study|Lack of virologic response|202
7747937|NCT00724893|12183571|FG000|Overall Study|Reason not specified|193
7747938|NCT00724893|12183572|FG001|Overall Study|Reason not specified|7
7747939|NCT00724893|12183571|FG000|Overall Study|Patient choice|0
7747940|NCT00724893|12183572|FG001|Overall Study|Patient choice|26
7747941|NCT00724893|12183571|FG000|Overall Study|Geographic reasons|0
7747942|NCT00724893|12183572|FG001|Overall Study|Geographic reasons|11
7747943|NCT00724893|12183571|FG000|Overall Study|Incarceration|0
7747944|NCT00724893|12183572|FG001|Overall Study|Incarceration|9
7747945|NCT00724893|12183571|FG000|Overall Study|Substance abuse|0
7747946|NCT00724893|12183572|FG001|Overall Study|Substance abuse|3
7747947|NCT00724893|12183571|FG000|Overall Study|Financial reasons|0
7747948|NCT00724893|12183572|FG001|Overall Study|Financial reasons|2
7747949|NCT00724893|12183571|FG000|Overall Study|Assigned shorter treatment|0
7747950|NCT00724893|12183572|FG001|Overall Study|Assigned shorter treatment|2
7747951|NCT00724893|12183571|FG000|Overall Study|Lost to Follow-up|0
7747952|NCT00724893|12183572|FG001|Overall Study|Lost to Follow-up|52
7747953|NCT00724893|12183571|FG000|Overall Study|Unknown, missing data|1
7747954|NCT00724893|12183572|FG001|Overall Study|Unknown, missing data|1
7747955|NCT00724932|12183595|FG000|Overall Study|Lost to Follow-up|1
7747956|NCT00724932|12183596|FG001|Overall Study|Lost to Follow-up|0
7747957|NCT00724932|12183595|FG000|Overall Study|Not treated|4
7747958|NCT00724932|12183596|FG001|Overall Study|Not treated|3
7747959|NCT00724945|12183604|FG000|Period 1|non-compliance|1
7747960|NCT00724945|12183605|FG001|Period 1|non-compliance|0
7747961|NCT00724945|12183604|FG000|Period 1|Adverse Event|1
7747962|NCT00724945|12183605|FG001|Period 1|Adverse Event|1
7747963|NCT00724945|12183604|FG000|Period 1|Lost to Follow-up|1
7747964|NCT00724945|12183605|FG001|Period 1|Lost to Follow-up|0
7747965|NCT00724945|12183604|FG000|Period 2|lens comfort issue|3
7747966|NCT00724945|12183605|FG001|Period 2|lens comfort issue|0
7747967|NCT00724945|12183604|FG000|Period 2|lens physiology issue|1
7747968|NCT00724945|12183605|FG001|Period 2|lens physiology issue|0
7747969|NCT00724958|12183611|FG000|Overall Study|Adverse Event|28
7747970|NCT00724958|12183611|FG000|Overall Study|Loss of Response|40
7747971|NCT00724958|12183611|FG000|Overall Study|No Response|18
7747972|NCT00724958|12183611|FG000|Overall Study|Remission|7
7747973|NCT00724958|12183611|FG000|Overall Study|Other Reason|76
7747974|NCT00724958|12183611|FG000|Overall Study|No documentation for end of therapy|13
7747975|NCT00724971|12183615|FG000|Overall Study|Adverse Event|5
7747976|NCT00724971|12183615|FG000|Overall Study|Withdrawal by Subject|1
7747977|NCT00725010|12183644|FG000|Overall Study|Toxicity|9
7747978|NCT00725010|12183644|FG000|Overall Study|Tumor Progression|7
7747979|NCT00725010|12183644|FG000|Overall Study|Withdrawal by Subject|2
7747980|NCT00725010|12183644|FG000|Overall Study|Death|1
7747981|NCT00725010|12183644|FG000|Overall Study|Lost to Follow-up|1
7747982|NCT00725010|12183644|FG000|Overall Study|Hepatopathy probably not Temodal-related|1
7747983|NCT00725010|12183644|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1
7747984|NCT00725010|12183644|FG000|Overall Study|No further documentation|1
7747985|NCT00725010|12183644|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2
7747986|NCT00725075|12183653|FG000|Overall Study|Use of Excluded Medication|0
7747987|NCT00725075|12183654|FG001|Overall Study|Use of Excluded Medication|1
7747988|NCT00725075|12183655|FG002|Overall Study|Use of Excluded Medication|0
7747989|NCT00725075|12183653|FG000|Overall Study|Protocol Violation|0
7747990|NCT00725075|12183654|FG001|Overall Study|Protocol Violation|0
7747991|NCT00725075|12183655|FG002|Overall Study|Protocol Violation|1
7747992|NCT00725075|12183653|FG000|Overall Study|Lost to Follow-up|1
7747993|NCT00725075|12183654|FG001|Overall Study|Lost to Follow-up|0
7747994|NCT00725075|12183655|FG002|Overall Study|Lost to Follow-up|0
7747995|NCT00725075|12183653|FG000|Overall Study|Withdrawal by Subject|4
7747996|NCT00725075|12183654|FG001|Overall Study|Withdrawal by Subject|5
7747997|NCT00725075|12183655|FG002|Overall Study|Withdrawal by Subject|4
7747998|NCT00725075|12183653|FG000|Overall Study|Adverse Event|2
7747999|NCT00725075|12183654|FG001|Overall Study|Adverse Event|1
7748000|NCT00725075|12183655|FG002|Overall Study|Adverse Event|1
7748001|NCT00725075|12183653|FG000|Overall Study|Worsening of Disease|2
7748002|NCT00725075|12183654|FG001|Overall Study|Worsening of Disease|1
7748003|NCT00725075|12183655|FG002|Overall Study|Worsening of Disease|2
7748004|NCT00725075|12183653|FG000|Overall Study|Inclusion/Exclusion Criteria|1
7748005|NCT00725075|12183654|FG001|Overall Study|Inclusion/Exclusion Criteria|0
7748006|NCT00725075|12183655|FG002|Overall Study|Inclusion/Exclusion Criteria|1
7748007|NCT00725075|12183653|FG000|Overall Study|Other|1
7748008|NCT00725075|12183654|FG001|Overall Study|Other|0
7748009|NCT00725075|12183655|FG002|Overall Study|Other|0
7748010|NCT00725101|12183663|FG000|Overall Study|Death|3
7748011|NCT00725101|12183663|FG000|Overall Study|Lost to Follow-up|353
7748012|NCT00725101|12183663|FG000|Overall Study|Protocol Violation|1
7748013|NCT00725101|12183663|FG000|Overall Study|Withdrawal by Subject|127
7748014|NCT00725101|12183663|FG000|Overall Study|not specified/no reason given|11
7748015|NCT00725205|12183674|FG000|Overall Study|Adverse Event|22
7748016|NCT00725205|12183674|FG000|Overall Study|Investigator Discontinued|1
7748017|NCT00725205|12183674|FG000|Overall Study|Non-compliance With Protocol|14
7748018|NCT00725205|12183674|FG000|Overall Study|Other|8
7748019|NCT00725205|12183674|FG000|Overall Study|Protocol Defined Clinical Event|1
7748020|NCT00725205|12183674|FG000|Overall Study|Treatment Failure|41
7748021|NCT00725283|12183687|FG000|Overall Study|Missing Code|3
7748022|NCT00725283|12183687|FG000|Overall Study|Death|5
7748023|NCT00725283|12183687|FG000|Overall Study|Other|6
7748024|NCT00725283|12183687|FG000|Overall Study|Withdrawal by Subject|10
7748025|NCT00725296|12183691|FG000|Overall Study|Adverse Event|11
7748026|NCT00725296|12183691|FG000|Overall Study|Lack of Efficacy|7
7748027|NCT00725296|12183691|FG000|Overall Study|Withdrawal by Subject|3
7748028|NCT00725296|12183691|FG000|Overall Study|Non-Compliance|2
7748029|NCT00725296|12183691|FG000|Overall Study|Lost to Follow-up|1
7748030|NCT00725296|12183691|FG000|Overall Study|Other|38
7748031|NCT00725322|12183698|FG000|Washout (28 Days)|Withdrawal by Subject|2
7748032|NCT00725322|12183699|FG001|Washout (28 Days)|Withdrawal by Subject|0
7748033|NCT00725322|12183698|FG000|Washout (28 Days)|Protocol Violation|0
7748034|NCT00725322|12183699|FG001|Washout (28 Days)|Protocol Violation|1
7769454|NCT00868790|12213068|FG010|Period 2|Withdrawal by Subject|0
7769455|NCT00868790|12213069|FG011|Period 2|Withdrawal by Subject|0
7769456|NCT00868790|12213070|FG012|Period 2|Withdrawal by Subject|0
7769457|NCT00868790|12213071|FG013|Period 2|Withdrawal by Subject|1
7769458|NCT00868790|12213058|FG000|Period 3|Adverse Event|0
7769459|NCT00868790|12213059|FG001|Period 3|Adverse Event|0
7769460|NCT00868790|12213060|FG002|Period 3|Adverse Event|0
7769461|NCT00868790|12213061|FG003|Period 3|Adverse Event|0
7769462|NCT00868790|12213062|FG004|Period 3|Adverse Event|0
7769463|NCT00868790|12213063|FG005|Period 3|Adverse Event|0
7769464|NCT00868790|12213064|FG006|Period 3|Adverse Event|0
7769465|NCT00868790|12213065|FG007|Period 3|Adverse Event|0
7769466|NCT00868790|12213066|FG008|Period 3|Adverse Event|0
7769467|NCT00868790|12213067|FG009|Period 3|Adverse Event|1
7769468|NCT00868790|12213068|FG010|Period 3|Adverse Event|0
7769469|NCT00868790|12213069|FG011|Period 3|Adverse Event|0
7769470|NCT00868790|12213070|FG012|Period 3|Adverse Event|0
7769471|NCT00868790|12213071|FG013|Period 3|Adverse Event|0
7769472|NCT00868790|12213058|FG000|Period 3|Protocol Violation|0
7769473|NCT00868790|12213059|FG001|Period 3|Protocol Violation|0
7769474|NCT00868790|12213060|FG002|Period 3|Protocol Violation|0
7769475|NCT00868790|12213061|FG003|Period 3|Protocol Violation|0
7769476|NCT00868790|12213062|FG004|Period 3|Protocol Violation|0
7769477|NCT00868790|12213063|FG005|Period 3|Protocol Violation|0
7769478|NCT00868790|12213064|FG006|Period 3|Protocol Violation|0
7769479|NCT00868790|12213065|FG007|Period 3|Protocol Violation|0
7769480|NCT00868790|12213066|FG008|Period 3|Protocol Violation|0
7769481|NCT00868790|12213067|FG009|Period 3|Protocol Violation|0
7769482|NCT00868790|12213068|FG010|Period 3|Protocol Violation|1
7769483|NCT00868790|12213069|FG011|Period 3|Protocol Violation|0
7769484|NCT00868790|12213070|FG012|Period 3|Protocol Violation|0
7769485|NCT00868790|12213071|FG013|Period 3|Protocol Violation|0
7769486|NCT00868790|12213058|FG000|Period 3|Study Terminated by Sponsor|0
7769487|NCT00868790|12213059|FG001|Period 3|Study Terminated by Sponsor|0
7769488|NCT00868790|12213060|FG002|Period 3|Study Terminated by Sponsor|0
7769489|NCT00868790|12213061|FG003|Period 3|Study Terminated by Sponsor|1
7769490|NCT00868790|12213062|FG004|Period 3|Study Terminated by Sponsor|0
7769491|NCT00868790|12213063|FG005|Period 3|Study Terminated by Sponsor|0
7769492|NCT00868790|12213064|FG006|Period 3|Study Terminated by Sponsor|0
7769493|NCT00868790|12213065|FG007|Period 3|Study Terminated by Sponsor|0
7769494|NCT00868790|12213066|FG008|Period 3|Study Terminated by Sponsor|0
7769495|NCT00868790|12213067|FG009|Period 3|Study Terminated by Sponsor|0
7769496|NCT00868790|12213068|FG010|Period 3|Study Terminated by Sponsor|0
7769497|NCT00868790|12213069|FG011|Period 3|Study Terminated by Sponsor|0
7769498|NCT00868790|12213070|FG012|Period 3|Study Terminated by Sponsor|0
7769499|NCT00868790|12213071|FG013|Period 3|Study Terminated by Sponsor|0
7769500|NCT00868790|12213058|FG000|Period 4|Adverse Event|0
7769501|NCT00868790|12213059|FG001|Period 4|Adverse Event|0
7769502|NCT00868790|12213060|FG002|Period 4|Adverse Event|0
7769503|NCT00868790|12213061|FG003|Period 4|Adverse Event|0
7769504|NCT00868790|12213062|FG004|Period 4|Adverse Event|0
7769505|NCT00868790|12213063|FG005|Period 4|Adverse Event|0
7769506|NCT00868790|12213064|FG006|Period 4|Adverse Event|0
7748035|NCT00725452|12183709|FG000|Overall Study|Adverse Event|3
7748036|NCT00725452|12183709|FG000|Overall Study|Lack of Efficacy|2
7748037|NCT00725452|12183709|FG000|Overall Study|Reason not specified|1
7748038|NCT00725452|12183709|FG000|Overall Study|Physician Decision|1
7748039|NCT00725452|12183709|FG000|Overall Study|Withdrawal by Subject|3
7748040|NCT00725452|12183709|FG000|Overall Study|Lost to Follow-up|1
7748041|NCT00725543|12183727|FG000|Overall Study|Adverse Event|10
7748042|NCT00725543|12183727|FG000|Overall Study|Lack of Efficacy|3
7748043|NCT00725543|12183727|FG000|Overall Study|Withdrawal by Subject|10
7748044|NCT00725543|12183727|FG000|Overall Study|Physician Decision|5
7748045|NCT00725543|12183727|FG000|Overall Study|Lost to Follow-up|4
7748046|NCT00725543|12183727|FG000|Overall Study|Non-compliance|2
7748047|NCT00725543|12183727|FG000|Overall Study|Other|119
7748048|NCT00725608|12183731|FG000|Overall Study|Lost to Follow-up|60
7748049|NCT00725608|12183731|FG000|Overall Study|Adverse Event|14
7748050|NCT00725608|12183731|FG000|Overall Study|Individual reasons|86
7748051|NCT00725608|12183731|FG000|Overall Study|Other|7
7748052|NCT00725621|12183735|FG000|Overall Study|Adverse Event|25
7748053|NCT00725621|12183735|FG000|Overall Study|Lack of Efficacy|46
7748054|NCT00725621|12183735|FG000|Overall Study|Withdrawal by Subject|57
7748055|NCT00725621|12183735|FG000|Overall Study|Physician Decision|19
7748056|NCT00725621|12183735|FG000|Overall Study|Lost to Follow-up|52
7748057|NCT00725621|12183735|FG000|Overall Study|Non-compliance|8
7748058|NCT00725621|12183735|FG000|Overall Study|Continued treatment by other physician|6
7748059|NCT00725621|12183735|FG000|Overall Study|Switched to other study|1
7748060|NCT00725621|12183735|FG000|Overall Study|Switched to other drug|1
7748061|NCT00725621|12183735|FG000|Overall Study|Prepared for elective surgery|1
7748062|NCT00725621|12183735|FG000|Overall Study|Reason not specified|55
7748063|NCT00725712|12183745|FG000|Overall Study|Withdrawal by Subject|2
7748064|NCT00725712|12183746|FG001|Overall Study|Withdrawal by Subject|1
7748065|NCT00725712|12183745|FG000|Overall Study|Protocol Violation|1
7748066|NCT00725712|12183746|FG001|Overall Study|Protocol Violation|0
7748067|NCT00725712|12183745|FG000|Overall Study|Progressive disease|37
7748068|NCT00725712|12183746|FG001|Overall Study|Progressive disease|16
7748069|NCT00725712|12183745|FG000|Overall Study|Clinical progression not based on RECIST|0
7748070|NCT00725712|12183746|FG001|Overall Study|Clinical progression not based on RECIST|3
7748071|NCT00725712|12183745|FG000|Overall Study|Adverse Event|5
7748072|NCT00725712|12183746|FG001|Overall Study|Adverse Event|5
7748073|NCT00725712|12183745|FG000|Overall Study|Death|2
7748074|NCT00725712|12183746|FG001|Overall Study|Death|0
7748075|NCT00725712|12183745|FG000|Overall Study|Other: Death|1
7748076|NCT00725712|12183746|FG001|Overall Study|Other: Death|0
7748077|NCT00725712|12183745|FG000|Overall Study|Hospitalized, unable to continue|0
7748078|NCT00725712|12183746|FG001|Overall Study|Hospitalized, unable to continue|1
7748079|NCT00725725|12183759|FG000|Overall Study|Adverse Event|1
7748080|NCT00725725|12183760|FG001|Overall Study|Adverse Event|3
7748081|NCT00725725|12183761|FG002|Overall Study|Adverse Event|2
7748082|NCT00725725|12183759|FG000|Overall Study|Lost to Follow-up|2
7748083|NCT00725725|12183760|FG001|Overall Study|Lost to Follow-up|0
7748084|NCT00725725|12183761|FG002|Overall Study|Lost to Follow-up|2
7748085|NCT00725725|12183759|FG000|Overall Study|Withdrawal by Subject|1
7748086|NCT00725725|12183760|FG001|Overall Study|Withdrawal by Subject|0
7748087|NCT00725725|12183761|FG002|Overall Study|Withdrawal by Subject|1
7748088|NCT00725725|12183759|FG000|Overall Study|Protocol Violation|0
7748089|NCT00725725|12183760|FG001|Overall Study|Protocol Violation|1
7748090|NCT00725725|12183761|FG002|Overall Study|Protocol Violation|0
7748091|NCT00725764|12183779|FG000|Overall Study|Withdrawal by Subject|2
7748092|NCT00725764|12183779|FG000|Overall Study|Physician Decision|1
7748093|NCT00725764|12183779|FG000|Overall Study|Progressive Disease|7
7748094|NCT00725764|12183779|FG000|Overall Study|Lost to Follow-up|1
7748095|NCT00725764|12183779|FG000|Overall Study|Death|1
7748096|NCT00725764|12183779|FG000|Overall Study|Participant non compliant with protocol|1
7748097|NCT00725764|12183779|FG000|Overall Study|Decline in performance status|1
7748098|NCT00725842|12183784|FG000|Overall Study|Lost to Follow-up|19
7748099|NCT00725842|12183784|FG000|Overall Study|Death|1
7748100|NCT00725842|12183784|FG000|Overall Study|Positive HCV-RNA at Visit 2|13
7748101|NCT00725842|12183784|FG000|Overall Study|Consent date prior to study start date|5
7748102|NCT00725842|12183784|FG000|Overall Study|Inclusion criterion not met|1
7748103|NCT00725842|12183784|FG000|Overall Study|No Visit 1 data|1
7748104|NCT00725920|12183790|FG000|Overall Study|Lack of Efficacy|3
7748105|NCT00725920|12183791|FG001|Overall Study|Lack of Efficacy|6
7748106|NCT00726232|12183812|FG000|Initial Phase (Dose-finding)|Death|0
7748107|NCT00726232|12183813|FG001|Initial Phase (Dose-finding)|Death|0
7748108|NCT00726232|12183814|FG002|Initial Phase (Dose-finding)|Death|0
7748109|NCT00726232|12183815|FG003|Initial Phase (Dose-finding)|Death|0
7748110|NCT00726232|12183816|FG004|Initial Phase (Dose-finding)|Death|1
7748111|NCT00726232|12183817|FG005|Initial Phase (Dose-finding)|Death|0
7748112|NCT00726232|12183818|FG006|Initial Phase (Dose-finding)|Death|0
7748113|NCT00726232|12183819|FG007|Initial Phase (Dose-finding)|Death|0
7748114|NCT00726232|12183812|FG000|Initial Phase (Dose-finding)|Adverse Event|2
7748115|NCT00726232|12183813|FG001|Initial Phase (Dose-finding)|Adverse Event|2
7748116|NCT00726232|12183814|FG002|Initial Phase (Dose-finding)|Adverse Event|2
7748117|NCT00726232|12183815|FG003|Initial Phase (Dose-finding)|Adverse Event|1
7748118|NCT00726232|12183816|FG004|Initial Phase (Dose-finding)|Adverse Event|7
7748119|NCT00726232|12183817|FG005|Initial Phase (Dose-finding)|Adverse Event|3
7748120|NCT00726232|12183818|FG006|Initial Phase (Dose-finding)|Adverse Event|0
7748121|NCT00726232|12183819|FG007|Initial Phase (Dose-finding)|Adverse Event|0
7748122|NCT00726232|12183812|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2
7748123|NCT00726232|12183813|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0
7748124|NCT00726232|12183814|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0
7748125|NCT00726232|12183815|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1
7748126|NCT00726232|12183816|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0
7748127|NCT00726232|12183817|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2
7748128|NCT00726232|12183818|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0
7748129|NCT00726232|12183819|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0
7748130|NCT00726232|12183812|FG000|Initial Phase (Dose-finding)|Disease progression|3
7748131|NCT00726232|12183813|FG001|Initial Phase (Dose-finding)|Disease progression|1
7748132|NCT00726232|12183814|FG002|Initial Phase (Dose-finding)|Disease progression|0
7748133|NCT00726232|12183815|FG003|Initial Phase (Dose-finding)|Disease progression|0
7748134|NCT00726232|12183816|FG004|Initial Phase (Dose-finding)|Disease progression|0
7748135|NCT00726232|12183817|FG005|Initial Phase (Dose-finding)|Disease progression|0
7748136|NCT00726232|12183818|FG006|Initial Phase (Dose-finding)|Disease progression|0
7748137|NCT00726232|12183819|FG007|Initial Phase (Dose-finding)|Disease progression|0
7748138|NCT00726232|12183812|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
7748139|NCT00726232|12183813|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
7748140|NCT00726232|12183814|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
7748141|NCT00726232|12183815|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
7748142|NCT00726232|12183816|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9
7748143|NCT00726232|12183817|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
7748144|NCT00726232|12183818|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
7748145|NCT00726232|12183819|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
7748146|NCT00726232|12183812|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
7748147|NCT00726232|12183813|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
7748148|NCT00726232|12183814|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
7748149|NCT00726232|12183815|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2
7748150|NCT00726232|12183816|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4
7748151|NCT00726232|12183817|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
7748152|NCT00726232|12183818|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
7748153|NCT00726232|12183819|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
7748154|NCT00726232|12183812|FG000|Initial Phase (Dose-finding)|Unspecified reason|1
7748155|NCT00726232|12183813|FG001|Initial Phase (Dose-finding)|Unspecified reason|0
7748156|NCT00726232|12183814|FG002|Initial Phase (Dose-finding)|Unspecified reason|0
7748157|NCT00726232|12183815|FG003|Initial Phase (Dose-finding)|Unspecified reason|0
7748158|NCT00726232|12183816|FG004|Initial Phase (Dose-finding)|Unspecified reason|0
7748159|NCT00726232|12183817|FG005|Initial Phase (Dose-finding)|Unspecified reason|0
7748160|NCT00726232|12183818|FG006|Initial Phase (Dose-finding)|Unspecified reason|0
7748161|NCT00726232|12183819|FG007|Initial Phase (Dose-finding)|Unspecified reason|0
7748162|NCT00726232|12183812|FG000|Expansion Phase|Death|0
7748163|NCT00726232|12183813|FG001|Expansion Phase|Death|0
7748164|NCT00726232|12183814|FG002|Expansion Phase|Death|0
7748165|NCT00726232|12183815|FG003|Expansion Phase|Death|0
7748166|NCT00726232|12183816|FG004|Expansion Phase|Death|0
7748167|NCT00726232|12183817|FG005|Expansion Phase|Death|0
7748168|NCT00726232|12183818|FG006|Expansion Phase|Death|0
7748169|NCT00726232|12183819|FG007|Expansion Phase|Death|1
7748170|NCT00726232|12183812|FG000|Expansion Phase|Adverse Event|0
7748171|NCT00726232|12183813|FG001|Expansion Phase|Adverse Event|0
7748172|NCT00726232|12183814|FG002|Expansion Phase|Adverse Event|0
7748173|NCT00726232|12183815|FG003|Expansion Phase|Adverse Event|0
7748174|NCT00726232|12183816|FG004|Expansion Phase|Adverse Event|0
7748175|NCT00726232|12183817|FG005|Expansion Phase|Adverse Event|0
7748176|NCT00726232|12183818|FG006|Expansion Phase|Adverse Event|6
7748177|NCT00726232|12183819|FG007|Expansion Phase|Adverse Event|11
7748178|NCT00726232|12183812|FG000|Expansion Phase|Withdrawal by Subject|0
7748179|NCT00726232|12183813|FG001|Expansion Phase|Withdrawal by Subject|0
7748180|NCT00726232|12183814|FG002|Expansion Phase|Withdrawal by Subject|0
7748181|NCT00726232|12183815|FG003|Expansion Phase|Withdrawal by Subject|0
7748182|NCT00726232|12183816|FG004|Expansion Phase|Withdrawal by Subject|0
7748183|NCT00726232|12183817|FG005|Expansion Phase|Withdrawal by Subject|0
7748184|NCT00726232|12183818|FG006|Expansion Phase|Withdrawal by Subject|2
7748185|NCT00726232|12183819|FG007|Expansion Phase|Withdrawal by Subject|3
7748186|NCT00726232|12183812|FG000|Expansion Phase|Disease progression|0
7748187|NCT00726232|12183813|FG001|Expansion Phase|Disease progression|0
7748188|NCT00726232|12183814|FG002|Expansion Phase|Disease progression|0
7748189|NCT00726232|12183815|FG003|Expansion Phase|Disease progression|0
7748190|NCT00726232|12183816|FG004|Expansion Phase|Disease progression|0
7748191|NCT00726232|12183817|FG005|Expansion Phase|Disease progression|0
7748192|NCT00726232|12183818|FG006|Expansion Phase|Disease progression|4
7748193|NCT00726232|12183819|FG007|Expansion Phase|Disease progression|0
7748194|NCT00726232|12183812|FG000|Expansion Phase|Termination of the trial by sponsor|0
7748195|NCT00726232|12183813|FG001|Expansion Phase|Termination of the trial by sponsor|0
7748196|NCT00726232|12183814|FG002|Expansion Phase|Termination of the trial by sponsor|0
7748197|NCT00726232|12183815|FG003|Expansion Phase|Termination of the trial by sponsor|0
7748198|NCT00726232|12183816|FG004|Expansion Phase|Termination of the trial by sponsor|0
7748199|NCT00726232|12183817|FG005|Expansion Phase|Termination of the trial by sponsor|0
7748200|NCT00726232|12183818|FG006|Expansion Phase|Termination of the trial by sponsor|10
7748201|NCT00726232|12183819|FG007|Expansion Phase|Termination of the trial by sponsor|16
7748202|NCT00726232|12183812|FG000|Expansion Phase|Per Investigator: lack of response|0
7748203|NCT00726232|12183813|FG001|Expansion Phase|Per Investigator: lack of response|0
7748204|NCT00726232|12183814|FG002|Expansion Phase|Per Investigator: lack of response|0
7748205|NCT00726232|12183815|FG003|Expansion Phase|Per Investigator: lack of response|0
7748206|NCT00726232|12183816|FG004|Expansion Phase|Per Investigator: lack of response|0
7748207|NCT00726232|12183817|FG005|Expansion Phase|Per Investigator: lack of response|0
7748208|NCT00726232|12183818|FG006|Expansion Phase|Per Investigator: lack of response|1
7748209|NCT00726232|12183819|FG007|Expansion Phase|Per Investigator: lack of response|7
7748210|NCT00726232|12183812|FG000|Expansion Phase|Unspecified reason|0
7748211|NCT00726232|12183813|FG001|Expansion Phase|Unspecified reason|0
7748212|NCT00726232|12183814|FG002|Expansion Phase|Unspecified reason|0
7748213|NCT00726232|12183815|FG003|Expansion Phase|Unspecified reason|0
7748214|NCT00726232|12183816|FG004|Expansion Phase|Unspecified reason|0
7748215|NCT00726232|12183817|FG005|Expansion Phase|Unspecified reason|0
7748216|NCT00726232|12183818|FG006|Expansion Phase|Unspecified reason|1
7748217|NCT00726232|12183819|FG007|Expansion Phase|Unspecified reason|0
7748218|NCT00726323|12183840|FG000|Overall Study|Withdrawal by Subject|3
7748219|NCT00726323|12183841|FG001|Overall Study|Withdrawal by Subject|1
7748220|NCT00726323|12183840|FG000|Overall Study|Physician Decision|1
7748221|NCT00726323|12183841|FG001|Overall Study|Physician Decision|0
7748222|NCT00726323|12183840|FG000|Overall Study|Progressive disease|23
7748223|NCT00726323|12183841|FG001|Overall Study|Progressive disease|16
7748224|NCT00726323|12183840|FG000|Overall Study|Clinical progression|0
7748225|NCT00726323|12183841|FG001|Overall Study|Clinical progression|3
7748226|NCT00726323|12183840|FG000|Overall Study|Adverse Event|9
7748227|NCT00726323|12183841|FG001|Overall Study|Adverse Event|9
7748228|NCT00726323|12183840|FG000|Overall Study|Death|1
7748229|NCT00726323|12183841|FG001|Overall Study|Death|0
7748230|NCT00726323|12183840|FG000|Overall Study|Participant wished to discontinue|0
7748231|NCT00726323|12183841|FG001|Overall Study|Participant wished to discontinue|1
7748232|NCT00726323|12183840|FG000|Overall Study|Metastatic lesions inferred cyst|0
7748233|NCT00726323|12183841|FG001|Overall Study|Metastatic lesions inferred cyst|1
7748234|NCT00726388|12183851|FG000|Overall Study|Withdrawal by Subject|5
7748235|NCT00726388|12183851|FG000|Overall Study|Adverse Event|3
7748236|NCT00726388|12183851|FG000|Overall Study|Lost to Follow-up|10
7748237|NCT00726388|12183851|FG000|Overall Study|Participants Non-compliant With Study Procedures|5
7748238|NCT00726388|12183851|FG000|Overall Study|Other|5
7748239|NCT00726388|12183851|FG000|Overall Study|Enrolled, Not Treated|79
7748240|NCT00726453|12183864|FG000|Primary Enrollment Group|Death|18
7748241|NCT00726453|12183865|FG001|Primary Enrollment Group|Death|0
7748242|NCT00726453|12183864|FG000|Primary Enrollment Group|Withdrawal by Subject|13
7748243|NCT00726453|12183865|FG001|Primary Enrollment Group|Withdrawal by Subject|0
7748244|NCT00726453|12183864|FG000|38 mm Length Group|Death|0
7748245|NCT00726453|12183865|FG001|38 mm Length Group|Death|3
7748246|NCT00726557|12183870|FG000|Overall Study|Screening failure|4
7748247|NCT00726557|12183870|FG000|Overall Study|No end of treatment documentation|37
7748248|NCT00726557|12183870|FG000|Overall Study|No follow-up documentation available|55
7748249|NCT00726557|12183870|FG000|Overall Study|Treatment less than 3 months|17
7748250|NCT00726557|12183870|FG000|Overall Study|Inclusion criteria not met|15
7748251|NCT00726609|12183875|FG000|Overall Study|Adverse Event|10
7748252|NCT00726609|12183875|FG000|Overall Study|Withdrawal by Subject|2
7748253|NCT00726609|12183875|FG000|Overall Study|Lack of Efficacy|25
7748254|NCT00726609|12183875|FG000|Overall Study|Other|16
7748255|NCT00726609|12183875|FG000|Overall Study|Missing|42
7748256|NCT00726609|12183875|FG000|Overall Study|Other|3
7748257|NCT00726622|12183881|FG000|Overall Study|Withdrawal by Subject|16
7748258|NCT00726622|12183882|FG001|Overall Study|Withdrawal by Subject|2
7748259|NCT00726622|12183881|FG000|Overall Study|Physician Decision|0
7748260|NCT00726622|12183882|FG001|Overall Study|Physician Decision|1
7748261|NCT00726622|12183881|FG000|Overall Study|Metastasis|2
7748262|NCT00726622|12183882|FG001|Overall Study|Metastasis|0
7748263|NCT00726661|12183890|FG000|Overall Study|Lost to Follow-up|36
7748264|NCT00726661|12183891|FG001|Overall Study|Lost to Follow-up|11
7748265|NCT00726661|12183890|FG000|Overall Study|Withdrawal by Subject|17
7748266|NCT00726661|12183891|FG001|Overall Study|Withdrawal by Subject|13
7748267|NCT00726661|12183890|FG000|Overall Study|Trial terminated by sponsor|214
7748268|NCT00726661|12183891|FG001|Overall Study|Trial terminated by sponsor|187
7748269|NCT00726661|12183890|FG000|Overall Study|Death|475
7748270|NCT00726661|12183891|FG001|Overall Study|Death|159
7748271|NCT00726661|12183890|FG000|Overall Study|Physician Decision|25
7748272|NCT00726661|12183891|FG001|Overall Study|Physician Decision|13
7748273|NCT00726661|12183890|FG000|Overall Study|Other|47
7748274|NCT00726661|12183891|FG001|Overall Study|Other|35
7748275|NCT00726752|12183918|FG000|Overall Study|Lack of Efficacy|6
7748276|NCT00726882|12183922|FG000|Overall Study|Withdrawal by Subject|5
7748277|NCT00726882|12183922|FG000|Overall Study|Lost to Follow-up|7
7748278|NCT00726882|12183922|FG000|Overall Study|Other|10
7748279|NCT00726895|12183928|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
7748280|NCT00726895|12183929|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7748281|NCT00726986|12183936|FG000|Induction Phase|Adverse Event|4
7748282|NCT00726986|12183936|FG000|Induction Phase|Withdrawal by Subject|2
7748283|NCT00726986|12183936|FG000|Induction Phase|Death|2
7748284|NCT00726986|12183936|FG000|Induction Phase|Lack of Efficacy|5
7748285|NCT00726986|12183936|FG000|Induction Phase|Secondary Disease|2
7748286|NCT00726986|12183936|FG000|Maintenance Phase|Adverse Event|1
7748287|NCT00726986|12183936|FG000|Maintenance Phase|Lack of Efficacy|2
7748288|NCT00726999|12183942|FG000|Overall Study|Physician Decision|0
7748289|NCT00726999|12183943|FG001|Overall Study|Physician Decision|1
7748290|NCT00726999|12183942|FG000|Overall Study|Withdrawal by Subject|2
7748291|NCT00726999|12183943|FG001|Overall Study|Withdrawal by Subject|0
7748292|NCT00726999|12183942|FG000|Overall Study|Protocol Violation|1
7748293|NCT00726999|12183943|FG001|Overall Study|Protocol Violation|0
7748294|NCT00727025|12183951|FG000|Overall Study|Physician Decision|23
7748295|NCT00727194|12183968|FG000|Screening Period|Low QMG scores|0
7748296|NCT00727194|12183969|FG001|Screening Period|Low QMG scores|0
7748297|NCT00727194|12183970|FG002|Screening Period|Low QMG scores|6
7748298|NCT00727194|12183968|FG000|Screening Period|Lacked AChR antibodies|0
7748299|NCT00727194|12183969|FG001|Screening Period|Lacked AChR antibodies|0
7748300|NCT00727194|12183970|FG002|Screening Period|Lacked AChR antibodies|5
7748301|NCT00727194|12183968|FG000|Screening Period|Not stable on concomitant MG therapy|0
7748302|NCT00727194|12183969|FG001|Screening Period|Not stable on concomitant MG therapy|0
7748303|NCT00727194|12183970|FG002|Screening Period|Not stable on concomitant MG therapy|2
7748304|NCT00727194|12183968|FG000|Screening Period|Severe infections|0
7748305|NCT00727194|12183969|FG001|Screening Period|Severe infections|0
7748306|NCT00727194|12183970|FG002|Screening Period|Severe infections|2
7748307|NCT00727194|12183968|FG000|Screening Period|History of thymoma|0
7748308|NCT00727194|12183969|FG001|Screening Period|History of thymoma|0
7748309|NCT00727194|12183970|FG002|Screening Period|History of thymoma|1
7748310|NCT00727194|12183968|FG000|Treatment Period 2|Lack of Efficacy|0
7748311|NCT00727194|12183969|FG001|Treatment Period 2|Lack of Efficacy|1
7748312|NCT00727194|12183970|FG002|Treatment Period 2|Lack of Efficacy|0
7748313|NCT00727246|12183997|FG000|Overall Study|could not complete MRI|0
7748314|NCT00727246|12183998|FG001|Overall Study|could not complete MRI|1
7748315|NCT00727246|12183999|FG002|Overall Study|could not complete MRI|0
7748316|NCT00727246|12184000|FG003|Overall Study|could not complete MRI|1
7748317|NCT00727246|12183997|FG000|Overall Study|incidental finding|0
7748318|NCT00727246|12183998|FG001|Overall Study|incidental finding|0
7748319|NCT00727246|12183999|FG002|Overall Study|incidental finding|0
7748320|NCT00727246|12184000|FG003|Overall Study|incidental finding|1
7748321|NCT00727246|12183997|FG000|Overall Study|withdrawn|0
7748322|NCT00727246|12183998|FG001|Overall Study|withdrawn|0
7748323|NCT00727246|12183999|FG002|Overall Study|withdrawn|1
7748324|NCT00727246|12184000|FG003|Overall Study|withdrawn|0
7748325|NCT00727259|12184010|FG000|Overall Study|Not all questionnaires completed|1055
7748326|NCT00727272|12184015|FG000|Washout Period A|Adverse Event|0
7748327|NCT00727272|12184016|FG001|Washout Period A|Adverse Event|0
7748328|NCT00727272|12184017|FG002|Washout Period A|Adverse Event|1
7748329|NCT00727272|12184015|FG000|Washout Period B|Withdrawal by Subject|0
7748330|NCT00727272|12184016|FG001|Washout Period B|Withdrawal by Subject|0
7748331|NCT00727272|12184017|FG002|Washout Period B|Withdrawal by Subject|1
7748332|NCT00727311|12184031|FG000|Overall Study|Did not receive drug|316
7748333|NCT00727311|12184031|FG000|Overall Study|Missing end of therapy data|205
7748334|NCT00727311|12184031|FG000|Overall Study|Adverse Event|58
7748335|NCT00727311|12184031|FG000|Overall Study|Lack of Efficacy|242
7748336|NCT00727311|12184031|FG000|Overall Study|Lost to Follow-up|73
7748337|NCT00727311|12184031|FG000|Overall Study|Withdrawal by Subject|77
7748338|NCT00727311|12184031|FG000|Overall Study|Other|97
7748339|NCT00727311|12184031|FG000|Overall Study|Multiple reasons|39
7748340|NCT00727402|12184057|FG000|Overall Study|Physician Decision|116
7748341|NCT00727415|12184061|FG000|Phase I|Dose Limiting Toxicity|2
7748342|NCT00727441|12184068|FG000|Overall Study|Disease Progression|11
7748343|NCT00727441|12184069|FG001|Overall Study|Disease Progression|14
7748344|NCT00727441|12184070|FG002|Overall Study|Disease Progression|17
7748345|NCT00727441|12184068|FG000|Overall Study|Eligibility|7
7748346|NCT00727441|12184069|FG001|Overall Study|Eligibility|5
7748347|NCT00727441|12184070|FG002|Overall Study|Eligibility|7
7748348|NCT00727441|12184068|FG000|Overall Study|Death|0
7748349|NCT00727441|12184069|FG001|Overall Study|Death|1
7748350|NCT00727441|12184070|FG002|Overall Study|Death|1
7748351|NCT00727441|12184068|FG000|Overall Study|Physician Decision|0
7748352|NCT00727441|12184069|FG001|Overall Study|Physician Decision|1
7748353|NCT00727441|12184070|FG002|Overall Study|Physician Decision|0
7748354|NCT00727441|12184068|FG000|Overall Study|Withdrawal by Subject|0
7748355|NCT00727441|12184069|FG001|Overall Study|Withdrawal by Subject|1
7748356|NCT00727441|12184070|FG002|Overall Study|Withdrawal by Subject|0
7748357|NCT00727506|12184087|FG000|Overall Study|Adverse Event|0
7748358|NCT00727506|12184088|FG001|Overall Study|Adverse Event|0
7748359|NCT00727506|12184089|FG002|Overall Study|Adverse Event|4
7748360|NCT00727506|12184090|FG003|Overall Study|Adverse Event|4
7748361|NCT00727506|12184091|FG004|Overall Study|Adverse Event|1
7748362|NCT00727506|12184092|FG005|Overall Study|Adverse Event|8
7748363|NCT00727506|12184087|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2
7748364|NCT00727506|12184088|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
7748365|NCT00727506|12184089|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2
7748366|NCT00727506|12184090|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
7748367|NCT00727506|12184091|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0
7748368|NCT00727506|12184092|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0
7748369|NCT00727506|12184087|FG000|Overall Study|Progressive disease|4
7748370|NCT00727506|12184088|FG001|Overall Study|Progressive disease|7
7748371|NCT00727506|12184089|FG002|Overall Study|Progressive disease|9
7748372|NCT00727506|12184090|FG003|Overall Study|Progressive disease|28
7748373|NCT00727506|12184091|FG004|Overall Study|Progressive disease|38
7748374|NCT00727506|12184092|FG005|Overall Study|Progressive disease|28
7748375|NCT00727506|12184087|FG000|Overall Study|Refused to continue medication|0
7748376|NCT00727506|12184088|FG001|Overall Study|Refused to continue medication|1
7748377|NCT00727506|12184089|FG002|Overall Study|Refused to continue medication|2
7748378|NCT00727506|12184090|FG003|Overall Study|Refused to continue medication|3
7748379|NCT00727506|12184091|FG004|Overall Study|Refused to continue medication|1
7748380|NCT00727506|12184092|FG005|Overall Study|Refused to continue medication|2
7748381|NCT00727506|12184087|FG000|Overall Study|Other reason not described above|0
7748382|NCT00727506|12184088|FG001|Overall Study|Other reason not described above|0
7748383|NCT00727506|12184089|FG002|Overall Study|Other reason not described above|1
7748384|NCT00727506|12184090|FG003|Overall Study|Other reason not described above|4
7748385|NCT00727506|12184091|FG004|Overall Study|Other reason not described above|1
7748386|NCT00727506|12184092|FG005|Overall Study|Other reason not described above|1
7748387|NCT00727532|12184112|FG000|Overall Study|Adverse Event|1
7748388|NCT00727532|12184112|FG000|Overall Study|Withdrawal by Subject|1
7748389|NCT00727558|12184118|FG000|Overall Study|Lens issue|0
7748390|NCT00727558|12184119|FG001|Overall Study|Lens issue|1
7748391|NCT00727558|12184118|FG000|Overall Study|Adverse Event|0
7748392|NCT00727558|12184119|FG001|Overall Study|Adverse Event|1
7748393|NCT00727558|12184118|FG000|Overall Study|Subject unable to return for follow-up|1
7748394|NCT00727558|12184119|FG001|Overall Study|Subject unable to return for follow-up|1
7748395|NCT00727558|12184118|FG000|Overall Study|Lost to Follow-up|1
7748396|NCT00727558|12184119|FG001|Overall Study|Lost to Follow-up|0
7748397|NCT00727571|12184129|FG000|Overall Study|Ineligibility determined|1
7748398|NCT00727571|12184130|FG001|Overall Study|Ineligibility determined|1
7748399|NCT00727571|12184131|FG002|Overall Study|Ineligibility determined|1
7748400|NCT00727571|12184132|FG003|Overall Study|Ineligibility determined|0
7748401|NCT00727571|12184129|FG000|Overall Study|Death|0
7748402|NCT00727571|12184130|FG001|Overall Study|Death|19
7748403|NCT00727571|12184131|FG002|Overall Study|Death|5
7748404|NCT00727571|12184132|FG003|Overall Study|Death|1
7748405|NCT00727571|12184129|FG000|Overall Study|Physician Decision|0
7748406|NCT00727571|12184130|FG001|Overall Study|Physician Decision|5
7748407|NCT00727571|12184131|FG002|Overall Study|Physician Decision|0
7748408|NCT00727571|12184132|FG003|Overall Study|Physician Decision|0
7748409|NCT00727571|12184129|FG000|Overall Study|Withdrawal by Subject|0
7748410|NCT00727571|12184130|FG001|Overall Study|Withdrawal by Subject|10
7748411|NCT00727571|12184131|FG002|Overall Study|Withdrawal by Subject|11
7748412|NCT00727571|12184132|FG003|Overall Study|Withdrawal by Subject|0
7748413|NCT00727571|12184129|FG000|Overall Study|Subject Non Compliance|0
7748414|NCT00727571|12184130|FG001|Overall Study|Subject Non Compliance|6
7748415|NCT00727571|12184131|FG002|Overall Study|Subject Non Compliance|0
7748416|NCT00727571|12184132|FG003|Overall Study|Subject Non Compliance|4
7748417|NCT00727571|12184129|FG000|Overall Study|Dismissed from nursing home|0
7748418|NCT00727571|12184130|FG001|Overall Study|Dismissed from nursing home|9
7748419|NCT00727571|12184131|FG002|Overall Study|Dismissed from nursing home|5
7748420|NCT00727571|12184132|FG003|Overall Study|Dismissed from nursing home|0
7748421|NCT00727571|12184129|FG000|Overall Study|Hospitalization|0
7748422|NCT00727571|12184130|FG001|Overall Study|Hospitalization|1
7748423|NCT00727571|12184131|FG002|Overall Study|Hospitalization|0
7748424|NCT00727571|12184132|FG003|Overall Study|Hospitalization|1
7748425|NCT00727571|12184129|FG000|Overall Study|AE not leading to hospitalization|0
7748426|NCT00727571|12184130|FG001|Overall Study|AE not leading to hospitalization|0
7748427|NCT00727571|12184131|FG002|Overall Study|AE not leading to hospitalization|2
7748428|NCT00727571|12184132|FG003|Overall Study|AE not leading to hospitalization|0
7748429|NCT00727571|12184129|FG000|Overall Study|Other|0
7748430|NCT00727571|12184130|FG001|Overall Study|Other|4
7748431|NCT00727571|12184131|FG002|Overall Study|Other|6
7748432|NCT00727571|12184132|FG003|Overall Study|Other|0
7748433|NCT00727649|12184162|FG000|First Intervention (4-weeks)|Lost to Follow-up|1
7748434|NCT00727649|12184163|FG001|First Intervention (4-weeks)|Lost to Follow-up|2
7748435|NCT00727649|12184162|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2
7748436|NCT00727649|12184163|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1
7748437|NCT00727649|12184162|FG000|Wash-out (2-weeks)|Lost to Follow-up|3
7748438|NCT00727649|12184163|FG001|Wash-out (2-weeks)|Lost to Follow-up|1
7748439|NCT00727649|12184162|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1
7748440|NCT00727649|12184163|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2
7748441|NCT00727649|12184162|FG000|Second Intervention (4-weeks)|Death|1
7748442|NCT00727649|12184163|FG001|Second Intervention (4-weeks)|Death|0
7748443|NCT00727649|12184162|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0
7748444|NCT00727649|12184163|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1
7748445|NCT00727649|12184162|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0
7748446|NCT00727649|12184163|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2
7748447|NCT00727714|12184171|FG000|Overall Study|Lost to Follow-up|2
7748448|NCT00727844|12184186|FG000|Initial Randomization|Physician Decision|2
7748449|NCT00727844|12184187|FG001|Initial Randomization|Physician Decision|0
7748450|NCT00727844|12184188|FG002|Initial Randomization|Physician Decision|0
7748451|NCT00727844|12184189|FG003|Initial Randomization|Physician Decision|0
7748452|NCT00727909|12184208|FG000|Overall Study|Withdrawal by Subject|5
7748453|NCT00727909|12184209|FG001|Overall Study|Withdrawal by Subject|11
7748454|NCT00727909|12184210|FG002|Overall Study|Withdrawal by Subject|8
7748455|NCT00727909|12184211|FG003|Overall Study|Withdrawal by Subject|5
7748456|NCT00727909|12184208|FG000|Overall Study|Death|0
7748457|NCT00727909|12184209|FG001|Overall Study|Death|0
7748458|NCT00727909|12184210|FG002|Overall Study|Death|1
7748459|NCT00727909|12184211|FG003|Overall Study|Death|0
7748460|NCT00727961|12184215|FG000|Overall Study|Lost to Follow-up|1
7748461|NCT00727961|12184215|FG000|Overall Study|Adverse Event|4
7748462|NCT00727961|12184215|FG000|Overall Study|Patient's refusal|2
7748463|NCT00727961|12184215|FG000|Overall Study|Progression|30
7748464|NCT00728130|12184219|FG000|Overall Study|Withdrawal by Subject|1
7748465|NCT00728130|12184219|FG000|Overall Study|Paperwork not completed in time|1
7748466|NCT00728130|12184219|FG000|Overall Study|Physician Decision|1
7748467|NCT00728182|12184225|FG000|Overall Study|Adverse Event|1
7748468|NCT00728182|12184226|FG001|Overall Study|Adverse Event|0
7748469|NCT00728182|12184225|FG000|Overall Study|Lost to Follow-up|2
7748470|NCT00728182|12184226|FG001|Overall Study|Lost to Follow-up|0
7748471|NCT00728182|12184225|FG000|Overall Study|Death|0
7748472|NCT00728182|12184226|FG001|Overall Study|Death|2
7748473|NCT00728182|12184225|FG000|Overall Study|Protocol Noncompliance|0
7748474|NCT00728182|12184226|FG001|Overall Study|Protocol Noncompliance|1
7748475|NCT00728468|12184238|FG000|Overall Study|Enrolled but not treated|1
7748476|NCT00728468|12184238|FG000|Overall Study|Death|1
7748477|NCT00728468|12184238|FG000|Overall Study|Protocol Violation|4
7748478|NCT00728468|12184238|FG000|Overall Study|Objective progression or relapse|9
7748479|NCT00728468|12184238|FG000|Overall Study|Study terminated by sponsor|1
7748480|NCT00728481|12184244|FG000|Overall Study|Withdrawal by Subject|0
7748481|NCT00728481|12184245|FG001|Overall Study|Withdrawal by Subject|1
7748482|NCT00728481|12184244|FG000|Overall Study|Adverse Event|0
7748483|NCT00728481|12184245|FG001|Overall Study|Adverse Event|1
7748484|NCT00728481|12184244|FG000|Overall Study|Study medication non-compliance|0
7748485|NCT00728481|12184245|FG001|Overall Study|Study medication non-compliance|2
7748486|NCT00728481|12184244|FG000|Overall Study|Incorrectly assigned to opposite arm|1
7748487|NCT00728481|12184245|FG001|Overall Study|Incorrectly assigned to opposite arm|0
7748488|NCT00728494|12184253|FG000|Overall Study|Adverse Event|7
7748489|NCT00728494|12184254|FG001|Overall Study|Adverse Event|0
7748490|NCT00728494|12184253|FG000|Overall Study|Withdrawal by Subject|0
7748491|NCT00728494|12184254|FG001|Overall Study|Withdrawal by Subject|2
7748492|NCT00728494|12184253|FG000|Overall Study|Lack of Efficacy|2
7748493|NCT00728494|12184254|FG001|Overall Study|Lack of Efficacy|4
7748494|NCT00728494|12184253|FG000|Overall Study|No data available|0
7748495|NCT00728494|12184254|FG001|Overall Study|No data available|1
7748496|NCT00728689|12184271|FG000|Washout Period (Days 4 - 10)|Death in family|1
7748497|NCT00728689|12184272|FG001|Washout Period (Days 4 - 10)|Death in family|0
7748498|NCT00728936|12184319|FG000|Overall Study|Withdrawal by Subject|0
7748499|NCT00728936|12184320|FG001|Overall Study|Withdrawal by Subject|0
7748500|NCT00728936|12184321|FG002|Overall Study|Withdrawal by Subject|0
7748501|NCT00728936|12184322|FG003|Overall Study|Withdrawal by Subject|0
7748502|NCT00728936|12184323|FG004|Overall Study|Withdrawal by Subject|0
7748503|NCT00728936|12184324|FG005|Overall Study|Withdrawal by Subject|1
7748504|NCT00728936|12184325|FG006|Overall Study|Withdrawal by Subject|0
7748505|NCT00728949|12184343|FG000|Overall Study|Adverse Event|8
7748506|NCT00728949|12184344|FG001|Overall Study|Adverse Event|0
7748507|NCT00728949|12184343|FG000|Overall Study|Withdrawal by Subject|2
7748508|NCT00728949|12184344|FG001|Overall Study|Withdrawal by Subject|2
7748509|NCT00728949|12184343|FG000|Overall Study|Abnormal Lab Results|0
7748510|NCT00728949|12184344|FG001|Overall Study|Abnormal Lab Results|2
7962268|NCT02711345|12516526|FG004|Overall Study|Physician Decision|0
7962269|NCT02711345|12516527|FG005|Overall Study|Physician Decision|0
7962270|NCT02711345|12516528|FG006|Overall Study|Physician Decision|0
7962271|NCT02711345|12516529|FG007|Overall Study|Physician Decision|0
7748511|NCT00728949|12184343|FG000|Overall Study|On treatment at cutoff date|1
7748512|NCT00728949|12184344|FG001|Overall Study|On treatment at cutoff date|0
7748513|NCT00728988|12184352|FG000|Overall Study|Not Treated|2
7748514|NCT00728988|12184353|FG001|Overall Study|Not Treated|2
7748515|NCT00728988|12184352|FG000|Overall Study|Death|1
7748516|NCT00728988|12184353|FG001|Overall Study|Death|1
7748517|NCT00728988|12184352|FG000|Overall Study|Adverse Event|3
7748518|NCT00728988|12184353|FG001|Overall Study|Adverse Event|2
7748519|NCT00728988|12184352|FG000|Overall Study|Other|85
7748520|NCT00728988|12184353|FG001|Overall Study|Other|77
7748521|NCT00728988|12184352|FG000|Overall Study|Withdrawal by Subject|2
7748522|NCT00728988|12184353|FG001|Overall Study|Withdrawal by Subject|6
7748523|NCT00729157|12184377|FG000|Overall Study|Withdrawal by Subject|1
7748524|NCT00729183|12184383|FG000|Overall Study|Adverse Event|11
7748525|NCT00729183|12184384|FG001|Overall Study|Adverse Event|5
7748526|NCT00729183|12184383|FG000|Overall Study|Lack of Efficacy|0
7748527|NCT00729183|12184384|FG001|Overall Study|Lack of Efficacy|1
7748528|NCT00729183|12184383|FG000|Overall Study|Lost to Follow-up|3
7748529|NCT00729183|12184384|FG001|Overall Study|Lost to Follow-up|1
7748530|NCT00729183|12184383|FG000|Overall Study|Physician Decision|1
7748531|NCT00729183|12184384|FG001|Overall Study|Physician Decision|1
7748532|NCT00729183|12184383|FG000|Overall Study|Protocol Violation|1
7748533|NCT00729183|12184384|FG001|Overall Study|Protocol Violation|0
7748534|NCT00729183|12184383|FG000|Overall Study|Withdrawal by Subject|9
7748535|NCT00729183|12184384|FG001|Overall Study|Withdrawal by Subject|7
7748536|NCT00729248|12184390|FG000|Overall Study|Physician Decision|2
7748537|NCT00729326|12184397|FG000|Overall Study|Lost to Follow-up|2
7748538|NCT00729326|12184398|FG001|Overall Study|Lost to Follow-up|0
7748539|NCT00729326|12184397|FG000|Overall Study|Physician Decision|0
7748540|NCT00729326|12184398|FG001|Overall Study|Physician Decision|1
7748541|NCT00729326|12184397|FG000|Overall Study|Protocol Violation|3
7748542|NCT00729326|12184398|FG001|Overall Study|Protocol Violation|2
7748543|NCT00729326|12184397|FG000|Overall Study|Subject Decision|4
7748544|NCT00729326|12184398|FG001|Overall Study|Subject Decision|4
7748545|NCT00729326|12184397|FG000|Overall Study|Sponsor Decision|1
7748546|NCT00729326|12184398|FG001|Overall Study|Sponsor Decision|2
7748547|NCT00729378|12184406|FG000|Baseline|Did not complete study measurements|72
7748548|NCT00729378|12184407|FG001|Baseline|Did not complete study measurements|33
7748549|NCT00729378|12184406|FG000|Baseline|Withdrawal by Subject|66
7748550|NCT00729378|12184407|FG001|Baseline|Withdrawal by Subject|59
7748551|NCT00729378|12184406|FG000|12-months|Lost to Follow-up|100
7748552|NCT00729378|12184407|FG001|12-months|Lost to Follow-up|65
7748553|NCT00729378|12184406|FG000|24-months|Lost to Follow-up|72
7748554|NCT00729378|12184407|FG001|24-months|Lost to Follow-up|51
7748555|NCT00729378|12184406|FG000|36-months|Lost to Follow-up|15
7748556|NCT00729378|12184407|FG001|36-months|Lost to Follow-up|6
7748557|NCT00729469|12184428|FG000|Overall Study|Adverse Event|14
7748558|NCT00729469|12184429|FG001|Overall Study|Adverse Event|25
7748559|NCT00729469|12184428|FG000|Overall Study|Lost to Follow-up|9
7748560|NCT00729469|12184429|FG001|Overall Study|Lost to Follow-up|9
7748561|NCT00729469|12184428|FG000|Overall Study|Protocol Violation|2
7748562|NCT00729469|12184429|FG001|Overall Study|Protocol Violation|1
7748563|NCT00729469|12184428|FG000|Overall Study|Withdrawal by Subject|19
7748564|NCT00729469|12184429|FG001|Overall Study|Withdrawal by Subject|8
7748565|NCT00729469|12184428|FG000|Overall Study|Other-Not mentioned|9
7748566|NCT00729469|12184429|FG001|Overall Study|Other-Not mentioned|4
7748567|NCT00729586|12184454|FG000|Overall Study|Ineligible|0
7748568|NCT00729586|12184455|FG001|Overall Study|Ineligible|1
7748569|NCT00729586|12184454|FG000|Overall Study|never treated|1
7748570|NCT00729586|12184455|FG001|Overall Study|never treated|0
7748571|NCT00729612|12184462|FG000|Overall Study|Non evaluable for response|10
7748572|NCT00729690|12184480|FG000|Overall Study|IT Catheter Malfunction|0
7748573|NCT00729690|12184481|FG001|Overall Study|IT Catheter Malfunction|2
7748574|NCT00729690|12184482|FG002|Overall Study|IT Catheter Malfunction|2
7748575|NCT00729833|12184498|FG000|Overall Study|Death|5
7748576|NCT00729833|12184499|FG001|Overall Study|Death|1
7748577|NCT00729833|12184500|FG002|Overall Study|Death|3
7748578|NCT00729833|12184501|FG003|Overall Study|Death|5
7748579|NCT00729833|12184498|FG000|Overall Study|Study Terminated by Sponsor|0
7748580|NCT00729833|12184499|FG001|Overall Study|Study Terminated by Sponsor|0
7748581|NCT00729833|12184500|FG002|Overall Study|Study Terminated by Sponsor|1
7748582|NCT00729833|12184501|FG003|Overall Study|Study Terminated by Sponsor|0
7748583|NCT00729833|12184498|FG000|Overall Study|Lost to Follow-up|1
7748584|NCT00729833|12184499|FG001|Overall Study|Lost to Follow-up|0
7748585|NCT00729833|12184500|FG002|Overall Study|Lost to Follow-up|0
7748586|NCT00729833|12184501|FG003|Overall Study|Lost to Follow-up|0
7748587|NCT00729833|12184498|FG000|Overall Study|Withdrawal by Subject|3
7748588|NCT00729833|12184499|FG001|Overall Study|Withdrawal by Subject|1
7748589|NCT00729833|12184500|FG002|Overall Study|Withdrawal by Subject|3
7748590|NCT00729833|12184501|FG003|Overall Study|Withdrawal by Subject|0
7748591|NCT00729833|12184498|FG000|Overall Study|Unspecified Reasons|11
7748592|NCT00729833|12184499|FG001|Overall Study|Unspecified Reasons|5
7748593|NCT00729833|12184500|FG002|Overall Study|Unspecified Reasons|5
7748594|NCT00729833|12184501|FG003|Overall Study|Unspecified Reasons|1
7748595|NCT00729859|12184524|FG000|Overall Study|Adverse Event|0
7748596|NCT00729859|12184525|FG001|Overall Study|Adverse Event|1
7748597|NCT00729859|12184526|FG002|Overall Study|Adverse Event|0
7748598|NCT00729859|12184524|FG000|Overall Study|Withdrawal by Subject|0
7748599|NCT00729859|12184525|FG001|Overall Study|Withdrawal by Subject|1
7748600|NCT00729859|12184526|FG002|Overall Study|Withdrawal by Subject|0
7748601|NCT00729937|12184555|FG000|Overall Study|Lost to Follow-up|49
7748602|NCT00729937|12184556|FG001|Overall Study|Lost to Follow-up|58
7748603|NCT00729937|12184557|FG002|Overall Study|Lost to Follow-up|18
7748604|NCT00729937|12184558|FG003|Overall Study|Lost to Follow-up|33
7748605|NCT00729937|12184559|FG004|Overall Study|Lost to Follow-up|18
7748606|NCT00729937|12184560|FG005|Overall Study|Lost to Follow-up|23
7748607|NCT00729937|12184555|FG000|Overall Study|Physician Decision|7
7748608|NCT00729937|12184556|FG001|Overall Study|Physician Decision|16
7748609|NCT00729937|12184557|FG002|Overall Study|Physician Decision|2
7748610|NCT00729937|12184558|FG003|Overall Study|Physician Decision|0
7748611|NCT00729937|12184559|FG004|Overall Study|Physician Decision|5
7748612|NCT00729937|12184560|FG005|Overall Study|Physician Decision|8
7748613|NCT00729937|12184555|FG000|Overall Study|Death|1
7748614|NCT00729937|12184556|FG001|Overall Study|Death|0
7748615|NCT00729937|12184557|FG002|Overall Study|Death|1
7748616|NCT00729937|12184558|FG003|Overall Study|Death|0
7748617|NCT00729937|12184559|FG004|Overall Study|Death|0
7748618|NCT00729937|12184560|FG005|Overall Study|Death|1
7748619|NCT00729937|12184555|FG000|Overall Study|Withdrawal by Subject|3
7748620|NCT00729937|12184556|FG001|Overall Study|Withdrawal by Subject|5
7748621|NCT00729937|12184557|FG002|Overall Study|Withdrawal by Subject|6
7748622|NCT00729937|12184558|FG003|Overall Study|Withdrawal by Subject|0
7748623|NCT00729937|12184559|FG004|Overall Study|Withdrawal by Subject|4
7748624|NCT00729937|12184560|FG005|Overall Study|Withdrawal by Subject|2
7748625|NCT00729937|12184555|FG000|Overall Study|Randomized but not treated|12
7748626|NCT00729937|12184556|FG001|Overall Study|Randomized but not treated|6
7748627|NCT00729937|12184557|FG002|Overall Study|Randomized but not treated|1
7748628|NCT00729937|12184558|FG003|Overall Study|Randomized but not treated|0
7748629|NCT00729937|12184559|FG004|Overall Study|Randomized but not treated|1
7748630|NCT00729937|12184560|FG005|Overall Study|Randomized but not treated|3
7748631|NCT00729937|12184555|FG000|Overall Study|Did not meet eligibility criteria|2
7748632|NCT00729937|12184556|FG001|Overall Study|Did not meet eligibility criteria|1
7748633|NCT00729937|12184557|FG002|Overall Study|Did not meet eligibility criteria|0
7748634|NCT00729937|12184558|FG003|Overall Study|Did not meet eligibility criteria|0
7748635|NCT00729937|12184559|FG004|Overall Study|Did not meet eligibility criteria|0
7748636|NCT00729937|12184560|FG005|Overall Study|Did not meet eligibility criteria|0
7748637|NCT00729937|12184555|FG000|Overall Study|Incarcerated|0
7748638|NCT00729937|12184556|FG001|Overall Study|Incarcerated|2
7748639|NCT00729937|12184557|FG002|Overall Study|Incarcerated|1
7748640|NCT00729937|12184558|FG003|Overall Study|Incarcerated|1
7748641|NCT00729937|12184559|FG004|Overall Study|Incarcerated|0
7748642|NCT00729937|12184560|FG005|Overall Study|Incarcerated|0
7748643|NCT00730015|12184577|FG000|Overall Study|Adverse Event|11
7748644|NCT00730015|12184578|FG001|Overall Study|Adverse Event|10
7748645|NCT00730015|12184579|FG002|Overall Study|Adverse Event|8
7748646|NCT00730015|12184577|FG000|Overall Study|Protocol Violation|2
7748647|NCT00730015|12184578|FG001|Overall Study|Protocol Violation|6
7748648|NCT00730015|12184579|FG002|Overall Study|Protocol Violation|4
7748649|NCT00730015|12184577|FG000|Overall Study|Withdrawal by Subject|12
7748650|NCT00730015|12184578|FG001|Overall Study|Withdrawal by Subject|12
7748651|NCT00730015|12184579|FG002|Overall Study|Withdrawal by Subject|8
7748652|NCT00730015|12184577|FG000|Overall Study|Lost to Follow-up|4
7748653|NCT00730015|12184578|FG001|Overall Study|Lost to Follow-up|10
7748654|NCT00730015|12184579|FG002|Overall Study|Lost to Follow-up|3
7748655|NCT00730015|12184577|FG000|Overall Study|Lack of Efficacy|1
7748656|NCT00730015|12184578|FG001|Overall Study|Lack of Efficacy|2
7748657|NCT00730015|12184579|FG002|Overall Study|Lack of Efficacy|8
7748658|NCT00730015|12184577|FG000|Overall Study|Other Reason|1
7748659|NCT00730015|12184578|FG001|Overall Study|Other Reason|0
7748660|NCT00730015|12184579|FG002|Overall Study|Other Reason|1
7748661|NCT00730028|12184597|FG000|Overall Study|Adverse Event|23
7748662|NCT00730028|12184598|FG001|Overall Study|Adverse Event|26
7748663|NCT00730028|12184599|FG002|Overall Study|Adverse Event|16
7748664|NCT00730028|12184600|FG003|Overall Study|Adverse Event|20
7748665|NCT00730028|12184601|FG004|Overall Study|Adverse Event|43
7748666|NCT00730028|12184597|FG000|Overall Study|Lost to Follow-up|13
7748667|NCT00730028|12184598|FG001|Overall Study|Lost to Follow-up|26
7748668|NCT00730028|12184599|FG002|Overall Study|Lost to Follow-up|22
7748669|NCT00730028|12184600|FG003|Overall Study|Lost to Follow-up|26
7748670|NCT00730028|12184601|FG004|Overall Study|Lost to Follow-up|25
7748671|NCT00730028|12184597|FG000|Overall Study|Protocol Violation|6
7748672|NCT00730028|12184598|FG001|Overall Study|Protocol Violation|1
7748673|NCT00730028|12184599|FG002|Overall Study|Protocol Violation|1
7748674|NCT00730028|12184600|FG003|Overall Study|Protocol Violation|2
7748675|NCT00730028|12184601|FG004|Overall Study|Protocol Violation|0
7748676|NCT00730028|12184597|FG000|Overall Study|Withdrawal by Subject|9
7748677|NCT00730028|12184598|FG001|Overall Study|Withdrawal by Subject|5
7748678|NCT00730028|12184599|FG002|Overall Study|Withdrawal by Subject|4
7748679|NCT00730028|12184600|FG003|Overall Study|Withdrawal by Subject|5
7748680|NCT00730028|12184601|FG004|Overall Study|Withdrawal by Subject|9
7748681|NCT00730028|12184597|FG000|Overall Study|Physician Decision|3
7748682|NCT00730028|12184598|FG001|Overall Study|Physician Decision|3
7748683|NCT00730028|12184599|FG002|Overall Study|Physician Decision|2
7748684|NCT00730028|12184600|FG003|Overall Study|Physician Decision|3
7748685|NCT00730028|12184601|FG004|Overall Study|Physician Decision|2
7748686|NCT00730028|12184597|FG000|Overall Study|Treatment Failure|5
7748687|NCT00730028|12184598|FG001|Overall Study|Treatment Failure|5
7748688|NCT00730028|12184599|FG002|Overall Study|Treatment Failure|0
7748689|NCT00730028|12184600|FG003|Overall Study|Treatment Failure|0
7748690|NCT00730028|12184601|FG004|Overall Study|Treatment Failure|1
7748691|NCT00730028|12184597|FG000|Overall Study|Randomization Error|1
7748692|NCT00730028|12184598|FG001|Overall Study|Randomization Error|0
7748693|NCT00730028|12184599|FG002|Overall Study|Randomization Error|0
7748694|NCT00730028|12184600|FG003|Overall Study|Randomization Error|0
7748695|NCT00730028|12184601|FG004|Overall Study|Randomization Error|2
7748696|NCT00730041|12184615|FG000|Overall Study|Lost to Follow-up|0
7748697|NCT00730041|12184616|FG001|Overall Study|Lost to Follow-up|2
7748698|NCT00730158|12184624|FG000|Overall Study|Withdrawal by Subject|1
7748699|NCT00730158|12184625|FG001|Overall Study|Withdrawal by Subject|1
7748700|NCT00730171|12184635|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
7748701|NCT00730171|12184635|FG000|Overall Study|Adverse Event|193
7748702|NCT00730171|12184635|FG000|Overall Study|Protocol Violation|48
7748703|NCT00730171|12184635|FG000|Overall Study|Withdrawal by Subject|202
7748704|NCT00730171|12184635|FG000|Overall Study|Lost to Follow-up|121
7748705|NCT00730171|12184635|FG000|Overall Study|Insufficient Therapeutic Response|141
7748706|NCT00730171|12184635|FG000|Overall Study|Other|61
7748707|NCT00730236|12184643|FG000|Overall Study|Adverse Event|4
7748708|NCT00730236|12184643|FG000|Overall Study|Withdrawal by Subject|1
7748709|NCT00730236|12184643|FG000|Overall Study|Non-compliance|1
7748710|NCT00730275|12184651|FG000|Overall Study|Withdrawal by Subject|0
7748711|NCT00730275|12184652|FG001|Overall Study|Withdrawal by Subject|0
7748712|NCT00730275|12184653|FG002|Overall Study|Withdrawal by Subject|0
7748713|NCT00730275|12184654|FG003|Overall Study|Withdrawal by Subject|1
7748714|NCT00730327|12184667|FG000|Overall Study|Lost to Follow-up|14
7748715|NCT00730327|12184668|FG001|Overall Study|Lost to Follow-up|16
7748716|NCT00730327|12184667|FG000|Overall Study|Adverse Event|8
7748717|NCT00730327|12184668|FG001|Overall Study|Adverse Event|1
7748718|NCT00730327|12184667|FG000|Overall Study|Withdrawal by Subject|3
7748719|NCT00730327|12184668|FG001|Overall Study|Withdrawal by Subject|13
7748720|NCT00730327|12184667|FG000|Overall Study|Subject withdrew (reason not specified)|2
7748721|NCT00730327|12184668|FG001|Overall Study|Subject withdrew (reason not specified)|7
7769507|NCT00868790|12213065|FG007|Period 4|Adverse Event|1
7769508|NCT00868790|12213066|FG008|Period 4|Adverse Event|0
7769509|NCT00868790|12213067|FG009|Period 4|Adverse Event|0
7769510|NCT00868790|12213068|FG010|Period 4|Adverse Event|1
7769511|NCT00868790|12213069|FG011|Period 4|Adverse Event|0
7769512|NCT00868790|12213070|FG012|Period 4|Adverse Event|1
7769513|NCT00868790|12213071|FG013|Period 4|Adverse Event|0
7769514|NCT00868790|12213058|FG000|Period 4|Lost to Follow-up|0
7769515|NCT00868790|12213059|FG001|Period 4|Lost to Follow-up|0
7769516|NCT00868790|12213060|FG002|Period 4|Lost to Follow-up|0
7769517|NCT00868790|12213061|FG003|Period 4|Lost to Follow-up|0
7769518|NCT00868790|12213062|FG004|Period 4|Lost to Follow-up|0
7769519|NCT00868790|12213063|FG005|Period 4|Lost to Follow-up|0
7769520|NCT00868790|12213064|FG006|Period 4|Lost to Follow-up|0
7769521|NCT00868790|12213065|FG007|Period 4|Lost to Follow-up|1
7769522|NCT00868790|12213066|FG008|Period 4|Lost to Follow-up|0
7769523|NCT00868790|12213067|FG009|Period 4|Lost to Follow-up|0
7769524|NCT00868790|12213068|FG010|Period 4|Lost to Follow-up|0
7769525|NCT00868790|12213069|FG011|Period 4|Lost to Follow-up|0
7769526|NCT00868790|12213070|FG012|Period 4|Lost to Follow-up|0
7769527|NCT00868790|12213071|FG013|Period 4|Lost to Follow-up|0
7769528|NCT00868790|12213058|FG000|Period 4|Study Terminated by Sponsor|2
7769529|NCT00868790|12213059|FG001|Period 4|Study Terminated by Sponsor|0
7769530|NCT00868790|12213060|FG002|Period 4|Study Terminated by Sponsor|0
7769531|NCT00868790|12213061|FG003|Period 4|Study Terminated by Sponsor|0
7769532|NCT00868790|12213062|FG004|Period 4|Study Terminated by Sponsor|0
7769533|NCT00868790|12213063|FG005|Period 4|Study Terminated by Sponsor|0
7769534|NCT00868790|12213064|FG006|Period 4|Study Terminated by Sponsor|0
7769535|NCT00868790|12213065|FG007|Period 4|Study Terminated by Sponsor|1
7769536|NCT00868790|12213066|FG008|Period 4|Study Terminated by Sponsor|2
7769537|NCT00868790|12213067|FG009|Period 4|Study Terminated by Sponsor|0
7769538|NCT00868790|12213068|FG010|Period 4|Study Terminated by Sponsor|2
7769539|NCT00868790|12213069|FG011|Period 4|Study Terminated by Sponsor|1
7769540|NCT00868790|12213070|FG012|Period 4|Study Terminated by Sponsor|0
7769541|NCT00868790|12213071|FG013|Period 4|Study Terminated by Sponsor|1
7769542|NCT00868790|12213058|FG000|Period 4|Abnormal ALT/AST|0
7769543|NCT00868790|12213059|FG001|Period 4|Abnormal ALT/AST|0
7769544|NCT00868790|12213060|FG002|Period 4|Abnormal ALT/AST|1
7769545|NCT00868790|12213061|FG003|Period 4|Abnormal ALT/AST|0
7769546|NCT00868790|12213062|FG004|Period 4|Abnormal ALT/AST|0
7769547|NCT00868790|12213063|FG005|Period 4|Abnormal ALT/AST|0
7769548|NCT00868790|12213064|FG006|Period 4|Abnormal ALT/AST|0
7769549|NCT00868790|12213065|FG007|Period 4|Abnormal ALT/AST|0
7769550|NCT00868790|12213066|FG008|Period 4|Abnormal ALT/AST|0
7769551|NCT00868790|12213067|FG009|Period 4|Abnormal ALT/AST|0
7769552|NCT00868790|12213068|FG010|Period 4|Abnormal ALT/AST|0
7769553|NCT00868790|12213069|FG011|Period 4|Abnormal ALT/AST|0
7769554|NCT00868790|12213070|FG012|Period 4|Abnormal ALT/AST|0
7769555|NCT00868790|12213071|FG013|Period 4|Abnormal ALT/AST|0
7769556|NCT00868790|12213058|FG000|Post-study|Withdrawal by Subject|0
7769557|NCT00868790|12213059|FG001|Post-study|Withdrawal by Subject|0
7769558|NCT00868790|12213060|FG002|Post-study|Withdrawal by Subject|0
7769559|NCT00868790|12213061|FG003|Post-study|Withdrawal by Subject|0
7769560|NCT00868790|12213062|FG004|Post-study|Withdrawal by Subject|1
7769561|NCT00868790|12213063|FG005|Post-study|Withdrawal by Subject|0
7769562|NCT00868790|12213064|FG006|Post-study|Withdrawal by Subject|0
7769563|NCT00868790|12213065|FG007|Post-study|Withdrawal by Subject|0
7769564|NCT00868790|12213066|FG008|Post-study|Withdrawal by Subject|0
7748722|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Adverse Event|5
7748723|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Adverse Event|10
7748724|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Adverse Event|4
7748725|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Adverse Event|8
7748726|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Adverse Event|4
7748727|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4
7748728|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5
7748729|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6
7748730|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4
7748731|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4
7748732|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
7748733|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
7748734|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
7748735|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
7748736|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
7748737|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7
7748738|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1
7748739|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2
7748740|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5
7748741|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8
7748742|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Did not met eligibility|0
7748743|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Did not met eligibility|0
7748744|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Did not met eligibility|1
7748745|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Did not met eligibility|0
7748746|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Did not met eligibility|0
7748747|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0
7748748|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0
7748749|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1
7748750|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0
7748751|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0
7748752|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1
7748753|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0
7748754|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0
7748755|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0
7748756|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0
7748757|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0
7748758|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1
7748759|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0
7748760|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0
7748761|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0
7748762|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0
7748763|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1
7748764|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0
7748765|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0
7748766|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2
7748767|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
7748768|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
7748769|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
7748770|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
7748771|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
7748772|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Misrandomized|0
7748773|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Misrandomized|1
7748774|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Misrandomized|0
7748775|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Misrandomized|0
7748776|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Misrandomized|0
7748777|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Study drug interrupted|0
7748778|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Study drug interrupted|1
7748779|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Study drug interrupted|0
7748780|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Study drug interrupted|0
7748781|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Study drug interrupted|0
7748782|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
7748783|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
7748784|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
7748785|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
7748786|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
7748787|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
7748788|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
7748789|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
7748790|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
7748791|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
7748792|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Change of location|0
7748793|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Change of location|0
7748794|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Change of location|0
7748795|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Change of location|1
7748796|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Change of location|0
7748797|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Pregnancy|0
7748798|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Pregnancy|1
7748799|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Pregnancy|0
7748800|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Pregnancy|0
7748801|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Pregnancy|0
7748802|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
7748803|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
7748804|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
7748805|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
7748806|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
7748807|NCT00730405|12184683|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1
7748808|NCT00730405|12184684|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0
7748809|NCT00730405|12184685|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0
7748810|NCT00730405|12184686|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0
7748811|NCT00730405|12184687|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0
7748812|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Adverse Event|2
7748813|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Adverse Event|6
7748814|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Adverse Event|2
7748815|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Adverse Event|3
7748816|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Adverse Event|4
7748817|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7
7748818|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6
7748819|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8
7748820|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4
7748821|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6
7748822|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7
7748823|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3
7748824|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3
7748825|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6
7748826|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10
7748827|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Death|0
7748828|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Death|1
7748829|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Death|0
7748830|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Death|1
7748831|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Death|0
7748832|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Change of location|1
7748833|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Change of location|1
7748834|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Change of location|0
7748835|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Change of location|1
7748836|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Change of location|0
7748837|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Did not met eligibility|0
7748838|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Did not met eligibility|0
7748839|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Did not met eligibility|1
7748840|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Did not met eligibility|0
7748841|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Did not met eligibility|0
7748842|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0
7748843|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0
7748844|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1
7748845|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0
7748846|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0
7748847|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
7748848|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
7748849|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
7748850|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
7748851|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
7748852|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
7748853|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
7748854|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
7748855|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
7748856|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
7769565|NCT00868790|12213067|FG009|Post-study|Withdrawal by Subject|0
7748857|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1
7748858|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0
7748859|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0
7748860|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0
7748861|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0
7748862|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0
7748863|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0
7748864|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0
7748865|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1
7748866|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0
7748867|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
7748868|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
7748869|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
7748870|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
7748871|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
7748872|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1
7748873|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1
7748874|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0
7748875|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0
7748876|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0
7748877|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Use of restricted medication|0
7748878|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Use of restricted medication|1
7748879|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Use of restricted medication|0
7748880|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Use of restricted medication|0
7748881|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Use of restricted medication|0
7748882|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Non-compliance|1
7748883|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Non-compliance|0
7748884|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Non-compliance|2
7748885|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Non-compliance|0
7748886|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Non-compliance|0
7748887|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Missing|0
7748888|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Missing|0
7748889|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Missing|2
7748890|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Missing|0
7748891|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Missing|0
7748892|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0
7748893|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0
7748894|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0
7748895|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0
7748896|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1
7748897|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
7748898|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
7748899|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
7748900|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
7748901|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
7748902|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Mis-randomized|0
7748903|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Mis-randomized|1
7748904|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Mis-randomized|0
7748905|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Mis-randomized|0
7748906|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Mis-randomized|0
7748907|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Other Protocol violation|0
7748908|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Other Protocol violation|0
7748909|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Other Protocol violation|1
7748910|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Other Protocol violation|0
7748911|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Other Protocol violation|0
7748912|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
7748913|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
7748914|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
7748915|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
7748916|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
7748917|NCT00730405|12184683|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1
7748918|NCT00730405|12184684|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0
7748919|NCT00730405|12184685|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0
7748920|NCT00730405|12184686|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0
7748921|NCT00730405|12184687|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0
7748922|NCT00730691|12184722|FG000|Overall Study|Adverse Event|4
7748923|NCT00730691|12184723|FG001|Overall Study|Adverse Event|8
7748924|NCT00730691|12184724|FG002|Overall Study|Adverse Event|11
7748925|NCT00730691|12184725|FG003|Overall Study|Adverse Event|11
7748926|NCT00730691|12184726|FG004|Overall Study|Adverse Event|23
7748927|NCT00730691|12184722|FG000|Overall Study|Lack of Efficacy|4
7748928|NCT00730691|12184723|FG001|Overall Study|Lack of Efficacy|4
7748929|NCT00730691|12184724|FG002|Overall Study|Lack of Efficacy|2
7748930|NCT00730691|12184725|FG003|Overall Study|Lack of Efficacy|1
7748931|NCT00730691|12184726|FG004|Overall Study|Lack of Efficacy|1
7748932|NCT00730691|12184722|FG000|Overall Study|Non-compliance with Study Drug|6
7748933|NCT00730691|12184723|FG001|Overall Study|Non-compliance with Study Drug|1
7748934|NCT00730691|12184724|FG002|Overall Study|Non-compliance with Study Drug|6
7748935|NCT00730691|12184725|FG003|Overall Study|Non-compliance with Study Drug|3
7748936|NCT00730691|12184726|FG004|Overall Study|Non-compliance with Study Drug|3
7748937|NCT00730691|12184722|FG000|Overall Study|Protocol Deviations|3
7748938|NCT00730691|12184723|FG001|Overall Study|Protocol Deviations|5
7748939|NCT00730691|12184724|FG002|Overall Study|Protocol Deviations|3
7748940|NCT00730691|12184725|FG003|Overall Study|Protocol Deviations|7
7748941|NCT00730691|12184726|FG004|Overall Study|Protocol Deviations|5
7748942|NCT00730691|12184722|FG000|Overall Study|Withdrawal of Consent|7
7748943|NCT00730691|12184723|FG001|Overall Study|Withdrawal of Consent|9
7748944|NCT00730691|12184724|FG002|Overall Study|Withdrawal of Consent|3
7748945|NCT00730691|12184725|FG003|Overall Study|Withdrawal of Consent|6
7748946|NCT00730691|12184726|FG004|Overall Study|Withdrawal of Consent|3
7748947|NCT00730691|12184722|FG000|Overall Study|Lost to Follow-up|11
7748948|NCT00730691|12184723|FG001|Overall Study|Lost to Follow-up|8
7748949|NCT00730691|12184724|FG002|Overall Study|Lost to Follow-up|13
7748950|NCT00730691|12184725|FG003|Overall Study|Lost to Follow-up|15
7748951|NCT00730691|12184726|FG004|Overall Study|Lost to Follow-up|13
7748952|NCT00730691|12184722|FG000|Overall Study|Other|1
7748953|NCT00730691|12184723|FG001|Overall Study|Other|1
7748954|NCT00730691|12184724|FG002|Overall Study|Other|1
7748955|NCT00730691|12184725|FG003|Overall Study|Other|2
7748956|NCT00730691|12184726|FG004|Overall Study|Other|2
7748957|NCT00730756|12184744|FG000|Overall Study|Adverse Event|2
7748958|NCT00730756|12184745|FG001|Overall Study|Adverse Event|0
7748959|NCT00730756|12184744|FG000|Overall Study|Lack of Efficacy|1
7748960|NCT00730756|12184745|FG001|Overall Study|Lack of Efficacy|1
7748961|NCT00730756|12184744|FG000|Overall Study|Protocol Deviation|1
7748962|NCT00730756|12184745|FG001|Overall Study|Protocol Deviation|2
7748963|NCT00730756|12184744|FG000|Overall Study|Lost to Follow-up|0
7748964|NCT00730756|12184745|FG001|Overall Study|Lost to Follow-up|1
7748965|NCT00730756|12184744|FG000|Overall Study|Withdrew Consent|0
7748966|NCT00730756|12184745|FG001|Overall Study|Withdrew Consent|1
7748967|NCT00730847|12184751|FG000|Overall Study|Adverse Event|1
7748968|NCT00730847|12184751|FG000|Overall Study|Protocol Violation|2
7748969|NCT00730847|12184751|FG000|Overall Study|Withdrawal by Subject|16
7748970|NCT00730847|12184751|FG000|Overall Study|Lost to Follow-up|67
7748971|NCT00730847|12184751|FG000|Overall Study|Unknown completion status|21
7748972|NCT00730847|12184751|FG000|Overall Study|Other|24
7748973|NCT00730912|12184758|FG000|Overall Study|Discontinued|0
7748974|NCT00730912|12184759|FG001|Overall Study|Discontinued|0
7748975|NCT00730912|12184760|FG002|Overall Study|Discontinued|1
7748976|NCT00730925|12184768|FG000|Overall Study|Progressive Disease|21
7748977|NCT00730925|12184768|FG000|Overall Study|Dose reducing Event|2
7748978|NCT00730925|12184768|FG000|Overall Study|Other Averse Event|7
7748979|NCT00730925|12184768|FG000|Overall Study|Protocol Violation|1
7748980|NCT00730925|12184768|FG000|Overall Study|Withdrawal by Subject|1
7748981|NCT00730925|12184768|FG000|Overall Study|Switch to combination therapy|8
7748982|NCT00730925|12184768|FG000|Overall Study|Other|1
7748983|NCT00731042|12184779|FG000|Second Intervention|Did not meet inclusion criteria|0
7748984|NCT00731042|12184780|FG001|Second Intervention|Did not meet inclusion criteria|2
7748985|NCT00731120|12184805|FG000|Overall Study|Adverse Event|7
7748986|NCT00731120|12184806|FG001|Overall Study|Adverse Event|6
7748987|NCT00731120|12184807|FG002|Overall Study|Adverse Event|8
7748988|NCT00731120|12184805|FG000|Overall Study|Lack of Efficacy|4
7748989|NCT00731120|12184806|FG001|Overall Study|Lack of Efficacy|5
7748990|NCT00731120|12184807|FG002|Overall Study|Lack of Efficacy|4
7748991|NCT00731120|12184805|FG000|Overall Study|Noncompliance with Study Drug|3
7748992|NCT00731120|12184806|FG001|Overall Study|Noncompliance with Study Drug|3
7748993|NCT00731120|12184807|FG002|Overall Study|Noncompliance with Study Drug|1
7748994|NCT00731120|12184805|FG000|Overall Study|Protocol Deviations|1
7748995|NCT00731120|12184806|FG001|Overall Study|Protocol Deviations|6
7748996|NCT00731120|12184807|FG002|Overall Study|Protocol Deviations|1
7748997|NCT00731120|12184805|FG000|Overall Study|Withdrawal of Consent|13
7748998|NCT00731120|12184806|FG001|Overall Study|Withdrawal of Consent|8
7748999|NCT00731120|12184807|FG002|Overall Study|Withdrawal of Consent|4
7749000|NCT00731120|12184805|FG000|Overall Study|Lost to Follow-up|10
7749001|NCT00731120|12184806|FG001|Overall Study|Lost to Follow-up|15
7749002|NCT00731120|12184807|FG002|Overall Study|Lost to Follow-up|17
7749003|NCT00731120|12184805|FG000|Overall Study|Other|4
7749004|NCT00731120|12184806|FG001|Overall Study|Other|0
7749005|NCT00731120|12184807|FG002|Overall Study|Other|1
7749006|NCT00731133|12184815|FG000|Overall Study|Withdrawal by Subject|10
7749007|NCT00731549|12184840|FG000|Overall Study|Lost to Follow-up|19
7749008|NCT00731549|12184840|FG000|Overall Study|Met withdrawal criteria|24
7749009|NCT00731549|12184840|FG000|Overall Study|Physician Decision|16
7749010|NCT00731549|12184840|FG000|Overall Study|Withdrawal by Subject|89
7749011|NCT00731549|12184840|FG000|Overall Study|Protocol deviation|1
7749012|NCT00731549|12184840|FG000|Overall Study|Adverse Event|31
7749013|NCT00731549|12184840|FG000|Overall Study|Lack of efficacy with AE|37
7749014|NCT00731549|12184840|FG000|Overall Study|Lack of efficacy without AE|6
7749015|NCT00731666|12184876|FG000|Overall Study|Adverse Event|2
7749016|NCT00731666|12184876|FG000|Overall Study|Lost to Follow-up|8
7749017|NCT00731666|12184876|FG000|Overall Study|Withdrawal by Subject|2
7749018|NCT00731679|12184882|FG000|Overall Study|Adverse Event|7
7749019|NCT00731679|12184883|FG001|Overall Study|Adverse Event|8
7749020|NCT00731679|12184882|FG000|Overall Study|Withdrawal by Subject|8
7749021|NCT00731679|12184883|FG001|Overall Study|Withdrawal by Subject|8
7749022|NCT00731679|12184882|FG000|Overall Study|Lost to Follow-up|7
7749023|NCT00731679|12184883|FG001|Overall Study|Lost to Follow-up|8
7749024|NCT00731679|12184882|FG000|Overall Study|Noncompliance|0
7749025|NCT00731679|12184883|FG001|Overall Study|Noncompliance|1
7749026|NCT00731679|12184882|FG000|Overall Study|Pregnancy|0
7749027|NCT00731679|12184883|FG001|Overall Study|Pregnancy|1
7749028|NCT00731692|12184892|FG000|Core Study (36 Months)|Lack of Efficacy|11
7749029|NCT00731692|12184893|FG001|Core Study (36 Months)|Lack of Efficacy|23
7749030|NCT00731692|12184894|FG002|Core Study (36 Months)|Lack of Efficacy|64
7749031|NCT00731692|12184892|FG000|Core Study (36 Months)|Physician Decision|1
7749032|NCT00731692|12184893|FG001|Core Study (36 Months)|Physician Decision|0
7749033|NCT00731692|12184894|FG002|Core Study (36 Months)|Physician Decision|2
7749034|NCT00731692|12184892|FG000|Core Study (36 Months)|Death|2
7749035|NCT00731692|12184893|FG001|Core Study (36 Months)|Death|1
7749036|NCT00731692|12184894|FG002|Core Study (36 Months)|Death|2
7749037|NCT00731692|12184892|FG000|Core Study (36 Months)|Lost to Follow-up|1
7749038|NCT00731692|12184893|FG001|Core Study (36 Months)|Lost to Follow-up|3
7749039|NCT00731692|12184894|FG002|Core Study (36 Months)|Lost to Follow-up|3
7749040|NCT00731692|12184892|FG000|Core Study (36 Months)|Administrative|2
7749041|NCT00731692|12184893|FG001|Core Study (36 Months)|Administrative|2
7749042|NCT00731692|12184894|FG002|Core Study (36 Months)|Administrative|6
7749043|NCT00731692|12184892|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4
7749044|NCT00731692|12184893|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3
7749045|NCT00731692|12184894|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5
7749046|NCT00731692|12184892|FG000|Core Study (36 Months)|Protocol Violation|4
7749047|NCT00731692|12184893|FG001|Core Study (36 Months)|Protocol Violation|5
7749048|NCT00731692|12184894|FG002|Core Study (36 Months)|Protocol Violation|8
7749049|NCT00731692|12184892|FG000|Core Study (36 Months)|Abnormal Lab values|6
7749050|NCT00731692|12184893|FG001|Core Study (36 Months)|Abnormal Lab values|19
7749051|NCT00731692|12184894|FG002|Core Study (36 Months)|Abnormal Lab values|5
7749052|NCT00731692|12184892|FG000|Core Study (36 Months)|Adverse Event|25
7749053|NCT00731692|12184893|FG001|Core Study (36 Months)|Adverse Event|28
7749054|NCT00731692|12184894|FG002|Core Study (36 Months)|Adverse Event|29
7749055|NCT00731692|12184892|FG000|Core Study (36 Months)|Withdrawal by Subject|12
7749056|NCT00731692|12184893|FG001|Core Study (36 Months)|Withdrawal by Subject|32
7749057|NCT00731692|12184894|FG002|Core Study (36 Months)|Withdrawal by Subject|46
7749058|NCT00731692|12184892|FG000|Extension Phase|Admin Problems: Terminated # patients|69
7749059|NCT00731692|12184893|FG001|Extension Phase|Admin Problems: Terminated # patients|189
7749060|NCT00731692|12184894|FG002|Extension Phase|Admin Problems: Terminated # patients|277
7749061|NCT00731692|12184892|FG000|Extension Phase|Abnormal test procedure|0
7749062|NCT00731692|12184893|FG001|Extension Phase|Abnormal test procedure|0
7749063|NCT00731692|12184894|FG002|Extension Phase|Abnormal test procedure|1
7749064|NCT00731692|12184892|FG000|Extension Phase|Abnormal lab values|0
7749065|NCT00731692|12184893|FG001|Extension Phase|Abnormal lab values|0
7749066|NCT00731692|12184894|FG002|Extension Phase|Abnormal lab values|1
7749067|NCT00731692|12184892|FG000|Extension Phase|Lost to Follow-up|0
7749068|NCT00731692|12184893|FG001|Extension Phase|Lost to Follow-up|1
7749069|NCT00731692|12184894|FG002|Extension Phase|Lost to Follow-up|4
7749070|NCT00731692|12184892|FG000|Extension Phase|Withdrawal by Subject|4
7749071|NCT00731692|12184893|FG001|Extension Phase|Withdrawal by Subject|5
7749072|NCT00731692|12184894|FG002|Extension Phase|Withdrawal by Subject|3
7749073|NCT00731692|12184892|FG000|Extension Phase|Adverse Event|1
7749074|NCT00731692|12184893|FG001|Extension Phase|Adverse Event|1
7749075|NCT00731692|12184894|FG002|Extension Phase|Adverse Event|15
7749076|NCT00731783|12184912|FG000|One Month Follow-Up Visit|Lost to Follow-up|14
7749077|NCT00731783|12184913|FG001|One Month Follow-Up Visit|Lost to Follow-up|22
7749078|NCT00731783|12184912|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7
7749079|NCT00731783|12184913|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16
7749080|NCT00731783|12184912|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6
7749081|NCT00731783|12184913|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3
7749082|NCT00731783|12184912|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6
7749083|NCT00731783|12184913|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7
7749084|NCT00731822|12184921|FG000|Overall Study|Adverse Event|2
7749085|NCT00731822|12184922|FG001|Overall Study|Adverse Event|1
7749086|NCT00731822|12184921|FG000|Overall Study|Protocol Violation|1
7749087|NCT00731822|12184922|FG001|Overall Study|Protocol Violation|0
7749088|NCT00731822|12184921|FG000|Overall Study|Lost to Follow-up|1
7749089|NCT00731822|12184922|FG001|Overall Study|Lost to Follow-up|0
7749090|NCT00731939|12184937|FG000|Overall Study|Adverse Event|6
7749091|NCT00731939|12184937|FG000|Overall Study|Lost to Follow-up|15
7749092|NCT00731939|12184937|FG000|Overall Study|Not implanted with study device|9
7749093|NCT00731939|12184937|FG000|Overall Study|Withdrawal by Subject|2
7749094|NCT00731939|12184937|FG000|Overall Study|Did not meet enrollment criteria|2
7749095|NCT00732069|12184945|FG000|Washout After First Study Drug|Adverse Event|1
7749096|NCT00732069|12184946|FG001|Washout After First Study Drug|Adverse Event|0
7749097|NCT00732069|12184947|FG002|Washout After First Study Drug|Adverse Event|0
7749098|NCT00732069|12184948|FG003|Washout After First Study Drug|Adverse Event|0
7749099|NCT00732069|12184949|FG004|Washout After First Study Drug|Adverse Event|0
7749100|NCT00732069|12184950|FG005|Washout After First Study Drug|Adverse Event|0
7749101|NCT00732160|12184962|FG000|Overall Study|Adverse Event|1
7749102|NCT00732160|12184963|FG001|Overall Study|Adverse Event|0
7749103|NCT00732160|12184964|FG002|Overall Study|Adverse Event|1
7749104|NCT00732160|12184965|FG003|Overall Study|Adverse Event|1
7749105|NCT00732160|12184962|FG000|Overall Study|scheduling|4
7749106|NCT00732160|12184963|FG001|Overall Study|scheduling|4
7749107|NCT00732160|12184964|FG002|Overall Study|scheduling|2
7749108|NCT00732160|12184965|FG003|Overall Study|scheduling|1
7749109|NCT00732199|12184977|FG000|Overall Study|Withdrawal by Subject|25
7749110|NCT00732199|12184978|FG001|Overall Study|Withdrawal by Subject|18
7749111|NCT00732199|12184977|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9
7749112|NCT00732199|12184978|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8
7749113|NCT00732238|12185010|FG000|Overall Study|Bacteremia|4
7749114|NCT00732238|12185011|FG001|Overall Study|Bacteremia|1
7749115|NCT00732238|12185010|FG000|Overall Study|Asymptomatic bacteriuria|1
7749116|NCT00732238|12185011|FG001|Overall Study|Asymptomatic bacteriuria|0
7749117|NCT00732251|12185019|FG000|Overall Study|Lost to Follow-up|3
7749118|NCT00732251|12185019|FG000|Overall Study|Withdrawal by Subject|3
7749119|NCT00732251|12185019|FG000|Overall Study|Early Term due to Site Closure|1
7749120|NCT00732303|12185023|FG000|Overall Study|Study Terminated|2
7749121|NCT00732472|12185031|FG000|Overall Study|Adverse Event|0
7749122|NCT00732472|12185032|FG001|Overall Study|Adverse Event|1
7749123|NCT00732472|12185033|FG002|Overall Study|Adverse Event|1
7749124|NCT00732472|12185034|FG003|Overall Study|Adverse Event|1
7749125|NCT00732472|12185031|FG000|Overall Study|Protocol Violation|0
7749126|NCT00732472|12185032|FG001|Overall Study|Protocol Violation|0
7749127|NCT00732472|12185033|FG002|Overall Study|Protocol Violation|0
7749128|NCT00732472|12185034|FG003|Overall Study|Protocol Violation|1
7749129|NCT00732472|12185031|FG000|Overall Study|Withdrawal by Subject|0
7749130|NCT00732472|12185032|FG001|Overall Study|Withdrawal by Subject|2
7749131|NCT00732472|12185033|FG002|Overall Study|Withdrawal by Subject|0
7749132|NCT00732472|12185034|FG003|Overall Study|Withdrawal by Subject|1
7749133|NCT00732498|12185045|FG000|Overall Study|Ineligible|1
7749134|NCT00732498|12185045|FG000|Overall Study|Adverse Event|2
7749135|NCT00732498|12185045|FG000|Overall Study|Physician Decision|3
7749136|NCT00732615|12185051|FG000|Overall Study|Withdrawal by Subject|3
7749137|NCT00732615|12185052|FG001|Overall Study|Withdrawal by Subject|1
7749138|NCT00732615|12185051|FG000|Overall Study|Lost to Follow-up|0
7749139|NCT00732615|12185052|FG001|Overall Study|Lost to Follow-up|1
7749140|NCT00732615|12185051|FG000|Overall Study|Adverse Event|0
7749141|NCT00732615|12185052|FG001|Overall Study|Adverse Event|2
7749142|NCT00732615|12185051|FG000|Overall Study|Physician Decision|3
7749143|NCT00732615|12185052|FG001|Overall Study|Physician Decision|0
7749144|NCT00732615|12185051|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1
7749145|NCT00732615|12185052|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1
7749146|NCT00732641|12185061|FG000|Overall Study|Relapse or Progressive Disease|65
7749147|NCT00732641|12185062|FG001|Overall Study|Relapse or Progressive Disease|101
7749148|NCT00732641|12185061|FG000|Overall Study|Serious Adverse Events|12
7749149|NCT00732641|12185062|FG001|Overall Study|Serious Adverse Events|3
7749150|NCT00732641|12185061|FG000|Overall Study|Physician Decision|6
7749151|NCT00732641|12185062|FG001|Overall Study|Physician Decision|0
7749152|NCT00732641|12185061|FG000|Overall Study|Withdrawal by Subject|4
7749153|NCT00732641|12185062|FG001|Overall Study|Withdrawal by Subject|2
7749154|NCT00732641|12185061|FG000|Overall Study|Unable to Complete|1
7749155|NCT00732641|12185062|FG001|Overall Study|Unable to Complete|1
7749156|NCT00732641|12185061|FG000|Overall Study|Other|18
7749157|NCT00732641|12185062|FG001|Overall Study|Other|5
7749158|NCT00732758|12185083|FG000|Overall Study|Lost to Follow-up|8
7749159|NCT00732758|12185084|FG001|Overall Study|Lost to Follow-up|16
7749160|NCT00732875|12185090|FG000|Overall Study|Adverse Event|16
7749161|NCT00732875|12185090|FG000|Overall Study|Withdrawal by Subject|6
7749162|NCT00732875|12185090|FG000|Overall Study|Lack of Efficacy|13
7749163|NCT00732940|12185105|FG000|Overall Study|Withdrawal by Subject|1
7749164|NCT00732940|12185106|FG001|Overall Study|Withdrawal by Subject|2
7749165|NCT00732940|12185105|FG000|Overall Study|Adverse Event|0
7749166|NCT00732940|12185106|FG001|Overall Study|Adverse Event|1
7749167|NCT00732940|12185105|FG000|Overall Study|Lost to Follow-up|1
7749168|NCT00732940|12185106|FG001|Overall Study|Lost to Follow-up|0
7749169|NCT00732992|12185114|FG000|Overall Study|Adverse Event|1
7749170|NCT00732992|12185115|FG001|Overall Study|Adverse Event|1
7749171|NCT00732992|12185114|FG000|Overall Study|Objective Progression or Relapse|3
7749172|NCT00732992|12185115|FG001|Overall Study|Objective Progression or Relapse|5
7749173|NCT00732992|12185114|FG000|Overall Study|Global Deterioration of Health Status|1
7749174|NCT00732992|12185115|FG001|Overall Study|Global Deterioration of Health Status|0
7749175|NCT00732992|12185114|FG000|Overall Study|Withdrawal by Subject|1
7749176|NCT00732992|12185115|FG001|Overall Study|Withdrawal by Subject|0
7749177|NCT00733226|12185143|FG000|Overall Study|Withdrawal by Subject|1
7749178|NCT00733226|12185144|FG001|Overall Study|Withdrawal by Subject|0
7749179|NCT00733226|12185143|FG000|Overall Study|Lost to Follow-up|2
7749180|NCT00733226|12185144|FG001|Overall Study|Lost to Follow-up|0
7749181|NCT00733226|12185143|FG000|Overall Study|moved to another place|2
7749182|NCT00733226|12185144|FG001|Overall Study|moved to another place|0
7749183|NCT00733291|12185157|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
7749184|NCT00733291|12185158|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
7749185|NCT00733291|12185159|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
7749186|NCT00733291|12185160|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
7749187|NCT00733304|12185174|FG000|Overall Study|Adverse Event|3
7749188|NCT00733304|12185175|FG001|Overall Study|Adverse Event|0
7749189|NCT00733304|12185176|FG002|Overall Study|Adverse Event|0
7749190|NCT00733304|12185174|FG000|Overall Study|Lack of Efficacy|0
7749191|NCT00733304|12185175|FG001|Overall Study|Lack of Efficacy|0
7749192|NCT00733304|12185176|FG002|Overall Study|Lack of Efficacy|2
7749193|NCT00733304|12185174|FG000|Overall Study|Lost to Follow-up|0
7749194|NCT00733304|12185175|FG001|Overall Study|Lost to Follow-up|1
7749195|NCT00733304|12185176|FG002|Overall Study|Lost to Follow-up|0
7749196|NCT00733304|12185174|FG000|Overall Study|Physician Decision|3
7749197|NCT00733304|12185175|FG001|Overall Study|Physician Decision|1
7749198|NCT00733304|12185176|FG002|Overall Study|Physician Decision|3
7749199|NCT00733304|12185174|FG000|Overall Study|Withdrawal by Subject|1
7749200|NCT00733304|12185175|FG001|Overall Study|Withdrawal by Subject|1
7749201|NCT00733304|12185176|FG002|Overall Study|Withdrawal by Subject|0
7749202|NCT00733369|12185211|FG000|Overall Study|Lost to Follow-up|2
7749203|NCT00733369|12185212|FG001|Overall Study|Lost to Follow-up|1
7749204|NCT00733369|12185211|FG000|Overall Study|Adverse Event|4
7749205|NCT00733369|12185212|FG001|Overall Study|Adverse Event|4
7749206|NCT00733369|12185211|FG000|Overall Study|Protocol Violation|4
7749207|NCT00733369|12185212|FG001|Overall Study|Protocol Violation|4
7749208|NCT00733408|12185218|FG000|Overall Study|Adverse Event|4
7749209|NCT00733421|12185224|FG000|Overall Study|Withdrawal by Subject|1
7749210|NCT00733421|12185225|FG001|Overall Study|Withdrawal by Subject|1
7749211|NCT00733499|12185233|FG000|Pre-operative|Protocol Violation|0
7749212|NCT00733499|12185234|FG001|Pre-operative|Protocol Violation|1
7749213|NCT00733499|12185233|FG000|3 Months Follow-up|Death|1
7749214|NCT00733499|12185234|FG001|3 Months Follow-up|Death|2
7749215|NCT00733499|12185233|FG000|6 Months Follow-up|Death|0
7749216|NCT00733499|12185234|FG001|6 Months Follow-up|Death|2
7749217|NCT00733499|12185233|FG000|6 Months Follow-up|Adverse Event|0
7749218|NCT00733499|12185234|FG001|6 Months Follow-up|Adverse Event|1
7749219|NCT00733499|12185233|FG000|12 Months Follow-up|Death|2
7749220|NCT00733499|12185234|FG001|12 Months Follow-up|Death|1
7749221|NCT00733499|12185233|FG000|24 Months Follow-up|Death|0
7749222|NCT00733499|12185234|FG001|24 Months Follow-up|Death|1
7749223|NCT00733499|12185233|FG000|5 Year Followup|Adverse Event|2
7749224|NCT00733499|12185234|FG001|5 Year Followup|Adverse Event|2
7749225|NCT00733499|12185233|FG000|5 Year Followup|Non device related AE|0
7749226|NCT00733499|12185234|FG001|5 Year Followup|Non device related AE|1
7749227|NCT00733499|12185233|FG000|5 Year Followup|Revision of Study Implant|0
7749228|NCT00733499|12185234|FG001|5 Year Followup|Revision of Study Implant|1
7749229|NCT00733499|12185233|FG000|5 Year Followup|Lost to Follow-up|2
7749230|NCT00733499|12185234|FG001|5 Year Followup|Lost to Follow-up|0
7749231|NCT00733499|12185233|FG000|5 Year Followup|Death|13
7749232|NCT00733499|12185234|FG001|5 Year Followup|Death|19
7749233|NCT00733499|12185233|FG000|5 Year Followup|missing, unable to locate|0
7749234|NCT00733499|12185234|FG001|5 Year Followup|missing, unable to locate|1
7749235|NCT00733499|12185233|FG000|5 Year Followup|Withdrawal by Subject|4
7749236|NCT00733499|12185234|FG001|5 Year Followup|Withdrawal by Subject|1
7749237|NCT00733499|12185233|FG000|10 Year Followup|Death|9
7749238|NCT00733499|12185234|FG001|10 Year Followup|Death|7
7749239|NCT00733499|12185233|FG000|10 Year Followup|Adverse Event|3
7749240|NCT00733499|12185234|FG001|10 Year Followup|Adverse Event|3
7749241|NCT00733499|12185233|FG000|10 Year Followup|Lost to Follow-up|3
7749242|NCT00733499|12185234|FG001|10 Year Followup|Lost to Follow-up|2
7749243|NCT00733499|12185233|FG000|10 Year Followup|Withdrawal by Subject|5
7749244|NCT00733499|12185234|FG001|10 Year Followup|Withdrawal by Subject|5
7749245|NCT00733499|12185233|FG000|10 Year Followup|missing, unable to locate|0
7749246|NCT00733499|12185234|FG001|10 Year Followup|missing, unable to locate|2
7749247|NCT00733746|12185244|FG000|Overall Study|Ineligible|5
7749248|NCT00733824|12185253|FG000|Phase I|Withdrawal by Subject|1
7749249|NCT00733824|12185254|FG001|Phase I|Withdrawal by Subject|0
7749250|NCT00733824|12185255|FG002|Phase I|Withdrawal by Subject|0
7749251|NCT00733824|12185256|FG003|Phase I|Withdrawal by Subject|0
7749252|NCT00733824|12185257|FG004|Phase I|Withdrawal by Subject|0
7749253|NCT00733902|12185275|FG000|Overall Study|Death|0
7749254|NCT00733902|12185276|FG001|Overall Study|Death|0
7749255|NCT00733902|12185277|FG002|Overall Study|Death|0
7749256|NCT00733902|12185278|FG003|Overall Study|Death|1
7749257|NCT00733902|12185275|FG000|Overall Study|Adverse Event|3
7749258|NCT00733902|12185276|FG001|Overall Study|Adverse Event|4
7749259|NCT00733902|12185277|FG002|Overall Study|Adverse Event|7
7749260|NCT00733902|12185278|FG003|Overall Study|Adverse Event|11
7749261|NCT00733902|12185275|FG000|Overall Study|Lack of Efficacy|56
7749262|NCT00733902|12185276|FG001|Overall Study|Lack of Efficacy|21
7749263|NCT00733902|12185277|FG002|Overall Study|Lack of Efficacy|34
7749264|NCT00733902|12185278|FG003|Overall Study|Lack of Efficacy|23
7749265|NCT00733902|12185275|FG000|Overall Study|Protocol Violation|4
7749266|NCT00733902|12185276|FG001|Overall Study|Protocol Violation|6
7749267|NCT00733902|12185277|FG002|Overall Study|Protocol Violation|3
7749268|NCT00733902|12185278|FG003|Overall Study|Protocol Violation|3
7749269|NCT00733902|12185275|FG000|Overall Study|Withdrawal by Subject|10
7749270|NCT00733902|12185276|FG001|Overall Study|Withdrawal by Subject|5
7749271|NCT00733902|12185277|FG002|Overall Study|Withdrawal by Subject|4
7749272|NCT00733902|12185278|FG003|Overall Study|Withdrawal by Subject|16
7749273|NCT00733902|12185275|FG000|Overall Study|Entered extension study|89
7749274|NCT00733902|12185276|FG001|Overall Study|Entered extension study|124
7749275|NCT00733902|12185277|FG002|Overall Study|Entered extension study|111
7749276|NCT00733902|12185278|FG003|Overall Study|Entered extension study|109
7749277|NCT00733902|12185275|FG000|Overall Study|Randomized but not treated|2
7749278|NCT00733902|12185276|FG001|Overall Study|Randomized but not treated|2
7749279|NCT00733902|12185277|FG002|Overall Study|Randomized but not treated|2
7749280|NCT00733902|12185278|FG003|Overall Study|Randomized but not treated|1
7749281|NCT00733980|12185290|FG000|Overall Study|Adverse Event|5
7749282|NCT00733980|12185291|FG001|Overall Study|Adverse Event|2
7749283|NCT00733980|12185290|FG000|Overall Study|Lack of Efficacy|0
7749284|NCT00733980|12185291|FG001|Overall Study|Lack of Efficacy|1
7749285|NCT00733980|12185290|FG000|Overall Study|Protocol Violation|2
7749286|NCT00733980|12185291|FG001|Overall Study|Protocol Violation|1
7749287|NCT00733980|12185290|FG000|Overall Study|Protocol defined stopping criteria reach|1
7749288|NCT00733980|12185291|FG001|Overall Study|Protocol defined stopping criteria reach|1
7749289|NCT00733980|12185290|FG000|Overall Study|Lost to Follow-up|6
7749290|NCT00733980|12185291|FG001|Overall Study|Lost to Follow-up|11
7749291|NCT00733980|12185290|FG000|Overall Study|Physician Decision|2
7749292|NCT00733980|12185291|FG001|Overall Study|Physician Decision|3
7749293|NCT00733980|12185290|FG000|Overall Study|Withdrawal by Subject|6
7749294|NCT00733980|12185291|FG001|Overall Study|Withdrawal by Subject|2
7749295|NCT00734032|12185316|FG000|Overall Study|Adverse Event|0
7749296|NCT00734032|12185317|FG001|Overall Study|Adverse Event|1
7749297|NCT00734032|12185318|FG002|Overall Study|Adverse Event|0
7749298|NCT00734032|12185319|FG003|Overall Study|Adverse Event|0
7749299|NCT00734071|12185331|FG000|Overall Study|Adverse Event|4
7749300|NCT00734071|12185332|FG001|Overall Study|Adverse Event|3
7749301|NCT00734071|12185331|FG000|Overall Study|Lack of Efficacy|3
7749302|NCT00734071|12185332|FG001|Overall Study|Lack of Efficacy|1
7749303|NCT00734071|12185331|FG000|Overall Study|Noncompliance|2
7749304|NCT00734071|12185332|FG001|Overall Study|Noncompliance|2
7749305|NCT00734071|12185331|FG000|Overall Study|Protocol Deviations|3
7749306|NCT00734071|12185332|FG001|Overall Study|Protocol Deviations|4
7749307|NCT00734071|12185331|FG000|Overall Study|Voluntary Withdrawal|9
7749308|NCT00734071|12185332|FG001|Overall Study|Voluntary Withdrawal|7
7749309|NCT00734071|12185331|FG000|Overall Study|Lost to Follow-up|16
7749310|NCT00734071|12185332|FG001|Overall Study|Lost to Follow-up|8
7749311|NCT00734071|12185331|FG000|Overall Study|Other|1
7749312|NCT00734071|12185332|FG001|Overall Study|Other|2
7749313|NCT00734097|12185338|FG000|Screening|Protocol Violation|12
7749314|NCT00734097|12185338|FG000|Screening|Withdrawal by Subject|5
7749315|NCT00734097|12185338|FG000|Screening|Lost to Follow-up|2
7749316|NCT00734097|12185338|FG000|Screening|Unconfirmed pregnancy|1
7749317|NCT00734097|12185338|FG000|Open Label|Lost to Follow-up|7
7749318|NCT00734097|12185338|FG000|Open Label|Withdrawal by Subject|5
7749319|NCT00734097|12185338|FG000|Open Label|Protocol Violation|4
7749320|NCT00734149|12185342|FG000|Overall Study|Withdrawal by Subject|1
7749321|NCT00734162|12185352|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0
7749322|NCT00734162|12185353|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1
7749323|NCT00734162|12185354|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0
7749324|NCT00734162|12185355|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2
7749325|NCT00734162|12185352|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
7749326|NCT00734162|12185353|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
7749327|NCT00734162|12185354|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
7749328|NCT00734162|12185355|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
7749329|NCT00734162|12185352|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
7749330|NCT00734162|12185353|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
7749331|NCT00734162|12185354|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
7749332|NCT00734162|12185355|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
7749333|NCT00734162|12185352|FG000|Open-Label Phase|Withdrew Consent|1
7749334|NCT00734162|12185353|FG001|Open-Label Phase|Withdrew Consent|0
7749335|NCT00734162|12185354|FG002|Open-Label Phase|Withdrew Consent|1
7749336|NCT00734162|12185355|FG003|Open-Label Phase|Withdrew Consent|1
7749337|NCT00734162|12185352|FG000|Open-Label Phase|Lost to Follow-up|1
7749338|NCT00734162|12185353|FG001|Open-Label Phase|Lost to Follow-up|2
7749339|NCT00734162|12185354|FG002|Open-Label Phase|Lost to Follow-up|0
7749340|NCT00734162|12185355|FG003|Open-Label Phase|Lost to Follow-up|1
7749341|NCT00734162|12185352|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0
7749342|NCT00734162|12185353|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0
7749343|NCT00734162|12185354|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0
7749344|NCT00734162|12185355|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1
7749345|NCT00734214|12185371|FG000|Overall Study|Withdrawal by Subject|3
7749346|NCT00734214|12185372|FG001|Overall Study|Withdrawal by Subject|4
7749347|NCT00734214|12185371|FG000|Overall Study|MD withdrawal|1
7749348|NCT00734214|12185372|FG001|Overall Study|MD withdrawal|0
7749349|NCT00734474|12185433|FG000|Overall Study|Entry Criteria Not Met|0
7749350|NCT00734474|12185434|FG001|Overall Study|Entry Criteria Not Met|0
7749351|NCT00734474|12185435|FG002|Overall Study|Entry Criteria Not Met|5
7749352|NCT00734474|12185436|FG003|Overall Study|Entry Criteria Not Met|0
7749353|NCT00734474|12185437|FG004|Overall Study|Entry Criteria Not Met|3
7749354|NCT00734474|12185438|FG005|Overall Study|Entry Criteria Not Met|1
7749355|NCT00734474|12185439|FG006|Overall Study|Entry Criteria Not Met|0
7749356|NCT00734474|12185440|FG007|Overall Study|Entry Criteria Not Met|1
7749357|NCT00734474|12185441|FG008|Overall Study|Entry Criteria Not Met|1
7749358|NCT00734474|12185433|FG000|Overall Study|Lost to Follow-up|1
7749359|NCT00734474|12185434|FG001|Overall Study|Lost to Follow-up|0
7749360|NCT00734474|12185435|FG002|Overall Study|Lost to Follow-up|13
7749361|NCT00734474|12185436|FG003|Overall Study|Lost to Follow-up|0
7749362|NCT00734474|12185437|FG004|Overall Study|Lost to Follow-up|11
7749363|NCT00734474|12185438|FG005|Overall Study|Lost to Follow-up|1
7749364|NCT00734474|12185439|FG006|Overall Study|Lost to Follow-up|0
7749365|NCT00734474|12185440|FG007|Overall Study|Lost to Follow-up|9
7749366|NCT00734474|12185441|FG008|Overall Study|Lost to Follow-up|4
7749367|NCT00734474|12185433|FG000|Overall Study|Withdrawal by Subject|2
7749368|NCT00734474|12185434|FG001|Overall Study|Withdrawal by Subject|1
7749369|NCT00734474|12185435|FG002|Overall Study|Withdrawal by Subject|18
7749370|NCT00734474|12185436|FG003|Overall Study|Withdrawal by Subject|0
7749371|NCT00734474|12185437|FG004|Overall Study|Withdrawal by Subject|24
7749372|NCT00734474|12185438|FG005|Overall Study|Withdrawal by Subject|2
7749373|NCT00734474|12185439|FG006|Overall Study|Withdrawal by Subject|0
7749374|NCT00734474|12185440|FG007|Overall Study|Withdrawal by Subject|36
7749375|NCT00734474|12185441|FG008|Overall Study|Withdrawal by Subject|21
7749376|NCT00734474|12185433|FG000|Overall Study|Physician Decision|0
7749377|NCT00734474|12185434|FG001|Overall Study|Physician Decision|0
7749378|NCT00734474|12185435|FG002|Overall Study|Physician Decision|4
7749379|NCT00734474|12185436|FG003|Overall Study|Physician Decision|1
7749380|NCT00734474|12185437|FG004|Overall Study|Physician Decision|11
7749381|NCT00734474|12185438|FG005|Overall Study|Physician Decision|0
7749382|NCT00734474|12185439|FG006|Overall Study|Physician Decision|0
7749383|NCT00734474|12185440|FG007|Overall Study|Physician Decision|9
7749384|NCT00734474|12185441|FG008|Overall Study|Physician Decision|9
7749385|NCT00734474|12185433|FG000|Overall Study|Adverse Event|4
7749386|NCT00734474|12185434|FG001|Overall Study|Adverse Event|4
7749387|NCT00734474|12185435|FG002|Overall Study|Adverse Event|63
7749388|NCT00734474|12185436|FG003|Overall Study|Adverse Event|1
7749389|NCT00734474|12185437|FG004|Overall Study|Adverse Event|64
7749390|NCT00734474|12185438|FG005|Overall Study|Adverse Event|0
7749391|NCT00734474|12185439|FG006|Overall Study|Adverse Event|1
7749392|NCT00734474|12185440|FG007|Overall Study|Adverse Event|65
7749393|NCT00734474|12185441|FG008|Overall Study|Adverse Event|39
7749394|NCT00734474|12185433|FG000|Overall Study|Protocol Violation|0
7749395|NCT00734474|12185434|FG001|Overall Study|Protocol Violation|0
7749396|NCT00734474|12185435|FG002|Overall Study|Protocol Violation|4
7749397|NCT00734474|12185436|FG003|Overall Study|Protocol Violation|0
7749398|NCT00734474|12185437|FG004|Overall Study|Protocol Violation|3
7749399|NCT00734474|12185438|FG005|Overall Study|Protocol Violation|0
7749400|NCT00734474|12185439|FG006|Overall Study|Protocol Violation|0
7749401|NCT00734474|12185440|FG007|Overall Study|Protocol Violation|3
7749402|NCT00734474|12185441|FG008|Overall Study|Protocol Violation|1
7749403|NCT00734474|12185433|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8
7749404|NCT00734474|12185434|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25
7749405|NCT00734474|12185435|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0
7749406|NCT00734474|12185436|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8
7749407|NCT00734474|12185437|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0
7749408|NCT00734474|12185438|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21
7769566|NCT00868790|12213068|FG010|Post-study|Withdrawal by Subject|0
7749409|NCT00734474|12185439|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23
7749410|NCT00734474|12185440|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0
7749411|NCT00734474|12185441|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0
7749412|NCT00734474|12185433|FG000|Overall Study|Sponsor Decision|0
7749413|NCT00734474|12185434|FG001|Overall Study|Sponsor Decision|0
7749414|NCT00734474|12185435|FG002|Overall Study|Sponsor Decision|0
7749415|NCT00734474|12185436|FG003|Overall Study|Sponsor Decision|0
7749416|NCT00734474|12185437|FG004|Overall Study|Sponsor Decision|2
7749417|NCT00734474|12185438|FG005|Overall Study|Sponsor Decision|0
7749418|NCT00734474|12185439|FG006|Overall Study|Sponsor Decision|0
7749419|NCT00734474|12185440|FG007|Overall Study|Sponsor Decision|0
7749420|NCT00734474|12185441|FG008|Overall Study|Sponsor Decision|0
7749421|NCT00734474|12185433|FG000|Overall Study|Death|0
7749422|NCT00734474|12185434|FG001|Overall Study|Death|0
7749423|NCT00734474|12185435|FG002|Overall Study|Death|1
7749424|NCT00734474|12185436|FG003|Overall Study|Death|0
7749425|NCT00734474|12185437|FG004|Overall Study|Death|0
7749426|NCT00734474|12185438|FG005|Overall Study|Death|0
7749427|NCT00734474|12185439|FG006|Overall Study|Death|0
7749428|NCT00734474|12185440|FG007|Overall Study|Death|2
7749429|NCT00734474|12185441|FG008|Overall Study|Death|1
7749430|NCT00734474|12185433|FG000|Overall Study|Lack of Efficacy|0
7749431|NCT00734474|12185434|FG001|Overall Study|Lack of Efficacy|0
7749432|NCT00734474|12185435|FG002|Overall Study|Lack of Efficacy|4
7749433|NCT00734474|12185436|FG003|Overall Study|Lack of Efficacy|0
7749434|NCT00734474|12185437|FG004|Overall Study|Lack of Efficacy|0
7749435|NCT00734474|12185438|FG005|Overall Study|Lack of Efficacy|0
7749436|NCT00734474|12185439|FG006|Overall Study|Lack of Efficacy|0
7749437|NCT00734474|12185440|FG007|Overall Study|Lack of Efficacy|4
7749438|NCT00734474|12185441|FG008|Overall Study|Lack of Efficacy|6
7749439|NCT00734539|12185473|FG000|Main Study|Death|33
7749440|NCT00734539|12185474|FG001|Main Study|Death|32
7749441|NCT00734539|12185473|FG000|Main Study|Physician Decision|2
7749442|NCT00734539|12185474|FG001|Main Study|Physician Decision|0
7749443|NCT00734539|12185473|FG000|Main Study|Withdrawal by Subject|1
7749444|NCT00734539|12185474|FG001|Main Study|Withdrawal by Subject|3
7749445|NCT00734539|12185473|FG000|Main Study|Enrolled in error; ineligible|1
7749446|NCT00734539|12185474|FG001|Main Study|Enrolled in error; ineligible|0
7749447|NCT00734578|12185486|FG000|Overall Study|Adverse Event|4
7749448|NCT00734578|12185487|FG001|Overall Study|Adverse Event|6
7749449|NCT00734578|12185488|FG002|Overall Study|Adverse Event|1
7749450|NCT00734578|12185486|FG000|Overall Study|Protocol Violation|8
7749451|NCT00734578|12185487|FG001|Overall Study|Protocol Violation|6
7749452|NCT00734578|12185488|FG002|Overall Study|Protocol Violation|3
7749453|NCT00734578|12185486|FG000|Overall Study|Withdrawal by Subject|7
7749454|NCT00734578|12185487|FG001|Overall Study|Withdrawal by Subject|8
7749455|NCT00734578|12185488|FG002|Overall Study|Withdrawal by Subject|11
7749456|NCT00734578|12185486|FG000|Overall Study|Lost to Follow-up|9
7749457|NCT00734578|12185487|FG001|Overall Study|Lost to Follow-up|3
7749458|NCT00734578|12185488|FG002|Overall Study|Lost to Follow-up|5
7749459|NCT00734578|12185486|FG000|Overall Study|Lack of Efficacy|3
7749460|NCT00734578|12185487|FG001|Overall Study|Lack of Efficacy|2
7749461|NCT00734578|12185488|FG002|Overall Study|Lack of Efficacy|5
7749462|NCT00734578|12185486|FG000|Overall Study|Randomized in error|1
7749463|NCT00734578|12185487|FG001|Overall Study|Randomized in error|0
7749464|NCT00734578|12185488|FG002|Overall Study|Randomized in error|0
7749465|NCT00734578|12185486|FG000|Overall Study|Exclusion criteria|1
7749466|NCT00734578|12185487|FG001|Overall Study|Exclusion criteria|0
7749467|NCT00734578|12185488|FG002|Overall Study|Exclusion criteria|0
7749468|NCT00734591|12185498|FG000|Screening for Prospective Period|Site did not participate|1604
7749469|NCT00734591|12185499|FG001|Screening for Prospective Period|Site did not participate|1488
7749470|NCT00734591|12185498|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913
7749471|NCT00734591|12185499|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803
7749472|NCT00734591|12185498|FG000|Prospective Period|Withdrawal by Subject|11
7749473|NCT00734591|12185499|FG001|Prospective Period|Withdrawal by Subject|9
7749474|NCT00734591|12185498|FG000|Prospective Period|Lost to Follow-up|37
7749475|NCT00734591|12185499|FG001|Prospective Period|Lost to Follow-up|33
7749476|NCT00734591|12185498|FG000|Prospective Period|Study Terminated|1
7749477|NCT00734591|12185499|FG001|Prospective Period|Study Terminated|0
7749478|NCT00734591|12185498|FG000|Prospective Period|Other|2
7749479|NCT00734591|12185499|FG001|Prospective Period|Other|2
7749480|NCT00734604|12185511|FG000|Overall Study|Adverse Event|0
7749481|NCT00734604|12185512|FG001|Overall Study|Adverse Event|2
7749482|NCT00734604|12185513|FG002|Overall Study|Adverse Event|0
7749483|NCT00734604|12185514|FG003|Overall Study|Adverse Event|2
7749484|NCT00734604|12185515|FG004|Overall Study|Adverse Event|1
7749485|NCT00734604|12185516|FG005|Overall Study|Adverse Event|1
7749486|NCT00734604|12185511|FG000|Overall Study|Serious Adverse Event|1
7749487|NCT00734604|12185512|FG001|Overall Study|Serious Adverse Event|0
7749488|NCT00734604|12185513|FG002|Overall Study|Serious Adverse Event|1
7749489|NCT00734604|12185514|FG003|Overall Study|Serious Adverse Event|2
7749490|NCT00734604|12185515|FG004|Overall Study|Serious Adverse Event|0
7749491|NCT00734604|12185516|FG005|Overall Study|Serious Adverse Event|1
7749492|NCT00734604|12185511|FG000|Overall Study|Lost to Follow-up|1
7749493|NCT00734604|12185512|FG001|Overall Study|Lost to Follow-up|2
7749494|NCT00734604|12185513|FG002|Overall Study|Lost to Follow-up|2
7749495|NCT00734604|12185514|FG003|Overall Study|Lost to Follow-up|4
7749496|NCT00734604|12185515|FG004|Overall Study|Lost to Follow-up|2
7749497|NCT00734604|12185516|FG005|Overall Study|Lost to Follow-up|3
7749498|NCT00734604|12185511|FG000|Overall Study|Physician Decision|0
7749499|NCT00734604|12185512|FG001|Overall Study|Physician Decision|1
7749500|NCT00734604|12185513|FG002|Overall Study|Physician Decision|1
7749501|NCT00734604|12185514|FG003|Overall Study|Physician Decision|0
7749502|NCT00734604|12185515|FG004|Overall Study|Physician Decision|0
7749503|NCT00734604|12185516|FG005|Overall Study|Physician Decision|0
7749504|NCT00734604|12185511|FG000|Overall Study|Protocol Violation|0
7749505|NCT00734604|12185512|FG001|Overall Study|Protocol Violation|2
7749506|NCT00734604|12185513|FG002|Overall Study|Protocol Violation|0
7749507|NCT00734604|12185514|FG003|Overall Study|Protocol Violation|0
7749508|NCT00734604|12185515|FG004|Overall Study|Protocol Violation|1
7749509|NCT00734604|12185516|FG005|Overall Study|Protocol Violation|0
7749510|NCT00734604|12185511|FG000|Overall Study|Sponsor Decision|1
7749511|NCT00734604|12185512|FG001|Overall Study|Sponsor Decision|2
7749512|NCT00734604|12185513|FG002|Overall Study|Sponsor Decision|1
7749513|NCT00734604|12185514|FG003|Overall Study|Sponsor Decision|0
7749514|NCT00734604|12185515|FG004|Overall Study|Sponsor Decision|2
7749515|NCT00734604|12185516|FG005|Overall Study|Sponsor Decision|0
7749516|NCT00734604|12185511|FG000|Overall Study|Withdrawal by Subject|0
7749517|NCT00734604|12185512|FG001|Overall Study|Withdrawal by Subject|2
7749518|NCT00734604|12185513|FG002|Overall Study|Withdrawal by Subject|0
7749519|NCT00734604|12185514|FG003|Overall Study|Withdrawal by Subject|1
7749520|NCT00734604|12185515|FG004|Overall Study|Withdrawal by Subject|2
7749521|NCT00734604|12185516|FG005|Overall Study|Withdrawal by Subject|1
7749522|NCT00734604|12185511|FG000|Overall Study|Lack of Efficacy|0
7749523|NCT00734604|12185512|FG001|Overall Study|Lack of Efficacy|1
7749524|NCT00734604|12185513|FG002|Overall Study|Lack of Efficacy|1
7749525|NCT00734604|12185514|FG003|Overall Study|Lack of Efficacy|0
7749526|NCT00734604|12185515|FG004|Overall Study|Lack of Efficacy|0
7749527|NCT00734604|12185516|FG005|Overall Study|Lack of Efficacy|0
7749528|NCT00734617|12185529|FG000|Overall Study|Adverse Event|4
7749529|NCT00734617|12185530|FG001|Overall Study|Adverse Event|7
7749530|NCT00734617|12185529|FG000|Overall Study|Withdrawal by Subject|103
7749531|NCT00734617|12185530|FG001|Overall Study|Withdrawal by Subject|95
7749532|NCT00734630|12185538|FG000|Overall Study|Lack of Efficacy|4
7749533|NCT00734630|12185539|FG001|Overall Study|Lack of Efficacy|4
7749534|NCT00734630|12185538|FG000|Overall Study|Withdrawal by Subject|7
7749535|NCT00734630|12185539|FG001|Overall Study|Withdrawal by Subject|9
7749536|NCT00734630|12185538|FG000|Overall Study|Lost to Follow-up|13
7749537|NCT00734630|12185539|FG001|Overall Study|Lost to Follow-up|7
7749538|NCT00734630|12185538|FG000|Overall Study|Protocol Violation|0
7749539|NCT00734630|12185539|FG001|Overall Study|Protocol Violation|3
7749540|NCT00734630|12185538|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
7749541|NCT00734630|12185539|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
7749542|NCT00734630|12185538|FG000|Overall Study|Adverse Event|3
7749543|NCT00734630|12185539|FG001|Overall Study|Adverse Event|6
7749544|NCT00734630|12185538|FG000|Overall Study|Randomized in Error|0
7749545|NCT00734630|12185539|FG001|Overall Study|Randomized in Error|1
7749546|NCT00734630|12185538|FG000|Overall Study|Tested Positive for Illegal Drug Use|1
7749547|NCT00734630|12185539|FG001|Overall Study|Tested Positive for Illegal Drug Use|1
7749548|NCT00734630|12185538|FG000|Overall Study|Poor Compliance|1
7749549|NCT00734630|12185539|FG001|Overall Study|Poor Compliance|1
7749550|NCT00734656|12185545|FG000|Lab Session 1|Withdrawal by Subject|2
7749551|NCT00734656|12185546|FG001|Lab Session 1|Withdrawal by Subject|0
7749552|NCT00734656|12185547|FG002|Lab Session 1|Withdrawal by Subject|0
7749553|NCT00734656|12185548|FG003|Lab Session 1|Withdrawal by Subject|0
7749554|NCT00734656|12185545|FG000|Washout 1|Withdrawal by Subject|1
7749555|NCT00734656|12185546|FG001|Washout 1|Withdrawal by Subject|5
7749556|NCT00734656|12185547|FG002|Washout 1|Withdrawal by Subject|2
7749557|NCT00734656|12185548|FG003|Washout 1|Withdrawal by Subject|3
7749558|NCT00734656|12185545|FG000|Lab Session 2|Withdrawal by Subject|1
7749559|NCT00734656|12185546|FG001|Lab Session 2|Withdrawal by Subject|0
7749560|NCT00734656|12185547|FG002|Lab Session 2|Withdrawal by Subject|0
7749561|NCT00734656|12185548|FG003|Lab Session 2|Withdrawal by Subject|1
7749562|NCT00734656|12185545|FG000|Washout 2|Withdrawal by Subject|1
7749563|NCT00734656|12185546|FG001|Washout 2|Withdrawal by Subject|1
7749564|NCT00734656|12185547|FG002|Washout 2|Withdrawal by Subject|1
7749565|NCT00734656|12185548|FG003|Washout 2|Withdrawal by Subject|0
7749566|NCT00734656|12185545|FG000|Washout 3|Withdrawal by Subject|1
7749567|NCT00734656|12185546|FG001|Washout 3|Withdrawal by Subject|0
7749568|NCT00734656|12185547|FG002|Washout 3|Withdrawal by Subject|0
7749569|NCT00734656|12185548|FG003|Washout 3|Withdrawal by Subject|1
7749570|NCT00734656|12185545|FG000|Lab Session 4|Withdrawal by Subject|0
7749571|NCT00734656|12185546|FG001|Lab Session 4|Withdrawal by Subject|0
7749572|NCT00734656|12185547|FG002|Lab Session 4|Withdrawal by Subject|0
7749573|NCT00734656|12185548|FG003|Lab Session 4|Withdrawal by Subject|1
7749574|NCT00734747|12185563|FG000|SRS Procedure|No staples placed|3
7749575|NCT00734747|12185563|FG000|6 Month Follow-up|Did not meet inclusion criteria|3
7749576|NCT00734851|12185576|FG000|Overall Study|Withdrawal by Subject|2
7749577|NCT00734851|12185576|FG000|Overall Study|Lost to Follow-up|1
7749578|NCT00734851|12185576|FG000|Overall Study|Physician Decision|18
7749579|NCT00734929|12185591|FG000|Overall Study|Lost to Follow-up|1
7749580|NCT00734929|12185592|FG001|Overall Study|Lost to Follow-up|2
7749581|NCT00734929|12185591|FG000|Overall Study|No intervention/ screen fail|5
7749582|NCT00734929|12185592|FG001|Overall Study|No intervention/ screen fail|3
7749583|NCT00734994|12185609|FG000|Overall Study|Withdrawal by Subject|1
7749584|NCT00735007|12185614|FG000|Overall Study|Adverse Event|4
7749585|NCT00735007|12185614|FG000|Overall Study|Protocol Violation|1
7749586|NCT00735072|12185620|FG000|Overall Study|interrupted study med during ARV change|1
7749587|NCT00735072|12185621|FG001|Overall Study|interrupted study med during ARV change|0
7749588|NCT00735072|12185620|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0
7749589|NCT00735072|12185621|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1
7749590|NCT00735371|12185638|FG000|Overall Study|Adverse Event|3
7749591|NCT00735371|12185639|FG001|Overall Study|Adverse Event|3
7749592|NCT00735371|12185640|FG002|Overall Study|Adverse Event|4
7749593|NCT00735371|12185641|FG003|Overall Study|Adverse Event|1
7749594|NCT00735371|12185638|FG000|Overall Study|Protocol Violation|2
7749595|NCT00735371|12185639|FG001|Overall Study|Protocol Violation|2
7749596|NCT00735371|12185640|FG002|Overall Study|Protocol Violation|0
7749597|NCT00735371|12185641|FG003|Overall Study|Protocol Violation|3
7749598|NCT00735371|12185638|FG000|Overall Study|Withdrawal by Subject|0
7749599|NCT00735371|12185639|FG001|Overall Study|Withdrawal by Subject|2
7749600|NCT00735371|12185640|FG002|Overall Study|Withdrawal by Subject|2
7749601|NCT00735371|12185641|FG003|Overall Study|Withdrawal by Subject|0
7749602|NCT00735371|12185638|FG000|Overall Study|Lost to Follow-up|1
7749603|NCT00735371|12185639|FG001|Overall Study|Lost to Follow-up|1
7749604|NCT00735371|12185640|FG002|Overall Study|Lost to Follow-up|3
7749605|NCT00735371|12185641|FG003|Overall Study|Lost to Follow-up|1
7749606|NCT00735371|12185638|FG000|Overall Study|Lack of Efficacy|4
7749607|NCT00735371|12185639|FG001|Overall Study|Lack of Efficacy|2
7749608|NCT00735371|12185640|FG002|Overall Study|Lack of Efficacy|0
7749609|NCT00735371|12185641|FG003|Overall Study|Lack of Efficacy|4
7749610|NCT00735371|12185638|FG000|Overall Study|Sponsor Decision|3
7749611|NCT00735371|12185639|FG001|Overall Study|Sponsor Decision|1
7749612|NCT00735371|12185640|FG002|Overall Study|Sponsor Decision|0
7749613|NCT00735371|12185641|FG003|Overall Study|Sponsor Decision|1
7749614|NCT00735371|12185638|FG000|Overall Study|Protocol Violation|0
7749615|NCT00735371|12185639|FG001|Overall Study|Protocol Violation|1
7749616|NCT00735371|12185640|FG002|Overall Study|Protocol Violation|2
7749617|NCT00735371|12185641|FG003|Overall Study|Protocol Violation|0
7749618|NCT00735371|12185638|FG000|Overall Study|Prior Vyvanse Exposure|1
7749619|NCT00735371|12185639|FG001|Overall Study|Prior Vyvanse Exposure|1
7749620|NCT00735371|12185640|FG002|Overall Study|Prior Vyvanse Exposure|0
7749621|NCT00735371|12185641|FG003|Overall Study|Prior Vyvanse Exposure|0
7749622|NCT00735371|12185638|FG000|Overall Study|Exclusion criteria|1
7749623|NCT00735371|12185639|FG001|Overall Study|Exclusion criteria|0
7749624|NCT00735371|12185640|FG002|Overall Study|Exclusion criteria|0
7749625|NCT00735371|12185641|FG003|Overall Study|Exclusion criteria|0
7749626|NCT00735397|12185651|FG000|Overall Study|Adverse Event|194
7749627|NCT00735397|12185651|FG000|Overall Study|Lost to Follow-up|33
7749628|NCT00735397|12185651|FG000|Overall Study|Participant choice|252
7962272|NCT02711345|12516530|FG008|Overall Study|Physician Decision|1
7962273|NCT02711345|12516531|FG009|Overall Study|Physician Decision|0
7962274|NCT02711345|12516522|FG000|Overall Study|Progressive disease|1
7962275|NCT02711345|12516523|FG001|Overall Study|Progressive disease|3
7962276|NCT02711345|12516524|FG002|Overall Study|Progressive disease|5
7962277|NCT02711345|12516525|FG003|Overall Study|Progressive disease|3
7962278|NCT02711345|12516526|FG004|Overall Study|Progressive disease|7
7962279|NCT02711345|12516527|FG005|Overall Study|Progressive disease|2
7962280|NCT02711345|12516528|FG006|Overall Study|Progressive disease|8
7962281|NCT02711345|12516529|FG007|Overall Study|Progressive disease|4
7962282|NCT02711345|12516530|FG008|Overall Study|Progressive disease|5
7962283|NCT02711345|12516531|FG009|Overall Study|Progressive disease|6
7962284|NCT02711345|12516522|FG000|Overall Study|Subject/guardian decision|0
7962285|NCT02711345|12516523|FG001|Overall Study|Subject/guardian decision|0
7962286|NCT02711345|12516524|FG002|Overall Study|Subject/guardian decision|0
7962287|NCT02711345|12516525|FG003|Overall Study|Subject/guardian decision|0
7962288|NCT02711345|12516526|FG004|Overall Study|Subject/guardian decision|0
7962289|NCT02711345|12516527|FG005|Overall Study|Subject/guardian decision|2
7962290|NCT02711345|12516528|FG006|Overall Study|Subject/guardian decision|3
7749629|NCT00735397|12185651|FG000|Overall Study|Inadequate therapeutic effect|202
7749630|NCT00735397|12185651|FG000|Overall Study|Administrative/Other|502
7769567|NCT00868790|12213069|FG011|Post-study|Withdrawal by Subject|0
7769568|NCT00868790|12213070|FG012|Post-study|Withdrawal by Subject|0
7769569|NCT00868790|12213071|FG013|Post-study|Withdrawal by Subject|0
7769570|NCT00868790|12213058|FG000|Post-study|Excluded Medication|0
7769571|NCT00868790|12213059|FG001|Post-study|Excluded Medication|0
7769572|NCT00868790|12213060|FG002|Post-study|Excluded Medication|0
7769573|NCT00868790|12213061|FG003|Post-study|Excluded Medication|0
7769574|NCT00868790|12213062|FG004|Post-study|Excluded Medication|0
7769575|NCT00868790|12213063|FG005|Post-study|Excluded Medication|0
7769576|NCT00868790|12213064|FG006|Post-study|Excluded Medication|0
7769577|NCT00868790|12213065|FG007|Post-study|Excluded Medication|2
7769578|NCT00868790|12213066|FG008|Post-study|Excluded Medication|0
7769579|NCT00868790|12213067|FG009|Post-study|Excluded Medication|1
7769580|NCT00868790|12213068|FG010|Post-study|Excluded Medication|0
7962291|NCT02711345|12516529|FG007|Overall Study|Subject/guardian decision|1
7749631|NCT00735475|12185687|FG000|Overall Study|Adverse Event|0
7749632|NCT00735475|12185688|FG001|Overall Study|Adverse Event|1
7749633|NCT00735475|12185687|FG000|Overall Study|Death|1
7749634|NCT00735475|12185688|FG001|Overall Study|Death|1
7749635|NCT00735475|12185687|FG000|Overall Study|Lost to Follow-up|3
7749636|NCT00735475|12185688|FG001|Overall Study|Lost to Follow-up|3
7749637|NCT00735475|12185687|FG000|Overall Study|Physician Decision|0
7749638|NCT00735475|12185688|FG001|Overall Study|Physician Decision|1
7749639|NCT00735475|12185687|FG000|Overall Study|Withdrawal by Subject|4
7749640|NCT00735475|12185688|FG001|Overall Study|Withdrawal by Subject|5
7749641|NCT00735644|12185703|FG000|Overall Study|Did not receive study vaccine|0
7749642|NCT00735644|12185704|FG001|Overall Study|Did not receive study vaccine|1
7749643|NCT00735644|12185705|FG002|Overall Study|Did not receive study vaccine|0
7749644|NCT00735644|12185706|FG003|Overall Study|Did not receive study vaccine|0
7749645|NCT00735644|12185707|FG004|Overall Study|Did not receive study vaccine|0
7749646|NCT00735644|12185703|FG000|Overall Study|Withdrawal by Subject|0
7749647|NCT00735644|12185704|FG001|Overall Study|Withdrawal by Subject|1
7749648|NCT00735644|12185705|FG002|Overall Study|Withdrawal by Subject|1
7749649|NCT00735644|12185706|FG003|Overall Study|Withdrawal by Subject|1
7749650|NCT00735644|12185707|FG004|Overall Study|Withdrawal by Subject|0
7749651|NCT00735696|12185735|FG000|Overall Study|Withdrawal by Subject|1
7749652|NCT00735696|12185735|FG000|Overall Study|Enrolled but never Treated|1
7749653|NCT00735709|12185743|FG000|Overall Study|Adverse Event|2
7749654|NCT00735709|12185744|FG001|Overall Study|Adverse Event|3
7749655|NCT00735709|12185745|FG002|Overall Study|Adverse Event|1
7749656|NCT00735709|12185746|FG003|Overall Study|Adverse Event|5
7749657|NCT00735709|12185743|FG000|Overall Study|Lack of Efficacy|8
7749658|NCT00735709|12185744|FG001|Overall Study|Lack of Efficacy|4
7749659|NCT00735709|12185745|FG002|Overall Study|Lack of Efficacy|2
7749660|NCT00735709|12185746|FG003|Overall Study|Lack of Efficacy|3
7749661|NCT00735709|12185743|FG000|Overall Study|Noncompliance|0
7749662|NCT00735709|12185744|FG001|Overall Study|Noncompliance|0
7749663|NCT00735709|12185745|FG002|Overall Study|Noncompliance|1
7749664|NCT00735709|12185746|FG003|Overall Study|Noncompliance|0
7749665|NCT00735709|12185743|FG000|Overall Study|Protocol deviations|1
7749666|NCT00735709|12185744|FG001|Overall Study|Protocol deviations|2
7749667|NCT00735709|12185745|FG002|Overall Study|Protocol deviations|1
7749668|NCT00735709|12185746|FG003|Overall Study|Protocol deviations|1
7749669|NCT00735709|12185743|FG000|Overall Study|Voluntary Withdrawal|1
7749670|NCT00735709|12185744|FG001|Overall Study|Voluntary Withdrawal|3
7749671|NCT00735709|12185745|FG002|Overall Study|Voluntary Withdrawal|5
7749672|NCT00735709|12185746|FG003|Overall Study|Voluntary Withdrawal|7
7749673|NCT00735709|12185743|FG000|Overall Study|Lost to Follow-up|0
7749674|NCT00735709|12185744|FG001|Overall Study|Lost to Follow-up|1
7749675|NCT00735709|12185745|FG002|Overall Study|Lost to Follow-up|1
7749676|NCT00735709|12185746|FG003|Overall Study|Lost to Follow-up|1
7749677|NCT00735709|12185743|FG000|Overall Study|Excluded medication|1
7749678|NCT00735709|12185744|FG001|Overall Study|Excluded medication|0
7749679|NCT00735709|12185745|FG002|Overall Study|Excluded medication|0
7749680|NCT00735709|12185746|FG003|Overall Study|Excluded medication|1
7749681|NCT00735878|12185783|FG000|Phase I- Dose Determination|Withdrawal by Subject|0
7749682|NCT00735878|12185784|FG001|Phase I- Dose Determination|Withdrawal by Subject|0
7749683|NCT00735878|12185785|FG002|Phase I- Dose Determination|Withdrawal by Subject|1
7962292|NCT02711345|12516530|FG008|Overall Study|Subject/guardian decision|0
7962293|NCT02711345|12516531|FG009|Overall Study|Subject/guardian decision|4
7962294|NCT02711345|12516522|FG000|Overall Study|Death|1
7962295|NCT02711345|12516523|FG001|Overall Study|Death|0
7749684|NCT00735904|12185796|FG000|Overall Study|Adverse Event|3
7749685|NCT00735904|12185796|FG000|Overall Study|Death|20
7749686|NCT00735904|12185796|FG000|Overall Study|Protocol Violation|1
7749687|NCT00735904|12185796|FG000|Overall Study|Withdrawal by Subject|1
7749688|NCT00735904|12185796|FG000|Overall Study|Study Terminated by Sponsor|5
7749689|NCT00735904|12185796|FG000|Overall Study|Other|8
7749690|NCT00735943|12185804|FG000|Overall Study|Lost to Follow-up|1
7749691|NCT00735943|12185804|FG000|Overall Study|Adverse Event|1
7749692|NCT00736034|12185812|FG000|Overall Study|Adverse Event|2
7749693|NCT00736099|12185828|FG000|Overall Study|Adverse Event|61
7749694|NCT00736099|12185829|FG001|Overall Study|Adverse Event|18
7749695|NCT00736099|12185828|FG000|Overall Study|Protocol Violation|10
7749696|NCT00736099|12185829|FG001|Overall Study|Protocol Violation|4
7749697|NCT00736099|12185828|FG000|Overall Study|Lost to Follow-up|12
7749698|NCT00736099|12185829|FG001|Overall Study|Lost to Follow-up|5
7749699|NCT00736099|12185828|FG000|Overall Study|Withdrawal by Subject|42
7749700|NCT00736099|12185829|FG001|Overall Study|Withdrawal by Subject|13
7749701|NCT00736099|12185828|FG000|Overall Study|Lack of Efficacy|15
7749702|NCT00736099|12185829|FG001|Overall Study|Lack of Efficacy|8
7749703|NCT00736099|12185828|FG000|Overall Study|Other reason|43
7749704|NCT00736099|12185829|FG001|Overall Study|Other reason|10
7749705|NCT00736190|12185844|FG000|Overall Study|Pregnancy|1
7749706|NCT00736190|12185844|FG000|Overall Study|Withdrawal by Subject|1
7749707|NCT00736190|12185844|FG000|Overall Study|Adverse Event|1
7749708|NCT00736255|12185868|FG000|Overall Study|Adverse Event|1
7749709|NCT00736255|12185869|FG001|Overall Study|Adverse Event|0
7749710|NCT00736255|12185868|FG000|Overall Study|Physician Decision|1
7749711|NCT00736255|12185869|FG001|Overall Study|Physician Decision|0
7749712|NCT00736255|12185868|FG000|Overall Study|Non-compliance|1
7749713|NCT00736255|12185869|FG001|Overall Study|Non-compliance|1
7749714|NCT00736333|12185875|FG000|Overall Study|Did Not Receive Drug or Not Documented|7
7749715|NCT00736333|12185875|FG000|Overall Study|Data Missing|2
7749716|NCT00736333|12185875|FG000|Overall Study|Tumor Progression|75
7749717|NCT00736333|12185875|FG000|Overall Study|Toxicity|6
7749718|NCT00736333|12185875|FG000|Overall Study|Withdrawal by Subject|10
7749719|NCT00736333|12185875|FG000|Overall Study|Death|7
7749720|NCT00736333|12185875|FG000|Overall Study|Other|4
7749721|NCT00736450|12185879|FG000|Overall Study|Not ABC gene eligible|19
7749722|NCT00736450|12185879|FG000|Overall Study|Withdrawal by Subject|5
7749723|NCT00736450|12185879|FG000|Overall Study|Physician Decision|1
7749724|NCT00736476|12185885|FG000|Overall Study|Adverse Event|1
7749725|NCT00736476|12185886|FG001|Overall Study|Adverse Event|0
7749726|NCT00736489|12185898|FG000|Period 1|Lost to Follow-up|1
7749727|NCT00736489|12185899|FG001|Period 1|Lost to Follow-up|0
7749728|NCT00736489|12185900|FG002|Period 1|Lost to Follow-up|0
7749729|NCT00736489|12185901|FG003|Period 1|Lost to Follow-up|0
7749730|NCT00736489|12185902|FG004|Period 1|Lost to Follow-up|0
7749731|NCT00736489|12185903|FG005|Period 1|Lost to Follow-up|0
7749732|NCT00736489|12185898|FG000|Period 1|Withdrawal by Subject|0
7749733|NCT00736489|12185899|FG001|Period 1|Withdrawal by Subject|0
7749734|NCT00736489|12185900|FG002|Period 1|Withdrawal by Subject|0
7962296|NCT02711345|12516524|FG002|Overall Study|Death|0
7749735|NCT00736489|12185901|FG003|Period 1|Withdrawal by Subject|0
7749736|NCT00736489|12185902|FG004|Period 1|Withdrawal by Subject|0
7749737|NCT00736489|12185903|FG005|Period 1|Withdrawal by Subject|1
7749738|NCT00736502|12185917|FG000|Overall Study|Adverse Event|22
7749739|NCT00736502|12185917|FG000|Overall Study|Lack of Efficacy|16
7749740|NCT00736502|12185917|FG000|Overall Study|Lost to Follow-up|27
7749741|NCT00736645|12185945|FG000|Overall Study|Adverse Event|0
7749742|NCT00736645|12185946|FG001|Overall Study|Adverse Event|2
7749743|NCT00736645|12185947|FG002|Overall Study|Adverse Event|0
7749744|NCT00736645|12185948|FG003|Overall Study|Adverse Event|0
7749745|NCT00736723|12185960|FG000|Overall Study|Withdrawal by Subject|4
7749746|NCT00736723|12185961|FG001|Overall Study|Withdrawal by Subject|3
7749747|NCT00736840|12185967|FG000|Overall Study|Lost to Follow-up|13
7749748|NCT00736853|12185971|FG000|Open-Label Period|Physician Decision|2
7749749|NCT00736853|12185972|FG001|Open-Label Period|Physician Decision|0
7749750|NCT00736853|12185973|FG002|Open-Label Period|Physician Decision|0
7749751|NCT00736853|12185971|FG000|Open-Label Period|Adverse Event|31
7749752|NCT00736853|12185972|FG001|Open-Label Period|Adverse Event|0
7749753|NCT00736853|12185973|FG002|Open-Label Period|Adverse Event|0
7749754|NCT00736853|12185971|FG000|Open-Label Period|Withdrawal by Subject|16
7749755|NCT00736853|12185972|FG001|Open-Label Period|Withdrawal by Subject|0
7749756|NCT00736853|12185973|FG002|Open-Label Period|Withdrawal by Subject|0
7749757|NCT00736853|12185971|FG000|Open-Label Period|Started but not treated|42
7749758|NCT00736853|12185972|FG001|Open-Label Period|Started but not treated|0
7749759|NCT00736853|12185973|FG002|Open-Label Period|Started but not treated|0
7749760|NCT00736853|12185971|FG000|Open-Label Period|Failed to meet the transfer criteria|40
7749761|NCT00736853|12185972|FG001|Open-Label Period|Failed to meet the transfer criteria|0
7749762|NCT00736853|12185973|FG002|Open-Label Period|Failed to meet the transfer criteria|0
7749763|NCT00736853|12185971|FG000|Open-Label Period|Unable to attend hospital appointments|1
7749764|NCT00736853|12185972|FG001|Open-Label Period|Unable to attend hospital appointments|0
7749765|NCT00736853|12185973|FG002|Open-Label Period|Unable to attend hospital appointments|0
7749766|NCT00736853|12185971|FG000|Double-Blind Period|Lack of Efficacy|0
7749767|NCT00736853|12185972|FG001|Double-Blind Period|Lack of Efficacy|19
7749768|NCT00736853|12185973|FG002|Double-Blind Period|Lack of Efficacy|42
7749769|NCT00736853|12185971|FG000|Double-Blind Period|Adverse Event|0
7749770|NCT00736853|12185972|FG001|Double-Blind Period|Adverse Event|3
7749771|NCT00736853|12185973|FG002|Double-Blind Period|Adverse Event|2
7749772|NCT00736853|12185971|FG000|Double-Blind Period|Withdrawal by Subject|0
7749773|NCT00736853|12185972|FG001|Double-Blind Period|Withdrawal by Subject|1
7749774|NCT00736853|12185973|FG002|Double-Blind Period|Withdrawal by Subject|4
7749775|NCT00736853|12185971|FG000|Double-Blind Period|Ineligible to participate the study|0
7749776|NCT00736853|12185972|FG001|Double-Blind Period|Ineligible to participate the study|1
7749777|NCT00736853|12185973|FG002|Double-Blind Period|Ineligible to participate the study|0
7749778|NCT00736879|12185986|FG000|Double Blind Treatment Period|Lack of Efficacy|1
7749779|NCT00736879|12185987|FG001|Double Blind Treatment Period|Lack of Efficacy|0
7749780|NCT00736879|12185988|FG002|Double Blind Treatment Period|Lack of Efficacy|0
7749781|NCT00736879|12185989|FG003|Double Blind Treatment Period|Lack of Efficacy|0
7749782|NCT00736879|12185986|FG000|Double Blind Treatment Period|Adverse Event|0
7749783|NCT00736879|12185987|FG001|Double Blind Treatment Period|Adverse Event|1
7749784|NCT00736879|12185988|FG002|Double Blind Treatment Period|Adverse Event|1
7749785|NCT00736879|12185989|FG003|Double Blind Treatment Period|Adverse Event|0
7749786|NCT00736879|12185986|FG000|Double Blind Treatment Period|Withdrawal by Subject|2
7749787|NCT00736879|12185987|FG001|Double Blind Treatment Period|Withdrawal by Subject|1
7749788|NCT00736879|12185988|FG002|Double Blind Treatment Period|Withdrawal by Subject|3
7749789|NCT00736879|12185989|FG003|Double Blind Treatment Period|Withdrawal by Subject|3
7749790|NCT00736879|12185986|FG000|Double Blind Treatment Period|Lost to Follow-up|0
7749791|NCT00736879|12185987|FG001|Double Blind Treatment Period|Lost to Follow-up|0
7749792|NCT00736879|12185988|FG002|Double Blind Treatment Period|Lost to Follow-up|2
7749793|NCT00736879|12185989|FG003|Double Blind Treatment Period|Lost to Follow-up|1
7749794|NCT00736879|12185986|FG000|Double Blind Treatment Period|Poor non-compliance|0
7749795|NCT00736879|12185987|FG001|Double Blind Treatment Period|Poor non-compliance|0
7749796|NCT00736879|12185988|FG002|Double Blind Treatment Period|Poor non-compliance|1
7749797|NCT00736879|12185989|FG003|Double Blind Treatment Period|Poor non-compliance|1
7749798|NCT00736879|12185986|FG000|Double Blind Treatment Period|No longer met criteria|0
7749799|NCT00736879|12185987|FG001|Double Blind Treatment Period|No longer met criteria|1
7749800|NCT00736879|12185988|FG002|Double Blind Treatment Period|No longer met criteria|0
7749801|NCT00736879|12185989|FG003|Double Blind Treatment Period|No longer met criteria|0
7749802|NCT00736879|12185986|FG000|Double Blind Treatment Period|non-specified|0
7749803|NCT00736879|12185987|FG001|Double Blind Treatment Period|non-specified|1
7749804|NCT00736879|12185988|FG002|Double Blind Treatment Period|non-specified|0
7749805|NCT00736879|12185989|FG003|Double Blind Treatment Period|non-specified|0
7749806|NCT00736879|12185986|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
7749807|NCT00736879|12185987|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
7749808|NCT00736879|12185988|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
7749809|NCT00736879|12185989|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
7749810|NCT00736879|12185986|FG000|Follow up Period - No Drug Treatment|non-specified|1
7749811|NCT00736879|12185987|FG001|Follow up Period - No Drug Treatment|non-specified|2
7749812|NCT00736879|12185988|FG002|Follow up Period - No Drug Treatment|non-specified|0
7749813|NCT00736879|12185989|FG003|Follow up Period - No Drug Treatment|non-specified|0
7749814|NCT00736944|12186002|FG000|Induction|Death|1
7749815|NCT00736944|12186002|FG000|Definitive Treatment|Physician Decision|1
7749816|NCT00736957|12186009|FG000|Overall Study|Adverse Event|43
7749817|NCT00736957|12186009|FG000|Overall Study|Withdrawal by Subject|49
7749818|NCT00736957|12186009|FG000|Overall Study|violation of eligibility criteria|2
7749819|NCT00736957|12186009|FG000|Overall Study|did not attend hospital appointments|1
7749820|NCT00736957|12186009|FG000|Overall Study|not eligible for Treatment Period I|22
7749821|NCT00736957|12186009|FG000|Overall Study|Physician Decision|5
7749822|NCT00736996|12186016|FG000|Overall Study|Lost to Follow-up|1
7749823|NCT00736996|12186017|FG001|Overall Study|Lost to Follow-up|9
7749824|NCT00736996|12186018|FG002|Overall Study|Lost to Follow-up|2
7749825|NCT00737048|12186029|FG000|Overall Study|Physician Decision|0
7749826|NCT00737048|12186030|FG001|Overall Study|Physician Decision|0
7749827|NCT00737048|12186031|FG002|Overall Study|Physician Decision|1
7749828|NCT00737048|12186029|FG000|Overall Study|Adverse Event|0
7749829|NCT00737048|12186030|FG001|Overall Study|Adverse Event|1
7749830|NCT00737048|12186031|FG002|Overall Study|Adverse Event|0
7749831|NCT00737048|12186029|FG000|Overall Study|Worsening of the symptoms|3
7749832|NCT00737048|12186030|FG001|Overall Study|Worsening of the symptoms|5
7749833|NCT00737048|12186031|FG002|Overall Study|Worsening of the symptoms|3
7749834|NCT00737061|12186039|FG000|Waiting Period|Lost to Follow-up|6
7749835|NCT00737061|12186039|FG000|Waiting Period|Withdrawal by Subject|1
7749836|NCT00737061|12186039|FG000|Waiting Period|Bilateral placement failure|34
7749837|NCT00737061|12186039|FG000|Waiting Period|Deemed patent following HSG|26
7749838|NCT00737061|12186039|FG000|Waiting Period|Alternative contraception failure|3
7749839|NCT00737061|12186039|FG000|Waiting Period|Elected surgical tubal ligation|5
7749840|NCT00737061|12186039|FG000|1 Year Wearing Period|Lost to Follow-up|11
7749841|NCT00737061|12186039|FG000|1 Year Wearing Period|Withdrawal by Subject|2
7749842|NCT00737061|12186039|FG000|1 Year Wearing Period|Discontinued reilance|3
7749843|NCT00737061|12186039|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1
7749844|NCT00737100|12186046|FG000|Overall Study|Adverse Event|6
7749845|NCT00737100|12186047|FG001|Overall Study|Adverse Event|5
7749846|NCT00737100|12186048|FG002|Overall Study|Adverse Event|3
7749847|NCT00737100|12186046|FG000|Overall Study|Lost to Follow-up|0
7749848|NCT00737100|12186047|FG001|Overall Study|Lost to Follow-up|1
7749849|NCT00737100|12186048|FG002|Overall Study|Lost to Follow-up|0
7749850|NCT00737100|12186046|FG000|Overall Study|Withdrawal by Subject|0
7749851|NCT00737100|12186047|FG001|Overall Study|Withdrawal by Subject|0
7749852|NCT00737100|12186048|FG002|Overall Study|Withdrawal by Subject|3
7749853|NCT00737100|12186046|FG000|Overall Study|Reason discontinued not explained above|1
7749854|NCT00737100|12186047|FG001|Overall Study|Reason discontinued not explained above|1
7749855|NCT00737100|12186048|FG002|Overall Study|Reason discontinued not explained above|1
7749856|NCT00737438|12186086|FG000|Overall Study|Withdrawal by Subject|2
7749857|NCT00737438|12186086|FG000|Overall Study|Patient ineligible|1
7749858|NCT00737464|12186090|FG000|Overall Study|Adverse Event|1
7749859|NCT00737464|12186090|FG000|Overall Study|Death|6
7749860|NCT00737464|12186090|FG000|Overall Study|Other - Failure to Return|1
7749861|NCT00737464|12186090|FG000|Overall Study|Refused Treatment / Withdrew Consent|6
7749862|NCT00737464|12186090|FG000|Overall Study|Other reasons|4
7749863|NCT00737477|12186094|FG000|Overall Study|Adverse Event|9
7749864|NCT00737477|12186094|FG000|Overall Study|Death|9
7749865|NCT00737477|12186094|FG000|Overall Study|Treatment Refusal|1
7749866|NCT00737477|12186094|FG000|Overall Study|Withdrawal by Subject|1
7749867|NCT00737477|12186094|FG000|Overall Study|Renal Transplantation|10
7749868|NCT00737477|12186094|FG000|Overall Study|Other|4
7749869|NCT00737529|12186098|FG000|Overall Study|Disease Progression|95
7749870|NCT00737529|12186098|FG000|Overall Study|Adverse Event|24
7749871|NCT00737529|12186098|FG000|Overall Study|Withdrawal by Subject|5
7749872|NCT00737529|12186098|FG000|Overall Study|Death|4
7749873|NCT00737529|12186098|FG000|Overall Study|Protocol Violation|1
7749874|NCT00737529|12186098|FG000|Overall Study|Other|4
7749875|NCT00737568|12186104|FG000|Treatment Period Through Week 240|Investigator's Discretion|6
7749876|NCT00737568|12186105|FG001|Treatment Period Through Week 240|Investigator's Discretion|5
7749877|NCT00737568|12186104|FG000|Treatment Period Through Week 240|Withdrew Consent|5
7749878|NCT00737568|12186105|FG001|Treatment Period Through Week 240|Withdrew Consent|6
7749879|NCT00737568|12186104|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
7749880|NCT00737568|12186105|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
7749881|NCT00737568|12186104|FG000|Treatment Period Through Week 240|Lost to Follow-up|3
7749882|NCT00737568|12186105|FG001|Treatment Period Through Week 240|Lost to Follow-up|3
7749883|NCT00737568|12186104|FG000|Treatment Period Through Week 240|Protocol Violation|2
7749884|NCT00737568|12186105|FG001|Treatment Period Through Week 240|Protocol Violation|3
7749885|NCT00737568|12186104|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
7749886|NCT00737568|12186105|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
7749887|NCT00737568|12186104|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
7749888|NCT00737568|12186105|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
7749889|NCT00737568|12186104|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0
7749890|NCT00737568|12186105|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1
7749891|NCT00737568|12186104|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
7749892|NCT00737568|12186105|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
7749893|NCT00737633|12186113|FG000|Overall Study|Study terminated by sponsor|44
7749894|NCT00737633|12186114|FG001|Overall Study|Study terminated by sponsor|55
7749895|NCT00737633|12186113|FG000|Overall Study|Lost to Follow-up|0
7749896|NCT00737633|12186114|FG001|Overall Study|Lost to Follow-up|1
7749897|NCT00737633|12186113|FG000|Overall Study|protocol non-compliance|0
7749898|NCT00737633|12186114|FG001|Overall Study|protocol non-compliance|1
7749899|NCT00737672|12186122|FG000|Overall Study|Graft Abandonment|48
7749900|NCT00737672|12186123|FG001|Overall Study|Graft Abandonment|56
7749901|NCT00737672|12186122|FG000|Overall Study|Death|23
7749902|NCT00737672|12186123|FG001|Overall Study|Death|22
7749903|NCT00737672|12186122|FG000|Overall Study|Withdrawal by Subject|1
7749904|NCT00737672|12186123|FG001|Overall Study|Withdrawal by Subject|2
7749905|NCT00737672|12186122|FG000|Overall Study|Lost to Follow-up|1
7749906|NCT00737672|12186123|FG001|Overall Study|Lost to Follow-up|0
7749907|NCT00737672|12186122|FG000|Overall Study|Miscellaneous|7
7749908|NCT00737672|12186123|FG001|Overall Study|Miscellaneous|1
7749909|NCT00737672|12186122|FG000|Overall Study|Physician Decision|0
7749910|NCT00737672|12186123|FG001|Overall Study|Physician Decision|2
7749911|NCT00737698|12186132|FG000|Overall Study|Withdrawal by Subject|6
7749912|NCT00737698|12186133|FG001|Overall Study|Withdrawal by Subject|5
7749913|NCT00737698|12186134|FG002|Overall Study|Withdrawal by Subject|3
7749914|NCT00737698|12186132|FG000|Overall Study|Death|0
7749915|NCT00737698|12186133|FG001|Overall Study|Death|0
7749916|NCT00737698|12186134|FG002|Overall Study|Death|1
7749917|NCT00737711|12186142|FG000|Overall Study|Adverse Event|2
7749918|NCT00737711|12186142|FG000|Overall Study|Death|8
7749919|NCT00737711|12186142|FG000|Overall Study|Failure to return|4
7749920|NCT00737711|12186142|FG000|Overall Study|Protocol Violation|1
7749921|NCT00737711|12186142|FG000|Overall Study|Withdrawal by Subject|5
7749922|NCT00737711|12186142|FG000|Overall Study|Blood transfusion|6
7749923|NCT00737711|12186142|FG000|Overall Study|Other|5
7749924|NCT00738062|12186192|FG000|Open Label Treatment|Lack of Efficacy|5
7749925|NCT00738062|12186193|FG001|Open Label Treatment|Lack of Efficacy|0
7749926|NCT00738062|12186194|FG002|Open Label Treatment|Lack of Efficacy|0
7749927|NCT00738062|12186192|FG000|Open Label Treatment|Adverse Event|11
7749928|NCT00738062|12186193|FG001|Open Label Treatment|Adverse Event|0
7749929|NCT00738062|12186194|FG002|Open Label Treatment|Adverse Event|0
7749930|NCT00738062|12186192|FG000|Open Label Treatment|Protocol Violation|2
7749931|NCT00738062|12186193|FG001|Open Label Treatment|Protocol Violation|0
7749932|NCT00738062|12186194|FG002|Open Label Treatment|Protocol Violation|0
7749933|NCT00738062|12186192|FG000|Open Label Treatment|Withdrawal by Subject|9
7749934|NCT00738062|12186193|FG001|Open Label Treatment|Withdrawal by Subject|0
7749935|NCT00738062|12186194|FG002|Open Label Treatment|Withdrawal by Subject|0
7749936|NCT00738062|12186192|FG000|Open Label Treatment|Investigator Decision|1
7749937|NCT00738062|12186193|FG001|Open Label Treatment|Investigator Decision|0
7749938|NCT00738062|12186194|FG002|Open Label Treatment|Investigator Decision|0
7749939|NCT00738062|12186192|FG000|Open-Label Extension|Adverse Event|5
7749940|NCT00738062|12186193|FG001|Open-Label Extension|Adverse Event|0
7749941|NCT00738062|12186194|FG002|Open-Label Extension|Adverse Event|0
7749942|NCT00738062|12186192|FG000|Open-Label Extension|Physician Decision|1
7749943|NCT00738062|12186193|FG001|Open-Label Extension|Physician Decision|0
7749944|NCT00738062|12186194|FG002|Open-Label Extension|Physician Decision|0
7749945|NCT00738062|12186192|FG000|Open-Label Extension|Lack of Efficacy|2
7749946|NCT00738062|12186193|FG001|Open-Label Extension|Lack of Efficacy|0
7749947|NCT00738062|12186194|FG002|Open-Label Extension|Lack of Efficacy|0
7749948|NCT00738062|12186192|FG000|Open-Label Extension|Withdrawal by Subject|6
7749949|NCT00738062|12186193|FG001|Open-Label Extension|Withdrawal by Subject|0
7749950|NCT00738062|12186194|FG002|Open-Label Extension|Withdrawal by Subject|0
7749951|NCT00738062|12186192|FG000|Open-Label Extension|Protocol Violation|1
7749952|NCT00738062|12186193|FG001|Open-Label Extension|Protocol Violation|0
7749953|NCT00738062|12186194|FG002|Open-Label Extension|Protocol Violation|0
7749954|NCT00738062|12186192|FG000|Open-Label Extension|Study Terminated|2
7749955|NCT00738062|12186193|FG001|Open-Label Extension|Study Terminated|0
7749956|NCT00738062|12186194|FG002|Open-Label Extension|Study Terminated|0
7749957|NCT00738101|12186203|FG000|Overall Study|Physician Decision|5
7749958|NCT00738101|12186203|FG000|Overall Study|Death|1
7749959|NCT00738101|12186203|FG000|Overall Study|Repeat enrollment|1
7749960|NCT00738283|12186207|FG000|Overall Study|Death|1
7749961|NCT00738283|12186207|FG000|Overall Study|Transfer to another facility|2
7749962|NCT00738283|12186207|FG000|Overall Study|Discharge home prior to end of study|1
7749963|NCT00738374|12186219|FG000|Induction Treatment Phase|Adverse Event|14
7749964|NCT00738374|12186220|FG001|Induction Treatment Phase|Adverse Event|0
7749965|NCT00738374|12186221|FG002|Induction Treatment Phase|Adverse Event|0
7749966|NCT00738374|12186222|FG003|Induction Treatment Phase|Adverse Event|0
7749967|NCT00738374|12186219|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4
7749968|NCT00738374|12186220|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0
7749969|NCT00738374|12186221|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0
7749970|NCT00738374|12186222|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0
7749971|NCT00738374|12186219|FG000|Induction Treatment Phase|Physician Decision|2
7749972|NCT00738374|12186220|FG001|Induction Treatment Phase|Physician Decision|0
7749973|NCT00738374|12186221|FG002|Induction Treatment Phase|Physician Decision|0
7749974|NCT00738374|12186222|FG003|Induction Treatment Phase|Physician Decision|0
7749975|NCT00738374|12186219|FG000|Induction Treatment Phase|Protocol Violation|2
7749976|NCT00738374|12186220|FG001|Induction Treatment Phase|Protocol Violation|0
7749977|NCT00738374|12186221|FG002|Induction Treatment Phase|Protocol Violation|0
7749978|NCT00738374|12186222|FG003|Induction Treatment Phase|Protocol Violation|0
7749979|NCT00738374|12186219|FG000|Induction Treatment Phase|Non-compliance|1
7749980|NCT00738374|12186220|FG001|Induction Treatment Phase|Non-compliance|0
7749981|NCT00738374|12186221|FG002|Induction Treatment Phase|Non-compliance|0
7749982|NCT00738374|12186222|FG003|Induction Treatment Phase|Non-compliance|0
7749983|NCT00738374|12186219|FG000|Induction Treatment Phase|Withdrawal by Subject|1
7749984|NCT00738374|12186220|FG001|Induction Treatment Phase|Withdrawal by Subject|0
7749985|NCT00738374|12186221|FG002|Induction Treatment Phase|Withdrawal by Subject|0
7749986|NCT00738374|12186222|FG003|Induction Treatment Phase|Withdrawal by Subject|0
7749987|NCT00738374|12186219|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0
7749988|NCT00738374|12186220|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1
7749989|NCT00738374|12186221|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2
7749990|NCT00738374|12186222|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0
7749991|NCT00738374|12186219|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
7749992|NCT00738374|12186220|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
7749993|NCT00738374|12186221|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
7749994|NCT00738374|12186222|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
7749995|NCT00738374|12186219|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
7749996|NCT00738374|12186220|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
7749997|NCT00738374|12186221|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
7749998|NCT00738374|12186222|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
7749999|NCT00738374|12186219|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0
7750000|NCT00738374|12186220|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1
7750001|NCT00738374|12186221|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0
7750002|NCT00738374|12186222|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0
7750003|NCT00738374|12186219|FG000|Maintenance Treatment/Observation Phase|Other|0
7750004|NCT00738374|12186220|FG001|Maintenance Treatment/Observation Phase|Other|1
7750005|NCT00738374|12186221|FG002|Maintenance Treatment/Observation Phase|Other|0
7750006|NCT00738374|12186222|FG003|Maintenance Treatment/Observation Phase|Other|0
7750007|NCT00738400|12186233|FG000|Overall Study|Adverse Event|3
7750008|NCT00738400|12186234|FG001|Overall Study|Adverse Event|1
7750009|NCT00738400|12186233|FG000|Overall Study|Withdrawal by Subject|0
7750010|NCT00738400|12186234|FG001|Overall Study|Withdrawal by Subject|1
7750011|NCT00738400|12186233|FG000|Overall Study|Lack of Efficacy|0
7750012|NCT00738400|12186234|FG001|Overall Study|Lack of Efficacy|1
7750013|NCT00738400|12186233|FG000|Overall Study|Lost to Follow-up|0
7750014|NCT00738400|12186234|FG001|Overall Study|Lost to Follow-up|3
7962297|NCT02711345|12516525|FG003|Overall Study|Death|0
7750015|NCT00738400|12186233|FG000|Overall Study|Protocol Violation|1
7750016|NCT00738400|12186234|FG001|Overall Study|Protocol Violation|0
7750017|NCT00738400|12186233|FG000|Overall Study|Non-compliant with study medication|0
7750018|NCT00738400|12186234|FG001|Overall Study|Non-compliant with study medication|1
7750019|NCT00738530|12186251|FG000|Overall Study|Death|220
7750020|NCT00738530|12186252|FG001|Overall Study|Death|224
7750021|NCT00738530|12186251|FG000|Overall Study|Lost to Follow-up|8
7750022|NCT00738530|12186252|FG001|Overall Study|Lost to Follow-up|6
7750023|NCT00738530|12186251|FG000|Overall Study|Withdrawal by Subject|6
7750024|NCT00738530|12186252|FG001|Overall Study|Withdrawal by Subject|8
7750025|NCT00738673|12186264|FG000|Overall Study|Adverse Event|1
7750026|NCT00738673|12186265|FG001|Overall Study|Adverse Event|0
7750027|NCT00738673|12186264|FG000|Overall Study|Lack of Efficacy|19
7750028|NCT00738673|12186265|FG001|Overall Study|Lack of Efficacy|8
7750029|NCT00738673|12186264|FG000|Overall Study|Protocol Violation|1
7750030|NCT00738673|12186265|FG001|Overall Study|Protocol Violation|2
7750031|NCT00738673|12186264|FG000|Overall Study|Withdrawal by Subject|3
7750032|NCT00738673|12186265|FG001|Overall Study|Withdrawal by Subject|1
7750033|NCT00738699|12186273|FG000|Overall Study|Withdrawal by Subject|5
7750034|NCT00738699|12186274|FG001|Overall Study|Withdrawal by Subject|0
7750035|NCT00738699|12186273|FG000|Overall Study|Lost to Follow-up|1
7750036|NCT00738699|12186274|FG001|Overall Study|Lost to Follow-up|0
7750037|NCT00738699|12186273|FG000|Overall Study|Death|144
7750038|NCT00738699|12186274|FG001|Overall Study|Death|68
7750039|NCT00738699|12186273|FG000|Overall Study|Discontinuation of study by Sponsor|123
7750040|NCT00738699|12186274|FG001|Overall Study|Discontinuation of study by Sponsor|72
7750041|NCT00738699|12186273|FG000|Overall Study|Other|2
7750042|NCT00738699|12186274|FG001|Overall Study|Other|0
7750043|NCT00738881|12186282|FG000|Overall Study|Withdrawal by Subject|0
7750044|NCT00738881|12186283|FG001|Overall Study|Withdrawal by Subject|2
7750045|NCT00738894|12186291|FG000|Overall Study|Lost to Follow-up|23
7750046|NCT00738894|12186292|FG001|Overall Study|Lost to Follow-up|13
7750047|NCT00738894|12186291|FG000|Overall Study|Withdrawal by Subject|10
7750048|NCT00738894|12186292|FG001|Overall Study|Withdrawal by Subject|15
7750049|NCT00738894|12186291|FG000|Overall Study|Physician Decision|4
7750050|NCT00738894|12186292|FG001|Overall Study|Physician Decision|5
7750051|NCT00738894|12186291|FG000|Overall Study|Death|2
7750052|NCT00738894|12186292|FG001|Overall Study|Death|0
7750053|NCT00739102|12186298|FG000|Overall Study|Death|5
7750054|NCT00739102|12186298|FG000|Overall Study|Withdrawal by Subject|10
7750055|NCT00739297|12186302|FG000|First Washout Period of 4-7 Days|Adverse Event|0
7750056|NCT00739297|12186303|FG001|First Washout Period of 4-7 Days|Adverse Event|0
7750057|NCT00739297|12186304|FG002|First Washout Period of 4-7 Days|Adverse Event|0
7750058|NCT00739297|12186305|FG003|First Washout Period of 4-7 Days|Adverse Event|2
7750059|NCT00739297|12186306|FG004|First Washout Period of 4-7 Days|Adverse Event|0
7750060|NCT00739297|12186307|FG005|First Washout Period of 4-7 Days|Adverse Event|0
7750061|NCT00739297|12186308|FG006|First Washout Period of 4-7 Days|Adverse Event|2
7769581|NCT00868790|12213069|FG011|Post-study|Excluded Medication|0
7750062|NCT00739297|12186302|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
7750063|NCT00739297|12186303|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
7750064|NCT00739297|12186304|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
7750065|NCT00739297|12186305|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
7750066|NCT00739297|12186306|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
7750067|NCT00739297|12186307|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
7750068|NCT00739297|12186308|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
7750069|NCT00739310|12186324|FG000|Overall Study|Poor adherance to prescribed therapy|4
7750070|NCT00739310|12186324|FG000|Overall Study|Withdrawal by Subject|1
7750071|NCT00739310|12186324|FG000|Overall Study|Lost to Follow-up|2
7750072|NCT00739596|12186349|FG000|Overall Study|Adverse Event|12
7750073|NCT00739596|12186350|FG001|Overall Study|Adverse Event|6
7750074|NCT00739596|12186349|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4
7750075|NCT00739596|12186350|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
7750076|NCT00739596|12186349|FG000|Overall Study|Patient Withdrew Consent|8
7750077|NCT00739596|12186350|FG001|Overall Study|Patient Withdrew Consent|8
7750078|NCT00739596|12186349|FG000|Overall Study|Lost to Follow-up|0
7750079|NCT00739596|12186350|FG001|Overall Study|Lost to Follow-up|2
7750080|NCT00739596|12186349|FG000|Overall Study|Protocol Deviation|1
7750081|NCT00739596|12186350|FG001|Overall Study|Protocol Deviation|1
7750082|NCT00739648|12186358|FG000|Overall Study|Adverse Event|3
7750083|NCT00739648|12186359|FG001|Overall Study|Adverse Event|15
7750084|NCT00739648|12186358|FG000|Overall Study|Withdrawal by Subject|13
7750085|NCT00739648|12186359|FG001|Overall Study|Withdrawal by Subject|25
7750086|NCT00739648|12186358|FG000|Overall Study|Lost to Follow-up|4
7750087|NCT00739648|12186359|FG001|Overall Study|Lost to Follow-up|7
7750088|NCT00739648|12186358|FG000|Overall Study|Death|2
7750089|NCT00739648|12186359|FG001|Overall Study|Death|0
7750090|NCT00739648|12186358|FG000|Overall Study|Do not know|4
7750091|NCT00739648|12186359|FG001|Overall Study|Do not know|6
7750092|NCT00739661|12186371|FG000|Overall Study|Adverse Event|2
7750093|NCT00739661|12186372|FG001|Overall Study|Adverse Event|0
7750094|NCT00739661|12186371|FG000|Overall Study|Physician decision to withdraw patient|1
7750095|NCT00739661|12186372|FG001|Overall Study|Physician decision to withdraw patient|0
7750096|NCT00739661|12186371|FG000|Overall Study|Patient decision to withdraw|9
7750097|NCT00739661|12186372|FG001|Overall Study|Patient decision to withdraw|4
7750098|NCT00739661|12186371|FG000|Overall Study|Disease progression, radiographic|33
7750099|NCT00739661|12186372|FG001|Overall Study|Disease progression, radiographic|37
7750100|NCT00739661|12186371|FG000|Overall Study|Reason for discontinuation not available|1
7750101|NCT00739661|12186372|FG001|Overall Study|Reason for discontinuation not available|1
7750102|NCT00739908|12186418|FG000|Overall Study|Adverse Event|5
7750103|NCT00739908|12186419|FG001|Overall Study|Adverse Event|6
7750104|NCT00739908|12186418|FG000|Overall Study|Withdrawal by Subject|4
7750105|NCT00739908|12186419|FG001|Overall Study|Withdrawal by Subject|2
7750106|NCT00739908|12186418|FG000|Overall Study|Lost to Follow-up|14
7750107|NCT00739908|12186419|FG001|Overall Study|Lost to Follow-up|9
7750108|NCT00739908|12186418|FG000|Overall Study|Non-Compliance With Study Procedures|2
7750109|NCT00739908|12186419|FG001|Overall Study|Non-Compliance With Study Procedures|3
7750110|NCT00739908|12186418|FG000|Overall Study|Non-Compliance With Study Medication|0
7750111|NCT00739908|12186419|FG001|Overall Study|Non-Compliance With Study Medication|3
7750112|NCT00739908|12186418|FG000|Overall Study|Lack of Efficacy|0
7750113|NCT00739908|12186419|FG001|Overall Study|Lack of Efficacy|1
7750114|NCT00739908|12186418|FG000|Overall Study|Relocation|0
7750115|NCT00739908|12186419|FG001|Overall Study|Relocation|1
7750116|NCT00739934|12186427|FG000|Voriconazole IV|Adverse Event|6
7750117|NCT00739934|12186427|FG000|Voriconazole Oral|Other|3
7750118|NCT00739973|12186449|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
7750119|NCT00739973|12186450|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7750120|NCT00739973|12186451|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7750121|NCT00739973|12186452|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7750122|NCT00739973|12186453|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7750123|NCT00739973|12186454|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7750124|NCT00739973|12186455|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7750125|NCT00739973|12186456|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7750126|NCT00739973|12186457|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7750127|NCT00739973|12186449|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
7750128|NCT00739973|12186450|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7750129|NCT00739973|12186451|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7750130|NCT00739973|12186452|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7750131|NCT00739973|12186453|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7750132|NCT00739973|12186454|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7750133|NCT00739973|12186455|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7750134|NCT00739973|12186456|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7750135|NCT00739973|12186457|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7750136|NCT00739973|12186449|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
7769582|NCT00868790|12213070|FG012|Post-study|Excluded Medication|0
7750137|NCT00739973|12186450|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7750138|NCT00739973|12186451|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7750139|NCT00739973|12186452|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7750140|NCT00739973|12186453|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7750141|NCT00739973|12186454|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7750142|NCT00739973|12186455|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7750143|NCT00739973|12186456|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7750144|NCT00739973|12186457|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7750145|NCT00739973|12186449|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
7750146|NCT00739973|12186450|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7750147|NCT00739973|12186451|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7750148|NCT00739973|12186452|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7750149|NCT00739973|12186453|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7750150|NCT00739973|12186454|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7750151|NCT00739973|12186455|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7750152|NCT00739973|12186456|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7750153|NCT00739973|12186457|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7750154|NCT00739973|12186449|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
7750155|NCT00739973|12186450|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7750156|NCT00739973|12186451|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7750157|NCT00739973|12186452|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7750158|NCT00739973|12186453|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7750159|NCT00739973|12186454|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7750160|NCT00739973|12186455|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7750161|NCT00739973|12186456|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7750162|NCT00739973|12186457|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7750163|NCT00739973|12186449|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
7750164|NCT00739973|12186450|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7750165|NCT00739973|12186451|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7750166|NCT00739973|12186452|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7750167|NCT00739973|12186453|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7750168|NCT00739973|12186454|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7750169|NCT00739973|12186455|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7750170|NCT00739973|12186456|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7750171|NCT00739973|12186457|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7750172|NCT00739973|12186449|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
7750173|NCT00739973|12186450|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7750174|NCT00739973|12186451|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7750175|NCT00739973|12186452|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7750176|NCT00739973|12186453|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7750177|NCT00739973|12186454|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7750178|NCT00739973|12186455|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7750179|NCT00739973|12186456|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7750180|NCT00739973|12186457|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7750181|NCT00739973|12186449|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
7750182|NCT00739973|12186450|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
7750183|NCT00739973|12186451|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
7750184|NCT00739973|12186452|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
7750185|NCT00739973|12186453|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
7750186|NCT00739973|12186454|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
7750187|NCT00739973|12186455|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
7750188|NCT00739973|12186456|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
7750189|NCT00739973|12186457|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
7750190|NCT00739973|12186449|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7750191|NCT00739973|12186450|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7750192|NCT00739973|12186451|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7750193|NCT00739973|12186452|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7750194|NCT00739973|12186453|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
7750195|NCT00739973|12186454|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7750196|NCT00739973|12186455|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7750197|NCT00739973|12186456|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
7750198|NCT00739973|12186457|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7750199|NCT00739973|12186449|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
7750200|NCT00739973|12186450|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
7750201|NCT00739973|12186451|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7769583|NCT00868790|12213071|FG013|Post-study|Excluded Medication|0
7750202|NCT00739973|12186452|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7750203|NCT00739973|12186453|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7750204|NCT00739973|12186454|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7750205|NCT00739973|12186455|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7750206|NCT00739973|12186456|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7750207|NCT00739973|12186457|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7750208|NCT00739973|12186449|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
7750209|NCT00739973|12186450|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
7750210|NCT00739973|12186451|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
7750211|NCT00739973|12186452|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
7750212|NCT00739973|12186453|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
7750213|NCT00739973|12186454|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
7750214|NCT00739973|12186455|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
7750215|NCT00739973|12186456|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
7750216|NCT00739973|12186457|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
7750217|NCT00739973|12186449|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7750218|NCT00739973|12186450|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7750219|NCT00739973|12186451|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
7750220|NCT00739973|12186452|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7750221|NCT00739973|12186453|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7750222|NCT00739973|12186454|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7750223|NCT00739973|12186455|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7750224|NCT00739973|12186456|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7750225|NCT00739973|12186457|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7750226|NCT00739973|12186449|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
7750227|NCT00739973|12186450|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
7750228|NCT00739973|12186451|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
7750229|NCT00739973|12186452|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
7750230|NCT00739973|12186453|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
7750231|NCT00739973|12186454|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
7750232|NCT00739973|12186455|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
7750233|NCT00739973|12186456|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
7750234|NCT00739973|12186457|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
7750235|NCT00739973|12186449|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
7750236|NCT00739973|12186450|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
7750237|NCT00739973|12186451|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
7750238|NCT00739973|12186452|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
7750239|NCT00739973|12186453|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
7750240|NCT00739973|12186454|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
7750241|NCT00739973|12186455|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
7750242|NCT00739973|12186456|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
7750243|NCT00739973|12186457|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
7750244|NCT00739973|12186449|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7750245|NCT00739973|12186450|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7750246|NCT00739973|12186451|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7750247|NCT00739973|12186452|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7750248|NCT00739973|12186453|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7750249|NCT00739973|12186454|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7750250|NCT00739973|12186455|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
7750251|NCT00739973|12186456|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7750252|NCT00739973|12186457|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7750253|NCT00739973|12186449|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
7750254|NCT00739973|12186450|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
7750255|NCT00739973|12186451|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
7750256|NCT00739973|12186452|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
7750257|NCT00739973|12186453|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
7750258|NCT00739973|12186454|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
7750259|NCT00739973|12186455|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
7750260|NCT00739973|12186456|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
7750261|NCT00739973|12186457|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
7750262|NCT00739973|12186449|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7750263|NCT00739973|12186450|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
7750264|NCT00739973|12186451|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7750265|NCT00739973|12186452|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7750266|NCT00739973|12186453|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7750267|NCT00739973|12186454|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7750268|NCT00739973|12186455|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
7750269|NCT00739973|12186456|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7750270|NCT00739973|12186457|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7750271|NCT00740051|12186501|FG000|Overall Study|Lack of Efficacy|2
7750272|NCT00740051|12186502|FG001|Overall Study|Lack of Efficacy|5
7750273|NCT00740051|12186501|FG000|Overall Study|Adverse Event|1
7750274|NCT00740051|12186502|FG001|Overall Study|Adverse Event|4
7750275|NCT00740051|12186501|FG000|Overall Study|Protocol Violation|2
7750276|NCT00740051|12186502|FG001|Overall Study|Protocol Violation|6
7750277|NCT00740051|12186501|FG000|Overall Study|Lost to Follow-up|3
7750278|NCT00740051|12186502|FG001|Overall Study|Lost to Follow-up|8
7750279|NCT00740051|12186501|FG000|Overall Study|Withdrawal by Subject|6
7750280|NCT00740051|12186502|FG001|Overall Study|Withdrawal by Subject|8
7750281|NCT00740051|12186501|FG000|Overall Study|Other reason (not specified)|4
7750282|NCT00740051|12186502|FG001|Overall Study|Other reason (not specified)|1
7750283|NCT00740220|12186527|FG000|Overall Study|screen failures (non-COPD patients)|9
7750284|NCT00740584|12186540|FG000|Overall Study|Withdrawal by Subject|1
7750285|NCT00740636|12186547|FG000|Overall Study|Adverse Event|0
7750286|NCT00740636|12186548|FG001|Overall Study|Adverse Event|2
7750287|NCT00740636|12186547|FG000|Overall Study|Patient Ineligible|0
7750288|NCT00740636|12186548|FG001|Overall Study|Patient Ineligible|1
7750289|NCT00740636|12186547|FG000|Overall Study|Patient Not Treated|0
7750290|NCT00740636|12186548|FG001|Overall Study|Patient Not Treated|1
7750291|NCT00740636|12186547|FG000|Overall Study|Progressive Disease|1
7750292|NCT00740636|12186548|FG001|Overall Study|Progressive Disease|0
7750293|NCT00740636|12186547|FG000|Overall Study|Death|1
7750294|NCT00740636|12186548|FG001|Overall Study|Death|0
7750295|NCT00740714|12186557|FG000|Overall Study|Withdrawal by Subject|17
7750296|NCT00740714|12186558|FG001|Overall Study|Withdrawal by Subject|19
7750297|NCT00740714|12186559|FG002|Overall Study|Withdrawal by Subject|29
7750298|NCT00740779|12186570|FG000|Overall Study|Adverse Event|4
7750299|NCT00740779|12186571|FG001|Overall Study|Adverse Event|6
7750300|NCT00740779|12186572|FG002|Overall Study|Adverse Event|3
7750301|NCT00740779|12186570|FG000|Overall Study|Protocol Violation|1
7750302|NCT00740779|12186571|FG001|Overall Study|Protocol Violation|1
7750303|NCT00740779|12186572|FG002|Overall Study|Protocol Violation|1
7750304|NCT00740779|12186570|FG000|Overall Study|Lack of Efficacy|0
7750305|NCT00740779|12186571|FG001|Overall Study|Lack of Efficacy|0
7750306|NCT00740779|12186572|FG002|Overall Study|Lack of Efficacy|2
7750307|NCT00740779|12186570|FG000|Overall Study|Withdrawal by Subject|2
7750308|NCT00740779|12186571|FG001|Overall Study|Withdrawal by Subject|4
7750309|NCT00740779|12186572|FG002|Overall Study|Withdrawal by Subject|2
7750310|NCT00740779|12186570|FG000|Overall Study|Lost to Follow-up|2
7750311|NCT00740779|12186571|FG001|Overall Study|Lost to Follow-up|3
7750312|NCT00740779|12186572|FG002|Overall Study|Lost to Follow-up|5
7750313|NCT00740792|12186584|FG000|Overall Study|Adverse Event|3
7750314|NCT00740792|12186585|FG001|Overall Study|Adverse Event|1
7750315|NCT00740792|12186586|FG002|Overall Study|Adverse Event|1
7750316|NCT00740792|12186587|FG003|Overall Study|Adverse Event|3
7750317|NCT00740792|12186584|FG000|Overall Study|Lack of Efficacy|1
7750318|NCT00740792|12186585|FG001|Overall Study|Lack of Efficacy|1
7750319|NCT00740792|12186586|FG002|Overall Study|Lack of Efficacy|0
7750320|NCT00740792|12186587|FG003|Overall Study|Lack of Efficacy|3
7750321|NCT00740792|12186584|FG000|Overall Study|Lost to Follow-up|2
7750322|NCT00740792|12186585|FG001|Overall Study|Lost to Follow-up|1
7750323|NCT00740792|12186586|FG002|Overall Study|Lost to Follow-up|0
7750324|NCT00740792|12186587|FG003|Overall Study|Lost to Follow-up|0
7750325|NCT00740792|12186584|FG000|Overall Study|Protocol Violation|0
7750326|NCT00740792|12186585|FG001|Overall Study|Protocol Violation|1
7750327|NCT00740792|12186586|FG002|Overall Study|Protocol Violation|0
7750328|NCT00740792|12186587|FG003|Overall Study|Protocol Violation|2
7750329|NCT00740792|12186584|FG000|Overall Study|Withdrawal by Subject|1
7750330|NCT00740792|12186585|FG001|Overall Study|Withdrawal by Subject|1
7750331|NCT00740792|12186586|FG002|Overall Study|Withdrawal by Subject|0
7750332|NCT00740792|12186587|FG003|Overall Study|Withdrawal by Subject|0
7750333|NCT00740792|12186584|FG000|Overall Study|administrative|3
7750334|NCT00740792|12186585|FG001|Overall Study|administrative|3
7750335|NCT00740792|12186586|FG002|Overall Study|administrative|8
7750336|NCT00740792|12186587|FG003|Overall Study|administrative|2
7750337|NCT00740857|12186613|FG000|Overall Study|Withdrawal by Subject|1
7750338|NCT00740857|12186614|FG001|Overall Study|Withdrawal by Subject|0
7750339|NCT00740857|12186615|FG002|Overall Study|Withdrawal by Subject|0
7769584|NCT00869024|12213093|FG000|Overall Study|Death|2
7769585|NCT00869024|12213094|FG001|Overall Study|Death|3
7750340|NCT00740870|12186623|FG000|Overall Study|Not Catheterized|4
7750341|NCT00740870|12186623|FG000|Overall Study|Further testing contraindicated implant|17
7750342|NCT00741013|12186633|FG000|Overall Study|Adverse Event|1
7750343|NCT00741013|12186634|FG001|Overall Study|Adverse Event|0
7750344|NCT00741013|12186635|FG002|Overall Study|Adverse Event|0
7750345|NCT00741013|12186633|FG000|Overall Study|Withdrawal by Subject|0
7750346|NCT00741013|12186634|FG001|Overall Study|Withdrawal by Subject|0
7750347|NCT00741013|12186635|FG002|Overall Study|Withdrawal by Subject|1
7750348|NCT00741013|12186633|FG000|Overall Study|Discovered failed screen after enrolled|0
7750349|NCT00741013|12186634|FG001|Overall Study|Discovered failed screen after enrolled|2
7750350|NCT00741013|12186635|FG002|Overall Study|Discovered failed screen after enrolled|0
7750351|NCT00741039|12186651|FG000|Overall Study|Patient non-compliance|2
7750352|NCT00741039|12186652|FG001|Overall Study|Patient non-compliance|0
7750353|NCT00741091|12186658|FG000|Overall Study|Death|13
7750354|NCT00741091|12186658|FG000|Overall Study|Lost to Follow-up|16
7750355|NCT00741091|12186658|FG000|Overall Study|Withdrawal by Subject|6
7750356|NCT00741091|12186658|FG000|Overall Study|Missed Visit|22
7750357|NCT00741260|12186688|FG000|Overall Study|Disease Progression|3
7750358|NCT00741260|12186689|FG001|Overall Study|Disease Progression|5
7750359|NCT00741260|12186690|FG002|Overall Study|Disease Progression|3
7750360|NCT00741260|12186691|FG003|Overall Study|Disease Progression|3
7750361|NCT00741260|12186692|FG004|Overall Study|Disease Progression|5
7750362|NCT00741260|12186693|FG005|Overall Study|Disease Progression|37
7750363|NCT00741260|12186694|FG006|Overall Study|Disease Progression|4
7750364|NCT00741260|12186688|FG000|Overall Study|Death|0
7750365|NCT00741260|12186689|FG001|Overall Study|Death|1
7750366|NCT00741260|12186690|FG002|Overall Study|Death|0
7750367|NCT00741260|12186691|FG003|Overall Study|Death|1
7750368|NCT00741260|12186692|FG004|Overall Study|Death|2
7750369|NCT00741260|12186693|FG005|Overall Study|Death|2
7750370|NCT00741260|12186694|FG006|Overall Study|Death|1
7750371|NCT00741260|12186688|FG000|Overall Study|Withdrawal by Subject|0
7750372|NCT00741260|12186689|FG001|Overall Study|Withdrawal by Subject|0
7750373|NCT00741260|12186690|FG002|Overall Study|Withdrawal by Subject|0
7750374|NCT00741260|12186691|FG003|Overall Study|Withdrawal by Subject|0
7750375|NCT00741260|12186692|FG004|Overall Study|Withdrawal by Subject|1
7750376|NCT00741260|12186693|FG005|Overall Study|Withdrawal by Subject|3
7750377|NCT00741260|12186694|FG006|Overall Study|Withdrawal by Subject|1
7750378|NCT00741260|12186688|FG000|Overall Study|Physician Decision|1
7750379|NCT00741260|12186689|FG001|Overall Study|Physician Decision|1
7750380|NCT00741260|12186690|FG002|Overall Study|Physician Decision|0
7750381|NCT00741260|12186691|FG003|Overall Study|Physician Decision|0
7750382|NCT00741260|12186692|FG004|Overall Study|Physician Decision|0
7750383|NCT00741260|12186693|FG005|Overall Study|Physician Decision|0
7750384|NCT00741260|12186694|FG006|Overall Study|Physician Decision|0
7750385|NCT00741260|12186688|FG000|Overall Study|Other|2
7750386|NCT00741260|12186689|FG001|Overall Study|Other|1
7750387|NCT00741260|12186690|FG002|Overall Study|Other|1
7750388|NCT00741260|12186691|FG003|Overall Study|Other|2
7750389|NCT00741260|12186692|FG004|Overall Study|Other|1
7750390|NCT00741260|12186693|FG005|Overall Study|Other|3
7750391|NCT00741260|12186694|FG006|Overall Study|Other|1
7750392|NCT00741286|12186730|FG000|Overall Study|Lost to Follow-up|15
7750393|NCT00741286|12186731|FG001|Overall Study|Lost to Follow-up|10
7750394|NCT00741286|12186730|FG000|Overall Study|Adverse Event|1
7750395|NCT00741286|12186731|FG001|Overall Study|Adverse Event|6
7750396|NCT00741286|12186730|FG000|Overall Study|Protocol Violation|3
7750397|NCT00741286|12186731|FG001|Overall Study|Protocol Violation|2
7750398|NCT00741286|12186730|FG000|Overall Study|Primary Outcome|1
7750399|NCT00741286|12186731|FG001|Overall Study|Primary Outcome|1
7750400|NCT00741338|12186739|FG000|Overall Study|Adverse Event|0
7750401|NCT00741338|12186740|FG001|Overall Study|Adverse Event|1
7750402|NCT00741598|12186782|FG000|Overall Study|Lost to Follow-up|3
7750403|NCT00741598|12186783|FG001|Overall Study|Lost to Follow-up|4
7750404|NCT00741598|12186782|FG000|Overall Study|Lack of Efficacy|1
7750405|NCT00741598|12186783|FG001|Overall Study|Lack of Efficacy|2
7750406|NCT00741598|12186782|FG000|Overall Study|Physician Decision|1
7750407|NCT00741598|12186783|FG001|Overall Study|Physician Decision|1
7750408|NCT00741598|12186782|FG000|Overall Study|Pregnancy|1
7750409|NCT00741598|12186783|FG001|Overall Study|Pregnancy|0
7750410|NCT00741598|12186782|FG000|Overall Study|Withdrawal by Subject|3
7750411|NCT00741598|12186783|FG001|Overall Study|Withdrawal by Subject|2
7750412|NCT00741611|12186793|FG000|Overall Study|Death|0
7750413|NCT00741611|12186794|FG001|Overall Study|Death|0
7750414|NCT00741611|12186795|FG002|Overall Study|Death|1
7750415|NCT00741611|12186793|FG000|Overall Study|Withdrawal by Subject|0
7750416|NCT00741611|12186794|FG001|Overall Study|Withdrawal by Subject|2
7750417|NCT00741611|12186795|FG002|Overall Study|Withdrawal by Subject|2
7750418|NCT00741819|12186804|FG000|Overall Study|Adverse Event|3
7750419|NCT00741819|12186804|FG000|Overall Study|Withdrawal by Subject|3
7750420|NCT00741819|12186804|FG000|Overall Study|Death|1
7750421|NCT00741819|12186804|FG000|Overall Study|Disease progression|1
7750422|NCT00741936|12186821|FG000|Overall Study|Lost to Follow-up|1
7750423|NCT00741936|12186822|FG001|Overall Study|Lost to Follow-up|1
7750424|NCT00741936|12186821|FG000|Overall Study|Adverse Event|3
7750425|NCT00741936|12186822|FG001|Overall Study|Adverse Event|4
7750426|NCT00741936|12186821|FG000|Overall Study|Pregnancy|0
7750427|NCT00741936|12186822|FG001|Overall Study|Pregnancy|1
7750428|NCT00741936|12186821|FG000|Overall Study|Protocol Violation|2
7750429|NCT00741936|12186822|FG001|Overall Study|Protocol Violation|0
7750430|NCT00741936|12186821|FG000|Overall Study|Lack of Efficacy|0
7750431|NCT00741936|12186822|FG001|Overall Study|Lack of Efficacy|2
7750432|NCT00741936|12186821|FG000|Overall Study|Low compliance|3
7750433|NCT00741936|12186822|FG001|Overall Study|Low compliance|0
7750434|NCT00742001|12186831|FG000|Overall Study|Withdrawn; health exclusion (flu)|0
7750435|NCT00742001|12186832|FG001|Overall Study|Withdrawn; health exclusion (flu)|0
7750436|NCT00742001|12186833|FG002|Overall Study|Withdrawn; health exclusion (flu)|1
7750437|NCT00742027|12186844|FG000|Overall Study|Disease Progression|76
7750438|NCT00742027|12186844|FG000|Overall Study|New Cancer Therapy|19
7750439|NCT00742027|12186844|FG000|Overall Study|Withdrawal by Subject|18
7750440|NCT00742027|12186844|FG000|Overall Study|Death|7
7750441|NCT00742027|12186844|FG000|Overall Study|Lost to Follow-up|4
7750442|NCT00742027|12186844|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2
7750443|NCT00742027|12186844|FG000|Overall Study|Missing|2
7750444|NCT00742027|12186844|FG000|Overall Study|Administrative Problems|1
7750445|NCT00742079|12186854|FG000|Overall Study|Lost to Follow-up|0
7750446|NCT00742079|12186855|FG001|Overall Study|Lost to Follow-up|1
7750447|NCT00742183|12186872|FG000|Overall Study|Adverse Event|2
7750448|NCT00742183|12186873|FG001|Overall Study|Adverse Event|2
7750449|NCT00742183|12186872|FG000|Overall Study|Death|1
7750450|NCT00742183|12186873|FG001|Overall Study|Death|0
7750451|NCT00742183|12186872|FG000|Overall Study|Physician Decision|0
7750452|NCT00742183|12186873|FG001|Overall Study|Physician Decision|2
7750453|NCT00742183|12186872|FG000|Overall Study|Lost to Follow-up|4
7750454|NCT00742183|12186873|FG001|Overall Study|Lost to Follow-up|4
7750455|NCT00742183|12186872|FG000|Overall Study|Required skin-graft|1
7750456|NCT00742183|12186873|FG001|Overall Study|Required skin-graft|1
7750457|NCT00742183|12186872|FG000|Overall Study|Withdrawal by Subject|1
7750458|NCT00742183|12186873|FG001|Overall Study|Withdrawal by Subject|0
7750459|NCT00742183|12186872|FG000|Overall Study|Lack of Efficacy|0
7750460|NCT00742183|12186873|FG001|Overall Study|Lack of Efficacy|3
7750461|NCT00742209|12186884|FG000|Overall Study|Adverse Event|11
7750462|NCT00742209|12186885|FG001|Overall Study|Adverse Event|4
7750463|NCT00742209|12186886|FG002|Overall Study|Adverse Event|17
7750464|NCT00742209|12186887|FG003|Overall Study|Adverse Event|16
7750465|NCT00742209|12186888|FG004|Overall Study|Adverse Event|13
7750466|NCT00742209|12186884|FG000|Overall Study|Participant Withdrew Consent|8
7750467|NCT00742209|12186885|FG001|Overall Study|Participant Withdrew Consent|4
7750468|NCT00742209|12186886|FG002|Overall Study|Participant Withdrew Consent|14
7750469|NCT00742209|12186887|FG003|Overall Study|Participant Withdrew Consent|7
7750470|NCT00742209|12186888|FG004|Overall Study|Participant Withdrew Consent|4
7750471|NCT00742209|12186884|FG000|Overall Study|Protocol Violation|6
7750472|NCT00742209|12186885|FG001|Overall Study|Protocol Violation|5
7750473|NCT00742209|12186886|FG002|Overall Study|Protocol Violation|4
7750474|NCT00742209|12186887|FG003|Overall Study|Protocol Violation|5
7750475|NCT00742209|12186888|FG004|Overall Study|Protocol Violation|3
7750476|NCT00742209|12186884|FG000|Overall Study|Lost to Follow-up|3
7750477|NCT00742209|12186885|FG001|Overall Study|Lost to Follow-up|4
7750478|NCT00742209|12186886|FG002|Overall Study|Lost to Follow-up|5
7750479|NCT00742209|12186887|FG003|Overall Study|Lost to Follow-up|5
7750480|NCT00742209|12186888|FG004|Overall Study|Lost to Follow-up|3
7750481|NCT00742209|12186884|FG000|Overall Study|Lack of Efficacy|6
7750482|NCT00742209|12186885|FG001|Overall Study|Lack of Efficacy|1
7750483|NCT00742209|12186886|FG002|Overall Study|Lack of Efficacy|1
7750484|NCT00742209|12186887|FG003|Overall Study|Lack of Efficacy|3
7750485|NCT00742209|12186888|FG004|Overall Study|Lack of Efficacy|1
7750486|NCT00742209|12186884|FG000|Overall Study|Investigator Discretion|0
7750487|NCT00742209|12186885|FG001|Overall Study|Investigator Discretion|0
7750488|NCT00742209|12186886|FG002|Overall Study|Investigator Discretion|5
7750489|NCT00742209|12186887|FG003|Overall Study|Investigator Discretion|1
7750490|NCT00742209|12186888|FG004|Overall Study|Investigator Discretion|1
7750491|NCT00742235|12186903|FG000|Overall Study|Lost to Follow-up|0
7750492|NCT00742235|12186904|FG001|Overall Study|Lost to Follow-up|31
7750493|NCT00742274|12186912|FG000|Overall Study|Death|1
7750494|NCT00742274|12186913|FG001|Overall Study|Death|0
7750495|NCT00742274|12186912|FG000|Overall Study|Withdrawal by Subject|1
7750496|NCT00742274|12186913|FG001|Overall Study|Withdrawal by Subject|2
7750497|NCT00742274|12186912|FG000|Overall Study|Removed for medical reasons|1
7750498|NCT00742274|12186913|FG001|Overall Study|Removed for medical reasons|1
7750499|NCT00742326|12186930|FG000|Overall Study|Physician Decision|0
7750500|NCT00742326|12186931|FG001|Overall Study|Physician Decision|1
7750501|NCT00742391|12186939|FG000|Overall Study|Adverse Event|2
7750502|NCT00742391|12186940|FG001|Overall Study|Adverse Event|1
7750503|NCT00742391|12186939|FG000|Overall Study|Lost to Follow-up|1
7750504|NCT00742391|12186940|FG001|Overall Study|Lost to Follow-up|0
7750505|NCT00742391|12186939|FG000|Overall Study|Protocol Violation|1
7750506|NCT00742391|12186940|FG001|Overall Study|Protocol Violation|0
7750507|NCT00742417|12186948|FG000|Randomized|Withdrawal by legal representative|0
7750508|NCT00742417|12186949|FG001|Randomized|Withdrawal by legal representative|1
7750509|NCT00742417|12186948|FG000|Randomized|Withdrawal by Subject|1
7750510|NCT00742417|12186949|FG001|Randomized|Withdrawal by Subject|0
7750511|NCT00742417|12186948|FG000|Randomized|Physician Decision|1
7750512|NCT00742417|12186949|FG001|Randomized|Physician Decision|0
7750513|NCT00742417|12186948|FG000|Intensive Period|Withdrawal by Subject|1
7750514|NCT00742417|12186949|FG001|Intensive Period|Withdrawal by Subject|1
7750515|NCT00742417|12186948|FG000|Intensive Period|Adverse Event|2
7750516|NCT00742417|12186949|FG001|Intensive Period|Adverse Event|0
7750517|NCT00742508|12186968|FG000|8-Week Primary Evaluation Period|Adverse Event|2
7750518|NCT00742508|12186969|FG001|8-Week Primary Evaluation Period|Adverse Event|4
7750519|NCT00742508|12186968|FG000|8-Week Primary Evaluation Period|Protocol Violation|1
7750520|NCT00742508|12186969|FG001|8-Week Primary Evaluation Period|Protocol Violation|0
7750521|NCT00742508|12186968|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
7750522|NCT00742508|12186969|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
7750523|NCT00742508|12186968|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0
7750524|NCT00742508|12186969|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2
7750525|NCT00742508|12186968|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
7750526|NCT00742508|12186969|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
7750527|NCT00742560|12186980|FG000|Overall Study|Adverse Event|0
7750528|NCT00742560|12186981|FG001|Overall Study|Adverse Event|0
7750529|NCT00742560|12186982|FG002|Overall Study|Adverse Event|1
7750530|NCT00742560|12186983|FG003|Overall Study|Adverse Event|1
7750531|NCT00742560|12186984|FG004|Overall Study|Adverse Event|1
7750532|NCT00742560|12186980|FG000|Overall Study|Death|0
7750533|NCT00742560|12186981|FG001|Overall Study|Death|2
7750534|NCT00742560|12186982|FG002|Overall Study|Death|0
7750535|NCT00742560|12186983|FG003|Overall Study|Death|2
7750536|NCT00742560|12186984|FG004|Overall Study|Death|3
7750537|NCT00742560|12186980|FG000|Overall Study|Subject's Decision|1
7750538|NCT00742560|12186981|FG001|Overall Study|Subject's Decision|0
7750539|NCT00742560|12186982|FG002|Overall Study|Subject's Decision|2
7750540|NCT00742560|12186983|FG003|Overall Study|Subject's Decision|3
7750541|NCT00742560|12186984|FG004|Overall Study|Subject's Decision|3
7750542|NCT00742560|12186980|FG000|Overall Study|Investigator's Decision|0
7750543|NCT00742560|12186981|FG001|Overall Study|Investigator's Decision|0
7750544|NCT00742560|12186982|FG002|Overall Study|Investigator's Decision|4
7750545|NCT00742560|12186983|FG003|Overall Study|Investigator's Decision|1
7750546|NCT00742560|12186984|FG004|Overall Study|Investigator's Decision|0
7750547|NCT00742560|12186980|FG000|Overall Study|Disease Progression|1
7750548|NCT00742560|12186981|FG001|Overall Study|Disease Progression|0
7750549|NCT00742560|12186982|FG002|Overall Study|Disease Progression|5
7750550|NCT00742560|12186983|FG003|Overall Study|Disease Progression|17
7750551|NCT00742560|12186984|FG004|Overall Study|Disease Progression|16
7750552|NCT00742560|12186980|FG000|Overall Study|New Multiple Myeloma Therapy|1
7750553|NCT00742560|12186981|FG001|Overall Study|New Multiple Myeloma Therapy|0
7750554|NCT00742560|12186982|FG002|Overall Study|New Multiple Myeloma Therapy|2
7750555|NCT00742560|12186983|FG003|Overall Study|New Multiple Myeloma Therapy|3
7750556|NCT00742560|12186984|FG004|Overall Study|New Multiple Myeloma Therapy|4
7750557|NCT00742560|12186980|FG000|Overall Study|Other|0
7750558|NCT00742560|12186981|FG001|Overall Study|Other|1
7750559|NCT00742560|12186982|FG002|Overall Study|Other|8
7750560|NCT00742560|12186983|FG003|Overall Study|Other|9
7750561|NCT00742560|12186984|FG004|Overall Study|Other|9
7750562|NCT00742560|12186980|FG000|Overall Study|MIssing|0
7750563|NCT00742560|12186981|FG001|Overall Study|MIssing|0
7750564|NCT00742560|12186982|FG002|Overall Study|MIssing|0
7750565|NCT00742560|12186983|FG003|Overall Study|MIssing|0
7750566|NCT00742560|12186984|FG004|Overall Study|MIssing|1
7750567|NCT00742625|12187024|FG000|Remission Induction|Progression|6
7750568|NCT00742625|12187024|FG000|Remission Induction|Failed induction|8
7750569|NCT00742625|12187024|FG000|Remission Induction|Adverse Event|3
7750570|NCT00742625|12187024|FG000|Remission Induction|Death|10
7750571|NCT00742625|12187024|FG000|Remission Induction|Refusal|5
7750572|NCT00742625|12187024|FG000|Remission Induction|Non protocol treatment|17
7750573|NCT00742625|12187024|FG000|Remission Induction|Other, not specified|5
7750574|NCT00742625|12187024|FG000|Consolidation|Progression|5
7750575|NCT00742625|12187024|FG000|Consolidation|Adverse Event|1
7750576|NCT00742625|12187024|FG000|Consolidation|Death|1
7750577|NCT00742625|12187024|FG000|Consolidation|Refused|1
7750578|NCT00742625|12187024|FG000|Consolidation|Non protocol therapy|13
7750579|NCT00742781|12187031|FG000|Overall Study|Withdrawal by Subject|3
7750580|NCT00742859|12187040|FG000|Overall Study|Adverse Event|5
7750581|NCT00742859|12187041|FG001|Overall Study|Adverse Event|6
7750582|NCT00742859|12187042|FG002|Overall Study|Adverse Event|3
7750583|NCT00742859|12187043|FG003|Overall Study|Adverse Event|1
7750584|NCT00742859|12187040|FG000|Overall Study|Death|1
7750585|NCT00742859|12187041|FG001|Overall Study|Death|0
7750586|NCT00742859|12187042|FG002|Overall Study|Death|0
7750587|NCT00742859|12187043|FG003|Overall Study|Death|1
7750588|NCT00742859|12187040|FG000|Overall Study|Physician Decision|1
7750589|NCT00742859|12187041|FG001|Overall Study|Physician Decision|2
7750590|NCT00742859|12187042|FG002|Overall Study|Physician Decision|0
7750591|NCT00742859|12187043|FG003|Overall Study|Physician Decision|0
7750592|NCT00742859|12187040|FG000|Overall Study|Withdrawal by Subject|4
7750593|NCT00742859|12187041|FG001|Overall Study|Withdrawal by Subject|2
7750594|NCT00742859|12187042|FG002|Overall Study|Withdrawal by Subject|4
7750595|NCT00742859|12187043|FG003|Overall Study|Withdrawal by Subject|1
7750596|NCT00742859|12187040|FG000|Overall Study|Endpoint|0
7750597|NCT00742859|12187041|FG001|Overall Study|Endpoint|1
7750598|NCT00742859|12187042|FG002|Overall Study|Endpoint|1
7750599|NCT00742859|12187043|FG003|Overall Study|Endpoint|2
7750600|NCT00742859|12187040|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0
7750601|NCT00742859|12187041|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1
7750602|NCT00742859|12187042|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1
7750603|NCT00742859|12187043|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0
7750604|NCT00742859|12187040|FG000|Overall Study|Sponsor req visit schedule noncompliance|0
7750605|NCT00742859|12187041|FG001|Overall Study|Sponsor req visit schedule noncompliance|0
7750606|NCT00742859|12187042|FG002|Overall Study|Sponsor req visit schedule noncompliance|0
7750607|NCT00742859|12187043|FG003|Overall Study|Sponsor req visit schedule noncompliance|1
7750608|NCT00742859|12187040|FG000|Overall Study|Sponsor request patient out of town|0
7750609|NCT00742859|12187041|FG001|Overall Study|Sponsor request patient out of town|0
7750610|NCT00742859|12187042|FG002|Overall Study|Sponsor request patient out of town|1
7750611|NCT00742859|12187043|FG003|Overall Study|Sponsor request patient out of town|1
7750612|NCT00742859|12187040|FG000|Overall Study|Site error|0
7750613|NCT00742859|12187041|FG001|Overall Study|Site error|0
7750614|NCT00742859|12187042|FG002|Overall Study|Site error|1
7750615|NCT00742859|12187043|FG003|Overall Study|Site error|1
7750616|NCT00742885|12187064|FG000|Overall Study|Lost to Follow-up|1
7750617|NCT00742885|12187065|FG001|Overall Study|Lost to Follow-up|0
7750618|NCT00742924|12187078|FG000|Overall Study|Adverse Event|0
7750619|NCT00742924|12187079|FG001|Overall Study|Adverse Event|0
7750620|NCT00742924|12187080|FG002|Overall Study|Adverse Event|1
7750621|NCT00742924|12187081|FG003|Overall Study|Adverse Event|1
7750622|NCT00742924|12187078|FG000|Overall Study|Lack of Efficacy|5
7750623|NCT00742924|12187079|FG001|Overall Study|Lack of Efficacy|1
7750624|NCT00742924|12187080|FG002|Overall Study|Lack of Efficacy|2
7750625|NCT00742924|12187081|FG003|Overall Study|Lack of Efficacy|4
7750626|NCT00742924|12187078|FG000|Overall Study|Physician Decision|0
7750627|NCT00742924|12187079|FG001|Overall Study|Physician Decision|0
7750628|NCT00742924|12187080|FG002|Overall Study|Physician Decision|0
7750629|NCT00742924|12187081|FG003|Overall Study|Physician Decision|1
7750630|NCT00742924|12187078|FG000|Overall Study|Withdrawal by Subject|0
7750631|NCT00742924|12187079|FG001|Overall Study|Withdrawal by Subject|1
7750632|NCT00742924|12187080|FG002|Overall Study|Withdrawal by Subject|1
7750633|NCT00742924|12187081|FG003|Overall Study|Withdrawal by Subject|0
7750634|NCT00743106|12187106|FG000|Overall Study|Met intraoperative exclusion criterion|8
7750635|NCT00743106|12187107|FG001|Overall Study|Met intraoperative exclusion criterion|5
7750636|NCT00743119|12187113|FG000|Overall Study|unreliable|3
7750637|NCT00743119|12187113|FG000|Overall Study|Withdrawal by Subject|1
7750638|NCT00743145|12187125|FG000|Overall Study|Withdrawal by Subject|1
7750639|NCT00743145|12187125|FG000|Overall Study|Adverse Event|2
7750640|NCT00743145|12187125|FG000|Overall Study|Pregnancy|1
7750641|NCT00743249|12187141|FG000|Overall Study|Adverse Event|0
7750642|NCT00743249|12187142|FG001|Overall Study|Adverse Event|4
7750643|NCT00743249|12187141|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0
7750644|NCT00743249|12187142|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1
7750645|NCT00743249|12187141|FG000|Overall Study|Unsuccessful insertion of stent|2
7750646|NCT00743249|12187142|FG001|Overall Study|Unsuccessful insertion of stent|1
7750647|NCT00743275|12187154|FG000|Overall Study|Protocol Violation|0
7750648|NCT00743275|12187155|FG001|Overall Study|Protocol Violation|1
7750649|NCT00743288|12187161|FG000|Overall Study|Adverse Event|1
7750650|NCT00743288|12187162|FG001|Overall Study|Adverse Event|1
7750651|NCT00743288|12187163|FG002|Overall Study|Adverse Event|2
7750652|NCT00743288|12187164|FG003|Overall Study|Adverse Event|2
7750653|NCT00743288|12187165|FG004|Overall Study|Adverse Event|1
7750654|NCT00743288|12187166|FG005|Overall Study|Adverse Event|1
7750655|NCT00743288|12187167|FG006|Overall Study|Adverse Event|2
7750656|NCT00743288|12187161|FG000|Overall Study|Withdrawal by Subject|0
7750657|NCT00743288|12187162|FG001|Overall Study|Withdrawal by Subject|0
7750658|NCT00743288|12187163|FG002|Overall Study|Withdrawal by Subject|1
7750659|NCT00743288|12187164|FG003|Overall Study|Withdrawal by Subject|0
7750660|NCT00743288|12187165|FG004|Overall Study|Withdrawal by Subject|0
7750661|NCT00743288|12187166|FG005|Overall Study|Withdrawal by Subject|1
7750662|NCT00743288|12187167|FG006|Overall Study|Withdrawal by Subject|1
7750663|NCT00743288|12187161|FG000|Overall Study|Progressive disease (PD)|2
7750664|NCT00743288|12187162|FG001|Overall Study|Progressive disease (PD)|0
7750665|NCT00743288|12187163|FG002|Overall Study|Progressive disease (PD)|1
7750666|NCT00743288|12187164|FG003|Overall Study|Progressive disease (PD)|4
7750667|NCT00743288|12187165|FG004|Overall Study|Progressive disease (PD)|5
7750668|NCT00743288|12187166|FG005|Overall Study|Progressive disease (PD)|3
7750669|NCT00743288|12187167|FG006|Overall Study|Progressive disease (PD)|6
7750670|NCT00743288|12187161|FG000|Overall Study|Worsening of condition (Not PD)|0
7750671|NCT00743288|12187162|FG001|Overall Study|Worsening of condition (Not PD)|2
7750672|NCT00743288|12187163|FG002|Overall Study|Worsening of condition (Not PD)|1
7750673|NCT00743288|12187164|FG003|Overall Study|Worsening of condition (Not PD)|1
7750674|NCT00743288|12187165|FG004|Overall Study|Worsening of condition (Not PD)|0
7750675|NCT00743288|12187166|FG005|Overall Study|Worsening of condition (Not PD)|0
7750676|NCT00743288|12187167|FG006|Overall Study|Worsening of condition (Not PD)|0
7750677|NCT00743340|12187178|FG000|Overall Study|Study medication non-compliance|1
7750678|NCT00743340|12187178|FG000|Overall Study|Lost to Follow-up|1
7750679|NCT00743340|12187178|FG000|Overall Study|Withdrawal from the Study|5
7750680|NCT00743340|12187178|FG000|Overall Study|Protocol Violation|1
7750681|NCT00743340|12187178|FG000|Overall Study|Virologic failure|8
7750682|NCT00743340|12187178|FG000|Overall Study|Pregnancy|1
7750683|NCT00743340|12187178|FG000|Overall Study|Rolled over to other Gilead Study|23
7750684|NCT00743340|12187178|FG000|Overall Study|Participant Relocated|1
7750685|NCT00743366|12187182|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3
7750686|NCT00743366|12187183|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3
7750687|NCT00743431|12187189|FG000|Overall Study|Toxicity|6
7750688|NCT00743431|12187189|FG000|Overall Study|Tumor progression|56
7750689|NCT00743431|12187189|FG000|Overall Study|Withdrawal by Subject|13
7750690|NCT00743431|12187189|FG000|Overall Study|Death|9
7750691|NCT00743431|12187189|FG000|Overall Study|Reason for discontinuation not specified|29
7750692|NCT00743431|12187189|FG000|Overall Study|No documentation available|13
7750693|NCT00743444|12187193|FG000|First Intervention|Catheter placement problems|0
7750694|NCT00743444|12187194|FG001|First Intervention|Catheter placement problems|1
7750695|NCT00743444|12187193|FG000|Washout Period|Adverse Event|0
7750696|NCT00743444|12187194|FG001|Washout Period|Adverse Event|1
7750697|NCT00743483|12187200|FG000|Baseline Period|Physician Decision|1
7750698|NCT00743483|12187200|FG000|Treatment Period|Adverse Event|1
7750699|NCT00743509|12187204|FG000|Overall Study|Withdrawal by Subject|2
7750700|NCT00743652|12187217|FG000|Overall Study|Parent/Legal Guardian Request|3
7750701|NCT00743652|12187218|FG001|Overall Study|Parent/Legal Guardian Request|2
7750702|NCT00743652|12187219|FG002|Overall Study|Parent/Legal Guardian Request|2
7750703|NCT00743652|12187220|FG003|Overall Study|Parent/Legal Guardian Request|2
7750704|NCT00743652|12187221|FG004|Overall Study|Parent/Legal Guardian Request|0
7750705|NCT00743652|12187217|FG000|Overall Study|Adverse Event|3
7750706|NCT00743652|12187218|FG001|Overall Study|Adverse Event|0
7750707|NCT00743652|12187219|FG002|Overall Study|Adverse Event|0
7750708|NCT00743652|12187220|FG003|Overall Study|Adverse Event|0
7750709|NCT00743652|12187221|FG004|Overall Study|Adverse Event|0
7750710|NCT00743652|12187217|FG000|Overall Study|Death|2
7750711|NCT00743652|12187218|FG001|Overall Study|Death|0
7750712|NCT00743652|12187219|FG002|Overall Study|Death|0
7750713|NCT00743652|12187220|FG003|Overall Study|Death|0
7750714|NCT00743652|12187221|FG004|Overall Study|Death|0
7750715|NCT00743652|12187217|FG000|Overall Study|Investigator Request|0
7750716|NCT00743652|12187218|FG001|Overall Study|Investigator Request|0
7750717|NCT00743652|12187219|FG002|Overall Study|Investigator Request|0
7750718|NCT00743652|12187220|FG003|Overall Study|Investigator Request|2
7750719|NCT00743652|12187221|FG004|Overall Study|Investigator Request|0
7750720|NCT00743652|12187217|FG000|Overall Study|Other|1
7750721|NCT00743652|12187218|FG001|Overall Study|Other|1
7750722|NCT00743652|12187219|FG002|Overall Study|Other|0
7750723|NCT00743652|12187220|FG003|Overall Study|Other|0
7750724|NCT00743652|12187221|FG004|Overall Study|Other|0
7750725|NCT00743652|12187217|FG000|Overall Study|Lost to Follow-up|1
7750726|NCT00743652|12187218|FG001|Overall Study|Lost to Follow-up|0
7750727|NCT00743652|12187219|FG002|Overall Study|Lost to Follow-up|0
7750728|NCT00743652|12187220|FG003|Overall Study|Lost to Follow-up|0
7750729|NCT00743652|12187221|FG004|Overall Study|Lost to Follow-up|0
7750730|NCT00744042|12187263|FG000|Overall Study|Withdrawal by Subject|1
7750731|NCT00744055|12187275|FG000|Overall Study|Withdrawal by Subject|6
7750732|NCT00744055|12187276|FG001|Overall Study|Withdrawal by Subject|9
7750733|NCT00744055|12187275|FG000|Overall Study|Lack of Efficacy|0
7750734|NCT00744055|12187276|FG001|Overall Study|Lack of Efficacy|1
7750735|NCT00744055|12187275|FG000|Overall Study|Physician Decision|0
7750736|NCT00744055|12187276|FG001|Overall Study|Physician Decision|2
7750737|NCT00744055|12187275|FG000|Overall Study|Protocol Violation|1
7750738|NCT00744055|12187276|FG001|Overall Study|Protocol Violation|1
7750739|NCT00744055|12187275|FG000|Overall Study|Lost to Follow-up|0
7750740|NCT00744055|12187276|FG001|Overall Study|Lost to Follow-up|1
7750741|NCT00744237|12187301|FG000|Overall Study|Lack of Efficacy|1
7750742|NCT00744237|12187302|FG001|Overall Study|Lack of Efficacy|1
7750743|NCT00744237|12187303|FG002|Overall Study|Lack of Efficacy|0
7750744|NCT00744237|12187301|FG000|Overall Study|Withdrawal by Subject|9
7750745|NCT00744237|12187302|FG001|Overall Study|Withdrawal by Subject|5
7750746|NCT00744237|12187303|FG002|Overall Study|Withdrawal by Subject|3
7750747|NCT00744237|12187301|FG000|Overall Study|Lost to Follow-up|1
7750748|NCT00744237|12187302|FG001|Overall Study|Lost to Follow-up|1
7750749|NCT00744237|12187303|FG002|Overall Study|Lost to Follow-up|1
7750750|NCT00744237|12187301|FG000|Overall Study|Protocol Violation|3
7750751|NCT00744237|12187302|FG001|Overall Study|Protocol Violation|4
7750752|NCT00744237|12187303|FG002|Overall Study|Protocol Violation|3
7750753|NCT00744237|12187301|FG000|Overall Study|Inclusion/Exclusion criteria not met|1
7750754|NCT00744237|12187302|FG001|Overall Study|Inclusion/Exclusion criteria not met|0
7750755|NCT00744237|12187303|FG002|Overall Study|Inclusion/Exclusion criteria not met|0
7750756|NCT00744237|12187301|FG000|Overall Study|Dosing Error|1
7750757|NCT00744237|12187302|FG001|Overall Study|Dosing Error|0
7750758|NCT00744237|12187303|FG002|Overall Study|Dosing Error|1
7750759|NCT00744237|12187301|FG000|Overall Study|Study Drug Error|1
7750760|NCT00744237|12187302|FG001|Overall Study|Study Drug Error|0
7750761|NCT00744237|12187303|FG002|Overall Study|Study Drug Error|0
7750762|NCT00744237|12187301|FG000|Overall Study|Prohibited Concomitant Medication|0
7750763|NCT00744237|12187302|FG001|Overall Study|Prohibited Concomitant Medication|0
7750764|NCT00744237|12187303|FG002|Overall Study|Prohibited Concomitant Medication|1
7750765|NCT00744237|12187301|FG000|Overall Study|Poor Compliance|0
7750766|NCT00744237|12187302|FG001|Overall Study|Poor Compliance|2
7750767|NCT00744237|12187303|FG002|Overall Study|Poor Compliance|0
7750768|NCT00744237|12187301|FG000|Overall Study|Administrative. Site Closed|1
7750769|NCT00744237|12187302|FG001|Overall Study|Administrative. Site Closed|1
7750770|NCT00744237|12187303|FG002|Overall Study|Administrative. Site Closed|1
7750771|NCT00744237|12187301|FG000|Overall Study|Adverse Event|9
7750772|NCT00744237|12187302|FG001|Overall Study|Adverse Event|13
7750773|NCT00744237|12187303|FG002|Overall Study|Adverse Event|5
7750774|NCT00744263|12187313|FG000|Overall Study|Death|3006
7750775|NCT00744263|12187314|FG001|Overall Study|Death|3005
7750776|NCT00744263|12187313|FG000|Overall Study|Lost to Follow-up|2038
7750777|NCT00744263|12187314|FG001|Overall Study|Lost to Follow-up|2135
7750778|NCT00744263|12187313|FG000|Overall Study|Withdrawal by Subject|166
7750779|NCT00744263|12187314|FG001|Overall Study|Withdrawal by Subject|150
7750780|NCT00744263|12187313|FG000|Overall Study|Physician Decision|20
7750781|NCT00744263|12187314|FG001|Overall Study|Physician Decision|23
7750782|NCT00744263|12187313|FG000|Overall Study|Protocol Violation|3
7750783|NCT00744263|12187314|FG001|Overall Study|Protocol Violation|5
7750784|NCT00744263|12187313|FG000|Overall Study|Adverse Event|1
7750785|NCT00744263|12187314|FG001|Overall Study|Adverse Event|0
7750786|NCT00744263|12187313|FG000|Overall Study|Other|2
7750787|NCT00744263|12187314|FG001|Overall Study|Other|2
7750788|NCT00744328|12187325|FG000|Overall Study|Lost to Follow-up|2
7750789|NCT00744328|12187326|FG001|Overall Study|Lost to Follow-up|5
7750790|NCT00744328|12187327|FG002|Overall Study|Lost to Follow-up|3
7750791|NCT00744328|12187325|FG000|Overall Study|Withdrawal by Subject|5
7750792|NCT00744328|12187326|FG001|Overall Study|Withdrawal by Subject|3
7750793|NCT00744328|12187327|FG002|Overall Study|Withdrawal by Subject|4
7750794|NCT00744328|12187325|FG000|Overall Study|Found ineligible after randomization|0
7750795|NCT00744328|12187326|FG001|Overall Study|Found ineligible after randomization|0
7750796|NCT00744328|12187327|FG002|Overall Study|Found ineligible after randomization|1
7750797|NCT00744471|12187349|FG000|Overall Study|Randomized but not treated|1
7750798|NCT00744471|12187350|FG001|Overall Study|Randomized but not treated|1
7750799|NCT00744471|12187351|FG002|Overall Study|Randomized but not treated|4
7750800|NCT00744471|12187352|FG003|Overall Study|Randomized but not treated|0
7750801|NCT00744471|12187349|FG000|Overall Study|Death|0
7750802|NCT00744471|12187350|FG001|Overall Study|Death|0
7750803|NCT00744471|12187351|FG002|Overall Study|Death|0
7750804|NCT00744471|12187352|FG003|Overall Study|Death|1
7750805|NCT00744471|12187349|FG000|Overall Study|Adverse Event|6
7750806|NCT00744471|12187350|FG001|Overall Study|Adverse Event|7
7750807|NCT00744471|12187351|FG002|Overall Study|Adverse Event|5
7750808|NCT00744471|12187352|FG003|Overall Study|Adverse Event|9
7750809|NCT00744471|12187349|FG000|Overall Study|Withdrawal by Subject|9
7750810|NCT00744471|12187350|FG001|Overall Study|Withdrawal by Subject|9
7750811|NCT00744471|12187351|FG002|Overall Study|Withdrawal by Subject|15
7750812|NCT00744471|12187352|FG003|Overall Study|Withdrawal by Subject|12
7750813|NCT00744471|12187349|FG000|Overall Study|Protocol Violation|1
7750814|NCT00744471|12187350|FG001|Overall Study|Protocol Violation|4
7750815|NCT00744471|12187351|FG002|Overall Study|Protocol Violation|1
7750816|NCT00744471|12187352|FG003|Overall Study|Protocol Violation|2
7750817|NCT00744471|12187349|FG000|Overall Study|Entered extension study|41
7750818|NCT00744471|12187350|FG001|Overall Study|Entered extension study|84
7750819|NCT00744471|12187351|FG002|Overall Study|Entered extension study|100
7750820|NCT00744471|12187352|FG003|Overall Study|Entered extension study|91
7750821|NCT00744471|12187349|FG000|Overall Study|Other|2
7750822|NCT00744471|12187350|FG001|Overall Study|Other|3
7750823|NCT00744471|12187351|FG002|Overall Study|Other|6
7750824|NCT00744471|12187352|FG003|Overall Study|Other|2
7750825|NCT00744471|12187349|FG000|Overall Study|Lack of Efficacy|83
7750826|NCT00744471|12187350|FG001|Overall Study|Lack of Efficacy|37
7750827|NCT00744471|12187351|FG002|Overall Study|Lack of Efficacy|19
7750828|NCT00744471|12187352|FG003|Overall Study|Lack of Efficacy|31
7750829|NCT00744471|12187349|FG000|Overall Study|Lost to Follow-up|0
7750830|NCT00744471|12187350|FG001|Overall Study|Lost to Follow-up|0
7750831|NCT00744471|12187351|FG002|Overall Study|Lost to Follow-up|2
7750832|NCT00744471|12187352|FG003|Overall Study|Lost to Follow-up|0
7750833|NCT00744497|12187364|FG000|Overall Study|Withdrawal by Subject|21
7750834|NCT00744497|12187365|FG001|Overall Study|Withdrawal by Subject|18
7750835|NCT00744497|12187364|FG000|Overall Study|Death|11
7750836|NCT00744497|12187365|FG001|Overall Study|Death|9
7750837|NCT00744497|12187364|FG000|Overall Study|Lost to Follow-up|4
7750838|NCT00744497|12187365|FG001|Overall Study|Lost to Follow-up|2
7750839|NCT00744497|12187364|FG000|Overall Study|Poor compliance/noncompliance|9
7750840|NCT00744497|12187365|FG001|Overall Study|Poor compliance/noncompliance|5
7750841|NCT00744497|12187364|FG000|Overall Study|No longer meets study criteria|7
7750842|NCT00744497|12187365|FG001|Overall Study|No longer meets study criteria|3
7750843|NCT00744497|12187364|FG000|Overall Study|Administrative Reason By Sponsor|25
7750844|NCT00744497|12187365|FG001|Overall Study|Administrative Reason By Sponsor|8
7750845|NCT00744497|12187364|FG000|Overall Study|Disease progression|312
7750846|NCT00744497|12187365|FG001|Overall Study|Disease progression|219
7750847|NCT00744497|12187364|FG000|Overall Study|Study drug toxicity|68
7750848|NCT00744497|12187365|FG001|Overall Study|Study drug toxicity|141
7750849|NCT00744497|12187364|FG000|Overall Study|Adverse event unrelated to study drug|78
7750850|NCT00744497|12187365|FG001|Overall Study|Adverse event unrelated to study drug|122
7750851|NCT00744497|12187364|FG000|Overall Study|Patient requested to stop study drug|65
7750852|NCT00744497|12187365|FG001|Overall Study|Patient requested to stop study drug|80
7750853|NCT00744497|12187364|FG000|Overall Study|Maximum clinical benefit|141
7750854|NCT00744497|12187365|FG001|Overall Study|Maximum clinical benefit|142
7750855|NCT00744497|12187364|FG000|Overall Study|Not defined|19
7750856|NCT00744497|12187365|FG001|Overall Study|Not defined|13
7750857|NCT00744523|12187373|FG000|30 Days After the Procedure|Insufficient follow-up|0
7750858|NCT00744523|12187374|FG001|30 Days After the Procedure|Insufficient follow-up|5
7750859|NCT00744627|12187384|FG000|Overall Study|Adverse Event|6
7750860|NCT00744627|12187385|FG001|Overall Study|Adverse Event|9
7750861|NCT00744627|12187384|FG000|Overall Study|Lack of Efficacy|7
7750862|NCT00744627|12187385|FG001|Overall Study|Lack of Efficacy|3
7750863|NCT00744627|12187384|FG000|Overall Study|Noncompliance|0
7750864|NCT00744627|12187385|FG001|Overall Study|Noncompliance|1
7750865|NCT00744627|12187384|FG000|Overall Study|Protocol Deviations|0
7750866|NCT00744627|12187385|FG001|Overall Study|Protocol Deviations|2
7750867|NCT00744627|12187384|FG000|Overall Study|Voluntary Withdrawal|9
7750868|NCT00744627|12187385|FG001|Overall Study|Voluntary Withdrawal|6
7750869|NCT00744627|12187384|FG000|Overall Study|Lost to Follow-up|2
7750870|NCT00744627|12187385|FG001|Overall Study|Lost to Follow-up|1
7750871|NCT00744627|12187384|FG000|Overall Study|Other|1
7750872|NCT00744627|12187385|FG001|Overall Study|Other|0
7750873|NCT00744653|12187391|FG000|Overall Study|antineoplastic treatment|11
7750874|NCT00744653|12187391|FG000|Overall Study|Death|1
7750875|NCT00744653|12187391|FG000|Overall Study|Lost to Follow-up|1
7750876|NCT00744653|12187391|FG000|Overall Study|Physician Decision|3
7750877|NCT00744757|12187400|FG000|Overall Study|Objective disease progression|7
7750878|NCT00744757|12187400|FG000|Overall Study|Physician Decision|5
7750879|NCT00744757|12187400|FG000|Overall Study|Withdrawal by Subject|1
7750880|NCT00744757|12187400|FG000|Overall Study|Death|6
7750881|NCT00744757|12187400|FG000|Overall Study|Adverse Event|2
7750882|NCT00744796|12187404|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12
7750883|NCT00744861|12187421|FG000|Feasibility Stage 1|Withdrawal by Subject|1
7750884|NCT00744861|12187422|FG001|Feasibility Stage 1|Withdrawal by Subject|1
7750885|NCT00744861|12187423|FG002|Feasibility Stage 1|Withdrawal by Subject|0
7750886|NCT00744861|12187424|FG003|Feasibility Stage 1|Withdrawal by Subject|0
7750887|NCT00744861|12187421|FG000|Feasibility Stage 1|Pregnancy|0
7750888|NCT00744861|12187422|FG001|Feasibility Stage 1|Pregnancy|1
7750889|NCT00744861|12187423|FG002|Feasibility Stage 1|Pregnancy|0
7750890|NCT00744861|12187424|FG003|Feasibility Stage 1|Pregnancy|0
7750891|NCT00744861|12187421|FG000|Pivotal Stage 2|Adverse Event|0
7750892|NCT00744861|12187422|FG001|Pivotal Stage 2|Adverse Event|0
7750893|NCT00744861|12187423|FG002|Pivotal Stage 2|Adverse Event|6
7750894|NCT00744861|12187424|FG003|Pivotal Stage 2|Adverse Event|11
7750895|NCT00744861|12187421|FG000|Pivotal Stage 2|Death|0
7750896|NCT00744861|12187422|FG001|Pivotal Stage 2|Death|0
7750897|NCT00744861|12187423|FG002|Pivotal Stage 2|Death|0
7750898|NCT00744861|12187424|FG003|Pivotal Stage 2|Death|1
7750899|NCT00744861|12187421|FG000|Pivotal Stage 2|Lost to Follow-up|0
7750900|NCT00744861|12187422|FG001|Pivotal Stage 2|Lost to Follow-up|0
7750901|NCT00744861|12187423|FG002|Pivotal Stage 2|Lost to Follow-up|13
7750902|NCT00744861|12187424|FG003|Pivotal Stage 2|Lost to Follow-up|14
7750903|NCT00744861|12187421|FG000|Pivotal Stage 2|Physician Decision|0
7750904|NCT00744861|12187422|FG001|Pivotal Stage 2|Physician Decision|0
7750905|NCT00744861|12187423|FG002|Pivotal Stage 2|Physician Decision|3
7750906|NCT00744861|12187424|FG003|Pivotal Stage 2|Physician Decision|1
7750907|NCT00744861|12187421|FG000|Pivotal Stage 2|Protocol Violation|0
7750908|NCT00744861|12187422|FG001|Pivotal Stage 2|Protocol Violation|0
7750909|NCT00744861|12187423|FG002|Pivotal Stage 2|Protocol Violation|0
7750910|NCT00744861|12187424|FG003|Pivotal Stage 2|Protocol Violation|1
7750911|NCT00744861|12187421|FG000|Pivotal Stage 2|Withdrawal by Subject|0
7750912|NCT00744861|12187422|FG001|Pivotal Stage 2|Withdrawal by Subject|0
7750913|NCT00744861|12187423|FG002|Pivotal Stage 2|Withdrawal by Subject|20
7750914|NCT00744861|12187424|FG003|Pivotal Stage 2|Withdrawal by Subject|14
7750915|NCT00744861|12187421|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0
7750916|NCT00744861|12187422|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0
7750917|NCT00744861|12187423|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60
7750918|NCT00744861|12187424|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63
7750919|NCT00744874|12187432|FG000|Overall Study|Lost to Follow-up|1
7750920|NCT00744874|12187432|FG000|Overall Study|Withdrawal by Subject|1
7750921|NCT00744874|12187432|FG000|Overall Study|Study Device not available at procedure|1
7750922|NCT00744874|12187432|FG000|Overall Study|Unable to accomodate schedule|1
7750923|NCT00744939|12187447|FG000|Overall Study|Withdrawal by Subject|9
7750924|NCT00744939|12187447|FG000|Overall Study|Protocol Violation|13
7750925|NCT00744939|12187447|FG000|Overall Study|Death|24
7750926|NCT00744939|12187447|FG000|Overall Study|distance|4
7750927|NCT00744939|12187447|FG000|Overall Study|Lost to Follow-up|12
7750928|NCT00744939|12187447|FG000|Overall Study|Medical history exclusionary|1
7750929|NCT00744939|12187447|FG000|Overall Study|Did not receive Magnevist|7
7750930|NCT00744939|12187447|FG000|Overall Study|Failed inclusion/exclusion criteria|19
7750931|NCT00744939|12187447|FG000|Overall Study|coma|1
7750932|NCT00744939|12187447|FG000|Overall Study|incorrect race|1
7750933|NCT00744978|12187470|FG000|Period 1|Lost to Follow-up|1
7750934|NCT00744978|12187471|FG001|Period 1|Lost to Follow-up|0
7750935|NCT00744978|12187470|FG000|Period 1|Withdrawal by Subject|0
7750936|NCT00744978|12187471|FG001|Period 1|Withdrawal by Subject|2
7750937|NCT00744978|12187470|FG000|Period 1|Other|0
7750938|NCT00744978|12187471|FG001|Period 1|Other|2
7750939|NCT00744978|12187470|FG000|Period 1|Adverse Event|4
7750940|NCT00744978|12187471|FG001|Period 1|Adverse Event|0
7750941|NCT00744978|12187470|FG000|Period 1|Randomized but not Treated|1
7750942|NCT00744978|12187471|FG001|Period 1|Randomized but not Treated|1
7750943|NCT00744978|12187470|FG000|Period 2|Adverse Event|0
7750944|NCT00744978|12187471|FG001|Period 2|Adverse Event|1
7750945|NCT00744991|12187477|FG000|Overall Study|Progressive Disease|11
7750946|NCT00744991|12187477|FG000|Overall Study|Withdrawal by Subject|8
7750947|NCT00744991|12187477|FG000|Overall Study|Physician Decision|3
7750948|NCT00744991|12187477|FG000|Overall Study|Adverse Event|2
7750949|NCT00744991|12187477|FG000|Overall Study|Protocol Entry Criteria Unmet|1
7750950|NCT00745095|12187490|FG000|Overall Study|Declined to participate|1
7750951|NCT00745095|12187491|FG001|Overall Study|Declined to participate|0
7750952|NCT00745095|12187492|FG002|Overall Study|Declined to participate|0
7750953|NCT00745095|12187493|FG003|Overall Study|Declined to participate|0
7750954|NCT00745095|12187494|FG004|Overall Study|Declined to participate|92
7750955|NCT00745095|12187495|FG005|Overall Study|Declined to participate|95
7750956|NCT00745095|12187490|FG000|Overall Study|Ineligible due to GFR criteria|0
7750957|NCT00745095|12187491|FG001|Overall Study|Ineligible due to GFR criteria|2
7750958|NCT00745095|12187492|FG002|Overall Study|Ineligible due to GFR criteria|3
7750959|NCT00745095|12187493|FG003|Overall Study|Ineligible due to GFR criteria|3
7750960|NCT00745095|12187494|FG004|Overall Study|Ineligible due to GFR criteria|30
7750961|NCT00745095|12187495|FG005|Overall Study|Ineligible due to GFR criteria|28
7750962|NCT00745121|12187514|FG000|Overall Study|Death|3
7750963|NCT00745121|12187515|FG001|Overall Study|Death|0
7750964|NCT00745121|12187514|FG000|Overall Study|Adverse Event|1
7750965|NCT00745121|12187515|FG001|Overall Study|Adverse Event|0
7750966|NCT00745121|12187514|FG000|Overall Study|Lost to Follow-up|1
7750967|NCT00745121|12187515|FG001|Overall Study|Lost to Follow-up|0
7750968|NCT00745121|12187514|FG000|Overall Study|Withdrawal by Subject|4
7750969|NCT00745121|12187515|FG001|Overall Study|Withdrawal by Subject|2
7750970|NCT00745251|12187523|FG000|Overall Study|Adverse Event|1
7750971|NCT00745251|12187524|FG001|Overall Study|Adverse Event|2
7750972|NCT00745251|12187523|FG000|Overall Study|Withdrawal by Subject|1
7750973|NCT00745251|12187524|FG001|Overall Study|Withdrawal by Subject|1
7750974|NCT00745368|12187539|FG000|Overall Study|Unable to provide sample|3
7750975|NCT00745420|12187543|FG000|Overall Study|Ineligible|1
7750976|NCT00745498|12187550|FG000|Overall Study|Lost to Follow-up|1
7750977|NCT00745498|12187551|FG001|Overall Study|Lost to Follow-up|1
7750978|NCT00745498|12187552|FG002|Overall Study|Lost to Follow-up|3
7750979|NCT00745498|12187550|FG000|Overall Study|Injection of intravitreal silicone oil o|3
7750980|NCT00745498|12187551|FG001|Overall Study|Injection of intravitreal silicone oil o|4
7750981|NCT00745498|12187552|FG002|Overall Study|Injection of intravitreal silicone oil o|4
7750982|NCT00745498|12187550|FG000|Overall Study|Non-PDR related VH|0
7750983|NCT00745498|12187551|FG001|Overall Study|Non-PDR related VH|1
7750984|NCT00745498|12187552|FG002|Overall Study|Non-PDR related VH|1
7750985|NCT00745498|12187550|FG000|Overall Study|Edophthalmitis after preoperative IVB|1
7750986|NCT00745498|12187551|FG001|Overall Study|Edophthalmitis after preoperative IVB|0
7750987|NCT00745498|12187552|FG002|Overall Study|Edophthalmitis after preoperative IVB|0
7750988|NCT00745615|12187564|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3
7750989|NCT00745615|12187565|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1
7750990|NCT00745615|12187566|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
7750991|NCT00745615|12187567|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4
7750992|NCT00745615|12187568|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
7750993|NCT00745615|12187569|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
7750994|NCT00745615|12187564|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0
7750995|NCT00745615|12187565|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1
7750996|NCT00745615|12187566|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0
7750997|NCT00745615|12187567|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0
7750998|NCT00745615|12187568|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0
7750999|NCT00745615|12187569|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0
7751000|NCT00745615|12187564|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2
7751001|NCT00745615|12187565|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3
7751002|NCT00745615|12187566|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1
7751003|NCT00745615|12187567|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1
7751004|NCT00745615|12187568|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0
7962298|NCT02711345|12516526|FG004|Overall Study|Death|0
7751005|NCT00745615|12187569|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0
7769586|NCT00869024|12213093|FG000|Overall Study|Lost to Follow-up|0
7751006|NCT00745615|12187564|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0
7751007|NCT00745615|12187565|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1
7751008|NCT00745615|12187566|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0
7751009|NCT00745615|12187567|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0
7751010|NCT00745615|12187568|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0
7751011|NCT00745615|12187569|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0
7751012|NCT00745615|12187564|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0
7751013|NCT00745615|12187565|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1
7751014|NCT00745615|12187566|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0
7751015|NCT00745615|12187567|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0
7751016|NCT00745615|12187568|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0
7751017|NCT00745615|12187569|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0
7751018|NCT00745615|12187564|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
7751019|NCT00745615|12187565|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
7751020|NCT00745615|12187566|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
7751021|NCT00745615|12187567|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
7751022|NCT00745615|12187568|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
7751023|NCT00745615|12187569|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
7751024|NCT00745615|12187564|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
7751025|NCT00745615|12187565|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
7751026|NCT00745615|12187566|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
7751027|NCT00745615|12187567|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
7751028|NCT00745615|12187568|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
7751029|NCT00745615|12187569|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
7751030|NCT00745615|12187564|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
7751031|NCT00745615|12187565|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
7751032|NCT00745615|12187566|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
7751033|NCT00745615|12187567|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
7751034|NCT00745615|12187568|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9
7751035|NCT00745615|12187569|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11
7751036|NCT00745615|12187564|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
7751037|NCT00745615|12187565|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
7751038|NCT00745615|12187566|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
7751039|NCT00745615|12187567|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
7751040|NCT00745615|12187568|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2
7751041|NCT00745615|12187569|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8
7751042|NCT00745615|12187564|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
7751043|NCT00745615|12187565|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
7751044|NCT00745615|12187566|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
7751045|NCT00745615|12187567|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
7751046|NCT00745615|12187568|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2
7751047|NCT00745615|12187569|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5
7751048|NCT00745615|12187564|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
7751049|NCT00745615|12187565|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
7751050|NCT00745615|12187566|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
7751051|NCT00745615|12187567|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
7751052|NCT00745615|12187568|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1
7751053|NCT00745615|12187569|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3
7751054|NCT00745615|12187564|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
7751055|NCT00745615|12187565|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
7751056|NCT00745615|12187566|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
7751057|NCT00745615|12187567|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
7751058|NCT00745615|12187568|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
7751059|NCT00745615|12187569|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1
7751060|NCT00745615|12187564|FG000|Open-Label (up to Approx 10.5 Years)|Death|0
7751061|NCT00745615|12187565|FG001|Open-Label (up to Approx 10.5 Years)|Death|0
7751062|NCT00745615|12187566|FG002|Open-Label (up to Approx 10.5 Years)|Death|0
7751063|NCT00745615|12187567|FG003|Open-Label (up to Approx 10.5 Years)|Death|0
7751064|NCT00745615|12187568|FG004|Open-Label (up to Approx 10.5 Years)|Death|0
7751065|NCT00745615|12187569|FG005|Open-Label (up to Approx 10.5 Years)|Death|1
7751066|NCT00745615|12187564|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
7751067|NCT00745615|12187565|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
7751068|NCT00745615|12187566|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
7751069|NCT00745615|12187567|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
7751070|NCT00745615|12187568|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8
7751071|NCT00745615|12187569|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10
7751072|NCT00745823|12187583|FG000|Overall Study|Adverse Event|5
7751073|NCT00745823|12187584|FG001|Overall Study|Adverse Event|3
7751074|NCT00745823|12187583|FG000|Overall Study|Lack of Efficacy|20
7751075|NCT00745823|12187584|FG001|Overall Study|Lack of Efficacy|6
7751076|NCT00745823|12187583|FG000|Overall Study|Lost to Follow-up|10
7751077|NCT00745823|12187584|FG001|Overall Study|Lost to Follow-up|11
7751078|NCT00745823|12187583|FG000|Overall Study|Physician Decision|10
7751079|NCT00745823|12187584|FG001|Overall Study|Physician Decision|5
7751080|NCT00745823|12187583|FG000|Overall Study|Pregnancy|0
7751081|NCT00745823|12187584|FG001|Overall Study|Pregnancy|4
7751082|NCT00745823|12187583|FG000|Overall Study|Withdrawal by Subject|14
7751083|NCT00745823|12187584|FG001|Overall Study|Withdrawal by Subject|8
7751084|NCT00745823|12187583|FG000|Overall Study|Study Terminated by Sponsor|326
7751085|NCT00745823|12187584|FG001|Overall Study|Study Terminated by Sponsor|349
7751086|NCT00745849|12187592|FG000|First Intervention|Withdrawal by Subject|0
7751087|NCT00745849|12187593|FG001|First Intervention|Withdrawal by Subject|1
7751088|NCT00745849|12187592|FG000|First Intervention|Lost to Follow-up|1
7751089|NCT00745849|12187593|FG001|First Intervention|Lost to Follow-up|1
7751090|NCT00745849|12187592|FG000|Second Intervention|Lost to Follow-up|2
7751091|NCT00745849|12187593|FG001|Second Intervention|Lost to Follow-up|1
7751092|NCT00745875|12187601|FG000|Overall Study|Continuing study treatment|4
7751093|NCT00745875|12187602|FG001|Overall Study|Continuing study treatment|4
7751094|NCT00745901|12187610|FG000|Overall Study|Adverse Event|3
7751095|NCT00745901|12187611|FG001|Overall Study|Adverse Event|4
7751096|NCT00745901|12187610|FG000|Overall Study|Protocol Violation|0
7751097|NCT00745901|12187611|FG001|Overall Study|Protocol Violation|1
7751098|NCT00745901|12187610|FG000|Overall Study|Withdrawal by Subject|1
7751099|NCT00745901|12187611|FG001|Overall Study|Withdrawal by Subject|0
7751100|NCT00745901|12187610|FG000|Overall Study|Lost to Follow-up|7
7751101|NCT00745901|12187611|FG001|Overall Study|Lost to Follow-up|4
7751102|NCT00745901|12187610|FG000|Overall Study|Pregnancy|2
7751103|NCT00745901|12187611|FG001|Overall Study|Pregnancy|4
7751104|NCT00745901|12187610|FG000|Overall Study|Lack of compliance|2
7751105|NCT00745901|12187611|FG001|Overall Study|Lack of compliance|2
7751106|NCT00745901|12187610|FG000|Overall Study|Patient's next menses did not start with|1
7751107|NCT00745901|12187611|FG001|Overall Study|Patient's next menses did not start with|0
7751108|NCT00745901|12187610|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0
7751109|NCT00745901|12187611|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2
7751110|NCT00745901|12187610|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1
7751111|NCT00745901|12187611|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1
7751112|NCT00745901|12187610|FG000|Overall Study|Patient didn't take any study medication|7
7751113|NCT00745901|12187611|FG001|Overall Study|Patient didn't take any study medication|3
7751114|NCT00746096|12187628|FG000|Overall Study|Adverse Event|1
7751115|NCT00746096|12187629|FG001|Overall Study|Adverse Event|0
7751116|NCT00746096|12187628|FG000|Overall Study|Withdrawal by Subject|5
7751117|NCT00746096|12187629|FG001|Overall Study|Withdrawal by Subject|1
7751118|NCT00746096|12187628|FG000|Overall Study|Lost to Follow-up|2
7751119|NCT00746096|12187629|FG001|Overall Study|Lost to Follow-up|1
7751120|NCT00746096|12187628|FG000|Overall Study|Protocol Violation|1
7751121|NCT00746096|12187629|FG001|Overall Study|Protocol Violation|0
7751122|NCT00746096|12187628|FG000|Overall Study|No study drug treatment|1
7751123|NCT00746096|12187629|FG001|Overall Study|No study drug treatment|1
7751124|NCT00746252|12187655|FG000|Overall Study|weight gain >7.5 %|1
7751125|NCT00746252|12187656|FG001|Overall Study|weight gain >7.5 %|2
7769587|NCT00869024|12213094|FG001|Overall Study|Lost to Follow-up|1
7769588|NCT00869024|12213093|FG000|Overall Study|Protocol Violation|0
7769589|NCT00869024|12213094|FG001|Overall Study|Protocol Violation|1
7769590|NCT00869050|12213100|FG000|Overall Study|Screen Failure|3
7769591|NCT00869089|12213104|FG000|Overall Study|Lost to Follow-up|1
7769592|NCT00869089|12213104|FG000|Overall Study|Withdrawal by Subject|1
7769593|NCT00869089|12213104|FG000|Overall Study|Screen Fail|1
7769594|NCT00869323|12213145|FG000|Maintenance Therapy|concurrent illness|1
7769595|NCT00869362|12213160|FG000|Overall Study|Death|0
7769596|NCT00869362|12213161|FG001|Overall Study|Death|2
7769597|NCT00869362|12213160|FG000|Overall Study|Lost to Follow-up|1
7769598|NCT00869362|12213161|FG001|Overall Study|Lost to Follow-up|3
7769599|NCT00869401|12213182|FG000|Overall Study|Withdrawal by Subject|0
7751126|NCT00746330|12187666|FG000|Period 1|Abnormal test procedure result|0
7751127|NCT00746330|12187667|FG001|Period 1|Abnormal test procedure result|0
7751128|NCT00746330|12187668|FG002|Period 1|Abnormal test procedure result|1
7751129|NCT00746330|12187669|FG003|Period 1|Abnormal test procedure result|0
7751130|NCT00746356|12187680|FG000|Overall Study|Withdrawal by Subject|2
7751131|NCT00746356|12187681|FG001|Overall Study|Withdrawal by Subject|3
7751132|NCT00746356|12187680|FG000|Overall Study|Death|7
7751133|NCT00746356|12187681|FG001|Overall Study|Death|3
7751134|NCT00746356|12187680|FG000|Overall Study|Lost to Follow-up|1
7751135|NCT00746356|12187681|FG001|Overall Study|Lost to Follow-up|0
7751136|NCT00746356|12187680|FG000|Overall Study|Removal of Device|0
7751137|NCT00746356|12187681|FG001|Overall Study|Removal of Device|1
7751138|NCT00746356|12187680|FG000|Overall Study|Patient relocated|1
7751139|NCT00746356|12187681|FG001|Overall Study|Patient relocated|0
7751140|NCT00746551|12187726|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2
7751141|NCT00746551|12187727|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4
7751142|NCT00746551|12187726|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
7751143|NCT00746551|12187727|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
7751144|NCT00746551|12187726|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
7751145|NCT00746551|12187727|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
7751146|NCT00746564|12187733|FG000|Overall Study|Required Pacemaker/ICD Implant|2
7751147|NCT00746733|12187762|FG000|Second Intervention|Adverse Event|1
7751148|NCT00746733|12187763|FG001|Second Intervention|Adverse Event|0
7751149|NCT00746733|12187762|FG000|Third Intervention|Withdrawal by Subject|1
7751150|NCT00746733|12187763|FG001|Third Intervention|Withdrawal by Subject|1
7751151|NCT00746785|12187779|FG000|Overall Study|Lost to Follow-up|29
7751152|NCT00746785|12187780|FG001|Overall Study|Lost to Follow-up|25
7751153|NCT00746785|12187781|FG002|Overall Study|Lost to Follow-up|27
7751154|NCT00746798|12187793|FG000|Overall Study|Protocol Violation|0
7751155|NCT00746798|12187794|FG001|Overall Study|Protocol Violation|1
7751156|NCT00746798|12187795|FG002|Overall Study|Protocol Violation|0
7751157|NCT00746798|12187796|FG003|Overall Study|Protocol Violation|0
7751158|NCT00746798|12187793|FG000|Overall Study|Withdrawal by Subject|0
7751159|NCT00746798|12187794|FG001|Overall Study|Withdrawal by Subject|1
7751160|NCT00746798|12187795|FG002|Overall Study|Withdrawal by Subject|1
7751161|NCT00746798|12187796|FG003|Overall Study|Withdrawal by Subject|0
7751162|NCT00746798|12187793|FG000|Overall Study|Death|0
7751163|NCT00746798|12187794|FG001|Overall Study|Death|0
7751164|NCT00746798|12187795|FG002|Overall Study|Death|2
7751165|NCT00746798|12187796|FG003|Overall Study|Death|0
7751166|NCT00746798|12187793|FG000|Overall Study|Participant unable to return for visit|1
7751167|NCT00746798|12187794|FG001|Overall Study|Participant unable to return for visit|0
7751168|NCT00746798|12187795|FG002|Overall Study|Participant unable to return for visit|0
7751169|NCT00746798|12187796|FG003|Overall Study|Participant unable to return for visit|0
7751170|NCT00746941|12187830|FG000|Overall Study|Death|2
7751171|NCT00746941|12187831|FG001|Overall Study|Death|0
7751172|NCT00746941|12187832|FG002|Overall Study|Death|0
7751173|NCT00746941|12187833|FG003|Overall Study|Death|6
7751174|NCT00746941|12187830|FG000|Overall Study|Physician Decision|0
7751175|NCT00746941|12187831|FG001|Overall Study|Physician Decision|0
7751176|NCT00746941|12187832|FG002|Overall Study|Physician Decision|2
7751177|NCT00746941|12187833|FG003|Overall Study|Physician Decision|0
7751178|NCT00746941|12187830|FG000|Overall Study|Withdrawal by Subject|3
7751179|NCT00746941|12187831|FG001|Overall Study|Withdrawal by Subject|0
7751180|NCT00746941|12187832|FG002|Overall Study|Withdrawal by Subject|0
7751181|NCT00746941|12187833|FG003|Overall Study|Withdrawal by Subject|2
7751182|NCT00746941|12187830|FG000|Overall Study|Other, reason not provided|2
7751183|NCT00746941|12187831|FG001|Overall Study|Other, reason not provided|4
7751184|NCT00746941|12187832|FG002|Overall Study|Other, reason not provided|0
7751185|NCT00746941|12187833|FG003|Overall Study|Other, reason not provided|4
7751186|NCT00746941|12187830|FG000|Overall Study|Adverse Event|0
7751187|NCT00746941|12187831|FG001|Overall Study|Adverse Event|0
7751188|NCT00746941|12187832|FG002|Overall Study|Adverse Event|0
7751189|NCT00746941|12187833|FG003|Overall Study|Adverse Event|1
7751190|NCT00747006|12187853|FG000|Overall Study|Adverse Event|1
7751191|NCT00747006|12187854|FG001|Overall Study|Adverse Event|0
7751192|NCT00747006|12187855|FG002|Overall Study|Adverse Event|0
7751193|NCT00747006|12187853|FG000|Overall Study|Lost to Follow-up|0
7751194|NCT00747006|12187854|FG001|Overall Study|Lost to Follow-up|1
7751195|NCT00747006|12187855|FG002|Overall Study|Lost to Follow-up|0
7751196|NCT00747006|12187853|FG000|Overall Study|Physician Decision|2
7751197|NCT00747006|12187854|FG001|Overall Study|Physician Decision|0
7751198|NCT00747006|12187855|FG002|Overall Study|Physician Decision|1
7751199|NCT00747149|12187868|FG000|Overall Study|Adverse Event|0
7751200|NCT00747149|12187869|FG001|Overall Study|Adverse Event|15
7751201|NCT00747149|12187868|FG000|Overall Study|Lost to Follow-up|0
7751202|NCT00747149|12187869|FG001|Overall Study|Lost to Follow-up|10
7751203|NCT00747149|12187868|FG000|Overall Study|Withdrawal by Subject|0
7751204|NCT00747149|12187869|FG001|Overall Study|Withdrawal by Subject|6
7751205|NCT00747149|12187868|FG000|Overall Study|Did not receive treatment|0
7751206|NCT00747149|12187869|FG001|Overall Study|Did not receive treatment|1
7751207|NCT00747149|12187868|FG000|Overall Study|Incorrect enrollment|0
7751208|NCT00747149|12187869|FG001|Overall Study|Incorrect enrollment|6
7751209|NCT00747149|12187868|FG000|Overall Study|Severe non-compliance to protocol|0
7751210|NCT00747149|12187869|FG001|Overall Study|Severe non-compliance to protocol|1
7751211|NCT00747149|12187868|FG000|Overall Study|Not reported|1
7751212|NCT00747149|12187869|FG001|Overall Study|Not reported|4
7751213|NCT00747227|12187892|FG000|Overall Study|Death|3
7751214|NCT00747227|12187893|FG001|Overall Study|Death|1
7751215|NCT00747227|12187892|FG000|Overall Study|Withdrawal by Subject|1
7751216|NCT00747227|12187893|FG001|Overall Study|Withdrawal by Subject|0
7751217|NCT00747227|12187892|FG000|Overall Study|Lost to Follow-up|1
7751218|NCT00747227|12187893|FG001|Overall Study|Lost to Follow-up|2
7751219|NCT00747227|12187892|FG000|Overall Study|Illness|1
7751220|NCT00747227|12187893|FG001|Overall Study|Illness|1
7751221|NCT00747344|12187901|FG000|Controlled Period|Adverse Event|3
7751222|NCT00747344|12187902|FG001|Controlled Period|Adverse Event|0
7751223|NCT00747344|12187903|FG002|Controlled Period|Adverse Event|0
7751224|NCT00747344|12187904|FG003|Controlled Period|Adverse Event|0
7751225|NCT00747344|12187901|FG000|Controlled Period|Lack of Efficacy|2
7751226|NCT00747344|12187902|FG001|Controlled Period|Lack of Efficacy|1
7751227|NCT00747344|12187903|FG002|Controlled Period|Lack of Efficacy|0
7751228|NCT00747344|12187904|FG003|Controlled Period|Lack of Efficacy|0
7751229|NCT00747344|12187901|FG000|Controlled Period|Other|0
7751230|NCT00747344|12187902|FG001|Controlled Period|Other|3
7751231|NCT00747344|12187903|FG002|Controlled Period|Other|0
7751232|NCT00747344|12187904|FG003|Controlled Period|Other|0
7751233|NCT00747344|12187901|FG000|After Controlled Period|Adverse Event|0
7751234|NCT00747344|12187902|FG001|After Controlled Period|Adverse Event|0
7751235|NCT00747344|12187903|FG002|After Controlled Period|Adverse Event|0
7751236|NCT00747344|12187904|FG003|After Controlled Period|Adverse Event|1
7751237|NCT00747435|12187912|FG000|Overall Study|Lost to Follow-up|2
7751238|NCT00747435|12187912|FG000|Overall Study|Withdrawal by Subject|3
7751239|NCT00747435|12187912|FG000|Overall Study|Still undergoing follow up|1
7751240|NCT00747474|12187916|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7751241|NCT00747474|12187917|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7751242|NCT00747474|12187918|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7751243|NCT00747474|12187919|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7751244|NCT00747474|12187920|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7751245|NCT00747474|12187921|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7751246|NCT00747474|12187922|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7751247|NCT00747474|12187923|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
7751248|NCT00747474|12187924|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7751249|NCT00747474|12187925|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7751250|NCT00747474|12187926|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7751251|NCT00747474|12187927|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7751252|NCT00747565|12187938|FG000|Overall Study|Withdrawal by Subject|10
7751253|NCT00747565|12187939|FG001|Overall Study|Withdrawal by Subject|6
7751254|NCT00747565|12187938|FG000|Overall Study|Lost to Follow-up|4
7751255|NCT00747565|12187939|FG001|Overall Study|Lost to Follow-up|1
7751256|NCT00747617|12187947|FG000|Overall Study|Lost to Follow-up|3
7751257|NCT00747617|12187948|FG001|Overall Study|Lost to Follow-up|1
7751258|NCT00747643|12187956|FG000|Overall Study|Withdrawal by Subject|36
7751259|NCT00747643|12187957|FG001|Overall Study|Withdrawal by Subject|27
7751260|NCT00747812|12187978|FG000|Overall Study|Research Site Staff Relocation|5
7751261|NCT00747812|12187979|FG001|Overall Study|Research Site Staff Relocation|3
7751262|NCT00748033|12187987|FG000|Overall Study|Adverse Event|0
7751263|NCT00748033|12187988|FG001|Overall Study|Adverse Event|1
7751264|NCT00748098|12188011|FG000|First Treatment Intervention Period|Adverse Event|1
7751265|NCT00748098|12188012|FG001|First Treatment Intervention Period|Adverse Event|1
7751266|NCT00748098|12188011|FG000|First Treatment Intervention Period|Protocol Violation|1
7751267|NCT00748098|12188012|FG001|First Treatment Intervention Period|Protocol Violation|0
7751268|NCT00748098|12188011|FG000|First Treatment Intervention Period|Lost to Follow-up|1
7751269|NCT00748098|12188012|FG001|First Treatment Intervention Period|Lost to Follow-up|0
7751270|NCT00748098|12188011|FG000|First Treatment Intervention Period|Withdrawal by Subject|2
7751271|NCT00748098|12188012|FG001|First Treatment Intervention Period|Withdrawal by Subject|0
7751272|NCT00748098|12188011|FG000|First Taper Period|Protocol Violation|1
7751273|NCT00748098|12188012|FG001|First Taper Period|Protocol Violation|0
7751274|NCT00748098|12188011|FG000|First Taper Period|Withdrawal by Subject|2
7751275|NCT00748098|12188012|FG001|First Taper Period|Withdrawal by Subject|0
7751276|NCT00748098|12188011|FG000|First Taper Period|Protocol Stopping Criteria Met|0
7751277|NCT00748098|12188012|FG001|First Taper Period|Protocol Stopping Criteria Met|1
7751278|NCT00748098|12188011|FG000|1-Week Washout Period|Adverse Event|0
7751279|NCT00748098|12188012|FG001|1-Week Washout Period|Adverse Event|1
7751280|NCT00748098|12188011|FG000|1-Week Washout Period|Withdrawal by Subject|2
7751281|NCT00748098|12188012|FG001|1-Week Washout Period|Withdrawal by Subject|0
7751282|NCT00748098|12188011|FG000|Second Treatment Intervention Period|Adverse Event|4
7751283|NCT00748098|12188012|FG001|Second Treatment Intervention Period|Adverse Event|1
7751284|NCT00748098|12188011|FG000|Second Treatment Intervention Period|Lost to Follow-up|1
7751285|NCT00748098|12188012|FG001|Second Treatment Intervention Period|Lost to Follow-up|1
7751286|NCT00748098|12188011|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1
7751287|NCT00748098|12188012|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1
7751288|NCT00748189|12188021|FG000|Overall Study|Death|99
7751289|NCT00748189|12188022|FG001|Overall Study|Death|84
7751290|NCT00748189|12188021|FG000|Overall Study|Withdrawal by Subject|23
7751291|NCT00748189|12188022|FG001|Overall Study|Withdrawal by Subject|29
7751292|NCT00748189|12188021|FG000|Overall Study|Physician Decision|16
7751293|NCT00748189|12188022|FG001|Overall Study|Physician Decision|5
7751294|NCT00748189|12188021|FG000|Overall Study|Lost to Follow-up|8
7751295|NCT00748189|12188022|FG001|Overall Study|Lost to Follow-up|15
7751296|NCT00748189|12188021|FG000|Overall Study|Study terminated by Sponsor|70
7751297|NCT00748189|12188022|FG001|Overall Study|Study terminated by Sponsor|79
7751298|NCT00748215|12188035|FG000|Overall Study|Withdrawal by Subject|7
7751299|NCT00748215|12188036|FG001|Overall Study|Withdrawal by Subject|7
7751300|NCT00748215|12188035|FG000|Overall Study|Treatment change|2
7751301|NCT00748215|12188036|FG001|Overall Study|Treatment change|1
7751302|NCT00748215|12188035|FG000|Overall Study|Change in patient condition|0
7751303|NCT00748215|12188036|FG001|Overall Study|Change in patient condition|3
7751304|NCT00748215|12188035|FG000|Overall Study|Non-compliant|0
7751305|NCT00748215|12188036|FG001|Overall Study|Non-compliant|2
7751306|NCT00748215|12188035|FG000|Overall Study|Adverse Event|0
7751307|NCT00748215|12188036|FG001|Overall Study|Adverse Event|5
7751308|NCT00748241|12188042|FG000|Overall Study|Implant failure|1
7751309|NCT00748241|12188042|FG000|Overall Study|Lost to Follow-up|5
7751310|NCT00748241|12188042|FG000|Overall Study|Death|2
7751311|NCT00748540|12188055|FG000|Overall Study|Physician Decision|1
7751312|NCT00748553|12188061|FG000|Overall Study|Adverse Event|0
7751313|NCT00748553|12188062|FG001|Overall Study|Adverse Event|1
7751314|NCT00748553|12188061|FG000|Overall Study|disease progression|2
7751315|NCT00748553|12188062|FG001|Overall Study|disease progression|0
7751316|NCT00748553|12188061|FG000|Overall Study|noncompliance|1
7751317|NCT00748553|12188062|FG001|Overall Study|noncompliance|0
7751318|NCT00748566|12188067|FG000|Overall Study|Adverse Event|49
7751319|NCT00748566|12188067|FG000|Overall Study|Death|1
7751320|NCT00748566|12188067|FG000|Overall Study|Lack of Efficacy|12
7751321|NCT00748566|12188067|FG000|Overall Study|Lost to Follow-up|1
7751322|NCT00748566|12188067|FG000|Overall Study|Protocol Violation|13
7751323|NCT00748566|12188067|FG000|Overall Study|Withdrawal by Subject|22
7751324|NCT00748566|12188067|FG000|Overall Study|Study terminated by sponsor|5
7751325|NCT00748566|12188067|FG000|Overall Study|Other|9
7751326|NCT00748709|12188081|FG000|Overall Study|Progressive disease|15
7751327|NCT00748709|12188081|FG000|Overall Study|Drug reducing Toxity|2
7751328|NCT00748709|12188081|FG000|Overall Study|Other Adverse Event|1
7751329|NCT00748709|12188081|FG000|Overall Study|Withdrawal by Subject|1
7751330|NCT00748709|12188081|FG000|Overall Study|Other Reasons|1
7751331|NCT00748969|12188111|FG000|Overall Study|Withdrawal by Subject|1
7751332|NCT00748969|12188112|FG001|Overall Study|Withdrawal by Subject|0
7751333|NCT00748969|12188111|FG000|Overall Study|Withdrawal by Subject|0
7751334|NCT00748969|12188112|FG001|Overall Study|Withdrawal by Subject|1
7751335|NCT00749190|12188148|FG000|Overall Study|Adverse Event|0
7751336|NCT00749190|12188149|FG001|Overall Study|Adverse Event|2
7751337|NCT00749190|12188150|FG002|Overall Study|Adverse Event|0
7751338|NCT00749190|12188151|FG003|Overall Study|Adverse Event|4
7751339|NCT00749190|12188152|FG004|Overall Study|Adverse Event|0
7751340|NCT00749190|12188153|FG005|Overall Study|Adverse Event|3
7751341|NCT00749190|12188154|FG006|Overall Study|Adverse Event|0
7751342|NCT00749190|12188148|FG000|Overall Study|Lack of Efficacy|3
7751343|NCT00749190|12188149|FG001|Overall Study|Lack of Efficacy|1
7751344|NCT00749190|12188150|FG002|Overall Study|Lack of Efficacy|1
7751345|NCT00749190|12188151|FG003|Overall Study|Lack of Efficacy|0
7751346|NCT00749190|12188152|FG004|Overall Study|Lack of Efficacy|0
7751347|NCT00749190|12188153|FG005|Overall Study|Lack of Efficacy|1
7751348|NCT00749190|12188154|FG006|Overall Study|Lack of Efficacy|0
7751349|NCT00749190|12188148|FG000|Overall Study|Withdrawal by Subject|2
7751350|NCT00749190|12188149|FG001|Overall Study|Withdrawal by Subject|1
7751351|NCT00749190|12188150|FG002|Overall Study|Withdrawal by Subject|0
7751352|NCT00749190|12188151|FG003|Overall Study|Withdrawal by Subject|0
7751353|NCT00749190|12188152|FG004|Overall Study|Withdrawal by Subject|0
7751354|NCT00749190|12188153|FG005|Overall Study|Withdrawal by Subject|1
7751355|NCT00749190|12188154|FG006|Overall Study|Withdrawal by Subject|0
7751356|NCT00749190|12188148|FG000|Overall Study|Protocol Violation|0
7751357|NCT00749190|12188149|FG001|Overall Study|Protocol Violation|1
7751358|NCT00749190|12188150|FG002|Overall Study|Protocol Violation|0
7751359|NCT00749190|12188151|FG003|Overall Study|Protocol Violation|0
7751360|NCT00749190|12188152|FG004|Overall Study|Protocol Violation|0
7751361|NCT00749190|12188153|FG005|Overall Study|Protocol Violation|0
7751362|NCT00749190|12188154|FG006|Overall Study|Protocol Violation|1
7751363|NCT00749190|12188148|FG000|Overall Study|Other reason not defined above|0
7751364|NCT00749190|12188149|FG001|Overall Study|Other reason not defined above|0
7751365|NCT00749190|12188150|FG002|Overall Study|Other reason not defined above|0
7751366|NCT00749190|12188151|FG003|Overall Study|Other reason not defined above|1
7751367|NCT00749190|12188152|FG004|Overall Study|Other reason not defined above|0
7751368|NCT00749190|12188153|FG005|Overall Study|Other reason not defined above|0
7751369|NCT00749190|12188154|FG006|Overall Study|Other reason not defined above|0
7751370|NCT00749203|12188177|FG000|no Infusion at Week 1|Lost to Follow-up|0
7751371|NCT00749203|12188178|FG001|no Infusion at Week 1|Lost to Follow-up|1
7751372|NCT00749203|12188177|FG000|no Infusion at Week 1|Withdrawal by Subject|0
7751373|NCT00749203|12188178|FG001|no Infusion at Week 1|Withdrawal by Subject|1
7751374|NCT00749203|12188177|FG000|no Infusion at Week 1|delayed-onset sedation|0
7751375|NCT00749203|12188178|FG001|no Infusion at Week 1|delayed-onset sedation|1
7751376|NCT00749203|12188177|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0
7751377|NCT00749203|12188178|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1
7751378|NCT00749203|12188177|FG000|Second Infusion at 2 Weeks|Protocol Violation|0
7751379|NCT00749203|12188178|FG001|Second Infusion at 2 Weeks|Protocol Violation|1
7751380|NCT00749203|12188177|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
7751381|NCT00749203|12188178|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
7962299|NCT02711345|12516527|FG005|Overall Study|Death|0
7962300|NCT02711345|12516528|FG006|Overall Study|Death|0
7962301|NCT02711345|12516529|FG007|Overall Study|Death|1
7962302|NCT02711345|12516530|FG008|Overall Study|Death|0
7962303|NCT02711345|12516531|FG009|Overall Study|Death|0
7962304|NCT02711553|12516562|FG000|Overall Study|Withdrawal by Subject|2
7962305|NCT02711553|12516563|FG001|Overall Study|Withdrawal by Subject|1
7962306|NCT02711553|12516564|FG002|Overall Study|Withdrawal by Subject|1
7962307|NCT02711553|12516565|FG003|Overall Study|Withdrawal by Subject|0
7962308|NCT02711553|12516562|FG000|Overall Study|Lost to Follow-up|3
7962309|NCT02711553|12516563|FG001|Overall Study|Lost to Follow-up|3
7962310|NCT02711553|12516564|FG002|Overall Study|Lost to Follow-up|6
7962311|NCT02711553|12516565|FG003|Overall Study|Lost to Follow-up|3
7962312|NCT02711553|12516562|FG000|Overall Study|On Study Treatment at Study Conclusion|1
7962313|NCT02711553|12516563|FG001|Overall Study|On Study Treatment at Study Conclusion|1
7962314|NCT02711553|12516564|FG002|Overall Study|On Study Treatment at Study Conclusion|3
7962315|NCT02711553|12516565|FG003|Overall Study|On Study Treatment at Study Conclusion|1
7962316|NCT02711800|12516577|FG000|Overall Study|Lost to Follow-up|1
7962317|NCT02711800|12516577|FG000|Overall Study|Withdrawal by Subject|1
7962318|NCT02711956|12516605|FG000|Overall Study|Adverse Event|0
7962319|NCT02711956|12516606|FG001|Overall Study|Adverse Event|0
7962320|NCT02711956|12516607|FG002|Overall Study|Adverse Event|0
7962321|NCT02711956|12516608|FG003|Overall Study|Adverse Event|1
7962322|NCT02711956|12516609|FG004|Overall Study|Adverse Event|2
7962323|NCT02711956|12516610|FG005|Overall Study|Adverse Event|0
7962324|NCT02711956|12516611|FG006|Overall Study|Adverse Event|0
7962325|NCT02711956|12516612|FG007|Overall Study|Adverse Event|1
7962326|NCT02711956|12516613|FG008|Overall Study|Adverse Event|1
7962327|NCT02711956|12516614|FG009|Overall Study|Adverse Event|1
7962328|NCT02711956|12516615|FG010|Overall Study|Adverse Event|1
7962329|NCT02711956|12516616|FG011|Overall Study|Adverse Event|0
7962330|NCT02711956|12516617|FG012|Overall Study|Adverse Event|0
7962331|NCT02711956|12516618|FG013|Overall Study|Adverse Event|0
7962332|NCT02711956|12516619|FG014|Overall Study|Adverse Event|2
7962333|NCT02711956|12516605|FG000|Overall Study|Physician Decision|0
7962334|NCT02711956|12516606|FG001|Overall Study|Physician Decision|0
7962335|NCT02711956|12516607|FG002|Overall Study|Physician Decision|0
7962336|NCT02711956|12516608|FG003|Overall Study|Physician Decision|2
7962337|NCT02711956|12516609|FG004|Overall Study|Physician Decision|0
7962338|NCT02711956|12516610|FG005|Overall Study|Physician Decision|0
7962339|NCT02711956|12516611|FG006|Overall Study|Physician Decision|0
7962340|NCT02711956|12516612|FG007|Overall Study|Physician Decision|0
7962341|NCT02711956|12516613|FG008|Overall Study|Physician Decision|0
7962342|NCT02711956|12516614|FG009|Overall Study|Physician Decision|0
7751382|NCT00749398|12188199|FG000|Overall Study|Lack of Efficacy|7
7751383|NCT00749398|12188199|FG000|Overall Study|Adverse Event|4
7751384|NCT00749398|12188199|FG000|Overall Study|Serious adverse event|11
7751385|NCT00749398|12188199|FG000|Overall Study|Withdrawal by Subject|17
7751386|NCT00749398|12188199|FG000|Overall Study|Lost to Follow-up|11
7751387|NCT00749398|12188199|FG000|Overall Study|Reason not specified|2
7751388|NCT00749398|12188199|FG000|Overall Study|Unknown reason|1
7751389|NCT00749411|12188205|FG000|Overall Study|Adverse Event|0
7751390|NCT00749411|12188206|FG001|Overall Study|Adverse Event|2
7751391|NCT00749411|12188205|FG000|Overall Study|Lack of Efficacy|0
7751392|NCT00749411|12188206|FG001|Overall Study|Lack of Efficacy|1
7751393|NCT00749411|12188205|FG000|Overall Study|Protocol Violation|1
7751394|NCT00749411|12188206|FG001|Overall Study|Protocol Violation|1
7751395|NCT00749411|12188205|FG000|Overall Study|Protocol-defined stopping criteria|0
7751396|NCT00749411|12188206|FG001|Overall Study|Protocol-defined stopping criteria|1
7751397|NCT00749463|12188215|FG000|Overall Study|Adverse Event|0
7751398|NCT00749463|12188216|FG001|Overall Study|Adverse Event|4
7751399|NCT00749463|12188217|FG002|Overall Study|Adverse Event|1
7751400|NCT00749463|12188215|FG000|Overall Study|Withdrawal by Subject|1
7751401|NCT00749463|12188216|FG001|Overall Study|Withdrawal by Subject|0
7751402|NCT00749463|12188217|FG002|Overall Study|Withdrawal by Subject|0
7751403|NCT00749580|12188236|FG000|Overall Study|Lost to Follow-up|4
7751404|NCT00749580|12188237|FG001|Overall Study|Lost to Follow-up|8
7751405|NCT00749580|12188236|FG000|Overall Study|Adverse Event|0
7751406|NCT00749580|12188237|FG001|Overall Study|Adverse Event|1
7751407|NCT00749684|12188265|FG000|Overall Study|Death|1
7751408|NCT00749684|12188265|FG000|Overall Study|Adverse Event|27
7751409|NCT00749684|12188265|FG000|Overall Study|Participant's Wish|10
7751410|NCT00749684|12188265|FG000|Overall Study|Not Documented|1
7751411|NCT00749684|12188265|FG000|Overall Study|Progressive Desease|31
7751412|NCT00749684|12188265|FG000|Overall Study|Therapy according to protocol + AE|2
7751413|NCT00749684|12188265|FG000|Overall Study|AE+discontinuation on participants wish|1
7751414|NCT00749684|12188265|FG000|Overall Study|Missing|9
7751415|NCT00749775|12188278|FG000|Overall Study|Protocol Violation|24
7751416|NCT00749775|12188278|FG000|Overall Study|Lost to Follow-up|36
7751417|NCT00749775|12188278|FG000|Overall Study|No visit after first day of treatment|44
7751418|NCT00749775|12188278|FG000|Overall Study|No drug administration|3
7751419|NCT00749892|12188304|FG000|Overall Study|Withdrawal by Subject|3
7751420|NCT00749944|12188321|FG000|Overall Study|Lost to Follow-up|2
7751421|NCT00749944|12188322|FG001|Overall Study|Lost to Follow-up|1
7751422|NCT00749944|12188321|FG000|Overall Study|Other|1
7751423|NCT00749944|12188322|FG001|Overall Study|Other|0
7751424|NCT00749944|12188321|FG000|Overall Study|Withdrawal by Subject|2
7751425|NCT00749944|12188322|FG001|Overall Study|Withdrawal by Subject|0
7751426|NCT00749996|12188341|FG000|Overall Study|Lost to Follow-up|7
7751427|NCT00749996|12188342|FG001|Overall Study|Lost to Follow-up|4
7751428|NCT00749996|12188341|FG000|Overall Study|Withdrawal by Subject|5
7751429|NCT00749996|12188342|FG001|Overall Study|Withdrawal by Subject|4
7751430|NCT00749996|12188341|FG000|Overall Study|Protocol Violation|2
7751431|NCT00749996|12188342|FG001|Overall Study|Protocol Violation|3
7751432|NCT00749996|12188341|FG000|Overall Study|Physician Decision|2
7751433|NCT00749996|12188342|FG001|Overall Study|Physician Decision|0
7751434|NCT00749996|12188341|FG000|Overall Study|Pregnancy|0
7751435|NCT00749996|12188342|FG001|Overall Study|Pregnancy|2
7751436|NCT00749996|12188341|FG000|Overall Study|Adverse Event|1
7751437|NCT00749996|12188342|FG001|Overall Study|Adverse Event|0
7751438|NCT00749996|12188341|FG000|Overall Study|Death|1
7751439|NCT00749996|12188342|FG001|Overall Study|Death|0
7751440|NCT00750061|12188350|FG000|Overall Study|Adverse Event|2
7751441|NCT00750061|12188351|FG001|Overall Study|Adverse Event|0
7751442|NCT00750061|12188350|FG000|Overall Study|Withdrawal by Subject|0
7751443|NCT00750061|12188351|FG001|Overall Study|Withdrawal by Subject|1
7751444|NCT00750061|12188350|FG000|Overall Study|Physician Decision|0
7751445|NCT00750061|12188351|FG001|Overall Study|Physician Decision|1
7751446|NCT00750139|12188361|FG000|Overall Study|Adverse Event|1
7751447|NCT00750139|12188362|FG001|Overall Study|Adverse Event|2
7751448|NCT00750139|12188363|FG002|Overall Study|Adverse Event|0
7751449|NCT00750139|12188364|FG003|Overall Study|Adverse Event|1
7751450|NCT00750139|12188361|FG000|Overall Study|Lost to Follow-up|17
7751451|NCT00750139|12188362|FG001|Overall Study|Lost to Follow-up|12
7751452|NCT00750139|12188363|FG002|Overall Study|Lost to Follow-up|15
7751453|NCT00750139|12188364|FG003|Overall Study|Lost to Follow-up|6
7751454|NCT00750139|12188361|FG000|Overall Study|Withdrawal by Subject|3
7751455|NCT00750139|12188362|FG001|Overall Study|Withdrawal by Subject|2
7751456|NCT00750139|12188363|FG002|Overall Study|Withdrawal by Subject|6
7751457|NCT00750139|12188364|FG003|Overall Study|Withdrawal by Subject|2
7751458|NCT00750139|12188361|FG000|Overall Study|Physician Decision|1
7751459|NCT00750139|12188362|FG001|Overall Study|Physician Decision|1
7751460|NCT00750139|12188363|FG002|Overall Study|Physician Decision|0
7751461|NCT00750139|12188364|FG003|Overall Study|Physician Decision|0
7751462|NCT00750139|12188361|FG000|Overall Study|Non-compliance|1
7751463|NCT00750139|12188362|FG001|Overall Study|Non-compliance|0
7751464|NCT00750139|12188363|FG002|Overall Study|Non-compliance|1
7751465|NCT00750139|12188364|FG003|Overall Study|Non-compliance|3
7751466|NCT00750139|12188361|FG000|Overall Study|Termination by sponsor|4
7751467|NCT00750139|12188362|FG001|Overall Study|Termination by sponsor|0
7751468|NCT00750139|12188363|FG002|Overall Study|Termination by sponsor|0
7751469|NCT00750139|12188364|FG003|Overall Study|Termination by sponsor|1
7751470|NCT00750139|12188361|FG000|Overall Study|Non-specific|62
7751471|NCT00750139|12188362|FG001|Overall Study|Non-specific|42
7751472|NCT00750139|12188363|FG002|Overall Study|Non-specific|79
7751473|NCT00750139|12188364|FG003|Overall Study|Non-specific|33
7751474|NCT00750152|12188378|FG000|Overall Study|Adverse Event|2
7751475|NCT00750152|12188379|FG001|Overall Study|Adverse Event|1
7751476|NCT00750152|12188378|FG000|Overall Study|Lost to Follow-up|8
7751477|NCT00750152|12188379|FG001|Overall Study|Lost to Follow-up|13
7751478|NCT00750152|12188378|FG000|Overall Study|Withdrawal by Subject|3
7751479|NCT00750152|12188379|FG001|Overall Study|Withdrawal by Subject|3
7751480|NCT00750152|12188378|FG000|Overall Study|Physician Decision|1
7751481|NCT00750152|12188379|FG001|Overall Study|Physician Decision|1
7751482|NCT00750152|12188378|FG000|Overall Study|Non-compliance|0
7751483|NCT00750152|12188379|FG001|Overall Study|Non-compliance|1
7751484|NCT00750152|12188378|FG000|Overall Study|Termination by sponsor|1
7751485|NCT00750152|12188379|FG001|Overall Study|Termination by sponsor|0
7751486|NCT00750152|12188378|FG000|Overall Study|Other|7
7751487|NCT00750152|12188379|FG001|Overall Study|Other|8
7751488|NCT00750308|12188429|FG000|First Treatment|Adverse Event|0
7751489|NCT00750308|12188430|FG001|First Treatment|Adverse Event|1
7751490|NCT00750308|12188431|FG002|First Treatment|Adverse Event|0
7751491|NCT00750308|12188432|FG003|First Treatment|Adverse Event|0
7751492|NCT00750308|12188433|FG004|First Treatment|Adverse Event|0
7751493|NCT00750308|12188434|FG005|First Treatment|Adverse Event|0
7751494|NCT00750308|12188435|FG006|First Treatment|Adverse Event|0
7751495|NCT00750308|12188436|FG007|First Treatment|Adverse Event|0
7751496|NCT00750308|12188437|FG008|First Treatment|Adverse Event|0
7751497|NCT00750308|12188438|FG009|First Treatment|Adverse Event|0
7751498|NCT00750308|12188439|FG010|First Treatment|Adverse Event|1
7751499|NCT00750308|12188440|FG011|First Treatment|Adverse Event|1
7751500|NCT00750308|12188429|FG000|First Treatment|Withdrawal by Subject|0
7751501|NCT00750308|12188430|FG001|First Treatment|Withdrawal by Subject|0
7751502|NCT00750308|12188431|FG002|First Treatment|Withdrawal by Subject|0
7751503|NCT00750308|12188432|FG003|First Treatment|Withdrawal by Subject|1
7751504|NCT00750308|12188433|FG004|First Treatment|Withdrawal by Subject|0
7751505|NCT00750308|12188434|FG005|First Treatment|Withdrawal by Subject|0
7751506|NCT00750308|12188435|FG006|First Treatment|Withdrawal by Subject|0
7751507|NCT00750308|12188436|FG007|First Treatment|Withdrawal by Subject|1
7751508|NCT00750308|12188437|FG008|First Treatment|Withdrawal by Subject|0
7751509|NCT00750308|12188438|FG009|First Treatment|Withdrawal by Subject|0
7751510|NCT00750308|12188439|FG010|First Treatment|Withdrawal by Subject|0
7751511|NCT00750308|12188440|FG011|First Treatment|Withdrawal by Subject|0
7751512|NCT00750308|12188429|FG000|Second Treatment|Adverse Event|0
7751513|NCT00750308|12188430|FG001|Second Treatment|Adverse Event|0
7751514|NCT00750308|12188431|FG002|Second Treatment|Adverse Event|0
7751515|NCT00750308|12188432|FG003|Second Treatment|Adverse Event|0
7751516|NCT00750308|12188433|FG004|Second Treatment|Adverse Event|0
7751517|NCT00750308|12188434|FG005|Second Treatment|Adverse Event|1
7751518|NCT00750308|12188435|FG006|Second Treatment|Adverse Event|0
7751519|NCT00750308|12188436|FG007|Second Treatment|Adverse Event|0
7751520|NCT00750308|12188437|FG008|Second Treatment|Adverse Event|1
7751521|NCT00750308|12188438|FG009|Second Treatment|Adverse Event|0
7751522|NCT00750308|12188439|FG010|Second Treatment|Adverse Event|0
7751523|NCT00750308|12188440|FG011|Second Treatment|Adverse Event|0
7751524|NCT00750308|12188429|FG000|Second Treatment|Withdrawal by Subject|0
7751525|NCT00750308|12188430|FG001|Second Treatment|Withdrawal by Subject|0
7751526|NCT00750308|12188431|FG002|Second Treatment|Withdrawal by Subject|0
7751527|NCT00750308|12188432|FG003|Second Treatment|Withdrawal by Subject|0
7751528|NCT00750308|12188433|FG004|Second Treatment|Withdrawal by Subject|1
7751529|NCT00750308|12188434|FG005|Second Treatment|Withdrawal by Subject|0
7751530|NCT00750308|12188435|FG006|Second Treatment|Withdrawal by Subject|0
7751531|NCT00750308|12188436|FG007|Second Treatment|Withdrawal by Subject|0
7751532|NCT00750308|12188437|FG008|Second Treatment|Withdrawal by Subject|0
7751533|NCT00750308|12188438|FG009|Second Treatment|Withdrawal by Subject|0
7751534|NCT00750308|12188439|FG010|Second Treatment|Withdrawal by Subject|0
7751535|NCT00750308|12188440|FG011|Second Treatment|Withdrawal by Subject|0
7751536|NCT00750308|12188429|FG000|Third Treatment|Withdrawal by Subject|0
7751537|NCT00750308|12188430|FG001|Third Treatment|Withdrawal by Subject|1
7751538|NCT00750308|12188431|FG002|Third Treatment|Withdrawal by Subject|0
7751539|NCT00750308|12188432|FG003|Third Treatment|Withdrawal by Subject|0
7751540|NCT00750308|12188433|FG004|Third Treatment|Withdrawal by Subject|0
7751541|NCT00750308|12188434|FG005|Third Treatment|Withdrawal by Subject|0
7751542|NCT00750308|12188435|FG006|Third Treatment|Withdrawal by Subject|0
7751543|NCT00750308|12188436|FG007|Third Treatment|Withdrawal by Subject|0
7751544|NCT00750308|12188437|FG008|Third Treatment|Withdrawal by Subject|0
7751545|NCT00750308|12188438|FG009|Third Treatment|Withdrawal by Subject|0
7751546|NCT00750308|12188439|FG010|Third Treatment|Withdrawal by Subject|0
7751547|NCT00750308|12188440|FG011|Third Treatment|Withdrawal by Subject|0
7751548|NCT00750438|12188496|FG000|Overall Study|Protocol Violation|4
7751549|NCT00750438|12188497|FG001|Overall Study|Protocol Violation|1
7751550|NCT00750438|12188496|FG000|Overall Study|Physician Decision|2
7751551|NCT00750438|12188497|FG001|Overall Study|Physician Decision|2
7751552|NCT00750438|12188496|FG000|Overall Study|Withdrawal by Subject|1
7751553|NCT00750438|12188497|FG001|Overall Study|Withdrawal by Subject|1
7751554|NCT00750737|12188505|FG000|Overall Study|Withdrawal by Subject|3
7751555|NCT00750737|12188506|FG001|Overall Study|Withdrawal by Subject|3
7751556|NCT00750867|12188525|FG000|Overall Study|Adverse Event|2
7751557|NCT00750880|12188529|FG000|Overall Study|Adverse Event|76
7751558|NCT00750880|12188529|FG000|Overall Study|Death|4
7751559|NCT00750880|12188529|FG000|Overall Study|Lack of Efficacy|46
7751560|NCT00750880|12188529|FG000|Overall Study|Lost to Follow-up|10
7751561|NCT00750880|12188529|FG000|Overall Study|Protocol Violation|15
7751562|NCT00750880|12188529|FG000|Overall Study|Withdrawal by Subject|33
7751563|NCT00750880|12188529|FG000|Overall Study|Physician Decision|20
7751564|NCT00750880|12188529|FG000|Overall Study|Administrative|11
7751565|NCT00750893|12188534|FG000|Overall Study|Adverse Event|5
7751566|NCT00750893|12188534|FG000|Overall Study|Withdrawal by Subject|10
7751567|NCT00750893|12188534|FG000|Overall Study|Lost to Follow-up|510
7751568|NCT00750893|12188534|FG000|Overall Study|Other|17
7751569|NCT00750919|12188538|FG000|Overall Study|Adverse Event|9
7751570|NCT00750919|12188538|FG000|Overall Study|Withdrawal by Subject|1
7751571|NCT00750919|12188538|FG000|Overall Study|Lack of Efficacy|8
7751572|NCT00750919|12188538|FG000|Overall Study|Could not cooperate, unrelated to trial|4
7751573|NCT00750919|12188538|FG000|Overall Study|Other|36
7751574|NCT00751023|12188544|FG000|Overall Study|Lost to Follow-up|11
7751575|NCT00751023|12188545|FG001|Overall Study|Lost to Follow-up|7
7751576|NCT00751036|12188553|FG000|Overall Study|Disease Progression|28
7751577|NCT00751036|12188554|FG001|Overall Study|Disease Progression|29
7751578|NCT00751036|12188553|FG000|Overall Study|Adverse Event|6
7751579|NCT00751036|12188554|FG001|Overall Study|Adverse Event|4
7751580|NCT00751036|12188553|FG000|Overall Study|Administrative Problems|3
7751581|NCT00751036|12188554|FG001|Overall Study|Administrative Problems|4
7751582|NCT00751036|12188553|FG000|Overall Study|Withdrawal by Subject|5
7751583|NCT00751036|12188554|FG001|Overall Study|Withdrawal by Subject|2
7751584|NCT00751036|12188553|FG000|Overall Study|Death|3
7751585|NCT00751036|12188554|FG001|Overall Study|Death|3
7751586|NCT00751036|12188553|FG000|Overall Study|Lost to Follow-up|0
7751587|NCT00751036|12188554|FG001|Overall Study|Lost to Follow-up|1
7751588|NCT00751036|12188553|FG000|Overall Study|Protocol Violation|1
7751589|NCT00751036|12188554|FG001|Overall Study|Protocol Violation|0
7751590|NCT00751036|12188553|FG000|Overall Study|Missing end of Treatment Page|2
7751591|NCT00751036|12188554|FG001|Overall Study|Missing end of Treatment Page|3
7751592|NCT00751101|12188562|FG000|Overall Study|Withdrawal by Subject|1
7751593|NCT00751101|12188563|FG001|Overall Study|Withdrawal by Subject|0
7751594|NCT00751101|12188562|FG000|Overall Study|No HFS / Never Started Patch/|0
7751595|NCT00751101|12188563|FG001|Overall Study|No HFS / Never Started Patch/|4
7751596|NCT00751101|12188562|FG000|Overall Study|Never began capecitabine|1
7751597|NCT00751101|12188563|FG001|Overall Study|Never began capecitabine|0
7751598|NCT00751101|12188562|FG000|Overall Study|Physician Decision|0
7751599|NCT00751101|12188563|FG001|Overall Study|Physician Decision|1
7751600|NCT00751114|12188575|FG000|Overall Study|Adverse Event|2
7751601|NCT00751114|12188576|FG001|Overall Study|Adverse Event|4
7751602|NCT00751114|12188575|FG000|Overall Study|Protocol Violation|8
7751603|NCT00751114|12188576|FG001|Overall Study|Protocol Violation|9
7751604|NCT00751114|12188575|FG000|Overall Study|Withdrawal by Subject|9
7751605|NCT00751114|12188576|FG001|Overall Study|Withdrawal by Subject|4
7751606|NCT00751114|12188575|FG000|Overall Study|Lost to Follow-up|4
7751607|NCT00751114|12188576|FG001|Overall Study|Lost to Follow-up|7
7751608|NCT00751114|12188575|FG000|Overall Study|Lack of Efficacy|0
7751609|NCT00751114|12188576|FG001|Overall Study|Lack of Efficacy|7
7751610|NCT00751114|12188575|FG000|Overall Study|Not Treated|13
7751611|NCT00751114|12188576|FG001|Overall Study|Not Treated|1
7751612|NCT00751114|12188575|FG000|Overall Study|Out of country for 2 months|1
7751613|NCT00751114|12188576|FG001|Overall Study|Out of country for 2 months|0
7751614|NCT00751114|12188575|FG000|Overall Study|Move to another city|1
7751615|NCT00751114|12188576|FG001|Overall Study|Move to another city|0
7751616|NCT00751140|12188582|FG000|Overall Study|benign angioma excluded from analysis|1
7751617|NCT00751296|12188600|FG000|Overall Study|Adverse Event|2
7751618|NCT00751348|12188606|FG000|Overall Study|Withdrawal by Subject|5
7751619|NCT00751348|12188607|FG001|Overall Study|Withdrawal by Subject|2
7751620|NCT00751348|12188606|FG000|Overall Study|Migration from study area|1
7751621|NCT00751348|12188607|FG001|Overall Study|Migration from study area|0
7751622|NCT00751400|12188613|FG000|Overall Study|Lost to Follow-up|10
7751623|NCT00751621|12188626|FG000|Overall Study|Adverse Event|1
7751624|NCT00751621|12188626|FG000|Overall Study|Withdrawal by Subject|1
7751625|NCT00751621|12188626|FG000|Overall Study|Subject moved to another country|1
7751626|NCT00751621|12188626|FG000|Overall Study|Poor adherence to asthma treatment|1
7751627|NCT00751790|12188646|FG000|Overall Study|Lost to Follow-up|1
7751628|NCT00751790|12188646|FG000|Overall Study|Death|3
7751629|NCT00751790|12188646|FG000|Overall Study|Withdrawal by Subject|1
7751630|NCT00751881|12188653|FG000|Core Treatment Period|Not treated|1
7751631|NCT00751881|12188654|FG001|Core Treatment Period|Not treated|1
7751632|NCT00751881|12188655|FG002|Core Treatment Period|Not treated|2
7751633|NCT00751881|12188653|FG000|Core Treatment Period|Adverse Event|26
7751634|NCT00751881|12188654|FG001|Core Treatment Period|Adverse Event|54
7751635|NCT00751881|12188655|FG002|Core Treatment Period|Adverse Event|58
7751636|NCT00751881|12188653|FG000|Core Treatment Period|Lack of Efficacy|37
7751637|NCT00751881|12188654|FG001|Core Treatment Period|Lack of Efficacy|30
7751638|NCT00751881|12188655|FG002|Core Treatment Period|Lack of Efficacy|20
7751639|NCT00751881|12188653|FG000|Core Treatment Period|Poor compliance to protocol|15
7751640|NCT00751881|12188654|FG001|Core Treatment Period|Poor compliance to protocol|3
7751641|NCT00751881|12188655|FG002|Core Treatment Period|Poor compliance to protocol|4
7751642|NCT00751881|12188653|FG000|Core Treatment Period|Lost to Follow-up|6
7751643|NCT00751881|12188654|FG001|Core Treatment Period|Lost to Follow-up|4
7751644|NCT00751881|12188655|FG002|Core Treatment Period|Lost to Follow-up|3
7751645|NCT00751881|12188653|FG000|Core Treatment Period|Other: protocol deviation|3
7751646|NCT00751881|12188654|FG001|Core Treatment Period|Other: protocol deviation|3
7751647|NCT00751881|12188655|FG002|Core Treatment Period|Other: protocol deviation|7
7751648|NCT00751881|12188653|FG000|Core Treatment Period|Other: wish to parent|5
7751649|NCT00751881|12188654|FG001|Core Treatment Period|Other: wish to parent|7
7751650|NCT00751881|12188655|FG002|Core Treatment Period|Other: wish to parent|4
7751651|NCT00751881|12188653|FG000|Core Treatment Period|Other: personal/family constraints|6
7751652|NCT00751881|12188654|FG001|Core Treatment Period|Other: personal/family constraints|7
7751653|NCT00751881|12188655|FG002|Core Treatment Period|Other: personal/family constraints|10
7751654|NCT00751881|12188653|FG000|Core Treatment Period|Other: MS treatment change|6
7751655|NCT00751881|12188654|FG001|Core Treatment Period|Other: MS treatment change|4
7751656|NCT00751881|12188655|FG002|Core Treatment Period|Other: MS treatment change|4
7751657|NCT00751881|12188653|FG000|Core Treatment Period|Other: tolerability complaints|2
7751658|NCT00751881|12188654|FG001|Core Treatment Period|Other: tolerability complaints|0
7751659|NCT00751881|12188655|FG002|Core Treatment Period|Other: tolerability complaints|0
7751660|NCT00751881|12188653|FG000|Core Treatment Period|Other:participant's decision/unspecified|19
7751661|NCT00751881|12188654|FG001|Core Treatment Period|Other:participant's decision/unspecified|22
7751662|NCT00751881|12188655|FG002|Core Treatment Period|Other:participant's decision/unspecified|16
7751663|NCT00751881|12188653|FG000|Extension Study Period|Adverse Event|18
7751664|NCT00751881|12188654|FG001|Extension Study Period|Adverse Event|20
7751665|NCT00751881|12188655|FG002|Extension Study Period|Adverse Event|21
7751666|NCT00751881|12188653|FG000|Extension Study Period|Lack of Efficacy|14
7751667|NCT00751881|12188654|FG001|Extension Study Period|Lack of Efficacy|10
7751668|NCT00751881|12188655|FG002|Extension Study Period|Lack of Efficacy|20
7751669|NCT00751881|12188653|FG000|Extension Study Period|Lost to Follow-up|4
7751670|NCT00751881|12188654|FG001|Extension Study Period|Lost to Follow-up|9
7751671|NCT00751881|12188655|FG002|Extension Study Period|Lost to Follow-up|6
7751672|NCT00751881|12188653|FG000|Extension Study Period|Poor Compliance to Protocol|3
7751673|NCT00751881|12188654|FG001|Extension Study Period|Poor Compliance to Protocol|2
7751674|NCT00751881|12188655|FG002|Extension Study Period|Poor Compliance to Protocol|1
7751675|NCT00751881|12188653|FG000|Extension Study Period|Other than specified above|26
7751676|NCT00751881|12188654|FG001|Extension Study Period|Other than specified above|30
7751677|NCT00751881|12188655|FG002|Extension Study Period|Other than specified above|18
7751678|NCT00751998|12188677|FG000|Overall Study|Lost to Follow-up|7
7751679|NCT00751998|12188677|FG000|Overall Study|Death|11
7751680|NCT00751998|12188677|FG000|Overall Study|Withdrawal by Subject|2
7769600|NCT00869401|12213183|FG001|Overall Study|Withdrawal by Subject|0
7769601|NCT00869401|12213184|FG002|Overall Study|Withdrawal by Subject|0
7769602|NCT00869401|12213185|FG003|Overall Study|Withdrawal by Subject|5
7769603|NCT00869401|12213186|FG004|Overall Study|Withdrawal by Subject|3
7769604|NCT00869440|12213202|FG000|Overall Study|Withdrawal by Subject|1
7769605|NCT00869440|12213203|FG001|Overall Study|Withdrawal by Subject|0
7769606|NCT00869440|12213204|FG002|Overall Study|Withdrawal by Subject|0
7769607|NCT00869440|12213205|FG003|Overall Study|Withdrawal by Subject|0
7769608|NCT00869440|12213202|FG000|Overall Study|Physician Decision|1
7769609|NCT00869440|12213203|FG001|Overall Study|Physician Decision|1
7769610|NCT00869440|12213204|FG002|Overall Study|Physician Decision|0
7769611|NCT00869440|12213205|FG003|Overall Study|Physician Decision|0
7769612|NCT00869518|12213217|FG000|Overall Study|Lost to Follow-up|1
7769613|NCT00869518|12213218|FG001|Overall Study|Lost to Follow-up|1
7769614|NCT00869557|12213226|FG000|Randomized Phase|Lost to Follow-up|2
7769615|NCT00869557|12213227|FG001|Randomized Phase|Lost to Follow-up|1
7769616|NCT00869557|12213226|FG000|Randomized Phase|Investigator's Discretion|1
7769617|NCT00869557|12213227|FG001|Randomized Phase|Investigator's Discretion|0
7769618|NCT00869557|12213226|FG000|Randomized Phase|Withdrew Consent|0
7769619|NCT00869557|12213227|FG001|Randomized Phase|Withdrew Consent|1
7769620|NCT00869557|12213226|FG000|Extension Phase|Adverse Event|2
7769621|NCT00869557|12213227|FG001|Extension Phase|Adverse Event|2
7769622|NCT00869557|12213226|FG000|Extension Phase|Lack of Efficacy|1
7769623|NCT00869557|12213227|FG001|Extension Phase|Lack of Efficacy|0
7769624|NCT00869557|12213226|FG000|Extension Phase|Lost to Follow-up|3
7751681|NCT00752089|12188681|FG000|Overall Study|Adverse Event|1
7751682|NCT00752089|12188681|FG000|Overall Study|Protocol Deviation|2
7751683|NCT00752089|12188681|FG000|Overall Study|Could not attend visit 9|1
7751684|NCT00752089|12188681|FG000|Overall Study|Not capable of wearing partial denture|1
7751685|NCT00752089|12188681|FG000|Overall Study|Cannot continue the study|1
7751686|NCT00752128|12188701|FG000|Overall Study|Withdrawal by Subject|4
7751687|NCT00752206|12188708|FG000|Overall Study|Disease progression|8
7751688|NCT00752206|12188709|FG001|Overall Study|Disease progression|11
7751689|NCT00752206|12188708|FG000|Overall Study|Pregnancy|1
7751690|NCT00752206|12188709|FG001|Overall Study|Pregnancy|0
7751691|NCT00752219|12188717|FG000|Overall Study|Clinical failure|0
7751692|NCT00752219|12188718|FG001|Overall Study|Clinical failure|1
7751693|NCT00752219|12188717|FG000|Overall Study|Adverse Event|5
7751694|NCT00752219|12188718|FG001|Overall Study|Adverse Event|3
7751695|NCT00752219|12188717|FG000|Overall Study|Protocol deviation|1
7751696|NCT00752219|12188718|FG001|Overall Study|Protocol deviation|0
7751697|NCT00752219|12188717|FG000|Overall Study|Lost to Follow-up|1
7751698|NCT00752219|12188718|FG001|Overall Study|Lost to Follow-up|2
7751699|NCT00752219|12188717|FG000|Overall Study|Randomized but not treated|1
7751700|NCT00752219|12188718|FG001|Overall Study|Randomized but not treated|0
7751701|NCT00752219|12188717|FG000|Overall Study|Other|3
7751702|NCT00752219|12188718|FG001|Overall Study|Other|0
7751703|NCT00752232|12188731|FG000|Overall Study|Protocol Violation|0
7751704|NCT00752232|12188732|FG001|Overall Study|Protocol Violation|0
7751705|NCT00752232|12188733|FG002|Overall Study|Protocol Violation|0
7751706|NCT00752232|12188734|FG003|Overall Study|Protocol Violation|0
7751707|NCT00752232|12188735|FG004|Overall Study|Protocol Violation|0
7751708|NCT00752232|12188736|FG005|Overall Study|Protocol Violation|1
7751709|NCT00752232|12188737|FG006|Overall Study|Protocol Violation|0
7751710|NCT00752232|12188731|FG000|Overall Study|Caregiver request|2
7751711|NCT00752232|12188732|FG001|Overall Study|Caregiver request|0
7751712|NCT00752232|12188733|FG002|Overall Study|Caregiver request|0
7751713|NCT00752232|12188734|FG003|Overall Study|Caregiver request|0
7751714|NCT00752232|12188735|FG004|Overall Study|Caregiver request|1
7751715|NCT00752232|12188736|FG005|Overall Study|Caregiver request|0
7751716|NCT00752232|12188737|FG006|Overall Study|Caregiver request|0
7751717|NCT00752232|12188731|FG000|Overall Study|Investigator request|0
7751718|NCT00752232|12188732|FG001|Overall Study|Investigator request|0
7751719|NCT00752232|12188733|FG002|Overall Study|Investigator request|0
7751720|NCT00752232|12188734|FG003|Overall Study|Investigator request|0
7751721|NCT00752232|12188735|FG004|Overall Study|Investigator request|1
7751722|NCT00752232|12188736|FG005|Overall Study|Investigator request|0
7751723|NCT00752232|12188737|FG006|Overall Study|Investigator request|0
7751724|NCT00752232|12188731|FG000|Overall Study|Subject request|0
7751725|NCT00752232|12188732|FG001|Overall Study|Subject request|0
7751726|NCT00752232|12188733|FG002|Overall Study|Subject request|1
7751727|NCT00752232|12188734|FG003|Overall Study|Subject request|0
7751728|NCT00752232|12188735|FG004|Overall Study|Subject request|0
7751729|NCT00752232|12188736|FG005|Overall Study|Subject request|0
7751730|NCT00752232|12188737|FG006|Overall Study|Subject request|0
7751731|NCT00752232|12188731|FG000|Overall Study|Group home admission|0
7751732|NCT00752232|12188732|FG001|Overall Study|Group home admission|0
7751733|NCT00752232|12188733|FG002|Overall Study|Group home admission|0
7751734|NCT00752232|12188734|FG003|Overall Study|Group home admission|1
7751735|NCT00752232|12188735|FG004|Overall Study|Group home admission|0
7751736|NCT00752232|12188736|FG005|Overall Study|Group home admission|0
7751737|NCT00752232|12188737|FG006|Overall Study|Group home admission|0
7751738|NCT00752232|12188731|FG000|Overall Study|Caregiver could not attend the subject|0
7751739|NCT00752232|12188732|FG001|Overall Study|Caregiver could not attend the subject|0
7751740|NCT00752232|12188733|FG002|Overall Study|Caregiver could not attend the subject|0
7751741|NCT00752232|12188734|FG003|Overall Study|Caregiver could not attend the subject|0
7751742|NCT00752232|12188735|FG004|Overall Study|Caregiver could not attend the subject|1
7751743|NCT00752232|12188736|FG005|Overall Study|Caregiver could not attend the subject|0
7751744|NCT00752232|12188737|FG006|Overall Study|Caregiver could not attend the subject|0
7751745|NCT00752557|12188757|FG000|Overall Study|Withdrawal by Subject|4
7751746|NCT00752557|12188758|FG001|Overall Study|Withdrawal by Subject|3
7751747|NCT00752557|12188759|FG002|Overall Study|Withdrawal by Subject|3
7751748|NCT00752557|12188757|FG000|Overall Study|Unspecified resaons|0
7751749|NCT00752557|12188758|FG001|Overall Study|Unspecified resaons|2
7751750|NCT00752557|12188759|FG002|Overall Study|Unspecified resaons|2
7751751|NCT00752557|12188757|FG000|Overall Study|Lost to Follow-up|1
7751752|NCT00752557|12188758|FG001|Overall Study|Lost to Follow-up|0
7751753|NCT00752557|12188759|FG002|Overall Study|Lost to Follow-up|1
7751754|NCT00752609|12188771|FG000|Overall Study|Adverse Event|2
7751755|NCT00752609|12188772|FG001|Overall Study|Adverse Event|2
7751756|NCT00752609|12188771|FG000|Overall Study|Withdrawal by Subject|3
7751757|NCT00752609|12188772|FG001|Overall Study|Withdrawal by Subject|0
7751758|NCT00752609|12188771|FG000|Overall Study|Physician Decision|1
7751759|NCT00752609|12188772|FG001|Overall Study|Physician Decision|0
7751760|NCT00752609|12188771|FG000|Overall Study|Death|1
7751761|NCT00752609|12188772|FG001|Overall Study|Death|0
7751762|NCT00752609|12188771|FG000|Overall Study|Met exclusion criteria|1
7751763|NCT00752609|12188772|FG001|Overall Study|Met exclusion criteria|0
7751764|NCT00752609|12188771|FG000|Overall Study|Received Aranesp in error|1
7751765|NCT00752609|12188772|FG001|Overall Study|Received Aranesp in error|0
7751766|NCT00752622|12188781|FG000|Induction Phase|Adverse Event|3
7751767|NCT00752622|12188781|FG000|Induction Phase|Other|3
7751768|NCT00752622|12188781|FG000|Induction Phase|Non-responder|14
7751769|NCT00752622|12188781|FG000|Induction Phase|Withdrawal by Subject|1
7751770|NCT00752622|12188781|FG000|Induction Phase|Premature study termination|14
7751771|NCT00752622|12188781|FG000|Observational Phase|Premature Study Termination|36
7751772|NCT00752622|12188781|FG000|Observational Phase|Non-responder|2
7751773|NCT00752622|12188781|FG000|Observational Phase|Withdrawal by Subject|2
7751774|NCT00752622|12188781|FG000|Observational Phase|Adverse Event|1
7751775|NCT00752622|12188781|FG000|Observational Phase|Other|2
7751776|NCT00752622|12188781|FG000|Interventional Phase|Non-responder|2
7751777|NCT00752622|12188781|FG000|Interventional Phase|Physician Decision|1
7751778|NCT00752622|12188781|FG000|Interventional Phase|Premature Study Termination|5
7751779|NCT00752726|12188788|FG000|Overall Study|Lost to Follow-up|2
7751780|NCT00752726|12188789|FG001|Overall Study|Lost to Follow-up|1
7751781|NCT00752726|12188788|FG000|Overall Study|Adverse Event|3
7751782|NCT00752726|12188789|FG001|Overall Study|Adverse Event|0
7751783|NCT00752726|12188788|FG000|Overall Study|Withdrawal by Subject|5
7751784|NCT00752726|12188789|FG001|Overall Study|Withdrawal by Subject|10
7751785|NCT00752726|12188788|FG000|Overall Study|Other Reason|1
7751786|NCT00752726|12188789|FG001|Overall Study|Other Reason|2
7751787|NCT00752791|12188795|FG000|Overall Study|Adverse Event|7
7751788|NCT00752791|12188795|FG000|Overall Study|Withdrawal by Subject|1
7751789|NCT00752791|12188795|FG000|Overall Study|Physician Decision|1
7751790|NCT00752791|12188795|FG000|Overall Study|Death|1
7751791|NCT00752791|12188795|FG000|Overall Study|Renal transplant|3
7751792|NCT00752791|12188795|FG000|Overall Study|Switched to hemodialysis|2
7751793|NCT00752791|12188795|FG000|Overall Study|Protocol deviation|1
7751794|NCT00752856|12188801|FG000|Overall Study|randomized but did not do viral kinetics|0
7751795|NCT00752856|12188802|FG001|Overall Study|randomized but did not do viral kinetics|1
7751796|NCT00752895|12188810|FG000|Overall Study|Withdrawal by Subject|8
7751797|NCT00752895|12188811|FG001|Overall Study|Withdrawal by Subject|3
7751798|NCT00753012|12188834|FG000|Overall Study|Ineligible, abnormal cardiac histo|1
7751799|NCT00753012|12188835|FG001|Overall Study|Ineligible, abnormal cardiac histo|0
7751800|NCT00753012|12188834|FG000|Overall Study|Adverse Event|2
7751801|NCT00753012|12188835|FG001|Overall Study|Adverse Event|0
7751802|NCT00753012|12188834|FG000|Overall Study|Withdrawal by Subject|0
7751803|NCT00753012|12188835|FG001|Overall Study|Withdrawal by Subject|1
7751804|NCT00753012|12188834|FG000|Overall Study|Lost to Follow-up|4
7751805|NCT00753012|12188835|FG001|Overall Study|Lost to Follow-up|0
7751806|NCT00753012|12188834|FG000|Overall Study|Confounded endpoint data|1
7751807|NCT00753012|12188835|FG001|Overall Study|Confounded endpoint data|0
7751808|NCT00753272|12188861|FG000|Overall Study|Adverse Event|878
7751809|NCT00753272|12188862|FG001|Overall Study|Adverse Event|869
7751810|NCT00753272|12188861|FG000|Overall Study|Protocol Violation|28
7751811|NCT00753272|12188862|FG001|Overall Study|Protocol Violation|46
7751812|NCT00753272|12188861|FG000|Overall Study|Withdrawal by Subject|2481
7751813|NCT00753272|12188862|FG001|Overall Study|Withdrawal by Subject|2407
7751814|NCT00753272|12188861|FG000|Overall Study|Lost to Follow-up|491
7751815|NCT00753272|12188862|FG001|Overall Study|Lost to Follow-up|497
7751816|NCT00753272|12188861|FG000|Overall Study|Other|1104
7751817|NCT00753272|12188862|FG001|Overall Study|Other|1088
7751818|NCT00753415|12188899|FG000|Part A|Disease progression|1
7751819|NCT00753415|12188900|FG001|Part A|Disease progression|0
7751820|NCT00753415|12188901|FG002|Part A|Disease progression|1
7751821|NCT00753415|12188902|FG003|Part A|Disease progression|2
7751822|NCT00753415|12188903|FG004|Part A|Disease progression|0
7751823|NCT00753415|12188904|FG005|Part A|Disease progression|0
7751824|NCT00753415|12188905|FG006|Part A|Disease progression|0
7751825|NCT00753415|12188906|FG007|Part A|Disease progression|0
7751826|NCT00753415|12188907|FG008|Part A|Disease progression|0
7751827|NCT00753415|12188908|FG009|Part A|Disease progression|0
7751828|NCT00753415|12188899|FG000|Part A|Withdrawal by Subject|0
7751829|NCT00753415|12188900|FG001|Part A|Withdrawal by Subject|0
7751830|NCT00753415|12188901|FG002|Part A|Withdrawal by Subject|1
7751831|NCT00753415|12188902|FG003|Part A|Withdrawal by Subject|0
7751832|NCT00753415|12188903|FG004|Part A|Withdrawal by Subject|0
7751833|NCT00753415|12188904|FG005|Part A|Withdrawal by Subject|0
7751834|NCT00753415|12188905|FG006|Part A|Withdrawal by Subject|0
7751835|NCT00753415|12188906|FG007|Part A|Withdrawal by Subject|0
7751836|NCT00753415|12188907|FG008|Part A|Withdrawal by Subject|0
7751837|NCT00753415|12188908|FG009|Part A|Withdrawal by Subject|0
7751838|NCT00753415|12188899|FG000|Part B|Lost to Follow-up|0
7751839|NCT00753415|12188900|FG001|Part B|Lost to Follow-up|0
7751840|NCT00753415|12188901|FG002|Part B|Lost to Follow-up|0
7751841|NCT00753415|12188902|FG003|Part B|Lost to Follow-up|0
7751842|NCT00753415|12188903|FG004|Part B|Lost to Follow-up|0
7751843|NCT00753415|12188904|FG005|Part B|Lost to Follow-up|0
7751844|NCT00753415|12188905|FG006|Part B|Lost to Follow-up|0
7751845|NCT00753415|12188906|FG007|Part B|Lost to Follow-up|1
7751846|NCT00753415|12188907|FG008|Part B|Lost to Follow-up|1
7751847|NCT00753415|12188908|FG009|Part B|Lost to Follow-up|0
7751848|NCT00753415|12188899|FG000|Part B|Disease progression|0
7751849|NCT00753415|12188900|FG001|Part B|Disease progression|0
7751850|NCT00753415|12188901|FG002|Part B|Disease progression|0
7751851|NCT00753415|12188902|FG003|Part B|Disease progression|0
7751852|NCT00753415|12188903|FG004|Part B|Disease progression|0
7751853|NCT00753415|12188904|FG005|Part B|Disease progression|0
7751854|NCT00753415|12188905|FG006|Part B|Disease progression|0
7751855|NCT00753415|12188906|FG007|Part B|Disease progression|0
7751856|NCT00753415|12188907|FG008|Part B|Disease progression|2
7751857|NCT00753415|12188908|FG009|Part B|Disease progression|1
7751858|NCT00753454|12188932|FG000|Overall Study|Adverse Event|4
7751859|NCT00753454|12188932|FG000|Overall Study|Lack of Efficacy|1
7751860|NCT00753454|12188932|FG000|Overall Study|Lost to Follow-up|3
7751861|NCT00753454|12188932|FG000|Overall Study|Withdrawal by Subject|5
7751862|NCT00753454|12188932|FG000|Overall Study|Investigator Decision|1
7751863|NCT00753506|12188938|FG000|Overall Study|Withdrawal by Subject|4
7751864|NCT00753506|12188939|FG001|Overall Study|Withdrawal by Subject|1
7751865|NCT00753506|12188938|FG000|Overall Study|Lost to Follow-up|2
7751866|NCT00753506|12188939|FG001|Overall Study|Lost to Follow-up|0
7751867|NCT00753506|12188938|FG000|Overall Study|Other reason|1
7751868|NCT00753506|12188939|FG001|Overall Study|Other reason|1
7751869|NCT00753519|12188947|FG000|Overall Study|Withdrawal by Subject|0
7751870|NCT00753519|12188948|FG001|Overall Study|Withdrawal by Subject|2
7751871|NCT00753623|12188958|FG000|Phase I (14 Days)|Withdrawal by Subject|1
7751872|NCT00753623|12188959|FG001|Phase I (14 Days)|Withdrawal by Subject|1
7751873|NCT00753623|12188958|FG000|Phase I (14 Days)|Physician Decision|1
7751874|NCT00753623|12188959|FG001|Phase I (14 Days)|Physician Decision|2
7751875|NCT00753623|12188958|FG000|Phase I (14 Days)|Adverse Event|0
7751876|NCT00753623|12188959|FG001|Phase I (14 Days)|Adverse Event|1
7751877|NCT00753623|12188958|FG000|Washout (7 Days)|Physician Decision|1
7751878|NCT00753623|12188959|FG001|Washout (7 Days)|Physician Decision|0
7751879|NCT00753623|12188958|FG000|Phase II (14 Days)|Physician Decision|0
7751880|NCT00753623|12188959|FG001|Phase II (14 Days)|Physician Decision|1
7751881|NCT00753649|12188971|FG000|Overall Study|Migrated/moved from study area|1
7751882|NCT00753649|12188972|FG001|Overall Study|Migrated/moved from study area|0
7751883|NCT00753649|12188971|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3
7751884|NCT00753649|12188972|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0
7751885|NCT00753649|12188971|FG000|Overall Study|Lost to follow-up-complete vaccination|1
7751886|NCT00753649|12188972|FG001|Overall Study|Lost to follow-up-complete vaccination|0
7751887|NCT00753649|12188971|FG000|Overall Study|Protocol Violation|2
7751888|NCT00753649|12188972|FG001|Overall Study|Protocol Violation|0
7751889|NCT00753675|12188981|FG000|Overall Study|other reason|11
7751890|NCT00753675|12188982|FG001|Overall Study|other reason|12
7751891|NCT00753675|12188983|FG002|Overall Study|other reason|13
7751892|NCT00753675|12188981|FG000|Overall Study|Death|1
7751893|NCT00753675|12188982|FG001|Overall Study|Death|2
7751894|NCT00753675|12188983|FG002|Overall Study|Death|4
7751895|NCT00753675|12188981|FG000|Overall Study|Adverse Event|11
7751896|NCT00753675|12188982|FG001|Overall Study|Adverse Event|9
7751897|NCT00753675|12188983|FG002|Overall Study|Adverse Event|4
7751898|NCT00753675|12188981|FG000|Overall Study|Objective progression of disease|35
7751899|NCT00753675|12188982|FG001|Overall Study|Objective progression of disease|35
7751900|NCT00753675|12188983|FG002|Overall Study|Objective progression of disease|35
7751901|NCT00753675|12188981|FG000|Overall Study|Withdrawal by Subject|0
7751902|NCT00753675|12188982|FG001|Overall Study|Withdrawal by Subject|1
7751903|NCT00753675|12188983|FG002|Overall Study|Withdrawal by Subject|0
7751904|NCT00753675|12188981|FG000|Overall Study|Lost to Follow-up|1
7751905|NCT00753675|12188982|FG001|Overall Study|Lost to Follow-up|0
7751906|NCT00753675|12188983|FG002|Overall Study|Lost to Follow-up|0
7751907|NCT00753688|12188993|FG000|Overall Study|Death|102
7751908|NCT00753688|12188994|FG001|Overall Study|Death|203
7751909|NCT00753688|12188993|FG000|Overall Study|Missing|4
7751910|NCT00753688|12188994|FG001|Overall Study|Missing|9
7751911|NCT00753688|12188993|FG000|Overall Study|Participant Withdrew Consent|2
7751912|NCT00753688|12188994|FG001|Overall Study|Participant Withdrew Consent|2
7751913|NCT00753688|12188993|FG000|Overall Study|Ongoing - in Follow-up|15
7751914|NCT00753688|12188994|FG001|Overall Study|Ongoing - in Follow-up|31
7751915|NCT00753688|12188993|FG000|Overall Study|Adverse Event|0
7751916|NCT00753688|12188994|FG001|Overall Study|Adverse Event|1
7751917|NCT00753714|12189002|FG000|Overall Study|Lack of Efficacy|21
7751918|NCT00753714|12189003|FG001|Overall Study|Lack of Efficacy|34
7751919|NCT00753714|12189002|FG000|Overall Study|Adverse Event|26
7751920|NCT00753714|12189003|FG001|Overall Study|Adverse Event|18
7751921|NCT00753714|12189002|FG000|Overall Study|Protocol Violation|1
7751922|NCT00753714|12189003|FG001|Overall Study|Protocol Violation|0
7751923|NCT00753714|12189002|FG000|Overall Study|Lost to Follow-up|0
7751924|NCT00753714|12189003|FG001|Overall Study|Lost to Follow-up|1
7751925|NCT00753714|12189002|FG000|Overall Study|Withdrawal by Subject|2
7751926|NCT00753714|12189003|FG001|Overall Study|Withdrawal by Subject|1
7751927|NCT00753714|12189002|FG000|Overall Study|Death|3
7751928|NCT00753714|12189003|FG001|Overall Study|Death|3
7751929|NCT00753714|12189002|FG000|Overall Study|Other|7
7751930|NCT00753714|12189003|FG001|Overall Study|Other|5
7751931|NCT00753766|12189014|FG000|Overall Study|Physician Decision|1
7751932|NCT00753766|12189015|FG001|Overall Study|Physician Decision|0
7751933|NCT00753896|12189022|FG000|Overall Study|Adverse Event|4
7751934|NCT00753896|12189022|FG000|Overall Study|Death|1
7751935|NCT00753896|12189022|FG000|Overall Study|Lost to Follow-up|2
7751936|NCT00753896|12189022|FG000|Overall Study|Protocol Violation|1
7751937|NCT00753896|12189022|FG000|Overall Study|Withdrawal by Subject|4
7751938|NCT00753896|12189022|FG000|Overall Study|Entry Criteria Not Met|4
7751939|NCT00753922|12189030|FG000|Overall Study|Lost to Follow-up|155
7751940|NCT00753922|12189031|FG001|Overall Study|Lost to Follow-up|24
7751941|NCT00753922|12189032|FG002|Overall Study|Lost to Follow-up|28
7751942|NCT00753922|12189033|FG003|Overall Study|Lost to Follow-up|5
7751943|NCT00753922|12189030|FG000|Overall Study|Withdrawal by Subject|9
7751944|NCT00753922|12189031|FG001|Overall Study|Withdrawal by Subject|11
7751945|NCT00753922|12189032|FG002|Overall Study|Withdrawal by Subject|4
7751946|NCT00753922|12189033|FG003|Overall Study|Withdrawal by Subject|2
7751947|NCT00753922|12189030|FG000|Overall Study|Patient Non-compliance|55
7751948|NCT00753922|12189031|FG001|Overall Study|Patient Non-compliance|22
7751949|NCT00753922|12189032|FG002|Overall Study|Patient Non-compliance|14
7751950|NCT00753922|12189033|FG003|Overall Study|Patient Non-compliance|11
7751951|NCT00753922|12189030|FG000|Overall Study|Patients Not Completing Visit|11
7751952|NCT00753922|12189031|FG001|Overall Study|Patients Not Completing Visit|0
7751953|NCT00753922|12189032|FG002|Overall Study|Patients Not Completing Visit|1
7751954|NCT00753922|12189033|FG003|Overall Study|Patients Not Completing Visit|0
7751955|NCT00753922|12189030|FG000|Overall Study|Death|2
7751956|NCT00753922|12189031|FG001|Overall Study|Death|23
7751957|NCT00753922|12189032|FG002|Overall Study|Death|2
7751958|NCT00753922|12189033|FG003|Overall Study|Death|1
7751959|NCT00753922|12189030|FG000|Overall Study|Discontinuation Due to Explantation|14
7751960|NCT00753922|12189031|FG001|Overall Study|Discontinuation Due to Explantation|14
7751961|NCT00753922|12189032|FG002|Overall Study|Discontinuation Due to Explantation|14
7751962|NCT00753922|12189033|FG003|Overall Study|Discontinuation Due to Explantation|4
7751963|NCT00754065|12189067|FG000|Overall Study|Never received treatment|12
7751964|NCT00754065|12189068|FG001|Overall Study|Never received treatment|2
7751965|NCT00754065|12189067|FG000|Overall Study|Adverse Event|19
7751966|NCT00754065|12189068|FG001|Overall Study|Adverse Event|25
7751967|NCT00754065|12189067|FG000|Overall Study|Lost to Follow-up|7
7751968|NCT00754065|12189068|FG001|Overall Study|Lost to Follow-up|11
7751969|NCT00754065|12189067|FG000|Overall Study|Protocol Violation|12
7751970|NCT00754065|12189068|FG001|Overall Study|Protocol Violation|10
7751971|NCT00754065|12189067|FG000|Overall Study|Withdrawal by Subject|4
7751972|NCT00754065|12189068|FG001|Overall Study|Withdrawal by Subject|5
7751973|NCT00754065|12189067|FG000|Overall Study|Pregnancy|6
7751974|NCT00754065|12189068|FG001|Overall Study|Pregnancy|0
7751975|NCT00754065|12189067|FG000|Overall Study|Reason not specified or unknown, etc.|21
7751976|NCT00754065|12189068|FG001|Overall Study|Reason not specified or unknown, etc.|27
7751977|NCT00754234|12189116|FG000|Overall Study|Withdrawal by Subject|3
7751978|NCT00754325|12189135|FG000|Initial Treatment|Continuing Active Treatment|4
7751979|NCT00754325|12189136|FG001|Initial Treatment|Continuing Active Treatment|5
7751980|NCT00754325|12189135|FG000|Initial Treatment|Adverse Event|7
7751981|NCT00754325|12189136|FG001|Initial Treatment|Adverse Event|6
7751982|NCT00754325|12189135|FG000|Initial Treatment|Withdrawal by Subject|2
7751983|NCT00754325|12189136|FG001|Initial Treatment|Withdrawal by Subject|2
7751984|NCT00754325|12189135|FG000|Initial Treatment|Physician Decision|2
7751985|NCT00754325|12189136|FG001|Initial Treatment|Physician Decision|0
7751986|NCT00754325|12189135|FG000|Initial Treatment|Sponsor Request|0
7751987|NCT00754325|12189136|FG001|Initial Treatment|Sponsor Request|1
7751988|NCT00754325|12189135|FG000|Initial Treatment|Disease Progression|35
7751989|NCT00754325|12189136|FG001|Initial Treatment|Disease Progression|35
7751990|NCT00754338|12189147|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
7751991|NCT00754338|12189148|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
7751992|NCT00754338|12189149|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
7751993|NCT00754338|12189150|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
7751994|NCT00754338|12189147|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
7751995|NCT00754338|12189148|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
7751996|NCT00754338|12189149|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
7751997|NCT00754338|12189150|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
7751998|NCT00754390|12189173|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
7751999|NCT00754390|12189173|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
7752000|NCT00754390|12189173|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
7752001|NCT00754390|12189173|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
7752002|NCT00754442|12189182|FG000|Overall Study|Withdrawal by Subject|5
7752003|NCT00754442|12189183|FG001|Overall Study|Withdrawal by Subject|3
7752004|NCT00754559|12189224|FG000|Overall Study|Adverse Event|15
7752005|NCT00754559|12189224|FG000|Overall Study|Protocol Violation|11
7752006|NCT00754559|12189224|FG000|Overall Study|Lack of Efficacy|10
7752007|NCT00754559|12189224|FG000|Overall Study|Lost to Follow-up|2
7752008|NCT00754559|12189224|FG000|Overall Study|Administrative reason|1
7752009|NCT00754559|12189224|FG000|Overall Study|Other|5
7752010|NCT00754559|12189224|FG000|Overall Study|Withdrawal by Subject|3
7752011|NCT00754572|12189231|FG000|Overall Study|Adverse Event|19
7752012|NCT00754572|12189231|FG000|Overall Study|Other|39
7752013|NCT00754572|12189231|FG000|Overall Study|Protocol Violation|3
7752014|NCT00754572|12189231|FG000|Overall Study|Withdrawal by Subject|3
7752015|NCT00754572|12189231|FG000|Overall Study|Lack of Efficacy|2
7752016|NCT00754572|12189231|FG000|Overall Study|Death|1
7752017|NCT00754572|12189231|FG000|Overall Study|Administrative Reason|3
7752018|NCT00754572|12189231|FG000|Overall Study|Lost to Follow-up|1
7752019|NCT00754624|12189235|FG000|Overall Study|Adverse Event|16
7752020|NCT00754624|12189235|FG000|Overall Study|Death|1
7752021|NCT00754624|12189235|FG000|Overall Study|Physician Decision|8
7752022|NCT00754624|12189235|FG000|Overall Study|Protocol Violation|1
7752023|NCT00754624|12189235|FG000|Overall Study|Withdrawal by Subject|28
7752024|NCT00754624|12189235|FG000|Overall Study|Various|12
7752025|NCT00754624|12189235|FG000|Overall Study|Lost to Follow-up|3
7752026|NCT00754650|12189239|FG000|Overall Study|Disease Progression|2
7752027|NCT00754741|12189246|FG000|Overall Study|Died or disenrolled|57
7752028|NCT00754741|12189247|FG001|Overall Study|Died or disenrolled|69
7752029|NCT00754741|12189248|FG002|Overall Study|Died or disenrolled|54
7752030|NCT00754936|12189278|FG000|Overall Study|Lost to Follow-up|3
7752031|NCT00754936|12189278|FG000|Overall Study|Physician Decision|1
7752032|NCT00754936|12189278|FG000|Overall Study|Withdrawal by Subject|2
7752033|NCT00754936|12189278|FG000|Overall Study|Side Effects|3
7752034|NCT00754936|12189278|FG000|Overall Study|Inter-current medical events|3
7752035|NCT00755079|12189293|FG000|Overall Study|Lost to Follow-up|1
7752036|NCT00755079|12189294|FG001|Overall Study|Lost to Follow-up|3
7752037|NCT00755079|12189293|FG000|Overall Study|Adverse Event|0
7752038|NCT00755079|12189294|FG001|Overall Study|Adverse Event|1
7752039|NCT00755079|12189293|FG000|Overall Study|Withdrawal by Subject|0
7752040|NCT00755079|12189294|FG001|Overall Study|Withdrawal by Subject|2
7752041|NCT00755105|12189303|FG000|Overall Study|Withdrawal by Subject|9
7752042|NCT00755105|12189304|FG001|Overall Study|Withdrawal by Subject|11
7752043|NCT00755105|12189305|FG002|Overall Study|Withdrawal by Subject|4
7752044|NCT00755183|12189324|FG000|Overall Study|Adverse Event|5
7752045|NCT00755183|12189325|FG001|Overall Study|Adverse Event|2
7752046|NCT00755183|12189324|FG000|Overall Study|Protocol Violation|0
7752047|NCT00755183|12189325|FG001|Overall Study|Protocol Violation|1
7752048|NCT00755183|12189324|FG000|Overall Study|Withdrawal by Subject|0
7752049|NCT00755183|12189325|FG001|Overall Study|Withdrawal by Subject|2
7752050|NCT00755183|12189324|FG000|Overall Study|Administrative|2
7752051|NCT00755183|12189325|FG001|Overall Study|Administrative|1
7752052|NCT00755196|12189333|FG000|Overall Study|Lost to Follow-up|1
7752053|NCT00755196|12189333|FG000|Overall Study|Lack of Efficiency|1
7752054|NCT00755222|12189340|FG000|Overall Study|Withdrawal by Subject|4
7752055|NCT00755222|12189341|FG001|Overall Study|Withdrawal by Subject|2
7752056|NCT00755222|12189340|FG000|Overall Study|Adverse Event|2
7752057|NCT00755222|12189341|FG001|Overall Study|Adverse Event|0
7752058|NCT00755222|12189340|FG000|Overall Study|Protocol Violation|2
7752059|NCT00755222|12189341|FG001|Overall Study|Protocol Violation|0
7752060|NCT00755326|12189367|FG000|Overall Study|Lost to Follow-up|2
7752061|NCT00755326|12189368|FG001|Overall Study|Lost to Follow-up|3
7752062|NCT00755417|12189378|FG000|Overall Study|Adverse Event|28
7752063|NCT00755417|12189379|FG001|Overall Study|Adverse Event|20
7752064|NCT00755417|12189380|FG002|Overall Study|Adverse Event|7
7752065|NCT00755417|12189378|FG000|Overall Study|Lack of Efficacy|8
7752066|NCT00755417|12189379|FG001|Overall Study|Lack of Efficacy|4
7752067|NCT00755417|12189380|FG002|Overall Study|Lack of Efficacy|9
7752068|NCT00755417|12189378|FG000|Overall Study|Protocol Violation|2
7752069|NCT00755417|12189379|FG001|Overall Study|Protocol Violation|1
7752070|NCT00755417|12189380|FG002|Overall Study|Protocol Violation|1
7752071|NCT00755417|12189378|FG000|Overall Study|Lost to Follow-up|3
7752072|NCT00755417|12189379|FG001|Overall Study|Lost to Follow-up|0
7752073|NCT00755417|12189380|FG002|Overall Study|Lost to Follow-up|1
7752074|NCT00755417|12189378|FG000|Overall Study|Withdrawal by Subject|12
7752075|NCT00755417|12189379|FG001|Overall Study|Withdrawal by Subject|12
7752076|NCT00755417|12189380|FG002|Overall Study|Withdrawal by Subject|12
7752077|NCT00755417|12189378|FG000|Overall Study|Not specified or missing data|9
7752078|NCT00755417|12189379|FG001|Overall Study|Not specified or missing data|18
7752079|NCT00755417|12189380|FG002|Overall Study|Not specified or missing data|12
7752080|NCT00755716|12189391|FG000|Overall Study|Adverse Event|1
7752081|NCT00755716|12189392|FG001|Overall Study|Adverse Event|4
7752082|NCT00755716|12189393|FG002|Overall Study|Adverse Event|1
7752083|NCT00755716|12189391|FG000|Overall Study|Lack of Efficacy|2
7752084|NCT00755716|12189392|FG001|Overall Study|Lack of Efficacy|0
7752085|NCT00755716|12189393|FG002|Overall Study|Lack of Efficacy|0
7752086|NCT00755716|12189391|FG000|Overall Study|Lost to Follow-up|5
7752087|NCT00755716|12189392|FG001|Overall Study|Lost to Follow-up|3
7752088|NCT00755716|12189393|FG002|Overall Study|Lost to Follow-up|1
7752089|NCT00755716|12189391|FG000|Overall Study|work schedule issues|0
7752090|NCT00755716|12189392|FG001|Overall Study|work schedule issues|1
7752091|NCT00755716|12189393|FG002|Overall Study|work schedule issues|1
7752092|NCT00755807|12189416|FG000|Acute Phase|Adverse Event|16
7752093|NCT00755807|12189417|FG001|Acute Phase|Adverse Event|5
7752094|NCT00755807|12189416|FG000|Acute Phase|Protocol Violation|1
7752095|NCT00755807|12189417|FG001|Acute Phase|Protocol Violation|3
7752096|NCT00755807|12189416|FG000|Acute Phase|Withdrawal by Subject|1
7752097|NCT00755807|12189417|FG001|Acute Phase|Withdrawal by Subject|2
7752098|NCT00755807|12189416|FG000|Acute Phase|Lack of Efficacy|0
7752099|NCT00755807|12189417|FG001|Acute Phase|Lack of Efficacy|1
7752100|NCT00755807|12189416|FG000|Acute Phase|Physician Decision|0
7752101|NCT00755807|12189417|FG001|Acute Phase|Physician Decision|1
7752102|NCT00755807|12189416|FG000|Open-label Extension Phase|Adverse Event|7
7752103|NCT00755807|12189417|FG001|Open-label Extension Phase|Adverse Event|7
7752104|NCT00755807|12189416|FG000|Open-label Extension Phase|Protocol Violation|5
7752105|NCT00755807|12189417|FG001|Open-label Extension Phase|Protocol Violation|2
7752106|NCT00755807|12189416|FG000|Open-label Extension Phase|Lack of Efficacy|3
7752107|NCT00755807|12189417|FG001|Open-label Extension Phase|Lack of Efficacy|3
7752108|NCT00755807|12189416|FG000|Open-label Extension Phase|Withdrawal by Subject|1
7752109|NCT00755807|12189417|FG001|Open-label Extension Phase|Withdrawal by Subject|3
7752110|NCT00755807|12189416|FG000|Open-label Extension Phase|Lost to Follow-up|2
7752111|NCT00755807|12189417|FG001|Open-label Extension Phase|Lost to Follow-up|0
7752112|NCT00755807|12189416|FG000|Open-label Extension Phase|Sponsor Decision|0
7752113|NCT00755807|12189417|FG001|Open-label Extension Phase|Sponsor Decision|1
7752114|NCT00755846|12189433|FG000|Overall Study|Adverse Event|0
7752115|NCT00755846|12189434|FG001|Overall Study|Adverse Event|0
7752116|NCT00755846|12189435|FG002|Overall Study|Adverse Event|0
7752117|NCT00755846|12189436|FG003|Overall Study|Adverse Event|1
7752118|NCT00755846|12189437|FG004|Overall Study|Adverse Event|3
7752119|NCT00755846|12189438|FG005|Overall Study|Adverse Event|2
7752120|NCT00755846|12189433|FG000|Overall Study|Protocol Violation|1
7752121|NCT00755846|12189434|FG001|Overall Study|Protocol Violation|1
7752122|NCT00755846|12189435|FG002|Overall Study|Protocol Violation|1
7752123|NCT00755846|12189436|FG003|Overall Study|Protocol Violation|1
7752124|NCT00755846|12189437|FG004|Overall Study|Protocol Violation|1
7752125|NCT00755846|12189438|FG005|Overall Study|Protocol Violation|1
7752126|NCT00755846|12189433|FG000|Overall Study|Lost to Follow-up|0
7752127|NCT00755846|12189434|FG001|Overall Study|Lost to Follow-up|2
7752128|NCT00755846|12189435|FG002|Overall Study|Lost to Follow-up|1
7752129|NCT00755846|12189436|FG003|Overall Study|Lost to Follow-up|0
7752130|NCT00755846|12189437|FG004|Overall Study|Lost to Follow-up|4
7752131|NCT00755846|12189438|FG005|Overall Study|Lost to Follow-up|2
7752132|NCT00755846|12189433|FG000|Overall Study|Withdrawal by Subject|2
7752133|NCT00755846|12189434|FG001|Overall Study|Withdrawal by Subject|3
7752134|NCT00755846|12189435|FG002|Overall Study|Withdrawal by Subject|5
7752135|NCT00755846|12189436|FG003|Overall Study|Withdrawal by Subject|2
7752136|NCT00755846|12189437|FG004|Overall Study|Withdrawal by Subject|0
7752137|NCT00755846|12189438|FG005|Overall Study|Withdrawal by Subject|1
7752138|NCT00755846|12189433|FG000|Overall Study|Hyperglycemic Rescue|21
7752139|NCT00755846|12189434|FG001|Overall Study|Hyperglycemic Rescue|7
7752140|NCT00755846|12189435|FG002|Overall Study|Hyperglycemic Rescue|5
7752141|NCT00755846|12189436|FG003|Overall Study|Hyperglycemic Rescue|8
7752142|NCT00755846|12189437|FG004|Overall Study|Hyperglycemic Rescue|8
7752143|NCT00755846|12189438|FG005|Overall Study|Hyperglycemic Rescue|7
7752144|NCT00755846|12189433|FG000|Overall Study|Physician Decision|1
7752145|NCT00755846|12189434|FG001|Overall Study|Physician Decision|3
7752146|NCT00755846|12189435|FG002|Overall Study|Physician Decision|0
7752147|NCT00755846|12189436|FG003|Overall Study|Physician Decision|1
7752148|NCT00755846|12189437|FG004|Overall Study|Physician Decision|0
7752149|NCT00755846|12189438|FG005|Overall Study|Physician Decision|1
7752150|NCT00755846|12189433|FG000|Overall Study|Administrative Error|0
7752151|NCT00755846|12189434|FG001|Overall Study|Administrative Error|1
7752152|NCT00755846|12189435|FG002|Overall Study|Administrative Error|0
7752153|NCT00755846|12189436|FG003|Overall Study|Administrative Error|0
7752154|NCT00755846|12189437|FG004|Overall Study|Administrative Error|0
7752155|NCT00755846|12189438|FG005|Overall Study|Administrative Error|0
7752156|NCT00755846|12189433|FG000|Overall Study|Participant Non-compliance|0
7752157|NCT00755846|12189434|FG001|Overall Study|Participant Non-compliance|0
7752158|NCT00755846|12189435|FG002|Overall Study|Participant Non-compliance|0
7752159|NCT00755846|12189436|FG003|Overall Study|Participant Non-compliance|0
7752160|NCT00755846|12189437|FG004|Overall Study|Participant Non-compliance|1
7752161|NCT00755846|12189438|FG005|Overall Study|Participant Non-compliance|0
7752162|NCT00755937|12189461|FG000|Recruitment|Unknown if infliximab received|164
7752163|NCT00755937|12189461|FG000|Observational Follow-up|Lost to Follow-up|148
7752164|NCT00756002|12189467|FG000|Double-Blind Treatment Period|Lack of Efficacy|1
7752165|NCT00756002|12189468|FG001|Double-Blind Treatment Period|Lack of Efficacy|1
7752166|NCT00756002|12189467|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7752167|NCT00756002|12189468|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
7752168|NCT00756002|12189467|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6
7752169|NCT00756002|12189468|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6
7752170|NCT00756002|12189467|FG000|Double-Blind Treatment Period|Protocol Violation|6
7752171|NCT00756002|12189468|FG001|Double-Blind Treatment Period|Protocol Violation|5
7752172|NCT00756002|12189467|FG000|Double-Blind Treatment Period|Other|2
7752173|NCT00756002|12189468|FG001|Double-Blind Treatment Period|Other|2
7752174|NCT00756275|12189506|FG000|Overall Study|Lost to Follow-up|25
7752175|NCT00756275|12189507|FG001|Overall Study|Lost to Follow-up|21
7752176|NCT00756275|12189506|FG000|Overall Study|Withdrawal by Subject|4
7752177|NCT00756275|12189507|FG001|Overall Study|Withdrawal by Subject|7
7752178|NCT00756314|12189515|FG000|Overall Study|Lost to Follow-up|2
7752179|NCT00756314|12189516|FG001|Overall Study|Lost to Follow-up|59
7752180|NCT00756444|12189524|FG000|Overall Study|Adverse Event|1
7752181|NCT00756444|12189525|FG001|Overall Study|Adverse Event|1
7752182|NCT00756444|12189524|FG000|Overall Study|Withdrawal by Subject|6
7752183|NCT00756444|12189525|FG001|Overall Study|Withdrawal by Subject|8
7752184|NCT00756444|12189524|FG000|Overall Study|Lost to Follow-up|0
7752185|NCT00756444|12189525|FG001|Overall Study|Lost to Follow-up|1
7752186|NCT00756444|12189524|FG000|Overall Study|Death|5
7752187|NCT00756444|12189525|FG001|Overall Study|Death|4
7752188|NCT00756444|12189524|FG000|Overall Study|Disease Progression|2
7752189|NCT00756444|12189525|FG001|Overall Study|Disease Progression|7
7752190|NCT00756444|12189524|FG000|Overall Study|Ineligibility Determined|1
7752191|NCT00756444|12189525|FG001|Overall Study|Ineligibility Determined|0
7752192|NCT00756457|12189534|FG000|Overall Study|Lost to Follow-up|1
7752193|NCT00756457|12189535|FG001|Overall Study|Lost to Follow-up|2
7752194|NCT00756470|12189557|FG000|Overall Study|Withdrawal by Subject|1
7752195|NCT00756470|12189557|FG000|Overall Study|Adverse Event|4
7752196|NCT00756652|12189604|FG000|Original Phase|Withdrawal by Subject|864
7752197|NCT00756652|12189605|FG001|Original Phase|Withdrawal by Subject|23
7752198|NCT00756652|12189604|FG000|Original Phase|Lost to Follow-up|601
7752199|NCT00756652|12189605|FG001|Original Phase|Lost to Follow-up|0
7752200|NCT00756652|12189604|FG000|Original Phase|Other Discontinuation|797
7752201|NCT00756652|12189605|FG001|Original Phase|Other Discontinuation|5
7752202|NCT00756652|12189604|FG000|Original Phase|Participant Noncompliance|18622
7752203|NCT00756652|12189605|FG001|Original Phase|Participant Noncompliance|424
7752204|NCT00756652|12189604|FG000|Original Phase|Unknown Discontinuation Reason|2
7752205|NCT00756652|12189605|FG001|Original Phase|Unknown Discontinuation Reason|0
7752206|NCT00756652|12189604|FG000|Original Phase|Participants without data|3259
7752207|NCT00756652|12189605|FG001|Original Phase|Participants without data|466
7752208|NCT00756652|12189604|FG000|Original Phase|Death|168
7752209|NCT00756652|12189605|FG001|Original Phase|Death|1
7752210|NCT00756652|12189604|FG000|Original Phase|Not due for F/U at Phase One closure|11076
7752211|NCT00756652|12189605|FG001|Original Phase|Not due for F/U at Phase One closure|2
7752212|NCT00756652|12189604|FG000|Re-Op Phase|Withdrawal by Subject|62
7752213|NCT00756652|12189605|FG001|Re-Op Phase|Withdrawal by Subject|0
7752214|NCT00756652|12189604|FG000|Re-Op Phase|Death|6
7752215|NCT00756652|12189605|FG001|Re-Op Phase|Death|0
7752216|NCT00756652|12189604|FG000|Re-Op Phase|Lost to Follow-up|340
7752217|NCT00756652|12189605|FG001|Re-Op Phase|Lost to Follow-up|0
7752218|NCT00756652|12189604|FG000|Re-Op Phase|Site Closed|2454
7752219|NCT00756652|12189605|FG001|Re-Op Phase|Site Closed|0
7752220|NCT00756652|12189604|FG000|Re-Op Phase|Withdrawn after explant|14
7752221|NCT00756652|12189605|FG001|Re-Op Phase|Withdrawn after explant|0
7752222|NCT00756717|12189614|FG000|Overall Study|Withdrawal by Subject|2
7752223|NCT00756730|12189620|FG000|Overall Study|discontinued due to rash prior to week 4|0
7752224|NCT00756730|12189621|FG001|Overall Study|discontinued due to rash prior to week 4|1
7752225|NCT00756730|12189620|FG000|Overall Study|persistent low-level viremmia|0
7752226|NCT00756730|12189621|FG001|Overall Study|persistent low-level viremmia|1
7752227|NCT00756886|12189629|FG000|Overall Study|Lost to Follow-up|1
7752228|NCT00756886|12189630|FG001|Overall Study|Lost to Follow-up|0
7752229|NCT00756886|12189629|FG000|Overall Study|Adverse Event|0
7752230|NCT00756886|12189630|FG001|Overall Study|Adverse Event|3
7752231|NCT00756886|12189629|FG000|Overall Study|Lack of Efficacy|1
7752232|NCT00756886|12189630|FG001|Overall Study|Lack of Efficacy|0
7752233|NCT00756886|12189629|FG000|Overall Study|Ineligible|9
7752234|NCT00756886|12189630|FG001|Overall Study|Ineligible|4
7752235|NCT00757003|12189654|FG000|Overall Study|Death|33
7752236|NCT00757003|12189654|FG000|Overall Study|Lost to Follow-up|9
7752237|NCT00757003|12189654|FG000|Overall Study|Withdrawal by Subject|4
7752238|NCT00757003|12189654|FG000|Overall Study|Surgically explanted|2
7752239|NCT00757003|12189654|FG000|Overall Study|Not implanted|1
7752240|NCT00757172|12189659|FG000|Overall Study|Withdrawal by Subject|4
7752241|NCT00757172|12189659|FG000|Overall Study|Physician Decision|3
7752242|NCT00757172|12189659|FG000|Overall Study|Progression|4
7752243|NCT00757237|12189665|FG000|Overall Study|Lost to Follow-up|0
7752244|NCT00757237|12189666|FG001|Overall Study|Lost to Follow-up|1
7752245|NCT00757237|12189665|FG000|Overall Study|Protocol Violation|0
7752246|NCT00757237|12189666|FG001|Overall Study|Protocol Violation|2
7752247|NCT00757237|12189665|FG000|Overall Study|Physician Decision|2
7752248|NCT00757237|12189666|FG001|Overall Study|Physician Decision|3
7752249|NCT00757237|12189665|FG000|Overall Study|Withdrawal by Subject|8
7752250|NCT00757237|12189666|FG001|Overall Study|Withdrawal by Subject|12
7752251|NCT00757237|12189665|FG000|Overall Study|Safety or Tolerability|3
7752252|NCT00757237|12189666|FG001|Overall Study|Safety or Tolerability|5
7752253|NCT00757237|12189665|FG000|Overall Study|Other|0
7752254|NCT00757237|12189666|FG001|Overall Study|Other|2
7769625|NCT00869557|12213227|FG001|Extension Phase|Lost to Follow-up|1
7769626|NCT00869557|12213226|FG000|Extension Phase|Investigator's Discretion|2
7752255|NCT00757588|12189680|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
7752256|NCT00757588|12189681|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
7752257|NCT00757588|12189680|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6
7752258|NCT00757588|12189681|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3
7752259|NCT00757588|12189680|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
7752260|NCT00757588|12189681|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
7752261|NCT00757588|12189680|FG000|Period 1: Short-term (24-week) Phase|Death|1
7752262|NCT00757588|12189681|FG001|Period 1: Short-term (24-week) Phase|Death|0
7752263|NCT00757588|12189680|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
7752264|NCT00757588|12189681|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
7752265|NCT00757588|12189680|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
7752266|NCT00757588|12189681|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
7752267|NCT00757588|12189680|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
7752268|NCT00757588|12189681|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
7752269|NCT00757588|12189680|FG000|Period 1: Short-term (24-week) Phase|Other|0
7752270|NCT00757588|12189681|FG001|Period 1: Short-term (24-week) Phase|Other|1
7752271|NCT00757588|12189680|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
7752272|NCT00757588|12189681|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
7752273|NCT00757588|12189680|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4
7752274|NCT00757588|12189681|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0
7752275|NCT00757588|12189680|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
7752276|NCT00757588|12189681|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
7752277|NCT00757588|12189680|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
7752278|NCT00757588|12189681|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
7752279|NCT00757588|12189680|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
7752280|NCT00757588|12189681|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
7752281|NCT00757588|12189680|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1
7752282|NCT00757588|12189681|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0
7752283|NCT00757588|12189680|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
7752284|NCT00757588|12189681|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
7752285|NCT00757588|12189680|FG000|Period 2: Long-term (52-week) Phase|Other|1
7752286|NCT00757588|12189681|FG001|Period 2: Long-term (52-week) Phase|Other|0
7752287|NCT00757705|12189741|FG000|Overall Study|Adverse Event|19
7752288|NCT00757705|12189741|FG000|Overall Study|Lost to Follow-up|16
7752289|NCT00757705|12189741|FG000|Overall Study|Withdrawal by Subject|25
7752290|NCT00757705|12189741|FG000|Overall Study|Insufficient Response|26
7752291|NCT00757705|12189741|FG000|Overall Study|Ineligible to continue|8
7752292|NCT00757705|12189741|FG000|Overall Study|Non-compliant|9
7752293|NCT00757705|12189741|FG000|Overall Study|Other|18
7752294|NCT00757783|12189747|FG000|Overall Study|Adverse Event|0
7752295|NCT00757783|12189748|FG001|Overall Study|Adverse Event|2
7752296|NCT00757783|12189747|FG000|Overall Study|Lost to Follow-up|1
7752297|NCT00757783|12189748|FG001|Overall Study|Lost to Follow-up|1
7752298|NCT00757783|12189747|FG000|Overall Study|Protocol Violation|1
7752299|NCT00757783|12189748|FG001|Overall Study|Protocol Violation|0
7752300|NCT00757783|12189747|FG000|Overall Study|Withdrawal by Subject|2
7752301|NCT00757783|12189748|FG001|Overall Study|Withdrawal by Subject|1
7752302|NCT00757783|12189747|FG000|Overall Study|Other|1
7752303|NCT00757783|12189748|FG001|Overall Study|Other|2
7752304|NCT00757848|12189768|FG000|Overall Study|Voluntary discontinuation|1
7752305|NCT00757848|12189769|FG001|Overall Study|Voluntary discontinuation|0
7752306|NCT00757848|12189768|FG000|Overall Study|Adverse Event|1
7752307|NCT00757848|12189769|FG001|Overall Study|Adverse Event|2
7752308|NCT00757848|12189768|FG000|Overall Study|Incorrect enrolment|1
7752309|NCT00757848|12189769|FG001|Overall Study|Incorrect enrolment|0
7752310|NCT00758043|12189779|FG000|Overall Study|Adverse Event|1
7752311|NCT00758043|12189780|FG001|Overall Study|Adverse Event|20
7752312|NCT00758043|12189781|FG002|Overall Study|Adverse Event|12
7752313|NCT00758043|12189782|FG003|Overall Study|Adverse Event|62
7752314|NCT00758043|12189779|FG000|Overall Study|Lack of Efficacy|0
7752315|NCT00758043|12189780|FG001|Overall Study|Lack of Efficacy|6
7752316|NCT00758043|12189781|FG002|Overall Study|Lack of Efficacy|18
7752317|NCT00758043|12189782|FG003|Overall Study|Lack of Efficacy|12
7752318|NCT00758043|12189779|FG000|Overall Study|Refused Further Treatment|0
7752319|NCT00758043|12189780|FG001|Overall Study|Refused Further Treatment|11
7752320|NCT00758043|12189781|FG002|Overall Study|Refused Further Treatment|5
7752321|NCT00758043|12189782|FG003|Overall Study|Refused Further Treatment|8
7752322|NCT00758043|12189779|FG000|Overall Study|Lost to Follow-up|0
7752323|NCT00758043|12189780|FG001|Overall Study|Lost to Follow-up|2
7752324|NCT00758043|12189781|FG002|Overall Study|Lost to Follow-up|2
7752325|NCT00758043|12189782|FG003|Overall Study|Lost to Follow-up|5
7752326|NCT00758043|12189779|FG000|Overall Study|Withdrawal by Subject|0
7752327|NCT00758043|12189780|FG001|Overall Study|Withdrawal by Subject|1
7752328|NCT00758043|12189781|FG002|Overall Study|Withdrawal by Subject|1
7962343|NCT02711956|12516615|FG010|Overall Study|Physician Decision|0
7962344|NCT02711956|12516616|FG011|Overall Study|Physician Decision|0
7962345|NCT02711956|12516617|FG012|Overall Study|Physician Decision|0
7962346|NCT02711956|12516618|FG013|Overall Study|Physician Decision|0
7962347|NCT02711956|12516619|FG014|Overall Study|Physician Decision|0
7962348|NCT02711956|12516605|FG000|Overall Study|Withdrawal by Subject|0
7962349|NCT02711956|12516606|FG001|Overall Study|Withdrawal by Subject|0
7962350|NCT02711956|12516607|FG002|Overall Study|Withdrawal by Subject|0
7962351|NCT02711956|12516608|FG003|Overall Study|Withdrawal by Subject|0
7962352|NCT02711956|12516609|FG004|Overall Study|Withdrawal by Subject|0
7962353|NCT02711956|12516610|FG005|Overall Study|Withdrawal by Subject|0
7962354|NCT02711956|12516611|FG006|Overall Study|Withdrawal by Subject|1
7962355|NCT02711956|12516612|FG007|Overall Study|Withdrawal by Subject|0
7962356|NCT02711956|12516613|FG008|Overall Study|Withdrawal by Subject|0
7962357|NCT02711956|12516614|FG009|Overall Study|Withdrawal by Subject|0
7752329|NCT00758043|12189782|FG003|Overall Study|Withdrawal by Subject|4
7769627|NCT00869557|12213227|FG001|Extension Phase|Investigator's Discretion|0
7962358|NCT02711956|12516615|FG010|Overall Study|Withdrawal by Subject|0
7962359|NCT02711956|12516616|FG011|Overall Study|Withdrawal by Subject|1
7962360|NCT02711956|12516617|FG012|Overall Study|Withdrawal by Subject|6
7962361|NCT02711956|12516618|FG013|Overall Study|Withdrawal by Subject|0
7962362|NCT02711956|12516619|FG014|Overall Study|Withdrawal by Subject|1
7962363|NCT02711956|12516605|FG000|Overall Study|Clinical progression|1
7962364|NCT02711956|12516606|FG001|Overall Study|Clinical progression|0
7962365|NCT02711956|12516607|FG002|Overall Study|Clinical progression|0
7962366|NCT02711956|12516608|FG003|Overall Study|Clinical progression|0
7962367|NCT02711956|12516609|FG004|Overall Study|Clinical progression|0
7962368|NCT02711956|12516610|FG005|Overall Study|Clinical progression|0
7962369|NCT02711956|12516611|FG006|Overall Study|Clinical progression|1
7962370|NCT02711956|12516612|FG007|Overall Study|Clinical progression|0
7752330|NCT00758043|12189779|FG000|Overall Study|Required Prohibited Medication|0
7752331|NCT00758043|12189780|FG001|Overall Study|Required Prohibited Medication|0
7752332|NCT00758043|12189781|FG002|Overall Study|Required Prohibited Medication|1
7752333|NCT00758043|12189782|FG003|Overall Study|Required Prohibited Medication|3
7752334|NCT00758043|12189779|FG000|Overall Study|Non-Compliant With study Drug|0
7752335|NCT00758043|12189780|FG001|Overall Study|Non-Compliant With study Drug|0
7752336|NCT00758043|12189781|FG002|Overall Study|Non-Compliant With study Drug|0
7752337|NCT00758043|12189782|FG003|Overall Study|Non-Compliant With study Drug|1
7752338|NCT00758043|12189779|FG000|Overall Study|Other Reasons|0
7752339|NCT00758043|12189780|FG001|Overall Study|Other Reasons|1
7752340|NCT00758043|12189781|FG002|Overall Study|Other Reasons|0
7752341|NCT00758043|12189782|FG003|Overall Study|Other Reasons|5
7752342|NCT00758069|12189801|FG000|Overall Study|Lack of Efficacy|0
7752343|NCT00758069|12189802|FG001|Overall Study|Lack of Efficacy|0
7752344|NCT00758069|12189803|FG002|Overall Study|Lack of Efficacy|1
7752345|NCT00758069|12189801|FG000|Overall Study|Incorrect Study Drug|1
7752346|NCT00758069|12189802|FG001|Overall Study|Incorrect Study Drug|0
7752347|NCT00758069|12189803|FG002|Overall Study|Incorrect Study Drug|0
7752348|NCT00758160|12189811|FG000|Overall Study|No Longer Requires Study Medication|4
7752349|NCT00758160|12189811|FG000|Overall Study|Administration Problems|3
7752350|NCT00758160|12189811|FG000|Overall Study|Adverse Event|15
7752351|NCT00758160|12189811|FG000|Overall Study|Lack of Efficacy|10
7752352|NCT00758160|12189811|FG000|Overall Study|Lost to Follow-up|14
7752353|NCT00758160|12189811|FG000|Overall Study|Protocol Violation|12
7752354|NCT00758160|12189811|FG000|Overall Study|Withdrawal by Subject|8
7752355|NCT00758264|12189822|FG000|Active Phase|Withdrawal by Subject|0
7752356|NCT00758264|12189823|FG001|Active Phase|Withdrawal by Subject|0
7752357|NCT00758264|12189824|FG002|Active Phase|Withdrawal by Subject|1
7962371|NCT02711956|12516613|FG008|Overall Study|Clinical progression|1
7752358|NCT00758264|12189822|FG000|Active Phase|Lost to Follow-up|1
7752359|NCT00758264|12189823|FG001|Active Phase|Lost to Follow-up|0
7752360|NCT00758264|12189824|FG002|Active Phase|Lost to Follow-up|0
7752361|NCT00758264|12189822|FG000|Active Phase|Other|0
7752362|NCT00758264|12189823|FG001|Active Phase|Other|0
7752363|NCT00758264|12189824|FG002|Active Phase|Other|4
7752364|NCT00758394|12189845|FG000|2nd Intervention Order|Lost to Follow-up|0
7752365|NCT00758394|12189846|FG001|2nd Intervention Order|Lost to Follow-up|1
7752366|NCT00758394|12189847|FG002|2nd Intervention Order|Lost to Follow-up|0
7752367|NCT00758394|12189848|FG003|2nd Intervention Order|Lost to Follow-up|0
7752368|NCT00758394|12189845|FG000|3rd Intervention|Lost to Follow-up|1
7752369|NCT00758394|12189846|FG001|3rd Intervention|Lost to Follow-up|0
7752370|NCT00758394|12189847|FG002|3rd Intervention|Lost to Follow-up|0
7752371|NCT00758394|12189848|FG003|3rd Intervention|Lost to Follow-up|1
7752372|NCT00758459|12189869|FG000|Overall Study|Adverse Event|3
7752373|NCT00758459|12189870|FG001|Overall Study|Adverse Event|2
7752374|NCT00758459|12189869|FG000|Overall Study|Protocol Violation|0
7752375|NCT00758459|12189870|FG001|Overall Study|Protocol Violation|1
7752376|NCT00758459|12189869|FG000|Overall Study|Withdrawal by Subject|0
7752377|NCT00758459|12189870|FG001|Overall Study|Withdrawal by Subject|1
7752378|NCT00758485|12189878|FG000|Overall Study|Lost to Follow-up|0
7752379|NCT00758485|12189879|FG001|Overall Study|Lost to Follow-up|1
7752380|NCT00758485|12189878|FG000|Overall Study|Not Treated|1
7752381|NCT00758485|12189879|FG001|Overall Study|Not Treated|2
7752382|NCT00758498|12189889|FG000|Overall Study|Adverse Event|2
7752383|NCT00758498|12189890|FG001|Overall Study|Adverse Event|2
7752384|NCT00758498|12189891|FG002|Overall Study|Adverse Event|3
7752385|NCT00758498|12189889|FG000|Overall Study|Subject legally detained out of state|1
7752386|NCT00758498|12189890|FG001|Overall Study|Subject legally detained out of state|0
7752387|NCT00758498|12189891|FG002|Overall Study|Subject legally detained out of state|0
7752388|NCT00758498|12189889|FG000|Overall Study|Withdrawal by Subject|0
7752389|NCT00758498|12189890|FG001|Overall Study|Withdrawal by Subject|0
7752390|NCT00758498|12189891|FG002|Overall Study|Withdrawal by Subject|1
7752391|NCT00758498|12189889|FG000|Overall Study|Noncompliance to study procedures|0
7752392|NCT00758498|12189890|FG001|Overall Study|Noncompliance to study procedures|0
7752393|NCT00758498|12189891|FG002|Overall Study|Noncompliance to study procedures|1
7752394|NCT00758524|12189905|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3
7752395|NCT00758524|12189906|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2
7752396|NCT00758524|12189907|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4
7752397|NCT00758524|12189908|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7752398|NCT00758524|12189909|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3
7752399|NCT00758524|12189910|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5
7752400|NCT00758524|12189911|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7752401|NCT00758524|12189912|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7752402|NCT00758524|12189913|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7752403|NCT00758524|12189914|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7752404|NCT00758524|12189915|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7752405|NCT00758524|12189916|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7752406|NCT00758524|12189917|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7752407|NCT00758524|12189918|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7752408|NCT00758524|12189919|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7752409|NCT00758524|12189920|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7752410|NCT00758524|12189921|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7752411|NCT00758524|12189905|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
7752412|NCT00758524|12189906|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7752413|NCT00758524|12189907|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2
7752414|NCT00758524|12189908|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
7752415|NCT00758524|12189909|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1
7752416|NCT00758524|12189910|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
7752417|NCT00758524|12189911|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7752418|NCT00758524|12189912|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7752419|NCT00758524|12189913|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7752420|NCT00758524|12189914|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7752421|NCT00758524|12189915|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7752422|NCT00758524|12189916|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7752423|NCT00758524|12189917|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7752424|NCT00758524|12189918|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7752425|NCT00758524|12189919|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7752426|NCT00758524|12189920|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7752427|NCT00758524|12189921|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7752428|NCT00758524|12189905|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2
7752429|NCT00758524|12189906|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1
7752430|NCT00758524|12189907|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1
7752431|NCT00758524|12189908|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3
7752432|NCT00758524|12189909|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2
7752433|NCT00758524|12189910|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1
7752434|NCT00758524|12189911|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0
7752435|NCT00758524|12189912|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0
7752436|NCT00758524|12189913|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0
7752437|NCT00758524|12189914|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0
7752438|NCT00758524|12189915|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0
7752439|NCT00758524|12189916|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0
7752440|NCT00758524|12189917|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0
7752441|NCT00758524|12189918|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0
7752442|NCT00758524|12189919|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0
7752443|NCT00758524|12189920|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0
7752444|NCT00758524|12189921|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0
7752445|NCT00758524|12189905|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7752446|NCT00758524|12189906|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2
7752447|NCT00758524|12189907|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1
7752448|NCT00758524|12189908|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7752449|NCT00758524|12189909|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2
7752450|NCT00758524|12189910|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1
7752451|NCT00758524|12189911|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7752452|NCT00758524|12189912|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7752453|NCT00758524|12189913|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7752454|NCT00758524|12189914|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7752455|NCT00758524|12189915|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7752456|NCT00758524|12189916|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7752457|NCT00758524|12189917|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7752458|NCT00758524|12189918|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7752459|NCT00758524|12189919|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7752460|NCT00758524|12189920|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7752461|NCT00758524|12189921|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7752462|NCT00758524|12189905|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0
7752463|NCT00758524|12189906|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0
7752464|NCT00758524|12189907|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1
7752465|NCT00758524|12189908|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1
7752466|NCT00758524|12189909|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0
7752467|NCT00758524|12189910|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0
7752468|NCT00758524|12189911|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0
7752469|NCT00758524|12189912|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0
7752470|NCT00758524|12189913|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0
7752471|NCT00758524|12189914|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0
7752472|NCT00758524|12189915|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0
7752473|NCT00758524|12189916|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0
7752474|NCT00758524|12189917|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0
7752475|NCT00758524|12189918|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0
7752476|NCT00758524|12189919|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0
7752477|NCT00758524|12189920|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0
7752478|NCT00758524|12189921|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0
7752479|NCT00758524|12189905|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752480|NCT00758524|12189906|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752481|NCT00758524|12189907|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752482|NCT00758524|12189908|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752483|NCT00758524|12189909|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1
7752484|NCT00758524|12189910|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752485|NCT00758524|12189911|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752486|NCT00758524|12189912|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752487|NCT00758524|12189913|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752488|NCT00758524|12189914|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752489|NCT00758524|12189915|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752490|NCT00758524|12189916|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752491|NCT00758524|12189917|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752492|NCT00758524|12189918|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752493|NCT00758524|12189919|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752494|NCT00758524|12189920|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752495|NCT00758524|12189921|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7752496|NCT00758524|12189905|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752497|NCT00758524|12189906|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1
7752498|NCT00758524|12189907|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752499|NCT00758524|12189908|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752500|NCT00758524|12189909|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752501|NCT00758524|12189910|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752502|NCT00758524|12189911|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752503|NCT00758524|12189912|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752504|NCT00758524|12189913|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752505|NCT00758524|12189914|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752506|NCT00758524|12189915|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752507|NCT00758524|12189916|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752508|NCT00758524|12189917|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752509|NCT00758524|12189918|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752510|NCT00758524|12189919|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752511|NCT00758524|12189920|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752512|NCT00758524|12189921|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7752513|NCT00758524|12189905|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0
7752514|NCT00758524|12189906|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1
7752515|NCT00758524|12189907|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0
7752516|NCT00758524|12189908|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0
7769628|NCT00869557|12213226|FG000|Extension Phase|Withdrew Consent|2
7752517|NCT00758524|12189909|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0
7752518|NCT00758524|12189910|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0
7752519|NCT00758524|12189911|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0
7752520|NCT00758524|12189912|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0
7752521|NCT00758524|12189913|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0
7752522|NCT00758524|12189914|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0
7752523|NCT00758524|12189915|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0
7752524|NCT00758524|12189916|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0
7752525|NCT00758524|12189917|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0
7752526|NCT00758524|12189918|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0
7752527|NCT00758524|12189919|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0
7752528|NCT00758524|12189920|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0
7752529|NCT00758524|12189921|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0
7752530|NCT00758524|12189905|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752531|NCT00758524|12189906|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752532|NCT00758524|12189907|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752533|NCT00758524|12189908|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752534|NCT00758524|12189909|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752535|NCT00758524|12189910|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752536|NCT00758524|12189911|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752537|NCT00758524|12189912|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752538|NCT00758524|12189913|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2
7752539|NCT00758524|12189914|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752540|NCT00758524|12189915|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752541|NCT00758524|12189916|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752542|NCT00758524|12189917|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752543|NCT00758524|12189918|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752544|NCT00758524|12189919|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752545|NCT00758524|12189920|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752546|NCT00758524|12189921|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7752547|NCT00758524|12189905|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752548|NCT00758524|12189906|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752549|NCT00758524|12189907|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752550|NCT00758524|12189908|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752551|NCT00758524|12189909|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752552|NCT00758524|12189910|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752553|NCT00758524|12189911|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1
7752554|NCT00758524|12189912|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752555|NCT00758524|12189913|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752556|NCT00758524|12189914|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752557|NCT00758524|12189915|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752558|NCT00758524|12189916|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752559|NCT00758524|12189917|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752560|NCT00758524|12189918|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752561|NCT00758524|12189919|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752562|NCT00758524|12189920|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752563|NCT00758524|12189921|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7752564|NCT00758589|12189976|FG000|Overall Study|Adverse Event|3
7752565|NCT00758589|12189977|FG001|Overall Study|Adverse Event|2
7752566|NCT00758589|12189978|FG002|Overall Study|Adverse Event|5
7752567|NCT00758589|12189979|FG003|Overall Study|Adverse Event|4
7752568|NCT00758589|12189976|FG000|Overall Study|Withdrawal by Subject|0
7752569|NCT00758589|12189977|FG001|Overall Study|Withdrawal by Subject|1
7752570|NCT00758589|12189978|FG002|Overall Study|Withdrawal by Subject|1
7752571|NCT00758589|12189979|FG003|Overall Study|Withdrawal by Subject|1
7752572|NCT00758589|12189976|FG000|Overall Study|Palm stopped to work|0
7752573|NCT00758589|12189977|FG001|Overall Study|Palm stopped to work|0
7752574|NCT00758589|12189978|FG002|Overall Study|Palm stopped to work|0
7752575|NCT00758589|12189979|FG003|Overall Study|Palm stopped to work|1
7752576|NCT00758602|12189991|FG000|Overall Study|Adverse Event|11
7752577|NCT00758602|12189992|FG001|Overall Study|Adverse Event|10
7752578|NCT00758602|12189991|FG000|Overall Study|Lost to Follow-up|4
7624423|NCT04052620|12035476|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1
7624424|NCT04052620|12035477|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0
7752579|NCT00758602|12189992|FG001|Overall Study|Lost to Follow-up|3
7752580|NCT00758602|12189991|FG000|Overall Study|Withdrawal by Subject|1
7752581|NCT00758602|12189992|FG001|Overall Study|Withdrawal by Subject|3
7752582|NCT00758602|12189991|FG000|Overall Study|Protocol Violation|0
7752583|NCT00758602|12189992|FG001|Overall Study|Protocol Violation|2
7752584|NCT00758602|12189991|FG000|Overall Study|Death|0
7752585|NCT00758602|12189992|FG001|Overall Study|Death|1
7752586|NCT00758602|12189991|FG000|Overall Study|Reason not specified|3
7752587|NCT00758602|12189992|FG001|Overall Study|Reason not specified|3
7752588|NCT00758680|12190009|FG000|Overall Study|Adverse Event|0
7752589|NCT00758680|12190010|FG001|Overall Study|Adverse Event|0
7752590|NCT00758680|12190011|FG002|Overall Study|Adverse Event|0
7752591|NCT00758680|12190012|FG003|Overall Study|Adverse Event|0
7752592|NCT00758680|12190013|FG004|Overall Study|Adverse Event|0
7752593|NCT00758680|12190014|FG005|Overall Study|Adverse Event|0
7752594|NCT00758680|12190015|FG006|Overall Study|Adverse Event|0
7752595|NCT00758680|12190016|FG007|Overall Study|Adverse Event|1
7752596|NCT00758680|12190017|FG008|Overall Study|Adverse Event|0
7752597|NCT00758680|12190018|FG009|Overall Study|Adverse Event|1
7752598|NCT00758680|12190009|FG000|Overall Study|Laboratory Adverse Event|0
7752599|NCT00758680|12190010|FG001|Overall Study|Laboratory Adverse Event|0
7752600|NCT00758680|12190011|FG002|Overall Study|Laboratory Adverse Event|0
7752601|NCT00758680|12190012|FG003|Overall Study|Laboratory Adverse Event|0
7752602|NCT00758680|12190013|FG004|Overall Study|Laboratory Adverse Event|0
7752603|NCT00758680|12190014|FG005|Overall Study|Laboratory Adverse Event|0
7752604|NCT00758680|12190015|FG006|Overall Study|Laboratory Adverse Event|0
7752605|NCT00758680|12190016|FG007|Overall Study|Laboratory Adverse Event|0
7752606|NCT00758680|12190017|FG008|Overall Study|Laboratory Adverse Event|1
7752607|NCT00758680|12190018|FG009|Overall Study|Laboratory Adverse Event|0
7752608|NCT00758680|12190009|FG000|Overall Study|Withdrawal by Subject|0
7752609|NCT00758680|12190010|FG001|Overall Study|Withdrawal by Subject|0
7752610|NCT00758680|12190011|FG002|Overall Study|Withdrawal by Subject|0
7752611|NCT00758680|12190012|FG003|Overall Study|Withdrawal by Subject|0
7752612|NCT00758680|12190013|FG004|Overall Study|Withdrawal by Subject|0
7752613|NCT00758680|12190014|FG005|Overall Study|Withdrawal by Subject|0
7752614|NCT00758680|12190015|FG006|Overall Study|Withdrawal by Subject|1
7752615|NCT00758680|12190016|FG007|Overall Study|Withdrawal by Subject|0
7752616|NCT00758680|12190017|FG008|Overall Study|Withdrawal by Subject|1
7752617|NCT00758680|12190018|FG009|Overall Study|Withdrawal by Subject|0
7752618|NCT00758706|12190043|FG000|Overall Study|Adverse Event|4
7752619|NCT00758706|12190044|FG001|Overall Study|Adverse Event|4
7752620|NCT00758771|12190102|FG000|Overall Study|Withdrawal by Subject|1
7752621|NCT00758771|12190103|FG001|Overall Study|Withdrawal by Subject|1
7752622|NCT00758771|12190102|FG000|Overall Study|Did not meet eligibility criteria|2
7752623|NCT00758771|12190103|FG001|Overall Study|Did not meet eligibility criteria|4
7752624|NCT00759031|12190136|FG000|First Intervention (1 Day)|Physician Decision|1
7769629|NCT00869557|12213227|FG001|Extension Phase|Withdrew Consent|0
7752625|NCT00759031|12190137|FG001|First Intervention (1 Day)|Physician Decision|0
7752626|NCT00759031|12190136|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
7752627|NCT00759031|12190137|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
7752628|NCT00759031|12190136|FG000|First Intervention (1 Day)|Screening failure|1
7752629|NCT00759031|12190137|FG001|First Intervention (1 Day)|Screening failure|0
7752630|NCT00759109|12190149|FG000|Overall Study|Adverse Event|17
7752631|NCT00759109|12190150|FG001|Overall Study|Adverse Event|12
7752632|NCT00759109|12190149|FG000|Overall Study|Inability to comply|1
7752633|NCT00759109|12190150|FG001|Overall Study|Inability to comply|1
7752634|NCT00759109|12190149|FG000|Overall Study|Withdrawal by Subject|9
7752635|NCT00759109|12190150|FG001|Overall Study|Withdrawal by Subject|5
7752636|NCT00759109|12190149|FG000|Overall Study|Death|4
7752637|NCT00759109|12190150|FG001|Overall Study|Death|3
7752638|NCT00759109|12190149|FG000|Overall Study|Lost to Follow-up|4
7752639|NCT00759109|12190150|FG001|Overall Study|Lost to Follow-up|6
7752640|NCT00759109|12190149|FG000|Overall Study|Started new therapy|2
7752641|NCT00759109|12190150|FG001|Overall Study|Started new therapy|6
7752642|NCT00759109|12190149|FG000|Overall Study|HCV RNA negative|1
7752643|NCT00759109|12190150|FG001|Overall Study|HCV RNA negative|0
7752644|NCT00759109|12190149|FG000|Overall Study|Participant moved to a different city|0
7752645|NCT00759109|12190150|FG001|Overall Study|Participant moved to a different city|1
7752646|NCT00759109|12190149|FG000|Overall Study|Participant had a liver transplant|0
7752647|NCT00759109|12190150|FG001|Overall Study|Participant had a liver transplant|1
7752648|NCT00759109|12190149|FG000|Overall Study|Lost during study|1
7752649|NCT00759109|12190150|FG001|Overall Study|Lost during study|0
7752650|NCT00759148|12190158|FG000|Overall Study|Adverse Event|1
7752651|NCT00759148|12190159|FG001|Overall Study|Adverse Event|6
7752652|NCT00759148|12190158|FG000|Overall Study|Withdrawal by Subject|3
7752653|NCT00759148|12190159|FG001|Overall Study|Withdrawal by Subject|7
7752654|NCT00759148|12190158|FG000|Overall Study|Lost to Follow-up|3
7752655|NCT00759148|12190159|FG001|Overall Study|Lost to Follow-up|9
7752656|NCT00759148|12190158|FG000|Overall Study|Treatment Failure|6
7752657|NCT00759148|12190159|FG001|Overall Study|Treatment Failure|10
7752658|NCT00759148|12190158|FG000|Overall Study|Reason not given|1
7752659|NCT00759148|12190159|FG001|Overall Study|Reason not given|0
7752660|NCT00759174|12190174|FG000|Overall Study|Other|0
7752661|NCT00759174|12190175|FG001|Overall Study|Other|2
7752662|NCT00759356|12190215|FG000|Overall Study|Adverse Event|0
7752663|NCT00759356|12190216|FG001|Overall Study|Adverse Event|1
7752664|NCT00759356|12190215|FG000|Overall Study|Withdrawal by Subject|0
7752665|NCT00759356|12190216|FG001|Overall Study|Withdrawal by Subject|2
7752666|NCT00759356|12190215|FG000|Overall Study|Subject was unable to return|1
7752667|NCT00759356|12190216|FG001|Overall Study|Subject was unable to return|0
7752668|NCT00759395|12190224|FG000|Overall Study|Adverse Event|1
7752669|NCT00759395|12190225|FG001|Overall Study|Adverse Event|0
7752670|NCT00759395|12190224|FG000|Overall Study|Withdrawal by Subject|1
7752671|NCT00759395|12190225|FG001|Overall Study|Withdrawal by Subject|0
7752672|NCT00759395|12190224|FG000|Overall Study|Lack of Efficacy|0
7752673|NCT00759395|12190225|FG001|Overall Study|Lack of Efficacy|2
7752674|NCT00759564|12190268|FG000|Washout Period (at Least 14 Days)|Adverse Event|0
7752675|NCT00759564|12190269|FG001|Washout Period (at Least 14 Days)|Adverse Event|0
7752676|NCT00759564|12190270|FG002|Washout Period (at Least 14 Days)|Adverse Event|0
7752677|NCT00759564|12190271|FG003|Washout Period (at Least 14 Days)|Adverse Event|0
7752678|NCT00759564|12190272|FG004|Washout Period (at Least 14 Days)|Adverse Event|1
7752679|NCT00759681|12190323|FG000|Overall Study|Death|2
7752680|NCT00759681|12190324|FG001|Overall Study|Death|5
7752681|NCT00759681|12190323|FG000|Overall Study|Lost to Follow-up|8
7752682|NCT00759681|12190324|FG001|Overall Study|Lost to Follow-up|5
7752683|NCT00759759|12190337|FG000|Overall Study|didn't return for period 2|1
7752684|NCT00759759|12190338|FG001|Overall Study|didn't return for period 2|0
7752685|NCT00759759|12190337|FG000|Overall Study|Didn't receive drug in period 2|1
7752686|NCT00759759|12190338|FG001|Overall Study|Didn't receive drug in period 2|0
7752687|NCT00759759|12190337|FG000|Overall Study|Withdrawal by Subject|2
7752688|NCT00759759|12190338|FG001|Overall Study|Withdrawal by Subject|1
7752689|NCT00759785|12190355|FG000|Overall Study|Participant sample not evaluable|11
7752690|NCT00759785|12190356|FG001|Overall Study|Participant sample not evaluable|2
7752691|NCT00759785|12190355|FG000|Overall Study|Participant sample lost|0
7752692|NCT00759785|12190356|FG001|Overall Study|Participant sample lost|1
7752693|NCT00759785|12190355|FG000|Overall Study|Protocol Violation|1
7752694|NCT00759785|12190356|FG001|Overall Study|Protocol Violation|0
7752695|NCT00759785|12190355|FG000|Overall Study|Physician Decision|0
7752696|NCT00759785|12190356|FG001|Overall Study|Physician Decision|1
7752697|NCT00759785|12190355|FG000|Overall Study|Withdrawal by Subject|0
7752698|NCT00759785|12190356|FG001|Overall Study|Withdrawal by Subject|1
7752699|NCT00759863|12190377|FG000|Overall Study|Death, moved, or lost contact|20
7752700|NCT00759863|12190378|FG001|Overall Study|Death, moved, or lost contact|18
7752701|NCT00759876|12190384|FG000|Overall Study|Sponsor terminated study early|36
7752702|NCT00759902|12190390|FG000|Overall Study|Adverse Event|0
7752703|NCT00759902|12190391|FG001|Overall Study|Adverse Event|1
7752704|NCT00759915|12190399|FG000|Overall Study|Withdrawal by Subject|1
7752705|NCT00759915|12190400|FG001|Overall Study|Withdrawal by Subject|0
7752706|NCT00759915|12190399|FG000|Overall Study|Adverse Event|0
7752707|NCT00759915|12190400|FG001|Overall Study|Adverse Event|1
7752708|NCT00759941|12190408|FG000|Overall Study|Use of medication|1
7752709|NCT00759941|12190409|FG001|Overall Study|Use of medication|0
7752710|NCT00759941|12190408|FG000|Overall Study|Adverse Event|1
7752711|NCT00759941|12190409|FG001|Overall Study|Adverse Event|0
7752712|NCT00759941|12190408|FG000|Overall Study|Exited in error by site|1
7752713|NCT00759941|12190409|FG001|Overall Study|Exited in error by site|1
7752714|NCT00759954|12190417|FG000|Overall Study|Personal reason|1
7752715|NCT00759954|12190418|FG001|Overall Study|Personal reason|0
7752716|NCT00759954|12190417|FG000|Overall Study|Adverse Event|1
7752717|NCT00759954|12190418|FG001|Overall Study|Adverse Event|2
7752718|NCT00760084|12190455|FG000|Overall Study|Physician Decision|5
7752719|NCT00760084|12190455|FG000|Overall Study|Withdrawal by Subject|2
7752720|NCT00760084|12190455|FG000|Overall Study|Progressive Disease|3
7752721|NCT00760214|12190462|FG000|Overall Study|Adverse Event|8
7752722|NCT00760214|12190463|FG001|Overall Study|Adverse Event|9
7752723|NCT00760214|12190464|FG002|Overall Study|Adverse Event|12
7752724|NCT00760214|12190462|FG000|Overall Study|Protocol Violation|3
7752725|NCT00760214|12190463|FG001|Overall Study|Protocol Violation|0
7752726|NCT00760214|12190464|FG002|Overall Study|Protocol Violation|3
7752727|NCT00760214|12190462|FG000|Overall Study|Lost to Follow-up|0
7752728|NCT00760214|12190463|FG001|Overall Study|Lost to Follow-up|0
7752729|NCT00760214|12190464|FG002|Overall Study|Lost to Follow-up|1
7752730|NCT00760214|12190462|FG000|Overall Study|Withdrawal by Subject|12
7752731|NCT00760214|12190463|FG001|Overall Study|Withdrawal by Subject|14
7752732|NCT00760214|12190464|FG002|Overall Study|Withdrawal by Subject|13
7752733|NCT00760214|12190462|FG000|Overall Study|Lack of Efficacy|3
7752734|NCT00760214|12190463|FG001|Overall Study|Lack of Efficacy|2
7752735|NCT00760214|12190464|FG002|Overall Study|Lack of Efficacy|4
7752736|NCT00760214|12190462|FG000|Overall Study|Pregnancy|0
7752737|NCT00760214|12190463|FG001|Overall Study|Pregnancy|0
7752738|NCT00760214|12190464|FG002|Overall Study|Pregnancy|1
7752739|NCT00760214|12190462|FG000|Overall Study|Physician Decision|1
7752740|NCT00760214|12190463|FG001|Overall Study|Physician Decision|1
7752741|NCT00760214|12190464|FG002|Overall Study|Physician Decision|1
7752742|NCT00760214|12190462|FG000|Overall Study|Other|3
7752743|NCT00760214|12190463|FG001|Overall Study|Other|4
7752744|NCT00760214|12190464|FG002|Overall Study|Other|6
7752745|NCT00760266|12190474|FG000|Overall Study|Adverse Event|13
7624431|NCT03826667|12035492|FG000|Overall Study|Protocol deviation|21
7752746|NCT00760266|12190475|FG001|Overall Study|Adverse Event|7
7752747|NCT00760266|12190474|FG000|Overall Study|Abnormal laboratory value(s)|1
7752748|NCT00760266|12190475|FG001|Overall Study|Abnormal laboratory value(s)|0
7752749|NCT00760266|12190474|FG000|Overall Study|Abnormal test procedure result(s)|1
7752750|NCT00760266|12190475|FG001|Overall Study|Abnormal test procedure result(s)|0
7752751|NCT00760266|12190474|FG000|Overall Study|Lack of Efficacy|2
7752752|NCT00760266|12190475|FG001|Overall Study|Lack of Efficacy|2
7752753|NCT00760266|12190474|FG000|Overall Study|Protocol deviation|2
7752754|NCT00760266|12190475|FG001|Overall Study|Protocol deviation|4
7752755|NCT00760266|12190474|FG000|Overall Study|Patient withdrew consent|3
7752756|NCT00760266|12190475|FG001|Overall Study|Patient withdrew consent|3
7752757|NCT00760266|12190474|FG000|Overall Study|Lost to Follow-up|2
7752758|NCT00760266|12190475|FG001|Overall Study|Lost to Follow-up|1
7752759|NCT00760266|12190474|FG000|Overall Study|Administrative Problems|0
7752760|NCT00760266|12190475|FG001|Overall Study|Administrative Problems|1
7752761|NCT00760383|12190483|FG000|Overall Study|moved away; withdrew; medical reasons|5
7752762|NCT00760383|12190484|FG001|Overall Study|moved away; withdrew; medical reasons|7
7752763|NCT00760474|12190499|FG000|Period 1 (P1)|Discontinued then re-entered|1
7752764|NCT00760474|12190500|FG001|Period 1 (P1)|Discontinued then re-entered|1
7752765|NCT00760474|12190499|FG000|Placebo Washout Period|Other|0
7752766|NCT00760474|12190500|FG001|Placebo Washout Period|Other|1
7752767|NCT00760474|12190499|FG000|Period 2 (P2)|Lost to Follow-up|1
7752768|NCT00760474|12190500|FG001|Period 2 (P2)|Lost to Follow-up|0
7752769|NCT00760474|12190499|FG000|Period 2 (P2)|Adverse Event|0
7752770|NCT00760474|12190500|FG001|Period 2 (P2)|Adverse Event|1
7752771|NCT00760487|12190507|FG000|Overall Study|Unilateral implantation|3
7752772|NCT00760513|12190513|FG000|Overall Study|Withdrawal by Subject|5
7752773|NCT00760513|12190514|FG001|Overall Study|Withdrawal by Subject|7
7752774|NCT00760552|12190540|FG000|Overall Study|Death|2
7752775|NCT00760552|12190541|FG001|Overall Study|Death|0
7752776|NCT00760552|12190540|FG000|Overall Study|Lost to Follow-up|11
7752777|NCT00760552|12190541|FG001|Overall Study|Lost to Follow-up|10
7752778|NCT00760617|12190572|FG000|Overall Study|Adverse Event|5
7752779|NCT00760617|12190573|FG001|Overall Study|Adverse Event|2
7752780|NCT00760617|12190574|FG002|Overall Study|Adverse Event|0
7752781|NCT00760617|12190572|FG000|Overall Study|Lost to Follow-up|0
7752782|NCT00760617|12190573|FG001|Overall Study|Lost to Follow-up|0
7752783|NCT00760617|12190574|FG002|Overall Study|Lost to Follow-up|5
7752784|NCT00760669|12190582|FG000|Overall Study|Not assessed for overall improvement|18
7752785|NCT00760669|12190582|FG000|Overall Study|Participants missing efficacy assessment|6
7752786|NCT00760669|12190582|FG000|Overall Study|Participants with overlapping cases|1
7752787|NCT00760669|12190582|FG000|Overall Study|Took drug before entering in contract|5
7752788|NCT00760747|12190588|FG000|Study Period II|Adverse Event|3
7752789|NCT00760747|12190589|FG001|Study Period II|Adverse Event|4
7624432|NCT03600909|12035505|FG000|Overall Study|Not treated|0
7624433|NCT03600909|12035506|FG001|Overall Study|Not treated|3
7624434|NCT03600909|12035507|FG002|Overall Study|Not treated|0
7752790|NCT00760747|12190588|FG000|Study Period II|Lack of Efficacy|0
7752791|NCT00760747|12190589|FG001|Study Period II|Lack of Efficacy|6
7752792|NCT00760747|12190588|FG000|Study Period II|Parent/Caregiver Decision|3
7752793|NCT00760747|12190589|FG001|Study Period II|Parent/Caregiver Decision|0
7752794|NCT00760747|12190588|FG000|Study Period II|Protocol Violation|6
7752795|NCT00760747|12190589|FG001|Study Period II|Protocol Violation|3
7752796|NCT00760747|12190588|FG000|Study Period II|Withdrawal by Subject|1
7752797|NCT00760747|12190589|FG001|Study Period II|Withdrawal by Subject|0
7752798|NCT00760747|12190588|FG000|Study Period II|No drug administered|0
7752799|NCT00760747|12190589|FG001|Study Period II|No drug administered|1
7752800|NCT00760747|12190588|FG000|Study Period III|Adverse Event|1
7752801|NCT00760747|12190589|FG001|Study Period III|Adverse Event|0
7752802|NCT00760747|12190588|FG000|Study Period III|Lack of Efficacy|1
7752803|NCT00760747|12190589|FG001|Study Period III|Lack of Efficacy|0
7769630|NCT00869778|12213256|FG000|Overall Study|Adverse Event|2
7752804|NCT00760747|12190588|FG000|Study Period III|Parent/Caregiver Decision|0
7752805|NCT00760747|12190589|FG001|Study Period III|Parent/Caregiver Decision|1
7752806|NCT00760747|12190588|FG000|Study Period III|Protocol Violation|1
7752807|NCT00760747|12190589|FG001|Study Period III|Protocol Violation|1
7752808|NCT00760747|12190588|FG000|Study Period III|Physician Decision|0
7752809|NCT00760747|12190589|FG001|Study Period III|Physician Decision|1
7752810|NCT00760838|12190597|FG000|Overall Study|Adverse Event|1
7752811|NCT00760838|12190598|FG001|Overall Study|Adverse Event|1
7752812|NCT00760838|12190597|FG000|Overall Study|Lack of Efficacy|1
7752813|NCT00760838|12190598|FG001|Overall Study|Lack of Efficacy|0
7752814|NCT00760838|12190597|FG000|Overall Study|Lost to Follow-up|2
7752815|NCT00760838|12190598|FG001|Overall Study|Lost to Follow-up|0
7752816|NCT00760838|12190597|FG000|Overall Study|Withdrawal by Subject|1
7752817|NCT00760838|12190598|FG001|Overall Study|Withdrawal by Subject|1
7752818|NCT00760877|12190606|FG000|Overall Study|Protocol Violation|1
7752819|NCT00760877|12190607|FG001|Overall Study|Protocol Violation|0
7752820|NCT00760877|12190606|FG000|Overall Study|Non-compliance with protocol treatment|2
7752821|NCT00760877|12190607|FG001|Overall Study|Non-compliance with protocol treatment|1
7752822|NCT00760877|12190606|FG000|Overall Study|Pregnancy|1
7752823|NCT00760877|12190607|FG001|Overall Study|Pregnancy|4
7752824|NCT00760877|12190606|FG000|Overall Study|Death|2
7752825|NCT00760877|12190607|FG001|Overall Study|Death|1
7752826|NCT00760877|12190606|FG000|Overall Study|Withdrawal by Subject|7
7752827|NCT00760877|12190607|FG001|Overall Study|Withdrawal by Subject|3
7752828|NCT00760877|12190606|FG000|Overall Study|Adverse Event|19
7752829|NCT00760877|12190607|FG001|Overall Study|Adverse Event|12
7752830|NCT00760877|12190606|FG000|Overall Study|Participant diagnosed with AML|0
7752831|NCT00760877|12190607|FG001|Overall Study|Participant diagnosed with AML|1
7624435|NCT03366428|12035523|FG000|Overall Study|Progressive disease per RECIST v1.1|33
7624436|NCT03366428|12035523|FG000|Overall Study|Adverse Event|12
7624437|NCT03366428|12035523|FG000|Overall Study|Clinical progression|2
7624438|NCT03366428|12035523|FG000|Overall Study|Withdrawal by Subject|4
7752832|NCT00760877|12190606|FG000|Overall Study|Participant not eligible to cross-over|0
7752833|NCT00760877|12190607|FG001|Overall Study|Participant not eligible to cross-over|1
7752834|NCT00760877|12190606|FG000|Overall Study|Physician Decision|1
7752835|NCT00760877|12190607|FG001|Overall Study|Physician Decision|2
7752836|NCT00760877|12190606|FG000|Overall Study|Participants transferred to AMN107A2408|11
7752837|NCT00760877|12190607|FG001|Overall Study|Participants transferred to AMN107A2408|1
7752838|NCT00760877|12190606|FG000|Overall Study|Treatment failure|1
7624446|NCT02756611|12035546|FG000|Overall Study|Death|39
7624447|NCT02756611|12035546|FG000|Overall Study|Withdrawal by Subject|1
7624448|NCT02756611|12035546|FG000|Overall Study|Lost to Follow-up|2
7624449|NCT02756611|12035546|FG000|Overall Study|Other|7
7624450|NCT02756611|12035546|FG000|Overall Study|Missing|2
7624451|NCT02756611|12035546|FG000|Overall Study|Active on Study|205
7752839|NCT00760877|12190607|FG001|Overall Study|Treatment failure|0
7624452|NCT02724878|12035550|FG000|Overall Study|Still on Active Therapy|15
7624453|NCT02724878|12035550|FG000|Overall Study|Disease Progression|31
7624454|NCT02724878|12035550|FG000|Overall Study|Toxicity|5
7624455|NCT02724878|12035550|FG000|Overall Study|Death|1
7624456|NCT02724878|12035550|FG000|Overall Study|Withdrawal by Subject|4
7624457|NCT02724878|12035550|FG000|Overall Study|Lost to Follow-up|2
7624458|NCT02724878|12035550|FG000|Overall Study|Protocol Violation|1
7624459|NCT02724878|12035550|FG000|Overall Study|Ineligible for Study Drug|5
7624460|NCT02724878|12035550|FG000|Overall Study|not started|1
7624461|NCT02487095|12035576|FG000|Dose Expansion|Unable to scan/restage participant|0
7752840|NCT00760929|12190618|FG000|Overall Study|Adverse Event|2
7752841|NCT00760929|12190619|FG001|Overall Study|Adverse Event|0
7752842|NCT00760929|12190620|FG002|Overall Study|Adverse Event|6
7752843|NCT00760929|12190621|FG003|Overall Study|Adverse Event|10
7752844|NCT00760929|12190618|FG000|Overall Study|Lack of Efficacy|0
7752845|NCT00760929|12190619|FG001|Overall Study|Lack of Efficacy|2
7752846|NCT00760929|12190620|FG002|Overall Study|Lack of Efficacy|1
7752847|NCT00760929|12190621|FG003|Overall Study|Lack of Efficacy|0
7752848|NCT00760929|12190618|FG000|Overall Study|Withdrawal by Subject|1
7752849|NCT00760929|12190619|FG001|Overall Study|Withdrawal by Subject|0
7752850|NCT00760929|12190620|FG002|Overall Study|Withdrawal by Subject|9
7752851|NCT00760929|12190621|FG003|Overall Study|Withdrawal by Subject|1
7752852|NCT00760929|12190618|FG000|Overall Study|Lost to Follow-up|0
7752853|NCT00760929|12190619|FG001|Overall Study|Lost to Follow-up|0
7752854|NCT00760929|12190620|FG002|Overall Study|Lost to Follow-up|1
7752855|NCT00760929|12190621|FG003|Overall Study|Lost to Follow-up|0
7752856|NCT00760929|12190618|FG000|Overall Study|Progression of Disease|21
7752857|NCT00760929|12190619|FG001|Overall Study|Progression of Disease|26
7752858|NCT00760929|12190620|FG002|Overall Study|Progression of Disease|38
7752859|NCT00760929|12190621|FG003|Overall Study|Progression of Disease|42
7752860|NCT00760929|12190618|FG000|Overall Study|Other|2
7752861|NCT00760929|12190619|FG001|Overall Study|Other|0
7752862|NCT00760929|12190620|FG002|Overall Study|Other|2
7752863|NCT00760929|12190621|FG003|Overall Study|Other|1
7752864|NCT00760929|12190618|FG000|Overall Study|Death|0
7752865|NCT00760929|12190619|FG001|Overall Study|Death|0
7752866|NCT00760929|12190620|FG002|Overall Study|Death|1
7752867|NCT00760929|12190621|FG003|Overall Study|Death|0
7752868|NCT00760929|12190618|FG000|Overall Study|Violation of Selection Criteria at Entry|0
7752869|NCT00760929|12190619|FG001|Overall Study|Violation of Selection Criteria at Entry|0
7752870|NCT00760929|12190620|FG002|Overall Study|Violation of Selection Criteria at Entry|0
7752871|NCT00760929|12190621|FG003|Overall Study|Violation of Selection Criteria at Entry|1
7752872|NCT00760994|12190633|FG000|Overall Study|Lost to Follow-up|4
7752873|NCT00760994|12190634|FG001|Overall Study|Lost to Follow-up|4
7752874|NCT00760994|12190635|FG002|Overall Study|Lost to Follow-up|3
7752875|NCT00761150|12190689|FG000|Open-label Period|Adverse Event|36
7752876|NCT00761150|12190690|FG001|Open-label Period|Adverse Event|0
7752877|NCT00761150|12190691|FG002|Open-label Period|Adverse Event|0
7752878|NCT00761150|12190689|FG000|Open-label Period|Did not meet DB randomization criteria|11
7752879|NCT00761150|12190690|FG001|Open-label Period|Did not meet DB randomization criteria|0
7752880|NCT00761150|12190691|FG002|Open-label Period|Did not meet DB randomization criteria|0
7752881|NCT00761150|12190689|FG000|Open-label Period|Lost to Follow-up|7
7752882|NCT00761150|12190690|FG001|Open-label Period|Lost to Follow-up|0
7752883|NCT00761150|12190691|FG002|Open-label Period|Lost to Follow-up|0
7752884|NCT00761150|12190689|FG000|Open-label Period|Lack of Efficacy|4
7752885|NCT00761150|12190690|FG001|Open-label Period|Lack of Efficacy|0
7752886|NCT00761150|12190691|FG002|Open-label Period|Lack of Efficacy|0
7752887|NCT00761150|12190689|FG000|Open-label Period|Withdrawal by Subject|5
7752888|NCT00761150|12190690|FG001|Open-label Period|Withdrawal by Subject|0
7752889|NCT00761150|12190691|FG002|Open-label Period|Withdrawal by Subject|0
7752890|NCT00761150|12190689|FG000|Open-label Period|Noncompliance|2
7752891|NCT00761150|12190690|FG001|Open-label Period|Noncompliance|0
7752892|NCT00761150|12190691|FG002|Open-label Period|Noncompliance|0
7752893|NCT00761150|12190689|FG000|Open-label Period|Other|5
7752894|NCT00761150|12190690|FG001|Open-label Period|Other|0
7752895|NCT00761150|12190691|FG002|Open-label Period|Other|0
7752896|NCT00761150|12190689|FG000|Double-blind Period|Lack of Efficacy|0
7752897|NCT00761150|12190690|FG001|Double-blind Period|Lack of Efficacy|2
7752898|NCT00761150|12190691|FG002|Double-blind Period|Lack of Efficacy|19
7752899|NCT00761150|12190689|FG000|Double-blind Period|Adverse Event|0
7752900|NCT00761150|12190690|FG001|Double-blind Period|Adverse Event|3
7752901|NCT00761150|12190691|FG002|Double-blind Period|Adverse Event|3
7752902|NCT00761150|12190689|FG000|Double-blind Period|Withdrawal by Subject|0
7752903|NCT00761150|12190690|FG001|Double-blind Period|Withdrawal by Subject|3
7752904|NCT00761150|12190691|FG002|Double-blind Period|Withdrawal by Subject|2
7752905|NCT00761150|12190689|FG000|Double-blind Period|Lost to Follow-up|0
7752906|NCT00761150|12190690|FG001|Double-blind Period|Lost to Follow-up|2
7752907|NCT00761150|12190691|FG002|Double-blind Period|Lost to Follow-up|1
7752908|NCT00761150|12190689|FG000|Double-blind Period|Did not meet DB randomization criteria|0
7752909|NCT00761150|12190690|FG001|Double-blind Period|Did not meet DB randomization criteria|0
7752910|NCT00761150|12190691|FG002|Double-blind Period|Did not meet DB randomization criteria|1
7752911|NCT00761150|12190689|FG000|Double-blind Period|Noncompliance|0
7752912|NCT00761150|12190690|FG001|Double-blind Period|Noncompliance|1
7752913|NCT00761150|12190691|FG002|Double-blind Period|Noncompliance|0
7752914|NCT00761150|12190689|FG000|Double-blind Period|Other|0
7752915|NCT00761150|12190690|FG001|Double-blind Period|Other|3
7752916|NCT00761150|12190691|FG002|Double-blind Period|Other|3
7752917|NCT00761189|12190698|FG000|Overall Study|Adverse Event|42
7752918|NCT00761189|12190698|FG000|Overall Study|Lack of Efficacy|45
7752919|NCT00761189|12190698|FG000|Overall Study|Lost to Follow-up|36
7752920|NCT00761189|12190698|FG000|Overall Study|Withdrawal by Subject|49
7752921|NCT00761189|12190698|FG000|Overall Study|Other|13
7752922|NCT00761215|12190714|FG000|Overall Study|Randomized but didn't receive drug|1
7752923|NCT00761215|12190715|FG001|Overall Study|Randomized but didn't receive drug|1
7752924|NCT00761215|12190716|FG002|Overall Study|Randomized but didn't receive drug|2
7752925|NCT00761215|12190714|FG000|Overall Study|Lost to Follow-up|6
7752926|NCT00761215|12190715|FG001|Overall Study|Lost to Follow-up|3
7752927|NCT00761215|12190716|FG002|Overall Study|Lost to Follow-up|6
7752928|NCT00761215|12190714|FG000|Overall Study|Withdrawal by Subject|1
7752929|NCT00761215|12190715|FG001|Overall Study|Withdrawal by Subject|0
7752930|NCT00761215|12190716|FG002|Overall Study|Withdrawal by Subject|0
7752931|NCT00761215|12190714|FG000|Overall Study|Bacteremia|1
7752932|NCT00761215|12190715|FG001|Overall Study|Bacteremia|0
7752933|NCT00761215|12190716|FG002|Overall Study|Bacteremia|0
7752934|NCT00761267|12190730|FG000|Overall Study|Death|1
7752935|NCT00761267|12190731|FG001|Overall Study|Death|2
7752936|NCT00761267|12190732|FG002|Overall Study|Death|5
7752937|NCT00761267|12190730|FG000|Overall Study|Lost to Follow-up|0
7752938|NCT00761267|12190731|FG001|Overall Study|Lost to Follow-up|0
7752939|NCT00761267|12190732|FG002|Overall Study|Lost to Follow-up|1
7752940|NCT00761267|12190730|FG000|Overall Study|Randomized but not treated|1
7752941|NCT00761267|12190731|FG001|Overall Study|Randomized but not treated|1
7752942|NCT00761267|12190732|FG002|Overall Study|Randomized but not treated|0
7752943|NCT00761267|12190730|FG000|Overall Study|Withdrawal by Subject|0
7752944|NCT00761267|12190731|FG001|Overall Study|Withdrawal by Subject|1
7752945|NCT00761267|12190732|FG002|Overall Study|Withdrawal by Subject|0
7752946|NCT00761280|12190753|FG000|Randomization to First Dose|Withdrawal by Subject|0
7752947|NCT00761280|12190754|FG001|Randomization to First Dose|Withdrawal by Subject|2
7752948|NCT00761280|12190753|FG000|Randomization to First Dose|Sponsor decision|1
7752949|NCT00761280|12190754|FG001|Randomization to First Dose|Sponsor decision|0
7752950|NCT00761280|12190753|FG000|Randomization to First Dose|Other|1
7752951|NCT00761280|12190754|FG001|Randomization to First Dose|Other|0
7752952|NCT00761280|12190753|FG000|First Dose to End of Study|End of trial|5
7752953|NCT00761280|12190754|FG001|First Dose to End of Study|End of trial|5
7752954|NCT00761280|12190753|FG000|First Dose to End of Study|Progressive disease|5
7752955|NCT00761280|12190754|FG001|First Dose to End of Study|Progressive disease|3
7752956|NCT00761280|12190753|FG000|First Dose to End of Study|Sponsor decision|1
7752957|NCT00761280|12190754|FG001|First Dose to End of Study|Sponsor decision|2
7752958|NCT00761280|12190753|FG000|First Dose to End of Study|Death|1
7752959|NCT00761280|12190754|FG001|First Dose to End of Study|Death|0
7752960|NCT00761280|12190753|FG000|First Dose to End of Study|Lost to Follow-up|0
7752961|NCT00761280|12190754|FG001|First Dose to End of Study|Lost to Follow-up|1
7752962|NCT00761306|12190760|FG000|Overall Study|Adverse Event|5
7752963|NCT00761306|12190760|FG000|Overall Study|Lack of Efficacy|4
7752964|NCT00761306|12190760|FG000|Overall Study|Protocol Violation|2
7752965|NCT00761306|12190760|FG000|Overall Study|Withdrawal of Consent|3
7752966|NCT00761306|12190760|FG000|Overall Study|Lost to Follow-up|1
7752967|NCT00761306|12190760|FG000|Overall Study|Administrative or Other Reasons|5
7752968|NCT00761319|12190766|FG000|Overall Study|Protocol Violation|21
7752969|NCT00761319|12190767|FG001|Overall Study|Protocol Violation|14
7752970|NCT00761319|12190766|FG000|Overall Study|Adverse Event|11
7752971|NCT00761319|12190767|FG001|Overall Study|Adverse Event|7
7752972|NCT00761319|12190766|FG000|Overall Study|Withdrawal by Subject|8
7752973|NCT00761319|12190767|FG001|Overall Study|Withdrawal by Subject|7
7752974|NCT00761319|12190766|FG000|Overall Study|Noncompliance|4
7752975|NCT00761319|12190767|FG001|Overall Study|Noncompliance|3
7752976|NCT00761319|12190766|FG000|Overall Study|Lost to Follow-up|1
7752977|NCT00761319|12190767|FG001|Overall Study|Lost to Follow-up|1
7752978|NCT00761319|12190766|FG000|Overall Study|Nonspecified|2
7752979|NCT00761319|12190767|FG001|Overall Study|Nonspecified|2
7752980|NCT00761319|12190766|FG000|Overall Study|Missing|1
7752981|NCT00761319|12190767|FG001|Overall Study|Missing|0
7752982|NCT00761462|12190779|FG000|Treatment|Subjects never received study medication|23
7752983|NCT00761462|12190780|FG001|Treatment|Subjects never received study medication|12
7752984|NCT00761462|12190779|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4
7752985|NCT00761462|12190780|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0
7752986|NCT00761462|12190779|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
7752987|NCT00761462|12190780|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
7752988|NCT00761462|12190779|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
7752989|NCT00761462|12190780|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
7752990|NCT00761514|12190786|FG000|Overall Study|Adverse Event|1
7752991|NCT00761514|12190786|FG000|Overall Study|Withdrawal by Subject|2
7752992|NCT00761514|12190786|FG000|Overall Study|Lost to Follow-up|1
7752993|NCT00761514|12190786|FG000|Overall Study|Health insurance didn't cover study drug|1
7752994|NCT00761514|12190786|FG000|Overall Study|Problem complying with study visit|1
7752995|NCT00761514|12190786|FG000|Overall Study|Unable to pay for medications|1
7752996|NCT00761579|12190790|FG000|Overall Study|Adverse Event|10
7752997|NCT00761579|12190790|FG000|Overall Study|Death|2
7752998|NCT00761579|12190790|FG000|Overall Study|Lack of Efficacy|21
7752999|NCT00761579|12190790|FG000|Overall Study|Lost to Follow-up|16
7753000|NCT00761579|12190790|FG000|Overall Study|Pregnancy|1
7753001|NCT00761579|12190790|FG000|Overall Study|Withdrawal by Subject|34
7753002|NCT00761579|12190790|FG000|Overall Study|Lack of compliance|2
7753003|NCT00761579|12190790|FG000|Overall Study|Protocol deviation|1
7753004|NCT00761579|12190790|FG000|Overall Study|Drug overdose|1
7753005|NCT00761579|12190790|FG000|Overall Study|Aggravation of depression|1
7753006|NCT00761579|12190790|FG000|Overall Study|Aggravation of symptoms by changing drug|1
7753007|NCT00761579|12190790|FG000|Overall Study|Lost survey form|1
7753008|NCT00761579|12190790|FG000|Overall Study|Intake of prohibited concomitant drug|1
7753009|NCT00761605|12190805|FG000|Overall Study|Adverse Event|26
7753010|NCT00761605|12190805|FG000|Overall Study|Death|2
7753011|NCT00761605|12190805|FG000|Overall Study|Lack of Efficacy|26
7753012|NCT00761605|12190805|FG000|Overall Study|Lost to Follow-up|29
7753013|NCT00761605|12190805|FG000|Overall Study|Withdrawal by Subject|37
7753014|NCT00761605|12190805|FG000|Overall Study|Other|21
7769631|NCT00869778|12213257|FG001|Overall Study|Adverse Event|0
7769632|NCT00869778|12213258|FG002|Overall Study|Adverse Event|0
7769633|NCT00869778|12213256|FG000|Overall Study|Withdrawal by Subject|3
7769634|NCT00869778|12213257|FG001|Overall Study|Withdrawal by Subject|4
7769635|NCT00869778|12213258|FG002|Overall Study|Withdrawal by Subject|5
7769636|NCT00869778|12213256|FG000|Overall Study|Pregnancy|1
7769637|NCT00869778|12213257|FG001|Overall Study|Pregnancy|0
7769638|NCT00869778|12213258|FG002|Overall Study|Pregnancy|0
7769639|NCT00869778|12213256|FG000|Overall Study|Protocol Violation|5
7769640|NCT00869778|12213257|FG001|Overall Study|Protocol Violation|3
7769641|NCT00869778|12213258|FG002|Overall Study|Protocol Violation|5
7769642|NCT00869778|12213256|FG000|Overall Study|Unblinding|1
7769643|NCT00869778|12213257|FG001|Overall Study|Unblinding|0
7769644|NCT00869778|12213258|FG002|Overall Study|Unblinding|0
7769645|NCT00869960|12213287|FG000|Overall Study|Lost to Follow-up|2
7769646|NCT00869999|12213291|FG000|Overall Study|Withdrawal by Subject|1
7769647|NCT00869999|12213291|FG000|Overall Study|removed prior to starting therapy|1
7769648|NCT00870103|12213295|FG000|Overall Study|Physician Decision|2
7769649|NCT00870103|12213295|FG000|Overall Study|Lost to Follow-up|2
7769650|NCT00870194|12213301|FG000|Overall Study|Adverse Event|10
7769651|NCT00870194|12213302|FG001|Overall Study|Adverse Event|5
7769652|NCT00870194|12213301|FG000|Overall Study|Lack of Efficacy|0
7769653|NCT00870194|12213302|FG001|Overall Study|Lack of Efficacy|1
7769654|NCT00870194|12213301|FG000|Overall Study|Lost to Follow-up|2
7769655|NCT00870194|12213302|FG001|Overall Study|Lost to Follow-up|0
7769656|NCT00870194|12213301|FG000|Overall Study|Physician Decision|3
7769657|NCT00870194|12213302|FG001|Overall Study|Physician Decision|1
7769658|NCT00870194|12213301|FG000|Overall Study|Protocol Violation|3
7769659|NCT00870194|12213302|FG001|Overall Study|Protocol Violation|3
7769660|NCT00870194|12213301|FG000|Overall Study|Entry Criteria Not Met|1
7769661|NCT00870194|12213302|FG001|Overall Study|Entry Criteria Not Met|2
7769662|NCT00870194|12213301|FG000|Overall Study|Subject Decision|7
7769663|NCT00870194|12213302|FG001|Overall Study|Subject Decision|2
7769664|NCT00870233|12213308|FG000|Overall Study|Withdrawal by Subject|18
7769665|NCT00870233|12213308|FG000|Overall Study|Did not undergo laparotomy|3
7769666|NCT00870233|12213308|FG000|Overall Study|Incompatible internet browser|2
7769667|NCT00870233|12213308|FG000|Overall Study|Death|1
7769668|NCT00870584|12213355|FG000|Overall Study|Adverse Event|3
7769669|NCT00870584|12213356|FG001|Overall Study|Adverse Event|3
7769670|NCT00870584|12213355|FG000|Overall Study|Withdrawal by Subject|6
7753015|NCT00761631|12190817|FG000|Overall Study|Parent/legal guardian request|8
7753016|NCT00761631|12190818|FG001|Overall Study|Parent/legal guardian request|3
7753017|NCT00761631|12190819|FG002|Overall Study|Parent/legal guardian request|8
7753018|NCT00761631|12190820|FG003|Overall Study|Parent/legal guardian request|0
7753019|NCT00761631|12190821|FG004|Overall Study|Parent/legal guardian request|5
7753020|NCT00761631|12190822|FG005|Overall Study|Parent/legal guardian request|0
7753021|NCT00761631|12190817|FG000|Overall Study|Lost to Follow-up|2
7753022|NCT00761631|12190818|FG001|Overall Study|Lost to Follow-up|4
7753023|NCT00761631|12190819|FG002|Overall Study|Lost to Follow-up|7
7753024|NCT00761631|12190820|FG003|Overall Study|Lost to Follow-up|1
7753025|NCT00761631|12190821|FG004|Overall Study|Lost to Follow-up|6
7753026|NCT00761631|12190822|FG005|Overall Study|Lost to Follow-up|1
7753027|NCT00761631|12190817|FG000|Overall Study|Protocol Violation|2
7753028|NCT00761631|12190818|FG001|Overall Study|Protocol Violation|0
7753029|NCT00761631|12190819|FG002|Overall Study|Protocol Violation|0
7753030|NCT00761631|12190820|FG003|Overall Study|Protocol Violation|1
7753031|NCT00761631|12190821|FG004|Overall Study|Protocol Violation|5
7753032|NCT00761631|12190822|FG005|Overall Study|Protocol Violation|1
7753033|NCT00761631|12190817|FG000|Overall Study|Randomized, not treated|1
7753034|NCT00761631|12190818|FG001|Overall Study|Randomized, not treated|0
7753035|NCT00761631|12190819|FG002|Overall Study|Randomized, not treated|0
7753036|NCT00761631|12190820|FG003|Overall Study|Randomized, not treated|0
7753037|NCT00761631|12190821|FG004|Overall Study|Randomized, not treated|0
7753038|NCT00761631|12190822|FG005|Overall Study|Randomized, not treated|0
7753039|NCT00761631|12190817|FG000|Overall Study|Failed to return|1
7753040|NCT00761631|12190818|FG001|Overall Study|Failed to return|0
7753041|NCT00761631|12190819|FG002|Overall Study|Failed to return|1
7753042|NCT00761631|12190820|FG003|Overall Study|Failed to return|1
7753043|NCT00761631|12190821|FG004|Overall Study|Failed to return|5
7753044|NCT00761631|12190822|FG005|Overall Study|Failed to return|2
7753045|NCT00761631|12190817|FG000|Overall Study|Physician Decision|1
7753046|NCT00761631|12190818|FG001|Overall Study|Physician Decision|0
7753047|NCT00761631|12190819|FG002|Overall Study|Physician Decision|0
7753048|NCT00761631|12190820|FG003|Overall Study|Physician Decision|0
7753049|NCT00761631|12190821|FG004|Overall Study|Physician Decision|0
7753050|NCT00761631|12190822|FG005|Overall Study|Physician Decision|0
7753051|NCT00761631|12190817|FG000|Overall Study|Other|0
7753052|NCT00761631|12190818|FG001|Overall Study|Other|0
7753053|NCT00761631|12190819|FG002|Overall Study|Other|0
7753054|NCT00761631|12190820|FG003|Overall Study|Other|0
7753055|NCT00761631|12190821|FG004|Overall Study|Other|1
7753056|NCT00761631|12190822|FG005|Overall Study|Other|1
7753057|NCT00761657|12190854|FG000|Part 1 (up to Day 57)|Adverse Event|0
7753058|NCT00761657|12190855|FG001|Part 1 (up to Day 57)|Adverse Event|0
7753059|NCT00761657|12190856|FG002|Part 1 (up to Day 57)|Adverse Event|0
7753060|NCT00761657|12190857|FG003|Part 1 (up to Day 57)|Adverse Event|1
7753061|NCT00761657|12190858|FG004|Part 1 (up to Day 57)|Adverse Event|0
7753062|NCT00761657|12190859|FG005|Part 1 (up to Day 57)|Adverse Event|0
7753063|NCT00761657|12190860|FG006|Part 1 (up to Day 57)|Adverse Event|0
7753064|NCT00761657|12190861|FG007|Part 1 (up to Day 57)|Adverse Event|0
7753065|NCT00761657|12190862|FG008|Part 1 (up to Day 57)|Adverse Event|0
7753066|NCT00761657|12190854|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0
7753067|NCT00761657|12190855|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0
7753068|NCT00761657|12190856|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1
7753069|NCT00761657|12190857|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1
7753070|NCT00761657|12190858|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0
7753071|NCT00761657|12190859|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0
7753072|NCT00761657|12190860|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0
7753073|NCT00761657|12190861|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0
7753074|NCT00761657|12190862|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0
7753075|NCT00761657|12190854|FG000|Part 1 (up to Day 57)|Sponsor Decision|0
7753076|NCT00761657|12190855|FG001|Part 1 (up to Day 57)|Sponsor Decision|0
7753077|NCT00761657|12190856|FG002|Part 1 (up to Day 57)|Sponsor Decision|3
7753078|NCT00761657|12190857|FG003|Part 1 (up to Day 57)|Sponsor Decision|4
7753079|NCT00761657|12190858|FG004|Part 1 (up to Day 57)|Sponsor Decision|0
7753080|NCT00761657|12190859|FG005|Part 1 (up to Day 57)|Sponsor Decision|0
7753081|NCT00761657|12190860|FG006|Part 1 (up to Day 57)|Sponsor Decision|1
7753082|NCT00761657|12190861|FG007|Part 1 (up to Day 57)|Sponsor Decision|1
7753083|NCT00761657|12190862|FG008|Part 1 (up to Day 57)|Sponsor Decision|1
7753084|NCT00761657|12190854|FG000|Part 2 (up to Day 114)|Adverse Event|0
7753085|NCT00761657|12190855|FG001|Part 2 (up to Day 114)|Adverse Event|0
7753086|NCT00761657|12190856|FG002|Part 2 (up to Day 114)|Adverse Event|0
7753087|NCT00761657|12190857|FG003|Part 2 (up to Day 114)|Adverse Event|0
7753088|NCT00761657|12190858|FG004|Part 2 (up to Day 114)|Adverse Event|0
7753089|NCT00761657|12190859|FG005|Part 2 (up to Day 114)|Adverse Event|0
7753090|NCT00761657|12190860|FG006|Part 2 (up to Day 114)|Adverse Event|0
7753091|NCT00761657|12190861|FG007|Part 2 (up to Day 114)|Adverse Event|0
7753092|NCT00761657|12190862|FG008|Part 2 (up to Day 114)|Adverse Event|1
7753093|NCT00761735|12190892|FG000|Overall Study|Lost to Follow-up|6
7753094|NCT00761735|12190892|FG000|Overall Study|Withdrawal by Subject|6
7753095|NCT00761735|12190892|FG000|Overall Study|Non-compliance with protocol|1
7753096|NCT00761735|12190892|FG000|Overall Study|Administrative|1
7753097|NCT00761748|12190900|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3
7753098|NCT00761748|12190901|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0
7753099|NCT00761748|12190900|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
7753100|NCT00761748|12190901|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
7753101|NCT00761761|12190909|FG000|Overall Study|Lost to Follow-up|3
7753102|NCT00761761|12190910|FG001|Overall Study|Lost to Follow-up|1
7753103|NCT00761761|12190909|FG000|Overall Study|Withdrawal by Subject|3
7753104|NCT00761761|12190910|FG001|Overall Study|Withdrawal by Subject|0
7753105|NCT00761774|12190918|FG000|Overall Study|Adverse Event|17
7753106|NCT00761774|12190918|FG000|Overall Study|Lack of Efficacy|37
7753107|NCT00761774|12190918|FG000|Overall Study|Lost to Follow-up|2
7753108|NCT00761774|12190918|FG000|Overall Study|Withdrawal by Subject|9
7753109|NCT00761774|12190918|FG000|Overall Study|Non-compliance|4
7753110|NCT00761774|12190918|FG000|Overall Study|End of study|2
7753111|NCT00761774|12190918|FG000|Overall Study|Reclassification of seizures|1
7753112|NCT00761774|12190918|FG000|Overall Study|Medical decision to read SUSAR reports|1
7753113|NCT00761774|12190918|FG000|Overall Study|Sponsor decision|1
7753114|NCT00761774|12190918|FG000|Overall Study|Investigator clinical judgement|1
7753115|NCT00761774|12190918|FG000|Overall Study|Patient moved out of study area|1
7753116|NCT00761774|12190918|FG000|Overall Study|Coordinator leaving site|1
7753117|NCT00761774|12190918|FG000|Overall Study|Subject IP non-compliance|1
7753118|NCT00761774|12190918|FG000|Overall Study|IP stopped by hospital physician|1
7753119|NCT00761865|12190935|FG000|Overall Study|Lost to Follow-up|8
7753120|NCT00761865|12190936|FG001|Overall Study|Lost to Follow-up|7
7753121|NCT00761891|12190942|FG000|Overall Study|Withdrawal by Subject|10
7753122|NCT00761956|12190962|FG000|Overall Study|Lost to Follow-up|6
7753123|NCT00761956|12190963|FG001|Overall Study|Lost to Follow-up|11
7753124|NCT00761956|12190962|FG000|Overall Study|Withdrawal by Subject|3
7753125|NCT00761956|12190963|FG001|Overall Study|Withdrawal by Subject|8
7753126|NCT00761956|12190962|FG000|Overall Study|Death|0
7753127|NCT00761956|12190963|FG001|Overall Study|Death|1
7753128|NCT00761956|12190962|FG000|Overall Study|Adverse Event|26
7753129|NCT00761956|12190963|FG001|Overall Study|Adverse Event|34
7753130|NCT00761969|12190971|FG000|Overall Study|Death|112
7753131|NCT00761969|12190972|FG001|Overall Study|Death|47
7753132|NCT00761969|12190971|FG000|Overall Study|Lost to Follow-up|88
7753133|NCT00761969|12190972|FG001|Overall Study|Lost to Follow-up|93
7753134|NCT00762034|12190989|FG000|Induction Period|Protocol Violation|1
7753135|NCT00762034|12190990|FG001|Induction Period|Protocol Violation|2
7753136|NCT00762034|12190989|FG000|Induction Period|Entry Criterion Not Met|12
7753137|NCT00762034|12190990|FG001|Induction Period|Entry Criterion Not Met|11
7753138|NCT00762034|12190989|FG000|Induction Period|Adverse Event|27
7753139|NCT00762034|12190990|FG001|Induction Period|Adverse Event|38
7753140|NCT00762034|12190989|FG000|Induction Period|Lost to Follow-up|1
7753141|NCT00762034|12190990|FG001|Induction Period|Lost to Follow-up|1
7753142|NCT00762034|12190989|FG000|Induction Period|Progressive Disease|73
7753143|NCT00762034|12190990|FG001|Induction Period|Progressive Disease|55
7753144|NCT00762034|12190989|FG000|Induction Period|Physician Decision|21
7753145|NCT00762034|12190990|FG001|Induction Period|Physician Decision|20
7753146|NCT00762034|12190989|FG000|Induction Period|Withdrawal by Subject|15
7753147|NCT00762034|12190990|FG001|Induction Period|Withdrawal by Subject|19
7753148|NCT00762034|12190989|FG000|Induction Period|Deaths Not Due to Study Disease|19
7753149|NCT00762034|12190990|FG001|Induction Period|Deaths Not Due to Study Disease|14
7753150|NCT00762034|12190989|FG000|Induction Period|Deaths Due to Study Disease|9
7753151|NCT00762034|12190990|FG001|Induction Period|Deaths Due to Study Disease|9
7753152|NCT00762034|12190989|FG000|Maintenance Period|Protocol Violation|1
7753153|NCT00762034|12190990|FG001|Maintenance Period|Protocol Violation|3
7753154|NCT00762034|12190989|FG000|Maintenance Period|Entry Criterion Not Met|0
7753155|NCT00762034|12190990|FG001|Maintenance Period|Entry Criterion Not Met|2
7753156|NCT00762034|12190989|FG000|Maintenance Period|Adverse Event|42
7753157|NCT00762034|12190990|FG001|Maintenance Period|Adverse Event|26
7753158|NCT00762034|12190989|FG000|Maintenance Period|Progressive Disease|186
7753159|NCT00762034|12190990|FG001|Maintenance Period|Progressive Disease|224
7753160|NCT00762034|12190989|FG000|Maintenance Period|Physician Decision|25
7753161|NCT00762034|12190990|FG001|Maintenance Period|Physician Decision|20
7753162|NCT00762034|12190989|FG000|Maintenance Period|Withdrawal by Subject|34
7753163|NCT00762034|12190990|FG001|Maintenance Period|Withdrawal by Subject|14
7753164|NCT00762034|12190989|FG000|Maintenance Period|Death not due to study disease|2
7753165|NCT00762034|12190990|FG001|Maintenance Period|Death not due to study disease|5
7753166|NCT00762034|12190989|FG000|Maintenance Period|Death due to study disease|3
7753167|NCT00762034|12190990|FG001|Maintenance Period|Death due to study disease|3
7753168|NCT00762034|12190989|FG000|Maintenance Period|Other|1
7753169|NCT00762034|12190990|FG001|Maintenance Period|Other|1
7753170|NCT00762073|12191008|FG000|Overall Study|Lack of Efficacy|1
7753171|NCT00762073|12191009|FG001|Overall Study|Lack of Efficacy|1
7753172|NCT00762073|12191010|FG002|Overall Study|Lack of Efficacy|0
7753173|NCT00762073|12191011|FG003|Overall Study|Lack of Efficacy|0
7753174|NCT00762073|12191008|FG000|Overall Study|Adverse Event|1
7753175|NCT00762073|12191009|FG001|Overall Study|Adverse Event|0
7753176|NCT00762073|12191010|FG002|Overall Study|Adverse Event|1
7753177|NCT00762073|12191011|FG003|Overall Study|Adverse Event|1
7753178|NCT00762073|12191008|FG000|Overall Study|Significant Subject Noncompliance|0
7753179|NCT00762073|12191009|FG001|Overall Study|Significant Subject Noncompliance|1
7753180|NCT00762073|12191010|FG002|Overall Study|Significant Subject Noncompliance|0
7753181|NCT00762073|12191011|FG003|Overall Study|Significant Subject Noncompliance|1
7753182|NCT00762073|12191008|FG000|Overall Study|Withdrawal by Subject|1
7753183|NCT00762073|12191009|FG001|Overall Study|Withdrawal by Subject|2
7753184|NCT00762073|12191010|FG002|Overall Study|Withdrawal by Subject|1
7753185|NCT00762073|12191011|FG003|Overall Study|Withdrawal by Subject|1
7753186|NCT00762073|12191008|FG000|Overall Study|Not on treatment for >/= 77 days|1
7753187|NCT00762073|12191009|FG001|Overall Study|Not on treatment for >/= 77 days|0
7753188|NCT00762073|12191010|FG002|Overall Study|Not on treatment for >/= 77 days|0
7753189|NCT00762073|12191011|FG003|Overall Study|Not on treatment for >/= 77 days|0
7753190|NCT00762086|12191030|FG000|Overall Study|Adverse Event|2
7753191|NCT00762086|12191031|FG001|Overall Study|Adverse Event|0
7753192|NCT00762086|12191030|FG000|Overall Study|Lost to Follow-up|0
7753193|NCT00762086|12191031|FG001|Overall Study|Lost to Follow-up|2
7753194|NCT00762086|12191030|FG000|Overall Study|Non compliance|1
7753195|NCT00762086|12191031|FG001|Overall Study|Non compliance|0
7753196|NCT00762086|12191030|FG000|Overall Study|Withdrawal by Subject|2
7753197|NCT00762086|12191031|FG001|Overall Study|Withdrawal by Subject|2
7753198|NCT00762086|12191030|FG000|Overall Study|Ineligible to participate in the study|1
7753199|NCT00762086|12191031|FG001|Overall Study|Ineligible to participate in the study|0
7753200|NCT00762164|12191039|FG000|Overall Study|Lost to Follow-up|1
7753201|NCT00762164|12191040|FG001|Overall Study|Lost to Follow-up|1
7753202|NCT00762164|12191039|FG000|Overall Study|Discontinued medication|2
7753203|NCT00762164|12191040|FG001|Overall Study|Discontinued medication|0
7753204|NCT00762164|12191039|FG000|Overall Study|Withdrawal by Subject|0
7753205|NCT00762164|12191040|FG001|Overall Study|Withdrawal by Subject|1
7753206|NCT00762229|12191068|FG000|Overall Study|Lost to Follow-up|1
7753207|NCT00762229|12191069|FG001|Overall Study|Lost to Follow-up|1
7753208|NCT00762229|12191068|FG000|Overall Study|did not recveive intervention|0
7753209|NCT00762229|12191069|FG001|Overall Study|did not recveive intervention|1
7753210|NCT00762268|12191077|FG000|Overall Study|Withdrawal by Subject|3
7753211|NCT00762268|12191078|FG001|Overall Study|Withdrawal by Subject|3
7753212|NCT00762359|12191123|FG000|Overall Study|Adverse Event|20
7753213|NCT00762359|12191124|FG001|Overall Study|Adverse Event|23
7753214|NCT00762359|12191123|FG000|Overall Study|Protocol Violation|21
7753215|NCT00762359|12191124|FG001|Overall Study|Protocol Violation|13
7753216|NCT00762359|12191123|FG000|Overall Study|Withdrawal by Subject|13
7753217|NCT00762359|12191124|FG001|Overall Study|Withdrawal by Subject|10
7753218|NCT00762359|12191123|FG000|Overall Study|Lack of Efficacy|0
7753219|NCT00762359|12191124|FG001|Overall Study|Lack of Efficacy|4
7753220|NCT00762359|12191123|FG000|Overall Study|Institution closed|2
7753221|NCT00762359|12191124|FG001|Overall Study|Institution closed|3
7753222|NCT00762359|12191123|FG000|Overall Study|Physician Decision|2
7753223|NCT00762359|12191124|FG001|Overall Study|Physician Decision|3
7753224|NCT00762359|12191123|FG000|Overall Study|Removal|0
7753225|NCT00762359|12191124|FG001|Overall Study|Removal|1
7753226|NCT00762359|12191123|FG000|Overall Study|Withdrew consent|1
7753227|NCT00762359|12191124|FG001|Overall Study|Withdrew consent|0
7753228|NCT00762372|12191133|FG000|Overall Study|Adverse Event|1
7753229|NCT00762372|12191134|FG001|Overall Study|Adverse Event|0
7753230|NCT00762372|12191135|FG002|Overall Study|Adverse Event|0
7753231|NCT00762385|12191149|FG000|First Intervention|Lens Issue|1
7753232|NCT00762385|12191150|FG001|First Intervention|Lens Issue|1
7753233|NCT00762385|12191149|FG000|First Intervention|Lost to Follow-up|0
7753234|NCT00762385|12191150|FG001|First Intervention|Lost to Follow-up|2
7753235|NCT00762385|12191149|FG000|First Intervention|Ineligible|1
7753236|NCT00762385|12191150|FG001|First Intervention|Ineligible|0
7753237|NCT00762385|12191149|FG000|First Intervention|Protocol Violation|0
7753238|NCT00762385|12191150|FG001|First Intervention|Protocol Violation|1
7753239|NCT00762385|12191149|FG000|Second Intervention|Protocol Violation|3
7753240|NCT00762385|12191150|FG001|Second Intervention|Protocol Violation|3
7753241|NCT00762411|12191161|FG000|Initial Treatment|Death|7
7753242|NCT00762411|12191162|FG001|Initial Treatment|Death|6
7753243|NCT00762411|12191161|FG000|Initial Treatment|Adverse Event|132
7753244|NCT00762411|12191162|FG001|Initial Treatment|Adverse Event|40
7753245|NCT00762411|12191161|FG000|Initial Treatment|Protocol Violation|4
7753246|NCT00762411|12191162|FG001|Initial Treatment|Protocol Violation|1
7753247|NCT00762411|12191161|FG000|Initial Treatment|Withdrawal by Subject|65
7753248|NCT00762411|12191162|FG001|Initial Treatment|Withdrawal by Subject|52
7753249|NCT00762411|12191161|FG000|Initial Treatment|Physician Decision|1
7753250|NCT00762411|12191162|FG001|Initial Treatment|Physician Decision|0
7753251|NCT00762411|12191161|FG000|Initial Treatment|Sponsor Decision|293
7753252|NCT00762411|12191162|FG001|Initial Treatment|Sponsor Decision|401
7753253|NCT00762411|12191161|FG000|Initial Treatment|Lost to Follow-up|5
7753254|NCT00762411|12191162|FG001|Initial Treatment|Lost to Follow-up|0
7753255|NCT00762411|12191161|FG000|Initial Treatment|Caregiver Decision|21
7753256|NCT00762411|12191162|FG001|Initial Treatment|Caregiver Decision|16
7753257|NCT00762411|12191161|FG000|Initial Treatment|Abnormal Lab/ECG Result|6
7753258|NCT00762411|12191162|FG001|Initial Treatment|Abnormal Lab/ECG Result|4
7753259|NCT00762411|12191161|FG000|Initial Treatment|Entry Criteria Exclusion|0
7753260|NCT00762411|12191162|FG001|Initial Treatment|Entry Criteria Exclusion|1
7753261|NCT00762411|12191161|FG000|Delayed Start|Adverse Event|0
7753262|NCT00762411|12191162|FG001|Delayed Start|Adverse Event|4
7753263|NCT00762411|12191161|FG000|Delayed Start|Protocol Violation|0
7753264|NCT00762411|12191162|FG001|Delayed Start|Protocol Violation|1
7753265|NCT00762411|12191161|FG000|Delayed Start|Sponsor Decision|16
7753266|NCT00762411|12191162|FG001|Delayed Start|Sponsor Decision|20
7753267|NCT00762411|12191161|FG000|Delayed Start|Caregiver Decision|1
7753268|NCT00762411|12191162|FG001|Delayed Start|Caregiver Decision|1
7753269|NCT00762411|12191161|FG000|Safety Follow Up (SFU)-Optional|Death|1
7753270|NCT00762411|12191162|FG001|Safety Follow Up (SFU)-Optional|Death|8
7753271|NCT00762411|12191161|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0
7753272|NCT00762411|12191162|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1
7753273|NCT00762411|12191161|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
7753274|NCT00762411|12191162|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
7753275|NCT00762411|12191161|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
7753276|NCT00762411|12191162|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
7753277|NCT00762411|12191161|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
7753278|NCT00762411|12191162|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
7753279|NCT00762411|12191161|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
7753280|NCT00762411|12191162|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
7753281|NCT00762463|12191196|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
7753282|NCT00762463|12191197|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
7753283|NCT00762463|12191198|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
7753284|NCT00762463|12191199|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
7753285|NCT00762463|12191196|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
7753286|NCT00762463|12191197|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
7753287|NCT00762463|12191198|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
7753288|NCT00762463|12191199|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
7753289|NCT00762463|12191196|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
7753290|NCT00762463|12191197|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
7753291|NCT00762463|12191198|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
7753292|NCT00762463|12191199|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
7753293|NCT00762463|12191196|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
7753294|NCT00762463|12191197|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
7753295|NCT00762463|12191198|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
7753296|NCT00762463|12191199|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
7753297|NCT00762463|12191196|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
7753298|NCT00762463|12191197|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
7753299|NCT00762463|12191198|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
7753300|NCT00762463|12191199|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
7753301|NCT00762463|12191196|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
7753302|NCT00762463|12191197|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
7753303|NCT00762463|12191198|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
7753304|NCT00762463|12191199|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
7753305|NCT00762463|12191196|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
7753306|NCT00762463|12191197|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
7753307|NCT00762463|12191198|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
7753308|NCT00762463|12191199|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
7753309|NCT00762463|12191196|FG000|Extension Phase (Week 6 to Week 12)|Other|0
7753310|NCT00762463|12191197|FG001|Extension Phase (Week 6 to Week 12)|Other|0
7753311|NCT00762463|12191198|FG002|Extension Phase (Week 6 to Week 12)|Other|0
7753312|NCT00762463|12191199|FG003|Extension Phase (Week 6 to Week 12)|Other|1
7753313|NCT00762476|12191214|FG000|Overall Study|Adverse Event|7
7753314|NCT00762476|12191215|FG001|Overall Study|Adverse Event|1
7753315|NCT00762476|12191214|FG000|Overall Study|Lost to Follow-up|2
7753316|NCT00762476|12191215|FG001|Overall Study|Lost to Follow-up|0
7753317|NCT00762476|12191214|FG000|Overall Study|Protocol Violation|5
7753318|NCT00762476|12191215|FG001|Overall Study|Protocol Violation|6
7753319|NCT00762476|12191214|FG000|Overall Study|Physician Decision|2
7753320|NCT00762476|12191215|FG001|Overall Study|Physician Decision|14
7753321|NCT00762476|12191214|FG000|Overall Study|Withdrawal by Subject|6
7753322|NCT00762476|12191215|FG001|Overall Study|Withdrawal by Subject|12
7753323|NCT00762476|12191214|FG000|Overall Study|antibiotic use|0
7753324|NCT00762476|12191215|FG001|Overall Study|antibiotic use|1
7753325|NCT00762476|12191214|FG000|Overall Study|non-compliance with study visits|0
7753326|NCT00762476|12191215|FG001|Overall Study|non-compliance with study visits|2
7753327|NCT00762476|12191214|FG000|Overall Study|Seasonal allergies|1
7753328|NCT00762476|12191215|FG001|Overall Study|Seasonal allergies|0
7753329|NCT00762502|12191225|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4
7753330|NCT00762502|12191226|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3
7753331|NCT00762502|12191227|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6
7753332|NCT00762502|12191225|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
7753333|NCT00762502|12191226|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
7753334|NCT00762502|12191227|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
7753335|NCT00762502|12191225|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0
7753336|NCT00762502|12191226|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1
7753337|NCT00762502|12191227|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0
7753338|NCT00762606|12191253|FG000|Overall Study|Lost to Follow-up|18
7753339|NCT00762606|12191254|FG001|Overall Study|Lost to Follow-up|13
7753340|NCT00762762|12191291|FG000|Overall Study|Did not report for appointments|8
7753341|NCT00762762|12191292|FG001|Overall Study|Did not report for appointments|10
7753342|NCT00762788|12191304|FG000|Overall Study|Lost to Follow-up|26
7753343|NCT00762788|12191305|FG001|Overall Study|Lost to Follow-up|37
7753344|NCT00762788|12191306|FG002|Overall Study|Lost to Follow-up|21
7753345|NCT00762788|12191307|FG003|Overall Study|Lost to Follow-up|26
7753346|NCT00762788|12191308|FG004|Overall Study|Lost to Follow-up|13
7753347|NCT00762788|12191309|FG005|Overall Study|Lost to Follow-up|21
7753348|NCT00762892|12191334|FG000|Overall Study|Lost to Follow-up|2
7753349|NCT00762892|12191335|FG001|Overall Study|Lost to Follow-up|5
7753350|NCT00762892|12191334|FG000|Overall Study|Withdrawal by Subject|0
7753351|NCT00762892|12191335|FG001|Overall Study|Withdrawal by Subject|1
7753352|NCT00762892|12191334|FG000|Overall Study|Death|1
7753353|NCT00762892|12191335|FG001|Overall Study|Death|0
7753354|NCT00762892|12191334|FG000|Overall Study|Pregnancy|1
7753355|NCT00762892|12191335|FG001|Overall Study|Pregnancy|0
7753356|NCT00762892|12191334|FG000|Overall Study|Incarceration|1
7753357|NCT00762892|12191335|FG001|Overall Study|Incarceration|0
7753358|NCT00762970|12191348|FG000|Overall Study|Withdrawal by Subject|7
7753359|NCT00762970|12191349|FG001|Overall Study|Withdrawal by Subject|4
7753360|NCT00762970|12191350|FG002|Overall Study|Withdrawal by Subject|0
7753361|NCT00762970|12191348|FG000|Overall Study|Protocol Violation|3
7753362|NCT00762970|12191349|FG001|Overall Study|Protocol Violation|1
7753363|NCT00762970|12191350|FG002|Overall Study|Protocol Violation|1
7753364|NCT00762970|12191348|FG000|Overall Study|Lost to Follow-up|1
7753365|NCT00762970|12191349|FG001|Overall Study|Lost to Follow-up|2
7753366|NCT00762970|12191350|FG002|Overall Study|Lost to Follow-up|0
7753367|NCT00762970|12191348|FG000|Overall Study|Difficulty of handling lens|1
7753368|NCT00762970|12191349|FG001|Overall Study|Difficulty of handling lens|2
7753369|NCT00762970|12191350|FG002|Overall Study|Difficulty of handling lens|0
7753370|NCT00762996|12191358|FG000|Period One|Protocol Violation|0
7753371|NCT00762996|12191359|FG001|Period One|Protocol Violation|0
7753372|NCT00762996|12191360|FG002|Period One|Protocol Violation|1
7753373|NCT00762996|12191361|FG003|Period One|Protocol Violation|0
7753374|NCT00762996|12191358|FG000|Period One|ineligible|0
7753375|NCT00762996|12191359|FG001|Period One|ineligible|0
7753376|NCT00762996|12191360|FG002|Period One|ineligible|1
7753377|NCT00762996|12191361|FG003|Period One|ineligible|1
7753378|NCT00762996|12191358|FG000|Period One|Adverse Event|0
7753379|NCT00762996|12191359|FG001|Period One|Adverse Event|0
7753380|NCT00762996|12191360|FG002|Period One|Adverse Event|1
7753381|NCT00762996|12191361|FG003|Period One|Adverse Event|0
7753382|NCT00762996|12191358|FG000|Period One|Withdrawal by Subject|0
7753383|NCT00762996|12191359|FG001|Period One|Withdrawal by Subject|0
7753384|NCT00762996|12191360|FG002|Period One|Withdrawal by Subject|1
7753385|NCT00762996|12191361|FG003|Period One|Withdrawal by Subject|0
7753386|NCT00763035|12191369|FG000|First Intervention|Did not meeting inclusion/exclusion|1
7753387|NCT00763035|12191370|FG001|First Intervention|Did not meeting inclusion/exclusion|0
7753388|NCT00763035|12191369|FG000|First Intervention|Adverse Event|0
7753389|NCT00763035|12191370|FG001|First Intervention|Adverse Event|1
7753390|NCT00763035|12191369|FG000|Second Intervention|Adverse Event|1
7753391|NCT00763035|12191370|FG001|Second Intervention|Adverse Event|0
7753392|NCT00763035|12191369|FG000|Second Intervention|Physician Decision|2
7753393|NCT00763035|12191370|FG001|Second Intervention|Physician Decision|0
7753394|NCT00763139|12191394|FG000|Overall Study|Adverse Event|4
7753395|NCT00763139|12191395|FG001|Overall Study|Adverse Event|2
7753396|NCT00763139|12191394|FG000|Overall Study|Withdrawal by Subject|0
7753397|NCT00763139|12191395|FG001|Overall Study|Withdrawal by Subject|1
7753398|NCT00763139|12191394|FG000|Overall Study|med change not allowed by protocol|1
7753399|NCT00763139|12191395|FG001|Overall Study|med change not allowed by protocol|0
7753400|NCT00763256|12191420|FG000|Overall Study|Didn't return for appointments|7
7753401|NCT00763256|12191421|FG001|Overall Study|Didn't return for appointments|10
7753402|NCT00763269|12191429|FG000|Overall Study|Lost to Follow-up|12
7753403|NCT00763269|12191430|FG001|Overall Study|Lost to Follow-up|13
7753404|NCT00763282|12191438|FG000|Overall Study|Withdrawal by Subject|6
7753405|NCT00763282|12191439|FG001|Overall Study|Withdrawal by Subject|5
7753406|NCT00763282|12191438|FG000|Overall Study|Death|4
7753407|NCT00763282|12191439|FG001|Overall Study|Death|3
7753408|NCT00763282|12191438|FG000|Overall Study|Lost to Follow-up|22
7753409|NCT00763282|12191439|FG001|Overall Study|Lost to Follow-up|26
7753410|NCT00763321|12191450|FG000|Open-label Period|Adverse Event|24
7753411|NCT00763321|12191451|FG001|Open-label Period|Adverse Event|0
7753412|NCT00763321|12191452|FG002|Open-label Period|Adverse Event|0
7753413|NCT00763321|12191450|FG000|Open-label Period|Lost to Follow-up|14
7753414|NCT00763321|12191451|FG001|Open-label Period|Lost to Follow-up|0
7753415|NCT00763321|12191452|FG002|Open-label Period|Lost to Follow-up|0
7753416|NCT00763321|12191450|FG000|Open-label Period|Withdrawal by Subject|7
7753417|NCT00763321|12191451|FG001|Open-label Period|Withdrawal by Subject|0
7753418|NCT00763321|12191452|FG002|Open-label Period|Withdrawal by Subject|0
7753419|NCT00763321|12191450|FG000|Open-label Period|Subject noncompliant|7
7753420|NCT00763321|12191451|FG001|Open-label Period|Subject noncompliant|0
7753421|NCT00763321|12191452|FG002|Open-label Period|Subject noncompliant|0
7753422|NCT00763321|12191450|FG000|Open-label Period|Did not meet DB randomization criteria|5
7753423|NCT00763321|12191451|FG001|Open-label Period|Did not meet DB randomization criteria|0
7753424|NCT00763321|12191452|FG002|Open-label Period|Did not meet DB randomization criteria|0
7753425|NCT00763321|12191450|FG000|Open-label Period|Lack of Efficacy|2
7753426|NCT00763321|12191451|FG001|Open-label Period|Lack of Efficacy|0
7753427|NCT00763321|12191452|FG002|Open-label Period|Lack of Efficacy|0
7753428|NCT00763321|12191450|FG000|Open-label Period|Other|4
7753429|NCT00763321|12191451|FG001|Open-label Period|Other|0
7753430|NCT00763321|12191452|FG002|Open-label Period|Other|0
7753431|NCT00763321|12191450|FG000|Double-blind Period|Lack of Efficacy|0
7753432|NCT00763321|12191451|FG001|Double-blind Period|Lack of Efficacy|9
7753433|NCT00763321|12191452|FG002|Double-blind Period|Lack of Efficacy|17
7753434|NCT00763321|12191450|FG000|Double-blind Period|Adverse Event|0
7753435|NCT00763321|12191451|FG001|Double-blind Period|Adverse Event|4
7753436|NCT00763321|12191452|FG002|Double-blind Period|Adverse Event|4
7753437|NCT00763321|12191450|FG000|Double-blind Period|Lost to Follow-up|0
7753438|NCT00763321|12191451|FG001|Double-blind Period|Lost to Follow-up|4
7753439|NCT00763321|12191452|FG002|Double-blind Period|Lost to Follow-up|2
7753440|NCT00763321|12191450|FG000|Double-blind Period|Withdrawal by Subject|0
7753441|NCT00763321|12191451|FG001|Double-blind Period|Withdrawal by Subject|2
7753442|NCT00763321|12191452|FG002|Double-blind Period|Withdrawal by Subject|3
7753443|NCT00763321|12191450|FG000|Double-blind Period|Other|0
7753444|NCT00763321|12191451|FG001|Double-blind Period|Other|2
7753445|NCT00763321|12191452|FG002|Double-blind Period|Other|3
7753446|NCT00763386|12191474|FG000|Overall Study|Adverse Event|43
7753447|NCT00763386|12191475|FG001|Overall Study|Adverse Event|33
7753448|NCT00763386|12191474|FG000|Overall Study|Death|1
7753449|NCT00763386|12191475|FG001|Overall Study|Death|2
7753450|NCT00763386|12191474|FG000|Overall Study|Lost to Follow-up|3
7753451|NCT00763386|12191475|FG001|Overall Study|Lost to Follow-up|3
7753452|NCT00763386|12191474|FG000|Overall Study|Withdrawal by Subject|0
7753453|NCT00763386|12191475|FG001|Overall Study|Withdrawal by Subject|1
7753454|NCT00763386|12191474|FG000|Overall Study|CRF missing|0
7753455|NCT00763386|12191475|FG001|Overall Study|CRF missing|1
7753456|NCT00763386|12191474|FG000|Overall Study|Study Prosthesis Removed|1
7753457|NCT00763386|12191475|FG001|Overall Study|Study Prosthesis Removed|0
7753458|NCT00763451|12191494|FG000|Overall Study|Adverse Event|4
7753459|NCT00763451|12191495|FG001|Overall Study|Adverse Event|6
7753460|NCT00763451|12191496|FG002|Overall Study|Adverse Event|19
7753461|NCT00763451|12191497|FG003|Overall Study|Adverse Event|14
7753462|NCT00763451|12191494|FG000|Overall Study|Lack of Efficacy|1
7753463|NCT00763451|12191495|FG001|Overall Study|Lack of Efficacy|4
7753464|NCT00763451|12191496|FG002|Overall Study|Lack of Efficacy|3
7753465|NCT00763451|12191497|FG003|Overall Study|Lack of Efficacy|2
7753466|NCT00763451|12191494|FG000|Overall Study|Withdrawal by Subject|1
7753467|NCT00763451|12191495|FG001|Overall Study|Withdrawal by Subject|6
7753468|NCT00763451|12191496|FG002|Overall Study|Withdrawal by Subject|9
7753469|NCT00763451|12191497|FG003|Overall Study|Withdrawal by Subject|7
7753470|NCT00763451|12191494|FG000|Overall Study|Protocol Violation|0
7753471|NCT00763451|12191495|FG001|Overall Study|Protocol Violation|0
7753472|NCT00763451|12191496|FG002|Overall Study|Protocol Violation|1
7753473|NCT00763451|12191497|FG003|Overall Study|Protocol Violation|0
7753474|NCT00763451|12191494|FG000|Overall Study|Poor Compliance to Protocol|1
7753475|NCT00763451|12191495|FG001|Overall Study|Poor Compliance to Protocol|1
7753476|NCT00763451|12191496|FG002|Overall Study|Poor Compliance to Protocol|2
7753477|NCT00763451|12191497|FG003|Overall Study|Poor Compliance to Protocol|2
7753478|NCT00763451|12191494|FG000|Overall Study|Familial and Personal Reasons|5
7753479|NCT00763451|12191495|FG001|Overall Study|Familial and Personal Reasons|3
7753480|NCT00763451|12191496|FG002|Overall Study|Familial and Personal Reasons|5
7753481|NCT00763451|12191497|FG003|Overall Study|Familial and Personal Reasons|4
7753482|NCT00763451|12191494|FG000|Overall Study|Randomized but not Treated|1
7753483|NCT00763451|12191495|FG001|Overall Study|Randomized but not Treated|1
7753484|NCT00763451|12191496|FG002|Overall Study|Randomized but not Treated|0
7753485|NCT00763451|12191497|FG003|Overall Study|Randomized but not Treated|0
7753486|NCT00763451|12191494|FG000|Overall Study|Study Site Reason|0
7753487|NCT00763451|12191495|FG001|Overall Study|Study Site Reason|1
7753488|NCT00763451|12191496|FG002|Overall Study|Study Site Reason|1
7753489|NCT00763451|12191497|FG003|Overall Study|Study Site Reason|1
7753490|NCT00763698|12191512|FG000|Overall Study|Unsuccessful Implant|5
7753491|NCT00763698|12191512|FG000|Overall Study|Death|4
7753492|NCT00763698|12191512|FG000|Overall Study|Withdrawal by Subject|1
7753493|NCT00763815|12191523|FG000|Overall Study|Adverse Event|14
7753494|NCT00763815|12191524|FG001|Overall Study|Adverse Event|29
7753495|NCT00763815|12191523|FG000|Overall Study|Lack of Efficacy|10
7753496|NCT00763815|12191524|FG001|Overall Study|Lack of Efficacy|11
7753497|NCT00763815|12191523|FG000|Overall Study|Poor Compliance to Protocol|6
7753498|NCT00763815|12191524|FG001|Overall Study|Poor Compliance to Protocol|6
7753499|NCT00763815|12191523|FG000|Overall Study|Lost to Follow-up|2
7753500|NCT00763815|12191524|FG001|Overall Study|Lost to Follow-up|4
7753501|NCT00763815|12191523|FG000|Overall Study|Early Termination|1
7753502|NCT00763815|12191524|FG001|Overall Study|Early Termination|0
7753503|NCT00763815|12191523|FG000|Overall Study|Familial and Personal Reasons|9
7753504|NCT00763815|12191524|FG001|Overall Study|Familial and Personal Reasons|16
7753505|NCT00763815|12191523|FG000|Overall Study|Physician Decision|1
7753506|NCT00763815|12191524|FG001|Overall Study|Physician Decision|0
7753507|NCT00763815|12191523|FG000|Overall Study|Withdrawal by Subject|7
7753508|NCT00763815|12191524|FG001|Overall Study|Withdrawal by Subject|12
7753509|NCT00763815|12191523|FG000|Overall Study|Protocol Violation|2
7753510|NCT00763815|12191524|FG001|Overall Study|Protocol Violation|5
7753511|NCT00763815|12191523|FG000|Overall Study|Sponsor's Decision|0
7753512|NCT00763815|12191524|FG001|Overall Study|Sponsor's Decision|1
7753513|NCT00763958|12191545|FG000|Overall Study|did not meet final criteria|4
7753514|NCT00763958|12191546|FG001|Overall Study|did not meet final criteria|4
7753515|NCT00763958|12191545|FG000|Overall Study|Lost to Follow-up|10
7753516|NCT00763958|12191546|FG001|Overall Study|Lost to Follow-up|2
7753517|NCT00763958|12191545|FG000|Overall Study|Believed they were receiving placebo|0
7753518|NCT00763958|12191546|FG001|Overall Study|Believed they were receiving placebo|5
7753519|NCT00763971|12191556|FG000|Overall Study|Adverse Event|5
7753520|NCT00763971|12191557|FG001|Overall Study|Adverse Event|2
7753521|NCT00763971|12191558|FG002|Overall Study|Adverse Event|4
7753522|NCT00763971|12191556|FG000|Overall Study|Protocol Violation|3
7753523|NCT00763971|12191557|FG001|Overall Study|Protocol Violation|3
7753524|NCT00763971|12191558|FG002|Overall Study|Protocol Violation|2
7753525|NCT00763971|12191556|FG000|Overall Study|Withdrawal by Subject|4
7753526|NCT00763971|12191557|FG001|Overall Study|Withdrawal by Subject|5
7753527|NCT00763971|12191558|FG002|Overall Study|Withdrawal by Subject|5
7753528|NCT00763971|12191556|FG000|Overall Study|Lost to Follow-up|0
7753529|NCT00763971|12191557|FG001|Overall Study|Lost to Follow-up|1
7753530|NCT00763971|12191558|FG002|Overall Study|Lost to Follow-up|0
7753531|NCT00763971|12191556|FG000|Overall Study|Lack of Efficacy|11
7753532|NCT00763971|12191557|FG001|Overall Study|Lack of Efficacy|22
7753533|NCT00763971|12191558|FG002|Overall Study|Lack of Efficacy|54
7753534|NCT00763971|12191556|FG000|Overall Study|Unable to swallow capsule|2
7753535|NCT00763971|12191557|FG001|Overall Study|Unable to swallow capsule|1
7753536|NCT00763971|12191558|FG002|Overall Study|Unable to swallow capsule|1
7753537|NCT00763971|12191556|FG000|Overall Study|Personal reason|3
7753538|NCT00763971|12191557|FG001|Overall Study|Personal reason|0
7753539|NCT00763971|12191558|FG002|Overall Study|Personal reason|0
7753540|NCT00763971|12191556|FG000|Overall Study|Exclusion criteria met|1
7753541|NCT00763971|12191557|FG001|Overall Study|Exclusion criteria met|0
7753542|NCT00763971|12191558|FG002|Overall Study|Exclusion criteria met|0
7753543|NCT00763971|12191556|FG000|Overall Study|Sponsor decision|1
7753544|NCT00763971|12191557|FG001|Overall Study|Sponsor decision|0
7753545|NCT00763971|12191558|FG002|Overall Study|Sponsor decision|0
7753546|NCT00763971|12191556|FG000|Overall Study|Due to holiday season|2
7753547|NCT00763971|12191557|FG001|Overall Study|Due to holiday season|0
7753548|NCT00763971|12191558|FG002|Overall Study|Due to holiday season|1
7753549|NCT00763971|12191556|FG000|Overall Study|Randomization error|0
7753550|NCT00763971|12191557|FG001|Overall Study|Randomization error|0
7753551|NCT00763971|12191558|FG002|Overall Study|Randomization error|1
7753552|NCT00763971|12191556|FG000|Overall Study|Medical monitor decision|0
7753553|NCT00763971|12191557|FG001|Overall Study|Medical monitor decision|0
7753554|NCT00763971|12191558|FG002|Overall Study|Medical monitor decision|1
7753555|NCT00763971|12191556|FG000|Overall Study|Moved to another country|0
7753556|NCT00763971|12191557|FG001|Overall Study|Moved to another country|1
7753557|NCT00763971|12191558|FG002|Overall Study|Moved to another country|0
7753558|NCT00763971|12191556|FG000|Overall Study|Subject wanted dose reduction|0
7753559|NCT00763971|12191557|FG001|Overall Study|Subject wanted dose reduction|1
7753560|NCT00763971|12191558|FG002|Overall Study|Subject wanted dose reduction|0
7753561|NCT00763971|12191556|FG000|Overall Study|Lack of availability|0
7753562|NCT00763971|12191557|FG001|Overall Study|Lack of availability|1
7753563|NCT00763971|12191558|FG002|Overall Study|Lack of availability|0
7753564|NCT00763971|12191556|FG000|Overall Study|Performed final visit on phone|0
7753565|NCT00763971|12191557|FG001|Overall Study|Performed final visit on phone|1
7753566|NCT00763971|12191558|FG002|Overall Study|Performed final visit on phone|0
7753567|NCT00763971|12191556|FG000|Overall Study|Participation in 489-326 required|1
7753568|NCT00763971|12191557|FG001|Overall Study|Participation in 489-326 required|0
7753569|NCT00763971|12191558|FG002|Overall Study|Participation in 489-326 required|0
7753570|NCT00764322|12191572|FG000|Overall Study|Withdrawal by Subject|11
7753571|NCT00764322|12191572|FG000|Overall Study|No CYP2D6 genotyping|9
7753572|NCT00764361|12191591|FG000|Overall Study|Withdrawal by Subject|2
7753573|NCT00764361|12191592|FG001|Overall Study|Withdrawal by Subject|3
7753574|NCT00764361|12191591|FG000|Overall Study|Adverse Event|0
7753575|NCT00764361|12191592|FG001|Overall Study|Adverse Event|1
7753576|NCT00764465|12191604|FG000|Overall Study|Adverse Event|2
7753577|NCT00764465|12191605|FG001|Overall Study|Adverse Event|0
7753578|NCT00764465|12191606|FG002|Overall Study|Adverse Event|0
7753579|NCT00764465|12191607|FG003|Overall Study|Adverse Event|1
7753580|NCT00764465|12191608|FG004|Overall Study|Adverse Event|1
7753581|NCT00764465|12191609|FG005|Overall Study|Adverse Event|1
7753582|NCT00764465|12191604|FG000|Overall Study|Withdrawal by Subject|0
7753583|NCT00764465|12191605|FG001|Overall Study|Withdrawal by Subject|1
7753584|NCT00764465|12191606|FG002|Overall Study|Withdrawal by Subject|1
7753585|NCT00764465|12191607|FG003|Overall Study|Withdrawal by Subject|0
7753586|NCT00764465|12191608|FG004|Overall Study|Withdrawal by Subject|0
7753587|NCT00764465|12191609|FG005|Overall Study|Withdrawal by Subject|0
7753588|NCT00764491|12191628|FG000|Overall Study|Lost to Follow-up|35
7753589|NCT00764491|12191629|FG001|Overall Study|Lost to Follow-up|17
7753590|NCT00764504|12191638|FG000|Overall Study|Death|12
7753591|NCT00764504|12191639|FG001|Overall Study|Death|6
7753592|NCT00764504|12191640|FG002|Overall Study|Death|13
7753593|NCT00764504|12191638|FG000|Overall Study|Revision of Device|12
7753594|NCT00764504|12191639|FG001|Overall Study|Revision of Device|23
7962372|NCT02711956|12516614|FG009|Overall Study|Clinical progression|0
7962373|NCT02711956|12516615|FG010|Overall Study|Clinical progression|0
7962374|NCT02711956|12516616|FG011|Overall Study|Clinical progression|2
7962375|NCT02711956|12516617|FG012|Overall Study|Clinical progression|4
7962376|NCT02711956|12516618|FG013|Overall Study|Clinical progression|1
7962377|NCT02711956|12516619|FG014|Overall Study|Clinical progression|1
7962378|NCT02711956|12516605|FG000|Overall Study|Radiographic progression|1
7962379|NCT02711956|12516606|FG001|Overall Study|Radiographic progression|1
7962380|NCT02711956|12516607|FG002|Overall Study|Radiographic progression|2
7962381|NCT02711956|12516608|FG003|Overall Study|Radiographic progression|0
7962382|NCT02711956|12516609|FG004|Overall Study|Radiographic progression|1
7962383|NCT02711956|12516610|FG005|Overall Study|Radiographic progression|0
7962384|NCT02711956|12516611|FG006|Overall Study|Radiographic progression|0
7962385|NCT02711956|12516612|FG007|Overall Study|Radiographic progression|0
7962386|NCT02711956|12516613|FG008|Overall Study|Radiographic progression|2
7962387|NCT02711956|12516614|FG009|Overall Study|Radiographic progression|1
7962388|NCT02711956|12516615|FG010|Overall Study|Radiographic progression|0
7962389|NCT02711956|12516616|FG011|Overall Study|Radiographic progression|5
7962390|NCT02711956|12516617|FG012|Overall Study|Radiographic progression|3
7962391|NCT02711956|12516618|FG013|Overall Study|Radiographic progression|0
7962392|NCT02711956|12516619|FG014|Overall Study|Radiographic progression|1
7962393|NCT02711956|12516605|FG000|Overall Study|PSA progression with clinical progression|0
7962394|NCT02711956|12516606|FG001|Overall Study|PSA progression with clinical progression|0
7962395|NCT02711956|12516607|FG002|Overall Study|PSA progression with clinical progression|0
7962396|NCT02711956|12516608|FG003|Overall Study|PSA progression with clinical progression|0
7962397|NCT02711956|12516609|FG004|Overall Study|PSA progression with clinical progression|1
7962398|NCT02711956|12516610|FG005|Overall Study|PSA progression with clinical progression|0
7962399|NCT02711956|12516611|FG006|Overall Study|PSA progression with clinical progression|0
7962400|NCT02711956|12516612|FG007|Overall Study|PSA progression with clinical progression|0
7753595|NCT00764504|12191640|FG002|Overall Study|Revision of Device|14
7753596|NCT00764504|12191638|FG000|Overall Study|Physician Decision|1
7753597|NCT00764504|12191639|FG001|Overall Study|Physician Decision|0
7753598|NCT00764504|12191640|FG002|Overall Study|Physician Decision|0
7753599|NCT00764504|12191638|FG000|Overall Study|Withdrawal by Subject|1
7753600|NCT00764504|12191639|FG001|Overall Study|Withdrawal by Subject|7
7753601|NCT00764504|12191640|FG002|Overall Study|Withdrawal by Subject|4
7753602|NCT00764504|12191638|FG000|Overall Study|Lost to Follow-up|40
7753603|NCT00764504|12191639|FG001|Overall Study|Lost to Follow-up|34
7753604|NCT00764504|12191640|FG002|Overall Study|Lost to Follow-up|72
7753605|NCT00764517|12191650|FG000|Overall Study|Adverse Event|9
7753606|NCT00764517|12191651|FG001|Overall Study|Adverse Event|3
7753607|NCT00764517|12191650|FG000|Overall Study|Death|3
7753608|NCT00764517|12191651|FG001|Overall Study|Death|11
7753609|NCT00764517|12191650|FG000|Overall Study|Physician Decision|3
7753610|NCT00764517|12191651|FG001|Overall Study|Physician Decision|0
7753611|NCT00764660|12191659|FG000|Overall Study|Adverse Event|6
7753612|NCT00764660|12191660|FG001|Overall Study|Adverse Event|3
7753613|NCT00764660|12191659|FG000|Overall Study|Lost to Follow-up|3
7753614|NCT00764660|12191660|FG001|Overall Study|Lost to Follow-up|4
7753615|NCT00764660|12191659|FG000|Overall Study|Withdrawal by Subject|7
7753616|NCT00764660|12191660|FG001|Overall Study|Withdrawal by Subject|3
7753617|NCT00764660|12191659|FG000|Overall Study|Noncompliance With Protocol|5
7753618|NCT00764660|12191660|FG001|Overall Study|Noncompliance With Protocol|1
7753619|NCT00764660|12191659|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
7753620|NCT00764660|12191660|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
7753621|NCT00764673|12191666|FG000|Overall Study|Death|1
7753622|NCT00764673|12191666|FG000|Overall Study|Lost to Follow-up|3
7753623|NCT00764673|12191666|FG000|Overall Study|Withdrawal by Subject|6
7753624|NCT00764673|12191666|FG000|Overall Study|Revision of Device|2
7753625|NCT00764751|12191689|FG000|Overall Study|Adverse Event|1
7753626|NCT00764751|12191690|FG001|Overall Study|Adverse Event|1
7753627|NCT00764751|12191689|FG000|Overall Study|Psoriasis flare up on the scalp|1
7753628|NCT00764751|12191690|FG001|Overall Study|Psoriasis flare up on the scalp|0
7753629|NCT00764790|12191704|FG000|Overall Study|Protocol Violation|0
7753630|NCT00764790|12191705|FG001|Overall Study|Protocol Violation|0
7753631|NCT00764790|12191706|FG002|Overall Study|Protocol Violation|1
7753632|NCT00764790|12191704|FG000|Overall Study|Withdrawal by Subject|10
7753633|NCT00764790|12191705|FG001|Overall Study|Withdrawal by Subject|12
7753634|NCT00764790|12191706|FG002|Overall Study|Withdrawal by Subject|6
7753635|NCT00764790|12191704|FG000|Overall Study|Lost to Follow-up|28
7753636|NCT00764790|12191705|FG001|Overall Study|Lost to Follow-up|29
7753637|NCT00764790|12191706|FG002|Overall Study|Lost to Follow-up|23
7753638|NCT00764868|12191714|FG000|Overall Study|Adverse Event|18
7753639|NCT00764868|12191714|FG000|Overall Study|Withdrawal by Subject|31
7753640|NCT00764868|12191714|FG000|Overall Study|Non-compliance|16
7753641|NCT00764868|12191714|FG000|Overall Study|Lost to Follow-up|25
7753642|NCT00764868|12191714|FG000|Overall Study|Lack of Efficacy|5
7753643|NCT00764868|12191714|FG000|Overall Study|Subject moved|7
7753644|NCT00764868|12191714|FG000|Overall Study|Pregnancy|3
7753645|NCT00764868|12191714|FG000|Overall Study|Prohibited medication|1
7753646|NCT00764868|12191714|FG000|Overall Study|Out of town|1
7753647|NCT00764868|12191714|FG000|Overall Study|Misuse and compliance of study drug|1
7753648|NCT00764868|12191714|FG000|Overall Study|Subject sent to boarding school|1
7753649|NCT00764868|12191714|FG000|Overall Study|Met an exclusion criteria|1
7753650|NCT00764868|12191714|FG000|Overall Study|Positive drug screen|2
7753651|NCT00764868|12191714|FG000|Overall Study|Sponsor requested withdrawal|1
7753652|NCT00764881|12191720|FG000|Overall Study|Adverse Event|5
7753653|NCT00764881|12191721|FG001|Overall Study|Adverse Event|1
7753654|NCT00764881|12191720|FG000|Overall Study|Withdrawal by Subject|1
7753655|NCT00764881|12191721|FG001|Overall Study|Withdrawal by Subject|3
7753656|NCT00764881|12191720|FG000|Overall Study|Protocol Violation|2
7753657|NCT00764881|12191721|FG001|Overall Study|Protocol Violation|2
7753658|NCT00764881|12191720|FG000|Overall Study|Lost to Follow-up|2
7753659|NCT00764881|12191721|FG001|Overall Study|Lost to Follow-up|0
7753660|NCT00764881|12191720|FG000|Overall Study|Noncompliant|1
7753661|NCT00764881|12191721|FG001|Overall Study|Noncompliant|0
7753662|NCT00764881|12191720|FG000|Overall Study|Accidentally discontinued study drug|1
7753663|NCT00764881|12191721|FG001|Overall Study|Accidentally discontinued study drug|0
7753664|NCT00764881|12191720|FG000|Overall Study|Wished to become pregnant|1
7753665|NCT00764881|12191721|FG001|Overall Study|Wished to become pregnant|0
7753666|NCT00764881|12191720|FG000|Overall Study|Carcinoma detected|1
7753667|NCT00764881|12191721|FG001|Overall Study|Carcinoma detected|0
7753668|NCT00764881|12191720|FG000|Overall Study|Possibly noncompliant (study drug)|0
7753669|NCT00764881|12191721|FG001|Overall Study|Possibly noncompliant (study drug)|2
7753670|NCT00764881|12191720|FG000|Overall Study|no treatment or no observation|2
7753671|NCT00764881|12191721|FG001|Overall Study|no treatment or no observation|2
7753672|NCT00764946|12191730|FG000|Overall Study|Lack of Efficacy|1
7753673|NCT00764946|12191731|FG001|Overall Study|Lack of Efficacy|0
7753674|NCT00764946|12191732|FG002|Overall Study|Lack of Efficacy|0
7753675|NCT00764946|12191730|FG000|Overall Study|Lost to Follow-up|3
7753676|NCT00764946|12191731|FG001|Overall Study|Lost to Follow-up|4
7753677|NCT00764946|12191732|FG002|Overall Study|Lost to Follow-up|0
7753678|NCT00764946|12191730|FG000|Overall Study|Physician Decision|2
7753679|NCT00764946|12191731|FG001|Overall Study|Physician Decision|4
7753680|NCT00764946|12191732|FG002|Overall Study|Physician Decision|0
7753681|NCT00764946|12191730|FG000|Overall Study|Adverse Event|3
7753682|NCT00764946|12191731|FG001|Overall Study|Adverse Event|2
7753683|NCT00764946|12191732|FG002|Overall Study|Adverse Event|1
7753684|NCT00764946|12191730|FG000|Overall Study|Withdrawal by Subject|3
7753685|NCT00764946|12191731|FG001|Overall Study|Withdrawal by Subject|6
7753686|NCT00764946|12191732|FG002|Overall Study|Withdrawal by Subject|2
7753687|NCT00764946|12191730|FG000|Overall Study|Never Treated|1
7753688|NCT00764946|12191731|FG001|Overall Study|Never Treated|1
7753689|NCT00764946|12191732|FG002|Overall Study|Never Treated|1
7753690|NCT00765037|12191746|FG000|Overall Study|Lost to Follow-up|5
7753691|NCT00765037|12191746|FG000|Overall Study|Adverse Event|1
7753692|NCT00765063|12191750|FG000|Overall Study|Lack of Efficacy|5
7753693|NCT00765063|12191750|FG000|Overall Study|Withdrawal by Subject|1
7753694|NCT00765063|12191750|FG000|Overall Study|Other|16
7753695|NCT00765063|12191750|FG000|Overall Study|Protocol Violation|6
7753696|NCT00765063|12191750|FG000|Overall Study|Adverse Event|4
7753697|NCT00765076|12191757|FG000|Overall Study|Adverse Event|1
7753698|NCT00765076|12191758|FG001|Overall Study|Adverse Event|0
7753699|NCT00765076|12191759|FG002|Overall Study|Adverse Event|0
7753700|NCT00765076|12191757|FG000|Overall Study|Withdrawal by Subject|0
7753701|NCT00765076|12191758|FG001|Overall Study|Withdrawal by Subject|0
7753702|NCT00765076|12191759|FG002|Overall Study|Withdrawal by Subject|1
7753703|NCT00765102|12191767|FG000|Overall Study|Progressive disease|18
7753704|NCT00765102|12191767|FG000|Overall Study|Adverse Event|6
7753705|NCT00765102|12191767|FG000|Overall Study|Physician Decision|4
7753706|NCT00765102|12191767|FG000|Overall Study|Withdrawal by Subject|2
7753707|NCT00765102|12191767|FG000|Overall Study|Protocol Violation|1
7753708|NCT00765245|12191807|FG000|Overall Study|disease progression|3
7753709|NCT00765245|12191808|FG001|Overall Study|disease progression|2
7753710|NCT00765245|12191807|FG000|Overall Study|Withdrawal by Subject|3
7753711|NCT00765245|12191808|FG001|Overall Study|Withdrawal by Subject|0
7753712|NCT00765245|12191807|FG000|Overall Study|Adverse Event|5
7753713|NCT00765245|12191808|FG001|Overall Study|Adverse Event|0
7753714|NCT00765245|12191807|FG000|Overall Study|Physician Decision|1
7753715|NCT00765245|12191808|FG001|Overall Study|Physician Decision|0
7753716|NCT00765245|12191807|FG000|Overall Study|Death|1
7753717|NCT00765245|12191808|FG001|Overall Study|Death|0
7753718|NCT00765336|12191816|FG000|Overall Study|Protocol Violation|4
7753719|NCT00765336|12191817|FG001|Overall Study|Protocol Violation|2
7753720|NCT00765336|12191816|FG000|Overall Study|Withdrawal by Subject|6
7753721|NCT00765336|12191817|FG001|Overall Study|Withdrawal by Subject|4
7753722|NCT00765336|12191816|FG000|Overall Study|Lost to Follow-up|7
7753723|NCT00765336|12191817|FG001|Overall Study|Lost to Follow-up|9
7753724|NCT00765336|12191816|FG000|Overall Study|Adverse Event|2
7753725|NCT00765336|12191817|FG001|Overall Study|Adverse Event|1
7753726|NCT00765362|12191823|FG000|Overall Study|Death|9
7753727|NCT00765362|12191823|FG000|Overall Study|Adverse Event|2
7753728|NCT00765362|12191823|FG000|Overall Study|Protocol Violation|18
7753729|NCT00765362|12191823|FG000|Overall Study|Withdrawal by Subject|13
7753730|NCT00765362|12191823|FG000|Overall Study|Lost to Follow-up|95
7753731|NCT00765388|12191833|FG000|Period 1|Lack of Efficacy|1
7753732|NCT00765388|12191834|FG001|Period 1|Lack of Efficacy|2
7753733|NCT00765388|12191833|FG000|Period 1|Lost to Follow-up|0
7753734|NCT00765388|12191834|FG001|Period 1|Lost to Follow-up|1
7753735|NCT00765388|12191833|FG000|Period 1|Herpes Zoster|0
7753736|NCT00765388|12191834|FG001|Period 1|Herpes Zoster|1
7753737|NCT00765388|12191833|FG000|Period 1|Hip operation|0
7753738|NCT00765388|12191834|FG001|Period 1|Hip operation|1
7753739|NCT00765674|12191871|FG000|Overall Study|Adverse Event|7
7753740|NCT00765674|12191872|FG001|Overall Study|Adverse Event|2
7753741|NCT00765674|12191873|FG002|Overall Study|Adverse Event|8
7753742|NCT00765674|12191874|FG003|Overall Study|Adverse Event|11
7753743|NCT00765674|12191871|FG000|Overall Study|Abnormal Laboratory Value(s)|0
7753744|NCT00765674|12191872|FG001|Overall Study|Abnormal Laboratory Value(s)|0
7753745|NCT00765674|12191873|FG002|Overall Study|Abnormal Laboratory Value(s)|1
7753746|NCT00765674|12191874|FG003|Overall Study|Abnormal Laboratory Value(s)|0
7753747|NCT00765674|12191871|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
7753748|NCT00765674|12191872|FG001|Overall Study|Abnormal Test Procedure Result(s)|3
7753749|NCT00765674|12191873|FG002|Overall Study|Abnormal Test Procedure Result(s)|1
7753750|NCT00765674|12191874|FG003|Overall Study|Abnormal Test Procedure Result(s)|2
7753751|NCT00765674|12191871|FG000|Overall Study|Lack of Efficacy|2
7753752|NCT00765674|12191872|FG001|Overall Study|Lack of Efficacy|3
7753753|NCT00765674|12191873|FG002|Overall Study|Lack of Efficacy|1
7753754|NCT00765674|12191874|FG003|Overall Study|Lack of Efficacy|2
7753755|NCT00765674|12191871|FG000|Overall Study|Protocol Violation|2
7753756|NCT00765674|12191872|FG001|Overall Study|Protocol Violation|0
7753757|NCT00765674|12191873|FG002|Overall Study|Protocol Violation|1
7753758|NCT00765674|12191874|FG003|Overall Study|Protocol Violation|0
7753759|NCT00765674|12191871|FG000|Overall Study|Withdrawal by Subject|5
7753760|NCT00765674|12191872|FG001|Overall Study|Withdrawal by Subject|7
7753761|NCT00765674|12191873|FG002|Overall Study|Withdrawal by Subject|3
7753762|NCT00765674|12191874|FG003|Overall Study|Withdrawal by Subject|8
7753763|NCT00765674|12191871|FG000|Overall Study|Lost to Follow-up|4
7753764|NCT00765674|12191872|FG001|Overall Study|Lost to Follow-up|6
7753765|NCT00765674|12191873|FG002|Overall Study|Lost to Follow-up|2
7753766|NCT00765674|12191874|FG003|Overall Study|Lost to Follow-up|1
7753767|NCT00765674|12191871|FG000|Overall Study|Randomized in Error - No Study Drug|0
7753768|NCT00765674|12191872|FG001|Overall Study|Randomized in Error - No Study Drug|1
7753769|NCT00765674|12191873|FG002|Overall Study|Randomized in Error - No Study Drug|0
7753770|NCT00765674|12191874|FG003|Overall Study|Randomized in Error - No Study Drug|1
7753771|NCT00765726|12191884|FG000|Overall Study|Withdrawal by Subject|1
7753772|NCT00765726|12191884|FG000|Overall Study|Discontinuation of study by sponsor|8
7753773|NCT00765817|12191890|FG000|Overall Study|Adverse Event|13
7753774|NCT00765817|12191891|FG001|Overall Study|Adverse Event|1
7753775|NCT00765817|12191890|FG000|Overall Study|Death|0
7753776|NCT00765817|12191891|FG001|Overall Study|Death|1
7753777|NCT00765817|12191890|FG000|Overall Study|Entry criteria not met|2
7753778|NCT00765817|12191891|FG001|Overall Study|Entry criteria not met|2
7753779|NCT00765817|12191890|FG000|Overall Study|Loss of glucose control|0
7753780|NCT00765817|12191891|FG001|Overall Study|Loss of glucose control|2
7753781|NCT00765817|12191890|FG000|Overall Study|Lost to Follow-up|1
7753782|NCT00765817|12191891|FG001|Overall Study|Lost to Follow-up|3
7753783|NCT00765817|12191890|FG000|Overall Study|Physician Decision|2
7753784|NCT00765817|12191891|FG001|Overall Study|Physician Decision|1
7753785|NCT00765817|12191890|FG000|Overall Study|Protocol Violation|1
7753786|NCT00765817|12191891|FG001|Overall Study|Protocol Violation|1
7753787|NCT00765817|12191890|FG000|Overall Study|Subject decision|7
7753788|NCT00765817|12191891|FG001|Overall Study|Subject decision|11
7769671|NCT00870584|12213356|FG001|Overall Study|Withdrawal by Subject|7
7769672|NCT00870584|12213355|FG000|Overall Study|Lost to Follow-up|5
7769673|NCT00870584|12213356|FG001|Overall Study|Lost to Follow-up|1
7769674|NCT00870584|12213355|FG000|Overall Study|Protocol Deviation|2
7769675|NCT00870584|12213356|FG001|Overall Study|Protocol Deviation|2
7769676|NCT00870727|12213364|FG000|Overall Study|Lost to Follow-up|0
7769677|NCT00870727|12213365|FG001|Overall Study|Lost to Follow-up|1
7769678|NCT00870727|12213364|FG000|Overall Study|Lack of Efficacy|1
7769679|NCT00870727|12213365|FG001|Overall Study|Lack of Efficacy|3
7769680|NCT00870727|12213364|FG000|Overall Study|Adverse Event|0
7769681|NCT00870727|12213365|FG001|Overall Study|Adverse Event|1
7769682|NCT00870740|12213377|FG000|Overall Study|Adverse Event|2
7769683|NCT00870740|12213378|FG001|Overall Study|Adverse Event|1
7769684|NCT00870740|12213379|FG002|Overall Study|Adverse Event|3
7769685|NCT00870740|12213380|FG003|Overall Study|Adverse Event|2
7769686|NCT00870740|12213381|FG004|Overall Study|Adverse Event|1
7769687|NCT00870740|12213382|FG005|Overall Study|Adverse Event|6
7769688|NCT00870740|12213377|FG000|Overall Study|Consent Withdrawn|6
7769689|NCT00870740|12213378|FG001|Overall Study|Consent Withdrawn|3
7769690|NCT00870740|12213379|FG002|Overall Study|Consent Withdrawn|4
7769691|NCT00870740|12213380|FG003|Overall Study|Consent Withdrawn|6
7769692|NCT00870740|12213381|FG004|Overall Study|Consent Withdrawn|6
7769693|NCT00870740|12213382|FG005|Overall Study|Consent Withdrawn|5
7769694|NCT00870740|12213377|FG000|Overall Study|Investigator Decision|2
7769695|NCT00870740|12213378|FG001|Overall Study|Investigator Decision|0
7769696|NCT00870740|12213379|FG002|Overall Study|Investigator Decision|1
7769697|NCT00870740|12213380|FG003|Overall Study|Investigator Decision|0
7769698|NCT00870740|12213381|FG004|Overall Study|Investigator Decision|0
7769699|NCT00870740|12213382|FG005|Overall Study|Investigator Decision|0
7769700|NCT00870740|12213377|FG000|Overall Study|Subject Non-compliance|0
7769701|NCT00870740|12213378|FG001|Overall Study|Subject Non-compliance|0
7769702|NCT00870740|12213379|FG002|Overall Study|Subject Non-compliance|0
7769703|NCT00870740|12213380|FG003|Overall Study|Subject Non-compliance|0
7769704|NCT00870740|12213381|FG004|Overall Study|Subject Non-compliance|0
7769705|NCT00870740|12213382|FG005|Overall Study|Subject Non-compliance|1
7769706|NCT00870740|12213377|FG000|Overall Study|Death|0
7769707|NCT00870740|12213378|FG001|Overall Study|Death|0
7769708|NCT00870740|12213379|FG002|Overall Study|Death|0
7769709|NCT00870740|12213380|FG003|Overall Study|Death|0
7769710|NCT00870740|12213381|FG004|Overall Study|Death|1
7769711|NCT00870740|12213382|FG005|Overall Study|Death|0
7769712|NCT00870740|12213377|FG000|Overall Study|Other|2
7769713|NCT00870740|12213378|FG001|Overall Study|Other|5
7769714|NCT00870740|12213379|FG002|Overall Study|Other|2
7769715|NCT00870740|12213380|FG003|Overall Study|Other|4
7769716|NCT00870740|12213381|FG004|Overall Study|Other|3
7769717|NCT00870740|12213382|FG005|Overall Study|Other|5
7769718|NCT00870870|12213411|FG000|Overall Study|Withdrawal by Subject|0
7769719|NCT00870870|12213412|FG001|Overall Study|Withdrawal by Subject|1
7769720|NCT00870870|12213413|FG002|Overall Study|Withdrawal by Subject|1
7769721|NCT00870870|12213414|FG003|Overall Study|Withdrawal by Subject|3
7769722|NCT00870870|12213411|FG000|Overall Study|Adverse Event|0
7769723|NCT00870870|12213412|FG001|Overall Study|Adverse Event|0
7769724|NCT00870870|12213413|FG002|Overall Study|Adverse Event|2
7769725|NCT00870870|12213414|FG003|Overall Study|Adverse Event|2
7769726|NCT00871000|12213437|FG000|Overall Study|Withdrawal by Subject|1
7769727|NCT00871000|12213438|FG001|Overall Study|Withdrawal by Subject|0
7769728|NCT00871117|12213446|FG000|Overall Study|Lost to Follow-up|5
7769729|NCT00871117|12213447|FG001|Overall Study|Lost to Follow-up|6
7769730|NCT00871117|12213446|FG000|Overall Study|Other|0
7769731|NCT00871117|12213447|FG001|Overall Study|Other|4
7753789|NCT00765843|12191900|FG000|Overall Study|Lost to Follow-up|1
7753790|NCT00765843|12191901|FG001|Overall Study|Lost to Follow-up|3
7753791|NCT00765843|12191902|FG002|Overall Study|Lost to Follow-up|2
7753792|NCT00765843|12191900|FG000|Overall Study|did not return to receive intervention|0
7753793|NCT00765843|12191901|FG001|Overall Study|did not return to receive intervention|1
7753794|NCT00765843|12191902|FG002|Overall Study|did not return to receive intervention|0
7753795|NCT00765843|12191900|FG000|Overall Study|Adverse Event|0
7753796|NCT00765843|12191901|FG001|Overall Study|Adverse Event|0
7753797|NCT00765843|12191902|FG002|Overall Study|Adverse Event|1
7753798|NCT00765882|12191920|FG000|Overall Study|Adverse Event|10
7753799|NCT00765882|12191921|FG001|Overall Study|Adverse Event|21
7753800|NCT00765882|12191922|FG002|Overall Study|Adverse Event|20
7753801|NCT00765882|12191920|FG000|Overall Study|Lack of Efficacy|4
7753802|NCT00765882|12191921|FG001|Overall Study|Lack of Efficacy|0
7753803|NCT00765882|12191922|FG002|Overall Study|Lack of Efficacy|1
7753804|NCT00765882|12191920|FG000|Overall Study|Protocol Violation|4
7753805|NCT00765882|12191921|FG001|Overall Study|Protocol Violation|3
7753806|NCT00765882|12191922|FG002|Overall Study|Protocol Violation|1
7753807|NCT00765882|12191920|FG000|Overall Study|Withdrawal by Subject|2
7753808|NCT00765882|12191921|FG001|Overall Study|Withdrawal by Subject|6
7753809|NCT00765882|12191922|FG002|Overall Study|Withdrawal by Subject|6
7753810|NCT00765882|12191920|FG000|Overall Study|Lost to Follow-up|1
7753811|NCT00765882|12191921|FG001|Overall Study|Lost to Follow-up|9
7753812|NCT00765882|12191922|FG002|Overall Study|Lost to Follow-up|6
7753813|NCT00765882|12191920|FG000|Overall Study|Other Reason|3
7753814|NCT00765882|12191921|FG001|Overall Study|Other Reason|1
7753815|NCT00765882|12191922|FG002|Overall Study|Other Reason|2
7753816|NCT00765999|12191945|FG000|Overall Study|Adverse Event|203
7753817|NCT00765999|12191945|FG000|Overall Study|Insufficient Therapeutic Response|100
7753818|NCT00765999|12191945|FG000|Overall Study|Protocol Violation|95
7753819|NCT00765999|12191945|FG000|Overall Study|Consent Withdrawn|202
7753820|NCT00765999|12191945|FG000|Overall Study|Lost to Follow-up|131
7753821|NCT00765999|12191945|FG000|Overall Study|Study Terminated by Sponsor|2
7753822|NCT00765999|12191945|FG000|Overall Study|Other Miscellaneous Reasons|51
7753823|NCT00766038|12191953|FG000|Overall Study|Lost to Follow-up|15
7753824|NCT00766038|12191954|FG001|Overall Study|Lost to Follow-up|14
7753825|NCT00766051|12191964|FG000|Overall Study|Withdrawal by Subject|2
7753826|NCT00766051|12191965|FG001|Overall Study|Withdrawal by Subject|0
7753827|NCT00766090|12191975|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7753828|NCT00766090|12191976|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7753829|NCT00766090|12191977|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7753830|NCT00766090|12191978|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7753831|NCT00766090|12191979|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7753832|NCT00766090|12191980|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7753833|NCT00766090|12191981|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7753834|NCT00766090|12191982|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7753835|NCT00766090|12191983|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1
7753836|NCT00766090|12191984|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7753837|NCT00766090|12191985|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7753838|NCT00766090|12191986|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7753839|NCT00766090|12191975|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2
7753840|NCT00766090|12191976|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7753841|NCT00766090|12191977|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7753842|NCT00766090|12191978|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7753843|NCT00766090|12191979|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7753844|NCT00766090|12191980|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7753845|NCT00766090|12191981|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7753846|NCT00766090|12191982|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7753847|NCT00766090|12191983|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7753848|NCT00766090|12191984|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7753849|NCT00766090|12191985|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7753850|NCT00766090|12191986|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7753851|NCT00766090|12191975|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7753852|NCT00766090|12191976|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7753853|NCT00766090|12191977|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7753854|NCT00766090|12191978|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7753855|NCT00766090|12191979|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7753856|NCT00766090|12191980|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7753857|NCT00766090|12191981|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7753858|NCT00766090|12191982|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7753859|NCT00766090|12191983|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7753860|NCT00766090|12191984|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7753861|NCT00766090|12191985|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7753862|NCT00766090|12191986|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7753863|NCT00766090|12191975|FG000|Washout Period 1 (14 Days)|Protocol Violation|0
7753864|NCT00766090|12191976|FG001|Washout Period 1 (14 Days)|Protocol Violation|0
7753865|NCT00766090|12191977|FG002|Washout Period 1 (14 Days)|Protocol Violation|1
7753866|NCT00766090|12191978|FG003|Washout Period 1 (14 Days)|Protocol Violation|0
7753867|NCT00766090|12191979|FG004|Washout Period 1 (14 Days)|Protocol Violation|0
7753868|NCT00766090|12191980|FG005|Washout Period 1 (14 Days)|Protocol Violation|0
7753869|NCT00766090|12191981|FG006|Washout Period 1 (14 Days)|Protocol Violation|0
7753870|NCT00766090|12191982|FG007|Washout Period 1 (14 Days)|Protocol Violation|0
7753871|NCT00766090|12191983|FG008|Washout Period 1 (14 Days)|Protocol Violation|0
7753872|NCT00766090|12191984|FG009|Washout Period 1 (14 Days)|Protocol Violation|0
7753873|NCT00766090|12191985|FG010|Washout Period 1 (14 Days)|Protocol Violation|0
7753874|NCT00766090|12191986|FG011|Washout Period 1 (14 Days)|Protocol Violation|0
7753875|NCT00766090|12191975|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7753876|NCT00766090|12191976|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7753877|NCT00766090|12191977|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7753878|NCT00766090|12191978|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7753879|NCT00766090|12191979|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2
7753880|NCT00766090|12191980|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7753881|NCT00766090|12191981|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7753882|NCT00766090|12191982|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7753883|NCT00766090|12191983|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7753884|NCT00766090|12191984|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7753885|NCT00766090|12191985|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7753886|NCT00766090|12191986|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7753887|NCT00766090|12191975|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7753888|NCT00766090|12191976|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7753889|NCT00766090|12191977|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1
7753890|NCT00766090|12191978|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7753891|NCT00766090|12191979|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7753892|NCT00766090|12191980|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7753893|NCT00766090|12191981|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7753894|NCT00766090|12191982|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7753895|NCT00766090|12191983|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7753896|NCT00766090|12191984|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7753897|NCT00766090|12191985|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7753898|NCT00766090|12191986|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7753899|NCT00766090|12191975|FG000|Washout Period 2 (14 Days)|Physician Decision|0
7753900|NCT00766090|12191976|FG001|Washout Period 2 (14 Days)|Physician Decision|0
7753901|NCT00766090|12191977|FG002|Washout Period 2 (14 Days)|Physician Decision|1
7753902|NCT00766090|12191978|FG003|Washout Period 2 (14 Days)|Physician Decision|0
7753903|NCT00766090|12191979|FG004|Washout Period 2 (14 Days)|Physician Decision|0
7753904|NCT00766090|12191980|FG005|Washout Period 2 (14 Days)|Physician Decision|0
7753905|NCT00766090|12191981|FG006|Washout Period 2 (14 Days)|Physician Decision|0
7753906|NCT00766090|12191982|FG007|Washout Period 2 (14 Days)|Physician Decision|0
7753907|NCT00766090|12191983|FG008|Washout Period 2 (14 Days)|Physician Decision|0
7753908|NCT00766090|12191984|FG009|Washout Period 2 (14 Days)|Physician Decision|0
7753909|NCT00766090|12191985|FG010|Washout Period 2 (14 Days)|Physician Decision|0
7753910|NCT00766090|12191986|FG011|Washout Period 2 (14 Days)|Physician Decision|0
7753911|NCT00766090|12191975|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0
7753912|NCT00766090|12191976|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0
7753913|NCT00766090|12191977|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0
7753914|NCT00766090|12191978|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0
7753915|NCT00766090|12191979|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0
7753916|NCT00766090|12191980|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1
7753917|NCT00766090|12191981|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0
7753918|NCT00766090|12191982|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0
7753919|NCT00766090|12191983|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0
7753920|NCT00766090|12191984|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0
7753921|NCT00766090|12191985|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0
7753922|NCT00766090|12191986|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0
7753923|NCT00766090|12191975|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7753924|NCT00766090|12191976|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1
7753925|NCT00766090|12191977|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7753926|NCT00766090|12191978|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1
7753927|NCT00766090|12191979|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7753928|NCT00766090|12191980|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7753929|NCT00766090|12191981|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7753930|NCT00766090|12191982|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7753931|NCT00766090|12191983|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7753932|NCT00766090|12191984|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7753933|NCT00766090|12191985|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7753934|NCT00766090|12191986|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1
7753935|NCT00766090|12191975|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7753936|NCT00766090|12191976|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7753937|NCT00766090|12191977|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7753938|NCT00766090|12191978|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7753939|NCT00766090|12191979|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1
7753940|NCT00766090|12191980|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7753941|NCT00766090|12191981|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7753942|NCT00766090|12191982|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7753943|NCT00766090|12191983|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7753944|NCT00766090|12191984|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7753945|NCT00766090|12191985|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7753946|NCT00766090|12191986|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7753947|NCT00766142|12192007|FG000|Overall Study|Protocol Violation|4
7753948|NCT00766363|12192015|FG000|Overall Study|Withdrawal by Subject|1
7753949|NCT00766363|12192016|FG001|Overall Study|Withdrawal by Subject|0
7753950|NCT00766363|12192017|FG002|Overall Study|Withdrawal by Subject|0
7753951|NCT00766363|12192018|FG003|Overall Study|Withdrawal by Subject|0
7753952|NCT00766363|12192015|FG000|Overall Study|Adverse Event Prior to Randomization|0
7753953|NCT00766363|12192016|FG001|Overall Study|Adverse Event Prior to Randomization|1
7753954|NCT00766363|12192017|FG002|Overall Study|Adverse Event Prior to Randomization|0
7753955|NCT00766363|12192018|FG003|Overall Study|Adverse Event Prior to Randomization|0
7753956|NCT00766376|12192029|FG000|Overall Study|Withdrawal by Subject|27
7753957|NCT00766415|12192035|FG000|Overall Study|Withdrawal by Subject|0
7753958|NCT00766415|12192036|FG001|Overall Study|Withdrawal by Subject|1
7753959|NCT00766467|12192044|FG000|Overall Study|Withdrawal by Subject|7
7753960|NCT00766467|12192045|FG001|Overall Study|Withdrawal by Subject|2
7753961|NCT00766467|12192044|FG000|Overall Study|Adverse Event|1
7753962|NCT00766467|12192045|FG001|Overall Study|Adverse Event|1
7753963|NCT00766467|12192044|FG000|Overall Study|Protocol Violation|2
7753964|NCT00766467|12192045|FG001|Overall Study|Protocol Violation|4
7753965|NCT00766467|12192044|FG000|Overall Study|Tumor Progression on Study|0
7753966|NCT00766467|12192045|FG001|Overall Study|Tumor Progression on Study|1
7753967|NCT00766467|12192044|FG000|Overall Study|Physician Decision|1
7753968|NCT00766467|12192045|FG001|Overall Study|Physician Decision|0
7753969|NCT00766493|12192051|FG000|30 Days Post-Procedure|Discontinued|7
7753970|NCT00766493|12192051|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
7753971|NCT00766493|12192051|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
7753972|NCT00766506|12192057|FG000|Overall Study|Use rescue medication after 3 hours|3
7753973|NCT00766506|12192058|FG001|Overall Study|Use rescue medication after 3 hours|0
7753974|NCT00766506|12192057|FG000|Overall Study|Other|2
7753975|NCT00766506|12192058|FG001|Overall Study|Other|2
7753976|NCT00766532|12192064|FG000|Overall Study|Protocol Violation|2
7753977|NCT00766597|12192068|FG000|Overall Study|Unexpected closure of study|4
7753978|NCT00766597|12192068|FG000|Overall Study|Without CCR5-tropic virus|5
7753979|NCT00766675|12192078|FG000|Overall Study|Adverse Event|16
7753980|NCT00766675|12192078|FG000|Overall Study|Lost to Follow-up|2
7753981|NCT00766675|12192078|FG000|Overall Study|Withdrawal by Subject|11
7753982|NCT00766675|12192078|FG000|Overall Study|Protocol Violation|8
7753983|NCT00766675|12192078|FG000|Overall Study|Participant took prohibited medication|1
7753984|NCT00766675|12192078|FG000|Overall Study|Receive other anti-neoplastic treatment|1
7753985|NCT00766675|12192078|FG000|Overall Study|Insufficient therapy|1
7753986|NCT00766831|12192098|FG000|Overall Study|Withdrawal by Subject|4
7753987|NCT00766831|12192098|FG000|Overall Study|Lost to Follow-up|3
7753988|NCT00766831|12192098|FG000|Overall Study|Adverse Event|20
7753989|NCT00766831|12192098|FG000|Overall Study|Protocol Violation|15
7753990|NCT00766831|12192098|FG000|Overall Study|Physician Decision|5
7753991|NCT00766831|12192098|FG000|Overall Study|Withdrawal of consent|26
7753992|NCT00766831|12192098|FG000|Overall Study|Non cooperation by participants|14
7753993|NCT00766831|12192098|FG000|Overall Study|Other|28
7753994|NCT00767000|12192107|FG000|54-week Study|Adverse Event|4
7753995|NCT00767000|12192108|FG001|54-week Study|Adverse Event|6
7753996|NCT00767000|12192109|FG002|54-week Study|Adverse Event|6
7753997|NCT00767000|12192110|FG003|54-week Study|Adverse Event|8
7753998|NCT00767000|12192111|FG004|54-week Study|Adverse Event|4
7753999|NCT00767000|12192107|FG000|54-week Study|Creaninine/creatinine clearance|2
7754000|NCT00767000|12192108|FG001|54-week Study|Creaninine/creatinine clearance|1
7754001|NCT00767000|12192109|FG002|54-week Study|Creaninine/creatinine clearance|2
7754002|NCT00767000|12192110|FG003|54-week Study|Creaninine/creatinine clearance|2
7754003|NCT00767000|12192111|FG004|54-week Study|Creaninine/creatinine clearance|4
7754004|NCT00767000|12192107|FG000|54-week Study|Hyperglycemia|0
7754005|NCT00767000|12192108|FG001|54-week Study|Hyperglycemia|0
7754006|NCT00767000|12192109|FG002|54-week Study|Hyperglycemia|1
7754007|NCT00767000|12192110|FG003|54-week Study|Hyperglycemia|0
7754008|NCT00767000|12192111|FG004|54-week Study|Hyperglycemia|1
7754009|NCT00767000|12192107|FG000|54-week Study|Hypoglycemia|0
7754010|NCT00767000|12192108|FG001|54-week Study|Hypoglycemia|1
7754011|NCT00767000|12192109|FG002|54-week Study|Hypoglycemia|0
7754012|NCT00767000|12192110|FG003|54-week Study|Hypoglycemia|0
7754013|NCT00767000|12192111|FG004|54-week Study|Hypoglycemia|0
7754014|NCT00767000|12192107|FG000|54-week Study|Interruption of study medication|0
7754015|NCT00767000|12192108|FG001|54-week Study|Interruption of study medication|0
7754016|NCT00767000|12192109|FG002|54-week Study|Interruption of study medication|1
7754017|NCT00767000|12192110|FG003|54-week Study|Interruption of study medication|0
7754018|NCT00767000|12192111|FG004|54-week Study|Interruption of study medication|0
7754019|NCT00767000|12192107|FG000|54-week Study|Lack of Efficacy|2
7754020|NCT00767000|12192108|FG001|54-week Study|Lack of Efficacy|0
7754021|NCT00767000|12192109|FG002|54-week Study|Lack of Efficacy|1
7754022|NCT00767000|12192110|FG003|54-week Study|Lack of Efficacy|0
7754023|NCT00767000|12192111|FG004|54-week Study|Lack of Efficacy|5
7754024|NCT00767000|12192107|FG000|54-week Study|Lost to Follow-up|4
7754025|NCT00767000|12192108|FG001|54-week Study|Lost to Follow-up|0
7754026|NCT00767000|12192109|FG002|54-week Study|Lost to Follow-up|1
7754027|NCT00767000|12192110|FG003|54-week Study|Lost to Follow-up|4
7754028|NCT00767000|12192111|FG004|54-week Study|Lost to Follow-up|2
7754029|NCT00767000|12192107|FG000|54-week Study|Physician Decision|4
7754030|NCT00767000|12192108|FG001|54-week Study|Physician Decision|0
7754031|NCT00767000|12192109|FG002|54-week Study|Physician Decision|1
7754032|NCT00767000|12192110|FG003|54-week Study|Physician Decision|1
7754033|NCT00767000|12192111|FG004|54-week Study|Physician Decision|1
7754034|NCT00767000|12192107|FG000|54-week Study|Progressive disease|0
7754035|NCT00767000|12192108|FG001|54-week Study|Progressive disease|0
7754036|NCT00767000|12192109|FG002|54-week Study|Progressive disease|1
7754037|NCT00767000|12192110|FG003|54-week Study|Progressive disease|0
7754038|NCT00767000|12192111|FG004|54-week Study|Progressive disease|0
7754039|NCT00767000|12192107|FG000|54-week Study|Protocol Violation|0
7754040|NCT00767000|12192108|FG001|54-week Study|Protocol Violation|0
7754041|NCT00767000|12192109|FG002|54-week Study|Protocol Violation|1
7754042|NCT00767000|12192110|FG003|54-week Study|Protocol Violation|2
7754043|NCT00767000|12192111|FG004|54-week Study|Protocol Violation|0
7754044|NCT00767000|12192107|FG000|54-week Study|Withdrawal by Subject|2
7754045|NCT00767000|12192108|FG001|54-week Study|Withdrawal by Subject|3
7754046|NCT00767000|12192109|FG002|54-week Study|Withdrawal by Subject|5
7754047|NCT00767000|12192110|FG003|54-week Study|Withdrawal by Subject|11
7754048|NCT00767000|12192111|FG004|54-week Study|Withdrawal by Subject|13
7754049|NCT00767000|12192107|FG000|54-week Study|Study terminated by sponsor|90
7754050|NCT00767000|12192108|FG001|54-week Study|Study terminated by sponsor|102
7754051|NCT00767000|12192109|FG002|54-week Study|Study terminated by sponsor|89
7754052|NCT00767000|12192110|FG003|54-week Study|Study terminated by sponsor|196
7754053|NCT00767000|12192111|FG004|54-week Study|Study terminated by sponsor|194
7754054|NCT00767000|12192107|FG000|54-week Study|Reason not reported|0
7754055|NCT00767000|12192108|FG001|54-week Study|Reason not reported|0
7754056|NCT00767000|12192109|FG002|54-week Study|Reason not reported|0
7754057|NCT00767000|12192110|FG003|54-week Study|Reason not reported|1
7754058|NCT00767000|12192111|FG004|54-week Study|Reason not reported|0
7754059|NCT00767000|12192107|FG000|Optional 104-week Extension|Study terminated by sponsor|7
7754060|NCT00767000|12192108|FG001|Optional 104-week Extension|Study terminated by sponsor|3
7754061|NCT00767000|12192109|FG002|Optional 104-week Extension|Study terminated by sponsor|7
7754062|NCT00767000|12192110|FG003|Optional 104-week Extension|Study terminated by sponsor|2
7754063|NCT00767000|12192111|FG004|Optional 104-week Extension|Study terminated by sponsor|4
7754064|NCT00767039|12192125|FG000|Overall Study|Death|5
7754065|NCT00767039|12192126|FG001|Overall Study|Death|2
7754066|NCT00767104|12192134|FG000|Overall Study|Lost to Follow-up|1
7754067|NCT00767104|12192135|FG001|Overall Study|Lost to Follow-up|2
7754068|NCT00767325|12192143|FG000|Overall Study|Lack of Efficacy|2
7754069|NCT00767325|12192143|FG000|Overall Study|Adverse Event|7
7754070|NCT00767325|12192143|FG000|Overall Study|Lost to Follow-up|3
7754071|NCT00767325|12192143|FG000|Overall Study|No longer met study criteria|2
7754072|NCT00767325|12192143|FG000|Overall Study|Missed visit due to family reasons|1
7754073|NCT00767455|12192173|FG000|Overall Study|Investigator error|19
7754074|NCT00767520|12192205|FG000|Overall Study|Participants still on treatment|11
7754075|NCT00767520|12192206|FG001|Overall Study|Participants still on treatment|15
7754076|NCT00767520|12192205|FG000|Overall Study|Randomized in error and Never treated|0
7754077|NCT00767520|12192206|FG001|Overall Study|Randomized in error and Never treated|2
7754078|NCT00767676|12192227|FG000|Overall Study|Investigator error|54
7754079|NCT00767806|12192254|FG000|Overall Study|Adverse Event|30
7754080|NCT00767806|12192255|FG001|Overall Study|Adverse Event|11
7754081|NCT00767806|12192254|FG000|Overall Study|Withdrawal by Subject|8
7754082|NCT00767806|12192255|FG001|Overall Study|Withdrawal by Subject|13
7754083|NCT00767806|12192254|FG000|Overall Study|Protocol Violation|6
7754084|NCT00767806|12192255|FG001|Overall Study|Protocol Violation|5
7754085|NCT00767806|12192254|FG000|Overall Study|Lack of Efficacy|1
7754086|NCT00767806|12192255|FG001|Overall Study|Lack of Efficacy|9
7754087|NCT00767806|12192254|FG000|Overall Study|Physician Decision|4
7754088|NCT00767806|12192255|FG001|Overall Study|Physician Decision|3
7754089|NCT00767806|12192254|FG000|Overall Study|Lost to Follow-up|1
7754090|NCT00767806|12192255|FG001|Overall Study|Lost to Follow-up|4
7754091|NCT00767806|12192254|FG000|Overall Study|Entry Criteria Not Met|1
7754092|NCT00767806|12192255|FG001|Overall Study|Entry Criteria Not Met|1
7754093|NCT00767806|12192254|FG000|Overall Study|Sponsor Decision|0
7754094|NCT00767806|12192255|FG001|Overall Study|Sponsor Decision|1
7754095|NCT00767819|12192264|FG000|Overall Study|Unsatisfactory therapeutic effect|18
7754096|NCT00767819|12192265|FG001|Overall Study|Unsatisfactory therapeutic effect|14
7754097|NCT00767819|12192266|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7754098|NCT00767819|12192264|FG000|Overall Study|Withdrawal by Subject|1
7754099|NCT00767819|12192265|FG001|Overall Study|Withdrawal by Subject|1
7754100|NCT00767819|12192266|FG002|Overall Study|Withdrawal by Subject|0
7754101|NCT00767819|12192264|FG000|Overall Study|Administrative problems|0
7754102|NCT00767819|12192265|FG001|Overall Study|Administrative problems|1
7754103|NCT00767819|12192266|FG002|Overall Study|Administrative problems|0
7754104|NCT00767819|12192264|FG000|Overall Study|Death|2
7754105|NCT00767819|12192265|FG001|Overall Study|Death|3
7754106|NCT00767819|12192266|FG002|Overall Study|Death|0
7754107|NCT00767819|12192264|FG000|Overall Study|Adverse Event|2
7754108|NCT00767819|12192265|FG001|Overall Study|Adverse Event|0
7754109|NCT00767819|12192266|FG002|Overall Study|Adverse Event|0
7754110|NCT00767819|12192264|FG000|Overall Study|Abnormal lab values|1
7754111|NCT00767819|12192265|FG001|Overall Study|Abnormal lab values|0
7754112|NCT00767819|12192266|FG002|Overall Study|Abnormal lab values|0
7754113|NCT00767819|12192264|FG000|Overall Study|Lost to Follow-up|1
7754114|NCT00767819|12192265|FG001|Overall Study|Lost to Follow-up|0
7754115|NCT00767819|12192266|FG002|Overall Study|Lost to Follow-up|0
7754116|NCT00768053|12192274|FG000|Overall Study|Adverse Event|10
7754117|NCT00768053|12192274|FG000|Overall Study|Lost to Follow-up|1
7754118|NCT00768066|12192281|FG000|Overall Study|Did not receive study product injection.|3
7754119|NCT00768066|12192282|FG001|Overall Study|Did not receive study product injection.|3
7754120|NCT00768066|12192283|FG002|Overall Study|Did not receive study product injection.|0
7754121|NCT00768079|12192294|FG000|Overall Study|Lost to Follow-up|2
7754122|NCT00768079|12192295|FG001|Overall Study|Lost to Follow-up|0
7754123|NCT00768079|12192296|FG002|Overall Study|Lost to Follow-up|4
7754124|NCT00768079|12192294|FG000|Overall Study|Participant incarcerated|0
7754125|NCT00768079|12192295|FG001|Overall Study|Participant incarcerated|1
7754126|NCT00768079|12192296|FG002|Overall Study|Participant incarcerated|0
7754127|NCT00768144|12192310|FG000|Overall Study|Adverse Event|13
7754128|NCT00768144|12192310|FG000|Overall Study|Progressive Disease|21
7754129|NCT00768144|12192310|FG000|Overall Study|Patient or MD Decision to End Treatment|1
7754130|NCT00768144|12192310|FG000|Overall Study|Pt Withdrew Consent|1
7754131|NCT00768222|12192316|FG000|Overall Study|Lost to Follow-up|1
7754132|NCT00768222|12192317|FG001|Overall Study|Lost to Follow-up|1
7754133|NCT00768222|12192316|FG000|Overall Study|Withdrawal by Subject|3
7754134|NCT00768222|12192317|FG001|Overall Study|Withdrawal by Subject|1
7754135|NCT00768222|12192316|FG000|Overall Study|Protocol Violation|0
7754136|NCT00768222|12192317|FG001|Overall Study|Protocol Violation|2
7754137|NCT00768300|12192362|FG000|Overall Study|Randomized but not treated|1
7754138|NCT00768300|12192363|FG001|Overall Study|Randomized but not treated|1
7754139|NCT00768300|12192362|FG000|Overall Study|Adverse Event|10
7754140|NCT00768300|12192363|FG001|Overall Study|Adverse Event|2
7754141|NCT00768300|12192362|FG000|Overall Study|Protocol Violation|6
7754142|NCT00768300|12192363|FG001|Overall Study|Protocol Violation|1
7754143|NCT00768300|12192362|FG000|Overall Study|Withdrawal by Subject|13
7754144|NCT00768300|12192363|FG001|Overall Study|Withdrawal by Subject|7
7754145|NCT00768300|12192362|FG000|Overall Study|Physician Decision|2
7754146|NCT00768300|12192363|FG001|Overall Study|Physician Decision|3
7754147|NCT00768300|12192362|FG000|Overall Study|Study discontinued by Sponsor|271
7754148|NCT00768300|12192363|FG001|Overall Study|Study discontinued by Sponsor|140
7754149|NCT00768300|12192362|FG000|Overall Study|Death|21
7754150|NCT00768300|12192363|FG001|Overall Study|Death|5
7754151|NCT00768300|12192362|FG000|Overall Study|Subject moved to pursue lung transplant|1
7754152|NCT00768300|12192363|FG001|Overall Study|Subject moved to pursue lung transplant|1
7754153|NCT00768300|12192362|FG000|Overall Study|Screen failure following randomization|1
7754154|NCT00768300|12192363|FG001|Overall Study|Screen failure following randomization|0
7754155|NCT00768300|12192362|FG000|Overall Study|Received lung transplant|1
7754156|NCT00768300|12192363|FG001|Overall Study|Received lung transplant|1
7754157|NCT00768300|12192362|FG000|Overall Study|Lost to Follow-up|0
7754158|NCT00768300|12192363|FG001|Overall Study|Lost to Follow-up|1
7754159|NCT00768300|12192362|FG000|Overall Study|Began prohibited concomitant medication|0
7754160|NCT00768300|12192363|FG001|Overall Study|Began prohibited concomitant medication|1
7754161|NCT00768300|12192362|FG000|Overall Study|Treated but never dosed with Study drug|1
7754162|NCT00768300|12192363|FG001|Overall Study|Treated but never dosed with Study drug|0
7754163|NCT00768300|12192362|FG000|Overall Study|Missing data|1
7754164|NCT00768300|12192363|FG001|Overall Study|Missing data|0
7754165|NCT00768430|12192371|FG000|7 Day Endpoint|Withdrawal by Subject|2
7754166|NCT00768430|12192372|FG001|7 Day Endpoint|Withdrawal by Subject|3
7754167|NCT00768469|12192380|FG000|Overall Study|Adverse Event|0
7754168|NCT00768469|12192381|FG001|Overall Study|Adverse Event|2
7754169|NCT00768469|12192380|FG000|Overall Study|Disease Progression|3
7754170|NCT00768469|12192381|FG001|Overall Study|Disease Progression|4
7754171|NCT00768469|12192380|FG000|Overall Study|Withdrawal by Subject|0
7754172|NCT00768469|12192381|FG001|Overall Study|Withdrawal by Subject|1
7754173|NCT00768560|12192401|FG000|Intervention Set 1|Adverse Event|0
7754174|NCT00768560|12192402|FG001|Intervention Set 1|Adverse Event|1
7754175|NCT00768560|12192403|FG002|Intervention Set 1|Adverse Event|0
7754176|NCT00768560|12192404|FG003|Intervention Set 1|Adverse Event|0
7754177|NCT00768560|12192405|FG004|Intervention Set 1|Adverse Event|0
7754178|NCT00768560|12192406|FG005|Intervention Set 1|Adverse Event|0
7754179|NCT00768651|12192427|FG000|Overall Study|Withdrawal by Subject|1
7754180|NCT00768664|12192432|FG000|Overall Study|Death|57
7754181|NCT00768664|12192432|FG000|Overall Study|Lost to Follow-up|2
7754182|NCT00768664|12192432|FG000|Overall Study|Other|9
7754183|NCT00768664|12192432|FG000|Overall Study|Participant refused|1
7754184|NCT00768755|12192452|FG000|Phase 1|Death|6
7754185|NCT00768755|12192453|FG001|Phase 1|Death|0
7754186|NCT00768755|12192454|FG002|Phase 1|Death|0
7754187|NCT00768755|12192455|FG003|Phase 1|Death|0
7754188|NCT00768755|12192452|FG000|Phase 1|Other|4
7754189|NCT00768755|12192453|FG001|Phase 1|Other|0
7754190|NCT00768755|12192454|FG002|Phase 1|Other|0
7754191|NCT00768755|12192455|FG003|Phase 1|Other|0
7754192|NCT00768755|12192452|FG000|Phase 2|Death|0
7754193|NCT00768755|12192453|FG001|Phase 2|Death|37
7754194|NCT00768755|12192454|FG002|Phase 2|Death|48
7754195|NCT00768755|12192455|FG003|Phase 2|Death|31
7754196|NCT00768755|12192452|FG000|Phase 2|Protocol Violation|0
7754197|NCT00768755|12192453|FG001|Phase 2|Protocol Violation|2
7754198|NCT00768755|12192454|FG002|Phase 2|Protocol Violation|0
7754199|NCT00768755|12192455|FG003|Phase 2|Protocol Violation|1
7754200|NCT00768755|12192452|FG000|Phase 2|Lost to Follow-up|0
7754201|NCT00768755|12192453|FG001|Phase 2|Lost to Follow-up|1
7754202|NCT00768755|12192454|FG002|Phase 2|Lost to Follow-up|1
7754203|NCT00768755|12192455|FG003|Phase 2|Lost to Follow-up|4
7754204|NCT00768755|12192452|FG000|Phase 2|Withdrawal by Subject|0
7754205|NCT00768755|12192453|FG001|Phase 2|Withdrawal by Subject|1
7754206|NCT00768755|12192454|FG002|Phase 2|Withdrawal by Subject|0
7754207|NCT00768755|12192455|FG003|Phase 2|Withdrawal by Subject|1
7754208|NCT00768755|12192452|FG000|Phase 2|Other|0
7754209|NCT00768755|12192453|FG001|Phase 2|Other|1
7754210|NCT00768755|12192454|FG002|Phase 2|Other|2
7754211|NCT00768755|12192455|FG003|Phase 2|Other|4
7754212|NCT00768755|12192452|FG000|Phase 2|Study Terminated by Sponsor|0
7754213|NCT00768755|12192453|FG001|Phase 2|Study Terminated by Sponsor|13
7754214|NCT00768755|12192454|FG002|Phase 2|Study Terminated by Sponsor|7
7754215|NCT00768755|12192455|FG003|Phase 2|Study Terminated by Sponsor|14
7754216|NCT00768755|12192452|FG000|Phase 2|Randomized but not treated|0
7754217|NCT00768755|12192453|FG001|Phase 2|Randomized but not treated|0
7754218|NCT00768755|12192454|FG002|Phase 2|Randomized but not treated|0
7754219|NCT00768755|12192455|FG003|Phase 2|Randomized but not treated|2
7754220|NCT00768898|12192464|FG000|Overall Study|Unrelated injury|1
7754221|NCT00768898|12192464|FG000|Overall Study|Headache|1
7754222|NCT00768989|12192475|FG000|Prior to Week 24|Withdrawal by Subject|1
7754223|NCT00768989|12192476|FG001|Prior to Week 24|Withdrawal by Subject|0
7754224|NCT00768989|12192475|FG000|Prior to Week 24|Adverse Event|3
7754225|NCT00768989|12192476|FG001|Prior to Week 24|Adverse Event|0
7754226|NCT00768989|12192475|FG000|Prior to Week 24|Lost to Follow-up|0
7754227|NCT00768989|12192476|FG001|Prior to Week 24|Lost to Follow-up|1
7754228|NCT00768989|12192475|FG000|Prior to Week 24|Protocol Violation|0
7754229|NCT00768989|12192476|FG001|Prior to Week 24|Protocol Violation|2
7754230|NCT00768989|12192475|FG000|Week 24 to Prior to Week 36|Adverse Event|1
7754231|NCT00768989|12192476|FG001|Week 24 to Prior to Week 36|Adverse Event|0
7754232|NCT00768989|12192475|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6
7754233|NCT00768989|12192476|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0
7754234|NCT00768989|12192475|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1
7754235|NCT00768989|12192476|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0
7754236|NCT00768989|12192475|FG000|On or After Week 36|Lack of Efficacy|1
7754237|NCT00768989|12192476|FG001|On or After Week 36|Lack of Efficacy|0
7754238|NCT00768989|12192475|FG000|On or After Week 36|Adverse Event|0
7754239|NCT00768989|12192476|FG001|On or After Week 36|Adverse Event|1
7754240|NCT00768989|12192475|FG000|On or After Week 36|Lost to Follow-up|1
7754241|NCT00768989|12192476|FG001|On or After Week 36|Lost to Follow-up|0
7754242|NCT00768989|12192475|FG000|On or After Week 36|Poor Compliance|1
7754243|NCT00768989|12192476|FG001|On or After Week 36|Poor Compliance|0
7754244|NCT00768989|12192475|FG000|On or After Week 36|Protocol Violation|1
7754245|NCT00768989|12192476|FG001|On or After Week 36|Protocol Violation|0
7754246|NCT00768989|12192475|FG000|On or After Week 36|Did not attend termination visit|2
7754247|NCT00768989|12192476|FG001|On or After Week 36|Did not attend termination visit|0
7754248|NCT00768989|12192475|FG000|On or After Week 36|Sponsor Termination|45
7754249|NCT00768989|12192476|FG001|On or After Week 36|Sponsor Termination|26
7754250|NCT00769067|12192495|FG000|Overall Study|Death|89
7754251|NCT00769067|12192496|FG001|Overall Study|Death|86
7754252|NCT00769067|12192495|FG000|Overall Study|Lost to Follow-up|3
7754253|NCT00769067|12192496|FG001|Overall Study|Lost to Follow-up|1
7754254|NCT00769067|12192495|FG000|Overall Study|Study terminated by sponsor|1
7754255|NCT00769067|12192496|FG001|Overall Study|Study terminated by sponsor|3
7754256|NCT00769067|12192495|FG000|Overall Study|Other|1
7754257|NCT00769067|12192496|FG001|Overall Study|Other|3
7754258|NCT00769067|12192495|FG000|Overall Study|Withdrawal by Subject|0
7754259|NCT00769067|12192496|FG001|Overall Study|Withdrawal by Subject|1
7754260|NCT00769119|12192505|FG000|Overall Study|Voluntary discontinuation|0
7754261|NCT00769119|12192506|FG001|Overall Study|Voluntary discontinuation|2
7754262|NCT00769119|12192505|FG000|Overall Study|Adverse Event|1
7754263|NCT00769119|12192506|FG001|Overall Study|Adverse Event|1
7754264|NCT00769119|12192505|FG000|Overall Study|Disallowed medication|1
7754265|NCT00769119|12192506|FG001|Overall Study|Disallowed medication|0
7754266|NCT00769132|12192512|FG000|Period 1|Adverse Event|1
7754267|NCT00769132|12192513|FG001|Period 1|Adverse Event|0
7754268|NCT00769132|12192514|FG002|Period 1|Adverse Event|0
7754269|NCT00769132|12192515|FG003|Period 1|Adverse Event|1
7754270|NCT00769132|12192512|FG000|Period 2|Withdrawal by Subject|0
7754271|NCT00769132|12192513|FG001|Period 2|Withdrawal by Subject|0
7754272|NCT00769132|12192514|FG002|Period 2|Withdrawal by Subject|0
7754273|NCT00769132|12192515|FG003|Period 2|Withdrawal by Subject|1
7754274|NCT00769132|12192512|FG000|Period 3|Withdrawal by Subject|1
7754275|NCT00769132|12192513|FG001|Period 3|Withdrawal by Subject|0
7754276|NCT00769132|12192514|FG002|Period 3|Withdrawal by Subject|0
7754277|NCT00769132|12192515|FG003|Period 3|Withdrawal by Subject|0
7754278|NCT00769132|12192512|FG000|Period 4|Withdrawal by Subject|0
7754279|NCT00769132|12192513|FG001|Period 4|Withdrawal by Subject|1
7754280|NCT00769132|12192514|FG002|Period 4|Withdrawal by Subject|0
7754281|NCT00769132|12192515|FG003|Period 4|Withdrawal by Subject|0
7754282|NCT00769184|12192525|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
7754283|NCT00769184|12192526|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
7754284|NCT00769184|12192525|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
7754285|NCT00769184|12192526|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
7754286|NCT00769184|12192525|FG000|No Treatment (6 Weeks)|Adverse Event|1
7754287|NCT00769184|12192526|FG001|No Treatment (6 Weeks)|Adverse Event|1
7754288|NCT00769483|12192553|FG000|Overall Study|Withdrawal by Subject|0
7754289|NCT00769483|12192554|FG001|Overall Study|Withdrawal by Subject|1
7754290|NCT00769483|12192555|FG002|Overall Study|Withdrawal by Subject|0
7754291|NCT00769483|12192556|FG003|Overall Study|Withdrawal by Subject|0
7754292|NCT00769483|12192557|FG004|Overall Study|Withdrawal by Subject|1
7754293|NCT00769483|12192558|FG005|Overall Study|Withdrawal by Subject|0
7754294|NCT00769561|12192576|FG000|Overall Study|Withdrawal by Subject|2
7754295|NCT00769561|12192577|FG001|Overall Study|Withdrawal by Subject|2
7754296|NCT00769561|12192576|FG000|Overall Study|Lost to Follow-up|1
7754297|NCT00769561|12192577|FG001|Overall Study|Lost to Follow-up|3
7754298|NCT00769704|12192597|FG000|Overall Study|Lost to Follow-up|3
7754299|NCT00769704|12192598|FG001|Overall Study|Lost to Follow-up|2
7754300|NCT00769704|12192597|FG000|Overall Study|Death|95
7754301|NCT00769704|12192598|FG001|Overall Study|Death|190
7754302|NCT00769704|12192597|FG000|Overall Study|Withdrawal by Subject|12
7754303|NCT00769704|12192598|FG001|Overall Study|Withdrawal by Subject|5
7754304|NCT00769704|12192597|FG000|Overall Study|Other|1
7754305|NCT00769704|12192598|FG001|Overall Study|Other|2
7754306|NCT00769860|12192611|FG000|Overall Study|Withdrawal by Subject|2
7754307|NCT00769860|12192612|FG001|Overall Study|Withdrawal by Subject|0
7754308|NCT00770029|12192637|FG000|Overall Study|Lost to Follow-up|2
7754309|NCT00770029|12192638|FG001|Overall Study|Lost to Follow-up|0
7754310|NCT00770029|12192637|FG000|Overall Study|Withdrawal by Subject|3
7754311|NCT00770029|12192638|FG001|Overall Study|Withdrawal by Subject|3
7754312|NCT00770029|12192637|FG000|Overall Study|Adverse Event|1
7754313|NCT00770029|12192638|FG001|Overall Study|Adverse Event|0
7754314|NCT00770120|12192644|FG000|Overall Study|Progression|31
7754315|NCT00770120|12192644|FG000|Overall Study|Adverse Event|11
7754316|NCT00770120|12192644|FG000|Overall Study|Not Protocol Specified|11
7754317|NCT00770120|12192644|FG000|Overall Study|Death|3
7754318|NCT00770120|12192644|FG000|Overall Study|Withdrawal by Subject|2
7754319|NCT00770120|12192644|FG000|Overall Study|Ineligible|1
7754320|NCT00770120|12192644|FG000|Overall Study|Never Received Treatment/Not Analyzable|1
7754321|NCT00770120|12192644|FG000|Overall Study|Reason under Review|1
7754322|NCT00770146|12192668|FG000|Treatment Period|Withdrawal by Subject|6
7754323|NCT00770146|12192669|FG001|Treatment Period|Withdrawal by Subject|13
7754324|NCT00770146|12192668|FG000|Treatment Period|Adverse Event|2
7754325|NCT00770146|12192669|FG001|Treatment Period|Adverse Event|26
7754326|NCT00770146|12192668|FG000|Treatment Period|Other|1
7754327|NCT00770146|12192669|FG001|Treatment Period|Other|5
7754328|NCT00770146|12192668|FG000|Treatment Period|Protocol non-compliance|0
7754329|NCT00770146|12192669|FG001|Treatment Period|Protocol non-compliance|1
7754330|NCT00770146|12192668|FG000|Follow-up Period|Withdrawal by Subject|7
7754331|NCT00770146|12192669|FG001|Follow-up Period|Withdrawal by Subject|13
7754332|NCT00770146|12192668|FG000|Follow-up Period|Adverse Event|0
7754333|NCT00770146|12192669|FG001|Follow-up Period|Adverse Event|2
7754334|NCT00770146|12192668|FG000|Follow-up Period|Other|4
7754335|NCT00770146|12192669|FG001|Follow-up Period|Other|5
7754336|NCT00770211|12192677|FG000|Overall Study|Lost to Follow-up|1
7754337|NCT00770211|12192678|FG001|Overall Study|Lost to Follow-up|0
7754338|NCT00770211|12192677|FG000|Overall Study|Withdrawal by Subject|0
7754339|NCT00770211|12192678|FG001|Overall Study|Withdrawal by Subject|2
7754340|NCT00770224|12192684|FG000|Step 1: Induction|Adverse Event|3
7754341|NCT00770224|12192685|FG001|Step 1: Induction|Adverse Event|0
7754342|NCT00770224|12192684|FG000|Step 1: Induction|Refusal unrelated to adverse event|6
7754343|NCT00770224|12192685|FG001|Step 1: Induction|Refusal unrelated to adverse event|0
7754344|NCT00770224|12192684|FG000|Step 1: Induction|Other reason not protocol specified|2
7754345|NCT00770224|12192685|FG001|Step 1: Induction|Other reason not protocol specified|0
7754346|NCT00770224|12192684|FG000|Step 1: Induction|Ineligible|2
7754347|NCT00770224|12192685|FG001|Step 1: Induction|Ineligible|0
7754348|NCT00770224|12192684|FG000|Step 1: Induction|No protocol treatment given|1
7754349|NCT00770224|12192685|FG001|Step 1: Induction|No protocol treatment given|0
7754350|NCT00770224|12192684|FG000|Step 2: Maintenance|Adverse Event|0
7754351|NCT00770224|12192685|FG001|Step 2: Maintenance|Adverse Event|10
7754352|NCT00770224|12192684|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0
7754353|NCT00770224|12192685|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8
7754354|NCT00770224|12192684|FG000|Step 2: Maintenance|Progression/relapse|0
7754355|NCT00770224|12192685|FG001|Step 2: Maintenance|Progression/relapse|1
7754356|NCT00770224|12192684|FG000|Step 2: Maintenance|Death|0
7754357|NCT00770224|12192685|FG001|Step 2: Maintenance|Death|2
7754358|NCT00770224|12192684|FG000|Step 2: Maintenance|Other reason not protocol specified|0
7754359|NCT00770224|12192685|FG001|Step 2: Maintenance|Other reason not protocol specified|7
7754360|NCT00770224|12192684|FG000|Step 2: Maintenance|Ineligible|0
7754361|NCT00770224|12192685|FG001|Step 2: Maintenance|Ineligible|2
7754362|NCT00770289|12192692|FG000|Overall Study|Other|6
7754363|NCT00770315|12192705|FG000|Overall Study|Adverse Event|11
7754364|NCT00770315|12192706|FG001|Overall Study|Adverse Event|17
7754365|NCT00770315|12192707|FG002|Overall Study|Adverse Event|16
7754366|NCT00770315|12192708|FG003|Overall Study|Adverse Event|6
7754367|NCT00770315|12192705|FG000|Overall Study|Lost to Follow-up|9
7754368|NCT00770315|12192706|FG001|Overall Study|Lost to Follow-up|5
7754369|NCT00770315|12192707|FG002|Overall Study|Lost to Follow-up|10
7754370|NCT00770315|12192708|FG003|Overall Study|Lost to Follow-up|3
7754371|NCT00770315|12192705|FG000|Overall Study|Withdrawal by Subject|13
7754372|NCT00770315|12192706|FG001|Overall Study|Withdrawal by Subject|17
7754373|NCT00770315|12192707|FG002|Overall Study|Withdrawal by Subject|24
7754374|NCT00770315|12192708|FG003|Overall Study|Withdrawal by Subject|20
7754375|NCT00770315|12192705|FG000|Overall Study|Noncompliance with Protocol|7
7754376|NCT00770315|12192706|FG001|Overall Study|Noncompliance with Protocol|4
7754377|NCT00770315|12192707|FG002|Overall Study|Noncompliance with Protocol|7
7754378|NCT00770315|12192708|FG003|Overall Study|Noncompliance with Protocol|9
7754379|NCT00770328|12192720|FG000|Overall Study|Adverse Event|11
7754380|NCT00770328|12192721|FG001|Overall Study|Adverse Event|2
7754381|NCT00770328|12192720|FG000|Overall Study|Lost to Follow-up|2
7754382|NCT00770328|12192721|FG001|Overall Study|Lost to Follow-up|2
7754383|NCT00770341|12192730|FG000|Overall Study|Did not meet eligibility criteria|1
7754384|NCT00770341|12192731|FG001|Overall Study|Did not meet eligibility criteria|0
7754385|NCT00770341|12192732|FG002|Overall Study|Did not meet eligibility criteria|0
7754386|NCT00770341|12192730|FG000|Overall Study|Withdrawal by Subject|0
7754387|NCT00770341|12192731|FG001|Overall Study|Withdrawal by Subject|1
7754388|NCT00770341|12192732|FG002|Overall Study|Withdrawal by Subject|0
7754389|NCT00770341|12192730|FG000|Overall Study|Clinical Adverse Event|3
7754390|NCT00770341|12192731|FG001|Overall Study|Clinical Adverse Event|1
7754391|NCT00770341|12192732|FG002|Overall Study|Clinical Adverse Event|2
7754392|NCT00770341|12192730|FG000|Overall Study|Laboratory adverse event|3
7754393|NCT00770341|12192731|FG001|Overall Study|Laboratory adverse event|3
7754394|NCT00770341|12192732|FG002|Overall Study|Laboratory adverse event|0
7754395|NCT00770341|12192730|FG000|Overall Study|Lack of Efficacy|3
7754396|NCT00770341|12192731|FG001|Overall Study|Lack of Efficacy|0
7754397|NCT00770341|12192732|FG002|Overall Study|Lack of Efficacy|1
7754398|NCT00770341|12192730|FG000|Overall Study|Other|1
7754399|NCT00770341|12192731|FG001|Overall Study|Other|0
7754400|NCT00770341|12192732|FG002|Overall Study|Other|0
7754401|NCT00770341|12192730|FG000|Overall Study|Not treated|1
7754402|NCT00770341|12192731|FG001|Overall Study|Not treated|0
7754403|NCT00770341|12192732|FG002|Overall Study|Not treated|0
7754404|NCT00770367|12192743|FG000|First Intervention|Withdrawal by Subject|0
7754405|NCT00770367|12192744|FG001|First Intervention|Withdrawal by Subject|2
7754406|NCT00770367|12192743|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0
7754407|NCT00770367|12192744|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1
7754408|NCT00770367|12192743|FG000|Second Intervention|Lost to Follow-up|2
7754409|NCT00770367|12192744|FG001|Second Intervention|Lost to Follow-up|0
7754410|NCT00770432|12192754|FG000|Overall Study|Other|4
7754411|NCT00770432|12192755|FG001|Overall Study|Other|6
7754412|NCT00770432|12192754|FG000|Overall Study|Non-compliance|0
7754413|NCT00770432|12192755|FG001|Overall Study|Non-compliance|1
7754414|NCT00770484|12192763|FG000|Overall Study|Withdrawal by Subject|1
7754415|NCT00770484|12192764|FG001|Overall Study|Withdrawal by Subject|0
7754416|NCT00770510|12192770|FG000|Overall Study|Lost to Follow-up|2
7754417|NCT00770510|12192770|FG000|Overall Study|Pregnancy|1
7754418|NCT00770510|12192770|FG000|Overall Study|Withdrawal by Subject|2
7754419|NCT00770562|12192784|FG000|Overall Study|Did not take treatment|1
7754420|NCT00770562|12192785|FG001|Overall Study|Did not take treatment|1
7754421|NCT00770588|12192794|FG000|Overall Study|Adverse Event|9
7754422|NCT00770588|12192795|FG001|Overall Study|Adverse Event|2
7754423|NCT00770588|12192794|FG000|Overall Study|Death caused by progression of disease|70
7754424|NCT00770588|12192795|FG001|Overall Study|Death caused by progression of disease|91
7754425|NCT00770588|12192794|FG000|Overall Study|Lost to Follow-up|1
7754426|NCT00770588|12192795|FG001|Overall Study|Lost to Follow-up|1
7754427|NCT00770588|12192794|FG000|Overall Study|Withdrawal by Subject|1
7754428|NCT00770588|12192795|FG001|Overall Study|Withdrawal by Subject|1
7754429|NCT00770601|12192802|FG000|Overall Study|Withdrawal by Subject|1
7754430|NCT00770653|12192808|FG000|Overall Study|Adverse Event|13
7754431|NCT00770653|12192809|FG001|Overall Study|Adverse Event|5
7754432|NCT00770653|12192808|FG000|Overall Study|Protocol Violation|8
7754433|NCT00770653|12192809|FG001|Overall Study|Protocol Violation|6
7754434|NCT00770653|12192808|FG000|Overall Study|Withdrawal by Subject|4
7754435|NCT00770653|12192809|FG001|Overall Study|Withdrawal by Subject|7
7754436|NCT00770653|12192808|FG000|Overall Study|Lack of Compliance|1
7754437|NCT00770653|12192809|FG001|Overall Study|Lack of Compliance|4
7754438|NCT00770653|12192808|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2
7754439|NCT00770653|12192809|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2
7754440|NCT00770653|12192808|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2
7754441|NCT00770653|12192809|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1
7754442|NCT00770653|12192808|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0
7754443|NCT00770653|12192809|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2
7754444|NCT00770653|12192808|FG000|Overall Study|Lost to Follow-up|1
7754445|NCT00770653|12192809|FG001|Overall Study|Lost to Follow-up|2
7754446|NCT00770653|12192808|FG000|Overall Study|Physician Decision|1
7754447|NCT00770653|12192809|FG001|Overall Study|Physician Decision|0
7754448|NCT00770679|12192815|FG000|Overall Study|Lost to Follow-up|3
7754449|NCT00770679|12192815|FG000|Overall Study|Follow-up LDL measurement not collected|3
7754450|NCT00770692|12192823|FG000|Overall Study|Withdrawal by Subject|7
7754451|NCT00770692|12192824|FG001|Overall Study|Withdrawal by Subject|9
7754452|NCT00770692|12192825|FG002|Overall Study|Withdrawal by Subject|9
7754453|NCT00770692|12192826|FG003|Overall Study|Withdrawal by Subject|6
7754454|NCT00770692|12192823|FG000|Overall Study|Adverse Event|3
7754455|NCT00770692|12192824|FG001|Overall Study|Adverse Event|0
7754456|NCT00770692|12192825|FG002|Overall Study|Adverse Event|4
7754457|NCT00770692|12192826|FG003|Overall Study|Adverse Event|4
7754458|NCT00770692|12192823|FG000|Overall Study|Investigator judgment|2
7754459|NCT00770692|12192824|FG001|Overall Study|Investigator judgment|0
7754460|NCT00770692|12192825|FG002|Overall Study|Investigator judgment|1
7754461|NCT00770692|12192826|FG003|Overall Study|Investigator judgment|1
7754462|NCT00770770|12192842|FG000|Overall Study|Lost to Follow-up|1
7754463|NCT00770770|12192843|FG001|Overall Study|Lost to Follow-up|0
7754464|NCT00770770|12192842|FG000|Overall Study|Withdrawal by Subject|1
7754465|NCT00770770|12192843|FG001|Overall Study|Withdrawal by Subject|0
7754466|NCT00770770|12192842|FG000|Overall Study|Death|0
7754467|NCT00770770|12192843|FG001|Overall Study|Death|1
7754468|NCT00770770|12192842|FG000|Overall Study|Study Terminated|8
7754469|NCT00770770|12192843|FG001|Overall Study|Study Terminated|0
7754470|NCT00770913|12192870|FG000|Overall Study|Adverse Event|1
7754471|NCT00770913|12192871|FG001|Overall Study|Adverse Event|3
7754472|NCT00770913|12192872|FG002|Overall Study|Adverse Event|6
7754473|NCT00770913|12192870|FG000|Overall Study|Refusal to continue participation|6
7754474|NCT00770913|12192871|FG001|Overall Study|Refusal to continue participation|4
7754475|NCT00770913|12192872|FG002|Overall Study|Refusal to continue participation|5
7754476|NCT00770913|12192870|FG000|Overall Study|Physician Decision|0
7754477|NCT00770913|12192871|FG001|Overall Study|Physician Decision|1
7754478|NCT00770913|12192872|FG002|Overall Study|Physician Decision|1
7754479|NCT00770913|12192870|FG000|Overall Study|Protocol Violation|3
7754480|NCT00770913|12192871|FG001|Overall Study|Protocol Violation|0
7754481|NCT00770913|12192872|FG002|Overall Study|Protocol Violation|1
7754482|NCT00770913|12192870|FG000|Overall Study|Incorrect drug was allocated|1
7754483|NCT00770913|12192871|FG001|Overall Study|Incorrect drug was allocated|0
7754484|NCT00770913|12192872|FG002|Overall Study|Incorrect drug was allocated|0
7754485|NCT00770991|12192882|FG000|Overall Study|Physician Decision|2
7754486|NCT00770991|12192883|FG001|Overall Study|Physician Decision|0
7754487|NCT00770991|12192882|FG000|Overall Study|Withdrawal by Subject|1
7754488|NCT00770991|12192883|FG001|Overall Study|Withdrawal by Subject|0
7754489|NCT00770991|12192882|FG000|Overall Study|Adverse Event|1
7754490|NCT00770991|12192883|FG001|Overall Study|Adverse Event|5
7754491|NCT00770991|12192882|FG000|Overall Study|Pregnancy|1
7754492|NCT00770991|12192883|FG001|Overall Study|Pregnancy|0
7754493|NCT00771030|12192901|FG000|Overall Study|Adverse Event|0
7754494|NCT00771030|12192902|FG001|Overall Study|Adverse Event|1
7754495|NCT00771030|12192903|FG002|Overall Study|Adverse Event|0
7754496|NCT00771030|12192904|FG003|Overall Study|Adverse Event|0
7754497|NCT00771030|12192905|FG004|Overall Study|Adverse Event|0
7754498|NCT00771030|12192906|FG005|Overall Study|Adverse Event|0
7754499|NCT00771030|12192907|FG006|Overall Study|Adverse Event|0
7769732|NCT00871169|12213463|FG000|Overall Study|Protocol Violation|1
7769733|NCT00871169|12213463|FG000|Overall Study|Patient did not receive study treatment|2
7769734|NCT00871234|12213467|FG000|Overall Study|Adverse Event|2
7769735|NCT00871234|12213467|FG000|Overall Study|Lost to Follow-up|3
7769736|NCT00871338|12213486|FG000|Prior to Booster|Withdrawal by Subject|1
7769737|NCT00871338|12213487|FG001|Prior to Booster|Withdrawal by Subject|3
7769738|NCT00871338|12213486|FG000|Prior to Booster|Lost to Follow-up|1
7769739|NCT00871338|12213487|FG001|Prior to Booster|Lost to Follow-up|0
7769740|NCT00871377|12213493|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0
7769741|NCT00871377|12213494|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0
7769742|NCT00871377|12213495|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1
7769743|NCT00871377|12213496|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0
7769744|NCT00871377|12213497|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0
7769745|NCT00871377|12213498|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0
7769746|NCT00871377|12213493|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0
7769747|NCT00871377|12213494|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0
7769748|NCT00871377|12213495|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0
7769749|NCT00871377|12213496|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0
7754500|NCT00771472|12192972|FG000|Overall Study|Physician Decision|2
7754501|NCT00771472|12192973|FG001|Overall Study|Physician Decision|3
7754502|NCT00771472|12192972|FG000|Overall Study|Progressive Disease|3
7754503|NCT00771472|12192973|FG001|Overall Study|Progressive Disease|1
7754504|NCT00771472|12192972|FG000|Overall Study|Protocol Violation|1
7754505|NCT00771472|12192973|FG001|Overall Study|Protocol Violation|0
7754506|NCT00771615|12193044|FG000|Overall Study|Withdrawal by Subject|0
7754507|NCT00771615|12193045|FG001|Overall Study|Withdrawal by Subject|1
7754508|NCT00771615|12193046|FG002|Overall Study|Withdrawal by Subject|0
7754509|NCT00771615|12193047|FG003|Overall Study|Withdrawal by Subject|0
7754510|NCT00771615|12193048|FG004|Overall Study|Withdrawal by Subject|0
7754511|NCT00771615|12193049|FG005|Overall Study|Withdrawal by Subject|0
7754512|NCT00771615|12193050|FG006|Overall Study|Withdrawal by Subject|0
7754513|NCT00771615|12193051|FG007|Overall Study|Withdrawal by Subject|1
7754514|NCT00771615|12193052|FG008|Overall Study|Withdrawal by Subject|0
7754515|NCT00771615|12193044|FG000|Overall Study|Lost to Follow-up|1
7754516|NCT00771615|12193045|FG001|Overall Study|Lost to Follow-up|1
7754517|NCT00771615|12193046|FG002|Overall Study|Lost to Follow-up|1
7754518|NCT00771615|12193047|FG003|Overall Study|Lost to Follow-up|1
7754519|NCT00771615|12193048|FG004|Overall Study|Lost to Follow-up|0
7754520|NCT00771615|12193049|FG005|Overall Study|Lost to Follow-up|1
7754521|NCT00771615|12193050|FG006|Overall Study|Lost to Follow-up|1
7754522|NCT00771615|12193051|FG007|Overall Study|Lost to Follow-up|0
7754523|NCT00771615|12193052|FG008|Overall Study|Lost to Follow-up|0
7754524|NCT00771667|12193085|FG000|Induction Phase|Adverse Event|5
7754525|NCT00771667|12193086|FG001|Induction Phase|Adverse Event|2
7754526|NCT00771667|12193087|FG002|Induction Phase|Adverse Event|4
7754527|NCT00771667|12193088|FG003|Induction Phase|Adverse Event|1
7754528|NCT00771667|12193089|FG004|Induction Phase|Adverse Event|0
7754529|NCT00771667|12193090|FG005|Induction Phase|Adverse Event|0
7754530|NCT00771667|12193091|FG006|Induction Phase|Adverse Event|0
7754531|NCT00771667|12193092|FG007|Induction Phase|Adverse Event|0
7754532|NCT00771667|12193093|FG008|Induction Phase|Adverse Event|0
7754533|NCT00771667|12193094|FG009|Induction Phase|Adverse Event|0
7754534|NCT00771667|12193085|FG000|Induction Phase|Lack of Efficacy|9
7754535|NCT00771667|12193086|FG001|Induction Phase|Lack of Efficacy|2
7754536|NCT00771667|12193087|FG002|Induction Phase|Lack of Efficacy|4
7754537|NCT00771667|12193088|FG003|Induction Phase|Lack of Efficacy|3
7754538|NCT00771667|12193089|FG004|Induction Phase|Lack of Efficacy|0
7754539|NCT00771667|12193090|FG005|Induction Phase|Lack of Efficacy|0
7754540|NCT00771667|12193091|FG006|Induction Phase|Lack of Efficacy|0
7754541|NCT00771667|12193092|FG007|Induction Phase|Lack of Efficacy|0
7754542|NCT00771667|12193093|FG008|Induction Phase|Lack of Efficacy|0
7754543|NCT00771667|12193094|FG009|Induction Phase|Lack of Efficacy|0
7754544|NCT00771667|12193085|FG000|Induction Phase|Lost to Follow-up|1
7754545|NCT00771667|12193086|FG001|Induction Phase|Lost to Follow-up|0
7754546|NCT00771667|12193087|FG002|Induction Phase|Lost to Follow-up|1
7754547|NCT00771667|12193088|FG003|Induction Phase|Lost to Follow-up|0
7754548|NCT00771667|12193089|FG004|Induction Phase|Lost to Follow-up|0
7754549|NCT00771667|12193090|FG005|Induction Phase|Lost to Follow-up|0
7754550|NCT00771667|12193091|FG006|Induction Phase|Lost to Follow-up|0
7754551|NCT00771667|12193092|FG007|Induction Phase|Lost to Follow-up|0
7754552|NCT00771667|12193093|FG008|Induction Phase|Lost to Follow-up|0
7754553|NCT00771667|12193094|FG009|Induction Phase|Lost to Follow-up|0
7754554|NCT00771667|12193085|FG000|Induction Phase|Other|4
7754555|NCT00771667|12193086|FG001|Induction Phase|Other|6
7754556|NCT00771667|12193087|FG002|Induction Phase|Other|3
7754557|NCT00771667|12193088|FG003|Induction Phase|Other|4
7754558|NCT00771667|12193089|FG004|Induction Phase|Other|0
7754559|NCT00771667|12193090|FG005|Induction Phase|Other|0
7754560|NCT00771667|12193091|FG006|Induction Phase|Other|0
7754561|NCT00771667|12193092|FG007|Induction Phase|Other|0
7754562|NCT00771667|12193093|FG008|Induction Phase|Other|0
7754563|NCT00771667|12193094|FG009|Induction Phase|Other|0
7754564|NCT00771667|12193085|FG000|Maintenance Phase|Adverse Event|0
7754565|NCT00771667|12193086|FG001|Maintenance Phase|Adverse Event|0
7754566|NCT00771667|12193087|FG002|Maintenance Phase|Adverse Event|0
7754567|NCT00771667|12193088|FG003|Maintenance Phase|Adverse Event|0
7754568|NCT00771667|12193089|FG004|Maintenance Phase|Adverse Event|1
7754569|NCT00771667|12193090|FG005|Maintenance Phase|Adverse Event|3
7754570|NCT00771667|12193091|FG006|Maintenance Phase|Adverse Event|5
7754571|NCT00771667|12193092|FG007|Maintenance Phase|Adverse Event|1
7754572|NCT00771667|12193093|FG008|Maintenance Phase|Adverse Event|8
7754573|NCT00771667|12193094|FG009|Maintenance Phase|Adverse Event|7
7754574|NCT00771667|12193085|FG000|Maintenance Phase|Lack of Efficacy|0
7754575|NCT00771667|12193086|FG001|Maintenance Phase|Lack of Efficacy|0
7754576|NCT00771667|12193087|FG002|Maintenance Phase|Lack of Efficacy|0
7754577|NCT00771667|12193088|FG003|Maintenance Phase|Lack of Efficacy|0
7754578|NCT00771667|12193089|FG004|Maintenance Phase|Lack of Efficacy|1
7754579|NCT00771667|12193090|FG005|Maintenance Phase|Lack of Efficacy|3
7754580|NCT00771667|12193091|FG006|Maintenance Phase|Lack of Efficacy|3
7754581|NCT00771667|12193092|FG007|Maintenance Phase|Lack of Efficacy|2
7754582|NCT00771667|12193093|FG008|Maintenance Phase|Lack of Efficacy|11
7754583|NCT00771667|12193094|FG009|Maintenance Phase|Lack of Efficacy|7
7754584|NCT00771667|12193085|FG000|Maintenance Phase|Other|0
7754585|NCT00771667|12193086|FG001|Maintenance Phase|Other|0
7754586|NCT00771667|12193087|FG002|Maintenance Phase|Other|0
7754587|NCT00771667|12193088|FG003|Maintenance Phase|Other|0
7754588|NCT00771667|12193089|FG004|Maintenance Phase|Other|0
7754589|NCT00771667|12193090|FG005|Maintenance Phase|Other|1
7754590|NCT00771667|12193091|FG006|Maintenance Phase|Other|2
7754591|NCT00771667|12193092|FG007|Maintenance Phase|Other|2
7754592|NCT00771667|12193093|FG008|Maintenance Phase|Other|3
7754593|NCT00771667|12193094|FG009|Maintenance Phase|Other|3
7754594|NCT00771758|12193124|FG000|Overall Study|Adverse Event|2
7754595|NCT00771758|12193125|FG001|Overall Study|Adverse Event|8
7754596|NCT00771758|12193126|FG002|Overall Study|Adverse Event|1
7754597|NCT00771758|12193124|FG000|Overall Study|Lack of Efficacy|0
7754598|NCT00771758|12193125|FG001|Overall Study|Lack of Efficacy|2
7754599|NCT00771758|12193126|FG002|Overall Study|Lack of Efficacy|1
7754600|NCT00771758|12193124|FG000|Overall Study|Lost to Follow-up|1
7754601|NCT00771758|12193125|FG001|Overall Study|Lost to Follow-up|0
7754602|NCT00771758|12193126|FG002|Overall Study|Lost to Follow-up|0
7754603|NCT00771758|12193124|FG000|Overall Study|Protocol Violation|1
7754604|NCT00771758|12193125|FG001|Overall Study|Protocol Violation|0
7754605|NCT00771758|12193126|FG002|Overall Study|Protocol Violation|0
7754606|NCT00771758|12193124|FG000|Overall Study|Withdrawal by Subject|1
7754607|NCT00771758|12193125|FG001|Overall Study|Withdrawal by Subject|0
7754608|NCT00771758|12193126|FG002|Overall Study|Withdrawal by Subject|0
7754609|NCT00771758|12193124|FG000|Overall Study|Other|3
7754610|NCT00771758|12193125|FG001|Overall Study|Other|2
7754611|NCT00771758|12193126|FG002|Overall Study|Other|0
7754612|NCT00771810|12193154|FG000|Overall Study|Adverse Event|3
7754613|NCT00771810|12193155|FG001|Overall Study|Adverse Event|0
7754614|NCT00771810|12193156|FG002|Overall Study|Adverse Event|2
7754615|NCT00771810|12193154|FG000|Overall Study|Lost to Follow-up|0
7754616|NCT00771810|12193155|FG001|Overall Study|Lost to Follow-up|0
7754617|NCT00771810|12193156|FG002|Overall Study|Lost to Follow-up|1
7754618|NCT00771810|12193154|FG000|Overall Study|Physician Decision|1
7754619|NCT00771810|12193155|FG001|Overall Study|Physician Decision|2
7754620|NCT00771810|12193156|FG002|Overall Study|Physician Decision|2
7754621|NCT00771810|12193154|FG000|Overall Study|Protocol Violation|0
7754622|NCT00771810|12193155|FG001|Overall Study|Protocol Violation|1
7754623|NCT00771810|12193156|FG002|Overall Study|Protocol Violation|1
7754624|NCT00771810|12193154|FG000|Overall Study|Withdrawal by Subject|1
7754625|NCT00771810|12193155|FG001|Overall Study|Withdrawal by Subject|2
7754626|NCT00771810|12193156|FG002|Overall Study|Withdrawal by Subject|0
7754627|NCT00771810|12193154|FG000|Overall Study|Other|0
7754628|NCT00771810|12193155|FG001|Overall Study|Other|0
7754629|NCT00771810|12193156|FG002|Overall Study|Other|1
7754630|NCT00771849|12193167|FG000|Overall Study|Lost to Follow-up|1
7754631|NCT00771849|12193168|FG001|Overall Study|Lost to Follow-up|2
7754632|NCT00771849|12193167|FG000|Overall Study|Withdrawal by Subject|1
7754633|NCT00771849|12193168|FG001|Overall Study|Withdrawal by Subject|1
7754634|NCT00771849|12193167|FG000|Overall Study|Not vaccinated|0
7754635|NCT00771849|12193168|FG001|Overall Study|Not vaccinated|1
7754636|NCT00771901|12193190|FG000|Overall Study|Dissat w/# of study medication (40/day)|0
7754637|NCT00771901|12193191|FG001|Overall Study|Dissat w/# of study medication (40/day)|0
7754638|NCT00771901|12193192|FG002|Overall Study|Dissat w/# of study medication (40/day)|4
7754639|NCT00771914|12193204|FG000|Overall Study|Physician Decision|0
7754640|NCT00771914|12193205|FG001|Overall Study|Physician Decision|0
7754641|NCT00771914|12193206|FG002|Overall Study|Physician Decision|0
7754642|NCT00771914|12193207|FG003|Overall Study|Physician Decision|1
7754643|NCT00771914|12193204|FG000|Overall Study|Lost to Follow-up|0
7754644|NCT00771914|12193205|FG001|Overall Study|Lost to Follow-up|0
7754645|NCT00771914|12193206|FG002|Overall Study|Lost to Follow-up|0
7754646|NCT00771914|12193207|FG003|Overall Study|Lost to Follow-up|1
7754647|NCT00771927|12193219|FG000|Overall Study|Adverse Event|100
7754648|NCT00771927|12193220|FG001|Overall Study|Adverse Event|105
7962401|NCT02711956|12516613|FG008|Overall Study|PSA progression with clinical progression|0
7962402|NCT02711956|12516614|FG009|Overall Study|PSA progression with clinical progression|0
7962403|NCT02711956|12516615|FG010|Overall Study|PSA progression with clinical progression|0
7962404|NCT02711956|12516616|FG011|Overall Study|PSA progression with clinical progression|0
7962405|NCT02711956|12516617|FG012|Overall Study|PSA progression with clinical progression|1
7962406|NCT02711956|12516618|FG013|Overall Study|PSA progression with clinical progression|1
7962407|NCT02711956|12516619|FG014|Overall Study|PSA progression with clinical progression|0
7962408|NCT02711956|12516605|FG000|Overall Study|PSA progression with radiographic progression|0
7962409|NCT02711956|12516606|FG001|Overall Study|PSA progression with radiographic progression|1
7962410|NCT02711956|12516607|FG002|Overall Study|PSA progression with radiographic progression|0
7962411|NCT02711956|12516608|FG003|Overall Study|PSA progression with radiographic progression|0
7962412|NCT02711956|12516609|FG004|Overall Study|PSA progression with radiographic progression|0
7962413|NCT02711956|12516610|FG005|Overall Study|PSA progression with radiographic progression|2
7962414|NCT02711956|12516611|FG006|Overall Study|PSA progression with radiographic progression|2
7962415|NCT02711956|12516612|FG007|Overall Study|PSA progression with radiographic progression|1
7962416|NCT02711956|12516613|FG008|Overall Study|PSA progression with radiographic progression|0
7962417|NCT02711956|12516614|FG009|Overall Study|PSA progression with radiographic progression|1
7962418|NCT02711956|12516615|FG010|Overall Study|PSA progression with radiographic progression|0
7962419|NCT02711956|12516616|FG011|Overall Study|PSA progression with radiographic progression|1
7962420|NCT02711956|12516617|FG012|Overall Study|PSA progression with radiographic progression|2
7962421|NCT02711956|12516618|FG013|Overall Study|PSA progression with radiographic progression|3
7962422|NCT02711956|12516619|FG014|Overall Study|PSA progression with radiographic progression|3
7962423|NCT02711995|12516660|FG000|Washout (90 Days)|Conflicting medication|1
7962424|NCT02712008|12516669|FG000|Baseline (Day 1) up to Week 12|Death|3
7962425|NCT02712008|12516670|FG001|Baseline (Day 1) up to Week 12|Death|0
7962426|NCT02712008|12516671|FG002|Baseline (Day 1) up to Week 12|Death|0
7962427|NCT02712008|12516672|FG003|Baseline (Day 1) up to Week 12|Death|0
7962428|NCT02712008|12516673|FG004|Baseline (Day 1) up to Week 12|Death|0
7962429|NCT02712008|12516674|FG005|Baseline (Day 1) up to Week 12|Death|0
7962430|NCT02712008|12516675|FG006|Baseline (Day 1) up to Week 12|Death|0
7962431|NCT02712008|12516676|FG007|Baseline (Day 1) up to Week 12|Death|0
7962432|NCT02712008|12516669|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7962433|NCT02712008|12516670|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
7962434|NCT02712008|12516671|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
7962435|NCT02712008|12516672|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7962436|NCT02712008|12516673|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7962437|NCT02712008|12516674|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7962438|NCT02712008|12516675|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7962439|NCT02712008|12516676|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7962440|NCT02712008|12516669|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
7962441|NCT02712008|12516670|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7962442|NCT02712008|12516671|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
7962443|NCT02712008|12516672|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7962444|NCT02712008|12516673|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7962445|NCT02712008|12516674|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7962446|NCT02712008|12516675|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7962447|NCT02712008|12516676|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7962448|NCT02712008|12516669|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0
7962449|NCT02712008|12516670|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0
7754649|NCT00771927|12193219|FG000|Overall Study|Lack of Efficacy|70
7754650|NCT00771927|12193220|FG001|Overall Study|Lack of Efficacy|42
7754651|NCT00771927|12193219|FG000|Overall Study|Lost to Follow-up|46
7754652|NCT00771927|12193220|FG001|Overall Study|Lost to Follow-up|46
7754653|NCT00771927|12193219|FG000|Overall Study|Withdrawal by Subject|16
7754654|NCT00771927|12193220|FG001|Overall Study|Withdrawal by Subject|17
7754655|NCT00771927|12193219|FG000|Overall Study|Other reason|23
7754656|NCT00771927|12193220|FG001|Overall Study|Other reason|27
7754657|NCT00771953|12193228|FG000|Overall Study|Adverse Event|5
7754658|NCT00771953|12193229|FG001|Overall Study|Adverse Event|3
7754659|NCT00771953|12193228|FG000|Overall Study|Death|2
7754660|NCT00771953|12193229|FG001|Overall Study|Death|2
7754661|NCT00771953|12193228|FG000|Overall Study|Progression before active Tx|1
7754662|NCT00771953|12193229|FG001|Overall Study|Progression before active Tx|2
7754663|NCT00771953|12193228|FG000|Overall Study|Sponsor decision|1
7754664|NCT00771953|12193229|FG001|Overall Study|Sponsor decision|0
7754665|NCT00771953|12193228|FG000|Overall Study|Other complicating disease|1
7754666|NCT00771953|12193229|FG001|Overall Study|Other complicating disease|0
7754667|NCT00771953|12193228|FG000|Overall Study|Withdrawal by Subject|0
7754668|NCT00771953|12193229|FG001|Overall Study|Withdrawal by Subject|3
7754669|NCT00772005|12193241|FG000|Overall Study|Adverse Event|9
7754670|NCT00772005|12193242|FG001|Overall Study|Adverse Event|14
7754671|NCT00772005|12193243|FG002|Overall Study|Adverse Event|10
7754672|NCT00772005|12193244|FG003|Overall Study|Adverse Event|13
7754673|NCT00772005|12193241|FG000|Overall Study|Lack of Efficacy|0
7754674|NCT00772005|12193242|FG001|Overall Study|Lack of Efficacy|1
7754675|NCT00772005|12193243|FG002|Overall Study|Lack of Efficacy|0
7754676|NCT00772005|12193244|FG003|Overall Study|Lack of Efficacy|0
7754677|NCT00772005|12193241|FG000|Overall Study|Withdrawal by Subject|3
7754678|NCT00772005|12193242|FG001|Overall Study|Withdrawal by Subject|7
7754679|NCT00772005|12193243|FG002|Overall Study|Withdrawal by Subject|10
7754680|NCT00772005|12193244|FG003|Overall Study|Withdrawal by Subject|2
7754681|NCT00772005|12193241|FG000|Overall Study|Protocol Violation|2
7754682|NCT00772005|12193242|FG001|Overall Study|Protocol Violation|4
7754683|NCT00772005|12193243|FG002|Overall Study|Protocol Violation|1
7754684|NCT00772005|12193244|FG003|Overall Study|Protocol Violation|6
7754685|NCT00772005|12193241|FG000|Overall Study|Lost to Follow-up|7
7754686|NCT00772005|12193242|FG001|Overall Study|Lost to Follow-up|3
7754687|NCT00772005|12193243|FG002|Overall Study|Lost to Follow-up|6
7754688|NCT00772005|12193244|FG003|Overall Study|Lost to Follow-up|3
7754689|NCT00772005|12193241|FG000|Overall Study|Non-compliance with study procedures|1
7754690|NCT00772005|12193242|FG001|Overall Study|Non-compliance with study procedures|1
7754691|NCT00772005|12193243|FG002|Overall Study|Non-compliance with study procedures|0
7754692|NCT00772005|12193244|FG003|Overall Study|Non-compliance with study procedures|1
7754693|NCT00772005|12193241|FG000|Overall Study|Non-compliance with drug administration|3
7754694|NCT00772005|12193242|FG001|Overall Study|Non-compliance with drug administration|0
7754695|NCT00772005|12193243|FG002|Overall Study|Non-compliance with drug administration|1
7754696|NCT00772005|12193244|FG003|Overall Study|Non-compliance with drug administration|1
7754697|NCT00772031|12193256|FG000|Overall Study|Early termination of trial|12
7754698|NCT00772031|12193257|FG001|Overall Study|Early termination of trial|10
7754699|NCT00772031|12193256|FG000|Overall Study|Lost to Follow-up|20
7754700|NCT00772031|12193257|FG001|Overall Study|Lost to Follow-up|33
7754701|NCT00772070|12193271|FG000|Overall Study|Lost to Follow-up|0
7754702|NCT00772070|12193272|FG001|Overall Study|Lost to Follow-up|8
7754703|NCT00772070|12193271|FG000|Overall Study|Withdrawal by Subject|0
7754704|NCT00772070|12193272|FG001|Overall Study|Withdrawal by Subject|2
7754705|NCT00772070|12193271|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2
7754706|NCT00772070|12193272|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0
7754707|NCT00772109|12193282|FG000|Overall Study|Serious adverse event|1
7754708|NCT00772109|12193283|FG001|Overall Study|Serious adverse event|0
7754709|NCT00772109|12193284|FG002|Overall Study|Serious adverse event|1
7754710|NCT00772109|12193285|FG003|Overall Study|Serious adverse event|0
7754711|NCT00772109|12193282|FG000|Overall Study|Protocol Violation|5
7754712|NCT00772109|12193283|FG001|Overall Study|Protocol Violation|8
7754713|NCT00772109|12193284|FG002|Overall Study|Protocol Violation|7
7754714|NCT00772109|12193285|FG003|Overall Study|Protocol Violation|6
7754715|NCT00772109|12193282|FG000|Overall Study|Lost to Follow-up|7
7754716|NCT00772109|12193283|FG001|Overall Study|Lost to Follow-up|3
7754717|NCT00772109|12193284|FG002|Overall Study|Lost to Follow-up|5
7754718|NCT00772109|12193285|FG003|Overall Study|Lost to Follow-up|9
7754719|NCT00772109|12193282|FG000|Overall Study|Withdrawal by Subject|8
7754720|NCT00772109|12193283|FG001|Overall Study|Withdrawal by Subject|8
7754721|NCT00772109|12193284|FG002|Overall Study|Withdrawal by Subject|6
7754722|NCT00772109|12193285|FG003|Overall Study|Withdrawal by Subject|16
7754723|NCT00772148|12193297|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3
7754724|NCT00772148|12193298|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1
7754725|NCT00772148|12193297|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
7754726|NCT00772148|12193298|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
7754727|NCT00772148|12193297|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2
7754728|NCT00772148|12193298|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0
7754729|NCT00772148|12193297|FG000|Maintenance Phase (Week 52)|Death|2
7754730|NCT00772148|12193298|FG001|Maintenance Phase (Week 52)|Death|2
7754731|NCT00772148|12193297|FG000|Maintenance Phase (Week 52)|Adverse Event|1
7754732|NCT00772148|12193298|FG001|Maintenance Phase (Week 52)|Adverse Event|0
7754733|NCT00772148|12193297|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0
7754734|NCT00772148|12193298|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1
7754735|NCT00772148|12193297|FG000|Maintenance Phase (Week 52)|Administrative/other|1
7754736|NCT00772148|12193298|FG001|Maintenance Phase (Week 52)|Administrative/other|2
7754737|NCT00772330|12193308|FG000|Overall Study|Lost to Follow-up|3
7754738|NCT00772369|12193315|FG000|Overall Study|Did not return record release form|1
7754739|NCT00772382|12193319|FG000|Overall Study|Adverse Event|19
7754740|NCT00772382|12193319|FG000|Overall Study|Death|6
7754741|NCT00772382|12193319|FG000|Overall Study|Lack of Efficacy|4
7754742|NCT00772382|12193319|FG000|Overall Study|Physician Decision|5
7754743|NCT00772382|12193319|FG000|Overall Study|Protocol Violation|1
7754744|NCT00772382|12193319|FG000|Overall Study|Withdrawal by Subject|10
7754745|NCT00772382|12193319|FG000|Overall Study|Other Reasons|10
7754746|NCT00772447|12193325|FG000|Overall Study|Withdrawal by Subject|9
7754747|NCT00772447|12193326|FG001|Overall Study|Withdrawal by Subject|5
7754748|NCT00772447|12193325|FG000|Overall Study|Physician Decision|4
7754749|NCT00772447|12193326|FG001|Overall Study|Physician Decision|8
7754750|NCT00772447|12193325|FG000|Overall Study|Lost to Follow-up|2
7754751|NCT00772447|12193326|FG001|Overall Study|Lost to Follow-up|4
7754752|NCT00772447|12193325|FG000|Overall Study|incorrect enrolment|3
7754753|NCT00772447|12193326|FG001|Overall Study|incorrect enrolment|4
7754754|NCT00772447|12193325|FG000|Overall Study|Protocol Violation|0
7754755|NCT00772447|12193326|FG001|Overall Study|Protocol Violation|1
7754756|NCT00772447|12193325|FG000|Overall Study|all others|2
7754757|NCT00772447|12193326|FG001|Overall Study|all others|2
7754758|NCT00772538|12193335|FG000|Overall Study|Adverse Event|6
7754759|NCT00772538|12193336|FG001|Overall Study|Adverse Event|6
7754760|NCT00772538|12193335|FG000|Overall Study|Protocol Violation|3
7754761|NCT00772538|12193336|FG001|Overall Study|Protocol Violation|3
7754762|NCT00772538|12193335|FG000|Overall Study|Lost to Follow-up|1
7754763|NCT00772538|12193336|FG001|Overall Study|Lost to Follow-up|1
7754764|NCT00772538|12193335|FG000|Overall Study|Withdrawal by Subject|3
7754765|NCT00772538|12193336|FG001|Overall Study|Withdrawal by Subject|8
7754766|NCT00772538|12193335|FG000|Overall Study|Lack of Efficacy|0
7754767|NCT00772538|12193336|FG001|Overall Study|Lack of Efficacy|1
7754768|NCT00772538|12193335|FG000|Overall Study|Other|7
7754769|NCT00772538|12193336|FG001|Overall Study|Other|7
7754770|NCT00772577|12193344|FG000|Overall Study|Adverse Event|6
7754771|NCT00772577|12193345|FG001|Overall Study|Adverse Event|3
7754772|NCT00772577|12193344|FG000|Overall Study|Abnormal laboratory values|0
7754773|NCT00772577|12193345|FG001|Overall Study|Abnormal laboratory values|1
7754774|NCT00772577|12193344|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7754775|NCT00772577|12193345|FG001|Overall Study|Unsatisfactory therapeutic effect|8
7754776|NCT00772577|12193344|FG000|Overall Study|Patient withdrew consent|8
7754777|NCT00772577|12193345|FG001|Overall Study|Patient withdrew consent|5
7754778|NCT00772577|12193344|FG000|Overall Study|Lost to Follow-up|4
7754779|NCT00772577|12193345|FG001|Overall Study|Lost to Follow-up|3
7754780|NCT00772577|12193344|FG000|Overall Study|Administrative problems|2
7754781|NCT00772577|12193345|FG001|Overall Study|Administrative problems|1
7754782|NCT00772577|12193344|FG000|Overall Study|Protocol Deviation|3
7754783|NCT00772577|12193345|FG001|Overall Study|Protocol Deviation|2
7754784|NCT00772603|12193371|FG000|Overall Study|Withdrawal by Subject|11
7754785|NCT00772603|12193372|FG001|Overall Study|Withdrawal by Subject|10
7754786|NCT00772603|12193373|FG002|Overall Study|Withdrawal by Subject|6
7754787|NCT00772603|12193371|FG000|Overall Study|Adverse Event|37
7754788|NCT00772603|12193372|FG001|Overall Study|Adverse Event|18
7754789|NCT00772603|12193373|FG002|Overall Study|Adverse Event|10
7754790|NCT00772603|12193371|FG000|Overall Study|Subject Non-compliance|1
7754791|NCT00772603|12193372|FG001|Overall Study|Subject Non-compliance|6
7754792|NCT00772603|12193373|FG002|Overall Study|Subject Non-compliance|4
7754793|NCT00772603|12193371|FG000|Overall Study|Protocol Violation|0
7754794|NCT00772603|12193372|FG001|Overall Study|Protocol Violation|1
7754795|NCT00772603|12193373|FG002|Overall Study|Protocol Violation|1
7754796|NCT00772603|12193371|FG000|Overall Study|Lost to Follow-up|1
7754797|NCT00772603|12193372|FG001|Overall Study|Lost to Follow-up|5
7754798|NCT00772603|12193373|FG002|Overall Study|Lost to Follow-up|2
7754799|NCT00772603|12193371|FG000|Overall Study|Physician Decision|0
7754800|NCT00772603|12193372|FG001|Overall Study|Physician Decision|0
7754801|NCT00772603|12193373|FG002|Overall Study|Physician Decision|1
7754802|NCT00772603|12193371|FG000|Overall Study|Other|2
7754803|NCT00772603|12193372|FG001|Overall Study|Other|0
7754804|NCT00772603|12193373|FG002|Overall Study|Other|2
7754805|NCT00772629|12193386|FG000|Overall Study|Subject was not vaccinated|1
7754806|NCT00772629|12193387|FG001|Overall Study|Subject was not vaccinated|0
7754807|NCT00772668|12193393|FG000|Overall Study|Physician Decision|3
7754808|NCT00772707|12193398|FG000|Overall Study|Withdrawn|3
7754809|NCT00772889|12193410|FG000|Overall Study|Adverse Event|7
7754810|NCT00772889|12193411|FG001|Overall Study|Adverse Event|4
7754811|NCT00772889|12193412|FG002|Overall Study|Adverse Event|0
7754812|NCT00772889|12193410|FG000|Overall Study|Withdrawal by Subject|9
7754813|NCT00772889|12193411|FG001|Overall Study|Withdrawal by Subject|8
7754814|NCT00772889|12193412|FG002|Overall Study|Withdrawal by Subject|9
7754815|NCT00772889|12193410|FG000|Overall Study|Lost to Follow-up|6
7754816|NCT00772889|12193411|FG001|Overall Study|Lost to Follow-up|6
7754817|NCT00772889|12193412|FG002|Overall Study|Lost to Follow-up|7
7754818|NCT00772928|12193426|FG000|Overall Study|Lost to Follow-up|9
7754819|NCT00772928|12193427|FG001|Overall Study|Lost to Follow-up|6
7754820|NCT00772928|12193426|FG000|Overall Study|Protocol Violation|10
7754821|NCT00772928|12193427|FG001|Overall Study|Protocol Violation|12
7754822|NCT00772928|12193426|FG000|Overall Study|Withdrawal by Subject|25
7754823|NCT00772928|12193427|FG001|Overall Study|Withdrawal by Subject|22
7754824|NCT00772928|12193426|FG000|Overall Study|Did not receive vaccine|0
7754825|NCT00772928|12193427|FG001|Overall Study|Did not receive vaccine|1
7754826|NCT00772941|12193433|FG000|Overall Study|CRFs not available|195
7754827|NCT00772941|12193433|FG000|Overall Study|Study not completed|16
7754828|NCT00772941|12193433|FG000|Overall Study|Missed Visits|374
7754829|NCT00772941|12193433|FG000|Overall Study|Poor Compliance|7
7754830|NCT00772941|12193433|FG000|Overall Study|GPSP Violation|90
7754831|NCT00772954|12193463|FG000|Overall Study|Adverse Event|0
7754832|NCT00772954|12193464|FG001|Overall Study|Adverse Event|0
7754833|NCT00772954|12193465|FG002|Overall Study|Adverse Event|1
7754834|NCT00772967|12193473|FG000|Crossover Treatment 1|Adverse Event (Pain)|0
7754835|NCT00772967|12193474|FG001|Crossover Treatment 1|Adverse Event (Pain)|0
7754836|NCT00772967|12193475|FG002|Crossover Treatment 1|Adverse Event (Pain)|0
7754837|NCT00772967|12193476|FG003|Crossover Treatment 1|Adverse Event (Pain)|1
7754838|NCT00772967|12193477|FG004|Crossover Treatment 1|Adverse Event (Pain)|0
7754839|NCT00772967|12193478|FG005|Crossover Treatment 1|Adverse Event (Pain)|0
7754840|NCT00772967|12193473|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0
7754841|NCT00772967|12193474|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1
7754842|NCT00772967|12193475|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0
7754843|NCT00772967|12193476|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0
7754844|NCT00772967|12193477|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0
7754845|NCT00772967|12193478|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0
7754846|NCT00772967|12193473|FG000|Crossover Treatment 3|Adverse Event|0
7754847|NCT00772967|12193474|FG001|Crossover Treatment 3|Adverse Event|0
7754848|NCT00772967|12193475|FG002|Crossover Treatment 3|Adverse Event|0
7754849|NCT00772967|12193476|FG003|Crossover Treatment 3|Adverse Event|0
7754850|NCT00772967|12193477|FG004|Crossover Treatment 3|Adverse Event|1
7754851|NCT00772967|12193478|FG005|Crossover Treatment 3|Adverse Event|0
7754852|NCT00773097|12193486|FG000|Overall Study|Withdrawal by Subject|1
7754853|NCT00773097|12193486|FG000|Overall Study|Physician Decision|6
7754854|NCT00773136|12193490|FG000|Overall Study|Physician Decision|2
7754855|NCT00773175|12193497|FG000|Overall Study|Adverse Event|2
7754856|NCT00773175|12193498|FG001|Overall Study|Adverse Event|0
7754857|NCT00773175|12193497|FG000|Overall Study|Consent Withdrawn|0
7754858|NCT00773175|12193498|FG001|Overall Study|Consent Withdrawn|2
7754859|NCT00773253|12193511|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0
7754860|NCT00773253|12193512|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1
7754861|NCT00773279|12193520|FG000|Period 1|Adverse Event|2
7754862|NCT00773279|12193521|FG001|Period 1|Adverse Event|1
7754863|NCT00773279|12193520|FG000|Period 1|Lack of Efficacy|0
7754864|NCT00773279|12193521|FG001|Period 1|Lack of Efficacy|2
7754865|NCT00773279|12193520|FG000|Period 1|Unclassified|5
7754866|NCT00773279|12193521|FG001|Period 1|Unclassified|1
7754867|NCT00773279|12193520|FG000|Period 2|Adverse Event|0
7754868|NCT00773279|12193521|FG001|Period 2|Adverse Event|1
7754869|NCT00773279|12193520|FG000|Period 2|Lack of Efficacy|1
7754870|NCT00773279|12193521|FG001|Period 2|Lack of Efficacy|0
7754871|NCT00773279|12193520|FG000|Period 2|Protocol Violation|0
7754872|NCT00773279|12193521|FG001|Period 2|Protocol Violation|3
7754873|NCT00773279|12193520|FG000|Period 2|Unclassified|2
7754874|NCT00773279|12193521|FG001|Period 2|Unclassified|2
7754875|NCT00773292|12193528|FG000|Treatment 48 Weeks|Adverse Event|1
7754876|NCT00773292|12193528|FG000|Treatment 48 Weeks|Lack of Efficacy|1
7754877|NCT00773383|12193541|FG000|Overall Study|Adverse Event|4
7754878|NCT00773383|12193541|FG000|Overall Study|Death|1
7754879|NCT00773383|12193541|FG000|Overall Study|Progression of Disease|23
7754880|NCT00773383|12193541|FG000|Overall Study|Other|2
7754881|NCT00773383|12193541|FG000|Overall Study|No study dose received|1
7754882|NCT00773461|12193564|FG000|Overall Study|Adverse Event|1
7754883|NCT00773461|12193565|FG001|Overall Study|Adverse Event|3
7754884|NCT00773461|12193564|FG000|Overall Study|Withdrawal by Subject|4
7754885|NCT00773461|12193565|FG001|Overall Study|Withdrawal by Subject|1
7754886|NCT00773513|12193578|FG000|Overall Study|Renal Transplant|254
7754887|NCT00773513|12193579|FG001|Overall Study|Renal Transplant|263
7754888|NCT00773513|12193578|FG000|Overall Study|Adverse Event / Intercurrent Illness|40
7754889|NCT00773513|12193579|FG001|Overall Study|Adverse Event / Intercurrent Illness|48
7754890|NCT00773513|12193578|FG000|Overall Study|Withdrew Consent|68
7754891|NCT00773513|12193579|FG001|Overall Study|Withdrew Consent|69
7754892|NCT00773513|12193578|FG000|Overall Study|Refused Treatment / Did not Cooperate|26
7754893|NCT00773513|12193579|FG001|Overall Study|Refused Treatment / Did not Cooperate|32
7754894|NCT00773513|12193578|FG000|Overall Study|Failure to Return|22
7754895|NCT00773513|12193579|FG001|Overall Study|Failure to Return|8
7754896|NCT00773513|12193578|FG000|Overall Study|Insufficient Therapeutic Response|1
7754897|NCT00773513|12193579|FG001|Overall Study|Insufficient Therapeutic Response|18
7754898|NCT00773513|12193578|FG000|Overall Study|Reason Not Specified|159
7754899|NCT00773513|12193579|FG001|Overall Study|Reason Not Specified|126
7754900|NCT00773513|12193578|FG000|Overall Study|Death|531
7754901|NCT00773513|12193579|FG001|Overall Study|Death|545
7754902|NCT00773734|12193593|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
7754903|NCT00773734|12193594|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
7754904|NCT00773734|12193595|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
7754905|NCT00773734|12193596|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
7754906|NCT00773734|12193597|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
7754907|NCT00773734|12193598|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
7754908|NCT00773734|12193593|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
7754909|NCT00773734|12193594|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
7754910|NCT00773734|12193595|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
7754911|NCT00773734|12193596|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
7754912|NCT00773734|12193597|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
7754913|NCT00773734|12193598|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
7754914|NCT00773734|12193593|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
7754915|NCT00773734|12193594|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
7754916|NCT00773734|12193595|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
7754917|NCT00773734|12193596|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
7754918|NCT00773734|12193597|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
7754919|NCT00773734|12193598|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
7754920|NCT00773734|12193593|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1
7754921|NCT00773734|12193594|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0
7754922|NCT00773734|12193595|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0
7754923|NCT00773734|12193596|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0
7754924|NCT00773734|12193597|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0
7754925|NCT00773734|12193598|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0
7754926|NCT00773734|12193593|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
7754927|NCT00773734|12193594|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
7754928|NCT00773734|12193595|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
7754929|NCT00773734|12193596|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
7754930|NCT00773734|12193597|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
7754931|NCT00773734|12193598|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
7754932|NCT00773734|12193593|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
7754933|NCT00773734|12193594|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
7754934|NCT00773734|12193595|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
7754935|NCT00773734|12193596|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
7754936|NCT00773734|12193597|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
7754937|NCT00773734|12193598|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
7754938|NCT00773734|12193593|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1
7754939|NCT00773734|12193594|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1
7754940|NCT00773734|12193595|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1
7754941|NCT00773734|12193596|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1
7754942|NCT00773734|12193597|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0
7754943|NCT00773734|12193598|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0
7754944|NCT00773734|12193593|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0
7754945|NCT00773734|12193594|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4
7754946|NCT00773734|12193595|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0
7754947|NCT00773734|12193596|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0
7754948|NCT00773734|12193597|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1
7754949|NCT00773734|12193598|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2
7754950|NCT00773734|12193593|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
7754951|NCT00773734|12193594|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
7754952|NCT00773734|12193595|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
7754953|NCT00773734|12193596|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
7754954|NCT00773734|12193597|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
7754955|NCT00773734|12193598|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
7754956|NCT00773734|12193593|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
7754957|NCT00773734|12193594|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
7754958|NCT00773734|12193595|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
7754959|NCT00773734|12193596|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
7754960|NCT00773734|12193597|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
7754961|NCT00773734|12193598|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
7754962|NCT00773734|12193593|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
7754963|NCT00773734|12193594|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
7754964|NCT00773734|12193595|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
7754965|NCT00773734|12193596|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
7754966|NCT00773734|12193597|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
7754967|NCT00773734|12193598|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
7770444|NCT00876460|12214451|FG003|Combination Therapy Phase|Adverse Event|2
7754968|NCT00773734|12193593|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
7754969|NCT00773734|12193594|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
7754970|NCT00773734|12193595|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
7754971|NCT00773734|12193596|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
7754972|NCT00773734|12193597|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
7754973|NCT00773734|12193598|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
7754974|NCT00773734|12193593|FG000|Core: Active Treatment Phase Week 16-24|Other|0
7754975|NCT00773734|12193594|FG001|Core: Active Treatment Phase Week 16-24|Other|1
7754976|NCT00773734|12193595|FG002|Core: Active Treatment Phase Week 16-24|Other|0
7754977|NCT00773734|12193596|FG003|Core: Active Treatment Phase Week 16-24|Other|0
7754978|NCT00773734|12193597|FG004|Core: Active Treatment Phase Week 16-24|Other|0
7754979|NCT00773734|12193598|FG005|Core: Active Treatment Phase Week 16-24|Other|0
7754980|NCT00773734|12193593|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0
7754981|NCT00773734|12193594|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0
7754982|NCT00773734|12193595|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0
7754983|NCT00773734|12193596|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0
7754984|NCT00773734|12193597|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2
7754985|NCT00773734|12193598|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1
7754986|NCT00773734|12193593|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
7754987|NCT00773734|12193594|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
7754988|NCT00773734|12193595|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
7754989|NCT00773734|12193596|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
7754990|NCT00773734|12193597|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
7754991|NCT00773734|12193598|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
7754992|NCT00773734|12193593|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
7754993|NCT00773734|12193594|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
7754994|NCT00773734|12193595|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
7754995|NCT00773734|12193596|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
7754996|NCT00773734|12193597|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
7754997|NCT00773734|12193598|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
7754998|NCT00773734|12193593|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
7754999|NCT00773734|12193594|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
7755000|NCT00773734|12193595|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
7755001|NCT00773734|12193596|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
7755002|NCT00773734|12193597|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
7755003|NCT00773734|12193598|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
7755004|NCT00773734|12193593|FG000|Extension: Active Treatment Week 24-52|Other|0
7755005|NCT00773734|12193594|FG001|Extension: Active Treatment Week 24-52|Other|0
7755006|NCT00773734|12193595|FG002|Extension: Active Treatment Week 24-52|Other|1
7755007|NCT00773734|12193596|FG003|Extension: Active Treatment Week 24-52|Other|2
7755008|NCT00773734|12193597|FG004|Extension: Active Treatment Week 24-52|Other|0
7755009|NCT00773734|12193598|FG005|Extension: Active Treatment Week 24-52|Other|1
7755010|NCT00773734|12193593|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0
7755011|NCT00773734|12193594|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0
7755012|NCT00773734|12193595|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0
7755013|NCT00773734|12193596|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1
7755014|NCT00773734|12193597|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0
7755015|NCT00773734|12193598|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0
7755016|NCT00773734|12193593|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
7755017|NCT00773734|12193594|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
7755018|NCT00773734|12193595|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
7755019|NCT00773734|12193596|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
7755020|NCT00773734|12193597|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
7755021|NCT00773734|12193598|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
7755022|NCT00773734|12193593|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
7755023|NCT00773734|12193594|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
7755024|NCT00773734|12193595|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
7755025|NCT00773734|12193596|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
7755026|NCT00773734|12193597|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
7755027|NCT00773734|12193598|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
7755028|NCT00773734|12193593|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
7755029|NCT00773734|12193594|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
7755030|NCT00773734|12193595|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
7755031|NCT00773734|12193596|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
7755032|NCT00773734|12193597|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
7755033|NCT00773734|12193598|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
7755034|NCT00773747|12193657|FG000|Overall Study|Lack of Efficacy|112
7755035|NCT00773747|12193658|FG001|Overall Study|Lack of Efficacy|144
7755036|NCT00773747|12193657|FG000|Overall Study|Physician Decision|26
7755037|NCT00773747|12193658|FG001|Overall Study|Physician Decision|18
7755038|NCT00773747|12193657|FG000|Overall Study|Lost to Follow-up|0
7755039|NCT00773747|12193658|FG001|Overall Study|Lost to Follow-up|1
7755040|NCT00773747|12193657|FG000|Overall Study|Protocol Violation|2
7755041|NCT00773747|12193658|FG001|Overall Study|Protocol Violation|2
7755042|NCT00773747|12193657|FG000|Overall Study|Withdrawal by Subject|89
7755043|NCT00773747|12193658|FG001|Overall Study|Withdrawal by Subject|61
7755044|NCT00773747|12193657|FG000|Overall Study|Adverse Event|61
7755045|NCT00773747|12193658|FG001|Overall Study|Adverse Event|62
7755046|NCT00773747|12193657|FG000|Overall Study|Death|5
7755047|NCT00773747|12193658|FG001|Overall Study|Death|8
7755048|NCT00773747|12193657|FG000|Overall Study|Not Treated|2
7755049|NCT00773747|12193658|FG001|Overall Study|Not Treated|0
7755050|NCT00773838|12193672|FG000|Overall Study|Adverse Event|29
7755051|NCT00773838|12193672|FG000|Overall Study|Lost to Follow-up|1
7755052|NCT00773838|12193672|FG000|Overall Study|Physician Decision|8
7755053|NCT00773838|12193672|FG000|Overall Study|Progressive Disease|82
7755054|NCT00773838|12193672|FG000|Overall Study|Protocol Violation|2
7755055|NCT00773838|12193672|FG000|Overall Study|Withdrawal by Subject|21
7755056|NCT00773968|12193680|FG000|Overall Study|Adverse Event|2
7755057|NCT00773968|12193680|FG000|Overall Study|Death|1
7755058|NCT00773968|12193680|FG000|Overall Study|Failure to Return|2
7755059|NCT00773968|12193680|FG000|Overall Study|Lack of Efficacy|3
7755060|NCT00773968|12193680|FG000|Overall Study|Protocol Violation|1
7755061|NCT00773968|12193680|FG000|Overall Study|Withdrawal by Subject|11
7755062|NCT00773968|12193680|FG000|Overall Study|Screen Failure|17
7755063|NCT00773968|12193680|FG000|Overall Study|Other|8
7755064|NCT00774046|12193684|FG000|Screening|Not eligible|56
7755065|NCT00774046|12193684|FG000|Enrollment|Desired other therapy/refused|28
7755066|NCT00774046|12193684|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
7755067|NCT00774397|12193734|FG000|Overall Study|Adverse Event|1
7755068|NCT00774397|12193735|FG001|Overall Study|Adverse Event|3
7755069|NCT00774397|12193736|FG002|Overall Study|Adverse Event|16
7755070|NCT00774397|12193737|FG003|Overall Study|Adverse Event|8
7755071|NCT00774397|12193738|FG004|Overall Study|Adverse Event|8
7755072|NCT00774397|12193739|FG005|Overall Study|Adverse Event|3
7755073|NCT00774397|12193740|FG006|Overall Study|Adverse Event|16
7755074|NCT00774397|12193734|FG000|Overall Study|Lack of Efficacy|11
7755075|NCT00774397|12193735|FG001|Overall Study|Lack of Efficacy|4
7755076|NCT00774397|12193736|FG002|Overall Study|Lack of Efficacy|5
7755077|NCT00774397|12193737|FG003|Overall Study|Lack of Efficacy|3
7755078|NCT00774397|12193738|FG004|Overall Study|Lack of Efficacy|27
7755079|NCT00774397|12193739|FG005|Overall Study|Lack of Efficacy|15
7755080|NCT00774397|12193740|FG006|Overall Study|Lack of Efficacy|9
7755081|NCT00774397|12193734|FG000|Overall Study|Protocol Violation|0
7755082|NCT00774397|12193735|FG001|Overall Study|Protocol Violation|1
7755083|NCT00774397|12193736|FG002|Overall Study|Protocol Violation|3
7755084|NCT00774397|12193737|FG003|Overall Study|Protocol Violation|1
7755085|NCT00774397|12193738|FG004|Overall Study|Protocol Violation|2
7755086|NCT00774397|12193739|FG005|Overall Study|Protocol Violation|1
7755087|NCT00774397|12193740|FG006|Overall Study|Protocol Violation|0
7755088|NCT00774397|12193734|FG000|Overall Study|Lost to Follow-up|0
7755089|NCT00774397|12193735|FG001|Overall Study|Lost to Follow-up|1
7755090|NCT00774397|12193736|FG002|Overall Study|Lost to Follow-up|1
7755091|NCT00774397|12193737|FG003|Overall Study|Lost to Follow-up|1
7755092|NCT00774397|12193738|FG004|Overall Study|Lost to Follow-up|0
7755093|NCT00774397|12193739|FG005|Overall Study|Lost to Follow-up|1
7755094|NCT00774397|12193740|FG006|Overall Study|Lost to Follow-up|0
7755095|NCT00774397|12193734|FG000|Overall Study|Refused to continue trial medication|1
7755096|NCT00774397|12193735|FG001|Overall Study|Refused to continue trial medication|3
7755097|NCT00774397|12193736|FG002|Overall Study|Refused to continue trial medication|2
7755098|NCT00774397|12193737|FG003|Overall Study|Refused to continue trial medication|2
7755099|NCT00774397|12193738|FG004|Overall Study|Refused to continue trial medication|6
7755100|NCT00774397|12193739|FG005|Overall Study|Refused to continue trial medication|2
7755101|NCT00774397|12193740|FG006|Overall Study|Refused to continue trial medication|3
7755102|NCT00774397|12193734|FG000|Overall Study|Not treated|0
7755103|NCT00774397|12193735|FG001|Overall Study|Not treated|0
7755104|NCT00774397|12193736|FG002|Overall Study|Not treated|0
7755105|NCT00774397|12193737|FG003|Overall Study|Not treated|0
7755106|NCT00774397|12193738|FG004|Overall Study|Not treated|1
7755107|NCT00774397|12193739|FG005|Overall Study|Not treated|0
7755108|NCT00774397|12193740|FG006|Overall Study|Not treated|1
7755109|NCT00774397|12193734|FG000|Overall Study|Other than those stated above|1
7755110|NCT00774397|12193735|FG001|Overall Study|Other than those stated above|1
7755111|NCT00774397|12193736|FG002|Overall Study|Other than those stated above|3
7755112|NCT00774397|12193737|FG003|Overall Study|Other than those stated above|2
7755113|NCT00774397|12193738|FG004|Overall Study|Other than those stated above|2
7755114|NCT00774397|12193739|FG005|Overall Study|Other than those stated above|0
7755115|NCT00774397|12193740|FG006|Overall Study|Other than those stated above|1
7755116|NCT00774566|12193765|FG000|Overall Study|Protocol Violation|18
7755117|NCT00774566|12193766|FG001|Overall Study|Protocol Violation|15
7755118|NCT00774748|12193781|FG000|Overall Study|Lost to Follow-up|3
7755119|NCT00774787|12193789|FG000|Overall Study|Lost to Follow-up|1
7755120|NCT00774800|12193793|FG000|Intervention 4|Withdrawal by Subject|1
7755121|NCT00774852|12193805|FG000|Overall Study|Adverse Event|9
7755122|NCT00774852|12193806|FG001|Overall Study|Adverse Event|6
7755123|NCT00774852|12193805|FG000|Overall Study|Death|2
7755124|NCT00774852|12193806|FG001|Overall Study|Death|1
7755125|NCT00774852|12193805|FG000|Overall Study|Lack of Efficacy|3
7755126|NCT00774852|12193806|FG001|Overall Study|Lack of Efficacy|7
7755127|NCT00774852|12193805|FG000|Overall Study|Lost to Follow-up|9
7755128|NCT00774852|12193806|FG001|Overall Study|Lost to Follow-up|5
7755129|NCT00774852|12193805|FG000|Overall Study|Physician Decision|2
7755130|NCT00774852|12193806|FG001|Overall Study|Physician Decision|6
7755131|NCT00774852|12193805|FG000|Overall Study|Pregnancy|1
7755132|NCT00774852|12193806|FG001|Overall Study|Pregnancy|2
7755133|NCT00774852|12193805|FG000|Overall Study|Withdrawal by Subject|2
7755134|NCT00774852|12193806|FG001|Overall Study|Withdrawal by Subject|2
7755135|NCT00774852|12193805|FG000|Overall Study|Non-responder|15
7755136|NCT00774852|12193806|FG001|Overall Study|Non-responder|11
7755137|NCT00774852|12193805|FG000|Overall Study|Subject non-compliance|0
7755138|NCT00774852|12193806|FG001|Overall Study|Subject non-compliance|1
7755139|NCT00774852|12193805|FG000|Overall Study|Protocol Violation|1
7755140|NCT00774852|12193806|FG001|Overall Study|Protocol Violation|0
7755141|NCT00774852|12193805|FG000|Overall Study|Subject received prohibited medication|1
7755142|NCT00774852|12193806|FG001|Overall Study|Subject received prohibited medication|0
7755143|NCT00774930|12193824|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11
7755144|NCT00774930|12193825|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12
7755145|NCT00774930|12193824|FG000|DB Phase|Adverse Event|1
7755146|NCT00774930|12193825|FG001|DB Phase|Adverse Event|2
7755147|NCT00774930|12193824|FG000|DB Phase|Subject Decision|1
7755148|NCT00774930|12193825|FG001|DB Phase|Subject Decision|5
7755149|NCT00774930|12193824|FG000|DB Phase|Sponsor Decision|0
7755150|NCT00774930|12193825|FG001|DB Phase|Sponsor Decision|1
7755151|NCT00774930|12193824|FG000|DB Phase|Disease Progression|1
7755152|NCT00774930|12193825|FG001|DB Phase|Disease Progression|1
7755153|NCT00774930|12193824|FG000|DB Phase|Started Nonprotocol Radiation therapy|0
7755154|NCT00774930|12193825|FG001|DB Phase|Started Nonprotocol Radiation therapy|1
7755155|NCT00774930|12193824|FG000|IOL Phase|Adverse Event|1
7755156|NCT00774930|12193825|FG001|IOL Phase|Adverse Event|1
7755157|NCT00774930|12193824|FG000|IOL Phase|Subject Decision|4
7755158|NCT00774930|12193825|FG001|IOL Phase|Subject Decision|3
7755159|NCT00774930|12193824|FG000|IOL Phase|Physician Decision|3
7755160|NCT00774930|12193825|FG001|IOL Phase|Physician Decision|2
7755161|NCT00774930|12193824|FG000|IOL Phase|Sponsor Decision|1
7755162|NCT00774930|12193825|FG001|IOL Phase|Sponsor Decision|0
7755163|NCT00774930|12193824|FG000|IOL Phase|Disease Progression|2
7755164|NCT00774930|12193825|FG001|IOL Phase|Disease Progression|1
7755165|NCT00774930|12193824|FG000|IOL Phase|Subject Consumed Prohibited Medication|1
7755166|NCT00774930|12193825|FG001|IOL Phase|Subject Consumed Prohibited Medication|0
7755167|NCT00774930|12193824|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0
7755168|NCT00774930|12193825|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1
7755169|NCT00774930|12193824|FG000|IOL Phase|Other|1
7755170|NCT00774930|12193825|FG001|IOL Phase|Other|0
7755171|NCT00774930|12193824|FG000|IOL Phase|Brain radiation|0
7755172|NCT00774930|12193825|FG001|IOL Phase|Brain radiation|1
7755173|NCT00774930|12193824|FG000|LTOLE Phase|Adverse Event|7
7755174|NCT00774930|12193825|FG001|LTOLE Phase|Adverse Event|3
7755175|NCT00774930|12193824|FG000|LTOLE Phase|Subject decision|0
7755176|NCT00774930|12193825|FG001|LTOLE Phase|Subject decision|5
7755177|NCT00774930|12193824|FG000|LTOLE Phase|Physician Decision|4
7755178|NCT00774930|12193825|FG001|LTOLE Phase|Physician Decision|1
7755179|NCT00774930|12193824|FG000|LTOLE Phase|Sponsor decision|2
7755180|NCT00774930|12193825|FG001|LTOLE Phase|Sponsor decision|1
7755181|NCT00774930|12193824|FG000|LTOLE Phase|Disease Progression|2
7755182|NCT00774930|12193825|FG001|LTOLE Phase|Disease Progression|5
7755183|NCT00774930|12193824|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
7755184|NCT00774930|12193825|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
7755185|NCT00774930|12193824|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
7755186|NCT00774930|12193825|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
7755187|NCT00774995|12193837|FG000|Overall Study|Protocol Violation|0
7755188|NCT00774995|12193838|FG001|Overall Study|Protocol Violation|0
7755189|NCT00774995|12193839|FG002|Overall Study|Protocol Violation|1
7755190|NCT00774995|12193840|FG003|Overall Study|Protocol Violation|0
7755191|NCT00775021|12193850|FG000|First Intervention|Lost to Follow-up|1
7755192|NCT00775021|12193851|FG001|First Intervention|Lost to Follow-up|0
7755193|NCT00775021|12193850|FG000|Second Intervention|Adverse Event|0
7755194|NCT00775021|12193851|FG001|Second Intervention|Adverse Event|1
7755195|NCT00775138|12193861|FG000|Overall Study|Withdrawal by Subject|0
7755196|NCT00775138|12193862|FG001|Overall Study|Withdrawal by Subject|0
7755197|NCT00775138|12193863|FG002|Overall Study|Withdrawal by Subject|2
7755198|NCT00775138|12193864|FG003|Overall Study|Withdrawal by Subject|2
7755199|NCT00775138|12193861|FG000|Overall Study|Adverse Event|0
7755200|NCT00775138|12193862|FG001|Overall Study|Adverse Event|0
7755201|NCT00775138|12193863|FG002|Overall Study|Adverse Event|1
7755202|NCT00775138|12193864|FG003|Overall Study|Adverse Event|0
7755203|NCT00775203|12193878|FG000|Overall Study|Adverse Event|25
7755204|NCT00775203|12193879|FG001|Overall Study|Adverse Event|6
7755205|NCT00775203|12193878|FG000|Overall Study|Lack of Efficacy|8
7755206|NCT00775203|12193879|FG001|Overall Study|Lack of Efficacy|9
7755207|NCT00775203|12193878|FG000|Overall Study|Withdrawal by Subject|11
7755208|NCT00775203|12193879|FG001|Overall Study|Withdrawal by Subject|9
7755209|NCT00775203|12193878|FG000|Overall Study|Lost to Follow-up|11
7755210|NCT00775203|12193879|FG001|Overall Study|Lost to Follow-up|15
7755211|NCT00775203|12193878|FG000|Overall Study|Administrative reason|2
7755212|NCT00775203|12193879|FG001|Overall Study|Administrative reason|0
7755213|NCT00775203|12193878|FG000|Overall Study|Noncompliance|4
7755214|NCT00775203|12193879|FG001|Overall Study|Noncompliance|2
7755215|NCT00775203|12193878|FG000|Overall Study|Protocol Violation|0
7755216|NCT00775203|12193879|FG001|Overall Study|Protocol Violation|1
7755217|NCT00775203|12193878|FG000|Overall Study|Entered other study|1
7755218|NCT00775203|12193879|FG001|Overall Study|Entered other study|0
7755219|NCT00775203|12193878|FG000|Overall Study|Physician Decision|0
7755220|NCT00775203|12193879|FG001|Overall Study|Physician Decision|1
7755221|NCT00775268|12193896|FG000|Baseline|Drug not synthesize dose|1
7755222|NCT00775268|12193897|FG001|Baseline|Drug not synthesize dose|0
7755223|NCT00775268|12193896|FG000|Baseline|Not treated-ineligible per CT|0
7755224|NCT00775268|12193897|FG001|Baseline|Not treated-ineligible per CT|1
7755225|NCT00775268|12193896|FG000|After 2 Cycles|Participant refused to be scanned further|1
7755226|NCT00775268|12193897|FG001|After 2 Cycles|Participant refused to be scanned further|0
7755227|NCT00775268|12193896|FG000|After Completion|Participant missed scan appointment|1
7755228|NCT00775268|12193897|FG001|After Completion|Participant missed scan appointment|0
7755229|NCT00775437|12193922|FG000|Overall Study|Loss of efficacy|2
7755230|NCT00775437|12193922|FG000|Overall Study|Withdrawal by Subject|3
7755231|NCT00775437|12193922|FG000|Overall Study|Lost to Follow-up|1
7755232|NCT00775450|12193931|FG000|Overall Study|Serious Adverse Event|2
7755233|NCT00775450|12193932|FG001|Overall Study|Serious Adverse Event|0
7755234|NCT00775450|12193933|FG002|Overall Study|Serious Adverse Event|0
7755235|NCT00775450|12193934|FG003|Overall Study|Serious Adverse Event|0
7755236|NCT00775450|12193935|FG004|Overall Study|Serious Adverse Event|0
7755237|NCT00775450|12193931|FG000|Overall Study|Protocol Violation|0
7755238|NCT00775450|12193932|FG001|Overall Study|Protocol Violation|0
7755239|NCT00775450|12193933|FG002|Overall Study|Protocol Violation|0
7755240|NCT00775450|12193934|FG003|Overall Study|Protocol Violation|0
7755241|NCT00775450|12193935|FG004|Overall Study|Protocol Violation|1
7755242|NCT00775450|12193931|FG000|Overall Study|Withdrawal by Subject|1
7755243|NCT00775450|12193932|FG001|Overall Study|Withdrawal by Subject|0
7755244|NCT00775450|12193933|FG002|Overall Study|Withdrawal by Subject|0
7755245|NCT00775450|12193934|FG003|Overall Study|Withdrawal by Subject|0
7755246|NCT00775450|12193935|FG004|Overall Study|Withdrawal by Subject|1
7755247|NCT00775463|12193949|FG000|Overall Study|Withdrawal by Subject|0
7755248|NCT00775463|12193950|FG001|Overall Study|Withdrawal by Subject|1
7755249|NCT00775463|12193949|FG000|Overall Study|Adverse Event|7
7755250|NCT00775463|12193950|FG001|Overall Study|Adverse Event|9
7755251|NCT00775463|12193949|FG000|Overall Study|Protocol Violation|2
7755252|NCT00775463|12193950|FG001|Overall Study|Protocol Violation|2
7755253|NCT00775463|12193949|FG000|Overall Study|Lost to Follow-up|1
7755254|NCT00775463|12193950|FG001|Overall Study|Lost to Follow-up|0
7755255|NCT00775463|12193949|FG000|Overall Study|Lack of Efficacy|1
7755256|NCT00775463|12193950|FG001|Overall Study|Lack of Efficacy|1
7755257|NCT00775528|12193963|FG000|Overall Study|Protocol Violation|1
7755258|NCT00775593|12193967|FG000|Overall Study|Unmet eligibility criteria|6
7755259|NCT00775593|12193967|FG000|Overall Study|Death|1
7755260|NCT00775606|12193973|FG000|Overall Study|Study sponsor terminated funding|3
7755261|NCT00775606|12193974|FG001|Overall Study|Study sponsor terminated funding|0
7755262|NCT00775983|12194035|FG000|Overall Study|Protocol Violation|1
7755263|NCT00775983|12194036|FG001|Overall Study|Protocol Violation|2
7755264|NCT00776009|12194048|FG000|Period 1: First Intervention|Withdrawal by Subject|0
7755265|NCT00776009|12194049|FG001|Period 1: First Intervention|Withdrawal by Subject|0
7755266|NCT00776009|12194050|FG002|Period 1: First Intervention|Withdrawal by Subject|1
7755267|NCT00776009|12194051|FG003|Period 1: First Intervention|Withdrawal by Subject|0
7755268|NCT00776009|12194052|FG004|Period 1: First Intervention|Withdrawal by Subject|1
7755269|NCT00776009|12194053|FG005|Period 1: First Intervention|Withdrawal by Subject|0
7755270|NCT00776009|12194048|FG000|Period 1: First Intervention|Protocol Violation|0
7755271|NCT00776009|12194049|FG001|Period 1: First Intervention|Protocol Violation|1
7755272|NCT00776009|12194050|FG002|Period 1: First Intervention|Protocol Violation|0
7755273|NCT00776009|12194051|FG003|Period 1: First Intervention|Protocol Violation|0
7755274|NCT00776009|12194052|FG004|Period 1: First Intervention|Protocol Violation|1
7755275|NCT00776009|12194053|FG005|Period 1: First Intervention|Protocol Violation|0
7755276|NCT00776009|12194048|FG000|Period 2: Second Intervention|Withdrawal by Subject|0
7755277|NCT00776009|12194049|FG001|Period 2: Second Intervention|Withdrawal by Subject|0
7755278|NCT00776009|12194050|FG002|Period 2: Second Intervention|Withdrawal by Subject|0
7755279|NCT00776009|12194051|FG003|Period 2: Second Intervention|Withdrawal by Subject|0
7755280|NCT00776009|12194052|FG004|Period 2: Second Intervention|Withdrawal by Subject|0
7755281|NCT00776009|12194053|FG005|Period 2: Second Intervention|Withdrawal by Subject|1
7755282|NCT00776009|12194048|FG000|Period 2: Second Intervention|Protocol Violation|1
7755283|NCT00776009|12194049|FG001|Period 2: Second Intervention|Protocol Violation|0
7755284|NCT00776009|12194050|FG002|Period 2: Second Intervention|Protocol Violation|1
7755285|NCT00776009|12194051|FG003|Period 2: Second Intervention|Protocol Violation|0
7755286|NCT00776009|12194052|FG004|Period 2: Second Intervention|Protocol Violation|0
7755287|NCT00776009|12194053|FG005|Period 2: Second Intervention|Protocol Violation|0
7755288|NCT00776009|12194048|FG000|Period 3: Third Intervention|Withdrawal by Subject|1
7755289|NCT00776009|12194049|FG001|Period 3: Third Intervention|Withdrawal by Subject|0
7755290|NCT00776009|12194050|FG002|Period 3: Third Intervention|Withdrawal by Subject|0
7755291|NCT00776009|12194051|FG003|Period 3: Third Intervention|Withdrawal by Subject|0
7755292|NCT00776009|12194052|FG004|Period 3: Third Intervention|Withdrawal by Subject|0
7755293|NCT00776009|12194053|FG005|Period 3: Third Intervention|Withdrawal by Subject|0
7755294|NCT00776230|12194064|FG000|Overall Study|Lost to Follow-up|2
7755295|NCT00776230|12194065|FG001|Overall Study|Lost to Follow-up|1
7755296|NCT00776230|12194066|FG002|Overall Study|Lost to Follow-up|5
7755297|NCT00776230|12194064|FG000|Overall Study|Not vaccinated at Day 0|1
7755298|NCT00776230|12194065|FG001|Overall Study|Not vaccinated at Day 0|0
7755299|NCT00776230|12194066|FG002|Overall Study|Not vaccinated at Day 0|0
7755300|NCT00776230|12194064|FG000|Overall Study|Withdrawal by Subject|0
7755301|NCT00776230|12194065|FG001|Overall Study|Withdrawal by Subject|1
7755302|NCT00776230|12194066|FG002|Overall Study|Withdrawal by Subject|0
7755303|NCT00776230|12194064|FG000|Overall Study|Subject missed Visit 4|0
7755304|NCT00776230|12194065|FG001|Overall Study|Subject missed Visit 4|1
7755305|NCT00776230|12194066|FG002|Overall Study|Subject missed Visit 4|0
7755306|NCT00776659|12194089|FG000|Overall Study|Lost to Follow-up|15
7755307|NCT00776659|12194089|FG000|Overall Study|Withdrawal by Subject|10
7755308|NCT00776659|12194089|FG000|Overall Study|Study Terminated by Sponsor|1
7755309|NCT00776789|12194095|FG000|Overall Study|Consent refusal|2
7755310|NCT00776789|12194096|FG001|Overall Study|Consent refusal|2
7755311|NCT00776789|12194095|FG000|Overall Study|Poor quality video|1
7755312|NCT00776789|12194096|FG001|Overall Study|Poor quality video|1
7769750|NCT00871377|12213497|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0
7769751|NCT00871377|12213498|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1
7769752|NCT00871377|12213493|FG000|Washout (6 Weeks)|Withdrawal by Subject|1
7769753|NCT00871377|12213494|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
7769754|NCT00871377|12213495|FG002|Washout (6 Weeks)|Withdrawal by Subject|0
7769755|NCT00871377|12213496|FG003|Washout (6 Weeks)|Withdrawal by Subject|0
7769756|NCT00871377|12213497|FG004|Washout (6 Weeks)|Withdrawal by Subject|0
7769757|NCT00871377|12213498|FG005|Washout (6 Weeks)|Withdrawal by Subject|0
7769758|NCT00871377|12213493|FG000|Washout (6 Weeks)|Withdrawal by Subject|0
7769759|NCT00871377|12213494|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
7769760|NCT00871377|12213495|FG002|Washout (6 Weeks)|Withdrawal by Subject|0
7769761|NCT00871377|12213496|FG003|Washout (6 Weeks)|Withdrawal by Subject|0
7769762|NCT00871377|12213497|FG004|Washout (6 Weeks)|Withdrawal by Subject|0
7769763|NCT00871377|12213498|FG005|Washout (6 Weeks)|Withdrawal by Subject|1
7769764|NCT00871377|12213493|FG000|Third Intervention (10 Weeks)|Death|0
7769765|NCT00871377|12213494|FG001|Third Intervention (10 Weeks)|Death|0
7769766|NCT00871377|12213495|FG002|Third Intervention (10 Weeks)|Death|0
7769767|NCT00871377|12213496|FG003|Third Intervention (10 Weeks)|Death|1
7769768|NCT00871377|12213497|FG004|Third Intervention (10 Weeks)|Death|0
7769769|NCT00871377|12213498|FG005|Third Intervention (10 Weeks)|Death|0
7769770|NCT00871403|12213509|FG000|Combination Treatment Phase|Randomized but Not Treated|1
7769771|NCT00871403|12213510|FG001|Combination Treatment Phase|Randomized but Not Treated|1
7769772|NCT00871403|12213511|FG002|Combination Treatment Phase|Randomized but Not Treated|1
7769773|NCT00871403|12213509|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
7769774|NCT00871403|12213510|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
7769775|NCT00871403|12213511|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
7769776|NCT00871403|12213509|FG000|Combination Treatment Phase|Adverse Event|0
7769777|NCT00871403|12213510|FG001|Combination Treatment Phase|Adverse Event|17
7769778|NCT00871403|12213511|FG002|Combination Treatment Phase|Adverse Event|2
7769779|NCT00871403|12213509|FG000|Combination Treatment Phase|Disease Progression|0
7755313|NCT00776919|12194108|FG000|Overall Study|Withdrawal by Subject|16
7755314|NCT00776919|12194109|FG001|Overall Study|Withdrawal by Subject|14
7755315|NCT00776919|12194110|FG002|Overall Study|Withdrawal by Subject|15
7755316|NCT00776919|12194111|FG003|Overall Study|Withdrawal by Subject|26
7755317|NCT00776919|12194108|FG000|Overall Study|Lost to Follow-up|8
7755318|NCT00776919|12194109|FG001|Overall Study|Lost to Follow-up|12
7755319|NCT00776919|12194110|FG002|Overall Study|Lost to Follow-up|11
7755320|NCT00776919|12194111|FG003|Overall Study|Lost to Follow-up|8
7755321|NCT00776919|12194108|FG000|Overall Study|Adverse Event|1
7755322|NCT00776919|12194109|FG001|Overall Study|Adverse Event|0
7755323|NCT00776919|12194110|FG002|Overall Study|Adverse Event|2
7755324|NCT00776919|12194111|FG003|Overall Study|Adverse Event|2
7755325|NCT00776919|12194108|FG000|Overall Study|Protocol Violation|1
7755326|NCT00776919|12194109|FG001|Overall Study|Protocol Violation|2
7755327|NCT00776919|12194110|FG002|Overall Study|Protocol Violation|0
7755328|NCT00776919|12194111|FG003|Overall Study|Protocol Violation|1
7755329|NCT00776919|12194108|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1
7755330|NCT00776919|12194109|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5
7755331|NCT00776919|12194110|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4
7755332|NCT00776919|12194111|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2
7755333|NCT00776984|12194123|FG000|Overall Study|Adverse Event|8
7755334|NCT00776984|12194124|FG001|Overall Study|Adverse Event|2
7755335|NCT00776984|12194123|FG000|Overall Study|Protocol Violation|4
7755336|NCT00776984|12194124|FG001|Overall Study|Protocol Violation|2
7755337|NCT00776984|12194123|FG000|Overall Study|Lost to Follow-up|2
7755338|NCT00776984|12194124|FG001|Overall Study|Lost to Follow-up|0
7755339|NCT00776984|12194123|FG000|Overall Study|Withdrawal by Subject|12
7755340|NCT00776984|12194124|FG001|Overall Study|Withdrawal by Subject|7
7755341|NCT00776984|12194123|FG000|Overall Study|Lack of Efficacy|0
7755342|NCT00776984|12194124|FG001|Overall Study|Lack of Efficacy|1
7755343|NCT00776984|12194123|FG000|Overall Study|Other|5
7755344|NCT00776984|12194124|FG001|Overall Study|Other|9
7755345|NCT00776997|12194130|FG000|Overall Study|Adverse Event|2
7755346|NCT00777023|12194137|FG000|Overall Study|Adverse Event|15
7755347|NCT00777023|12194138|FG001|Overall Study|Adverse Event|21
7755348|NCT00777023|12194139|FG002|Overall Study|Adverse Event|8
7755349|NCT00777023|12194137|FG000|Overall Study|Lack of Efficacy|1
7755350|NCT00777023|12194138|FG001|Overall Study|Lack of Efficacy|0
7755351|NCT00777023|12194139|FG002|Overall Study|Lack of Efficacy|14
7755352|NCT00777023|12194137|FG000|Overall Study|Protocol Violation|2
7755353|NCT00777023|12194138|FG001|Overall Study|Protocol Violation|1
7755354|NCT00777023|12194139|FG002|Overall Study|Protocol Violation|1
7755355|NCT00777023|12194137|FG000|Overall Study|Lost to Follow-up|2
7755356|NCT00777023|12194138|FG001|Overall Study|Lost to Follow-up|3
7755357|NCT00777023|12194139|FG002|Overall Study|Lost to Follow-up|3
7755358|NCT00777023|12194137|FG000|Overall Study|Death|0
7755359|NCT00777023|12194138|FG001|Overall Study|Death|1
7755360|NCT00777023|12194139|FG002|Overall Study|Death|0
7755361|NCT00777023|12194137|FG000|Overall Study|Withdrawal by Subject|7
7755362|NCT00777023|12194138|FG001|Overall Study|Withdrawal by Subject|7
7755363|NCT00777023|12194139|FG002|Overall Study|Withdrawal by Subject|8
7755364|NCT00777023|12194137|FG000|Overall Study|Missing data|1
7755365|NCT00777023|12194138|FG001|Overall Study|Missing data|1
7755366|NCT00777023|12194139|FG002|Overall Study|Missing data|0
7755367|NCT00777023|12194137|FG000|Overall Study|Reasons not specified|4
7755368|NCT00777023|12194138|FG001|Overall Study|Reasons not specified|4
7755369|NCT00777023|12194139|FG002|Overall Study|Reasons not specified|2
7755370|NCT00777023|12194137|FG000|Overall Study|Last dose date unknown|3
7755371|NCT00777023|12194138|FG001|Overall Study|Last dose date unknown|3
7755372|NCT00777023|12194139|FG002|Overall Study|Last dose date unknown|1
7755373|NCT00777049|12194149|FG000|Overall Study|Withdrawal by Subject|1
7755374|NCT00777049|12194150|FG001|Overall Study|Withdrawal by Subject|0
7755375|NCT00777049|12194149|FG000|Overall Study|No treatment (elevated liver enzymes)|0
7755376|NCT00777049|12194150|FG001|Overall Study|No treatment (elevated liver enzymes)|1
7755377|NCT00777088|12194165|FG000|Overall Study|PED Treatment not attempted|1
7755378|NCT00777101|12194172|FG000|Overall Study|Death|48
7755379|NCT00777101|12194173|FG001|Overall Study|Death|43
7755380|NCT00777101|12194172|FG000|Overall Study|Withdrawal by Subject|11
7755381|NCT00777101|12194173|FG001|Overall Study|Withdrawal by Subject|6
7755382|NCT00777101|12194172|FG000|Overall Study|Lost to Follow-up|2
7755383|NCT00777101|12194173|FG001|Overall Study|Lost to Follow-up|1
7755384|NCT00777101|12194172|FG000|Overall Study|Discontinuation of Study by Sponsor|1
7755385|NCT00777101|12194173|FG001|Overall Study|Discontinuation of Study by Sponsor|0
7755386|NCT00777101|12194172|FG000|Overall Study|Failed to Return|0
7755387|NCT00777101|12194173|FG001|Overall Study|Failed to Return|1
7755388|NCT00777153|12194183|FG000|Overall Study|Lost to Follow-up|1
7755389|NCT00777153|12194184|FG001|Overall Study|Lost to Follow-up|1
7755390|NCT00777153|12194185|FG002|Overall Study|Lost to Follow-up|0
7755391|NCT00777153|12194183|FG000|Overall Study|Death|85
7755392|NCT00777153|12194184|FG001|Overall Study|Death|73
7755393|NCT00777153|12194185|FG002|Overall Study|Death|33
7755394|NCT00777153|12194183|FG000|Overall Study|Withdrawal by Subject|3
7755395|NCT00777153|12194184|FG001|Overall Study|Withdrawal by Subject|4
7755396|NCT00777153|12194185|FG002|Overall Study|Withdrawal by Subject|3
7755397|NCT00777153|12194183|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1
7755398|NCT00777153|12194184|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5
7755399|NCT00777153|12194185|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1
7755400|NCT00777205|12194208|FG000|Overall Study|Lost to Follow-up|25
7755401|NCT00777205|12194209|FG001|Overall Study|Lost to Follow-up|9
7755402|NCT00777205|12194208|FG000|Overall Study|Withdrawal by Subject|6
7755403|NCT00777205|12194209|FG001|Overall Study|Withdrawal by Subject|4
7755404|NCT00777205|12194208|FG000|Overall Study|Death|0
7755405|NCT00777205|12194209|FG001|Overall Study|Death|2
7755406|NCT00777205|12194208|FG000|Overall Study|Protocol Violation|0
7755407|NCT00777205|12194209|FG001|Overall Study|Protocol Violation|56
7755408|NCT00777257|12194220|FG000|Overall Study|Adverse Event|3
7755409|NCT00777257|12194221|FG001|Overall Study|Adverse Event|1
7755410|NCT00777257|12194222|FG002|Overall Study|Adverse Event|0
7755411|NCT00777257|12194220|FG000|Overall Study|Lost to Follow-up|3
7755412|NCT00777257|12194221|FG001|Overall Study|Lost to Follow-up|3
7755413|NCT00777257|12194222|FG002|Overall Study|Lost to Follow-up|2
7755414|NCT00777257|12194220|FG000|Overall Study|Protocol Violation|2
7755415|NCT00777257|12194221|FG001|Overall Study|Protocol Violation|2
7755416|NCT00777257|12194222|FG002|Overall Study|Protocol Violation|2
7755417|NCT00777257|12194220|FG000|Overall Study|Withdrawal by Subject|3
7755418|NCT00777257|12194221|FG001|Overall Study|Withdrawal by Subject|6
7755419|NCT00777257|12194222|FG002|Overall Study|Withdrawal by Subject|5
7755420|NCT00777296|12194234|FG000|Overall Study|Adverse Event|0
7755421|NCT00777296|12194235|FG001|Overall Study|Adverse Event|1
7755422|NCT00777296|12194236|FG002|Overall Study|Adverse Event|0
7755423|NCT00777296|12194237|FG003|Overall Study|Adverse Event|1
7755424|NCT00777296|12194234|FG000|Overall Study|Withdrawal by Subject|1
7755425|NCT00777296|12194235|FG001|Overall Study|Withdrawal by Subject|0
7755426|NCT00777296|12194236|FG002|Overall Study|Withdrawal by Subject|0
7755427|NCT00777296|12194237|FG003|Overall Study|Withdrawal by Subject|0
7755428|NCT00777296|12194234|FG000|Overall Study|CRF form not completed|0
7755429|NCT00777296|12194235|FG001|Overall Study|CRF form not completed|0
7755430|NCT00777296|12194236|FG002|Overall Study|CRF form not completed|2
7755431|NCT00777296|12194237|FG003|Overall Study|CRF form not completed|0
7755432|NCT00777556|12194268|FG000|Overall Study|Inappropriate self-selection|34
7755433|NCT00777556|12194268|FG000|Overall Study|Dispensed but did not use product|12
7755434|NCT00777556|12194268|FG000|Overall Study|Did not complete all 3 follow-up visits|20
7755435|NCT00777608|12194274|FG000|Overall Study|Lost to Follow-up|1
7755436|NCT00777608|12194275|FG001|Overall Study|Lost to Follow-up|1
7755437|NCT00777608|12194274|FG000|Overall Study|Withdrawal by Subject|1
7755438|NCT00777608|12194275|FG001|Overall Study|Withdrawal by Subject|3
7755439|NCT00777608|12194274|FG000|Overall Study|Protocol Violation|1
7755440|NCT00777608|12194275|FG001|Overall Study|Protocol Violation|0
7755441|NCT00777608|12194274|FG000|Overall Study|Investigator Decision|1
7755442|NCT00777608|12194275|FG001|Overall Study|Investigator Decision|2
7755443|NCT00777803|12194316|FG000|Overall Study|Lost to Follow-up|12
7755444|NCT00777803|12194317|FG001|Overall Study|Lost to Follow-up|5
7755445|NCT00777803|12194316|FG000|Overall Study|Adverse Event|1
7755446|NCT00777803|12194317|FG001|Overall Study|Adverse Event|0
7755447|NCT00777803|12194316|FG000|Overall Study|Non-compliance|2
7755448|NCT00777803|12194317|FG001|Overall Study|Non-compliance|2
7755449|NCT00777829|12194323|FG000|Overall Study|Withdrawal by Subject|0
7755450|NCT00777829|12194324|FG001|Overall Study|Withdrawal by Subject|2
7755451|NCT00777920|12194338|FG000|Overall Study|Adverse Event|39
7755452|NCT00777920|12194338|FG000|Overall Study|Withdrawal of Consent|4
7755453|NCT00777920|12194338|FG000|Overall Study|Lost to Follow-up|1
7755454|NCT00777920|12194338|FG000|Overall Study|Investigator's discretion|1
7755455|NCT00777920|12194338|FG000|Overall Study|Clinical status did not improve|1
7755456|NCT00777920|12194338|FG000|Overall Study|Other, not specified|4
7755457|NCT00777946|12194345|FG000|Overall Study|Adverse Event|11
7755458|NCT00777946|12194346|FG001|Overall Study|Adverse Event|1
7755459|NCT00777946|12194347|FG002|Overall Study|Adverse Event|3
7755460|NCT00777946|12194345|FG000|Overall Study|Lack of Efficacy|0
7755461|NCT00777946|12194346|FG001|Overall Study|Lack of Efficacy|0
7755462|NCT00777946|12194347|FG002|Overall Study|Lack of Efficacy|9
7755463|NCT00777946|12194345|FG000|Overall Study|Condition no longer required study drug|1
7755464|NCT00777946|12194346|FG001|Overall Study|Condition no longer required study drug|0
7755465|NCT00777946|12194347|FG002|Overall Study|Condition no longer required study drug|0
7755466|NCT00777946|12194345|FG000|Overall Study|Patient withdrew consent|3
7755467|NCT00777946|12194346|FG001|Overall Study|Patient withdrew consent|2
7755468|NCT00777946|12194347|FG002|Overall Study|Patient withdrew consent|3
7755469|NCT00777946|12194345|FG000|Overall Study|Lost to Follow-up|3
7755470|NCT00777946|12194346|FG001|Overall Study|Lost to Follow-up|1
7755471|NCT00777946|12194347|FG002|Overall Study|Lost to Follow-up|0
7755472|NCT00777946|12194345|FG000|Overall Study|Protocol deviation|2
7755473|NCT00777946|12194346|FG001|Overall Study|Protocol deviation|1
7755474|NCT00777946|12194347|FG002|Overall Study|Protocol deviation|1
7755475|NCT00777946|12194345|FG000|Overall Study|Randomized in error|1
7755476|NCT00777946|12194346|FG001|Overall Study|Randomized in error|1
7755477|NCT00777946|12194347|FG002|Overall Study|Randomized in error|0
7755478|NCT00778102|12194357|FG000|Overall Study|Adverse Event|8
7755479|NCT00778102|12194358|FG001|Overall Study|Adverse Event|5
7755480|NCT00778102|12194357|FG000|Overall Study|Death|1
7755481|NCT00778102|12194358|FG001|Overall Study|Death|1
7755482|NCT00778102|12194357|FG000|Overall Study|Lost to Follow-up|1
7755483|NCT00778102|12194358|FG001|Overall Study|Lost to Follow-up|0
7755484|NCT00778102|12194357|FG000|Overall Study|Violation of Selection Criteria|1
7755485|NCT00778102|12194358|FG001|Overall Study|Violation of Selection Criteria|1
7755486|NCT00778102|12194357|FG000|Overall Study|Protocol Violation|0
7755487|NCT00778102|12194358|FG001|Overall Study|Protocol Violation|1
7755488|NCT00778102|12194357|FG000|Overall Study|Refused Treatment|2
7755489|NCT00778102|12194358|FG001|Overall Study|Refused Treatment|3
7755490|NCT00778102|12194357|FG000|Overall Study|Withdrawal by Subject|1
7755491|NCT00778102|12194358|FG001|Overall Study|Withdrawal by Subject|1
7755492|NCT00778102|12194357|FG000|Overall Study|Administrative Reason|7
7755493|NCT00778102|12194358|FG001|Overall Study|Administrative Reason|10
7755494|NCT00778258|12194386|FG000|Overall Study|Adverse Event|1
7755495|NCT00778258|12194387|FG001|Overall Study|Adverse Event|0
7755496|NCT00778258|12194388|FG002|Overall Study|Adverse Event|0
7755497|NCT00778258|12194389|FG003|Overall Study|Adverse Event|0
7755498|NCT00778258|12194390|FG004|Overall Study|Adverse Event|0
7755499|NCT00778258|12194391|FG005|Overall Study|Adverse Event|1
7755500|NCT00778258|12194392|FG006|Overall Study|Adverse Event|0
7755501|NCT00778258|12194393|FG007|Overall Study|Adverse Event|0
7755502|NCT00778258|12194394|FG008|Overall Study|Adverse Event|0
7755503|NCT00778258|12194386|FG000|Overall Study|Lost to Follow-up|0
7755504|NCT00778258|12194387|FG001|Overall Study|Lost to Follow-up|0
7755505|NCT00778258|12194388|FG002|Overall Study|Lost to Follow-up|2
7755506|NCT00778258|12194389|FG003|Overall Study|Lost to Follow-up|0
7755507|NCT00778258|12194390|FG004|Overall Study|Lost to Follow-up|0
7755508|NCT00778258|12194391|FG005|Overall Study|Lost to Follow-up|3
7755509|NCT00778258|12194392|FG006|Overall Study|Lost to Follow-up|2
7755510|NCT00778258|12194393|FG007|Overall Study|Lost to Follow-up|2
7755511|NCT00778258|12194394|FG008|Overall Study|Lost to Follow-up|0
7755512|NCT00778258|12194386|FG000|Overall Study|Withdrawal by Subject|6
7755513|NCT00778258|12194387|FG001|Overall Study|Withdrawal by Subject|2
7755514|NCT00778258|12194388|FG002|Overall Study|Withdrawal by Subject|8
7755515|NCT00778258|12194389|FG003|Overall Study|Withdrawal by Subject|2
7755516|NCT00778258|12194390|FG004|Overall Study|Withdrawal by Subject|0
7755517|NCT00778258|12194391|FG005|Overall Study|Withdrawal by Subject|6
7755518|NCT00778258|12194392|FG006|Overall Study|Withdrawal by Subject|12
7755519|NCT00778258|12194393|FG007|Overall Study|Withdrawal by Subject|12
7755520|NCT00778258|12194394|FG008|Overall Study|Withdrawal by Subject|4
7755521|NCT00778258|12194386|FG000|Overall Study|New Contraindication|0
7755522|NCT00778258|12194387|FG001|Overall Study|New Contraindication|0
7755523|NCT00778258|12194388|FG002|Overall Study|New Contraindication|0
7755524|NCT00778258|12194389|FG003|Overall Study|New Contraindication|0
7755525|NCT00778258|12194390|FG004|Overall Study|New Contraindication|0
7755526|NCT00778258|12194391|FG005|Overall Study|New Contraindication|0
7755527|NCT00778258|12194392|FG006|Overall Study|New Contraindication|0
7755528|NCT00778258|12194393|FG007|Overall Study|New Contraindication|1
7755529|NCT00778258|12194394|FG008|Overall Study|New Contraindication|0
7755530|NCT00778258|12194386|FG000|Overall Study|Non-compliance|0
7755531|NCT00778258|12194387|FG001|Overall Study|Non-compliance|0
7755532|NCT00778258|12194388|FG002|Overall Study|Non-compliance|0
7755533|NCT00778258|12194389|FG003|Overall Study|Non-compliance|1
7755534|NCT00778258|12194390|FG004|Overall Study|Non-compliance|0
7755535|NCT00778258|12194391|FG005|Overall Study|Non-compliance|0
7755536|NCT00778258|12194392|FG006|Overall Study|Non-compliance|0
7755537|NCT00778258|12194393|FG007|Overall Study|Non-compliance|0
7755538|NCT00778258|12194394|FG008|Overall Study|Non-compliance|0
7755539|NCT00778258|12194386|FG000|Overall Study|Other|0
7755540|NCT00778258|12194387|FG001|Overall Study|Other|0
7755541|NCT00778258|12194388|FG002|Overall Study|Other|0
7755542|NCT00778258|12194389|FG003|Overall Study|Other|0
7755543|NCT00778258|12194390|FG004|Overall Study|Other|0
7755544|NCT00778258|12194391|FG005|Overall Study|Other|0
7755545|NCT00778258|12194392|FG006|Overall Study|Other|1
7755546|NCT00778258|12194393|FG007|Overall Study|Other|0
7755547|NCT00778258|12194394|FG008|Overall Study|Other|0
7755548|NCT00778336|12194435|FG000|Index Procedure-Discharge|Death|6
7755549|NCT00778336|12194436|FG001|Index Procedure-Discharge|Death|3
7755550|NCT00778336|12194437|FG002|Index Procedure-Discharge|Death|2
7755551|NCT00778336|12194438|FG003|Index Procedure-Discharge|Death|0
7755552|NCT00778336|12194435|FG000|3 Month Follow Up|Lost to Follow-up|15
7755553|NCT00778336|12194436|FG001|3 Month Follow Up|Lost to Follow-up|20
7755554|NCT00778336|12194437|FG002|3 Month Follow Up|Lost to Follow-up|3
7755555|NCT00778336|12194438|FG003|3 Month Follow Up|Lost to Follow-up|0
7755556|NCT00778336|12194435|FG000|3 Month Follow Up|Death|8
7755557|NCT00778336|12194436|FG001|3 Month Follow Up|Death|3
7755558|NCT00778336|12194437|FG002|3 Month Follow Up|Death|2
7755559|NCT00778336|12194438|FG003|3 Month Follow Up|Death|0
7755560|NCT00778375|12194448|FG000|Overall Study|Ineligible|3
7755561|NCT00778622|12194457|FG000|Overall Study|Adverse Event|5
7755562|NCT00778622|12194458|FG001|Overall Study|Adverse Event|4
7755563|NCT00778622|12194459|FG002|Overall Study|Adverse Event|7
7755564|NCT00778622|12194457|FG000|Overall Study|Withdrawal by Subject|4
7755565|NCT00778622|12194458|FG001|Overall Study|Withdrawal by Subject|5
7755566|NCT00778622|12194459|FG002|Overall Study|Withdrawal by Subject|5
7755567|NCT00778622|12194457|FG000|Overall Study|Lost to Follow-up|3
7755568|NCT00778622|12194458|FG001|Overall Study|Lost to Follow-up|3
7755569|NCT00778622|12194459|FG002|Overall Study|Lost to Follow-up|2
7755570|NCT00778622|12194457|FG000|Overall Study|Protocol Violation|0
7755571|NCT00778622|12194458|FG001|Overall Study|Protocol Violation|3
7755572|NCT00778622|12194459|FG002|Overall Study|Protocol Violation|0
7755573|NCT00778622|12194457|FG000|Overall Study|Lack of Efficacy|2
7755574|NCT00778622|12194458|FG001|Overall Study|Lack of Efficacy|0
7755575|NCT00778622|12194459|FG002|Overall Study|Lack of Efficacy|0
7755576|NCT00778622|12194457|FG000|Overall Study|immigration|1
7755577|NCT00778622|12194458|FG001|Overall Study|immigration|0
7755578|NCT00778622|12194459|FG002|Overall Study|immigration|0
7755579|NCT00778622|12194457|FG000|Overall Study|Other|1
7755580|NCT00778622|12194458|FG001|Overall Study|Other|0
7755581|NCT00778622|12194459|FG002|Overall Study|Other|1
7755582|NCT00778817|12194480|FG000|Overall Study|Adverse Event|2
7755583|NCT00778817|12194480|FG000|Overall Study|Withdrawal by Subject|2
7755584|NCT00778830|12194486|FG000|Overall Study|Ongoing at data cut-off|0
7755585|NCT00778830|12194487|FG001|Overall Study|Ongoing at data cut-off|1
7755586|NCT00778895|12194500|FG000|Active Phase|Adverse Event|3
7755587|NCT00778895|12194501|FG001|Active Phase|Adverse Event|1
7755588|NCT00778895|12194502|FG002|Active Phase|Adverse Event|0
7755589|NCT00778895|12194500|FG000|Active Phase|Withdrawal by Subject|1
7755590|NCT00778895|12194501|FG001|Active Phase|Withdrawal by Subject|4
7755591|NCT00778895|12194502|FG002|Active Phase|Withdrawal by Subject|0
7755592|NCT00778895|12194500|FG000|Active Phase|Lost to Follow-up|1
7755593|NCT00778895|12194501|FG001|Active Phase|Lost to Follow-up|1
7755594|NCT00778895|12194502|FG002|Active Phase|Lost to Follow-up|0
7755595|NCT00778895|12194500|FG000|Active Phase|Other|2
7755596|NCT00778895|12194501|FG001|Active Phase|Other|0
7755597|NCT00778895|12194502|FG002|Active Phase|Other|0
7755598|NCT00778895|12194500|FG000|ESFU Phase|Adverse Event|2
7755599|NCT00778895|12194501|FG001|ESFU Phase|Adverse Event|1
7755600|NCT00778895|12194502|FG002|ESFU Phase|Adverse Event|0
7755601|NCT00778895|12194500|FG000|ESFU Phase|Withdrawal by Subject|1
7755602|NCT00778895|12194501|FG001|ESFU Phase|Withdrawal by Subject|4
7755603|NCT00778895|12194502|FG002|ESFU Phase|Withdrawal by Subject|0
7755604|NCT00778895|12194500|FG000|ESFU Phase|Lost to Follow-up|6
7755605|NCT00778895|12194501|FG001|ESFU Phase|Lost to Follow-up|7
7755606|NCT00778895|12194502|FG002|ESFU Phase|Lost to Follow-up|2
7755607|NCT00778895|12194500|FG000|ESFU Phase|Other|2
7755608|NCT00778895|12194501|FG001|ESFU Phase|Other|0
7755609|NCT00778895|12194502|FG002|ESFU Phase|Other|0
7755610|NCT00778921|12194514|FG000|Overall Study|Adverse Event|9
7755611|NCT00778921|12194515|FG001|Overall Study|Adverse Event|10
7755612|NCT00778921|12194516|FG002|Overall Study|Adverse Event|14
7755613|NCT00778921|12194514|FG000|Overall Study|Abnormal Laboratory Value(s)|1
7755614|NCT00778921|12194515|FG001|Overall Study|Abnormal Laboratory Value(s)|0
7755615|NCT00778921|12194516|FG002|Overall Study|Abnormal Laboratory Value(s)|0
7755616|NCT00778921|12194514|FG000|Overall Study|Abnormal Test Procedure Result(s)|0
7755617|NCT00778921|12194515|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
7755618|NCT00778921|12194516|FG002|Overall Study|Abnormal Test Procedure Result(s)|2
7755619|NCT00778921|12194514|FG000|Overall Study|Unsatisfactory therapeutic response|1
7755620|NCT00778921|12194515|FG001|Overall Study|Unsatisfactory therapeutic response|1
7755621|NCT00778921|12194516|FG002|Overall Study|Unsatisfactory therapeutic response|1
7755622|NCT00778921|12194514|FG000|Overall Study|Patient No Longer Requires Study Drug|0
7755623|NCT00778921|12194515|FG001|Overall Study|Patient No Longer Requires Study Drug|1
7755624|NCT00778921|12194516|FG002|Overall Study|Patient No Longer Requires Study Drug|0
7755625|NCT00778921|12194514|FG000|Overall Study|Patient withdrew request|3
7755626|NCT00778921|12194515|FG001|Overall Study|Patient withdrew request|1
7755627|NCT00778921|12194516|FG002|Overall Study|Patient withdrew request|6
7755628|NCT00778921|12194514|FG000|Overall Study|Lost to Follow-up|0
7755629|NCT00778921|12194515|FG001|Overall Study|Lost to Follow-up|2
7755630|NCT00778921|12194516|FG002|Overall Study|Lost to Follow-up|1
7755631|NCT00778921|12194514|FG000|Overall Study|Administrative Problems|1
7755632|NCT00778921|12194515|FG001|Overall Study|Administrative Problems|2
7755633|NCT00778921|12194516|FG002|Overall Study|Administrative Problems|0
7755634|NCT00778921|12194514|FG000|Overall Study|Protocol Violation|3
7755635|NCT00778921|12194515|FG001|Overall Study|Protocol Violation|0
7755636|NCT00778921|12194516|FG002|Overall Study|Protocol Violation|2
7755637|NCT00778921|12194514|FG000|Overall Study|Not treated|0
7755638|NCT00778921|12194515|FG001|Overall Study|Not treated|2
7755639|NCT00778921|12194516|FG002|Overall Study|Not treated|2
7755640|NCT00779025|12194524|FG000|Overall Study|Withdrawal by Subject|1
7755641|NCT00779142|12194537|FG000|Overall Study|Screen Failures|3
7755642|NCT00779246|12194553|FG000|Overall Study|Missing sufficient data for analysis|33
7755643|NCT00779246|12194554|FG001|Overall Study|Missing sufficient data for analysis|53
7755644|NCT00779259|12194560|FG000|Quinine Alone|Adverse Event|2
7755645|NCT00779402|12194605|FG000|Treatment Phase 1|Disease Progression|1
7755646|NCT00779402|12194606|FG001|Treatment Phase 1|Disease Progression|0
7755647|NCT00779402|12194605|FG000|Treatment Phase 1|Adverse Event|2
7755648|NCT00779402|12194606|FG001|Treatment Phase 1|Adverse Event|0
7755649|NCT00779402|12194605|FG000|Treatment Phase 1|Protocol Violation|1
7755650|NCT00779402|12194606|FG001|Treatment Phase 1|Protocol Violation|0
7755651|NCT00779402|12194605|FG000|Treatment Phase 1|Patient Refused to Continue|17
7755652|NCT00779402|12194606|FG001|Treatment Phase 1|Patient Refused to Continue|2
7755653|NCT00779402|12194605|FG000|Treatment Phase 1|Lost to Follow-up|0
7755654|NCT00779402|12194606|FG001|Treatment Phase 1|Lost to Follow-up|1
7755655|NCT00779402|12194605|FG000|Treatment Phase 1|Death|0
7755656|NCT00779402|12194606|FG001|Treatment Phase 1|Death|1
7755657|NCT00779402|12194605|FG000|Treatment Phase 1|Intercurrent Illness|1
7755658|NCT00779402|12194606|FG001|Treatment Phase 1|Intercurrent Illness|1
7755659|NCT00779402|12194605|FG000|Treatment Phase 1|Withdrawal by Subject|1
7755660|NCT00779402|12194606|FG001|Treatment Phase 1|Withdrawal by Subject|0
7755661|NCT00779402|12194605|FG000|Treatment Phase 1|Other|4
7755662|NCT00779402|12194606|FG001|Treatment Phase 1|Other|2
7755663|NCT00779402|12194605|FG000|Treatment Phase 1|Closure of Study|3
7755664|NCT00779402|12194606|FG001|Treatment Phase 1|Closure of Study|2
7755665|NCT00779402|12194605|FG000|Treatment Phase 1|Completed Protocol Visits|3
7755666|NCT00779402|12194606|FG001|Treatment Phase 1|Completed Protocol Visits|6
7755667|NCT00779402|12194605|FG000|Surveillance Phase|Protocol Violation|0
7755668|NCT00779402|12194606|FG001|Surveillance Phase|Protocol Violation|1
7755669|NCT00779402|12194605|FG000|Surveillance Phase|Patient refused to continue|22
7755670|NCT00779402|12194606|FG001|Surveillance Phase|Patient refused to continue|14
7755671|NCT00779402|12194605|FG000|Surveillance Phase|Lost to Follow-up|2
7755672|NCT00779402|12194606|FG001|Surveillance Phase|Lost to Follow-up|1
7755673|NCT00779402|12194605|FG000|Surveillance Phase|Death|0
7755674|NCT00779402|12194606|FG001|Surveillance Phase|Death|1
7755675|NCT00779402|12194605|FG000|Surveillance Phase|Intercurrent Illness|2
7755676|NCT00779402|12194606|FG001|Surveillance Phase|Intercurrent Illness|0
7755677|NCT00779402|12194605|FG000|Surveillance Phase|Other|5
7755678|NCT00779402|12194606|FG001|Surveillance Phase|Other|5
7755679|NCT00779402|12194605|FG000|Surveillance Phase|Withdrawal by Subject|4
7755680|NCT00779402|12194606|FG001|Surveillance Phase|Withdrawal by Subject|1
7755681|NCT00779402|12194605|FG000|Surveillance Phase|Closure of study|5
7755682|NCT00779402|12194606|FG001|Surveillance Phase|Closure of study|6
7755683|NCT00779402|12194605|FG000|Surveillance Phase|Completed Protocol Visits|3
7755684|NCT00779402|12194606|FG001|Surveillance Phase|Completed Protocol Visits|2
7755685|NCT00779402|12194605|FG000|Long-term Follow-up|Patient refused to continue|2
7755686|NCT00779402|12194606|FG001|Long-term Follow-up|Patient refused to continue|0
7755687|NCT00779402|12194605|FG000|Long-term Follow-up|Other|5
7755688|NCT00779402|12194606|FG001|Long-term Follow-up|Other|0
7755689|NCT00779402|12194605|FG000|Long-term Follow-up|Closure of Study|8
7755690|NCT00779402|12194606|FG001|Long-term Follow-up|Closure of Study|4
7755691|NCT00779402|12194605|FG000|Long-term Follow-up|Completed Protocol Visits|6
7755692|NCT00779402|12194606|FG001|Long-term Follow-up|Completed Protocol Visits|2
7755693|NCT00779467|12194616|FG000|Overall Study|Lack of Efficacy|11
7755694|NCT00779467|12194617|FG001|Overall Study|Lack of Efficacy|2
7755695|NCT00779467|12194618|FG002|Overall Study|Lack of Efficacy|6
7755696|NCT00779467|12194619|FG003|Overall Study|Lack of Efficacy|11
7755697|NCT00779467|12194616|FG000|Overall Study|failed inclusion criteria|3
7755698|NCT00779467|12194617|FG001|Overall Study|failed inclusion criteria|3
7755699|NCT00779467|12194618|FG002|Overall Study|failed inclusion criteria|1
7755700|NCT00779467|12194619|FG003|Overall Study|failed inclusion criteria|2
7755701|NCT00779467|12194616|FG000|Overall Study|missing data|1
7755702|NCT00779467|12194617|FG001|Overall Study|missing data|0
7755703|NCT00779467|12194618|FG002|Overall Study|missing data|1
7755704|NCT00779467|12194619|FG003|Overall Study|missing data|4
7755705|NCT00779467|12194616|FG000|Overall Study|technical issue|0
7755706|NCT00779467|12194617|FG001|Overall Study|technical issue|0
7755707|NCT00779467|12194618|FG002|Overall Study|technical issue|2
7755708|NCT00779467|12194619|FG003|Overall Study|technical issue|1
7755709|NCT00779467|12194616|FG000|Overall Study|unavailable research staff|0
7755710|NCT00779467|12194617|FG001|Overall Study|unavailable research staff|0
7755711|NCT00779467|12194618|FG002|Overall Study|unavailable research staff|0
7755712|NCT00779467|12194619|FG003|Overall Study|unavailable research staff|1
7755713|NCT00779506|12194629|FG000|Overall Study|Screening Failed|2
7755714|NCT00779506|12194629|FG000|Overall Study|Adverse Event|4
7755715|NCT00779506|12194629|FG000|Overall Study|Lack of Efficacy|11
7755716|NCT00779506|12194629|FG000|Overall Study|Protocol Violation|5
7755717|NCT00779506|12194629|FG000|Overall Study|Withdrawal by Subject|6
7755718|NCT00779506|12194629|FG000|Overall Study|Lost to Follow-up|1
7755719|NCT00779584|12194651|FG000|Overall Study|Protocol Violation|0
7755720|NCT00779584|12194652|FG001|Overall Study|Protocol Violation|0
7755721|NCT00779584|12194653|FG002|Overall Study|Protocol Violation|0
7755722|NCT00779584|12194654|FG003|Overall Study|Protocol Violation|0
7755723|NCT00779584|12194655|FG004|Overall Study|Protocol Violation|0
7755724|NCT00779584|12194656|FG005|Overall Study|Protocol Violation|1
7755725|NCT00779584|12194657|FG006|Overall Study|Protocol Violation|0
7755726|NCT00779584|12194658|FG007|Overall Study|Protocol Violation|0
7755727|NCT00779584|12194659|FG008|Overall Study|Protocol Violation|0
7755728|NCT00779584|12194651|FG000|Overall Study|Withdrawal by Subject|1
7755729|NCT00779584|12194652|FG001|Overall Study|Withdrawal by Subject|1
7755730|NCT00779584|12194653|FG002|Overall Study|Withdrawal by Subject|2
7755731|NCT00779584|12194654|FG003|Overall Study|Withdrawal by Subject|0
7755732|NCT00779584|12194655|FG004|Overall Study|Withdrawal by Subject|0
7755733|NCT00779584|12194656|FG005|Overall Study|Withdrawal by Subject|2
7755734|NCT00779584|12194657|FG006|Overall Study|Withdrawal by Subject|1
7755735|NCT00779584|12194658|FG007|Overall Study|Withdrawal by Subject|0
7755736|NCT00779584|12194659|FG008|Overall Study|Withdrawal by Subject|0
7755737|NCT00779584|12194651|FG000|Overall Study|Lost to Follow-up|0
7755738|NCT00779584|12194652|FG001|Overall Study|Lost to Follow-up|0
7755739|NCT00779584|12194653|FG002|Overall Study|Lost to Follow-up|0
7755740|NCT00779584|12194654|FG003|Overall Study|Lost to Follow-up|0
7755741|NCT00779584|12194655|FG004|Overall Study|Lost to Follow-up|1
7755742|NCT00779584|12194656|FG005|Overall Study|Lost to Follow-up|0
7755743|NCT00779584|12194657|FG006|Overall Study|Lost to Follow-up|0
7755744|NCT00779584|12194658|FG007|Overall Study|Lost to Follow-up|0
7755745|NCT00779584|12194659|FG008|Overall Study|Lost to Follow-up|0
7755746|NCT00779584|12194651|FG000|Overall Study|Progression of Disease|0
7755747|NCT00779584|12194652|FG001|Overall Study|Progression of Disease|1
7755748|NCT00779584|12194653|FG002|Overall Study|Progression of Disease|2
7755749|NCT00779584|12194654|FG003|Overall Study|Progression of Disease|6
7755750|NCT00779584|12194655|FG004|Overall Study|Progression of Disease|5
7755751|NCT00779584|12194656|FG005|Overall Study|Progression of Disease|1
7755752|NCT00779584|12194657|FG006|Overall Study|Progression of Disease|4
7755753|NCT00779584|12194658|FG007|Overall Study|Progression of Disease|2
7755754|NCT00779584|12194659|FG008|Overall Study|Progression of Disease|1
7755755|NCT00779584|12194651|FG000|Overall Study|Adverse Event|1
7755756|NCT00779584|12194652|FG001|Overall Study|Adverse Event|0
7755757|NCT00779584|12194653|FG002|Overall Study|Adverse Event|2
7755758|NCT00779584|12194654|FG003|Overall Study|Adverse Event|0
7755759|NCT00779584|12194655|FG004|Overall Study|Adverse Event|0
7755760|NCT00779584|12194656|FG005|Overall Study|Adverse Event|0
7755761|NCT00779584|12194657|FG006|Overall Study|Adverse Event|2
7755762|NCT00779584|12194658|FG007|Overall Study|Adverse Event|1
7624462|NCT02487095|12035577|FG001|Dose Expansion|Unable to scan/restage participant|0
7624463|NCT02487095|12035578|FG002|Dose Expansion|Unable to scan/restage participant|0
7755763|NCT00779584|12194659|FG008|Overall Study|Adverse Event|1
7755764|NCT00779584|12194651|FG000|Overall Study|Symptomatic Deterioration|1
7755765|NCT00779584|12194652|FG001|Overall Study|Symptomatic Deterioration|1
7755766|NCT00779584|12194653|FG002|Overall Study|Symptomatic Deterioration|1
7755767|NCT00779584|12194654|FG003|Overall Study|Symptomatic Deterioration|0
7755768|NCT00779584|12194655|FG004|Overall Study|Symptomatic Deterioration|0
7755769|NCT00779584|12194656|FG005|Overall Study|Symptomatic Deterioration|1
7755770|NCT00779584|12194657|FG006|Overall Study|Symptomatic Deterioration|1
7755771|NCT00779584|12194658|FG007|Overall Study|Symptomatic Deterioration|0
7624464|NCT02487095|12035579|FG003|Dose Expansion|Unable to scan/restage participant|0
7624465|NCT02487095|12035580|FG004|Dose Expansion|Unable to scan/restage participant|1
7624466|NCT02335658|12035627|FG000|Overall Study|Adverse Event|18
7624467|NCT02335658|12035628|FG001|Overall Study|Adverse Event|12
7624468|NCT02335658|12035627|FG000|Overall Study|Lack of Efficacy|4
7624469|NCT02335658|12035628|FG001|Overall Study|Lack of Efficacy|5
7624470|NCT02335658|12035627|FG000|Overall Study|Pregnancy|1
7624471|NCT02335658|12035628|FG001|Overall Study|Pregnancy|0
7624472|NCT02335658|12035627|FG000|Overall Study|Withdrawal by Subject|13
7624473|NCT02335658|12035628|FG001|Overall Study|Withdrawal by Subject|21
7624474|NCT02335658|12035627|FG000|Overall Study|non-compliance|2
7624475|NCT02335658|12035628|FG001|Overall Study|non-compliance|3
7624476|NCT02335658|12035627|FG000|Overall Study|other reason|2
7624477|NCT02335658|12035628|FG001|Overall Study|other reason|3
7624478|NCT02287584|12035639|FG000|the Double-blind Phase|Adverse Event|17
7624479|NCT02287584|12035640|FG001|the Double-blind Phase|Adverse Event|17
7624480|NCT02287584|12035641|FG002|the Double-blind Phase|Adverse Event|12
7624481|NCT02287584|12035642|FG003|the Double-blind Phase|Adverse Event|0
7755772|NCT00779584|12194659|FG008|Overall Study|Symptomatic Deterioration|0
7755773|NCT00779584|12194651|FG000|Overall Study|Ongoing in Study|0
7755774|NCT00779584|12194652|FG001|Overall Study|Ongoing in Study|0
7755775|NCT00779584|12194653|FG002|Overall Study|Ongoing in Study|0
7755776|NCT00779584|12194654|FG003|Overall Study|Ongoing in Study|0
7755777|NCT00779584|12194655|FG004|Overall Study|Ongoing in Study|1
7755778|NCT00779584|12194656|FG005|Overall Study|Ongoing in Study|1
7755779|NCT00779584|12194657|FG006|Overall Study|Ongoing in Study|0
7755780|NCT00779584|12194658|FG007|Overall Study|Ongoing in Study|0
7755781|NCT00779584|12194659|FG008|Overall Study|Ongoing in Study|0
7755782|NCT00779675|12194679|FG000|Treatment Period|Adverse Event|87
7755783|NCT00779675|12194679|FG000|Treatment Period|Treatment Failure|80
7755784|NCT00779675|12194679|FG000|Treatment Period|Transferred to Another Study|38
7755785|NCT00779675|12194679|FG000|Treatment Period|Lost to Follow-up|23
7755786|NCT00779675|12194679|FG000|Treatment Period|Withdrawal by Subject|46
7755787|NCT00779675|12194679|FG000|Treatment Period|Protocol Violation|54
7755788|NCT00779675|12194679|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1
7755789|NCT00779675|12194679|FG000|Treatment Period|Administrative|3
7755790|NCT00779675|12194679|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9
7755791|NCT00779675|12194679|FG000|Extended Treatment Period|Protocol Violation|13
7755792|NCT00779675|12194679|FG000|Extended Treatment Period|Adverse Event|6
7755793|NCT00779675|12194679|FG000|Extended Treatment Period|Treatment Failure|11
7755794|NCT00779675|12194679|FG000|Extended Treatment Period|Protocol defined clinical event|1
7755795|NCT00779675|12194679|FG000|Extended Treatment Period|Lost to Follow-up|6
7755796|NCT00779766|12194693|FG000|Month 24|Serious Adverse Event|2
7755797|NCT00779766|12194694|FG001|Month 24|Serious Adverse Event|3
7755798|NCT00779766|12194693|FG000|Month 24|Adverse Event|3
7755799|NCT00779766|12194694|FG001|Month 24|Adverse Event|3
7755800|NCT00779766|12194693|FG000|Month 24|Protocol Violation|3
7755801|NCT00779766|12194694|FG001|Month 24|Protocol Violation|1
7755802|NCT00779766|12194693|FG000|Month 24|Withdrawal by Subject|159
7755803|NCT00779766|12194694|FG001|Month 24|Withdrawal by Subject|127
7755804|NCT00779766|12194693|FG000|Month 24|Migrated/moved from study area|138
7755805|NCT00779766|12194694|FG001|Month 24|Migrated/moved from study area|162
7755806|NCT00779766|12194693|FG000|Month 24|Lost to Follow-up|9
7755807|NCT00779766|12194694|FG001|Month 24|Lost to Follow-up|9
7755808|NCT00779766|12194693|FG000|Month 24|Other|18
7755809|NCT00779766|12194694|FG001|Month 24|Other|27
7755810|NCT00779766|12194693|FG000|Month 48|Withdrawal by Subject|68
7755811|NCT00779766|12194694|FG001|Month 48|Withdrawal by Subject|63
7755812|NCT00779766|12194693|FG000|Month 48|Migrated/moved from study area|76
7755813|NCT00779766|12194694|FG001|Month 48|Migrated/moved from study area|75
7755814|NCT00779766|12194693|FG000|Month 48|Lost to Follow-up|29
7755815|NCT00779766|12194694|FG001|Month 48|Lost to Follow-up|30
7755816|NCT00779766|12194693|FG000|Month 48|Other|1
7755817|NCT00779766|12194694|FG001|Month 48|Other|0
7755818|NCT00779766|12194693|FG000|Month 72|Withdrawal by Subject|55
7755819|NCT00779766|12194694|FG001|Month 72|Withdrawal by Subject|71
7755820|NCT00779766|12194693|FG000|Month 72|Migrated/moved from study area|124
7755821|NCT00779766|12194694|FG001|Month 72|Migrated/moved from study area|109
7755822|NCT00779766|12194693|FG000|Month 72|Lost to Follow-up|6
7755823|NCT00779766|12194694|FG001|Month 72|Lost to Follow-up|8
7755824|NCT00779766|12194693|FG000|Month 72|Other|0
7755825|NCT00779766|12194694|FG001|Month 72|Other|1
7755826|NCT00779779|12194701|FG000|Overall Study|Adverse Event|1
7755827|NCT00779779|12194701|FG000|Overall Study|Protocol Violation|14
7755828|NCT00779779|12194701|FG000|Overall Study|Withdrawal by Subject|4
7755829|NCT00779779|12194701|FG000|Overall Study|Lost to Follow-up|5
7755830|NCT00779857|12194705|FG000|Overall Study|Death|1
7755831|NCT00779857|12194705|FG000|Overall Study|Withdrawal by Subject|3
7755832|NCT00779857|12194705|FG000|Overall Study|Missed Visit|2
7755833|NCT00779909|12194726|FG000|Overall Study|Lost to Follow-up|1
7755834|NCT00779909|12194727|FG001|Overall Study|Lost to Follow-up|0
7755835|NCT00779909|12194728|FG002|Overall Study|Lost to Follow-up|0
7755836|NCT00779909|12194729|FG003|Overall Study|Lost to Follow-up|1
7755837|NCT00779909|12194726|FG000|Overall Study|Withdrawal by Subject|0
7755838|NCT00779909|12194727|FG001|Overall Study|Withdrawal by Subject|1
7755839|NCT00779909|12194728|FG002|Overall Study|Withdrawal by Subject|0
7755840|NCT00779909|12194729|FG003|Overall Study|Withdrawal by Subject|0
7755841|NCT00780143|12194755|FG000|Overall Study|Progressive disease|1
7755842|NCT00780143|12194755|FG000|Overall Study|Toxicity|1
7755843|NCT00780143|12194755|FG000|Overall Study|Adverse Event|1
7755844|NCT00780273|12194772|FG000|Overall Study|Death|1
7755845|NCT00780273|12194772|FG000|Overall Study|Lost to Follow-up|1
7755846|NCT00780416|12194792|FG000|Overall Study|Physician Decision|3
7755847|NCT00780416|12194793|FG001|Overall Study|Physician Decision|3
7755848|NCT00780416|12194792|FG000|Overall Study|Protocol Violation|1
7755849|NCT00780416|12194793|FG001|Overall Study|Protocol Violation|0
7755850|NCT00780416|12194792|FG000|Overall Study|Withdrawal by Subject|8
7755851|NCT00780416|12194793|FG001|Overall Study|Withdrawal by Subject|6
7755852|NCT00780559|12194814|FG000|Overall Study|Lost to Follow-up|2
7755853|NCT00780559|12194815|FG001|Overall Study|Lost to Follow-up|7
7755854|NCT00780559|12194814|FG000|Overall Study|Death|1
7755855|NCT00780559|12194815|FG001|Overall Study|Death|0
7755856|NCT00780910|12194874|FG000|Overall Study|Adverse Event|2
7755857|NCT00780975|12194887|FG000|Overall Study|Progressive disease|3
7755858|NCT00780975|12194887|FG000|Overall Study|Toxicity|5
7755859|NCT00781274|12194900|FG000|Overall Study|Withdrawal by Subject|2
7755860|NCT00781326|12194904|FG000|Phase I|Adverse Event|1
7755861|NCT00781326|12194904|FG000|Phase I|Withdrawal by Subject|1
7755862|NCT00781326|12194904|FG000|Phase I|Physician Decision|2
7755863|NCT00781365|12194910|FG000|Overall Study|Withdrawal by Subject|13
7755864|NCT00781365|12194911|FG001|Overall Study|Withdrawal by Subject|8
7755865|NCT00781365|12194910|FG000|Overall Study|Did Not Attend Visit|20
7755866|NCT00781365|12194911|FG001|Overall Study|Did Not Attend Visit|28
7755867|NCT00781365|12194910|FG000|Overall Study|Language barrier|1
7755868|NCT00781365|12194911|FG001|Overall Study|Language barrier|0
7755869|NCT00781391|12194920|FG000|Overall Study|never received study drug|24
7755870|NCT00781391|12194921|FG001|Overall Study|never received study drug|23
7755871|NCT00781391|12194922|FG002|Overall Study|never received study drug|32
7755872|NCT00781391|12194920|FG000|Overall Study|Protocol Violation|19
7755873|NCT00781391|12194921|FG001|Overall Study|Protocol Violation|17
7755874|NCT00781391|12194922|FG002|Overall Study|Protocol Violation|20
7755875|NCT00781391|12194920|FG000|Overall Study|Death|789
7755876|NCT00781391|12194921|FG001|Overall Study|Death|730
7755877|NCT00781391|12194922|FG002|Overall Study|Death|706
7755878|NCT00781391|12194920|FG000|Overall Study|Withdrawal by Subject|47
7755879|NCT00781391|12194921|FG001|Overall Study|Withdrawal by Subject|37
7755880|NCT00781391|12194922|FG002|Overall Study|Withdrawal by Subject|25
7755881|NCT00781391|12194920|FG000|Overall Study|Lost to Follow-up|0
7755882|NCT00781391|12194921|FG001|Overall Study|Lost to Follow-up|0
7755883|NCT00781391|12194922|FG002|Overall Study|Lost to Follow-up|1
7755884|NCT00781456|12194932|FG000|Overall Study|Adverse Event|3
7755885|NCT00781456|12194933|FG001|Overall Study|Adverse Event|3
7755886|NCT00781456|12194932|FG000|Overall Study|Withdrawal by Subject|3
7755887|NCT00781456|12194933|FG001|Overall Study|Withdrawal by Subject|5
7755888|NCT00781456|12194932|FG000|Overall Study|Protocol Violation|4
7755889|NCT00781456|12194933|FG001|Overall Study|Protocol Violation|1
7755890|NCT00781456|12194932|FG000|Overall Study|Noncompliance With Protocol|1
7755891|NCT00781456|12194933|FG001|Overall Study|Noncompliance With Protocol|1
7755892|NCT00781456|12194932|FG000|Overall Study|Lost to Follow-up|10
7755893|NCT00781456|12194933|FG001|Overall Study|Lost to Follow-up|5
7755894|NCT00781456|12194932|FG000|Overall Study|Other Reason, Unknown|0
7755895|NCT00781456|12194933|FG001|Overall Study|Other Reason, Unknown|1
7755896|NCT00781599|12194952|FG000|Overall Study|Lost to Follow-up|7
7755897|NCT00781599|12194953|FG001|Overall Study|Lost to Follow-up|4
7755898|NCT00781768|12194961|FG000|Overall Study|Not transplanted.|0
7755899|NCT00781768|12194962|FG001|Overall Study|Not transplanted.|2
7755900|NCT00781859|12194970|FG000|Overall Study|Adverse Event|2
7755901|NCT00781859|12194971|FG001|Overall Study|Adverse Event|2
7755902|NCT00781859|12194970|FG000|Overall Study|Withdrawal by Subject|8
7755903|NCT00781859|12194971|FG001|Overall Study|Withdrawal by Subject|4
7755904|NCT00781859|12194970|FG000|Overall Study|Lost to Follow-up|6
7755905|NCT00781859|12194971|FG001|Overall Study|Lost to Follow-up|3
7755906|NCT00781859|12194970|FG000|Overall Study|Death|3
7755907|NCT00781859|12194971|FG001|Overall Study|Death|0
7755908|NCT00781885|12194977|FG000|Overall Study|Physician Decision|1
7755909|NCT00781911|12194992|FG000|Overall Study|Adverse Event|4
7755910|NCT00781911|12194993|FG001|Overall Study|Adverse Event|4
7755911|NCT00781911|12194992|FG000|Overall Study|Withdrawal by Subject|1
7755912|NCT00781911|12194993|FG001|Overall Study|Withdrawal by Subject|2
7755913|NCT00781911|12194992|FG000|Overall Study|Physician Decision|0
7755914|NCT00781911|12194993|FG001|Overall Study|Physician Decision|2
7755915|NCT00781911|12194992|FG000|Overall Study|Sponsor Decision|1
7755916|NCT00781911|12194993|FG001|Overall Study|Sponsor Decision|0
7755917|NCT00781937|12195003|FG000|Main Trial Period Through Week 56|Adverse Event|18
7755918|NCT00781937|12195004|FG001|Main Trial Period Through Week 56|Adverse Event|18
7755919|NCT00781937|12195003|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0
7755920|NCT00781937|12195004|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2
7755921|NCT00781937|12195003|FG000|Main Trial Period Through Week 56|Protocol Violation|8
7755922|NCT00781937|12195004|FG001|Main Trial Period Through Week 56|Protocol Violation|5
7755923|NCT00781937|12195003|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17
7755924|NCT00781937|12195004|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24
7755925|NCT00781937|12195003|FG000|Main Trial Period Through Week 56|Unclassified|10
7755926|NCT00781937|12195004|FG001|Main Trial Period Through Week 56|Unclassified|15
7755927|NCT00781937|12195003|FG000|Follow up Period (Week 56-68)|Protocol Violation|1
7755928|NCT00781937|12195004|FG001|Follow up Period (Week 56-68)|Protocol Violation|1
7755929|NCT00781937|12195003|FG000|Follow up Period (Week 56-68)|Unclassified|5
7755930|NCT00781937|12195004|FG001|Follow up Period (Week 56-68)|Unclassified|4
7755931|NCT00781963|12195022|FG000|Overall Study|Death|3
7755932|NCT00781963|12195023|FG001|Overall Study|Death|0
7755933|NCT00781963|12195022|FG000|Overall Study|Lost to Follow-up|2
7755934|NCT00781963|12195023|FG001|Overall Study|Lost to Follow-up|1
7755935|NCT00781963|12195022|FG000|Overall Study|Withdrawal by Subject|3
7755936|NCT00781963|12195023|FG001|Overall Study|Withdrawal by Subject|1
7755937|NCT00781963|12195022|FG000|Overall Study|Refused follow-up|9
7755938|NCT00781963|12195023|FG001|Overall Study|Refused follow-up|0
7755939|NCT00782067|12195029|FG000|Overall Study|Adverse Event|35
7755940|NCT00782067|12195029|FG000|Overall Study|Subject withdrew consent|11
7755941|NCT00782067|12195029|FG000|Overall Study|Lost to Follow-up|2
7755942|NCT00782067|12195029|FG000|Overall Study|Administrative problems|14
7755943|NCT00782067|12195029|FG000|Overall Study|Death|9
7755944|NCT00782067|12195029|FG000|Overall Study|Disease progression|43
7755945|NCT00782067|12195029|FG000|Overall Study|Protocol deviation|2
7755946|NCT00782171|12195035|FG000|Overall Study|Lost to Follow-up|2
7755947|NCT00782171|12195036|FG001|Overall Study|Lost to Follow-up|2
7755948|NCT00782171|12195035|FG000|Overall Study|Withdrawal by Subject|2
7755949|NCT00782171|12195036|FG001|Overall Study|Withdrawal by Subject|1
7755950|NCT00782171|12195035|FG000|Overall Study|complications|3
7755951|NCT00782171|12195036|FG001|Overall Study|complications|1
7755952|NCT00782171|12195035|FG000|Overall Study|others|7
7755953|NCT00782171|12195036|FG001|Overall Study|others|9
7755954|NCT00782171|12195035|FG000|Overall Study|not eligible|8
7755955|NCT00782171|12195036|FG001|Overall Study|not eligible|6
7755956|NCT00782210|12195045|FG000|Overall Study|Adverse Event|21
7755957|NCT00782210|12195046|FG001|Overall Study|Adverse Event|17
7755958|NCT00782210|12195047|FG002|Overall Study|Adverse Event|16
7755959|NCT00782210|12195045|FG000|Overall Study|Lost to Follow-up|2
7755960|NCT00782210|12195046|FG001|Overall Study|Lost to Follow-up|1
7755961|NCT00782210|12195047|FG002|Overall Study|Lost to Follow-up|2
7755962|NCT00782210|12195045|FG000|Overall Study|Withdrawal by Subject|11
7755963|NCT00782210|12195046|FG001|Overall Study|Withdrawal by Subject|8
7755964|NCT00782210|12195047|FG002|Overall Study|Withdrawal by Subject|11
7755965|NCT00782210|12195045|FG000|Overall Study|Non compliance with protocol|0
7755966|NCT00782210|12195046|FG001|Overall Study|Non compliance with protocol|3
7755967|NCT00782210|12195047|FG002|Overall Study|Non compliance with protocol|2
7755968|NCT00782210|12195045|FG000|Overall Study|Lack of Efficacy|13
7755969|NCT00782210|12195046|FG001|Overall Study|Lack of Efficacy|4
7755970|NCT00782210|12195047|FG002|Overall Study|Lack of Efficacy|1
7755971|NCT00782210|12195045|FG000|Overall Study|Other reason not described above|3
7755972|NCT00782210|12195046|FG001|Overall Study|Other reason not described above|2
7755973|NCT00782210|12195047|FG002|Overall Study|Other reason not described above|3
7755974|NCT00782275|12195064|FG000|Overall Study|Adverse Event|11
7755975|NCT00782275|12195064|FG000|Overall Study|Withdrawal by Subject|1
7755976|NCT00782275|12195064|FG000|Overall Study|Progressive Disease|21
7755977|NCT00782275|12195064|FG000|Overall Study|Physician Decision|4
7755978|NCT00782275|12195064|FG000|Overall Study|Not started treatment|1
7755979|NCT00782275|12195064|FG000|Overall Study|Other|3
7755980|NCT00782340|12195071|FG000|Open Label Titration|Adverse Event|12
7755981|NCT00782340|12195072|FG001|Open Label Titration|Adverse Event|0
7755982|NCT00782340|12195073|FG002|Open Label Titration|Adverse Event|0
7755983|NCT00782340|12195071|FG000|Open Label Titration|Treatment failure|50
7755984|NCT00782340|12195072|FG001|Open Label Titration|Treatment failure|0
7755985|NCT00782340|12195073|FG002|Open Label Titration|Treatment failure|0
7755986|NCT00782340|12195071|FG000|Open Label Titration|Protocol Violation|5
7755987|NCT00782340|12195072|FG001|Open Label Titration|Protocol Violation|0
7755988|NCT00782340|12195073|FG002|Open Label Titration|Protocol Violation|0
7755989|NCT00782340|12195071|FG000|Open Label Titration|Withdrawal by Subject|5
7755990|NCT00782340|12195072|FG001|Open Label Titration|Withdrawal by Subject|0
7755991|NCT00782340|12195073|FG002|Open Label Titration|Withdrawal by Subject|0
7755992|NCT00782340|12195071|FG000|Open Label Titration|Enrollment capped|16
7755993|NCT00782340|12195072|FG001|Open Label Titration|Enrollment capped|0
7755994|NCT00782340|12195073|FG002|Open Label Titration|Enrollment capped|0
7755995|NCT00782340|12195071|FG000|Open Label Titration|Did not meet responder criteria|2
7755996|NCT00782340|12195072|FG001|Open Label Titration|Did not meet responder criteria|0
7755997|NCT00782340|12195073|FG002|Open Label Titration|Did not meet responder criteria|0
7755998|NCT00782340|12195071|FG000|Open Label Titration|Lost to Follow-up|5
7755999|NCT00782340|12195072|FG001|Open Label Titration|Lost to Follow-up|0
7756000|NCT00782340|12195073|FG002|Open Label Titration|Lost to Follow-up|0
7756001|NCT00782340|12195071|FG000|Open Label Titration|Randomized in error|6
7756002|NCT00782340|12195072|FG001|Open Label Titration|Randomized in error|0
7756003|NCT00782340|12195073|FG002|Open Label Titration|Randomized in error|0
7756004|NCT00782418|12195084|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1
7756005|NCT00782418|12195085|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0
7756006|NCT00782418|12195086|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0
7756007|NCT00782418|12195087|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0
7756008|NCT00782418|12195088|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0
7756009|NCT00782418|12195089|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0
7756010|NCT00782418|12195090|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0
7756011|NCT00782418|12195084|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
7756012|NCT00782418|12195085|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
7756013|NCT00782418|12195086|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
7756014|NCT00782418|12195087|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
7756015|NCT00782418|12195088|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
7756016|NCT00782418|12195089|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
7756017|NCT00782418|12195090|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
7756018|NCT00782496|12195106|FG000|Overall Study|Lost to Follow-up|14
7756019|NCT00782496|12195107|FG001|Overall Study|Lost to Follow-up|15
7756020|NCT00782509|12195117|FG000|Overall Study|Adverse Event|20
7756021|NCT00782509|12195118|FG001|Overall Study|Adverse Event|10
7756022|NCT00782509|12195119|FG002|Overall Study|Adverse Event|20
7756023|NCT00782509|12195117|FG000|Overall Study|Lost to Follow-up|1
7756024|NCT00782509|12195118|FG001|Overall Study|Lost to Follow-up|2
7756025|NCT00782509|12195119|FG002|Overall Study|Lost to Follow-up|3
7756026|NCT00782509|12195117|FG000|Overall Study|Withdrawal by Subject|3
7756027|NCT00782509|12195118|FG001|Overall Study|Withdrawal by Subject|5
7756028|NCT00782509|12195119|FG002|Overall Study|Withdrawal by Subject|8
7756029|NCT00782509|12195117|FG000|Overall Study|Non compliance with protocol|2
7756030|NCT00782509|12195118|FG001|Overall Study|Non compliance with protocol|0
7756031|NCT00782509|12195119|FG002|Overall Study|Non compliance with protocol|0
7756032|NCT00782509|12195117|FG000|Overall Study|Other reasons not stated above|5
7756033|NCT00782509|12195118|FG001|Overall Study|Other reasons not stated above|2
7756034|NCT00782509|12195119|FG002|Overall Study|Other reasons not stated above|3
7756035|NCT00782509|12195117|FG000|Overall Study|Lack of Efficacy|10
7756036|NCT00782509|12195118|FG001|Overall Study|Lack of Efficacy|5
7756037|NCT00782509|12195119|FG002|Overall Study|Lack of Efficacy|2
7756038|NCT00782626|12195134|FG000|Overall Study|Adverse Event|1
7756039|NCT00782626|12195134|FG000|Overall Study|Progressive Disease|5
7756040|NCT00782626|12195134|FG000|Overall Study|Other Complicating Disease|1
7769780|NCT00871403|12213510|FG001|Combination Treatment Phase|Disease Progression|8
7769781|NCT00871403|12213511|FG002|Combination Treatment Phase|Disease Progression|5
7769782|NCT00871403|12213509|FG000|Combination Treatment Phase|Withdrawal by Subject|0
7769783|NCT00871403|12213510|FG001|Combination Treatment Phase|Withdrawal by Subject|3
7769784|NCT00871403|12213511|FG002|Combination Treatment Phase|Withdrawal by Subject|1
7769785|NCT00871403|12213509|FG000|Combination Treatment Phase|Physician Decision|0
7769786|NCT00871403|12213510|FG001|Combination Treatment Phase|Physician Decision|1
7769787|NCT00871403|12213511|FG002|Combination Treatment Phase|Physician Decision|3
7769788|NCT00871403|12213509|FG000|Monotherapy Treatment Phase|Disease Progression|0
7769789|NCT00871403|12213510|FG001|Monotherapy Treatment Phase|Disease Progression|9
7769790|NCT00871403|12213511|FG002|Monotherapy Treatment Phase|Disease Progression|1
7769791|NCT00871403|12213509|FG000|Monotherapy Treatment Phase|Adverse Event|0
7769792|NCT00871403|12213510|FG001|Monotherapy Treatment Phase|Adverse Event|4
7769793|NCT00871403|12213511|FG002|Monotherapy Treatment Phase|Adverse Event|0
7769794|NCT00871429|12213518|FG000|Overall Study|Lost to Follow-up|6
7769795|NCT00871429|12213518|FG000|Overall Study|Withdrawal by Subject|17
7769796|NCT00871429|12213518|FG000|Overall Study|Questionnaire not completed|1
7769797|NCT00871494|12213526|FG000|Overall Study|Protocol Violation|5
7769798|NCT00871494|12213526|FG000|Overall Study|Lack of Efficacy|4
7769799|NCT00871494|12213526|FG000|Overall Study|Adverse Event|4
7756041|NCT00782717|12195151|FG000|Overall Study|Adverse Event|2
7756042|NCT00782717|12195152|FG001|Overall Study|Adverse Event|5
7756043|NCT00782717|12195151|FG000|Overall Study|Patient decision unrelated to AE|6
7756044|NCT00782717|12195152|FG001|Overall Study|Patient decision unrelated to AE|3
7756045|NCT00782717|12195151|FG000|Overall Study|Noncompliance|2
7756046|NCT00782717|12195152|FG001|Overall Study|Noncompliance|1
7756047|NCT00782717|12195151|FG000|Overall Study|Treatment failure|3
7756048|NCT00782717|12195152|FG001|Overall Study|Treatment failure|14
7756049|NCT00782717|12195151|FG000|Overall Study|Enrollment close prior to surgery|1
7756050|NCT00782717|12195152|FG001|Overall Study|Enrollment close prior to surgery|0
7756051|NCT00782717|12195151|FG000|Overall Study|Did not meet entrance criteria|1
7756052|NCT00782717|12195152|FG001|Overall Study|Did not meet entrance criteria|3
7756053|NCT00782717|12195151|FG000|Overall Study|Exited in error|0
7756054|NCT00782717|12195152|FG001|Overall Study|Exited in error|2
7756055|NCT00782795|12195164|FG000|Overall Study|Withdrawal by Subject|1
7756056|NCT00782795|12195165|FG001|Overall Study|Withdrawal by Subject|2
7756057|NCT00782834|12195195|FG000|Treatment Phase|fibrous tumor not GIST|1
7756058|NCT00783094|12195202|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4
7756059|NCT00783094|12195203|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5
7756060|NCT00783094|12195204|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5
7756061|NCT00783094|12195202|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
7756062|NCT00783094|12195203|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
7756063|NCT00783094|12195204|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
7756064|NCT00783094|12195202|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0
7756065|NCT00783094|12195203|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2
7756066|NCT00783094|12195204|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0
7756067|NCT00783094|12195202|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1
7756068|NCT00783094|12195203|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2
7756069|NCT00783094|12195204|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1
7756070|NCT00783094|12195202|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
7756071|NCT00783094|12195203|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
7756072|NCT00783094|12195204|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
7756073|NCT00783094|12195202|FG000|Open-Label Extension Period|Adverse Event|12
7756074|NCT00783094|12195203|FG001|Open-Label Extension Period|Adverse Event|7
7756075|NCT00783094|12195204|FG002|Open-Label Extension Period|Adverse Event|16
7756076|NCT00783094|12195202|FG000|Open-Label Extension Period|Death|0
7756077|NCT00783094|12195203|FG001|Open-Label Extension Period|Death|0
7756078|NCT00783094|12195204|FG002|Open-Label Extension Period|Death|1
7756079|NCT00783094|12195202|FG000|Open-Label Extension Period|Protocol Violation|4
7756080|NCT00783094|12195203|FG001|Open-Label Extension Period|Protocol Violation|5
7756081|NCT00783094|12195204|FG002|Open-Label Extension Period|Protocol Violation|7
7756082|NCT00783094|12195202|FG000|Open-Label Extension Period|Withdrawal by Subject|1
7756083|NCT00783094|12195203|FG001|Open-Label Extension Period|Withdrawal by Subject|1
7756084|NCT00783094|12195204|FG002|Open-Label Extension Period|Withdrawal by Subject|3
7756085|NCT00783094|12195202|FG000|Open-Label Extension Period|Physician Decision|4
7756086|NCT00783094|12195203|FG001|Open-Label Extension Period|Physician Decision|2
7756087|NCT00783094|12195204|FG002|Open-Label Extension Period|Physician Decision|3
7756088|NCT00783094|12195202|FG000|Open-Label Extension Period|Lack of Efficacy|1
7756089|NCT00783094|12195203|FG001|Open-Label Extension Period|Lack of Efficacy|4
7756090|NCT00783094|12195204|FG002|Open-Label Extension Period|Lack of Efficacy|0
7756091|NCT00783198|12195218|FG000|Overall Study|Adverse Event|15
7756092|NCT00783198|12195219|FG001|Overall Study|Adverse Event|19
7756093|NCT00783198|12195220|FG002|Overall Study|Adverse Event|3
7756094|NCT00783198|12195218|FG000|Overall Study|Lost to Follow-up|11
7756095|NCT00783198|12195219|FG001|Overall Study|Lost to Follow-up|1
7756096|NCT00783198|12195220|FG002|Overall Study|Lost to Follow-up|7
7756097|NCT00783198|12195218|FG000|Overall Study|Withdrawal by Subject|22
7756098|NCT00783198|12195219|FG001|Overall Study|Withdrawal by Subject|14
7756099|NCT00783198|12195220|FG002|Overall Study|Withdrawal by Subject|20
7756100|NCT00783198|12195218|FG000|Overall Study|Noncompliance with protocol|7
7756101|NCT00783198|12195219|FG001|Overall Study|Noncompliance with protocol|7
7756102|NCT00783198|12195220|FG002|Overall Study|Noncompliance with protocol|10
7756103|NCT00783198|12195218|FG000|Overall Study|Did not meet protocol eligibility|0
7756104|NCT00783198|12195219|FG001|Overall Study|Did not meet protocol eligibility|1
7756105|NCT00783198|12195220|FG002|Overall Study|Did not meet protocol eligibility|0
7756106|NCT00783198|12195218|FG000|Overall Study|Administrative|2
7756107|NCT00783198|12195219|FG001|Overall Study|Administrative|1
7756108|NCT00783198|12195220|FG002|Overall Study|Administrative|2
7756109|NCT00783289|12195232|FG000|Overall Study|Protocol Violation|0
7756110|NCT00783289|12195233|FG001|Overall Study|Protocol Violation|1
7756111|NCT00783289|12195234|FG002|Overall Study|Protocol Violation|0
7756112|NCT00783289|12195235|FG003|Overall Study|Protocol Violation|0
7756113|NCT00783302|12195248|FG000|Overall Study|Lost to Follow-up|17
7756114|NCT00783302|12195248|FG000|Overall Study|Technical Problems|11
7756115|NCT00783302|12195248|FG000|Overall Study|Protocol Violation|3
7756116|NCT00783302|12195248|FG000|Overall Study|Physician Decision|1
7756117|NCT00783302|12195248|FG000|Overall Study|Withdrawal by Subject|3
7756118|NCT00783432|12195268|FG000|Overall Study|Adverse Event|22
7756119|NCT00783432|12195269|FG001|Overall Study|Adverse Event|17
7756120|NCT00783432|12195268|FG000|Overall Study|Lack of Efficacy|20
7756121|NCT00783432|12195269|FG001|Overall Study|Lack of Efficacy|21
7756122|NCT00783432|12195268|FG000|Overall Study|Lost to Follow-up|11
7756123|NCT00783432|12195269|FG001|Overall Study|Lost to Follow-up|6
7756124|NCT00783432|12195268|FG000|Overall Study|Withdrawal by Subject|23
7756125|NCT00783432|12195269|FG001|Overall Study|Withdrawal by Subject|20
7756126|NCT00783432|12195268|FG000|Overall Study|subject moved|3
7756127|NCT00783432|12195269|FG001|Overall Study|subject moved|5
7756128|NCT00783432|12195268|FG000|Overall Study|Protocol Violation|6
7756129|NCT00783432|12195269|FG001|Overall Study|Protocol Violation|9
7756130|NCT00783692|12195295|FG000|Induction Phase|Adverse Event|7
7756131|NCT00783692|12195296|FG001|Induction Phase|Adverse Event|9
7756132|NCT00783692|12195297|FG002|Induction Phase|Adverse Event|24
7756133|NCT00783692|12195298|FG003|Induction Phase|Adverse Event|0
7756134|NCT00783692|12195299|FG004|Induction Phase|Adverse Event|0
7756135|NCT00783692|12195300|FG005|Induction Phase|Adverse Event|0
7756136|NCT00783692|12195301|FG006|Induction Phase|Adverse Event|0
7756137|NCT00783692|12195295|FG000|Induction Phase|Protocol Violation|0
7756138|NCT00783692|12195296|FG001|Induction Phase|Protocol Violation|0
7756139|NCT00783692|12195297|FG002|Induction Phase|Protocol Violation|1
7756140|NCT00783692|12195298|FG003|Induction Phase|Protocol Violation|0
7756141|NCT00783692|12195299|FG004|Induction Phase|Protocol Violation|0
7756142|NCT00783692|12195300|FG005|Induction Phase|Protocol Violation|0
7756143|NCT00783692|12195301|FG006|Induction Phase|Protocol Violation|0
7756144|NCT00783692|12195295|FG000|Induction Phase|Lack of Efficacy|1
7756145|NCT00783692|12195296|FG001|Induction Phase|Lack of Efficacy|3
7756146|NCT00783692|12195297|FG002|Induction Phase|Lack of Efficacy|28
7756147|NCT00783692|12195298|FG003|Induction Phase|Lack of Efficacy|0
7756148|NCT00783692|12195299|FG004|Induction Phase|Lack of Efficacy|0
7756149|NCT00783692|12195300|FG005|Induction Phase|Lack of Efficacy|0
7756150|NCT00783692|12195301|FG006|Induction Phase|Lack of Efficacy|0
7756151|NCT00783692|12195295|FG000|Induction Phase|Withdrawal by Subject|3
7756152|NCT00783692|12195296|FG001|Induction Phase|Withdrawal by Subject|9
7756153|NCT00783692|12195297|FG002|Induction Phase|Withdrawal by Subject|16
7962450|NCT02712008|12516671|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1
7962451|NCT02712008|12516672|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0
7962452|NCT02712008|12516673|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0
7962453|NCT02712008|12516674|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0
7962454|NCT02712008|12516675|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0
7962455|NCT02712008|12516676|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0
7962456|NCT02712008|12516669|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0
7962457|NCT02712008|12516670|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1
7962458|NCT02712008|12516671|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0
7962459|NCT02712008|12516672|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0
7962460|NCT02712008|12516673|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0
7962461|NCT02712008|12516674|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0
7962462|NCT02712008|12516675|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0
7962463|NCT02712008|12516676|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0
7962464|NCT02712008|12516669|FG000|From Week 12 up to Week 36|Adverse Event|0
7962465|NCT02712008|12516670|FG001|From Week 12 up to Week 36|Adverse Event|0
7756154|NCT00783692|12195298|FG003|Induction Phase|Withdrawal by Subject|0
7756155|NCT00783692|12195299|FG004|Induction Phase|Withdrawal by Subject|0
7756156|NCT00783692|12195300|FG005|Induction Phase|Withdrawal by Subject|0
7756157|NCT00783692|12195301|FG006|Induction Phase|Withdrawal by Subject|0
7756158|NCT00783692|12195295|FG000|Induction Phase|Lost to Follow-up|0
7756159|NCT00783692|12195296|FG001|Induction Phase|Lost to Follow-up|0
7756160|NCT00783692|12195297|FG002|Induction Phase|Lost to Follow-up|3
7756161|NCT00783692|12195298|FG003|Induction Phase|Lost to Follow-up|0
7756162|NCT00783692|12195299|FG004|Induction Phase|Lost to Follow-up|0
7756163|NCT00783692|12195300|FG005|Induction Phase|Lost to Follow-up|0
7756164|NCT00783692|12195301|FG006|Induction Phase|Lost to Follow-up|0
7756165|NCT00783692|12195295|FG000|Induction Phase|Other|0
7756166|NCT00783692|12195296|FG001|Induction Phase|Other|0
7756167|NCT00783692|12195297|FG002|Induction Phase|Other|2
7756168|NCT00783692|12195298|FG003|Induction Phase|Other|0
7756169|NCT00783692|12195299|FG004|Induction Phase|Other|0
7756170|NCT00783692|12195300|FG005|Induction Phase|Other|0
7756171|NCT00783692|12195301|FG006|Induction Phase|Other|0
7756172|NCT00783692|12195295|FG000|Maintenance Phase|Adverse Event|7
7756173|NCT00783692|12195296|FG001|Maintenance Phase|Adverse Event|0
7756174|NCT00783692|12195297|FG002|Maintenance Phase|Adverse Event|0
7756175|NCT00783692|12195298|FG003|Maintenance Phase|Adverse Event|15
7756176|NCT00783692|12195299|FG004|Maintenance Phase|Adverse Event|12
7756177|NCT00783692|12195300|FG005|Maintenance Phase|Adverse Event|9
7756178|NCT00783692|12195301|FG006|Maintenance Phase|Adverse Event|38
7756179|NCT00783692|12195295|FG000|Maintenance Phase|Protocol Violation|0
7756180|NCT00783692|12195296|FG001|Maintenance Phase|Protocol Violation|0
7756181|NCT00783692|12195297|FG002|Maintenance Phase|Protocol Violation|0
7756182|NCT00783692|12195298|FG003|Maintenance Phase|Protocol Violation|1
7756183|NCT00783692|12195299|FG004|Maintenance Phase|Protocol Violation|2
7756184|NCT00783692|12195300|FG005|Maintenance Phase|Protocol Violation|3
7756185|NCT00783692|12195301|FG006|Maintenance Phase|Protocol Violation|4
7756186|NCT00783692|12195295|FG000|Maintenance Phase|Lack of Efficacy|79
7756187|NCT00783692|12195296|FG001|Maintenance Phase|Lack of Efficacy|0
7756188|NCT00783692|12195297|FG002|Maintenance Phase|Lack of Efficacy|0
7756189|NCT00783692|12195298|FG003|Maintenance Phase|Lack of Efficacy|64
7756190|NCT00783692|12195299|FG004|Maintenance Phase|Lack of Efficacy|58
7756191|NCT00783692|12195300|FG005|Maintenance Phase|Lack of Efficacy|48
7756192|NCT00783692|12195301|FG006|Maintenance Phase|Lack of Efficacy|177
7756193|NCT00783692|12195295|FG000|Maintenance Phase|Withdrawal by Subject|7
7756194|NCT00783692|12195296|FG001|Maintenance Phase|Withdrawal by Subject|0
7756195|NCT00783692|12195297|FG002|Maintenance Phase|Withdrawal by Subject|0
7756196|NCT00783692|12195298|FG003|Maintenance Phase|Withdrawal by Subject|7
7756197|NCT00783692|12195299|FG004|Maintenance Phase|Withdrawal by Subject|6
7756198|NCT00783692|12195300|FG005|Maintenance Phase|Withdrawal by Subject|9
7756199|NCT00783692|12195301|FG006|Maintenance Phase|Withdrawal by Subject|24
7756200|NCT00783692|12195295|FG000|Maintenance Phase|Lost to Follow-up|2
7756201|NCT00783692|12195296|FG001|Maintenance Phase|Lost to Follow-up|0
7756202|NCT00783692|12195297|FG002|Maintenance Phase|Lost to Follow-up|0
7756203|NCT00783692|12195298|FG003|Maintenance Phase|Lost to Follow-up|1
7756204|NCT00783692|12195299|FG004|Maintenance Phase|Lost to Follow-up|3
7756205|NCT00783692|12195300|FG005|Maintenance Phase|Lost to Follow-up|2
7756206|NCT00783692|12195301|FG006|Maintenance Phase|Lost to Follow-up|5
7756207|NCT00783692|12195295|FG000|Maintenance Phase|Other|0
7756208|NCT00783692|12195296|FG001|Maintenance Phase|Other|0
7756209|NCT00783692|12195297|FG002|Maintenance Phase|Other|0
7756210|NCT00783692|12195298|FG003|Maintenance Phase|Other|1
7756211|NCT00783692|12195299|FG004|Maintenance Phase|Other|0
7756212|NCT00783692|12195300|FG005|Maintenance Phase|Other|1
7756213|NCT00783692|12195301|FG006|Maintenance Phase|Other|1
7756214|NCT00783705|12195316|FG000|Overall Study|Adverse Event|2
7756215|NCT00783705|12195317|FG001|Overall Study|Adverse Event|0
7756216|NCT00783705|12195316|FG000|Overall Study|Withdrawal by Subject|3
7756217|NCT00783705|12195317|FG001|Overall Study|Withdrawal by Subject|2
7756218|NCT00783705|12195316|FG000|Overall Study|Lost to Follow-up|1
7756219|NCT00783705|12195317|FG001|Overall Study|Lost to Follow-up|3
7756220|NCT00783718|12195326|FG000|Induction Phase|Adverse Event|4
7756221|NCT00783718|12195327|FG001|Induction Phase|Adverse Event|0
7756222|NCT00783718|12195328|FG002|Induction Phase|Adverse Event|7
7756223|NCT00783718|12195329|FG003|Induction Phase|Adverse Event|0
7756224|NCT00783718|12195330|FG004|Induction Phase|Adverse Event|0
7756225|NCT00783718|12195331|FG005|Induction Phase|Adverse Event|0
7756226|NCT00783718|12195332|FG006|Induction Phase|Adverse Event|0
7756227|NCT00783718|12195326|FG000|Induction Phase|Protocol Violation|1
7756228|NCT00783718|12195327|FG001|Induction Phase|Protocol Violation|1
7756229|NCT00783718|12195328|FG002|Induction Phase|Protocol Violation|6
7756230|NCT00783718|12195329|FG003|Induction Phase|Protocol Violation|0
7756231|NCT00783718|12195330|FG004|Induction Phase|Protocol Violation|0
7756232|NCT00783718|12195331|FG005|Induction Phase|Protocol Violation|0
7756233|NCT00783718|12195332|FG006|Induction Phase|Protocol Violation|0
7756234|NCT00783718|12195326|FG000|Induction Phase|Lack of Efficacy|5
7756235|NCT00783718|12195327|FG001|Induction Phase|Lack of Efficacy|2
7756236|NCT00783718|12195328|FG002|Induction Phase|Lack of Efficacy|14
7756237|NCT00783718|12195329|FG003|Induction Phase|Lack of Efficacy|0
7756238|NCT00783718|12195330|FG004|Induction Phase|Lack of Efficacy|0
7756239|NCT00783718|12195331|FG005|Induction Phase|Lack of Efficacy|0
7756240|NCT00783718|12195332|FG006|Induction Phase|Lack of Efficacy|0
7756241|NCT00783718|12195326|FG000|Induction Phase|Withdrawal by Subject|3
7756242|NCT00783718|12195327|FG001|Induction Phase|Withdrawal by Subject|4
7756243|NCT00783718|12195328|FG002|Induction Phase|Withdrawal by Subject|8
7756244|NCT00783718|12195329|FG003|Induction Phase|Withdrawal by Subject|0
7756245|NCT00783718|12195330|FG004|Induction Phase|Withdrawal by Subject|0
7756246|NCT00783718|12195331|FG005|Induction Phase|Withdrawal by Subject|0
7756247|NCT00783718|12195332|FG006|Induction Phase|Withdrawal by Subject|0
7756248|NCT00783718|12195326|FG000|Induction Phase|Lost to Follow-up|1
7756249|NCT00783718|12195327|FG001|Induction Phase|Lost to Follow-up|0
7756250|NCT00783718|12195328|FG002|Induction Phase|Lost to Follow-up|1
7756251|NCT00783718|12195329|FG003|Induction Phase|Lost to Follow-up|0
7756252|NCT00783718|12195330|FG004|Induction Phase|Lost to Follow-up|0
7756253|NCT00783718|12195331|FG005|Induction Phase|Lost to Follow-up|0
7756254|NCT00783718|12195332|FG006|Induction Phase|Lost to Follow-up|0
7756255|NCT00783718|12195326|FG000|Maintenance Phase|Adverse Event|12
7756256|NCT00783718|12195327|FG001|Maintenance Phase|Adverse Event|0
7756257|NCT00783718|12195328|FG002|Maintenance Phase|Adverse Event|0
7756258|NCT00783718|12195329|FG003|Maintenance Phase|Adverse Event|15
7756259|NCT00783718|12195330|FG004|Maintenance Phase|Adverse Event|7
7756260|NCT00783718|12195331|FG005|Maintenance Phase|Adverse Event|6
7756261|NCT00783718|12195332|FG006|Maintenance Phase|Adverse Event|16
7756262|NCT00783718|12195326|FG000|Maintenance Phase|Protocol Violation|1
7756263|NCT00783718|12195327|FG001|Maintenance Phase|Protocol Violation|0
7756264|NCT00783718|12195328|FG002|Maintenance Phase|Protocol Violation|0
7756265|NCT00783718|12195329|FG003|Maintenance Phase|Protocol Violation|0
7756266|NCT00783718|12195330|FG004|Maintenance Phase|Protocol Violation|0
7756267|NCT00783718|12195331|FG005|Maintenance Phase|Protocol Violation|0
7756268|NCT00783718|12195332|FG006|Maintenance Phase|Protocol Violation|2
7756269|NCT00783718|12195326|FG000|Maintenance Phase|Lack of Efficacy|83
7756270|NCT00783718|12195327|FG001|Maintenance Phase|Lack of Efficacy|0
7756271|NCT00783718|12195328|FG002|Maintenance Phase|Lack of Efficacy|0
7756272|NCT00783718|12195329|FG003|Maintenance Phase|Lack of Efficacy|61
7756273|NCT00783718|12195330|FG004|Maintenance Phase|Lack of Efficacy|31
7756274|NCT00783718|12195331|FG005|Maintenance Phase|Lack of Efficacy|33
7756275|NCT00783718|12195332|FG006|Maintenance Phase|Lack of Efficacy|155
7756276|NCT00783718|12195326|FG000|Maintenance Phase|Withdrawal by Subject|6
7756277|NCT00783718|12195327|FG001|Maintenance Phase|Withdrawal by Subject|0
7756278|NCT00783718|12195328|FG002|Maintenance Phase|Withdrawal by Subject|0
7756279|NCT00783718|12195329|FG003|Maintenance Phase|Withdrawal by Subject|2
7756280|NCT00783718|12195330|FG004|Maintenance Phase|Withdrawal by Subject|5
7756281|NCT00783718|12195331|FG005|Maintenance Phase|Withdrawal by Subject|2
7756282|NCT00783718|12195332|FG006|Maintenance Phase|Withdrawal by Subject|20
7756283|NCT00783718|12195326|FG000|Maintenance Phase|Lost to Follow-up|3
7756284|NCT00783718|12195327|FG001|Maintenance Phase|Lost to Follow-up|0
7756285|NCT00783718|12195328|FG002|Maintenance Phase|Lost to Follow-up|0
7756286|NCT00783718|12195329|FG003|Maintenance Phase|Lost to Follow-up|0
7756287|NCT00783718|12195330|FG004|Maintenance Phase|Lost to Follow-up|2
7756288|NCT00783718|12195331|FG005|Maintenance Phase|Lost to Follow-up|0
7756289|NCT00783718|12195332|FG006|Maintenance Phase|Lost to Follow-up|2
7756290|NCT00783796|12195342|FG000|Overall Study|Did not receive any stent|4
7756291|NCT00783796|12195342|FG000|Overall Study|Received non-XIENCE V stent|1
7756292|NCT00783796|12195342|FG000|Overall Study|Received commercial XIENCE V stent|1
7756293|NCT00783835|12195348|FG000|Overall Study|Adverse Event|3
7756294|NCT00783835|12195348|FG000|Overall Study|Medical Criteria|1
7756295|NCT00783835|12195348|FG000|Overall Study|Withdrawal by Subject|2
7756296|NCT00783835|12195348|FG000|Overall Study|Lost to Follow-up|1
7756297|NCT00783835|12195348|FG000|Overall Study|Participant not Adherent|3
7756298|NCT00784134|12195393|FG000|Overall Study|Lost to Follow-up|3
7756299|NCT00784134|12195394|FG001|Overall Study|Lost to Follow-up|6
7756300|NCT00784147|12195402|FG000|Overall Study|Lost to Follow-up|2
7756301|NCT00784147|12195403|FG001|Overall Study|Lost to Follow-up|4
7756302|NCT00784147|12195402|FG000|Overall Study|Withdrawal by Subject|1
7756303|NCT00784147|12195403|FG001|Overall Study|Withdrawal by Subject|3
7756304|NCT00784147|12195402|FG000|Overall Study|Physician Decision|2
7756305|NCT00784147|12195403|FG001|Overall Study|Physician Decision|1
7756306|NCT00784147|12195402|FG000|Overall Study|Protocol Violation|1
7756307|NCT00784147|12195403|FG001|Overall Study|Protocol Violation|1
7756308|NCT00784147|12195402|FG000|Overall Study|Death|2
7756309|NCT00784147|12195403|FG001|Overall Study|Death|0
7756310|NCT00784238|12195430|FG000|Overall Study|Adverse Event|14
7756311|NCT00784238|12195430|FG000|Overall Study|Death|2
7756312|NCT00784238|12195430|FG000|Overall Study|Lack of Efficacy|33
7756313|NCT00784238|12195430|FG000|Overall Study|Lost to Follow-up|29
7756314|NCT00784238|12195430|FG000|Overall Study|Pregnancy|1
7756315|NCT00784238|12195430|FG000|Overall Study|Withdrawal by Subject|26
7756316|NCT00784238|12195430|FG000|Overall Study|Other|14
7756317|NCT00784277|12195441|FG000|IR Treatment|Adverse Event|4
7756318|NCT00784277|12195442|FG001|IR Treatment|Adverse Event|8
7756319|NCT00784277|12195443|FG002|IR Treatment|Adverse Event|19
7756320|NCT00784277|12195444|FG003|IR Treatment|Adverse Event|35
7756321|NCT00784277|12195445|FG004|IR Treatment|Adverse Event|0
7756322|NCT00784277|12195446|FG005|IR Treatment|Adverse Event|0
7756323|NCT00784277|12195447|FG006|IR Treatment|Adverse Event|0
7756324|NCT00784277|12195441|FG000|IR Treatment|Lack of Efficacy|4
7756325|NCT00784277|12195442|FG001|IR Treatment|Lack of Efficacy|4
7756326|NCT00784277|12195443|FG002|IR Treatment|Lack of Efficacy|1
7756327|NCT00784277|12195444|FG003|IR Treatment|Lack of Efficacy|0
7756328|NCT00784277|12195445|FG004|IR Treatment|Lack of Efficacy|0
7756329|NCT00784277|12195446|FG005|IR Treatment|Lack of Efficacy|0
7756330|NCT00784277|12195447|FG006|IR Treatment|Lack of Efficacy|0
7756331|NCT00784277|12195441|FG000|IR Treatment|Lost to Follow-up|1
7756332|NCT00784277|12195442|FG001|IR Treatment|Lost to Follow-up|0
7756333|NCT00784277|12195443|FG002|IR Treatment|Lost to Follow-up|1
7756334|NCT00784277|12195444|FG003|IR Treatment|Lost to Follow-up|0
7756335|NCT00784277|12195445|FG004|IR Treatment|Lost to Follow-up|0
7756336|NCT00784277|12195446|FG005|IR Treatment|Lost to Follow-up|0
7756337|NCT00784277|12195447|FG006|IR Treatment|Lost to Follow-up|0
7756338|NCT00784277|12195441|FG000|IR Treatment|Withdrawal by Subject|5
7756339|NCT00784277|12195442|FG001|IR Treatment|Withdrawal by Subject|1
7756340|NCT00784277|12195443|FG002|IR Treatment|Withdrawal by Subject|4
7756341|NCT00784277|12195444|FG003|IR Treatment|Withdrawal by Subject|6
7756342|NCT00784277|12195445|FG004|IR Treatment|Withdrawal by Subject|0
7756343|NCT00784277|12195446|FG005|IR Treatment|Withdrawal by Subject|0
7756344|NCT00784277|12195447|FG006|IR Treatment|Withdrawal by Subject|0
7756345|NCT00784277|12195441|FG000|IR Treatment|Resolution Of Pain|0
7756346|NCT00784277|12195442|FG001|IR Treatment|Resolution Of Pain|1
7756347|NCT00784277|12195443|FG002|IR Treatment|Resolution Of Pain|0
7756348|NCT00784277|12195444|FG003|IR Treatment|Resolution Of Pain|0
7756349|NCT00784277|12195445|FG004|IR Treatment|Resolution Of Pain|0
7756350|NCT00784277|12195446|FG005|IR Treatment|Resolution Of Pain|0
7756351|NCT00784277|12195447|FG006|IR Treatment|Resolution Of Pain|0
7756352|NCT00784277|12195441|FG000|IR Treatment|Other|2
7756353|NCT00784277|12195442|FG001|IR Treatment|Other|3
7756354|NCT00784277|12195443|FG002|IR Treatment|Other|3
7756355|NCT00784277|12195444|FG003|IR Treatment|Other|2
7756356|NCT00784277|12195445|FG004|IR Treatment|Other|0
7756357|NCT00784277|12195446|FG005|IR Treatment|Other|0
7756358|NCT00784277|12195447|FG006|IR Treatment|Other|0
7756359|NCT00784277|12195441|FG000|ER Treatment|Adverse Event|0
7756360|NCT00784277|12195442|FG001|ER Treatment|Adverse Event|0
7756361|NCT00784277|12195443|FG002|ER Treatment|Adverse Event|0
7756362|NCT00784277|12195444|FG003|ER Treatment|Adverse Event|0
7756363|NCT00784277|12195445|FG004|ER Treatment|Adverse Event|1
7756364|NCT00784277|12195446|FG005|ER Treatment|Adverse Event|7
7756365|NCT00784277|12195447|FG006|ER Treatment|Adverse Event|7
7756366|NCT00784277|12195441|FG000|ER Treatment|Lack of Efficacy|0
7756367|NCT00784277|12195442|FG001|ER Treatment|Lack of Efficacy|0
7756368|NCT00784277|12195443|FG002|ER Treatment|Lack of Efficacy|0
7756369|NCT00784277|12195444|FG003|ER Treatment|Lack of Efficacy|0
7756370|NCT00784277|12195445|FG004|ER Treatment|Lack of Efficacy|3
7756371|NCT00784277|12195446|FG005|ER Treatment|Lack of Efficacy|4
7756372|NCT00784277|12195447|FG006|ER Treatment|Lack of Efficacy|0
7756373|NCT00784277|12195441|FG000|ER Treatment|Lost to Follow-up|0
7756374|NCT00784277|12195442|FG001|ER Treatment|Lost to Follow-up|0
7756375|NCT00784277|12195443|FG002|ER Treatment|Lost to Follow-up|0
7756376|NCT00784277|12195444|FG003|ER Treatment|Lost to Follow-up|0
7756377|NCT00784277|12195445|FG004|ER Treatment|Lost to Follow-up|0
7756378|NCT00784277|12195446|FG005|ER Treatment|Lost to Follow-up|2
7756379|NCT00784277|12195447|FG006|ER Treatment|Lost to Follow-up|0
7756380|NCT00784277|12195441|FG000|ER Treatment|Withdrawal by Subject|0
7756381|NCT00784277|12195442|FG001|ER Treatment|Withdrawal by Subject|0
7756382|NCT00784277|12195443|FG002|ER Treatment|Withdrawal by Subject|0
7756383|NCT00784277|12195444|FG003|ER Treatment|Withdrawal by Subject|0
7756384|NCT00784277|12195445|FG004|ER Treatment|Withdrawal by Subject|2
7756385|NCT00784277|12195446|FG005|ER Treatment|Withdrawal by Subject|5
7756386|NCT00784277|12195447|FG006|ER Treatment|Withdrawal by Subject|3
7756387|NCT00784277|12195441|FG000|ER Treatment|Study Medication Non-Compliant|0
7756388|NCT00784277|12195442|FG001|ER Treatment|Study Medication Non-Compliant|0
7756389|NCT00784277|12195443|FG002|ER Treatment|Study Medication Non-Compliant|0
7756390|NCT00784277|12195444|FG003|ER Treatment|Study Medication Non-Compliant|0
7756391|NCT00784277|12195445|FG004|ER Treatment|Study Medication Non-Compliant|2
7756392|NCT00784277|12195446|FG005|ER Treatment|Study Medication Non-Compliant|3
7756393|NCT00784277|12195447|FG006|ER Treatment|Study Medication Non-Compliant|3
7756394|NCT00784277|12195441|FG000|ER Treatment|Other|0
7756395|NCT00784277|12195442|FG001|ER Treatment|Other|0
7756396|NCT00784277|12195443|FG002|ER Treatment|Other|0
7756397|NCT00784277|12195444|FG003|ER Treatment|Other|0
7756398|NCT00784277|12195445|FG004|ER Treatment|Other|1
7756399|NCT00784277|12195446|FG005|ER Treatment|Other|3
7756400|NCT00784277|12195447|FG006|ER Treatment|Other|2
7756401|NCT00784368|12195473|FG000|Overall Study|Physician Decision|0
7756402|NCT00784368|12195474|FG001|Overall Study|Physician Decision|0
7756403|NCT00784368|12195475|FG002|Overall Study|Physician Decision|6
7756404|NCT00784368|12195473|FG000|Overall Study|Lack of Efficacy|2
7756405|NCT00784368|12195474|FG001|Overall Study|Lack of Efficacy|0
7756406|NCT00784368|12195475|FG002|Overall Study|Lack of Efficacy|1
7756407|NCT00784368|12195473|FG000|Overall Study|Adverse Event|6
7756408|NCT00784368|12195474|FG001|Overall Study|Adverse Event|9
7756409|NCT00784368|12195475|FG002|Overall Study|Adverse Event|2
7756410|NCT00784368|12195473|FG000|Overall Study|Diagnosis of fever|0
7756411|NCT00784368|12195474|FG001|Overall Study|Diagnosis of fever|0
7756412|NCT00784368|12195475|FG002|Overall Study|Diagnosis of fever|1
7756413|NCT00784368|12195473|FG000|Overall Study|Worsening of complications|0
7756414|NCT00784368|12195474|FG001|Overall Study|Worsening of complications|0
7756415|NCT00784368|12195475|FG002|Overall Study|Worsening of complications|1
7756416|NCT00784368|12195473|FG000|Overall Study|Worsening of symptoms|0
7756417|NCT00784368|12195474|FG001|Overall Study|Worsening of symptoms|1
7756418|NCT00784368|12195475|FG002|Overall Study|Worsening of symptoms|0
7756419|NCT00784368|12195473|FG000|Overall Study|Withdrawal of informed consent|0
7756420|NCT00784368|12195474|FG001|Overall Study|Withdrawal of informed consent|1
7756421|NCT00784368|12195475|FG002|Overall Study|Withdrawal of informed consent|0
7756422|NCT00784459|12195488|FG000|Overall Study|Adverse Event|0
7756423|NCT00784459|12195489|FG001|Overall Study|Adverse Event|2
7756424|NCT00784550|12195501|FG000|Overall Study|Adverse Event|12
7756425|NCT00784550|12195502|FG001|Overall Study|Adverse Event|10
7756426|NCT00784550|12195501|FG000|Overall Study|Lack of Efficacy|0
7756427|NCT00784550|12195502|FG001|Overall Study|Lack of Efficacy|1
7756428|NCT00784550|12195501|FG000|Overall Study|Protocol Violation|10
7756429|NCT00784550|12195502|FG001|Overall Study|Protocol Violation|10
7756430|NCT00784550|12195501|FG000|Overall Study|Lost to Follow-up|8
7756431|NCT00784550|12195502|FG001|Overall Study|Lost to Follow-up|5
7756432|NCT00784550|12195501|FG000|Overall Study|Physician Decision|2
7756433|NCT00784550|12195502|FG001|Overall Study|Physician Decision|3
7756434|NCT00784550|12195501|FG000|Overall Study|Withdrawal by Subject|4
7756435|NCT00784550|12195502|FG001|Overall Study|Withdrawal by Subject|13
7756436|NCT00784563|12195511|FG000|Years 1 & 2|Withdrawal by Subject|3
7756437|NCT00784563|12195512|FG001|Years 1 & 2|Withdrawal by Subject|2
7756438|NCT00784563|12195513|FG002|Years 1 & 2|Withdrawal by Subject|0
7756439|NCT00784563|12195511|FG000|Years 1 & 2|Adverse Event|0
7756440|NCT00784563|12195512|FG001|Years 1 & 2|Adverse Event|3
7756441|NCT00784563|12195513|FG002|Years 1 & 2|Adverse Event|0
7756442|NCT00784563|12195511|FG000|Year 3|Withdrawal by Subject|0
7756443|NCT00784563|12195512|FG001|Year 3|Withdrawal by Subject|0
7756444|NCT00784563|12195513|FG002|Year 3|Withdrawal by Subject|2
7756445|NCT00784563|12195511|FG000|Year 3|Adverse Event|0
7756446|NCT00784563|12195512|FG001|Year 3|Adverse Event|0
7756447|NCT00784563|12195513|FG002|Year 3|Adverse Event|1
7756448|NCT00784654|12195532|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44
7756449|NCT00784654|12195533|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0
7756450|NCT00784654|12195534|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0
7756451|NCT00784654|12195532|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
7756452|NCT00784654|12195533|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
7756453|NCT00784654|12195534|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
7756454|NCT00784654|12195532|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
7756455|NCT00784654|12195533|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
7756456|NCT00784654|12195534|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
7756457|NCT00784654|12195532|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
7756458|NCT00784654|12195533|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
7756459|NCT00784654|12195534|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
7756460|NCT00784654|12195532|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7
7756461|NCT00784654|12195533|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0
7756462|NCT00784654|12195534|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0
7756463|NCT00784654|12195532|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
7756464|NCT00784654|12195533|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
7756465|NCT00784654|12195534|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
7756466|NCT00784654|12195532|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
7756467|NCT00784654|12195533|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
7756468|NCT00784654|12195534|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
7756469|NCT00784654|12195532|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1
7756470|NCT00784654|12195533|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0
7756471|NCT00784654|12195534|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0
7756472|NCT00784654|12195532|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
7756473|NCT00784654|12195533|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
7756474|NCT00784654|12195534|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
7756475|NCT00784654|12195532|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
7756476|NCT00784654|12195533|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
7756477|NCT00784654|12195534|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
7756478|NCT00784654|12195532|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
7756479|NCT00784654|12195533|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
7756480|NCT00784654|12195534|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
7756481|NCT00784654|12195532|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0
7756482|NCT00784654|12195533|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8
7756483|NCT00784654|12195534|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35
7756484|NCT00784654|12195532|FG000|Randomized Withdrawal Period|Lack of Efficacy|0
7756485|NCT00784654|12195533|FG001|Randomized Withdrawal Period|Lack of Efficacy|5
7756486|NCT00784654|12195534|FG002|Randomized Withdrawal Period|Lack of Efficacy|18
7756487|NCT00784654|12195532|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
7756488|NCT00784654|12195533|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1
7756489|NCT00784654|12195534|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7
7756490|NCT00784654|12195532|FG000|Randomized Withdrawal Period|Protocol Violation|0
7756491|NCT00784654|12195533|FG001|Randomized Withdrawal Period|Protocol Violation|2
7756492|NCT00784654|12195534|FG002|Randomized Withdrawal Period|Protocol Violation|1
7756493|NCT00784654|12195532|FG000|Randomized Withdrawal Period|Adverse Event|0
7756494|NCT00784654|12195533|FG001|Randomized Withdrawal Period|Adverse Event|1
7756495|NCT00784654|12195534|FG002|Randomized Withdrawal Period|Adverse Event|1
7756496|NCT00784654|12195532|FG000|Randomized Withdrawal Period|Did not complete a visit|0
7756497|NCT00784654|12195533|FG001|Randomized Withdrawal Period|Did not complete a visit|1
7756498|NCT00784654|12195534|FG002|Randomized Withdrawal Period|Did not complete a visit|0
7756499|NCT00784654|12195532|FG000|Randomized Withdrawal Period|Family reasons|0
7756500|NCT00784654|12195533|FG001|Randomized Withdrawal Period|Family reasons|0
7756501|NCT00784654|12195534|FG002|Randomized Withdrawal Period|Family reasons|1
7756502|NCT00784693|12195547|FG000|Overall Study|Lost to Follow-up|0
7756503|NCT00784693|12195548|FG001|Overall Study|Lost to Follow-up|1
7756504|NCT00784693|12195547|FG000|Overall Study|Lack of Efficacy|1
7756505|NCT00784693|12195548|FG001|Overall Study|Lack of Efficacy|1
7756506|NCT00784693|12195547|FG000|Overall Study|Withdrawal by Subject|0
7756507|NCT00784693|12195548|FG001|Overall Study|Withdrawal by Subject|4
7756508|NCT00784693|12195547|FG000|Overall Study|Randomized but not Treated|1
7756509|NCT00784693|12195548|FG001|Overall Study|Randomized but not Treated|0
7756510|NCT00784693|12195547|FG000|Overall Study|Other|1
7756511|NCT00784693|12195548|FG001|Overall Study|Other|0
7756512|NCT00784719|12195561|FG000|Overall Study|Adverse Event|0
7756513|NCT00784719|12195562|FG001|Overall Study|Adverse Event|2
7756514|NCT00784719|12195563|FG002|Overall Study|Adverse Event|0
7756515|NCT00784719|12195564|FG003|Overall Study|Adverse Event|0
7756516|NCT00784719|12195565|FG004|Overall Study|Adverse Event|1
7756517|NCT00784719|12195566|FG005|Overall Study|Adverse Event|1
7756518|NCT00784719|12195567|FG006|Overall Study|Adverse Event|1
7756519|NCT00784719|12195561|FG000|Overall Study|Lost to Follow-up|0
7756520|NCT00784719|12195562|FG001|Overall Study|Lost to Follow-up|0
7756521|NCT00784719|12195563|FG002|Overall Study|Lost to Follow-up|0
7756522|NCT00784719|12195564|FG003|Overall Study|Lost to Follow-up|0
7756523|NCT00784719|12195565|FG004|Overall Study|Lost to Follow-up|1
7756524|NCT00784719|12195566|FG005|Overall Study|Lost to Follow-up|1
7756525|NCT00784719|12195567|FG006|Overall Study|Lost to Follow-up|0
7756526|NCT00784719|12195561|FG000|Overall Study|Other|2
7756527|NCT00784719|12195562|FG001|Overall Study|Other|1
7756528|NCT00784719|12195563|FG002|Overall Study|Other|1
7756529|NCT00784719|12195564|FG003|Overall Study|Other|0
7756530|NCT00784719|12195565|FG004|Overall Study|Other|2
7756531|NCT00784719|12195566|FG005|Overall Study|Other|1
7756532|NCT00784719|12195567|FG006|Overall Study|Other|3
7756533|NCT00784719|12195561|FG000|Overall Study|Withdrawal by Subject|1
7756534|NCT00784719|12195562|FG001|Overall Study|Withdrawal by Subject|0
7756535|NCT00784719|12195563|FG002|Overall Study|Withdrawal by Subject|0
7756536|NCT00784719|12195564|FG003|Overall Study|Withdrawal by Subject|0
7756537|NCT00784719|12195565|FG004|Overall Study|Withdrawal by Subject|2
7756538|NCT00784719|12195566|FG005|Overall Study|Withdrawal by Subject|0
7756539|NCT00784719|12195567|FG006|Overall Study|Withdrawal by Subject|1
7756540|NCT00784758|12195585|FG000|Overall Study|Withdrawal by Subject|3
7756541|NCT00784758|12195586|FG001|Overall Study|Withdrawal by Subject|0
7756542|NCT00784758|12195585|FG000|Overall Study|Adverse Event|1
7756543|NCT00784758|12195586|FG001|Overall Study|Adverse Event|0
7756544|NCT00784784|12195596|FG000|Overall Study|Withdrawal by Subject|2
7756545|NCT00784784|12195597|FG001|Overall Study|Withdrawal by Subject|2
7756546|NCT00784810|12195605|FG000|Overall Study|Adverse Event|32
7756547|NCT00784810|12195606|FG001|Overall Study|Adverse Event|20
7756548|NCT00784810|12195605|FG000|Overall Study|Lack of Efficacy|14
7756549|NCT00784810|12195606|FG001|Overall Study|Lack of Efficacy|11
7756550|NCT00784810|12195605|FG000|Overall Study|Withdrawal by Subject|11
7756551|NCT00784810|12195606|FG001|Overall Study|Withdrawal by Subject|9
7756552|NCT00784810|12195605|FG000|Overall Study|Administrative|5
7756553|NCT00784810|12195606|FG001|Overall Study|Administrative|8
7756554|NCT00784810|12195605|FG000|Overall Study|Lost to Follow-up|1
7756555|NCT00784810|12195606|FG001|Overall Study|Lost to Follow-up|1
7756556|NCT00784836|12195612|FG000|Overall Study|Early Study Termination|3
7756557|NCT00784875|12195624|FG000|Period A - Baseline|Entry Criteria Not Met|0
7756558|NCT00784875|12195625|FG001|Period A - Baseline|Entry Criteria Not Met|0
7756559|NCT00784875|12195626|FG002|Period A - Baseline|Entry Criteria Not Met|0
7756560|NCT00784875|12195627|FG003|Period A - Baseline|Entry Criteria Not Met|5
7756561|NCT00784875|12195624|FG000|Period A - Baseline|Adverse Event|0
7756562|NCT00784875|12195625|FG001|Period A - Baseline|Adverse Event|0
7756563|NCT00784875|12195626|FG002|Period A - Baseline|Adverse Event|0
7756564|NCT00784875|12195627|FG003|Period A - Baseline|Adverse Event|8
7756565|NCT00784875|12195624|FG000|Period A - Baseline|Protocol Violation|0
7756566|NCT00784875|12195625|FG001|Period A - Baseline|Protocol Violation|0
7756567|NCT00784875|12195626|FG002|Period A - Baseline|Protocol Violation|0
7756568|NCT00784875|12195627|FG003|Period A - Baseline|Protocol Violation|25
7756569|NCT00784875|12195624|FG000|Period A - Baseline|Withdrawal by Subject|0
7756570|NCT00784875|12195625|FG001|Period A - Baseline|Withdrawal by Subject|0
7756571|NCT00784875|12195626|FG002|Period A - Baseline|Withdrawal by Subject|0
7756572|NCT00784875|12195627|FG003|Period A - Baseline|Withdrawal by Subject|27
7756573|NCT00784875|12195624|FG000|Period A - Baseline|Physician Decision|0
7756574|NCT00784875|12195625|FG001|Period A - Baseline|Physician Decision|0
7756575|NCT00784875|12195626|FG002|Period A - Baseline|Physician Decision|0
7756576|NCT00784875|12195627|FG003|Period A - Baseline|Physician Decision|2
7756577|NCT00784875|12195624|FG000|Period A - Baseline|Sponsor Decision|0
7756578|NCT00784875|12195625|FG001|Period A - Baseline|Sponsor Decision|0
7756579|NCT00784875|12195626|FG002|Period A - Baseline|Sponsor Decision|0
7756580|NCT00784875|12195627|FG003|Period A - Baseline|Sponsor Decision|113
7756581|NCT00784875|12195624|FG000|Period A - Baseline|Lost to Follow-up|0
7756582|NCT00784875|12195625|FG001|Period A - Baseline|Lost to Follow-up|0
7756583|NCT00784875|12195626|FG002|Period A - Baseline|Lost to Follow-up|0
7756584|NCT00784875|12195627|FG003|Period A - Baseline|Lost to Follow-up|2
7756585|NCT00784875|12195624|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
7756586|NCT00784875|12195625|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
7756587|NCT00784875|12195626|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
7756588|NCT00784875|12195627|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
7756589|NCT00784875|12195624|FG000|Period B - Efficacy Endpoint|Adverse Event|0
7756590|NCT00784875|12195625|FG001|Period B - Efficacy Endpoint|Adverse Event|3
7756591|NCT00784875|12195626|FG002|Period B - Efficacy Endpoint|Adverse Event|2
7756592|NCT00784875|12195627|FG003|Period B - Efficacy Endpoint|Adverse Event|1
7756593|NCT00784875|12195624|FG000|Period B - Efficacy Endpoint|Protocol Violation|1
7756594|NCT00784875|12195625|FG001|Period B - Efficacy Endpoint|Protocol Violation|1
7756595|NCT00784875|12195626|FG002|Period B - Efficacy Endpoint|Protocol Violation|2
7756596|NCT00784875|12195627|FG003|Period B - Efficacy Endpoint|Protocol Violation|3
7756597|NCT00784875|12195624|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0
7756598|NCT00784875|12195625|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1
7756599|NCT00784875|12195626|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0
7756600|NCT00784875|12195627|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0
7756601|NCT00784875|12195624|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4
7756602|NCT00784875|12195625|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1
7756603|NCT00784875|12195626|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1
7756604|NCT00784875|12195627|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2
7756605|NCT00784875|12195624|FG000|Period B - Efficacy Endpoint|Physician Decision|0
7756606|NCT00784875|12195625|FG001|Period B - Efficacy Endpoint|Physician Decision|0
7756607|NCT00784875|12195626|FG002|Period B - Efficacy Endpoint|Physician Decision|1
7756608|NCT00784875|12195627|FG003|Period B - Efficacy Endpoint|Physician Decision|0
7756609|NCT00784875|12195624|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9
7756610|NCT00784875|12195625|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6
7756611|NCT00784875|12195626|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12
7756612|NCT00784875|12195627|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12
7756613|NCT00784875|12195624|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0
7756614|NCT00784875|12195625|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0
7756615|NCT00784875|12195626|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1
7756616|NCT00784875|12195627|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0
7756617|NCT00784875|12195624|FG000|Period C|Adverse Event|1
7756618|NCT00784875|12195625|FG001|Period C|Adverse Event|0
7756619|NCT00784875|12195626|FG002|Period C|Adverse Event|4
7756620|NCT00784875|12195627|FG003|Period C|Adverse Event|2
7756621|NCT00784875|12195624|FG000|Period C|Protocol Violation|0
7756622|NCT00784875|12195625|FG001|Period C|Protocol Violation|0
7756623|NCT00784875|12195626|FG002|Period C|Protocol Violation|1
7756624|NCT00784875|12195627|FG003|Period C|Protocol Violation|2
7756625|NCT00784875|12195624|FG000|Period C|Lack of Efficacy|0
7756626|NCT00784875|12195625|FG001|Period C|Lack of Efficacy|0
7756627|NCT00784875|12195626|FG002|Period C|Lack of Efficacy|1
7756628|NCT00784875|12195627|FG003|Period C|Lack of Efficacy|0
7756629|NCT00784875|12195624|FG000|Period C|Withdrawal by Subject|1
7756630|NCT00784875|12195625|FG001|Period C|Withdrawal by Subject|1
7756631|NCT00784875|12195626|FG002|Period C|Withdrawal by Subject|2
7756632|NCT00784875|12195627|FG003|Period C|Withdrawal by Subject|0
7756633|NCT00784875|12195624|FG000|Period C|Physician Decision|0
7756634|NCT00784875|12195625|FG001|Period C|Physician Decision|0
7756635|NCT00784875|12195626|FG002|Period C|Physician Decision|1
7756636|NCT00784875|12195627|FG003|Period C|Physician Decision|1
7756637|NCT00784875|12195624|FG000|Period C|Sponsor Decision|5
7756638|NCT00784875|12195625|FG001|Period C|Sponsor Decision|5
7756639|NCT00784875|12195626|FG002|Period C|Sponsor Decision|4
7756640|NCT00784875|12195627|FG003|Period C|Sponsor Decision|2
7756641|NCT00784875|12195624|FG000|Period D|Adverse Event|0
7756642|NCT00784875|12195625|FG001|Period D|Adverse Event|2
7756643|NCT00784875|12195626|FG002|Period D|Adverse Event|2
7756644|NCT00784875|12195627|FG003|Period D|Adverse Event|0
7756645|NCT00784875|12195624|FG000|Period D|Protocol Violation|1
7756646|NCT00784875|12195625|FG001|Period D|Protocol Violation|0
7756647|NCT00784875|12195626|FG002|Period D|Protocol Violation|0
7756648|NCT00784875|12195627|FG003|Period D|Protocol Violation|0
7756649|NCT00784875|12195624|FG000|Period D|Withdrawal by Subject|2
7756650|NCT00784875|12195625|FG001|Period D|Withdrawal by Subject|0
7756651|NCT00784875|12195626|FG002|Period D|Withdrawal by Subject|2
7756652|NCT00784875|12195627|FG003|Period D|Withdrawal by Subject|0
7756653|NCT00784875|12195624|FG000|Period D|Physician Decision|0
7756654|NCT00784875|12195625|FG001|Period D|Physician Decision|1
7756655|NCT00784875|12195626|FG002|Period D|Physician Decision|0
7756656|NCT00784875|12195627|FG003|Period D|Physician Decision|0
7756657|NCT00784875|12195624|FG000|Period D|Sponsor Decision|1
7756658|NCT00784875|12195625|FG001|Period D|Sponsor Decision|1
7756659|NCT00784875|12195626|FG002|Period D|Sponsor Decision|1
7756660|NCT00784875|12195627|FG003|Period D|Sponsor Decision|0
7756661|NCT00784875|12195624|FG000|Period D|Lost to Follow-up|1
7756662|NCT00784875|12195625|FG001|Period D|Lost to Follow-up|0
7756663|NCT00784875|12195626|FG002|Period D|Lost to Follow-up|1
7756664|NCT00784875|12195627|FG003|Period D|Lost to Follow-up|1
7756665|NCT00784927|12195650|FG000|Overall Study|Cancel Prior to Initiating Treatment|1
7756666|NCT00784927|12195650|FG000|Overall Study|Protocol Violation|1
7756667|NCT00784927|12195650|FG000|Overall Study|Ineligible|1
7756668|NCT00784979|12195655|FG000|Overall Study|incomplete data|6
7756669|NCT00785044|12195659|FG000|Overall Study|Dosed at non-participating sites|152
7756670|NCT00785044|12195659|FG000|Overall Study|Death|77
7756671|NCT00785044|12195659|FG000|Overall Study|Lost to Follow-up|266
7756672|NCT00785044|12195659|FG000|Overall Study|Withdrawal by Subject|1
7756673|NCT00785213|12195664|FG000|Quinine Sulfate Alone|Adverse Event|4
7756674|NCT00785213|12195664|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1
7756675|NCT00785486|12195671|FG000|Midazolam Alone|Withdrawal by Subject|1
7756676|NCT00785512|12195694|FG000|Overall Study|Inclusion/Exclusion not meet|0
7756677|NCT00785512|12195695|FG001|Overall Study|Inclusion/Exclusion not meet|0
7756678|NCT00785512|12195694|FG000|Overall Study|Adverse Event|0
7756679|NCT00785512|12195695|FG001|Overall Study|Adverse Event|0
7756680|NCT00785512|12195694|FG000|Overall Study|Lack of Efficacy|0
7756681|NCT00785512|12195695|FG001|Overall Study|Lack of Efficacy|2
7756682|NCT00785512|12195694|FG000|Overall Study|Withdrawal by Subject|0
7756683|NCT00785512|12195695|FG001|Overall Study|Withdrawal by Subject|1
7756684|NCT00785512|12195694|FG000|Overall Study|Lost to Follow-up|3
7756685|NCT00785512|12195695|FG001|Overall Study|Lost to Follow-up|0
7756686|NCT00785512|12195694|FG000|Overall Study|Precedure Refused|0
7756687|NCT00785512|12195695|FG001|Overall Study|Precedure Refused|0
7756688|NCT00785512|12195694|FG000|Overall Study|IVRS Programing Error|0
7756689|NCT00785512|12195695|FG001|Overall Study|IVRS Programing Error|0
7756690|NCT00785512|12195694|FG000|Overall Study|Physician Decision|0
7756691|NCT00785512|12195695|FG001|Overall Study|Physician Decision|0
7756692|NCT00785512|12195694|FG000|Overall Study|Lack of compliance|0
7756693|NCT00785512|12195695|FG001|Overall Study|Lack of compliance|1
7756694|NCT00785538|12195706|FG000|Treatment Period|Adverse Event|1
7756695|NCT00785538|12195707|FG001|Treatment Period|Adverse Event|2
7756696|NCT00785538|12195708|FG002|Treatment Period|Adverse Event|2
7756697|NCT00785538|12195709|FG003|Treatment Period|Adverse Event|0
7756698|NCT00785538|12195706|FG000|Treatment Period|Withdrawal by Subject|0
7756699|NCT00785538|12195707|FG001|Treatment Period|Withdrawal by Subject|0
7756700|NCT00785538|12195708|FG002|Treatment Period|Withdrawal by Subject|0
7756701|NCT00785538|12195709|FG003|Treatment Period|Withdrawal by Subject|1
7756702|NCT00785577|12195725|FG000|Study Period 2: Therapy Phase|Adverse Event|5
7756703|NCT00785577|12195726|FG001|Study Period 2: Therapy Phase|Adverse Event|7
7756704|NCT00785577|12195727|FG002|Study Period 2: Therapy Phase|Adverse Event|14
7756705|NCT00785577|12195728|FG003|Study Period 2: Therapy Phase|Adverse Event|10
7756706|NCT00785577|12195729|FG004|Study Period 2: Therapy Phase|Adverse Event|17
7756707|NCT00785577|12195725|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0
7756708|NCT00785577|12195726|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0
7756709|NCT00785577|12195727|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0
7756710|NCT00785577|12195728|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0
7756711|NCT00785577|12195729|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1
7756712|NCT00785577|12195725|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0
7756713|NCT00785577|12195726|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0
7756714|NCT00785577|12195727|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0
7756715|NCT00785577|12195728|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1
7756716|NCT00785577|12195729|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0
7756717|NCT00785577|12195725|FG000|Study Period 2: Therapy Phase|Physician Decision|1
7756718|NCT00785577|12195726|FG001|Study Period 2: Therapy Phase|Physician Decision|0
7756719|NCT00785577|12195727|FG002|Study Period 2: Therapy Phase|Physician Decision|0
7756720|NCT00785577|12195728|FG003|Study Period 2: Therapy Phase|Physician Decision|0
7756721|NCT00785577|12195729|FG004|Study Period 2: Therapy Phase|Physician Decision|0
7756722|NCT00785577|12195725|FG000|Study Period 2: Therapy Phase|Protocol Violation|1
7756723|NCT00785577|12195726|FG001|Study Period 2: Therapy Phase|Protocol Violation|1
7756724|NCT00785577|12195727|FG002|Study Period 2: Therapy Phase|Protocol Violation|1
7756725|NCT00785577|12195728|FG003|Study Period 2: Therapy Phase|Protocol Violation|0
7756726|NCT00785577|12195729|FG004|Study Period 2: Therapy Phase|Protocol Violation|1
7756727|NCT00785577|12195725|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2
7756728|NCT00785577|12195726|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1
7756729|NCT00785577|12195727|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1
7756730|NCT00785577|12195728|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0
7756731|NCT00785577|12195729|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1
7756732|NCT00785577|12195725|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
7756733|NCT00785577|12195726|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
7756734|NCT00785577|12195727|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
7756735|NCT00785577|12195728|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
7756736|NCT00785577|12195729|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
7756737|NCT00785577|12195725|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1
7756738|NCT00785577|12195726|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0
7756739|NCT00785577|12195727|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1
7756740|NCT00785577|12195728|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1
7756741|NCT00785577|12195729|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0
7756742|NCT00785577|12195725|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0
7756743|NCT00785577|12195726|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0
7756744|NCT00785577|12195727|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0
7756745|NCT00785577|12195728|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1
7756746|NCT00785577|12195729|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0
7756747|NCT00785577|12195725|FG000|Study Period 3: 1-Week Washout Phase|Death|0
7756748|NCT00785577|12195726|FG001|Study Period 3: 1-Week Washout Phase|Death|0
7756749|NCT00785577|12195727|FG002|Study Period 3: 1-Week Washout Phase|Death|0
7756750|NCT00785577|12195728|FG003|Study Period 3: 1-Week Washout Phase|Death|0
7756751|NCT00785577|12195729|FG004|Study Period 3: 1-Week Washout Phase|Death|1
7756752|NCT00785629|12195755|FG000|Overall Study|Adverse Event|2
7756753|NCT00785629|12195756|FG001|Overall Study|Adverse Event|1
7756754|NCT00785629|12195757|FG002|Overall Study|Adverse Event|1
7756755|NCT00785629|12195758|FG003|Overall Study|Adverse Event|5
7756756|NCT00785629|12195755|FG000|Overall Study|Protocol Violation|1
7756757|NCT00785629|12195756|FG001|Overall Study|Protocol Violation|2
7756758|NCT00785629|12195757|FG002|Overall Study|Protocol Violation|4
7756759|NCT00785629|12195758|FG003|Overall Study|Protocol Violation|5
7756760|NCT00785629|12195755|FG000|Overall Study|administrative decision|5
7756761|NCT00785629|12195756|FG001|Overall Study|administrative decision|1
7756762|NCT00785629|12195757|FG002|Overall Study|administrative decision|3
7756763|NCT00785629|12195758|FG003|Overall Study|administrative decision|4
7756764|NCT00785629|12195755|FG000|Overall Study|Withdrawal by Subject|0
7756765|NCT00785629|12195756|FG001|Overall Study|Withdrawal by Subject|1
7756766|NCT00785629|12195757|FG002|Overall Study|Withdrawal by Subject|2
7756767|NCT00785629|12195758|FG003|Overall Study|Withdrawal by Subject|2
7756768|NCT00785707|12195766|FG000|Overall Study|Lost to Follow-up|7
7756769|NCT00785785|12195776|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
7756770|NCT00785785|12195777|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
7756771|NCT00785785|12195776|FG000|Core Phase up to 36 Months|Adverse Event|31
7756772|NCT00785785|12195777|FG001|Core Phase up to 36 Months|Adverse Event|21
7756773|NCT00785785|12195776|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1
7756774|NCT00785785|12195777|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0
7756775|NCT00785785|12195776|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2
7756776|NCT00785785|12195777|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2
7756777|NCT00785785|12195776|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16
7756778|NCT00785785|12195777|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17
7756779|NCT00785785|12195776|FG000|Core Phase up to 36 Months|Lost to Follow-up|3
7756780|NCT00785785|12195777|FG001|Core Phase up to 36 Months|Lost to Follow-up|7
7756781|NCT00785785|12195776|FG000|Core Phase up to 36 Months|Administrative problems|3
7756782|NCT00785785|12195777|FG001|Core Phase up to 36 Months|Administrative problems|3
7756783|NCT00785785|12195776|FG000|Core Phase up to 36 Months|Death|5
7756784|NCT00785785|12195777|FG001|Core Phase up to 36 Months|Death|8
7756785|NCT00785785|12195776|FG000|Core Phase up to 36 Months|Disease progression|139
7756786|NCT00785785|12195777|FG001|Core Phase up to 36 Months|Disease progression|119
7756787|NCT00785785|12195776|FG000|Core Phase up to 36 Months|Protocol deviation|5
7756788|NCT00785785|12195777|FG001|Core Phase up to 36 Months|Protocol deviation|6
7756789|NCT00785785|12195776|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116
7756790|NCT00785785|12195777|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133
7756791|NCT00785785|12195776|FG000|Optional Extension Phase|Adverse Event|4
7756792|NCT00785785|12195777|FG001|Optional Extension Phase|Adverse Event|5
7756793|NCT00785785|12195776|FG000|Optional Extension Phase|Withdrawal by Subject|6
7756794|NCT00785785|12195777|FG001|Optional Extension Phase|Withdrawal by Subject|6
7756795|NCT00785785|12195776|FG000|Optional Extension Phase|Lost to Follow-up|1
7756796|NCT00785785|12195777|FG001|Optional Extension Phase|Lost to Follow-up|0
7756797|NCT00785785|12195776|FG000|Optional Extension Phase|Administrative problems|2
7756798|NCT00785785|12195777|FG001|Optional Extension Phase|Administrative problems|0
7756799|NCT00785785|12195776|FG000|Optional Extension Phase|Death|1
7756800|NCT00785785|12195777|FG001|Optional Extension Phase|Death|5
7756801|NCT00785785|12195776|FG000|Optional Extension Phase|Disease progression|22
7756802|NCT00785785|12195777|FG001|Optional Extension Phase|Disease progression|70
7756803|NCT00785785|12195776|FG000|Optional Extension Phase|Protocol deviation|0
7756804|NCT00785785|12195777|FG001|Optional Extension Phase|Protocol deviation|2
7756805|NCT00785785|12195776|FG000|Optional Extension Phase|Study terminated by sponsor|3
7756806|NCT00785785|12195777|FG001|Optional Extension Phase|Study terminated by sponsor|37
7756807|NCT00785928|12195792|FG000|Treatment Phase|Adverse Event|1
7756808|NCT00785928|12195793|FG001|Treatment Phase|Adverse Event|1
7756809|NCT00785928|12195794|FG002|Treatment Phase|Adverse Event|2
7756810|NCT00785928|12195795|FG003|Treatment Phase|Adverse Event|0
7756811|NCT00785928|12195796|FG004|Treatment Phase|Adverse Event|0
7756812|NCT00785928|12195797|FG005|Treatment Phase|Adverse Event|0
7756813|NCT00785928|12195798|FG006|Treatment Phase|Adverse Event|2
7756814|NCT00785928|12195792|FG000|Treatment Phase|Inadequate Response|0
7756815|NCT00785928|12195793|FG001|Treatment Phase|Inadequate Response|1
7756816|NCT00785928|12195794|FG002|Treatment Phase|Inadequate Response|0
7756817|NCT00785928|12195795|FG003|Treatment Phase|Inadequate Response|0
7756818|NCT00785928|12195796|FG004|Treatment Phase|Inadequate Response|0
7756819|NCT00785928|12195797|FG005|Treatment Phase|Inadequate Response|0
7756820|NCT00785928|12195798|FG006|Treatment Phase|Inadequate Response|0
7756821|NCT00785928|12195792|FG000|Treatment Phase|Lack of Efficacy|0
7756822|NCT00785928|12195793|FG001|Treatment Phase|Lack of Efficacy|1
7756823|NCT00785928|12195794|FG002|Treatment Phase|Lack of Efficacy|1
7756824|NCT00785928|12195795|FG003|Treatment Phase|Lack of Efficacy|0
7756825|NCT00785928|12195796|FG004|Treatment Phase|Lack of Efficacy|0
7756826|NCT00785928|12195797|FG005|Treatment Phase|Lack of Efficacy|0
7756827|NCT00785928|12195798|FG006|Treatment Phase|Lack of Efficacy|0
7756828|NCT00785928|12195792|FG000|Treatment Phase|Physician Decision|0
7756829|NCT00785928|12195793|FG001|Treatment Phase|Physician Decision|0
7756830|NCT00785928|12195794|FG002|Treatment Phase|Physician Decision|0
7756831|NCT00785928|12195795|FG003|Treatment Phase|Physician Decision|0
7756832|NCT00785928|12195796|FG004|Treatment Phase|Physician Decision|1
7756833|NCT00785928|12195797|FG005|Treatment Phase|Physician Decision|0
7756834|NCT00785928|12195798|FG006|Treatment Phase|Physician Decision|0
7756835|NCT00785928|12195792|FG000|Treatment Phase|Sponsor Decision|1
7756836|NCT00785928|12195793|FG001|Treatment Phase|Sponsor Decision|0
7756837|NCT00785928|12195794|FG002|Treatment Phase|Sponsor Decision|0
7756838|NCT00785928|12195795|FG003|Treatment Phase|Sponsor Decision|0
7756839|NCT00785928|12195796|FG004|Treatment Phase|Sponsor Decision|0
7756840|NCT00785928|12195797|FG005|Treatment Phase|Sponsor Decision|0
7756841|NCT00785928|12195798|FG006|Treatment Phase|Sponsor Decision|1
7756842|NCT00785928|12195792|FG000|Treatment Phase|Withdrawal by Subject|1
7756843|NCT00785928|12195793|FG001|Treatment Phase|Withdrawal by Subject|2
7756844|NCT00785928|12195794|FG002|Treatment Phase|Withdrawal by Subject|0
7756845|NCT00785928|12195795|FG003|Treatment Phase|Withdrawal by Subject|0
7756846|NCT00785928|12195796|FG004|Treatment Phase|Withdrawal by Subject|1
7756847|NCT00785928|12195797|FG005|Treatment Phase|Withdrawal by Subject|0
7756848|NCT00785928|12195798|FG006|Treatment Phase|Withdrawal by Subject|0
7756849|NCT00785980|12195836|FG000|7 Day Washout Period|Protocol Violation|3
7756850|NCT00786032|12195854|FG000|Overall Study|Death|4
7756851|NCT00786032|12195854|FG000|Overall Study|Withdrawal by Subject|14
7756852|NCT00786032|12195854|FG000|Overall Study|Did not complete in the timeframe|6
7756853|NCT00786188|12195862|FG000|Overall Study|Adverse Event|3
7756854|NCT00786188|12195863|FG001|Overall Study|Adverse Event|1
7756855|NCT00786188|12195862|FG000|Overall Study|Withdrawal by Subject|2
7756856|NCT00786188|12195863|FG001|Overall Study|Withdrawal by Subject|0
7756857|NCT00786409|12195871|FG000|Overall Study|Withdrawal by Subject|2
7756858|NCT00786409|12195871|FG000|Overall Study|Adverse Event|2
7756859|NCT00786409|12195871|FG000|Overall Study|Pregnancy|2
7756860|NCT00786409|12195871|FG000|Overall Study|Lost to Follow-up|1
7756861|NCT00786422|12195875|FG000|Rivaroxaban Treatment|Death|2
7756862|NCT00786422|12195875|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3
7756863|NCT00786422|12195875|FG000|Rivaroxaban Treatment|Lack of Efficacy|1
7756864|NCT00786422|12195875|FG000|Rivaroxaban Treatment|Physician Decision|1
7756865|NCT00786422|12195875|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1
7756866|NCT00786422|12195875|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
7756867|NCT00786422|12195875|FG000|Rivaroxaban Treatment|Adverse Event|2
7756868|NCT00786422|12195875|FG000|Follow-up Period|Death|1
7756869|NCT00786422|12195875|FG000|Follow-up Period|End-of-study done up to 4 days early|2
7756870|NCT00786474|12195883|FG000|Overall Study|Death|5
7756871|NCT00786474|12195884|FG001|Overall Study|Death|4
7756872|NCT00786474|12195883|FG000|Overall Study|Withdrawal by Subject|23
7756873|NCT00786474|12195884|FG001|Overall Study|Withdrawal by Subject|31
7756874|NCT00786474|12195883|FG000|Overall Study|Lost to Follow-up|3
7756875|NCT00786474|12195884|FG001|Overall Study|Lost to Follow-up|3
7756876|NCT00786474|12195883|FG000|Overall Study|Physician Decision|2
7756877|NCT00786474|12195884|FG001|Overall Study|Physician Decision|1
7756878|NCT00786474|12195883|FG000|Overall Study|Other|4
7756879|NCT00786474|12195884|FG001|Overall Study|Other|4
7756880|NCT00786565|12195907|FG000|Enrollment Prior to Surgery|Site Closed|3
7756881|NCT00786565|12195907|FG000|Enrollment Prior to Surgery|Protocol Violation|3
7756882|NCT00786565|12195907|FG000|Post Surgery|Abnormal macular pucker|1
7756883|NCT00786565|12195907|FG000|Post Surgery|Adapt AO implanted posterior side up|1
7756884|NCT00786799|12195924|FG000|Overall Study|Lost to Follow-up|1
7756885|NCT00786799|12195925|FG001|Overall Study|Lost to Follow-up|1
7756886|NCT00786838|12195945|FG000|Overall Study|Physician Decision|4
7756887|NCT00786838|12195945|FG000|Overall Study|Death|4
7756888|NCT00786838|12195945|FG000|Overall Study|Adverse Event|6
7756889|NCT00786838|12195945|FG000|Overall Study|Progressive disease|31
7756890|NCT00786838|12195945|FG000|Overall Study|Withdrawal by Subject|4
7756891|NCT00786864|12195956|FG000|Overall Study|Lost to Follow-up|0
7756892|NCT00786864|12195957|FG001|Overall Study|Lost to Follow-up|1
7756893|NCT00786864|12195956|FG000|Overall Study|Sustained serious back injury|1
7756894|NCT00786864|12195957|FG001|Overall Study|Sustained serious back injury|0
7756895|NCT00787137|12196004|FG000|Overall Study|Study Termination|0
7756896|NCT00787137|12196005|FG001|Overall Study|Study Termination|0
7756897|NCT00787137|12196006|FG002|Overall Study|Study Termination|1
7756898|NCT00787150|12196017|FG000|Overall Study|Adverse Event|4
7756899|NCT00787150|12196018|FG001|Overall Study|Adverse Event|4
7756900|NCT00787150|12196019|FG002|Overall Study|Adverse Event|4
7756901|NCT00787150|12196017|FG000|Overall Study|Physician Decision|1
7756902|NCT00787150|12196018|FG001|Overall Study|Physician Decision|2
7756903|NCT00787150|12196019|FG002|Overall Study|Physician Decision|1
7756904|NCT00787150|12196017|FG000|Overall Study|Withdrawal by Subject|2
7756905|NCT00787150|12196018|FG001|Overall Study|Withdrawal by Subject|1
7756906|NCT00787150|12196019|FG002|Overall Study|Withdrawal by Subject|0
7756907|NCT00787150|12196017|FG000|Overall Study|Dosing incorrect study durg|2
7756908|NCT00787150|12196018|FG001|Overall Study|Dosing incorrect study durg|0
7756909|NCT00787150|12196019|FG002|Overall Study|Dosing incorrect study durg|0
7756910|NCT00787189|12196031|FG000|Overall Study|Lost to Follow-up|2
7756911|NCT00787189|12196032|FG001|Overall Study|Lost to Follow-up|2
7756912|NCT00787202|12196043|FG000|Overall Study|Adverse Event|3
7756913|NCT00787202|12196044|FG001|Overall Study|Adverse Event|2
7756914|NCT00787202|12196045|FG002|Overall Study|Adverse Event|0
7756915|NCT00787202|12196046|FG003|Overall Study|Adverse Event|0
7756916|NCT00787202|12196047|FG004|Overall Study|Adverse Event|2
7756917|NCT00787202|12196043|FG000|Overall Study|Lack of Efficacy|5
7756918|NCT00787202|12196044|FG001|Overall Study|Lack of Efficacy|6
7756919|NCT00787202|12196045|FG002|Overall Study|Lack of Efficacy|5
7756920|NCT00787202|12196046|FG003|Overall Study|Lack of Efficacy|2
7756921|NCT00787202|12196047|FG004|Overall Study|Lack of Efficacy|1
7756922|NCT00787202|12196043|FG000|Overall Study|Lost to Follow-up|1
7756923|NCT00787202|12196044|FG001|Overall Study|Lost to Follow-up|0
7756924|NCT00787202|12196045|FG002|Overall Study|Lost to Follow-up|0
7756925|NCT00787202|12196046|FG003|Overall Study|Lost to Follow-up|0
7756926|NCT00787202|12196047|FG004|Overall Study|Lost to Follow-up|0
7756927|NCT00787202|12196043|FG000|Overall Study|Withdrawal by Subject|2
7756928|NCT00787202|12196044|FG001|Overall Study|Withdrawal by Subject|2
7756929|NCT00787202|12196045|FG002|Overall Study|Withdrawal by Subject|2
7756930|NCT00787202|12196046|FG003|Overall Study|Withdrawal by Subject|0
7756931|NCT00787202|12196047|FG004|Overall Study|Withdrawal by Subject|0
7756932|NCT00787202|12196043|FG000|Overall Study|Protocol Violation|2
7756933|NCT00787202|12196044|FG001|Overall Study|Protocol Violation|1
7756934|NCT00787202|12196045|FG002|Overall Study|Protocol Violation|0
7756935|NCT00787202|12196046|FG003|Overall Study|Protocol Violation|0
7756936|NCT00787202|12196047|FG004|Overall Study|Protocol Violation|1
7756937|NCT00787202|12196043|FG000|Overall Study|Randomized, not treated|1
7756938|NCT00787202|12196044|FG001|Overall Study|Randomized, not treated|0
7756939|NCT00787202|12196045|FG002|Overall Study|Randomized, not treated|0
7756940|NCT00787202|12196046|FG003|Overall Study|Randomized, not treated|0
7756941|NCT00787202|12196047|FG004|Overall Study|Randomized, not treated|0
7756942|NCT00787254|12196078|FG000|Overall Study|Adverse Event|24
7756943|NCT00787254|12196079|FG001|Overall Study|Adverse Event|23
7756944|NCT00787254|12196078|FG000|Overall Study|Protocol Violation|26
7756945|NCT00787254|12196079|FG001|Overall Study|Protocol Violation|23
7756946|NCT00787254|12196078|FG000|Overall Study|Withdrawal by Subject|16
7756947|NCT00787254|12196079|FG001|Overall Study|Withdrawal by Subject|11
7756948|NCT00787254|12196078|FG000|Overall Study|Lack of Efficacy|4
7756949|NCT00787254|12196079|FG001|Overall Study|Lack of Efficacy|15
7756950|NCT00787254|12196078|FG000|Overall Study|NSAIDs discontinuation|1
7756951|NCT00787254|12196079|FG001|Overall Study|NSAIDs discontinuation|2
7756952|NCT00787254|12196078|FG000|Overall Study|Institution closed|1
7756953|NCT00787254|12196079|FG001|Overall Study|Institution closed|0
7756954|NCT00787254|12196078|FG000|Overall Study|Physician Decision|4
7756955|NCT00787254|12196079|FG001|Overall Study|Physician Decision|8
7756956|NCT00787267|12196085|FG000|Overall Study|Screen failure/Ineligible|10
7756957|NCT00787267|12196085|FG000|Overall Study|No Reason Provided|1
7756958|NCT00787267|12196085|FG000|Overall Study|Withdrawal by Subject|1
7756959|NCT00787319|12196089|FG000|Overall Study|Lost to Follow-up|2
7756960|NCT00787319|12196089|FG000|Overall Study|Withdrawal by Subject|15
7756961|NCT00787319|12196089|FG000|Overall Study|Adverse Event|3
7756962|NCT00787319|12196089|FG000|Overall Study|Objective progression or relapse|30
7756963|NCT00787319|12196089|FG000|Overall Study|Lack of Efficacy|1
7756964|NCT00787319|12196089|FG000|Overall Study|Budget exhausted/exceeded|1
7756965|NCT00787319|12196089|FG000|Overall Study|Unresponsiveness to visit invitation|1
7756966|NCT00787319|12196089|FG000|Overall Study|No health insurance reimbursement|2
7756967|NCT00787319|12196089|FG000|Overall Study|Stabilized disease findings|3
7756968|NCT00787319|12196089|FG000|Overall Study|Inactive disease|5
7756969|NCT00787527|12196102|FG000|Overall Study|Toxicity|3
7756970|NCT00787566|12196113|FG000|Overall Study|AE related to chemotherapy|0
7756971|NCT00787566|12196114|FG001|Overall Study|AE related to chemotherapy|1
7756972|NCT00787566|12196115|FG002|Overall Study|AE related to chemotherapy|0
7756973|NCT00787605|12196125|FG000|Overall Study|Administrative Problems|3
7756974|NCT00787605|12196126|FG001|Overall Study|Administrative Problems|0
7756975|NCT00787605|12196125|FG000|Overall Study|Adverse Event|14
7756976|NCT00787605|12196126|FG001|Overall Study|Adverse Event|25
7756977|NCT00787605|12196125|FG000|Overall Study|Lost to Follow-up|3
7756978|NCT00787605|12196126|FG001|Overall Study|Lost to Follow-up|6
7756979|NCT00787605|12196125|FG000|Overall Study|Protocol Violation|7
7756980|NCT00787605|12196126|FG001|Overall Study|Protocol Violation|3
7756981|NCT00787605|12196125|FG000|Overall Study|Withdrawal by Subject|6
7756982|NCT00787605|12196126|FG001|Overall Study|Withdrawal by Subject|13
7756983|NCT00787605|12196125|FG000|Overall Study|Lack of Efficacy|13
7756984|NCT00787605|12196126|FG001|Overall Study|Lack of Efficacy|9
7756985|NCT00787644|12196134|FG000|Overall Study|Lost to Follow-up|1
7756986|NCT00787644|12196135|FG001|Overall Study|Lost to Follow-up|1
7756987|NCT00787644|12196134|FG000|Overall Study|Withdrawal by Subject|1
7756988|NCT00787644|12196135|FG001|Overall Study|Withdrawal by Subject|1
7756989|NCT00787787|12196152|FG000|Overall Study|Lack of Efficacy|4
7756990|NCT00787787|12196152|FG000|Overall Study|Adverse Event|3
7756991|NCT00787800|12196158|FG000|Overall Study|Withdrawal by Subject|3
7756992|NCT00787800|12196159|FG001|Overall Study|Withdrawal by Subject|5
7756993|NCT00787800|12196158|FG000|Overall Study|Death|0
7756994|NCT00787800|12196159|FG001|Overall Study|Death|2
7756995|NCT00787839|12196166|FG000|Overall Study|Failure to have the OGTT was most common|404
7756996|NCT00787891|12196198|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1
7756997|NCT00787891|12196199|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2
7756998|NCT00787891|12196198|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
7756999|NCT00787891|12196199|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
7757000|NCT00787891|12196198|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
7757001|NCT00787891|12196199|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
7757002|NCT00787891|12196198|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1
7757003|NCT00787891|12196199|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0
7757004|NCT00787891|12196198|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
7757005|NCT00787891|12196199|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
7757006|NCT00787891|12196198|FG000|Short-term Double-blind Phase (Part 1)|Other|0
7757007|NCT00787891|12196199|FG001|Short-term Double-blind Phase (Part 1)|Other|2
7757008|NCT00787891|12196198|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
7757009|NCT00787891|12196199|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
7757010|NCT00787891|12196198|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
7757011|NCT00787891|12196199|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
7757012|NCT00787891|12196198|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
7757013|NCT00787891|12196199|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
7757014|NCT00787891|12196198|FG000|Maintenance Double-blind Phase (Part 2)|Other|5
7757015|NCT00787891|12196199|FG001|Maintenance Double-blind Phase (Part 2)|Other|2
7757016|NCT00787930|12196216|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
7757017|NCT00788073|12196245|FG000|STX209 Then Placebo|Adverse Event|1
7757018|NCT00788073|12196246|FG001|STX209 Then Placebo|Adverse Event|0
7757019|NCT00788073|12196245|FG000|STX209 Then Placebo|Lost to Follow-up|0
7757020|NCT00788073|12196246|FG001|STX209 Then Placebo|Lost to Follow-up|1
7757021|NCT00788073|12196245|FG000|STX209 Then Placebo|Withdrawal by Subject|0
7757022|NCT00788073|12196246|FG001|STX209 Then Placebo|Withdrawal by Subject|1
7757023|NCT00788073|12196245|FG000|STX209 Then Placebo|unable to return due to travel|0
7757024|NCT00788073|12196246|FG001|STX209 Then Placebo|unable to return due to travel|1
7757025|NCT00788073|12196245|FG000|Placebo Then STX209|Adverse Event|2
7757026|NCT00788073|12196246|FG001|Placebo Then STX209|Adverse Event|0
7757027|NCT00788073|12196245|FG000|Placebo Then STX209|Protocol Violation|0
7757028|NCT00788073|12196246|FG001|Placebo Then STX209|Protocol Violation|1
7757029|NCT00788372|12196259|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18
7757030|NCT00788372|12196259|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
7757031|NCT00788372|12196259|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
7757032|NCT00788372|12196259|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13
7757033|NCT00788372|12196259|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9
7757034|NCT00788372|12196259|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
7757035|NCT00788372|12196259|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
7757036|NCT00788593|12196263|FG000|Placebo Run-in Phase|Adverse Event|2
7757037|NCT00788593|12196264|FG001|Placebo Run-in Phase|Adverse Event|0
7757038|NCT00788593|12196265|FG002|Placebo Run-in Phase|Adverse Event|0
7757039|NCT00788593|12196263|FG000|Placebo Run-in Phase|Withdrawal by Subject|2
7757040|NCT00788593|12196264|FG001|Placebo Run-in Phase|Withdrawal by Subject|0
7757041|NCT00788593|12196265|FG002|Placebo Run-in Phase|Withdrawal by Subject|0
7757042|NCT00788593|12196263|FG000|Placebo Run-in Phase|Protocol Violation|2
7757043|NCT00788593|12196264|FG001|Placebo Run-in Phase|Protocol Violation|0
7757044|NCT00788593|12196265|FG002|Placebo Run-in Phase|Protocol Violation|0
7757045|NCT00788593|12196263|FG000|First Intervention Period|Adverse Event|0
7757046|NCT00788593|12196264|FG001|First Intervention Period|Adverse Event|1
7757047|NCT00788593|12196265|FG002|First Intervention Period|Adverse Event|0
7757048|NCT00788593|12196263|FG000|Second Intervention Period|Lost to Follow-up|0
7757049|NCT00788593|12196264|FG001|Second Intervention Period|Lost to Follow-up|1
7757050|NCT00788593|12196265|FG002|Second Intervention Period|Lost to Follow-up|0
7757051|NCT00788593|12196263|FG000|Second Intervention Period|Other|0
7757052|NCT00788593|12196264|FG001|Second Intervention Period|Other|0
7757053|NCT00788593|12196265|FG002|Second Intervention Period|Other|1
7769800|NCT00871494|12213526|FG000|Overall Study|Lost to Follow-up|1
7769801|NCT00871572|12213534|FG000|Overall Study|Adverse Event|0
7769802|NCT00871572|12213535|FG001|Overall Study|Adverse Event|2
7769803|NCT00871572|12213536|FG002|Overall Study|Adverse Event|0
7769804|NCT00871572|12213537|FG003|Overall Study|Adverse Event|3
7769805|NCT00871572|12213534|FG000|Overall Study|Investigator Decision|0
7769806|NCT00871572|12213535|FG001|Overall Study|Investigator Decision|1
7769807|NCT00871572|12213536|FG002|Overall Study|Investigator Decision|0
7769808|NCT00871572|12213537|FG003|Overall Study|Investigator Decision|1
7769809|NCT00871572|12213534|FG000|Overall Study|Lost to Follow-up|0
7769810|NCT00871572|12213535|FG001|Overall Study|Lost to Follow-up|1
7769811|NCT00871572|12213536|FG002|Overall Study|Lost to Follow-up|0
7769812|NCT00871572|12213537|FG003|Overall Study|Lost to Follow-up|1
7769813|NCT00871572|12213534|FG000|Overall Study|Protocol Violation|0
7769814|NCT00871572|12213535|FG001|Overall Study|Protocol Violation|0
7769815|NCT00871572|12213536|FG002|Overall Study|Protocol Violation|1
7769816|NCT00871572|12213537|FG003|Overall Study|Protocol Violation|1
7769817|NCT00871572|12213534|FG000|Overall Study|Sponsor Decision|1
7769818|NCT00871572|12213535|FG001|Overall Study|Sponsor Decision|0
7769819|NCT00871572|12213536|FG002|Overall Study|Sponsor Decision|0
7769820|NCT00871572|12213537|FG003|Overall Study|Sponsor Decision|0
7769821|NCT00871572|12213534|FG000|Overall Study|Withdrawal by Subject|1
7769822|NCT00871572|12213535|FG001|Overall Study|Withdrawal by Subject|2
7769823|NCT00871572|12213536|FG002|Overall Study|Withdrawal by Subject|3
7769824|NCT00871572|12213537|FG003|Overall Study|Withdrawal by Subject|1
7769825|NCT00871715|12213565|FG000|Overall Study|Withdrawal by Subject|6
7769826|NCT00871715|12213566|FG001|Overall Study|Withdrawal by Subject|10
7769827|NCT00871715|12213567|FG002|Overall Study|Withdrawal by Subject|15
7769828|NCT00871715|12213565|FG000|Overall Study|Physician Decision|6
7769829|NCT00871715|12213566|FG001|Overall Study|Physician Decision|0
7769830|NCT00871715|12213567|FG002|Overall Study|Physician Decision|2
7769831|NCT00871715|12213565|FG000|Overall Study|Lost to Follow-up|3
7769832|NCT00871715|12213566|FG001|Overall Study|Lost to Follow-up|6
7769833|NCT00871715|12213567|FG002|Overall Study|Lost to Follow-up|9
7769834|NCT00871728|12213576|FG000|Overall Study|Adverse Event|1
7769835|NCT00871728|12213576|FG000|Overall Study|Protocol Violation|7
7769836|NCT00871728|12213576|FG000|Overall Study|Lost to Follow-up|2
7769837|NCT00871728|12213576|FG000|Overall Study|Failed to Visit Hospital|4
7769838|NCT00871728|12213576|FG000|Overall Study|Participant Non-compliance|1
7769839|NCT00871728|12213576|FG000|Overall Study|Withdrawal of Informed Consent|5
7769840|NCT00871741|12213582|FG000|Overall Study|Premature study termination|9
7769841|NCT00871741|12213583|FG001|Overall Study|Premature study termination|7
7769842|NCT00871780|12213589|FG000|Overall Study|Enrolled But Not Treated|6
7769843|NCT00871780|12213589|FG000|Overall Study|Withdrawal by Subject|9
7769844|NCT00871780|12213589|FG000|Overall Study|Adverse Event|6
7769845|NCT00871780|12213589|FG000|Overall Study|Voluntary Discontinuation|4
7769846|NCT00871780|12213589|FG000|Overall Study|Death|1
7769847|NCT00871780|12213589|FG000|Overall Study|Physician Decision|1
7769848|NCT00871858|12213615|FG000|Overall Study|Protocol Violation|3
7769849|NCT00871858|12213616|FG001|Overall Study|Protocol Violation|4
7769850|NCT00871858|12213615|FG000|Overall Study|Adverse Event|1
7769851|NCT00871858|12213616|FG001|Overall Study|Adverse Event|1
7769852|NCT00871858|12213615|FG000|Overall Study|Withdrawal by Subject|1
7769853|NCT00871858|12213616|FG001|Overall Study|Withdrawal by Subject|1
7769854|NCT00871858|12213615|FG000|Overall Study|Lost to Follow-up|0
7769855|NCT00871858|12213616|FG001|Overall Study|Lost to Follow-up|1
7769856|NCT00871871|12213624|FG000|Part I|Adverse Event|0
7769857|NCT00871871|12213625|FG001|Part I|Adverse Event|2
7757054|NCT00788697|12196275|FG000|Overall Study|No study drug administered|12
7757055|NCT00788697|12196275|FG000|Overall Study|Training Patients|74
7757056|NCT00788697|12196275|FG000|Overall Study|no truth standard procedure available|5
7757057|NCT00788697|12196275|FG000|Overall Study|Technically inadequate truth standard|1
7757058|NCT00788697|12196275|FG000|Overall Study|Indeterminate diagnosis from truth stand|17
7757059|NCT00788775|12196289|FG000|Overall Study|Progressive Disease|8
7757060|NCT00788775|12196290|FG001|Overall Study|Progressive Disease|6
7757061|NCT00788775|12196289|FG000|Overall Study|Withdrawal by Subject|0
7757062|NCT00788775|12196290|FG001|Overall Study|Withdrawal by Subject|2
7757063|NCT00788775|12196289|FG000|Overall Study|Patient Non-Compliance|1
7757064|NCT00788775|12196290|FG001|Overall Study|Patient Non-Compliance|0
7757065|NCT00788775|12196289|FG000|Overall Study|Patient's measurable disease resected.|1
7757066|NCT00788775|12196290|FG001|Overall Study|Patient's measurable disease resected.|0
7757067|NCT00788827|12196296|FG000|Overall Study|Lack of Efficacy|2
7757068|NCT00788957|12196315|FG000|Part 1|Death|8
7757069|NCT00788957|12196316|FG001|Part 1|Death|0
7757070|NCT00788957|12196317|FG002|Part 1|Death|0
7757071|NCT00788957|12196318|FG003|Part 1|Death|0
7757072|NCT00788957|12196319|FG004|Part 1|Death|0
7757073|NCT00788957|12196320|FG005|Part 1|Death|0
7757074|NCT00788957|12196315|FG000|Part 1|Lost to Follow-up|1
7757075|NCT00788957|12196316|FG001|Part 1|Lost to Follow-up|0
7757076|NCT00788957|12196317|FG002|Part 1|Lost to Follow-up|0
7757077|NCT00788957|12196318|FG003|Part 1|Lost to Follow-up|0
7757078|NCT00788957|12196319|FG004|Part 1|Lost to Follow-up|0
7757079|NCT00788957|12196320|FG005|Part 1|Lost to Follow-up|0
7757080|NCT00788957|12196315|FG000|Part 2|Withdrawal by Subject|0
7757081|NCT00788957|12196316|FG001|Part 2|Withdrawal by Subject|9
7757082|NCT00788957|12196317|FG002|Part 2|Withdrawal by Subject|5
7757083|NCT00788957|12196318|FG003|Part 2|Withdrawal by Subject|3
7757084|NCT00788957|12196319|FG004|Part 2|Withdrawal by Subject|0
7757085|NCT00788957|12196320|FG005|Part 2|Withdrawal by Subject|0
7757086|NCT00788957|12196315|FG000|Part 2|Death|0
7757087|NCT00788957|12196316|FG001|Part 2|Death|32
7757088|NCT00788957|12196317|FG002|Part 2|Death|35
7757089|NCT00788957|12196318|FG003|Part 2|Death|37
7757090|NCT00788957|12196319|FG004|Part 2|Death|0
7757091|NCT00788957|12196320|FG005|Part 2|Death|0
7757092|NCT00788957|12196315|FG000|Part 2|Lost to Follow-up|0
7757093|NCT00788957|12196316|FG001|Part 2|Lost to Follow-up|0
7757094|NCT00788957|12196317|FG002|Part 2|Lost to Follow-up|3
7757095|NCT00788957|12196318|FG003|Part 2|Lost to Follow-up|0
7757096|NCT00788957|12196319|FG004|Part 2|Lost to Follow-up|0
7757097|NCT00788957|12196320|FG005|Part 2|Lost to Follow-up|0
7757098|NCT00788957|12196315|FG000|Part 2|On-study at time of data cut-off|0
7757099|NCT00788957|12196316|FG001|Part 2|On-study at time of data cut-off|1
7757100|NCT00788957|12196317|FG002|Part 2|On-study at time of data cut-off|1
7757101|NCT00788957|12196318|FG003|Part 2|On-study at time of data cut-off|1
7757102|NCT00788957|12196319|FG004|Part 2|On-study at time of data cut-off|0
7757103|NCT00788957|12196320|FG005|Part 2|On-study at time of data cut-off|0
7757104|NCT00788957|12196315|FG000|Part 3|Withdrawal by Subject|0
7757105|NCT00788957|12196316|FG001|Part 3|Withdrawal by Subject|0
7757106|NCT00788957|12196317|FG002|Part 3|Withdrawal by Subject|0
7757107|NCT00788957|12196318|FG003|Part 3|Withdrawal by Subject|0
7757108|NCT00788957|12196319|FG004|Part 3|Withdrawal by Subject|0
7757109|NCT00788957|12196320|FG005|Part 3|Withdrawal by Subject|2
7757110|NCT00788957|12196315|FG000|Part 3|Death|0
7757111|NCT00788957|12196316|FG001|Part 3|Death|0
7757112|NCT00788957|12196317|FG002|Part 3|Death|0
7757113|NCT00788957|12196318|FG003|Part 3|Death|0
7757114|NCT00788957|12196319|FG004|Part 3|Death|8
7757115|NCT00788957|12196320|FG005|Part 3|Death|9
7757116|NCT00788957|12196315|FG000|Part 3|On-study at time of data cut-off|0
7757117|NCT00788957|12196316|FG001|Part 3|On-study at time of data cut-off|0
7757118|NCT00788957|12196317|FG002|Part 3|On-study at time of data cut-off|0
7757119|NCT00788957|12196318|FG003|Part 3|On-study at time of data cut-off|0
7757120|NCT00788957|12196319|FG004|Part 3|On-study at time of data cut-off|1
7757121|NCT00788957|12196320|FG005|Part 3|On-study at time of data cut-off|0
7757122|NCT00789035|12196342|FG000|Overall Study|Adverse Event|0
7757123|NCT00789035|12196343|FG001|Overall Study|Adverse Event|2
7757124|NCT00789035|12196344|FG002|Overall Study|Adverse Event|0
7757125|NCT00789035|12196345|FG003|Overall Study|Adverse Event|1
7757126|NCT00789035|12196346|FG004|Overall Study|Adverse Event|3
7757127|NCT00789035|12196342|FG000|Overall Study|Lack of Efficacy|3
7757128|NCT00789035|12196343|FG001|Overall Study|Lack of Efficacy|0
7757129|NCT00789035|12196344|FG002|Overall Study|Lack of Efficacy|0
7757130|NCT00789035|12196345|FG003|Overall Study|Lack of Efficacy|0
7757131|NCT00789035|12196346|FG004|Overall Study|Lack of Efficacy|2
7757132|NCT00789035|12196342|FG000|Overall Study|Protocol Violation|1
7757133|NCT00789035|12196343|FG001|Overall Study|Protocol Violation|0
7757134|NCT00789035|12196344|FG002|Overall Study|Protocol Violation|0
7757135|NCT00789035|12196345|FG003|Overall Study|Protocol Violation|0
7757136|NCT00789035|12196346|FG004|Overall Study|Protocol Violation|0
7962466|NCT02712008|12516671|FG002|From Week 12 up to Week 36|Adverse Event|0
7962467|NCT02712008|12516672|FG003|From Week 12 up to Week 36|Adverse Event|0
7962468|NCT02712008|12516673|FG004|From Week 12 up to Week 36|Adverse Event|1
7962469|NCT02712008|12516674|FG005|From Week 12 up to Week 36|Adverse Event|0
7962470|NCT02712008|12516675|FG006|From Week 12 up to Week 36|Adverse Event|0
7757137|NCT00789035|12196342|FG000|Overall Study|Withdrawal by Subject|0
7757138|NCT00789035|12196343|FG001|Overall Study|Withdrawal by Subject|2
7757139|NCT00789035|12196344|FG002|Overall Study|Withdrawal by Subject|0
7757140|NCT00789035|12196345|FG003|Overall Study|Withdrawal by Subject|0
7757141|NCT00789035|12196346|FG004|Overall Study|Withdrawal by Subject|0
7757142|NCT00789035|12196342|FG000|Overall Study|Other reason not defined above|2
7757143|NCT00789035|12196343|FG001|Overall Study|Other reason not defined above|3
7757144|NCT00789035|12196344|FG002|Overall Study|Other reason not defined above|1
7757145|NCT00789035|12196345|FG003|Overall Study|Other reason not defined above|0
7757146|NCT00789035|12196346|FG004|Overall Study|Other reason not defined above|1
7757147|NCT00789191|12196380|FG000|Overall Study|Adverse Event|2
7757148|NCT00789191|12196381|FG001|Overall Study|Adverse Event|4
7757149|NCT00789191|12196380|FG000|Overall Study|Lack of Efficacy|0
7757150|NCT00789191|12196381|FG001|Overall Study|Lack of Efficacy|5
7757151|NCT00789191|12196380|FG000|Overall Study|Protocol Violation|5
7757152|NCT00789191|12196381|FG001|Overall Study|Protocol Violation|3
7757153|NCT00789191|12196380|FG000|Overall Study|Withdrawal Criteria|2
7757154|NCT00789191|12196381|FG001|Overall Study|Withdrawal Criteria|4
7757155|NCT00789191|12196380|FG000|Overall Study|Unclassified|5
7757156|NCT00789191|12196381|FG001|Overall Study|Unclassified|3
7757157|NCT00789321|12196401|FG000|Overall Study|Adverse Event|0
7757158|NCT00789321|12196402|FG001|Overall Study|Adverse Event|1
7757159|NCT00789360|12196410|FG000|Overall Study|Protocol Violation|3
7757160|NCT00789360|12196411|FG001|Overall Study|Protocol Violation|1
7757161|NCT00789373|12196418|FG000|Induction|Adverse Event|64
7757162|NCT00789373|12196419|FG001|Induction|Adverse Event|0
7757163|NCT00789373|12196420|FG002|Induction|Adverse Event|0
7757164|NCT00789373|12196418|FG000|Induction|Death Due to study disease|24
7757165|NCT00789373|12196419|FG001|Induction|Death Due to study disease|0
7757166|NCT00789373|12196420|FG002|Induction|Death Due to study disease|0
7757167|NCT00789373|12196418|FG000|Induction|Death due to adverse event|19
7757168|NCT00789373|12196419|FG001|Induction|Death due to adverse event|0
7757169|NCT00789373|12196420|FG002|Induction|Death due to adverse event|0
7757170|NCT00789373|12196418|FG000|Induction|Death due to toxicity|11
7757171|NCT00789373|12196419|FG001|Induction|Death due to toxicity|0
7757172|NCT00789373|12196420|FG002|Induction|Death due to toxicity|0
7757173|NCT00789373|12196418|FG000|Induction|Death due to procedure|1
7757174|NCT00789373|12196419|FG001|Induction|Death due to procedure|0
7757175|NCT00789373|12196420|FG002|Induction|Death due to procedure|0
7757176|NCT00789373|12196418|FG000|Induction|Investigator decision|7
7757177|NCT00789373|12196419|FG001|Induction|Investigator decision|0
7757178|NCT00789373|12196420|FG002|Induction|Investigator decision|0
7757179|NCT00789373|12196418|FG000|Induction|Protocol entry criteria not met|9
7757180|NCT00789373|12196419|FG001|Induction|Protocol entry criteria not met|0
7757181|NCT00789373|12196420|FG002|Induction|Protocol entry criteria not met|0
7757182|NCT00789373|12196418|FG000|Induction|Lost to Follow-up|6
7757183|NCT00789373|12196419|FG001|Induction|Lost to Follow-up|0
7757184|NCT00789373|12196420|FG002|Induction|Lost to Follow-up|0
7757185|NCT00789373|12196418|FG000|Induction|Protocol Violation|1
7757186|NCT00789373|12196419|FG001|Induction|Protocol Violation|0
7757187|NCT00789373|12196420|FG002|Induction|Protocol Violation|0
7757188|NCT00789373|12196418|FG000|Induction|Progressive Disease|220
7757189|NCT00789373|12196419|FG001|Induction|Progressive Disease|0
7757190|NCT00789373|12196420|FG002|Induction|Progressive Disease|0
7757191|NCT00789373|12196418|FG000|Induction|Withdrawal by Subject|37
7757192|NCT00789373|12196419|FG001|Induction|Withdrawal by Subject|0
7757193|NCT00789373|12196420|FG002|Induction|Withdrawal by Subject|0
7757194|NCT00789373|12196418|FG000|Maintenance|Adverse Event|0
7757195|NCT00789373|12196419|FG001|Maintenance|Adverse Event|65
7757196|NCT00789373|12196420|FG002|Maintenance|Adverse Event|12
7757197|NCT00789373|12196418|FG000|Maintenance|Death due to study disease|0
7757198|NCT00789373|12196419|FG001|Maintenance|Death due to study disease|3
7757199|NCT00789373|12196420|FG002|Maintenance|Death due to study disease|1
7757200|NCT00789373|12196418|FG000|Maintenance|Death due to adverse event|0
7757201|NCT00789373|12196419|FG001|Maintenance|Death due to adverse event|4
7757202|NCT00789373|12196420|FG002|Maintenance|Death due to adverse event|1
7757203|NCT00789373|12196418|FG000|Maintenance|Death due to toxicity|0
7757204|NCT00789373|12196419|FG001|Maintenance|Death due to toxicity|1
7757205|NCT00789373|12196420|FG002|Maintenance|Death due to toxicity|2
7757206|NCT00789373|12196418|FG000|Maintenance|Investigator Decision|0
7757207|NCT00789373|12196419|FG001|Maintenance|Investigator Decision|4
7757208|NCT00789373|12196420|FG002|Maintenance|Investigator Decision|2
7757209|NCT00789373|12196418|FG000|Maintenance|Protocol entry criteria not met|0
7757210|NCT00789373|12196419|FG001|Maintenance|Protocol entry criteria not met|2
7757211|NCT00789373|12196420|FG002|Maintenance|Protocol entry criteria not met|0
7757212|NCT00789373|12196418|FG000|Maintenance|Lost to Follow-up|0
7757213|NCT00789373|12196419|FG001|Maintenance|Lost to Follow-up|2
7757214|NCT00789373|12196420|FG002|Maintenance|Lost to Follow-up|0
7757215|NCT00789373|12196418|FG000|Maintenance|Progressive Disease|0
7757216|NCT00789373|12196419|FG001|Maintenance|Progressive Disease|253
7757217|NCT00789373|12196420|FG002|Maintenance|Progressive Disease|152
7757218|NCT00789373|12196418|FG000|Maintenance|Withdrawal by Subject|0
7757219|NCT00789373|12196419|FG001|Maintenance|Withdrawal by Subject|21
7757220|NCT00789373|12196420|FG002|Maintenance|Withdrawal by Subject|8
7757221|NCT00789373|12196418|FG000|Maintenance|Sponsor Decision|0
7757222|NCT00789373|12196419|FG001|Maintenance|Sponsor Decision|0
7757223|NCT00789373|12196420|FG002|Maintenance|Sponsor Decision|2
7757224|NCT00789373|12196418|FG000|Maintenance|Participants On-Going at Data Cut-Off|0
7757225|NCT00789373|12196419|FG001|Maintenance|Participants On-Going at Data Cut-Off|4
7757226|NCT00789373|12196420|FG002|Maintenance|Participants On-Going at Data Cut-Off|0
7757227|NCT00789477|12196449|FG000|Overall Study|Withdrawal by Subject|2
7757228|NCT00789477|12196450|FG001|Overall Study|Withdrawal by Subject|1
7757229|NCT00789477|12196451|FG002|Overall Study|Withdrawal by Subject|3
7757230|NCT00789477|12196452|FG003|Overall Study|Withdrawal by Subject|2
7757231|NCT00789477|12196453|FG004|Overall Study|Withdrawal by Subject|3
7757232|NCT00789477|12196449|FG000|Overall Study|Protocol Violation|1
7757233|NCT00789477|12196450|FG001|Overall Study|Protocol Violation|0
7757234|NCT00789477|12196451|FG002|Overall Study|Protocol Violation|0
7757235|NCT00789477|12196452|FG003|Overall Study|Protocol Violation|1
7757236|NCT00789477|12196453|FG004|Overall Study|Protocol Violation|0
7757237|NCT00789477|12196449|FG000|Overall Study|Adverse Event|3
7757238|NCT00789477|12196450|FG001|Overall Study|Adverse Event|3
7757239|NCT00789477|12196451|FG002|Overall Study|Adverse Event|1
7757240|NCT00789477|12196452|FG003|Overall Study|Adverse Event|0
7757241|NCT00789477|12196453|FG004|Overall Study|Adverse Event|0
7757242|NCT00789477|12196449|FG000|Overall Study|Death|1
7757243|NCT00789477|12196450|FG001|Overall Study|Death|1
7757244|NCT00789477|12196451|FG002|Overall Study|Death|2
7757245|NCT00789477|12196452|FG003|Overall Study|Death|2
7757246|NCT00789477|12196453|FG004|Overall Study|Death|0
7757247|NCT00789477|12196449|FG000|Overall Study|Lost to Follow-up|0
7757248|NCT00789477|12196450|FG001|Overall Study|Lost to Follow-up|1
7757249|NCT00789477|12196451|FG002|Overall Study|Lost to Follow-up|4
7757250|NCT00789477|12196452|FG003|Overall Study|Lost to Follow-up|2
7757251|NCT00789477|12196453|FG004|Overall Study|Lost to Follow-up|4
7757252|NCT00789477|12196449|FG000|Overall Study|Lack of Efficacy|2
7757253|NCT00789477|12196450|FG001|Overall Study|Lack of Efficacy|0
7757254|NCT00789477|12196451|FG002|Overall Study|Lack of Efficacy|0
7757255|NCT00789477|12196452|FG003|Overall Study|Lack of Efficacy|0
7757256|NCT00789477|12196453|FG004|Overall Study|Lack of Efficacy|0
7757257|NCT00789477|12196449|FG000|Overall Study|Other|2
7757258|NCT00789477|12196450|FG001|Overall Study|Other|0
7757259|NCT00789477|12196451|FG002|Overall Study|Other|1
7757260|NCT00789477|12196452|FG003|Overall Study|Other|3
7757261|NCT00789477|12196453|FG004|Overall Study|Other|0
7757262|NCT00789529|12196469|FG000|Overall Study|Withdrawal by Subject|0
7757263|NCT00789529|12196470|FG001|Overall Study|Withdrawal by Subject|1
7757264|NCT00789529|12196469|FG000|Overall Study|Other Reason|1
7757265|NCT00789529|12196470|FG001|Overall Study|Other Reason|0
7757266|NCT00789555|12196479|FG000|Overall Study|Protocol Amendment|78
7757267|NCT00789555|12196480|FG001|Overall Study|Protocol Amendment|76
7757268|NCT00789555|12196481|FG002|Overall Study|Protocol Amendment|80
7757269|NCT00789555|12196479|FG000|Overall Study|Adverse Event|17
7757270|NCT00789555|12196480|FG001|Overall Study|Adverse Event|7
7757271|NCT00789555|12196481|FG002|Overall Study|Adverse Event|10
7757272|NCT00789555|12196479|FG000|Overall Study|Lost to Follow-up|9
7757273|NCT00789555|12196480|FG001|Overall Study|Lost to Follow-up|10
7757274|NCT00789555|12196481|FG002|Overall Study|Lost to Follow-up|18
7757275|NCT00789555|12196479|FG000|Overall Study|Patient decision unnrelated to adv event|38
7757276|NCT00789555|12196480|FG001|Overall Study|Patient decision unnrelated to adv event|29
7757277|NCT00789555|12196481|FG002|Overall Study|Patient decision unnrelated to adv event|26
7757278|NCT00789555|12196479|FG000|Overall Study|Treatment failure|11
7757279|NCT00789555|12196480|FG001|Overall Study|Treatment failure|8
7757280|NCT00789555|12196481|FG002|Overall Study|Treatment failure|12
7757281|NCT00789555|12196479|FG000|Overall Study|Protocol Violation|6
7757282|NCT00789555|12196480|FG001|Overall Study|Protocol Violation|9
7757283|NCT00789555|12196481|FG002|Overall Study|Protocol Violation|13
7757284|NCT00789581|12196491|FG000|AC Therapy|Adverse Event|2
7757285|NCT00789581|12196492|FG001|AC Therapy|Adverse Event|3
7757286|NCT00789581|12196491|FG000|AC Therapy|Withdrawal by Subject|4
7757287|NCT00789581|12196492|FG001|AC Therapy|Withdrawal by Subject|7
7757288|NCT00789581|12196491|FG000|AC Therapy|Disease recurrence|3
7757289|NCT00789581|12196492|FG001|AC Therapy|Disease recurrence|1
7757290|NCT00789581|12196491|FG000|AC Therapy|Intercurrent Illness|1
7757291|NCT00789581|12196492|FG001|AC Therapy|Intercurrent Illness|0
7757292|NCT00789581|12196491|FG000|AC Therapy|Never Treated|1
7757293|NCT00789581|12196492|FG001|AC Therapy|Never Treated|4
7757294|NCT00789581|12196491|FG000|AC Therapy|Other|0
7757295|NCT00789581|12196492|FG001|AC Therapy|Other|2
7757296|NCT00789581|12196491|FG000|Adjuvant Therapy|Never treated|2
7757297|NCT00789581|12196492|FG001|Adjuvant Therapy|Never treated|2
7757298|NCT00789581|12196491|FG000|Adjuvant Therapy|Adverse Event|20
7757299|NCT00789581|12196492|FG001|Adjuvant Therapy|Adverse Event|44
7757300|NCT00789581|12196491|FG000|Adjuvant Therapy|Withdrawal by Subject|14
7757301|NCT00789581|12196492|FG001|Adjuvant Therapy|Withdrawal by Subject|5
7757302|NCT00789581|12196491|FG000|Adjuvant Therapy|Disease recurrence|2
7757303|NCT00789581|12196492|FG001|Adjuvant Therapy|Disease recurrence|1
7757304|NCT00789581|12196491|FG000|Adjuvant Therapy|Intercurrent Illness|1
7757305|NCT00789581|12196492|FG001|Adjuvant Therapy|Intercurrent Illness|3
7757306|NCT00789581|12196491|FG000|Adjuvant Therapy|Protocol Violation|1
7757307|NCT00789581|12196492|FG001|Adjuvant Therapy|Protocol Violation|1
7757308|NCT00789581|12196491|FG000|Adjuvant Therapy|Other|0
7757309|NCT00789581|12196492|FG001|Adjuvant Therapy|Other|1
7757310|NCT00789698|12196516|FG000|Overall Study|Lack of Efficacy|10
7757311|NCT00789698|12196517|FG001|Overall Study|Lack of Efficacy|4
7757312|NCT00789698|12196518|FG002|Overall Study|Lack of Efficacy|5
7757313|NCT00789698|12196519|FG003|Overall Study|Lack of Efficacy|18
7757314|NCT00789698|12196516|FG000|Overall Study|Adverse Event|5
7757315|NCT00789698|12196517|FG001|Overall Study|Adverse Event|5
7757316|NCT00789698|12196518|FG002|Overall Study|Adverse Event|3
7757317|NCT00789698|12196519|FG003|Overall Study|Adverse Event|4
7757318|NCT00789698|12196516|FG000|Overall Study|Lost to Follow-up|5
7757319|NCT00789698|12196517|FG001|Overall Study|Lost to Follow-up|5
7757320|NCT00789698|12196518|FG002|Overall Study|Lost to Follow-up|2
7757321|NCT00789698|12196519|FG003|Overall Study|Lost to Follow-up|9
7757322|NCT00789698|12196516|FG000|Overall Study|Protocol Violation|6
7757323|NCT00789698|12196517|FG001|Overall Study|Protocol Violation|1
7757324|NCT00789698|12196518|FG002|Overall Study|Protocol Violation|2
7757325|NCT00789698|12196519|FG003|Overall Study|Protocol Violation|1
7757326|NCT00789698|12196516|FG000|Overall Study|Withdrawal by Subject|14
7757327|NCT00789698|12196517|FG001|Overall Study|Withdrawal by Subject|15
7757328|NCT00789698|12196518|FG002|Overall Study|Withdrawal by Subject|12
7757329|NCT00789698|12196519|FG003|Overall Study|Withdrawal by Subject|19
7757330|NCT00789698|12196516|FG000|Overall Study|Administrative|0
7757331|NCT00789698|12196517|FG001|Overall Study|Administrative|3
7757332|NCT00789698|12196518|FG002|Overall Study|Administrative|3
7757333|NCT00789698|12196519|FG003|Overall Study|Administrative|1
7757334|NCT00789737|12196539|FG000|Overall Study|Withdrawal by Subject|13
7757335|NCT00789737|12196540|FG001|Overall Study|Withdrawal by Subject|22
7757336|NCT00789737|12196539|FG000|Overall Study|Lost to Follow-up|10
7757337|NCT00789737|12196540|FG001|Overall Study|Lost to Follow-up|14
7962471|NCT02712008|12516676|FG007|From Week 12 up to Week 36|Adverse Event|2
7962472|NCT02712008|12516669|FG000|From Week 12 up to Week 36|Death|1
7962473|NCT02712008|12516670|FG001|From Week 12 up to Week 36|Death|0
7962474|NCT02712008|12516671|FG002|From Week 12 up to Week 36|Death|0
7962475|NCT02712008|12516672|FG003|From Week 12 up to Week 36|Death|0
7962476|NCT02712008|12516673|FG004|From Week 12 up to Week 36|Death|0
7962477|NCT02712008|12516674|FG005|From Week 12 up to Week 36|Death|0
7962478|NCT02712008|12516675|FG006|From Week 12 up to Week 36|Death|1
7962479|NCT02712008|12516676|FG007|From Week 12 up to Week 36|Death|0
7962480|NCT02712008|12516669|FG000|From Week 12 up to Week 36|Lost to Follow-up|0
7962481|NCT02712008|12516670|FG001|From Week 12 up to Week 36|Lost to Follow-up|0
7962482|NCT02712008|12516671|FG002|From Week 12 up to Week 36|Lost to Follow-up|0
7962483|NCT02712008|12516672|FG003|From Week 12 up to Week 36|Lost to Follow-up|1
7962484|NCT02712008|12516673|FG004|From Week 12 up to Week 36|Lost to Follow-up|0
7962485|NCT02712008|12516674|FG005|From Week 12 up to Week 36|Lost to Follow-up|0
7962486|NCT02712008|12516675|FG006|From Week 12 up to Week 36|Lost to Follow-up|1
7962487|NCT02712008|12516676|FG007|From Week 12 up to Week 36|Lost to Follow-up|0
7962488|NCT02712008|12516669|FG000|From Week 12 up to Week 36|Physician Decision|0
7757338|NCT00789737|12196539|FG000|Overall Study|Adverse Event|8
7757339|NCT00789737|12196540|FG001|Overall Study|Adverse Event|8
7962489|NCT02712008|12516670|FG001|From Week 12 up to Week 36|Physician Decision|0
7962490|NCT02712008|12516671|FG002|From Week 12 up to Week 36|Physician Decision|0
7962491|NCT02712008|12516672|FG003|From Week 12 up to Week 36|Physician Decision|1
7962492|NCT02712008|12516673|FG004|From Week 12 up to Week 36|Physician Decision|1
7962493|NCT02712008|12516674|FG005|From Week 12 up to Week 36|Physician Decision|0
7962494|NCT02712008|12516675|FG006|From Week 12 up to Week 36|Physician Decision|0
7962495|NCT02712008|12516676|FG007|From Week 12 up to Week 36|Physician Decision|0
7962496|NCT02712008|12516669|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0
7962497|NCT02712008|12516670|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0
7962498|NCT02712008|12516671|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0
7962499|NCT02712008|12516672|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0
7962500|NCT02712008|12516673|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0
7962501|NCT02712008|12516674|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0
7962502|NCT02712008|12516675|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3
7962503|NCT02712008|12516676|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2
7962504|NCT02712320|12516706|FG000|Overall Study|Lost to Follow-up|1
7962505|NCT02712320|12516706|FG000|Overall Study|Withdrawal by Subject|1
7962506|NCT02712320|12516706|FG000|Overall Study|Transferred to another facility|1
7962507|NCT02712320|12516706|FG000|Overall Study|Treating with the prohibited medications|2
7962508|NCT02712333|12516712|FG000|First Period|Withdrawal by Subject|3
7962509|NCT02712333|12516713|FG001|First Period|Withdrawal by Subject|2
7962510|NCT02712398|12516741|FG000|Overall Study|Withdrawal by Subject|6
7962511|NCT02712398|12516741|FG000|Overall Study|Lost to Follow-up|6
7962512|NCT02712398|12516741|FG000|Overall Study|Sponsor Decision|1
7962513|NCT02712398|12516741|FG000|Overall Study|Physician Decision|1
7962514|NCT02712398|12516741|FG000|Overall Study|Death|2
7962515|NCT02712398|12516741|FG000|Overall Study|Re-operation|21
7962516|NCT02712424|12516747|FG000|Overall Study|Lost to Follow-up|34
7757340|NCT00789737|12196539|FG000|Overall Study|Protocol Violation|3
7757341|NCT00789737|12196540|FG001|Overall Study|Protocol Violation|0
7757342|NCT00789737|12196539|FG000|Overall Study|Lack of Efficacy|3
7757343|NCT00789737|12196540|FG001|Overall Study|Lack of Efficacy|0
7757344|NCT00789737|12196539|FG000|Overall Study|hyperglycemia that met protocol-specifie|0
7757345|NCT00789737|12196540|FG001|Overall Study|hyperglycemia that met protocol-specifie|4
7757346|NCT00789737|12196539|FG000|Overall Study|Other|11
7757347|NCT00789737|12196540|FG001|Overall Study|Other|7
7757348|NCT00789815|12196582|FG000|Overall Study|Protocol Violation|6
7757349|NCT00789815|12196583|FG001|Overall Study|Protocol Violation|1
7757350|NCT00789815|12196582|FG000|Overall Study|Intubation due to massive bleeding|1
7757351|NCT00789815|12196583|FG001|Overall Study|Intubation due to massive bleeding|0
7757352|NCT00789828|12196591|FG000|Core Period (48 Weeks)|Administrative problems|0
7757353|NCT00789828|12196592|FG001|Core Period (48 Weeks)|Administrative problems|1
7757354|NCT00789828|12196591|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0
7757355|NCT00789828|12196592|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4
7757356|NCT00789828|12196591|FG000|Core Period (48 Weeks)|Lost to Follow-up|0
7757357|NCT00789828|12196592|FG001|Core Period (48 Weeks)|Lost to Follow-up|1
7757358|NCT00789828|12196591|FG000|Open-label Extension Period (4 Years)|Adverse Event|10
7757359|NCT00789828|12196592|FG001|Open-label Extension Period (4 Years)|Adverse Event|0
7757360|NCT00789828|12196591|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
7757361|NCT00789828|12196592|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
7757362|NCT00789828|12196591|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3
7757363|NCT00789828|12196592|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0
7757364|NCT00789828|12196591|FG000|Open-label Extension Period (4 Years)|Administrative problems|7
7757365|NCT00789828|12196592|FG001|Open-label Extension Period (4 Years)|Administrative problems|0
7757366|NCT00789828|12196591|FG000|Open-label Extension Period (4 Years)|Death|1
7757367|NCT00789828|12196592|FG001|Open-label Extension Period (4 Years)|Death|0
7757368|NCT00789828|12196591|FG000|Open-label Extension Period (4 Years)|Disease progression|1
7757369|NCT00789828|12196592|FG001|Open-label Extension Period (4 Years)|Disease progression|0
7757370|NCT00789828|12196591|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1
7757371|NCT00789828|12196592|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0
7757372|NCT00789854|12196604|FG000|Overall Study|Adverse Event|28
7757373|NCT00789854|12196605|FG001|Overall Study|Adverse Event|23
7757374|NCT00789854|12196606|FG002|Overall Study|Adverse Event|18
7757375|NCT00789854|12196604|FG000|Overall Study|Lost to Follow-up|1
7757376|NCT00789854|12196605|FG001|Overall Study|Lost to Follow-up|1
7757377|NCT00789854|12196606|FG002|Overall Study|Lost to Follow-up|4
7757378|NCT00789854|12196604|FG000|Overall Study|Withdrawal by Subject|9
7757379|NCT00789854|12196605|FG001|Overall Study|Withdrawal by Subject|6
7757380|NCT00789854|12196606|FG002|Overall Study|Withdrawal by Subject|17
7757381|NCT00789854|12196604|FG000|Overall Study|Eligibility criteria not fulfilled|2
7757382|NCT00789854|12196605|FG001|Overall Study|Eligibility criteria not fulfilled|5
7757383|NCT00789854|12196606|FG002|Overall Study|Eligibility criteria not fulfilled|1
7757384|NCT00789854|12196604|FG000|Overall Study|Severe non-compliance to the protocol|3
7757385|NCT00789854|12196605|FG001|Overall Study|Severe non-compliance to the protocol|0
7757386|NCT00789854|12196606|FG002|Overall Study|Severe non-compliance to the protocol|0
7757387|NCT00789854|12196604|FG000|Overall Study|Safety reasons|0
7757388|NCT00789854|12196605|FG001|Overall Study|Safety reasons|0
7757389|NCT00789854|12196606|FG002|Overall Study|Safety reasons|2
7757390|NCT00789854|12196604|FG000|Overall Study|Other|6
7757391|NCT00789854|12196605|FG001|Overall Study|Other|0
7757392|NCT00789854|12196606|FG002|Overall Study|Other|5
7757393|NCT00789880|12196634|FG000|Overall Study|Adverse Event|0
7757394|NCT00789880|12196635|FG001|Overall Study|Adverse Event|0
7757395|NCT00789880|12196636|FG002|Overall Study|Adverse Event|0
7757396|NCT00789880|12196637|FG003|Overall Study|Adverse Event|0
7757397|NCT00789880|12196638|FG004|Overall Study|Adverse Event|1
7757398|NCT00789880|12196639|FG005|Overall Study|Adverse Event|0
7757399|NCT00789880|12196634|FG000|Overall Study|Protocol Violation|0
7757400|NCT00789880|12196635|FG001|Overall Study|Protocol Violation|1
7757401|NCT00789880|12196636|FG002|Overall Study|Protocol Violation|0
7757402|NCT00789880|12196637|FG003|Overall Study|Protocol Violation|1
7757403|NCT00789880|12196638|FG004|Overall Study|Protocol Violation|0
7757404|NCT00789880|12196639|FG005|Overall Study|Protocol Violation|0
7757405|NCT00789880|12196634|FG000|Overall Study|Withdrawal by Subject|1
7757406|NCT00789880|12196635|FG001|Overall Study|Withdrawal by Subject|0
7757407|NCT00789880|12196636|FG002|Overall Study|Withdrawal by Subject|0
7962517|NCT02712424|12516748|FG001|Overall Study|Lost to Follow-up|32
7962518|NCT02712554|12516756|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0
7962519|NCT02712554|12516757|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13
7962520|NCT02712554|12516756|FG000|Part B: Qualification Phase|Sponsor Decision|0
7962521|NCT02712554|12516757|FG001|Part B: Qualification Phase|Sponsor Decision|4
7962522|NCT02712554|12516756|FG000|Part B: Qualification Phase|Withdrawal by Subject|0
7962523|NCT02712554|12516757|FG001|Part B: Qualification Phase|Withdrawal by Subject|3
7962524|NCT02712554|12516756|FG000|Part B: Qualification Phase|Adverse Event|0
7962525|NCT02712554|12516757|FG001|Part B: Qualification Phase|Adverse Event|1
7962526|NCT02712554|12516756|FG000|Part B: Treatment Phase|Adverse Event|0
7962527|NCT02712554|12516757|FG001|Part B: Treatment Phase|Adverse Event|1
7962528|NCT02712554|12516756|FG000|Part B: Treatment Phase|Withdrawal by Subject|0
7962529|NCT02712554|12516757|FG001|Part B: Treatment Phase|Withdrawal by Subject|1
7962530|NCT02712554|12516756|FG000|Part B: Treatment Phase|Other|0
7962531|NCT02712554|12516757|FG001|Part B: Treatment Phase|Other|1
7962532|NCT02712788|12516782|FG000|Overall Study|Physician Decision|1
7962533|NCT02712788|12516783|FG001|Overall Study|Physician Decision|0
7962534|NCT02712788|12516782|FG000|Overall Study|Protocol Violation|1
7962535|NCT02712788|12516783|FG001|Overall Study|Protocol Violation|0
7757408|NCT00789880|12196637|FG003|Overall Study|Withdrawal by Subject|0
7757409|NCT00789880|12196638|FG004|Overall Study|Withdrawal by Subject|2
7757410|NCT00789880|12196639|FG005|Overall Study|Withdrawal by Subject|0
7757411|NCT00789958|12196653|FG000|Overall Study|Adverse Event|3
7962536|NCT02712983|12516798|FG000|Treatment Phase|Adverse Event|3
7962537|NCT02712983|12516799|FG001|Treatment Phase|Adverse Event|1
7757412|NCT00789958|12196653|FG000|Overall Study|Withdrawal by Subject|4
7757413|NCT00789958|12196653|FG000|Overall Study|Progression|3
7757414|NCT00789958|12196653|FG000|Overall Study|not protocol specified|1
7757415|NCT00789958|12196653|FG000|Overall Study|Not eligible/not analyzable|26
7757416|NCT00790023|12196671|FG000|Overall Study|Adverse Event|2
7757417|NCT00790023|12196672|FG001|Overall Study|Adverse Event|1
7757418|NCT00790023|12196673|FG002|Overall Study|Adverse Event|4
7757419|NCT00790023|12196671|FG000|Overall Study|Protocol Violation|2
7757420|NCT00790023|12196672|FG001|Overall Study|Protocol Violation|4
7757421|NCT00790023|12196673|FG002|Overall Study|Protocol Violation|2
7757422|NCT00790023|12196671|FG000|Overall Study|Withdrawal by Subject|2
7757423|NCT00790023|12196672|FG001|Overall Study|Withdrawal by Subject|0
7757424|NCT00790023|12196673|FG002|Overall Study|Withdrawal by Subject|6
7757425|NCT00790023|12196671|FG000|Overall Study|Lost to Follow-up|0
7757426|NCT00790023|12196672|FG001|Overall Study|Lost to Follow-up|0
7757427|NCT00790023|12196673|FG002|Overall Study|Lost to Follow-up|1
7757428|NCT00790023|12196671|FG000|Overall Study|Other|5
7757429|NCT00790023|12196672|FG001|Overall Study|Other|5
7757430|NCT00790023|12196673|FG002|Overall Study|Other|8
7757431|NCT00790036|12196684|FG000|Overall Study|Abnormal lab values|3
7757432|NCT00790036|12196685|FG001|Overall Study|Abnormal lab values|2
7757433|NCT00790036|12196684|FG000|Overall Study|Administrative problems|5
7757434|NCT00790036|12196685|FG001|Overall Study|Administrative problems|9
7757435|NCT00790036|12196684|FG000|Overall Study|Adverse Event|113
7757436|NCT00790036|12196685|FG001|Overall Study|Adverse Event|44
7757437|NCT00790036|12196684|FG000|Overall Study|Death|1
7757438|NCT00790036|12196685|FG001|Overall Study|Death|0
7757439|NCT00790036|12196684|FG000|Overall Study|Disease progression|24
7757440|NCT00790036|12196685|FG001|Overall Study|Disease progression|48
7757441|NCT00790036|12196684|FG000|Overall Study|Lost to Follow-up|1
7757442|NCT00790036|12196685|FG001|Overall Study|Lost to Follow-up|2
7757443|NCT00790036|12196684|FG000|Overall Study|Protocol Violation|10
7757444|NCT00790036|12196685|FG001|Overall Study|Protocol Violation|2
7757445|NCT00790036|12196684|FG000|Overall Study|Withdrawal by Subject|18
7757446|NCT00790036|12196685|FG001|Overall Study|Withdrawal by Subject|7
7757447|NCT00790036|12196684|FG000|Overall Study|Subject/guardian decision|20
7757448|NCT00790036|12196685|FG001|Overall Study|Subject/guardian decision|7
7769858|NCT00871871|12213626|FG002|Part I|Adverse Event|0
7769859|NCT00871871|12213627|FG003|Part I|Adverse Event|0
7769860|NCT00871871|12213624|FG000|Part I|Withdrawal by Subject|3
7769861|NCT00871871|12213625|FG001|Part I|Withdrawal by Subject|0
7769862|NCT00871871|12213626|FG002|Part I|Withdrawal by Subject|0
7769863|NCT00871871|12213627|FG003|Part I|Withdrawal by Subject|0
7769864|NCT00871871|12213624|FG000|Part I|Laboratory abnormality|0
7769865|NCT00871871|12213625|FG001|Part I|Laboratory abnormality|1
7769866|NCT00871871|12213626|FG002|Part I|Laboratory abnormality|0
7769867|NCT00871871|12213627|FG003|Part I|Laboratory abnormality|0
7769868|NCT00871871|12213624|FG000|Part II|Lack of Efficacy|0
7769869|NCT00871871|12213625|FG001|Part II|Lack of Efficacy|0
7769870|NCT00871871|12213626|FG002|Part II|Lack of Efficacy|1
7769871|NCT00871871|12213627|FG003|Part II|Lack of Efficacy|0
7769872|NCT00871871|12213624|FG000|Part II|Withdrawal by Subject|0
7769873|NCT00871871|12213625|FG001|Part II|Withdrawal by Subject|0
7769874|NCT00871871|12213626|FG002|Part II|Withdrawal by Subject|2
7769875|NCT00871871|12213627|FG003|Part II|Withdrawal by Subject|1
7769876|NCT00871871|12213624|FG000|Part II|Adverse Event|0
7769877|NCT00871871|12213625|FG001|Part II|Adverse Event|0
7769878|NCT00871871|12213626|FG002|Part II|Adverse Event|1
7769879|NCT00871871|12213627|FG003|Part II|Adverse Event|2
7769880|NCT00871871|12213624|FG000|Part II|Protocol Violation|0
7769881|NCT00871871|12213625|FG001|Part II|Protocol Violation|0
7769882|NCT00871871|12213626|FG002|Part II|Protocol Violation|0
7769883|NCT00871871|12213627|FG003|Part II|Protocol Violation|1
7769884|NCT00871923|12213637|FG000|Overall Study|Death|1
7769885|NCT00871923|12213637|FG000|Overall Study|Withdrawal by Subject|1
7769886|NCT00871975|12213641|FG000|Overall Study|Technical difficulty w155-1ith equipment|3
7769887|NCT00871975|12213641|FG000|Overall Study|Catheters could not be inserted|1
7769888|NCT00871975|12213641|FG000|Overall Study|Patient unable to void/insufficient vol|13
7769889|NCT00871975|12213641|FG000|Overall Study|Motion artifact, tracing uninterpretable|5
7769890|NCT00872001|12213647|FG000|Overall Study|Adverse Event|34
7769891|NCT00872001|12213648|FG001|Overall Study|Adverse Event|23
7769892|NCT00872001|12213647|FG000|Overall Study|Protocol Defined Clinical Event|5
7769893|NCT00872001|12213648|FG001|Overall Study|Protocol Defined Clinical Event|7
7769894|NCT00872001|12213647|FG000|Overall Study|Lost to Follow-up|13
7769895|NCT00872001|12213648|FG001|Overall Study|Lost to Follow-up|12
7769896|NCT00872001|12213647|FG000|Overall Study|Withdrawal by Subject|18
7769897|NCT00872001|12213648|FG001|Overall Study|Withdrawal by Subject|30
7769898|NCT00872001|12213647|FG000|Overall Study|Protocol Violation|5
7769899|NCT00872001|12213648|FG001|Overall Study|Protocol Violation|8
7769900|NCT00872001|12213647|FG000|Overall Study|Did Not Meet Protocol Eligibility|38
7769901|NCT00872001|12213648|FG001|Overall Study|Did Not Meet Protocol Eligibility|36
7769902|NCT00872001|12213647|FG000|Overall Study|Administrative|23
7769903|NCT00872001|12213648|FG001|Overall Study|Administrative|15
7757449|NCT00790088|12196714|FG000|Overall Study|Protocol Violation|11
7757450|NCT00790088|12196714|FG000|Overall Study|Withdrawal by Subject|17
7757451|NCT00790088|12196714|FG000|Overall Study|Lost to Follow-up|7
7757452|NCT00790088|12196714|FG000|Overall Study|Physician Decision|4
7757453|NCT00790205|12196739|FG000|Overall Study|Lost to Follow-up|61
7757454|NCT00790205|12196740|FG001|Overall Study|Lost to Follow-up|71
7757455|NCT00790205|12196739|FG000|Overall Study|Withdrawal by Subject|299
7757456|NCT00790205|12196740|FG001|Overall Study|Withdrawal by Subject|363
7757457|NCT00790296|12196761|FG000|Overall Study|Did not meet study eligibility criteria|1
7757458|NCT00790296|12196762|FG001|Overall Study|Did not meet study eligibility criteria|1
7757459|NCT00790296|12196761|FG000|Overall Study|Adverse Event|0
7757460|NCT00790296|12196762|FG001|Overall Study|Adverse Event|1
7757461|NCT00790400|12196779|FG000|Double-blind Period (Core Phase)|Protocol Violation|1
7757462|NCT00790400|12196780|FG001|Double-blind Period (Core Phase)|Protocol Violation|0
7757463|NCT00790400|12196779|FG000|Double-blind Period (Core Phase)|Progressive disease|0
7757464|NCT00790400|12196780|FG001|Double-blind Period (Core Phase)|Progressive disease|9
7757465|NCT00790400|12196779|FG000|Double-blind Period (Core Phase)|Adverse Event|2
7757466|NCT00790400|12196780|FG001|Double-blind Period (Core Phase)|Adverse Event|4
7757467|NCT00790400|12196779|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
7757468|NCT00790400|12196780|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
7757469|NCT00790400|12196779|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1
7757470|NCT00790400|12196780|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0
7757471|NCT00790400|12196779|FG000|Double-blind Period (Core Phase)|Administrative problems|1
7757472|NCT00790400|12196780|FG001|Double-blind Period (Core Phase)|Administrative problems|0
7757473|NCT00790400|12196779|FG000|Double-blind Period (Core Phase)|Death|1
7757474|NCT00790400|12196780|FG001|Double-blind Period (Core Phase)|Death|0
7757475|NCT00790400|12196779|FG000|Everolimus Period (Core or Extension)|Adverse Event|9
7757476|NCT00790400|12196780|FG001|Everolimus Period (Core or Extension)|Adverse Event|0
7757477|NCT00790400|12196779|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
7757478|NCT00790400|12196780|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
7757479|NCT00790400|12196779|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
7757480|NCT00790400|12196780|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
7757481|NCT00790400|12196779|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1
7757482|NCT00790400|12196780|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0
7757483|NCT00790400|12196779|FG000|Everolimus Period (Core or Extension)|Administrative problems|2
7757484|NCT00790400|12196780|FG001|Everolimus Period (Core or Extension)|Administrative problems|0
7757485|NCT00790400|12196779|FG000|Everolimus Period (Core or Extension)|Death|1
7757486|NCT00790400|12196780|FG001|Everolimus Period (Core or Extension)|Death|0
7757487|NCT00790400|12196779|FG000|Everolimus Period (Core or Extension)|Disease progression|5
7962538|NCT02712983|12516800|FG002|Treatment Phase|Adverse Event|1
7962539|NCT02712983|12516801|FG003|Treatment Phase|Adverse Event|4
7962540|NCT02712983|12516802|FG004|Treatment Phase|Adverse Event|3
7962541|NCT02712983|12516803|FG005|Treatment Phase|Adverse Event|0
7962542|NCT02712983|12516804|FG006|Treatment Phase|Adverse Event|6
7962543|NCT02712983|12516805|FG007|Treatment Phase|Adverse Event|6
7962544|NCT02712983|12516806|FG008|Treatment Phase|Adverse Event|1
7962545|NCT02712983|12516798|FG000|Treatment Phase|Protocol Deviation|0
7962546|NCT02712983|12516799|FG001|Treatment Phase|Protocol Deviation|0
7962547|NCT02712983|12516800|FG002|Treatment Phase|Protocol Deviation|0
7962548|NCT02712983|12516801|FG003|Treatment Phase|Protocol Deviation|2
7962549|NCT02712983|12516802|FG004|Treatment Phase|Protocol Deviation|0
7962550|NCT02712983|12516803|FG005|Treatment Phase|Protocol Deviation|0
7962551|NCT02712983|12516804|FG006|Treatment Phase|Protocol Deviation|1
7962552|NCT02712983|12516805|FG007|Treatment Phase|Protocol Deviation|0
7962553|NCT02712983|12516806|FG008|Treatment Phase|Protocol Deviation|0
7962554|NCT02712983|12516798|FG000|Treatment Phase|Technical Problems|0
7757488|NCT00790400|12196780|FG001|Everolimus Period (Core or Extension)|Disease progression|0
7757489|NCT00790400|12196779|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1
7757490|NCT00790400|12196780|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0
7757491|NCT00790400|12196779|FG000|Everolimus Period (Core or Extension)|New treatment|2
7757492|NCT00790400|12196780|FG001|Everolimus Period (Core or Extension)|New treatment|0
7757493|NCT00790556|12196789|FG000|Treatment Period 1|Physician Decision|1
7757494|NCT00790556|12196790|FG001|Treatment Period 1|Physician Decision|0
7624482|NCT02287584|12035643|FG004|the Double-blind Phase|Adverse Event|0
7624483|NCT02287584|12035644|FG005|the Double-blind Phase|Adverse Event|0
7624484|NCT02287584|12035639|FG000|the Double-blind Phase|Lack of Efficacy|18
7624485|NCT02287584|12035640|FG001|the Double-blind Phase|Lack of Efficacy|8
7624486|NCT02287584|12035641|FG002|the Double-blind Phase|Lack of Efficacy|8
7624487|NCT02287584|12035642|FG003|the Double-blind Phase|Lack of Efficacy|0
7624488|NCT02287584|12035643|FG004|the Double-blind Phase|Lack of Efficacy|0
7624489|NCT02287584|12035644|FG005|the Double-blind Phase|Lack of Efficacy|0
7624490|NCT02287584|12035639|FG000|the Double-blind Phase|Lost to Follow-up|0
7624491|NCT02287584|12035640|FG001|the Double-blind Phase|Lost to Follow-up|1
7624492|NCT02287584|12035641|FG002|the Double-blind Phase|Lost to Follow-up|1
7624493|NCT02287584|12035642|FG003|the Double-blind Phase|Lost to Follow-up|0
7624494|NCT02287584|12035643|FG004|the Double-blind Phase|Lost to Follow-up|0
7624495|NCT02287584|12035644|FG005|the Double-blind Phase|Lost to Follow-up|0
7624496|NCT02287584|12035639|FG000|the Double-blind Phase|Withdrawal by Subject|17
7624497|NCT02287584|12035640|FG001|the Double-blind Phase|Withdrawal by Subject|17
7624498|NCT02287584|12035641|FG002|the Double-blind Phase|Withdrawal by Subject|11
7624499|NCT02287584|12035642|FG003|the Double-blind Phase|Withdrawal by Subject|0
7624500|NCT02287584|12035643|FG004|the Double-blind Phase|Withdrawal by Subject|0
7624501|NCT02287584|12035644|FG005|the Double-blind Phase|Withdrawal by Subject|0
7624502|NCT02287584|12035639|FG000|the Double-blind Phase|Pregnancy|0
7624503|NCT02287584|12035640|FG001|the Double-blind Phase|Pregnancy|1
7624504|NCT02287584|12035641|FG002|the Double-blind Phase|Pregnancy|0
7624505|NCT02287584|12035642|FG003|the Double-blind Phase|Pregnancy|0
7624506|NCT02287584|12035643|FG004|the Double-blind Phase|Pregnancy|0
7624507|NCT02287584|12035644|FG005|the Double-blind Phase|Pregnancy|0
7624508|NCT02287584|12035639|FG000|the Double-blind Phase|Protocol Violation|0
7624509|NCT02287584|12035640|FG001|the Double-blind Phase|Protocol Violation|3
7624510|NCT02287584|12035641|FG002|the Double-blind Phase|Protocol Violation|0
7624511|NCT02287584|12035642|FG003|the Double-blind Phase|Protocol Violation|0
7624512|NCT02287584|12035643|FG004|the Double-blind Phase|Protocol Violation|0
7624513|NCT02287584|12035644|FG005|the Double-blind Phase|Protocol Violation|0
7624514|NCT02287584|12035639|FG000|the Double-blind Phase|other reasons|0
7624515|NCT02287584|12035640|FG001|the Double-blind Phase|other reasons|0
7624516|NCT02287584|12035641|FG002|the Double-blind Phase|other reasons|1
7624517|NCT02287584|12035642|FG003|the Double-blind Phase|other reasons|0
7624518|NCT02287584|12035643|FG004|the Double-blind Phase|other reasons|0
7624519|NCT02287584|12035644|FG005|the Double-blind Phase|other reasons|0
7624520|NCT02287584|12035639|FG000|the Open-label Phase|Did not receive drug|0
7624521|NCT02287584|12035640|FG001|the Open-label Phase|Did not receive drug|0
7624522|NCT02287584|12035641|FG002|the Open-label Phase|Did not receive drug|0
7624523|NCT02287584|12035642|FG003|the Open-label Phase|Did not receive drug|7
7624524|NCT02287584|12035643|FG004|the Open-label Phase|Did not receive drug|6
7624525|NCT02287584|12035644|FG005|the Open-label Phase|Did not receive drug|4
7624526|NCT02287584|12035639|FG000|the Open-label Phase|Adverse Event|0
7624527|NCT02287584|12035640|FG001|the Open-label Phase|Adverse Event|0
7624528|NCT02287584|12035641|FG002|the Open-label Phase|Adverse Event|0
7624529|NCT02287584|12035642|FG003|the Open-label Phase|Adverse Event|15
7624530|NCT02287584|12035643|FG004|the Open-label Phase|Adverse Event|12
7624531|NCT02287584|12035644|FG005|the Open-label Phase|Adverse Event|16
7624532|NCT02287584|12035639|FG000|the Open-label Phase|Lack of Efficacy|0
7624533|NCT02287584|12035640|FG001|the Open-label Phase|Lack of Efficacy|0
7624534|NCT02287584|12035641|FG002|the Open-label Phase|Lack of Efficacy|0
7624535|NCT02287584|12035642|FG003|the Open-label Phase|Lack of Efficacy|8
7624536|NCT02287584|12035643|FG004|the Open-label Phase|Lack of Efficacy|3
7624537|NCT02287584|12035644|FG005|the Open-label Phase|Lack of Efficacy|7
7624538|NCT02287584|12035639|FG000|the Open-label Phase|Lost to Follow-up|0
7624539|NCT02287584|12035640|FG001|the Open-label Phase|Lost to Follow-up|0
7757495|NCT00790556|12196789|FG000|Treatment Period 1|Withdrawal by Subject|1
7757496|NCT00790556|12196790|FG001|Treatment Period 1|Withdrawal by Subject|0
7757497|NCT00790569|12196799|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20
7757498|NCT00790569|12196800|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8
7757499|NCT00790569|12196801|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20
7757500|NCT00790569|12196799|FG000|End of Treatment (6 Month Interview)|Death|0
7757501|NCT00790569|12196800|FG001|End of Treatment (6 Month Interview)|Death|2
7624540|NCT02287584|12035641|FG002|the Open-label Phase|Lost to Follow-up|0
7624541|NCT02287584|12035642|FG003|the Open-label Phase|Lost to Follow-up|4
7624542|NCT02287584|12035643|FG004|the Open-label Phase|Lost to Follow-up|1
7624543|NCT02287584|12035644|FG005|the Open-label Phase|Lost to Follow-up|2
7624544|NCT02287584|12035639|FG000|the Open-label Phase|Withdrawal by Subject|0
7624545|NCT02287584|12035640|FG001|the Open-label Phase|Withdrawal by Subject|0
7624546|NCT02287584|12035641|FG002|the Open-label Phase|Withdrawal by Subject|0
7624547|NCT02287584|12035642|FG003|the Open-label Phase|Withdrawal by Subject|18
7624548|NCT02287584|12035643|FG004|the Open-label Phase|Withdrawal by Subject|29
7624549|NCT02287584|12035644|FG005|the Open-label Phase|Withdrawal by Subject|21
7624550|NCT02287584|12035639|FG000|the Open-label Phase|non-compliance|0
7624551|NCT02287584|12035640|FG001|the Open-label Phase|non-compliance|0
7624552|NCT02287584|12035641|FG002|the Open-label Phase|non-compliance|0
7624553|NCT02287584|12035642|FG003|the Open-label Phase|non-compliance|2
7624554|NCT02287584|12035643|FG004|the Open-label Phase|non-compliance|5
7624555|NCT02287584|12035644|FG005|the Open-label Phase|non-compliance|1
7624556|NCT02287584|12035639|FG000|the Open-label Phase|other reasons|0
7624557|NCT02287584|12035640|FG001|the Open-label Phase|other reasons|0
7624558|NCT02287584|12035641|FG002|the Open-label Phase|other reasons|0
7624559|NCT02287584|12035642|FG003|the Open-label Phase|other reasons|3
7624560|NCT02287584|12035643|FG004|the Open-label Phase|other reasons|6
7624561|NCT02287584|12035644|FG005|the Open-label Phase|other reasons|6
7624562|NCT02178566|12035660|FG000|Overall Study|patient did not complete due to noncompliance|0
7624563|NCT02178566|12035661|FG001|Overall Study|patient did not complete due to noncompliance|1
7624564|NCT02173301|12035671|FG000|Overall Study|Adverse Event|7
7624565|NCT02173301|12035672|FG001|Overall Study|Adverse Event|8
7757502|NCT00790569|12196801|FG002|End of Treatment (6 Month Interview)|Death|1
7757503|NCT00790569|12196799|FG000|End of Treatment (6 Month Interview)|Hospitalized|2
7757504|NCT00790569|12196800|FG001|End of Treatment (6 Month Interview)|Hospitalized|0
7757505|NCT00790569|12196801|FG002|End of Treatment (6 Month Interview)|Hospitalized|0
7757506|NCT00790569|12196799|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0
7757507|NCT00790569|12196800|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0
7757508|NCT00790569|12196801|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2
7757509|NCT00790569|12196799|FG000|End of Treatment (6 Month Interview)|Incarcerated|0
7757510|NCT00790569|12196800|FG001|End of Treatment (6 Month Interview)|Incarcerated|0
7757511|NCT00790569|12196801|FG002|End of Treatment (6 Month Interview)|Incarcerated|3
7757512|NCT00790569|12196799|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66
7757513|NCT00790569|12196800|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19
7757514|NCT00790569|12196801|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50
7757515|NCT00790582|12196811|FG000|Overall Study|Death|14
7757516|NCT00790582|12196812|FG001|Overall Study|Death|32
7757517|NCT00790582|12196811|FG000|Overall Study|Physician Decision|7
7757518|NCT00790582|12196812|FG001|Overall Study|Physician Decision|1
7757519|NCT00790582|12196811|FG000|Overall Study|Lost to Follow-up|3
7757520|NCT00790582|12196812|FG001|Overall Study|Lost to Follow-up|3
7757521|NCT00790582|12196811|FG000|Overall Study|Withdrawal by Subject|7
7757522|NCT00790582|12196812|FG001|Overall Study|Withdrawal by Subject|51
7757523|NCT00790647|12196820|FG000|Overall Study|Adverse Event|1
7757524|NCT00790751|12196867|FG000|Overall Study|Protocol non-compliance|16
7757525|NCT00790751|12196868|FG001|Overall Study|Protocol non-compliance|16
7757526|NCT00790751|12196869|FG002|Overall Study|Protocol non-compliance|10
7757527|NCT00790751|12196870|FG003|Overall Study|Protocol non-compliance|11
7757528|NCT00790751|12196867|FG000|Overall Study|Lost to Follow-up|4
7757529|NCT00790751|12196868|FG001|Overall Study|Lost to Follow-up|9
7757530|NCT00790751|12196869|FG002|Overall Study|Lost to Follow-up|4
7757531|NCT00790751|12196870|FG003|Overall Study|Lost to Follow-up|5
7757532|NCT00790751|12196867|FG000|Overall Study|Adverse Event|5
7757533|NCT00790751|12196868|FG001|Overall Study|Adverse Event|3
7757534|NCT00790751|12196869|FG002|Overall Study|Adverse Event|5
7757535|NCT00790751|12196870|FG003|Overall Study|Adverse Event|4
7757536|NCT00790751|12196867|FG000|Overall Study|Requirement for restricted medication|0
7757537|NCT00790751|12196868|FG001|Overall Study|Requirement for restricted medication|2
7757538|NCT00790751|12196869|FG002|Overall Study|Requirement for restricted medication|0
7757539|NCT00790751|12196870|FG003|Overall Study|Requirement for restricted medication|0
7757540|NCT00790751|12196867|FG000|Overall Study|Death|0
7757541|NCT00790751|12196868|FG001|Overall Study|Death|0
7757542|NCT00790751|12196869|FG002|Overall Study|Death|1
7757543|NCT00790751|12196870|FG003|Overall Study|Death|0
7757544|NCT00790751|12196867|FG000|Overall Study|Physician Decision|0
7757545|NCT00790751|12196868|FG001|Overall Study|Physician Decision|0
7757546|NCT00790751|12196869|FG002|Overall Study|Physician Decision|0
7757547|NCT00790751|12196870|FG003|Overall Study|Physician Decision|1
7757548|NCT00790790|12196883|FG000|Study Period 2: Therapy Phase|Adverse Event|3
7757549|NCT00790790|12196884|FG001|Study Period 2: Therapy Phase|Adverse Event|16
7757550|NCT00790790|12196885|FG002|Study Period 2: Therapy Phase|Adverse Event|16
7757551|NCT00790790|12196883|FG000|Study Period 2: Therapy Phase|Protocol Violation|1
7757552|NCT00790790|12196884|FG001|Study Period 2: Therapy Phase|Protocol Violation|1
7757553|NCT00790790|12196885|FG002|Study Period 2: Therapy Phase|Protocol Violation|0
7757554|NCT00790790|12196883|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7
7757555|NCT00790790|12196884|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0
7757556|NCT00790790|12196885|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2
7757557|NCT00790790|12196883|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1
7757558|NCT00790790|12196884|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0
7757559|NCT00790790|12196885|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3
7757560|NCT00790790|12196883|FG000|Study Period 2: Therapy Phase|Physician Decision|0
7757561|NCT00790790|12196884|FG001|Study Period 2: Therapy Phase|Physician Decision|1
7757562|NCT00790790|12196885|FG002|Study Period 2: Therapy Phase|Physician Decision|0
7757563|NCT00790842|12196901|FG000|Dose Level 1|Adverse Event|1
7757564|NCT00790842|12196902|FG001|Dose Level 1|Adverse Event|0
7757565|NCT00790842|12196903|FG002|Dose Level 1|Adverse Event|0
7757566|NCT00790842|12196904|FG003|Dose Level 1|Adverse Event|2
7757567|NCT00790842|12196905|FG004|Dose Level 1|Adverse Event|0
7757568|NCT00790842|12196906|FG005|Dose Level 1|Adverse Event|0
7757569|NCT00790842|12196907|FG006|Dose Level 1|Adverse Event|0
7757570|NCT00790842|12196908|FG007|Dose Level 1|Adverse Event|1
7757571|NCT00790842|12196909|FG008|Dose Level 1|Adverse Event|0
7757572|NCT00790842|12196910|FG009|Dose Level 1|Adverse Event|0
7757573|NCT00790842|12196911|FG010|Dose Level 1|Adverse Event|0
7757574|NCT00790842|12196901|FG000|Dose Level 1|Physician Decision|1
7757575|NCT00790842|12196902|FG001|Dose Level 1|Physician Decision|0
7757576|NCT00790842|12196903|FG002|Dose Level 1|Physician Decision|0
7757577|NCT00790842|12196904|FG003|Dose Level 1|Physician Decision|0
7757578|NCT00790842|12196905|FG004|Dose Level 1|Physician Decision|0
7757579|NCT00790842|12196906|FG005|Dose Level 1|Physician Decision|0
7757580|NCT00790842|12196907|FG006|Dose Level 1|Physician Decision|0
7757581|NCT00790842|12196908|FG007|Dose Level 1|Physician Decision|1
7757582|NCT00790842|12196909|FG008|Dose Level 1|Physician Decision|0
7757583|NCT00790842|12196910|FG009|Dose Level 1|Physician Decision|0
7757584|NCT00790842|12196911|FG010|Dose Level 1|Physician Decision|0
7757585|NCT00790842|12196901|FG000|Dose Level 1|Withdrawal by Subject|1
7757586|NCT00790842|12196902|FG001|Dose Level 1|Withdrawal by Subject|0
7757587|NCT00790842|12196903|FG002|Dose Level 1|Withdrawal by Subject|0
7757588|NCT00790842|12196904|FG003|Dose Level 1|Withdrawal by Subject|0
7757589|NCT00790842|12196905|FG004|Dose Level 1|Withdrawal by Subject|0
7757590|NCT00790842|12196906|FG005|Dose Level 1|Withdrawal by Subject|0
7757591|NCT00790842|12196907|FG006|Dose Level 1|Withdrawal by Subject|0
7757592|NCT00790842|12196908|FG007|Dose Level 1|Withdrawal by Subject|0
7757593|NCT00790842|12196909|FG008|Dose Level 1|Withdrawal by Subject|0
7757594|NCT00790842|12196910|FG009|Dose Level 1|Withdrawal by Subject|0
7757595|NCT00790842|12196911|FG010|Dose Level 1|Withdrawal by Subject|0
7757596|NCT00790842|12196901|FG000|Dose Level 2|Death|0
7757597|NCT00790842|12196902|FG001|Dose Level 2|Death|1
7757598|NCT00790842|12196903|FG002|Dose Level 2|Death|0
7757599|NCT00790842|12196904|FG003|Dose Level 2|Death|0
7757600|NCT00790842|12196905|FG004|Dose Level 2|Death|1
7757601|NCT00790842|12196906|FG005|Dose Level 2|Death|0
7757602|NCT00790842|12196907|FG006|Dose Level 2|Death|0
7757603|NCT00790842|12196908|FG007|Dose Level 2|Death|0
7757604|NCT00790842|12196909|FG008|Dose Level 2|Death|0
7757605|NCT00790842|12196910|FG009|Dose Level 2|Death|0
7757606|NCT00790842|12196911|FG010|Dose Level 2|Death|0
7757607|NCT00790842|12196901|FG000|Dose Level 2|Physician Decision|0
7757608|NCT00790842|12196902|FG001|Dose Level 2|Physician Decision|1
7757609|NCT00790842|12196903|FG002|Dose Level 2|Physician Decision|0
7757610|NCT00790842|12196904|FG003|Dose Level 2|Physician Decision|0
7757611|NCT00790842|12196905|FG004|Dose Level 2|Physician Decision|0
7757612|NCT00790842|12196906|FG005|Dose Level 2|Physician Decision|0
7757613|NCT00790842|12196907|FG006|Dose Level 2|Physician Decision|0
7757614|NCT00790842|12196908|FG007|Dose Level 2|Physician Decision|0
7757615|NCT00790842|12196909|FG008|Dose Level 2|Physician Decision|0
7757616|NCT00790842|12196910|FG009|Dose Level 2|Physician Decision|0
7757617|NCT00790842|12196911|FG010|Dose Level 2|Physician Decision|0
7757618|NCT00790842|12196901|FG000|Dose Level 2|Withdrawal by Subject|0
7757619|NCT00790842|12196902|FG001|Dose Level 2|Withdrawal by Subject|1
7757620|NCT00790842|12196903|FG002|Dose Level 2|Withdrawal by Subject|0
7757621|NCT00790842|12196904|FG003|Dose Level 2|Withdrawal by Subject|0
7757622|NCT00790842|12196905|FG004|Dose Level 2|Withdrawal by Subject|0
7757623|NCT00790842|12196906|FG005|Dose Level 2|Withdrawal by Subject|0
7757624|NCT00790842|12196907|FG006|Dose Level 2|Withdrawal by Subject|0
7757625|NCT00790842|12196908|FG007|Dose Level 2|Withdrawal by Subject|0
7757626|NCT00790842|12196909|FG008|Dose Level 2|Withdrawal by Subject|0
7757627|NCT00790842|12196910|FG009|Dose Level 2|Withdrawal by Subject|0
7757628|NCT00790842|12196911|FG010|Dose Level 2|Withdrawal by Subject|0
7757629|NCT00790842|12196901|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0
7757630|NCT00790842|12196902|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0
7757631|NCT00790842|12196903|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0
7757632|NCT00790842|12196904|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0
7757633|NCT00790842|12196905|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0
7757634|NCT00790842|12196906|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0
7757635|NCT00790842|12196907|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0
7757636|NCT00790842|12196908|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0
7757637|NCT00790842|12196909|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2
7757638|NCT00790842|12196910|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0
7757639|NCT00790842|12196911|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0
7757640|NCT00790842|12196901|FG000|Dose Level 3|Adverse Event|0
7757641|NCT00790842|12196902|FG001|Dose Level 3|Adverse Event|0
7757642|NCT00790842|12196903|FG002|Dose Level 3|Adverse Event|1
7757643|NCT00790842|12196904|FG003|Dose Level 3|Adverse Event|0
7757644|NCT00790842|12196905|FG004|Dose Level 3|Adverse Event|0
7757645|NCT00790842|12196906|FG005|Dose Level 3|Adverse Event|0
7757646|NCT00790842|12196907|FG006|Dose Level 3|Adverse Event|0
7757647|NCT00790842|12196908|FG007|Dose Level 3|Adverse Event|0
7757648|NCT00790842|12196909|FG008|Dose Level 3|Adverse Event|0
7757649|NCT00790842|12196910|FG009|Dose Level 3|Adverse Event|0
7757650|NCT00790842|12196911|FG010|Dose Level 3|Adverse Event|0
7757651|NCT00790842|12196901|FG000|Dose Level 3|Withdrawal by Subject|0
7757652|NCT00790842|12196902|FG001|Dose Level 3|Withdrawal by Subject|0
7757653|NCT00790842|12196903|FG002|Dose Level 3|Withdrawal by Subject|3
7757654|NCT00790842|12196904|FG003|Dose Level 3|Withdrawal by Subject|0
7757655|NCT00790842|12196905|FG004|Dose Level 3|Withdrawal by Subject|0
7757656|NCT00790842|12196906|FG005|Dose Level 3|Withdrawal by Subject|0
7757657|NCT00790842|12196907|FG006|Dose Level 3|Withdrawal by Subject|0
7757658|NCT00790842|12196908|FG007|Dose Level 3|Withdrawal by Subject|0
7757659|NCT00790842|12196909|FG008|Dose Level 3|Withdrawal by Subject|0
7757660|NCT00790842|12196910|FG009|Dose Level 3|Withdrawal by Subject|2
7757661|NCT00790842|12196911|FG010|Dose Level 3|Withdrawal by Subject|0
7757662|NCT00790842|12196901|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7757663|NCT00790842|12196902|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7757664|NCT00790842|12196903|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7757665|NCT00790842|12196904|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7757666|NCT00790842|12196905|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7757667|NCT00790842|12196906|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
7757668|NCT00790842|12196907|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7757669|NCT00790842|12196908|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7757670|NCT00790842|12196909|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7757671|NCT00790842|12196910|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7757672|NCT00790842|12196911|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7757673|NCT00790842|12196901|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0
7757674|NCT00790842|12196902|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0
7757675|NCT00790842|12196903|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1
7757676|NCT00790842|12196904|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0
7757677|NCT00790842|12196905|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0
7757678|NCT00790842|12196906|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0
7757679|NCT00790842|12196907|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0
7757680|NCT00790842|12196908|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0
7757681|NCT00790842|12196909|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0
7757682|NCT00790842|12196910|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0
7757683|NCT00790842|12196911|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0
7757684|NCT00790842|12196901|FG000|Dose Level 4|Adverse Event|0
7757685|NCT00790842|12196902|FG001|Dose Level 4|Adverse Event|0
7757686|NCT00790842|12196903|FG002|Dose Level 4|Adverse Event|0
7757687|NCT00790842|12196904|FG003|Dose Level 4|Adverse Event|0
7757688|NCT00790842|12196905|FG004|Dose Level 4|Adverse Event|0
7757689|NCT00790842|12196906|FG005|Dose Level 4|Adverse Event|0
7757690|NCT00790842|12196907|FG006|Dose Level 4|Adverse Event|1
7757691|NCT00790842|12196908|FG007|Dose Level 4|Adverse Event|0
7757692|NCT00790842|12196909|FG008|Dose Level 4|Adverse Event|0
7757693|NCT00790842|12196910|FG009|Dose Level 4|Adverse Event|0
7757694|NCT00790842|12196911|FG010|Dose Level 4|Adverse Event|0
7757695|NCT00790842|12196901|FG000|Dose Level 4|Physician Decision|0
7757696|NCT00790842|12196902|FG001|Dose Level 4|Physician Decision|0
7757697|NCT00790842|12196903|FG002|Dose Level 4|Physician Decision|0
7757698|NCT00790842|12196904|FG003|Dose Level 4|Physician Decision|0
7757699|NCT00790842|12196905|FG004|Dose Level 4|Physician Decision|0
7757700|NCT00790842|12196906|FG005|Dose Level 4|Physician Decision|0
7757701|NCT00790842|12196907|FG006|Dose Level 4|Physician Decision|1
7757702|NCT00790842|12196908|FG007|Dose Level 4|Physician Decision|0
7757703|NCT00790842|12196909|FG008|Dose Level 4|Physician Decision|0
7757704|NCT00790842|12196910|FG009|Dose Level 4|Physician Decision|0
7757705|NCT00790842|12196911|FG010|Dose Level 4|Physician Decision|1
7757706|NCT00790842|12196901|FG000|Dose Level 4|Withdrawal by Subject|0
7757707|NCT00790842|12196902|FG001|Dose Level 4|Withdrawal by Subject|0
7757708|NCT00790842|12196903|FG002|Dose Level 4|Withdrawal by Subject|0
7757709|NCT00790842|12196904|FG003|Dose Level 4|Withdrawal by Subject|0
7757710|NCT00790842|12196905|FG004|Dose Level 4|Withdrawal by Subject|0
7757711|NCT00790842|12196906|FG005|Dose Level 4|Withdrawal by Subject|0
7757712|NCT00790842|12196907|FG006|Dose Level 4|Withdrawal by Subject|0
7757713|NCT00790842|12196908|FG007|Dose Level 4|Withdrawal by Subject|0
7757714|NCT00790842|12196909|FG008|Dose Level 4|Withdrawal by Subject|0
7757715|NCT00790842|12196910|FG009|Dose Level 4|Withdrawal by Subject|0
7757716|NCT00790842|12196911|FG010|Dose Level 4|Withdrawal by Subject|1
7757717|NCT00790842|12196901|FG000|Expansion Cohort|Adverse Event|0
7757718|NCT00790842|12196902|FG001|Expansion Cohort|Adverse Event|0
7757719|NCT00790842|12196903|FG002|Expansion Cohort|Adverse Event|0
7757720|NCT00790842|12196904|FG003|Expansion Cohort|Adverse Event|0
7757721|NCT00790842|12196905|FG004|Expansion Cohort|Adverse Event|0
7757722|NCT00790842|12196906|FG005|Expansion Cohort|Adverse Event|0
7757723|NCT00790842|12196907|FG006|Expansion Cohort|Adverse Event|1
7757724|NCT00790842|12196908|FG007|Expansion Cohort|Adverse Event|0
7757725|NCT00790842|12196909|FG008|Expansion Cohort|Adverse Event|0
7757726|NCT00790842|12196910|FG009|Expansion Cohort|Adverse Event|0
7757727|NCT00790842|12196911|FG010|Expansion Cohort|Adverse Event|0
7757728|NCT00790842|12196901|FG000|Expansion Cohort|Death|0
7757729|NCT00790842|12196902|FG001|Expansion Cohort|Death|0
7757730|NCT00790842|12196903|FG002|Expansion Cohort|Death|2
7757731|NCT00790842|12196904|FG003|Expansion Cohort|Death|0
7757732|NCT00790842|12196905|FG004|Expansion Cohort|Death|0
7757733|NCT00790842|12196906|FG005|Expansion Cohort|Death|0
7757734|NCT00790842|12196907|FG006|Expansion Cohort|Death|0
7757735|NCT00790842|12196908|FG007|Expansion Cohort|Death|0
7757736|NCT00790842|12196909|FG008|Expansion Cohort|Death|0
7757737|NCT00790842|12196910|FG009|Expansion Cohort|Death|0
7757738|NCT00790842|12196911|FG010|Expansion Cohort|Death|0
7757739|NCT00790842|12196901|FG000|Expansion Cohort|Physician Decision|0
7757740|NCT00790842|12196902|FG001|Expansion Cohort|Physician Decision|0
7757741|NCT00790842|12196903|FG002|Expansion Cohort|Physician Decision|1
7757742|NCT00790842|12196904|FG003|Expansion Cohort|Physician Decision|0
7757743|NCT00790842|12196905|FG004|Expansion Cohort|Physician Decision|0
7757744|NCT00790842|12196906|FG005|Expansion Cohort|Physician Decision|0
7757745|NCT00790842|12196907|FG006|Expansion Cohort|Physician Decision|0
7757746|NCT00790842|12196908|FG007|Expansion Cohort|Physician Decision|0
7757747|NCT00790842|12196909|FG008|Expansion Cohort|Physician Decision|0
7757748|NCT00790842|12196910|FG009|Expansion Cohort|Physician Decision|0
7757749|NCT00790842|12196911|FG010|Expansion Cohort|Physician Decision|0
7757750|NCT00790842|12196901|FG000|Expansion Cohort|Withdrawal by Subject|0
7757751|NCT00790842|12196902|FG001|Expansion Cohort|Withdrawal by Subject|0
7757752|NCT00790842|12196903|FG002|Expansion Cohort|Withdrawal by Subject|3
7757753|NCT00790842|12196904|FG003|Expansion Cohort|Withdrawal by Subject|0
7757754|NCT00790842|12196905|FG004|Expansion Cohort|Withdrawal by Subject|0
7757755|NCT00790842|12196906|FG005|Expansion Cohort|Withdrawal by Subject|0
7757756|NCT00790842|12196907|FG006|Expansion Cohort|Withdrawal by Subject|0
7757757|NCT00790842|12196908|FG007|Expansion Cohort|Withdrawal by Subject|0
7757758|NCT00790842|12196909|FG008|Expansion Cohort|Withdrawal by Subject|0
7757759|NCT00790842|12196910|FG009|Expansion Cohort|Withdrawal by Subject|0
7757760|NCT00790842|12196911|FG010|Expansion Cohort|Withdrawal by Subject|0
7757761|NCT00790842|12196901|FG000|Expansion Cohort|Study Closure|0
7757762|NCT00790842|12196902|FG001|Expansion Cohort|Study Closure|0
7757763|NCT00790842|12196903|FG002|Expansion Cohort|Study Closure|1
7757764|NCT00790842|12196904|FG003|Expansion Cohort|Study Closure|0
7757765|NCT00790842|12196905|FG004|Expansion Cohort|Study Closure|0
7757766|NCT00790842|12196906|FG005|Expansion Cohort|Study Closure|0
7757767|NCT00790842|12196907|FG006|Expansion Cohort|Study Closure|0
7757768|NCT00790842|12196908|FG007|Expansion Cohort|Study Closure|0
7757769|NCT00790842|12196909|FG008|Expansion Cohort|Study Closure|0
7757770|NCT00790842|12196910|FG009|Expansion Cohort|Study Closure|0
7757771|NCT00790842|12196911|FG010|Expansion Cohort|Study Closure|0
7757772|NCT00790868|12196966|FG000|Overall Study|Withdrawal by Subject|4
7757773|NCT00790868|12196967|FG001|Overall Study|Withdrawal by Subject|5
7757774|NCT00790868|12196966|FG000|Overall Study|Lost to Follow-up|2
7757775|NCT00790868|12196967|FG001|Overall Study|Lost to Follow-up|12
7757776|NCT00790907|12196978|FG000|Overall Study|Adverse Event|9
7757777|NCT00790907|12196979|FG001|Overall Study|Adverse Event|7
7757778|NCT00790907|12196980|FG002|Overall Study|Adverse Event|6
7757779|NCT00790907|12196978|FG000|Overall Study|Physician Decision|304
7757780|NCT00790907|12196979|FG001|Overall Study|Physician Decision|271
7757781|NCT00790907|12196980|FG002|Overall Study|Physician Decision|255
7757782|NCT00790907|12196978|FG000|Overall Study|Withdrawal by Subject|1
7757783|NCT00790907|12196979|FG001|Overall Study|Withdrawal by Subject|7
7757784|NCT00790907|12196980|FG002|Overall Study|Withdrawal by Subject|5
7757785|NCT00790907|12196978|FG000|Overall Study|Bleeding Event|11
7757786|NCT00790907|12196979|FG001|Overall Study|Bleeding Event|16
7757787|NCT00790907|12196980|FG002|Overall Study|Bleeding Event|21
7757788|NCT00790907|12196978|FG000|Overall Study|Required Protocol-prohibited Therapy|17
7757789|NCT00790907|12196979|FG001|Overall Study|Required Protocol-prohibited Therapy|5
7757790|NCT00790907|12196980|FG002|Overall Study|Required Protocol-prohibited Therapy|7
7757791|NCT00790907|12196978|FG000|Overall Study|Qualifying Condition Not Present|29
7757792|NCT00790907|12196979|FG001|Overall Study|Qualifying Condition Not Present|14
7757793|NCT00790907|12196980|FG002|Overall Study|Qualifying Condition Not Present|16
7757794|NCT00790907|12196978|FG000|Overall Study|Verbatim Reason on the Case Report Form|74
7757795|NCT00790907|12196979|FG001|Overall Study|Verbatim Reason on the Case Report Form|20
7757796|NCT00790907|12196980|FG002|Overall Study|Verbatim Reason on the Case Report Form|29
7757797|NCT00790907|12196978|FG000|Overall Study|Did Not Receive Study Drug|10
7757798|NCT00790907|12196979|FG001|Overall Study|Did Not Receive Study Drug|0
7757799|NCT00790907|12196980|FG002|Overall Study|Did Not Receive Study Drug|0
7757800|NCT00791128|12197009|FG000|Overall Study|Adverse Event|4
7757801|NCT00791128|12197009|FG000|Overall Study|Device migration|2
7757802|NCT00791128|12197009|FG000|Overall Study|non-compliance by subject|2
7757803|NCT00791128|12197009|FG000|Overall Study|abdominal tumor, unrelated to device|1
7757804|NCT00791258|12197026|FG000|Overall Study|Adverse Event|87
7757805|NCT00791258|12197026|FG000|Overall Study|Lost to Follow-up|18
7757806|NCT00791258|12197026|FG000|Overall Study|Protocol Violation|109
7757807|NCT00791258|12197026|FG000|Overall Study|Withdrawal by Subject|40
7757808|NCT00791258|12197026|FG000|Overall Study|Did not take medication for >3 days|1
7757809|NCT00791258|12197026|FG000|Overall Study|subject left area|2
7757810|NCT00791258|12197026|FG000|Overall Study|non-compliance|3
7757811|NCT00791258|12197026|FG000|Overall Study|Subject incarcerated|1
7757812|NCT00791258|12197026|FG000|Overall Study|Subject required restricted medication|1
7757813|NCT00791258|12197026|FG000|Overall Study|Lack of Efficacy|1
7757814|NCT00791388|12197044|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
7757815|NCT00791388|12197045|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
7757816|NCT00791388|12197046|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
7757817|NCT00791388|12197047|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
7757818|NCT00791388|12197048|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
7757819|NCT00791388|12197044|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
7757820|NCT00791388|12197045|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
7757821|NCT00791388|12197046|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
7757822|NCT00791388|12197047|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
7757823|NCT00791388|12197048|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
7757824|NCT00791388|12197044|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0
7757825|NCT00791388|12197045|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0
7757826|NCT00791388|12197046|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0
7757827|NCT00791388|12197047|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0
7757828|NCT00791388|12197048|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4
7757829|NCT00791479|12197066|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0
7757830|NCT00791479|12197067|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0
7757831|NCT00791479|12197068|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0
7757832|NCT00791479|12197069|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0
7757833|NCT00791479|12197070|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3
7757834|NCT00791479|12197071|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0
7757835|NCT00791479|12197066|FG000|Overall Study|Adverse Event|0
7757836|NCT00791479|12197067|FG001|Overall Study|Adverse Event|1
7757837|NCT00791479|12197068|FG002|Overall Study|Adverse Event|0
7757838|NCT00791479|12197069|FG003|Overall Study|Adverse Event|2
7757839|NCT00791479|12197070|FG004|Overall Study|Adverse Event|0
7757840|NCT00791479|12197071|FG005|Overall Study|Adverse Event|1
7757841|NCT00791479|12197066|FG000|Overall Study|Lost to Follow-up|0
7757842|NCT00791479|12197067|FG001|Overall Study|Lost to Follow-up|1
7757843|NCT00791479|12197068|FG002|Overall Study|Lost to Follow-up|0
7757844|NCT00791479|12197069|FG003|Overall Study|Lost to Follow-up|0
7757845|NCT00791479|12197070|FG004|Overall Study|Lost to Follow-up|0
7757846|NCT00791479|12197071|FG005|Overall Study|Lost to Follow-up|1
7757847|NCT00791479|12197066|FG000|Overall Study|Protocol Violation|2
7757848|NCT00791479|12197067|FG001|Overall Study|Protocol Violation|1
7757849|NCT00791479|12197068|FG002|Overall Study|Protocol Violation|0
7757850|NCT00791479|12197069|FG003|Overall Study|Protocol Violation|1
7757851|NCT00791479|12197070|FG004|Overall Study|Protocol Violation|0
7757852|NCT00791479|12197071|FG005|Overall Study|Protocol Violation|0
7757853|NCT00791479|12197066|FG000|Overall Study|Withdrawal by Subject|0
7757854|NCT00791479|12197067|FG001|Overall Study|Withdrawal by Subject|0
7757855|NCT00791479|12197068|FG002|Overall Study|Withdrawal by Subject|0
7757856|NCT00791479|12197069|FG003|Overall Study|Withdrawal by Subject|1
7757857|NCT00791479|12197070|FG004|Overall Study|Withdrawal by Subject|0
7757858|NCT00791479|12197071|FG005|Overall Study|Withdrawal by Subject|1
7757859|NCT00791492|12197094|FG000|Overall Study|Withdrawal by Subject|1
7757860|NCT00791492|12197095|FG001|Overall Study|Withdrawal by Subject|2
7757861|NCT00791492|12197094|FG000|Overall Study|Liver transplantation|5
7757862|NCT00791492|12197095|FG001|Overall Study|Liver transplantation|1
7757863|NCT00791518|12197101|FG000|Overall Study|Protocol Violation|93
7757864|NCT00791557|12197120|FG000|Overall Study|Adverse Event|1
7757865|NCT00791648|12197126|FG000|Overall Study|Physician Decision|0
7757866|NCT00791648|12197127|FG001|Overall Study|Physician Decision|1
7757867|NCT00791648|12197126|FG000|Overall Study|Withdrawal by Subject|0
7757868|NCT00791648|12197127|FG001|Overall Study|Withdrawal by Subject|1
7757869|NCT00791661|12197136|FG000|7 Day Wash-out|Adverse Event|0
7757870|NCT00791661|12197137|FG001|7 Day Wash-out|Adverse Event|0
7757871|NCT00791661|12197138|FG002|7 Day Wash-out|Adverse Event|1
7757872|NCT00791661|12197136|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
7757873|NCT00791661|12197137|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
7757874|NCT00791661|12197138|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
7757875|NCT00791700|12197166|FG000|Overall Study|Insufficient clinical response|1
7757876|NCT00791700|12197167|FG001|Overall Study|Insufficient clinical response|4
7757877|NCT00791700|12197168|FG002|Overall Study|Insufficient clinical response|1
7757878|NCT00791700|12197169|FG003|Overall Study|Insufficient clinical response|8
7757879|NCT00791700|12197166|FG000|Overall Study|No longer willing to participate|1
7757880|NCT00791700|12197167|FG001|Overall Study|No longer willing to participate|1
7757881|NCT00791700|12197168|FG002|Overall Study|No longer willing to participate|0
7757882|NCT00791700|12197169|FG003|Overall Study|No longer willing to participate|8
7757883|NCT00791700|12197166|FG000|Overall Study|Non-compliance with study treatment|0
7757884|NCT00791700|12197167|FG001|Overall Study|Non-compliance with study treatment|2
7757885|NCT00791700|12197168|FG002|Overall Study|Non-compliance with study treatment|0
7757886|NCT00791700|12197169|FG003|Overall Study|Non-compliance with study treatment|4
7757887|NCT00791700|12197166|FG000|Overall Study|Withdrawn due to pregnancy|0
7757888|NCT00791700|12197167|FG001|Overall Study|Withdrawn due to pregnancy|0
7757889|NCT00791700|12197168|FG002|Overall Study|Withdrawn due to pregnancy|0
7757890|NCT00791700|12197169|FG003|Overall Study|Withdrawn due to pregnancy|1
7757891|NCT00791700|12197166|FG000|Overall Study|Other|0
7757892|NCT00791700|12197167|FG001|Overall Study|Other|1
7757893|NCT00791700|12197168|FG002|Overall Study|Other|0
7757894|NCT00791700|12197169|FG003|Overall Study|Other|1
7757895|NCT00791700|12197166|FG000|Overall Study|Death|0
7757896|NCT00791700|12197167|FG001|Overall Study|Death|0
7757897|NCT00791700|12197168|FG002|Overall Study|Death|0
7757898|NCT00791700|12197169|FG003|Overall Study|Death|1
7757899|NCT00791700|12197166|FG000|Overall Study|Lost to Follow-up|4
7757900|NCT00791700|12197167|FG001|Overall Study|Lost to Follow-up|3
7757901|NCT00791700|12197168|FG002|Overall Study|Lost to Follow-up|4
7757902|NCT00791700|12197169|FG003|Overall Study|Lost to Follow-up|6
7757903|NCT00791700|12197166|FG000|Overall Study|Adverse Event|0
7757904|NCT00791700|12197167|FG001|Overall Study|Adverse Event|0
7757905|NCT00791700|12197168|FG002|Overall Study|Adverse Event|1
7757906|NCT00791700|12197169|FG003|Overall Study|Adverse Event|1
7757907|NCT00791765|12197192|FG000|Weeks 1 to 12|Adverse Event|0
7757908|NCT00791765|12197193|FG001|Weeks 1 to 12|Adverse Event|1
7757909|NCT00791765|12197192|FG000|Weeks 1 to 12|Lost to Follow-up|1
7757910|NCT00791765|12197193|FG001|Weeks 1 to 12|Lost to Follow-up|0
7757911|NCT00791765|12197192|FG000|Weeks 1 to 12|Withdrawal by Subject|3
7757912|NCT00791765|12197193|FG001|Weeks 1 to 12|Withdrawal by Subject|0
7757913|NCT00791765|12197192|FG000|Weeks 1 to 12|Physician Decision|1
7757914|NCT00791765|12197193|FG001|Weeks 1 to 12|Physician Decision|0
7757915|NCT00791765|12197192|FG000|Weeks 1 to 12|Disease progression|3
7757916|NCT00791765|12197193|FG001|Weeks 1 to 12|Disease progression|0
7757917|NCT00791765|12197192|FG000|Weeks 1 to 12|Ineligibility determined|0
7757918|NCT00791765|12197193|FG001|Weeks 1 to 12|Ineligibility determined|3
7757919|NCT00791765|12197192|FG000|Weeks 13 to 24|Protocol deviation|2
7757920|NCT00791765|12197193|FG001|Weeks 13 to 24|Protocol deviation|0
7757921|NCT00791765|12197192|FG000|Weeks 13 to 24|Adverse Event|0
7757922|NCT00791765|12197193|FG001|Weeks 13 to 24|Adverse Event|3
7757923|NCT00791765|12197192|FG000|Weeks 13 to 24|Withdrawal by Subject|2
7757924|NCT00791765|12197193|FG001|Weeks 13 to 24|Withdrawal by Subject|1
7757925|NCT00791765|12197192|FG000|Weeks 13 to 24|Disease progression|0
7757926|NCT00791765|12197193|FG001|Weeks 13 to 24|Disease progression|1
7757927|NCT00791765|12197192|FG000|Weeks 13 to 24|Lost to Follow-up|1
7757928|NCT00791765|12197193|FG001|Weeks 13 to 24|Lost to Follow-up|2
7757929|NCT00791765|12197192|FG000|Weeks 13 to 24|Other|0
7757930|NCT00791765|12197193|FG001|Weeks 13 to 24|Other|1
7757931|NCT00791778|12197201|FG000|Double-blind Treatment|Adverse Event|49
7757932|NCT00791778|12197202|FG001|Double-blind Treatment|Adverse Event|9
7757933|NCT00791778|12197201|FG000|Double-blind Treatment|Physician Decision|6
7757934|NCT00791778|12197202|FG001|Double-blind Treatment|Physician Decision|26
7757935|NCT00791778|12197201|FG000|Double-blind Treatment|Protocol Violation|0
7757936|NCT00791778|12197202|FG001|Double-blind Treatment|Protocol Violation|4
7757937|NCT00791778|12197201|FG000|Double-blind Treatment|Withdrawal by Subject|20
7757938|NCT00791778|12197202|FG001|Double-blind Treatment|Withdrawal by Subject|9
7757939|NCT00791778|12197201|FG000|Double-blind Treatment|Non-compliant with study medication|2
7757940|NCT00791778|12197202|FG001|Double-blind Treatment|Non-compliant with study medication|0
7757941|NCT00791778|12197201|FG000|Follow-up|Withdrawal by Subject|3
7757942|NCT00791778|12197202|FG001|Follow-up|Withdrawal by Subject|0
7757943|NCT00791778|12197201|FG000|Follow-up|Lost to Follow-up|2
7757944|NCT00791778|12197202|FG001|Follow-up|Lost to Follow-up|1
7757945|NCT00791921|12197227|FG000|Overall Study|Protocol planed|24
7757946|NCT00791921|12197228|FG001|Overall Study|Protocol planed|88
7757947|NCT00791921|12197227|FG000|Overall Study|Withdrawal by Subject|1
7757948|NCT00791921|12197228|FG001|Overall Study|Withdrawal by Subject|2
7757949|NCT00791921|12197227|FG000|Overall Study|Adverse Event|8
7757950|NCT00791921|12197228|FG001|Overall Study|Adverse Event|2
7757951|NCT00791921|12197227|FG000|Overall Study|Lack of Efficacy|0
7757952|NCT00791921|12197228|FG001|Overall Study|Lack of Efficacy|2
7757953|NCT00791921|12197227|FG000|Overall Study|Lack of study drug administration|1
7757954|NCT00791921|12197228|FG001|Overall Study|Lack of study drug administration|1
7757955|NCT00791921|12197227|FG000|Overall Study|Reason other than those above|0
7757956|NCT00791921|12197228|FG001|Overall Study|Reason other than those above|1
7757957|NCT00791934|12197234|FG000|Overall Study|Withdrawal by Subject|2
7757958|NCT00791934|12197234|FG000|Overall Study|Did not consent for extended follow-up|13
7757959|NCT00791999|12197251|FG000|Overall Study|Protocol planed withdrawal|14
7757960|NCT00791999|12197252|FG001|Overall Study|Protocol planed withdrawal|11
7757961|NCT00791999|12197253|FG002|Overall Study|Protocol planed withdrawal|11
7757962|NCT00791999|12197254|FG003|Overall Study|Protocol planed withdrawal|45
7757963|NCT00791999|12197251|FG000|Overall Study|Withdrawal by Subject|0
7757964|NCT00791999|12197252|FG001|Overall Study|Withdrawal by Subject|1
7757965|NCT00791999|12197253|FG002|Overall Study|Withdrawal by Subject|0
7757966|NCT00791999|12197254|FG003|Overall Study|Withdrawal by Subject|2
7757967|NCT00791999|12197251|FG000|Overall Study|Protocol Violation|3
7757968|NCT00791999|12197252|FG001|Overall Study|Protocol Violation|0
7757969|NCT00791999|12197253|FG002|Overall Study|Protocol Violation|1
7757970|NCT00791999|12197254|FG003|Overall Study|Protocol Violation|0
7757971|NCT00791999|12197251|FG000|Overall Study|Adverse Event|3
7757972|NCT00791999|12197252|FG001|Overall Study|Adverse Event|3
7757973|NCT00791999|12197253|FG002|Overall Study|Adverse Event|7
7757974|NCT00791999|12197254|FG003|Overall Study|Adverse Event|3
7757975|NCT00791999|12197251|FG000|Overall Study|Lack of Efficacy|0
7757976|NCT00791999|12197252|FG001|Overall Study|Lack of Efficacy|1
7757977|NCT00791999|12197253|FG002|Overall Study|Lack of Efficacy|0
7757978|NCT00791999|12197254|FG003|Overall Study|Lack of Efficacy|2
7757979|NCT00791999|12197251|FG000|Overall Study|Reason other than those above|1
7757980|NCT00791999|12197252|FG001|Overall Study|Reason other than those above|0
7757981|NCT00791999|12197253|FG002|Overall Study|Reason other than those above|1
7757982|NCT00791999|12197254|FG003|Overall Study|Reason other than those above|0
7757983|NCT00792103|12197268|FG000|Overall Study|Enrolled, not treated|15
7757984|NCT00792103|12197268|FG000|Overall Study|Lost to Follow-up|17
7757985|NCT00792103|12197268|FG000|Overall Study|Adverse Event|25
7757986|NCT00792103|12197268|FG000|Overall Study|Withdrawal by Subject|52
7757987|NCT00792103|12197268|FG000|Overall Study|Protocol Violation|10
7757988|NCT00792103|12197268|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14
7757989|NCT00792298|12197276|FG000|Treatment Period 1|Adverse Event|0
7757990|NCT00792298|12197277|FG001|Treatment Period 1|Adverse Event|1
7757991|NCT00792298|12197278|FG002|Treatment Period 1|Adverse Event|0
7757992|NCT00792298|12197279|FG003|Treatment Period 1|Adverse Event|1
7757993|NCT00792298|12197280|FG004|Treatment Period 1|Adverse Event|0
7757994|NCT00792298|12197281|FG005|Treatment Period 1|Adverse Event|1
7757995|NCT00792298|12197282|FG006|Treatment Period 1|Adverse Event|1
7757996|NCT00792298|12197283|FG007|Treatment Period 1|Adverse Event|0
7757997|NCT00792298|12197276|FG000|Treatment Period 1|Lack of Efficacy|0
7757998|NCT00792298|12197277|FG001|Treatment Period 1|Lack of Efficacy|0
7757999|NCT00792298|12197278|FG002|Treatment Period 1|Lack of Efficacy|1
7758000|NCT00792298|12197279|FG003|Treatment Period 1|Lack of Efficacy|0
7758001|NCT00792298|12197280|FG004|Treatment Period 1|Lack of Efficacy|0
7758002|NCT00792298|12197281|FG005|Treatment Period 1|Lack of Efficacy|0
7758003|NCT00792298|12197282|FG006|Treatment Period 1|Lack of Efficacy|0
7758004|NCT00792298|12197283|FG007|Treatment Period 1|Lack of Efficacy|0
7758005|NCT00792298|12197276|FG000|Treatment Period 1|Withdrawal by Subject|1
7758006|NCT00792298|12197277|FG001|Treatment Period 1|Withdrawal by Subject|0
7758007|NCT00792298|12197278|FG002|Treatment Period 1|Withdrawal by Subject|1
7758008|NCT00792298|12197279|FG003|Treatment Period 1|Withdrawal by Subject|2
7758009|NCT00792298|12197280|FG004|Treatment Period 1|Withdrawal by Subject|0
7758010|NCT00792298|12197281|FG005|Treatment Period 1|Withdrawal by Subject|2
7758011|NCT00792298|12197282|FG006|Treatment Period 1|Withdrawal by Subject|1
7758012|NCT00792298|12197283|FG007|Treatment Period 1|Withdrawal by Subject|0
7758013|NCT00792298|12197276|FG000|Treatment Period 1|Lost to Follow-up|0
7758014|NCT00792298|12197277|FG001|Treatment Period 1|Lost to Follow-up|0
7758015|NCT00792298|12197278|FG002|Treatment Period 1|Lost to Follow-up|0
7758016|NCT00792298|12197279|FG003|Treatment Period 1|Lost to Follow-up|0
7758017|NCT00792298|12197280|FG004|Treatment Period 1|Lost to Follow-up|0
7758018|NCT00792298|12197281|FG005|Treatment Period 1|Lost to Follow-up|0
7758019|NCT00792298|12197282|FG006|Treatment Period 1|Lost to Follow-up|1
7758020|NCT00792298|12197283|FG007|Treatment Period 1|Lost to Follow-up|0
7758021|NCT00792298|12197276|FG000|Treatment Period 1|Physician Decision|0
7758022|NCT00792298|12197277|FG001|Treatment Period 1|Physician Decision|0
7758023|NCT00792298|12197278|FG002|Treatment Period 1|Physician Decision|0
7758024|NCT00792298|12197279|FG003|Treatment Period 1|Physician Decision|1
7758025|NCT00792298|12197280|FG004|Treatment Period 1|Physician Decision|0
7758026|NCT00792298|12197281|FG005|Treatment Period 1|Physician Decision|0
7758027|NCT00792298|12197282|FG006|Treatment Period 1|Physician Decision|1
7758028|NCT00792298|12197283|FG007|Treatment Period 1|Physician Decision|0
7758029|NCT00792298|12197276|FG000|Treatment Period 1|Protocol Violation|0
7758030|NCT00792298|12197277|FG001|Treatment Period 1|Protocol Violation|0
7758031|NCT00792298|12197278|FG002|Treatment Period 1|Protocol Violation|0
7758032|NCT00792298|12197279|FG003|Treatment Period 1|Protocol Violation|0
7758033|NCT00792298|12197280|FG004|Treatment Period 1|Protocol Violation|0
7758034|NCT00792298|12197281|FG005|Treatment Period 1|Protocol Violation|0
7758035|NCT00792298|12197282|FG006|Treatment Period 1|Protocol Violation|0
7758036|NCT00792298|12197283|FG007|Treatment Period 1|Protocol Violation|1
7758037|NCT00792298|12197276|FG000|Washout|Adverse Event|0
7758038|NCT00792298|12197277|FG001|Washout|Adverse Event|0
7758039|NCT00792298|12197278|FG002|Washout|Adverse Event|0
7758040|NCT00792298|12197279|FG003|Washout|Adverse Event|0
7758041|NCT00792298|12197280|FG004|Washout|Adverse Event|0
7758042|NCT00792298|12197281|FG005|Washout|Adverse Event|1
7758043|NCT00792298|12197282|FG006|Washout|Adverse Event|0
7758044|NCT00792298|12197283|FG007|Washout|Adverse Event|0
7962555|NCT02712983|12516799|FG001|Treatment Phase|Technical Problems|0
7962556|NCT02712983|12516800|FG002|Treatment Phase|Technical Problems|0
7962557|NCT02712983|12516801|FG003|Treatment Phase|Technical Problems|0
7962558|NCT02712983|12516802|FG004|Treatment Phase|Technical Problems|0
7962559|NCT02712983|12516803|FG005|Treatment Phase|Technical Problems|0
7962560|NCT02712983|12516804|FG006|Treatment Phase|Technical Problems|1
7962561|NCT02712983|12516805|FG007|Treatment Phase|Technical Problems|0
7962562|NCT02712983|12516806|FG008|Treatment Phase|Technical Problems|0
7962563|NCT02712983|12516798|FG000|Treatment Phase|Physician Decision|0
7962564|NCT02712983|12516799|FG001|Treatment Phase|Physician Decision|0
7962565|NCT02712983|12516800|FG002|Treatment Phase|Physician Decision|0
7962566|NCT02712983|12516801|FG003|Treatment Phase|Physician Decision|0
7962567|NCT02712983|12516802|FG004|Treatment Phase|Physician Decision|0
7962568|NCT02712983|12516803|FG005|Treatment Phase|Physician Decision|0
7962569|NCT02712983|12516804|FG006|Treatment Phase|Physician Decision|0
7962570|NCT02712983|12516805|FG007|Treatment Phase|Physician Decision|1
7962571|NCT02712983|12516806|FG008|Treatment Phase|Physician Decision|1
7962572|NCT02712983|12516798|FG000|Treatment Phase|Subject Decision|2
7962573|NCT02712983|12516799|FG001|Treatment Phase|Subject Decision|0
7962574|NCT02712983|12516800|FG002|Treatment Phase|Subject Decision|0
7962575|NCT02712983|12516801|FG003|Treatment Phase|Subject Decision|2
7962576|NCT02712983|12516802|FG004|Treatment Phase|Subject Decision|1
7962577|NCT02712983|12516803|FG005|Treatment Phase|Subject Decision|0
7962578|NCT02712983|12516804|FG006|Treatment Phase|Subject Decision|1
7962579|NCT02712983|12516805|FG007|Treatment Phase|Subject Decision|2
7962580|NCT02712983|12516806|FG008|Treatment Phase|Subject Decision|0
7962581|NCT02712983|12516798|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7962582|NCT02712983|12516799|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
7962583|NCT02712983|12516800|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7962584|NCT02712983|12516801|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7758045|NCT00792298|12197276|FG000|Washout|Withdrawal by Subject|0
7758046|NCT00792298|12197277|FG001|Washout|Withdrawal by Subject|0
7758047|NCT00792298|12197278|FG002|Washout|Withdrawal by Subject|1
7758048|NCT00792298|12197279|FG003|Washout|Withdrawal by Subject|0
7758049|NCT00792298|12197280|FG004|Washout|Withdrawal by Subject|0
7758050|NCT00792298|12197281|FG005|Washout|Withdrawal by Subject|1
7758051|NCT00792298|12197282|FG006|Washout|Withdrawal by Subject|0
7758052|NCT00792298|12197283|FG007|Washout|Withdrawal by Subject|0
7758053|NCT00792298|12197276|FG000|Treatment Period 2|Lack of Efficacy|0
7758054|NCT00792298|12197277|FG001|Treatment Period 2|Lack of Efficacy|0
7758055|NCT00792298|12197278|FG002|Treatment Period 2|Lack of Efficacy|0
7758056|NCT00792298|12197279|FG003|Treatment Period 2|Lack of Efficacy|0
7758057|NCT00792298|12197280|FG004|Treatment Period 2|Lack of Efficacy|1
7758058|NCT00792298|12197281|FG005|Treatment Period 2|Lack of Efficacy|0
7758059|NCT00792298|12197282|FG006|Treatment Period 2|Lack of Efficacy|0
7758060|NCT00792298|12197283|FG007|Treatment Period 2|Lack of Efficacy|0
7758061|NCT00792298|12197276|FG000|Treatment Period 2|Physician Decision|0
7758062|NCT00792298|12197277|FG001|Treatment Period 2|Physician Decision|0
7758063|NCT00792298|12197278|FG002|Treatment Period 2|Physician Decision|0
7758064|NCT00792298|12197279|FG003|Treatment Period 2|Physician Decision|0
7758065|NCT00792298|12197280|FG004|Treatment Period 2|Physician Decision|0
7758066|NCT00792298|12197281|FG005|Treatment Period 2|Physician Decision|0
7758067|NCT00792298|12197282|FG006|Treatment Period 2|Physician Decision|1
7758068|NCT00792298|12197283|FG007|Treatment Period 2|Physician Decision|0
7758069|NCT00792298|12197276|FG000|Treatment Period 2|Pregnancy|0
7758070|NCT00792298|12197277|FG001|Treatment Period 2|Pregnancy|0
7758071|NCT00792298|12197278|FG002|Treatment Period 2|Pregnancy|1
7758072|NCT00792298|12197279|FG003|Treatment Period 2|Pregnancy|0
7758073|NCT00792298|12197280|FG004|Treatment Period 2|Pregnancy|0
7758074|NCT00792298|12197281|FG005|Treatment Period 2|Pregnancy|0
7758075|NCT00792298|12197282|FG006|Treatment Period 2|Pregnancy|0
7758076|NCT00792298|12197283|FG007|Treatment Period 2|Pregnancy|0
7758077|NCT00792298|12197276|FG000|Treatment Period 2|Withdrawal by Subject|1
7758078|NCT00792298|12197277|FG001|Treatment Period 2|Withdrawal by Subject|1
7758079|NCT00792298|12197278|FG002|Treatment Period 2|Withdrawal by Subject|0
7758080|NCT00792298|12197279|FG003|Treatment Period 2|Withdrawal by Subject|2
7758081|NCT00792298|12197280|FG004|Treatment Period 2|Withdrawal by Subject|1
7758082|NCT00792298|12197281|FG005|Treatment Period 2|Withdrawal by Subject|0
7758083|NCT00792298|12197282|FG006|Treatment Period 2|Withdrawal by Subject|0
7758084|NCT00792298|12197283|FG007|Treatment Period 2|Withdrawal by Subject|2
7758085|NCT00792467|12197309|FG000|Overall Study|progression of disease|17
7758086|NCT00792467|12197309|FG000|Overall Study|Adverse Event|1
7758087|NCT00792467|12197309|FG000|Overall Study|patient request|1
7758088|NCT00792467|12197309|FG000|Overall Study|Lost to Follow-up|1
7758089|NCT00792467|12197309|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1
7758090|NCT00792467|12197309|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1
7758091|NCT00792571|12197314|FG000|Overall Study|Death|1
7758092|NCT00792571|12197314|FG000|Overall Study|Adverse Event|4
7758093|NCT00792571|12197314|FG000|Overall Study|Withdrawal by Subject|1
7758094|NCT00792571|12197314|FG000|Overall Study|Other|4
7758095|NCT00792623|12197322|FG000|Overall Study|Adverse Event|2
7758096|NCT00792623|12197322|FG000|Overall Study|Withdrawal by Subject|5
7758097|NCT00792636|12197330|FG000|Overall Study|Protocol Violation|17
7758098|NCT00792636|12197331|FG001|Overall Study|Protocol Violation|23
7758099|NCT00792636|12197332|FG002|Overall Study|Protocol Violation|20
7758100|NCT00792636|12197330|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19
7758101|NCT00792636|12197331|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20
7758102|NCT00792636|12197332|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20
7758103|NCT00792636|12197330|FG000|Overall Study|Lost to Follow-up|13
7758104|NCT00792636|12197331|FG001|Overall Study|Lost to Follow-up|19
7758105|NCT00792636|12197332|FG002|Overall Study|Lost to Follow-up|14
7758106|NCT00792636|12197330|FG000|Overall Study|Withdrew Consent|10
7758107|NCT00792636|12197331|FG001|Overall Study|Withdrew Consent|13
7758108|NCT00792636|12197332|FG002|Overall Study|Withdrew Consent|9
7758109|NCT00792636|12197330|FG000|Overall Study|Lack of Efficacy|3
7758110|NCT00792636|12197331|FG001|Overall Study|Lack of Efficacy|4
7758111|NCT00792636|12197332|FG002|Overall Study|Lack of Efficacy|13
7758112|NCT00792636|12197330|FG000|Overall Study|Adverse Event|4
7758113|NCT00792636|12197331|FG001|Overall Study|Adverse Event|2
7758114|NCT00792636|12197332|FG002|Overall Study|Adverse Event|3
7758115|NCT00792636|12197330|FG000|Overall Study|Investigator Discretion|2
7758116|NCT00792636|12197331|FG001|Overall Study|Investigator Discretion|0
7758117|NCT00792636|12197332|FG002|Overall Study|Investigator Discretion|2
7624566|NCT02173301|12035673|FG002|Overall Study|Adverse Event|13
7624567|NCT02173301|12035674|FG003|Overall Study|Adverse Event|5
7624568|NCT02173301|12035671|FG000|Overall Study|Withdrawal by Subject|8
7758118|NCT00792701|12197357|FG000|Overall Study|Adverse Event|0
7758119|NCT00792701|12197358|FG001|Overall Study|Adverse Event|22
7758120|NCT00792701|12197357|FG000|Overall Study|Ineligible|1
7624569|NCT02173301|12035672|FG001|Overall Study|Withdrawal by Subject|10
7758121|NCT00792701|12197358|FG001|Overall Study|Ineligible|3
7624570|NCT02173301|12035673|FG002|Overall Study|Withdrawal by Subject|4
7624571|NCT02173301|12035674|FG003|Overall Study|Withdrawal by Subject|8
7624572|NCT02173301|12035671|FG000|Overall Study|Lost to Follow-up|4
7624573|NCT02173301|12035672|FG001|Overall Study|Lost to Follow-up|4
7624574|NCT02173301|12035673|FG002|Overall Study|Lost to Follow-up|2
7624575|NCT02173301|12035674|FG003|Overall Study|Lost to Follow-up|2
7624576|NCT02173301|12035671|FG000|Overall Study|Protocol Violation|0
7624577|NCT02173301|12035672|FG001|Overall Study|Protocol Violation|1
7624578|NCT02173301|12035673|FG002|Overall Study|Protocol Violation|0
7624579|NCT02173301|12035674|FG003|Overall Study|Protocol Violation|0
7624580|NCT02173301|12035671|FG000|Overall Study|Physician Decision|0
7624581|NCT02173301|12035672|FG001|Overall Study|Physician Decision|0
7758122|NCT00792701|12197357|FG000|Overall Study|Withdrawal by Subject|1
7758123|NCT00792701|12197358|FG001|Overall Study|Withdrawal by Subject|19
7758124|NCT00792701|12197357|FG000|Overall Study|Not protocol specified|17
7758125|NCT00792701|12197358|FG001|Overall Study|Not protocol specified|0
7758126|NCT00792805|12197369|FG000|Overall Study|Adverse Event|12
7758127|NCT00792805|12197370|FG001|Overall Study|Adverse Event|10
7758128|NCT00792805|12197371|FG002|Overall Study|Adverse Event|10
7758129|NCT00792805|12197369|FG000|Overall Study|Subject withdrew consent|5
7758130|NCT00792805|12197370|FG001|Overall Study|Subject withdrew consent|6
7758131|NCT00792805|12197371|FG002|Overall Study|Subject withdrew consent|5
7758132|NCT00792805|12197369|FG000|Overall Study|Administrative problems|2
7758133|NCT00792805|12197370|FG001|Overall Study|Administrative problems|0
7758134|NCT00792805|12197371|FG002|Overall Study|Administrative problems|4
7758135|NCT00792805|12197369|FG000|Overall Study|Abnormal test procedure result(s)|1
7758136|NCT00792805|12197370|FG001|Overall Study|Abnormal test procedure result(s)|2
7758137|NCT00792805|12197371|FG002|Overall Study|Abnormal test procedure result(s)|0
7758138|NCT00792805|12197369|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7758139|NCT00792805|12197370|FG001|Overall Study|Unsatisfactory therapeutic effect|6
7758140|NCT00792805|12197371|FG002|Overall Study|Unsatisfactory therapeutic effect|6
7758141|NCT00792805|12197369|FG000|Overall Study|Lost to Follow-up|1
7758142|NCT00792805|12197370|FG001|Overall Study|Lost to Follow-up|1
7758143|NCT00792805|12197371|FG002|Overall Study|Lost to Follow-up|6
7758144|NCT00792805|12197369|FG000|Overall Study|Abnormal laboratory value(s)|0
7758145|NCT00792805|12197370|FG001|Overall Study|Abnormal laboratory value(s)|0
7758146|NCT00792805|12197371|FG002|Overall Study|Abnormal laboratory value(s)|1
7758147|NCT00792805|12197369|FG000|Overall Study|Protocol deviation|0
7758148|NCT00792805|12197370|FG001|Overall Study|Protocol deviation|1
7758149|NCT00792805|12197371|FG002|Overall Study|Protocol deviation|1
7758150|NCT00792909|12197382|FG000|Overall Study|Withdrawal by Subject|0
7758151|NCT00792909|12197383|FG001|Overall Study|Withdrawal by Subject|1
7758152|NCT00792909|12197384|FG002|Overall Study|Withdrawal by Subject|0
7758153|NCT00792935|12197416|FG000|Overall Study|Adverse Event|2
7758154|NCT00792935|12197417|FG001|Overall Study|Adverse Event|1
7758155|NCT00792935|12197416|FG000|Overall Study|Lost to Follow-up|0
7758156|NCT00792935|12197417|FG001|Overall Study|Lost to Follow-up|1
7758157|NCT00792935|12197416|FG000|Overall Study|Protocol Violation|2
7758158|NCT00792935|12197417|FG001|Overall Study|Protocol Violation|0
7758159|NCT00792935|12197416|FG000|Overall Study|Withdrawal by Subject|0
7758160|NCT00792935|12197417|FG001|Overall Study|Withdrawal by Subject|1
7758161|NCT00793104|12197423|FG000|Overall Study|Lost to Follow-up|1
7758162|NCT00793182|12197429|FG000|Overall Study|Adverse Event|0
7758163|NCT00793182|12197430|FG001|Overall Study|Adverse Event|1
7758164|NCT00793325|12197436|FG000|Overall Study|Protocol Violation|18
7758165|NCT00793325|12197436|FG000|Overall Study|Lost to Follow-up|1
7758166|NCT00793403|12197459|FG000|Overall Study|Other|73
7769904|NCT00872170|12213671|FG000|Overall Study|Adverse Event|1
7769905|NCT00872170|12213672|FG001|Overall Study|Adverse Event|0
7769906|NCT00872521|12213693|FG000|Completed PAD Induction|Patient choice|0
7769907|NCT00872521|12213694|FG001|Completed PAD Induction|Patient choice|1
7769908|NCT00872521|12213695|FG002|Completed PAD Induction|Patient choice|0
7769909|NCT00872521|12213693|FG000|Completed PAD Induction|Disease progression|0
7769910|NCT00872521|12213694|FG001|Completed PAD Induction|Disease progression|2
7769911|NCT00872521|12213695|FG002|Completed PAD Induction|Disease progression|0
7769912|NCT00872521|12213693|FG000|Completed PAD Induction|Adverse Event|4
7769913|NCT00872521|12213694|FG001|Completed PAD Induction|Adverse Event|0
7769914|NCT00872521|12213695|FG002|Completed PAD Induction|Adverse Event|0
7769915|NCT00872521|12213693|FG000|Completed PAD Induction|Death|1
7769916|NCT00872521|12213694|FG001|Completed PAD Induction|Death|1
7769917|NCT00872521|12213695|FG002|Completed PAD Induction|Death|0
7769918|NCT00872521|12213693|FG000|Primary Endpoint Analysis|Other|1
7769919|NCT00872521|12213694|FG001|Primary Endpoint Analysis|Other|2
7769920|NCT00872521|12213695|FG002|Primary Endpoint Analysis|Other|0
7769921|NCT00872521|12213693|FG000|Primary Endpoint Analysis|Patient choice|0
7769922|NCT00872521|12213694|FG001|Primary Endpoint Analysis|Patient choice|1
7769923|NCT00872521|12213695|FG002|Primary Endpoint Analysis|Patient choice|0
7769924|NCT00872521|12213693|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0
7769925|NCT00872521|12213694|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2
7769926|NCT00872521|12213695|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0
7769927|NCT00872521|12213693|FG000|Primary Endpoint Analysis|Patient response missing|0
7769928|NCT00872521|12213694|FG001|Primary Endpoint Analysis|Patient response missing|0
7769929|NCT00872521|12213695|FG002|Primary Endpoint Analysis|Patient response missing|1
7769930|NCT00872521|12213693|FG000|Completed 3-month Follow up|Other|0
7769931|NCT00872521|12213694|FG001|Completed 3-month Follow up|Other|2
7769932|NCT00872521|12213695|FG002|Completed 3-month Follow up|Other|0
7769933|NCT00872521|12213693|FG000|Completed 3-month Follow up|Physician Decision|0
7769934|NCT00872521|12213694|FG001|Completed 3-month Follow up|Physician Decision|1
7769935|NCT00872521|12213695|FG002|Completed 3-month Follow up|Physician Decision|0
7769936|NCT00872521|12213693|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0
7769937|NCT00872521|12213694|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2
7769938|NCT00872521|12213695|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1
7769939|NCT00872599|12213723|FG000|Second Washout Period|Adverse Event|1
7769940|NCT00872599|12213724|FG001|Second Washout Period|Adverse Event|1
7769941|NCT00872898|12213769|FG000|Part Two - Double Blind|Adverse Event|4
7769942|NCT00872898|12213770|FG001|Part Two - Double Blind|Adverse Event|3
7769943|NCT00872898|12213769|FG000|Part Two - Double Blind|Lack of Efficacy|1
7769944|NCT00872898|12213770|FG001|Part Two - Double Blind|Lack of Efficacy|0
7769945|NCT00872898|12213769|FG000|Part Two - Double Blind|Protocol Violation|1
7769946|NCT00872898|12213770|FG001|Part Two - Double Blind|Protocol Violation|0
7769947|NCT00872898|12213769|FG000|Part Two - Double Blind|Withdrawal by Subject|3
7769948|NCT00872898|12213770|FG001|Part Two - Double Blind|Withdrawal by Subject|1
7769949|NCT00872898|12213769|FG000|Part Two - Double Blind|Lost to Follow-up|0
7769950|NCT00872898|12213770|FG001|Part Two - Double Blind|Lost to Follow-up|2
7769951|NCT00872898|12213769|FG000|Part Two - Double Blind|Other reasons|2
7769952|NCT00872898|12213770|FG001|Part Two - Double Blind|Other reasons|0
7769953|NCT00872989|12213781|FG000|Overall Study|Adverse Event|7
7769954|NCT00872989|12213782|FG001|Overall Study|Adverse Event|15
7769955|NCT00872989|12213781|FG000|Overall Study|Withdrawal by Subject|8
7769956|NCT00872989|12213782|FG001|Overall Study|Withdrawal by Subject|5
7769957|NCT00872989|12213781|FG000|Overall Study|Progression/relapse|47
7769958|NCT00872989|12213782|FG001|Overall Study|Progression/relapse|35
7769959|NCT00872989|12213781|FG000|Overall Study|Not protocol specified|3
7769960|NCT00872989|12213782|FG001|Overall Study|Not protocol specified|8
7769961|NCT00873015|12213798|FG000|Overall Study|Withdrawal by Subject|0
7769962|NCT00873015|12213799|FG001|Overall Study|Withdrawal by Subject|1
7769963|NCT00873015|12213800|FG002|Overall Study|Withdrawal by Subject|0
7769964|NCT00873015|12213801|FG003|Overall Study|Withdrawal by Subject|0
7769965|NCT00873041|12213813|FG000|Core Study|Adverse Event|2
7769966|NCT00873041|12213814|FG001|Core Study|Adverse Event|3
7769967|NCT00873041|12213815|FG002|Core Study|Adverse Event|1
7769968|NCT00873041|12213813|FG000|Core Study|Withdrawal by Subject|1
7769969|NCT00873041|12213814|FG001|Core Study|Withdrawal by Subject|2
7769970|NCT00873041|12213815|FG002|Core Study|Withdrawal by Subject|2
7769971|NCT00873041|12213813|FG000|Core Study|Lost to Follow-up|3
7769972|NCT00873041|12213814|FG001|Core Study|Lost to Follow-up|1
7769973|NCT00873041|12213815|FG002|Core Study|Lost to Follow-up|0
7769974|NCT00873041|12213813|FG000|Core Study|Abnormal laboratory value|0
7769975|NCT00873041|12213814|FG001|Core Study|Abnormal laboratory value|0
7769976|NCT00873041|12213815|FG002|Core Study|Abnormal laboratory value|1
7769977|NCT00873041|12213813|FG000|Core Study|Protocol deviation|1
7769978|NCT00873041|12213814|FG001|Core Study|Protocol deviation|0
7758167|NCT00793546|12197475|FG000|Overall Study|Death|3
7758168|NCT00793546|12197476|FG001|Overall Study|Death|0
7758169|NCT00793546|12197475|FG000|Overall Study|Lost to Follow-up|1
7758170|NCT00793546|12197476|FG001|Overall Study|Lost to Follow-up|0
7758171|NCT00793546|12197475|FG000|Overall Study|Withdrawal by Subject|1
7758172|NCT00793546|12197476|FG001|Overall Study|Withdrawal by Subject|1
7758173|NCT00793546|12197475|FG000|Overall Study|Study Terminated by Sponsor|8
7758174|NCT00793546|12197476|FG001|Overall Study|Study Terminated by Sponsor|27
7758175|NCT00793546|12197475|FG000|Overall Study|Other|1
7758176|NCT00793546|12197476|FG001|Overall Study|Other|0
7758177|NCT00793585|12197490|FG000|Overall Study|Adverse Event|1
7758178|NCT00793585|12197491|FG001|Overall Study|Adverse Event|1
7758179|NCT00793585|12197490|FG000|Overall Study|Protocol Violation|1
7758180|NCT00793585|12197491|FG001|Overall Study|Protocol Violation|2
7758181|NCT00793598|12197502|FG000|Overall Study|Patient Request|0
7758182|NCT00793598|12197503|FG001|Overall Study|Patient Request|1
7758183|NCT00793598|12197504|FG002|Overall Study|Patient Request|0
7758184|NCT00793598|12197505|FG003|Overall Study|Patient Request|0
7758185|NCT00793598|12197506|FG004|Overall Study|Patient Request|0
7758186|NCT00793598|12197507|FG005|Overall Study|Patient Request|0
7758187|NCT00793598|12197508|FG006|Overall Study|Patient Request|0
7758188|NCT00793598|12197509|FG007|Overall Study|Patient Request|0
7758189|NCT00793598|12197502|FG000|Overall Study|Protocol Violation|0
7758190|NCT00793598|12197503|FG001|Overall Study|Protocol Violation|0
7758191|NCT00793598|12197504|FG002|Overall Study|Protocol Violation|0
7758192|NCT00793598|12197505|FG003|Overall Study|Protocol Violation|0
7758193|NCT00793598|12197506|FG004|Overall Study|Protocol Violation|0
7758194|NCT00793598|12197507|FG005|Overall Study|Protocol Violation|0
7758195|NCT00793598|12197508|FG006|Overall Study|Protocol Violation|0
7758196|NCT00793598|12197509|FG007|Overall Study|Protocol Violation|1
7758197|NCT00793598|12197502|FG000|Overall Study|Subject not dosed|0
7758198|NCT00793598|12197503|FG001|Overall Study|Subject not dosed|0
7758199|NCT00793598|12197504|FG002|Overall Study|Subject not dosed|0
7758200|NCT00793598|12197505|FG003|Overall Study|Subject not dosed|0
7758201|NCT00793598|12197506|FG004|Overall Study|Subject not dosed|0
7758202|NCT00793598|12197507|FG005|Overall Study|Subject not dosed|1
7758203|NCT00793598|12197508|FG006|Overall Study|Subject not dosed|0
7758204|NCT00793598|12197509|FG007|Overall Study|Subject not dosed|0
7758205|NCT00793624|12197544|FG000|Overall Study|Adverse Event|18
7758206|NCT00793624|12197545|FG001|Overall Study|Adverse Event|16
7758207|NCT00793624|12197546|FG002|Overall Study|Adverse Event|15
7758208|NCT00793624|12197547|FG003|Overall Study|Adverse Event|20
7758209|NCT00793624|12197544|FG000|Overall Study|Lost to Follow-up|2
7758210|NCT00793624|12197545|FG001|Overall Study|Lost to Follow-up|2
7758211|NCT00793624|12197546|FG002|Overall Study|Lost to Follow-up|4
7758212|NCT00793624|12197547|FG003|Overall Study|Lost to Follow-up|0
7758213|NCT00793624|12197544|FG000|Overall Study|Withdrawal by Subject|20
7758214|NCT00793624|12197545|FG001|Overall Study|Withdrawal by Subject|9
7758215|NCT00793624|12197546|FG002|Overall Study|Withdrawal by Subject|11
7758216|NCT00793624|12197547|FG003|Overall Study|Withdrawal by Subject|14
7758217|NCT00793624|12197544|FG000|Overall Study|Lack of Efficacy|9
7758218|NCT00793624|12197545|FG001|Overall Study|Lack of Efficacy|2
7758219|NCT00793624|12197546|FG002|Overall Study|Lack of Efficacy|1
7758220|NCT00793624|12197547|FG003|Overall Study|Lack of Efficacy|3
7758221|NCT00793624|12197544|FG000|Overall Study|Non compliance with protocol|2
7758222|NCT00793624|12197545|FG001|Overall Study|Non compliance with protocol|3
7758223|NCT00793624|12197546|FG002|Overall Study|Non compliance with protocol|2
7758224|NCT00793624|12197547|FG003|Overall Study|Non compliance with protocol|3
7758225|NCT00793624|12197544|FG000|Overall Study|Other reason not described above|6
7758226|NCT00793624|12197545|FG001|Overall Study|Other reason not described above|4
7758227|NCT00793624|12197546|FG002|Overall Study|Other reason not described above|6
7758228|NCT00793624|12197547|FG003|Overall Study|Other reason not described above|3
7758229|NCT00793780|12197578|FG000|Overall Study|Withdrawal by Subject|2
7758230|NCT00793780|12197579|FG001|Overall Study|Withdrawal by Subject|1
7758231|NCT00793793|12197597|FG000|Overall Study|Adverse Event|0
7758232|NCT00793793|12197598|FG001|Overall Study|Adverse Event|0
7758233|NCT00793793|12197599|FG002|Overall Study|Adverse Event|1
7758234|NCT00793793|12197600|FG003|Overall Study|Adverse Event|1
7758235|NCT00793793|12197601|FG004|Overall Study|Adverse Event|0
7758236|NCT00793793|12197602|FG005|Overall Study|Adverse Event|1
7758237|NCT00793793|12197603|FG006|Overall Study|Adverse Event|2
7758238|NCT00793793|12197604|FG007|Overall Study|Adverse Event|0
7758239|NCT00793793|12197605|FG008|Overall Study|Adverse Event|0
7758240|NCT00793793|12197606|FG009|Overall Study|Adverse Event|0
7758241|NCT00793793|12197607|FG010|Overall Study|Adverse Event|0
7758242|NCT00793793|12197608|FG011|Overall Study|Adverse Event|2
7758243|NCT00793793|12197597|FG000|Overall Study|Protocol Violation|0
7758244|NCT00793793|12197598|FG001|Overall Study|Protocol Violation|0
7758245|NCT00793793|12197599|FG002|Overall Study|Protocol Violation|0
7758246|NCT00793793|12197600|FG003|Overall Study|Protocol Violation|1
7758247|NCT00793793|12197601|FG004|Overall Study|Protocol Violation|0
7758248|NCT00793793|12197602|FG005|Overall Study|Protocol Violation|0
7758249|NCT00793793|12197603|FG006|Overall Study|Protocol Violation|0
7758250|NCT00793793|12197604|FG007|Overall Study|Protocol Violation|0
7758251|NCT00793793|12197605|FG008|Overall Study|Protocol Violation|0
7758252|NCT00793793|12197606|FG009|Overall Study|Protocol Violation|0
7758253|NCT00793793|12197607|FG010|Overall Study|Protocol Violation|0
7758254|NCT00793793|12197608|FG011|Overall Study|Protocol Violation|0
7758255|NCT00793793|12197597|FG000|Overall Study|Lost to Follow-up|0
7758256|NCT00793793|12197598|FG001|Overall Study|Lost to Follow-up|0
7758257|NCT00793793|12197599|FG002|Overall Study|Lost to Follow-up|1
7758258|NCT00793793|12197600|FG003|Overall Study|Lost to Follow-up|0
7758259|NCT00793793|12197601|FG004|Overall Study|Lost to Follow-up|0
7758260|NCT00793793|12197602|FG005|Overall Study|Lost to Follow-up|0
7758261|NCT00793793|12197603|FG006|Overall Study|Lost to Follow-up|0
7758262|NCT00793793|12197604|FG007|Overall Study|Lost to Follow-up|0
7758263|NCT00793793|12197605|FG008|Overall Study|Lost to Follow-up|1
7758264|NCT00793793|12197606|FG009|Overall Study|Lost to Follow-up|3
7758265|NCT00793793|12197607|FG010|Overall Study|Lost to Follow-up|1
7758266|NCT00793793|12197608|FG011|Overall Study|Lost to Follow-up|0
7758267|NCT00793793|12197597|FG000|Overall Study|Withdrawal by Subject|0
7758268|NCT00793793|12197598|FG001|Overall Study|Withdrawal by Subject|0
7758269|NCT00793793|12197599|FG002|Overall Study|Withdrawal by Subject|0
7758270|NCT00793793|12197600|FG003|Overall Study|Withdrawal by Subject|0
7758271|NCT00793793|12197601|FG004|Overall Study|Withdrawal by Subject|1
7758272|NCT00793793|12197602|FG005|Overall Study|Withdrawal by Subject|0
7758273|NCT00793793|12197603|FG006|Overall Study|Withdrawal by Subject|0
7758274|NCT00793793|12197604|FG007|Overall Study|Withdrawal by Subject|0
7758275|NCT00793793|12197605|FG008|Overall Study|Withdrawal by Subject|1
7758276|NCT00793793|12197606|FG009|Overall Study|Withdrawal by Subject|0
7758277|NCT00793793|12197607|FG010|Overall Study|Withdrawal by Subject|0
7758278|NCT00793793|12197608|FG011|Overall Study|Withdrawal by Subject|0
7758279|NCT00793793|12197597|FG000|Overall Study|reason not specified|0
7758280|NCT00793793|12197598|FG001|Overall Study|reason not specified|1
7758281|NCT00793793|12197599|FG002|Overall Study|reason not specified|0
7758282|NCT00793793|12197600|FG003|Overall Study|reason not specified|1
7758283|NCT00793793|12197601|FG004|Overall Study|reason not specified|1
7758284|NCT00793793|12197602|FG005|Overall Study|reason not specified|1
7758285|NCT00793793|12197603|FG006|Overall Study|reason not specified|2
7758286|NCT00793793|12197604|FG007|Overall Study|reason not specified|0
7758287|NCT00793793|12197605|FG008|Overall Study|reason not specified|7
7758288|NCT00793793|12197606|FG009|Overall Study|reason not specified|6
7758289|NCT00793793|12197607|FG010|Overall Study|reason not specified|2
7758290|NCT00793793|12197608|FG011|Overall Study|reason not specified|4
7758291|NCT00793819|12197656|FG000|Overall Study|Adverse Event|8
7758292|NCT00793819|12197657|FG001|Overall Study|Adverse Event|4
7758293|NCT00793819|12197656|FG000|Overall Study|Lack of Efficacy|1
7758294|NCT00793819|12197657|FG001|Overall Study|Lack of Efficacy|1
7758295|NCT00793819|12197656|FG000|Overall Study|Withdrawal by Subject|4
7758296|NCT00793819|12197657|FG001|Overall Study|Withdrawal by Subject|3
7758297|NCT00793819|12197656|FG000|Overall Study|Lost to Follow-up|1
7758298|NCT00793819|12197657|FG001|Overall Study|Lost to Follow-up|1
7758299|NCT00793871|12197663|FG000|Overall Study|Death|50
7758300|NCT00793871|12197663|FG000|Overall Study|Lost to Follow-up|3
7758301|NCT00793871|12197663|FG000|Overall Study|Study terminated by the Sponsor|7
7758302|NCT00793910|12197669|FG000|Overall Study|discarded study pills|0
7758303|NCT00793910|12197670|FG001|Overall Study|discarded study pills|1
7758304|NCT00793910|12197669|FG000|Overall Study|did not pick up medications|1
7758305|NCT00793910|12197670|FG001|Overall Study|did not pick up medications|1
7758306|NCT00793910|12197669|FG000|Overall Study|ineligible based on entry criteria|2
7758307|NCT00793910|12197670|FG001|Overall Study|ineligible based on entry criteria|3
7758308|NCT00793910|12197669|FG000|Overall Study|decided to undergo LASIK instead of PRK|2
7758309|NCT00793910|12197670|FG001|Overall Study|decided to undergo LASIK instead of PRK|1
7758310|NCT00793910|12197669|FG000|Overall Study|Withdrawal by Subject|0
7758311|NCT00793910|12197670|FG001|Overall Study|Withdrawal by Subject|1
7758312|NCT00794040|12197678|FG000|Overall Study|Withdrawal by Subject|3
7758313|NCT00794040|12197679|FG001|Overall Study|Withdrawal by Subject|4
7758314|NCT00794040|12197678|FG000|Overall Study|Physician Decision|0
7758315|NCT00794040|12197679|FG001|Overall Study|Physician Decision|1
7758316|NCT00794118|12197685|FG000|Overall Study|Lost to Follow-up|16
7758317|NCT00794118|12197685|FG000|Overall Study|Withdrawal by Subject|9
7758318|NCT00794118|12197685|FG000|Overall Study|Changed hospital center|2
7758319|NCT00794157|12197701|FG000|Overall Study|Adverse Event|4
7758320|NCT00794157|12197702|FG001|Overall Study|Adverse Event|1
7758321|NCT00794157|12197703|FG002|Overall Study|Adverse Event|8
7758322|NCT00794157|12197701|FG000|Overall Study|Subject withdrew consent|2
7758323|NCT00794157|12197702|FG001|Overall Study|Subject withdrew consent|0
7758324|NCT00794157|12197703|FG002|Overall Study|Subject withdrew consent|3
7758325|NCT00794157|12197701|FG000|Overall Study|Lost to Follow-up|2
7758326|NCT00794157|12197702|FG001|Overall Study|Lost to Follow-up|0
7758327|NCT00794157|12197703|FG002|Overall Study|Lost to Follow-up|1
7758328|NCT00794157|12197701|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7758329|NCT00794157|12197702|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7758330|NCT00794157|12197703|FG002|Overall Study|Unsatisfactory therapeutic effect|2
7758331|NCT00794157|12197701|FG000|Overall Study|Administrative problems|1
7758332|NCT00794157|12197702|FG001|Overall Study|Administrative problems|7
7758333|NCT00794157|12197703|FG002|Overall Study|Administrative problems|4
7758334|NCT00794157|12197701|FG000|Overall Study|Abnormal test procedure result(s)|0
7758335|NCT00794157|12197702|FG001|Overall Study|Abnormal test procedure result(s)|1
7758336|NCT00794157|12197703|FG002|Overall Study|Abnormal test procedure result(s)|0
7758337|NCT00794157|12197701|FG000|Overall Study|Protocol deviation|0
7758338|NCT00794157|12197702|FG001|Overall Study|Protocol deviation|1
7758339|NCT00794157|12197703|FG002|Overall Study|Protocol deviation|1
7758340|NCT00794196|12197722|FG000|Overall Study|Lost to Follow-up|5
7758341|NCT00794196|12197723|FG001|Overall Study|Lost to Follow-up|23
7758342|NCT00794339|12197742|FG000|Overall Study|Withdrawal by Subject|3
7758343|NCT00794339|12197742|FG000|Overall Study|Ineligible|4
7758344|NCT00794339|12197742|FG000|Overall Study|Tx prior to ATSM|3
7758345|NCT00794339|12197742|FG000|Overall Study|ATSM imaging not complete or inadequate|3
7758346|NCT00794339|12197742|FG000|Overall Study|Tx not per protocol|1
7758347|NCT00794365|12197763|FG000|Overall Study|Lost to Follow-up|38
7758348|NCT00794365|12197763|FG000|Overall Study|Other|17
7758349|NCT00794365|12197763|FG000|Overall Study|Poor Compliance|11
7758350|NCT00794365|12197763|FG000|Overall Study|Adverse Event|10
7758351|NCT00794365|12197763|FG000|Overall Study|Lack of Efficacy|3
7758352|NCT00794417|12197771|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0
7758353|NCT00794417|12197772|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0
7758354|NCT00794417|12197773|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2
7758355|NCT00794417|12197774|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0
7758356|NCT00794417|12197771|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
7758357|NCT00794417|12197772|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
7758358|NCT00794417|12197773|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1
7758359|NCT00794417|12197774|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0
7758360|NCT00794417|12197771|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0
7758361|NCT00794417|12197772|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0
7758362|NCT00794417|12197773|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0
7758363|NCT00794417|12197774|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7
7758364|NCT00794417|12197771|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
7758365|NCT00794417|12197772|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
7758366|NCT00794417|12197773|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
7758367|NCT00794417|12197774|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11
7758368|NCT00794417|12197771|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
7758369|NCT00794417|12197772|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
7758370|NCT00794417|12197773|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
7758371|NCT00794417|12197774|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4
7758372|NCT00794417|12197771|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
7758373|NCT00794417|12197772|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
7758374|NCT00794417|12197773|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
7758375|NCT00794417|12197774|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13
7758376|NCT00794573|12197818|FG000|Overall Study|Death|3
7758377|NCT00794573|12197819|FG001|Overall Study|Death|0
7758378|NCT00794573|12197818|FG000|Overall Study|Withdrawal by Subject|9
7758379|NCT00794573|12197819|FG001|Overall Study|Withdrawal by Subject|12
7758380|NCT00794573|12197818|FG000|Overall Study|Lost to Follow-up|26
7758381|NCT00794573|12197819|FG001|Overall Study|Lost to Follow-up|33
7758382|NCT00794664|12197827|FG000|Treatment Period|Withdrawal by Subject|0
7758383|NCT00794664|12197828|FG001|Treatment Period|Withdrawal by Subject|2
7758384|NCT00794664|12197827|FG000|Treatment Period|Protocol non-compliance|0
7758385|NCT00794664|12197828|FG001|Treatment Period|Protocol non-compliance|1
7758386|NCT00794664|12197827|FG000|Treatment Period|Other|0
7758387|NCT00794664|12197828|FG001|Treatment Period|Other|1
7758388|NCT00794664|12197827|FG000|Treatment Period|Adverse Event|1
7758389|NCT00794664|12197828|FG001|Treatment Period|Adverse Event|8
7758390|NCT00794664|12197827|FG000|Follow-up Period|Other|1
7758391|NCT00794664|12197828|FG001|Follow-up Period|Other|2
7758392|NCT00794664|12197827|FG000|Follow-up Period|Withdrawal by Subject|0
7758393|NCT00794664|12197828|FG001|Follow-up Period|Withdrawal by Subject|2
7758394|NCT00794664|12197827|FG000|Follow-up Period|Protocol non-compliance|0
7758395|NCT00794664|12197828|FG001|Follow-up Period|Protocol non-compliance|1
7758396|NCT00794820|12197834|FG000|Overall Study|Adverse Event|11
7758397|NCT00794820|12197834|FG000|Overall Study|Secondary Malignancies|2
7758398|NCT00794820|12197834|FG000|Overall Study|Resistant Disease|2
7758399|NCT00794820|12197834|FG000|Overall Study|Ineligible/Screen Failure|1
7758400|NCT00794950|12197838|FG000|BCG Induction|Withdrawal by Subject|2
7758401|NCT00794950|12197838|FG000|BCG Induction|ineligible|3
7758402|NCT00794950|12197838|FG000|BCG Induction|noncompliant w. BCG|1
7758403|NCT00794950|12197838|FG000|BCG Induction|Adverse Event|1
7758404|NCT00794950|12197838|FG000|Beginning Sunitinib Treatment|cystectomy|5
7758405|NCT00794950|12197838|FG000|Beginning Sunitinib Treatment|Physician Decision|5
7758406|NCT00794950|12197838|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1
7758407|NCT00794950|12197838|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1
7758408|NCT00794963|12197845|FG000|Overall Study|Withdrawal by Subject|1
7758409|NCT00794963|12197846|FG001|Overall Study|Withdrawal by Subject|4
7758410|NCT00795132|12197861|FG000|Overall Study|Death|1
7758411|NCT00795132|12197861|FG000|Overall Study|Relapse|2
7758412|NCT00795184|12197908|FG000|Overall Study|Tissue sampling incomplete/conclusive|8
7758413|NCT00795184|12197909|FG001|Overall Study|Tissue sampling incomplete/conclusive|13
7758414|NCT00795509|12197971|FG000|Overall Study|Protocol Violation|31
7758415|NCT00795535|12197975|FG000|Overall Study|incomplete data and technical problems|20
7758416|NCT00795600|12197981|FG000|Overall Study|Adverse Event|1
7758417|NCT00795600|12197982|FG001|Overall Study|Adverse Event|1
7758418|NCT00795600|12197981|FG000|Overall Study|Protocol Violation|1
7758419|NCT00795600|12197982|FG001|Overall Study|Protocol Violation|2
7758420|NCT00795600|12197981|FG000|Overall Study|Withdrawal by Subject|1
7758421|NCT00795600|12197982|FG001|Overall Study|Withdrawal by Subject|0
7758422|NCT00795600|12197981|FG000|Overall Study|Unclassified|1
7758423|NCT00795600|12197982|FG001|Overall Study|Unclassified|1
7758424|NCT00795639|12197990|FG000|Overall Study|Death|1
7758425|NCT00795639|12197991|FG001|Overall Study|Death|6
7758426|NCT00795639|12197990|FG000|Overall Study|Withdrawal by Subject|1
7758427|NCT00795639|12197991|FG001|Overall Study|Withdrawal by Subject|3
7758428|NCT00795639|12197990|FG000|Overall Study|Pregnancy|1
7758429|NCT00795639|12197991|FG001|Overall Study|Pregnancy|0
7758430|NCT00795639|12197990|FG000|Overall Study|Adverse Event|5
7758431|NCT00795639|12197991|FG001|Overall Study|Adverse Event|2
7758432|NCT00795639|12197990|FG000|Overall Study|Other|0
7758433|NCT00795639|12197991|FG001|Overall Study|Other|2
7758434|NCT00795639|12197990|FG000|Overall Study|Terminated by sponsor|13
7758435|NCT00795639|12197991|FG001|Overall Study|Terminated by sponsor|12
7758436|NCT00795639|12197990|FG000|Overall Study|Randomized and not treated|0
7758437|NCT00795639|12197991|FG001|Overall Study|Randomized and not treated|1
7758438|NCT00795704|12197999|FG000|Overall Study|Withdrawal by Subject|3
7758439|NCT00795704|12198000|FG001|Overall Study|Withdrawal by Subject|2
7758440|NCT00795704|12197999|FG000|Overall Study|Adverse Event|1
7758441|NCT00795704|12198000|FG001|Overall Study|Adverse Event|1
7758442|NCT00795717|12198008|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
7758443|NCT00795717|12198009|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
7758444|NCT00795717|12198008|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
7758445|NCT00795717|12198009|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
7758446|NCT00795717|12198008|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
7758447|NCT00795717|12198009|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
7758448|NCT00795717|12198008|FG000|Phase II|too busy|0
7758449|NCT00795717|12198009|FG001|Phase II|too busy|1
7758450|NCT00795821|12198022|FG000|Acute Treatment Phase|Adverse Event|23
7758451|NCT00795821|12198023|FG001|Acute Treatment Phase|Adverse Event|4
7758452|NCT00795821|12198022|FG000|Acute Treatment Phase|Death|1
7758453|NCT00795821|12198023|FG001|Acute Treatment Phase|Death|0
7758454|NCT00795821|12198022|FG000|Acute Treatment Phase|Lack of Efficacy|5
7758455|NCT00795821|12198023|FG001|Acute Treatment Phase|Lack of Efficacy|2
7758456|NCT00795821|12198022|FG000|Acute Treatment Phase|Lost to Follow-up|9
7758457|NCT00795821|12198023|FG001|Acute Treatment Phase|Lost to Follow-up|12
7758458|NCT00795821|12198022|FG000|Acute Treatment Phase|Physician Decision|1
7758459|NCT00795821|12198023|FG001|Acute Treatment Phase|Physician Decision|1
7758460|NCT00795821|12198022|FG000|Acute Treatment Phase|Protocol Violation|1
7758461|NCT00795821|12198023|FG001|Acute Treatment Phase|Protocol Violation|2
7758462|NCT00795821|12198022|FG000|Acute Treatment Phase|Withdrawal by Subject|16
7758463|NCT00795821|12198023|FG001|Acute Treatment Phase|Withdrawal by Subject|10
7758464|NCT00795821|12198022|FG000|Long-term Extension Phase|Adverse Event|25
7758465|NCT00795821|12198023|FG001|Long-term Extension Phase|Adverse Event|32
7758466|NCT00795821|12198022|FG000|Long-term Extension Phase|Lack of Efficacy|16
7758467|NCT00795821|12198023|FG001|Long-term Extension Phase|Lack of Efficacy|12
7758468|NCT00795821|12198022|FG000|Long-term Extension Phase|Lost to Follow-up|20
7758469|NCT00795821|12198023|FG001|Long-term Extension Phase|Lost to Follow-up|16
7758470|NCT00795821|12198022|FG000|Long-term Extension Phase|Physician Decision|1
7758471|NCT00795821|12198023|FG001|Long-term Extension Phase|Physician Decision|2
7758472|NCT00795821|12198022|FG000|Long-term Extension Phase|Protocol Violation|3
7758473|NCT00795821|12198023|FG001|Long-term Extension Phase|Protocol Violation|5
7758474|NCT00795821|12198022|FG000|Long-term Extension Phase|Withdrawal by Subject|25
7758475|NCT00795821|12198023|FG001|Long-term Extension Phase|Withdrawal by Subject|25
7758476|NCT00795821|12198022|FG000|Taper Phase|Adverse Event|2
7758477|NCT00795821|12198023|FG001|Taper Phase|Adverse Event|0
7758478|NCT00795821|12198022|FG000|Taper Phase|Lost to Follow-up|1
7758479|NCT00795821|12198023|FG001|Taper Phase|Lost to Follow-up|0
7758480|NCT00795821|12198022|FG000|Taper Phase|Physician Decision|2
7758481|NCT00795821|12198023|FG001|Taper Phase|Physician Decision|0
7758482|NCT00795821|12198022|FG000|Taper Phase|Withdrawal by Subject|4
7758483|NCT00795821|12198023|FG001|Taper Phase|Withdrawal by Subject|0
7758484|NCT00795886|12198039|FG000|Overall Study|Death|10
7758485|NCT00795951|12198044|FG000|Overall Study|Lost to Follow-up|1
7758486|NCT00795951|12198044|FG000|Overall Study|Withdrawal by Subject|1
7758487|NCT00796003|12198051|FG000|Overall Study|Disease Progression|2
7758488|NCT00796003|12198052|FG001|Overall Study|Disease Progression|13
7758489|NCT00796003|12198051|FG000|Overall Study|Adverse Event|1
7758490|NCT00796003|12198052|FG001|Overall Study|Adverse Event|7
7758491|NCT00796003|12198051|FG000|Overall Study|Specified organ function not met|0
7758492|NCT00796003|12198052|FG001|Overall Study|Specified organ function not met|1
7758493|NCT00796003|12198051|FG000|Overall Study|Physician Decision|0
7758494|NCT00796003|12198052|FG001|Overall Study|Physician Decision|4
7758495|NCT00796003|12198051|FG000|Overall Study|Withdrawal by Subject|0
7758496|NCT00796003|12198052|FG001|Overall Study|Withdrawal by Subject|1
7758497|NCT00796003|12198051|FG000|Overall Study|Other|0
7758498|NCT00796003|12198052|FG001|Overall Study|Other|1
7758499|NCT00796003|12198051|FG000|Overall Study|Participants Not treated|0
7758500|NCT00796003|12198052|FG001|Overall Study|Participants Not treated|2
7758501|NCT00796120|12198063|FG000|Overall Study|Death|3
7758502|NCT00796120|12198064|FG001|Overall Study|Death|0
7758503|NCT00796120|12198063|FG000|Overall Study|Adverse Event|11
7758504|NCT00796120|12198064|FG001|Overall Study|Adverse Event|6
7758505|NCT00796120|12198063|FG000|Overall Study|Progressive disease|22
7758506|NCT00796120|12198064|FG001|Overall Study|Progressive disease|13
7758507|NCT00796120|12198063|FG000|Overall Study|Participant refusal|3
7758508|NCT00796120|12198064|FG001|Overall Study|Participant refusal|4
7758509|NCT00796120|12198063|FG000|Overall Study|Other|6
7758510|NCT00796120|12198064|FG001|Overall Study|Other|17
7758511|NCT00796120|12198063|FG000|Overall Study|Physician Decision|16
7758512|NCT00796120|12198064|FG001|Overall Study|Physician Decision|17
7758513|NCT00796120|12198063|FG000|Overall Study|Randomized but not treated|0
7758514|NCT00796120|12198064|FG001|Overall Study|Randomized but not treated|3
7758515|NCT00796224|12198072|FG000|Overall Study|Adverse Event|1
7758516|NCT00796224|12198073|FG001|Overall Study|Adverse Event|0
7758517|NCT00796224|12198072|FG000|Overall Study|Protocol Violation|0
7758518|NCT00796224|12198073|FG001|Overall Study|Protocol Violation|1
7758519|NCT00796315|12198091|FG000|Overall Study|Protocol Violation|0
7758520|NCT00796315|12198092|FG001|Overall Study|Protocol Violation|1
7758521|NCT00796315|12198093|FG002|Overall Study|Protocol Violation|0
7758522|NCT00796328|12198104|FG000|Overall Study|experienced hypotension requiring tx|6
7758523|NCT00796367|12198111|FG000|Overall Study|Adverse Event|6
7758524|NCT00796367|12198112|FG001|Overall Study|Adverse Event|4
7758525|NCT00796367|12198113|FG002|Overall Study|Adverse Event|7
7758526|NCT00796367|12198111|FG000|Overall Study|Lost to Follow-up|5
7758527|NCT00796367|12198112|FG001|Overall Study|Lost to Follow-up|4
7758528|NCT00796367|12198113|FG002|Overall Study|Lost to Follow-up|21
7758529|NCT00796367|12198111|FG000|Overall Study|Withdrawal by Subject|9
7758530|NCT00796367|12198112|FG001|Overall Study|Withdrawal by Subject|11
7758531|NCT00796367|12198113|FG002|Overall Study|Withdrawal by Subject|12
7758532|NCT00796367|12198111|FG000|Overall Study|Lack of Efficacy|2
7758533|NCT00796367|12198112|FG001|Overall Study|Lack of Efficacy|1
7758534|NCT00796367|12198113|FG002|Overall Study|Lack of Efficacy|0
7758535|NCT00796367|12198111|FG000|Overall Study|non compliance|3
7758536|NCT00796367|12198112|FG001|Overall Study|non compliance|1
7758537|NCT00796367|12198113|FG002|Overall Study|non compliance|1
7758538|NCT00796367|12198111|FG000|Overall Study|Pregnancy|1
7758539|NCT00796367|12198112|FG001|Overall Study|Pregnancy|0
7758540|NCT00796367|12198113|FG002|Overall Study|Pregnancy|1
7758541|NCT00796367|12198111|FG000|Overall Study|Requirement for restricted medication|2
7758542|NCT00796367|12198112|FG001|Overall Study|Requirement for restricted medication|0
7758543|NCT00796367|12198113|FG002|Overall Study|Requirement for restricted medication|2
7758544|NCT00796367|12198111|FG000|Overall Study|other|2
7758545|NCT00796367|12198112|FG001|Overall Study|other|4
7758546|NCT00796367|12198113|FG002|Overall Study|other|3
7758547|NCT00796419|12198123|FG000|Overall Study|Death|0
7758548|NCT00796419|12198124|FG001|Overall Study|Death|1
7758549|NCT00796445|12198132|FG000|Overall Study|Protocol Violation|5
7758550|NCT00796445|12198133|FG001|Overall Study|Protocol Violation|3
7758551|NCT00796445|12198132|FG000|Overall Study|Adverse event, serious fatal|10
7758552|NCT00796445|12198133|FG001|Overall Study|Adverse event, serious fatal|5
7758553|NCT00796445|12198132|FG000|Overall Study|Adverse event, non-fatal|4
7758554|NCT00796445|12198133|FG001|Overall Study|Adverse event, non-fatal|0
7758555|NCT00796445|12198132|FG000|Overall Study|Disease progression/recurrence|537
7758556|NCT00796445|12198133|FG001|Overall Study|Disease progression/recurrence|268
7758557|NCT00796445|12198132|FG000|Overall Study|Other|10
7758558|NCT00796445|12198133|FG001|Overall Study|Other|7
7758559|NCT00796445|12198132|FG000|Overall Study|Withdrawal by Subject|18
7758560|NCT00796445|12198133|FG001|Overall Study|Withdrawal by Subject|9
7758561|NCT00796445|12198132|FG000|Overall Study|Invalid Informed Consent Form|1
7758562|NCT00796445|12198133|FG001|Overall Study|Invalid Informed Consent Form|0
7758563|NCT00796549|12198147|FG000|Overall Study|Adverse Event|11
7758564|NCT00796549|12198147|FG000|Overall Study|not entered|149
7758565|NCT00796549|12198147|FG000|Overall Study|Other|2
7758566|NCT00796549|12198147|FG000|Overall Study|Progressive disease|56
7758567|NCT00796562|12198153|FG000|Overall Study|Death|49
7758568|NCT00796614|12198161|FG000|Overall Study|Adverse Event|1
7758569|NCT00796614|12198162|FG001|Overall Study|Adverse Event|2
7758570|NCT00796614|12198163|FG002|Overall Study|Adverse Event|0
7758571|NCT00796614|12198164|FG003|Overall Study|Adverse Event|0
7758572|NCT00796614|12198161|FG000|Overall Study|Protocol Violation|0
7758573|NCT00796614|12198162|FG001|Overall Study|Protocol Violation|0
7758574|NCT00796614|12198163|FG002|Overall Study|Protocol Violation|2
7758575|NCT00796614|12198164|FG003|Overall Study|Protocol Violation|0
7758576|NCT00796614|12198161|FG000|Overall Study|Lost to Follow-up|2
7758577|NCT00796614|12198162|FG001|Overall Study|Lost to Follow-up|2
7758578|NCT00796614|12198163|FG002|Overall Study|Lost to Follow-up|1
7758579|NCT00796614|12198164|FG003|Overall Study|Lost to Follow-up|0
7758580|NCT00796614|12198161|FG000|Overall Study|Withdrawal by Subject|1
7758581|NCT00796614|12198162|FG001|Overall Study|Withdrawal by Subject|0
7758582|NCT00796614|12198163|FG002|Overall Study|Withdrawal by Subject|0
7758583|NCT00796614|12198164|FG003|Overall Study|Withdrawal by Subject|1
7758584|NCT00796614|12198161|FG000|Overall Study|Other than stated|1
7758585|NCT00796614|12198162|FG001|Overall Study|Other than stated|0
7758586|NCT00796614|12198163|FG002|Overall Study|Other than stated|0
7758587|NCT00796614|12198164|FG003|Overall Study|Other than stated|0
7758588|NCT00796653|12198187|FG000|Overall Study|Adverse Event|19
7758589|NCT00796653|12198188|FG001|Overall Study|Adverse Event|16
7758590|NCT00796653|12198189|FG002|Overall Study|Adverse Event|16
7758591|NCT00796653|12198190|FG003|Overall Study|Adverse Event|16
7758592|NCT00796653|12198187|FG000|Overall Study|Lost to Follow-up|2
7758593|NCT00796653|12198188|FG001|Overall Study|Lost to Follow-up|1
7758594|NCT00796653|12198189|FG002|Overall Study|Lost to Follow-up|2
7758595|NCT00796653|12198190|FG003|Overall Study|Lost to Follow-up|3
7758596|NCT00796653|12198187|FG000|Overall Study|Withdrawal by Subject|16
7758597|NCT00796653|12198188|FG001|Overall Study|Withdrawal by Subject|8
7758598|NCT00796653|12198189|FG002|Overall Study|Withdrawal by Subject|8
7758599|NCT00796653|12198190|FG003|Overall Study|Withdrawal by Subject|13
7758600|NCT00796653|12198187|FG000|Overall Study|Lack of Efficacy|8
7758601|NCT00796653|12198188|FG001|Overall Study|Lack of Efficacy|1
7758602|NCT00796653|12198189|FG002|Overall Study|Lack of Efficacy|3
7758603|NCT00796653|12198190|FG003|Overall Study|Lack of Efficacy|2
7758604|NCT00796653|12198187|FG000|Overall Study|Non compliance with protocol|2
7758605|NCT00796653|12198188|FG001|Overall Study|Non compliance with protocol|2
7758606|NCT00796653|12198189|FG002|Overall Study|Non compliance with protocol|0
7758607|NCT00796653|12198190|FG003|Overall Study|Non compliance with protocol|2
7758608|NCT00796653|12198187|FG000|Overall Study|Other reason not described above|4
7758609|NCT00796653|12198188|FG001|Overall Study|Other reason not described above|9
7758610|NCT00796653|12198189|FG002|Overall Study|Other reason not described above|7
7758611|NCT00796653|12198190|FG003|Overall Study|Other reason not described above|4
7758612|NCT00796666|12198210|FG000|Overall Study|Death|2
7758613|NCT00796666|12198211|FG001|Overall Study|Death|4
7758614|NCT00796666|12198210|FG000|Overall Study|Withdrawal by Subject|2
7758615|NCT00796666|12198211|FG001|Overall Study|Withdrawal by Subject|0
7758616|NCT00796666|12198210|FG000|Overall Study|Adverse Event|7
7758617|NCT00796666|12198211|FG001|Overall Study|Adverse Event|5
7758618|NCT00796666|12198210|FG000|Overall Study|Protocol Violation|1
7758619|NCT00796666|12198211|FG001|Overall Study|Protocol Violation|0
7758620|NCT00796666|12198210|FG000|Overall Study|Other|1
7758621|NCT00796666|12198211|FG001|Overall Study|Other|0
7758622|NCT00796666|12198210|FG000|Overall Study|Terminated by sponsor|53
7758623|NCT00796666|12198211|FG001|Overall Study|Terminated by sponsor|55
7758624|NCT00796666|12198210|FG000|Overall Study|Randomized and not treated|1
7758625|NCT00796666|12198211|FG001|Overall Study|Randomized and not treated|0
7758626|NCT00796718|12198236|FG000|Overall Study|Adverse Event|2
7758627|NCT00796718|12198236|FG000|Overall Study|Exclusion Criteria|1
7758628|NCT00796718|12198236|FG000|Overall Study|Lost to Follow-up|5
7758629|NCT00796718|12198236|FG000|Overall Study|Withdrawal by Informed Consent|1
7758630|NCT00796757|12198255|FG000|Overall Study|Withdrawal by Subject|14
7758631|NCT00796757|12198255|FG000|Overall Study|Death|61
7758632|NCT00796757|12198255|FG000|Overall Study|Protocol Violation|1
7758633|NCT00796757|12198255|FG000|Overall Study|Participant noncompliance|1
7758634|NCT00796757|12198255|FG000|Overall Study|Investigator's decision|2
7758635|NCT00796757|12198255|FG000|Overall Study|Other|7
7758636|NCT00796822|12198261|FG000|Overall Study|Lost to Follow-up|2
7758637|NCT00796822|12198262|FG001|Overall Study|Lost to Follow-up|0
7758638|NCT00796822|12198261|FG000|Overall Study|Adverse Event|1
7758639|NCT00796822|12198262|FG001|Overall Study|Adverse Event|0
7758640|NCT00796978|12198277|FG000|Overall Study|Cardiac adverse event|5
7758641|NCT00796978|12198277|FG000|Overall Study|Adverse Event|4
7758642|NCT00796978|12198277|FG000|Overall Study|Withdrawal by Subject|3
7758643|NCT00796991|12198284|FG000|Overall Study|Adverse Event|0
7758644|NCT00796991|12198285|FG001|Overall Study|Adverse Event|0
7758645|NCT00796991|12198286|FG002|Overall Study|Adverse Event|1
7758646|NCT00796991|12198284|FG000|Overall Study|Death|2
7758647|NCT00796991|12198285|FG001|Overall Study|Death|0
7758648|NCT00796991|12198286|FG002|Overall Study|Death|0
7758649|NCT00796991|12198284|FG000|Overall Study|Disease Progression|10
7758650|NCT00796991|12198285|FG001|Overall Study|Disease Progression|9
7758651|NCT00796991|12198286|FG002|Overall Study|Disease Progression|7
7758652|NCT00796991|12198284|FG000|Overall Study|Study Drug Toxicity|3
7758653|NCT00796991|12198285|FG001|Overall Study|Study Drug Toxicity|3
7758654|NCT00796991|12198286|FG002|Overall Study|Study Drug Toxicity|5
7758655|NCT00796991|12198284|FG000|Overall Study|Withdrawal by Subject|0
7758656|NCT00796991|12198285|FG001|Overall Study|Withdrawal by Subject|0
7758657|NCT00796991|12198286|FG002|Overall Study|Withdrawal by Subject|1
7758658|NCT00797108|12198297|FG000|Overall Study|Adverse Event|1
7758659|NCT00797108|12198298|FG001|Overall Study|Adverse Event|0
7758660|NCT00797108|12198299|FG002|Overall Study|Adverse Event|3
7758661|NCT00797108|12198297|FG000|Overall Study|Did Not Meet Entrance Criteria|0
7758662|NCT00797108|12198298|FG001|Overall Study|Did Not Meet Entrance Criteria|1
7758663|NCT00797108|12198299|FG002|Overall Study|Did Not Meet Entrance Criteria|0
7758664|NCT00797108|12198297|FG000|Overall Study|Global Deterioration of Health Status|0
7758665|NCT00797108|12198298|FG001|Overall Study|Global Deterioration of Health Status|1
7758666|NCT00797108|12198299|FG002|Overall Study|Global Deterioration of Health Status|0
7758667|NCT00797108|12198297|FG000|Overall Study|Lack of Efficacy|1
7758668|NCT00797108|12198298|FG001|Overall Study|Lack of Efficacy|0
7758669|NCT00797108|12198299|FG002|Overall Study|Lack of Efficacy|1
7758670|NCT00797108|12198297|FG000|Overall Study|Other|0
7758671|NCT00797108|12198298|FG001|Overall Study|Other|0
7758672|NCT00797108|12198299|FG002|Overall Study|Other|2
7758673|NCT00797108|12198297|FG000|Overall Study|Randomized but not Treated|2
7758674|NCT00797108|12198298|FG001|Overall Study|Randomized but not Treated|0
7758675|NCT00797108|12198299|FG002|Overall Study|Randomized but not Treated|0
7758676|NCT00797225|12198315|FG000|Weeks 1 to 12|Adverse Event|0
7758677|NCT00797225|12198316|FG001|Weeks 1 to 12|Adverse Event|0
7758678|NCT00797225|12198317|FG002|Weeks 1 to 12|Adverse Event|1
7758679|NCT00797225|12198318|FG003|Weeks 1 to 12|Adverse Event|0
7758680|NCT00797225|12198319|FG004|Weeks 1 to 12|Adverse Event|0
7758681|NCT00797225|12198320|FG005|Weeks 1 to 12|Adverse Event|0
7758682|NCT00797225|12198321|FG006|Weeks 1 to 12|Adverse Event|0
7758683|NCT00797225|12198322|FG007|Weeks 1 to 12|Adverse Event|0
7758684|NCT00797225|12198315|FG000|Weeks 1 to 12|Non-compliance|0
7758685|NCT00797225|12198316|FG001|Weeks 1 to 12|Non-compliance|1
7758686|NCT00797225|12198317|FG002|Weeks 1 to 12|Non-compliance|0
7758687|NCT00797225|12198318|FG003|Weeks 1 to 12|Non-compliance|0
7758688|NCT00797225|12198319|FG004|Weeks 1 to 12|Non-compliance|0
7758689|NCT00797225|12198320|FG005|Weeks 1 to 12|Non-compliance|0
7758690|NCT00797225|12198321|FG006|Weeks 1 to 12|Non-compliance|0
7758691|NCT00797225|12198322|FG007|Weeks 1 to 12|Non-compliance|0
7758692|NCT00797225|12198315|FG000|Weeks 1 to 12|Lack of Efficacy|1
7758693|NCT00797225|12198316|FG001|Weeks 1 to 12|Lack of Efficacy|0
7758694|NCT00797225|12198317|FG002|Weeks 1 to 12|Lack of Efficacy|0
7758695|NCT00797225|12198318|FG003|Weeks 1 to 12|Lack of Efficacy|0
7758696|NCT00797225|12198319|FG004|Weeks 1 to 12|Lack of Efficacy|0
7758697|NCT00797225|12198320|FG005|Weeks 1 to 12|Lack of Efficacy|0
7758698|NCT00797225|12198321|FG006|Weeks 1 to 12|Lack of Efficacy|0
7758699|NCT00797225|12198322|FG007|Weeks 1 to 12|Lack of Efficacy|0
7758700|NCT00797225|12198315|FG000|Weeks 1 to 12|Sponsor Decision|1
7758701|NCT00797225|12198316|FG001|Weeks 1 to 12|Sponsor Decision|0
7758702|NCT00797225|12198317|FG002|Weeks 1 to 12|Sponsor Decision|0
7758703|NCT00797225|12198318|FG003|Weeks 1 to 12|Sponsor Decision|0
7758704|NCT00797225|12198319|FG004|Weeks 1 to 12|Sponsor Decision|0
7758705|NCT00797225|12198320|FG005|Weeks 1 to 12|Sponsor Decision|0
7758706|NCT00797225|12198321|FG006|Weeks 1 to 12|Sponsor Decision|0
7758707|NCT00797225|12198322|FG007|Weeks 1 to 12|Sponsor Decision|0
7758708|NCT00797225|12198315|FG000|Weeks 13 to 24|Non-compliance|0
7758709|NCT00797225|12198316|FG001|Weeks 13 to 24|Non-compliance|2
7758710|NCT00797225|12198317|FG002|Weeks 13 to 24|Non-compliance|0
7758711|NCT00797225|12198318|FG003|Weeks 13 to 24|Non-compliance|0
7758712|NCT00797225|12198319|FG004|Weeks 13 to 24|Non-compliance|0
7758713|NCT00797225|12198320|FG005|Weeks 13 to 24|Non-compliance|0
7758714|NCT00797225|12198321|FG006|Weeks 13 to 24|Non-compliance|0
7758715|NCT00797225|12198322|FG007|Weeks 13 to 24|Non-compliance|0
7758716|NCT00797225|12198315|FG000|Weeks 13 to 24|Withdrawal by Subject|0
7758717|NCT00797225|12198316|FG001|Weeks 13 to 24|Withdrawal by Subject|1
7758718|NCT00797225|12198317|FG002|Weeks 13 to 24|Withdrawal by Subject|1
7758719|NCT00797225|12198318|FG003|Weeks 13 to 24|Withdrawal by Subject|0
7758720|NCT00797225|12198319|FG004|Weeks 13 to 24|Withdrawal by Subject|0
7758721|NCT00797225|12198320|FG005|Weeks 13 to 24|Withdrawal by Subject|0
7758722|NCT00797225|12198321|FG006|Weeks 13 to 24|Withdrawal by Subject|0
7758723|NCT00797225|12198322|FG007|Weeks 13 to 24|Withdrawal by Subject|0
7758724|NCT00797225|12198315|FG000|Weeks 13 to 24|Lost to Follow-up|0
7758725|NCT00797225|12198316|FG001|Weeks 13 to 24|Lost to Follow-up|0
7758726|NCT00797225|12198317|FG002|Weeks 13 to 24|Lost to Follow-up|1
7758727|NCT00797225|12198318|FG003|Weeks 13 to 24|Lost to Follow-up|0
7758728|NCT00797225|12198319|FG004|Weeks 13 to 24|Lost to Follow-up|1
7758729|NCT00797225|12198320|FG005|Weeks 13 to 24|Lost to Follow-up|0
7758730|NCT00797225|12198321|FG006|Weeks 13 to 24|Lost to Follow-up|0
7758731|NCT00797225|12198322|FG007|Weeks 13 to 24|Lost to Follow-up|0
7758732|NCT00797225|12198315|FG000|Weeks 13 to 24|Adverse Event|0
7758733|NCT00797225|12198316|FG001|Weeks 13 to 24|Adverse Event|1
7758734|NCT00797225|12198317|FG002|Weeks 13 to 24|Adverse Event|0
7758735|NCT00797225|12198318|FG003|Weeks 13 to 24|Adverse Event|0
7758736|NCT00797225|12198319|FG004|Weeks 13 to 24|Adverse Event|0
7758737|NCT00797225|12198320|FG005|Weeks 13 to 24|Adverse Event|0
7758738|NCT00797225|12198321|FG006|Weeks 13 to 24|Adverse Event|1
7758739|NCT00797225|12198322|FG007|Weeks 13 to 24|Adverse Event|0
7758740|NCT00797225|12198315|FG000|Weeks 13 to 24|Sponsor Decision|0
7758741|NCT00797225|12198316|FG001|Weeks 13 to 24|Sponsor Decision|0
7758742|NCT00797225|12198317|FG002|Weeks 13 to 24|Sponsor Decision|0
7758743|NCT00797225|12198318|FG003|Weeks 13 to 24|Sponsor Decision|0
7758744|NCT00797225|12198319|FG004|Weeks 13 to 24|Sponsor Decision|0
7758745|NCT00797225|12198320|FG005|Weeks 13 to 24|Sponsor Decision|0
7758746|NCT00797225|12198321|FG006|Weeks 13 to 24|Sponsor Decision|1
7758747|NCT00797225|12198322|FG007|Weeks 13 to 24|Sponsor Decision|0
7758748|NCT00797316|12198350|FG000|Overall Study|Administrative problems|1
7758749|NCT00797316|12198351|FG001|Overall Study|Administrative problems|0
7758750|NCT00797316|12198350|FG000|Overall Study|Adverse Event|5
7758751|NCT00797316|12198351|FG001|Overall Study|Adverse Event|3
7758752|NCT00797316|12198350|FG000|Overall Study|Lost to Follow-up|4
7758753|NCT00797316|12198351|FG001|Overall Study|Lost to Follow-up|8
7758754|NCT00797316|12198350|FG000|Overall Study|Protocol Deviation|1
7758755|NCT00797316|12198351|FG001|Overall Study|Protocol Deviation|2
7758756|NCT00797316|12198350|FG000|Overall Study|Patient withdrew consent|12
7758757|NCT00797316|12198351|FG001|Overall Study|Patient withdrew consent|6
7758758|NCT00797316|12198350|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7758759|NCT00797316|12198351|FG001|Overall Study|Unsatisfactory therapeutic effect|13
7758760|NCT00797511|12198365|FG000|Overall Study|Withdrawal by Subject|1
7758761|NCT00797563|12198370|FG000|Overall Study|Adverse Event|1
7758762|NCT00797667|12198377|FG000|Overall Study|Lack of Efficacy|0
7758763|NCT00797667|12198378|FG001|Overall Study|Lack of Efficacy|1
7758764|NCT00797667|12198379|FG002|Overall Study|Lack of Efficacy|0
7758765|NCT00797667|12198377|FG000|Overall Study|Lost to Follow-up|8
7758766|NCT00797667|12198378|FG001|Overall Study|Lost to Follow-up|12
7758767|NCT00797667|12198379|FG002|Overall Study|Lost to Follow-up|2
7758768|NCT00797667|12198377|FG000|Overall Study|Physician Decision|3
7758769|NCT00797667|12198378|FG001|Overall Study|Physician Decision|1
7758770|NCT00797667|12198379|FG002|Overall Study|Physician Decision|0
7758771|NCT00797667|12198377|FG000|Overall Study|Pregnancy|2
7758772|NCT00797667|12198378|FG001|Overall Study|Pregnancy|0
7758773|NCT00797667|12198379|FG002|Overall Study|Pregnancy|0
7758774|NCT00797667|12198377|FG000|Overall Study|Protocol Violation|2
7758775|NCT00797667|12198378|FG001|Overall Study|Protocol Violation|7
7758776|NCT00797667|12198379|FG002|Overall Study|Protocol Violation|0
7758777|NCT00797667|12198377|FG000|Overall Study|Study Terminated by Sponsor|217
7758778|NCT00797667|12198378|FG001|Overall Study|Study Terminated by Sponsor|216
7758779|NCT00797667|12198379|FG002|Overall Study|Study Terminated by Sponsor|115
7758780|NCT00797667|12198377|FG000|Overall Study|Withdrawal by Subject|9
7758781|NCT00797667|12198378|FG001|Overall Study|Withdrawal by Subject|14
7758782|NCT00797667|12198379|FG002|Overall Study|Withdrawal by Subject|2
7758783|NCT00797667|12198377|FG000|Overall Study|Adverse Event|19
7758784|NCT00797667|12198378|FG001|Overall Study|Adverse Event|8
7758785|NCT00797667|12198379|FG002|Overall Study|Adverse Event|8
7758786|NCT00797732|12198389|FG000|Overall Study|Withdrawal by Subject|3
7758787|NCT00797732|12198390|FG001|Overall Study|Withdrawal by Subject|3
7758788|NCT00797732|12198391|FG002|Overall Study|Withdrawal by Subject|0
7758789|NCT00797732|12198389|FG000|Overall Study|Lost to Follow-up|1
7758790|NCT00797732|12198390|FG001|Overall Study|Lost to Follow-up|0
7758791|NCT00797732|12198391|FG002|Overall Study|Lost to Follow-up|0
7758792|NCT00797732|12198389|FG000|Overall Study|Death|1
7758793|NCT00797732|12198390|FG001|Overall Study|Death|0
7758794|NCT00797732|12198391|FG002|Overall Study|Death|0
7758795|NCT00797732|12198389|FG000|Overall Study|Not meet inclusion criteria|0
7758796|NCT00797732|12198390|FG001|Overall Study|Not meet inclusion criteria|0
7758797|NCT00797732|12198391|FG002|Overall Study|Not meet inclusion criteria|7
7758798|NCT00797732|12198389|FG000|Overall Study|Excluded due to time constraints|0
7758799|NCT00797732|12198390|FG001|Overall Study|Excluded due to time constraints|0
7758800|NCT00797732|12198391|FG002|Overall Study|Excluded due to time constraints|24
7758801|NCT00797732|12198389|FG000|Overall Study|Refused to Participate|0
7758802|NCT00797732|12198390|FG001|Overall Study|Refused to Participate|0
7758803|NCT00797732|12198391|FG002|Overall Study|Refused to Participate|123
7758804|NCT00797823|12198409|FG000|First Period (Initial Randomization)|Physician Decision|1
7758805|NCT00797823|12198410|FG001|First Period (Initial Randomization)|Physician Decision|0
7758806|NCT00797823|12198411|FG002|First Period (Initial Randomization)|Physician Decision|0
7758807|NCT00797862|12198421|FG000|Overall Study|Adverse Event|86
7758808|NCT00797862|12198422|FG001|Overall Study|Adverse Event|44
7758809|NCT00797862|12198423|FG002|Overall Study|Adverse Event|58
7758810|NCT00797862|12198421|FG000|Overall Study|Abnormal Test Procedure Result|0
7758811|NCT00797862|12198422|FG001|Overall Study|Abnormal Test Procedure Result|1
7758812|NCT00797862|12198423|FG002|Overall Study|Abnormal Test Procedure Result|1
7758813|NCT00797862|12198421|FG000|Overall Study|Lack of Efficacy|1
7758814|NCT00797862|12198422|FG001|Overall Study|Lack of Efficacy|7
7758815|NCT00797862|12198423|FG002|Overall Study|Lack of Efficacy|6
7758816|NCT00797862|12198421|FG000|Overall Study|No longer required study medication|1
7758817|NCT00797862|12198422|FG001|Overall Study|No longer required study medication|0
7758818|NCT00797862|12198423|FG002|Overall Study|No longer required study medication|0
7758819|NCT00797862|12198421|FG000|Overall Study|Withdrawal by Subject|14
7758820|NCT00797862|12198422|FG001|Overall Study|Withdrawal by Subject|7
7758821|NCT00797862|12198423|FG002|Overall Study|Withdrawal by Subject|7
7758822|NCT00797862|12198421|FG000|Overall Study|Lost to Follow-up|11
7758823|NCT00797862|12198422|FG001|Overall Study|Lost to Follow-up|0
7758824|NCT00797862|12198423|FG002|Overall Study|Lost to Follow-up|5
7758825|NCT00797862|12198421|FG000|Overall Study|Administrative Problem|4
7758826|NCT00797862|12198422|FG001|Overall Study|Administrative Problem|0
7758827|NCT00797862|12198423|FG002|Overall Study|Administrative Problem|0
7758828|NCT00797862|12198421|FG000|Overall Study|Protocol Violation|4
7758829|NCT00797862|12198422|FG001|Overall Study|Protocol Violation|6
7758830|NCT00797862|12198423|FG002|Overall Study|Protocol Violation|8
7758831|NCT00797862|12198421|FG000|Overall Study|Mis-randomized|3
7758832|NCT00797862|12198422|FG001|Overall Study|Mis-randomized|3
7758833|NCT00797862|12198423|FG002|Overall Study|Mis-randomized|1
7758834|NCT00797966|12198435|FG000|Phase A|Lost to Follow-up|0
7758835|NCT00797966|12198436|FG001|Phase A|Lost to Follow-up|0
7758836|NCT00797966|12198437|FG002|Phase A|Lost to Follow-up|0
7758837|NCT00797966|12198438|FG003|Phase A|Lost to Follow-up|0
7758838|NCT00797966|12198439|FG004|Phase A|Lost to Follow-up|33
7758839|NCT00797966|12198440|FG005|Phase A|Lost to Follow-up|0
7758840|NCT00797966|12198435|FG000|Phase A|Adverse Event|0
7758841|NCT00797966|12198436|FG001|Phase A|Adverse Event|0
7758842|NCT00797966|12198437|FG002|Phase A|Adverse Event|0
7758843|NCT00797966|12198438|FG003|Phase A|Adverse Event|0
7758844|NCT00797966|12198439|FG004|Phase A|Adverse Event|46
7758845|NCT00797966|12198440|FG005|Phase A|Adverse Event|0
7758846|NCT00797966|12198435|FG000|Phase A|Met withdrawal criteria|0
7758847|NCT00797966|12198436|FG001|Phase A|Met withdrawal criteria|0
7758848|NCT00797966|12198437|FG002|Phase A|Met withdrawal criteria|0
7758849|NCT00797966|12198438|FG003|Phase A|Met withdrawal criteria|0
7758850|NCT00797966|12198439|FG004|Phase A|Met withdrawal criteria|4
7758851|NCT00797966|12198440|FG005|Phase A|Met withdrawal criteria|0
7758852|NCT00797966|12198435|FG000|Phase A|Physician Decision|0
7758853|NCT00797966|12198436|FG001|Phase A|Physician Decision|0
7758854|NCT00797966|12198437|FG002|Phase A|Physician Decision|0
7758855|NCT00797966|12198438|FG003|Phase A|Physician Decision|0
7758856|NCT00797966|12198439|FG004|Phase A|Physician Decision|13
7758857|NCT00797966|12198440|FG005|Phase A|Physician Decision|0
7758858|NCT00797966|12198435|FG000|Phase A|Withdrawal by Subject|0
7758859|NCT00797966|12198436|FG001|Phase A|Withdrawal by Subject|0
7758860|NCT00797966|12198437|FG002|Phase A|Withdrawal by Subject|0
7758861|NCT00797966|12198438|FG003|Phase A|Withdrawal by Subject|0
7758862|NCT00797966|12198439|FG004|Phase A|Withdrawal by Subject|33
7758863|NCT00797966|12198440|FG005|Phase A|Withdrawal by Subject|0
7758864|NCT00797966|12198435|FG000|Phase A|Protocol deviation|0
7758865|NCT00797966|12198436|FG001|Phase A|Protocol deviation|0
7758866|NCT00797966|12198437|FG002|Phase A|Protocol deviation|0
7758867|NCT00797966|12198438|FG003|Phase A|Protocol deviation|0
7758868|NCT00797966|12198439|FG004|Phase A|Protocol deviation|56
7758869|NCT00797966|12198440|FG005|Phase A|Protocol deviation|0
7758870|NCT00797966|12198435|FG000|Phase B|Lost to Follow-up|0
7758871|NCT00797966|12198436|FG001|Phase B|Lost to Follow-up|1
7758872|NCT00797966|12198437|FG002|Phase B|Lost to Follow-up|3
7758873|NCT00797966|12198438|FG003|Phase B|Lost to Follow-up|0
7758874|NCT00797966|12198439|FG004|Phase B|Lost to Follow-up|0
7758875|NCT00797966|12198440|FG005|Phase B|Lost to Follow-up|0
7758876|NCT00797966|12198435|FG000|Phase B|Adverse Event|2
7758877|NCT00797966|12198436|FG001|Phase B|Adverse Event|1
7758878|NCT00797966|12198437|FG002|Phase B|Adverse Event|3
7758879|NCT00797966|12198438|FG003|Phase B|Adverse Event|1
7758880|NCT00797966|12198439|FG004|Phase B|Adverse Event|0
7758881|NCT00797966|12198440|FG005|Phase B|Adverse Event|0
7758882|NCT00797966|12198435|FG000|Phase B|Met Withdrawal Criteria|3
7758883|NCT00797966|12198436|FG001|Phase B|Met Withdrawal Criteria|3
7758884|NCT00797966|12198437|FG002|Phase B|Met Withdrawal Criteria|6
7758885|NCT00797966|12198438|FG003|Phase B|Met Withdrawal Criteria|1
7758886|NCT00797966|12198439|FG004|Phase B|Met Withdrawal Criteria|0
7758887|NCT00797966|12198440|FG005|Phase B|Met Withdrawal Criteria|0
7758888|NCT00797966|12198435|FG000|Phase B|Physician Decision|1
7758889|NCT00797966|12198436|FG001|Phase B|Physician Decision|0
7758890|NCT00797966|12198437|FG002|Phase B|Physician Decision|3
7758891|NCT00797966|12198438|FG003|Phase B|Physician Decision|1
7758892|NCT00797966|12198439|FG004|Phase B|Physician Decision|0
7758893|NCT00797966|12198440|FG005|Phase B|Physician Decision|0
7758894|NCT00797966|12198435|FG000|Phase B|Withdrawal by Subject|1
7758895|NCT00797966|12198436|FG001|Phase B|Withdrawal by Subject|4
7758896|NCT00797966|12198437|FG002|Phase B|Withdrawal by Subject|3
7758897|NCT00797966|12198438|FG003|Phase B|Withdrawal by Subject|3
7758898|NCT00797966|12198439|FG004|Phase B|Withdrawal by Subject|0
7758899|NCT00797966|12198440|FG005|Phase B|Withdrawal by Subject|0
7758900|NCT00797966|12198435|FG000|Phase B|Protocol Deviation|4
7758901|NCT00797966|12198436|FG001|Phase B|Protocol Deviation|8
7758902|NCT00797966|12198437|FG002|Phase B|Protocol Deviation|2
7758903|NCT00797966|12198438|FG003|Phase B|Protocol Deviation|6
7758904|NCT00797966|12198439|FG004|Phase B|Protocol Deviation|0
7758905|NCT00797966|12198440|FG005|Phase B|Protocol Deviation|0
7758906|NCT00797966|12198435|FG000|Phase B|Lack of Efficacy|0
7758907|NCT00797966|12198436|FG001|Phase B|Lack of Efficacy|1
7758908|NCT00797966|12198437|FG002|Phase B|Lack of Efficacy|1
7758909|NCT00797966|12198438|FG003|Phase B|Lack of Efficacy|4
7758910|NCT00797966|12198439|FG004|Phase B|Lack of Efficacy|0
7758911|NCT00797966|12198440|FG005|Phase B|Lack of Efficacy|0
7758912|NCT00797966|12198435|FG000|Phase A+|Lost to Follow-up|0
7758913|NCT00797966|12198436|FG001|Phase A+|Lost to Follow-up|0
7758914|NCT00797966|12198437|FG002|Phase A+|Lost to Follow-up|0
7758915|NCT00797966|12198438|FG003|Phase A+|Lost to Follow-up|0
7758916|NCT00797966|12198439|FG004|Phase A+|Lost to Follow-up|0
7758917|NCT00797966|12198440|FG005|Phase A+|Lost to Follow-up|9
7758918|NCT00797966|12198435|FG000|Phase A+|Met withdrawal criteria|0
7758919|NCT00797966|12198436|FG001|Phase A+|Met withdrawal criteria|0
7758920|NCT00797966|12198437|FG002|Phase A+|Met withdrawal criteria|0
7758921|NCT00797966|12198438|FG003|Phase A+|Met withdrawal criteria|0
7758922|NCT00797966|12198439|FG004|Phase A+|Met withdrawal criteria|0
7758923|NCT00797966|12198440|FG005|Phase A+|Met withdrawal criteria|5
7758924|NCT00797966|12198435|FG000|Phase A+|Withdrawal by Subject|0
7758925|NCT00797966|12198436|FG001|Phase A+|Withdrawal by Subject|0
7758926|NCT00797966|12198437|FG002|Phase A+|Withdrawal by Subject|0
7758927|NCT00797966|12198438|FG003|Phase A+|Withdrawal by Subject|0
7758928|NCT00797966|12198439|FG004|Phase A+|Withdrawal by Subject|0
7758929|NCT00797966|12198440|FG005|Phase A+|Withdrawal by Subject|6
7758930|NCT00797966|12198435|FG000|Phase A+|Adverse Event|0
7758931|NCT00797966|12198436|FG001|Phase A+|Adverse Event|0
7758932|NCT00797966|12198437|FG002|Phase A+|Adverse Event|0
7758933|NCT00797966|12198438|FG003|Phase A+|Adverse Event|0
7758934|NCT00797966|12198439|FG004|Phase A+|Adverse Event|0
7758935|NCT00797966|12198440|FG005|Phase A+|Adverse Event|4
7758936|NCT00797966|12198435|FG000|Phase A+|Protocol deviation|0
7758937|NCT00797966|12198436|FG001|Phase A+|Protocol deviation|0
7758938|NCT00797966|12198437|FG002|Phase A+|Protocol deviation|0
7758939|NCT00797966|12198438|FG003|Phase A+|Protocol deviation|0
7758940|NCT00797966|12198439|FG004|Phase A+|Protocol deviation|0
7758941|NCT00797966|12198440|FG005|Phase A+|Protocol deviation|4
7758942|NCT00798096|12198469|FG000|Overall Study|Ongoing|2
7758943|NCT00798135|12198473|FG000|Overall Study|Disease progression, relapse|11
7758944|NCT00798135|12198473|FG000|Overall Study|Disease progression, refractory|1
7758945|NCT00798135|12198473|FG000|Overall Study|Physician Decision|1
7758946|NCT00798161|12198484|FG000|Overall Study|Adverse Event|3
7758947|NCT00798161|12198485|FG001|Overall Study|Adverse Event|4
7758948|NCT00798161|12198486|FG002|Overall Study|Adverse Event|6
7758949|NCT00798161|12198487|FG003|Overall Study|Adverse Event|6
7758950|NCT00798161|12198488|FG004|Overall Study|Adverse Event|5
7758951|NCT00798161|12198489|FG005|Overall Study|Adverse Event|2
7758952|NCT00798161|12198490|FG006|Overall Study|Adverse Event|4
7758953|NCT00798161|12198484|FG000|Overall Study|Protocol Violation|2
7758954|NCT00798161|12198485|FG001|Overall Study|Protocol Violation|1
7758955|NCT00798161|12198486|FG002|Overall Study|Protocol Violation|3
7758956|NCT00798161|12198487|FG003|Overall Study|Protocol Violation|3
7758957|NCT00798161|12198488|FG004|Overall Study|Protocol Violation|3
7758958|NCT00798161|12198489|FG005|Overall Study|Protocol Violation|2
7758959|NCT00798161|12198490|FG006|Overall Study|Protocol Violation|0
7758960|NCT00798161|12198484|FG000|Overall Study|Lost to Follow-up|1
7758961|NCT00798161|12198485|FG001|Overall Study|Lost to Follow-up|3
7758962|NCT00798161|12198486|FG002|Overall Study|Lost to Follow-up|4
7758963|NCT00798161|12198487|FG003|Overall Study|Lost to Follow-up|3
7758964|NCT00798161|12198488|FG004|Overall Study|Lost to Follow-up|4
7758965|NCT00798161|12198489|FG005|Overall Study|Lost to Follow-up|0
7758966|NCT00798161|12198490|FG006|Overall Study|Lost to Follow-up|0
7758967|NCT00798161|12198484|FG000|Overall Study|Withdrawal by Subject|5
7758968|NCT00798161|12198485|FG001|Overall Study|Withdrawal by Subject|4
7758969|NCT00798161|12198486|FG002|Overall Study|Withdrawal by Subject|5
7758970|NCT00798161|12198487|FG003|Overall Study|Withdrawal by Subject|4
7758971|NCT00798161|12198488|FG004|Overall Study|Withdrawal by Subject|2
7758972|NCT00798161|12198489|FG005|Overall Study|Withdrawal by Subject|3
7758973|NCT00798161|12198490|FG006|Overall Study|Withdrawal by Subject|1
7758974|NCT00798161|12198484|FG000|Overall Study|Other reason (incl. lack of efficacy)|7
7758975|NCT00798161|12198485|FG001|Overall Study|Other reason (incl. lack of efficacy)|5
7758976|NCT00798161|12198486|FG002|Overall Study|Other reason (incl. lack of efficacy)|3
7758977|NCT00798161|12198487|FG003|Overall Study|Other reason (incl. lack of efficacy)|5
7758978|NCT00798161|12198488|FG004|Overall Study|Other reason (incl. lack of efficacy)|2
7758979|NCT00798161|12198489|FG005|Overall Study|Other reason (incl. lack of efficacy)|4
7758980|NCT00798161|12198490|FG006|Overall Study|Other reason (incl. lack of efficacy)|5
7962585|NCT02712983|12516802|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7962586|NCT02712983|12516803|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7962587|NCT02712983|12516804|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
7962588|NCT02712983|12516805|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
7962589|NCT02712983|12516806|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7962590|NCT02712983|12516798|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7962591|NCT02712983|12516799|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7962592|NCT02712983|12516800|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7962593|NCT02712983|12516801|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1
7962594|NCT02712983|12516802|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7962595|NCT02712983|12516803|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7962596|NCT02712983|12516804|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7962597|NCT02712983|12516805|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7962598|NCT02712983|12516806|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7962599|NCT02712983|12516798|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7962600|NCT02712983|12516799|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7962601|NCT02712983|12516800|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7758981|NCT00798174|12198506|FG000|Overall Study|inability to implant azygos coil|3
7758982|NCT00798174|12198507|FG001|Overall Study|inability to implant azygos coil|3
7758983|NCT00798174|12198506|FG000|Overall Study|Inability to sedate for DFT testing|1
7758984|NCT00798174|12198507|FG001|Overall Study|Inability to sedate for DFT testing|0
7758985|NCT00798304|12198514|FG000|Overall Study|Adverse Event|0
7758986|NCT00798304|12198515|FG001|Overall Study|Adverse Event|1
7758987|NCT00798304|12198516|FG002|Overall Study|Adverse Event|1
7758988|NCT00798304|12198514|FG000|Overall Study|Discontinuation by Sponsor|14
7758989|NCT00798304|12198515|FG001|Overall Study|Discontinuation by Sponsor|21
7758990|NCT00798304|12198516|FG002|Overall Study|Discontinuation by Sponsor|9
7758991|NCT00798317|12198526|FG000|Overall Study|Physician Decision|0
7758992|NCT00798317|12198527|FG001|Overall Study|Physician Decision|1
7758993|NCT00798317|12198526|FG000|Overall Study|Withdrawal by Subject|5
7758994|NCT00798317|12198527|FG001|Overall Study|Withdrawal by Subject|4
7758995|NCT00798317|12198526|FG000|Overall Study|Lost to Follow-up|2
7758996|NCT00798317|12198527|FG001|Overall Study|Lost to Follow-up|2
7758997|NCT00798317|12198526|FG000|Overall Study|Adverse Event|2
7758998|NCT00798317|12198527|FG001|Overall Study|Adverse Event|0
7758999|NCT00798317|12198526|FG000|Overall Study|Death|1
7759000|NCT00798317|12198527|FG001|Overall Study|Death|0
7759001|NCT00798369|12198539|FG000|Overall Study|Subject withdrew consent|0
7759002|NCT00798369|12198540|FG001|Overall Study|Subject withdrew consent|0
7759003|NCT00798369|12198541|FG002|Overall Study|Subject withdrew consent|1
7759004|NCT00798369|12198542|FG003|Overall Study|Subject withdrew consent|1
7759005|NCT00798369|12198543|FG004|Overall Study|Subject withdrew consent|0
7759006|NCT00798369|12198544|FG005|Overall Study|Subject withdrew consent|2
7759007|NCT00798369|12198539|FG000|Overall Study|Lost to Follow-up|1
7759008|NCT00798369|12198540|FG001|Overall Study|Lost to Follow-up|1
7759009|NCT00798369|12198541|FG002|Overall Study|Lost to Follow-up|1
7759010|NCT00798369|12198542|FG003|Overall Study|Lost to Follow-up|0
7759011|NCT00798369|12198543|FG004|Overall Study|Lost to Follow-up|1
7759012|NCT00798369|12198544|FG005|Overall Study|Lost to Follow-up|0
7759013|NCT00798369|12198539|FG000|Overall Study|Adminstrative problems|0
7759014|NCT00798369|12198540|FG001|Overall Study|Adminstrative problems|0
7759015|NCT00798369|12198541|FG002|Overall Study|Adminstrative problems|0
7759016|NCT00798369|12198542|FG003|Overall Study|Adminstrative problems|0
7759017|NCT00798369|12198543|FG004|Overall Study|Adminstrative problems|0
7759018|NCT00798369|12198544|FG005|Overall Study|Adminstrative problems|1
7759019|NCT00798434|12198561|FG000|Double-Blind|Adverse Event|22
7759020|NCT00798434|12198562|FG001|Double-Blind|Adverse Event|46
7759021|NCT00798434|12198561|FG000|Double-Blind|Death|0
7759022|NCT00798434|12198562|FG001|Double-Blind|Death|1
7759023|NCT00798434|12198561|FG000|Double-Blind|Lost to Follow-up|1
7759024|NCT00798434|12198562|FG001|Double-Blind|Lost to Follow-up|0
7759025|NCT00798434|12198561|FG000|Double-Blind|Lack of Efficacy|8
7759026|NCT00798434|12198562|FG001|Double-Blind|Lack of Efficacy|12
7759027|NCT00798434|12198561|FG000|Double-Blind|Withdrawal by Subject|17
7759028|NCT00798434|12198562|FG001|Double-Blind|Withdrawal by Subject|14
7759029|NCT00798434|12198561|FG000|Double-Blind|Protocol Violation|1
7759030|NCT00798434|12198562|FG001|Double-Blind|Protocol Violation|4
7759031|NCT00798434|12198561|FG000|Double-Blind|Did Not Meet Entrance Criteria|2
7759032|NCT00798434|12198562|FG001|Double-Blind|Did Not Meet Entrance Criteria|1
7759033|NCT00798434|12198561|FG000|Double-Blind|Other|1
7759034|NCT00798434|12198562|FG001|Double-Blind|Other|0
7759035|NCT00798434|12198561|FG000|Double-Blind|Not Treated|3
7759036|NCT00798434|12198562|FG001|Double-Blind|Not Treated|6
7759037|NCT00798434|12198561|FG000|Open-Label|Adverse Event|33
7759038|NCT00798434|12198562|FG001|Open-Label|Adverse Event|11
7759039|NCT00798434|12198561|FG000|Open-Label|Lack of Efficacy|5
7759040|NCT00798434|12198562|FG001|Open-Label|Lack of Efficacy|11
7759041|NCT00798434|12198561|FG000|Open-Label|Withdrawal by Subject|2
7759042|NCT00798434|12198562|FG001|Open-Label|Withdrawal by Subject|7
7759043|NCT00798434|12198561|FG000|Open-Label|Protocol Violation|1
7759044|NCT00798434|12198562|FG001|Open-Label|Protocol Violation|0
7759045|NCT00798434|12198561|FG000|Open-Label|Other|1
7759046|NCT00798434|12198562|FG001|Open-Label|Other|2
7759047|NCT00798434|12198561|FG000|Open-Label|Not Treated|0
7759048|NCT00798434|12198562|FG001|Open-Label|Not Treated|1
7759049|NCT00798603|12198586|FG000|Overall Study|Still on treatment as of 11/6/2012|1
7759050|NCT00798603|12198586|FG000|Overall Study|Withdrawal by Subject|10
7759051|NCT00798603|12198586|FG000|Overall Study|Adverse Event|22
7759052|NCT00798603|12198586|FG000|Overall Study|Physician Decision|1
7759053|NCT00798603|12198586|FG000|Overall Study|Lack of insurance coverage|1
7759054|NCT00798655|12198590|FG000|Overall Study|Did not receive at least one dose of pan|2
7769979|NCT00873041|12213815|FG002|Core Study|Protocol deviation|1
7769980|NCT00873041|12213813|FG000|Extension Study|Adverse Event|1
7769981|NCT00873041|12213814|FG001|Extension Study|Adverse Event|0
7769982|NCT00873041|12213815|FG002|Extension Study|Adverse Event|1
7769983|NCT00873041|12213813|FG000|Extension Study|Administrative reasons|0
7769984|NCT00873041|12213814|FG001|Extension Study|Administrative reasons|0
7769985|NCT00873041|12213815|FG002|Extension Study|Administrative reasons|1
7769986|NCT00873093|12213835|FG000|Overall Study|Adverse Event|0
7769987|NCT00873093|12213836|FG001|Overall Study|Adverse Event|2
7769988|NCT00873093|12213837|FG002|Overall Study|Adverse Event|0
7769989|NCT00873093|12213838|FG003|Overall Study|Adverse Event|0
7769990|NCT00873093|12213839|FG004|Overall Study|Adverse Event|0
7769991|NCT00873093|12213835|FG000|Overall Study|Death|0
7769992|NCT00873093|12213836|FG001|Overall Study|Death|3
7769993|NCT00873093|12213837|FG002|Overall Study|Death|2
7769994|NCT00873093|12213838|FG003|Overall Study|Death|0
7769995|NCT00873093|12213839|FG004|Overall Study|Death|0
7769996|NCT00873093|12213835|FG000|Overall Study|Physician Decision|0
7769997|NCT00873093|12213836|FG001|Overall Study|Physician Decision|17
7769998|NCT00873093|12213837|FG002|Overall Study|Physician Decision|10
7769999|NCT00873093|12213838|FG003|Overall Study|Physician Decision|10
7770000|NCT00873093|12213839|FG004|Overall Study|Physician Decision|2
7770001|NCT00873093|12213835|FG000|Overall Study|Withdrawal by Subject|1
7770002|NCT00873093|12213836|FG001|Overall Study|Withdrawal by Subject|4
7770003|NCT00873093|12213837|FG002|Overall Study|Withdrawal by Subject|4
7770004|NCT00873093|12213838|FG003|Overall Study|Withdrawal by Subject|0
7770005|NCT00873093|12213839|FG004|Overall Study|Withdrawal by Subject|0
7759055|NCT00798694|12198596|FG000|Overall Study|Lost to Follow-up|1
7759056|NCT00798694|12198597|FG001|Overall Study|Lost to Follow-up|1
7759057|NCT00798694|12198596|FG000|Overall Study|Physician Decision|1
7759058|NCT00798694|12198597|FG001|Overall Study|Physician Decision|0
7759059|NCT00798707|12198612|FG000|Overall Study|Adverse Event|6
7759060|NCT00798707|12198613|FG001|Overall Study|Adverse Event|8
7759061|NCT00798707|12198614|FG002|Overall Study|Adverse Event|8
7759062|NCT00798707|12198612|FG000|Overall Study|Failed to return|2
7759063|NCT00798707|12198613|FG001|Overall Study|Failed to return|2
7759064|NCT00798707|12198614|FG002|Overall Study|Failed to return|0
7759065|NCT00798707|12198612|FG000|Overall Study|Investigator|0
7759066|NCT00798707|12198613|FG001|Overall Study|Investigator|1
7759067|NCT00798707|12198614|FG002|Overall Study|Investigator|2
7759068|NCT00798707|12198612|FG000|Overall Study|Lack of Efficacy|2
7759069|NCT00798707|12198613|FG001|Overall Study|Lack of Efficacy|2
7759070|NCT00798707|12198614|FG002|Overall Study|Lack of Efficacy|1
7759071|NCT00798707|12198612|FG000|Overall Study|Lost to Follow-up|5
7759072|NCT00798707|12198613|FG001|Overall Study|Lost to Follow-up|6
7759073|NCT00798707|12198614|FG002|Overall Study|Lost to Follow-up|6
7759074|NCT00798707|12198612|FG000|Overall Study|Other|0
7759075|NCT00798707|12198613|FG001|Overall Study|Other|1
7759076|NCT00798707|12198614|FG002|Overall Study|Other|0
7759077|NCT00798707|12198612|FG000|Overall Study|Protocol Violation|4
7759078|NCT00798707|12198613|FG001|Overall Study|Protocol Violation|0
7759079|NCT00798707|12198614|FG002|Overall Study|Protocol Violation|2
7759080|NCT00798707|12198612|FG000|Overall Study|Withdrawal by Subject|3
7759081|NCT00798707|12198613|FG001|Overall Study|Withdrawal by Subject|8
7759082|NCT00798707|12198614|FG002|Overall Study|Withdrawal by Subject|2
7759083|NCT00798707|12198612|FG000|Overall Study|Randomized not treated|4
7759084|NCT00798707|12198613|FG001|Overall Study|Randomized not treated|5
7759085|NCT00798707|12198614|FG002|Overall Study|Randomized not treated|1
7759086|NCT00798759|12198628|FG000|Overall Study|Adverse Event|3
7759087|NCT00798759|12198629|FG001|Overall Study|Adverse Event|3
7759088|NCT00798759|12198628|FG000|Overall Study|Lost to Follow-up|1
7759089|NCT00798759|12198629|FG001|Overall Study|Lost to Follow-up|1
7759090|NCT00798759|12198628|FG000|Overall Study|Protocol Violation|4
7759091|NCT00798759|12198629|FG001|Overall Study|Protocol Violation|8
7759092|NCT00798759|12198628|FG000|Overall Study|Other|0
7759093|NCT00798759|12198629|FG001|Overall Study|Other|1
7759094|NCT00798889|12198635|FG000|Overall Study|Adverse Event|53
7759095|NCT00798889|12198635|FG000|Overall Study|Protocol Violation|2
7759096|NCT00798889|12198635|FG000|Overall Study|Withdrawal by Subject|31
7759097|NCT00798889|12198635|FG000|Overall Study|Lost to Follow-up|1
7759098|NCT00798889|12198635|FG000|Overall Study|Lack of Efficacy|213
7759099|NCT00798889|12198635|FG000|Overall Study|Decision of Sponsor|11
7759100|NCT00798889|12198635|FG000|Overall Study|Enrolled, Not treated|3
7759101|NCT00798967|12198641|FG000|Overall Study|Adverse Event|2
7759102|NCT00798967|12198642|FG001|Overall Study|Adverse Event|3
7759103|NCT00798967|12198641|FG000|Overall Study|Withdrawal by Subject|0
7759104|NCT00798967|12198642|FG001|Overall Study|Withdrawal by Subject|1
7759105|NCT00798967|12198641|FG000|Overall Study|Physician Decision|1
7759106|NCT00798967|12198642|FG001|Overall Study|Physician Decision|0
7759107|NCT00798967|12198641|FG000|Overall Study|Randomized in error by site|1
7759108|NCT00798967|12198642|FG001|Overall Study|Randomized in error by site|0
7759109|NCT00799383|12198655|FG000|Overall Study|Protocol Violation|1
7759110|NCT00799383|12198656|FG001|Overall Study|Protocol Violation|1
7759111|NCT00799383|12198655|FG000|Overall Study|Adverse Event|0
7759112|NCT00799383|12198656|FG001|Overall Study|Adverse Event|1
7759113|NCT00799383|12198655|FG000|Overall Study|Lost to Follow-up|1
7759114|NCT00799383|12198656|FG001|Overall Study|Lost to Follow-up|2
7759115|NCT00799383|12198655|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1
7759116|NCT00799383|12198656|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1
7759117|NCT00799383|12198655|FG000|Overall Study|Withdrawal by Subject|0
7759118|NCT00799383|12198656|FG001|Overall Study|Withdrawal by Subject|1
7759119|NCT00799409|12198665|FG000|Overall Study|Withdrawal by Subject|1
7759120|NCT00799409|12198666|FG001|Overall Study|Withdrawal by Subject|0
7759121|NCT00799409|12198667|FG002|Overall Study|Withdrawal by Subject|0
7759122|NCT00799409|12198665|FG000|Overall Study|Lost to Follow-up|1
7759123|NCT00799409|12198666|FG001|Overall Study|Lost to Follow-up|0
7759124|NCT00799409|12198667|FG002|Overall Study|Lost to Follow-up|0
7759125|NCT00799409|12198665|FG000|Overall Study|Optimal Dose Not Achieved|2
7759126|NCT00799409|12198666|FG001|Overall Study|Optimal Dose Not Achieved|0
7759127|NCT00799409|12198667|FG002|Overall Study|Optimal Dose Not Achieved|0
7759128|NCT00799409|12198665|FG000|Overall Study|Failure to follow study protocol)|1
7759129|NCT00799409|12198666|FG001|Overall Study|Failure to follow study protocol)|0
7759130|NCT00799409|12198667|FG002|Overall Study|Failure to follow study protocol)|0
7759131|NCT00799409|12198665|FG000|Overall Study|Did not attend lab school day 1|1
7759132|NCT00799409|12198666|FG001|Overall Study|Did not attend lab school day 1|0
7759133|NCT00799409|12198667|FG002|Overall Study|Did not attend lab school day 1|0
7759134|NCT00799409|12198665|FG000|Overall Study|medication compliance|1
7759135|NCT00799409|12198666|FG001|Overall Study|medication compliance|0
7759136|NCT00799409|12198667|FG002|Overall Study|medication compliance|0
7759137|NCT00799422|12198675|FG000|First Week of Wear|Lost to Follow-up|0
7759138|NCT00799422|12198676|FG001|First Week of Wear|Lost to Follow-up|0
7759139|NCT00799422|12198677|FG002|First Week of Wear|Lost to Follow-up|1
7759140|NCT00799422|12198678|FG003|First Week of Wear|Lost to Follow-up|0
7759141|NCT00799422|12198679|FG004|First Week of Wear|Lost to Follow-up|0
7759142|NCT00799422|12198680|FG005|First Week of Wear|Lost to Follow-up|0
7759143|NCT00799422|12198675|FG000|First Week of Wear|Adverse Event|0
7759144|NCT00799422|12198676|FG001|First Week of Wear|Adverse Event|0
7759145|NCT00799422|12198677|FG002|First Week of Wear|Adverse Event|0
7759146|NCT00799422|12198678|FG003|First Week of Wear|Adverse Event|1
7759147|NCT00799422|12198679|FG004|First Week of Wear|Adverse Event|0
7759148|NCT00799422|12198680|FG005|First Week of Wear|Adverse Event|0
7759149|NCT00799487|12198704|FG000|Dose Adjustment Period|Lost to Follow-up|1
7759150|NCT00799487|12198705|FG001|Dose Adjustment Period|Lost to Follow-up|0
7759151|NCT00799487|12198706|FG002|Dose Adjustment Period|Lost to Follow-up|0
7759152|NCT00799487|12198704|FG000|Dose Adjustment Period|Adverse Event|2
7759153|NCT00799487|12198705|FG001|Dose Adjustment Period|Adverse Event|0
7759154|NCT00799487|12198706|FG002|Dose Adjustment Period|Adverse Event|0
7759155|NCT00799487|12198704|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8
7759156|NCT00799487|12198705|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0
7759157|NCT00799487|12198706|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0
7759158|NCT00799487|12198704|FG000|Dose Adjustment Period|Investigator Discretion|2
7759159|NCT00799487|12198705|FG001|Dose Adjustment Period|Investigator Discretion|0
7759160|NCT00799487|12198706|FG002|Dose Adjustment Period|Investigator Discretion|0
7759161|NCT00799487|12198704|FG000|Dose Adjustment Period|Withdrawal by Subject|3
7759162|NCT00799487|12198705|FG001|Dose Adjustment Period|Withdrawal by Subject|0
7759163|NCT00799487|12198706|FG002|Dose Adjustment Period|Withdrawal by Subject|0
7759164|NCT00799487|12198704|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1
7759165|NCT00799487|12198705|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0
7759166|NCT00799487|12198706|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0
7759167|NCT00799487|12198704|FG000|Dose Adjustment Period|Child too young (exclusion)|1
7759168|NCT00799487|12198705|FG001|Dose Adjustment Period|Child too young (exclusion)|0
7759169|NCT00799487|12198706|FG002|Dose Adjustment Period|Child too young (exclusion)|0
7759170|NCT00799487|12198704|FG000|Dose Adjustment Period|Missed laboratory day 1|1
7759171|NCT00799487|12198705|FG001|Dose Adjustment Period|Missed laboratory day 1|0
7759172|NCT00799487|12198706|FG002|Dose Adjustment Period|Missed laboratory day 1|0
7759173|NCT00799487|12198704|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
7759174|NCT00799487|12198705|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
7759175|NCT00799487|12198706|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
7759176|NCT00799487|12198704|FG000|Double-Blind Assessment Period|Lost to Follow-up|0
7759177|NCT00799487|12198705|FG001|Double-Blind Assessment Period|Lost to Follow-up|0
7759178|NCT00799487|12198706|FG002|Double-Blind Assessment Period|Lost to Follow-up|1
7759179|NCT00799487|12198704|FG000|Double-Blind Assessment Period|Subject was out of the state|0
7759180|NCT00799487|12198705|FG001|Double-Blind Assessment Period|Subject was out of the state|0
7759181|NCT00799487|12198706|FG002|Double-Blind Assessment Period|Subject was out of the state|1
7759182|NCT00799487|12198704|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0
7759183|NCT00799487|12198705|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1
7759184|NCT00799487|12198706|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0
7759185|NCT00799591|12198721|FG000|Overall Study|De-escalation of doses|20
7759186|NCT00799591|12198721|FG000|Overall Study|Death|14
7759187|NCT00799591|12198721|FG000|Overall Study|Technical failure|12
7759188|NCT00799591|12198721|FG000|Overall Study|Resistant germ|11
7759189|NCT00799591|12198721|FG000|Overall Study|New infection|4
7759190|NCT00799591|12198721|FG000|Overall Study|Resistance germ and technical failure|2
7759191|NCT00799591|12198721|FG000|Overall Study|Persistance of fever undetermined origin|1
7759192|NCT00799591|12198721|FG000|Overall Study|Antibiotic changed, no apparent reason|1
7759193|NCT00799591|12198721|FG000|Overall Study|Infectious origin not probable|1
7759194|NCT00799617|12198740|FG000|Main Testosterone Trial|Randomized in error|1
7759195|NCT00799617|12198741|FG001|Main Testosterone Trial|Randomized in error|1
7759196|NCT00799617|12198740|FG000|Main Testosterone Trial|Lost to Follow-up|18
7759197|NCT00799617|12198741|FG001|Main Testosterone Trial|Lost to Follow-up|20
7759198|NCT00799617|12198740|FG000|Sexual Funtion Trial|Lost to Follow-up|12
7759199|NCT00799617|12198741|FG001|Sexual Funtion Trial|Lost to Follow-up|14
7759200|NCT00799617|12198740|FG000|Sexual Funtion Trial|No Baseline Data|4
7759201|NCT00799617|12198741|FG001|Sexual Funtion Trial|No Baseline Data|7
7759202|NCT00799617|12198740|FG000|Physical Function Trial|Lost to Follow-up|6
7759203|NCT00799617|12198741|FG001|Physical Function Trial|Lost to Follow-up|11
7759204|NCT00799617|12198740|FG000|Vitality Trial|Lost to Follow-up|7
7759205|NCT00799617|12198741|FG001|Vitality Trial|Lost to Follow-up|22
7759206|NCT00799617|12198740|FG000|Cardiovascular Trial|Month 12 scan not available|15
7759207|NCT00799617|12198741|FG001|Cardiovascular Trial|Month 12 scan not available|15
7759208|NCT00799617|12198740|FG000|Cardiovascular Trial|Baseline scan not analyzable|0
7759209|NCT00799617|12198741|FG001|Cardiovascular Trial|Baseline scan not analyzable|2
7759210|NCT00799617|12198740|FG000|Bone Trial|Month 12 scan not available|6
7759211|NCT00799617|12198741|FG001|Bone Trial|Month 12 scan not available|16
7759212|NCT00799617|12198740|FG000|Cognitive Function Trial|Lost to Follow-up|0
7759213|NCT00799617|12198741|FG001|Cognitive Function Trial|Lost to Follow-up|1
7759214|NCT00799617|12198740|FG000|Anemia Trial|Withdrawal by Subject|3
7759215|NCT00799617|12198741|FG001|Anemia Trial|Withdrawal by Subject|3
7759216|NCT00799708|12198760|FG000|Overall Study|non-compliance|1
7759217|NCT00799708|12198761|FG001|Overall Study|non-compliance|0
7759218|NCT00799708|12198762|FG002|Overall Study|non-compliance|0
7759219|NCT00799825|12198784|FG000|Overall Study|Adverse Event|1
7759220|NCT00799825|12198784|FG000|Overall Study|Withdrawal by Subject|6
7759221|NCT00799825|12198784|FG000|Overall Study|Lost to Follow-up|38
7759222|NCT00799825|12198784|FG000|Overall Study|Pregnancy|3
7759223|NCT00799903|12198790|FG000|Overall Study|Investigator Site Closed|25
7759224|NCT00799903|12198791|FG001|Overall Study|Investigator Site Closed|23
7759225|NCT00799903|12198790|FG000|Overall Study|Withdrawal by Subject|179
7759226|NCT00799903|12198791|FG001|Overall Study|Withdrawal by Subject|175
7759227|NCT00799903|12198790|FG000|Overall Study|Lost to Follow-up|69
7759228|NCT00799903|12198791|FG001|Overall Study|Lost to Follow-up|80
7759229|NCT00800176|12198817|FG000|Overall Study|Adverse Event|2
7759230|NCT00800176|12198818|FG001|Overall Study|Adverse Event|1
7759231|NCT00800176|12198819|FG002|Overall Study|Adverse Event|0
7759232|NCT00800176|12198820|FG003|Overall Study|Adverse Event|2
7759233|NCT00800176|12198821|FG004|Overall Study|Adverse Event|1
7759234|NCT00800176|12198822|FG005|Overall Study|Adverse Event|1
7759235|NCT00800176|12198817|FG000|Overall Study|Refused treatment|3
7759236|NCT00800176|12198818|FG001|Overall Study|Refused treatment|2
7759237|NCT00800176|12198819|FG002|Overall Study|Refused treatment|0
7759238|NCT00800176|12198820|FG003|Overall Study|Refused treatment|0
7759239|NCT00800176|12198821|FG004|Overall Study|Refused treatment|1
7759240|NCT00800176|12198822|FG005|Overall Study|Refused treatment|4
7759241|NCT00800176|12198817|FG000|Overall Study|Failure to return|3
7759242|NCT00800176|12198818|FG001|Overall Study|Failure to return|3
7759243|NCT00800176|12198819|FG002|Overall Study|Failure to return|0
7759244|NCT00800176|12198820|FG003|Overall Study|Failure to return|2
7759245|NCT00800176|12198821|FG004|Overall Study|Failure to return|0
7759246|NCT00800176|12198822|FG005|Overall Study|Failure to return|0
7759247|NCT00800176|12198817|FG000|Overall Study|Other|1
7759248|NCT00800176|12198818|FG001|Overall Study|Other|0
7759249|NCT00800176|12198819|FG002|Overall Study|Other|0
7759250|NCT00800176|12198820|FG003|Overall Study|Other|0
7759251|NCT00800176|12198821|FG004|Overall Study|Other|2
7759252|NCT00800176|12198822|FG005|Overall Study|Other|0
7759253|NCT00800202|12198838|FG000|Overall Study|Adverse Event|7
7759254|NCT00800202|12198839|FG001|Overall Study|Adverse Event|6
7759255|NCT00800202|12198838|FG000|Overall Study|Death|1
7759256|NCT00800202|12198839|FG001|Overall Study|Death|0
7759257|NCT00800202|12198838|FG000|Overall Study|Other|5
7759258|NCT00800202|12198839|FG001|Overall Study|Other|0
7759259|NCT00800202|12198838|FG000|Overall Study|Disease Progression|54
7759260|NCT00800202|12198839|FG001|Overall Study|Disease Progression|18
7759261|NCT00800384|12198860|FG000|Overall Study|Withdrawal by Subject|24
7759262|NCT00800384|12198861|FG001|Overall Study|Withdrawal by Subject|17
7759263|NCT00800384|12198860|FG000|Overall Study|Lost to Follow-up|17
7759264|NCT00800384|12198861|FG001|Overall Study|Lost to Follow-up|26
7759265|NCT00800436|12198875|FG000|Overall Study|Withdrawal by Subject|0
7759266|NCT00800436|12198876|FG001|Overall Study|Withdrawal by Subject|0
7759267|NCT00800436|12198877|FG002|Overall Study|Withdrawal by Subject|1
7759268|NCT00800436|12198878|FG003|Overall Study|Withdrawal by Subject|1
7759269|NCT00800436|12198879|FG004|Overall Study|Withdrawal by Subject|0
7759270|NCT00800436|12198880|FG005|Overall Study|Withdrawal by Subject|0
7759271|NCT00800436|12198881|FG006|Overall Study|Withdrawal by Subject|0
7759272|NCT00800540|12198897|FG000|Period One: 6 Weeks|Noncompliance|1
7759273|NCT00800540|12198898|FG001|Period One: 6 Weeks|Noncompliance|0
7759274|NCT00800540|12198897|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
7759275|NCT00800540|12198898|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
7759276|NCT00800540|12198897|FG000|Period 2: 6 Weeks|Adverse Event|0
7759277|NCT00800540|12198898|FG001|Period 2: 6 Weeks|Adverse Event|1
7759278|NCT00800683|12198906|FG000|Overall Study|Adverse Event|11
7759279|NCT00800683|12198907|FG001|Overall Study|Adverse Event|8
7759280|NCT00800683|12198906|FG000|Overall Study|Lost to Follow-up|3
7759281|NCT00800683|12198907|FG001|Overall Study|Lost to Follow-up|1
7759282|NCT00800683|12198906|FG000|Overall Study|Withdrawal by Subject|1
7759283|NCT00800683|12198907|FG001|Overall Study|Withdrawal by Subject|7
7759284|NCT00800683|12198906|FG000|Overall Study|Lack of Efficacy|1
7759285|NCT00800683|12198907|FG001|Overall Study|Lack of Efficacy|1
7759286|NCT00800683|12198906|FG000|Overall Study|Other|1
7759287|NCT00800683|12198907|FG001|Overall Study|Other|2
7759288|NCT00800735|12198913|FG000|Overall Study|Administrative/Other|2
7759289|NCT00800735|12198913|FG000|Overall Study|Insufficient Therapeutic Response|2
7759290|NCT00800735|12198913|FG000|Overall Study|Violation of Selection Criteria at Entry|7
7759291|NCT00800735|12198913|FG000|Overall Study|Withdrew Consent|3
7759292|NCT00800982|12198932|FG000|Overall Study|Lost to Follow-up|1
7759293|NCT00800982|12198933|FG001|Overall Study|Lost to Follow-up|2
7759294|NCT00800982|12198932|FG000|Overall Study|Withdrawal by Subject|0
7759295|NCT00800982|12198933|FG001|Overall Study|Withdrawal by Subject|1
7759296|NCT00800982|12198932|FG000|Overall Study|Patient moved out of state|1
7759297|NCT00800982|12198933|FG001|Overall Study|Patient moved out of state|0
7759298|NCT00801099|12198939|FG000|Overall Study|Lost to Follow-up|101
7759299|NCT00801229|12198962|FG000|Signed Consent|Withdrawal by Subject|2
7759300|NCT00801229|12198963|FG001|Signed Consent|Withdrawal by Subject|2
7759301|NCT00801229|12198962|FG000|Signed Consent|Found Ineligible|1
7759302|NCT00801229|12198963|FG001|Signed Consent|Found Ineligible|1
7759303|NCT00801229|12198962|FG000|Received Study Drug/Placebo|Elevated SGOT level|1
7759304|NCT00801229|12198963|FG001|Received Study Drug/Placebo|Elevated SGOT level|0
7759305|NCT00801229|12198962|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0
7759306|NCT00801229|12198963|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1
7759307|NCT00801229|12198962|FG000|Received Study Drug/Placebo|Simulator sickness|1
7759308|NCT00801229|12198963|FG001|Received Study Drug/Placebo|Simulator sickness|1
7759309|NCT00801229|12198962|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1
7759310|NCT00801229|12198963|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0
7759311|NCT00801229|12198962|FG000|Received Study Drug/Placebo|Lost to Follow-up|0
7759312|NCT00801229|12198963|FG001|Received Study Drug/Placebo|Lost to Follow-up|1
7759313|NCT00801229|12198962|FG000|Received Study Drug/Placebo|Adverse Event|1
7759314|NCT00801229|12198963|FG001|Received Study Drug/Placebo|Adverse Event|1
7759315|NCT00801242|12198969|FG000|Overall Study|Adverse Event|10
7759316|NCT00801242|12198969|FG000|Overall Study|Withdrawal by Subject|13
7759317|NCT00801242|12198969|FG000|Overall Study|Protocol Violation|5
7759318|NCT00801242|12198969|FG000|Overall Study|Physician Decision|3
7759319|NCT00801242|12198969|FG000|Overall Study|Lost to Follow-up|1
7759320|NCT00801242|12198969|FG000|Overall Study|Miscellaneous reasons|20
7759321|NCT00801632|12199012|FG000|Overall Study|Re-transplant|1
7759322|NCT00801892|12199053|FG000|Main Study Period|Withdrawal by Subject|0
7759323|NCT00801892|12199054|FG001|Main Study Period|Withdrawal by Subject|1
7759324|NCT00801892|12199053|FG000|Sham Crossover Period|Lost to Follow-up|0
7759325|NCT00801892|12199054|FG001|Sham Crossover Period|Lost to Follow-up|2
7759326|NCT00801983|12199064|FG000|Period 1|Lost to Follow-up|2
7759327|NCT00801983|12199065|FG001|Period 1|Lost to Follow-up|0
7759328|NCT00801983|12199064|FG000|Period 1|Withdrawal by Subject|2
7759329|NCT00801983|12199065|FG001|Period 1|Withdrawal by Subject|8
7759330|NCT00801983|12199064|FG000|Period 2|Withdrawal by Subject|2
7759331|NCT00801983|12199065|FG001|Period 2|Withdrawal by Subject|1
7759332|NCT00802074|12199077|FG000|Overall Study|Adverse Event|1
7759333|NCT00802074|12199078|FG001|Overall Study|Adverse Event|1
7759334|NCT00802074|12199079|FG002|Overall Study|Adverse Event|1
7759335|NCT00802074|12199080|FG003|Overall Study|Adverse Event|0
7759336|NCT00802074|12199081|FG004|Overall Study|Adverse Event|0
7759337|NCT00802074|12199082|FG005|Overall Study|Adverse Event|0
7759338|NCT00802074|12199077|FG000|Overall Study|Withdrawal by Subject|1
7759339|NCT00802074|12199078|FG001|Overall Study|Withdrawal by Subject|0
7759340|NCT00802074|12199079|FG002|Overall Study|Withdrawal by Subject|0
7759341|NCT00802074|12199080|FG003|Overall Study|Withdrawal by Subject|0
7759342|NCT00802074|12199081|FG004|Overall Study|Withdrawal by Subject|0
7759343|NCT00802074|12199082|FG005|Overall Study|Withdrawal by Subject|0
7759344|NCT00802178|12199122|FG000|Overall Study|Lack of Efficacy|36
7759345|NCT00802178|12199122|FG000|Overall Study|Insufficient tolerability (IT)|17
7759346|NCT00802178|12199122|FG000|Overall Study|Withdrawal by Subject|18
7759347|NCT00802178|12199122|FG000|Overall Study|Other|32
7759348|NCT00802178|12199122|FG000|Overall Study|Lack of efficacy and patient wish|1
7759349|NCT00802178|12199122|FG000|Overall Study|IT and patient wish|8
7759350|NCT00802178|12199122|FG000|Overall Study|Patients wish and other reason|1
7759351|NCT00802360|12199142|FG000|Overall Study|Stimulation failure|4
7759352|NCT00802360|12199143|FG001|Overall Study|Stimulation failure|0
7759353|NCT00802360|12199144|FG002|Overall Study|Stimulation failure|3
7759354|NCT00802360|12199145|FG003|Overall Study|Stimulation failure|3
7759355|NCT00802360|12199142|FG000|Overall Study|Inadequate number of oocytes retrieved|0
7759356|NCT00802360|12199143|FG001|Overall Study|Inadequate number of oocytes retrieved|0
7759357|NCT00802360|12199144|FG002|Overall Study|Inadequate number of oocytes retrieved|0
7759358|NCT00802360|12199145|FG003|Overall Study|Inadequate number of oocytes retrieved|1
7759359|NCT00802360|12199142|FG000|Overall Study|Cycle cancelled|0
7759360|NCT00802360|12199143|FG001|Overall Study|Cycle cancelled|1
7759361|NCT00802360|12199144|FG002|Overall Study|Cycle cancelled|1
7759362|NCT00802360|12199145|FG003|Overall Study|Cycle cancelled|1
7759363|NCT00802360|12199142|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0
7759364|NCT00802360|12199143|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0
7759365|NCT00802360|12199144|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0
7759366|NCT00802360|12199145|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1
7759367|NCT00802360|12199142|FG000|Overall Study|No positive serum pregnancy|17
7759368|NCT00802360|12199143|FG001|Overall Study|No positive serum pregnancy|20
7759369|NCT00802360|12199144|FG002|Overall Study|No positive serum pregnancy|14
7759370|NCT00802360|12199145|FG003|Overall Study|No positive serum pregnancy|10
7759371|NCT00802360|12199142|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1
7759372|NCT00802360|12199143|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0
7759373|NCT00802360|12199144|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1
7759374|NCT00802360|12199145|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0
7759375|NCT00802360|12199142|FG000|Overall Study|Pregnancy loss/miscarriage|0
7759376|NCT00802360|12199143|FG001|Overall Study|Pregnancy loss/miscarriage|2
7759377|NCT00802360|12199144|FG002|Overall Study|Pregnancy loss/miscarriage|0
7759378|NCT00802360|12199145|FG003|Overall Study|Pregnancy loss/miscarriage|3
7759379|NCT00802360|12199142|FG000|Overall Study|Other|2
7759380|NCT00802360|12199143|FG001|Overall Study|Other|3
7759381|NCT00802360|12199144|FG002|Overall Study|Other|6
7759382|NCT00802360|12199145|FG003|Overall Study|Other|3
7759383|NCT00802438|12199166|FG000|Overall Study|Screen Failure|20
7759384|NCT00802438|12199166|FG000|Overall Study|Withdrawal by Subject|7
7759385|NCT00802438|12199166|FG000|Overall Study|Physician Decision|1
7759386|NCT00802464|12199174|FG000|Month 0 - Month 8|Adverse Event|0
7759387|NCT00802464|12199175|FG001|Month 0 - Month 8|Adverse Event|1
7759388|NCT00802464|12199176|FG002|Month 0 - Month 8|Adverse Event|1
7759389|NCT00802464|12199177|FG003|Month 0 - Month 8|Adverse Event|2
7759390|NCT00802464|12199174|FG000|Month 0 - Month 8|Protocol Violation|0
7759391|NCT00802464|12199175|FG001|Month 0 - Month 8|Protocol Violation|0
7759392|NCT00802464|12199176|FG002|Month 0 - Month 8|Protocol Violation|1
7759393|NCT00802464|12199177|FG003|Month 0 - Month 8|Protocol Violation|0
7759394|NCT00802464|12199174|FG000|Month 0 - Month 8|Withdrawal by Subject|0
7759395|NCT00802464|12199175|FG001|Month 0 - Month 8|Withdrawal by Subject|1
7759396|NCT00802464|12199176|FG002|Month 0 - Month 8|Withdrawal by Subject|2
7759397|NCT00802464|12199177|FG003|Month 0 - Month 8|Withdrawal by Subject|5
7759398|NCT00802464|12199174|FG000|Month 0 - Month 8|Lost to Follow-up|0
7759399|NCT00802464|12199175|FG001|Month 0 - Month 8|Lost to Follow-up|1
7759400|NCT00802464|12199176|FG002|Month 0 - Month 8|Lost to Follow-up|2
7759401|NCT00802464|12199177|FG003|Month 0 - Month 8|Lost to Follow-up|2
7759402|NCT00802464|12199174|FG000|Month 0 - Month 8|Other|0
7759403|NCT00802464|12199175|FG001|Month 0 - Month 8|Other|0
7759404|NCT00802464|12199176|FG002|Month 0 - Month 8|Other|1
7759405|NCT00802464|12199177|FG003|Month 0 - Month 8|Other|0
7759406|NCT00802464|12199174|FG000|Month 8 - Month 14|Adverse Event|0
7759407|NCT00802464|12199175|FG001|Month 8 - Month 14|Adverse Event|1
7759408|NCT00802464|12199176|FG002|Month 8 - Month 14|Adverse Event|0
7759409|NCT00802464|12199177|FG003|Month 8 - Month 14|Adverse Event|0
7759410|NCT00802464|12199174|FG000|Month 8 - Month 14|Withdrawal by Subject|1
7759411|NCT00802464|12199175|FG001|Month 8 - Month 14|Withdrawal by Subject|1
7759412|NCT00802464|12199176|FG002|Month 8 - Month 14|Withdrawal by Subject|0
7759413|NCT00802464|12199177|FG003|Month 8 - Month 14|Withdrawal by Subject|0
7759414|NCT00802464|12199174|FG000|Month 8 - Month 14|Lost to Follow-up|0
7759415|NCT00802464|12199175|FG001|Month 8 - Month 14|Lost to Follow-up|0
7759416|NCT00802464|12199176|FG002|Month 8 - Month 14|Lost to Follow-up|1
7759417|NCT00802464|12199177|FG003|Month 8 - Month 14|Lost to Follow-up|0
7759418|NCT00802529|12199204|FG000|Overall Study|Lost to Follow-up|0
7759419|NCT00802529|12199205|FG001|Overall Study|Lost to Follow-up|1
7759420|NCT00802672|12199223|FG000|Overall Study|Lack of fungal pathogen at baseline|56
7759421|NCT00802672|12199224|FG001|Overall Study|Lack of fungal pathogen at baseline|43
7759422|NCT00802672|12199225|FG002|Overall Study|Lack of fungal pathogen at baseline|25
7759423|NCT00802672|12199223|FG000|Overall Study|Adverse Event|1
7759424|NCT00802672|12199224|FG001|Overall Study|Adverse Event|1
7759425|NCT00802672|12199225|FG002|Overall Study|Adverse Event|1
7759426|NCT00802672|12199223|FG000|Overall Study|Protocol Violation|2
7759427|NCT00802672|12199224|FG001|Overall Study|Protocol Violation|1
7759428|NCT00802672|12199225|FG002|Overall Study|Protocol Violation|1
7759429|NCT00802672|12199223|FG000|Overall Study|Lost to Follow-up|5
7759430|NCT00802672|12199224|FG001|Overall Study|Lost to Follow-up|5
7759431|NCT00802672|12199225|FG002|Overall Study|Lost to Follow-up|3
7759432|NCT00802672|12199223|FG000|Overall Study|Withdrawal by Subject|1
7759433|NCT00802672|12199224|FG001|Overall Study|Withdrawal by Subject|1
7759434|NCT00802672|12199225|FG002|Overall Study|Withdrawal by Subject|2
7759435|NCT00802672|12199223|FG000|Overall Study|other|3
7759436|NCT00802672|12199224|FG001|Overall Study|other|1
7759437|NCT00802672|12199225|FG002|Overall Study|other|2
7759438|NCT00802737|12199245|FG000|Overall Study|Withdrawn due to Disease Progression|9
7759439|NCT00802737|12199246|FG001|Overall Study|Withdrawn due to Disease Progression|3
7759440|NCT00802737|12199247|FG002|Overall Study|Withdrawn due to Disease Progression|0
7759441|NCT00802737|12199245|FG000|Overall Study|Death|6
7759442|NCT00802737|12199246|FG001|Overall Study|Death|5
7759443|NCT00802737|12199247|FG002|Overall Study|Death|1
7759444|NCT00802737|12199245|FG000|Overall Study|Adverse Event|1
7759445|NCT00802737|12199246|FG001|Overall Study|Adverse Event|0
7759446|NCT00802737|12199247|FG002|Overall Study|Adverse Event|0
7759447|NCT00802737|12199245|FG000|Overall Study|Received Prohibited Therapy|1
7759448|NCT00802737|12199246|FG001|Overall Study|Received Prohibited Therapy|0
7759449|NCT00802737|12199247|FG002|Overall Study|Received Prohibited Therapy|0
7759450|NCT00802737|12199245|FG000|Overall Study|Ongoing CLL-Treatment|0
7759451|NCT00802737|12199246|FG001|Overall Study|Ongoing CLL-Treatment|1
7759452|NCT00802737|12199247|FG002|Overall Study|Ongoing CLL-Treatment|0
7759453|NCT00802737|12199245|FG000|Overall Study|Participant too Unwell|0
7759454|NCT00802737|12199246|FG001|Overall Study|Participant too Unwell|2
7759455|NCT00802737|12199247|FG002|Overall Study|Participant too Unwell|0
7759456|NCT00802841|12199258|FG000|Overall Study|Administrative problems|1
7759457|NCT00802841|12199259|FG001|Overall Study|Administrative problems|0
7759458|NCT00802841|12199258|FG000|Overall Study|Lost to Follow-up|2
7759459|NCT00802841|12199259|FG001|Overall Study|Lost to Follow-up|1
7759460|NCT00802841|12199258|FG000|Overall Study|Death|1
7759461|NCT00802841|12199259|FG001|Overall Study|Death|2
7759462|NCT00802841|12199258|FG000|Overall Study|Adverse Event|8
7759463|NCT00802841|12199259|FG001|Overall Study|Adverse Event|2
7759464|NCT00802841|12199258|FG000|Overall Study|Disease progression|7
7759465|NCT00802841|12199259|FG001|Overall Study|Disease progression|3
7759466|NCT00802841|12199258|FG000|Overall Study|Withdrawal by Subject|9
7759467|NCT00802841|12199259|FG001|Overall Study|Withdrawal by Subject|5
7759468|NCT00802841|12199258|FG000|Overall Study|Protocol deviation|2
7759469|NCT00802841|12199259|FG001|Overall Study|Protocol deviation|6
7759470|NCT00802841|12199258|FG000|Overall Study|Treatment duration completed|66
7759471|NCT00802841|12199259|FG001|Overall Study|Treatment duration completed|76
7759472|NCT00802867|12199271|FG000|Overall Study|Lost to Follow-up|6
7759473|NCT00802867|12199271|FG000|Overall Study|Protocol Violation|6
7759474|NCT00802867|12199271|FG000|Overall Study|Withdrawal by Subject|1
7759475|NCT00802945|12199295|FG000|Overall Study|Death|27
7759476|NCT00802945|12199296|FG001|Overall Study|Death|23
7759477|NCT00802945|12199295|FG000|Overall Study|Terminated by sponsor|8
7759478|NCT00802945|12199296|FG001|Overall Study|Terminated by sponsor|12
7759479|NCT00803023|12199326|FG000|Overall Study|Adverse Event|5
7759480|NCT00803023|12199327|FG001|Overall Study|Adverse Event|4
7759481|NCT00803023|12199328|FG002|Overall Study|Adverse Event|8
7759482|NCT00803023|12199329|FG003|Overall Study|Adverse Event|6
7759483|NCT00803023|12199326|FG000|Overall Study|Withdrawal by Subject|0
7759484|NCT00803023|12199327|FG001|Overall Study|Withdrawal by Subject|2
7759485|NCT00803023|12199328|FG002|Overall Study|Withdrawal by Subject|0
7759486|NCT00803023|12199329|FG003|Overall Study|Withdrawal by Subject|0
7759487|NCT00803023|12199326|FG000|Overall Study|Lost to Follow-up|0
7759488|NCT00803023|12199327|FG001|Overall Study|Lost to Follow-up|1
7759489|NCT00803023|12199328|FG002|Overall Study|Lost to Follow-up|2
7759490|NCT00803023|12199329|FG003|Overall Study|Lost to Follow-up|1
7759491|NCT00803023|12199326|FG000|Overall Study|Lack of Efficacy|0
7759492|NCT00803023|12199327|FG001|Overall Study|Lack of Efficacy|1
7759493|NCT00803023|12199328|FG002|Overall Study|Lack of Efficacy|1
7759494|NCT00803023|12199329|FG003|Overall Study|Lack of Efficacy|1
7759495|NCT00803049|12199343|FG000|Overall Study|Adverse Event|21
7759496|NCT00803049|12199344|FG001|Overall Study|Adverse Event|33
7759497|NCT00803049|12199345|FG002|Overall Study|Adverse Event|13
7759498|NCT00803049|12199346|FG003|Overall Study|Adverse Event|27
7759499|NCT00803049|12199343|FG000|Overall Study|Lack of Efficacy|10
7759500|NCT00803049|12199344|FG001|Overall Study|Lack of Efficacy|19
7759501|NCT00803049|12199345|FG002|Overall Study|Lack of Efficacy|6
7759502|NCT00803049|12199346|FG003|Overall Study|Lack of Efficacy|13
7759503|NCT00803049|12199343|FG000|Overall Study|Lost to Follow-up|0
7759504|NCT00803049|12199344|FG001|Overall Study|Lost to Follow-up|2
7759505|NCT00803049|12199345|FG002|Overall Study|Lost to Follow-up|0
7759506|NCT00803049|12199346|FG003|Overall Study|Lost to Follow-up|3
7759507|NCT00803049|12199343|FG000|Overall Study|Death|2
7759508|NCT00803049|12199344|FG001|Overall Study|Death|1
7759509|NCT00803049|12199345|FG002|Overall Study|Death|0
7759510|NCT00803049|12199346|FG003|Overall Study|Death|2
7759511|NCT00803049|12199343|FG000|Overall Study|Progressive Disease|6
7759512|NCT00803049|12199344|FG001|Overall Study|Progressive Disease|10
7759513|NCT00803049|12199345|FG002|Overall Study|Progressive Disease|6
7759514|NCT00803049|12199346|FG003|Overall Study|Progressive Disease|6
7759515|NCT00803049|12199343|FG000|Overall Study|Withdrawal by Subject|19
7759516|NCT00803049|12199344|FG001|Overall Study|Withdrawal by Subject|43
7759517|NCT00803049|12199345|FG002|Overall Study|Withdrawal by Subject|16
7759518|NCT00803049|12199346|FG003|Overall Study|Withdrawal by Subject|44
7759519|NCT00803049|12199343|FG000|Overall Study|Protocol Violation|0
7759520|NCT00803049|12199344|FG001|Overall Study|Protocol Violation|1
7759521|NCT00803049|12199345|FG002|Overall Study|Protocol Violation|1
7759522|NCT00803049|12199346|FG003|Overall Study|Protocol Violation|0
7759523|NCT00803049|12199343|FG000|Overall Study|Randomized and Not Treated|0
7759524|NCT00803049|12199344|FG001|Overall Study|Randomized and Not Treated|0
7759525|NCT00803049|12199345|FG002|Overall Study|Randomized and Not Treated|0
7759526|NCT00803049|12199346|FG003|Overall Study|Randomized and Not Treated|2
7759527|NCT00803049|12199343|FG000|Overall Study|Other than Specified Above|3
7759528|NCT00803049|12199344|FG001|Overall Study|Other than Specified Above|9
7759529|NCT00803049|12199345|FG002|Overall Study|Other than Specified Above|2
7759530|NCT00803049|12199346|FG003|Overall Study|Other than Specified Above|5
7759531|NCT00803101|12199375|FG000|Overall Study|Death / Serious Adverse Event|4
7759532|NCT00803101|12199376|FG001|Overall Study|Death / Serious Adverse Event|6
7759533|NCT00803101|12199375|FG000|Overall Study|Withdrawal by Subject|6
7759534|NCT00803101|12199376|FG001|Overall Study|Withdrawal by Subject|4
7759535|NCT00803101|12199375|FG000|Overall Study|Lost to Follow-up|2
7759536|NCT00803101|12199376|FG001|Overall Study|Lost to Follow-up|2
7759537|NCT00803101|12199375|FG000|Overall Study|Protocol Violation|1
7759538|NCT00803101|12199376|FG001|Overall Study|Protocol Violation|7
7759539|NCT00803101|12199375|FG000|Overall Study|Surgery finished outside protocol window|1
7759540|NCT00803101|12199376|FG001|Overall Study|Surgery finished outside protocol window|1
7759541|NCT00803101|12199375|FG000|Overall Study|Patient died outside SAE report period|1
7759542|NCT00803101|12199376|FG001|Overall Study|Patient died outside SAE report period|0
7759543|NCT00803101|12199375|FG000|Overall Study|Patient did not attend scheduled visit|2
7759544|NCT00803101|12199376|FG001|Overall Study|Patient did not attend scheduled visit|1
7759545|NCT00803101|12199375|FG000|Overall Study|Patient did not have surgery|1
7759546|NCT00803101|12199376|FG001|Overall Study|Patient did not have surgery|1
7759547|NCT00803205|12199384|FG000|Overall Study|Adverse Event|7
7759548|NCT00803205|12199385|FG001|Overall Study|Adverse Event|2
7759549|NCT00803205|12199384|FG000|Overall Study|Lost to Follow-up|1
7759550|NCT00803205|12199385|FG001|Overall Study|Lost to Follow-up|0
7759551|NCT00803205|12199384|FG000|Overall Study|Withdrawal by Subject|9
7759552|NCT00803205|12199385|FG001|Overall Study|Withdrawal by Subject|9
7759553|NCT00803205|12199384|FG000|Overall Study|Physician Decision|1
7759554|NCT00803205|12199385|FG001|Overall Study|Physician Decision|0
7759555|NCT00803205|12199384|FG000|Overall Study|Protocol Violation|1
7759556|NCT00803205|12199385|FG001|Overall Study|Protocol Violation|1
7759557|NCT00803205|12199384|FG000|Overall Study|Medical Monitor Decision|1
7759558|NCT00803205|12199385|FG001|Overall Study|Medical Monitor Decision|0
7759559|NCT00803205|12199384|FG000|Overall Study|Acquired a Lung Infection|0
7759560|NCT00803205|12199385|FG001|Overall Study|Acquired a Lung Infection|1
7759561|NCT00803205|12199384|FG000|Overall Study|Sponsor Decision|0
7759562|NCT00803205|12199385|FG001|Overall Study|Sponsor Decision|1
7759563|NCT00803244|12199393|FG000|Overall Study|Adverse Event|1
7759564|NCT00803244|12199394|FG001|Overall Study|Adverse Event|2
7759565|NCT00803244|12199393|FG000|Overall Study|Withdrawal by Subject|2
7759566|NCT00803244|12199394|FG001|Overall Study|Withdrawal by Subject|3
7624582|NCT02173301|12035673|FG002|Overall Study|Physician Decision|1
7759567|NCT00803244|12199393|FG000|Overall Study|Any other reason not above-mentioned|4
7759568|NCT00803244|12199394|FG001|Overall Study|Any other reason not above-mentioned|10
7759569|NCT00803270|12199402|FG000|Overall Study|Lost to Follow-up|1
7759570|NCT00803270|12199403|FG001|Overall Study|Lost to Follow-up|2
7624583|NCT02173301|12035674|FG003|Overall Study|Physician Decision|0
7624584|NCT02173301|12035671|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1
7624585|NCT02173301|12035672|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0
7624586|NCT02173301|12035673|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0
7624587|NCT02173301|12035674|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0
7624588|NCT01986114|12035684|FG000|Overall Study|Adverse Event|59
7759571|NCT00803361|12199411|FG000|Overall Study|Adverse Event|13
7759572|NCT00803361|12199412|FG001|Overall Study|Adverse Event|3
7759573|NCT00803361|12199411|FG000|Overall Study|Lack of Efficacy|4
7759574|NCT00803361|12199412|FG001|Overall Study|Lack of Efficacy|13
7759575|NCT00803361|12199411|FG000|Overall Study|Lost to Follow-up|1
7759576|NCT00803361|12199412|FG001|Overall Study|Lost to Follow-up|2
7759577|NCT00803361|12199411|FG000|Overall Study|Physician Decision|1
7759578|NCT00803361|12199412|FG001|Overall Study|Physician Decision|0
7759579|NCT00803361|12199411|FG000|Overall Study|Protocol Violation|2
7759580|NCT00803361|12199412|FG001|Overall Study|Protocol Violation|4
7759581|NCT00803361|12199411|FG000|Overall Study|Withdrawal by Subject|5
7759582|NCT00803361|12199412|FG001|Overall Study|Withdrawal by Subject|6
7759583|NCT00803452|12199430|FG000|Overall Study|Adverse Event|0
7759584|NCT00803452|12199431|FG001|Overall Study|Adverse Event|2
7759585|NCT00803452|12199430|FG000|Overall Study|Lost to Follow-up|0
7759586|NCT00803452|12199431|FG001|Overall Study|Lost to Follow-up|3
7759587|NCT00803569|12199446|FG000|Overall Study|Progressive Disease|3
7759588|NCT00803569|12199446|FG000|Overall Study|Noncompliance|1
7759589|NCT00803595|12199453|FG000|Overall Study|Adverse Event|3
7759590|NCT00803595|12199454|FG001|Overall Study|Adverse Event|4
7759591|NCT00803595|12199455|FG002|Overall Study|Adverse Event|1
7759592|NCT00803595|12199453|FG000|Overall Study|Protocol Violation|7
7759593|NCT00803595|12199454|FG001|Overall Study|Protocol Violation|2
7759594|NCT00803595|12199455|FG002|Overall Study|Protocol Violation|12
7759595|NCT00803595|12199453|FG000|Overall Study|Withdrawal by Subject|5
7759596|NCT00803595|12199454|FG001|Overall Study|Withdrawal by Subject|2
7759597|NCT00803595|12199455|FG002|Overall Study|Withdrawal by Subject|3
7759598|NCT00803634|12199465|FG000|Overall Study|Withdrew Consent|1
7759599|NCT00803634|12199466|FG001|Overall Study|Withdrew Consent|0
7759600|NCT00803634|12199465|FG000|Overall Study|Lost to Follow-up|2
7759601|NCT00803634|12199466|FG001|Overall Study|Lost to Follow-up|3
7759602|NCT00803634|12199465|FG000|Overall Study|Death|3
7759603|NCT00803634|12199466|FG001|Overall Study|Death|2
7759604|NCT00803712|12199498|FG000|Overall Study|Noncompliance|3
7759605|NCT00803712|12199499|FG001|Overall Study|Noncompliance|0
7759606|NCT00803712|12199498|FG000|Overall Study|Adverse Event|5
7759607|NCT00803712|12199499|FG001|Overall Study|Adverse Event|0
7759608|NCT00803712|12199498|FG000|Overall Study|Death|8
7759609|NCT00803712|12199499|FG001|Overall Study|Death|7
7759610|NCT00803712|12199498|FG000|Overall Study|Lost to Follow-up|3
7759611|NCT00803712|12199499|FG001|Overall Study|Lost to Follow-up|1
7759612|NCT00803712|12199498|FG000|Overall Study|Withdrawal by Subject|2
7759613|NCT00803712|12199499|FG001|Overall Study|Withdrawal by Subject|4
7759614|NCT00803712|12199498|FG000|Overall Study|"Other in electronic Case Report Form"|0
7759615|NCT00803712|12199499|FG001|Overall Study|"Other in electronic Case Report Form"|1
7759616|NCT00803712|12199498|FG000|Overall Study|Protocol criteria (other)|0
7759617|NCT00803712|12199499|FG001|Overall Study|Protocol criteria (other)|2
7759618|NCT00803712|12199498|FG000|Overall Study|Protocol criteria (renal transplant)|12
7759619|NCT00803712|12199499|FG001|Overall Study|Protocol criteria (renal transplant)|8
7759620|NCT00803712|12199498|FG000|Overall Study|Administrative decision|2
7759621|NCT00803712|12199499|FG001|Overall Study|Administrative decision|3
7759622|NCT00803712|12199498|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1
7759623|NCT00803712|12199499|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1
7759624|NCT00803738|12199507|FG000|Overall Study|Adverse Event|3
7759625|NCT00803738|12199508|FG001|Overall Study|Adverse Event|5
7759626|NCT00803738|12199507|FG000|Overall Study|Lost to Follow-up|4
7759627|NCT00803738|12199508|FG001|Overall Study|Lost to Follow-up|4
7759628|NCT00803738|12199507|FG000|Overall Study|Protocol Violation|18
7759629|NCT00803738|12199508|FG001|Overall Study|Protocol Violation|10
7759630|NCT00803738|12199507|FG000|Overall Study|Withdrawal by Subject|1
7759631|NCT00803738|12199508|FG001|Overall Study|Withdrawal by Subject|4
7759632|NCT00803738|12199507|FG000|Overall Study|Lack of Efficacy|10
7759633|NCT00803738|12199508|FG001|Overall Study|Lack of Efficacy|16
7759634|NCT00803738|12199507|FG000|Overall Study|Negative Baseline Culture of Candida|56
7759635|NCT00803738|12199508|FG001|Overall Study|Negative Baseline Culture of Candida|63
7759636|NCT00803738|12199507|FG000|Overall Study|Positive Results for STD or abnormal PAP|2
7759637|NCT00803738|12199508|FG001|Overall Study|Positive Results for STD or abnormal PAP|8
7759638|NCT00804141|12199536|FG000|Overall Study|Adverse Event|157
7759639|NCT00804141|12199536|FG000|Overall Study|Death|4
7759640|NCT00804141|12199536|FG000|Overall Study|Failed to return|96
7759641|NCT00804141|12199536|FG000|Overall Study|Investigator request|8
7759642|NCT00804141|12199536|FG000|Overall Study|Protocol Violation|85
7759643|NCT00804141|12199536|FG000|Overall Study|Withdrawal by Subject|131
7759644|NCT00804141|12199536|FG000|Overall Study|Lack of Efficacy|46
7759645|NCT00804141|12199536|FG000|Overall Study|Other than specified|30
7759646|NCT00804141|12199536|FG000|Overall Study|Enrolled but not treated|6
7759647|NCT00804193|12199543|FG000|Overall Study|Lack of baseline fungus|32
7759648|NCT00804193|12199544|FG001|Overall Study|Lack of baseline fungus|31
7759649|NCT00804193|12199545|FG002|Overall Study|Lack of baseline fungus|19
7759650|NCT00804193|12199543|FG000|Overall Study|Adverse Event|0
7759651|NCT00804193|12199544|FG001|Overall Study|Adverse Event|0
7759652|NCT00804193|12199545|FG002|Overall Study|Adverse Event|2
7759653|NCT00804193|12199543|FG000|Overall Study|Lack of Efficacy|1
7759654|NCT00804193|12199544|FG001|Overall Study|Lack of Efficacy|1
7759655|NCT00804193|12199545|FG002|Overall Study|Lack of Efficacy|3
7759656|NCT00804193|12199543|FG000|Overall Study|Protocol Violation|0
7759657|NCT00804193|12199544|FG001|Overall Study|Protocol Violation|8
7759658|NCT00804193|12199545|FG002|Overall Study|Protocol Violation|2
7759659|NCT00804193|12199543|FG000|Overall Study|Lost to Follow-up|3
7759660|NCT00804193|12199544|FG001|Overall Study|Lost to Follow-up|3
7759661|NCT00804193|12199545|FG002|Overall Study|Lost to Follow-up|4
7759662|NCT00804193|12199543|FG000|Overall Study|Withdrawal by Subject|3
7759663|NCT00804193|12199544|FG001|Overall Study|Withdrawal by Subject|1
7759664|NCT00804193|12199545|FG002|Overall Study|Withdrawal by Subject|2
7759665|NCT00804570|12199555|FG000|Overall Study|Adverse Event|14
7759666|NCT00804570|12199556|FG001|Overall Study|Adverse Event|7
7759667|NCT00804570|12199555|FG000|Overall Study|Lack of Efficacy|0
7759668|NCT00804570|12199556|FG001|Overall Study|Lack of Efficacy|1
7759669|NCT00804570|12199555|FG000|Overall Study|Lost to Follow-up|18
7759670|NCT00804570|12199556|FG001|Overall Study|Lost to Follow-up|21
7759671|NCT00804570|12199555|FG000|Overall Study|Entry criteria not met|5
7759672|NCT00804570|12199556|FG001|Overall Study|Entry criteria not met|5
7759673|NCT00804570|12199555|FG000|Overall Study|Protocol Violation|12
7759674|NCT00804570|12199556|FG001|Overall Study|Protocol Violation|16
7759675|NCT00804570|12199555|FG000|Overall Study|Physician Decision|1
7759676|NCT00804570|12199556|FG001|Overall Study|Physician Decision|2
7759677|NCT00804570|12199555|FG000|Overall Study|Sponsor decision|1
7759678|NCT00804570|12199556|FG001|Overall Study|Sponsor decision|4
7759679|NCT00804570|12199555|FG000|Overall Study|Withdrawal by Subject|21
7759680|NCT00804570|12199556|FG001|Overall Study|Withdrawal by Subject|38
7759681|NCT00804687|12199589|FG000|Period 3: Treatment Period|Positive Drug screen|0
7759682|NCT00804687|12199590|FG001|Period 3: Treatment Period|Positive Drug screen|0
7759683|NCT00804687|12199591|FG002|Period 3: Treatment Period|Positive Drug screen|0
7759684|NCT00804687|12199592|FG003|Period 3: Treatment Period|Positive Drug screen|1
7759685|NCT00804687|12199593|FG004|Period 3: Treatment Period|Positive Drug screen|0
7759686|NCT00804687|12199594|FG005|Period 3: Treatment Period|Positive Drug screen|0
7759687|NCT00804687|12199589|FG000|Period 5: Treatment Period|Withdrawal by Subject|0
7759688|NCT00804687|12199590|FG001|Period 5: Treatment Period|Withdrawal by Subject|0
7759689|NCT00804687|12199591|FG002|Period 5: Treatment Period|Withdrawal by Subject|0
7759690|NCT00804687|12199592|FG003|Period 5: Treatment Period|Withdrawal by Subject|0
7759691|NCT00804687|12199593|FG004|Period 5: Treatment Period|Withdrawal by Subject|1
7759692|NCT00804687|12199594|FG005|Period 5: Treatment Period|Withdrawal by Subject|0
7759693|NCT00804687|12199589|FG000|Period 5: Treatment Period|Positive drugs of abuse|0
7759694|NCT00804687|12199590|FG001|Period 5: Treatment Period|Positive drugs of abuse|0
7759695|NCT00804687|12199591|FG002|Period 5: Treatment Period|Positive drugs of abuse|1
7759696|NCT00804687|12199592|FG003|Period 5: Treatment Period|Positive drugs of abuse|0
7759697|NCT00804687|12199593|FG004|Period 5: Treatment Period|Positive drugs of abuse|0
7759698|NCT00804687|12199594|FG005|Period 5: Treatment Period|Positive drugs of abuse|0
7759699|NCT00804687|12199589|FG000|Period 5: Treatment Period|Positive drug test|1
7759700|NCT00804687|12199590|FG001|Period 5: Treatment Period|Positive drug test|0
7759701|NCT00804687|12199591|FG002|Period 5: Treatment Period|Positive drug test|0
7759702|NCT00804687|12199592|FG003|Period 5: Treatment Period|Positive drug test|0
7759703|NCT00804687|12199593|FG004|Period 5: Treatment Period|Positive drug test|0
7759704|NCT00804687|12199594|FG005|Period 5: Treatment Period|Positive drug test|0
7759705|NCT00804843|12199604|FG000|Overall Study|Protocol Violation|1
7759706|NCT00804843|12199605|FG001|Overall Study|Protocol Violation|0
7759707|NCT00804843|12199604|FG000|Overall Study|Adverse Event|8
7759708|NCT00804843|12199605|FG001|Overall Study|Adverse Event|5
7759709|NCT00804843|12199604|FG000|Overall Study|Withdrawal by Subject|1
7759710|NCT00804843|12199605|FG001|Overall Study|Withdrawal by Subject|2
7759711|NCT00804908|12199615|FG000|Overall Study|Other|115
7759712|NCT00804908|12199616|FG001|Overall Study|Other|116
7759713|NCT00804908|12199617|FG002|Overall Study|Other|114
7770006|NCT00873093|12213835|FG000|Overall Study|Ineligible|0
7770007|NCT00873093|12213836|FG001|Overall Study|Ineligible|1
7770008|NCT00873093|12213837|FG002|Overall Study|Ineligible|0
7770009|NCT00873093|12213838|FG003|Overall Study|Ineligible|1
7770010|NCT00873093|12213839|FG004|Overall Study|Ineligible|0
7770011|NCT00873119|12213863|FG000|Overall Study|Patient request|4
7770012|NCT00873119|12213864|FG001|Overall Study|Patient request|2
7770013|NCT00873119|12213863|FG000|Overall Study|Adverse Event|8
7770014|NCT00873119|12213864|FG001|Overall Study|Adverse Event|0
7770015|NCT00873119|12213863|FG000|Overall Study|Progressive disease|26
7770016|NCT00873119|12213864|FG001|Overall Study|Progressive disease|18
7770017|NCT00873119|12213863|FG000|Overall Study|Death|2
7770018|NCT00873119|12213864|FG001|Overall Study|Death|1
7770019|NCT00873119|12213863|FG000|Overall Study|Other|2
7770020|NCT00873119|12213864|FG001|Overall Study|Other|5
7770021|NCT00873119|12213863|FG000|Overall Study|Not treated|2
7770022|NCT00873119|12213864|FG001|Overall Study|Not treated|0
7770023|NCT00873730|12213880|FG000|Overall Study|Protocol Deviation|5
7770024|NCT00873730|12213881|FG001|Overall Study|Protocol Deviation|2
7770025|NCT00873730|12213880|FG000|Overall Study|Adverse Event|0
7770026|NCT00873730|12213881|FG001|Overall Study|Adverse Event|2
7770027|NCT00873730|12213880|FG000|Overall Study|Withdrawal by Subject|0
7770028|NCT00873730|12213881|FG001|Overall Study|Withdrawal by Subject|1
7770029|NCT00873730|12213880|FG000|Overall Study|Sponsor decision|1
7770030|NCT00873730|12213881|FG001|Overall Study|Sponsor decision|0
7770031|NCT00873860|12213904|FG000|Overall Study|Lost to Follow-up|1
7770032|NCT00873860|12213905|FG001|Overall Study|Lost to Follow-up|0
7770033|NCT00873860|12213906|FG002|Overall Study|Lost to Follow-up|0
7770034|NCT00873860|12213907|FG003|Overall Study|Lost to Follow-up|1
7770035|NCT00873860|12213904|FG000|Overall Study|Withdrawal by Subject|1
7770036|NCT00873860|12213905|FG001|Overall Study|Withdrawal by Subject|0
7770037|NCT00873860|12213906|FG002|Overall Study|Withdrawal by Subject|2
7770038|NCT00873860|12213907|FG003|Overall Study|Withdrawal by Subject|0
7759714|NCT00804986|12199644|FG000|Overall Study|Adverse Event|0
7759715|NCT00804986|12199645|FG001|Overall Study|Adverse Event|1
7759716|NCT00804986|12199646|FG002|Overall Study|Adverse Event|2
7759717|NCT00804986|12199647|FG003|Overall Study|Adverse Event|1
7759718|NCT00804986|12199648|FG004|Overall Study|Adverse Event|3
7759719|NCT00804986|12199649|FG005|Overall Study|Adverse Event|0
7759720|NCT00804986|12199644|FG000|Overall Study|Lack of Efficacy|0
7759721|NCT00804986|12199645|FG001|Overall Study|Lack of Efficacy|0
7759722|NCT00804986|12199646|FG002|Overall Study|Lack of Efficacy|0
7759723|NCT00804986|12199647|FG003|Overall Study|Lack of Efficacy|1
7759724|NCT00804986|12199648|FG004|Overall Study|Lack of Efficacy|0
7759725|NCT00804986|12199649|FG005|Overall Study|Lack of Efficacy|3
7759726|NCT00804986|12199644|FG000|Overall Study|Lost to Follow-up|0
7759727|NCT00804986|12199645|FG001|Overall Study|Lost to Follow-up|0
7759728|NCT00804986|12199646|FG002|Overall Study|Lost to Follow-up|0
7759729|NCT00804986|12199647|FG003|Overall Study|Lost to Follow-up|1
7759730|NCT00804986|12199648|FG004|Overall Study|Lost to Follow-up|1
7759731|NCT00804986|12199649|FG005|Overall Study|Lost to Follow-up|3
7759732|NCT00804986|12199644|FG000|Overall Study|Protocol Violation|0
7759733|NCT00804986|12199645|FG001|Overall Study|Protocol Violation|1
7759734|NCT00804986|12199646|FG002|Overall Study|Protocol Violation|0
7759735|NCT00804986|12199647|FG003|Overall Study|Protocol Violation|1
7759736|NCT00804986|12199648|FG004|Overall Study|Protocol Violation|0
7759737|NCT00804986|12199649|FG005|Overall Study|Protocol Violation|0
7759738|NCT00804986|12199644|FG000|Overall Study|Withdrawal by Subject|0
7759739|NCT00804986|12199645|FG001|Overall Study|Withdrawal by Subject|3
7759740|NCT00804986|12199646|FG002|Overall Study|Withdrawal by Subject|0
7759741|NCT00804986|12199647|FG003|Overall Study|Withdrawal by Subject|3
7759742|NCT00804986|12199648|FG004|Overall Study|Withdrawal by Subject|5
7759743|NCT00804986|12199649|FG005|Overall Study|Withdrawal by Subject|3
7759744|NCT00804986|12199644|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
7759745|NCT00804986|12199645|FG001|Overall Study|Inclusion/Exclusion criteria not met|2
7759746|NCT00804986|12199646|FG002|Overall Study|Inclusion/Exclusion criteria not met|0
7759747|NCT00804986|12199647|FG003|Overall Study|Inclusion/Exclusion criteria not met|1
7759748|NCT00804986|12199648|FG004|Overall Study|Inclusion/Exclusion criteria not met|0
7759749|NCT00804986|12199649|FG005|Overall Study|Inclusion/Exclusion criteria not met|1
7759750|NCT00804986|12199644|FG000|Overall Study|Sponsor Decision|0
7759751|NCT00804986|12199645|FG001|Overall Study|Sponsor Decision|1
7962602|NCT02712983|12516801|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7962603|NCT02712983|12516802|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
7962604|NCT02712983|12516803|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
7962605|NCT02712983|12516804|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
7962606|NCT02712983|12516805|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
7962607|NCT02712983|12516806|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7962608|NCT02712996|12516828|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0
7962609|NCT02712996|12516829|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1
7962610|NCT02713204|12516853|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1
7962611|NCT02713204|12516854|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0
7962612|NCT02713204|12516855|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1
7962613|NCT02713204|12516856|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0
7962614|NCT02713204|12516857|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0
7962615|NCT02713204|12516858|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0
7962616|NCT02713204|12516859|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0
7962617|NCT02713204|12516860|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0
7962618|NCT02713204|12516853|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7962619|NCT02713204|12516854|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7962620|NCT02713204|12516855|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
7962621|NCT02713204|12516856|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7962622|NCT02713204|12516857|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7962623|NCT02713204|12516858|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7962624|NCT02713204|12516859|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7759752|NCT00804986|12199646|FG002|Overall Study|Sponsor Decision|0
7759753|NCT00804986|12199647|FG003|Overall Study|Sponsor Decision|0
7759754|NCT00804986|12199648|FG004|Overall Study|Sponsor Decision|0
7759755|NCT00804986|12199649|FG005|Overall Study|Sponsor Decision|0
7759756|NCT00804986|12199644|FG000|Overall Study|Physician Decision|1
7759757|NCT00804986|12199645|FG001|Overall Study|Physician Decision|0
7759758|NCT00804986|12199646|FG002|Overall Study|Physician Decision|0
7759759|NCT00804986|12199647|FG003|Overall Study|Physician Decision|0
7759760|NCT00804986|12199648|FG004|Overall Study|Physician Decision|0
7759761|NCT00804986|12199649|FG005|Overall Study|Physician Decision|0
7759762|NCT00805025|12199680|FG000|Overall Study|Screened but not enrolled/treated|42
7759763|NCT00805025|12199680|FG000|Overall Study|Adverse Event|4
7759764|NCT00805025|12199680|FG000|Overall Study|Withdrawal by Subject|2
7759765|NCT00805025|12199680|FG000|Overall Study|Physician Decision|1
7759766|NCT00805142|12199695|FG000|Titration Period|Adverse Event|3
7759767|NCT00805142|12199696|FG001|Titration Period|Adverse Event|3
7759768|NCT00805142|12199695|FG000|Titration Period|Lack of Efficacy|1
7759769|NCT00805142|12199696|FG001|Titration Period|Lack of Efficacy|1
7759770|NCT00805142|12199695|FG000|Titration Period|Lost to Follow-up|0
7759771|NCT00805142|12199696|FG001|Titration Period|Lost to Follow-up|1
7759772|NCT00805142|12199695|FG000|Titration Period|Disease Progression|2
7759773|NCT00805142|12199696|FG001|Titration Period|Disease Progression|1
7759774|NCT00805142|12199695|FG000|Titration Period|Withdrawal of consent|0
7759775|NCT00805142|12199696|FG001|Titration Period|Withdrawal of consent|1
7759776|NCT00805142|12199695|FG000|Titration Period|Other|0
7759777|NCT00805142|12199696|FG001|Titration Period|Other|3
7759778|NCT00805142|12199695|FG000|Maintenance Period|Adverse Event|0
7759779|NCT00805142|12199696|FG001|Maintenance Period|Adverse Event|1
7759780|NCT00805142|12199695|FG000|Maintenance Period|Other|0
7759781|NCT00805142|12199696|FG001|Maintenance Period|Other|1
7759782|NCT00805194|12199711|FG000|Overall Study|Progressive disease (modified RECIST)|404
7759783|NCT00805194|12199712|FG001|Overall Study|Progressive disease (modified RECIST)|435
7759784|NCT00805194|12199711|FG000|Overall Study|Worsening or AE of underlying disease|64
7759785|NCT00805194|12199712|FG001|Overall Study|Worsening or AE of underlying disease|70
7759786|NCT00805194|12199711|FG000|Overall Study|Other AE|84
7759787|NCT00805194|12199712|FG001|Overall Study|Other AE|73
7759788|NCT00805194|12199711|FG000|Overall Study|Protocol Violation|9
7759789|NCT00805194|12199712|FG001|Overall Study|Protocol Violation|9
7759790|NCT00805194|12199711|FG000|Overall Study|Lost to Follow-up|5
7759791|NCT00805194|12199712|FG001|Overall Study|Lost to Follow-up|5
7759792|NCT00805194|12199711|FG000|Overall Study|Withdrawal by Subject|60
7759793|NCT00805194|12199712|FG001|Overall Study|Withdrawal by Subject|42
7759794|NCT00805194|12199711|FG000|Overall Study|Not treated|3
7759795|NCT00805194|12199712|FG001|Overall Study|Not treated|4
7759796|NCT00805194|12199711|FG000|Overall Study|Reasons other than stated above|20
7759797|NCT00805194|12199712|FG001|Overall Study|Reasons other than stated above|16
7759798|NCT00805207|12199732|FG000|Overall Study|Protocol Violation|0
7759799|NCT00805207|12199733|FG001|Overall Study|Protocol Violation|0
7759800|NCT00805207|12199734|FG002|Overall Study|Protocol Violation|1
7759801|NCT00805207|12199735|FG003|Overall Study|Protocol Violation|0
7759802|NCT00805207|12199736|FG004|Overall Study|Protocol Violation|0
7759803|NCT00805207|12199737|FG005|Overall Study|Protocol Violation|0
7759804|NCT00805207|12199738|FG006|Overall Study|Protocol Violation|0
7759805|NCT00805207|12199739|FG007|Overall Study|Protocol Violation|0
7759806|NCT00805207|12199740|FG008|Overall Study|Protocol Violation|0
7759807|NCT00805207|12199732|FG000|Overall Study|Physician Decision|0
7759808|NCT00805207|12199733|FG001|Overall Study|Physician Decision|1
7759809|NCT00805207|12199734|FG002|Overall Study|Physician Decision|0
7759810|NCT00805207|12199735|FG003|Overall Study|Physician Decision|0
7759811|NCT00805207|12199736|FG004|Overall Study|Physician Decision|0
7759812|NCT00805207|12199737|FG005|Overall Study|Physician Decision|1
7759813|NCT00805207|12199738|FG006|Overall Study|Physician Decision|0
7759814|NCT00805207|12199739|FG007|Overall Study|Physician Decision|0
7759815|NCT00805207|12199740|FG008|Overall Study|Physician Decision|0
7759816|NCT00805207|12199732|FG000|Overall Study|Withdrawal by Subject|0
7759817|NCT00805207|12199733|FG001|Overall Study|Withdrawal by Subject|1
7759818|NCT00805207|12199734|FG002|Overall Study|Withdrawal by Subject|0
7759819|NCT00805207|12199735|FG003|Overall Study|Withdrawal by Subject|0
7759820|NCT00805207|12199736|FG004|Overall Study|Withdrawal by Subject|1
7759821|NCT00805207|12199737|FG005|Overall Study|Withdrawal by Subject|2
7759822|NCT00805207|12199738|FG006|Overall Study|Withdrawal by Subject|0
7759823|NCT00805207|12199739|FG007|Overall Study|Withdrawal by Subject|0
7759824|NCT00805207|12199740|FG008|Overall Study|Withdrawal by Subject|0
7759825|NCT00805285|12199764|FG000|Overall Study|Lack of Efficacy|1
7759826|NCT00805389|12199773|FG000|Overall Study|Adverse Event|0
7759827|NCT00805389|12199774|FG001|Overall Study|Adverse Event|0
7759828|NCT00805389|12199775|FG002|Overall Study|Adverse Event|1
7759829|NCT00805389|12199776|FG003|Overall Study|Adverse Event|2
7759830|NCT00805389|12199777|FG004|Overall Study|Adverse Event|0
7759831|NCT00805389|12199773|FG000|Overall Study|Lost to Follow-up|4
7759832|NCT00805389|12199774|FG001|Overall Study|Lost to Follow-up|3
7759833|NCT00805389|12199775|FG002|Overall Study|Lost to Follow-up|6
7759834|NCT00805389|12199776|FG003|Overall Study|Lost to Follow-up|10
7759835|NCT00805389|12199777|FG004|Overall Study|Lost to Follow-up|9
7759836|NCT00805389|12199773|FG000|Overall Study|Protocol Violation|0
7759837|NCT00805389|12199774|FG001|Overall Study|Protocol Violation|0
7759838|NCT00805389|12199775|FG002|Overall Study|Protocol Violation|1
7759839|NCT00805389|12199776|FG003|Overall Study|Protocol Violation|0
7759840|NCT00805389|12199777|FG004|Overall Study|Protocol Violation|0
7759841|NCT00805389|12199773|FG000|Overall Study|Withdrawal by Subject|3
7759842|NCT00805389|12199774|FG001|Overall Study|Withdrawal by Subject|2
7759843|NCT00805389|12199775|FG002|Overall Study|Withdrawal by Subject|4
7759844|NCT00805389|12199776|FG003|Overall Study|Withdrawal by Subject|5
7759845|NCT00805389|12199777|FG004|Overall Study|Withdrawal by Subject|4
7759846|NCT00805441|12199801|FG000|Overall Study|Adverse Event|5
7759847|NCT00805441|12199802|FG001|Overall Study|Adverse Event|2
7759848|NCT00805441|12199801|FG000|Overall Study|Lack of Efficacy|0
7759849|NCT00805441|12199802|FG001|Overall Study|Lack of Efficacy|2
7759850|NCT00805441|12199801|FG000|Overall Study|Protocol Violation|4
7759851|NCT00805441|12199802|FG001|Overall Study|Protocol Violation|8
7759852|NCT00805441|12199801|FG000|Overall Study|Lost to Follow-up|10
7759853|NCT00805441|12199802|FG001|Overall Study|Lost to Follow-up|13
7759854|NCT00805441|12199801|FG000|Overall Study|Withdrawal by Subject|15
7759855|NCT00805441|12199802|FG001|Overall Study|Withdrawal by Subject|9
7759856|NCT00805441|12199801|FG000|Overall Study|Physician Decision|0
7759857|NCT00805441|12199802|FG001|Overall Study|Physician Decision|1
7759858|NCT00805441|12199801|FG000|Overall Study|Acute Alcohol Withdrawal|0
7759859|NCT00805441|12199802|FG001|Overall Study|Acute Alcohol Withdrawal|1
7759860|NCT00805467|12199812|FG000|Overall Study|Lack of Efficacy|0
7759861|NCT00805467|12199813|FG001|Overall Study|Lack of Efficacy|8
7759862|NCT00805467|12199814|FG002|Overall Study|Lack of Efficacy|13
7759863|NCT00805467|12199815|FG003|Overall Study|Lack of Efficacy|86
7759864|NCT00805467|12199812|FG000|Overall Study|Lost to Follow-up|0
7759865|NCT00805467|12199813|FG001|Overall Study|Lost to Follow-up|1
7759866|NCT00805467|12199814|FG002|Overall Study|Lost to Follow-up|7
7759867|NCT00805467|12199815|FG003|Overall Study|Lost to Follow-up|21
7759868|NCT00805467|12199812|FG000|Overall Study|Withdrawal by Subject|0
7759869|NCT00805467|12199813|FG001|Overall Study|Withdrawal by Subject|6
7759870|NCT00805467|12199814|FG002|Overall Study|Withdrawal by Subject|45
7759871|NCT00805467|12199815|FG003|Overall Study|Withdrawal by Subject|50
7759872|NCT00805467|12199812|FG000|Overall Study|Protocol Violation|0
7759873|NCT00805467|12199813|FG001|Overall Study|Protocol Violation|3
7759874|NCT00805467|12199814|FG002|Overall Study|Protocol Violation|0
7759875|NCT00805467|12199815|FG003|Overall Study|Protocol Violation|5
7759876|NCT00805467|12199812|FG000|Overall Study|Adverse Event|0
7759877|NCT00805467|12199813|FG001|Overall Study|Adverse Event|13
7759878|NCT00805467|12199814|FG002|Overall Study|Adverse Event|26
7759879|NCT00805467|12199815|FG003|Overall Study|Adverse Event|57
7759880|NCT00805467|12199812|FG000|Overall Study|Death|0
7759881|NCT00805467|12199813|FG001|Overall Study|Death|2
7759882|NCT00805467|12199814|FG002|Overall Study|Death|7
7759883|NCT00805467|12199815|FG003|Overall Study|Death|5
7759884|NCT00805467|12199812|FG000|Overall Study|Physician Decision|0
7759885|NCT00805467|12199813|FG001|Overall Study|Physician Decision|1
7759886|NCT00805467|12199814|FG002|Overall Study|Physician Decision|2
7759887|NCT00805467|12199815|FG003|Overall Study|Physician Decision|6
7759888|NCT00805467|12199812|FG000|Overall Study|Not reported|0
7759889|NCT00805467|12199813|FG001|Overall Study|Not reported|0
7759890|NCT00805467|12199814|FG002|Overall Study|Not reported|3
7759891|NCT00805467|12199815|FG003|Overall Study|Not reported|7
7759892|NCT00805480|12199829|FG000|Overall Study|Withdrawal by Subject|13
7759893|NCT00805480|12199830|FG001|Overall Study|Withdrawal by Subject|5
7759894|NCT00805480|12199831|FG002|Overall Study|Withdrawal by Subject|11
7759895|NCT00805480|12199832|FG003|Overall Study|Withdrawal by Subject|5
7759896|NCT00805480|12199829|FG000|Overall Study|Lost to Follow-up|1
7759897|NCT00805480|12199830|FG001|Overall Study|Lost to Follow-up|2
7759898|NCT00805480|12199831|FG002|Overall Study|Lost to Follow-up|0
7759899|NCT00805480|12199832|FG003|Overall Study|Lost to Follow-up|0
7759900|NCT00805480|12199829|FG000|Overall Study|Adverse Event|0
7759901|NCT00805480|12199830|FG001|Overall Study|Adverse Event|0
7759902|NCT00805480|12199831|FG002|Overall Study|Adverse Event|1
7759903|NCT00805480|12199832|FG003|Overall Study|Adverse Event|0
7759904|NCT00805532|12199860|FG000|Overall Study|invalid data|0
7759905|NCT00805532|12199861|FG001|Overall Study|invalid data|1
7759906|NCT00805545|12199871|FG000|Overall Study|Protocol Violation|3
7759907|NCT00805545|12199872|FG001|Overall Study|Protocol Violation|2
7759908|NCT00805545|12199871|FG000|Overall Study|Protocol Violation|3
7759909|NCT00805545|12199872|FG001|Overall Study|Protocol Violation|1
7759910|NCT00805675|12199881|FG000|Overall Study|Adverse Event|0
7759911|NCT00805675|12199882|FG001|Overall Study|Adverse Event|0
7759912|NCT00805675|12199883|FG002|Overall Study|Adverse Event|1
7759913|NCT00805740|12199893|FG000|Overall Study|Death|7
7759914|NCT00805740|12199894|FG001|Overall Study|Death|4
7759915|NCT00805740|12199893|FG000|Overall Study|Withdrawal by Subject|1
7759916|NCT00805740|12199894|FG001|Overall Study|Withdrawal by Subject|0
7759917|NCT00805740|12199893|FG000|Overall Study|Lost to Follow-up|1
7759918|NCT00805740|12199894|FG001|Overall Study|Lost to Follow-up|0
7759919|NCT00805740|12199893|FG000|Overall Study|Randomized, but not treated|2
7759920|NCT00805740|12199894|FG001|Overall Study|Randomized, but not treated|0
7759921|NCT00805766|12199900|FG000|Screening Period|Adverse Event|1
7759922|NCT00805766|12199900|FG000|Screening Period|Lack of Efficacy|2
7759923|NCT00805766|12199900|FG000|Screening Period|Pregnancy|1
7759924|NCT00805766|12199900|FG000|Screening Period|Responder|2
7759925|NCT00805766|12199900|FG000|Increased Dose Period|Adverse Event|4
7759926|NCT00805766|12199900|FG000|Increased Dose Period|Lack of Efficacy|7
7759927|NCT00805766|12199900|FG000|Increased Dose Period|Pregnancy|1
7759928|NCT00805766|12199900|FG000|Increased Dose Period|Withdrawal by Subject|1
7759929|NCT00805792|12199908|FG000|Overall Study|Death|3
7759930|NCT00805792|12199908|FG000|Overall Study|Lost to Follow-up|2
7759931|NCT00805935|12199925|FG000|Overall Study|Stimulation Failure|1
7759932|NCT00805935|12199926|FG001|Overall Study|Stimulation Failure|5
7759933|NCT00805935|12199927|FG002|Overall Study|Stimulation Failure|2
7759934|NCT00805935|12199928|FG003|Overall Study|Stimulation Failure|2
7759935|NCT00805935|12199925|FG000|Overall Study|Cycle cancelled|0
7759936|NCT00805935|12199926|FG001|Overall Study|Cycle cancelled|0
7759937|NCT00805935|12199927|FG002|Overall Study|Cycle cancelled|2
7759938|NCT00805935|12199928|FG003|Overall Study|Cycle cancelled|0
7759939|NCT00805935|12199925|FG000|Overall Study|Cycle cancellation for risk of OHSS|1
7759940|NCT00805935|12199926|FG001|Overall Study|Cycle cancellation for risk of OHSS|0
7759941|NCT00805935|12199927|FG002|Overall Study|Cycle cancellation for risk of OHSS|1
7759942|NCT00805935|12199928|FG003|Overall Study|Cycle cancellation for risk of OHSS|0
7759943|NCT00805935|12199925|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
7759944|NCT00805935|12199926|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
7759945|NCT00805935|12199927|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
7759946|NCT00805935|12199928|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
7759947|NCT00805935|12199925|FG000|Overall Study|Lost to Follow-up|1
7759948|NCT00805935|12199926|FG001|Overall Study|Lost to Follow-up|0
7759949|NCT00805935|12199927|FG002|Overall Study|Lost to Follow-up|0
7759950|NCT00805935|12199928|FG003|Overall Study|Lost to Follow-up|0
7759951|NCT00805935|12199925|FG000|Overall Study|No positive serum pregnancy|8
7759952|NCT00805935|12199926|FG001|Overall Study|No positive serum pregnancy|7
7759953|NCT00805935|12199927|FG002|Overall Study|No positive serum pregnancy|6
7759954|NCT00805935|12199928|FG003|Overall Study|No positive serum pregnancy|5
7759955|NCT00805935|12199925|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0
7759956|NCT00805935|12199926|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0
7759957|NCT00805935|12199927|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0
7759958|NCT00805935|12199928|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1
7759959|NCT00805935|12199925|FG000|Overall Study|Pregnancy loss/miscarriage|2
7759960|NCT00805935|12199926|FG001|Overall Study|Pregnancy loss/miscarriage|0
7759961|NCT00805935|12199927|FG002|Overall Study|Pregnancy loss/miscarriage|0
7759962|NCT00805935|12199928|FG003|Overall Study|Pregnancy loss/miscarriage|0
7759963|NCT00805935|12199925|FG000|Overall Study|Biochemical pregnancy|0
7759964|NCT00805935|12199926|FG001|Overall Study|Biochemical pregnancy|1
7759965|NCT00805935|12199927|FG002|Overall Study|Biochemical pregnancy|0
7759966|NCT00805935|12199928|FG003|Overall Study|Biochemical pregnancy|0
7759967|NCT00805935|12199925|FG000|Overall Study|Chemical pregnancy|0
7759968|NCT00805935|12199926|FG001|Overall Study|Chemical pregnancy|5
7759969|NCT00805935|12199927|FG002|Overall Study|Chemical pregnancy|3
7759970|NCT00805935|12199928|FG003|Overall Study|Chemical pregnancy|2
7759971|NCT00805935|12199925|FG000|Overall Study|Ectopic pregnancy|0
7759972|NCT00805935|12199926|FG001|Overall Study|Ectopic pregnancy|0
7759973|NCT00805935|12199927|FG002|Overall Study|Ectopic pregnancy|1
7759974|NCT00805935|12199928|FG003|Overall Study|Ectopic pregnancy|0
7759975|NCT00805935|12199925|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0
7759976|NCT00805935|12199926|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1
7759977|NCT00805935|12199927|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0
7759978|NCT00805935|12199928|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0
7759979|NCT00806026|12199956|FG000|Overall Study|Death|0
7759980|NCT00806026|12199957|FG001|Overall Study|Death|0
7759981|NCT00806026|12199958|FG002|Overall Study|Death|0
7759982|NCT00806026|12199959|FG003|Overall Study|Death|1
7759983|NCT00806026|12199960|FG004|Overall Study|Death|0
7759984|NCT00806026|12199961|FG005|Overall Study|Death|0
7759985|NCT00806026|12199956|FG000|Overall Study|Did not meet entrance criteria|4
7759986|NCT00806026|12199957|FG001|Overall Study|Did not meet entrance criteria|1
7759987|NCT00806026|12199958|FG002|Overall Study|Did not meet entrance criteria|2
7759988|NCT00806026|12199959|FG003|Overall Study|Did not meet entrance criteria|1
7759989|NCT00806026|12199960|FG004|Overall Study|Did not meet entrance criteria|0
7759990|NCT00806026|12199961|FG005|Overall Study|Did not meet entrance criteria|0
7759991|NCT00806026|12199956|FG000|Overall Study|Lack of Efficacy|5
7759992|NCT00806026|12199957|FG001|Overall Study|Lack of Efficacy|18
7759993|NCT00806026|12199958|FG002|Overall Study|Lack of Efficacy|13
7759994|NCT00806026|12199959|FG003|Overall Study|Lack of Efficacy|4
7759995|NCT00806026|12199960|FG004|Overall Study|Lack of Efficacy|8
7759996|NCT00806026|12199961|FG005|Overall Study|Lack of Efficacy|7
7759997|NCT00806026|12199956|FG000|Overall Study|Lost to Follow-up|8
7759998|NCT00806026|12199957|FG001|Overall Study|Lost to Follow-up|15
7759999|NCT00806026|12199958|FG002|Overall Study|Lost to Follow-up|8
7760000|NCT00806026|12199959|FG003|Overall Study|Lost to Follow-up|2
7760001|NCT00806026|12199960|FG004|Overall Study|Lost to Follow-up|6
7760002|NCT00806026|12199961|FG005|Overall Study|Lost to Follow-up|6
7760003|NCT00806026|12199956|FG000|Overall Study|Withdrawal by Subject|14
7760004|NCT00806026|12199957|FG001|Overall Study|Withdrawal by Subject|17
7760005|NCT00806026|12199958|FG002|Overall Study|Withdrawal by Subject|9
7760006|NCT00806026|12199959|FG003|Overall Study|Withdrawal by Subject|2
7760007|NCT00806026|12199960|FG004|Overall Study|Withdrawal by Subject|5
7760008|NCT00806026|12199961|FG005|Overall Study|Withdrawal by Subject|3
7760009|NCT00806026|12199956|FG000|Overall Study|Other|3
7760010|NCT00806026|12199957|FG001|Overall Study|Other|6
7760011|NCT00806026|12199958|FG002|Overall Study|Other|8
7760012|NCT00806026|12199959|FG003|Overall Study|Other|2
7760013|NCT00806026|12199960|FG004|Overall Study|Other|0
7760014|NCT00806026|12199961|FG005|Overall Study|Other|4
7760015|NCT00806026|12199956|FG000|Overall Study|Protocol Violation|6
7760016|NCT00806026|12199957|FG001|Overall Study|Protocol Violation|9
7760017|NCT00806026|12199958|FG002|Overall Study|Protocol Violation|9
7760018|NCT00806026|12199959|FG003|Overall Study|Protocol Violation|0
7760019|NCT00806026|12199960|FG004|Overall Study|Protocol Violation|2
7760020|NCT00806026|12199961|FG005|Overall Study|Protocol Violation|3
7760021|NCT00806026|12199956|FG000|Overall Study|Adverse Event|52
7760022|NCT00806026|12199957|FG001|Overall Study|Adverse Event|35
7760023|NCT00806026|12199958|FG002|Overall Study|Adverse Event|44
7760024|NCT00806026|12199959|FG003|Overall Study|Adverse Event|17
7760025|NCT00806026|12199960|FG004|Overall Study|Adverse Event|9
7760026|NCT00806026|12199961|FG005|Overall Study|Adverse Event|9
7760027|NCT00806156|12199984|FG000|Overall Study|Death|35
7760028|NCT00806156|12199985|FG001|Overall Study|Death|95
7760029|NCT00806156|12199984|FG000|Overall Study|Did not meet eligibility criteria|1
7760030|NCT00806156|12199985|FG001|Overall Study|Did not meet eligibility criteria|0
7760031|NCT00806156|12199984|FG000|Overall Study|Study terminated by Sponsor|2
7760032|NCT00806156|12199985|FG001|Overall Study|Study terminated by Sponsor|40
7760033|NCT00806156|12199984|FG000|Overall Study|Consent withdrawn by subject|1
7760034|NCT00806156|12199985|FG001|Overall Study|Consent withdrawn by subject|3
7760035|NCT00806156|12199984|FG000|Overall Study|Lost to Follow-up|0
7760036|NCT00806156|12199985|FG001|Overall Study|Lost to Follow-up|1
7760037|NCT00806195|12200007|FG000|Overall Study|Death|6
7760038|NCT00806195|12200008|FG001|Overall Study|Death|0
7760039|NCT00806195|12200009|FG002|Overall Study|Death|1
7760040|NCT00806195|12200010|FG003|Overall Study|Death|0
7760041|NCT00806195|12200007|FG000|Overall Study|Adverse Event|25
7760042|NCT00806195|12200008|FG001|Overall Study|Adverse Event|5
7760043|NCT00806195|12200009|FG002|Overall Study|Adverse Event|11
7760044|NCT00806195|12200010|FG003|Overall Study|Adverse Event|2
7760045|NCT00806195|12200007|FG000|Overall Study|Withdrawal by Subject|119
7760046|NCT00806195|12200008|FG001|Overall Study|Withdrawal by Subject|31
7760047|NCT00806195|12200009|FG002|Overall Study|Withdrawal by Subject|76
7760048|NCT00806195|12200010|FG003|Overall Study|Withdrawal by Subject|35
7760049|NCT00806195|12200007|FG000|Overall Study|Lost to Follow-up|217
7760050|NCT00806195|12200008|FG001|Overall Study|Lost to Follow-up|66
7760051|NCT00806195|12200009|FG002|Overall Study|Lost to Follow-up|90
7760052|NCT00806195|12200010|FG003|Overall Study|Lost to Follow-up|34
7760053|NCT00806195|12200007|FG000|Overall Study|Inappropriate Enrollment|0
7760054|NCT00806195|12200008|FG001|Overall Study|Inappropriate Enrollment|1
7760055|NCT00806195|12200009|FG002|Overall Study|Inappropriate Enrollment|0
7760056|NCT00806195|12200010|FG003|Overall Study|Inappropriate Enrollment|0
7760057|NCT00806195|12200007|FG000|Overall Study|Administrative Reason|113
7760058|NCT00806195|12200008|FG001|Overall Study|Administrative Reason|35
7760059|NCT00806195|12200009|FG002|Overall Study|Administrative Reason|66
7760060|NCT00806195|12200010|FG003|Overall Study|Administrative Reason|26
7760061|NCT00806195|12200007|FG000|Overall Study|Protocol Violation|34
7760062|NCT00806195|12200008|FG001|Overall Study|Protocol Violation|24
7760063|NCT00806195|12200009|FG002|Overall Study|Protocol Violation|26
7760064|NCT00806195|12200010|FG003|Overall Study|Protocol Violation|9
7760065|NCT00806260|12200045|FG000|Period 1 (1 Day)|Adverse Event|0
7760066|NCT00806260|12200046|FG001|Period 1 (1 Day)|Adverse Event|0
7760067|NCT00806260|12200047|FG002|Period 1 (1 Day)|Adverse Event|0
7760068|NCT00806260|12200048|FG003|Period 1 (1 Day)|Adverse Event|0
7760069|NCT00806260|12200049|FG004|Period 1 (1 Day)|Adverse Event|3
7760070|NCT00806260|12200050|FG005|Period 1 (1 Day)|Adverse Event|0
7760071|NCT00806260|12200045|FG000|Period 2|Adverse Event|0
7760072|NCT00806260|12200046|FG001|Period 2|Adverse Event|0
7760073|NCT00806260|12200047|FG002|Period 2|Adverse Event|0
7760074|NCT00806260|12200048|FG003|Period 2|Adverse Event|1
7760075|NCT00806260|12200049|FG004|Period 2|Adverse Event|0
7760076|NCT00806260|12200050|FG005|Period 2|Adverse Event|0
7760077|NCT00806260|12200045|FG000|Period 2|Protocol Violation|1
7760078|NCT00806260|12200046|FG001|Period 2|Protocol Violation|0
7760079|NCT00806260|12200047|FG002|Period 2|Protocol Violation|1
7760080|NCT00806260|12200048|FG003|Period 2|Protocol Violation|0
7760081|NCT00806260|12200049|FG004|Period 2|Protocol Violation|0
7760082|NCT00806260|12200050|FG005|Period 2|Protocol Violation|0
7760083|NCT00806260|12200045|FG000|Period 2|Need to take concomitant medication|1
7760084|NCT00806260|12200046|FG001|Period 2|Need to take concomitant medication|0
7760085|NCT00806260|12200047|FG002|Period 2|Need to take concomitant medication|0
7760086|NCT00806260|12200048|FG003|Period 2|Need to take concomitant medication|0
7760087|NCT00806260|12200049|FG004|Period 2|Need to take concomitant medication|0
7760088|NCT00806260|12200050|FG005|Period 2|Need to take concomitant medication|0
7760089|NCT00806260|12200045|FG000|Period 2|sponsor request|0
7760090|NCT00806260|12200046|FG001|Period 2|sponsor request|0
7760091|NCT00806260|12200047|FG002|Period 2|sponsor request|1
7760092|NCT00806260|12200048|FG003|Period 2|sponsor request|1
7760093|NCT00806260|12200049|FG004|Period 2|sponsor request|0
7760094|NCT00806260|12200050|FG005|Period 2|sponsor request|0
7760095|NCT00806260|12200045|FG000|Period 3|Protocol Violation|0
7760096|NCT00806260|12200046|FG001|Period 3|Protocol Violation|1
7760097|NCT00806260|12200047|FG002|Period 3|Protocol Violation|1
7760098|NCT00806260|12200048|FG003|Period 3|Protocol Violation|0
7760099|NCT00806260|12200049|FG004|Period 3|Protocol Violation|0
7760100|NCT00806260|12200050|FG005|Period 3|Protocol Violation|0
7760101|NCT00806260|12200045|FG000|Period 3|Pregnancy|1
7760102|NCT00806260|12200046|FG001|Period 3|Pregnancy|0
7760103|NCT00806260|12200047|FG002|Period 3|Pregnancy|0
7760104|NCT00806260|12200048|FG003|Period 3|Pregnancy|0
7760105|NCT00806260|12200049|FG004|Period 3|Pregnancy|0
7760106|NCT00806260|12200050|FG005|Period 3|Pregnancy|0
7760107|NCT00806286|12200065|FG000|Overall Study|Adverse Event|5
7760108|NCT00806286|12200066|FG001|Overall Study|Adverse Event|2
7760109|NCT00806286|12200067|FG002|Overall Study|Adverse Event|0
7760110|NCT00806286|12200065|FG000|Overall Study|Disease progression|31
7760111|NCT00806286|12200066|FG001|Overall Study|Disease progression|38
7760112|NCT00806286|12200067|FG002|Overall Study|Disease progression|1
7760113|NCT00806286|12200065|FG000|Overall Study|Death|1
7760114|NCT00806286|12200066|FG001|Overall Study|Death|6
7760115|NCT00806286|12200067|FG002|Overall Study|Death|0
7760116|NCT00806286|12200065|FG000|Overall Study|Lost to Follow-up|0
7760117|NCT00806286|12200066|FG001|Overall Study|Lost to Follow-up|1
7760118|NCT00806286|12200067|FG002|Overall Study|Lost to Follow-up|0
7760119|NCT00806286|12200065|FG000|Overall Study|Withdrawal by Subject|8
7760120|NCT00806286|12200066|FG001|Overall Study|Withdrawal by Subject|3
7760121|NCT00806286|12200067|FG002|Overall Study|Withdrawal by Subject|1
7760122|NCT00806286|12200065|FG000|Overall Study|Physician Decision|2
7760123|NCT00806286|12200066|FG001|Overall Study|Physician Decision|2
7760124|NCT00806286|12200067|FG002|Overall Study|Physician Decision|0
7760125|NCT00806286|12200065|FG000|Overall Study|Due to a variety of reasons|7
7760126|NCT00806286|12200066|FG001|Overall Study|Due to a variety of reasons|2
7760127|NCT00806286|12200067|FG002|Overall Study|Due to a variety of reasons|1
7760128|NCT00806351|12200077|FG000|Overall Study|Death|5
7760129|NCT00806351|12200078|FG001|Overall Study|Death|4
7760130|NCT00806442|12200084|FG000|Overall Study|Lost to Follow-up|3
7760131|NCT00806442|12200085|FG001|Overall Study|Lost to Follow-up|2
7760132|NCT00806442|12200084|FG000|Overall Study|Withdrawal by Subject|1
7760133|NCT00806442|12200085|FG001|Overall Study|Withdrawal by Subject|5
7760134|NCT00806494|12200093|FG000|Overall Study|Adverse Event|29
7760135|NCT00806494|12200093|FG000|Overall Study|Lack of Efficacy|6
7760136|NCT00806494|12200093|FG000|Overall Study|Lost to Follow-up|10
7760137|NCT00806494|12200093|FG000|Overall Study|Other|30
7760138|NCT00806494|12200093|FG000|Overall Study|Withdrawal by Subject|5
7760139|NCT00806546|12200098|FG000|Overall Study|Enrolled, not treated|35
7760140|NCT00806546|12200098|FG000|Overall Study|Lost to Follow-up|32
7760141|NCT00806546|12200098|FG000|Overall Study|Adverse Event|74
7760142|NCT00806546|12200098|FG000|Overall Study|Withdrawal by Subject|75
7760143|NCT00806546|12200098|FG000|Overall Study|Protocol Violation|49
7760144|NCT00806546|12200098|FG000|Overall Study|Various|42
7760145|NCT00806585|12200107|FG000|Overall Study|Study terminated by Sponsor|0
7760146|NCT00806585|12200108|FG001|Overall Study|Study terminated by Sponsor|0
7760147|NCT00806585|12200109|FG002|Overall Study|Study terminated by Sponsor|1
7760148|NCT00806585|12200110|FG003|Overall Study|Study terminated by Sponsor|2
7760149|NCT00806585|12200111|FG004|Overall Study|Study terminated by Sponsor|0
7760150|NCT00806585|12200107|FG000|Overall Study|Protocol Violation|3
7760151|NCT00806585|12200108|FG001|Overall Study|Protocol Violation|1
7760152|NCT00806585|12200109|FG002|Overall Study|Protocol Violation|2
7760153|NCT00806585|12200110|FG003|Overall Study|Protocol Violation|0
7760154|NCT00806585|12200111|FG004|Overall Study|Protocol Violation|0
7760155|NCT00806585|12200107|FG000|Overall Study|Physician Decision|0
7760156|NCT00806585|12200108|FG001|Overall Study|Physician Decision|2
7760157|NCT00806585|12200109|FG002|Overall Study|Physician Decision|3
7760158|NCT00806585|12200110|FG003|Overall Study|Physician Decision|0
7760159|NCT00806585|12200111|FG004|Overall Study|Physician Decision|1
7760160|NCT00806585|12200107|FG000|Overall Study|Lost to Follow-up|2
7760161|NCT00806585|12200108|FG001|Overall Study|Lost to Follow-up|1
7760162|NCT00806585|12200109|FG002|Overall Study|Lost to Follow-up|2
7760163|NCT00806585|12200110|FG003|Overall Study|Lost to Follow-up|2
7760164|NCT00806585|12200111|FG004|Overall Study|Lost to Follow-up|5
7760165|NCT00806585|12200107|FG000|Overall Study|Lack of Efficacy|1
7760166|NCT00806585|12200108|FG001|Overall Study|Lack of Efficacy|0
7760167|NCT00806585|12200109|FG002|Overall Study|Lack of Efficacy|0
7760168|NCT00806585|12200110|FG003|Overall Study|Lack of Efficacy|0
7760169|NCT00806585|12200111|FG004|Overall Study|Lack of Efficacy|0
7760170|NCT00806585|12200107|FG000|Overall Study|Adverse Event|1
7760171|NCT00806585|12200108|FG001|Overall Study|Adverse Event|5
7760172|NCT00806585|12200109|FG002|Overall Study|Adverse Event|3
7760173|NCT00806585|12200110|FG003|Overall Study|Adverse Event|4
7760174|NCT00806585|12200111|FG004|Overall Study|Adverse Event|2
7760175|NCT00806585|12200107|FG000|Overall Study|Withdrawal by Subject|10
7760176|NCT00806585|12200108|FG001|Overall Study|Withdrawal by Subject|8
7760177|NCT00806585|12200109|FG002|Overall Study|Withdrawal by Subject|9
7760178|NCT00806585|12200110|FG003|Overall Study|Withdrawal by Subject|3
7760179|NCT00806585|12200111|FG004|Overall Study|Withdrawal by Subject|11
7760180|NCT00806585|12200107|FG000|Overall Study|Completion status unknown|15
7760181|NCT00806585|12200108|FG001|Overall Study|Completion status unknown|14
7760182|NCT00806585|12200109|FG002|Overall Study|Completion status unknown|12
7760183|NCT00806585|12200110|FG003|Overall Study|Completion status unknown|4
7760184|NCT00806585|12200111|FG004|Overall Study|Completion status unknown|12
7760185|NCT00806624|12200130|FG000|Overall Study|Adverse Event|2
7760186|NCT00806624|12200131|FG001|Overall Study|Adverse Event|8
7760187|NCT00806624|12200132|FG002|Overall Study|Adverse Event|0
7760188|NCT00806624|12200130|FG000|Overall Study|Death|0
7760189|NCT00806624|12200131|FG001|Overall Study|Death|1
7760190|NCT00806624|12200132|FG002|Overall Study|Death|1
7760191|NCT00806624|12200130|FG000|Overall Study|Lost to Follow-up|1
7760192|NCT00806624|12200131|FG001|Overall Study|Lost to Follow-up|0
7760193|NCT00806624|12200132|FG002|Overall Study|Lost to Follow-up|1
7760194|NCT00806624|12200130|FG000|Overall Study|Withdrawal by Subject|6
7760195|NCT00806624|12200131|FG001|Overall Study|Withdrawal by Subject|3
7760196|NCT00806624|12200132|FG002|Overall Study|Withdrawal by Subject|3
7760197|NCT00806624|12200130|FG000|Overall Study|discontinued before start of treatment|0
7760198|NCT00806624|12200131|FG001|Overall Study|discontinued before start of treatment|0
7760199|NCT00806624|12200132|FG002|Overall Study|discontinued before start of treatment|1
7760200|NCT00806819|12200156|FG000|Overall Study|progressive disease (modified RECIST )|217
7760201|NCT00806819|12200157|FG001|Overall Study|progressive disease (modified RECIST )|216
7760202|NCT00806819|12200156|FG000|Overall Study|Worsening or AE of underlying disease|18
7760203|NCT00806819|12200157|FG001|Overall Study|Worsening or AE of underlying disease|25
7760204|NCT00806819|12200156|FG000|Overall Study|Other AE|38
7760205|NCT00806819|12200157|FG001|Overall Study|Other AE|40
7760206|NCT00806819|12200156|FG000|Overall Study|Protocol Violation|9
7760207|NCT00806819|12200157|FG001|Overall Study|Protocol Violation|4
7760208|NCT00806819|12200156|FG000|Overall Study|Lost to Follow-up|1
7760209|NCT00806819|12200157|FG001|Overall Study|Lost to Follow-up|0
7760210|NCT00806819|12200156|FG000|Overall Study|Withdrawal by Subject|32
7760211|NCT00806819|12200157|FG001|Overall Study|Withdrawal by Subject|29
7760212|NCT00806819|12200156|FG000|Overall Study|Not treated|6
7760213|NCT00806819|12200157|FG001|Overall Study|Not treated|3
7760214|NCT00806819|12200156|FG000|Overall Study|Reasons other than stated above|25
7760215|NCT00806819|12200157|FG001|Overall Study|Reasons other than stated above|41
7760216|NCT00806988|12200166|FG000|Overall Study|Death|15
7760217|NCT00806988|12200167|FG001|Overall Study|Death|16
7760218|NCT00806988|12200166|FG000|Overall Study|Withdrawal by Subject|8
7760219|NCT00806988|12200167|FG001|Overall Study|Withdrawal by Subject|8
7760220|NCT00806988|12200166|FG000|Overall Study|Lost to Follow-up|4
7760221|NCT00806988|12200167|FG001|Overall Study|Lost to Follow-up|19
7760222|NCT00807001|12200178|FG000|Overall Study|Non-compliance|0
7760223|NCT00807001|12200179|FG001|Overall Study|Non-compliance|1
7760224|NCT00807001|12200180|FG002|Overall Study|Non-compliance|0
7760225|NCT00807001|12200181|FG003|Overall Study|Non-compliance|0
7760226|NCT00807001|12200182|FG004|Overall Study|Non-compliance|0
7760227|NCT00807014|12200196|FG000|Overall Study|Participant Considered Disease Cured|13
7760228|NCT00807014|12200197|FG001|Overall Study|Participant Considered Disease Cured|2
7760229|NCT00807014|12200196|FG000|Overall Study|Participant Considered Disease Not Cured|2
7760230|NCT00807014|12200197|FG001|Overall Study|Participant Considered Disease Not Cured|7
7760231|NCT00807014|12200196|FG000|Overall Study|Protocol Violation|2
7760232|NCT00807014|12200197|FG001|Overall Study|Protocol Violation|8
7760233|NCT00807014|12200196|FG000|Overall Study|Adverse Event|0
7760234|NCT00807014|12200197|FG001|Overall Study|Adverse Event|2
7760235|NCT00807014|12200196|FG000|Overall Study|Lost to Follow-up|9
7760236|NCT00807014|12200197|FG001|Overall Study|Lost to Follow-up|7
7760237|NCT00807014|12200196|FG000|Overall Study|Recovery|1
7760238|NCT00807014|12200197|FG001|Overall Study|Recovery|0
7760239|NCT00807014|12200196|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0
7760240|NCT00807014|12200197|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1
7760241|NCT00807040|12200205|FG000|Overall Study|Death|24
7760242|NCT00807040|12200206|FG001|Overall Study|Death|29
7760243|NCT00807040|12200205|FG000|Overall Study|Withdrawal by Subject|8
7760244|NCT00807040|12200206|FG001|Overall Study|Withdrawal by Subject|6
7760245|NCT00807040|12200205|FG000|Overall Study|Lost to Follow-up|4
7760246|NCT00807040|12200206|FG001|Overall Study|Lost to Follow-up|6
7760247|NCT00807092|12200214|FG000|Overall Study|Adverse Event|0
7760248|NCT00807092|12200215|FG001|Overall Study|Adverse Event|1
7760249|NCT00807092|12200214|FG000|Overall Study|Protocol Violation|0
7760250|NCT00807092|12200215|FG001|Overall Study|Protocol Violation|2
7760251|NCT00807092|12200214|FG000|Overall Study|Withdrawal by Subject|1
7760252|NCT00807092|12200215|FG001|Overall Study|Withdrawal by Subject|0
7760253|NCT00807092|12200214|FG000|Overall Study|CGMS data collection failed|0
7760254|NCT00807092|12200215|FG001|Overall Study|CGMS data collection failed|1
7760255|NCT00807144|12200223|FG000|Overall Study|Lost to Follow-up|0
7760256|NCT00807144|12200224|FG001|Overall Study|Lost to Follow-up|1
7760257|NCT00807235|12200245|FG000|Overall Study|Adverse Event|1
7760258|NCT00807235|12200246|FG001|Overall Study|Adverse Event|0
7760259|NCT00807248|12200256|FG000|Overall Study|Adverse Event|1
7760260|NCT00807248|12200257|FG001|Overall Study|Adverse Event|2
7760261|NCT00807248|12200258|FG002|Overall Study|Adverse Event|2
7760262|NCT00807248|12200259|FG003|Overall Study|Adverse Event|6
7760263|NCT00807248|12200256|FG000|Overall Study|Lack of Efficacy|14
7760264|NCT00807248|12200257|FG001|Overall Study|Lack of Efficacy|4
7760265|NCT00807248|12200258|FG002|Overall Study|Lack of Efficacy|8
7760266|NCT00807248|12200259|FG003|Overall Study|Lack of Efficacy|3
7760267|NCT00807248|12200256|FG000|Overall Study|Protocol Violation|0
7760268|NCT00807248|12200257|FG001|Overall Study|Protocol Violation|1
7760269|NCT00807248|12200258|FG002|Overall Study|Protocol Violation|1
7760270|NCT00807248|12200259|FG003|Overall Study|Protocol Violation|0
7760271|NCT00807248|12200256|FG000|Overall Study|Withdrawal of Consent|5
7760272|NCT00807248|12200257|FG001|Overall Study|Withdrawal of Consent|5
7760273|NCT00807248|12200258|FG002|Overall Study|Withdrawal of Consent|5
7760274|NCT00807248|12200259|FG003|Overall Study|Withdrawal of Consent|5
7760275|NCT00807248|12200256|FG000|Overall Study|Lost to Follow-up|1
7760276|NCT00807248|12200257|FG001|Overall Study|Lost to Follow-up|0
7760277|NCT00807248|12200258|FG002|Overall Study|Lost to Follow-up|0
7760278|NCT00807248|12200259|FG003|Overall Study|Lost to Follow-up|0
7760279|NCT00807248|12200256|FG000|Overall Study|Other Reason|0
7760280|NCT00807248|12200257|FG001|Overall Study|Other Reason|0
7760281|NCT00807248|12200258|FG002|Overall Study|Other Reason|2
7760282|NCT00807248|12200259|FG003|Overall Study|Other Reason|0
7760283|NCT00807495|12200278|FG000|Overall Study|Adverse Event|6
7760284|NCT00807495|12200279|FG001|Overall Study|Adverse Event|3
7760285|NCT00807495|12200280|FG002|Overall Study|Adverse Event|1
7760286|NCT00807495|12200281|FG003|Overall Study|Adverse Event|1
7760287|NCT00807495|12200282|FG004|Overall Study|Adverse Event|2
7760288|NCT00807495|12200278|FG000|Overall Study|Withdrawal by Patient|2
7760289|NCT00807495|12200279|FG001|Overall Study|Withdrawal by Patient|0
7760290|NCT00807495|12200280|FG002|Overall Study|Withdrawal by Patient|1
7760291|NCT00807495|12200281|FG003|Overall Study|Withdrawal by Patient|0
7760292|NCT00807495|12200282|FG004|Overall Study|Withdrawal by Patient|0
7760293|NCT00807495|12200278|FG000|Overall Study|Reason Not Specified|0
7760294|NCT00807495|12200279|FG001|Overall Study|Reason Not Specified|3
7760295|NCT00807495|12200280|FG002|Overall Study|Reason Not Specified|2
7760296|NCT00807495|12200281|FG003|Overall Study|Reason Not Specified|0
7760297|NCT00807495|12200282|FG004|Overall Study|Reason Not Specified|3
7760298|NCT00807573|12200303|FG000|Overall Study|Withdrawal by Subject|1
7760299|NCT00807573|12200303|FG000|Overall Study|Adverse Event|1
7760300|NCT00807599|12200318|FG000|Overall Study|Not treated on protocol study|0
7760301|NCT00807599|12200319|FG001|Overall Study|Not treated on protocol study|0
7760302|NCT00807599|12200320|FG002|Overall Study|Not treated on protocol study|2
7760303|NCT00807599|12200318|FG000|Overall Study|Adverse Event|0
7760304|NCT00807599|12200319|FG001|Overall Study|Adverse Event|0
7760305|NCT00807599|12200320|FG002|Overall Study|Adverse Event|5
7760306|NCT00807599|12200318|FG000|Overall Study|Inadequate response to induction|0
7760307|NCT00807599|12200319|FG001|Overall Study|Inadequate response to induction|0
7760308|NCT00807599|12200320|FG002|Overall Study|Inadequate response to induction|9
7760309|NCT00807599|12200318|FG000|Overall Study|Withdrawal by Subject|0
7760310|NCT00807599|12200319|FG001|Overall Study|Withdrawal by Subject|0
7760311|NCT00807599|12200320|FG002|Overall Study|Withdrawal by Subject|1
7760312|NCT00807742|12200338|FG000|Overall Study|Death|9
7760313|NCT00807742|12200339|FG001|Overall Study|Death|2
7760314|NCT00807742|12200338|FG000|Overall Study|Withdrawal by Subject|2
7760315|NCT00807742|12200339|FG001|Overall Study|Withdrawal by Subject|1
7760316|NCT00807742|12200338|FG000|Overall Study|Lost to Follow-up|35
7760317|NCT00807742|12200339|FG001|Overall Study|Lost to Follow-up|51
7760318|NCT00807846|12200356|FG000|Overall Study|Adverse Event|5
7760319|NCT00807846|12200357|FG001|Overall Study|Adverse Event|0
7760320|NCT00807846|12200356|FG000|Overall Study|Lack of Efficacy|2
7760321|NCT00807846|12200357|FG001|Overall Study|Lack of Efficacy|0
7760322|NCT00807846|12200356|FG000|Overall Study|Protocol Violation|2
7760323|NCT00807846|12200357|FG001|Overall Study|Protocol Violation|1
7760324|NCT00807846|12200356|FG000|Overall Study|Withdrawal by Subject|2
7760325|NCT00807846|12200357|FG001|Overall Study|Withdrawal by Subject|1
7760326|NCT00807846|12200356|FG000|Overall Study|Other|1
7760327|NCT00807846|12200357|FG001|Overall Study|Other|2
7760328|NCT00807885|12200372|FG000|Overall Study|Lost to Follow-up|0
7760329|NCT00807885|12200373|FG001|Overall Study|Lost to Follow-up|0
7760330|NCT00807885|12200374|FG002|Overall Study|Lost to Follow-up|0
7760331|NCT00807885|12200375|FG003|Overall Study|Lost to Follow-up|0
7760332|NCT00807885|12200376|FG004|Overall Study|Lost to Follow-up|0
7760333|NCT00807885|12200377|FG005|Overall Study|Lost to Follow-up|1
7760334|NCT00807885|12200378|FG006|Overall Study|Lost to Follow-up|0
7760335|NCT00807885|12200379|FG007|Overall Study|Lost to Follow-up|0
7760336|NCT00807885|12200380|FG008|Overall Study|Lost to Follow-up|0
7760337|NCT00807937|12200404|FG000|Overall Study|Adverse Event|12
7760338|NCT00807937|12200405|FG001|Overall Study|Adverse Event|12
7760339|NCT00807937|12200406|FG002|Overall Study|Adverse Event|5
7760340|NCT00807937|12200407|FG003|Overall Study|Adverse Event|4
7760341|NCT00807937|12200404|FG000|Overall Study|Protocol Violation|4
7760342|NCT00807937|12200405|FG001|Overall Study|Protocol Violation|5
7760343|NCT00807937|12200406|FG002|Overall Study|Protocol Violation|3
7760344|NCT00807937|12200407|FG003|Overall Study|Protocol Violation|3
7760345|NCT00807937|12200404|FG000|Overall Study|Withdrawal by Subject|5
7760346|NCT00807937|12200405|FG001|Overall Study|Withdrawal by Subject|4
7760347|NCT00807937|12200406|FG002|Overall Study|Withdrawal by Subject|1
7760348|NCT00807937|12200407|FG003|Overall Study|Withdrawal by Subject|4
7760349|NCT00807937|12200404|FG000|Overall Study|Lost to Follow-up|4
7760350|NCT00807937|12200405|FG001|Overall Study|Lost to Follow-up|0
7760351|NCT00807937|12200406|FG002|Overall Study|Lost to Follow-up|2
7760352|NCT00807937|12200407|FG003|Overall Study|Lost to Follow-up|1
7760353|NCT00807937|12200404|FG000|Overall Study|Lack of Efficacy|0
7760354|NCT00807937|12200405|FG001|Overall Study|Lack of Efficacy|0
7760355|NCT00807937|12200406|FG002|Overall Study|Lack of Efficacy|1
7760356|NCT00807937|12200407|FG003|Overall Study|Lack of Efficacy|2
7770039|NCT00873860|12213904|FG000|Overall Study|Death|1
7760357|NCT00807937|12200404|FG000|Overall Study|Intake of prohibited medicine|0
7760358|NCT00807937|12200405|FG001|Overall Study|Intake of prohibited medicine|0
7760359|NCT00807937|12200406|FG002|Overall Study|Intake of prohibited medicine|2
7760360|NCT00807937|12200407|FG003|Overall Study|Intake of prohibited medicine|0
7760361|NCT00807937|12200404|FG000|Overall Study|All other reasons (not provided)|2
7760362|NCT00807937|12200405|FG001|Overall Study|All other reasons (not provided)|4
7760363|NCT00807937|12200406|FG002|Overall Study|All other reasons (not provided)|0
7760364|NCT00807937|12200407|FG003|Overall Study|All other reasons (not provided)|1
7760365|NCT00808015|12200426|FG000|Overall Study|Death|1
7760366|NCT00808015|12200426|FG000|Overall Study|Lack of Efficacy|58
7760367|NCT00808015|12200426|FG000|Overall Study|Lost to Follow-up|76
7760368|NCT00808015|12200426|FG000|Overall Study|Participants not willing to participate|158
7760369|NCT00808015|12200426|FG000|Overall Study|Adverse Event|22
7760370|NCT00808015|12200426|FG000|Overall Study|Other|25
7760371|NCT00808015|12200426|FG000|Overall Study|Enrolled but not treated|4
7760372|NCT00808028|12200434|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3
7760373|NCT00808028|12200435|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0
7760374|NCT00808028|12200436|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2
7760375|NCT00808028|12200437|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5
7760376|NCT00808028|12200434|FG000|Stage 1 (6 Months)|Other|1
7760377|NCT00808028|12200435|FG001|Stage 1 (6 Months)|Other|0
7760378|NCT00808028|12200436|FG002|Stage 1 (6 Months)|Other|2
7760379|NCT00808028|12200437|FG003|Stage 1 (6 Months)|Other|4
7760380|NCT00808028|12200434|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0
7760381|NCT00808028|12200435|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1
7760382|NCT00808028|12200436|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1
7760383|NCT00808028|12200437|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3
7760384|NCT00808028|12200434|FG000|Stage 1 (6 Months)|Adverse Event|0
7760385|NCT00808028|12200435|FG001|Stage 1 (6 Months)|Adverse Event|0
7760386|NCT00808028|12200436|FG002|Stage 1 (6 Months)|Adverse Event|1
7760387|NCT00808028|12200437|FG003|Stage 1 (6 Months)|Adverse Event|2
7760388|NCT00808028|12200434|FG000|Stage 1 (6 Months)|Lost to Follow-up|1
7760389|NCT00808028|12200435|FG001|Stage 1 (6 Months)|Lost to Follow-up|0
7760390|NCT00808028|12200436|FG002|Stage 1 (6 Months)|Lost to Follow-up|1
7760391|NCT00808028|12200437|FG003|Stage 1 (6 Months)|Lost to Follow-up|0
7760392|NCT00808028|12200434|FG000|Stage 1 (6 Months)|Protocol Violation|0
7760393|NCT00808028|12200435|FG001|Stage 1 (6 Months)|Protocol Violation|0
7760394|NCT00808028|12200436|FG002|Stage 1 (6 Months)|Protocol Violation|0
7760395|NCT00808028|12200437|FG003|Stage 1 (6 Months)|Protocol Violation|1
7760396|NCT00808028|12200434|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
7760397|NCT00808028|12200435|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
7760398|NCT00808028|12200436|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
7760399|NCT00808028|12200437|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
7760400|NCT00808028|12200434|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
7760401|NCT00808028|12200435|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
7760402|NCT00808028|12200436|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
7760403|NCT00808028|12200437|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
7760404|NCT00808028|12200434|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
7760405|NCT00808028|12200435|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
7760406|NCT00808028|12200436|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
7760407|NCT00808028|12200437|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
7760408|NCT00808028|12200434|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2
7760409|NCT00808028|12200435|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0
7760410|NCT00808028|12200436|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5
7760411|NCT00808028|12200437|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4
7760412|NCT00808028|12200434|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1
7760413|NCT00808028|12200435|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0
7760414|NCT00808028|12200436|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1
7760415|NCT00808028|12200437|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0
7760416|NCT00808028|12200434|FG000|Stage 2 (Followed up to 48 Months )|Other|0
7760417|NCT00808028|12200435|FG001|Stage 2 (Followed up to 48 Months )|Other|0
7760418|NCT00808028|12200436|FG002|Stage 2 (Followed up to 48 Months )|Other|1
7760419|NCT00808028|12200437|FG003|Stage 2 (Followed up to 48 Months )|Other|1
7760420|NCT00808028|12200434|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
7760421|NCT00808028|12200435|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
7760422|NCT00808028|12200436|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
7760423|NCT00808028|12200437|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
7760424|NCT00808028|12200434|FG000|Stage 2 (Followed up to 48 Months )|Death|0
7760425|NCT00808028|12200435|FG001|Stage 2 (Followed up to 48 Months )|Death|0
7760426|NCT00808028|12200436|FG002|Stage 2 (Followed up to 48 Months )|Death|1
7760427|NCT00808028|12200437|FG003|Stage 2 (Followed up to 48 Months )|Death|0
7760428|NCT00808028|12200434|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0
7760429|NCT00808028|12200435|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0
7760430|NCT00808028|12200436|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1
7760431|NCT00808028|12200437|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0
7760432|NCT00808067|12200459|FG000|Overall Study|Major/minor bleed|30
7760433|NCT00808067|12200460|FG001|Overall Study|Major/minor bleed|44
7760434|NCT00808067|12200459|FG000|Overall Study|Outcome event - other|33
7760435|NCT00808067|12200460|FG001|Overall Study|Outcome event - other|25
7760436|NCT00808067|12200459|FG000|Overall Study|Adverse Event|111
7760437|NCT00808067|12200460|FG001|Overall Study|Adverse Event|121
7760438|NCT00808067|12200459|FG000|Overall Study|Hospitalization (not including surgery)|18
7760439|NCT00808067|12200460|FG001|Overall Study|Hospitalization (not including surgery)|17
7760440|NCT00808067|12200459|FG000|Overall Study|Hospitalization due to surgery|37
7760441|NCT00808067|12200460|FG001|Overall Study|Hospitalization due to surgery|40
7760442|NCT00808067|12200459|FG000|Overall Study|Reduced creatinine clearance|53
7760443|NCT00808067|12200460|FG001|Overall Study|Reduced creatinine clearance|55
7760444|NCT00808067|12200459|FG000|Overall Study|Elevated LFT results|7
7760445|NCT00808067|12200460|FG001|Overall Study|Elevated LFT results|3
7760446|NCT00808067|12200459|FG000|Overall Study|Patient refused to take study medication|65
7760447|NCT00808067|12200460|FG001|Overall Study|Patient refused to take study medication|76
7760448|NCT00808067|12200459|FG000|Overall Study|Missing|1
7760449|NCT00808067|12200460|FG001|Overall Study|Missing|0
7760450|NCT00808067|12200459|FG000|Overall Study|Death|1
7760451|NCT00808067|12200460|FG001|Overall Study|Death|1
7760452|NCT00808067|12200459|FG000|Overall Study|Procedure|6
7760453|NCT00808067|12200460|FG001|Overall Study|Procedure|7
7760454|NCT00808067|12200459|FG000|Overall Study|Withdrawal by Subject|21
7760455|NCT00808067|12200460|FG001|Overall Study|Withdrawal by Subject|25
7760456|NCT00808067|12200459|FG000|Overall Study|Site closed|4
7760457|NCT00808067|12200460|FG001|Overall Study|Site closed|3
7760458|NCT00808067|12200459|FG000|Overall Study|Physician Decision|47
7760459|NCT00808067|12200460|FG001|Overall Study|Physician Decision|38
7760460|NCT00808067|12200459|FG000|Overall Study|Protocol Violation|3
7760461|NCT00808067|12200460|FG001|Overall Study|Protocol Violation|11
7760462|NCT00808067|12200459|FG000|Overall Study|Patient elected|7
7760463|NCT00808067|12200460|FG001|Overall Study|Patient elected|9
7760464|NCT00808067|12200459|FG000|Overall Study|Site closed for cause|19
7760465|NCT00808067|12200460|FG001|Overall Study|Site closed for cause|19
7760466|NCT00808067|12200459|FG000|Overall Study|Other reason not defined above|5
7760467|NCT00808067|12200460|FG001|Overall Study|Other reason not defined above|5
7760468|NCT00808067|12200459|FG000|Overall Study|Excluded from analysis|13
7760469|NCT00808067|12200460|FG001|Overall Study|Excluded from analysis|19
7760470|NCT00808132|12200471|FG000|Overall Study|Adverse Event|34
7760471|NCT00808132|12200472|FG001|Overall Study|Adverse Event|33
7760472|NCT00808132|12200473|FG002|Overall Study|Adverse Event|16
7760473|NCT00808132|12200474|FG003|Overall Study|Adverse Event|31
7760474|NCT00808132|12200475|FG004|Overall Study|Adverse Event|33
7760475|NCT00808132|12200471|FG000|Overall Study|Death|0
7760476|NCT00808132|12200472|FG001|Overall Study|Death|0
7760477|NCT00808132|12200473|FG002|Overall Study|Death|0
7760478|NCT00808132|12200474|FG003|Overall Study|Death|0
7760479|NCT00808132|12200475|FG004|Overall Study|Death|1
7760480|NCT00808132|12200471|FG000|Overall Study|Physician Decision|0
7760481|NCT00808132|12200472|FG001|Overall Study|Physician Decision|1
7760482|NCT00808132|12200473|FG002|Overall Study|Physician Decision|0
7760483|NCT00808132|12200474|FG003|Overall Study|Physician Decision|0
7760484|NCT00808132|12200475|FG004|Overall Study|Physician Decision|0
7760485|NCT00808132|12200471|FG000|Overall Study|Lost to Follow-up|8
7760486|NCT00808132|12200472|FG001|Overall Study|Lost to Follow-up|10
7760487|NCT00808132|12200473|FG002|Overall Study|Lost to Follow-up|11
7760488|NCT00808132|12200474|FG003|Overall Study|Lost to Follow-up|8
7760489|NCT00808132|12200475|FG004|Overall Study|Lost to Follow-up|9
7760490|NCT00808132|12200471|FG000|Overall Study|Protocol Violation|8
7760491|NCT00808132|12200472|FG001|Overall Study|Protocol Violation|9
7760492|NCT00808132|12200473|FG002|Overall Study|Protocol Violation|4
7760493|NCT00808132|12200474|FG003|Overall Study|Protocol Violation|9
7760494|NCT00808132|12200475|FG004|Overall Study|Protocol Violation|5
7760495|NCT00808132|12200471|FG000|Overall Study|Withdrawal by Subject|27
7760496|NCT00808132|12200472|FG001|Overall Study|Withdrawal by Subject|18
7760497|NCT00808132|12200473|FG002|Overall Study|Withdrawal by Subject|2
7760498|NCT00808132|12200474|FG003|Overall Study|Withdrawal by Subject|7
7760499|NCT00808132|12200475|FG004|Overall Study|Withdrawal by Subject|16
7760500|NCT00808132|12200471|FG000|Overall Study|Other|6
7760501|NCT00808132|12200472|FG001|Overall Study|Other|4
7760502|NCT00808132|12200473|FG002|Overall Study|Other|6
7760503|NCT00808132|12200474|FG003|Overall Study|Other|2
7760504|NCT00808132|12200475|FG004|Overall Study|Other|15
7760505|NCT00808132|12200471|FG000|Overall Study|Randomized, but not treated|10
7760506|NCT00808132|12200472|FG001|Overall Study|Randomized, but not treated|7
7760507|NCT00808132|12200473|FG002|Overall Study|Randomized, but not treated|9
7760508|NCT00808132|12200474|FG003|Overall Study|Randomized, but not treated|8
7760509|NCT00808132|12200475|FG004|Overall Study|Randomized, but not treated|9
7760510|NCT00808132|12200471|FG000|Overall Study|Unsatisfactory response|5
7760511|NCT00808132|12200472|FG001|Overall Study|Unsatisfactory response|6
7760512|NCT00808132|12200473|FG002|Overall Study|Unsatisfactory response|6
7760513|NCT00808132|12200474|FG003|Overall Study|Unsatisfactory response|4
7760514|NCT00808132|12200475|FG004|Overall Study|Unsatisfactory response|12
7760515|NCT00808210|12200489|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3
7760516|NCT00808210|12200490|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7
7760517|NCT00808210|12200489|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6
7760518|NCT00808210|12200490|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2
7760519|NCT00808210|12200489|FG000|Double-Blind TX Period|Adverse Event|0
7760520|NCT00808210|12200490|FG001|Double-Blind TX Period|Adverse Event|1
7760521|NCT00808210|12200489|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1
7760522|NCT00808210|12200490|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1
7760523|NCT00808210|12200489|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1
7760524|NCT00808210|12200490|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1
7760525|NCT00808210|12200489|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9
7760526|NCT00808210|12200490|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4
7760527|NCT00808236|12200498|FG000|Overall Study|Was not resuscitated|50
7760528|NCT00808236|12200499|FG001|Overall Study|Was not resuscitated|56
7760529|NCT00808236|12200498|FG000|Overall Study|Pre-defined exclusion|13
7760530|NCT00808236|12200499|FG001|Overall Study|Pre-defined exclusion|3
7760531|NCT00808236|12200498|FG000|Overall Study|Lost to Follow-up|1
7760532|NCT00808236|12200499|FG001|Overall Study|Lost to Follow-up|1
7760533|NCT00808236|12200498|FG000|Overall Study|Physician Decision|0
7760534|NCT00808236|12200499|FG001|Overall Study|Physician Decision|1
7760535|NCT00808236|12200498|FG000|Overall Study|Death|18
7760536|NCT00808236|12200499|FG001|Overall Study|Death|30
7760537|NCT00808249|12200509|FG000|Overall Study|Adverse Event|4
7760538|NCT00808249|12200510|FG001|Overall Study|Adverse Event|7
7760539|NCT00808249|12200511|FG002|Overall Study|Adverse Event|10
7760540|NCT00808249|12200512|FG003|Overall Study|Adverse Event|6
7760541|NCT00808249|12200509|FG000|Overall Study|Lost to Follow-up|2
7760542|NCT00808249|12200510|FG001|Overall Study|Lost to Follow-up|3
7760543|NCT00808249|12200511|FG002|Overall Study|Lost to Follow-up|3
7760544|NCT00808249|12200512|FG003|Overall Study|Lost to Follow-up|5
7760545|NCT00808249|12200509|FG000|Overall Study|Withdrawal by Subject|4
7760546|NCT00808249|12200510|FG001|Overall Study|Withdrawal by Subject|0
7760547|NCT00808249|12200511|FG002|Overall Study|Withdrawal by Subject|2
7760548|NCT00808249|12200512|FG003|Overall Study|Withdrawal by Subject|4
7760549|NCT00808249|12200509|FG000|Overall Study|Protocol Violation|3
7760550|NCT00808249|12200510|FG001|Overall Study|Protocol Violation|3
7760551|NCT00808249|12200511|FG002|Overall Study|Protocol Violation|3
7760552|NCT00808249|12200512|FG003|Overall Study|Protocol Violation|0
7760553|NCT00808249|12200509|FG000|Overall Study|Lack of Efficacy|1
7760554|NCT00808249|12200510|FG001|Overall Study|Lack of Efficacy|1
7760555|NCT00808249|12200511|FG002|Overall Study|Lack of Efficacy|0
7760556|NCT00808249|12200512|FG003|Overall Study|Lack of Efficacy|0
7760557|NCT00808249|12200509|FG000|Overall Study|study specific discontinuation criteria|1
7760558|NCT00808249|12200510|FG001|Overall Study|study specific discontinuation criteria|0
7760559|NCT00808249|12200511|FG002|Overall Study|study specific discontinuation criteria|1
7760560|NCT00808249|12200512|FG003|Overall Study|study specific discontinuation criteria|0
7760561|NCT00808249|12200509|FG000|Overall Study|All other reasons|2
7760562|NCT00808249|12200510|FG001|Overall Study|All other reasons|1
7760563|NCT00808249|12200511|FG002|Overall Study|All other reasons|3
7760564|NCT00808249|12200512|FG003|Overall Study|All other reasons|1
7760565|NCT00808444|12200546|FG000|Overall Study|Withdrawal by Subject|1
7760566|NCT00808444|12200547|FG001|Overall Study|Withdrawal by Subject|0
7760567|NCT00808444|12200546|FG000|Overall Study|Lost to Follow-up|0
7760568|NCT00808444|12200547|FG001|Overall Study|Lost to Follow-up|1
7760569|NCT00808483|12200568|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
7760570|NCT00808483|12200569|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
7760571|NCT00808483|12200568|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1
7760572|NCT00808483|12200569|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0
7760573|NCT00808483|12200568|FG000|From 5 Months to 12 Months|Lack of Efficacy|1
7760574|NCT00808483|12200569|FG001|From 5 Months to 12 Months|Lack of Efficacy|0
7760575|NCT00808509|12200584|FG000|Randomized Phase|Did not meet eligibility criteria|1
7760576|NCT00808509|12200585|FG001|Randomized Phase|Did not meet eligibility criteria|0
7962625|NCT02713204|12516860|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7760577|NCT00808509|12200584|FG000|Randomized Phase|Reduced methotrexate dose|1
7760578|NCT00808509|12200585|FG001|Randomized Phase|Reduced methotrexate dose|2
7760579|NCT00808509|12200584|FG000|Randomized Phase|Patient refused rescue therapy|0
7760580|NCT00808509|12200585|FG001|Randomized Phase|Patient refused rescue therapy|3
7760581|NCT00808639|12200593|FG000|Overall Study|Disease progression before surgery.|1
7760582|NCT00808665|12200599|FG000|Overall Study|Withdrawal by Subject|1
7760583|NCT00808665|12200600|FG001|Overall Study|Withdrawal by Subject|0
7760584|NCT00808665|12200599|FG000|Overall Study|only required minimally invasive surgery|1
7760585|NCT00808665|12200600|FG001|Overall Study|only required minimally invasive surgery|0
7760586|NCT00808665|12200599|FG000|Overall Study|surgery cancelled|1
7760587|NCT00808665|12200600|FG001|Overall Study|surgery cancelled|0
7760588|NCT00808665|12200599|FG000|Overall Study|required an additional procedure|0
7760589|NCT00808665|12200600|FG001|Overall Study|required an additional procedure|1
7760590|NCT00808665|12200599|FG000|Overall Study|Physician Decision|3
7760591|NCT00808665|12200600|FG001|Overall Study|Physician Decision|1
7760592|NCT00808665|12200599|FG000|Overall Study|Medication stopped by resident|0
7760593|NCT00808665|12200600|FG001|Overall Study|Medication stopped by resident|1
7760594|NCT00808808|12200609|FG000|Overall Study|Vaccinated; survey not completed|131
7760595|NCT00808808|12200610|FG001|Overall Study|Vaccinated; survey not completed|169
7760596|NCT00808808|12200611|FG002|Overall Study|Vaccinated; survey not completed|302
7760597|NCT00808808|12200609|FG000|Overall Study|Employee was not vaccinated.|2686
7760598|NCT00808808|12200610|FG001|Overall Study|Employee was not vaccinated.|2268
7760599|NCT00808808|12200611|FG002|Overall Study|Employee was not vaccinated.|2255
7760600|NCT00809094|12200643|FG000|Overall Study|Lost to Follow-up|0
7760601|NCT00809094|12200644|FG001|Overall Study|Lost to Follow-up|1
7760602|NCT00809133|12200664|FG000|Overall Study|Progressive disease|2
7760603|NCT00809133|12200665|FG001|Overall Study|Progressive disease|5
7760604|NCT00809133|12200666|FG002|Overall Study|Progressive disease|5
7760605|NCT00809133|12200667|FG003|Overall Study|Progressive disease|3
7760606|NCT00809133|12200668|FG004|Overall Study|Progressive disease|4
7760607|NCT00809133|12200669|FG005|Overall Study|Progressive disease|1
7760608|NCT00809133|12200670|FG006|Overall Study|Progressive disease|3
7760609|NCT00809133|12200671|FG007|Overall Study|Progressive disease|3
7760610|NCT00809133|12200672|FG008|Overall Study|Progressive disease|3
7760611|NCT00809133|12200673|FG009|Overall Study|Progressive disease|9
7760612|NCT00809133|12200674|FG010|Overall Study|Progressive disease|5
7760613|NCT00809133|12200675|FG011|Overall Study|Progressive disease|7
7760614|NCT00809133|12200676|FG012|Overall Study|Progressive disease|5
7760615|NCT00809133|12200677|FG013|Overall Study|Progressive disease|4
7760616|NCT00809133|12200664|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0
7760617|NCT00809133|12200665|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
7760618|NCT00809133|12200666|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0
7760619|NCT00809133|12200667|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
7760620|NCT00809133|12200668|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0
7760621|NCT00809133|12200669|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1
7760622|NCT00809133|12200670|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1
7760623|NCT00809133|12200671|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1
7760624|NCT00809133|12200672|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0
7760625|NCT00809133|12200673|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0
7760626|NCT00809133|12200674|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0
7760627|NCT00809133|12200675|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0
7760628|NCT00809133|12200676|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0
7760629|NCT00809133|12200677|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2
7760630|NCT00809133|12200664|FG000|Overall Study|Other adverse event|1
7760631|NCT00809133|12200665|FG001|Overall Study|Other adverse event|1
7760632|NCT00809133|12200666|FG002|Overall Study|Other adverse event|1
7760633|NCT00809133|12200667|FG003|Overall Study|Other adverse event|0
7760634|NCT00809133|12200668|FG004|Overall Study|Other adverse event|0
7760635|NCT00809133|12200669|FG005|Overall Study|Other adverse event|3
7760636|NCT00809133|12200670|FG006|Overall Study|Other adverse event|2
7760637|NCT00809133|12200671|FG007|Overall Study|Other adverse event|4
7760638|NCT00809133|12200672|FG008|Overall Study|Other adverse event|0
7760639|NCT00809133|12200673|FG009|Overall Study|Other adverse event|0
7760640|NCT00809133|12200674|FG010|Overall Study|Other adverse event|1
7962626|NCT02713204|12516853|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7760641|NCT00809133|12200675|FG011|Overall Study|Other adverse event|1
7760642|NCT00809133|12200676|FG012|Overall Study|Other adverse event|0
7760643|NCT00809133|12200677|FG013|Overall Study|Other adverse event|1
7760644|NCT00809133|12200664|FG000|Overall Study|Lost to Follow-up|0
7760645|NCT00809133|12200665|FG001|Overall Study|Lost to Follow-up|0
7760646|NCT00809133|12200666|FG002|Overall Study|Lost to Follow-up|0
7760647|NCT00809133|12200667|FG003|Overall Study|Lost to Follow-up|0
7760648|NCT00809133|12200668|FG004|Overall Study|Lost to Follow-up|0
7760649|NCT00809133|12200669|FG005|Overall Study|Lost to Follow-up|1
7760650|NCT00809133|12200670|FG006|Overall Study|Lost to Follow-up|0
7760651|NCT00809133|12200671|FG007|Overall Study|Lost to Follow-up|0
7760652|NCT00809133|12200672|FG008|Overall Study|Lost to Follow-up|0
7760653|NCT00809133|12200673|FG009|Overall Study|Lost to Follow-up|0
7760654|NCT00809133|12200674|FG010|Overall Study|Lost to Follow-up|0
7760655|NCT00809133|12200675|FG011|Overall Study|Lost to Follow-up|0
7760656|NCT00809133|12200676|FG012|Overall Study|Lost to Follow-up|0
7760657|NCT00809133|12200677|FG013|Overall Study|Lost to Follow-up|0
7760658|NCT00809133|12200664|FG000|Overall Study|Consent withdrawn|0
7760659|NCT00809133|12200665|FG001|Overall Study|Consent withdrawn|0
7760660|NCT00809133|12200666|FG002|Overall Study|Consent withdrawn|0
7760661|NCT00809133|12200667|FG003|Overall Study|Consent withdrawn|0
7760662|NCT00809133|12200668|FG004|Overall Study|Consent withdrawn|1
7760663|NCT00809133|12200669|FG005|Overall Study|Consent withdrawn|0
7760664|NCT00809133|12200670|FG006|Overall Study|Consent withdrawn|0
7760665|NCT00809133|12200671|FG007|Overall Study|Consent withdrawn|0
7760666|NCT00809133|12200672|FG008|Overall Study|Consent withdrawn|0
7760667|NCT00809133|12200673|FG009|Overall Study|Consent withdrawn|0
7760668|NCT00809133|12200674|FG010|Overall Study|Consent withdrawn|0
7760669|NCT00809133|12200675|FG011|Overall Study|Consent withdrawn|0
7760670|NCT00809133|12200676|FG012|Overall Study|Consent withdrawn|0
7760671|NCT00809133|12200677|FG013|Overall Study|Consent withdrawn|0
7760672|NCT00809133|12200664|FG000|Overall Study|Other not mentioned above|0
7760673|NCT00809133|12200665|FG001|Overall Study|Other not mentioned above|1
7760674|NCT00809133|12200666|FG002|Overall Study|Other not mentioned above|0
7760675|NCT00809133|12200667|FG003|Overall Study|Other not mentioned above|0
7760676|NCT00809133|12200668|FG004|Overall Study|Other not mentioned above|0
7760677|NCT00809133|12200669|FG005|Overall Study|Other not mentioned above|1
7760678|NCT00809133|12200670|FG006|Overall Study|Other not mentioned above|0
7760679|NCT00809133|12200671|FG007|Overall Study|Other not mentioned above|0
7760680|NCT00809133|12200672|FG008|Overall Study|Other not mentioned above|0
7760681|NCT00809133|12200673|FG009|Overall Study|Other not mentioned above|0
7760682|NCT00809133|12200674|FG010|Overall Study|Other not mentioned above|0
7760683|NCT00809133|12200675|FG011|Overall Study|Other not mentioned above|0
7760684|NCT00809133|12200676|FG012|Overall Study|Other not mentioned above|0
7760685|NCT00809133|12200677|FG013|Overall Study|Other not mentioned above|0
7760686|NCT00809159|12200733|FG000|Part 1|Adverse Event|1
7760687|NCT00809159|12200734|FG001|Part 1|Adverse Event|1
7760688|NCT00809159|12200735|FG002|Part 1|Adverse Event|0
7760689|NCT00809159|12200736|FG003|Part 1|Adverse Event|0
7760690|NCT00809159|12200737|FG004|Part 1|Adverse Event|0
7760691|NCT00809159|12200738|FG005|Part 1|Adverse Event|0
7760692|NCT00809159|12200733|FG000|Part 1|Lost to Follow-up|1
7760693|NCT00809159|12200734|FG001|Part 1|Lost to Follow-up|0
7760694|NCT00809159|12200735|FG002|Part 1|Lost to Follow-up|0
7760695|NCT00809159|12200736|FG003|Part 1|Lost to Follow-up|0
7760696|NCT00809159|12200737|FG004|Part 1|Lost to Follow-up|0
7760697|NCT00809159|12200738|FG005|Part 1|Lost to Follow-up|0
7760698|NCT00809159|12200733|FG000|Part 1|Withdrawal by Subject|3
7760699|NCT00809159|12200734|FG001|Part 1|Withdrawal by Subject|1
7760700|NCT00809159|12200735|FG002|Part 1|Withdrawal by Subject|0
7760701|NCT00809159|12200736|FG003|Part 1|Withdrawal by Subject|0
7760702|NCT00809159|12200737|FG004|Part 1|Withdrawal by Subject|0
7760703|NCT00809159|12200738|FG005|Part 1|Withdrawal by Subject|0
7760704|NCT00809159|12200733|FG000|Part 1|Unsatisfactory therapeutic effect|3
7760705|NCT00809159|12200734|FG001|Part 1|Unsatisfactory therapeutic effect|1
7760706|NCT00809159|12200735|FG002|Part 1|Unsatisfactory therapeutic effect|0
7760707|NCT00809159|12200736|FG003|Part 1|Unsatisfactory therapeutic effect|0
7760708|NCT00809159|12200737|FG004|Part 1|Unsatisfactory therapeutic effect|0
7760709|NCT00809159|12200738|FG005|Part 1|Unsatisfactory therapeutic effect|0
7760710|NCT00809159|12200733|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0
7760711|NCT00809159|12200734|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0
7760712|NCT00809159|12200735|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4
7760713|NCT00809159|12200736|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3
7760714|NCT00809159|12200737|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5
7760715|NCT00809159|12200738|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1
7760716|NCT00809159|12200733|FG000|Part 1 and 2|Administrative problems|0
7760717|NCT00809159|12200734|FG001|Part 1 and 2|Administrative problems|0
7760718|NCT00809159|12200735|FG002|Part 1 and 2|Administrative problems|0
7760719|NCT00809159|12200736|FG003|Part 1 and 2|Administrative problems|1
7760720|NCT00809159|12200737|FG004|Part 1 and 2|Administrative problems|0
7760721|NCT00809159|12200738|FG005|Part 1 and 2|Administrative problems|0
7760722|NCT00809159|12200733|FG000|Part 1 and 2|Adverse Event|0
7760723|NCT00809159|12200734|FG001|Part 1 and 2|Adverse Event|0
7760724|NCT00809159|12200735|FG002|Part 1 and 2|Adverse Event|1
7760725|NCT00809159|12200736|FG003|Part 1 and 2|Adverse Event|0
7760726|NCT00809159|12200737|FG004|Part 1 and 2|Adverse Event|1
7760727|NCT00809159|12200738|FG005|Part 1 and 2|Adverse Event|1
7760728|NCT00809159|12200733|FG000|Part 1 and 2|Lost to Follow-up|0
7760729|NCT00809159|12200734|FG001|Part 1 and 2|Lost to Follow-up|0
7760730|NCT00809159|12200735|FG002|Part 1 and 2|Lost to Follow-up|1
7760731|NCT00809159|12200736|FG003|Part 1 and 2|Lost to Follow-up|1
7760732|NCT00809159|12200737|FG004|Part 1 and 2|Lost to Follow-up|0
7760733|NCT00809159|12200738|FG005|Part 1 and 2|Lost to Follow-up|0
7760734|NCT00809159|12200733|FG000|Part 1 and 2|Withdrawal by Subject|0
7760735|NCT00809159|12200734|FG001|Part 1 and 2|Withdrawal by Subject|0
7760736|NCT00809159|12200735|FG002|Part 1 and 2|Withdrawal by Subject|4
7760737|NCT00809159|12200736|FG003|Part 1 and 2|Withdrawal by Subject|0
7760738|NCT00809159|12200737|FG004|Part 1 and 2|Withdrawal by Subject|0
7760739|NCT00809159|12200738|FG005|Part 1 and 2|Withdrawal by Subject|1
7760740|NCT00809328|12200761|FG000|Overall Study|Lack of Efficacy|18
7760741|NCT00809328|12200761|FG000|Overall Study|Adverse Event|6
7760742|NCT00809328|12200761|FG000|Overall Study|Protocol Violation|3
7760743|NCT00809328|12200761|FG000|Overall Study|Withdrawal by Subject|2
7760744|NCT00809354|12200775|FG000|Overall Study|Adverse Event|32
7760745|NCT00809354|12200776|FG001|Overall Study|Adverse Event|45
7760746|NCT00809354|12200777|FG002|Overall Study|Adverse Event|37
7760747|NCT00809354|12200778|FG003|Overall Study|Adverse Event|53
7760748|NCT00809354|12200779|FG004|Overall Study|Adverse Event|26
7760749|NCT00809354|12200780|FG005|Overall Study|Adverse Event|33
7760750|NCT00809354|12200781|FG006|Overall Study|Adverse Event|44
7760751|NCT00809354|12200782|FG007|Overall Study|Adverse Event|40
7760752|NCT00809354|12200783|FG008|Overall Study|Adverse Event|46
7760753|NCT00809354|12200784|FG009|Overall Study|Adverse Event|26
7760754|NCT00809354|12200775|FG000|Overall Study|Lack of Efficacy|23
7760755|NCT00809354|12200776|FG001|Overall Study|Lack of Efficacy|23
7760756|NCT00809354|12200777|FG002|Overall Study|Lack of Efficacy|22
7760757|NCT00809354|12200778|FG003|Overall Study|Lack of Efficacy|15
7760758|NCT00809354|12200779|FG004|Overall Study|Lack of Efficacy|40
7760759|NCT00809354|12200780|FG005|Overall Study|Lack of Efficacy|19
7760760|NCT00809354|12200781|FG006|Overall Study|Lack of Efficacy|21
7760761|NCT00809354|12200782|FG007|Overall Study|Lack of Efficacy|15
7760762|NCT00809354|12200783|FG008|Overall Study|Lack of Efficacy|18
7760763|NCT00809354|12200784|FG009|Overall Study|Lack of Efficacy|38
7760764|NCT00809354|12200775|FG000|Overall Study|Lost to Follow-up|10
7760765|NCT00809354|12200776|FG001|Overall Study|Lost to Follow-up|11
7760766|NCT00809354|12200777|FG002|Overall Study|Lost to Follow-up|8
7760767|NCT00809354|12200778|FG003|Overall Study|Lost to Follow-up|13
7760768|NCT00809354|12200779|FG004|Overall Study|Lost to Follow-up|6
7760769|NCT00809354|12200780|FG005|Overall Study|Lost to Follow-up|2
7760770|NCT00809354|12200781|FG006|Overall Study|Lost to Follow-up|0
7760771|NCT00809354|12200782|FG007|Overall Study|Lost to Follow-up|5
7760772|NCT00809354|12200783|FG008|Overall Study|Lost to Follow-up|4
7760773|NCT00809354|12200784|FG009|Overall Study|Lost to Follow-up|0
7760774|NCT00809354|12200775|FG000|Overall Study|Protocol Violation|7
7760775|NCT00809354|12200776|FG001|Overall Study|Protocol Violation|14
7760776|NCT00809354|12200777|FG002|Overall Study|Protocol Violation|14
7760777|NCT00809354|12200778|FG003|Overall Study|Protocol Violation|12
7760778|NCT00809354|12200779|FG004|Overall Study|Protocol Violation|14
7760779|NCT00809354|12200780|FG005|Overall Study|Protocol Violation|6
7760780|NCT00809354|12200781|FG006|Overall Study|Protocol Violation|4
7760781|NCT00809354|12200782|FG007|Overall Study|Protocol Violation|6
7760782|NCT00809354|12200783|FG008|Overall Study|Protocol Violation|9
7760783|NCT00809354|12200784|FG009|Overall Study|Protocol Violation|3
7760784|NCT00809354|12200775|FG000|Overall Study|Withdrawal by Subject|32
7760785|NCT00809354|12200776|FG001|Overall Study|Withdrawal by Subject|27
7760786|NCT00809354|12200777|FG002|Overall Study|Withdrawal by Subject|31
7760787|NCT00809354|12200778|FG003|Overall Study|Withdrawal by Subject|33
7760788|NCT00809354|12200779|FG004|Overall Study|Withdrawal by Subject|34
7760789|NCT00809354|12200780|FG005|Overall Study|Withdrawal by Subject|29
7760790|NCT00809354|12200781|FG006|Overall Study|Withdrawal by Subject|27
7760791|NCT00809354|12200782|FG007|Overall Study|Withdrawal by Subject|19
7760792|NCT00809354|12200783|FG008|Overall Study|Withdrawal by Subject|18
7760793|NCT00809354|12200784|FG009|Overall Study|Withdrawal by Subject|20
7760794|NCT00809354|12200775|FG000|Overall Study|Other|10
7760795|NCT00809354|12200776|FG001|Overall Study|Other|2
7760796|NCT00809354|12200777|FG002|Overall Study|Other|7
7760797|NCT00809354|12200778|FG003|Overall Study|Other|10
7760798|NCT00809354|12200779|FG004|Overall Study|Other|5
7760799|NCT00809354|12200780|FG005|Overall Study|Other|3
7760800|NCT00809354|12200781|FG006|Overall Study|Other|2
7760801|NCT00809354|12200782|FG007|Overall Study|Other|3
7760802|NCT00809354|12200783|FG008|Overall Study|Other|4
7760803|NCT00809354|12200784|FG009|Overall Study|Other|3
7760804|NCT00809354|12200775|FG000|Overall Study|Study terminated by sponsor|138
7760805|NCT00809354|12200776|FG001|Overall Study|Study terminated by sponsor|134
7760806|NCT00809354|12200777|FG002|Overall Study|Study terminated by sponsor|129
7760807|NCT00809354|12200778|FG003|Overall Study|Study terminated by sponsor|120
7760808|NCT00809354|12200779|FG004|Overall Study|Study terminated by sponsor|126
7760809|NCT00809354|12200780|FG005|Overall Study|Study terminated by sponsor|133
7760810|NCT00809354|12200781|FG006|Overall Study|Study terminated by sponsor|124
7760811|NCT00809354|12200782|FG007|Overall Study|Study terminated by sponsor|148
7760812|NCT00809354|12200783|FG008|Overall Study|Study terminated by sponsor|127
7760813|NCT00809354|12200784|FG009|Overall Study|Study terminated by sponsor|135
7760814|NCT00809354|12200775|FG000|Overall Study|Withdrawn due to pregnancy|0
7760815|NCT00809354|12200776|FG001|Overall Study|Withdrawn due to pregnancy|1
7760816|NCT00809354|12200777|FG002|Overall Study|Withdrawn due to pregnancy|0
7760817|NCT00809354|12200778|FG003|Overall Study|Withdrawn due to pregnancy|0
7760818|NCT00809354|12200779|FG004|Overall Study|Withdrawn due to pregnancy|0
7760819|NCT00809354|12200780|FG005|Overall Study|Withdrawn due to pregnancy|0
7760820|NCT00809354|12200781|FG006|Overall Study|Withdrawn due to pregnancy|0
7760821|NCT00809354|12200782|FG007|Overall Study|Withdrawn due to pregnancy|0
7760822|NCT00809354|12200783|FG008|Overall Study|Withdrawn due to pregnancy|0
7760823|NCT00809354|12200784|FG009|Overall Study|Withdrawn due to pregnancy|0
7760824|NCT00809354|12200775|FG000|Overall Study|Randomized but not Treated|3
7760825|NCT00809354|12200776|FG001|Overall Study|Randomized but not Treated|1
7760826|NCT00809354|12200777|FG002|Overall Study|Randomized but not Treated|6
7760827|NCT00809354|12200778|FG003|Overall Study|Randomized but not Treated|0
7760828|NCT00809354|12200779|FG004|Overall Study|Randomized but not Treated|5
7760829|NCT00809354|12200780|FG005|Overall Study|Randomized but not Treated|0
7760830|NCT00809354|12200781|FG006|Overall Study|Randomized but not Treated|1
7760831|NCT00809354|12200782|FG007|Overall Study|Randomized but not Treated|1
7760832|NCT00809354|12200783|FG008|Overall Study|Randomized but not Treated|2
7760833|NCT00809354|12200784|FG009|Overall Study|Randomized but not Treated|1
7760834|NCT00809354|12200775|FG000|Overall Study|Death|0
7760835|NCT00809354|12200776|FG001|Overall Study|Death|0
7760836|NCT00809354|12200777|FG002|Overall Study|Death|0
7760837|NCT00809354|12200778|FG003|Overall Study|Death|0
7760838|NCT00809354|12200779|FG004|Overall Study|Death|0
7760839|NCT00809354|12200780|FG005|Overall Study|Death|0
7760840|NCT00809354|12200781|FG006|Overall Study|Death|0
7760841|NCT00809354|12200782|FG007|Overall Study|Death|1
7760842|NCT00809354|12200783|FG008|Overall Study|Death|0
7760843|NCT00809354|12200784|FG009|Overall Study|Death|0
7760844|NCT00809445|12200814|FG000|1 Month Follow-up|Lost contact|1
7760845|NCT00809445|12200815|FG001|1 Month Follow-up|Lost contact|2
7760846|NCT00809445|12200816|FG002|1 Month Follow-up|Lost contact|1
7760847|NCT00809445|12200814|FG000|1 Month Follow-up|Withdrew consent|1
7760848|NCT00809445|12200815|FG001|1 Month Follow-up|Withdrew consent|1
7760849|NCT00809445|12200816|FG002|1 Month Follow-up|Withdrew consent|1
7760850|NCT00809445|12200814|FG000|1 Month Follow-up|Death|0
7760851|NCT00809445|12200815|FG001|1 Month Follow-up|Death|1
7760852|NCT00809445|12200816|FG002|1 Month Follow-up|Death|1
7760853|NCT00809445|12200814|FG000|1 Month Follow-up|Incarcerated|0
7760854|NCT00809445|12200815|FG001|1 Month Follow-up|Incarcerated|0
7760855|NCT00809445|12200816|FG002|1 Month Follow-up|Incarcerated|1
7760856|NCT00809445|12200814|FG000|6 Month Follow-up|Lost contact|16
7760857|NCT00809445|12200815|FG001|6 Month Follow-up|Lost contact|14
7760858|NCT00809445|12200816|FG002|6 Month Follow-up|Lost contact|14
7760859|NCT00809445|12200814|FG000|6 Month Follow-up|Death|2
7760860|NCT00809445|12200815|FG001|6 Month Follow-up|Death|1
7760861|NCT00809445|12200816|FG002|6 Month Follow-up|Death|1
7760862|NCT00809445|12200814|FG000|6 Month Follow-up|Incarcerated|6
7760863|NCT00809445|12200815|FG001|6 Month Follow-up|Incarcerated|8
7760864|NCT00809445|12200816|FG002|6 Month Follow-up|Incarcerated|8
7760865|NCT00809445|12200814|FG000|6 Month Follow-up|Withdrew consent|0
7760866|NCT00809445|12200815|FG001|6 Month Follow-up|Withdrew consent|0
7760867|NCT00809445|12200816|FG002|6 Month Follow-up|Withdrew consent|1
7760868|NCT00809471|12200827|FG000|Overall Study|Protocol non-compliance|15
7760869|NCT00809471|12200828|FG001|Overall Study|Protocol non-compliance|15
7760870|NCT00809471|12200829|FG002|Overall Study|Protocol non-compliance|6
7760871|NCT00809471|12200827|FG000|Overall Study|Lost to Follow-up|4
7760872|NCT00809471|12200828|FG001|Overall Study|Lost to Follow-up|2
7760873|NCT00809471|12200829|FG002|Overall Study|Lost to Follow-up|9
7760874|NCT00809471|12200827|FG000|Overall Study|Adverse Event|0
7760875|NCT00809471|12200828|FG001|Overall Study|Adverse Event|2
7760876|NCT00809471|12200829|FG002|Overall Study|Adverse Event|2
7760877|NCT00809471|12200827|FG000|Overall Study|Requirement for restricted medication|1
7760878|NCT00809471|12200828|FG001|Overall Study|Requirement for restricted medication|1
7760879|NCT00809471|12200829|FG002|Overall Study|Requirement for restricted medication|0
7760880|NCT00809614|12200848|FG000|Overall Study|Lack of Efficacy|2
7760881|NCT00809614|12200849|FG001|Overall Study|Lack of Efficacy|3
7760882|NCT00809614|12200848|FG000|Overall Study|Withdrawal by Subject|1
7760883|NCT00809614|12200849|FG001|Overall Study|Withdrawal by Subject|1
7760884|NCT00809757|12200858|FG000|Overall Study|Adverse Event|2
7760885|NCT00809757|12200859|FG001|Overall Study|Adverse Event|3
7760886|NCT00809757|12200860|FG002|Overall Study|Adverse Event|3
7760887|NCT00809757|12200858|FG000|Overall Study|Lost to Follow-up|0
7760888|NCT00809757|12200859|FG001|Overall Study|Lost to Follow-up|0
7760889|NCT00809757|12200860|FG002|Overall Study|Lost to Follow-up|1
7760890|NCT00809757|12200858|FG000|Overall Study|Protocol Violation|1
7760891|NCT00809757|12200859|FG001|Overall Study|Protocol Violation|1
7760892|NCT00809757|12200860|FG002|Overall Study|Protocol Violation|1
7760893|NCT00809757|12200858|FG000|Overall Study|Withdrawal by Subject|2
7760894|NCT00809757|12200859|FG001|Overall Study|Withdrawal by Subject|1
7760895|NCT00809757|12200860|FG002|Overall Study|Withdrawal by Subject|3
7760896|NCT00809757|12200858|FG000|Overall Study|Subject Uncooperative|1
7760897|NCT00809757|12200859|FG001|Overall Study|Subject Uncooperative|0
7760898|NCT00809757|12200860|FG002|Overall Study|Subject Uncooperative|2
7760899|NCT00809757|12200858|FG000|Overall Study|Noncompliance with Medication|0
7760900|NCT00809757|12200859|FG001|Overall Study|Noncompliance with Medication|0
7760901|NCT00809757|12200860|FG002|Overall Study|Noncompliance with Medication|1
7760902|NCT00809783|12200877|FG000|Overall Study|Death|1
7760903|NCT00809783|12200878|FG001|Overall Study|Death|0
7760904|NCT00809783|12200879|FG002|Overall Study|Death|0
7760905|NCT00809783|12200877|FG000|Overall Study|Adverse Event|34
7760906|NCT00809783|12200878|FG001|Overall Study|Adverse Event|52
7760907|NCT00809783|12200879|FG002|Overall Study|Adverse Event|71
7760908|NCT00809783|12200877|FG000|Overall Study|Lack of Efficacy|39
7760909|NCT00809783|12200878|FG001|Overall Study|Lack of Efficacy|52
7760910|NCT00809783|12200879|FG002|Overall Study|Lack of Efficacy|63
7760911|NCT00809783|12200877|FG000|Overall Study|Lost to Follow-up|0
7760912|NCT00809783|12200878|FG001|Overall Study|Lost to Follow-up|3
7760913|NCT00809783|12200879|FG002|Overall Study|Lost to Follow-up|4
7760914|NCT00809783|12200877|FG000|Overall Study|Withdrawal by Subject|47
7760915|NCT00809783|12200878|FG001|Overall Study|Withdrawal by Subject|72
7760916|NCT00809783|12200879|FG002|Overall Study|Withdrawal by Subject|64
7760917|NCT00809783|12200877|FG000|Overall Study|Protocol Violation|2
7760918|NCT00809783|12200878|FG001|Overall Study|Protocol Violation|6
7760919|NCT00809783|12200879|FG002|Overall Study|Protocol Violation|5
7760920|NCT00809783|12200877|FG000|Overall Study|Randomized, but not treated|3
7760921|NCT00809783|12200878|FG001|Overall Study|Randomized, but not treated|0
7760922|NCT00809783|12200879|FG002|Overall Study|Randomized, but not treated|2
7760923|NCT00809783|12200877|FG000|Overall Study|Study Terminated by Sponsor|378
7760924|NCT00809783|12200878|FG001|Overall Study|Study Terminated by Sponsor|626
7760925|NCT00809783|12200879|FG002|Overall Study|Study Terminated by Sponsor|565
7760926|NCT00809783|12200877|FG000|Overall Study|Other|21
7760927|NCT00809783|12200878|FG001|Overall Study|Other|21
7760928|NCT00809783|12200879|FG002|Overall Study|Other|16
7760929|NCT00809835|12200900|FG000|Overall Study|Lost to Follow-up|7
7760930|NCT00809835|12200901|FG001|Overall Study|Lost to Follow-up|6
7760931|NCT00809835|12200902|FG002|Overall Study|Lost to Follow-up|10
7760932|NCT00809835|12200903|FG003|Overall Study|Lost to Follow-up|2
7760933|NCT00809835|12200900|FG000|Overall Study|Withdrawal by Subject|1
7760934|NCT00809835|12200901|FG001|Overall Study|Withdrawal by Subject|1
7760935|NCT00809835|12200902|FG002|Overall Study|Withdrawal by Subject|1
7760936|NCT00809835|12200903|FG003|Overall Study|Withdrawal by Subject|0
7760937|NCT00809926|12200937|FG000|Overall Study|Adverse Event|18
7760938|NCT00809926|12200938|FG001|Overall Study|Adverse Event|10
7760939|NCT00809926|12200937|FG000|Overall Study|Unsatisfactory therapeutic effect|3
7760940|NCT00809926|12200938|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7760941|NCT00809926|12200937|FG000|Overall Study|Patient withdrew consent|8
7760942|NCT00809926|12200938|FG001|Overall Study|Patient withdrew consent|6
7760943|NCT00809926|12200937|FG000|Overall Study|Lost to Follow-up|2
7760944|NCT00809926|12200938|FG001|Overall Study|Lost to Follow-up|1
7760945|NCT00809926|12200937|FG000|Overall Study|Administrative Problems|0
7760946|NCT00809926|12200938|FG001|Overall Study|Administrative Problems|1
7760947|NCT00809926|12200937|FG000|Overall Study|Protocol deviation|0
7760948|NCT00809926|12200938|FG001|Overall Study|Protocol deviation|2
7760949|NCT00809965|12200947|FG000|Overall Study|Death|194
7760950|NCT00809965|12200948|FG001|Overall Study|Death|147
7760951|NCT00809965|12200949|FG002|Overall Study|Death|196
7760952|NCT00809965|12200947|FG000|Overall Study|Lost to Follow-up|17
7760953|NCT00809965|12200948|FG001|Overall Study|Lost to Follow-up|10
7760954|NCT00809965|12200949|FG002|Overall Study|Lost to Follow-up|18
7760955|NCT00809965|12200947|FG000|Overall Study|Withdrawal by Subject|405
7760956|NCT00809965|12200948|FG001|Overall Study|Withdrawal by Subject|448
7760957|NCT00809965|12200949|FG002|Overall Study|Withdrawal by Subject|441
7760958|NCT00809965|12200947|FG000|Overall Study|Other Reason|167
7760959|NCT00809965|12200948|FG001|Overall Study|Other Reason|170
7760960|NCT00809965|12200949|FG002|Overall Study|Other Reason|189
7760961|NCT00810043|12200959|FG000|Overall Study|Withdrawal by Subject|1
7760962|NCT00810043|12200960|FG001|Overall Study|Withdrawal by Subject|0
7760963|NCT00810043|12200961|FG002|Overall Study|Withdrawal by Subject|2
7760964|NCT00810043|12200959|FG000|Overall Study|Lost to Follow-up|1
7760965|NCT00810043|12200960|FG001|Overall Study|Lost to Follow-up|0
7760966|NCT00810043|12200961|FG002|Overall Study|Lost to Follow-up|0
7760967|NCT00810043|12200959|FG000|Overall Study|Physician Decision|0
7760968|NCT00810043|12200960|FG001|Overall Study|Physician Decision|0
7760969|NCT00810043|12200961|FG002|Overall Study|Physician Decision|2
7760970|NCT00810043|12200959|FG000|Overall Study|Death|2
7760971|NCT00810043|12200960|FG001|Overall Study|Death|0
7760972|NCT00810043|12200961|FG002|Overall Study|Death|0
7760973|NCT00810043|12200959|FG000|Overall Study|Unrelated medical problem|0
7760974|NCT00810043|12200960|FG001|Overall Study|Unrelated medical problem|1
7760975|NCT00810043|12200961|FG002|Overall Study|Unrelated medical problem|0
7760976|NCT00810043|12200959|FG000|Overall Study|Non-medical problem|0
7760977|NCT00810043|12200960|FG001|Overall Study|Non-medical problem|0
7760978|NCT00810043|12200961|FG002|Overall Study|Non-medical problem|1
7760979|NCT00810043|12200959|FG000|Overall Study|No longer met enrollment criteria|0
7760980|NCT00810043|12200960|FG001|Overall Study|No longer met enrollment criteria|0
7760981|NCT00810043|12200961|FG002|Overall Study|No longer met enrollment criteria|3
7770040|NCT00873860|12213905|FG001|Overall Study|Death|0
7770041|NCT00873860|12213906|FG002|Overall Study|Death|0
7770042|NCT00873860|12213907|FG003|Overall Study|Death|0
7770043|NCT00873860|12213904|FG000|Overall Study|Other|1
7770044|NCT00873860|12213905|FG001|Overall Study|Other|0
7770045|NCT00873860|12213906|FG002|Overall Study|Other|1
7770046|NCT00873860|12213907|FG003|Overall Study|Other|0
7770047|NCT00873912|12213939|FG000|Overall Study|Withdrawal by Subject|1
7770048|NCT00873912|12213940|FG001|Overall Study|Withdrawal by Subject|0
7770049|NCT00873912|12213939|FG000|Overall Study|Lost to Follow-up|2
7770050|NCT00873912|12213940|FG001|Overall Study|Lost to Follow-up|0
7770051|NCT00874029|12213946|FG000|Overall Study|Withdrawal by Subject|10
7770052|NCT00874029|12213946|FG000|Overall Study|Pregnancy|4
7770053|NCT00874029|12213946|FG000|Overall Study|Physician Decision|1
7770054|NCT00874029|12213946|FG000|Overall Study|Adverse Event|1
7770055|NCT00874029|12213946|FG000|Overall Study|Lost to Follow-up|5
7770056|NCT00874120|12213966|FG000|First Intervention|Adverse Event|0
7770057|NCT00874120|12213967|FG001|First Intervention|Adverse Event|1
7770058|NCT00874120|12213966|FG000|First Intervention|Withdrawal by Subject|2
7770059|NCT00874120|12213967|FG001|First Intervention|Withdrawal by Subject|0
7770060|NCT00874120|12213966|FG000|First Intervention|Lost to Follow-up|0
7770061|NCT00874120|12213967|FG001|First Intervention|Lost to Follow-up|1
7770062|NCT00874120|12213966|FG000|First Intervention|Protocol Violation|3
7770063|NCT00874120|12213967|FG001|First Intervention|Protocol Violation|0
7770064|NCT00874120|12213966|FG000|First Intervention|positive drug test|1
7770065|NCT00874120|12213967|FG001|First Intervention|positive drug test|0
7770066|NCT00874120|12213966|FG000|Second Intervention|Withdrawal by Subject|1
7770067|NCT00874120|12213967|FG001|Second Intervention|Withdrawal by Subject|0
7770068|NCT00874120|12213966|FG000|Second Intervention|Protocol Violation|1
7770069|NCT00874120|12213967|FG001|Second Intervention|Protocol Violation|0
7770070|NCT00874237|12213973|FG000|Overall Study|Physician Decision|0
7770071|NCT00874237|12213974|FG001|Overall Study|Physician Decision|1
7770072|NCT00874237|12213975|FG002|Overall Study|Physician Decision|0
7770073|NCT00874237|12213976|FG003|Overall Study|Physician Decision|0
7770074|NCT00874237|12213977|FG004|Overall Study|Physician Decision|0
7770075|NCT00874237|12213978|FG005|Overall Study|Physician Decision|0
7770076|NCT00874237|12213973|FG000|Overall Study|Withdrawal by Subject|0
7770077|NCT00874237|12213974|FG001|Overall Study|Withdrawal by Subject|0
7760982|NCT00810069|12200972|FG000|Lead-in Period I|Adverse Event|43
7760983|NCT00810069|12200973|FG001|Lead-in Period I|Adverse Event|0
7760984|NCT00810069|12200974|FG002|Lead-in Period I|Adverse Event|0
7760985|NCT00810069|12200972|FG000|Lead-in Period I|Lack of Efficacy|1
7760986|NCT00810069|12200973|FG001|Lead-in Period I|Lack of Efficacy|0
7760987|NCT00810069|12200974|FG002|Lead-in Period I|Lack of Efficacy|0
7760988|NCT00810069|12200972|FG000|Lead-in Period I|Lost to Follow-up|19
7760989|NCT00810069|12200973|FG001|Lead-in Period I|Lost to Follow-up|0
7760990|NCT00810069|12200974|FG002|Lead-in Period I|Lost to Follow-up|0
7760991|NCT00810069|12200972|FG000|Lead-in Period I|Physician Decision|1
7760992|NCT00810069|12200973|FG001|Lead-in Period I|Physician Decision|0
7760993|NCT00810069|12200974|FG002|Lead-in Period I|Physician Decision|0
7760994|NCT00810069|12200972|FG000|Lead-in Period I|Protocol Violation|1
7760995|NCT00810069|12200973|FG001|Lead-in Period I|Protocol Violation|0
7760996|NCT00810069|12200974|FG002|Lead-in Period I|Protocol Violation|0
7760997|NCT00810069|12200972|FG000|Lead-in Period I|Withdrawal by Subject|46
7760998|NCT00810069|12200973|FG001|Lead-in Period I|Withdrawal by Subject|0
7760999|NCT00810069|12200974|FG002|Lead-in Period I|Withdrawal by Subject|0
7761000|NCT00810069|12200972|FG000|Lead-in Period I|Protocol entry criterion not met|5
7761001|NCT00810069|12200973|FG001|Lead-in Period I|Protocol entry criterion not met|0
7761002|NCT00810069|12200974|FG002|Lead-in Period I|Protocol entry criterion not met|0
7761003|NCT00810069|12200972|FG000|Lead-in Period I|Randomization criteria not met|158
7761004|NCT00810069|12200973|FG001|Lead-in Period I|Randomization criteria not met|0
7761005|NCT00810069|12200974|FG002|Lead-in Period I|Randomization criteria not met|0
7761006|NCT00810069|12200972|FG000|Double-Blind Period II|Adverse Event|0
7761007|NCT00810069|12200973|FG001|Double-Blind Period II|Adverse Event|9
7761008|NCT00810069|12200974|FG002|Double-Blind Period II|Adverse Event|8
7761009|NCT00810069|12200972|FG000|Double-Blind Period II|Lack of Efficacy|0
7761010|NCT00810069|12200973|FG001|Double-Blind Period II|Lack of Efficacy|7
7761011|NCT00810069|12200974|FG002|Double-Blind Period II|Lack of Efficacy|12
7761012|NCT00810069|12200972|FG000|Double-Blind Period II|Lost to Follow-up|0
7761013|NCT00810069|12200973|FG001|Double-Blind Period II|Lost to Follow-up|9
7761014|NCT00810069|12200974|FG002|Double-Blind Period II|Lost to Follow-up|9
7761015|NCT00810069|12200972|FG000|Double-Blind Period II|Physician Decision|0
7761016|NCT00810069|12200973|FG001|Double-Blind Period II|Physician Decision|0
7761017|NCT00810069|12200974|FG002|Double-Blind Period II|Physician Decision|1
7761018|NCT00810069|12200972|FG000|Double-Blind Period II|Withdrawal by Subject|0
7761019|NCT00810069|12200973|FG001|Double-Blind Period II|Withdrawal by Subject|21
7761020|NCT00810069|12200974|FG002|Double-Blind Period II|Withdrawal by Subject|35
7761021|NCT00810069|12200972|FG000|Double-Blind Period II|Protocol entry criterion not met|0
7761022|NCT00810069|12200973|FG001|Double-Blind Period II|Protocol entry criterion not met|0
7761023|NCT00810069|12200974|FG002|Double-Blind Period II|Protocol entry criterion not met|1
7761024|NCT00810069|12200972|FG000|Double-Blind Period II|Clinical relapse|0
7761025|NCT00810069|12200973|FG001|Double-Blind Period II|Clinical relapse|3
7761026|NCT00810069|12200974|FG002|Double-Blind Period II|Clinical relapse|0
7761027|NCT00810069|12200972|FG000|Double-Blind Period II|Protocol Violation|0
7761028|NCT00810069|12200973|FG001|Double-Blind Period II|Protocol Violation|7
7761029|NCT00810069|12200974|FG002|Double-Blind Period II|Protocol Violation|6
7761030|NCT00810082|12200985|FG000|Overall Study|Lost to Follow-up|0
7761031|NCT00810082|12200986|FG001|Overall Study|Lost to Follow-up|4
7761032|NCT00810108|12200998|FG000|Overall Study|Withdrawal by Subject|1
7761033|NCT00810108|12200999|FG001|Overall Study|Withdrawal by Subject|0
7761034|NCT00810199|12201006|FG000|Overall Study|Adverse Event|24
7761035|NCT00810199|12201007|FG001|Overall Study|Adverse Event|26
7761036|NCT00810199|12201006|FG000|Overall Study|Death|4
7761037|NCT00810199|12201007|FG001|Overall Study|Death|6
7761038|NCT00810199|12201006|FG000|Overall Study|Withdrew consent|9
7761039|NCT00810199|12201007|FG001|Overall Study|Withdrew consent|12
7761040|NCT00810199|12201006|FG000|Overall Study|Insufficient therapeutic response|5
7761041|NCT00810199|12201007|FG001|Overall Study|Insufficient therapeutic response|14
7761042|NCT00810199|12201006|FG000|Overall Study|Refused treatment/Did not cooperate|7
7761043|NCT00810199|12201007|FG001|Overall Study|Refused treatment/Did not cooperate|7
7761044|NCT00810199|12201006|FG000|Overall Study|Administrative/Other|5
7761045|NCT00810199|12201007|FG001|Overall Study|Administrative/Other|6
7761046|NCT00810199|12201006|FG000|Overall Study|Protocol Violation|2
7761047|NCT00810199|12201007|FG001|Overall Study|Protocol Violation|6
7761048|NCT00810199|12201006|FG000|Overall Study|Failure to return|1
7761049|NCT00810199|12201007|FG001|Overall Study|Failure to return|4
7761050|NCT00810199|12201006|FG000|Overall Study|Did not receive study drug|2
7761051|NCT00810199|12201007|FG001|Overall Study|Did not receive study drug|1
7761052|NCT00810264|12201019|FG000|Overall Study|Lost to Follow-up|191
7761053|NCT00810264|12201019|FG000|Overall Study|Withdrawal by subject or physician|721
7761054|NCT00810264|12201019|FG000|Overall Study|Death|641
7761055|NCT00810277|12201027|FG000|Overall Study|Adverse Event|1
7761056|NCT00810342|12201041|FG000|Month 1 Follow-up|Lost to Follow-up|4
7761057|NCT00810342|12201042|FG001|Month 1 Follow-up|Lost to Follow-up|2
7962627|NCT02713204|12516854|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
7624589|NCT01986114|12035684|FG000|Overall Study|Lack of Efficacy|23
7761058|NCT00810342|12201041|FG000|Month 1 Follow-up|Pregnancy|1
7761059|NCT00810342|12201042|FG001|Month 1 Follow-up|Pregnancy|0
7962628|NCT02713204|12516855|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7962629|NCT02713204|12516856|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7962630|NCT02713204|12516857|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7962631|NCT02713204|12516858|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7962632|NCT02713204|12516859|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7962633|NCT02713204|12516860|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7962634|NCT02713204|12516853|FG000|From Week 12 up to Week 36|Adverse Event|1
7761060|NCT00810342|12201041|FG000|6-month Follow-up|Lost to Follow-up|18
7761061|NCT00810342|12201042|FG001|6-month Follow-up|Lost to Follow-up|6
7761062|NCT00810342|12201041|FG000|6-month Follow-up|Pregnancy|6
7761063|NCT00810342|12201042|FG001|6-month Follow-up|Pregnancy|2
7761064|NCT00810342|12201041|FG000|12-month Followup|Pregnancy|9
7761065|NCT00810342|12201042|FG001|12-month Followup|Pregnancy|10
7761066|NCT00810342|12201041|FG000|12-month Followup|Lost to Follow-up|3
7761067|NCT00810342|12201042|FG001|12-month Followup|Lost to Follow-up|1
7761068|NCT00810355|12201053|FG000|Overall Study|Lost to Follow-up|13
7761069|NCT00810355|12201054|FG001|Overall Study|Lost to Follow-up|17
7761070|NCT00810355|12201055|FG002|Overall Study|Lost to Follow-up|11
7761071|NCT00810355|12201053|FG000|Overall Study|Withdrawal by Subject|1
7761072|NCT00810355|12201054|FG001|Overall Study|Withdrawal by Subject|0
7761073|NCT00810355|12201055|FG002|Overall Study|Withdrawal by Subject|0
7761074|NCT00810368|12201065|FG000|Overall Study|Lost to Follow-up|4
7761075|NCT00810368|12201066|FG001|Overall Study|Lost to Follow-up|2
7761076|NCT00810368|12201065|FG000|Overall Study|Lack of Efficacy|2
7761077|NCT00810368|12201066|FG001|Overall Study|Lack of Efficacy|0
7761078|NCT00810394|12201074|FG000|Overall Study|Withdrawal by Subject|3
7761079|NCT00810407|12201078|FG000|Overall Study|Protocol Violation|3
7761080|NCT00810407|12201078|FG000|Overall Study|No Visit After First Day of Treatment|3
7761081|NCT00810511|12201099|FG000|Overall Study|Protocol Violation|0
7761082|NCT00810511|12201100|FG001|Overall Study|Protocol Violation|1
7761083|NCT00810511|12201099|FG000|Overall Study|Lack of Efficacy|9
7761084|NCT00810511|12201100|FG001|Overall Study|Lack of Efficacy|1
7761085|NCT00810511|12201099|FG000|Overall Study|death in the family|0
7761086|NCT00810511|12201100|FG001|Overall Study|death in the family|1
7761087|NCT00810511|12201099|FG000|Overall Study|Lost to Follow-up|1
7761088|NCT00810511|12201100|FG001|Overall Study|Lost to Follow-up|0
7761089|NCT00810511|12201099|FG000|Overall Study|deposits on contact lens|0
7761090|NCT00810511|12201100|FG001|Overall Study|deposits on contact lens|1
7761091|NCT00810602|12201110|FG000|Overall Study|Withdrawal by Subject|8
7761092|NCT00810602|12201111|FG001|Overall Study|Withdrawal by Subject|3
7761093|NCT00810615|12201117|FG000|Overall Study|Withdrawal by Subject|1
7761094|NCT00810615|12201118|FG001|Overall Study|Withdrawal by Subject|1
7761095|NCT00810641|12201139|FG000|Overall Study|Withdrawal by Subject|0
7761096|NCT00810641|12201140|FG001|Overall Study|Withdrawal by Subject|1
7761097|NCT00810641|12201141|FG002|Overall Study|Withdrawal by Subject|2
7761098|NCT00810693|12201152|FG000|Treatment Period|Adverse Event|8
7761099|NCT00810693|12201153|FG001|Treatment Period|Adverse Event|1
7761100|NCT00810693|12201154|FG002|Treatment Period|Adverse Event|7
7761101|NCT00810693|12201152|FG000|Treatment Period|Death|0
7761102|NCT00810693|12201153|FG001|Treatment Period|Death|1
7761103|NCT00810693|12201154|FG002|Treatment Period|Death|2
7761104|NCT00810693|12201152|FG000|Treatment Period|Lack of Efficacy|0
7761105|NCT00810693|12201153|FG001|Treatment Period|Lack of Efficacy|0
7761106|NCT00810693|12201154|FG002|Treatment Period|Lack of Efficacy|1
7761107|NCT00810693|12201152|FG000|Treatment Period|Lost to Follow-up|1
7761108|NCT00810693|12201153|FG001|Treatment Period|Lost to Follow-up|0
7761109|NCT00810693|12201154|FG002|Treatment Period|Lost to Follow-up|0
7761110|NCT00810693|12201152|FG000|Treatment Period|Non-compliance|1
7761111|NCT00810693|12201153|FG001|Treatment Period|Non-compliance|0
7761112|NCT00810693|12201154|FG002|Treatment Period|Non-compliance|0
7761113|NCT00810693|12201152|FG000|Treatment Period|Protocol Violation|1
7761114|NCT00810693|12201153|FG001|Treatment Period|Protocol Violation|2
7761115|NCT00810693|12201154|FG002|Treatment Period|Protocol Violation|2
7761116|NCT00810693|12201152|FG000|Treatment Period|Withdrawal by Subject|6
7761117|NCT00810693|12201153|FG001|Treatment Period|Withdrawal by Subject|2
7761118|NCT00810693|12201154|FG002|Treatment Period|Withdrawal by Subject|3
7761119|NCT00810693|12201152|FG000|Treatment Period|Not treated|0
7761120|NCT00810693|12201153|FG001|Treatment Period|Not treated|1
7761121|NCT00810693|12201154|FG002|Treatment Period|Not treated|1
7761122|NCT00810693|12201152|FG000|Follow-up Period (FUP)|Adverse Event|3
7761123|NCT00810693|12201153|FG001|Follow-up Period (FUP)|Adverse Event|1
7761124|NCT00810693|12201154|FG002|Follow-up Period (FUP)|Adverse Event|1
7761125|NCT00810693|12201152|FG000|Follow-up Period (FUP)|Death|2
7761126|NCT00810693|12201153|FG001|Follow-up Period (FUP)|Death|0
7761127|NCT00810693|12201154|FG002|Follow-up Period (FUP)|Death|1
7761128|NCT00810693|12201152|FG000|Follow-up Period (FUP)|Lost to Follow-up|1
7761129|NCT00810693|12201153|FG001|Follow-up Period (FUP)|Lost to Follow-up|0
7761130|NCT00810693|12201154|FG002|Follow-up Period (FUP)|Lost to Follow-up|2
7761131|NCT00810693|12201152|FG000|Follow-up Period (FUP)|Protocol Violation|0
7761132|NCT00810693|12201153|FG001|Follow-up Period (FUP)|Protocol Violation|1
7761133|NCT00810693|12201154|FG002|Follow-up Period (FUP)|Protocol Violation|0
7761134|NCT00810693|12201152|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2
7761135|NCT00810693|12201153|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1
7761136|NCT00810693|12201154|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0
7761137|NCT00810810|12201189|FG000|Overall Study|Withdrawal by Subject|0
7761138|NCT00810810|12201190|FG001|Overall Study|Withdrawal by Subject|8
7761139|NCT00810810|12201191|FG002|Overall Study|Withdrawal by Subject|10
7761140|NCT00810810|12201192|FG003|Overall Study|Withdrawal by Subject|8
7761141|NCT00810810|12201189|FG000|Overall Study|Physician Decision|0
7761142|NCT00810810|12201190|FG001|Overall Study|Physician Decision|3
7761143|NCT00810810|12201191|FG002|Overall Study|Physician Decision|1
7761144|NCT00810810|12201192|FG003|Overall Study|Physician Decision|5
7761145|NCT00810901|12201217|FG000|Overall Study|Lost to Follow-up|88
7761146|NCT00810901|12201218|FG001|Overall Study|Lost to Follow-up|58
7761147|NCT00811018|12201224|FG000|Overall Study|Additional Chronic Treatment|31
7761148|NCT00811018|12201224|FG000|Overall Study|Adverse Event|79
7761149|NCT00811018|12201224|FG000|Overall Study|Death|147
7761150|NCT00811018|12201224|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
7761151|NCT00811018|12201224|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
7761152|NCT00811018|12201224|FG000|Overall Study|Investigator Decision|57
7761153|NCT00811018|12201224|FG000|Overall Study|Lost to Follow-up|19
7761154|NCT00811018|12201224|FG000|Overall Study|Pregnancy|6
7761155|NCT00811018|12201224|FG000|Overall Study|Sponsor Decision|450
7761156|NCT00811018|12201224|FG000|Overall Study|Withdrawal by Subject|70
7761157|NCT00811018|12201224|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9
7761158|NCT00811018|12201224|FG000|Overall Study|Other|26
7761159|NCT00811057|12201231|FG000|Overall Study|Protocol Violation|5
7761160|NCT00811057|12201232|FG001|Overall Study|Protocol Violation|10
7761161|NCT00811057|12201233|FG002|Overall Study|Protocol Violation|10
7761162|NCT00811070|12201247|FG000|Overall Study|Death|0
7761163|NCT00811070|12201248|FG001|Overall Study|Death|0
7761164|NCT00811070|12201249|FG002|Overall Study|Death|0
7761165|NCT00811070|12201250|FG003|Overall Study|Death|2
7761166|NCT00811070|12201251|FG004|Overall Study|Death|5
7761167|NCT00811070|12201252|FG005|Overall Study|Death|0
7761168|NCT00811070|12201247|FG000|Overall Study|Other|1
7761169|NCT00811070|12201248|FG001|Overall Study|Other|0
7761170|NCT00811070|12201249|FG002|Overall Study|Other|0
7761171|NCT00811070|12201250|FG003|Overall Study|Other|0
7761172|NCT00811070|12201251|FG004|Overall Study|Other|0
7761173|NCT00811070|12201252|FG005|Overall Study|Other|0
7761174|NCT00811070|12201247|FG000|Overall Study|Withdrawal by Subject|0
7761175|NCT00811070|12201248|FG001|Overall Study|Withdrawal by Subject|1
7761176|NCT00811070|12201249|FG002|Overall Study|Withdrawal by Subject|0
7761177|NCT00811070|12201250|FG003|Overall Study|Withdrawal by Subject|0
7761178|NCT00811070|12201251|FG004|Overall Study|Withdrawal by Subject|0
7761179|NCT00811070|12201252|FG005|Overall Study|Withdrawal by Subject|0
7761180|NCT00811070|12201247|FG000|Overall Study|Physician Decision|0
7761181|NCT00811070|12201248|FG001|Overall Study|Physician Decision|0
7761182|NCT00811070|12201249|FG002|Overall Study|Physician Decision|0
7761183|NCT00811070|12201250|FG003|Overall Study|Physician Decision|0
7761184|NCT00811070|12201251|FG004|Overall Study|Physician Decision|0
7761185|NCT00811070|12201252|FG005|Overall Study|Physician Decision|1
7761186|NCT00811135|12201268|FG000|Overall Study|Adverse Event/Intercurrent Illness|8
7761187|NCT00811135|12201268|FG000|Overall Study|Death|3
7761188|NCT00811135|12201268|FG000|Overall Study|Protocol Violation|2
7761189|NCT00811135|12201268|FG000|Overall Study|Violation of Selection Criteria|1
7761190|NCT00811135|12201268|FG000|Overall Study|Refused Treatment|1
7761191|NCT00811135|12201268|FG000|Overall Study|Withdrawal by Subject|3
7761192|NCT00811135|12201268|FG000|Overall Study|Administrative/Other Unspecified|11
7761193|NCT00811135|12201268|FG000|Overall Study|Ongoing|59
7761194|NCT00811174|12201272|FG000|Overall Study|Protocol Violation|2
7761195|NCT00811174|12201272|FG000|Overall Study|Sponsors Decision|1
7761196|NCT00811187|12201278|FG000|Overall Study|Unable to place device / procedure abort|3
7761197|NCT00811187|12201279|FG001|Overall Study|Unable to place device / procedure abort|3
7761198|NCT00811252|12201288|FG000|Overall Study|Adverse Event|6
7761199|NCT00811252|12201289|FG001|Overall Study|Adverse Event|10
7761200|NCT00811252|12201290|FG002|Overall Study|Adverse Event|15
7761201|NCT00811252|12201288|FG000|Overall Study|Lack of Efficacy|7
7761202|NCT00811252|12201289|FG001|Overall Study|Lack of Efficacy|2
7761203|NCT00811252|12201290|FG002|Overall Study|Lack of Efficacy|0
7761204|NCT00811252|12201288|FG000|Overall Study|Protocol Violation|3
7761205|NCT00811252|12201289|FG001|Overall Study|Protocol Violation|3
7761206|NCT00811252|12201290|FG002|Overall Study|Protocol Violation|2
7761207|NCT00811252|12201288|FG000|Overall Study|Withdrawal of Consent|1
7761208|NCT00811252|12201289|FG001|Overall Study|Withdrawal of Consent|2
7761209|NCT00811252|12201290|FG002|Overall Study|Withdrawal of Consent|2
7761210|NCT00811252|12201288|FG000|Overall Study|Lost to Follow-up|0
7761211|NCT00811252|12201289|FG001|Overall Study|Lost to Follow-up|0
7761212|NCT00811252|12201290|FG002|Overall Study|Lost to Follow-up|2
7761213|NCT00811252|12201288|FG000|Overall Study|Administrative or Other Reasons|0
7761214|NCT00811252|12201289|FG001|Overall Study|Administrative or Other Reasons|3
7761215|NCT00811252|12201290|FG002|Overall Study|Administrative or Other Reasons|2
7761216|NCT00811395|12201319|FG000|Extension Treatment|Adverse Event|1
7761217|NCT00811395|12201320|FG001|Extension Treatment|Adverse Event|2
7761218|NCT00811395|12201321|FG002|Extension Treatment|Adverse Event|2
7761219|NCT00811395|12201322|FG003|Extension Treatment|Adverse Event|2
7761220|NCT00811395|12201323|FG004|Extension Treatment|Adverse Event|0
7761221|NCT00811395|12201324|FG005|Extension Treatment|Adverse Event|1
7761222|NCT00811395|12201319|FG000|Extension Treatment|Progressive disease|1
7761223|NCT00811395|12201320|FG001|Extension Treatment|Progressive disease|1
7761224|NCT00811395|12201321|FG002|Extension Treatment|Progressive disease|0
7761225|NCT00811395|12201322|FG003|Extension Treatment|Progressive disease|0
7761226|NCT00811395|12201323|FG004|Extension Treatment|Progressive disease|0
7761227|NCT00811395|12201324|FG005|Extension Treatment|Progressive disease|0
7761228|NCT00811395|12201319|FG000|Extension Treatment|Participant did not wish to continue|0
7761229|NCT00811395|12201320|FG001|Extension Treatment|Participant did not wish to continue|3
7761230|NCT00811395|12201321|FG002|Extension Treatment|Participant did not wish to continue|0
7761231|NCT00811395|12201322|FG003|Extension Treatment|Participant did not wish to continue|1
7761232|NCT00811395|12201323|FG004|Extension Treatment|Participant did not wish to continue|0
7761233|NCT00811395|12201324|FG005|Extension Treatment|Participant did not wish to continue|1
7761234|NCT00811395|12201319|FG000|Extension Treatment|Other than above|0
7761235|NCT00811395|12201320|FG001|Extension Treatment|Other than above|0
7761236|NCT00811395|12201321|FG002|Extension Treatment|Other than above|1
7761237|NCT00811395|12201322|FG003|Extension Treatment|Other than above|0
7761238|NCT00811395|12201323|FG004|Extension Treatment|Other than above|0
7761239|NCT00811395|12201324|FG005|Extension Treatment|Other than above|0
7761240|NCT00811473|12201351|FG000|Overall Study|Adverse Event|3
7761241|NCT00811473|12201352|FG001|Overall Study|Adverse Event|12
7761242|NCT00811473|12201351|FG000|Overall Study|Lost to Follow-up|5
7761243|NCT00811473|12201352|FG001|Overall Study|Lost to Follow-up|1
7761244|NCT00811473|12201351|FG000|Overall Study|Withdrawal by Subject|2
7761245|NCT00811473|12201352|FG001|Overall Study|Withdrawal by Subject|4
7761246|NCT00811473|12201351|FG000|Overall Study|Severe non-compliance to protocol|2
7761247|NCT00811473|12201352|FG001|Overall Study|Severe non-compliance to protocol|4
7761248|NCT00811473|12201351|FG000|Overall Study|Lack of therapeutic response|4
7761249|NCT00811473|12201352|FG001|Overall Study|Lack of therapeutic response|1
7761250|NCT00811473|12201351|FG000|Overall Study|Condition under investigation worsened|1
7761251|NCT00811473|12201352|FG001|Overall Study|Condition under investigation worsened|3
7761252|NCT00811473|12201351|FG000|Overall Study|Other 2|4
7761253|NCT00811473|12201352|FG001|Overall Study|Other 2|1
7761254|NCT00811473|12201351|FG000|Overall Study|Incorrect Enrollment|1
7761255|NCT00811473|12201352|FG001|Overall Study|Incorrect Enrollment|0
7761256|NCT00811473|12201351|FG000|Overall Study|Safety Reasons|1
7761257|NCT00811473|12201352|FG001|Overall Study|Safety Reasons|0
7761258|NCT00811577|12201369|FG000|Overall Study|Lost to Follow-up|7
7761259|NCT00811577|12201370|FG001|Overall Study|Lost to Follow-up|1
7761260|NCT00811577|12201369|FG000|Overall Study|Withdrawal by Subject|3
7761261|NCT00811577|12201370|FG001|Overall Study|Withdrawal by Subject|0
7761262|NCT00811642|12201419|FG000|Overall Study|Adverse Event|3
7761263|NCT00811642|12201419|FG000|Overall Study|Protocol Violation|1
7761264|NCT00811642|12201419|FG000|Overall Study|Death|2
7761265|NCT00811642|12201419|FG000|Overall Study|Withdrawal by Subject|7
7761266|NCT00811642|12201419|FG000|Overall Study|Cumulative use of antifungal agent|2
7761267|NCT00811655|12201423|FG000|Overall Study|Physician Decision|1
7761268|NCT00811720|12201429|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2
7761269|NCT00811720|12201430|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4
7761270|NCT00811720|12201429|FG000|All Treated Patients|Adverse Event|20
7761271|NCT00811720|12201430|FG001|All Treated Patients|Adverse Event|62
7761272|NCT00811720|12201429|FG000|All Treated Patients|Lack of Efficacy|22
7761273|NCT00811720|12201430|FG001|All Treated Patients|Lack of Efficacy|18
7761274|NCT00811720|12201429|FG000|All Treated Patients|Non-compliance|0
7761275|NCT00811720|12201430|FG001|All Treated Patients|Non-compliance|14
7761276|NCT00811720|12201429|FG000|All Treated Patients|Protocol Violation|9
7761277|NCT00811720|12201430|FG001|All Treated Patients|Protocol Violation|16
7761278|NCT00811720|12201429|FG000|All Treated Patients|Withdrawal by Subject|28
7761279|NCT00811720|12201430|FG001|All Treated Patients|Withdrawal by Subject|34
7761280|NCT00811720|12201429|FG000|All Treated Patients|Lost to Follow-up|10
7761281|NCT00811720|12201430|FG001|All Treated Patients|Lost to Follow-up|16
7761282|NCT00811720|12201429|FG000|All Treated Patients|Other Reason|7
7761283|NCT00811720|12201430|FG001|All Treated Patients|Other Reason|4
7761284|NCT00811733|12201438|FG000|Overall Study|Investigator Discretion|10
7761285|NCT00811733|12201439|FG001|Overall Study|Investigator Discretion|8
7761286|NCT00811733|12201438|FG000|Overall Study|Withdrawal by Subject|1
7761287|NCT00811733|12201439|FG001|Overall Study|Withdrawal by Subject|2
7761288|NCT00811928|12201457|FG000|Overall Study|AEs and SAEs Including Death|7
7761289|NCT00811928|12201458|FG001|Overall Study|AEs and SAEs Including Death|11
7761290|NCT00811928|12201457|FG000|Overall Study|Withdrawal by Subject|18
7761291|NCT00811928|12201458|FG001|Overall Study|Withdrawal by Subject|12
7761292|NCT00811928|12201457|FG000|Overall Study|Did Not Take Study Drug|3
7761293|NCT00811928|12201458|FG001|Overall Study|Did Not Take Study Drug|0
7761294|NCT00811928|12201457|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7
7761295|NCT00811928|12201458|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4
7761296|NCT00811928|12201457|FG000|Overall Study|Investigator Decision|2
7761297|NCT00811928|12201458|FG001|Overall Study|Investigator Decision|1
7761298|NCT00811928|12201457|FG000|Overall Study|Poor Compliance|2
7761299|NCT00811928|12201458|FG001|Overall Study|Poor Compliance|5
7761300|NCT00811941|12201466|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2
7761301|NCT00811941|12201467|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8
7761302|NCT00811941|12201466|FG000|All Treated Patients|Adverse Event|2
7761303|NCT00811941|12201467|FG001|All Treated Patients|Adverse Event|43
7761304|NCT00811941|12201466|FG000|All Treated Patients|Lack of Efficacy|2
7761305|NCT00811941|12201467|FG001|All Treated Patients|Lack of Efficacy|3
7761306|NCT00811941|12201466|FG000|All Treated Patients|Non-compliance|1
7761307|NCT00811941|12201467|FG001|All Treated Patients|Non-compliance|8
7761308|NCT00811941|12201466|FG000|All Treated Patients|Protocol Violation|5
7761309|NCT00811941|12201467|FG001|All Treated Patients|Protocol Violation|17
7761310|NCT00811941|12201466|FG000|All Treated Patients|Withdrawal by Subject|35
7761311|NCT00811941|12201467|FG001|All Treated Patients|Withdrawal by Subject|94
7761312|NCT00811941|12201466|FG000|All Treated Patients|Lost to Follow-up|3
7761313|NCT00811941|12201467|FG001|All Treated Patients|Lost to Follow-up|12
7761314|NCT00811941|12201466|FG000|All Treated Patients|Other Reason|4
7761315|NCT00811941|12201467|FG001|All Treated Patients|Other Reason|14
7761316|NCT00811954|12201476|FG000|Overall Study|Death|10
7761317|NCT00811954|12201477|FG001|Overall Study|Death|6
7761318|NCT00811954|12201478|FG002|Overall Study|Death|13
7761319|NCT00811954|12201476|FG000|Overall Study|Lost to Follow-up|29
7761320|NCT00811954|12201477|FG001|Overall Study|Lost to Follow-up|23
7761321|NCT00811954|12201478|FG002|Overall Study|Lost to Follow-up|34
7761322|NCT00811954|12201476|FG000|Overall Study|Not able to get to clinic|28
7761323|NCT00811954|12201477|FG001|Overall Study|Not able to get to clinic|35
7761324|NCT00811954|12201478|FG002|Overall Study|Not able to get to clinic|30
7761325|NCT00811954|12201476|FG000|Overall Study|Not willing to adhere to requirements|12
7761326|NCT00811954|12201477|FG001|Overall Study|Not willing to adhere to requirements|2
7761327|NCT00811954|12201478|FG002|Overall Study|Not willing to adhere to requirements|16
7761328|NCT00811954|12201476|FG000|Overall Study|Withdraw consent prior study completion|4
7761329|NCT00811954|12201477|FG001|Overall Study|Withdraw consent prior study completion|6
7761330|NCT00811954|12201478|FG002|Overall Study|Withdraw consent prior study completion|5
7761331|NCT00811954|12201476|FG000|Overall Study|Site Closure|4
7761332|NCT00811954|12201477|FG001|Overall Study|Site Closure|0
7761333|NCT00811954|12201478|FG002|Overall Study|Site Closure|1
7761334|NCT00811954|12201476|FG000|Overall Study|Severe Debilitation|2
7761335|NCT00811954|12201477|FG001|Overall Study|Severe Debilitation|0
7761336|NCT00811954|12201478|FG002|Overall Study|Severe Debilitation|1
7761337|NCT00811954|12201476|FG000|Overall Study|Complete Protocol: No follow-up|0
7761338|NCT00811954|12201477|FG001|Overall Study|Complete Protocol: No follow-up|0
7761339|NCT00811954|12201478|FG002|Overall Study|Complete Protocol: No follow-up|1
7761340|NCT00812097|12201490|FG000|Overall Study|Death|3
7761341|NCT00812097|12201491|FG001|Overall Study|Death|10
7761342|NCT00812097|12201492|FG002|Overall Study|Death|3
7761343|NCT00812097|12201493|FG003|Overall Study|Death|3
7761344|NCT00812097|12201490|FG000|Overall Study|Withdrawal by Subject|14
7761345|NCT00812097|12201491|FG001|Overall Study|Withdrawal by Subject|12
7761346|NCT00812097|12201492|FG002|Overall Study|Withdrawal by Subject|8
7761347|NCT00812097|12201493|FG003|Overall Study|Withdrawal by Subject|2
7761348|NCT00812097|12201490|FG000|Overall Study|Lost to Follow-up|90
7761349|NCT00812097|12201491|FG001|Overall Study|Lost to Follow-up|14
7624590|NCT01986114|12035684|FG000|Overall Study|Withdrawal by Subject|58
7761350|NCT00812097|12201492|FG002|Overall Study|Lost to Follow-up|17
7761351|NCT00812097|12201493|FG003|Overall Study|Lost to Follow-up|5
7761352|NCT00812097|12201490|FG000|Overall Study|Explantation of study device(s)|27
7761353|NCT00812097|12201491|FG001|Overall Study|Explantation of study device(s)|29
7761354|NCT00812097|12201492|FG002|Overall Study|Explantation of study device(s)|14
7761355|NCT00812097|12201493|FG003|Overall Study|Explantation of study device(s)|20
7761356|NCT00812097|12201490|FG000|Overall Study|Unknown reasons and patient/doctor moves|111
7761357|NCT00812097|12201491|FG001|Overall Study|Unknown reasons and patient/doctor moves|24
7761358|NCT00812097|12201492|FG002|Overall Study|Unknown reasons and patient/doctor moves|15
7761359|NCT00812097|12201493|FG003|Overall Study|Unknown reasons and patient/doctor moves|5
7761360|NCT00812253|12201509|FG000|Overall Study|Withdrawal by Subject|3
7761361|NCT00812253|12201510|FG001|Overall Study|Withdrawal by Subject|2
7761362|NCT00812253|12201509|FG000|Overall Study|Protocol Violation|1
7761363|NCT00812253|12201510|FG001|Overall Study|Protocol Violation|1
7761364|NCT00812253|12201509|FG000|Overall Study|Lost to Follow-up|2
7761365|NCT00812253|12201510|FG001|Overall Study|Lost to Follow-up|0
7761366|NCT00812331|12201521|FG000|Overall Study|Adverse Event|1
7761367|NCT00812331|12201522|FG001|Overall Study|Adverse Event|0
7761368|NCT00812331|12201523|FG002|Overall Study|Adverse Event|0
7761369|NCT00812331|12201524|FG003|Overall Study|Adverse Event|0
7761370|NCT00812331|12201525|FG004|Overall Study|Adverse Event|0
7761371|NCT00812461|12201535|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23
7761372|NCT00812461|12201536|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17
7761373|NCT00812461|12201535|FG000|All Treated Patients|Adverse Event|8
7761374|NCT00812461|12201536|FG001|All Treated Patients|Adverse Event|15
7761375|NCT00812461|12201535|FG000|All Treated Patients|Lack of Efficacy|13
7761376|NCT00812461|12201536|FG001|All Treated Patients|Lack of Efficacy|7
7761377|NCT00812461|12201535|FG000|All Treated Patients|Non-compliance|6
7624591|NCT01986114|12035684|FG000|Overall Study|Noncompliance|3
7761378|NCT00812461|12201536|FG001|All Treated Patients|Non-compliance|9
7761379|NCT00812461|12201535|FG000|All Treated Patients|Protocol Violation|36
7761380|NCT00812461|12201536|FG001|All Treated Patients|Protocol Violation|27
7761381|NCT00812461|12201535|FG000|All Treated Patients|Withdrawal by Subject|45
7761382|NCT00812461|12201536|FG001|All Treated Patients|Withdrawal by Subject|54
7761383|NCT00812461|12201535|FG000|All Treated Patients|Lost to Follow-up|11
7761384|NCT00812461|12201536|FG001|All Treated Patients|Lost to Follow-up|14
7761385|NCT00812461|12201535|FG000|All Treated Patients|Other Reason|13
7761386|NCT00812461|12201536|FG001|All Treated Patients|Other Reason|21
7761387|NCT00812487|12201544|FG000|Overall Study|Lost to Follow-up|2
7761388|NCT00812487|12201545|FG001|Overall Study|Lost to Follow-up|0
7761389|NCT00812487|12201544|FG000|Overall Study|Withdrawal by Subject|3
7761390|NCT00812487|12201545|FG001|Overall Study|Withdrawal by Subject|2
7761391|NCT00812487|12201544|FG000|Overall Study|Transfer to ICU prior to intervention|1
7761392|NCT00812487|12201545|FG001|Overall Study|Transfer to ICU prior to intervention|0
7761393|NCT00812487|12201544|FG000|Overall Study|Protocol Violation|0
7761394|NCT00812487|12201545|FG001|Overall Study|Protocol Violation|1
7761395|NCT00812565|12201559|FG000|Overall Study|Did Not Receive Study Medication|1
7761396|NCT00812565|12201560|FG001|Overall Study|Did Not Receive Study Medication|1
7761397|NCT00812565|12201561|FG002|Overall Study|Did Not Receive Study Medication|0
7761398|NCT00812565|12201562|FG003|Overall Study|Did Not Receive Study Medication|0
7761399|NCT00812565|12201563|FG004|Overall Study|Did Not Receive Study Medication|0
7761400|NCT00812565|12201564|FG005|Overall Study|Did Not Receive Study Medication|0
7761401|NCT00812565|12201565|FG006|Overall Study|Did Not Receive Study Medication|0
7761402|NCT00812565|12201566|FG007|Overall Study|Did Not Receive Study Medication|0
7761403|NCT00812565|12201559|FG000|Overall Study|Adverse Event|0
7761404|NCT00812565|12201560|FG001|Overall Study|Adverse Event|0
7761405|NCT00812565|12201561|FG002|Overall Study|Adverse Event|0
7761406|NCT00812565|12201562|FG003|Overall Study|Adverse Event|2
7761407|NCT00812565|12201563|FG004|Overall Study|Adverse Event|0
7761408|NCT00812565|12201564|FG005|Overall Study|Adverse Event|0
7761409|NCT00812565|12201565|FG006|Overall Study|Adverse Event|0
7761410|NCT00812565|12201566|FG007|Overall Study|Adverse Event|1
7761411|NCT00812565|12201559|FG000|Overall Study|Did Not Come to Study Visit|1
7761412|NCT00812565|12201560|FG001|Overall Study|Did Not Come to Study Visit|0
7761413|NCT00812565|12201561|FG002|Overall Study|Did Not Come to Study Visit|0
7761414|NCT00812565|12201562|FG003|Overall Study|Did Not Come to Study Visit|0
7761415|NCT00812565|12201563|FG004|Overall Study|Did Not Come to Study Visit|0
7761416|NCT00812565|12201564|FG005|Overall Study|Did Not Come to Study Visit|0
7761417|NCT00812565|12201565|FG006|Overall Study|Did Not Come to Study Visit|0
7761418|NCT00812565|12201566|FG007|Overall Study|Did Not Come to Study Visit|0
7761419|NCT00812565|12201559|FG000|Overall Study|Withdrawal of Consent|1
7761420|NCT00812565|12201560|FG001|Overall Study|Withdrawal of Consent|0
7761421|NCT00812565|12201561|FG002|Overall Study|Withdrawal of Consent|0
7761422|NCT00812565|12201562|FG003|Overall Study|Withdrawal of Consent|0
7761423|NCT00812565|12201563|FG004|Overall Study|Withdrawal of Consent|1
7761424|NCT00812565|12201564|FG005|Overall Study|Withdrawal of Consent|0
7761425|NCT00812565|12201565|FG006|Overall Study|Withdrawal of Consent|0
7761426|NCT00812565|12201566|FG007|Overall Study|Withdrawal of Consent|0
7761427|NCT00812565|12201559|FG000|Overall Study|Reason Not Specified|0
7962635|NCT02713204|12516854|FG001|From Week 12 up to Week 36|Adverse Event|0
7962636|NCT02713204|12516855|FG002|From Week 12 up to Week 36|Adverse Event|0
7962637|NCT02713204|12516856|FG003|From Week 12 up to Week 36|Adverse Event|1
7962638|NCT02713204|12516857|FG004|From Week 12 up to Week 36|Adverse Event|1
7962639|NCT02713204|12516858|FG005|From Week 12 up to Week 36|Adverse Event|0
7962640|NCT02713204|12516859|FG006|From Week 12 up to Week 36|Adverse Event|2
7962641|NCT02713204|12516860|FG007|From Week 12 up to Week 36|Adverse Event|1
7962642|NCT02713204|12516853|FG000|From Week 12 up to Week 36|Death|0
7962643|NCT02713204|12516854|FG001|From Week 12 up to Week 36|Death|0
7962644|NCT02713204|12516855|FG002|From Week 12 up to Week 36|Death|0
7962645|NCT02713204|12516856|FG003|From Week 12 up to Week 36|Death|1
7962646|NCT02713204|12516857|FG004|From Week 12 up to Week 36|Death|0
7962647|NCT02713204|12516858|FG005|From Week 12 up to Week 36|Death|1
7962648|NCT02713204|12516859|FG006|From Week 12 up to Week 36|Death|0
7962649|NCT02713204|12516860|FG007|From Week 12 up to Week 36|Death|3
7962650|NCT02713204|12516853|FG000|From Week 12 up to Week 36|Lost to Follow-up|0
7962651|NCT02713204|12516854|FG001|From Week 12 up to Week 36|Lost to Follow-up|0
7962652|NCT02713204|12516855|FG002|From Week 12 up to Week 36|Lost to Follow-up|0
7962653|NCT02713204|12516856|FG003|From Week 12 up to Week 36|Lost to Follow-up|2
7962654|NCT02713204|12516857|FG004|From Week 12 up to Week 36|Lost to Follow-up|0
7962655|NCT02713204|12516858|FG005|From Week 12 up to Week 36|Lost to Follow-up|0
7962656|NCT02713204|12516859|FG006|From Week 12 up to Week 36|Lost to Follow-up|0
7962657|NCT02713204|12516860|FG007|From Week 12 up to Week 36|Lost to Follow-up|0
7962658|NCT02713204|12516853|FG000|From Week 12 up to Week 36|Participant Re-located|0
7761428|NCT00812565|12201560|FG001|Overall Study|Reason Not Specified|0
7761429|NCT00812565|12201561|FG002|Overall Study|Reason Not Specified|0
7761430|NCT00812565|12201562|FG003|Overall Study|Reason Not Specified|0
7761431|NCT00812565|12201563|FG004|Overall Study|Reason Not Specified|0
7761432|NCT00812565|12201564|FG005|Overall Study|Reason Not Specified|1
7761433|NCT00812565|12201565|FG006|Overall Study|Reason Not Specified|0
7761434|NCT00812565|12201566|FG007|Overall Study|Reason Not Specified|0
7761435|NCT00812812|12201595|FG000|Overall Study|Adverse Event|2
7761436|NCT00812812|12201596|FG001|Overall Study|Adverse Event|1
7761437|NCT00812812|12201595|FG000|Overall Study|Lack of Efficacy|1
7761438|NCT00812812|12201596|FG001|Overall Study|Lack of Efficacy|0
7761439|NCT00812812|12201595|FG000|Overall Study|Lost to Follow-up|0
7761440|NCT00812812|12201596|FG001|Overall Study|Lost to Follow-up|1
7761441|NCT00812812|12201595|FG000|Overall Study|Withdrawal by Subject|0
7761442|NCT00812812|12201596|FG001|Overall Study|Withdrawal by Subject|2
7761443|NCT00812929|12201630|FG000|Washout Period 1 (7 Days)|Physician Decision|0
7761444|NCT00812929|12201631|FG001|Washout Period 1 (7 Days)|Physician Decision|0
7761445|NCT00812929|12201632|FG002|Washout Period 1 (7 Days)|Physician Decision|1
7761446|NCT00812929|12201633|FG003|Washout Period 1 (7 Days)|Physician Decision|0
7761447|NCT00812929|12201634|FG004|Washout Period 1 (7 Days)|Physician Decision|0
7761448|NCT00812929|12201635|FG005|Washout Period 1 (7 Days)|Physician Decision|0
7761449|NCT00812929|12201636|FG006|Washout Period 1 (7 Days)|Physician Decision|0
7761450|NCT00812929|12201637|FG007|Washout Period 1 (7 Days)|Physician Decision|0
7761451|NCT00812929|12201638|FG008|Washout Period 1 (7 Days)|Physician Decision|0
7761452|NCT00812929|12201639|FG009|Washout Period 1 (7 Days)|Physician Decision|0
7761453|NCT00812929|12201630|FG000|Washout Period 2 (7 Days)|Physician Decision|0
7761454|NCT00812929|12201631|FG001|Washout Period 2 (7 Days)|Physician Decision|0
7761455|NCT00812929|12201632|FG002|Washout Period 2 (7 Days)|Physician Decision|0
7761456|NCT00812929|12201633|FG003|Washout Period 2 (7 Days)|Physician Decision|0
7761457|NCT00812929|12201634|FG004|Washout Period 2 (7 Days)|Physician Decision|0
7761458|NCT00812929|12201635|FG005|Washout Period 2 (7 Days)|Physician Decision|0
7761459|NCT00812929|12201636|FG006|Washout Period 2 (7 Days)|Physician Decision|0
7761460|NCT00812929|12201637|FG007|Washout Period 2 (7 Days)|Physician Decision|0
7761461|NCT00812929|12201638|FG008|Washout Period 2 (7 Days)|Physician Decision|0
7761462|NCT00812929|12201639|FG009|Washout Period 2 (7 Days)|Physician Decision|1
7761463|NCT00812929|12201630|FG000|Washout Period 3 (7 Days)|Adverse Event|0
7761464|NCT00812929|12201631|FG001|Washout Period 3 (7 Days)|Adverse Event|0
7761465|NCT00812929|12201632|FG002|Washout Period 3 (7 Days)|Adverse Event|0
7761466|NCT00812929|12201633|FG003|Washout Period 3 (7 Days)|Adverse Event|0
7761467|NCT00812929|12201634|FG004|Washout Period 3 (7 Days)|Adverse Event|0
7761468|NCT00812929|12201635|FG005|Washout Period 3 (7 Days)|Adverse Event|1
7761469|NCT00812929|12201636|FG006|Washout Period 3 (7 Days)|Adverse Event|0
7761470|NCT00812929|12201637|FG007|Washout Period 3 (7 Days)|Adverse Event|0
7761471|NCT00812929|12201638|FG008|Washout Period 3 (7 Days)|Adverse Event|0
7761472|NCT00812929|12201639|FG009|Washout Period 3 (7 Days)|Adverse Event|0
7761473|NCT00812955|12201660|FG000|Overall Study|Adverse Event|7
7761474|NCT00812955|12201661|FG001|Overall Study|Adverse Event|6
7761475|NCT00812955|12201662|FG002|Overall Study|Adverse Event|3
7761476|NCT00812955|12201663|FG003|Overall Study|Adverse Event|4
7761477|NCT00812955|12201660|FG000|Overall Study|Lost to Follow-up|2
7761478|NCT00812955|12201661|FG001|Overall Study|Lost to Follow-up|1
7761479|NCT00812955|12201662|FG002|Overall Study|Lost to Follow-up|1
7761480|NCT00812955|12201663|FG003|Overall Study|Lost to Follow-up|2
7761481|NCT00812955|12201660|FG000|Overall Study|Withdrawal by Subject|1
7761482|NCT00812955|12201661|FG001|Overall Study|Withdrawal by Subject|0
7761483|NCT00812955|12201662|FG002|Overall Study|Withdrawal by Subject|1
7761484|NCT00812955|12201663|FG003|Overall Study|Withdrawal by Subject|2
7761485|NCT00812955|12201660|FG000|Overall Study|randomized in error|0
7761486|NCT00812955|12201661|FG001|Overall Study|randomized in error|0
7761487|NCT00812955|12201662|FG002|Overall Study|randomized in error|1
7761488|NCT00812955|12201663|FG003|Overall Study|randomized in error|0
7761489|NCT00812968|12201677|FG000|Overall Study|Relapse after erythroid response|6
7761490|NCT00812968|12201677|FG000|Overall Study|Disease progression|1
7761491|NCT00812968|12201677|FG000|Overall Study|No further treatment required|1
7761492|NCT00812968|12201677|FG000|Overall Study|Study closed due to marketing approval|3
7761493|NCT00812981|12201685|FG000|Overall Study|Other|0
7761494|NCT00812981|12201686|FG001|Overall Study|Other|1
7761495|NCT00813098|12201695|FG000|Overall Study|Adverse Event|2
7761496|NCT00813098|12201696|FG001|Overall Study|Adverse Event|4
7761497|NCT00813098|12201697|FG002|Overall Study|Adverse Event|1
7761498|NCT00813098|12201695|FG000|Overall Study|Withdrawal by Subject|0
7761499|NCT00813098|12201696|FG001|Overall Study|Withdrawal by Subject|1
7761500|NCT00813098|12201697|FG002|Overall Study|Withdrawal by Subject|0
7761501|NCT00813098|12201695|FG000|Overall Study|Inability to complete study procedures|1
7761502|NCT00813098|12201696|FG001|Overall Study|Inability to complete study procedures|0
7761503|NCT00813098|12201697|FG002|Overall Study|Inability to complete study procedures|0
7761504|NCT00813098|12201695|FG000|Overall Study|Lost to Follow-up|0
7761505|NCT00813098|12201696|FG001|Overall Study|Lost to Follow-up|1
7761506|NCT00813098|12201697|FG002|Overall Study|Lost to Follow-up|0
7761507|NCT00813098|12201695|FG000|Overall Study|Protocol Violation|0
7761508|NCT00813098|12201696|FG001|Overall Study|Protocol Violation|0
7761509|NCT00813098|12201697|FG002|Overall Study|Protocol Violation|1
7761510|NCT00813098|12201695|FG000|Overall Study|Principal Investigator decision|0
7761511|NCT00813098|12201696|FG001|Overall Study|Principal Investigator decision|1
7761512|NCT00813098|12201697|FG002|Overall Study|Principal Investigator decision|0
7761513|NCT00813098|12201695|FG000|Overall Study|Withdrew Consent|0
7761514|NCT00813098|12201696|FG001|Overall Study|Withdrew Consent|1
7761515|NCT00813098|12201697|FG002|Overall Study|Withdrew Consent|0
7761516|NCT00813124|12201714|FG000|Overall Study|Death|2
7761517|NCT00813124|12201714|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9
7761518|NCT00813124|12201714|FG000|Overall Study|Withdrawal by Subject|1
7761519|NCT00813150|12201720|FG000|Treatment Period|Adverse Event|16
7761520|NCT00813150|12201721|FG001|Treatment Period|Adverse Event|15
7761521|NCT00813150|12201720|FG000|Treatment Period|Death|2
7761522|NCT00813150|12201721|FG001|Treatment Period|Death|0
7761523|NCT00813150|12201720|FG000|Treatment Period|Progressive disease|1
7761524|NCT00813150|12201721|FG001|Treatment Period|Progressive disease|0
7761525|NCT00813150|12201720|FG000|Treatment Period|Complete response|0
7761526|NCT00813150|12201721|FG001|Treatment Period|Complete response|1
7761527|NCT00813150|12201720|FG000|Treatment Period|Stable disease|1
7761528|NCT00813150|12201721|FG001|Treatment Period|Stable disease|2
7761529|NCT00813150|12201720|FG000|Treatment Period|Protocol Violation|3
7761530|NCT00813150|12201721|FG001|Treatment Period|Protocol Violation|4
7761531|NCT00813150|12201720|FG000|Treatment Period|Withdrawal by Subject|5
7761532|NCT00813150|12201721|FG001|Treatment Period|Withdrawal by Subject|3
7761533|NCT00813150|12201720|FG000|Treatment Period|Non compliance|0
7761534|NCT00813150|12201721|FG001|Treatment Period|Non compliance|1
7761535|NCT00813150|12201720|FG000|Treatment Period|Reason not specified|3
7761536|NCT00813150|12201721|FG001|Treatment Period|Reason not specified|4
7761537|NCT00813150|12201720|FG000|Treatment Period|Data not available|1
7761538|NCT00813150|12201721|FG001|Treatment Period|Data not available|2
7761539|NCT00813150|12201720|FG000|Long Term Follow-up|Death|0
7761540|NCT00813150|12201721|FG001|Long Term Follow-up|Death|4
7761541|NCT00813150|12201720|FG000|Long Term Follow-up|Other|0
7761542|NCT00813150|12201721|FG001|Long Term Follow-up|Other|3
7761543|NCT00813150|12201720|FG000|Long Term Follow-up|Lost to Follow-up|2
7761544|NCT00813150|12201721|FG001|Long Term Follow-up|Lost to Follow-up|0
7761545|NCT00813150|12201720|FG000|Long Term Follow-up|Progression/Relapse|22
7761546|NCT00813150|12201721|FG001|Long Term Follow-up|Progression/Relapse|24
7761547|NCT00813293|12201740|FG000|Overall Study|Intercurrent illness|1
7761548|NCT00813293|12201741|FG001|Overall Study|Intercurrent illness|0
7761549|NCT00813293|12201740|FG000|Overall Study|Adverse Event|0
7761550|NCT00813293|12201741|FG001|Overall Study|Adverse Event|1
7761551|NCT00813358|12201756|FG000|Overall Study|Death|32
7761552|NCT00813358|12201756|FG000|Overall Study|Lost to Follow-up|12
7761553|NCT00813358|12201756|FG000|Overall Study|other endpoints|5
7761554|NCT00813358|12201756|FG000|Overall Study|Withdrawal by Subject|20
7761555|NCT00813488|12201760|FG000|Titration Period 1|Adverse Event|6
7761556|NCT00813488|12201761|FG001|Titration Period 1|Adverse Event|1
7761557|NCT00813488|12201760|FG000|Titration Period 1|Lack of Efficacy|9
7761558|NCT00813488|12201761|FG001|Titration Period 1|Lack of Efficacy|7
7761559|NCT00813488|12201760|FG000|Titration Period 1|Withdrawal by Subject|2
7761560|NCT00813488|12201761|FG001|Titration Period 1|Withdrawal by Subject|2
7761561|NCT00813488|12201760|FG000|Titration Period 1|Protocol Violation|4
7761562|NCT00813488|12201761|FG001|Titration Period 1|Protocol Violation|3
7761563|NCT00813488|12201760|FG000|Titration Period 1|Non-compliance to study medication|4
7761564|NCT00813488|12201761|FG001|Titration Period 1|Non-compliance to study medication|1
7761565|NCT00813488|12201760|FG000|Titration Period 1|Non-compliance to study procedures|2
7761566|NCT00813488|12201761|FG001|Titration Period 1|Non-compliance to study procedures|2
7761567|NCT00813488|12201760|FG000|Titration Period 1|Technical Difficulties|0
7761568|NCT00813488|12201761|FG001|Titration Period 1|Technical Difficulties|1
7761569|NCT00813488|12201760|FG000|Titration Period 2|Adverse Event|2
7761570|NCT00813488|12201761|FG001|Titration Period 2|Adverse Event|3
7761571|NCT00813488|12201760|FG000|Titration Period 2|Lack of Efficacy|8
7761572|NCT00813488|12201761|FG001|Titration Period 2|Lack of Efficacy|4
7761573|NCT00813488|12201760|FG000|Titration Period 2|Protocol Violation|3
7761574|NCT00813488|12201761|FG001|Titration Period 2|Protocol Violation|2
7761575|NCT00813488|12201760|FG000|Titration Period 2|Lost to Follow-up|1
7761576|NCT00813488|12201761|FG001|Titration Period 2|Lost to Follow-up|0
7761577|NCT00813488|12201760|FG000|Titration Period 2|Non-compliance with study procedures|2
7761578|NCT00813488|12201761|FG001|Titration Period 2|Non-compliance with study procedures|1
7761579|NCT00813488|12201760|FG000|Double-blind Treatment Period 1|Adverse Event|1
7761580|NCT00813488|12201761|FG001|Double-blind Treatment Period 1|Adverse Event|1
7761581|NCT00813488|12201760|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0
7761582|NCT00813488|12201761|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1
7761583|NCT00813488|12201760|FG000|Double-blind Treatment Period 1|Protocol Violation|0
7761584|NCT00813488|12201761|FG001|Double-blind Treatment Period 1|Protocol Violation|2
7761585|NCT00813488|12201760|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0
7761586|NCT00813488|12201761|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1
7761587|NCT00813488|12201760|FG000|Double-blind Treatment Period 2|Adverse Event|1
7761588|NCT00813488|12201761|FG001|Double-blind Treatment Period 2|Adverse Event|0
7761589|NCT00813488|12201760|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1
7761590|NCT00813488|12201761|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1
7761591|NCT00813488|12201760|FG000|Double-blind Treatment Period 2|Protocol Violation|2
7761592|NCT00813488|12201761|FG001|Double-blind Treatment Period 2|Protocol Violation|0
7761593|NCT00813488|12201760|FG000|Double-blind Treatment Period 2|Other|1
7761594|NCT00813488|12201761|FG001|Double-blind Treatment Period 2|Other|0
7761595|NCT00813488|12201760|FG000|Open-label Extension|Adverse Event|1
7761596|NCT00813488|12201761|FG001|Open-label Extension|Adverse Event|2
7761597|NCT00813488|12201760|FG000|Open-label Extension|Lack of Efficacy|3
7761598|NCT00813488|12201761|FG001|Open-label Extension|Lack of Efficacy|0
7761599|NCT00813488|12201760|FG000|Open-label Extension|Withdrawal by Subject|0
7761600|NCT00813488|12201761|FG001|Open-label Extension|Withdrawal by Subject|2
7761601|NCT00813488|12201760|FG000|Open-label Extension|Protocol Violation|1
7761602|NCT00813488|12201761|FG001|Open-label Extension|Protocol Violation|2
7761603|NCT00813488|12201760|FG000|Open-label Extension|Non-compliance study medication|4
7761604|NCT00813488|12201761|FG001|Open-label Extension|Non-compliance study medication|0
7761605|NCT00813488|12201760|FG000|Open-label Extension|Non-compliance study procedures|2
7761606|NCT00813488|12201761|FG001|Open-label Extension|Non-compliance study procedures|1
7761607|NCT00813488|12201760|FG000|Open-label Extension|Other|1
7761608|NCT00813488|12201761|FG001|Open-label Extension|Other|0
7761609|NCT00813592|12201771|FG000|Overall Study|Disease assessment was not completed per|2
7761610|NCT00813709|12201779|FG000|Double Blind Period|Adverse Event|4
7761611|NCT00813709|12201780|FG001|Double Blind Period|Adverse Event|1
7761612|NCT00813709|12201781|FG002|Double Blind Period|Adverse Event|4
7761613|NCT00813709|12201782|FG003|Double Blind Period|Adverse Event|0
7761614|NCT00813709|12201783|FG004|Double Blind Period|Adverse Event|0
7761615|NCT00813709|12201784|FG005|Double Blind Period|Adverse Event|0
7761616|NCT00813709|12201779|FG000|Double Blind Period|Lost to Follow-up|3
7761617|NCT00813709|12201780|FG001|Double Blind Period|Lost to Follow-up|2
7761618|NCT00813709|12201781|FG002|Double Blind Period|Lost to Follow-up|2
7761619|NCT00813709|12201782|FG003|Double Blind Period|Lost to Follow-up|0
7761620|NCT00813709|12201783|FG004|Double Blind Period|Lost to Follow-up|0
7761621|NCT00813709|12201784|FG005|Double Blind Period|Lost to Follow-up|0
7761622|NCT00813709|12201779|FG000|Double Blind Period|Switched to open label phase|9
7761623|NCT00813709|12201780|FG001|Double Blind Period|Switched to open label phase|26
7761624|NCT00813709|12201781|FG002|Double Blind Period|Switched to open label phase|18
7761625|NCT00813709|12201782|FG003|Double Blind Period|Switched to open label phase|0
7761626|NCT00813709|12201783|FG004|Double Blind Period|Switched to open label phase|0
7761627|NCT00813709|12201784|FG005|Double Blind Period|Switched to open label phase|0
7761628|NCT00813709|12201779|FG000|Double Blind Period|Randomized but not treated|1
7761629|NCT00813709|12201780|FG001|Double Blind Period|Randomized but not treated|3
7761630|NCT00813709|12201781|FG002|Double Blind Period|Randomized but not treated|1
7761631|NCT00813709|12201782|FG003|Double Blind Period|Randomized but not treated|0
7761632|NCT00813709|12201783|FG004|Double Blind Period|Randomized but not treated|0
7761633|NCT00813709|12201784|FG005|Double Blind Period|Randomized but not treated|0
7761634|NCT00813709|12201779|FG000|Double Blind Period|Other|14
7761635|NCT00813709|12201780|FG001|Double Blind Period|Other|9
7761636|NCT00813709|12201781|FG002|Double Blind Period|Other|6
7761637|NCT00813709|12201782|FG003|Double Blind Period|Other|0
7761638|NCT00813709|12201783|FG004|Double Blind Period|Other|0
7761639|NCT00813709|12201784|FG005|Double Blind Period|Other|0
7761640|NCT00813709|12201779|FG000|Open Label Period|Adverse Event|0
7761641|NCT00813709|12201780|FG001|Open Label Period|Adverse Event|0
7761642|NCT00813709|12201781|FG002|Open Label Period|Adverse Event|0
7761643|NCT00813709|12201782|FG003|Open Label Period|Adverse Event|5
7761644|NCT00813709|12201783|FG004|Open Label Period|Adverse Event|4
7761645|NCT00813709|12201784|FG005|Open Label Period|Adverse Event|3
7761646|NCT00813709|12201779|FG000|Open Label Period|Lack of Efficacy|0
7761647|NCT00813709|12201780|FG001|Open Label Period|Lack of Efficacy|0
7761648|NCT00813709|12201781|FG002|Open Label Period|Lack of Efficacy|0
7761649|NCT00813709|12201782|FG003|Open Label Period|Lack of Efficacy|3
7761650|NCT00813709|12201783|FG004|Open Label Period|Lack of Efficacy|1
7761651|NCT00813709|12201784|FG005|Open Label Period|Lack of Efficacy|1
7761652|NCT00813709|12201779|FG000|Open Label Period|Randomized but not treated|0
7761653|NCT00813709|12201780|FG001|Open Label Period|Randomized but not treated|0
7761654|NCT00813709|12201781|FG002|Open Label Period|Randomized but not treated|0
7761655|NCT00813709|12201782|FG003|Open Label Period|Randomized but not treated|1
7761656|NCT00813709|12201783|FG004|Open Label Period|Randomized but not treated|0
7761657|NCT00813709|12201784|FG005|Open Label Period|Randomized but not treated|1
7761658|NCT00813709|12201779|FG000|Open Label Period|Other|0
7761659|NCT00813709|12201780|FG001|Open Label Period|Other|0
7761660|NCT00813709|12201781|FG002|Open Label Period|Other|0
7761661|NCT00813709|12201782|FG003|Open Label Period|Other|11
7761662|NCT00813709|12201783|FG004|Open Label Period|Other|5
7761663|NCT00813709|12201784|FG005|Open Label Period|Other|6
7761664|NCT00813748|12201815|FG000|Skin Test Substudy|Physician Decision|0
7761665|NCT00813748|12201816|FG001|Skin Test Substudy|Physician Decision|1
7761666|NCT00813761|12201826|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
7761667|NCT00813761|12201827|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
7761668|NCT00813761|12201828|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
7761669|NCT00813761|12201829|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
7761670|NCT00813761|12201826|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
7761671|NCT00813761|12201827|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
7761672|NCT00813761|12201828|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
7761673|NCT00813761|12201829|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
7761674|NCT00813761|12201826|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
7761675|NCT00813761|12201827|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
7761676|NCT00813761|12201828|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
7761677|NCT00813761|12201829|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
7761678|NCT00813761|12201826|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0
7761679|NCT00813761|12201827|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0
7761680|NCT00813761|12201828|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3
7761681|NCT00813761|12201829|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0
7761682|NCT00813761|12201826|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
7761683|NCT00813761|12201827|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
7761684|NCT00813761|12201828|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
7761685|NCT00813761|12201829|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
7761686|NCT00813761|12201826|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
7761687|NCT00813761|12201827|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
7761688|NCT00813761|12201828|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
7761689|NCT00813761|12201829|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
7761690|NCT00813761|12201826|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
7761691|NCT00813761|12201827|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
7761692|NCT00813761|12201828|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
7761693|NCT00813761|12201829|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
7761694|NCT00813761|12201826|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
7761695|NCT00813761|12201827|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
7761696|NCT00813761|12201828|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
7761697|NCT00813761|12201829|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
7761698|NCT00813761|12201826|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
7761699|NCT00813761|12201827|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
7761700|NCT00813761|12201828|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
7761701|NCT00813761|12201829|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
7761702|NCT00813761|12201826|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
7761703|NCT00813761|12201827|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
7761704|NCT00813761|12201828|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
7761705|NCT00813761|12201829|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
7761706|NCT00813761|12201826|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
7761707|NCT00813761|12201827|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
7761708|NCT00813761|12201828|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
7761709|NCT00813761|12201829|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
7761710|NCT00813761|12201826|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
7761711|NCT00813761|12201827|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
7761712|NCT00813761|12201828|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
7761713|NCT00813761|12201829|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
7761714|NCT00813800|12201845|FG000|Overall Study|Screen Failure after Consent|2
7761715|NCT00813800|12201845|FG000|Overall Study|Adverse Event|1
7761716|NCT00813800|12201845|FG000|Overall Study|Worsening of depression|2
7761717|NCT00813800|12201845|FG000|Overall Study|Physician Decision|1
7761718|NCT00813813|12201851|FG000|Overall Study|Withdrawal by Subject|1
7761719|NCT00813813|12201852|FG001|Overall Study|Withdrawal by Subject|1
7761720|NCT00813813|12201851|FG000|Overall Study|Lost to Follow-up|2
7761721|NCT00813813|12201852|FG001|Overall Study|Lost to Follow-up|7
7761722|NCT00813813|12201851|FG000|Overall Study|Other|0
7761723|NCT00813813|12201852|FG001|Overall Study|Other|1
7761724|NCT00813865|12201858|FG000|Overall Study|Failure to Respond|3
7761725|NCT00813865|12201858|FG000|Overall Study|Lost to Follow-up|3
7761726|NCT00813865|12201858|FG000|Overall Study|Withdrawal by Subject|1
7761727|NCT00813904|12201862|FG000|Overall Study|Death|1
7761728|NCT00813917|12201868|FG000|Overall Study|Adverse Event|0
7761729|NCT00813917|12201869|FG001|Overall Study|Adverse Event|1
7761730|NCT00813917|12201868|FG000|Overall Study|Withdrawal by Subject|3
7761731|NCT00813917|12201869|FG001|Overall Study|Withdrawal by Subject|4
7761732|NCT00813917|12201868|FG000|Overall Study|Lost to Follow-up|3
7761733|NCT00813917|12201869|FG001|Overall Study|Lost to Follow-up|1
7761734|NCT00813943|12201878|FG000|Overall Study|Ongoing at cut-off date|5
7761735|NCT00813943|12201879|FG001|Overall Study|Ongoing at cut-off date|5
7761736|NCT00813943|12201880|FG002|Overall Study|Ongoing at cut-off date|3
7761737|NCT00813995|12201897|FG000|Overall Study|Clinical adverse event|9
7761738|NCT00813995|12201898|FG001|Overall Study|Clinical adverse event|3
7761739|NCT00813995|12201897|FG000|Overall Study|Laboratory adverse event|0
7761740|NCT00813995|12201898|FG001|Overall Study|Laboratory adverse event|2
7761741|NCT00813995|12201897|FG000|Overall Study|Lack of Efficacy|1
7761742|NCT00813995|12201898|FG001|Overall Study|Lack of Efficacy|0
7761743|NCT00813995|12201897|FG000|Overall Study|Lost to Follow-up|4
7761744|NCT00813995|12201898|FG001|Overall Study|Lost to Follow-up|2
7761745|NCT00813995|12201897|FG000|Overall Study|Other reason|2
7761746|NCT00813995|12201898|FG001|Overall Study|Other reason|2
7761747|NCT00813995|12201897|FG000|Overall Study|Protocol Violation|3
7761748|NCT00813995|12201898|FG001|Overall Study|Protocol Violation|2
7761749|NCT00813995|12201897|FG000|Overall Study|Subject moved|4
7761750|NCT00813995|12201898|FG001|Overall Study|Subject moved|0
7761751|NCT00813995|12201897|FG000|Overall Study|Withdrawal by Subject|0
7761752|NCT00813995|12201898|FG001|Overall Study|Withdrawal by Subject|5
7761753|NCT00814164|12201919|FG000|Overall Study|Progression|7
7761754|NCT00814164|12201919|FG000|Overall Study|not stated|7
7761755|NCT00814164|12201919|FG000|Overall Study|Death|5
7761756|NCT00814307|12201952|FG000|Overall Study|Randomized but not treated|1
7761757|NCT00814307|12201953|FG001|Overall Study|Randomized but not treated|0
7761758|NCT00814307|12201954|FG002|Overall Study|Randomized but not treated|0
7761759|NCT00814307|12201955|FG003|Overall Study|Randomized but not treated|0
7761760|NCT00814307|12201952|FG000|Overall Study|Adverse Event|3
7761761|NCT00814307|12201953|FG001|Overall Study|Adverse Event|9
7761762|NCT00814307|12201954|FG002|Overall Study|Adverse Event|3
7761763|NCT00814307|12201955|FG003|Overall Study|Adverse Event|2
7761764|NCT00814307|12201952|FG000|Overall Study|Lack of Efficacy|1
7761765|NCT00814307|12201953|FG001|Overall Study|Lack of Efficacy|1
7761766|NCT00814307|12201954|FG002|Overall Study|Lack of Efficacy|3
7761767|NCT00814307|12201955|FG003|Overall Study|Lack of Efficacy|4
7761768|NCT00814307|12201952|FG000|Overall Study|Other|1
7761769|NCT00814307|12201953|FG001|Overall Study|Other|2
7761770|NCT00814307|12201954|FG002|Overall Study|Other|0
7761771|NCT00814307|12201955|FG003|Overall Study|Other|1
7761772|NCT00814307|12201952|FG000|Overall Study|Protocol Violation|2
7761773|NCT00814307|12201953|FG001|Overall Study|Protocol Violation|8
7761774|NCT00814307|12201954|FG002|Overall Study|Protocol Violation|1
7761775|NCT00814307|12201955|FG003|Overall Study|Protocol Violation|1
7761776|NCT00814307|12201952|FG000|Overall Study|Withdrawal by Subject|4
7761777|NCT00814307|12201953|FG001|Overall Study|Withdrawal by Subject|6
7761778|NCT00814307|12201954|FG002|Overall Study|Withdrawal by Subject|0
7761779|NCT00814307|12201955|FG003|Overall Study|Withdrawal by Subject|2
7761780|NCT00814307|12201952|FG000|Overall Study|Death|0
7761781|NCT00814307|12201953|FG001|Overall Study|Death|1
7761782|NCT00814307|12201954|FG002|Overall Study|Death|0
7761783|NCT00814307|12201955|FG003|Overall Study|Death|0
7761784|NCT00814320|12201969|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
7761785|NCT00814320|12201970|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
7761786|NCT00814320|12201969|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
7761787|NCT00814320|12201970|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
7761788|NCT00814320|12201969|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
7761789|NCT00814320|12201970|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
7761790|NCT00814320|12201969|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
7761791|NCT00814320|12201970|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
7761792|NCT00814320|12201969|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
7761793|NCT00814320|12201970|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
7761794|NCT00814320|12201969|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
7761795|NCT00814320|12201970|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
7761796|NCT00814320|12201969|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
7761797|NCT00814320|12201970|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
7761798|NCT00814320|12201969|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
7761799|NCT00814320|12201970|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
7761800|NCT00814320|12201969|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
7761801|NCT00814320|12201970|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
7761802|NCT00814320|12201969|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
7761803|NCT00814320|12201970|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
7761804|NCT00814346|12201995|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0
7761805|NCT00814346|12201996|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1
7761806|NCT00814346|12201995|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0
7761807|NCT00814346|12201996|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2
7761808|NCT00814346|12201995|FG000|Open Phase (17 Months)|Adverse Event|5
7761809|NCT00814346|12201996|FG001|Open Phase (17 Months)|Adverse Event|0
7761810|NCT00814346|12201995|FG000|Open Phase (17 Months)|Consent|2
7761811|NCT00814346|12201996|FG001|Open Phase (17 Months)|Consent|0
7761812|NCT00814346|12201995|FG000|Open Phase (17 Months)|Lost to Follow-up|2
7761813|NCT00814346|12201996|FG001|Open Phase (17 Months)|Lost to Follow-up|0
7761814|NCT00814346|12201995|FG000|Open Phase (17 Months)|Not otherwise specified|1
7761815|NCT00814346|12201996|FG001|Open Phase (17 Months)|Not otherwise specified|0
7761816|NCT00814463|12202015|FG000|Overall Study|Lost to Follow-up|1
7761817|NCT00814489|12202023|FG000|Overall Study|Other|2
7761818|NCT00814489|12202024|FG001|Overall Study|Other|0
7761819|NCT00814489|12202025|FG002|Overall Study|Other|1
7761820|NCT00814502|12202037|FG000|Overall Study|Adverse Event|1
7761821|NCT00814502|12202038|FG001|Overall Study|Adverse Event|0
7761822|NCT00814502|12202037|FG000|Overall Study|Withdrawal by Subject|0
7761823|NCT00814502|12202038|FG001|Overall Study|Withdrawal by Subject|2
7761824|NCT00814580|12202048|FG000|Overall Study|Adverse Event|6
7761825|NCT00814580|12202049|FG001|Overall Study|Adverse Event|15
7761826|NCT00814580|12202048|FG000|Overall Study|Lack of Efficacy|18
7761827|NCT00814580|12202049|FG001|Overall Study|Lack of Efficacy|25
7761828|NCT00814580|12202048|FG000|Overall Study|Protocol Violation|2
7761829|NCT00814580|12202049|FG001|Overall Study|Protocol Violation|0
7761830|NCT00814580|12202048|FG000|Overall Study|Withdrawal by Subject|2
7761831|NCT00814580|12202049|FG001|Overall Study|Withdrawal by Subject|2
7761832|NCT00814580|12202048|FG000|Overall Study|Other|1
7761833|NCT00814580|12202049|FG001|Overall Study|Other|3
7761834|NCT00814580|12202048|FG000|Overall Study|Did Not Take Drug|2
7761835|NCT00814580|12202049|FG001|Overall Study|Did Not Take Drug|2
7761836|NCT00814632|12202067|FG000|Overall Study|Lack of Efficacy|2
7761837|NCT00814658|12202073|FG000|Overall Study|Lost to Follow-up|0
7761838|NCT00814658|12202074|FG001|Overall Study|Lost to Follow-up|1
7761839|NCT00814658|12202073|FG000|Overall Study|Physician Decision|1
7761840|NCT00814658|12202074|FG001|Overall Study|Physician Decision|0
7761841|NCT00814658|12202073|FG000|Overall Study|Adverse Event|3
7761842|NCT00814658|12202074|FG001|Overall Study|Adverse Event|3
7770078|NCT00874237|12213975|FG002|Overall Study|Withdrawal by Subject|1
7770079|NCT00874237|12213976|FG003|Overall Study|Withdrawal by Subject|0
7770080|NCT00874237|12213977|FG004|Overall Study|Withdrawal by Subject|0
7770081|NCT00874237|12213978|FG005|Overall Study|Withdrawal by Subject|0
7770082|NCT00874276|12213995|FG000|Overall Study|Withdrawal by Subject|1
7770083|NCT00874276|12213996|FG001|Overall Study|Withdrawal by Subject|1
7770084|NCT00874432|12214008|FG000|Overall Study|Withdrawal by Subject|1
7770085|NCT00874432|12214009|FG001|Overall Study|Withdrawal by Subject|0
7770086|NCT00874432|12214010|FG002|Overall Study|Withdrawal by Subject|0
7770087|NCT00874432|12214011|FG003|Overall Study|Withdrawal by Subject|0
7770088|NCT00874432|12214008|FG000|Overall Study|Physician Decision|1
7770089|NCT00874432|12214009|FG001|Overall Study|Physician Decision|0
7761843|NCT00814710|12202113|FG000|Overall Study|Adverse Event|1
7761844|NCT00814710|12202114|FG001|Overall Study|Adverse Event|0
7761845|NCT00814710|12202113|FG000|Overall Study|Lost to Follow-up|7
7761846|NCT00814710|12202114|FG001|Overall Study|Lost to Follow-up|3
7761847|NCT00814801|12202138|FG000|Overall Study|Adverse Event|15
7761848|NCT00814801|12202139|FG001|Overall Study|Adverse Event|16
7761849|NCT00814801|12202140|FG002|Overall Study|Adverse Event|19
7761850|NCT00814801|12202138|FG000|Overall Study|Withdrawal by Subject|9
7761851|NCT00814801|12202139|FG001|Overall Study|Withdrawal by Subject|11
7761852|NCT00814801|12202140|FG002|Overall Study|Withdrawal by Subject|14
7761853|NCT00814801|12202138|FG000|Overall Study|Inappropriate as a subject|1
7761854|NCT00814801|12202139|FG001|Overall Study|Inappropriate as a subject|1
7761855|NCT00814801|12202140|FG002|Overall Study|Inappropriate as a subject|1
7761856|NCT00814801|12202138|FG000|Overall Study|Change of patients for CIBIC plus-J|1
7761857|NCT00814801|12202139|FG001|Overall Study|Change of patients for CIBIC plus-J|1
7761858|NCT00814801|12202140|FG002|Overall Study|Change of patients for CIBIC plus-J|0
7761859|NCT00814801|12202138|FG000|Overall Study|Missing or change of caregiver|6
7761860|NCT00814801|12202139|FG001|Overall Study|Missing or change of caregiver|2
7761861|NCT00814801|12202140|FG002|Overall Study|Missing or change of caregiver|4
7761862|NCT00814801|12202138|FG000|Overall Study|Non-compliance|0
7761863|NCT00814801|12202139|FG001|Overall Study|Non-compliance|1
7761864|NCT00814801|12202140|FG002|Overall Study|Non-compliance|1
7761865|NCT00814801|12202138|FG000|Overall Study|Other|2
7761866|NCT00814801|12202139|FG001|Overall Study|Other|6
7761867|NCT00814801|12202140|FG002|Overall Study|Other|4
7761868|NCT00814879|12202150|FG000|By Week 24|Cancer Diagnosis|1
7761869|NCT00814879|12202151|FG001|By Week 24|Cancer Diagnosis|0
7761870|NCT00814879|12202150|FG000|By Week 24|Incarceration|0
7761871|NCT00814879|12202151|FG001|By Week 24|Incarceration|1
7761872|NCT00814879|12202150|FG000|By Week 48|Lost to Follow-up|2
7761873|NCT00814879|12202151|FG001|By Week 48|Lost to Follow-up|2
7761874|NCT00814879|12202150|FG000|By Week 48|Death|0
7761875|NCT00814879|12202151|FG001|By Week 48|Death|1
7761876|NCT00815191|12202188|FG000|Overall Study|Protocol Violation|1
7761877|NCT00815191|12202189|FG001|Overall Study|Protocol Violation|1
7761878|NCT00815295|12202198|FG000|Overall Study|Cetuximab hypersensitivity reaction|0
7761879|NCT00815295|12202199|FG001|Overall Study|Cetuximab hypersensitivity reaction|1
7761880|NCT00815295|12202200|FG002|Overall Study|Cetuximab hypersensitivity reaction|3
7761881|NCT00815308|12202208|FG000|Overall Study|Adverse Event|4
7761882|NCT00815308|12202208|FG000|Overall Study|Withdrawal by Subject|0
7761883|NCT00815308|12202208|FG000|Overall Study|Protocol Violation|6
7761884|NCT00815516|12202238|FG000|Overall Study|Death|3
7761885|NCT00815516|12202239|FG001|Overall Study|Death|1
7761886|NCT00815516|12202238|FG000|Overall Study|Physician Decision|1
7761887|NCT00815516|12202239|FG001|Overall Study|Physician Decision|0
7761888|NCT00815659|12202245|FG000|Overall Study|Adverse Event|9
7761889|NCT00815659|12202245|FG000|Overall Study|Withdrawal by Subject|9
7761890|NCT00815659|12202245|FG000|Overall Study|Lost to Follow-up|4
7761891|NCT00815659|12202245|FG000|Overall Study|Protocol Violation|1
7761892|NCT00815919|12202278|FG000|Overall Study|Unrelated Fungal Infection|1
7761893|NCT00815919|12202278|FG000|Overall Study|AML Relapse|1
7761894|NCT00815919|12202278|FG000|Overall Study|Lack of Efficacy|2
7761895|NCT00816023|12202297|FG000|Overall Study|Lost to Follow-up|1
7761896|NCT00816023|12202298|FG001|Overall Study|Lost to Follow-up|1
7761897|NCT00816023|12202299|FG002|Overall Study|Lost to Follow-up|0
7761898|NCT00816023|12202300|FG003|Overall Study|Lost to Follow-up|0
7761899|NCT00816023|12202297|FG000|Overall Study|Withdrawal by Subject|1
7761900|NCT00816023|12202298|FG001|Overall Study|Withdrawal by Subject|0
7761901|NCT00816023|12202299|FG002|Overall Study|Withdrawal by Subject|0
7761902|NCT00816023|12202300|FG003|Overall Study|Withdrawal by Subject|0
7761903|NCT00816023|12202297|FG000|Overall Study|Physician Decision|0
7761904|NCT00816023|12202298|FG001|Overall Study|Physician Decision|0
7761905|NCT00816023|12202299|FG002|Overall Study|Physician Decision|1
7761906|NCT00816023|12202300|FG003|Overall Study|Physician Decision|0
7761907|NCT00816023|12202297|FG000|Overall Study|assessments complete prior to window|1
7761908|NCT00816023|12202298|FG001|Overall Study|assessments complete prior to window|1
7761909|NCT00816023|12202299|FG002|Overall Study|assessments complete prior to window|2
7761910|NCT00816023|12202300|FG003|Overall Study|assessments complete prior to window|1
7761911|NCT00816023|12202297|FG000|Overall Study|Randomized Not Treated|6
7761912|NCT00816023|12202298|FG001|Overall Study|Randomized Not Treated|4
7761913|NCT00816023|12202299|FG002|Overall Study|Randomized Not Treated|6
7761914|NCT00816023|12202300|FG003|Overall Study|Randomized Not Treated|11
7761915|NCT00816036|12202312|FG000|Overall Study|Death|47
7761916|NCT00816036|12202313|FG001|Overall Study|Death|28
7761917|NCT00816036|12202312|FG000|Overall Study|Lost to Follow-up|75
7761918|NCT00816036|12202313|FG001|Overall Study|Lost to Follow-up|57
7761919|NCT00816036|12202312|FG000|Overall Study|Withdrawal by Subject|54
7761920|NCT00816036|12202313|FG001|Overall Study|Withdrawal by Subject|23
7761921|NCT00816166|12202339|FG000|Overall Study|Lost to Follow-up|6
7761922|NCT00816166|12202340|FG001|Overall Study|Lost to Follow-up|10
7761923|NCT00816166|12202339|FG000|Overall Study|Death|4
7761924|NCT00816166|12202340|FG001|Overall Study|Death|2
7761925|NCT00816361|12202357|FG000|Overall Study|Withdrawal by Subject|0
7761926|NCT00816361|12202358|FG001|Overall Study|Withdrawal by Subject|0
7761927|NCT00816361|12202359|FG002|Overall Study|Withdrawal by Subject|0
7761928|NCT00816361|12202360|FG003|Overall Study|Withdrawal by Subject|0
7761929|NCT00816361|12202361|FG004|Overall Study|Withdrawal by Subject|1
7761930|NCT00816361|12202362|FG005|Overall Study|Withdrawal by Subject|2
7761931|NCT00816361|12202363|FG006|Overall Study|Withdrawal by Subject|0
7761932|NCT00816361|12202364|FG007|Overall Study|Withdrawal by Subject|2
7761933|NCT00816361|12202365|FG008|Overall Study|Withdrawal by Subject|1
7761934|NCT00816361|12202357|FG000|Overall Study|Death|4
7761935|NCT00816361|12202358|FG001|Overall Study|Death|3
7761936|NCT00816361|12202359|FG002|Overall Study|Death|3
7761937|NCT00816361|12202360|FG003|Overall Study|Death|3
7761938|NCT00816361|12202361|FG004|Overall Study|Death|1
7761939|NCT00816361|12202362|FG005|Overall Study|Death|1
7761940|NCT00816361|12202363|FG006|Overall Study|Death|3
7761941|NCT00816361|12202364|FG007|Overall Study|Death|7
7761942|NCT00816361|12202365|FG008|Overall Study|Death|8
7761943|NCT00816361|12202357|FG000|Overall Study|Other|0
7761944|NCT00816361|12202358|FG001|Overall Study|Other|0
7761945|NCT00816361|12202359|FG002|Overall Study|Other|0
7761946|NCT00816361|12202360|FG003|Overall Study|Other|0
7761947|NCT00816361|12202361|FG004|Overall Study|Other|0
7761948|NCT00816361|12202362|FG005|Overall Study|Other|0
7761949|NCT00816361|12202363|FG006|Overall Study|Other|0
7761950|NCT00816361|12202364|FG007|Overall Study|Other|0
7761951|NCT00816361|12202365|FG008|Overall Study|Other|1
7761952|NCT00816400|12202395|FG000|Overall Study|Death|2
7761953|NCT00816400|12202396|FG001|Overall Study|Death|3
7761954|NCT00816400|12202397|FG002|Overall Study|Death|3
7761955|NCT00816400|12202398|FG003|Overall Study|Death|3
7761956|NCT00816400|12202399|FG004|Overall Study|Death|2
7761957|NCT00816400|12202400|FG005|Overall Study|Death|3
7761958|NCT00816400|12202401|FG006|Overall Study|Death|2
7761959|NCT00816400|12202402|FG007|Overall Study|Death|5
7761960|NCT00816400|12202403|FG008|Overall Study|Death|6
7761961|NCT00816400|12202395|FG000|Overall Study|In hospice care at the end of the study|0
7761962|NCT00816400|12202396|FG001|Overall Study|In hospice care at the end of the study|0
7761963|NCT00816400|12202397|FG002|Overall Study|In hospice care at the end of the study|2
7761964|NCT00816400|12202398|FG003|Overall Study|In hospice care at the end of the study|0
7761965|NCT00816400|12202399|FG004|Overall Study|In hospice care at the end of the study|0
7761966|NCT00816400|12202400|FG005|Overall Study|In hospice care at the end of the study|0
7761967|NCT00816400|12202401|FG006|Overall Study|In hospice care at the end of the study|0
7761968|NCT00816400|12202402|FG007|Overall Study|In hospice care at the end of the study|0
7761969|NCT00816400|12202403|FG008|Overall Study|In hospice care at the end of the study|0
7761970|NCT00816556|12202427|FG000|Overall Study|Adverse Event|1
7761971|NCT00816556|12202428|FG001|Overall Study|Adverse Event|1
7761972|NCT00816556|12202429|FG002|Overall Study|Adverse Event|1
7761973|NCT00816556|12202427|FG000|Overall Study|Withdrawal by Subject|1
7761974|NCT00816556|12202428|FG001|Overall Study|Withdrawal by Subject|1
7761975|NCT00816556|12202429|FG002|Overall Study|Withdrawal by Subject|1
7761976|NCT00816556|12202427|FG000|Overall Study|Lost to Follow-up|0
7761977|NCT00816556|12202428|FG001|Overall Study|Lost to Follow-up|0
7761978|NCT00816556|12202429|FG002|Overall Study|Lost to Follow-up|1
7761979|NCT00816595|12202439|FG000|Overall Study|Withdrawal by Subject|2
7761980|NCT00816595|12202440|FG001|Overall Study|Withdrawal by Subject|0
7761981|NCT00817063|12202479|FG000|Overall Study|Adverse Event|32
7761982|NCT00817063|12202480|FG001|Overall Study|Adverse Event|13
7761983|NCT00817063|12202479|FG000|Overall Study|Death|1
7761984|NCT00817063|12202480|FG001|Overall Study|Death|1
7761985|NCT00817063|12202479|FG000|Overall Study|Lack of Efficacy|33
7761986|NCT00817063|12202480|FG001|Overall Study|Lack of Efficacy|86
7761987|NCT00817063|12202479|FG000|Overall Study|Failure to Return|13
7761988|NCT00817063|12202480|FG001|Overall Study|Failure to Return|12
7761989|NCT00817063|12202479|FG000|Overall Study|Violation of Selection at Entry|7
7761990|NCT00817063|12202480|FG001|Overall Study|Violation of Selection at Entry|4
7761991|NCT00817063|12202479|FG000|Overall Study|Protocol Violation|3
7761992|NCT00817063|12202480|FG001|Overall Study|Protocol Violation|8
7761993|NCT00817063|12202479|FG000|Overall Study|Withdrawal by Subject|17
7761994|NCT00817063|12202480|FG001|Overall Study|Withdrawal by Subject|37
7761995|NCT00817063|12202479|FG000|Overall Study|Early Improvement|19
7761996|NCT00817063|12202480|FG001|Overall Study|Early Improvement|4
7761997|NCT00817063|12202479|FG000|Overall Study|Administrative|10
7761998|NCT00817063|12202480|FG001|Overall Study|Administrative|4
7761999|NCT00817063|12202479|FG000|Overall Study|Abnormality of Laboratory Test|2
7762000|NCT00817063|12202480|FG001|Overall Study|Abnormality of Laboratory Test|1
7762001|NCT00817089|12202490|FG000|First Alcohol Challenge|Lost to Follow-up|0
7762002|NCT00817089|12202491|FG001|First Alcohol Challenge|Lost to Follow-up|0
7762003|NCT00817089|12202492|FG002|First Alcohol Challenge|Lost to Follow-up|0
7762004|NCT00817089|12202493|FG003|First Alcohol Challenge|Lost to Follow-up|1
7762005|NCT00817089|12202490|FG000|Second Alcohol Challenge|Lost to Follow-up|0
7762006|NCT00817089|12202491|FG001|Second Alcohol Challenge|Lost to Follow-up|1
7762007|NCT00817089|12202492|FG002|Second Alcohol Challenge|Lost to Follow-up|0
7762008|NCT00817089|12202493|FG003|Second Alcohol Challenge|Lost to Follow-up|0
7762009|NCT00817206|12202509|FG000|Overall Study|Adverse Event|10
7762010|NCT00817206|12202510|FG001|Overall Study|Adverse Event|3
7762011|NCT00817206|12202509|FG000|Overall Study|Protocol Violation|0
7762012|NCT00817206|12202510|FG001|Overall Study|Protocol Violation|2
7762013|NCT00817206|12202509|FG000|Overall Study|Lost to Follow-up|0
7762014|NCT00817206|12202510|FG001|Overall Study|Lost to Follow-up|1
7762015|NCT00817206|12202509|FG000|Overall Study|Death|2
7762016|NCT00817206|12202510|FG001|Overall Study|Death|0
7762017|NCT00817206|12202509|FG000|Overall Study|Withdrawal by Subject|7
7762018|NCT00817206|12202510|FG001|Overall Study|Withdrawal by Subject|3
7762019|NCT00817206|12202509|FG000|Overall Study|Physician Decision|2
7762020|NCT00817206|12202510|FG001|Overall Study|Physician Decision|0
7762021|NCT00817336|12202522|FG000|Overall Study|Withdrawal by Subject|1
7762022|NCT00817336|12202523|FG001|Overall Study|Withdrawal by Subject|1
7762023|NCT00817414|12202533|FG000|Overall Study|Adverse Event|1
7762024|NCT00817414|12202534|FG001|Overall Study|Adverse Event|1
7762025|NCT00817414|12202535|FG002|Overall Study|Adverse Event|1
7762026|NCT00817414|12202536|FG003|Overall Study|Adverse Event|0
7762027|NCT00817414|12202537|FG004|Overall Study|Adverse Event|0
7762028|NCT00817414|12202533|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0
7762029|NCT00817414|12202534|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1
7762030|NCT00817414|12202535|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2
7762031|NCT00817414|12202536|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4
7762032|NCT00817414|12202537|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0
7762033|NCT00817414|12202533|FG000|Overall Study|Withdrawal by Subject|1
7762034|NCT00817414|12202534|FG001|Overall Study|Withdrawal by Subject|1
7762035|NCT00817414|12202535|FG002|Overall Study|Withdrawal by Subject|0
7762036|NCT00817414|12202536|FG003|Overall Study|Withdrawal by Subject|0
7762037|NCT00817414|12202537|FG004|Overall Study|Withdrawal by Subject|0
7762038|NCT00817414|12202533|FG000|Overall Study|Lost to Follow-up|0
7762039|NCT00817414|12202534|FG001|Overall Study|Lost to Follow-up|0
7762040|NCT00817414|12202535|FG002|Overall Study|Lost to Follow-up|1
7762041|NCT00817414|12202536|FG003|Overall Study|Lost to Follow-up|1
7762042|NCT00817414|12202537|FG004|Overall Study|Lost to Follow-up|1
7762043|NCT00817414|12202533|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
7762044|NCT00817414|12202534|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
7770090|NCT00874432|12214010|FG002|Overall Study|Physician Decision|0
7762045|NCT00817414|12202535|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
7762046|NCT00817414|12202536|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7
7762047|NCT00817414|12202537|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
7762048|NCT00817414|12202533|FG000|Overall Study|Protocol Violation|0
7762049|NCT00817414|12202534|FG001|Overall Study|Protocol Violation|0
7762050|NCT00817414|12202535|FG002|Overall Study|Protocol Violation|0
7762051|NCT00817414|12202536|FG003|Overall Study|Protocol Violation|0
7762052|NCT00817414|12202537|FG004|Overall Study|Protocol Violation|1
7762053|NCT00817479|12202556|FG000|Overall Study|Physician Decision|1
7762054|NCT00817479|12202557|FG001|Overall Study|Physician Decision|1
7762055|NCT00817531|12202563|FG000|Overall Study|Adverse Event|1
7762056|NCT00817531|12202563|FG000|Overall Study|Lack of Efficacy|1
7762057|NCT00817635|12202576|FG000|Overall Study|Adverse Event|1
7762058|NCT00817635|12202577|FG001|Overall Study|Adverse Event|0
7762059|NCT00817635|12202578|FG002|Overall Study|Adverse Event|0
7762060|NCT00817635|12202579|FG003|Overall Study|Adverse Event|1
7762061|NCT00817635|12202580|FG004|Overall Study|Adverse Event|1
7762062|NCT00817635|12202576|FG000|Overall Study|Abnormal Laboratory Value(s)|1
7762063|NCT00817635|12202577|FG001|Overall Study|Abnormal Laboratory Value(s)|1
7762064|NCT00817635|12202578|FG002|Overall Study|Abnormal Laboratory Value(s)|0
7762065|NCT00817635|12202579|FG003|Overall Study|Abnormal Laboratory Value(s)|0
7762066|NCT00817635|12202580|FG004|Overall Study|Abnormal Laboratory Value(s)|1
7762067|NCT00817635|12202576|FG000|Overall Study|Withdrawal by Subject|2
7762068|NCT00817635|12202577|FG001|Overall Study|Withdrawal by Subject|1
7762069|NCT00817635|12202578|FG002|Overall Study|Withdrawal by Subject|0
7762070|NCT00817635|12202579|FG003|Overall Study|Withdrawal by Subject|1
7762071|NCT00817635|12202580|FG004|Overall Study|Withdrawal by Subject|2
7762072|NCT00817635|12202576|FG000|Overall Study|Lost to Follow-up|0
7762073|NCT00817635|12202577|FG001|Overall Study|Lost to Follow-up|1
7762074|NCT00817635|12202578|FG002|Overall Study|Lost to Follow-up|0
7762075|NCT00817635|12202579|FG003|Overall Study|Lost to Follow-up|1
7762076|NCT00817635|12202580|FG004|Overall Study|Lost to Follow-up|0
7762077|NCT00817635|12202576|FG000|Overall Study|Administrative Problems|0
7762078|NCT00817635|12202577|FG001|Overall Study|Administrative Problems|0
7762079|NCT00817635|12202578|FG002|Overall Study|Administrative Problems|0
7762080|NCT00817635|12202579|FG003|Overall Study|Administrative Problems|0
7762081|NCT00817635|12202580|FG004|Overall Study|Administrative Problems|1
7762082|NCT00817635|12202576|FG000|Overall Study|Protocol Violation|5
7762083|NCT00817635|12202577|FG001|Overall Study|Protocol Violation|1
7762084|NCT00817635|12202578|FG002|Overall Study|Protocol Violation|3
7762085|NCT00817635|12202579|FG003|Overall Study|Protocol Violation|2
7762086|NCT00817635|12202580|FG004|Overall Study|Protocol Violation|3
7762087|NCT00817778|12202601|FG000|Overall Study|Adverse Event|1
7762088|NCT00817778|12202602|FG001|Overall Study|Adverse Event|0
7762089|NCT00817778|12202601|FG000|Overall Study|Withdrawal by Subject|1
7762090|NCT00817778|12202602|FG001|Overall Study|Withdrawal by Subject|1
7762091|NCT00817778|12202601|FG000|Overall Study|Protocol Violation|0
7762092|NCT00817778|12202602|FG001|Overall Study|Protocol Violation|1
7762093|NCT00817778|12202601|FG000|Overall Study|Study-specific discontinuation criteria|0
7762094|NCT00817778|12202602|FG001|Overall Study|Study-specific discontinuation criteria|1
7762095|NCT00817778|12202601|FG000|Overall Study|Poor venous access|1
7762096|NCT00817778|12202602|FG001|Overall Study|Poor venous access|0
7762097|NCT00818168|12202638|FG000|Overall Study|Lack of Efficacy|18
7762098|NCT00818168|12202638|FG000|Overall Study|Pregnancy|2
7762099|NCT00818168|12202638|FG000|Overall Study|Withdrawal by Subject|16
7762100|NCT00818168|12202638|FG000|Overall Study|Lost to Follow-up|7
7762101|NCT00818168|12202638|FG000|Overall Study|Adverse Event|19
7762102|NCT00818168|12202638|FG000|Overall Study|Reason for Non-completion Not reported|6
7762103|NCT00818168|12202638|FG000|Overall Study|Participant Moved|2
7762104|NCT00818207|12202644|FG000|Overall Study|Adverse Event|6
7762105|NCT00818207|12202645|FG001|Overall Study|Adverse Event|0
7762106|NCT00818207|12202644|FG000|Overall Study|Lost to Follow-up|160
7762107|NCT00818207|12202645|FG001|Overall Study|Lost to Follow-up|146
7762108|NCT00818207|12202644|FG000|Overall Study|Multiple reasons|11
7762109|NCT00818207|12202645|FG001|Overall Study|Multiple reasons|12
7762110|NCT00818207|12202644|FG000|Overall Study|Withdrawal by Subject|42
7762111|NCT00818207|12202645|FG001|Overall Study|Withdrawal by Subject|104
7762112|NCT00818207|12202644|FG000|Overall Study|Death|3
7762113|NCT00818207|12202645|FG001|Overall Study|Death|5
7762114|NCT00818246|12202651|FG000|Overall Study|Impossible to match pictures|5
7762115|NCT00818259|12202662|FG000|Part I|Withdrawal by Subject|1
7762116|NCT00818259|12202663|FG001|Part I|Withdrawal by Subject|0
7762117|NCT00818259|12202664|FG002|Part I|Withdrawal by Subject|0
7762118|NCT00818259|12202665|FG003|Part I|Withdrawal by Subject|0
7762119|NCT00818259|12202666|FG004|Part I|Withdrawal by Subject|0
7762120|NCT00818259|12202667|FG005|Part I|Withdrawal by Subject|0
7762121|NCT00818259|12202668|FG006|Part I|Withdrawal by Subject|0
7762122|NCT00818259|12202669|FG007|Part I|Withdrawal by Subject|0
7762123|NCT00818259|12202670|FG008|Part I|Withdrawal by Subject|0
7762124|NCT00818259|12202662|FG000|Part II|Physician Decision|0
7762125|NCT00818259|12202663|FG001|Part II|Physician Decision|0
7762126|NCT00818259|12202664|FG002|Part II|Physician Decision|1
7762127|NCT00818259|12202665|FG003|Part II|Physician Decision|0
7762128|NCT00818259|12202666|FG004|Part II|Physician Decision|0
7762129|NCT00818259|12202667|FG005|Part II|Physician Decision|0
7762130|NCT00818259|12202668|FG006|Part II|Physician Decision|0
7762131|NCT00818259|12202669|FG007|Part II|Physician Decision|0
7762132|NCT00818259|12202670|FG008|Part II|Physician Decision|0
7762133|NCT00818259|12202662|FG000|Part II|Lack of Efficacy|0
7762134|NCT00818259|12202663|FG001|Part II|Lack of Efficacy|0
7762135|NCT00818259|12202664|FG002|Part II|Lack of Efficacy|0
7762136|NCT00818259|12202665|FG003|Part II|Lack of Efficacy|1
7762137|NCT00818259|12202666|FG004|Part II|Lack of Efficacy|0
7762138|NCT00818259|12202667|FG005|Part II|Lack of Efficacy|0
7762139|NCT00818259|12202668|FG006|Part II|Lack of Efficacy|0
7762140|NCT00818259|12202669|FG007|Part II|Lack of Efficacy|0
7762141|NCT00818259|12202670|FG008|Part II|Lack of Efficacy|0
7762142|NCT00818259|12202662|FG000|Part II|Not Treated|0
7762143|NCT00818259|12202663|FG001|Part II|Not Treated|0
7762144|NCT00818259|12202664|FG002|Part II|Not Treated|0
7762145|NCT00818259|12202665|FG003|Part II|Not Treated|1
7762146|NCT00818259|12202666|FG004|Part II|Not Treated|0
7762147|NCT00818259|12202667|FG005|Part II|Not Treated|0
7762148|NCT00818259|12202668|FG006|Part II|Not Treated|0
7762149|NCT00818259|12202669|FG007|Part II|Not Treated|0
7762150|NCT00818259|12202670|FG008|Part II|Not Treated|0
7762151|NCT00818259|12202662|FG000|Part IV|Physician Decision|0
7762152|NCT00818259|12202663|FG001|Part IV|Physician Decision|0
7762153|NCT00818259|12202664|FG002|Part IV|Physician Decision|0
7762154|NCT00818259|12202665|FG003|Part IV|Physician Decision|0
7762155|NCT00818259|12202666|FG004|Part IV|Physician Decision|0
7762156|NCT00818259|12202667|FG005|Part IV|Physician Decision|1
7762157|NCT00818259|12202668|FG006|Part IV|Physician Decision|0
7762158|NCT00818259|12202669|FG007|Part IV|Physician Decision|0
7762159|NCT00818259|12202670|FG008|Part IV|Physician Decision|0
7762160|NCT00818259|12202662|FG000|Part V|Adverse Event|0
7762161|NCT00818259|12202663|FG001|Part V|Adverse Event|0
7762162|NCT00818259|12202664|FG002|Part V|Adverse Event|0
7962659|NCT02713204|12516854|FG001|From Week 12 up to Week 36|Participant Re-located|0
7962660|NCT02713204|12516855|FG002|From Week 12 up to Week 36|Participant Re-located|0
7962661|NCT02713204|12516856|FG003|From Week 12 up to Week 36|Participant Re-located|0
7962662|NCT02713204|12516857|FG004|From Week 12 up to Week 36|Participant Re-located|1
7962663|NCT02713204|12516858|FG005|From Week 12 up to Week 36|Participant Re-located|0
7962664|NCT02713204|12516859|FG006|From Week 12 up to Week 36|Participant Re-located|0
7962665|NCT02713204|12516860|FG007|From Week 12 up to Week 36|Participant Re-located|0
7962666|NCT02713243|12516891|FG000|Overall Study|Abnormal laboratory value(s)#|1
7962667|NCT02713243|12516892|FG001|Overall Study|Abnormal laboratory value(s)#|0
7962668|NCT02713243|12516891|FG000|Overall Study|Administrative problems|0
7962669|NCT02713243|12516892|FG001|Overall Study|Administrative problems|1
7962670|NCT02713243|12516891|FG000|Overall Study|Protocol deviation|0
7762163|NCT00818259|12202665|FG003|Part V|Adverse Event|0
7762164|NCT00818259|12202666|FG004|Part V|Adverse Event|0
7762165|NCT00818259|12202667|FG005|Part V|Adverse Event|0
7962671|NCT02713243|12516892|FG001|Overall Study|Protocol deviation|1
7962672|NCT02713490|12516908|FG000|Overall Study|Withdrawal by Subject|2
7962673|NCT02713490|12516909|FG001|Overall Study|Withdrawal by Subject|1
7962674|NCT02713490|12516908|FG000|Overall Study|Did not receive study drug|1
7962675|NCT02713490|12516909|FG001|Overall Study|Did not receive study drug|0
7962676|NCT02713490|12516908|FG000|Overall Study|Met exclusion criteria|0
7962677|NCT02713490|12516909|FG001|Overall Study|Met exclusion criteria|1
7962678|NCT02713529|12516922|FG000|Overall Study|Withdrawal by Subject|3
7962679|NCT02713529|12516923|FG001|Overall Study|Withdrawal by Subject|1
7962680|NCT02713529|12516924|FG002|Overall Study|Withdrawal by Subject|4
7962681|NCT02713529|12516925|FG003|Overall Study|Withdrawal by Subject|2
7962682|NCT02713529|12516926|FG004|Overall Study|Withdrawal by Subject|0
7962683|NCT02713529|12516927|FG005|Overall Study|Withdrawal by Subject|1
7962684|NCT02713529|12516928|FG006|Overall Study|Withdrawal by Subject|1
7962685|NCT02713529|12516922|FG000|Overall Study|Lost to Follow-up|1
7762166|NCT00818259|12202668|FG006|Part V|Adverse Event|0
7762167|NCT00818259|12202669|FG007|Part V|Adverse Event|1
7762168|NCT00818259|12202670|FG008|Part V|Adverse Event|0
7762169|NCT00818389|12202710|FG000|Overall Study|Death|1
7762170|NCT00818389|12202711|FG001|Overall Study|Death|3
7762171|NCT00818389|12202710|FG000|Overall Study|ALS Disease Progression|1
7762172|NCT00818389|12202711|FG001|Overall Study|ALS Disease Progression|0
7762173|NCT00818389|12202710|FG000|Overall Study|Withdrawal by Subject|2
7762174|NCT00818389|12202711|FG001|Overall Study|Withdrawal by Subject|2
7762175|NCT00818389|12202710|FG000|Overall Study|Adverse Event|0
7762176|NCT00818389|12202711|FG001|Overall Study|Adverse Event|1
7762177|NCT00818441|12202719|FG000|Overall Study|Death|69
7762178|NCT00818441|12202720|FG001|Overall Study|Death|26
7762179|NCT00818441|12202719|FG000|Overall Study|Other|5
7762180|NCT00818441|12202720|FG001|Overall Study|Other|0
7762181|NCT00818441|12202719|FG000|Overall Study|Lost to Follow-up|2
7762182|NCT00818441|12202720|FG001|Overall Study|Lost to Follow-up|1
7762183|NCT00818441|12202719|FG000|Overall Study|Withdrawal by Subject|2
7762184|NCT00818441|12202720|FG001|Overall Study|Withdrawal by Subject|0
7762185|NCT00818441|12202719|FG000|Overall Study|Adverse Event|0
7762186|NCT00818441|12202720|FG001|Overall Study|Adverse Event|1
7762187|NCT00818441|12202719|FG000|Overall Study|Study terminated by sponsor|11
7762188|NCT00818441|12202720|FG001|Overall Study|Study terminated by sponsor|2
7762189|NCT00818454|12202727|FG000|Treatment Period 1|Adverse Event|0
7762190|NCT00818454|12202728|FG001|Treatment Period 1|Adverse Event|1
7762191|NCT00818454|12202729|FG002|Treatment Period 1|Adverse Event|0
7762192|NCT00818454|12202730|FG003|Treatment Period 1|Adverse Event|0
7762193|NCT00818454|12202727|FG000|Treatment Period 1|Other|3
7762194|NCT00818454|12202728|FG001|Treatment Period 1|Other|0
7762195|NCT00818454|12202729|FG002|Treatment Period 1|Other|0
7762196|NCT00818454|12202730|FG003|Treatment Period 1|Other|0
7762197|NCT00818454|12202727|FG000|Washout Period of 1 Week|Adverse Event|1
7762198|NCT00818454|12202728|FG001|Washout Period of 1 Week|Adverse Event|1
7762199|NCT00818454|12202729|FG002|Washout Period of 1 Week|Adverse Event|0
7762200|NCT00818454|12202730|FG003|Washout Period of 1 Week|Adverse Event|0
7762201|NCT00818454|12202727|FG000|Washout Period of 1 Week|Protocol Violation|2
7762202|NCT00818454|12202728|FG001|Washout Period of 1 Week|Protocol Violation|0
7762203|NCT00818454|12202729|FG002|Washout Period of 1 Week|Protocol Violation|0
7762204|NCT00818454|12202730|FG003|Washout Period of 1 Week|Protocol Violation|0
7762205|NCT00818454|12202727|FG000|Washout Period of 1 Week|Other|1
7762206|NCT00818454|12202728|FG001|Washout Period of 1 Week|Other|2
7762207|NCT00818454|12202729|FG002|Washout Period of 1 Week|Other|0
7762208|NCT00818454|12202730|FG003|Washout Period of 1 Week|Other|0
7762209|NCT00818454|12202727|FG000|Treatment Period 2|Other|2
7762210|NCT00818454|12202728|FG001|Treatment Period 2|Other|1
7762211|NCT00818454|12202729|FG002|Treatment Period 2|Other|0
7762212|NCT00818454|12202730|FG003|Treatment Period 2|Other|0
7762213|NCT00818454|12202727|FG000|Treatment Period 3|Adverse Event|0
7762214|NCT00818454|12202728|FG001|Treatment Period 3|Adverse Event|0
7762215|NCT00818454|12202729|FG002|Treatment Period 3|Adverse Event|0
7762216|NCT00818454|12202730|FG003|Treatment Period 3|Adverse Event|1
7762217|NCT00818519|12202742|FG000|Overall Study|Adverse Event|2
7762218|NCT00818519|12202743|FG001|Overall Study|Adverse Event|2
7762219|NCT00818519|12202742|FG000|Overall Study|Lost to Follow-up|4
7762220|NCT00818519|12202743|FG001|Overall Study|Lost to Follow-up|6
7762221|NCT00818519|12202742|FG000|Overall Study|Protocol Violation|2
7762222|NCT00818519|12202743|FG001|Overall Study|Protocol Violation|1
7762223|NCT00818519|12202742|FG000|Overall Study|Pregnancy|0
7762224|NCT00818519|12202743|FG001|Overall Study|Pregnancy|1
7762225|NCT00818519|12202742|FG000|Overall Study|Withdrawal by Subject|4
7762226|NCT00818519|12202743|FG001|Overall Study|Withdrawal by Subject|9
7762227|NCT00818519|12202742|FG000|Overall Study|participant recovered completely|1
7762228|NCT00818519|12202743|FG001|Overall Study|participant recovered completely|0
7762229|NCT00818519|12202742|FG000|Overall Study|participant will leave for long tme|1
7762230|NCT00818519|12202743|FG001|Overall Study|participant will leave for long tme|0
7762231|NCT00818623|12202757|FG000|Overall Study|Adverse Event|1
7762232|NCT00818623|12202758|FG001|Overall Study|Adverse Event|0
7762233|NCT00818623|12202759|FG002|Overall Study|Adverse Event|1
7762234|NCT00818623|12202760|FG003|Overall Study|Adverse Event|0
7762235|NCT00818623|12202761|FG004|Overall Study|Adverse Event|0
7762236|NCT00818623|12202762|FG005|Overall Study|Adverse Event|1
7762237|NCT00818623|12202763|FG006|Overall Study|Adverse Event|0
7762238|NCT00818623|12202764|FG007|Overall Study|Adverse Event|0
7762239|NCT00818623|12202757|FG000|Overall Study|Bad prostate specific antigen response|0
7762240|NCT00818623|12202758|FG001|Overall Study|Bad prostate specific antigen response|3
7762241|NCT00818623|12202759|FG002|Overall Study|Bad prostate specific antigen response|2
7762242|NCT00818623|12202760|FG003|Overall Study|Bad prostate specific antigen response|5
7762243|NCT00818623|12202761|FG004|Overall Study|Bad prostate specific antigen response|0
7762244|NCT00818623|12202762|FG005|Overall Study|Bad prostate specific antigen response|1
7762245|NCT00818623|12202763|FG006|Overall Study|Bad prostate specific antigen response|0
7762246|NCT00818623|12202764|FG007|Overall Study|Bad prostate specific antigen response|0
7762247|NCT00818623|12202757|FG000|Overall Study|Withdrawal by Subject|0
7762248|NCT00818623|12202758|FG001|Overall Study|Withdrawal by Subject|1
7762249|NCT00818623|12202759|FG002|Overall Study|Withdrawal by Subject|1
7762250|NCT00818623|12202760|FG003|Overall Study|Withdrawal by Subject|0
7762251|NCT00818623|12202761|FG004|Overall Study|Withdrawal by Subject|0
7762252|NCT00818623|12202762|FG005|Overall Study|Withdrawal by Subject|1
7762253|NCT00818623|12202763|FG006|Overall Study|Withdrawal by Subject|1
7762254|NCT00818623|12202764|FG007|Overall Study|Withdrawal by Subject|1
7762255|NCT00818623|12202757|FG000|Overall Study|Protocol Violation|1
7762256|NCT00818623|12202758|FG001|Overall Study|Protocol Violation|0
7762257|NCT00818623|12202759|FG002|Overall Study|Protocol Violation|0
7762258|NCT00818623|12202760|FG003|Overall Study|Protocol Violation|0
7762259|NCT00818623|12202761|FG004|Overall Study|Protocol Violation|1
7762260|NCT00818623|12202762|FG005|Overall Study|Protocol Violation|0
7762261|NCT00818623|12202763|FG006|Overall Study|Protocol Violation|1
7762262|NCT00818623|12202764|FG007|Overall Study|Protocol Violation|0
7762263|NCT00818623|12202757|FG000|Overall Study|Need of additional treatment|0
7762264|NCT00818623|12202758|FG001|Overall Study|Need of additional treatment|0
7762265|NCT00818623|12202759|FG002|Overall Study|Need of additional treatment|0
7762266|NCT00818623|12202760|FG003|Overall Study|Need of additional treatment|0
7762267|NCT00818623|12202761|FG004|Overall Study|Need of additional treatment|1
7762268|NCT00818623|12202762|FG005|Overall Study|Need of additional treatment|0
7762269|NCT00818623|12202763|FG006|Overall Study|Need of additional treatment|0
7762270|NCT00818623|12202764|FG007|Overall Study|Need of additional treatment|0
7762271|NCT00818623|12202757|FG000|Overall Study|Lack of trial drug at site|0
7762272|NCT00818623|12202758|FG001|Overall Study|Lack of trial drug at site|0
7762273|NCT00818623|12202759|FG002|Overall Study|Lack of trial drug at site|0
7762274|NCT00818623|12202760|FG003|Overall Study|Lack of trial drug at site|0
7762275|NCT00818623|12202761|FG004|Overall Study|Lack of trial drug at site|2
7762276|NCT00818623|12202762|FG005|Overall Study|Lack of trial drug at site|0
7762277|NCT00818623|12202763|FG006|Overall Study|Lack of trial drug at site|1
7762278|NCT00818623|12202764|FG007|Overall Study|Lack of trial drug at site|0
7762279|NCT00818623|12202757|FG000|Overall Study|Disease progression|0
7762280|NCT00818623|12202758|FG001|Overall Study|Disease progression|0
7762281|NCT00818623|12202759|FG002|Overall Study|Disease progression|0
7762282|NCT00818623|12202760|FG003|Overall Study|Disease progression|0
7762283|NCT00818623|12202761|FG004|Overall Study|Disease progression|0
7762284|NCT00818623|12202762|FG005|Overall Study|Disease progression|0
7762285|NCT00818623|12202763|FG006|Overall Study|Disease progression|1
7762286|NCT00818623|12202764|FG007|Overall Study|Disease progression|0
7762287|NCT00818649|12202782|FG000|Overall Study|Declining performance status|2
7762288|NCT00818649|12202782|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1
7762289|NCT00818649|12202782|FG000|Overall Study|Adverse Event|1
7762290|NCT00818662|12202791|FG000|Overall Study|Adverse Event|5
7762291|NCT00818662|12202792|FG001|Overall Study|Adverse Event|14
7762292|NCT00818662|12202793|FG002|Overall Study|Adverse Event|4
7762293|NCT00818662|12202794|FG003|Overall Study|Adverse Event|3
7762294|NCT00818662|12202791|FG000|Overall Study|Withdrawal by Subject|5
7762295|NCT00818662|12202792|FG001|Overall Study|Withdrawal by Subject|4
7762296|NCT00818662|12202793|FG002|Overall Study|Withdrawal by Subject|2
7762297|NCT00818662|12202794|FG003|Overall Study|Withdrawal by Subject|2
7762298|NCT00818662|12202791|FG000|Overall Study|Death|1
7762299|NCT00818662|12202792|FG001|Overall Study|Death|3
7762300|NCT00818662|12202793|FG002|Overall Study|Death|0
7762301|NCT00818662|12202794|FG003|Overall Study|Death|0
7762302|NCT00818662|12202791|FG000|Overall Study|Physician Decision|1
7762303|NCT00818662|12202792|FG001|Overall Study|Physician Decision|0
7762304|NCT00818662|12202793|FG002|Overall Study|Physician Decision|0
7762305|NCT00818662|12202794|FG003|Overall Study|Physician Decision|0
7762306|NCT00818662|12202791|FG000|Overall Study|Lost to Follow-up|0
7762307|NCT00818662|12202792|FG001|Overall Study|Lost to Follow-up|0
7762308|NCT00818662|12202793|FG002|Overall Study|Lost to Follow-up|0
7762309|NCT00818662|12202794|FG003|Overall Study|Lost to Follow-up|1
7762310|NCT00818662|12202791|FG000|Overall Study|Unwilling or Unable to Participate|4
7762311|NCT00818662|12202792|FG001|Overall Study|Unwilling or Unable to Participate|6
7762312|NCT00818662|12202793|FG002|Overall Study|Unwilling or Unable to Participate|2
7762313|NCT00818662|12202794|FG003|Overall Study|Unwilling or Unable to Participate|4
7762314|NCT00818662|12202791|FG000|Overall Study|Protocol Violation|1
7762315|NCT00818662|12202792|FG001|Overall Study|Protocol Violation|1
7762316|NCT00818662|12202793|FG002|Overall Study|Protocol Violation|0
7762317|NCT00818662|12202794|FG003|Overall Study|Protocol Violation|0
7762318|NCT00818662|12202791|FG000|Overall Study|Requires a Prohibited Medication|1
7762319|NCT00818662|12202792|FG001|Overall Study|Requires a Prohibited Medication|0
7762320|NCT00818662|12202793|FG002|Overall Study|Requires a Prohibited Medication|0
7762321|NCT00818662|12202794|FG003|Overall Study|Requires a Prohibited Medication|0
7762322|NCT00818662|12202791|FG000|Overall Study|Safety Risk|1
7762323|NCT00818662|12202792|FG001|Overall Study|Safety Risk|1
7762324|NCT00818662|12202793|FG002|Overall Study|Safety Risk|0
7762325|NCT00818662|12202794|FG003|Overall Study|Safety Risk|1
7762326|NCT00818662|12202791|FG000|Overall Study|Study Partner Unwilling or Unable|3
7762327|NCT00818662|12202792|FG001|Overall Study|Study Partner Unwilling or Unable|2
7762328|NCT00818662|12202793|FG002|Overall Study|Study Partner Unwilling or Unable|1
7762329|NCT00818662|12202794|FG003|Overall Study|Study Partner Unwilling or Unable|1
7762330|NCT00818662|12202791|FG000|Overall Study|Participant's health declined|0
7762331|NCT00818662|12202792|FG001|Overall Study|Participant's health declined|0
7762332|NCT00818662|12202793|FG002|Overall Study|Participant's health declined|0
7762333|NCT00818662|12202794|FG003|Overall Study|Participant's health declined|1
7762334|NCT00818662|12202791|FG000|Overall Study|Caregiver to pursue other treatment|0
7762335|NCT00818662|12202792|FG001|Overall Study|Caregiver to pursue other treatment|1
7762336|NCT00818662|12202793|FG002|Overall Study|Caregiver to pursue other treatment|0
7762337|NCT00818662|12202794|FG003|Overall Study|Caregiver to pursue other treatment|0
7762338|NCT00818662|12202791|FG000|Overall Study|Moving out of state|0
7762339|NCT00818662|12202792|FG001|Overall Study|Moving out of state|0
7762340|NCT00818662|12202793|FG002|Overall Study|Moving out of state|0
7762341|NCT00818662|12202794|FG003|Overall Study|Moving out of state|1
7762342|NCT00818662|12202791|FG000|Overall Study|Declined move to another study site|1
7762343|NCT00818662|12202792|FG001|Overall Study|Declined move to another study site|0
7762344|NCT00818662|12202793|FG002|Overall Study|Declined move to another study site|0
7762345|NCT00818662|12202794|FG003|Overall Study|Declined move to another study site|0
7762346|NCT00818662|12202791|FG000|Overall Study|Change in living situation|0
7762347|NCT00818662|12202792|FG001|Overall Study|Change in living situation|0
7762348|NCT00818662|12202793|FG002|Overall Study|Change in living situation|0
7762349|NCT00818662|12202794|FG003|Overall Study|Change in living situation|1
7762350|NCT00818662|12202791|FG000|Overall Study|Study partner decision|0
7762351|NCT00818662|12202792|FG001|Overall Study|Study partner decision|0
7762352|NCT00818662|12202793|FG002|Overall Study|Study partner decision|0
7762353|NCT00818662|12202794|FG003|Overall Study|Study partner decision|1
7762354|NCT00818662|12202791|FG000|Overall Study|Admitted to long term nursing care|0
7762355|NCT00818662|12202792|FG001|Overall Study|Admitted to long term nursing care|1
7762356|NCT00818662|12202793|FG002|Overall Study|Admitted to long term nursing care|0
7762357|NCT00818662|12202794|FG003|Overall Study|Admitted to long term nursing care|0
7762358|NCT00818753|12202808|FG000|Overall Study|Protocol Violation|1
7762359|NCT00818753|12202809|FG001|Overall Study|Protocol Violation|0
7762360|NCT00818753|12202810|FG002|Overall Study|Protocol Violation|0
7762361|NCT00818753|12202808|FG000|Overall Study|Other reason (not specified)|0
7762362|NCT00818753|12202809|FG001|Overall Study|Other reason (not specified)|0
7762363|NCT00818753|12202810|FG002|Overall Study|Other reason (not specified)|1
7762364|NCT00818753|12202808|FG000|Overall Study|Randomised and not treated|2
7762365|NCT00818753|12202809|FG001|Overall Study|Randomised and not treated|0
7762366|NCT00818753|12202810|FG002|Overall Study|Randomised and not treated|0
7762367|NCT00818766|12202820|FG000|Overall Study|Could not be Contacted on Day 28|11
7762368|NCT00818766|12202821|FG001|Overall Study|Could not be Contacted on Day 28|10
7762369|NCT00818766|12202820|FG000|Overall Study|Death|1
7762370|NCT00818766|12202821|FG001|Overall Study|Death|0
7762371|NCT00818766|12202820|FG000|Overall Study|Did not Receive Allocated Intervention|3
7762372|NCT00818766|12202821|FG001|Overall Study|Did not Receive Allocated Intervention|0
7762373|NCT00818779|12202829|FG000|Overall Study|Protocol Violation|1
7762374|NCT00818779|12202830|FG001|Overall Study|Protocol Violation|0
7762375|NCT00818779|12202829|FG000|Overall Study|Lost to Follow-up|1
7762376|NCT00818779|12202830|FG001|Overall Study|Lost to Follow-up|0
7762377|NCT00818779|12202829|FG000|Overall Study|Adverse Event|4
7762378|NCT00818779|12202830|FG001|Overall Study|Adverse Event|1
7762379|NCT00818883|12202849|FG000|Overall Study|Adverse Event|28
7762380|NCT00818883|12202850|FG001|Overall Study|Adverse Event|19
7762381|NCT00818883|12202849|FG000|Overall Study|Protocol Violation|2
7762382|NCT00818883|12202850|FG001|Overall Study|Protocol Violation|2
7762383|NCT00818883|12202849|FG000|Overall Study|Lost to Follow-up|3
7762384|NCT00818883|12202850|FG001|Overall Study|Lost to Follow-up|2
7762385|NCT00818883|12202849|FG000|Overall Study|Withdrawal by Subject|16
7762386|NCT00818883|12202850|FG001|Overall Study|Withdrawal by Subject|14
7762387|NCT00818883|12202849|FG000|Overall Study|Lack of Efficacy|0
7762388|NCT00818883|12202850|FG001|Overall Study|Lack of Efficacy|2
7762389|NCT00818883|12202849|FG000|Overall Study|Other|2
7762390|NCT00818883|12202850|FG001|Overall Study|Other|7
7762391|NCT00819013|12202864|FG000|Overall Study|Not meeting continuing study eligibility|2
7762392|NCT00819013|12202865|FG001|Overall Study|Not meeting continuing study eligibility|1
7762393|NCT00819013|12202866|FG002|Overall Study|Not meeting continuing study eligibility|2
7762394|NCT00819013|12202867|FG003|Overall Study|Not meeting continuing study eligibility|1
7762395|NCT00819013|12202864|FG000|Overall Study|Adverse Event|0
7762396|NCT00819013|12202865|FG001|Overall Study|Adverse Event|0
7762397|NCT00819013|12202866|FG002|Overall Study|Adverse Event|1
7762398|NCT00819013|12202867|FG003|Overall Study|Adverse Event|0
7762399|NCT00819013|12202864|FG000|Overall Study|Withdrawal by Subject|1
7762400|NCT00819013|12202865|FG001|Overall Study|Withdrawal by Subject|0
7762401|NCT00819013|12202866|FG002|Overall Study|Withdrawal by Subject|1
7762402|NCT00819013|12202867|FG003|Overall Study|Withdrawal by Subject|0
7762403|NCT00819013|12202864|FG000|Overall Study|Lost to Follow-up|0
7762404|NCT00819013|12202865|FG001|Overall Study|Lost to Follow-up|0
7762405|NCT00819013|12202866|FG002|Overall Study|Lost to Follow-up|1
7762406|NCT00819013|12202867|FG003|Overall Study|Lost to Follow-up|2
7762407|NCT00819013|12202864|FG000|Overall Study|Death|0
7762408|NCT00819013|12202865|FG001|Overall Study|Death|0
7762409|NCT00819013|12202866|FG002|Overall Study|Death|0
7762410|NCT00819013|12202867|FG003|Overall Study|Death|1
7762411|NCT00819039|12202880|FG000|Overall Study|Physician Decision|1
7762412|NCT00819039|12202881|FG001|Overall Study|Physician Decision|0
7762413|NCT00819039|12202882|FG002|Overall Study|Physician Decision|1
7762414|NCT00819039|12202880|FG000|Overall Study|Protocol Violation|1
7762415|NCT00819039|12202881|FG001|Overall Study|Protocol Violation|0
7762416|NCT00819039|12202882|FG002|Overall Study|Protocol Violation|0
7762417|NCT00819052|12202894|FG000|Overall Study|Adverse Event|0
7762418|NCT00819052|12202895|FG001|Overall Study|Adverse Event|5
7762419|NCT00819052|12202894|FG000|Overall Study|Protocol Violation|1
7762420|NCT00819052|12202895|FG001|Overall Study|Protocol Violation|2
7762421|NCT00819052|12202894|FG000|Overall Study|Lost to Follow-up|1
7762422|NCT00819052|12202895|FG001|Overall Study|Lost to Follow-up|2
7762423|NCT00819052|12202894|FG000|Overall Study|Withdrawal by Subject|1
7762424|NCT00819052|12202895|FG001|Overall Study|Withdrawal by Subject|2
7762425|NCT00819052|12202894|FG000|Overall Study|Lack of Efficacy|1
7762426|NCT00819052|12202895|FG001|Overall Study|Lack of Efficacy|1
7762427|NCT00819052|12202894|FG000|Overall Study|Pregnancy|1
7762428|NCT00819052|12202895|FG001|Overall Study|Pregnancy|2
7762429|NCT00819052|12202894|FG000|Overall Study|Death or events leading to death|1
7762430|NCT00819052|12202895|FG001|Overall Study|Death or events leading to death|0
7762431|NCT00819091|12202906|FG000|Overall Study|Adverse Event|3
7762432|NCT00819091|12202907|FG001|Overall Study|Adverse Event|5
7762433|NCT00819091|12202906|FG000|Overall Study|Protocol Violation|0
7762434|NCT00819091|12202907|FG001|Overall Study|Protocol Violation|1
7762435|NCT00819091|12202906|FG000|Overall Study|Lost to Follow-up|2
7762436|NCT00819091|12202907|FG001|Overall Study|Lost to Follow-up|0
7762437|NCT00819091|12202906|FG000|Overall Study|Withdrawal by Subject|1
7762438|NCT00819091|12202907|FG001|Overall Study|Withdrawal by Subject|2
7762439|NCT00819091|12202906|FG000|Overall Study|Other|1
7762440|NCT00819091|12202907|FG001|Overall Study|Other|2
7762441|NCT00819156|12202919|FG000|Overall Study|Adverse Event|1
7762442|NCT00819156|12202920|FG001|Overall Study|Adverse Event|4
7762443|NCT00819156|12202921|FG002|Overall Study|Adverse Event|2
7762444|NCT00819156|12202922|FG003|Overall Study|Adverse Event|1
7762445|NCT00819156|12202923|FG004|Overall Study|Adverse Event|2
7762446|NCT00819156|12202924|FG005|Overall Study|Adverse Event|3
7762447|NCT00819156|12202919|FG000|Overall Study|Withdrawal by Subject|0
7762448|NCT00819156|12202920|FG001|Overall Study|Withdrawal by Subject|3
7762449|NCT00819156|12202921|FG002|Overall Study|Withdrawal by Subject|2
7762450|NCT00819156|12202922|FG003|Overall Study|Withdrawal by Subject|0
7762451|NCT00819156|12202923|FG004|Overall Study|Withdrawal by Subject|1
7762452|NCT00819156|12202924|FG005|Overall Study|Withdrawal by Subject|0
7762453|NCT00819156|12202919|FG000|Overall Study|Protocol Violation|1
7762454|NCT00819156|12202920|FG001|Overall Study|Protocol Violation|0
7762455|NCT00819156|12202921|FG002|Overall Study|Protocol Violation|1
7762456|NCT00819156|12202922|FG003|Overall Study|Protocol Violation|0
7762457|NCT00819156|12202923|FG004|Overall Study|Protocol Violation|0
7762458|NCT00819156|12202924|FG005|Overall Study|Protocol Violation|1
7762459|NCT00819156|12202919|FG000|Overall Study|Lost to Follow-up|0
7762460|NCT00819156|12202920|FG001|Overall Study|Lost to Follow-up|1
7762461|NCT00819156|12202921|FG002|Overall Study|Lost to Follow-up|0
7762462|NCT00819156|12202922|FG003|Overall Study|Lost to Follow-up|0
7762463|NCT00819156|12202923|FG004|Overall Study|Lost to Follow-up|0
7762464|NCT00819156|12202924|FG005|Overall Study|Lost to Follow-up|2
7762465|NCT00819156|12202919|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5
7762466|NCT00819156|12202920|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2
7762467|NCT00819156|12202921|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1
7762468|NCT00819156|12202922|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1
7762469|NCT00819156|12202923|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1
7762470|NCT00819156|12202924|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2
7762471|NCT00819156|12202919|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3
7762472|NCT00819156|12202920|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0
7762473|NCT00819156|12202921|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0
7762474|NCT00819156|12202922|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0
7762475|NCT00819156|12202923|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1
7762476|NCT00819156|12202924|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0
7762477|NCT00819156|12202919|FG000|Overall Study|Prostate-specific antigen progression|0
7762478|NCT00819156|12202920|FG001|Overall Study|Prostate-specific antigen progression|0
7762479|NCT00819156|12202921|FG002|Overall Study|Prostate-specific antigen progression|0
7762480|NCT00819156|12202922|FG003|Overall Study|Prostate-specific antigen progression|0
7762481|NCT00819156|12202923|FG004|Overall Study|Prostate-specific antigen progression|1
7762482|NCT00819156|12202924|FG005|Overall Study|Prostate-specific antigen progression|0
7762483|NCT00819234|12202959|FG000|Overall Study|Withdrawal by Subject|8
7762484|NCT00819234|12202960|FG001|Overall Study|Withdrawal by Subject|13
7762485|NCT00819234|12202961|FG002|Overall Study|Withdrawal by Subject|6
7762486|NCT00819234|12202962|FG003|Overall Study|Withdrawal by Subject|3
7762487|NCT00819234|12202963|FG004|Overall Study|Withdrawal by Subject|0
7762488|NCT00819234|12202964|FG005|Overall Study|Withdrawal by Subject|4
7762489|NCT00819234|12202965|FG006|Overall Study|Withdrawal by Subject|4
7762490|NCT00819234|12202966|FG007|Overall Study|Withdrawal by Subject|8
7762491|NCT00819234|12202967|FG008|Overall Study|Withdrawal by Subject|5
7762492|NCT00819234|12202968|FG009|Overall Study|Withdrawal by Subject|3
7762493|NCT00819234|12202959|FG000|Overall Study|Adverse Event|0
7762494|NCT00819234|12202960|FG001|Overall Study|Adverse Event|0
7762495|NCT00819234|12202961|FG002|Overall Study|Adverse Event|1
7762496|NCT00819234|12202962|FG003|Overall Study|Adverse Event|0
7762497|NCT00819234|12202963|FG004|Overall Study|Adverse Event|0
7762498|NCT00819234|12202964|FG005|Overall Study|Adverse Event|2
7762499|NCT00819234|12202965|FG006|Overall Study|Adverse Event|0
7762500|NCT00819234|12202966|FG007|Overall Study|Adverse Event|0
7762501|NCT00819234|12202967|FG008|Overall Study|Adverse Event|0
7762502|NCT00819234|12202968|FG009|Overall Study|Adverse Event|0
7762503|NCT00819234|12202959|FG000|Overall Study|Physician Decision|0
7762504|NCT00819234|12202960|FG001|Overall Study|Physician Decision|0
7762505|NCT00819234|12202961|FG002|Overall Study|Physician Decision|0
7762506|NCT00819234|12202962|FG003|Overall Study|Physician Decision|1
7762507|NCT00819234|12202963|FG004|Overall Study|Physician Decision|0
7762508|NCT00819234|12202964|FG005|Overall Study|Physician Decision|0
7762509|NCT00819234|12202965|FG006|Overall Study|Physician Decision|0
7762510|NCT00819234|12202966|FG007|Overall Study|Physician Decision|0
7762511|NCT00819234|12202967|FG008|Overall Study|Physician Decision|0
7762512|NCT00819234|12202968|FG009|Overall Study|Physician Decision|2
7762513|NCT00819234|12202959|FG000|Overall Study|Protocol Violation|0
7762514|NCT00819234|12202960|FG001|Overall Study|Protocol Violation|0
7762515|NCT00819234|12202961|FG002|Overall Study|Protocol Violation|1
7762516|NCT00819234|12202962|FG003|Overall Study|Protocol Violation|0
7762517|NCT00819234|12202963|FG004|Overall Study|Protocol Violation|0
7762518|NCT00819234|12202964|FG005|Overall Study|Protocol Violation|0
7762519|NCT00819234|12202965|FG006|Overall Study|Protocol Violation|0
7762520|NCT00819234|12202966|FG007|Overall Study|Protocol Violation|0
7762521|NCT00819234|12202967|FG008|Overall Study|Protocol Violation|0
7762522|NCT00819234|12202968|FG009|Overall Study|Protocol Violation|0
7762523|NCT00819234|12202959|FG000|Overall Study|Lost to Follow-up|2
7762524|NCT00819234|12202960|FG001|Overall Study|Lost to Follow-up|2
7762525|NCT00819234|12202961|FG002|Overall Study|Lost to Follow-up|0
7762526|NCT00819234|12202962|FG003|Overall Study|Lost to Follow-up|2
7762527|NCT00819234|12202963|FG004|Overall Study|Lost to Follow-up|1
7762528|NCT00819234|12202964|FG005|Overall Study|Lost to Follow-up|1
7762529|NCT00819234|12202965|FG006|Overall Study|Lost to Follow-up|1
7762530|NCT00819234|12202966|FG007|Overall Study|Lost to Follow-up|1
7762531|NCT00819234|12202967|FG008|Overall Study|Lost to Follow-up|1
7762532|NCT00819234|12202968|FG009|Overall Study|Lost to Follow-up|2
7762533|NCT00819247|12203026|FG000|Overall Study|Adverse Event|0
7762534|NCT00819247|12203027|FG001|Overall Study|Adverse Event|5
7762535|NCT00819247|12203028|FG002|Overall Study|Adverse Event|3
7762536|NCT00819247|12203026|FG000|Overall Study|Insufficient testosterone response|5
7762537|NCT00819247|12203027|FG001|Overall Study|Insufficient testosterone response|8
7762538|NCT00819247|12203028|FG002|Overall Study|Insufficient testosterone response|10
7762539|NCT00819247|12203026|FG000|Overall Study|Withdrawal by Subject|1
7762540|NCT00819247|12203027|FG001|Overall Study|Withdrawal by Subject|0
7762541|NCT00819247|12203028|FG002|Overall Study|Withdrawal by Subject|0
7762542|NCT00819247|12203026|FG000|Overall Study|Protocol Violation|1
7762543|NCT00819247|12203027|FG001|Overall Study|Protocol Violation|0
7762544|NCT00819247|12203028|FG002|Overall Study|Protocol Violation|1
7762545|NCT00819247|12203026|FG000|Overall Study|Mistakenly withdrawn|0
7762546|NCT00819247|12203027|FG001|Overall Study|Mistakenly withdrawn|1
7762547|NCT00819247|12203028|FG002|Overall Study|Mistakenly withdrawn|0
7762548|NCT00819247|12203026|FG000|Overall Study|Bad prostate-specific antigen response|3
7762549|NCT00819247|12203027|FG001|Overall Study|Bad prostate-specific antigen response|2
7762550|NCT00819247|12203028|FG002|Overall Study|Bad prostate-specific antigen response|0
7762551|NCT00819247|12203026|FG000|Overall Study|Other|1
7762552|NCT00819247|12203027|FG001|Overall Study|Other|0
7762553|NCT00819247|12203028|FG002|Overall Study|Other|0
7624592|NCT01986114|12035684|FG000|Overall Study|Protocol Violation|1
7762554|NCT00819390|12203055|FG000|Overall Study|Lost to Follow-up|1
7762555|NCT00819390|12203056|FG001|Overall Study|Lost to Follow-up|1
7762556|NCT00819390|12203057|FG002|Overall Study|Lost to Follow-up|0
7762557|NCT00819390|12203058|FG003|Overall Study|Lost to Follow-up|0
7762558|NCT00819390|12203055|FG000|Overall Study|Withdrawal by Subject|2
7762559|NCT00819390|12203056|FG001|Overall Study|Withdrawal by Subject|0
7762560|NCT00819390|12203057|FG002|Overall Study|Withdrawal by Subject|0
7762561|NCT00819390|12203058|FG003|Overall Study|Withdrawal by Subject|0
7762562|NCT00819390|12203055|FG000|Overall Study|Adverse Event|0
7762563|NCT00819390|12203056|FG001|Overall Study|Adverse Event|0
7762564|NCT00819390|12203057|FG002|Overall Study|Adverse Event|1
7762565|NCT00819390|12203058|FG003|Overall Study|Adverse Event|0
7762566|NCT00819585|12203092|FG000|Core Study|Adverse Event|2
7762567|NCT00819585|12203093|FG001|Core Study|Adverse Event|1
7762568|NCT00819585|12203094|FG002|Core Study|Adverse Event|1
7762569|NCT00819585|12203095|FG003|Core Study|Adverse Event|4
7762570|NCT00819585|12203096|FG004|Core Study|Adverse Event|1
7762571|NCT00819585|12203097|FG005|Core Study|Adverse Event|0
7762572|NCT00819585|12203098|FG006|Core Study|Adverse Event|2
7762573|NCT00819585|12203099|FG007|Core Study|Adverse Event|0
7762574|NCT00819585|12203100|FG008|Core Study|Adverse Event|0
7762575|NCT00819585|12203101|FG009|Core Study|Adverse Event|0
7762576|NCT00819585|12203102|FG010|Core Study|Adverse Event|0
7762577|NCT00819585|12203092|FG000|Core Study|Abnormal Laboratory Value(s)|2
7762578|NCT00819585|12203093|FG001|Core Study|Abnormal Laboratory Value(s)|0
7762579|NCT00819585|12203094|FG002|Core Study|Abnormal Laboratory Value(s)|0
7762580|NCT00819585|12203095|FG003|Core Study|Abnormal Laboratory Value(s)|0
7762581|NCT00819585|12203096|FG004|Core Study|Abnormal Laboratory Value(s)|0
7762582|NCT00819585|12203097|FG005|Core Study|Abnormal Laboratory Value(s)|0
7762583|NCT00819585|12203098|FG006|Core Study|Abnormal Laboratory Value(s)|0
7762584|NCT00819585|12203099|FG007|Core Study|Abnormal Laboratory Value(s)|0
7762585|NCT00819585|12203100|FG008|Core Study|Abnormal Laboratory Value(s)|0
7762586|NCT00819585|12203101|FG009|Core Study|Abnormal Laboratory Value(s)|0
7762587|NCT00819585|12203102|FG010|Core Study|Abnormal Laboratory Value(s)|0
7762588|NCT00819585|12203092|FG000|Core Study|Unsatisfactory Therapeutic Effect|0
7762589|NCT00819585|12203093|FG001|Core Study|Unsatisfactory Therapeutic Effect|1
7762590|NCT00819585|12203094|FG002|Core Study|Unsatisfactory Therapeutic Effect|0
7762591|NCT00819585|12203095|FG003|Core Study|Unsatisfactory Therapeutic Effect|0
7762592|NCT00819585|12203096|FG004|Core Study|Unsatisfactory Therapeutic Effect|0
7762593|NCT00819585|12203097|FG005|Core Study|Unsatisfactory Therapeutic Effect|0
7762594|NCT00819585|12203098|FG006|Core Study|Unsatisfactory Therapeutic Effect|1
7762595|NCT00819585|12203099|FG007|Core Study|Unsatisfactory Therapeutic Effect|0
7762596|NCT00819585|12203100|FG008|Core Study|Unsatisfactory Therapeutic Effect|0
7762597|NCT00819585|12203101|FG009|Core Study|Unsatisfactory Therapeutic Effect|0
7762598|NCT00819585|12203102|FG010|Core Study|Unsatisfactory Therapeutic Effect|0
7762599|NCT00819585|12203092|FG000|Core Study|Subject No Longer Requires Study Drug|0
7762600|NCT00819585|12203093|FG001|Core Study|Subject No Longer Requires Study Drug|0
7762601|NCT00819585|12203094|FG002|Core Study|Subject No Longer Requires Study Drug|0
7762602|NCT00819585|12203095|FG003|Core Study|Subject No Longer Requires Study Drug|0
7762603|NCT00819585|12203096|FG004|Core Study|Subject No Longer Requires Study Drug|1
7762604|NCT00819585|12203097|FG005|Core Study|Subject No Longer Requires Study Drug|0
7762605|NCT00819585|12203098|FG006|Core Study|Subject No Longer Requires Study Drug|0
7762606|NCT00819585|12203099|FG007|Core Study|Subject No Longer Requires Study Drug|0
7762607|NCT00819585|12203100|FG008|Core Study|Subject No Longer Requires Study Drug|0
7762608|NCT00819585|12203101|FG009|Core Study|Subject No Longer Requires Study Drug|0
7762609|NCT00819585|12203102|FG010|Core Study|Subject No Longer Requires Study Drug|0
7762610|NCT00819585|12203092|FG000|Core Study|Subject Withdrew Consent|0
7762611|NCT00819585|12203093|FG001|Core Study|Subject Withdrew Consent|3
7762612|NCT00819585|12203094|FG002|Core Study|Subject Withdrew Consent|2
7762613|NCT00819585|12203095|FG003|Core Study|Subject Withdrew Consent|1
7762614|NCT00819585|12203096|FG004|Core Study|Subject Withdrew Consent|0
7762615|NCT00819585|12203097|FG005|Core Study|Subject Withdrew Consent|0
7762616|NCT00819585|12203098|FG006|Core Study|Subject Withdrew Consent|3
7624593|NCT01986114|12035684|FG000|Overall Study|Lost to Follow-up|5
7762617|NCT00819585|12203099|FG007|Core Study|Subject Withdrew Consent|0
7762618|NCT00819585|12203100|FG008|Core Study|Subject Withdrew Consent|0
7762619|NCT00819585|12203101|FG009|Core Study|Subject Withdrew Consent|0
7762620|NCT00819585|12203102|FG010|Core Study|Subject Withdrew Consent|0
7762621|NCT00819585|12203092|FG000|Core Study|Lost to Follow-up|2
7762622|NCT00819585|12203093|FG001|Core Study|Lost to Follow-up|1
7762623|NCT00819585|12203094|FG002|Core Study|Lost to Follow-up|2
7762624|NCT00819585|12203095|FG003|Core Study|Lost to Follow-up|0
7762625|NCT00819585|12203096|FG004|Core Study|Lost to Follow-up|1
7762626|NCT00819585|12203097|FG005|Core Study|Lost to Follow-up|1
7762627|NCT00819585|12203098|FG006|Core Study|Lost to Follow-up|1
7762628|NCT00819585|12203099|FG007|Core Study|Lost to Follow-up|0
7762629|NCT00819585|12203100|FG008|Core Study|Lost to Follow-up|0
7762630|NCT00819585|12203101|FG009|Core Study|Lost to Follow-up|0
7762631|NCT00819585|12203102|FG010|Core Study|Lost to Follow-up|0
7762632|NCT00819585|12203092|FG000|Core Study|Administrative Problems|0
7762633|NCT00819585|12203093|FG001|Core Study|Administrative Problems|0
7762634|NCT00819585|12203094|FG002|Core Study|Administrative Problems|0
7762635|NCT00819585|12203095|FG003|Core Study|Administrative Problems|0
7762636|NCT00819585|12203096|FG004|Core Study|Administrative Problems|0
7762637|NCT00819585|12203097|FG005|Core Study|Administrative Problems|0
7762638|NCT00819585|12203098|FG006|Core Study|Administrative Problems|2
7762639|NCT00819585|12203099|FG007|Core Study|Administrative Problems|0
7762640|NCT00819585|12203100|FG008|Core Study|Administrative Problems|0
7762641|NCT00819585|12203101|FG009|Core Study|Administrative Problems|0
7762642|NCT00819585|12203102|FG010|Core Study|Administrative Problems|0
7762643|NCT00819585|12203092|FG000|Core Study|Death|0
7762644|NCT00819585|12203093|FG001|Core Study|Death|0
7762645|NCT00819585|12203094|FG002|Core Study|Death|0
7762646|NCT00819585|12203095|FG003|Core Study|Death|0
7762647|NCT00819585|12203096|FG004|Core Study|Death|0
7762648|NCT00819585|12203097|FG005|Core Study|Death|0
7762649|NCT00819585|12203098|FG006|Core Study|Death|1
7762650|NCT00819585|12203099|FG007|Core Study|Death|0
7762651|NCT00819585|12203100|FG008|Core Study|Death|0
7762652|NCT00819585|12203101|FG009|Core Study|Death|0
7762653|NCT00819585|12203102|FG010|Core Study|Death|0
7762654|NCT00819585|12203092|FG000|Core Study|Protocol Violation|0
7762655|NCT00819585|12203093|FG001|Core Study|Protocol Violation|0
7762656|NCT00819585|12203094|FG002|Core Study|Protocol Violation|1
7762657|NCT00819585|12203095|FG003|Core Study|Protocol Violation|0
7762658|NCT00819585|12203096|FG004|Core Study|Protocol Violation|0
7762659|NCT00819585|12203097|FG005|Core Study|Protocol Violation|1
7762660|NCT00819585|12203098|FG006|Core Study|Protocol Violation|3
7762661|NCT00819585|12203099|FG007|Core Study|Protocol Violation|0
7762662|NCT00819585|12203100|FG008|Core Study|Protocol Violation|0
7762663|NCT00819585|12203101|FG009|Core Study|Protocol Violation|0
7762664|NCT00819585|12203102|FG010|Core Study|Protocol Violation|0
7762665|NCT00819585|12203092|FG000|Extension Study|Abnormal Laboratory Value(s)|0
7762666|NCT00819585|12203093|FG001|Extension Study|Abnormal Laboratory Value(s)|0
7762667|NCT00819585|12203094|FG002|Extension Study|Abnormal Laboratory Value(s)|0
7762668|NCT00819585|12203095|FG003|Extension Study|Abnormal Laboratory Value(s)|0
7762669|NCT00819585|12203096|FG004|Extension Study|Abnormal Laboratory Value(s)|0
7762670|NCT00819585|12203097|FG005|Extension Study|Abnormal Laboratory Value(s)|0
7762671|NCT00819585|12203098|FG006|Extension Study|Abnormal Laboratory Value(s)|0
7762672|NCT00819585|12203099|FG007|Extension Study|Abnormal Laboratory Value(s)|0
7762673|NCT00819585|12203100|FG008|Extension Study|Abnormal Laboratory Value(s)|1
7762674|NCT00819585|12203101|FG009|Extension Study|Abnormal Laboratory Value(s)|0
7762675|NCT00819585|12203102|FG010|Extension Study|Abnormal Laboratory Value(s)|0
7762676|NCT00819585|12203092|FG000|Extension Study|Subject Withdrew Consent|0
7762677|NCT00819585|12203093|FG001|Extension Study|Subject Withdrew Consent|0
7762678|NCT00819585|12203094|FG002|Extension Study|Subject Withdrew Consent|0
7762679|NCT00819585|12203095|FG003|Extension Study|Subject Withdrew Consent|0
7762680|NCT00819585|12203096|FG004|Extension Study|Subject Withdrew Consent|0
7762681|NCT00819585|12203097|FG005|Extension Study|Subject Withdrew Consent|0
7762682|NCT00819585|12203098|FG006|Extension Study|Subject Withdrew Consent|0
7762683|NCT00819585|12203099|FG007|Extension Study|Subject Withdrew Consent|0
7762684|NCT00819585|12203100|FG008|Extension Study|Subject Withdrew Consent|3
7762685|NCT00819585|12203101|FG009|Extension Study|Subject Withdrew Consent|0
7762686|NCT00819585|12203102|FG010|Extension Study|Subject Withdrew Consent|1
7762687|NCT00819585|12203092|FG000|Extension Study|Lost to Follow-up|0
7762688|NCT00819585|12203093|FG001|Extension Study|Lost to Follow-up|0
7762689|NCT00819585|12203094|FG002|Extension Study|Lost to Follow-up|0
7762690|NCT00819585|12203095|FG003|Extension Study|Lost to Follow-up|0
7762691|NCT00819585|12203096|FG004|Extension Study|Lost to Follow-up|0
7762692|NCT00819585|12203097|FG005|Extension Study|Lost to Follow-up|0
7762693|NCT00819585|12203098|FG006|Extension Study|Lost to Follow-up|0
7762694|NCT00819585|12203099|FG007|Extension Study|Lost to Follow-up|0
7762695|NCT00819585|12203100|FG008|Extension Study|Lost to Follow-up|2
7762696|NCT00819585|12203101|FG009|Extension Study|Lost to Follow-up|1
7762697|NCT00819585|12203102|FG010|Extension Study|Lost to Follow-up|1
7762698|NCT00819585|12203092|FG000|Extension Study|Death|0
7762699|NCT00819585|12203093|FG001|Extension Study|Death|0
7762700|NCT00819585|12203094|FG002|Extension Study|Death|0
7762701|NCT00819585|12203095|FG003|Extension Study|Death|0
7762702|NCT00819585|12203096|FG004|Extension Study|Death|0
7762703|NCT00819585|12203097|FG005|Extension Study|Death|0
7762704|NCT00819585|12203098|FG006|Extension Study|Death|0
7762705|NCT00819585|12203099|FG007|Extension Study|Death|0
7762706|NCT00819585|12203100|FG008|Extension Study|Death|2
7762707|NCT00819585|12203101|FG009|Extension Study|Death|0
7762708|NCT00819585|12203102|FG010|Extension Study|Death|0
7762709|NCT00819741|12203145|FG000|Overall Study|Adverse Event|5
7762710|NCT00819741|12203146|FG001|Overall Study|Adverse Event|2
7762711|NCT00819741|12203145|FG000|Overall Study|Lack of Efficacy|0
7762712|NCT00819741|12203146|FG001|Overall Study|Lack of Efficacy|2
7762713|NCT00819741|12203145|FG000|Overall Study|Lost to Follow-up|3
7762714|NCT00819741|12203146|FG001|Overall Study|Lost to Follow-up|1
7762715|NCT00819741|12203145|FG000|Overall Study|Protocol Violation|3
7762716|NCT00819741|12203146|FG001|Overall Study|Protocol Violation|4
7762717|NCT00819741|12203145|FG000|Overall Study|Withdrawal by Subject|2
7762718|NCT00819741|12203146|FG001|Overall Study|Withdrawal by Subject|2
7762719|NCT00819741|12203145|FG000|Overall Study|Unclassified|6
7762720|NCT00819741|12203146|FG001|Overall Study|Unclassified|0
7762721|NCT00819741|12203145|FG000|Overall Study|Reasons unknown|3
7762722|NCT00819741|12203146|FG001|Overall Study|Reasons unknown|3
7762723|NCT00819767|12203154|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7762724|NCT00819767|12203155|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7762725|NCT00819910|12203165|FG000|Overall Study|Adverse Event|0
7762726|NCT00819910|12203166|FG001|Overall Study|Adverse Event|0
7762727|NCT00819910|12203167|FG002|Overall Study|Adverse Event|2
7762728|NCT00819910|12203168|FG003|Overall Study|Adverse Event|1
7762729|NCT00819910|12203165|FG000|Overall Study|Withdrawal by Subject|1
7762730|NCT00819910|12203166|FG001|Overall Study|Withdrawal by Subject|1
7762731|NCT00819910|12203167|FG002|Overall Study|Withdrawal by Subject|1
7762732|NCT00819910|12203168|FG003|Overall Study|Withdrawal by Subject|0
7762733|NCT00819910|12203165|FG000|Overall Study|Lost to Follow-up|1
7762734|NCT00819910|12203166|FG001|Overall Study|Lost to Follow-up|0
7762735|NCT00819910|12203167|FG002|Overall Study|Lost to Follow-up|0
7762736|NCT00819910|12203168|FG003|Overall Study|Lost to Follow-up|0
7762737|NCT00820040|12203180|FG000|Overall Study|Death|1
7762738|NCT00820040|12203180|FG000|Overall Study|Sponsor terminated study|1
7762739|NCT00820040|12203180|FG000|Overall Study|Screen failure|1
7762740|NCT00820170|12203189|FG000|Overall Study|Adverse Event|0
7762741|NCT00820170|12203190|FG001|Overall Study|Adverse Event|0
7762742|NCT00820170|12203191|FG002|Overall Study|Adverse Event|0
7762743|NCT00820170|12203192|FG003|Overall Study|Adverse Event|0
7762744|NCT00820170|12203193|FG004|Overall Study|Adverse Event|2
7762745|NCT00820170|12203189|FG000|Overall Study|Progressive Disease|0
7762746|NCT00820170|12203190|FG001|Overall Study|Progressive Disease|0
7762747|NCT00820170|12203191|FG002|Overall Study|Progressive Disease|0
7762748|NCT00820170|12203192|FG003|Overall Study|Progressive Disease|0
7762749|NCT00820170|12203193|FG004|Overall Study|Progressive Disease|2
7762750|NCT00820222|12203212|FG000|Overall Study|Lost to Follow-up|10
7762751|NCT00820222|12203213|FG001|Overall Study|Lost to Follow-up|9
7762752|NCT00820222|12203212|FG000|Overall Study|Withdrawal by Subject|19
7762753|NCT00820222|12203213|FG001|Overall Study|Withdrawal by Subject|21
7762754|NCT00820222|12203212|FG000|Overall Study|Physician Decision|93
7762755|NCT00820222|12203213|FG001|Overall Study|Physician Decision|88
7762756|NCT00820222|12203212|FG000|Overall Study|Sponsor Terminated Study|43
7762757|NCT00820222|12203213|FG001|Overall Study|Sponsor Terminated Study|65
7762758|NCT00820222|12203212|FG000|Overall Study|Unkown|11
7762759|NCT00820222|12203213|FG001|Overall Study|Unkown|7
7762760|NCT00820248|12203234|FG000|Overall Study|No treated|4
7762761|NCT00820248|12203235|FG001|Overall Study|No treated|1
7762762|NCT00820599|12203281|FG000|Overall Study|Death|129
7762763|NCT00820599|12203281|FG000|Overall Study|Withdrawal by Subject|2
7770091|NCT00874432|12214011|FG003|Overall Study|Physician Decision|0
7770092|NCT00874432|12214008|FG000|Overall Study|Other|1
7770093|NCT00874432|12214009|FG001|Overall Study|Other|2
7770094|NCT00874432|12214010|FG002|Overall Study|Other|8
7770095|NCT00874432|12214011|FG003|Overall Study|Other|3
7770096|NCT00874497|12214025|FG000|Overall Study|Lost to Follow-up|2
7770097|NCT00874497|12214026|FG001|Overall Study|Lost to Follow-up|4
7770098|NCT00874497|12214025|FG000|Overall Study|Adverse Event|9
7770099|NCT00874497|12214026|FG001|Overall Study|Adverse Event|4
7770100|NCT00874497|12214025|FG000|Overall Study|Sponsor Discontinued Trial|7
7770101|NCT00874497|12214026|FG001|Overall Study|Sponsor Discontinued Trial|3
7770102|NCT00874497|12214025|FG000|Overall Study|Met Withdrawal Criteria|4
7770103|NCT00874497|12214026|FG001|Overall Study|Met Withdrawal Criteria|2
7770104|NCT00874497|12214025|FG000|Overall Study|Physician Decision|1
7770105|NCT00874497|12214026|FG001|Overall Study|Physician Decision|1
7770106|NCT00874497|12214025|FG000|Overall Study|Withdrawal by Subject|5
7770107|NCT00874497|12214026|FG001|Overall Study|Withdrawal by Subject|4
7770108|NCT00874549|12214045|FG000|Overall Study|Adverse Event|0
7770109|NCT00874549|12214046|FG001|Overall Study|Adverse Event|0
7770110|NCT00874549|12214047|FG002|Overall Study|Adverse Event|1
7770111|NCT00874549|12214048|FG003|Overall Study|Adverse Event|0
7770112|NCT00874549|12214045|FG000|Overall Study|Protocol Violation|1
7770113|NCT00874549|12214046|FG001|Overall Study|Protocol Violation|0
7770114|NCT00874549|12214047|FG002|Overall Study|Protocol Violation|2
7770115|NCT00874549|12214048|FG003|Overall Study|Protocol Violation|1
7770116|NCT00874549|12214045|FG000|Overall Study|Lost to Follow-up|0
7770117|NCT00874549|12214046|FG001|Overall Study|Lost to Follow-up|0
7770118|NCT00874549|12214047|FG002|Overall Study|Lost to Follow-up|1
7770119|NCT00874549|12214048|FG003|Overall Study|Lost to Follow-up|0
7770120|NCT00874549|12214045|FG000|Overall Study|Withdrawal by Subject|0
7770121|NCT00874549|12214046|FG001|Overall Study|Withdrawal by Subject|1
7770122|NCT00874549|12214047|FG002|Overall Study|Withdrawal by Subject|0
7770123|NCT00874549|12214048|FG003|Overall Study|Withdrawal by Subject|1
7770124|NCT00874731|12214064|FG000|Part 1, Day 1: Placebo|Disease Progression|1
7770125|NCT00874731|12214065|FG001|Part 1, Day 1: Placebo|Disease Progression|0
7770126|NCT00874731|12214066|FG002|Part 1, Day 1: Placebo|Disease Progression|0
7770127|NCT00874731|12214064|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0
7770128|NCT00874731|12214065|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0
7770129|NCT00874731|12214066|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3
7770130|NCT00874731|12214064|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0
7770131|NCT00874731|12214065|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0
7770132|NCT00874731|12214066|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19
7770133|NCT00874770|12214078|FG000|Overall Study|Lack of Efficacy|2
7770134|NCT00874770|12214079|FG001|Overall Study|Lack of Efficacy|0
7770135|NCT00874770|12214080|FG002|Overall Study|Lack of Efficacy|0
7770136|NCT00874770|12214081|FG003|Overall Study|Lack of Efficacy|2
7770137|NCT00874770|12214078|FG000|Overall Study|Adverse Event|1
7770138|NCT00874770|12214079|FG001|Overall Study|Adverse Event|1
7762764|NCT00820755|12203307|FG000|Period 1: Combination Therapy Phase|Adverse Event|77
7762765|NCT00820755|12203308|FG001|Period 1: Combination Therapy Phase|Adverse Event|0
7762766|NCT00820755|12203309|FG002|Period 1: Combination Therapy Phase|Adverse Event|0
7762767|NCT00820755|12203307|FG000|Period 1: Combination Therapy Phase|Death|28
7762768|NCT00820755|12203308|FG001|Period 1: Combination Therapy Phase|Death|0
7762769|NCT00820755|12203309|FG002|Period 1: Combination Therapy Phase|Death|0
7762770|NCT00820755|12203307|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4
7762771|NCT00820755|12203308|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0
7762772|NCT00820755|12203309|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0
7762773|NCT00820755|12203307|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1
7762774|NCT00820755|12203308|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0
7762775|NCT00820755|12203309|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0
7762776|NCT00820755|12203307|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
7762777|NCT00820755|12203308|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
7762778|NCT00820755|12203309|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
7762779|NCT00820755|12203307|FG000|Period 1: Combination Therapy Phase|Progressive disease|114
7762780|NCT00820755|12203308|FG001|Period 1: Combination Therapy Phase|Progressive disease|0
7762781|NCT00820755|12203309|FG002|Period 1: Combination Therapy Phase|Progressive disease|0
7762782|NCT00820755|12203307|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
7762783|NCT00820755|12203308|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
7762784|NCT00820755|12203309|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
7762785|NCT00820755|12203307|FG000|Period 1: Combination Therapy Phase|Other|11
7762786|NCT00820755|12203308|FG001|Period 1: Combination Therapy Phase|Other|0
7762787|NCT00820755|12203309|FG002|Period 1: Combination Therapy Phase|Other|0
7762788|NCT00820755|12203307|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
7762789|NCT00820755|12203308|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
7762790|NCT00820755|12203309|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
7762791|NCT00820898|12203321|FG000|Overall Study|Inelgible - wrong primary site|1
7762792|NCT00821015|12203331|FG000|Overall Study|Lost to Follow-up|12
7762793|NCT00821093|12203346|FG000|Overall Study|Adverse Event|20
7762794|NCT00821093|12203347|FG001|Overall Study|Adverse Event|12
7762795|NCT00821093|12203346|FG000|Overall Study|Withdrawal by Subject|9
7762796|NCT00821093|12203347|FG001|Overall Study|Withdrawal by Subject|13
7762797|NCT00821093|12203346|FG000|Overall Study|Lost to Follow-up|9
7762798|NCT00821093|12203347|FG001|Overall Study|Lost to Follow-up|3
7762799|NCT00821093|12203346|FG000|Overall Study|Protocol deviation|3
7762800|NCT00821093|12203347|FG001|Overall Study|Protocol deviation|6
7762801|NCT00821093|12203346|FG000|Overall Study|Abnormal laboratory value(s)|2
7762802|NCT00821093|12203347|FG001|Overall Study|Abnormal laboratory value(s)|0
7762803|NCT00821093|12203346|FG000|Overall Study|Lack of Efficacy|2
7762804|NCT00821093|12203347|FG001|Overall Study|Lack of Efficacy|2
7762805|NCT00821093|12203346|FG000|Overall Study|Death|2
7762806|NCT00821093|12203347|FG001|Overall Study|Death|1
7762807|NCT00821093|12203346|FG000|Overall Study|Abnormal test procedure result(s)|1
7762808|NCT00821093|12203347|FG001|Overall Study|Abnormal test procedure result(s)|1
7762809|NCT00821093|12203346|FG000|Overall Study|Administrative problems|1
7762810|NCT00821093|12203347|FG001|Overall Study|Administrative problems|2
7770139|NCT00874770|12214080|FG002|Overall Study|Adverse Event|4
7770140|NCT00874770|12214081|FG003|Overall Study|Adverse Event|2
7770141|NCT00874770|12214078|FG000|Overall Study|Lost to Follow-up|1
7770142|NCT00874770|12214079|FG001|Overall Study|Lost to Follow-up|0
7770143|NCT00874770|12214080|FG002|Overall Study|Lost to Follow-up|0
7770144|NCT00874770|12214081|FG003|Overall Study|Lost to Follow-up|1
7770145|NCT00874770|12214078|FG000|Overall Study|Subject no Longer Meets Study Criteria|1
7770146|NCT00874770|12214079|FG001|Overall Study|Subject no Longer Meets Study Criteria|0
7770147|NCT00874770|12214080|FG002|Overall Study|Subject no Longer Meets Study Criteria|0
7770148|NCT00874770|12214081|FG003|Overall Study|Subject no Longer Meets Study Criteria|0
7770149|NCT00874822|12214101|FG000|Overall Study|excluded by criteria|8
7770150|NCT00874848|12214107|FG000|Overall Study|Adverse Event|13
7770151|NCT00874848|12214108|FG001|Overall Study|Adverse Event|2
7770152|NCT00874848|12214107|FG000|Overall Study|Progressive neoplastic disease|38
7770153|NCT00874848|12214108|FG001|Overall Study|Progressive neoplastic disease|18
7770154|NCT00874848|12214107|FG000|Overall Study|Withdrawal by Subject|7
7770155|NCT00874848|12214108|FG001|Overall Study|Withdrawal by Subject|4
7770156|NCT00874848|12214107|FG000|Overall Study|Noncompliance|1
7770157|NCT00874848|12214108|FG001|Overall Study|Noncompliance|1
7770158|NCT00874848|12214107|FG000|Overall Study|Failure to comply with protocol|0
7770159|NCT00874848|12214108|FG001|Overall Study|Failure to comply with protocol|1
7770160|NCT00874848|12214107|FG000|Overall Study|Physician Decision|0
7770161|NCT00874848|12214108|FG001|Overall Study|Physician Decision|2
7770445|NCT00876460|12214452|FG004|Combination Therapy Phase|Adverse Event|2
7770446|NCT00876460|12214453|FG005|Combination Therapy Phase|Adverse Event|0
7770447|NCT00876460|12214454|FG006|Combination Therapy Phase|Adverse Event|3
7770448|NCT00876460|12214455|FG007|Combination Therapy Phase|Adverse Event|2
7770449|NCT00876460|12214448|FG000|Combination Therapy Phase|Withdrawal by Subject|1
7770450|NCT00876460|12214449|FG001|Combination Therapy Phase|Withdrawal by Subject|1
7770451|NCT00876460|12214450|FG002|Combination Therapy Phase|Withdrawal by Subject|0
7770452|NCT00876460|12214451|FG003|Combination Therapy Phase|Withdrawal by Subject|0
7770453|NCT00876460|12214452|FG004|Combination Therapy Phase|Withdrawal by Subject|1
7770454|NCT00876460|12214453|FG005|Combination Therapy Phase|Withdrawal by Subject|0
7770455|NCT00876460|12214454|FG006|Combination Therapy Phase|Withdrawal by Subject|0
7770456|NCT00876460|12214455|FG007|Combination Therapy Phase|Withdrawal by Subject|0
7770457|NCT00876460|12214448|FG000|Combination Therapy Phase|Other reason not defined above|0
7770458|NCT00876460|12214449|FG001|Combination Therapy Phase|Other reason not defined above|0
7770459|NCT00876460|12214450|FG002|Combination Therapy Phase|Other reason not defined above|0
7770460|NCT00876460|12214451|FG003|Combination Therapy Phase|Other reason not defined above|0
7770461|NCT00876460|12214452|FG004|Combination Therapy Phase|Other reason not defined above|0
7770462|NCT00876460|12214453|FG005|Combination Therapy Phase|Other reason not defined above|0
7770463|NCT00876460|12214454|FG006|Combination Therapy Phase|Other reason not defined above|1
7770464|NCT00876460|12214455|FG007|Combination Therapy Phase|Other reason not defined above|2
7770465|NCT00876460|12214448|FG000|Combination Therapy Phase|Not treated|0
7762811|NCT04187989|12203377|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6
7762812|NCT04187989|12203378|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8
7762813|NCT04187989|12203377|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8
7762814|NCT04187989|12203378|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8
7762815|NCT04109118|12203384|FG000|Overall Study|Lost to Follow-up|3
7762816|NCT03846219|12203392|FG000|Overall Study|Withdrawal by Subject|3
7762817|NCT03846219|12203393|FG001|Overall Study|Withdrawal by Subject|2
7762818|NCT03846219|12203394|FG002|Overall Study|Withdrawal by Subject|2
7762819|NCT03846219|12203392|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0
7762820|NCT03846219|12203393|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2
7762821|NCT03846219|12203394|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1
7762822|NCT03846219|12203392|FG000|Overall Study|Physician Decision|0
7762823|NCT03846219|12203393|FG001|Overall Study|Physician Decision|0
7762824|NCT03846219|12203394|FG002|Overall Study|Physician Decision|2
7762825|NCT03606668|12203436|FG000|Overall Study|Screen Failure|1
7762826|NCT03606668|12203436|FG000|Overall Study|Lost to Follow-up|1
7762827|NCT03575897|12203442|FG000|Overall Study|Lost to Follow-up|12
7762828|NCT03575897|12203443|FG001|Overall Study|Lost to Follow-up|13
7770162|NCT00875017|12214129|FG000|First Intervention|Withdrawal by Subject|1
7770163|NCT00875017|12214130|FG001|First Intervention|Withdrawal by Subject|0
7770164|NCT00875017|12214131|FG002|First Intervention|Withdrawal by Subject|1
7770165|NCT00875017|12214132|FG003|First Intervention|Withdrawal by Subject|0
7770166|NCT00875017|12214133|FG004|First Intervention|Withdrawal by Subject|0
7770167|NCT00875017|12214134|FG005|First Intervention|Withdrawal by Subject|0
7770168|NCT00875017|12214129|FG000|First Intervention|Adverse Event|0
7770169|NCT00875017|12214130|FG001|First Intervention|Adverse Event|0
7770170|NCT00875017|12214131|FG002|First Intervention|Adverse Event|0
7770171|NCT00875017|12214132|FG003|First Intervention|Adverse Event|1
7770172|NCT00875017|12214133|FG004|First Intervention|Adverse Event|0
7770173|NCT00875017|12214134|FG005|First Intervention|Adverse Event|0
7770174|NCT00875017|12214129|FG000|First Intervention|Problems collecting rectal effluent|1
7770175|NCT00875017|12214130|FG001|First Intervention|Problems collecting rectal effluent|0
7770176|NCT00875017|12214131|FG002|First Intervention|Problems collecting rectal effluent|0
7770177|NCT00875017|12214132|FG003|First Intervention|Problems collecting rectal effluent|0
7770178|NCT00875017|12214133|FG004|First Intervention|Problems collecting rectal effluent|0
7770179|NCT00875017|12214134|FG005|First Intervention|Problems collecting rectal effluent|0
7770180|NCT00875017|12214129|FG000|First Intervention|Intolerance to nasogastric tube|0
7770181|NCT00875017|12214130|FG001|First Intervention|Intolerance to nasogastric tube|0
7770182|NCT00875017|12214131|FG002|First Intervention|Intolerance to nasogastric tube|0
7770183|NCT00875017|12214132|FG003|First Intervention|Intolerance to nasogastric tube|0
7770184|NCT00875017|12214133|FG004|First Intervention|Intolerance to nasogastric tube|1
7770185|NCT00875017|12214134|FG005|First Intervention|Intolerance to nasogastric tube|0
7770186|NCT00875017|12214129|FG000|Washout|Problem collecting rectal effluent|0
7770187|NCT00875017|12214130|FG001|Washout|Problem collecting rectal effluent|0
7770188|NCT00875017|12214131|FG002|Washout|Problem collecting rectal effluent|1
7762829|NCT03343626|12203457|FG000|Overall Study|Lost to Follow-up|4
7762830|NCT03343626|12203458|FG001|Overall Study|Lost to Follow-up|3
7762831|NCT03343626|12203459|FG002|Overall Study|Lost to Follow-up|2
7762832|NCT03343626|12203460|FG003|Overall Study|Lost to Follow-up|5
7762833|NCT03343626|12203461|FG004|Overall Study|Lost to Follow-up|4
7762834|NCT03343626|12203462|FG005|Overall Study|Lost to Follow-up|4
7762835|NCT03343626|12203463|FG006|Overall Study|Lost to Follow-up|4
7762836|NCT03343626|12203464|FG007|Overall Study|Lost to Follow-up|7
7762837|NCT03343626|12203457|FG000|Overall Study|Withdrawal of Consent|2
7762838|NCT03343626|12203458|FG001|Overall Study|Withdrawal of Consent|1
7762839|NCT03343626|12203459|FG002|Overall Study|Withdrawal of Consent|0
7762840|NCT03343626|12203460|FG003|Overall Study|Withdrawal of Consent|3
7762841|NCT03343626|12203461|FG004|Overall Study|Withdrawal of Consent|3
7762842|NCT03343626|12203462|FG005|Overall Study|Withdrawal of Consent|1
7762843|NCT03343626|12203463|FG006|Overall Study|Withdrawal of Consent|1
7762844|NCT03343626|12203464|FG007|Overall Study|Withdrawal of Consent|2
7762845|NCT03343626|12203457|FG000|Overall Study|Reason not Specified|0
7762846|NCT03343626|12203458|FG001|Overall Study|Reason not Specified|1
7762847|NCT03343626|12203459|FG002|Overall Study|Reason not Specified|0
7762848|NCT03343626|12203460|FG003|Overall Study|Reason not Specified|0
7762849|NCT03343626|12203461|FG004|Overall Study|Reason not Specified|0
7762850|NCT03343626|12203462|FG005|Overall Study|Reason not Specified|0
7762851|NCT03343626|12203463|FG006|Overall Study|Reason not Specified|0
7762852|NCT03343626|12203464|FG007|Overall Study|Reason not Specified|1
7762853|NCT03343626|12203457|FG000|Overall Study|Data Entry Error|0
7762854|NCT03343626|12203458|FG001|Overall Study|Data Entry Error|0
7762855|NCT03343626|12203459|FG002|Overall Study|Data Entry Error|0
7762856|NCT03343626|12203460|FG003|Overall Study|Data Entry Error|0
7762857|NCT03343626|12203461|FG004|Overall Study|Data Entry Error|0
7762858|NCT03343626|12203462|FG005|Overall Study|Data Entry Error|0
7762859|NCT03343626|12203463|FG006|Overall Study|Data Entry Error|0
7762860|NCT03343626|12203464|FG007|Overall Study|Data Entry Error|1
7762861|NCT02807363|12203519|FG000|Dosing Period|Adverse Event|0
7762862|NCT02807363|12203520|FG001|Dosing Period|Adverse Event|1
7762863|NCT02807363|12203521|FG002|Dosing Period|Adverse Event|0
7762864|NCT02807363|12203522|FG003|Dosing Period|Adverse Event|0
7762865|NCT02756403|12203538|FG000|Overall Study|Unable to swallow medication|0
7762866|NCT02756403|12203539|FG001|Overall Study|Unable to swallow medication|1
7762867|NCT02756403|12203540|FG002|Overall Study|Unable to swallow medication|1
7762868|NCT02756403|12203541|FG003|Overall Study|Unable to swallow medication|1
7762869|NCT02756403|12203538|FG000|Overall Study|Did not complete Procedure|0
7762870|NCT02756403|12203539|FG001|Overall Study|Did not complete Procedure|1
7762871|NCT02756403|12203540|FG002|Overall Study|Did not complete Procedure|0
7762872|NCT02756403|12203541|FG003|Overall Study|Did not complete Procedure|0
7762873|NCT02756403|12203538|FG000|Overall Study|Changed Mind About Procedure|0
7762874|NCT02756403|12203539|FG001|Overall Study|Changed Mind About Procedure|0
7762875|NCT02756403|12203540|FG002|Overall Study|Changed Mind About Procedure|1
7762876|NCT02756403|12203541|FG003|Overall Study|Changed Mind About Procedure|0
7762877|NCT02756403|12203538|FG000|Overall Study|Protocol Violation|0
7762878|NCT02756403|12203539|FG001|Overall Study|Protocol Violation|1
7762879|NCT02756403|12203540|FG002|Overall Study|Protocol Violation|0
7762880|NCT02756403|12203541|FG003|Overall Study|Protocol Violation|1
7762881|NCT02751502|12203551|FG000|Overall Study|Lack of funding|4
7762882|NCT01981096|12203583|FG000|Overall Study|Parent illness|1
7762883|NCT01981096|12203584|FG001|Overall Study|Parent illness|0
7762884|NCT01981096|12203583|FG000|Overall Study|Withdrawal by Subject|0
7762885|NCT01981096|12203584|FG001|Overall Study|Withdrawal by Subject|1
7762886|NCT01981096|12203583|FG000|Overall Study|Lost to Follow-up|2
7762887|NCT01981096|12203584|FG001|Overall Study|Lost to Follow-up|0
7762888|NCT01935336|12203594|FG000|Overall Study|Adverse Event|1
7762889|NCT01935336|12203595|FG001|Overall Study|Adverse Event|0
7762890|NCT01935336|12203596|FG002|Overall Study|Adverse Event|0
7762891|NCT01935336|12203597|FG003|Overall Study|Adverse Event|0
7762892|NCT01935336|12203594|FG000|Overall Study|Progressive disease|5
7762893|NCT01935336|12203595|FG001|Overall Study|Progressive disease|3
7762894|NCT01935336|12203596|FG002|Overall Study|Progressive disease|47
7762895|NCT01935336|12203597|FG003|Overall Study|Progressive disease|66
7762896|NCT01712490|12203615|FG000|Overall Study|Ongoing|601
7762897|NCT01712490|12203616|FG001|Overall Study|Ongoing|586
7762898|NCT01712490|12203615|FG000|Overall Study|Other|11
7762899|NCT01712490|12203616|FG001|Overall Study|Other|11
7762900|NCT01712490|12203615|FG000|Overall Study|Withdrawal by Subject|36
7762901|NCT01712490|12203616|FG001|Overall Study|Withdrawal by Subject|44
7762902|NCT01712490|12203615|FG000|Overall Study|Lost to Follow-up|16
7762903|NCT01712490|12203616|FG001|Overall Study|Lost to Follow-up|29
7762904|NCT01702805|12203624|FG000|Overall Study|Data withdrawn prior to hospital discharge|3
7762905|NCT01702805|12203625|FG001|Overall Study|Data withdrawn prior to hospital discharge|7
7762906|NCT01702805|12203624|FG000|Overall Study|Incomplete Follow-up|18
7762907|NCT01702805|12203625|FG001|Overall Study|Incomplete Follow-up|15
7762908|NCT01702805|12203624|FG000|Overall Study|Vital Status Assessment Only|40
7762909|NCT01702805|12203625|FG001|Overall Study|Vital Status Assessment Only|39
7762910|NCT01702805|12203624|FG000|Overall Study|Lost to Follow-up|5
7762911|NCT01702805|12203625|FG001|Overall Study|Lost to Follow-up|5
7762912|NCT01499160|12203631|FG000|Overall Study|Adverse Event|1
7762913|NCT01499160|12203631|FG000|Overall Study|Withdrawal by Subject|1
7762914|NCT01061151|12203673|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
7762915|NCT01061151|12203674|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
7762916|NCT01061151|12203675|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
7762917|NCT01061151|12203676|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
7762918|NCT01061151|12203673|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6
7762919|NCT01061151|12203674|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9
7762920|NCT01061151|12203675|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1
7762921|NCT01061151|12203676|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2
7762922|NCT01061151|12203673|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
7762923|NCT01061151|12203674|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
7762924|NCT01061151|12203675|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
7762925|NCT01061151|12203676|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
7762926|NCT01061151|12203673|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
7762927|NCT01061151|12203674|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
7762928|NCT01061151|12203675|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
7762929|NCT01061151|12203676|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
7624594|NCT01986114|12035684|FG000|Overall Study|Other reason|7
7762930|NCT01061151|12203673|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
7762931|NCT01061151|12203674|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
7762932|NCT01061151|12203675|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
7762933|NCT01061151|12203676|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
7762934|NCT01061151|12203673|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
7762935|NCT01061151|12203674|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
7762936|NCT01061151|12203675|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
7762937|NCT01061151|12203676|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
7762938|NCT01061151|12203673|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
7762939|NCT01061151|12203674|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
7762940|NCT01061151|12203675|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
7762941|NCT01061151|12203676|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
7762942|NCT01061151|12203673|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
7762943|NCT01061151|12203674|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
7762944|NCT01061151|12203675|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
7762945|NCT01061151|12203676|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
7762946|NCT01061151|12203673|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
7762947|NCT01061151|12203674|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
7762948|NCT01061151|12203675|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
7762949|NCT01061151|12203676|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
7762950|NCT01061151|12203673|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3
7762951|NCT01061151|12203674|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5
7762952|NCT01061151|12203675|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1
7762953|NCT01061151|12203676|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1
7762954|NCT01061151|12203673|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
7762955|NCT01061151|12203674|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
7770466|NCT00876460|12214449|FG001|Combination Therapy Phase|Not treated|0
7762956|NCT01061151|12203675|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
7762957|NCT01061151|12203676|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
7762958|NCT01061151|12203673|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
7762959|NCT01061151|12203674|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
7762960|NCT01061151|12203675|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
7762961|NCT01061151|12203676|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
7762962|NCT01061151|12203673|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
7762963|NCT01061151|12203674|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
7762964|NCT01061151|12203675|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
7762965|NCT01061151|12203676|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
7762966|NCT01061151|12203673|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
7762967|NCT01061151|12203674|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
7762968|NCT01061151|12203675|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
7762969|NCT01061151|12203676|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
7762970|NCT01061151|12203673|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
7762971|NCT01061151|12203674|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
7762972|NCT01061151|12203675|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
7762973|NCT01061151|12203676|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
7762974|NCT00981058|12203698|FG000|Overall Study|Adverse Event|1
7762975|NCT00981058|12203699|FG001|Overall Study|Adverse Event|1
7762976|NCT00981058|12203698|FG000|Overall Study|Progressive Disease|61
7762977|NCT00981058|12203699|FG001|Overall Study|Progressive Disease|49
7762978|NCT00981058|12203698|FG000|Overall Study|Lost to Follow-up|16
7762979|NCT00981058|12203699|FG001|Overall Study|Lost to Follow-up|15
7762980|NCT00981058|12203698|FG000|Overall Study|New Anticancer Therapy|6
7762981|NCT00981058|12203699|FG001|Overall Study|New Anticancer Therapy|6
7762982|NCT00981058|12203698|FG000|Overall Study|Noncompliance|1
7762983|NCT00981058|12203699|FG001|Overall Study|Noncompliance|0
7762984|NCT00981058|12203698|FG000|Overall Study|Radiologist Error|0
7762985|NCT00981058|12203699|FG001|Overall Study|Radiologist Error|1
7762986|NCT00981058|12203698|FG000|Overall Study|Randomization Error|1
7762987|NCT00981058|12203699|FG001|Overall Study|Randomization Error|2
7762988|NCT00981058|12203698|FG000|Overall Study|Withdrawal by Subject|25
7762989|NCT00981058|12203699|FG001|Overall Study|Withdrawal by Subject|23
7762990|NCT00981058|12203698|FG000|Overall Study|On study treatment at conclusion|9
7762991|NCT00981058|12203699|FG001|Overall Study|On study treatment at conclusion|0
7762992|NCT00885495|12203707|FG000|Overall Study|Adverse Event|1
7762993|NCT00885495|12203708|FG001|Overall Study|Adverse Event|2
7762994|NCT00885495|12203707|FG000|Overall Study|Protocol Violation|0
7762995|NCT00885495|12203708|FG001|Overall Study|Protocol Violation|1
7762996|NCT00885495|12203707|FG000|Overall Study|Withdrawal by Subject|1
7762997|NCT00885495|12203708|FG001|Overall Study|Withdrawal by Subject|0
7770189|NCT00875017|12214132|FG003|Washout|Problem collecting rectal effluent|0
7770190|NCT00875017|12214133|FG004|Washout|Problem collecting rectal effluent|0
7770191|NCT00875017|12214134|FG005|Washout|Problem collecting rectal effluent|0
7770192|NCT00875017|12214129|FG000|Second Intervention|Adverse Event|0
7770193|NCT00875017|12214130|FG001|Second Intervention|Adverse Event|0
7770194|NCT00875017|12214131|FG002|Second Intervention|Adverse Event|0
7770195|NCT00875017|12214132|FG003|Second Intervention|Adverse Event|1
7770196|NCT00875017|12214133|FG004|Second Intervention|Adverse Event|0
7762998|NCT00084799|12203721|FG000|Overall Study|Disease Progression|1
7762999|NCT00084799|12203722|FG001|Overall Study|Disease Progression|0
7763000|NCT00821236|12203731|FG000|Overall Study|Lost to Follow-up|3
7763001|NCT00821327|12203739|FG000|Overall Study|Adverse Event|13
7763002|NCT00821327|12203739|FG000|Overall Study|Patient Request|1
7763003|NCT00821327|12203739|FG000|Overall Study|Investigator Request|2
7763004|NCT00821327|12203739|FG000|Overall Study|Sponsor Request|1
7763005|NCT00821327|12203739|FG000|Overall Study|Disease Progression|13
7763006|NCT00821327|12203739|FG000|Overall Study|Other/Unknown|5
7763007|NCT00821431|12203745|FG000|Overall Study|Adverse Event|6
7763008|NCT00821431|12203746|FG001|Overall Study|Adverse Event|3
7763009|NCT00821431|12203745|FG000|Overall Study|Withdrawal by Subject|5
7763010|NCT00821431|12203746|FG001|Overall Study|Withdrawal by Subject|0
7763011|NCT00821431|12203745|FG000|Overall Study|Lost to Follow-up|1
7763012|NCT00821431|12203746|FG001|Overall Study|Lost to Follow-up|0
7763013|NCT00821431|12203745|FG000|Overall Study|Protocol Violation|3
7763014|NCT00821431|12203746|FG001|Overall Study|Protocol Violation|1
7763015|NCT00821431|12203745|FG000|Overall Study|Physician Decision|0
7763016|NCT00821431|12203746|FG001|Overall Study|Physician Decision|1
7763017|NCT00821509|12203755|FG000|Overall Study|Withdrawal by Subject|12
7763018|NCT00821509|12203756|FG001|Overall Study|Withdrawal by Subject|11
7763019|NCT00821509|12203757|FG002|Overall Study|Withdrawal by Subject|34
7763020|NCT00821678|12203778|FG000|Overall Study|Withdrawal by Subject|8
7763021|NCT00821678|12203779|FG001|Overall Study|Withdrawal by Subject|0
7763022|NCT00821678|12203778|FG000|Overall Study|Lost to Follow-up|13
7763023|NCT00821678|12203779|FG001|Overall Study|Lost to Follow-up|12
7763024|NCT00821678|12203778|FG000|Overall Study|Death|0
7763025|NCT00821678|12203779|FG001|Overall Study|Death|2
7763026|NCT00821873|12203811|FG000|Overall Study|Lost to Follow-up|4
7763027|NCT00822172|12203845|FG000|Overall Study|Adverse Event|10
7763028|NCT00822172|12203846|FG001|Overall Study|Adverse Event|12
7763029|NCT00822172|12203845|FG000|Overall Study|Death|1
7763030|NCT00822172|12203846|FG001|Overall Study|Death|0
7763031|NCT00822172|12203845|FG000|Overall Study|Lost to Follow-up|3
7962686|NCT02713529|12516923|FG001|Overall Study|Lost to Follow-up|0
7763032|NCT00822172|12203846|FG001|Overall Study|Lost to Follow-up|1
7763033|NCT00822172|12203845|FG000|Overall Study|Withdrawal by Subject|1
7763034|NCT00822172|12203846|FG001|Overall Study|Withdrawal by Subject|4
7763035|NCT00822172|12203845|FG000|Overall Study|site closed|0
7763036|NCT00822172|12203846|FG001|Overall Study|site closed|1
7763037|NCT00822172|12203845|FG000|Overall Study|Other|0
7763038|NCT00822172|12203846|FG001|Overall Study|Other|1
7763039|NCT00822237|12203875|FG000|Dose 1 Vaccination|Not vaccinated|3
7763040|NCT00822237|12203876|FG001|Dose 1 Vaccination|Not vaccinated|0
7763041|NCT00822237|12203875|FG000|Dose 1 Vaccination|Withdrawal by Subject|13
7763042|NCT00822237|12203876|FG001|Dose 1 Vaccination|Withdrawal by Subject|14
7763043|NCT00822237|12203875|FG000|Dose 1 Vaccination|Lost to Follow-up|9
7763044|NCT00822237|12203876|FG001|Dose 1 Vaccination|Lost to Follow-up|12
7763045|NCT00822237|12203875|FG000|Dose 2 Vaccination|Withdrawal by Subject|2
7763046|NCT00822237|12203876|FG001|Dose 2 Vaccination|Withdrawal by Subject|2
7763047|NCT00822237|12203875|FG000|Dose 2 Vaccination|Lost to Follow-up|2
7763048|NCT00822237|12203876|FG001|Dose 2 Vaccination|Lost to Follow-up|9
7763049|NCT00822692|12203944|FG000|Overall Study|Lost to Follow-up|17
7763050|NCT00822692|12203945|FG001|Overall Study|Lost to Follow-up|25
7763051|NCT00822770|12203962|FG000|Overall Study|Not treated|1
7763052|NCT00822770|12203963|FG001|Overall Study|Not treated|0
7763053|NCT00822770|12203962|FG000|Overall Study|Complication/Incomplete treatment|1
7763054|NCT00822770|12203963|FG001|Overall Study|Complication/Incomplete treatment|0
7763055|NCT00822770|12203962|FG000|Overall Study|Death|1
7763056|NCT00822770|12203963|FG001|Overall Study|Death|1
7763057|NCT00822900|12203971|FG000|Overall Study|Withdrawal by Subject|14
7763058|NCT00822900|12203972|FG001|Overall Study|Withdrawal by Subject|14
7763059|NCT00822900|12203971|FG000|Overall Study|Lost to Follow-up|9
7763060|NCT00822900|12203972|FG001|Overall Study|Lost to Follow-up|9
7763061|NCT00822900|12203971|FG000|Overall Study|Death|83
7763062|NCT00822900|12203972|FG001|Overall Study|Death|69
7763063|NCT00822900|12203971|FG000|Overall Study|Became a ward of the state|2
7763064|NCT00822900|12203972|FG001|Overall Study|Became a ward of the state|1
7763065|NCT00822926|12203980|FG000|Second Injection Visit|Lost to Follow-up|1
7763066|NCT00822926|12203981|FG001|Second Injection Visit|Lost to Follow-up|0
7763067|NCT00822926|12203980|FG000|Second Injection Visit|Withdrawal by Subject|0
7763068|NCT00822926|12203981|FG001|Second Injection Visit|Withdrawal by Subject|1
7763069|NCT00823134|12204012|FG000|Overall Study|Invalid measurement|1
7763070|NCT00823199|12204017|FG000|Overall Study|Withdrawal by Subject|2
7763071|NCT00823212|12204024|FG000|Overall Study|Death|8
7763072|NCT00823212|12204025|FG001|Overall Study|Death|10
7763073|NCT00823212|12204024|FG000|Overall Study|Withdrawal by Subject|6
7763074|NCT00823212|12204025|FG001|Overall Study|Withdrawal by Subject|1
7763075|NCT00823212|12204024|FG000|Overall Study|Incarcerated|0
7763076|NCT00823212|12204025|FG001|Overall Study|Incarcerated|1
7763077|NCT00823212|12204024|FG000|Overall Study|Missed 12-month visit|21
7763078|NCT00823212|12204025|FG001|Overall Study|Missed 12-month visit|21
7763079|NCT00823264|12204035|FG000|Overall Study|Protocol Violation|2
7763080|NCT00823264|12204036|FG001|Overall Study|Protocol Violation|0
7763081|NCT00823472|12204058|FG000|Overall Study|Physician Decision|24
7763082|NCT00823472|12204059|FG001|Overall Study|Physician Decision|28
7763083|NCT00823615|12204065|FG000|Period 2|Lost to Follow-up|2
7763084|NCT00823615|12204066|FG001|Period 2|Lost to Follow-up|0
7763085|NCT00823615|12204065|FG000|Period 2|Time/Job Conflict|1
7763086|NCT00823615|12204066|FG001|Period 2|Time/Job Conflict|2
7763087|NCT00823719|12204074|FG000|Overall Study|Adverse Event|1
7763088|NCT00823719|12204075|FG001|Overall Study|Adverse Event|2
7763089|NCT00823719|12204074|FG000|Overall Study|Physician Decision|1
7763090|NCT00823719|12204075|FG001|Overall Study|Physician Decision|4
7763091|NCT00823719|12204074|FG000|Overall Study|Withdrawal by Subject|0
7763092|NCT00823719|12204075|FG001|Overall Study|Withdrawal by Subject|1
7763093|NCT00823719|12204074|FG000|Overall Study|Disease Progression|4
7763094|NCT00823719|12204075|FG001|Overall Study|Disease Progression|4
7763095|NCT00823823|12204093|FG000|Overall Study|Lost to Follow-up|3
7763096|NCT00823823|12204094|FG001|Overall Study|Lost to Follow-up|1
7763097|NCT00823823|12204093|FG000|Overall Study|Protocol Violation|5
7763098|NCT00823823|12204094|FG001|Overall Study|Protocol Violation|5
7763099|NCT00823836|12204102|FG000|NV and PR/XR Switching Phases|Adverse Event|22
7763100|NCT00823836|12204103|FG001|NV and PR/XR Switching Phases|Adverse Event|21
7763101|NCT00823836|12204102|FG000|NV and PR/XR Switching Phases|Protocol Violation|1
7763102|NCT00823836|12204103|FG001|NV and PR/XR Switching Phases|Protocol Violation|1
7763103|NCT00823836|12204102|FG000|NV and PR/XR Switching Phases|Physician Decision|5
7763104|NCT00823836|12204103|FG001|NV and PR/XR Switching Phases|Physician Decision|2
7763105|NCT00823836|12204102|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4
7763106|NCT00823836|12204103|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5
7763107|NCT00823836|12204102|FG000|Long-term Phase|Adverse Event|3
7763108|NCT00823836|12204103|FG001|Long-term Phase|Adverse Event|2
7763109|NCT00823836|12204102|FG000|Long-term Phase|Physician Decision|1
7763110|NCT00823836|12204103|FG001|Long-term Phase|Physician Decision|2
7763111|NCT00823836|12204102|FG000|Long-term Phase|Withdrawal by Subject|1
7763112|NCT00823836|12204103|FG001|Long-term Phase|Withdrawal by Subject|1
7763113|NCT00823901|12204114|FG000|Overall Study|Adverse Event|1
7763114|NCT00823901|12204115|FG001|Overall Study|Adverse Event|1
7763115|NCT00823901|12204114|FG000|Overall Study|Lack of Efficacy|1
7763116|NCT00823901|12204115|FG001|Overall Study|Lack of Efficacy|0
7763117|NCT00823901|12204114|FG000|Overall Study|Lost to Follow-up|2
7763118|NCT00823901|12204115|FG001|Overall Study|Lost to Follow-up|1
7763119|NCT00823979|12204128|FG000|Overall Study|Lack of Efficacy|13
7763120|NCT00823979|12204129|FG001|Overall Study|Lack of Efficacy|16
7763121|NCT00823979|12204130|FG002|Overall Study|Lack of Efficacy|9
7763122|NCT00823979|12204128|FG000|Overall Study|Lost to Follow-up|2
7763123|NCT00823979|12204129|FG001|Overall Study|Lost to Follow-up|1
7763124|NCT00823979|12204130|FG002|Overall Study|Lost to Follow-up|0
7763125|NCT00823979|12204128|FG000|Overall Study|Withdrawal by Subject|2
7763126|NCT00823979|12204129|FG001|Overall Study|Withdrawal by Subject|3
7763127|NCT00823979|12204130|FG002|Overall Study|Withdrawal by Subject|2
7763128|NCT00823979|12204128|FG000|Overall Study|Protocol Violation|1
7763129|NCT00823979|12204129|FG001|Overall Study|Protocol Violation|1
7763130|NCT00823979|12204130|FG002|Overall Study|Protocol Violation|0
7763131|NCT00823979|12204128|FG000|Overall Study|Pregnancy|0
7763132|NCT00823979|12204129|FG001|Overall Study|Pregnancy|1
7763133|NCT00823979|12204130|FG002|Overall Study|Pregnancy|0
7763134|NCT00823979|12204128|FG000|Overall Study|Adverse Event|0
7763135|NCT00823979|12204129|FG001|Overall Study|Adverse Event|2
7763136|NCT00823979|12204130|FG002|Overall Study|Adverse Event|4
7763137|NCT00823979|12204128|FG000|Overall Study|Other|2
7763138|NCT00823979|12204129|FG001|Overall Study|Other|0
7763139|NCT00823979|12204130|FG002|Overall Study|Other|1
7763140|NCT00823979|12204128|FG000|Overall Study|Randomized but not Treated|4
7763141|NCT00823979|12204129|FG001|Overall Study|Randomized but not Treated|3
7763142|NCT00823979|12204130|FG002|Overall Study|Randomized but not Treated|1
7763143|NCT00823979|12204128|FG000|Overall Study|Study Terminated by Sponsor|5
7763144|NCT00823979|12204129|FG001|Overall Study|Study Terminated by Sponsor|5
7763145|NCT00823979|12204130|FG002|Overall Study|Study Terminated by Sponsor|7
7763146|NCT00824005|12204140|FG000|Overall Study|Death|0
7763147|NCT00824005|12204141|FG001|Overall Study|Death|1
7763148|NCT00824005|12204140|FG000|Overall Study|Lost to Follow-up|0
7763149|NCT00824005|12204141|FG001|Overall Study|Lost to Follow-up|1
7763150|NCT00824161|12204173|FG000|Overall Study|Withdrawal by Subject|1
7763151|NCT00824161|12204173|FG000|Overall Study|Screen Failure|1
7763152|NCT00824265|12204180|FG000|Treatment Phase|Adverse Event,non-fatal|50
7763153|NCT00824265|12204181|FG001|Treatment Phase|Adverse Event,non-fatal|52
7763154|NCT00824265|12204180|FG000|Treatment Phase|Protocol Violation|1
7763155|NCT00824265|12204181|FG001|Treatment Phase|Protocol Violation|0
7763156|NCT00824265|12204180|FG000|Treatment Phase|Lost to Follow-up|1
7763157|NCT00824265|12204181|FG001|Treatment Phase|Lost to Follow-up|1
7763158|NCT00824265|12204180|FG000|Treatment Phase|Physician Decision|6
7763159|NCT00824265|12204181|FG001|Treatment Phase|Physician Decision|12
7763160|NCT00824265|12204180|FG000|Treatment Phase|Withdrawal by Subject|6
7763161|NCT00824265|12204181|FG001|Treatment Phase|Withdrawal by Subject|15
7763162|NCT00824265|12204180|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
7763163|NCT00824265|12204181|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
7763164|NCT00824265|12204180|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
7763165|NCT00824265|12204181|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
7763166|NCT00824291|12204193|FG000|Overall Study|Adverse Event|15
7763167|NCT00824291|12204194|FG001|Overall Study|Adverse Event|6
7763168|NCT00824291|12204193|FG000|Overall Study|Discontinuation of Study by Sponsor|1
7763169|NCT00824291|12204194|FG001|Overall Study|Discontinuation of Study by Sponsor|2
7763170|NCT00824291|12204193|FG000|Overall Study|Lost to Follow-up|11
7763171|NCT00824291|12204194|FG001|Overall Study|Lost to Follow-up|9
7763172|NCT00824291|12204193|FG000|Overall Study|Non-compliance|1
7763173|NCT00824291|12204194|FG001|Overall Study|Non-compliance|1
7763174|NCT00824291|12204193|FG000|Overall Study|Protocol Violation|4
7763175|NCT00824291|12204194|FG001|Overall Study|Protocol Violation|1
7763176|NCT00824291|12204193|FG000|Overall Study|Withdrawal by Subject|14
7763177|NCT00824291|12204194|FG001|Overall Study|Withdrawal by Subject|8
7763178|NCT00824291|12204193|FG000|Overall Study|Lack of Efficacy|7
7763179|NCT00824291|12204194|FG001|Overall Study|Lack of Efficacy|8
7763180|NCT00824291|12204193|FG000|Overall Study|Participant on prohibited medication|1
7763181|NCT00824291|12204194|FG001|Overall Study|Participant on prohibited medication|0
7763182|NCT00824369|12204206|FG000|Overall Study|Nolonger willing to participate in study|1
7763183|NCT00824369|12204207|FG001|Overall Study|Nolonger willing to participate in study|0
7763184|NCT00824369|12204208|FG002|Overall Study|Nolonger willing to participate in study|1
7763185|NCT00824369|12204209|FG003|Overall Study|Nolonger willing to participate in study|2
7763186|NCT00824369|12204210|FG004|Overall Study|Nolonger willing to participate in study|0
7763187|NCT00824369|12204211|FG005|Overall Study|Nolonger willing to participate in study|1
7763188|NCT00824369|12204206|FG000|Overall Study|Lost to Follow-up|0
7763189|NCT00824369|12204207|FG001|Overall Study|Lost to Follow-up|0
7763190|NCT00824369|12204208|FG002|Overall Study|Lost to Follow-up|0
7763191|NCT00824369|12204209|FG003|Overall Study|Lost to Follow-up|0
7763192|NCT00824369|12204210|FG004|Overall Study|Lost to Follow-up|1
7763193|NCT00824369|12204211|FG005|Overall Study|Lost to Follow-up|0
7763194|NCT00824382|12204229|FG000|Overall Study|Adverse Event|4
7763195|NCT00824382|12204230|FG001|Overall Study|Adverse Event|1
7763196|NCT00824382|12204231|FG002|Overall Study|Adverse Event|1
7763197|NCT00824382|12204232|FG003|Overall Study|Adverse Event|4
7763198|NCT00824382|12204229|FG000|Overall Study|Protocol Violation|1
7763199|NCT00824382|12204230|FG001|Overall Study|Protocol Violation|0
7763200|NCT00824382|12204231|FG002|Overall Study|Protocol Violation|0
7763201|NCT00824382|12204232|FG003|Overall Study|Protocol Violation|1
7763202|NCT00824382|12204229|FG000|Overall Study|Investigator's decision|0
7763203|NCT00824382|12204230|FG001|Overall Study|Investigator's decision|1
7763204|NCT00824382|12204231|FG002|Overall Study|Investigator's decision|2
7763205|NCT00824382|12204232|FG003|Overall Study|Investigator's decision|0
7763206|NCT00824408|12204249|FG000|Run-in Phase|Progressive disease|4
7763207|NCT00824408|12204250|FG001|Run-in Phase|Progressive disease|4
7763208|NCT00824408|12204251|FG002|Run-in Phase|Progressive disease|0
7763209|NCT00824408|12204252|FG003|Run-in Phase|Progressive disease|0
7763210|NCT00824408|12204253|FG004|Run-in Phase|Progressive disease|0
7763211|NCT00824408|12204249|FG000|Run-in Phase|Adverse Event|1
7763212|NCT00824408|12204250|FG001|Run-in Phase|Adverse Event|1
7763213|NCT00824408|12204251|FG002|Run-in Phase|Adverse Event|0
7763214|NCT00824408|12204252|FG003|Run-in Phase|Adverse Event|0
7763215|NCT00824408|12204253|FG004|Run-in Phase|Adverse Event|0
7763216|NCT00824408|12204249|FG000|Run-in Phase|Refused to continue medication|1
7763217|NCT00824408|12204250|FG001|Run-in Phase|Refused to continue medication|0
7763218|NCT00824408|12204251|FG002|Run-in Phase|Refused to continue medication|0
7763219|NCT00824408|12204252|FG003|Run-in Phase|Refused to continue medication|0
7763220|NCT00824408|12204253|FG004|Run-in Phase|Refused to continue medication|0
7763221|NCT00824408|12204249|FG000|Run-in Phase|Other reason not defined above|0
7763222|NCT00824408|12204250|FG001|Run-in Phase|Other reason not defined above|1
7763223|NCT00824408|12204251|FG002|Run-in Phase|Other reason not defined above|0
7763224|NCT00824408|12204252|FG003|Run-in Phase|Other reason not defined above|0
7763225|NCT00824408|12204253|FG004|Run-in Phase|Other reason not defined above|0
7763226|NCT00824408|12204249|FG000|Randomized Phase|Not treated|0
7763227|NCT00824408|12204250|FG001|Randomized Phase|Not treated|0
7763228|NCT00824408|12204251|FG002|Randomized Phase|Not treated|1
7763229|NCT00824408|12204252|FG003|Randomized Phase|Not treated|1
7763230|NCT00824408|12204253|FG004|Randomized Phase|Not treated|1
7763231|NCT00824408|12204249|FG000|Randomized Phase|Progressive disease|0
7763232|NCT00824408|12204250|FG001|Randomized Phase|Progressive disease|0
7763233|NCT00824408|12204251|FG002|Randomized Phase|Progressive disease|25
7763234|NCT00824408|12204252|FG003|Randomized Phase|Progressive disease|36
7763235|NCT00824408|12204253|FG004|Randomized Phase|Progressive disease|34
7763236|NCT00824408|12204249|FG000|Randomized Phase|Adverse Event|0
7763237|NCT00824408|12204250|FG001|Randomized Phase|Adverse Event|0
7763238|NCT00824408|12204251|FG002|Randomized Phase|Adverse Event|4
7763239|NCT00824408|12204252|FG003|Randomized Phase|Adverse Event|5
7763240|NCT00824408|12204253|FG004|Randomized Phase|Adverse Event|5
7763241|NCT00824408|12204249|FG000|Randomized Phase|Refused to continue medication|0
7763242|NCT00824408|12204250|FG001|Randomized Phase|Refused to continue medication|0
7763243|NCT00824408|12204251|FG002|Randomized Phase|Refused to continue medication|2
7763244|NCT00824408|12204252|FG003|Randomized Phase|Refused to continue medication|2
7763245|NCT00824408|12204253|FG004|Randomized Phase|Refused to continue medication|2
7763246|NCT00824408|12204249|FG000|Randomized Phase|Other reason not defined above|0
7763247|NCT00824408|12204250|FG001|Randomized Phase|Other reason not defined above|0
7763248|NCT00824408|12204251|FG002|Randomized Phase|Other reason not defined above|4
7763249|NCT00824408|12204252|FG003|Randomized Phase|Other reason not defined above|2
7763250|NCT00824408|12204253|FG004|Randomized Phase|Other reason not defined above|4
7763251|NCT00824421|12204274|FG000|Overall Study|Adverse Event|6
7763252|NCT00824421|12204275|FG001|Overall Study|Adverse Event|6
7763253|NCT00824421|12204276|FG002|Overall Study|Adverse Event|6
7763254|NCT00824421|12204274|FG000|Overall Study|Death|0
7763255|NCT00824421|12204275|FG001|Overall Study|Death|1
7763256|NCT00824421|12204276|FG002|Overall Study|Death|0
7763257|NCT00824421|12204274|FG000|Overall Study|Lack of Efficacy|5
7763258|NCT00824421|12204275|FG001|Overall Study|Lack of Efficacy|7
7763259|NCT00824421|12204276|FG002|Overall Study|Lack of Efficacy|4
7763260|NCT00824421|12204274|FG000|Overall Study|Lost to Follow-up|2
7763261|NCT00824421|12204275|FG001|Overall Study|Lost to Follow-up|3
7763262|NCT00824421|12204276|FG002|Overall Study|Lost to Follow-up|0
7763263|NCT00824421|12204274|FG000|Overall Study|Pregnancy|1
7763264|NCT00824421|12204275|FG001|Overall Study|Pregnancy|0
7763265|NCT00824421|12204276|FG002|Overall Study|Pregnancy|1
7763266|NCT00824421|12204274|FG000|Overall Study|Withdrawal by Subject|2
7763267|NCT00824421|12204275|FG001|Overall Study|Withdrawal by Subject|3
7763268|NCT00824421|12204276|FG002|Overall Study|Withdrawal by Subject|3
7763269|NCT00824421|12204274|FG000|Overall Study|Randomized but not Treated|1
7763270|NCT00824421|12204275|FG001|Overall Study|Randomized but not Treated|1
7763271|NCT00824421|12204276|FG002|Overall Study|Randomized but not Treated|0
7763272|NCT00824421|12204274|FG000|Overall Study|Other|0
7763273|NCT00824421|12204275|FG001|Overall Study|Other|1
7763274|NCT00824421|12204276|FG002|Overall Study|Other|0
7763275|NCT00824473|12204325|FG000|Overall Study|Adverse Event|4
7763276|NCT00824473|12204326|FG001|Overall Study|Adverse Event|5
7763277|NCT00824473|12204325|FG000|Overall Study|Lack of Efficacy|2
7763278|NCT00824473|12204326|FG001|Overall Study|Lack of Efficacy|2
7763279|NCT00824473|12204325|FG000|Overall Study|Protocol Violation|2
7763280|NCT00824473|12204326|FG001|Overall Study|Protocol Violation|0
7763281|NCT00824473|12204325|FG000|Overall Study|Non-Compliance|4
7763282|NCT00824473|12204326|FG001|Overall Study|Non-Compliance|2
7763283|NCT00824473|12204325|FG000|Overall Study|Withdrawal by Subject|2
7763284|NCT00824473|12204326|FG001|Overall Study|Withdrawal by Subject|3
7763285|NCT00824473|12204325|FG000|Overall Study|Other|1
7763286|NCT00824473|12204326|FG001|Overall Study|Other|1
7763287|NCT00824564|12204348|FG000|Overall Study|Lost to Follow-up|5
7763288|NCT00824564|12204349|FG001|Overall Study|Lost to Follow-up|7
7763289|NCT00824564|12204348|FG000|Overall Study|Withdrawal by Subject|1
7763290|NCT00824564|12204349|FG001|Overall Study|Withdrawal by Subject|1
7763291|NCT00824564|12204348|FG000|Overall Study|Other|1
7763292|NCT00824564|12204349|FG001|Overall Study|Other|2
7763293|NCT00824564|12204348|FG000|Overall Study|Randomized, but not treated|1
7763294|NCT00824564|12204349|FG001|Overall Study|Randomized, but not treated|0
7763295|NCT00824616|12204357|FG000|Overall Study|Adverse Event|2
7763296|NCT00824616|12204358|FG001|Overall Study|Adverse Event|1
7763297|NCT00824616|12204357|FG000|Overall Study|Creatinine/Creatinine Clearance|0
7763298|NCT00824616|12204358|FG001|Overall Study|Creatinine/Creatinine Clearance|2
7763299|NCT00824616|12204357|FG000|Overall Study|Hyperglycemia|1
7763300|NCT00824616|12204358|FG001|Overall Study|Hyperglycemia|1
7763301|NCT00824616|12204357|FG000|Overall Study|Lack of Efficacy|2
7763302|NCT00824616|12204358|FG001|Overall Study|Lack of Efficacy|1
7763303|NCT00824616|12204357|FG000|Overall Study|Lost to Follow-up|0
7763304|NCT00824616|12204358|FG001|Overall Study|Lost to Follow-up|1
7763305|NCT00824616|12204357|FG000|Overall Study|Withdrawal by Subject|1
7763306|NCT00824616|12204358|FG001|Overall Study|Withdrawal by Subject|1
7763307|NCT00824655|12204366|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1
7763308|NCT00824655|12204367|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0
7763309|NCT00824655|12204366|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
7770197|NCT00875017|12214134|FG005|Second Intervention|Adverse Event|0
7763310|NCT00824655|12204367|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
7763311|NCT00824720|12204378|FG000|Overall Study|failed plug insertion|3
7763312|NCT00824720|12204379|FG001|Overall Study|failed plug insertion|1
7763313|NCT00824720|12204380|FG002|Overall Study|failed plug insertion|0
7763314|NCT00824720|12204378|FG000|Overall Study|Protocol Violation|0
7763315|NCT00824720|12204379|FG001|Overall Study|Protocol Violation|0
7763316|NCT00824720|12204380|FG002|Overall Study|Protocol Violation|1
7763317|NCT00824772|12204398|FG000|Overall Study|Withdrawal by Subject|8
7763318|NCT00824850|12204413|FG000|Overall Study|Withdrawal by Subject|0
7763319|NCT00824850|12204414|FG001|Overall Study|Withdrawal by Subject|1
7763320|NCT00824993|12204428|FG000|Overall Study|Withdrawal by Subject|1
7763321|NCT00824993|12204429|FG001|Overall Study|Withdrawal by Subject|1
7763322|NCT00824993|12204428|FG000|Overall Study|Malignancy Relapse|9
7763323|NCT00824993|12204429|FG001|Overall Study|Malignancy Relapse|10
7763324|NCT00824993|12204428|FG000|Overall Study|Rapid Bone Loss|0
7763325|NCT00824993|12204429|FG001|Overall Study|Rapid Bone Loss|1
7763326|NCT00824993|12204428|FG000|Overall Study|Non-Compliant|2
7763327|NCT00824993|12204429|FG001|Overall Study|Non-Compliant|1
7763328|NCT00824993|12204428|FG000|Overall Study|Insurance Issue|2
7763329|NCT00824993|12204429|FG001|Overall Study|Insurance Issue|1
7763330|NCT00824993|12204428|FG000|Overall Study|Death|0
7763331|NCT00824993|12204429|FG001|Overall Study|Death|3
7763332|NCT00825162|12204438|FG000|Overall Study|Withdrawal by Subject|11
7763333|NCT00825162|12204439|FG001|Overall Study|Withdrawal by Subject|13
7763334|NCT00825162|12204440|FG002|Overall Study|Withdrawal by Subject|3
7763335|NCT00825162|12204438|FG000|Overall Study|Lost to Follow-up|9
7763336|NCT00825162|12204439|FG001|Overall Study|Lost to Follow-up|6
7763337|NCT00825162|12204440|FG002|Overall Study|Lost to Follow-up|3
7763338|NCT00825162|12204438|FG000|Overall Study|Physician Decision|2
7763339|NCT00825162|12204439|FG001|Overall Study|Physician Decision|0
7763340|NCT00825162|12204440|FG002|Overall Study|Physician Decision|0
7763341|NCT00825162|12204438|FG000|Overall Study|Move away from the study area|1
7763342|NCT00825162|12204439|FG001|Overall Study|Move away from the study area|0
7763343|NCT00825162|12204440|FG002|Overall Study|Move away from the study area|0
7763344|NCT00825162|12204438|FG000|Overall Study|Unable to attend the study visit|5
7763345|NCT00825162|12204439|FG001|Overall Study|Unable to attend the study visit|2
7763346|NCT00825162|12204440|FG002|Overall Study|Unable to attend the study visit|0
7763347|NCT00825175|12204455|FG000|Overall Study|Withdrawal by Subject|0
7763348|NCT00825175|12204456|FG001|Overall Study|Withdrawal by Subject|5
7763349|NCT00825305|12204473|FG000|Overall Study|Adverse Event|1
7763350|NCT00825305|12204474|FG001|Overall Study|Adverse Event|1
7763351|NCT00825305|12204473|FG000|Overall Study|Withdrawal by Subject|6
7763352|NCT00825305|12204474|FG001|Overall Study|Withdrawal by Subject|12
7763353|NCT00825305|12204473|FG000|Overall Study|Inappropriate inclusion|1
7763354|NCT00825305|12204474|FG001|Overall Study|Inappropriate inclusion|0
7763355|NCT00825305|12204473|FG000|Overall Study|Protocol Violation|9
7763356|NCT00825305|12204474|FG001|Overall Study|Protocol Violation|9
7763357|NCT00825305|12204473|FG000|Overall Study|Can not be classified|0
7763358|NCT00825305|12204474|FG001|Overall Study|Can not be classified|1
7763359|NCT00825682|12204548|FG000|Overall Study|personal reasons/ inconvenience|13
7763360|NCT00825682|12204549|FG001|Overall Study|personal reasons/ inconvenience|5
7763361|NCT00825812|12204576|FG000|Overall Study|Never entered follow up|0
7763362|NCT00825812|12204577|FG001|Overall Study|Never entered follow up|0
7763363|NCT00825812|12204578|FG002|Overall Study|Never entered follow up|0
7763364|NCT00825812|12204579|FG003|Overall Study|Never entered follow up|1
7763365|NCT00825812|12204576|FG000|Overall Study|Adverse Event|0
7763366|NCT00825812|12204577|FG001|Overall Study|Adverse Event|0
7763367|NCT00825812|12204578|FG002|Overall Study|Adverse Event|0
7763368|NCT00825812|12204579|FG003|Overall Study|Adverse Event|1
7763369|NCT00825812|12204576|FG000|Overall Study|Subject withdrew consent|0
7763370|NCT00825812|12204577|FG001|Overall Study|Subject withdrew consent|0
7763371|NCT00825812|12204578|FG002|Overall Study|Subject withdrew consent|3
7763372|NCT00825812|12204579|FG003|Overall Study|Subject withdrew consent|2
7763373|NCT00825812|12204576|FG000|Overall Study|Non-compliance with protocol|0
7763374|NCT00825812|12204577|FG001|Overall Study|Non-compliance with protocol|0
7763375|NCT00825812|12204578|FG002|Overall Study|Non-compliance with protocol|0
7763376|NCT00825812|12204579|FG003|Overall Study|Non-compliance with protocol|1
7763377|NCT00825812|12204576|FG000|Overall Study|Administrative|0
7763378|NCT00825812|12204577|FG001|Overall Study|Administrative|1
7763379|NCT00825812|12204578|FG002|Overall Study|Administrative|3
7763380|NCT00825812|12204579|FG003|Overall Study|Administrative|5
7763381|NCT00825825|12204589|FG000|First Medication Period (14 Days)|Adverse Event|1
7763382|NCT00825825|12204590|FG001|First Medication Period (14 Days)|Adverse Event|0
7763383|NCT00825825|12204591|FG002|First Medication Period (14 Days)|Adverse Event|0
7763384|NCT00825825|12204592|FG003|First Medication Period (14 Days)|Adverse Event|0
7763385|NCT00825825|12204593|FG004|First Medication Period (14 Days)|Adverse Event|0
7763386|NCT00825825|12204594|FG005|First Medication Period (14 Days)|Adverse Event|1
7763387|NCT00825825|12204589|FG000|First Medication Period (14 Days)|Physician Decision|2
7763388|NCT00825825|12204590|FG001|First Medication Period (14 Days)|Physician Decision|0
7763389|NCT00825825|12204591|FG002|First Medication Period (14 Days)|Physician Decision|1
7763390|NCT00825825|12204592|FG003|First Medication Period (14 Days)|Physician Decision|0
7763391|NCT00825825|12204593|FG004|First Medication Period (14 Days)|Physician Decision|0
7763392|NCT00825825|12204594|FG005|First Medication Period (14 Days)|Physician Decision|1
7763393|NCT00825825|12204589|FG000|Second Medication Period (14 Days)|Physician Decision|1
7763394|NCT00825825|12204590|FG001|Second Medication Period (14 Days)|Physician Decision|0
7763395|NCT00825825|12204591|FG002|Second Medication Period (14 Days)|Physician Decision|0
7763396|NCT00825825|12204592|FG003|Second Medication Period (14 Days)|Physician Decision|2
7763397|NCT00825825|12204593|FG004|Second Medication Period (14 Days)|Physician Decision|0
7763398|NCT00825825|12204594|FG005|Second Medication Period (14 Days)|Physician Decision|0
7763399|NCT00825825|12204589|FG000|Second Medication Period (14 Days)|Protocol Violation|1
7763400|NCT00825825|12204590|FG001|Second Medication Period (14 Days)|Protocol Violation|0
7763401|NCT00825825|12204591|FG002|Second Medication Period (14 Days)|Protocol Violation|0
7763402|NCT00825825|12204592|FG003|Second Medication Period (14 Days)|Protocol Violation|0
7763403|NCT00825825|12204593|FG004|Second Medication Period (14 Days)|Protocol Violation|1
7763404|NCT00825825|12204594|FG005|Second Medication Period (14 Days)|Protocol Violation|0
7763405|NCT00825825|12204589|FG000|Third Medication Period (14 Days)|Adverse Event|0
7763406|NCT00825825|12204590|FG001|Third Medication Period (14 Days)|Adverse Event|1
7763407|NCT00825825|12204591|FG002|Third Medication Period (14 Days)|Adverse Event|0
7763408|NCT00825825|12204592|FG003|Third Medication Period (14 Days)|Adverse Event|0
7763409|NCT00825825|12204593|FG004|Third Medication Period (14 Days)|Adverse Event|0
7763410|NCT00825825|12204594|FG005|Third Medication Period (14 Days)|Adverse Event|0
7763411|NCT00825825|12204589|FG000|Third Medication Period (14 Days)|Protocol Violation|0
7763412|NCT00825825|12204590|FG001|Third Medication Period (14 Days)|Protocol Violation|0
7763413|NCT00825825|12204591|FG002|Third Medication Period (14 Days)|Protocol Violation|0
7763414|NCT00825825|12204592|FG003|Third Medication Period (14 Days)|Protocol Violation|0
7763415|NCT00825825|12204593|FG004|Third Medication Period (14 Days)|Protocol Violation|0
7763416|NCT00825825|12204594|FG005|Third Medication Period (14 Days)|Protocol Violation|2
7763417|NCT00825825|12204589|FG000|Third Medication Period (14 Days)|poor data quality|0
7763418|NCT00825825|12204590|FG001|Third Medication Period (14 Days)|poor data quality|1
7763419|NCT00825825|12204591|FG002|Third Medication Period (14 Days)|poor data quality|0
7763420|NCT00825825|12204592|FG003|Third Medication Period (14 Days)|poor data quality|0
7763421|NCT00825825|12204593|FG004|Third Medication Period (14 Days)|poor data quality|0
7763422|NCT00825825|12204594|FG005|Third Medication Period (14 Days)|poor data quality|0
7763423|NCT00825916|12204604|FG000|Overall Study|Lost to Follow-up|4
7763424|NCT00825916|12204605|FG001|Overall Study|Lost to Follow-up|2
7763425|NCT00825916|12204606|FG002|Overall Study|Lost to Follow-up|1
7763426|NCT00825994|12204647|FG000|Overall Study|Withdrawal by Subject|2
7763427|NCT00825994|12204647|FG000|Overall Study|Lost to Follow-up|1
7763428|NCT00825994|12204647|FG000|Overall Study|Protocol Violation|1
7763429|NCT00825994|12204647|FG000|Overall Study|Placebo Responder at V2|1
7770198|NCT00875017|12214129|FG000|Washout|Problems collecting rectal effluent|0
7770199|NCT00875017|12214130|FG001|Washout|Problems collecting rectal effluent|1
7770200|NCT00875017|12214131|FG002|Washout|Problems collecting rectal effluent|0
7770201|NCT00875017|12214132|FG003|Washout|Problems collecting rectal effluent|0
7770202|NCT00875017|12214133|FG004|Washout|Problems collecting rectal effluent|0
7770203|NCT00875017|12214134|FG005|Washout|Problems collecting rectal effluent|0
7770204|NCT00875017|12214129|FG000|Third Intervention|Adverse Event|0
7770205|NCT00875017|12214130|FG001|Third Intervention|Adverse Event|1
7770206|NCT00875017|12214131|FG002|Third Intervention|Adverse Event|1
7770207|NCT00875017|12214132|FG003|Third Intervention|Adverse Event|0
7962687|NCT02713529|12516924|FG002|Overall Study|Lost to Follow-up|1
7962688|NCT02713529|12516925|FG003|Overall Study|Lost to Follow-up|0
7962689|NCT02713529|12516926|FG004|Overall Study|Lost to Follow-up|0
7962690|NCT02713529|12516927|FG005|Overall Study|Lost to Follow-up|0
7962691|NCT02713529|12516928|FG006|Overall Study|Lost to Follow-up|0
7962692|NCT02713529|12516922|FG000|Overall Study|Death|3
7962693|NCT02713529|12516923|FG001|Overall Study|Death|3
7962694|NCT02713529|12516924|FG002|Overall Study|Death|26
7962695|NCT02713529|12516925|FG003|Overall Study|Death|27
7962696|NCT02713529|12516926|FG004|Overall Study|Death|3
7962697|NCT02713529|12516927|FG005|Overall Study|Death|13
7962698|NCT02713529|12516928|FG006|Overall Study|Death|3
7962699|NCT02713542|12516950|FG000|Overall Study|Use of prohibited medication|14
7962700|NCT02713542|12516951|FG001|Overall Study|Use of prohibited medication|5
7962701|NCT02713542|12516950|FG000|Overall Study|Withdrawal by Subject|4
7962702|NCT02713542|12516951|FG001|Overall Study|Withdrawal by Subject|1
7962703|NCT02713594|12516959|FG000|Overall Study|Withdrawal by Subject|32
7962704|NCT02713594|12516960|FG001|Overall Study|Withdrawal by Subject|22
7962705|NCT02713594|12516959|FG000|Overall Study|Lost to Follow-up|358
7962706|NCT02713594|12516960|FG001|Overall Study|Lost to Follow-up|374
7962707|NCT02713789|12517009|FG000|Overall Study|Lost to Follow-up|0
7962708|NCT02713789|12517010|FG001|Overall Study|Lost to Follow-up|1
7962709|NCT02713789|12517011|FG002|Overall Study|Lost to Follow-up|1
7962710|NCT02713828|12517021|FG000|Overall Study|Death|2
7962711|NCT02713828|12517022|FG001|Overall Study|Death|0
7962712|NCT02713828|12517021|FG000|Overall Study|Withdrawal by Subject|1
7763430|NCT00826111|12204665|FG000|Overall Study|Lost to Follow-up|0
7763431|NCT00826111|12204666|FG001|Overall Study|Lost to Follow-up|1
7763432|NCT00826111|12204665|FG000|Overall Study|Protocol Violation|1
7763433|NCT00826111|12204666|FG001|Overall Study|Protocol Violation|0
7763434|NCT00826111|12204665|FG000|Overall Study|Withdrawal by Subject|5
7763435|NCT00826111|12204666|FG001|Overall Study|Withdrawal by Subject|0
7763436|NCT00826111|12204665|FG000|Overall Study|Physician Decision|1
7763437|NCT00826111|12204666|FG001|Overall Study|Physician Decision|1
7763438|NCT00826176|12204692|FG000|Overall Study|Lost to Follow-up|1
7763439|NCT00826176|12204693|FG001|Overall Study|Lost to Follow-up|0
7763440|NCT00826176|12204692|FG000|Overall Study|Subject Withdrew Consent|3
7763441|NCT00826176|12204693|FG001|Overall Study|Subject Withdrew Consent|0
7763442|NCT00826176|12204692|FG000|Overall Study|Administrative|9
7763443|NCT00826176|12204693|FG001|Overall Study|Administrative|0
7763444|NCT00826228|12204708|FG000|Overall Study|Withdrawal by Subject|1
7763445|NCT00826241|12204713|FG000|Overall Study|Withdrawal from Follow-up|1
7763446|NCT00826241|12204713|FG000|Overall Study|Withdrew consent|2
7763447|NCT00826241|12204713|FG000|Overall Study|Death|4
7763448|NCT00826241|12204713|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1
7763449|NCT00826241|12204713|FG000|Overall Study|Non-compliance|1
7763450|NCT00826241|12204713|FG000|Overall Study|Progression of disease|1
7763451|NCT00826241|12204713|FG000|Overall Study|Patient refused follow-up|3
7763452|NCT00826241|12204713|FG000|Overall Study|Lost to Follow-up|9
7763453|NCT00826241|12204713|FG000|Overall Study|Could not obtain records|1
7763454|NCT00826241|12204713|FG000|Overall Study|Screen failure|2
7763455|NCT00826241|12204713|FG000|Overall Study|Pt unable to proceed to registration|1
7763456|NCT00826241|12204713|FG000|Overall Study|Pt opt not to proceed w/trmt|1
7763457|NCT00826267|12204720|FG000|Overall Study|Other Adverse Event|1
7763458|NCT00826267|12204721|FG001|Overall Study|Other Adverse Event|0
7763459|NCT00826267|12204722|FG002|Overall Study|Other Adverse Event|0
7763460|NCT00826280|12204734|FG000|Overall Study|Randomized but drug not received|1
7763461|NCT00826280|12204735|FG001|Overall Study|Randomized but drug not received|0
7763462|NCT00826280|12204736|FG002|Overall Study|Randomized but drug not received|1
7763463|NCT00826280|12204734|FG000|Overall Study|Adverse Event|1
7763464|NCT00826280|12204735|FG001|Overall Study|Adverse Event|3
7763465|NCT00826280|12204736|FG002|Overall Study|Adverse Event|0
7763466|NCT00826280|12204734|FG000|Overall Study|Lost to Follow-up|0
7763467|NCT00826280|12204735|FG001|Overall Study|Lost to Follow-up|1
7763468|NCT00826280|12204736|FG002|Overall Study|Lost to Follow-up|0
7763469|NCT00826280|12204734|FG000|Overall Study|Sponsor discontinued subject or study|1
7763470|NCT00826280|12204735|FG001|Overall Study|Sponsor discontinued subject or study|0
7763471|NCT00826280|12204736|FG002|Overall Study|Sponsor discontinued subject or study|0
7763472|NCT00826280|12204734|FG000|Overall Study|Reversible ischemic defect not present|43
7763473|NCT00826280|12204735|FG001|Overall Study|Reversible ischemic defect not present|40
7763474|NCT00826280|12204736|FG002|Overall Study|Reversible ischemic defect not present|44
7763475|NCT00826280|12204734|FG000|Overall Study|Interpretation Failure|1
7763476|NCT00826280|12204735|FG001|Overall Study|Interpretation Failure|0
7763477|NCT00826280|12204736|FG002|Overall Study|Interpretation Failure|0
7763478|NCT00826280|12204734|FG000|Overall Study|Machine Failure|1
7763479|NCT00826280|12204735|FG001|Overall Study|Machine Failure|1
7763480|NCT00826280|12204736|FG002|Overall Study|Machine Failure|0
7763481|NCT00826280|12204734|FG000|Overall Study|One or more non-interpretable scan|0
7763482|NCT00826280|12204735|FG001|Overall Study|One or more non-interpretable scan|1
7763483|NCT00826280|12204736|FG002|Overall Study|One or more non-interpretable scan|1
7763484|NCT00826449|12204746|FG000|Overall Study|Disease Progression|4
7763485|NCT00826449|12204746|FG000|Overall Study|Withdrawal by Subject|1
7763486|NCT00826514|12204753|FG000|Overall Study|Adverse Event|1
7763487|NCT00826514|12204754|FG001|Overall Study|Adverse Event|1
7763488|NCT00826514|12204753|FG000|Overall Study|Lack of Efficacy|0
7763489|NCT00826514|12204754|FG001|Overall Study|Lack of Efficacy|1
7763490|NCT00826514|12204753|FG000|Overall Study|Withdrawal by Subject|2
7763491|NCT00826514|12204754|FG001|Overall Study|Withdrawal by Subject|3
7763492|NCT00826540|12204760|FG000|Overall Study|ineligible|3
7763493|NCT00826540|12204760|FG000|Overall Study|Withdrawal by Subject|1
7763494|NCT00826618|12204764|FG000|Overall Study|Withdrawal by Subject|1
7763495|NCT00826748|12204771|FG000|Overall Study|Withdrawal by Subject|0
7763496|NCT00826748|12204772|FG001|Overall Study|Withdrawal by Subject|0
7763497|NCT00826748|12204773|FG002|Overall Study|Withdrawal by Subject|2
7763498|NCT00826748|12204771|FG000|Overall Study|Physician Decision|0
7763499|NCT00826748|12204772|FG001|Overall Study|Physician Decision|0
7763500|NCT00826748|12204773|FG002|Overall Study|Physician Decision|1
7763501|NCT00826748|12204771|FG000|Overall Study|Samples Did Not pass QC|0
7763502|NCT00826748|12204772|FG001|Overall Study|Samples Did Not pass QC|0
7763503|NCT00826748|12204773|FG002|Overall Study|Samples Did Not pass QC|1
7763504|NCT00826943|12204785|FG000|Overall Study|Withdrawal by Subject|0
7763505|NCT00826943|12204786|FG001|Overall Study|Withdrawal by Subject|0
7763506|NCT00826943|12204787|FG002|Overall Study|Withdrawal by Subject|0
7763507|NCT00826943|12204788|FG003|Overall Study|Withdrawal by Subject|0
7763508|NCT00826943|12204789|FG004|Overall Study|Withdrawal by Subject|1
7763509|NCT00826943|12204790|FG005|Overall Study|Withdrawal by Subject|0
7763510|NCT00827112|12204813|FG000|Overall Study|Adverse Event|2
7763511|NCT00827112|12204814|FG001|Overall Study|Adverse Event|0
7763512|NCT00827112|12204813|FG000|Overall Study|Lack of Efficacy|2
7763513|NCT00827112|12204814|FG001|Overall Study|Lack of Efficacy|0
7763514|NCT00827112|12204813|FG000|Overall Study|Lost to Follow-up|3
7763515|NCT00827112|12204814|FG001|Overall Study|Lost to Follow-up|2
7763516|NCT00827112|12204813|FG000|Overall Study|Pregnancy|0
7763517|NCT00827112|12204814|FG001|Overall Study|Pregnancy|1
7763518|NCT00827112|12204813|FG000|Overall Study|Protocol Violation|0
7763519|NCT00827112|12204814|FG001|Overall Study|Protocol Violation|2
7763520|NCT00827112|12204813|FG000|Overall Study|Withdrawal by Subject|2
7763521|NCT00827112|12204814|FG001|Overall Study|Withdrawal by Subject|1
7763522|NCT00827112|12204813|FG000|Overall Study|Randomized but not treated|5
7763523|NCT00827112|12204814|FG001|Overall Study|Randomized but not treated|3
7763524|NCT00827112|12204813|FG000|Overall Study|Other|1
7763525|NCT00827112|12204814|FG001|Overall Study|Other|3
7763526|NCT00827242|12204822|FG000|Overall Study|Withdrawal by Subject|2
7763527|NCT00827242|12204823|FG001|Overall Study|Withdrawal by Subject|4
7763528|NCT00827242|12204822|FG000|Overall Study|Protocol Violation|1
7763529|NCT00827242|12204823|FG001|Overall Study|Protocol Violation|3
7763530|NCT00827242|12204822|FG000|Overall Study|Lost to Follow-up|0
7763531|NCT00827242|12204823|FG001|Overall Study|Lost to Follow-up|3
7763532|NCT00827242|12204822|FG000|Overall Study|Adverse Event Excluding Death|2
7763533|NCT00827242|12204823|FG001|Overall Study|Adverse Event Excluding Death|1
7763534|NCT00827242|12204822|FG000|Overall Study|Entry Criteria Not Met|4
7763535|NCT00827242|12204823|FG001|Overall Study|Entry Criteria Not Met|1
7763536|NCT00827242|12204822|FG000|Overall Study|Physician Decision|2
7763537|NCT00827242|12204823|FG001|Overall Study|Physician Decision|0
7763538|NCT00827242|12204822|FG000|Overall Study|Death|1
7763539|NCT00827242|12204823|FG001|Overall Study|Death|0
7763540|NCT00827242|12204822|FG000|Overall Study|Lack of Efficacy|1
7763541|NCT00827242|12204823|FG001|Overall Study|Lack of Efficacy|0
7763542|NCT00827359|12204833|FG000|Overall Study|Progressive Diseas|19
7763543|NCT00827359|12204833|FG000|Overall Study|Unacceptable Toxicity|5
7763544|NCT00827359|12204833|FG000|Overall Study|Ineligible|1
7763545|NCT00827372|12204837|FG000|Overall Study|Adverse Event|5
7763546|NCT00827372|12204837|FG000|Overall Study|Lack of Efficacy|3
7763547|NCT00827502|12204842|FG000|Overall Study|randomized but not treated|11
7763548|NCT00827502|12204842|FG000|Overall Study|Adverse Event|1
7763549|NCT00827502|12204842|FG000|Overall Study|Lost to Follow-up|4
7763550|NCT00827502|12204842|FG000|Overall Study|Withdrawal by Subject|5
7763551|NCT00827541|12204848|FG000|Overall Study|Exitus|1
7763552|NCT00827541|12204849|FG001|Overall Study|Exitus|8
7763553|NCT00827541|12204848|FG000|Overall Study|Other|1
7763554|NCT00827541|12204849|FG001|Overall Study|Other|3
7763555|NCT00827541|12204848|FG000|Overall Study|Pathogen not susceptible|1
7763556|NCT00827541|12204849|FG001|Overall Study|Pathogen not susceptible|0
7763557|NCT00827541|12204848|FG000|Overall Study|Lack of effectiveness|1
7763558|NCT00827541|12204849|FG001|Overall Study|Lack of effectiveness|0
7763559|NCT00827606|12204857|FG000|Overall Study|Protocol Violation|4
7763560|NCT00827606|12204858|FG001|Overall Study|Protocol Violation|3
7763561|NCT00827606|12204857|FG000|Overall Study|Lost to Follow-up|3
7763562|NCT00827606|12204858|FG001|Overall Study|Lost to Follow-up|1
7763563|NCT00827606|12204857|FG000|Overall Study|Withdrawal by Subject|7
7763564|NCT00827606|12204858|FG001|Overall Study|Withdrawal by Subject|6
7763565|NCT00827606|12204857|FG000|Overall Study|Pregnancy|0
7763566|NCT00827606|12204858|FG001|Overall Study|Pregnancy|1
7763567|NCT00827606|12204857|FG000|Overall Study|Other|5
7763568|NCT00827606|12204858|FG001|Overall Study|Other|13
7763569|NCT00827606|12204857|FG000|Overall Study|LDL below 2.59 mmol/L|4
7763570|NCT00827606|12204858|FG001|Overall Study|LDL below 2.59 mmol/L|12
7763571|NCT00827606|12204857|FG000|Overall Study|Adverse Event|4
7763572|NCT00827606|12204858|FG001|Overall Study|Adverse Event|2
7763573|NCT00827632|12204872|FG000|Overall Study|Lost to Follow-up|8
7763574|NCT00827632|12204873|FG001|Overall Study|Lost to Follow-up|12
7763575|NCT00827632|12204872|FG000|Overall Study|Early withdrawal|14
7763576|NCT00827632|12204873|FG001|Overall Study|Early withdrawal|11
7763577|NCT00827775|12204881|FG000|Overall Study|Withdrawal by Subject|0
7763578|NCT00827775|12204882|FG001|Overall Study|Withdrawal by Subject|5
7763579|NCT00827827|12204890|FG000|Overall Study|Lost to Follow-up|3
7763580|NCT00827827|12204891|FG001|Overall Study|Lost to Follow-up|0
7763581|NCT00827827|12204890|FG000|Overall Study|Fall at home- hospitalization|1
7763582|NCT00827827|12204891|FG001|Overall Study|Fall at home- hospitalization|0
7763583|NCT00827827|12204890|FG000|Overall Study|Another cerebrovascular accident (CVA)|1
7763584|NCT00827827|12204891|FG001|Overall Study|Another cerebrovascular accident (CVA)|0
7763585|NCT00827827|12204890|FG000|Overall Study|Gout|1
7763586|NCT00827827|12204891|FG001|Overall Study|Gout|0
7763587|NCT00827827|12204890|FG000|Overall Study|Transportation issues|1
7763588|NCT00827827|12204891|FG001|Overall Study|Transportation issues|0
7763589|NCT00827827|12204890|FG000|Overall Study|Burned with water at home|1
7763590|NCT00827827|12204891|FG001|Overall Study|Burned with water at home|0
7763591|NCT00827918|12204901|FG000|Overall Study|Adverse Event|4
7763592|NCT00827918|12204902|FG001|Overall Study|Adverse Event|0
7763593|NCT00827918|12204903|FG002|Overall Study|Adverse Event|0
7763594|NCT00827918|12204901|FG000|Overall Study|Lack of Efficacy|16
7763595|NCT00827918|12204902|FG001|Overall Study|Lack of Efficacy|4
7763596|NCT00827918|12204903|FG002|Overall Study|Lack of Efficacy|15
7763597|NCT00827918|12204901|FG000|Overall Study|Physician Decision|1
7763598|NCT00827918|12204902|FG001|Overall Study|Physician Decision|0
7763599|NCT00827918|12204903|FG002|Overall Study|Physician Decision|0
7763600|NCT00827918|12204901|FG000|Overall Study|Pregnancy|0
7763601|NCT00827918|12204902|FG001|Overall Study|Pregnancy|1
7763602|NCT00827918|12204903|FG002|Overall Study|Pregnancy|0
7763603|NCT00827918|12204901|FG000|Overall Study|Progressive Disease|1
7763604|NCT00827918|12204902|FG001|Overall Study|Progressive Disease|1
7763605|NCT00827918|12204903|FG002|Overall Study|Progressive Disease|0
7763606|NCT00827918|12204901|FG000|Overall Study|Protocol Violation|0
7763607|NCT00827918|12204902|FG001|Overall Study|Protocol Violation|1
7763608|NCT00827918|12204903|FG002|Overall Study|Protocol Violation|0
7763609|NCT00827918|12204901|FG000|Overall Study|Withdrawal by Subject|6
7763610|NCT00827918|12204902|FG001|Overall Study|Withdrawal by Subject|2
7763611|NCT00827918|12204903|FG002|Overall Study|Withdrawal by Subject|6
7763612|NCT00827931|12204913|FG000|Overall Study|Death|3
7763613|NCT00827931|12204914|FG001|Overall Study|Death|5
7763614|NCT00827931|12204913|FG000|Overall Study|Adverse Event|1
7763615|NCT00827931|12204914|FG001|Overall Study|Adverse Event|0
7763616|NCT00827931|12204913|FG000|Overall Study|Lost to Follow-up|1
7763617|NCT00827931|12204914|FG001|Overall Study|Lost to Follow-up|0
7763618|NCT00827931|12204913|FG000|Overall Study|Withdrawal by Subject|0
7763619|NCT00827931|12204914|FG001|Overall Study|Withdrawal by Subject|1
7763620|NCT00827931|12204913|FG000|Overall Study|Other|1
7763621|NCT00827931|12204914|FG001|Overall Study|Other|0
7770208|NCT00875017|12214133|FG004|Third Intervention|Adverse Event|0
7763622|NCT00828009|12204938|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10
7763623|NCT00828009|12204938|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2
7763624|NCT00828009|12204938|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3
7763625|NCT00828009|12204938|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11
7763626|NCT00828009|12204938|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1
7763627|NCT00828009|12204938|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2
7763628|NCT00828009|12204938|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2
7763629|NCT00828009|12204938|FG000|Step 2 - Maintenance Therapy|Progressive disease|12
7763630|NCT00828009|12204938|FG000|Step 2 - Maintenance Therapy|Adverse Event|13
7763631|NCT00828009|12204938|FG000|Step 2 - Maintenance Therapy|Death|1
7763632|NCT00828009|12204938|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4
7763633|NCT00828009|12204938|FG000|Step 2 - Maintenance Therapy|Complicating disease|2
7763634|NCT00828009|12204938|FG000|Step 2 - Maintenance Therapy|Other|1
7763635|NCT00828113|12204972|FG000|Overall Study|Withdrawal by Subject|27
7763636|NCT00828113|12204973|FG001|Overall Study|Withdrawal by Subject|26
7763637|NCT00828113|12204972|FG000|Overall Study|Lost to Follow-up|3
7763638|NCT00828113|12204973|FG001|Overall Study|Lost to Follow-up|5
7763639|NCT00828139|12204983|FG000|Overall Study|Adverse Event|8
7763640|NCT00828139|12204984|FG001|Overall Study|Adverse Event|1
7763641|NCT00828139|12204985|FG002|Overall Study|Adverse Event|10
7763642|NCT00828139|12204986|FG003|Overall Study|Adverse Event|5
7763643|NCT00828139|12204983|FG000|Overall Study|Death|2
7763644|NCT00828139|12204984|FG001|Overall Study|Death|1
7763645|NCT00828139|12204985|FG002|Overall Study|Death|0
7763646|NCT00828139|12204986|FG003|Overall Study|Death|2
7763647|NCT00828139|12204983|FG000|Overall Study|Refusal unrelated to toxicity|3
7763648|NCT00828139|12204984|FG001|Overall Study|Refusal unrelated to toxicity|4
7763649|NCT00828139|12204985|FG002|Overall Study|Refusal unrelated to toxicity|5
7763650|NCT00828139|12204986|FG003|Overall Study|Refusal unrelated to toxicity|3
7763651|NCT00828139|12204983|FG000|Overall Study|Disease Progression|24
7763652|NCT00828139|12204984|FG001|Overall Study|Disease Progression|33
7763653|NCT00828139|12204985|FG002|Overall Study|Disease Progression|35
7763654|NCT00828139|12204986|FG003|Overall Study|Disease Progression|39
7763655|NCT00828139|12204983|FG000|Overall Study|Other|4
7763656|NCT00828139|12204984|FG001|Overall Study|Other|2
7763657|NCT00828139|12204985|FG002|Overall Study|Other|5
7763658|NCT00828139|12204986|FG003|Overall Study|Other|2
7763659|NCT00828204|12205018|FG000|Main Study: Prior to Study Suspension|Adverse Event|1
7763660|NCT00828204|12205019|FG001|Main Study: Prior to Study Suspension|Adverse Event|0
7763661|NCT00828204|12205018|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
7763662|NCT00828204|12205019|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
7763663|NCT00828204|12205018|FG000|Main Study: Prior to Study Suspension|Study Suspension|11
7763664|NCT00828204|12205019|FG001|Main Study: Prior to Study Suspension|Study Suspension|0
7763665|NCT00828204|12205018|FG000|Main Study: After Study Restart|Adverse Event|0
7763666|NCT00828204|12205019|FG001|Main Study: After Study Restart|Adverse Event|2
7763667|NCT00828204|12205018|FG000|Main Study: After Study Restart|Noncompliance|0
7763668|NCT00828204|12205019|FG001|Main Study: After Study Restart|Noncompliance|1
7763669|NCT00828204|12205018|FG000|Extension Study|Lost to Follow-up|0
7763670|NCT00828204|12205019|FG001|Extension Study|Lost to Follow-up|1
7763671|NCT00828204|12205018|FG000|Extension Study|Physician Decision|0
7763672|NCT00828204|12205019|FG001|Extension Study|Physician Decision|2
7763673|NCT00828451|12205053|FG000|Overall Study|Death|2
7763674|NCT00828451|12205053|FG000|Overall Study|Lack of intravenous line|7
7763675|NCT00828451|12205053|FG000|Overall Study|Withdrawal by Subject|1
7763676|NCT00828451|12205053|FG000|Overall Study|Deterioration in clinical status|1
7763677|NCT00828464|12205057|FG000|Overall Study|Withdrawal by Subject|1
7763678|NCT00828516|12205061|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2
7763679|NCT00828568|12205077|FG000|Randomized|Withdrawal by Subject|1
7763680|NCT00828568|12205078|FG001|Randomized|Withdrawal by Subject|0
7763681|NCT00828568|12205079|FG002|Randomized|Withdrawal by Subject|2
7624595|NCT01813305|12035749|FG000|Overall Study|Withdrawal by Subject|12
7763682|NCT00828568|12205077|FG000|Treated - Received at Least One Dose|Adverse Event|11
7763683|NCT00828568|12205078|FG001|Treated - Received at Least One Dose|Adverse Event|8
7763684|NCT00828568|12205079|FG002|Treated - Received at Least One Dose|Adverse Event|1
7763685|NCT00828568|12205077|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9
7763686|NCT00828568|12205078|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11
7763687|NCT00828568|12205079|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0
7763688|NCT00828568|12205077|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1
7763689|NCT00828568|12205078|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5
7624596|NCT01813305|12035750|FG001|Overall Study|Withdrawal by Subject|5
7763690|NCT00828568|12205079|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1
7763691|NCT00828568|12205077|FG000|Treated - Received at Least One Dose|Protocol Violation|9
7763692|NCT00828568|12205078|FG001|Treated - Received at Least One Dose|Protocol Violation|5
7763693|NCT00828568|12205079|FG002|Treated - Received at Least One Dose|Protocol Violation|3
7763694|NCT00828672|12205090|FG000|Study Treatment|Lost to Follow-up|1
7763695|NCT00828672|12205091|FG001|Study Treatment|Lost to Follow-up|0
7763696|NCT00828672|12205090|FG000|Study Treatment|Adverse Event|0
7763697|NCT00828672|12205091|FG001|Study Treatment|Adverse Event|1
7763698|NCT00828672|12205090|FG000|Study Treatment|Complete response, no surgery|1
7763699|NCT00828672|12205091|FG001|Study Treatment|Complete response, no surgery|1
7763700|NCT00828672|12205090|FG000|Post-surgery (<30 Days)|No central review materials|0
7763701|NCT00828672|12205091|FG001|Post-surgery (<30 Days)|No central review materials|1
7763702|NCT00828711|12205100|FG000|Overall Study|Lost to Follow-up|1
7763703|NCT00828711|12205101|FG001|Overall Study|Lost to Follow-up|0
7763704|NCT00828711|12205102|FG002|Overall Study|Lost to Follow-up|0
7763705|NCT00828750|12205110|FG000|Overall Study|Lack of Efficacy|3
7763706|NCT00828750|12205110|FG000|Overall Study|Normal PC Remained While No Treatment|1
7763707|NCT00828945|12205130|FG000|Overall Study|Death|4
7763708|NCT00828945|12205130|FG000|Overall Study|Participant was missing|1
7763709|NCT00828945|12205130|FG000|Overall Study|Other|36
7763710|NCT00828984|12205137|FG000|Overall Study|Adverse Event|2
7763711|NCT00828984|12205138|FG001|Overall Study|Adverse Event|3
7763712|NCT00828984|12205139|FG002|Overall Study|Adverse Event|0
7763713|NCT00828984|12205137|FG000|Overall Study|Lost to Follow-up|5
7763714|NCT00828984|12205138|FG001|Overall Study|Lost to Follow-up|3
7763715|NCT00828984|12205139|FG002|Overall Study|Lost to Follow-up|1
7763716|NCT00828984|12205137|FG000|Overall Study|Withdrawal by Subject|4
7763717|NCT00828984|12205138|FG001|Overall Study|Withdrawal by Subject|4
7763718|NCT00828984|12205139|FG002|Overall Study|Withdrawal by Subject|4
7763719|NCT00828984|12205137|FG000|Overall Study|Ineligable|1
7763720|NCT00828984|12205138|FG001|Overall Study|Ineligable|2
7763721|NCT00828984|12205139|FG002|Overall Study|Ineligable|0
7763722|NCT00828984|12205137|FG000|Overall Study|Medical Contraindication|0
7763723|NCT00828984|12205138|FG001|Overall Study|Medical Contraindication|1
7763724|NCT00828984|12205139|FG002|Overall Study|Medical Contraindication|0
7763725|NCT00828984|12205137|FG000|Overall Study|Noncompliant|1
7763726|NCT00828984|12205138|FG001|Overall Study|Noncompliant|2
7763727|NCT00828984|12205139|FG002|Overall Study|Noncompliant|3
7763728|NCT00828984|12205137|FG000|Overall Study|ConMed|1
7763729|NCT00828984|12205138|FG001|Overall Study|ConMed|1
7763730|NCT00828984|12205139|FG002|Overall Study|ConMed|1
7763731|NCT00829010|12205152|FG000|Overall Study|Adverse Event|1
7763732|NCT00829010|12205153|FG001|Overall Study|Adverse Event|0
7763733|NCT00829010|12205154|FG002|Overall Study|Adverse Event|0
7763734|NCT00829010|12205155|FG003|Overall Study|Adverse Event|0
7763735|NCT00829010|12205156|FG004|Overall Study|Adverse Event|0
7763736|NCT00829010|12205152|FG000|Overall Study|Withdrawal by Subject|0
7763737|NCT00829010|12205153|FG001|Overall Study|Withdrawal by Subject|1
7763738|NCT00829010|12205154|FG002|Overall Study|Withdrawal by Subject|1
7763739|NCT00829010|12205155|FG003|Overall Study|Withdrawal by Subject|0
7763740|NCT00829010|12205156|FG004|Overall Study|Withdrawal by Subject|2
7763741|NCT00829010|12205152|FG000|Overall Study|Lost to Follow-up|1
7763742|NCT00829010|12205153|FG001|Overall Study|Lost to Follow-up|0
7763743|NCT00829010|12205154|FG002|Overall Study|Lost to Follow-up|2
7763744|NCT00829010|12205155|FG003|Overall Study|Lost to Follow-up|0
7763745|NCT00829010|12205156|FG004|Overall Study|Lost to Follow-up|0
7763746|NCT00829010|12205152|FG000|Overall Study|Fatality|5
7763747|NCT00829010|12205153|FG001|Overall Study|Fatality|4
7763748|NCT00829010|12205154|FG002|Overall Study|Fatality|0
7763749|NCT00829010|12205155|FG003|Overall Study|Fatality|3
7763750|NCT00829010|12205156|FG004|Overall Study|Fatality|0
7763751|NCT00829010|12205152|FG000|Overall Study|Migrated/Moved from study area|3
7763752|NCT00829010|12205153|FG001|Overall Study|Migrated/Moved from study area|4
7763753|NCT00829010|12205154|FG002|Overall Study|Migrated/Moved from study area|0
7763754|NCT00829010|12205155|FG003|Overall Study|Migrated/Moved from study area|5
7763755|NCT00829010|12205156|FG004|Overall Study|Migrated/Moved from study area|0
7763756|NCT00829166|12205183|FG000|Overall Study|Death|305
7763757|NCT00829166|12205184|FG001|Overall Study|Death|333
7763758|NCT00829166|12205183|FG000|Overall Study|Lost to Follow-up|5
7763759|NCT00829166|12205184|FG001|Overall Study|Lost to Follow-up|4
7763760|NCT00829166|12205183|FG000|Overall Study|Physician's Decision|4
7763761|NCT00829166|12205184|FG001|Overall Study|Physician's Decision|3
7763762|NCT00829166|12205183|FG000|Overall Study|Subject's Decision|41
7763763|NCT00829166|12205184|FG001|Overall Study|Subject's Decision|55
7763764|NCT00829166|12205183|FG000|Overall Study|Sponsor's Decision|137
7763765|NCT00829166|12205184|FG001|Overall Study|Sponsor's Decision|98
7763766|NCT00829166|12205183|FG000|Overall Study|Reason Not Specified|3
7763767|NCT00829166|12205184|FG001|Overall Study|Reason Not Specified|3
7763768|NCT00829179|12205191|FG000|Overall Study|Withdrawal by Subject|1
7763769|NCT00829244|12205197|FG000|Overall Study|Adverse Event|1
7763770|NCT00829244|12205198|FG001|Overall Study|Adverse Event|3
7763771|NCT00829244|12205197|FG000|Overall Study|Protocol Violation|1
7763772|NCT00829244|12205198|FG001|Overall Study|Protocol Violation|0
7763773|NCT00829244|12205197|FG000|Overall Study|Lack of ovarian response to stimulation|9
7763774|NCT00829244|12205198|FG001|Overall Study|Lack of ovarian response to stimulation|5
7763775|NCT00829244|12205197|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
7763776|NCT00829244|12205198|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
7763777|NCT00829244|12205197|FG000|Overall Study|No fertilization|2
7763778|NCT00829244|12205198|FG001|Overall Study|No fertilization|2
7763779|NCT00829244|12205197|FG000|Overall Study|All embryos discarded|0
7763780|NCT00829244|12205198|FG001|Overall Study|All embryos discarded|3
7763781|NCT00829244|12205197|FG000|Overall Study|No embryo cleavage|0
7763782|NCT00829244|12205198|FG001|Overall Study|No embryo cleavage|2
7763783|NCT00829283|12205206|FG000|Overall Study|Lost to Follow-up|7
7763784|NCT00829283|12205207|FG001|Overall Study|Lost to Follow-up|25
7763785|NCT00829296|12205215|FG000|Overall Study|Adverse Event|5
7763786|NCT00829296|12205216|FG001|Overall Study|Adverse Event|4
7763787|NCT00829387|12205224|FG000|Overall Study|Withdrawal by Subject|2
7763788|NCT00829387|12205225|FG001|Overall Study|Withdrawal by Subject|3
7763789|NCT00829387|12205224|FG000|Overall Study|Disqualified by PI|1
7763790|NCT00829387|12205225|FG001|Overall Study|Disqualified by PI|0
7763791|NCT00829413|12205231|FG000|Overall Study|No study drug admimnistered|13
7763792|NCT00829413|12205231|FG000|Overall Study|Training Patients|67
7763793|NCT00829413|12205231|FG000|Overall Study|No truth standard procedure available|9
7763794|NCT00829413|12205231|FG000|Overall Study|Technically inadequate truth standard|2
7763795|NCT00829413|12205231|FG000|Overall Study|Indeterminate diagnosis from truth stand|3
7763796|NCT00829439|12205242|FG000|Overall Study|Adverse Event|0
7763797|NCT00829439|12205243|FG001|Overall Study|Adverse Event|0
7763798|NCT00829439|12205244|FG002|Overall Study|Adverse Event|1
7763799|NCT00829439|12205245|FG003|Overall Study|Adverse Event|0
7763800|NCT00829621|12205251|FG000|Overall Study|Death|1
7763801|NCT00829621|12205252|FG001|Overall Study|Death|0
7763802|NCT00829621|12205251|FG000|Overall Study|Lost to Follow-up|3
7763803|NCT00829621|12205252|FG001|Overall Study|Lost to Follow-up|4
7763804|NCT00829829|12205266|FG000|Overall Study|Protocol Violation|0
7763805|NCT00829829|12205267|FG001|Overall Study|Protocol Violation|3
7763806|NCT00829829|12205268|FG002|Overall Study|Protocol Violation|0
7763807|NCT00829829|12205266|FG000|Overall Study|Adverse Event|4
7763808|NCT00829829|12205267|FG001|Overall Study|Adverse Event|4
7763809|NCT00829829|12205268|FG002|Overall Study|Adverse Event|3
7763810|NCT00829829|12205266|FG000|Overall Study|Withdrawal by Subject|8
7763811|NCT00829829|12205267|FG001|Overall Study|Withdrawal by Subject|4
7763812|NCT00829829|12205268|FG002|Overall Study|Withdrawal by Subject|2
7763813|NCT00829829|12205266|FG000|Overall Study|Decision by the Sponsor|1
7763814|NCT00829829|12205267|FG001|Overall Study|Decision by the Sponsor|0
7763815|NCT00829829|12205268|FG002|Overall Study|Decision by the Sponsor|2
7763816|NCT00829829|12205266|FG000|Overall Study|Lost to Follow-up|7
7763817|NCT00829829|12205267|FG001|Overall Study|Lost to Follow-up|3
7763818|NCT00829829|12205268|FG002|Overall Study|Lost to Follow-up|3
7763819|NCT00829829|12205266|FG000|Overall Study|Other than specified above|2
7763820|NCT00829829|12205267|FG001|Overall Study|Other than specified above|2
7763821|NCT00829829|12205268|FG002|Overall Study|Other than specified above|1
7763822|NCT00829933|12205281|FG000|Overall Study|Adverse Event|2
7763823|NCT00829933|12205282|FG001|Overall Study|Adverse Event|3
7763824|NCT00829933|12205283|FG002|Overall Study|Adverse Event|2
7763825|NCT00829933|12205284|FG003|Overall Study|Adverse Event|1
7763826|NCT00829933|12205281|FG000|Overall Study|Death|0
7763827|NCT00829933|12205282|FG001|Overall Study|Death|0
7763828|NCT00829933|12205283|FG002|Overall Study|Death|1
7763829|NCT00829933|12205284|FG003|Overall Study|Death|1
7763830|NCT00829933|12205281|FG000|Overall Study|Lack of Efficacy|0
7763831|NCT00829933|12205282|FG001|Overall Study|Lack of Efficacy|1
7763832|NCT00829933|12205283|FG002|Overall Study|Lack of Efficacy|0
7763833|NCT00829933|12205284|FG003|Overall Study|Lack of Efficacy|0
7763834|NCT00829933|12205281|FG000|Overall Study|Physician Decision|5
7763835|NCT00829933|12205282|FG001|Overall Study|Physician Decision|7
7763836|NCT00829933|12205283|FG002|Overall Study|Physician Decision|8
7763837|NCT00829933|12205284|FG003|Overall Study|Physician Decision|1
7763838|NCT00829933|12205281|FG000|Overall Study|Pregnancy|0
7763839|NCT00829933|12205282|FG001|Overall Study|Pregnancy|0
7763840|NCT00829933|12205283|FG002|Overall Study|Pregnancy|0
7763841|NCT00829933|12205284|FG003|Overall Study|Pregnancy|2
7763842|NCT00829933|12205281|FG000|Overall Study|Protocol Violation|2
7763843|NCT00829933|12205282|FG001|Overall Study|Protocol Violation|1
7763844|NCT00829933|12205283|FG002|Overall Study|Protocol Violation|0
7763845|NCT00829933|12205284|FG003|Overall Study|Protocol Violation|0
7763846|NCT00829933|12205281|FG000|Overall Study|withdrew before treatment started|5
7763847|NCT00829933|12205282|FG001|Overall Study|withdrew before treatment started|1
7763848|NCT00829933|12205283|FG002|Overall Study|withdrew before treatment started|2
7763849|NCT00829933|12205284|FG003|Overall Study|withdrew before treatment started|9
7763850|NCT00830037|12205305|FG000|Overall Study|Withdrawal by Subject|2
7763851|NCT00830037|12205306|FG001|Overall Study|Withdrawal by Subject|3
7763852|NCT00830037|12205305|FG000|Overall Study|Lost to Follow-up|1
7763853|NCT00830037|12205306|FG001|Overall Study|Lost to Follow-up|2
7763854|NCT00830037|12205305|FG000|Overall Study|Active when terminated by DSMB|15
7763855|NCT00830037|12205306|FG001|Overall Study|Active when terminated by DSMB|14
7763856|NCT00830063|12205316|FG000|Overall Study|Adverse Event|7
7763857|NCT00830063|12205317|FG001|Overall Study|Adverse Event|13
7763858|NCT00830063|12205318|FG002|Overall Study|Adverse Event|16
7763859|NCT00830063|12205319|FG003|Overall Study|Adverse Event|13
7763860|NCT00830063|12205316|FG000|Overall Study|Death|1
7763861|NCT00830063|12205317|FG001|Overall Study|Death|0
7763862|NCT00830063|12205318|FG002|Overall Study|Death|0
7763863|NCT00830063|12205319|FG003|Overall Study|Death|0
7763864|NCT00830063|12205316|FG000|Overall Study|Lost to Follow-up|0
7763865|NCT00830063|12205317|FG001|Overall Study|Lost to Follow-up|0
7763866|NCT00830063|12205318|FG002|Overall Study|Lost to Follow-up|3
7763867|NCT00830063|12205319|FG003|Overall Study|Lost to Follow-up|1
7763868|NCT00830063|12205316|FG000|Overall Study|Preferred Time Entry in Extension Study|119
7763869|NCT00830063|12205317|FG001|Overall Study|Preferred Time Entry in Extension Study|139
7763870|NCT00830063|12205318|FG002|Overall Study|Preferred Time Entry in Extension Study|127
7763871|NCT00830063|12205319|FG003|Overall Study|Preferred Time Entry in Extension Study|126
7763872|NCT00830063|12205316|FG000|Overall Study|Lack of Efficacy|51
7763873|NCT00830063|12205317|FG001|Overall Study|Lack of Efficacy|23
7763874|NCT00830063|12205318|FG002|Overall Study|Lack of Efficacy|25
7763875|NCT00830063|12205319|FG003|Overall Study|Lack of Efficacy|32
7763876|NCT00830063|12205316|FG000|Overall Study|Other|5
7763877|NCT00830063|12205317|FG001|Overall Study|Other|5
7763878|NCT00830063|12205318|FG002|Overall Study|Other|8
7763879|NCT00830063|12205319|FG003|Overall Study|Other|6
7763880|NCT00830063|12205316|FG000|Overall Study|Withdrawal by Subject|16
7763881|NCT00830063|12205317|FG001|Overall Study|Withdrawal by Subject|10
7763882|NCT00830063|12205318|FG002|Overall Study|Withdrawal by Subject|16
7763883|NCT00830063|12205319|FG003|Overall Study|Withdrawal by Subject|13
7763884|NCT00830063|12205316|FG000|Overall Study|Protocol Violation|1
7763885|NCT00830063|12205317|FG001|Overall Study|Protocol Violation|0
7763886|NCT00830063|12205318|FG002|Overall Study|Protocol Violation|3
7763887|NCT00830063|12205319|FG003|Overall Study|Protocol Violation|2
7763888|NCT00830063|12205316|FG000|Overall Study|Randomized But Not Treated|0
7763889|NCT00830063|12205317|FG001|Overall Study|Randomized But Not Treated|2
7763890|NCT00830063|12205318|FG002|Overall Study|Randomized But Not Treated|0
7763891|NCT00830063|12205319|FG003|Overall Study|Randomized But Not Treated|2
7763892|NCT00830115|12205338|FG000|Overall Study|Adverse Event|2
7763893|NCT00830115|12205338|FG000|Overall Study|Improvement/recovery|1
7763894|NCT00830128|12205344|FG000|Overall Study|Adverse Event|5
7763895|NCT00830128|12205344|FG000|Overall Study|Lack of Efficacy|7
7763896|NCT00830128|12205344|FG000|Overall Study|Protocol Violation|1
7763897|NCT00830128|12205344|FG000|Overall Study|Withdrawal by Subject|2
7763898|NCT00830128|12205344|FG000|Overall Study|Family obligation|1
7763899|NCT00830128|12205344|FG000|Overall Study|Relocation|1
7763900|NCT00830128|12205344|FG000|Overall Study|Work obligation|1
7763901|NCT00830128|12205344|FG000|Overall Study|Operating a vehicle|1
7763902|NCT00830167|12205350|FG000|Overall Study|Lack of Efficacy|26
7763903|NCT00830167|12205351|FG001|Overall Study|Lack of Efficacy|10
7763904|NCT00830167|12205350|FG000|Overall Study|Adverse Event|8
7763905|NCT00830167|12205351|FG001|Overall Study|Adverse Event|24
7763906|NCT00830167|12205350|FG000|Overall Study|Not meeting entrance criteria|2
7763907|NCT00830167|12205351|FG001|Overall Study|Not meeting entrance criteria|5
7763908|NCT00830167|12205350|FG000|Overall Study|Withdrawal by Subject|2
7763909|NCT00830167|12205351|FG001|Overall Study|Withdrawal by Subject|0
7763910|NCT00830167|12205350|FG000|Overall Study|Lost to Follow-up|0
7763911|NCT00830167|12205351|FG001|Overall Study|Lost to Follow-up|1
7763912|NCT00830167|12205350|FG000|Overall Study|Protocol Violation|0
7763913|NCT00830167|12205351|FG001|Overall Study|Protocol Violation|1
7763914|NCT00830167|12205350|FG000|Overall Study|Other|2
7763915|NCT00830167|12205351|FG001|Overall Study|Other|2
7763916|NCT00830180|12205357|FG000|Overall Study|Adverse Event|6
7763917|NCT00830180|12205357|FG000|Overall Study|Death|11
7763918|NCT00830180|12205357|FG000|Overall Study|Insufficient clinical response|1
7763919|NCT00830180|12205357|FG000|Overall Study|Withdrawal by Subject|5
7763920|NCT00830180|12205357|FG000|Overall Study|Progressive disease|2
7763921|NCT00830180|12205357|FG000|Overall Study|Other - Unspecified|1
7763922|NCT00830375|12205389|FG000|Overall Study|Lost to Follow-up|1
7763923|NCT00830440|12205399|FG000|Overall Study|Protocol Violation|1
7763924|NCT00830440|12205400|FG001|Overall Study|Protocol Violation|0
7763925|NCT00830440|12205399|FG000|Overall Study|Withdrawal by Subject|1
7763926|NCT00830440|12205400|FG001|Overall Study|Withdrawal by Subject|0
7763927|NCT00830440|12205399|FG000|Overall Study|unsuccessful procedure|4
7763928|NCT00830440|12205400|FG001|Overall Study|unsuccessful procedure|0
7763929|NCT00830440|12205399|FG000|Overall Study|Adverse Event|2
7763930|NCT00830440|12205400|FG001|Overall Study|Adverse Event|0
7763931|NCT00830518|12205409|FG000|Overall Study|Progressive Disease|18
7763932|NCT00830518|12205410|FG001|Overall Study|Progressive Disease|8
7763933|NCT00830518|12205409|FG000|Overall Study|Symptomatic Deterioration|4
7763934|NCT00830518|12205410|FG001|Overall Study|Symptomatic Deterioration|1
7763935|NCT00830518|12205409|FG000|Overall Study|Adverse Event|14
7763936|NCT00830518|12205410|FG001|Overall Study|Adverse Event|1
7763937|NCT00830518|12205409|FG000|Overall Study|Withdrawal by Patient|2
7763938|NCT00830518|12205410|FG001|Overall Study|Withdrawal by Patient|0
7763939|NCT00830518|12205409|FG000|Overall Study|Reason not Specified|8
7763940|NCT00830518|12205410|FG001|Overall Study|Reason not Specified|1
7763941|NCT00830765|12205432|FG000|Overall Study|Protocol Violation|3
7763942|NCT00830765|12205433|FG001|Overall Study|Protocol Violation|2
7763943|NCT00830804|12205463|FG000|Overall Study|Lost to Follow-up|4
7763944|NCT00830804|12205463|FG000|Overall Study|Death|1
7763945|NCT00830804|12205463|FG000|Overall Study|Unable to get to clinic|7
7763946|NCT00830804|12205463|FG000|Overall Study|Consent withdrawn|2
7763947|NCT00830804|12205463|FG000|Overall Study|Unwilling to adhere to study requirement|1
7763948|NCT00830869|12205480|FG000|Period 1: Part 1|Symptomatic deterioration|0
7763949|NCT00830869|12205481|FG001|Period 1: Part 1|Symptomatic deterioration|0
7763950|NCT00830869|12205482|FG002|Period 1: Part 1|Symptomatic deterioration|0
7763951|NCT00830869|12205483|FG003|Period 1: Part 1|Symptomatic deterioration|1
7763952|NCT00830869|12205484|FG004|Period 1: Part 1|Symptomatic deterioration|0
7763953|NCT00830869|12205485|FG005|Period 1: Part 1|Symptomatic deterioration|1
7763954|NCT00830869|12205486|FG006|Period 1: Part 1|Symptomatic deterioration|1
7763955|NCT00830869|12205487|FG007|Period 1: Part 1|Symptomatic deterioration|0
7763956|NCT00830869|12205488|FG008|Period 1: Part 1|Symptomatic deterioration|0
7763957|NCT00830869|12205489|FG009|Period 1: Part 1|Symptomatic deterioration|0
7763958|NCT00830869|12205490|FG010|Period 1: Part 1|Symptomatic deterioration|0
7763959|NCT00830869|12205491|FG011|Period 1: Part 1|Symptomatic deterioration|0
7763960|NCT00830869|12205480|FG000|Period 1: Part 1|Withdrawal by Subject|0
7763961|NCT00830869|12205481|FG001|Period 1: Part 1|Withdrawal by Subject|1
7763962|NCT00830869|12205482|FG002|Period 1: Part 1|Withdrawal by Subject|0
7763963|NCT00830869|12205483|FG003|Period 1: Part 1|Withdrawal by Subject|0
7763964|NCT00830869|12205484|FG004|Period 1: Part 1|Withdrawal by Subject|0
7763965|NCT00830869|12205485|FG005|Period 1: Part 1|Withdrawal by Subject|0
7763966|NCT00830869|12205486|FG006|Period 1: Part 1|Withdrawal by Subject|0
7763967|NCT00830869|12205487|FG007|Period 1: Part 1|Withdrawal by Subject|0
7763968|NCT00830869|12205488|FG008|Period 1: Part 1|Withdrawal by Subject|0
7763969|NCT00830869|12205489|FG009|Period 1: Part 1|Withdrawal by Subject|0
7763970|NCT00830869|12205490|FG010|Period 1: Part 1|Withdrawal by Subject|0
7763971|NCT00830869|12205491|FG011|Period 1: Part 1|Withdrawal by Subject|0
7763972|NCT00830869|12205480|FG000|Period 1: Part 1|Adverse Event|0
7763973|NCT00830869|12205481|FG001|Period 1: Part 1|Adverse Event|0
7763974|NCT00830869|12205482|FG002|Period 1: Part 1|Adverse Event|0
7763975|NCT00830869|12205483|FG003|Period 1: Part 1|Adverse Event|0
7763976|NCT00830869|12205484|FG004|Period 1: Part 1|Adverse Event|0
7763977|NCT00830869|12205485|FG005|Period 1: Part 1|Adverse Event|1
7763978|NCT00830869|12205486|FG006|Period 1: Part 1|Adverse Event|1
7763979|NCT00830869|12205487|FG007|Period 1: Part 1|Adverse Event|0
7763980|NCT00830869|12205488|FG008|Period 1: Part 1|Adverse Event|0
7763981|NCT00830869|12205489|FG009|Period 1: Part 1|Adverse Event|0
7763982|NCT00830869|12205490|FG010|Period 1: Part 1|Adverse Event|0
7763983|NCT00830869|12205491|FG011|Period 1: Part 1|Adverse Event|0
7763984|NCT00830869|12205480|FG000|Period 1: Part 1|Progressive disease|1
7763985|NCT00830869|12205481|FG001|Period 1: Part 1|Progressive disease|0
7763986|NCT00830869|12205482|FG002|Period 1: Part 1|Progressive disease|1
7763987|NCT00830869|12205483|FG003|Period 1: Part 1|Progressive disease|6
7763988|NCT00830869|12205484|FG004|Period 1: Part 1|Progressive disease|4
7763989|NCT00830869|12205485|FG005|Period 1: Part 1|Progressive disease|4
7763990|NCT00830869|12205486|FG006|Period 1: Part 1|Progressive disease|1
7763991|NCT00830869|12205487|FG007|Period 1: Part 1|Progressive disease|0
7763992|NCT00830869|12205488|FG008|Period 1: Part 1|Progressive disease|0
7763993|NCT00830869|12205489|FG009|Period 1: Part 1|Progressive disease|0
7763994|NCT00830869|12205490|FG010|Period 1: Part 1|Progressive disease|0
7763995|NCT00830869|12205491|FG011|Period 1: Part 1|Progressive disease|0
7763996|NCT00830869|12205480|FG000|Period 2: Part 2|Protocol Violation|0
7763997|NCT00830869|12205481|FG001|Period 2: Part 2|Protocol Violation|0
7763998|NCT00830869|12205482|FG002|Period 2: Part 2|Protocol Violation|0
7763999|NCT00830869|12205483|FG003|Period 2: Part 2|Protocol Violation|0
7764000|NCT00830869|12205484|FG004|Period 2: Part 2|Protocol Violation|0
7764001|NCT00830869|12205485|FG005|Period 2: Part 2|Protocol Violation|0
7764002|NCT00830869|12205486|FG006|Period 2: Part 2|Protocol Violation|0
7764003|NCT00830869|12205487|FG007|Period 2: Part 2|Protocol Violation|1
7764004|NCT00830869|12205488|FG008|Period 2: Part 2|Protocol Violation|0
7764005|NCT00830869|12205489|FG009|Period 2: Part 2|Protocol Violation|1
7764006|NCT00830869|12205490|FG010|Period 2: Part 2|Protocol Violation|0
7764007|NCT00830869|12205491|FG011|Period 2: Part 2|Protocol Violation|0
7764008|NCT00830869|12205480|FG000|Period 2: Part 2|Withdrawal by Subject|0
7764009|NCT00830869|12205481|FG001|Period 2: Part 2|Withdrawal by Subject|0
7764010|NCT00830869|12205482|FG002|Period 2: Part 2|Withdrawal by Subject|0
7764011|NCT00830869|12205483|FG003|Period 2: Part 2|Withdrawal by Subject|0
7764012|NCT00830869|12205484|FG004|Period 2: Part 2|Withdrawal by Subject|0
7764013|NCT00830869|12205485|FG005|Period 2: Part 2|Withdrawal by Subject|0
7764014|NCT00830869|12205486|FG006|Period 2: Part 2|Withdrawal by Subject|0
7764015|NCT00830869|12205487|FG007|Period 2: Part 2|Withdrawal by Subject|1
7764016|NCT00830869|12205488|FG008|Period 2: Part 2|Withdrawal by Subject|2
7764017|NCT00830869|12205489|FG009|Period 2: Part 2|Withdrawal by Subject|1
7764018|NCT00830869|12205490|FG010|Period 2: Part 2|Withdrawal by Subject|0
7764019|NCT00830869|12205491|FG011|Period 2: Part 2|Withdrawal by Subject|1
7764020|NCT00830869|12205480|FG000|Period 2: Part 2|Adverse Event|0
7764021|NCT00830869|12205481|FG001|Period 2: Part 2|Adverse Event|0
7764022|NCT00830869|12205482|FG002|Period 2: Part 2|Adverse Event|0
7764023|NCT00830869|12205483|FG003|Period 2: Part 2|Adverse Event|0
7764024|NCT00830869|12205484|FG004|Period 2: Part 2|Adverse Event|0
7764025|NCT00830869|12205485|FG005|Period 2: Part 2|Adverse Event|0
7764026|NCT00830869|12205486|FG006|Period 2: Part 2|Adverse Event|0
7764027|NCT00830869|12205487|FG007|Period 2: Part 2|Adverse Event|4
7764028|NCT00830869|12205488|FG008|Period 2: Part 2|Adverse Event|3
7764029|NCT00830869|12205489|FG009|Period 2: Part 2|Adverse Event|2
7764030|NCT00830869|12205490|FG010|Period 2: Part 2|Adverse Event|2
7764031|NCT00830869|12205491|FG011|Period 2: Part 2|Adverse Event|0
7764032|NCT00830869|12205480|FG000|Period 2: Part 2|Symptomatic Deterioration|0
7764033|NCT00830869|12205481|FG001|Period 2: Part 2|Symptomatic Deterioration|0
7764034|NCT00830869|12205482|FG002|Period 2: Part 2|Symptomatic Deterioration|0
7764035|NCT00830869|12205483|FG003|Period 2: Part 2|Symptomatic Deterioration|0
7764036|NCT00830869|12205484|FG004|Period 2: Part 2|Symptomatic Deterioration|0
7764037|NCT00830869|12205485|FG005|Period 2: Part 2|Symptomatic Deterioration|0
7764038|NCT00830869|12205486|FG006|Period 2: Part 2|Symptomatic Deterioration|0
7764039|NCT00830869|12205487|FG007|Period 2: Part 2|Symptomatic Deterioration|0
7764040|NCT00830869|12205488|FG008|Period 2: Part 2|Symptomatic Deterioration|6
7764041|NCT00830869|12205489|FG009|Period 2: Part 2|Symptomatic Deterioration|3
7764042|NCT00830869|12205490|FG010|Period 2: Part 2|Symptomatic Deterioration|1
7764043|NCT00830869|12205491|FG011|Period 2: Part 2|Symptomatic Deterioration|4
7764044|NCT00830869|12205480|FG000|Period 2: Part 2|Progressive disease|0
7764045|NCT00830869|12205481|FG001|Period 2: Part 2|Progressive disease|0
7764046|NCT00830869|12205482|FG002|Period 2: Part 2|Progressive disease|0
7764047|NCT00830869|12205483|FG003|Period 2: Part 2|Progressive disease|0
7764048|NCT00830869|12205484|FG004|Period 2: Part 2|Progressive disease|0
7764049|NCT00830869|12205485|FG005|Period 2: Part 2|Progressive disease|0
7764050|NCT00830869|12205486|FG006|Period 2: Part 2|Progressive disease|0
7764051|NCT00830869|12205487|FG007|Period 2: Part 2|Progressive disease|14
7764052|NCT00830869|12205488|FG008|Period 2: Part 2|Progressive disease|11
7764053|NCT00830869|12205489|FG009|Period 2: Part 2|Progressive disease|12
7764054|NCT00830869|12205490|FG010|Period 2: Part 2|Progressive disease|8
7764055|NCT00830869|12205491|FG011|Period 2: Part 2|Progressive disease|15
7764056|NCT00830869|12205480|FG000|Period 2: Part 2|Other|0
7764057|NCT00830869|12205481|FG001|Period 2: Part 2|Other|0
7764058|NCT00830869|12205482|FG002|Period 2: Part 2|Other|0
7764059|NCT00830869|12205483|FG003|Period 2: Part 2|Other|0
7764060|NCT00830869|12205484|FG004|Period 2: Part 2|Other|0
7764061|NCT00830869|12205485|FG005|Period 2: Part 2|Other|0
7764062|NCT00830869|12205486|FG006|Period 2: Part 2|Other|0
7764063|NCT00830869|12205487|FG007|Period 2: Part 2|Other|0
7764064|NCT00830869|12205488|FG008|Period 2: Part 2|Other|0
7764065|NCT00830869|12205489|FG009|Period 2: Part 2|Other|1
7764066|NCT00830869|12205490|FG010|Period 2: Part 2|Other|0
7764067|NCT00830869|12205491|FG011|Period 2: Part 2|Other|0
7764068|NCT00830947|12205520|FG000|Overall Study|Lost to Follow-up|4
7764069|NCT00830947|12205521|FG001|Overall Study|Lost to Follow-up|4
7764070|NCT00830960|12205533|FG000|Overall Study|Death|5
7764071|NCT00830960|12205534|FG001|Overall Study|Death|4
7764072|NCT00830960|12205535|FG002|Overall Study|Death|3
7764073|NCT00830960|12205536|FG003|Overall Study|Death|2
7764074|NCT00830960|12205537|FG004|Overall Study|Death|6
7764075|NCT00830960|12205538|FG005|Overall Study|Death|1
7764076|NCT00830960|12205533|FG000|Overall Study|Lost to Follow-up|1
7764077|NCT00830960|12205534|FG001|Overall Study|Lost to Follow-up|1
7764078|NCT00830960|12205535|FG002|Overall Study|Lost to Follow-up|1
7764079|NCT00830960|12205536|FG003|Overall Study|Lost to Follow-up|0
7764080|NCT00830960|12205537|FG004|Overall Study|Lost to Follow-up|0
7764081|NCT00830960|12205538|FG005|Overall Study|Lost to Follow-up|1
7764082|NCT00830960|12205533|FG000|Overall Study|Withdrawal by Subject|19
7764083|NCT00830960|12205534|FG001|Overall Study|Withdrawal by Subject|19
7764084|NCT00830960|12205535|FG002|Overall Study|Withdrawal by Subject|18
7764085|NCT00830960|12205536|FG003|Overall Study|Withdrawal by Subject|23
7764086|NCT00830960|12205537|FG004|Overall Study|Withdrawal by Subject|16
7764087|NCT00830960|12205538|FG005|Overall Study|Withdrawal by Subject|21
7764088|NCT00830960|12205533|FG000|Overall Study|Sponsor Decision|1
7764089|NCT00830960|12205534|FG001|Overall Study|Sponsor Decision|2
7764090|NCT00830960|12205535|FG002|Overall Study|Sponsor Decision|3
7764091|NCT00830960|12205536|FG003|Overall Study|Sponsor Decision|4
7764092|NCT00830960|12205537|FG004|Overall Study|Sponsor Decision|5
7764093|NCT00830960|12205538|FG005|Overall Study|Sponsor Decision|7
7764094|NCT00830960|12205533|FG000|Overall Study|No study drug received|7
7764095|NCT00830960|12205534|FG001|Overall Study|No study drug received|2
7764096|NCT00830960|12205535|FG002|Overall Study|No study drug received|4
7764097|NCT00830960|12205536|FG003|Overall Study|No study drug received|3
7764098|NCT00830960|12205537|FG004|Overall Study|No study drug received|5
7764099|NCT00830960|12205538|FG005|Overall Study|No study drug received|7
7764100|NCT00831129|12205577|FG000|Overall Study|Adverse Event|0
7764101|NCT00831129|12205578|FG001|Overall Study|Adverse Event|1
7764102|NCT00831129|12205577|FG000|Overall Study|9 lost to follow-up reasons uknown|0
7764103|NCT00831129|12205578|FG001|Overall Study|9 lost to follow-up reasons uknown|9
7764104|NCT00831181|12205584|FG000|Overall Study|Adverse Event|12
7764105|NCT00831233|12205591|FG000|Overall Study|Adverse Event|0
7764106|NCT00831233|12205592|FG001|Overall Study|Adverse Event|1
7764107|NCT00831233|12205591|FG000|Overall Study|Protocol Violation|1
7764108|NCT00831233|12205592|FG001|Overall Study|Protocol Violation|0
7764109|NCT00831233|12205591|FG000|Overall Study|Selection Criteria Not Met|2
7764110|NCT00831233|12205592|FG001|Overall Study|Selection Criteria Not Met|0
7764111|NCT00831311|12205617|FG000|Overall Study|Definitive Contraindication|3
7764112|NCT00831311|12205618|FG001|Overall Study|Definitive Contraindication|3
7764113|NCT00831311|12205617|FG000|Overall Study|Lost to Follow-up|3
7764114|NCT00831311|12205618|FG001|Overall Study|Lost to Follow-up|0
7764115|NCT00831311|12205617|FG000|Overall Study|Physician Decision|0
7764116|NCT00831311|12205618|FG001|Overall Study|Physician Decision|1
7764117|NCT00831311|12205617|FG000|Overall Study|Withdrawal by Subject|6
7764118|NCT00831311|12205618|FG001|Overall Study|Withdrawal by Subject|4
7764119|NCT00831389|12205627|FG000|Overall Study|Withdrawal by Subject|0
7764120|NCT00831389|12205628|FG001|Overall Study|Withdrawal by Subject|1
7764121|NCT00831415|12205634|FG000|Overall Study|Adverse Event|14
7764122|NCT00831415|12205634|FG000|Overall Study|Failed to return|3
7764123|NCT00831415|12205634|FG000|Overall Study|Physician Decision|6
7764124|NCT00831415|12205634|FG000|Overall Study|Lost to Follow-up|9
7764125|NCT00831415|12205634|FG000|Overall Study|Protocol Violation|3
7764126|NCT00831415|12205634|FG000|Overall Study|Withdrawal by Subject|35
7764127|NCT00831415|12205634|FG000|Overall Study|Unsatisfactory response - Efficacy|4
7764128|NCT00831415|12205634|FG000|Overall Study|Death|1
7770209|NCT00875017|12214134|FG005|Third Intervention|Adverse Event|0
7770210|NCT00875017|12214129|FG000|Washout|Withdrawal by Subject|0
7770211|NCT00875017|12214130|FG001|Washout|Withdrawal by Subject|0
7770212|NCT00875017|12214131|FG002|Washout|Withdrawal by Subject|0
7770213|NCT00875017|12214132|FG003|Washout|Withdrawal by Subject|0
7770214|NCT00875017|12214133|FG004|Washout|Withdrawal by Subject|1
7770215|NCT00875017|12214134|FG005|Washout|Withdrawal by Subject|0
7770216|NCT00875017|12214129|FG000|Fourth Intervention|Inability to comply with fasting|0
7770217|NCT00875017|12214130|FG001|Fourth Intervention|Inability to comply with fasting|0
7962713|NCT02713828|12517022|FG001|Overall Study|Withdrawal by Subject|0
7770218|NCT00875017|12214131|FG002|Fourth Intervention|Inability to comply with fasting|0
7770219|NCT00875017|12214132|FG003|Fourth Intervention|Inability to comply with fasting|0
7770220|NCT00875017|12214133|FG004|Fourth Intervention|Inability to comply with fasting|0
7770221|NCT00875017|12214134|FG005|Fourth Intervention|Inability to comply with fasting|1
7770222|NCT00875056|12214150|FG000|Overall Study|Adverse Event|6
7770223|NCT00875056|12214151|FG001|Overall Study|Adverse Event|1
7770224|NCT00875056|12214152|FG002|Overall Study|Adverse Event|2
7770225|NCT00875056|12214150|FG000|Overall Study|Progressive Disease|14
7770226|NCT00875056|12214151|FG001|Overall Study|Progressive Disease|8
7770227|NCT00875056|12214152|FG002|Overall Study|Progressive Disease|3
7770228|NCT00875056|12214150|FG000|Overall Study|Withdrawal by Subject|3
7770229|NCT00875056|12214151|FG001|Overall Study|Withdrawal by Subject|0
7770230|NCT00875056|12214152|FG002|Overall Study|Withdrawal by Subject|1
7770231|NCT00875420|12214200|FG000|Overall Study|Adverse Event|0
7770232|NCT00875420|12214201|FG001|Overall Study|Adverse Event|1
7770233|NCT00875420|12214202|FG002|Overall Study|Adverse Event|1
7770234|NCT00875420|12214203|FG003|Overall Study|Adverse Event|0
7770235|NCT00875420|12214204|FG004|Overall Study|Adverse Event|0
7770236|NCT00875420|12214200|FG000|Overall Study|Inability to complete study procedures|1
7764129|NCT00831441|12205644|FG000|Randomized|Death|82
7764130|NCT00831441|12205645|FG001|Randomized|Death|81
7764131|NCT00831441|12205644|FG000|Randomized|Adverse Event|248
7764132|NCT00831441|12205645|FG001|Randomized|Adverse Event|321
7764133|NCT00831441|12205644|FG000|Randomized|Emergency procedure|2
7764134|NCT00831441|12205645|FG001|Randomized|Emergency procedure|2
7764135|NCT00831441|12205644|FG000|Randomized|Elective procedure|26
7764136|NCT00831441|12205645|FG001|Randomized|Elective procedure|25
7764137|NCT00831441|12205644|FG000|Randomized|Physician Decision|26
7764138|NCT00831441|12205645|FG001|Randomized|Physician Decision|35
7764139|NCT00831441|12205644|FG000|Randomized|No longer met criteria|13
7764140|NCT00831441|12205645|FG001|Randomized|No longer met criteria|19
7764141|NCT00831441|12205644|FG000|Randomized|Withdrawal by Subject|178
7764142|NCT00831441|12205645|FG001|Randomized|Withdrawal by Subject|212
7764143|NCT00831441|12205644|FG000|Randomized|Lost to Follow-up|26
7764144|NCT00831441|12205645|FG001|Randomized|Lost to Follow-up|35
7764145|NCT00831441|12205644|FG000|Randomized|Administrative reason by sponsor|2780
7764146|NCT00831441|12205645|FG001|Randomized|Administrative reason by sponsor|2671
7764147|NCT00831441|12205644|FG000|Randomized|poor/non-compliance|30
7764148|NCT00831441|12205645|FG001|Randomized|poor/non-compliance|38
7764149|NCT00831441|12205644|FG000|Randomized|non-specified|276
7764150|NCT00831441|12205645|FG001|Randomized|non-specified|266
7764151|NCT00831441|12205644|FG000|Follow Up (30 Days)|Withdrawal by Subject|41
7764152|NCT00831441|12205645|FG001|Follow Up (30 Days)|Withdrawal by Subject|34
7764153|NCT00831441|12205644|FG000|Follow Up (30 Days)|Lost to Follow-up|13
7764154|NCT00831441|12205645|FG001|Follow Up (30 Days)|Lost to Follow-up|27
7764155|NCT00831441|12205644|FG000|Follow Up (30 Days)|Death|63
7764156|NCT00831441|12205645|FG001|Follow Up (30 Days)|Death|86
7764157|NCT00831441|12205644|FG000|Follow Up (30 Days)|non-specified|16
7764158|NCT00831441|12205645|FG001|Follow Up (30 Days)|non-specified|26
7764159|NCT00831441|12205644|FG000|Follow Up (30 Days)|missing end of study status|0
7764160|NCT00831441|12205645|FG001|Follow Up (30 Days)|missing end of study status|1
7764161|NCT00831493|12205656|FG000|Overall Study|Intractable nausea and vomiting|1
7764162|NCT00831701|12205671|FG000|Overall Study|Withdrawal by Subject|2
7764163|NCT00831701|12205672|FG001|Overall Study|Withdrawal by Subject|0
7764164|NCT00831701|12205671|FG000|Overall Study|Stone expulsion before first medication|2
7764165|NCT00831701|12205672|FG001|Overall Study|Stone expulsion before first medication|2
7764166|NCT00831701|12205671|FG000|Overall Study|Lost to Follow-up|1
7764167|NCT00831701|12205672|FG001|Overall Study|Lost to Follow-up|3
7764168|NCT00831779|12205699|FG000|Overall Study|Lost to Follow-up|1
7764169|NCT00831779|12205700|FG001|Overall Study|Lost to Follow-up|0
7764170|NCT00831779|12205699|FG000|Overall Study|No longer met criteria|0
7764171|NCT00831779|12205700|FG001|Overall Study|No longer met criteria|1
7764172|NCT00831792|12205706|FG000|Overall Study|Not Eligible|3
7764173|NCT00831792|12205706|FG000|Overall Study|Adverse Event|1
7764174|NCT00831792|12205706|FG000|Overall Study|Death|1
7764175|NCT00831792|12205706|FG000|Overall Study|Lack of Efficacy|1
7764176|NCT00831844|12205720|FG000|Overall Study|Adverse Event|2
7764177|NCT00831844|12205721|FG001|Overall Study|Adverse Event|0
7764178|NCT00831844|12205722|FG002|Overall Study|Adverse Event|0
7764179|NCT00831844|12205723|FG003|Overall Study|Adverse Event|0
7764180|NCT00831844|12205724|FG004|Overall Study|Adverse Event|1
7764181|NCT00831844|12205725|FG005|Overall Study|Adverse Event|1
7764182|NCT00831844|12205726|FG006|Overall Study|Adverse Event|2
7764183|NCT00831844|12205727|FG007|Overall Study|Adverse Event|0
7764184|NCT00831844|12205728|FG008|Overall Study|Adverse Event|0
7764185|NCT00831844|12205729|FG009|Overall Study|Adverse Event|0
7764186|NCT00831844|12205720|FG000|Overall Study|Death|0
7764187|NCT00831844|12205721|FG001|Overall Study|Death|0
7764188|NCT00831844|12205722|FG002|Overall Study|Death|0
7764189|NCT00831844|12205723|FG003|Overall Study|Death|1
7764190|NCT00831844|12205724|FG004|Overall Study|Death|0
7764191|NCT00831844|12205725|FG005|Overall Study|Death|0
7764192|NCT00831844|12205726|FG006|Overall Study|Death|0
7764193|NCT00831844|12205727|FG007|Overall Study|Death|0
7764194|NCT00831844|12205728|FG008|Overall Study|Death|0
7764195|NCT00831844|12205729|FG009|Overall Study|Death|0
7764196|NCT00831844|12205720|FG000|Overall Study|Lack of Efficacy|8
7764197|NCT00831844|12205721|FG001|Overall Study|Lack of Efficacy|10
7764198|NCT00831844|12205722|FG002|Overall Study|Lack of Efficacy|15
7764199|NCT00831844|12205723|FG003|Overall Study|Lack of Efficacy|8
7764200|NCT00831844|12205724|FG004|Overall Study|Lack of Efficacy|11
7764201|NCT00831844|12205725|FG005|Overall Study|Lack of Efficacy|17
7764202|NCT00831844|12205726|FG006|Overall Study|Lack of Efficacy|8
7764203|NCT00831844|12205727|FG007|Overall Study|Lack of Efficacy|9
7764204|NCT00831844|12205728|FG008|Overall Study|Lack of Efficacy|7
7764205|NCT00831844|12205729|FG009|Overall Study|Lack of Efficacy|0
7764206|NCT00831844|12205720|FG000|Overall Study|Physician Decision|0
7764207|NCT00831844|12205721|FG001|Overall Study|Physician Decision|1
7764208|NCT00831844|12205722|FG002|Overall Study|Physician Decision|3
7764209|NCT00831844|12205723|FG003|Overall Study|Physician Decision|1
7764210|NCT00831844|12205724|FG004|Overall Study|Physician Decision|1
7764211|NCT00831844|12205725|FG005|Overall Study|Physician Decision|1
7764212|NCT00831844|12205726|FG006|Overall Study|Physician Decision|0
7764213|NCT00831844|12205727|FG007|Overall Study|Physician Decision|0
7764214|NCT00831844|12205728|FG008|Overall Study|Physician Decision|1
7764215|NCT00831844|12205729|FG009|Overall Study|Physician Decision|0
7764216|NCT00831844|12205720|FG000|Overall Study|Withdrawal by Subject|0
7764217|NCT00831844|12205721|FG001|Overall Study|Withdrawal by Subject|0
7764218|NCT00831844|12205722|FG002|Overall Study|Withdrawal by Subject|1
7764219|NCT00831844|12205723|FG003|Overall Study|Withdrawal by Subject|0
7764220|NCT00831844|12205724|FG004|Overall Study|Withdrawal by Subject|0
7764221|NCT00831844|12205725|FG005|Overall Study|Withdrawal by Subject|0
7764222|NCT00831844|12205726|FG006|Overall Study|Withdrawal by Subject|0
7764223|NCT00831844|12205727|FG007|Overall Study|Withdrawal by Subject|1
7764224|NCT00831844|12205728|FG008|Overall Study|Withdrawal by Subject|1
7764225|NCT00831844|12205729|FG009|Overall Study|Withdrawal by Subject|0
7764226|NCT00831844|12205720|FG000|Overall Study|Ineligible|0
7764227|NCT00831844|12205721|FG001|Overall Study|Ineligible|1
7764228|NCT00831844|12205722|FG002|Overall Study|Ineligible|1
7764229|NCT00831844|12205723|FG003|Overall Study|Ineligible|0
7764230|NCT00831844|12205724|FG004|Overall Study|Ineligible|1
7764231|NCT00831844|12205725|FG005|Overall Study|Ineligible|0
7764232|NCT00831844|12205726|FG006|Overall Study|Ineligible|0
7764233|NCT00831844|12205727|FG007|Overall Study|Ineligible|0
7764234|NCT00831844|12205728|FG008|Overall Study|Ineligible|0
7764235|NCT00831844|12205729|FG009|Overall Study|Ineligible|0
7764236|NCT00832000|12205760|FG000|Overall Study|Adverse Event|2
7764237|NCT00832000|12205761|FG001|Overall Study|Adverse Event|0
7764238|NCT00832000|12205760|FG000|Overall Study|Withdrawal by Subject|1
7764239|NCT00832000|12205761|FG001|Overall Study|Withdrawal by Subject|0
7764240|NCT00832000|12205760|FG000|Overall Study|No calls to IVR in either period|1
7764241|NCT00832000|12205761|FG001|Overall Study|No calls to IVR in either period|1
7764242|NCT00832000|12205760|FG000|Overall Study|No calls to IVR in period 2|2
7764243|NCT00832000|12205761|FG001|Overall Study|No calls to IVR in period 2|0
7764244|NCT00832078|12205796|FG000|Test Day 1-2 Period|Lack of Efficacy|0
7764245|NCT00832078|12205797|FG001|Test Day 1-2 Period|Lack of Efficacy|2
7764246|NCT00832078|12205796|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1
7764247|NCT00832078|12205797|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0
7764248|NCT00832091|12205805|FG000|Overall Study|Adverse Event|1
7764249|NCT00832091|12205806|FG001|Overall Study|Adverse Event|1
7764250|NCT00832091|12205805|FG000|Overall Study|Protocol Violation|1
7764251|NCT00832091|12205806|FG001|Overall Study|Protocol Violation|0
7764252|NCT00832091|12205805|FG000|Overall Study|Withdrawal by Subject|2
7764253|NCT00832091|12205806|FG001|Overall Study|Withdrawal by Subject|1
7764254|NCT00832091|12205805|FG000|Overall Study|Prohibited Medication|1
7764255|NCT00832091|12205806|FG001|Overall Study|Prohibited Medication|0
7764256|NCT00832117|12205814|FG000|Overall Study|Death|1
7764257|NCT00832117|12205814|FG000|Overall Study|Disease Progression|11
7764258|NCT00832377|12205838|FG000|Overall Study|Protocol Violation|1
7764259|NCT00832416|12205859|FG000|Overall Study|Lack of Efficacy|17
7764260|NCT00832416|12205860|FG001|Overall Study|Lack of Efficacy|15
7764261|NCT00832416|12205861|FG002|Overall Study|Lack of Efficacy|13
7764262|NCT00832416|12205862|FG003|Overall Study|Lack of Efficacy|52
7764263|NCT00832416|12205859|FG000|Overall Study|Withdrawal by Subject|5
7764264|NCT00832416|12205860|FG001|Overall Study|Withdrawal by Subject|7
7764265|NCT00832416|12205861|FG002|Overall Study|Withdrawal by Subject|2
7764266|NCT00832416|12205862|FG003|Overall Study|Withdrawal by Subject|10
7764267|NCT00832416|12205859|FG000|Overall Study|Physician Decision|2
7764268|NCT00832416|12205860|FG001|Overall Study|Physician Decision|12
7764269|NCT00832416|12205861|FG002|Overall Study|Physician Decision|5
7764270|NCT00832416|12205862|FG003|Overall Study|Physician Decision|10
7764271|NCT00832416|12205859|FG000|Overall Study|Administrative|0
7764272|NCT00832416|12205860|FG001|Overall Study|Administrative|0
7764273|NCT00832416|12205861|FG002|Overall Study|Administrative|0
7764274|NCT00832416|12205862|FG003|Overall Study|Administrative|1
7764275|NCT00832416|12205859|FG000|Overall Study|Adverse Event|21
7764276|NCT00832416|12205860|FG001|Overall Study|Adverse Event|19
7764277|NCT00832416|12205861|FG002|Overall Study|Adverse Event|41
7764278|NCT00832416|12205862|FG003|Overall Study|Adverse Event|10
7764279|NCT00832416|12205859|FG000|Overall Study|Death|1
7764280|NCT00832416|12205860|FG001|Overall Study|Death|0
7764281|NCT00832416|12205861|FG002|Overall Study|Death|0
7764282|NCT00832416|12205862|FG003|Overall Study|Death|0
7764283|NCT00832585|12205872|FG000|Overall Study|Withdrawal by Subject|1
7764284|NCT00832585|12205872|FG000|Overall Study|Lost to Follow-up|1
7764285|NCT00832650|12205883|FG000|Overall Study|Randomized but not treated|0
7764286|NCT00832650|12205884|FG001|Overall Study|Randomized but not treated|0
7764287|NCT00832650|12205885|FG002|Overall Study|Randomized but not treated|1
7764288|NCT00832780|12205904|FG000|Overall Study|Death|16
7764289|NCT00832780|12205904|FG000|Overall Study|Lost to Follow-up|4
7764290|NCT00832780|12205904|FG000|Overall Study|no reason given|2
7764291|NCT00832780|12205904|FG000|Overall Study|other complicating condition|2
7764292|NCT00832780|12205904|FG000|Overall Study|Physician Decision|1
7764293|NCT00832819|12205911|FG000|Overall Study|Adverse Event|0
7764294|NCT00832819|12205912|FG001|Overall Study|Adverse Event|1
7764295|NCT00832819|12205913|FG002|Overall Study|Adverse Event|0
7764296|NCT00832819|12205911|FG000|Overall Study|Protocol Violation|0
7764297|NCT00832819|12205912|FG001|Overall Study|Protocol Violation|0
7764298|NCT00832819|12205913|FG002|Overall Study|Protocol Violation|1
7764299|NCT00832975|12205923|FG000|Overall Study|Lost to Follow-up|7
7764300|NCT00832975|12205923|FG000|Overall Study|Protocol Violation|6
7764301|NCT00832975|12205923|FG000|Overall Study|Death|5
7764302|NCT00832975|12205923|FG000|Overall Study|Physician Decision|4
7764303|NCT00832975|12205923|FG000|Overall Study|Withdrawal by Subject|3
7764304|NCT00832975|12205923|FG000|Overall Study|Other reasons|14
7764305|NCT00833027|12205927|FG000|Overall Study|Adverse Event|33
7764306|NCT00833027|12205927|FG000|Overall Study|Death|1
7764307|NCT00833027|12205927|FG000|Overall Study|Lack of Efficacy|12
7764308|NCT00833027|12205927|FG000|Overall Study|Lost to Follow-up|24
7764309|NCT00833027|12205927|FG000|Overall Study|Protocol Violation|115
7764310|NCT00833027|12205927|FG000|Overall Study|Withdrawal by Subject|16
7764311|NCT00833027|12205927|FG000|Overall Study|Missing|10
7764312|NCT00833040|12205931|FG000|Overall Study|Adverse Event|0
7764313|NCT00833040|12205932|FG001|Overall Study|Adverse Event|0
7764314|NCT00833040|12205933|FG002|Overall Study|Adverse Event|0
7764315|NCT00833040|12205934|FG003|Overall Study|Adverse Event|0
7764316|NCT00833040|12205935|FG004|Overall Study|Adverse Event|0
7764317|NCT00833040|12205936|FG005|Overall Study|Adverse Event|1
7764318|NCT00833053|12205943|FG000|Overall Study|Adverse Event|4
7764319|NCT00833053|12205944|FG001|Overall Study|Adverse Event|0
7764320|NCT00833053|12205943|FG000|Overall Study|Treatment Failure|3
7764321|NCT00833053|12205944|FG001|Overall Study|Treatment Failure|1
7764322|NCT00833053|12205943|FG000|Overall Study|Withdrawal by Subject|0
7764323|NCT00833053|12205944|FG001|Overall Study|Withdrawal by Subject|1
7764324|NCT00833053|12205943|FG000|Overall Study|Protocol Violation|2
7764325|NCT00833053|12205944|FG001|Overall Study|Protocol Violation|1
7764326|NCT00833092|12205952|FG000|Overall Study|Withdrawal by Subject|2
7764327|NCT00833092|12205953|FG001|Overall Study|Withdrawal by Subject|3
7764328|NCT00833092|12205952|FG000|Overall Study|Protocol Violation|2
7764329|NCT00833092|12205953|FG001|Overall Study|Protocol Violation|1
7764330|NCT00833092|12205952|FG000|Overall Study|Diarrhea|0
7764331|NCT00833092|12205953|FG001|Overall Study|Diarrhea|2
7764332|NCT00833092|12205952|FG000|Overall Study|constipation|0
7764333|NCT00833092|12205953|FG001|Overall Study|constipation|1
7764334|NCT00833105|12205959|FG000|Overall Study|Withdrawal by Subject|1
7764335|NCT00833105|12205959|FG000|Overall Study|Adverse Event|2
7764336|NCT00833248|12205967|FG000|Overall Study|Adverse Event|3
7764337|NCT00833248|12205968|FG001|Overall Study|Adverse Event|0
7764338|NCT00833248|12205967|FG000|Overall Study|Protocol Violation|1
7764339|NCT00833248|12205968|FG001|Overall Study|Protocol Violation|2
7764340|NCT00833248|12205967|FG000|Overall Study|Withdrawal by Subject|0
7764341|NCT00833248|12205968|FG001|Overall Study|Withdrawal by Subject|1
7764342|NCT00833261|12205974|FG000|Overall Study|Withdrawal by Subject|4
7764343|NCT00833417|12205989|FG000|Overall Study|Adverse Event|5
7764344|NCT00833417|12205990|FG001|Overall Study|Adverse Event|16
7764345|NCT00833417|12205989|FG000|Overall Study|Death|1
7764346|NCT00833417|12205990|FG001|Overall Study|Death|3
7764347|NCT00833417|12205989|FG000|Overall Study|Lost to Follow-up|1
7764348|NCT00833417|12205990|FG001|Overall Study|Lost to Follow-up|2
7764349|NCT00833417|12205989|FG000|Overall Study|Physician Decision to Withdraw Patient|3
7764350|NCT00833417|12205990|FG001|Overall Study|Physician Decision to Withdraw Patient|7
7764351|NCT00833417|12205989|FG000|Overall Study|Patient Decision to Withdraw|4
7764352|NCT00833417|12205990|FG001|Overall Study|Patient Decision to Withdraw|23
7764353|NCT00833417|12205989|FG000|Overall Study|Sponsor Decision to Terminate Study|1
7764354|NCT00833417|12205990|FG001|Overall Study|Sponsor Decision to Terminate Study|2
7764355|NCT00833417|12205989|FG000|Overall Study|Disease Progression|18
7764356|NCT00833417|12205990|FG001|Overall Study|Disease Progression|17
7764357|NCT00833417|12205989|FG000|Overall Study|Reason Not Specified|0
7764358|NCT00833417|12205990|FG001|Overall Study|Reason Not Specified|1
7764359|NCT00833469|12206008|FG000|Overall Study|Withdrawal by Subject|1
7764360|NCT00833469|12206008|FG000|Overall Study|Lost to Follow-up|1
7764361|NCT00833482|12206014|FG000|Days 11-20|Adverse Event|0
7764362|NCT00833482|12206015|FG001|Days 11-20|Adverse Event|2
7764363|NCT00833482|12206016|FG002|Days 11-20|Adverse Event|0
7764364|NCT00833482|12206017|FG003|Days 11-20|Adverse Event|0
7764365|NCT00833482|12206018|FG004|Days 11-20|Adverse Event|0
7764366|NCT00833482|12206019|FG005|Days 11-20|Adverse Event|0
7764367|NCT00833482|12206014|FG000|Days 11-20|Withdrawal by Subject|0
7764368|NCT00833482|12206015|FG001|Days 11-20|Withdrawal by Subject|1
7764369|NCT00833482|12206016|FG002|Days 11-20|Withdrawal by Subject|0
7764370|NCT00833482|12206017|FG003|Days 11-20|Withdrawal by Subject|0
7764371|NCT00833482|12206018|FG004|Days 11-20|Withdrawal by Subject|0
7764372|NCT00833482|12206019|FG005|Days 11-20|Withdrawal by Subject|0
7764373|NCT00833482|12206014|FG000|Days 21-30|Adverse Event|0
7764374|NCT00833482|12206015|FG001|Days 21-30|Adverse Event|0
7764375|NCT00833482|12206016|FG002|Days 21-30|Adverse Event|1
7764376|NCT00833482|12206017|FG003|Days 21-30|Adverse Event|0
7764377|NCT00833482|12206018|FG004|Days 21-30|Adverse Event|0
7764378|NCT00833482|12206019|FG005|Days 21-30|Adverse Event|0
7764379|NCT00833482|12206014|FG000|Days 21-30|Withdrawal by Subject|0
7764380|NCT00833482|12206015|FG001|Days 21-30|Withdrawal by Subject|0
7764381|NCT00833482|12206016|FG002|Days 21-30|Withdrawal by Subject|0
7764382|NCT00833482|12206017|FG003|Days 21-30|Withdrawal by Subject|0
7764383|NCT00833482|12206018|FG004|Days 21-30|Withdrawal by Subject|1
7764384|NCT00833482|12206019|FG005|Days 21-30|Withdrawal by Subject|0
7764385|NCT00833547|12206043|FG000|Overall Study|Withdrawal by Subject|2
7764386|NCT00833547|12206044|FG001|Overall Study|Withdrawal by Subject|2
7764387|NCT00833560|12206050|FG000|Overall Study|Toxicity|13
7764388|NCT00833560|12206050|FG000|Overall Study|Adverse Event|11
7764389|NCT00833560|12206050|FG000|Overall Study|Protocol Violation|6
7764390|NCT00833560|12206050|FG000|Overall Study|Lack of Efficacy|4
7764391|NCT00833560|12206050|FG000|Overall Study|Death|2
7764392|NCT00833560|12206050|FG000|Overall Study|Pregression of other disease|1
7764393|NCT00833560|12206050|FG000|Overall Study|Other|5
7764394|NCT00833638|12206057|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1
7764395|NCT00833638|12206058|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2
7764396|NCT00833638|12206059|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0
7764397|NCT00833638|12206057|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
7764398|NCT00833638|12206058|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
7764399|NCT00833638|12206059|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
7764400|NCT00833638|12206057|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
7764401|NCT00833638|12206058|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
7764402|NCT00833638|12206059|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
7764403|NCT00833638|12206057|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1
7764404|NCT00833638|12206058|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0
7764405|NCT00833638|12206059|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0
7764406|NCT00833638|12206057|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
7764407|NCT00833638|12206058|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
7764408|NCT00833638|12206059|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
7764409|NCT00833638|12206057|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
7764410|NCT00833638|12206058|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
7764411|NCT00833638|12206059|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
7764412|NCT00833638|12206057|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
7764413|NCT00833638|12206058|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
7764414|NCT00833638|12206059|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
7764415|NCT00833638|12206057|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
7764416|NCT00833638|12206058|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
7764417|NCT00833638|12206059|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
7764418|NCT00833638|12206057|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0
7764419|NCT00833638|12206058|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1
7764420|NCT00833638|12206059|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2
7764421|NCT00833690|12206078|FG000|Overall Study|Withdrawal by Subject|1
7764422|NCT00833690|12206079|FG001|Overall Study|Withdrawal by Subject|0
7764423|NCT00833690|12206080|FG002|Overall Study|Withdrawal by Subject|0
7764424|NCT00833690|12206078|FG000|Overall Study|Discontinued study drug|3
7764425|NCT00833690|12206079|FG001|Overall Study|Discontinued study drug|2
7764426|NCT00833690|12206080|FG002|Overall Study|Discontinued study drug|0
7764427|NCT00833703|12206090|FG000|Overall Study|Parent(s)/guardian(s)'s request|0
7764428|NCT00833703|12206091|FG001|Overall Study|Parent(s)/guardian(s)'s request|1
7764429|NCT00833755|12206101|FG000|Overall Study|Physician Decision|4
7764430|NCT00833755|12206102|FG001|Overall Study|Physician Decision|4
7764431|NCT00833755|12206103|FG002|Overall Study|Physician Decision|2
7764432|NCT00833755|12206104|FG003|Overall Study|Physician Decision|6
7764433|NCT00833755|12206101|FG000|Overall Study|Subject had scheduling issues|0
7764434|NCT00833755|12206102|FG001|Overall Study|Subject had scheduling issues|1
7764435|NCT00833755|12206103|FG002|Overall Study|Subject had scheduling issues|0
7764436|NCT00833755|12206104|FG003|Overall Study|Subject had scheduling issues|0
7764437|NCT00833794|12206125|FG000|Open-label Phase|Adverse Event|225
7764438|NCT00833794|12206126|FG001|Open-label Phase|Adverse Event|0
7764439|NCT00833794|12206125|FG000|Open-label Phase|Lack of Efficacy|28
7764440|NCT00833794|12206126|FG001|Open-label Phase|Lack of Efficacy|0
7764441|NCT00833794|12206125|FG000|Open-label Phase|Withdrawal by Subject|48
7764442|NCT00833794|12206126|FG001|Open-label Phase|Withdrawal by Subject|0
7764443|NCT00833794|12206125|FG000|Open-label Phase|Physician Decision|20
7764444|NCT00833794|12206126|FG001|Open-label Phase|Physician Decision|0
7764445|NCT00833794|12206125|FG000|Open-label Phase|Administrative reason|1
7764446|NCT00833794|12206126|FG001|Open-label Phase|Administrative reason|0
7764447|NCT00833794|12206125|FG000|Open-label Phase|Protocol Violation|47
7764448|NCT00833794|12206126|FG001|Open-label Phase|Protocol Violation|0
7764449|NCT00833794|12206125|FG000|Open-label Phase|Did not complete wash-out period|12
7764450|NCT00833794|12206126|FG001|Open-label Phase|Did not complete wash-out period|0
7764451|NCT00833794|12206125|FG000|Open-label Phase|enrolled in error (immediately D/C)|1
7764452|NCT00833794|12206126|FG001|Open-label Phase|enrolled in error (immediately D/C)|0
7764453|NCT00833794|12206125|FG000|Double-blind Phase|Adverse Event|44
7764454|NCT00833794|12206126|FG001|Double-blind Phase|Adverse Event|11
7764455|NCT00833794|12206125|FG000|Double-blind Phase|Lack of Efficacy|34
7764456|NCT00833794|12206126|FG001|Double-blind Phase|Lack of Efficacy|22
7764457|NCT00833794|12206125|FG000|Double-blind Phase|Withdrawal by Subject|23
7764458|NCT00833794|12206126|FG001|Double-blind Phase|Withdrawal by Subject|6
7764459|NCT00833794|12206125|FG000|Double-blind Phase|Physician Decision|4
7764460|NCT00833794|12206126|FG001|Double-blind Phase|Physician Decision|7
7764461|NCT00833794|12206125|FG000|Double-blind Phase|Administrative reason|1
7764462|NCT00833794|12206126|FG001|Double-blind Phase|Administrative reason|3
7764463|NCT00833833|12206140|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0
7764464|NCT00833833|12206141|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0
7764465|NCT00833833|12206142|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2
7764466|NCT00833833|12206143|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2
7764467|NCT00833833|12206144|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0
7764468|NCT00833833|12206145|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0
7764469|NCT00833833|12206140|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
7764470|NCT00833833|12206141|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
7764471|NCT00833833|12206142|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
7764472|NCT00833833|12206143|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
7764473|NCT00833833|12206144|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
7764474|NCT00833833|12206145|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
7764475|NCT00833833|12206140|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1
7764476|NCT00833833|12206141|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0
7764477|NCT00833833|12206142|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2
7764478|NCT00833833|12206143|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1
7764479|NCT00833833|12206144|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0
7764480|NCT00833833|12206145|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0
7764481|NCT00833833|12206140|FG000|Phase 1 (as of 01 April 2011)|Death|0
7764482|NCT00833833|12206141|FG001|Phase 1 (as of 01 April 2011)|Death|1
7764483|NCT00833833|12206142|FG002|Phase 1 (as of 01 April 2011)|Death|2
7764484|NCT00833833|12206143|FG003|Phase 1 (as of 01 April 2011)|Death|0
7764485|NCT00833833|12206144|FG004|Phase 1 (as of 01 April 2011)|Death|0
7764486|NCT00833833|12206145|FG005|Phase 1 (as of 01 April 2011)|Death|0
7764487|NCT00833833|12206140|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
7764488|NCT00833833|12206141|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
7764489|NCT00833833|12206142|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
7764490|NCT00833833|12206143|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
7764491|NCT00833833|12206144|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
7764492|NCT00833833|12206145|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
7764493|NCT00833833|12206140|FG000|Phase 1 (as of 01 April 2011)|Other|1
7764494|NCT00833833|12206141|FG001|Phase 1 (as of 01 April 2011)|Other|3
7764495|NCT00833833|12206142|FG002|Phase 1 (as of 01 April 2011)|Other|0
7764496|NCT00833833|12206143|FG003|Phase 1 (as of 01 April 2011)|Other|1
7764497|NCT00833833|12206144|FG004|Phase 1 (as of 01 April 2011)|Other|0
7962714|NCT02713828|12517021|FG000|Overall Study|study terminated but patient allowed to|2
7962715|NCT02713828|12517022|FG001|Overall Study|study terminated but patient allowed to|0
7962716|NCT02714153|12517027|FG000|Overall Study|Death|1
7962717|NCT02714426|12517053|FG000|Overall Study|Withdrawal by Subject|2
7962718|NCT02714426|12517054|FG001|Overall Study|Withdrawal by Subject|2
7962719|NCT02714569|12517080|FG000|Part A Second Intervention|Withdrawal by Subject|0
7962720|NCT02714569|12517081|FG001|Part A Second Intervention|Withdrawal by Subject|1
7962721|NCT02714569|12517082|FG002|Part A Second Intervention|Withdrawal by Subject|0
7962722|NCT02714569|12517083|FG003|Part A Second Intervention|Withdrawal by Subject|0
7962723|NCT02714569|12517084|FG004|Part A Second Intervention|Withdrawal by Subject|0
7962724|NCT02714569|12517085|FG005|Part A Second Intervention|Withdrawal by Subject|0
7962725|NCT02714569|12517086|FG006|Part A Second Intervention|Withdrawal by Subject|0
7962726|NCT02714569|12517087|FG007|Part A Second Intervention|Withdrawal by Subject|0
7962727|NCT02714569|12517088|FG008|Part A Second Intervention|Withdrawal by Subject|0
7962728|NCT02714569|12517089|FG009|Part A Second Intervention|Withdrawal by Subject|0
7962729|NCT02714569|12517090|FG010|Part A Second Intervention|Withdrawal by Subject|0
7962730|NCT02714569|12517080|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7962731|NCT02714569|12517081|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7962732|NCT02714569|12517082|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7764498|NCT00833833|12206145|FG005|Phase 1 (as of 01 April 2011)|Other|0
7764499|NCT00833833|12206140|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0
7764500|NCT00833833|12206141|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0
7764501|NCT00833833|12206142|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0
7764502|NCT00833833|12206143|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0
7764503|NCT00833833|12206144|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23
7764504|NCT00833833|12206145|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22
7764505|NCT00833833|12206140|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0
7764506|NCT00833833|12206141|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0
7764507|NCT00833833|12206142|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0
7764508|NCT00833833|12206143|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0
7764509|NCT00833833|12206144|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8
7764510|NCT00833833|12206145|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13
7764511|NCT00833833|12206140|FG000|Phase 2 (as of 01 April 2011)|Death|0
7764512|NCT00833833|12206141|FG001|Phase 2 (as of 01 April 2011)|Death|0
7764513|NCT00833833|12206142|FG002|Phase 2 (as of 01 April 2011)|Death|0
7764514|NCT00833833|12206143|FG003|Phase 2 (as of 01 April 2011)|Death|0
7764515|NCT00833833|12206144|FG004|Phase 2 (as of 01 April 2011)|Death|8
7764516|NCT00833833|12206145|FG005|Phase 2 (as of 01 April 2011)|Death|9
7764517|NCT00833833|12206140|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
7764518|NCT00833833|12206141|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
7764519|NCT00833833|12206142|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
7764520|NCT00833833|12206143|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
7764521|NCT00833833|12206144|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
7764522|NCT00833833|12206145|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
7764523|NCT00833833|12206140|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
7764524|NCT00833833|12206141|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
7764525|NCT00833833|12206142|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
7764526|NCT00833833|12206143|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
7764527|NCT00833833|12206144|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
7764528|NCT00833833|12206145|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
7764529|NCT00833833|12206140|FG000|Phase 2 (as of 01 April 2011)|Other|0
7764530|NCT00833833|12206141|FG001|Phase 2 (as of 01 April 2011)|Other|0
7764531|NCT00833833|12206142|FG002|Phase 2 (as of 01 April 2011)|Other|0
7764532|NCT00833833|12206143|FG003|Phase 2 (as of 01 April 2011)|Other|0
7764533|NCT00833833|12206144|FG004|Phase 2 (as of 01 April 2011)|Other|4
7764534|NCT00833833|12206145|FG005|Phase 2 (as of 01 April 2011)|Other|3
7764535|NCT00833833|12206140|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
7764536|NCT00833833|12206141|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
7764537|NCT00833833|12206142|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
7764538|NCT00833833|12206143|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
7764539|NCT00833833|12206144|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
7764540|NCT00833833|12206145|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
7764541|NCT00833898|12206167|FG000|Overall Study|Withdrawal by Subject|33
7764542|NCT00833898|12206168|FG001|Overall Study|Withdrawal by Subject|27
7764543|NCT00833898|12206167|FG000|Overall Study|Lost to Follow-up|7
7764544|NCT00833898|12206168|FG001|Overall Study|Lost to Follow-up|7
7764545|NCT00833898|12206167|FG000|Overall Study|Patient did not receive transplant|0
7764546|NCT00833898|12206168|FG001|Overall Study|Patient did not receive transplant|2
7764547|NCT00833911|12206174|FG000|Titration|Adverse Event|18
7764548|NCT00833911|12206174|FG000|Titration|Withdrawal by Subject|3
7764549|NCT00833911|12206174|FG000|Maintenance Phase I|Adverse Event|73
7764550|NCT00833911|12206174|FG000|Maintenance Phase I|Withdrawal by Subject|11
7764551|NCT00833911|12206174|FG000|Maintenance Phase I|Physician Decision|10
7764552|NCT00833911|12206174|FG000|Maintenance Phase I|Lack of Efficacy|4
7764553|NCT00833911|12206174|FG000|Maintenance Phase II|Adverse Event|6
7764554|NCT00833911|12206174|FG000|Maintenance Phase II|Physician Decision|2
7764555|NCT00833911|12206174|FG000|Maintenance Phase II|Withdrawal by Subject|1
7764556|NCT00833911|12206174|FG000|Maintenance Phase II|Lack of Efficacy|1
7764557|NCT00833924|12206182|FG000|Overall Study|Death|21
7764558|NCT00833924|12206182|FG000|Overall Study|Conversion|2
7764559|NCT00833924|12206182|FG000|Overall Study|Lost to Follow-up|2
7764560|NCT00833924|12206182|FG000|Overall Study|Withdrawal by Subject|13
7764561|NCT00833924|12206182|FG000|Overall Study|In study follow-up|71
7764562|NCT00833976|12206186|FG000|Overall Study|Withdrawal by Subject|5
7764563|NCT00833976|12206186|FG000|Overall Study|Lost to Follow-up|4
7764564|NCT00833976|12206186|FG000|Overall Study|Did not meet eligibility criteria|41
7764565|NCT00833976|12206186|FG000|Overall Study|Physician Decision|1
7764566|NCT00833989|12206194|FG000|Overall Study|Physician Decision|0
7764567|NCT00833989|12206195|FG001|Overall Study|Physician Decision|0
7764568|NCT00833989|12206196|FG002|Overall Study|Physician Decision|0
7764569|NCT00833989|12206197|FG003|Overall Study|Physician Decision|1
7764570|NCT00833989|12206194|FG000|Overall Study|Withdrawal by Subject|3
7764571|NCT00833989|12206195|FG001|Overall Study|Withdrawal by Subject|0
7764572|NCT00833989|12206196|FG002|Overall Study|Withdrawal by Subject|1
7764573|NCT00833989|12206197|FG003|Overall Study|Withdrawal by Subject|1
7764574|NCT00834041|12206212|FG000|Overall Study|Withdrawal by Subject|1
7764575|NCT00834041|12206213|FG001|Overall Study|Withdrawal by Subject|0
7764576|NCT00834041|12206212|FG000|Overall Study|Lost to Follow-up|0
7764577|NCT00834041|12206213|FG001|Overall Study|Lost to Follow-up|1
7764578|NCT00834080|12206219|FG000|Overall Study|Adverse Event|7
7764579|NCT00834080|12206219|FG000|Overall Study|Lost to Follow-up|7
7764580|NCT00834080|12206219|FG000|Overall Study|Withdrawal by Subject|5
7764581|NCT00834080|12206219|FG000|Overall Study|Other - Pregnancy|1
7764582|NCT00834080|12206219|FG000|Overall Study|Other - False positive tests of the UDS|1
7764583|NCT00834080|12206219|FG000|Overall Study|Physician Decision|1
7764584|NCT00834080|12206219|FG000|Overall Study|Subject Relocated|1
7764585|NCT00834366|12206270|FG000|Treatment Period 1|Adverse Event|1
7764586|NCT00834366|12206271|FG001|Treatment Period 1|Adverse Event|1
7764587|NCT00834834|12206321|FG000|Overall Study|Withdrawal by Subject|4
7764588|NCT00834834|12206322|FG001|Overall Study|Withdrawal by Subject|3
7764589|NCT00834899|12206347|FG000|Overall Study|Withdrawal by Subject|1
7764590|NCT00834899|12206348|FG001|Overall Study|Withdrawal by Subject|1
7764591|NCT00834912|12206360|FG000|Treatment Period 1|Adverse Event|0
7764592|NCT00834912|12206361|FG001|Treatment Period 1|Adverse Event|1
7764593|NCT00834912|12206362|FG002|Treatment Period 1|Adverse Event|0
7764594|NCT00834912|12206363|FG003|Treatment Period 1|Adverse Event|1
7764595|NCT00834912|12206364|FG004|Treatment Period 1|Adverse Event|0
7764596|NCT00834912|12206365|FG005|Treatment Period 1|Adverse Event|0
7764597|NCT00834912|12206360|FG000|Treatment Period 2|Withdrawal by Subject|0
7764598|NCT00834912|12206361|FG001|Treatment Period 2|Withdrawal by Subject|0
7764599|NCT00834912|12206362|FG002|Treatment Period 2|Withdrawal by Subject|1
7764600|NCT00834912|12206363|FG003|Treatment Period 2|Withdrawal by Subject|0
7764601|NCT00834912|12206364|FG004|Treatment Period 2|Withdrawal by Subject|1
7764602|NCT00834912|12206365|FG005|Treatment Period 2|Withdrawal by Subject|0
7764603|NCT00835068|12206384|FG000|Overall Study|Death|1
7764604|NCT00835068|12206385|FG001|Overall Study|Death|0
7764605|NCT00835068|12206384|FG000|Overall Study|Adverse Event|0
7764606|NCT00835068|12206385|FG001|Overall Study|Adverse Event|1
7764607|NCT00835068|12206384|FG000|Overall Study|Other|8
7764608|NCT00835068|12206385|FG001|Overall Study|Other|0
7764609|NCT00835068|12206384|FG000|Overall Study|Withdrawal by Subject|1
7764610|NCT00835068|12206385|FG001|Overall Study|Withdrawal by Subject|0
7764611|NCT00835120|12206391|FG000|Overall Study|Lack of Efficacy|1
7764612|NCT00835120|12206391|FG000|Overall Study|Lost to Follow-up|3
7764613|NCT00835120|12206391|FG000|Overall Study|Adverse Event|2
7764614|NCT00835120|12206391|FG000|Overall Study|Withdrawal by Subject|2
7764615|NCT00835237|12206434|FG000|Overall Study|Lost to Follow-up|4
7764616|NCT00835237|12206435|FG001|Overall Study|Lost to Follow-up|0
7764617|NCT00835237|12206434|FG000|Overall Study|Withdrawal by Subject|2
7764618|NCT00835237|12206435|FG001|Overall Study|Withdrawal by Subject|0
7764619|NCT00835341|12206443|FG000|Overall Study|Lost to Follow-up|3
7764620|NCT00835341|12206444|FG001|Overall Study|Lost to Follow-up|12
7764621|NCT00835380|12206450|FG000|Overall Study|Withdrawal by Subject|2
7764622|NCT00835731|12206469|FG000|Overall Study|Withdrawal by Subject|1
7764623|NCT00835731|12206470|FG001|Overall Study|Withdrawal by Subject|0
7624597|NCT01813305|12035749|FG000|Overall Study|Safety Concern|4
7624598|NCT01813305|12035750|FG001|Overall Study|Safety Concern|0
7624599|NCT01813305|12035749|FG000|Overall Study|Ulcer became worse|4
7624600|NCT01813305|12035750|FG001|Overall Study|Ulcer became worse|0
7624601|NCT01813305|12035749|FG000|Overall Study|Physician Decision|4
7624602|NCT01813305|12035750|FG001|Overall Study|Physician Decision|0
7624603|NCT01813305|12035749|FG000|Overall Study|Lost to Follow-up|3
7624604|NCT01813305|12035750|FG001|Overall Study|Lost to Follow-up|1
7624605|NCT01813305|12035749|FG000|Overall Study|Protocol Violation|1
7624606|NCT01813305|12035750|FG001|Overall Study|Protocol Violation|0
7624607|NCT01813305|12035749|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7
7624608|NCT01813305|12035750|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2
7624609|NCT01680965|12035762|FG000|Overall Study|Death|0
7624610|NCT01680965|12035763|FG001|Overall Study|Death|0
7624611|NCT01680965|12035764|FG002|Overall Study|Death|0
7624612|NCT01680965|12035765|FG003|Overall Study|Death|6
7624613|NCT00152477|12035811|FG000|Chemotherapy Period|Adverse Event|9
7764624|NCT00835731|12206469|FG000|Overall Study|Physician Decision|1
7764625|NCT00835731|12206470|FG001|Overall Study|Physician Decision|1
7764626|NCT00835770|12206478|FG000|Overall Study|MS Relapse|17
7764627|NCT00835770|12206479|FG001|Overall Study|MS Relapse|23
7764628|NCT00835770|12206478|FG000|Overall Study|MS Progression|14
7764629|NCT00835770|12206479|FG001|Overall Study|MS Progression|9
7764630|NCT00835770|12206478|FG000|Overall Study|Adverse Event|113
7764631|NCT00835770|12206479|FG001|Overall Study|Adverse Event|124
7764632|NCT00835770|12206478|FG000|Overall Study|Lost to Follow-up|22
7764633|NCT00835770|12206479|FG001|Overall Study|Lost to Follow-up|19
7764634|NCT00835770|12206478|FG000|Overall Study|Consent Withdrawn|144
7764635|NCT00835770|12206479|FG001|Overall Study|Consent Withdrawn|156
7764636|NCT00835770|12206478|FG000|Overall Study|Investigator Decision|42
7764637|NCT00835770|12206479|FG001|Overall Study|Investigator Decision|42
7764638|NCT00835770|12206478|FG000|Overall Study|Participant Non-Compliance|11
7764639|NCT00835770|12206479|FG001|Overall Study|Participant Non-Compliance|9
7764640|NCT00835770|12206478|FG000|Overall Study|Death|4
7764641|NCT00835770|12206479|FG001|Overall Study|Death|6
7764642|NCT00835770|12206478|FG000|Overall Study|Other|115
7764643|NCT00835770|12206479|FG001|Overall Study|Other|104
7764644|NCT00835770|12206478|FG000|Overall Study|Other|2
7764645|NCT00835770|12206479|FG001|Overall Study|Other|1
7764646|NCT00835978|12206522|FG000|Overall Study|Death|33
7764647|NCT00835978|12206523|FG001|Overall Study|Death|40
7764648|NCT00835978|12206524|FG002|Overall Study|Death|49
7764649|NCT00835978|12206525|FG003|Overall Study|Death|4
7764650|NCT00835978|12206522|FG000|Overall Study|Lost to Follow-up|3
7764651|NCT00835978|12206523|FG001|Overall Study|Lost to Follow-up|4
7764652|NCT00835978|12206524|FG002|Overall Study|Lost to Follow-up|2
7764653|NCT00835978|12206525|FG003|Overall Study|Lost to Follow-up|1
7764654|NCT00835978|12206522|FG000|Overall Study|Other|5
7764655|NCT00835978|12206523|FG001|Overall Study|Other|1
7764656|NCT00835978|12206524|FG002|Overall Study|Other|8
7764657|NCT00835978|12206525|FG003|Overall Study|Other|0
7764658|NCT00835978|12206522|FG000|Overall Study|Objective progression or relapse|2
7764659|NCT00835978|12206523|FG001|Overall Study|Objective progression or relapse|0
7764660|NCT00835978|12206524|FG002|Overall Study|Objective progression or relapse|1
7764661|NCT00835978|12206525|FG003|Overall Study|Objective progression or relapse|0
7764662|NCT00835978|12206522|FG000|Overall Study|Adverse Event|1
7764663|NCT00835978|12206523|FG001|Overall Study|Adverse Event|0
7764664|NCT00835978|12206524|FG002|Overall Study|Adverse Event|1
7764665|NCT00835978|12206525|FG003|Overall Study|Adverse Event|0
7764666|NCT00835978|12206522|FG000|Overall Study|Withdrawal by Subject|0
7764667|NCT00835978|12206523|FG001|Overall Study|Withdrawal by Subject|3
7764668|NCT00835978|12206524|FG002|Overall Study|Withdrawal by Subject|0
7764669|NCT00835978|12206525|FG003|Overall Study|Withdrawal by Subject|5
7764670|NCT00835978|12206522|FG000|Overall Study|Study terminated by sponsor|12
7764671|NCT00835978|12206523|FG001|Overall Study|Study terminated by sponsor|8
7764672|NCT00835978|12206524|FG002|Overall Study|Study terminated by sponsor|30
7764673|NCT00835978|12206525|FG003|Overall Study|Study terminated by sponsor|0
7764674|NCT00836095|12206546|FG000|Overall Study|Physician Decision|0
7764675|NCT00836095|12206547|FG001|Overall Study|Physician Decision|3
7764676|NCT00836186|12206553|FG000|Overall Study|Blood could not be drawn|1
7764677|NCT00836277|12206558|FG000|Overall Study|Not evaluable for response|6
7764678|NCT00836498|12206599|FG000|Overall Study|Adverse Event|1
7764679|NCT00836498|12206600|FG001|Overall Study|Adverse Event|0
7764680|NCT00836498|12206599|FG000|Overall Study|Lost to Follow-up|1
7764681|NCT00836498|12206600|FG001|Overall Study|Lost to Follow-up|0
7764682|NCT00836498|12206599|FG000|Overall Study|Withdrawal by Subject|2
7764683|NCT00836498|12206600|FG001|Overall Study|Withdrawal by Subject|1
7764684|NCT00836589|12206607|FG000|Overall Study|Lost to Follow-up|246
7764685|NCT00836589|12206607|FG000|Overall Study|Death|429
7764686|NCT00836589|12206607|FG000|Overall Study|Withdrawal by Subject or Physician|591
7770237|NCT00875420|12214201|FG001|Overall Study|Inability to complete study procedures|0
7770238|NCT00875420|12214202|FG002|Overall Study|Inability to complete study procedures|1
7770239|NCT00875420|12214203|FG003|Overall Study|Inability to complete study procedures|1
7770240|NCT00875420|12214204|FG004|Overall Study|Inability to complete study procedures|1
7770241|NCT00875420|12214200|FG000|Overall Study|Lost to Follow-up|1
7770242|NCT00875420|12214201|FG001|Overall Study|Lost to Follow-up|0
7770243|NCT00875420|12214202|FG002|Overall Study|Lost to Follow-up|0
7770244|NCT00875420|12214203|FG003|Overall Study|Lost to Follow-up|0
7770245|NCT00875420|12214204|FG004|Overall Study|Lost to Follow-up|0
7770246|NCT00875420|12214200|FG000|Overall Study|Personal reason|0
7770247|NCT00875420|12214201|FG001|Overall Study|Personal reason|0
7770248|NCT00875420|12214202|FG002|Overall Study|Personal reason|0
7770249|NCT00875420|12214203|FG003|Overall Study|Personal reason|0
7770250|NCT00875420|12214204|FG004|Overall Study|Personal reason|1
7770251|NCT00875420|12214200|FG000|Overall Study|Prohibited medication|0
7770252|NCT00875420|12214201|FG001|Overall Study|Prohibited medication|0
7770253|NCT00875420|12214202|FG002|Overall Study|Prohibited medication|0
7770254|NCT00875420|12214203|FG003|Overall Study|Prohibited medication|1
7770255|NCT00875420|12214204|FG004|Overall Study|Prohibited medication|0
7770256|NCT00875420|12214200|FG000|Overall Study|Sponsor decision|0
7770257|NCT00875420|12214201|FG001|Overall Study|Sponsor decision|1
7770258|NCT00875420|12214202|FG002|Overall Study|Sponsor decision|0
7770259|NCT00875420|12214203|FG003|Overall Study|Sponsor decision|0
7770260|NCT00875420|12214204|FG004|Overall Study|Sponsor decision|0
7770261|NCT00875420|12214200|FG000|Overall Study|Withdrawal by Subject|0
7770262|NCT00875420|12214201|FG001|Overall Study|Withdrawal by Subject|0
7770263|NCT00875420|12214202|FG002|Overall Study|Withdrawal by Subject|1
7770264|NCT00875420|12214203|FG003|Overall Study|Withdrawal by Subject|0
7770265|NCT00875420|12214204|FG004|Overall Study|Withdrawal by Subject|0
7770266|NCT00875433|12214216|FG000|Overall Study|Progressive disease|41
7770267|NCT00875433|12214216|FG000|Overall Study|Other Adverse Event|14
7770268|NCT00875433|12214216|FG000|Overall Study|Withdrawal by Subject|2
7770269|NCT00875433|12214216|FG000|Overall Study|Other|3
7770270|NCT00875485|12214222|FG000|Challenge Dose Epoch|Pregnancy|1
7770271|NCT00875485|12214223|FG001|Challenge Dose Epoch|Pregnancy|0
7770272|NCT00875563|12214240|FG000|Overall Study|Death|4
7770273|NCT00875563|12214240|FG000|Overall Study|Withdrawal by Subject|7
7770274|NCT00875563|12214240|FG000|Overall Study|No long-term (3-5 year) consent|6
7770275|NCT00875563|12214240|FG000|Overall Study|Still be eligible for follow-up|7
7770276|NCT00875615|12214253|FG000|Overall Study|Withdrawal by Subject|1
7770277|NCT00875667|12214272|FG000|Overall Study|Adverse Event|29
7770278|NCT00875667|12214273|FG001|Overall Study|Adverse Event|10
7770279|NCT00875667|12214272|FG000|Overall Study|Withdrawal by Subject|17
7770280|NCT00875667|12214273|FG001|Overall Study|Withdrawal by Subject|5
7770281|NCT00875667|12214272|FG000|Overall Study|Death|7
7770282|NCT00875667|12214273|FG001|Overall Study|Death|2
7770283|NCT00875667|12214272|FG000|Overall Study|Protocol Violation|2
7770284|NCT00875667|12214273|FG001|Overall Study|Protocol Violation|0
7770285|NCT00875667|12214272|FG000|Overall Study|Disease Progression|100
7770286|NCT00875667|12214273|FG001|Overall Study|Disease Progression|49
7770287|NCT00875667|12214272|FG000|Overall Study|Miscellaneous|12
7770288|NCT00875667|12214273|FG001|Overall Study|Miscellaneous|6
7770289|NCT00875667|12214272|FG000|Overall Study|Randomized but no Study Drug Given|3
7770290|NCT00875667|12214273|FG001|Overall Study|Randomized but no Study Drug Given|1
7770291|NCT00875706|12214282|FG000|Overall Study|Withdrawal by Subject|1
7770292|NCT00875706|12214283|FG001|Overall Study|Withdrawal by Subject|0
7770293|NCT00875706|12214284|FG002|Overall Study|Withdrawal by Subject|0
7770294|NCT00875797|12214294|FG000|Overall Study|Protocol Violation|6
7770295|NCT00875797|12214295|FG001|Overall Study|Protocol Violation|3
7770296|NCT00875810|12214304|FG000|Overall Study|Withdrawal by Subject|1
7764687|NCT00836693|12206629|FG000|Overall Study|Adverse Event|4
7764688|NCT00836693|12206630|FG001|Overall Study|Adverse Event|1
7764689|NCT00836693|12206629|FG000|Overall Study|Sponsor Decision|0
7764690|NCT00836693|12206630|FG001|Overall Study|Sponsor Decision|1
7764691|NCT00836693|12206629|FG000|Overall Study|Physician Decision|2
7764692|NCT00836693|12206630|FG001|Overall Study|Physician Decision|0
7764693|NCT00836693|12206629|FG000|Overall Study|Withdrawal by Subject|9
7764694|NCT00836693|12206630|FG001|Overall Study|Withdrawal by Subject|4
7764695|NCT00836693|12206629|FG000|Overall Study|Protocol Violation|1
7764696|NCT00836693|12206630|FG001|Overall Study|Protocol Violation|0
7764697|NCT00836693|12206629|FG000|Overall Study|Lost to Follow-up|1
7764698|NCT00836693|12206630|FG001|Overall Study|Lost to Follow-up|0
7764699|NCT00836745|12206640|FG000|Overall Study|Death|2
7764700|NCT00836745|12206640|FG000|Overall Study|Lost to Follow-up|10
7764701|NCT00836745|12206640|FG000|Overall Study|Adverse Event|3
7764702|NCT00836745|12206640|FG000|Overall Study|Objective progression or relapse|4
7764703|NCT00836745|12206640|FG000|Overall Study|Other|2
7764704|NCT00836875|12206652|FG000|Overall Study|Death|3
7764705|NCT00836875|12206653|FG001|Overall Study|Death|2
7764706|NCT00836875|12206652|FG000|Overall Study|Withdrawal by Subject|0
7764707|NCT00836875|12206653|FG001|Overall Study|Withdrawal by Subject|1
7764708|NCT00836927|12206681|FG000|Overall Study|Progressive disease|2
7764709|NCT00836927|12206682|FG001|Overall Study|Progressive disease|0
7764710|NCT00836927|12206683|FG002|Overall Study|Progressive disease|0
7764711|NCT00836927|12206684|FG003|Overall Study|Progressive disease|1
7764712|NCT00836927|12206685|FG004|Overall Study|Progressive disease|1
7764713|NCT00836927|12206681|FG000|Overall Study|Withdrawal by Subject|1
7764714|NCT00836927|12206682|FG001|Overall Study|Withdrawal by Subject|0
7764715|NCT00836927|12206683|FG002|Overall Study|Withdrawal by Subject|0
7764716|NCT00836927|12206684|FG003|Overall Study|Withdrawal by Subject|0
7764717|NCT00836927|12206685|FG004|Overall Study|Withdrawal by Subject|0
7764718|NCT00836953|12206699|FG000|Overall Study|Withdrawal by Subject|1
7764719|NCT00836953|12206699|FG000|Overall Study|Lost to Follow-up|1
7764720|NCT00837148|12206707|FG000|Overall Study|Adverse Event|1
7764721|NCT00837148|12206707|FG000|Overall Study|Death|1
7764722|NCT00837161|12206711|FG000|Overall Study|refused hysterectomy|2
7764723|NCT00837213|12206721|FG000|Overall Study|Lost to Follow-up|3
7764724|NCT00837213|12206722|FG001|Overall Study|Lost to Follow-up|2
7764725|NCT00837213|12206721|FG000|Overall Study|Withdrawal by Subject|2
7764726|NCT00837213|12206722|FG001|Overall Study|Withdrawal by Subject|2
7764727|NCT00837213|12206721|FG000|Overall Study|not stated|1
7764728|NCT00837213|12206722|FG001|Overall Study|not stated|1
7764729|NCT00837330|12206734|FG000|Overall Study|Lost to Follow-up|1
7764730|NCT00837330|12206735|FG001|Overall Study|Lost to Follow-up|3
7764731|NCT00837434|12206743|FG000|Overall Study|Physician Decision|3
7764732|NCT00837434|12206744|FG001|Overall Study|Physician Decision|0
7764733|NCT00837434|12206743|FG000|Overall Study|Lost to Follow-up|1
7764734|NCT00837434|12206744|FG001|Overall Study|Lost to Follow-up|1
7764735|NCT00837434|12206743|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1
7764736|NCT00837434|12206744|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0
7764737|NCT00837434|12206743|FG000|Overall Study|Noncompliant|2
7764738|NCT00837434|12206744|FG001|Overall Study|Noncompliant|0
7764739|NCT00837434|12206743|FG000|Overall Study|Baseline assessments not done in time|1
7764740|NCT00837434|12206744|FG001|Overall Study|Baseline assessments not done in time|0
7764741|NCT00837434|12206743|FG000|Overall Study|Unable to obtain study drug|1
7764742|NCT00837434|12206744|FG001|Overall Study|Unable to obtain study drug|0
7764743|NCT00837473|12206755|FG000|Overall Study|Lost to Follow-up|1
7764744|NCT00837473|12206755|FG000|Overall Study|Withdrawal by Subject|2
7764745|NCT00837486|12206761|FG000|Blinded-treatment Phase|Physician Decision|1
7764746|NCT00837486|12206762|FG001|Blinded-treatment Phase|Physician Decision|0
7624614|NCT00152477|12035812|FG001|Chemotherapy Period|Adverse Event|4
7624615|NCT00152477|12035813|FG002|Chemotherapy Period|Adverse Event|5
7624616|NCT00152477|12035811|FG000|Chemotherapy Period|Death|1
7624617|NCT00152477|12035812|FG001|Chemotherapy Period|Death|3
7624618|NCT00152477|12035813|FG002|Chemotherapy Period|Death|3
7624619|NCT00152477|12035811|FG000|Chemotherapy Period|Lack of Efficacy|4
7624620|NCT00152477|12035812|FG001|Chemotherapy Period|Lack of Efficacy|5
7624621|NCT00152477|12035813|FG002|Chemotherapy Period|Lack of Efficacy|6
7624622|NCT00152477|12035811|FG000|Chemotherapy Period|Lost to Follow-up|1
7624623|NCT00152477|12035812|FG001|Chemotherapy Period|Lost to Follow-up|0
7624624|NCT00152477|12035813|FG002|Chemotherapy Period|Lost to Follow-up|1
7624625|NCT00152477|12035811|FG000|Chemotherapy Period|Protocol Violation|1
7624626|NCT00152477|12035812|FG001|Chemotherapy Period|Protocol Violation|1
7624627|NCT00152477|12035813|FG002|Chemotherapy Period|Protocol Violation|0
7624628|NCT00152477|12035811|FG000|Chemotherapy Period|Withdrawal by Subject|5
7624629|NCT00152477|12035812|FG001|Chemotherapy Period|Withdrawal by Subject|1
7624630|NCT00152477|12035813|FG002|Chemotherapy Period|Withdrawal by Subject|0
7624631|NCT00152477|12035811|FG000|Chemotherapy Period|Progression of Disease|6
7624632|NCT00152477|12035812|FG001|Chemotherapy Period|Progression of Disease|8
7624633|NCT00152477|12035813|FG002|Chemotherapy Period|Progression of Disease|4
7624634|NCT00152477|12035811|FG000|Chemotherapy Period|Investigator decision|0
7624635|NCT00152477|12035812|FG001|Chemotherapy Period|Investigator decision|0
7624636|NCT00152477|12035813|FG002|Chemotherapy Period|Investigator decision|1
7624637|NCT00152477|12035811|FG000|Chemotherapy Period|Patient condition worsened|1
7764747|NCT00837486|12206761|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2
7764748|NCT00837486|12206762|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0
7764749|NCT00837486|12206761|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
7764750|NCT00837486|12206762|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
7764751|NCT00837486|12206761|FG000|Long-term Follow-up Phase - Open Label|Death|1
7764752|NCT00837486|12206762|FG001|Long-term Follow-up Phase - Open Label|Death|0
7770297|NCT00875810|12214304|FG000|Overall Study|Physician Decision|3
7764753|NCT00837577|12206779|FG000|Double-blind Period|Clinical Adverse Event|1
7764754|NCT00837577|12206780|FG001|Double-blind Period|Clinical Adverse Event|0
7624638|NCT00152477|12035812|FG001|Chemotherapy Period|Patient condition worsened|0
7624639|NCT00152477|12035813|FG002|Chemotherapy Period|Patient condition worsened|0
7624640|NCT00152477|12035811|FG000|Monotherapy Period|Adverse Event|1
7624641|NCT00152477|12035812|FG001|Monotherapy Period|Adverse Event|0
7624642|NCT00152477|12035813|FG002|Monotherapy Period|Adverse Event|5
7624643|NCT00152477|12035811|FG000|Monotherapy Period|Death|2
7624644|NCT00152477|12035812|FG001|Monotherapy Period|Death|0
7624645|NCT00152477|12035813|FG002|Monotherapy Period|Death|1
7624646|NCT00152477|12035811|FG000|Monotherapy Period|Lack of Efficacy|7
7764755|NCT00837577|12206779|FG000|Double-blind Period|Withdrawal by Subject|1
7764756|NCT00837577|12206780|FG001|Double-blind Period|Withdrawal by Subject|0
7764757|NCT00837577|12206779|FG000|Open-label Period|Clinical Adverse Event|2
7764758|NCT00837577|12206780|FG001|Open-label Period|Clinical Adverse Event|2
7764759|NCT00837577|12206779|FG000|Open-label Period|Laboratory Adverse Event|0
7764760|NCT00837577|12206780|FG001|Open-label Period|Laboratory Adverse Event|1
7764761|NCT00837577|12206779|FG000|Open-label Period|Lack of Efficacy|4
7764762|NCT00837577|12206780|FG001|Open-label Period|Lack of Efficacy|3
7764763|NCT00837577|12206779|FG000|Open-label Period|Withdrawal by Subject|1
7764764|NCT00837577|12206780|FG001|Open-label Period|Withdrawal by Subject|2
7764765|NCT00837577|12206779|FG000|Open-label Period|Other Reason|1
7764766|NCT00837577|12206780|FG001|Open-label Period|Other Reason|1
7624647|NCT00152477|12035812|FG001|Monotherapy Period|Lack of Efficacy|16
7624648|NCT00152477|12035813|FG002|Monotherapy Period|Lack of Efficacy|10
7624649|NCT00152477|12035811|FG000|Monotherapy Period|Protocol Violation|0
7624650|NCT00152477|12035812|FG001|Monotherapy Period|Protocol Violation|1
7624651|NCT00152477|12035813|FG002|Monotherapy Period|Protocol Violation|0
7624652|NCT00152477|12035811|FG000|Monotherapy Period|Withdrawal by Subject|0
7624653|NCT00152477|12035812|FG001|Monotherapy Period|Withdrawal by Subject|0
7624654|NCT00152477|12035813|FG002|Monotherapy Period|Withdrawal by Subject|4
7624655|NCT00152477|12035811|FG000|Monotherapy Period|Progression of Disease|5
7624656|NCT00152477|12035812|FG001|Monotherapy Period|Progression of Disease|11
7624657|NCT00152477|12035813|FG002|Monotherapy Period|Progression of Disease|12
7624658|NCT00152477|12035811|FG000|Monotherapy Period|Patient decision|0
7624659|NCT00152477|12035812|FG001|Monotherapy Period|Patient decision|1
7624660|NCT00152477|12035813|FG002|Monotherapy Period|Patient decision|1
7624661|NCT00152477|12035811|FG000|Monotherapy Period|Study personel decision|0
7624662|NCT00152477|12035812|FG001|Monotherapy Period|Study personel decision|0
7624663|NCT00152477|12035813|FG002|Monotherapy Period|Study personel decision|1
7624664|NCT04585646|12035824|FG000|First Intervention|Physician Decision|1
7624665|NCT04585646|12035825|FG001|First Intervention|Physician Decision|0
7624666|NCT04585646|12035824|FG000|First Intervention|Lost to Follow-up|0
7624667|NCT04585646|12035825|FG001|First Intervention|Lost to Follow-up|3
7624668|NCT04585646|12035824|FG000|First Intervention|Withdrawal by Subject|0
7624669|NCT04585646|12035825|FG001|First Intervention|Withdrawal by Subject|1
7624670|NCT04451330|12035834|FG000|Overall Study|Adverse Event|1
7624671|NCT04451330|12035835|FG001|Overall Study|Adverse Event|2
7624672|NCT04451330|12035834|FG000|Overall Study|Lost to Follow-up|5
7624673|NCT04451330|12035835|FG001|Overall Study|Lost to Follow-up|0
7624674|NCT04451330|12035834|FG000|Overall Study|Withdrawal by Subject|3
7624675|NCT04451330|12035835|FG001|Overall Study|Withdrawal by Subject|1
7624676|NCT04451330|12035834|FG000|Overall Study|Withdrawal by parent/guardian|1
7624677|NCT04451330|12035835|FG001|Overall Study|Withdrawal by parent/guardian|0
7624678|NCT04451330|12035834|FG000|Overall Study|Other than specified|0
7624679|NCT04451330|12035835|FG001|Overall Study|Other than specified|1
7624680|NCT04003623|12035895|FG000|Overall Study|Withdrawal by Subject|1
7624681|NCT04003623|12035896|FG001|Overall Study|Withdrawal by Subject|0
7624682|NCT03828383|12035914|FG000|Overall Study|Lost to Follow-up|3
7624683|NCT03828383|12035915|FG001|Overall Study|Lost to Follow-up|2
7624684|NCT03828383|12035914|FG000|Overall Study|Withdrawal by Subject|4
7624685|NCT03828383|12035915|FG001|Overall Study|Withdrawal by Subject|5
7764767|NCT00837616|12206802|FG000|Overall Study|Withdrawal by Subject|0
7764768|NCT00837616|12206803|FG001|Overall Study|Withdrawal by Subject|1
7764769|NCT00837694|12206815|FG000|Overall Study|Lost to Follow-up|2
7764770|NCT00837694|12206816|FG001|Overall Study|Lost to Follow-up|0
7764771|NCT00837694|12206817|FG002|Overall Study|Lost to Follow-up|2
7764772|NCT00837694|12206818|FG003|Overall Study|Lost to Follow-up|1
7764773|NCT00837694|12206819|FG004|Overall Study|Lost to Follow-up|1
7764774|NCT00837694|12206820|FG005|Overall Study|Lost to Follow-up|1
7764775|NCT00837759|12206834|FG000|Overall Study|Protocol Violation|3
7764776|NCT00837759|12206834|FG000|Overall Study|Lost to Follow-up|1
7764777|NCT00837811|12206841|FG000|Overall Study|Adverse Event|4
7764778|NCT00837811|12206842|FG001|Overall Study|Adverse Event|6
7764779|NCT00837811|12206843|FG002|Overall Study|Adverse Event|0
7764780|NCT00837811|12206841|FG000|Overall Study|Death|1
7764781|NCT00837811|12206842|FG001|Overall Study|Death|1
7764782|NCT00837811|12206843|FG002|Overall Study|Death|0
7764783|NCT00837811|12206841|FG000|Overall Study|Lack of Efficacy|0
7764784|NCT00837811|12206842|FG001|Overall Study|Lack of Efficacy|11
7764785|NCT00837811|12206843|FG002|Overall Study|Lack of Efficacy|0
7764786|NCT00837811|12206841|FG000|Overall Study|Lost to Follow-up|1
7764787|NCT00837811|12206842|FG001|Overall Study|Lost to Follow-up|3
7764788|NCT00837811|12206843|FG002|Overall Study|Lost to Follow-up|0
7764789|NCT00837811|12206841|FG000|Overall Study|Physician Decision|0
7764790|NCT00837811|12206842|FG001|Overall Study|Physician Decision|2
7764791|NCT00837811|12206843|FG002|Overall Study|Physician Decision|1
7764792|NCT00837811|12206841|FG000|Overall Study|Withdrawal by Subject|1
7764793|NCT00837811|12206842|FG001|Overall Study|Withdrawal by Subject|9
7764794|NCT00837811|12206843|FG002|Overall Study|Withdrawal by Subject|0
7764795|NCT00837811|12206841|FG000|Overall Study|Sponsor Decision|0
7764796|NCT00837811|12206842|FG001|Overall Study|Sponsor Decision|2
7764797|NCT00837811|12206843|FG002|Overall Study|Sponsor Decision|0
7764798|NCT00837876|12206870|FG000|Overall Study|Death|2
7764799|NCT00837876|12206870|FG000|Overall Study|Adverse Event|7
7624719|NCT03717480|12035931|FG000|Overall Study|Never received investigational product due to product viability limitations.|1
7624720|NCT03615066|12035938|FG000|Main Study|Withdrew Consent|0
7624721|NCT03615066|12035939|FG001|Main Study|Withdrew Consent|1
7624722|NCT03615066|12035940|FG002|Main Study|Withdrew Consent|1
7624723|NCT03615066|12035938|FG000|Main Study|Lost to Follow-up|0
7624724|NCT03615066|12035939|FG001|Main Study|Lost to Follow-up|0
7624725|NCT03615066|12035940|FG002|Main Study|Lost to Follow-up|1
7624726|NCT03615066|12035938|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1
7624727|NCT03615066|12035939|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0
7624728|NCT03615066|12035940|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0
7624729|NCT03615066|12035938|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1
7624730|NCT03615066|12035939|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0
7624731|NCT03615066|12035940|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0
7624732|NCT03615066|12035938|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0
7624733|NCT03615066|12035939|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1
7624734|NCT03615066|12035940|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0
7624735|NCT03557931|12035955|FG000|Overall Study|Adverse Event|4
7624736|NCT03557931|12035956|FG001|Overall Study|Adverse Event|6
7624737|NCT03557931|12035957|FG002|Overall Study|Adverse Event|1
7624738|NCT03557931|12035955|FG000|Overall Study|Lost to Follow-up|4
7624739|NCT03557931|12035956|FG001|Overall Study|Lost to Follow-up|4
7624740|NCT03557931|12035957|FG002|Overall Study|Lost to Follow-up|1
7624741|NCT03557931|12035955|FG000|Overall Study|Protocol Violation|1
7624742|NCT03557931|12035956|FG001|Overall Study|Protocol Violation|4
7624743|NCT03557931|12035957|FG002|Overall Study|Protocol Violation|1
7624744|NCT03557931|12035955|FG000|Overall Study|Withdrawal by Subject|14
7624745|NCT03557931|12035956|FG001|Overall Study|Withdrawal by Subject|0
7624746|NCT03557931|12035957|FG002|Overall Study|Withdrawal by Subject|7
7624747|NCT03557931|12035955|FG000|Overall Study|Miscellaneous|8
7624748|NCT03557931|12035956|FG001|Overall Study|Miscellaneous|5
7624749|NCT03557931|12035957|FG002|Overall Study|Miscellaneous|3
7624750|NCT02596035|12035979|FG000|Overall Study|Disease Progression|62
7624751|NCT02596035|12035980|FG001|Overall Study|Disease Progression|32
7624752|NCT02596035|12035981|FG002|Overall Study|Disease Progression|1
7624753|NCT02596035|12035979|FG000|Overall Study|Study Drug Toxicity|11
7624754|NCT02596035|12035980|FG001|Overall Study|Study Drug Toxicity|3
7764800|NCT00837876|12206870|FG000|Overall Study|Physician Decision|1
7764801|NCT00837876|12206870|FG000|Overall Study|Withdrawal by Subject|3
7764802|NCT00837876|12206870|FG000|Overall Study|disease progression|24
7764803|NCT00837967|12206884|FG000|Washout Period of 7 - 14 Days|Adverse Event|2
7764804|NCT00837967|12206885|FG001|Washout Period of 7 - 14 Days|Adverse Event|0
7764805|NCT00838097|12206906|FG000|Overall Study|Ineligibility determined|6
7624755|NCT02596035|12035981|FG002|Overall Study|Study Drug Toxicity|0
7624756|NCT02596035|12035979|FG000|Overall Study|Adverse Event|6
7624757|NCT02596035|12035980|FG001|Overall Study|Adverse Event|2
7624758|NCT02596035|12035981|FG002|Overall Study|Adverse Event|0
7624759|NCT02596035|12035979|FG000|Overall Study|Withdrawal by Subject|4
7624760|NCT02596035|12035980|FG001|Overall Study|Withdrawal by Subject|2
7624761|NCT02596035|12035981|FG002|Overall Study|Withdrawal by Subject|0
7624762|NCT02596035|12035979|FG000|Overall Study|Poor/Non-Compliance|0
7624763|NCT02596035|12035980|FG001|Overall Study|Poor/Non-Compliance|1
7624764|NCT02596035|12035981|FG002|Overall Study|Poor/Non-Compliance|0
7624765|NCT02596035|12035979|FG000|Overall Study|Other Reasons|3
7624766|NCT02596035|12035980|FG001|Overall Study|Other Reasons|4
7624767|NCT02596035|12035981|FG002|Overall Study|Other Reasons|0
7764806|NCT00838097|12206906|FG000|Overall Study|Adverse Event|2
7764807|NCT00838097|12206906|FG000|Overall Study|Withdrawal by Subject|3
7764808|NCT00838097|12206906|FG000|Overall Study|Requirement for alternative therapy|2
7764809|NCT00838097|12206906|FG000|Overall Study|Physician Decision|4
7764810|NCT00838097|12206906|FG000|Overall Study|Lost to Follow-up|11
7764811|NCT00838097|12206906|FG000|Overall Study|Death|6
7764812|NCT00838097|12206906|FG000|Overall Study|Protocol-specified criteria|142
7764813|NCT00838110|12206912|FG000|Overall Study|Death|0
7764814|NCT00838110|12206913|FG001|Overall Study|Death|0
7764815|NCT00838110|12206914|FG002|Overall Study|Death|1
7764816|NCT00838110|12206915|FG003|Overall Study|Death|2
7764817|NCT00838110|12206912|FG000|Overall Study|Adverse Event|11
7764818|NCT00838110|12206913|FG001|Overall Study|Adverse Event|10
7764819|NCT00838110|12206914|FG002|Overall Study|Adverse Event|8
7764820|NCT00838110|12206915|FG003|Overall Study|Adverse Event|7
7764821|NCT00838110|12206912|FG000|Overall Study|Withdrawal by Subject|5
7764822|NCT00838110|12206913|FG001|Overall Study|Withdrawal by Subject|6
7764823|NCT00838110|12206914|FG002|Overall Study|Withdrawal by Subject|3
7764824|NCT00838110|12206915|FG003|Overall Study|Withdrawal by Subject|4
7764825|NCT00838110|12206912|FG000|Overall Study|Other|3
7764826|NCT00838110|12206913|FG001|Overall Study|Other|3
7764827|NCT00838110|12206914|FG002|Overall Study|Other|3
7764828|NCT00838110|12206915|FG003|Overall Study|Other|2
7764829|NCT00838110|12206912|FG000|Overall Study|Protocol Violation|0
7764830|NCT00838110|12206913|FG001|Overall Study|Protocol Violation|2
7764831|NCT00838110|12206914|FG002|Overall Study|Protocol Violation|1
7764832|NCT00838110|12206915|FG003|Overall Study|Protocol Violation|1
7764833|NCT00838110|12206912|FG000|Overall Study|Lost to Follow-up|3
7764834|NCT00838110|12206913|FG001|Overall Study|Lost to Follow-up|0
7764835|NCT00838110|12206914|FG002|Overall Study|Lost to Follow-up|0
7764836|NCT00838110|12206915|FG003|Overall Study|Lost to Follow-up|0
7764837|NCT00838110|12206912|FG000|Overall Study|Did not meet eligibility criteria|0
7764838|NCT00838110|12206913|FG001|Overall Study|Did not meet eligibility criteria|0
7764839|NCT00838110|12206914|FG002|Overall Study|Did not meet eligibility criteria|1
7764840|NCT00838110|12206915|FG003|Overall Study|Did not meet eligibility criteria|2
7764841|NCT00838110|12206912|FG000|Overall Study|Randomized but not treated|0
7764842|NCT00838110|12206913|FG001|Overall Study|Randomized but not treated|1
7764843|NCT00838110|12206914|FG002|Overall Study|Randomized but not treated|0
7764844|NCT00838110|12206915|FG003|Overall Study|Randomized but not treated|0
7764845|NCT00838201|12206944|FG000|Overall Study|Investigator decision, or other reasons|2
7764846|NCT00838201|12206945|FG001|Overall Study|Investigator decision, or other reasons|3
7764847|NCT00838201|12206944|FG000|Overall Study|Noncompliance|0
7624807|NCT02318095|12036004|FG000|Overall Study|Adverse Event|1
7624808|NCT02155647|12036011|FG000|Overall Study|Still on Treatment|26
7624809|NCT02155647|12036012|FG001|Overall Study|Still on Treatment|26
7624810|NCT02155647|12036011|FG000|Overall Study|Off-Treatment, but follow up ongoing|15
7624811|NCT02155647|12036012|FG001|Overall Study|Off-Treatment, but follow up ongoing|26
7624812|NCT01904903|12036035|FG000|Overall Study|Withdrawal by Subject|1
7624813|NCT01827384|12036053|FG000|Overall Study|Switched to alternative treatment|0
7624814|NCT01827384|12036054|FG001|Overall Study|Switched to alternative treatment|0
7624815|NCT01827384|12036055|FG002|Overall Study|Switched to alternative treatment|0
7624816|NCT01827384|12036056|FG003|Overall Study|Switched to alternative treatment|0
7624817|NCT01827384|12036057|FG004|Overall Study|Switched to alternative treatment|0
7624818|NCT01827384|12036058|FG005|Overall Study|Switched to alternative treatment|0
7624819|NCT01827384|12036059|FG006|Overall Study|Switched to alternative treatment|0
7624820|NCT01827384|12036060|FG007|Overall Study|Switched to alternative treatment|0
7624821|NCT01827384|12036061|FG008|Overall Study|Switched to alternative treatment|0
7624822|NCT01827384|12036062|FG009|Overall Study|Switched to alternative treatment|0
7624823|NCT01827384|12036063|FG010|Overall Study|Switched to alternative treatment|0
7624824|NCT01827384|12036064|FG011|Overall Study|Switched to alternative treatment|0
7624825|NCT01827384|12036065|FG012|Overall Study|Switched to alternative treatment|0
7624826|NCT01827384|12036066|FG013|Overall Study|Switched to alternative treatment|2
7624827|NCT01827384|12036053|FG000|Overall Study|Disease progression before treatment|0
7624828|NCT01827384|12036054|FG001|Overall Study|Disease progression before treatment|0
7624829|NCT01827384|12036055|FG002|Overall Study|Disease progression before treatment|0
7624830|NCT01827384|12036056|FG003|Overall Study|Disease progression before treatment|0
7624831|NCT01827384|12036057|FG004|Overall Study|Disease progression before treatment|0
7624832|NCT01827384|12036058|FG005|Overall Study|Disease progression before treatment|0
7624833|NCT01827384|12036059|FG006|Overall Study|Disease progression before treatment|0
7624834|NCT01827384|12036060|FG007|Overall Study|Disease progression before treatment|0
7624835|NCT01827384|12036061|FG008|Overall Study|Disease progression before treatment|0
7624836|NCT01827384|12036062|FG009|Overall Study|Disease progression before treatment|0
7624837|NCT01827384|12036063|FG010|Overall Study|Disease progression before treatment|0
7624838|NCT01827384|12036064|FG011|Overall Study|Disease progression before treatment|0
7624839|NCT01827384|12036065|FG012|Overall Study|Disease progression before treatment|0
7624840|NCT01827384|12036066|FG013|Overall Study|Disease progression before treatment|4
7624841|NCT01827384|12036053|FG000|Overall Study|Ineligible|0
7624842|NCT01827384|12036054|FG001|Overall Study|Ineligible|0
7624843|NCT01827384|12036055|FG002|Overall Study|Ineligible|0
7624844|NCT01827384|12036056|FG003|Overall Study|Ineligible|0
7624845|NCT01827384|12036057|FG004|Overall Study|Ineligible|0
7624846|NCT01827384|12036058|FG005|Overall Study|Ineligible|0
7624847|NCT01827384|12036059|FG006|Overall Study|Ineligible|0
7624848|NCT01827384|12036060|FG007|Overall Study|Ineligible|0
7624849|NCT01827384|12036061|FG008|Overall Study|Ineligible|0
7624850|NCT01827384|12036062|FG009|Overall Study|Ineligible|0
7624851|NCT01827384|12036063|FG010|Overall Study|Ineligible|0
7624852|NCT01827384|12036064|FG011|Overall Study|Ineligible|0
7624853|NCT01827384|12036065|FG012|Overall Study|Ineligible|0
7624854|NCT01827384|12036066|FG013|Overall Study|Ineligible|19
7624855|NCT01827384|12036053|FG000|Overall Study|Participant died before treatment|0
7624856|NCT01827384|12036054|FG001|Overall Study|Participant died before treatment|0
7624857|NCT01827384|12036055|FG002|Overall Study|Participant died before treatment|0
7624858|NCT01827384|12036056|FG003|Overall Study|Participant died before treatment|0
7624859|NCT01827384|12036057|FG004|Overall Study|Participant died before treatment|0
7624860|NCT01827384|12036058|FG005|Overall Study|Participant died before treatment|0
7624861|NCT01827384|12036059|FG006|Overall Study|Participant died before treatment|0
7624862|NCT01827384|12036060|FG007|Overall Study|Participant died before treatment|0
7624863|NCT01827384|12036061|FG008|Overall Study|Participant died before treatment|0
7624864|NCT01827384|12036062|FG009|Overall Study|Participant died before treatment|0
7624865|NCT01827384|12036063|FG010|Overall Study|Participant died before treatment|0
7624866|NCT01827384|12036064|FG011|Overall Study|Participant died before treatment|0
7624867|NCT01827384|12036065|FG012|Overall Study|Participant died before treatment|0
7624868|NCT01827384|12036066|FG013|Overall Study|Participant died before treatment|5
7624869|NCT01827384|12036053|FG000|Overall Study|Insufficient tumor cells|0
7624870|NCT01827384|12036054|FG001|Overall Study|Insufficient tumor cells|0
7624871|NCT01827384|12036055|FG002|Overall Study|Insufficient tumor cells|0
7624872|NCT01827384|12036056|FG003|Overall Study|Insufficient tumor cells|0
7624873|NCT01827384|12036057|FG004|Overall Study|Insufficient tumor cells|0
7624874|NCT01827384|12036058|FG005|Overall Study|Insufficient tumor cells|0
7624875|NCT01827384|12036059|FG006|Overall Study|Insufficient tumor cells|0
7624876|NCT01827384|12036060|FG007|Overall Study|Insufficient tumor cells|0
7624877|NCT01827384|12036061|FG008|Overall Study|Insufficient tumor cells|0
7624878|NCT01827384|12036062|FG009|Overall Study|Insufficient tumor cells|0
7624879|NCT01827384|12036063|FG010|Overall Study|Insufficient tumor cells|0
7624880|NCT01827384|12036064|FG011|Overall Study|Insufficient tumor cells|0
7624881|NCT01827384|12036065|FG012|Overall Study|Insufficient tumor cells|0
7624882|NCT01827384|12036066|FG013|Overall Study|Insufficient tumor cells|13
7624883|NCT01827384|12036053|FG000|Overall Study|No actionable mutation|0
7624884|NCT01827384|12036054|FG001|Overall Study|No actionable mutation|0
7624885|NCT01827384|12036055|FG002|Overall Study|No actionable mutation|0
7624886|NCT01827384|12036056|FG003|Overall Study|No actionable mutation|0
7624887|NCT01827384|12036057|FG004|Overall Study|No actionable mutation|0
7624888|NCT01827384|12036058|FG005|Overall Study|No actionable mutation|0
7624889|NCT01827384|12036059|FG006|Overall Study|No actionable mutation|0
7624890|NCT01827384|12036060|FG007|Overall Study|No actionable mutation|0
7624891|NCT01827384|12036061|FG008|Overall Study|No actionable mutation|0
7624892|NCT01827384|12036062|FG009|Overall Study|No actionable mutation|0
7624893|NCT01827384|12036063|FG010|Overall Study|No actionable mutation|0
7624894|NCT01827384|12036064|FG011|Overall Study|No actionable mutation|0
7624895|NCT01827384|12036065|FG012|Overall Study|No actionable mutation|0
7624896|NCT01827384|12036066|FG013|Overall Study|No actionable mutation|73
7624897|NCT01827384|12036053|FG000|Overall Study|Participant declined to participate (before treatment started)|0
7624898|NCT01827384|12036054|FG001|Overall Study|Participant declined to participate (before treatment started)|0
7624899|NCT01827384|12036055|FG002|Overall Study|Participant declined to participate (before treatment started)|0
7624900|NCT01827384|12036056|FG003|Overall Study|Participant declined to participate (before treatment started)|0
7624901|NCT01827384|12036057|FG004|Overall Study|Participant declined to participate (before treatment started)|0
7624902|NCT01827384|12036058|FG005|Overall Study|Participant declined to participate (before treatment started)|0
7624903|NCT01827384|12036059|FG006|Overall Study|Participant declined to participate (before treatment started)|0
7624904|NCT01827384|12036060|FG007|Overall Study|Participant declined to participate (before treatment started)|0
7624905|NCT01827384|12036061|FG008|Overall Study|Participant declined to participate (before treatment started)|0
7764848|NCT00838201|12206945|FG001|Overall Study|Noncompliance|1
7764849|NCT00838201|12206944|FG000|Overall Study|Administrative decision|1
7764850|NCT00838201|12206945|FG001|Overall Study|Administrative decision|2
7764851|NCT00838201|12206944|FG000|Overall Study|Disease progression|3
7764852|NCT00838201|12206945|FG001|Overall Study|Disease progression|3
7764853|NCT00838201|12206944|FG000|Overall Study|Consent withdrawn|16
7764854|NCT00838201|12206945|FG001|Overall Study|Consent withdrawn|19
7764855|NCT00838201|12206944|FG000|Overall Study|Lost to Follow-up|4
7764856|NCT00838201|12206945|FG001|Overall Study|Lost to Follow-up|3
7764857|NCT00838201|12206944|FG000|Overall Study|Adverse Event|5
7764858|NCT00838201|12206945|FG001|Overall Study|Adverse Event|9
7624906|NCT01827384|12036062|FG009|Overall Study|Participant declined to participate (before treatment started)|0
7624907|NCT01827384|12036063|FG010|Overall Study|Participant declined to participate (before treatment started)|0
7624908|NCT01827384|12036064|FG011|Overall Study|Participant declined to participate (before treatment started)|0
7624909|NCT01827384|12036065|FG012|Overall Study|Participant declined to participate (before treatment started)|0
7764859|NCT00838201|12206944|FG000|Overall Study|Death|11
7764860|NCT00838201|12206945|FG001|Overall Study|Death|13
7624910|NCT01827384|12036066|FG013|Overall Study|Participant declined to participate (before treatment started)|15
7624911|NCT01636258|12036102|FG000|Overall Study|Lost to Follow-up|1
7624912|NCT01636258|12036103|FG001|Overall Study|Lost to Follow-up|0
7624913|NCT01517802|12036164|FG000|Overall Study|Death|1
7624914|NCT00455325|12036168|FG000|Cohort 1: Placebo|Started exclusionary drug|1
7624915|NCT00455325|12036169|FG001|Cohort 1: Placebo|Started exclusionary drug|0
7624916|NCT00455325|12036170|FG002|Cohort 1: Placebo|Started exclusionary drug|0
7624917|NCT00455325|12036171|FG003|Cohort 1: Placebo|Started exclusionary drug|0
7624918|NCT00455325|12036168|FG000|Cohort 1: Placebo|Withdrawal by Subject|4
7624919|NCT00455325|12036169|FG001|Cohort 1: Placebo|Withdrawal by Subject|0
7624920|NCT00455325|12036170|FG002|Cohort 1: Placebo|Withdrawal by Subject|0
7624921|NCT00455325|12036171|FG003|Cohort 1: Placebo|Withdrawal by Subject|0
7624922|NCT00455325|12036168|FG000|Cohort 1: Placebo|Lost to Follow-up|1
7624923|NCT00455325|12036169|FG001|Cohort 1: Placebo|Lost to Follow-up|0
7624924|NCT00455325|12036170|FG002|Cohort 1: Placebo|Lost to Follow-up|0
7624925|NCT00455325|12036171|FG003|Cohort 1: Placebo|Lost to Follow-up|0
7624926|NCT00455325|12036168|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1
7624927|NCT00455325|12036169|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0
7624928|NCT00455325|12036170|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0
7624929|NCT00455325|12036171|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0
7624930|NCT00455325|12036168|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1
7624931|NCT00455325|12036169|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0
7624932|NCT00455325|12036170|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0
7624933|NCT00455325|12036171|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0
7624934|NCT00455325|12036168|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0
7624935|NCT00455325|12036169|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1
7624936|NCT00455325|12036170|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0
7624937|NCT00455325|12036171|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0
7624938|NCT00455325|12036168|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0
7624939|NCT00455325|12036169|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0
7624940|NCT00455325|12036170|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1
7624941|NCT00455325|12036171|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0
7624942|NCT00321555|12036182|FG000|Overall Study|Developed antibodies|1
7624943|NCT00321555|12036182|FG000|Overall Study|Switched to alternative treatment|3
7624944|NCT00321555|12036182|FG000|Overall Study|Physician Decision|1
7624945|NCT00321555|12036182|FG000|Overall Study|Disease progression on study|1
7770298|NCT00875810|12214304|FG000|Overall Study|Lost to Follow-up|39
7624946|NCT04471935|12036186|FG000|Overall Study|Withdrawal by Subject|1
7624947|NCT04471935|12036186|FG000|Overall Study|Deemed ineligible to participate|1
7624948|NCT04498832|12036218|FG000|Overall Study|Adverse Event|1
7624949|NCT04498832|12036219|FG001|Overall Study|Adverse Event|3
7624950|NCT04498832|12036218|FG000|Overall Study|Withdrawal by Subject|0
7624951|NCT04498832|12036219|FG001|Overall Study|Withdrawal by Subject|1
7624952|NCT04109222|12036228|FG000|Overall Study|Adverse Event|1
7624953|NCT04109222|12036229|FG001|Overall Study|Adverse Event|0
7624954|NCT04109222|12036230|FG002|Overall Study|Adverse Event|0
7624955|NCT04046939|12036242|FG000|Primary Assessment Period|Adverse Event|1
7624956|NCT04046939|12036243|FG001|Primary Assessment Period|Adverse Event|0
7624957|NCT04046939|12036244|FG002|Primary Assessment Period|Adverse Event|0
7624958|NCT04046939|12036245|FG003|Primary Assessment Period|Adverse Event|0
7624959|NCT04046939|12036242|FG000|Primary Assessment Period|Withdrawal by Subject|1
7624960|NCT04046939|12036243|FG001|Primary Assessment Period|Withdrawal by Subject|0
7624961|NCT04046939|12036244|FG002|Primary Assessment Period|Withdrawal by Subject|1
7624962|NCT04046939|12036245|FG003|Primary Assessment Period|Withdrawal by Subject|0
7624963|NCT04046939|12036242|FG000|Primary Assessment Period|Physician Decision|0
7624964|NCT04046939|12036243|FG001|Primary Assessment Period|Physician Decision|0
7624965|NCT04046939|12036244|FG002|Primary Assessment Period|Physician Decision|1
7624966|NCT04046939|12036245|FG003|Primary Assessment Period|Physician Decision|0
7624967|NCT04046939|12036242|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1
7624968|NCT04046939|12036243|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0
7624969|NCT04046939|12036244|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0
7624970|NCT04046939|12036245|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1
7624971|NCT03912259|12036263|FG000|Overall Study|Adverse Event (AE)|2
7624972|NCT03912259|12036264|FG001|Overall Study|Adverse Event (AE)|4
7624973|NCT03912259|12036263|FG000|Overall Study|Lack of Efficacy|4
7624974|NCT03912259|12036264|FG001|Overall Study|Lack of Efficacy|1
7624975|NCT03912259|12036263|FG000|Overall Study|Withdrawal by Subject|11
7624976|NCT03912259|12036264|FG001|Overall Study|Withdrawal by Subject|1
7624977|NCT03890367|12036274|FG000|Overall Study|Withdrawal by parent/guardian|1
7624978|NCT03890367|12036275|FG001|Overall Study|Withdrawal by parent/guardian|3
7624979|NCT03890367|12036276|FG002|Overall Study|Withdrawal by parent/guardian|0
7764861|NCT00838331|12206951|FG000|Aged Blood Transfusion|Withdrawal by Subject|9
7764862|NCT00838435|12206955|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1
7764863|NCT00838435|12206955|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2
7764864|NCT00838435|12206955|FG000|Part 2 (7 Years)|Adverse Event|2
7764865|NCT00838435|12206955|FG000|Part 2 (7 Years)|Lost to Follow-up|2
7764866|NCT00838435|12206955|FG000|Part 2 (7 Years)|Physician Decision|1
7764867|NCT00838435|12206955|FG000|Part 2 (7 Years)|Sponsor Decision|6
7764868|NCT00838435|12206955|FG000|Part 2 (7 Years)|Withdrawal by Subject|5
7764869|NCT00838513|12206962|FG000|Screening Period|Screen Failure|3
7764870|NCT00838513|12206962|FG000|Extension Treatment Period|Death|1
7764871|NCT00838513|12206962|FG000|Post Treatment Period (Patients Who Disc|Death|1
7764872|NCT00838539|12206978|FG000|Overall Study|Disease Progression|2
7764873|NCT00838539|12206979|FG001|Overall Study|Disease Progression|4
7764874|NCT00838539|12206980|FG002|Overall Study|Disease Progression|3
7764875|NCT00838539|12206981|FG003|Overall Study|Disease Progression|2
7764876|NCT00838539|12206982|FG004|Overall Study|Disease Progression|4
7764877|NCT00838539|12206983|FG005|Overall Study|Disease Progression|2
7764878|NCT00838539|12206984|FG006|Overall Study|Disease Progression|3
7764879|NCT00838539|12206985|FG007|Overall Study|Disease Progression|4
7764880|NCT00838539|12206986|FG008|Overall Study|Disease Progression|4
7764881|NCT00838539|12206987|FG009|Overall Study|Disease Progression|5
7764882|NCT00838539|12206988|FG010|Overall Study|Disease Progression|1
7764883|NCT00838539|12206989|FG011|Overall Study|Disease Progression|4
7764884|NCT00838539|12206978|FG000|Overall Study|Adverse Event|1
7764885|NCT00838539|12206979|FG001|Overall Study|Adverse Event|1
7764886|NCT00838539|12206980|FG002|Overall Study|Adverse Event|1
7764887|NCT00838539|12206981|FG003|Overall Study|Adverse Event|1
7764888|NCT00838539|12206982|FG004|Overall Study|Adverse Event|2
7764889|NCT00838539|12206983|FG005|Overall Study|Adverse Event|1
7764890|NCT00838539|12206984|FG006|Overall Study|Adverse Event|0
7764891|NCT00838539|12206985|FG007|Overall Study|Adverse Event|2
7764892|NCT00838539|12206986|FG008|Overall Study|Adverse Event|0
7764893|NCT00838539|12206987|FG009|Overall Study|Adverse Event|1
7764894|NCT00838539|12206988|FG010|Overall Study|Adverse Event|2
7764895|NCT00838539|12206989|FG011|Overall Study|Adverse Event|0
7764896|NCT00838539|12206978|FG000|Overall Study|Withdrawal by Subject|0
7764897|NCT00838539|12206979|FG001|Overall Study|Withdrawal by Subject|1
7764898|NCT00838539|12206980|FG002|Overall Study|Withdrawal by Subject|0
7764899|NCT00838539|12206981|FG003|Overall Study|Withdrawal by Subject|0
7764900|NCT00838539|12206982|FG004|Overall Study|Withdrawal by Subject|0
7764901|NCT00838539|12206983|FG005|Overall Study|Withdrawal by Subject|0
7764902|NCT00838539|12206984|FG006|Overall Study|Withdrawal by Subject|0
7764903|NCT00838539|12206985|FG007|Overall Study|Withdrawal by Subject|0
7764904|NCT00838539|12206986|FG008|Overall Study|Withdrawal by Subject|0
7624980|NCT03890367|12036274|FG000|Overall Study|Protocol deviation|2
7624981|NCT03890367|12036275|FG001|Overall Study|Protocol deviation|2
7624982|NCT03890367|12036276|FG002|Overall Study|Protocol deviation|1
7624983|NCT03890367|12036274|FG000|Overall Study|Lost to Follow-up|1
7624984|NCT03890367|12036275|FG001|Overall Study|Lost to Follow-up|1
7624985|NCT03890367|12036276|FG002|Overall Study|Lost to Follow-up|0
7624986|NCT03607422|12036294|FG000|Overall Study|Adverse Event|7
7624987|NCT03607422|12036295|FG001|Overall Study|Adverse Event|3
7624988|NCT03607422|12036296|FG002|Overall Study|Adverse Event|2
7624989|NCT03607422|12036297|FG003|Overall Study|Adverse Event|0
7624990|NCT03607422|12036298|FG004|Overall Study|Adverse Event|2
7624991|NCT03607422|12036299|FG005|Overall Study|Adverse Event|0
7624992|NCT03607422|12036294|FG000|Overall Study|Withdrawal by Subject|11
7624993|NCT03607422|12036295|FG001|Overall Study|Withdrawal by Subject|3
7624994|NCT03607422|12036296|FG002|Overall Study|Withdrawal by Subject|6
7624995|NCT03607422|12036297|FG003|Overall Study|Withdrawal by Subject|2
7624996|NCT03607422|12036298|FG004|Overall Study|Withdrawal by Subject|0
7624997|NCT03607422|12036299|FG005|Overall Study|Withdrawal by Subject|0
7764905|NCT00838539|12206987|FG009|Overall Study|Withdrawal by Subject|1
7764906|NCT00838539|12206988|FG010|Overall Study|Withdrawal by Subject|2
7764907|NCT00838539|12206989|FG011|Overall Study|Withdrawal by Subject|0
7764908|NCT00838539|12206978|FG000|Overall Study|Death|0
7764909|NCT00838539|12206979|FG001|Overall Study|Death|0
7764910|NCT00838539|12206980|FG002|Overall Study|Death|0
7764911|NCT00838539|12206981|FG003|Overall Study|Death|0
7624998|NCT03607422|12036294|FG000|Overall Study|Lost to Follow-up|0
7624999|NCT03607422|12036295|FG001|Overall Study|Lost to Follow-up|0
7625000|NCT03607422|12036296|FG002|Overall Study|Lost to Follow-up|1
7625001|NCT03607422|12036297|FG003|Overall Study|Lost to Follow-up|0
7625002|NCT03607422|12036298|FG004|Overall Study|Lost to Follow-up|0
7625003|NCT03607422|12036299|FG005|Overall Study|Lost to Follow-up|0
7625004|NCT03607422|12036294|FG000|Overall Study|Other|12
7625005|NCT03607422|12036295|FG001|Overall Study|Other|4
7625006|NCT03607422|12036296|FG002|Overall Study|Other|1
7625007|NCT03607422|12036297|FG003|Overall Study|Other|2
7625008|NCT03607422|12036298|FG004|Overall Study|Other|0
7625009|NCT03607422|12036299|FG005|Overall Study|Other|2
7625010|NCT03607422|12036294|FG000|Overall Study|Ongoing at Time of Analysis|8
7625011|NCT03607422|12036295|FG001|Overall Study|Ongoing at Time of Analysis|0
7625012|NCT03607422|12036296|FG002|Overall Study|Ongoing at Time of Analysis|2
7625013|NCT03607422|12036297|FG003|Overall Study|Ongoing at Time of Analysis|1
7625014|NCT03607422|12036298|FG004|Overall Study|Ongoing at Time of Analysis|1
7625015|NCT03607422|12036299|FG005|Overall Study|Ongoing at Time of Analysis|1
7625016|NCT03600805|12036317|FG000|Overall Study|Adverse Event|2
7625017|NCT03600805|12036318|FG001|Overall Study|Adverse Event|1
7625018|NCT03600805|12036319|FG002|Overall Study|Adverse Event|1
7625019|NCT03600805|12036320|FG003|Overall Study|Adverse Event|7
7625020|NCT03600805|12036317|FG000|Overall Study|Lack of Efficacy|2
7625021|NCT03600805|12036318|FG001|Overall Study|Lack of Efficacy|1
7625022|NCT03600805|12036319|FG002|Overall Study|Lack of Efficacy|0
7625023|NCT03600805|12036320|FG003|Overall Study|Lack of Efficacy|0
7625024|NCT03600805|12036317|FG000|Overall Study|Withdrawal by Subject|1
7625025|NCT03600805|12036318|FG001|Overall Study|Withdrawal by Subject|0
7625026|NCT03600805|12036319|FG002|Overall Study|Withdrawal by Subject|0
7625027|NCT03600805|12036320|FG003|Overall Study|Withdrawal by Subject|1
7625028|NCT03600805|12036317|FG000|Overall Study|Other unspecified|14
7625029|NCT03600805|12036318|FG001|Overall Study|Other unspecified|6
7625030|NCT03600805|12036319|FG002|Overall Study|Other unspecified|7
7625031|NCT03600805|12036320|FG003|Overall Study|Other unspecified|11
7625032|NCT03434119|12036343|FG000|Overall Study|Randomized but not treated|1
7625033|NCT03434119|12036344|FG001|Overall Study|Randomized but not treated|0
7625034|NCT03434119|12036343|FG000|Overall Study|Adverse Event|1
7625035|NCT03434119|12036344|FG001|Overall Study|Adverse Event|0
7625036|NCT03434119|12036343|FG000|Overall Study|Poor Compliance to Protocol|0
7625037|NCT03434119|12036344|FG001|Overall Study|Poor Compliance to Protocol|1
7625038|NCT03434119|12036343|FG000|Overall Study|Study Terminated by Sponsor|91
7625039|NCT03434119|12036344|FG001|Overall Study|Study Terminated by Sponsor|102
7764912|NCT00838539|12206982|FG004|Overall Study|Death|0
7625040|NCT03434119|12036343|FG000|Overall Study|Withdrawal by Subject|7
7625041|NCT03434119|12036344|FG001|Overall Study|Withdrawal by Subject|5
7625042|NCT03434119|12036343|FG000|Overall Study|Other than specified|7
7625043|NCT03434119|12036344|FG001|Overall Study|Other than specified|5
7625044|NCT03417245|12036352|FG000|Overall Study|Adverse Event|1
7625045|NCT03417245|12036353|FG001|Overall Study|Adverse Event|0
7625046|NCT03417245|12036352|FG000|Overall Study|Protocol Violation|1
7625047|NCT03417245|12036353|FG001|Overall Study|Protocol Violation|0
7625048|NCT03417245|12036352|FG000|Overall Study|Withdrawal by Subject|1
7625049|NCT03417245|12036353|FG001|Overall Study|Withdrawal by Subject|1
7625050|NCT03417102|12036361|FG000|Overall Study|Adverse Event|0
7625051|NCT03417102|12036362|FG001|Overall Study|Adverse Event|1
7764913|NCT00838539|12206983|FG005|Overall Study|Death|0
7764914|NCT00838539|12206984|FG006|Overall Study|Death|1
7764915|NCT00838539|12206985|FG007|Overall Study|Death|0
7764916|NCT00838539|12206986|FG008|Overall Study|Death|0
7764917|NCT00838539|12206987|FG009|Overall Study|Death|0
7764918|NCT00838539|12206988|FG010|Overall Study|Death|0
7764919|NCT00838539|12206989|FG011|Overall Study|Death|0
7625052|NCT03417102|12036361|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0
7625053|NCT03417102|12036362|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3
7625054|NCT03417102|12036361|FG000|Overall Study|Other|0
7625055|NCT03417102|12036362|FG001|Overall Study|Other|1
7625056|NCT03278626|12036368|FG000|Overall Study|Death|2
7625057|NCT03278626|12036368|FG000|Overall Study|Toxicity|1
7625058|NCT03278626|12036368|FG000|Overall Study|Disease Progression|2
7625059|NCT03211858|12036374|FG000|Overall Study|Adverse Event|8
7625060|NCT03211858|12036375|FG001|Overall Study|Adverse Event|6
7625061|NCT03211858|12036374|FG000|Overall Study|Lack of Efficacy|0
7625062|NCT03211858|12036375|FG001|Overall Study|Lack of Efficacy|4
7625063|NCT03211858|12036374|FG000|Overall Study|Poor compliance to protocol|6
7625064|NCT03211858|12036375|FG001|Overall Study|Poor compliance to protocol|2
7625065|NCT03211858|12036374|FG000|Overall Study|Non-serious Hypoglycemia|1
7625066|NCT03211858|12036375|FG001|Overall Study|Non-serious Hypoglycemia|0
7625067|NCT03211858|12036374|FG000|Overall Study|Other than specified above|22
7625068|NCT03211858|12036375|FG001|Overall Study|Other than specified above|21
7625069|NCT03077438|12036391|FG000|Overall Study|Protocol Violation|3
7625070|NCT03077438|12036392|FG001|Overall Study|Protocol Violation|5
7625071|NCT03077438|12036391|FG000|Overall Study|Withdrawal by Subject|3
7625072|NCT03077438|12036392|FG001|Overall Study|Withdrawal by Subject|6
7625073|NCT03077438|12036391|FG000|Overall Study|Lost to Follow-up|6
7625074|NCT03077438|12036392|FG001|Overall Study|Lost to Follow-up|3
7625075|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0
7625076|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2
7625077|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Adverse Event|2
7625078|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Adverse Event|5
7625079|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2
7625080|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2
7625081|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1
7625082|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6
7625083|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Randomized by error|0
7625084|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Randomized by error|5
7625085|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Randomized and not treated|0
7625086|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Randomized and not treated|3
7625087|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0
7625088|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1
7625089|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Change of residence location|0
7625090|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Change of residence location|1
7625091|NCT02948959|12036408|FG000|12 Weeks Follow-up Period|Adverse Event|0
7625092|NCT02948959|12036409|FG001|12 Weeks Follow-up Period|Adverse Event|2
7625093|NCT02948959|12036408|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1
7625094|NCT02948959|12036409|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2
7625095|NCT02948959|12036408|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3
7625096|NCT02948959|12036409|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3
7625097|NCT02948959|12036408|FG000|12 Weeks Follow-up Period|Randomized by error|0
7625098|NCT02948959|12036409|FG001|12 Weeks Follow-up Period|Randomized by error|3
7625099|NCT02948959|12036408|FG000|12 Weeks Follow-up Period|Change of residence location|0
7625100|NCT02948959|12036409|FG001|12 Weeks Follow-up Period|Change of residence location|2
7625101|NCT02948959|12036408|FG000|12 Weeks Follow-up Period|Study site closure|1
7625102|NCT02948959|12036409|FG001|12 Weeks Follow-up Period|Study site closure|0
7625103|NCT02878603|12036425|FG000|Overall Study|Lost to Follow-up|4
7625104|NCT02878603|12036426|FG001|Overall Study|Lost to Follow-up|1
7625105|NCT02878603|12036425|FG000|Overall Study|Withdrawal by Subject|1
7625106|NCT02878603|12036426|FG001|Overall Study|Withdrawal by Subject|1
7625107|NCT02878603|12036425|FG000|Overall Study|Death|1
7625108|NCT02878603|12036426|FG001|Overall Study|Death|0
7625109|NCT02878603|12036425|FG000|Overall Study|Physician Decision|0
7625110|NCT02878603|12036426|FG001|Overall Study|Physician Decision|3
7625111|NCT02864407|12036432|FG000|Overall Study|Protocol Violation|3
7625112|NCT02864407|12036432|FG000|Overall Study|Lost to Follow-up|115
7625113|NCT02864407|12036432|FG000|Overall Study|Not treated with Vahelva® Respimat®|1
7625114|NCT02864407|12036432|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3
7625115|NCT02864407|12036432|FG000|Overall Study|Consent prior to the contract date|1
7625116|NCT02846532|12036439|FG000|Overall Study|Lost to Follow-up|0
7625117|NCT02846532|12036440|FG001|Overall Study|Lost to Follow-up|1
7625118|NCT02846532|12036441|FG002|Overall Study|Lost to Follow-up|1
7625119|NCT02846532|12036439|FG000|Overall Study|Withdrawal by Subject|1
7625120|NCT02846532|12036440|FG001|Overall Study|Withdrawal by Subject|2
7625121|NCT02846532|12036441|FG002|Overall Study|Withdrawal by Subject|0
7625122|NCT02688933|12036451|FG000|Overall Study|Adverse Event|3
7625123|NCT02688933|12036452|FG001|Overall Study|Adverse Event|1
7625124|NCT02688933|12036451|FG000|Overall Study|Lack of Efficacy|2
7625125|NCT02688933|12036452|FG001|Overall Study|Lack of Efficacy|2
7625126|NCT02688933|12036451|FG000|Overall Study|Poor compliance to protocol|7
7625127|NCT02688933|12036452|FG001|Overall Study|Poor compliance to protocol|4
7625128|NCT02688933|12036451|FG000|Overall Study|Hypoglycemia|2
7625129|NCT02688933|12036452|FG001|Overall Study|Hypoglycemia|0
7625130|NCT02688933|12036451|FG000|Overall Study|Other than Specified|14
7625131|NCT02688933|12036452|FG001|Overall Study|Other than Specified|25
7625132|NCT02688933|12036451|FG000|Overall Study|Lost to Follow-up|1
7625133|NCT02688933|12036452|FG001|Overall Study|Lost to Follow-up|5
7625134|NCT02492165|12036471|FG000|Overall Study|Withdrawal by Subject|0
7625135|NCT02492165|12036472|FG001|Overall Study|Withdrawal by Subject|1
7625136|NCT02492165|12036473|FG002|Overall Study|Withdrawal by Subject|0
7625137|NCT02492165|12036474|FG003|Overall Study|Withdrawal by Subject|0
7625138|NCT02476006|12036484|FG000|Overall Study|Death|4
7625139|NCT02476006|12036484|FG000|Overall Study|Lack of treatment efficacy|2
7625140|NCT02476006|12036484|FG000|Overall Study|Pregnancy|1
7625141|NCT02476006|12036484|FG000|Overall Study|Participant did not wish to continue|39
7625142|NCT02476006|12036484|FG000|Overall Study|Adverse Event|41
7625143|NCT02476006|12036484|FG000|Overall Study|Poor compliance to study protocol|3
7625144|NCT02476006|12036484|FG000|Overall Study|Sponsor decision|6
7625145|NCT02476006|12036484|FG000|Overall Study|Lost to Follow-up|5
7625146|NCT02476006|12036484|FG000|Overall Study|Physician Decision|5
7625147|NCT02476006|12036484|FG000|Overall Study|Study ended treatment not available|4
7625148|NCT02476006|12036484|FG000|Overall Study|Switched to commercial drug|4
7625149|NCT02476006|12036484|FG000|Overall Study|Excluded from study|1
7625150|NCT02476006|12036484|FG000|Overall Study|Protocol Violation|1
7625151|NCT02476006|12036484|FG000|Overall Study|Enrolled but not treated|4
7625152|NCT02468414|12036490|FG000|Overall Study|Early Study Termination by Sponsor|1
7625153|NCT02468414|12036491|FG001|Overall Study|Early Study Termination by Sponsor|0
7625154|NCT02468414|12036490|FG000|Overall Study|Poor in-vitro secreting TARGTs|1
7625155|NCT02468414|12036491|FG001|Overall Study|Poor in-vitro secreting TARGTs|0
7625156|NCT02468414|12036490|FG000|Overall Study|Screen Failure|1
7625157|NCT02468414|12036491|FG001|Overall Study|Screen Failure|0
7625158|NCT02462876|12036497|FG000|Overall Study|Death|3
7625159|NCT02462876|12036497|FG000|Overall Study|Lost to Follow-up|7
7625160|NCT02462876|12036497|FG000|Overall Study|Surgical Bypass|9
7625161|NCT02462876|12036497|FG000|Overall Study|Amputation Above the Metatarsals|1
7625162|NCT02462876|12036497|FG000|Overall Study|36 months follow-up visit missed|1
7625163|NCT02462876|12036497|FG000|Overall Study|Patient did not come back since 4 months follow-up|1
7625164|NCT02462876|12036497|FG000|Overall Study|Patient did not come back to the vascular department|1
7625165|NCT02462876|12036497|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1
7625166|NCT02462876|12036497|FG000|Overall Study|Patient refused to come back|1
7625167|NCT02462876|12036497|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1
7625168|NCT02462876|12036497|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1
7625169|NCT02332590|12036503|FG000|DB Period (up to 24 Weeks)|Adverse Event|15
7625170|NCT02332590|12036504|FG001|DB Period (up to 24 Weeks)|Adverse Event|11
7625171|NCT02332590|12036503|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4
7625172|NCT02332590|12036504|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2
7625173|NCT02332590|12036503|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3
7625174|NCT02332590|12036504|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1
7625175|NCT02332590|12036503|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1
7625176|NCT02332590|12036504|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0
7625177|NCT02332590|12036503|FG000|DB Period (up to 24 Weeks)|Other than specified above|6
7625178|NCT02332590|12036504|FG001|DB Period (up to 24 Weeks)|Other than specified above|5
7625179|NCT02332590|12036503|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20
7625180|NCT02332590|12036504|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23
7625181|NCT02332590|12036503|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2
7625182|NCT02332590|12036504|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6
7625183|NCT02332590|12036503|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5
7625184|NCT02332590|12036504|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1
7625185|NCT02332590|12036503|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20
7625186|NCT02332590|12036504|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15
7625187|NCT02255656|12036512|FG000|Overall Study|Adverse Event|11
7625188|NCT02255656|12036512|FG000|Overall Study|Poor compliance to protocol|3
7625189|NCT02255656|12036512|FG000|Overall Study|Lost to Follow-up|30
7625190|NCT02255656|12036512|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300
7625191|NCT02255656|12036512|FG000|Overall Study|Other|126
7625192|NCT02134028|12036531|FG000|Overall Study|Lack of Efficacy|1
7625193|NCT02134028|12036532|FG001|Overall Study|Lack of Efficacy|0
7625194|NCT02134028|12036533|FG002|Overall Study|Lack of Efficacy|3
7625195|NCT02134028|12036534|FG003|Overall Study|Lack of Efficacy|2
7625196|NCT02134028|12036535|FG004|Overall Study|Lack of Efficacy|1
7625197|NCT02134028|12036536|FG005|Overall Study|Lack of Efficacy|2
7625198|NCT02134028|12036537|FG006|Overall Study|Lack of Efficacy|1
7625199|NCT02134028|12036538|FG007|Overall Study|Lack of Efficacy|0
7625200|NCT02134028|12036531|FG000|Overall Study|Poor compliance to protocol|1
7625201|NCT02134028|12036532|FG001|Overall Study|Poor compliance to protocol|1
7625202|NCT02134028|12036533|FG002|Overall Study|Poor compliance to protocol|3
7625203|NCT02134028|12036534|FG003|Overall Study|Poor compliance to protocol|7
7625204|NCT02134028|12036535|FG004|Overall Study|Poor compliance to protocol|1
7625205|NCT02134028|12036536|FG005|Overall Study|Poor compliance to protocol|1
7625206|NCT02134028|12036537|FG006|Overall Study|Poor compliance to protocol|0
7625207|NCT02134028|12036538|FG007|Overall Study|Poor compliance to protocol|0
7625208|NCT02134028|12036531|FG000|Overall Study|Other unspecified|4
7625209|NCT02134028|12036532|FG001|Overall Study|Other unspecified|22
7625210|NCT02134028|12036533|FG002|Overall Study|Other unspecified|33
7625211|NCT02134028|12036534|FG003|Overall Study|Other unspecified|64
7625212|NCT02134028|12036535|FG004|Overall Study|Other unspecified|8
7625213|NCT02134028|12036536|FG005|Overall Study|Other unspecified|6
7625214|NCT02134028|12036537|FG006|Overall Study|Other unspecified|2
7625215|NCT02134028|12036538|FG007|Overall Study|Other unspecified|1
7625216|NCT02134028|12036531|FG000|Overall Study|Adverse Event|3
7625217|NCT02134028|12036532|FG001|Overall Study|Adverse Event|19
7625218|NCT02134028|12036533|FG002|Overall Study|Adverse Event|13
7625219|NCT02134028|12036534|FG003|Overall Study|Adverse Event|32
7625220|NCT02134028|12036535|FG004|Overall Study|Adverse Event|4
7625221|NCT02134028|12036536|FG005|Overall Study|Adverse Event|5
7625222|NCT02134028|12036537|FG006|Overall Study|Adverse Event|1
7625223|NCT02134028|12036538|FG007|Overall Study|Adverse Event|2
7625224|NCT01900444|12036562|FG000|Overall Study|Protocol Violation|2
7625225|NCT01900444|12036562|FG000|Overall Study|Lost to Follow-up|1
7625226|NCT01887912|12036568|FG000|Overall Study|Serious adverse event|400
7625227|NCT01887912|12036569|FG001|Overall Study|Serious adverse event|198
7625228|NCT01887912|12036568|FG000|Overall Study|Other Adverse Event|34
7625229|NCT01887912|12036569|FG001|Overall Study|Other Adverse Event|15
7625230|NCT01887912|12036568|FG000|Overall Study|Protocol Violation|67
7625231|NCT01887912|12036569|FG001|Overall Study|Protocol Violation|37
7625232|NCT01887912|12036568|FG000|Overall Study|Lost to Follow-up|163
7625233|NCT01887912|12036569|FG001|Overall Study|Lost to Follow-up|74
7625234|NCT01887912|12036568|FG000|Overall Study|Withdrawal by Subject|606
7625235|NCT01887912|12036569|FG001|Overall Study|Withdrawal by Subject|349
7625236|NCT01887912|12036568|FG000|Overall Study|Other|122
7625237|NCT01887912|12036569|FG001|Overall Study|Other|58
7625238|NCT01437423|12036602|FG000|Overall Study|Lost to Follow-up|12
7625239|NCT01437423|12036602|FG000|Overall Study|Off label usage|3
7625240|NCT01410890|12036608|FG000|Overall Study|Withdrawal by Subject|0
7625241|NCT01410890|12036609|FG001|Overall Study|Withdrawal by Subject|1
7625242|NCT01190228|12036620|FG000|Overall Study|Protocol Violation|4
7625243|NCT01190228|12036621|FG001|Overall Study|Protocol Violation|0
7625244|NCT01190228|12036622|FG002|Overall Study|Protocol Violation|0
7625245|NCT01190228|12036620|FG000|Overall Study|Withdrawal by Subject|1
7625246|NCT01190228|12036621|FG001|Overall Study|Withdrawal by Subject|0
7625247|NCT01190228|12036622|FG002|Overall Study|Withdrawal by Subject|0
7625248|NCT01146652|12036634|FG000|Overall Study|Adverse Event|506
7625249|NCT01146652|12036635|FG001|Overall Study|Adverse Event|15
7625250|NCT01146652|12036634|FG000|Overall Study|Lack of Efficacy|91
7625251|NCT01146652|12036635|FG001|Overall Study|Lack of Efficacy|7
7625252|NCT01146652|12036634|FG000|Overall Study|Poor compliance to protocol|38
7625253|NCT01146652|12036635|FG001|Overall Study|Poor compliance to protocol|1
7625254|NCT01146652|12036634|FG000|Overall Study|Other unspecified reasons|314
7625255|NCT01146652|12036635|FG001|Overall Study|Other unspecified reasons|22
7625256|NCT01146652|12036634|FG000|Overall Study|Enrolled but not treated|2
7625257|NCT01146652|12036635|FG001|Overall Study|Enrolled but not treated|0
7625258|NCT01049035|12036655|FG000|Overall Study|Serious adverse event|0
7625259|NCT01049035|12036656|FG001|Overall Study|Serious adverse event|1
7625260|NCT01049035|12036657|FG002|Overall Study|Serious adverse event|1
7625261|NCT01049035|12036658|FG003|Overall Study|Serious adverse event|2
7625262|NCT01049035|12036659|FG004|Overall Study|Serious adverse event|0
7625263|NCT01049035|12036660|FG005|Overall Study|Serious adverse event|0
7625264|NCT01049035|12036661|FG006|Overall Study|Serious adverse event|0
7625265|NCT01049035|12036655|FG000|Overall Study|Other adverse event (AE)|0
7625266|NCT01049035|12036656|FG001|Overall Study|Other adverse event (AE)|0
7625267|NCT01049035|12036657|FG002|Overall Study|Other adverse event (AE)|0
7625268|NCT01049035|12036658|FG003|Overall Study|Other adverse event (AE)|1
7625269|NCT01049035|12036659|FG004|Overall Study|Other adverse event (AE)|0
7625270|NCT01049035|12036660|FG005|Overall Study|Other adverse event (AE)|0
7625271|NCT01049035|12036661|FG006|Overall Study|Other adverse event (AE)|0
7625272|NCT01049035|12036655|FG000|Overall Study|Non-compliance with the protocol|12
7625273|NCT01049035|12036656|FG001|Overall Study|Non-compliance with the protocol|6
7625274|NCT01049035|12036657|FG002|Overall Study|Non-compliance with the protocol|14
7625275|NCT01049035|12036658|FG003|Overall Study|Non-compliance with the protocol|5
7625276|NCT01049035|12036659|FG004|Overall Study|Non-compliance with the protocol|3
7625277|NCT01049035|12036660|FG005|Overall Study|Non-compliance with the protocol|4
7625278|NCT01049035|12036661|FG006|Overall Study|Non-compliance with the protocol|10
7625279|NCT01049035|12036655|FG000|Overall Study|Lost to Follow-up|5
7625280|NCT01049035|12036656|FG001|Overall Study|Lost to Follow-up|4
7625281|NCT01049035|12036657|FG002|Overall Study|Lost to Follow-up|4
7625282|NCT01049035|12036658|FG003|Overall Study|Lost to Follow-up|1
7625283|NCT01049035|12036659|FG004|Overall Study|Lost to Follow-up|0
7625284|NCT01049035|12036660|FG005|Overall Study|Lost to Follow-up|3
7625285|NCT01049035|12036661|FG006|Overall Study|Lost to Follow-up|3
7625286|NCT01049035|12036655|FG000|Overall Study|Voluntary withdrawal not due to an AE|16
7625287|NCT01049035|12036656|FG001|Overall Study|Voluntary withdrawal not due to an AE|10
7625288|NCT01049035|12036657|FG002|Overall Study|Voluntary withdrawal not due to an AE|8
7625289|NCT01049035|12036658|FG003|Overall Study|Voluntary withdrawal not due to an AE|2
7625290|NCT01049035|12036659|FG004|Overall Study|Voluntary withdrawal not due to an AE|1
7625291|NCT01049035|12036660|FG005|Overall Study|Voluntary withdrawal not due to an AE|5
7625292|NCT01049035|12036661|FG006|Overall Study|Voluntary withdrawal not due to an AE|2
7764920|NCT00838539|12206978|FG000|Overall Study|Physician Decision|0
7764921|NCT00838539|12206979|FG001|Overall Study|Physician Decision|0
7625295|NCT00726063|12036704|FG000|Overall Study|Adverse Event|9
7625296|NCT00726063|12036705|FG001|Overall Study|Adverse Event|7
7625297|NCT00713206|12036722|FG000|Overall Study|Lost to Follow-up|4
7625298|NCT00713206|12036723|FG001|Overall Study|Lost to Follow-up|4
7625299|NCT00713206|12036722|FG000|Overall Study|Death|1
7625300|NCT00713206|12036723|FG001|Overall Study|Death|0
7764922|NCT00838539|12206980|FG002|Overall Study|Physician Decision|0
7764923|NCT00838539|12206981|FG003|Overall Study|Physician Decision|0
7764924|NCT00838539|12206982|FG004|Overall Study|Physician Decision|0
7764925|NCT00838539|12206983|FG005|Overall Study|Physician Decision|0
7764926|NCT00838539|12206984|FG006|Overall Study|Physician Decision|0
7764927|NCT00838539|12206985|FG007|Overall Study|Physician Decision|0
7764928|NCT00838539|12206986|FG008|Overall Study|Physician Decision|1
7764929|NCT00838539|12206987|FG009|Overall Study|Physician Decision|0
7764930|NCT00838539|12206988|FG010|Overall Study|Physician Decision|0
7764931|NCT00838539|12206989|FG011|Overall Study|Physician Decision|0
7764932|NCT00838539|12206978|FG000|Overall Study|Clinical Progression|0
7764933|NCT00838539|12206979|FG001|Overall Study|Clinical Progression|0
7764934|NCT00838539|12206980|FG002|Overall Study|Clinical Progression|0
7764935|NCT00838539|12206981|FG003|Overall Study|Clinical Progression|0
7764936|NCT00838539|12206982|FG004|Overall Study|Clinical Progression|0
7764937|NCT00838539|12206983|FG005|Overall Study|Clinical Progression|0
7764938|NCT00838539|12206984|FG006|Overall Study|Clinical Progression|1
7764939|NCT00838539|12206985|FG007|Overall Study|Clinical Progression|0
7764940|NCT00838539|12206986|FG008|Overall Study|Clinical Progression|0
7764941|NCT00838539|12206987|FG009|Overall Study|Clinical Progression|0
7764942|NCT00838539|12206988|FG010|Overall Study|Clinical Progression|0
7764943|NCT00838539|12206989|FG011|Overall Study|Clinical Progression|0
7764944|NCT00838539|12206978|FG000|Overall Study|Symptomatic Deterioration|0
7764945|NCT00838539|12206979|FG001|Overall Study|Symptomatic Deterioration|0
7764946|NCT00838539|12206980|FG002|Overall Study|Symptomatic Deterioration|1
7764947|NCT00838539|12206981|FG003|Overall Study|Symptomatic Deterioration|1
7764948|NCT00838539|12206982|FG004|Overall Study|Symptomatic Deterioration|0
7764949|NCT00838539|12206983|FG005|Overall Study|Symptomatic Deterioration|1
7764950|NCT00838539|12206984|FG006|Overall Study|Symptomatic Deterioration|0
7764951|NCT00838539|12206985|FG007|Overall Study|Symptomatic Deterioration|0
7764952|NCT00838539|12206986|FG008|Overall Study|Symptomatic Deterioration|0
7764953|NCT00838539|12206987|FG009|Overall Study|Symptomatic Deterioration|1
7764954|NCT00838539|12206988|FG010|Overall Study|Symptomatic Deterioration|0
7764955|NCT00838539|12206989|FG011|Overall Study|Symptomatic Deterioration|0
7764956|NCT00838565|12207035|FG000|Overall Study|Withdrawal by Subject|0
7764957|NCT00838565|12207036|FG001|Overall Study|Withdrawal by Subject|0
7764958|NCT00838565|12207037|FG002|Overall Study|Withdrawal by Subject|1
7764959|NCT00838565|12207038|FG003|Overall Study|Withdrawal by Subject|0
7764960|NCT00838565|12207039|FG004|Overall Study|Withdrawal by Subject|0
7764961|NCT00838565|12207040|FG005|Overall Study|Withdrawal by Subject|2
7625301|NCT04422990|12036736|FG000|Overall Study|Withdrawal by Subject|0
7625302|NCT04422990|12036737|FG001|Overall Study|Withdrawal by Subject|1
7625303|NCT04422990|12036736|FG000|Overall Study|Travel|3
7625304|NCT04422990|12036737|FG001|Overall Study|Travel|0
7625305|NCT04358549|12036752|FG000|Overall Study|Adverse Event|0
7625306|NCT04358549|12036753|FG001|Overall Study|Adverse Event|1
7625307|NCT04358549|12036752|FG000|Overall Study|Death|1
7625308|NCT04358549|12036753|FG001|Overall Study|Death|0
7625309|NCT04358549|12036752|FG000|Overall Study|Lost to Follow-up|2
7625310|NCT04358549|12036753|FG001|Overall Study|Lost to Follow-up|1
7625311|NCT04358549|12036752|FG000|Overall Study|Withdrawal by Subject|6
7625312|NCT04358549|12036753|FG001|Overall Study|Withdrawal by Subject|6
7625313|NCT04358549|12036752|FG000|Overall Study|Start remdesivir|1
7625314|NCT04358549|12036753|FG001|Overall Study|Start remdesivir|0
7764962|NCT00838565|12207035|FG000|Overall Study|Other|0
7625315|NCT04532099|12036782|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1
7583172|NCT00162370|11988053|FG000|Efficacy Population|Lost to Follow-up|51
7583173|NCT00214500|11988069|FG000|Treatment Period|Adverse Event|1
7583174|NCT00214500|11988069|FG000|Extension Period|Withdrawal by Subject|2
7583175|NCT00283959|11988081|FG000|Extension Period|Low Compliance|1
7583176|NCT00290758|11988087|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
7583177|NCT00290758|11988088|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
7583178|NCT00290758|11988087|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
7583179|NCT00290758|11988088|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
7583180|NCT00290758|11988087|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
7583181|NCT00290758|11988088|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
7583182|NCT00290758|11988087|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
7583183|NCT00290758|11988088|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
7583184|NCT00290758|11988087|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
7583185|NCT00290758|11988088|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
7583186|NCT00290758|11988087|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
7583187|NCT00290758|11988088|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
7583188|NCT00290758|11988087|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
7583189|NCT00290758|11988088|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
7583190|NCT00290758|11988087|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6
7583191|NCT00290758|11988088|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5
7583192|NCT00310388|11988098|FG000|Primary Reporting Phase|Adverse Event|101
7583193|NCT00310388|11988099|FG001|Primary Reporting Phase|Adverse Event|0
7583194|NCT00310388|11988098|FG000|Primary Reporting Phase|Lack of Efficacy|56
7583195|NCT00310388|11988099|FG001|Primary Reporting Phase|Lack of Efficacy|0
7583196|NCT00310388|11988098|FG000|Primary Reporting Phase|Withdrawal by Subject|97
7583197|NCT00310388|11988099|FG001|Primary Reporting Phase|Withdrawal by Subject|0
7583198|NCT00310388|11988098|FG000|Primary Reporting Phase|Protocol Violation|10
7583199|NCT00310388|11988099|FG001|Primary Reporting Phase|Protocol Violation|0
7583200|NCT00310388|11988098|FG000|Primary Reporting Phase|Pregnancy|3
7583201|NCT00310388|11988099|FG001|Primary Reporting Phase|Pregnancy|0
7583202|NCT00310388|11988098|FG000|Primary Reporting Phase|Change in participant medical condition|3
7583203|NCT00310388|11988099|FG001|Primary Reporting Phase|Change in participant medical condition|0
7583204|NCT00310388|11988098|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
7583205|NCT00310388|11988099|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
7583206|NCT00310388|11988098|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
7583207|NCT00310388|11988099|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
7583208|NCT00310388|11988098|FG000|Primary Reporting Phase|Physician Decision|2
7583209|NCT00310388|11988099|FG001|Primary Reporting Phase|Physician Decision|0
7583210|NCT00310388|11988098|FG000|Primary Reporting Phase|Request of the sponsor|19
7583211|NCT00310388|11988099|FG001|Primary Reporting Phase|Request of the sponsor|0
7583212|NCT00310388|11988098|FG000|Primary Reporting Phase|Failed to return|8
7583213|NCT00310388|11988099|FG001|Primary Reporting Phase|Failed to return|0
7583214|NCT00310388|11988098|FG000|Primary Reporting Phase|Participant request unrelated to study|2
7583215|NCT00310388|11988099|FG001|Primary Reporting Phase|Participant request unrelated to study|0
7583216|NCT00310388|11988098|FG000|Primary Reporting Phase|Participant request|2
7583217|NCT00310388|11988099|FG001|Primary Reporting Phase|Participant request|0
7583218|NCT00310388|11988098|FG000|Primary Reporting Phase|Ministry of Health decision|25
7583219|NCT00310388|11988099|FG001|Primary Reporting Phase|Ministry of Health decision|0
7583220|NCT00310388|11988098|FG000|Primary Reporting Phase|Discontinuation of study|1
7583221|NCT00310388|11988099|FG001|Primary Reporting Phase|Discontinuation of study|0
7583222|NCT00310388|11988098|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1
7583223|NCT00310388|11988099|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0
7583224|NCT00310388|11988098|FG000|Primary Reporting Phase|Termination of study at sponsor request|3
7583225|NCT00310388|11988099|FG001|Primary Reporting Phase|Termination of study at sponsor request|0
7583226|NCT00310388|11988098|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1
7583227|NCT00310388|11988099|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0
7583228|NCT00310388|11988098|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2
7583229|NCT00310388|11988099|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0
7583230|NCT00310388|11988098|FG000|Primary Reporting Phase|Participant passed away|1
7583231|NCT00310388|11988099|FG001|Primary Reporting Phase|Participant passed away|0
7583232|NCT00310388|11988098|FG000|Primary Reporting Phase|Participant retired the informed consent|1
7583233|NCT00310388|11988099|FG001|Primary Reporting Phase|Participant retired the informed consent|0
7583234|NCT00310388|11988098|FG000|Primary Reporting Phase|Missing|1
7583235|NCT00310388|11988099|FG001|Primary Reporting Phase|Missing|0
7583236|NCT00310388|11988098|FG000|Primary Reporting Phase|Other|1
7583237|NCT00310388|11988099|FG001|Primary Reporting Phase|Other|0
7583238|NCT00310388|11988098|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
7583239|NCT00310388|11988099|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
7583240|NCT00310388|11988098|FG000|Safety Follow-up Continuation Phase|Adverse Event|0
7583241|NCT00310388|11988099|FG001|Safety Follow-up Continuation Phase|Adverse Event|1
7583242|NCT00310388|11988098|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
7583243|NCT00310388|11988099|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
7583244|NCT00310388|11988098|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
7583245|NCT00310388|11988099|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
7625316|NCT04532099|12036783|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0
7625317|NCT04532099|12036784|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0
7625318|NCT04385199|12036798|FG000|Overall Study|Withdrawal by Subject|1
7625319|NCT04385199|12036799|FG001|Overall Study|Withdrawal by Subject|0
7764963|NCT00838565|12207036|FG001|Overall Study|Other|2
7764964|NCT00838565|12207037|FG002|Overall Study|Other|0
7764965|NCT00838565|12207038|FG003|Overall Study|Other|0
7764966|NCT00838565|12207039|FG004|Overall Study|Other|0
7764967|NCT00838565|12207040|FG005|Overall Study|Other|0
7764968|NCT00838565|12207035|FG000|Overall Study|Randomized but not Treated|0
7764969|NCT00838565|12207036|FG001|Overall Study|Randomized but not Treated|1
7764970|NCT00838565|12207037|FG002|Overall Study|Randomized but not Treated|0
7583246|NCT04651114|11988104|FG000|Overall Study|Withdrawal by Subject|8
7764971|NCT00838565|12207038|FG003|Overall Study|Randomized but not Treated|0
7764972|NCT00838565|12207039|FG004|Overall Study|Randomized but not Treated|0
7764973|NCT00838565|12207040|FG005|Overall Study|Randomized but not Treated|0
7764974|NCT00838578|12207059|FG000|Overall Study|Protocol Violation|2
7764975|NCT00838682|12207069|FG000|Overall Study|Lost to Follow-up|21
7764976|NCT00838682|12207070|FG001|Overall Study|Lost to Follow-up|14
7764977|NCT00838682|12207069|FG000|Overall Study|detection of exclusion criteria|4
7764978|NCT00838682|12207070|FG001|Overall Study|detection of exclusion criteria|3
7764979|NCT00838682|12207069|FG000|Overall Study|Protocol Violation|0
7583256|NCT03768089|11988162|FG000|Part A|Lost to Follow-up|0
7583257|NCT03768089|11988163|FG001|Part A|Lost to Follow-up|0
7583258|NCT03768089|11988164|FG002|Part A|Lost to Follow-up|0
7583259|NCT03768089|11988165|FG003|Part A|Lost to Follow-up|0
7583260|NCT03768089|11988166|FG004|Part A|Lost to Follow-up|1
7583261|NCT03768089|11988167|FG005|Part A|Lost to Follow-up|0
7583262|NCT03768089|11988168|FG006|Part A|Lost to Follow-up|0
7583263|NCT03768089|11988169|FG007|Part A|Lost to Follow-up|0
7583264|NCT03768089|11988170|FG008|Part A|Lost to Follow-up|0
7583265|NCT03768089|11988171|FG009|Part A|Lost to Follow-up|0
7583266|NCT03768089|11988172|FG010|Part A|Lost to Follow-up|0
7583267|NCT03768089|11988173|FG011|Part A|Lost to Follow-up|0
7583268|NCT03768089|11988174|FG012|Part A|Lost to Follow-up|0
7583269|NCT03768089|11988175|FG013|Part A|Lost to Follow-up|0
7583270|NCT03768089|11988176|FG014|Part A|Lost to Follow-up|0
7583271|NCT03768089|11988177|FG015|Part A|Lost to Follow-up|0
7583272|NCT03768089|11988178|FG016|Part A|Lost to Follow-up|0
7583273|NCT03768089|11988179|FG017|Part A|Lost to Follow-up|0
7583274|NCT03768089|11988162|FG000|Part C|Randomized, Never Dosed|0
7583275|NCT03768089|11988163|FG001|Part C|Randomized, Never Dosed|0
7583276|NCT03768089|11988164|FG002|Part C|Randomized, Never Dosed|0
7583277|NCT03768089|11988165|FG003|Part C|Randomized, Never Dosed|0
7583278|NCT03768089|11988166|FG004|Part C|Randomized, Never Dosed|0
7583279|NCT03768089|11988167|FG005|Part C|Randomized, Never Dosed|0
7583280|NCT03768089|11988168|FG006|Part C|Randomized, Never Dosed|0
7583281|NCT03768089|11988169|FG007|Part C|Randomized, Never Dosed|0
7583282|NCT03768089|11988170|FG008|Part C|Randomized, Never Dosed|0
7583283|NCT03768089|11988171|FG009|Part C|Randomized, Never Dosed|0
7583284|NCT03768089|11988172|FG010|Part C|Randomized, Never Dosed|0
7583285|NCT03768089|11988173|FG011|Part C|Randomized, Never Dosed|0
7583286|NCT03768089|11988174|FG012|Part C|Randomized, Never Dosed|0
7583287|NCT03768089|11988175|FG013|Part C|Randomized, Never Dosed|0
7583288|NCT03768089|11988176|FG014|Part C|Randomized, Never Dosed|1
7583289|NCT03768089|11988177|FG015|Part C|Randomized, Never Dosed|0
7583290|NCT03768089|11988178|FG016|Part C|Randomized, Never Dosed|0
7583291|NCT03768089|11988179|FG017|Part C|Randomized, Never Dosed|0
7764980|NCT00838682|12207070|FG001|Overall Study|Protocol Violation|1
7764981|NCT00838682|12207069|FG000|Overall Study|Withdrawal by Subject|0
7764982|NCT00838682|12207070|FG001|Overall Study|Withdrawal by Subject|1
7764983|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Adverse Event|5
7764984|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Adverse Event|13
7764985|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Adverse Event|17
7764986|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Adverse Event|25
7583299|NCT03446573|11988255|FG000|Overall Study|Withdrawal by Subject|7
7583300|NCT03446573|11988256|FG001|Overall Study|Withdrawal by Subject|16
7583301|NCT03446573|11988255|FG000|Overall Study|Physician Decision|1
7583302|NCT03446573|11988256|FG001|Overall Study|Physician Decision|1
7583303|NCT03446573|11988255|FG000|Overall Study|Lost to Follow-up|3
7583304|NCT03446573|11988256|FG001|Overall Study|Lost to Follow-up|5
7583305|NCT03446573|11988255|FG000|Overall Study|Protocol Violation|3
7583306|NCT03446573|11988256|FG001|Overall Study|Protocol Violation|2
7583307|NCT03446573|11988255|FG000|Overall Study|Lack of Efficacy|0
7583308|NCT03446573|11988256|FG001|Overall Study|Lack of Efficacy|3
7583309|NCT03446573|11988255|FG000|Overall Study|Adverse Event|13
7583310|NCT03446573|11988256|FG001|Overall Study|Adverse Event|2
7583311|NCT03446573|11988255|FG000|Overall Study|Ongoing at the time of interim analysis|342
7583312|NCT03446573|11988256|FG001|Overall Study|Ongoing at the time of interim analysis|343
7583313|NCT03409666|11988267|FG000|Overall Study|Physician Decision|0
7583314|NCT03409666|11988268|FG001|Overall Study|Physician Decision|1
7583315|NCT03409666|11988267|FG000|Overall Study|Protocol Violation|0
7583316|NCT03409666|11988268|FG001|Overall Study|Protocol Violation|3
7764987|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Protocol Violation|1
7764988|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Protocol Violation|6
7764989|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Protocol Violation|6
7764990|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Protocol Violation|5
7764991|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Noncompliance|9
7764992|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Noncompliance|13
7764993|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Noncompliance|12
7764994|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Noncompliance|6
7764995|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
7764996|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
7764997|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
7764998|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
7764999|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4
7765000|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16
7765001|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15
7765002|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13
7765003|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20
7765004|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55
7765005|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56
7765006|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53
7765007|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Physician Decision|1
7765008|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Physician Decision|2
7765009|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Physician Decision|1
7765010|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Physician Decision|2
7765011|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
7765012|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
7765013|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
7765014|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
7765015|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
7765016|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
7765017|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
7765018|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
7765019|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0
7765020|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0
7765021|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0
7765022|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1
7765023|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
7765024|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
7765025|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
7583357|NCT03126019|11988341|FG000|Overall Study|Participants Still Ongoing in the Study|17
7583358|NCT03126019|11988342|FG001|Overall Study|Participants Still Ongoing in the Study|87
7583359|NCT03126019|11988341|FG000|Overall Study|Death|2
7583360|NCT03126019|11988342|FG001|Overall Study|Death|7
7583361|NCT03126019|11988341|FG000|Overall Study|Lost to Follow-up|2
7583362|NCT03126019|11988342|FG001|Overall Study|Lost to Follow-up|3
7583363|NCT03126019|11988341|FG000|Overall Study|Withdrawal by Participant|1
7583364|NCT03126019|11988342|FG001|Overall Study|Withdrawal by Participant|3
7583365|NCT03126019|11988341|FG000|Overall Study|Reason not Specified|1
7583366|NCT03126019|11988342|FG001|Overall Study|Reason not Specified|3
7765026|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
7765027|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Pregnancy|0
7765028|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Pregnancy|0
7765029|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Pregnancy|1
7765030|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Pregnancy|0
7765031|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
7765032|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
7765033|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
7765034|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
7765035|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Site closed|0
7765036|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Site closed|0
7765037|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Site closed|1
7765038|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Site closed|0
7765039|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
7765040|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
7765041|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
7765042|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
7765043|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
7583385|NCT03089606|11988362|FG000|Overall Study|Progression after Cycle 1|1
7583386|NCT02955602|11988388|FG000|Overall Study|Adverse Event|0
7583387|NCT02955602|11988389|FG001|Overall Study|Adverse Event|3
7583388|NCT02955602|11988390|FG002|Overall Study|Adverse Event|0
7583389|NCT02955602|11988388|FG000|Overall Study|Withdrawal of informed consent|1
7583390|NCT02955602|11988389|FG001|Overall Study|Withdrawal of informed consent|3
7583391|NCT02955602|11988390|FG002|Overall Study|Withdrawal of informed consent|2
7583392|NCT02955602|11988388|FG000|Overall Study|Lost to Follow-up|0
7583393|NCT02955602|11988389|FG001|Overall Study|Lost to Follow-up|0
7583394|NCT02955602|11988390|FG002|Overall Study|Lost to Follow-up|1
7583395|NCT02955602|11988388|FG000|Overall Study|Other|0
7583396|NCT02955602|11988389|FG001|Overall Study|Other|1
7583397|NCT02955602|11988390|FG002|Overall Study|Other|3
7583398|NCT02850016|11988405|FG000|Overall Study|Withdrawal by Subject|1
7583399|NCT02850016|11988406|FG001|Overall Study|Withdrawal by Subject|2
7583400|NCT02846545|11988414|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1
7583401|NCT02846545|11988415|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1
7583402|NCT02846545|11988414|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1
7583403|NCT02846545|11988415|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0
7583404|NCT02846545|11988414|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1
7583405|NCT02846545|11988415|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5
7583406|NCT02846545|11988414|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1
7583407|NCT02846545|11988415|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1
7583408|NCT02846545|11988414|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1
7583409|NCT02846545|11988415|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1
7765044|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
7765045|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
7765046|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
7765047|NCT00838903|12207089|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
7765048|NCT00838903|12207090|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
7765049|NCT00838903|12207091|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
7765050|NCT00838903|12207092|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
7765051|NCT00838903|12207089|FG000|Follow-up Period (8 Weeks)|Adverse Event|0
7765052|NCT00838903|12207090|FG001|Follow-up Period (8 Weeks)|Adverse Event|0
7765053|NCT00838903|12207091|FG002|Follow-up Period (8 Weeks)|Adverse Event|3
7583430|NCT02544750|11988495|FG000|Overall Study|Physician Decision|3
7583431|NCT02544750|11988496|FG001|Overall Study|Physician Decision|1
7583432|NCT02544750|11988495|FG000|Overall Study|Other reasons|69
7583433|NCT02544750|11988496|FG001|Overall Study|Other reasons|39
7583434|NCT02544750|11988495|FG000|Overall Study|Met withdrawal criteria|2
7583435|NCT02544750|11988496|FG001|Overall Study|Met withdrawal criteria|2
7583436|NCT02544750|11988495|FG000|Overall Study|Transition To Commercial Product|1
7583437|NCT02544750|11988496|FG001|Overall Study|Transition To Commercial Product|0
7583438|NCT02544750|11988495|FG000|Overall Study|Withdrawal by Parent/Guardian|8
7583439|NCT02544750|11988496|FG001|Overall Study|Withdrawal by Parent/Guardian|7
7583440|NCT02544750|11988495|FG000|Overall Study|Adverse Event|8
7583441|NCT02544750|11988496|FG001|Overall Study|Adverse Event|10
7583442|NCT02544750|11988495|FG000|Overall Study|Withdrawal by Subject|10
7583443|NCT02544750|11988496|FG001|Overall Study|Withdrawal by Subject|4
7583444|NCT02544750|11988495|FG000|Overall Study|Lost to Follow-up|1
7583445|NCT02544750|11988496|FG001|Overall Study|Lost to Follow-up|0
7583446|NCT02448771|11988502|FG000|Overall Study|Disease Progression|30
7583447|NCT02448771|11988502|FG000|Overall Study|Unacceptable Toxicity|1
7583448|NCT02448771|11988502|FG000|Overall Study|Physician Decision|3
7583449|NCT02448771|11988502|FG000|Overall Study|Started new therapy|2
7583450|NCT02337829|11988511|FG000|Overall Study|Death|0
7583451|NCT02337829|11988512|FG001|Overall Study|Death|1
7583452|NCT02337829|11988513|FG002|Overall Study|Death|0
7583453|NCT02337829|11988514|FG003|Overall Study|Death|0
7583454|NCT02337829|11988511|FG000|Overall Study|Study terminated by sponsor|12
7583455|NCT02337829|11988512|FG001|Overall Study|Study terminated by sponsor|10
7583456|NCT02337829|11988513|FG002|Overall Study|Study terminated by sponsor|5
7583457|NCT02337829|11988514|FG003|Overall Study|Study terminated by sponsor|6
7583458|NCT02337829|11988511|FG000|Overall Study|discontinued for other reasons|6
7583459|NCT02337829|11988512|FG001|Overall Study|discontinued for other reasons|3
7583460|NCT02337829|11988513|FG002|Overall Study|discontinued for other reasons|1
7583461|NCT02337829|11988514|FG003|Overall Study|discontinued for other reasons|4
7583462|NCT02062944|11988526|FG000|Overall Study|Lost to Follow-up|1
7583463|NCT02062944|11988526|FG000|Overall Study|New hemotological disorder identified|1
7583464|NCT02062944|11988526|FG000|Overall Study|Uncontrolled Hypertension|1
7583465|NCT02062944|11988526|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3
7583466|NCT02053792|11988533|FG000|Overall Study|Physician Decision|0
7583467|NCT02053792|11988534|FG001|Overall Study|Physician Decision|1
7583468|NCT02053792|11988533|FG000|Overall Study|Development of High titer FIX inhibitor|0
7583469|NCT02053792|11988534|FG001|Overall Study|Development of High titer FIX inhibitor|1
7583470|NCT02053792|11988533|FG000|Overall Study|Lack of Efficacy|1
7583471|NCT02053792|11988534|FG001|Overall Study|Lack of Efficacy|0
7583472|NCT02053792|11988533|FG000|Overall Study|Adverse Event|1
7583473|NCT02053792|11988534|FG001|Overall Study|Adverse Event|0
7583474|NCT02053792|11988533|FG000|Overall Study|Withdrawal by Subject|2
7583475|NCT02053792|11988534|FG001|Overall Study|Withdrawal by Subject|2
7583476|NCT02053792|11988533|FG000|Overall Study|The patient was not compliant to the study procedure|1
7583477|NCT02053792|11988534|FG001|Overall Study|The patient was not compliant to the study procedure|0
7583478|NCT02053792|11988533|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1
7583479|NCT02053792|11988534|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0
7583480|NCT01972217|11988544|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
7583481|NCT01972217|11988545|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
7583482|NCT01972217|11988546|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
7583483|NCT01972217|11988547|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
7583484|NCT01972217|11988544|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
7583485|NCT01972217|11988545|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
7583486|NCT01972217|11988546|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
7583487|NCT01972217|11988547|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
7583488|NCT01972217|11988544|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0
7583489|NCT01972217|11988545|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1
7583490|NCT01972217|11988546|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0
7583491|NCT01972217|11988547|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0
7583492|NCT01972217|11988544|FG000|Part A: Open-label Safety Run-in Period|Death|0
7583493|NCT01972217|11988545|FG001|Part A: Open-label Safety Run-in Period|Death|1
7583494|NCT01972217|11988546|FG002|Part A: Open-label Safety Run-in Period|Death|0
7583495|NCT01972217|11988547|FG003|Part A: Open-label Safety Run-in Period|Death|0
7583496|NCT01972217|11988544|FG000|Part B Double-blind, Randomised Period|Death|0
7583497|NCT01972217|11988545|FG001|Part B Double-blind, Randomised Period|Death|0
7583498|NCT01972217|11988546|FG002|Part B Double-blind, Randomised Period|Death|43
7583499|NCT01972217|11988547|FG003|Part B Double-blind, Randomised Period|Death|44
7583500|NCT01972217|11988544|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0
7583501|NCT01972217|11988545|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0
7583502|NCT01972217|11988546|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1
7583503|NCT01972217|11988547|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0
7583504|NCT01972217|11988544|FG000|Part B Double-blind, Randomised Period|Screen failure|0
7583505|NCT01972217|11988545|FG001|Part B Double-blind, Randomised Period|Screen failure|0
7583506|NCT01972217|11988546|FG002|Part B Double-blind, Randomised Period|Screen failure|0
7583507|NCT01972217|11988547|FG003|Part B Double-blind, Randomised Period|Screen failure|1
7583508|NCT01972217|11988544|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0
7583509|NCT01972217|11988545|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0
7583510|NCT01972217|11988546|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2
7583511|NCT01972217|11988547|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1
7583512|NCT01972217|11988544|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
7583513|NCT01972217|11988545|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
7583514|NCT01972217|11988546|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
7583515|NCT01972217|11988547|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
7765054|NCT00838903|12207092|FG003|Follow-up Period (8 Weeks)|Adverse Event|1
7765055|NCT00838903|12207089|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
7765056|NCT00838903|12207090|FG001|Follow-up Period (8 Weeks)|Noncompliance|8
7765057|NCT00838903|12207091|FG002|Follow-up Period (8 Weeks)|Noncompliance|5
7765058|NCT00838903|12207092|FG003|Follow-up Period (8 Weeks)|Noncompliance|5
7765059|NCT00838903|12207089|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6
7765060|NCT00838903|12207090|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28
7765061|NCT00838903|12207091|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22
7765062|NCT00838903|12207092|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24
7765063|NCT00838903|12207089|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
7765064|NCT00838903|12207090|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
7765065|NCT00838903|12207091|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
7765066|NCT00838903|12207092|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
7765067|NCT00838903|12207089|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
7765068|NCT00838903|12207090|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
7765069|NCT00838903|12207091|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
7765070|NCT00838903|12207092|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
7765071|NCT00838903|12207089|FG000|Follow-up Period (8 Weeks)|Physician Decision|1
7583536|NCT01640301|11988594|FG000|Overall Study|Death|0
7583537|NCT01640301|11988595|FG001|Overall Study|Death|8
7583538|NCT00554515|11988608|FG000|Overall Study|Withdrawal by Subject|3
7583539|NCT00554515|11988608|FG000|Overall Study|Disease progression|52
7583540|NCT00554515|11988608|FG000|Overall Study|Physician Decision|18
7583541|NCT00554515|11988608|FG000|Overall Study|Withdrawal by Subject|11
7583542|NCT00554515|11988608|FG000|Overall Study|Adverse Event|9
7583543|NCT00554515|11988608|FG000|Overall Study|Death|2
7583544|NCT00554515|11988608|FG000|Overall Study|Achieved Stable Disease|7
7583545|NCT00554515|11988608|FG000|Overall Study|Other|1
7583546|NCT00554515|11988608|FG000|Overall Study|Misc|15
7583547|NCT00107198|11988633|FG000|Overall Study|Lack of Efficacy|28
7583548|NCT00107198|11988633|FG000|Overall Study|Lost to Follow-up|12
7583549|NCT00107198|11988633|FG000|Overall Study|Protocol Violation|1
7583550|NCT00107198|11988633|FG000|Overall Study|Withdrawal by Subject|6
7583551|NCT00107198|11988633|FG000|Overall Study|Ineligible|5
7625328|NCT04311177|12036817|FG000|Overall Study|Adverse Event|3
7625329|NCT04311177|12036818|FG001|Overall Study|Adverse Event|1
7625330|NCT04311177|12036817|FG000|Overall Study|Physician Decision|4
7625331|NCT04311177|12036818|FG001|Overall Study|Physician Decision|3
7625332|NCT04311177|12036817|FG000|Overall Study|Withdrawal by Subject|1
7625333|NCT04311177|12036818|FG001|Overall Study|Withdrawal by Subject|0
7625334|NCT04241133|12036826|FG000|Overall Study|COVID19 Precautions|14
7625335|NCT04241133|12036827|FG001|Overall Study|COVID19 Precautions|34
7625336|NCT04150068|12036857|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24
7625337|NCT04150068|12036858|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12
7625338|NCT04150068|12036859|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35
7625339|NCT04150068|12036857|FG000|Maintenance Period (Week 26 Analysis)|Death|0
7625340|NCT04150068|12036858|FG001|Maintenance Period (Week 26 Analysis)|Death|0
7625341|NCT04150068|12036859|FG002|Maintenance Period (Week 26 Analysis)|Death|1
7625342|NCT04133519|12036868|FG000|Overall Study|Withdrawal by Subject|5
7583552|NCT00345358|11988641|FG000|Primary Vaccination Phase|Other|0
7583553|NCT00345358|11988642|FG001|Primary Vaccination Phase|Other|1
7583554|NCT00345358|11988643|FG002|Primary Vaccination Phase|Other|1
7583555|NCT00345358|11988644|FG003|Primary Vaccination Phase|Other|0
7583556|NCT00345358|11988641|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3
7583557|NCT00345358|11988642|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1
7583558|NCT00345358|11988643|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1
7583559|NCT00345358|11988644|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0
7583560|NCT00345358|11988641|FG000|Primary Vaccination Phase|Withdrawal by Subject|1
7583561|NCT00345358|11988642|FG001|Primary Vaccination Phase|Withdrawal by Subject|2
7583562|NCT00345358|11988643|FG002|Primary Vaccination Phase|Withdrawal by Subject|4
7583563|NCT00345358|11988644|FG003|Primary Vaccination Phase|Withdrawal by Subject|0
7583564|NCT00345358|11988641|FG000|Primary Vaccination Phase|Lost to Follow-up|1
7583565|NCT00345358|11988642|FG001|Primary Vaccination Phase|Lost to Follow-up|0
7583566|NCT00345358|11988643|FG002|Primary Vaccination Phase|Lost to Follow-up|2
7583567|NCT00345358|11988644|FG003|Primary Vaccination Phase|Lost to Follow-up|2
7583568|NCT00345358|11988641|FG000|Booster Vaccination Phase|Withdrawal by Subject|1
7583569|NCT00345358|11988642|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
7583570|NCT00345358|11988643|FG002|Booster Vaccination Phase|Withdrawal by Subject|0
7583571|NCT00345358|11988644|FG003|Booster Vaccination Phase|Withdrawal by Subject|0
7583572|NCT00345358|11988641|FG000|Booster Vaccination Phase|Lost to Follow-up|3
7583573|NCT00345358|11988642|FG001|Booster Vaccination Phase|Lost to Follow-up|0
7583574|NCT00345358|11988643|FG002|Booster Vaccination Phase|Lost to Follow-up|0
7583575|NCT00345358|11988644|FG003|Booster Vaccination Phase|Lost to Follow-up|0
7583576|NCT00372229|11988660|FG000|Study Phase|Graft loss|0
7583577|NCT00372229|11988661|FG001|Study Phase|Graft loss|3
7583578|NCT00372229|11988660|FG000|Study Phase|Protocol Violation|3
7583579|NCT00372229|11988661|FG001|Study Phase|Protocol Violation|4
7583580|NCT00372229|11988660|FG000|Study Phase|Consent withdrawn|16
7583581|NCT00372229|11988661|FG001|Study Phase|Consent withdrawn|14
7583582|NCT00372229|11988660|FG000|Study Phase|Refused treatment/did not cooperate|3
7583583|NCT00372229|11988661|FG001|Study Phase|Refused treatment/did not cooperate|1
7583584|NCT00372229|11988660|FG000|Study Phase|Death|3
7583585|NCT00372229|11988661|FG001|Study Phase|Death|2
7583586|NCT00372229|11988660|FG000|Study Phase|Reason not specified|3
7583587|NCT00372229|11988661|FG001|Study Phase|Reason not specified|2
7583588|NCT00372229|11988660|FG000|Study Phase|Lost to Follow-up|3
7583589|NCT00372229|11988661|FG001|Study Phase|Lost to Follow-up|3
7583590|NCT00372229|11988660|FG000|Follow-Up Phase|Graft loss|8
7583591|NCT00372229|11988661|FG001|Follow-Up Phase|Graft loss|7
7583592|NCT00372229|11988660|FG000|Follow-Up Phase|Consent withdrawn|13
7583593|NCT00372229|11988661|FG001|Follow-Up Phase|Consent withdrawn|19
7583594|NCT00372229|11988660|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0
7583595|NCT00372229|11988661|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1
7583596|NCT00372229|11988660|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1
7583597|NCT00372229|11988661|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0
7583598|NCT00372229|11988660|FG000|Follow-Up Phase|Death|9
7583599|NCT00372229|11988661|FG001|Follow-Up Phase|Death|12
7583600|NCT00372229|11988660|FG000|Follow-Up Phase|Administrative|1
7583601|NCT00372229|11988661|FG001|Follow-Up Phase|Administrative|0
7583602|NCT00372229|11988660|FG000|Follow-Up Phase|Reason not specified|2
7583603|NCT00372229|11988661|FG001|Follow-Up Phase|Reason not specified|3
7583604|NCT00372229|11988660|FG000|Follow-Up Phase|Lost to Follow-up|12
7583605|NCT00372229|11988661|FG001|Follow-Up Phase|Lost to Follow-up|10
7765072|NCT00838903|12207090|FG001|Follow-up Period (8 Weeks)|Physician Decision|1
7765073|NCT00838903|12207091|FG002|Follow-up Period (8 Weeks)|Physician Decision|1
7765074|NCT00838903|12207092|FG003|Follow-up Period (8 Weeks)|Physician Decision|1
7765075|NCT00838903|12207089|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
7765076|NCT00838903|12207090|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
7583612|NCT00413699|11988678|FG000|Initial Period|Death|25
7583613|NCT00413699|11988679|FG001|Initial Period|Death|30
7583614|NCT00413699|11988680|FG002|Initial Period|Death|0
7583615|NCT00413699|11988678|FG000|Initial Period|Lack of Efficacy|59
7583616|NCT00413699|11988679|FG001|Initial Period|Lack of Efficacy|115
7583617|NCT00413699|11988680|FG002|Initial Period|Lack of Efficacy|0
7583618|NCT00413699|11988678|FG000|Initial Period|Lost to Follow-up|31
7583619|NCT00413699|11988679|FG001|Initial Period|Lost to Follow-up|101
7583620|NCT00413699|11988680|FG002|Initial Period|Lost to Follow-up|0
7583621|NCT00413699|11988678|FG000|Initial Period|Protocol Violation|38
7583622|NCT00413699|11988679|FG001|Initial Period|Protocol Violation|89
7583623|NCT00413699|11988680|FG002|Initial Period|Protocol Violation|0
7583624|NCT00413699|11988678|FG000|Initial Period|Pregnancy|10
7583625|NCT00413699|11988679|FG001|Initial Period|Pregnancy|8
7583626|NCT00413699|11988680|FG002|Initial Period|Pregnancy|0
7583627|NCT00413699|11988678|FG000|Initial Period|Did not meet entrance criteria|2
7583628|NCT00413699|11988679|FG001|Initial Period|Did not meet entrance criteria|2
7583629|NCT00413699|11988680|FG002|Initial Period|Did not meet entrance criteria|0
7583630|NCT00413699|11988678|FG000|Initial Period|Medication error without adverse event|0
7583631|NCT00413699|11988679|FG001|Initial Period|Medication error without adverse event|1
7583632|NCT00413699|11988680|FG002|Initial Period|Medication error without adverse event|0
7583633|NCT00413699|11988678|FG000|Initial Period|Study terminated by Sponsor|0
7583634|NCT00413699|11988679|FG001|Initial Period|Study terminated by Sponsor|1
7583635|NCT00413699|11988680|FG002|Initial Period|Study terminated by Sponsor|0
7583636|NCT00413699|11988678|FG000|Initial Period|Other|67
7583637|NCT00413699|11988679|FG001|Initial Period|Other|211
7583638|NCT00413699|11988680|FG002|Initial Period|Other|0
7583639|NCT00413699|11988678|FG000|Initial Period|Adverse event related to study drug|178
7583640|NCT00413699|11988679|FG001|Initial Period|Adverse event related to study drug|527
7583641|NCT00413699|11988680|FG002|Initial Period|Adverse event related to study drug|0
7583642|NCT00413699|11988678|FG000|Initial Period|Adverse event not related to study drug|113
7583643|NCT00413699|11988679|FG001|Initial Period|Adverse event not related to study drug|248
7583644|NCT00413699|11988680|FG002|Initial Period|Adverse event not related to study drug|0
7583645|NCT00413699|11988678|FG000|Initial Period|Missing end of study page|0
7583646|NCT00413699|11988679|FG001|Initial Period|Missing end of study page|4
7583647|NCT00413699|11988680|FG002|Initial Period|Missing end of study page|0
7583648|NCT00413699|11988678|FG000|Initial Period|No longer willing to participate|116
7583649|NCT00413699|11988679|FG001|Initial Period|No longer willing to participate|368
7583650|NCT00413699|11988680|FG002|Initial Period|No longer willing to participate|0
7583651|NCT00413699|11988678|FG000|Extension Period|No Longer Willing to Participate|0
7583652|NCT00413699|11988679|FG001|Extension Period|No Longer Willing to Participate|0
7583653|NCT00413699|11988680|FG002|Extension Period|No Longer Willing to Participate|2
7583654|NCT00413699|11988678|FG000|Extension Period|Protocol Violation|0
7583655|NCT00413699|11988679|FG001|Extension Period|Protocol Violation|0
7583656|NCT00413699|11988680|FG002|Extension Period|Protocol Violation|1
7583657|NCT00413699|11988678|FG000|Extension Period|Adverse Event|0
7583658|NCT00413699|11988679|FG001|Extension Period|Adverse Event|0
7583659|NCT00413699|11988680|FG002|Extension Period|Adverse Event|2
7625343|NCT04133519|12036869|FG001|Overall Study|Withdrawal by Subject|4
7625344|NCT04133519|12036868|FG000|Overall Study|Protocol Violation|0
7625345|NCT04133519|12036869|FG001|Overall Study|Protocol Violation|1
7625346|NCT04133519|12036868|FG000|Overall Study|Never started treatment|1
7625347|NCT04133519|12036869|FG001|Overall Study|Never started treatment|1
7625348|NCT04098367|12036889|FG000|Overall Study|Adverse Event|0
7625349|NCT04098367|12036890|FG001|Overall Study|Adverse Event|0
7625350|NCT04098367|12036891|FG002|Overall Study|Adverse Event|1
7625351|NCT04098367|12036889|FG000|Overall Study|Lost to Follow-up|1
7625352|NCT04098367|12036890|FG001|Overall Study|Lost to Follow-up|5
7625353|NCT04098367|12036891|FG002|Overall Study|Lost to Follow-up|2
7625354|NCT04098367|12036889|FG000|Overall Study|Withdrawal by Subject|0
7625355|NCT04098367|12036890|FG001|Overall Study|Withdrawal by Subject|0
7625356|NCT04098367|12036891|FG002|Overall Study|Withdrawal by Subject|1
7625357|NCT04098367|12036889|FG000|Overall Study|Sick . Could not attend visit|1
7625358|NCT04098367|12036890|FG001|Overall Study|Sick . Could not attend visit|0
7625359|NCT04098367|12036891|FG002|Overall Study|Sick . Could not attend visit|0
7625360|NCT04091087|12036908|FG000|Overall Study|Not treated|1
7625361|NCT04091087|12036909|FG001|Overall Study|Not treated|0
7625362|NCT04091087|12036908|FG000|Overall Study|Adverse Event|4
7625363|NCT04091087|12036909|FG001|Overall Study|Adverse Event|4
7625364|NCT04091087|12036908|FG000|Overall Study|Protocol Violation|0
7625365|NCT04091087|12036909|FG001|Overall Study|Protocol Violation|1
7625366|NCT04091087|12036908|FG000|Overall Study|Withdrawal by Subject|5
7625367|NCT04091087|12036909|FG001|Overall Study|Withdrawal by Subject|2
7625368|NCT04009629|12036917|FG000|Overall Study|Withdrawal by Subject|2
7625369|NCT04009629|12036918|FG001|Overall Study|Withdrawal by Subject|0
7625370|NCT03937908|12036927|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0
7625371|NCT03937908|12036928|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1
7583660|NCT00436826|11988718|FG000|Double Blind Period (DBP)|Adverse Event|2
7583661|NCT00436826|11988719|FG001|Double Blind Period (DBP)|Adverse Event|0
7583662|NCT00436826|11988720|FG002|Double Blind Period (DBP)|Adverse Event|0
7583663|NCT00436826|11988721|FG003|Double Blind Period (DBP)|Adverse Event|0
7583664|NCT00436826|11988722|FG004|Double Blind Period (DBP)|Adverse Event|0
7583665|NCT00436826|11988723|FG005|Double Blind Period (DBP)|Adverse Event|0
7583666|NCT00436826|11988718|FG000|Double Blind Period (DBP)|Protocol Violation|1
7583667|NCT00436826|11988719|FG001|Double Blind Period (DBP)|Protocol Violation|0
7583668|NCT00436826|11988720|FG002|Double Blind Period (DBP)|Protocol Violation|0
7583669|NCT00436826|11988721|FG003|Double Blind Period (DBP)|Protocol Violation|0
7583670|NCT00436826|11988722|FG004|Double Blind Period (DBP)|Protocol Violation|0
7583671|NCT00436826|11988723|FG005|Double Blind Period (DBP)|Protocol Violation|0
7583672|NCT00436826|11988718|FG000|Double Blind Period (DBP)|Other|10
7583673|NCT00436826|11988719|FG001|Double Blind Period (DBP)|Other|11
7583674|NCT00436826|11988720|FG002|Double Blind Period (DBP)|Other|0
7583675|NCT00436826|11988721|FG003|Double Blind Period (DBP)|Other|0
7583676|NCT00436826|11988722|FG004|Double Blind Period (DBP)|Other|0
7583677|NCT00436826|11988723|FG005|Double Blind Period (DBP)|Other|0
7583678|NCT00436826|11988718|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7583679|NCT00436826|11988719|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7583680|NCT00436826|11988720|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7583681|NCT00436826|11988721|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1
7583682|NCT00436826|11988722|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7583683|NCT00436826|11988723|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7583684|NCT00436826|11988718|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7583685|NCT00436826|11988719|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7583686|NCT00436826|11988720|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46
7583687|NCT00436826|11988721|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25
7583688|NCT00436826|11988722|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7583689|NCT00436826|11988723|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7583690|NCT00436826|11988718|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7583691|NCT00436826|11988719|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7583692|NCT00436826|11988720|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7583693|NCT00436826|11988721|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7583694|NCT00436826|11988722|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
7583695|NCT00436826|11988723|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
7625372|NCT03891264|12036934|FG000|Overall Study|Adverse Event|1
7625373|NCT03891264|12036934|FG000|Overall Study|Withdrawal by Subject|2
7625374|NCT03891264|12036934|FG000|Overall Study|Physician Decision|2
7765077|NCT00838903|12207091|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
7765078|NCT00838903|12207092|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
7765079|NCT00838903|12207089|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0
7765080|NCT00838903|12207090|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1
7765081|NCT00838903|12207091|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0
7765082|NCT00838903|12207092|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0
7765083|NCT00838903|12207089|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
7765084|NCT00838903|12207090|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
7765085|NCT00838903|12207091|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
7765086|NCT00838903|12207092|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
7765087|NCT00838903|12207089|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
7765088|NCT00838903|12207090|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
7765089|NCT00838903|12207091|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
7765090|NCT00838903|12207092|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
7765091|NCT00838903|12207089|FG000|Follow-up Period (8 Weeks)|Missing|1
7765092|NCT00838903|12207090|FG001|Follow-up Period (8 Weeks)|Missing|2
7625391|NCT03823287|12036967|FG000|Overall Study|Withdrawal by Subject|7
7625392|NCT03823287|12036968|FG001|Overall Study|Withdrawal by Subject|6
7625393|NCT03823287|12036967|FG000|Overall Study|Death|4
7625394|NCT03823287|12036968|FG001|Overall Study|Death|1
7625395|NCT03823287|12036967|FG000|Overall Study|Lost to Follow-up|2
7625396|NCT03823287|12036968|FG001|Overall Study|Lost to Follow-up|3
7625397|NCT03823287|12036967|FG000|Overall Study|Physician Decision|2
7625398|NCT03823287|12036968|FG001|Overall Study|Physician Decision|1
7625399|NCT03823287|12036967|FG000|Overall Study|Adverse Event|0
7625400|NCT03823287|12036968|FG001|Overall Study|Adverse Event|3
7625401|NCT03823287|12036967|FG000|Overall Study|Ongoing in the study at Primary Completion Date|319
7625402|NCT03823287|12036968|FG001|Overall Study|Ongoing in the study at Primary Completion Date|323
7625403|NCT03815175|12036974|FG000|Overall Study|Subject Lost to Follow-up|6
7625404|NCT03815175|12036974|FG000|Overall Study|Subject Withdrew Consent|48
7625405|NCT03815175|12036974|FG000|Overall Study|Subject Withdrawn by Physician/Site|10
7625406|NCT03815175|12036974|FG000|Overall Study|Death|86
7625407|NCT03815175|12036974|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1
7625408|NCT03815175|12036974|FG000|Overall Study|Subject Discontinued by Sponsor|2
7625409|NCT03815175|12036974|FG000|Overall Study|Other Status Change Reason|1
7625410|NCT03815175|12036974|FG000|Overall Study|Missed Visit|12
7765093|NCT00838903|12207091|FG002|Follow-up Period (8 Weeks)|Missing|1
7765094|NCT00838903|12207092|FG003|Follow-up Period (8 Weeks)|Missing|1
7765095|NCT00838916|12207104|FG000|Treatment Period (156 Weeks)|Adverse Event|50
7765096|NCT00838916|12207105|FG001|Treatment Period (156 Weeks)|Adverse Event|11
7765097|NCT00838916|12207104|FG000|Treatment Period (156 Weeks)|Protocol Violation|12
7625419|NCT03603639|12037046|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0
7625420|NCT03603639|12037047|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0
7625421|NCT03603639|12037048|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0
7625422|NCT03603639|12037049|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1
7625423|NCT03603639|12037050|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0
7625424|NCT03603639|12037051|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0
7625425|NCT03603639|12037046|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0
7625426|NCT03603639|12037047|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0
7625427|NCT03603639|12037048|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1
7625428|NCT03603639|12037049|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0
7625429|NCT03603639|12037050|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1
7625430|NCT03603639|12037051|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1
7625431|NCT03587636|12037063|FG000|Overall Study|Lost to Follow-up|2
7625432|NCT03587636|12037064|FG001|Overall Study|Lost to Follow-up|5
7583696|NCT00442546|11988742|FG000|Overall Study|Adverse Event|11
7583697|NCT00442546|11988743|FG001|Overall Study|Adverse Event|17
7583698|NCT00442546|11988744|FG002|Overall Study|Adverse Event|13
7583699|NCT00442546|11988742|FG000|Overall Study|Lost to Follow-up|1
7583700|NCT00442546|11988743|FG001|Overall Study|Lost to Follow-up|2
7583701|NCT00442546|11988744|FG002|Overall Study|Lost to Follow-up|1
7583702|NCT00442546|11988742|FG000|Overall Study|Other|4
7583703|NCT00442546|11988743|FG001|Overall Study|Other|9
7583704|NCT00442546|11988744|FG002|Overall Study|Other|6
7583705|NCT00442546|11988742|FG000|Overall Study|Withdrawal by Subject|5
7583706|NCT00442546|11988743|FG001|Overall Study|Withdrawal by Subject|5
7583707|NCT00442546|11988744|FG002|Overall Study|Withdrawal by Subject|7
7583708|NCT00442546|11988742|FG000|Overall Study|Randomized But Not Treated|5
7583709|NCT00442546|11988743|FG001|Overall Study|Randomized But Not Treated|4
7583710|NCT00442546|11988744|FG002|Overall Study|Randomized But Not Treated|6
7583711|NCT04715932|11988756|FG000|Overall Study|Lost to Follow-up|1
7583712|NCT04715932|11988757|FG001|Overall Study|Lost to Follow-up|0
7583713|NCT04666441|11988771|FG000|Overall Study|Lost to Follow-up|1
7583714|NCT04666441|11988772|FG001|Overall Study|Lost to Follow-up|4
7583715|NCT04666441|11988773|FG002|Overall Study|Lost to Follow-up|1
7583716|NCT04666441|11988774|FG003|Overall Study|Lost to Follow-up|3
7583717|NCT04666441|11988775|FG004|Overall Study|Lost to Follow-up|0
7583718|NCT04666441|11988776|FG005|Overall Study|Lost to Follow-up|2
7583719|NCT04666441|11988777|FG006|Overall Study|Lost to Follow-up|2
7583720|NCT04666441|11988778|FG007|Overall Study|Lost to Follow-up|2
7583721|NCT04666441|11988771|FG000|Overall Study|Subject Decision|1
7583722|NCT04666441|11988772|FG001|Overall Study|Subject Decision|1
7583723|NCT04666441|11988773|FG002|Overall Study|Subject Decision|3
7583724|NCT04666441|11988774|FG003|Overall Study|Subject Decision|1
7583725|NCT04666441|11988775|FG004|Overall Study|Subject Decision|0
7583726|NCT04666441|11988776|FG005|Overall Study|Subject Decision|1
7583727|NCT04666441|11988777|FG006|Overall Study|Subject Decision|3
7583728|NCT04666441|11988778|FG007|Overall Study|Subject Decision|2
7583729|NCT04259346|11988832|FG000|Overall Study|Lost to Follow-up|1
7583730|NCT04259346|11988833|FG001|Overall Study|Lost to Follow-up|3
7583731|NCT04259346|11988832|FG000|Overall Study|Protocol Violation|1
7583732|NCT04259346|11988833|FG001|Overall Study|Protocol Violation|0
7583733|NCT04259346|11988832|FG000|Overall Study|Withdrawal by Subject|1
7583734|NCT04259346|11988833|FG001|Overall Study|Withdrawal by Subject|0
7583735|NCT04259346|11988832|FG000|Overall Study|Adverse Event|1
7583736|NCT04259346|11988833|FG001|Overall Study|Adverse Event|1
7583737|NCT03959423|11988841|FG000|Overall Study|Withdrawal by Subject|2
7583738|NCT03959423|11988842|FG001|Overall Study|Withdrawal by Subject|3
7583739|NCT03959423|11988841|FG000|Overall Study|Physician Decision|0
7583740|NCT03959423|11988842|FG001|Overall Study|Physician Decision|1
7583741|NCT03959423|11988841|FG000|Overall Study|Lost to Follow-up|1
7583742|NCT03959423|11988842|FG001|Overall Study|Lost to Follow-up|0
7583743|NCT03959423|11988841|FG000|Overall Study|Withdrawal by Parent/Guardian|6
7583744|NCT03959423|11988842|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7583745|NCT03713320|11988850|FG000|Randomized Period|Adverse Event|1
7583746|NCT03713320|11988851|FG001|Randomized Period|Adverse Event|5
7583747|NCT03713320|11988852|FG002|Randomized Period|Adverse Event|0
7583748|NCT03713320|11988850|FG000|Randomized Period|Physician Decision|1
7583749|NCT03713320|11988851|FG001|Randomized Period|Physician Decision|1
7583750|NCT03713320|11988852|FG002|Randomized Period|Physician Decision|0
7583751|NCT03713320|11988850|FG000|Randomized Period|Withdrawal by Subject|4
7583752|NCT03713320|11988851|FG001|Randomized Period|Withdrawal by Subject|0
7583753|NCT03713320|11988852|FG002|Randomized Period|Withdrawal by Subject|0
7583754|NCT03713320|11988850|FG000|Randomized Period|Participant decision|3
7583755|NCT03713320|11988851|FG001|Randomized Period|Participant decision|1
7583756|NCT03713320|11988852|FG002|Randomized Period|Participant decision|0
7583757|NCT03713320|11988850|FG000|Randomized Period|Study terminated by sponsor|6
7583758|NCT03713320|11988851|FG001|Randomized Period|Study terminated by sponsor|3
7583759|NCT03713320|11988852|FG002|Randomized Period|Study terminated by sponsor|0
7583760|NCT03713320|11988850|FG000|Cobomarsen Crossover Period|Physician Decision|0
7583761|NCT03713320|11988851|FG001|Cobomarsen Crossover Period|Physician Decision|0
7583762|NCT03713320|11988852|FG002|Cobomarsen Crossover Period|Physician Decision|2
7583763|NCT03713320|11988850|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0
7583764|NCT03713320|11988851|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0
7583765|NCT03713320|11988852|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5
7625433|NCT03573336|12037094|FG000|Overall Study|Study terminated|2
7625434|NCT03573336|12037095|FG001|Overall Study|Study terminated|4
7625435|NCT03573336|12037096|FG002|Overall Study|Study terminated|2
7625436|NCT03570697|12037106|FG000|Overall Study|Lost to Follow-up|0
7625437|NCT03570697|12037107|FG001|Overall Study|Lost to Follow-up|1
7625438|NCT03570697|12037106|FG000|Overall Study|Death|2
7625439|NCT03570697|12037107|FG001|Overall Study|Death|0
7625440|NCT03570697|12037106|FG000|Overall Study|Withdrawal by Subject|4
7625441|NCT03570697|12037107|FG001|Overall Study|Withdrawal by Subject|2
7625442|NCT03548051|12037115|FG000|Overall Study|Death|1
7625443|NCT03548051|12037116|FG001|Overall Study|Death|1
7625444|NCT03548051|12037115|FG000|Overall Study|Withdrawal by Subject|1
7625445|NCT03548051|12037116|FG001|Overall Study|Withdrawal by Subject|0
7625446|NCT03503318|12037142|FG000|Overall Study|Death|1
7625447|NCT03503318|12037143|FG001|Overall Study|Death|0
7625448|NCT03503318|12037144|FG002|Overall Study|Death|4
7625449|NCT03503318|12037142|FG000|Overall Study|Adverse Event|3
7625450|NCT03503318|12037143|FG001|Overall Study|Adverse Event|4
7625451|NCT03503318|12037144|FG002|Overall Study|Adverse Event|2
7625452|NCT03503318|12037142|FG000|Overall Study|Withdrawal by Subject|12
7625453|NCT03503318|12037143|FG001|Overall Study|Withdrawal by Subject|17
7625454|NCT03503318|12037144|FG002|Overall Study|Withdrawal by Subject|16
7625455|NCT03503318|12037142|FG000|Overall Study|Protocol Violation|5
7625456|NCT03503318|12037143|FG001|Overall Study|Protocol Violation|0
7625457|NCT03503318|12037144|FG002|Overall Study|Protocol Violation|3
7625458|NCT03503318|12037142|FG000|Overall Study|Lost to Follow-up|17
7625459|NCT03503318|12037143|FG001|Overall Study|Lost to Follow-up|15
7625460|NCT03503318|12037144|FG002|Overall Study|Lost to Follow-up|12
7625461|NCT03503318|12037142|FG000|Overall Study|Other than specified|1
7625462|NCT03503318|12037143|FG001|Overall Study|Other than specified|3
7625463|NCT03503318|12037144|FG002|Overall Study|Other than specified|3
7625464|NCT03493854|12037154|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3
7625465|NCT03493854|12037155|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5
7625466|NCT03493854|12037154|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
7625467|NCT03493854|12037155|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
7625468|NCT03493854|12037154|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0
7625469|NCT03493854|12037155|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1
7625470|NCT03493854|12037154|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1
7625471|NCT03493854|12037155|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2
7625472|NCT03493854|12037154|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
7625473|NCT03493854|12037155|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
7625474|NCT03493854|12037154|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
7625475|NCT03493854|12037155|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2
7625476|NCT03493854|12037154|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
7625477|NCT03493854|12037155|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0
7625478|NCT03493854|12037154|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229
7765098|NCT00838916|12207105|FG001|Treatment Period (156 Weeks)|Protocol Violation|3
7765099|NCT00838916|12207104|FG000|Treatment Period (156 Weeks)|Noncompliance|21
7765100|NCT00838916|12207105|FG001|Treatment Period (156 Weeks)|Noncompliance|14
7765101|NCT00838916|12207104|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
7765102|NCT00838916|12207105|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
7765103|NCT00838916|12207104|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19
7765104|NCT00838916|12207105|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18
7765105|NCT00838916|12207104|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81
7765106|NCT00838916|12207105|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29
7765107|NCT00838916|12207104|FG000|Treatment Period (156 Weeks)|Physician Decision|6
7765108|NCT00838916|12207105|FG001|Treatment Period (156 Weeks)|Physician Decision|1
7765109|NCT00838916|12207104|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
7765110|NCT00838916|12207105|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
7765111|NCT00838916|12207104|FG000|Treatment Period (156 Weeks)|Missing|3
7765112|NCT00838916|12207105|FG001|Treatment Period (156 Weeks)|Missing|1
7765113|NCT00838916|12207104|FG000|Treatment Period (156 Weeks)|Pregnancy|2
7765114|NCT00838916|12207105|FG001|Treatment Period (156 Weeks)|Pregnancy|0
7765115|NCT00838916|12207104|FG000|Follow-up Period (8 Weeks)|Adverse Event|10
7583784|NCT03409731|11988868|FG000|Overall Study|Withdrawal by Subject|1
7583785|NCT03409731|11988868|FG000|Overall Study|Death|2
7583786|NCT03283566|11988874|FG000|Overall Study|Lost to Follow-up|1
7583787|NCT03283566|11988875|FG001|Overall Study|Lost to Follow-up|2
7583788|NCT03077412|11988884|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1
7583789|NCT03077412|11988885|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5
7583790|NCT03077412|11988886|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3
7583791|NCT03077412|11988884|FG000|Overall Study|Protocol-Specified Disease Worsening|1
7583792|NCT03077412|11988885|FG001|Overall Study|Protocol-Specified Disease Worsening|3
7583793|NCT03077412|11988886|FG002|Overall Study|Protocol-Specified Disease Worsening|3
7583794|NCT03077412|11988884|FG000|Overall Study|Adverse Event|1
7583795|NCT03077412|11988885|FG001|Overall Study|Adverse Event|2
7583796|NCT03077412|11988886|FG002|Overall Study|Adverse Event|2
7583797|NCT03077412|11988884|FG000|Overall Study|Investigator's Discretion|0
7583798|NCT03077412|11988885|FG001|Overall Study|Investigator's Discretion|1
7583799|NCT03077412|11988886|FG002|Overall Study|Investigator's Discretion|1
7583800|NCT03077412|11988884|FG000|Overall Study|Withdrew Consent|0
7583801|NCT03077412|11988885|FG001|Overall Study|Withdrew Consent|2
7583802|NCT03077412|11988886|FG002|Overall Study|Withdrew Consent|0
7583803|NCT02384850|11988931|FG000|Overall Study|Withdrawal by Subject|2
7583804|NCT02384850|11988932|FG001|Overall Study|Withdrawal by Subject|2
7765116|NCT00838916|12207105|FG001|Follow-up Period (8 Weeks)|Adverse Event|5
7765117|NCT00838916|12207104|FG000|Follow-up Period (8 Weeks)|Noncompliance|6
7765118|NCT00838916|12207105|FG001|Follow-up Period (8 Weeks)|Noncompliance|5
7765119|NCT00838916|12207104|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38
7583836|NCT00971867|11988991|FG000|Overall Study|Adverse Event|4
7583837|NCT00971867|11988991|FG000|Overall Study|Participant Withdrew Consent|1
7583838|NCT00971867|11988991|FG000|Overall Study|Disease Progression|6
7583839|NCT00853307|11988997|FG000|Overall Study|Adverse Event|1
7583840|NCT00853307|11988998|FG001|Overall Study|Adverse Event|2
7583841|NCT00853307|11988997|FG000|Overall Study|Withdrawal by Subject|1
7583842|NCT00853307|11988998|FG001|Overall Study|Withdrawal by Subject|2
7583843|NCT00853307|11988997|FG000|Overall Study|Reason Not Specified|0
7583844|NCT00853307|11988998|FG001|Overall Study|Reason Not Specified|1
7583845|NCT00545129|11989012|FG000|Overall Study|Lack of Efficacy|2
7583846|NCT00545129|11989013|FG001|Overall Study|Lack of Efficacy|5
7583847|NCT00545129|11989012|FG000|Overall Study|Death|2
7583848|NCT00545129|11989013|FG001|Overall Study|Death|1
7583849|NCT00545129|11989012|FG000|Overall Study|Adverse Event|1
7583850|NCT00545129|11989013|FG001|Overall Study|Adverse Event|1
7583851|NCT00545129|11989012|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9
7583852|NCT00545129|11989013|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14
7583853|NCT00545129|11989012|FG000|Overall Study|Other|3
7583854|NCT00545129|11989013|FG001|Overall Study|Other|3
7625479|NCT03493854|12037155|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228
7625480|NCT03493854|12037154|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
7625481|NCT03493854|12037155|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
7625482|NCT03493854|12037154|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0
7625483|NCT03493854|12037155|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1
7625484|NCT03493854|12037154|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3
7625485|NCT03493854|12037155|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0
7625486|NCT03493854|12037154|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1
7625487|NCT03493854|12037155|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0
7625488|NCT03493854|12037154|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2
7625489|NCT03493854|12037155|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0
7625490|NCT03493854|12037154|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5
7625491|NCT03493854|12037155|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3
7625492|NCT03493854|12037154|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
7625493|NCT03493854|12037155|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
7625494|NCT03493854|12037154|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18
7625495|NCT03493854|12037155|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16
7625496|NCT03493451|12037164|FG000|Overall Study|Death|11
7625497|NCT03493451|12037165|FG001|Overall Study|Death|26
7625498|NCT03493451|12037166|FG002|Overall Study|Death|3
7625499|NCT03493451|12037164|FG000|Overall Study|Lost to Follow-up|1
7625500|NCT03493451|12037165|FG001|Overall Study|Lost to Follow-up|4
7625501|NCT03493451|12037166|FG002|Overall Study|Lost to Follow-up|1
7625502|NCT03493451|12037164|FG000|Overall Study|Withdrawal by Subject|1
7625503|NCT03493451|12037165|FG001|Overall Study|Withdrawal by Subject|1
7625504|NCT03493451|12037166|FG002|Overall Study|Withdrawal by Subject|2
7625505|NCT03493451|12037164|FG000|Overall Study|Progressive Disease|1
7625506|NCT03493451|12037165|FG001|Overall Study|Progressive Disease|0
7625507|NCT03493451|12037166|FG002|Overall Study|Progressive Disease|0
7625508|NCT03493451|12037164|FG000|Overall Study|Transferred to long term extension study|8
7625509|NCT03493451|12037165|FG001|Overall Study|Transferred to long term extension study|13
7625510|NCT03493451|12037166|FG002|Overall Study|Transferred to long term extension study|5
7625511|NCT03476239|12037174|FG000|Overall Study|Withdrawal by Subject|10
7625512|NCT03476239|12037174|FG000|Overall Study|Death|80
7625513|NCT03476239|12037174|FG000|Overall Study|Lost to Follow-up|8
7625514|NCT03401749|12037190|FG000|Overall Study|Lost to Follow-up|20
7625515|NCT03401749|12037191|FG001|Overall Study|Lost to Follow-up|16
7625516|NCT03401749|12037192|FG002|Overall Study|Lost to Follow-up|26
7583855|NCT00548093|11989021|FG000|Overall Study|Death|33
7583856|NCT00548093|11989022|FG001|Overall Study|Death|13
7583857|NCT00548093|11989021|FG000|Overall Study|Lost to Follow-up|3
7583858|NCT00548093|11989022|FG001|Overall Study|Lost to Follow-up|1
7583859|NCT00548093|11989021|FG000|Overall Study|Objective progression or relapse|1
7583860|NCT00548093|11989022|FG001|Overall Study|Objective progression or relapse|1
7583861|NCT00548093|11989021|FG000|Overall Study|Other|11
7583862|NCT00548093|11989022|FG001|Overall Study|Other|1
7583863|NCT00548093|11989021|FG000|Overall Study|Withdrawal by Subject|1
7583864|NCT00548093|11989022|FG001|Overall Study|Withdrawal by Subject|0
7583865|NCT00548093|11989021|FG000|Overall Study|Completed post-treatment follow-up|1
7583866|NCT00548093|11989022|FG001|Overall Study|Completed post-treatment follow-up|0
7625517|NCT03337113|12037204|FG000|Overall Study|Adverse Event|1
7625518|NCT03337113|12037205|FG001|Overall Study|Adverse Event|1
7625519|NCT03337113|12037206|FG002|Overall Study|Adverse Event|0
7625520|NCT03337113|12037207|FG003|Overall Study|Adverse Event|1
7625521|NCT03337113|12037204|FG000|Overall Study|Physician Decision|0
7625522|NCT03337113|12037205|FG001|Overall Study|Physician Decision|2
7625523|NCT03337113|12037206|FG002|Overall Study|Physician Decision|0
7625524|NCT03337113|12037207|FG003|Overall Study|Physician Decision|1
7625525|NCT03337113|12037204|FG000|Overall Study|Withdrawal by Subject|0
7625526|NCT03337113|12037205|FG001|Overall Study|Withdrawal by Subject|0
7625527|NCT03337113|12037206|FG002|Overall Study|Withdrawal by Subject|1
7625528|NCT03337113|12037207|FG003|Overall Study|Withdrawal by Subject|0
7765120|NCT00838916|12207105|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22
7765121|NCT00838916|12207104|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
7765122|NCT00838916|12207105|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
7765123|NCT00838916|12207104|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
7765124|NCT00838916|12207105|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
7765125|NCT00838916|12207104|FG000|Follow-up Period (8 Weeks)|Physician Decision|2
7765126|NCT00838916|12207105|FG001|Follow-up Period (8 Weeks)|Physician Decision|0
7765127|NCT00838916|12207104|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
7765128|NCT00838916|12207105|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
7765129|NCT00838916|12207104|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
7765130|NCT00838916|12207105|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
7765131|NCT00838916|12207104|FG000|Follow-up Period (8 Weeks)|Missing|3
7765132|NCT00838916|12207105|FG001|Follow-up Period (8 Weeks)|Missing|0
7765133|NCT00838929|12207114|FG000|Overall Study|Protocol Violation|0
7765134|NCT00838929|12207115|FG001|Overall Study|Protocol Violation|1
7765135|NCT00838929|12207116|FG002|Overall Study|Protocol Violation|0
7765136|NCT00838929|12207114|FG000|Overall Study|Disease progression|0
7765137|NCT00838929|12207115|FG001|Overall Study|Disease progression|2
7765138|NCT00838929|12207116|FG002|Overall Study|Disease progression|1
7765139|NCT00839072|12207122|FG000|First Intervention Period|Withdrawal by Subject|1
7765140|NCT00839072|12207123|FG001|First Intervention Period|Withdrawal by Subject|0
7765141|NCT00839072|12207122|FG000|First Intervention Period|Adverse Event|1
7765142|NCT00839072|12207123|FG001|First Intervention Period|Adverse Event|1
7765143|NCT00839072|12207122|FG000|Second Intervention Period|Withdrawal by Subject|1
7765144|NCT00839072|12207123|FG001|Second Intervention Period|Withdrawal by Subject|0
7765145|NCT00839098|12207132|FG000|Overall Study|Withdrawal by Subject|2
7765146|NCT00839098|12207133|FG001|Overall Study|Withdrawal by Subject|1
7765147|NCT00839098|12207134|FG002|Overall Study|Withdrawal by Subject|7
7765148|NCT00839254|12207159|FG000|Overall Study|Protocol Violation|0
7765149|NCT00839254|12207160|FG001|Overall Study|Protocol Violation|1
7765150|NCT00839254|12207161|FG002|Overall Study|Protocol Violation|1
7765151|NCT00839254|12207162|FG003|Overall Study|Protocol Violation|1
7765152|NCT00839254|12207163|FG004|Overall Study|Protocol Violation|0
7765153|NCT00839254|12207164|FG005|Overall Study|Protocol Violation|0
7765154|NCT00839254|12207165|FG006|Overall Study|Protocol Violation|1
7765155|NCT00839254|12207166|FG007|Overall Study|Protocol Violation|2
7765156|NCT00839254|12207159|FG000|Overall Study|Physician Decision|0
7765157|NCT00839254|12207160|FG001|Overall Study|Physician Decision|1
7765158|NCT00839254|12207161|FG002|Overall Study|Physician Decision|0
7765159|NCT00839254|12207162|FG003|Overall Study|Physician Decision|0
7765160|NCT00839254|12207163|FG004|Overall Study|Physician Decision|0
7765161|NCT00839254|12207164|FG005|Overall Study|Physician Decision|0
7765162|NCT00839254|12207165|FG006|Overall Study|Physician Decision|0
7765163|NCT00839254|12207166|FG007|Overall Study|Physician Decision|1
7765164|NCT00839254|12207159|FG000|Overall Study|Wrong treatment number allocation|0
7765165|NCT00839254|12207160|FG001|Overall Study|Wrong treatment number allocation|1
7765166|NCT00839254|12207161|FG002|Overall Study|Wrong treatment number allocation|0
7765167|NCT00839254|12207162|FG003|Overall Study|Wrong treatment number allocation|0
7765168|NCT00839254|12207163|FG004|Overall Study|Wrong treatment number allocation|0
7583867|NCT00554606|11989031|FG000|Overall Study|Adverse Event|3
7583868|NCT00554606|11989031|FG000|Overall Study|Abnormal laboratory values|1
7583869|NCT00554606|11989031|FG000|Overall Study|Unsatisfactory therapeutic effect|14
7583870|NCT00554606|11989031|FG000|Overall Study|Subject withdrew consent|2
7583871|NCT00554606|11989031|FG000|Overall Study|Lost to Follow-up|2
7583872|NCT00554606|11989031|FG000|Overall Study|Administrative problems|60
7583873|NCT00554606|11989031|FG000|Overall Study|Death|1
7583874|NCT00554606|11989031|FG000|Overall Study|Protocol deviation|2
7583879|NCT00566995|11989069|FG000|Overall Study|Toxicity|4
7583880|NCT00566995|11989069|FG000|Overall Study|Withdrew consent|3
7583881|NCT00586924|11989079|FG000|Overall Study|Adverse event/serious adverse event|0
7583882|NCT00586924|11989080|FG001|Overall Study|Adverse event/serious adverse event|0
7583883|NCT00586924|11989081|FG002|Overall Study|Adverse event/serious adverse event|0
7583884|NCT00586924|11989082|FG003|Overall Study|Adverse event/serious adverse event|1
7583885|NCT00586924|11989083|FG004|Overall Study|Adverse event/serious adverse event|0
7583886|NCT00586924|11989084|FG005|Overall Study|Adverse event/serious adverse event|2
7583887|NCT00586924|11989079|FG000|Overall Study|Initiation of alternative cancer therapy|0
7583888|NCT00586924|11989080|FG001|Overall Study|Initiation of alternative cancer therapy|0
7583889|NCT00586924|11989081|FG002|Overall Study|Initiation of alternative cancer therapy|0
7583890|NCT00586924|11989082|FG003|Overall Study|Initiation of alternative cancer therapy|0
7583891|NCT00586924|11989083|FG004|Overall Study|Initiation of alternative cancer therapy|0
7583892|NCT00586924|11989084|FG005|Overall Study|Initiation of alternative cancer therapy|1
7583893|NCT00586924|11989079|FG000|Overall Study|Disease progression|0
7583894|NCT00586924|11989080|FG001|Overall Study|Disease progression|0
7583895|NCT00586924|11989081|FG002|Overall Study|Disease progression|0
7583896|NCT00586924|11989082|FG003|Overall Study|Disease progression|1
7583897|NCT00586924|11989083|FG004|Overall Study|Disease progression|1
7583898|NCT00586924|11989084|FG005|Overall Study|Disease progression|0
7583899|NCT00586924|11989079|FG000|Overall Study|Development of neutralizing antibodies|2
7583900|NCT00586924|11989080|FG001|Overall Study|Development of neutralizing antibodies|2
7583901|NCT00586924|11989081|FG002|Overall Study|Development of neutralizing antibodies|2
7583902|NCT00586924|11989082|FG003|Overall Study|Development of neutralizing antibodies|0
7583903|NCT00586924|11989083|FG004|Overall Study|Development of neutralizing antibodies|0
7583904|NCT00586924|11989084|FG005|Overall Study|Development of neutralizing antibodies|22
7583905|NCT00586924|11989079|FG000|Overall Study|Complete response|0
7583906|NCT00586924|11989080|FG001|Overall Study|Complete response|1
7583907|NCT00586924|11989081|FG002|Overall Study|Complete response|0
7583908|NCT00586924|11989082|FG003|Overall Study|Complete response|0
7583909|NCT00586924|11989083|FG004|Overall Study|Complete response|2
7583910|NCT00586924|11989084|FG005|Overall Study|Complete response|2
7583911|NCT00586924|11989079|FG000|Overall Study|Other|1
7583912|NCT00586924|11989080|FG001|Overall Study|Other|0
7765169|NCT00839254|12207164|FG005|Overall Study|Wrong treatment number allocation|1
7765170|NCT00839254|12207165|FG006|Overall Study|Wrong treatment number allocation|0
7765171|NCT00839254|12207166|FG007|Overall Study|Wrong treatment number allocation|0
7765172|NCT00839254|12207159|FG000|Overall Study|Adverse Event|12
7765173|NCT00839254|12207160|FG001|Overall Study|Adverse Event|6
7765174|NCT00839254|12207161|FG002|Overall Study|Adverse Event|3
7765175|NCT00839254|12207162|FG003|Overall Study|Adverse Event|5
7765176|NCT00839254|12207163|FG004|Overall Study|Adverse Event|2
7765177|NCT00839254|12207164|FG005|Overall Study|Adverse Event|1
7583913|NCT00586924|11989081|FG002|Overall Study|Other|1
7583914|NCT00586924|11989082|FG003|Overall Study|Other|1
7583915|NCT00586924|11989083|FG004|Overall Study|Other|1
7583916|NCT00586924|11989084|FG005|Overall Study|Other|6
7765178|NCT00839254|12207165|FG006|Overall Study|Adverse Event|0
7765179|NCT00839254|12207166|FG007|Overall Study|Adverse Event|1
7765180|NCT00839254|12207159|FG000|Overall Study|Withdrawal by Subject|87
7765181|NCT00839254|12207160|FG001|Overall Study|Withdrawal by Subject|53
7765182|NCT00839254|12207161|FG002|Overall Study|Withdrawal by Subject|54
7765183|NCT00839254|12207162|FG003|Overall Study|Withdrawal by Subject|32
7765184|NCT00839254|12207163|FG004|Overall Study|Withdrawal by Subject|27
7765185|NCT00839254|12207164|FG005|Overall Study|Withdrawal by Subject|15
7765186|NCT00839254|12207165|FG006|Overall Study|Withdrawal by Subject|22
7765187|NCT00839254|12207166|FG007|Overall Study|Withdrawal by Subject|9
7765188|NCT00839254|12207159|FG000|Overall Study|Wrong group allocation|0
7765189|NCT00839254|12207160|FG001|Overall Study|Wrong group allocation|0
7765190|NCT00839254|12207161|FG002|Overall Study|Wrong group allocation|0
7765191|NCT00839254|12207162|FG003|Overall Study|Wrong group allocation|0
7765192|NCT00839254|12207163|FG004|Overall Study|Wrong group allocation|0
7765193|NCT00839254|12207164|FG005|Overall Study|Wrong group allocation|0
7765194|NCT00839254|12207165|FG006|Overall Study|Wrong group allocation|1
7765195|NCT00839254|12207166|FG007|Overall Study|Wrong group allocation|0
7765196|NCT00839254|12207159|FG000|Overall Study|Parents wanted pneumococcal vaccine|1
7765197|NCT00839254|12207160|FG001|Overall Study|Parents wanted pneumococcal vaccine|0
7765198|NCT00839254|12207161|FG002|Overall Study|Parents wanted pneumococcal vaccine|0
7765199|NCT00839254|12207162|FG003|Overall Study|Parents wanted pneumococcal vaccine|0
7765200|NCT00839254|12207163|FG004|Overall Study|Parents wanted pneumococcal vaccine|0
7765201|NCT00839254|12207164|FG005|Overall Study|Parents wanted pneumococcal vaccine|1
7765202|NCT00839254|12207165|FG006|Overall Study|Parents wanted pneumococcal vaccine|0
7765203|NCT00839254|12207166|FG007|Overall Study|Parents wanted pneumococcal vaccine|0
7765204|NCT00839254|12207159|FG000|Overall Study|Withdrawn due to non-compliance|2
7765205|NCT00839254|12207160|FG001|Overall Study|Withdrawn due to non-compliance|0
7765206|NCT00839254|12207161|FG002|Overall Study|Withdrawn due to non-compliance|0
7765207|NCT00839254|12207162|FG003|Overall Study|Withdrawn due to non-compliance|0
7765208|NCT00839254|12207163|FG004|Overall Study|Withdrawn due to non-compliance|0
7765209|NCT00839254|12207164|FG005|Overall Study|Withdrawn due to non-compliance|0
7583875|NCT00555009|11989039|FG000|Overall Study|Withdrawal by Subject|0
7583876|NCT00555009|11989040|FG001|Overall Study|Withdrawal by Subject|1
7583877|NCT00555009|11989039|FG000|Overall Study|Terminated by Sponsor|2
7583878|NCT00555009|11989040|FG001|Overall Study|Terminated by Sponsor|5
7583917|NCT00588861|11989100|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95
7583918|NCT00588861|11989101|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86
7583919|NCT00588861|11989100|FG000|6 Months|Patients did not return for follow-up|98
7583920|NCT00588861|11989101|FG001|6 Months|Patients did not return for follow-up|73
7583921|NCT00588861|11989100|FG000|1 Year|Patients did not return for follow-up|89
7583922|NCT00588861|11989101|FG001|1 Year|Patients did not return for follow-up|82
7583923|NCT00588861|11989100|FG000|2 Years|Patients did not return for follow-up|92
7583924|NCT00588861|11989101|FG001|2 Years|Patients did not return for follow-up|87
7583925|NCT00588861|11989100|FG000|4 Years|Patients did not return for follow-up|91
7583926|NCT00588861|11989101|FG001|4 Years|Patients did not return for follow-up|103
7583927|NCT00588861|11989100|FG000|6 Years|Patients did not return for follow-up|104
7583928|NCT00588861|11989101|FG001|6 Years|Patients did not return for follow-up|109
7583929|NCT00588861|11989100|FG000|8 Years|Patients did not return for follow-up|105
7583930|NCT00588861|11989101|FG001|8 Years|Patients did not return for follow-up|114
7583931|NCT00588861|11989100|FG000|10 Years|Incomplete due to study termination|107
7583932|NCT00588861|11989101|FG001|10 Years|Incomplete due to study termination|114
7765210|NCT00839254|12207165|FG006|Overall Study|Withdrawn due to non-compliance|0
7765211|NCT00839254|12207166|FG007|Overall Study|Withdrawn due to non-compliance|0
7765212|NCT00839254|12207159|FG000|Overall Study|Lost to Follow-up|51
7765213|NCT00839254|12207160|FG001|Overall Study|Lost to Follow-up|30
7765214|NCT00839254|12207161|FG002|Overall Study|Lost to Follow-up|32
7765215|NCT00839254|12207162|FG003|Overall Study|Lost to Follow-up|24
7765216|NCT00839254|12207163|FG004|Overall Study|Lost to Follow-up|8
7765217|NCT00839254|12207164|FG005|Overall Study|Lost to Follow-up|8
7765218|NCT00839254|12207165|FG006|Overall Study|Lost to Follow-up|4
7765219|NCT00839254|12207166|FG007|Overall Study|Lost to Follow-up|2
7765220|NCT00839306|12207217|FG000|Overall Study|Adverse Event|3
7765221|NCT00839306|12207218|FG001|Overall Study|Adverse Event|5
7765222|NCT00839306|12207217|FG000|Overall Study|Lost to Follow-up|6
7765223|NCT00839306|12207218|FG001|Overall Study|Lost to Follow-up|9
7765224|NCT00839306|12207217|FG000|Overall Study|Withdrawal by Subject|5
7765225|NCT00839306|12207218|FG001|Overall Study|Withdrawal by Subject|7
7765226|NCT00839306|12207217|FG000|Overall Study|Lack of Efficacy|5
7765227|NCT00839306|12207218|FG001|Overall Study|Lack of Efficacy|4
7765228|NCT00839306|12207217|FG000|Overall Study|Other|6
7765229|NCT00839306|12207218|FG001|Overall Study|Other|18
7765230|NCT00839332|12207249|FG000|Phase 1|Disease Progression|38
7765231|NCT00839332|12207250|FG001|Phase 1|Disease Progression|0
7765232|NCT00839332|12207251|FG002|Phase 1|Disease Progression|0
7765233|NCT00839332|12207249|FG000|Phase 1|Adverse Event|6
7765234|NCT00839332|12207250|FG001|Phase 1|Adverse Event|0
7765235|NCT00839332|12207251|FG002|Phase 1|Adverse Event|0
7765236|NCT00839332|12207249|FG000|Phase 1|Withdrawal by Subject|4
7765237|NCT00839332|12207250|FG001|Phase 1|Withdrawal by Subject|0
7765238|NCT00839332|12207251|FG002|Phase 1|Withdrawal by Subject|0
7765239|NCT00839332|12207249|FG000|Phase 1|Physician Decision|2
7765240|NCT00839332|12207250|FG001|Phase 1|Physician Decision|0
7765241|NCT00839332|12207251|FG002|Phase 1|Physician Decision|0
7765242|NCT00839332|12207249|FG000|Phase 2|Protocol Violation|0
7765243|NCT00839332|12207250|FG001|Phase 2|Protocol Violation|1
7765244|NCT00839332|12207251|FG002|Phase 2|Protocol Violation|0
7765245|NCT00839332|12207249|FG000|Phase 2|Disease Progression|0
7765246|NCT00839332|12207250|FG001|Phase 2|Disease Progression|46
7625584|NCT03233048|12037241|FG000|Overall Study|Withdrawal by Subject|1
7765247|NCT00839332|12207251|FG002|Phase 2|Disease Progression|21
7765248|NCT00839332|12207249|FG000|Phase 2|Adverse Event|0
7765249|NCT00839332|12207250|FG001|Phase 2|Adverse Event|8
7765250|NCT00839332|12207251|FG002|Phase 2|Adverse Event|6
7765251|NCT00839332|12207249|FG000|Phase 2|Death|0
7765252|NCT00839332|12207250|FG001|Phase 2|Death|4
7765253|NCT00839332|12207251|FG002|Phase 2|Death|2
7765254|NCT00839332|12207249|FG000|Phase 2|Withdrawal by Subject|0
7765255|NCT00839332|12207250|FG001|Phase 2|Withdrawal by Subject|5
7765256|NCT00839332|12207251|FG002|Phase 2|Withdrawal by Subject|8
7765257|NCT00839332|12207249|FG000|Phase 2|Physician Decision|0
7765258|NCT00839332|12207250|FG001|Phase 2|Physician Decision|4
7765259|NCT00839332|12207251|FG002|Phase 2|Physician Decision|1
7765260|NCT00839332|12207249|FG000|Phase 2|Lost to Follow-up|0
7765261|NCT00839332|12207250|FG001|Phase 2|Lost to Follow-up|0
7765262|NCT00839332|12207251|FG002|Phase 2|Lost to Follow-up|1
7765263|NCT00839423|12207264|FG000|Overall Study|Adverse Event|4
7765264|NCT00839423|12207265|FG001|Overall Study|Adverse Event|3
7765265|NCT00839423|12207266|FG002|Overall Study|Adverse Event|7
7765266|NCT00839423|12207267|FG003|Overall Study|Adverse Event|16
7583998|NCT03288142|11989129|FG000|Overall Study|Lost to Follow-up|22
7583999|NCT03288142|11989130|FG001|Overall Study|Lost to Follow-up|15
7584000|NCT03112603|11989140|FG000|End of Randomization Period|Lost to Follow-up|1
7584001|NCT03112603|11989141|FG001|End of Randomization Period|Lost to Follow-up|0
7584002|NCT03112603|11989142|FG002|End of Randomization Period|Lost to Follow-up|0
7584003|NCT03112603|11989140|FG000|End of Randomization Period|Subject/Guardian Decision|4
7584004|NCT03112603|11989141|FG001|End of Randomization Period|Subject/Guardian Decision|11
7584005|NCT03112603|11989142|FG002|End of Randomization Period|Subject/Guardian Decision|0
7584006|NCT03112603|11989140|FG000|End of Randomization Period|Physician Decision|4
7584007|NCT03112603|11989141|FG001|End of Randomization Period|Physician Decision|14
7584008|NCT03112603|11989142|FG002|End of Randomization Period|Physician Decision|0
7584009|NCT03112603|11989140|FG000|End of Randomization Period|Failure to meet protocol continuation criteria|4
7584010|NCT03112603|11989141|FG001|End of Randomization Period|Failure to meet protocol continuation criteria|5
7584011|NCT03112603|11989142|FG002|End of Randomization Period|Failure to meet protocol continuation criteria|0
7584012|NCT03112603|11989140|FG000|End of Randomization Period|Death|8
7584013|NCT03112603|11989141|FG001|End of Randomization Period|Death|7
7584014|NCT03112603|11989142|FG002|End of Randomization Period|Death|0
7584015|NCT03112603|11989140|FG000|End of Randomization Period|Disease Relapse|9
7584016|NCT03112603|11989141|FG001|End of Randomization Period|Disease Relapse|7
7584017|NCT03112603|11989142|FG002|End of Randomization Period|Disease Relapse|0
7584018|NCT03112603|11989140|FG000|End of Randomization Period|Lack of Efficacy|24
7584019|NCT03112603|11989141|FG001|End of Randomization Period|Lack of Efficacy|70
7584020|NCT03112603|11989142|FG002|End of Randomization Period|Lack of Efficacy|0
7584021|NCT03112603|11989140|FG000|End of Randomization Period|Adverse Event|28
7584022|NCT03112603|11989141|FG001|End of Randomization Period|Adverse Event|8
7584023|NCT03112603|11989142|FG002|End of Randomization Period|Adverse Event|0
7584024|NCT03112603|11989140|FG000|End of Randomization Period|Ongoing Treatment|83
7584025|NCT03112603|11989141|FG001|End of Randomization Period|Ongoing Treatment|42
7584026|NCT03112603|11989142|FG002|End of Randomization Period|Ongoing Treatment|0
7584027|NCT03112603|11989140|FG000|End of Cross Over Period|Death|0
7584028|NCT03112603|11989141|FG001|End of Cross Over Period|Death|0
7584029|NCT03112603|11989142|FG002|End of Cross Over Period|Death|1
7584030|NCT03112603|11989140|FG000|End of Cross Over Period|Subject/Guardian Decision|0
7584031|NCT03112603|11989141|FG001|End of Cross Over Period|Subject/Guardian Decision|0
7584032|NCT03112603|11989142|FG002|End of Cross Over Period|Subject/Guardian Decision|3
7584033|NCT03112603|11989140|FG000|End of Cross Over Period|Physician Decision|0
7584034|NCT03112603|11989141|FG001|End of Cross Over Period|Physician Decision|0
7584035|NCT03112603|11989142|FG002|End of Cross Over Period|Physician Decision|3
7584036|NCT03112603|11989140|FG000|End of Cross Over Period|Lack of Efficacy|0
7584037|NCT03112603|11989141|FG001|End of Cross Over Period|Lack of Efficacy|0
7584038|NCT03112603|11989142|FG002|End of Cross Over Period|Lack of Efficacy|4
7584039|NCT03112603|11989140|FG000|End of Cross Over Period|Adverse Event|0
7584040|NCT03112603|11989141|FG001|End of Cross Over Period|Adverse Event|0
7584041|NCT03112603|11989142|FG002|End of Cross Over Period|Adverse Event|4
7584042|NCT03112603|11989140|FG000|End of Cross Over Period|Treatment Ongoing|0
7584043|NCT03112603|11989141|FG001|End of Cross Over Period|Treatment Ongoing|0
7765267|NCT00839423|12207264|FG000|Overall Study|Lack of Efficacy|6
7765268|NCT00839423|12207265|FG001|Overall Study|Lack of Efficacy|6
7765269|NCT00839423|12207266|FG002|Overall Study|Lack of Efficacy|3
7584044|NCT03112603|11989142|FG002|End of Cross Over Period|Treatment Ongoing|46
7765270|NCT00839423|12207267|FG003|Overall Study|Lack of Efficacy|2
7765271|NCT00839423|12207264|FG000|Overall Study|Non-compliance|0
7765272|NCT00839423|12207265|FG001|Overall Study|Non-compliance|0
7765273|NCT00839423|12207266|FG002|Overall Study|Non-compliance|0
7765274|NCT00839423|12207267|FG003|Overall Study|Non-compliance|1
7765275|NCT00839423|12207264|FG000|Overall Study|Protocol Violation|0
7765276|NCT00839423|12207265|FG001|Overall Study|Protocol Violation|1
7765277|NCT00839423|12207266|FG002|Overall Study|Protocol Violation|2
7765278|NCT00839423|12207267|FG003|Overall Study|Protocol Violation|0
7765279|NCT00839423|12207264|FG000|Overall Study|Withdrawal of consent|4
7765280|NCT00839423|12207265|FG001|Overall Study|Withdrawal of consent|0
7765281|NCT00839423|12207266|FG002|Overall Study|Withdrawal of consent|4
7765282|NCT00839423|12207267|FG003|Overall Study|Withdrawal of consent|1
7765283|NCT00839423|12207264|FG000|Overall Study|Lost to Follow-up|1
7584059|NCT02767570|11989159|FG000|Overall Study|Lost to Follow-up|3
7584060|NCT02767570|11989160|FG001|Overall Study|Lost to Follow-up|0
7584061|NCT02767570|11989159|FG000|Overall Study|COVID shutdown|2
7584062|NCT02767570|11989160|FG001|Overall Study|COVID shutdown|5
7584063|NCT02767570|11989159|FG000|Overall Study|Increased pain|2
7584064|NCT02767570|11989160|FG001|Overall Study|Increased pain|0
7584065|NCT02767570|11989159|FG000|Overall Study|Withdrawal by Subject|1
7584066|NCT02767570|11989160|FG001|Overall Study|Withdrawal by Subject|3
7584067|NCT02767570|11989159|FG000|Overall Study|Unrelated medical issue|1
7584068|NCT02767570|11989160|FG001|Overall Study|Unrelated medical issue|1
7584069|NCT02767570|11989159|FG000|Overall Study|Received intra-articular injection|0
7584070|NCT02767570|11989160|FG001|Overall Study|Received intra-articular injection|1
7584071|NCT02702180|11989169|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
7584072|NCT02702180|11989170|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
7584073|NCT02702180|11989171|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7584074|NCT02702180|11989169|FG000|Double-blind Treatment Period|Adverse Event|0
7584075|NCT02702180|11989170|FG001|Double-blind Treatment Period|Adverse Event|0
7584076|NCT02702180|11989171|FG002|Double-blind Treatment Period|Adverse Event|1
7584077|NCT02702180|11989169|FG000|Double-blind Treatment Period|Lack of Efficacy|0
7584078|NCT02702180|11989170|FG001|Double-blind Treatment Period|Lack of Efficacy|0
7584079|NCT02702180|11989171|FG002|Double-blind Treatment Period|Lack of Efficacy|1
7584080|NCT02702180|11989169|FG000|Double-blind Treatment Period|Protocol Violation|0
7584081|NCT02702180|11989170|FG001|Double-blind Treatment Period|Protocol Violation|0
7584082|NCT02702180|11989171|FG002|Double-blind Treatment Period|Protocol Violation|2
7584083|NCT02702180|11989169|FG000|Open-label Treatment Period|Withdrawal by Subject|0
7584084|NCT02702180|11989170|FG001|Open-label Treatment Period|Withdrawal by Subject|1
7584085|NCT02702180|11989171|FG002|Open-label Treatment Period|Withdrawal by Subject|1
7584086|NCT02702180|11989169|FG000|Open-label Treatment Period|Withdrawn in error|0
7584087|NCT02702180|11989170|FG001|Open-label Treatment Period|Withdrawn in error|0
7584088|NCT02702180|11989171|FG002|Open-label Treatment Period|Withdrawn in error|1
7584089|NCT02545049|11989182|FG000|Overall Study|Withdrawal by Subject|1
7584090|NCT02545049|11989183|FG001|Overall Study|Withdrawal by Subject|7
7584091|NCT02545049|11989182|FG000|Overall Study|Lost to Follow-up|4
7584092|NCT02545049|11989183|FG001|Overall Study|Lost to Follow-up|6
7584093|NCT02545049|11989182|FG000|Overall Study|GCP violations|37
7584094|NCT02545049|11989183|FG001|Overall Study|GCP violations|48
7765284|NCT00839423|12207265|FG001|Overall Study|Lost to Follow-up|0
7765285|NCT00839423|12207266|FG002|Overall Study|Lost to Follow-up|1
7765286|NCT00839423|12207267|FG003|Overall Study|Lost to Follow-up|0
7765287|NCT00839423|12207264|FG000|Overall Study|Administrative or other reasons|3
7765288|NCT00839423|12207265|FG001|Overall Study|Administrative or other reasons|0
7765289|NCT00839423|12207266|FG002|Overall Study|Administrative or other reasons|1
7765290|NCT00839423|12207267|FG003|Overall Study|Administrative or other reasons|0
7765291|NCT00839436|12207280|FG000|Overall Study|Developed exclusionary condition|1
7584095|NCT02448381|11989191|FG000|Overall Study|Adverse Event|2
7584096|NCT02448381|11989192|FG001|Overall Study|Adverse Event|0
7584097|NCT02448381|11989191|FG000|Overall Study|Lost to Follow-up|16
7584098|NCT02448381|11989192|FG001|Overall Study|Lost to Follow-up|9
7584099|NCT02448381|11989191|FG000|Overall Study|Physician Decision|1
7765292|NCT00839436|12207281|FG001|Overall Study|Developed exclusionary condition|0
7765293|NCT00839436|12207282|FG002|Overall Study|Developed exclusionary condition|0
7765294|NCT00839436|12207280|FG000|Overall Study|Withdrawal by Subject|0
7765295|NCT00839436|12207281|FG001|Overall Study|Withdrawal by Subject|1
7765296|NCT00839436|12207282|FG002|Overall Study|Withdrawal by Subject|0
7765297|NCT00839436|12207280|FG000|Overall Study|Study drug no longer available|0
7765298|NCT00839436|12207281|FG001|Overall Study|Study drug no longer available|0
7765299|NCT00839436|12207282|FG002|Overall Study|Study drug no longer available|1
7765300|NCT00839527|12207293|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11
7765301|NCT00839527|12207294|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29
7765302|NCT00839527|12207295|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22
7765303|NCT00839527|12207293|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
7765304|NCT00839527|12207294|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
7765305|NCT00839527|12207295|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
7765306|NCT00839527|12207293|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5
7765307|NCT00839527|12207294|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6
7765308|NCT00839527|12207295|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16
7765309|NCT00839527|12207293|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
7765310|NCT00839527|12207294|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
7765311|NCT00839527|12207295|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
7765312|NCT00839527|12207293|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
7765313|NCT00839527|12207294|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
7765314|NCT00839527|12207295|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
7765315|NCT00839527|12207293|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1
7765316|NCT00839527|12207294|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6
7765317|NCT00839527|12207295|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1
7765318|NCT00839527|12207293|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
7765319|NCT00839527|12207294|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
7765320|NCT00839527|12207295|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
7765321|NCT00839527|12207293|FG000|Treatment Period (TP) (156 Weeks)|Missing|0
7765322|NCT00839527|12207294|FG001|Treatment Period (TP) (156 Weeks)|Missing|1
7765323|NCT00839527|12207295|FG002|Treatment Period (TP) (156 Weeks)|Missing|0
7765324|NCT00839527|12207293|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
7765325|NCT00839527|12207294|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
7765326|NCT00839527|12207295|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
7765327|NCT00839527|12207293|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0
7765328|NCT00839527|12207294|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1
7765329|NCT00839527|12207295|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1
7765330|NCT00839527|12207293|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1
7765331|NCT00839527|12207294|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2
7765332|NCT00839527|12207295|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0
7765333|NCT00839527|12207293|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
7765334|NCT00839527|12207294|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
7765335|NCT00839527|12207295|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
7765336|NCT00839527|12207293|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
7765337|NCT00839527|12207294|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
7765338|NCT00839527|12207295|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
7765339|NCT00839527|12207293|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
7765340|NCT00839527|12207294|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
7765341|NCT00839527|12207295|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
7765342|NCT00839527|12207293|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
7765343|NCT00839527|12207294|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
7765344|NCT00839527|12207295|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
7584100|NCT02448381|11989192|FG001|Overall Study|Physician Decision|1
7584101|NCT02448381|11989191|FG000|Overall Study|Pregnancy|1
7584102|NCT02448381|11989192|FG001|Overall Study|Pregnancy|0
7584103|NCT02448381|11989191|FG000|Overall Study|Withdrawal by Subject|13
7584104|NCT02448381|11989192|FG001|Overall Study|Withdrawal by Subject|9
7584105|NCT02448381|11989191|FG000|Overall Study|Noncompliance with Study Procedures|2
7584106|NCT02448381|11989192|FG001|Overall Study|Noncompliance with Study Procedures|0
7584123|NCT01849874|11989215|FG000|Overall Study|Death|34
7584124|NCT01849874|11989216|FG001|Overall Study|Death|16
7584125|NCT01849874|11989215|FG000|Overall Study|Withdrawal by Subject|4
7584126|NCT01849874|11989216|FG001|Overall Study|Withdrawal by Subject|8
7584127|NCT01849874|11989215|FG000|Overall Study|Lost to Follow-up|0
7584128|NCT01849874|11989216|FG001|Overall Study|Lost to Follow-up|1
7584129|NCT01849874|11989215|FG000|Overall Study|Randomized but Never Treated|1
7584130|NCT01849874|11989216|FG001|Overall Study|Randomized but Never Treated|8
7584131|NCT01849874|11989215|FG000|Overall Study|Ongoing|162
7584132|NCT01849874|11989216|FG001|Overall Study|Ongoing|69
7584133|NCT01724866|11989226|FG000|Overall Study|Adverse Event|0
7584134|NCT01724866|11989227|FG001|Overall Study|Adverse Event|0
7584135|NCT01724866|11989228|FG002|Overall Study|Adverse Event|1
7584136|NCT01724866|11989229|FG003|Overall Study|Adverse Event|1
7584137|NCT01724866|11989226|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0
7584138|NCT01724866|11989227|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2
7584139|NCT01724866|11989228|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0
7584140|NCT01724866|11989229|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0
7584141|NCT01724866|11989226|FG000|Overall Study|Investigator's Discretion|0
7584142|NCT01724866|11989227|FG001|Overall Study|Investigator's Discretion|1
7584143|NCT01724866|11989228|FG002|Overall Study|Investigator's Discretion|1
7584144|NCT01724866|11989229|FG003|Overall Study|Investigator's Discretion|0
7584145|NCT01724866|11989226|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1
7584146|NCT01724866|11989227|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0
7584147|NCT01724866|11989228|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0
7584148|NCT01724866|11989229|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0
7584149|NCT01724866|11989226|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0
7584150|NCT01724866|11989227|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2
7584151|NCT01724866|11989228|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1
7584152|NCT01724866|11989229|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0
7584153|NCT01670877|11989243|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0
7584154|NCT01670877|11989244|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1
7584155|NCT01670877|11989245|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0
7584156|NCT01670877|11989246|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0
7584157|NCT01670877|11989247|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0
7584158|NCT01670877|11989248|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0
7584159|NCT01670877|11989243|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
7584160|NCT01670877|11989244|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
7584161|NCT01670877|11989245|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1
7584162|NCT01670877|11989246|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
7584163|NCT01670877|11989247|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
7584164|NCT01670877|11989248|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
7584165|NCT01670877|11989243|FG000|Part I and Part 2|Grade 2 vomiting|0
7584166|NCT01670877|11989244|FG001|Part I and Part 2|Grade 2 vomiting|0
7584167|NCT01670877|11989245|FG002|Part I and Part 2|Grade 2 vomiting|0
7584168|NCT01670877|11989246|FG003|Part I and Part 2|Grade 2 vomiting|1
7584169|NCT01670877|11989247|FG004|Part I and Part 2|Grade 2 vomiting|0
7584170|NCT01670877|11989248|FG005|Part I and Part 2|Grade 2 vomiting|0
7584171|NCT01670877|11989243|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0
7584172|NCT01670877|11989244|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0
7584173|NCT01670877|11989245|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0
7584174|NCT01670877|11989246|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1
7584175|NCT01670877|11989247|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0
7584176|NCT01670877|11989248|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0
7584177|NCT01670877|11989243|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
7584178|NCT01670877|11989244|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
7584179|NCT01670877|11989245|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
7584180|NCT01670877|11989246|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1
7584181|NCT01670877|11989247|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
7584182|NCT01670877|11989248|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
7765345|NCT00839527|12207293|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
7765346|NCT00839527|12207294|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
7765347|NCT00839527|12207295|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
7765348|NCT00839527|12207293|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
7765349|NCT00839527|12207294|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
7765350|NCT00839527|12207295|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
7765351|NCT00839527|12207293|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
7765352|NCT00839527|12207294|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
7584191|NCT00667628|11989273|FG000|Overall Study|Lost to Follow-up|1
7584192|NCT00667628|11989274|FG001|Overall Study|Lost to Follow-up|0
7584193|NCT00667628|11989273|FG000|Overall Study|Death|6
7584194|NCT00667628|11989274|FG001|Overall Study|Death|6
7584195|NCT00667628|11989273|FG000|Overall Study|Investigator Considers in Best Interest|1
7584196|NCT00667628|11989274|FG001|Overall Study|Investigator Considers in Best Interest|0
7584197|NCT00667628|11989273|FG000|Overall Study|Sponsor Terminated Study|17
7584198|NCT00667628|11989274|FG001|Overall Study|Sponsor Terminated Study|21
7625615|NCT02943993|12037291|FG000|Overall Study|Withdrawal by Subject|52
7625616|NCT02943993|12037291|FG000|Overall Study|Transfer to another institution|6
7625617|NCT02943993|12037291|FG000|Overall Study|Lost to Follow-up|135
7625618|NCT02943993|12037291|FG000|Overall Study|Death|98
7625619|NCT02943993|12037291|FG000|Overall Study|Other reason for premature termination|32
7625620|NCT02943993|12037291|FG000|Overall Study|Missing reason for termination|7
7625621|NCT02877134|12037313|FG000|Overall Study|Death|0
7625622|NCT02877134|12037314|FG001|Overall Study|Death|1
7625623|NCT02877134|12037315|FG002|Overall Study|Death|0
7625624|NCT02877134|12037316|FG003|Overall Study|Death|0
7625625|NCT02877134|12037317|FG004|Overall Study|Death|0
7625626|NCT02877134|12037318|FG005|Overall Study|Death|1
7625627|NCT02877134|12037319|FG006|Overall Study|Death|0
7625628|NCT02877134|12037313|FG000|Overall Study|Lost to Follow-up|0
7625629|NCT02877134|12037314|FG001|Overall Study|Lost to Follow-up|4
7625630|NCT02877134|12037315|FG002|Overall Study|Lost to Follow-up|0
7625631|NCT02877134|12037316|FG003|Overall Study|Lost to Follow-up|1
7625632|NCT02877134|12037317|FG004|Overall Study|Lost to Follow-up|0
7625633|NCT02877134|12037318|FG005|Overall Study|Lost to Follow-up|0
7625634|NCT02877134|12037319|FG006|Overall Study|Lost to Follow-up|0
7625635|NCT02877134|12037313|FG000|Overall Study|Withdrawal by Subject|13
7625636|NCT02877134|12037314|FG001|Overall Study|Withdrawal by Subject|19
7625637|NCT02877134|12037315|FG002|Overall Study|Withdrawal by Subject|4
7625638|NCT02877134|12037316|FG003|Overall Study|Withdrawal by Subject|6
7625639|NCT02877134|12037317|FG004|Overall Study|Withdrawal by Subject|3
7625640|NCT02877134|12037318|FG005|Overall Study|Withdrawal by Subject|5
7625641|NCT02877134|12037319|FG006|Overall Study|Withdrawal by Subject|0
7625642|NCT02877134|12037313|FG000|Overall Study|Other|1
7625643|NCT02877134|12037314|FG001|Overall Study|Other|1
7625644|NCT02877134|12037315|FG002|Overall Study|Other|2
7625645|NCT02877134|12037316|FG003|Overall Study|Other|6
7625646|NCT02877134|12037317|FG004|Overall Study|Other|3
7625647|NCT02877134|12037318|FG005|Overall Study|Other|1
7625648|NCT02877134|12037319|FG006|Overall Study|Other|1
7625649|NCT02762708|12037341|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0
7625650|NCT02762708|12037342|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2
7625651|NCT02762708|12037343|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0
7625652|NCT02762708|12037344|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0
7765353|NCT00839527|12207295|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
7765354|NCT00839527|12207293|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
7765355|NCT00839527|12207294|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
7765356|NCT00839527|12207295|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
7765357|NCT00839527|12207293|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
7765358|NCT00839527|12207294|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
7765359|NCT00839527|12207295|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
7765360|NCT00839527|12207293|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
7765361|NCT00839527|12207294|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
7765362|NCT00839527|12207295|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
7765363|NCT00839527|12207293|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
7765364|NCT00839527|12207294|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
7765365|NCT00839527|12207295|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
7765366|NCT00839527|12207293|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
7584199|NCT03581786|11989299|FG000|Overall Study|Death|17
7584200|NCT03581786|11989300|FG001|Overall Study|Death|12
7584201|NCT03581786|11989299|FG000|Overall Study|Withdrawal by Subject|2
7584202|NCT03581786|11989300|FG001|Overall Study|Withdrawal by Subject|4
7584203|NCT03581786|11989299|FG000|Overall Study|Lost to Follow-up|1
7584204|NCT03581786|11989300|FG001|Overall Study|Lost to Follow-up|0
7584205|NCT03581786|11989299|FG000|Overall Study|reason other than specified above|0
7584206|NCT03581786|11989300|FG001|Overall Study|reason other than specified above|1
7584207|NCT03581786|11989299|FG000|Overall Study|Ongoing in the study|123
7584208|NCT03581786|11989300|FG001|Overall Study|Ongoing in the study|129
7584209|NCT03486314|11989323|FG000|Part A|Adverse Event|1
7584210|NCT03486314|11989324|FG001|Part A|Adverse Event|0
7584211|NCT03486314|11989325|FG002|Part A|Adverse Event|0
7584212|NCT03486314|11989323|FG000|Part A|Symptomatic Deterioration|2
7584213|NCT03486314|11989324|FG001|Part A|Symptomatic Deterioration|0
7584214|NCT03486314|11989325|FG002|Part A|Symptomatic Deterioration|0
7584215|NCT02988713|11989333|FG000|Overall Study|Withdrawal by Subject|1
7584216|NCT02988713|11989333|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2
7584217|NCT02794883|11989340|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0
7584218|NCT02794883|11989341|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0
7584219|NCT02794883|11989342|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1
7584220|NCT02794883|11989340|FG000|Pre-Surgical Treatment|Progressive Disease|0
7584221|NCT02794883|11989341|FG001|Pre-Surgical Treatment|Progressive Disease|1
7584222|NCT02794883|11989342|FG002|Pre-Surgical Treatment|Progressive Disease|0
7584223|NCT02794883|11989340|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1
7584224|NCT02794883|11989341|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4
7584225|NCT02794883|11989342|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0
7584226|NCT02794883|11989340|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1
7584227|NCT02794883|11989341|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0
7584228|NCT02794883|11989342|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0
7584229|NCT02794883|11989340|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10
7584230|NCT02794883|11989341|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6
7584231|NCT02794883|11989342|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10
7584232|NCT02794883|11989340|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0
7584233|NCT02794883|11989341|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1
7584234|NCT02794883|11989342|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1
7584235|NCT02794883|11989340|FG000|Follow-up Period (up to 2 Years)|Death|12
7584236|NCT02794883|11989341|FG001|Follow-up Period (up to 2 Years)|Death|10
7584237|NCT02794883|11989342|FG002|Follow-up Period (up to 2 Years)|Death|10
7584238|NCT02677987|11989352|FG000|Overall Study|Withdrawal by Subject|3
7584239|NCT02677987|11989353|FG001|Overall Study|Withdrawal by Subject|0
7584240|NCT02677987|11989352|FG000|Overall Study|Lost to Follow-up|1
7584241|NCT02677987|11989353|FG001|Overall Study|Lost to Follow-up|0
7765367|NCT00839527|12207294|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
7765368|NCT00839527|12207295|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
7765369|NCT00839527|12207293|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
7765370|NCT00839527|12207294|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
7765371|NCT00839527|12207295|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
7765372|NCT00839800|12207320|FG000|Overall Study|Adverse Event|8
7765373|NCT00839800|12207321|FG001|Overall Study|Adverse Event|12
7765374|NCT00839800|12207320|FG000|Overall Study|Lost to Follow-up|31
7765375|NCT00839800|12207321|FG001|Overall Study|Lost to Follow-up|26
7765376|NCT00839800|12207320|FG000|Overall Study|Withdrawal by Subject|28
7765377|NCT00839800|12207321|FG001|Overall Study|Withdrawal by Subject|34
7765378|NCT00839800|12207320|FG000|Overall Study|Incorrect Enrolment|3
7765379|NCT00839800|12207321|FG001|Overall Study|Incorrect Enrolment|3
7584260|NCT01928394|11989396|FG000|Treatment Period|Disease progression|17
7584261|NCT01928394|11989397|FG001|Treatment Period|Disease progression|2
7584262|NCT01928394|11989398|FG002|Treatment Period|Disease progression|12
7584263|NCT01928394|11989399|FG003|Treatment Period|Disease progression|48
7584264|NCT01928394|11989400|FG004|Treatment Period|Disease progression|3
7584265|NCT01928394|11989401|FG005|Treatment Period|Disease progression|25
7584266|NCT01928394|11989402|FG006|Treatment Period|Disease progression|38
7584267|NCT01928394|11989403|FG007|Treatment Period|Disease progression|16
7584268|NCT01928394|11989404|FG008|Treatment Period|Disease progression|3
7584269|NCT01928394|11989405|FG009|Treatment Period|Disease progression|11
7584270|NCT01928394|11989406|FG010|Treatment Period|Disease progression|22
7584271|NCT01928394|11989407|FG011|Treatment Period|Disease progression|73
7584272|NCT01928394|11989408|FG012|Treatment Period|Disease progression|38
7584273|NCT01928394|11989409|FG013|Treatment Period|Disease progression|118
7584274|NCT01928394|11989410|FG014|Treatment Period|Disease progression|59
7584275|NCT01928394|11989411|FG015|Treatment Period|Disease progression|1
7584276|NCT01928394|11989412|FG016|Treatment Period|Disease progression|43
7584277|NCT01928394|11989413|FG017|Treatment Period|Disease progression|56
7584278|NCT01928394|11989414|FG018|Treatment Period|Disease progression|50
7584279|NCT01928394|11989415|FG019|Treatment Period|Disease progression|71
7584280|NCT01928394|11989416|FG020|Treatment Period|Disease progression|30
7584281|NCT01928394|11989417|FG021|Treatment Period|Disease progression|31
7584282|NCT01928394|11989418|FG022|Treatment Period|Disease progression|31
7584283|NCT01928394|11989396|FG000|Treatment Period|Study drug toxicity|1
7584284|NCT01928394|11989397|FG001|Treatment Period|Study drug toxicity|1
7584285|NCT01928394|11989398|FG002|Treatment Period|Study drug toxicity|3
7584286|NCT01928394|11989399|FG003|Treatment Period|Study drug toxicity|3
7584287|NCT01928394|11989400|FG004|Treatment Period|Study drug toxicity|0
7584288|NCT01928394|11989401|FG005|Treatment Period|Study drug toxicity|9
7584289|NCT01928394|11989402|FG006|Treatment Period|Study drug toxicity|7
7584290|NCT01928394|11989403|FG007|Treatment Period|Study drug toxicity|1
7584291|NCT01928394|11989404|FG008|Treatment Period|Study drug toxicity|0
7584292|NCT01928394|11989405|FG009|Treatment Period|Study drug toxicity|5
7584293|NCT01928394|11989406|FG010|Treatment Period|Study drug toxicity|2
7584294|NCT01928394|11989407|FG011|Treatment Period|Study drug toxicity|3
7584295|NCT01928394|11989408|FG012|Treatment Period|Study drug toxicity|7
7584296|NCT01928394|11989409|FG013|Treatment Period|Study drug toxicity|5
7584297|NCT01928394|11989410|FG014|Treatment Period|Study drug toxicity|12
7584298|NCT01928394|11989411|FG015|Treatment Period|Study drug toxicity|0
7584299|NCT01928394|11989412|FG016|Treatment Period|Study drug toxicity|3
7584300|NCT01928394|11989413|FG017|Treatment Period|Study drug toxicity|3
7584301|NCT01928394|11989414|FG018|Treatment Period|Study drug toxicity|12
7584302|NCT01928394|11989415|FG019|Treatment Period|Study drug toxicity|15
7584303|NCT01928394|11989416|FG020|Treatment Period|Study drug toxicity|4
7584304|NCT01928394|11989417|FG021|Treatment Period|Study drug toxicity|7
7584305|NCT01928394|11989418|FG022|Treatment Period|Study drug toxicity|4
7584306|NCT01928394|11989396|FG000|Treatment Period|AE unrelated to study drug|0
7584307|NCT01928394|11989397|FG001|Treatment Period|AE unrelated to study drug|0
7584308|NCT01928394|11989398|FG002|Treatment Period|AE unrelated to study drug|2
7584309|NCT01928394|11989399|FG003|Treatment Period|AE unrelated to study drug|3
7584310|NCT01928394|11989400|FG004|Treatment Period|AE unrelated to study drug|0
7584311|NCT01928394|11989401|FG005|Treatment Period|AE unrelated to study drug|5
7584312|NCT01928394|11989402|FG006|Treatment Period|AE unrelated to study drug|1
7584313|NCT01928394|11989403|FG007|Treatment Period|AE unrelated to study drug|0
7584314|NCT01928394|11989404|FG008|Treatment Period|AE unrelated to study drug|0
7584315|NCT01928394|11989405|FG009|Treatment Period|AE unrelated to study drug|2
7584316|NCT01928394|11989406|FG010|Treatment Period|AE unrelated to study drug|0
7584317|NCT01928394|11989407|FG011|Treatment Period|AE unrelated to study drug|12
7584318|NCT01928394|11989408|FG012|Treatment Period|AE unrelated to study drug|6
7584319|NCT01928394|11989409|FG013|Treatment Period|AE unrelated to study drug|13
7584320|NCT01928394|11989410|FG014|Treatment Period|AE unrelated to study drug|6
7584321|NCT01928394|11989411|FG015|Treatment Period|AE unrelated to study drug|1
7584322|NCT01928394|11989412|FG016|Treatment Period|AE unrelated to study drug|1
7584323|NCT01928394|11989413|FG017|Treatment Period|AE unrelated to study drug|6
7584324|NCT01928394|11989414|FG018|Treatment Period|AE unrelated to study drug|3
7584325|NCT01928394|11989415|FG019|Treatment Period|AE unrelated to study drug|5
7584326|NCT01928394|11989416|FG020|Treatment Period|AE unrelated to study drug|1
7584327|NCT01928394|11989417|FG021|Treatment Period|AE unrelated to study drug|1
7584328|NCT01928394|11989418|FG022|Treatment Period|AE unrelated to study drug|0
7584329|NCT01928394|11989396|FG000|Treatment Period|Participant request to stop therapy|0
7584330|NCT01928394|11989397|FG001|Treatment Period|Participant request to stop therapy|0
7584331|NCT01928394|11989398|FG002|Treatment Period|Participant request to stop therapy|0
7765380|NCT00839800|12207320|FG000|Overall Study|Study-Specific Discontinuation Criteria|6
7584332|NCT01928394|11989399|FG003|Treatment Period|Participant request to stop therapy|0
7584333|NCT01928394|11989400|FG004|Treatment Period|Participant request to stop therapy|0
7584334|NCT01928394|11989401|FG005|Treatment Period|Participant request to stop therapy|3
7584335|NCT01928394|11989402|FG006|Treatment Period|Participant request to stop therapy|3
7584336|NCT01928394|11989403|FG007|Treatment Period|Participant request to stop therapy|0
7584337|NCT01928394|11989404|FG008|Treatment Period|Participant request to stop therapy|0
7584338|NCT01928394|11989405|FG009|Treatment Period|Participant request to stop therapy|0
7584339|NCT01928394|11989406|FG010|Treatment Period|Participant request to stop therapy|3
7584340|NCT01928394|11989407|FG011|Treatment Period|Participant request to stop therapy|2
7584341|NCT01928394|11989408|FG012|Treatment Period|Participant request to stop therapy|1
7584342|NCT01928394|11989409|FG013|Treatment Period|Participant request to stop therapy|2
7584343|NCT01928394|11989410|FG014|Treatment Period|Participant request to stop therapy|4
7584344|NCT01928394|11989411|FG015|Treatment Period|Participant request to stop therapy|0
7584345|NCT01928394|11989412|FG016|Treatment Period|Participant request to stop therapy|1
7584346|NCT01928394|11989413|FG017|Treatment Period|Participant request to stop therapy|3
7584347|NCT01928394|11989414|FG018|Treatment Period|Participant request to stop therapy|1
7584348|NCT01928394|11989415|FG019|Treatment Period|Participant request to stop therapy|1
7584349|NCT01928394|11989416|FG020|Treatment Period|Participant request to stop therapy|3
7584350|NCT01928394|11989417|FG021|Treatment Period|Participant request to stop therapy|1
7584351|NCT01928394|11989418|FG022|Treatment Period|Participant request to stop therapy|3
7584352|NCT01928394|11989396|FG000|Treatment Period|Participant withdrew consent|0
7584353|NCT01928394|11989397|FG001|Treatment Period|Participant withdrew consent|0
7584354|NCT01928394|11989398|FG002|Treatment Period|Participant withdrew consent|1
7584355|NCT01928394|11989399|FG003|Treatment Period|Participant withdrew consent|1
7584356|NCT01928394|11989400|FG004|Treatment Period|Participant withdrew consent|0
7584357|NCT01928394|11989401|FG005|Treatment Period|Participant withdrew consent|1
7584358|NCT01928394|11989402|FG006|Treatment Period|Participant withdrew consent|0
7584359|NCT01928394|11989403|FG007|Treatment Period|Participant withdrew consent|1
7584360|NCT01928394|11989404|FG008|Treatment Period|Participant withdrew consent|0
7584361|NCT01928394|11989405|FG009|Treatment Period|Participant withdrew consent|0
7584362|NCT01928394|11989406|FG010|Treatment Period|Participant withdrew consent|1
7584363|NCT01928394|11989407|FG011|Treatment Period|Participant withdrew consent|1
7584364|NCT01928394|11989408|FG012|Treatment Period|Participant withdrew consent|1
7584365|NCT01928394|11989409|FG013|Treatment Period|Participant withdrew consent|0
7584366|NCT01928394|11989410|FG014|Treatment Period|Participant withdrew consent|2
7584367|NCT01928394|11989411|FG015|Treatment Period|Participant withdrew consent|0
7584368|NCT01928394|11989412|FG016|Treatment Period|Participant withdrew consent|2
7584369|NCT01928394|11989413|FG017|Treatment Period|Participant withdrew consent|1
7584370|NCT01928394|11989414|FG018|Treatment Period|Participant withdrew consent|1
7584371|NCT01928394|11989415|FG019|Treatment Period|Participant withdrew consent|1
7584372|NCT01928394|11989416|FG020|Treatment Period|Participant withdrew consent|0
7584373|NCT01928394|11989417|FG021|Treatment Period|Participant withdrew consent|2
7584374|NCT01928394|11989418|FG022|Treatment Period|Participant withdrew consent|0
7584375|NCT01928394|11989396|FG000|Treatment Period|Poor/non-compliance|0
7584376|NCT01928394|11989397|FG001|Treatment Period|Poor/non-compliance|0
7584377|NCT01928394|11989398|FG002|Treatment Period|Poor/non-compliance|0
7584378|NCT01928394|11989399|FG003|Treatment Period|Poor/non-compliance|1
7584379|NCT01928394|11989400|FG004|Treatment Period|Poor/non-compliance|0
7584380|NCT01928394|11989401|FG005|Treatment Period|Poor/non-compliance|0
7584381|NCT01928394|11989402|FG006|Treatment Period|Poor/non-compliance|0
7584382|NCT01928394|11989403|FG007|Treatment Period|Poor/non-compliance|0
7584383|NCT01928394|11989404|FG008|Treatment Period|Poor/non-compliance|0
7584384|NCT01928394|11989405|FG009|Treatment Period|Poor/non-compliance|0
7584385|NCT01928394|11989406|FG010|Treatment Period|Poor/non-compliance|0
7584386|NCT01928394|11989407|FG011|Treatment Period|Poor/non-compliance|0
7584387|NCT01928394|11989408|FG012|Treatment Period|Poor/non-compliance|1
7584388|NCT01928394|11989409|FG013|Treatment Period|Poor/non-compliance|0
7584389|NCT01928394|11989410|FG014|Treatment Period|Poor/non-compliance|1
7584390|NCT01928394|11989411|FG015|Treatment Period|Poor/non-compliance|0
7584391|NCT01928394|11989412|FG016|Treatment Period|Poor/non-compliance|0
7584392|NCT01928394|11989413|FG017|Treatment Period|Poor/non-compliance|1
7584393|NCT01928394|11989414|FG018|Treatment Period|Poor/non-compliance|0
7584394|NCT01928394|11989415|FG019|Treatment Period|Poor/non-compliance|1
7584395|NCT01928394|11989416|FG020|Treatment Period|Poor/non-compliance|0
7584396|NCT01928394|11989417|FG021|Treatment Period|Poor/non-compliance|0
7584397|NCT01928394|11989418|FG022|Treatment Period|Poor/non-compliance|0
7584398|NCT01928394|11989396|FG000|Treatment Period|other reason|0
7584399|NCT01928394|11989397|FG001|Treatment Period|other reason|0
7584400|NCT01928394|11989398|FG002|Treatment Period|other reason|0
7584401|NCT01928394|11989399|FG003|Treatment Period|other reason|0
7584402|NCT01928394|11989400|FG004|Treatment Period|other reason|0
7584403|NCT01928394|11989401|FG005|Treatment Period|other reason|0
7584404|NCT01928394|11989402|FG006|Treatment Period|other reason|0
7584405|NCT01928394|11989403|FG007|Treatment Period|other reason|0
7584406|NCT01928394|11989404|FG008|Treatment Period|other reason|0
7584407|NCT01928394|11989405|FG009|Treatment Period|other reason|0
7584408|NCT01928394|11989406|FG010|Treatment Period|other reason|1
7584409|NCT01928394|11989407|FG011|Treatment Period|other reason|1
7584410|NCT01928394|11989408|FG012|Treatment Period|other reason|1
7584411|NCT01928394|11989409|FG013|Treatment Period|other reason|0
7584412|NCT01928394|11989410|FG014|Treatment Period|other reason|1
7584413|NCT01928394|11989411|FG015|Treatment Period|other reason|0
7584414|NCT01928394|11989412|FG016|Treatment Period|other reason|0
7584415|NCT01928394|11989413|FG017|Treatment Period|other reason|0
7584416|NCT01928394|11989414|FG018|Treatment Period|other reason|2
7584417|NCT01928394|11989415|FG019|Treatment Period|other reason|2
7584418|NCT01928394|11989416|FG020|Treatment Period|other reason|0
7584419|NCT01928394|11989417|FG021|Treatment Period|other reason|0
7584420|NCT01928394|11989418|FG022|Treatment Period|other reason|0
7584421|NCT01928394|11989396|FG000|Treatment Period|Maximum clinical benefit|0
7584422|NCT01928394|11989397|FG001|Treatment Period|Maximum clinical benefit|0
7584423|NCT01928394|11989398|FG002|Treatment Period|Maximum clinical benefit|0
7584424|NCT01928394|11989399|FG003|Treatment Period|Maximum clinical benefit|0
7584425|NCT01928394|11989400|FG004|Treatment Period|Maximum clinical benefit|0
7584426|NCT01928394|11989401|FG005|Treatment Period|Maximum clinical benefit|0
7584427|NCT01928394|11989402|FG006|Treatment Period|Maximum clinical benefit|0
7584428|NCT01928394|11989403|FG007|Treatment Period|Maximum clinical benefit|0
7584429|NCT01928394|11989404|FG008|Treatment Period|Maximum clinical benefit|0
7584430|NCT01928394|11989405|FG009|Treatment Period|Maximum clinical benefit|0
7584431|NCT01928394|11989406|FG010|Treatment Period|Maximum clinical benefit|1
7584432|NCT01928394|11989407|FG011|Treatment Period|Maximum clinical benefit|1
7584433|NCT01928394|11989408|FG012|Treatment Period|Maximum clinical benefit|0
7584434|NCT01928394|11989409|FG013|Treatment Period|Maximum clinical benefit|0
7584435|NCT01928394|11989410|FG014|Treatment Period|Maximum clinical benefit|1
7584436|NCT01928394|11989411|FG015|Treatment Period|Maximum clinical benefit|0
7584437|NCT01928394|11989412|FG016|Treatment Period|Maximum clinical benefit|0
7584438|NCT01928394|11989413|FG017|Treatment Period|Maximum clinical benefit|1
7584439|NCT01928394|11989414|FG018|Treatment Period|Maximum clinical benefit|1
7584440|NCT01928394|11989415|FG019|Treatment Period|Maximum clinical benefit|0
7584441|NCT01928394|11989416|FG020|Treatment Period|Maximum clinical benefit|2
7584442|NCT01928394|11989417|FG021|Treatment Period|Maximum clinical benefit|0
7584443|NCT01928394|11989418|FG022|Treatment Period|Maximum clinical benefit|0
7584444|NCT01928394|11989396|FG000|Treatment Period|Lost to Follow-up|0
7584445|NCT01928394|11989397|FG001|Treatment Period|Lost to Follow-up|0
7584446|NCT01928394|11989398|FG002|Treatment Period|Lost to Follow-up|0
7584447|NCT01928394|11989399|FG003|Treatment Period|Lost to Follow-up|0
7584448|NCT01928394|11989400|FG004|Treatment Period|Lost to Follow-up|0
7584449|NCT01928394|11989401|FG005|Treatment Period|Lost to Follow-up|0
7584450|NCT01928394|11989402|FG006|Treatment Period|Lost to Follow-up|0
7584451|NCT01928394|11989403|FG007|Treatment Period|Lost to Follow-up|0
7584452|NCT01928394|11989404|FG008|Treatment Period|Lost to Follow-up|0
7584453|NCT01928394|11989405|FG009|Treatment Period|Lost to Follow-up|0
7584454|NCT01928394|11989406|FG010|Treatment Period|Lost to Follow-up|0
7584455|NCT01928394|11989407|FG011|Treatment Period|Lost to Follow-up|0
7584456|NCT01928394|11989408|FG012|Treatment Period|Lost to Follow-up|0
7584457|NCT01928394|11989409|FG013|Treatment Period|Lost to Follow-up|0
7584458|NCT01928394|11989410|FG014|Treatment Period|Lost to Follow-up|0
7584459|NCT01928394|11989411|FG015|Treatment Period|Lost to Follow-up|0
7584460|NCT01928394|11989412|FG016|Treatment Period|Lost to Follow-up|0
7584461|NCT01928394|11989413|FG017|Treatment Period|Lost to Follow-up|0
7584462|NCT01928394|11989414|FG018|Treatment Period|Lost to Follow-up|0
7584463|NCT01928394|11989415|FG019|Treatment Period|Lost to Follow-up|0
7584464|NCT01928394|11989416|FG020|Treatment Period|Lost to Follow-up|0
7584465|NCT01928394|11989417|FG021|Treatment Period|Lost to Follow-up|0
7584466|NCT01928394|11989418|FG022|Treatment Period|Lost to Follow-up|1
7584467|NCT01928394|11989396|FG000|Treatment Period|Death|0
7584468|NCT01928394|11989397|FG001|Treatment Period|Death|0
7584469|NCT01928394|11989398|FG002|Treatment Period|Death|0
7584470|NCT01928394|11989399|FG003|Treatment Period|Death|0
7584471|NCT01928394|11989400|FG004|Treatment Period|Death|0
7584472|NCT01928394|11989401|FG005|Treatment Period|Death|0
7584473|NCT01928394|11989402|FG006|Treatment Period|Death|0
7584474|NCT01928394|11989403|FG007|Treatment Period|Death|0
7584475|NCT01928394|11989404|FG008|Treatment Period|Death|0
7584476|NCT01928394|11989405|FG009|Treatment Period|Death|0
7584477|NCT01928394|11989406|FG010|Treatment Period|Death|0
7584478|NCT01928394|11989407|FG011|Treatment Period|Death|0
7584479|NCT01928394|11989408|FG012|Treatment Period|Death|0
7584480|NCT01928394|11989409|FG013|Treatment Period|Death|1
7584481|NCT01928394|11989410|FG014|Treatment Period|Death|2
7584482|NCT01928394|11989411|FG015|Treatment Period|Death|0
7584483|NCT01928394|11989412|FG016|Treatment Period|Death|0
7584484|NCT01928394|11989413|FG017|Treatment Period|Death|0
7584485|NCT01928394|11989414|FG018|Treatment Period|Death|0
7584486|NCT01928394|11989415|FG019|Treatment Period|Death|0
7584487|NCT01928394|11989416|FG020|Treatment Period|Death|0
7584488|NCT01928394|11989417|FG021|Treatment Period|Death|0
7584489|NCT01928394|11989418|FG022|Treatment Period|Death|0
7584490|NCT01928394|11989396|FG000|Follow-up Period|Participant withdrew consent|3
7584491|NCT01928394|11989397|FG001|Follow-up Period|Participant withdrew consent|0
7584492|NCT01928394|11989398|FG002|Follow-up Period|Participant withdrew consent|1
7584493|NCT01928394|11989399|FG003|Follow-up Period|Participant withdrew consent|4
7584578|NCT01928394|11989415|FG019|Follow-up Period|Lost to Follow-up|0
7584494|NCT01928394|11989400|FG004|Follow-up Period|Participant withdrew consent|0
7584495|NCT01928394|11989401|FG005|Follow-up Period|Participant withdrew consent|2
7584496|NCT01928394|11989402|FG006|Follow-up Period|Participant withdrew consent|5
7584497|NCT01928394|11989403|FG007|Follow-up Period|Participant withdrew consent|1
7584498|NCT01928394|11989404|FG008|Follow-up Period|Participant withdrew consent|0
7584499|NCT01928394|11989405|FG009|Follow-up Period|Participant withdrew consent|0
7584500|NCT01928394|11989406|FG010|Follow-up Period|Participant withdrew consent|5
7584501|NCT01928394|11989407|FG011|Follow-up Period|Participant withdrew consent|8
7584502|NCT01928394|11989408|FG012|Follow-up Period|Participant withdrew consent|2
7584503|NCT01928394|11989409|FG013|Follow-up Period|Participant withdrew consent|12
7584504|NCT01928394|11989410|FG014|Follow-up Period|Participant withdrew consent|7
7584505|NCT01928394|11989411|FG015|Follow-up Period|Participant withdrew consent|0
7584506|NCT01928394|11989412|FG016|Follow-up Period|Participant withdrew consent|5
7584507|NCT01928394|11989413|FG017|Follow-up Period|Participant withdrew consent|3
7584508|NCT01928394|11989414|FG018|Follow-up Period|Participant withdrew consent|2
7584509|NCT01928394|11989415|FG019|Follow-up Period|Participant withdrew consent|7
7584510|NCT01928394|11989416|FG020|Follow-up Period|Participant withdrew consent|4
7584511|NCT01928394|11989417|FG021|Follow-up Period|Participant withdrew consent|6
7584512|NCT01928394|11989418|FG022|Follow-up Period|Participant withdrew consent|2
7584513|NCT01928394|11989396|FG000|Follow-up Period|Death|0
7584514|NCT01928394|11989397|FG001|Follow-up Period|Death|0
7584515|NCT01928394|11989398|FG002|Follow-up Period|Death|2
7584516|NCT01928394|11989399|FG003|Follow-up Period|Death|6
7584517|NCT01928394|11989400|FG004|Follow-up Period|Death|0
7584518|NCT01928394|11989401|FG005|Follow-up Period|Death|6
7584519|NCT01928394|11989402|FG006|Follow-up Period|Death|6
7584520|NCT01928394|11989403|FG007|Follow-up Period|Death|2
7584521|NCT01928394|11989404|FG008|Follow-up Period|Death|1
7584522|NCT01928394|11989405|FG009|Follow-up Period|Death|2
7584523|NCT01928394|11989406|FG010|Follow-up Period|Death|4
7584524|NCT01928394|11989407|FG011|Follow-up Period|Death|12
7584525|NCT01928394|11989408|FG012|Follow-up Period|Death|11
7584526|NCT01928394|11989409|FG013|Follow-up Period|Death|25
7584527|NCT01928394|11989410|FG014|Follow-up Period|Death|18
7584528|NCT01928394|11989411|FG015|Follow-up Period|Death|0
7584529|NCT01928394|11989412|FG016|Follow-up Period|Death|6
7584530|NCT01928394|11989413|FG017|Follow-up Period|Death|5
7584531|NCT01928394|11989414|FG018|Follow-up Period|Death|13
7584532|NCT01928394|11989415|FG019|Follow-up Period|Death|13
7584533|NCT01928394|11989416|FG020|Follow-up Period|Death|5
7584534|NCT01928394|11989417|FG021|Follow-up Period|Death|3
7584535|NCT01928394|11989418|FG022|Follow-up Period|Death|2
7765381|NCT00839800|12207321|FG001|Overall Study|Study-Specific Discontinuation Criteria|13
7584536|NCT01928394|11989396|FG000|Follow-up Period|other reason|0
7584537|NCT01928394|11989397|FG001|Follow-up Period|other reason|0
7584538|NCT01928394|11989398|FG002|Follow-up Period|other reason|0
7584539|NCT01928394|11989399|FG003|Follow-up Period|other reason|0
7584540|NCT01928394|11989400|FG004|Follow-up Period|other reason|0
7584541|NCT01928394|11989401|FG005|Follow-up Period|other reason|0
7584542|NCT01928394|11989402|FG006|Follow-up Period|other reason|1
7584543|NCT01928394|11989403|FG007|Follow-up Period|other reason|3
7584544|NCT01928394|11989404|FG008|Follow-up Period|other reason|0
7584545|NCT01928394|11989405|FG009|Follow-up Period|other reason|0
7584546|NCT01928394|11989406|FG010|Follow-up Period|other reason|2
7584547|NCT01928394|11989407|FG011|Follow-up Period|other reason|1
7584548|NCT01928394|11989408|FG012|Follow-up Period|other reason|0
7584549|NCT01928394|11989409|FG013|Follow-up Period|other reason|1
7584550|NCT01928394|11989410|FG014|Follow-up Period|other reason|4
7584551|NCT01928394|11989411|FG015|Follow-up Period|other reason|0
7584552|NCT01928394|11989412|FG016|Follow-up Period|other reason|2
7584553|NCT01928394|11989413|FG017|Follow-up Period|other reason|0
7584554|NCT01928394|11989414|FG018|Follow-up Period|other reason|1
7584555|NCT01928394|11989415|FG019|Follow-up Period|other reason|1
7584556|NCT01928394|11989416|FG020|Follow-up Period|other reason|0
7584557|NCT01928394|11989417|FG021|Follow-up Period|other reason|0
7584558|NCT01928394|11989418|FG022|Follow-up Period|other reason|1
7584559|NCT01928394|11989396|FG000|Follow-up Period|Lost to Follow-up|0
7584560|NCT01928394|11989397|FG001|Follow-up Period|Lost to Follow-up|0
7584561|NCT01928394|11989398|FG002|Follow-up Period|Lost to Follow-up|0
7584562|NCT01928394|11989399|FG003|Follow-up Period|Lost to Follow-up|0
7584563|NCT01928394|11989400|FG004|Follow-up Period|Lost to Follow-up|0
7584564|NCT01928394|11989401|FG005|Follow-up Period|Lost to Follow-up|0
7584565|NCT01928394|11989402|FG006|Follow-up Period|Lost to Follow-up|0
7584566|NCT01928394|11989403|FG007|Follow-up Period|Lost to Follow-up|0
7584567|NCT01928394|11989404|FG008|Follow-up Period|Lost to Follow-up|0
7584568|NCT01928394|11989405|FG009|Follow-up Period|Lost to Follow-up|0
7584569|NCT01928394|11989406|FG010|Follow-up Period|Lost to Follow-up|0
7584570|NCT01928394|11989407|FG011|Follow-up Period|Lost to Follow-up|1
7584571|NCT01928394|11989408|FG012|Follow-up Period|Lost to Follow-up|1
7584572|NCT01928394|11989409|FG013|Follow-up Period|Lost to Follow-up|0
7584573|NCT01928394|11989410|FG014|Follow-up Period|Lost to Follow-up|1
7584574|NCT01928394|11989411|FG015|Follow-up Period|Lost to Follow-up|0
7584575|NCT01928394|11989412|FG016|Follow-up Period|Lost to Follow-up|1
7584576|NCT01928394|11989413|FG017|Follow-up Period|Lost to Follow-up|0
7584577|NCT01928394|11989414|FG018|Follow-up Period|Lost to Follow-up|0
7584579|NCT01928394|11989416|FG020|Follow-up Period|Lost to Follow-up|0
7584580|NCT01928394|11989417|FG021|Follow-up Period|Lost to Follow-up|0
7584581|NCT01928394|11989418|FG022|Follow-up Period|Lost to Follow-up|1
7584582|NCT01657500|11989468|FG000|Overall Study|set impropperly matched|3
7584583|NCT01657500|11989469|FG001|Overall Study|set impropperly matched|3
7584584|NCT01657500|11989468|FG000|Overall Study|Lost to Follow-up|2
7584585|NCT01657500|11989469|FG001|Overall Study|Lost to Follow-up|2
7765382|NCT00839800|12207320|FG000|Overall Study|Safety Reasons|2
7765383|NCT00839800|12207321|FG001|Overall Study|Safety Reasons|1
7765384|NCT00839800|12207320|FG000|Overall Study|Other|8
7765385|NCT00839800|12207321|FG001|Overall Study|Other|14
7765386|NCT00839800|12207320|FG000|Overall Study|Severe Non-Compliance to Protocol|7
7765387|NCT00839800|12207321|FG001|Overall Study|Severe Non-Compliance to Protocol|7
7765388|NCT00839852|12207327|FG000|Overall Study|Adverse Event|10
7765389|NCT00839852|12207327|FG000|Overall Study|Insufficient Therapeutic Response|3
7765390|NCT00839852|12207327|FG000|Overall Study|Protocol Violation|9
7765391|NCT00839852|12207327|FG000|Overall Study|Withdrawal of Consent|16
7765392|NCT00839852|12207327|FG000|Overall Study|Lost to Follow-up|7
7765393|NCT00839852|12207327|FG000|Overall Study|Lack of Compliance While in Jail|1
7765394|NCT00839852|12207327|FG000|Overall Study|Pregnancy|1
7765395|NCT00839917|12207333|FG000|Overall Study|Lost to Follow-up|1
7765396|NCT00839917|12207334|FG001|Overall Study|Lost to Follow-up|0
7765397|NCT00839917|12207333|FG000|Overall Study|Did not receive vaccine|0
7765398|NCT00839917|12207334|FG001|Overall Study|Did not receive vaccine|1
7765399|NCT00839956|12207340|FG000|Overall Study|Adverse Event|2
7765400|NCT00839956|12207340|FG000|Overall Study|Lack of Efficacy|6
7765401|NCT00839956|12207340|FG000|Overall Study|Physician Decision|1
7765402|NCT00839956|12207340|FG000|Overall Study|Withdrawal by Subject|3
7765403|NCT00840034|12207357|FG000|Acute Treatment Phase|Adverse Event|6
7765404|NCT00840034|12207358|FG001|Acute Treatment Phase|Adverse Event|8
7765405|NCT00840034|12207357|FG000|Acute Treatment Phase|Lack of Efficacy|2
7765406|NCT00840034|12207358|FG001|Acute Treatment Phase|Lack of Efficacy|0
7765407|NCT00840034|12207357|FG000|Acute Treatment Phase|Lost to Follow-up|5
7765408|NCT00840034|12207358|FG001|Acute Treatment Phase|Lost to Follow-up|12
7765409|NCT00840034|12207357|FG000|Acute Treatment Phase|Physician Decision|0
7765410|NCT00840034|12207358|FG001|Acute Treatment Phase|Physician Decision|1
7765411|NCT00840034|12207357|FG000|Acute Treatment Phase|Protocol Violation|2
7765412|NCT00840034|12207358|FG001|Acute Treatment Phase|Protocol Violation|4
7765413|NCT00840034|12207357|FG000|Acute Treatment Phase|Withdrawal by Subject|6
7765414|NCT00840034|12207358|FG001|Acute Treatment Phase|Withdrawal by Subject|11
7765415|NCT00840034|12207357|FG000|Taper Phase|Adverse Event|1
7584586|NCT04810221|11989475|FG000|Overall Study|Physician Decision|3
7584587|NCT04575038|11989481|FG000|Overall Study|Withdrawal by Subject|1
7584588|NCT04575038|11989482|FG001|Overall Study|Withdrawal by Subject|1
7584589|NCT04545567|11989490|FG000|Overall Study|tested positive for SARS-co-V2|1
7584590|NCT04545567|11989491|FG001|Overall Study|tested positive for SARS-co-V2|1
7584591|NCT04545567|11989490|FG000|Overall Study|Withdrawal by Subject|0
7584592|NCT04545567|11989491|FG001|Overall Study|Withdrawal by Subject|1
7584593|NCT04397757|11989503|FG000|Overall Study|Death|3
7584594|NCT04397757|11989504|FG001|Overall Study|Death|11
7584595|NCT04397757|11989503|FG000|Overall Study|Withdrawal by Subject|2
7584596|NCT04397757|11989504|FG001|Overall Study|Withdrawal by Subject|0
7584597|NCT04397757|11989503|FG000|Overall Study|Lost to Follow-up|4
7584598|NCT04397757|11989504|FG001|Overall Study|Lost to Follow-up|3
7584599|NCT04112303|11989541|FG000|Overall Study|Death|1
7584600|NCT03896477|11989548|FG000|Overall Study|Met Ineligibility Criteria During the Study|1
7584601|NCT03896477|11989549|FG001|Overall Study|Met Ineligibility Criteria During the Study|1
7584602|NCT03896477|11989550|FG002|Overall Study|Met Ineligibility Criteria During the Study|2
7584603|NCT03896477|11989548|FG000|Overall Study|Parent Requested Withdrawal|8
7584604|NCT03896477|11989549|FG001|Overall Study|Parent Requested Withdrawal|12
7584605|NCT03896477|11989550|FG002|Overall Study|Parent Requested Withdrawal|9
7584606|NCT03896477|11989548|FG000|Overall Study|Adverse Event|0
7584607|NCT03896477|11989549|FG001|Overall Study|Adverse Event|0
7584608|NCT03896477|11989550|FG002|Overall Study|Adverse Event|1
7584609|NCT03896477|11989548|FG000|Overall Study|Death|1
7584610|NCT03896477|11989549|FG001|Overall Study|Death|0
7584611|NCT03896477|11989550|FG002|Overall Study|Death|0
7584612|NCT03896477|11989548|FG000|Overall Study|Other|5
7584613|NCT03896477|11989549|FG001|Overall Study|Other|6
7584614|NCT03896477|11989550|FG002|Overall Study|Other|7
7584615|NCT03896477|11989548|FG000|Overall Study|Lost to Follow-up|2
7584616|NCT03896477|11989549|FG001|Overall Study|Lost to Follow-up|1
7584617|NCT03896477|11989550|FG002|Overall Study|Lost to Follow-up|1
7584618|NCT03760185|11989561|FG000|Overall Study|Lost to Follow-up|1
7584619|NCT03760185|11989562|FG001|Overall Study|Lost to Follow-up|1
7584620|NCT03732534|11989570|FG000|Overall Study|Study terminated by Sponsor|6
7584621|NCT03692910|11989574|FG000|Overall Study|Lost to Follow-up|4
7584622|NCT03692910|11989575|FG001|Overall Study|Lost to Follow-up|0
7584623|NCT03692910|11989576|FG002|Overall Study|Lost to Follow-up|0
7584624|NCT03692910|11989574|FG000|Overall Study|Withdrawal by Subject|2
7584625|NCT03692910|11989575|FG001|Overall Study|Withdrawal by Subject|0
7584626|NCT03692910|11989576|FG002|Overall Study|Withdrawal by Subject|0
7765416|NCT00840034|12207358|FG001|Taper Phase|Adverse Event|0
7765417|NCT00840034|12207357|FG000|Taper Phase|Lost to Follow-up|1
7765418|NCT00840034|12207358|FG001|Taper Phase|Lost to Follow-up|1
7584627|NCT03673956|11989586|FG000|Overall Study|Lost to Follow-up|1
7584628|NCT03673956|11989587|FG001|Overall Study|Lost to Follow-up|0
7584629|NCT03673956|11989588|FG002|Overall Study|Lost to Follow-up|0
7584630|NCT03673956|11989589|FG003|Overall Study|Lost to Follow-up|0
7584631|NCT03673956|11989586|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1
7584632|NCT03673956|11989587|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0
7584633|NCT03673956|11989588|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0
7584634|NCT03673956|11989589|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0
7765419|NCT00840034|12207357|FG000|Taper Phase|Withdrawal by Subject|1
7765420|NCT00840034|12207358|FG001|Taper Phase|Withdrawal by Subject|1
7765421|NCT00840060|12207368|FG000|Overall Study|Withdrawal by Subject|1
7765422|NCT00840060|12207369|FG001|Overall Study|Withdrawal by Subject|0
7584640|NCT03205163|11989660|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1
7584641|NCT03205163|11989661|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0
7584642|NCT03178045|11989678|FG000|Overall Study|Withdrawal by Subject|5
7584643|NCT03178045|11989679|FG001|Overall Study|Withdrawal by Subject|7
7584644|NCT03178045|11989678|FG000|Overall Study|Surgery Cancelled/Relocated|34
7584645|NCT03178045|11989679|FG001|Overall Study|Surgery Cancelled/Relocated|30
7584646|NCT03178045|11989678|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47
7584647|NCT03178045|11989679|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46
7584648|NCT03145766|11989691|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
7584649|NCT03145766|11989692|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
7584650|NCT03145766|11989693|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0
7584651|NCT03145766|11989694|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
7584652|NCT03145766|11989695|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2
7584653|NCT03145766|11989691|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
7584654|NCT03145766|11989692|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
7584655|NCT03145766|11989693|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
7584656|NCT03145766|11989694|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2
7584657|NCT03145766|11989695|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
7584658|NCT03145766|11989691|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
7584659|NCT03145766|11989692|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
7584660|NCT03145766|11989693|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
7584661|NCT03145766|11989694|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3
7584662|NCT03145766|11989695|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
7584663|NCT03145766|11989691|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4
7584664|NCT03145766|11989692|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
7584665|NCT03145766|11989693|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
7584666|NCT03145766|11989694|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
7584667|NCT03145766|11989695|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0
7584668|NCT03145766|11989691|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2
7584669|NCT03145766|11989692|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
7584670|NCT03145766|11989693|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
7584671|NCT03145766|11989694|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1
7584672|NCT03145766|11989695|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
7584673|NCT03145766|11989691|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
7584674|NCT03145766|11989692|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1
7584675|NCT03145766|11989693|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
7584676|NCT03145766|11989694|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2
7584677|NCT03145766|11989695|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3
7584678|NCT03145766|11989691|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
7584679|NCT03145766|11989692|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
7584680|NCT03145766|11989693|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
7584681|NCT03145766|11989694|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
7584682|NCT03145766|11989695|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
7584683|NCT03106987|11989712|FG000|Overall Study|Death|37
7584684|NCT03106987|11989713|FG001|Overall Study|Death|22
7584685|NCT03106987|11989714|FG002|Overall Study|Death|12
7584686|NCT03106987|11989715|FG003|Overall Study|Death|8
7584687|NCT03106987|11989712|FG000|Overall Study|Lost to Follow-up|2
7584688|NCT03106987|11989713|FG001|Overall Study|Lost to Follow-up|0
7584689|NCT03106987|11989714|FG002|Overall Study|Lost to Follow-up|2
7584690|NCT03106987|11989715|FG003|Overall Study|Lost to Follow-up|2
7584691|NCT03106987|11989712|FG000|Overall Study|Withdrawal by Subject|5
7584692|NCT03106987|11989713|FG001|Overall Study|Withdrawal by Subject|1
7584693|NCT03106987|11989714|FG002|Overall Study|Withdrawal by Subject|4
7584694|NCT03106987|11989715|FG003|Overall Study|Withdrawal by Subject|1
7584695|NCT03103087|11989728|FG000|Overall Study|Did not receive any study drug|1
7584696|NCT03103087|11989729|FG001|Overall Study|Did not receive any study drug|0
7584697|NCT03103087|11989730|FG002|Overall Study|Did not receive any study drug|0
7584698|NCT03103087|11989728|FG000|Overall Study|Protocol Violation|1
7584699|NCT03103087|11989729|FG001|Overall Study|Protocol Violation|2
7584700|NCT03103087|11989730|FG002|Overall Study|Protocol Violation|1
7584701|NCT03103087|11989728|FG000|Overall Study|Lack of Efficacy|2
7584702|NCT03103087|11989729|FG001|Overall Study|Lack of Efficacy|1
7584703|NCT03103087|11989730|FG002|Overall Study|Lack of Efficacy|1
7584704|NCT03103087|11989728|FG000|Overall Study|Pregnancy|0
7584705|NCT03103087|11989729|FG001|Overall Study|Pregnancy|0
7584706|NCT03103087|11989730|FG002|Overall Study|Pregnancy|1
7584707|NCT03103087|11989728|FG000|Overall Study|Adverse Event|2
7584708|NCT03103087|11989729|FG001|Overall Study|Adverse Event|15
7584709|NCT03103087|11989730|FG002|Overall Study|Adverse Event|6
7584710|NCT03103087|11989728|FG000|Overall Study|Withdrawal by Subject|13
7584711|NCT03103087|11989729|FG001|Overall Study|Withdrawal by Subject|6
7584712|NCT03103087|11989730|FG002|Overall Study|Withdrawal by Subject|6
7584713|NCT03103087|11989728|FG000|Overall Study|Lost to Follow-up|4
7584714|NCT03103087|11989729|FG001|Overall Study|Lost to Follow-up|2
7584715|NCT03103087|11989730|FG002|Overall Study|Lost to Follow-up|7
7584716|NCT03103087|11989728|FG000|Overall Study|Other reason not reported|1
7584717|NCT03103087|11989729|FG001|Overall Study|Other reason not reported|3
7584718|NCT03103087|11989730|FG002|Overall Study|Other reason not reported|5
7584719|NCT03049735|11989743|FG000|Overall Study|Discontinued due to AE (not dosed)|0
7584720|NCT03049735|11989744|FG001|Overall Study|Discontinued due to AE (not dosed)|0
7584721|NCT03049735|11989745|FG002|Overall Study|Discontinued due to AE (not dosed)|1
7584722|NCT03049735|11989743|FG000|Overall Study|Other|5
7584723|NCT03049735|11989744|FG001|Overall Study|Other|3
7584724|NCT03049735|11989745|FG002|Overall Study|Other|1
7584725|NCT03049735|11989743|FG000|Overall Study|Lack of Efficacy|4
7584726|NCT03049735|11989744|FG001|Overall Study|Lack of Efficacy|0
7584727|NCT03049735|11989745|FG002|Overall Study|Lack of Efficacy|3
7584728|NCT03049735|11989743|FG000|Overall Study|Protocol deviation|1
7584729|NCT03049735|11989744|FG001|Overall Study|Protocol deviation|0
7584730|NCT03049735|11989745|FG002|Overall Study|Protocol deviation|0
7584731|NCT03049735|11989743|FG000|Overall Study|Pregnancy|0
7584732|NCT03049735|11989744|FG001|Overall Study|Pregnancy|0
7584733|NCT03049735|11989745|FG002|Overall Study|Pregnancy|1
7584734|NCT03049735|11989743|FG000|Overall Study|Adverse Event|7
7584735|NCT03049735|11989744|FG001|Overall Study|Adverse Event|18
7584736|NCT03049735|11989745|FG002|Overall Study|Adverse Event|5
7584737|NCT03049735|11989743|FG000|Overall Study|Withdrawal by Subject|10
7584738|NCT03049735|11989744|FG001|Overall Study|Withdrawal by Subject|3
7584739|NCT03049735|11989745|FG002|Overall Study|Withdrawal by Subject|7
7584740|NCT03049735|11989743|FG000|Overall Study|Lost to Follow-up|1
7584741|NCT03049735|11989744|FG001|Overall Study|Lost to Follow-up|5
7584742|NCT03049735|11989745|FG002|Overall Study|Lost to Follow-up|5
7584743|NCT03021551|11989753|FG000|Overall Study|Equipment Issues|2
7584744|NCT03021551|11989753|FG000|Overall Study|Protocol Violation|1
7584745|NCT02990338|11989759|FG000|Overall Study|Adverse Event|19
7584746|NCT02990338|11989760|FG001|Overall Study|Adverse Event|11
7584747|NCT02990338|11989759|FG000|Overall Study|Progressive disease|88
7584748|NCT02990338|11989760|FG001|Overall Study|Progressive disease|66
7584749|NCT02990338|11989759|FG000|Overall Study|Poor compliance to protocol|0
7584750|NCT02990338|11989760|FG001|Overall Study|Poor compliance to protocol|1
7584751|NCT02990338|11989759|FG000|Overall Study|Withdrawal by Subject|6
7584752|NCT02990338|11989760|FG001|Overall Study|Withdrawal by Subject|5
7584753|NCT02990338|11989759|FG000|Overall Study|Other|1
7584754|NCT02990338|11989760|FG001|Overall Study|Other|4
7584755|NCT02990338|11989759|FG000|Overall Study|Randomized but not treated|4
7584756|NCT02990338|11989760|FG001|Overall Study|Randomized but not treated|2
7584757|NCT02932332|11989780|FG000|Overall Study|Withdrawal by Subject|1
7584758|NCT02932332|11989781|FG001|Overall Study|Withdrawal by Subject|1
7584759|NCT02932332|11989782|FG002|Overall Study|Withdrawal by Subject|0
7584760|NCT02932332|11989783|FG003|Overall Study|Withdrawal by Subject|1
7584761|NCT02932332|11989780|FG000|Overall Study|Chest pain|0
7584762|NCT02932332|11989781|FG001|Overall Study|Chest pain|0
7584763|NCT02932332|11989782|FG002|Overall Study|Chest pain|0
7584764|NCT02932332|11989783|FG003|Overall Study|Chest pain|1
7584765|NCT02932332|11989780|FG000|Overall Study|Not Dyspneic cough|1
7584766|NCT02932332|11989781|FG001|Overall Study|Not Dyspneic cough|2
7584767|NCT02932332|11989782|FG002|Overall Study|Not Dyspneic cough|1
7584768|NCT02932332|11989783|FG003|Overall Study|Not Dyspneic cough|0
7765423|NCT00840060|12207368|FG000|Overall Study|Change in emotional/behavioral status|0
7625702|NCT02550873|12037421|FG000|Randomized Double Blind|Adverse Event|3
7625703|NCT02550873|12037422|FG001|Randomized Double Blind|Adverse Event|1
7625704|NCT02550873|12037423|FG002|Randomized Double Blind|Adverse Event|0
7625705|NCT02550873|12037421|FG000|Randomized Double Blind|Disease progression|1
7625706|NCT02550873|12037422|FG001|Randomized Double Blind|Disease progression|1
7625707|NCT02550873|12037423|FG002|Randomized Double Blind|Disease progression|0
7625708|NCT02550873|12037421|FG000|Open Label Extension|Study ongoing|0
7625709|NCT02550873|12037422|FG001|Open Label Extension|Study ongoing|0
7625710|NCT02550873|12037423|FG002|Open Label Extension|Study ongoing|111
7625711|NCT02542267|12037445|FG000|Overall Study|Withdrawal by Subject|10
7625712|NCT02542267|12037445|FG000|Overall Study|Physician Decision|6
7625713|NCT02542267|12037445|FG000|Overall Study|Lost to Follow-up|4
7625714|NCT02542267|12037445|FG000|Overall Study|Death|13
7625715|NCT02542267|12037445|FG000|Overall Study|Surgical Bypass of All Study Devices|13
7625716|NCT02542267|12037445|FG000|Overall Study|Other|9
7625717|NCT02462603|12037449|FG000|Overall Study|Investigator Decision|1
7625718|NCT02462603|12037449|FG000|Overall Study|Non-Compliance|1
7625719|NCT02462603|12037449|FG000|Overall Study|Withdrawal by Subject|2
7625720|NCT02420717|12037460|FG000|Overall Study|Did not receive all study medication|2
7625721|NCT02420717|12037461|FG001|Overall Study|Did not receive all study medication|0
7625722|NCT02420717|12037462|FG002|Overall Study|Did not receive all study medication|0
7625723|NCT02408068|12037470|FG000|Treatment 3 (1.5 Days)|Adverse Event|0
7625724|NCT02408068|12037471|FG001|Treatment 3 (1.5 Days)|Adverse Event|0
7625725|NCT02408068|12037472|FG002|Treatment 3 (1.5 Days)|Adverse Event|1
7625726|NCT02408068|12037473|FG003|Treatment 3 (1.5 Days)|Adverse Event|0
7625727|NCT02408068|12037474|FG004|Treatment 3 (1.5 Days)|Adverse Event|0
7625728|NCT02408068|12037475|FG005|Treatment 3 (1.5 Days)|Adverse Event|0
7584769|NCT02588248|11989826|FG000|Overall Study|Physician Decision|4
7584770|NCT02588248|11989827|FG001|Overall Study|Physician Decision|3
7584771|NCT02535065|11989838|FG000|Overall Study|Death|13
7584772|NCT02535065|11989838|FG000|Overall Study|Lost to Follow-up|1
7584773|NCT02535065|11989838|FG000|Overall Study|Withdrawal by Subject|6
7584774|NCT02451358|11989850|FG000|Overall Study|Withdrawal by Subject|1
7584775|NCT02451358|11989851|FG001|Overall Study|Withdrawal by Subject|1
7584776|NCT02451358|11989852|FG002|Overall Study|Withdrawal by Subject|0
7584777|NCT02451358|11989853|FG003|Overall Study|Withdrawal by Subject|0
7584778|NCT02451358|11989850|FG000|Overall Study|Protocol Violation|0
7584779|NCT02451358|11989851|FG001|Overall Study|Protocol Violation|1
7584780|NCT02451358|11989852|FG002|Overall Study|Protocol Violation|1
7584781|NCT02451358|11989853|FG003|Overall Study|Protocol Violation|0
7584782|NCT02178709|11989872|FG000|Overall Study|Adverse Event|5
7584783|NCT02178709|11989872|FG000|Overall Study|Death|2
7584784|NCT02178709|11989872|FG000|Overall Study|Withdrawal by Subject|2
7584785|NCT02178709|11989872|FG000|Overall Study|Physician Decision|2
7584786|NCT02178709|11989872|FG000|Overall Study|Disease Progression|5
7584787|NCT01980017|11989882|FG000|Overall Study|Lost to Follow-up|30
7584788|NCT01980017|11989883|FG001|Overall Study|Lost to Follow-up|21
7584789|NCT01980017|11989882|FG000|Overall Study|Death|0
7584790|NCT01980017|11989883|FG001|Overall Study|Death|1
7584791|NCT01890759|11989894|FG000|Overall Study|Protocol Violation|0
7584792|NCT01890759|11989895|FG001|Overall Study|Protocol Violation|2
7584793|NCT01890759|11989894|FG000|Overall Study|Lost to Follow-up|0
7584794|NCT01890759|11989895|FG001|Overall Study|Lost to Follow-up|2
7584795|NCT01890759|11989894|FG000|Overall Study|Withdrawal by Subject|2
7584796|NCT01890759|11989895|FG001|Overall Study|Withdrawal by Subject|8
7584797|NCT01721746|11989908|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0
7584798|NCT01721746|11989909|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13
7584799|NCT01721746|11989908|FG000|Pre-Treatment|Withdrawal by Subject|1
7584800|NCT01721746|11989909|FG001|Pre-Treatment|Withdrawal by Subject|16
7584801|NCT01721746|11989908|FG000|Pre-Treatment|Poor/Non-compliance|1
7584802|NCT01721746|11989909|FG001|Pre-Treatment|Poor/Non-compliance|0
7584803|NCT01721746|11989908|FG000|Pre-Treatment|Participant no longer met study criteria|2
7584804|NCT01721746|11989909|FG001|Pre-Treatment|Participant no longer met study criteria|2
7584805|NCT01721746|11989908|FG000|Treatment|Disease Progression|192
7584806|NCT01721746|11989909|FG001|Treatment|Disease Progression|74
7584807|NCT01721746|11989908|FG000|Treatment|Study Drug Toxicity|19
7584808|NCT01721746|11989909|FG001|Treatment|Study Drug Toxicity|11
7584809|NCT01721746|11989908|FG000|Treatment|Adverse Event unrelated to Study Drug|6
7584810|NCT01721746|11989909|FG001|Treatment|Adverse Event unrelated to Study Drug|3
7584811|NCT01721746|11989908|FG000|Treatment|Participant request to discontinue Study treatment|26
7584812|NCT01721746|11989909|FG001|Treatment|Participant request to discontinue Study treatment|7
7584813|NCT01721746|11989908|FG000|Treatment|Participant withdrew consent|4
7584814|NCT01721746|11989909|FG001|Treatment|Participant withdrew consent|2
7584815|NCT01721746|11989908|FG000|Treatment|Maximum Clinical Benefit|9
7584816|NCT01721746|11989909|FG001|Treatment|Maximum Clinical Benefit|3
7584817|NCT01721746|11989908|FG000|Treatment|Poor/Non-compliance|2
7584818|NCT01721746|11989909|FG001|Treatment|Poor/Non-compliance|0
7584819|NCT01721746|11989908|FG000|Treatment|Participant no longer met Study criteria|4
7584820|NCT01721746|11989909|FG001|Treatment|Participant no longer met Study criteria|0
7584821|NCT01721746|11989908|FG000|Treatment|Other reasons|6
7584822|NCT01721746|11989909|FG001|Treatment|Other reasons|2
7584823|NCT01587040|11989920|FG000|Overall Study|Protocol Violation|0
7584824|NCT01587040|11989921|FG001|Overall Study|Protocol Violation|0
7584825|NCT01587040|11989922|FG002|Overall Study|Protocol Violation|1
7584826|NCT01587040|11989923|FG003|Overall Study|Protocol Violation|0
7584827|NCT01587040|11989920|FG000|Overall Study|Adverse Event|0
7584828|NCT01587040|11989921|FG001|Overall Study|Adverse Event|1
7584829|NCT01587040|11989922|FG002|Overall Study|Adverse Event|10
7584830|NCT01587040|11989923|FG003|Overall Study|Adverse Event|0
7584831|NCT01587040|11989920|FG000|Overall Study|Disease progression|12
7584832|NCT01587040|11989921|FG001|Overall Study|Disease progression|1
7584833|NCT01587040|11989922|FG002|Overall Study|Disease progression|15
7584834|NCT01587040|11989923|FG003|Overall Study|Disease progression|3
7584835|NCT01587040|11989920|FG000|Overall Study|Other than specified|5
7584836|NCT01587040|11989921|FG001|Overall Study|Other than specified|1
7584837|NCT01587040|11989922|FG002|Overall Study|Other than specified|11
7584838|NCT01587040|11989923|FG003|Overall Study|Other than specified|1
7584839|NCT01254409|11989941|FG000|Overall Study|Adverse Event|0
7584840|NCT01254409|11989942|FG001|Overall Study|Adverse Event|1
7584841|NCT01254409|11989943|FG002|Overall Study|Adverse Event|0
7584842|NCT01254409|11989944|FG003|Overall Study|Adverse Event|0
7584843|NCT01253161|11989957|FG000|Overall Study|Adverse Event|1
7584844|NCT00728962|11989984|FG000|Implant Placement Surgery|Adverse Event|8
7584845|NCT00728962|11989984|FG000|Implant Placement Surgery|Lost to Follow-up|1
7584846|NCT00728962|11989984|FG000|Implant Placement Surgery|Protocol Violation|1
7584847|NCT00728962|11989984|FG000|Permanent Prosthesis Placement|Adverse Event|3
7584848|NCT00728962|11989984|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3
7584849|NCT00728754|11989990|FG000|Permanent Prosthesis Placement|Adverse Event|1
7584850|NCT00728754|11989991|FG001|Permanent Prosthesis Placement|Adverse Event|1
7584851|NCT00728754|11989990|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3
7584852|NCT00728754|11989991|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3
7584853|NCT00728754|11989990|FG000|One Year Post Placement Follow-up|Adverse Event|1
7584854|NCT00728754|11989991|FG001|One Year Post Placement Follow-up|Adverse Event|0
7584855|NCT00723944|11989999|FG000|Permanent Prosthesis Placement|Adverse Event|1
7584856|NCT00723944|11990000|FG001|Permanent Prosthesis Placement|Adverse Event|7
7584857|NCT00723944|11989999|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2
7584858|NCT00723944|11990000|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2
7584859|NCT00723944|11989999|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1
7584860|NCT00723944|11990000|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4
7584861|NCT00467142|11990006|FG000|Overall Study|Withdrawal by Subject|1
7584862|NCT00467142|11990006|FG000|Overall Study|Adverse Event|1
7584863|NCT00467142|11990006|FG000|Overall Study|Protocol Violation|1
7625729|NCT02174861|12037486|FG000|Overall Study|Decision by sponsor|8
7625730|NCT02174861|12037486|FG000|Overall Study|Withdrawal by Subject|124
7625731|NCT02174861|12037486|FG000|Overall Study|Lost to Follow-up|26
7625732|NCT02052739|12037494|FG000|Overall Study|Withdrew due to Adverse Event|3
7625733|NCT02052739|12037495|FG001|Overall Study|Withdrew due to Adverse Event|0
7625734|NCT02052739|12037494|FG000|Overall Study|Participant Died|2
7625735|NCT02052739|12037495|FG001|Overall Study|Participant Died|1
7625736|NCT01944020|12037505|FG000|Overall Study|Withdrawal by Subject|5
7625737|NCT01944020|12037506|FG001|Overall Study|Withdrawal by Subject|0
7625738|NCT01689519|12037514|FG000|Intent to Treat|Death|157
7625739|NCT01689519|12037515|FG001|Intent to Treat|Death|167
7625740|NCT01689519|12037514|FG000|Intent to Treat|Lost to Follow-up|4
7625741|NCT01689519|12037515|FG001|Intent to Treat|Lost to Follow-up|8
7625742|NCT01689519|12037514|FG000|Intent to Treat|Other|2
7625743|NCT01689519|12037515|FG001|Intent to Treat|Other|4
7625744|NCT01689519|12037514|FG000|Intent to Treat|Physician Decision|4
7625745|NCT01689519|12037515|FG001|Intent to Treat|Physician Decision|1
7625746|NCT01689519|12037514|FG000|Intent to Treat|Study terminated by Spon6sor|59
7625747|NCT01689519|12037515|FG001|Intent to Treat|Study terminated by Spon6sor|48
7625748|NCT01689519|12037514|FG000|Intent to Treat|Withdrawal by Subject|21
7625749|NCT01689519|12037515|FG001|Intent to Treat|Withdrawal by Subject|20
7625750|NCT01689519|12037514|FG000|Safety Population|Death|158
7625751|NCT01689519|12037515|FG001|Safety Population|Death|165
7625752|NCT01689519|12037514|FG000|Safety Population|Lost to Follow-up|4
7625753|NCT01689519|12037515|FG001|Safety Population|Lost to Follow-up|8
7625754|NCT01689519|12037514|FG000|Safety Population|Other|2
7625755|NCT01689519|12037515|FG001|Safety Population|Other|4
7625756|NCT01689519|12037514|FG000|Safety Population|Physician Decision|4
7625757|NCT01689519|12037515|FG001|Safety Population|Physician Decision|1
7625758|NCT01689519|12037514|FG000|Safety Population|Study Terminated By Sponsor|60
7625759|NCT01689519|12037515|FG001|Safety Population|Study Terminated By Sponsor|47
7625760|NCT01689519|12037514|FG000|Safety Population|Withdrawal by Subject|20
7625761|NCT01689519|12037515|FG001|Safety Population|Withdrawal by Subject|20
7625762|NCT01622088|12037521|FG000|Overall Study|Adverse Event|20
7625763|NCT01622088|12037521|FG000|Overall Study|Lost to Follow-up|1
7625764|NCT01622088|12037521|FG000|Overall Study|Withdrawal by Subject|20
7625765|NCT01622088|12037521|FG000|Overall Study|Investigator Decision|1
7625766|NCT01622088|12037521|FG000|Overall Study|Death|53
7625767|NCT01622088|12037521|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521
7625768|NCT01486264|12037528|FG000|Overall Study|Death|1
7625769|NCT01486264|12037529|FG001|Overall Study|Death|1
7625770|NCT01486264|12037528|FG000|Overall Study|Adverse Event|3
7625771|NCT01486264|12037529|FG001|Overall Study|Adverse Event|3
7625772|NCT01486264|12037528|FG000|Overall Study|Lack of Efficacy|6
7625773|NCT01486264|12037529|FG001|Overall Study|Lack of Efficacy|10
7625774|NCT01486264|12037528|FG000|Overall Study|Withdrawal by Subject|7
7625775|NCT01486264|12037529|FG001|Overall Study|Withdrawal by Subject|18
7625776|NCT01486264|12037528|FG000|Overall Study|Physician Decision|1
7625777|NCT01486264|12037529|FG001|Overall Study|Physician Decision|1
7625778|NCT01486264|12037528|FG000|Overall Study|Protocol Violation|3
7625779|NCT01486264|12037529|FG001|Overall Study|Protocol Violation|0
7625780|NCT01486264|12037528|FG000|Overall Study|Lost to Follow-up|3
7625781|NCT01486264|12037529|FG001|Overall Study|Lost to Follow-up|2
7625782|NCT01486264|12037528|FG000|Overall Study|Other|5
7625783|NCT01486264|12037529|FG001|Overall Study|Other|11
7625784|NCT01486264|12037528|FG000|Overall Study|Not treated|0
7625785|NCT01486264|12037529|FG001|Overall Study|Not treated|1
7625786|NCT01419080|12037535|FG000|Overall Study|Withdrawal by Subject|75
7625787|NCT01419080|12037535|FG000|Overall Study|Death|30
7625788|NCT01419080|12037535|FG000|Overall Study|Lost to Follow-up|23
7625789|NCT01419080|12037535|FG000|Overall Study|Too Ill|3
7625790|NCT01317160|12037543|FG000|Overall Study|Incorrect inclusion|1
7625791|NCT01317160|12037544|FG001|Overall Study|Incorrect inclusion|1
7625792|NCT01317160|12037543|FG000|Overall Study|Lost to Follow-up|3
7625793|NCT01317160|12037544|FG001|Overall Study|Lost to Follow-up|3
7625794|NCT01317160|12037543|FG000|Overall Study|Withdrawal by Subject|0
7625795|NCT01317160|12037544|FG001|Overall Study|Withdrawal by Subject|2
7625796|NCT01094782|12037584|FG000|Overall Study|Withdrawal by Subject|5
7625797|NCT01094782|12037585|FG001|Overall Study|Withdrawal by Subject|5
7625798|NCT01094782|12037586|FG002|Overall Study|Withdrawal by Subject|1
7625799|NCT01094782|12037587|FG003|Overall Study|Withdrawal by Subject|5
7584864|NCT04557371|11990043|FG000|Overall Study|Covid-19-related|0
7584865|NCT04557371|11990044|FG001|Overall Study|Covid-19-related|1
7584866|NCT04557371|11990045|FG002|Overall Study|Covid-19-related|0
7584867|NCT04557371|11990043|FG000|Overall Study|Withdrawal by Subject|0
7584868|NCT04557371|11990044|FG001|Overall Study|Withdrawal by Subject|1
7584869|NCT04557371|11990045|FG002|Overall Study|Withdrawal by Subject|0
7584870|NCT04557371|11990043|FG000|Overall Study|Adverse Event|1
7584871|NCT04557371|11990044|FG001|Overall Study|Adverse Event|0
7584872|NCT04557371|11990045|FG002|Overall Study|Adverse Event|0
7584873|NCT04369742|11990066|FG000|Overall Study|Lost to Follow-Up (Day 14)|7
7584874|NCT04369742|11990067|FG001|Overall Study|Lost to Follow-Up (Day 14)|4
7584875|NCT04369742|11990066|FG000|Overall Study|Lost to Follow-Up (Day 30)|7
7584876|NCT04369742|11990067|FG001|Overall Study|Lost to Follow-Up (Day 30)|7
7584877|NCT03969589|11990097|FG000|Overall Study|Lost to Follow-up|3
7584878|NCT03969589|11990098|FG001|Overall Study|Lost to Follow-up|2
7584879|NCT03969589|11990097|FG000|Overall Study|Declined Follow-Up|0
7584880|NCT03969589|11990098|FG001|Overall Study|Declined Follow-Up|1
7584881|NCT03655691|11990141|FG000|Overall Study|Adverse Event|0
7584882|NCT03655691|11990142|FG001|Overall Study|Adverse Event|0
7584883|NCT03655691|11990143|FG002|Overall Study|Adverse Event|1
7584884|NCT03655691|11990141|FG000|Overall Study|Lost to Follow-up|1
7584885|NCT03655691|11990142|FG001|Overall Study|Lost to Follow-up|1
7584886|NCT03655691|11990143|FG002|Overall Study|Lost to Follow-up|2
7584887|NCT03655691|11990141|FG000|Overall Study|Protocol Violation|0
7584888|NCT03655691|11990142|FG001|Overall Study|Protocol Violation|1
7584889|NCT03655691|11990143|FG002|Overall Study|Protocol Violation|0
7584890|NCT03655691|11990141|FG000|Overall Study|Withdrawal by Subject|1
7765424|NCT00840060|12207369|FG001|Overall Study|Change in emotional/behavioral status|1
7765425|NCT00840086|12207375|FG000|Overall Study|Adverse Event|1
7765426|NCT00840086|12207375|FG000|Overall Study|Protocol Violation|2
7765427|NCT00840086|12207375|FG000|Overall Study|Lost to Follow-up|1
7765428|NCT00840294|12207384|FG000|Overall Study|Withdrawal by Subject|2
7765429|NCT00840294|12207385|FG001|Overall Study|Withdrawal by Subject|1
7765430|NCT00840294|12207384|FG000|Overall Study|Protocol Violation|1
7765431|NCT00840294|12207385|FG001|Overall Study|Protocol Violation|3
7765432|NCT00840294|12207384|FG000|Overall Study|Illness|0
7765433|NCT00840294|12207385|FG001|Overall Study|Illness|1
7765434|NCT00840450|12207395|FG000|Overall Study|Adverse Event|1
7765435|NCT00840450|12207395|FG000|Overall Study|Lack of Efficacy|2
7765436|NCT00840463|12207401|FG000|Overall Study|Adverse Event|1
7765437|NCT00840463|12207402|FG001|Overall Study|Adverse Event|0
7765438|NCT00840658|12207412|FG000|Overall Study|Death|2
7765439|NCT00840658|12207413|FG001|Overall Study|Death|2
7765440|NCT00840658|12207414|FG002|Overall Study|Death|3
7765441|NCT00840658|12207415|FG003|Overall Study|Death|3
7765442|NCT00840658|12207412|FG000|Overall Study|Lost to Follow-up|3
7765443|NCT00840658|12207413|FG001|Overall Study|Lost to Follow-up|1
7765444|NCT00840658|12207414|FG002|Overall Study|Lost to Follow-up|2
7584891|NCT03655691|11990142|FG001|Overall Study|Withdrawal by Subject|1
7584892|NCT03655691|11990143|FG002|Overall Study|Withdrawal by Subject|0
7584893|NCT03364686|11990155|FG000|Overall Study|Physician Decision|2
7584894|NCT03326856|11990173|FG000|Overall Study|Lost to Follow-up|1
7765445|NCT00840658|12207415|FG003|Overall Study|Lost to Follow-up|1
7584895|NCT03326856|11990174|FG001|Overall Study|Lost to Follow-up|1
7584896|NCT03326856|11990175|FG002|Overall Study|Lost to Follow-up|0
7584897|NCT03326856|11990176|FG003|Overall Study|Lost to Follow-up|0
7584898|NCT03326856|11990177|FG004|Overall Study|Lost to Follow-up|0
7765446|NCT00840749|12207431|FG000|Overall Study|Death|1
7765447|NCT00840749|12207432|FG001|Overall Study|Death|2
7765448|NCT00840749|12207431|FG000|Overall Study|not treated on study arm|11
7765449|NCT00840749|12207432|FG001|Overall Study|not treated on study arm|11
7765450|NCT00840749|12207431|FG000|Overall Study|study closed|19
7765451|NCT00840749|12207432|FG001|Overall Study|study closed|14
7584905|NCT03240692|11990202|FG000|Overall Study|Physician Decision|1
7584906|NCT03240692|11990202|FG000|Overall Study|Withdrawal by Subject|1
7584907|NCT03227029|11990209|FG000|Overall Study|Child Wheezed (no treatment)|0
7584908|NCT03227029|11990210|FG001|Overall Study|Child Wheezed (no treatment)|1
7584909|NCT03227029|11990211|FG002|Overall Study|Child Wheezed (no treatment)|0
7584910|NCT03227029|11990209|FG000|Overall Study|No post RSV season visit due to COVID|3
7584911|NCT03227029|11990210|FG001|Overall Study|No post RSV season visit due to COVID|3
7584912|NCT03227029|11990211|FG002|Overall Study|No post RSV season visit due to COVID|2
7584913|NCT03227029|11990209|FG000|Overall Study|Not able to get to clinic|0
7584914|NCT03227029|11990210|FG001|Overall Study|Not able to get to clinic|0
7584915|NCT03227029|11990211|FG002|Overall Study|Not able to get to clinic|1
7584916|NCT03227029|11990209|FG000|Overall Study|Withdrawal by Subject|1
7584917|NCT03227029|11990210|FG001|Overall Study|Withdrawal by Subject|0
7584918|NCT03227029|11990211|FG002|Overall Study|Withdrawal by Subject|0
7584919|NCT03227029|11990209|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0
7584920|NCT03227029|11990210|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0
7584921|NCT03227029|11990211|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1
7584922|NCT03182829|11990239|FG000|Overall Study|Protocol Violation|12
7584923|NCT03182829|11990240|FG001|Overall Study|Protocol Violation|12
7584924|NCT03182829|11990239|FG000|Overall Study|Other|4
7584925|NCT03182829|11990240|FG001|Overall Study|Other|3
7584926|NCT03181789|11990250|FG000|Overall Study|Withdrawal by Subject|0
7584927|NCT03181789|11990251|FG001|Overall Study|Withdrawal by Subject|1
7584928|NCT03181789|11990252|FG002|Overall Study|Withdrawal by Subject|1
7584929|NCT03181789|11990253|FG003|Overall Study|Withdrawal by Subject|0
7584930|NCT03181789|11990250|FG000|Overall Study|Lost to Follow-up|7
7584931|NCT03181789|11990251|FG001|Overall Study|Lost to Follow-up|1
7584932|NCT03181789|11990252|FG002|Overall Study|Lost to Follow-up|0
7584933|NCT03181789|11990253|FG003|Overall Study|Lost to Follow-up|0
7584934|NCT03181789|11990250|FG000|Overall Study|Participant unable to adhere to visit|0
7584935|NCT03181789|11990251|FG001|Overall Study|Participant unable to adhere to visit|1
7584936|NCT03181789|11990252|FG002|Overall Study|Participant unable to adhere to visit|0
7584937|NCT03181789|11990253|FG003|Overall Study|Participant unable to adhere to visit|0
7584938|NCT03164356|11990268|FG000|Overall Study|Lost to Follow-up|1
7584939|NCT03164356|11990269|FG001|Overall Study|Lost to Follow-up|1
7584940|NCT03164356|11990270|FG002|Overall Study|Lost to Follow-up|2
7584941|NCT03164356|11990271|FG003|Overall Study|Lost to Follow-up|1
7584942|NCT03164356|11990268|FG000|Overall Study|Physician Decision|0
7584943|NCT03164356|11990269|FG001|Overall Study|Physician Decision|0
7584944|NCT03164356|11990270|FG002|Overall Study|Physician Decision|3
7584945|NCT03164356|11990271|FG003|Overall Study|Physician Decision|0
7584946|NCT03164356|11990268|FG000|Overall Study|Protocol Violation|2
7584947|NCT03164356|11990269|FG001|Overall Study|Protocol Violation|1
7584948|NCT03164356|11990270|FG002|Overall Study|Protocol Violation|0
7584949|NCT03164356|11990271|FG003|Overall Study|Protocol Violation|0
7584950|NCT03164356|11990268|FG000|Overall Study|Withdrawal by Subject|1
7584951|NCT03164356|11990269|FG001|Overall Study|Withdrawal by Subject|0
7584952|NCT03164356|11990270|FG002|Overall Study|Withdrawal by Subject|0
7584953|NCT03164356|11990271|FG003|Overall Study|Withdrawal by Subject|0
7584954|NCT03164356|11990268|FG000|Overall Study|Study timeframe interrupted by COVID-19|1
7584955|NCT03164356|11990269|FG001|Overall Study|Study timeframe interrupted by COVID-19|0
7584956|NCT03164356|11990270|FG002|Overall Study|Study timeframe interrupted by COVID-19|0
7584957|NCT03164356|11990271|FG003|Overall Study|Study timeframe interrupted by COVID-19|1
7584958|NCT03164356|11990268|FG000|Overall Study|Subject Incarcerated|0
7584959|NCT03164356|11990269|FG001|Overall Study|Subject Incarcerated|1
7584960|NCT03164356|11990270|FG002|Overall Study|Subject Incarcerated|0
7584961|NCT03164356|11990271|FG003|Overall Study|Subject Incarcerated|0
7584962|NCT03164356|11990268|FG000|Overall Study|Prosthetist unable to participate|0
7584963|NCT03164356|11990269|FG001|Overall Study|Prosthetist unable to participate|2
7584964|NCT03164356|11990270|FG002|Overall Study|Prosthetist unable to participate|1
7584965|NCT03164356|11990271|FG003|Overall Study|Prosthetist unable to participate|0
7625800|NCT01094782|12037588|FG004|Overall Study|Withdrawal by Subject|5
7625801|NCT01094782|12037589|FG005|Overall Study|Withdrawal by Subject|0
7625802|NCT01094782|12037584|FG000|Overall Study|Lost to Follow-up|1
7625803|NCT01094782|12037585|FG001|Overall Study|Lost to Follow-up|0
7625804|NCT01094782|12037586|FG002|Overall Study|Lost to Follow-up|0
7625805|NCT01094782|12037587|FG003|Overall Study|Lost to Follow-up|2
7625806|NCT01094782|12037588|FG004|Overall Study|Lost to Follow-up|1
7625807|NCT01094782|12037589|FG005|Overall Study|Lost to Follow-up|4
7625808|NCT01094782|12037584|FG000|Overall Study|Positive Drug Screen|2
7625809|NCT01094782|12037585|FG001|Overall Study|Positive Drug Screen|2
7625810|NCT01094782|12037586|FG002|Overall Study|Positive Drug Screen|1
7625811|NCT01094782|12037587|FG003|Overall Study|Positive Drug Screen|1
7625812|NCT01094782|12037588|FG004|Overall Study|Positive Drug Screen|3
7584966|NCT02975700|11990291|FG000|Overall Study|Adverse Event|1
7584967|NCT02975700|11990291|FG000|Overall Study|Progressive disease|3
7584968|NCT02975700|11990291|FG000|Overall Study|Failed screening criteria|2
7584969|NCT02941549|11990298|FG000|Overall Study|Adverse Event|1
7584970|NCT02941549|11990299|FG001|Overall Study|Adverse Event|0
7584971|NCT02941549|11990300|FG002|Overall Study|Adverse Event|0
7584972|NCT02941549|11990298|FG000|Overall Study|Withdrawal by Subject|2
7584973|NCT02941549|11990299|FG001|Overall Study|Withdrawal by Subject|1
7584974|NCT02941549|11990300|FG002|Overall Study|Withdrawal by Subject|2
7584975|NCT02927938|11990324|FG000|Overall Study|Death|0
7584976|NCT02927938|11990325|FG001|Overall Study|Death|1
7584977|NCT02927938|11990326|FG002|Overall Study|Death|0
7584978|NCT02927938|11990327|FG003|Overall Study|Death|4
7584979|NCT02927938|11990324|FG000|Overall Study|Early Study Termination|1
7584980|NCT02927938|11990325|FG001|Overall Study|Early Study Termination|5
7584981|NCT02927938|11990326|FG002|Overall Study|Early Study Termination|4
7584982|NCT02927938|11990327|FG003|Overall Study|Early Study Termination|3
7584983|NCT02823574|11990367|FG000|Pre-Treatment Period|Adverse Event Unrelated to Study drug|1
7584984|NCT02823574|11990368|FG001|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0
7584985|NCT02823574|11990369|FG002|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0
7584986|NCT02823574|11990370|FG003|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0
7584987|NCT02823574|11990367|FG000|Pre-Treatment Period|Disease progression|0
7584988|NCT02823574|11990368|FG001|Pre-Treatment Period|Disease progression|0
7584989|NCT02823574|11990369|FG002|Pre-Treatment Period|Disease progression|1
7584990|NCT02823574|11990370|FG003|Pre-Treatment Period|Disease progression|0
7584991|NCT02823574|11990367|FG000|Treatment Period|Poor/Non Compliance|1
7584992|NCT02823574|11990368|FG001|Treatment Period|Poor/Non Compliance|0
7584993|NCT02823574|11990369|FG002|Treatment Period|Poor/Non Compliance|0
7584994|NCT02823574|11990370|FG003|Treatment Period|Poor/Non Compliance|1
7584995|NCT02823574|11990367|FG000|Treatment Period|Maximum Clinical Benefit|1
7584996|NCT02823574|11990368|FG001|Treatment Period|Maximum Clinical Benefit|0
7584997|NCT02823574|11990369|FG002|Treatment Period|Maximum Clinical Benefit|2
7584998|NCT02823574|11990370|FG003|Treatment Period|Maximum Clinical Benefit|0
7584999|NCT02823574|11990367|FG000|Treatment Period|Lost to Follow-up|1
7585000|NCT02823574|11990368|FG001|Treatment Period|Lost to Follow-up|0
7585001|NCT02823574|11990369|FG002|Treatment Period|Lost to Follow-up|0
7585002|NCT02823574|11990370|FG003|Treatment Period|Lost to Follow-up|0
7585003|NCT02823574|11990367|FG000|Treatment Period|Participant withdrew consent|2
7625813|NCT01094782|12037589|FG005|Overall Study|Positive Drug Screen|2
7625814|NCT01094782|12037584|FG000|Overall Study|Sensory Deficit at Site of QST|0
7625815|NCT01094782|12037585|FG001|Overall Study|Sensory Deficit at Site of QST|1
7625816|NCT01094782|12037586|FG002|Overall Study|Sensory Deficit at Site of QST|0
7625817|NCT01094782|12037587|FG003|Overall Study|Sensory Deficit at Site of QST|0
7625818|NCT01094782|12037588|FG004|Overall Study|Sensory Deficit at Site of QST|0
7625819|NCT01094782|12037589|FG005|Overall Study|Sensory Deficit at Site of QST|0
7625820|NCT01094782|12037584|FG000|Overall Study|Unable to Complete Questionnaires|0
7625821|NCT01094782|12037585|FG001|Overall Study|Unable to Complete Questionnaires|1
7625822|NCT01094782|12037586|FG002|Overall Study|Unable to Complete Questionnaires|0
7625823|NCT01094782|12037587|FG003|Overall Study|Unable to Complete Questionnaires|0
7585004|NCT02823574|11990368|FG001|Treatment Period|Participant withdrew consent|0
7585005|NCT02823574|11990369|FG002|Treatment Period|Participant withdrew consent|0
7585006|NCT02823574|11990370|FG003|Treatment Period|Participant withdrew consent|0
7585007|NCT02823574|11990367|FG000|Treatment Period|Participant request to discontinue|4
7585008|NCT02823574|11990368|FG001|Treatment Period|Participant request to discontinue|0
7585009|NCT02823574|11990369|FG002|Treatment Period|Participant request to discontinue|2
7585010|NCT02823574|11990370|FG003|Treatment Period|Participant request to discontinue|3
7585011|NCT02823574|11990367|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10
7585012|NCT02823574|11990368|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2
7585013|NCT02823574|11990369|FG002|Treatment Period|Adverse Event unrelated to to study Drug|8
7585014|NCT02823574|11990370|FG003|Treatment Period|Adverse Event unrelated to to study Drug|1
7585015|NCT02823574|11990367|FG000|Treatment Period|Study Drug Toxicity|7
7585016|NCT02823574|11990368|FG001|Treatment Period|Study Drug Toxicity|2
7585017|NCT02823574|11990369|FG002|Treatment Period|Study Drug Toxicity|13
7585018|NCT02823574|11990370|FG003|Treatment Period|Study Drug Toxicity|3
7585019|NCT02823574|11990367|FG000|Treatment Period|Disease Progression|112
7585020|NCT02823574|11990368|FG001|Treatment Period|Disease Progression|60
7585021|NCT02823574|11990369|FG002|Treatment Period|Disease Progression|80
7585022|NCT02823574|11990370|FG003|Treatment Period|Disease Progression|41
7585023|NCT02823574|11990367|FG000|Treatment Period|participant no longer meets study criteria|0
7585024|NCT02823574|11990368|FG001|Treatment Period|participant no longer meets study criteria|0
7585025|NCT02823574|11990369|FG002|Treatment Period|participant no longer meets study criteria|1
7585026|NCT02823574|11990370|FG003|Treatment Period|participant no longer meets study criteria|0
7585027|NCT02823574|11990367|FG000|Treatment Period|Death|0
7585028|NCT02823574|11990368|FG001|Treatment Period|Death|0
7585029|NCT02823574|11990369|FG002|Treatment Period|Death|2
7585030|NCT02823574|11990370|FG003|Treatment Period|Death|1
7585031|NCT02823574|11990367|FG000|Treatment Period|Other reasons|1
7585032|NCT02823574|11990368|FG001|Treatment Period|Other reasons|2
7585033|NCT02823574|11990369|FG002|Treatment Period|Other reasons|0
7585034|NCT02823574|11990370|FG003|Treatment Period|Other reasons|1
7585035|NCT02743819|11990392|FG000|Overall Study|Lack of Efficacy|5
7585036|NCT02743819|11990392|FG000|Overall Study|Death|2
7585037|NCT02743819|11990392|FG000|Overall Study|Adverse Event|1
7585038|NCT02729753|11990398|FG000|Overall Study|Device Malfunction. No units in stock.|0
7765452|NCT00840970|12207438|FG000|Overall Study|Adverse Event|0
7765453|NCT00840970|12207439|FG001|Overall Study|Adverse Event|0
7765454|NCT00840970|12207440|FG002|Overall Study|Adverse Event|1
7765455|NCT00840996|12207452|FG000|Overall Study|Withdrawal by Subject|1
7765456|NCT00840996|12207453|FG001|Overall Study|Withdrawal by Subject|0
7765457|NCT00841100|12207468|FG000|Phase 1 (28 Days)|Adverse Event|1
7765458|NCT00841100|12207468|FG000|Phase 1 (28 Days)|Participant non-compliance|2
7765459|NCT00841321|12207493|FG000|Overall Study|Lost to Follow-up|1
7765460|NCT00841321|12207494|FG001|Overall Study|Lost to Follow-up|1
7765461|NCT00841321|12207493|FG000|Overall Study|Adverse Event|0
7765462|NCT00841321|12207494|FG001|Overall Study|Adverse Event|2
7765463|NCT00841568|12207518|FG000|Overall Study|Adverse Event|1
7765464|NCT00841568|12207518|FG000|Overall Study|Death|1
7765465|NCT00841568|12207518|FG000|Overall Study|Withdrawal by Subject|2
7765466|NCT00841568|12207518|FG000|Overall Study|Creatinine over the withdrawal criteria|1
7765467|NCT00841672|12207528|FG000|Overall Study|Adverse Event|7
7765468|NCT00841672|12207529|FG001|Overall Study|Adverse Event|16
7765469|NCT00841672|12207528|FG000|Overall Study|Abnormal test procedure result(s)|0
7765470|NCT00841672|12207529|FG001|Overall Study|Abnormal test procedure result(s)|1
7765471|NCT00841672|12207528|FG000|Overall Study|Subject withdrew consent|2
7765472|NCT00841672|12207529|FG001|Overall Study|Subject withdrew consent|4
7765473|NCT00841672|12207528|FG000|Overall Study|Lost to Follow-up|1
7765474|NCT00841672|12207529|FG001|Overall Study|Lost to Follow-up|1
7765475|NCT00841672|12207528|FG000|Overall Study|Administrative problems|9
7765476|NCT00841672|12207529|FG001|Overall Study|Administrative problems|9
7765477|NCT00841672|12207528|FG000|Overall Study|Misrandomized|1
7765478|NCT00841672|12207529|FG001|Overall Study|Misrandomized|0
7765479|NCT00841672|12207528|FG000|Overall Study|Protocol Deviation|0
7765480|NCT00841672|12207529|FG001|Overall Study|Protocol Deviation|1
7765481|NCT00841763|12207537|FG000|Overall Study|Withdrawal by Subject|60
7765482|NCT00841763|12207538|FG001|Overall Study|Withdrawal by Subject|17
7765483|NCT00841763|12207539|FG002|Overall Study|Withdrawal by Subject|4
7765484|NCT00841763|12207540|FG003|Overall Study|Withdrawal by Subject|1
7765485|NCT00841763|12207537|FG000|Overall Study|Adverse Event|9
7765486|NCT00841763|12207538|FG001|Overall Study|Adverse Event|10
7765487|NCT00841763|12207539|FG002|Overall Study|Adverse Event|3
7765488|NCT00841763|12207540|FG003|Overall Study|Adverse Event|2
7765489|NCT00841763|12207537|FG000|Overall Study|Lost to Follow-up|63
7765490|NCT00841763|12207538|FG001|Overall Study|Lost to Follow-up|25
7585039|NCT02729753|11990399|FG001|Overall Study|Device Malfunction. No units in stock.|1
7585040|NCT02704130|11990410|FG000|Overall Study|Physician Decision|5
7585041|NCT02704130|11990411|FG001|Overall Study|Physician Decision|3
7585042|NCT02701192|11990417|FG000|Overall Study|Protocol Violation|2
7585043|NCT02701192|11990417|FG000|Overall Study|Lost to Follow-up|4
7585044|NCT02653482|11990451|FG000|Overall Study|Death|1
7585045|NCT02653482|11990452|FG001|Overall Study|Death|1
7585046|NCT02632409|11990460|FG000|Randomized|AE unrelated to study Drug|0
7585047|NCT02632409|11990461|FG001|Randomized|AE unrelated to study Drug|1
7585048|NCT02632409|11990460|FG000|Randomized|Participant withdrew consent|2
7585049|NCT02632409|11990461|FG001|Randomized|Participant withdrew consent|1
7585050|NCT02632409|11990460|FG000|Randomized|No Longer meets study criteria|5
7585051|NCT02632409|11990461|FG001|Randomized|No Longer meets study criteria|0
7585052|NCT02632409|11990460|FG000|Randomized|other reasons|1
7585053|NCT02632409|11990461|FG001|Randomized|other reasons|0
7585054|NCT02632409|11990460|FG000|Treatment Period|Ongoing Treatment|20
7585055|NCT02632409|11990461|FG001|Treatment Period|Ongoing Treatment|21
7585056|NCT02632409|11990460|FG000|Treatment Period|Disease Recurrence|147
7585057|NCT02632409|11990461|FG001|Treatment Period|Disease Recurrence|90
7585058|NCT02632409|11990460|FG000|Treatment Period|Study Drug Toxicity|8
7585059|NCT02632409|11990461|FG001|Treatment Period|Study Drug Toxicity|49
7585060|NCT02632409|11990460|FG000|Treatment Period|Death|1
7585061|NCT02632409|11990461|FG001|Treatment Period|Death|0
7585062|NCT02632409|11990460|FG000|Treatment Period|AE unrelated to study drug|15
7585063|NCT02632409|11990461|FG001|Treatment Period|AE unrelated to study drug|16
7585064|NCT02632409|11990460|FG000|Treatment Period|Request to discontinue treatment|4
7585065|NCT02632409|11990461|FG001|Treatment Period|Request to discontinue treatment|19
7585066|NCT02632409|11990460|FG000|Treatment Period|Participant withdrew consent|7
7585067|NCT02632409|11990461|FG001|Treatment Period|Participant withdrew consent|5
7585068|NCT02632409|11990460|FG000|Treatment Period|Lost to Follow-up|0
7585069|NCT02632409|11990461|FG001|Treatment Period|Lost to Follow-up|1
7585070|NCT02632409|11990460|FG000|Treatment Period|Maximum clinical benefit|1
7585071|NCT02632409|11990461|FG001|Treatment Period|Maximum clinical benefit|0
7585072|NCT02632409|11990460|FG000|Treatment Period|No longer meets study criteria|3
7585073|NCT02632409|11990461|FG001|Treatment Period|No longer meets study criteria|0
7585074|NCT02632409|11990460|FG000|Treatment Period|Administrative Reason by sponsor|0
7585075|NCT02632409|11990461|FG001|Treatment Period|Administrative Reason by sponsor|1
7585076|NCT02632409|11990460|FG000|Treatment Period|Other Reasons|10
7585077|NCT02632409|11990461|FG001|Treatment Period|Other Reasons|6
7585078|NCT02612194|11990470|FG000|Overall Study|Death|5
7585079|NCT02612194|11990471|FG001|Overall Study|Death|0
7585080|NCT02612194|11990472|FG002|Overall Study|Death|2
7585081|NCT02612194|11990470|FG000|Overall Study|Early Study Termination|1
7585082|NCT02612194|11990471|FG001|Overall Study|Early Study Termination|0
7585083|NCT02612194|11990472|FG002|Overall Study|Early Study Termination|0
7585084|NCT02586207|11990479|FG000|Overall Study|Physician Decision|1
7585085|NCT02586207|11990479|FG000|Overall Study|Withdrawal by Subject|1
7585086|NCT02542397|11990483|FG000|Overall Study|Death|2
7585087|NCT02542397|11990483|FG000|Overall Study|Physician Decision|6
7585088|NCT02542397|11990483|FG000|Overall Study|Withdrawal by Subject|6
7585089|NCT02542397|11990483|FG000|Overall Study|Lost to Follow-up|2
7585090|NCT02519777|11990491|FG000|Overall Study|Death|1
7585091|NCT02519777|11990492|FG001|Overall Study|Death|0
7585092|NCT02519777|11990493|FG002|Overall Study|Death|0
7585093|NCT02519777|11990491|FG000|Overall Study|Lost to Follow-up|0
7585094|NCT02519777|11990492|FG001|Overall Study|Lost to Follow-up|4
7585095|NCT02519777|11990493|FG002|Overall Study|Lost to Follow-up|2
7585096|NCT02519777|11990491|FG000|Overall Study|Withdrawal by Subject|3
7585097|NCT02519777|11990492|FG001|Overall Study|Withdrawal by Subject|1
7585098|NCT02519777|11990493|FG002|Overall Study|Withdrawal by Subject|0
7585099|NCT02519777|11990491|FG000|Overall Study|Severe Debilitation|1
7585100|NCT02519777|11990492|FG001|Overall Study|Severe Debilitation|1
7585101|NCT02519777|11990493|FG002|Overall Study|Severe Debilitation|1
7585102|NCT02519777|11990491|FG000|Overall Study|Not able to get to clinic|1
7585103|NCT02519777|11990492|FG001|Overall Study|Not able to get to clinic|2
7585104|NCT02519777|11990493|FG002|Overall Study|Not able to get to clinic|1
7585108|NCT02395666|11990507|FG000|Overall Study|Physician Decision|3
7585109|NCT02395666|11990508|FG001|Overall Study|Physician Decision|0
7585110|NCT02395666|11990507|FG000|Overall Study|Lost to Follow-up|1
7585111|NCT02395666|11990508|FG001|Overall Study|Lost to Follow-up|0
7585112|NCT02395666|11990507|FG000|Overall Study|Withdrawal by Subject|2
7585113|NCT02395666|11990508|FG001|Overall Study|Withdrawal by Subject|1
7585114|NCT02357810|11990518|FG000|Registered and Started Treatment|Withdrawal by Subject|1
7585115|NCT02357810|11990518|FG000|Registered and Started Treatment|Found not to be eligible for the study|26
7585116|NCT02357810|11990518|FG000|Reached 12 Weeks Response|Adverse Event|5
7585117|NCT02357810|11990518|FG000|Reached 12 Weeks Response|Progressive Disease|39
7585118|NCT02357810|11990518|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8
7585119|NCT02357810|11990518|FG000|Reached 12 Weeks Response|Protocol Violation|1
7585120|NCT02357810|11990518|FG000|Reached 12 Weeks Response|Death|1
7585121|NCT02357810|11990518|FG000|Reached 12 Weeks Response|Physician Decision|1
7585122|NCT02357810|11990518|FG000|Reached 12 Weeks Response|Other|1
7585123|NCT02357810|11990518|FG000|12 Week Response and Further Treatment|Adverse Event|5
7585124|NCT02357810|11990518|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1
7585125|NCT02357810|11990518|FG000|12 Week Response and Further Treatment|Progressive Disease|15
7585126|NCT02357810|11990518|FG000|12 Week Response and Further Treatment|Wound Complications|1
7585127|NCT02357810|11990518|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4
7585128|NCT02357810|11990518|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3
7585129|NCT02343549|11990522|FG000|Overall Study|Death|11
7585130|NCT02343549|11990522|FG000|Overall Study|Withdrawal by Subject|2
7765491|NCT00841763|12207539|FG002|Overall Study|Lost to Follow-up|0
7765492|NCT00841763|12207540|FG003|Overall Study|Lost to Follow-up|0
7765493|NCT00841763|12207537|FG000|Overall Study|Protocol Violation|20
7625824|NCT01094782|12037588|FG004|Overall Study|Unable to Complete Questionnaires|0
7625825|NCT01094782|12037589|FG005|Overall Study|Unable to Complete Questionnaires|0
7625826|NCT01094782|12037584|FG000|Overall Study|Healthy Subject Had Pain|0
7625827|NCT01094782|12037585|FG001|Overall Study|Healthy Subject Had Pain|1
7625828|NCT01094782|12037586|FG002|Overall Study|Healthy Subject Had Pain|0
7625829|NCT01094782|12037587|FG003|Overall Study|Healthy Subject Had Pain|0
7625830|NCT01094782|12037588|FG004|Overall Study|Healthy Subject Had Pain|0
7625831|NCT01094782|12037589|FG005|Overall Study|Healthy Subject Had Pain|0
7625832|NCT01094782|12037584|FG000|Overall Study|Hypertension|0
7625833|NCT01094782|12037585|FG001|Overall Study|Hypertension|0
7625834|NCT01094782|12037586|FG002|Overall Study|Hypertension|1
7625835|NCT01094782|12037587|FG003|Overall Study|Hypertension|0
7625836|NCT01094782|12037588|FG004|Overall Study|Hypertension|0
7625837|NCT01094782|12037589|FG005|Overall Study|Hypertension|0
7625838|NCT01094782|12037584|FG000|Overall Study|Wrong Pain Condition|0
7625839|NCT01094782|12037585|FG001|Overall Study|Wrong Pain Condition|0
7625840|NCT01094782|12037586|FG002|Overall Study|Wrong Pain Condition|0
7625841|NCT01094782|12037587|FG003|Overall Study|Wrong Pain Condition|2
7625842|NCT01094782|12037588|FG004|Overall Study|Wrong Pain Condition|1
7625843|NCT01094782|12037589|FG005|Overall Study|Wrong Pain Condition|1
7625844|NCT01094782|12037584|FG000|Overall Study|Recent Interventional Injection|0
7625845|NCT01094782|12037585|FG001|Overall Study|Recent Interventional Injection|0
7625846|NCT01094782|12037586|FG002|Overall Study|Recent Interventional Injection|0
7625847|NCT01094782|12037587|FG003|Overall Study|Recent Interventional Injection|0
7625848|NCT01094782|12037588|FG004|Overall Study|Recent Interventional Injection|0
7625849|NCT01094782|12037589|FG005|Overall Study|Recent Interventional Injection|1
7625850|NCT01094782|12037584|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0
7625851|NCT01094782|12037585|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0
7625852|NCT01094782|12037586|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0
7625853|NCT01094782|12037587|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0
7625854|NCT01094782|12037588|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1
7625855|NCT01094782|12037589|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0
7625856|NCT01094782|12037584|FG000|Overall Study|Noncompliance With Study Schedule|0
7625857|NCT01094782|12037585|FG001|Overall Study|Noncompliance With Study Schedule|0
7625858|NCT01094782|12037586|FG002|Overall Study|Noncompliance With Study Schedule|0
7625859|NCT01094782|12037587|FG003|Overall Study|Noncompliance With Study Schedule|1
7625860|NCT01094782|12037588|FG004|Overall Study|Noncompliance With Study Schedule|0
7625861|NCT01094782|12037589|FG005|Overall Study|Noncompliance With Study Schedule|0
7625862|NCT00932737|12037625|FG000|Overall Study|Not treated in second episode|1
7625863|NCT00932737|12037626|FG001|Overall Study|Not treated in second episode|0
7625864|NCT00932737|12037625|FG000|Overall Study|Adverse Event|0
7625865|NCT00932737|12037626|FG001|Overall Study|Adverse Event|1
7625866|NCT00710710|12037652|FG000|Overall Study|Consent withdrawn|2
7625867|NCT00710710|12037653|FG001|Overall Study|Consent withdrawn|2
7625868|NCT00710710|12037652|FG000|Overall Study|Protocol Violation|0
7625869|NCT00710710|12037653|FG001|Overall Study|Protocol Violation|1
7765494|NCT00841763|12207538|FG001|Overall Study|Protocol Violation|3
7625870|NCT00710710|12037652|FG000|Overall Study|Adverse Event|3
7625871|NCT00710710|12037653|FG001|Overall Study|Adverse Event|3
7625872|NCT00710710|12037652|FG000|Overall Study|Progressive disease|40
7625873|NCT00710710|12037653|FG001|Overall Study|Progressive disease|38
7625889|NCT00551616|12037677|FG000|Overall Study|Lost to Follow-up|48
7585134|NCT02315066|11990548|FG000|Overall Study|Lost to Follow-up|0
7585135|NCT02315066|11990549|FG001|Overall Study|Lost to Follow-up|1
7585136|NCT02315066|11990550|FG002|Overall Study|Lost to Follow-up|1
7585137|NCT02315066|11990551|FG003|Overall Study|Lost to Follow-up|0
7585138|NCT02315066|11990552|FG004|Overall Study|Lost to Follow-up|1
7585139|NCT02315066|11990553|FG005|Overall Study|Lost to Follow-up|0
7585140|NCT02315066|11990554|FG006|Overall Study|Lost to Follow-up|2
7585141|NCT02315066|11990555|FG007|Overall Study|Lost to Follow-up|1
7585142|NCT02315066|11990556|FG008|Overall Study|Lost to Follow-up|0
7585143|NCT02315066|11990557|FG009|Overall Study|Lost to Follow-up|0
7585144|NCT02315066|11990558|FG010|Overall Study|Lost to Follow-up|1
7585145|NCT02315066|11990559|FG011|Overall Study|Lost to Follow-up|2
7585146|NCT02315066|11990560|FG012|Overall Study|Lost to Follow-up|0
7585147|NCT02315066|11990561|FG013|Overall Study|Lost to Follow-up|4
7585148|NCT02315066|11990548|FG000|Overall Study|Death|2
7585149|NCT02315066|11990549|FG001|Overall Study|Death|7
7585150|NCT02315066|11990550|FG002|Overall Study|Death|6
7585151|NCT02315066|11990551|FG003|Overall Study|Death|11
7585152|NCT02315066|11990552|FG004|Overall Study|Death|10
7585153|NCT02315066|11990553|FG005|Overall Study|Death|3
7585154|NCT02315066|11990554|FG006|Overall Study|Death|9
7585155|NCT02315066|11990555|FG007|Overall Study|Death|9
7585156|NCT02315066|11990556|FG008|Overall Study|Death|10
7585157|NCT02315066|11990557|FG009|Overall Study|Death|8
7585158|NCT02315066|11990558|FG010|Overall Study|Death|10
7585159|NCT02315066|11990559|FG011|Overall Study|Death|7
7585160|NCT02315066|11990560|FG012|Overall Study|Death|8
7585161|NCT02315066|11990561|FG013|Overall Study|Death|21
7585162|NCT02315066|11990548|FG000|Overall Study|Other|0
7585163|NCT02315066|11990549|FG001|Overall Study|Other|0
7585164|NCT02315066|11990550|FG002|Overall Study|Other|0
7585165|NCT02315066|11990551|FG003|Overall Study|Other|0
7585166|NCT02315066|11990552|FG004|Overall Study|Other|0
7585167|NCT02315066|11990553|FG005|Overall Study|Other|0
7585168|NCT02315066|11990554|FG006|Overall Study|Other|0
7585169|NCT02315066|11990555|FG007|Overall Study|Other|1
7585170|NCT02315066|11990556|FG008|Overall Study|Other|1
7585171|NCT02315066|11990557|FG009|Overall Study|Other|2
7585172|NCT02315066|11990558|FG010|Overall Study|Other|0
7585173|NCT02315066|11990559|FG011|Overall Study|Other|0
7585174|NCT02315066|11990560|FG012|Overall Study|Other|0
7585175|NCT02315066|11990561|FG013|Overall Study|Other|0
7585176|NCT02315066|11990548|FG000|Overall Study|Subject refused further follow-up|0
7585177|NCT02315066|11990549|FG001|Overall Study|Subject refused further follow-up|2
7585178|NCT02315066|11990550|FG002|Overall Study|Subject refused further follow-up|2
7585179|NCT02315066|11990551|FG003|Overall Study|Subject refused further follow-up|0
7585180|NCT02315066|11990552|FG004|Overall Study|Subject refused further follow-up|0
7585181|NCT02315066|11990553|FG005|Overall Study|Subject refused further follow-up|0
7585182|NCT02315066|11990554|FG006|Overall Study|Subject refused further follow-up|2
7585183|NCT02315066|11990555|FG007|Overall Study|Subject refused further follow-up|3
7585184|NCT02315066|11990556|FG008|Overall Study|Subject refused further follow-up|0
7585185|NCT02315066|11990557|FG009|Overall Study|Subject refused further follow-up|1
7585186|NCT02315066|11990558|FG010|Overall Study|Subject refused further follow-up|1
7585187|NCT02315066|11990559|FG011|Overall Study|Subject refused further follow-up|2
7585188|NCT02315066|11990560|FG012|Overall Study|Subject refused further follow-up|2
7585189|NCT02315066|11990561|FG013|Overall Study|Subject refused further follow-up|4
7585190|NCT02315066|11990548|FG000|Overall Study|Study ongoing at date of cut-off|0
7585191|NCT02315066|11990549|FG001|Overall Study|Study ongoing at date of cut-off|0
7585192|NCT02315066|11990550|FG002|Overall Study|Study ongoing at date of cut-off|0
7585193|NCT02315066|11990551|FG003|Overall Study|Study ongoing at date of cut-off|0
7585194|NCT02315066|11990552|FG004|Overall Study|Study ongoing at date of cut-off|0
7585195|NCT02315066|11990553|FG005|Overall Study|Study ongoing at date of cut-off|0
7585196|NCT02315066|11990554|FG006|Overall Study|Study ongoing at date of cut-off|0
7585197|NCT02315066|11990555|FG007|Overall Study|Study ongoing at date of cut-off|0
7585198|NCT02315066|11990556|FG008|Overall Study|Study ongoing at date of cut-off|0
7585199|NCT02315066|11990557|FG009|Overall Study|Study ongoing at date of cut-off|0
7585200|NCT02315066|11990558|FG010|Overall Study|Study ongoing at date of cut-off|0
7585201|NCT02315066|11990559|FG011|Overall Study|Study ongoing at date of cut-off|0
7585202|NCT02315066|11990560|FG012|Overall Study|Study ongoing at date of cut-off|0
7585203|NCT02315066|11990561|FG013|Overall Study|Study ongoing at date of cut-off|1
7585204|NCT02256631|11990607|FG000|Overall Study|Lost to Follow-up|1
7585205|NCT02256631|11990608|FG001|Overall Study|Lost to Follow-up|1
7585206|NCT02256631|11990609|FG002|Overall Study|Lost to Follow-up|0
7585207|NCT02256631|11990610|FG003|Overall Study|Lost to Follow-up|2
7585208|NCT02256631|11990611|FG004|Overall Study|Lost to Follow-up|0
7585209|NCT02256631|11990612|FG005|Overall Study|Lost to Follow-up|1
7585210|NCT02256631|11990613|FG006|Overall Study|Lost to Follow-up|1
7585211|NCT02256631|11990607|FG000|Overall Study|Withdrawal by Subject|0
7585212|NCT02256631|11990608|FG001|Overall Study|Withdrawal by Subject|0
7585213|NCT02256631|11990609|FG002|Overall Study|Withdrawal by Subject|0
7585214|NCT02256631|11990610|FG003|Overall Study|Withdrawal by Subject|1
7585215|NCT02256631|11990611|FG004|Overall Study|Withdrawal by Subject|1
7585216|NCT02256631|11990612|FG005|Overall Study|Withdrawal by Subject|0
7585217|NCT02256631|11990613|FG006|Overall Study|Withdrawal by Subject|1
7585218|NCT02256631|11990607|FG000|Overall Study|Unable to get to clinic|0
7585219|NCT02256631|11990608|FG001|Overall Study|Unable to get to clinic|2
7585220|NCT02256631|11990609|FG002|Overall Study|Unable to get to clinic|0
7585221|NCT02256631|11990610|FG003|Overall Study|Unable to get to clinic|1
7585222|NCT02256631|11990611|FG004|Overall Study|Unable to get to clinic|0
7585223|NCT02256631|11990612|FG005|Overall Study|Unable to get to clinic|1
7585224|NCT02256631|11990613|FG006|Overall Study|Unable to get to clinic|2
7765495|NCT00841763|12207539|FG002|Overall Study|Protocol Violation|1
7765496|NCT00841763|12207540|FG003|Overall Study|Protocol Violation|0
7765497|NCT00841763|12207537|FG000|Overall Study|Administrative Reasons|3
7765498|NCT00841763|12207538|FG001|Overall Study|Administrative Reasons|1
7765499|NCT00841763|12207539|FG002|Overall Study|Administrative Reasons|0
7765500|NCT00841763|12207540|FG003|Overall Study|Administrative Reasons|0
7765501|NCT00841763|12207537|FG000|Overall Study|Unable to Classify|7
7765502|NCT00841763|12207538|FG001|Overall Study|Unable to Classify|1
7585233|NCT02080260|11990648|FG000|Overall Study|Death|18
7585234|NCT02080260|11990648|FG000|Overall Study|Withdrawal by Subject|1
7585235|NCT02051933|11990654|FG000|Overall Study|Physician Decision|0
7585236|NCT02051933|11990655|FG001|Overall Study|Physician Decision|1
7765503|NCT00841763|12207539|FG002|Overall Study|Unable to Classify|0
7765504|NCT00841763|12207540|FG003|Overall Study|Unable to Classify|0
7765505|NCT00841776|12207587|FG000|Overall Study|Lack of Efficacy|0
7765506|NCT00841776|12207588|FG001|Overall Study|Lack of Efficacy|1
7765507|NCT00841776|12207587|FG000|Overall Study|Lost to Follow-up|2
7585243|NCT01774253|11990734|FG000|Overall Study|Lack of Efficacy|4
7585244|NCT01774253|11990734|FG000|Overall Study|Physician Decision|2
7585245|NCT01774253|11990734|FG000|Overall Study|Withdrawal by Subject|2
7585246|NCT01774253|11990734|FG000|Overall Study|Death|1
7585247|NCT01505608|11990744|FG000|Phase I|Lack of Efficacy|0
7585248|NCT01505608|11990745|FG001|Phase I|Lack of Efficacy|4
7585249|NCT01505608|11990744|FG000|Phase I|Adverse Event|0
7585250|NCT01505608|11990745|FG001|Phase I|Adverse Event|1
7585251|NCT01505608|11990744|FG000|Phase I|Withdrawal by Subject|0
7585252|NCT01505608|11990745|FG001|Phase I|Withdrawal by Subject|1
7585253|NCT01505608|11990744|FG000|Phase II|Lack of Efficacy|2
7585254|NCT01505608|11990745|FG001|Phase II|Lack of Efficacy|1
7585255|NCT01505608|11990744|FG000|Phase II|Protocol Violation|0
7585256|NCT01505608|11990745|FG001|Phase II|Protocol Violation|1
7585257|NCT01483820|11990754|FG000|Overall Study|Lack of Efficacy|6
7585258|NCT01483820|11990754|FG000|Overall Study|Adverse Event|1
7585259|NCT01483820|11990754|FG000|Overall Study|Death|1
7585260|NCT01355679|11990758|FG000|Overall Study|benign tumor types found at biopsy|2
7585261|NCT01166386|11990783|FG000|Overall Study|Withdrawal by Subject|3
7585262|NCT01166386|11990784|FG001|Overall Study|Withdrawal by Subject|5
7585263|NCT01114217|11990792|FG000|Overall Study|Adverse Event|5
7585264|NCT01114217|11990793|FG001|Overall Study|Adverse Event|3
7585265|NCT01114217|11990792|FG000|Overall Study|Lost to Follow-up|17
7585266|NCT01114217|11990793|FG001|Overall Study|Lost to Follow-up|33
7585267|NCT01114217|11990792|FG000|Overall Study|Withdrawal by Subject|21
7585268|NCT01114217|11990793|FG001|Overall Study|Withdrawal by Subject|28
7585269|NCT01114217|11990792|FG000|Overall Study|Other-Clerical Error|3
7585270|NCT01114217|11990793|FG001|Overall Study|Other-Clerical Error|0
7585271|NCT01114217|11990792|FG000|Overall Study|Other-Early termination|6
7585272|NCT01114217|11990793|FG001|Overall Study|Other-Early termination|10
7585273|NCT01114217|11990792|FG000|Overall Study|Other-Procedure|1
7585274|NCT01114217|11990793|FG001|Overall Study|Other-Procedure|1
7585275|NCT01114217|11990792|FG000|Overall Study|Other-Pregnancy|2
7585276|NCT01114217|11990793|FG001|Overall Study|Other-Pregnancy|4
7585277|NCT01114217|11990792|FG000|Overall Study|Other-Protocol Violation|1
7585278|NCT01114217|11990793|FG001|Overall Study|Other-Protocol Violation|3
7585279|NCT01114217|11990792|FG000|Overall Study|Other-Lack of Efficacy|1
7585280|NCT01114217|11990793|FG001|Overall Study|Other-Lack of Efficacy|0
7585281|NCT01114217|11990792|FG000|Overall Study|Other-Non Compliance|2
7585282|NCT01114217|11990793|FG001|Overall Study|Other-Non Compliance|0
7585283|NCT01114217|11990792|FG000|Overall Study|Other-Physician Decision|1
7585284|NCT01114217|11990793|FG001|Overall Study|Other-Physician Decision|1
7585285|NCT01114217|11990792|FG000|Overall Study|Other-Sponsor Decision|10
7585286|NCT01114217|11990793|FG001|Overall Study|Other-Sponsor Decision|12
7585287|NCT01114217|11990792|FG000|Overall Study|Other-Study Termination|0
7585288|NCT01114217|11990793|FG001|Overall Study|Other-Study Termination|1
7585289|NCT01114217|11990792|FG000|Overall Study|Other-Study Withdrawn|1
7585290|NCT01114217|11990793|FG001|Overall Study|Other-Study Withdrawn|1
7585291|NCT01114217|11990792|FG000|Overall Study|Other-Site Stopped Communicating|2
7585292|NCT01114217|11990793|FG001|Overall Study|Other-Site Stopped Communicating|0
7585293|NCT01114217|11990792|FG000|Overall Study|Other-Lost to Follow-up|1
7585294|NCT01114217|11990793|FG001|Overall Study|Other-Lost to Follow-up|0
7585295|NCT01114217|11990792|FG000|Overall Study|Other-Withdrawal by Subject|1
7585296|NCT01114217|11990793|FG001|Overall Study|Other-Withdrawal by Subject|1
7585297|NCT01114204|11990799|FG000|Overall Study|Adverse Event|3
7585298|NCT01114204|11990800|FG001|Overall Study|Adverse Event|2
7585299|NCT01114204|11990799|FG000|Overall Study|Lost to Follow-up|1
7585300|NCT01114204|11990800|FG001|Overall Study|Lost to Follow-up|0
7585301|NCT01114204|11990799|FG000|Overall Study|Withdrawal by Subject|10
7585302|NCT01114204|11990800|FG001|Overall Study|Withdrawal by Subject|6
7585303|NCT01114204|11990799|FG000|Overall Study|Death|1
7585304|NCT01114204|11990800|FG001|Overall Study|Death|0
7585305|NCT01114204|11990799|FG000|Overall Study|Other-Personal reasons|2
7585306|NCT01114204|11990800|FG001|Overall Study|Other-Personal reasons|0
7585307|NCT01114204|11990799|FG000|Overall Study|Other-Medical monitor request|1
7585308|NCT01114204|11990800|FG001|Overall Study|Other-Medical monitor request|0
7585309|NCT01114204|11990799|FG000|Overall Study|Other-Participant request|2
7585310|NCT01114204|11990800|FG001|Overall Study|Other-Participant request|0
7585311|NCT01114204|11990799|FG000|Overall Study|Other-Protocol Violation|1
7585312|NCT01114204|11990800|FG001|Overall Study|Other-Protocol Violation|0
7585313|NCT01114139|11990808|FG000|Overall Study|Adverse Event|3
7585314|NCT01114139|11990809|FG001|Overall Study|Adverse Event|2
7585315|NCT01114139|11990808|FG000|Overall Study|Lost to Follow-up|15
7585316|NCT01114139|11990809|FG001|Overall Study|Lost to Follow-up|3
7585317|NCT01114139|11990808|FG000|Overall Study|Withdrawal by Subject|17
7585318|NCT01114139|11990809|FG001|Overall Study|Withdrawal by Subject|6
7585319|NCT01114139|11990808|FG000|Overall Study|Other-Missed 1 visit|1
7585320|NCT01114139|11990809|FG001|Overall Study|Other-Missed 1 visit|0
7585321|NCT01114139|11990808|FG000|Overall Study|Other-Protocol Violation|1
7585322|NCT01114139|11990809|FG001|Overall Study|Other-Protocol Violation|0
7585323|NCT01114139|11990808|FG000|Overall Study|Other-Out of window for study drug dose|1
7585324|NCT01114139|11990809|FG001|Overall Study|Other-Out of window for study drug dose|0
7585325|NCT01114139|11990808|FG000|Overall Study|Other-Participant falsified records|0
7585326|NCT01114139|11990809|FG001|Overall Study|Other-Participant falsified records|1
7585327|NCT01114139|11990808|FG000|Overall Study|Other-Participant went on hospice|0
7585328|NCT01114139|11990809|FG001|Overall Study|Other-Participant went on hospice|1
7585329|NCT01114139|11990808|FG000|Overall Study|Other-Physician changed treatment|1
7585330|NCT01114139|11990809|FG001|Overall Study|Other-Physician changed treatment|0
7585331|NCT01114139|11990808|FG000|Overall Study|Other-Withdrew prior to receiving dose|1
7585332|NCT01114139|11990809|FG001|Overall Study|Other-Withdrew prior to receiving dose|3
7585333|NCT01059071|11990815|FG000|Overall Study|Lack of Efficacy|1
7585334|NCT01059071|11990816|FG001|Overall Study|Lack of Efficacy|4
7585335|NCT01059071|11990817|FG002|Overall Study|Lack of Efficacy|2
7585336|NCT01059071|11990818|FG003|Overall Study|Lack of Efficacy|3
7585337|NCT01059071|11990815|FG000|Overall Study|Withdrawal by Subject|1
7585338|NCT01059071|11990816|FG001|Overall Study|Withdrawal by Subject|0
7585339|NCT01059071|11990817|FG002|Overall Study|Withdrawal by Subject|0
7585340|NCT01059071|11990818|FG003|Overall Study|Withdrawal by Subject|2
7585341|NCT01059071|11990815|FG000|Overall Study|Physician Decision|0
7585342|NCT01059071|11990816|FG001|Overall Study|Physician Decision|0
7585343|NCT01059071|11990817|FG002|Overall Study|Physician Decision|0
7585344|NCT01059071|11990818|FG003|Overall Study|Physician Decision|1
7585345|NCT01027702|11990826|FG000|Overall Study|Received subsequent therapy|1
7585346|NCT01027702|11990827|FG001|Overall Study|Received subsequent therapy|2
7585347|NCT01027702|11990828|FG002|Overall Study|Received subsequent therapy|0
7585348|NCT01027702|11990829|FG003|Overall Study|Received subsequent therapy|4
7585349|NCT01027702|11990830|FG004|Overall Study|Received subsequent therapy|1
7585350|NCT01027702|11990831|FG005|Overall Study|Received subsequent therapy|0
7585351|NCT01027702|11990832|FG006|Overall Study|Received subsequent therapy|1
7585352|NCT01027702|11990826|FG000|Overall Study|Death|0
7585353|NCT01027702|11990827|FG001|Overall Study|Death|0
7585354|NCT01027702|11990828|FG002|Overall Study|Death|1
7585355|NCT01027702|11990829|FG003|Overall Study|Death|0
7585356|NCT01027702|11990830|FG004|Overall Study|Death|0
7585357|NCT01027702|11990831|FG005|Overall Study|Death|0
7585358|NCT01027702|11990832|FG006|Overall Study|Death|0
7585359|NCT00991887|11990845|FG000|Overall Study|Lost to Follow-up|2
7585360|NCT00991887|11990846|FG001|Overall Study|Lost to Follow-up|1
7585361|NCT00968864|11990852|FG000|Overall Study|Protocol exception/ not evaluable|1
7585362|NCT00934700|11990863|FG000|Overall Study|missing scan|5
7585363|NCT00934700|11990864|FG001|Overall Study|missing scan|9
7585364|NCT00934700|11990863|FG000|Overall Study|Death|8
7585365|NCT00934700|11990864|FG001|Overall Study|Death|3
7585366|NCT00867568|11990871|FG000|Overall Study|Lack of Efficacy|10
7585367|NCT00867568|11990871|FG000|Overall Study|Adverse Event|4
7585368|NCT00867568|11990871|FG000|Overall Study|Withdrawal by Subject|1
7585390|NCT00628446|11990908|FG000|Overall Study|Lost to Follow-up|3
7585391|NCT00628446|11990908|FG000|Overall Study|Withdrawal by Subject|1
7585392|NCT00628446|11990908|FG000|Overall Study|Protocol Violation|3
7585393|NCT00621751|11990915|FG000|Overall Study|Adverse Event|0
7585394|NCT00621751|11990916|FG001|Overall Study|Adverse Event|1
7585395|NCT00605215|11990925|FG000|Overall Study|Death|0
7585396|NCT00605215|11990926|FG001|Overall Study|Death|0
7585397|NCT00605215|11990927|FG002|Overall Study|Death|1
7585398|NCT00605215|11990925|FG000|Overall Study|Adverse Event|19
7585399|NCT00605215|11990926|FG001|Overall Study|Adverse Event|21
7585400|NCT00605215|11990927|FG002|Overall Study|Adverse Event|26
7585401|NCT00605215|11990925|FG000|Overall Study|Refusal to sign the re-consent form|8
7585402|NCT00605215|11990926|FG001|Overall Study|Refusal to sign the re-consent form|3
7585403|NCT00605215|11990927|FG002|Overall Study|Refusal to sign the re-consent form|3
7585404|NCT00605215|11990925|FG000|Overall Study|Withdrawal by Subject|39
7585405|NCT00605215|11990926|FG001|Overall Study|Withdrawal by Subject|37
7585406|NCT00605215|11990927|FG002|Overall Study|Withdrawal by Subject|27
7585407|NCT00605215|11990925|FG000|Overall Study|Request of Primary Care Physician or Investigator|6
7585408|NCT00605215|11990926|FG001|Overall Study|Request of Primary Care Physician or Investigator|4
7585409|NCT00605215|11990927|FG002|Overall Study|Request of Primary Care Physician or Investigator|4
7585410|NCT00605215|11990925|FG000|Overall Study|Protocol Violation|3
7585411|NCT00605215|11990926|FG001|Overall Study|Protocol Violation|4
7585412|NCT00605215|11990927|FG002|Overall Study|Protocol Violation|1
7585413|NCT00605215|11990925|FG000|Overall Study|Pregnancy|8
7585414|NCT00605215|11990926|FG001|Overall Study|Pregnancy|5
7585415|NCT00605215|11990927|FG002|Overall Study|Pregnancy|4
7585416|NCT00605215|11990925|FG000|Overall Study|Lost to Follow-up|8
7585417|NCT00605215|11990926|FG001|Overall Study|Lost to Follow-up|5
7585418|NCT00605215|11990927|FG002|Overall Study|Lost to Follow-up|2
7585419|NCT00605215|11990925|FG000|Overall Study|Other than specified|0
7585420|NCT00605215|11990926|FG001|Overall Study|Other than specified|2
7585421|NCT00605215|11990927|FG002|Overall Study|Other than specified|1
7585422|NCT00552513|11990941|FG000|Overall Study|Lost to Follow-up|5
7585423|NCT00552513|11990942|FG001|Overall Study|Lost to Follow-up|1
7585424|NCT00368836|11990952|FG000|Phase II|Screen Failure|1
7585425|NCT00368836|11990952|FG000|Phase II|Withdrawal by Subject|1
7585426|NCT00368836|11990952|FG000|Phase II|unable to collect blood and/or breath|17
7585427|NCT00368836|11990952|FG000|Phase II|Protocol Violation|2
7585428|NCT00290511|11990959|FG000|Overall Study|Adverse Event|1
7585429|NCT00290511|11990959|FG000|Overall Study|Death|1
7585430|NCT00290511|11990959|FG000|Overall Study|Physician Decision|1
7585431|NCT00290511|11990959|FG000|Overall Study|Withdrawal by Subject|1
7625890|NCT00551616|12037678|FG001|Overall Study|Lost to Follow-up|40
7765508|NCT00841776|12207588|FG001|Overall Study|Lost to Follow-up|1
7625892|NCT00492050|12037688|FG000|Overall Study|Adverse Event|1
7625893|NCT00492050|12037688|FG000|Overall Study|Lack of Efficacy|1
7625894|NCT00492050|12037688|FG000|Overall Study|Withdrawal by Subject|3
7625895|NCT00492050|12037688|FG000|Overall Study|Unable to collect SCT|2
7625896|NCT00492050|12037688|FG000|Overall Study|Progressive Disease|2
7585432|NCT00641537|11990972|FG000|96-week Period|Adverse Event|0
7585433|NCT00641537|11990973|FG001|96-week Period|Adverse Event|1
7585434|NCT00641537|11990974|FG002|96-week Period|Adverse Event|3
7585435|NCT00641537|11990975|FG003|96-week Period|Adverse Event|0
7585436|NCT00641537|11990976|FG004|96-week Period|Adverse Event|2
7585437|NCT00641537|11990977|FG005|96-week Period|Adverse Event|0
7585438|NCT00641537|11990978|FG006|96-week Period|Adverse Event|0
7585439|NCT00641537|11990979|FG007|96-week Period|Adverse Event|0
7585440|NCT00641537|11990972|FG000|96-week Period|Lost to Follow-up|3
7585441|NCT00641537|11990973|FG001|96-week Period|Lost to Follow-up|1
7585442|NCT00641537|11990974|FG002|96-week Period|Lost to Follow-up|2
7585443|NCT00641537|11990975|FG003|96-week Period|Lost to Follow-up|2
7585444|NCT00641537|11990976|FG004|96-week Period|Lost to Follow-up|4
7585445|NCT00641537|11990977|FG005|96-week Period|Lost to Follow-up|0
7585446|NCT00641537|11990978|FG006|96-week Period|Lost to Follow-up|1
7585447|NCT00641537|11990979|FG007|96-week Period|Lost to Follow-up|0
7585448|NCT00641537|11990972|FG000|96-week Period|Protocol Violation|0
7585449|NCT00641537|11990973|FG001|96-week Period|Protocol Violation|1
7585450|NCT00641537|11990974|FG002|96-week Period|Protocol Violation|0
7585451|NCT00641537|11990975|FG003|96-week Period|Protocol Violation|1
7585452|NCT00641537|11990976|FG004|96-week Period|Protocol Violation|0
7585453|NCT00641537|11990977|FG005|96-week Period|Protocol Violation|1
7585454|NCT00641537|11990978|FG006|96-week Period|Protocol Violation|0
7585455|NCT00641537|11990979|FG007|96-week Period|Protocol Violation|0
7585456|NCT00641537|11990972|FG000|96-week Period|Death|2
7585457|NCT00641537|11990973|FG001|96-week Period|Death|0
7585458|NCT00641537|11990974|FG002|96-week Period|Death|1
7585459|NCT00641537|11990975|FG003|96-week Period|Death|0
7585460|NCT00641537|11990976|FG004|96-week Period|Death|0
7585461|NCT00641537|11990977|FG005|96-week Period|Death|0
7585462|NCT00641537|11990978|FG006|96-week Period|Death|0
7585463|NCT00641537|11990979|FG007|96-week Period|Death|0
7585464|NCT00641537|11990972|FG000|96-week Period|Other|4
7585465|NCT00641537|11990973|FG001|96-week Period|Other|7
7585466|NCT00641537|11990974|FG002|96-week Period|Other|14
7585467|NCT00641537|11990975|FG003|96-week Period|Other|9
7585468|NCT00641537|11990976|FG004|96-week Period|Other|11
7585469|NCT00641537|11990977|FG005|96-week Period|Other|6
7585470|NCT00641537|11990978|FG006|96-week Period|Other|4
7585471|NCT00641537|11990979|FG007|96-week Period|Other|6
7585472|NCT00641537|11990972|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
7585473|NCT00641537|11990973|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
7585474|NCT00641537|11990974|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
7585475|NCT00641537|11990975|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
7585476|NCT00641537|11990976|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
7585477|NCT00641537|11990977|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
7585478|NCT00641537|11990978|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
7585479|NCT00641537|11990979|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
7585480|NCT00641537|11990972|FG000|24-Week Supplemental Follow-up Period|Other|0
7585481|NCT00641537|11990973|FG001|24-Week Supplemental Follow-up Period|Other|2
7585482|NCT00641537|11990974|FG002|24-Week Supplemental Follow-up Period|Other|2
7585483|NCT00641537|11990975|FG003|24-Week Supplemental Follow-up Period|Other|1
7585484|NCT00641537|11990976|FG004|24-Week Supplemental Follow-up Period|Other|3
7585485|NCT00641537|11990977|FG005|24-Week Supplemental Follow-up Period|Other|0
7585486|NCT00641537|11990978|FG006|24-Week Supplemental Follow-up Period|Other|1
7585487|NCT00641537|11990979|FG007|24-Week Supplemental Follow-up Period|Other|1
7585488|NCT00655824|11990997|FG000|Overall Study|Adverse Event|3
7585489|NCT00655824|11990997|FG000|Overall Study|Early Termination of Study by Sponsor|74
7585490|NCT00655824|11990997|FG000|Overall Study|Protocol Violation|1
7585491|NCT00655824|11990997|FG000|Overall Study|Withdrawal by Subject|4
7585492|NCT00655824|11990997|FG000|Overall Study|Deterioration of Trial Disease|2
7585493|NCT00663052|11991003|FG000|Overall Study|Adverse Event|6
7585494|NCT00663052|11991004|FG001|Overall Study|Adverse Event|3
7585495|NCT00663052|11991003|FG000|Overall Study|Discontinuation of Study by Sponsor|2
7585496|NCT00663052|11991004|FG001|Overall Study|Discontinuation of Study by Sponsor|0
7585497|NCT00663052|11991003|FG000|Overall Study|Protocol Violation|1
7585498|NCT00663052|11991004|FG001|Overall Study|Protocol Violation|0
7585499|NCT00663052|11991003|FG000|Overall Study|Withdrawal by Subject|2
7585500|NCT00663052|11991004|FG001|Overall Study|Withdrawal by Subject|5
7585501|NCT00663052|11991003|FG000|Overall Study|Unsatisfactory Response - Efficacy|1
7585502|NCT00663052|11991004|FG001|Overall Study|Unsatisfactory Response - Efficacy|1
7585503|NCT00663052|11991003|FG000|Overall Study|Other|0
7585504|NCT00663052|11991004|FG001|Overall Study|Other|1
7585505|NCT00686374|11991010|FG000|Overall Study|Lack of Efficacy|10
7585506|NCT00686374|11991010|FG000|Overall Study|Adverse Event|8
7585507|NCT00686374|11991010|FG000|Overall Study|Withdrew consent|5
7585508|NCT00686374|11991010|FG000|Overall Study|Lost to Follow-up|1
7585509|NCT00686374|11991010|FG000|Overall Study|Missing reason|33
7585510|NCT00686374|11991010|FG000|Overall Study|Other, not specified|4
7585511|NCT00698828|11991017|FG000|Overall Study|Adverse Event|3
7585512|NCT00698828|11991018|FG001|Overall Study|Adverse Event|4
7585513|NCT00698828|11991019|FG002|Overall Study|Adverse Event|4
7585514|NCT00698828|11991017|FG000|Overall Study|Death|0
7585515|NCT00698828|11991018|FG001|Overall Study|Death|0
7585516|NCT00698828|11991019|FG002|Overall Study|Death|1
7585517|NCT00698828|11991017|FG000|Overall Study|Exacerbation of COPD|1
7585518|NCT00698828|11991018|FG001|Overall Study|Exacerbation of COPD|3
7585519|NCT00698828|11991019|FG002|Overall Study|Exacerbation of COPD|0
7585520|NCT00698828|11991017|FG000|Overall Study|Exacerbation of COPD (Not treated)|1
7585521|NCT00698828|11991018|FG001|Overall Study|Exacerbation of COPD (Not treated)|0
7585522|NCT00698828|11991019|FG002|Overall Study|Exacerbation of COPD (Not treated)|0
7585523|NCT00698828|11991017|FG000|Overall Study|Investigator/Sponsor decision|1
7585524|NCT00698828|11991018|FG001|Overall Study|Investigator/Sponsor decision|0
7585525|NCT00698828|11991019|FG002|Overall Study|Investigator/Sponsor decision|2
7585526|NCT00698828|11991017|FG000|Overall Study|Lost to Follow-up|1
7585527|NCT00698828|11991018|FG001|Overall Study|Lost to Follow-up|1
7585528|NCT00698828|11991019|FG002|Overall Study|Lost to Follow-up|0
7585529|NCT00698828|11991017|FG000|Overall Study|Withdrew consent|0
7585530|NCT00698828|11991018|FG001|Overall Study|Withdrew consent|7
7585531|NCT00698828|11991019|FG002|Overall Study|Withdrew consent|4
7585532|NCT00698828|11991017|FG000|Overall Study|Withdrew consent (not treated)|2
7585533|NCT00698828|11991018|FG001|Overall Study|Withdrew consent (not treated)|0
7585534|NCT00698828|11991019|FG002|Overall Study|Withdrew consent (not treated)|0
7765509|NCT00841776|12207587|FG000|Overall Study|Withdrawal by Subject|0
7765510|NCT00841776|12207588|FG001|Overall Study|Withdrawal by Subject|1
7765511|NCT00841906|12207607|FG000|Overall Study|Withdrawal by Subject|2
7765512|NCT00841906|12207608|FG001|Overall Study|Withdrawal by Subject|0
7765513|NCT00842153|12207648|FG000|Overall Study|Adverse Event|0
7765514|NCT00842153|12207649|FG001|Overall Study|Adverse Event|1
7765515|NCT00842153|12207648|FG000|Overall Study|Lost to Follow-up|1
7765516|NCT00842153|12207649|FG001|Overall Study|Lost to Follow-up|2
7625905|NCT00061945|12037773|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18
7625906|NCT00061945|12037774|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25
7625907|NCT00061945|12037773|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76
7625908|NCT00061945|12037774|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90
7625909|NCT00061945|12037773|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1
7625910|NCT00061945|12037774|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1
7625911|NCT00061945|12037773|FG000|Course IV: Alemtuzumab|Early exits|6
7625912|NCT00061945|12037774|FG001|Course IV: Alemtuzumab|Early exits|15
7625913|NCT04018612|12037786|FG000|Overall Study|Withdrawal by Subject|1
7625914|NCT04018612|12037787|FG001|Overall Study|Withdrawal by Subject|0
7625915|NCT04018612|12037788|FG002|Overall Study|Withdrawal by Subject|1
7625916|NCT03976648|12037798|FG000|Overall Study|Adverse Event|0
7625917|NCT03976648|12037799|FG001|Overall Study|Adverse Event|2
7625918|NCT03976648|12037798|FG000|Overall Study|Study terminated by sponsor|21
7625919|NCT03976648|12037799|FG001|Overall Study|Study terminated by sponsor|8
7765517|NCT00842244|12207659|FG000|Overall Study|Death|3
7765518|NCT00842244|12207659|FG000|Overall Study|Withdrawal by Subject|1
7765519|NCT00842244|12207659|FG000|Overall Study|Other|17
7765520|NCT00842257|12207666|FG000|Overall Study|Adverse Event|1
7765521|NCT00842309|12207676|FG000|Overall Study|Withdrawal by Subject|3
7765522|NCT00842309|12207677|FG001|Overall Study|Withdrawal by Subject|1
7765523|NCT00842348|12207691|FG000|Patients Randomised in Study 726|Did not enter Study 729|59
7765524|NCT00842348|12207692|FG001|Patients Randomised in Study 726|Did not enter Study 729|56
7765525|NCT00842348|12207691|FG000|Study 729|Disease progression/death|19
7765526|NCT00842348|12207692|FG001|Study 729|Disease progression/death|30
7765527|NCT00842348|12207691|FG000|Study 729|Adverse Event|1
7765528|NCT00842348|12207692|FG001|Study 729|Adverse Event|1
7765529|NCT00842348|12207691|FG000|Study 729|Protocol Violation|1
7765530|NCT00842348|12207692|FG001|Study 729|Protocol Violation|1
7765531|NCT00842348|12207691|FG000|Study 729|Withdrawal by Subject|2
7765532|NCT00842348|12207692|FG001|Study 729|Withdrawal by Subject|4
7765533|NCT00842348|12207691|FG000|Study 729|Due to Sponsor stopping the study|1
7765534|NCT00842348|12207692|FG001|Study 729|Due to Sponsor stopping the study|1
7765535|NCT00842348|12207691|FG000|Study 729|Due to non-availability of IP|0
7765536|NCT00842348|12207692|FG001|Study 729|Due to non-availability of IP|1
7765537|NCT00842348|12207691|FG000|Study 729|Sponsor's decision|1
7765538|NCT00842348|12207692|FG001|Study 729|Sponsor's decision|0
7765539|NCT00842348|12207691|FG000|Study 729|Surgical resection|1
7625920|NCT03619902|12037809|FG000|Overall Study|Termination of Study by Investigator|1
7625921|NCT03619902|12037809|FG000|Overall Study|Use of Excluded/Prohibited Medication|1
7765540|NCT00842348|12207692|FG001|Study 729|Surgical resection|0
7765541|NCT00842361|12207704|FG000|Overall Study|Protocol Violation|1
7585535|NCT00712933|11991027|FG000|Overall Study|Adverse Event|69
7585536|NCT00712933|11991027|FG000|Overall Study|Lack of Efficacy|6
7585537|NCT00712933|11991027|FG000|Overall Study|Lost to Follow-up|22
7585538|NCT00712933|11991027|FG000|Overall Study|Non-compliance with study drug|13
7585539|NCT00712933|11991027|FG000|Overall Study|Other Pregnancy|37
7585540|NCT00712933|11991027|FG000|Overall Study|Sponsor decision|14
7585541|NCT00712933|11991027|FG000|Overall Study|Withdrew consent|4
7585542|NCT00712933|11991027|FG000|Overall Study|Hip replacement surgery|1
7585543|NCT00712933|11991027|FG000|Overall Study|Involved in Clinical research|3
7585544|NCT00712933|11991027|FG000|Overall Study|Participant hospitalized|1
7585545|NCT00712933|11991027|FG000|Overall Study|Participant travelled overseas|2
7585546|NCT00712933|11991027|FG000|Overall Study|Death of patient|1
7585547|NCT00712933|11991027|FG000|Overall Study|Other Physician decision|1
7585548|NCT00712933|11991027|FG000|Overall Study|Not committed to contraception|1
7585549|NCT00712933|11991027|FG000|Overall Study|Participant received medication|1
7585550|NCT00712933|11991027|FG000|Overall Study|Physician Decision|36
7585551|NCT00712933|11991027|FG000|Overall Study|Protocol Violation|4
7585552|NCT00712933|11991027|FG000|Overall Study|Withdrawal by Subject|151
7585553|NCT00725985|11991051|FG000|ITP- Treatment Disposition|Adverse Event|20
7585554|NCT00725985|11991052|FG001|ITP- Treatment Disposition|Adverse Event|10
7585555|NCT00725985|11991053|FG002|ITP- Treatment Disposition|Adverse Event|5
7585556|NCT00725985|11991054|FG003|ITP- Treatment Disposition|Adverse Event|0
7585557|NCT00725985|11991055|FG004|ITP- Treatment Disposition|Adverse Event|0
7585558|NCT00725985|11991056|FG005|ITP- Treatment Disposition|Adverse Event|0
7585559|NCT00725985|11991057|FG006|ITP- Treatment Disposition|Adverse Event|0
7585560|NCT00725985|11991058|FG007|ITP- Treatment Disposition|Adverse Event|0
7585561|NCT00725985|11991059|FG008|ITP- Treatment Disposition|Adverse Event|0
7585562|NCT00725985|11991060|FG009|ITP- Treatment Disposition|Adverse Event|0
7585563|NCT00725985|11991061|FG010|ITP- Treatment Disposition|Adverse Event|0
7585564|NCT00725985|11991062|FG011|ITP- Treatment Disposition|Adverse Event|0
7585565|NCT00725985|11991051|FG000|ITP- Treatment Disposition|Lost to Follow-up|0
7585566|NCT00725985|11991052|FG001|ITP- Treatment Disposition|Lost to Follow-up|0
7585567|NCT00725985|11991053|FG002|ITP- Treatment Disposition|Lost to Follow-up|2
7585568|NCT00725985|11991054|FG003|ITP- Treatment Disposition|Lost to Follow-up|0
7585569|NCT00725985|11991055|FG004|ITP- Treatment Disposition|Lost to Follow-up|0
7585570|NCT00725985|11991056|FG005|ITP- Treatment Disposition|Lost to Follow-up|0
7585571|NCT00725985|11991057|FG006|ITP- Treatment Disposition|Lost to Follow-up|0
7585572|NCT00725985|11991058|FG007|ITP- Treatment Disposition|Lost to Follow-up|0
7585573|NCT00725985|11991059|FG008|ITP- Treatment Disposition|Lost to Follow-up|0
7585574|NCT00725985|11991060|FG009|ITP- Treatment Disposition|Lost to Follow-up|0
7585575|NCT00725985|11991061|FG010|ITP- Treatment Disposition|Lost to Follow-up|0
7585576|NCT00725985|11991062|FG011|ITP- Treatment Disposition|Lost to Follow-up|0
7585577|NCT00725985|11991051|FG000|ITP- Treatment Disposition|Randomized but not treated|1
7585578|NCT00725985|11991052|FG001|ITP- Treatment Disposition|Randomized but not treated|0
7585579|NCT00725985|11991053|FG002|ITP- Treatment Disposition|Randomized but not treated|0
7585580|NCT00725985|11991054|FG003|ITP- Treatment Disposition|Randomized but not treated|0
7625922|NCT03517449|12037850|FG000|Overall Study|Death|184
7625923|NCT03517449|12037851|FG001|Overall Study|Death|236
7625924|NCT03517449|12037850|FG000|Overall Study|Lost to Follow-up|0
7625925|NCT03517449|12037851|FG001|Overall Study|Lost to Follow-up|2
7625926|NCT03517449|12037850|FG000|Overall Study|Withdrawal by Subject|7
7625927|NCT03517449|12037851|FG001|Overall Study|Withdrawal by Subject|26
7625928|NCT03517449|12037850|FG000|Overall Study|Participants Ongoing|220
7625929|NCT03517449|12037851|FG001|Overall Study|Participants Ongoing|152
7625930|NCT03470922|12037859|FG000|Overall Study|Death|107
7585581|NCT00725985|11991055|FG004|ITP- Treatment Disposition|Randomized but not treated|0
7585582|NCT00725985|11991056|FG005|ITP- Treatment Disposition|Randomized but not treated|0
7585583|NCT00725985|11991057|FG006|ITP- Treatment Disposition|Randomized but not treated|0
7585584|NCT00725985|11991058|FG007|ITP- Treatment Disposition|Randomized but not treated|0
7585585|NCT00725985|11991059|FG008|ITP- Treatment Disposition|Randomized but not treated|0
7585586|NCT00725985|11991060|FG009|ITP- Treatment Disposition|Randomized but not treated|0
7585587|NCT00725985|11991061|FG010|ITP- Treatment Disposition|Randomized but not treated|0
7585588|NCT00725985|11991062|FG011|ITP- Treatment Disposition|Randomized but not treated|0
7585589|NCT00725985|11991051|FG000|ITP- Treatment Disposition|Converted to CDMS|30
7585590|NCT00725985|11991052|FG001|ITP- Treatment Disposition|Converted to CDMS|27
7585591|NCT00725985|11991053|FG002|ITP- Treatment Disposition|Converted to CDMS|71
7585592|NCT00725985|11991054|FG003|ITP- Treatment Disposition|Converted to CDMS|0
7585593|NCT00725985|11991055|FG004|ITP- Treatment Disposition|Converted to CDMS|0
7585594|NCT00725985|11991056|FG005|ITP- Treatment Disposition|Converted to CDMS|0
7585595|NCT00725985|11991057|FG006|ITP- Treatment Disposition|Converted to CDMS|0
7585596|NCT00725985|11991058|FG007|ITP- Treatment Disposition|Converted to CDMS|0
7585597|NCT00725985|11991059|FG008|ITP- Treatment Disposition|Converted to CDMS|0
7585598|NCT00725985|11991060|FG009|ITP- Treatment Disposition|Converted to CDMS|0
7585599|NCT00725985|11991061|FG010|ITP- Treatment Disposition|Converted to CDMS|0
7585600|NCT00725985|11991062|FG011|ITP- Treatment Disposition|Converted to CDMS|0
7585601|NCT00725985|11991051|FG000|ITP- Treatment Disposition|Other|50
7585602|NCT00725985|11991052|FG001|ITP- Treatment Disposition|Other|38
7585603|NCT00725985|11991053|FG002|ITP- Treatment Disposition|Other|24
7585604|NCT00725985|11991054|FG003|ITP- Treatment Disposition|Other|0
7585605|NCT00725985|11991055|FG004|ITP- Treatment Disposition|Other|0
7585606|NCT00725985|11991056|FG005|ITP- Treatment Disposition|Other|0
7585607|NCT00725985|11991057|FG006|ITP- Treatment Disposition|Other|0
7585608|NCT00725985|11991058|FG007|ITP- Treatment Disposition|Other|0
7585609|NCT00725985|11991059|FG008|ITP- Treatment Disposition|Other|0
7585610|NCT00725985|11991060|FG009|ITP- Treatment Disposition|Other|0
7585611|NCT00725985|11991061|FG010|ITP- Treatment Disposition|Other|0
7585612|NCT00725985|11991062|FG011|ITP- Treatment Disposition|Other|0
7585613|NCT00725985|11991051|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0
7585614|NCT00725985|11991052|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0
7585615|NCT00725985|11991053|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0
7585616|NCT00725985|11991054|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2
7585617|NCT00725985|11991055|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2
7585618|NCT00725985|11991056|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5
7585619|NCT00725985|11991057|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0
7585620|NCT00725985|11991058|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0
7585621|NCT00725985|11991059|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0
7585622|NCT00725985|11991060|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0
7585623|NCT00725985|11991061|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0
7585624|NCT00725985|11991062|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0
7585625|NCT00725985|11991051|FG000|OLMP (Up to 96 Weeks)|Death|0
7585626|NCT00725985|11991052|FG001|OLMP (Up to 96 Weeks)|Death|0
7585627|NCT00725985|11991053|FG002|OLMP (Up to 96 Weeks)|Death|0
7585628|NCT00725985|11991054|FG003|OLMP (Up to 96 Weeks)|Death|0
7585629|NCT00725985|11991055|FG004|OLMP (Up to 96 Weeks)|Death|1
7585630|NCT00725985|11991056|FG005|OLMP (Up to 96 Weeks)|Death|0
7585631|NCT00725985|11991057|FG006|OLMP (Up to 96 Weeks)|Death|0
7585632|NCT00725985|11991058|FG007|OLMP (Up to 96 Weeks)|Death|0
7585633|NCT00725985|11991059|FG008|OLMP (Up to 96 Weeks)|Death|0
7585634|NCT00725985|11991060|FG009|OLMP (Up to 96 Weeks)|Death|0
7585635|NCT00725985|11991061|FG010|OLMP (Up to 96 Weeks)|Death|0
7585636|NCT00725985|11991062|FG011|OLMP (Up to 96 Weeks)|Death|0
7585637|NCT00725985|11991051|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585638|NCT00725985|11991052|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585639|NCT00725985|11991053|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585640|NCT00725985|11991054|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1
7585641|NCT00725985|11991055|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585642|NCT00725985|11991056|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585643|NCT00725985|11991057|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585644|NCT00725985|11991058|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585645|NCT00725985|11991059|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585646|NCT00725985|11991060|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585647|NCT00725985|11991061|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585648|NCT00725985|11991062|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585649|NCT00725985|11991051|FG000|OLMP (Up to 96 Weeks)|Disease progression|0
7585650|NCT00725985|11991052|FG001|OLMP (Up to 96 Weeks)|Disease progression|0
7585651|NCT00725985|11991053|FG002|OLMP (Up to 96 Weeks)|Disease progression|0
7585652|NCT00725985|11991054|FG003|OLMP (Up to 96 Weeks)|Disease progression|0
7585653|NCT00725985|11991055|FG004|OLMP (Up to 96 Weeks)|Disease progression|0
7585654|NCT00725985|11991056|FG005|OLMP (Up to 96 Weeks)|Disease progression|4
7585655|NCT00725985|11991057|FG006|OLMP (Up to 96 Weeks)|Disease progression|0
7585656|NCT00725985|11991058|FG007|OLMP (Up to 96 Weeks)|Disease progression|0
7585657|NCT00725985|11991059|FG008|OLMP (Up to 96 Weeks)|Disease progression|0
7585658|NCT00725985|11991060|FG009|OLMP (Up to 96 Weeks)|Disease progression|0
7585659|NCT00725985|11991061|FG010|OLMP (Up to 96 Weeks)|Disease progression|0
7585660|NCT00725985|11991062|FG011|OLMP (Up to 96 Weeks)|Disease progression|0
7585661|NCT00725985|11991051|FG000|OLMP (Up to 96 Weeks)|Other|0
7585662|NCT00725985|11991052|FG001|OLMP (Up to 96 Weeks)|Other|0
7585663|NCT00725985|11991053|FG002|OLMP (Up to 96 Weeks)|Other|0
7585664|NCT00725985|11991054|FG003|OLMP (Up to 96 Weeks)|Other|15
7585665|NCT00725985|11991055|FG004|OLMP (Up to 96 Weeks)|Other|20
7585666|NCT00725985|11991056|FG005|OLMP (Up to 96 Weeks)|Other|44
7585667|NCT00725985|11991057|FG006|OLMP (Up to 96 Weeks)|Other|0
7585668|NCT00725985|11991058|FG007|OLMP (Up to 96 Weeks)|Other|0
7585669|NCT00725985|11991059|FG008|OLMP (Up to 96 Weeks)|Other|0
7585670|NCT00725985|11991060|FG009|OLMP (Up to 96 Weeks)|Other|0
7585671|NCT00725985|11991061|FG010|OLMP (Up to 96 Weeks)|Other|0
7585672|NCT00725985|11991062|FG011|OLMP (Up to 96 Weeks)|Other|0
7585673|NCT00725985|11991051|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585674|NCT00725985|11991052|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585675|NCT00725985|11991053|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585676|NCT00725985|11991054|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585677|NCT00725985|11991055|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585678|NCT00725985|11991056|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585679|NCT00725985|11991057|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585680|NCT00725985|11991058|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1
7585681|NCT00725985|11991059|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585682|NCT00725985|11991060|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585683|NCT00725985|11991061|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585684|NCT00725985|11991062|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585685|NCT00725985|11991051|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585686|NCT00725985|11991052|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585687|NCT00725985|11991053|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585688|NCT00725985|11991054|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585689|NCT00725985|11991055|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585690|NCT00725985|11991056|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585691|NCT00725985|11991057|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585692|NCT00725985|11991058|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585693|NCT00725985|11991059|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1
7585694|NCT00725985|11991060|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585695|NCT00725985|11991061|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585696|NCT00725985|11991062|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585697|NCT00725985|11991051|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585698|NCT00725985|11991052|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585699|NCT00725985|11991053|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585700|NCT00725985|11991054|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585701|NCT00725985|11991055|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585702|NCT00725985|11991056|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585703|NCT00725985|11991057|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9
7585704|NCT00725985|11991058|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8
7585705|NCT00725985|11991059|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16
7585706|NCT00725985|11991060|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585707|NCT00725985|11991061|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585708|NCT00725985|11991062|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585709|NCT00725985|11991051|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0
7585710|NCT00725985|11991052|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0
7585711|NCT00725985|11991053|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0
7585712|NCT00725985|11991054|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0
7585713|NCT00725985|11991055|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0
7585714|NCT00725985|11991056|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0
7585715|NCT00725985|11991057|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0
7585716|NCT00725985|11991058|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0
7585717|NCT00725985|11991059|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0
7585718|NCT00725985|11991060|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34
7585719|NCT00725985|11991061|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36
7585720|NCT00725985|11991062|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14
7625931|NCT03470922|12037860|FG001|Overall Study|Death|118
7625932|NCT03470922|12037859|FG000|Overall Study|Lost to Follow-up|5
7625933|NCT03470922|12037860|FG001|Overall Study|Lost to Follow-up|5
7625934|NCT03470922|12037859|FG000|Overall Study|Participant Withdrew Consent|4
7625935|NCT03470922|12037860|FG001|Overall Study|Participant Withdrew Consent|9
7625936|NCT03470922|12037859|FG000|Overall Study|Other reasons|1
7625937|NCT03470922|12037860|FG001|Overall Study|Other reasons|0
7625938|NCT03470922|12037859|FG000|Overall Study|Not reported|1
7625939|NCT03470922|12037860|FG001|Overall Study|Not reported|0
7625940|NCT03308825|12037870|FG000|Overall Study|Lost to Follow-up|2
7625941|NCT03308825|12037871|FG001|Overall Study|Lost to Follow-up|2
7625942|NCT03308825|12037872|FG002|Overall Study|Lost to Follow-up|1
7625943|NCT03308825|12037873|FG003|Overall Study|Lost to Follow-up|0
7625944|NCT03308825|12037870|FG000|Overall Study|Protocol Violation|0
7625945|NCT03308825|12037871|FG001|Overall Study|Protocol Violation|2
7625946|NCT03308825|12037872|FG002|Overall Study|Protocol Violation|0
7625947|NCT03308825|12037873|FG003|Overall Study|Protocol Violation|0
7625948|NCT02915302|12037889|FG000|Overall Study|Adverse Event|3
7765542|NCT00842361|12207705|FG001|Overall Study|Protocol Violation|0
7585721|NCT04860258|11991095|FG000|Overall Study|Withdrawal by Subject|0
7585722|NCT04860258|11991096|FG001|Overall Study|Withdrawal by Subject|0
7585723|NCT04860258|11991097|FG002|Overall Study|Withdrawal by Subject|4
7585724|NCT04860258|11991098|FG003|Overall Study|Withdrawal by Subject|1
7585725|NCT04860258|11991099|FG004|Overall Study|Withdrawal by Subject|4
7585726|NCT04860258|11991100|FG005|Overall Study|Withdrawal by Subject|1
7585727|NCT04860258|11991101|FG006|Overall Study|Withdrawal by Subject|0
7585729|NCT03787303|11991134|FG000|Overall Study|Death|1
7585730|NCT03787303|11991134|FG000|Overall Study|Premature Termination of Study|1
7585731|NCT03673098|11991144|FG000|Overall Study|Lost to Follow-up|2
7585732|NCT03673098|11991145|FG001|Overall Study|Lost to Follow-up|3
7585733|NCT03673098|11991144|FG000|Overall Study|Withdrawal by Subject|6
7585734|NCT03673098|11991145|FG001|Overall Study|Withdrawal by Subject|1
7585735|NCT03673098|11991144|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2
7585736|NCT03673098|11991145|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0
7585737|NCT03520569|11991158|FG000|Overall Study|Withdrawal by Subject|1
7585738|NCT03499899|11991171|FG000|Overall Study|Adverse Event|2
7585739|NCT03499899|11991172|FG001|Overall Study|Adverse Event|3
7585740|NCT03499899|11991173|FG002|Overall Study|Adverse Event|3
7585741|NCT03499899|11991171|FG000|Overall Study|Death|0
7585742|NCT03499899|11991172|FG001|Overall Study|Death|0
7585743|NCT03499899|11991173|FG002|Overall Study|Death|1
7585744|NCT03499899|11991171|FG000|Overall Study|Physician Decision|3
7585745|NCT03499899|11991172|FG001|Overall Study|Physician Decision|6
7585746|NCT03499899|11991173|FG002|Overall Study|Physician Decision|6
7585747|NCT03499899|11991171|FG000|Overall Study|Progressive disease|15
7585748|NCT03499899|11991172|FG001|Overall Study|Progressive disease|23
7585749|NCT03499899|11991173|FG002|Overall Study|Progressive disease|23
7585750|NCT03499899|11991171|FG000|Overall Study|Patient decision|0
7585751|NCT03499899|11991172|FG001|Overall Study|Patient decision|1
7585752|NCT03499899|11991173|FG002|Overall Study|Patient decision|1
7585753|NCT03499899|11991171|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0
7585754|NCT03499899|11991172|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1
7585755|NCT03499899|11991173|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0
7765543|NCT00842361|12207704|FG000|Overall Study|Unclassified|0
7765544|NCT00842361|12207705|FG001|Overall Study|Unclassified|2
7765545|NCT00842543|12207715|FG000|Overall Study|Withdrawal by Subject|2
7765546|NCT00842543|12207716|FG001|Overall Study|Withdrawal by Subject|0
7765547|NCT00842543|12207717|FG002|Overall Study|Withdrawal by Subject|3
7765548|NCT00842543|12207718|FG003|Overall Study|Withdrawal by Subject|4
7770299|NCT00875810|12214304|FG000|Overall Study|Patient enroled but not implanted|2
7770300|NCT00875810|12214304|FG000|Overall Study|Device explanted|1
7770301|NCT00875979|12214319|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
7585766|NCT03419741|11991192|FG000|Overall Study|Adverse Event|1
7585767|NCT03419741|11991193|FG001|Overall Study|Adverse Event|0
7585768|NCT03419741|11991192|FG000|Overall Study|Withdrawal by Subject|1
7585769|NCT03419741|11991193|FG001|Overall Study|Withdrawal by Subject|2
7585770|NCT02688530|11991221|FG000|Overall Study|Withdrawal by Subject|0
7585771|NCT02688530|11991222|FG001|Overall Study|Withdrawal by Subject|1
7585772|NCT02688530|11991223|FG002|Overall Study|Withdrawal by Subject|0
7585773|NCT02688530|11991224|FG003|Overall Study|Withdrawal by Subject|0
7585774|NCT02688530|11991221|FG000|Overall Study|Lost to Follow-up|0
7585775|NCT02688530|11991222|FG001|Overall Study|Lost to Follow-up|0
7585776|NCT02688530|11991223|FG002|Overall Study|Lost to Follow-up|2
7585777|NCT02688530|11991224|FG003|Overall Study|Lost to Follow-up|0
7585790|NCT02383966|11991250|FG000|Overall Study|Ongoing at clinical cut-off date|25
7585791|NCT02383966|11991251|FG001|Overall Study|Ongoing at clinical cut-off date|4
7585792|NCT02383966|11991250|FG000|Overall Study|Randomized, but not treated|1
7585793|NCT02383966|11991251|FG001|Overall Study|Randomized, but not treated|3
7585794|NCT02073565|11991259|FG000|Cohort A|Withdrawal by Subject|1
7585795|NCT02073565|11991260|FG001|Cohort A|Withdrawal by Subject|0
7585796|NCT02073565|11991259|FG000|Cohort B|Withdrawal by Subject|1
7585797|NCT02073565|11991260|FG001|Cohort B|Withdrawal by Subject|2
7585798|NCT02073565|11991259|FG000|Cohort C|Withdrawal by Subject|0
7585799|NCT02073565|11991260|FG001|Cohort C|Withdrawal by Subject|2
7585800|NCT02073565|11991259|FG000|Cohort C|Lost to Follow-up|0
7585801|NCT02073565|11991260|FG001|Cohort C|Lost to Follow-up|2
7585802|NCT02060487|11991269|FG000|Overall Study|Other|1
7585803|NCT02060487|11991270|FG001|Overall Study|Other|2
7585804|NCT02060487|11991271|FG002|Overall Study|Other|1
7585805|NCT02060487|11991269|FG000|Overall Study|Lack of Efficacy|0
7585806|NCT02060487|11991270|FG001|Overall Study|Lack of Efficacy|1
7585807|NCT02060487|11991271|FG002|Overall Study|Lack of Efficacy|0
7585808|NCT02060487|11991269|FG000|Overall Study|Withdrawal by Subject|3
7585809|NCT02060487|11991270|FG001|Overall Study|Withdrawal by Subject|10
7585810|NCT02060487|11991271|FG002|Overall Study|Withdrawal by Subject|4
7585811|NCT02060487|11991269|FG000|Overall Study|Study Terminated By Sponsor|87
7585812|NCT02060487|11991270|FG001|Overall Study|Study Terminated By Sponsor|89
7585813|NCT02060487|11991271|FG002|Overall Study|Study Terminated By Sponsor|100
7765549|NCT00842712|12207754|FG000|Safety Run-in Part|Adverse Event|0
7765550|NCT00842712|12207755|FG001|Safety Run-in Part|Adverse Event|1
7765551|NCT00842712|12207756|FG002|Safety Run-in Part|Adverse Event|0
7765552|NCT00842712|12207757|FG003|Safety Run-in Part|Adverse Event|0
7765553|NCT00842712|12207758|FG004|Safety Run-in Part|Adverse Event|0
7765554|NCT00842712|12207759|FG005|Safety Run-in Part|Adverse Event|0
7585814|NCT02060487|11991269|FG000|Overall Study|Randomized in error|1
7585815|NCT02060487|11991270|FG001|Overall Study|Randomized in error|0
7585816|NCT02060487|11991271|FG002|Overall Study|Randomized in error|0
7585817|NCT02060487|11991269|FG000|Overall Study|Protocol Violation|0
7585818|NCT02060487|11991270|FG001|Overall Study|Protocol Violation|1
7585819|NCT02060487|11991271|FG002|Overall Study|Protocol Violation|1
7585820|NCT02060487|11991269|FG000|Overall Study|Lost to Follow-up|3
7585821|NCT02060487|11991270|FG001|Overall Study|Lost to Follow-up|0
7585822|NCT02060487|11991271|FG002|Overall Study|Lost to Follow-up|2
7585823|NCT02060487|11991269|FG000|Overall Study|Death|34
7585824|NCT02060487|11991270|FG001|Overall Study|Death|25
7585825|NCT02060487|11991271|FG002|Overall Study|Death|19
7585826|NCT02060487|11991269|FG000|Overall Study|Adverse Event|0
7585827|NCT02060487|11991270|FG001|Overall Study|Adverse Event|0
7585828|NCT02060487|11991271|FG002|Overall Study|Adverse Event|1
7585829|NCT00331773|11991316|FG000|Overall Study|Withdrawal by Subject|6
7585830|NCT00331773|11991317|FG001|Overall Study|Withdrawal by Subject|4
7585831|NCT00331773|11991316|FG000|Overall Study|Protocol Violation|10
7585832|NCT00331773|11991317|FG001|Overall Study|Protocol Violation|3
7625949|NCT02915302|12037890|FG001|Overall Study|Adverse Event|0
7625950|NCT02915302|12037889|FG000|Overall Study|Protocol Violation|20
7625951|NCT02915302|12037890|FG001|Overall Study|Protocol Violation|27
7625952|NCT02915302|12037889|FG000|Overall Study|Lost to Follow-up|19
7625953|NCT02915302|12037890|FG001|Overall Study|Lost to Follow-up|22
7625954|NCT02915302|12037889|FG000|Overall Study|Withdrawal by Subject|22
7625955|NCT02915302|12037890|FG001|Overall Study|Withdrawal by Subject|29
7625956|NCT02915302|12037889|FG000|Overall Study|Other|1
7625957|NCT02915302|12037890|FG001|Overall Study|Other|0
7625958|NCT02744040|12037913|FG000|Overall Study|Withdrawal by Subject|3
7625959|NCT02744040|12037914|FG001|Overall Study|Withdrawal by Subject|2
7625960|NCT02744040|12037915|FG002|Overall Study|Withdrawal by Subject|2
7625961|NCT02744040|12037913|FG000|Overall Study|Physician Decision|0
7625962|NCT02744040|12037914|FG001|Overall Study|Physician Decision|8
7625963|NCT02744040|12037915|FG002|Overall Study|Physician Decision|13
7625964|NCT02744040|12037913|FG000|Overall Study|Lost to Follow-up|3
7625965|NCT02744040|12037914|FG001|Overall Study|Lost to Follow-up|1
7625966|NCT02744040|12037915|FG002|Overall Study|Lost to Follow-up|7
7625967|NCT02698826|12037923|FG000|Overall Study|Death|13
7625968|NCT02698826|12037923|FG000|Overall Study|Adverse Event|1
7625969|NCT02617589|12037931|FG000|All Randomized|Request to discontinue study treatment|1
7625970|NCT02617589|12037932|FG001|All Randomized|Request to discontinue study treatment|3
7625971|NCT02617589|12037931|FG000|All Randomized|Participant Withdrew Consent|1
7625972|NCT02617589|12037932|FG001|All Randomized|Participant Withdrew Consent|2
7765555|NCT00842712|12207760|FG006|Safety Run-in Part|Adverse Event|0
7765556|NCT00842712|12207754|FG000|Safety Run-in Part|Progressive disease|3
7765557|NCT00842712|12207755|FG001|Safety Run-in Part|Progressive disease|1
7765558|NCT00842712|12207756|FG002|Safety Run-in Part|Progressive disease|0
7765559|NCT00842712|12207757|FG003|Safety Run-in Part|Progressive disease|1
7625973|NCT02617589|12037931|FG000|Treatment Period|Other Reasons|2
7625974|NCT02617589|12037932|FG001|Treatment Period|Other Reasons|2
7625975|NCT02617589|12037931|FG000|Treatment Period|Not reported|1
7625976|NCT02617589|12037932|FG001|Treatment Period|Not reported|0
7625977|NCT02617589|12037931|FG000|Treatment Period|Poor/Non compliance|1
7625978|NCT02617589|12037932|FG001|Treatment Period|Poor/Non compliance|1
7625979|NCT02617589|12037931|FG000|Treatment Period|Maximum Clinical Benefit|0
7625980|NCT02617589|12037932|FG001|Treatment Period|Maximum Clinical Benefit|2
7625981|NCT02617589|12037931|FG000|Treatment Period|Participant Withdrew Consent|2
7625982|NCT02617589|12037932|FG001|Treatment Period|Participant Withdrew Consent|6
7625983|NCT02617589|12037931|FG000|Treatment Period|Participant Request to discontinue|12
7625984|NCT02617589|12037932|FG001|Treatment Period|Participant Request to discontinue|20
7585833|NCT04882995|11991365|FG000|Overall Study|Withdrawal by Subject|1
7585834|NCT04882995|11991366|FG001|Overall Study|Withdrawal by Subject|2
7585835|NCT04882995|11991365|FG000|Overall Study|Protocol Violation|4
7585836|NCT04882995|11991366|FG001|Overall Study|Protocol Violation|4
7585837|NCT04882995|11991365|FG000|Overall Study|Surgery postponed due to COVID|1
7585838|NCT04882995|11991366|FG001|Overall Study|Surgery postponed due to COVID|1
7585839|NCT04640168|11991383|FG000|Overall Study|Withdrawal by Subject|8
7585840|NCT04640168|11991384|FG001|Overall Study|Withdrawal by Subject|7
7585841|NCT04640168|11991383|FG000|Overall Study|Lost to Follow-up|1
7585842|NCT04640168|11991384|FG001|Overall Study|Lost to Follow-up|0
7585843|NCT04640168|11991383|FG000|Overall Study|Enrolled but not treated|12
7585844|NCT04640168|11991384|FG001|Overall Study|Enrolled but not treated|12
7585845|NCT04465630|11991390|FG000|Overall Study|Sponsor Decision to terminate the study|54
7765560|NCT00842712|12207758|FG004|Safety Run-in Part|Progressive disease|0
7585846|NCT04465630|11991390|FG000|Overall Study|Screen failure|8
7585847|NCT04465630|11991390|FG000|Overall Study|Baseline failure|16
7585848|NCT04459598|11991397|FG000|Overall Study|Adverse Event|1
7585849|NCT04459598|11991398|FG001|Overall Study|Adverse Event|1
7585905|NCT03584009|11991531|FG000|Overall Study|Death|25
7585906|NCT03584009|11991532|FG001|Overall Study|Death|18
7585907|NCT03584009|11991531|FG000|Overall Study|Lost to Follow-up|0
7585908|NCT03584009|11991532|FG001|Overall Study|Lost to Follow-up|1
7585909|NCT03584009|11991531|FG000|Overall Study|Physician Decision|1
7585910|NCT03584009|11991532|FG001|Overall Study|Physician Decision|1
7585911|NCT03584009|11991531|FG000|Overall Study|Study Terminated by Sponsor|22
7585912|NCT03584009|11991532|FG001|Overall Study|Study Terminated by Sponsor|30
7585913|NCT03584009|11991531|FG000|Overall Study|Withdrawal by Subject|3
7585914|NCT03584009|11991532|FG001|Overall Study|Withdrawal by Subject|2
7585915|NCT03583359|11991543|FG000|Overall Study|Withdrawal by Subject|15
7585916|NCT03583359|11991544|FG001|Overall Study|Withdrawal by Subject|6
7585917|NCT03583359|11991543|FG000|Overall Study|Lost to Follow-up|12
7585918|NCT03583359|11991544|FG001|Overall Study|Lost to Follow-up|3
7585919|NCT03583359|11991543|FG000|Overall Study|Adverse Event|0
7585920|NCT03583359|11991544|FG001|Overall Study|Adverse Event|1
7585921|NCT03583359|11991543|FG000|Overall Study|Protocol Violation|0
7585922|NCT03583359|11991544|FG001|Overall Study|Protocol Violation|1
7585923|NCT03583359|11991543|FG000|Overall Study|Other|2
7585924|NCT03583359|11991544|FG001|Overall Study|Other|1
7765561|NCT00842712|12207759|FG005|Safety Run-in Part|Progressive disease|0
7765562|NCT00842712|12207760|FG006|Safety Run-in Part|Progressive disease|0
7765563|NCT00842712|12207754|FG000|Randomized Part|Randomized but not treated|0
7765564|NCT00842712|12207755|FG001|Randomized Part|Randomized but not treated|0
7765565|NCT00842712|12207756|FG002|Randomized Part|Randomized but not treated|0
7765566|NCT00842712|12207757|FG003|Randomized Part|Randomized but not treated|0
7765567|NCT00842712|12207758|FG004|Randomized Part|Randomized but not treated|0
7765568|NCT00842712|12207759|FG005|Randomized Part|Randomized but not treated|1
7765569|NCT00842712|12207760|FG006|Randomized Part|Randomized but not treated|4
7765570|NCT00842712|12207754|FG000|Randomized Part|Ongoing at cut-off date|0
7765571|NCT00842712|12207755|FG001|Randomized Part|Ongoing at cut-off date|0
7765572|NCT00842712|12207756|FG002|Randomized Part|Ongoing at cut-off date|0
7765573|NCT00842712|12207757|FG003|Randomized Part|Ongoing at cut-off date|0
7765574|NCT00842712|12207758|FG004|Randomized Part|Ongoing at cut-off date|0
7765575|NCT00842712|12207759|FG005|Randomized Part|Ongoing at cut-off date|0
7765576|NCT00842712|12207760|FG006|Randomized Part|Ongoing at cut-off date|2
7765577|NCT00842829|12207795|FG000|Dose Titration Period|Adverse Event|11
7765578|NCT00842829|12207796|FG001|Dose Titration Period|Adverse Event|10
7765579|NCT00842829|12207797|FG002|Dose Titration Period|Adverse Event|0
7765580|NCT00842829|12207795|FG000|Dose Titration Period|Lack of Efficacy|4
7765581|NCT00842829|12207796|FG001|Dose Titration Period|Lack of Efficacy|1
7765582|NCT00842829|12207797|FG002|Dose Titration Period|Lack of Efficacy|0
7765583|NCT00842829|12207795|FG000|Dose Titration Period|Unstable persistent cancer pain|1
7765584|NCT00842829|12207796|FG001|Dose Titration Period|Unstable persistent cancer pain|0
7765585|NCT00842829|12207797|FG002|Dose Titration Period|Unstable persistent cancer pain|0
7765586|NCT00842829|12207795|FG000|Dose Titration Period|Withdrawal by Subject|2
7765587|NCT00842829|12207796|FG001|Dose Titration Period|Withdrawal by Subject|6
7765588|NCT00842829|12207797|FG002|Dose Titration Period|Withdrawal by Subject|0
7765589|NCT00842829|12207795|FG000|Dose Titration Period|Other|5
7765590|NCT00842829|12207796|FG001|Dose Titration Period|Other|4
7765591|NCT00842829|12207797|FG002|Dose Titration Period|Other|0
7765592|NCT00842829|12207795|FG000|Dose Titration Period|Non-compliance to study procedures|1
7585878|NCT04387136|11991422|FG000|Overall Study|Protocol Deviation by SOC staff|1
7585879|NCT04387136|11991423|FG001|Overall Study|Protocol Deviation by SOC staff|2
7585880|NCT04351269|11991432|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70
7585881|NCT04351269|11991433|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32
7585882|NCT04351269|11991434|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29
7585883|NCT04351269|11991432|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0
7585884|NCT04351269|11991433|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1
7585885|NCT04351269|11991434|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0
7585886|NCT04351269|11991432|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1
7585887|NCT04351269|11991433|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1
7585888|NCT04351269|11991434|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0
7585889|NCT04351269|11991432|FG000|Overall Study|Subjects followed long-term at different health care system|0
7585890|NCT04351269|11991433|FG001|Overall Study|Subjects followed long-term at different health care system|4
7585891|NCT04351269|11991434|FG002|Overall Study|Subjects followed long-term at different health care system|0
7585892|NCT04351269|11991432|FG000|Overall Study|Lost to Follow-up|1
7585893|NCT04351269|11991433|FG001|Overall Study|Lost to Follow-up|3
7585894|NCT04351269|11991434|FG002|Overall Study|Lost to Follow-up|0
7585895|NCT04285229|11991451|FG000|Overall Study|Adverse Event|1
7585896|NCT04285229|11991452|FG001|Overall Study|Adverse Event|2
7585897|NCT04285229|11991451|FG000|Overall Study|Withdrawal by Subject|1
7585898|NCT04285229|11991452|FG001|Overall Study|Withdrawal by Subject|0
7585899|NCT04285229|11991451|FG000|Overall Study|Sponsor Decision|1
7585900|NCT04285229|11991452|FG001|Overall Study|Sponsor Decision|0
7585901|NCT03668808|11991502|FG000|First Intervention|Withdrawal by Subject|2
7585902|NCT03668808|11991503|FG001|First Intervention|Withdrawal by Subject|2
7585903|NCT03656874|11991522|FG000|Overall Study|Lost to Follow-up|3
7585904|NCT03656874|11991523|FG001|Overall Study|Lost to Follow-up|17
7765593|NCT00842829|12207796|FG001|Dose Titration Period|Non-compliance to study procedures|1
7765594|NCT00842829|12207797|FG002|Dose Titration Period|Non-compliance to study procedures|0
7765595|NCT00842829|12207795|FG000|Dose Titration Period|Non-compliance to study drug|2
7765596|NCT00842829|12207796|FG001|Dose Titration Period|Non-compliance to study drug|1
7765597|NCT00842829|12207797|FG002|Dose Titration Period|Non-compliance to study drug|0
7765598|NCT00842829|12207795|FG000|Treatment Period|Adverse Event|0
7765599|NCT00842829|12207796|FG001|Treatment Period|Adverse Event|0
7765600|NCT00842829|12207797|FG002|Treatment Period|Adverse Event|15
7765601|NCT00842829|12207795|FG000|Treatment Period|Lack of Efficacy|0
7765602|NCT00842829|12207796|FG001|Treatment Period|Lack of Efficacy|0
7765603|NCT00842829|12207797|FG002|Treatment Period|Lack of Efficacy|6
7585973|NCT03557307|11991578|FG000|To End of OCS Reduction Phase|Withdrawal by Subject|10
7585974|NCT03557307|11991578|FG000|To End of OCS Reduction Phase|Adverse Event|7
7585975|NCT03557307|11991578|FG000|To End of OCS Reduction Phase|Protocol Violation|6
7585976|NCT03557307|11991578|FG000|To End of OCS Reduction Phase|Lost to Follow-up|5
7585977|NCT03557307|11991578|FG000|To End of OCS Reduction Phase|other|3
7585978|NCT03557307|11991578|FG000|To End of OCS Reduction Phase|Death|2
7585979|NCT03557307|11991578|FG000|To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2
7585980|NCT03557307|11991578|FG000|Maintenance Phase|Adverse Event|4
7585981|NCT03557307|11991578|FG000|Maintenance Phase|Death|3
7585982|NCT03557307|11991578|FG000|Maintenance Phase|Lost to Follow-up|2
7585983|NCT03557307|11991578|FG000|Maintenance Phase|Pregnancy|2
7585984|NCT03557307|11991578|FG000|Maintenance Phase|Protocol Violation|11
7585985|NCT03557307|11991578|FG000|Maintenance Phase|Withdrawal by Subject|2
7585986|NCT03557307|11991578|FG000|Maintenance Phase|other|3
7585987|NCT03379675|11991625|FG000|Overall Study|Lost to Follow-up|0
7585988|NCT03379675|11991626|FG001|Overall Study|Lost to Follow-up|1
7585989|NCT03379675|11991627|FG002|Overall Study|Lost to Follow-up|0
7585990|NCT03379675|11991625|FG000|Overall Study|Adverse Event|2
7585991|NCT03379675|11991626|FG001|Overall Study|Adverse Event|0
7585992|NCT03379675|11991627|FG002|Overall Study|Adverse Event|0
7585993|NCT03379675|11991625|FG000|Overall Study|Withdrawal by Subject|2
7585994|NCT03379675|11991626|FG001|Overall Study|Withdrawal by Subject|1
7585995|NCT03379675|11991627|FG002|Overall Study|Withdrawal by Subject|2
7585996|NCT03336619|11991648|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192
7585997|NCT03336619|11991649|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204
7585998|NCT03336619|11991648|FG000|Overall Study|Withdrawal by Subject|17
7585999|NCT03336619|11991649|FG001|Overall Study|Withdrawal by Subject|16
7586000|NCT03336619|11991648|FG000|Overall Study|Adverse Event|2
7586001|NCT03336619|11991649|FG001|Overall Study|Adverse Event|5
7586002|NCT03336619|11991648|FG000|Overall Study|Physician Decision|3
7586003|NCT03336619|11991649|FG001|Overall Study|Physician Decision|0
7586004|NCT03274687|11991660|FG000|Overall Study|Protocol Violation|1
7586005|NCT03274687|11991661|FG001|Overall Study|Protocol Violation|1
7586006|NCT03245450|11991674|FG000|Overall Study|Radiological disease progression|3
7586007|NCT03245450|11991675|FG001|Overall Study|Radiological disease progression|3
7586008|NCT03245450|11991676|FG002|Overall Study|Radiological disease progression|2
7586009|NCT03245450|11991677|FG003|Overall Study|Radiological disease progression|2
7586010|NCT03245450|11991678|FG004|Overall Study|Radiological disease progression|7
7586011|NCT03245450|11991679|FG005|Overall Study|Radiological disease progression|6
7586012|NCT03245450|11991680|FG006|Overall Study|Radiological disease progression|6
7586013|NCT03245450|11991674|FG000|Overall Study|Clinical disease progression|0
7586014|NCT03245450|11991675|FG001|Overall Study|Clinical disease progression|0
7586015|NCT03245450|11991676|FG002|Overall Study|Clinical disease progression|1
7586016|NCT03245450|11991677|FG003|Overall Study|Clinical disease progression|0
7586017|NCT03245450|11991678|FG004|Overall Study|Clinical disease progression|0
7586018|NCT03245450|11991679|FG005|Overall Study|Clinical disease progression|2
7586019|NCT03245450|11991680|FG006|Overall Study|Clinical disease progression|0
7586020|NCT03245450|11991674|FG000|Overall Study|Other|0
7586021|NCT03245450|11991675|FG001|Overall Study|Other|0
7586022|NCT03245450|11991676|FG002|Overall Study|Other|0
7586023|NCT03245450|11991677|FG003|Overall Study|Other|1
7586024|NCT03245450|11991678|FG004|Overall Study|Other|1
7586025|NCT03245450|11991679|FG005|Overall Study|Other|1
7586026|NCT03245450|11991680|FG006|Overall Study|Other|1
7586027|NCT03245450|11991674|FG000|Overall Study|Withdrawal by Subject|0
7586028|NCT03245450|11991675|FG001|Overall Study|Withdrawal by Subject|1
7586029|NCT03245450|11991676|FG002|Overall Study|Withdrawal by Subject|0
7586030|NCT03245450|11991677|FG003|Overall Study|Withdrawal by Subject|0
7586031|NCT03245450|11991678|FG004|Overall Study|Withdrawal by Subject|0
7586032|NCT03245450|11991679|FG005|Overall Study|Withdrawal by Subject|0
7586033|NCT03245450|11991680|FG006|Overall Study|Withdrawal by Subject|0
7586034|NCT03245450|11991674|FG000|Overall Study|Adverse Event|0
7586035|NCT03245450|11991675|FG001|Overall Study|Adverse Event|0
7586036|NCT03245450|11991676|FG002|Overall Study|Adverse Event|0
7765604|NCT00842829|12207795|FG000|Treatment Period|Unstable persistent cancer pain|0
7765605|NCT00842829|12207796|FG001|Treatment Period|Unstable persistent cancer pain|0
7765606|NCT00842829|12207797|FG002|Treatment Period|Unstable persistent cancer pain|5
7765607|NCT00842829|12207795|FG000|Treatment Period|Withdrawal by Subject|0
7586037|NCT03245450|11991677|FG003|Overall Study|Adverse Event|0
7765608|NCT00842829|12207796|FG001|Treatment Period|Withdrawal by Subject|0
7765609|NCT00842829|12207797|FG002|Treatment Period|Withdrawal by Subject|11
7586038|NCT03245450|11991678|FG004|Overall Study|Adverse Event|1
7586039|NCT03245450|11991679|FG005|Overall Study|Adverse Event|0
7586040|NCT03245450|11991680|FG006|Overall Study|Adverse Event|2
7586041|NCT03086369|11991707|FG000|Overall Study|Lost to Follow-up|1
7586042|NCT03086369|11991708|FG001|Overall Study|Lost to Follow-up|0
7586043|NCT03086369|11991709|FG002|Overall Study|Lost to Follow-up|0
7586044|NCT03086369|11991710|FG003|Overall Study|Lost to Follow-up|2
7586045|NCT03086369|11991711|FG004|Overall Study|Lost to Follow-up|1
7586046|NCT03086369|11991707|FG000|Overall Study|Physician Decision|0
7586047|NCT03086369|11991708|FG001|Overall Study|Physician Decision|0
7586048|NCT03086369|11991709|FG002|Overall Study|Physician Decision|0
7586049|NCT03086369|11991710|FG003|Overall Study|Physician Decision|1
7586050|NCT03086369|11991711|FG004|Overall Study|Physician Decision|2
7586051|NCT03086369|11991707|FG000|Overall Study|Withdrawal by Subject|0
7586052|NCT03086369|11991708|FG001|Overall Study|Withdrawal by Subject|0
7586053|NCT03086369|11991709|FG002|Overall Study|Withdrawal by Subject|0
7586054|NCT03086369|11991710|FG003|Overall Study|Withdrawal by Subject|5
7586055|NCT03086369|11991711|FG004|Overall Study|Withdrawal by Subject|3
7586056|NCT03086369|11991707|FG000|Overall Study|Progressive Disease|0
7586057|NCT03086369|11991708|FG001|Overall Study|Progressive Disease|0
7586058|NCT03086369|11991709|FG002|Overall Study|Progressive Disease|0
7586059|NCT03086369|11991710|FG003|Overall Study|Progressive Disease|1
7586060|NCT03086369|11991711|FG004|Overall Study|Progressive Disease|1
7765610|NCT00842829|12207795|FG000|Treatment Period|Consistently >4 BTP episodes daily|0
7765611|NCT00842829|12207796|FG001|Treatment Period|Consistently >4 BTP episodes daily|0
7765612|NCT00842829|12207797|FG002|Treatment Period|Consistently >4 BTP episodes daily|1
7765613|NCT00842829|12207795|FG000|Treatment Period|Protocol Violation|0
7586065|NCT02927847|11991735|FG000|Overall Study|Lost to Follow-up|1
7586066|NCT02927847|11991736|FG001|Overall Study|Lost to Follow-up|0
7586067|NCT02927847|11991735|FG000|Overall Study|Withdrawal by Subject|4
7586068|NCT02927847|11991736|FG001|Overall Study|Withdrawal by Subject|2
7586069|NCT02927847|11991735|FG000|Overall Study|PI withdrawn due to missed visits|1
7586070|NCT02927847|11991736|FG001|Overall Study|PI withdrawn due to missed visits|1
7586071|NCT02892149|11991753|FG000|Overall Study|Death|262
7586072|NCT02892149|11991754|FG001|Overall Study|Death|278
7586073|NCT02892149|11991753|FG000|Overall Study|Withdrawal by Subject|53
7586074|NCT02892149|11991754|FG001|Overall Study|Withdrawal by Subject|47
7586075|NCT02892149|11991753|FG000|Overall Study|Lost to Follow-up|37
7586076|NCT02892149|11991754|FG001|Overall Study|Lost to Follow-up|31
7765614|NCT00842829|12207796|FG001|Treatment Period|Protocol Violation|0
7765615|NCT00842829|12207797|FG002|Treatment Period|Protocol Violation|2
7765616|NCT00842829|12207795|FG000|Treatment Period|Other|0
7765617|NCT00842829|12207796|FG001|Treatment Period|Other|0
7765618|NCT00842829|12207797|FG002|Treatment Period|Other|18
7765619|NCT00842829|12207795|FG000|Treatment Period|Non-compliance to study procedures|0
7765620|NCT00842829|12207796|FG001|Treatment Period|Non-compliance to study procedures|0
7765621|NCT00842829|12207797|FG002|Treatment Period|Non-compliance to study procedures|4
7765622|NCT00842829|12207795|FG000|Treatment Period|Unclear completion status|0
7765623|NCT00842829|12207796|FG001|Treatment Period|Unclear completion status|0
7765624|NCT00842829|12207797|FG002|Treatment Period|Unclear completion status|1
7765625|NCT00842829|12207795|FG000|Continuation Period|Adverse Event|0
7765626|NCT00842829|12207796|FG001|Continuation Period|Adverse Event|0
7765627|NCT00842829|12207797|FG002|Continuation Period|Adverse Event|32
7765628|NCT00842829|12207795|FG000|Continuation Period|Lack of Efficacy|0
7765629|NCT00842829|12207796|FG001|Continuation Period|Lack of Efficacy|0
7765630|NCT00842829|12207797|FG002|Continuation Period|Lack of Efficacy|6
7765631|NCT00842829|12207795|FG000|Continuation Period|Unstable persistent cancer pain|0
7765632|NCT00842829|12207796|FG001|Continuation Period|Unstable persistent cancer pain|0
7765633|NCT00842829|12207797|FG002|Continuation Period|Unstable persistent cancer pain|3
7765634|NCT00842829|12207795|FG000|Continuation Period|Withdrawal by Subject|0
7765635|NCT00842829|12207796|FG001|Continuation Period|Withdrawal by Subject|0
7765636|NCT00842829|12207797|FG002|Continuation Period|Withdrawal by Subject|10
7765637|NCT00842829|12207795|FG000|Continuation Period|Other|0
7765638|NCT00842829|12207796|FG001|Continuation Period|Other|0
7765639|NCT00842829|12207797|FG002|Continuation Period|Other|7
7765640|NCT00842829|12207795|FG000|Continuation Period|Non-compliance to study procedures|0
7765641|NCT00842829|12207796|FG001|Continuation Period|Non-compliance to study procedures|0
7765642|NCT00842829|12207797|FG002|Continuation Period|Non-compliance to study procedures|2
7765643|NCT00842829|12207795|FG000|Continuation Period|Non-compliance to study drug|0
7765644|NCT00842829|12207796|FG001|Continuation Period|Non-compliance to study drug|0
7765645|NCT00842829|12207797|FG002|Continuation Period|Non-compliance to study drug|1
7765646|NCT00842985|12207818|FG000|Screening|Did not meet entrance requirements|27
7765647|NCT00842985|12207818|FG000|First Intervention|Withdrawal by Subject|3
7765648|NCT00842985|12207818|FG000|First Intervention|Protocol Violation|3
7765649|NCT00842985|12207818|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2
7770467|NCT00876460|12214450|FG002|Combination Therapy Phase|Not treated|0
7765650|NCT00842985|12207818|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2
7765651|NCT00843024|12207829|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
7765652|NCT00843024|12207830|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
7765653|NCT00843024|12207831|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
7765654|NCT00843024|12207832|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
7765655|NCT00843024|12207833|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
7765656|NCT00843024|12207834|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
7765657|NCT00843024|12207829|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
7765658|NCT00843024|12207830|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
7765659|NCT00843024|12207831|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
7765660|NCT00843024|12207832|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
7765661|NCT00843024|12207833|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
7765662|NCT00843024|12207834|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
7765663|NCT00843024|12207829|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
7765664|NCT00843024|12207830|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
7765665|NCT00843024|12207831|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
7765666|NCT00843024|12207832|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
7765667|NCT00843024|12207833|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
7765668|NCT00843024|12207834|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
7765669|NCT00843024|12207829|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4
7586107|NCT02720523|11991790|FG000|Period 1: Placebo-controlled Period|Adverse Event|0
7586108|NCT02720523|11991791|FG001|Period 1: Placebo-controlled Period|Adverse Event|0
7586109|NCT02720523|11991792|FG002|Period 1: Placebo-controlled Period|Adverse Event|1
7586110|NCT02720523|11991793|FG003|Period 1: Placebo-controlled Period|Adverse Event|5
7586111|NCT02720523|11991794|FG004|Period 1: Placebo-controlled Period|Adverse Event|0
7586112|NCT02720523|11991795|FG005|Period 1: Placebo-controlled Period|Adverse Event|0
7586113|NCT02720523|11991796|FG006|Period 1: Placebo-controlled Period|Adverse Event|0
7586114|NCT02720523|11991790|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1
7586115|NCT02720523|11991791|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7586116|NCT02720523|11991792|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7586117|NCT02720523|11991793|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7586118|NCT02720523|11991794|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7586119|NCT02720523|11991795|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7586120|NCT02720523|11991796|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7586121|NCT02720523|11991790|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1
7586122|NCT02720523|11991791|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7586123|NCT02720523|11991792|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7586124|NCT02720523|11991793|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7586125|NCT02720523|11991794|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7586126|NCT02720523|11991795|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7586127|NCT02720523|11991796|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7586128|NCT02720523|11991790|FG000|Period 1: Placebo-controlled Period|Other|0
7586129|NCT02720523|11991791|FG001|Period 1: Placebo-controlled Period|Other|0
7586130|NCT02720523|11991792|FG002|Period 1: Placebo-controlled Period|Other|1
7586131|NCT02720523|11991793|FG003|Period 1: Placebo-controlled Period|Other|1
7586132|NCT02720523|11991794|FG004|Period 1: Placebo-controlled Period|Other|0
7765670|NCT00843024|12207830|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5
7765671|NCT00843024|12207831|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0
7765672|NCT00843024|12207832|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0
7765673|NCT00843024|12207833|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0
7765674|NCT00843024|12207834|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0
7765675|NCT00843024|12207829|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2
7765676|NCT00843024|12207830|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6
7765677|NCT00843024|12207831|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0
7586133|NCT02720523|11991795|FG005|Period 1: Placebo-controlled Period|Other|0
7586134|NCT02720523|11991796|FG006|Period 1: Placebo-controlled Period|Other|0
7586135|NCT02720523|11991790|FG000|Period 2: Long-term Extension Period|Ongoing|0
7586136|NCT02720523|11991791|FG001|Period 2: Long-term Extension Period|Ongoing|0
7586137|NCT02720523|11991792|FG002|Period 2: Long-term Extension Period|Ongoing|0
7586138|NCT02720523|11991793|FG003|Period 2: Long-term Extension Period|Ongoing|0
7586139|NCT02720523|11991794|FG004|Period 2: Long-term Extension Period|Ongoing|57
7586140|NCT02720523|11991795|FG005|Period 2: Long-term Extension Period|Ongoing|54
7586141|NCT02720523|11991796|FG006|Period 2: Long-term Extension Period|Ongoing|45
7586142|NCT02720523|11991790|FG000|Period 2: Long-term Extension Period|Adverse Event|0
7586143|NCT02720523|11991791|FG001|Period 2: Long-term Extension Period|Adverse Event|0
7586144|NCT02720523|11991792|FG002|Period 2: Long-term Extension Period|Adverse Event|0
7586145|NCT02720523|11991793|FG003|Period 2: Long-term Extension Period|Adverse Event|0
7586146|NCT02720523|11991794|FG004|Period 2: Long-term Extension Period|Adverse Event|4
7586147|NCT02720523|11991795|FG005|Period 2: Long-term Extension Period|Adverse Event|7
7586148|NCT02720523|11991796|FG006|Period 2: Long-term Extension Period|Adverse Event|11
7586149|NCT02720523|11991790|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7586150|NCT02720523|11991791|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7586151|NCT02720523|11991792|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7765678|NCT00843024|12207832|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0
7765679|NCT00843024|12207833|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0
7765680|NCT00843024|12207834|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0
7765681|NCT00843024|12207829|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0
7586152|NCT02720523|11991793|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7586153|NCT02720523|11991794|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2
7586154|NCT02720523|11991795|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1
7586155|NCT02720523|11991796|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1
7586156|NCT02720523|11991790|FG000|Period 2: Long-term Extension Period|Other|0
7586157|NCT02720523|11991791|FG001|Period 2: Long-term Extension Period|Other|0
7586158|NCT02720523|11991792|FG002|Period 2: Long-term Extension Period|Other|0
7586159|NCT02720523|11991793|FG003|Period 2: Long-term Extension Period|Other|0
7586160|NCT02720523|11991794|FG004|Period 2: Long-term Extension Period|Other|2
7586161|NCT02720523|11991795|FG005|Period 2: Long-term Extension Period|Other|0
7586162|NCT02720523|11991796|FG006|Period 2: Long-term Extension Period|Other|3
7586163|NCT02625324|11991809|FG000|30-Day Follow-up for Primary Endpoint|Death|1
7586164|NCT02625324|11991809|FG000|30-Day Follow-up for Secondary Endpoint|Death|1
7586165|NCT02625324|11991809|FG000|6-Month Follow-up Subject Accountability|Death|5
7586166|NCT02625324|11991809|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2
7586167|NCT02625324|11991809|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1
7586168|NCT02625324|11991809|FG000|12-Month Follow-up Secondary Endpoint|Death|4
7586169|NCT02625324|11991809|FG000|24-Month Follow-up Secondary Endpoint|Death|2
7586170|NCT02625324|11991809|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
7586171|NCT02625324|11991809|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
7586172|NCT02625324|11991809|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|27
7586173|NCT02625324|11991809|FG000|36-Month Follow-up Secondary Endpoint|Death|2
7586174|NCT02625324|11991809|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1
7586175|NCT02625324|11991809|FG000|36-Month Follow-up Secondary Endpoint|Subject declined extended follow up at 12 month timepoint. Data entry error to be corrected by site|1
7765682|NCT00843024|12207830|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1
7765683|NCT00843024|12207831|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0
7765684|NCT00843024|12207832|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0
7765685|NCT00843024|12207833|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0
7765686|NCT00843024|12207834|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0
7765687|NCT00843024|12207829|FG000|Single-blind Placebo Run-In Phase|Other|0
7765688|NCT00843024|12207830|FG001|Single-blind Placebo Run-In Phase|Other|1
7765689|NCT00843024|12207831|FG002|Single-blind Placebo Run-In Phase|Other|0
7765690|NCT00843024|12207832|FG003|Single-blind Placebo Run-In Phase|Other|0
7765691|NCT00843024|12207833|FG004|Single-blind Placebo Run-In Phase|Other|0
7765692|NCT00843024|12207834|FG005|Single-blind Placebo Run-In Phase|Other|0
7765693|NCT00843024|12207829|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0
7765694|NCT00843024|12207830|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0
7765695|NCT00843024|12207831|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20
7625985|NCT02617589|12037931|FG000|Treatment Period|Adverse event unrelated to study drug|15
7625986|NCT02617589|12037932|FG001|Treatment Period|Adverse event unrelated to study drug|9
7625987|NCT02617589|12037931|FG000|Treatment Period|Death|1
7625988|NCT02617589|12037932|FG001|Treatment Period|Death|1
7625989|NCT02617589|12037931|FG000|Treatment Period|Study Drug Toxicity|26
7625990|NCT02617589|12037932|FG001|Treatment Period|Study Drug Toxicity|20
7625991|NCT02617589|12037931|FG000|Treatment Period|Disease Progression|214
7625992|NCT02617589|12037932|FG001|Treatment Period|Disease Progression|137
7625993|NCT02617589|12037931|FG000|Treatment Period|Completed Treatment|0
7625994|NCT02617589|12037932|FG001|Treatment Period|Completed Treatment|76
7625995|NCT02614859|12037940|FG000|Overall Study|Physician Decision|0
7625996|NCT02614859|12037941|FG001|Overall Study|Physician Decision|1
7765696|NCT00843024|12207832|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10
7765697|NCT00843024|12207833|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13
7765698|NCT00843024|12207834|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14
7765699|NCT00843024|12207829|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
7765700|NCT00843024|12207830|FG001|Double-blind Treatment Phase|Lost to Follow-up|0
7765701|NCT00843024|12207831|FG002|Double-blind Treatment Phase|Lost to Follow-up|8
7765702|NCT00843024|12207832|FG003|Double-blind Treatment Phase|Lost to Follow-up|4
7765703|NCT00843024|12207833|FG004|Double-blind Treatment Phase|Lost to Follow-up|4
7765704|NCT00843024|12207834|FG005|Double-blind Treatment Phase|Lost to Follow-up|4
7765705|NCT00843024|12207829|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
7765706|NCT00843024|12207830|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0
7765707|NCT00843024|12207831|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0
7765708|NCT00843024|12207832|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6
7765709|NCT00843024|12207833|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0
7765710|NCT00843024|12207834|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2
7765711|NCT00843024|12207829|FG000|Double-blind Treatment Phase|Protocol Violation|0
7586192|NCT02468778|11991853|FG000|Overall Study|Death|2
7586193|NCT02468778|11991854|FG001|Overall Study|Death|1
7586194|NCT02468778|11991855|FG002|Overall Study|Death|0
7586195|NCT02468778|11991853|FG000|Overall Study|Lost to Follow-up|1
7586196|NCT02468778|11991854|FG001|Overall Study|Lost to Follow-up|2
7586197|NCT02468778|11991855|FG002|Overall Study|Lost to Follow-up|2
7586198|NCT02468778|11991853|FG000|Overall Study|Withdrawal by Subject|0
7586199|NCT02468778|11991854|FG001|Overall Study|Withdrawal by Subject|1
7586200|NCT02468778|11991855|FG002|Overall Study|Withdrawal by Subject|1
7586201|NCT02435849|11991863|FG000|Overall Study|Enrolled but not infused|18
7586202|NCT02435849|11991863|FG000|Overall Study|Death|16
7765712|NCT00843024|12207830|FG001|Double-blind Treatment Phase|Protocol Violation|0
7765713|NCT00843024|12207831|FG002|Double-blind Treatment Phase|Protocol Violation|3
7765714|NCT00843024|12207832|FG003|Double-blind Treatment Phase|Protocol Violation|0
7586203|NCT02435849|11991863|FG000|Overall Study|Lack of Efficacy|9
7586204|NCT02435849|11991863|FG000|Overall Study|New therapy for study indication|7
7586205|NCT02435849|11991863|FG000|Overall Study|Subject/guardian decision|2
7586206|NCT02435849|11991863|FG000|Overall Study|Study follow-up ongoing|45
7765715|NCT00843024|12207833|FG004|Double-blind Treatment Phase|Protocol Violation|0
7765716|NCT00843024|12207834|FG005|Double-blind Treatment Phase|Protocol Violation|3
7765717|NCT00843024|12207829|FG000|Double-blind Treatment Phase|Physician Decision|0
7765718|NCT00843024|12207830|FG001|Double-blind Treatment Phase|Physician Decision|0
7765719|NCT00843024|12207831|FG002|Double-blind Treatment Phase|Physician Decision|0
7765720|NCT00843024|12207832|FG003|Double-blind Treatment Phase|Physician Decision|3
7765721|NCT00843024|12207833|FG004|Double-blind Treatment Phase|Physician Decision|1
7765722|NCT00843024|12207834|FG005|Double-blind Treatment Phase|Physician Decision|1
7765723|NCT00843024|12207829|FG000|Double-blind Treatment Phase|Adverse Event|0
7765724|NCT00843024|12207830|FG001|Double-blind Treatment Phase|Adverse Event|0
7765725|NCT00843024|12207831|FG002|Double-blind Treatment Phase|Adverse Event|0
7765726|NCT00843024|12207832|FG003|Double-blind Treatment Phase|Adverse Event|0
7765727|NCT00843024|12207833|FG004|Double-blind Treatment Phase|Adverse Event|1
7765728|NCT00843024|12207834|FG005|Double-blind Treatment Phase|Adverse Event|1
7765729|NCT00843024|12207829|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
7765730|NCT00843024|12207830|FG001|Double-blind Treatment Phase|Lack of Efficacy|0
7765731|NCT00843024|12207831|FG002|Double-blind Treatment Phase|Lack of Efficacy|0
7765732|NCT00843024|12207832|FG003|Double-blind Treatment Phase|Lack of Efficacy|0
7765733|NCT00843024|12207833|FG004|Double-blind Treatment Phase|Lack of Efficacy|1
7765734|NCT00843024|12207834|FG005|Double-blind Treatment Phase|Lack of Efficacy|0
7765735|NCT00843115|12207847|FG000|Overall Study|Death|4
7765736|NCT00843115|12207847|FG000|Overall Study|Adverse Event|30
7765737|NCT00843115|12207847|FG000|Overall Study|Lost to Follow-up|4
7765738|NCT00843115|12207847|FG000|Overall Study|Withdrawal by Subject|17
7765739|NCT00843115|12207847|FG000|Overall Study|Family wanted meds stopped|1
7765740|NCT00843115|12207847|FG000|Overall Study|Family does not want continuation|1
7765741|NCT00843115|12207847|FG000|Overall Study|Patient forgot to take meds|1
7765742|NCT00843115|12207847|FG000|Overall Study|Does not meet entrance criteria|1
7765743|NCT00843115|12207847|FG000|Overall Study|Physician Decision|1
7765744|NCT00843115|12207847|FG000|Overall Study|Family discontinued meds|1
7765745|NCT00843115|12207847|FG000|Overall Study|patient took for 2 days then stopped|1
7765746|NCT00843115|12207847|FG000|Overall Study|patient never took the medication|1
7765747|NCT00843115|12207847|FG000|Overall Study|hospitalized due to deterioration|1
7765748|NCT00843115|12207847|FG000|Overall Study|week 12 not done|1
7765749|NCT00843115|12207847|FG000|Overall Study|Syndrome De Glissement|1
7765750|NCT00843167|12207853|FG000|Treatment Period|Adverse Event|1
7765751|NCT00843167|12207854|FG001|Treatment Period|Adverse Event|5
7765752|NCT00843167|12207853|FG000|Treatment Period|Withdrawal by Subject|2
7765753|NCT00843167|12207854|FG001|Treatment Period|Withdrawal by Subject|3
7765754|NCT00843193|12207875|FG000|Overall Study|Adverse Event|2
7765755|NCT00843193|12207876|FG001|Overall Study|Adverse Event|4
7765756|NCT00843193|12207875|FG000|Overall Study|Lack of Efficacy|1
7765757|NCT00843193|12207876|FG001|Overall Study|Lack of Efficacy|1
7765758|NCT00843193|12207875|FG000|Overall Study|Protocol Violation|1
7765759|NCT00843193|12207876|FG001|Overall Study|Protocol Violation|2
7765760|NCT00843193|12207875|FG000|Overall Study|Lost to Follow-up|1
7765761|NCT00843193|12207876|FG001|Overall Study|Lost to Follow-up|0
7765762|NCT00843193|12207875|FG000|Overall Study|Physician Decision|0
7765763|NCT00843193|12207876|FG001|Overall Study|Physician Decision|1
7765764|NCT00843193|12207875|FG000|Overall Study|Withdrawal by Subject|3
7765765|NCT00843193|12207876|FG001|Overall Study|Withdrawal by Subject|3
7765766|NCT00843284|12207883|FG000|Overall Study|Adverse Event|39
7765767|NCT00843284|12207883|FG000|Overall Study|Lack of Efficacy|5
7765768|NCT00843284|12207883|FG000|Overall Study|Lost to Follow-up|11
7765769|NCT00843284|12207883|FG000|Overall Study|Other|10
7765770|NCT00843284|12207883|FG000|Overall Study|Withdrawal by Subject|4
7586265|NCT02311478|11991926|FG000|Overall Study|Withdrawal by Subject|1
7586266|NCT02311478|11991926|FG000|Overall Study|Lost to Follow-up|5
7586267|NCT02311478|11991926|FG000|Overall Study|Failed IUD Insertion|1
7586268|NCT02292238|11991933|FG000|Overall Study|Protocol Violation|1
7586269|NCT02292238|11991934|FG001|Overall Study|Protocol Violation|2
7586270|NCT02292238|11991933|FG000|Overall Study|Withdrawal by Subject|2
7586271|NCT02292238|11991934|FG001|Overall Study|Withdrawal by Subject|1
7586272|NCT02292238|11991933|FG000|Overall Study|Lost to Follow-up|1
7586273|NCT02292238|11991934|FG001|Overall Study|Lost to Follow-up|0
7586274|NCT02292238|11991933|FG000|Overall Study|Physician Decision|0
7586275|NCT02292238|11991934|FG001|Overall Study|Physician Decision|1
7586276|NCT02277119|11991953|FG000|Overall Study|Lack of Efficacy|1
7586277|NCT02277119|11991954|FG001|Overall Study|Lack of Efficacy|1
7586278|NCT02277119|11991955|FG002|Overall Study|Lack of Efficacy|1
7586279|NCT02277119|11991953|FG000|Overall Study|Protocol Violation|2
7586280|NCT02277119|11991954|FG001|Overall Study|Protocol Violation|3
7586281|NCT02277119|11991955|FG002|Overall Study|Protocol Violation|7
7765771|NCT00843284|12207883|FG000|Overall Study|Death|3
7765772|NCT00843492|12207926|FG000|Overall Study|Adverse Event|0
7765773|NCT00843492|12207927|FG001|Overall Study|Adverse Event|3
7586285|NCT02255097|11991967|FG000|Overall Study|Death|151
7586286|NCT02255097|11991967|FG000|Overall Study|Lost to Follow-up|5
7586287|NCT02255097|11991967|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8
7586288|NCT02255097|11991967|FG000|Overall Study|Withdrawal by Subject|7
7586289|NCT02255097|11991967|FG000|Overall Study|Allocated but not treated|1
7586290|NCT02200614|11991978|FG000|Double Blind Treatment|Adverse Event|86
7586291|NCT02200614|11991979|FG001|Double Blind Treatment|Adverse Event|48
7586292|NCT02200614|11991978|FG000|Double Blind Treatment|Confirmed metastasis|120
7586293|NCT02200614|11991979|FG001|Double Blind Treatment|Confirmed metastasis|140
7586294|NCT02200614|11991978|FG000|Double Blind Treatment|Judgment of the investigator|59
7586295|NCT02200614|11991979|FG001|Double Blind Treatment|Judgment of the investigator|99
7586296|NCT02200614|11991978|FG000|Double Blind Treatment|Metastasis by local reading|1
7586297|NCT02200614|11991979|FG001|Double Blind Treatment|Metastasis by local reading|3
7586298|NCT02200614|11991978|FG000|Double Blind Treatment|Other reason|6
7586299|NCT02200614|11991979|FG001|Double Blind Treatment|Other reason|2
7586300|NCT02200614|11991978|FG000|Double Blind Treatment|Personal reason|77
7586301|NCT02200614|11991979|FG001|Double Blind Treatment|Personal reason|85
7586302|NCT02200614|11991978|FG000|Double Blind Treatment|Protocol deviation|14
7586303|NCT02200614|11991979|FG001|Double Blind Treatment|Protocol deviation|7
7586304|NCT02200614|11991978|FG000|Double Blind Treatment|Not treated|1
7586305|NCT02200614|11991979|FG001|Double Blind Treatment|Not treated|0
7586306|NCT02200614|11991978|FG000|Open Label|Adverse Event|41
7586307|NCT02200614|11991979|FG001|Open Label|Adverse Event|11
7586308|NCT02200614|11991978|FG000|Open Label|Confirmed metastasis|1
7586309|NCT02200614|11991979|FG001|Open Label|Confirmed metastasis|0
7586310|NCT02200614|11991978|FG000|Open Label|Judgment of the investigator|29
7586311|NCT02200614|11991979|FG001|Open Label|Judgment of the investigator|2
7586312|NCT02200614|11991978|FG000|Open Label|Metastasis by local reading|138
7586313|NCT02200614|11991979|FG001|Open Label|Metastasis by local reading|27
7586314|NCT02200614|11991978|FG000|Open Label|Other reason|22
7586315|NCT02200614|11991979|FG001|Open Label|Other reason|4
7586316|NCT02200614|11991978|FG000|Open Label|Personal reason|60
7586317|NCT02200614|11991979|FG001|Open Label|Personal reason|8
7586318|NCT02200614|11991978|FG000|Open Label|Protocol deviation|3
7586319|NCT02200614|11991979|FG001|Open Label|Protocol deviation|2
7586320|NCT02200614|11991978|FG000|Open Label|Missing|2
7586321|NCT02200614|11991979|FG001|Open Label|Missing|2
7765774|NCT00843492|12207926|FG000|Overall Study|Lost to Follow-up|4
7765775|NCT00843492|12207927|FG001|Overall Study|Lost to Follow-up|4
7765776|NCT00843492|12207926|FG000|Overall Study|Withdrawal by Subject|0
7765777|NCT00843492|12207927|FG001|Overall Study|Withdrawal by Subject|4
7586326|NCT02083081|11991993|FG000|Overall Study|Lost to Follow-up|31
7586327|NCT02083081|11991994|FG001|Overall Study|Lost to Follow-up|9
7586328|NCT02069899|11992003|FG000|Overall Study|Adverse Event|6
7586329|NCT02069899|11992004|FG001|Overall Study|Adverse Event|0
7586330|NCT02069899|11992005|FG002|Overall Study|Adverse Event|1
7586331|NCT02069899|11992003|FG000|Overall Study|Withdrawal by Participant|2
7586332|NCT02069899|11992004|FG001|Overall Study|Withdrawal by Participant|0
7586333|NCT02069899|11992005|FG002|Overall Study|Withdrawal by Participant|0
7586334|NCT02069899|11992003|FG000|Overall Study|Lost to Follow-up|1
7765778|NCT00843492|12207926|FG000|Overall Study|Immobilization Stopped|1
7765779|NCT00843492|12207927|FG001|Overall Study|Immobilization Stopped|0
7765780|NCT00843492|12207926|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1
7765781|NCT00843492|12207927|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1
7765782|NCT00843492|12207926|FG000|Overall Study|Orthopedic Surgery|0
7765783|NCT00843492|12207927|FG001|Overall Study|Orthopedic Surgery|2
7765784|NCT00843492|12207926|FG000|Overall Study|Visit Not Performed|1
7765785|NCT00843492|12207927|FG001|Overall Study|Visit Not Performed|0
7765786|NCT00843492|12207926|FG000|Overall Study|Deep-vein Thrombosis|1
7765787|NCT00843492|12207927|FG001|Overall Study|Deep-vein Thrombosis|0
7765788|NCT00843518|12207935|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5
7586335|NCT02069899|11992004|FG001|Overall Study|Lost to Follow-up|0
7586336|NCT02069899|11992005|FG002|Overall Study|Lost to Follow-up|1
7586337|NCT02069899|11992003|FG000|Overall Study|Other|4
7586338|NCT02069899|11992004|FG001|Overall Study|Other|0
7586339|NCT02069899|11992005|FG002|Overall Study|Other|0
7586340|NCT02069899|11992003|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0
7586341|NCT02069899|11992004|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1
7586342|NCT02069899|11992005|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0
7586395|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586343|NCT02069899|11992003|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0
7586344|NCT02069899|11992004|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0
7586345|NCT02069899|11992005|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1
7765789|NCT00843518|12207936|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3
7765790|NCT00843518|12207935|FG000|Period 2 (Double-blind Treatment)|Death|0
7765791|NCT00843518|12207936|FG001|Period 2 (Double-blind Treatment)|Death|1
7765792|NCT00843518|12207935|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
7765793|NCT00843518|12207936|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
7765794|NCT00843518|12207935|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2
7765795|NCT00843518|12207936|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1
7765796|NCT00843518|12207935|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2
7765797|NCT00843518|12207936|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5
7765798|NCT00843518|12207935|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
7765799|NCT00843518|12207936|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
7765800|NCT00843518|12207935|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7
7765801|NCT00843518|12207936|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7
7765802|NCT00843635|12207966|FG000|Overall Study|Adverse Event|2
7765803|NCT00843635|12207967|FG001|Overall Study|Adverse Event|2
7765804|NCT00843635|12207968|FG002|Overall Study|Adverse Event|0
7765805|NCT00843726|12207991|FG000|Overall Study|Death|1
7765806|NCT00843726|12207992|FG001|Overall Study|Death|0
7765807|NCT00843726|12207991|FG000|Overall Study|Withdrawal by Subject|0
7765808|NCT00843726|12207992|FG001|Overall Study|Withdrawal by Subject|1
7765809|NCT00843778|12207999|FG000|Overall Study|Adverse Event|15
7586351|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0
7586352|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2
7586353|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1
7586354|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6
7586355|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4
7586356|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1
7586357|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0
7586358|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0
7586359|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0
7586360|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0
7586361|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7586362|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7586363|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7586364|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1
7586365|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1
7586366|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7586367|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7586368|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7586369|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7586370|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7765810|NCT00843778|12207999|FG000|Overall Study|Lack of Efficacy|14
7765811|NCT00843778|12207999|FG000|Overall Study|Loss of efficacy|2
7586371|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0
7586372|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1
7586373|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1
7586374|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13
7586375|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18
7586376|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1
7586377|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0
7586378|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0
7586379|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0
7586380|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0
7586381|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1
7586382|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7586383|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7586384|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3
7586385|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1
7586386|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7586387|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7586388|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7586389|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7586390|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7586391|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586392|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586393|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1
7586394|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1
7586396|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586397|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586398|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586399|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586400|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586401|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586402|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586403|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586404|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586405|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1
7586406|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586407|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586408|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586409|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7765812|NCT00843778|12207999|FG000|Overall Study|Withdrawal by Subject|4
7765813|NCT00843843|12208005|FG000|Overall Study|Physician Decision|1
7765814|NCT00843843|12208006|FG001|Overall Study|Physician Decision|1
7765815|NCT00843843|12208005|FG000|Overall Study|Protocol Violation|1
7765816|NCT00843843|12208006|FG001|Overall Study|Protocol Violation|1
7765817|NCT00843856|12208014|FG000|Overall Study|Lost to Follow-up|1
7765818|NCT00843856|12208015|FG001|Overall Study|Lost to Follow-up|2
7765819|NCT00844194|12208041|FG000|Overall Study|Adverse Event|17
7765820|NCT00844194|12208042|FG001|Overall Study|Adverse Event|5
7765821|NCT00844194|12208041|FG000|Overall Study|Protocol Violation|1
7765822|NCT00844194|12208042|FG001|Overall Study|Protocol Violation|1
7765823|NCT00844194|12208041|FG000|Overall Study|Lost to Follow-up|1
7765824|NCT00844194|12208042|FG001|Overall Study|Lost to Follow-up|1
7765825|NCT00844194|12208041|FG000|Overall Study|Withdrawal by Subject|2
7765826|NCT00844194|12208042|FG001|Overall Study|Withdrawal by Subject|1
7765827|NCT00844194|12208041|FG000|Overall Study|Lack of Efficacy|3
7586410|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586411|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7765828|NCT00844194|12208042|FG001|Overall Study|Lack of Efficacy|0
7765829|NCT00844194|12208041|FG000|Overall Study|Other reason (not specified)|1
7765830|NCT00844194|12208042|FG001|Overall Study|Other reason (not specified)|0
7765831|NCT00844376|12208056|FG000|Period 1: First Intervention|Withdrawal by Subject|1
7765832|NCT00844376|12208057|FG001|Period 1: First Intervention|Withdrawal by Subject|0
7586412|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7586413|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7586414|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4
7586415|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1
7586416|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2
7586417|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7586418|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7586419|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7586420|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7586421|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586422|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586423|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586424|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2
7586425|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1
7586426|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586427|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586428|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586429|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586430|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586431|NCT02018861|11992028|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586432|NCT02018861|11992029|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586433|NCT02018861|11992030|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586434|NCT02018861|11992031|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586435|NCT02018861|11992032|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586436|NCT02018861|11992033|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586437|NCT02018861|11992034|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5
7586438|NCT02018861|11992035|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2
7586439|NCT02018861|11992036|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586440|NCT02018861|11992037|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586441|NCT02018861|11992028|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586442|NCT02018861|11992029|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586443|NCT02018861|11992030|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586444|NCT02018861|11992031|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586445|NCT02018861|11992032|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586446|NCT02018861|11992033|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586447|NCT02018861|11992034|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3
7586448|NCT02018861|11992035|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1
7586449|NCT02018861|11992036|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586450|NCT02018861|11992037|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586451|NCT02018861|11992028|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586452|NCT02018861|11992029|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586453|NCT02018861|11992030|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586454|NCT02018861|11992031|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586455|NCT02018861|11992032|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586456|NCT02018861|11992033|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586457|NCT02018861|11992034|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586458|NCT02018861|11992035|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586459|NCT02018861|11992036|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1
7586460|NCT02018861|11992037|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586461|NCT02018861|11992028|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586462|NCT02018861|11992029|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586463|NCT02018861|11992030|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586464|NCT02018861|11992031|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586465|NCT02018861|11992032|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586466|NCT02018861|11992033|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586467|NCT02018861|11992034|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586468|NCT02018861|11992035|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586469|NCT02018861|11992036|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1
7586470|NCT02018861|11992037|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586471|NCT02018861|11992028|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586472|NCT02018861|11992029|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586473|NCT02018861|11992030|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586474|NCT02018861|11992031|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586475|NCT02018861|11992032|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586476|NCT02018861|11992033|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586477|NCT02018861|11992034|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586478|NCT02018861|11992035|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586479|NCT02018861|11992036|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1
7586480|NCT02018861|11992037|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7765833|NCT00844415|12208063|FG000|Overall Study|Withdrawal by Subject|1
7765834|NCT00844428|12208068|FG000|Screening Period|Screen Failure|3
7765835|NCT00844428|12208068|FG000|Extension Treatment Period|Death|1
7765836|NCT00844428|12208068|FG000|Post Treatment Period (Patients Who Disc|Death|1
7765837|NCT00844519|12208074|FG000|Overall Study|Withdrawal by Subject|1
7765838|NCT00844519|12208075|FG001|Overall Study|Withdrawal by Subject|1
7765839|NCT00844519|12208074|FG000|Overall Study|Adverse Event|1
7765840|NCT00844519|12208075|FG001|Overall Study|Adverse Event|0
7765841|NCT00844532|12208081|FG000|Overall Study|Death|16
7765842|NCT00844532|12208081|FG000|Overall Study|Withdrawal by Subject|16
7765843|NCT00844532|12208081|FG000|Overall Study|Lost to Follow-up|7
7765844|NCT00844545|12208085|FG000|Treatment Period (26 Weeks)|Adverse Event|1
7765845|NCT00844545|12208085|FG000|Treatment Period (26 Weeks)|Protocol Violation|1
7765846|NCT00844545|12208085|FG000|Extension Treatment Period|Adverse Event|2
7765847|NCT00844545|12208085|FG000|Post Treatment Period|Withdrawal by Subject|1
7765848|NCT00844558|12208092|FG000|Overall Study|Withdrawal by Subject|9
7765849|NCT00844558|12208093|FG001|Overall Study|Withdrawal by Subject|2
7765850|NCT00844558|12208092|FG000|Overall Study|Death|1
7765851|NCT00844558|12208093|FG001|Overall Study|Death|0
7765852|NCT00844558|12208092|FG000|Overall Study|Protocol Violation|1
7765853|NCT00844558|12208093|FG001|Overall Study|Protocol Violation|1
7765854|NCT00844558|12208092|FG000|Overall Study|Lost to Follow-up|0
7765855|NCT00844558|12208093|FG001|Overall Study|Lost to Follow-up|1
7765856|NCT00844558|12208092|FG000|Overall Study|Physician Decision|1
7765857|NCT00844558|12208093|FG001|Overall Study|Physician Decision|0
7765858|NCT00844597|12208110|FG000|Overall Study|Adverse Event|0
7765859|NCT00844597|12208111|FG001|Overall Study|Adverse Event|0
7765860|NCT00844597|12208112|FG002|Overall Study|Adverse Event|0
7765861|NCT00844597|12208113|FG003|Overall Study|Adverse Event|1
7765862|NCT00844597|12208114|FG004|Overall Study|Adverse Event|0
7765863|NCT00844597|12208115|FG005|Overall Study|Adverse Event|0
7765864|NCT00844649|12208133|FG000|Overall Study|Progressive Disease|196
7765865|NCT00844649|12208134|FG001|Overall Study|Progressive Disease|245
7765866|NCT00844649|12208133|FG000|Overall Study|Adverse Event|128
7765867|NCT00844649|12208134|FG001|Overall Study|Adverse Event|73
7765868|NCT00844649|12208133|FG000|Overall Study|Physician Decision|25
7765869|NCT00844649|12208134|FG001|Overall Study|Physician Decision|18
7765870|NCT00844649|12208133|FG000|Overall Study|Protocol Violation|10
7586493|NCT01721759|11992075|FG000|Treatment Period|Disease Progression|85
7765871|NCT00844649|12208134|FG001|Overall Study|Protocol Violation|6
7765872|NCT00844649|12208133|FG000|Overall Study|Withdrawal by Subject|28
7765873|NCT00844649|12208134|FG001|Overall Study|Withdrawal by Subject|39
7586494|NCT01721759|11992075|FG000|Treatment Period|Study drug toxicity|14
7586495|NCT01721759|11992075|FG000|Treatment Period|Death|1
7586496|NCT01721759|11992075|FG000|Treatment Period|Adverse event unrelated to study drug|11
7586497|NCT01721759|11992075|FG000|Treatment Period|Participant request to withdraw|3
7586498|NCT01721759|11992075|FG000|Treatment Period|Other Reasons|3
7586499|NCT01721759|11992075|FG000|End of Study Period|Participant Withdrew Consent|5
7586500|NCT01721759|11992075|FG000|End of Study Period|Death|101
7586501|NCT01721759|11992075|FG000|End of Study Period|Lost to Follow-up|1
7586502|NCT01721759|11992075|FG000|End of Study Period|Other Reasons|10
7765874|NCT00844649|12208133|FG000|Overall Study|Other|7
7765875|NCT00844649|12208134|FG001|Overall Study|Other|10
7765876|NCT00844649|12208133|FG000|Overall Study|Withdrew prior to starting treatment|11
7765877|NCT00844649|12208134|FG001|Overall Study|Withdrew prior to starting treatment|27
7765878|NCT00844753|12208150|FG000|Overall Study|Lack of Efficacy|1
7765879|NCT00844753|12208151|FG001|Overall Study|Lack of Efficacy|0
7765880|NCT00844753|12208152|FG002|Overall Study|Lack of Efficacy|2
7765881|NCT00844753|12208153|FG003|Overall Study|Lack of Efficacy|2
7765882|NCT00844753|12208150|FG000|Overall Study|Adverse Event|3
7765883|NCT00844753|12208151|FG001|Overall Study|Adverse Event|2
7765884|NCT00844753|12208152|FG002|Overall Study|Adverse Event|5
7765885|NCT00844753|12208153|FG003|Overall Study|Adverse Event|5
7765886|NCT00844753|12208150|FG000|Overall Study|Lost to Follow-up|1
7765887|NCT00844753|12208151|FG001|Overall Study|Lost to Follow-up|1
7765888|NCT00844753|12208152|FG002|Overall Study|Lost to Follow-up|0
7765889|NCT00844753|12208153|FG003|Overall Study|Lost to Follow-up|1
7765890|NCT00844753|12208150|FG000|Overall Study|could not swallow medication|2
7765891|NCT00844753|12208151|FG001|Overall Study|could not swallow medication|0
7765892|NCT00844753|12208152|FG002|Overall Study|could not swallow medication|0
7765893|NCT00844753|12208153|FG003|Overall Study|could not swallow medication|0
7765894|NCT00844753|12208150|FG000|Overall Study|Withdrawal by Subject|1
7765895|NCT00844753|12208151|FG001|Overall Study|Withdrawal by Subject|0
7765896|NCT00844753|12208152|FG002|Overall Study|Withdrawal by Subject|0
7765897|NCT00844753|12208153|FG003|Overall Study|Withdrawal by Subject|3
7765898|NCT00844805|12208163|FG000|Treatment Phase|Adverse Event|5
7765899|NCT00844805|12208164|FG001|Treatment Phase|Adverse Event|1
7765900|NCT00844805|12208165|FG002|Treatment Phase|Adverse Event|0
7765901|NCT00844805|12208166|FG003|Treatment Phase|Adverse Event|0
7765902|NCT00844805|12208163|FG000|Treatment Phase|Withdrawal by Subject|3
7765903|NCT00844805|12208164|FG001|Treatment Phase|Withdrawal by Subject|4
7765904|NCT00844805|12208165|FG002|Treatment Phase|Withdrawal by Subject|0
7765905|NCT00844805|12208166|FG003|Treatment Phase|Withdrawal by Subject|0
7765906|NCT00844805|12208163|FG000|Treatment Phase|Noncompliance With Protocol|1
7765907|NCT00844805|12208164|FG001|Treatment Phase|Noncompliance With Protocol|0
7586551|NCT01544335|11992144|FG000|Overall Study|Lost to Follow-up|27
7586552|NCT01544335|11992144|FG000|Overall Study|Death|4
7586553|NCT01544335|11992144|FG000|Overall Study|Disease progression|3
7586554|NCT01544335|11992144|FG000|Overall Study|Baseline Measurements not Available|19
7586576|NCT01451515|11992177|FG000|Overall Study|Death|0
7586577|NCT01451515|11992178|FG001|Overall Study|Death|1
7586578|NCT01451515|11992179|FG002|Overall Study|Death|0
7586579|NCT01451515|11992177|FG000|Overall Study|Withdrawal by Subject|0
7586580|NCT01451515|11992178|FG001|Overall Study|Withdrawal by Subject|1
7586581|NCT01451515|11992179|FG002|Overall Study|Withdrawal by Subject|0
7586582|NCT01451515|11992177|FG000|Overall Study|Development of unacceptable toxicity during treatment|0
7586583|NCT01451515|11992178|FG001|Overall Study|Development of unacceptable toxicity during treatment|0
7586584|NCT01451515|11992179|FG002|Overall Study|Development of unacceptable toxicity during treatment|1
7586585|NCT01451515|11992177|FG000|Overall Study|Relapse (except CNS)|1
7586586|NCT01451515|11992178|FG001|Overall Study|Relapse (except CNS)|1
7586587|NCT01451515|11992179|FG002|Overall Study|Relapse (except CNS)|0
7586714|NCT01302834|11992273|FG000|Overall Study|Protocol Violation|17
7586715|NCT01302834|11992274|FG001|Overall Study|Protocol Violation|23
7586716|NCT01302834|11992273|FG000|Overall Study|HIV positive|1
7586717|NCT01302834|11992274|FG001|Overall Study|HIV positive|3
7586730|NCT01177540|11992313|FG000|Overall Study|Adverse Event|1
7962733|NCT02714569|12517083|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1
7586731|NCT01177540|11992314|FG001|Overall Study|Adverse Event|0
7586794|NCT00792259|11992372|FG000|Overall Study|Poor Quality Scans|1
7586795|NCT00792259|11992373|FG001|Overall Study|Poor Quality Scans|0
7586796|NCT00792259|11992374|FG002|Overall Study|Poor Quality Scans|0
7586797|NCT00662792|11992382|FG000|Period 1|Personal Reasons|0
7586798|NCT00662792|11992383|FG001|Period 1|Personal Reasons|0
7586799|NCT00662792|11992384|FG002|Period 1|Personal Reasons|1
7586800|NCT00662792|11992385|FG003|Period 1|Personal Reasons|0
7586801|NCT00662792|11992382|FG000|Period 1|Refused continuing medication|0
7586802|NCT00662792|11992383|FG001|Period 1|Refused continuing medication|1
7586803|NCT00662792|11992384|FG002|Period 1|Refused continuing medication|1
7586804|NCT00662792|11992385|FG003|Period 1|Refused continuing medication|0
7586805|NCT00662792|11992382|FG000|Period 1|Lost to Follow-up|1
7586806|NCT00662792|11992383|FG001|Period 1|Lost to Follow-up|0
7586807|NCT00662792|11992384|FG002|Period 1|Lost to Follow-up|0
7586808|NCT00662792|11992385|FG003|Period 1|Lost to Follow-up|0
7765908|NCT00844805|12208165|FG002|Treatment Phase|Noncompliance With Protocol|0
7765909|NCT00844805|12208166|FG003|Treatment Phase|Noncompliance With Protocol|0
7586809|NCT00662792|11992382|FG000|Period 1|Other adverse event (AE)|0
7586810|NCT00662792|11992383|FG001|Period 1|Other adverse event (AE)|2
7586811|NCT00662792|11992384|FG002|Period 1|Other adverse event (AE)|0
7586812|NCT00662792|11992385|FG003|Period 1|Other adverse event (AE)|0
7586813|NCT00662792|11992382|FG000|Period 1|Worsening of disease under study (AE)|1
7586814|NCT00662792|11992383|FG001|Period 1|Worsening of disease under study (AE)|3
7586815|NCT00662792|11992384|FG002|Period 1|Worsening of disease under study (AE)|2
7586816|NCT00662792|11992385|FG003|Period 1|Worsening of disease under study (AE)|0
7586817|NCT00662792|11992382|FG000|Period 1|Not treated|0
7586818|NCT00662792|11992383|FG001|Period 1|Not treated|1
7586819|NCT00662792|11992384|FG002|Period 1|Not treated|0
7962734|NCT02714569|12517084|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7586820|NCT00662792|11992385|FG003|Period 1|Not treated|0
7586821|NCT00662792|11992382|FG000|Period 2|Worsening of disease under study|1
7586822|NCT00662792|11992383|FG001|Period 2|Worsening of disease under study|0
7586823|NCT00662792|11992384|FG002|Period 2|Worsening of disease under study|0
7586824|NCT00662792|11992385|FG003|Period 2|Worsening of disease under study|3
7586825|NCT00662792|11992382|FG000|Period 3|Refused continuing medication|1
7586826|NCT00662792|11992383|FG001|Period 3|Refused continuing medication|0
7586827|NCT00662792|11992384|FG002|Period 3|Refused continuing medication|1
7586828|NCT00662792|11992385|FG003|Period 3|Refused continuing medication|0
7586829|NCT00662792|11992382|FG000|Period 3|Other adverse event (AE)|0
7586830|NCT00662792|11992383|FG001|Period 3|Other adverse event (AE)|0
7586831|NCT00662792|11992384|FG002|Period 3|Other adverse event (AE)|1
7586832|NCT00662792|11992385|FG003|Period 3|Other adverse event (AE)|1
7586833|NCT00662792|11992382|FG000|Period 4|Refused continuing medication|0
7586834|NCT00662792|11992383|FG001|Period 4|Refused continuing medication|1
7586835|NCT00662792|11992384|FG002|Period 4|Refused continuing medication|0
7586836|NCT00662792|11992385|FG003|Period 4|Refused continuing medication|0
7586837|NCT00662792|11992382|FG000|Period 4|Other adverse event (AE)|1
7586838|NCT00662792|11992383|FG001|Period 4|Other adverse event (AE)|0
7586839|NCT00662792|11992384|FG002|Period 4|Other adverse event (AE)|0
7586840|NCT00662792|11992385|FG003|Period 4|Other adverse event (AE)|0
7586841|NCT00662792|11992382|FG000|Period 4|Worsening of disease under study (AE)|0
7586842|NCT00662792|11992383|FG001|Period 4|Worsening of disease under study (AE)|0
7586843|NCT00662792|11992384|FG002|Period 4|Worsening of disease under study (AE)|0
7586844|NCT00662792|11992385|FG003|Period 4|Worsening of disease under study (AE)|1
7765910|NCT00844805|12208163|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1
7586846|NCT00567580|11992427|FG000|Overall Study|Protocol Violation|28
7586847|NCT00567580|11992428|FG001|Overall Study|Protocol Violation|24
7586848|NCT00567580|11992429|FG002|Overall Study|Protocol Violation|24
7586849|NCT00528021|11992444|FG000|Overall Study|Lack of Efficacy|17
7586850|NCT00528021|11992445|FG001|Overall Study|Lack of Efficacy|13
7586851|NCT00528021|11992446|FG002|Overall Study|Lack of Efficacy|7
7586852|NCT00528021|11992447|FG003|Overall Study|Lack of Efficacy|9
7765911|NCT00844805|12208164|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2
7765912|NCT00844805|12208165|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0
7765913|NCT00844805|12208166|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0
7765914|NCT00844805|12208163|FG000|Follow-Up Phase|Adverse Event|0
7765915|NCT00844805|12208164|FG001|Follow-Up Phase|Adverse Event|0
7765916|NCT00844805|12208165|FG002|Follow-Up Phase|Adverse Event|1
7765917|NCT00844805|12208166|FG003|Follow-Up Phase|Adverse Event|0
7765918|NCT00844805|12208163|FG000|Follow-Up Phase|Withdrawal by Subject|0
7765919|NCT00844805|12208164|FG001|Follow-Up Phase|Withdrawal by Subject|0
7765920|NCT00844805|12208165|FG002|Follow-Up Phase|Withdrawal by Subject|6
7765921|NCT00844805|12208166|FG003|Follow-Up Phase|Withdrawal by Subject|3
7765922|NCT00844805|12208163|FG000|Follow-Up Phase|Noncompliance With Protocol|0
7765923|NCT00844805|12208164|FG001|Follow-Up Phase|Noncompliance With Protocol|0
7765924|NCT00844805|12208165|FG002|Follow-Up Phase|Noncompliance With Protocol|0
7765925|NCT00844805|12208166|FG003|Follow-Up Phase|Noncompliance With Protocol|1
7765926|NCT00844805|12208163|FG000|Follow-Up Phase|Relapse/Recurrence|0
7765927|NCT00844805|12208164|FG001|Follow-Up Phase|Relapse/Recurrence|0
7765928|NCT00844805|12208165|FG002|Follow-Up Phase|Relapse/Recurrence|2
7765929|NCT00844805|12208166|FG003|Follow-Up Phase|Relapse/Recurrence|4
7765930|NCT00844805|12208163|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
7765931|NCT00844805|12208164|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
7765932|NCT00844805|12208165|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
7765933|NCT00844805|12208166|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
7765934|NCT00844831|12208177|FG000|Overall Study|Withdrawal by Subject|4
7765935|NCT00844831|12208177|FG000|Overall Study|Adverse Event|1
7765936|NCT00844831|12208177|FG000|Overall Study|Physician Decision|1
7765937|NCT00844844|12208185|FG000|Treatment Period (26 Weeks)|Adverse Event|1
7765938|NCT00844844|12208185|FG000|Treatment Period (26 Weeks)|Protocol Violation|1
7765939|NCT00844844|12208185|FG000|Extension Treatment Period|Adverse Event|2
7765940|NCT00844844|12208185|FG000|Post Treatment Period|Withdrawal by Subject|1
7626017|NCT02519348|12037973|FG000|Overall Study|Death|31
7626018|NCT02519348|12037974|FG001|Overall Study|Death|74
7626019|NCT02519348|12037975|FG002|Overall Study|Death|47
7626020|NCT02519348|12037976|FG003|Overall Study|Death|54
7626021|NCT02519348|12037977|FG004|Overall Study|Death|63
7626022|NCT02519348|12037978|FG005|Overall Study|Death|18
7626023|NCT02519348|12037979|FG006|Overall Study|Death|2
7626024|NCT02519348|12037980|FG007|Overall Study|Death|5
7626025|NCT02519348|12037981|FG008|Overall Study|Death|5
7626026|NCT02519348|12037973|FG000|Overall Study|Withdrawal by Subject|4
7626027|NCT02519348|12037974|FG001|Overall Study|Withdrawal by Subject|7
7626028|NCT02519348|12037975|FG002|Overall Study|Withdrawal by Subject|4
7626029|NCT02519348|12037976|FG003|Overall Study|Withdrawal by Subject|3
7626030|NCT02519348|12037977|FG004|Overall Study|Withdrawal by Subject|3
7626031|NCT02519348|12037978|FG005|Overall Study|Withdrawal by Subject|2
7626032|NCT02519348|12037979|FG006|Overall Study|Withdrawal by Subject|0
7626033|NCT02519348|12037980|FG007|Overall Study|Withdrawal by Subject|0
7626034|NCT02519348|12037981|FG008|Overall Study|Withdrawal by Subject|1
7626035|NCT02519348|12037973|FG000|Overall Study|Lost to Follow-up|0
7626036|NCT02519348|12037974|FG001|Overall Study|Lost to Follow-up|0
7626037|NCT02519348|12037975|FG002|Overall Study|Lost to Follow-up|1
7626038|NCT02519348|12037976|FG003|Overall Study|Lost to Follow-up|0
7626039|NCT02519348|12037977|FG004|Overall Study|Lost to Follow-up|2
7626040|NCT02519348|12037978|FG005|Overall Study|Lost to Follow-up|1
7626041|NCT02519348|12037979|FG006|Overall Study|Lost to Follow-up|1
7626042|NCT02519348|12037980|FG007|Overall Study|Lost to Follow-up|0
7626043|NCT02519348|12037981|FG008|Overall Study|Lost to Follow-up|0
7626044|NCT02519348|12037973|FG000|Overall Study|Other|0
7626045|NCT02519348|12037974|FG001|Overall Study|Other|3
7626046|NCT02519348|12037975|FG002|Overall Study|Other|0
7626047|NCT02519348|12037976|FG003|Overall Study|Other|0
7626048|NCT02519348|12037977|FG004|Overall Study|Other|1
7626049|NCT02519348|12037978|FG005|Overall Study|Other|0
7626050|NCT02519348|12037979|FG006|Overall Study|Other|0
7626051|NCT02519348|12037980|FG007|Overall Study|Other|0
7626052|NCT02519348|12037981|FG008|Overall Study|Other|0
7626053|NCT02519348|12037973|FG000|Overall Study|Ongoing at the time of data cut-off date|5
7626054|NCT02519348|12037974|FG001|Overall Study|Ongoing at the time of data cut-off date|20
7626055|NCT02519348|12037975|FG002|Overall Study|Ongoing at the time of data cut-off date|23
7626056|NCT02519348|12037976|FG003|Overall Study|Ongoing at the time of data cut-off date|12
7626057|NCT02519348|12037977|FG004|Overall Study|Ongoing at the time of data cut-off date|15
7626058|NCT02519348|12037978|FG005|Overall Study|Ongoing at the time of data cut-off date|26
7626059|NCT02519348|12037979|FG006|Overall Study|Ongoing at the time of data cut-off date|0
7626060|NCT02519348|12037980|FG007|Overall Study|Ongoing at the time of data cut-off date|0
7626061|NCT02519348|12037981|FG008|Overall Study|Ongoing at the time of data cut-off date|0
7586887|NCT00799266|11992533|FG000|Overall Study|Adverse Event|0
7586888|NCT00799266|11992534|FG001|Overall Study|Adverse Event|1
7586889|NCT00799266|11992533|FG000|Overall Study|Subject withdrew consent|3
7586890|NCT00799266|11992534|FG001|Overall Study|Subject withdrew consent|0
7586891|NCT00844480|11992546|FG000|Overall Study|Withdrawal by Subject|2
7586892|NCT00844480|11992547|FG001|Overall Study|Withdrawal by Subject|3
7586893|NCT00873366|11992557|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1
7586894|NCT00873366|11992557|FG000|Overall Study|Off tamoxifen due to side effects|2
7586895|NCT00873366|11992557|FG000|Overall Study|Refused to continue DM-BT testing|3
7586896|NCT00930722|11992593|FG000|Overall Study|Lost to Follow-up|16
7586897|NCT00930722|11992593|FG000|Overall Study|No longer willing to participate|9
7586898|NCT00930722|11992593|FG000|Overall Study|Study terminated by sponsor|2
7586899|NCT00940498|11992605|FG000|Overall Study|Death|2
7586900|NCT00940498|11992606|FG001|Overall Study|Death|0
7586901|NCT00940498|11992607|FG002|Overall Study|Death|0
7586902|NCT00940498|11992608|FG003|Overall Study|Death|1
7586903|NCT00940498|11992609|FG004|Overall Study|Death|5
7586904|NCT00940498|11992610|FG005|Overall Study|Death|0
7586905|NCT00940498|11992611|FG006|Overall Study|Death|1
7586906|NCT00940498|11992612|FG007|Overall Study|Death|0
7586907|NCT00940498|11992605|FG000|Overall Study|Lost to Follow-up|1
7586908|NCT00940498|11992606|FG001|Overall Study|Lost to Follow-up|1
7586909|NCT00940498|11992607|FG002|Overall Study|Lost to Follow-up|2
7586910|NCT00940498|11992608|FG003|Overall Study|Lost to Follow-up|0
7586911|NCT00940498|11992609|FG004|Overall Study|Lost to Follow-up|1
7586912|NCT00940498|11992610|FG005|Overall Study|Lost to Follow-up|0
7586913|NCT00940498|11992611|FG006|Overall Study|Lost to Follow-up|0
7586914|NCT00940498|11992612|FG007|Overall Study|Lost to Follow-up|1
7586915|NCT00940498|11992605|FG000|Overall Study|Disease Progression|0
7586916|NCT00940498|11992606|FG001|Overall Study|Disease Progression|0
7586917|NCT00940498|11992607|FG002|Overall Study|Disease Progression|1
7586918|NCT00940498|11992608|FG003|Overall Study|Disease Progression|1
7586919|NCT00940498|11992609|FG004|Overall Study|Disease Progression|0
7586920|NCT00940498|11992610|FG005|Overall Study|Disease Progression|1
7586921|NCT00940498|11992611|FG006|Overall Study|Disease Progression|0
7586922|NCT00940498|11992612|FG007|Overall Study|Disease Progression|0
7586923|NCT00940498|11992605|FG000|Overall Study|Physician Decision|0
7586924|NCT00940498|11992606|FG001|Overall Study|Physician Decision|0
7586925|NCT00940498|11992607|FG002|Overall Study|Physician Decision|0
7586926|NCT00940498|11992608|FG003|Overall Study|Physician Decision|0
7586927|NCT00940498|11992609|FG004|Overall Study|Physician Decision|2
7586928|NCT00940498|11992610|FG005|Overall Study|Physician Decision|0
7586929|NCT00940498|11992611|FG006|Overall Study|Physician Decision|0
7586930|NCT00940498|11992612|FG007|Overall Study|Physician Decision|0
7586931|NCT00940498|11992605|FG000|Overall Study|Not treated due to disease related pain|0
7586932|NCT00940498|11992606|FG001|Overall Study|Not treated due to disease related pain|0
7586933|NCT00940498|11992607|FG002|Overall Study|Not treated due to disease related pain|0
7587061|NCT02711137|11992762|FG000|Overall Study|Physician Decision|1
7586934|NCT00940498|11992608|FG003|Overall Study|Not treated due to disease related pain|0
7586935|NCT00940498|11992609|FG004|Overall Study|Not treated due to disease related pain|1
7586936|NCT00940498|11992610|FG005|Overall Study|Not treated due to disease related pain|0
7586937|NCT00940498|11992611|FG006|Overall Study|Not treated due to disease related pain|0
7586938|NCT00940498|11992612|FG007|Overall Study|Not treated due to disease related pain|0
7626062|NCT02429414|12038004|FG000|Overall Study|Physician Decision|0
7626063|NCT02429414|12038005|FG001|Overall Study|Physician Decision|1
7626064|NCT02258659|12038015|FG000|Overall Study|Withdrawal by Subject|1
7626065|NCT02111850|12038030|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626066|NCT02111850|12038031|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626067|NCT02111850|12038032|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626068|NCT02111850|12038033|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626069|NCT02111850|12038034|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1
7626070|NCT02111850|12038035|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626071|NCT02111850|12038036|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626072|NCT02111850|12038037|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626073|NCT02111850|12038038|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626074|NCT02111850|12038039|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626075|NCT02111850|12038040|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626076|NCT01483027|12038081|FG000|Overall Study|Administrative Reasons|2
7626077|NCT01483027|12038082|FG001|Overall Study|Administrative Reasons|1
7626078|NCT01483027|12038081|FG000|Overall Study|Withdrawal by Subject|21
7626079|NCT01483027|12038082|FG001|Overall Study|Withdrawal by Subject|32
7626080|NCT01483027|12038081|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22
7626081|NCT01483027|12038082|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24
7626082|NCT01483027|12038081|FG000|Overall Study|Lost to Follow-up|1
7626083|NCT01483027|12038082|FG001|Overall Study|Lost to Follow-up|1
7626084|NCT01483027|12038081|FG000|Overall Study|Adverse Event|0
7626085|NCT01483027|12038082|FG001|Overall Study|Adverse Event|1
7626086|NCT01483027|12038081|FG000|Overall Study|Withdrawal by Subject|0
7626087|NCT01483027|12038082|FG001|Overall Study|Withdrawal by Subject|1
7626088|NCT01379781|12038094|FG000|Overall Study|Lost to Follow-up|11
7626089|NCT01379781|12038095|FG001|Overall Study|Lost to Follow-up|8
7765941|NCT00844857|12208191|FG000|Overall Study|Adverse Event|24
7586939|NCT04553913|11992645|FG000|Overall Study|patient's block resolved prior to PACU|1
7586940|NCT04553913|11992645|FG000|Overall Study|did not use the device properly|5
7586941|NCT04009824|11992660|FG000|Overall Study|COVID-19 pandemic restriction/closure|2
7586942|NCT04009824|11992661|FG001|Overall Study|COVID-19 pandemic restriction/closure|3
7586943|NCT04009824|11992662|FG002|Overall Study|COVID-19 pandemic restriction/closure|5
7586944|NCT04009824|11992663|FG003|Overall Study|COVID-19 pandemic restriction/closure|2
7586945|NCT04009824|11992664|FG004|Overall Study|COVID-19 pandemic restriction/closure|3
7586946|NCT03449758|11992686|FG000|Overall Study|Major protocol deviation|1
7586947|NCT03449758|11992686|FG000|Overall Study|Treatment inefficacy|5
7586948|NCT03449758|11992686|FG000|Overall Study|Adverse Event|9
7586949|NCT03449758|11992686|FG000|Overall Study|Consent withdrawal|1
7586950|NCT03449758|11992686|FG000|Overall Study|Other unspecified reason|3
7586951|NCT03222973|11992693|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3
7586952|NCT03222973|11992694|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0
7586953|NCT03222973|11992695|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0
7586954|NCT03222973|11992696|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0
7586955|NCT03222973|11992693|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1
7586956|NCT03222973|11992694|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1
7586957|NCT03222973|11992695|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0
7586958|NCT03222973|11992696|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0
7586959|NCT03222973|11992693|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12
7586960|NCT03222973|11992694|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9
7586961|NCT03222973|11992695|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0
7586962|NCT03222973|11992696|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0
7586963|NCT03222973|11992693|FG000|Part 1 (Week 0 to Week 72)|Death|0
7586964|NCT03222973|11992694|FG001|Part 1 (Week 0 to Week 72)|Death|1
7586965|NCT03222973|11992695|FG002|Part 1 (Week 0 to Week 72)|Death|0
7586966|NCT03222973|11992696|FG003|Part 1 (Week 0 to Week 72)|Death|0
7586967|NCT03222973|11992693|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0
7586968|NCT03222973|11992694|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1
7586969|NCT03222973|11992695|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0
7586970|NCT03222973|11992696|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0
7586971|NCT03222973|11992693|FG000|Part 1 (Week 0 to Week 72)|Other|8
7586972|NCT03222973|11992694|FG001|Part 1 (Week 0 to Week 72)|Other|2
7586973|NCT03222973|11992695|FG002|Part 1 (Week 0 to Week 72)|Other|0
7586974|NCT03222973|11992696|FG003|Part 1 (Week 0 to Week 72)|Other|0
7586975|NCT03222973|11992693|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0
7586976|NCT03222973|11992694|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0
7586977|NCT03222973|11992695|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2
7586978|NCT03222973|11992696|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0
7587062|NCT02711137|11992763|FG001|Overall Study|Physician Decision|0
7586979|NCT03222973|11992693|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0
7586980|NCT03222973|11992694|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0
7586981|NCT03222973|11992695|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10
7586982|NCT03222973|11992696|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11
7586983|NCT03222973|11992693|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0
7586984|NCT03222973|11992694|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0
7586985|NCT03222973|11992695|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2
7586986|NCT03222973|11992696|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1
7586987|NCT03222973|11992693|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0
7586988|NCT03222973|11992694|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0
7586989|NCT03222973|11992695|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2
7586990|NCT03222973|11992696|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1
7586991|NCT03222973|11992693|FG000|Part 2 (Week 73 to Week 168)|Other|0
7586992|NCT03222973|11992694|FG001|Part 2 (Week 73 to Week 168)|Other|0
7586993|NCT03222973|11992695|FG002|Part 2 (Week 73 to Week 168)|Other|84
7586994|NCT03222973|11992696|FG003|Part 2 (Week 73 to Week 168)|Other|100
7586995|NCT03222973|11992693|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0
7586996|NCT03222973|11992694|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0
7586997|NCT03222973|11992695|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1
7586998|NCT03222973|11992696|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0
7586999|NCT03187262|11992706|FG000|Induction|Lack of Efficacy|2
7587000|NCT03187262|11992706|FG000|Induction|Progressive Disease|4
7587001|NCT03187262|11992706|FG000|Consolidation|Progressive Disease|5
7587002|NCT02987959|11992714|FG000|Overall Study|Grantor stopped supply of drugs|6
7587003|NCT02985541|11992718|FG000|Overall Study|Withdrawal by Subject|33
7587004|NCT02985541|11992718|FG000|Overall Study|Lost to Follow-up|26
7587005|NCT02985541|11992718|FG000|Overall Study|Adverse Event|27
7587006|NCT02985541|11992718|FG000|Overall Study|Physician Decision|2
7587007|NCT02985541|11992718|FG000|Overall Study|Pregnancy|2
7587008|NCT02985541|11992718|FG000|Overall Study|Wish for pregnancy|44
7587009|NCT02985541|11992718|FG000|Overall Study|Other reason|5
7587010|NCT02985541|11992718|FG000|Overall Study|Not valid for analysis|2
7587011|NCT02960893|11992724|FG000|Randomization Phase (8-week)|Adverse Event|5
7587012|NCT02960893|11992725|FG001|Randomization Phase (8-week)|Adverse Event|0
7587013|NCT02960893|11992724|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2
7587014|NCT02960893|11992725|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1
7587015|NCT02960893|11992724|FG000|Randomization Phase (8-week)|Reason Not Specified|0
7587016|NCT02960893|11992725|FG001|Randomization Phase (8-week)|Reason Not Specified|1
7587017|NCT02960893|11992724|FG000|Extension Phase (48-week)|Adverse Event|2
7587018|NCT02960893|11992725|FG001|Extension Phase (48-week)|Adverse Event|3
7587019|NCT02960893|11992724|FG000|Extension Phase (48-week)|Withdrawal by Subject|8
7587020|NCT02960893|11992725|FG001|Extension Phase (48-week)|Withdrawal by Subject|8
7587021|NCT02960893|11992724|FG000|Extension Phase (48-week)|Other Reason|2
7587022|NCT02960893|11992725|FG001|Extension Phase (48-week)|Other Reason|1
7587023|NCT02960893|11992724|FG000|Extension Phase (48-week)|Lost to Follow-up|1
7587024|NCT02960893|11992725|FG001|Extension Phase (48-week)|Lost to Follow-up|1
7587025|NCT02960893|11992724|FG000|Extension Phase (48-week)|Sponsors Decision|1
7587026|NCT02960893|11992725|FG001|Extension Phase (48-week)|Sponsors Decision|0
7587027|NCT02940522|11992740|FG000|Overall Study|Lost to Follow-up|1
7587028|NCT02940522|11992741|FG001|Overall Study|Lost to Follow-up|2
7587029|NCT02940522|11992740|FG000|Overall Study|Withdrawal by Subject|1
7587030|NCT02940522|11992741|FG001|Overall Study|Withdrawal by Subject|0
7587031|NCT02711137|11992762|FG000|Overall Study|Death|1
7587032|NCT02711137|11992763|FG001|Overall Study|Death|4
7587033|NCT02711137|11992764|FG002|Overall Study|Death|5
7587034|NCT02711137|11992765|FG003|Overall Study|Death|5
7587035|NCT02711137|11992766|FG004|Overall Study|Death|3
7587036|NCT02711137|11992767|FG005|Overall Study|Death|1
7587037|NCT02711137|11992768|FG006|Overall Study|Death|61
7587038|NCT02711137|11992769|FG007|Overall Study|Death|3
7587039|NCT02711137|11992770|FG008|Overall Study|Death|0
7587040|NCT02711137|11992771|FG009|Overall Study|Death|1
7587041|NCT02711137|11992772|FG010|Overall Study|Death|1
7587042|NCT02711137|11992773|FG011|Overall Study|Death|1
7587043|NCT02711137|11992774|FG012|Overall Study|Death|0
7587044|NCT02711137|11992775|FG013|Overall Study|Death|0
7587045|NCT02711137|11992776|FG014|Overall Study|Death|0
7587046|NCT02711137|11992762|FG000|Overall Study|Study Terminated by Sponsor|0
7587047|NCT02711137|11992763|FG001|Overall Study|Study Terminated by Sponsor|0
7587048|NCT02711137|11992764|FG002|Overall Study|Study Terminated by Sponsor|1
7587049|NCT02711137|11992765|FG003|Overall Study|Study Terminated by Sponsor|0
7587050|NCT02711137|11992766|FG004|Overall Study|Study Terminated by Sponsor|0
7587051|NCT02711137|11992767|FG005|Overall Study|Study Terminated by Sponsor|0
7587052|NCT02711137|11992768|FG006|Overall Study|Study Terminated by Sponsor|1
7587053|NCT02711137|11992769|FG007|Overall Study|Study Terminated by Sponsor|0
7587054|NCT02711137|11992770|FG008|Overall Study|Study Terminated by Sponsor|0
7587055|NCT02711137|11992771|FG009|Overall Study|Study Terminated by Sponsor|0
7587056|NCT02711137|11992772|FG010|Overall Study|Study Terminated by Sponsor|0
7587057|NCT02711137|11992773|FG011|Overall Study|Study Terminated by Sponsor|0
7587058|NCT02711137|11992774|FG012|Overall Study|Study Terminated by Sponsor|0
7587059|NCT02711137|11992775|FG013|Overall Study|Study Terminated by Sponsor|0
7587060|NCT02711137|11992776|FG014|Overall Study|Study Terminated by Sponsor|0
7587063|NCT02711137|11992764|FG002|Overall Study|Physician Decision|2
7587064|NCT02711137|11992765|FG003|Overall Study|Physician Decision|1
7587065|NCT02711137|11992766|FG004|Overall Study|Physician Decision|1
7587066|NCT02711137|11992767|FG005|Overall Study|Physician Decision|0
7587067|NCT02711137|11992768|FG006|Overall Study|Physician Decision|12
7587068|NCT02711137|11992769|FG007|Overall Study|Physician Decision|2
7587069|NCT02711137|11992770|FG008|Overall Study|Physician Decision|1
7587070|NCT02711137|11992771|FG009|Overall Study|Physician Decision|1
7587071|NCT02711137|11992772|FG010|Overall Study|Physician Decision|3
7587072|NCT02711137|11992773|FG011|Overall Study|Physician Decision|2
7587073|NCT02711137|11992774|FG012|Overall Study|Physician Decision|1
7587074|NCT02711137|11992775|FG013|Overall Study|Physician Decision|1
7587075|NCT02711137|11992776|FG014|Overall Study|Physician Decision|2
7587076|NCT02711137|11992762|FG000|Overall Study|Other|0
7587077|NCT02711137|11992763|FG001|Overall Study|Other|1
7587078|NCT02711137|11992764|FG002|Overall Study|Other|0
7587079|NCT02711137|11992765|FG003|Overall Study|Other|0
7587080|NCT02711137|11992766|FG004|Overall Study|Other|0
7587081|NCT02711137|11992767|FG005|Overall Study|Other|0
7587082|NCT02711137|11992768|FG006|Overall Study|Other|3
7587083|NCT02711137|11992769|FG007|Overall Study|Other|0
7587084|NCT02711137|11992770|FG008|Overall Study|Other|0
7587085|NCT02711137|11992771|FG009|Overall Study|Other|0
7587086|NCT02711137|11992772|FG010|Overall Study|Other|0
7587087|NCT02711137|11992773|FG011|Overall Study|Other|0
7587088|NCT02711137|11992774|FG012|Overall Study|Other|0
7587089|NCT02711137|11992775|FG013|Overall Study|Other|0
7587090|NCT02711137|11992776|FG014|Overall Study|Other|1
7587091|NCT02711137|11992762|FG000|Overall Study|Withdrawal by Subject|1
7587092|NCT02711137|11992763|FG001|Overall Study|Withdrawal by Subject|0
7587093|NCT02711137|11992764|FG002|Overall Study|Withdrawal by Subject|0
7587094|NCT02711137|11992765|FG003|Overall Study|Withdrawal by Subject|1
7587095|NCT02711137|11992766|FG004|Overall Study|Withdrawal by Subject|1
7587096|NCT02711137|11992767|FG005|Overall Study|Withdrawal by Subject|0
7587097|NCT02711137|11992768|FG006|Overall Study|Withdrawal by Subject|7
7587098|NCT02711137|11992769|FG007|Overall Study|Withdrawal by Subject|0
7587099|NCT02711137|11992770|FG008|Overall Study|Withdrawal by Subject|0
7587100|NCT02711137|11992771|FG009|Overall Study|Withdrawal by Subject|0
7587101|NCT02711137|11992772|FG010|Overall Study|Withdrawal by Subject|0
7587102|NCT02711137|11992773|FG011|Overall Study|Withdrawal by Subject|0
7587103|NCT02711137|11992774|FG012|Overall Study|Withdrawal by Subject|0
7587104|NCT02711137|11992775|FG013|Overall Study|Withdrawal by Subject|1
7587105|NCT02711137|11992776|FG014|Overall Study|Withdrawal by Subject|0
7587106|NCT02711137|11992762|FG000|Overall Study|Lost to Follow-up|1
7587107|NCT02711137|11992763|FG001|Overall Study|Lost to Follow-up|0
7587108|NCT02711137|11992764|FG002|Overall Study|Lost to Follow-up|0
7587109|NCT02711137|11992765|FG003|Overall Study|Lost to Follow-up|0
7587110|NCT02711137|11992766|FG004|Overall Study|Lost to Follow-up|0
7587111|NCT02711137|11992767|FG005|Overall Study|Lost to Follow-up|0
7587112|NCT02711137|11992768|FG006|Overall Study|Lost to Follow-up|2
7587113|NCT02711137|11992769|FG007|Overall Study|Lost to Follow-up|0
7587114|NCT02711137|11992770|FG008|Overall Study|Lost to Follow-up|0
7587115|NCT02711137|11992771|FG009|Overall Study|Lost to Follow-up|0
7587116|NCT02711137|11992772|FG010|Overall Study|Lost to Follow-up|0
7587117|NCT02711137|11992773|FG011|Overall Study|Lost to Follow-up|0
7587118|NCT02711137|11992774|FG012|Overall Study|Lost to Follow-up|0
7587119|NCT02711137|11992775|FG013|Overall Study|Lost to Follow-up|0
7587120|NCT02711137|11992776|FG014|Overall Study|Lost to Follow-up|0
7765942|NCT00844857|12208192|FG001|Overall Study|Adverse Event|5
7765943|NCT00844857|12208191|FG000|Overall Study|Sponsor Decision|1
7765944|NCT00844857|12208192|FG001|Overall Study|Sponsor Decision|1
7765945|NCT00844857|12208191|FG000|Overall Study|Physician Decision|2
7765946|NCT00844857|12208192|FG001|Overall Study|Physician Decision|0
7765947|NCT00844857|12208191|FG000|Overall Study|Parent/Caregiver Decision|6
7765948|NCT00844857|12208192|FG001|Overall Study|Parent/Caregiver Decision|2
7765949|NCT00844857|12208191|FG000|Overall Study|Withdrawal by Subject|8
7765950|NCT00844857|12208192|FG001|Overall Study|Withdrawal by Subject|7
7765951|NCT00844857|12208191|FG000|Overall Study|Protocol Violation|6
7765952|NCT00844857|12208192|FG001|Overall Study|Protocol Violation|0
7765953|NCT00844857|12208191|FG000|Overall Study|Lack of Efficacy|5
7765954|NCT00844857|12208192|FG001|Overall Study|Lack of Efficacy|5
7765955|NCT00844857|12208191|FG000|Overall Study|Clinical Relapse|0
7765956|NCT00844857|12208192|FG001|Overall Study|Clinical Relapse|1
7765957|NCT00844857|12208191|FG000|Overall Study|Entry Criteria Not Met|0
7765958|NCT00844857|12208192|FG001|Overall Study|Entry Criteria Not Met|1
7765959|NCT00844857|12208191|FG000|Overall Study|Lost to Follow-up|2
7765960|NCT00844857|12208192|FG001|Overall Study|Lost to Follow-up|3
7765961|NCT00844857|12208191|FG000|Overall Study|Did Not Take Study Drug|3
7765962|NCT00844857|12208192|FG001|Overall Study|Did Not Take Study Drug|1
7765963|NCT00844857|12208191|FG000|Overall Study|Good Clinical Practice Violations|21
7765964|NCT00844857|12208192|FG001|Overall Study|Good Clinical Practice Violations|11
7587219|NCT02343120|11992910|FG001|Part 2: Expansion|Lost to Follow-up|0
7765965|NCT00844883|12208201|FG000|Overall Study|Bridged to liver transplant|3
7765966|NCT00844883|12208201|FG000|Overall Study|Bridged to resection|1
7765967|NCT00844896|12208207|FG000|Overall Study|Lost to Follow-up|12
7765968|NCT00844896|12208208|FG001|Overall Study|Lost to Follow-up|16
7765969|NCT00844896|12208207|FG000|Overall Study|Parents did not have time to complete|0
7765970|NCT00844896|12208208|FG001|Overall Study|Parents did not have time to complete|1
7765971|NCT00845065|12208247|FG000|Overall Study|Adverse Event|3
7765972|NCT00845065|12208248|FG001|Overall Study|Adverse Event|23
7765973|NCT00845065|12208247|FG000|Overall Study|Lack of Efficacy|43
7765974|NCT00845065|12208248|FG001|Overall Study|Lack of Efficacy|21
7765975|NCT00845065|12208247|FG000|Overall Study|Non-Medical Reasons|1
7765976|NCT00845065|12208248|FG001|Overall Study|Non-Medical Reasons|11
7765977|NCT00845182|12208268|FG000|Overall Study|Lost to Follow-up|3
7765978|NCT00845182|12208269|FG001|Overall Study|Lost to Follow-up|3
7765979|NCT00845182|12208270|FG002|Overall Study|Lost to Follow-up|4
7765980|NCT00845182|12208268|FG000|Overall Study|Adverse Event|0
7765981|NCT00845182|12208269|FG001|Overall Study|Adverse Event|1
7765982|NCT00845182|12208270|FG002|Overall Study|Adverse Event|1
7765983|NCT00845182|12208268|FG000|Overall Study|Physician Decision|0
7765984|NCT00845182|12208269|FG001|Overall Study|Physician Decision|0
7765985|NCT00845182|12208270|FG002|Overall Study|Physician Decision|1
7765986|NCT00845429|12208294|FG000|Overall Study|Protocol Violation|5
7765987|NCT00845429|12208295|FG001|Overall Study|Protocol Violation|4
7765988|NCT00845429|12208296|FG002|Overall Study|Protocol Violation|7
7765989|NCT00845429|12208294|FG000|Overall Study|Lost to Follow-up|7
7765990|NCT00845429|12208295|FG001|Overall Study|Lost to Follow-up|9
7765991|NCT00845429|12208296|FG002|Overall Study|Lost to Follow-up|10
7765992|NCT00845429|12208294|FG000|Overall Study|Withdrawal by Subject|2
7765993|NCT00845429|12208295|FG001|Overall Study|Withdrawal by Subject|2
7765994|NCT00845429|12208296|FG002|Overall Study|Withdrawal by Subject|2
7765995|NCT00845429|12208294|FG000|Overall Study|Serious adverse event|0
7765996|NCT00845429|12208295|FG001|Overall Study|Serious adverse event|0
7765997|NCT00845429|12208296|FG002|Overall Study|Serious adverse event|1
7765998|NCT00845520|12208325|FG000|Overall Study|Death|1
7765999|NCT00845520|12208326|FG001|Overall Study|Death|2
7766000|NCT00845520|12208327|FG002|Overall Study|Death|0
7766001|NCT00845520|12208325|FG000|Overall Study|Lost to Follow-up|1
7766002|NCT00845520|12208326|FG001|Overall Study|Lost to Follow-up|0
7766003|NCT00845520|12208327|FG002|Overall Study|Lost to Follow-up|0
7587177|NCT02545868|11992874|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
7587178|NCT02545868|11992875|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
7587179|NCT02545868|11992876|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
7587180|NCT02470091|11992891|FG000|Overall Study|Withdrawal by Subject|1
7587181|NCT02470091|11992892|FG001|Overall Study|Withdrawal by Subject|0
7587182|NCT02470091|11992891|FG000|Overall Study|Ineligible|0
7587183|NCT02470091|11992892|FG001|Overall Study|Ineligible|2
7587184|NCT02440425|11992900|FG000|Overall Study|Death likely due to disease progression|1
7587185|NCT02440425|11992900|FG000|Overall Study|Withdrawal by Subject|2
7587186|NCT02440425|11992900|FG000|Overall Study|Adverse Event|1
7587187|NCT02440425|11992900|FG000|Overall Study|Adverse Event/Ineligible|1
7587188|NCT02343120|11992909|FG000|Part 1: Dose Escalation|Sponsor decision|1
7587189|NCT02343120|11992910|FG001|Part 1: Dose Escalation|Sponsor decision|2
7587190|NCT02343120|11992911|FG002|Part 1: Dose Escalation|Sponsor decision|3
7587191|NCT02343120|11992912|FG003|Part 1: Dose Escalation|Sponsor decision|2
7587192|NCT02343120|11992913|FG004|Part 1: Dose Escalation|Sponsor decision|0
7587193|NCT02343120|11992909|FG000|Part 1: Dose Escalation|Death|1
7587194|NCT02343120|11992910|FG001|Part 1: Dose Escalation|Death|2
7587195|NCT02343120|11992911|FG002|Part 1: Dose Escalation|Death|2
7587196|NCT02343120|11992912|FG003|Part 1: Dose Escalation|Death|2
7587197|NCT02343120|11992913|FG004|Part 1: Dose Escalation|Death|1
7587198|NCT02343120|11992909|FG000|Part 1: Dose Escalation|Lost to Follow-up|1
7587199|NCT02343120|11992910|FG001|Part 1: Dose Escalation|Lost to Follow-up|0
7587200|NCT02343120|11992911|FG002|Part 1: Dose Escalation|Lost to Follow-up|0
7587201|NCT02343120|11992912|FG003|Part 1: Dose Escalation|Lost to Follow-up|0
7587202|NCT02343120|11992913|FG004|Part 1: Dose Escalation|Lost to Follow-up|0
7587203|NCT02343120|11992909|FG000|Part 2: Expansion|Sponsor decision|0
7587204|NCT02343120|11992910|FG001|Part 2: Expansion|Sponsor decision|0
7587205|NCT02343120|11992911|FG002|Part 2: Expansion|Sponsor decision|0
7587206|NCT02343120|11992912|FG003|Part 2: Expansion|Sponsor decision|165
7587207|NCT02343120|11992913|FG004|Part 2: Expansion|Sponsor decision|67
7587208|NCT02343120|11992909|FG000|Part 2: Expansion|Death|0
7587209|NCT02343120|11992910|FG001|Part 2: Expansion|Death|0
7587210|NCT02343120|11992911|FG002|Part 2: Expansion|Death|0
7587211|NCT02343120|11992912|FG003|Part 2: Expansion|Death|74
7587212|NCT02343120|11992913|FG004|Part 2: Expansion|Death|17
7587213|NCT02343120|11992909|FG000|Part 2: Expansion|Withdrawal by Subject|0
7587214|NCT02343120|11992910|FG001|Part 2: Expansion|Withdrawal by Subject|0
7587215|NCT02343120|11992911|FG002|Part 2: Expansion|Withdrawal by Subject|0
7587216|NCT02343120|11992912|FG003|Part 2: Expansion|Withdrawal by Subject|28
7587217|NCT02343120|11992913|FG004|Part 2: Expansion|Withdrawal by Subject|2
7587218|NCT02343120|11992909|FG000|Part 2: Expansion|Lost to Follow-up|0
7766004|NCT00845520|12208325|FG000|Overall Study|Adverse Event|0
7766005|NCT00845520|12208326|FG001|Overall Study|Adverse Event|0
7766006|NCT00845520|12208327|FG002|Overall Study|Adverse Event|1
7766007|NCT00845650|12208347|FG000|Overall Study|Withdrawal by Subject|0
7766008|NCT00845650|12208348|FG001|Overall Study|Withdrawal by Subject|0
7766009|NCT00845650|12208349|FG002|Overall Study|Withdrawal by Subject|0
7766010|NCT00845650|12208350|FG003|Overall Study|Withdrawal by Subject|0
7766011|NCT00845650|12208351|FG004|Overall Study|Withdrawal by Subject|2
7766012|NCT00845650|12208352|FG005|Overall Study|Withdrawal by Subject|0
7587220|NCT02343120|11992911|FG002|Part 2: Expansion|Lost to Follow-up|0
7587221|NCT02343120|11992912|FG003|Part 2: Expansion|Lost to Follow-up|5
7587222|NCT02343120|11992913|FG004|Part 2: Expansion|Lost to Follow-up|2
7587223|NCT02343120|11992909|FG000|Part 2: Expansion|Other|0
7587224|NCT02343120|11992910|FG001|Part 2: Expansion|Other|0
7587225|NCT02343120|11992911|FG002|Part 2: Expansion|Other|0
7587226|NCT02343120|11992912|FG003|Part 2: Expansion|Other|1
7587227|NCT02343120|11992913|FG004|Part 2: Expansion|Other|5
7587228|NCT02343120|11992909|FG000|Part 2: Expansion|Adverse Event|0
7587229|NCT02343120|11992910|FG001|Part 2: Expansion|Adverse Event|0
7587230|NCT02343120|11992911|FG002|Part 2: Expansion|Adverse Event|0
7587231|NCT02343120|11992912|FG003|Part 2: Expansion|Adverse Event|1
7587232|NCT02343120|11992913|FG004|Part 2: Expansion|Adverse Event|1
7766013|NCT00845650|12208347|FG000|Overall Study|Lost to Follow-up|0
7766014|NCT00845650|12208348|FG001|Overall Study|Lost to Follow-up|0
7766015|NCT00845650|12208349|FG002|Overall Study|Lost to Follow-up|3
7766016|NCT00845650|12208350|FG003|Overall Study|Lost to Follow-up|1
7766017|NCT00845650|12208351|FG004|Overall Study|Lost to Follow-up|0
7766018|NCT00845650|12208352|FG005|Overall Study|Lost to Follow-up|1
7766019|NCT00845650|12208347|FG000|Overall Study|Sponsor hold on dosing|0
7766020|NCT00845650|12208348|FG001|Overall Study|Sponsor hold on dosing|0
7766021|NCT00845650|12208349|FG002|Overall Study|Sponsor hold on dosing|0
7766022|NCT00845650|12208350|FG003|Overall Study|Sponsor hold on dosing|0
7766023|NCT00845650|12208351|FG004|Overall Study|Sponsor hold on dosing|1
7766024|NCT00845650|12208352|FG005|Overall Study|Sponsor hold on dosing|1
7766025|NCT00845650|12208347|FG000|Overall Study|Unable to access IV line|1
7766026|NCT00845650|12208348|FG001|Overall Study|Unable to access IV line|0
7766027|NCT00845650|12208349|FG002|Overall Study|Unable to access IV line|0
7766028|NCT00845650|12208350|FG003|Overall Study|Unable to access IV line|0
7766029|NCT00845650|12208351|FG004|Overall Study|Unable to access IV line|0
7766030|NCT00845650|12208352|FG005|Overall Study|Unable to access IV line|0
7766031|NCT00845676|12208377|FG000|Overall Study|Virologic breakthrough at week 20|1
7766032|NCT00845676|12208377|FG000|Overall Study|Adverse Event|1
7766033|NCT00845728|12208384|FG000|Overall Study|Abnormal laboratory value (s)|2
7766034|NCT00845728|12208385|FG001|Overall Study|Abnormal laboratory value (s)|2
7766035|NCT00845728|12208384|FG000|Overall Study|Patient's inability to use the device|4
7766036|NCT00845728|12208385|FG001|Overall Study|Patient's inability to use the device|6
7766037|NCT00845728|12208384|FG000|Overall Study|Abnormal test procedure result (s)|7
7766038|NCT00845728|12208385|FG001|Overall Study|Abnormal test procedure result (s)|2
7766039|NCT00845728|12208384|FG000|Overall Study|Lost to Follow-up|22
7766040|NCT00845728|12208385|FG001|Overall Study|Lost to Follow-up|13
7766041|NCT00845728|12208384|FG000|Overall Study|Death|24
7766042|NCT00845728|12208385|FG001|Overall Study|Death|26
7766043|NCT00845728|12208384|FG000|Overall Study|Administrative Problems|34
7766044|NCT00845728|12208385|FG001|Overall Study|Administrative Problems|26
7766045|NCT00845728|12208384|FG000|Overall Study|Protocol Violation|36
7766046|NCT00845728|12208385|FG001|Overall Study|Protocol Violation|24
7766047|NCT00845728|12208384|FG000|Overall Study|Lack of Efficacy|51
7766048|NCT00845728|12208385|FG001|Overall Study|Lack of Efficacy|39
7766049|NCT00845728|12208384|FG000|Overall Study|Adverse Event|101
7766050|NCT00845728|12208385|FG001|Overall Study|Adverse Event|96
7766051|NCT00845728|12208384|FG000|Overall Study|Withdrawal by Subject|105
7766052|NCT00845728|12208385|FG001|Overall Study|Withdrawal by Subject|108
7766053|NCT00845832|12208394|FG000|Treatment Period|Adverse Event|0
7766054|NCT00845832|12208395|FG001|Treatment Period|Adverse Event|2
7766055|NCT00845832|12208396|FG002|Treatment Period|Adverse Event|0
7766056|NCT00845832|12208394|FG000|Treatment Period|Protocol Violation|1
7766057|NCT00845832|12208395|FG001|Treatment Period|Protocol Violation|1
7766058|NCT00845832|12208396|FG002|Treatment Period|Protocol Violation|0
7766059|NCT00845832|12208394|FG000|Safety Follow-Up|Withdrawal by Subject|1
7766060|NCT00845832|12208395|FG001|Safety Follow-Up|Withdrawal by Subject|0
7766061|NCT00845832|12208396|FG002|Safety Follow-Up|Withdrawal by Subject|0
7766062|NCT00845832|12208394|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0
7766063|NCT00845832|12208395|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0
7766064|NCT00845832|12208396|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7
7766065|NCT00845858|12208407|FG000|Overall Study|Withdrawal by Subject|5
7766066|NCT00845858|12208408|FG001|Overall Study|Withdrawal by Subject|1
7766067|NCT00845858|12208409|FG002|Overall Study|Withdrawal by Subject|1
7766068|NCT00845858|12208407|FG000|Overall Study|Adverse Event|3
7766069|NCT00845858|12208408|FG001|Overall Study|Adverse Event|8
7766070|NCT00845858|12208409|FG002|Overall Study|Adverse Event|4
7766071|NCT00845858|12208407|FG000|Overall Study|Protocol Violation|0
7766072|NCT00845858|12208408|FG001|Overall Study|Protocol Violation|0
7766073|NCT00845858|12208409|FG002|Overall Study|Protocol Violation|1
7766074|NCT00845858|12208407|FG000|Overall Study|not eligible|0
7766075|NCT00845858|12208408|FG001|Overall Study|not eligible|3
7766076|NCT00845858|12208409|FG002|Overall Study|not eligible|2
7766077|NCT00845871|12208420|FG000|Assessment Period|Adverse Event|2
7766078|NCT00845871|12208420|FG000|Assessment Period|Abnormal laboratory values|1
7766079|NCT00845871|12208420|FG000|Assessment Period|Abnormal test procedure results|1
7766080|NCT00845871|12208420|FG000|Assessment Period|Patient withdrew consent|3
7766081|NCT00845897|12208447|FG000|Overall Study|Lost to Follow-up|1
7766082|NCT00845897|12208448|FG001|Overall Study|Lost to Follow-up|1
7766083|NCT00845897|12208449|FG002|Overall Study|Lost to Follow-up|0
7766084|NCT00845897|12208447|FG000|Overall Study|Withdrawal by Subject|0
7766085|NCT00845897|12208448|FG001|Overall Study|Withdrawal by Subject|3
7766086|NCT00845897|12208449|FG002|Overall Study|Withdrawal by Subject|2
7766087|NCT00845897|12208447|FG000|Overall Study|Ulcer did not heal|1
7766088|NCT00845897|12208448|FG001|Overall Study|Ulcer did not heal|0
7766089|NCT00845897|12208449|FG002|Overall Study|Ulcer did not heal|1
7766090|NCT00845897|12208447|FG000|Overall Study|Too ill to participate|0
7766091|NCT00845897|12208448|FG001|Overall Study|Too ill to participate|1
7766092|NCT00845897|12208449|FG002|Overall Study|Too ill to participate|0
7766093|NCT00846027|12208466|FG000|Overall Study|Death|3
7766094|NCT00846027|12208466|FG000|Overall Study|Disease Progression|30
7766095|NCT00846027|12208466|FG000|Overall Study|Toxicity|12
7766096|NCT00846027|12208466|FG000|Overall Study|Patient Decision|7
7861292|NCT01590758|12349953|FG001|Overall Study|Physician Decision|2
7626090|NCT02513394|12038107|FG000|Overall Study|Withdrawal by Subject|11
7626091|NCT02513394|12038108|FG001|Overall Study|Withdrawal by Subject|23
7626092|NCT02513394|12038107|FG000|Overall Study|Ineligible|1
7626093|NCT02513394|12038108|FG001|Overall Study|Ineligible|0
7626094|NCT02445339|12038143|FG000|Overall Study|Physician Decision|1
7626095|NCT02445339|12038144|FG001|Overall Study|Physician Decision|0
7626096|NCT02445339|12038143|FG000|Overall Study|Lost to Follow-up|11
7626097|NCT02445339|12038144|FG001|Overall Study|Lost to Follow-up|15
7626098|NCT03298867|12038165|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1
7626099|NCT03298867|12038166|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1
7626100|NCT03298867|12038165|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1
7626101|NCT03298867|12038166|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1
7626102|NCT03298867|12038165|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1
7626103|NCT03298867|12038166|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9
7626104|NCT03298867|12038165|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0
7626105|NCT03298867|12038166|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1
7626106|NCT03298867|12038165|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0
7626107|NCT03298867|12038166|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1
7626108|NCT03298867|12038165|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0
7626109|NCT03298867|12038166|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2
7626110|NCT03298867|12038165|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0
7626111|NCT03298867|12038166|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1
7626112|NCT03298867|12038165|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0
7626113|NCT03298867|12038166|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2
7626114|NCT03298867|12038165|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0
7626115|NCT03298867|12038166|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1
7626116|NCT03220581|12038174|FG000|Overall Study|Withdrawal by Subject|0
7626117|NCT03220581|12038175|FG001|Overall Study|Withdrawal by Subject|1
7626118|NCT03220581|12038174|FG000|Overall Study|Lost to Follow-up|3
7626119|NCT03220581|12038175|FG001|Overall Study|Lost to Follow-up|6
7766097|NCT00846027|12208466|FG000|Overall Study|Investigator Discretion|29
7766098|NCT00846027|12208466|FG000|Overall Study|Protocol Violation|2
7766099|NCT00846027|12208466|FG000|Overall Study|Subject Not Treated|7
7766100|NCT00846040|12208473|FG000|Baseline: Days 1-5|Withdrawal by Subject|1
7766101|NCT00846040|12208474|FG001|Baseline: Days 1-5|Withdrawal by Subject|0
7766102|NCT00846040|12208475|FG002|Baseline: Days 1-5|Withdrawal by Subject|0
7766103|NCT00846040|12208473|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0
7766104|NCT00846040|12208474|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2
7766105|NCT00846040|12208475|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0
7766106|NCT00846053|12208486|FG000|Overall Study|Physician Decision|3
7766107|NCT00846053|12208487|FG001|Overall Study|Physician Decision|0
7766108|NCT00846365|12208517|FG000|Overall Study|Adverse Event|20
7766109|NCT00846365|12208518|FG001|Overall Study|Adverse Event|30
7766110|NCT00846365|12208519|FG002|Overall Study|Adverse Event|11
7766111|NCT00846365|12208517|FG000|Overall Study|Protocol Violation|5
7766112|NCT00846365|12208518|FG001|Overall Study|Protocol Violation|4
7766113|NCT00846365|12208519|FG002|Overall Study|Protocol Violation|0
7766114|NCT00846365|12208517|FG000|Overall Study|Lost to Follow-up|8
7766115|NCT00846365|12208518|FG001|Overall Study|Lost to Follow-up|2
7766116|NCT00846365|12208519|FG002|Overall Study|Lost to Follow-up|5
7626140|NCT02768870|12038196|FG000|Overall Study|Not Implanted with Device|2
7626141|NCT02768870|12038196|FG000|Overall Study|Death|1
7626142|NCT02768870|12038196|FG000|Overall Study|Reoperation|4
7626143|NCT02768870|12038196|FG000|Overall Study|On Study|19
7626144|NCT02648698|12038202|FG000|Overall Study|Protocol Violation|1
7626145|NCT02648698|12038203|FG001|Overall Study|Protocol Violation|5
7766117|NCT00846365|12208517|FG000|Overall Study|Withdrawal by Subject|11
7766118|NCT00846365|12208518|FG001|Overall Study|Withdrawal by Subject|11
7766119|NCT00846365|12208519|FG002|Overall Study|Withdrawal by Subject|9
7766120|NCT00846365|12208517|FG000|Overall Study|Pregnancy|1
7626150|NCT02000882|12038213|FG000|Overall Study|Adverse Event|3
7626151|NCT02000882|12038213|FG000|Overall Study|Physician Decision|2
7626152|NCT02000882|12038213|FG000|Overall Study|Withdrawal by Subject|1
7626153|NCT01642004|12038232|FG000|Randomization|Adverse Event unrelated to study drug|1
7766121|NCT00846365|12208518|FG001|Overall Study|Pregnancy|0
7766122|NCT00846365|12208519|FG002|Overall Study|Pregnancy|0
7626154|NCT01642004|12038233|FG001|Randomization|Adverse Event unrelated to study drug|0
7626155|NCT01642004|12038232|FG000|Randomization|Withdrawal by Subject|1
7626156|NCT01642004|12038233|FG001|Randomization|Withdrawal by Subject|6
7626157|NCT01642004|12038232|FG000|Randomization|No longer meets study criteria|2
7626158|NCT01642004|12038233|FG001|Randomization|No longer meets study criteria|2
7626159|NCT01642004|12038232|FG000|Treatment|Disease progression|88
7626160|NCT01642004|12038233|FG001|Treatment|Disease progression|80
7626161|NCT01642004|12038232|FG000|Treatment|Study drug toxicity|5
7587313|NCT01539863|11992995|FG000|Overall Study|Lost to Follow-up|5
7587314|NCT01539863|11992996|FG001|Overall Study|Lost to Follow-up|4
7587315|NCT01439165|11993017|FG000|Overall Study|Protocol Violation|3
7587316|NCT01439165|11993018|FG001|Overall Study|Protocol Violation|0
7587317|NCT01439165|11993017|FG000|Overall Study|Lost to Follow-up|11
7587318|NCT01439165|11993018|FG001|Overall Study|Lost to Follow-up|1
7587319|NCT01439165|11993017|FG000|Overall Study|Withdrawal by Subject|7
7587320|NCT01439165|11993018|FG001|Overall Study|Withdrawal by Subject|1
7587321|NCT01264679|11993024|FG000|Overall Study|Participation in Another Clinical Trial|1
7587322|NCT01264679|11993024|FG000|Overall Study|Physician Decision|1
7587323|NCT01264679|11993024|FG000|Overall Study|Sponsor's Suspension of Dosing|2
7587324|NCT01264679|11993024|FG000|Overall Study|Withdrawal by Subject|1
7587325|NCT01155388|11993031|FG000|Overall Study|Adverse Event|1
7587326|NCT01155388|11993032|FG001|Overall Study|Adverse Event|0
7587327|NCT01137435|11993039|FG000|Overall Study|Lost to Follow-up|24
7587328|NCT01137435|11993039|FG000|Overall Study|Off label usage|4
7587329|NCT01064817|11993056|FG000|Study Completion|Physician Decision|1
7587330|NCT01064817|11993057|FG001|Study Completion|Physician Decision|0
7587331|NCT01064817|11993056|FG000|Study Completion|Withdrawal by Subject|1
7587332|NCT01064817|11993057|FG001|Study Completion|Withdrawal by Subject|0
7587333|NCT01026220|11993063|FG000|Induction|Death|1
7587334|NCT01026220|11993064|FG001|Induction|Death|0
7587335|NCT01026220|11993065|FG002|Induction|Death|0
7587336|NCT01026220|11993063|FG000|Induction|Lack of Efficacy|2
7587337|NCT01026220|11993064|FG001|Induction|Lack of Efficacy|0
7587338|NCT01026220|11993065|FG002|Induction|Lack of Efficacy|0
7587339|NCT01026220|11993063|FG000|Induction|Physician Decision|12
7587340|NCT01026220|11993064|FG001|Induction|Physician Decision|0
7587341|NCT01026220|11993065|FG002|Induction|Physician Decision|0
7587342|NCT01026220|11993063|FG000|Induction|Withdrawal by Subject|9
7587343|NCT01026220|11993064|FG001|Induction|Withdrawal by Subject|0
7587344|NCT01026220|11993065|FG002|Induction|Withdrawal by Subject|0
7587345|NCT01026220|11993063|FG000|Induction|Ineligible|1
7587346|NCT01026220|11993064|FG001|Induction|Ineligible|0
7587347|NCT01026220|11993065|FG002|Induction|Ineligible|0
7587348|NCT01026220|11993063|FG000|Consolidation Maintenance|Death|0
7587349|NCT01026220|11993064|FG001|Consolidation Maintenance|Death|1
7587350|NCT01026220|11993065|FG002|Consolidation Maintenance|Death|0
7587351|NCT01026220|11993063|FG000|Consolidation Maintenance|Lack of Efficacy|0
7587352|NCT01026220|11993064|FG001|Consolidation Maintenance|Lack of Efficacy|1
7587353|NCT01026220|11993065|FG002|Consolidation Maintenance|Lack of Efficacy|1
7587354|NCT01026220|11993063|FG000|Consolidation Maintenance|Physician Decision|0
7587355|NCT01026220|11993064|FG001|Consolidation Maintenance|Physician Decision|2
7587356|NCT01026220|11993065|FG002|Consolidation Maintenance|Physician Decision|7
7587357|NCT01026220|11993063|FG000|Consolidation Maintenance|Withdrawal by Subject|0
7587358|NCT01026220|11993064|FG001|Consolidation Maintenance|Withdrawal by Subject|2
7587359|NCT01026220|11993065|FG002|Consolidation Maintenance|Withdrawal by Subject|6
7587360|NCT00567567|11993087|FG000|Overall Study|Adverse Event|0
7587361|NCT00567567|11993088|FG001|Overall Study|Adverse Event|2
7587362|NCT00567567|11993089|FG002|Overall Study|Adverse Event|5
7587363|NCT00567567|11993087|FG000|Overall Study|Death|8
7587364|NCT00567567|11993088|FG001|Overall Study|Death|1
7587365|NCT00567567|11993089|FG002|Overall Study|Death|5
7587366|NCT00567567|11993087|FG000|Overall Study|Lack of Efficacy|16
7587367|NCT00567567|11993088|FG001|Overall Study|Lack of Efficacy|17
7587368|NCT00567567|11993089|FG002|Overall Study|Lack of Efficacy|48
7587369|NCT00567567|11993087|FG000|Overall Study|Lost to Follow-up|0
7587370|NCT00567567|11993088|FG001|Overall Study|Lost to Follow-up|0
7587371|NCT00567567|11993089|FG002|Overall Study|Lost to Follow-up|1
7587372|NCT00567567|11993087|FG000|Overall Study|Physician Decision|16
7587373|NCT00567567|11993088|FG001|Overall Study|Physician Decision|18
7587374|NCT00567567|11993089|FG002|Overall Study|Physician Decision|84
7587375|NCT00567567|11993087|FG000|Overall Study|Withdrawal by Subject|0
7587376|NCT00567567|11993088|FG001|Overall Study|Withdrawal by Subject|0
7587377|NCT00567567|11993089|FG002|Overall Study|Withdrawal by Subject|2
7587378|NCT00567567|11993087|FG000|Overall Study|Ineligible|4
7587379|NCT00567567|11993088|FG001|Overall Study|Ineligible|0
7587380|NCT00567567|11993089|FG002|Overall Study|Ineligible|9
7587381|NCT00567567|11993087|FG000|Overall Study|Refusal by patient/parent/guardian|9
7587382|NCT00567567|11993088|FG001|Overall Study|Refusal by patient/parent/guardian|16
7587383|NCT00567567|11993089|FG002|Overall Study|Refusal by patient/parent/guardian|122
7587384|NCT00567567|11993087|FG000|Overall Study|Enrolled another COG therapeutic study|99
7587385|NCT00567567|11993088|FG001|Overall Study|Enrolled another COG therapeutic study|80
7587386|NCT00567567|11993089|FG002|Overall Study|Enrolled another COG therapeutic study|0
7587387|NCT00567567|11993087|FG000|Overall Study|Unable adequate stem cell for transplant|0
7587388|NCT00567567|11993088|FG001|Overall Study|Unable adequate stem cell for transplant|0
7587389|NCT00567567|11993089|FG002|Overall Study|Unable adequate stem cell for transplant|2
7587390|NCT00450450|11993101|FG000|Overall Study|Death|1
7587391|NCT00450450|11993102|FG001|Overall Study|Death|3
7587392|NCT00450450|11993101|FG000|Overall Study|Relapse|2
7587393|NCT00450450|11993102|FG001|Overall Study|Relapse|0
7587394|NCT00450450|11993101|FG000|Overall Study|Missing Data|2
7587395|NCT00450450|11993102|FG001|Overall Study|Missing Data|0
7587396|NCT00346164|11993112|FG000|Overall Study|Adverse Event|0
7587397|NCT00346164|11993113|FG001|Overall Study|Adverse Event|0
7587398|NCT00346164|11993114|FG002|Overall Study|Adverse Event|0
7587399|NCT00346164|11993115|FG003|Overall Study|Adverse Event|1
7587400|NCT00346164|11993112|FG000|Overall Study|Lack of Efficacy|0
7587401|NCT00346164|11993113|FG001|Overall Study|Lack of Efficacy|1
7587402|NCT00346164|11993114|FG002|Overall Study|Lack of Efficacy|7
7587403|NCT00346164|11993115|FG003|Overall Study|Lack of Efficacy|25
7587404|NCT00346164|11993112|FG000|Overall Study|Physician Decision|0
7587405|NCT00346164|11993113|FG001|Overall Study|Physician Decision|1
7587406|NCT00346164|11993114|FG002|Overall Study|Physician Decision|2
7587407|NCT00346164|11993115|FG003|Overall Study|Physician Decision|27
7587408|NCT00346164|11993112|FG000|Overall Study|Protocol Violation|6
7587409|NCT00346164|11993113|FG001|Overall Study|Protocol Violation|2
7587410|NCT00346164|11993114|FG002|Overall Study|Protocol Violation|10
7587411|NCT00346164|11993115|FG003|Overall Study|Protocol Violation|4
7587412|NCT00346164|11993112|FG000|Overall Study|Withdrawal by Subject|0
7587413|NCT00346164|11993113|FG001|Overall Study|Withdrawal by Subject|0
7587414|NCT00346164|11993114|FG002|Overall Study|Withdrawal by Subject|2
7587415|NCT00346164|11993115|FG003|Overall Study|Withdrawal by Subject|0
7587416|NCT00346164|11993112|FG000|Overall Study|Ineligible|11
7587417|NCT00346164|11993113|FG001|Overall Study|Ineligible|2
7587418|NCT00346164|11993114|FG002|Overall Study|Ineligible|2
7587419|NCT00346164|11993115|FG003|Overall Study|Ineligible|23
7587420|NCT00346164|11993112|FG000|Overall Study|Refusal of further protocol therapy|0
7587421|NCT00346164|11993113|FG001|Overall Study|Refusal of further protocol therapy|1
7587422|NCT00346164|11993114|FG002|Overall Study|Refusal of further protocol therapy|3
7587423|NCT00346164|11993115|FG003|Overall Study|Refusal of further protocol therapy|15
7587424|NCT00346164|11993112|FG000|Overall Study|Inability to start week 16 tx on time|0
7587425|NCT00346164|11993113|FG001|Overall Study|Inability to start week 16 tx on time|0
7587426|NCT00346164|11993114|FG002|Overall Study|Inability to start week 16 tx on time|0
7587427|NCT00346164|11993115|FG003|Overall Study|Inability to start week 16 tx on time|11
7626162|NCT01642004|12038233|FG001|Treatment|Study drug toxicity|13
7626163|NCT01642004|12038232|FG000|Treatment|Death|1
7626164|NCT01642004|12038233|FG001|Treatment|Death|0
7626165|NCT01642004|12038232|FG000|Treatment|Adverse event unrelated to study drug|6
7626166|NCT01642004|12038233|FG001|Treatment|Adverse event unrelated to study drug|13
7626167|NCT01642004|12038232|FG000|Treatment|Withdrawal by Subject|5
7626168|NCT01642004|12038233|FG001|Treatment|Withdrawal by Subject|9
7626169|NCT01642004|12038232|FG000|Treatment|Maximum clinical benefit|2
7626170|NCT01642004|12038233|FG001|Treatment|Maximum clinical benefit|7
7626171|NCT01642004|12038232|FG000|Treatment|Poor/non-compliance|1
7626172|NCT01642004|12038233|FG001|Treatment|Poor/non-compliance|0
7626173|NCT01642004|12038232|FG000|Treatment|No longer meets study criteria|1
7626174|NCT01642004|12038233|FG001|Treatment|No longer meets study criteria|2
7626175|NCT01642004|12038232|FG000|Treatment|Other|1
7626176|NCT01642004|12038233|FG001|Treatment|Other|2
7626177|NCT01642004|12038232|FG000|Treatment|Missing from data|0
7626178|NCT01642004|12038233|FG001|Treatment|Missing from data|1
7626179|NCT01326104|12038241|FG000|Overall Study|progressed prior to vaccine|0
7626180|NCT01326104|12038242|FG001|Overall Study|progressed prior to vaccine|2
7626181|NCT01326104|12038241|FG000|Overall Study|unable to make vaccine|0
7626182|NCT01326104|12038242|FG001|Overall Study|unable to make vaccine|2
7626183|NCT01244815|12038252|FG000|Overall Study|Not Treated|0
7626184|NCT01244815|12038253|FG001|Overall Study|Not Treated|1
7626185|NCT01244815|12038254|FG002|Overall Study|Not Treated|0
7626186|NCT01244815|12038255|FG003|Overall Study|Not Treated|0
7626187|NCT01244815|12038252|FG000|Overall Study|Adverse Event|4
7626188|NCT01244815|12038253|FG001|Overall Study|Adverse Event|7
7626189|NCT01244815|12038254|FG002|Overall Study|Adverse Event|5
7626190|NCT01244815|12038255|FG003|Overall Study|Adverse Event|5
7626191|NCT01244815|12038252|FG000|Overall Study|Treatment Failure|0
7626192|NCT01244815|12038253|FG001|Overall Study|Treatment Failure|0
7626193|NCT01244815|12038254|FG002|Overall Study|Treatment Failure|0
7626194|NCT01244815|12038255|FG003|Overall Study|Treatment Failure|1
7626195|NCT01244815|12038252|FG000|Overall Study|Lost to Follow-up|3
7626196|NCT01244815|12038253|FG001|Overall Study|Lost to Follow-up|2
7626197|NCT01244815|12038254|FG002|Overall Study|Lost to Follow-up|3
7626198|NCT01244815|12038255|FG003|Overall Study|Lost to Follow-up|2
7626199|NCT01244815|12038252|FG000|Overall Study|Withdrawal by Subject|0
7626200|NCT01244815|12038253|FG001|Overall Study|Withdrawal by Subject|2
7626201|NCT01244815|12038254|FG002|Overall Study|Withdrawal by Subject|0
7626202|NCT01244815|12038255|FG003|Overall Study|Withdrawal by Subject|3
7626203|NCT01244815|12038252|FG000|Overall Study|Protocol Violation|7
7626204|NCT01244815|12038253|FG001|Overall Study|Protocol Violation|4
7626205|NCT01244815|12038254|FG002|Overall Study|Protocol Violation|3
7626206|NCT01244815|12038255|FG003|Overall Study|Protocol Violation|1
7626207|NCT01244815|12038252|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
7626208|NCT01244815|12038253|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
7626209|NCT01244815|12038254|FG002|Overall Study|Did Not Meet Protocol Eligibility|0
7766123|NCT00846365|12208517|FG000|Overall Study|Lack of Efficacy|1
7766124|NCT00846365|12208518|FG001|Overall Study|Lack of Efficacy|1
7766125|NCT00846365|12208519|FG002|Overall Study|Lack of Efficacy|2
7766126|NCT00846365|12208517|FG000|Overall Study|Other|9
7766127|NCT00846365|12208518|FG001|Overall Study|Other|1
7766128|NCT00846365|12208519|FG002|Overall Study|Other|6
7766129|NCT00846391|12208530|FG000|Overall Study|Physician Decision|0
7766130|NCT00846391|12208531|FG001|Overall Study|Physician Decision|0
7766131|NCT00846391|12208532|FG002|Overall Study|Physician Decision|1
7766132|NCT00846391|12208530|FG000|Overall Study|Study Terminated by Sponsor|1
7766133|NCT00846391|12208531|FG001|Overall Study|Study Terminated by Sponsor|2
7766134|NCT00846391|12208532|FG002|Overall Study|Study Terminated by Sponsor|2
7766135|NCT00846495|12208547|FG000|Overall Study|Lost to Follow-up|1
7766136|NCT00846495|12208548|FG001|Overall Study|Lost to Follow-up|0
7766137|NCT00846495|12208547|FG000|Overall Study|Adverse Event|5
7766138|NCT00846495|12208548|FG001|Overall Study|Adverse Event|1
7766139|NCT00846495|12208547|FG000|Overall Study|Lack of Efficacy|1
7766140|NCT00846495|12208548|FG001|Overall Study|Lack of Efficacy|2
7766141|NCT00846495|12208547|FG000|Overall Study|Physician Decision|1
7766142|NCT00846495|12208548|FG001|Overall Study|Physician Decision|0
7766143|NCT00846521|12208554|FG000|Overall Study|Withdrawal by Subject|5
7766144|NCT00846521|12208554|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5
7766145|NCT00846521|12208554|FG000|Overall Study|Protocol Violation|1
7766146|NCT00846586|12208578|FG000|Overall Study|Adverse Event|20
7766147|NCT00846586|12208579|FG001|Overall Study|Adverse Event|10
7766148|NCT00846586|12208578|FG000|Overall Study|Subject withdrew consent|8
7766149|NCT00846586|12208579|FG001|Overall Study|Subject withdrew consent|10
7766150|NCT00846586|12208578|FG000|Overall Study|Administrative problems|5
7587456|NCT04360187|11993176|FG000|Double-Blind Treatment|Adverse Event|9
7587457|NCT04360187|11993177|FG001|Double-Blind Treatment|Adverse Event|11
7587458|NCT04360187|11993176|FG000|Double-Blind Treatment|Lack of Efficacy|7
7587459|NCT04360187|11993177|FG001|Double-Blind Treatment|Lack of Efficacy|2
7587460|NCT04360187|11993176|FG000|Double-Blind Treatment|Physician Decision|1
7587461|NCT04360187|11993177|FG001|Double-Blind Treatment|Physician Decision|0
7587462|NCT04360187|11993176|FG000|Double-Blind Treatment|Withdrawal by Subject|4
7587463|NCT04360187|11993177|FG001|Double-Blind Treatment|Withdrawal by Subject|2
7587464|NCT04360187|11993176|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2
7587465|NCT04360187|11993177|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0
7587466|NCT04360187|11993176|FG000|Follow-Up|Lost to Follow-up|1
7587467|NCT04360187|11993177|FG001|Follow-Up|Lost to Follow-up|0
7766151|NCT00846586|12208579|FG001|Overall Study|Administrative problems|4
7766152|NCT00846586|12208578|FG000|Overall Study|Death|2
7766153|NCT00846586|12208579|FG001|Overall Study|Death|0
7766154|NCT00846586|12208578|FG000|Overall Study|Protocol deviation|2
7766155|NCT00846586|12208579|FG001|Overall Study|Protocol deviation|6
7766156|NCT00846586|12208578|FG000|Overall Study|Abnormal test procedure result(s)|1
7766157|NCT00846586|12208579|FG001|Overall Study|Abnormal test procedure result(s)|0
7766158|NCT00846586|12208578|FG000|Overall Study|Lost to Follow-up|1
7587476|NCT03978091|11993201|FG000|Overall Study|Lost to Follow-up|0
7587477|NCT03978091|11993202|FG001|Overall Study|Lost to Follow-up|0
7587478|NCT03978091|11993203|FG002|Overall Study|Lost to Follow-up|1
7587479|NCT03978091|11993204|FG003|Overall Study|Lost to Follow-up|0
7587480|NCT03978091|11993205|FG004|Overall Study|Lost to Follow-up|0
7587481|NCT03978091|11993206|FG005|Overall Study|Lost to Follow-up|0
7587482|NCT03978091|11993201|FG000|Overall Study|Withdrawal by Subject|0
7587483|NCT03978091|11993202|FG001|Overall Study|Withdrawal by Subject|0
7587484|NCT03978091|11993203|FG002|Overall Study|Withdrawal by Subject|0
7587485|NCT03978091|11993204|FG003|Overall Study|Withdrawal by Subject|1
7587486|NCT03978091|11993205|FG004|Overall Study|Withdrawal by Subject|1
7587487|NCT03978091|11993206|FG005|Overall Study|Withdrawal by Subject|0
7587488|NCT03853291|11993230|FG000|Overall Study|Lost to Follow-up|1
7587489|NCT03853291|11993231|FG001|Overall Study|Lost to Follow-up|2
7587490|NCT03853291|11993232|FG002|Overall Study|Lost to Follow-up|0
7587491|NCT03853291|11993233|FG003|Overall Study|Lost to Follow-up|0
7587492|NCT03853291|11993234|FG004|Overall Study|Lost to Follow-up|0
7587493|NCT03853291|11993235|FG005|Overall Study|Lost to Follow-up|0
7587494|NCT03853291|11993230|FG000|Overall Study|Determined to be ineligible|1
7587495|NCT03853291|11993231|FG001|Overall Study|Determined to be ineligible|1
7587496|NCT03853291|11993232|FG002|Overall Study|Determined to be ineligible|0
7587497|NCT03853291|11993233|FG003|Overall Study|Determined to be ineligible|0
7587498|NCT03853291|11993234|FG004|Overall Study|Determined to be ineligible|0
7587499|NCT03853291|11993235|FG005|Overall Study|Determined to be ineligible|0
7766159|NCT00846586|12208579|FG001|Overall Study|Lost to Follow-up|4
7766160|NCT00846586|12208578|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7766161|NCT00846586|12208579|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7766162|NCT00846768|12208596|FG000|Overall Study|Adverse Event|0
7766163|NCT00846768|12208597|FG001|Overall Study|Adverse Event|1
7766164|NCT00846768|12208598|FG002|Overall Study|Adverse Event|0
7766165|NCT00846768|12208599|FG003|Overall Study|Adverse Event|0
7766166|NCT00846807|12208609|FG000|Overall Study|Adverse Event|270
7766167|NCT00846807|12208609|FG000|Overall Study|Lost to Follow-up|94
7766168|NCT00846807|12208609|FG000|Overall Study|Withdrawal by Subject|56
7766169|NCT00846807|12208609|FG000|Overall Study|Non compliant with European label|7
7766170|NCT00846807|12208609|FG000|Overall Study|Switch to other anticoagulants|89
7766171|NCT00846807|12208609|FG000|Overall Study|No prescription after hospital discharge|56
7766172|NCT00846807|12208609|FG000|Overall Study|Other|60
7766173|NCT00846846|12208613|FG000|Overall Study|Death|56
7766174|NCT00846846|12208613|FG000|Overall Study|Withdrawal by Subject|19
7766175|NCT00847015|12208617|FG000|Overall Study|Withdrawal by Subject|1
7766176|NCT00847015|12208617|FG000|Overall Study|declined any surgery|1
7766177|NCT00847015|12208617|FG000|Overall Study|partial cystectomy vs radical cystectomy|1
7766178|NCT00847132|12208623|FG000|Overall Study|Death|1
7766179|NCT00847132|12208624|FG001|Overall Study|Death|1
7766180|NCT00847145|12208638|FG000|Overall Study|AE or Death|0
7766181|NCT00847145|12208639|FG001|Overall Study|AE or Death|1
7766182|NCT00847145|12208640|FG002|Overall Study|AE or Death|1
7766183|NCT00847145|12208641|FG003|Overall Study|AE or Death|0
7766184|NCT00847145|12208642|FG004|Overall Study|AE or Death|0
7766185|NCT00847145|12208643|FG005|Overall Study|AE or Death|0
7766186|NCT00847145|12208644|FG006|Overall Study|AE or Death|0
7766187|NCT00847145|12208645|FG007|Overall Study|AE or Death|0
7766188|NCT00847145|12208638|FG000|Overall Study|Withdrawal by Subject|3
7766189|NCT00847145|12208639|FG001|Overall Study|Withdrawal by Subject|4
7766190|NCT00847145|12208640|FG002|Overall Study|Withdrawal by Subject|6
7766191|NCT00847145|12208641|FG003|Overall Study|Withdrawal by Subject|1
7766192|NCT00847145|12208642|FG004|Overall Study|Withdrawal by Subject|0
7766193|NCT00847145|12208643|FG005|Overall Study|Withdrawal by Subject|0
7766194|NCT00847145|12208644|FG006|Overall Study|Withdrawal by Subject|1
7766195|NCT00847145|12208645|FG007|Overall Study|Withdrawal by Subject|1
7766196|NCT00847145|12208638|FG000|Overall Study|Lost to Follow-up|3
7766197|NCT00847145|12208639|FG001|Overall Study|Lost to Follow-up|1
7766198|NCT00847145|12208640|FG002|Overall Study|Lost to Follow-up|1
7766199|NCT00847145|12208641|FG003|Overall Study|Lost to Follow-up|0
7766200|NCT00847145|12208642|FG004|Overall Study|Lost to Follow-up|4
7766201|NCT00847145|12208643|FG005|Overall Study|Lost to Follow-up|4
7766202|NCT00847145|12208644|FG006|Overall Study|Lost to Follow-up|8
7766203|NCT00847145|12208645|FG007|Overall Study|Lost to Follow-up|2
7766204|NCT00847145|12208638|FG000|Overall Study|Inappropriate enrollment|0
7766205|NCT00847145|12208639|FG001|Overall Study|Inappropriate enrollment|0
7766206|NCT00847145|12208640|FG002|Overall Study|Inappropriate enrollment|0
7766207|NCT00847145|12208641|FG003|Overall Study|Inappropriate enrollment|0
7766208|NCT00847145|12208642|FG004|Overall Study|Inappropriate enrollment|1
7766209|NCT00847145|12208643|FG005|Overall Study|Inappropriate enrollment|0
7587551|NCT03120949|11993336|FG000|Overall Study|randomized in error|1
7587552|NCT03120949|11993337|FG001|Overall Study|randomized in error|0
7587553|NCT03120949|11993336|FG000|Overall Study|Death|13
7587554|NCT03120949|11993337|FG001|Overall Study|Death|13
7587555|NCT03120949|11993336|FG000|Overall Study|Lost to Follow-up|23
7587556|NCT03120949|11993337|FG001|Overall Study|Lost to Follow-up|13
7587557|NCT03120949|11993336|FG000|Overall Study|Withdrawal by Subject|139
7587558|NCT03120949|11993337|FG001|Overall Study|Withdrawal by Subject|124
7587559|NCT03120949|11993336|FG000|Overall Study|Covid-19|43
7587560|NCT03120949|11993337|FG001|Overall Study|Covid-19|34
7587561|NCT03120949|11993336|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1
7587562|NCT03120949|11993337|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3
7587563|NCT03120949|11993336|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1
7587564|NCT03120949|11993337|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0
7587565|NCT03120949|11993336|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1
7587566|NCT03120949|11993337|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0
7587567|NCT03120949|11993336|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1
7587568|NCT03120949|11993337|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0
7587569|NCT03120949|11993336|FG000|Overall Study|Site was closed|2
7587570|NCT03120949|11993337|FG001|Overall Study|Site was closed|3
7587571|NCT03120949|11993336|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1
7587572|NCT03120949|11993337|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0
7587573|NCT03120949|11993336|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0
7587574|NCT03120949|11993337|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1
7587575|NCT03120949|11993336|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1
7587576|NCT03120949|11993337|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0
7587577|NCT03120949|11993336|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1
7587578|NCT03120949|11993337|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0
7587579|NCT03120949|11993336|FG000|Overall Study|Other: Adverse Event|0
7587580|NCT03120949|11993337|FG001|Overall Study|Other: Adverse Event|1
7587581|NCT03120949|11993336|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0
7587582|NCT03120949|11993337|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1
7587583|NCT03120949|11993336|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0
7587584|NCT03120949|11993337|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2
7587585|NCT03120949|11993336|FG000|Overall Study|Subject Refusal To Attend Visit|0
7587586|NCT03120949|11993337|FG001|Overall Study|Subject Refusal To Attend Visit|1
7587587|NCT03120949|11993336|FG000|Overall Study|Personal Reasons|0
7587588|NCT03120949|11993337|FG001|Overall Study|Personal Reasons|1
7587589|NCT03120949|11993336|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0
7587590|NCT03120949|11993337|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1
7587591|NCT03120949|11993336|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0
7587592|NCT03120949|11993337|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1
7587593|NCT03120949|11993336|FG000|Overall Study|Compliance With Medication|0
7587594|NCT03120949|11993337|FG001|Overall Study|Compliance With Medication|1
7587595|NCT03120949|11993336|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0
7587596|NCT03120949|11993337|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1
7587597|NCT03120949|11993336|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0
7587598|NCT03120949|11993337|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1
7587599|NCT03120949|11993336|FG000|Overall Study|Study Terminated By Principal Investigator|0
7587600|NCT03120949|11993337|FG001|Overall Study|Study Terminated By Principal Investigator|1
7587601|NCT03077698|11993358|FG000|Progestin Monotherapy|Stable Disease|8
7587602|NCT03077698|11993359|FG001|Progestin Monotherapy|Stable Disease|0
7587603|NCT03077698|11993358|FG000|Progestin Monotherapy|Adverse Event|1
7587604|NCT03077698|11993359|FG001|Progestin Monotherapy|Adverse Event|0
7587605|NCT03077698|11993358|FG000|Progestin Monotherapy|Death|1
7587606|NCT03077698|11993359|FG001|Progestin Monotherapy|Death|0
7587607|NCT03077698|11993358|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0
7587608|NCT03077698|11993359|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2
7587609|NCT03077698|11993358|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6
7587610|NCT03077698|11993359|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5
7587611|NCT03077698|11993358|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0
7587612|NCT03077698|11993359|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2
7587613|NCT03077698|11993358|FG000|Safety Follow Up|Withdrawal by Subject|2
7587614|NCT03077698|11993359|FG001|Safety Follow Up|Withdrawal by Subject|1
7587615|NCT03077698|11993358|FG000|Safety Follow Up|Transfer of care to hospice|1
7587616|NCT03077698|11993359|FG001|Safety Follow Up|Transfer of care to hospice|0
7587617|NCT02911935|11993366|FG000|Overall Study|Lost to Follow-up|5
7587618|NCT02911935|11993367|FG001|Overall Study|Lost to Follow-up|7
7587619|NCT02874742|11993376|FG000|Overall Study|Death|3
7587620|NCT02874742|11993377|FG001|Overall Study|Death|1
7587621|NCT02874742|11993378|FG002|Overall Study|Death|1
7587622|NCT02874742|11993376|FG000|Overall Study|Lost to Follow-up|2
7587623|NCT02874742|11993377|FG001|Overall Study|Lost to Follow-up|0
7587624|NCT02874742|11993378|FG002|Overall Study|Lost to Follow-up|0
7587625|NCT02874742|11993376|FG000|Overall Study|Withdrawal by Subject|8
7587626|NCT02874742|11993377|FG001|Overall Study|Withdrawal by Subject|4
7587627|NCT02874742|11993378|FG002|Overall Study|Withdrawal by Subject|0
7587628|NCT02874742|11993376|FG000|Overall Study|Other|3
7587629|NCT02874742|11993377|FG001|Overall Study|Other|1
7587630|NCT02874742|11993378|FG002|Overall Study|Other|0
7587631|NCT02874742|11993376|FG000|Overall Study|Ongoing|87
7587632|NCT02874742|11993377|FG001|Overall Study|Ongoing|98
7587633|NCT02874742|11993378|FG002|Overall Study|Ongoing|15
7766210|NCT00847145|12208644|FG006|Overall Study|Inappropriate enrollment|0
7766211|NCT00847145|12208645|FG007|Overall Study|Inappropriate enrollment|0
7766212|NCT00847145|12208638|FG000|Overall Study|Protocol Violation|0
7766213|NCT00847145|12208639|FG001|Overall Study|Protocol Violation|0
7766214|NCT00847145|12208640|FG002|Overall Study|Protocol Violation|3
7766215|NCT00847145|12208641|FG003|Overall Study|Protocol Violation|0
7766216|NCT00847145|12208642|FG004|Overall Study|Protocol Violation|1
7766217|NCT00847145|12208643|FG005|Overall Study|Protocol Violation|0
7587642|NCT02557672|11993414|FG000|Overall Study|Withdrawal by Subject|4
7587643|NCT02557672|11993415|FG001|Overall Study|Withdrawal by Subject|2
7587644|NCT02509312|11993423|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5
7587645|NCT02509312|11993424|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3
7587646|NCT02509312|11993423|FG000|Overall Study|Obstetrician refusal|0
7587647|NCT02509312|11993424|FG001|Overall Study|Obstetrician refusal|1
7587648|NCT02509312|11993423|FG000|Overall Study|Patient elected for TOLAC|1
7587649|NCT02509312|11993424|FG001|Overall Study|Patient elected for TOLAC|0
7587650|NCT02509312|11993423|FG000|Overall Study|Cesarean deemed stat|1
7587651|NCT02509312|11993424|FG001|Overall Study|Cesarean deemed stat|0
7587652|NCT02509312|11993423|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0
7587653|NCT02509312|11993424|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1
7626210|NCT01244815|12038255|FG003|Overall Study|Did Not Meet Protocol Eligibility|0
7626211|NCT01142596|12038267|FG000|Overall Study|Withdrawal by Subject|9
7626212|NCT01142596|12038268|FG001|Overall Study|Withdrawal by Subject|35
7626213|NCT01142596|12038267|FG000|Overall Study|Adverse Event|8
7626214|NCT01142596|12038268|FG001|Overall Study|Adverse Event|35
7587654|NCT02360280|11993454|FG000|Overall Study|Withdrawal by Subject|2
7766218|NCT00847145|12208644|FG006|Overall Study|Protocol Violation|0
7587655|NCT02360280|11993455|FG001|Overall Study|Withdrawal by Subject|0
7587656|NCT02360280|11993454|FG000|Overall Study|Adverse Event|0
7587657|NCT02360280|11993455|FG001|Overall Study|Adverse Event|1
7587658|NCT02360280|11993454|FG000|Overall Study|Lost to Follow-up|1
7587659|NCT02360280|11993455|FG001|Overall Study|Lost to Follow-up|0
7587660|NCT02163395|11993461|FG000|Overall Study|Withdrawal by Subject|1
7587661|NCT02163395|11993461|FG000|Overall Study|Lost to Follow-up|3
7587662|NCT02163395|11993461|FG000|Overall Study|Adverse Event|1
7587663|NCT02097134|11993465|FG000|Overall Study|Physician Decision|4
7587664|NCT02097134|11993465|FG000|Overall Study|Non-Protocol Therapy|1
7587665|NCT02097134|11993465|FG000|Overall Study|Progressive Disease|3
7587666|NCT02097134|11993465|FG000|Overall Study|Refusal of Further Protocol Therapy|1
7587667|NCT02096588|11993472|FG000|Overall Study|Lack of Efficacy|2
7587668|NCT02096588|11993473|FG001|Overall Study|Lack of Efficacy|0
7587669|NCT02096588|11993472|FG000|Overall Study|Withdrawal by Subject|0
7587670|NCT02096588|11993473|FG001|Overall Study|Withdrawal by Subject|1
7587671|NCT02053350|11993479|FG000|Overall Study|Withdrawal by Subject|1
7587672|NCT02053350|11993479|FG000|Overall Study|Adverse Event|4
7766219|NCT00847145|12208645|FG007|Overall Study|Protocol Violation|1
7766220|NCT00847197|12208679|FG000|Overall Study|Adverse Event|21
7766221|NCT00847197|12208680|FG001|Overall Study|Adverse Event|3
7766222|NCT00847197|12208679|FG000|Overall Study|Protocol Violation|0
7766223|NCT00847197|12208680|FG001|Overall Study|Protocol Violation|1
7766224|NCT00847197|12208679|FG000|Overall Study|Withdrawal by Subject|3
7766225|NCT00847197|12208680|FG001|Overall Study|Withdrawal by Subject|1
7766226|NCT00847301|12208704|FG000|Overall Study|Adverse Event|35
7766227|NCT00847301|12208704|FG000|Overall Study|Switch to other anticoagulants|16
7766228|NCT00847301|12208704|FG000|Overall Study|Lost to Follow-up|1
7766229|NCT00847301|12208704|FG000|Overall Study|No prescription after hospital discharge|1
7766230|NCT00847301|12208704|FG000|Overall Study|Other reason not defined above|1
7766231|NCT00847379|12208711|FG000|Overall Study|Study terminated by Sponsor|59
7587687|NCT01965704|11993499|FG000|Overall Study|Withdrawal by Subject|2
7587688|NCT01965704|11993500|FG001|Overall Study|Withdrawal by Subject|2
7587689|NCT01965704|11993501|FG002|Overall Study|Withdrawal by Subject|1
7587690|NCT01965704|11993502|FG003|Overall Study|Withdrawal by Subject|1
7587691|NCT01965704|11993499|FG000|Overall Study|Delivered at home|1
7587692|NCT01965704|11993500|FG001|Overall Study|Delivered at home|1
7587693|NCT01965704|11993501|FG002|Overall Study|Delivered at home|0
7587694|NCT01965704|11993502|FG003|Overall Study|Delivered at home|0
7587695|NCT01965704|11993499|FG000|Overall Study|Experienced complications|0
7587696|NCT01965704|11993500|FG001|Overall Study|Experienced complications|0
7587697|NCT01965704|11993501|FG002|Overall Study|Experienced complications|2
7587698|NCT01965704|11993502|FG003|Overall Study|Experienced complications|2
7587699|NCT01965704|11993499|FG000|Overall Study|Adverse Event|0
7587700|NCT01965704|11993500|FG001|Overall Study|Adverse Event|0
7587701|NCT01965704|11993501|FG002|Overall Study|Adverse Event|1
7587702|NCT01965704|11993502|FG003|Overall Study|Adverse Event|1
7587703|NCT01965704|11993499|FG000|Overall Study|Did not meet inclusion criteria|0
7587704|NCT01965704|11993500|FG001|Overall Study|Did not meet inclusion criteria|0
7587705|NCT01965704|11993501|FG002|Overall Study|Did not meet inclusion criteria|1
7587706|NCT01965704|11993502|FG003|Overall Study|Did not meet inclusion criteria|1
7587725|NCT01661881|11993555|FG000|Overall Study|Disease Progression|1
7587726|NCT01621568|11993570|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1
7587727|NCT01621568|11993571|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0
7587728|NCT01621568|11993570|FG000|Week 5-6 No Treatment|Death|1
7587729|NCT01621568|11993571|FG001|Week 5-6 No Treatment|Death|0
7587730|NCT01070069|11993594|FG000|Overall Study|Death|1
7587731|NCT01070069|11993595|FG001|Overall Study|Death|0
7587732|NCT01070069|11993596|FG002|Overall Study|Death|2
7587733|NCT01070069|11993597|FG003|Overall Study|Death|0
7587734|NCT01070069|11993598|FG004|Overall Study|Death|1
7587735|NCT01070069|11993594|FG000|Overall Study|Withdrawal by Subject|1
7587736|NCT01070069|11993595|FG001|Overall Study|Withdrawal by Subject|1
7587737|NCT01070069|11993596|FG002|Overall Study|Withdrawal by Subject|4
7587738|NCT01070069|11993597|FG003|Overall Study|Withdrawal by Subject|0
7587739|NCT01070069|11993598|FG004|Overall Study|Withdrawal by Subject|0
7587740|NCT01070069|11993594|FG000|Overall Study|Lost to Follow-up|4
7587741|NCT01070069|11993595|FG001|Overall Study|Lost to Follow-up|1
7587742|NCT01070069|11993596|FG002|Overall Study|Lost to Follow-up|0
7587743|NCT01070069|11993597|FG003|Overall Study|Lost to Follow-up|0
7587744|NCT01070069|11993598|FG004|Overall Study|Lost to Follow-up|3
7587745|NCT00501046|11993637|FG000|Overall Study|Adverse Event|21
7587746|NCT00501046|11993638|FG001|Overall Study|Adverse Event|25
7587747|NCT00501046|11993637|FG000|Overall Study|Death|23
7587748|NCT00501046|11993638|FG001|Overall Study|Death|30
7587749|NCT00501046|11993637|FG000|Overall Study|Lost to Follow-up|14
7587750|NCT00501046|11993638|FG001|Overall Study|Lost to Follow-up|13
7587751|NCT00501046|11993637|FG000|Overall Study|Physician Decision|7
7587752|NCT00501046|11993638|FG001|Overall Study|Physician Decision|2
7587753|NCT00501046|11993637|FG000|Overall Study|Pregnancy|0
7587754|NCT00501046|11993638|FG001|Overall Study|Pregnancy|3
7587755|NCT00501046|11993637|FG000|Overall Study|Protocol Violation|2
7587756|NCT00501046|11993638|FG001|Overall Study|Protocol Violation|1
7587757|NCT00501046|11993637|FG000|Overall Study|Withdrawal by Subject|84
7587758|NCT00501046|11993638|FG001|Overall Study|Withdrawal by Subject|83
7587759|NCT00501046|11993637|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119
7587760|NCT00501046|11993638|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137
7587761|NCT00500682|11993646|FG000|Overall Study|Adverse Event|37
7587762|NCT00500682|11993647|FG001|Overall Study|Adverse Event|29
7587763|NCT00500682|11993646|FG000|Overall Study|Death|25
7587764|NCT00500682|11993647|FG001|Overall Study|Death|16
7587765|NCT00500682|11993646|FG000|Overall Study|Lost to Follow-up|11
7587766|NCT00500682|11993647|FG001|Overall Study|Lost to Follow-up|11
7587767|NCT00500682|11993646|FG000|Overall Study|Physician Decision|6
7587768|NCT00500682|11993647|FG001|Overall Study|Physician Decision|10
7587769|NCT00500682|11993646|FG000|Overall Study|Pregnancy|2
7587770|NCT00500682|11993647|FG001|Overall Study|Pregnancy|0
7587771|NCT00500682|11993646|FG000|Overall Study|Protocol Violation|1
7587772|NCT00500682|11993647|FG001|Overall Study|Protocol Violation|3
7587773|NCT00500682|11993646|FG000|Overall Study|Withdrawal by Subject|80
7587774|NCT00500682|11993647|FG001|Overall Study|Withdrawal by Subject|74
7587775|NCT00500682|11993646|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144
7587776|NCT00500682|11993647|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144
7587789|NCT00001277|11993667|FG000|Overall Study|Adverse Event|0
7587790|NCT00001277|11993668|FG001|Overall Study|Adverse Event|0
7587791|NCT00001277|11993669|FG002|Overall Study|Adverse Event|1
7587792|NCT00001277|11993667|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0
7587793|NCT00001277|11993668|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0
7587794|NCT00001277|11993669|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2
7626215|NCT01142596|12038267|FG000|Overall Study|Lack of Efficacy|5
7626216|NCT01142596|12038268|FG001|Overall Study|Lack of Efficacy|9
7626217|NCT01142596|12038267|FG000|Overall Study|Lost to Follow-up|2
7626218|NCT01142596|12038268|FG001|Overall Study|Lost to Follow-up|3
7626219|NCT01142596|12038267|FG000|Overall Study|Other reason (not specified)|5
7626220|NCT01142596|12038268|FG001|Overall Study|Other reason (not specified)|4
7626221|NCT01098110|12038277|FG000|Overall Study|Withdrawal by Subject|14
7626222|NCT01098110|12038278|FG001|Overall Study|Withdrawal by Subject|24
7626223|NCT01098110|12038279|FG002|Overall Study|Withdrawal by Subject|19
7626224|NCT01098110|12038277|FG000|Overall Study|Adverse Event|30
7626225|NCT01098110|12038278|FG001|Overall Study|Adverse Event|32
7626226|NCT01098110|12038279|FG002|Overall Study|Adverse Event|43
7626227|NCT01098110|12038277|FG000|Overall Study|Lack of Efficacy|13
7626228|NCT01098110|12038278|FG001|Overall Study|Lack of Efficacy|9
7626229|NCT01098110|12038279|FG002|Overall Study|Lack of Efficacy|27
7626230|NCT01098110|12038277|FG000|Overall Study|Other|4
7626231|NCT01098110|12038278|FG001|Overall Study|Other|7
7626232|NCT01098110|12038279|FG002|Overall Study|Other|5
7626233|NCT01098110|12038277|FG000|Overall Study|Untreated|1
7626234|NCT01098110|12038278|FG001|Overall Study|Untreated|1
7626235|NCT01098110|12038279|FG002|Overall Study|Untreated|0
7626236|NCT01006265|12038291|FG000|Overall Study|Lost to Follow-up|1
7626237|NCT01006265|12038292|FG001|Overall Study|Lost to Follow-up|0
7587795|NCT01009294|11993678|FG000|Overall Study|Study discontinued by Sponsor|6
7587796|NCT01072175|11993703|FG000|Part A (Drug-Drug Interaction)|Death|1
7587797|NCT01072175|11993704|FG001|Part A (Drug-Drug Interaction)|Death|0
7587798|NCT01072175|11993705|FG002|Part A (Drug-Drug Interaction)|Death|0
7587799|NCT01072175|11993706|FG003|Part A (Drug-Drug Interaction)|Death|0
7587800|NCT01072175|11993707|FG004|Part A (Drug-Drug Interaction)|Death|0
7587801|NCT01072175|11993708|FG005|Part A (Drug-Drug Interaction)|Death|0
7587802|NCT01072175|11993709|FG006|Part A (Drug-Drug Interaction)|Death|0
7587803|NCT01072175|11993710|FG007|Part A (Drug-Drug Interaction)|Death|0
7587804|NCT01072175|11993711|FG008|Part A (Drug-Drug Interaction)|Death|0
7587805|NCT01072175|11993712|FG009|Part A (Drug-Drug Interaction)|Death|0
7587806|NCT01072175|11993713|FG010|Part A (Drug-Drug Interaction)|Death|0
7587807|NCT01072175|11993714|FG011|Part A (Drug-Drug Interaction)|Death|0
7587808|NCT01072175|11993715|FG012|Part A (Drug-Drug Interaction)|Death|0
7587809|NCT01072175|11993703|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6
7587810|NCT01072175|11993704|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0
7587811|NCT01072175|11993705|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0
7587812|NCT01072175|11993706|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0
7587813|NCT01072175|11993707|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0
7587814|NCT01072175|11993708|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0
7587815|NCT01072175|11993709|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0
7587816|NCT01072175|11993710|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0
7587817|NCT01072175|11993711|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0
7587818|NCT01072175|11993712|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0
7587819|NCT01072175|11993713|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0
7587820|NCT01072175|11993714|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0
7587821|NCT01072175|11993715|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0
7587822|NCT01072175|11993703|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
7587823|NCT01072175|11993704|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587824|NCT01072175|11993705|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587825|NCT01072175|11993706|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587826|NCT01072175|11993707|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587827|NCT01072175|11993708|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587828|NCT01072175|11993709|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587829|NCT01072175|11993710|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587830|NCT01072175|11993711|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587831|NCT01072175|11993712|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587832|NCT01072175|11993713|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587833|NCT01072175|11993714|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587834|NCT01072175|11993715|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587835|NCT01072175|11993703|FG000|Part B (Dose Escalation and Expansion)|Death|0
7587836|NCT01072175|11993704|FG001|Part B (Dose Escalation and Expansion)|Death|4
7587837|NCT01072175|11993705|FG002|Part B (Dose Escalation and Expansion)|Death|18
7587838|NCT01072175|11993706|FG003|Part B (Dose Escalation and Expansion)|Death|21
7587839|NCT01072175|11993707|FG004|Part B (Dose Escalation and Expansion)|Death|68
7766232|NCT00847379|12208712|FG001|Overall Study|Study terminated by Sponsor|57
7587840|NCT01072175|11993708|FG005|Part B (Dose Escalation and Expansion)|Death|0
7587841|NCT01072175|11993709|FG006|Part B (Dose Escalation and Expansion)|Death|0
7587842|NCT01072175|11993710|FG007|Part B (Dose Escalation and Expansion)|Death|0
7587843|NCT01072175|11993711|FG008|Part B (Dose Escalation and Expansion)|Death|0
7587844|NCT01072175|11993712|FG009|Part B (Dose Escalation and Expansion)|Death|0
7587845|NCT01072175|11993713|FG010|Part B (Dose Escalation and Expansion)|Death|0
7587846|NCT01072175|11993714|FG011|Part B (Dose Escalation and Expansion)|Death|0
7587847|NCT01072175|11993715|FG012|Part B (Dose Escalation and Expansion)|Death|0
7587848|NCT01072175|11993703|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587849|NCT01072175|11993704|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587850|NCT01072175|11993705|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2
7587851|NCT01072175|11993706|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587852|NCT01072175|11993707|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4
7587853|NCT01072175|11993708|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587854|NCT01072175|11993709|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587855|NCT01072175|11993710|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587856|NCT01072175|11993711|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587857|NCT01072175|11993712|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587858|NCT01072175|11993713|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587859|NCT01072175|11993714|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587860|NCT01072175|11993715|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587861|NCT01072175|11993703|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587862|NCT01072175|11993704|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
7587863|NCT01072175|11993705|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587864|NCT01072175|11993706|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
7587865|NCT01072175|11993707|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6
7587866|NCT01072175|11993708|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587867|NCT01072175|11993709|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587868|NCT01072175|11993710|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587869|NCT01072175|11993711|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587870|NCT01072175|11993712|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587871|NCT01072175|11993713|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7766233|NCT00847379|12208713|FG002|Overall Study|Study terminated by Sponsor|57
7766234|NCT00847535|12208727|FG000|Overall Study|Withdrawal by Subject|2
7766235|NCT00847535|12208728|FG001|Overall Study|Withdrawal by Subject|1
7766236|NCT00847535|12208729|FG002|Overall Study|Withdrawal by Subject|1
7766237|NCT00847535|12208727|FG000|Overall Study|Lost to Follow-up|0
7587872|NCT01072175|11993714|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7626238|NCT01006265|12038293|FG002|Overall Study|Lost to Follow-up|1
7626239|NCT01006265|12038294|FG003|Overall Study|Lost to Follow-up|0
7626240|NCT01006265|12038291|FG000|Overall Study|Withdrawal by Subject|4
7626241|NCT01006265|12038292|FG001|Overall Study|Withdrawal by Subject|7
7626242|NCT01006265|12038293|FG002|Overall Study|Withdrawal by Subject|5
7626243|NCT01006265|12038294|FG003|Overall Study|Withdrawal by Subject|5
7626244|NCT01006265|12038291|FG000|Overall Study|Administrative reason|1
7626245|NCT01006265|12038292|FG001|Overall Study|Administrative reason|2
7626246|NCT01006265|12038293|FG002|Overall Study|Administrative reason|3
7626247|NCT01006265|12038294|FG003|Overall Study|Administrative reason|0
7626248|NCT00534976|12038316|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
7626249|NCT00534976|12038317|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
7626250|NCT00534976|12038316|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
7626251|NCT00534976|12038317|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
7626252|NCT00534976|12038316|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
7626253|NCT00534976|12038317|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
7626254|NCT00337675|12038326|FG000|Overall Study|Adverse Event|10
7626255|NCT00337675|12038327|FG001|Overall Study|Adverse Event|9
7626256|NCT00337675|12038328|FG002|Overall Study|Adverse Event|19
7626257|NCT00337675|12038326|FG000|Overall Study|Lack of Efficacy|10
7626258|NCT00337675|12038327|FG001|Overall Study|Lack of Efficacy|7
7626259|NCT00337675|12038328|FG002|Overall Study|Lack of Efficacy|9
7626260|NCT00337675|12038326|FG000|Overall Study|Lost to Follow-up|22
7626261|NCT00337675|12038327|FG001|Overall Study|Lost to Follow-up|19
7626262|NCT00337675|12038328|FG002|Overall Study|Lost to Follow-up|17
7626263|NCT00337675|12038326|FG000|Overall Study|Physician Decision|9
7626264|NCT00337675|12038327|FG001|Overall Study|Physician Decision|17
7626265|NCT00337675|12038328|FG002|Overall Study|Physician Decision|14
7626266|NCT00337675|12038326|FG000|Overall Study|Protocol Violation|21
7626267|NCT00337675|12038327|FG001|Overall Study|Protocol Violation|24
7626268|NCT00337675|12038328|FG002|Overall Study|Protocol Violation|19
7626269|NCT00337675|12038326|FG000|Overall Study|Withdrawal by Subject|25
7626270|NCT00337675|12038327|FG001|Overall Study|Withdrawal by Subject|25
7626271|NCT00337675|12038328|FG002|Overall Study|Withdrawal by Subject|19
7626272|NCT00337675|12038326|FG000|Overall Study|Progressive Disease|0
7626273|NCT00337675|12038327|FG001|Overall Study|Progressive Disease|2
7626274|NCT00337675|12038328|FG002|Overall Study|Progressive Disease|0
7626275|NCT00337675|12038326|FG000|Overall Study|Trial Terminated|0
7626276|NCT00337675|12038327|FG001|Overall Study|Trial Terminated|0
7626277|NCT00337675|12038328|FG002|Overall Study|Trial Terminated|2
7626278|NCT00317772|12038340|FG000|Overall Study|Adverse Event|0
7626279|NCT00317772|12038341|FG001|Overall Study|Adverse Event|0
7626280|NCT00317772|12038342|FG002|Overall Study|Adverse Event|0
7626281|NCT00317772|12038343|FG003|Overall Study|Adverse Event|2
7626282|NCT00317772|12038340|FG000|Overall Study|Disease Progression|2
7626283|NCT00317772|12038341|FG001|Overall Study|Disease Progression|2
7626284|NCT00317772|12038342|FG002|Overall Study|Disease Progression|1
7587873|NCT01072175|11993715|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587874|NCT01072175|11993703|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587875|NCT01072175|11993704|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587876|NCT01072175|11993705|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3
7587877|NCT01072175|11993706|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2
7587878|NCT01072175|11993707|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10
7587879|NCT01072175|11993708|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587880|NCT01072175|11993709|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587881|NCT01072175|11993710|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587882|NCT01072175|11993711|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587883|NCT01072175|11993712|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587884|NCT01072175|11993713|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587885|NCT01072175|11993714|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587886|NCT01072175|11993715|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587887|NCT01072175|11993703|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587888|NCT01072175|11993704|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1
7587889|NCT01072175|11993705|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587890|NCT01072175|11993706|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3
7587891|NCT01072175|11993707|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6
7587892|NCT01072175|11993708|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587893|NCT01072175|11993709|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587894|NCT01072175|11993710|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587895|NCT01072175|11993711|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587896|NCT01072175|11993712|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587897|NCT01072175|11993713|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587898|NCT01072175|11993714|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587899|NCT01072175|11993715|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587900|NCT01072175|11993703|FG000|Part C (Phase II: Randomized Phase)|Death|0
7587901|NCT01072175|11993704|FG001|Part C (Phase II: Randomized Phase)|Death|0
7587902|NCT01072175|11993705|FG002|Part C (Phase II: Randomized Phase)|Death|0
7587903|NCT01072175|11993706|FG003|Part C (Phase II: Randomized Phase)|Death|0
7587904|NCT01072175|11993707|FG004|Part C (Phase II: Randomized Phase)|Death|0
7587905|NCT01072175|11993708|FG005|Part C (Phase II: Randomized Phase)|Death|44
7587906|NCT01072175|11993709|FG006|Part C (Phase II: Randomized Phase)|Death|34
7587907|NCT01072175|11993710|FG007|Part C (Phase II: Randomized Phase)|Death|39
7587908|NCT01072175|11993711|FG008|Part C (Phase II: Randomized Phase)|Death|0
7587909|NCT01072175|11993712|FG009|Part C (Phase II: Randomized Phase)|Death|0
7587910|NCT01072175|11993713|FG010|Part C (Phase II: Randomized Phase)|Death|0
7587911|NCT01072175|11993714|FG011|Part C (Phase II: Randomized Phase)|Death|0
7587912|NCT01072175|11993715|FG012|Part C (Phase II: Randomized Phase)|Death|0
7587913|NCT01072175|11993703|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587914|NCT01072175|11993704|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587915|NCT01072175|11993705|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587916|NCT01072175|11993706|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587917|NCT01072175|11993707|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587918|NCT01072175|11993708|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1
7587919|NCT01072175|11993709|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1
7587920|NCT01072175|11993710|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1
7587921|NCT01072175|11993711|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587922|NCT01072175|11993712|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587923|NCT01072175|11993713|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587924|NCT01072175|11993714|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587925|NCT01072175|11993715|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587926|NCT01072175|11993703|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587927|NCT01072175|11993704|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587928|NCT01072175|11993705|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587929|NCT01072175|11993706|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587930|NCT01072175|11993707|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587931|NCT01072175|11993708|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587932|NCT01072175|11993709|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
7587933|NCT01072175|11993710|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
7587934|NCT01072175|11993711|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587935|NCT01072175|11993712|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587936|NCT01072175|11993713|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587937|NCT01072175|11993714|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587938|NCT01072175|11993715|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587939|NCT01072175|11993703|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587940|NCT01072175|11993704|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587941|NCT01072175|11993705|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587942|NCT01072175|11993706|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587943|NCT01072175|11993707|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587944|NCT01072175|11993708|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6
7587945|NCT01072175|11993709|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9
7587946|NCT01072175|11993710|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11
7587947|NCT01072175|11993711|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587948|NCT01072175|11993712|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587949|NCT01072175|11993713|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587950|NCT01072175|11993714|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587951|NCT01072175|11993715|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587952|NCT01072175|11993703|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587953|NCT01072175|11993704|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587954|NCT01072175|11993705|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587955|NCT01072175|11993706|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587956|NCT01072175|11993707|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587957|NCT01072175|11993708|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3
7587958|NCT01072175|11993709|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7
7587959|NCT01072175|11993710|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587960|NCT01072175|11993711|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587961|NCT01072175|11993712|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587962|NCT01072175|11993713|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587963|NCT01072175|11993714|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587964|NCT01072175|11993715|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587965|NCT01072175|11993703|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0
7587966|NCT01072175|11993704|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0
7587967|NCT01072175|11993705|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0
7587968|NCT01072175|11993706|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0
7587969|NCT01072175|11993707|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0
7587970|NCT01072175|11993708|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0
7587971|NCT01072175|11993709|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0
7587972|NCT01072175|11993710|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0
7587973|NCT01072175|11993711|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37
7587974|NCT01072175|11993712|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0
7587975|NCT01072175|11993713|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0
7587976|NCT01072175|11993714|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0
7587977|NCT01072175|11993715|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0
7587978|NCT01072175|11993703|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587979|NCT01072175|11993704|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587980|NCT01072175|11993705|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587981|NCT01072175|11993706|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587982|NCT01072175|11993707|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587983|NCT01072175|11993708|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587984|NCT01072175|11993709|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587985|NCT01072175|11993710|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587986|NCT01072175|11993711|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1
7587987|NCT01072175|11993712|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587988|NCT01072175|11993713|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587989|NCT01072175|11993714|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587990|NCT01072175|11993715|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587991|NCT01072175|11993703|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587992|NCT01072175|11993704|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587993|NCT01072175|11993705|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587994|NCT01072175|11993706|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587995|NCT01072175|11993707|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587996|NCT01072175|11993708|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587997|NCT01072175|11993709|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587998|NCT01072175|11993710|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587999|NCT01072175|11993711|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4
7588000|NCT01072175|11993712|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7588001|NCT01072175|11993713|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7588002|NCT01072175|11993714|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7588003|NCT01072175|11993715|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7588004|NCT01072175|11993703|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588005|NCT01072175|11993704|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588006|NCT01072175|11993705|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588007|NCT01072175|11993706|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588008|NCT01072175|11993707|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588009|NCT01072175|11993708|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588010|NCT01072175|11993709|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588011|NCT01072175|11993710|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588012|NCT01072175|11993711|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3
7588013|NCT01072175|11993712|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588014|NCT01072175|11993713|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588015|NCT01072175|11993714|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588016|NCT01072175|11993715|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588017|NCT01072175|11993703|FG000|Part D (HPMC Capsules)|Death|0
7588018|NCT01072175|11993704|FG001|Part D (HPMC Capsules)|Death|0
7588019|NCT01072175|11993705|FG002|Part D (HPMC Capsules)|Death|0
7588020|NCT01072175|11993706|FG003|Part D (HPMC Capsules)|Death|0
7588021|NCT01072175|11993707|FG004|Part D (HPMC Capsules)|Death|0
7588022|NCT01072175|11993708|FG005|Part D (HPMC Capsules)|Death|0
7588023|NCT01072175|11993709|FG006|Part D (HPMC Capsules)|Death|0
7588024|NCT01072175|11993710|FG007|Part D (HPMC Capsules)|Death|0
7588025|NCT01072175|11993711|FG008|Part D (HPMC Capsules)|Death|0
7588026|NCT01072175|11993712|FG009|Part D (HPMC Capsules)|Death|10
7588027|NCT01072175|11993713|FG010|Part D (HPMC Capsules)|Death|12
7588028|NCT01072175|11993714|FG011|Part D (HPMC Capsules)|Death|28
7588029|NCT01072175|11993715|FG012|Part D (HPMC Capsules)|Death|26
7588030|NCT01072175|11993703|FG000|Part D (HPMC Capsules)|Physician Decision|0
7588031|NCT01072175|11993704|FG001|Part D (HPMC Capsules)|Physician Decision|0
7588032|NCT01072175|11993705|FG002|Part D (HPMC Capsules)|Physician Decision|0
7588033|NCT01072175|11993706|FG003|Part D (HPMC Capsules)|Physician Decision|0
7588034|NCT01072175|11993707|FG004|Part D (HPMC Capsules)|Physician Decision|0
7588035|NCT01072175|11993708|FG005|Part D (HPMC Capsules)|Physician Decision|0
7588036|NCT01072175|11993709|FG006|Part D (HPMC Capsules)|Physician Decision|0
7588037|NCT01072175|11993710|FG007|Part D (HPMC Capsules)|Physician Decision|0
7588038|NCT01072175|11993711|FG008|Part D (HPMC Capsules)|Physician Decision|0
7588039|NCT01072175|11993712|FG009|Part D (HPMC Capsules)|Physician Decision|0
7588040|NCT01072175|11993713|FG010|Part D (HPMC Capsules)|Physician Decision|1
7588041|NCT01072175|11993714|FG011|Part D (HPMC Capsules)|Physician Decision|1
7588042|NCT01072175|11993715|FG012|Part D (HPMC Capsules)|Physician Decision|1
7588043|NCT01072175|11993703|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0
7588044|NCT01072175|11993704|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0
7588045|NCT01072175|11993705|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0
7588046|NCT01072175|11993706|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0
7588047|NCT01072175|11993707|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0
7588048|NCT01072175|11993708|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0
7588049|NCT01072175|11993709|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0
7588050|NCT01072175|11993710|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0
7588051|NCT01072175|11993711|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0
7588052|NCT01072175|11993712|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0
7588053|NCT01072175|11993713|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1
7588054|NCT01072175|11993714|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1
7588055|NCT01072175|11993715|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3
7588056|NCT01072175|11993703|FG000|Part D (HPMC Capsules)|Study closed/terminated|0
7588057|NCT01072175|11993704|FG001|Part D (HPMC Capsules)|Study closed/terminated|0
7588058|NCT01072175|11993705|FG002|Part D (HPMC Capsules)|Study closed/terminated|0
7588059|NCT01072175|11993706|FG003|Part D (HPMC Capsules)|Study closed/terminated|0
7588060|NCT01072175|11993707|FG004|Part D (HPMC Capsules)|Study closed/terminated|0
7588061|NCT01072175|11993708|FG005|Part D (HPMC Capsules)|Study closed/terminated|0
7588062|NCT01072175|11993709|FG006|Part D (HPMC Capsules)|Study closed/terminated|0
7588063|NCT01072175|11993710|FG007|Part D (HPMC Capsules)|Study closed/terminated|0
7588064|NCT01072175|11993711|FG008|Part D (HPMC Capsules)|Study closed/terminated|0
7588065|NCT01072175|11993712|FG009|Part D (HPMC Capsules)|Study closed/terminated|2
7588066|NCT01072175|11993713|FG010|Part D (HPMC Capsules)|Study closed/terminated|1
7588067|NCT01072175|11993714|FG011|Part D (HPMC Capsules)|Study closed/terminated|10
7588131|NCT01174563|11993807|FG000|Overall Study|Sponsor's decision|1
7588068|NCT01072175|11993715|FG012|Part D (HPMC Capsules)|Study closed/terminated|9
7588069|NCT01072175|11993703|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588070|NCT01072175|11993704|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588071|NCT01072175|11993705|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588072|NCT01072175|11993706|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588073|NCT01072175|11993707|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588074|NCT01072175|11993708|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588075|NCT01072175|11993709|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588076|NCT01072175|11993710|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588077|NCT01072175|11993711|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588078|NCT01072175|11993712|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588079|NCT01072175|11993713|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1
7588080|NCT01072175|11993714|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3
7588081|NCT01072175|11993715|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0
7626285|NCT00317772|12038343|FG003|Overall Study|Disease Progression|7
7626286|NCT00291486|12038359|FG000|Overall Study|Adverse Event|0
7626287|NCT00291486|12038360|FG001|Overall Study|Adverse Event|3
7626288|NCT00291486|12038361|FG002|Overall Study|Adverse Event|0
7626289|NCT00291486|12038362|FG003|Overall Study|Adverse Event|1
7626290|NCT00291486|12038363|FG004|Overall Study|Adverse Event|0
7626291|NCT00291486|12038359|FG000|Overall Study|Withdrawal by Subject|0
7626292|NCT00291486|12038360|FG001|Overall Study|Withdrawal by Subject|0
7626293|NCT00291486|12038361|FG002|Overall Study|Withdrawal by Subject|0
7626294|NCT00291486|12038362|FG003|Overall Study|Withdrawal by Subject|0
7766238|NCT00847535|12208728|FG001|Overall Study|Lost to Follow-up|1
7766239|NCT00847535|12208729|FG002|Overall Study|Lost to Follow-up|0
7766240|NCT00847561|12208736|FG000|Overall Study|Withdrawal by Subject|4
7766241|NCT00847561|12208737|FG001|Overall Study|Withdrawal by Subject|3
7766242|NCT00847561|12208736|FG000|Overall Study|Unable to schedule|9
7766243|NCT00847561|12208737|FG001|Overall Study|Unable to schedule|1
7766244|NCT00847613|12208756|FG000|Overall Study|Ongoing at cut-off date|250
7766245|NCT00847613|12208757|FG001|Overall Study|Ongoing at cut-off date|265
7766246|NCT00847613|12208758|FG002|Overall Study|Ongoing at cut-off date|64
7766247|NCT00847613|12208759|FG003|Overall Study|Ongoing at cut-off date|64
7766248|NCT00847613|12208756|FG000|Overall Study|Death|1
7766249|NCT00847613|12208757|FG001|Overall Study|Death|1
7766250|NCT00847613|12208758|FG002|Overall Study|Death|0
7766251|NCT00847613|12208759|FG003|Overall Study|Death|0
7766252|NCT00847613|12208756|FG000|Overall Study|Adverse Event|36
7626295|NCT00291486|12038363|FG004|Overall Study|Withdrawal by Subject|1
7626296|NCT00291486|12038359|FG000|Overall Study|Disease progression|1
7626297|NCT00291486|12038360|FG001|Overall Study|Disease progression|0
7626298|NCT00291486|12038361|FG002|Overall Study|Disease progression|1
7626299|NCT00291486|12038362|FG003|Overall Study|Disease progression|0
7626300|NCT00291486|12038363|FG004|Overall Study|Disease progression|0
7626301|NCT00284856|12038387|FG000|Overall Study|Adverse Event|3
7626302|NCT00284856|12038388|FG001|Overall Study|Adverse Event|3
7626303|NCT00284856|12038389|FG002|Overall Study|Adverse Event|3
7626304|NCT00284856|12038387|FG000|Overall Study|Lack of Efficacy|2
7588082|NCT01087203|11993749|FG000|Overall Study|Lost to Follow-up|2
7588083|NCT01087203|11993750|FG001|Overall Study|Lost to Follow-up|0
7588084|NCT01087203|11993749|FG000|Overall Study|Withdrawal by Subject|2
7588085|NCT01087203|11993750|FG001|Overall Study|Withdrawal by Subject|6
7588086|NCT01087203|11993749|FG000|Overall Study|Lack of Efficacy|1
7588087|NCT01087203|11993750|FG001|Overall Study|Lack of Efficacy|2
7588088|NCT01087203|11993749|FG000|Overall Study|Study terminated by sponsor|27
7588089|NCT01087203|11993750|FG001|Overall Study|Study terminated by sponsor|27
7588090|NCT01108055|11993761|FG000|Overall Study|Ineligible|11
7588091|NCT01108055|11993761|FG000|Overall Study|Not evaluable- didn't complete treatment|4
7588094|NCT01136967|11993771|FG000|Overall Study|Adverse Event|9
7588095|NCT01136967|11993772|FG001|Overall Study|Adverse Event|12
7588096|NCT01136967|11993771|FG000|Overall Study|Participant Choice|8
7588097|NCT01136967|11993772|FG001|Overall Study|Participant Choice|3
7588098|NCT01136967|11993771|FG000|Overall Study|Lost to Follow-up|0
7588099|NCT01136967|11993772|FG001|Overall Study|Lost to Follow-up|1
7588100|NCT01136967|11993771|FG000|Overall Study|Withdrawal by Subject|1
7588101|NCT01136967|11993772|FG001|Overall Study|Withdrawal by Subject|2
7588102|NCT01136967|11993771|FG000|Overall Study|Clinical Progression|3
7588103|NCT01136967|11993772|FG001|Overall Study|Clinical Progression|5
7588104|NCT01136967|11993771|FG000|Overall Study|Radiation|1
7588105|NCT01136967|11993772|FG001|Overall Study|Radiation|0
7588106|NCT01136967|11993771|FG000|Overall Study|Non-compliance|1
7588107|NCT01136967|11993772|FG001|Overall Study|Non-compliance|0
7588108|NCT01136967|11993771|FG000|Overall Study|Investigator's Choice|1
7588109|NCT01136967|11993772|FG001|Overall Study|Investigator's Choice|1
7588110|NCT01136967|11993771|FG000|Overall Study|Increase in Lesion Size|0
7588111|NCT01136967|11993772|FG001|Overall Study|Increase in Lesion Size|2
7588112|NCT01136967|11993771|FG000|Overall Study|Diagnosis of Second Primary Cancer|0
7588113|NCT01136967|11993772|FG001|Overall Study|Diagnosis of Second Primary Cancer|1
7588126|NCT01174563|11993807|FG000|Overall Study|Progressive Disease|45
7588127|NCT01174563|11993807|FG000|Overall Study|Death|5
7588128|NCT01174563|11993807|FG000|Overall Study|Investigator's Discretion|5
7588129|NCT01174563|11993807|FG000|Overall Study|Participant Withdrew Consent|3
7588130|NCT01174563|11993807|FG000|Overall Study|Rash Adverse Event|1
7588132|NCT01235962|11993887|FG000|Overall Study|Withdrawal by Subject|20
7588133|NCT01235962|11993888|FG001|Overall Study|Withdrawal by Subject|19
7588134|NCT01235962|11993889|FG002|Overall Study|Withdrawal by Subject|62
7588135|NCT01235962|11993890|FG003|Overall Study|Withdrawal by Subject|49
7588136|NCT01235962|11993887|FG000|Overall Study|Lost to Follow-up|21
7588137|NCT01235962|11993888|FG001|Overall Study|Lost to Follow-up|16
7588138|NCT01235962|11993889|FG002|Overall Study|Lost to Follow-up|47
7588139|NCT01235962|11993890|FG003|Overall Study|Lost to Follow-up|32
7588140|NCT01235962|11993887|FG000|Overall Study|Physician Decision|5
7588141|NCT01235962|11993888|FG001|Overall Study|Physician Decision|0
7588142|NCT01235962|11993889|FG002|Overall Study|Physician Decision|9
7588143|NCT01235962|11993890|FG003|Overall Study|Physician Decision|5
7588144|NCT01239368|11993918|FG000|Overall Study|Principal investigator discretion|1
7588145|NCT01239368|11993919|FG001|Overall Study|Principal investigator discretion|0
7588146|NCT01239368|11993920|FG002|Overall Study|Principal investigator discretion|0
7588147|NCT01239368|11993921|FG003|Overall Study|Principal investigator discretion|0
7588148|NCT01239368|11993922|FG004|Overall Study|Principal investigator discretion|1
7588149|NCT01239368|11993923|FG005|Overall Study|Principal investigator discretion|2
7588150|NCT01239368|11993924|FG006|Overall Study|Principal investigator discretion|0
7588151|NCT01239368|11993925|FG007|Overall Study|Principal investigator discretion|0
7588152|NCT01239368|11993926|FG008|Overall Study|Principal investigator discretion|0
7588153|NCT01239368|11993927|FG009|Overall Study|Principal investigator discretion|1
7588154|NCT01239368|11993918|FG000|Overall Study|Disease progression on study|1
7588155|NCT01239368|11993919|FG001|Overall Study|Disease progression on study|1
7588156|NCT01239368|11993920|FG002|Overall Study|Disease progression on study|1
7588157|NCT01239368|11993921|FG003|Overall Study|Disease progression on study|1
7588158|NCT01239368|11993922|FG004|Overall Study|Disease progression on study|4
7588159|NCT01239368|11993923|FG005|Overall Study|Disease progression on study|2
7588160|NCT01239368|11993924|FG006|Overall Study|Disease progression on study|5
7588161|NCT01239368|11993925|FG007|Overall Study|Disease progression on study|0
7588162|NCT01239368|11993926|FG008|Overall Study|Disease progression on study|0
7588163|NCT01239368|11993927|FG009|Overall Study|Disease progression on study|2
7588164|NCT01239368|11993918|FG000|Overall Study|Refused further treatment|0
7588165|NCT01239368|11993919|FG001|Overall Study|Refused further treatment|0
7588166|NCT01239368|11993920|FG002|Overall Study|Refused further treatment|0
7588167|NCT01239368|11993921|FG003|Overall Study|Refused further treatment|0
7588168|NCT01239368|11993922|FG004|Overall Study|Refused further treatment|0
7588169|NCT01239368|11993923|FG005|Overall Study|Refused further treatment|0
7588170|NCT01239368|11993924|FG006|Overall Study|Refused further treatment|0
7588171|NCT01239368|11993925|FG007|Overall Study|Refused further treatment|0
7588172|NCT01239368|11993926|FG008|Overall Study|Refused further treatment|0
7588173|NCT01239368|11993927|FG009|Overall Study|Refused further treatment|1
7588174|NCT01239368|11993918|FG000|Overall Study|Death|0
7588175|NCT01239368|11993919|FG001|Overall Study|Death|0
7588176|NCT01239368|11993920|FG002|Overall Study|Death|0
7588177|NCT01239368|11993921|FG003|Overall Study|Death|0
7588092|NCT01111019|11993765|FG000|Overall Study|Withdrew Prematurely|2
7588093|NCT01111019|11993765|FG000|Overall Study|Other|1
7588114|NCT01137955|11993789|FG000|Overall Study|Withdrawal by Subject|5
7588115|NCT01137955|11993790|FG001|Overall Study|Withdrawal by Subject|4
7588178|NCT01239368|11993922|FG004|Overall Study|Death|0
7588179|NCT01239368|11993923|FG005|Overall Study|Death|0
7588180|NCT01239368|11993924|FG006|Overall Study|Death|1
7588181|NCT01239368|11993925|FG007|Overall Study|Death|0
7588182|NCT01239368|11993926|FG008|Overall Study|Death|0
7588183|NCT01239368|11993927|FG009|Overall Study|Death|0
7626305|NCT00284856|12038388|FG001|Overall Study|Lack of Efficacy|1
7626306|NCT00284856|12038389|FG002|Overall Study|Lack of Efficacy|8
7626307|NCT00284856|12038387|FG000|Overall Study|Lost to Follow-up|25
7626308|NCT00284856|12038388|FG001|Overall Study|Lost to Follow-up|21
7626309|NCT00284856|12038389|FG002|Overall Study|Lost to Follow-up|22
7626310|NCT00284856|12038387|FG000|Overall Study|Protocol Violation|5
7626311|NCT00284856|12038388|FG001|Overall Study|Protocol Violation|4
7626312|NCT00284856|12038389|FG002|Overall Study|Protocol Violation|5
7626313|NCT00284856|12038387|FG000|Overall Study|Withdrawal by Subject|12
7626314|NCT00284856|12038388|FG001|Overall Study|Withdrawal by Subject|16
7626315|NCT00284856|12038389|FG002|Overall Study|Withdrawal by Subject|18
7626316|NCT00284856|12038387|FG000|Overall Study|Other|4
7626317|NCT00284856|12038388|FG001|Overall Study|Other|5
7626318|NCT00284856|12038389|FG002|Overall Study|Other|4
7588116|NCT01140451|11993799|FG000|Overall Study|Withdrawal by Subject|26
7588117|NCT01140451|11993800|FG001|Overall Study|Withdrawal by Subject|33
7588118|NCT01140451|11993799|FG000|Overall Study|Adverse Event|2
7588119|NCT01140451|11993800|FG001|Overall Study|Adverse Event|6
7588120|NCT01140451|11993799|FG000|Overall Study|Physician Decision|5
7588121|NCT01140451|11993800|FG001|Overall Study|Physician Decision|3
7588122|NCT01140451|11993799|FG000|Overall Study|Lost to Follow-up|2
7588123|NCT01140451|11993800|FG001|Overall Study|Lost to Follow-up|0
7588124|NCT01140451|11993799|FG000|Overall Study|Participants Planning Pregnancy|3
7588125|NCT01140451|11993800|FG001|Overall Study|Participants Planning Pregnancy|0
7588184|NCT01247701|11993960|FG000|Overall Study|Death|2
7588185|NCT01247701|11993960|FG000|Overall Study|Relapsed|8
7588186|NCT01266031|11993967|FG000|Overall Study|Not treated|0
7588187|NCT01266031|11993968|FG001|Overall Study|Not treated|3
7588188|NCT01266031|11993969|FG002|Overall Study|Not treated|2
7588189|NCT01287741|11993990|FG000|Overall Study|Withdrawal by Subject|35
7588190|NCT01287741|11993991|FG001|Overall Study|Withdrawal by Subject|38
7588191|NCT01287741|11993990|FG000|Overall Study|Protocol Violation|2
7588192|NCT01287741|11993991|FG001|Overall Study|Protocol Violation|0
7588193|NCT01287741|11993990|FG000|Overall Study|Physician Decision|15
7588194|NCT01287741|11993991|FG001|Overall Study|Physician Decision|23
7588195|NCT01287741|11993990|FG000|Overall Study|Non-compliance|8
7588196|NCT01287741|11993991|FG001|Overall Study|Non-compliance|6
7588197|NCT01287741|11993990|FG000|Overall Study|Lost to Follow-up|10
7588198|NCT01287741|11993991|FG001|Overall Study|Lost to Follow-up|8
7588199|NCT01287741|11993990|FG000|Overall Study|Death|32
7588200|NCT01287741|11993991|FG001|Overall Study|Death|44
7588201|NCT01287741|11993990|FG000|Overall Study|Adverse Event|4
7588202|NCT01287741|11993991|FG001|Overall Study|Adverse Event|6
7588203|NCT01287741|11993990|FG000|Overall Study|Study terminated by Sponsor|307
7588204|NCT01287741|11993991|FG001|Overall Study|Study terminated by Sponsor|315
7588205|NCT01287741|11993990|FG000|Overall Study|Progressive disease|190
7588206|NCT01287741|11993991|FG001|Overall Study|Progressive disease|166
7588207|NCT01287741|11993990|FG000|Overall Study|Reason not specified|23
7588208|NCT01287741|11993991|FG001|Overall Study|Reason not specified|9
7588209|NCT01313689|11994008|FG000|24-Week Randomization 1|Adverse Event|10
7588210|NCT01313689|11994009|FG001|24-Week Randomization 1|Adverse Event|5
7588211|NCT01313689|11994010|FG002|24-Week Randomization 1|Adverse Event|0
7588212|NCT01313689|11994011|FG003|24-Week Randomization 1|Adverse Event|0
7588213|NCT01313689|11994012|FG004|24-Week Randomization 1|Adverse Event|0
7588214|NCT01313689|11994008|FG000|24-Week Randomization 1|Physician Decision|4
7588215|NCT01313689|11994009|FG001|24-Week Randomization 1|Physician Decision|5
7588216|NCT01313689|11994010|FG002|24-Week Randomization 1|Physician Decision|0
7588217|NCT01313689|11994011|FG003|24-Week Randomization 1|Physician Decision|0
7588218|NCT01313689|11994012|FG004|24-Week Randomization 1|Physician Decision|0
7588219|NCT01313689|11994008|FG000|24-Week Randomization 1|Withdrawal by Subject|5
7588220|NCT01313689|11994009|FG001|24-Week Randomization 1|Withdrawal by Subject|0
7588221|NCT01313689|11994010|FG002|24-Week Randomization 1|Withdrawal by Subject|0
7588222|NCT01313689|11994011|FG003|24-Week Randomization 1|Withdrawal by Subject|0
7588223|NCT01313689|11994012|FG004|24-Week Randomization 1|Withdrawal by Subject|0
7588224|NCT01313689|11994008|FG000|24-Week Randomization 2|Adverse Event|0
7588225|NCT01313689|11994009|FG001|24-Week Randomization 2|Adverse Event|0
7588226|NCT01313689|11994010|FG002|24-Week Randomization 2|Adverse Event|2
7588227|NCT01313689|11994011|FG003|24-Week Randomization 2|Adverse Event|0
7588228|NCT01313689|11994012|FG004|24-Week Randomization 2|Adverse Event|8
7588229|NCT01313689|11994008|FG000|24-Week Randomization 2|Withdrawal by Subject|0
7588230|NCT01313689|11994009|FG001|24-Week Randomization 2|Withdrawal by Subject|0
7588231|NCT01313689|11994010|FG002|24-Week Randomization 2|Withdrawal by Subject|1
7588232|NCT01313689|11994011|FG003|24-Week Randomization 2|Withdrawal by Subject|1
7588233|NCT01313689|11994012|FG004|24-Week Randomization 2|Withdrawal by Subject|3
7588234|NCT01313689|11994008|FG000|24-Week Randomization 2|Physician Decision|0
7588235|NCT01313689|11994009|FG001|24-Week Randomization 2|Physician Decision|0
7766253|NCT00847613|12208757|FG001|Overall Study|Adverse Event|26
7588236|NCT01313689|11994010|FG002|24-Week Randomization 2|Physician Decision|0
7588237|NCT01313689|11994011|FG003|24-Week Randomization 2|Physician Decision|0
7588238|NCT01313689|11994012|FG004|24-Week Randomization 2|Physician Decision|4
7588260|NCT01318993|11994044|FG000|Overall Study|Adverse Event|53
7588261|NCT01318993|11994044|FG000|Overall Study|Lack of Efficacy|121
7588262|NCT01318993|11994044|FG000|Overall Study|Protocol Violation|3
7588263|NCT01318993|11994044|FG000|Overall Study|Protocol based stopping criteria|6
7588264|NCT01318993|11994044|FG000|Overall Study|Study closed or terminated|174
7588265|NCT01318993|11994044|FG000|Overall Study|Lost to Follow-up|4
7588266|NCT01318993|11994044|FG000|Overall Study|Physician Decision|13
7588267|NCT01318993|11994044|FG000|Overall Study|Withdrawal by Subject|24
7588268|NCT04480710|11994066|FG000|Overall Study|Adverse Event|0
7588269|NCT04480710|11994067|FG001|Overall Study|Adverse Event|2
7588270|NCT04480710|11994068|FG002|Overall Study|Adverse Event|0
7588271|NCT04480710|11994069|FG003|Overall Study|Adverse Event|0
7588272|NCT04480710|11994066|FG000|Overall Study|Withdrawal by Subject|0
7588273|NCT04480710|11994067|FG001|Overall Study|Withdrawal by Subject|1
7588274|NCT04480710|11994068|FG002|Overall Study|Withdrawal by Subject|0
7588275|NCT04480710|11994069|FG003|Overall Study|Withdrawal by Subject|0
7588239|NCT01315353|11994034|FG000|Overall Study|Death|2
7588240|NCT01315353|11994035|FG001|Overall Study|Death|1
7588241|NCT01315353|11994036|FG002|Overall Study|Death|0
7588242|NCT01315353|11994034|FG000|Overall Study|Withdrawal by Subject|2
7588243|NCT01315353|11994035|FG001|Overall Study|Withdrawal by Subject|6
7588244|NCT01315353|11994036|FG002|Overall Study|Withdrawal by Subject|1
7588245|NCT01315353|11994034|FG000|Overall Study|Lost to Follow-up|13
7588246|NCT01315353|11994035|FG001|Overall Study|Lost to Follow-up|6
7588247|NCT01315353|11994036|FG002|Overall Study|Lost to Follow-up|6
7588248|NCT01315353|11994034|FG000|Overall Study|Unwilling to adhere to requirements|5
7588249|NCT01315353|11994035|FG001|Overall Study|Unwilling to adhere to requirements|5
7588250|NCT01315353|11994036|FG002|Overall Study|Unwilling to adhere to requirements|4
7588251|NCT01315353|11994034|FG000|Overall Study|Site closing|7
7588252|NCT01315353|11994035|FG001|Overall Study|Site closing|4
7588253|NCT01315353|11994036|FG002|Overall Study|Site closing|0
7588254|NCT01315353|11994034|FG000|Overall Study|Taken off study by site in error|0
7588255|NCT01315353|11994035|FG001|Overall Study|Taken off study by site in error|1
7588256|NCT01315353|11994036|FG002|Overall Study|Taken off study by site in error|0
7588257|NCT01315353|11994034|FG000|Overall Study|Inadvertent randomization/assignment|0
7588258|NCT01315353|11994035|FG001|Overall Study|Inadvertent randomization/assignment|0
7588259|NCT01315353|11994036|FG002|Overall Study|Inadvertent randomization/assignment|2
7588276|NCT04480710|11994066|FG000|Overall Study|Physician Decision|0
7588277|NCT04480710|11994067|FG001|Overall Study|Physician Decision|0
7588278|NCT04480710|11994068|FG002|Overall Study|Physician Decision|1
7588279|NCT04480710|11994069|FG003|Overall Study|Physician Decision|0
7766254|NCT00847613|12208758|FG002|Overall Study|Adverse Event|5
7588281|NCT04225676|11994089|FG000|Overall Study|Physician Decision|1
7588282|NCT04225676|11994089|FG000|Overall Study|Lack of Efficacy|1
7588283|NCT04225676|11994089|FG000|Overall Study|Study terminated by sponsor|3
7588284|NCT04045132|11994097|FG000|Overall Study|Lost to Follow-up|3
7588285|NCT04045132|11994098|FG001|Overall Study|Lost to Follow-up|6
7588286|NCT03891524|11994123|FG000|Overall Study|Death|0
7588287|NCT03891524|11994124|FG001|Overall Study|Death|0
7588288|NCT03891524|11994125|FG002|Overall Study|Death|0
7588289|NCT03891524|11994126|FG003|Overall Study|Death|0
7588290|NCT03891524|11994127|FG004|Overall Study|Death|0
7588291|NCT03891524|11994128|FG005|Overall Study|Death|0
7588292|NCT03891524|11994129|FG006|Overall Study|Death|0
7588293|NCT03891524|11994130|FG007|Overall Study|Death|1
7588294|NCT03891524|11994123|FG000|Overall Study|Withdrawal by Subject|0
7588295|NCT03891524|11994124|FG001|Overall Study|Withdrawal by Subject|1
7588296|NCT03891524|11994125|FG002|Overall Study|Withdrawal by Subject|2
7588297|NCT03891524|11994126|FG003|Overall Study|Withdrawal by Subject|1
7588298|NCT03891524|11994127|FG004|Overall Study|Withdrawal by Subject|2
7588299|NCT03891524|11994128|FG005|Overall Study|Withdrawal by Subject|2
7588300|NCT03891524|11994129|FG006|Overall Study|Withdrawal by Subject|2
7588301|NCT03891524|11994130|FG007|Overall Study|Withdrawal by Subject|1
7588302|NCT03796208|11994167|FG000|Overall Study|Withdrawal by Subject|3
7588303|NCT03796208|11994168|FG001|Overall Study|Withdrawal by Subject|0
7588304|NCT03796208|11994167|FG000|Overall Study|Loss of pregnancy|1
7588305|NCT03796208|11994168|FG001|Overall Study|Loss of pregnancy|1
7588306|NCT03796208|11994167|FG000|Overall Study|Changed prenatal clinics|0
7588307|NCT03796208|11994168|FG001|Overall Study|Changed prenatal clinics|5
7588308|NCT03796208|11994167|FG000|Overall Study|Lost to Follow-up|20
7588309|NCT03796208|11994168|FG001|Overall Study|Lost to Follow-up|16
7588310|NCT03611010|11994187|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1
7588311|NCT03611010|11994188|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0
7588312|NCT03611010|11994189|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0
7588313|NCT03611010|11994190|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0
7588314|NCT03476798|11994211|FG000|Overall Study|Death|1
7588315|NCT03476798|11994211|FG000|Overall Study|Withdrawal by Subject|2
7588316|NCT03476798|11994211|FG000|Overall Study|Protocol Violation|2
7766255|NCT00847613|12208759|FG003|Overall Study|Adverse Event|6
7766256|NCT00847613|12208756|FG000|Overall Study|Lack of Efficacy|7
7766257|NCT00847613|12208757|FG001|Overall Study|Lack of Efficacy|3
7766258|NCT00847613|12208758|FG002|Overall Study|Lack of Efficacy|3
7766259|NCT00847613|12208759|FG003|Overall Study|Lack of Efficacy|1
7766260|NCT00847613|12208756|FG000|Overall Study|Study terminated by Sponsor|1
7766261|NCT00847613|12208757|FG001|Overall Study|Study terminated by Sponsor|0
7766262|NCT00847613|12208758|FG002|Overall Study|Study terminated by Sponsor|2
7766263|NCT00847613|12208759|FG003|Overall Study|Study terminated by Sponsor|1
7766264|NCT00847613|12208756|FG000|Overall Study|Lost to Follow-up|5
7766265|NCT00847613|12208757|FG001|Overall Study|Lost to Follow-up|0
7766266|NCT00847613|12208758|FG002|Overall Study|Lost to Follow-up|0
7766267|NCT00847613|12208759|FG003|Overall Study|Lost to Follow-up|3
7766268|NCT00847613|12208756|FG000|Overall Study|Protocol Violation|6
7766269|NCT00847613|12208757|FG001|Overall Study|Protocol Violation|6
7766270|NCT00847613|12208758|FG002|Overall Study|Protocol Violation|3
7766271|NCT00847613|12208759|FG003|Overall Study|Protocol Violation|1
7766272|NCT00847613|12208756|FG000|Overall Study|Pregnancy|1
7766273|NCT00847613|12208757|FG001|Overall Study|Pregnancy|1
7766274|NCT00847613|12208758|FG002|Overall Study|Pregnancy|0
7588337|NCT03355664|11994239|FG000|Overall Study|Adverse Event|1
7588338|NCT03355664|11994240|FG001|Overall Study|Adverse Event|2
7588339|NCT03355664|11994239|FG000|Overall Study|Lost to Follow-up|11
7588340|NCT03355664|11994240|FG001|Overall Study|Lost to Follow-up|7
7588341|NCT03355664|11994239|FG000|Overall Study|Protocol Violation|1
7588342|NCT03355664|11994240|FG001|Overall Study|Protocol Violation|2
7588343|NCT03355664|11994239|FG000|Overall Study|Withdrawal by Subject|2
7588344|NCT03355664|11994240|FG001|Overall Study|Withdrawal by Subject|1
7766275|NCT00847613|12208759|FG003|Overall Study|Pregnancy|0
7766276|NCT00847613|12208756|FG000|Overall Study|Site closure|1
7766277|NCT00847613|12208757|FG001|Overall Study|Site closure|0
7588349|NCT03290131|11994254|FG000|Overall Study|Adverse Event|22
7588350|NCT03290131|11994255|FG001|Overall Study|Adverse Event|57
7588351|NCT03290131|11994256|FG002|Overall Study|Adverse Event|11
7588352|NCT03290131|11994254|FG000|Overall Study|Withdrawal by Subject|18
7588353|NCT03290131|11994255|FG001|Overall Study|Withdrawal by Subject|13
7588354|NCT03290131|11994256|FG002|Overall Study|Withdrawal by Subject|8
7588355|NCT03290131|11994254|FG000|Overall Study|MS Relapse|2
7588356|NCT03290131|11994255|FG001|Overall Study|MS Relapse|1
7588357|NCT03290131|11994256|FG002|Overall Study|MS Relapse|0
7588358|NCT03290131|11994254|FG000|Overall Study|Unknown reason|0
7588359|NCT03290131|11994255|FG001|Overall Study|Unknown reason|1
7588360|NCT03290131|11994256|FG002|Overall Study|Unknown reason|0
7766278|NCT00847613|12208758|FG002|Overall Study|Site closure|0
7766279|NCT00847613|12208759|FG003|Overall Study|Site closure|1
7766280|NCT00847613|12208756|FG000|Overall Study|Withdrawal by Subject|8
7766281|NCT00847613|12208757|FG001|Overall Study|Withdrawal by Subject|11
7766282|NCT00847613|12208758|FG002|Overall Study|Withdrawal by Subject|2
7766283|NCT00847613|12208759|FG003|Overall Study|Withdrawal by Subject|2
7766284|NCT00847613|12208756|FG000|Overall Study|Participant moved|4
7766285|NCT00847613|12208757|FG001|Overall Study|Participant moved|1
7766286|NCT00847613|12208758|FG002|Overall Study|Participant moved|0
7766287|NCT00847613|12208759|FG003|Overall Study|Participant moved|0
7766288|NCT00847613|12208756|FG000|Overall Study|Sponsor request|0
7766289|NCT00847613|12208757|FG001|Overall Study|Sponsor request|1
7766290|NCT00847613|12208758|FG002|Overall Study|Sponsor request|0
7766291|NCT00847613|12208759|FG003|Overall Study|Sponsor request|0
7766292|NCT00847613|12208756|FG000|Overall Study|Randomized, but not treated|0
7766293|NCT00847613|12208757|FG001|Overall Study|Randomized, but not treated|3
7766294|NCT00847613|12208758|FG002|Overall Study|Randomized, but not treated|0
7766295|NCT00847613|12208759|FG003|Overall Study|Randomized, but not treated|0
7766296|NCT00847613|12208756|FG000|Overall Study|Other|1
7766297|NCT00847613|12208757|FG001|Overall Study|Other|1
7766298|NCT00847613|12208758|FG002|Overall Study|Other|2
7766299|NCT00847613|12208759|FG003|Overall Study|Other|0
7588383|NCT03117049|11994312|FG000|Overall Study|Continued the follow-up period|109
7588384|NCT03117049|11994313|FG001|Overall Study|Continued the follow-up period|129
7588385|NCT03117049|11994312|FG000|Overall Study|Died|82
7588386|NCT03117049|11994313|FG001|Overall Study|Died|93
7588387|NCT03117049|11994312|FG000|Overall Study|Consent withdrawal|7
7588388|NCT03117049|11994313|FG001|Overall Study|Consent withdrawal|6
7588389|NCT03117049|11994312|FG000|Overall Study|Missing contact|3
7588390|NCT03117049|11994313|FG001|Overall Study|Missing contact|3
7588391|NCT02842086|11994321|FG000|Overall Study|Randomized but Never Treated|6
7588392|NCT02842086|11994322|FG001|Overall Study|Randomized but Never Treated|6
7588393|NCT02842086|11994321|FG000|Overall Study|Still in Double-Blind Phase|7
7588394|NCT02842086|11994322|FG001|Overall Study|Still in Double-Blind Phase|3
7588395|NCT02842086|11994321|FG000|Overall Study|Adverse Event|18
7588396|NCT02842086|11994322|FG001|Overall Study|Adverse Event|20
7588397|NCT02842086|11994321|FG000|Overall Study|Death|3
7588398|NCT02842086|11994322|FG001|Overall Study|Death|3
7588399|NCT02842086|11994321|FG000|Overall Study|Investigator's Discretion|9
7588400|NCT02842086|11994322|FG001|Overall Study|Investigator's Discretion|13
7588401|NCT02842086|11994321|FG000|Overall Study|Non-Compliance with Study Drug|9
7588402|NCT02842086|11994322|FG001|Overall Study|Non-Compliance with Study Drug|8
7588403|NCT02842086|11994321|FG000|Overall Study|Protocol Violation|8
7588404|NCT02842086|11994322|FG001|Overall Study|Protocol Violation|4
7588405|NCT02842086|11994321|FG000|Overall Study|Withdrew Consent|205
7588406|NCT02842086|11994322|FG001|Overall Study|Withdrew Consent|194
7588407|NCT02842086|11994321|FG000|Overall Study|Lost to Follow-up|274
7588408|NCT02842086|11994322|FG001|Overall Study|Lost to Follow-up|236
7588409|NCT02842086|11994321|FG000|Overall Study|HIV-1 Infection|5
7588410|NCT02842086|11994322|FG001|Overall Study|HIV-1 Infection|6
7588411|NCT02663622|11994332|FG000|Overall Study|Death|3
7588412|NCT02663622|11994333|FG001|Overall Study|Death|1
7588413|NCT02663622|11994334|FG002|Overall Study|Death|1
7588414|NCT02663622|11994335|FG003|Overall Study|Death|8
7588415|NCT02663622|11994332|FG000|Overall Study|Protocol Violation|0
7588416|NCT02663622|11994333|FG001|Overall Study|Protocol Violation|0
7588417|NCT02663622|11994334|FG002|Overall Study|Protocol Violation|0
7588418|NCT02663622|11994335|FG003|Overall Study|Protocol Violation|1
7588419|NCT02655016|11994348|FG000|Overall Study|Disease progression|6
7588420|NCT02655016|11994349|FG001|Overall Study|Disease progression|4
7588421|NCT02655016|11994348|FG000|Overall Study|Site closed|0
7588422|NCT02655016|11994349|FG001|Overall Study|Site closed|1
7588423|NCT02655016|11994348|FG000|Overall Study|Death|30
7588424|NCT02655016|11994349|FG001|Overall Study|Death|48
7588425|NCT02655016|11994348|FG000|Overall Study|Lost to Follow-up|1
7588426|NCT02655016|11994349|FG001|Overall Study|Lost to Follow-up|1
7588427|NCT02655016|11994348|FG000|Overall Study|Withdrawal by Subject|18
7588428|NCT02655016|11994349|FG001|Overall Study|Withdrawal by Subject|36
7588429|NCT02636439|11994358|FG000|Overall Study|Adverse Event|2
7588430|NCT02636439|11994359|FG001|Overall Study|Adverse Event|2
7588431|NCT02636439|11994358|FG000|Overall Study|Lost to Follow-up|1
7588432|NCT02636439|11994359|FG001|Overall Study|Lost to Follow-up|0
7588433|NCT02636439|11994358|FG000|Overall Study|Non-compliance|1
7588434|NCT02636439|11994359|FG001|Overall Study|Non-compliance|1
7588435|NCT02636439|11994358|FG000|Overall Study|Personal reasons|2
7588436|NCT02636439|11994359|FG001|Overall Study|Personal reasons|0
7588437|NCT02567825|11994367|FG000|Overall Study|No follow-up post-randomization|5
7588438|NCT02567825|11994368|FG001|Overall Study|No follow-up post-randomization|1
7588439|NCT02567825|11994367|FG000|Overall Study|Follow-up less than 23 months|16
7588440|NCT02567825|11994368|FG001|Overall Study|Follow-up less than 23 months|20
7588442|NCT02536755|11994383|FG000|Overall Study|Adverse Event|4
7588443|NCT02516241|11994393|FG000|Overall Study|Death|255
7588444|NCT02516241|11994394|FG001|Overall Study|Death|262
7588445|NCT02516241|11994395|FG002|Overall Study|Death|270
7588446|NCT02516241|11994393|FG000|Overall Study|Lost to Follow-up|1
7588447|NCT02516241|11994394|FG001|Overall Study|Lost to Follow-up|1
7588448|NCT02516241|11994395|FG002|Overall Study|Lost to Follow-up|3
7588449|NCT02516241|11994393|FG000|Overall Study|Withdrawal by Subject|2
7588450|NCT02516241|11994394|FG001|Overall Study|Withdrawal by Subject|7
7588451|NCT02516241|11994395|FG002|Overall Study|Withdrawal by Subject|12
7588452|NCT02516241|11994393|FG000|Overall Study|participants ongoing at data cut-off|84
7588453|NCT02516241|11994394|FG001|Overall Study|participants ongoing at data cut-off|76
7588454|NCT02516241|11994395|FG002|Overall Study|participants ongoing at data cut-off|59
7588455|NCT02442349|11994408|FG000|Overall Study|Death|14
7588456|NCT02442349|11994408|FG000|Overall Study|Withdrawal by Subject|8
7588457|NCT02442349|11994408|FG000|Overall Study|On-going Study at Data Cut-off|149
7588458|NCT02362035|11994412|FG000|Overall Study|Death|67
7588459|NCT02362035|11994412|FG000|Overall Study|Lost to Follow-up|3
7588460|NCT02362035|11994412|FG000|Overall Study|Adverse Event|1
7588461|NCT02362035|11994412|FG000|Overall Study|Physician Decision|1
7588462|NCT02362035|11994412|FG000|Overall Study|Subject started another cancer therapy|10
7588463|NCT02362035|11994412|FG000|Overall Study|Study terminated by sponsor|45
7588464|NCT02362035|11994412|FG000|Overall Study|Decision by subject not related to AE/SAE|2
7588465|NCT02362035|11994412|FG000|Overall Study|Decision by PI not related to AE/SAE|1
7588466|NCT02362035|11994412|FG000|Overall Study|Disease progression|11
7588467|NCT02362035|11994412|FG000|Overall Study|Withdrawal by Subject|20
7588468|NCT02328014|11994424|FG000|Overall Study|Adverse Event|1
7588469|NCT02328014|11994425|FG001|Overall Study|Adverse Event|0
7588470|NCT02328014|11994426|FG002|Overall Study|Adverse Event|0
7588471|NCT02328014|11994427|FG003|Overall Study|Adverse Event|1
7588472|NCT02328014|11994424|FG000|Overall Study|Death|0
7588473|NCT02328014|11994425|FG001|Overall Study|Death|0
7588474|NCT02328014|11994426|FG002|Overall Study|Death|0
7588475|NCT02328014|11994427|FG003|Overall Study|Death|4
7588476|NCT02328014|11994424|FG000|Overall Study|Physician Decision|0
7588477|NCT02328014|11994425|FG001|Overall Study|Physician Decision|0
7588478|NCT02328014|11994426|FG002|Overall Study|Physician Decision|0
7588479|NCT02328014|11994427|FG003|Overall Study|Physician Decision|1
7588480|NCT02328014|11994424|FG000|Overall Study|Disease Progression|1
7588481|NCT02328014|11994425|FG001|Overall Study|Disease Progression|0
7588482|NCT02328014|11994426|FG002|Overall Study|Disease Progression|1
7588483|NCT02328014|11994427|FG003|Overall Study|Disease Progression|3
7588484|NCT02328014|11994424|FG000|Overall Study|Study Terminated by Sponsor|4
7588485|NCT02328014|11994425|FG001|Overall Study|Study Terminated by Sponsor|1
7588486|NCT02328014|11994426|FG002|Overall Study|Study Terminated by Sponsor|1
7588487|NCT02328014|11994427|FG003|Overall Study|Study Terminated by Sponsor|0
7588488|NCT02328014|11994424|FG000|Overall Study|Subject Started Another Cancer Therapy|0
7588489|NCT02328014|11994425|FG001|Overall Study|Subject Started Another Cancer Therapy|5
7588490|NCT02328014|11994426|FG002|Overall Study|Subject Started Another Cancer Therapy|4
7588491|NCT02328014|11994427|FG003|Overall Study|Subject Started Another Cancer Therapy|12
7588492|NCT02328014|11994424|FG000|Overall Study|Withdrawal by Subject|0
7588493|NCT02328014|11994425|FG001|Overall Study|Withdrawal by Subject|0
7588494|NCT02328014|11994426|FG002|Overall Study|Withdrawal by Subject|0
7588495|NCT02328014|11994427|FG003|Overall Study|Withdrawal by Subject|1
7766300|NCT00847626|12208787|FG000|Overall Study|Adverse Event|10
7766301|NCT00847626|12208788|FG001|Overall Study|Adverse Event|10
7766302|NCT00847626|12208789|FG002|Overall Study|Adverse Event|6
7766303|NCT00847626|12208790|FG003|Overall Study|Adverse Event|19
7766304|NCT00847626|12208791|FG004|Overall Study|Adverse Event|11
7766305|NCT00847626|12208792|FG005|Overall Study|Adverse Event|22
7766306|NCT00847626|12208793|FG006|Overall Study|Adverse Event|4
7766307|NCT00847626|12208794|FG007|Overall Study|Adverse Event|6
7766308|NCT00847626|12208795|FG008|Overall Study|Adverse Event|3
7588505|NCT02207569|11994450|FG000|1-Month|Death|6
7588506|NCT02207569|11994450|FG000|1-Month|Withdrawal by Subject|2
7588507|NCT02207569|11994450|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1
7588508|NCT02207569|11994450|FG000|6-Month|Death|8
7588509|NCT02207569|11994450|FG000|6-Month|Withdrawal by Subject|2
7588510|NCT02207569|11994450|FG000|12-Month|Death|14
7588511|NCT02207569|11994450|FG000|12-Month|Withdrawal by Subject|2
7588512|NCT02207569|11994450|FG000|24-Month|Death|23
7588513|NCT02207569|11994450|FG000|24-Month|Withdrawal by Subject|3
7588514|NCT02207569|11994450|FG000|36-Month|Death|23
7588515|NCT02207569|11994450|FG000|36-Month|Withdrawal by Subject|4
7588516|NCT02207569|11994450|FG000|48-Month|Death|25
7588517|NCT02207569|11994450|FG000|48-Month|Withdrawal by Subject|2
7588518|NCT02207569|11994450|FG000|48-Month|Lost to Follow-up|4
7588519|NCT02207569|11994450|FG000|60-Month|Death|1
7588520|NCT02207569|11994450|FG000|60-Month|Lost to Follow-up|1
7588521|NCT02207569|11994450|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1
7588522|NCT02207569|11994450|FG000|60-Month|Covid-19 pt not willing to be seen|1
7588523|NCT02201108|11994456|FG000|Double-blind Period (up to Week 96)|Adverse Event|0
7588524|NCT02201108|11994457|FG001|Double-blind Period (up to Week 96)|Adverse Event|6
7588525|NCT02201108|11994456|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2
7588526|NCT02201108|11994457|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1
7588527|NCT02201108|11994456|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2
7588528|NCT02201108|11994457|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0
7588529|NCT02201108|11994456|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10
7588530|NCT02201108|11994457|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14
7588531|NCT02201108|11994456|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0
7588532|NCT02201108|11994457|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1
7588533|NCT02201108|11994456|FG000|Open Label Period (up to Week 192)|Other reason|4
7588534|NCT02201108|11994457|FG001|Open Label Period (up to Week 192)|Other reason|7
7588535|NCT02201108|11994456|FG000|Open Label Period (up to Week 192)|Adverse Event|7
7588536|NCT02201108|11994457|FG001|Open Label Period (up to Week 192)|Adverse Event|5
7766309|NCT00847626|12208796|FG009|Overall Study|Adverse Event|6
7766310|NCT00847626|12208797|FG010|Overall Study|Adverse Event|6
7766311|NCT00847626|12208787|FG000|Overall Study|Protocol Violation|2
7766312|NCT00847626|12208788|FG001|Overall Study|Protocol Violation|1
7766313|NCT00847626|12208789|FG002|Overall Study|Protocol Violation|2
7766314|NCT00847626|12208790|FG003|Overall Study|Protocol Violation|1
7766315|NCT00847626|12208791|FG004|Overall Study|Protocol Violation|1
7766316|NCT00847626|12208792|FG005|Overall Study|Protocol Violation|1
7766317|NCT00847626|12208793|FG006|Overall Study|Protocol Violation|1
7766318|NCT00847626|12208794|FG007|Overall Study|Protocol Violation|1
7766319|NCT00847626|12208795|FG008|Overall Study|Protocol Violation|0
7766320|NCT00847626|12208796|FG009|Overall Study|Protocol Violation|1
7766321|NCT00847626|12208797|FG010|Overall Study|Protocol Violation|1
7766322|NCT00847626|12208787|FG000|Overall Study|Lost to Follow-up|0
7766323|NCT00847626|12208788|FG001|Overall Study|Lost to Follow-up|1
7766324|NCT00847626|12208789|FG002|Overall Study|Lost to Follow-up|1
7766325|NCT00847626|12208790|FG003|Overall Study|Lost to Follow-up|1
7766326|NCT00847626|12208791|FG004|Overall Study|Lost to Follow-up|0
7766327|NCT00847626|12208792|FG005|Overall Study|Lost to Follow-up|3
7766328|NCT00847626|12208793|FG006|Overall Study|Lost to Follow-up|1
7766329|NCT00847626|12208794|FG007|Overall Study|Lost to Follow-up|3
7766330|NCT00847626|12208795|FG008|Overall Study|Lost to Follow-up|1
7766331|NCT00847626|12208796|FG009|Overall Study|Lost to Follow-up|0
7766332|NCT00847626|12208797|FG010|Overall Study|Lost to Follow-up|1
7766333|NCT00847626|12208787|FG000|Overall Study|Withdrawal by Subject|5
7766334|NCT00847626|12208788|FG001|Overall Study|Withdrawal by Subject|5
7766335|NCT00847626|12208789|FG002|Overall Study|Withdrawal by Subject|3
7766336|NCT00847626|12208790|FG003|Overall Study|Withdrawal by Subject|8
7766337|NCT00847626|12208791|FG004|Overall Study|Withdrawal by Subject|12
7766338|NCT00847626|12208792|FG005|Overall Study|Withdrawal by Subject|9
7766339|NCT00847626|12208793|FG006|Overall Study|Withdrawal by Subject|8
7766340|NCT00847626|12208794|FG007|Overall Study|Withdrawal by Subject|4
7766341|NCT00847626|12208795|FG008|Overall Study|Withdrawal by Subject|4
7766342|NCT00847626|12208796|FG009|Overall Study|Withdrawal by Subject|5
7766343|NCT00847626|12208797|FG010|Overall Study|Withdrawal by Subject|2
7766344|NCT00847626|12208787|FG000|Overall Study|Lack of Efficacy|3
7766345|NCT00847626|12208788|FG001|Overall Study|Lack of Efficacy|1
7766346|NCT00847626|12208789|FG002|Overall Study|Lack of Efficacy|0
7766347|NCT00847626|12208790|FG003|Overall Study|Lack of Efficacy|1
7766348|NCT00847626|12208791|FG004|Overall Study|Lack of Efficacy|2
7766349|NCT00847626|12208792|FG005|Overall Study|Lack of Efficacy|0
7766350|NCT00847626|12208793|FG006|Overall Study|Lack of Efficacy|6
7766351|NCT00847626|12208794|FG007|Overall Study|Lack of Efficacy|2
7766352|NCT00847626|12208795|FG008|Overall Study|Lack of Efficacy|5
7766353|NCT00847626|12208796|FG009|Overall Study|Lack of Efficacy|1
7766354|NCT00847626|12208797|FG010|Overall Study|Lack of Efficacy|7
7766355|NCT00847626|12208787|FG000|Overall Study|Other|1
7766356|NCT00847626|12208788|FG001|Overall Study|Other|5
7766357|NCT00847626|12208789|FG002|Overall Study|Other|4
7766358|NCT00847626|12208790|FG003|Overall Study|Other|1
7766359|NCT00847626|12208791|FG004|Overall Study|Other|2
7766360|NCT00847626|12208792|FG005|Overall Study|Other|2
7766361|NCT00847626|12208793|FG006|Overall Study|Other|2
7766362|NCT00847626|12208794|FG007|Overall Study|Other|3
7766363|NCT00847626|12208795|FG008|Overall Study|Other|1
7766364|NCT00847626|12208796|FG009|Overall Study|Other|1
7766365|NCT00847626|12208797|FG010|Overall Study|Other|3
7766366|NCT00847665|12208826|FG000|Overall Study|Withdrawal by Subject|1
7766367|NCT00847665|12208827|FG001|Overall Study|Withdrawal by Subject|0
7766368|NCT00847704|12208833|FG000|Overall Study|Withdrawal by Subject|1
7766369|NCT00847808|12208837|FG000|Overall Study|Adverse Event|7
7766370|NCT00847808|12208837|FG000|Overall Study|Protocol Violation|1
7766371|NCT00847808|12208837|FG000|Overall Study|Lost to Follow-up|1
7766372|NCT00847808|12208837|FG000|Overall Study|Withdrawal by Subject|4
7766373|NCT00847808|12208837|FG000|Overall Study|Participant Reported Lack of Efficacy|1
7766374|NCT00847808|12208837|FG000|Overall Study|Participant Took Excluded Medication|1
7770302|NCT00875979|12214320|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
7770303|NCT00875979|12214319|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
7770304|NCT00875979|12214320|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
7770305|NCT00875979|12214319|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
7770306|NCT00875979|12214320|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
7770307|NCT00875979|12214319|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
7770308|NCT00875979|12214320|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
7766375|NCT00847886|12208843|FG000|Overall Study|Adverse Event|0
7766376|NCT00847886|12208844|FG001|Overall Study|Adverse Event|1
7766377|NCT00847912|12208852|FG000|Overall Study|Protocol Violation|6
7766378|NCT00847912|12208853|FG001|Overall Study|Protocol Violation|7
7766379|NCT00847912|12208852|FG000|Overall Study|Withdrawal by Subject|3
7766380|NCT00847912|12208853|FG001|Overall Study|Withdrawal by Subject|6
7766381|NCT00848042|12208884|FG000|Overall Study|Death|1
7766382|NCT00848042|12208885|FG001|Overall Study|Death|2
7766383|NCT00848042|12208886|FG002|Overall Study|Death|0
7766384|NCT00848042|12208884|FG000|Overall Study|Other Therapy|3
7766385|NCT00848042|12208885|FG001|Overall Study|Other Therapy|0
7766386|NCT00848042|12208886|FG002|Overall Study|Other Therapy|0
7766387|NCT00848081|12208896|FG000|Overall Study|Adverse Event|6
7766388|NCT00848081|12208897|FG001|Overall Study|Adverse Event|7
7766389|NCT00848081|12208896|FG000|Overall Study|Protocol Violation|8
7766390|NCT00848081|12208897|FG001|Overall Study|Protocol Violation|5
7766391|NCT00848081|12208896|FG000|Overall Study|Lost to Follow-up|1
7766392|NCT00848081|12208897|FG001|Overall Study|Lost to Follow-up|0
7766393|NCT00848081|12208896|FG000|Overall Study|Physician Decision|0
7766394|NCT00848081|12208897|FG001|Overall Study|Physician Decision|3
7766395|NCT00848081|12208896|FG000|Overall Study|Withdrawal by Subject|5
7766396|NCT00848081|12208897|FG001|Overall Study|Withdrawal by Subject|3
7766397|NCT00848107|12208903|FG000|Overall Study|Lost to Follow-up|2
7766398|NCT00848107|12208903|FG000|Overall Study|Withdrawal by Subject|8
7766399|NCT00848107|12208903|FG000|Overall Study|Adverse Event|9
7766400|NCT00848107|12208903|FG000|Overall Study|Death|1
7766401|NCT00848107|12208903|FG000|Overall Study|Pregnancy|1
7766402|NCT00848120|12208907|FG000|Overall Study|Adverse Event|1
7766403|NCT00848198|12208936|FG000|Overall Study|Incomplete Case Report Forms|15
7766404|NCT00848211|12208948|FG000|Overall Study|Protocol Violation|0
7766405|NCT00848211|12208949|FG001|Overall Study|Protocol Violation|1
7766406|NCT00848211|12208950|FG002|Overall Study|Protocol Violation|1
7766407|NCT00848211|12208951|FG003|Overall Study|Protocol Violation|0
7766408|NCT00848211|12208948|FG000|Overall Study|Adverse Event|0
7766409|NCT00848211|12208949|FG001|Overall Study|Adverse Event|0
7766410|NCT00848211|12208950|FG002|Overall Study|Adverse Event|0
7766411|NCT00848211|12208951|FG003|Overall Study|Adverse Event|0
7766412|NCT00848250|12208967|FG000|Overall Study|surgery was completed without cardiopulm|0
7766413|NCT00848250|12208968|FG001|Overall Study|surgery was completed without cardiopulm|1
7766414|NCT00848354|12208977|FG000|Phase 1|Adverse Event|5
7766415|NCT00848354|12208978|FG001|Phase 1|Adverse Event|4
7766416|NCT00848354|12208977|FG000|Phase 1|Discontinuation of study by sponsor|2
7766417|NCT00848354|12208978|FG001|Phase 1|Discontinuation of study by sponsor|1
7766418|NCT00848354|12208977|FG000|Phase 1|Failed to return|0
7766419|NCT00848354|12208978|FG001|Phase 1|Failed to return|1
7766420|NCT00848354|12208977|FG000|Phase 1|Lost to Follow-up|1
7766421|NCT00848354|12208978|FG001|Phase 1|Lost to Follow-up|1
7766422|NCT00848354|12208977|FG000|Phase 1|Unspecified Reason|1
7766423|NCT00848354|12208978|FG001|Phase 1|Unspecified Reason|1
7766424|NCT00848354|12208977|FG000|Phase 1|Protocol Violation|1
7766425|NCT00848354|12208978|FG001|Phase 1|Protocol Violation|1
7766426|NCT00848354|12208977|FG000|Phase 1|Withdrawal by Subject|2
7766427|NCT00848354|12208978|FG001|Phase 1|Withdrawal by Subject|4
7766428|NCT00848354|12208977|FG000|Phase 1|Lack of Efficacy|0
7588637|NCT01116648|11994597|FG000|Phase 1 Dose Level 3|Adverse Event|0
7588638|NCT01116648|11994598|FG001|Phase 1 Dose Level 3|Adverse Event|0
7588639|NCT01116648|11994599|FG002|Phase 1 Dose Level 3|Adverse Event|0
7588640|NCT01116648|11994600|FG003|Phase 1 Dose Level 3|Adverse Event|2
7588641|NCT01116648|11994601|FG004|Phase 1 Dose Level 3|Adverse Event|0
7588642|NCT01116648|11994602|FG005|Phase 1 Dose Level 3|Adverse Event|0
7588643|NCT01116648|11994603|FG006|Phase 1 Dose Level 3|Adverse Event|0
7588644|NCT01116648|11994604|FG007|Phase 1 Dose Level 3|Adverse Event|0
7588645|NCT01116648|11994605|FG008|Phase 1 Dose Level 3|Adverse Event|0
7588646|NCT01116648|11994606|FG009|Phase 1 Dose Level 3|Adverse Event|0
7588647|NCT01116648|11994607|FG010|Phase 1 Dose Level 3|Adverse Event|0
7588648|NCT01116648|11994608|FG011|Phase 1 Dose Level 3|Adverse Event|0
7588649|NCT01116648|11994609|FG012|Phase 1 Dose Level 3|Adverse Event|0
7588650|NCT01116648|11994610|FG013|Phase 1 Dose Level 3|Adverse Event|0
7588651|NCT01116648|11994611|FG014|Phase 1 Dose Level 3|Adverse Event|0
7588652|NCT01078662|11994641|FG000|Overall Study|Death|41
7588653|NCT01078662|11994642|FG001|Overall Study|Death|103
7588654|NCT01078662|11994643|FG002|Overall Study|Death|18
7588655|NCT01078662|11994644|FG003|Overall Study|Death|5
7588656|NCT01078662|11994645|FG004|Overall Study|Death|8
7588657|NCT01078662|11994641|FG000|Overall Study|Patients reached data cut-off|12
7588658|NCT01078662|11994642|FG001|Overall Study|Patients reached data cut-off|53
7588659|NCT01078662|11994643|FG002|Overall Study|Patients reached data cut-off|2
7588660|NCT01078662|11994644|FG003|Overall Study|Patients reached data cut-off|2
7588661|NCT01078662|11994645|FG004|Overall Study|Patients reached data cut-off|3
7588662|NCT01078662|11994641|FG000|Overall Study|Withdrawal by Subject|4
7588663|NCT01078662|11994642|FG001|Overall Study|Withdrawal by Subject|11
7588664|NCT01078662|11994643|FG002|Overall Study|Withdrawal by Subject|1
7588665|NCT01078662|11994644|FG003|Overall Study|Withdrawal by Subject|0
7588666|NCT01078662|11994645|FG004|Overall Study|Withdrawal by Subject|0
7588667|NCT01078662|11994641|FG000|Overall Study|Protocol Violation|0
7766429|NCT00848354|12208978|FG001|Phase 1|Lack of Efficacy|1
7588668|NCT01078662|11994642|FG001|Overall Study|Protocol Violation|1
7588669|NCT01078662|11994643|FG002|Overall Study|Protocol Violation|0
7588670|NCT01078662|11994644|FG003|Overall Study|Protocol Violation|0
7588671|NCT01078662|11994645|FG004|Overall Study|Protocol Violation|0
7588672|NCT01078662|11994641|FG000|Overall Study|Lost to Follow-up|1
7588673|NCT01078662|11994642|FG001|Overall Study|Lost to Follow-up|0
7588674|NCT01078662|11994643|FG002|Overall Study|Lost to Follow-up|0
7588675|NCT01078662|11994644|FG003|Overall Study|Lost to Follow-up|0
7588676|NCT01078662|11994645|FG004|Overall Study|Lost to Follow-up|0
7588677|NCT00680901|11994656|FG000|Overall Study|Lost to Follow-up|8
7588678|NCT00680901|11994657|FG001|Overall Study|Lost to Follow-up|8
7588679|NCT00680901|11994656|FG000|Overall Study|Withdrawal by Subject|4
7588680|NCT00680901|11994657|FG001|Overall Study|Withdrawal by Subject|13
7588681|NCT00680901|11994656|FG000|Overall Study|Physician Decision|0
7588682|NCT00680901|11994657|FG001|Overall Study|Physician Decision|1
7588683|NCT00680901|11994656|FG000|Overall Study|Ongoing: On Study Treatment|16
7588684|NCT00680901|11994657|FG001|Overall Study|Ongoing: On Study Treatment|13
7588685|NCT00680901|11994656|FG000|Overall Study|Ongoing: In Follow Up|45
7588686|NCT00680901|11994657|FG001|Overall Study|Ongoing: In Follow Up|41
7766430|NCT00848354|12208977|FG000|Phase 2 Year 1|Adverse Event|7
7766431|NCT00848354|12208978|FG001|Phase 2 Year 1|Adverse Event|2
7766432|NCT00848354|12208977|FG000|Phase 2 Year 1|Death|1
7766433|NCT00848354|12208978|FG001|Phase 2 Year 1|Death|0
7766434|NCT00848354|12208977|FG000|Phase 2 Year 1|Failed to Return|1
7766435|NCT00848354|12208978|FG001|Phase 2 Year 1|Failed to Return|1
7766436|NCT00848354|12208977|FG000|Phase 2 Year 1|Lost to Follow-up|1
7766437|NCT00848354|12208978|FG001|Phase 2 Year 1|Lost to Follow-up|0
7766438|NCT00848354|12208977|FG000|Phase 2 Year 1|Unspecified Reason|3
7766439|NCT00848354|12208978|FG001|Phase 2 Year 1|Unspecified Reason|0
7766440|NCT00848354|12208977|FG000|Phase 2 Year 1|Protocol Violation|4
7766441|NCT00848354|12208978|FG001|Phase 2 Year 1|Protocol Violation|1
7766442|NCT00848354|12208977|FG000|Phase 2 Year 1|Subject Request|1
7766443|NCT00848354|12208978|FG001|Phase 2 Year 1|Subject Request|2
7766444|NCT00848354|12208977|FG000|Phase 2 Year 2|Adverse Event|12
7766445|NCT00848354|12208978|FG001|Phase 2 Year 2|Adverse Event|2
7766446|NCT00848354|12208977|FG000|Phase 2 Year 2|Death|2
7766447|NCT00848354|12208978|FG001|Phase 2 Year 2|Death|0
7766448|NCT00848354|12208977|FG000|Phase 2 Year 2|Failed to return|3
7766449|NCT00848354|12208978|FG001|Phase 2 Year 2|Failed to return|0
7766450|NCT00848354|12208977|FG000|Phase 2 Year 2|Lost to Follow-up|1
7766451|NCT00848354|12208978|FG001|Phase 2 Year 2|Lost to Follow-up|3
7766452|NCT00848354|12208977|FG000|Phase 2 Year 2|Unspecified Reason|1
7766453|NCT00848354|12208978|FG001|Phase 2 Year 2|Unspecified Reason|0
7766454|NCT00848354|12208977|FG000|Phase 2 Year 2|Protocol Violation|1
7766455|NCT00848354|12208978|FG001|Phase 2 Year 2|Protocol Violation|1
7766456|NCT00848354|12208977|FG000|Phase 2 Year 2|Subject Request|1
7766457|NCT00848354|12208978|FG001|Phase 2 Year 2|Subject Request|1
7766458|NCT00848354|12208977|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
7766459|NCT00848354|12208978|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
7766460|NCT00848393|12209002|FG000|Overall Study|Protocol Violation|0
7766461|NCT00848393|12209003|FG001|Overall Study|Protocol Violation|0
7766462|NCT00848393|12209004|FG002|Overall Study|Protocol Violation|1
7766463|NCT00848393|12209002|FG000|Overall Study|surgical complications unrelated to stud|0
7766464|NCT00848393|12209003|FG001|Overall Study|surgical complications unrelated to stud|0
7766465|NCT00848393|12209004|FG002|Overall Study|surgical complications unrelated to stud|2
7766466|NCT00848484|12209018|FG000|First Intervention (Treatment Period 1)|Adverse Event|2
7766467|NCT00848484|12209019|FG001|First Intervention (Treatment Period 1)|Adverse Event|1
7766468|NCT00848484|12209018|FG000|First Intervention (Treatment Period 1)|Physician Decision|0
7766469|NCT00848484|12209019|FG001|First Intervention (Treatment Period 1)|Physician Decision|1
7766470|NCT00848484|12209018|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
7766471|NCT00848484|12209019|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
7766472|NCT00848484|12209018|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0
7766473|NCT00848484|12209019|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3
7766474|NCT00848484|12209018|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
7766475|NCT00848484|12209019|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
7766476|NCT00848497|12209027|FG000|Overall Study|Screen failure|2
7766477|NCT00848497|12209028|FG001|Overall Study|Screen failure|0
7766478|NCT00848497|12209027|FG000|Overall Study|Withdrawal by Subject|0
7766479|NCT00848497|12209028|FG001|Overall Study|Withdrawal by Subject|1
7766480|NCT00848536|12209055|FG000|Overall Study|Adverse Event|2
7766481|NCT00848536|12209056|FG001|Overall Study|Adverse Event|2
7766482|NCT00848536|12209055|FG000|Overall Study|Withdrawal by Subject|0
7766483|NCT00848536|12209056|FG001|Overall Study|Withdrawal by Subject|1
7766484|NCT00848536|12209055|FG000|Overall Study|Protocol Violation|0
7766485|NCT00848536|12209056|FG001|Overall Study|Protocol Violation|1
7766486|NCT00848536|12209055|FG000|Overall Study|Noncompliance|1
7766487|NCT00848536|12209056|FG001|Overall Study|Noncompliance|0
7766488|NCT00848536|12209055|FG000|Overall Study|Inadequate Control of IOP|1
7766489|NCT00848536|12209056|FG001|Overall Study|Inadequate Control of IOP|1
7766490|NCT00848536|12209055|FG000|Overall Study|Patient Moved|0
7766491|NCT00848536|12209056|FG001|Overall Study|Patient Moved|2
7766492|NCT00848549|12209064|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
7766493|NCT00848549|12209065|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
7766494|NCT00848549|12209064|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
7766495|NCT00848549|12209065|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
7766496|NCT00848549|12209064|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
7766497|NCT00848549|12209065|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
7766498|NCT00848549|12209064|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
7766499|NCT00848549|12209065|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
7766500|NCT00848549|12209064|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
7766501|NCT00848549|12209065|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
7766502|NCT00848549|12209064|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
7766503|NCT00848549|12209065|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
7766504|NCT00848549|12209064|FG000|E2090-E044-310 (Base Study) Disposition|Other|4
7766505|NCT00848549|12209065|FG001|E2090-E044-310 (Base Study) Disposition|Other|3
7766506|NCT00848549|12209064|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
7766507|NCT00848549|12209065|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
7766508|NCT00848549|12209064|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2
7766509|NCT00848549|12209065|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1
7766510|NCT00848549|12209064|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1
7766511|NCT00848549|12209065|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2
7766512|NCT00848549|12209064|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
7766513|NCT00848549|12209065|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
7766514|NCT00848549|12209064|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
7766515|NCT00848549|12209065|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
7766516|NCT00848549|12209064|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0
7766517|NCT00848549|12209065|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2
7766518|NCT00848549|12209064|FG000|E2090-E044-314 (Extension Study)|Other|5
7766519|NCT00848549|12209065|FG001|E2090-E044-314 (Extension Study)|Other|6
7766520|NCT00848718|12209086|FG000|Overall Study|Adverse Event|2
7766521|NCT00848718|12209087|FG001|Overall Study|Adverse Event|2
7766522|NCT00848718|12209088|FG002|Overall Study|Adverse Event|1
7766523|NCT00848718|12209089|FG003|Overall Study|Adverse Event|1
7766524|NCT00848718|12209090|FG004|Overall Study|Adverse Event|1
7766525|NCT00848718|12209091|FG005|Overall Study|Adverse Event|0
7766526|NCT00848718|12209092|FG006|Overall Study|Adverse Event|0
7766527|NCT00848718|12209093|FG007|Overall Study|Adverse Event|1
7766528|NCT00848718|12209094|FG008|Overall Study|Adverse Event|1
7766529|NCT00848718|12209095|FG009|Overall Study|Adverse Event|0
7766530|NCT00848718|12209096|FG010|Overall Study|Adverse Event|0
7766531|NCT00848718|12209097|FG011|Overall Study|Adverse Event|0
7766532|NCT00848718|12209098|FG012|Overall Study|Adverse Event|2
7766533|NCT00848718|12209086|FG000|Overall Study|Lack of Efficacy|0
7766534|NCT00848718|12209087|FG001|Overall Study|Lack of Efficacy|0
7766535|NCT00848718|12209088|FG002|Overall Study|Lack of Efficacy|1
7766536|NCT00848718|12209089|FG003|Overall Study|Lack of Efficacy|0
7766537|NCT00848718|12209090|FG004|Overall Study|Lack of Efficacy|0
7766538|NCT00848718|12209091|FG005|Overall Study|Lack of Efficacy|0
7766539|NCT00848718|12209092|FG006|Overall Study|Lack of Efficacy|1
7766540|NCT00848718|12209093|FG007|Overall Study|Lack of Efficacy|0
7766541|NCT00848718|12209094|FG008|Overall Study|Lack of Efficacy|0
7766542|NCT00848718|12209095|FG009|Overall Study|Lack of Efficacy|0
7766543|NCT00848718|12209096|FG010|Overall Study|Lack of Efficacy|0
7766544|NCT00848718|12209097|FG011|Overall Study|Lack of Efficacy|0
7626319|NCT00070707|12038399|FG000|Overall Study|Adverse Event|1
7626320|NCT00070707|12038400|FG001|Overall Study|Adverse Event|2
7626321|NCT00070707|12038399|FG000|Overall Study|Lack of Efficacy|4
7626322|NCT00070707|12038400|FG001|Overall Study|Lack of Efficacy|1
7626323|NCT00070707|12038399|FG000|Overall Study|Protocol Violation|8
7626324|NCT00070707|12038400|FG001|Overall Study|Protocol Violation|4
7626325|NCT00070707|12038399|FG000|Overall Study|Unrelated to Study Medication|1
7626326|NCT00070707|12038400|FG001|Overall Study|Unrelated to Study Medication|0
7588813|NCT01335685|11994691|FG000|Overall Study|Study Terminated by Sponsor|2
7588814|NCT01335685|11994692|FG001|Overall Study|Study Terminated by Sponsor|1
7588815|NCT01335685|11994693|FG002|Overall Study|Study Terminated by Sponsor|1
7588816|NCT01335685|11994694|FG003|Overall Study|Study Terminated by Sponsor|10
7588817|NCT01335685|11994695|FG004|Overall Study|Study Terminated by Sponsor|0
7588818|NCT01335685|11994696|FG005|Overall Study|Study Terminated by Sponsor|4
7588819|NCT01335685|11994697|FG006|Overall Study|Study Terminated by Sponsor|2
7588820|NCT01335685|11994698|FG007|Overall Study|Study Terminated by Sponsor|3
7588821|NCT01335685|11994691|FG000|Overall Study|Withdrawal by Subject|1
7588822|NCT01335685|11994692|FG001|Overall Study|Withdrawal by Subject|0
7588823|NCT01335685|11994693|FG002|Overall Study|Withdrawal by Subject|0
7588824|NCT01335685|11994694|FG003|Overall Study|Withdrawal by Subject|1
7588825|NCT01335685|11994695|FG004|Overall Study|Withdrawal by Subject|0
7588826|NCT01335685|11994696|FG005|Overall Study|Withdrawal by Subject|0
7588827|NCT01335685|11994697|FG006|Overall Study|Withdrawal by Subject|0
7588828|NCT01335685|11994698|FG007|Overall Study|Withdrawal by Subject|0
7588829|NCT01335685|11994691|FG000|Overall Study|Reason not Specified|0
7588830|NCT01335685|11994692|FG001|Overall Study|Reason not Specified|0
7588831|NCT01335685|11994693|FG002|Overall Study|Reason not Specified|1
7588832|NCT01335685|11994694|FG003|Overall Study|Reason not Specified|0
7588833|NCT01335685|11994695|FG004|Overall Study|Reason not Specified|0
7588834|NCT01335685|11994696|FG005|Overall Study|Reason not Specified|1
7588835|NCT01335685|11994697|FG006|Overall Study|Reason not Specified|0
7588836|NCT01335685|11994698|FG007|Overall Study|Reason not Specified|0
7588837|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
7588838|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
7588839|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
7588840|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
7588841|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
7588842|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
7588843|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
7588844|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
7588845|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
7588846|NCT01336621|11994721|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
7588847|NCT01336621|11994721|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1
7588848|NCT01336621|11994721|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
7588849|NCT01336621|11994721|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1
7588850|NCT01336621|11994721|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
7588851|NCT04170296|11994741|FG000|Overall Study|Adverse Event|1
7588852|NCT04170296|11994742|FG001|Overall Study|Adverse Event|0
7588853|NCT04170296|11994741|FG000|Overall Study|Withdrawal by Subject|3
7588854|NCT04170296|11994742|FG001|Overall Study|Withdrawal by Subject|2
7588855|NCT04170296|11994741|FG000|Overall Study|Lost to Follow-up|4
7588856|NCT04170296|11994742|FG001|Overall Study|Lost to Follow-up|2
7588857|NCT04039217|11994754|FG000|Overall Study|Lost to Follow-up|1
7588858|NCT03078192|11994808|FG000|Overall Study|Withdrawal by Subject|2
7588859|NCT03078192|11994809|FG001|Overall Study|Withdrawal by Subject|1
7588860|NCT03078192|11994808|FG000|Overall Study|screen failure|0
7588861|NCT03078192|11994809|FG001|Overall Study|screen failure|3
7588862|NCT02903823|11994824|FG000|Overall Study|Physician Decision|5
7588863|NCT02903823|11994824|FG000|Overall Study|Could not advance catheter|1
7588864|NCT02903823|11994824|FG000|Overall Study|Catheter dislodgement|1
7588865|NCT01547117|11994846|FG000|Overall Study|Physician Decision|0
7588866|NCT01547117|11994847|FG001|Overall Study|Physician Decision|1
7588867|NCT01547117|11994848|FG002|Overall Study|Physician Decision|1
7588868|NCT01547117|11994849|FG003|Overall Study|Physician Decision|3
7588869|NCT01547117|11994846|FG000|Overall Study|Withdrawal by Subject|1
7588870|NCT01547117|11994847|FG001|Overall Study|Withdrawal by Subject|2
7588871|NCT01547117|11994848|FG002|Overall Study|Withdrawal by Subject|1
7588872|NCT01547117|11994849|FG003|Overall Study|Withdrawal by Subject|2
7588873|NCT01431508|11994875|FG000|Overall Study|Lack of Efficacy|1
7588874|NCT01431508|11994875|FG000|Overall Study|Unable to Follow Protocol Procedures|1
7588875|NCT00871351|11994882|FG000|Overall Study|Withdrawal by Subject|1
7588876|NCT00871351|11994883|FG001|Overall Study|Withdrawal by Subject|0
7588877|NCT00871351|11994884|FG002|Overall Study|Withdrawal by Subject|0
7588878|NCT00871351|11994882|FG000|Overall Study|Adverse Event|3
7588879|NCT00871351|11994883|FG001|Overall Study|Adverse Event|1
7588880|NCT00871351|11994884|FG002|Overall Study|Adverse Event|0
7588881|NCT00832455|11994892|FG000|Overall Study|Adverse Event|13
7588882|NCT00832455|11994892|FG000|Overall Study|Lost to Follow-up|26
7588883|NCT00832455|11994892|FG000|Overall Study|Protocol Violation|4
7588884|NCT00832455|11994892|FG000|Overall Study|Withdrawal by Subject|17
7588885|NCT00832455|11994892|FG000|Overall Study|Screening Failure|2
7588886|NCT00832455|11994892|FG000|Overall Study|Stopped Medication|4
7588887|NCT00832455|11994892|FG000|Overall Study|Parent misunderstood study|1
7588888|NCT00832455|11994892|FG000|Overall Study|Parent dissatisfied|1
7588889|NCT00832455|11994892|FG000|Overall Study|No improvement|3
7588890|NCT00832455|11994892|FG000|Overall Study|Patient moved|1
7588891|NCT00812006|11994908|FG000|Overall Study|Lost to Follow-up|0
7766545|NCT00848718|12209098|FG012|Overall Study|Lack of Efficacy|0
7766546|NCT00848718|12209086|FG000|Overall Study|Physician Decision|0
7766547|NCT00848718|12209087|FG001|Overall Study|Physician Decision|1
7766548|NCT00848718|12209088|FG002|Overall Study|Physician Decision|0
7766549|NCT00848718|12209089|FG003|Overall Study|Physician Decision|0
7766550|NCT00848718|12209090|FG004|Overall Study|Physician Decision|1
7766551|NCT00848718|12209091|FG005|Overall Study|Physician Decision|1
7766552|NCT00848718|12209092|FG006|Overall Study|Physician Decision|0
7766553|NCT00848718|12209093|FG007|Overall Study|Physician Decision|0
7766554|NCT00848718|12209094|FG008|Overall Study|Physician Decision|1
7766555|NCT00848718|12209095|FG009|Overall Study|Physician Decision|2
7766556|NCT00848718|12209096|FG010|Overall Study|Physician Decision|0
7766557|NCT00848718|12209097|FG011|Overall Study|Physician Decision|0
7766558|NCT00848718|12209098|FG012|Overall Study|Physician Decision|1
7766559|NCT00848718|12209086|FG000|Overall Study|Progressive disease before treatment|1
7766560|NCT00848718|12209087|FG001|Overall Study|Progressive disease before treatment|5
7766561|NCT00848718|12209088|FG002|Overall Study|Progressive disease before treatment|1
7766562|NCT00848718|12209089|FG003|Overall Study|Progressive disease before treatment|3
7766563|NCT00848718|12209090|FG004|Overall Study|Progressive disease before treatment|4
7766564|NCT00848718|12209091|FG005|Overall Study|Progressive disease before treatment|4
7766565|NCT00848718|12209092|FG006|Overall Study|Progressive disease before treatment|2
7766566|NCT00848718|12209093|FG007|Overall Study|Progressive disease before treatment|1
7766567|NCT00848718|12209094|FG008|Overall Study|Progressive disease before treatment|2
7766568|NCT00848718|12209095|FG009|Overall Study|Progressive disease before treatment|7
7766569|NCT00848718|12209096|FG010|Overall Study|Progressive disease before treatment|3
7766570|NCT00848718|12209097|FG011|Overall Study|Progressive disease before treatment|6
7766571|NCT00848718|12209098|FG012|Overall Study|Progressive disease before treatment|2
7766572|NCT00848718|12209086|FG000|Overall Study|Protocol Violation|0
7766573|NCT00848718|12209087|FG001|Overall Study|Protocol Violation|1
7766574|NCT00848718|12209088|FG002|Overall Study|Protocol Violation|0
7766575|NCT00848718|12209089|FG003|Overall Study|Protocol Violation|0
7766576|NCT00848718|12209090|FG004|Overall Study|Protocol Violation|0
7766577|NCT00848718|12209091|FG005|Overall Study|Protocol Violation|0
7766578|NCT00848718|12209092|FG006|Overall Study|Protocol Violation|0
7766579|NCT00848718|12209093|FG007|Overall Study|Protocol Violation|1
7766580|NCT00848718|12209094|FG008|Overall Study|Protocol Violation|0
7766581|NCT00848718|12209095|FG009|Overall Study|Protocol Violation|0
7588892|NCT00812006|11994909|FG001|Overall Study|Lost to Follow-up|0
7588893|NCT00812006|11994910|FG002|Overall Study|Lost to Follow-up|2
7588894|NCT00812006|11994908|FG000|Overall Study|Physician Decision|0
7588895|NCT00812006|11994909|FG001|Overall Study|Physician Decision|0
7588896|NCT00812006|11994910|FG002|Overall Study|Physician Decision|1
7766582|NCT00848718|12209096|FG010|Overall Study|Protocol Violation|0
7766583|NCT00848718|12209097|FG011|Overall Study|Protocol Violation|0
7766584|NCT00848718|12209098|FG012|Overall Study|Protocol Violation|1
7766585|NCT00848718|12209086|FG000|Overall Study|Withdrawal by Subject|1
7766586|NCT00848718|12209087|FG001|Overall Study|Withdrawal by Subject|0
7766587|NCT00848718|12209088|FG002|Overall Study|Withdrawal by Subject|0
7766588|NCT00848718|12209089|FG003|Overall Study|Withdrawal by Subject|1
7766589|NCT00848718|12209090|FG004|Overall Study|Withdrawal by Subject|0
7766590|NCT00848718|12209091|FG005|Overall Study|Withdrawal by Subject|0
7766591|NCT00848718|12209092|FG006|Overall Study|Withdrawal by Subject|0
7766592|NCT00848718|12209093|FG007|Overall Study|Withdrawal by Subject|0
7766593|NCT00848718|12209094|FG008|Overall Study|Withdrawal by Subject|0
7766594|NCT00848718|12209095|FG009|Overall Study|Withdrawal by Subject|0
7766595|NCT00848718|12209096|FG010|Overall Study|Withdrawal by Subject|1
7766596|NCT00848718|12209097|FG011|Overall Study|Withdrawal by Subject|0
7766597|NCT00848718|12209098|FG012|Overall Study|Withdrawal by Subject|0
7766598|NCT00848718|12209086|FG000|Overall Study|Progressive disease during treatment|3
7766599|NCT00848718|12209087|FG001|Overall Study|Progressive disease during treatment|0
7766600|NCT00848718|12209088|FG002|Overall Study|Progressive disease during treatment|3
7766601|NCT00848718|12209089|FG003|Overall Study|Progressive disease during treatment|0
7766602|NCT00848718|12209090|FG004|Overall Study|Progressive disease during treatment|0
7766603|NCT00848718|12209091|FG005|Overall Study|Progressive disease during treatment|0
7766604|NCT00848718|12209092|FG006|Overall Study|Progressive disease during treatment|0
7766605|NCT00848718|12209093|FG007|Overall Study|Progressive disease during treatment|2
7766606|NCT00848718|12209094|FG008|Overall Study|Progressive disease during treatment|0
7766607|NCT00848718|12209095|FG009|Overall Study|Progressive disease during treatment|0
7766608|NCT00848718|12209096|FG010|Overall Study|Progressive disease during treatment|0
7766609|NCT00848718|12209097|FG011|Overall Study|Progressive disease during treatment|0
7766610|NCT00848718|12209098|FG012|Overall Study|Progressive disease during treatment|2
7766611|NCT00848926|12209149|FG000|Treatment Period|Progressive disease|45
7766612|NCT00848926|12209149|FG000|Treatment Period|Adverse Event|20
7588897|NCT00812006|11994908|FG000|Overall Study|Withdrawal by Subject|2
7588898|NCT00812006|11994909|FG001|Overall Study|Withdrawal by Subject|1
7588899|NCT00812006|11994910|FG002|Overall Study|Withdrawal by Subject|1
7588900|NCT00812006|11994908|FG000|Overall Study|Lack of Qualifying Event|4
7588901|NCT00812006|11994909|FG001|Overall Study|Lack of Qualifying Event|2
7588902|NCT00812006|11994910|FG002|Overall Study|Lack of Qualifying Event|2
7588903|NCT00687531|11994923|FG000|Overall Study|Did not meet protocol eligibility|104
7588904|NCT00687531|11994923|FG000|Overall Study|Adverse Event|5
7588905|NCT00687531|11994923|FG000|Overall Study|Lost to Follow-up|26
7588906|NCT00654628|11994927|FG000|6-week Active Treatment Period|Adverse Event|9
7588907|NCT00654628|11994927|FG000|6-week Active Treatment Period|Lost to Follow-up|10
7588908|NCT00654628|11994927|FG000|6-week Active Treatment Period|Transferred to branch hospital|1
7588909|NCT00654628|11994927|FG000|6-week Active Treatment Period|Out of window period|1
7588910|NCT00654628|11994927|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4
7588911|NCT00654628|11994927|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1
7588912|NCT00536380|11994953|FG000|Overall Study|Adverse Event|0
7588913|NCT00536380|11994954|FG001|Overall Study|Adverse Event|2
7588914|NCT00536380|11994955|FG002|Overall Study|Adverse Event|2
7588915|NCT00536380|11994953|FG000|Overall Study|Lost to Follow-up|0
7588916|NCT00536380|11994954|FG001|Overall Study|Lost to Follow-up|0
7588917|NCT00536380|11994955|FG002|Overall Study|Lost to Follow-up|1
7588918|NCT00536380|11994953|FG000|Overall Study|Withdrawal unrelated to study drug|2
7588919|NCT00536380|11994954|FG001|Overall Study|Withdrawal unrelated to study drug|0
7588920|NCT00536380|11994955|FG002|Overall Study|Withdrawal unrelated to study drug|1
7588921|NCT00536380|11994953|FG000|Overall Study|Withdrawal related to study drug|7
7588922|NCT00536380|11994954|FG001|Overall Study|Withdrawal related to study drug|5
7588923|NCT00536380|11994955|FG002|Overall Study|Withdrawal related to study drug|2
7588924|NCT00536380|11994953|FG000|Overall Study|Noncompliance with protocol|3
7588925|NCT00536380|11994954|FG001|Overall Study|Noncompliance with protocol|2
7588926|NCT00536380|11994955|FG002|Overall Study|Noncompliance with protocol|2
7588927|NCT00536380|11994953|FG000|Overall Study|Did not meet protocol eligibility|0
7588928|NCT00536380|11994954|FG001|Overall Study|Did not meet protocol eligibility|0
7588929|NCT00536380|11994955|FG002|Overall Study|Did not meet protocol eligibility|1
7588930|NCT00536380|11994953|FG000|Overall Study|Administrative|0
7588931|NCT00536380|11994954|FG001|Overall Study|Administrative|0
7588932|NCT00536380|11994955|FG002|Overall Study|Administrative|1
7588933|NCT00521599|11994966|FG000|Overall Study|Adverse Event|5
7588934|NCT00521599|11994967|FG001|Overall Study|Adverse Event|7
7588935|NCT00521599|11994968|FG002|Overall Study|Adverse Event|6
7588936|NCT00521599|11994966|FG000|Overall Study|Treatment Failure|8
7588937|NCT00521599|11994967|FG001|Overall Study|Treatment Failure|9
7588938|NCT00521599|11994968|FG002|Overall Study|Treatment Failure|22
7588939|NCT00521599|11994966|FG000|Overall Study|Lost to Follow-up|2
7588940|NCT00521599|11994967|FG001|Overall Study|Lost to Follow-up|1
7588941|NCT00521599|11994968|FG002|Overall Study|Lost to Follow-up|2
7588942|NCT00521599|11994966|FG000|Overall Study|Withdrawal by Subject|3
7588943|NCT00521599|11994967|FG001|Overall Study|Withdrawal by Subject|5
7588944|NCT00521599|11994968|FG002|Overall Study|Withdrawal by Subject|1
7588945|NCT00521599|11994966|FG000|Overall Study|Withdrawal by subject treatment related|3
7588946|NCT00521599|11994967|FG001|Overall Study|Withdrawal by subject treatment related|1
7588947|NCT00521599|11994968|FG002|Overall Study|Withdrawal by subject treatment related|2
7588948|NCT00521599|11994966|FG000|Overall Study|Protocol Violation|2
7588949|NCT00521599|11994967|FG001|Overall Study|Protocol Violation|4
7588950|NCT00521599|11994968|FG002|Overall Study|Protocol Violation|2
7588951|NCT00521599|11994966|FG000|Overall Study|Did not meet protocol eligibility|2
7588952|NCT00521599|11994967|FG001|Overall Study|Did not meet protocol eligibility|2
7588953|NCT00521599|11994968|FG002|Overall Study|Did not meet protocol eligibility|1
7588954|NCT00496834|11994979|FG000|Overall Study|Withdrawal by Subject|4
7588955|NCT00496834|11994980|FG001|Overall Study|Withdrawal by Subject|6
7588956|NCT00496834|11994979|FG000|Overall Study|Contraindicated medication administered|0
7588957|NCT00496834|11994980|FG001|Overall Study|Contraindicated medication administered|1
7588958|NCT00496834|11994979|FG000|Overall Study|Inclusion/exclusion criteria not met|3
7588959|NCT00496834|11994980|FG001|Overall Study|Inclusion/exclusion criteria not met|2
7588960|NCT00496834|11994979|FG000|Overall Study|Adverse Event|5
7588961|NCT00496834|11994980|FG001|Overall Study|Adverse Event|3
7588962|NCT00496834|11994979|FG000|Overall Study|IP administration violation|2
7588963|NCT00496834|11994980|FG001|Overall Study|IP administration violation|0
7588964|NCT00496834|11994979|FG000|Overall Study|Lost to Follow-up|2
7588965|NCT00496834|11994980|FG001|Overall Study|Lost to Follow-up|0
7588966|NCT00496834|11994979|FG000|Overall Study|Blood Pressure control failure|2
7588967|NCT00496834|11994980|FG001|Overall Study|Blood Pressure control failure|1
7588968|NCT00442897|11994990|FG000|Base Study (12 Week Follow-up)|Adverse Event|1
7588969|NCT00442897|11994991|FG001|Base Study (12 Week Follow-up)|Adverse Event|0
7588970|NCT00442897|11994990|FG000|Base Study (12 Week Follow-up)|Death|0
7588971|NCT00442897|11994991|FG001|Base Study (12 Week Follow-up)|Death|1
7588972|NCT00442897|11994990|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7
7588973|NCT00442897|11994991|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3
7588974|NCT00442897|11994990|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
7588975|NCT00442897|11994991|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
7588976|NCT00442897|11994990|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1
7588977|NCT00442897|11994991|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0
7588978|NCT00442897|11994990|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
7588979|NCT00442897|11994991|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
7588980|NCT00442897|11994990|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
7588981|NCT00442897|11994991|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
7588982|NCT00442897|11994990|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
7588983|NCT00442897|11994991|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
7588984|NCT00423579|11994999|FG000|Overall Study|Lost to Follow-up|3
7588985|NCT00423579|11995000|FG001|Overall Study|Lost to Follow-up|0
7588986|NCT00423579|11994999|FG000|Overall Study|Protocol Violation|1
7588987|NCT00423579|11995000|FG001|Overall Study|Protocol Violation|3
7588988|NCT00423579|11994999|FG000|Overall Study|Diagnosis of diabetes|0
7588989|NCT00423579|11995000|FG001|Overall Study|Diagnosis of diabetes|1
7588990|NCT00394355|11995010|FG000|Overall Study|Adverse Event|10
7588991|NCT00394355|11995011|FG001|Overall Study|Adverse Event|6
7588992|NCT00394355|11995012|FG002|Overall Study|Adverse Event|7
7588993|NCT00394355|11995013|FG003|Overall Study|Adverse Event|8
7588994|NCT00394355|11995010|FG000|Overall Study|Did not meet protocol eligibility|1
7588995|NCT00394355|11995011|FG001|Overall Study|Did not meet protocol eligibility|5
7588996|NCT00394355|11995012|FG002|Overall Study|Did not meet protocol eligibility|4
7588997|NCT00394355|11995013|FG003|Overall Study|Did not meet protocol eligibility|2
7588998|NCT00394355|11995010|FG000|Overall Study|Subject withdrawal - unrelated to drug|12
7588999|NCT00394355|11995011|FG001|Overall Study|Subject withdrawal - unrelated to drug|14
7589000|NCT00394355|11995012|FG002|Overall Study|Subject withdrawal - unrelated to drug|10
7589001|NCT00394355|11995013|FG003|Overall Study|Subject withdrawal - unrelated to drug|6
7589002|NCT00394355|11995010|FG000|Overall Study|Subject withdrawal - related to drug|1
7589003|NCT00394355|11995011|FG001|Overall Study|Subject withdrawal - related to drug|0
7589004|NCT00394355|11995012|FG002|Overall Study|Subject withdrawal - related to drug|0
7589005|NCT00394355|11995013|FG003|Overall Study|Subject withdrawal - related to drug|0
7589006|NCT00394355|11995010|FG000|Overall Study|Lost to Follow-up|7
7589007|NCT00394355|11995011|FG001|Overall Study|Lost to Follow-up|5
7589008|NCT00394355|11995012|FG002|Overall Study|Lost to Follow-up|4
7589009|NCT00394355|11995013|FG003|Overall Study|Lost to Follow-up|3
7589010|NCT00394355|11995010|FG000|Overall Study|Noncompliance with protocol|4
7589011|NCT00394355|11995011|FG001|Overall Study|Noncompliance with protocol|3
7589012|NCT00394355|11995012|FG002|Overall Study|Noncompliance with protocol|10
7589013|NCT00394355|11995013|FG003|Overall Study|Noncompliance with protocol|8
7589014|NCT00394355|11995010|FG000|Overall Study|Administrative|0
7589015|NCT00394355|11995011|FG001|Overall Study|Administrative|1
7589016|NCT00394355|11995012|FG002|Overall Study|Administrative|1
7589017|NCT00394355|11995013|FG003|Overall Study|Administrative|1
7589018|NCT00394355|11995010|FG000|Overall Study|Lack of Efficacy|0
7589019|NCT00394355|11995011|FG001|Overall Study|Lack of Efficacy|0
7589020|NCT00394355|11995012|FG002|Overall Study|Lack of Efficacy|2
7589021|NCT00394355|11995013|FG003|Overall Study|Lack of Efficacy|3
7589022|NCT00166504|11995034|FG000|Overall Study|Adverse Event|3
7589023|NCT00166504|11995035|FG001|Overall Study|Adverse Event|3
7589024|NCT00166504|11995034|FG000|Overall Study|Lost to Follow-up|1
7589025|NCT00166504|11995035|FG001|Overall Study|Lost to Follow-up|1
7589026|NCT00166504|11995034|FG000|Overall Study|Withdrawal by Subject|1
7589027|NCT00166504|11995035|FG001|Overall Study|Withdrawal by Subject|0
7626327|NCT04474197|12038430|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0
7626328|NCT04474197|12038431|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1
7626329|NCT04474197|12038432|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0
7626330|NCT04474197|12038433|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0
7626358|NCT03712345|12038511|FG000|Overall Study|Failure to meet randomization criteria|0
7626359|NCT03712345|12038512|FG001|Overall Study|Failure to meet randomization criteria|0
7626360|NCT03712345|12038513|FG002|Overall Study|Failure to meet randomization criteria|1
7626361|NCT03694275|12038523|FG000|Overall Study|Adverse Event|0
7626362|NCT03694275|12038524|FG001|Overall Study|Adverse Event|1
7626363|NCT03694275|12038523|FG000|Overall Study|Reason not Specified|0
7626364|NCT03694275|12038524|FG001|Overall Study|Reason not Specified|1
7626365|NCT03391232|12038533|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0
7626366|NCT03391232|12038534|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1
7626367|NCT03391232|12038533|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0
7626368|NCT03391232|12038534|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2
7626369|NCT03323736|12038545|FG000|Overall Study|Screen Failure|14
7626370|NCT03323736|12038546|FG001|Overall Study|Screen Failure|9
7626371|NCT03323736|12038547|FG002|Overall Study|Screen Failure|1
7626372|NCT03323736|12038545|FG000|Overall Study|Withdrawal Before Treatment|3
7626373|NCT03323736|12038546|FG001|Overall Study|Withdrawal Before Treatment|1
7626374|NCT03323736|12038547|FG002|Overall Study|Withdrawal Before Treatment|1
7626375|NCT03323736|12038545|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2
7626376|NCT03323736|12038546|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2
7626377|NCT03323736|12038547|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0
7626378|NCT03073980|12038569|FG000|Overall Study|Lost to Follow-up|10
7626379|NCT03073980|12038570|FG001|Overall Study|Lost to Follow-up|2
7626380|NCT03073980|12038571|FG002|Overall Study|Lost to Follow-up|9
7626381|NCT03073980|12038569|FG000|Overall Study|No post-procedure data|0
7626382|NCT03073980|12038570|FG001|Overall Study|No post-procedure data|0
7626383|NCT03073980|12038571|FG002|Overall Study|No post-procedure data|2
7626384|NCT02544074|12038613|FG000|Overall Study|Withdrawal by Subject|0
7626385|NCT02544074|12038614|FG001|Overall Study|Withdrawal by Subject|1
7626386|NCT02544074|12038615|FG002|Overall Study|Withdrawal by Subject|0
7626387|NCT02544074|12038616|FG003|Overall Study|Withdrawal by Subject|0
7626388|NCT02544074|12038617|FG004|Overall Study|Withdrawal by Subject|0
7626389|NCT02544074|12038618|FG005|Overall Study|Withdrawal by Subject|0
7626390|NCT02544074|12038619|FG006|Overall Study|Withdrawal by Subject|0
7626391|NCT02544074|12038620|FG007|Overall Study|Withdrawal by Subject|0
7626392|NCT02544074|12038621|FG008|Overall Study|Withdrawal by Subject|0
7626393|NCT02544074|12038622|FG009|Overall Study|Withdrawal by Subject|0
7626394|NCT02544074|12038623|FG010|Overall Study|Withdrawal by Subject|0
7626395|NCT02544074|12038624|FG011|Overall Study|Withdrawal by Subject|0
7626396|NCT02544074|12038625|FG012|Overall Study|Withdrawal by Subject|0
7589028|NCT01345240|11995046|FG000|Overall Study|Adverse Event|3
7589029|NCT01345240|11995047|FG001|Overall Study|Adverse Event|5
7589030|NCT01345240|11995048|FG002|Overall Study|Adverse Event|4
7589031|NCT01345240|11995049|FG003|Overall Study|Adverse Event|2
7589032|NCT01345240|11995050|FG004|Overall Study|Adverse Event|1
7589033|NCT01345240|11995046|FG000|Overall Study|Lost to Follow-up|8
7589034|NCT01345240|11995047|FG001|Overall Study|Lost to Follow-up|9
7589035|NCT01345240|11995048|FG002|Overall Study|Lost to Follow-up|14
7589036|NCT01345240|11995049|FG003|Overall Study|Lost to Follow-up|7
7589037|NCT01345240|11995050|FG004|Overall Study|Lost to Follow-up|9
7626331|NCT04369950|12038450|FG000|Overall Study|Protocol Violation|2
7626332|NCT04369950|12038451|FG001|Overall Study|Protocol Violation|2
7626333|NCT04070326|12038459|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1
7626334|NCT04070326|12038460|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0
7626335|NCT04003610|12038471|FG000|Overall Study|Lost to Follow-up|0
7626336|NCT04003610|12038472|FG001|Overall Study|Lost to Follow-up|1
7626337|NCT04003610|12038473|FG002|Overall Study|Lost to Follow-up|0
7626338|NCT04003610|12038471|FG000|Overall Study|Death|0
7626339|NCT04003610|12038472|FG001|Overall Study|Death|0
7626340|NCT04003610|12038473|FG002|Overall Study|Death|3
7626341|NCT04003610|12038471|FG000|Overall Study|Study Terminated by Sponsor|0
7626342|NCT04003610|12038472|FG001|Overall Study|Study Terminated by Sponsor|0
7626343|NCT04003610|12038473|FG002|Overall Study|Study Terminated by Sponsor|3
7626344|NCT03920293|12038484|FG000|Overall Study|Withdrawal by Subject|2
7626345|NCT03920293|12038485|FG001|Overall Study|Withdrawal by Subject|1
7626346|NCT03920293|12038484|FG000|Overall Study|Physician Decision|1
7626347|NCT03920293|12038485|FG001|Overall Study|Physician Decision|2
7626348|NCT03920293|12038484|FG000|Overall Study|Adverse Event|0
7626349|NCT03920293|12038485|FG001|Overall Study|Adverse Event|2
7626350|NCT03920293|12038484|FG000|Overall Study|Sponsor Decision|0
7626351|NCT03920293|12038485|FG001|Overall Study|Sponsor Decision|1
7626352|NCT03920293|12038484|FG000|Overall Study|Death|2
7626353|NCT03920293|12038485|FG001|Overall Study|Death|0
7626354|NCT03920293|12038484|FG000|Overall Study|Protocol Violation|1
7626355|NCT03920293|12038485|FG001|Overall Study|Protocol Violation|0
7626356|NCT03920293|12038484|FG000|Overall Study|Noncompliance|1
7626357|NCT03920293|12038485|FG001|Overall Study|Noncompliance|0
7626397|NCT02544074|12038626|FG013|Overall Study|Withdrawal by Subject|0
7626398|NCT02544074|12038627|FG014|Overall Study|Withdrawal by Subject|0
7626399|NCT02544074|12038628|FG015|Overall Study|Withdrawal by Subject|0
7626400|NCT02544074|12038629|FG016|Overall Study|Withdrawal by Subject|0
7626401|NCT02544074|12038630|FG017|Overall Study|Withdrawal by Subject|0
7626402|NCT02544074|12038631|FG018|Overall Study|Withdrawal by Subject|0
7626403|NCT02544074|12038632|FG019|Overall Study|Withdrawal by Subject|0
7626404|NCT02544074|12038633|FG020|Overall Study|Withdrawal by Subject|0
7626405|NCT02544074|12038613|FG000|Overall Study|Tablet error|0
7626406|NCT02544074|12038614|FG001|Overall Study|Tablet error|0
7626407|NCT02544074|12038615|FG002|Overall Study|Tablet error|0
7626408|NCT02544074|12038616|FG003|Overall Study|Tablet error|0
7626409|NCT02544074|12038617|FG004|Overall Study|Tablet error|0
7626410|NCT02544074|12038618|FG005|Overall Study|Tablet error|1
7626411|NCT02544074|12038619|FG006|Overall Study|Tablet error|0
7626412|NCT02544074|12038620|FG007|Overall Study|Tablet error|0
7626413|NCT02544074|12038621|FG008|Overall Study|Tablet error|0
7626414|NCT02544074|12038622|FG009|Overall Study|Tablet error|1
7626415|NCT02544074|12038623|FG010|Overall Study|Tablet error|0
7626416|NCT02544074|12038624|FG011|Overall Study|Tablet error|0
7626417|NCT02544074|12038625|FG012|Overall Study|Tablet error|0
7626418|NCT02544074|12038626|FG013|Overall Study|Tablet error|0
7626419|NCT02544074|12038627|FG014|Overall Study|Tablet error|0
7626420|NCT02544074|12038628|FG015|Overall Study|Tablet error|0
7626421|NCT02544074|12038629|FG016|Overall Study|Tablet error|0
7626422|NCT02544074|12038630|FG017|Overall Study|Tablet error|0
7626423|NCT02544074|12038631|FG018|Overall Study|Tablet error|0
7626424|NCT02544074|12038632|FG019|Overall Study|Tablet error|0
7626425|NCT02544074|12038633|FG020|Overall Study|Tablet error|0
7626426|NCT02317627|12038670|FG000|Overall Study|Withdrawal by Subject|0
7626427|NCT02317627|12038671|FG001|Overall Study|Withdrawal by Subject|1
7626428|NCT02317627|12038672|FG002|Overall Study|Withdrawal by Subject|1
7626429|NCT02317627|12038670|FG000|Overall Study|Lost to Follow-up|2
7626430|NCT02317627|12038671|FG001|Overall Study|Lost to Follow-up|0
7626431|NCT02317627|12038672|FG002|Overall Study|Lost to Follow-up|0
7626432|NCT02317627|12038670|FG000|Overall Study|Stopped by Investigator|0
7626433|NCT02317627|12038671|FG001|Overall Study|Stopped by Investigator|1
7626434|NCT02317627|12038672|FG002|Overall Study|Stopped by Investigator|0
7626435|NCT02317627|12038670|FG000|Overall Study|Adverse Event|0
7626436|NCT02317627|12038671|FG001|Overall Study|Adverse Event|2
7626437|NCT02317627|12038672|FG002|Overall Study|Adverse Event|3
7626438|NCT02317627|12038670|FG000|Overall Study|Non-compliance with study drug|0
7626439|NCT02317627|12038671|FG001|Overall Study|Non-compliance with study drug|1
7626440|NCT02317627|12038672|FG002|Overall Study|Non-compliance with study drug|0
7626441|NCT01935128|12038686|FG000|Overall Study|Death|1
7626442|NCT01935128|12038686|FG000|Overall Study|Adverse Event|6
7626443|NCT01909934|12038690|FG000|Overall Study|Ongoing|23
7626444|NCT01909934|12038690|FG000|Overall Study|Withdrawal by Subject|3
7589038|NCT01371305|11995077|FG000|Overall Study|Adverse Event|0
7589039|NCT01371305|11995078|FG001|Overall Study|Adverse Event|0
7589040|NCT01371305|11995079|FG002|Overall Study|Adverse Event|0
7589041|NCT01371305|11995080|FG003|Overall Study|Adverse Event|2
7589042|NCT01371305|11995081|FG004|Overall Study|Adverse Event|1
7589043|NCT01371305|11995082|FG005|Overall Study|Adverse Event|0
7589044|NCT01371305|11995077|FG000|Overall Study|Study terminated by sponsor|0
7589045|NCT01371305|11995078|FG001|Overall Study|Study terminated by sponsor|0
7589046|NCT01371305|11995079|FG002|Overall Study|Study terminated by sponsor|0
7589047|NCT01371305|11995080|FG003|Overall Study|Study terminated by sponsor|0
7589048|NCT01371305|11995081|FG004|Overall Study|Study terminated by sponsor|3
7589049|NCT01371305|11995082|FG005|Overall Study|Study terminated by sponsor|1
7589050|NCT01371305|11995077|FG000|Overall Study|Subject request|0
7589051|NCT01371305|11995078|FG001|Overall Study|Subject request|0
7766613|NCT00848926|12209149|FG000|Treatment Period|Physician Decision|12
7766614|NCT00848926|12209149|FG000|Treatment Period|Withdrawal by Subject|7
7766615|NCT00848926|12209149|FG000|Follow-up Period|Lost to Follow-up|7
7766616|NCT00848926|12209149|FG000|Follow-up Period|Withdrawal by Subject|3
7766617|NCT00848926|12209149|FG000|Follow-up Period|Other|2
7766618|NCT00848965|12209153|FG000|Overall Study|Adverse Event|1
7766619|NCT00848965|12209153|FG000|Overall Study|Withdrawal by Subject|1
7766620|NCT00849017|12209168|FG000|Treatment Period (156 Weeks)|Adverse Event|5
7766621|NCT00849017|12209169|FG001|Treatment Period (156 Weeks)|Adverse Event|6
7766622|NCT00849017|12209170|FG002|Treatment Period (156 Weeks)|Adverse Event|15
7766623|NCT00849017|12209168|FG000|Treatment Period (156 Weeks)|Noncompliance|3
7766624|NCT00849017|12209169|FG001|Treatment Period (156 Weeks)|Noncompliance|3
7766625|NCT00849017|12209170|FG002|Treatment Period (156 Weeks)|Noncompliance|4
7766626|NCT00849017|12209168|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10
7766627|NCT00849017|12209169|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7
7766628|NCT00849017|12209170|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8
7766629|NCT00849017|12209168|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18
7766630|NCT00849017|12209169|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14
7766631|NCT00849017|12209170|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11
7766632|NCT00849017|12209168|FG000|Treatment Period (156 Weeks)|Physician Decision|0
7766633|NCT00849017|12209169|FG001|Treatment Period (156 Weeks)|Physician Decision|2
7766634|NCT00849017|12209170|FG002|Treatment Period (156 Weeks)|Physician Decision|1
7766635|NCT00849017|12209168|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
7766636|NCT00849017|12209169|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
7766637|NCT00849017|12209170|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
7766638|NCT00849017|12209168|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1
7766639|NCT00849017|12209169|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0
7766640|NCT00849017|12209170|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0
7766641|NCT00849017|12209168|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
7766642|NCT00849017|12209169|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
7766643|NCT00849017|12209170|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
7766644|NCT00849017|12209168|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1
7766645|NCT00849017|12209169|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0
7766646|NCT00849017|12209170|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0
7766647|NCT00849017|12209168|FG000|Treatment Period (156 Weeks)|Pregnancy|1
7766648|NCT00849017|12209169|FG001|Treatment Period (156 Weeks)|Pregnancy|0
7766649|NCT00849017|12209170|FG002|Treatment Period (156 Weeks)|Pregnancy|1
7766650|NCT00849017|12209168|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
7766651|NCT00849017|12209169|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
7766652|NCT00849017|12209170|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
7766653|NCT00849017|12209168|FG000|Follow-up Period (8 Weeks)|Adverse Event|1
7766654|NCT00849017|12209169|FG001|Follow-up Period (8 Weeks)|Adverse Event|0
7766655|NCT00849017|12209170|FG002|Follow-up Period (8 Weeks)|Adverse Event|0
7766656|NCT00849017|12209168|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
7766657|NCT00849017|12209169|FG001|Follow-up Period (8 Weeks)|Noncompliance|1
7766658|NCT00849017|12209170|FG002|Follow-up Period (8 Weeks)|Noncompliance|0
7766659|NCT00849017|12209168|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13
7766660|NCT00849017|12209169|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12
7766661|NCT00849017|12209170|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16
7766662|NCT00849017|12209168|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
7766663|NCT00849017|12209169|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
7766664|NCT00849017|12209170|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
7766665|NCT00849017|12209168|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
7766666|NCT00849017|12209169|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
7766667|NCT00849017|12209170|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
7766668|NCT00849017|12209168|FG000|Follow-up Period (8 Weeks)|Physician Decision|0
7766669|NCT00849017|12209169|FG001|Follow-up Period (8 Weeks)|Physician Decision|1
7770468|NCT00876460|12214451|FG003|Combination Therapy Phase|Not treated|0
7589052|NCT01371305|11995079|FG002|Overall Study|Subject request|0
7589053|NCT01371305|11995080|FG003|Overall Study|Subject request|0
7589054|NCT01371305|11995081|FG004|Overall Study|Subject request|0
7589055|NCT01371305|11995082|FG005|Overall Study|Subject request|1
7626445|NCT01909934|12038690|FG000|Overall Study|Lost to Follow-up|1
7626446|NCT01909934|12038690|FG000|Overall Study|Withdrawal of Informed Consent|1
7626447|NCT01909934|12038690|FG000|Overall Study|Death|22
7626448|NCT01841359|12038694|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2
7626449|NCT01841359|12038694|FG000|Overall Study|Concommitant medical issues|2
7626450|NCT01841359|12038694|FG000|Overall Study|Adverse Event|3
7626451|NCT01841359|12038694|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1
7626452|NCT01459666|12038703|FG000|Overall Study|PI left institution|5
7626453|NCT01459666|12038704|FG001|Overall Study|PI left institution|4
7626454|NCT01369199|12038710|FG000|Overall Study|Withdrawal by Subject|1
7626455|NCT01369199|12038710|FG000|Overall Study|Lost to Follow-up|2
7626456|NCT01368497|12038714|FG000|Overall Study|Lost to Follow-up|2
7589056|NCT01376323|11995102|FG000|Overall Study|Adverse Event|1
7589057|NCT01376323|11995103|FG001|Overall Study|Adverse Event|0
7589058|NCT01376323|11995104|FG002|Overall Study|Adverse Event|0
7589059|NCT01376323|11995105|FG003|Overall Study|Adverse Event|2
7589060|NCT01376323|11995106|FG004|Overall Study|Adverse Event|0
7589061|NCT01376323|11995102|FG000|Overall Study|Lost to Follow-up|0
7589062|NCT01376323|11995103|FG001|Overall Study|Lost to Follow-up|0
7589063|NCT01376323|11995104|FG002|Overall Study|Lost to Follow-up|0
7589064|NCT01376323|11995105|FG003|Overall Study|Lost to Follow-up|2
7589065|NCT01376323|11995106|FG004|Overall Study|Lost to Follow-up|0
7589066|NCT01376323|11995102|FG000|Overall Study|Physician Decision|1
7589067|NCT01376323|11995103|FG001|Overall Study|Physician Decision|0
7589068|NCT01376323|11995104|FG002|Overall Study|Physician Decision|2
7589069|NCT01376323|11995105|FG003|Overall Study|Physician Decision|1
7589070|NCT01376323|11995106|FG004|Overall Study|Physician Decision|1
7589071|NCT01376323|11995102|FG000|Overall Study|Withdrawal by Subject|0
7589072|NCT01376323|11995103|FG001|Overall Study|Withdrawal by Subject|1
7589073|NCT01376323|11995104|FG002|Overall Study|Withdrawal by Subject|1
7589074|NCT01376323|11995105|FG003|Overall Study|Withdrawal by Subject|0
7589075|NCT01376323|11995106|FG004|Overall Study|Withdrawal by Subject|0
7589076|NCT01386658|11995130|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0
7589077|NCT01386658|11995131|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9
7589078|NCT01386658|11995130|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0
7589079|NCT01386658|11995131|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3
7589080|NCT01386684|11995141|FG000|Overall Study|Lost to Follow-up|51
7589081|NCT01386684|11995141|FG000|Overall Study|Other|51
7589082|NCT01386684|11995141|FG000|Overall Study|Death|47
7589083|NCT01386684|11995141|FG000|Overall Study|Withdrawal of Consent|44
7589084|NCT01386684|11995141|FG000|Overall Study|Alternative Therapy Required|37
7589085|NCT01386684|11995141|FG000|Overall Study|Disease Progression|28
7589086|NCT01386684|11995141|FG000|Overall Study|Adverse Event|20
7589087|NCT01386684|11995141|FG000|Overall Study|Noncompliance|8
7589088|NCT01386684|11995141|FG000|Overall Study|Protocol Violation|4
7589089|NCT01386684|11995141|FG000|Overall Study|Missing|3
7589090|NCT04980014|11995158|FG000|Overall Study|Participants who are Duplicated|1
7589091|NCT04980014|11995158|FG000|Overall Study|Follow-up Failure|13
7589092|NCT04980014|11995158|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2
7589093|NCT04980014|11995158|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2
7589094|NCT04980014|11995158|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57
7766670|NCT00849017|12209170|FG002|Follow-up Period (8 Weeks)|Physician Decision|1
7766671|NCT00849017|12209168|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
7766672|NCT00849017|12209169|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
7766673|NCT00849017|12209170|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
7766674|NCT00849017|12209168|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
7766675|NCT00849017|12209169|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
7766676|NCT00849017|12209170|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
7766677|NCT00849056|12209184|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13
7766678|NCT00849056|12209185|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11
7766679|NCT00849056|12209184|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
7766680|NCT00849056|12209185|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
7766681|NCT00849056|12209184|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3
7766682|NCT00849056|12209185|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3
7766683|NCT00849056|12209184|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
7766684|NCT00849056|12209185|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
7766685|NCT00849056|12209184|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
7766686|NCT00849056|12209185|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
7766687|NCT00849056|12209184|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3
7766688|NCT00849056|12209185|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3
7766689|NCT00849056|12209184|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
7766690|NCT00849056|12209185|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
7766691|NCT00849056|12209184|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
7766692|NCT00849056|12209185|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
7766693|NCT00849056|12209184|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1
7766694|NCT00849056|12209185|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0
7766695|NCT00849056|12209184|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
7766696|NCT00849056|12209185|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
7766697|NCT00849056|12209184|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
7766698|NCT00849056|12209185|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
7766699|NCT00849056|12209184|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
7766700|NCT00849056|12209185|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
7766701|NCT00849056|12209184|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
7766702|NCT00849056|12209185|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
7766703|NCT00849056|12209184|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
7766704|NCT00849056|12209185|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
7766705|NCT00849056|12209184|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
7766706|NCT00849056|12209185|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
7626469|NCT03560258|12038743|FG002|Overall Study|Lost to Follow-up|0
7766707|NCT00849056|12209184|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
7766708|NCT00849056|12209185|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
7766709|NCT00849108|12209194|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
7766710|NCT00849108|12209195|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
7589145|NCT03735849|11995234|FG000|Overall Study|Lost to Follow-up|1
7589146|NCT03735849|11995235|FG001|Overall Study|Lost to Follow-up|0
7589147|NCT03735849|11995236|FG002|Overall Study|Lost to Follow-up|0
7766711|NCT00849108|12209194|FG000|Cohort 2 Efficacy|Adverse Event|0
7766712|NCT00849108|12209195|FG001|Cohort 2 Efficacy|Adverse Event|1
7766713|NCT00849108|12209194|FG000|Cohort 2 Efficacy|Other|0
7766714|NCT00849108|12209195|FG001|Cohort 2 Efficacy|Other|9
7766715|NCT00849147|12209212|FG000|Overall Study|Withdrawal by Subject|1
7766716|NCT00849147|12209212|FG000|Overall Study|Protocol Violation|2
7766717|NCT00849147|12209212|FG000|Overall Study|Disease Relapse/Progression|2
7766718|NCT00849186|12209216|FG000|Overall Study|Adverse Event|2
7766719|NCT00849186|12209216|FG000|Overall Study|Withdrawal by Subject|1
7766720|NCT00849186|12209216|FG000|Overall Study|not treated|6
7766721|NCT00849186|12209216|FG000|Overall Study|Other|1
7766722|NCT00849212|12209221|FG000|Overall Study|Lack of Efficacy|1
7766723|NCT00849212|12209221|FG000|Overall Study|Withdrawal by Subject|3
7766724|NCT00849212|12209221|FG000|Overall Study|Adverse Event|2
7766725|NCT00849212|12209221|FG000|Overall Study|Miscellaneous|1
7766726|NCT00849290|12209232|FG000|Overall Study|Adverse Event|3
7766727|NCT00849290|12209232|FG000|Overall Study|Death|14
7766728|NCT00849290|12209232|FG000|Overall Study|Withdrawal by Subject|11
7766729|NCT00849290|12209232|FG000|Overall Study|Lost to Follow-up|2
7766730|NCT00849290|12209232|FG000|Overall Study|Protocol Violation|5
7766731|NCT00849290|12209232|FG000|Overall Study|Disease Progression|20
7766732|NCT00849381|12209236|FG000|Overall Study|Adverse Event|1
7766733|NCT00849381|12209236|FG000|Overall Study|Lost to Follow-up|129
7766734|NCT00849381|12209236|FG000|Overall Study|Protocol Violation|5
7766735|NCT00849381|12209236|FG000|Overall Study|Withdrawal by Subject|6
7766736|NCT00849381|12209236|FG000|Overall Study|Other|4
7766737|NCT00849472|12209240|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
7766738|NCT00849472|12209240|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
7766739|NCT00849472|12209240|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
7766740|NCT00849472|12209240|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
7766741|NCT00849472|12209240|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
7766742|NCT00849472|12209240|FG000|Weekly Paclitaxel|Disease Progression|1
7766743|NCT00849472|12209240|FG000|Weekly Paclitaxel|Adverse Event|11
7766744|NCT00849472|12209240|FG000|Weekly Paclitaxel|Withdrawal by Subject|1
7766745|NCT00849472|12209240|FG000|Weekly Paclitaxel|Physician Decision|3
7766746|NCT00849472|12209240|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
7766747|NCT00849472|12209240|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
7766748|NCT00849472|12209240|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
7766749|NCT00849472|12209240|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
7766750|NCT00849472|12209240|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19
7766751|NCT00849472|12209240|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
7766752|NCT00849472|12209240|FG000|Pazopanib Postsurgery Treatment|Moved|1
7766753|NCT00849472|12209240|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
7766754|NCT00849680|12209253|FG000|Overall Study|Adverse Event|0
7766755|NCT00849680|12209254|FG001|Overall Study|Adverse Event|0
7766756|NCT00849680|12209255|FG002|Overall Study|Adverse Event|0
7766757|NCT00849680|12209256|FG003|Overall Study|Adverse Event|0
7766758|NCT00849680|12209257|FG004|Overall Study|Adverse Event|0
7766759|NCT00849680|12209258|FG005|Overall Study|Adverse Event|0
7766760|NCT00849680|12209259|FG006|Overall Study|Adverse Event|2
7766761|NCT00849680|12209260|FG007|Overall Study|Adverse Event|0
7766762|NCT00849680|12209253|FG000|Overall Study|Lost to Follow-up|7
7766763|NCT00849680|12209254|FG001|Overall Study|Lost to Follow-up|3
7766764|NCT00849680|12209255|FG002|Overall Study|Lost to Follow-up|12
7766765|NCT00849680|12209256|FG003|Overall Study|Lost to Follow-up|11
7766766|NCT00849680|12209257|FG004|Overall Study|Lost to Follow-up|8
7766767|NCT00849680|12209258|FG005|Overall Study|Lost to Follow-up|11
7589148|NCT03735849|11995234|FG000|Overall Study|Participant unable to adhere to visit|1
7589149|NCT03735849|11995235|FG001|Overall Study|Participant unable to adhere to visit|0
7589150|NCT03735849|11995236|FG002|Overall Study|Participant unable to adhere to visit|0
7589151|NCT03735849|11995234|FG000|Overall Study|Not Randomized|0
7589152|NCT03735849|11995235|FG001|Overall Study|Not Randomized|0
7589153|NCT03735849|11995236|FG002|Overall Study|Not Randomized|4
7626457|NCT05096312|12038720|FG000|Overall Study|Lost to Follow-up|2
7626458|NCT05096312|12038721|FG001|Overall Study|Lost to Follow-up|4
7626459|NCT05096312|12038720|FG000|Overall Study|Adverse Event|1
7626460|NCT05096312|12038721|FG001|Overall Study|Adverse Event|0
7766768|NCT00849680|12209259|FG006|Overall Study|Lost to Follow-up|12
7766769|NCT00849680|12209260|FG007|Overall Study|Lost to Follow-up|5
7766770|NCT00849680|12209253|FG000|Overall Study|Subject moved|1
7766771|NCT00849680|12209254|FG001|Overall Study|Subject moved|0
7766772|NCT00849680|12209255|FG002|Overall Study|Subject moved|3
7766773|NCT00849680|12209256|FG003|Overall Study|Subject moved|1
7626467|NCT03560258|12038741|FG000|Overall Study|Lost to Follow-up|3
7626468|NCT03560258|12038742|FG001|Overall Study|Lost to Follow-up|0
7626470|NCT03560258|12038741|FG000|Overall Study|Protocol Violation|0
7626471|NCT03560258|12038742|FG001|Overall Study|Protocol Violation|1
7626472|NCT03560258|12038743|FG002|Overall Study|Protocol Violation|0
7626473|NCT03560258|12038741|FG000|Overall Study|Withdrawal by Subject|0
7626474|NCT03560258|12038742|FG001|Overall Study|Withdrawal by Subject|0
7626475|NCT03560258|12038743|FG002|Overall Study|Withdrawal by Subject|1
7626476|NCT03684304|12038753|FG000|Overall Study|Lost to Follow-up|19
7626477|NCT03684304|12038754|FG001|Overall Study|Lost to Follow-up|17
7626478|NCT04528641|12038775|FG000|Overall Study|Withdrawal by Subject|0
7626479|NCT04528641|12038776|FG001|Overall Study|Withdrawal by Subject|0
7626480|NCT04528641|12038777|FG002|Overall Study|Withdrawal by Subject|0
7626481|NCT04528641|12038778|FG003|Overall Study|Withdrawal by Subject|1
7626482|NCT04528641|12038779|FG004|Overall Study|Withdrawal by Subject|0
7626483|NCT04528641|12038780|FG005|Overall Study|Withdrawal by Subject|1
7626484|NCT04034238|12038816|FG000|Dose Escalation Phase|Withdrawal by Subject|1
7626485|NCT04034238|12038817|FG001|Dose Escalation Phase|Withdrawal by Subject|0
7626486|NCT04034238|12038818|FG002|Dose Escalation Phase|Withdrawal by Subject|0
7626487|NCT04034238|12038819|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7626488|NCT04034238|12038816|FG000|Dose Escalation Phase|Screen failures|0
7626489|NCT04034238|12038817|FG001|Dose Escalation Phase|Screen failures|0
7626490|NCT04034238|12038818|FG002|Dose Escalation Phase|Screen failures|0
7626491|NCT04034238|12038819|FG003|Dose Escalation Phase|Screen failures|2
7626492|NCT04034238|12038816|FG000|Dose Expansion Phase|Not treated due to study hold.|0
7626493|NCT04034238|12038817|FG001|Dose Expansion Phase|Not treated due to study hold.|0
7626494|NCT04034238|12038818|FG002|Dose Expansion Phase|Not treated due to study hold.|0
7626495|NCT04034238|12038819|FG003|Dose Expansion Phase|Not treated due to study hold.|1
7626496|NCT04034238|12038816|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0
7626497|NCT04034238|12038817|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0
7626498|NCT04034238|12038818|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1
7626499|NCT04034238|12038819|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0
7626500|NCT03984305|12038832|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19
7626501|NCT03984305|12038833|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15
7626502|NCT03984305|12038832|FG000|Overall Study|Withdrawal by Subject|3
7626503|NCT03984305|12038833|FG001|Overall Study|Withdrawal by Subject|3
7626504|NCT03984305|12038832|FG000|Overall Study|Lost to Follow-up|1
7626505|NCT03984305|12038833|FG001|Overall Study|Lost to Follow-up|0
7626506|NCT03982368|12038842|FG000|Overall Study|Adverse Event|6
7626507|NCT03982368|12038843|FG001|Overall Study|Adverse Event|4
7626508|NCT03982368|12038844|FG002|Overall Study|Adverse Event|3
7626509|NCT03982368|12038842|FG000|Overall Study|Lost to Follow-up|2
7626510|NCT03982368|12038843|FG001|Overall Study|Lost to Follow-up|1
7626511|NCT03982368|12038844|FG002|Overall Study|Lost to Follow-up|0
7626512|NCT03982368|12038842|FG000|Overall Study|Withdrawal by Subject|1
7626513|NCT03982368|12038843|FG001|Overall Study|Withdrawal by Subject|2
7626514|NCT03982368|12038844|FG002|Overall Study|Withdrawal by Subject|0
7626515|NCT03982368|12038842|FG000|Overall Study|unknow|4
7626516|NCT03982368|12038843|FG001|Overall Study|unknow|0
7626517|NCT03982368|12038844|FG002|Overall Study|unknow|2
7626518|NCT03952143|12038857|FG000|Lead-In Period|Adverse Event|2
7626519|NCT03952143|12038858|FG001|Lead-In Period|Adverse Event|0
7626520|NCT03952143|12038859|FG002|Lead-In Period|Adverse Event|0
7626521|NCT03952143|12038857|FG000|Lead-In Period|Lack of Efficacy|2
7626522|NCT03952143|12038858|FG001|Lead-In Period|Lack of Efficacy|0
7626523|NCT03952143|12038859|FG002|Lead-In Period|Lack of Efficacy|0
7626524|NCT03952143|12038857|FG000|Lead-In Period|Physician Decision|5
7626525|NCT03952143|12038858|FG001|Lead-In Period|Physician Decision|0
7626526|NCT03952143|12038859|FG002|Lead-In Period|Physician Decision|0
7626527|NCT03952143|12038857|FG000|Lead-In Period|Protocol Violation|5
7626528|NCT03952143|12038858|FG001|Lead-In Period|Protocol Violation|0
7626529|NCT03952143|12038859|FG002|Lead-In Period|Protocol Violation|0
7626530|NCT03952143|12038857|FG000|Lead-In Period|Withdrawal by Subject|19
7626531|NCT03952143|12038858|FG001|Lead-In Period|Withdrawal by Subject|0
7589154|NCT03552393|11995252|FG000|Core Period|Kidney Transplant|1
7589155|NCT03552393|11995252|FG000|Core Period|Prohibited Medication|1
7589156|NCT03552393|11995252|FG000|Safety Extension Period|Kidney Transplant|4
7626532|NCT03952143|12038859|FG002|Lead-In Period|Withdrawal by Subject|0
7626533|NCT03952143|12038857|FG000|Treatment Period|Adverse Event|0
7626534|NCT03952143|12038858|FG001|Treatment Period|Adverse Event|0
7626535|NCT03952143|12038859|FG002|Treatment Period|Adverse Event|1
7626536|NCT03952143|12038857|FG000|Treatment Period|Lost to Follow-up|0
7626537|NCT03952143|12038858|FG001|Treatment Period|Lost to Follow-up|2
7626538|NCT03952143|12038859|FG002|Treatment Period|Lost to Follow-up|0
7626539|NCT03952143|12038857|FG000|Treatment Period|Physician Decision|0
7626540|NCT03952143|12038858|FG001|Treatment Period|Physician Decision|0
7626541|NCT03952143|12038859|FG002|Treatment Period|Physician Decision|2
7626542|NCT03952143|12038857|FG000|Treatment Period|Protocol Violation|0
7626543|NCT03952143|12038858|FG001|Treatment Period|Protocol Violation|0
7626544|NCT03952143|12038859|FG002|Treatment Period|Protocol Violation|1
7626545|NCT03952143|12038857|FG000|Treatment Period|Withdrawal by Subject|0
7626546|NCT03952143|12038858|FG001|Treatment Period|Withdrawal by Subject|5
7626547|NCT03952143|12038859|FG002|Treatment Period|Withdrawal by Subject|26
7626548|NCT03952143|12038857|FG000|Treatment Period|Due to COVID 19 restrictions|0
7589205|NCT03333382|11995281|FG000|Overall Study|Lost to Follow-up|1
7589206|NCT03333382|11995282|FG001|Overall Study|Lost to Follow-up|0
7589207|NCT03107611|11995321|FG000|Overall Study|Adverse Event|1
7589208|NCT03107611|11995322|FG001|Overall Study|Adverse Event|0
7589209|NCT03107611|11995323|FG002|Overall Study|Adverse Event|2
7589210|NCT03107611|11995321|FG000|Overall Study|Lost to Follow-up|3
7589211|NCT03107611|11995322|FG001|Overall Study|Lost to Follow-up|3
7589212|NCT03107611|11995323|FG002|Overall Study|Lost to Follow-up|3
7589213|NCT03107611|11995321|FG000|Overall Study|Protocol Violation|0
7589214|NCT03107611|11995322|FG001|Overall Study|Protocol Violation|0
7589215|NCT03107611|11995323|FG002|Overall Study|Protocol Violation|1
7589216|NCT03107611|11995321|FG000|Overall Study|Withdrawal by Subject|1
7589217|NCT03107611|11995322|FG001|Overall Study|Withdrawal by Subject|0
7589218|NCT03107611|11995323|FG002|Overall Study|Withdrawal by Subject|1
7589219|NCT03107611|11995321|FG000|Overall Study|Worsening signs/symptoms|2
7589220|NCT03107611|11995322|FG001|Overall Study|Worsening signs/symptoms|1
7589221|NCT03107611|11995323|FG002|Overall Study|Worsening signs/symptoms|2
7589222|NCT02720016|11995334|FG000|Overall Study|Separation of couple|6
7589223|NCT02720016|11995335|FG001|Overall Study|Separation of couple|8
7589224|NCT02720016|11995336|FG002|Overall Study|Separation of couple|2
7589225|NCT02720016|11995334|FG000|Overall Study|Withdrawal by Subject|6
7589226|NCT02720016|11995335|FG001|Overall Study|Withdrawal by Subject|6
7589227|NCT02720016|11995336|FG002|Overall Study|Withdrawal by Subject|4
7589228|NCT02720016|11995334|FG000|Overall Study|Scheduling issues|2
7589229|NCT02720016|11995335|FG001|Overall Study|Scheduling issues|4
7589230|NCT02720016|11995336|FG002|Overall Study|Scheduling issues|7
7589231|NCT02720016|11995334|FG000|Overall Study|Childcare|2
7589232|NCT02720016|11995335|FG001|Overall Study|Childcare|0
7589233|NCT02720016|11995336|FG002|Overall Study|Childcare|2
7589234|NCT02720016|11995334|FG000|Overall Study|Withdrawal by PI|2
7589235|NCT02720016|11995335|FG001|Overall Study|Withdrawal by PI|2
7589236|NCT02720016|11995336|FG002|Overall Study|Withdrawal by PI|0
7589237|NCT02720016|11995334|FG000|Overall Study|Moved away|2
7589238|NCT02720016|11995335|FG001|Overall Study|Moved away|0
7589239|NCT02720016|11995336|FG002|Overall Study|Moved away|0
7589240|NCT02720016|11995334|FG000|Overall Study|Not Primary Health Concern|0
7589241|NCT02720016|11995335|FG001|Overall Study|Not Primary Health Concern|0
7589242|NCT02720016|11995336|FG002|Overall Study|Not Primary Health Concern|2
7589243|NCT02720016|11995334|FG000|Overall Study|Transportation issues|0
7589244|NCT02720016|11995335|FG001|Overall Study|Transportation issues|0
7589245|NCT02720016|11995336|FG002|Overall Study|Transportation issues|1
7589246|NCT02720016|11995334|FG000|Overall Study|Other|0
7589247|NCT02720016|11995335|FG001|Overall Study|Other|0
7589248|NCT02720016|11995336|FG002|Overall Study|Other|2
7589249|NCT02607956|11995347|FG000|Double-Blinded Phase|Withdrew Consent|17
7589250|NCT02607956|11995348|FG001|Double-Blinded Phase|Withdrew Consent|19
7589251|NCT02607956|11995349|FG002|Double-Blinded Phase|Withdrew Consent|0
7589252|NCT02607956|11995350|FG003|Double-Blinded Phase|Withdrew Consent|0
7589253|NCT02607956|11995347|FG000|Double-Blinded Phase|Lost to Follow-up|19
7589254|NCT02607956|11995348|FG001|Double-Blinded Phase|Lost to Follow-up|16
7589255|NCT02607956|11995349|FG002|Double-Blinded Phase|Lost to Follow-up|0
7589256|NCT02607956|11995350|FG003|Double-Blinded Phase|Lost to Follow-up|0
7589257|NCT02607956|11995347|FG000|Double-Blinded Phase|Randomized but never treated|7
7589258|NCT02607956|11995348|FG001|Double-Blinded Phase|Randomized but never treated|5
7589259|NCT02607956|11995349|FG002|Double-Blinded Phase|Randomized but never treated|0
7589260|NCT02607956|11995350|FG003|Double-Blinded Phase|Randomized but never treated|0
7589261|NCT02607956|11995347|FG000|Double-Blinded Phase|Investigator's Discretion|7
7589262|NCT02607956|11995348|FG001|Double-Blinded Phase|Investigator's Discretion|2
7589263|NCT02607956|11995349|FG002|Double-Blinded Phase|Investigator's Discretion|0
7589264|NCT02607956|11995350|FG003|Double-Blinded Phase|Investigator's Discretion|0
7589265|NCT02607956|11995347|FG000|Double-Blinded Phase|Death|4
7589266|NCT02607956|11995348|FG001|Double-Blinded Phase|Death|4
7589267|NCT02607956|11995349|FG002|Double-Blinded Phase|Death|0
7589268|NCT02607956|11995350|FG003|Double-Blinded Phase|Death|0
7589269|NCT02607956|11995347|FG000|Double-Blinded Phase|Adverse Event|4
7589270|NCT02607956|11995348|FG001|Double-Blinded Phase|Adverse Event|3
7589271|NCT02607956|11995349|FG002|Double-Blinded Phase|Adverse Event|0
7589272|NCT02607956|11995350|FG003|Double-Blinded Phase|Adverse Event|0
7589273|NCT02607956|11995347|FG000|Double-Blinded Phase|Protocol Violation|3
7589274|NCT02607956|11995348|FG001|Double-Blinded Phase|Protocol Violation|1
7589275|NCT02607956|11995349|FG002|Double-Blinded Phase|Protocol Violation|0
7589276|NCT02607956|11995350|FG003|Double-Blinded Phase|Protocol Violation|0
7589277|NCT02607956|11995347|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0
7589278|NCT02607956|11995348|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3
7589279|NCT02607956|11995349|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0
7589280|NCT02607956|11995350|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0
7589281|NCT02607956|11995347|FG000|Open-Label Extension Phase|Withdrew Consent|0
7589282|NCT02607956|11995348|FG001|Open-Label Extension Phase|Withdrew Consent|0
7589283|NCT02607956|11995349|FG002|Open-Label Extension Phase|Withdrew Consent|10
7589284|NCT02607956|11995350|FG003|Open-Label Extension Phase|Withdrew Consent|16
7589285|NCT02607956|11995347|FG000|Open-Label Extension Phase|Lost to Follow-up|0
7589371|NCT02564523|11995388|FG008|Overall Study|Lost to Follow-up|0
7589286|NCT02607956|11995348|FG001|Open-Label Extension Phase|Lost to Follow-up|0
7589287|NCT02607956|11995349|FG002|Open-Label Extension Phase|Lost to Follow-up|14
7589288|NCT02607956|11995350|FG003|Open-Label Extension Phase|Lost to Follow-up|6
7589289|NCT02607956|11995347|FG000|Open-Label Extension Phase|Death|0
7589290|NCT02607956|11995348|FG001|Open-Label Extension Phase|Death|0
7589291|NCT02607956|11995349|FG002|Open-Label Extension Phase|Death|1
7589292|NCT02607956|11995350|FG003|Open-Label Extension Phase|Death|3
7589293|NCT02607956|11995347|FG000|Open-Label Extension Phase|Investigator's Discretion|0
7589294|NCT02607956|11995348|FG001|Open-Label Extension Phase|Investigator's Discretion|0
7589295|NCT02607956|11995349|FG002|Open-Label Extension Phase|Investigator's Discretion|2
7589296|NCT02607956|11995350|FG003|Open-Label Extension Phase|Investigator's Discretion|2
7589297|NCT02607956|11995347|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0
7589298|NCT02607956|11995348|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0
7589299|NCT02607956|11995349|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2
7589300|NCT02607956|11995350|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0
7589301|NCT02607956|11995347|FG000|Open-Label Extension Phase|Protocol Violation|0
7589302|NCT02607956|11995348|FG001|Open-Label Extension Phase|Protocol Violation|0
7589303|NCT02607956|11995349|FG002|Open-Label Extension Phase|Protocol Violation|0
7589304|NCT02607956|11995350|FG003|Open-Label Extension Phase|Protocol Violation|2
7589305|NCT02607956|11995347|FG000|Open-Label Extension Phase|Pregnancy|0
7589306|NCT02607956|11995348|FG001|Open-Label Extension Phase|Pregnancy|0
7589307|NCT02607956|11995349|FG002|Open-Label Extension Phase|Pregnancy|0
7589308|NCT02607956|11995350|FG003|Open-Label Extension Phase|Pregnancy|1
7589309|NCT02564523|11995380|FG000|Overall Study|Withdrawal by Subject|3
7589310|NCT02564523|11995381|FG001|Overall Study|Withdrawal by Subject|0
7589311|NCT02564523|11995382|FG002|Overall Study|Withdrawal by Subject|1
7589312|NCT02564523|11995383|FG003|Overall Study|Withdrawal by Subject|0
7589313|NCT02564523|11995384|FG004|Overall Study|Withdrawal by Subject|1
7589314|NCT02564523|11995385|FG005|Overall Study|Withdrawal by Subject|0
7589315|NCT02564523|11995386|FG006|Overall Study|Withdrawal by Subject|1
7589316|NCT02564523|11995387|FG007|Overall Study|Withdrawal by Subject|0
7589317|NCT02564523|11995388|FG008|Overall Study|Withdrawal by Subject|0
7589318|NCT02564523|11995389|FG009|Overall Study|Withdrawal by Subject|0
7589319|NCT02564523|11995390|FG010|Overall Study|Withdrawal by Subject|1
7589320|NCT02564523|11995391|FG011|Overall Study|Withdrawal by Subject|0
7589321|NCT02564523|11995392|FG012|Overall Study|Withdrawal by Subject|1
7589322|NCT02564523|11995393|FG013|Overall Study|Withdrawal by Subject|0
7589323|NCT02564523|11995394|FG014|Overall Study|Withdrawal by Subject|0
7589324|NCT02564523|11995395|FG015|Overall Study|Withdrawal by Subject|0
7589325|NCT02564523|11995396|FG016|Overall Study|Withdrawal by Subject|0
7589326|NCT02564523|11995397|FG017|Overall Study|Withdrawal by Subject|0
7589327|NCT02564523|11995380|FG000|Overall Study|Adverse Event|0
7589328|NCT02564523|11995381|FG001|Overall Study|Adverse Event|0
7589329|NCT02564523|11995382|FG002|Overall Study|Adverse Event|0
7589330|NCT02564523|11995383|FG003|Overall Study|Adverse Event|0
7589331|NCT02564523|11995384|FG004|Overall Study|Adverse Event|0
7589332|NCT02564523|11995385|FG005|Overall Study|Adverse Event|0
7589333|NCT02564523|11995386|FG006|Overall Study|Adverse Event|0
7589334|NCT02564523|11995387|FG007|Overall Study|Adverse Event|0
7589335|NCT02564523|11995388|FG008|Overall Study|Adverse Event|0
7589336|NCT02564523|11995389|FG009|Overall Study|Adverse Event|0
7589337|NCT02564523|11995390|FG010|Overall Study|Adverse Event|0
7589338|NCT02564523|11995391|FG011|Overall Study|Adverse Event|0
7589339|NCT02564523|11995392|FG012|Overall Study|Adverse Event|0
7589340|NCT02564523|11995393|FG013|Overall Study|Adverse Event|0
7589341|NCT02564523|11995394|FG014|Overall Study|Adverse Event|0
7589342|NCT02564523|11995395|FG015|Overall Study|Adverse Event|0
7589343|NCT02564523|11995396|FG016|Overall Study|Adverse Event|0
7589344|NCT02564523|11995397|FG017|Overall Study|Adverse Event|1
7589345|NCT02564523|11995380|FG000|Overall Study|Death|0
7589346|NCT02564523|11995381|FG001|Overall Study|Death|0
7589347|NCT02564523|11995382|FG002|Overall Study|Death|0
7589348|NCT02564523|11995383|FG003|Overall Study|Death|0
7589349|NCT02564523|11995384|FG004|Overall Study|Death|0
7589350|NCT02564523|11995385|FG005|Overall Study|Death|0
7589351|NCT02564523|11995386|FG006|Overall Study|Death|1
7589352|NCT02564523|11995387|FG007|Overall Study|Death|0
7589353|NCT02564523|11995388|FG008|Overall Study|Death|0
7589354|NCT02564523|11995389|FG009|Overall Study|Death|0
7589355|NCT02564523|11995390|FG010|Overall Study|Death|1
7589356|NCT02564523|11995391|FG011|Overall Study|Death|0
7589357|NCT02564523|11995392|FG012|Overall Study|Death|0
7589358|NCT02564523|11995393|FG013|Overall Study|Death|0
7589359|NCT02564523|11995394|FG014|Overall Study|Death|0
7589360|NCT02564523|11995395|FG015|Overall Study|Death|0
7589361|NCT02564523|11995396|FG016|Overall Study|Death|0
7589362|NCT02564523|11995397|FG017|Overall Study|Death|0
7589363|NCT02564523|11995380|FG000|Overall Study|Lost to Follow-up|2
7589364|NCT02564523|11995381|FG001|Overall Study|Lost to Follow-up|1
7589365|NCT02564523|11995382|FG002|Overall Study|Lost to Follow-up|4
7589366|NCT02564523|11995383|FG003|Overall Study|Lost to Follow-up|0
7589367|NCT02564523|11995384|FG004|Overall Study|Lost to Follow-up|1
7589368|NCT02564523|11995385|FG005|Overall Study|Lost to Follow-up|0
7589369|NCT02564523|11995386|FG006|Overall Study|Lost to Follow-up|1
7589370|NCT02564523|11995387|FG007|Overall Study|Lost to Follow-up|0
7589372|NCT02564523|11995389|FG009|Overall Study|Lost to Follow-up|0
7589373|NCT02564523|11995390|FG010|Overall Study|Lost to Follow-up|0
7589374|NCT02564523|11995391|FG011|Overall Study|Lost to Follow-up|1
7589375|NCT02564523|11995392|FG012|Overall Study|Lost to Follow-up|1
7589376|NCT02564523|11995393|FG013|Overall Study|Lost to Follow-up|0
7589377|NCT02564523|11995394|FG014|Overall Study|Lost to Follow-up|0
7589378|NCT02564523|11995395|FG015|Overall Study|Lost to Follow-up|0
7589379|NCT02564523|11995396|FG016|Overall Study|Lost to Follow-up|0
7589380|NCT02564523|11995397|FG017|Overall Study|Lost to Follow-up|0
7589381|NCT02564523|11995380|FG000|Overall Study|Physician Decision|0
7589382|NCT02564523|11995381|FG001|Overall Study|Physician Decision|0
7589383|NCT02564523|11995382|FG002|Overall Study|Physician Decision|0
7589384|NCT02564523|11995383|FG003|Overall Study|Physician Decision|0
7589385|NCT02564523|11995384|FG004|Overall Study|Physician Decision|1
7589386|NCT02564523|11995385|FG005|Overall Study|Physician Decision|0
7589387|NCT02564523|11995386|FG006|Overall Study|Physician Decision|0
7589388|NCT02564523|11995387|FG007|Overall Study|Physician Decision|0
7589389|NCT02564523|11995388|FG008|Overall Study|Physician Decision|0
7589390|NCT02564523|11995389|FG009|Overall Study|Physician Decision|0
7589391|NCT02564523|11995390|FG010|Overall Study|Physician Decision|1
7589392|NCT02564523|11995391|FG011|Overall Study|Physician Decision|0
7589393|NCT02564523|11995392|FG012|Overall Study|Physician Decision|0
7589394|NCT02564523|11995393|FG013|Overall Study|Physician Decision|0
7589395|NCT02564523|11995394|FG014|Overall Study|Physician Decision|0
7589396|NCT02564523|11995395|FG015|Overall Study|Physician Decision|0
7589397|NCT02564523|11995396|FG016|Overall Study|Physician Decision|0
7589398|NCT02564523|11995397|FG017|Overall Study|Physician Decision|0
7589399|NCT02564523|11995380|FG000|Overall Study|Protocol Violation|2
7589400|NCT02564523|11995381|FG001|Overall Study|Protocol Violation|2
7589401|NCT02564523|11995382|FG002|Overall Study|Protocol Violation|5
7589402|NCT02564523|11995383|FG003|Overall Study|Protocol Violation|0
7589403|NCT02564523|11995384|FG004|Overall Study|Protocol Violation|1
7589404|NCT02564523|11995385|FG005|Overall Study|Protocol Violation|0
7589405|NCT02564523|11995386|FG006|Overall Study|Protocol Violation|0
7589406|NCT02564523|11995387|FG007|Overall Study|Protocol Violation|0
7589407|NCT02564523|11995388|FG008|Overall Study|Protocol Violation|0
7589408|NCT02564523|11995389|FG009|Overall Study|Protocol Violation|0
7589409|NCT02564523|11995390|FG010|Overall Study|Protocol Violation|0
7589410|NCT02564523|11995391|FG011|Overall Study|Protocol Violation|0
7589411|NCT02564523|11995392|FG012|Overall Study|Protocol Violation|0
7589412|NCT02564523|11995393|FG013|Overall Study|Protocol Violation|0
7589413|NCT02564523|11995394|FG014|Overall Study|Protocol Violation|0
7589414|NCT02564523|11995395|FG015|Overall Study|Protocol Violation|0
7589415|NCT02564523|11995396|FG016|Overall Study|Protocol Violation|0
7589416|NCT02564523|11995397|FG017|Overall Study|Protocol Violation|0
7589417|NCT02564523|11995380|FG000|Overall Study|Other|3
7589418|NCT02564523|11995381|FG001|Overall Study|Other|0
7589419|NCT02564523|11995382|FG002|Overall Study|Other|0
7766774|NCT00849680|12209257|FG004|Overall Study|Subject moved|0
7589420|NCT02564523|11995383|FG003|Overall Study|Other|1
7589421|NCT02564523|11995384|FG004|Overall Study|Other|0
7589422|NCT02564523|11995385|FG005|Overall Study|Other|0
7589423|NCT02564523|11995386|FG006|Overall Study|Other|0
7589424|NCT02564523|11995387|FG007|Overall Study|Other|0
7589425|NCT02564523|11995388|FG008|Overall Study|Other|0
7589426|NCT02564523|11995389|FG009|Overall Study|Other|0
7766775|NCT00849680|12209258|FG005|Overall Study|Subject moved|2
7589427|NCT02564523|11995390|FG010|Overall Study|Other|0
7589428|NCT02564523|11995391|FG011|Overall Study|Other|0
7589429|NCT02564523|11995392|FG012|Overall Study|Other|0
7589430|NCT02564523|11995393|FG013|Overall Study|Other|0
7589431|NCT02564523|11995394|FG014|Overall Study|Other|0
7589432|NCT02564523|11995395|FG015|Overall Study|Other|0
7589433|NCT02564523|11995396|FG016|Overall Study|Other|0
7589434|NCT02564523|11995397|FG017|Overall Study|Other|0
7766776|NCT00849680|12209259|FG006|Overall Study|Subject moved|2
7766777|NCT00849680|12209260|FG007|Overall Study|Subject moved|2
7766778|NCT00849680|12209253|FG000|Overall Study|Withdrawal by Subject|2
7766779|NCT00849680|12209254|FG001|Overall Study|Withdrawal by Subject|0
7766780|NCT00849680|12209255|FG002|Overall Study|Withdrawal by Subject|0
7589440|NCT01798004|11995502|FG000|Overall Study|Death|2
7589441|NCT01798004|11995502|FG000|Overall Study|Lack of Efficacy|8
7589442|NCT01798004|11995502|FG000|Overall Study|Physician Decision|25
7589443|NCT01798004|11995502|FG000|Overall Study|Withdrawal by Subject|4
7589444|NCT01798004|11995502|FG000|Overall Study|Ineligible|4
7589445|NCT01798004|11995502|FG000|Overall Study|Patient/parent refusal|7
7589446|NCT01798004|11995502|FG000|Overall Study|Initiation of other non-protocol therapy|5
7589447|NCT01798004|11995502|FG000|Overall Study|Enrollment another COG therapeutic trial|32
7589448|NCT01447628|11995529|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0
7589449|NCT01447628|11995530|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0
7589450|NCT01447628|11995531|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0
7589451|NCT01447628|11995532|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1
7589452|NCT01175356|11995552|FG000|Overall Study|Death|1
7589453|NCT01175356|11995552|FG000|Overall Study|Lack of Efficacy|12
7589454|NCT01175356|11995552|FG000|Overall Study|Lost to Follow-up|1
7589455|NCT01175356|11995552|FG000|Overall Study|Physician Decision|23
7589456|NCT01175356|11995552|FG000|Overall Study|Ineligible|1
7589457|NCT01175356|11995552|FG000|Overall Study|Treatment Slot Not Available|18
7589458|NCT01175356|11995552|FG000|Overall Study|Refusal by patient/parent/guardian|6
7589459|NCT01175356|11995552|FG000|Overall Study|Pts MIBG non-avid after enrollment|2
7589460|NCT01175356|11995552|FG000|Overall Study|On other COG study w/tumor tx intent|7
7589461|NCT01175356|11995552|FG000|Overall Study|Inadequate stem cell for transplant|1
7589462|NCT01175356|11995552|FG000|Overall Study|Initiation other tx prior to completion|9
7589463|NCT00515853|11995558|FG000|Overall Study|Lost to Follow-up|9
7589464|NCT00515853|11995559|FG001|Overall Study|Lost to Follow-up|13
7589465|NCT00515853|11995558|FG000|Overall Study|Withdrawal by Subject|6
7589466|NCT00515853|11995559|FG001|Overall Study|Withdrawal by Subject|4
7589467|NCT00003458|11995565|FG000|Overall Study|Not evaluable|4
7626549|NCT03952143|12038858|FG001|Treatment Period|Due to COVID 19 restrictions|2
7626550|NCT03952143|12038859|FG002|Treatment Period|Due to COVID 19 restrictions|5
7626551|NCT03952143|12038857|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0
7626552|NCT03952143|12038858|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0
7626553|NCT03952143|12038859|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1
7626554|NCT03691428|12038876|FG000|Overall Study|Withdrawal by Subject|6
7626555|NCT03691428|12038877|FG001|Overall Study|Withdrawal by Subject|8
7626556|NCT03685708|12038886|FG000|Overall Study|Withdrawal by Subject|0
7626557|NCT03685708|12038887|FG001|Overall Study|Withdrawal by Subject|0
7626558|NCT03685708|12038888|FG002|Overall Study|Withdrawal by Subject|1
7626559|NCT03685708|12038886|FG000|Overall Study|Screen Fail|0
7626560|NCT03685708|12038887|FG001|Overall Study|Screen Fail|1
7626561|NCT03685708|12038888|FG002|Overall Study|Screen Fail|1
7626562|NCT03685708|12038886|FG000|Overall Study|COVID 19 Pandemic|1
7626563|NCT03685708|12038887|FG001|Overall Study|COVID 19 Pandemic|1
7626564|NCT03685708|12038888|FG002|Overall Study|COVID 19 Pandemic|6
7626565|NCT03685708|12038886|FG000|Overall Study|Disease Progression|0
7626566|NCT03685708|12038887|FG001|Overall Study|Disease Progression|0
7626567|NCT03685708|12038888|FG002|Overall Study|Disease Progression|1
7626568|NCT03669588|12038898|FG000|Overall Study|Adverse Event|1
7626569|NCT03669588|12038899|FG001|Overall Study|Adverse Event|0
7626570|NCT03669588|12038898|FG000|Overall Study|Physician Decision|0
7626571|NCT03669588|12038899|FG001|Overall Study|Physician Decision|1
7626572|NCT03669588|12038898|FG000|Overall Study|Protocol Violation|1
7626573|NCT03669588|12038899|FG001|Overall Study|Protocol Violation|0
7626574|NCT03669588|12038898|FG000|Overall Study|Sponsor Decision|1
7626575|NCT03669588|12038899|FG001|Overall Study|Sponsor Decision|1
7626576|NCT03669588|12038898|FG000|Overall Study|Withdrawal by Subject|1
7626577|NCT03669588|12038899|FG001|Overall Study|Withdrawal by Subject|4
7626578|NCT03669588|12038898|FG000|Overall Study|Rescue Therapy Needed|0
7626579|NCT03669588|12038899|FG001|Overall Study|Rescue Therapy Needed|1
7626580|NCT03531632|12038908|FG000|Overall Study|Adverse Event|0
7626581|NCT03531632|12038909|FG001|Overall Study|Adverse Event|0
7626582|NCT03531632|12038910|FG002|Overall Study|Adverse Event|1
7626583|NCT03531632|12038908|FG000|Overall Study|Death|4
7626584|NCT03531632|12038909|FG001|Overall Study|Death|0
7626585|NCT03531632|12038910|FG002|Overall Study|Death|14
7626586|NCT03531632|12038908|FG000|Overall Study|Study Terminated|1
7626587|NCT03531632|12038909|FG001|Overall Study|Study Terminated|3
7626588|NCT03531632|12038910|FG002|Overall Study|Study Terminated|11
7589468|NCT04613739|11995590|FG000|Overall Study|Lost to Follow-up|6
7589469|NCT04613739|11995591|FG001|Overall Study|Lost to Follow-up|9
7589470|NCT04613739|11995590|FG000|Overall Study|potentially duplicative/fraudulent|1
7589471|NCT04613739|11995591|FG001|Overall Study|potentially duplicative/fraudulent|3
7589472|NCT04573972|11995599|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32
7589473|NCT04573972|11995600|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14
7589474|NCT04407806|11995618|FG000|Overall Study|Withdrawal by Subject|1
7589475|NCT04407806|11995619|FG001|Overall Study|Withdrawal by Subject|2
7589487|NCT04186663|11995646|FG000|Overall Study|Lost to Follow-up|1
7589488|NCT04186663|11995646|FG000|Overall Study|Unable to complete blood draw|3
7589489|NCT04158219|11995650|FG000|Overall Study|Lost to Follow-up|1
7589490|NCT04056299|11995670|FG000|Overall Study|Sponsor discontinued study|3
7589491|NCT04056299|11995671|FG001|Overall Study|Sponsor discontinued study|3
7589492|NCT03954743|11995719|FG000|Overall Study|Adverse Event|1
7589493|NCT03954743|11995720|FG001|Overall Study|Adverse Event|0
7589494|NCT03954743|11995719|FG000|Overall Study|Lost to Follow-up|6
7589495|NCT03954743|11995720|FG001|Overall Study|Lost to Follow-up|4
7589496|NCT03954743|11995719|FG000|Overall Study|Protocol Violation|1
7589497|NCT03954743|11995720|FG001|Overall Study|Protocol Violation|0
7589498|NCT03954743|11995719|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13
7589499|NCT03954743|11995720|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12
7589500|NCT03954743|11995719|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
7589501|NCT03954743|11995720|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7589502|NCT03880565|11995728|FG000|Overall Study|Withdrawal by Subject|1
7589503|NCT03880565|11995729|FG001|Overall Study|Withdrawal by Subject|0
7589504|NCT03833661|11995735|FG000|Overall Study|Treatment ongoing|9
7589505|NCT03809663|11995743|FG000|Overall Study|Decision by sponsor|24
7589506|NCT03809663|11995744|FG001|Overall Study|Decision by sponsor|18
7589507|NCT03809663|11995745|FG002|Overall Study|Decision by sponsor|20
7589508|NCT03809663|11995746|FG003|Overall Study|Decision by sponsor|20
7589509|NCT03809663|11995747|FG004|Overall Study|Decision by sponsor|0
7589510|NCT03809663|11995748|FG005|Overall Study|Decision by sponsor|0
7589511|NCT03809663|11995743|FG000|Overall Study|Withdrawal by Subject|26
7589512|NCT03809663|11995744|FG001|Overall Study|Withdrawal by Subject|22
7589513|NCT03809663|11995745|FG002|Overall Study|Withdrawal by Subject|27
7589514|NCT03809663|11995746|FG003|Overall Study|Withdrawal by Subject|26
7589515|NCT03809663|11995747|FG004|Overall Study|Withdrawal by Subject|0
7589516|NCT03809663|11995748|FG005|Overall Study|Withdrawal by Subject|0
7589517|NCT03809663|11995743|FG000|Overall Study|Lost to Follow-up|1
7589518|NCT03809663|11995744|FG001|Overall Study|Lost to Follow-up|4
7589519|NCT03809663|11995745|FG002|Overall Study|Lost to Follow-up|1
7589520|NCT03809663|11995746|FG003|Overall Study|Lost to Follow-up|1
7589521|NCT03809663|11995747|FG004|Overall Study|Lost to Follow-up|0
7589522|NCT03809663|11995748|FG005|Overall Study|Lost to Follow-up|0
7589523|NCT03782792|11995775|FG000|Overall Study|Patient left the country|0
7589524|NCT03782792|11995776|FG001|Overall Study|Patient left the country|1
7589525|NCT03782792|11995775|FG000|Overall Study|Withdrawal by Subject|1
7589526|NCT03782792|11995776|FG001|Overall Study|Withdrawal by Subject|2
7589527|NCT03733119|11995795|FG000|Overall Study|Physician Decision|2
7589528|NCT03733119|11995796|FG001|Overall Study|Physician Decision|1
7589529|NCT03733119|11995795|FG000|Overall Study|ineligible to treat per protocol|0
7589530|NCT03733119|11995796|FG001|Overall Study|ineligible to treat per protocol|1
7589531|NCT03661996|11995807|FG000|Overall Study|Adverse Event|0
7589532|NCT03661996|11995808|FG001|Overall Study|Adverse Event|0
7589533|NCT03661996|11995809|FG002|Overall Study|Adverse Event|1
7589534|NCT03661996|11995810|FG003|Overall Study|Adverse Event|1
7589535|NCT03661996|11995811|FG004|Overall Study|Adverse Event|0
7589536|NCT03661996|11995807|FG000|Overall Study|Lost to Follow-up|5
7589537|NCT03661996|11995808|FG001|Overall Study|Lost to Follow-up|1
7589538|NCT03661996|11995809|FG002|Overall Study|Lost to Follow-up|2
7589539|NCT03661996|11995810|FG003|Overall Study|Lost to Follow-up|2
7589540|NCT03661996|11995811|FG004|Overall Study|Lost to Follow-up|6
7589541|NCT03661996|11995807|FG000|Overall Study|Physician Decision|1
7589542|NCT03661996|11995808|FG001|Overall Study|Physician Decision|1
7589543|NCT03661996|11995809|FG002|Overall Study|Physician Decision|1
7589544|NCT03661996|11995810|FG003|Overall Study|Physician Decision|2
7589545|NCT03661996|11995811|FG004|Overall Study|Physician Decision|0
7589546|NCT03661996|11995807|FG000|Overall Study|Protocol Violation|0
7589547|NCT03661996|11995808|FG001|Overall Study|Protocol Violation|0
7589548|NCT03661996|11995809|FG002|Overall Study|Protocol Violation|0
7589549|NCT03661996|11995810|FG003|Overall Study|Protocol Violation|0
7589550|NCT03661996|11995811|FG004|Overall Study|Protocol Violation|1
7589551|NCT03661996|11995807|FG000|Overall Study|Withdrawal by Subject|3
7589552|NCT03661996|11995808|FG001|Overall Study|Withdrawal by Subject|5
7589553|NCT03661996|11995809|FG002|Overall Study|Withdrawal by Subject|1
7589554|NCT03661996|11995810|FG003|Overall Study|Withdrawal by Subject|7
7589555|NCT03661996|11995811|FG004|Overall Study|Withdrawal by Subject|7
7589556|NCT03661996|11995807|FG000|Overall Study|Sponsors Decision|2
7589557|NCT03661996|11995808|FG001|Overall Study|Sponsors Decision|0
7589558|NCT03661996|11995809|FG002|Overall Study|Sponsors Decision|0
7589559|NCT03661996|11995810|FG003|Overall Study|Sponsors Decision|0
7589560|NCT03661996|11995811|FG004|Overall Study|Sponsors Decision|0
7589561|NCT03661996|11995807|FG000|Overall Study|Other|1
7589562|NCT03661996|11995808|FG001|Overall Study|Other|1
7589476|NCT04324021|11995628|FG000|Overall Study|Adverse Event|1
7589477|NCT04324021|11995629|FG001|Overall Study|Adverse Event|0
7589478|NCT04324021|11995630|FG002|Overall Study|Adverse Event|0
7589479|NCT04324021|11995628|FG000|Overall Study|Lack of Efficacy|0
7589480|NCT04324021|11995629|FG001|Overall Study|Lack of Efficacy|0
7589481|NCT04324021|11995630|FG002|Overall Study|Lack of Efficacy|1
7589482|NCT04324021|11995628|FG000|Overall Study|Death|1
7589483|NCT04324021|11995629|FG001|Overall Study|Death|1
7589484|NCT04324021|11995630|FG002|Overall Study|Death|0
7589485|NCT04209621|11995641|FG000|Overall Study|Death|1
7589486|NCT04209621|11995641|FG000|Overall Study|Study Terminated Early|2
7589563|NCT03661996|11995809|FG002|Overall Study|Other|1
7589564|NCT03661996|11995810|FG003|Overall Study|Other|1
7589565|NCT03661996|11995811|FG004|Overall Study|Other|0
7589566|NCT03633461|11995828|FG000|Overall Study|Lost to Follow-up|0
7589567|NCT03633461|11995829|FG001|Overall Study|Lost to Follow-up|1
7589568|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Adverse Event|9
7589569|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Adverse Event|11
7589570|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Death|0
7589571|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Death|4
7589572|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2
7589573|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3
7589574|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Pregnancy|0
7589575|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Pregnancy|1
7589576|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Protocol Violation|1
7589577|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Protocol Violation|0
7589578|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11
7589579|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11
7589580|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76
7589581|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120
7589582|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Other|4
7589583|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Other|3
7589584|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0
7589585|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2
7589586|NCT03517722|11995857|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0
7589587|NCT03517722|11995858|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1
7589588|NCT03517722|11995857|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0
7589589|NCT03517722|11995858|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1
7589590|NCT03517722|11995857|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1
7589591|NCT03517722|11995858|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1
7589592|NCT03517722|11995857|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87
7589593|NCT03517722|11995858|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134
7589594|NCT03499314|11995867|FG000|Overall Study|Time Commitment|1
7589595|NCT03499314|11995868|FG001|Overall Study|Time Commitment|2
7589596|NCT03499314|11995867|FG000|Overall Study|Medical issue unrelated to research study|1
7589597|NCT03499314|11995868|FG001|Overall Study|Medical issue unrelated to research study|1
7766781|NCT00849680|12209256|FG003|Overall Study|Withdrawal by Subject|2
7626590|NCT03206073|12038941|FG000|Overall Study|Participant Noncompliance|0
7626591|NCT03206073|12038942|FG001|Overall Study|Participant Noncompliance|1
7626592|NCT03206073|12038943|FG002|Overall Study|Participant Noncompliance|0
7626593|NCT03206073|12038944|FG003|Overall Study|Participant Noncompliance|0
7626594|NCT03206073|12038941|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1
7626595|NCT03206073|12038942|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0
7626596|NCT03206073|12038943|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0
7626597|NCT03206073|12038944|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0
7626598|NCT03206073|12038941|FG000|Overall Study|Death|0
7626599|NCT03206073|12038942|FG001|Overall Study|Death|0
7626600|NCT03206073|12038943|FG002|Overall Study|Death|1
7626601|NCT03206073|12038944|FG003|Overall Study|Death|0
7626602|NCT03206073|12038941|FG000|Overall Study|Taken off active treatment|0
7626603|NCT03206073|12038942|FG001|Overall Study|Taken off active treatment|0
7626604|NCT03206073|12038943|FG002|Overall Study|Taken off active treatment|3
7626605|NCT03206073|12038944|FG003|Overall Study|Taken off active treatment|0
7626606|NCT03102034|12038969|FG000|Overall Study|Withdrawal by Subject|1
7626607|NCT03102034|12038970|FG001|Overall Study|Withdrawal by Subject|0
7626608|NCT02723864|12038987|FG000|Overall Study|Refused further treatment|1
7626609|NCT02723864|12038988|FG001|Overall Study|Refused further treatment|0
7626610|NCT02723864|12038989|FG002|Overall Study|Refused further treatment|0
7626611|NCT02723864|12038990|FG003|Overall Study|Refused further treatment|0
7626612|NCT02723864|12038991|FG004|Overall Study|Refused further treatment|1
7626613|NCT02723864|12038992|FG005|Overall Study|Refused further treatment|2
7626614|NCT02723864|12038993|FG006|Overall Study|Refused further treatment|0
7626615|NCT02723864|12038987|FG000|Overall Study|Exceed treatment hold time|0
7626616|NCT02723864|12038988|FG001|Overall Study|Exceed treatment hold time|1
7626617|NCT02723864|12038989|FG002|Overall Study|Exceed treatment hold time|0
7626618|NCT02723864|12038990|FG003|Overall Study|Exceed treatment hold time|0
7626619|NCT02723864|12038991|FG004|Overall Study|Exceed treatment hold time|0
7626620|NCT02723864|12038992|FG005|Overall Study|Exceed treatment hold time|0
7589598|NCT03439124|11995876|FG000|Overall Study|Adverse Event|2
7589599|NCT03439124|11995877|FG001|Overall Study|Adverse Event|0
7589600|NCT03439124|11995876|FG000|Overall Study|Lost to Follow-up|1
7589601|NCT03439124|11995877|FG001|Overall Study|Lost to Follow-up|0
7589602|NCT03439124|11995876|FG000|Overall Study|Other reasons|1
7589603|NCT03439124|11995877|FG001|Overall Study|Other reasons|0
7589604|NCT03369431|11995885|FG000|Overall Study|Lost to Follow-up|1
7589605|NCT03369431|11995886|FG001|Overall Study|Lost to Follow-up|3
7589606|NCT03369431|11995885|FG000|Overall Study|Withdrawal by Subject|2
7589607|NCT03369431|11995886|FG001|Overall Study|Withdrawal by Subject|3
7589608|NCT03369431|11995885|FG000|Overall Study|Protocol Violation|1
7589609|NCT03369431|11995886|FG001|Overall Study|Protocol Violation|1
7766782|NCT00849680|12209257|FG004|Overall Study|Withdrawal by Subject|2
7766783|NCT00849680|12209258|FG005|Overall Study|Withdrawal by Subject|2
7766784|NCT00849680|12209259|FG006|Overall Study|Withdrawal by Subject|1
7766785|NCT00849680|12209260|FG007|Overall Study|Withdrawal by Subject|1
7766786|NCT00849680|12209253|FG000|Overall Study|Subject unable to comply with protocol|1
7766787|NCT00849680|12209254|FG001|Overall Study|Subject unable to comply with protocol|0
7766788|NCT00849680|12209255|FG002|Overall Study|Subject unable to comply with protocol|0
7766789|NCT00849680|12209256|FG003|Overall Study|Subject unable to comply with protocol|0
7766790|NCT00849680|12209257|FG004|Overall Study|Subject unable to comply with protocol|0
7766791|NCT00849680|12209258|FG005|Overall Study|Subject unable to comply with protocol|0
7766792|NCT00849680|12209259|FG006|Overall Study|Subject unable to comply with protocol|0
7766793|NCT00849680|12209260|FG007|Overall Study|Subject unable to comply with protocol|0
7589622|NCT03336866|11995909|FG000|Overall Study|Lost to Follow-up|2
7589623|NCT03336866|11995910|FG001|Overall Study|Lost to Follow-up|0
7589624|NCT03336866|11995911|FG002|Overall Study|Lost to Follow-up|3
7589625|NCT03336866|11995909|FG000|Overall Study|Withdrawal by Subject|1
7589626|NCT03336866|11995910|FG001|Overall Study|Withdrawal by Subject|1
7589627|NCT03336866|11995911|FG002|Overall Study|Withdrawal by Subject|0
7766794|NCT00849693|12209282|FG000|Acute Treatment Phase|Adverse Event|12
7766795|NCT00849693|12209283|FG001|Acute Treatment Phase|Adverse Event|7
7589628|NCT03336866|11995909|FG000|Overall Study|Noncompliance with clinic house rules|0
7589629|NCT03336866|11995910|FG001|Overall Study|Noncompliance with clinic house rules|0
7589630|NCT03336866|11995911|FG002|Overall Study|Noncompliance with clinic house rules|1
7589631|NCT03332173|11995924|FG000|Overall Study|Death|7
7589632|NCT03332173|11995924|FG000|Overall Study|Withdrawal by Subject|6
7589633|NCT03332173|11995924|FG000|Overall Study|Lost to Follow-up|2
7589634|NCT03332173|11995924|FG000|Overall Study|Transferred to long-term extension study|29
7589635|NCT03322293|11995931|FG000|Overall Study|Lost to Follow-up|0
7589636|NCT03322293|11995932|FG001|Overall Study|Lost to Follow-up|0
7589637|NCT03322293|11995933|FG002|Overall Study|Lost to Follow-up|1
7589638|NCT03254394|11995955|FG000|Overall Study|Withdrawal by Subject|0
7589639|NCT03254394|11995956|FG001|Overall Study|Withdrawal by Subject|2
7589640|NCT03253809|11995962|FG000|Overall Study|Unable to obtain study related data|14
7589641|NCT03151408|11995982|FG000|Overall Study|Adverse Event|24
7589642|NCT03151408|11995983|FG001|Overall Study|Adverse Event|23
7589643|NCT03151408|11995982|FG000|Overall Study|Death|46
7589644|NCT03151408|11995983|FG001|Overall Study|Death|26
7589645|NCT03151408|11995982|FG000|Overall Study|Physician Decision|13
7589646|NCT03151408|11995983|FG001|Overall Study|Physician Decision|19
7589647|NCT03151408|11995982|FG000|Overall Study|Withdrawal by Subject|16
7589648|NCT03151408|11995983|FG001|Overall Study|Withdrawal by Subject|20
7589649|NCT03151408|11995982|FG000|Overall Study|Progressive disease|45
7589650|NCT03151408|11995983|FG001|Overall Study|Progressive disease|61
7589651|NCT03151408|11995982|FG000|Overall Study|non-compliance by patient|1
7589652|NCT03151408|11995983|FG001|Overall Study|non-compliance by patient|0
7589653|NCT03151408|11995982|FG000|Overall Study|other reasons|56
7589654|NCT03151408|11995983|FG001|Overall Study|other reasons|52
7589655|NCT03151408|11995982|FG000|Overall Study|randomized and not treated|2
7589656|NCT03151408|11995983|FG001|Overall Study|randomized and not treated|2
7589657|NCT03137173|11995991|FG000|Overall Study|Withdrawal by Subject|8
7589658|NCT03137173|11995992|FG001|Overall Study|Withdrawal by Subject|13
7589659|NCT03137173|11995991|FG000|Overall Study|Death|1
7589660|NCT03137173|11995992|FG001|Overall Study|Death|3
7589661|NCT03137173|11995991|FG000|Overall Study|Physician Decision|1
7589662|NCT03137173|11995992|FG001|Overall Study|Physician Decision|0
7589663|NCT03137173|11995991|FG000|Overall Study|Lost to Follow-up|13
7589664|NCT03137173|11995992|FG001|Overall Study|Lost to Follow-up|18
7589665|NCT03137173|11995991|FG000|Overall Study|Other reasons|3
7589666|NCT03137173|11995992|FG001|Overall Study|Other reasons|2
7589667|NCT03028740|11996031|FG000|Overall Study|Did not Receive Study Drug|4
7589668|NCT03028740|11996032|FG001|Overall Study|Did not Receive Study Drug|5
7589669|NCT03028740|11996031|FG000|Overall Study|Adverse Event|8
7589670|NCT03028740|11996032|FG001|Overall Study|Adverse Event|26
7589671|NCT03028740|11996031|FG000|Overall Study|Lack of Efficacy|0
7589672|NCT03028740|11996032|FG001|Overall Study|Lack of Efficacy|1
7589673|NCT03028740|11996031|FG000|Overall Study|Withdrawal by Subject|48
7589674|NCT03028740|11996032|FG001|Overall Study|Withdrawal by Subject|101
7589675|NCT03028740|11996031|FG000|Overall Study|Lost to Follow-up|30
7589676|NCT03028740|11996032|FG001|Overall Study|Lost to Follow-up|54
7589677|NCT03028740|11996031|FG000|Overall Study|Physician Decision|4
7589678|NCT03028740|11996032|FG001|Overall Study|Physician Decision|11
7589679|NCT03028740|11996031|FG000|Overall Study|Protocol Violation|4
7589680|NCT03028740|11996032|FG001|Overall Study|Protocol Violation|8
7589681|NCT03028740|11996031|FG000|Overall Study|Non-compliance with Study Drug|0
7589682|NCT03028740|11996032|FG001|Overall Study|Non-compliance with Study Drug|2
7589683|NCT03028740|11996031|FG000|Overall Study|Study Terminated by Sponsor|467
7589684|NCT03028740|11996032|FG001|Overall Study|Study Terminated by Sponsor|917
7589685|NCT03028740|11996031|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27
7589686|NCT03028740|11996032|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55
7589687|NCT03028740|11996031|FG000|Overall Study|Reason not Specified|1
7589688|NCT03028740|11996032|FG001|Overall Study|Reason not Specified|5
7589689|NCT02998476|11996084|FG000|Overall Study|Lost to Follow-up|1
7589690|NCT02998476|11996085|FG001|Overall Study|Lost to Follow-up|0
7589691|NCT02998476|11996084|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2
7589692|NCT02998476|11996085|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0
7589693|NCT02998476|11996084|FG000|Overall Study|Withdrawal by Subject|1
7589694|NCT02998476|11996085|FG001|Overall Study|Withdrawal by Subject|2
7589695|NCT02998476|11996084|FG000|Overall Study|Death|45
7589696|NCT02998476|11996085|FG001|Overall Study|Death|2
7589697|NCT02998476|11996084|FG000|Overall Study|Other|6
7589698|NCT02998476|11996085|FG001|Overall Study|Other|1
7766796|NCT00849693|12209284|FG002|Acute Treatment Phase|Adverse Event|6
7766797|NCT00849693|12209285|FG003|Acute Treatment Phase|Adverse Event|4
7766798|NCT00849693|12209282|FG000|Acute Treatment Phase|Lost to Follow-up|5
7766799|NCT00849693|12209283|FG001|Acute Treatment Phase|Lost to Follow-up|8
7766800|NCT00849693|12209284|FG002|Acute Treatment Phase|Lost to Follow-up|11
7766801|NCT00849693|12209285|FG003|Acute Treatment Phase|Lost to Follow-up|9
7766802|NCT00849693|12209282|FG000|Acute Treatment Phase|Protocol Violation|1
7589706|NCT02924064|11996107|FG000|Overall Study|Adverse Event|2
7589707|NCT02924064|11996108|FG001|Overall Study|Adverse Event|2
7589708|NCT02924064|11996107|FG000|Overall Study|Lost to Follow-up|0
7589709|NCT02924064|11996108|FG001|Overall Study|Lost to Follow-up|2
7589710|NCT02924064|11996107|FG000|Overall Study|Physician Decision|0
7766803|NCT00849693|12209283|FG001|Acute Treatment Phase|Protocol Violation|5
7589711|NCT02924064|11996108|FG001|Overall Study|Physician Decision|2
7589712|NCT02924064|11996107|FG000|Overall Study|Protocol Violation|1
7589713|NCT02924064|11996108|FG001|Overall Study|Protocol Violation|3
7589714|NCT02924064|11996107|FG000|Overall Study|Withdrawal by Subject|4
7589715|NCT02924064|11996108|FG001|Overall Study|Withdrawal by Subject|5
7589716|NCT02924064|11996107|FG000|Overall Study|Other|17
7589717|NCT02924064|11996108|FG001|Overall Study|Other|29
7589718|NCT02916706|11996116|FG000|Overall Study|Adverse Event|0
7589719|NCT02916706|11996117|FG001|Overall Study|Adverse Event|1
7589720|NCT02916706|11996116|FG000|Overall Study|Lost to Follow-up|0
7589721|NCT02916706|11996117|FG001|Overall Study|Lost to Follow-up|1
7589722|NCT02916706|11996116|FG000|Overall Study|Physician Decision|1
7589723|NCT02916706|11996117|FG001|Overall Study|Physician Decision|0
7589724|NCT02916706|11996116|FG000|Overall Study|Protocol Violation|3
7589725|NCT02916706|11996117|FG001|Overall Study|Protocol Violation|1
7589726|NCT02916706|11996116|FG000|Overall Study|Withdrawal by Subject|6
7589727|NCT02916706|11996117|FG001|Overall Study|Withdrawal by Subject|9
7589728|NCT02916706|11996116|FG000|Overall Study|Other|5
7589729|NCT02916706|11996117|FG001|Overall Study|Other|19
7589730|NCT02889900|11996123|FG000|Overall Study|Adverse Event|11
7589731|NCT02889900|11996123|FG000|Overall Study|Condition under investigation worsened|32
7589732|NCT02889900|11996123|FG000|Overall Study|Other|5
7589733|NCT02889900|11996123|FG000|Overall Study|Withdrawal by Subject|7
7589734|NCT02889900|11996123|FG000|Overall Study|Not treated|2
7589735|NCT02866695|11996127|FG000|Overall Study|Adverse Event|1
7589736|NCT02866695|11996127|FG000|Overall Study|Lost to Follow-up|1
7589737|NCT02834793|11996133|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2
7589738|NCT02834793|11996134|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1
7589739|NCT02834793|11996135|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0
7589740|NCT02834793|11996136|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0
7589741|NCT02834793|11996133|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1
7589742|NCT02834793|11996134|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0
7589743|NCT02834793|11996135|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0
7589744|NCT02834793|11996136|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0
7589745|NCT02834793|11996133|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1
7589746|NCT02834793|11996134|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0
7589747|NCT02834793|11996135|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0
7589748|NCT02834793|11996136|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0
7589749|NCT02834793|11996133|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0
7589750|NCT02834793|11996134|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3
7589751|NCT02834793|11996135|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0
7589752|NCT02834793|11996136|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0
7589753|NCT02834793|11996133|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0
7589754|NCT02834793|11996134|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1
7589755|NCT02834793|11996135|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0
7589756|NCT02834793|11996136|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0
7589757|NCT02834793|11996133|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0
7589758|NCT02834793|11996134|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0
7589759|NCT02834793|11996135|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7
7589760|NCT02834793|11996136|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0
7589761|NCT02834793|11996133|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0
7589762|NCT02834793|11996134|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0
7589763|NCT02834793|11996135|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4
7589764|NCT02834793|11996136|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0
7589765|NCT02834793|11996133|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0
7589766|NCT02834793|11996134|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0
7589767|NCT02834793|11996135|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5
7589768|NCT02834793|11996136|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0
7589769|NCT02834793|11996133|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0
7589770|NCT02834793|11996134|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0
7589771|NCT02834793|11996135|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9
7589772|NCT02834793|11996136|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0
7589773|NCT02834793|11996133|FG000|Extension Phase A (up to 52 Weeks)|Other|0
7589774|NCT02834793|11996134|FG001|Extension Phase A (up to 52 Weeks)|Other|0
7589775|NCT02834793|11996135|FG002|Extension Phase A (up to 52 Weeks)|Other|1
7589776|NCT02834793|11996136|FG003|Extension Phase A (up to 52 Weeks)|Other|0
7589777|NCT02834793|11996133|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0
7589778|NCT02834793|11996134|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0
7589779|NCT02834793|11996135|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0
7589780|NCT02834793|11996136|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1
7589781|NCT02834793|11996133|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0
7589782|NCT02834793|11996134|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0
7589783|NCT02834793|11996135|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0
7589784|NCT02834793|11996136|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1
7589785|NCT02834793|11996133|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0
7589786|NCT02834793|11996134|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0
7589787|NCT02834793|11996135|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0
7589788|NCT02834793|11996136|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8
7589789|NCT02834793|11996133|FG000|Extension Phase B (up to 188 Weeks)|Other|0
7589790|NCT02834793|11996134|FG001|Extension Phase B (up to 188 Weeks)|Other|0
7589791|NCT02834793|11996135|FG002|Extension Phase B (up to 188 Weeks)|Other|0
7589792|NCT02834793|11996136|FG003|Extension Phase B (up to 188 Weeks)|Other|1
7589793|NCT02834793|11996133|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0
7589794|NCT02834793|11996134|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0
7589795|NCT02834793|11996135|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0
7589796|NCT02834793|11996136|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1
7589797|NCT02810457|11996146|FG000|Overall Study|Randomised but no treatment received|2
7589798|NCT02810457|11996147|FG001|Overall Study|Randomised but no treatment received|1
7589799|NCT02810457|11996146|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191
7589800|NCT02810457|11996147|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199
7589801|NCT02810457|11996146|FG000|Overall Study|Adverse Event|37
7589802|NCT02810457|11996147|FG001|Overall Study|Adverse Event|43
7589803|NCT02810457|11996146|FG000|Overall Study|Patient decision|31
7589804|NCT02810457|11996147|FG001|Overall Study|Patient decision|35
7589805|NCT02810457|11996146|FG000|Overall Study|Patient lost to follow-up|2
7589806|NCT02810457|11996147|FG001|Overall Study|Patient lost to follow-up|2
7589807|NCT02810457|11996146|FG000|Overall Study|Death|39
7589808|NCT02810457|11996147|FG001|Overall Study|Death|28
7589809|NCT02810457|11996146|FG000|Overall Study|Ongoing at data cutoff and discontinued|3
7589810|NCT02810457|11996147|FG001|Overall Study|Ongoing at data cutoff and discontinued|2
7589811|NCT02810457|11996146|FG000|Overall Study|Clinical progression|15
7589812|NCT02810457|11996147|FG001|Overall Study|Clinical progression|16
7589813|NCT02810457|11996146|FG000|Overall Study|Investigator decision|3
7589814|NCT02810457|11996147|FG001|Overall Study|Investigator decision|2
7589815|NCT02810457|11996146|FG000|Overall Study|Patient ineligibility|3
7589816|NCT02810457|11996147|FG001|Overall Study|Patient ineligibility|0
7589817|NCT02810457|11996146|FG000|Overall Study|Miscalculated PD|1
7589818|NCT02810457|11996147|FG001|Overall Study|Miscalculated PD|0
7589819|NCT02810457|11996146|FG000|Overall Study|Physician Decision|0
7589820|NCT02810457|11996147|FG001|Overall Study|Physician Decision|1
7626621|NCT02723864|12038993|FG006|Overall Study|Exceed treatment hold time|0
7626622|NCT02723864|12038987|FG000|Overall Study|Clinical progression|0
7626623|NCT02723864|12038988|FG001|Overall Study|Clinical progression|0
7626624|NCT02723864|12038989|FG002|Overall Study|Clinical progression|1
7626625|NCT02723864|12038990|FG003|Overall Study|Clinical progression|0
7626626|NCT02723864|12038991|FG004|Overall Study|Clinical progression|0
7626627|NCT02723864|12038992|FG005|Overall Study|Clinical progression|3
7626628|NCT02723864|12038993|FG006|Overall Study|Clinical progression|1
7626629|NCT02723864|12038987|FG000|Overall Study|Physician Decision|0
7626630|NCT02723864|12038988|FG001|Overall Study|Physician Decision|0
7626631|NCT02723864|12038989|FG002|Overall Study|Physician Decision|0
7626632|NCT02723864|12038990|FG003|Overall Study|Physician Decision|0
7626633|NCT02723864|12038991|FG004|Overall Study|Physician Decision|0
7626634|NCT02723864|12038992|FG005|Overall Study|Physician Decision|0
7626635|NCT02723864|12038993|FG006|Overall Study|Physician Decision|1
7589821|NCT02745535|11996183|FG000|Overall Study|Death|1
7589822|NCT02745535|11996183|FG000|Overall Study|Adverse Event|3
7589823|NCT02745535|11996183|FG000|Overall Study|Lost to Follow-up|2
7589824|NCT02625090|11996221|FG000|Overall Study|Participant wants to be pregnant|2
7589825|NCT02625090|11996221|FG000|Overall Study|For the Promoter|1
7589826|NCT02625090|11996221|FG000|Overall Study|Sponsor's Decision|9
7589827|NCT02625090|11996221|FG000|Overall Study|Somnolence|1
7589828|NCT02625090|11996221|FG000|Overall Study|Study terminated by Sponsor|7
7589829|NCT02625090|11996221|FG000|Overall Study|Negative Benefit/Risk|1
7589830|NCT02625090|11996221|FG000|Overall Study|Protocol Deviation|2
7589831|NCT02625090|11996221|FG000|Overall Study|Lack of Efficacy|16
7589832|NCT02625090|11996221|FG000|Overall Study|Adverse Event|3
7589833|NCT02539225|11996228|FG000|Part A|Adverse Event|13
7589834|NCT02539225|11996229|FG001|Part A|Adverse Event|4
7589835|NCT02539225|11996228|FG000|Part A|Withdrawal by Subject|2
7589836|NCT02539225|11996229|FG001|Part A|Withdrawal by Subject|4
7589837|NCT02539225|11996228|FG000|Part A|Physician Decision|4
7589838|NCT02539225|11996229|FG001|Part A|Physician Decision|7
7589839|NCT02539225|11996228|FG000|Part A|Did Not Receive study Drug|1
7589840|NCT02539225|11996229|FG001|Part A|Did Not Receive study Drug|1
7589841|NCT02539225|11996228|FG000|Pre Treatment for Part B|Progressive disease|1
7589842|NCT02539225|11996229|FG001|Pre Treatment for Part B|Progressive disease|1
7589843|NCT02539225|11996228|FG000|Pre Treatment for Part B|Adverse Event|1
7589844|NCT02539225|11996229|FG001|Pre Treatment for Part B|Adverse Event|1
7589845|NCT02539225|11996228|FG000|Pre Treatment for Part B|Withdrawal by Subject|1
7589846|NCT02539225|11996229|FG001|Pre Treatment for Part B|Withdrawal by Subject|0
7589847|NCT02539225|11996228|FG000|Pre Treatment for Part B|Physician Decision|2
7589848|NCT02539225|11996229|FG001|Pre Treatment for Part B|Physician Decision|0
7589849|NCT02539225|11996228|FG000|Part B|Adverse Event|4
7589850|NCT02539225|11996229|FG001|Part B|Adverse Event|4
7589851|NCT02539225|11996228|FG000|Part B|Withdrawal by Subject|0
7589852|NCT02539225|11996229|FG001|Part B|Withdrawal by Subject|3
7589853|NCT02539225|11996228|FG000|Part B|Physician Decision|0
7589854|NCT02539225|11996229|FG001|Part B|Physician Decision|9
7589855|NCT02526017|11996257|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589856|NCT02526017|11996258|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589857|NCT02526017|11996259|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589858|NCT02526017|11996260|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589859|NCT02526017|11996261|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1
7589860|NCT02526017|11996262|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589861|NCT02526017|11996263|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589862|NCT02526017|11996264|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589863|NCT02526017|11996265|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589864|NCT02482233|11996327|FG000|Overall Study|Lost to Follow-up|1
7589865|NCT02482233|11996328|FG001|Overall Study|Lost to Follow-up|1
7589866|NCT02400736|11996345|FG000|Overall Study|Lost to Follow-up|6
7589867|NCT02400736|11996346|FG001|Overall Study|Lost to Follow-up|6
7589868|NCT02400736|11996345|FG000|Overall Study|Withdrawal by Subject|2
7589869|NCT02400736|11996346|FG001|Overall Study|Withdrawal by Subject|1
7589870|NCT02400736|11996345|FG000|Overall Study|Moved from the area|3
7589871|NCT02400736|11996346|FG001|Overall Study|Moved from the area|1
7589872|NCT02369653|11996358|FG000|Overall Study|Lost to Follow-up|0
7589873|NCT02369653|11996359|FG001|Overall Study|Lost to Follow-up|1
7589874|NCT02369653|11996358|FG000|Overall Study|Administrative reason by sponsor|0
7589875|NCT02369653|11996359|FG001|Overall Study|Administrative reason by sponsor|1
7589876|NCT02369653|11996358|FG000|Overall Study|Death|1
7589877|NCT02369653|11996359|FG001|Overall Study|Death|2
7589878|NCT02369653|11996358|FG000|Overall Study|Participant withdrew consent|13
7589879|NCT02369653|11996359|FG001|Overall Study|Participant withdrew consent|3
7766804|NCT00849693|12209284|FG002|Acute Treatment Phase|Protocol Violation|2
7766805|NCT00849693|12209285|FG003|Acute Treatment Phase|Protocol Violation|6
7766806|NCT00849693|12209282|FG000|Acute Treatment Phase|Withdrawal by Subject|5
7766807|NCT00849693|12209283|FG001|Acute Treatment Phase|Withdrawal by Subject|5
7766808|NCT00849693|12209284|FG002|Acute Treatment Phase|Withdrawal by Subject|3
7766809|NCT00849693|12209285|FG003|Acute Treatment Phase|Withdrawal by Subject|8
7589887|NCT02326974|11996373|FG000|Overall Study|Withdrawal by Subject|2
7589888|NCT02326974|11996373|FG000|Overall Study|failed heterogenity evaluation|5
7589889|NCT02284568|11996384|FG000|Overall Study|Adverse Event|2
7589890|NCT02284568|11996385|FG001|Overall Study|Adverse Event|9
7589891|NCT02284568|11996386|FG002|Overall Study|Adverse Event|4
7589892|NCT02284568|11996384|FG000|Overall Study|Withdrawal by Subject|22
7589893|NCT02284568|11996385|FG001|Overall Study|Withdrawal by Subject|21
7589894|NCT02284568|11996386|FG002|Overall Study|Withdrawal by Subject|1
7589895|NCT02284568|11996384|FG000|Overall Study|Noncompliance with study drug admin|1
7589896|NCT02284568|11996385|FG001|Overall Study|Noncompliance with study drug admin|2
7589897|NCT02284568|11996386|FG002|Overall Study|Noncompliance with study drug admin|0
7589898|NCT02284568|11996384|FG000|Overall Study|Noncompliance|1
7589899|NCT02284568|11996385|FG001|Overall Study|Noncompliance|0
7589900|NCT02284568|11996386|FG002|Overall Study|Noncompliance|0
7589901|NCT02284568|11996384|FG000|Overall Study|Protocol Violation|0
7589902|NCT02284568|11996385|FG001|Overall Study|Protocol Violation|1
7589903|NCT02284568|11996386|FG002|Overall Study|Protocol Violation|0
7589904|NCT02284568|11996384|FG000|Overall Study|Sponsor requested patient stop treatment|0
7589905|NCT02284568|11996385|FG001|Overall Study|Sponsor requested patient stop treatment|0
7589906|NCT02284568|11996386|FG002|Overall Study|Sponsor requested patient stop treatment|90
7589907|NCT02284568|11996384|FG000|Overall Study|Lost to Follow-up|0
7589908|NCT02284568|11996385|FG001|Overall Study|Lost to Follow-up|3
7589909|NCT02284568|11996386|FG002|Overall Study|Lost to Follow-up|0
7589910|NCT02284568|11996384|FG000|Overall Study|Lack of Efficacy|4
7589911|NCT02284568|11996385|FG001|Overall Study|Lack of Efficacy|7
7589912|NCT02284568|11996386|FG002|Overall Study|Lack of Efficacy|0
7589913|NCT02284568|11996384|FG000|Overall Study|Other|1
7589914|NCT02284568|11996385|FG001|Overall Study|Other|2
7589915|NCT02284568|11996386|FG002|Overall Study|Other|0
7589916|NCT02284568|11996384|FG000|Overall Study|Withdrew before taking study drug|0
7589917|NCT02284568|11996385|FG001|Overall Study|Withdrew before taking study drug|1
7589918|NCT02284568|11996386|FG002|Overall Study|Withdrew before taking study drug|0
7626636|NCT02723864|12038987|FG000|Overall Study|Changes in patient condition|0
7626637|NCT02723864|12038988|FG001|Overall Study|Changes in patient condition|0
7626638|NCT02723864|12038989|FG002|Overall Study|Changes in patient condition|0
7626639|NCT02723864|12038990|FG003|Overall Study|Changes in patient condition|0
7626640|NCT02723864|12038991|FG004|Overall Study|Changes in patient condition|0
7626641|NCT02723864|12038992|FG005|Overall Study|Changes in patient condition|1
7626642|NCT02723864|12038993|FG006|Overall Study|Changes in patient condition|0
7626643|NCT02723864|12038987|FG000|Overall Study|Patient choice|0
7626644|NCT02723864|12038988|FG001|Overall Study|Patient choice|0
7626645|NCT02723864|12038989|FG002|Overall Study|Patient choice|0
7626646|NCT02723864|12038990|FG003|Overall Study|Patient choice|0
7626647|NCT02723864|12038991|FG004|Overall Study|Patient choice|0
7626648|NCT02723864|12038992|FG005|Overall Study|Patient choice|1
7626649|NCT02723864|12038993|FG006|Overall Study|Patient choice|0
7626650|NCT02723864|12038987|FG000|Overall Study|Adverse Event|0
7626651|NCT02723864|12038988|FG001|Overall Study|Adverse Event|0
7626652|NCT02723864|12038989|FG002|Overall Study|Adverse Event|0
7626653|NCT02723864|12038990|FG003|Overall Study|Adverse Event|0
7626654|NCT02723864|12038991|FG004|Overall Study|Adverse Event|0
7626655|NCT02723864|12038992|FG005|Overall Study|Adverse Event|1
7626656|NCT02723864|12038993|FG006|Overall Study|Adverse Event|0
7626657|NCT02723864|12038987|FG000|Overall Study|Started new treatment|0
7626658|NCT02723864|12038988|FG001|Overall Study|Started new treatment|0
7626659|NCT02723864|12038989|FG002|Overall Study|Started new treatment|0
7626660|NCT02723864|12038990|FG003|Overall Study|Started new treatment|0
7626661|NCT02723864|12038991|FG004|Overall Study|Started new treatment|0
7626662|NCT02723864|12038992|FG005|Overall Study|Started new treatment|1
7626663|NCT02723864|12038993|FG006|Overall Study|Started new treatment|0
7626664|NCT02723864|12038987|FG000|Overall Study|Switched to alternative treatment|0
7626665|NCT02723864|12038988|FG001|Overall Study|Switched to alternative treatment|0
7626666|NCT02723864|12038989|FG002|Overall Study|Switched to alternative treatment|0
7626667|NCT02723864|12038990|FG003|Overall Study|Switched to alternative treatment|0
7626668|NCT02723864|12038991|FG004|Overall Study|Switched to alternative treatment|0
7626669|NCT02723864|12038992|FG005|Overall Study|Switched to alternative treatment|1
7626670|NCT02723864|12038993|FG006|Overall Study|Switched to alternative treatment|0
7626671|NCT02723864|12038987|FG000|Overall Study|Late determination of ineligibility|0
7626672|NCT02723864|12038988|FG001|Overall Study|Late determination of ineligibility|0
7626673|NCT02723864|12038989|FG002|Overall Study|Late determination of ineligibility|0
7626674|NCT02723864|12038990|FG003|Overall Study|Late determination of ineligibility|0
7626675|NCT02723864|12038991|FG004|Overall Study|Late determination of ineligibility|0
7626676|NCT02723864|12038992|FG005|Overall Study|Late determination of ineligibility|1
7626677|NCT02723864|12038993|FG006|Overall Study|Late determination of ineligibility|0
7626678|NCT02691013|12039041|FG000|Overall Study|Withdrawal by Subject|3
7626679|NCT02691013|12039042|FG001|Overall Study|Withdrawal by Subject|0
7626680|NCT02597062|12039050|FG000|Overall Study|Ineligible|1
7626681|NCT02130882|12039056|FG000|Overall Study|Withdrawal by Subject|0
7626682|NCT02130882|12039057|FG001|Overall Study|Withdrawal by Subject|1
7626683|NCT01850563|12039065|FG000|Overall Study|Not eligible|3
7626684|NCT01850563|12039066|FG001|Overall Study|Not eligible|0
7626685|NCT01827111|12039073|FG000|Overall Study|Disease Progression|1
7626686|NCT01437111|12039077|FG000|Overall Study|Adverse Event|2
7626687|NCT01437111|12039077|FG000|Overall Study|Withdrawal by Subject|4
7626688|NCT01437111|12039077|FG000|Overall Study|Not reported|5
7626689|NCT01437111|12039077|FG000|Overall Study|Physician Decision|1
7626690|NCT01437111|12039077|FG000|Overall Study|Lost to Follow-up|5
7626691|NCT01437111|12039077|FG000|Overall Study|Protocol Violation|1
7626692|NCT01004263|12039114|FG000|Overall Study|Adverse Event|15
7626693|NCT01004263|12039114|FG000|Overall Study|Withdrawal by Subject|58
7626694|NCT01004263|12039114|FG000|Overall Study|Protocol Violation|10
7626695|NCT01004263|12039114|FG000|Overall Study|Lost to Follow-up|64
7626696|NCT01004263|12039114|FG000|Overall Study|Lack of Efficacy|13
7626697|NCT01004263|12039114|FG000|Overall Study|Pregnancy|2
7626698|NCT01004263|12039114|FG000|Overall Study|Physician Decision|15
7626699|NCT01004263|12039114|FG000|Overall Study|Lack of Qualifying Event|2
7626700|NCT01001234|12039123|FG000|Overall Study|Withdrawal by Subject|2
7626701|NCT01001234|12039124|FG001|Overall Study|Withdrawal by Subject|0
7589919|NCT02227238|11996400|FG000|Overall Study|Other: Reached stopping criteria|0
7589920|NCT02227238|11996401|FG001|Overall Study|Other: Reached stopping criteria|1
7589921|NCT02227238|11996400|FG000|Overall Study|Adverse Event|8
7589922|NCT02227238|11996401|FG001|Overall Study|Adverse Event|18
7589923|NCT02227238|11996400|FG000|Overall Study|Lack of Efficacy|10
7589924|NCT02227238|11996401|FG001|Overall Study|Lack of Efficacy|22
7589925|NCT02227238|11996400|FG000|Overall Study|Protocol Violation|7
7589926|NCT02227238|11996401|FG001|Overall Study|Protocol Violation|8
7589927|NCT02227238|11996400|FG000|Overall Study|Withdrawal by Subject|5
7589928|NCT02227238|11996401|FG001|Overall Study|Withdrawal by Subject|4
7589929|NCT02227238|11996400|FG000|Overall Study|Physician Decision|0
7589930|NCT02227238|11996401|FG001|Overall Study|Physician Decision|9
7589931|NCT02227238|11996400|FG000|Overall Study|Lost to Follow-up|7
7589932|NCT02227238|11996401|FG001|Overall Study|Lost to Follow-up|5
7589933|NCT02195986|11996410|FG000|Overall Study|Adverse Event|3
7589934|NCT02195986|11996411|FG001|Overall Study|Adverse Event|0
7589935|NCT02195986|11996412|FG002|Overall Study|Adverse Event|0
7589936|NCT02195986|11996410|FG000|Overall Study|Withdrawal by Subject|0
7589937|NCT02195986|11996411|FG001|Overall Study|Withdrawal by Subject|3
7589938|NCT02195986|11996412|FG002|Overall Study|Withdrawal by Subject|0
7589939|NCT02195986|11996410|FG000|Overall Study|Family Emergency|0
7589940|NCT02195986|11996411|FG001|Overall Study|Family Emergency|0
7589941|NCT02195986|11996412|FG002|Overall Study|Family Emergency|1
7589942|NCT02195986|11996410|FG000|Overall Study|Protocol Violation|0
7589943|NCT02195986|11996411|FG001|Overall Study|Protocol Violation|1
7589944|NCT02195986|11996412|FG002|Overall Study|Protocol Violation|1
7589945|NCT02195986|11996410|FG000|Overall Study|Non-compliance|0
7589946|NCT02195986|11996411|FG001|Overall Study|Non-compliance|1
7589947|NCT02195986|11996412|FG002|Overall Study|Non-compliance|0
7589948|NCT02086448|11996433|FG000|Overall Study|Withdrawal by Subject|1
7589949|NCT02086448|11996434|FG001|Overall Study|Withdrawal by Subject|0
7589950|NCT02086448|11996435|FG002|Overall Study|Withdrawal by Subject|0
7589951|NCT02086448|11996436|FG003|Overall Study|Withdrawal by Subject|2
7589952|NCT01982630|11996454|FG000|Overall Study|Adverse Event|2
7589953|NCT01982630|11996455|FG001|Overall Study|Adverse Event|0
7589954|NCT01982630|11996456|FG002|Overall Study|Adverse Event|1
7589955|NCT01982630|11996457|FG003|Overall Study|Adverse Event|0
7589956|NCT01982630|11996458|FG004|Overall Study|Adverse Event|1
7589957|NCT01982630|11996459|FG005|Overall Study|Adverse Event|2
7589958|NCT01982630|11996460|FG006|Overall Study|Adverse Event|1
7589959|NCT01982630|11996461|FG007|Overall Study|Adverse Event|0
7589960|NCT01982630|11996454|FG000|Overall Study|Physician Decision|1
7589961|NCT01982630|11996455|FG001|Overall Study|Physician Decision|0
7589962|NCT01982630|11996456|FG002|Overall Study|Physician Decision|2
7589963|NCT01982630|11996457|FG003|Overall Study|Physician Decision|1
7589964|NCT01982630|11996458|FG004|Overall Study|Physician Decision|2
7589965|NCT01982630|11996459|FG005|Overall Study|Physician Decision|0
7589966|NCT01982630|11996460|FG006|Overall Study|Physician Decision|0
7589967|NCT01982630|11996461|FG007|Overall Study|Physician Decision|0
7589968|NCT01982630|11996454|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0
7589969|NCT01982630|11996455|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0
7589970|NCT01982630|11996456|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2
7589971|NCT01982630|11996457|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0
7589972|NCT01982630|11996458|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0
7589973|NCT01982630|11996459|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0
7589974|NCT01982630|11996460|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0
7589975|NCT01982630|11996461|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0
7589976|NCT01982630|11996454|FG000|Overall Study|Withdrawal by Subject|0
7589977|NCT01982630|11996455|FG001|Overall Study|Withdrawal by Subject|0
7589978|NCT01982630|11996456|FG002|Overall Study|Withdrawal by Subject|0
7589979|NCT01982630|11996457|FG003|Overall Study|Withdrawal by Subject|0
7589980|NCT01982630|11996458|FG004|Overall Study|Withdrawal by Subject|0
7589981|NCT01982630|11996459|FG005|Overall Study|Withdrawal by Subject|1
7589982|NCT01982630|11996460|FG006|Overall Study|Withdrawal by Subject|0
7589983|NCT01982630|11996461|FG007|Overall Study|Withdrawal by Subject|0
7589984|NCT01982448|11996516|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2
7589985|NCT01982448|11996517|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2
7589986|NCT01982448|11996516|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1
7589987|NCT01982448|11996517|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0
7589988|NCT01982448|11996516|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0
7589989|NCT01982448|11996517|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2
7589990|NCT01982448|11996516|FG000|Preoperative Chemotherapy|Lost to Follow-up|0
7589991|NCT01982448|11996517|FG001|Preoperative Chemotherapy|Lost to Follow-up|1
7589992|NCT01752920|11996549|FG000|Overall Study|Adverse Event|1
7589993|NCT01752920|11996550|FG001|Overall Study|Adverse Event|0
7589994|NCT01752920|11996551|FG002|Overall Study|Adverse Event|5
7589995|NCT01752920|11996552|FG003|Overall Study|Adverse Event|10
7589996|NCT01752920|11996549|FG000|Overall Study|Clinical Disease Progression|6
7589997|NCT01752920|11996550|FG001|Overall Study|Clinical Disease Progression|4
7589998|NCT01752920|11996551|FG002|Overall Study|Clinical Disease Progression|1
7589999|NCT01752920|11996552|FG003|Overall Study|Clinical Disease Progression|13
7590000|NCT01752920|11996549|FG000|Overall Study|Physician Decision|1
7590001|NCT01752920|11996550|FG001|Overall Study|Physician Decision|0
7590002|NCT01752920|11996551|FG002|Overall Study|Physician Decision|0
7590003|NCT01752920|11996552|FG003|Overall Study|Physician Decision|3
7590004|NCT01752920|11996549|FG000|Overall Study|Radiographic Disease Progression|20
7590005|NCT01752920|11996550|FG001|Overall Study|Radiographic Disease Progression|7
7590006|NCT01752920|11996551|FG002|Overall Study|Radiographic Disease Progression|12
7590007|NCT01752920|11996552|FG003|Overall Study|Radiographic Disease Progression|29
7590008|NCT01752920|11996549|FG000|Overall Study|Study Terminated by Sponsor|0
7590009|NCT01752920|11996550|FG001|Overall Study|Study Terminated by Sponsor|0
7590010|NCT01752920|11996551|FG002|Overall Study|Study Terminated by Sponsor|0
7590011|NCT01752920|11996552|FG003|Overall Study|Study Terminated by Sponsor|1
7590012|NCT01752920|11996549|FG000|Overall Study|Withdrawal by Subject|0
7590013|NCT01752920|11996550|FG001|Overall Study|Withdrawal by Subject|1
7590014|NCT01752920|11996551|FG002|Overall Study|Withdrawal by Subject|0
7590015|NCT01752920|11996552|FG003|Overall Study|Withdrawal by Subject|1
7590016|NCT01752920|11996549|FG000|Overall Study|Lack of clinical benefit|1
7590017|NCT01752920|11996550|FG001|Overall Study|Lack of clinical benefit|1
7590018|NCT01752920|11996551|FG002|Overall Study|Lack of clinical benefit|1
7590019|NCT01752920|11996552|FG003|Overall Study|Lack of clinical benefit|1
7590022|NCT01740297|11996584|FG000|Overall Study|Withdrawal by Subject|4
7590023|NCT01740297|11996585|FG001|Overall Study|Withdrawal by Subject|16
7766810|NCT00849693|12209282|FG000|Acute Treatment Phase|Parent or caregiver decision|7
7766811|NCT00849693|12209283|FG001|Acute Treatment Phase|Parent or caregiver decision|6
7766812|NCT00849693|12209284|FG002|Acute Treatment Phase|Parent or caregiver decision|7
7766813|NCT00849693|12209285|FG003|Acute Treatment Phase|Parent or caregiver decision|7
7766814|NCT00849693|12209282|FG000|Acute Treatment Phase|Physician Decision|2
7590024|NCT01740297|11996586|FG002|Overall Study|Withdrawal by Subject|17
7590025|NCT01740297|11996584|FG000|Overall Study|Death|8
7590026|NCT01740297|11996585|FG001|Overall Study|Death|46
7590027|NCT01740297|11996586|FG002|Overall Study|Death|40
7590028|NCT01740297|11996584|FG000|Overall Study|Lost to Follow-up|1
7590029|NCT01740297|11996585|FG001|Overall Study|Lost to Follow-up|2
7590030|NCT01740297|11996586|FG002|Overall Study|Lost to Follow-up|4
7590031|NCT01729754|11996600|FG000|Part 1|Adverse Event|2
7590032|NCT01729754|11996601|FG001|Part 1|Adverse Event|0
7590033|NCT01729754|11996602|FG002|Part 1|Adverse Event|0
7590034|NCT01729754|11996603|FG003|Part 1|Adverse Event|1
7590035|NCT01729754|11996604|FG004|Part 1|Adverse Event|0
7590036|NCT01729754|11996605|FG005|Part 1|Adverse Event|0
7590037|NCT01729754|11996606|FG006|Part 1|Adverse Event|2
7590038|NCT01729754|11996607|FG007|Part 1|Adverse Event|0
7590039|NCT01729754|11996608|FG008|Part 1|Adverse Event|0
7590040|NCT01729754|11996609|FG009|Part 1|Adverse Event|5
7590041|NCT01729754|11996600|FG000|Part 1|Lack of Efficacy|1
7590042|NCT01729754|11996601|FG001|Part 1|Lack of Efficacy|0
7590043|NCT01729754|11996602|FG002|Part 1|Lack of Efficacy|0
7590044|NCT01729754|11996603|FG003|Part 1|Lack of Efficacy|0
7590045|NCT01729754|11996604|FG004|Part 1|Lack of Efficacy|0
7590046|NCT01729754|11996605|FG005|Part 1|Lack of Efficacy|0
7590047|NCT01729754|11996606|FG006|Part 1|Lack of Efficacy|2
7590048|NCT01729754|11996607|FG007|Part 1|Lack of Efficacy|0
7590049|NCT01729754|11996608|FG008|Part 1|Lack of Efficacy|0
7590050|NCT01729754|11996609|FG009|Part 1|Lack of Efficacy|0
7590051|NCT01729754|11996600|FG000|Part 1|Lost to Follow-up|1
7590052|NCT01729754|11996601|FG001|Part 1|Lost to Follow-up|0
7590053|NCT01729754|11996602|FG002|Part 1|Lost to Follow-up|0
7590054|NCT01729754|11996603|FG003|Part 1|Lost to Follow-up|2
7590055|NCT01729754|11996604|FG004|Part 1|Lost to Follow-up|0
7590056|NCT01729754|11996605|FG005|Part 1|Lost to Follow-up|0
7590057|NCT01729754|11996606|FG006|Part 1|Lost to Follow-up|3
7590058|NCT01729754|11996607|FG007|Part 1|Lost to Follow-up|0
7590059|NCT01729754|11996608|FG008|Part 1|Lost to Follow-up|0
7590060|NCT01729754|11996609|FG009|Part 1|Lost to Follow-up|3
7590061|NCT01729754|11996600|FG000|Part 1|Non-compliance with Study Drug|1
7590062|NCT01729754|11996601|FG001|Part 1|Non-compliance with Study Drug|0
7590063|NCT01729754|11996602|FG002|Part 1|Non-compliance with Study Drug|0
7590064|NCT01729754|11996603|FG003|Part 1|Non-compliance with Study Drug|0
7590065|NCT01729754|11996604|FG004|Part 1|Non-compliance with Study Drug|0
7590066|NCT01729754|11996605|FG005|Part 1|Non-compliance with Study Drug|0
7590067|NCT01729754|11996606|FG006|Part 1|Non-compliance with Study Drug|0
7590068|NCT01729754|11996607|FG007|Part 1|Non-compliance with Study Drug|0
7590069|NCT01729754|11996608|FG008|Part 1|Non-compliance with Study Drug|0
7590070|NCT01729754|11996609|FG009|Part 1|Non-compliance with Study Drug|0
7590071|NCT01729754|11996600|FG000|Part 1|Physician Decision|0
7590072|NCT01729754|11996601|FG001|Part 1|Physician Decision|0
7590073|NCT01729754|11996602|FG002|Part 1|Physician Decision|0
7590074|NCT01729754|11996603|FG003|Part 1|Physician Decision|0
7590075|NCT01729754|11996604|FG004|Part 1|Physician Decision|0
7590076|NCT01729754|11996605|FG005|Part 1|Physician Decision|0
7590077|NCT01729754|11996606|FG006|Part 1|Physician Decision|0
7590078|NCT01729754|11996607|FG007|Part 1|Physician Decision|0
7590079|NCT01729754|11996608|FG008|Part 1|Physician Decision|0
7590080|NCT01729754|11996609|FG009|Part 1|Physician Decision|4
7590081|NCT01729754|11996600|FG000|Part 1|Pregnancy|0
7590082|NCT01729754|11996601|FG001|Part 1|Pregnancy|0
7590083|NCT01729754|11996602|FG002|Part 1|Pregnancy|0
7590084|NCT01729754|11996603|FG003|Part 1|Pregnancy|1
7590085|NCT01729754|11996604|FG004|Part 1|Pregnancy|0
7590086|NCT01729754|11996605|FG005|Part 1|Pregnancy|0
7590087|NCT01729754|11996606|FG006|Part 1|Pregnancy|0
7590088|NCT01729754|11996607|FG007|Part 1|Pregnancy|0
7590089|NCT01729754|11996608|FG008|Part 1|Pregnancy|0
7590090|NCT01729754|11996609|FG009|Part 1|Pregnancy|1
7590091|NCT01729754|11996600|FG000|Part 1|Progressive Disease|0
7590092|NCT01729754|11996601|FG001|Part 1|Progressive Disease|0
7590093|NCT01729754|11996602|FG002|Part 1|Progressive Disease|0
7590094|NCT01729754|11996603|FG003|Part 1|Progressive Disease|0
7590095|NCT01729754|11996604|FG004|Part 1|Progressive Disease|0
7590096|NCT01729754|11996605|FG005|Part 1|Progressive Disease|0
7590097|NCT01729754|11996606|FG006|Part 1|Progressive Disease|0
7590098|NCT01729754|11996607|FG007|Part 1|Progressive Disease|0
7590099|NCT01729754|11996608|FG008|Part 1|Progressive Disease|0
7590100|NCT01729754|11996609|FG009|Part 1|Progressive Disease|1
7590101|NCT01729754|11996600|FG000|Part 1|Protocol Violation|2
7590102|NCT01729754|11996601|FG001|Part 1|Protocol Violation|0
7590103|NCT01729754|11996602|FG002|Part 1|Protocol Violation|0
7590104|NCT01729754|11996603|FG003|Part 1|Protocol Violation|1
7590105|NCT01729754|11996604|FG004|Part 1|Protocol Violation|0
7590106|NCT01729754|11996605|FG005|Part 1|Protocol Violation|0
7590107|NCT01729754|11996606|FG006|Part 1|Protocol Violation|1
7590108|NCT01729754|11996607|FG007|Part 1|Protocol Violation|0
7590109|NCT01729754|11996608|FG008|Part 1|Protocol Violation|0
7590110|NCT01729754|11996609|FG009|Part 1|Protocol Violation|0
7590111|NCT01729754|11996600|FG000|Part 1|Withdrawal by Subject|5
7590112|NCT01729754|11996601|FG001|Part 1|Withdrawal by Subject|0
7590113|NCT01729754|11996602|FG002|Part 1|Withdrawal by Subject|0
7590114|NCT01729754|11996603|FG003|Part 1|Withdrawal by Subject|7
7590115|NCT01729754|11996604|FG004|Part 1|Withdrawal by Subject|0
7590116|NCT01729754|11996605|FG005|Part 1|Withdrawal by Subject|0
7590117|NCT01729754|11996606|FG006|Part 1|Withdrawal by Subject|5
7590118|NCT01729754|11996607|FG007|Part 1|Withdrawal by Subject|0
7590119|NCT01729754|11996608|FG008|Part 1|Withdrawal by Subject|0
7590120|NCT01729754|11996609|FG009|Part 1|Withdrawal by Subject|6
7590121|NCT01729754|11996600|FG000|Part 1|Other Protocol Specified Criteria|2
7590122|NCT01729754|11996601|FG001|Part 1|Other Protocol Specified Criteria|0
7590123|NCT01729754|11996602|FG002|Part 1|Other Protocol Specified Criteria|0
7590124|NCT01729754|11996603|FG003|Part 1|Other Protocol Specified Criteria|0
7590125|NCT01729754|11996604|FG004|Part 1|Other Protocol Specified Criteria|0
7590126|NCT01729754|11996605|FG005|Part 1|Other Protocol Specified Criteria|0
7590127|NCT01729754|11996606|FG006|Part 1|Other Protocol Specified Criteria|1
7590128|NCT01729754|11996607|FG007|Part 1|Other Protocol Specified Criteria|0
7590129|NCT01729754|11996608|FG008|Part 1|Other Protocol Specified Criteria|0
7590130|NCT01729754|11996609|FG009|Part 1|Other Protocol Specified Criteria|4
7590131|NCT01729754|11996600|FG000|Part 2|Adverse Event|2
7590132|NCT01729754|11996601|FG001|Part 2|Adverse Event|0
7590133|NCT01729754|11996602|FG002|Part 2|Adverse Event|0
7590134|NCT01729754|11996603|FG003|Part 2|Adverse Event|0
7590135|NCT01729754|11996604|FG004|Part 2|Adverse Event|0
7590136|NCT01729754|11996605|FG005|Part 2|Adverse Event|0
7590137|NCT01729754|11996606|FG006|Part 2|Adverse Event|0
7590138|NCT01729754|11996607|FG007|Part 2|Adverse Event|0
7590139|NCT01729754|11996608|FG008|Part 2|Adverse Event|1
7590140|NCT01729754|11996609|FG009|Part 2|Adverse Event|2
7590141|NCT01729754|11996600|FG000|Part 2|Lack of Efficacy|0
7590142|NCT01729754|11996601|FG001|Part 2|Lack of Efficacy|0
7590143|NCT01729754|11996602|FG002|Part 2|Lack of Efficacy|0
7590144|NCT01729754|11996603|FG003|Part 2|Lack of Efficacy|0
7590145|NCT01729754|11996604|FG004|Part 2|Lack of Efficacy|0
7590146|NCT01729754|11996605|FG005|Part 2|Lack of Efficacy|0
7590147|NCT01729754|11996606|FG006|Part 2|Lack of Efficacy|0
7590148|NCT01729754|11996607|FG007|Part 2|Lack of Efficacy|0
7590149|NCT01729754|11996608|FG008|Part 2|Lack of Efficacy|2
7590150|NCT01729754|11996609|FG009|Part 2|Lack of Efficacy|2
7590151|NCT01729754|11996600|FG000|Part 2|Lost to Follow-up|0
7590152|NCT01729754|11996601|FG001|Part 2|Lost to Follow-up|0
7590153|NCT01729754|11996602|FG002|Part 2|Lost to Follow-up|0
7590154|NCT01729754|11996603|FG003|Part 2|Lost to Follow-up|2
7590155|NCT01729754|11996604|FG004|Part 2|Lost to Follow-up|0
7590156|NCT01729754|11996605|FG005|Part 2|Lost to Follow-up|0
7590157|NCT01729754|11996606|FG006|Part 2|Lost to Follow-up|0
7590158|NCT01729754|11996607|FG007|Part 2|Lost to Follow-up|1
7590159|NCT01729754|11996608|FG008|Part 2|Lost to Follow-up|0
7766815|NCT00849693|12209283|FG001|Acute Treatment Phase|Physician Decision|1
7766816|NCT00849693|12209284|FG002|Acute Treatment Phase|Physician Decision|2
7766817|NCT00849693|12209285|FG003|Acute Treatment Phase|Physician Decision|1
7590160|NCT01729754|11996609|FG009|Part 2|Lost to Follow-up|2
7590161|NCT01729754|11996600|FG000|Part 2|Non-Compliance with Study Drug|0
7590162|NCT01729754|11996601|FG001|Part 2|Non-Compliance with Study Drug|0
7590163|NCT01729754|11996602|FG002|Part 2|Non-Compliance with Study Drug|0
7590164|NCT01729754|11996603|FG003|Part 2|Non-Compliance with Study Drug|0
7590165|NCT01729754|11996604|FG004|Part 2|Non-Compliance with Study Drug|0
7590166|NCT01729754|11996605|FG005|Part 2|Non-Compliance with Study Drug|0
7590167|NCT01729754|11996606|FG006|Part 2|Non-Compliance with Study Drug|0
7590168|NCT01729754|11996607|FG007|Part 2|Non-Compliance with Study Drug|0
7590169|NCT01729754|11996608|FG008|Part 2|Non-Compliance with Study Drug|0
7590170|NCT01729754|11996609|FG009|Part 2|Non-Compliance with Study Drug|1
7590171|NCT01729754|11996600|FG000|Part 2|Pregnancy|0
7590172|NCT01729754|11996601|FG001|Part 2|Pregnancy|0
7590173|NCT01729754|11996602|FG002|Part 2|Pregnancy|0
7590174|NCT01729754|11996603|FG003|Part 2|Pregnancy|1
7590175|NCT01729754|11996604|FG004|Part 2|Pregnancy|0
7590176|NCT01729754|11996605|FG005|Part 2|Pregnancy|0
7590177|NCT01729754|11996606|FG006|Part 2|Pregnancy|0
7590178|NCT01729754|11996607|FG007|Part 2|Pregnancy|0
7590179|NCT01729754|11996608|FG008|Part 2|Pregnancy|0
7590180|NCT01729754|11996609|FG009|Part 2|Pregnancy|1
7590181|NCT01729754|11996600|FG000|Part 2|Withdrawal by Subject|3
7590182|NCT01729754|11996601|FG001|Part 2|Withdrawal by Subject|0
7590183|NCT01729754|11996602|FG002|Part 2|Withdrawal by Subject|0
7590184|NCT01729754|11996603|FG003|Part 2|Withdrawal by Subject|2
7590185|NCT01729754|11996604|FG004|Part 2|Withdrawal by Subject|0
7590186|NCT01729754|11996605|FG005|Part 2|Withdrawal by Subject|0
7590187|NCT01729754|11996606|FG006|Part 2|Withdrawal by Subject|0
7590188|NCT01729754|11996607|FG007|Part 2|Withdrawal by Subject|1
7590189|NCT01729754|11996608|FG008|Part 2|Withdrawal by Subject|1
7590190|NCT01729754|11996609|FG009|Part 2|Withdrawal by Subject|4
7590191|NCT01729754|11996600|FG000|Part 2|Other Protocol Specified Criteria|1
7590192|NCT01729754|11996601|FG001|Part 2|Other Protocol Specified Criteria|0
7590193|NCT01729754|11996602|FG002|Part 2|Other Protocol Specified Criteria|0
7590194|NCT01729754|11996603|FG003|Part 2|Other Protocol Specified Criteria|0
7590195|NCT01729754|11996604|FG004|Part 2|Other Protocol Specified Criteria|0
7590196|NCT01729754|11996605|FG005|Part 2|Other Protocol Specified Criteria|0
7590197|NCT01729754|11996606|FG006|Part 2|Other Protocol Specified Criteria|0
7590198|NCT01729754|11996607|FG007|Part 2|Other Protocol Specified Criteria|1
7590199|NCT01729754|11996608|FG008|Part 2|Other Protocol Specified Criteria|0
7590200|NCT01729754|11996609|FG009|Part 2|Other Protocol Specified Criteria|0
7590201|NCT01729754|11996600|FG000|Part 3|Adverse Event|0
7590202|NCT01729754|11996601|FG001|Part 3|Adverse Event|0
7590203|NCT01729754|11996602|FG002|Part 3|Adverse Event|1
7590204|NCT01729754|11996603|FG003|Part 3|Adverse Event|0
7590205|NCT01729754|11996604|FG004|Part 3|Adverse Event|0
7590206|NCT01729754|11996605|FG005|Part 3|Adverse Event|5
7590207|NCT01729754|11996606|FG006|Part 3|Adverse Event|0
7590208|NCT01729754|11996607|FG007|Part 3|Adverse Event|0
7590209|NCT01729754|11996608|FG008|Part 3|Adverse Event|0
7766818|NCT00849693|12209282|FG000|Acute Treatment Phase|Sponsor decision|0
7590210|NCT01729754|11996609|FG009|Part 3|Adverse Event|3
7590211|NCT01729754|11996600|FG000|Part 3|Death|0
7590212|NCT01729754|11996601|FG001|Part 3|Death|0
7590213|NCT01729754|11996602|FG002|Part 3|Death|0
7590214|NCT01729754|11996603|FG003|Part 3|Death|0
7590215|NCT01729754|11996604|FG004|Part 3|Death|0
7590216|NCT01729754|11996605|FG005|Part 3|Death|2
7590217|NCT01729754|11996606|FG006|Part 3|Death|0
7590218|NCT01729754|11996607|FG007|Part 3|Death|0
7590219|NCT01729754|11996608|FG008|Part 3|Death|0
7590220|NCT01729754|11996609|FG009|Part 3|Death|0
7590221|NCT01729754|11996600|FG000|Part 3|Lack of Efficacy|0
7590222|NCT01729754|11996601|FG001|Part 3|Lack of Efficacy|0
7590223|NCT01729754|11996602|FG002|Part 3|Lack of Efficacy|0
7590224|NCT01729754|11996603|FG003|Part 3|Lack of Efficacy|0
7590225|NCT01729754|11996604|FG004|Part 3|Lack of Efficacy|2
7590226|NCT01729754|11996605|FG005|Part 3|Lack of Efficacy|0
7590227|NCT01729754|11996606|FG006|Part 3|Lack of Efficacy|0
7590228|NCT01729754|11996607|FG007|Part 3|Lack of Efficacy|0
7590229|NCT01729754|11996608|FG008|Part 3|Lack of Efficacy|0
7590230|NCT01729754|11996609|FG009|Part 3|Lack of Efficacy|4
7766819|NCT00849693|12209283|FG001|Acute Treatment Phase|Sponsor decision|0
7766820|NCT00849693|12209284|FG002|Acute Treatment Phase|Sponsor decision|1
7962735|NCT02714569|12517085|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7590231|NCT01729754|11996600|FG000|Part 3|Lost to Follow-up|0
7590232|NCT01729754|11996601|FG001|Part 3|Lost to Follow-up|1
7590233|NCT01729754|11996602|FG002|Part 3|Lost to Follow-up|2
7590234|NCT01729754|11996603|FG003|Part 3|Lost to Follow-up|0
7590235|NCT01729754|11996604|FG004|Part 3|Lost to Follow-up|0
7590236|NCT01729754|11996605|FG005|Part 3|Lost to Follow-up|3
7590237|NCT01729754|11996606|FG006|Part 3|Lost to Follow-up|0
7590238|NCT01729754|11996607|FG007|Part 3|Lost to Follow-up|0
7590239|NCT01729754|11996608|FG008|Part 3|Lost to Follow-up|1
7590240|NCT01729754|11996609|FG009|Part 3|Lost to Follow-up|0
7590241|NCT01729754|11996600|FG000|Part 3|Physician Decision|0
7590242|NCT01729754|11996601|FG001|Part 3|Physician Decision|0
7590243|NCT01729754|11996602|FG002|Part 3|Physician Decision|1
7590244|NCT01729754|11996603|FG003|Part 3|Physician Decision|0
7590245|NCT01729754|11996604|FG004|Part 3|Physician Decision|0
7590246|NCT01729754|11996605|FG005|Part 3|Physician Decision|0
7590247|NCT01729754|11996606|FG006|Part 3|Physician Decision|0
7590248|NCT01729754|11996607|FG007|Part 3|Physician Decision|0
7590249|NCT01729754|11996608|FG008|Part 3|Physician Decision|0
7590250|NCT01729754|11996609|FG009|Part 3|Physician Decision|0
7590251|NCT01729754|11996600|FG000|Part 3|Withdrawal by Subject|0
7590252|NCT01729754|11996601|FG001|Part 3|Withdrawal by Subject|4
7590253|NCT01729754|11996602|FG002|Part 3|Withdrawal by Subject|1
7590254|NCT01729754|11996603|FG003|Part 3|Withdrawal by Subject|0
7590255|NCT01729754|11996604|FG004|Part 3|Withdrawal by Subject|2
7590256|NCT01729754|11996605|FG005|Part 3|Withdrawal by Subject|1
7590257|NCT01729754|11996606|FG006|Part 3|Withdrawal by Subject|0
7590258|NCT01729754|11996607|FG007|Part 3|Withdrawal by Subject|2
7590259|NCT01729754|11996608|FG008|Part 3|Withdrawal by Subject|0
7590260|NCT01729754|11996609|FG009|Part 3|Withdrawal by Subject|0
7590261|NCT01729754|11996600|FG000|Part 3|Other Protocol Specified Criteria|0
7590262|NCT01729754|11996601|FG001|Part 3|Other Protocol Specified Criteria|0
7590263|NCT01729754|11996602|FG002|Part 3|Other Protocol Specified Criteria|0
7962736|NCT02714569|12517086|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7962737|NCT02714569|12517087|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7962738|NCT02714569|12517088|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7962739|NCT02714569|12517089|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7962740|NCT02714569|12517090|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7962741|NCT02714569|12517080|FG000|Part A Third Intervention|Adverse Event|0
7962742|NCT02714569|12517081|FG001|Part A Third Intervention|Adverse Event|0
7590264|NCT01729754|11996603|FG003|Part 3|Other Protocol Specified Criteria|0
7590265|NCT01729754|11996604|FG004|Part 3|Other Protocol Specified Criteria|0
7590266|NCT01729754|11996605|FG005|Part 3|Other Protocol Specified Criteria|2
7590267|NCT01729754|11996606|FG006|Part 3|Other Protocol Specified Criteria|0
7590268|NCT01729754|11996607|FG007|Part 3|Other Protocol Specified Criteria|1
7590269|NCT01729754|11996608|FG008|Part 3|Other Protocol Specified Criteria|0
7590270|NCT01729754|11996609|FG009|Part 3|Other Protocol Specified Criteria|0
7766821|NCT00849693|12209285|FG003|Acute Treatment Phase|Sponsor decision|0
7766822|NCT00849693|12209282|FG000|Acute Treatment Phase|Lack of Efficacy|1
7766823|NCT00849693|12209283|FG001|Acute Treatment Phase|Lack of Efficacy|3
7766824|NCT00849693|12209284|FG002|Acute Treatment Phase|Lack of Efficacy|1
7766825|NCT00849693|12209285|FG003|Acute Treatment Phase|Lack of Efficacy|2
7766826|NCT00849693|12209282|FG000|Extension Phase|Adverse Event|4
7766827|NCT00849693|12209283|FG001|Extension Phase|Adverse Event|6
7766828|NCT00849693|12209284|FG002|Extension Phase|Adverse Event|3
7766829|NCT00849693|12209285|FG003|Extension Phase|Adverse Event|7
7766830|NCT00849693|12209282|FG000|Extension Phase|Lost to Follow-up|7
7766831|NCT00849693|12209283|FG001|Extension Phase|Lost to Follow-up|5
7766832|NCT00849693|12209284|FG002|Extension Phase|Lost to Follow-up|6
7766833|NCT00849693|12209285|FG003|Extension Phase|Lost to Follow-up|6
7766834|NCT00849693|12209282|FG000|Extension Phase|Protocol Violation|0
7766835|NCT00849693|12209283|FG001|Extension Phase|Protocol Violation|3
7766836|NCT00849693|12209284|FG002|Extension Phase|Protocol Violation|2
7766837|NCT00849693|12209285|FG003|Extension Phase|Protocol Violation|3
7766838|NCT00849693|12209282|FG000|Extension Phase|Withdrawal by Subject|6
7766839|NCT00849693|12209283|FG001|Extension Phase|Withdrawal by Subject|9
7766840|NCT00849693|12209284|FG002|Extension Phase|Withdrawal by Subject|10
7766841|NCT00849693|12209285|FG003|Extension Phase|Withdrawal by Subject|15
7766842|NCT00849693|12209282|FG000|Extension Phase|Parent or caregiver decision|9
7766843|NCT00849693|12209283|FG001|Extension Phase|Parent or caregiver decision|4
7766844|NCT00849693|12209284|FG002|Extension Phase|Parent or caregiver decision|10
7766845|NCT00849693|12209285|FG003|Extension Phase|Parent or caregiver decision|5
7766846|NCT00849693|12209282|FG000|Extension Phase|Physician Decision|1
7766847|NCT00849693|12209283|FG001|Extension Phase|Physician Decision|1
7766848|NCT00849693|12209284|FG002|Extension Phase|Physician Decision|2
7590299|NCT01564537|11996674|FG000|Overall Study|Withdrawal by Participant|4
7590300|NCT01564537|11996675|FG001|Overall Study|Withdrawal by Participant|4
7590301|NCT01564537|11996674|FG000|Overall Study|Lost to Follow-up|1
7590302|NCT01564537|11996675|FG001|Overall Study|Lost to Follow-up|0
7590303|NCT01564537|11996674|FG000|Overall Study|Other Miscellaneous Reasons|1
7590304|NCT01564537|11996675|FG001|Overall Study|Other Miscellaneous Reasons|2
7590305|NCT01515306|11996684|FG000|Overall Study|Adverse Event|3
7590306|NCT01515306|11996685|FG001|Overall Study|Adverse Event|2
7590307|NCT01515306|11996684|FG000|Overall Study|Progressive Disease|19
7590308|NCT01515306|11996685|FG001|Overall Study|Progressive Disease|9
7590309|NCT01515306|11996684|FG000|Overall Study|Withdrawal by Subject|1
7590310|NCT01515306|11996685|FG001|Overall Study|Withdrawal by Subject|2
7590311|NCT01515306|11996684|FG000|Overall Study|Physician Decision|1
7590312|NCT01515306|11996685|FG001|Overall Study|Physician Decision|1
7590313|NCT01423851|11996706|FG000|Whole Study|Disease progression|2
7590314|NCT01423851|11996707|FG001|Whole Study|Disease progression|1
7590315|NCT01423851|11996708|FG002|Whole Study|Disease progression|1
7590316|NCT01423851|11996709|FG003|Whole Study|Disease progression|4
7590317|NCT01423851|11996710|FG004|Whole Study|Disease progression|1
7590318|NCT01423851|11996711|FG005|Whole Study|Disease progression|3
7590319|NCT01423851|11996712|FG006|Whole Study|Disease progression|1
7590320|NCT01423851|11996713|FG007|Whole Study|Disease progression|4
7590321|NCT01423851|11996714|FG008|Whole Study|Disease progression|0
7590322|NCT01423851|11996715|FG009|Whole Study|Disease progression|2
7590323|NCT01423851|11996716|FG010|Whole Study|Disease progression|10
7590324|NCT01423851|11996706|FG000|Whole Study|Physician Decision|0
7590325|NCT01423851|11996707|FG001|Whole Study|Physician Decision|1
7590326|NCT01423851|11996708|FG002|Whole Study|Physician Decision|2
7590327|NCT01423851|11996709|FG003|Whole Study|Physician Decision|0
7590328|NCT01423851|11996710|FG004|Whole Study|Physician Decision|2
7590329|NCT01423851|11996711|FG005|Whole Study|Physician Decision|0
7590330|NCT01423851|11996712|FG006|Whole Study|Physician Decision|2
7766849|NCT00849693|12209285|FG003|Extension Phase|Physician Decision|0
7766850|NCT00849693|12209282|FG000|Extension Phase|Sponsor decision|1
7766851|NCT00849693|12209283|FG001|Extension Phase|Sponsor decision|0
7766852|NCT00849693|12209284|FG002|Extension Phase|Sponsor decision|0
7766853|NCT00849693|12209285|FG003|Extension Phase|Sponsor decision|1
7766854|NCT00849693|12209282|FG000|Extension Phase|Lack of Efficacy|2
7766855|NCT00849693|12209283|FG001|Extension Phase|Lack of Efficacy|2
7766856|NCT00849693|12209284|FG002|Extension Phase|Lack of Efficacy|2
7766857|NCT00849693|12209285|FG003|Extension Phase|Lack of Efficacy|1
7766858|NCT00849875|12209314|FG000|Overall Study|Death|28
7766859|NCT00849875|12209314|FG000|Overall Study|Ongoing (unknown completion status)|11
7766860|NCT00849875|12209314|FG000|Overall Study|Others|6
7766861|NCT00849875|12209314|FG000|Overall Study|Lost to Follow-up|2
7766862|NCT00849901|12209328|FG000|Acute Treatment Phase|Adverse Event|9
7766863|NCT00849901|12209329|FG001|Acute Treatment Phase|Adverse Event|1
7766864|NCT00849901|12209330|FG002|Acute Treatment Phase|Adverse Event|3
7766865|NCT00849901|12209328|FG000|Acute Treatment Phase|Lost to Follow-up|2
7766866|NCT00849901|12209329|FG001|Acute Treatment Phase|Lost to Follow-up|4
7766867|NCT00849901|12209330|FG002|Acute Treatment Phase|Lost to Follow-up|1
7766868|NCT00849901|12209328|FG000|Acute Treatment Phase|Protocol Violation|0
7766869|NCT00849901|12209329|FG001|Acute Treatment Phase|Protocol Violation|2
7766870|NCT00849901|12209330|FG002|Acute Treatment Phase|Protocol Violation|1
7766871|NCT00849901|12209328|FG000|Acute Treatment Phase|Withdrawal by Subject|4
7766872|NCT00849901|12209329|FG001|Acute Treatment Phase|Withdrawal by Subject|10
7766873|NCT00849901|12209330|FG002|Acute Treatment Phase|Withdrawal by Subject|4
7766874|NCT00849901|12209328|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11
7766875|NCT00849901|12209329|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5
7766876|NCT00849901|12209330|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4
7766877|NCT00849901|12209328|FG000|Acute Treatment Phase|Physician Decision|1
7766878|NCT00849901|12209329|FG001|Acute Treatment Phase|Physician Decision|1
7766879|NCT00849901|12209330|FG002|Acute Treatment Phase|Physician Decision|1
7766880|NCT00849901|12209328|FG000|Acute Treatment Phase|Sponsor Decision|1
7766881|NCT00849901|12209329|FG001|Acute Treatment Phase|Sponsor Decision|0
7766882|NCT00849901|12209330|FG002|Acute Treatment Phase|Sponsor Decision|0
7766883|NCT00849901|12209328|FG000|Acute Treatment Phase|Lack of Efficacy|2
7766884|NCT00849901|12209329|FG001|Acute Treatment Phase|Lack of Efficacy|3
7766885|NCT00849901|12209330|FG002|Acute Treatment Phase|Lack of Efficacy|2
7766886|NCT00849901|12209328|FG000|Extension Phase|Adverse Event|2
7766887|NCT00849901|12209329|FG001|Extension Phase|Adverse Event|8
7766888|NCT00849901|12209330|FG002|Extension Phase|Adverse Event|4
7766889|NCT00849901|12209328|FG000|Extension Phase|Lost to Follow-up|3
7766890|NCT00849901|12209329|FG001|Extension Phase|Lost to Follow-up|0
7766891|NCT00849901|12209330|FG002|Extension Phase|Lost to Follow-up|1
7766892|NCT00849901|12209328|FG000|Extension Phase|Protocol Violation|2
7766893|NCT00849901|12209329|FG001|Extension Phase|Protocol Violation|2
7766894|NCT00849901|12209330|FG002|Extension Phase|Protocol Violation|4
7766895|NCT00849901|12209328|FG000|Extension Phase|Withdrawal by Subject|7
7766896|NCT00849901|12209329|FG001|Extension Phase|Withdrawal by Subject|6
7766897|NCT00849901|12209330|FG002|Extension Phase|Withdrawal by Subject|3
7766898|NCT00849901|12209328|FG000|Extension Phase|Parent or Caregiver Decision|10
7766899|NCT00849901|12209329|FG001|Extension Phase|Parent or Caregiver Decision|4
7766900|NCT00849901|12209330|FG002|Extension Phase|Parent or Caregiver Decision|4
7766901|NCT00849901|12209328|FG000|Extension Phase|Physician Decision|1
7766902|NCT00849901|12209329|FG001|Extension Phase|Physician Decision|2
7766903|NCT00849901|12209330|FG002|Extension Phase|Physician Decision|0
7590331|NCT01423851|11996713|FG007|Whole Study|Physician Decision|1
7766904|NCT00849901|12209328|FG000|Extension Phase|Lack of Efficacy|2
7766905|NCT00849901|12209329|FG001|Extension Phase|Lack of Efficacy|4
7766906|NCT00849901|12209330|FG002|Extension Phase|Lack of Efficacy|1
7766907|NCT00849940|12209344|FG000|Overall Study|Physician Decision|4
7766908|NCT00850070|12209354|FG000|Overall Study|Lack of Efficacy|1
7766909|NCT00850070|12209355|FG001|Overall Study|Lack of Efficacy|1
7766910|NCT00850070|12209354|FG000|Overall Study|Adverse Event|2
7766911|NCT00850070|12209355|FG001|Overall Study|Adverse Event|0
7590332|NCT01423851|11996714|FG008|Whole Study|Physician Decision|3
7590333|NCT01423851|11996715|FG009|Whole Study|Physician Decision|4
7590334|NCT01423851|11996716|FG010|Whole Study|Physician Decision|12
7590335|NCT01423851|11996706|FG000|Whole Study|Withdrawal by Subject|1
7590336|NCT01423851|11996707|FG001|Whole Study|Withdrawal by Subject|1
7590337|NCT01423851|11996708|FG002|Whole Study|Withdrawal by Subject|0
7590338|NCT01423851|11996709|FG003|Whole Study|Withdrawal by Subject|0
7590339|NCT01423851|11996710|FG004|Whole Study|Withdrawal by Subject|0
7590340|NCT01423851|11996711|FG005|Whole Study|Withdrawal by Subject|0
7590341|NCT01423851|11996712|FG006|Whole Study|Withdrawal by Subject|0
7590342|NCT01423851|11996713|FG007|Whole Study|Withdrawal by Subject|0
7590343|NCT01423851|11996714|FG008|Whole Study|Withdrawal by Subject|2
7590344|NCT01423851|11996715|FG009|Whole Study|Withdrawal by Subject|0
7590345|NCT01423851|11996716|FG010|Whole Study|Withdrawal by Subject|4
7590346|NCT01423851|11996706|FG000|Whole Study|Adverse Event|0
7590347|NCT01423851|11996707|FG001|Whole Study|Adverse Event|0
7590348|NCT01423851|11996708|FG002|Whole Study|Adverse Event|0
7590349|NCT01423851|11996709|FG003|Whole Study|Adverse Event|2
7590350|NCT01423851|11996710|FG004|Whole Study|Adverse Event|0
7590351|NCT01423851|11996711|FG005|Whole Study|Adverse Event|0
7590352|NCT01423851|11996712|FG006|Whole Study|Adverse Event|0
7590353|NCT01423851|11996713|FG007|Whole Study|Adverse Event|3
7590354|NCT01423851|11996714|FG008|Whole Study|Adverse Event|3
7590355|NCT01423851|11996715|FG009|Whole Study|Adverse Event|2
7590356|NCT01423851|11996716|FG010|Whole Study|Adverse Event|3
7766912|NCT00850135|12209375|FG000|Overall Study|Physician Decision|1
7766913|NCT00850200|12209381|FG000|Overall Study|Physician Decision|2
7766914|NCT00850200|12209381|FG000|Overall Study|Did not recieve treatment|2
7766915|NCT00850200|12209381|FG000|Overall Study|Withdrawal by Subject|1
7766916|NCT00850343|12209392|FG000|Overall Study|Withdrawal by Subject|11
7766917|NCT00850343|12209393|FG001|Overall Study|Withdrawal by Subject|0
7766918|NCT00850343|12209394|FG002|Overall Study|Withdrawal by Subject|3
7766919|NCT00850343|12209395|FG003|Overall Study|Withdrawal by Subject|2
7766920|NCT00850343|12209392|FG000|Overall Study|Adverse Event|15
7766921|NCT00850343|12209393|FG001|Overall Study|Adverse Event|2
7590367|NCT01334606|11996772|FG000|Overall Study|Study Terminated due to slow enrolment|18
7590368|NCT01317875|11996788|FG000|Overall Study|Other|0
7590369|NCT01317875|11996789|FG001|Overall Study|Other|0
7590370|NCT01317875|11996790|FG002|Overall Study|Other|1
7590371|NCT01317875|11996791|FG003|Overall Study|Other|0
7590372|NCT01317875|11996792|FG004|Overall Study|Other|0
7590373|NCT01317875|11996793|FG005|Overall Study|Other|0
7590374|NCT01317875|11996794|FG006|Overall Study|Other|0
7590375|NCT01317875|11996795|FG007|Overall Study|Other|0
7590376|NCT01317875|11996796|FG008|Overall Study|Other|0
7590377|NCT01317875|11996797|FG009|Overall Study|Other|0
7590378|NCT01317875|11996788|FG000|Overall Study|Noncompliance with study drug|0
7590379|NCT01317875|11996789|FG001|Overall Study|Noncompliance with study drug|0
7590380|NCT01317875|11996790|FG002|Overall Study|Noncompliance with study drug|1
7590381|NCT01317875|11996791|FG003|Overall Study|Noncompliance with study drug|0
7590382|NCT01317875|11996792|FG004|Overall Study|Noncompliance with study drug|0
7590383|NCT01317875|11996793|FG005|Overall Study|Noncompliance with study drug|0
7590384|NCT01317875|11996794|FG006|Overall Study|Noncompliance with study drug|0
7590385|NCT01317875|11996795|FG007|Overall Study|Noncompliance with study drug|0
7590386|NCT01317875|11996796|FG008|Overall Study|Noncompliance with study drug|0
7590387|NCT01317875|11996797|FG009|Overall Study|Noncompliance with study drug|0
7590388|NCT01317875|11996788|FG000|Overall Study|Progressive Disease|1
7590389|NCT01317875|11996789|FG001|Overall Study|Progressive Disease|0
7590390|NCT01317875|11996790|FG002|Overall Study|Progressive Disease|2
7590391|NCT01317875|11996791|FG003|Overall Study|Progressive Disease|0
7590392|NCT01317875|11996792|FG004|Overall Study|Progressive Disease|1
7590393|NCT01317875|11996793|FG005|Overall Study|Progressive Disease|0
7590394|NCT01317875|11996794|FG006|Overall Study|Progressive Disease|0
7590395|NCT01317875|11996795|FG007|Overall Study|Progressive Disease|1
7590396|NCT01317875|11996796|FG008|Overall Study|Progressive Disease|0
7590397|NCT01317875|11996797|FG009|Overall Study|Progressive Disease|0
7590398|NCT01317875|11996788|FG000|Overall Study|Withdrawal by Subject|0
7590399|NCT01317875|11996789|FG001|Overall Study|Withdrawal by Subject|0
7590400|NCT01317875|11996790|FG002|Overall Study|Withdrawal by Subject|0
7590401|NCT01317875|11996791|FG003|Overall Study|Withdrawal by Subject|0
7590402|NCT01317875|11996792|FG004|Overall Study|Withdrawal by Subject|1
7590403|NCT01317875|11996793|FG005|Overall Study|Withdrawal by Subject|0
7590404|NCT01317875|11996794|FG006|Overall Study|Withdrawal by Subject|0
7590405|NCT01317875|11996795|FG007|Overall Study|Withdrawal by Subject|3
7590406|NCT01317875|11996796|FG008|Overall Study|Withdrawal by Subject|0
7590407|NCT01317875|11996797|FG009|Overall Study|Withdrawal by Subject|0
7590408|NCT01317875|11996788|FG000|Overall Study|Physician Decision|0
7590409|NCT01317875|11996789|FG001|Overall Study|Physician Decision|1
7590410|NCT01317875|11996790|FG002|Overall Study|Physician Decision|1
7590411|NCT01317875|11996791|FG003|Overall Study|Physician Decision|0
7590412|NCT01317875|11996792|FG004|Overall Study|Physician Decision|2
7590413|NCT01317875|11996793|FG005|Overall Study|Physician Decision|0
7590414|NCT01317875|11996794|FG006|Overall Study|Physician Decision|0
7590415|NCT01317875|11996795|FG007|Overall Study|Physician Decision|2
7590416|NCT01317875|11996796|FG008|Overall Study|Physician Decision|0
7590417|NCT01317875|11996797|FG009|Overall Study|Physician Decision|0
7590418|NCT01317875|11996788|FG000|Overall Study|Death|0
7590419|NCT01317875|11996789|FG001|Overall Study|Death|0
7590420|NCT01317875|11996790|FG002|Overall Study|Death|2
7590421|NCT01317875|11996791|FG003|Overall Study|Death|1
7590422|NCT01317875|11996792|FG004|Overall Study|Death|0
7590423|NCT01317875|11996793|FG005|Overall Study|Death|1
7590424|NCT01317875|11996794|FG006|Overall Study|Death|0
7590425|NCT01317875|11996795|FG007|Overall Study|Death|4
7590426|NCT01317875|11996796|FG008|Overall Study|Death|0
7590427|NCT01317875|11996797|FG009|Overall Study|Death|0
7590428|NCT01317875|11996788|FG000|Overall Study|Adverse Event|2
7590429|NCT01317875|11996789|FG001|Overall Study|Adverse Event|1
7590430|NCT01317875|11996790|FG002|Overall Study|Adverse Event|2
7590431|NCT01317875|11996791|FG003|Overall Study|Adverse Event|1
7590432|NCT01317875|11996792|FG004|Overall Study|Adverse Event|5
7590433|NCT01317875|11996793|FG005|Overall Study|Adverse Event|1
7590434|NCT01317875|11996794|FG006|Overall Study|Adverse Event|2
7590435|NCT01317875|11996795|FG007|Overall Study|Adverse Event|5
7590436|NCT01317875|11996796|FG008|Overall Study|Adverse Event|0
7590437|NCT01317875|11996797|FG009|Overall Study|Adverse Event|0
7590438|NCT01216683|11996862|FG000|Induction|Never started treatment|0
7590439|NCT01216683|11996863|FG001|Induction|Never started treatment|6
7590440|NCT01216683|11996864|FG002|Induction|Never started treatment|3
7590441|NCT01216683|11996862|FG000|Induction|Lack of Efficacy|4
7590442|NCT01216683|11996863|FG001|Induction|Lack of Efficacy|3
7590443|NCT01216683|11996864|FG002|Induction|Lack of Efficacy|7
7590444|NCT01216683|11996862|FG000|Induction|Adverse Event|0
7590445|NCT01216683|11996863|FG001|Induction|Adverse Event|5
7590446|NCT01216683|11996864|FG002|Induction|Adverse Event|5
7590447|NCT01216683|11996862|FG000|Induction|Death|0
7590448|NCT01216683|11996863|FG001|Induction|Death|0
7590449|NCT01216683|11996864|FG002|Induction|Death|2
7590450|NCT01216683|11996862|FG000|Induction|Withdrawal by Subject|0
7590451|NCT01216683|11996863|FG001|Induction|Withdrawal by Subject|4
7590452|NCT01216683|11996864|FG002|Induction|Withdrawal by Subject|2
7590453|NCT01216683|11996862|FG000|Induction|Other disease|0
7590454|NCT01216683|11996863|FG001|Induction|Other disease|1
7590455|NCT01216683|11996864|FG002|Induction|Other disease|2
7766922|NCT00850343|12209394|FG002|Overall Study|Adverse Event|6
7766923|NCT00850343|12209395|FG003|Overall Study|Adverse Event|6
7766924|NCT00850343|12209392|FG000|Overall Study|Pregnancy|0
7766925|NCT00850343|12209393|FG001|Overall Study|Pregnancy|0
7590456|NCT01216683|11996862|FG000|Continuation|Lack of Efficacy|3
7590457|NCT01216683|11996863|FG001|Continuation|Lack of Efficacy|2
7590458|NCT01216683|11996864|FG002|Continuation|Lack of Efficacy|7
7590459|NCT01216683|11996862|FG000|Continuation|Adverse Event|5
7766926|NCT00850343|12209394|FG002|Overall Study|Pregnancy|0
7766927|NCT00850343|12209395|FG003|Overall Study|Pregnancy|1
7766928|NCT00850343|12209392|FG000|Overall Study|Lack of Efficacy|17
7766929|NCT00850343|12209393|FG001|Overall Study|Lack of Efficacy|0
7766930|NCT00850343|12209394|FG002|Overall Study|Lack of Efficacy|3
7766931|NCT00850343|12209395|FG003|Overall Study|Lack of Efficacy|2
7766932|NCT00850343|12209392|FG000|Overall Study|Non-compliance with Study Procedures|1
7766933|NCT00850343|12209393|FG001|Overall Study|Non-compliance with Study Procedures|0
7766934|NCT00850343|12209394|FG002|Overall Study|Non-compliance with Study Procedures|1
7766935|NCT00850343|12209395|FG003|Overall Study|Non-compliance with Study Procedures|1
7766936|NCT00850343|12209392|FG000|Overall Study|Physician Decision|2
7766937|NCT00850343|12209393|FG001|Overall Study|Physician Decision|1
7766938|NCT00850343|12209394|FG002|Overall Study|Physician Decision|1
7766939|NCT00850343|12209395|FG003|Overall Study|Physician Decision|1
7766940|NCT00850395|12209405|FG000|Overall Study|Death|1
7766941|NCT00850395|12209405|FG000|Overall Study|Adverse Event|1
7766942|NCT00850395|12209405|FG000|Overall Study|Insufficient clinical response|3
7766943|NCT00850395|12209405|FG000|Overall Study|Other|5
7766944|NCT00850460|12209411|FG000|Overall Study|Lost to Follow-up|4
7766945|NCT00850460|12209412|FG001|Overall Study|Lost to Follow-up|4
7766946|NCT00850499|12209424|FG000|Overall Study|Adverse Event|3
7766947|NCT00850499|12209425|FG001|Overall Study|Adverse Event|1
7766948|NCT00850499|12209424|FG000|Overall Study|Lack of Efficacy|0
7766949|NCT00850499|12209425|FG001|Overall Study|Lack of Efficacy|1
7766950|NCT00850538|12209431|FG000|Overall Study|unable/unwilling to complete MRI|13
7766951|NCT00850538|12209431|FG000|Overall Study|specimen missed due to scheduling error|14
7766952|NCT00850538|12209431|FG000|Overall Study|specimen unusable|7
7766953|NCT00850538|12209431|FG000|Overall Study|Withdrawal by Subject|3
7766954|NCT00850538|12209431|FG000|Overall Study|radiology error|2
7766955|NCT00850538|12209431|FG000|Overall Study|Protocol Violation|2
7766956|NCT00850564|12209435|FG000|Overall Study|Withdrawal by Subject|2
7766957|NCT00850759|12209478|FG000|Overall Study|Lost to Follow-up|7
7766958|NCT00850759|12209479|FG001|Overall Study|Lost to Follow-up|5
7766959|NCT00850759|12209480|FG002|Overall Study|Lost to Follow-up|5
7766960|NCT00850759|12209481|FG003|Overall Study|Lost to Follow-up|3
7766961|NCT00850993|12209502|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1
7766962|NCT00850993|12209503|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0
7766963|NCT00850993|12209504|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0
7766964|NCT00850993|12209505|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1
7766965|NCT00851084|12209525|FG000|Overall Study|Randomized but not treated|1
7766966|NCT00851084|12209526|FG001|Overall Study|Randomized but not treated|0
7766967|NCT00851084|12209525|FG000|Overall Study|Adverse Event|26
7590460|NCT01216683|11996863|FG001|Continuation|Adverse Event|3
7590461|NCT01216683|11996864|FG002|Continuation|Adverse Event|16
7590462|NCT01216683|11996862|FG000|Continuation|Death|1
7590463|NCT01216683|11996863|FG001|Continuation|Death|0
7590464|NCT01216683|11996864|FG002|Continuation|Death|2
7590465|NCT01216683|11996862|FG000|Continuation|Withdrawal by Subject|4
7590466|NCT01216683|11996863|FG001|Continuation|Withdrawal by Subject|5
7590467|NCT01216683|11996864|FG002|Continuation|Withdrawal by Subject|9
7590468|NCT01216683|11996862|FG000|Continuation|Other diseases|0
7590469|NCT01216683|11996863|FG001|Continuation|Other diseases|2
7590470|NCT01216683|11996864|FG002|Continuation|Other diseases|1
7590471|NCT01216683|11996862|FG000|Continuation|Physician Decision|1
7590472|NCT01216683|11996863|FG001|Continuation|Physician Decision|0
7590473|NCT01216683|11996864|FG002|Continuation|Physician Decision|1
7590474|NCT01216683|11996862|FG000|Continuation|Non-compliance|1
7590475|NCT01216683|11996863|FG001|Continuation|Non-compliance|0
7590476|NCT01216683|11996864|FG002|Continuation|Non-compliance|1
7590477|NCT01216683|11996862|FG000|Continuation|Insurance change|0
7590478|NCT01216683|11996863|FG001|Continuation|Insurance change|1
7590479|NCT01216683|11996864|FG002|Continuation|Insurance change|0
7590480|NCT01216683|11996862|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0
7590481|NCT01216683|11996863|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1
7590482|NCT01216683|11996864|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0
7590483|NCT01216683|11996862|FG000|Continuation|Not reported|0
7590484|NCT01216683|11996863|FG001|Continuation|Not reported|0
7590485|NCT01216683|11996864|FG002|Continuation|Not reported|1
7590486|NCT01216683|11996862|FG000|Continuation|Never started treatment|0
7590487|NCT01216683|11996863|FG001|Continuation|Never started treatment|1
7590488|NCT01216683|11996864|FG002|Continuation|Never started treatment|5
7590489|NCT01085097|11996888|FG000|Overall Study|Adverse Event|0
7590490|NCT01085097|11996889|FG001|Overall Study|Adverse Event|0
7590491|NCT01085097|11996890|FG002|Overall Study|Adverse Event|2
7590492|NCT01085097|11996888|FG000|Overall Study|Treatment failure|2
7590493|NCT01085097|11996889|FG001|Overall Study|Treatment failure|0
7590494|NCT01085097|11996890|FG002|Overall Study|Treatment failure|0
7590495|NCT00920621|11996902|FG000|Overall Study|Lost to Follow-up|16
7590496|NCT00920621|11996903|FG001|Overall Study|Lost to Follow-up|17
7590497|NCT00920621|11996904|FG002|Overall Study|Lost to Follow-up|19
7590498|NCT00920621|11996905|FG003|Overall Study|Lost to Follow-up|21
7590499|NCT00920621|11996902|FG000|Overall Study|Fetal/neonatal deaths|16
7590500|NCT00920621|11996903|FG001|Overall Study|Fetal/neonatal deaths|14
7590501|NCT00920621|11996904|FG002|Overall Study|Fetal/neonatal deaths|16
7590502|NCT00920621|11996905|FG003|Overall Study|Fetal/neonatal deaths|14
7590503|NCT00920621|11996902|FG000|Overall Study|Blood sample not collected|22
7590504|NCT00920621|11996903|FG001|Overall Study|Blood sample not collected|14
7590505|NCT00920621|11996904|FG002|Overall Study|Blood sample not collected|0
7590506|NCT00920621|11996905|FG003|Overall Study|Blood sample not collected|0
7626702|NCT01001234|12039125|FG002|Overall Study|Withdrawal by Subject|3
7626703|NCT01001234|12039126|FG003|Overall Study|Withdrawal by Subject|0
7626704|NCT01001234|12039127|FG004|Overall Study|Withdrawal by Subject|0
7626705|NCT01001234|12039123|FG000|Overall Study|Protocol Violation|34
7626706|NCT01001234|12039124|FG001|Overall Study|Protocol Violation|3
7626707|NCT01001234|12039125|FG002|Overall Study|Protocol Violation|19
7626708|NCT01001234|12039126|FG003|Overall Study|Protocol Violation|18
7626709|NCT01001234|12039127|FG004|Overall Study|Protocol Violation|0
7626710|NCT01001234|12039123|FG000|Overall Study|Lost to Follow-up|0
7626711|NCT01001234|12039124|FG001|Overall Study|Lost to Follow-up|0
7626712|NCT01001234|12039125|FG002|Overall Study|Lost to Follow-up|1
7626713|NCT01001234|12039126|FG003|Overall Study|Lost to Follow-up|2
7626714|NCT01001234|12039127|FG004|Overall Study|Lost to Follow-up|0
7626715|NCT01001234|12039123|FG000|Overall Study|Physician Decision|1
7626716|NCT01001234|12039124|FG001|Overall Study|Physician Decision|0
7626717|NCT01001234|12039125|FG002|Overall Study|Physician Decision|0
7626718|NCT01001234|12039126|FG003|Overall Study|Physician Decision|0
7626719|NCT01001234|12039127|FG004|Overall Study|Physician Decision|0
7626720|NCT01001234|12039123|FG000|Overall Study|Not Treated: Adverse Event|1
7626721|NCT01001234|12039124|FG001|Overall Study|Not Treated: Adverse Event|0
7626722|NCT01001234|12039125|FG002|Overall Study|Not Treated: Adverse Event|0
7626723|NCT01001234|12039126|FG003|Overall Study|Not Treated: Adverse Event|0
7626724|NCT01001234|12039127|FG004|Overall Study|Not Treated: Adverse Event|0
7626725|NCT01001234|12039123|FG000|Overall Study|Not Treated: Withdrawal by Subject|23
7626726|NCT01001234|12039124|FG001|Overall Study|Not Treated: Withdrawal by Subject|2
7626727|NCT01001234|12039125|FG002|Overall Study|Not Treated: Withdrawal by Subject|2
7626728|NCT01001234|12039126|FG003|Overall Study|Not Treated: Withdrawal by Subject|0
7626729|NCT01001234|12039127|FG004|Overall Study|Not Treated: Withdrawal by Subject|0
7626730|NCT01001234|12039123|FG000|Overall Study|Not Treated: Protocol Violation|3
7626731|NCT01001234|12039124|FG001|Overall Study|Not Treated: Protocol Violation|0
7626732|NCT01001234|12039125|FG002|Overall Study|Not Treated: Protocol Violation|0
7626733|NCT01001234|12039126|FG003|Overall Study|Not Treated: Protocol Violation|0
7626734|NCT01001234|12039127|FG004|Overall Study|Not Treated: Protocol Violation|0
7626735|NCT01001234|12039123|FG000|Overall Study|Not Treated: Lost to Follow-up|53
7626736|NCT01001234|12039124|FG001|Overall Study|Not Treated: Lost to Follow-up|4
7626737|NCT01001234|12039125|FG002|Overall Study|Not Treated: Lost to Follow-up|7
7626738|NCT01001234|12039126|FG003|Overall Study|Not Treated: Lost to Follow-up|5
7626739|NCT01001234|12039127|FG004|Overall Study|Not Treated: Lost to Follow-up|0
7626740|NCT01001234|12039123|FG000|Overall Study|Not Treated: Pregnancy|3
7626741|NCT01001234|12039124|FG001|Overall Study|Not Treated: Pregnancy|0
7626742|NCT01001234|12039125|FG002|Overall Study|Not Treated: Pregnancy|0
7626743|NCT01001234|12039126|FG003|Overall Study|Not Treated: Pregnancy|0
7626744|NCT01001234|12039127|FG004|Overall Study|Not Treated: Pregnancy|0
7590507|NCT00500071|11996930|FG000|Screening and Washout Phase|Protocol Violation|1
7590508|NCT00500071|11996930|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13
7590509|NCT00500071|11996930|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2
7590510|NCT00500071|11996930|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
7590511|NCT00500071|11996930|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
7590512|NCT00500071|11996930|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
7590513|NCT00500071|11996930|FG000|30-day Safety Follow-up|Lost to Follow-up|17
7590514|NCT00447122|11996938|FG000|Overall Study|worsening medical condition -came off|0
7590515|NCT00447122|11996939|FG001|Overall Study|worsening medical condition -came off|1
7590516|NCT00447122|11996940|FG002|Overall Study|worsening medical condition -came off|0
7590517|NCT00447122|11996941|FG003|Overall Study|worsening medical condition -came off|0
7590518|NCT00382252|11996951|FG000|Overall Study|Death|4
7590519|NCT00382252|11996951|FG000|Overall Study|Protocol Violation|8
7590520|NCT00382252|11996951|FG000|Overall Study|Not treated by RFA|1
7590539|NCT00309985|11996983|FG000|Overall Study|Disease progression|12
7590540|NCT00309985|11996984|FG001|Overall Study|Disease progression|0
7590541|NCT00309985|11996983|FG000|Overall Study|Adverse Event|30
7590542|NCT00309985|11996984|FG001|Overall Study|Adverse Event|0
7590543|NCT00309985|11996983|FG000|Overall Study|Death|2
7590544|NCT00309985|11996984|FG001|Overall Study|Death|0
7590545|NCT00309985|11996983|FG000|Overall Study|Withdrawal by Subject|5
7590546|NCT00309985|11996984|FG001|Overall Study|Withdrawal by Subject|1
7590547|NCT00309985|11996983|FG000|Overall Study|Physician Decision|3
7590548|NCT00309985|11996984|FG001|Overall Study|Physician Decision|0
7590549|NCT00309985|11996983|FG000|Overall Study|Never started treatment|7
7590550|NCT00309985|11996984|FG001|Overall Study|Never started treatment|0
7590551|NCT00309985|11996983|FG000|Overall Study|Complicating disease|1
7590552|NCT00309985|11996984|FG001|Overall Study|Complicating disease|0
7590553|NCT00309985|11996983|FG000|Overall Study|Non-compliance|1
7590554|NCT00309985|11996984|FG001|Overall Study|Non-compliance|0
7590555|NCT00309985|11996983|FG000|Overall Study|Chemotherapy discontinued only|1
7590556|NCT00309985|11996984|FG001|Overall Study|Chemotherapy discontinued only|0
7590557|NCT00290251|11996993|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
7590558|NCT00290251|11996994|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
7590559|NCT00290251|11996995|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
7590560|NCT00290251|11996996|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
7590561|NCT00290251|11996997|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
7766968|NCT00851084|12209526|FG001|Overall Study|Adverse Event|36
7766969|NCT00851084|12209525|FG000|Overall Study|Disease progression|52
7766970|NCT00851084|12209526|FG001|Overall Study|Disease progression|47
7766971|NCT00851084|12209525|FG000|Overall Study|Poor compliance to protocol|1
7766972|NCT00851084|12209526|FG001|Overall Study|Poor compliance to protocol|1
7766973|NCT00851084|12209525|FG000|Overall Study|Physician Decision|13
7766974|NCT00851084|12209526|FG001|Overall Study|Physician Decision|14
7766975|NCT00851084|12209525|FG000|Overall Study|Consent withdrawn|0
7590562|NCT00290251|11996998|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2
7590563|NCT00290251|11996993|FG000|Treatment 1 (Months 2-4)|headache|0
7590564|NCT00290251|11996994|FG001|Treatment 1 (Months 2-4)|headache|0
7590565|NCT00290251|11996995|FG002|Treatment 1 (Months 2-4)|headache|0
7590566|NCT00290251|11996996|FG003|Treatment 1 (Months 2-4)|headache|0
7590567|NCT00290251|11996997|FG004|Treatment 1 (Months 2-4)|headache|1
7590568|NCT00290251|11996998|FG005|Treatment 1 (Months 2-4)|headache|0
7590569|NCT00290251|11996993|FG000|Treatment 1 (Months 2-4)|Out of body experience|0
7590570|NCT00290251|11996994|FG001|Treatment 1 (Months 2-4)|Out of body experience|0
7590571|NCT00290251|11996995|FG002|Treatment 1 (Months 2-4)|Out of body experience|0
7590572|NCT00290251|11996996|FG003|Treatment 1 (Months 2-4)|Out of body experience|1
7590573|NCT00290251|11996997|FG004|Treatment 1 (Months 2-4)|Out of body experience|0
7590574|NCT00290251|11996998|FG005|Treatment 1 (Months 2-4)|Out of body experience|0
7626745|NCT01001234|12039123|FG000|Overall Study|Not Treated: Physician Decision|37
7626746|NCT01001234|12039124|FG001|Overall Study|Not Treated: Physician Decision|4
7626747|NCT01001234|12039125|FG002|Overall Study|Not Treated: Physician Decision|0
7626748|NCT01001234|12039126|FG003|Overall Study|Not Treated: Physician Decision|0
7626749|NCT01001234|12039127|FG004|Overall Study|Not Treated: Physician Decision|0
7626750|NCT01001234|12039123|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248
7626751|NCT01001234|12039124|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13
7626752|NCT01001234|12039125|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0
7626753|NCT01001234|12039126|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0
7626754|NCT01001234|12039127|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0
7626755|NCT00924170|12039135|FG000|Overall Study|Refused further treatment|0
7626756|NCT00924170|12039136|FG001|Overall Study|Refused further treatment|1
7626757|NCT00924170|12039135|FG000|Overall Study|Physician Decision|0
7626758|NCT00924170|12039136|FG001|Overall Study|Physician Decision|1
7626759|NCT00924170|12039135|FG000|Overall Study|Progressive disease|3
7626760|NCT00924170|12039136|FG001|Overall Study|Progressive disease|6
7626761|NCT00924170|12039135|FG000|Overall Study|Stopped due to neutralizing antibodies|3
7626762|NCT00924170|12039136|FG001|Overall Study|Stopped due to neutralizing antibodies|0
7626763|NCT00924170|12039135|FG000|Overall Study|Death|1
7626764|NCT00924170|12039136|FG001|Overall Study|Death|0
7626765|NCT00894556|12039151|FG000|Baseline Phase|Did not meet Randomization Criteria|0
7626766|NCT00894556|12039152|FG001|Baseline Phase|Did not meet Randomization Criteria|0
7626767|NCT00894556|12039153|FG002|Baseline Phase|Did not meet Randomization Criteria|0
7626768|NCT00894556|12039154|FG003|Baseline Phase|Did not meet Randomization Criteria|85
7626769|NCT00894556|12039151|FG000|Treatment Phase|Lost to Follow-up|2
7626770|NCT00894556|12039152|FG001|Treatment Phase|Lost to Follow-up|3
7626771|NCT00894556|12039153|FG002|Treatment Phase|Lost to Follow-up|1
7626772|NCT00894556|12039154|FG003|Treatment Phase|Lost to Follow-up|0
7626773|NCT00894556|12039151|FG000|Treatment Phase|Lack of Qualifying Event|2
7626774|NCT00894556|12039152|FG001|Treatment Phase|Lack of Qualifying Event|1
7626775|NCT00894556|12039153|FG002|Treatment Phase|Lack of Qualifying Event|0
7626776|NCT00894556|12039154|FG003|Treatment Phase|Lack of Qualifying Event|0
7626777|NCT00840177|12039164|FG000|Overall Study|Adverse Event|5
7626778|NCT00840177|12039165|FG001|Overall Study|Adverse Event|1
7626779|NCT00840177|12039166|FG002|Overall Study|Adverse Event|1
7626780|NCT00840177|12039164|FG000|Overall Study|Refusal unrelated to adverse events|1
7626781|NCT00840177|12039165|FG001|Overall Study|Refusal unrelated to adverse events|0
7626782|NCT00840177|12039166|FG002|Overall Study|Refusal unrelated to adverse events|1
7626783|NCT00840177|12039164|FG000|Overall Study|Progression/relapse|2
7626784|NCT00840177|12039165|FG001|Overall Study|Progression/relapse|0
7626785|NCT00840177|12039166|FG002|Overall Study|Progression/relapse|0
7626786|NCT00840177|12039164|FG000|Overall Study|Death|4
7626787|NCT00840177|12039165|FG001|Overall Study|Death|5
7626788|NCT00840177|12039166|FG002|Overall Study|Death|5
7626789|NCT00840177|12039164|FG000|Overall Study|not protocol specified|6
7626790|NCT00840177|12039165|FG001|Overall Study|not protocol specified|3
7626791|NCT00840177|12039166|FG002|Overall Study|not protocol specified|0
7626792|NCT00840177|12039164|FG000|Overall Study|Ineligible|0
7626793|NCT00840177|12039165|FG001|Overall Study|Ineligible|0
7626794|NCT00840177|12039166|FG002|Overall Study|Ineligible|3
7626795|NCT00840177|12039164|FG000|Overall Study|Did not start treatment|0
7626796|NCT00840177|12039165|FG001|Overall Study|Did not start treatment|0
7626797|NCT00840177|12039166|FG002|Overall Study|Did not start treatment|1
7590575|NCT01403948|11997034|FG000|Overall Study|Progressive disease|0
7590576|NCT01403948|11997035|FG001|Overall Study|Progressive disease|2
7590577|NCT01403948|11997036|FG002|Overall Study|Progressive disease|2
7590578|NCT01403948|11997037|FG003|Overall Study|Progressive disease|4
7590579|NCT01403948|11997038|FG004|Overall Study|Progressive disease|2
7590580|NCT01403948|11997039|FG005|Overall Study|Progressive disease|6
7590581|NCT01403948|11997040|FG006|Overall Study|Progressive disease|2
7590582|NCT01403948|11997041|FG007|Overall Study|Progressive disease|4
7590583|NCT01403948|11997042|FG008|Overall Study|Progressive disease|5
7590584|NCT01403948|11997043|FG009|Overall Study|Progressive disease|5
7590585|NCT01403948|11997034|FG000|Overall Study|Other Adverse Event (Other than DLT)|0
7590586|NCT01403948|11997035|FG001|Overall Study|Other Adverse Event (Other than DLT)|0
7590587|NCT01403948|11997036|FG002|Overall Study|Other Adverse Event (Other than DLT)|0
7590588|NCT01403948|11997037|FG003|Overall Study|Other Adverse Event (Other than DLT)|0
7590589|NCT01403948|11997038|FG004|Overall Study|Other Adverse Event (Other than DLT)|2
7590590|NCT01403948|11997039|FG005|Overall Study|Other Adverse Event (Other than DLT)|0
7590591|NCT01403948|11997040|FG006|Overall Study|Other Adverse Event (Other than DLT)|2
7590592|NCT01403948|11997041|FG007|Overall Study|Other Adverse Event (Other than DLT)|0
7590593|NCT01403948|11997042|FG008|Overall Study|Other Adverse Event (Other than DLT)|1
7590594|NCT01403948|11997043|FG009|Overall Study|Other Adverse Event (Other than DLT)|0
7590595|NCT01403948|11997034|FG000|Overall Study|Lost to Follow-up|0
7590596|NCT01403948|11997035|FG001|Overall Study|Lost to Follow-up|0
7590597|NCT01403948|11997036|FG002|Overall Study|Lost to Follow-up|0
7590598|NCT01403948|11997037|FG003|Overall Study|Lost to Follow-up|0
7590599|NCT01403948|11997038|FG004|Overall Study|Lost to Follow-up|0
7590600|NCT01403948|11997039|FG005|Overall Study|Lost to Follow-up|0
7590601|NCT01403948|11997040|FG006|Overall Study|Lost to Follow-up|0
7590602|NCT01403948|11997041|FG007|Overall Study|Lost to Follow-up|0
7590603|NCT01403948|11997042|FG008|Overall Study|Lost to Follow-up|0
7590604|NCT01403948|11997043|FG009|Overall Study|Lost to Follow-up|1
7590605|NCT01403948|11997034|FG000|Overall Study|Refused cont. medication|0
7590606|NCT01403948|11997035|FG001|Overall Study|Refused cont. medication|0
7590607|NCT01403948|11997036|FG002|Overall Study|Refused cont. medication|0
7590608|NCT01403948|11997037|FG003|Overall Study|Refused cont. medication|0
7590609|NCT01403948|11997038|FG004|Overall Study|Refused cont. medication|1
7590610|NCT01403948|11997039|FG005|Overall Study|Refused cont. medication|0
7590611|NCT01403948|11997040|FG006|Overall Study|Refused cont. medication|0
7590612|NCT01403948|11997041|FG007|Overall Study|Refused cont. medication|0
7590613|NCT01403948|11997042|FG008|Overall Study|Refused cont. medication|0
7590614|NCT01403948|11997043|FG009|Overall Study|Refused cont. medication|1
7590615|NCT01403948|11997034|FG000|Overall Study|other than above|1
7590616|NCT01403948|11997035|FG001|Overall Study|other than above|2
7590617|NCT01403948|11997036|FG002|Overall Study|other than above|1
7590618|NCT01403948|11997037|FG003|Overall Study|other than above|0
7590619|NCT01403948|11997038|FG004|Overall Study|other than above|1
7590620|NCT01403948|11997039|FG005|Overall Study|other than above|1
7590621|NCT01403948|11997040|FG006|Overall Study|other than above|2
7590622|NCT01403948|11997041|FG007|Overall Study|other than above|0
7590623|NCT01403948|11997042|FG008|Overall Study|other than above|0
7590624|NCT01403948|11997043|FG009|Overall Study|other than above|0
7626798|NCT00820950|12039179|FG000|Overall Study|Scheduling Conflict|0
7626799|NCT00820950|12039180|FG001|Overall Study|Scheduling Conflict|0
7626800|NCT00820950|12039181|FG002|Overall Study|Scheduling Conflict|0
7626801|NCT00820950|12039182|FG003|Overall Study|Scheduling Conflict|0
7626802|NCT00820950|12039183|FG004|Overall Study|Scheduling Conflict|0
7626803|NCT00820950|12039184|FG005|Overall Study|Scheduling Conflict|0
7626804|NCT00820950|12039185|FG006|Overall Study|Scheduling Conflict|1
7626805|NCT00820950|12039186|FG007|Overall Study|Scheduling Conflict|1
7626806|NCT00820950|12039187|FG008|Overall Study|Scheduling Conflict|0
7626807|NCT00820950|12039188|FG009|Overall Study|Scheduling Conflict|0
7626808|NCT00820950|12039179|FG000|Overall Study|Protocol Violation|1
7626809|NCT00820950|12039180|FG001|Overall Study|Protocol Violation|1
7626810|NCT00820950|12039181|FG002|Overall Study|Protocol Violation|0
7626811|NCT00820950|12039182|FG003|Overall Study|Protocol Violation|0
7626812|NCT00820950|12039183|FG004|Overall Study|Protocol Violation|0
7626813|NCT00820950|12039184|FG005|Overall Study|Protocol Violation|0
7626814|NCT00820950|12039185|FG006|Overall Study|Protocol Violation|0
7626815|NCT00820950|12039186|FG007|Overall Study|Protocol Violation|0
7626816|NCT00820950|12039187|FG008|Overall Study|Protocol Violation|0
7626817|NCT00820950|12039188|FG009|Overall Study|Protocol Violation|0
7626818|NCT00806416|12039230|FG000|Period 1 - Part I|Adverse Event|0
7626819|NCT00806416|12039231|FG001|Period 1 - Part I|Adverse Event|1
7626820|NCT00806416|12039232|FG002|Period 1 - Part I|Adverse Event|0
7626821|NCT00806416|12039233|FG003|Period 1 - Part I|Adverse Event|0
7626822|NCT00806416|12039230|FG000|Period 1 - Part I|Lost to Follow-up|0
7626823|NCT00806416|12039231|FG001|Period 1 - Part I|Lost to Follow-up|2
7626824|NCT00806416|12039232|FG002|Period 1 - Part I|Lost to Follow-up|0
7626825|NCT00806416|12039233|FG003|Period 1 - Part I|Lost to Follow-up|0
7626826|NCT00806416|12039230|FG000|Period 1 - Part I|Withdrawal by Subject|3
7626827|NCT00806416|12039231|FG001|Period 1 - Part I|Withdrawal by Subject|1
7626828|NCT00806416|12039232|FG002|Period 1 - Part I|Withdrawal by Subject|0
7626829|NCT00806416|12039233|FG003|Period 1 - Part I|Withdrawal by Subject|0
7626830|NCT00806416|12039230|FG000|Period 1 - Part II|Withdrawal by Subject|0
7626831|NCT00806416|12039231|FG001|Period 1 - Part II|Withdrawal by Subject|0
7626832|NCT00806416|12039232|FG002|Period 1 - Part II|Withdrawal by Subject|0
7626833|NCT00806416|12039233|FG003|Period 1 - Part II|Withdrawal by Subject|2
7590625|NCT01404312|11997071|FG000|Overall Study|Death|21
7590626|NCT01404312|11997072|FG001|Overall Study|Death|27
7590627|NCT01404312|11997071|FG000|Overall Study|Withdrawal by Subject|15
7590628|NCT01404312|11997072|FG001|Overall Study|Withdrawal by Subject|18
7590629|NCT01404312|11997071|FG000|Overall Study|Participant Unable to get to clinic|93
7590630|NCT01404312|11997072|FG001|Overall Study|Participant Unable to get to clinic|103
7590631|NCT01404312|11997071|FG000|Overall Study|Lost to Follow-up|115
7590632|NCT01404312|11997072|FG001|Overall Study|Lost to Follow-up|111
7590633|NCT01404312|11997071|FG000|Overall Study|Site closed|22
7590634|NCT01404312|11997072|FG001|Overall Study|Site closed|21
7590635|NCT01404312|11997071|FG000|Overall Study|Participant not willing to adhere to req|31
7590636|NCT01404312|11997072|FG001|Overall Study|Participant not willing to adhere to req|29
7590637|NCT01404312|11997071|FG000|Overall Study|Severe debilitation, unable to continue|1
7590638|NCT01404312|11997072|FG001|Overall Study|Severe debilitation, unable to continue|2
7626834|NCT00729651|12039243|FG000|Overall Study|Withdrawal by Subject|5
7626835|NCT00729651|12039244|FG001|Overall Study|Withdrawal by Subject|6
7626836|NCT00729651|12039243|FG000|Overall Study|Lost to Follow-up|5
7626837|NCT00729651|12039244|FG001|Overall Study|Lost to Follow-up|4
7626838|NCT00729651|12039243|FG000|Overall Study|Protocol Violation|0
7626839|NCT00729651|12039244|FG001|Overall Study|Protocol Violation|1
7626840|NCT00729651|12039243|FG000|Overall Study|Adverse Event|7
7626841|NCT00729651|12039244|FG001|Overall Study|Adverse Event|3
7626842|NCT00729651|12039243|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
7626843|NCT00729651|12039244|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
7626844|NCT00729651|12039243|FG000|Overall Study|Subject's private reason|2
7626845|NCT00729651|12039244|FG001|Overall Study|Subject's private reason|0
7626846|NCT00698815|12039253|FG000|Overall Study|Death|1
7626847|NCT00698815|12039254|FG001|Overall Study|Death|2
7626848|NCT00698815|12039255|FG002|Overall Study|Death|4
7626849|NCT00698815|12039253|FG000|Overall Study|Withdrawal by Subject|6
7626850|NCT00698815|12039254|FG001|Overall Study|Withdrawal by Subject|3
7626851|NCT00698815|12039255|FG002|Overall Study|Withdrawal by Subject|2
7626852|NCT00698815|12039253|FG000|Overall Study|MD discretion|2
7626853|NCT00698815|12039254|FG001|Overall Study|MD discretion|7
7626854|NCT00698815|12039255|FG002|Overall Study|MD discretion|2
7626855|NCT00698815|12039253|FG000|Overall Study|Did not receive protocol treatment|1
7626856|NCT00698815|12039254|FG001|Overall Study|Did not receive protocol treatment|2
7626857|NCT00698815|12039255|FG002|Overall Study|Did not receive protocol treatment|2
7626858|NCT00692913|12039278|FG000|Overall Study|Adverse Event|8
7626859|NCT00692913|12039279|FG001|Overall Study|Adverse Event|4
7626860|NCT00692913|12039278|FG000|Overall Study|Lost to Follow-up|3
7626861|NCT00692913|12039279|FG001|Overall Study|Lost to Follow-up|5
7626862|NCT00692913|12039278|FG000|Overall Study|Physician Decision|2
7626863|NCT00692913|12039279|FG001|Overall Study|Physician Decision|0
7626864|NCT00692913|12039278|FG000|Overall Study|Protocol Violation|1
7626865|NCT00692913|12039279|FG001|Overall Study|Protocol Violation|1
7626866|NCT00692913|12039278|FG000|Overall Study|Withdrawal by Subject|15
7626867|NCT00692913|12039279|FG001|Overall Study|Withdrawal by Subject|20
7626868|NCT00617708|12039325|FG000|Overall Study|Adverse Event|0
7626869|NCT00617708|12039326|FG001|Overall Study|Adverse Event|6
7590639|NCT01425008|11997098|FG000|Dose Escalation Phase|Progressive Disease|2
7590640|NCT01425008|11997099|FG001|Dose Escalation Phase|Progressive Disease|3
7590641|NCT01425008|11997100|FG002|Dose Escalation Phase|Progressive Disease|2
7590642|NCT01425008|11997101|FG003|Dose Escalation Phase|Progressive Disease|3
7590643|NCT01425008|11997102|FG004|Dose Escalation Phase|Progressive Disease|5
7590644|NCT01425008|11997103|FG005|Dose Escalation Phase|Progressive Disease|4
7590645|NCT01425008|11997104|FG006|Dose Escalation Phase|Progressive Disease|0
7590646|NCT01425008|11997105|FG007|Dose Escalation Phase|Progressive Disease|2
7590647|NCT01425008|11997106|FG008|Dose Escalation Phase|Progressive Disease|6
7590648|NCT01425008|11997107|FG009|Dose Escalation Phase|Progressive Disease|2
7590649|NCT01425008|11997108|FG010|Dose Escalation Phase|Progressive Disease|0
7590650|NCT01425008|11997109|FG011|Dose Escalation Phase|Progressive Disease|0
7590651|NCT01425008|11997110|FG012|Dose Escalation Phase|Progressive Disease|0
7590652|NCT01425008|11997111|FG013|Dose Escalation Phase|Progressive Disease|0
7590653|NCT01425008|11997112|FG014|Dose Escalation Phase|Progressive Disease|0
7590654|NCT01425008|11997113|FG015|Dose Escalation Phase|Progressive Disease|0
7590655|NCT01425008|11997114|FG016|Dose Escalation Phase|Progressive Disease|0
7590656|NCT01425008|11997115|FG017|Dose Escalation Phase|Progressive Disease|0
7590657|NCT01425008|11997116|FG018|Dose Escalation Phase|Progressive Disease|0
7590658|NCT01425008|11997098|FG000|Dose Escalation Phase|Adverse Event|2
7590659|NCT01425008|11997099|FG001|Dose Escalation Phase|Adverse Event|0
7590660|NCT01425008|11997100|FG002|Dose Escalation Phase|Adverse Event|0
7590661|NCT01425008|11997101|FG003|Dose Escalation Phase|Adverse Event|0
7590662|NCT01425008|11997102|FG004|Dose Escalation Phase|Adverse Event|0
7590663|NCT01425008|11997103|FG005|Dose Escalation Phase|Adverse Event|2
7590664|NCT01425008|11997104|FG006|Dose Escalation Phase|Adverse Event|0
7590665|NCT01425008|11997105|FG007|Dose Escalation Phase|Adverse Event|0
7590666|NCT01425008|11997106|FG008|Dose Escalation Phase|Adverse Event|2
7590667|NCT01425008|11997107|FG009|Dose Escalation Phase|Adverse Event|0
7590668|NCT01425008|11997108|FG010|Dose Escalation Phase|Adverse Event|0
7590669|NCT01425008|11997109|FG011|Dose Escalation Phase|Adverse Event|0
7590670|NCT01425008|11997110|FG012|Dose Escalation Phase|Adverse Event|0
7590671|NCT01425008|11997111|FG013|Dose Escalation Phase|Adverse Event|0
7590672|NCT01425008|11997112|FG014|Dose Escalation Phase|Adverse Event|0
7590673|NCT01425008|11997113|FG015|Dose Escalation Phase|Adverse Event|0
7590674|NCT01425008|11997114|FG016|Dose Escalation Phase|Adverse Event|0
7590675|NCT01425008|11997115|FG017|Dose Escalation Phase|Adverse Event|0
7590676|NCT01425008|11997116|FG018|Dose Escalation Phase|Adverse Event|0
7590677|NCT01425008|11997098|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590678|NCT01425008|11997099|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7766976|NCT00851084|12209526|FG001|Overall Study|Consent withdrawn|2
7766977|NCT00851084|12209525|FG000|Overall Study|Withdrawal by Subject|11
7766978|NCT00851084|12209526|FG001|Overall Study|Withdrawal by Subject|12
7766979|NCT00851084|12209525|FG000|Overall Study|Metastatic surgery|6
7766980|NCT00851084|12209526|FG001|Overall Study|Metastatic surgery|6
7590679|NCT01425008|11997100|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590680|NCT01425008|11997101|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590681|NCT01425008|11997102|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
7590682|NCT01425008|11997103|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590683|NCT01425008|11997104|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2
7590684|NCT01425008|11997105|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
7590685|NCT01425008|11997106|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
7590686|NCT01425008|11997107|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590687|NCT01425008|11997108|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590688|NCT01425008|11997109|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590689|NCT01425008|11997110|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590690|NCT01425008|11997111|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590691|NCT01425008|11997112|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590692|NCT01425008|11997113|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590693|NCT01425008|11997114|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590694|NCT01425008|11997115|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590695|NCT01425008|11997116|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590696|NCT01425008|11997098|FG000|Dose Escalation Phase|Withdrawal by Subject|0
7590697|NCT01425008|11997099|FG001|Dose Escalation Phase|Withdrawal by Subject|0
7590698|NCT01425008|11997100|FG002|Dose Escalation Phase|Withdrawal by Subject|0
7590699|NCT01425008|11997101|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7590700|NCT01425008|11997102|FG004|Dose Escalation Phase|Withdrawal by Subject|1
7590701|NCT01425008|11997103|FG005|Dose Escalation Phase|Withdrawal by Subject|1
7590702|NCT01425008|11997104|FG006|Dose Escalation Phase|Withdrawal by Subject|1
7590703|NCT01425008|11997105|FG007|Dose Escalation Phase|Withdrawal by Subject|0
7590704|NCT01425008|11997106|FG008|Dose Escalation Phase|Withdrawal by Subject|1
7590705|NCT01425008|11997107|FG009|Dose Escalation Phase|Withdrawal by Subject|0
7590706|NCT01425008|11997108|FG010|Dose Escalation Phase|Withdrawal by Subject|0
7590707|NCT01425008|11997109|FG011|Dose Escalation Phase|Withdrawal by Subject|0
7590708|NCT01425008|11997110|FG012|Dose Escalation Phase|Withdrawal by Subject|0
7590709|NCT01425008|11997111|FG013|Dose Escalation Phase|Withdrawal by Subject|0
7590710|NCT01425008|11997112|FG014|Dose Escalation Phase|Withdrawal by Subject|0
7590711|NCT01425008|11997113|FG015|Dose Escalation Phase|Withdrawal by Subject|0
7590712|NCT01425008|11997114|FG016|Dose Escalation Phase|Withdrawal by Subject|0
7590713|NCT01425008|11997115|FG017|Dose Escalation Phase|Withdrawal by Subject|0
7590714|NCT01425008|11997116|FG018|Dose Escalation Phase|Withdrawal by Subject|0
7590715|NCT01425008|11997098|FG000|Dose Escalation Phase|Symptomatic Deterioration|0
7590716|NCT01425008|11997099|FG001|Dose Escalation Phase|Symptomatic Deterioration|0
7590717|NCT01425008|11997100|FG002|Dose Escalation Phase|Symptomatic Deterioration|1
7590718|NCT01425008|11997101|FG003|Dose Escalation Phase|Symptomatic Deterioration|0
7590719|NCT01425008|11997102|FG004|Dose Escalation Phase|Symptomatic Deterioration|0
7590720|NCT01425008|11997103|FG005|Dose Escalation Phase|Symptomatic Deterioration|0
7590721|NCT01425008|11997104|FG006|Dose Escalation Phase|Symptomatic Deterioration|0
7590722|NCT01425008|11997105|FG007|Dose Escalation Phase|Symptomatic Deterioration|0
7590723|NCT01425008|11997106|FG008|Dose Escalation Phase|Symptomatic Deterioration|2
7590724|NCT01425008|11997107|FG009|Dose Escalation Phase|Symptomatic Deterioration|2
7590725|NCT01425008|11997108|FG010|Dose Escalation Phase|Symptomatic Deterioration|0
7590726|NCT01425008|11997109|FG011|Dose Escalation Phase|Symptomatic Deterioration|0
7590727|NCT01425008|11997110|FG012|Dose Escalation Phase|Symptomatic Deterioration|0
7590728|NCT01425008|11997111|FG013|Dose Escalation Phase|Symptomatic Deterioration|0
7590729|NCT01425008|11997112|FG014|Dose Escalation Phase|Symptomatic Deterioration|0
7590730|NCT01425008|11997113|FG015|Dose Escalation Phase|Symptomatic Deterioration|0
7590731|NCT01425008|11997114|FG016|Dose Escalation Phase|Symptomatic Deterioration|0
7590732|NCT01425008|11997115|FG017|Dose Escalation Phase|Symptomatic Deterioration|0
7590733|NCT01425008|11997116|FG018|Dose Escalation Phase|Symptomatic Deterioration|0
7590734|NCT01425008|11997098|FG000|Dose Escalation Phase|Other|0
7590735|NCT01425008|11997099|FG001|Dose Escalation Phase|Other|0
7590736|NCT01425008|11997100|FG002|Dose Escalation Phase|Other|0
7590737|NCT01425008|11997101|FG003|Dose Escalation Phase|Other|0
7590738|NCT01425008|11997102|FG004|Dose Escalation Phase|Other|0
7590739|NCT01425008|11997103|FG005|Dose Escalation Phase|Other|0
7590740|NCT01425008|11997104|FG006|Dose Escalation Phase|Other|0
7590741|NCT01425008|11997105|FG007|Dose Escalation Phase|Other|0
7590742|NCT01425008|11997106|FG008|Dose Escalation Phase|Other|1
7590743|NCT01425008|11997107|FG009|Dose Escalation Phase|Other|0
7590744|NCT01425008|11997108|FG010|Dose Escalation Phase|Other|0
7590745|NCT01425008|11997109|FG011|Dose Escalation Phase|Other|0
7590746|NCT01425008|11997110|FG012|Dose Escalation Phase|Other|0
7590747|NCT01425008|11997111|FG013|Dose Escalation Phase|Other|0
7590748|NCT01425008|11997112|FG014|Dose Escalation Phase|Other|0
7590749|NCT01425008|11997113|FG015|Dose Escalation Phase|Other|0
7590750|NCT01425008|11997114|FG016|Dose Escalation Phase|Other|0
7590751|NCT01425008|11997115|FG017|Dose Escalation Phase|Other|0
7590752|NCT01425008|11997116|FG018|Dose Escalation Phase|Other|0
7590753|NCT01425008|11997098|FG000|Dose Expansion Phase|Progressive Disease|0
7590754|NCT01425008|11997099|FG001|Dose Expansion Phase|Progressive Disease|0
7590755|NCT01425008|11997100|FG002|Dose Expansion Phase|Progressive Disease|0
7590756|NCT01425008|11997101|FG003|Dose Expansion Phase|Progressive Disease|0
7590757|NCT01425008|11997102|FG004|Dose Expansion Phase|Progressive Disease|0
7590758|NCT01425008|11997103|FG005|Dose Expansion Phase|Progressive Disease|0
7590759|NCT01425008|11997104|FG006|Dose Expansion Phase|Progressive Disease|0
7590760|NCT01425008|11997105|FG007|Dose Expansion Phase|Progressive Disease|0
7590761|NCT01425008|11997106|FG008|Dose Expansion Phase|Progressive Disease|0
7590762|NCT01425008|11997107|FG009|Dose Expansion Phase|Progressive Disease|0
7590763|NCT01425008|11997108|FG010|Dose Expansion Phase|Progressive Disease|10
7590764|NCT01425008|11997109|FG011|Dose Expansion Phase|Progressive Disease|4
7590765|NCT01425008|11997110|FG012|Dose Expansion Phase|Progressive Disease|12
7590766|NCT01425008|11997111|FG013|Dose Expansion Phase|Progressive Disease|1
7590767|NCT01425008|11997112|FG014|Dose Expansion Phase|Progressive Disease|5
7590768|NCT01425008|11997113|FG015|Dose Expansion Phase|Progressive Disease|8
7590769|NCT01425008|11997114|FG016|Dose Expansion Phase|Progressive Disease|9
7590770|NCT01425008|11997115|FG017|Dose Expansion Phase|Progressive Disease|2
7590771|NCT01425008|11997116|FG018|Dose Expansion Phase|Progressive Disease|10
7590772|NCT01425008|11997098|FG000|Dose Expansion Phase|Withdrawal by Subject|0
7590773|NCT01425008|11997099|FG001|Dose Expansion Phase|Withdrawal by Subject|0
7590774|NCT01425008|11997100|FG002|Dose Expansion Phase|Withdrawal by Subject|0
7590775|NCT01425008|11997101|FG003|Dose Expansion Phase|Withdrawal by Subject|0
7590776|NCT01425008|11997102|FG004|Dose Expansion Phase|Withdrawal by Subject|0
7590777|NCT01425008|11997103|FG005|Dose Expansion Phase|Withdrawal by Subject|0
7590778|NCT01425008|11997104|FG006|Dose Expansion Phase|Withdrawal by Subject|0
7590779|NCT01425008|11997105|FG007|Dose Expansion Phase|Withdrawal by Subject|0
7590780|NCT01425008|11997106|FG008|Dose Expansion Phase|Withdrawal by Subject|0
7590781|NCT01425008|11997107|FG009|Dose Expansion Phase|Withdrawal by Subject|0
7590782|NCT01425008|11997108|FG010|Dose Expansion Phase|Withdrawal by Subject|1
7590783|NCT01425008|11997109|FG011|Dose Expansion Phase|Withdrawal by Subject|0
7590784|NCT01425008|11997110|FG012|Dose Expansion Phase|Withdrawal by Subject|0
7590785|NCT01425008|11997111|FG013|Dose Expansion Phase|Withdrawal by Subject|0
7590786|NCT01425008|11997112|FG014|Dose Expansion Phase|Withdrawal by Subject|0
7590787|NCT01425008|11997113|FG015|Dose Expansion Phase|Withdrawal by Subject|1
7590788|NCT01425008|11997114|FG016|Dose Expansion Phase|Withdrawal by Subject|1
7590789|NCT01425008|11997115|FG017|Dose Expansion Phase|Withdrawal by Subject|0
7590790|NCT01425008|11997116|FG018|Dose Expansion Phase|Withdrawal by Subject|0
7590791|NCT01425008|11997098|FG000|Dose Expansion Phase|Other|0
7590792|NCT01425008|11997099|FG001|Dose Expansion Phase|Other|0
7590793|NCT01425008|11997100|FG002|Dose Expansion Phase|Other|0
7590794|NCT01425008|11997101|FG003|Dose Expansion Phase|Other|0
7590795|NCT01425008|11997102|FG004|Dose Expansion Phase|Other|0
7590796|NCT01425008|11997103|FG005|Dose Expansion Phase|Other|0
7590797|NCT01425008|11997104|FG006|Dose Expansion Phase|Other|0
7590798|NCT01425008|11997105|FG007|Dose Expansion Phase|Other|0
7590799|NCT01425008|11997106|FG008|Dose Expansion Phase|Other|0
7590800|NCT01425008|11997107|FG009|Dose Expansion Phase|Other|0
7590801|NCT01425008|11997108|FG010|Dose Expansion Phase|Other|0
7590802|NCT01425008|11997109|FG011|Dose Expansion Phase|Other|0
7590803|NCT01425008|11997110|FG012|Dose Expansion Phase|Other|1
7590804|NCT01425008|11997111|FG013|Dose Expansion Phase|Other|0
7590805|NCT01425008|11997112|FG014|Dose Expansion Phase|Other|0
7590806|NCT01425008|11997113|FG015|Dose Expansion Phase|Other|0
7590807|NCT01425008|11997114|FG016|Dose Expansion Phase|Other|2
7590808|NCT01425008|11997115|FG017|Dose Expansion Phase|Other|0
7590809|NCT01425008|11997116|FG018|Dose Expansion Phase|Other|4
7590810|NCT01425008|11997098|FG000|Dose Expansion Phase|Symptomatic Deterioration|0
7590811|NCT01425008|11997099|FG001|Dose Expansion Phase|Symptomatic Deterioration|0
7590812|NCT01425008|11997100|FG002|Dose Expansion Phase|Symptomatic Deterioration|0
7590813|NCT01425008|11997101|FG003|Dose Expansion Phase|Symptomatic Deterioration|0
7590814|NCT01425008|11997102|FG004|Dose Expansion Phase|Symptomatic Deterioration|0
7590815|NCT01425008|11997103|FG005|Dose Expansion Phase|Symptomatic Deterioration|0
7590816|NCT01425008|11997104|FG006|Dose Expansion Phase|Symptomatic Deterioration|0
7590817|NCT01425008|11997105|FG007|Dose Expansion Phase|Symptomatic Deterioration|0
7590818|NCT01425008|11997106|FG008|Dose Expansion Phase|Symptomatic Deterioration|0
7590819|NCT01425008|11997107|FG009|Dose Expansion Phase|Symptomatic Deterioration|0
7590893|NCT03861481|11997197|FG000|Overall Study|Relapse|1
7590820|NCT01425008|11997108|FG010|Dose Expansion Phase|Symptomatic Deterioration|2
7590821|NCT01425008|11997109|FG011|Dose Expansion Phase|Symptomatic Deterioration|1
7590822|NCT01425008|11997110|FG012|Dose Expansion Phase|Symptomatic Deterioration|0
7590823|NCT01425008|11997111|FG013|Dose Expansion Phase|Symptomatic Deterioration|0
7590824|NCT01425008|11997112|FG014|Dose Expansion Phase|Symptomatic Deterioration|0
7590825|NCT01425008|11997113|FG015|Dose Expansion Phase|Symptomatic Deterioration|1
7590826|NCT01425008|11997114|FG016|Dose Expansion Phase|Symptomatic Deterioration|2
7590827|NCT01425008|11997115|FG017|Dose Expansion Phase|Symptomatic Deterioration|0
7590828|NCT01425008|11997116|FG018|Dose Expansion Phase|Symptomatic Deterioration|1
7590829|NCT01425008|11997098|FG000|Dose Expansion Phase|Adverse Event|0
7590830|NCT01425008|11997099|FG001|Dose Expansion Phase|Adverse Event|0
7590831|NCT01425008|11997100|FG002|Dose Expansion Phase|Adverse Event|0
7590832|NCT01425008|11997101|FG003|Dose Expansion Phase|Adverse Event|0
7590833|NCT01425008|11997102|FG004|Dose Expansion Phase|Adverse Event|0
7590834|NCT01425008|11997103|FG005|Dose Expansion Phase|Adverse Event|0
7590835|NCT01425008|11997104|FG006|Dose Expansion Phase|Adverse Event|0
7590836|NCT01425008|11997105|FG007|Dose Expansion Phase|Adverse Event|0
7590837|NCT01425008|11997106|FG008|Dose Expansion Phase|Adverse Event|0
7590838|NCT01425008|11997107|FG009|Dose Expansion Phase|Adverse Event|0
7590839|NCT01425008|11997108|FG010|Dose Expansion Phase|Adverse Event|2
7590840|NCT01425008|11997109|FG011|Dose Expansion Phase|Adverse Event|3
7590841|NCT01425008|11997110|FG012|Dose Expansion Phase|Adverse Event|3
7590842|NCT01425008|11997111|FG013|Dose Expansion Phase|Adverse Event|0
7590843|NCT01425008|11997112|FG014|Dose Expansion Phase|Adverse Event|1
7590844|NCT01425008|11997113|FG015|Dose Expansion Phase|Adverse Event|1
7590845|NCT01425008|11997114|FG016|Dose Expansion Phase|Adverse Event|5
7590846|NCT01425008|11997115|FG017|Dose Expansion Phase|Adverse Event|0
7590847|NCT01425008|11997116|FG018|Dose Expansion Phase|Adverse Event|3
7590848|NCT01425008|11997098|FG000|Dose Expansion Phase|Lost to Follow-up|0
7590849|NCT01425008|11997099|FG001|Dose Expansion Phase|Lost to Follow-up|0
7590850|NCT01425008|11997100|FG002|Dose Expansion Phase|Lost to Follow-up|0
7590851|NCT01425008|11997101|FG003|Dose Expansion Phase|Lost to Follow-up|0
7590852|NCT01425008|11997102|FG004|Dose Expansion Phase|Lost to Follow-up|0
7590853|NCT01425008|11997103|FG005|Dose Expansion Phase|Lost to Follow-up|0
7590854|NCT01425008|11997104|FG006|Dose Expansion Phase|Lost to Follow-up|0
7590855|NCT01425008|11997105|FG007|Dose Expansion Phase|Lost to Follow-up|0
7590856|NCT01425008|11997106|FG008|Dose Expansion Phase|Lost to Follow-up|0
7590857|NCT01425008|11997107|FG009|Dose Expansion Phase|Lost to Follow-up|0
7590858|NCT01425008|11997108|FG010|Dose Expansion Phase|Lost to Follow-up|0
7590859|NCT01425008|11997109|FG011|Dose Expansion Phase|Lost to Follow-up|0
7590860|NCT01425008|11997110|FG012|Dose Expansion Phase|Lost to Follow-up|0
7590861|NCT01425008|11997111|FG013|Dose Expansion Phase|Lost to Follow-up|0
7590862|NCT01425008|11997112|FG014|Dose Expansion Phase|Lost to Follow-up|0
7590863|NCT01425008|11997113|FG015|Dose Expansion Phase|Lost to Follow-up|0
7590864|NCT01425008|11997114|FG016|Dose Expansion Phase|Lost to Follow-up|1
7590865|NCT01425008|11997115|FG017|Dose Expansion Phase|Lost to Follow-up|0
7590866|NCT01425008|11997116|FG018|Dose Expansion Phase|Lost to Follow-up|0
7590867|NCT01425008|11997098|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590868|NCT01425008|11997099|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590869|NCT01425008|11997100|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590870|NCT01425008|11997101|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590871|NCT01425008|11997102|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590872|NCT01425008|11997103|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590873|NCT01425008|11997104|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590874|NCT01425008|11997105|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590875|NCT01425008|11997106|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590876|NCT01425008|11997107|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7766981|NCT00851084|12209525|FG000|Overall Study|Other|7
7766982|NCT00851084|12209526|FG001|Overall Study|Other|1
7766983|NCT00851253|12209536|FG000|Overall Study|Disease Progression|1
7766984|NCT00851253|12209537|FG001|Overall Study|Disease Progression|0
7766985|NCT00851318|12209551|FG000|Overall Study|Withdrawal by Subject|7
7766986|NCT00851318|12209552|FG001|Overall Study|Withdrawal by Subject|1
7766987|NCT00851318|12209553|FG002|Overall Study|Withdrawal by Subject|5
7766988|NCT00851318|12209554|FG003|Overall Study|Withdrawal by Subject|3
7766989|NCT00851318|12209551|FG000|Overall Study|Adverse Event|13
7766990|NCT00851318|12209552|FG001|Overall Study|Adverse Event|2
7766991|NCT00851318|12209553|FG002|Overall Study|Adverse Event|9
7766992|NCT00851318|12209554|FG003|Overall Study|Adverse Event|12
7766993|NCT00851318|12209551|FG000|Overall Study|Pregnancy|0
7766994|NCT00851318|12209552|FG001|Overall Study|Pregnancy|0
7766995|NCT00851318|12209553|FG002|Overall Study|Pregnancy|1
7590877|NCT01425008|11997108|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590878|NCT01425008|11997109|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590879|NCT01425008|11997110|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590880|NCT01425008|11997111|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590881|NCT01425008|11997112|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590882|NCT01425008|11997113|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7766996|NCT00851318|12209554|FG003|Overall Study|Pregnancy|1
7590883|NCT01425008|11997114|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590884|NCT01425008|11997115|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590885|NCT01425008|11997116|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1
7626870|NCT00617708|12039327|FG002|Overall Study|Adverse Event|9
7626871|NCT00617708|12039325|FG000|Overall Study|Withdrawal by Subject|1
7626872|NCT00617708|12039326|FG001|Overall Study|Withdrawal by Subject|1
7626873|NCT00617708|12039327|FG002|Overall Study|Withdrawal by Subject|7
7626874|NCT00617708|12039325|FG000|Overall Study|Death|0
7626875|NCT00617708|12039326|FG001|Overall Study|Death|6
7626876|NCT00617708|12039327|FG002|Overall Study|Death|5
7626877|NCT00617708|12039325|FG000|Overall Study|Progression/Relapse|7
7626878|NCT00617708|12039326|FG001|Overall Study|Progression/Relapse|40
7626879|NCT00617708|12039327|FG002|Overall Study|Progression/Relapse|36
7626880|NCT00617708|12039325|FG000|Overall Study|Not protocol specified|1
7626881|NCT00617708|12039326|FG001|Overall Study|Not protocol specified|4
7626882|NCT00617708|12039327|FG002|Overall Study|Not protocol specified|2
7626883|NCT00617708|12039325|FG000|Overall Study|Not eligible|1
7626884|NCT00617708|12039326|FG001|Overall Study|Not eligible|3
7626885|NCT00617708|12039327|FG002|Overall Study|Not eligible|5
7626886|NCT00516737|12039339|FG000|Overall Study|Lost to Follow-up|2
7626887|NCT00516737|12039340|FG001|Overall Study|Lost to Follow-up|0
7626888|NCT00516737|12039339|FG000|Overall Study|Physician Decision|0
7626889|NCT00516737|12039340|FG001|Overall Study|Physician Decision|1
7626890|NCT00516737|12039339|FG000|Overall Study|Withdrawal by Subject|0
7626891|NCT00516737|12039340|FG001|Overall Study|Withdrawal by Subject|1
7626892|NCT00516737|12039339|FG000|Overall Study|Lack of Qualifying Event|9
7626893|NCT00516737|12039340|FG001|Overall Study|Lack of Qualifying Event|6
7626894|NCT00358527|12039348|FG000|Overall Study|Adverse Event|4
7626895|NCT00358527|12039349|FG001|Overall Study|Adverse Event|0
7626896|NCT00358527|12039348|FG000|Overall Study|Withdrawal by Subject|1
7626897|NCT00358527|12039349|FG001|Overall Study|Withdrawal by Subject|1
7626898|NCT00358527|12039348|FG000|Overall Study|Non-compliance with protocol|6
7626899|NCT00358527|12039349|FG001|Overall Study|Non-compliance with protocol|1
7626900|NCT00358527|12039348|FG000|Overall Study|Administrative|2
7626901|NCT00358527|12039349|FG001|Overall Study|Administrative|1
7626902|NCT00326898|12039358|FG000|Overall Study|Disease progression|52
7626903|NCT00326898|12039359|FG001|Overall Study|Disease progression|54
7626904|NCT00326898|12039360|FG002|Overall Study|Disease progression|102
7626905|NCT00326898|12039358|FG000|Overall Study|Adverse Event|124
7626906|NCT00326898|12039359|FG001|Overall Study|Adverse Event|128
7626907|NCT00326898|12039360|FG002|Overall Study|Adverse Event|33
7626908|NCT00326898|12039358|FG000|Overall Study|Death|2
7626909|NCT00326898|12039359|FG001|Overall Study|Death|0
7626910|NCT00326898|12039360|FG002|Overall Study|Death|0
7626911|NCT00326898|12039358|FG000|Overall Study|Withdrawal by Subject|134
7626912|NCT00326898|12039359|FG001|Overall Study|Withdrawal by Subject|128
7626913|NCT00326898|12039360|FG002|Overall Study|Withdrawal by Subject|32
7626914|NCT00326898|12039358|FG000|Overall Study|Alternative therapy|1
7626915|NCT00326898|12039359|FG001|Overall Study|Alternative therapy|0
7626916|NCT00326898|12039360|FG002|Overall Study|Alternative therapy|0
7626917|NCT00326898|12039358|FG000|Overall Study|Other complicating disease|5
7626918|NCT00326898|12039359|FG001|Overall Study|Other complicating disease|5
7626919|NCT00326898|12039360|FG002|Overall Study|Other complicating disease|4
7626920|NCT00326898|12039358|FG000|Overall Study|Other/Missing/Unknown|33
7626921|NCT00326898|12039359|FG001|Overall Study|Other/Missing/Unknown|28
7626922|NCT00326898|12039360|FG002|Overall Study|Other/Missing/Unknown|32
7626923|NCT00156065|12039371|FG000|Overall Study|Enrolled But Never Received Treatment|1
7626924|NCT00156065|12039372|FG001|Overall Study|Enrolled But Never Received Treatment|1
7626925|NCT00156065|12039373|FG002|Overall Study|Enrolled But Never Received Treatment|0
7626926|NCT00156065|12039371|FG000|Overall Study|Adverse Event|8
7626927|NCT00156065|12039372|FG001|Overall Study|Adverse Event|11
7626928|NCT00156065|12039373|FG002|Overall Study|Adverse Event|4
7626929|NCT00156065|12039371|FG000|Overall Study|Lack of Efficacy|2
7626930|NCT00156065|12039372|FG001|Overall Study|Lack of Efficacy|9
7626931|NCT00156065|12039373|FG002|Overall Study|Lack of Efficacy|3
7626932|NCT00156065|12039371|FG000|Overall Study|Withdrawal by Subject|13
7626933|NCT00156065|12039372|FG001|Overall Study|Withdrawal by Subject|26
7626934|NCT00156065|12039373|FG002|Overall Study|Withdrawal by Subject|16
7626935|NCT00156065|12039371|FG000|Overall Study|Lost to Follow-up|5
7626936|NCT00156065|12039372|FG001|Overall Study|Lost to Follow-up|7
7626937|NCT00156065|12039373|FG002|Overall Study|Lost to Follow-up|1
7626938|NCT00156065|12039371|FG000|Overall Study|Other|2
7626939|NCT00156065|12039372|FG001|Overall Study|Other|9
7626940|NCT00156065|12039373|FG002|Overall Study|Other|3
7626941|NCT00150176|12039383|FG000|Overall Study|Adverse Event|16
7626942|NCT00150176|12039384|FG001|Overall Study|Adverse Event|53
7626943|NCT00150176|12039383|FG000|Overall Study|Relapse/Impending relapse, non-AE|10
7590886|NCT04425902|11997169|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1
7590887|NCT04072146|11997182|FG000|Overall Study|Adverse Event|0
7590888|NCT04072146|11997183|FG001|Overall Study|Adverse Event|1
7590889|NCT03861481|11997197|FG000|Overall Study|COVID-19 pandemic circumstances|0
7590890|NCT03861481|11997198|FG001|Overall Study|COVID-19 pandemic circumstances|1
7590891|NCT03861481|11997197|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1
7590892|NCT03861481|11997198|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0
7590894|NCT03861481|11997198|FG001|Overall Study|Relapse|0
7590895|NCT03861481|11997197|FG000|Overall Study|Withdrawal by Subject|0
7590896|NCT03861481|11997198|FG001|Overall Study|Withdrawal by Subject|1
7590897|NCT03861481|11997197|FG000|Overall Study|Lack of Efficacy|4
7590898|NCT03861481|11997198|FG001|Overall Study|Lack of Efficacy|5
7766997|NCT00851318|12209551|FG000|Overall Study|Lack of Efficacy|8
7766998|NCT00851318|12209552|FG001|Overall Study|Lack of Efficacy|2
7766999|NCT00851318|12209553|FG002|Overall Study|Lack of Efficacy|4
7767000|NCT00851318|12209554|FG003|Overall Study|Lack of Efficacy|2
7590903|NCT03648476|11997214|FG000|Overall Study|Withdrawal by Subject|2
7590904|NCT03648476|11997215|FG001|Overall Study|Withdrawal by Subject|1
7590905|NCT03375203|11997227|FG000|Overall Study|Protocol Violation|0
7590906|NCT03375203|11997228|FG001|Overall Study|Protocol Violation|0
7590907|NCT03375203|11997229|FG002|Overall Study|Protocol Violation|1
7590908|NCT03375203|11997230|FG003|Overall Study|Protocol Violation|0
7590909|NCT03375203|11997231|FG004|Overall Study|Protocol Violation|0
7590910|NCT03375203|11997227|FG000|Overall Study|Adverse Event|2
7590911|NCT03375203|11997228|FG001|Overall Study|Adverse Event|3
7590912|NCT03375203|11997229|FG002|Overall Study|Adverse Event|0
7590913|NCT03375203|11997230|FG003|Overall Study|Adverse Event|2
7590914|NCT03375203|11997231|FG004|Overall Study|Adverse Event|2
7590915|NCT03375203|11997227|FG000|Overall Study|Withdrawal by Subject|3
7590916|NCT03375203|11997228|FG001|Overall Study|Withdrawal by Subject|0
7590917|NCT03375203|11997229|FG002|Overall Study|Withdrawal by Subject|1
7590918|NCT03375203|11997230|FG003|Overall Study|Withdrawal by Subject|0
7590919|NCT03375203|11997231|FG004|Overall Study|Withdrawal by Subject|2
7590920|NCT03375203|11997227|FG000|Overall Study|Non-compliance with study drug|1
7590921|NCT03375203|11997228|FG001|Overall Study|Non-compliance with study drug|0
7590922|NCT03375203|11997229|FG002|Overall Study|Non-compliance with study drug|0
7590923|NCT03375203|11997230|FG003|Overall Study|Non-compliance with study drug|0
7590924|NCT03375203|11997231|FG004|Overall Study|Non-compliance with study drug|0
7590925|NCT03375203|11997227|FG000|Overall Study|Randomized, not treated.|0
7590926|NCT03375203|11997228|FG001|Overall Study|Randomized, not treated.|1
7590927|NCT03375203|11997229|FG002|Overall Study|Randomized, not treated.|0
7590928|NCT03375203|11997230|FG003|Overall Study|Randomized, not treated.|0
7590929|NCT03375203|11997231|FG004|Overall Study|Randomized, not treated.|0
7590930|NCT02926833|11997248|FG000|Overall Study|Full Consent Withdrawal|0
7590931|NCT02926833|11997249|FG001|Overall Study|Full Consent Withdrawal|0
7590932|NCT02926833|11997250|FG002|Overall Study|Full Consent Withdrawal|0
7590933|NCT02926833|11997251|FG003|Overall Study|Full Consent Withdrawal|2
7590934|NCT02926833|11997248|FG000|Overall Study|Death|1
7590935|NCT02926833|11997249|FG001|Overall Study|Death|1
7590936|NCT02926833|11997250|FG002|Overall Study|Death|1
7590937|NCT02926833|11997251|FG003|Overall Study|Death|7
7590938|NCT02926833|11997248|FG000|Overall Study|Still on study|2
7590939|NCT02926833|11997249|FG001|Overall Study|Still on study|3
7590940|NCT02926833|11997250|FG002|Overall Study|Still on study|5
7590941|NCT02926833|11997251|FG003|Overall Study|Still on study|14
7590942|NCT02926833|11997248|FG000|Overall Study|Adverse Event|0
7590943|NCT02926833|11997249|FG001|Overall Study|Adverse Event|0
7590944|NCT02926833|11997250|FG002|Overall Study|Adverse Event|1
7590945|NCT02926833|11997251|FG003|Overall Study|Adverse Event|0
7767001|NCT00851318|12209551|FG000|Overall Study|Non-compliance with Study Procedures|2
7767002|NCT00851318|12209552|FG001|Overall Study|Non-compliance with Study Procedures|0
7767003|NCT00851318|12209553|FG002|Overall Study|Non-compliance with Study Procedures|1
7767004|NCT00851318|12209554|FG003|Overall Study|Non-compliance with Study Procedures|0
7767005|NCT00851318|12209551|FG000|Overall Study|Physician Decision|0
7767006|NCT00851318|12209552|FG001|Overall Study|Physician Decision|0
7767007|NCT00851318|12209553|FG002|Overall Study|Physician Decision|1
7767008|NCT00851318|12209554|FG003|Overall Study|Physician Decision|1
7767009|NCT00851630|12209584|FG000|Overall Study|Death|2
7767010|NCT00851630|12209585|FG001|Overall Study|Death|1
7767011|NCT00851630|12209584|FG000|Overall Study|Clinical failure|0
7767012|NCT00851630|12209585|FG001|Overall Study|Clinical failure|1
7767013|NCT00851643|12209597|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1
7767014|NCT00851643|12209598|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0
7767015|NCT00851643|12209599|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0
7767016|NCT00851643|12209600|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0
7767017|NCT00851643|12209601|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0
7767018|NCT00851643|12209602|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0
7767019|NCT00851643|12209597|FG000|Base Study (Up to 12 Months)|Other|0
7767020|NCT00851643|12209598|FG001|Base Study (Up to 12 Months)|Other|0
7767021|NCT00851643|12209599|FG002|Base Study (Up to 12 Months)|Other|0
7767022|NCT00851643|12209600|FG003|Base Study (Up to 12 Months)|Other|0
7767023|NCT00851643|12209601|FG004|Base Study (Up to 12 Months)|Other|0
7767024|NCT00851643|12209602|FG005|Base Study (Up to 12 Months)|Other|1
7767025|NCT00851643|12209597|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4
7767026|NCT00851643|12209598|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2
7767027|NCT00851643|12209599|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4
7767028|NCT00851643|12209600|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1
7767029|NCT00851643|12209601|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2
7767030|NCT00851643|12209602|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0
7767031|NCT00851643|12209597|FG000|Extension Study (Up to 36 Months)|Moved|0
7767032|NCT00851643|12209598|FG001|Extension Study (Up to 36 Months)|Moved|2
7590978|NCT02348216|11997282|FG000|Overall Study|Death|4
7590979|NCT02348216|11997283|FG001|Overall Study|Death|27
7590980|NCT02348216|11997284|FG002|Overall Study|Death|3
7590981|NCT02348216|11997285|FG003|Overall Study|Death|18
7590982|NCT02348216|11997286|FG004|Overall Study|Death|9
7590983|NCT02348216|11997287|FG005|Overall Study|Death|23
7590984|NCT02348216|11997288|FG006|Overall Study|Death|6
7590985|NCT02348216|11997282|FG000|Overall Study|Full consent withdrawal|0
7590986|NCT02348216|11997283|FG001|Overall Study|Full consent withdrawal|0
7590987|NCT02348216|11997284|FG002|Overall Study|Full consent withdrawal|0
7590988|NCT02348216|11997285|FG003|Overall Study|Full consent withdrawal|1
7590989|NCT02348216|11997286|FG004|Overall Study|Full consent withdrawal|0
7590990|NCT02348216|11997287|FG005|Overall Study|Full consent withdrawal|0
7590991|NCT02348216|11997288|FG006|Overall Study|Full consent withdrawal|1
7590992|NCT02348216|11997282|FG000|Overall Study|Lost to Follow-up|0
7590993|NCT02348216|11997283|FG001|Overall Study|Lost to Follow-up|0
7590994|NCT02348216|11997284|FG002|Overall Study|Lost to Follow-up|0
7590995|NCT02348216|11997285|FG003|Overall Study|Lost to Follow-up|0
7590996|NCT02348216|11997286|FG004|Overall Study|Lost to Follow-up|0
7590997|NCT02348216|11997287|FG005|Overall Study|Lost to Follow-up|0
7590998|NCT02348216|11997288|FG006|Overall Study|Lost to Follow-up|1
7590999|NCT02348216|11997282|FG000|Overall Study|Still on study|3
7591000|NCT02348216|11997283|FG001|Overall Study|Still on study|50
7591001|NCT02348216|11997284|FG002|Overall Study|Still on study|21
7591002|NCT02348216|11997285|FG003|Overall Study|Still on study|19
7591003|NCT02348216|11997286|FG004|Overall Study|Still on study|32
7591004|NCT02348216|11997287|FG005|Overall Study|Still on study|27
7591005|NCT02348216|11997288|FG006|Overall Study|Still on study|32
7591006|NCT02348216|11997282|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1
7591007|NCT02348216|11997283|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4
7591008|NCT02348216|11997284|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6
7591009|NCT02348216|11997285|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4
7591010|NCT02348216|11997286|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5
7591011|NCT02348216|11997287|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8
7591012|NCT02348216|11997288|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2
7626944|NCT00150176|12039384|FG001|Overall Study|Relapse/Impending relapse, non-AE|39
7626945|NCT00150176|12039383|FG000|Overall Study|Withdrawal by Subject|19
7626946|NCT00150176|12039384|FG001|Overall Study|Withdrawal by Subject|12
7626947|NCT00150176|12039383|FG000|Overall Study|Lost to Follow-up|3
7626948|NCT00150176|12039384|FG001|Overall Study|Lost to Follow-up|3
7626949|NCT00150176|12039383|FG000|Overall Study|OTHER|11
7626950|NCT00150176|12039384|FG001|Overall Study|OTHER|13
7626951|NCT00145509|12039393|FG000|Overall Study|Adverse Event|10
7626952|NCT00145509|12039394|FG001|Overall Study|Adverse Event|3
7626953|NCT00145509|12039393|FG000|Overall Study|Lack of Efficacy|3
7626954|NCT00145509|12039394|FG001|Overall Study|Lack of Efficacy|1
7626955|NCT00145509|12039393|FG000|Overall Study|Lost to Follow-up|5
7626956|NCT00145509|12039394|FG001|Overall Study|Lost to Follow-up|9
7626957|NCT00145509|12039393|FG000|Overall Study|Withdrew Consent|2
7626958|NCT00145509|12039394|FG001|Overall Study|Withdrew Consent|7
7626959|NCT00145509|12039393|FG000|Overall Study|Reason not provided|2
7626960|NCT00145509|12039394|FG001|Overall Study|Reason not provided|1
7626961|NCT00145496|12039402|FG000|Overall Study|Adverse Event|42
7626962|NCT00145496|12039403|FG001|Overall Study|Adverse Event|30
7626963|NCT00145496|12039402|FG000|Overall Study|Lack of Efficacy|12
7626964|NCT00145496|12039403|FG001|Overall Study|Lack of Efficacy|7
7767033|NCT00851643|12209599|FG002|Extension Study (Up to 36 Months)|Moved|1
7767034|NCT00851643|12209600|FG003|Extension Study (Up to 36 Months)|Moved|1
7767035|NCT00851643|12209601|FG004|Extension Study (Up to 36 Months)|Moved|0
7767036|NCT00851643|12209602|FG005|Extension Study (Up to 36 Months)|Moved|1
7767037|NCT00851721|12209617|FG000|Overall Study|planned surgery|1
7767038|NCT00851721|12209618|FG001|Overall Study|planned surgery|0
7767039|NCT00851721|12209617|FG000|Overall Study|Death|1
7767040|NCT00851721|12209618|FG001|Overall Study|Death|0
7767041|NCT00851721|12209617|FG000|Overall Study|Adverse Event|0
7767042|NCT00851721|12209618|FG001|Overall Study|Adverse Event|1
7767043|NCT00851786|12209632|FG000|Overall Study|Withdrawal by Subject|0
7767044|NCT00851786|12209633|FG001|Overall Study|Withdrawal by Subject|1
7767045|NCT00851786|12209632|FG000|Overall Study|Protocol Violation|0
7767046|NCT00851786|12209633|FG001|Overall Study|Protocol Violation|1
7767047|NCT00851786|12209632|FG000|Overall Study|Lost to Follow-up|1
7767048|NCT00851786|12209633|FG001|Overall Study|Lost to Follow-up|0
7767049|NCT00851786|12209632|FG000|Overall Study|Incarceration|1
7767050|NCT00851786|12209633|FG001|Overall Study|Incarceration|0
7767051|NCT00851786|12209632|FG000|Overall Study|Site Closure|1
7767052|NCT00851786|12209633|FG001|Overall Study|Site Closure|0
7767053|NCT00851786|12209632|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2
7767054|NCT00851786|12209633|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0
7767055|NCT00851799|12209642|FG000|Overall Study|Death|1
7767056|NCT00851799|12209643|FG001|Overall Study|Death|0
7767057|NCT00851799|12209644|FG002|Overall Study|Death|1
7767058|NCT00851799|12209642|FG000|Overall Study|Lost to Follow-up|5
7767059|NCT00851799|12209643|FG001|Overall Study|Lost to Follow-up|3
7767060|NCT00851799|12209644|FG002|Overall Study|Lost to Follow-up|10
7767061|NCT00851799|12209642|FG000|Overall Study|Not able to get to clinic|8
7767062|NCT00851799|12209643|FG001|Overall Study|Not able to get to clinic|5
7767063|NCT00851799|12209644|FG002|Overall Study|Not able to get to clinic|9
7767064|NCT00851799|12209642|FG000|Overall Study|Not willing to adhere to requirements|1
7767065|NCT00851799|12209643|FG001|Overall Study|Not willing to adhere to requirements|2
7767066|NCT00851799|12209644|FG002|Overall Study|Not willing to adhere to requirements|2
7767067|NCT00851799|12209642|FG000|Overall Study|Withdrew consent prior study completion|1
7767068|NCT00851799|12209643|FG001|Overall Study|Withdrew consent prior study completion|2
7767069|NCT00851799|12209644|FG002|Overall Study|Withdrew consent prior study completion|1
7767070|NCT00851799|12209642|FG000|Overall Study|Severe Debilitation|0
7767071|NCT00851799|12209643|FG001|Overall Study|Severe Debilitation|1
7767072|NCT00851799|12209644|FG002|Overall Study|Severe Debilitation|0
7767073|NCT00851799|12209642|FG000|Overall Study|Completed protocol due to pregnancy|0
7767074|NCT00851799|12209643|FG001|Overall Study|Completed protocol due to pregnancy|0
7767075|NCT00851799|12209644|FG002|Overall Study|Completed protocol due to pregnancy|1
7767076|NCT00851877|12209652|FG000|Phase I-1|Death|1
7767077|NCT00851877|12209653|FG001|Phase I-1|Death|0
7767078|NCT00851877|12209654|FG002|Phase I-1|Death|0
7767079|NCT00851877|12209652|FG000|Phase II|Withdrawal by Subject|0
7767080|NCT00851877|12209653|FG001|Phase II|Withdrawal by Subject|0
7767081|NCT00851877|12209654|FG002|Phase II|Withdrawal by Subject|3
7767082|NCT00851890|12209664|FG000|Overall Study|Lost to Follow-up|0
7767083|NCT00851890|12209665|FG001|Overall Study|Lost to Follow-up|1
7767084|NCT00851890|12209666|FG002|Overall Study|Lost to Follow-up|0
7767085|NCT00851890|12209667|FG003|Overall Study|Lost to Follow-up|1
7767086|NCT00851903|12209677|FG000|Overall Study|Withdrawal by Subject|2
7767087|NCT00852202|12209693|FG000|Overall Study|Adverse Event|2
7767088|NCT00852202|12209694|FG001|Overall Study|Adverse Event|3
7767089|NCT00852202|12209695|FG002|Overall Study|Adverse Event|7
7767090|NCT00852202|12209693|FG000|Overall Study|Lack of Efficacy|4
7767091|NCT00852202|12209694|FG001|Overall Study|Lack of Efficacy|1
7767092|NCT00852202|12209695|FG002|Overall Study|Lack of Efficacy|2
7767093|NCT00852202|12209693|FG000|Overall Study|Protocol Violation|2
7767094|NCT00852202|12209694|FG001|Overall Study|Protocol Violation|2
7767095|NCT00852202|12209695|FG002|Overall Study|Protocol Violation|7
7767096|NCT00852202|12209693|FG000|Overall Study|Withdrawal by Subject|3
7767097|NCT00852202|12209694|FG001|Overall Study|Withdrawal by Subject|1
7767098|NCT00852202|12209695|FG002|Overall Study|Withdrawal by Subject|2
7767099|NCT00852202|12209693|FG000|Overall Study|Lost to Follow-up|5
7767100|NCT00852202|12209694|FG001|Overall Study|Lost to Follow-up|5
7767101|NCT00852202|12209695|FG002|Overall Study|Lost to Follow-up|6
7767102|NCT00852202|12209693|FG000|Overall Study|pregnancy,moving away and surgery|1
7767103|NCT00852202|12209694|FG001|Overall Study|pregnancy,moving away and surgery|0
7767104|NCT00852202|12209695|FG002|Overall Study|pregnancy,moving away and surgery|2
7767105|NCT00852397|12209707|FG000|Overall Study|Adverse Event|4
7767106|NCT00852397|12209708|FG001|Overall Study|Adverse Event|6
7767107|NCT00852397|12209709|FG002|Overall Study|Adverse Event|4
7767108|NCT00852397|12209707|FG000|Overall Study|Death|0
7767109|NCT00852397|12209708|FG001|Overall Study|Death|0
7767110|NCT00852397|12209709|FG002|Overall Study|Death|1
7767111|NCT00852397|12209707|FG000|Overall Study|Withdrawal by Subject|4
7767112|NCT00852397|12209708|FG001|Overall Study|Withdrawal by Subject|1
7767113|NCT00852397|12209709|FG002|Overall Study|Withdrawal by Subject|2
7767114|NCT00852397|12209707|FG000|Overall Study|Study terminated by sponsor|2
7767115|NCT00852397|12209708|FG001|Overall Study|Study terminated by sponsor|1
7767116|NCT00852397|12209709|FG002|Overall Study|Study terminated by sponsor|6
7767117|NCT00852397|12209707|FG000|Overall Study|Difficulty in study site visit|1
7767118|NCT00852397|12209708|FG001|Overall Study|Difficulty in study site visit|0
7767119|NCT00852397|12209709|FG002|Overall Study|Difficulty in study site visit|0
7767120|NCT00852397|12209707|FG000|Overall Study|Protocol Violation|0
7767121|NCT00852397|12209708|FG001|Overall Study|Protocol Violation|0
7767122|NCT00852397|12209709|FG002|Overall Study|Protocol Violation|1
7767123|NCT00852475|12209719|FG000|Overall Study|Lost to Follow-up|3
7767124|NCT00852475|12209720|FG001|Overall Study|Lost to Follow-up|4
7767125|NCT00852540|12209736|FG000|Overall Study|Adverse Event|10
7767126|NCT00852540|12209737|FG001|Overall Study|Adverse Event|3
7767127|NCT00852540|12209736|FG000|Overall Study|Lack of Efficacy|15
7767128|NCT00852540|12209737|FG001|Overall Study|Lack of Efficacy|3
7767129|NCT00852540|12209736|FG000|Overall Study|Protocol Violation|1
7767130|NCT00852540|12209737|FG001|Overall Study|Protocol Violation|2
7767131|NCT00852540|12209736|FG000|Overall Study|Lost to Follow-up|2
7767132|NCT00852540|12209737|FG001|Overall Study|Lost to Follow-up|3
7767133|NCT00852540|12209736|FG000|Overall Study|Investigator Discretion|2
7767134|NCT00852540|12209737|FG001|Overall Study|Investigator Discretion|3
7767135|NCT00852540|12209736|FG000|Overall Study|Withdrawal by Subject|3
7767136|NCT00852540|12209737|FG001|Overall Study|Withdrawal by Subject|1
7767137|NCT00852540|12209736|FG000|Overall Study|Did Not Receive Study Drug|3
7767138|NCT00852540|12209737|FG001|Overall Study|Did Not Receive Study Drug|3
7767139|NCT00852917|12209790|FG000|Overall Study|Adverse Event|13
7767140|NCT00852917|12209791|FG001|Overall Study|Adverse Event|20
7767141|NCT00852917|12209792|FG002|Overall Study|Adverse Event|35
7767142|NCT00852917|12209793|FG003|Overall Study|Adverse Event|17
7767143|NCT00852917|12209790|FG000|Overall Study|Lack of Efficacy|21
7767144|NCT00852917|12209791|FG001|Overall Study|Lack of Efficacy|11
7767145|NCT00852917|12209792|FG002|Overall Study|Lack of Efficacy|11
7767146|NCT00852917|12209793|FG003|Overall Study|Lack of Efficacy|47
7767147|NCT00852917|12209790|FG000|Overall Study|Withdrawal by Subject|4
7767148|NCT00852917|12209791|FG001|Overall Study|Withdrawal by Subject|8
7767149|NCT00852917|12209792|FG002|Overall Study|Withdrawal by Subject|10
7767150|NCT00852917|12209793|FG003|Overall Study|Withdrawal by Subject|9
7767151|NCT00852917|12209790|FG000|Overall Study|Physician Decision|6
7767152|NCT00852917|12209791|FG001|Overall Study|Physician Decision|7
7767153|NCT00852917|12209792|FG002|Overall Study|Physician Decision|2
7767154|NCT00852917|12209793|FG003|Overall Study|Physician Decision|19
7767155|NCT00852917|12209790|FG000|Overall Study|Death|0
7767156|NCT00852917|12209791|FG001|Overall Study|Death|0
7767157|NCT00852917|12209792|FG002|Overall Study|Death|0
7767158|NCT00852917|12209793|FG003|Overall Study|Death|1
7767159|NCT00852930|12209806|FG000|Overall Study|Withdrawal by Subject|1
7767160|NCT00852930|12209807|FG001|Overall Study|Withdrawal by Subject|1
7767161|NCT00852930|12209808|FG002|Overall Study|Withdrawal by Subject|1
7767162|NCT00852930|12209806|FG000|Overall Study|Physician Decision|0
7767163|NCT00852930|12209807|FG001|Overall Study|Physician Decision|0
7767164|NCT00852930|12209808|FG002|Overall Study|Physician Decision|1
7767165|NCT00852969|12209819|FG000|Overall Study|Adverse Event|0
7767166|NCT00852969|12209820|FG001|Overall Study|Adverse Event|1
7767167|NCT00852969|12209819|FG000|Overall Study|Lost to Follow-up|0
7767168|NCT00852969|12209820|FG001|Overall Study|Lost to Follow-up|1
7767169|NCT00852995|12209831|FG000|Overall Study|Adverse Event|1
7767170|NCT00852995|12209832|FG001|Overall Study|Adverse Event|0
7767171|NCT00852995|12209833|FG002|Overall Study|Adverse Event|4
7767172|NCT00852995|12209834|FG003|Overall Study|Adverse Event|0
7767173|NCT00852995|12209835|FG004|Overall Study|Adverse Event|0
7767174|NCT00852995|12209831|FG000|Overall Study|Lost to Follow-up|0
7767175|NCT00852995|12209832|FG001|Overall Study|Lost to Follow-up|1
7767176|NCT00852995|12209833|FG002|Overall Study|Lost to Follow-up|1
7767177|NCT00852995|12209834|FG003|Overall Study|Lost to Follow-up|0
7767178|NCT00852995|12209835|FG004|Overall Study|Lost to Follow-up|0
7767179|NCT00852995|12209831|FG000|Overall Study|Withdrawal by Subject|4
7767180|NCT00852995|12209832|FG001|Overall Study|Withdrawal by Subject|0
7767181|NCT00852995|12209833|FG002|Overall Study|Withdrawal by Subject|0
7767182|NCT00852995|12209834|FG003|Overall Study|Withdrawal by Subject|1
7767183|NCT00852995|12209835|FG004|Overall Study|Withdrawal by Subject|2
7767184|NCT00852995|12209831|FG000|Overall Study|Non-Compliance|0
7767185|NCT00852995|12209832|FG001|Overall Study|Non-Compliance|0
7767186|NCT00852995|12209833|FG002|Overall Study|Non-Compliance|0
7767187|NCT00852995|12209834|FG003|Overall Study|Non-Compliance|2
7767188|NCT00852995|12209835|FG004|Overall Study|Non-Compliance|0
7767189|NCT00852995|12209831|FG000|Overall Study|Progressive Disease|1
7767190|NCT00852995|12209832|FG001|Overall Study|Progressive Disease|0
7767191|NCT00852995|12209833|FG002|Overall Study|Progressive Disease|0
7767192|NCT00852995|12209834|FG003|Overall Study|Progressive Disease|2
7767193|NCT00852995|12209835|FG004|Overall Study|Progressive Disease|1
7767194|NCT00852995|12209831|FG000|Overall Study|Physician Decision|1
7767195|NCT00852995|12209832|FG001|Overall Study|Physician Decision|0
7767196|NCT00852995|12209833|FG002|Overall Study|Physician Decision|0
7767197|NCT00852995|12209834|FG003|Overall Study|Physician Decision|0
7767198|NCT00852995|12209835|FG004|Overall Study|Physician Decision|0
7767199|NCT00852995|12209831|FG000|Overall Study|Protocol Violation|0
7767200|NCT00852995|12209832|FG001|Overall Study|Protocol Violation|0
7767201|NCT00852995|12209833|FG002|Overall Study|Protocol Violation|0
7767202|NCT00852995|12209834|FG003|Overall Study|Protocol Violation|0
7767203|NCT00852995|12209835|FG004|Overall Study|Protocol Violation|1
7767204|NCT00852995|12209831|FG000|Overall Study|Moved Out of Area|1
7767205|NCT00852995|12209832|FG001|Overall Study|Moved Out of Area|0
7767206|NCT00852995|12209833|FG002|Overall Study|Moved Out of Area|0
7767207|NCT00852995|12209834|FG003|Overall Study|Moved Out of Area|0
7767208|NCT00852995|12209835|FG004|Overall Study|Moved Out of Area|0
7767209|NCT00853021|12209852|FG000|Overall Study|Adverse Event|2
7767210|NCT00853021|12209852|FG000|Overall Study|Withdrawal by Subject|2
7767211|NCT00853021|12209852|FG000|Overall Study|Death|1
7767212|NCT00853047|12209861|FG000|Core Phase|Participant Request|0
7767213|NCT00853047|12209862|FG001|Core Phase|Participant Request|0
7767214|NCT00853047|12209863|FG002|Core Phase|Participant Request|0
7767215|NCT00853047|12209864|FG003|Core Phase|Participant Request|1
7767216|NCT00853047|12209865|FG004|Core Phase|Participant Request|0
7767217|NCT00853047|12209866|FG005|Core Phase|Participant Request|0
7767218|NCT00853047|12209861|FG000|Open-Label Extension Phase|Participant Request|0
7767219|NCT00853047|12209862|FG001|Open-Label Extension Phase|Participant Request|0
7767220|NCT00853047|12209863|FG002|Open-Label Extension Phase|Participant Request|0
7767221|NCT00853047|12209864|FG003|Open-Label Extension Phase|Participant Request|0
7767222|NCT00853047|12209865|FG004|Open-Label Extension Phase|Participant Request|0
7767223|NCT00853047|12209866|FG005|Open-Label Extension Phase|Participant Request|7
7767224|NCT00853047|12209861|FG000|Open-Label Extension Phase|Lost to Follow-up|0
7767225|NCT00853047|12209862|FG001|Open-Label Extension Phase|Lost to Follow-up|0
7767226|NCT00853047|12209863|FG002|Open-Label Extension Phase|Lost to Follow-up|0
7767227|NCT00853047|12209864|FG003|Open-Label Extension Phase|Lost to Follow-up|0
7767228|NCT00853047|12209865|FG004|Open-Label Extension Phase|Lost to Follow-up|0
7767229|NCT00853047|12209866|FG005|Open-Label Extension Phase|Lost to Follow-up|1
7767230|NCT00853047|12209861|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0
7767231|NCT00853047|12209862|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0
7767232|NCT00853047|12209863|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0
7767233|NCT00853047|12209864|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0
7767234|NCT00853047|12209865|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0
7767235|NCT00853047|12209866|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2
7767236|NCT00853047|12209861|FG000|Open-Label Extension Phase|Investigator Decision|0
7767237|NCT00853047|12209862|FG001|Open-Label Extension Phase|Investigator Decision|0
7767238|NCT00853047|12209863|FG002|Open-Label Extension Phase|Investigator Decision|0
7767239|NCT00853047|12209864|FG003|Open-Label Extension Phase|Investigator Decision|0
7767240|NCT00853047|12209865|FG004|Open-Label Extension Phase|Investigator Decision|0
7767241|NCT00853047|12209866|FG005|Open-Label Extension Phase|Investigator Decision|1
7767242|NCT00853047|12209861|FG000|Open-Label Extension Phase|Reason Not Specified|0
7767243|NCT00853047|12209862|FG001|Open-Label Extension Phase|Reason Not Specified|0
7767244|NCT00853047|12209863|FG002|Open-Label Extension Phase|Reason Not Specified|0
7767245|NCT00853047|12209864|FG003|Open-Label Extension Phase|Reason Not Specified|0
7767246|NCT00853047|12209865|FG004|Open-Label Extension Phase|Reason Not Specified|0
7767247|NCT00853047|12209866|FG005|Open-Label Extension Phase|Reason Not Specified|6
7767248|NCT00853073|12209883|FG000|Overall Study|Withdrawal by Subject|3
7767249|NCT00853073|12209884|FG001|Overall Study|Withdrawal by Subject|2
7767250|NCT00853099|12209893|FG000|Double-blind Period|Adverse Event|7
7767251|NCT00853099|12209894|FG001|Double-blind Period|Adverse Event|9
7767252|NCT00853099|12209895|FG002|Double-blind Period|Adverse Event|13
7767253|NCT00853099|12209896|FG003|Double-blind Period|Adverse Event|0
7767254|NCT00853099|12209893|FG000|Double-blind Period|Withdrawal by Subject|2
7767255|NCT00853099|12209894|FG001|Double-blind Period|Withdrawal by Subject|3
7767256|NCT00853099|12209895|FG002|Double-blind Period|Withdrawal by Subject|0
7767257|NCT00853099|12209896|FG003|Double-blind Period|Withdrawal by Subject|0
7767258|NCT00853099|12209893|FG000|Double-blind Period|Lack of Efficacy|14
7767259|NCT00853099|12209894|FG001|Double-blind Period|Lack of Efficacy|17
7767260|NCT00853099|12209895|FG002|Double-blind Period|Lack of Efficacy|16
7767261|NCT00853099|12209896|FG003|Double-blind Period|Lack of Efficacy|0
7767262|NCT00853099|12209893|FG000|Double-blind Period|Other|0
7767263|NCT00853099|12209894|FG001|Double-blind Period|Other|0
7767264|NCT00853099|12209895|FG002|Double-blind Period|Other|1
7767265|NCT00853099|12209896|FG003|Double-blind Period|Other|0
7767266|NCT00853099|12209893|FG000|Double-blind Period|Mistreated with rescue study drug|0
7767267|NCT00853099|12209894|FG001|Double-blind Period|Mistreated with rescue study drug|0
7591197|NCT01231906|11997356|FG000|Overall Study|Lack of Efficacy|75
7591198|NCT01231906|11997357|FG001|Overall Study|Lack of Efficacy|68
7591199|NCT01231906|11997356|FG000|Overall Study|Lost to Follow-up|1
7591200|NCT01231906|11997357|FG001|Overall Study|Lost to Follow-up|0
7591201|NCT01231906|11997356|FG000|Overall Study|Physician Decision|34
7591202|NCT01231906|11997357|FG001|Overall Study|Physician Decision|24
7591203|NCT01231906|11997356|FG000|Overall Study|Withdrawal by Subject|0
7591204|NCT01231906|11997357|FG001|Overall Study|Withdrawal by Subject|4
7591205|NCT01231906|11997356|FG000|Overall Study|Ineligible|10
7591206|NCT01231906|11997357|FG001|Overall Study|Ineligible|3
7591207|NCT01231906|11997356|FG000|Overall Study|No treatment|1
7591208|NCT01231906|11997357|FG001|Overall Study|No treatment|2
7626965|NCT00145496|12039402|FG000|Overall Study|Withdrawal by Subject|32
7626966|NCT00145496|12039403|FG001|Overall Study|Withdrawal by Subject|26
7626967|NCT00145496|12039402|FG000|Overall Study|Lost to Follow-up|12
7626968|NCT00145496|12039403|FG001|Overall Study|Lost to Follow-up|5
7626969|NCT00145496|12039402|FG000|Overall Study|Other|25
7626970|NCT00145496|12039403|FG001|Overall Study|Other|13
7626971|NCT00145470|12039411|FG000|Overall Study|Adverse Event|19
7626972|NCT00145470|12039412|FG001|Overall Study|Adverse Event|25
7626973|NCT00145470|12039411|FG000|Overall Study|Lack of Efficacy|27
7626974|NCT00145470|12039412|FG001|Overall Study|Lack of Efficacy|13
7626975|NCT00145470|12039411|FG000|Overall Study|Withdrawal by Subject|36
7626976|NCT00145470|12039412|FG001|Overall Study|Withdrawal by Subject|34
7626977|NCT00145470|12039411|FG000|Overall Study|Lost to Follow-up|21
7626978|NCT00145470|12039412|FG001|Overall Study|Lost to Follow-up|17
7626979|NCT00145470|12039411|FG000|Overall Study|Reason Not Reported|9
7626980|NCT00145470|12039412|FG001|Overall Study|Reason Not Reported|9
7626981|NCT00129402|12039420|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
7626982|NCT00129402|12039421|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
7626983|NCT00129402|12039422|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
7626984|NCT00129402|12039423|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
7626985|NCT00129402|12039424|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
7626986|NCT00129402|12039425|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
7626987|NCT00129402|12039426|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
7626988|NCT00129402|12039420|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7626989|NCT00129402|12039421|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7626990|NCT00129402|12039422|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7626991|NCT00129402|12039423|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7626992|NCT00129402|12039424|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7626993|NCT00129402|12039425|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
7626994|NCT00129402|12039426|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7626995|NCT00129402|12039420|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7626996|NCT00129402|12039421|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7626997|NCT00129402|12039422|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7626998|NCT00129402|12039423|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
7626999|NCT00129402|12039424|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7627000|NCT00129402|12039425|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7627001|NCT00129402|12039426|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7627002|NCT00129402|12039420|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
7627003|NCT00129402|12039421|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
7627004|NCT00129402|12039422|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
7627005|NCT00129402|12039423|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
7627006|NCT00129402|12039424|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
7627007|NCT00129402|12039425|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
7627008|NCT00129402|12039426|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
7627009|NCT00129402|12039420|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7627010|NCT00129402|12039421|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7627011|NCT00129402|12039422|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
7627012|NCT00129402|12039423|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7627013|NCT00129402|12039424|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7627014|NCT00129402|12039425|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7627015|NCT00129402|12039426|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7627016|NCT00129402|12039420|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
7627017|NCT00129402|12039421|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
7627018|NCT00129402|12039422|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
7627019|NCT00129402|12039423|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
7627020|NCT00129402|12039424|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
7627021|NCT00129402|12039425|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
7627022|NCT00129402|12039426|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
7627023|NCT00129402|12039420|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7627024|NCT00129402|12039421|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7627025|NCT00129402|12039422|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
7591209|NCT01470326|11997363|FG000|Overall Study|Protocol Violation|32
7591210|NCT01470326|11997363|FG000|Overall Study|No Drug Administration Information|2
7591211|NCT01470326|11997363|FG000|Overall Study|No Visit After 1st Day of Treatment|119
7591212|NCT01480180|11997369|FG000|Main Phase|Withdrawal criteria|12
7591213|NCT01480180|11997370|FG001|Main Phase|Withdrawal criteria|1
7591214|NCT01480180|11997371|FG002|Main Phase|Withdrawal criteria|0
7591215|NCT01480180|11997372|FG003|Main Phase|Withdrawal criteria|0
7591216|NCT01480180|11997373|FG004|Main Phase|Withdrawal criteria|0
7591217|NCT01480180|11997374|FG005|Main Phase|Withdrawal criteria|0
7591218|NCT01480180|11997369|FG000|Main Phase|Lack of Efficacy|1
7591219|NCT01480180|11997370|FG001|Main Phase|Lack of Efficacy|0
7591220|NCT01480180|11997371|FG002|Main Phase|Lack of Efficacy|0
7591221|NCT01480180|11997372|FG003|Main Phase|Lack of Efficacy|0
7591222|NCT01480180|11997373|FG004|Main Phase|Lack of Efficacy|0
7591223|NCT01480180|11997374|FG005|Main Phase|Lack of Efficacy|0
7591224|NCT01480180|11997369|FG000|Main Phase|Non-compliance|3
7591225|NCT01480180|11997370|FG001|Main Phase|Non-compliance|0
7591226|NCT01480180|11997371|FG002|Main Phase|Non-compliance|0
7591227|NCT01480180|11997372|FG003|Main Phase|Non-compliance|0
7591228|NCT01480180|11997373|FG004|Main Phase|Non-compliance|0
7591229|NCT01480180|11997374|FG005|Main Phase|Non-compliance|0
7591230|NCT01480180|11997369|FG000|Main Phase|Unclassified|3
7591231|NCT01480180|11997370|FG001|Main Phase|Unclassified|0
7591232|NCT01480180|11997371|FG002|Main Phase|Unclassified|0
7591233|NCT01480180|11997372|FG003|Main Phase|Unclassified|0
7591234|NCT01480180|11997373|FG004|Main Phase|Unclassified|0
7591235|NCT01480180|11997374|FG005|Main Phase|Unclassified|0
7591236|NCT01480180|11997369|FG000|Extension Phase, Part 1|Withdrawal criteria|0
7591237|NCT01480180|11997370|FG001|Extension Phase, Part 1|Withdrawal criteria|0
7591238|NCT01480180|11997371|FG002|Extension Phase, Part 1|Withdrawal criteria|5
7591239|NCT01480180|11997372|FG003|Extension Phase, Part 1|Withdrawal criteria|0
7591240|NCT01480180|11997373|FG004|Extension Phase, Part 1|Withdrawal criteria|0
7591241|NCT01480180|11997374|FG005|Extension Phase, Part 1|Withdrawal criteria|0
7591242|NCT01480180|11997369|FG000|Extension Phase, Part 1|Unclassified|0
7591243|NCT01480180|11997370|FG001|Extension Phase, Part 1|Unclassified|0
7591244|NCT01480180|11997371|FG002|Extension Phase, Part 1|Unclassified|1
7591245|NCT01480180|11997372|FG003|Extension Phase, Part 1|Unclassified|0
7591246|NCT01480180|11997373|FG004|Extension Phase, Part 1|Unclassified|0
7591247|NCT01480180|11997374|FG005|Extension Phase, Part 1|Unclassified|0
7591248|NCT01480180|11997369|FG000|Extension Phase, Part 1|Adverse Event|0
7591249|NCT01480180|11997370|FG001|Extension Phase, Part 1|Adverse Event|0
7591250|NCT01480180|11997371|FG002|Extension Phase, Part 1|Adverse Event|4
7591251|NCT01480180|11997372|FG003|Extension Phase, Part 1|Adverse Event|1
7591252|NCT01480180|11997373|FG004|Extension Phase, Part 1|Adverse Event|0
7591253|NCT01480180|11997374|FG005|Extension Phase, Part 1|Adverse Event|0
7591254|NCT01480180|11997369|FG000|Extension Phase, Part 1|Change of treatment|0
7591255|NCT01480180|11997370|FG001|Extension Phase, Part 1|Change of treatment|0
7591256|NCT01480180|11997371|FG002|Extension Phase, Part 1|Change of treatment|0
7591257|NCT01480180|11997372|FG003|Extension Phase, Part 1|Change of treatment|9
7591258|NCT01480180|11997373|FG004|Extension Phase, Part 1|Change of treatment|0
7591259|NCT01480180|11997374|FG005|Extension Phase, Part 1|Change of treatment|0
7591260|NCT01480180|11997369|FG000|Extension Phase, Part 2|Withdrawal criteria|0
7591261|NCT01480180|11997370|FG001|Extension Phase, Part 2|Withdrawal criteria|0
7591262|NCT01480180|11997371|FG002|Extension Phase, Part 2|Withdrawal criteria|10
7591263|NCT01480180|11997372|FG003|Extension Phase, Part 2|Withdrawal criteria|6
7591264|NCT01480180|11997373|FG004|Extension Phase, Part 2|Withdrawal criteria|1
7591265|NCT01480180|11997374|FG005|Extension Phase, Part 2|Withdrawal criteria|0
7591266|NCT01480180|11997369|FG000|Extension Phase, Part 2|Lack of Efficacy|0
7591267|NCT01480180|11997370|FG001|Extension Phase, Part 2|Lack of Efficacy|0
7591268|NCT01480180|11997371|FG002|Extension Phase, Part 2|Lack of Efficacy|4
7591269|NCT01480180|11997372|FG003|Extension Phase, Part 2|Lack of Efficacy|0
7591270|NCT01480180|11997373|FG004|Extension Phase, Part 2|Lack of Efficacy|0
7591271|NCT01480180|11997374|FG005|Extension Phase, Part 2|Lack of Efficacy|0
7591272|NCT01480180|11997369|FG000|Extension Phase, Part 2|Unclassified|0
7591273|NCT01480180|11997370|FG001|Extension Phase, Part 2|Unclassified|0
7591274|NCT01480180|11997371|FG002|Extension Phase, Part 2|Unclassified|3
7591275|NCT01480180|11997372|FG003|Extension Phase, Part 2|Unclassified|1
7591276|NCT01480180|11997373|FG004|Extension Phase, Part 2|Unclassified|1
7591277|NCT01480180|11997374|FG005|Extension Phase, Part 2|Unclassified|0
7627026|NCT00129402|12039423|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7627027|NCT00129402|12039424|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7627028|NCT00129402|12039425|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7627029|NCT00129402|12039426|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7627030|NCT00129402|12039420|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
7627031|NCT00129402|12039421|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
7627032|NCT00129402|12039422|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
7627033|NCT00129402|12039423|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
7627034|NCT00129402|12039424|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
7627035|NCT00129402|12039425|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
7627036|NCT00129402|12039426|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
7627037|NCT00129402|12039420|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7627038|NCT00129402|12039421|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7627039|NCT00129402|12039422|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
7627040|NCT00129402|12039423|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7627041|NCT00129402|12039424|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7627042|NCT00129402|12039425|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
7627043|NCT00129402|12039426|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7627044|NCT00129402|12039420|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7627045|NCT00129402|12039421|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7591278|NCT01545050|11997410|FG000|Overall Study|Lack of Efficacy|0
7591279|NCT01545050|11997411|FG001|Overall Study|Lack of Efficacy|0
7591280|NCT01545050|11997412|FG002|Overall Study|Lack of Efficacy|0
7591281|NCT01545050|11997413|FG003|Overall Study|Lack of Efficacy|3
7591282|NCT01545050|11997414|FG004|Overall Study|Lack of Efficacy|2
7591283|NCT01545050|11997410|FG000|Overall Study|Adverse Event|1
7591284|NCT01545050|11997411|FG001|Overall Study|Adverse Event|1
7591285|NCT01545050|11997412|FG002|Overall Study|Adverse Event|2
7591286|NCT01545050|11997413|FG003|Overall Study|Adverse Event|2
7591287|NCT01545050|11997414|FG004|Overall Study|Adverse Event|0
7591288|NCT01545050|11997410|FG000|Overall Study|Discontinued study treatment|1
7591289|NCT01545050|11997411|FG001|Overall Study|Discontinued study treatment|0
7591290|NCT01545050|11997412|FG002|Overall Study|Discontinued study treatment|0
7591291|NCT01545050|11997413|FG003|Overall Study|Discontinued study treatment|0
7591292|NCT01545050|11997414|FG004|Overall Study|Discontinued study treatment|0
7591293|NCT01545050|11997410|FG000|Overall Study|Withdrawal by Subject|1
7591294|NCT01545050|11997411|FG001|Overall Study|Withdrawal by Subject|0
7591295|NCT01545050|11997412|FG002|Overall Study|Withdrawal by Subject|0
7591296|NCT01545050|11997413|FG003|Overall Study|Withdrawal by Subject|2
7591297|NCT01545050|11997414|FG004|Overall Study|Withdrawal by Subject|1
7591298|NCT01545050|11997410|FG000|Overall Study|Participant no longer meets study criteria|0
7591299|NCT01545050|11997411|FG001|Overall Study|Participant no longer meets study criteria|2
7591300|NCT01545050|11997412|FG002|Overall Study|Participant no longer meets study criteria|0
7591301|NCT01545050|11997413|FG003|Overall Study|Participant no longer meets study criteria|0
7591302|NCT01545050|11997414|FG004|Overall Study|Participant no longer meets study criteria|1
7591303|NCT01545050|11997410|FG000|Overall Study|Administrative reason by sponsor|4
7591304|NCT01545050|11997411|FG001|Overall Study|Administrative reason by sponsor|2
7591305|NCT01545050|11997412|FG002|Overall Study|Administrative reason by sponsor|3
7591306|NCT01545050|11997413|FG003|Overall Study|Administrative reason by sponsor|5
7591307|NCT01545050|11997414|FG004|Overall Study|Administrative reason by sponsor|5
7627046|NCT00129402|12039422|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7627047|NCT00129402|12039423|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7627048|NCT00129402|12039424|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7627049|NCT00129402|12039425|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7627050|NCT00129402|12039426|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
7627051|NCT00129402|12039420|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7627052|NCT00129402|12039421|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7627053|NCT00129402|12039422|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7627054|NCT00129402|12039423|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7627055|NCT00129402|12039424|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7627056|NCT00129402|12039425|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7627057|NCT00129402|12039426|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
7627058|NCT00129402|12039420|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7627059|NCT00129402|12039421|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7627060|NCT00129402|12039422|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7627061|NCT00129402|12039423|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7627062|NCT00129402|12039424|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7627063|NCT00129402|12039425|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7627064|NCT00129402|12039426|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1
7627065|NCT00129402|12039420|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7627066|NCT00129402|12039421|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7627067|NCT00129402|12039422|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7627068|NCT00129402|12039423|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7627069|NCT00129402|12039424|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7627070|NCT00129402|12039425|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7627071|NCT00129402|12039426|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
7627072|NCT00101439|12039436|FG000|Period 2|Withdrawal by Subject|0
7627073|NCT00101439|12039437|FG001|Period 2|Withdrawal by Subject|2
7627074|NCT00096200|12039446|FG000|Overall Study|Adverse Event|0
7627075|NCT00096200|12039447|FG001|Overall Study|Adverse Event|4
7627076|NCT00096200|12039448|FG002|Overall Study|Adverse Event|0
7627077|NCT00096200|12039446|FG000|Overall Study|Withdrawal by Subject|1
7627078|NCT00096200|12039447|FG001|Overall Study|Withdrawal by Subject|2
7627079|NCT00096200|12039448|FG002|Overall Study|Withdrawal by Subject|0
7627080|NCT00096200|12039446|FG000|Overall Study|Ineligible pathology|0
7627081|NCT00096200|12039447|FG001|Overall Study|Ineligible pathology|1
7627082|NCT00096200|12039448|FG002|Overall Study|Ineligible pathology|0
7767268|NCT00853099|12209895|FG002|Double-blind Period|Mistreated with rescue study drug|1
7767269|NCT00853099|12209896|FG003|Double-blind Period|Mistreated with rescue study drug|0
7767270|NCT00853099|12209893|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0
7767271|NCT00853099|12209894|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0
7767272|NCT00853099|12209895|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0
7767273|NCT00853099|12209896|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74
7767274|NCT00853099|12209893|FG000|Double-blind + Open-label Periods|Adverse Event|0
7767275|NCT00853099|12209894|FG001|Double-blind + Open-label Periods|Adverse Event|0
7767276|NCT00853099|12209895|FG002|Double-blind + Open-label Periods|Adverse Event|0
7767277|NCT00853099|12209896|FG003|Double-blind + Open-label Periods|Adverse Event|47
7767278|NCT00853099|12209893|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0
7767279|NCT00853099|12209894|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0
7767280|NCT00853099|12209895|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0
7767281|NCT00853099|12209896|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20
7767282|NCT00853099|12209893|FG000|Double-blind + Open-label Periods|Other|0
7767283|NCT00853099|12209894|FG001|Double-blind + Open-label Periods|Other|0
7767284|NCT00853099|12209895|FG002|Double-blind + Open-label Periods|Other|0
7591308|NCT01555021|11997441|FG000|Overall Study|Lost to Follow-up|1
7591309|NCT01555021|11997442|FG001|Overall Study|Lost to Follow-up|2
7591310|NCT01561430|11997458|FG000|Overall Study|Adverse Event|0
7591311|NCT01561430|11997459|FG001|Overall Study|Adverse Event|0
7591312|NCT01561430|11997460|FG002|Overall Study|Adverse Event|3
7591313|NCT01561430|11997461|FG003|Overall Study|Adverse Event|1
7591314|NCT01561430|11997458|FG000|Overall Study|Withdrawal by Subject|0
7591315|NCT01561430|11997459|FG001|Overall Study|Withdrawal by Subject|0
7591316|NCT01561430|11997460|FG002|Overall Study|Withdrawal by Subject|1
7591317|NCT01561430|11997461|FG003|Overall Study|Withdrawal by Subject|0
7591318|NCT01561430|11997458|FG000|Overall Study|Physician Decision|0
7591319|NCT01561430|11997459|FG001|Overall Study|Physician Decision|1
7591320|NCT01561430|11997460|FG002|Overall Study|Physician Decision|0
7591321|NCT01561430|11997461|FG003|Overall Study|Physician Decision|0
7591322|NCT01561430|11997458|FG000|Overall Study|Sponsor Decision|1
7591323|NCT01561430|11997459|FG001|Overall Study|Sponsor Decision|14
7591324|NCT01561430|11997460|FG002|Overall Study|Sponsor Decision|13
7591325|NCT01561430|11997461|FG003|Overall Study|Sponsor Decision|12
7591326|NCT01595009|11997481|FG000|Core|Patients completed per protocol|85
7591327|NCT01595009|11997482|FG001|Core|Patients completed per protocol|44
7591328|NCT01595009|11997483|FG002|Core|Patients completed per protocol|0
7591329|NCT01595009|11997484|FG003|Core|Patients completed per protocol|0
7591330|NCT01595009|11997481|FG000|Core|Adverse Event|19
7591331|NCT01595009|11997482|FG001|Core|Adverse Event|23
7591332|NCT01595009|11997483|FG002|Core|Adverse Event|0
7591333|NCT01595009|11997484|FG003|Core|Adverse Event|0
7591334|NCT01595009|11997481|FG000|Core|Disease progression|14
7591335|NCT01595009|11997482|FG001|Core|Disease progression|26
7591336|NCT01595009|11997483|FG002|Core|Disease progression|0
7591337|NCT01595009|11997484|FG003|Core|Disease progression|0
7591338|NCT01595009|11997481|FG000|Core|Withdrawal by Subject|4
7591339|NCT01595009|11997482|FG001|Core|Withdrawal by Subject|17
7591340|NCT01595009|11997483|FG002|Core|Withdrawal by Subject|0
7591341|NCT01595009|11997484|FG003|Core|Withdrawal by Subject|0
7591342|NCT01595009|11997481|FG000|Core|Death|3
7591343|NCT01595009|11997482|FG001|Core|Death|6
7591344|NCT01595009|11997483|FG002|Core|Death|0
7591345|NCT01595009|11997484|FG003|Core|Death|0
7591346|NCT01595009|11997481|FG000|Core|Lost to Follow-up|1
7591347|NCT01595009|11997482|FG001|Core|Lost to Follow-up|2
7591348|NCT01595009|11997483|FG002|Core|Lost to Follow-up|0
7591349|NCT01595009|11997484|FG003|Core|Lost to Follow-up|0
7591350|NCT01595009|11997481|FG000|Core|Protocol deviation|0
7591351|NCT01595009|11997482|FG001|Core|Protocol deviation|1
7591352|NCT01595009|11997483|FG002|Core|Protocol deviation|0
7591353|NCT01595009|11997484|FG003|Core|Protocol deviation|0
7591354|NCT01595009|11997481|FG000|Core|Administrative problems|0
7591355|NCT01595009|11997482|FG001|Core|Administrative problems|1
7591356|NCT01595009|11997483|FG002|Core|Administrative problems|0
7591357|NCT01595009|11997484|FG003|Core|Administrative problems|0
7591358|NCT01595009|11997481|FG000|Extension|Administrative problems|0
7591359|NCT01595009|11997482|FG001|Extension|Administrative problems|0
7591360|NCT01595009|11997483|FG002|Extension|Administrative problems|0
7591361|NCT01595009|11997484|FG003|Extension|Administrative problems|1
7591362|NCT01595009|11997481|FG000|Extension|Patients completed per protocol|0
7591363|NCT01595009|11997482|FG001|Extension|Patients completed per protocol|0
7591364|NCT01595009|11997483|FG002|Extension|Patients completed per protocol|0
7591365|NCT01595009|11997484|FG003|Extension|Patients completed per protocol|2
7591366|NCT01595009|11997481|FG000|Extension|Disease progression|0
7591367|NCT01595009|11997482|FG001|Extension|Disease progression|0
7591368|NCT01595009|11997483|FG002|Extension|Disease progression|4
7591369|NCT01595009|11997484|FG003|Extension|Disease progression|7
7591370|NCT01595009|11997481|FG000|Extension|Adverse Event|0
7591371|NCT01595009|11997482|FG001|Extension|Adverse Event|0
7591372|NCT01595009|11997483|FG002|Extension|Adverse Event|0
7591373|NCT01595009|11997484|FG003|Extension|Adverse Event|1
7591374|NCT01620944|11997512|FG000|Overall Study|Early termination of Study|2
7591375|NCT01620944|11997513|FG001|Overall Study|Early termination of Study|1
7591376|NCT01627561|11997521|FG000|Overall Study|Lost to Follow-up|1
7591377|NCT01627561|11997522|FG001|Overall Study|Lost to Follow-up|0
7591378|NCT01627561|11997521|FG000|Overall Study|Withdrawal by Subject|0
7591379|NCT01627561|11997522|FG001|Overall Study|Withdrawal by Subject|1
7591380|NCT01627561|11997521|FG000|Overall Study|Migrated/moved from study area|0
7591381|NCT01627561|11997522|FG001|Overall Study|Migrated/moved from study area|2
7591382|NCT01652534|11997547|FG000|Overall Study|Lack of Efficacy|1
7591383|NCT01652534|11997548|FG001|Overall Study|Lack of Efficacy|0
7591384|NCT04799405|11997574|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2
7591385|NCT04529499|11997584|FG000|Overall Study|Withdrawal by Subject|9
7591386|NCT04529499|11997585|FG001|Overall Study|Withdrawal by Subject|11
7591387|NCT04529499|11997584|FG000|Overall Study|Physician Decision|1
7591388|NCT04529499|11997585|FG001|Overall Study|Physician Decision|2
7591389|NCT04529499|11997584|FG000|Overall Study|Adverse Event|4
7591390|NCT04529499|11997585|FG001|Overall Study|Adverse Event|4
7591391|NCT04529499|11997584|FG000|Overall Study|Death|14
7591392|NCT04529499|11997585|FG001|Overall Study|Death|11
7591393|NCT04529499|11997584|FG000|Overall Study|Lost to Follow-up|1
7591394|NCT04529499|11997585|FG001|Overall Study|Lost to Follow-up|1
7591395|NCT04529499|11997584|FG000|Overall Study|Others|7
7591396|NCT04529499|11997585|FG001|Overall Study|Others|11
7591397|NCT04501094|11997593|FG000|Overall Study|Death (unrelated to research)|1
7591398|NCT04501094|11997594|FG001|Overall Study|Death (unrelated to research)|0
7627083|NCT03257267|12039458|FG000|Overall Study|Adverse Event|9
7627084|NCT03257267|12039459|FG001|Overall Study|Adverse Event|7
7627085|NCT03257267|12039458|FG000|Overall Study|Death|92
7627086|NCT03257267|12039459|FG001|Overall Study|Death|95
7627087|NCT03257267|12039458|FG000|Overall Study|Lost to Follow-up|2
7627088|NCT03257267|12039459|FG001|Overall Study|Lost to Follow-up|2
7627089|NCT03257267|12039458|FG000|Overall Study|Non-compliance with Study Drug|0
7627090|NCT03257267|12039459|FG001|Overall Study|Non-compliance with Study Drug|1
7627091|NCT03257267|12039458|FG000|Overall Study|Participant Decision|34
7627092|NCT03257267|12039459|FG001|Overall Study|Participant Decision|42
7627093|NCT03257267|12039458|FG000|Overall Study|Physician Decision|1
7627094|NCT03257267|12039459|FG001|Overall Study|Physician Decision|3
7627095|NCT03257267|12039458|FG000|Overall Study|Disease Progression|98
7627096|NCT03257267|12039459|FG001|Overall Study|Disease Progression|117
7627097|NCT03257267|12039458|FG000|Overall Study|Withdrawal of Consent|8
7627098|NCT03257267|12039459|FG001|Overall Study|Withdrawal of Consent|26
7627099|NCT03257267|12039458|FG000|Overall Study|Study Ongoing|53
7627100|NCT03257267|12039459|FG001|Overall Study|Study Ongoing|11
7627101|NCT04223830|12039487|FG000|Overall Study|Lost to Follow-up|9
7627102|NCT04223830|12039487|FG000|Overall Study|Adverse Event|1
7627103|NCT04153188|12039503|FG000|Overall Study|Lost to Follow-up|1
7627104|NCT04153188|12039504|FG001|Overall Study|Lost to Follow-up|1
7627105|NCT04153188|12039503|FG000|Overall Study|Withdrawal by Subject|2
7627106|NCT04153188|12039504|FG001|Overall Study|Withdrawal by Subject|0
7627107|NCT04153188|12039503|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0
7627108|NCT04153188|12039504|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1
7767285|NCT00853099|12209896|FG003|Double-blind + Open-label Periods|Other|6
7767286|NCT00853112|12209913|FG000|Overall Study|Randomized but not treated|0
7767287|NCT00853112|12209914|FG001|Overall Study|Randomized but not treated|1
7767288|NCT00853112|12209915|FG002|Overall Study|Randomized but not treated|0
7767289|NCT00853112|12209916|FG003|Overall Study|Randomized but not treated|2
7767290|NCT00853112|12209917|FG004|Overall Study|Randomized but not treated|0
7767291|NCT00853112|12209918|FG005|Overall Study|Randomized but not treated|0
7767292|NCT00853112|12209919|FG006|Overall Study|Randomized but not treated|1
7767293|NCT00853125|12209935|FG000|Overall Study|Study participant's donor was CMV +|1
7767294|NCT00853151|12209944|FG000|Overall Study|Adverse Event|1
7767295|NCT00853151|12209945|FG001|Overall Study|Adverse Event|4
7767296|NCT00853151|12209946|FG002|Overall Study|Adverse Event|2
7767297|NCT00853151|12209947|FG003|Overall Study|Adverse Event|0
7767298|NCT00853151|12209944|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7767299|NCT00853151|12209945|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7767300|NCT00853151|12209946|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7767301|NCT00853151|12209947|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7767302|NCT00853151|12209944|FG000|Overall Study|Lost to Follow-up|2
7767303|NCT00853151|12209945|FG001|Overall Study|Lost to Follow-up|0
7767304|NCT00853151|12209946|FG002|Overall Study|Lost to Follow-up|3
7767305|NCT00853151|12209947|FG003|Overall Study|Lost to Follow-up|0
7627130|NCT04179786|12039540|FG000|Overall Study|Withdrawal by Subject|8
7627131|NCT04140292|12039546|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4
7627132|NCT04140292|12039547|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16
7767306|NCT00853151|12209944|FG000|Overall Study|Death|1
7767307|NCT00853151|12209945|FG001|Overall Study|Death|0
7767308|NCT00853151|12209946|FG002|Overall Study|Death|0
7767309|NCT00853151|12209947|FG003|Overall Study|Death|1
7767310|NCT00853151|12209944|FG000|Overall Study|Protocol Violation|0
7767311|NCT00853151|12209945|FG001|Overall Study|Protocol Violation|0
7627141|NCT03553836|12039591|FG000|Overall Study|Ongoing in Study|460
7627142|NCT03553836|12039592|FG001|Overall Study|Ongoing in Study|459
7627143|NCT03553836|12039591|FG000|Overall Study|Withdrawal by Subject|9
7627144|NCT03553836|12039592|FG001|Overall Study|Withdrawal by Subject|10
7627145|NCT03553836|12039591|FG000|Overall Study|Lost to Follow-up|1
7627146|NCT03553836|12039592|FG001|Overall Study|Lost to Follow-up|3
7627147|NCT03553836|12039591|FG000|Overall Study|Death|17
7627148|NCT03553836|12039592|FG001|Overall Study|Death|17
7627149|NCT02954237|12039614|FG000|Overall Study|Withdrawal by Subject|25
7627150|NCT02954237|12039614|FG000|Overall Study|Missed visit|16
7627151|NCT02954237|12039614|FG000|Overall Study|Death|2
7627152|NCT02714218|12039630|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0
7627153|NCT02714218|12039631|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1
7627154|NCT02714218|12039632|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0
7627155|NCT02714218|12039630|FG000|Pre-Treatment Period|Other reasons|0
7627156|NCT02714218|12039631|FG001|Pre-Treatment Period|Other reasons|1
7627157|NCT02714218|12039632|FG002|Pre-Treatment Period|Other reasons|0
7627158|NCT02714218|12039630|FG000|Treatment Period|Disease Progression|55
7627159|NCT02714218|12039631|FG001|Treatment Period|Disease Progression|52
7627160|NCT02714218|12039632|FG002|Treatment Period|Disease Progression|14
7627161|NCT02714218|12039630|FG000|Treatment Period|Study drug toxicity|46
7627162|NCT02714218|12039631|FG001|Treatment Period|Study drug toxicity|70
7627163|NCT02714218|12039632|FG002|Treatment Period|Study drug toxicity|6
7591399|NCT04414618|11997602|FG000|Overall Study|Death|3
7591400|NCT04414618|11997603|FG001|Overall Study|Death|3
7591401|NCT04414618|11997602|FG000|Overall Study|Withdrawal by Subject|2
7591402|NCT04414618|11997603|FG001|Overall Study|Withdrawal by Subject|1
7591403|NCT04414618|11997602|FG000|Overall Study|Lost to Follow-up|2
7591404|NCT04414618|11997603|FG001|Overall Study|Lost to Follow-up|3
7591405|NCT04414618|11997602|FG000|Overall Study|Physician Decision|1
7591406|NCT04414618|11997603|FG001|Overall Study|Physician Decision|0
7591407|NCT04412057|11997612|FG000|Overall Study|Death|3
7591408|NCT04412057|11997613|FG001|Overall Study|Death|7
7591409|NCT04412057|11997612|FG000|Overall Study|Discharged prior to receiving study treatment|1
7591410|NCT04412057|11997613|FG001|Overall Study|Discharged prior to receiving study treatment|0
7591411|NCT04402060|11997622|FG000|Overall Study|Death|1
7591412|NCT04402060|11997623|FG001|Overall Study|Death|12
7591413|NCT04402060|11997624|FG002|Overall Study|Death|7
7591414|NCT04402060|11997622|FG000|Overall Study|Adverse Event|0
7591415|NCT04402060|11997623|FG001|Overall Study|Adverse Event|0
7591416|NCT04402060|11997624|FG002|Overall Study|Adverse Event|1
7591417|NCT04402060|11997622|FG000|Overall Study|Withdrawal by Subject|0
7591418|NCT04402060|11997623|FG001|Overall Study|Withdrawal by Subject|1
7591419|NCT04402060|11997624|FG002|Overall Study|Withdrawal by Subject|2
7591420|NCT04402060|11997622|FG000|Overall Study|Sponsor Request|0
7591421|NCT04402060|11997623|FG001|Overall Study|Sponsor Request|2
7591422|NCT04402060|11997624|FG002|Overall Study|Sponsor Request|0
7591423|NCT04402060|11997622|FG000|Overall Study|Physician Decision|0
7591424|NCT04402060|11997623|FG001|Overall Study|Physician Decision|0
7591425|NCT04402060|11997624|FG002|Overall Study|Physician Decision|1
7591426|NCT04402060|11997622|FG000|Overall Study|Other|0
7591427|NCT04402060|11997623|FG001|Overall Study|Other|1
7591428|NCT04402060|11997624|FG002|Overall Study|Other|0
7591429|NCT04396626|11997637|FG000|Overall Study|Premature termination of study|975
7591430|NCT04376684|11997663|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7
7591431|NCT04376684|11997664|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8
7591432|NCT04376684|11997665|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0
7591433|NCT04376684|11997666|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0
7591434|NCT04376684|11997663|FG000|Part 1 (Up to Day 60)|Protocol Violation|2
7591435|NCT04376684|11997664|FG001|Part 1 (Up to Day 60)|Protocol Violation|3
7591436|NCT04376684|11997665|FG002|Part 1 (Up to Day 60)|Protocol Violation|0
7591437|NCT04376684|11997666|FG003|Part 1 (Up to Day 60)|Protocol Violation|0
7591438|NCT04376684|11997663|FG000|Part 1 (Up to Day 60)|Physician Decision|2
7591439|NCT04376684|11997664|FG001|Part 1 (Up to Day 60)|Physician Decision|5
7591440|NCT04376684|11997665|FG002|Part 1 (Up to Day 60)|Physician Decision|0
7591441|NCT04376684|11997666|FG003|Part 1 (Up to Day 60)|Physician Decision|0
7591442|NCT04376684|11997663|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4
7591443|NCT04376684|11997664|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8
7591444|NCT04376684|11997665|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0
7591445|NCT04376684|11997666|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0
7591446|NCT04376684|11997663|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0
7591447|NCT04376684|11997664|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0
7591448|NCT04376684|11997665|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1
7591449|NCT04376684|11997666|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1
7591450|NCT04376684|11997663|FG000|Part 2 (Up to Day 60)|Physician Decision|0
7591451|NCT04376684|11997664|FG001|Part 2 (Up to Day 60)|Physician Decision|0
7591452|NCT04376684|11997665|FG002|Part 2 (Up to Day 60)|Physician Decision|1
7591453|NCT04376684|11997666|FG003|Part 2 (Up to Day 60)|Physician Decision|1
7591454|NCT04376684|11997663|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0
7591455|NCT04376684|11997664|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0
7591456|NCT04376684|11997665|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3
7591457|NCT04376684|11997666|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2
7591458|NCT04353284|11997678|FG000|Overall Study|Adverse Event|1
7591459|NCT04353284|11997679|FG001|Overall Study|Adverse Event|1
7591460|NCT04353284|11997678|FG000|Overall Study|Lost to Follow-up|1
7591461|NCT04353284|11997679|FG001|Overall Study|Lost to Follow-up|0
7591462|NCT04294147|11997687|FG000|Overall Study|Protocol Violation|2
7591463|NCT04294147|11997688|FG001|Overall Study|Protocol Violation|0
7591464|NCT04231825|11997700|FG000|Overall Study|Protocol Violation|3
7591465|NCT04231825|11997701|FG001|Overall Study|Protocol Violation|3
7591466|NCT04231825|11997700|FG000|Overall Study|Lost to Follow-up|0
7591467|NCT04231825|11997701|FG001|Overall Study|Lost to Follow-up|1
7591468|NCT04196686|11997707|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0
7591469|NCT04196686|11997708|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3
7591470|NCT04178772|11997714|FG000|Overall Study|Unsatisfacotry VIsual Response|1
7591471|NCT04178772|11997714|FG000|Overall Study|study terminated early due to COVID-19|7
7591472|NCT04148651|11997718|FG000|Overall Study|Lost to Follow-up|2
7591473|NCT03893448|11997733|FG000|Overall Study|Withdrawal by Parent/Guardian|59
7591474|NCT03893448|11997734|FG001|Overall Study|Withdrawal by Parent/Guardian|85
7591475|NCT03893448|11997733|FG000|Overall Study|Physician Decision|8
7591476|NCT03893448|11997734|FG001|Overall Study|Physician Decision|14
7591477|NCT03893448|11997733|FG000|Overall Study|Lost to Follow-up|34
7591478|NCT03893448|11997734|FG001|Overall Study|Lost to Follow-up|27
7591479|NCT03893448|11997733|FG000|Overall Study|Death|1
7591480|NCT03893448|11997734|FG001|Overall Study|Death|0
7767312|NCT00853151|12209946|FG002|Overall Study|Protocol Violation|0
7767313|NCT00853151|12209947|FG003|Overall Study|Protocol Violation|1
7767314|NCT00853151|12209944|FG000|Overall Study|Withdrawal by Subject|5
7767315|NCT00853151|12209945|FG001|Overall Study|Withdrawal by Subject|4
7767316|NCT00853151|12209946|FG002|Overall Study|Withdrawal by Subject|2
7767317|NCT00853151|12209947|FG003|Overall Study|Withdrawal by Subject|1
7767318|NCT00853151|12209944|FG000|Overall Study|Physician Decision|0
7767319|NCT00853151|12209945|FG001|Overall Study|Physician Decision|2
7767320|NCT00853151|12209946|FG002|Overall Study|Physician Decision|1
7767321|NCT00853151|12209947|FG003|Overall Study|Physician Decision|0
7767322|NCT00853151|12209944|FG000|Overall Study|Sponsor Decision|0
7767323|NCT00853151|12209945|FG001|Overall Study|Sponsor Decision|3
7767324|NCT00853151|12209946|FG002|Overall Study|Sponsor Decision|0
7767325|NCT00853151|12209947|FG003|Overall Study|Sponsor Decision|0
7767326|NCT00853242|12209967|FG000|Overall Study|Adverse Event|0
7767327|NCT00853242|12209968|FG001|Overall Study|Adverse Event|1
7767328|NCT00853242|12209969|FG002|Overall Study|Adverse Event|1
7767329|NCT00853242|12209970|FG003|Overall Study|Adverse Event|0
7767330|NCT00853242|12209971|FG004|Overall Study|Adverse Event|3
7767331|NCT00853242|12209972|FG005|Overall Study|Adverse Event|1
7767332|NCT00853242|12209973|FG006|Overall Study|Adverse Event|1
7767333|NCT00853242|12209967|FG000|Overall Study|Noncompliant|0
7767334|NCT00853242|12209968|FG001|Overall Study|Noncompliant|0
7767335|NCT00853242|12209969|FG002|Overall Study|Noncompliant|0
7767336|NCT00853242|12209970|FG003|Overall Study|Noncompliant|0
7767337|NCT00853242|12209971|FG004|Overall Study|Noncompliant|1
7767338|NCT00853242|12209972|FG005|Overall Study|Noncompliant|0
7767339|NCT00853242|12209973|FG006|Overall Study|Noncompliant|0
7767340|NCT00853242|12209967|FG000|Overall Study|Withdrawal by Subject|1
7767341|NCT00853242|12209968|FG001|Overall Study|Withdrawal by Subject|2
7767342|NCT00853242|12209969|FG002|Overall Study|Withdrawal by Subject|0
7767343|NCT00853242|12209970|FG003|Overall Study|Withdrawal by Subject|4
7767344|NCT00853242|12209971|FG004|Overall Study|Withdrawal by Subject|0
7767345|NCT00853242|12209972|FG005|Overall Study|Withdrawal by Subject|0
7767346|NCT00853242|12209973|FG006|Overall Study|Withdrawal by Subject|2
7767347|NCT00853242|12209967|FG000|Overall Study|Other|2
7767348|NCT00853242|12209968|FG001|Overall Study|Other|0
7767349|NCT00853242|12209969|FG002|Overall Study|Other|2
7767350|NCT00853242|12209970|FG003|Overall Study|Other|0
7767351|NCT00853242|12209971|FG004|Overall Study|Other|0
7767352|NCT00853242|12209972|FG005|Overall Study|Other|1
7767353|NCT00853242|12209973|FG006|Overall Study|Other|2
7767354|NCT00853372|12210010|FG000|Overall Study|Death|30
7767355|NCT00853372|12210011|FG001|Overall Study|Death|26
7767356|NCT00853372|12210010|FG000|Overall Study|Lost to Follow-up|1
7767357|NCT00853372|12210011|FG001|Overall Study|Lost to Follow-up|2
7767358|NCT00853372|12210010|FG000|Overall Study|Full Consent Withdrawn|1
7767359|NCT00853372|12210011|FG001|Overall Study|Full Consent Withdrawn|1
7770309|NCT00875979|12214319|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
7770310|NCT00875979|12214320|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
7770311|NCT00875979|12214319|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
7770312|NCT00875979|12214320|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
7770313|NCT00875979|12214319|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
7770314|NCT00875979|12214320|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
7770315|NCT00875979|12214319|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
7770316|NCT00875979|12214320|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
7770317|NCT00875979|12214319|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0
7770318|NCT00875979|12214320|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1
7770319|NCT00876018|12214329|FG000|Overall Study|Lost to Follow-up|0
7770320|NCT00876018|12214330|FG001|Overall Study|Lost to Follow-up|1
7770321|NCT00876018|12214331|FG002|Overall Study|Lost to Follow-up|1
7770322|NCT00876018|12214329|FG000|Overall Study|Withdrew Consent due to Adverse Event|5
7770323|NCT00876018|12214330|FG001|Overall Study|Withdrew Consent due to Adverse Event|4
7770324|NCT00876018|12214331|FG002|Overall Study|Withdrew Consent due to Adverse Event|2
7770325|NCT00876187|12214346|FG000|Overall Study|Adverse Event|14
7770326|NCT00876187|12214347|FG001|Overall Study|Adverse Event|12
7770327|NCT00876187|12214348|FG002|Overall Study|Adverse Event|19
7770328|NCT00876187|12214349|FG003|Overall Study|Adverse Event|29
7770329|NCT00876187|12214350|FG004|Overall Study|Adverse Event|10
7770330|NCT00876187|12214346|FG000|Overall Study|Lack of Efficacy|59
7770331|NCT00876187|12214347|FG001|Overall Study|Lack of Efficacy|34
7770332|NCT00876187|12214348|FG002|Overall Study|Lack of Efficacy|45
7770333|NCT00876187|12214349|FG003|Overall Study|Lack of Efficacy|34
7770334|NCT00876187|12214350|FG004|Overall Study|Lack of Efficacy|59
7770335|NCT00876187|12214346|FG000|Overall Study|Lost to Follow-up|9
7770336|NCT00876187|12214347|FG001|Overall Study|Lost to Follow-up|10
7770337|NCT00876187|12214348|FG002|Overall Study|Lost to Follow-up|8
7770338|NCT00876187|12214349|FG003|Overall Study|Lost to Follow-up|8
7770339|NCT00876187|12214350|FG004|Overall Study|Lost to Follow-up|11
7770340|NCT00876187|12214346|FG000|Overall Study|Protocol Violation|6
7770341|NCT00876187|12214347|FG001|Overall Study|Protocol Violation|7
7770342|NCT00876187|12214348|FG002|Overall Study|Protocol Violation|7
7770343|NCT00876187|12214349|FG003|Overall Study|Protocol Violation|6
7770344|NCT00876187|12214350|FG004|Overall Study|Protocol Violation|3
7770345|NCT00876187|12214346|FG000|Overall Study|Withdrawal by Subject|16
7770346|NCT00876187|12214347|FG001|Overall Study|Withdrawal by Subject|26
7770347|NCT00876187|12214348|FG002|Overall Study|Withdrawal by Subject|32
7770348|NCT00876187|12214349|FG003|Overall Study|Withdrawal by Subject|38
7770349|NCT00876187|12214350|FG004|Overall Study|Withdrawal by Subject|37
7770350|NCT00876187|12214346|FG000|Overall Study|Entered extension study|101
7770351|NCT00876187|12214347|FG001|Overall Study|Entered extension study|120
7770352|NCT00876187|12214348|FG002|Overall Study|Entered extension study|156
7770353|NCT00876187|12214349|FG003|Overall Study|Entered extension study|151
7770354|NCT00876187|12214350|FG004|Overall Study|Entered extension study|144
7770355|NCT00876187|12214346|FG000|Overall Study|Randomized but not treated|3
7770356|NCT00876187|12214347|FG001|Overall Study|Randomized but not treated|1
7770357|NCT00876187|12214348|FG002|Overall Study|Randomized but not treated|3
7770358|NCT00876187|12214349|FG003|Overall Study|Randomized but not treated|2
7770359|NCT00876187|12214350|FG004|Overall Study|Randomized but not treated|3
7770360|NCT00876187|12214346|FG000|Overall Study|Other|2
7770361|NCT00876187|12214347|FG001|Overall Study|Other|5
7770362|NCT00876187|12214348|FG002|Overall Study|Other|9
7770363|NCT00876187|12214349|FG003|Overall Study|Other|7
7770364|NCT00876187|12214350|FG004|Overall Study|Other|4
7770365|NCT00876265|12214374|FG000|Overall Study|Miscellaneous reasons|4
7770366|NCT00876265|12214374|FG000|Overall Study|Lost to Follow-up|6
7770367|NCT00876265|12214374|FG000|Overall Study|Withdrawal by Subject|2
7770368|NCT00876343|12214383|FG000|Overall Study|Adverse Event|7
7767360|NCT00853385|12210022|FG000|Overall Study|Death|0
7767361|NCT00853385|12210023|FG001|Overall Study|Death|0
7767362|NCT00853385|12210024|FG002|Overall Study|Death|0
7767363|NCT00853385|12210025|FG003|Overall Study|Death|0
7767364|NCT00853385|12210026|FG004|Overall Study|Death|1
7767365|NCT00853385|12210022|FG000|Overall Study|Adverse Event|24
7767366|NCT00853385|12210023|FG001|Overall Study|Adverse Event|24
7767367|NCT00853385|12210024|FG002|Overall Study|Adverse Event|2
7767368|NCT00853385|12210025|FG003|Overall Study|Adverse Event|5
7767369|NCT00853385|12210026|FG004|Overall Study|Adverse Event|22
7767370|NCT00853385|12210022|FG000|Overall Study|Lack of Efficacy|6
7767371|NCT00853385|12210023|FG001|Overall Study|Lack of Efficacy|7
7767372|NCT00853385|12210024|FG002|Overall Study|Lack of Efficacy|3
7767373|NCT00853385|12210025|FG003|Overall Study|Lack of Efficacy|3
7767374|NCT00853385|12210026|FG004|Overall Study|Lack of Efficacy|6
7767375|NCT00853385|12210022|FG000|Overall Study|Lost to Follow-up|2
7767376|NCT00853385|12210023|FG001|Overall Study|Lost to Follow-up|1
7767377|NCT00853385|12210024|FG002|Overall Study|Lost to Follow-up|0
7767378|NCT00853385|12210025|FG003|Overall Study|Lost to Follow-up|0
7767379|NCT00853385|12210026|FG004|Overall Study|Lost to Follow-up|0
7767380|NCT00853385|12210022|FG000|Overall Study|Withdrawal by Subject|4
7767381|NCT00853385|12210023|FG001|Overall Study|Withdrawal by Subject|2
7767382|NCT00853385|12210024|FG002|Overall Study|Withdrawal by Subject|0
7767383|NCT00853385|12210025|FG003|Overall Study|Withdrawal by Subject|1
7767384|NCT00853385|12210026|FG004|Overall Study|Withdrawal by Subject|1
7767385|NCT00853385|12210022|FG000|Overall Study|Other|18
7767386|NCT00853385|12210023|FG001|Overall Study|Other|9
7767387|NCT00853385|12210024|FG002|Overall Study|Other|4
7767388|NCT00853385|12210025|FG003|Overall Study|Other|4
7767389|NCT00853385|12210026|FG004|Overall Study|Other|12
7767390|NCT00853489|12210050|FG000|Overall Study|Lost to Follow-up|5
7767391|NCT00853489|12210051|FG001|Overall Study|Lost to Follow-up|2
7767392|NCT00853580|12210059|FG000|Overall Study|Lost to Follow-up|3
7767393|NCT00853580|12210060|FG001|Overall Study|Lost to Follow-up|5
7767394|NCT00853580|12210059|FG000|Overall Study|Protocol Violation|2
7767395|NCT00853580|12210060|FG001|Overall Study|Protocol Violation|1
7767396|NCT00853580|12210059|FG000|Overall Study|Withdrawal by Subject|2
7767397|NCT00853580|12210060|FG001|Overall Study|Withdrawal by Subject|8
7767398|NCT00853580|12210059|FG000|Overall Study|Commenced contraindicated therapy|0
7767399|NCT00853580|12210060|FG001|Overall Study|Commenced contraindicated therapy|2
7767400|NCT00853593|12210066|FG000|Overall Study|Subjects did not receive a 4396 lead|12
7767401|NCT00853593|12210066|FG000|Overall Study|Model 4396 lead not attempted|29
7767402|NCT00853593|12210066|FG000|Overall Study|Implant not attempted|4
7767403|NCT00853658|12210098|FG000|Overall Study|Death|713
7767404|NCT00853658|12210099|FG001|Overall Study|Death|768
7767405|NCT00853658|12210100|FG002|Overall Study|Death|753
7767406|NCT00853658|12210098|FG000|Overall Study|Lost to Follow-up|11
7767407|NCT00853658|12210099|FG001|Overall Study|Lost to Follow-up|6
7767408|NCT00853658|12210100|FG002|Overall Study|Lost to Follow-up|11
7767409|NCT00853658|12210098|FG000|Overall Study|H.A. Request|26
7767410|NCT00853658|12210099|FG001|Overall Study|H.A. Request|23
7767411|NCT00853658|12210100|FG002|Overall Study|H.A. Request|19
7767412|NCT00853658|12210098|FG000|Overall Study|IRB request|0
7767413|NCT00853658|12210099|FG001|Overall Study|IRB request|0
7767414|NCT00853658|12210100|FG002|Overall Study|IRB request|2
7767415|NCT00853658|12210098|FG000|Overall Study|Vital Status known (alive) at study end|2
7591565|NCT03811574|11997845|FG000|Overall Study|Withdrawal by Subject|2
7591566|NCT03811574|11997846|FG001|Overall Study|Withdrawal by Subject|4
7591567|NCT03811574|11997847|FG002|Overall Study|Withdrawal by Subject|0
7627164|NCT02714218|12039630|FG000|Treatment Period|Adverse event unrelated to study drug|13
7627165|NCT02714218|12039631|FG001|Treatment Period|Adverse event unrelated to study drug|6
7627166|NCT02714218|12039632|FG002|Treatment Period|Adverse event unrelated to study drug|1
7627167|NCT02714218|12039630|FG000|Treatment Period|Request to discontinue treatment|1
7627168|NCT02714218|12039631|FG001|Treatment Period|Request to discontinue treatment|4
7627169|NCT02714218|12039632|FG002|Treatment Period|Request to discontinue treatment|1
7627170|NCT02714218|12039630|FG000|Treatment Period|Participant withdrew consent|2
7627171|NCT02714218|12039631|FG001|Treatment Period|Participant withdrew consent|2
7627172|NCT02714218|12039632|FG002|Treatment Period|Participant withdrew consent|0
7627173|NCT02714218|12039630|FG000|Treatment Period|Maximum clinical benefit|4
7627174|NCT02714218|12039631|FG001|Treatment Period|Maximum clinical benefit|2
7627175|NCT02714218|12039632|FG002|Treatment Period|Maximum clinical benefit|0
7627176|NCT02714218|12039630|FG000|Treatment Period|Administrative reason by sponsor|2
7627177|NCT02714218|12039631|FG001|Treatment Period|Administrative reason by sponsor|1
7627178|NCT02714218|12039632|FG002|Treatment Period|Administrative reason by sponsor|0
7627179|NCT02714218|12039630|FG000|Treatment Period|Other reasons|6
7627180|NCT02714218|12039631|FG001|Treatment Period|Other reasons|6
7627181|NCT02714218|12039632|FG002|Treatment Period|Other reasons|0
7627182|NCT02714218|12039630|FG000|Treatment Period|Completed treatment as per protocol|36
7627183|NCT02714218|12039631|FG001|Treatment Period|Completed treatment as per protocol|27
7627184|NCT02714218|12039632|FG002|Treatment Period|Completed treatment as per protocol|3
7627185|NCT02714218|12039630|FG000|Treatment Period|Not reported|9
7767416|NCT00853658|12210099|FG001|Overall Study|Vital Status known (alive) at study end|3
7767417|NCT00853658|12210100|FG002|Overall Study|Vital Status known (alive) at study end|3
7767418|NCT00853658|12210098|FG000|Overall Study|Vital Status unknown at study end|1
7767419|NCT00853658|12210099|FG001|Overall Study|Vital Status unknown at study end|1
7767420|NCT00853658|12210100|FG002|Overall Study|Vital Status unknown at study end|0
7767421|NCT00853658|12210098|FG000|Overall Study|Vital Status at study end N/A|8
7767422|NCT00853658|12210099|FG001|Overall Study|Vital Status at study end N/A|10
7767423|NCT00853658|12210100|FG002|Overall Study|Vital Status at study end N/A|10
7767424|NCT00853658|12210098|FG000|Overall Study|Patient's request|21
7767425|NCT00853658|12210099|FG001|Overall Study|Patient's request|17
7767426|NCT00853658|12210100|FG002|Overall Study|Patient's request|11
7767427|NCT00853658|12210098|FG000|Overall Study|Missing study completion information|5
7767428|NCT00853658|12210099|FG001|Overall Study|Missing study completion information|4
7767429|NCT00853658|12210100|FG002|Overall Study|Missing study completion information|6
7767430|NCT00853723|12210115|FG000|Overall Study|Adverse Event|3
7767431|NCT00853723|12210116|FG001|Overall Study|Adverse Event|4
7767432|NCT00853723|12210117|FG002|Overall Study|Adverse Event|1
7767433|NCT00853723|12210115|FG000|Overall Study|Withdrawal by Subject|2
7767434|NCT00853723|12210116|FG001|Overall Study|Withdrawal by Subject|1
7767435|NCT00853723|12210117|FG002|Overall Study|Withdrawal by Subject|0
7767436|NCT00853723|12210115|FG000|Overall Study|Protocol Violation|1
7767437|NCT00853723|12210116|FG001|Overall Study|Protocol Violation|2
7767438|NCT00853723|12210117|FG002|Overall Study|Protocol Violation|1
7767439|NCT00853749|12210130|FG000|Overall Study|Lost to Follow-up|0
7767440|NCT00853749|12210131|FG001|Overall Study|Lost to Follow-up|1
7767441|NCT00853762|12210141|FG000|Overall Study|Premature Termination|16
7767442|NCT00853762|12210142|FG001|Overall Study|Premature Termination|15
7767443|NCT00853762|12210143|FG002|Overall Study|Premature Termination|14
7767444|NCT00853762|12210144|FG003|Overall Study|Premature Termination|21
7591568|NCT03727750|11997883|FG000|Overall Study|Death|45
7591569|NCT03727750|11997883|FG000|Overall Study|Withdrawal by Subject|2
7591570|NCT03727750|11997883|FG000|Overall Study|Lost to Follow-up|1
7591571|NCT03727750|11997883|FG000|Overall Study|Other|1
7591572|NCT03715829|11997893|FG000|Dose Ranging Period|Adverse Event|2
7591573|NCT03715829|11997894|FG001|Dose Ranging Period|Adverse Event|4
7591574|NCT03715829|11997895|FG002|Dose Ranging Period|Adverse Event|5
7591575|NCT03715829|11997896|FG003|Dose Ranging Period|Adverse Event|2
7591576|NCT03715829|11997897|FG004|Dose Ranging Period|Adverse Event|3
7591577|NCT03715829|11997898|FG005|Dose Ranging Period|Adverse Event|3
7591578|NCT03715829|11997899|FG006|Dose Ranging Period|Adverse Event|0
7591579|NCT03715829|11997900|FG007|Dose Ranging Period|Adverse Event|0
7591580|NCT03715829|11997901|FG008|Dose Ranging Period|Adverse Event|0
7591581|NCT03715829|11997902|FG009|Dose Ranging Period|Adverse Event|0
7591582|NCT03715829|11997903|FG010|Dose Ranging Period|Adverse Event|0
7591583|NCT03715829|11997893|FG000|Dose Ranging Period|Lack of Efficacy|0
7591584|NCT03715829|11997894|FG001|Dose Ranging Period|Lack of Efficacy|1
7591585|NCT03715829|11997895|FG002|Dose Ranging Period|Lack of Efficacy|0
7591586|NCT03715829|11997896|FG003|Dose Ranging Period|Lack of Efficacy|1
7591587|NCT03715829|11997897|FG004|Dose Ranging Period|Lack of Efficacy|0
7591588|NCT03715829|11997898|FG005|Dose Ranging Period|Lack of Efficacy|0
7591589|NCT03715829|11997899|FG006|Dose Ranging Period|Lack of Efficacy|0
7591590|NCT03715829|11997900|FG007|Dose Ranging Period|Lack of Efficacy|0
7591591|NCT03715829|11997901|FG008|Dose Ranging Period|Lack of Efficacy|0
7591592|NCT03715829|11997902|FG009|Dose Ranging Period|Lack of Efficacy|0
7591593|NCT03715829|11997903|FG010|Dose Ranging Period|Lack of Efficacy|0
7591594|NCT03715829|11997893|FG000|Dose Ranging Period|Lost to Follow-up|2
7591595|NCT03715829|11997894|FG001|Dose Ranging Period|Lost to Follow-up|0
7591596|NCT03715829|11997895|FG002|Dose Ranging Period|Lost to Follow-up|1
7591597|NCT03715829|11997896|FG003|Dose Ranging Period|Lost to Follow-up|1
7591598|NCT03715829|11997897|FG004|Dose Ranging Period|Lost to Follow-up|1
7591599|NCT03715829|11997898|FG005|Dose Ranging Period|Lost to Follow-up|2
7591600|NCT03715829|11997899|FG006|Dose Ranging Period|Lost to Follow-up|0
7591601|NCT03715829|11997900|FG007|Dose Ranging Period|Lost to Follow-up|0
7591602|NCT03715829|11997901|FG008|Dose Ranging Period|Lost to Follow-up|0
7591603|NCT03715829|11997902|FG009|Dose Ranging Period|Lost to Follow-up|0
7591604|NCT03715829|11997903|FG010|Dose Ranging Period|Lost to Follow-up|0
7591605|NCT03715829|11997893|FG000|Dose Ranging Period|Protocol Violation|0
7591606|NCT03715829|11997894|FG001|Dose Ranging Period|Protocol Violation|0
7591607|NCT03715829|11997895|FG002|Dose Ranging Period|Protocol Violation|0
7591608|NCT03715829|11997896|FG003|Dose Ranging Period|Protocol Violation|1
7591609|NCT03715829|11997897|FG004|Dose Ranging Period|Protocol Violation|0
7591610|NCT03715829|11997898|FG005|Dose Ranging Period|Protocol Violation|0
7591611|NCT03715829|11997899|FG006|Dose Ranging Period|Protocol Violation|0
7591612|NCT03715829|11997900|FG007|Dose Ranging Period|Protocol Violation|0
7591613|NCT03715829|11997901|FG008|Dose Ranging Period|Protocol Violation|0
7591614|NCT03715829|11997902|FG009|Dose Ranging Period|Protocol Violation|0
7591615|NCT03715829|11997903|FG010|Dose Ranging Period|Protocol Violation|0
7591616|NCT03715829|11997893|FG000|Dose Ranging Period|Withdrawal by Subject|8
7767445|NCT00853762|12210141|FG000|Overall Study|Protocol Violation|0
7767446|NCT00853762|12210142|FG001|Overall Study|Protocol Violation|0
7767447|NCT00853762|12210143|FG002|Overall Study|Protocol Violation|0
7767448|NCT00853762|12210144|FG003|Overall Study|Protocol Violation|1
7767449|NCT00853762|12210141|FG000|Overall Study|Withdrawal by Subject|0
7767450|NCT00853762|12210142|FG001|Overall Study|Withdrawal by Subject|0
7767451|NCT00853762|12210143|FG002|Overall Study|Withdrawal by Subject|1
7767452|NCT00853762|12210144|FG003|Overall Study|Withdrawal by Subject|0
7767453|NCT00853762|12210141|FG000|Overall Study|Other|0
7767454|NCT00853762|12210142|FG001|Overall Study|Other|2
7767455|NCT00853762|12210143|FG002|Overall Study|Other|0
7767456|NCT00853762|12210144|FG003|Overall Study|Other|0
7767457|NCT00853762|12210141|FG000|Overall Study|Randomised but not Treated|0
7767458|NCT00853762|12210142|FG001|Overall Study|Randomised but not Treated|2
7767459|NCT00853762|12210143|FG002|Overall Study|Randomised but not Treated|2
7767460|NCT00853762|12210144|FG003|Overall Study|Randomised but not Treated|0
7767461|NCT00853827|12210156|FG000|Single Blind Period (1 Week)|Other|4
7767462|NCT00853827|12210157|FG001|Single Blind Period (1 Week)|Other|0
7767463|NCT00853827|12210156|FG000|Single Blind Period (1 Week)|Adverse Event|9
7767464|NCT00853827|12210157|FG001|Single Blind Period (1 Week)|Adverse Event|0
7767465|NCT00853827|12210156|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3
7767466|NCT00853827|12210157|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0
7767467|NCT00853827|12210156|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1
7767468|NCT00853827|12210157|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0
7767469|NCT00853827|12210156|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9
7767470|NCT00853827|12210157|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0
7767471|NCT00853827|12210156|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1
7767472|NCT00853827|12210157|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0
7767473|NCT00853827|12210156|FG000|Single Blind Period (1 Week)|Protocol Violation|12
7767474|NCT00853827|12210157|FG001|Single Blind Period (1 Week)|Protocol Violation|0
7767475|NCT00853827|12210156|FG000|Double Blind Period (103 Weeks)|Adverse Event|25
7767476|NCT00853827|12210157|FG001|Double Blind Period (103 Weeks)|Adverse Event|14
7767477|NCT00853827|12210156|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
7767478|NCT00853827|12210157|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
7767479|NCT00853827|12210156|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1
7767480|NCT00853827|12210157|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0
7767481|NCT00853827|12210156|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3
7767482|NCT00853827|12210157|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1
7767483|NCT00853827|12210156|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2
7767484|NCT00853827|12210157|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1
7767485|NCT00853827|12210156|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
7767486|NCT00853827|12210157|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
7767487|NCT00853827|12210156|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8
7767488|NCT00853827|12210157|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10
7767489|NCT00853827|12210156|FG000|Double Blind Period (103 Weeks)|Administrative problems|45
7767490|NCT00853827|12210157|FG001|Double Blind Period (103 Weeks)|Administrative problems|56
7767491|NCT00853827|12210156|FG000|Double Blind Period (103 Weeks)|Death|1
7767492|NCT00853827|12210157|FG001|Double Blind Period (103 Weeks)|Death|6
7767493|NCT00853905|12210173|FG000|Overall Study|Lost to Follow-up|1
7767494|NCT00853905|12210174|FG001|Overall Study|Lost to Follow-up|3
7767495|NCT00853905|12210173|FG000|Overall Study|Withdrawal by Subject|0
7767496|NCT00853905|12210174|FG001|Overall Study|Withdrawal by Subject|1
7767497|NCT00853905|12210173|FG000|Overall Study|never had surgery|1
7767498|NCT00853905|12210174|FG001|Overall Study|never had surgery|0
7767499|NCT00853957|12210185|FG000|Overall Study|Adverse Event|9
7767500|NCT00853957|12210186|FG001|Overall Study|Adverse Event|3
7767501|NCT00853957|12210185|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7767502|NCT00853957|12210186|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7767503|NCT00853957|12210185|FG000|Overall Study|Subject withdrew consent|4
7767504|NCT00853957|12210186|FG001|Overall Study|Subject withdrew consent|5
7767505|NCT00853957|12210185|FG000|Overall Study|Lost to Follow-up|1
7767506|NCT00853957|12210186|FG001|Overall Study|Lost to Follow-up|6
7591617|NCT03715829|11997894|FG001|Dose Ranging Period|Withdrawal by Subject|4
7591618|NCT03715829|11997895|FG002|Dose Ranging Period|Withdrawal by Subject|3
7591619|NCT03715829|11997896|FG003|Dose Ranging Period|Withdrawal by Subject|9
7591620|NCT03715829|11997897|FG004|Dose Ranging Period|Withdrawal by Subject|2
7591621|NCT03715829|11997898|FG005|Dose Ranging Period|Withdrawal by Subject|3
7591622|NCT03715829|11997899|FG006|Dose Ranging Period|Withdrawal by Subject|0
7591623|NCT03715829|11997900|FG007|Dose Ranging Period|Withdrawal by Subject|0
7591624|NCT03715829|11997901|FG008|Dose Ranging Period|Withdrawal by Subject|0
7591625|NCT03715829|11997902|FG009|Dose Ranging Period|Withdrawal by Subject|0
7591626|NCT03715829|11997903|FG010|Dose Ranging Period|Withdrawal by Subject|0
7591627|NCT03715829|11997893|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591628|NCT03715829|11997894|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591629|NCT03715829|11997895|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1
7591630|NCT03715829|11997896|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591631|NCT03715829|11997897|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591632|NCT03715829|11997898|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591633|NCT03715829|11997899|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591634|NCT03715829|11997900|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591635|NCT03715829|11997901|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591636|NCT03715829|11997902|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591832|NCT03387150|11998110|FG005|Overall Study|Withdrawal by Subject|2
7591637|NCT03715829|11997903|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591638|NCT03715829|11997893|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591639|NCT03715829|11997894|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591640|NCT03715829|11997895|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1
7591641|NCT03715829|11997896|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591642|NCT03715829|11997897|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1
7591643|NCT03715829|11997898|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591644|NCT03715829|11997899|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591645|NCT03715829|11997900|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591646|NCT03715829|11997901|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591647|NCT03715829|11997902|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591648|NCT03715829|11997903|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591649|NCT03715829|11997893|FG000|Dose Ranging Period|Other|0
7591650|NCT03715829|11997894|FG001|Dose Ranging Period|Other|0
7591651|NCT03715829|11997895|FG002|Dose Ranging Period|Other|2
7591652|NCT03715829|11997896|FG003|Dose Ranging Period|Other|0
7591653|NCT03715829|11997897|FG004|Dose Ranging Period|Other|0
7591654|NCT03715829|11997898|FG005|Dose Ranging Period|Other|3
7591655|NCT03715829|11997899|FG006|Dose Ranging Period|Other|0
7591656|NCT03715829|11997900|FG007|Dose Ranging Period|Other|0
7591657|NCT03715829|11997901|FG008|Dose Ranging Period|Other|0
7591658|NCT03715829|11997902|FG009|Dose Ranging Period|Other|0
7591659|NCT03715829|11997903|FG010|Dose Ranging Period|Other|0
7591660|NCT03715829|11997893|FG000|Extension Period|Adverse Event|0
7591661|NCT03715829|11997894|FG001|Extension Period|Adverse Event|0
7591662|NCT03715829|11997895|FG002|Extension Period|Adverse Event|0
7591663|NCT03715829|11997896|FG003|Extension Period|Adverse Event|0
7591664|NCT03715829|11997897|FG004|Extension Period|Adverse Event|0
7591665|NCT03715829|11997898|FG005|Extension Period|Adverse Event|0
7591666|NCT03715829|11997899|FG006|Extension Period|Adverse Event|3
7591667|NCT03715829|11997900|FG007|Extension Period|Adverse Event|1
7591668|NCT03715829|11997901|FG008|Extension Period|Adverse Event|6
7591669|NCT03715829|11997902|FG009|Extension Period|Adverse Event|0
7591670|NCT03715829|11997903|FG010|Extension Period|Adverse Event|0
7591671|NCT03715829|11997893|FG000|Extension Period|Lack of Efficacy|0
7591672|NCT03715829|11997894|FG001|Extension Period|Lack of Efficacy|0
7591673|NCT03715829|11997895|FG002|Extension Period|Lack of Efficacy|0
7591674|NCT03715829|11997896|FG003|Extension Period|Lack of Efficacy|0
7591675|NCT03715829|11997897|FG004|Extension Period|Lack of Efficacy|0
7591676|NCT03715829|11997898|FG005|Extension Period|Lack of Efficacy|0
7591677|NCT03715829|11997899|FG006|Extension Period|Lack of Efficacy|1
7591678|NCT03715829|11997900|FG007|Extension Period|Lack of Efficacy|9
7591679|NCT03715829|11997901|FG008|Extension Period|Lack of Efficacy|2
7591680|NCT03715829|11997902|FG009|Extension Period|Lack of Efficacy|0
7591681|NCT03715829|11997903|FG010|Extension Period|Lack of Efficacy|0
7591682|NCT03715829|11997893|FG000|Extension Period|Lost to Follow-up|0
7591683|NCT03715829|11997894|FG001|Extension Period|Lost to Follow-up|0
7767507|NCT00853957|12210185|FG000|Overall Study|Protocol deviation|0
7767508|NCT00853957|12210186|FG001|Overall Study|Protocol deviation|3
7591684|NCT03715829|11997895|FG002|Extension Period|Lost to Follow-up|0
7591685|NCT03715829|11997896|FG003|Extension Period|Lost to Follow-up|0
7591686|NCT03715829|11997897|FG004|Extension Period|Lost to Follow-up|0
7591687|NCT03715829|11997898|FG005|Extension Period|Lost to Follow-up|0
7591688|NCT03715829|11997899|FG006|Extension Period|Lost to Follow-up|0
7591689|NCT03715829|11997900|FG007|Extension Period|Lost to Follow-up|0
7591690|NCT03715829|11997901|FG008|Extension Period|Lost to Follow-up|2
7591691|NCT03715829|11997902|FG009|Extension Period|Lost to Follow-up|0
7591692|NCT03715829|11997903|FG010|Extension Period|Lost to Follow-up|0
7591693|NCT03715829|11997893|FG000|Extension Period|Protocol Violation|0
7591694|NCT03715829|11997894|FG001|Extension Period|Protocol Violation|0
7591695|NCT03715829|11997895|FG002|Extension Period|Protocol Violation|0
7591696|NCT03715829|11997896|FG003|Extension Period|Protocol Violation|0
7591697|NCT03715829|11997897|FG004|Extension Period|Protocol Violation|0
7591698|NCT03715829|11997898|FG005|Extension Period|Protocol Violation|0
7591699|NCT03715829|11997899|FG006|Extension Period|Protocol Violation|0
7591700|NCT03715829|11997900|FG007|Extension Period|Protocol Violation|0
7591701|NCT03715829|11997901|FG008|Extension Period|Protocol Violation|1
7591702|NCT03715829|11997902|FG009|Extension Period|Protocol Violation|0
7591703|NCT03715829|11997903|FG010|Extension Period|Protocol Violation|0
7591704|NCT03715829|11997893|FG000|Extension Period|Withdrawal by Subject|0
7591705|NCT03715829|11997894|FG001|Extension Period|Withdrawal by Subject|0
7591706|NCT03715829|11997895|FG002|Extension Period|Withdrawal by Subject|0
7591707|NCT03715829|11997896|FG003|Extension Period|Withdrawal by Subject|0
7591708|NCT03715829|11997897|FG004|Extension Period|Withdrawal by Subject|0
7591709|NCT03715829|11997898|FG005|Extension Period|Withdrawal by Subject|0
7591710|NCT03715829|11997899|FG006|Extension Period|Withdrawal by Subject|3
7591711|NCT03715829|11997900|FG007|Extension Period|Withdrawal by Subject|3
7591712|NCT03715829|11997901|FG008|Extension Period|Withdrawal by Subject|12
7591713|NCT03715829|11997902|FG009|Extension Period|Withdrawal by Subject|3
7591714|NCT03715829|11997903|FG010|Extension Period|Withdrawal by Subject|0
7591715|NCT03715829|11997893|FG000|Extension Period|Medication Error Without Associated Adverse Event|0
7591716|NCT03715829|11997894|FG001|Extension Period|Medication Error Without Associated Adverse Event|0
7591717|NCT03715829|11997895|FG002|Extension Period|Medication Error Without Associated Adverse Event|0
7591718|NCT03715829|11997896|FG003|Extension Period|Medication Error Without Associated Adverse Event|0
7591719|NCT03715829|11997897|FG004|Extension Period|Medication Error Without Associated Adverse Event|0
7591720|NCT03715829|11997898|FG005|Extension Period|Medication Error Without Associated Adverse Event|0
7591721|NCT03715829|11997899|FG006|Extension Period|Medication Error Without Associated Adverse Event|0
7591722|NCT03715829|11997900|FG007|Extension Period|Medication Error Without Associated Adverse Event|1
7591723|NCT03715829|11997901|FG008|Extension Period|Medication Error Without Associated Adverse Event|1
7591724|NCT03715829|11997902|FG009|Extension Period|Medication Error Without Associated Adverse Event|0
7591725|NCT03715829|11997903|FG010|Extension Period|Medication Error Without Associated Adverse Event|0
7591726|NCT03715829|11997893|FG000|Extension Period|No Longer Meets Eligibility Criteria|0
7591727|NCT03715829|11997894|FG001|Extension Period|No Longer Meets Eligibility Criteria|0
7591728|NCT03715829|11997895|FG002|Extension Period|No Longer Meets Eligibility Criteria|0
7591729|NCT03715829|11997896|FG003|Extension Period|No Longer Meets Eligibility Criteria|0
7591730|NCT03715829|11997897|FG004|Extension Period|No Longer Meets Eligibility Criteria|0
7591731|NCT03715829|11997898|FG005|Extension Period|No Longer Meets Eligibility Criteria|0
7591732|NCT03715829|11997899|FG006|Extension Period|No Longer Meets Eligibility Criteria|0
7591733|NCT03715829|11997900|FG007|Extension Period|No Longer Meets Eligibility Criteria|0
7591734|NCT03715829|11997901|FG008|Extension Period|No Longer Meets Eligibility Criteria|1
7591735|NCT03715829|11997902|FG009|Extension Period|No Longer Meets Eligibility Criteria|0
7591736|NCT03715829|11997903|FG010|Extension Period|No Longer Meets Eligibility Criteria|0
7591737|NCT03715829|11997893|FG000|Extension Period|Other|0
7591738|NCT03715829|11997894|FG001|Extension Period|Other|0
7591739|NCT03715829|11997895|FG002|Extension Period|Other|0
7591740|NCT03715829|11997896|FG003|Extension Period|Other|0
7591741|NCT03715829|11997897|FG004|Extension Period|Other|0
7591742|NCT03715829|11997898|FG005|Extension Period|Other|0
7591743|NCT03715829|11997899|FG006|Extension Period|Other|1
7591744|NCT03715829|11997900|FG007|Extension Period|Other|2
7591745|NCT03715829|11997901|FG008|Extension Period|Other|4
7591746|NCT03715829|11997902|FG009|Extension Period|Other|0
7591747|NCT03715829|11997903|FG010|Extension Period|Other|0
7591748|NCT03693430|11997931|FG000|Overall Study|Lost to Follow-up|3
7591749|NCT03693430|11997932|FG001|Overall Study|Lost to Follow-up|14
7591750|NCT03693430|11997931|FG000|Overall Study|Death|1
7591751|NCT03693430|11997932|FG001|Overall Study|Death|0
7591752|NCT03693430|11997931|FG000|Overall Study|Withdrawal by Subject|0
7591753|NCT03693430|11997932|FG001|Overall Study|Withdrawal by Subject|4
7591754|NCT03677934|11997940|FG000|Overall Study|Study is ongoing|240
7591755|NCT03677934|11997941|FG001|Overall Study|Study is ongoing|161
7591756|NCT03677934|11997940|FG000|Overall Study|Adverse Event|5
7591757|NCT03677934|11997941|FG001|Overall Study|Adverse Event|0
7591758|NCT03677934|11997940|FG000|Overall Study|Death|2
7591759|NCT03677934|11997941|FG001|Overall Study|Death|0
7591760|NCT03677934|11997940|FG000|Overall Study|Withdrawal by Subject|0
7591761|NCT03677934|11997941|FG001|Overall Study|Withdrawal by Subject|5
7591762|NCT03677934|11997940|FG000|Overall Study|Physician Decision|0
7591763|NCT03677934|11997941|FG001|Overall Study|Physician Decision|1
7591764|NCT03677934|11997940|FG000|Overall Study|Damaged implant (no associated AE reported)|1
7591765|NCT03677934|11997941|FG001|Overall Study|Damaged implant (no associated AE reported)|0
7627186|NCT02714218|12039631|FG001|Treatment Period|Not reported|6
7627187|NCT02714218|12039632|FG002|Treatment Period|Not reported|0
7767509|NCT00853970|12210194|FG000|Overall Study|Withdrawal by Subject|2
7767510|NCT00853970|12210195|FG001|Overall Study|Withdrawal by Subject|1
7767511|NCT00853970|12210194|FG000|Overall Study|Cancelled surgery|4
7767512|NCT00853970|12210195|FG001|Overall Study|Cancelled surgery|2
7767513|NCT00854100|12210223|FG000|Overall Study|Inability to complete the study visits|0
7767514|NCT00854100|12210224|FG001|Overall Study|Inability to complete the study visits|0
7767515|NCT00854100|12210225|FG002|Overall Study|Inability to complete the study visits|1
7767516|NCT00854100|12210223|FG000|Overall Study|Lost to Follow-up|2
7767517|NCT00854100|12210224|FG001|Overall Study|Lost to Follow-up|0
7767518|NCT00854100|12210225|FG002|Overall Study|Lost to Follow-up|3
7767519|NCT00854100|12210223|FG000|Overall Study|Withdrawal by Subject|3
7767520|NCT00854100|12210224|FG001|Overall Study|Withdrawal by Subject|1
7767521|NCT00854100|12210225|FG002|Overall Study|Withdrawal by Subject|2
7767522|NCT00854100|12210223|FG000|Overall Study|Protocol Violation|2
7767523|NCT00854100|12210224|FG001|Overall Study|Protocol Violation|4
7767524|NCT00854100|12210225|FG002|Overall Study|Protocol Violation|3
7767525|NCT00854100|12210223|FG000|Overall Study|Adverse Event|2
7767526|NCT00854100|12210224|FG001|Overall Study|Adverse Event|1
7767527|NCT00854100|12210225|FG002|Overall Study|Adverse Event|2
7767528|NCT00854113|12210245|FG000|Overall Study|Adverse Event|0
7767529|NCT00854113|12210246|FG001|Overall Study|Adverse Event|0
7767530|NCT00854113|12210247|FG002|Overall Study|Adverse Event|0
7767531|NCT00854113|12210248|FG003|Overall Study|Adverse Event|0
7767532|NCT00854113|12210249|FG004|Overall Study|Adverse Event|0
7767533|NCT00854113|12210250|FG005|Overall Study|Adverse Event|0
7767534|NCT00854113|12210251|FG006|Overall Study|Adverse Event|0
7767535|NCT00854113|12210252|FG007|Overall Study|Adverse Event|2
7767536|NCT00854113|12210253|FG008|Overall Study|Adverse Event|0
7767537|NCT00854113|12210254|FG009|Overall Study|Adverse Event|0
7767538|NCT00854113|12210255|FG010|Overall Study|Adverse Event|0
7767539|NCT00854113|12210245|FG000|Overall Study|Withdrawal by Subject|0
7767540|NCT00854113|12210246|FG001|Overall Study|Withdrawal by Subject|0
7767541|NCT00854113|12210247|FG002|Overall Study|Withdrawal by Subject|0
7767542|NCT00854113|12210248|FG003|Overall Study|Withdrawal by Subject|0
7627216|NCT02652949|12039649|FG000|30-Day Follow-up for Primary Endpoint|Death|1
7627217|NCT02652949|12039649|FG000|30-Day Follow-up for Secondary Endpoint|Death|1
7627218|NCT02652949|12039649|FG000|6-Month Follow-up Secondary Endpoint|Death|5
7627219|NCT02652949|12039649|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2
7627220|NCT02652949|12039649|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1
7591766|NCT03575104|11997983|FG000|Overall Study|Adverse Event|4
7591767|NCT03575104|11997984|FG001|Overall Study|Adverse Event|3
7591768|NCT03575104|11997985|FG002|Overall Study|Adverse Event|4
7591769|NCT03575104|11997983|FG000|Overall Study|Withdrawal by Subject|13
7591770|NCT03575104|11997984|FG001|Overall Study|Withdrawal by Subject|16
7591771|NCT03575104|11997985|FG002|Overall Study|Withdrawal by Subject|11
7591772|NCT03575104|11997983|FG000|Overall Study|Other reasons|6
7591773|NCT03575104|11997984|FG001|Overall Study|Other reasons|8
7591774|NCT03575104|11997985|FG002|Overall Study|Other reasons|6
7591775|NCT03575104|11997983|FG000|Overall Study|Lost to Follow-up|1
7591776|NCT03575104|11997984|FG001|Overall Study|Lost to Follow-up|2
7591777|NCT03575104|11997985|FG002|Overall Study|Lost to Follow-up|1
7591778|NCT03569475|11997996|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
7591779|NCT03569475|11997997|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2
7591780|NCT03569475|11997998|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5
7591781|NCT03569475|11997996|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
7591782|NCT03569475|11997997|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
7591783|NCT03569475|11997998|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
7591784|NCT03569475|11997996|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7
7591785|NCT03569475|11997997|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10
7591786|NCT03569475|11997998|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9
7591787|NCT03569475|11997996|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7
7591788|NCT03569475|11997997|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7
7591789|NCT03569475|11997998|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6
7591790|NCT03569475|11997996|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1
7591791|NCT03569475|11997997|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1
7591792|NCT03569475|11997998|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1
7591793|NCT03569475|11997996|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1
7591794|NCT03569475|11997997|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1
7591795|NCT03569475|11997998|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1
7591796|NCT03569475|11997996|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1
7591797|NCT03569475|11997997|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1
7591798|NCT03569475|11997998|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2
7591799|NCT03569475|11997996|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0
7591800|NCT03569475|11997997|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1
7591801|NCT03569475|11997998|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1
7591802|NCT03569475|11997996|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0
7591803|NCT03569475|11997997|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1
7591804|NCT03569475|11997998|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1
7591805|NCT03545191|11998052|FG000|Overall Study|Death|1
7591806|NCT03545191|11998053|FG001|Overall Study|Death|0
7591807|NCT03545191|11998054|FG002|Overall Study|Death|0
7591808|NCT03545191|11998052|FG000|Overall Study|Adverse Event|4
7591809|NCT03545191|11998053|FG001|Overall Study|Adverse Event|2
7591810|NCT03545191|11998054|FG002|Overall Study|Adverse Event|7
7591811|NCT03545191|11998052|FG000|Overall Study|Other reasons|3
7591812|NCT03545191|11998053|FG001|Overall Study|Other reasons|11
7591813|NCT03545191|11998054|FG002|Overall Study|Other reasons|8
7591814|NCT03545191|11998052|FG000|Overall Study|Withdrawal by Subject|13
7591815|NCT03545191|11998053|FG001|Overall Study|Withdrawal by Subject|10
7591816|NCT03545191|11998054|FG002|Overall Study|Withdrawal by Subject|12
7591817|NCT03545191|11998052|FG000|Overall Study|Lost to Follow-up|1
7591818|NCT03545191|11998053|FG001|Overall Study|Lost to Follow-up|2
7591819|NCT03545191|11998054|FG002|Overall Study|Lost to Follow-up|3
7591820|NCT03500549|11998064|FG000|RCP (Day 1 - Week 16)|Adverse Event|3
7591821|NCT03500549|11998065|FG001|RCP (Day 1 - Week 16)|Adverse Event|0
7591822|NCT03500549|11998064|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3
7591823|NCT03500549|11998065|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7
7591824|NCT03456700|11998076|FG000|Overall Study|Withdrawal by Subject|1
7591825|NCT03427411|11998091|FG000|Overall Study|Screen failure - platelets too low|0
7591826|NCT03427411|11998092|FG001|Overall Study|Screen failure - platelets too low|1
7591827|NCT03387150|11998105|FG000|Overall Study|Withdrawal by Subject|3
7591828|NCT03387150|11998106|FG001|Overall Study|Withdrawal by Subject|0
7591829|NCT03387150|11998107|FG002|Overall Study|Withdrawal by Subject|3
7591830|NCT03387150|11998108|FG003|Overall Study|Withdrawal by Subject|4
7591831|NCT03387150|11998109|FG004|Overall Study|Withdrawal by Subject|1
7767543|NCT00854113|12210249|FG004|Overall Study|Withdrawal by Subject|0
7591833|NCT03387150|11998111|FG006|Overall Study|Withdrawal by Subject|0
7591834|NCT03387150|11998105|FG000|Overall Study|Lost to Follow-up|3
7591835|NCT03387150|11998106|FG001|Overall Study|Lost to Follow-up|2
7591836|NCT03387150|11998107|FG002|Overall Study|Lost to Follow-up|2
7591837|NCT03387150|11998108|FG003|Overall Study|Lost to Follow-up|3
7591838|NCT03387150|11998109|FG004|Overall Study|Lost to Follow-up|3
7591839|NCT03387150|11998110|FG005|Overall Study|Lost to Follow-up|3
7591840|NCT03387150|11998111|FG006|Overall Study|Lost to Follow-up|0
7591841|NCT03387150|11998105|FG000|Overall Study|Participant unable to adhere to visit|0
7591842|NCT03387150|11998106|FG001|Overall Study|Participant unable to adhere to visit|1
7591843|NCT03387150|11998107|FG002|Overall Study|Participant unable to adhere to visit|0
7591844|NCT03387150|11998108|FG003|Overall Study|Participant unable to adhere to visit|0
7591845|NCT03387150|11998109|FG004|Overall Study|Participant unable to adhere to visit|2
7591846|NCT03387150|11998110|FG005|Overall Study|Participant unable to adhere to visit|2
7591847|NCT03387150|11998111|FG006|Overall Study|Participant unable to adhere to visit|0
7767544|NCT00854113|12210250|FG005|Overall Study|Withdrawal by Subject|0
7767545|NCT00854113|12210251|FG006|Overall Study|Withdrawal by Subject|0
7767546|NCT00854113|12210252|FG007|Overall Study|Withdrawal by Subject|1
7767547|NCT00854113|12210253|FG008|Overall Study|Withdrawal by Subject|1
7767548|NCT00854113|12210254|FG009|Overall Study|Withdrawal by Subject|0
7767549|NCT00854113|12210255|FG010|Overall Study|Withdrawal by Subject|0
7767550|NCT00854308|12210281|FG000|Overall Study|Disease progression|42
7767551|NCT00854308|12210282|FG001|Overall Study|Disease progression|50
7767552|NCT00854308|12210281|FG000|Overall Study|Adverse Event|8
7767553|NCT00854308|12210282|FG001|Overall Study|Adverse Event|3
7767554|NCT00854308|12210281|FG000|Overall Study|Death|2
7767555|NCT00854308|12210282|FG001|Overall Study|Death|5
7767556|NCT00854308|12210281|FG000|Overall Study|Physician Decision|6
7767557|NCT00854308|12210282|FG001|Overall Study|Physician Decision|6
7767558|NCT00854308|12210281|FG000|Overall Study|Withdrawal by Subject|4
7767559|NCT00854308|12210282|FG001|Overall Study|Withdrawal by Subject|2
7767560|NCT00854308|12210281|FG000|Overall Study|Sponsor's decision to terminate study|0
7767561|NCT00854308|12210282|FG001|Overall Study|Sponsor's decision to terminate study|1
7767562|NCT00854360|12210292|FG000|Overall Study|Adverse Event|0
7767563|NCT00854360|12210293|FG001|Overall Study|Adverse Event|1
7767564|NCT00854360|12210294|FG002|Overall Study|Adverse Event|2
7767565|NCT00854360|12210295|FG003|Overall Study|Adverse Event|6
7767566|NCT00854360|12210292|FG000|Overall Study|Withdrawal by Subject|0
7767567|NCT00854360|12210293|FG001|Overall Study|Withdrawal by Subject|0
7767568|NCT00854360|12210294|FG002|Overall Study|Withdrawal by Subject|0
7767569|NCT00854360|12210295|FG003|Overall Study|Withdrawal by Subject|1
7767570|NCT00854360|12210292|FG000|Overall Study|Pregnancy|0
7767571|NCT00854360|12210293|FG001|Overall Study|Pregnancy|1
7767572|NCT00854360|12210294|FG002|Overall Study|Pregnancy|0
7767573|NCT00854360|12210295|FG003|Overall Study|Pregnancy|0
7767574|NCT00854360|12210292|FG000|Overall Study|Lack of Efficacy|2
7767575|NCT00854360|12210293|FG001|Overall Study|Lack of Efficacy|1
7767576|NCT00854360|12210294|FG002|Overall Study|Lack of Efficacy|0
7767577|NCT00854360|12210295|FG003|Overall Study|Lack of Efficacy|0
7767578|NCT00854360|12210292|FG000|Overall Study|Other|0
7767579|NCT00854360|12210293|FG001|Overall Study|Other|0
7767580|NCT00854360|12210294|FG002|Overall Study|Other|0
7767581|NCT00854360|12210295|FG003|Overall Study|Other|3
7767582|NCT00854373|12210307|FG000|Overall Study|Withdrawal by Subject|1
7767583|NCT00854373|12210308|FG001|Overall Study|Withdrawal by Subject|3
7767584|NCT00854373|12210307|FG000|Overall Study|Forgot to take study drug|1
7767585|NCT00854373|12210308|FG001|Overall Study|Forgot to take study drug|1
7767586|NCT00854581|12210314|FG000|Induction (Up to Day 21)|Lack of Efficacy|4
7767587|NCT00854581|12210314|FG000|Induction (Up to Day 21)|Death|1
7767588|NCT00854581|12210314|FG000|Induction (Up to Day 21)|Physician Decision|1
7767589|NCT00854581|12210314|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
7767590|NCT00854607|12210332|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
7767591|NCT00854620|12210343|FG000|Overall Study|Adverse Event|1
7767592|NCT00854724|12210349|FG000|First Intervention|Withdrawal by Subject|1
7767593|NCT00854724|12210350|FG001|First Intervention|Withdrawal by Subject|1
7767594|NCT00854724|12210349|FG000|Washout|Protocol Violation|1
7767595|NCT00854724|12210350|FG001|Washout|Protocol Violation|0
7767596|NCT00854724|12210349|FG000|Washout|Withdrawal by Subject|0
7767597|NCT00854724|12210350|FG001|Washout|Withdrawal by Subject|1
7767598|NCT00854724|12210349|FG000|Second Intervention|Protocol Violation|1
7767599|NCT00854724|12210350|FG001|Second Intervention|Protocol Violation|0
7767600|NCT00854724|12210349|FG000|Second Intervention|Physician Decision|0
7767601|NCT00854724|12210350|FG001|Second Intervention|Physician Decision|1
7767602|NCT00854828|12210360|FG000|Overall Study|Death|1
7767603|NCT00854828|12210361|FG001|Overall Study|Death|0
7767604|NCT00854828|12210362|FG002|Overall Study|Death|0
7767605|NCT00854828|12210363|FG003|Overall Study|Death|0
7767606|NCT00854828|12210360|FG000|Overall Study|Withdrawal by Subject|1
7767607|NCT00854828|12210361|FG001|Overall Study|Withdrawal by Subject|1
7767608|NCT00854828|12210362|FG002|Overall Study|Withdrawal by Subject|0
7767609|NCT00854828|12210363|FG003|Overall Study|Withdrawal by Subject|9
7767610|NCT00854828|12210360|FG000|Overall Study|Missed 24mo visit|1
7767611|NCT00854828|12210361|FG001|Overall Study|Missed 24mo visit|1
7767612|NCT00854828|12210362|FG002|Overall Study|Missed 24mo visit|8
7767613|NCT00854828|12210363|FG003|Overall Study|Missed 24mo visit|8
7767614|NCT00854906|12210373|FG000|Overall Study|One person had no ocular history|1
7767615|NCT00855062|12210395|FG000|Step1|Early Study Closure|5
7767616|NCT00855062|12210396|FG001|Step1|Early Study Closure|7
7767617|NCT00855062|12210395|FG000|Step1|Adverse Event|1
7767618|NCT00855062|12210396|FG001|Step1|Adverse Event|1
7767619|NCT00855062|12210395|FG000|Step1|Protocol Violation|1
7767620|NCT00855062|12210396|FG001|Step1|Protocol Violation|0
7767621|NCT00855062|12210395|FG000|Step1|Pregnancy|1
7767622|NCT00855062|12210396|FG001|Step1|Pregnancy|0
7767623|NCT00855062|12210395|FG000|Step1|Withdrawal by Subject|2
7767624|NCT00855062|12210396|FG001|Step1|Withdrawal by Subject|3
7767625|NCT00855062|12210395|FG000|Step2|Early Study Closure|6
7767626|NCT00855062|12210396|FG001|Step2|Early Study Closure|2
7767627|NCT00855062|12210395|FG000|Step2|Adverse Event|0
7767628|NCT00855062|12210396|FG001|Step2|Adverse Event|3
7767629|NCT00855062|12210395|FG000|Step2|Initiation of antiretroviral therapy/ART|0
7767630|NCT00855062|12210396|FG001|Step2|Initiation of antiretroviral therapy/ART|1
7767631|NCT00855166|12210404|FG000|Overall Study|Adverse Event|0
7767632|NCT00855166|12210405|FG001|Overall Study|Adverse Event|2
7767633|NCT00855166|12210404|FG000|Overall Study|Death|0
7767634|NCT00855166|12210405|FG001|Overall Study|Death|1
7767635|NCT00855166|12210404|FG000|Overall Study|Withdrawal by Subject|1
7767636|NCT00855166|12210405|FG001|Overall Study|Withdrawal by Subject|4
7767637|NCT00855166|12210404|FG000|Overall Study|Poor/non-compliance|2
7767638|NCT00855166|12210405|FG001|Overall Study|Poor/non-compliance|0
7767639|NCT00855166|12210404|FG000|Overall Study|Administrative reasons by sponsor|1
7767640|NCT00855166|12210405|FG001|Overall Study|Administrative reasons by sponsor|0
7767641|NCT00855166|12210404|FG000|Overall Study|Subject no longer meets study criteria|1
7767642|NCT00855166|12210405|FG001|Overall Study|Subject no longer meets study criteria|1
7767643|NCT00855218|12210415|FG000|Overall Study|Adverse Event|43
7627221|NCT02652949|12039649|FG000|12-Month Follow-up Secondary Endpoint|Death|4
7627222|NCT02652949|12039649|FG000|24-Month Follow-up Secondary Endpoint|Death|2
7627223|NCT02652949|12039649|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
7627224|NCT02652949|12039649|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
7627225|NCT02652949|12039649|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|27
7627226|NCT02652949|12039649|FG000|36-Month Follow-up Secondary Endpoint|Death|2
7627227|NCT02652949|12039649|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1
7627228|NCT02652949|12039649|FG000|36-Month Follow-up Secondary Endpoint|Subject declined extended follow up at 12 month timepoint. Data entry error-to be corrected by site|1
7627229|NCT02649439|12039661|FG000|Overall Study|Switched to alternative treatment|6
7627230|NCT02649439|12039662|FG001|Overall Study|Switched to alternative treatment|4
7627231|NCT02649439|12039661|FG000|Overall Study|Patient decision|1
7627232|NCT02649439|12039662|FG001|Overall Study|Patient decision|0
7627233|NCT02649439|12039661|FG000|Overall Study|Patient going out of country|1
7627234|NCT02649439|12039662|FG001|Overall Study|Patient going out of country|0
7627235|NCT02649439|12039661|FG000|Overall Study|To start finasteride|1
7627236|NCT02649439|12039662|FG001|Overall Study|To start finasteride|0
7627237|NCT02649439|12039661|FG000|Overall Study|Physician Decision|1
7627238|NCT02649439|12039662|FG001|Overall Study|Physician Decision|0
7591938|NCT03366792|11998153|FG000|Overall Study|Withdrawal by Subject|7
7591939|NCT03366792|11998153|FG000|Overall Study|Lost to Follow-up|2
7591940|NCT03366792|11998153|FG000|Overall Study|Ineligible (could not reach perinium)|2
7591941|NCT03366792|11998153|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4
7591942|NCT03366337|11998161|FG000|Overall Study|Lost to Follow-up|1
7591943|NCT03366337|11998162|FG001|Overall Study|Lost to Follow-up|0
7591944|NCT03366337|11998163|FG002|Overall Study|Lost to Follow-up|1
7591945|NCT03366337|11998164|FG003|Overall Study|Lost to Follow-up|0
7591946|NCT03366337|11998161|FG000|Overall Study|Withdrawal by Subject|2
7591947|NCT03366337|11998162|FG001|Overall Study|Withdrawal by Subject|0
7591948|NCT03366337|11998163|FG002|Overall Study|Withdrawal by Subject|1
7591949|NCT03366337|11998164|FG003|Overall Study|Withdrawal by Subject|1
7591950|NCT03342053|11998176|FG000|Overall Study|Adverse Event|2
7591951|NCT03342053|11998177|FG001|Overall Study|Adverse Event|0
7591952|NCT03342053|11998176|FG000|Overall Study|Withdrawal by Subject|0
7591953|NCT03342053|11998177|FG001|Overall Study|Withdrawal by Subject|1
7591954|NCT03283241|11998185|FG000|Overall Study|Adverse Event|4
7591955|NCT03283241|11998186|FG001|Overall Study|Adverse Event|1
7591956|NCT03283241|11998185|FG000|Overall Study|Withdrawal by Subject|0
7591957|NCT03283241|11998186|FG001|Overall Study|Withdrawal by Subject|1
7591958|NCT03283241|11998185|FG000|Overall Study|Subject relocated to Finland|0
7591959|NCT03283241|11998186|FG001|Overall Study|Subject relocated to Finland|1
7591960|NCT03242772|11998194|FG000|Overall Study|Lost to Follow-up|2
7767644|NCT00855218|12210416|FG001|Overall Study|Adverse Event|27
7767645|NCT00855218|12210415|FG000|Overall Study|Withdrawal by Subject|10
7767646|NCT00855218|12210416|FG001|Overall Study|Withdrawal by Subject|6
7767647|NCT00855218|12210415|FG000|Overall Study|Physician Decision|18
7767648|NCT00855218|12210416|FG001|Overall Study|Physician Decision|11
7767649|NCT00855218|12210415|FG000|Overall Study|Lost to Follow-up|0
7767650|NCT00855218|12210416|FG001|Overall Study|Lost to Follow-up|1
7767651|NCT00855218|12210415|FG000|Overall Study|Protocol Violation|5
7767652|NCT00855218|12210416|FG001|Overall Study|Protocol Violation|9
7767653|NCT00855218|12210415|FG000|Overall Study|non-compliant with study drug|3
7591961|NCT03242772|11998195|FG001|Overall Study|Lost to Follow-up|0
7591962|NCT03242772|11998194|FG000|Overall Study|Physician Decision|0
7591963|NCT03242772|11998195|FG001|Overall Study|Physician Decision|1
7591964|NCT03242772|11998194|FG000|Overall Study|Withdrawal by Subject|1
7591965|NCT03242772|11998195|FG001|Overall Study|Withdrawal by Subject|0
7591966|NCT03236311|11998203|FG000|Overall Study|Study terminated by sponsor|0
7591967|NCT03236311|11998204|FG001|Overall Study|Study terminated by sponsor|2
7591968|NCT03236311|11998203|FG000|Overall Study|Adverse Event|0
7591969|NCT03236311|11998204|FG001|Overall Study|Adverse Event|1
7591970|NCT03192046|11998212|FG000|Overall Study|Withdrawal by Subject|1
7591971|NCT03192046|11998213|FG001|Overall Study|Withdrawal by Subject|1
7591972|NCT03190369|11998221|FG000|Overall Study|Poor compliance to protocol|0
7591973|NCT03190369|11998222|FG001|Overall Study|Poor compliance to protocol|1
7591974|NCT03190369|11998221|FG000|Overall Study|Withdraw before treatment|1
7591975|NCT03190369|11998222|FG001|Overall Study|Withdraw before treatment|5
7591976|NCT03190369|11998221|FG000|Overall Study|Randomized but not treated|0
7591977|NCT03190369|11998222|FG001|Overall Study|Randomized but not treated|2
7627239|NCT02649439|12039661|FG000|Overall Study|Disease progression on study|12
7627240|NCT02649439|12039662|FG001|Overall Study|Disease progression on study|13
7627241|NCT02649439|12039661|FG000|Overall Study|Refused further treatment|1
7627242|NCT02649439|12039662|FG001|Overall Study|Refused further treatment|0
7627243|NCT02649439|12039661|FG000|Overall Study|Refused further follow up|2
7627244|NCT02649439|12039662|FG001|Overall Study|Refused further follow up|7
7627245|NCT02649439|12039661|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1
7627246|NCT02649439|12039662|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0
7627247|NCT02649439|12039661|FG000|Overall Study|No treatment, per protocol|1
7627248|NCT02649439|12039662|FG001|Overall Study|No treatment, per protocol|0
7627249|NCT02649439|12039661|FG000|Overall Study|PSA DT makes ineligible|0
7627250|NCT02649439|12039662|FG001|Overall Study|PSA DT makes ineligible|1
7627251|NCT02649439|12039661|FG000|Overall Study|Rising PSA No Mets|0
7627252|NCT02649439|12039662|FG001|Overall Study|Rising PSA No Mets|1
7627253|NCT02649439|12039661|FG000|Overall Study|Rising PSA|0
7627254|NCT02649439|12039662|FG001|Overall Study|Rising PSA|1
7627255|NCT02649439|12039661|FG000|Overall Study|Signed follow up protocol|0
7627256|NCT02649439|12039662|FG001|Overall Study|Signed follow up protocol|1
7767654|NCT00855218|12210416|FG001|Overall Study|non-compliant with study drug|1
7767655|NCT00855218|12210415|FG000|Overall Study|patient convenience|2
7767656|NCT00855218|12210416|FG001|Overall Study|patient convenience|0
7767657|NCT00855218|12210415|FG000|Overall Study|technical problems|2
7767658|NCT00855218|12210416|FG001|Overall Study|technical problems|1
7767659|NCT00855218|12210415|FG000|Overall Study|Still treated with study medication|0
7767660|NCT00855218|12210416|FG001|Overall Study|Still treated with study medication|1
7767661|NCT00855218|12210415|FG000|Overall Study|Untreatable disease progression|54
7767662|NCT00855218|12210416|FG001|Overall Study|Untreatable disease progression|67
7767663|NCT00855218|12210415|FG000|Overall Study|Second malignancy|0
7767664|NCT00855218|12210416|FG001|Overall Study|Second malignancy|1
7767665|NCT00855218|12210415|FG000|Overall Study|Progression measurement proven|7
7767666|NCT00855218|12210416|FG001|Overall Study|Progression measurement proven|15
7767667|NCT00855218|12210415|FG000|Overall Study|Clinical endpoint reached|10
7767668|NCT00855218|12210416|FG001|Overall Study|Clinical endpoint reached|13
7767669|NCT00855309|12210424|FG000|Overall Study|patient never recieved drug|1
7767670|NCT00855309|12210425|FG001|Overall Study|patient never recieved drug|0
7767671|NCT00855335|12210436|FG000|Overall Study|Lost to Follow-up|0
7767672|NCT00855335|12210437|FG001|Overall Study|Lost to Follow-up|0
7767673|NCT00855335|12210438|FG002|Overall Study|Lost to Follow-up|3
7767674|NCT00855335|12210439|FG003|Overall Study|Lost to Follow-up|1
7767675|NCT00855335|12210440|FG004|Overall Study|Lost to Follow-up|0
7767676|NCT00855335|12210436|FG000|Overall Study|Withdrawal by Subject|0
7591978|NCT04657198|11998231|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1
7591979|NCT04657198|11998232|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0
7591980|NCT04657198|11998233|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0
7591981|NCT04590586|11998247|FG000|Overall Study|Death|7
7591982|NCT04590586|11998248|FG001|Overall Study|Death|1
7591983|NCT04590586|11998249|FG002|Overall Study|Death|37
7591984|NCT04590586|11998250|FG003|Overall Study|Death|34
7591985|NCT04590586|11998251|FG004|Overall Study|Death|19
7591986|NCT04590586|11998252|FG005|Overall Study|Death|3
7591987|NCT04590586|11998247|FG000|Overall Study|Lost to Follow-up|3
7591988|NCT04590586|11998248|FG001|Overall Study|Lost to Follow-up|0
7591989|NCT04590586|11998249|FG002|Overall Study|Lost to Follow-up|11
7591990|NCT04590586|11998250|FG003|Overall Study|Lost to Follow-up|11
7591991|NCT04590586|11998251|FG004|Overall Study|Lost to Follow-up|6
7591992|NCT04590586|11998252|FG005|Overall Study|Lost to Follow-up|0
7591993|NCT04590586|11998247|FG000|Overall Study|Withdrawal by Subject|0
7591994|NCT04590586|11998248|FG001|Overall Study|Withdrawal by Subject|0
7591995|NCT04590586|11998249|FG002|Overall Study|Withdrawal by Subject|6
7591996|NCT04590586|11998250|FG003|Overall Study|Withdrawal by Subject|0
7591997|NCT04590586|11998251|FG004|Overall Study|Withdrawal by Subject|3
7591998|NCT04590586|11998252|FG005|Overall Study|Withdrawal by Subject|0
7591999|NCT04590586|11998247|FG000|Overall Study|Other|3
7592000|NCT04590586|11998248|FG001|Overall Study|Other|0
7592001|NCT04590586|11998249|FG002|Overall Study|Other|1
7592002|NCT04590586|11998250|FG003|Overall Study|Other|1
7592003|NCT04590586|11998251|FG004|Overall Study|Other|2
7592004|NCT04590586|11998252|FG005|Overall Study|Other|1
7592005|NCT04312009|11998278|FG000|Overall Study|Withdrawal by Subject|2
7592006|NCT04312009|11998279|FG001|Overall Study|Withdrawal by Subject|1
7592007|NCT04191382|11998288|FG000|Overall Study|Withdrawal by Subject|1
7592008|NCT04191382|11998289|FG001|Overall Study|Withdrawal by Subject|0
7592009|NCT04191382|11998290|FG002|Overall Study|Withdrawal by Subject|0
7592010|NCT03937466|11998307|FG000|Overall Study|not eligbile after the 2-week diary|9
7592011|NCT03937466|11998307|FG000|Overall Study|never returned their diary|6
7592012|NCT03937466|11998307|FG000|Overall Study|dropped out of study before getting Chilipad|5
7592013|NCT03937466|11998307|FG000|Overall Study|3 did not complete follow-up questionnaire.|3
7592014|NCT03850483|11998320|FG000|Treatment for Stage 1|Adverse Event|1
7592015|NCT03850483|11998321|FG001|Treatment for Stage 1|Adverse Event|1
7592016|NCT03850483|11998322|FG002|Treatment for Stage 1|Adverse Event|3
7592017|NCT03850483|11998323|FG003|Treatment for Stage 1|Adverse Event|0
7592018|NCT03850483|11998324|FG004|Treatment for Stage 1|Adverse Event|2
7592019|NCT03850483|11998325|FG005|Treatment for Stage 1|Adverse Event|0
7592020|NCT03850483|11998326|FG006|Treatment for Stage 1|Adverse Event|2
7592021|NCT03850483|11998327|FG007|Treatment for Stage 1|Adverse Event|2
7592022|NCT03850483|11998328|FG008|Treatment for Stage 1|Adverse Event|0
7592023|NCT03850483|11998329|FG009|Treatment for Stage 1|Adverse Event|0
7592024|NCT03850483|11998320|FG000|Treatment for Stage 1|Withdrawal by Subject|4
7592025|NCT03850483|11998321|FG001|Treatment for Stage 1|Withdrawal by Subject|4
7592026|NCT03850483|11998322|FG002|Treatment for Stage 1|Withdrawal by Subject|2
7592027|NCT03850483|11998323|FG003|Treatment for Stage 1|Withdrawal by Subject|2
7592028|NCT03850483|11998324|FG004|Treatment for Stage 1|Withdrawal by Subject|2
7592029|NCT03850483|11998325|FG005|Treatment for Stage 1|Withdrawal by Subject|1
7592030|NCT03850483|11998326|FG006|Treatment for Stage 1|Withdrawal by Subject|2
7592031|NCT03850483|11998327|FG007|Treatment for Stage 1|Withdrawal by Subject|3
7592032|NCT03850483|11998328|FG008|Treatment for Stage 1|Withdrawal by Subject|0
7592033|NCT03850483|11998329|FG009|Treatment for Stage 1|Withdrawal by Subject|0
7592034|NCT03850483|11998320|FG000|Treatment for Stage 1|Protocol Violation|1
7592035|NCT03850483|11998321|FG001|Treatment for Stage 1|Protocol Violation|0
7592036|NCT03850483|11998322|FG002|Treatment for Stage 1|Protocol Violation|0
7592037|NCT03850483|11998323|FG003|Treatment for Stage 1|Protocol Violation|0
7592038|NCT03850483|11998324|FG004|Treatment for Stage 1|Protocol Violation|0
7767677|NCT00855335|12210437|FG001|Overall Study|Withdrawal by Subject|0
7767678|NCT00855335|12210438|FG002|Overall Study|Withdrawal by Subject|0
7767679|NCT00855335|12210439|FG003|Overall Study|Withdrawal by Subject|1
7592039|NCT03850483|11998325|FG005|Treatment for Stage 1|Protocol Violation|0
7592040|NCT03850483|11998326|FG006|Treatment for Stage 1|Protocol Violation|1
7592041|NCT03850483|11998327|FG007|Treatment for Stage 1|Protocol Violation|0
7592042|NCT03850483|11998328|FG008|Treatment for Stage 1|Protocol Violation|0
7592043|NCT03850483|11998329|FG009|Treatment for Stage 1|Protocol Violation|0
7592044|NCT03850483|11998320|FG000|Treatment for Stage 1|Physician Decision|0
7592045|NCT03850483|11998321|FG001|Treatment for Stage 1|Physician Decision|0
7592046|NCT03850483|11998322|FG002|Treatment for Stage 1|Physician Decision|0
7592047|NCT03850483|11998323|FG003|Treatment for Stage 1|Physician Decision|0
7592048|NCT03850483|11998324|FG004|Treatment for Stage 1|Physician Decision|0
7592049|NCT03850483|11998325|FG005|Treatment for Stage 1|Physician Decision|1
7592050|NCT03850483|11998326|FG006|Treatment for Stage 1|Physician Decision|0
7592051|NCT03850483|11998327|FG007|Treatment for Stage 1|Physician Decision|0
7592052|NCT03850483|11998328|FG008|Treatment for Stage 1|Physician Decision|0
7592053|NCT03850483|11998329|FG009|Treatment for Stage 1|Physician Decision|0
7592054|NCT03850483|11998320|FG000|Treatment for Stage 1|Other|0
7592055|NCT03850483|11998321|FG001|Treatment for Stage 1|Other|0
7592056|NCT03850483|11998322|FG002|Treatment for Stage 1|Other|0
7592057|NCT03850483|11998323|FG003|Treatment for Stage 1|Other|0
7592058|NCT03850483|11998324|FG004|Treatment for Stage 1|Other|2
7592059|NCT03850483|11998325|FG005|Treatment for Stage 1|Other|1
7592060|NCT03850483|11998326|FG006|Treatment for Stage 1|Other|0
7592061|NCT03850483|11998327|FG007|Treatment for Stage 1|Other|0
7592062|NCT03850483|11998328|FG008|Treatment for Stage 1|Other|0
7592063|NCT03850483|11998329|FG009|Treatment for Stage 1|Other|0
7592064|NCT03850483|11998320|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592065|NCT03850483|11998321|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592066|NCT03850483|11998322|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1
7592067|NCT03850483|11998323|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592068|NCT03850483|11998324|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592069|NCT03850483|11998325|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592070|NCT03850483|11998326|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592071|NCT03850483|11998327|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592072|NCT03850483|11998328|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592073|NCT03850483|11998329|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592074|NCT03850483|11998320|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592075|NCT03850483|11998321|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592076|NCT03850483|11998322|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592077|NCT03850483|11998323|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592078|NCT03850483|11998324|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592079|NCT03850483|11998325|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1
7592080|NCT03850483|11998326|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592081|NCT03850483|11998327|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592082|NCT03850483|11998328|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592083|NCT03850483|11998329|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592084|NCT03850483|11998320|FG000|Treatment for Stage 1|Lost to Follow-up|0
7592085|NCT03850483|11998321|FG001|Treatment for Stage 1|Lost to Follow-up|1
7592086|NCT03850483|11998322|FG002|Treatment for Stage 1|Lost to Follow-up|1
7592087|NCT03850483|11998323|FG003|Treatment for Stage 1|Lost to Follow-up|1
7592088|NCT03850483|11998324|FG004|Treatment for Stage 1|Lost to Follow-up|0
7592089|NCT03850483|11998325|FG005|Treatment for Stage 1|Lost to Follow-up|1
7592090|NCT03850483|11998326|FG006|Treatment for Stage 1|Lost to Follow-up|2
7592091|NCT03850483|11998327|FG007|Treatment for Stage 1|Lost to Follow-up|0
7592092|NCT03850483|11998328|FG008|Treatment for Stage 1|Lost to Follow-up|0
7592093|NCT03850483|11998329|FG009|Treatment for Stage 1|Lost to Follow-up|0
7592094|NCT03850483|11998320|FG000|Treatment for Stage 1|Lack of Efficacy|1
7592095|NCT03850483|11998321|FG001|Treatment for Stage 1|Lack of Efficacy|2
7592096|NCT03850483|11998322|FG002|Treatment for Stage 1|Lack of Efficacy|2
7592097|NCT03850483|11998323|FG003|Treatment for Stage 1|Lack of Efficacy|3
7592098|NCT03850483|11998324|FG004|Treatment for Stage 1|Lack of Efficacy|2
7592099|NCT03850483|11998325|FG005|Treatment for Stage 1|Lack of Efficacy|4
7592100|NCT03850483|11998326|FG006|Treatment for Stage 1|Lack of Efficacy|3
7592101|NCT03850483|11998327|FG007|Treatment for Stage 1|Lack of Efficacy|1
7592102|NCT03850483|11998328|FG008|Treatment for Stage 1|Lack of Efficacy|0
7592103|NCT03850483|11998329|FG009|Treatment for Stage 1|Lack of Efficacy|0
7592104|NCT03850483|11998320|FG000|Treatment for Stage 1|Death|0
7592105|NCT03850483|11998321|FG001|Treatment for Stage 1|Death|0
7592106|NCT03850483|11998322|FG002|Treatment for Stage 1|Death|0
7592107|NCT03850483|11998323|FG003|Treatment for Stage 1|Death|0
7592108|NCT03850483|11998324|FG004|Treatment for Stage 1|Death|0
7592109|NCT03850483|11998325|FG005|Treatment for Stage 1|Death|1
7592110|NCT03850483|11998326|FG006|Treatment for Stage 1|Death|0
7592111|NCT03850483|11998327|FG007|Treatment for Stage 1|Death|0
7592112|NCT03850483|11998328|FG008|Treatment for Stage 1|Death|0
7592113|NCT03850483|11998329|FG009|Treatment for Stage 1|Death|0
7592114|NCT03850483|11998320|FG000|Treatment for Stage 1|Refused Further Treatment|1
7592115|NCT03850483|11998321|FG001|Treatment for Stage 1|Refused Further Treatment|0
7592116|NCT03850483|11998322|FG002|Treatment for Stage 1|Refused Further Treatment|2
7592117|NCT03850483|11998323|FG003|Treatment for Stage 1|Refused Further Treatment|0
7592118|NCT03850483|11998324|FG004|Treatment for Stage 1|Refused Further Treatment|1
7592119|NCT03850483|11998325|FG005|Treatment for Stage 1|Refused Further Treatment|0
7592120|NCT03850483|11998326|FG006|Treatment for Stage 1|Refused Further Treatment|1
7592121|NCT03850483|11998327|FG007|Treatment for Stage 1|Refused Further Treatment|0
7592122|NCT03850483|11998328|FG008|Treatment for Stage 1|Refused Further Treatment|0
7592123|NCT03850483|11998329|FG009|Treatment for Stage 1|Refused Further Treatment|0
7592124|NCT03850483|11998320|FG000|Treatment for Stage 1|Randomized but not Treated|0
7592125|NCT03850483|11998321|FG001|Treatment for Stage 1|Randomized but not Treated|0
7592126|NCT03850483|11998322|FG002|Treatment for Stage 1|Randomized but not Treated|0
7592127|NCT03850483|11998323|FG003|Treatment for Stage 1|Randomized but not Treated|0
7592128|NCT03850483|11998324|FG004|Treatment for Stage 1|Randomized but not Treated|0
7592129|NCT03850483|11998325|FG005|Treatment for Stage 1|Randomized but not Treated|1
7592130|NCT03850483|11998326|FG006|Treatment for Stage 1|Randomized but not Treated|0
7592131|NCT03850483|11998327|FG007|Treatment for Stage 1|Randomized but not Treated|0
7592132|NCT03850483|11998328|FG008|Treatment for Stage 1|Randomized but not Treated|0
7592133|NCT03850483|11998329|FG009|Treatment for Stage 1|Randomized but not Treated|0
7592134|NCT03850483|11998320|FG000|Follow-up for Stage 1|Withdrawal by Subject|0
7592135|NCT03850483|11998321|FG001|Follow-up for Stage 1|Withdrawal by Subject|0
7592136|NCT03850483|11998322|FG002|Follow-up for Stage 1|Withdrawal by Subject|0
7592137|NCT03850483|11998323|FG003|Follow-up for Stage 1|Withdrawal by Subject|0
7592138|NCT03850483|11998324|FG004|Follow-up for Stage 1|Withdrawal by Subject|0
7592139|NCT03850483|11998325|FG005|Follow-up for Stage 1|Withdrawal by Subject|0
7592140|NCT03850483|11998326|FG006|Follow-up for Stage 1|Withdrawal by Subject|1
7592141|NCT03850483|11998327|FG007|Follow-up for Stage 1|Withdrawal by Subject|2
7592142|NCT03850483|11998328|FG008|Follow-up for Stage 1|Withdrawal by Subject|0
7592143|NCT03850483|11998329|FG009|Follow-up for Stage 1|Withdrawal by Subject|0
7592144|NCT03850483|11998320|FG000|Follow-up for Stage 1|Physician Decision|0
7592145|NCT03850483|11998321|FG001|Follow-up for Stage 1|Physician Decision|0
7592146|NCT03850483|11998322|FG002|Follow-up for Stage 1|Physician Decision|0
7592147|NCT03850483|11998323|FG003|Follow-up for Stage 1|Physician Decision|0
7592148|NCT03850483|11998324|FG004|Follow-up for Stage 1|Physician Decision|1
7592149|NCT03850483|11998325|FG005|Follow-up for Stage 1|Physician Decision|0
7592150|NCT03850483|11998326|FG006|Follow-up for Stage 1|Physician Decision|1
7592151|NCT03850483|11998327|FG007|Follow-up for Stage 1|Physician Decision|0
7592152|NCT03850483|11998328|FG008|Follow-up for Stage 1|Physician Decision|0
7592153|NCT03850483|11998329|FG009|Follow-up for Stage 1|Physician Decision|0
7592154|NCT03850483|11998320|FG000|Follow-up for Stage 1|Lack of Efficacy|0
7592155|NCT03850483|11998321|FG001|Follow-up for Stage 1|Lack of Efficacy|0
7592156|NCT03850483|11998322|FG002|Follow-up for Stage 1|Lack of Efficacy|1
7592157|NCT03850483|11998323|FG003|Follow-up for Stage 1|Lack of Efficacy|0
7592158|NCT03850483|11998324|FG004|Follow-up for Stage 1|Lack of Efficacy|0
7592159|NCT03850483|11998325|FG005|Follow-up for Stage 1|Lack of Efficacy|0
7592160|NCT03850483|11998326|FG006|Follow-up for Stage 1|Lack of Efficacy|0
7592161|NCT03850483|11998327|FG007|Follow-up for Stage 1|Lack of Efficacy|1
7592162|NCT03850483|11998328|FG008|Follow-up for Stage 1|Lack of Efficacy|0
7592163|NCT03850483|11998329|FG009|Follow-up for Stage 1|Lack of Efficacy|0
7592164|NCT03850483|11998320|FG000|Follow-up for Stage 1|Adverse Event|0
7592165|NCT03850483|11998321|FG001|Follow-up for Stage 1|Adverse Event|0
7592166|NCT03850483|11998322|FG002|Follow-up for Stage 1|Adverse Event|1
7592167|NCT03850483|11998323|FG003|Follow-up for Stage 1|Adverse Event|0
7592168|NCT03850483|11998324|FG004|Follow-up for Stage 1|Adverse Event|0
7592169|NCT03850483|11998325|FG005|Follow-up for Stage 1|Adverse Event|1
7592170|NCT03850483|11998326|FG006|Follow-up for Stage 1|Adverse Event|0
7592171|NCT03850483|11998327|FG007|Follow-up for Stage 1|Adverse Event|0
7592172|NCT03850483|11998328|FG008|Follow-up for Stage 1|Adverse Event|0
7592173|NCT03850483|11998329|FG009|Follow-up for Stage 1|Adverse Event|0
7592174|NCT03850483|11998320|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0
7592175|NCT03850483|11998321|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1
7592176|NCT03850483|11998322|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0
7592177|NCT03850483|11998323|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0
7592178|NCT03850483|11998324|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2
7592179|NCT03850483|11998325|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2
7592180|NCT03850483|11998326|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0
7592181|NCT03850483|11998327|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0
7592182|NCT03850483|11998328|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0
7592183|NCT03850483|11998329|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0
7592184|NCT03850483|11998320|FG000|Follow-up for Stage 1|Other|0
7592185|NCT03850483|11998321|FG001|Follow-up for Stage 1|Other|2
7592186|NCT03850483|11998322|FG002|Follow-up for Stage 1|Other|0
7592187|NCT03850483|11998323|FG003|Follow-up for Stage 1|Other|2
7592188|NCT03850483|11998324|FG004|Follow-up for Stage 1|Other|0
7592189|NCT03850483|11998325|FG005|Follow-up for Stage 1|Other|1
7592190|NCT03850483|11998326|FG006|Follow-up for Stage 1|Other|0
7592191|NCT03850483|11998327|FG007|Follow-up for Stage 1|Other|0
7592192|NCT03850483|11998328|FG008|Follow-up for Stage 1|Other|0
7592193|NCT03850483|11998329|FG009|Follow-up for Stage 1|Other|0
7592194|NCT03850483|11998320|FG000|Treatment for Stage 2|Adverse Event|0
7592195|NCT03850483|11998321|FG001|Treatment for Stage 2|Adverse Event|0
7592196|NCT03850483|11998322|FG002|Treatment for Stage 2|Adverse Event|0
7592197|NCT03850483|11998323|FG003|Treatment for Stage 2|Adverse Event|0
7592198|NCT03850483|11998324|FG004|Treatment for Stage 2|Adverse Event|0
7592199|NCT03850483|11998325|FG005|Treatment for Stage 2|Adverse Event|0
7592200|NCT03850483|11998326|FG006|Treatment for Stage 2|Adverse Event|0
7592201|NCT03850483|11998327|FG007|Treatment for Stage 2|Adverse Event|0
7592202|NCT03850483|11998328|FG008|Treatment for Stage 2|Adverse Event|0
7592203|NCT03850483|11998329|FG009|Treatment for Stage 2|Adverse Event|1
7592204|NCT03850483|11998320|FG000|Treatment for Stage 2|Lack of Efficacy|0
7592205|NCT03850483|11998321|FG001|Treatment for Stage 2|Lack of Efficacy|0
7592206|NCT03850483|11998322|FG002|Treatment for Stage 2|Lack of Efficacy|0
7767680|NCT00855335|12210440|FG004|Overall Study|Withdrawal by Subject|0
7767681|NCT00855335|12210436|FG000|Overall Study|Adverse Event|2
7767682|NCT00855335|12210437|FG001|Overall Study|Adverse Event|0
7767683|NCT00855335|12210438|FG002|Overall Study|Adverse Event|0
7767684|NCT00855335|12210439|FG003|Overall Study|Adverse Event|0
7767685|NCT00855335|12210440|FG004|Overall Study|Adverse Event|0
7767686|NCT00855335|12210436|FG000|Overall Study|Physician Decision|1
7767687|NCT00855335|12210437|FG001|Overall Study|Physician Decision|1
7767688|NCT00855335|12210438|FG002|Overall Study|Physician Decision|0
7767689|NCT00855335|12210439|FG003|Overall Study|Physician Decision|0
7767690|NCT00855335|12210440|FG004|Overall Study|Physician Decision|0
7767691|NCT00855335|12210436|FG000|Overall Study|Other|2
7767692|NCT00855335|12210437|FG001|Overall Study|Other|1
7767693|NCT00855335|12210438|FG002|Overall Study|Other|2
7767694|NCT00855335|12210439|FG003|Overall Study|Other|5
7767695|NCT00855335|12210440|FG004|Overall Study|Other|1
7767696|NCT00855439|12210471|FG000|Overall Study|Withdrawal by Subject|2
7767697|NCT00855439|12210472|FG001|Overall Study|Withdrawal by Subject|0
7767698|NCT00855439|12210471|FG000|Overall Study|Pregnancy|1
7767699|NCT00855439|12210472|FG001|Overall Study|Pregnancy|0
7767700|NCT00855465|12210480|FG000|Treatment Period|Adverse Event|4
7767701|NCT00855465|12210481|FG001|Treatment Period|Adverse Event|2
7767702|NCT00855465|12210480|FG000|Treatment Period|Death|2
7592207|NCT03850483|11998323|FG003|Treatment for Stage 2|Lack of Efficacy|0
7592208|NCT03850483|11998324|FG004|Treatment for Stage 2|Lack of Efficacy|0
7592209|NCT03850483|11998325|FG005|Treatment for Stage 2|Lack of Efficacy|0
7767703|NCT00855465|12210481|FG001|Treatment Period|Death|2
7767704|NCT00855465|12210480|FG000|Treatment Period|Lack of Efficacy|2
7767705|NCT00855465|12210481|FG001|Treatment Period|Lack of Efficacy|1
7592210|NCT03850483|11998326|FG006|Treatment for Stage 2|Lack of Efficacy|0
7592211|NCT03850483|11998327|FG007|Treatment for Stage 2|Lack of Efficacy|0
7767706|NCT00855465|12210480|FG000|Treatment Period|Non-compliance|1
7767707|NCT00855465|12210481|FG001|Treatment Period|Non-compliance|0
7767708|NCT00855465|12210480|FG000|Treatment Period|Protocol Violation|2
7592212|NCT03850483|11998328|FG008|Treatment for Stage 2|Lack of Efficacy|1
7592213|NCT03850483|11998329|FG009|Treatment for Stage 2|Lack of Efficacy|0
7592214|NCT03850483|11998320|FG000|Treatment for Stage 2|Lost to Follow-up|0
7592215|NCT03850483|11998321|FG001|Treatment for Stage 2|Lost to Follow-up|0
7592216|NCT03850483|11998322|FG002|Treatment for Stage 2|Lost to Follow-up|0
7592217|NCT03850483|11998323|FG003|Treatment for Stage 2|Lost to Follow-up|0
7592218|NCT03850483|11998324|FG004|Treatment for Stage 2|Lost to Follow-up|0
7592219|NCT03850483|11998325|FG005|Treatment for Stage 2|Lost to Follow-up|0
7592220|NCT03850483|11998326|FG006|Treatment for Stage 2|Lost to Follow-up|0
7592221|NCT03850483|11998327|FG007|Treatment for Stage 2|Lost to Follow-up|0
7592222|NCT03850483|11998328|FG008|Treatment for Stage 2|Lost to Follow-up|0
7592223|NCT03850483|11998329|FG009|Treatment for Stage 2|Lost to Follow-up|3
7592224|NCT03850483|11998320|FG000|Treatment for Stage 2|Physician Decision|0
7592225|NCT03850483|11998321|FG001|Treatment for Stage 2|Physician Decision|0
7592226|NCT03850483|11998322|FG002|Treatment for Stage 2|Physician Decision|0
7592227|NCT03850483|11998323|FG003|Treatment for Stage 2|Physician Decision|0
7592228|NCT03850483|11998324|FG004|Treatment for Stage 2|Physician Decision|0
7592229|NCT03850483|11998325|FG005|Treatment for Stage 2|Physician Decision|0
7592230|NCT03850483|11998326|FG006|Treatment for Stage 2|Physician Decision|0
7592231|NCT03850483|11998327|FG007|Treatment for Stage 2|Physician Decision|0
7592232|NCT03850483|11998328|FG008|Treatment for Stage 2|Physician Decision|0
7592233|NCT03850483|11998329|FG009|Treatment for Stage 2|Physician Decision|1
7592234|NCT03850483|11998320|FG000|Treatment for Stage 2|Protocol Violation|0
7592235|NCT03850483|11998321|FG001|Treatment for Stage 2|Protocol Violation|0
7592236|NCT03850483|11998322|FG002|Treatment for Stage 2|Protocol Violation|0
7592237|NCT03850483|11998323|FG003|Treatment for Stage 2|Protocol Violation|0
7592238|NCT03850483|11998324|FG004|Treatment for Stage 2|Protocol Violation|0
7592239|NCT03850483|11998325|FG005|Treatment for Stage 2|Protocol Violation|0
7592240|NCT03850483|11998326|FG006|Treatment for Stage 2|Protocol Violation|0
7592241|NCT03850483|11998327|FG007|Treatment for Stage 2|Protocol Violation|0
7592242|NCT03850483|11998328|FG008|Treatment for Stage 2|Protocol Violation|1
7592243|NCT03850483|11998329|FG009|Treatment for Stage 2|Protocol Violation|0
7592244|NCT03850483|11998320|FG000|Treatment for Stage 2|Withdrawal by Subject|0
7592245|NCT03850483|11998321|FG001|Treatment for Stage 2|Withdrawal by Subject|0
7592246|NCT03850483|11998322|FG002|Treatment for Stage 2|Withdrawal by Subject|0
7592247|NCT03850483|11998323|FG003|Treatment for Stage 2|Withdrawal by Subject|0
7592248|NCT03850483|11998324|FG004|Treatment for Stage 2|Withdrawal by Subject|0
7592249|NCT03850483|11998325|FG005|Treatment for Stage 2|Withdrawal by Subject|0
7592250|NCT03850483|11998326|FG006|Treatment for Stage 2|Withdrawal by Subject|0
7592251|NCT03850483|11998327|FG007|Treatment for Stage 2|Withdrawal by Subject|0
7592252|NCT03850483|11998328|FG008|Treatment for Stage 2|Withdrawal by Subject|2
7592253|NCT03850483|11998329|FG009|Treatment for Stage 2|Withdrawal by Subject|5
7592254|NCT03850483|11998320|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592255|NCT03850483|11998321|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592256|NCT03850483|11998322|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592257|NCT03850483|11998323|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592258|NCT03850483|11998324|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592259|NCT03850483|11998325|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592260|NCT03850483|11998326|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592261|NCT03850483|11998327|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592262|NCT03850483|11998328|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592263|NCT03850483|11998329|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1
7592264|NCT03850483|11998320|FG000|Treatment for Stage 2|Refused Further Treatment|0
7592265|NCT03850483|11998321|FG001|Treatment for Stage 2|Refused Further Treatment|0
7592266|NCT03850483|11998322|FG002|Treatment for Stage 2|Refused Further Treatment|0
7592267|NCT03850483|11998323|FG003|Treatment for Stage 2|Refused Further Treatment|0
7592268|NCT03850483|11998324|FG004|Treatment for Stage 2|Refused Further Treatment|0
7592269|NCT03850483|11998325|FG005|Treatment for Stage 2|Refused Further Treatment|0
7592270|NCT03850483|11998326|FG006|Treatment for Stage 2|Refused Further Treatment|0
7592271|NCT03850483|11998327|FG007|Treatment for Stage 2|Refused Further Treatment|0
7592272|NCT03850483|11998328|FG008|Treatment for Stage 2|Refused Further Treatment|1
7592273|NCT03850483|11998329|FG009|Treatment for Stage 2|Refused Further Treatment|0
7592274|NCT03850483|11998320|FG000|Follow-up For Stage 2|Lost to Follow-up|0
7592275|NCT03850483|11998321|FG001|Follow-up For Stage 2|Lost to Follow-up|0
7592276|NCT03850483|11998322|FG002|Follow-up For Stage 2|Lost to Follow-up|0
7592277|NCT03850483|11998323|FG003|Follow-up For Stage 2|Lost to Follow-up|0
7592278|NCT03850483|11998324|FG004|Follow-up For Stage 2|Lost to Follow-up|0
7592279|NCT03850483|11998325|FG005|Follow-up For Stage 2|Lost to Follow-up|0
7592280|NCT03850483|11998326|FG006|Follow-up For Stage 2|Lost to Follow-up|0
7592281|NCT03850483|11998327|FG007|Follow-up For Stage 2|Lost to Follow-up|0
7592282|NCT03850483|11998328|FG008|Follow-up For Stage 2|Lost to Follow-up|0
7592283|NCT03850483|11998329|FG009|Follow-up For Stage 2|Lost to Follow-up|1
7592284|NCT03850483|11998320|FG000|Follow-up For Stage 2|Other|0
7592285|NCT03850483|11998321|FG001|Follow-up For Stage 2|Other|0
7592286|NCT03850483|11998322|FG002|Follow-up For Stage 2|Other|0
7592287|NCT03850483|11998323|FG003|Follow-up For Stage 2|Other|0
7592288|NCT03850483|11998324|FG004|Follow-up For Stage 2|Other|0
7592289|NCT03850483|11998325|FG005|Follow-up For Stage 2|Other|0
7592290|NCT03850483|11998326|FG006|Follow-up For Stage 2|Other|0
7592291|NCT03850483|11998327|FG007|Follow-up For Stage 2|Other|0
7592292|NCT03850483|11998328|FG008|Follow-up For Stage 2|Other|0
7592293|NCT03850483|11998329|FG009|Follow-up For Stage 2|Other|1
7767709|NCT00855465|12210481|FG001|Treatment Period|Protocol Violation|0
7767710|NCT00855465|12210480|FG000|Treatment Period|Withdrawal by Subject|2
7767711|NCT00855465|12210481|FG001|Treatment Period|Withdrawal by Subject|0
7767712|NCT00855465|12210480|FG000|Treatment Period|Not treated|1
7767713|NCT00855465|12210481|FG001|Treatment Period|Not treated|0
7767714|NCT00855465|12210480|FG000|Follow-up Period (FUP)|Adverse Event|0
7592300|NCT03804684|11998361|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3
7592301|NCT03804684|11998362|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18
7767715|NCT00855465|12210481|FG001|Follow-up Period (FUP)|Adverse Event|1
7767716|NCT00855465|12210480|FG000|Follow-up Period (FUP)|Death|0
7767717|NCT00855465|12210481|FG001|Follow-up Period (FUP)|Death|1
7767718|NCT00855465|12210480|FG000|Follow-up Period (FUP)|Lost to Follow-up|3
7767719|NCT00855465|12210481|FG001|Follow-up Period (FUP)|Lost to Follow-up|0
7767720|NCT00855465|12210480|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4
7592308|NCT03473925|11998403|FG000|Overall Study|Death|48
7592309|NCT03473925|11998404|FG001|Overall Study|Death|44
7592310|NCT03473925|11998403|FG000|Overall Study|Sponsor Decision|2
7592311|NCT03473925|11998404|FG001|Overall Study|Sponsor Decision|7
7592312|NCT03473925|11998403|FG000|Overall Study|Withdrawal by Subject|1
7592313|NCT03473925|11998404|FG001|Overall Study|Withdrawal by Subject|3
7592314|NCT03473925|11998403|FG000|Overall Study|Not Treated|1
7592315|NCT03473925|11998404|FG001|Overall Study|Not Treated|1
7767721|NCT00855465|12210481|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0
7767722|NCT00855465|12210480|FG000|Follow-up Period (FUP)|Missing|1
7767723|NCT00855465|12210481|FG001|Follow-up Period (FUP)|Missing|0
7767724|NCT00855582|12210490|FG000|Overall Study|Adverse Event|2
7592320|NCT03230097|11998432|FG000|Overall Study|Adverse Event|2
7592321|NCT03230097|11998433|FG001|Overall Study|Adverse Event|1
7592322|NCT03230097|11998432|FG000|Overall Study|non-compliance|0
7592323|NCT03230097|11998433|FG001|Overall Study|non-compliance|1
7592324|NCT03230097|11998432|FG000|Overall Study|Lost to Follow-up|2
7592325|NCT03230097|11998433|FG001|Overall Study|Lost to Follow-up|4
7592326|NCT03230097|11998432|FG000|Overall Study|Withdrawal by Subject|7
7592327|NCT03230097|11998433|FG001|Overall Study|Withdrawal by Subject|3
7592328|NCT03230097|11998432|FG000|Overall Study|Trial termination|4
7592329|NCT03230097|11998433|FG001|Overall Study|Trial termination|5
7592330|NCT03230097|11998432|FG000|Overall Study|Covid-19 pandemic outbreak|0
7592331|NCT03230097|11998433|FG001|Overall Study|Covid-19 pandemic outbreak|1
7592332|NCT03230097|11998432|FG000|Overall Study|outcome event|0
7592333|NCT03230097|11998433|FG001|Overall Study|outcome event|1
7592334|NCT03029780|11998454|FG000|Overall Study|Disease Progression|20
7592335|NCT03029780|11998455|FG001|Overall Study|Disease Progression|22
7592336|NCT03029780|11998454|FG000|Overall Study|Study Drug Toxicity|15
7592337|NCT03029780|11998455|FG001|Overall Study|Study Drug Toxicity|11
7592338|NCT03029780|11998454|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2
7592339|NCT03029780|11998455|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
7592340|NCT03029780|11998454|FG000|Overall Study|Participant request to discontinue study treatment|4
7592341|NCT03029780|11998455|FG001|Overall Study|Participant request to discontinue study treatment|1
7592342|NCT03029780|11998454|FG000|Overall Study|Maximum clinical benefit|1
7592343|NCT03029780|11998455|FG001|Overall Study|Maximum clinical benefit|0
7592344|NCT03029780|11998454|FG000|Overall Study|Participant no longer meets study criteria|0
7592345|NCT03029780|11998455|FG001|Overall Study|Participant no longer meets study criteria|1
7592346|NCT03029780|11998454|FG000|Overall Study|Other reasons|6
7592347|NCT03029780|11998455|FG001|Overall Study|Other reasons|6
7592348|NCT03029780|11998454|FG000|Overall Study|Not reported|1
7592349|NCT03029780|11998455|FG001|Overall Study|Not reported|1
7592350|NCT03029780|11998454|FG000|Overall Study|Death|2
7592351|NCT03029780|11998455|FG001|Overall Study|Death|6
7627281|NCT02447718|12039694|FG000|Overall Study|Lost to Follow-up|8
7627282|NCT02447718|12039695|FG001|Overall Study|Lost to Follow-up|0
7627283|NCT02447718|12039694|FG000|Overall Study|Withdrawal by Subject|3
7627284|NCT02447718|12039695|FG001|Overall Study|Withdrawal by Subject|0
7627285|NCT02447718|12039694|FG000|Overall Study|Screen Failure|1
7627286|NCT02447718|12039695|FG001|Overall Study|Screen Failure|0
7767725|NCT00855582|12210491|FG001|Overall Study|Adverse Event|6
7767726|NCT00855582|12210492|FG002|Overall Study|Adverse Event|3
7767727|NCT00855582|12210490|FG000|Overall Study|Death|1
7767728|NCT00855582|12210491|FG001|Overall Study|Death|0
7767729|NCT00855582|12210492|FG002|Overall Study|Death|0
7767730|NCT00855582|12210490|FG000|Overall Study|Lack of Efficacy|1
7767731|NCT00855582|12210491|FG001|Overall Study|Lack of Efficacy|3
7767732|NCT00855582|12210492|FG002|Overall Study|Lack of Efficacy|8
7767733|NCT00855582|12210490|FG000|Overall Study|Lost to Follow-up|1
7767734|NCT00855582|12210491|FG001|Overall Study|Lost to Follow-up|3
7767735|NCT00855582|12210492|FG002|Overall Study|Lost to Follow-up|1
7767736|NCT00855582|12210490|FG000|Overall Study|Physician Decision|0
7767737|NCT00855582|12210491|FG001|Overall Study|Physician Decision|0
7767738|NCT00855582|12210492|FG002|Overall Study|Physician Decision|1
7767739|NCT00855582|12210490|FG000|Overall Study|Protocol Violation|6
7767740|NCT00855582|12210491|FG001|Overall Study|Protocol Violation|2
7767741|NCT00855582|12210492|FG002|Overall Study|Protocol Violation|6
7767742|NCT00855582|12210490|FG000|Overall Study|Entry Criteria Not Met|8
7767743|NCT00855582|12210491|FG001|Overall Study|Entry Criteria Not Met|6
7767744|NCT00855582|12210492|FG002|Overall Study|Entry Criteria Not Met|3
7767745|NCT00855582|12210490|FG000|Overall Study|Withdrawal by Subject|7
7767746|NCT00855582|12210491|FG001|Overall Study|Withdrawal by Subject|4
7767747|NCT00855582|12210492|FG002|Overall Study|Withdrawal by Subject|8
7767748|NCT00855595|12210505|FG000|Overall Study|Withdrawal by Subject|1
7767749|NCT00855595|12210506|FG001|Overall Study|Withdrawal by Subject|2
7767750|NCT00855595|12210505|FG000|Overall Study|Lost to Follow-up|3
7767751|NCT00855595|12210506|FG001|Overall Study|Lost to Follow-up|3
7767752|NCT00855595|12210505|FG000|Overall Study|Adverse Event|1
7767753|NCT00855595|12210506|FG001|Overall Study|Adverse Event|1
7767754|NCT00855595|12210505|FG000|Overall Study|patient moved out of state|1
7767755|NCT00855595|12210506|FG001|Overall Study|patient moved out of state|0
7592375|NCT02803593|11998503|FG000|Overall Study|Lost to Follow-up|17
7592376|NCT02803593|11998504|FG001|Overall Study|Lost to Follow-up|35
7592377|NCT02663908|11998512|FG000|Overall Study|Withdrawal by Subject|8
7592378|NCT02663908|11998513|FG001|Overall Study|Withdrawal by Subject|5
7592379|NCT02663908|11998512|FG000|Overall Study|Lost to Follow-up|1
7592380|NCT02663908|11998513|FG001|Overall Study|Lost to Follow-up|5
7592381|NCT02663908|11998512|FG000|Overall Study|Adverse Event|13
7592382|NCT02663908|11998513|FG001|Overall Study|Adverse Event|11
7592383|NCT02663908|11998512|FG000|Overall Study|Protocol Violation|1
7592384|NCT02663908|11998513|FG001|Overall Study|Protocol Violation|2
7592385|NCT02663908|11998512|FG000|Overall Study|Lack of therapeutic response|2
7592386|NCT02663908|11998513|FG001|Overall Study|Lack of therapeutic response|0
7592387|NCT02663908|11998512|FG000|Overall Study|COVID-19|1
7592388|NCT02663908|11998513|FG001|Overall Study|COVID-19|0
7592389|NCT02663908|11998512|FG000|Overall Study|Site closed|1
7592390|NCT02663908|11998513|FG001|Overall Study|Site closed|0
7592391|NCT02663908|11998512|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1
7592392|NCT02663908|11998513|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0
7592393|NCT02663908|11998512|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1
7592394|NCT02663908|11998513|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0
7592395|NCT02663908|11998512|FG000|Overall Study|Intolerance to FIRMAGON therapy|1
7592396|NCT02663908|11998513|FG001|Overall Study|Intolerance to FIRMAGON therapy|0
7592397|NCT02663908|11998512|FG000|Overall Study|Death|1
7592398|NCT02663908|11998513|FG001|Overall Study|Death|0
7592399|NCT02663908|11998512|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1
7592400|NCT02663908|11998513|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0
7592401|NCT02663908|11998512|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0
7592402|NCT02663908|11998513|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1
7592403|NCT02650284|11998521|FG000|Overall Study|Lost to Follow-up|3
7592404|NCT02650284|11998522|FG001|Overall Study|Lost to Follow-up|3
7592405|NCT02650284|11998521|FG000|Overall Study|Consent incorrectly taken|0
7592406|NCT02650284|11998522|FG001|Overall Study|Consent incorrectly taken|1
7767756|NCT00855595|12210505|FG000|Overall Study|patient left country|0
7767757|NCT00855595|12210506|FG001|Overall Study|patient left country|1
7767758|NCT00855738|12210512|FG000|Overall Study|Lost to Follow-up|2
7767759|NCT00855738|12210512|FG000|Overall Study|Adverse Event|1
7767760|NCT00855738|12210512|FG000|Overall Study|Subject Defaulted|1
7592412|NCT02500797|11998555|FG000|Overall Study|Cancel (rapid disease progression)|0
7592413|NCT02500797|11998556|FG001|Overall Study|Cancel (rapid disease progression)|0
7592414|NCT02500797|11998557|FG002|Overall Study|Cancel (rapid disease progression)|0
7592415|NCT02500797|11998558|FG003|Overall Study|Cancel (rapid disease progression)|0
7592416|NCT02500797|11998559|FG004|Overall Study|Cancel (rapid disease progression)|1
7592417|NCT02500797|11998560|FG005|Overall Study|Cancel (rapid disease progression)|1
7592418|NCT02500797|11998561|FG006|Overall Study|Cancel (rapid disease progression)|0
7592419|NCT02500797|11998562|FG007|Overall Study|Cancel (rapid disease progression)|0
7592420|NCT02500797|11998555|FG000|Overall Study|Withdrawal by Subject|1
7592421|NCT02500797|11998556|FG001|Overall Study|Withdrawal by Subject|0
7592422|NCT02500797|11998557|FG002|Overall Study|Withdrawal by Subject|0
7592423|NCT02500797|11998558|FG003|Overall Study|Withdrawal by Subject|0
7592424|NCT02500797|11998559|FG004|Overall Study|Withdrawal by Subject|0
7592425|NCT02500797|11998560|FG005|Overall Study|Withdrawal by Subject|0
7592426|NCT02500797|11998561|FG006|Overall Study|Withdrawal by Subject|0
7592427|NCT02500797|11998562|FG007|Overall Study|Withdrawal by Subject|0
7767761|NCT00855738|12210512|FG000|Overall Study|Death|1
7767762|NCT00855816|12210520|FG000|Overall Study|Withdrawal by Subject|22
7767763|NCT00855816|12210521|FG001|Overall Study|Withdrawal by Subject|15
7767764|NCT00855816|12210520|FG000|Overall Study|Lost to Follow-up|3
7767765|NCT00855816|12210521|FG001|Overall Study|Lost to Follow-up|5
7767766|NCT00855816|12210520|FG000|Overall Study|Death|1
7767767|NCT00855816|12210521|FG001|Overall Study|Death|0
7767768|NCT00855816|12210520|FG000|Overall Study|Became ineligible|0
7767769|NCT00855816|12210521|FG001|Overall Study|Became ineligible|1
7767770|NCT00855894|12210540|FG000|Overall Study|Death|31
7767771|NCT00855894|12210540|FG000|Overall Study|Patient's decision|1
7767772|NCT00855894|12210540|FG000|Overall Study|Disease progression|1
7767773|NCT00855920|12210547|FG000|Overall Study|Protocol Violation|0
7767774|NCT00855920|12210548|FG001|Overall Study|Protocol Violation|0
7767775|NCT00855920|12210549|FG002|Overall Study|Protocol Violation|2
7767776|NCT00855920|12210547|FG000|Overall Study|Adverse Event|2
7592444|NCT02426658|11998610|FG000|Overall Study|Withdrawal by Subject|1
7592445|NCT02426658|11998610|FG000|Overall Study|Patient expired before treatment|2
7592462|NCT02277106|11998631|FG000|Stage 2|Adverse Event|0
7592463|NCT02277106|11998632|FG001|Stage 2|Adverse Event|0
7592464|NCT02277106|11998633|FG002|Stage 2|Adverse Event|1
7592465|NCT02175030|11998646|FG000|Overall Study|Failed screen after consent|7
7592466|NCT02175030|11998647|FG001|Overall Study|Failed screen after consent|6
7592467|NCT02175030|11998646|FG000|Overall Study|Failed IUD Insertion|20
7592468|NCT02175030|11998647|FG001|Overall Study|Failed IUD Insertion|21
7592469|NCT02175030|11998646|FG000|Overall Study|Physician Decision|1
7767777|NCT00855920|12210548|FG001|Overall Study|Adverse Event|1
7767778|NCT00855920|12210549|FG002|Overall Study|Adverse Event|1
7767779|NCT00855920|12210547|FG000|Overall Study|Lack of Efficacy|2
7767780|NCT00855920|12210548|FG001|Overall Study|Lack of Efficacy|2
7767781|NCT00855920|12210549|FG002|Overall Study|Lack of Efficacy|2
7767782|NCT00855920|12210547|FG000|Overall Study|Withdrawal by Subject|2
7767783|NCT00855920|12210548|FG001|Overall Study|Withdrawal by Subject|3
7767784|NCT00855920|12210549|FG002|Overall Study|Withdrawal by Subject|2
7767785|NCT00855920|12210547|FG000|Overall Study|Lost to Follow-up|1
7767786|NCT00855920|12210548|FG001|Overall Study|Lost to Follow-up|0
7767787|NCT00855920|12210549|FG002|Overall Study|Lost to Follow-up|2
7767788|NCT00855920|12210547|FG000|Overall Study|Death|0
7767789|NCT00855920|12210548|FG001|Overall Study|Death|1
7767790|NCT00855920|12210549|FG002|Overall Study|Death|0
7767791|NCT00855920|12210547|FG000|Overall Study|Decision by the sponsor|0
7767792|NCT00855920|12210548|FG001|Overall Study|Decision by the sponsor|1
7767793|NCT00855920|12210549|FG002|Overall Study|Decision by the sponsor|1
7767794|NCT00855920|12210547|FG000|Overall Study|Other than specified above|1
7767795|NCT00855920|12210548|FG001|Overall Study|Other than specified above|1
7767796|NCT00855920|12210549|FG002|Overall Study|Other than specified above|1
7767797|NCT00855933|12210559|FG000|Overall Study|Withdrawal by Subject|0
7767798|NCT00855933|12210560|FG001|Overall Study|Withdrawal by Subject|1
7767799|NCT00855959|12210566|FG000|Overall Study|Adverse Event|2
7767800|NCT00855959|12210566|FG000|Overall Study|Lost to Follow-up|2
7767801|NCT00855959|12210566|FG000|Overall Study|Withdrawal by Subject|3
7767802|NCT00855959|12210566|FG000|Overall Study|Pregnancy|1
7767803|NCT00855959|12210566|FG000|Overall Study|Incorrect enrolment|1
7767804|NCT00856180|12210580|FG000|Overall Study|Adverse Event|4
7767805|NCT00856180|12210580|FG000|Overall Study|Progressive Disease|16
7767806|NCT00856193|12210586|FG000|Period 2|Abnormal test procedure results|0
7767807|NCT00856193|12210587|FG001|Period 2|Abnormal test procedure results|1
7767808|NCT00856193|12210586|FG000|Period 2|Lost to Follow-up|0
7767809|NCT00856193|12210587|FG001|Period 2|Lost to Follow-up|1
7767810|NCT00856206|12210595|FG000|Overall Study|Protocol Violation|6
7767811|NCT00856206|12210596|FG001|Overall Study|Protocol Violation|18
7592470|NCT02175030|11998647|FG001|Overall Study|Physician Decision|1
7767812|NCT00856206|12210595|FG000|Overall Study|Adverse Event|10
7592471|NCT02175030|11998646|FG000|Overall Study|Lost to Follow-up|6
7592472|NCT02175030|11998647|FG001|Overall Study|Lost to Follow-up|6
7592473|NCT02175030|11998646|FG000|Overall Study|Withdrawal by Subject|1
7592474|NCT02175030|11998647|FG001|Overall Study|Withdrawal by Subject|4
7592476|NCT02017717|11998666|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0
7592477|NCT02017717|11998667|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0
7592478|NCT02017717|11998668|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0
7592479|NCT02017717|11998669|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1
7592480|NCT02017717|11998670|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0
7592481|NCT02017717|11998671|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0
7592482|NCT02017717|11998672|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0
7592483|NCT02017717|11998673|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0
7592484|NCT02017717|11998674|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0
7592485|NCT02017717|11998666|FG000|Before Treatment Period|Participant request to stop therapy|0
7592486|NCT02017717|11998667|FG001|Before Treatment Period|Participant request to stop therapy|0
7592487|NCT02017717|11998668|FG002|Before Treatment Period|Participant request to stop therapy|0
7592488|NCT02017717|11998669|FG003|Before Treatment Period|Participant request to stop therapy|0
7592489|NCT02017717|11998670|FG004|Before Treatment Period|Participant request to stop therapy|5
7592490|NCT02017717|11998671|FG005|Before Treatment Period|Participant request to stop therapy|0
7592491|NCT02017717|11998672|FG006|Before Treatment Period|Participant request to stop therapy|0
7592492|NCT02017717|11998673|FG007|Before Treatment Period|Participant request to stop therapy|0
7592493|NCT02017717|11998674|FG008|Before Treatment Period|Participant request to stop therapy|0
7592494|NCT02017717|11998666|FG000|Before Treatment Period|Participant withdrew consent|0
7592495|NCT02017717|11998667|FG001|Before Treatment Period|Participant withdrew consent|0
7592496|NCT02017717|11998668|FG002|Before Treatment Period|Participant withdrew consent|0
7592497|NCT02017717|11998669|FG003|Before Treatment Period|Participant withdrew consent|0
7592498|NCT02017717|11998670|FG004|Before Treatment Period|Participant withdrew consent|11
7592499|NCT02017717|11998671|FG005|Before Treatment Period|Participant withdrew consent|0
7592500|NCT02017717|11998672|FG006|Before Treatment Period|Participant withdrew consent|0
7592501|NCT02017717|11998673|FG007|Before Treatment Period|Participant withdrew consent|0
7592502|NCT02017717|11998674|FG008|Before Treatment Period|Participant withdrew consent|2
7592503|NCT02017717|11998666|FG000|Before Treatment Period|Lost to Follow-up|0
7592504|NCT02017717|11998667|FG001|Before Treatment Period|Lost to Follow-up|0
7592505|NCT02017717|11998668|FG002|Before Treatment Period|Lost to Follow-up|0
7592506|NCT02017717|11998669|FG003|Before Treatment Period|Lost to Follow-up|0
7592507|NCT02017717|11998670|FG004|Before Treatment Period|Lost to Follow-up|1
7592508|NCT02017717|11998671|FG005|Before Treatment Period|Lost to Follow-up|0
7592509|NCT02017717|11998672|FG006|Before Treatment Period|Lost to Follow-up|0
7592510|NCT02017717|11998673|FG007|Before Treatment Period|Lost to Follow-up|0
7592511|NCT02017717|11998674|FG008|Before Treatment Period|Lost to Follow-up|0
7592512|NCT02017717|11998666|FG000|Before Treatment Period|Participant no longer met criteria|0
7592513|NCT02017717|11998667|FG001|Before Treatment Period|Participant no longer met criteria|0
7592514|NCT02017717|11998668|FG002|Before Treatment Period|Participant no longer met criteria|0
7592515|NCT02017717|11998669|FG003|Before Treatment Period|Participant no longer met criteria|1
7592516|NCT02017717|11998670|FG004|Before Treatment Period|Participant no longer met criteria|2
7592517|NCT02017717|11998671|FG005|Before Treatment Period|Participant no longer met criteria|0
7592518|NCT02017717|11998672|FG006|Before Treatment Period|Participant no longer met criteria|0
7592519|NCT02017717|11998673|FG007|Before Treatment Period|Participant no longer met criteria|1
7592520|NCT02017717|11998674|FG008|Before Treatment Period|Participant no longer met criteria|0
7592521|NCT02017717|11998666|FG000|Before Treatment Period|other reason|0
7592522|NCT02017717|11998667|FG001|Before Treatment Period|other reason|0
7592523|NCT02017717|11998668|FG002|Before Treatment Period|other reason|0
7592524|NCT02017717|11998669|FG003|Before Treatment Period|other reason|0
7592525|NCT02017717|11998670|FG004|Before Treatment Period|other reason|1
7592526|NCT02017717|11998671|FG005|Before Treatment Period|other reason|0
7592527|NCT02017717|11998672|FG006|Before Treatment Period|other reason|0
7592528|NCT02017717|11998673|FG007|Before Treatment Period|other reason|0
7592529|NCT02017717|11998674|FG008|Before Treatment Period|other reason|0
7592530|NCT02017717|11998666|FG000|Treatment Period|Disease progression|7
7592531|NCT02017717|11998667|FG001|Treatment Period|Disease progression|9
7592532|NCT02017717|11998668|FG002|Treatment Period|Disease progression|12
7592533|NCT02017717|11998669|FG003|Treatment Period|Disease progression|165
7592534|NCT02017717|11998670|FG004|Treatment Period|Disease progression|134
7592535|NCT02017717|11998671|FG005|Treatment Period|Disease progression|20
7592536|NCT02017717|11998672|FG006|Treatment Period|Disease progression|26
7592537|NCT02017717|11998673|FG007|Treatment Period|Disease progression|17
7592538|NCT02017717|11998674|FG008|Treatment Period|Disease progression|22
7592539|NCT02017717|11998666|FG000|Treatment Period|Study drug toxicity|3
7592540|NCT02017717|11998667|FG001|Treatment Period|Study drug toxicity|0
7592541|NCT02017717|11998668|FG002|Treatment Period|Study drug toxicity|1
7592542|NCT02017717|11998669|FG003|Treatment Period|Study drug toxicity|7
7592543|NCT02017717|11998670|FG004|Treatment Period|Study drug toxicity|11
7592544|NCT02017717|11998671|FG005|Treatment Period|Study drug toxicity|4
7592545|NCT02017717|11998672|FG006|Treatment Period|Study drug toxicity|4
7592546|NCT02017717|11998673|FG007|Treatment Period|Study drug toxicity|5
7592547|NCT02017717|11998674|FG008|Treatment Period|Study drug toxicity|3
7592548|NCT02017717|11998666|FG000|Treatment Period|Death|0
7592549|NCT02017717|11998667|FG001|Treatment Period|Death|0
7592550|NCT02017717|11998668|FG002|Treatment Period|Death|1
7592551|NCT02017717|11998669|FG003|Treatment Period|Death|0
7592552|NCT02017717|11998670|FG004|Treatment Period|Death|0
7592553|NCT02017717|11998671|FG005|Treatment Period|Death|0
7592554|NCT02017717|11998672|FG006|Treatment Period|Death|0
7592555|NCT02017717|11998673|FG007|Treatment Period|Death|1
7592556|NCT02017717|11998674|FG008|Treatment Period|Death|0
7592557|NCT02017717|11998666|FG000|Treatment Period|Adverse event unrelated to study drug|0
7592558|NCT02017717|11998667|FG001|Treatment Period|Adverse event unrelated to study drug|0
7592559|NCT02017717|11998668|FG002|Treatment Period|Adverse event unrelated to study drug|2
7592560|NCT02017717|11998669|FG003|Treatment Period|Adverse event unrelated to study drug|4
7592561|NCT02017717|11998670|FG004|Treatment Period|Adverse event unrelated to study drug|5
7592562|NCT02017717|11998671|FG005|Treatment Period|Adverse event unrelated to study drug|0
7592563|NCT02017717|11998672|FG006|Treatment Period|Adverse event unrelated to study drug|0
7592564|NCT02017717|11998673|FG007|Treatment Period|Adverse event unrelated to study drug|0
7592565|NCT02017717|11998674|FG008|Treatment Period|Adverse event unrelated to study drug|1
7592566|NCT02017717|11998666|FG000|Treatment Period|Participant request to stop therapy|0
7592567|NCT02017717|11998667|FG001|Treatment Period|Participant request to stop therapy|0
7592568|NCT02017717|11998668|FG002|Treatment Period|Participant request to stop therapy|3
7592569|NCT02017717|11998669|FG003|Treatment Period|Participant request to stop therapy|4
7592570|NCT02017717|11998670|FG004|Treatment Period|Participant request to stop therapy|7
7592571|NCT02017717|11998671|FG005|Treatment Period|Participant request to stop therapy|5
7592572|NCT02017717|11998672|FG006|Treatment Period|Participant request to stop therapy|0
7592573|NCT02017717|11998673|FG007|Treatment Period|Participant request to stop therapy|2
7592574|NCT02017717|11998674|FG008|Treatment Period|Participant request to stop therapy|1
7592575|NCT02017717|11998666|FG000|Treatment Period|Participant withdrew consent|0
7592576|NCT02017717|11998667|FG001|Treatment Period|Participant withdrew consent|0
7592577|NCT02017717|11998668|FG002|Treatment Period|Participant withdrew consent|1
7592578|NCT02017717|11998669|FG003|Treatment Period|Participant withdrew consent|1
7592579|NCT02017717|11998670|FG004|Treatment Period|Participant withdrew consent|4
7592580|NCT02017717|11998671|FG005|Treatment Period|Participant withdrew consent|0
7592581|NCT02017717|11998672|FG006|Treatment Period|Participant withdrew consent|0
7592582|NCT02017717|11998673|FG007|Treatment Period|Participant withdrew consent|2
7592583|NCT02017717|11998674|FG008|Treatment Period|Participant withdrew consent|0
7592584|NCT02017717|11998666|FG000|Treatment Period|Participant no longer met criteria|0
7592585|NCT02017717|11998667|FG001|Treatment Period|Participant no longer met criteria|0
7592586|NCT02017717|11998668|FG002|Treatment Period|Participant no longer met criteria|0
7592587|NCT02017717|11998669|FG003|Treatment Period|Participant no longer met criteria|0
7592588|NCT02017717|11998670|FG004|Treatment Period|Participant no longer met criteria|1
7592589|NCT02017717|11998671|FG005|Treatment Period|Participant no longer met criteria|0
7592590|NCT02017717|11998672|FG006|Treatment Period|Participant no longer met criteria|0
7592591|NCT02017717|11998673|FG007|Treatment Period|Participant no longer met criteria|0
7592592|NCT02017717|11998674|FG008|Treatment Period|Participant no longer met criteria|0
7592593|NCT02017717|11998666|FG000|Treatment Period|other reasons|0
7592594|NCT02017717|11998667|FG001|Treatment Period|other reasons|0
7592595|NCT02017717|11998668|FG002|Treatment Period|other reasons|0
7592596|NCT02017717|11998669|FG003|Treatment Period|other reasons|0
7592597|NCT02017717|11998670|FG004|Treatment Period|other reasons|1
7592598|NCT02017717|11998671|FG005|Treatment Period|other reasons|0
7592599|NCT02017717|11998672|FG006|Treatment Period|other reasons|0
7592600|NCT02017717|11998673|FG007|Treatment Period|other reasons|1
7592601|NCT02017717|11998674|FG008|Treatment Period|other reasons|1
7592602|NCT02017717|11998666|FG000|Treatment Period|Maximum clinical benefit|0
7592603|NCT02017717|11998667|FG001|Treatment Period|Maximum clinical benefit|0
7592604|NCT02017717|11998668|FG002|Treatment Period|Maximum clinical benefit|0
7592605|NCT02017717|11998669|FG003|Treatment Period|Maximum clinical benefit|0
7592606|NCT02017717|11998670|FG004|Treatment Period|Maximum clinical benefit|1
7592607|NCT02017717|11998671|FG005|Treatment Period|Maximum clinical benefit|0
7592608|NCT02017717|11998672|FG006|Treatment Period|Maximum clinical benefit|0
7592609|NCT02017717|11998673|FG007|Treatment Period|Maximum clinical benefit|0
7592610|NCT02017717|11998674|FG008|Treatment Period|Maximum clinical benefit|0
7717419|NCT00519636|12141043|FG003|Washout Period|Withdrawal by Subject|0
7717420|NCT00519636|12141040|FG000|Washout Period|Failed to meet continuation criteria|14
7717421|NCT00519636|12141041|FG001|Washout Period|Failed to meet continuation criteria|11
7717422|NCT00519636|12141042|FG002|Washout Period|Failed to meet continuation criteria|9
7717423|NCT00519636|12141043|FG003|Washout Period|Failed to meet continuation criteria|3
7717424|NCT00519636|12141040|FG000|Washout Period|Out of pollen area > 48 hours|1
7717425|NCT00519636|12141041|FG001|Washout Period|Out of pollen area > 48 hours|0
7717426|NCT00519636|12141042|FG002|Washout Period|Out of pollen area > 48 hours|0
7717427|NCT00519636|12141043|FG003|Washout Period|Out of pollen area > 48 hours|0
7717428|NCT00519636|12141040|FG000|Washout Period|Participating in study at another site|1
7717429|NCT00519636|12141041|FG001|Washout Period|Participating in study at another site|0
7717430|NCT00519636|12141042|FG002|Washout Period|Participating in study at another site|0
7717431|NCT00519636|12141043|FG003|Washout Period|Participating in study at another site|0
7717432|NCT00519636|12141040|FG000|Washout Period|Non-compliant|0
7717433|NCT00519636|12141041|FG001|Washout Period|Non-compliant|1
7717434|NCT00519636|12141042|FG002|Washout Period|Non-compliant|0
7717435|NCT00519636|12141043|FG003|Washout Period|Non-compliant|0
7717436|NCT00519636|12141040|FG000|Washout Period|Per doctors request|0
7717437|NCT00519636|12141041|FG001|Washout Period|Per doctors request|1
7717438|NCT00519636|12141042|FG002|Washout Period|Per doctors request|0
7717439|NCT00519636|12141043|FG003|Washout Period|Per doctors request|0
7717440|NCT00519636|12141040|FG000|Washout Period|Subject randomized in error|0
7717441|NCT00519636|12141041|FG001|Washout Period|Subject randomized in error|0
7717442|NCT00519636|12141042|FG002|Washout Period|Subject randomized in error|1
7717443|NCT00519636|12141043|FG003|Washout Period|Subject randomized in error|0
7717444|NCT00519636|12141040|FG000|Washout Period|Prohibited medications|0
7717445|NCT00519636|12141041|FG001|Washout Period|Prohibited medications|0
7592644|NCT01746173|11998739|FG000|Overall Study|Disease Progression|2
7717446|NCT00519636|12141042|FG002|Washout Period|Prohibited medications|1
7717447|NCT00519636|12141043|FG003|Washout Period|Prohibited medications|0
7717448|NCT00519636|12141040|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0
7717449|NCT00519636|12141041|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0
7717450|NCT00519636|12141042|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0
7717451|NCT00519636|12141043|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1
7717452|NCT00519636|12141040|FG000|Treatment Period 2|Subject randomized in error|0
7717453|NCT00519636|12141041|FG001|Treatment Period 2|Subject randomized in error|1
7717454|NCT00519636|12141042|FG002|Treatment Period 2|Subject randomized in error|0
7717455|NCT00519636|12141043|FG003|Treatment Period 2|Subject randomized in error|0
7717456|NCT00519636|12141040|FG000|Treatment Period 2|Per doctors request|0
7717457|NCT00519636|12141041|FG001|Treatment Period 2|Per doctors request|0
7717458|NCT00519636|12141042|FG002|Treatment Period 2|Per doctors request|1
7717459|NCT00519636|12141043|FG003|Treatment Period 2|Per doctors request|0
7717460|NCT00519636|12141040|FG000|Treatment Period 2|Subject misrandomized|0
7717461|NCT00519636|12141041|FG001|Treatment Period 2|Subject misrandomized|0
7717462|NCT00519636|12141042|FG002|Treatment Period 2|Subject misrandomized|0
7717463|NCT00519636|12141043|FG003|Treatment Period 2|Subject misrandomized|1
7717464|NCT00519636|12141040|FG000|Post Study Period|Subject randomized in error|0
7717465|NCT00519636|12141041|FG001|Post Study Period|Subject randomized in error|0
7717466|NCT00519636|12141042|FG002|Post Study Period|Subject randomized in error|0
7717467|NCT00519636|12141043|FG003|Post Study Period|Subject randomized in error|1
7717468|NCT00519649|12141057|FG000|Overall Study|Withdrawal by Subject|1
7770469|NCT00876460|12214452|FG004|Combination Therapy Phase|Not treated|0
7770470|NCT00876460|12214453|FG005|Combination Therapy Phase|Not treated|0
7770471|NCT00876460|12214454|FG006|Combination Therapy Phase|Not treated|1
7770472|NCT00876460|12214455|FG007|Combination Therapy Phase|Not treated|0
7770473|NCT00876460|12214448|FG000|Mono Therapy Phase|Progressive disease|0
7770474|NCT00876460|12214449|FG001|Mono Therapy Phase|Progressive disease|0
7770475|NCT00876460|12214450|FG002|Mono Therapy Phase|Progressive disease|0
7770476|NCT00876460|12214451|FG003|Mono Therapy Phase|Progressive disease|0
7770477|NCT00876460|12214452|FG004|Mono Therapy Phase|Progressive disease|2
7770478|NCT00876460|12214453|FG005|Mono Therapy Phase|Progressive disease|0
7770479|NCT00876460|12214454|FG006|Mono Therapy Phase|Progressive disease|1
7770480|NCT00876460|12214455|FG007|Mono Therapy Phase|Progressive disease|3
7770481|NCT00876460|12214448|FG000|Mono Therapy Phase|Withdrawal by Subject|0
7770482|NCT00876460|12214449|FG001|Mono Therapy Phase|Withdrawal by Subject|1
7770483|NCT00876460|12214450|FG002|Mono Therapy Phase|Withdrawal by Subject|0
7770484|NCT00876460|12214451|FG003|Mono Therapy Phase|Withdrawal by Subject|0
7770485|NCT00876460|12214452|FG004|Mono Therapy Phase|Withdrawal by Subject|0
7770486|NCT00876460|12214453|FG005|Mono Therapy Phase|Withdrawal by Subject|0
7770487|NCT00876460|12214454|FG006|Mono Therapy Phase|Withdrawal by Subject|0
7770488|NCT00876460|12214455|FG007|Mono Therapy Phase|Withdrawal by Subject|0
7770489|NCT00876460|12214448|FG000|Mono Therapy Phase|Adverse Event|0
7770490|NCT00876460|12214449|FG001|Mono Therapy Phase|Adverse Event|0
7770491|NCT00876460|12214450|FG002|Mono Therapy Phase|Adverse Event|0
7770492|NCT00876460|12214451|FG003|Mono Therapy Phase|Adverse Event|1
7770493|NCT00876460|12214452|FG004|Mono Therapy Phase|Adverse Event|0
7770494|NCT00876460|12214453|FG005|Mono Therapy Phase|Adverse Event|0
7770495|NCT00876460|12214454|FG006|Mono Therapy Phase|Adverse Event|0
7770496|NCT00876460|12214455|FG007|Mono Therapy Phase|Adverse Event|0
7770497|NCT00876694|12214487|FG000|Overall Study|Adverse Event|10
7770498|NCT00876694|12214488|FG001|Overall Study|Adverse Event|7
7770499|NCT00876694|12214487|FG000|Overall Study|Subject withdrew consent|6
7770500|NCT00876694|12214488|FG001|Overall Study|Subject withdrew consent|4
7770501|NCT00876694|12214487|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7770502|NCT00876694|12214488|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7770503|NCT00876694|12214487|FG000|Overall Study|Abnormal test procedure result(s)|1
7770504|NCT00876694|12214488|FG001|Overall Study|Abnormal test procedure result(s)|0
7770505|NCT00876694|12214487|FG000|Overall Study|Administrative problems|1
7770506|NCT00876694|12214488|FG001|Overall Study|Administrative problems|1
7770507|NCT00876694|12214487|FG000|Overall Study|Death|1
7770508|NCT00876694|12214488|FG001|Overall Study|Death|0
7770509|NCT00876733|12214498|FG000|Overall Study|Adverse Event|34
7770510|NCT00876733|12214499|FG001|Overall Study|Adverse Event|20
7770511|NCT00876733|12214500|FG002|Overall Study|Adverse Event|10
7770512|NCT00876733|12214501|FG003|Overall Study|Adverse Event|3
7770513|NCT00876733|12214498|FG000|Overall Study|Lack of Efficacy|17
7770514|NCT00876733|12214499|FG001|Overall Study|Lack of Efficacy|9
7770515|NCT00876733|12214500|FG002|Overall Study|Lack of Efficacy|10
7770516|NCT00876733|12214501|FG003|Overall Study|Lack of Efficacy|1
7770517|NCT00876733|12214498|FG000|Overall Study|Lost to Follow-up|26
7770518|NCT00876733|12214499|FG001|Overall Study|Lost to Follow-up|10
7770519|NCT00876733|12214500|FG002|Overall Study|Lost to Follow-up|3
7770520|NCT00876733|12214501|FG003|Overall Study|Lost to Follow-up|2
7770521|NCT00876733|12214498|FG000|Overall Study|Data not available|14
7770522|NCT00876733|12214499|FG001|Overall Study|Data not available|3
7770523|NCT00876733|12214500|FG002|Overall Study|Data not available|7
7770524|NCT00876733|12214501|FG003|Overall Study|Data not available|1
7770525|NCT00876928|12214526|FG000|Overall Study|Lost to Follow-up|2
7770526|NCT00876928|12214527|FG001|Overall Study|Lost to Follow-up|5
7770527|NCT00876928|12214526|FG000|Overall Study|Hypokalemia-affects insulin secretion|1
7770528|NCT00876928|12214527|FG001|Overall Study|Hypokalemia-affects insulin secretion|0
7770529|NCT00877006|12214558|FG000|Treatment Period|Death|2
7770530|NCT00877006|12214559|FG001|Treatment Period|Death|1
7770531|NCT00877006|12214558|FG000|Treatment Period|Adverse Event|10
7770532|NCT00877006|12214559|FG001|Treatment Period|Adverse Event|3
7770533|NCT00877006|12214558|FG000|Treatment Period|Withdrawal by Subject|2
7770534|NCT00877006|12214559|FG001|Treatment Period|Withdrawal by Subject|3
7770535|NCT00877006|12214558|FG000|Treatment Period|Protocol Violation|1
7770536|NCT00877006|12214559|FG001|Treatment Period|Protocol Violation|0
7770537|NCT00877006|12214558|FG000|Treatment Period|Lost to Follow-up|0
7770538|NCT00877006|12214559|FG001|Treatment Period|Lost to Follow-up|1
7770539|NCT00877006|12214558|FG000|Treatment Period|Disease Progression|1
7770540|NCT00877006|12214559|FG001|Treatment Period|Disease Progression|2
7770541|NCT00877006|12214558|FG000|Treatment Period|Started New Treatment Regimen|2
7770542|NCT00877006|12214559|FG001|Treatment Period|Started New Treatment Regimen|5
7770543|NCT00877006|12214558|FG000|Treatment Period|Other|4
7770544|NCT00877006|12214559|FG001|Treatment Period|Other|4
7770545|NCT00877006|12214558|FG000|Treatment Period|Randomized but Not Treated|3
7770546|NCT00877006|12214559|FG001|Treatment Period|Randomized but Not Treated|8
7770547|NCT00877006|12214558|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12
7770548|NCT00877006|12214559|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19
7770549|NCT00877006|12214558|FG000|Long-Term Follow-up Period|Lost to Follow-up|8
7770550|NCT00877006|12214559|FG001|Long-Term Follow-up Period|Lost to Follow-up|9
7770551|NCT00877006|12214558|FG000|Long-Term Follow-up Period|Death|26
7770552|NCT00877006|12214559|FG001|Long-Term Follow-up Period|Death|18
7770553|NCT00877006|12214558|FG000|Long-Term Follow-up Period|Other|7
7770554|NCT00877006|12214559|FG001|Long-Term Follow-up Period|Other|9
7770555|NCT00877032|12214574|FG000|Overall Study|Did not meet entrance criteria|0
7770556|NCT00877032|12214575|FG001|Overall Study|Did not meet entrance criteria|0
7770557|NCT00877032|12214576|FG002|Overall Study|Did not meet entrance criteria|0
7770558|NCT00877032|12214577|FG003|Overall Study|Did not meet entrance criteria|1
7770559|NCT00877032|12214578|FG004|Overall Study|Did not meet entrance criteria|0
7770560|NCT00877032|12214579|FG005|Overall Study|Did not meet entrance criteria|0
7770561|NCT00877032|12214580|FG006|Overall Study|Did not meet entrance criteria|2
7770562|NCT00877383|12214615|FG000|Overall Study|Adverse Event|13
7770563|NCT00877383|12214616|FG001|Overall Study|Adverse Event|14
7770564|NCT00877383|12214615|FG000|Overall Study|Lost to Follow-up|5
7770565|NCT00877383|12214616|FG001|Overall Study|Lost to Follow-up|3
7770566|NCT00877383|12214615|FG000|Overall Study|Subject withdrew consent|3
7770567|NCT00877383|12214616|FG001|Overall Study|Subject withdrew consent|12
7770568|NCT00877383|12214615|FG000|Overall Study|Subject no longer requires study drug|2
7770569|NCT00877383|12214616|FG001|Overall Study|Subject no longer requires study drug|0
7770570|NCT00877383|12214615|FG000|Overall Study|Administrative problems|2
7770571|NCT00877383|12214616|FG001|Overall Study|Administrative problems|0
7770572|NCT00877383|12214615|FG000|Overall Study|Protocol deviation|2
7592713|NCT01349959|11998795|FG000|Overall Study|Adverse Event|7
7770573|NCT00877383|12214616|FG001|Overall Study|Protocol deviation|6
7770574|NCT00877383|12214615|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7770575|NCT00877383|12214616|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7770576|NCT00877383|12214615|FG000|Overall Study|Death|1
7770577|NCT00877383|12214616|FG001|Overall Study|Death|2
7770578|NCT00877487|12214651|FG000|Open-label Treatment Phase|Adverse Event|1
7770579|NCT00877487|12214652|FG001|Open-label Treatment Phase|Adverse Event|0
7770580|NCT00877487|12214651|FG000|Open-label Treatment Phase|Protocol Violation|3
7770581|NCT00877487|12214652|FG001|Open-label Treatment Phase|Protocol Violation|0
7770582|NCT00877487|12214651|FG000|Open-label Treatment Phase|Withdrawal by Subject|1
7770583|NCT00877487|12214652|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
7770584|NCT00877487|12214651|FG000|Open-label Treatment Phase|Lost to Follow-up|1
7770585|NCT00877487|12214652|FG001|Open-label Treatment Phase|Lost to Follow-up|0
7770586|NCT00877487|12214651|FG000|Open-label Treatment Phase|Out of country for business|1
7770587|NCT00877487|12214652|FG001|Open-label Treatment Phase|Out of country for business|0
7770588|NCT00877487|12214651|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
7770589|NCT00877487|12214652|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
7770590|NCT00877487|12214651|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0
7770591|NCT00877487|12214652|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1
7770592|NCT00877487|12214651|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
7770593|NCT00877487|12214652|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
7770594|NCT00877487|12214651|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1
7770595|NCT00877487|12214652|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0
7770596|NCT00877773|12214667|FG000|Overall Study|Disease Progression|44
7770597|NCT00877799|12214676|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
7770598|NCT00877799|12214677|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
7770599|NCT00877799|12214678|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
7770600|NCT00877799|12214679|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
7770601|NCT00877799|12214680|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
7770602|NCT00877799|12214676|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
7770603|NCT00877799|12214677|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
7770604|NCT00877799|12214678|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
7770605|NCT00877799|12214679|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
7770606|NCT00877799|12214680|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
7770607|NCT00877799|12214676|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
7770608|NCT00877799|12214677|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
7770609|NCT00877799|12214678|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
7770610|NCT00877799|12214679|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
7770611|NCT00877799|12214680|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
7770612|NCT00877799|12214676|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
7770613|NCT00877799|12214677|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
7770614|NCT00877799|12214678|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
7770615|NCT00877799|12214679|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
7770616|NCT00877799|12214680|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
7770617|NCT00877799|12214676|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
7770618|NCT00877799|12214677|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
7770619|NCT00877799|12214678|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
7770620|NCT00877799|12214679|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
7770621|NCT00877799|12214680|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
7770622|NCT00877890|12214702|FG000|Overall Study|Adverse Event|6
7770623|NCT00877890|12214703|FG001|Overall Study|Adverse Event|6
7770624|NCT00877890|12214702|FG000|Overall Study|Lost to Follow-up|5
7770625|NCT00877890|12214703|FG001|Overall Study|Lost to Follow-up|5
7770626|NCT00877890|12214702|FG000|Overall Study|Protocol Violation|0
7770627|NCT00877890|12214703|FG001|Overall Study|Protocol Violation|1
7770628|NCT00877890|12214702|FG000|Overall Study|Withdrawal of Consent|6
7770629|NCT00877890|12214703|FG001|Overall Study|Withdrawal of Consent|12
7770630|NCT00877890|12214702|FG000|Overall Study|Investigator Decision|0
7770631|NCT00877890|12214703|FG001|Overall Study|Investigator Decision|2
7770632|NCT00877890|12214702|FG000|Overall Study|Loss of Glucose Control|3
7770633|NCT00877890|12214703|FG001|Overall Study|Loss of Glucose Control|4
7770634|NCT00877929|12214715|FG000|Overall Study|Adverse Event|11
7770635|NCT00877929|12214716|FG001|Overall Study|Adverse Event|20
7770636|NCT00877929|12214715|FG000|Overall Study|Protocol Violation|3
7770637|NCT00877929|12214716|FG001|Overall Study|Protocol Violation|3
7770638|NCT00877929|12214715|FG000|Overall Study|Lost to Follow-up|0
7770639|NCT00877929|12214716|FG001|Overall Study|Lost to Follow-up|1
7770640|NCT00877929|12214715|FG000|Overall Study|Withdrawal by Subject|4
7770641|NCT00877929|12214716|FG001|Overall Study|Withdrawal by Subject|4
7770642|NCT00877929|12214715|FG000|Overall Study|Lack of Efficacy|0
7770643|NCT00877929|12214716|FG001|Overall Study|Lack of Efficacy|1
7770644|NCT00877929|12214715|FG000|Overall Study|Other reason (not specified)|2
7770645|NCT00877929|12214716|FG001|Overall Study|Other reason (not specified)|6
7770646|NCT00878072|12214726|FG000|Overall Study|Withdrew consent|2
7770647|NCT00878189|12214737|FG000|Overall Study|Death|0
7770648|NCT00878189|12214738|FG001|Overall Study|Death|1
7770649|NCT00878189|12214739|FG002|Overall Study|Death|0
7770650|NCT00878189|12214740|FG003|Overall Study|Death|1
7770651|NCT00878189|12214741|FG004|Overall Study|Death|0
7770652|NCT00878189|12214742|FG005|Overall Study|Death|0
7770653|NCT00878189|12214743|FG006|Overall Study|Death|0
7770654|NCT00878189|12214744|FG007|Overall Study|Death|0
7770655|NCT00878189|12214745|FG008|Overall Study|Death|1
7770656|NCT00878189|12214737|FG000|Overall Study|Participant Refused to Follow-up|0
7770657|NCT00878189|12214738|FG001|Overall Study|Participant Refused to Follow-up|0
7770658|NCT00878189|12214739|FG002|Overall Study|Participant Refused to Follow-up|0
7770659|NCT00878189|12214740|FG003|Overall Study|Participant Refused to Follow-up|0
7770660|NCT00878189|12214741|FG004|Overall Study|Participant Refused to Follow-up|0
7770661|NCT00878189|12214742|FG005|Overall Study|Participant Refused to Follow-up|4
7770662|NCT00878189|12214743|FG006|Overall Study|Participant Refused to Follow-up|0
7770663|NCT00878189|12214744|FG007|Overall Study|Participant Refused to Follow-up|0
7770664|NCT00878189|12214745|FG008|Overall Study|Participant Refused to Follow-up|0
7770665|NCT00878189|12214737|FG000|Overall Study|Other|3
7770666|NCT00878189|12214738|FG001|Overall Study|Other|2
7770667|NCT00878189|12214739|FG002|Overall Study|Other|4
7770668|NCT00878189|12214740|FG003|Overall Study|Other|7
7770669|NCT00878189|12214741|FG004|Overall Study|Other|4
7770670|NCT00878189|12214742|FG005|Overall Study|Other|18
7770671|NCT00878189|12214743|FG006|Overall Study|Other|15
7770672|NCT00878189|12214744|FG007|Overall Study|Other|3
7770673|NCT00878189|12214745|FG008|Overall Study|Other|4
7770674|NCT00878189|12214737|FG000|Overall Study|Lost to Follow-up|0
7770675|NCT00878189|12214738|FG001|Overall Study|Lost to Follow-up|0
7770676|NCT00878189|12214739|FG002|Overall Study|Lost to Follow-up|0
7770677|NCT00878189|12214740|FG003|Overall Study|Lost to Follow-up|0
7770678|NCT00878189|12214741|FG004|Overall Study|Lost to Follow-up|0
7770679|NCT00878189|12214742|FG005|Overall Study|Lost to Follow-up|1
7770680|NCT00878189|12214743|FG006|Overall Study|Lost to Follow-up|1
7770681|NCT00878189|12214744|FG007|Overall Study|Lost to Follow-up|0
7770682|NCT00878189|12214745|FG008|Overall Study|Lost to Follow-up|0
7770683|NCT00878189|12214737|FG000|Overall Study|Objection Progression or Relapse|0
7770684|NCT00878189|12214738|FG001|Overall Study|Objection Progression or Relapse|0
7770685|NCT00878189|12214739|FG002|Overall Study|Objection Progression or Relapse|0
7770686|NCT00878189|12214740|FG003|Overall Study|Objection Progression or Relapse|0
7770687|NCT00878189|12214741|FG004|Overall Study|Objection Progression or Relapse|0
7770688|NCT00878189|12214742|FG005|Overall Study|Objection Progression or Relapse|0
7770689|NCT00878189|12214743|FG006|Overall Study|Objection Progression or Relapse|0
7770690|NCT00878189|12214744|FG007|Overall Study|Objection Progression or Relapse|0
7770691|NCT00878189|12214745|FG008|Overall Study|Objection Progression or Relapse|3
7770692|NCT00878215|12214783|FG000|Overall Study|Determined to be ineligible|0
7770693|NCT00878215|12214784|FG001|Overall Study|Determined to be ineligible|10
7770694|NCT00878215|12214785|FG002|Overall Study|Determined to be ineligible|0
7770695|NCT00878215|12214786|FG003|Overall Study|Determined to be ineligible|0
7770696|NCT00878501|12214817|FG000|Overall Study|Adverse Event|11
7770697|NCT00878501|12214818|FG001|Overall Study|Adverse Event|3
7770698|NCT00878501|12214819|FG002|Overall Study|Adverse Event|3
7770699|NCT00878501|12214817|FG000|Overall Study|Lack of Efficacy|2
7770700|NCT00878501|12214818|FG001|Overall Study|Lack of Efficacy|1
7770701|NCT00878501|12214819|FG002|Overall Study|Lack of Efficacy|0
7770702|NCT00878501|12214817|FG000|Overall Study|Withdrawal by Subject|2
7770703|NCT00878501|12214818|FG001|Overall Study|Withdrawal by Subject|1
7770704|NCT00878501|12214819|FG002|Overall Study|Withdrawal by Subject|2
7770705|NCT00878501|12214817|FG000|Overall Study|Protocol Violation|0
7770706|NCT00878501|12214818|FG001|Overall Study|Protocol Violation|0
7770707|NCT00878501|12214819|FG002|Overall Study|Protocol Violation|1
7770708|NCT00878501|12214817|FG000|Overall Study|Incorrect enrolment|1
7770709|NCT00878501|12214818|FG001|Overall Study|Incorrect enrolment|2
7770710|NCT00878501|12214819|FG002|Overall Study|Incorrect enrolment|0
7770711|NCT00878501|12214817|FG000|Overall Study|Intake of prohibited concom. medication|0
7770712|NCT00878501|12214818|FG001|Overall Study|Intake of prohibited concom. medication|0
7770713|NCT00878501|12214819|FG002|Overall Study|Intake of prohibited concom. medication|1
7770714|NCT00878501|12214817|FG000|Overall Study|Mis-randomisation of patient|1
7770715|NCT00878501|12214818|FG001|Overall Study|Mis-randomisation of patient|0
7770716|NCT00878501|12214819|FG002|Overall Study|Mis-randomisation of patient|0
7770717|NCT00878501|12214817|FG000|Overall Study|Administrative|0
7770718|NCT00878501|12214818|FG001|Overall Study|Administrative|0
7770719|NCT00878501|12214819|FG002|Overall Study|Administrative|1
7770720|NCT00878553|12214831|FG000|Sleep Study|Withdrawal by Subject|2
7770721|NCT00878553|12214832|FG001|Sleep Study|Withdrawal by Subject|0
7770722|NCT00878553|12214833|FG002|Sleep Study|Withdrawal by Subject|0
7770723|NCT00878553|12214834|FG003|Sleep Study|Withdrawal by Subject|0
7770724|NCT00878553|12214835|FG004|Sleep Study|Withdrawal by Subject|0
7770725|NCT00878553|12214831|FG000|Sleep Study|Lost to Follow-up|1
7770726|NCT00878553|12214832|FG001|Sleep Study|Lost to Follow-up|0
7770727|NCT00878553|12214833|FG002|Sleep Study|Lost to Follow-up|0
7770728|NCT00878553|12214834|FG003|Sleep Study|Lost to Follow-up|0
7770729|NCT00878553|12214835|FG004|Sleep Study|Lost to Follow-up|0
7770730|NCT00878553|12214831|FG000|Sleep Study|car accident|1
7770731|NCT00878553|12214832|FG001|Sleep Study|car accident|0
7770732|NCT00878553|12214833|FG002|Sleep Study|car accident|0
7770733|NCT00878553|12214834|FG003|Sleep Study|car accident|0
7770734|NCT00878553|12214835|FG004|Sleep Study|car accident|0
7770735|NCT00878553|12214831|FG000|Sleep Study|family emergency|1
7770736|NCT00878553|12214832|FG001|Sleep Study|family emergency|0
7770737|NCT00878553|12214833|FG002|Sleep Study|family emergency|0
7770738|NCT00878553|12214834|FG003|Sleep Study|family emergency|0
7770739|NCT00878553|12214835|FG004|Sleep Study|family emergency|0
7770740|NCT00878553|12214831|FG000|PK Study|Withdrawal by Subject|0
7770741|NCT00878553|12214832|FG001|PK Study|Withdrawal by Subject|0
7770742|NCT00878553|12214833|FG002|PK Study|Withdrawal by Subject|0
7770743|NCT00878553|12214834|FG003|PK Study|Withdrawal by Subject|1
7770744|NCT00878553|12214835|FG004|PK Study|Withdrawal by Subject|0
7770745|NCT00878709|12214863|FG000|Overall Study|Withdrawal by Subject|197
7770746|NCT00878709|12214864|FG001|Overall Study|Withdrawal by Subject|120
7770747|NCT00878709|12214863|FG000|Overall Study|Lost to Follow-up|35
7770748|NCT00878709|12214864|FG001|Overall Study|Lost to Follow-up|33
7770749|NCT00878709|12214863|FG000|Overall Study|Other Reasons|93
7770750|NCT00878709|12214864|FG001|Overall Study|Other Reasons|84
7770751|NCT00878722|12214879|FG000|Overall Study|Progressive disease|3
7770752|NCT00878722|12214880|FG001|Overall Study|Progressive disease|3
7770753|NCT00878722|12214881|FG002|Overall Study|Progressive disease|3
7770754|NCT00878722|12214882|FG003|Overall Study|Progressive disease|7
7770755|NCT00878722|12214883|FG004|Overall Study|Progressive disease|7
7770756|NCT00878722|12214884|FG005|Overall Study|Progressive disease|1
7770757|NCT00878722|12214885|FG006|Overall Study|Progressive disease|4
7770758|NCT00878722|12214886|FG007|Overall Study|Progressive disease|3
7770759|NCT00878722|12214879|FG000|Overall Study|Death|0
7770760|NCT00878722|12214880|FG001|Overall Study|Death|0
7770761|NCT00878722|12214881|FG002|Overall Study|Death|0
7770762|NCT00878722|12214882|FG003|Overall Study|Death|1
7770763|NCT00878722|12214883|FG004|Overall Study|Death|0
7770764|NCT00878722|12214884|FG005|Overall Study|Death|1
7770765|NCT00878722|12214885|FG006|Overall Study|Death|0
7770766|NCT00878722|12214886|FG007|Overall Study|Death|2
7770767|NCT00878722|12214879|FG000|Overall Study|Adverse Event|0
7770768|NCT00878722|12214880|FG001|Overall Study|Adverse Event|0
7770769|NCT00878722|12214881|FG002|Overall Study|Adverse Event|0
7770770|NCT00878722|12214882|FG003|Overall Study|Adverse Event|0
7770771|NCT00878722|12214883|FG004|Overall Study|Adverse Event|0
7770772|NCT00878722|12214884|FG005|Overall Study|Adverse Event|0
7770773|NCT00878722|12214885|FG006|Overall Study|Adverse Event|2
7770774|NCT00878722|12214886|FG007|Overall Study|Adverse Event|0
7770775|NCT00878722|12214879|FG000|Overall Study|Withdrawal by Subject|0
7770776|NCT00878722|12214880|FG001|Overall Study|Withdrawal by Subject|0
7770777|NCT00878722|12214881|FG002|Overall Study|Withdrawal by Subject|0
7770778|NCT00878722|12214882|FG003|Overall Study|Withdrawal by Subject|0
7770779|NCT00878722|12214883|FG004|Overall Study|Withdrawal by Subject|0
7770780|NCT00878722|12214884|FG005|Overall Study|Withdrawal by Subject|0
7770781|NCT00878722|12214885|FG006|Overall Study|Withdrawal by Subject|0
7770782|NCT00878722|12214886|FG007|Overall Study|Withdrawal by Subject|2
7770783|NCT00878722|12214879|FG000|Overall Study|Relapse|0
7770784|NCT00878722|12214880|FG001|Overall Study|Relapse|0
7770785|NCT00878722|12214881|FG002|Overall Study|Relapse|0
7770786|NCT00878722|12214882|FG003|Overall Study|Relapse|1
7770787|NCT00878722|12214883|FG004|Overall Study|Relapse|0
7770788|NCT00878722|12214884|FG005|Overall Study|Relapse|0
7770789|NCT00878722|12214885|FG006|Overall Study|Relapse|0
7770790|NCT00878722|12214886|FG007|Overall Study|Relapse|0
7770791|NCT00878800|12214912|FG000|Overall Study|Adverse Event|0
7770792|NCT00878800|12214913|FG001|Overall Study|Adverse Event|0
7770793|NCT00878800|12214914|FG002|Overall Study|Adverse Event|2
7770794|NCT00878800|12214915|FG003|Overall Study|Adverse Event|0
7770795|NCT00878800|12214916|FG004|Overall Study|Adverse Event|1
7770796|NCT00878800|12214912|FG000|Overall Study|Progressive disease|1
7770797|NCT00878800|12214913|FG001|Overall Study|Progressive disease|5
7770798|NCT00878800|12214914|FG002|Overall Study|Progressive disease|6
7770799|NCT00878800|12214915|FG003|Overall Study|Progressive disease|5
7770800|NCT00878800|12214916|FG004|Overall Study|Progressive disease|13
7770801|NCT00878800|12214912|FG000|Overall Study|Withdrew consent|1
7770802|NCT00878800|12214913|FG001|Overall Study|Withdrew consent|1
7770803|NCT00878800|12214914|FG002|Overall Study|Withdrew consent|0
7770804|NCT00878800|12214915|FG003|Overall Study|Withdrew consent|1
7770805|NCT00878800|12214916|FG004|Overall Study|Withdrew consent|1
7770806|NCT00878800|12214912|FG000|Overall Study|Death|0
7770807|NCT00878800|12214913|FG001|Overall Study|Death|0
7770808|NCT00878800|12214914|FG002|Overall Study|Death|1
7770809|NCT00878800|12214915|FG003|Overall Study|Death|0
7770810|NCT00878800|12214916|FG004|Overall Study|Death|0
7770811|NCT00878800|12214912|FG000|Overall Study|Other|1
7770812|NCT00878800|12214913|FG001|Overall Study|Other|1
7770813|NCT00878800|12214914|FG002|Overall Study|Other|0
7770814|NCT00878800|12214915|FG003|Overall Study|Other|0
7770815|NCT00878800|12214916|FG004|Overall Study|Other|1
7770816|NCT00878995|12214953|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0
7770817|NCT00878995|12214954|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2
7770818|NCT00879229|12214987|FG000|Overall Study|Study terminated by Sponsor|13
7770819|NCT00879229|12214988|FG001|Overall Study|Study terminated by Sponsor|12
7770820|NCT00879229|12214987|FG000|Overall Study|Death|4
7770821|NCT00879229|12214988|FG001|Overall Study|Death|2
7770822|NCT00879229|12214987|FG000|Overall Study|Adverse Event|2
7770823|NCT00879229|12214988|FG001|Overall Study|Adverse Event|0
7592948|NCT00700882|11998960|FG000|Overall Study|Never received treatment|6
7592949|NCT00700882|11998960|FG000|Overall Study|Ineligible|2
7592950|NCT00700882|11998960|FG000|Overall Study|No KIT mutation|51
7770824|NCT00879229|12214987|FG000|Overall Study|Withdrawal by Subject|1
7770825|NCT00879229|12214988|FG001|Overall Study|Withdrawal by Subject|0
7770826|NCT00879229|12214987|FG000|Overall Study|Clinical status did not improve|1
7770827|NCT00879229|12214988|FG001|Overall Study|Clinical status did not improve|0
7770828|NCT00879229|12214987|FG000|Overall Study|Other|1
7770829|NCT00879229|12214988|FG001|Overall Study|Other|0
7770830|NCT00879333|12215005|FG000|Overall Study|Adverse Event|94
7770831|NCT00879333|12215006|FG001|Overall Study|Adverse Event|34
7770832|NCT00879333|12215005|FG000|Overall Study|Abnormal Laboratory Value|1
7770833|NCT00879333|12215006|FG001|Overall Study|Abnormal Laboratory Value|0
7770834|NCT00879333|12215005|FG000|Overall Study|Withdrawal by Subject|20
7770835|NCT00879333|12215006|FG001|Overall Study|Withdrawal by Subject|7
7770836|NCT00879333|12215005|FG000|Overall Study|Lost to Follow-up|2
7770837|NCT00879333|12215006|FG001|Overall Study|Lost to Follow-up|1
7770838|NCT00879333|12215005|FG000|Overall Study|Administrative Problems|2
7770839|NCT00879333|12215006|FG001|Overall Study|Administrative Problems|0
7770840|NCT00879333|12215005|FG000|Overall Study|Death|16
7770841|NCT00879333|12215006|FG001|Overall Study|Death|5
7770842|NCT00879333|12215005|FG000|Overall Study|Disease Progression|292
7770843|NCT00879333|12215006|FG001|Overall Study|Disease Progression|169
7770844|NCT00879333|12215005|FG000|Overall Study|Protocol Violation|1
7770845|NCT00879333|12215006|FG001|Overall Study|Protocol Violation|1
7592973|NCT00644228|11998979|FG000|Randomization & Eligibility|Ineligible|31
7592974|NCT00644228|11998980|FG001|Randomization & Eligibility|Ineligible|21
7592975|NCT00644228|11998979|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
7592976|NCT00644228|11998980|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
7592977|NCT00644228|11998979|FG000|Randomization & Eligibility|Invalid Consent|0
7592978|NCT00644228|11998980|FG001|Randomization & Eligibility|Invalid Consent|1
7592979|NCT00644228|11998979|FG000|Induction Therapy|Adverse Event|22
7592980|NCT00644228|11998980|FG001|Induction Therapy|Adverse Event|55
7592981|NCT00644228|11998979|FG000|Induction Therapy|Withdrawal by Subject|10
7592982|NCT00644228|11998980|FG001|Induction Therapy|Withdrawal by Subject|3
7592983|NCT00644228|11998979|FG000|Induction Therapy|Progression/Relapse|24
7592984|NCT00644228|11998980|FG001|Induction Therapy|Progression/Relapse|12
7592985|NCT00644228|11998979|FG000|Induction Therapy|Death|3
7592986|NCT00644228|11998980|FG001|Induction Therapy|Death|7
7592987|NCT00644228|11998979|FG000|Induction Therapy|Not Protocol-Specified|24
7592988|NCT00644228|11998980|FG001|Induction Therapy|Not Protocol-Specified|28
7592989|NCT00644228|11998979|FG000|Maintenance|Adverse Event|27
7592990|NCT00644228|11998980|FG001|Maintenance|Adverse Event|31
7592991|NCT00644228|11998979|FG000|Maintenance|Withdrawal by Subject|6
7592992|NCT00644228|11998980|FG001|Maintenance|Withdrawal by Subject|4
7592993|NCT00644228|11998979|FG000|Maintenance|Progression/Relapse|67
7592994|NCT00644228|11998980|FG001|Maintenance|Progression/Relapse|42
7770846|NCT00879398|12215019|FG000|Overall Study|Visit Stop|399
7770847|NCT00879398|12215019|FG000|Overall Study|Lack of Efficacy|64
7770848|NCT00879398|12215019|FG000|Overall Study|Adverse Event|41
7770849|NCT00879398|12215019|FG000|Overall Study|Other Reasons|171
7770850|NCT00879411|12215023|FG000|Overall Study|lost to follow-up (non-AE)|162
7592995|NCT00644228|11998979|FG000|Maintenance|Death|3
7592996|NCT00644228|11998980|FG001|Maintenance|Death|3
7592997|NCT00644228|11998979|FG000|Maintenance|Not Protocol-Specified|14
7592998|NCT00644228|11998980|FG001|Maintenance|Not Protocol-Specified|15
7592999|NCT00644228|11998979|FG000|Maintenance|On Treatment|26
7593000|NCT00644228|11998980|FG001|Maintenance|On Treatment|40
7770851|NCT00879437|12215027|FG000|Overall Study|Protocol Violation|0
7770852|NCT00879437|12215028|FG001|Overall Study|Protocol Violation|1
7770853|NCT00879437|12215027|FG000|Overall Study|Death|1
7770854|NCT00879437|12215028|FG001|Overall Study|Death|0
7770855|NCT00879645|12215040|FG000|Overall Study|Adverse Event|1
7770856|NCT00879645|12215041|FG001|Overall Study|Adverse Event|0
7770857|NCT00879645|12215042|FG002|Overall Study|Adverse Event|0
7770858|NCT00879645|12215043|FG003|Overall Study|Adverse Event|0
7770859|NCT00879658|12215060|FG000|Overall Study|Abnormal laboratory value(s)|3
7770860|NCT00879658|12215061|FG001|Overall Study|Abnormal laboratory value(s)|0
7770861|NCT00879658|12215062|FG002|Overall Study|Abnormal laboratory value(s)|0
7770862|NCT00879658|12215063|FG003|Overall Study|Abnormal laboratory value(s)|1
7770863|NCT00879658|12215064|FG004|Overall Study|Abnormal laboratory value(s)|0
7770864|NCT00879658|12215065|FG005|Overall Study|Abnormal laboratory value(s)|0
7770865|NCT00879658|12215066|FG006|Overall Study|Abnormal laboratory value(s)|0
7770866|NCT00879658|12215060|FG000|Overall Study|Administrative problems|2
7770867|NCT00879658|12215061|FG001|Overall Study|Administrative problems|1
7770868|NCT00879658|12215062|FG002|Overall Study|Administrative problems|0
7770869|NCT00879658|12215063|FG003|Overall Study|Administrative problems|1
7770870|NCT00879658|12215064|FG004|Overall Study|Administrative problems|0
7770871|NCT00879658|12215065|FG005|Overall Study|Administrative problems|0
7770872|NCT00879658|12215066|FG006|Overall Study|Administrative problems|0
7770873|NCT00879658|12215060|FG000|Overall Study|Adverse Event|6
7770874|NCT00879658|12215061|FG001|Overall Study|Adverse Event|4
7770875|NCT00879658|12215062|FG002|Overall Study|Adverse Event|3
7770876|NCT00879658|12215063|FG003|Overall Study|Adverse Event|1
7770877|NCT00879658|12215064|FG004|Overall Study|Adverse Event|2
7770878|NCT00879658|12215065|FG005|Overall Study|Adverse Event|0
7770879|NCT00879658|12215066|FG006|Overall Study|Adverse Event|0
7770880|NCT00879658|12215060|FG000|Overall Study|Protocol Violation|1
7770881|NCT00879658|12215061|FG001|Overall Study|Protocol Violation|0
7770882|NCT00879658|12215062|FG002|Overall Study|Protocol Violation|0
7770883|NCT00879658|12215063|FG003|Overall Study|Protocol Violation|0
7770884|NCT00879658|12215064|FG004|Overall Study|Protocol Violation|0
7770885|NCT00879658|12215065|FG005|Overall Study|Protocol Violation|0
7770886|NCT00879658|12215066|FG006|Overall Study|Protocol Violation|0
7770887|NCT00879658|12215060|FG000|Overall Study|Withdrawal by Subject|3
7770888|NCT00879658|12215061|FG001|Overall Study|Withdrawal by Subject|0
7770889|NCT00879658|12215062|FG002|Overall Study|Withdrawal by Subject|2
7770890|NCT00879658|12215063|FG003|Overall Study|Withdrawal by Subject|0
7770891|NCT00879658|12215064|FG004|Overall Study|Withdrawal by Subject|0
7770892|NCT00879658|12215065|FG005|Overall Study|Withdrawal by Subject|1
7770893|NCT00879658|12215066|FG006|Overall Study|Withdrawal by Subject|0
7770894|NCT00879658|12215060|FG000|Overall Study|Lack of Efficacy|0
7770895|NCT00879658|12215061|FG001|Overall Study|Lack of Efficacy|0
7770896|NCT00879658|12215062|FG002|Overall Study|Lack of Efficacy|2
7770897|NCT00879658|12215063|FG003|Overall Study|Lack of Efficacy|0
7770898|NCT00879658|12215064|FG004|Overall Study|Lack of Efficacy|0
7770899|NCT00879658|12215065|FG005|Overall Study|Lack of Efficacy|0
7770900|NCT00879658|12215066|FG006|Overall Study|Lack of Efficacy|0
7770901|NCT00879658|12215060|FG000|Overall Study|misrandomized (never received study med)|0
7770902|NCT00879658|12215061|FG001|Overall Study|misrandomized (never received study med)|0
7770903|NCT00879658|12215062|FG002|Overall Study|misrandomized (never received study med)|0
7770904|NCT00879658|12215063|FG003|Overall Study|misrandomized (never received study med)|1
7770905|NCT00879658|12215064|FG004|Overall Study|misrandomized (never received study med)|0
7770906|NCT00879658|12215065|FG005|Overall Study|misrandomized (never received study med)|0
7770907|NCT00879658|12215066|FG006|Overall Study|misrandomized (never received study med)|0
7770908|NCT00879684|12215088|FG000|Stage 1: Dose Escalation|Adverse Event|1
7770909|NCT00879684|12215089|FG001|Stage 1: Dose Escalation|Adverse Event|0
7770910|NCT00879684|12215090|FG002|Stage 1: Dose Escalation|Adverse Event|0
7770911|NCT00879684|12215091|FG003|Stage 1: Dose Escalation|Adverse Event|0
7770912|NCT00879684|12215092|FG004|Stage 1: Dose Escalation|Adverse Event|0
7770913|NCT00879684|12215093|FG005|Stage 1: Dose Escalation|Adverse Event|0
7770914|NCT00879684|12215094|FG006|Stage 1: Dose Escalation|Adverse Event|0
7770915|NCT00879684|12215088|FG000|Stage 1: Dose Escalation|Progressive Disease|2
7770916|NCT00879684|12215089|FG001|Stage 1: Dose Escalation|Progressive Disease|3
7770917|NCT00879684|12215090|FG002|Stage 1: Dose Escalation|Progressive Disease|0
7770918|NCT00879684|12215091|FG003|Stage 1: Dose Escalation|Progressive Disease|4
7770919|NCT00879684|12215092|FG004|Stage 1: Dose Escalation|Progressive Disease|3
7770920|NCT00879684|12215093|FG005|Stage 1: Dose Escalation|Progressive Disease|3
7770921|NCT00879684|12215094|FG006|Stage 1: Dose Escalation|Progressive Disease|0
7770922|NCT00879684|12215088|FG000|Stage 1: Dose Escalation|Investigator declined participation|0
7770923|NCT00879684|12215089|FG001|Stage 1: Dose Escalation|Investigator declined participation|0
7770924|NCT00879684|12215090|FG002|Stage 1: Dose Escalation|Investigator declined participation|2
7770925|NCT00879684|12215091|FG003|Stage 1: Dose Escalation|Investigator declined participation|2
7770926|NCT00879684|12215092|FG004|Stage 1: Dose Escalation|Investigator declined participation|0
7770927|NCT00879684|12215093|FG005|Stage 1: Dose Escalation|Investigator declined participation|0
7770928|NCT00879684|12215094|FG006|Stage 1: Dose Escalation|Investigator declined participation|0
7770929|NCT00879684|12215088|FG000|Stage 1: Dose Escalation|Death|0
7770930|NCT00879684|12215089|FG001|Stage 1: Dose Escalation|Death|0
7770931|NCT00879684|12215090|FG002|Stage 1: Dose Escalation|Death|1
7770932|NCT00879684|12215091|FG003|Stage 1: Dose Escalation|Death|0
7770933|NCT00879684|12215092|FG004|Stage 1: Dose Escalation|Death|0
7770934|NCT00879684|12215093|FG005|Stage 1: Dose Escalation|Death|0
7770935|NCT00879684|12215094|FG006|Stage 1: Dose Escalation|Death|0
7770936|NCT00879684|12215088|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0
7770937|NCT00879684|12215089|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0
7770938|NCT00879684|12215090|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0
7770939|NCT00879684|12215091|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0
7770940|NCT00879684|12215092|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0
7770941|NCT00879684|12215093|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0
7770942|NCT00879684|12215094|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1
7770943|NCT00879684|12215088|FG000|Stage 2: Expanded Cohort|Progressive Disease|0
7770944|NCT00879684|12215089|FG001|Stage 2: Expanded Cohort|Progressive Disease|0
7770945|NCT00879684|12215090|FG002|Stage 2: Expanded Cohort|Progressive Disease|0
7770946|NCT00879684|12215091|FG003|Stage 2: Expanded Cohort|Progressive Disease|0
7770947|NCT00879684|12215092|FG004|Stage 2: Expanded Cohort|Progressive Disease|0
7770948|NCT00879684|12215093|FG005|Stage 2: Expanded Cohort|Progressive Disease|0
7770949|NCT00879684|12215094|FG006|Stage 2: Expanded Cohort|Progressive Disease|11
7770950|NCT00879684|12215088|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0
7770951|NCT00879684|12215089|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0
7770952|NCT00879684|12215090|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0
7770953|NCT00879684|12215091|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0
7770954|NCT00879684|12215092|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0
7770955|NCT00879684|12215093|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0
7770956|NCT00879684|12215094|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1
7770957|NCT00879697|12215115|FG000|Overall Study|Physician Decision|2
7770958|NCT00879697|12215116|FG001|Overall Study|Physician Decision|2
7770959|NCT00879710|12215124|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2
7770960|NCT00879710|12215125|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3
7770961|NCT00879710|12215126|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1
7770962|NCT00879710|12215127|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4
7770963|NCT00879710|12215124|FG000|Phase 1 - 6 Weeks|Adverse Event|0
7770964|NCT00879710|12215125|FG001|Phase 1 - 6 Weeks|Adverse Event|0
7770965|NCT00879710|12215126|FG002|Phase 1 - 6 Weeks|Adverse Event|1
7770966|NCT00879710|12215127|FG003|Phase 1 - 6 Weeks|Adverse Event|0
7770967|NCT00879775|12215137|FG000|Overall Study|Lost to Follow-up|2
7770968|NCT00879775|12215138|FG001|Overall Study|Lost to Follow-up|1
7770969|NCT00879814|12215148|FG000|Overall Study|Adverse Event|0
7770970|NCT00879814|12215149|FG001|Overall Study|Adverse Event|1
7770971|NCT00879814|12215150|FG002|Overall Study|Adverse Event|0
7770972|NCT00879814|12215151|FG003|Overall Study|Adverse Event|0
7770973|NCT00879814|12215148|FG000|Overall Study|Lost to Follow-up|1
7770974|NCT00879814|12215149|FG001|Overall Study|Lost to Follow-up|0
7770975|NCT00879814|12215150|FG002|Overall Study|Lost to Follow-up|0
7770976|NCT00879814|12215151|FG003|Overall Study|Lost to Follow-up|2
7770977|NCT00879814|12215148|FG000|Overall Study|Participant Failed to Return|0
7770978|NCT00879814|12215149|FG001|Overall Study|Participant Failed to Return|0
7770979|NCT00879814|12215150|FG002|Overall Study|Participant Failed to Return|0
7770980|NCT00879814|12215151|FG003|Overall Study|Participant Failed to Return|1
7770981|NCT00879814|12215148|FG000|Overall Study|Withdrawal by Subject|3
7770982|NCT00879814|12215149|FG001|Overall Study|Withdrawal by Subject|1
7770983|NCT00879814|12215150|FG002|Overall Study|Withdrawal by Subject|1
7770984|NCT00879814|12215151|FG003|Overall Study|Withdrawal by Subject|2
7770985|NCT00879814|12215148|FG000|Overall Study|Physician Decision|0
7770986|NCT00879814|12215149|FG001|Overall Study|Physician Decision|0
7770987|NCT00879814|12215150|FG002|Overall Study|Physician Decision|1
7770988|NCT00879814|12215151|FG003|Overall Study|Physician Decision|0
7770989|NCT00879814|12215148|FG000|Overall Study|Other|0
7770990|NCT00879814|12215149|FG001|Overall Study|Other|0
7770991|NCT00879814|12215150|FG002|Overall Study|Other|1
7770992|NCT00879814|12215151|FG003|Overall Study|Other|0
7770993|NCT00879879|12215161|FG000|Overall Study|Death|1
7770994|NCT00879879|12215161|FG000|Overall Study|Withdrawal by Subject|1
7770995|NCT00879879|12215161|FG000|Overall Study|Physician Decision|1
7770996|NCT00879970|12215170|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3
7770997|NCT00879970|12215171|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3
7770998|NCT00879970|12215172|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4
7770999|NCT00879970|12215173|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0
7771000|NCT00879970|12215174|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0
7771001|NCT00879970|12215170|FG000|Period 1 TZD Randomization|Lost to Follow-up|1
7771002|NCT00879970|12215171|FG001|Period 1 TZD Randomization|Lost to Follow-up|0
7771003|NCT00879970|12215172|FG002|Period 1 TZD Randomization|Lost to Follow-up|1
7771004|NCT00879970|12215173|FG003|Period 1 TZD Randomization|Lost to Follow-up|0
7771005|NCT00879970|12215174|FG004|Period 1 TZD Randomization|Lost to Follow-up|0
7771006|NCT00879970|12215170|FG000|Period 1 TZD Randomization|Death|2
7771007|NCT00879970|12215171|FG001|Period 1 TZD Randomization|Death|1
7771008|NCT00879970|12215172|FG002|Period 1 TZD Randomization|Death|0
7771009|NCT00879970|12215173|FG003|Period 1 TZD Randomization|Death|0
7771010|NCT00879970|12215174|FG004|Period 1 TZD Randomization|Death|0
7771011|NCT00879970|12215170|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
7771012|NCT00879970|12215171|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
7771013|NCT00879970|12215172|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
7771014|NCT00879970|12215173|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
7771015|NCT00879970|12215174|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
7771016|NCT00879970|12215170|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
7771017|NCT00879970|12215171|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
7771018|NCT00879970|12215172|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
7771019|NCT00879970|12215173|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
7771020|NCT00879970|12215174|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
7771021|NCT00879970|12215170|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0
7771022|NCT00879970|12215171|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0
7771023|NCT00879970|12215172|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0
7771024|NCT00879970|12215173|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0
7771025|NCT00879970|12215174|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1
7771026|NCT00879970|12215170|FG000|Period 2 Vitamin D Randomization|Death|0
7771027|NCT00879970|12215171|FG001|Period 2 Vitamin D Randomization|Death|0
7771028|NCT00879970|12215172|FG002|Period 2 Vitamin D Randomization|Death|0
7771029|NCT00879970|12215173|FG003|Period 2 Vitamin D Randomization|Death|2
7771030|NCT00879970|12215174|FG004|Period 2 Vitamin D Randomization|Death|0
7771031|NCT00879996|12215194|FG000|Overall Study|Lost to Follow-up|7
7771032|NCT00879996|12215195|FG001|Overall Study|Lost to Follow-up|6
7771033|NCT00879996|12215194|FG000|Overall Study|non-compliance|6
7771034|NCT00879996|12215195|FG001|Overall Study|non-compliance|4
7771035|NCT00879996|12215194|FG000|Overall Study|Physician Decision|1
7771036|NCT00879996|12215195|FG001|Overall Study|Physician Decision|2
7771037|NCT00879996|12215194|FG000|Overall Study|psychiatric problem|0
7771038|NCT00879996|12215195|FG001|Overall Study|psychiatric problem|1
7771039|NCT00879996|12215194|FG000|Overall Study|put on parole|1
7771040|NCT00879996|12215195|FG001|Overall Study|put on parole|0
7771041|NCT00880009|12215203|FG000|Overall Study|Study terminated by sponsor|14
7771042|NCT00880009|12215203|FG000|Overall Study|Withdrawal by Subject|1
7771043|NCT00880009|12215203|FG000|Overall Study|Protocol Violation|1
7771044|NCT00880048|12215224|FG000|Overall Study|Adverse Event|2
7771045|NCT00880048|12215225|FG001|Overall Study|Adverse Event|3
7771046|NCT00880048|12215226|FG002|Overall Study|Adverse Event|5
7771047|NCT00880048|12215224|FG000|Overall Study|Lack of Efficacy|1
7771048|NCT00880048|12215225|FG001|Overall Study|Lack of Efficacy|2
7771049|NCT00880048|12215226|FG002|Overall Study|Lack of Efficacy|2
7771050|NCT00880048|12215224|FG000|Overall Study|Protocol Violation|4
7771051|NCT00880048|12215225|FG001|Overall Study|Protocol Violation|6
7771052|NCT00880048|12215226|FG002|Overall Study|Protocol Violation|5
7771053|NCT00880048|12215224|FG000|Overall Study|Lost to Follow-up|6
7771054|NCT00880048|12215225|FG001|Overall Study|Lost to Follow-up|6
7771055|NCT00880048|12215226|FG002|Overall Study|Lost to Follow-up|5
7771056|NCT00880048|12215224|FG000|Overall Study|Physician Decision|1
7771057|NCT00880048|12215225|FG001|Overall Study|Physician Decision|1
7771058|NCT00880048|12215226|FG002|Overall Study|Physician Decision|7
7771059|NCT00880048|12215224|FG000|Overall Study|Withdrawal by Subject|5
7771060|NCT00880048|12215225|FG001|Overall Study|Withdrawal by Subject|8
7771061|NCT00880048|12215226|FG002|Overall Study|Withdrawal by Subject|5
7771062|NCT00880048|12215224|FG000|Overall Study|Study closed/terminated|9
7771063|NCT00880048|12215225|FG001|Overall Study|Study closed/terminated|7
7771064|NCT00880048|12215226|FG002|Overall Study|Study closed/terminated|6
7771065|NCT00880087|12215236|FG000|Overall Study|Lost to Follow-up|0
7771066|NCT00880087|12215237|FG001|Overall Study|Lost to Follow-up|2
7771067|NCT00880100|12215243|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
7771068|NCT00880100|12215243|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1
7771069|NCT00880100|12215243|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2
7771070|NCT00880165|12215249|FG000|Overall Study|Withdrawal by Subject|27
7771071|NCT00880165|12215250|FG001|Overall Study|Withdrawal by Subject|23
7771072|NCT00880165|12215249|FG000|Overall Study|Not diagnosed with OSA|14
7771073|NCT00880165|12215250|FG001|Overall Study|Not diagnosed with OSA|8
7771074|NCT00880165|12215249|FG000|Overall Study|Required BIPAP or oxygen treatment|12
7771075|NCT00880165|12215250|FG001|Overall Study|Required BIPAP or oxygen treatment|4
7771076|NCT00880165|12215249|FG000|Overall Study|Lost to follow|9
7771077|NCT00880165|12215250|FG001|Overall Study|Lost to follow|15
7771078|NCT00880191|12215258|FG000|Overall Study|Refused further treatment|4
7771079|NCT00880191|12215259|FG001|Overall Study|Refused further treatment|1
7771080|NCT00880191|12215258|FG000|Overall Study|Adverse Event|8
7771081|NCT00880191|12215259|FG001|Overall Study|Adverse Event|6
7771082|NCT00880191|12215258|FG000|Overall Study|Hospitalization/efficacy|1
7771083|NCT00880191|12215259|FG001|Overall Study|Hospitalization/efficacy|1
7771084|NCT00880256|12215269|FG000|Overall Study|Lost to Follow-up|28
7771085|NCT00880269|12215275|FG000|Overall Study|Protocol Violation|1
7771086|NCT00880269|12215276|FG001|Overall Study|Protocol Violation|0
7771087|NCT00880269|12215275|FG000|Overall Study|Disease Progression|13
7771088|NCT00880269|12215276|FG001|Overall Study|Disease Progression|11
7771089|NCT00880269|12215275|FG000|Overall Study|New Cancer Therapy|1
7771090|NCT00880269|12215276|FG001|Overall Study|New Cancer Therapy|0
7771091|NCT00880269|12215275|FG000|Overall Study|Death|4
7771092|NCT00880269|12215276|FG001|Overall Study|Death|2
7771093|NCT00880269|12215275|FG000|Overall Study|Lost to Follow-up|0
7771094|NCT00880269|12215276|FG001|Overall Study|Lost to Follow-up|1
7771095|NCT00880269|12215275|FG000|Overall Study|Withdrawal by Subject|3
7771096|NCT00880269|12215276|FG001|Overall Study|Withdrawal by Subject|4
7771097|NCT00880269|12215275|FG000|Overall Study|Adverse Event|10
7771098|NCT00880269|12215276|FG001|Overall Study|Adverse Event|9
7771099|NCT00880334|12215284|FG000|Randomized Phase|Physician Decision|1
7593255|NCT00378482|11999024|FG000|Overall Study|Lost to Follow-up|1
7593256|NCT00378482|11999024|FG000|Overall Study|Lack of Efficacy|8
7593257|NCT00378482|11999024|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9
7593258|NCT00378482|11999024|FG000|Overall Study|Withdrawal by Subject|4
7593259|NCT00378482|11999024|FG000|Overall Study|Adverse Event|9
7593260|NCT00316888|11999030|FG000|Overall Study|Adverse Event|4
7593261|NCT00316888|11999031|FG001|Overall Study|Adverse Event|5
7593262|NCT00316888|11999030|FG000|Overall Study|Withdrawal by Subject|2
7593263|NCT00316888|11999031|FG001|Overall Study|Withdrawal by Subject|2
7771100|NCT00880334|12215285|FG001|Randomized Phase|Physician Decision|0
7771101|NCT00880334|12215284|FG000|Randomized Phase|Withdrawal by Subject|2
7771102|NCT00880334|12215285|FG001|Randomized Phase|Withdrawal by Subject|1
7771103|NCT00880334|12215284|FG000|Randomized Phase|Inadequate Labs|1
7771104|NCT00880334|12215285|FG001|Randomized Phase|Inadequate Labs|1
7771105|NCT00880334|12215284|FG000|Randomized Phase|Brain Metastasis|0
7771106|NCT00880334|12215285|FG001|Randomized Phase|Brain Metastasis|1
7771107|NCT00880334|12215284|FG000|Randomized Phase|Crossover Participants|0
7771108|NCT00880334|12215285|FG001|Randomized Phase|Crossover Participants|37
7771109|NCT00880399|12215303|FG000|Overall Study|Adverse Event|4
7771110|NCT00880399|12215304|FG001|Overall Study|Adverse Event|6
7771111|NCT00880399|12215305|FG002|Overall Study|Adverse Event|5
7771112|NCT00880399|12215303|FG000|Overall Study|Lack of Efficacy|1
7771113|NCT00880399|12215304|FG001|Overall Study|Lack of Efficacy|4
7771114|NCT00880399|12215305|FG002|Overall Study|Lack of Efficacy|2
7771115|NCT00880399|12215303|FG000|Overall Study|Protocol Violation|4
7771116|NCT00880399|12215304|FG001|Overall Study|Protocol Violation|4
7771117|NCT00880399|12215305|FG002|Overall Study|Protocol Violation|6
7771118|NCT00880399|12215303|FG000|Overall Study|Study closed/terminated|3
7771119|NCT00880399|12215304|FG001|Overall Study|Study closed/terminated|7
7771120|NCT00880399|12215305|FG002|Overall Study|Study closed/terminated|4
7771121|NCT00880399|12215303|FG000|Overall Study|Lost to Follow-up|8
7771122|NCT00880399|12215304|FG001|Overall Study|Lost to Follow-up|5
7771123|NCT00880399|12215305|FG002|Overall Study|Lost to Follow-up|3
7771124|NCT00880399|12215303|FG000|Overall Study|Physician Decision|5
7771125|NCT00880399|12215304|FG001|Overall Study|Physician Decision|0
7771126|NCT00880399|12215305|FG002|Overall Study|Physician Decision|3
7771127|NCT00880399|12215303|FG000|Overall Study|Withdrawal by Subject|6
7771128|NCT00880399|12215304|FG001|Overall Study|Withdrawal by Subject|3
7771129|NCT00880399|12215305|FG002|Overall Study|Withdrawal by Subject|3
7771130|NCT00880555|12215327|FG000|Overall Study|Physician Decision|0
7771131|NCT00880555|12215328|FG001|Overall Study|Physician Decision|8
7771132|NCT00880555|12215329|FG002|Overall Study|Physician Decision|0
7771133|NCT00880555|12215330|FG003|Overall Study|Physician Decision|2
7771134|NCT00880555|12215331|FG004|Overall Study|Physician Decision|1
7771135|NCT00880555|12215332|FG005|Overall Study|Physician Decision|0
7771136|NCT00880555|12215327|FG000|Overall Study|Withdrawal by Subject|1
7771137|NCT00880555|12215328|FG001|Overall Study|Withdrawal by Subject|1
7771138|NCT00880555|12215329|FG002|Overall Study|Withdrawal by Subject|0
7771139|NCT00880555|12215330|FG003|Overall Study|Withdrawal by Subject|0
7771140|NCT00880555|12215331|FG004|Overall Study|Withdrawal by Subject|0
7771141|NCT00880555|12215332|FG005|Overall Study|Withdrawal by Subject|0
7771142|NCT00880555|12215327|FG000|Overall Study|Lack of resources (hired rater)|9
7771143|NCT00880555|12215328|FG001|Overall Study|Lack of resources (hired rater)|7
7771144|NCT00880555|12215329|FG002|Overall Study|Lack of resources (hired rater)|5
7771145|NCT00880555|12215330|FG003|Overall Study|Lack of resources (hired rater)|0
7771146|NCT00880555|12215331|FG004|Overall Study|Lack of resources (hired rater)|0
7593264|NCT00316888|11999030|FG000|Overall Study|Not start protocol therapy|0
7593265|NCT00316888|11999031|FG001|Overall Study|Not start protocol therapy|1
7771147|NCT00880555|12215332|FG005|Overall Study|Lack of resources (hired rater)|0
7771148|NCT00880555|12215327|FG000|Overall Study|Death|0
7771149|NCT00880555|12215328|FG001|Overall Study|Death|0
7771150|NCT00880555|12215329|FG002|Overall Study|Death|0
7771151|NCT00880555|12215330|FG003|Overall Study|Death|0
7771152|NCT00880555|12215331|FG004|Overall Study|Death|0
7771153|NCT00880555|12215332|FG005|Overall Study|Death|1
7771154|NCT00880555|12215327|FG000|Overall Study|Lost to Follow-up|0
7771155|NCT00880555|12215328|FG001|Overall Study|Lost to Follow-up|1
7771156|NCT00880555|12215329|FG002|Overall Study|Lost to Follow-up|0
7771157|NCT00880555|12215330|FG003|Overall Study|Lost to Follow-up|0
7771158|NCT00880555|12215331|FG004|Overall Study|Lost to Follow-up|0
7771159|NCT00880555|12215332|FG005|Overall Study|Lost to Follow-up|0
7771160|NCT00880568|12215352|FG000|Overall Study|Disease progression|3
7771161|NCT00880568|12215353|FG001|Overall Study|Disease progression|3
7771162|NCT00880568|12215354|FG002|Overall Study|Disease progression|3
7771163|NCT00880568|12215355|FG003|Overall Study|Disease progression|1
7771164|NCT00880568|12215356|FG004|Overall Study|Disease progression|3
7771165|NCT00880568|12215357|FG005|Overall Study|Disease progression|3
7771166|NCT00880568|12215358|FG006|Overall Study|Disease progression|5
7771167|NCT00880568|12215359|FG007|Overall Study|Disease progression|0
7771168|NCT00880568|12215360|FG008|Overall Study|Disease progression|3
7771169|NCT00880568|12215352|FG000|Overall Study|Adverse Event|0
7771170|NCT00880568|12215353|FG001|Overall Study|Adverse Event|0
7771171|NCT00880568|12215354|FG002|Overall Study|Adverse Event|0
7771172|NCT00880568|12215355|FG003|Overall Study|Adverse Event|0
7771173|NCT00880568|12215356|FG004|Overall Study|Adverse Event|0
7771174|NCT00880568|12215357|FG005|Overall Study|Adverse Event|0
7771175|NCT00880568|12215358|FG006|Overall Study|Adverse Event|1
7771176|NCT00880568|12215359|FG007|Overall Study|Adverse Event|1
7771177|NCT00880568|12215360|FG008|Overall Study|Adverse Event|0
7771178|NCT00880568|12215352|FG000|Overall Study|Withdrawal by Subject|0
7771179|NCT00880568|12215353|FG001|Overall Study|Withdrawal by Subject|0
7771180|NCT00880568|12215354|FG002|Overall Study|Withdrawal by Subject|0
7771181|NCT00880568|12215355|FG003|Overall Study|Withdrawal by Subject|0
7771182|NCT00880568|12215356|FG004|Overall Study|Withdrawal by Subject|0
7771183|NCT00880568|12215357|FG005|Overall Study|Withdrawal by Subject|0
7771184|NCT00880568|12215358|FG006|Overall Study|Withdrawal by Subject|0
7771185|NCT00880568|12215359|FG007|Overall Study|Withdrawal by Subject|1
7771186|NCT00880568|12215360|FG008|Overall Study|Withdrawal by Subject|0
7771187|NCT00880607|12215391|FG000|Overall Study|Physician Decision|2
7771188|NCT00880607|12215392|FG001|Overall Study|Physician Decision|2
7771189|NCT00880607|12215391|FG000|Overall Study|Protocol Violation|2
7771190|NCT00880607|12215392|FG001|Overall Study|Protocol Violation|1
7771191|NCT00880607|12215391|FG000|Overall Study|surgery did not extend past L1 level|3
7771192|NCT00880607|12215392|FG001|Overall Study|surgery did not extend past L1 level|0
7799891|NCT01090310|12257085|FG003|Extension Study|Unsatisfactory therapeutic effect|1
7799892|NCT01090310|12257082|FG000|Extension Study|Subject withdrew consent|0
7799893|NCT01090310|12257083|FG001|Extension Study|Subject withdrew consent|1
7799894|NCT01090310|12257084|FG002|Extension Study|Subject withdrew consent|0
7799895|NCT01090310|12257085|FG003|Extension Study|Subject withdrew consent|0
7799896|NCT01090323|12257097|FG000|Overall Study|Adverse Event|12
7799897|NCT01090323|12257098|FG001|Overall Study|Adverse Event|2
7799898|NCT01090323|12257097|FG000|Overall Study|Abnormal Lab Values|3
7799899|NCT01090323|12257098|FG001|Overall Study|Abnormal Lab Values|1
7799900|NCT01090323|12257097|FG000|Overall Study|Abnormal Test Procedure Results|2
7799901|NCT01090323|12257098|FG001|Overall Study|Abnormal Test Procedure Results|0
7799902|NCT01090323|12257097|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7799903|NCT01090323|12257098|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7799904|NCT01090323|12257097|FG000|Overall Study|Condition no longer requires drug|5
7799905|NCT01090323|12257098|FG001|Overall Study|Condition no longer requires drug|4
7799906|NCT01090323|12257097|FG000|Overall Study|Protocol Violation|2
7799907|NCT01090323|12257098|FG001|Overall Study|Protocol Violation|1
7799908|NCT01090323|12257097|FG000|Overall Study|Withdrew consent|33
7799909|NCT01090323|12257098|FG001|Overall Study|Withdrew consent|11
7799910|NCT01090323|12257097|FG000|Overall Study|Lost to Follow-up|11
7593298|NCT03178487|11999069|FG000|Overall Study|Adverse Event|1
7799911|NCT01090323|12257098|FG001|Overall Study|Lost to Follow-up|6
7799912|NCT01090323|12257097|FG000|Overall Study|Administrative problems|6
7799913|NCT01090323|12257098|FG001|Overall Study|Administrative problems|4
7799914|NCT01090323|12257097|FG000|Overall Study|Death|1
7593299|NCT03178487|11999070|FG001|Overall Study|Adverse Event|1
7593300|NCT03178487|11999069|FG000|Overall Study|Withdrawal by Subject|2
7593301|NCT03178487|11999070|FG001|Overall Study|Withdrawal by Subject|1
7593302|NCT03178487|11999069|FG000|Overall Study|Lost to Follow-up|1
7593303|NCT03178487|11999070|FG001|Overall Study|Lost to Follow-up|0
7593304|NCT03178487|11999069|FG000|Overall Study|Other|0
7593305|NCT03178487|11999070|FG001|Overall Study|Other|2
7864075|NCT01609556|12353458|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7864076|NCT01609556|12353459|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1
7864077|NCT01609556|12353444|FG000|Dose Expansion: Maximum 124 Weeks|Death|0
7864078|NCT01609556|12353445|FG001|Dose Expansion: Maximum 124 Weeks|Death|0
7627296|NCT01938001|12039725|FG000|Overall Study|Withdrawal by Subject|25
7627297|NCT01938001|12039726|FG001|Overall Study|Withdrawal by Subject|17
7627298|NCT01938001|12039725|FG000|Overall Study|Non-compliant|1
7627299|NCT01938001|12039726|FG001|Overall Study|Non-compliant|0
7627300|NCT01938001|12039725|FG000|Overall Study|Participant Moved|0
7627301|NCT01938001|12039726|FG001|Overall Study|Participant Moved|1
7627302|NCT01938001|12039725|FG000|Overall Study|Lost to Follow-up|1
7627303|NCT01938001|12039726|FG001|Overall Study|Lost to Follow-up|3
7627304|NCT01938001|12039725|FG000|Overall Study|Death|16
7627305|NCT01938001|12039726|FG001|Overall Study|Death|26
7627306|NCT01529008|12039734|FG000|Bone Marrow Harvesting|Physician Decision|1
7627307|NCT01529008|12039735|FG001|Bone Marrow Harvesting|Physician Decision|1
7864079|NCT01609556|12353446|FG002|Dose Expansion: Maximum 124 Weeks|Death|0
7864080|NCT01609556|12353447|FG003|Dose Expansion: Maximum 124 Weeks|Death|0
7627308|NCT01529008|12039734|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0
7627309|NCT01529008|12039735|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2
7627310|NCT01529008|12039734|FG000|Treatment|Adverse Event|6
7627311|NCT01529008|12039735|FG001|Treatment|Adverse Event|0
7627312|NCT01529008|12039734|FG000|Treatment|Other|3
7627313|NCT01529008|12039735|FG001|Treatment|Other|1
7627314|NCT01529008|12039734|FG000|Efficacy Analysis|Protocol Violation|2
7627315|NCT01529008|12039735|FG001|Efficacy Analysis|Protocol Violation|0
7627316|NCT01529008|12039734|FG000|Efficacy Analysis|Physician Decision|0
7627317|NCT01529008|12039735|FG001|Efficacy Analysis|Physician Decision|1
7627318|NCT01529008|12039734|FG000|Efficacy Analysis|Withdrawal by Subject|0
7627319|NCT01529008|12039735|FG001|Efficacy Analysis|Withdrawal by Subject|2
7627320|NCT01484691|12039744|FG000|Overall Study|Withdrawal by Subject|1
7627321|NCT01484691|12039745|FG001|Overall Study|Withdrawal by Subject|1
7627322|NCT01484691|12039746|FG002|Overall Study|Withdrawal by Subject|1
7627323|NCT01484691|12039744|FG000|Overall Study|Physician Decision|0
7627324|NCT01484691|12039745|FG001|Overall Study|Physician Decision|2
7627325|NCT01484691|12039746|FG002|Overall Study|Physician Decision|1
7593306|NCT03096834|11999083|FG000|Double-Blind Treatment Epoch|Protocol deviation|2
7593307|NCT03096834|11999084|FG001|Double-Blind Treatment Epoch|Protocol deviation|1
7593308|NCT03096834|11999085|FG002|Double-Blind Treatment Epoch|Protocol deviation|0
7593309|NCT03096834|11999086|FG003|Double-Blind Treatment Epoch|Protocol deviation|0
7593310|NCT03096834|11999083|FG000|Double-Blind Treatment Epoch|Pregnancy|0
7593311|NCT03096834|11999084|FG001|Double-Blind Treatment Epoch|Pregnancy|1
7593312|NCT03096834|11999085|FG002|Double-Blind Treatment Epoch|Pregnancy|0
7593313|NCT03096834|11999086|FG003|Double-Blind Treatment Epoch|Pregnancy|0
7593314|NCT03096834|11999083|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1
7593315|NCT03096834|11999084|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1
7593316|NCT03096834|11999085|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0
7593317|NCT03096834|11999086|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0
7593318|NCT03096834|11999083|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0
7593319|NCT03096834|11999084|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0
7593320|NCT03096834|11999085|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15
7593321|NCT03096834|11999086|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15
7593322|NCT03096834|11999083|FG000|Open-Label Treatment Epoch|Adverse Event|0
7593323|NCT03096834|11999084|FG001|Open-Label Treatment Epoch|Adverse Event|0
7593324|NCT03096834|11999085|FG002|Open-Label Treatment Epoch|Adverse Event|5
7593325|NCT03096834|11999086|FG003|Open-Label Treatment Epoch|Adverse Event|6
7593326|NCT03096834|11999083|FG000|Open-Label Treatment Epoch|New therapy for study indication|0
7593327|NCT03096834|11999084|FG001|Open-Label Treatment Epoch|New therapy for study indication|0
7593328|NCT03096834|11999085|FG002|Open-Label Treatment Epoch|New therapy for study indication|1
7593329|NCT03096834|11999086|FG003|Open-Label Treatment Epoch|New therapy for study indication|1
7771193|NCT00880620|12215404|FG000|Overall Study|Adverse Event|4
7593330|NCT03096834|11999083|FG000|Open-Label Treatment Epoch|Physician Decision|0
7593331|NCT03096834|11999084|FG001|Open-Label Treatment Epoch|Physician Decision|0
7593332|NCT03096834|11999085|FG002|Open-Label Treatment Epoch|Physician Decision|1
7771194|NCT00880620|12215405|FG001|Overall Study|Adverse Event|5
7771195|NCT00880620|12215406|FG002|Overall Study|Adverse Event|15
7771196|NCT00880620|12215407|FG003|Overall Study|Adverse Event|15
7771197|NCT00880620|12215404|FG000|Overall Study|Death|0
7771198|NCT00880620|12215405|FG001|Overall Study|Death|0
7593333|NCT03096834|11999086|FG003|Open-Label Treatment Epoch|Physician Decision|0
7593334|NCT03096834|11999083|FG000|Open-Label Treatment Epoch|Pregnancy|0
7593335|NCT03096834|11999084|FG001|Open-Label Treatment Epoch|Pregnancy|0
7593336|NCT03096834|11999085|FG002|Open-Label Treatment Epoch|Pregnancy|1
7593337|NCT03096834|11999086|FG003|Open-Label Treatment Epoch|Pregnancy|0
7593338|NCT03096834|11999083|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0
7593339|NCT03096834|11999084|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0
7593340|NCT03096834|11999085|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9
7593341|NCT03096834|11999086|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17
7593342|NCT03096834|11999083|FG000|Safety Follow-Up Epoch|New therapy for study indication|0
7593343|NCT03096834|11999084|FG001|Safety Follow-Up Epoch|New therapy for study indication|0
7593344|NCT03096834|11999085|FG002|Safety Follow-Up Epoch|New therapy for study indication|0
7593345|NCT03096834|11999086|FG003|Safety Follow-Up Epoch|New therapy for study indication|1
7593346|NCT03096834|11999083|FG000|Safety Follow-Up Epoch|Protocol deviation|0
7593347|NCT03096834|11999084|FG001|Safety Follow-Up Epoch|Protocol deviation|0
7593348|NCT03096834|11999085|FG002|Safety Follow-Up Epoch|Protocol deviation|0
7593349|NCT03096834|11999086|FG003|Safety Follow-Up Epoch|Protocol deviation|1
7593350|NCT03096834|11999083|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0
7593351|NCT03096834|11999084|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0
7593352|NCT03096834|11999085|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1
7593353|NCT03096834|11999086|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0
7593354|NCT03089853|11999097|FG000|Overall Study|Lost to Follow-up|2
7593355|NCT03089853|11999098|FG001|Overall Study|Lost to Follow-up|1
7593356|NCT03070392|11999106|FG000|Overall Study|Not Treated|7
7593357|NCT03070392|11999107|FG001|Overall Study|Not Treated|0
7593358|NCT03070392|11999108|FG002|Overall Study|Not Treated|3
7593359|NCT03070392|11999109|FG003|Overall Study|Not Treated|12
7593360|NCT03070392|11999106|FG000|Overall Study|Death|3
7771199|NCT00880620|12215406|FG002|Overall Study|Death|1
7593361|NCT03070392|11999107|FG001|Overall Study|Death|0
7593362|NCT03070392|11999108|FG002|Overall Study|Death|0
7593363|NCT03070392|11999109|FG003|Overall Study|Death|1
7593364|NCT03070392|11999106|FG000|Overall Study|Withdrawal by Subject|7
7593365|NCT03070392|11999107|FG001|Overall Study|Withdrawal by Subject|0
7593366|NCT03070392|11999108|FG002|Overall Study|Withdrawal by Subject|0
7593367|NCT03070392|11999109|FG003|Overall Study|Withdrawal by Subject|3
7593368|NCT03070392|11999106|FG000|Overall Study|Physician Decision|1
7593369|NCT03070392|11999107|FG001|Overall Study|Physician Decision|0
7593370|NCT03070392|11999108|FG002|Overall Study|Physician Decision|0
7593371|NCT03070392|11999109|FG003|Overall Study|Physician Decision|2
7593372|NCT03070392|11999106|FG000|Overall Study|Progressive Disease|154
7593373|NCT03070392|11999107|FG001|Overall Study|Progressive Disease|6
7593374|NCT03070392|11999108|FG002|Overall Study|Progressive Disease|2
7593375|NCT03070392|11999109|FG003|Overall Study|Progressive Disease|70
7593376|NCT03070392|11999106|FG000|Overall Study|Adverse Event|6
7593377|NCT03070392|11999107|FG001|Overall Study|Adverse Event|1
7593378|NCT03070392|11999108|FG002|Overall Study|Adverse Event|1
7593379|NCT03070392|11999109|FG003|Overall Study|Adverse Event|3
7593380|NCT03070392|11999106|FG000|Overall Study|Alternate anticancer treatment|1
7593381|NCT03070392|11999107|FG001|Overall Study|Alternate anticancer treatment|0
7593382|NCT03070392|11999108|FG002|Overall Study|Alternate anticancer treatment|0
7593383|NCT03070392|11999109|FG003|Overall Study|Alternate anticancer treatment|1
7593384|NCT03070392|11999106|FG000|Overall Study|Ongoing|73
7593385|NCT03070392|11999107|FG001|Overall Study|Ongoing|0
7593386|NCT03070392|11999108|FG002|Overall Study|Ongoing|0
7593387|NCT03070392|11999109|FG003|Overall Study|Ongoing|11
7593388|NCT03048578|11999117|FG000|Overall Study|Withdrawal by Subject|5
7593389|NCT03048578|11999118|FG001|Overall Study|Withdrawal by Subject|6
7593390|NCT03048578|11999117|FG000|Overall Study|Lost to Follow-up|22
7593391|NCT03048578|11999118|FG001|Overall Study|Lost to Follow-up|10
7593392|NCT03048578|11999117|FG000|Overall Study|Adverse Event|1
7593393|NCT03048578|11999118|FG001|Overall Study|Adverse Event|2
7593394|NCT03048578|11999117|FG000|Overall Study|Terminated|3
7593395|NCT03048578|11999118|FG001|Overall Study|Terminated|2
7593396|NCT03015194|11999124|FG000|Overall Study|Death|10
7593397|NCT03015194|11999124|FG000|Overall Study|Withdrawal by Subject|2
7593398|NCT03012815|11999131|FG000|Overall Study|Lost to Follow-up|1
7593399|NCT03012815|11999132|FG001|Overall Study|Lost to Follow-up|0
7593400|NCT03012815|11999131|FG000|Overall Study|Physician Decision|3
7593401|NCT03012815|11999132|FG001|Overall Study|Physician Decision|2
7593402|NCT03012815|11999131|FG000|Overall Study|Adverse Event|1
7593403|NCT03012815|11999132|FG001|Overall Study|Adverse Event|0
7593404|NCT03001011|11999141|FG000|Overall Study|Adverse Event|9
7593405|NCT03001011|11999142|FG001|Overall Study|Adverse Event|3
7593406|NCT03001011|11999141|FG000|Overall Study|Chronic kidney disease lead to dialysis|15
7593407|NCT03001011|11999142|FG001|Overall Study|Chronic kidney disease lead to dialysis|10
7593408|NCT03001011|11999141|FG000|Overall Study|Other than specified above|3
7593409|NCT03001011|11999142|FG001|Overall Study|Other than specified above|8
7593410|NCT02999633|11999149|FG000|Overall Study|Adverse Event|2
7593411|NCT02999633|11999149|FG000|Overall Study|Progressive disease|12
7593412|NCT02993757|11999155|FG000|Overall Study|Non compliance with the protocol|155
7593413|NCT02993757|11999156|FG001|Overall Study|Non compliance with the protocol|170
7593414|NCT02993757|11999155|FG000|Overall Study|Lost to Follow-up|1
7593415|NCT02993757|11999156|FG001|Overall Study|Lost to Follow-up|0
7593416|NCT02993757|11999155|FG000|Overall Study|Voluntary withdraw not due adverse event|8
7593417|NCT02993757|11999156|FG001|Overall Study|Voluntary withdraw not due adverse event|8
7593418|NCT02992418|11999164|FG000|Overall Study|Withdrawal by Subject|11
7593419|NCT02992418|11999165|FG001|Overall Study|Withdrawal by Subject|12
7593420|NCT02992418|11999164|FG000|Overall Study|Non-compliance with the protocol|308
7593421|NCT02992418|11999165|FG001|Overall Study|Non-compliance with the protocol|308
7593422|NCT02992418|11999164|FG000|Overall Study|Lost to Follow-up|27
7593423|NCT02992418|11999165|FG001|Overall Study|Lost to Follow-up|22
7593424|NCT02979535|11999173|FG000|Overall Study|Non compliance with the protocol|78
7593425|NCT02979535|11999174|FG001|Overall Study|Non compliance with the protocol|82
7593426|NCT02979535|11999173|FG000|Overall Study|Consent withdrawn by participant|11
7593427|NCT02979535|11999174|FG001|Overall Study|Consent withdrawn by participant|18
7593428|NCT02979535|11999173|FG000|Overall Study|Lost to Follow-up|6
7593429|NCT02979535|11999174|FG001|Overall Study|Lost to Follow-up|1
7593430|NCT02978716|11999183|FG000|Overall Study|Death|25
7593431|NCT02978716|11999184|FG001|Overall Study|Death|13
7593432|NCT02978716|11999185|FG002|Overall Study|Death|20
7593433|NCT02978716|11999183|FG000|Overall Study|Lost to Follow-up|0
7593434|NCT02978716|11999184|FG001|Overall Study|Lost to Follow-up|0
7593435|NCT02978716|11999185|FG002|Overall Study|Lost to Follow-up|1
7593436|NCT02978716|11999183|FG000|Overall Study|Withdrawal by Subject|6
7593437|NCT02978716|11999184|FG001|Overall Study|Withdrawal by Subject|4
7593438|NCT02978716|11999185|FG002|Overall Study|Withdrawal by Subject|5
7593439|NCT02978716|11999183|FG000|Overall Study|Sponsor terminated|2
7593440|NCT02978716|11999184|FG001|Overall Study|Sponsor terminated|13
7593441|NCT02978716|11999185|FG002|Overall Study|Sponsor terminated|9
7593442|NCT02978716|11999183|FG000|Overall Study|Other|1
7593443|NCT02978716|11999184|FG001|Overall Study|Other|3
7593444|NCT02978716|11999185|FG002|Overall Study|Other|0
7593445|NCT02973321|11999200|FG000|Overall Study|Other than specified|0
7593446|NCT02973321|11999201|FG001|Overall Study|Other than specified|5
7593447|NCT02973321|11999202|FG002|Overall Study|Other than specified|3
7593448|NCT02973321|11999203|FG003|Overall Study|Other than specified|3
7593449|NCT02973321|11999204|FG004|Overall Study|Other than specified|1
7593450|NCT02973321|11999200|FG000|Overall Study|Lack of Efficacy|0
7593451|NCT02973321|11999201|FG001|Overall Study|Lack of Efficacy|0
7593452|NCT02973321|11999202|FG002|Overall Study|Lack of Efficacy|0
7593453|NCT02973321|11999203|FG003|Overall Study|Lack of Efficacy|0
7593454|NCT02973321|11999204|FG004|Overall Study|Lack of Efficacy|1
7593455|NCT02973321|11999200|FG000|Overall Study|Adverse Event|1
7593456|NCT02973321|11999201|FG001|Overall Study|Adverse Event|10
7593457|NCT02973321|11999202|FG002|Overall Study|Adverse Event|11
7593458|NCT02973321|11999203|FG003|Overall Study|Adverse Event|13
7593459|NCT02973321|11999204|FG004|Overall Study|Adverse Event|3
7593460|NCT02943785|11999219|FG000|Overall Study|Adverse Event|112
7593461|NCT02943785|11999220|FG001|Overall Study|Adverse Event|97
7593462|NCT02943785|11999219|FG000|Overall Study|Withdrawal by Subject|63
7593463|NCT02943785|11999220|FG001|Overall Study|Withdrawal by Subject|126
7593464|NCT02943785|11999219|FG000|Overall Study|Physician Decision|23
7593465|NCT02943785|11999220|FG001|Overall Study|Physician Decision|47
7593466|NCT02943785|11999219|FG000|Overall Study|Death|46
7593467|NCT02943785|11999220|FG001|Overall Study|Death|46
7593468|NCT02943785|11999219|FG000|Overall Study|Lost to Follow-up|1
7593469|NCT02943785|11999220|FG001|Overall Study|Lost to Follow-up|0
7593470|NCT02943785|11999219|FG000|Overall Study|Other|16
7593471|NCT02943785|11999220|FG001|Overall Study|Other|19
7593472|NCT02943785|11999219|FG000|Overall Study|Did not receive any study medication|21
7593473|NCT02943785|11999220|FG001|Overall Study|Did not receive any study medication|28
7593474|NCT02923674|11999229|FG000|Overall Study|Clinic Closed Due to COVID-19|14
7593475|NCT02923674|11999230|FG001|Overall Study|Clinic Closed Due to COVID-19|11
7593476|NCT02923674|11999231|FG002|Overall Study|Clinic Closed Due to COVID-19|14
7593477|NCT02923674|11999229|FG000|Overall Study|Lost to Follow-up|7
7593478|NCT02923674|11999230|FG001|Overall Study|Lost to Follow-up|12
7593479|NCT02923674|11999231|FG002|Overall Study|Lost to Follow-up|7
7593480|NCT02923674|11999229|FG000|Overall Study|Problem with intervention|2
7593481|NCT02923674|11999230|FG001|Overall Study|Problem with intervention|2
7593482|NCT02923674|11999231|FG002|Overall Study|Problem with intervention|1
7593483|NCT02923674|11999229|FG000|Overall Study|Adverse Event|3
7593484|NCT02923674|11999230|FG001|Overall Study|Adverse Event|1
7593485|NCT02923674|11999231|FG002|Overall Study|Adverse Event|1
7593486|NCT02923674|11999229|FG000|Overall Study|Withdrawal by Subject|2
7593487|NCT02923674|11999230|FG001|Overall Study|Withdrawal by Subject|2
7593488|NCT02923674|11999231|FG002|Overall Study|Withdrawal by Subject|2
7593489|NCT02921971|11999241|FG000|Overall Study|Adverse Event|1
7593490|NCT02921971|11999242|FG001|Overall Study|Adverse Event|2
7593491|NCT02921971|11999241|FG000|Overall Study|Lack of Efficacy|3
7593492|NCT02921971|11999242|FG001|Overall Study|Lack of Efficacy|1
7593493|NCT02921971|11999241|FG000|Overall Study|Other than specified above|2
7593494|NCT02921971|11999242|FG001|Overall Study|Other than specified above|1
7627326|NCT00400946|12039773|FG000|Overall Study|Ineligible|0
7627327|NCT00400946|12039774|FG001|Overall Study|Ineligible|0
7627328|NCT00400946|12039775|FG002|Overall Study|Ineligible|0
7627329|NCT00400946|12039776|FG003|Overall Study|Ineligible|5
7627330|NCT00400946|12039777|FG004|Overall Study|Ineligible|1
7627331|NCT00400946|12039773|FG000|Overall Study|Induction Failure|0
7627332|NCT00400946|12039774|FG001|Overall Study|Induction Failure|0
7627333|NCT00400946|12039775|FG002|Overall Study|Induction Failure|0
7627334|NCT00400946|12039776|FG003|Overall Study|Induction Failure|11
7627335|NCT00400946|12039777|FG004|Overall Study|Induction Failure|8
7627336|NCT00400946|12039773|FG000|Overall Study|Induction Death|0
7627337|NCT00400946|12039774|FG001|Overall Study|Induction Death|0
7627338|NCT00400946|12039775|FG002|Overall Study|Induction Death|0
7627339|NCT00400946|12039776|FG003|Overall Study|Induction Death|13
7627340|NCT00400946|12039777|FG004|Overall Study|Induction Death|3
7627341|NCT00400946|12039773|FG000|Overall Study|Lost to Follow-up|1
7627342|NCT00400946|12039774|FG001|Overall Study|Lost to Follow-up|1
7627343|NCT00400946|12039775|FG002|Overall Study|Lost to Follow-up|0
7627344|NCT00400946|12039776|FG003|Overall Study|Lost to Follow-up|0
7627345|NCT00400946|12039777|FG004|Overall Study|Lost to Follow-up|1
7627346|NCT00400946|12039773|FG000|Overall Study|Remission Death|1
7627347|NCT00400946|12039774|FG001|Overall Study|Remission Death|1
7627348|NCT00400946|12039775|FG002|Overall Study|Remission Death|0
7593495|NCT02886286|11999250|FG000|Overall Study|pump motor stall|0
7593496|NCT02886286|11999251|FG001|Overall Study|pump motor stall|1
7593497|NCT02865187|11999259|FG000|Overall Study|Lost to Follow-up|12
7593498|NCT02865187|11999260|FG001|Overall Study|Lost to Follow-up|7
7593499|NCT02865187|11999259|FG000|Overall Study|Adverse Event|1
7593500|NCT02865187|11999260|FG001|Overall Study|Adverse Event|0
7771200|NCT00880620|12215407|FG003|Overall Study|Death|0
7771201|NCT00880620|12215404|FG000|Overall Study|Lack of Efficacy|12
7771202|NCT00880620|12215405|FG001|Overall Study|Lack of Efficacy|4
7771203|NCT00880620|12215406|FG002|Overall Study|Lack of Efficacy|0
7771204|NCT00880620|12215407|FG003|Overall Study|Lack of Efficacy|1
7771205|NCT00880620|12215404|FG000|Overall Study|Lost to Follow-up|0
7771206|NCT00880620|12215405|FG001|Overall Study|Lost to Follow-up|1
7771207|NCT00880620|12215406|FG002|Overall Study|Lost to Follow-up|1
7771208|NCT00880620|12215407|FG003|Overall Study|Lost to Follow-up|0
7771209|NCT00880620|12215404|FG000|Overall Study|Protocol Violation|0
7771210|NCT00880620|12215405|FG001|Overall Study|Protocol Violation|1
7771211|NCT00880620|12215406|FG002|Overall Study|Protocol Violation|0
7771212|NCT00880620|12215407|FG003|Overall Study|Protocol Violation|2
7771213|NCT00880620|12215404|FG000|Overall Study|Withdrawal by Subject|4
7593515|NCT02824198|11999281|FG000|Overall Study|Non-compliance with the protocol|5
7593516|NCT02824198|11999282|FG001|Overall Study|Non-compliance with the protocol|1
7593517|NCT02824198|11999281|FG000|Overall Study|Lost to Follow-up|5
7593518|NCT02824198|11999282|FG001|Overall Study|Lost to Follow-up|2
7593519|NCT02824198|11999281|FG000|Overall Study|Withdrawal by Subject|5
7593520|NCT02824198|11999282|FG001|Overall Study|Withdrawal by Subject|0
7593521|NCT02821754|11999293|FG000|Overall Study|Procedure not required prior to amendment change|13
7593522|NCT02821754|11999294|FG001|Overall Study|Procedure not required prior to amendment change|11
7593523|NCT02821754|11999295|FG002|Overall Study|Procedure not required prior to amendment change|0
7593524|NCT02821754|11999293|FG000|Overall Study|Participant's Clinical status|2
7593525|NCT02821754|11999294|FG001|Overall Study|Participant's Clinical status|0
7593526|NCT02821754|11999295|FG002|Overall Study|Participant's Clinical status|0
7593527|NCT02821754|11999293|FG000|Overall Study|Participant removed for noncompliance|1
7593528|NCT02821754|11999294|FG001|Overall Study|Participant removed for noncompliance|0
7593529|NCT02821754|11999295|FG002|Overall Study|Participant removed for noncompliance|0
7593530|NCT02821754|11999293|FG000|Overall Study|Drug not available.|0
7593531|NCT02821754|11999294|FG001|Overall Study|Drug not available.|0
7593532|NCT02821754|11999295|FG002|Overall Study|Drug not available.|1
7593533|NCT02821754|11999293|FG000|Overall Study|Participant declined to participate (before treatment started.)|0
7593534|NCT02821754|11999294|FG001|Overall Study|Participant declined to participate (before treatment started.)|1
7593535|NCT02821754|11999295|FG002|Overall Study|Participant declined to participate (before treatment started.)|1
7593536|NCT02787551|11999303|FG000|Core Period: 26 Weeks|Adverse Event|10
7593537|NCT02787551|11999304|FG001|Core Period: 26 Weeks|Adverse Event|0
7593538|NCT02787551|11999303|FG000|Core Period: 26 Weeks|Lack of Efficacy|1
7593539|NCT02787551|11999304|FG001|Core Period: 26 Weeks|Lack of Efficacy|0
7593540|NCT02787551|11999303|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2
7593541|NCT02787551|11999304|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0
7593542|NCT02787551|11999303|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9
7593543|NCT02787551|11999304|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9
7593544|NCT02787551|11999303|FG000|Core Period: 26 Weeks|Randomized but not treated|2
7593545|NCT02787551|11999304|FG001|Core Period: 26 Weeks|Randomized but not treated|1
7593546|NCT02787551|11999303|FG000|Core Period: 26 Weeks|Other than specified|3
7593547|NCT02787551|11999304|FG001|Core Period: 26 Weeks|Other than specified|1
7593548|NCT02787551|11999303|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1
7593549|NCT02787551|11999304|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0
7593550|NCT02787551|11999303|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3
7593551|NCT02787551|11999304|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0
7593552|NCT02787551|11999303|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5
7593553|NCT02787551|11999304|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0
7593554|NCT02735044|11999324|FG000|Overall Study|Adverse Event|3
7593555|NCT02735044|11999325|FG001|Overall Study|Adverse Event|3
7593556|NCT02735044|11999324|FG000|Overall Study|Lack of Efficacy|1
7593557|NCT02735044|11999325|FG001|Overall Study|Lack of Efficacy|0
7593558|NCT02735044|11999324|FG000|Overall Study|Poor compliance to protocol|7
7593559|NCT02735044|11999325|FG001|Overall Study|Poor compliance to protocol|7
7593560|NCT02735044|11999324|FG000|Overall Study|Randomized and not treated|0
7593561|NCT02735044|11999325|FG001|Overall Study|Randomized and not treated|2
7593562|NCT02735044|11999324|FG000|Overall Study|Other, not specified above|5
7593563|NCT02735044|11999325|FG001|Overall Study|Other, not specified above|11
7593564|NCT02720744|11999333|FG000|Overall Study|Protocol Violation|0
7593565|NCT02720744|11999334|FG001|Overall Study|Protocol Violation|2
7593566|NCT02720744|11999333|FG000|Overall Study|Pregnancy|2
7593567|NCT02720744|11999334|FG001|Overall Study|Pregnancy|0
7593568|NCT02720744|11999333|FG000|Overall Study|Lack of Efficacy|2
7593569|NCT02720744|11999334|FG001|Overall Study|Lack of Efficacy|8
7593570|NCT02720744|11999333|FG000|Overall Study|Adverse Event|21
7593571|NCT02720744|11999334|FG001|Overall Study|Adverse Event|3
7593572|NCT02720744|11999333|FG000|Overall Study|Withdrawal by Subject|11
7593573|NCT02720744|11999334|FG001|Overall Study|Withdrawal by Subject|11
7593574|NCT02720744|11999333|FG000|Overall Study|Lost to follow up|2
7593575|NCT02720744|11999334|FG001|Overall Study|Lost to follow up|0
7593576|NCT02720744|11999333|FG000|Overall Study|Non Compliance with Investigational Product|0
7593577|NCT02720744|11999334|FG001|Overall Study|Non Compliance with Investigational Product|1
7593578|NCT02720744|11999333|FG000|Overall Study|Excluded Concomitant Medication|0
7593579|NCT02720744|11999334|FG001|Overall Study|Excluded Concomitant Medication|1
7593580|NCT02713867|11999342|FG000|Randomization|Other Reason|2
7593581|NCT02713867|11999343|FG001|Randomization|Other Reason|1
7593582|NCT02713867|11999342|FG000|Randomization|Participant Withdrew consent|0
7593583|NCT02713867|11999343|FG001|Randomization|Participant Withdrew consent|2
7593584|NCT02713867|11999342|FG000|Treatment Period|Not Reported|1
7593585|NCT02713867|11999343|FG001|Treatment Period|Not Reported|0
7593586|NCT02713867|11999342|FG000|Treatment Period|Other Reasons|12
7593587|NCT02713867|11999343|FG001|Treatment Period|Other Reasons|18
7593588|NCT02713867|11999342|FG000|Treatment Period|Administrative reason by sponsor|9
7593589|NCT02713867|11999343|FG001|Treatment Period|Administrative reason by sponsor|4
7593590|NCT02713867|11999342|FG000|Treatment Period|No longer meets study criteria|2
7593591|NCT02713867|11999343|FG001|Treatment Period|No longer meets study criteria|1
7593592|NCT02713867|11999342|FG000|Treatment Period|Poor/Non Compliance|1
7593593|NCT02713867|11999343|FG001|Treatment Period|Poor/Non Compliance|0
7593594|NCT02713867|11999342|FG000|Treatment Period|Maximum Clinical Benefit|3
7593595|NCT02713867|11999343|FG001|Treatment Period|Maximum Clinical Benefit|4
7593596|NCT02713867|11999342|FG000|Treatment Period|Withdrew consent|1
7593597|NCT02713867|11999343|FG001|Treatment Period|Withdrew consent|6
7593598|NCT02713867|11999342|FG000|Treatment Period|Requested to Discontinue|8
7593599|NCT02713867|11999343|FG001|Treatment Period|Requested to Discontinue|7
7593600|NCT02713867|11999342|FG000|Treatment Period|AE unrelated to Study Drug|8
7593601|NCT02713867|11999343|FG001|Treatment Period|AE unrelated to Study Drug|9
7593602|NCT02713867|11999342|FG000|Treatment Period|Death|7
7593603|NCT02713867|11999343|FG001|Treatment Period|Death|3
7593604|NCT02713867|11999342|FG000|Treatment Period|Study Drug Toxicity|16
7593605|NCT02713867|11999343|FG001|Treatment Period|Study Drug Toxicity|20
7593606|NCT02713867|11999342|FG000|Treatment Period|Disease Progression|79
7593607|NCT02713867|11999343|FG001|Treatment Period|Disease Progression|78
7593608|NCT02704403|11999351|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4
7593609|NCT02704403|11999352|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3
7593610|NCT02704403|11999351|FG000|Overall Study|Administrative reasons by sponsor|1251
7593611|NCT02704403|11999352|FG001|Overall Study|Administrative reasons by sponsor|616
7593612|NCT02704403|11999351|FG000|Overall Study|Death|4
7593613|NCT02704403|11999352|FG001|Overall Study|Death|3
7593614|NCT02704403|11999351|FG000|Overall Study|Endpoint event|52
7593615|NCT02704403|11999352|FG001|Overall Study|Endpoint event|24
7593616|NCT02704403|11999351|FG000|Overall Study|Lost to Follow-up|22
7593617|NCT02704403|11999352|FG001|Overall Study|Lost to Follow-up|11
7593618|NCT02704403|11999351|FG000|Overall Study|Protocol Violation|15
7593619|NCT02704403|11999352|FG001|Overall Study|Protocol Violation|15
7593620|NCT02704403|11999351|FG000|Overall Study|Adverse Event|2
7593621|NCT02704403|11999352|FG001|Overall Study|Adverse Event|0
7593622|NCT02704403|11999351|FG000|Overall Study|Withdrawal by Subject|85
7593623|NCT02704403|11999352|FG001|Overall Study|Withdrawal by Subject|45
7593624|NCT02704403|11999351|FG000|Overall Study|Investigator decision|1
7593625|NCT02704403|11999352|FG001|Overall Study|Investigator decision|1
7593626|NCT02704403|11999351|FG000|Overall Study|Follow-up not possible|1
7593627|NCT02704403|11999352|FG001|Overall Study|Follow-up not possible|2
7593628|NCT02694185|11999360|FG000|Overall Study|Withdrawal by Subject|45
7771214|NCT00880620|12215405|FG001|Overall Study|Withdrawal by Subject|3
7771215|NCT00880620|12215406|FG002|Overall Study|Withdrawal by Subject|1
7771216|NCT00880620|12215407|FG003|Overall Study|Withdrawal by Subject|3
7771217|NCT00880620|12215404|FG000|Overall Study|Noncompliance|0
7771218|NCT00880620|12215405|FG001|Overall Study|Noncompliance|0
7771219|NCT00880620|12215406|FG002|Overall Study|Noncompliance|1
7771220|NCT00880620|12215407|FG003|Overall Study|Noncompliance|1
7771221|NCT00880620|12215404|FG000|Overall Study|Other|1
7771222|NCT00880620|12215405|FG001|Overall Study|Other|1
7771223|NCT00880620|12215406|FG002|Overall Study|Other|2
7771224|NCT00880620|12215407|FG003|Overall Study|Other|2
7771225|NCT00880685|12215421|FG000|Memantine 10mg|Lost to Follow-up|2
7771226|NCT00880685|12215421|FG000|Memantine 20mg|Withdrawal by Subject|1
7771227|NCT00880698|12215432|FG000|Overall Study|Death|0
7771228|NCT00880698|12215433|FG001|Overall Study|Death|0
7771229|NCT00880698|12215434|FG002|Overall Study|Death|1
7593629|NCT02694185|11999361|FG001|Overall Study|Withdrawal by Subject|0
7593630|NCT02692651|11999369|FG000|Study Treatment|Death|7
7593631|NCT02692651|11999370|FG001|Study Treatment|Death|3
7593632|NCT02692651|11999369|FG000|Study Treatment|comfort care|1
7593633|NCT02692651|11999370|FG001|Study Treatment|comfort care|1
7593634|NCT02692651|11999369|FG000|Study Treatment|Protocol violation per treating team preference|8
7593635|NCT02692651|11999370|FG001|Study Treatment|Protocol violation per treating team preference|6
7593636|NCT02692651|11999369|FG000|Post Study Treatment Follow-up|Death|4
7593637|NCT02692651|11999370|FG001|Post Study Treatment Follow-up|Death|4
7593638|NCT02674061|11999378|FG000|Overall Study|Death|229
7593639|NCT02674061|11999379|FG001|Overall Study|Death|77
7593640|NCT02674061|11999378|FG000|Overall Study|Lost to Follow-up|3
7593641|NCT02674061|11999379|FG001|Overall Study|Lost to Follow-up|3
7593642|NCT02674061|11999378|FG000|Overall Study|Withdrawal by Subject|9
7593643|NCT02674061|11999379|FG001|Overall Study|Withdrawal by Subject|1
7593644|NCT02674061|11999378|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44
7593645|NCT02674061|11999379|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10
7593646|NCT02656706|11999387|FG000|Overall Study|Insurance Denial|1
7593647|NCT02628444|11999403|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1
7593648|NCT02628444|11999404|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593649|NCT02628444|11999405|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593650|NCT02628444|11999406|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593651|NCT02628444|11999407|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593652|NCT02628444|11999408|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593653|NCT02628444|11999409|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593654|NCT02628444|11999410|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593655|NCT02628444|11999411|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593656|NCT02628444|11999403|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7593657|NCT02628444|11999404|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4
7593658|NCT02628444|11999405|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3
7593659|NCT02628444|11999406|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7593660|NCT02628444|11999407|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7593661|NCT02628444|11999408|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7593662|NCT02628444|11999409|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7593663|NCT02628444|11999410|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7593664|NCT02628444|11999411|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7593665|NCT02628444|11999403|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21
7593666|NCT02628444|11999404|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16
7593667|NCT02628444|11999405|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25
7593668|NCT02628444|11999406|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7593669|NCT02628444|11999407|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7593670|NCT02628444|11999408|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7593671|NCT02628444|11999409|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7593672|NCT02628444|11999410|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7593673|NCT02628444|11999411|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7593674|NCT02628444|11999403|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
7593675|NCT02628444|11999404|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16
7593676|NCT02628444|11999405|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
7593677|NCT02628444|11999406|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7593678|NCT02628444|11999407|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7593679|NCT02628444|11999408|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7593680|NCT02628444|11999409|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7593681|NCT02628444|11999410|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7593682|NCT02628444|11999411|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7593683|NCT02628444|11999403|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
7593684|NCT02628444|11999404|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3
7593685|NCT02628444|11999405|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
7593686|NCT02628444|11999406|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7593687|NCT02628444|11999407|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7593688|NCT02628444|11999408|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7593689|NCT02628444|11999409|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7593690|NCT02628444|11999410|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7593691|NCT02628444|11999411|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7593692|NCT02628444|11999403|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593693|NCT02628444|11999404|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593694|NCT02628444|11999405|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593695|NCT02628444|11999406|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1
7771230|NCT00880698|12215435|FG003|Overall Study|Death|2
7593696|NCT02628444|11999407|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593697|NCT02628444|11999408|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593698|NCT02628444|11999409|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593699|NCT02628444|11999410|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593700|NCT02628444|11999411|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593701|NCT02628444|11999403|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
7593702|NCT02628444|11999404|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
7593703|NCT02628444|11999405|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
7593704|NCT02628444|11999406|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
7593705|NCT02628444|11999407|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
7593706|NCT02628444|11999408|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
7593707|NCT02628444|11999409|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81
7593708|NCT02628444|11999410|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84
7593709|NCT02628444|11999411|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85
7593710|NCT02628444|11999403|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
7593711|NCT02628444|11999404|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
7593712|NCT02628444|11999405|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
7593713|NCT02628444|11999406|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5
7593794|NCT02587520|11999492|FG010|Overall Study|Withdrawal by Subject|0
7593714|NCT02628444|11999407|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6
7593715|NCT02628444|11999408|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10
7593716|NCT02628444|11999409|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12
7593717|NCT02628444|11999410|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11
7593718|NCT02628444|11999411|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9
7593719|NCT02628444|11999403|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7593720|NCT02628444|11999404|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7593721|NCT02628444|11999405|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7593722|NCT02628444|11999406|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7593723|NCT02628444|11999407|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
7593724|NCT02628444|11999408|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7593725|NCT02628444|11999409|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7593726|NCT02628444|11999410|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2
7593727|NCT02628444|11999411|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
7593728|NCT02628444|11999403|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
7593729|NCT02628444|11999404|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
7593730|NCT02628444|11999405|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
7593731|NCT02628444|11999406|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
7593732|NCT02628444|11999407|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
7593733|NCT02628444|11999408|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
7593734|NCT02628444|11999409|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3
7593735|NCT02628444|11999410|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
7593736|NCT02628444|11999411|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
7593737|NCT02623725|11999447|FG000|Overall Study|Non compliance with protocol|9
7593738|NCT02623725|11999448|FG001|Overall Study|Non compliance with protocol|3
7593739|NCT02623725|11999447|FG000|Overall Study|Serious adverse event|0
7593740|NCT02623725|11999448|FG001|Overall Study|Serious adverse event|2
7593741|NCT02623725|11999447|FG000|Overall Study|Withdrawal by Subject|7
7593742|NCT02623725|11999448|FG001|Overall Study|Withdrawal by Subject|1
7593743|NCT02608684|11999456|FG000|Overall Study|Physician Decision|2
7593744|NCT02608684|11999456|FG000|Overall Study|Withdrawal by Subject|1
7593745|NCT02603887|11999460|FG000|Stage 1|Adverse Event|4
7593746|NCT02603887|11999460|FG000|Stage 1|Disease progression|1
7593747|NCT02603887|11999460|FG000|Stage 2|FDA guidance|1
7593748|NCT02587520|11999482|FG000|Overall Study|Protocol Violation|2
7593749|NCT02587520|11999483|FG001|Overall Study|Protocol Violation|0
7593750|NCT02587520|11999484|FG002|Overall Study|Protocol Violation|0
7593751|NCT02587520|11999485|FG003|Overall Study|Protocol Violation|2
7593752|NCT02587520|11999486|FG004|Overall Study|Protocol Violation|0
7593753|NCT02587520|11999487|FG005|Overall Study|Protocol Violation|1
7593754|NCT02587520|11999488|FG006|Overall Study|Protocol Violation|1
7593755|NCT02587520|11999489|FG007|Overall Study|Protocol Violation|1
7593756|NCT02587520|11999490|FG008|Overall Study|Protocol Violation|3
7593757|NCT02587520|11999491|FG009|Overall Study|Protocol Violation|3
7593758|NCT02587520|11999492|FG010|Overall Study|Protocol Violation|1
7593759|NCT02587520|11999493|FG011|Overall Study|Protocol Violation|2
7593760|NCT02587520|11999494|FG012|Overall Study|Protocol Violation|0
7593761|NCT02587520|11999495|FG013|Overall Study|Protocol Violation|0
7593762|NCT02587520|11999496|FG014|Overall Study|Protocol Violation|0
7593763|NCT02587520|11999497|FG015|Overall Study|Protocol Violation|0
7593764|NCT02587520|11999498|FG016|Overall Study|Protocol Violation|0
7593765|NCT02587520|11999499|FG017|Overall Study|Protocol Violation|0
7593766|NCT02587520|11999482|FG000|Overall Study|Adverse Event|0
7593767|NCT02587520|11999483|FG001|Overall Study|Adverse Event|0
7593768|NCT02587520|11999484|FG002|Overall Study|Adverse Event|0
7593769|NCT02587520|11999485|FG003|Overall Study|Adverse Event|0
7593770|NCT02587520|11999486|FG004|Overall Study|Adverse Event|0
7593771|NCT02587520|11999487|FG005|Overall Study|Adverse Event|0
7593772|NCT02587520|11999488|FG006|Overall Study|Adverse Event|0
7593773|NCT02587520|11999489|FG007|Overall Study|Adverse Event|0
7593774|NCT02587520|11999490|FG008|Overall Study|Adverse Event|0
7593775|NCT02587520|11999491|FG009|Overall Study|Adverse Event|0
7593776|NCT02587520|11999492|FG010|Overall Study|Adverse Event|0
7593777|NCT02587520|11999493|FG011|Overall Study|Adverse Event|1
7593778|NCT02587520|11999494|FG012|Overall Study|Adverse Event|0
7593779|NCT02587520|11999495|FG013|Overall Study|Adverse Event|0
7593780|NCT02587520|11999496|FG014|Overall Study|Adverse Event|0
7593781|NCT02587520|11999497|FG015|Overall Study|Adverse Event|0
7593782|NCT02587520|11999498|FG016|Overall Study|Adverse Event|0
7593783|NCT02587520|11999499|FG017|Overall Study|Adverse Event|0
7593784|NCT02587520|11999482|FG000|Overall Study|Withdrawal by Subject|0
7593785|NCT02587520|11999483|FG001|Overall Study|Withdrawal by Subject|0
7593786|NCT02587520|11999484|FG002|Overall Study|Withdrawal by Subject|1
7593787|NCT02587520|11999485|FG003|Overall Study|Withdrawal by Subject|1
7593788|NCT02587520|11999486|FG004|Overall Study|Withdrawal by Subject|0
7593789|NCT02587520|11999487|FG005|Overall Study|Withdrawal by Subject|1
7593790|NCT02587520|11999488|FG006|Overall Study|Withdrawal by Subject|1
7593791|NCT02587520|11999489|FG007|Overall Study|Withdrawal by Subject|0
7593792|NCT02587520|11999490|FG008|Overall Study|Withdrawal by Subject|0
7593793|NCT02587520|11999491|FG009|Overall Study|Withdrawal by Subject|0
7593795|NCT02587520|11999493|FG011|Overall Study|Withdrawal by Subject|0
7593796|NCT02587520|11999494|FG012|Overall Study|Withdrawal by Subject|0
7593797|NCT02587520|11999495|FG013|Overall Study|Withdrawal by Subject|1
7593798|NCT02587520|11999496|FG014|Overall Study|Withdrawal by Subject|0
7593799|NCT02587520|11999497|FG015|Overall Study|Withdrawal by Subject|0
7593800|NCT02587520|11999498|FG016|Overall Study|Withdrawal by Subject|0
7593801|NCT02587520|11999499|FG017|Overall Study|Withdrawal by Subject|0
7593802|NCT02587520|11999482|FG000|Overall Study|Lost to Follow-up|0
7593803|NCT02587520|11999483|FG001|Overall Study|Lost to Follow-up|2
7593804|NCT02587520|11999484|FG002|Overall Study|Lost to Follow-up|0
7593805|NCT02587520|11999485|FG003|Overall Study|Lost to Follow-up|2
7593806|NCT02587520|11999486|FG004|Overall Study|Lost to Follow-up|0
7593807|NCT02587520|11999487|FG005|Overall Study|Lost to Follow-up|1
7593808|NCT02587520|11999488|FG006|Overall Study|Lost to Follow-up|1
7593809|NCT02587520|11999489|FG007|Overall Study|Lost to Follow-up|1
7593810|NCT02587520|11999490|FG008|Overall Study|Lost to Follow-up|0
7593811|NCT02587520|11999491|FG009|Overall Study|Lost to Follow-up|2
7593812|NCT02587520|11999492|FG010|Overall Study|Lost to Follow-up|2
7593813|NCT02587520|11999493|FG011|Overall Study|Lost to Follow-up|1
7593814|NCT02587520|11999494|FG012|Overall Study|Lost to Follow-up|0
7593815|NCT02587520|11999495|FG013|Overall Study|Lost to Follow-up|0
7593816|NCT02587520|11999496|FG014|Overall Study|Lost to Follow-up|0
7593817|NCT02587520|11999497|FG015|Overall Study|Lost to Follow-up|0
7593818|NCT02587520|11999498|FG016|Overall Study|Lost to Follow-up|0
7593819|NCT02587520|11999499|FG017|Overall Study|Lost to Follow-up|0
7593820|NCT02584829|11999539|FG000|Overall Study|Physician Decision|1
7593821|NCT02584829|11999540|FG001|Overall Study|Physician Decision|0
7593822|NCT02584829|11999539|FG000|Overall Study|Withdrawal by Subject|0
7593823|NCT02584829|11999540|FG001|Overall Study|Withdrawal by Subject|1
7593824|NCT02584829|11999539|FG000|Overall Study|Progressive Disease|0
7593825|NCT02584829|11999540|FG001|Overall Study|Progressive Disease|3
7593826|NCT02570308|11999553|FG000|Overall Study|Death|1
7593827|NCT02570308|11999554|FG001|Overall Study|Death|5
7593828|NCT02570308|11999555|FG002|Overall Study|Death|4
7593829|NCT02570308|11999556|FG003|Overall Study|Death|4
7593830|NCT02570308|11999557|FG004|Overall Study|Death|69
7593831|NCT02570308|11999553|FG000|Overall Study|Lost to Follow-up|0
7593832|NCT02570308|11999554|FG001|Overall Study|Lost to Follow-up|0
7593833|NCT02570308|11999555|FG002|Overall Study|Lost to Follow-up|0
7593834|NCT02570308|11999556|FG003|Overall Study|Lost to Follow-up|0
7593835|NCT02570308|11999557|FG004|Overall Study|Lost to Follow-up|2
7593836|NCT02570308|11999553|FG000|Overall Study|Withdrawal by Subject|0
7593837|NCT02570308|11999554|FG001|Overall Study|Withdrawal by Subject|0
7593838|NCT02570308|11999555|FG002|Overall Study|Withdrawal by Subject|0
7593839|NCT02570308|11999556|FG003|Overall Study|Withdrawal by Subject|0
7593840|NCT02570308|11999557|FG004|Overall Study|Withdrawal by Subject|1
7593841|NCT02570308|11999553|FG000|Overall Study|Other|0
7593842|NCT02570308|11999554|FG001|Overall Study|Other|0
7593843|NCT02570308|11999555|FG002|Overall Study|Other|0
7593844|NCT02570308|11999556|FG003|Overall Study|Other|0
7593845|NCT02570308|11999557|FG004|Overall Study|Other|2
7593846|NCT02514083|11999575|FG000|Overall Study|Adverse Event|1
7627349|NCT00400946|12039776|FG003|Overall Study|Remission Death|0
7627350|NCT00400946|12039777|FG004|Overall Study|Remission Death|1
7627351|NCT00400946|12039773|FG000|Overall Study|Relapse|9
7627352|NCT00400946|12039774|FG001|Overall Study|Relapse|2
7627353|NCT00400946|12039775|FG002|Overall Study|Relapse|1
7627354|NCT00400946|12039776|FG003|Overall Study|Relapse|1
7627355|NCT00400946|12039777|FG004|Overall Study|Relapse|5
7627356|NCT00400946|12039773|FG000|Overall Study|Transplant in CR1|0
7627357|NCT00400946|12039774|FG001|Overall Study|Transplant in CR1|0
7627358|NCT00400946|12039775|FG002|Overall Study|Transplant in CR1|0
7627359|NCT00400946|12039776|FG003|Overall Study|Transplant in CR1|10
7627360|NCT00400946|12039777|FG004|Overall Study|Transplant in CR1|1
7627361|NCT00400946|12039773|FG000|Overall Study|Withdrawal by Subject|2
7627362|NCT00400946|12039774|FG001|Overall Study|Withdrawal by Subject|5
7627363|NCT00400946|12039775|FG002|Overall Study|Withdrawal by Subject|1
7627364|NCT00400946|12039776|FG003|Overall Study|Withdrawal by Subject|5
7627365|NCT00400946|12039777|FG004|Overall Study|Withdrawal by Subject|8
7627366|NCT00400946|12039773|FG000|Overall Study|Clinical|1
7627367|NCT00400946|12039774|FG001|Overall Study|Clinical|2
7627368|NCT00400946|12039775|FG002|Overall Study|Clinical|0
7627369|NCT00400946|12039776|FG003|Overall Study|Clinical|2
7627370|NCT00400946|12039777|FG004|Overall Study|Clinical|9
7627371|NCT00400946|12039773|FG000|Overall Study|Other|0
7627372|NCT00400946|12039774|FG001|Overall Study|Other|0
7627373|NCT00400946|12039775|FG002|Overall Study|Other|0
7627374|NCT00400946|12039776|FG003|Overall Study|Other|0
7627375|NCT00400946|12039777|FG004|Overall Study|Other|1
7627376|NCT00180414|12039797|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4
7627377|NCT00180414|12039798|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4
7627378|NCT03886220|12039835|FG000|Treatment Period|Discontinued study drug during the treatment period|5
7627379|NCT03886220|12039836|FG001|Treatment Period|Discontinued study drug during the treatment period|12
7627380|NCT03886220|12039835|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
7627381|NCT03886220|12039836|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7771231|NCT00880698|12215432|FG000|Overall Study|Lost to Follow-up|1
7771232|NCT00880698|12215433|FG001|Overall Study|Lost to Follow-up|3
7627382|NCT03886220|12039835|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1
7627383|NCT03886220|12039836|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7593847|NCT02497612|11999583|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57
7593848|NCT02497612|11999584|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51
7593849|NCT02497612|11999585|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39
7593850|NCT02497612|11999586|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41
7593851|NCT02497612|11999583|FG000|Overall Study|Participant's request|2
7593852|NCT02497612|11999584|FG001|Overall Study|Participant's request|3
7593853|NCT02497612|11999585|FG002|Overall Study|Participant's request|4
7593854|NCT02497612|11999586|FG003|Overall Study|Participant's request|1
7593855|NCT02497612|11999583|FG000|Overall Study|Investigator's judgement|1
7593856|NCT02497612|11999584|FG001|Overall Study|Investigator's judgement|0
7593857|NCT02497612|11999585|FG002|Overall Study|Investigator's judgement|0
7593858|NCT02497612|11999586|FG003|Overall Study|Investigator's judgement|2
7593859|NCT02497612|11999583|FG000|Overall Study|Adverse Event|3
7593860|NCT02497612|11999584|FG001|Overall Study|Adverse Event|1
7593861|NCT02497612|11999585|FG002|Overall Study|Adverse Event|4
7593862|NCT02497612|11999586|FG003|Overall Study|Adverse Event|1
7593863|NCT02497612|11999583|FG000|Overall Study|Lost to Follow-up|1
7593864|NCT02497612|11999584|FG001|Overall Study|Lost to Follow-up|1
7593865|NCT02497612|11999585|FG002|Overall Study|Lost to Follow-up|0
7593866|NCT02497612|11999586|FG003|Overall Study|Lost to Follow-up|1
7593867|NCT02497612|11999583|FG000|Overall Study|Other unspecified|1
7593868|NCT02497612|11999584|FG001|Overall Study|Other unspecified|1
7593869|NCT02497612|11999585|FG002|Overall Study|Other unspecified|2
7593870|NCT02497612|11999586|FG003|Overall Study|Other unspecified|0
7593871|NCT02497612|11999583|FG000|Overall Study|Not eligible|1
7593872|NCT02497612|11999584|FG001|Overall Study|Not eligible|0
7593873|NCT02497612|11999585|FG002|Overall Study|Not eligible|0
7593874|NCT02497612|11999586|FG003|Overall Study|Not eligible|1
7593875|NCT02460458|11999596|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47
7593876|NCT02460458|11999596|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27
7593877|NCT02460458|11999596|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14
7593878|NCT02460458|11999596|FG000|First Prospective Phase|Lost to Follow-up|16
7593879|NCT02460458|11999596|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9
7593880|NCT02457559|11999611|FG000|Overall Study|Progressive Disease|1
7593881|NCT02457559|11999612|FG001|Overall Study|Progressive Disease|2
7593882|NCT02457559|11999613|FG002|Overall Study|Progressive Disease|3
7593883|NCT02457559|11999614|FG003|Overall Study|Progressive Disease|0
7593884|NCT02457559|11999615|FG004|Overall Study|Progressive Disease|0
7593885|NCT02457559|11999616|FG005|Overall Study|Progressive Disease|2
7593886|NCT02457559|11999617|FG006|Overall Study|Progressive Disease|1
7593887|NCT02457559|11999618|FG007|Overall Study|Progressive Disease|0
7593888|NCT02457559|11999619|FG008|Overall Study|Progressive Disease|1
7593889|NCT02457559|11999620|FG009|Overall Study|Progressive Disease|1
7593890|NCT02457559|11999621|FG010|Overall Study|Progressive Disease|1
7593891|NCT02457559|11999611|FG000|Overall Study|Investigator's Discretion|0
7593892|NCT02457559|11999612|FG001|Overall Study|Investigator's Discretion|0
7593893|NCT02457559|11999613|FG002|Overall Study|Investigator's Discretion|2
7593894|NCT02457559|11999614|FG003|Overall Study|Investigator's Discretion|0
7593895|NCT02457559|11999615|FG004|Overall Study|Investigator's Discretion|1
7593896|NCT02457559|11999616|FG005|Overall Study|Investigator's Discretion|0
7593897|NCT02457559|11999617|FG006|Overall Study|Investigator's Discretion|1
7593898|NCT02457559|11999618|FG007|Overall Study|Investigator's Discretion|0
7593899|NCT02457559|11999619|FG008|Overall Study|Investigator's Discretion|1
7593900|NCT02457559|11999620|FG009|Overall Study|Investigator's Discretion|0
7593901|NCT02457559|11999621|FG010|Overall Study|Investigator's Discretion|1
7593902|NCT02457559|11999611|FG000|Overall Study|Adverse Event|0
7593903|NCT02457559|11999612|FG001|Overall Study|Adverse Event|1
7593904|NCT02457559|11999613|FG002|Overall Study|Adverse Event|2
7593905|NCT02457559|11999614|FG003|Overall Study|Adverse Event|0
7593906|NCT02457559|11999615|FG004|Overall Study|Adverse Event|0
7593907|NCT02457559|11999616|FG005|Overall Study|Adverse Event|0
7593908|NCT02457559|11999617|FG006|Overall Study|Adverse Event|0
7593909|NCT02457559|11999618|FG007|Overall Study|Adverse Event|0
7593910|NCT02457559|11999619|FG008|Overall Study|Adverse Event|0
7593911|NCT02457559|11999620|FG009|Overall Study|Adverse Event|0
7593912|NCT02457559|11999621|FG010|Overall Study|Adverse Event|0
7593913|NCT02457559|11999611|FG000|Overall Study|Reason not Specified|1
7593914|NCT02457559|11999612|FG001|Overall Study|Reason not Specified|0
7593915|NCT02457559|11999613|FG002|Overall Study|Reason not Specified|0
7593916|NCT02457559|11999614|FG003|Overall Study|Reason not Specified|0
7593917|NCT02457559|11999615|FG004|Overall Study|Reason not Specified|0
7593918|NCT02457559|11999616|FG005|Overall Study|Reason not Specified|0
7593919|NCT02457559|11999617|FG006|Overall Study|Reason not Specified|0
7593920|NCT02457559|11999618|FG007|Overall Study|Reason not Specified|0
7593921|NCT02457559|11999619|FG008|Overall Study|Reason not Specified|0
7593922|NCT02457559|11999620|FG009|Overall Study|Reason not Specified|2
7593923|NCT02457559|11999621|FG010|Overall Study|Reason not Specified|0
7593924|NCT02457559|11999611|FG000|Overall Study|Death|0
7593925|NCT02457559|11999612|FG001|Overall Study|Death|0
7593926|NCT02457559|11999613|FG002|Overall Study|Death|0
7593927|NCT02457559|11999614|FG003|Overall Study|Death|0
7593928|NCT02457559|11999615|FG004|Overall Study|Death|0
7593929|NCT02457559|11999616|FG005|Overall Study|Death|0
7593930|NCT02457559|11999617|FG006|Overall Study|Death|0
7593931|NCT02457559|11999618|FG007|Overall Study|Death|0
7593932|NCT02457559|11999619|FG008|Overall Study|Death|1
7593933|NCT02457559|11999620|FG009|Overall Study|Death|1
7593934|NCT02457559|11999621|FG010|Overall Study|Death|0
7593935|NCT02381652|11999671|FG000|Overall Study|Withdrawal by Subject|0
7593936|NCT02381652|11999672|FG001|Overall Study|Withdrawal by Subject|0
7593937|NCT02381652|11999673|FG002|Overall Study|Withdrawal by Subject|1
7593938|NCT02367794|11999682|FG000|Overall Study|Death|252
7593939|NCT02367794|11999683|FG001|Overall Study|Death|245
7593940|NCT02367794|11999684|FG002|Overall Study|Death|243
7593941|NCT02367794|11999682|FG000|Overall Study|Lost to Follow-up|1
7593942|NCT02367794|11999683|FG001|Overall Study|Lost to Follow-up|2
7593943|NCT02367794|11999684|FG002|Overall Study|Lost to Follow-up|2
7593944|NCT02367794|11999682|FG000|Overall Study|Physician Decision|0
7593945|NCT02367794|11999683|FG001|Overall Study|Physician Decision|5
7593946|NCT02367794|11999684|FG002|Overall Study|Physician Decision|3
7593947|NCT02367794|11999682|FG000|Overall Study|Protocol Violation|1
7593948|NCT02367794|11999683|FG001|Overall Study|Protocol Violation|0
7593949|NCT02367794|11999684|FG002|Overall Study|Protocol Violation|1
7593950|NCT02367794|11999682|FG000|Overall Study|Withdrawal by Subject|25
7593951|NCT02367794|11999683|FG001|Overall Study|Withdrawal by Subject|12
7593952|NCT02367794|11999684|FG002|Overall Study|Withdrawal by Subject|20
7593953|NCT02367794|11999682|FG000|Overall Study|Brain metastasis|1
7593954|NCT02367794|11999683|FG001|Overall Study|Brain metastasis|0
7593955|NCT02367794|11999684|FG002|Overall Study|Brain metastasis|0
7593956|NCT02367794|11999682|FG000|Overall Study|Randomized in error|0
7593957|NCT02367794|11999683|FG001|Overall Study|Randomized in error|0
7593958|NCT02367794|11999684|FG002|Overall Study|Randomized in error|1
7593959|NCT02367794|11999682|FG000|Overall Study|Patient unable to receive carboplatin|0
7593960|NCT02367794|11999683|FG001|Overall Study|Patient unable to receive carboplatin|0
7593961|NCT02367794|11999684|FG002|Overall Study|Patient unable to receive carboplatin|1
7593962|NCT02367794|11999682|FG000|Overall Study|Hypercalcemia prior to C1D1|0
7593963|NCT02367794|11999683|FG001|Overall Study|Hypercalcemia prior to C1D1|0
7593964|NCT02367794|11999684|FG002|Overall Study|Hypercalcemia prior to C1D1|1
7593965|NCT02367794|11999682|FG000|Overall Study|Adverse Event|0
7593966|NCT02367794|11999683|FG001|Overall Study|Adverse Event|0
7593967|NCT02367794|11999684|FG002|Overall Study|Adverse Event|2
7593968|NCT02367794|11999682|FG000|Overall Study|Study Terminated By Sponsor|0
7593969|NCT02367794|11999683|FG001|Overall Study|Study Terminated By Sponsor|1
7593970|NCT02367794|11999684|FG002|Overall Study|Study Terminated By Sponsor|1
7593971|NCT02367794|11999682|FG000|Overall Study|Moved to Roll-Over Study|0
7593972|NCT02367794|11999683|FG001|Overall Study|Moved to Roll-Over Study|15
7593973|NCT02367794|11999684|FG002|Overall Study|Moved to Roll-Over Study|13
7593974|NCT02367794|11999682|FG000|Overall Study|Sponsor Request|60
7593975|NCT02367794|11999683|FG001|Overall Study|Sponsor Request|57
7593976|NCT02367794|11999684|FG002|Overall Study|Sponsor Request|45
7593977|NCT02367794|11999682|FG000|Overall Study|Moved into PTAP Study|0
7593978|NCT02367794|11999683|FG001|Overall Study|Moved into PTAP Study|2
7593979|NCT02367794|11999684|FG002|Overall Study|Moved into PTAP Study|3
7593980|NCT02367794|11999682|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0
7593981|NCT02367794|11999683|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2
7593982|NCT02367794|11999684|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1
7593983|NCT02367794|11999682|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0
7593984|NCT02367794|11999683|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1
7593985|NCT02367794|11999684|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0
7593986|NCT02367794|11999682|FG000|Overall Study|Participant Enrolled in Extended Protocol|0
7593987|NCT02367794|11999683|FG001|Overall Study|Participant Enrolled in Extended Protocol|1
7593988|NCT02367794|11999684|FG002|Overall Study|Participant Enrolled in Extended Protocol|0
7593989|NCT02367794|11999682|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0
7593990|NCT02367794|11999683|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0
7593991|NCT02367794|11999684|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1
7593992|NCT02353832|11999717|FG000|Overall Study|Ineligible after enrollment|1
7593993|NCT02353832|11999717|FG000|Overall Study|Lost to Follow-up|1
7593994|NCT02353728|11999721|FG000|Overall Study|Subject non-compliance|1
7593995|NCT02345070|11999728|FG000|Overall Study|Adverse Event|12
7593996|NCT02345070|11999729|FG001|Overall Study|Adverse Event|8
7593997|NCT02345070|11999730|FG002|Overall Study|Adverse Event|16
7593998|NCT02345070|11999728|FG000|Overall Study|Poor compliance to protocol|2
7593999|NCT02345070|11999729|FG001|Overall Study|Poor compliance to protocol|0
7594000|NCT02345070|11999730|FG002|Overall Study|Poor compliance to protocol|0
7594001|NCT02345070|11999728|FG000|Overall Study|Other than specified above|6
7594002|NCT02345070|11999729|FG001|Overall Study|Other than specified above|3
7594003|NCT02345070|11999730|FG002|Overall Study|Other than specified above|7
7594004|NCT02325466|11999738|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0
7594005|NCT02325466|11999739|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0
7594006|NCT02325466|11999740|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1
7594007|NCT02325466|11999738|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0
7594008|NCT02325466|11999739|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2
7594009|NCT02325466|11999740|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0
7594010|NCT02325466|11999738|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1
7594011|NCT02325466|11999739|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0
7594012|NCT02325466|11999740|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2
7594013|NCT02325466|11999738|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1
7594014|NCT02325466|11999739|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0
7594015|NCT02325466|11999740|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0
7594016|NCT02325466|11999738|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1
7594017|NCT02325466|11999739|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1
7594018|NCT02325466|11999740|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0
7594019|NCT02325466|11999738|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1
7594020|NCT02325466|11999739|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0
7594021|NCT02325466|11999740|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0
7594022|NCT02325466|11999738|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1
7594023|NCT02325466|11999739|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0
7594024|NCT02325466|11999740|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0
7594025|NCT02325466|11999738|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0
7594026|NCT02325466|11999739|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1
7594027|NCT02325466|11999740|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0
7594028|NCT02325466|11999738|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0
7594029|NCT02325466|11999739|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1
7594030|NCT02325466|11999740|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0
7594031|NCT02322710|11999751|FG000|Overall Study|No efficacy assessment post-baseline|0
7594032|NCT02322710|11999752|FG001|Overall Study|No efficacy assessment post-baseline|1
7594033|NCT02322710|11999751|FG000|Overall Study|Protocol Violation|20
7594034|NCT02322710|11999752|FG001|Overall Study|Protocol Violation|25
7594035|NCT02234310|11999800|FG000|Overall Study|Physician Decision|1
7594036|NCT02234310|11999800|FG000|Overall Study|Adverse Event|1
7594037|NCT02234310|11999800|FG000|Overall Study|Eligibility Criteria not fulfilled|2
7594038|NCT02234310|11999800|FG000|Overall Study|Withdrawal by Subject|2
7594042|NCT02106195|11999853|FG000|Overall Study|Adverse Event|2
7594043|NCT02106195|11999853|FG000|Overall Study|Protocol Violation|1
7594044|NCT02104180|11999865|FG000|Overall Study|Protocol Violation|1
7594045|NCT02104180|11999866|FG001|Overall Study|Protocol Violation|0
7594046|NCT02040857|11999876|FG000|Overall Study|Adverse Event|14
7594047|NCT02040857|11999876|FG000|Overall Study|Physician Decision|5
7594048|NCT02040857|11999876|FG000|Overall Study|Withdrawal by Subject|31
7594049|NCT02040857|11999876|FG000|Overall Study|patient non-compliance|3
7594050|NCT02040857|11999876|FG000|Overall Study|Lost to Follow-up|2
7594051|NCT02040857|11999876|FG000|Overall Study|recurrence|4
7594052|NCT02040857|11999876|FG000|Overall Study|ineligible|1
7594053|NCT01943825|11999896|FG000|Overall Study|Lost to Follow-up|9
7594054|NCT01943825|11999897|FG001|Overall Study|Lost to Follow-up|3
7594055|NCT01943825|11999898|FG002|Overall Study|Lost to Follow-up|12
7594056|NCT01943825|11999899|FG003|Overall Study|Lost to Follow-up|8
7594057|NCT01943825|11999896|FG000|Overall Study|Withdrawal by Subject|1
7594058|NCT01943825|11999897|FG001|Overall Study|Withdrawal by Subject|0
7594059|NCT01943825|11999898|FG002|Overall Study|Withdrawal by Subject|3
7771233|NCT00880698|12215434|FG002|Overall Study|Lost to Follow-up|0
7771234|NCT00880698|12215435|FG003|Overall Study|Lost to Follow-up|1
7771235|NCT00880750|12215449|FG000|First Intervention|Adverse Event|1
7771236|NCT00880750|12215450|FG001|First Intervention|Adverse Event|0
7771237|NCT00880750|12215449|FG000|First Intervention|Unable to collect urine|4
7771238|NCT00880750|12215450|FG001|First Intervention|Unable to collect urine|0
7771239|NCT00880750|12215449|FG000|First Intervention|Non-compliance with meals|0
7771240|NCT00880750|12215450|FG001|First Intervention|Non-compliance with meals|1
7771241|NCT00880750|12215449|FG000|First Intervention|Withdrawal by Subject|2
7771242|NCT00880750|12215450|FG001|First Intervention|Withdrawal by Subject|0
7771243|NCT00880750|12215449|FG000|First Intervention|Lost to Follow-up|2
7771244|NCT00880750|12215450|FG001|First Intervention|Lost to Follow-up|0
7771245|NCT00880750|12215449|FG000|Second Intervention|Withdrawal by Subject|2
7771246|NCT00880750|12215450|FG001|Second Intervention|Withdrawal by Subject|2
7771247|NCT00880750|12215449|FG000|Second Intervention|Protocol Violation|1
7771248|NCT00880750|12215450|FG001|Second Intervention|Protocol Violation|0
7771249|NCT00880750|12215449|FG000|Second Intervention|Unable to collect urine|1
7771250|NCT00880750|12215450|FG001|Second Intervention|Unable to collect urine|0
7771251|NCT00880763|12215460|FG000|Extension Period (Part 2)|Adverse Event|0
7771252|NCT00880763|12215461|FG001|Extension Period (Part 2)|Adverse Event|0
7771253|NCT00880763|12215462|FG002|Extension Period (Part 2)|Adverse Event|1
7771254|NCT00880763|12215463|FG003|Extension Period (Part 2)|Adverse Event|1
7771255|NCT00880763|12215460|FG000|Extension Period (Part 2)|Withdrawal by Subject|0
7771256|NCT00880763|12215461|FG001|Extension Period (Part 2)|Withdrawal by Subject|2
7771257|NCT00880763|12215462|FG002|Extension Period (Part 2)|Withdrawal by Subject|1
7771258|NCT00880763|12215463|FG003|Extension Period (Part 2)|Withdrawal by Subject|1
7771259|NCT00880763|12215460|FG000|Extension Period (Part 2)|Physician Decision|0
7771260|NCT00880763|12215461|FG001|Extension Period (Part 2)|Physician Decision|1
7771261|NCT00880763|12215462|FG002|Extension Period (Part 2)|Physician Decision|1
7771262|NCT00880763|12215463|FG003|Extension Period (Part 2)|Physician Decision|0
7771263|NCT00880763|12215460|FG000|Extension Period (Part 2)|Lack of Efficacy|0
7771264|NCT00880763|12215461|FG001|Extension Period (Part 2)|Lack of Efficacy|0
7771265|NCT00880763|12215462|FG002|Extension Period (Part 2)|Lack of Efficacy|0
7771266|NCT00880763|12215463|FG003|Extension Period (Part 2)|Lack of Efficacy|1
7771267|NCT00880906|12215475|FG000|Overall Study|Lost to Follow-up|0
7771268|NCT00880906|12215476|FG001|Overall Study|Lost to Follow-up|1
7771269|NCT00880906|12215475|FG000|Overall Study|Did not meet criteria following patholog|12
7771270|NCT00880906|12215476|FG001|Overall Study|Did not meet criteria following patholog|6
7771271|NCT00881335|12215513|FG000|Overall Study|Lost to Follow-up|3
7594060|NCT01943825|11999899|FG003|Overall Study|Withdrawal by Subject|2
7594061|NCT01943825|11999896|FG000|Overall Study|Other than specified above|0
7771272|NCT00881335|12215514|FG001|Overall Study|Lost to Follow-up|2
7771273|NCT00881361|12215522|FG000|Overall Study|Terminated prior to surgery|27
7594062|NCT01943825|11999897|FG001|Overall Study|Other than specified above|1
7594063|NCT01943825|11999898|FG002|Overall Study|Other than specified above|0
7594064|NCT01943825|11999899|FG003|Overall Study|Other than specified above|1
7771274|NCT00881361|12215523|FG001|Overall Study|Terminated prior to surgery|7
7771275|NCT00881361|12215524|FG002|Overall Study|Terminated prior to surgery|0
7771276|NCT00881361|12215522|FG000|Overall Study|Ineligible|17
7771277|NCT00881361|12215523|FG001|Overall Study|Ineligible|2
7771278|NCT00881361|12215524|FG002|Overall Study|Ineligible|2
7771279|NCT00881504|12215542|FG000|Overall Study|Withdrawal by Subject|1
7771280|NCT00881530|12215552|FG000|Overall Study|Adverse Event|5
7771281|NCT00881530|12215553|FG001|Overall Study|Adverse Event|1
7771282|NCT00881530|12215554|FG002|Overall Study|Adverse Event|1
7771283|NCT00881530|12215555|FG003|Overall Study|Adverse Event|4
7771284|NCT00881530|12215556|FG004|Overall Study|Adverse Event|10
7771285|NCT00881530|12215557|FG005|Overall Study|Adverse Event|2
7771286|NCT00881530|12215552|FG000|Overall Study|Lack of Efficacy|1
7771287|NCT00881530|12215553|FG001|Overall Study|Lack of Efficacy|0
7771288|NCT00881530|12215554|FG002|Overall Study|Lack of Efficacy|0
7771289|NCT00881530|12215555|FG003|Overall Study|Lack of Efficacy|0
7771290|NCT00881530|12215556|FG004|Overall Study|Lack of Efficacy|1
7771291|NCT00881530|12215557|FG005|Overall Study|Lack of Efficacy|1
7771292|NCT00881530|12215552|FG000|Overall Study|Not compliant with the protocol|0
7771293|NCT00881530|12215553|FG001|Overall Study|Not compliant with the protocol|0
7771294|NCT00881530|12215554|FG002|Overall Study|Not compliant with the protocol|0
7771295|NCT00881530|12215555|FG003|Overall Study|Not compliant with the protocol|0
7771296|NCT00881530|12215556|FG004|Overall Study|Not compliant with the protocol|2
7771297|NCT00881530|12215557|FG005|Overall Study|Not compliant with the protocol|0
7771298|NCT00881530|12215552|FG000|Overall Study|Lost to Follow-up|0
7771299|NCT00881530|12215553|FG001|Overall Study|Lost to Follow-up|1
7627384|NCT03627091|12039858|FG000|Overall Study|Adverse Event|0
7627385|NCT03627091|12039859|FG001|Overall Study|Adverse Event|0
7627386|NCT03627091|12039860|FG002|Overall Study|Adverse Event|2
7627387|NCT03627091|12039858|FG000|Overall Study|Withdrawal by Subject|2
7627388|NCT03627091|12039859|FG001|Overall Study|Withdrawal by Subject|0
7627389|NCT03627091|12039860|FG002|Overall Study|Withdrawal by Subject|2
7627390|NCT03627091|12039858|FG000|Overall Study|Physician Decision|2
7627391|NCT03627091|12039859|FG001|Overall Study|Physician Decision|0
7627392|NCT03627091|12039860|FG002|Overall Study|Physician Decision|0
7627393|NCT03627091|12039858|FG000|Overall Study|Site terminated by sponsor|0
7627394|NCT03627091|12039859|FG001|Overall Study|Site terminated by sponsor|1
7627395|NCT03627091|12039860|FG002|Overall Study|Site terminated by sponsor|0
7627396|NCT03627091|12039858|FG000|Overall Study|Disease relapse|7
7627397|NCT03627091|12039859|FG001|Overall Study|Disease relapse|5
7627398|NCT03627091|12039860|FG002|Overall Study|Disease relapse|1
7627399|NCT03627091|12039858|FG000|Overall Study|Other|1
7627400|NCT03627091|12039859|FG001|Overall Study|Other|0
7627401|NCT03627091|12039860|FG002|Overall Study|Other|0
7627402|NCT03568318|12039875|FG000|Overall Study|Adverse Event|3
7627403|NCT03568318|12039876|FG001|Overall Study|Adverse Event|1
7627404|NCT03568318|12039877|FG002|Overall Study|Adverse Event|1
7627405|NCT03568318|12039878|FG003|Overall Study|Adverse Event|0
7627406|NCT03568318|12039879|FG004|Overall Study|Adverse Event|1
7627407|NCT03568318|12039880|FG005|Overall Study|Adverse Event|0
7627408|NCT03568318|12039875|FG000|Overall Study|Withdrawal by Subject|6
7627409|NCT03568318|12039876|FG001|Overall Study|Withdrawal by Subject|5
7627410|NCT03568318|12039877|FG002|Overall Study|Withdrawal by Subject|2
7627411|NCT03568318|12039878|FG003|Overall Study|Withdrawal by Subject|1
7627412|NCT03568318|12039879|FG004|Overall Study|Withdrawal by Subject|0
7627413|NCT03568318|12039880|FG005|Overall Study|Withdrawal by Subject|0
7627414|NCT03568318|12039875|FG000|Overall Study|Lost to Follow-up|3
7627415|NCT03568318|12039876|FG001|Overall Study|Lost to Follow-up|2
7627416|NCT03568318|12039877|FG002|Overall Study|Lost to Follow-up|2
7627417|NCT03568318|12039878|FG003|Overall Study|Lost to Follow-up|2
7627418|NCT03568318|12039879|FG004|Overall Study|Lost to Follow-up|1
7627419|NCT03568318|12039880|FG005|Overall Study|Lost to Follow-up|0
7627420|NCT03568318|12039875|FG000|Overall Study|Other|3
7627421|NCT03568318|12039876|FG001|Overall Study|Other|1
7627422|NCT03568318|12039877|FG002|Overall Study|Other|3
7627423|NCT03568318|12039878|FG003|Overall Study|Other|0
7627424|NCT03568318|12039879|FG004|Overall Study|Other|0
7627425|NCT03568318|12039880|FG005|Overall Study|Other|0
7627426|NCT03568318|12039875|FG000|Overall Study|Ongoing at Time of Analysis|5
7627427|NCT03568318|12039876|FG001|Overall Study|Ongoing at Time of Analysis|3
7627428|NCT03568318|12039877|FG002|Overall Study|Ongoing at Time of Analysis|2
7627429|NCT03568318|12039878|FG003|Overall Study|Ongoing at Time of Analysis|1
7627430|NCT03568318|12039879|FG004|Overall Study|Ongoing at Time of Analysis|0
7627431|NCT03568318|12039880|FG005|Overall Study|Ongoing at Time of Analysis|0
7627432|NCT03498560|12039894|FG000|Overall Study|Found Ineligible|2
7627433|NCT03498560|12039894|FG000|Overall Study|Withdrawal by Subject|14
7627434|NCT03498560|12039894|FG000|Overall Study|Lost to Follow-up|4
7627435|NCT03498560|12039894|FG000|Overall Study|Death|1
7627436|NCT03441360|12039902|FG000|Overall Study|Radiological disease progression|5
7627437|NCT03441360|12039903|FG001|Overall Study|Radiological disease progression|6
7627438|NCT03441360|12039904|FG002|Overall Study|Radiological disease progression|4
7627439|NCT03441360|12039902|FG000|Overall Study|Clinical disease progression|2
7627440|NCT03441360|12039903|FG001|Overall Study|Clinical disease progression|2
7594107|NCT01853748|11999957|FG000|Allocation|Withdrawal by Subject|1
7594108|NCT01853748|11999958|FG001|Allocation|Withdrawal by Subject|13
7594109|NCT01853748|11999957|FG000|Allocation|not sufficient to receive intervention|0
7594110|NCT01853748|11999958|FG001|Allocation|not sufficient to receive intervention|1
7594111|NCT01853748|11999957|FG000|Follow-Up|Withdrawal by Subject|7
7594112|NCT01853748|11999958|FG001|Follow-Up|Withdrawal by Subject|6
7594113|NCT01853748|11999957|FG000|Follow-Up|Adverse Event|67
7594114|NCT01853748|11999958|FG001|Follow-Up|Adverse Event|7
7594115|NCT01853748|11999957|FG000|Follow-Up|not available for data collection|16
7594116|NCT01853748|11999958|FG001|Follow-Up|not available for data collection|4
7594117|NCT01817751|11999973|FG000|Overall Study|Physician Decision|1
7594118|NCT01722331|11999980|FG000|Part 1|Adverse Event|5
7594119|NCT01722331|11999981|FG001|Part 1|Adverse Event|0
7594120|NCT01722331|11999982|FG002|Part 1|Adverse Event|0
7594121|NCT01722331|11999983|FG003|Part 1|Adverse Event|0
7594122|NCT01722331|11999984|FG004|Part 1|Adverse Event|0
7594123|NCT01722331|11999985|FG005|Part 1|Adverse Event|0
7594124|NCT01722331|11999986|FG006|Part 1|Adverse Event|0
7594125|NCT01722331|11999980|FG000|Part 1|Lack of Efficacy|0
7594126|NCT01722331|11999981|FG001|Part 1|Lack of Efficacy|0
7594127|NCT01722331|11999982|FG002|Part 1|Lack of Efficacy|1
7594128|NCT01722331|11999983|FG003|Part 1|Lack of Efficacy|0
7594129|NCT01722331|11999984|FG004|Part 1|Lack of Efficacy|2
7594130|NCT01722331|11999985|FG005|Part 1|Lack of Efficacy|0
7594131|NCT01722331|11999986|FG006|Part 1|Lack of Efficacy|0
7594132|NCT01722331|11999980|FG000|Part 1|Lost to Follow-up|1
7594133|NCT01722331|11999981|FG001|Part 1|Lost to Follow-up|0
7594134|NCT01722331|11999982|FG002|Part 1|Lost to Follow-up|2
7594135|NCT01722331|11999983|FG003|Part 1|Lost to Follow-up|0
7594136|NCT01722331|11999984|FG004|Part 1|Lost to Follow-up|1
7594137|NCT01722331|11999985|FG005|Part 1|Lost to Follow-up|0
7594138|NCT01722331|11999986|FG006|Part 1|Lost to Follow-up|0
7594139|NCT01722331|11999980|FG000|Part 1|Physician Decision|0
7594140|NCT01722331|11999981|FG001|Part 1|Physician Decision|0
7594141|NCT01722331|11999982|FG002|Part 1|Physician Decision|3
7594142|NCT01722331|11999983|FG003|Part 1|Physician Decision|0
7594143|NCT01722331|11999984|FG004|Part 1|Physician Decision|1
7594144|NCT01722331|11999985|FG005|Part 1|Physician Decision|0
7594145|NCT01722331|11999986|FG006|Part 1|Physician Decision|0
7594146|NCT01722331|11999980|FG000|Part 1|Pregnancy|1
7594147|NCT01722331|11999981|FG001|Part 1|Pregnancy|0
7594148|NCT01722331|11999982|FG002|Part 1|Pregnancy|0
7594149|NCT01722331|11999983|FG003|Part 1|Pregnancy|0
7594150|NCT01722331|11999984|FG004|Part 1|Pregnancy|0
7594151|NCT01722331|11999985|FG005|Part 1|Pregnancy|0
7594152|NCT01722331|11999986|FG006|Part 1|Pregnancy|0
7594153|NCT01722331|11999980|FG000|Part 1|Progressive Disease|0
7594154|NCT01722331|11999981|FG001|Part 1|Progressive Disease|0
7594155|NCT01722331|11999982|FG002|Part 1|Progressive Disease|0
7594156|NCT01722331|11999983|FG003|Part 1|Progressive Disease|0
7594157|NCT01722331|11999984|FG004|Part 1|Progressive Disease|1
7594158|NCT01722331|11999985|FG005|Part 1|Progressive Disease|0
7594159|NCT01722331|11999986|FG006|Part 1|Progressive Disease|0
7594160|NCT01722331|11999980|FG000|Part 1|Protocol Violation|1
7594161|NCT01722331|11999981|FG001|Part 1|Protocol Violation|0
7594162|NCT01722331|11999982|FG002|Part 1|Protocol Violation|0
7594163|NCT01722331|11999983|FG003|Part 1|Protocol Violation|0
7594164|NCT01722331|11999984|FG004|Part 1|Protocol Violation|1
7594165|NCT01722331|11999985|FG005|Part 1|Protocol Violation|0
7594166|NCT01722331|11999986|FG006|Part 1|Protocol Violation|0
7594167|NCT01722331|11999980|FG000|Part 1|Withdrawal by Subject|2
7594168|NCT01722331|11999981|FG001|Part 1|Withdrawal by Subject|0
7594169|NCT01722331|11999982|FG002|Part 1|Withdrawal by Subject|3
7594170|NCT01722331|11999983|FG003|Part 1|Withdrawal by Subject|0
7594171|NCT01722331|11999984|FG004|Part 1|Withdrawal by Subject|3
7594172|NCT01722331|11999985|FG005|Part 1|Withdrawal by Subject|0
7594173|NCT01722331|11999986|FG006|Part 1|Withdrawal by Subject|0
7594174|NCT01722331|11999980|FG000|Part 2|Adverse Event|3
7594175|NCT01722331|11999981|FG001|Part 2|Adverse Event|0
7594176|NCT01722331|11999982|FG002|Part 2|Adverse Event|0
7594177|NCT01722331|11999983|FG003|Part 2|Adverse Event|0
7594178|NCT01722331|11999984|FG004|Part 2|Adverse Event|0
7594179|NCT01722331|11999985|FG005|Part 2|Adverse Event|1
7594180|NCT01722331|11999986|FG006|Part 2|Adverse Event|0
7594181|NCT01722331|11999980|FG000|Part 2|Lack of Efficacy|3
7594182|NCT01722331|11999981|FG001|Part 2|Lack of Efficacy|0
7594183|NCT01722331|11999982|FG002|Part 2|Lack of Efficacy|11
7594184|NCT01722331|11999983|FG003|Part 2|Lack of Efficacy|0
7594185|NCT01722331|11999984|FG004|Part 2|Lack of Efficacy|0
7594186|NCT01722331|11999985|FG005|Part 2|Lack of Efficacy|3
7594187|NCT01722331|11999986|FG006|Part 2|Lack of Efficacy|3
7594188|NCT01722331|11999980|FG000|Part 2|Lost to Follow-up|0
7594189|NCT01722331|11999981|FG001|Part 2|Lost to Follow-up|0
7594190|NCT01722331|11999982|FG002|Part 2|Lost to Follow-up|3
7594191|NCT01722331|11999983|FG003|Part 2|Lost to Follow-up|0
7594192|NCT01722331|11999984|FG004|Part 2|Lost to Follow-up|0
7594193|NCT01722331|11999985|FG005|Part 2|Lost to Follow-up|1
7594194|NCT01722331|11999986|FG006|Part 2|Lost to Follow-up|1
7594195|NCT01722331|11999980|FG000|Part 2|Non-Compliance with Study Drug|1
7594196|NCT01722331|11999981|FG001|Part 2|Non-Compliance with Study Drug|0
7594197|NCT01722331|11999982|FG002|Part 2|Non-Compliance with Study Drug|1
7594198|NCT01722331|11999983|FG003|Part 2|Non-Compliance with Study Drug|0
7594199|NCT01722331|11999984|FG004|Part 2|Non-Compliance with Study Drug|0
7594200|NCT01722331|11999985|FG005|Part 2|Non-Compliance with Study Drug|0
7594201|NCT01722331|11999986|FG006|Part 2|Non-Compliance with Study Drug|0
7594202|NCT01722331|11999980|FG000|Part 2|Physician Decision|0
7594203|NCT01722331|11999981|FG001|Part 2|Physician Decision|0
7594204|NCT01722331|11999982|FG002|Part 2|Physician Decision|2
7594205|NCT01722331|11999983|FG003|Part 2|Physician Decision|0
7594206|NCT01722331|11999984|FG004|Part 2|Physician Decision|0
7594207|NCT01722331|11999985|FG005|Part 2|Physician Decision|0
7594208|NCT01722331|11999986|FG006|Part 2|Physician Decision|0
7594209|NCT01722331|11999980|FG000|Part 2|Pregnancy|0
7594210|NCT01722331|11999981|FG001|Part 2|Pregnancy|0
7594211|NCT01722331|11999982|FG002|Part 2|Pregnancy|0
7594212|NCT01722331|11999983|FG003|Part 2|Pregnancy|0
7594213|NCT01722331|11999984|FG004|Part 2|Pregnancy|0
7594214|NCT01722331|11999985|FG005|Part 2|Pregnancy|1
7594215|NCT01722331|11999986|FG006|Part 2|Pregnancy|0
7594216|NCT01722331|11999980|FG000|Part 2|Progressive Disease|0
7594217|NCT01722331|11999981|FG001|Part 2|Progressive Disease|0
7594218|NCT01722331|11999982|FG002|Part 2|Progressive Disease|1
7594219|NCT01722331|11999983|FG003|Part 2|Progressive Disease|0
7594220|NCT01722331|11999984|FG004|Part 2|Progressive Disease|0
7594221|NCT01722331|11999985|FG005|Part 2|Progressive Disease|0
7594222|NCT01722331|11999986|FG006|Part 2|Progressive Disease|0
7594223|NCT01722331|11999980|FG000|Part 2|Protocol Violation|1
7594224|NCT01722331|11999981|FG001|Part 2|Protocol Violation|0
7594225|NCT01722331|11999982|FG002|Part 2|Protocol Violation|0
7594226|NCT01722331|11999983|FG003|Part 2|Protocol Violation|0
7594227|NCT01722331|11999984|FG004|Part 2|Protocol Violation|0
7594228|NCT01722331|11999985|FG005|Part 2|Protocol Violation|0
7594229|NCT01722331|11999986|FG006|Part 2|Protocol Violation|0
7594230|NCT01722331|11999980|FG000|Part 2|Withdrawal by Subject|5
7594231|NCT01722331|11999981|FG001|Part 2|Withdrawal by Subject|0
7594232|NCT01722331|11999982|FG002|Part 2|Withdrawal by Subject|3
7594233|NCT01722331|11999983|FG003|Part 2|Withdrawal by Subject|0
7594234|NCT01722331|11999984|FG004|Part 2|Withdrawal by Subject|0
7594235|NCT01722331|11999985|FG005|Part 2|Withdrawal by Subject|2
7594236|NCT01722331|11999986|FG006|Part 2|Withdrawal by Subject|2
7594237|NCT01722331|11999980|FG000|Part 2|Other Protocol Specified Criteria|6
7594238|NCT01722331|11999981|FG001|Part 2|Other Protocol Specified Criteria|0
7594239|NCT01722331|11999982|FG002|Part 2|Other Protocol Specified Criteria|10
7594240|NCT01722331|11999983|FG003|Part 2|Other Protocol Specified Criteria|0
7594241|NCT01722331|11999984|FG004|Part 2|Other Protocol Specified Criteria|0
7594242|NCT01722331|11999985|FG005|Part 2|Other Protocol Specified Criteria|2
7594243|NCT01722331|11999986|FG006|Part 2|Other Protocol Specified Criteria|1
7594244|NCT01722331|11999980|FG000|Part 3|Adverse Event|2
7594245|NCT01722331|11999981|FG001|Part 3|Adverse Event|2
7594246|NCT01722331|11999982|FG002|Part 3|Adverse Event|0
7594247|NCT01722331|11999983|FG003|Part 3|Adverse Event|1
7594248|NCT01722331|11999984|FG004|Part 3|Adverse Event|0
7594249|NCT01722331|11999985|FG005|Part 3|Adverse Event|0
7594250|NCT01722331|11999986|FG006|Part 3|Adverse Event|0
7594251|NCT01722331|11999980|FG000|Part 3|Death|1
7594252|NCT01722331|11999981|FG001|Part 3|Death|0
7594253|NCT01722331|11999982|FG002|Part 3|Death|0
7594254|NCT01722331|11999983|FG003|Part 3|Death|0
7594255|NCT01722331|11999984|FG004|Part 3|Death|0
7594256|NCT01722331|11999985|FG005|Part 3|Death|0
7594257|NCT01722331|11999986|FG006|Part 3|Death|0
7594258|NCT01722331|11999980|FG000|Part 3|Lack of Efficacy|1
7594259|NCT01722331|11999981|FG001|Part 3|Lack of Efficacy|0
7594260|NCT01722331|11999982|FG002|Part 3|Lack of Efficacy|0
7594261|NCT01722331|11999983|FG003|Part 3|Lack of Efficacy|0
7594262|NCT01722331|11999984|FG004|Part 3|Lack of Efficacy|0
7594263|NCT01722331|11999985|FG005|Part 3|Lack of Efficacy|0
7594264|NCT01722331|11999986|FG006|Part 3|Lack of Efficacy|0
7594265|NCT01722331|11999980|FG000|Part 3|Lost to Follow-up|3
7594266|NCT01722331|11999981|FG001|Part 3|Lost to Follow-up|4
7594267|NCT01722331|11999982|FG002|Part 3|Lost to Follow-up|0
7594268|NCT01722331|11999983|FG003|Part 3|Lost to Follow-up|0
7594269|NCT01722331|11999984|FG004|Part 3|Lost to Follow-up|0
7594270|NCT01722331|11999985|FG005|Part 3|Lost to Follow-up|1
7594271|NCT01722331|11999986|FG006|Part 3|Lost to Follow-up|0
7594272|NCT01722331|11999980|FG000|Part 3|Non-Compliance with Study Drug|0
7594273|NCT01722331|11999981|FG001|Part 3|Non-Compliance with Study Drug|1
7594274|NCT01722331|11999982|FG002|Part 3|Non-Compliance with Study Drug|0
7594275|NCT01722331|11999983|FG003|Part 3|Non-Compliance with Study Drug|0
7594276|NCT01722331|11999984|FG004|Part 3|Non-Compliance with Study Drug|0
7594277|NCT01722331|11999985|FG005|Part 3|Non-Compliance with Study Drug|0
7594278|NCT01722331|11999986|FG006|Part 3|Non-Compliance with Study Drug|0
7594279|NCT01722331|11999980|FG000|Part 3|Physician Decision|1
7594280|NCT01722331|11999981|FG001|Part 3|Physician Decision|1
7594281|NCT01722331|11999982|FG002|Part 3|Physician Decision|0
7594282|NCT01722331|11999983|FG003|Part 3|Physician Decision|0
7594283|NCT01722331|11999984|FG004|Part 3|Physician Decision|0
7594284|NCT01722331|11999985|FG005|Part 3|Physician Decision|0
7594285|NCT01722331|11999986|FG006|Part 3|Physician Decision|1
7594286|NCT01722331|11999980|FG000|Part 3|Protocol Violation|2
7594287|NCT01722331|11999981|FG001|Part 3|Protocol Violation|1
7594288|NCT01722331|11999982|FG002|Part 3|Protocol Violation|0
7594289|NCT01722331|11999983|FG003|Part 3|Protocol Violation|0
7594290|NCT01722331|11999984|FG004|Part 3|Protocol Violation|0
7594291|NCT01722331|11999985|FG005|Part 3|Protocol Violation|0
7594292|NCT01722331|11999986|FG006|Part 3|Protocol Violation|0
7594293|NCT01722331|11999980|FG000|Part 3|Withdrawal by Subject|4
7594294|NCT01722331|11999981|FG001|Part 3|Withdrawal by Subject|7
7594295|NCT01722331|11999982|FG002|Part 3|Withdrawal by Subject|0
7594296|NCT01722331|11999983|FG003|Part 3|Withdrawal by Subject|0
7594297|NCT01722331|11999984|FG004|Part 3|Withdrawal by Subject|0
7594298|NCT01722331|11999985|FG005|Part 3|Withdrawal by Subject|2
7594299|NCT01722331|11999986|FG006|Part 3|Withdrawal by Subject|1
7594300|NCT01722331|11999980|FG000|Part 3|Other Protocol Specified Criteria|1
7594301|NCT01722331|11999981|FG001|Part 3|Other Protocol Specified Criteria|1
7594302|NCT01722331|11999982|FG002|Part 3|Other Protocol Specified Criteria|0
7594303|NCT01722331|11999983|FG003|Part 3|Other Protocol Specified Criteria|0
7594304|NCT01722331|11999984|FG004|Part 3|Other Protocol Specified Criteria|0
7594305|NCT01722331|11999985|FG005|Part 3|Other Protocol Specified Criteria|0
7594306|NCT01722331|11999986|FG006|Part 3|Other Protocol Specified Criteria|0
7594307|NCT01716117|12000000|FG000|Overall Study|Death|5
7594308|NCT01716117|12000001|FG001|Overall Study|Death|2
7594309|NCT01716117|12000000|FG000|Overall Study|Withdrawal by Subject|2
7594310|NCT01716117|12000001|FG001|Overall Study|Withdrawal by Subject|0
7594311|NCT01698905|12000015|FG000|Overall Study|Adverse Event|4
7594312|NCT01698905|12000015|FG000|Overall Study|Physician Decision|2
7594313|NCT01698905|12000015|FG000|Overall Study|Pregnancy|1
7594314|NCT01698905|12000015|FG000|Overall Study|Protocol Violation|1
7594315|NCT01698905|12000015|FG000|Overall Study|Subject/guardian decision|2
7594316|NCT01698905|12000015|FG000|Overall Study|Death|1
7594317|NCT01630590|12000036|FG000|Overall Study|Adverse Event|9
7594318|NCT01630590|12000036|FG000|Overall Study|Lack of Efficacy|37
7594319|NCT01630590|12000036|FG000|Overall Study|Withdrawal by Subject|4
7594320|NCT01630590|12000036|FG000|Overall Study|2nd primary tumor|2
7594321|NCT01630590|12000036|FG000|Overall Study|Automobile accident|1
7594322|NCT01630590|12000036|FG000|Overall Study|Maximum benefit|4
7594323|NCT01619085|12000040|FG000|Overall Study|Adverse Event|231
7594324|NCT01619085|12000040|FG000|Overall Study|Protocol Violation|4
7771300|NCT00881530|12215554|FG002|Overall Study|Lost to Follow-up|1
7594325|NCT01619085|12000040|FG000|Overall Study|Lost to Follow-up|3
7594326|NCT01619085|12000040|FG000|Overall Study|Withdrawal by Subject|45
7594327|NCT01619085|12000040|FG000|Overall Study|Other than specified|96
7594328|NCT01619085|12000040|FG000|Overall Study|Not treated|1
7594329|NCT01619085|12000040|FG000|Overall Study|Death|145
7594330|NCT01499095|12000053|FG000|Overall Study|Randomized But Not Treated|1
7594331|NCT01499095|12000054|FG001|Overall Study|Randomized But Not Treated|1
7594332|NCT01499095|12000053|FG000|Overall Study|Adverse Event|12
7594333|NCT01499095|12000054|FG001|Overall Study|Adverse Event|7
7594334|NCT01499095|12000053|FG000|Overall Study|Lack of Efficacy|2
7594335|NCT01499095|12000054|FG001|Overall Study|Lack of Efficacy|1
7594336|NCT01499095|12000053|FG000|Overall Study|Protocol Violation|6
7594337|NCT01499095|12000054|FG001|Overall Study|Protocol Violation|7
7594338|NCT01499095|12000053|FG000|Overall Study|Received Rescue Therapy|32
7594339|NCT01499095|12000054|FG001|Overall Study|Received Rescue Therapy|40
7594340|NCT01499095|12000053|FG000|Overall Study|Diverse Reasons|22
7594341|NCT01499095|12000054|FG001|Overall Study|Diverse Reasons|25
7594342|NCT01499095|12000053|FG000|Overall Study|Lost to Follow-up|6
7594343|NCT01499095|12000054|FG001|Overall Study|Lost to Follow-up|4
7594344|NCT01499095|12000053|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0
7594345|NCT01499095|12000054|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5
7771301|NCT00881530|12215555|FG003|Overall Study|Lost to Follow-up|3
7594346|NCT01499095|12000053|FG000|Overall Study|Hypoglycemia|3
7594347|NCT01499095|12000054|FG001|Overall Study|Hypoglycemia|1
7594348|NCT01499095|12000053|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
7594349|NCT01499095|12000054|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
7594350|NCT01499095|12000053|FG000|Overall Study|Change in Injection Schedule|2
7594351|NCT01499095|12000054|FG001|Overall Study|Change in Injection Schedule|0
7594352|NCT01499095|12000053|FG000|Overall Study|Perceived Lack of Efficacy|1
7594353|NCT01499095|12000054|FG001|Overall Study|Perceived Lack of Efficacy|1
7594354|NCT01499082|12000065|FG000|Overall Study|Randomized but not Treated|0
7594355|NCT01499082|12000066|FG001|Overall Study|Randomized but not Treated|1
7594356|NCT01499082|12000065|FG000|Overall Study|Adverse Event|12
7594357|NCT01499082|12000066|FG001|Overall Study|Adverse Event|16
7594358|NCT01499082|12000065|FG000|Overall Study|Lack of Efficacy|1
7594359|NCT01499082|12000066|FG001|Overall Study|Lack of Efficacy|1
7594360|NCT01499082|12000065|FG000|Overall Study|Protocol Violation|6
7594361|NCT01499082|12000066|FG001|Overall Study|Protocol Violation|8
7594362|NCT01499082|12000065|FG000|Overall Study|Diverse Reasons|18
7594363|NCT01499082|12000066|FG001|Overall Study|Diverse Reasons|14
7594364|NCT01499082|12000065|FG000|Overall Study|Site Closure for Noncompliance|5
7594365|NCT01499082|12000066|FG001|Overall Study|Site Closure for Noncompliance|2
7594366|NCT01499082|12000065|FG000|Overall Study|Hypoglycemia|2
7594367|NCT01499082|12000066|FG001|Overall Study|Hypoglycemia|3
7594368|NCT01499082|12000065|FG000|Overall Study|Lost to Follow-up|1
7594369|NCT01499082|12000066|FG001|Overall Study|Lost to Follow-up|3
7771302|NCT00881530|12215556|FG004|Overall Study|Lost to Follow-up|1
7594371|NCT01488890|12000082|FG000|Overall Study|Serious adverse event|2
7594372|NCT01488890|12000083|FG001|Overall Study|Serious adverse event|0
7594373|NCT01488890|12000084|FG002|Overall Study|Serious adverse event|0
7594374|NCT01488890|12000085|FG003|Overall Study|Serious adverse event|0
7594375|NCT01488890|12000082|FG000|Overall Study|Protocol Violation|3
7594376|NCT01488890|12000083|FG001|Overall Study|Protocol Violation|0
7594377|NCT01488890|12000084|FG002|Overall Study|Protocol Violation|4
7594378|NCT01488890|12000085|FG003|Overall Study|Protocol Violation|0
7594379|NCT01488890|12000082|FG000|Overall Study|Lost to Follow-up|13
7594380|NCT01488890|12000083|FG001|Overall Study|Lost to Follow-up|10
7594381|NCT01488890|12000084|FG002|Overall Study|Lost to Follow-up|20
7594382|NCT01488890|12000085|FG003|Overall Study|Lost to Follow-up|3
7594383|NCT01488890|12000082|FG000|Overall Study|Withdrawal by Subject|14
7594384|NCT01488890|12000083|FG001|Overall Study|Withdrawal by Subject|10
7594385|NCT01488890|12000084|FG002|Overall Study|Withdrawal by Subject|11
7594386|NCT01488890|12000085|FG003|Overall Study|Withdrawal by Subject|2
7594387|NCT01436396|12000101|FG000|Overall Study|Protocol Violation|7
7594388|NCT01436396|12000102|FG001|Overall Study|Protocol Violation|5
7594389|NCT01436396|12000101|FG000|Overall Study|Adverse Event|1
7594390|NCT01436396|12000102|FG001|Overall Study|Adverse Event|2
7594391|NCT01436396|12000101|FG000|Overall Study|Withdrawal by Subject|19
7594392|NCT01436396|12000102|FG001|Overall Study|Withdrawal by Subject|29
7594393|NCT01436396|12000101|FG000|Overall Study|Serious adverse event|2
7594394|NCT01436396|12000102|FG001|Overall Study|Serious adverse event|3
7594395|NCT01436396|12000101|FG000|Overall Study|Lost to Follow-up|3
7594396|NCT01436396|12000102|FG001|Overall Study|Lost to Follow-up|3
7594397|NCT01411241|12000110|FG000|Overall Study|Protocol Violation|0
7594398|NCT01411241|12000111|FG001|Overall Study|Protocol Violation|5
7594399|NCT01411241|12000110|FG000|Overall Study|Withdrawal by Subject|9
7594400|NCT01411241|12000111|FG001|Overall Study|Withdrawal by Subject|10
7594401|NCT01411241|12000110|FG000|Overall Study|Serious Adverse Event|0
7594402|NCT01411241|12000111|FG001|Overall Study|Serious Adverse Event|3
7594403|NCT01411241|12000110|FG000|Overall Study|Lost to Follow-up|2
7594404|NCT01411241|12000111|FG001|Overall Study|Lost to Follow-up|4
7594405|NCT01374516|12000119|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43
7594406|NCT01374516|12000120|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14
7594407|NCT01374516|12000119|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3
7594408|NCT01374516|12000120|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0
7594409|NCT01374516|12000119|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480
7594410|NCT01374516|12000120|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240
7594411|NCT01374516|12000119|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106
7594412|NCT01374516|12000120|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46
7594413|NCT01374516|12000119|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7
7594414|NCT01374516|12000120|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9
7594415|NCT01374516|12000119|FG000|Surveillance Expansion Period|Protocol Violation|386
7594416|NCT01374516|12000120|FG001|Surveillance Expansion Period|Protocol Violation|217
7594417|NCT01374516|12000119|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870
7594418|NCT01374516|12000120|FG001|Surveillance Expansion Period|Withdrawal by Subject|986
7594419|NCT01374516|12000119|FG000|Surveillance Expansion Period|Lost to Follow-up|73
7594420|NCT01374516|12000120|FG001|Surveillance Expansion Period|Lost to Follow-up|45
7594421|NCT01374516|12000119|FG000|Surveillance Expansion Period|Serious adverse event|20
7594422|NCT01374516|12000120|FG001|Surveillance Expansion Period|Serious adverse event|5
7594423|NCT01373281|12000135|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
7594424|NCT01373281|12000136|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
7594425|NCT01373281|12000135|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
7594426|NCT01373281|12000136|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
7594427|NCT01373281|12000135|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
7594428|NCT01373281|12000136|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
7594429|NCT01373281|12000135|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
7594430|NCT01373281|12000136|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
7594431|NCT01373281|12000135|FG000|Surveillance Expansion Period|Withdrawal by Subject|180
7594432|NCT01373281|12000136|FG001|Surveillance Expansion Period|Withdrawal by Subject|105
7594433|NCT01373281|12000135|FG000|Surveillance Expansion Period|Protocol Violation|9
7594434|NCT01373281|12000136|FG001|Surveillance Expansion Period|Protocol Violation|1
7594435|NCT01373281|12000135|FG000|Surveillance Expansion Period|Lost to Follow-up|10
7594436|NCT01373281|12000136|FG001|Surveillance Expansion Period|Lost to Follow-up|8
7594437|NCT01373281|12000135|FG000|Surveillance Expansion Period|Serious adverse event|3
7594438|NCT01373281|12000136|FG001|Surveillance Expansion Period|Serious adverse event|4
7594439|NCT01302847|12000157|FG000|Overall Study|Ongoing|0
7594440|NCT01302847|12000158|FG001|Overall Study|Ongoing|0
7594441|NCT01302847|12000159|FG002|Overall Study|Ongoing|0
7594442|NCT01302847|12000160|FG003|Overall Study|Ongoing|0
7594443|NCT01302847|12000161|FG004|Overall Study|Ongoing|0
7594444|NCT01302847|12000162|FG005|Overall Study|Ongoing|27
7594445|NCT01302847|12000163|FG006|Overall Study|Ongoing|22
7594446|NCT01302847|12000164|FG007|Overall Study|Ongoing|17
7594447|NCT01302847|12000157|FG000|Overall Study|Death|0
7594448|NCT01302847|12000158|FG001|Overall Study|Death|1
7594449|NCT01302847|12000159|FG002|Overall Study|Death|0
7594450|NCT01302847|12000160|FG003|Overall Study|Death|0
7594451|NCT01302847|12000161|FG004|Overall Study|Death|0
7594452|NCT01302847|12000162|FG005|Overall Study|Death|1
7594453|NCT01302847|12000163|FG006|Overall Study|Death|1
7594454|NCT01302847|12000164|FG007|Overall Study|Death|0
7594455|NCT01302847|12000157|FG000|Overall Study|Pregnancy|2
7594456|NCT01302847|12000158|FG001|Overall Study|Pregnancy|0
7594457|NCT01302847|12000159|FG002|Overall Study|Pregnancy|0
7594458|NCT01302847|12000160|FG003|Overall Study|Pregnancy|0
7594459|NCT01302847|12000161|FG004|Overall Study|Pregnancy|0
7594460|NCT01302847|12000162|FG005|Overall Study|Pregnancy|0
7594461|NCT01302847|12000163|FG006|Overall Study|Pregnancy|0
7594462|NCT01302847|12000164|FG007|Overall Study|Pregnancy|0
7594463|NCT01302847|12000157|FG000|Overall Study|Virologic failure|0
7594464|NCT01302847|12000158|FG001|Overall Study|Virologic failure|2
7594465|NCT01302847|12000159|FG002|Overall Study|Virologic failure|2
7594466|NCT01302847|12000160|FG003|Overall Study|Virologic failure|0
7594467|NCT01302847|12000161|FG004|Overall Study|Virologic failure|1
7594468|NCT01302847|12000162|FG005|Overall Study|Virologic failure|1
7594469|NCT01302847|12000163|FG006|Overall Study|Virologic failure|0
7594470|NCT01302847|12000164|FG007|Overall Study|Virologic failure|2
7594471|NCT01302847|12000157|FG000|Overall Study|Severe debilitation, unable to continue|0
7594472|NCT01302847|12000158|FG001|Overall Study|Severe debilitation, unable to continue|0
7594473|NCT01302847|12000159|FG002|Overall Study|Severe debilitation, unable to continue|0
7594474|NCT01302847|12000160|FG003|Overall Study|Severe debilitation, unable to continue|0
7594475|NCT01302847|12000161|FG004|Overall Study|Severe debilitation, unable to continue|0
7594476|NCT01302847|12000162|FG005|Overall Study|Severe debilitation, unable to continue|1
7594477|NCT01302847|12000163|FG006|Overall Study|Severe debilitation, unable to continue|1
7594478|NCT01302847|12000164|FG007|Overall Study|Severe debilitation, unable to continue|0
7594479|NCT01302847|12000157|FG000|Overall Study|Not able to get to clinic|1
7594480|NCT01302847|12000158|FG001|Overall Study|Not able to get to clinic|1
7594481|NCT01302847|12000159|FG002|Overall Study|Not able to get to clinic|0
7594482|NCT01302847|12000160|FG003|Overall Study|Not able to get to clinic|0
7594483|NCT01302847|12000161|FG004|Overall Study|Not able to get to clinic|0
7594484|NCT01302847|12000162|FG005|Overall Study|Not able to get to clinic|0
7594485|NCT01302847|12000163|FG006|Overall Study|Not able to get to clinic|0
7594486|NCT01302847|12000164|FG007|Overall Study|Not able to get to clinic|0
7594487|NCT01302847|12000157|FG000|Overall Study|Site closing|2
7594488|NCT01302847|12000158|FG001|Overall Study|Site closing|2
7594489|NCT01302847|12000159|FG002|Overall Study|Site closing|0
7594490|NCT01302847|12000160|FG003|Overall Study|Site closing|0
7594491|NCT01302847|12000161|FG004|Overall Study|Site closing|0
7594492|NCT01302847|12000162|FG005|Overall Study|Site closing|0
7594493|NCT01302847|12000163|FG006|Overall Study|Site closing|0
7594494|NCT01302847|12000164|FG007|Overall Study|Site closing|0
7594495|NCT01302847|12000157|FG000|Overall Study|Withdrawal by Subject|1
7771303|NCT00881530|12215557|FG005|Overall Study|Lost to Follow-up|0
7771304|NCT00881530|12215552|FG000|Overall Study|Refused to continue medication|7
7771305|NCT00881530|12215553|FG001|Overall Study|Refused to continue medication|2
7771306|NCT00881530|12215554|FG002|Overall Study|Refused to continue medication|1
7771307|NCT00881530|12215555|FG003|Overall Study|Refused to continue medication|2
7771308|NCT00881530|12215556|FG004|Overall Study|Refused to continue medication|0
7771309|NCT00881530|12215557|FG005|Overall Study|Refused to continue medication|0
7771310|NCT00881530|12215552|FG000|Overall Study|Other reason not defined above|1
7771311|NCT00881530|12215553|FG001|Overall Study|Other reason not defined above|1
7771312|NCT00881530|12215554|FG002|Overall Study|Other reason not defined above|2
7771313|NCT00881530|12215555|FG003|Overall Study|Other reason not defined above|0
7771314|NCT00881530|12215556|FG004|Overall Study|Other reason not defined above|0
7771315|NCT00881530|12215557|FG005|Overall Study|Other reason not defined above|2
7771316|NCT00881569|12215573|FG000|Overall Study|Disease progression|1
7771317|NCT00881569|12215574|FG001|Overall Study|Disease progression|1
7771318|NCT00881621|12215580|FG000|Overall Study|Physician Decision|34
7771319|NCT00881712|12215596|FG000|Overall Study|Death|1
7771320|NCT00881712|12215597|FG001|Overall Study|Death|0
7771321|NCT00881712|12215598|FG002|Overall Study|Death|0
7771322|NCT00881712|12215596|FG000|Overall Study|Withdrawal by Subject|1
7771323|NCT00881712|12215597|FG001|Overall Study|Withdrawal by Subject|0
7771324|NCT00881712|12215598|FG002|Overall Study|Withdrawal by Subject|0
7594496|NCT01302847|12000158|FG001|Overall Study|Withdrawal by Subject|0
7594497|NCT01302847|12000159|FG002|Overall Study|Withdrawal by Subject|0
7594498|NCT01302847|12000160|FG003|Overall Study|Withdrawal by Subject|0
7594499|NCT01302847|12000161|FG004|Overall Study|Withdrawal by Subject|1
7771325|NCT00881751|12215608|FG000|Overall Study|Physician Decision|0
7594500|NCT01302847|12000162|FG005|Overall Study|Withdrawal by Subject|0
7594501|NCT01302847|12000163|FG006|Overall Study|Withdrawal by Subject|0
7594502|NCT01302847|12000164|FG007|Overall Study|Withdrawal by Subject|1
7594503|NCT01302847|12000157|FG000|Overall Study|Not willing to adhere to requirements|5
7594504|NCT01302847|12000158|FG001|Overall Study|Not willing to adhere to requirements|0
7594505|NCT01302847|12000159|FG002|Overall Study|Not willing to adhere to requirements|0
7594506|NCT01302847|12000160|FG003|Overall Study|Not willing to adhere to requirements|1
7594507|NCT01302847|12000161|FG004|Overall Study|Not willing to adhere to requirements|0
7594508|NCT01302847|12000162|FG005|Overall Study|Not willing to adhere to requirements|0
7594509|NCT01302847|12000163|FG006|Overall Study|Not willing to adhere to requirements|0
7594510|NCT01302847|12000164|FG007|Overall Study|Not willing to adhere to requirements|2
7594511|NCT01302847|12000157|FG000|Overall Study|Site unable to contact participant|2
7594512|NCT01302847|12000158|FG001|Overall Study|Site unable to contact participant|1
7594513|NCT01302847|12000159|FG002|Overall Study|Site unable to contact participant|0
7594514|NCT01302847|12000160|FG003|Overall Study|Site unable to contact participant|0
7594515|NCT01302847|12000161|FG004|Overall Study|Site unable to contact participant|0
7594516|NCT01302847|12000162|FG005|Overall Study|Site unable to contact participant|0
7594517|NCT01302847|12000163|FG006|Overall Study|Site unable to contact participant|2
7594518|NCT01302847|12000164|FG007|Overall Study|Site unable to contact participant|0
7594519|NCT01287611|12000193|FG000|Overall Study|Lost to Follow-up|29
7594520|NCT01287611|12000194|FG001|Overall Study|Lost to Follow-up|16
7594521|NCT01287611|12000193|FG000|Overall Study|Exclusion due to expanded Kerr incision|4
7594522|NCT01287611|12000194|FG001|Overall Study|Exclusion due to expanded Kerr incision|3
7594523|NCT01254422|12000204|FG000|Overall Study|Protocol Violation|1
7594524|NCT01254422|12000205|FG001|Overall Study|Protocol Violation|0
7594525|NCT01254422|12000204|FG000|Overall Study|Adverse Event|1
7594526|NCT01254422|12000205|FG001|Overall Study|Adverse Event|0
7594527|NCT01254422|12000204|FG000|Overall Study|Serious adverse event|0
7594528|NCT01254422|12000205|FG001|Overall Study|Serious adverse event|1
7594529|NCT01254422|12000204|FG000|Overall Study|Lost to Follow-up|1
7594530|NCT01254422|12000205|FG001|Overall Study|Lost to Follow-up|0
7594531|NCT01187433|12000213|FG000|Overall Study|Protocol Violation|6
7594532|NCT01187433|12000214|FG001|Overall Study|Protocol Violation|2
7594533|NCT01187433|12000213|FG000|Overall Study|Withdrawal by Subject|5
7594534|NCT01187433|12000214|FG001|Overall Study|Withdrawal by Subject|2
7594535|NCT01150045|12000224|FG000|Overall Study|Protocol Violation|0
7594536|NCT01150045|12000225|FG001|Overall Study|Protocol Violation|1
7594537|NCT01150045|12000226|FG002|Overall Study|Protocol Violation|0
7594538|NCT01150045|12000227|FG003|Overall Study|Protocol Violation|1
7594539|NCT01098032|12000237|FG000|Overall Study|Withdrawal by Subject|1
7594540|NCT01098032|12000238|FG001|Overall Study|Withdrawal by Subject|1
7594541|NCT01034306|12000246|FG000|Overall Study|Adverse Event|1
7594542|NCT01034306|12000247|FG001|Overall Study|Adverse Event|0
7594543|NCT01034306|12000246|FG000|Overall Study|Lost to Follow-up|0
7594544|NCT01034306|12000247|FG001|Overall Study|Lost to Follow-up|1
7594545|NCT01034306|12000246|FG000|Overall Study|Withdrawal by Subject|2
7594546|NCT01034306|12000247|FG001|Overall Study|Withdrawal by Subject|2
7594547|NCT01034306|12000246|FG000|Overall Study|hospitalized and decided to stop|1
7594548|NCT01034306|12000247|FG001|Overall Study|hospitalized and decided to stop|0
7594549|NCT01034306|12000246|FG000|Overall Study|Noncomplience|1
7594550|NCT01034306|12000247|FG001|Overall Study|Noncomplience|0
7771326|NCT00881751|12215609|FG001|Overall Study|Physician Decision|1
7771327|NCT00881751|12215608|FG000|Overall Study|Adverse Event|0
7771328|NCT00881751|12215609|FG001|Overall Study|Adverse Event|2
7771329|NCT00881751|12215608|FG000|Overall Study|Withdrawal by Subject|0
7594555|NCT00993447|12000259|FG000|Overall Study|Withdrawal by Subject|23
7594556|NCT00993447|12000260|FG001|Overall Study|Withdrawal by Subject|8
7594557|NCT00993447|12000259|FG000|Overall Study|Protocol Violation|12
7594558|NCT00993447|12000260|FG001|Overall Study|Protocol Violation|8
7594559|NCT00993447|12000259|FG000|Overall Study|Lost to Follow-up|1
7594560|NCT00993447|12000260|FG001|Overall Study|Lost to Follow-up|3
7594561|NCT00993447|12000259|FG000|Overall Study|Adverse Event|1
7594562|NCT00993447|12000260|FG001|Overall Study|Adverse Event|0
7594563|NCT00945009|12000269|FG000|Overall Study|Lack of Efficacy|10
7594564|NCT00945009|12000270|FG001|Overall Study|Lack of Efficacy|0
7594565|NCT00945009|12000271|FG002|Overall Study|Lack of Efficacy|0
7594566|NCT00945009|12000269|FG000|Overall Study|Physician Decision|21
7594567|NCT00945009|12000270|FG001|Overall Study|Physician Decision|4
7594568|NCT00945009|12000271|FG002|Overall Study|Physician Decision|3
7594569|NCT00945009|12000269|FG000|Overall Study|Protocol Violation|6
7594570|NCT00945009|12000270|FG001|Overall Study|Protocol Violation|1
7594571|NCT00945009|12000271|FG002|Overall Study|Protocol Violation|0
7594572|NCT00945009|12000269|FG000|Overall Study|Withdrawal by Subject|1
7594573|NCT00945009|12000270|FG001|Overall Study|Withdrawal by Subject|0
7594574|NCT00945009|12000271|FG002|Overall Study|Withdrawal by Subject|0
7594575|NCT00945009|12000269|FG000|Overall Study|Ineligible|6
7594576|NCT00945009|12000270|FG001|Overall Study|Ineligible|1
7594577|NCT00945009|12000271|FG002|Overall Study|Ineligible|0
7594578|NCT00945009|12000269|FG000|Overall Study|Inevaluable|0
7594579|NCT00945009|12000270|FG001|Overall Study|Inevaluable|1
7594580|NCT00945009|12000271|FG002|Overall Study|Inevaluable|0
7594581|NCT00945009|12000269|FG000|Overall Study|Refusal of further protocol|1
7771330|NCT00881751|12215609|FG001|Overall Study|Withdrawal by Subject|2
7594582|NCT00945009|12000270|FG001|Overall Study|Refusal of further protocol|0
7594583|NCT00945009|12000271|FG002|Overall Study|Refusal of further protocol|0
7594584|NCT00942877|12000281|FG000|Overall Study|Refused further treatment|1
7594585|NCT00942877|12000282|FG001|Overall Study|Refused further treatment|1
7594586|NCT00942877|12000281|FG000|Overall Study|Patient was not treated|1
7594587|NCT00942877|12000282|FG001|Overall Study|Patient was not treated|0
7594588|NCT00942877|12000281|FG000|Overall Study|Adverse Event|1
7594589|NCT00942877|12000282|FG001|Overall Study|Adverse Event|0
7594590|NCT00942877|12000281|FG000|Overall Study|Progressive disease|42
7594591|NCT00942877|12000282|FG001|Overall Study|Progressive disease|3
7594592|NCT00880893|12000297|FG000|Overall Study|Protocol Violation|13
7594593|NCT00880893|12000298|FG001|Overall Study|Protocol Violation|1
7594594|NCT00880893|12000297|FG000|Overall Study|Withdrawal by Subject|15
7594595|NCT00880893|12000298|FG001|Overall Study|Withdrawal by Subject|11
7594596|NCT00880893|12000297|FG000|Overall Study|Lost to Follow-up|76
7594597|NCT00880893|12000298|FG001|Overall Study|Lost to Follow-up|33
7594598|NCT00880893|12000297|FG000|Overall Study|Serious adverse event|3
7594599|NCT00880893|12000298|FG001|Overall Study|Serious adverse event|0
7594600|NCT00866918|12000306|FG000|Overall Study|Death|1
7594601|NCT00866918|12000307|FG001|Overall Study|Death|5
7594602|NCT00866918|12000306|FG000|Overall Study|Lack of Efficacy|1
7594603|NCT00866918|12000307|FG001|Overall Study|Lack of Efficacy|1
7594604|NCT00866918|12000306|FG000|Overall Study|Physician Decision|10
7594605|NCT00866918|12000307|FG001|Overall Study|Physician Decision|2
7594606|NCT00866918|12000306|FG000|Overall Study|Ineligible|2
7594607|NCT00866918|12000307|FG001|Overall Study|Ineligible|4
7594608|NCT00866918|12000306|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
7594609|NCT00866918|12000307|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
7594610|NCT00866918|12000306|FG000|Overall Study|Secondary malignancy|1
7594611|NCT00866918|12000307|FG001|Overall Study|Secondary malignancy|0
7627441|NCT03441360|12039904|FG002|Overall Study|Clinical disease progression|0
7627442|NCT03441360|12039902|FG000|Overall Study|Adverse Event|1
7627443|NCT03441360|12039903|FG001|Overall Study|Adverse Event|0
7627444|NCT03441360|12039904|FG002|Overall Study|Adverse Event|1
7627445|NCT03368170|12039914|FG000|Overall Study|Adverse Event|2
7627446|NCT03368170|12039915|FG001|Overall Study|Adverse Event|1
7627447|NCT03336528|12039923|FG000|Overall Study|Protocol Violation|1
7627448|NCT03336528|12039924|FG001|Overall Study|Protocol Violation|1
7627449|NCT03336528|12039923|FG000|Overall Study|Discharged within 48 hours of study medication|8
7627450|NCT03336528|12039924|FG001|Overall Study|Discharged within 48 hours of study medication|6
7627451|NCT03336528|12039923|FG000|Overall Study|Did not receive study medication|1
7627452|NCT03336528|12039924|FG001|Overall Study|Did not receive study medication|2
7627453|NCT03334409|12039934|FG000|Overall Study|Did not meet inclusion criteria|1
7627454|NCT03334409|12039935|FG001|Overall Study|Did not meet inclusion criteria|0
7594612|NCT00587301|12000313|FG000|Overall Study|Screen Failure|9
7594613|NCT00587301|12000313|FG000|Overall Study|Lost to Follow-up|22
7594614|NCT00587301|12000313|FG000|Overall Study|Withdrawal by Subject|7
7594615|NCT00587301|12000313|FG000|Overall Study|Protocol Violation|7
7594616|NCT00579527|12000317|FG000|Overall Study|Death|4
7594617|NCT00576836|12000322|FG000|Overall Study|Death|0
7594618|NCT00576836|12000323|FG001|Overall Study|Death|1
7594619|NCT00576836|12000322|FG000|Overall Study|Physician Decision|0
7594620|NCT00576836|12000323|FG001|Overall Study|Physician Decision|1
7594621|NCT00576407|12000327|FG000|Overall Study|Death|7
7594622|NCT00576407|12000327|FG000|Overall Study|Physician Decision|1
7771331|NCT00881894|12215617|FG000|Overall Study|Consent withdrawn|0
7771332|NCT00881894|12215618|FG001|Overall Study|Consent withdrawn|1
7771333|NCT00881894|12215617|FG000|Overall Study|Other reasons for premature termination|1
7771334|NCT00881894|12215618|FG001|Overall Study|Other reasons for premature termination|2
7771335|NCT00881959|12215626|FG000|Overall Study|Lost to Follow-up|2
7771336|NCT00881959|12215627|FG001|Overall Study|Lost to Follow-up|4
7771337|NCT00882115|12215637|FG000|Overall Study|Withdrawal by Subject|3
7771338|NCT00882115|12215637|FG000|Overall Study|did not respond to DEP challe|6
7771339|NCT00882362|12215648|FG000|Overall Study|Adverse Event|13
7771340|NCT00882362|12215649|FG001|Overall Study|Adverse Event|10
7771341|NCT00882362|12215648|FG000|Overall Study|Withdrawal by Subject|13
7771342|NCT00882362|12215649|FG001|Overall Study|Withdrawal by Subject|10
7771343|NCT00882362|12215648|FG000|Overall Study|Lack of Efficacy|3
7771344|NCT00882362|12215649|FG001|Overall Study|Lack of Efficacy|0
7771345|NCT00882362|12215648|FG000|Overall Study|Protocol Violation|7
7771346|NCT00882362|12215649|FG001|Overall Study|Protocol Violation|2
7771347|NCT00882362|12215648|FG000|Overall Study|Pregnancy|1
7771348|NCT00882362|12215649|FG001|Overall Study|Pregnancy|0
7771349|NCT00882362|12215648|FG000|Overall Study|Physician Decision|5
7771350|NCT00882362|12215649|FG001|Overall Study|Physician Decision|1
7771351|NCT00882362|12215648|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
7771352|NCT00882362|12215649|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
7771353|NCT00882362|12215648|FG000|Overall Study|change of residence or other commitments|5
7771354|NCT00882362|12215649|FG001|Overall Study|change of residence or other commitments|0
7771355|NCT00882518|12215657|FG000|Overall Study|Adverse Event|9
7771356|NCT00882518|12215658|FG001|Overall Study|Adverse Event|18
7771357|NCT00882518|12215657|FG000|Overall Study|Withdrawal by Subject|9
7771358|NCT00882518|12215658|FG001|Overall Study|Withdrawal by Subject|13
7771359|NCT00882518|12215657|FG000|Overall Study|Lack of Efficacy|12
7771360|NCT00882518|12215658|FG001|Overall Study|Lack of Efficacy|9
7771361|NCT00882518|12215657|FG000|Overall Study|Severe non-compliance to protocol|3
7771362|NCT00882518|12215658|FG001|Overall Study|Severe non-compliance to protocol|1
7771363|NCT00882518|12215657|FG000|Overall Study|Incorrect enrolment|4
7771364|NCT00882518|12215658|FG001|Overall Study|Incorrect enrolment|2
7771365|NCT00882518|12215657|FG000|Overall Study|Central lab closure for National day|1
7771366|NCT00882518|12215658|FG001|Overall Study|Central lab closure for National day|0
7771367|NCT00882518|12215657|FG000|Overall Study|Allocating random number by mistake|0
7771368|NCT00882518|12215658|FG001|Overall Study|Allocating random number by mistake|1
7771369|NCT00882557|12215666|FG000|Overall Study|Withdrawal by Subject|1
7771370|NCT00882557|12215667|FG001|Overall Study|Withdrawal by Subject|0
7771371|NCT00882557|12215666|FG000|Overall Study|Trouble with Vein Access|1
7771372|NCT00882557|12215667|FG001|Overall Study|Trouble with Vein Access|0
7771373|NCT00882557|12215666|FG000|Overall Study|Randomized Not Treated|0
7771374|NCT00882557|12215667|FG001|Overall Study|Randomized Not Treated|1
7771375|NCT00882583|12215675|FG000|Overall Study|Physician Decision|1
7771376|NCT00882583|12215676|FG001|Overall Study|Physician Decision|0
7771377|NCT00882583|12215675|FG000|Overall Study|Adverse Event|0
7771378|NCT00882583|12215676|FG001|Overall Study|Adverse Event|1
7771379|NCT00882713|12215711|FG000|Overall Study|Adverse Event|2
7771380|NCT00882713|12215711|FG000|Overall Study|Death|3
7771381|NCT00882713|12215711|FG000|Overall Study|Administrative reasons|4
7771382|NCT00882713|12215711|FG000|Overall Study|refused treatment/withdrew consent|4
7771383|NCT00882713|12215711|FG000|Overall Study|Blood transfusion|2
7771384|NCT00882713|12215711|FG000|Overall Study|Insufficient therapeutic response|3
7771385|NCT00882713|12215711|FG000|Overall Study|Failure to return|2
7771386|NCT00882713|12215711|FG000|Overall Study|Other - Reasons|2
7771387|NCT00882908|12215725|FG000|Overall Study|Adverse Event|0
7771388|NCT00882908|12215726|FG001|Overall Study|Adverse Event|0
7771389|NCT00882908|12215727|FG002|Overall Study|Adverse Event|1
7771390|NCT00882908|12215728|FG003|Overall Study|Adverse Event|0
7771391|NCT00882908|12215729|FG004|Overall Study|Adverse Event|1
7771392|NCT00882908|12215725|FG000|Overall Study|Lost to Follow-up|3
7771393|NCT00882908|12215726|FG001|Overall Study|Lost to Follow-up|5
7771394|NCT00882908|12215727|FG002|Overall Study|Lost to Follow-up|3
7771395|NCT00882908|12215728|FG003|Overall Study|Lost to Follow-up|1
7771396|NCT00882908|12215729|FG004|Overall Study|Lost to Follow-up|2
7771397|NCT00882908|12215725|FG000|Overall Study|Protocol Violation|0
7771398|NCT00882908|12215726|FG001|Overall Study|Protocol Violation|1
7771399|NCT00882908|12215727|FG002|Overall Study|Protocol Violation|0
7771400|NCT00882908|12215728|FG003|Overall Study|Protocol Violation|0
7771401|NCT00882908|12215729|FG004|Overall Study|Protocol Violation|0
7771402|NCT00882908|12215725|FG000|Overall Study|Withdrawal by Subject|0
7771403|NCT00882908|12215726|FG001|Overall Study|Withdrawal by Subject|0
7771404|NCT00882908|12215727|FG002|Overall Study|Withdrawal by Subject|3
7771405|NCT00882908|12215728|FG003|Overall Study|Withdrawal by Subject|5
7771406|NCT00882908|12215729|FG004|Overall Study|Withdrawal by Subject|2
7771407|NCT00882908|12215725|FG000|Overall Study|Subject reached a virologic endpoint|0
7771408|NCT00882908|12215726|FG001|Overall Study|Subject reached a virologic endpoint|0
7771409|NCT00882908|12215727|FG002|Overall Study|Subject reached a virologic endpoint|0
7771410|NCT00882908|12215728|FG003|Overall Study|Subject reached a virologic endpoint|0
7771411|NCT00882908|12215729|FG004|Overall Study|Subject reached a virologic endpoint|1
7771412|NCT00882908|12215725|FG000|Overall Study|Study terminated in error|0
7771413|NCT00882908|12215726|FG001|Overall Study|Study terminated in error|0
7771414|NCT00882908|12215727|FG002|Overall Study|Study terminated in error|0
7771415|NCT00882908|12215728|FG003|Overall Study|Study terminated in error|1
7771416|NCT00882908|12215729|FG004|Overall Study|Study terminated in error|0
7771417|NCT00882921|12215742|FG000|Overall Study|Death|2
7771418|NCT00882921|12215742|FG000|Overall Study|Other|3
7771419|NCT00882921|12215742|FG000|Overall Study|Lost to Follow-up|2
7771420|NCT00882921|12215742|FG000|Overall Study|Termination By Investigator|3
7771421|NCT00882921|12215742|FG000|Overall Study|Withdrawal Of Consent|1
7771422|NCT00882999|12215754|FG000|Overall Study|Adverse Event|0
7771423|NCT00882999|12215755|FG001|Overall Study|Adverse Event|0
7771424|NCT00882999|12215756|FG002|Overall Study|Adverse Event|0
7594719|NCT00547339|12000366|FG000|Overall Study|Physician Decision|0
7594720|NCT00547339|12000367|FG001|Overall Study|Physician Decision|0
7594721|NCT00547339|12000368|FG002|Overall Study|Physician Decision|1
7594722|NCT00547339|12000369|FG003|Overall Study|Physician Decision|0
7594723|NCT00531232|12000391|FG000|Overall Study|Investigator decision|0
7771425|NCT00882999|12215757|FG003|Overall Study|Adverse Event|0
7771426|NCT00882999|12215758|FG004|Overall Study|Adverse Event|1
7771427|NCT00882999|12215759|FG005|Overall Study|Adverse Event|0
7771428|NCT00882999|12215760|FG006|Overall Study|Adverse Event|0
7771429|NCT00882999|12215754|FG000|Overall Study|Death|0
7771430|NCT00882999|12215755|FG001|Overall Study|Death|1
7771431|NCT00882999|12215756|FG002|Overall Study|Death|0
7771432|NCT00882999|12215757|FG003|Overall Study|Death|0
7771433|NCT00882999|12215758|FG004|Overall Study|Death|0
7771434|NCT00882999|12215759|FG005|Overall Study|Death|0
7771435|NCT00882999|12215760|FG006|Overall Study|Death|0
7771436|NCT00882999|12215754|FG000|Overall Study|Withdrawal by Subject|7
7771437|NCT00882999|12215755|FG001|Overall Study|Withdrawal by Subject|6
7771438|NCT00882999|12215756|FG002|Overall Study|Withdrawal by Subject|3
7594724|NCT00531232|12000392|FG001|Overall Study|Investigator decision|0
7594725|NCT00531232|12000393|FG002|Overall Study|Investigator decision|4
7594726|NCT00531232|12000391|FG000|Overall Study|Participants refused further treatment|0
7594727|NCT00531232|12000392|FG001|Overall Study|Participants refused further treatment|1
7594728|NCT00531232|12000393|FG002|Overall Study|Participants refused further treatment|2
7594729|NCT00531232|12000391|FG000|Overall Study|Adverse events (AEs)|1
7594730|NCT00531232|12000392|FG001|Overall Study|Adverse events (AEs)|2
7594731|NCT00531232|12000393|FG002|Overall Study|Adverse events (AEs)|2
7594732|NCT00531232|12000391|FG000|Overall Study|Treatment failure|1
7594733|NCT00531232|12000392|FG001|Overall Study|Treatment failure|3
7594734|NCT00531232|12000393|FG002|Overall Study|Treatment failure|7
7594735|NCT00531232|12000391|FG000|Overall Study|Disease recurrence|0
7594736|NCT00531232|12000392|FG001|Overall Study|Disease recurrence|0
7594737|NCT00531232|12000393|FG002|Overall Study|Disease recurrence|1
7594738|NCT00531232|12000391|FG000|Overall Study|Deceased|2
7594739|NCT00531232|12000392|FG001|Overall Study|Deceased|2
7594740|NCT00531232|12000393|FG002|Overall Study|Deceased|2
7594741|NCT00531232|12000391|FG000|Overall Study|Withdrawal by Subject|0
7594742|NCT00531232|12000392|FG001|Overall Study|Withdrawal by Subject|1
7594743|NCT00531232|12000393|FG002|Overall Study|Withdrawal by Subject|2
7594744|NCT00531232|12000391|FG000|Overall Study|Other|0
7594745|NCT00531232|12000392|FG001|Overall Study|Other|0
7594746|NCT00531232|12000393|FG002|Overall Study|Other|5
7594747|NCT00379340|12000409|FG000|Overall Study|Death|0
7594748|NCT00379340|12000410|FG001|Overall Study|Death|0
7594749|NCT00379340|12000411|FG002|Overall Study|Death|0
7594750|NCT00379340|12000412|FG003|Overall Study|Death|2
7594751|NCT00379340|12000413|FG004|Overall Study|Death|0
7594752|NCT00379340|12000409|FG000|Overall Study|Lack of Efficacy|6
7594753|NCT00379340|12000410|FG001|Overall Study|Lack of Efficacy|1
7594754|NCT00379340|12000411|FG002|Overall Study|Lack of Efficacy|0
7594755|NCT00379340|12000412|FG003|Overall Study|Lack of Efficacy|4
7594756|NCT00379340|12000413|FG004|Overall Study|Lack of Efficacy|3
7594757|NCT00379340|12000409|FG000|Overall Study|Physician Decision|6
7594758|NCT00379340|12000410|FG001|Overall Study|Physician Decision|2
7594759|NCT00379340|12000411|FG002|Overall Study|Physician Decision|1
7594760|NCT00379340|12000412|FG003|Overall Study|Physician Decision|2
7594761|NCT00379340|12000413|FG004|Overall Study|Physician Decision|3
7594762|NCT00379340|12000409|FG000|Overall Study|Withdrawal by Subject|0
7594763|NCT00379340|12000410|FG001|Overall Study|Withdrawal by Subject|0
7594764|NCT00379340|12000411|FG002|Overall Study|Withdrawal by Subject|0
7594765|NCT00379340|12000412|FG003|Overall Study|Withdrawal by Subject|1
7594766|NCT00379340|12000413|FG004|Overall Study|Withdrawal by Subject|0
7594767|NCT00379340|12000409|FG000|Overall Study|Refusal of further protocol therapy|1
7594768|NCT00379340|12000410|FG001|Overall Study|Refusal of further protocol therapy|0
7594769|NCT00379340|12000411|FG002|Overall Study|Refusal of further protocol therapy|1
7594770|NCT00379340|12000412|FG003|Overall Study|Refusal of further protocol therapy|1
7594771|NCT00379340|12000413|FG004|Overall Study|Refusal of further protocol therapy|7
7594772|NCT00379340|12000409|FG000|Overall Study|On more than 1 tumor therapeutic study|0
7594773|NCT00379340|12000410|FG001|Overall Study|On more than 1 tumor therapeutic study|0
7594774|NCT00379340|12000411|FG002|Overall Study|On more than 1 tumor therapeutic study|0
7594775|NCT00379340|12000412|FG003|Overall Study|On more than 1 tumor therapeutic study|2
7594776|NCT00379340|12000413|FG004|Overall Study|On more than 1 tumor therapeutic study|0
7594777|NCT00379340|12000409|FG000|Overall Study|Delayed nephrectomy and anaplasia|0
7594778|NCT00379340|12000410|FG001|Overall Study|Delayed nephrectomy and anaplasia|0
7771439|NCT00882999|12215757|FG003|Overall Study|Withdrawal by Subject|3
7771440|NCT00882999|12215758|FG004|Overall Study|Withdrawal by Subject|6
7771441|NCT00882999|12215759|FG005|Overall Study|Withdrawal by Subject|5
7771442|NCT00882999|12215760|FG006|Overall Study|Withdrawal by Subject|5
7771443|NCT00882999|12215754|FG000|Overall Study|Lost to Follow-up|0
7771444|NCT00882999|12215755|FG001|Overall Study|Lost to Follow-up|1
7771445|NCT00882999|12215756|FG002|Overall Study|Lost to Follow-up|1
7771446|NCT00882999|12215757|FG003|Overall Study|Lost to Follow-up|2
7771447|NCT00882999|12215758|FG004|Overall Study|Lost to Follow-up|1
7771448|NCT00882999|12215759|FG005|Overall Study|Lost to Follow-up|1
7771449|NCT00882999|12215760|FG006|Overall Study|Lost to Follow-up|2
7771450|NCT00882999|12215754|FG000|Overall Study|Physician Decision|1
7771451|NCT00882999|12215755|FG001|Overall Study|Physician Decision|0
7771452|NCT00882999|12215756|FG002|Overall Study|Physician Decision|0
7771453|NCT00882999|12215757|FG003|Overall Study|Physician Decision|0
7771454|NCT00882999|12215758|FG004|Overall Study|Physician Decision|0
7771455|NCT00882999|12215759|FG005|Overall Study|Physician Decision|1
7771456|NCT00882999|12215760|FG006|Overall Study|Physician Decision|1
7771457|NCT00883051|12215788|FG000|Overall Study|Lost to Follow-up|0
7771458|NCT00883051|12215789|FG001|Overall Study|Lost to Follow-up|0
7771459|NCT00883051|12215790|FG002|Overall Study|Lost to Follow-up|0
7771460|NCT00883051|12215791|FG003|Overall Study|Lost to Follow-up|0
7771461|NCT00883051|12215792|FG004|Overall Study|Lost to Follow-up|1
7771462|NCT00883051|12215788|FG000|Overall Study|Did not use study medication|24
7771463|NCT00883051|12215789|FG001|Overall Study|Did not use study medication|22
7771464|NCT00883051|12215790|FG002|Overall Study|Did not use study medication|29
7771465|NCT00883051|12215791|FG003|Overall Study|Did not use study medication|29
7771466|NCT00883051|12215792|FG004|Overall Study|Did not use study medication|17
7771467|NCT00883090|12215804|FG000|Overall Study|Sponsor's decision|1
7771468|NCT00883090|12215804|FG000|Overall Study|Withdrawal by Subject|1
7771469|NCT00883116|12215819|FG000|Overall Study|Adverse event unrelated to study drug|5
7771470|NCT00883116|12215820|FG001|Overall Study|Adverse event unrelated to study drug|10
7771471|NCT00883116|12215819|FG000|Overall Study|Death|6
7594779|NCT00379340|12000411|FG002|Overall Study|Delayed nephrectomy and anaplasia|0
7594780|NCT00379340|12000412|FG003|Overall Study|Delayed nephrectomy and anaplasia|1
7594781|NCT00379340|12000413|FG004|Overall Study|Delayed nephrectomy and anaplasia|1
7594782|NCT00304070|12000429|FG000|Overall Study|Death|0
7594783|NCT00304070|12000430|FG001|Overall Study|Death|0
7594784|NCT00304070|12000431|FG002|Overall Study|Death|3
7594785|NCT00304070|12000429|FG000|Overall Study|Lost to Follow-up|0
7594786|NCT00304070|12000430|FG001|Overall Study|Lost to Follow-up|0
7594787|NCT00304070|12000431|FG002|Overall Study|Lost to Follow-up|1
7594788|NCT00304070|12000429|FG000|Overall Study|Physician Decision|0
7594789|NCT00304070|12000430|FG001|Overall Study|Physician Decision|0
7594790|NCT00304070|12000431|FG002|Overall Study|Physician Decision|3
7594791|NCT00304070|12000429|FG000|Overall Study|Withdrawal by Subject|0
7771472|NCT00883116|12215820|FG001|Overall Study|Death|2
7771473|NCT00883116|12215819|FG000|Overall Study|Disease progression|130
7771474|NCT00883116|12215820|FG001|Overall Study|Disease progression|128
7594792|NCT00304070|12000430|FG001|Overall Study|Withdrawal by Subject|0
7594793|NCT00304070|12000431|FG002|Overall Study|Withdrawal by Subject|1
7594794|NCT00304070|12000429|FG000|Overall Study|Progressive Disease|3
7594795|NCT00304070|12000430|FG001|Overall Study|Progressive Disease|7
7594796|NCT00304070|12000431|FG002|Overall Study|Progressive Disease|4
7627455|NCT03084536|12039953|FG000|Overall Study|Determined to be ineligible|0
7627456|NCT03084536|12039954|FG001|Overall Study|Determined to be ineligible|0
7627457|NCT03084536|12039955|FG002|Overall Study|Determined to be ineligible|16
7627458|NCT03084536|12039953|FG000|Overall Study|Withdrawal by Subject|0
7627459|NCT03084536|12039954|FG001|Overall Study|Withdrawal by Subject|0
7627460|NCT03084536|12039955|FG002|Overall Study|Withdrawal by Subject|4
7627461|NCT03084536|12039953|FG000|Overall Study|Physician Decision|0
7627462|NCT03084536|12039954|FG001|Overall Study|Physician Decision|0
7627463|NCT03084536|12039955|FG002|Overall Study|Physician Decision|3
7627464|NCT03084536|12039953|FG000|Overall Study|Death|0
7627465|NCT03084536|12039954|FG001|Overall Study|Death|0
7771475|NCT00883116|12215819|FG000|Overall Study|Lost to Follow-up|0
7771476|NCT00883116|12215820|FG001|Overall Study|Lost to Follow-up|1
7771477|NCT00883116|12215819|FG000|Overall Study|Maximum clinical benefit|13
7771478|NCT00883116|12215820|FG001|Overall Study|Maximum clinical benefit|46
7771479|NCT00883116|12215819|FG000|Overall Study|Not identified|3
7771480|NCT00883116|12215820|FG001|Overall Study|Not identified|6
7771481|NCT00883116|12215819|FG000|Overall Study|Study drug toxicity|36
7771482|NCT00883116|12215820|FG001|Overall Study|Study drug toxicity|16
7771483|NCT00883116|12215819|FG000|Overall Study|Withdrawal by Subject|14
7771484|NCT00883116|12215820|FG001|Overall Study|Withdrawal by Subject|8
7771485|NCT00883116|12215819|FG000|Overall Study|No longer meets study criteria|2
7771486|NCT00883116|12215820|FG001|Overall Study|No longer meets study criteria|2
7771487|NCT00883129|12215830|FG000|Overall Study|Adverse Event|7
7771488|NCT00883129|12215831|FG001|Overall Study|Adverse Event|15
7771489|NCT00883129|12215830|FG000|Overall Study|Withdrawal by Subject|8
7771490|NCT00883129|12215831|FG001|Overall Study|Withdrawal by Subject|9
7771491|NCT00883129|12215830|FG000|Overall Study|Non-compliance|3
7771492|NCT00883129|12215831|FG001|Overall Study|Non-compliance|6
7771493|NCT00883129|12215830|FG000|Overall Study|Lost to Follow-up|1
7771494|NCT00883129|12215831|FG001|Overall Study|Lost to Follow-up|2
7771495|NCT00883129|12215830|FG000|Overall Study|Death|1
7771496|NCT00883129|12215831|FG001|Overall Study|Death|2
7627466|NCT03084536|12039955|FG002|Overall Study|Death|1
7627467|NCT03084536|12039953|FG000|Overall Study|Lost to Follow-up|0
7627468|NCT03084536|12039954|FG001|Overall Study|Lost to Follow-up|0
7627469|NCT03084536|12039955|FG002|Overall Study|Lost to Follow-up|1
7627470|NCT03084536|12039953|FG000|Overall Study|Protocol Violation|0
7627471|NCT03084536|12039954|FG001|Overall Study|Protocol Violation|0
7627472|NCT03084536|12039955|FG002|Overall Study|Protocol Violation|1
7627473|NCT03084536|12039953|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0
7627474|NCT03084536|12039954|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0
7627475|NCT03084536|12039955|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1
7627476|NCT02988661|12040007|FG000|Overall Study|Death|2
7627477|NCT02988661|12040008|FG001|Overall Study|Death|18
7627478|NCT02988661|12040007|FG000|Overall Study|Lost to Follow-up|0
7627479|NCT02988661|12040008|FG001|Overall Study|Lost to Follow-up|33
7627480|NCT02988661|12040007|FG000|Overall Study|Withdrawal by Subject|0
7627481|NCT02988661|12040008|FG001|Overall Study|Withdrawal by Subject|6
7627482|NCT02988661|12040007|FG000|Overall Study|Unable to complete the 18-month survey|1
7627483|NCT02988661|12040008|FG001|Overall Study|Unable to complete the 18-month survey|27
7627484|NCT02921776|12040020|FG000|Overall Study|patient deterioration, fatigue|2
7627485|NCT02921776|12040021|FG001|Overall Study|patient deterioration, fatigue|6
7627486|NCT02921776|12040022|FG002|Overall Study|patient deterioration, fatigue|0
7627487|NCT02921776|12040023|FG003|Overall Study|patient deterioration, fatigue|0
7627488|NCT02921776|12040024|FG004|Overall Study|patient deterioration, fatigue|0
7627489|NCT02921776|12040025|FG005|Overall Study|patient deterioration, fatigue|0
7627490|NCT02921776|12040026|FG006|Overall Study|patient deterioration, fatigue|0
7627491|NCT02921776|12040027|FG007|Overall Study|patient deterioration, fatigue|0
7627492|NCT02921776|12040020|FG000|Overall Study|Withdrawal by Subject|0
7627493|NCT02921776|12040021|FG001|Overall Study|Withdrawal by Subject|2
7771497|NCT00883129|12215830|FG000|Overall Study|Defined Treatment Failure|0
7771498|NCT00883129|12215831|FG001|Overall Study|Defined Treatment Failure|2
7594797|NCT01701583|12000455|FG000|Overall Study|Withdrawal by Subject|2
7594798|NCT01701583|12000456|FG001|Overall Study|Withdrawal by Subject|0
7594799|NCT01714817|12000465|FG000|Year 1 Period|Lack of Efficacy|11
7594800|NCT01714817|12000466|FG001|Year 1 Period|Lack of Efficacy|9
7594801|NCT01714817|12000465|FG000|Year 1 Period|Adverse Event|20
7594802|NCT01714817|12000466|FG001|Year 1 Period|Adverse Event|17
7594803|NCT01714817|12000465|FG000|Year 1 Period|Withdrawal by Subject|6
7594804|NCT01714817|12000466|FG001|Year 1 Period|Withdrawal by Subject|7
7594805|NCT01714817|12000465|FG000|Year 1 Period|Death|1
7594806|NCT01714817|12000466|FG001|Year 1 Period|Death|1
7594807|NCT01714817|12000465|FG000|Year 1 Period|Lost to Follow-up|0
7594808|NCT01714817|12000466|FG001|Year 1 Period|Lost to Follow-up|2
7594809|NCT01714817|12000465|FG000|Year 1 Period|Poor / non-compliance|0
7594810|NCT01714817|12000466|FG001|Year 1 Period|Poor / non-compliance|1
7594811|NCT01714817|12000465|FG000|Year 1 Period|Pregnancy|2
7594812|NCT01714817|12000466|FG001|Year 1 Period|Pregnancy|0
7594813|NCT01714817|12000465|FG000|Year 1 Period|Participant no longer meets criteria|6
7594814|NCT01714817|12000466|FG001|Year 1 Period|Participant no longer meets criteria|2
7594815|NCT01714817|12000465|FG000|Year 1 Period|Not treated- received ACE inhibition|1
7594816|NCT01714817|12000466|FG001|Year 1 Period|Not treated- received ACE inhibition|0
7594817|NCT01714817|12000465|FG000|Year 1 Period|Change in Concomitant Medication|0
7594818|NCT01714817|12000466|FG001|Year 1 Period|Change in Concomitant Medication|1
7594819|NCT01714817|12000465|FG000|Year 1 Period|Need of use of Prohibited Medications|1
7594820|NCT01714817|12000466|FG001|Year 1 Period|Need of use of Prohibited Medications|0
7594821|NCT01714817|12000465|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0
7594822|NCT01714817|12000466|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1
7594823|NCT01714817|12000465|FG000|Year 1 Period|Hypersensitivity to the medication|0
7594824|NCT01714817|12000466|FG001|Year 1 Period|Hypersensitivity to the medication|1
7594825|NCT01714817|12000465|FG000|Year 2 Period|Lack of Efficacy|4
7594826|NCT01714817|12000466|FG001|Year 2 Period|Lack of Efficacy|12
7594827|NCT01714817|12000465|FG000|Year 2 Period|Adverse Event|7
7594828|NCT01714817|12000466|FG001|Year 2 Period|Adverse Event|6
7594829|NCT01714817|12000465|FG000|Year 2 Period|Participant request to stop treatment|4
7594830|NCT01714817|12000466|FG001|Year 2 Period|Participant request to stop treatment|4
7594831|NCT01714817|12000465|FG000|Year 2 Period|Administrative reason by Sponsor|4
7594832|NCT01714817|12000466|FG001|Year 2 Period|Administrative reason by Sponsor|3
7594833|NCT01714817|12000465|FG000|Year 2 Period|Participant withdrew consent|1
7594834|NCT01714817|12000466|FG001|Year 2 Period|Participant withdrew consent|5
7594835|NCT01714817|12000465|FG000|Year 2 Period|Participant no longer meets criteria|1
7594836|NCT01714817|12000466|FG001|Year 2 Period|Participant no longer meets criteria|4
7594837|NCT01714817|12000465|FG000|Year 2 Period|Lost to Follow-up|2
7594838|NCT01714817|12000466|FG001|Year 2 Period|Lost to Follow-up|0
7594839|NCT01714817|12000465|FG000|Year 2 Period|Participant went to US stopped treatment|0
7594840|NCT01714817|12000466|FG001|Year 2 Period|Participant went to US stopped treatment|1
7594841|NCT01714817|12000465|FG000|Year 2 Period|Pregnancy|1
7594842|NCT01714817|12000466|FG001|Year 2 Period|Pregnancy|1
7594843|NCT01714817|12000465|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2
7594844|NCT01714817|12000466|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1
7594845|NCT01714817|12000465|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0
7594846|NCT01714817|12000466|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1
7594847|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27
7594848|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21
7594849|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Disease progression|1
7594850|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Disease progression|4
7594851|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Not effective|0
7594852|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Not effective|1
7594853|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
7594854|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
7594855|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1
7594856|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1
7594857|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1
7594858|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0
7594859|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0
7594860|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1
7594861|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Pregnancy|1
7594862|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Pregnancy|0
7594863|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1
7594864|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0
7594865|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1
7594866|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0
7594867|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33
7594868|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38
7594869|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0
7594870|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1
7594871|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0
7594872|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1
7594873|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Study was terminated|0
7594874|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Study was terminated|1
7627494|NCT02921776|12040022|FG002|Overall Study|Withdrawal by Subject|0
7627495|NCT02921776|12040023|FG003|Overall Study|Withdrawal by Subject|1
7627496|NCT02921776|12040024|FG004|Overall Study|Withdrawal by Subject|1
7627497|NCT02921776|12040025|FG005|Overall Study|Withdrawal by Subject|0
7627498|NCT02921776|12040026|FG006|Overall Study|Withdrawal by Subject|8
7627499|NCT02921776|12040027|FG007|Overall Study|Withdrawal by Subject|1
7627500|NCT02921776|12040020|FG000|Overall Study|Death|0
7627501|NCT02921776|12040021|FG001|Overall Study|Death|0
7627502|NCT02921776|12040022|FG002|Overall Study|Death|0
7627503|NCT02921776|12040023|FG003|Overall Study|Death|2
7627504|NCT02921776|12040024|FG004|Overall Study|Death|0
7627505|NCT02921776|12040025|FG005|Overall Study|Death|0
7627506|NCT02921776|12040026|FG006|Overall Study|Death|0
7627507|NCT02921776|12040027|FG007|Overall Study|Death|0
7627508|NCT02921776|12040020|FG000|Overall Study|extubation or early discharge|0
7627509|NCT02921776|12040021|FG001|Overall Study|extubation or early discharge|0
7627510|NCT02921776|12040022|FG002|Overall Study|extubation or early discharge|0
7627511|NCT02921776|12040023|FG003|Overall Study|extubation or early discharge|5
7627512|NCT02921776|12040024|FG004|Overall Study|extubation or early discharge|5
7627513|NCT02921776|12040025|FG005|Overall Study|extubation or early discharge|0
7627514|NCT02921776|12040026|FG006|Overall Study|extubation or early discharge|0
7627515|NCT02921776|12040027|FG007|Overall Study|extubation or early discharge|0
7627516|NCT02921776|12040020|FG000|Overall Study|Lost to Follow-up|0
7594875|NCT01755689|12000479|FG000|Overall Study|Withdrawal by Subject|1
7594876|NCT01755689|12000480|FG001|Overall Study|Withdrawal by Subject|3
7594877|NCT01755689|12000481|FG002|Overall Study|Withdrawal by Subject|2
7594878|NCT01755689|12000482|FG003|Overall Study|Withdrawal by Subject|1
7594879|NCT01755689|12000483|FG004|Overall Study|Withdrawal by Subject|1
7594880|NCT01755689|12000479|FG000|Overall Study|Migrated/moved from study area|0
7594881|NCT01755689|12000480|FG001|Overall Study|Migrated/moved from study area|1
7594882|NCT01755689|12000481|FG002|Overall Study|Migrated/moved from study area|1
7594883|NCT01755689|12000482|FG003|Overall Study|Migrated/moved from study area|1
7594884|NCT01755689|12000483|FG004|Overall Study|Migrated/moved from study area|1
7594885|NCT01755689|12000479|FG000|Overall Study|Lost to Follow-up|1
7594886|NCT01755689|12000480|FG001|Overall Study|Lost to Follow-up|0
7594887|NCT01755689|12000481|FG002|Overall Study|Lost to Follow-up|1
7594888|NCT01755689|12000482|FG003|Overall Study|Lost to Follow-up|0
7594889|NCT01755689|12000483|FG004|Overall Study|Lost to Follow-up|2
7594890|NCT01755689|12000479|FG000|Overall Study|Pregnancy|1
7594891|NCT01755689|12000480|FG001|Overall Study|Pregnancy|1
7594892|NCT01755689|12000481|FG002|Overall Study|Pregnancy|2
7594893|NCT01755689|12000482|FG003|Overall Study|Pregnancy|4
7594894|NCT01755689|12000483|FG004|Overall Study|Pregnancy|2
7594895|NCT01762761|12000505|FG000|Overall Study|Adverse Event|15
7594896|NCT01762761|12000506|FG001|Overall Study|Adverse Event|17
7594897|NCT01762761|12000505|FG000|Overall Study|Lack of Efficacy|9
7594898|NCT01762761|12000506|FG001|Overall Study|Lack of Efficacy|25
7594899|NCT01762761|12000505|FG000|Overall Study|Protocol Violation|1
7594900|NCT01762761|12000506|FG001|Overall Study|Protocol Violation|1
7594901|NCT01762761|12000505|FG000|Overall Study|Study closed/terminated|0
7594902|NCT01762761|12000506|FG001|Overall Study|Study closed/terminated|2
7594903|NCT01762761|12000505|FG000|Overall Study|Lost to Follow-up|3
7594904|NCT01762761|12000506|FG001|Overall Study|Lost to Follow-up|6
7594905|NCT01762761|12000505|FG000|Overall Study|Physician Decision|4
7594906|NCT01762761|12000506|FG001|Overall Study|Physician Decision|6
7594907|NCT01762761|12000505|FG000|Overall Study|Withdrawal by Subject|7
7594908|NCT01762761|12000506|FG001|Overall Study|Withdrawal by Subject|8
7594913|NCT01774370|12000530|FG000|Overall Study|Never taken the PRADAXA during the study|4
7594914|NCT01774370|12000530|FG000|Overall Study|Administered prior to the contract date|4
7594915|NCT01774370|12000530|FG000|Overall Study|Subjects of contraindications|34
7594916|NCT01774370|12000530|FG000|Overall Study|Violated inclusion/exclusion criteria|53
7594917|NCT01774370|12000530|FG000|Overall Study|Follow-up failure|34
7594918|NCT01777295|12000536|FG000|Overall Study|Withdrawal by Subject|2
7594919|NCT01777295|12000537|FG001|Overall Study|Withdrawal by Subject|2
7594920|NCT01777295|12000536|FG000|Overall Study|Pregnancy|0
7594921|NCT01777295|12000537|FG001|Overall Study|Pregnancy|1
7594922|NCT01777295|12000536|FG000|Overall Study|Personal problem|1
7594923|NCT01777295|12000537|FG001|Overall Study|Personal problem|0
7594924|NCT01777295|12000536|FG000|Overall Study|Investigator call for AEs check|1
7594925|NCT01777295|12000537|FG001|Overall Study|Investigator call for AEs check|0
7594926|NCT01787552|12000557|FG000|Overall Study|Withdrawal by Subject|2
7594927|NCT01787552|12000558|FG001|Overall Study|Withdrawal by Subject|0
7594928|NCT01787552|12000559|FG002|Overall Study|Withdrawal by Subject|0
7594929|NCT01787552|12000560|FG003|Overall Study|Withdrawal by Subject|4
7594930|NCT01787552|12000557|FG000|Overall Study|Physician Decision|2
7594931|NCT01787552|12000558|FG001|Overall Study|Physician Decision|2
7594932|NCT01787552|12000559|FG002|Overall Study|Physician Decision|1
7594933|NCT01787552|12000560|FG003|Overall Study|Physician Decision|2
7594934|NCT01787552|12000557|FG000|Overall Study|Death|0
7594935|NCT01787552|12000558|FG001|Overall Study|Death|0
7594936|NCT01787552|12000559|FG002|Overall Study|Death|0
7594937|NCT01787552|12000560|FG003|Overall Study|Death|1
7594938|NCT01787552|12000557|FG000|Overall Study|Adverse Event|2
7594939|NCT01787552|12000558|FG001|Overall Study|Adverse Event|5
7594940|NCT01787552|12000559|FG002|Overall Study|Adverse Event|2
7594941|NCT01787552|12000560|FG003|Overall Study|Adverse Event|16
7594942|NCT01787552|12000557|FG000|Overall Study|Study terminated by Sponsor|0
7594943|NCT01787552|12000558|FG001|Overall Study|Study terminated by Sponsor|0
7594944|NCT01787552|12000559|FG002|Overall Study|Study terminated by Sponsor|1
7594945|NCT01787552|12000560|FG003|Overall Study|Study terminated by Sponsor|3
7594946|NCT01787552|12000557|FG000|Overall Study|Progressive Disease|2
7594947|NCT01787552|12000558|FG001|Overall Study|Progressive Disease|2
7594948|NCT01787552|12000559|FG002|Overall Study|Progressive Disease|1
7594949|NCT01787552|12000560|FG003|Overall Study|Progressive Disease|1
7594950|NCT01807117|12000575|FG000|Overall Study|Physician Decision|2
7594951|NCT01807117|12000575|FG000|Overall Study|Disease diagnosis not a study disease|1
7594962|NCT01814826|12000603|FG000|Overall Study|Other|3
7594963|NCT01814826|12000604|FG001|Overall Study|Other|5
7594964|NCT01814826|12000605|FG002|Overall Study|Other|0
7594965|NCT01814826|12000603|FG000|Overall Study|Death|29
7594966|NCT01814826|12000604|FG001|Overall Study|Death|24
7594967|NCT01814826|12000605|FG002|Overall Study|Death|3
7594968|NCT01829711|12000614|FG000|Overall Study|Lost to Follow-up|2
7594969|NCT01829711|12000614|FG000|Overall Study|Withdrawal by Subject|3
7594970|NCT01829711|12000614|FG000|Overall Study|Death|4
7594971|NCT01829711|12000614|FG000|Overall Study|Started new therapies|17
7594972|NCT01829711|12000614|FG000|Overall Study|Adverse Event|3
7594973|NCT01829711|12000614|FG000|Overall Study|Due to progression of disease|13
7594909|NCT01763788|12000517|FG000|Overall Study|Lost to Follow-up|0
7594910|NCT01763788|12000518|FG001|Overall Study|Lost to Follow-up|0
7594911|NCT01763788|12000519|FG002|Overall Study|Lost to Follow-up|1
7594912|NCT01763788|12000520|FG003|Overall Study|Lost to Follow-up|0
7594952|NCT01808261|12000583|FG000|Overall Study|Physician Decision|0
7594953|NCT01808261|12000584|FG001|Overall Study|Physician Decision|2
7594954|NCT01808261|12000583|FG000|Overall Study|Study Closed/Terminated|25
7594955|NCT01808261|12000584|FG001|Overall Study|Study Closed/Terminated|23
7594956|NCT01808261|12000583|FG000|Overall Study|Adverse event, non-fatal|2
7594957|NCT01808261|12000584|FG001|Overall Study|Adverse event, non-fatal|0
7594958|NCT01808261|12000583|FG000|Overall Study|Consent withdrawn by subject|6
7594959|NCT01808261|12000584|FG001|Overall Study|Consent withdrawn by subject|7
7594960|NCT01808261|12000583|FG000|Overall Study|Lost to Follow-up|3
7594961|NCT01808261|12000584|FG001|Overall Study|Lost to Follow-up|1
7594974|NCT01829711|12000614|FG000|Overall Study|Due to lack of response|1
7627517|NCT02921776|12040021|FG001|Overall Study|Lost to Follow-up|0
7627518|NCT02921776|12040022|FG002|Overall Study|Lost to Follow-up|0
7627519|NCT02921776|12040023|FG003|Overall Study|Lost to Follow-up|0
7627520|NCT02921776|12040024|FG004|Overall Study|Lost to Follow-up|0
7627521|NCT02921776|12040025|FG005|Overall Study|Lost to Follow-up|2
7627522|NCT02921776|12040026|FG006|Overall Study|Lost to Follow-up|3
7627523|NCT02921776|12040027|FG007|Overall Study|Lost to Follow-up|6
7627524|NCT02870348|12040051|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4
7627525|NCT02841280|12040057|FG000|Overall Study|Adverse Event|2
7627526|NCT02841280|12040058|FG001|Overall Study|Adverse Event|1
7627527|NCT02841280|12040057|FG000|Overall Study|Death|1
7627528|NCT02841280|12040058|FG001|Overall Study|Death|0
7627529|NCT02841280|12040057|FG000|Overall Study|Lost to Follow-up|2
7627530|NCT02841280|12040058|FG001|Overall Study|Lost to Follow-up|2
7627531|NCT02841280|12040057|FG000|Overall Study|Withdrawal by Subject|7
7627532|NCT02841280|12040058|FG001|Overall Study|Withdrawal by Subject|3
7627533|NCT02841280|12040057|FG000|Overall Study|Stop Point: BP above threshold|2
7627534|NCT02841280|12040058|FG001|Overall Study|Stop Point: BP above threshold|0
7627535|NCT02771275|12040081|FG000|Overall Study|Reoperation|2
7627536|NCT02771275|12040081|FG000|Overall Study|On Study|11
7627537|NCT02675426|12040088|FG000|Overall Study|Adverse Event|6
7627538|NCT02675426|12040089|FG001|Overall Study|Adverse Event|2
7627539|NCT02675426|12040090|FG002|Overall Study|Adverse Event|9
7627540|NCT02675426|12040088|FG000|Overall Study|Withdrawal by Subject|3
7627541|NCT02675426|12040089|FG001|Overall Study|Withdrawal by Subject|5
7627542|NCT02675426|12040090|FG002|Overall Study|Withdrawal by Subject|5
7627543|NCT02675426|12040088|FG000|Overall Study|Lost to Follow-up|1
7627544|NCT02675426|12040089|FG001|Overall Study|Lost to Follow-up|0
7627545|NCT02675426|12040090|FG002|Overall Study|Lost to Follow-up|2
7627546|NCT02675426|12040088|FG000|Overall Study|Other|3
7627547|NCT02675426|12040089|FG001|Overall Study|Other|1
7627548|NCT02675426|12040090|FG002|Overall Study|Other|2
7771499|NCT00883181|12215854|FG000|Overall Study|Hematological Adverse Event|26
7771500|NCT00883181|12215854|FG000|Overall Study|Non-hematological Adverse Event|55
7771501|NCT00883181|12215854|FG000|Overall Study|Disease Progression|94
7771502|NCT00883181|12215854|FG000|Overall Study|Administrative Reason|24
7771503|NCT00883181|12215854|FG000|Overall Study|Withdrawal by Subject|4
7771504|NCT00883181|12215854|FG000|Overall Study|Death|31
7771505|NCT00883181|12215854|FG000|Overall Study|Other|38
7771506|NCT00883181|12215854|FG000|Overall Study|Protocol Deviation|3
7771507|NCT00883181|12215854|FG000|Overall Study|Noncompliance|3
7771508|NCT00883337|12215901|FG000|Core Treatment Period|Adverse Event|9
7771509|NCT00883337|12215902|FG001|Core Treatment Period|Adverse Event|12
7771510|NCT00883337|12215903|FG002|Core Treatment Period|Adverse Event|22
7771511|NCT00883337|12215901|FG000|Core Treatment Period|Lack of Efficacy|7
7771512|NCT00883337|12215902|FG001|Core Treatment Period|Lack of Efficacy|4
7771513|NCT00883337|12215903|FG002|Core Treatment Period|Lack of Efficacy|2
7771514|NCT00883337|12215901|FG000|Core Treatment Period|Lost to Follow-up|1
7771515|NCT00883337|12215902|FG001|Core Treatment Period|Lost to Follow-up|1
7771516|NCT00883337|12215903|FG002|Core Treatment Period|Lost to Follow-up|0
7771517|NCT00883337|12215901|FG000|Core Treatment Period|Withdrawal by Subject|2
7771518|NCT00883337|12215902|FG001|Core Treatment Period|Withdrawal by Subject|2
7771519|NCT00883337|12215903|FG002|Core Treatment Period|Withdrawal by Subject|6
7771520|NCT00883337|12215901|FG000|Core Treatment Period|Wish to be pregnant|1
7771521|NCT00883337|12215902|FG001|Core Treatment Period|Wish to be pregnant|2
7771522|NCT00883337|12215903|FG002|Core Treatment Period|Wish to be pregnant|1
7771523|NCT00883337|12215901|FG000|Core Treatment Period|Poor compliance to protocol|0
7771524|NCT00883337|12215902|FG001|Core Treatment Period|Poor compliance to protocol|0
7771525|NCT00883337|12215903|FG002|Core Treatment Period|Poor compliance to protocol|1
7771526|NCT00883337|12215901|FG000|Core Treatment Period|Other than above|0
7771527|NCT00883337|12215902|FG001|Core Treatment Period|Other than above|1
7771528|NCT00883337|12215903|FG002|Core Treatment Period|Other than above|1
7771529|NCT00883337|12215901|FG000|Extension Treatment Period|Adverse Event|8
7771530|NCT00883337|12215902|FG001|Extension Treatment Period|Adverse Event|5
7771531|NCT00883337|12215903|FG002|Extension Treatment Period|Adverse Event|5
7771532|NCT00883337|12215901|FG000|Extension Treatment Period|Lack of Efficacy|8
7771533|NCT00883337|12215902|FG001|Extension Treatment Period|Lack of Efficacy|8
7771534|NCT00883337|12215903|FG002|Extension Treatment Period|Lack of Efficacy|8
7594975|NCT01846273|12000621|FG000|Overall Study|Adverse Event|9
7594976|NCT01846273|12000622|FG001|Overall Study|Adverse Event|7
7594977|NCT01846273|12000623|FG002|Overall Study|Adverse Event|0
7594978|NCT01846273|12000621|FG000|Overall Study|Subject withdrew consent|5
7594979|NCT01846273|12000622|FG001|Overall Study|Subject withdrew consent|8
7594980|NCT01846273|12000623|FG002|Overall Study|Subject withdrew consent|0
7594981|NCT01846273|12000621|FG000|Overall Study|Lost to Follow-up|2
7594982|NCT01846273|12000622|FG001|Overall Study|Lost to Follow-up|1
7594983|NCT01846273|12000623|FG002|Overall Study|Lost to Follow-up|0
7594984|NCT01846273|12000621|FG000|Overall Study|Administrative problems|1
7594985|NCT01846273|12000622|FG001|Overall Study|Administrative problems|0
7594986|NCT01846273|12000623|FG002|Overall Study|Administrative problems|0
7594987|NCT01846273|12000621|FG000|Overall Study|Death|2
7594988|NCT01846273|12000622|FG001|Overall Study|Death|1
7594989|NCT01846273|12000623|FG002|Overall Study|Death|0
7594990|NCT01846273|12000621|FG000|Overall Study|Disease Progression|0
7594991|NCT01846273|12000622|FG001|Overall Study|Disease Progression|4
7594992|NCT01846273|12000623|FG002|Overall Study|Disease Progression|0
7594993|NCT01846273|12000621|FG000|Overall Study|Protocol Deviation|2
7594994|NCT01846273|12000622|FG001|Overall Study|Protocol Deviation|3
7594995|NCT01846273|12000623|FG002|Overall Study|Protocol Deviation|0
7594996|NCT01846273|12000621|FG000|Overall Study|Physician Decision|1
7594997|NCT01846273|12000622|FG001|Overall Study|Physician Decision|2
7594998|NCT01846273|12000623|FG002|Overall Study|Physician Decision|0
7594999|NCT01875185|12000633|FG000|Overall Study|study was terminated|52
7595000|NCT01875185|12000634|FG001|Overall Study|study was terminated|48
7595001|NCT01891643|12000660|FG000|Overall Study|Adverse event unrelated to study drug|2
7595002|NCT01891643|12000661|FG001|Overall Study|Adverse event unrelated to study drug|5
7595003|NCT01891643|12000660|FG000|Overall Study|Disease Progression|4
7595004|NCT01891643|12000661|FG001|Overall Study|Disease Progression|3
7595005|NCT01891643|12000660|FG000|Overall Study|Study Drug Toxicity|3
7595006|NCT01891643|12000661|FG001|Overall Study|Study Drug Toxicity|0
7595007|NCT01891643|12000660|FG000|Overall Study|Maximum Clinical Benefit|0
7595008|NCT01891643|12000661|FG001|Overall Study|Maximum Clinical Benefit|1
7595009|NCT01891643|12000660|FG000|Overall Study|Poor/Non-compliance|0
7595010|NCT01891643|12000661|FG001|Overall Study|Poor/Non-compliance|1
7595011|NCT01891643|12000660|FG000|Overall Study|Participant request to discontinue|1
7595012|NCT01891643|12000661|FG001|Overall Study|Participant request to discontinue|0
7771535|NCT00883337|12215901|FG000|Extension Treatment Period|Poor compliance to protocol|1
7771536|NCT00883337|12215902|FG001|Extension Treatment Period|Poor compliance to protocol|1
7771537|NCT00883337|12215903|FG002|Extension Treatment Period|Poor compliance to protocol|1
7771538|NCT00883337|12215901|FG000|Extension Treatment Period|Lost to Follow-up|1
7771539|NCT00883337|12215902|FG001|Extension Treatment Period|Lost to Follow-up|0
7771540|NCT00883337|12215903|FG002|Extension Treatment Period|Lost to Follow-up|0
7771541|NCT00883337|12215901|FG000|Extension Treatment Period|Other than above|10
7771542|NCT00883337|12215902|FG001|Extension Treatment Period|Other than above|9
7771543|NCT00883337|12215903|FG002|Extension Treatment Period|Other than above|5
7771544|NCT00883493|12215927|FG000|Overall Study|Adverse Event|11
7771545|NCT00883493|12215928|FG001|Overall Study|Adverse Event|12
7771546|NCT00883493|12215927|FG000|Overall Study|Lack of Efficacy|4
7771547|NCT00883493|12215928|FG001|Overall Study|Lack of Efficacy|3
7771548|NCT00883493|12215927|FG000|Overall Study|Lost to Follow-up|7
7771549|NCT00883493|12215928|FG001|Overall Study|Lost to Follow-up|6
7771550|NCT00883493|12215927|FG000|Overall Study|Withdrawal by Subject|11
7771551|NCT00883493|12215928|FG001|Overall Study|Withdrawal by Subject|20
7771552|NCT00883493|12215927|FG000|Overall Study|Eligibility Criteria not fullfilled|6
7771553|NCT00883493|12215928|FG001|Overall Study|Eligibility Criteria not fullfilled|6
7771554|NCT00883493|12215927|FG000|Overall Study|Study specific disc. criteria|2
7771555|NCT00883493|12215928|FG001|Overall Study|Study specific disc. criteria|0
7771556|NCT00883493|12215927|FG000|Overall Study|Other|5
7771557|NCT00883493|12215928|FG001|Overall Study|Other|3
7771558|NCT00883558|12215934|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
7771559|NCT00883558|12215935|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
7771560|NCT00883558|12215936|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
7771561|NCT00883558|12215934|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
7771562|NCT00883558|12215935|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
7627607|NCT02498444|12040162|FG000|Overall Study|Withdrawal by Subject|3
7627608|NCT02498444|12040163|FG001|Overall Study|Withdrawal by Subject|0
7627609|NCT02498444|12040162|FG000|Overall Study|Physician Decision|1
7627610|NCT02498444|12040163|FG001|Overall Study|Physician Decision|0
7771563|NCT00883558|12215936|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
7595019|NCT01901432|12000677|FG000|Overall Study|Adverse Event|0
7595020|NCT01901432|12000678|FG001|Overall Study|Adverse Event|1
7595021|NCT01901432|12000679|FG002|Overall Study|Adverse Event|1
7595022|NCT01901432|12000680|FG003|Overall Study|Adverse Event|0
7595023|NCT01901432|12000681|FG004|Overall Study|Adverse Event|1
7595024|NCT01901432|12000677|FG000|Overall Study|Withdrawal by Subject|0
7595025|NCT01901432|12000678|FG001|Overall Study|Withdrawal by Subject|0
7771564|NCT00883558|12215934|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
7771565|NCT00883558|12215935|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
7771566|NCT00883558|12215936|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
7771567|NCT00883558|12215934|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
7771568|NCT00883558|12215935|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
7771569|NCT00883558|12215936|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
7771570|NCT00883558|12215934|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
7595026|NCT01901432|12000679|FG002|Overall Study|Withdrawal by Subject|1
7595027|NCT01901432|12000680|FG003|Overall Study|Withdrawal by Subject|0
7595028|NCT01901432|12000681|FG004|Overall Study|Withdrawal by Subject|5
7595029|NCT01901432|12000677|FG000|Overall Study|Physician Decision|0
7595030|NCT01901432|12000678|FG001|Overall Study|Physician Decision|0
7595031|NCT01901432|12000679|FG002|Overall Study|Physician Decision|0
7595032|NCT01901432|12000680|FG003|Overall Study|Physician Decision|0
7595033|NCT01901432|12000681|FG004|Overall Study|Physician Decision|2
7595034|NCT01901432|12000677|FG000|Overall Study|Patient decision to stop study drug|0
7595035|NCT01901432|12000678|FG001|Overall Study|Patient decision to stop study drug|0
7595036|NCT01901432|12000679|FG002|Overall Study|Patient decision to stop study drug|0
7595037|NCT01901432|12000680|FG003|Overall Study|Patient decision to stop study drug|0
7595038|NCT01901432|12000681|FG004|Overall Study|Patient decision to stop study drug|1
7627611|NCT02487108|12040173|FG000|Overall Study|Adverse Event|1
7627612|NCT02487108|12040174|FG001|Overall Study|Adverse Event|6
7627613|NCT02487108|12040175|FG002|Overall Study|Adverse Event|12
7627614|NCT02487108|12040176|FG003|Overall Study|Adverse Event|6
7627615|NCT02487108|12040173|FG000|Overall Study|Withdrawal by Subject|8
7627616|NCT02487108|12040174|FG001|Overall Study|Withdrawal by Subject|5
7627617|NCT02487108|12040175|FG002|Overall Study|Withdrawal by Subject|5
7627618|NCT02487108|12040176|FG003|Overall Study|Withdrawal by Subject|0
7627619|NCT02487108|12040173|FG000|Overall Study|Non-compliance to study medication|3
7627620|NCT02487108|12040174|FG001|Overall Study|Non-compliance to study medication|2
7627621|NCT02487108|12040175|FG002|Overall Study|Non-compliance to study medication|5
7627622|NCT02487108|12040176|FG003|Overall Study|Non-compliance to study medication|4
7627623|NCT02487108|12040173|FG000|Overall Study|Protocol Violation|1
7627624|NCT02487108|12040174|FG001|Overall Study|Protocol Violation|1
7627625|NCT02487108|12040175|FG002|Overall Study|Protocol Violation|2
7627626|NCT02487108|12040176|FG003|Overall Study|Protocol Violation|0
7627627|NCT02487108|12040173|FG000|Overall Study|Non-compliance to study procedures|0
7627628|NCT02487108|12040174|FG001|Overall Study|Non-compliance to study procedures|0
7627629|NCT02487108|12040175|FG002|Overall Study|Non-compliance to study procedures|0
7595039|NCT01904279|12000702|FG000|Overall Study|Lack of Efficacy|2
7595040|NCT01904279|12000703|FG001|Overall Study|Lack of Efficacy|3
7595041|NCT01904279|12000702|FG000|Overall Study|Withdrawal by Subject|1
7595042|NCT01904279|12000703|FG001|Overall Study|Withdrawal by Subject|0
7627630|NCT02487108|12040176|FG003|Overall Study|Non-compliance to study procedures|1
7627631|NCT02487108|12040173|FG000|Overall Study|Other than specified|3
7627632|NCT02487108|12040174|FG001|Overall Study|Other than specified|2
7627633|NCT02487108|12040175|FG002|Overall Study|Other than specified|2
7627634|NCT02487108|12040176|FG003|Overall Study|Other than specified|0
7627635|NCT02455557|12040186|FG000|Overall Study|Withdrawal by Subject|2
7627636|NCT02387996|12040199|FG000|Overall Study|Disease Progression|144
7627637|NCT02387996|12040199|FG000|Overall Study|Study Drug Toxicity|14
7627638|NCT02387996|12040199|FG000|Overall Study|Adverse Event Unrelated to Study Drug|34
7627639|NCT02387996|12040199|FG000|Overall Study|Subject Request to Discontinue Treatment|9
7627640|NCT02387996|12040199|FG000|Overall Study|Subject Withdrew Consent|1
7627641|NCT02387996|12040199|FG000|Overall Study|Lost to Follow-up|1
7627642|NCT02387996|12040199|FG000|Overall Study|Poor/Non-Compliance|1
7627643|NCT02351856|12040216|FG000|Overall Study|Adverse Event|2
7627644|NCT02351856|12040216|FG000|Overall Study|Physician Decision|5
7627645|NCT02351856|12040216|FG000|Overall Study|Study terminated by sponsor|1
7627646|NCT02349386|12040224|FG000|24-Week Double-Blind Main Study|Adverse Event|0
7627647|NCT02349386|12040225|FG001|24-Week Double-Blind Main Study|Adverse Event|0
7627648|NCT02349386|12040226|FG002|24-Week Double-Blind Main Study|Adverse Event|1
7627649|NCT02349386|12040227|FG003|24-Week Double-Blind Main Study|Adverse Event|1
7627650|NCT02349386|12040224|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6
7627651|NCT02349386|12040225|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6
7627652|NCT02349386|12040226|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2
7627653|NCT02349386|12040227|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7
7627654|NCT02349386|12040224|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0
7627655|NCT02349386|12040225|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0
7627656|NCT02349386|12040226|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1
7627657|NCT02349386|12040227|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0
7627658|NCT02349386|12040224|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0
7627659|NCT02349386|12040225|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0
7627660|NCT02349386|12040226|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1
7627661|NCT02349386|12040227|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0
7627662|NCT02349386|12040224|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2
7627663|NCT02349386|12040225|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0
7627664|NCT02349386|12040226|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2
7627665|NCT02349386|12040227|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0
7627666|NCT02349386|12040224|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0
7627667|NCT02349386|12040225|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0
7627668|NCT02349386|12040226|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1
7627669|NCT02349386|12040227|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0
7627670|NCT01904032|12040261|FG000|Overall Study|Adverse Event|3
7627671|NCT01904032|12040262|FG001|Overall Study|Adverse Event|1
7627672|NCT01904032|12040261|FG000|Overall Study|Lost to Follow-up|4
7627673|NCT01904032|12040262|FG001|Overall Study|Lost to Follow-up|2
7627674|NCT01632878|12040288|FG000|Screening|Physician Decision|268
7627675|NCT01632878|12040288|FG000|Treatment|Lost to Follow-up|41
7627676|NCT01632878|12040288|FG000|Treatment|Withdrawal by Subject|36
7627677|NCT01632878|12040288|FG000|Treatment|Physician Decision|34
7627678|NCT01632878|12040288|FG000|Treatment|missing information|4
7627679|NCT01632878|12040288|FG000|Treatment|no information on study completion|43
7627680|NCT01097005|12040296|FG000|Overall Study|Case Report Form not collected|18
7627681|NCT01097005|12040296|FG000|Overall Study|Subjects cannot visit the hospital|1
7627682|NCT01097005|12040296|FG000|Overall Study|Poor medication compliance|1
7627683|NCT01097005|12040296|FG000|Overall Study|No examination data available|244
7627684|NCT01097005|12040296|FG000|Overall Study|Deviation from exclusion criteria|37
7627685|NCT01097005|12040296|FG000|Overall Study|Adverse Event|14
7627686|NCT01097005|12040296|FG000|Overall Study|Discontinuance by complication|50
7627687|NCT00931255|12040308|FG000|Overall Study|Follow up biopsy not done|2
7627688|NCT00931255|12040309|FG001|Overall Study|Follow up biopsy not done|3
7595043|NCT01917318|12000712|FG000|First Treatment|Withdrawal by Subject|0
7595044|NCT01917318|12000713|FG001|First Treatment|Withdrawal by Subject|1
7595045|NCT01921218|12000721|FG000|Overall Study|Death|2
7595046|NCT01921218|12000722|FG001|Overall Study|Death|1
7595047|NCT01921218|12000721|FG000|Overall Study|Withdrawal by Subject|0
7595048|NCT01921218|12000722|FG001|Overall Study|Withdrawal by Subject|2
7595049|NCT01921218|12000721|FG000|Overall Study|Kidney transplant|1
7595050|NCT01921218|12000722|FG001|Overall Study|Kidney transplant|1
7595069|NCT01931098|12000763|FG000|Overall Study|Withdrawal by Subject|0
7595070|NCT01931098|12000764|FG001|Overall Study|Withdrawal by Subject|1
7595071|NCT01931098|12000763|FG000|Overall Study|Enrolled in different protocol|0
7595072|NCT01931098|12000764|FG001|Overall Study|Enrolled in different protocol|1
7595073|NCT01931098|12000763|FG000|Overall Study|Unable to begin trmt:active infection|0
7595074|NCT01931098|12000764|FG001|Overall Study|Unable to begin trmt:active infection|1
7595075|NCT01931098|12000763|FG000|Overall Study|Refused further treatment|0
7595076|NCT01931098|12000764|FG001|Overall Study|Refused further treatment|1
7595077|NCT01945021|12000772|FG000|Overall Study|Adverse Event|1
7595078|NCT01945021|12000772|FG000|Overall Study|Withdrawal of consent|12
7595079|NCT01945021|12000772|FG000|Overall Study|Lost to Follow-up|5
7595080|NCT01945021|12000772|FG000|Overall Study|Death|65
7595081|NCT03951077|12000822|FG000|Overall Study|Adverse Event|1
7595082|NCT03951077|12000823|FG001|Overall Study|Adverse Event|0
7595083|NCT03951077|12000824|FG002|Overall Study|Adverse Event|0
7595084|NCT03951077|12000825|FG003|Overall Study|Adverse Event|0
7595085|NCT03951077|12000826|FG004|Overall Study|Adverse Event|0
7595086|NCT03951077|12000827|FG005|Overall Study|Adverse Event|0
7595087|NCT03951077|12000822|FG000|Overall Study|Withdrawal by Subject|3
7595088|NCT03951077|12000823|FG001|Overall Study|Withdrawal by Subject|3
7595089|NCT03951077|12000824|FG002|Overall Study|Withdrawal by Subject|0
7595090|NCT03951077|12000825|FG003|Overall Study|Withdrawal by Subject|3
7595091|NCT03951077|12000826|FG004|Overall Study|Withdrawal by Subject|3
7595092|NCT03951077|12000827|FG005|Overall Study|Withdrawal by Subject|2
7595093|NCT03951077|12000822|FG000|Overall Study|Lost to Follow-up|1
7595094|NCT03951077|12000823|FG001|Overall Study|Lost to Follow-up|1
7595095|NCT03951077|12000824|FG002|Overall Study|Lost to Follow-up|2
7595096|NCT03951077|12000825|FG003|Overall Study|Lost to Follow-up|3
7595097|NCT03951077|12000826|FG004|Overall Study|Lost to Follow-up|2
7595098|NCT03951077|12000827|FG005|Overall Study|Lost to Follow-up|3
7595099|NCT03951077|12000822|FG000|Overall Study|Non-Compliance With Study Procedures|0
7595100|NCT03951077|12000823|FG001|Overall Study|Non-Compliance With Study Procedures|0
7595101|NCT03951077|12000824|FG002|Overall Study|Non-Compliance With Study Procedures|0
7595102|NCT03951077|12000825|FG003|Overall Study|Non-Compliance With Study Procedures|0
7595103|NCT03951077|12000826|FG004|Overall Study|Non-Compliance With Study Procedures|1
7595104|NCT03951077|12000827|FG005|Overall Study|Non-Compliance With Study Procedures|0
7595105|NCT03951077|12000822|FG000|Overall Study|Other, Not Specified|12
7595106|NCT03951077|12000823|FG001|Overall Study|Other, Not Specified|10
7595107|NCT03951077|12000824|FG002|Overall Study|Other, Not Specified|10
7595108|NCT03951077|12000825|FG003|Overall Study|Other, Not Specified|5
7595109|NCT03951077|12000826|FG004|Overall Study|Other, Not Specified|9
7595110|NCT03951077|12000827|FG005|Overall Study|Other, Not Specified|6
7595111|NCT03951077|12000822|FG000|Overall Study|Did Not Receive Any Study Drug|1
7595112|NCT03951077|12000823|FG001|Overall Study|Did Not Receive Any Study Drug|0
7595113|NCT03951077|12000824|FG002|Overall Study|Did Not Receive Any Study Drug|1
7595114|NCT03951077|12000825|FG003|Overall Study|Did Not Receive Any Study Drug|1
7595115|NCT03951077|12000826|FG004|Overall Study|Did Not Receive Any Study Drug|1
7595116|NCT03951077|12000827|FG005|Overall Study|Did Not Receive Any Study Drug|0
7595117|NCT03873246|12000844|FG000|Overall Study|Adverse Event|1
7595118|NCT03873246|12000845|FG001|Overall Study|Adverse Event|3
7595119|NCT03873246|12000846|FG002|Overall Study|Adverse Event|3
7595120|NCT03873246|12000844|FG000|Overall Study|Lost to Follow-up|4
7595121|NCT03873246|12000845|FG001|Overall Study|Lost to Follow-up|4
7595122|NCT03873246|12000846|FG002|Overall Study|Lost to Follow-up|5
7595123|NCT03873246|12000844|FG000|Overall Study|Protocol Violation|0
7595124|NCT03873246|12000845|FG001|Overall Study|Protocol Violation|1
7595051|NCT01923168|12000731|FG000|Overall Study|Protocol Violation|1
7595052|NCT01923168|12000732|FG001|Overall Study|Protocol Violation|1
7595053|NCT01923168|12000733|FG002|Overall Study|Protocol Violation|0
7595054|NCT01923168|12000731|FG000|Overall Study|Subject/guardian decision|14
7595055|NCT01923168|12000732|FG001|Overall Study|Subject/guardian decision|14
7595056|NCT01923168|12000733|FG002|Overall Study|Subject/guardian decision|4
7595057|NCT01923168|12000731|FG000|Overall Study|Adverse Event|12
7595058|NCT01923168|12000732|FG001|Overall Study|Adverse Event|12
7595059|NCT01923168|12000733|FG002|Overall Study|Adverse Event|0
7595060|NCT01923168|12000731|FG000|Overall Study|Physician Decision|6
7595061|NCT01923168|12000732|FG001|Overall Study|Physician Decision|9
7595062|NCT01923168|12000733|FG002|Overall Study|Physician Decision|5
7595063|NCT01923168|12000731|FG000|Overall Study|Progressive disease|4
7595064|NCT01923168|12000732|FG001|Overall Study|Progressive disease|3
7595065|NCT01923168|12000733|FG002|Overall Study|Progressive disease|7
7595066|NCT01923168|12000731|FG000|Overall Study|Death|0
7595067|NCT01923168|12000732|FG001|Overall Study|Death|0
7595068|NCT01923168|12000733|FG002|Overall Study|Death|1
7595125|NCT03873246|12000846|FG002|Overall Study|Protocol Violation|0
7595126|NCT03873246|12000844|FG000|Overall Study|Withdrawal by Subject|0
7595127|NCT03873246|12000845|FG001|Overall Study|Withdrawal by Subject|4
7595128|NCT03873246|12000846|FG002|Overall Study|Withdrawal by Subject|1
7595129|NCT03807349|12000855|FG000|Overall Study|Early Study Termination|9
7595130|NCT03769649|12000859|FG000|Overall Study|Lost to Follow-up|4
7595131|NCT03408444|12000924|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1
7595132|NCT03408444|12000925|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0
7595133|NCT03408444|12000926|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0
7595134|NCT03408444|12000927|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0
7595135|NCT03408444|12000924|FG000|Overall Study|Lens Discomfort|0
7595136|NCT03408444|12000925|FG001|Overall Study|Lens Discomfort|1
7595137|NCT03408444|12000926|FG002|Overall Study|Lens Discomfort|0
7595138|NCT03408444|12000927|FG003|Overall Study|Lens Discomfort|0
7595139|NCT03408444|12000924|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0
7595140|NCT03408444|12000925|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0
7595141|NCT03408444|12000926|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1
7595142|NCT03408444|12000927|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0
7595143|NCT03408444|12000924|FG000|Overall Study|Withdrawal by Subject|0
7595144|NCT03408444|12000925|FG001|Overall Study|Withdrawal by Subject|2
7595145|NCT03408444|12000926|FG002|Overall Study|Withdrawal by Subject|3
7595146|NCT03408444|12000927|FG003|Overall Study|Withdrawal by Subject|0
7595147|NCT03408444|12000924|FG000|Overall Study|Lost to Follow-up|0
7595148|NCT03408444|12000925|FG001|Overall Study|Lost to Follow-up|0
7595149|NCT03408444|12000926|FG002|Overall Study|Lost to Follow-up|1
7595150|NCT03408444|12000927|FG003|Overall Study|Lost to Follow-up|0
7595151|NCT03408444|12000924|FG000|Overall Study|Adverse Event|0
7595152|NCT03408444|12000925|FG001|Overall Study|Adverse Event|0
7595153|NCT03408444|12000926|FG002|Overall Study|Adverse Event|0
7595154|NCT03408444|12000927|FG003|Overall Study|Adverse Event|1
7595155|NCT03408444|12000924|FG000|Overall Study|Lens Handling Difficulties|0
7595156|NCT03408444|12000925|FG001|Overall Study|Lens Handling Difficulties|0
7595157|NCT03408444|12000926|FG002|Overall Study|Lens Handling Difficulties|1
7595158|NCT03408444|12000927|FG003|Overall Study|Lens Handling Difficulties|0
7595159|NCT03408444|12000924|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0
7595160|NCT03408444|12000925|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0
7595161|NCT03408444|12000926|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0
7595162|NCT03408444|12000927|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3
7627689|NCT04537078|12040355|FG000|Overall Study|Protocol Violation|3
7627690|NCT04537078|12040356|FG001|Overall Study|Protocol Violation|2
7627691|NCT04537078|12040355|FG000|Overall Study|Lost to Follow-up|1
7627692|NCT04537078|12040356|FG001|Overall Study|Lost to Follow-up|0
7627693|NCT04537078|12040355|FG000|Overall Study|Withdrawal by Subject|0
7627694|NCT04537078|12040356|FG001|Overall Study|Withdrawal by Subject|1
7627695|NCT04425252|12040371|FG000|Overall Study|Withdrawal by Subject|2
7627696|NCT04425252|12040372|FG001|Overall Study|Withdrawal by Subject|1
7627697|NCT04425252|12040371|FG000|Overall Study|Lost to Follow-up|1
7627698|NCT04425252|12040372|FG001|Overall Study|Lost to Follow-up|0
7627699|NCT04425252|12040371|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1
7627700|NCT04425252|12040372|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1
7627701|NCT03875313|12040401|FG000|Overall Study|Withdrawal by Subject|1
7627702|NCT03875313|12040402|FG001|Overall Study|Withdrawal by Subject|3
7627703|NCT03875313|12040403|FG002|Overall Study|Withdrawal by Subject|0
7627704|NCT03875313|12040404|FG003|Overall Study|Withdrawal by Subject|0
7627705|NCT03875313|12040405|FG004|Overall Study|Withdrawal by Subject|0
7627706|NCT03875313|12040401|FG000|Overall Study|Death|0
7627707|NCT03875313|12040402|FG001|Overall Study|Death|0
7627708|NCT03875313|12040403|FG002|Overall Study|Death|0
7627709|NCT03875313|12040404|FG003|Overall Study|Death|0
7771571|NCT00883558|12215935|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
7771572|NCT00883558|12215936|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
7771573|NCT00883688|12215946|FG000|Overall Study|Ineligible|2
7771574|NCT00883740|12215950|FG000|First Intervention|Lost to Follow-up|1
7771575|NCT00883740|12215951|FG001|First Intervention|Lost to Follow-up|0
7771576|NCT00883740|12215950|FG000|First Intervention|No longer willing to participate|2
7771577|NCT00883740|12215951|FG001|First Intervention|No longer willing to participate|0
7771578|NCT00883740|12215950|FG000|First Intervention|Protocol Violation|3
7771579|NCT00883740|12215951|FG001|First Intervention|Protocol Violation|6
7771580|NCT00883740|12215950|FG000|First Intervention|Adverse Event|1
7771581|NCT00883740|12215951|FG001|First Intervention|Adverse Event|2
7771582|NCT00883740|12215950|FG000|Second Intervention|Protocol Violation|1
7771583|NCT00883740|12215951|FG001|Second Intervention|Protocol Violation|0
7771584|NCT00883740|12215950|FG000|Second Intervention|No longer willing to participate|0
7771585|NCT00883740|12215951|FG001|Second Intervention|No longer willing to participate|1
7771586|NCT00883753|12215957|FG000|Overall Study|Adverse Event|37
7771587|NCT00883753|12215957|FG000|Overall Study|Death|2
7771588|NCT00883753|12215957|FG000|Overall Study|Insufficient therapeutic response|16
7771589|NCT00883753|12215957|FG000|Overall Study|Lost to Follow-up|4
7771590|NCT00883753|12215957|FG000|Overall Study|Violation of selection criteria at entry|7
7771591|NCT00883753|12215957|FG000|Overall Study|Protocol Violation|2
7771592|NCT00883753|12215957|FG000|Overall Study|Refused treatment|4
7771593|NCT00883753|12215957|FG000|Overall Study|Withdrew consent|10
7771594|NCT00883753|12215957|FG000|Overall Study|Investigator's decision|17
7771595|NCT00883753|12215957|FG000|Overall Study|Administrative/Other|8
7771596|NCT00883779|12215966|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4
7771597|NCT00883779|12215967|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4
7771598|NCT00883779|12215966|FG000|Primary Study Treatment Phase|Disease progression|75
7771599|NCT00883779|12215967|FG001|Primary Study Treatment Phase|Disease progression|59
7771600|NCT00883779|12215966|FG000|Primary Study Treatment Phase|Adverse Event|16
7771601|NCT00883779|12215967|FG001|Primary Study Treatment Phase|Adverse Event|16
7771602|NCT00883779|12215966|FG000|Primary Study Treatment Phase|Death|2
7771603|NCT00883779|12215967|FG001|Primary Study Treatment Phase|Death|3
7771604|NCT00883779|12215966|FG000|Primary Study Treatment Phase|Refused Treatment|5
7771605|NCT00883779|12215967|FG001|Primary Study Treatment Phase|Refused Treatment|4
7771606|NCT00883779|12215966|FG000|Primary Study Treatment Phase|Other|3
7771607|NCT00883779|12215967|FG001|Primary Study Treatment Phase|Other|0
7771608|NCT00883779|12215966|FG000|Post-Study Treatment Phase|Adverse Event|2
7771609|NCT00883779|12215967|FG001|Post-Study Treatment Phase|Adverse Event|3
7771610|NCT00883779|12215966|FG000|Post-Study Treatment Phase|Death|1
7771611|NCT00883779|12215967|FG001|Post-Study Treatment Phase|Death|3
7771612|NCT00883779|12215966|FG000|Post-Study Treatment Phase|Protocol Violation|0
7771613|NCT00883779|12215967|FG001|Post-Study Treatment Phase|Protocol Violation|1
7771614|NCT00883779|12215966|FG000|Post-Study Treatment Phase|Refused Treatment|3
7771615|NCT00883779|12215967|FG001|Post-Study Treatment Phase|Refused Treatment|0
7771616|NCT00883779|12215966|FG000|Post-Study Treatment Phase|Disease progression|103
7771617|NCT00883779|12215967|FG001|Post-Study Treatment Phase|Disease progression|122
7771618|NCT00883779|12215966|FG000|Post-Study Treatment Phase|Other|3
7771619|NCT00883779|12215967|FG001|Post-Study Treatment Phase|Other|0
7771620|NCT00883779|12215966|FG000|Post-Study Treatment Phase|Ongoing in the study|0
7771621|NCT00883779|12215967|FG001|Post-Study Treatment Phase|Ongoing in the study|6
7771622|NCT00883779|12215966|FG000|Off-study Phase|Death|185
7771623|NCT00883779|12215967|FG001|Off-study Phase|Death|174
7771624|NCT00883779|12215966|FG000|Off-study Phase|Refused treatment|1
7771625|NCT00883779|12215967|FG001|Off-study Phase|Refused treatment|1
7771626|NCT00883779|12215966|FG000|Off-study Phase|Failure to return|5
7771627|NCT00883779|12215967|FG001|Off-study Phase|Failure to return|6
7771628|NCT00883779|12215966|FG000|Off-study Phase|Other|18
7771629|NCT00883779|12215967|FG001|Off-study Phase|Other|21
7771630|NCT00884039|12215975|FG000|Overall Study|Withdrawal by Subject|0
7771631|NCT00884039|12215976|FG001|Overall Study|Withdrawal by Subject|1
7771632|NCT00884039|12215975|FG000|Overall Study|Lack of Efficacy|2
7771633|NCT00884039|12215976|FG001|Overall Study|Lack of Efficacy|0
7771634|NCT00884117|12215998|FG000|Overall Study|Adverse Event|2
7771635|NCT00884117|12215998|FG000|Overall Study|Withdrawal by Subject|89
7771636|NCT00884117|12215998|FG000|Overall Study|Death|3
7771637|NCT00884117|12215998|FG000|Overall Study|Lost to Follow-up|143
7771638|NCT00884117|12215998|FG000|Overall Study|Other|12
7771639|NCT00884221|12216017|FG000|Overall Study|Withdrawal by Subject|0
7771640|NCT00884221|12216018|FG001|Overall Study|Withdrawal by Subject|3
7771641|NCT00884221|12216017|FG000|Overall Study|Adverse Event|6
7771642|NCT00884221|12216018|FG001|Overall Study|Adverse Event|3
7595166|NCT02862548|12000961|FG000|Randomized Phase (Up to Week 48)|Death|0
7595167|NCT02862548|12000962|FG001|Randomized Phase (Up to Week 48)|Death|1
7595168|NCT02862548|12000961|FG000|OLE Phase (Week 49 to Week 192)|Death|2
7595169|NCT02862548|12000962|FG001|OLE Phase (Week 49 to Week 192)|Death|0
7595170|NCT02862548|12000961|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1
7595171|NCT02862548|12000962|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0
7595172|NCT02862548|12000961|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0
7595173|NCT02862548|12000962|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1
7595174|NCT02335099|12000981|FG000|Treatment|Withdrawal by Subject|1
7595175|NCT02335099|12000982|FG001|Treatment|Withdrawal by Subject|3
7595176|NCT02335099|12000981|FG000|Treatment|Lost to Follow-up|2
7595177|NCT02335099|12000982|FG001|Treatment|Lost to Follow-up|0
7595178|NCT02335099|12000981|FG000|Treatment|Death|1
7595179|NCT02335099|12000982|FG001|Treatment|Death|0
7595180|NCT02335099|12000981|FG000|Treatment|Adverse Event|1
7595181|NCT02335099|12000982|FG001|Treatment|Adverse Event|2
7595182|NCT02335099|12000981|FG000|Follow-up|Death|0
7595183|NCT02335099|12000982|FG001|Follow-up|Death|1
7595184|NCT02330562|12000999|FG000|Overall Study|Adverse Event|0
7595185|NCT02330562|12001000|FG001|Overall Study|Adverse Event|0
7595186|NCT02330562|12001001|FG002|Overall Study|Adverse Event|3
7595187|NCT02330562|12001002|FG003|Overall Study|Adverse Event|0
7595188|NCT02330562|12001003|FG004|Overall Study|Adverse Event|3
7595189|NCT02330562|12001004|FG005|Overall Study|Adverse Event|1
7595190|NCT02330562|12001005|FG006|Overall Study|Adverse Event|0
7595191|NCT02330562|12001006|FG007|Overall Study|Adverse Event|0
7595192|NCT02330562|12001007|FG008|Overall Study|Adverse Event|0
7595193|NCT02330562|12001008|FG009|Overall Study|Adverse Event|1
7595194|NCT02330562|12001009|FG010|Overall Study|Adverse Event|1
7595195|NCT02330562|12000999|FG000|Overall Study|Participant decision|1
7595196|NCT02330562|12001000|FG001|Overall Study|Participant decision|0
7595197|NCT02330562|12001001|FG002|Overall Study|Participant decision|4
7595198|NCT02330562|12001002|FG003|Overall Study|Participant decision|1
7595199|NCT02330562|12001003|FG004|Overall Study|Participant decision|5
7595200|NCT02330562|12001004|FG005|Overall Study|Participant decision|2
7595201|NCT02330562|12001005|FG006|Overall Study|Participant decision|0
7595202|NCT02330562|12001006|FG007|Overall Study|Participant decision|0
7595203|NCT02330562|12001007|FG008|Overall Study|Participant decision|0
7595204|NCT02330562|12001008|FG009|Overall Study|Participant decision|3
7595205|NCT02330562|12001009|FG010|Overall Study|Participant decision|0
7595206|NCT02330562|12000999|FG000|Overall Study|Disease progression|5
7595207|NCT02330562|12001000|FG001|Overall Study|Disease progression|3
7595208|NCT02330562|12001001|FG002|Overall Study|Disease progression|20
7595209|NCT02330562|12001002|FG003|Overall Study|Disease progression|28
7595210|NCT02330562|12001003|FG004|Overall Study|Disease progression|23
7595211|NCT02330562|12001004|FG005|Overall Study|Disease progression|7
7595212|NCT02330562|12001005|FG006|Overall Study|Disease progression|1
7595213|NCT02330562|12001006|FG007|Overall Study|Disease progression|1
7595214|NCT02330562|12001007|FG008|Overall Study|Disease progression|1
7595215|NCT02330562|12001008|FG009|Overall Study|Disease progression|0
7595216|NCT02330562|12001009|FG010|Overall Study|Disease progression|5
7595217|NCT02330562|12000999|FG000|Overall Study|Other reasons|0
7595218|NCT02330562|12001000|FG001|Overall Study|Other reasons|0
7595219|NCT02330562|12001001|FG002|Overall Study|Other reasons|0
7595220|NCT02330562|12001002|FG003|Overall Study|Other reasons|1
7595221|NCT02330562|12001003|FG004|Overall Study|Other reasons|0
7595222|NCT02330562|12001004|FG005|Overall Study|Other reasons|0
7595223|NCT02330562|12001005|FG006|Overall Study|Other reasons|0
7595224|NCT02330562|12001006|FG007|Overall Study|Other reasons|0
7771643|NCT00884221|12216017|FG000|Overall Study|Protocol Violation|16
7771644|NCT00884221|12216018|FG001|Overall Study|Protocol Violation|13
7595225|NCT02330562|12001007|FG008|Overall Study|Other reasons|0
7595226|NCT02330562|12001008|FG009|Overall Study|Other reasons|0
7595227|NCT02330562|12001009|FG010|Overall Study|Other reasons|0
7595228|NCT02330562|12000999|FG000|Overall Study|Withdrawal by Subject|0
7595229|NCT02330562|12001000|FG001|Overall Study|Withdrawal by Subject|0
7595230|NCT02330562|12001001|FG002|Overall Study|Withdrawal by Subject|0
7595231|NCT02330562|12001002|FG003|Overall Study|Withdrawal by Subject|0
7595232|NCT02330562|12001003|FG004|Overall Study|Withdrawal by Subject|0
7595233|NCT02330562|12001004|FG005|Overall Study|Withdrawal by Subject|0
7595234|NCT02330562|12001005|FG006|Overall Study|Withdrawal by Subject|0
7595235|NCT02330562|12001006|FG007|Overall Study|Withdrawal by Subject|0
7595236|NCT02330562|12001007|FG008|Overall Study|Withdrawal by Subject|0
7595237|NCT02330562|12001008|FG009|Overall Study|Withdrawal by Subject|1
7595238|NCT02330562|12001009|FG010|Overall Study|Withdrawal by Subject|0
7595239|NCT02035137|12001066|FG000|Overall Study|Physician Decision|0
7595240|NCT02035137|12001067|FG001|Overall Study|Physician Decision|0
7595241|NCT02035137|12001068|FG002|Overall Study|Physician Decision|1
7595242|NCT02035137|12001066|FG000|Overall Study|Withdrawal by Subject|0
7595243|NCT02035137|12001067|FG001|Overall Study|Withdrawal by Subject|1
7595244|NCT02035137|12001068|FG002|Overall Study|Withdrawal by Subject|2
7595245|NCT02035137|12001066|FG000|Overall Study|Ineligible|0
7595246|NCT02035137|12001067|FG001|Overall Study|Ineligible|1
7595247|NCT02035137|12001068|FG002|Overall Study|Ineligible|2
7595248|NCT02035137|12001066|FG000|Overall Study|Disease progression prior to treatment start|2
7595249|NCT02035137|12001067|FG001|Overall Study|Disease progression prior to treatment start|0
7595250|NCT02035137|12001068|FG002|Overall Study|Disease progression prior to treatment start|0
7595251|NCT01589523|12001089|FG000|Overall Study|Withdrawal by Subject|1
7595252|NCT00777036|12001109|FG000|On Treatment|Reason Not Specified|4
7595253|NCT00777036|12001110|FG001|On Treatment|Reason Not Specified|7
7595254|NCT00777036|12001111|FG002|On Treatment|Reason Not Specified|12
7595255|NCT00777036|12001109|FG000|On Treatment|Failure to Meet Study Criteria|0
7595256|NCT00777036|12001110|FG001|On Treatment|Failure to Meet Study Criteria|1
7595257|NCT00777036|12001111|FG002|On Treatment|Failure to Meet Study Criteria|0
7595258|NCT00777036|12001109|FG000|On Treatment|Non-compliance with Study Drug|1
7595259|NCT00777036|12001110|FG001|On Treatment|Non-compliance with Study Drug|0
7595260|NCT00777036|12001111|FG002|On Treatment|Non-compliance with Study Drug|0
7595261|NCT00777036|12001109|FG000|On Treatment|Maximum Clinical Benefit|2
7595262|NCT00777036|12001110|FG001|On Treatment|Maximum Clinical Benefit|0
7595263|NCT00777036|12001111|FG002|On Treatment|Maximum Clinical Benefit|1
7595264|NCT00777036|12001109|FG000|On Treatment|Withdrawal by Subject|3
7595265|NCT00777036|12001110|FG001|On Treatment|Withdrawal by Subject|2
7595266|NCT00777036|12001111|FG002|On Treatment|Withdrawal by Subject|3
7595267|NCT00777036|12001109|FG000|On Treatment|Death|0
7595268|NCT00777036|12001110|FG001|On Treatment|Death|2
7595269|NCT00777036|12001111|FG002|On Treatment|Death|0
7595270|NCT00777036|12001109|FG000|On Treatment|Study Drug Toxicity|0
7595271|NCT00777036|12001110|FG001|On Treatment|Study Drug Toxicity|0
7595272|NCT00777036|12001111|FG002|On Treatment|Study Drug Toxicity|1
7595273|NCT00777036|12001109|FG000|On Treatment|Progressive Disease|5
7595274|NCT00777036|12001110|FG001|On Treatment|Progressive Disease|4
7595275|NCT00777036|12001111|FG002|On Treatment|Progressive Disease|6
7595276|NCT00777036|12001109|FG000|Follow-Up|Lost to Follow-up|1
7595277|NCT00777036|12001110|FG001|Follow-Up|Lost to Follow-up|0
7595278|NCT00777036|12001111|FG002|Follow-Up|Lost to Follow-up|0
7595279|NCT00777036|12001109|FG000|Follow-Up|Reason Not Specified|2
7595280|NCT00777036|12001110|FG001|Follow-Up|Reason Not Specified|0
7595281|NCT00777036|12001111|FG002|Follow-Up|Reason Not Specified|0
7595282|NCT00777036|12001109|FG000|Follow-Up|Withdrawal by Subject|1
7595283|NCT00777036|12001110|FG001|Follow-Up|Withdrawal by Subject|0
7595284|NCT00777036|12001111|FG002|Follow-Up|Withdrawal by Subject|4
7595285|NCT00777036|12001109|FG000|Follow-Up|Death|1
7595286|NCT00777036|12001110|FG001|Follow-Up|Death|8
7595287|NCT00777036|12001111|FG002|Follow-Up|Death|0
7627710|NCT03875313|12040405|FG004|Overall Study|Death|1
7627711|NCT03875313|12040401|FG000|Overall Study|Lost to Follow-up|0
7627712|NCT03875313|12040402|FG001|Overall Study|Lost to Follow-up|0
7627713|NCT03875313|12040403|FG002|Overall Study|Lost to Follow-up|0
7627714|NCT03875313|12040404|FG003|Overall Study|Lost to Follow-up|0
7627715|NCT03875313|12040405|FG004|Overall Study|Lost to Follow-up|1
7627716|NCT03875313|12040401|FG000|Overall Study|Study Termination by Sponsor|0
7627717|NCT03875313|12040402|FG001|Overall Study|Study Termination by Sponsor|1
7627718|NCT03875313|12040403|FG002|Overall Study|Study Termination by Sponsor|1
7627719|NCT03875313|12040404|FG003|Overall Study|Study Termination by Sponsor|0
7627720|NCT03875313|12040405|FG004|Overall Study|Study Termination by Sponsor|1
7627721|NCT03875313|12040401|FG000|Overall Study|New Anticancer Treatment|0
7627722|NCT03875313|12040402|FG001|Overall Study|New Anticancer Treatment|1
7627723|NCT03875313|12040403|FG002|Overall Study|New Anticancer Treatment|2
7627724|NCT03875313|12040404|FG003|Overall Study|New Anticancer Treatment|1
7627725|NCT03875313|12040405|FG004|Overall Study|New Anticancer Treatment|0
7627726|NCT03875313|12040401|FG000|Overall Study|Other, Not Specified|2
7627727|NCT03875313|12040402|FG001|Overall Study|Other, Not Specified|11
7627728|NCT03875313|12040403|FG002|Overall Study|Other, Not Specified|3
7627729|NCT03875313|12040404|FG003|Overall Study|Other, Not Specified|3
7627730|NCT03875313|12040405|FG004|Overall Study|Other, Not Specified|1
7627731|NCT03694353|12040417|FG000|Overall Study|Withdrawal by Subject|1
7627732|NCT03694353|12040417|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1
7627733|NCT03583554|12040421|FG000|Period 2|Did not receive treatment due to loss of contact|1
7627734|NCT03583554|12040422|FG001|Period 2|Did not receive treatment due to loss of contact|0
7627735|NCT03583554|12040423|FG002|Period 2|Did not receive treatment due to loss of contact|1
7595288|NCT03703102|12001172|FG000|Overall Study|Adverse Event|4
7595289|NCT03703102|12001173|FG001|Overall Study|Adverse Event|3
7595290|NCT03703102|12001174|FG002|Overall Study|Adverse Event|7
7595291|NCT03703102|12001175|FG003|Overall Study|Adverse Event|3
7595292|NCT03703102|12001176|FG004|Overall Study|Adverse Event|13
7595293|NCT03703102|12001172|FG000|Overall Study|Lack of Efficacy|4
7595294|NCT03703102|12001173|FG001|Overall Study|Lack of Efficacy|0
7595295|NCT03703102|12001174|FG002|Overall Study|Lack of Efficacy|1
7595296|NCT03703102|12001175|FG003|Overall Study|Lack of Efficacy|4
7595297|NCT03703102|12001176|FG004|Overall Study|Lack of Efficacy|1
7595298|NCT03703102|12001172|FG000|Overall Study|Lost to Follow-up|0
7595299|NCT03703102|12001173|FG001|Overall Study|Lost to Follow-up|0
7595300|NCT03703102|12001174|FG002|Overall Study|Lost to Follow-up|1
7595301|NCT03703102|12001175|FG003|Overall Study|Lost to Follow-up|2
7595302|NCT03703102|12001176|FG004|Overall Study|Lost to Follow-up|2
7595303|NCT03703102|12001172|FG000|Overall Study|Physician Decision|2
7595304|NCT03703102|12001173|FG001|Overall Study|Physician Decision|2
7595305|NCT03703102|12001174|FG002|Overall Study|Physician Decision|2
7595306|NCT03703102|12001175|FG003|Overall Study|Physician Decision|2
7595307|NCT03703102|12001176|FG004|Overall Study|Physician Decision|4
7595308|NCT03703102|12001172|FG000|Overall Study|Withdrawal by Subject|7
7595309|NCT03703102|12001173|FG001|Overall Study|Withdrawal by Subject|5
7595310|NCT03703102|12001174|FG002|Overall Study|Withdrawal by Subject|5
7595311|NCT03703102|12001175|FG003|Overall Study|Withdrawal by Subject|5
7595312|NCT03703102|12001176|FG004|Overall Study|Withdrawal by Subject|9
7595313|NCT03703102|12001172|FG000|Overall Study|Ineligibility|0
7595314|NCT03703102|12001173|FG001|Overall Study|Ineligibility|0
7595315|NCT03703102|12001174|FG002|Overall Study|Ineligibility|1
7595316|NCT03703102|12001175|FG003|Overall Study|Ineligibility|0
7595317|NCT03703102|12001176|FG004|Overall Study|Ineligibility|0
7595318|NCT03703102|12001172|FG000|Overall Study|Protocol Deviation|4
7595319|NCT03703102|12001173|FG001|Overall Study|Protocol Deviation|4
7595320|NCT03703102|12001174|FG002|Overall Study|Protocol Deviation|3
7595321|NCT03703102|12001175|FG003|Overall Study|Protocol Deviation|0
7595322|NCT03703102|12001176|FG004|Overall Study|Protocol Deviation|0
7595323|NCT03703102|12001172|FG000|Overall Study|Non-Compliance with Study Drug|1
7595324|NCT03703102|12001173|FG001|Overall Study|Non-Compliance with Study Drug|1
7595325|NCT03703102|12001174|FG002|Overall Study|Non-Compliance with Study Drug|2
7595326|NCT03703102|12001175|FG003|Overall Study|Non-Compliance with Study Drug|1
7595327|NCT03703102|12001176|FG004|Overall Study|Non-Compliance with Study Drug|4
7595373|NCT02514447|12001274|FG007|Overall Study|Sponsor Termination of Study|0
7595374|NCT02514447|12001275|FG008|Overall Study|Sponsor Termination of Study|0
7595375|NCT02514447|12001267|FG000|Overall Study|Study completion per Investigator|1
7595376|NCT02514447|12001268|FG001|Overall Study|Study completion per Investigator|0
7595377|NCT02514447|12001269|FG002|Overall Study|Study completion per Investigator|1
7595378|NCT02514447|12001270|FG003|Overall Study|Study completion per Investigator|2
7595379|NCT02514447|12001271|FG004|Overall Study|Study completion per Investigator|0
7595380|NCT02514447|12001272|FG005|Overall Study|Study completion per Investigator|0
7595381|NCT02514447|12001273|FG006|Overall Study|Study completion per Investigator|0
7595382|NCT02514447|12001274|FG007|Overall Study|Study completion per Investigator|0
7595383|NCT02514447|12001275|FG008|Overall Study|Study completion per Investigator|1
7627736|NCT03408873|12040440|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3
7627737|NCT03408873|12040440|FG000|Visit 2 Assessment|Lost to Follow-up|1
7627738|NCT03408873|12040440|FG000|Visit 3 Assessment|Withdrawal by Subject|1
7627739|NCT03408873|12040440|FG000|Visit 4 Assessment|Lost to Follow-up|2
7627740|NCT03408873|12040440|FG000|Visit 5 Assessment|Lost to Follow-up|1
7627741|NCT03408873|12040440|FG000|Visit 6 Assessment|Withdrawal by Subject|1
7771645|NCT00884221|12216017|FG000|Overall Study|Cancellation of Cycle and Other Reason|12
7771646|NCT00884221|12216018|FG001|Overall Study|Cancellation of Cycle and Other Reason|13
7627744|NCT03096288|12040453|FG000|Overall Study|Withdrawal by Subject|0
7627745|NCT03096288|12040454|FG001|Overall Study|Withdrawal by Subject|1
7627746|NCT03096288|12040455|FG002|Overall Study|Withdrawal by Subject|0
7771647|NCT00884273|12216028|FG000|Overall Study|Adverse Event|0
7771648|NCT00884273|12216029|FG001|Overall Study|Adverse Event|2
7771649|NCT00884273|12216028|FG000|Overall Study|Protocol Violation|1
7771650|NCT00884273|12216029|FG001|Overall Study|Protocol Violation|3
7771651|NCT00884273|12216028|FG000|Overall Study|Practical reasons|1
7771652|NCT00884273|12216029|FG001|Overall Study|Practical reasons|0
7771653|NCT00884286|12216037|FG000|Overall Study|Progressive disease|21
7627747|NCT03096288|12040456|FG003|Overall Study|Withdrawal by Subject|1
7627748|NCT02919436|12040468|FG000|Overall Study|Did not undergo surgery|16
7627749|NCT02919436|12040469|FG001|Overall Study|Did not undergo surgery|20
7627750|NCT02919436|12040468|FG000|Overall Study|Enrolled before trial registration|44
7595328|NCT03395704|12001195|FG000|Overall Study|Adverse Event|2
7595329|NCT03395704|12001196|FG001|Overall Study|Adverse Event|1
7595330|NCT03395704|12001195|FG000|Overall Study|Withdrawal by Subject|2
7595331|NCT03395704|12001196|FG001|Overall Study|Withdrawal by Subject|1
7595332|NCT03395704|12001195|FG000|Overall Study|Physician Decision|0
7595333|NCT03395704|12001196|FG001|Overall Study|Physician Decision|1
7595334|NCT03335813|12001202|FG000|Overall Study|Withdrawal by Subject|1
7595335|NCT03246503|12001206|FG000|Overall Study|Lost to Follow-up|23
7595336|NCT03246503|12001206|FG000|Overall Study|Withdrawal by Subject|20
7595337|NCT03246503|12001206|FG000|Overall Study|Physician Decision|5
7595338|NCT03246503|12001206|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5
7595339|NCT02514447|12001267|FG000|Overall Study|Withdrawal by Subject|3
7595340|NCT02514447|12001268|FG001|Overall Study|Withdrawal by Subject|1
7595341|NCT02514447|12001269|FG002|Overall Study|Withdrawal by Subject|1
7595342|NCT02514447|12001270|FG003|Overall Study|Withdrawal by Subject|0
7595343|NCT02514447|12001271|FG004|Overall Study|Withdrawal by Subject|0
7595344|NCT02514447|12001272|FG005|Overall Study|Withdrawal by Subject|0
7595345|NCT02514447|12001273|FG006|Overall Study|Withdrawal by Subject|0
7595346|NCT02514447|12001274|FG007|Overall Study|Withdrawal by Subject|1
7595347|NCT02514447|12001275|FG008|Overall Study|Withdrawal by Subject|1
7595348|NCT02514447|12001267|FG000|Overall Study|Death|24
7595349|NCT02514447|12001268|FG001|Overall Study|Death|28
7595350|NCT02514447|12001269|FG002|Overall Study|Death|29
7595351|NCT02514447|12001270|FG003|Overall Study|Death|0
7595352|NCT02514447|12001271|FG004|Overall Study|Death|3
7595353|NCT02514447|12001272|FG005|Overall Study|Death|4
7595354|NCT02514447|12001273|FG006|Overall Study|Death|8
7595355|NCT02514447|12001274|FG007|Overall Study|Death|6
7595356|NCT02514447|12001275|FG008|Overall Study|Death|5
7595357|NCT02514447|12001267|FG000|Overall Study|Lost to Follow-up|1
7595358|NCT02514447|12001268|FG001|Overall Study|Lost to Follow-up|0
7595359|NCT02514447|12001269|FG002|Overall Study|Lost to Follow-up|0
7595360|NCT02514447|12001270|FG003|Overall Study|Lost to Follow-up|0
7595361|NCT02514447|12001271|FG004|Overall Study|Lost to Follow-up|0
7595362|NCT02514447|12001272|FG005|Overall Study|Lost to Follow-up|0
7595363|NCT02514447|12001273|FG006|Overall Study|Lost to Follow-up|0
7595364|NCT02514447|12001274|FG007|Overall Study|Lost to Follow-up|0
7595365|NCT02514447|12001275|FG008|Overall Study|Lost to Follow-up|1
7595366|NCT02514447|12001267|FG000|Overall Study|Sponsor Termination of Study|0
7595367|NCT02514447|12001268|FG001|Overall Study|Sponsor Termination of Study|1
7595368|NCT02514447|12001269|FG002|Overall Study|Sponsor Termination of Study|1
7595369|NCT02514447|12001270|FG003|Overall Study|Sponsor Termination of Study|0
7595370|NCT02514447|12001271|FG004|Overall Study|Sponsor Termination of Study|0
7595371|NCT02514447|12001272|FG005|Overall Study|Sponsor Termination of Study|0
7595372|NCT02514447|12001273|FG006|Overall Study|Sponsor Termination of Study|0
7595384|NCT01785563|12001319|FG000|Overall Study|Physician Decision|10
7595385|NCT01785563|12001319|FG000|Overall Study|Withdrawal by Subject|1
7595386|NCT01785563|12001319|FG000|Overall Study|Protocol Violation|2
7595387|NCT01434290|12001334|FG000|Overall Study|Protocol Violation|6
7595388|NCT01434290|12001335|FG001|Overall Study|Protocol Violation|3
7595389|NCT01434290|12001334|FG000|Overall Study|No protocol treatment|2
7595390|NCT01434290|12001335|FG001|Overall Study|No protocol treatment|4
7595391|NCT01062399|12001347|FG000|Overall Study|Protocol Violation|0
7595392|NCT01062399|12001348|FG001|Overall Study|Protocol Violation|1
7595393|NCT01062399|12001349|FG002|Overall Study|Protocol Violation|0
7595394|NCT01062399|12001350|FG003|Overall Study|Protocol Violation|6
7595395|NCT01062399|12001351|FG004|Overall Study|Protocol Violation|4
7595396|NCT00750269|12001368|FG000|Overall Study|Protocol Violation|0
7595397|NCT00750269|12001369|FG001|Overall Study|Protocol Violation|1
7595398|NCT00750269|12001370|FG002|Overall Study|Protocol Violation|1
7595399|NCT00750269|12001371|FG003|Overall Study|Protocol Violation|2
7595400|NCT00750269|12001372|FG004|Overall Study|Protocol Violation|4
7595401|NCT00750269|12001368|FG000|Overall Study|Withdrawal by Subject|0
7595402|NCT00750269|12001369|FG001|Overall Study|Withdrawal by Subject|0
7595403|NCT00750269|12001370|FG002|Overall Study|Withdrawal by Subject|2
7595404|NCT00750269|12001371|FG003|Overall Study|Withdrawal by Subject|2
7595405|NCT00750269|12001372|FG004|Overall Study|Withdrawal by Subject|2
7595406|NCT00750269|12001368|FG000|Overall Study|Physician Decision|0
7595407|NCT00750269|12001369|FG001|Overall Study|Physician Decision|0
7595408|NCT00750269|12001370|FG002|Overall Study|Physician Decision|0
7595409|NCT00750269|12001371|FG003|Overall Study|Physician Decision|0
7595410|NCT00750269|12001372|FG004|Overall Study|Physician Decision|2
7595411|NCT00750269|12001368|FG000|Overall Study|Patient too large for positioning|0
7595412|NCT00750269|12001369|FG001|Overall Study|Patient too large for positioning|0
7595413|NCT00750269|12001370|FG002|Overall Study|Patient too large for positioning|1
7595414|NCT00750269|12001371|FG003|Overall Study|Patient too large for positioning|0
7595415|NCT00750269|12001372|FG004|Overall Study|Patient too large for positioning|0
7595416|NCT00750269|12001368|FG000|Overall Study|Site error|0
7595417|NCT00750269|12001369|FG001|Overall Study|Site error|0
7595418|NCT00750269|12001370|FG002|Overall Study|Site error|0
7595419|NCT00750269|12001371|FG003|Overall Study|Site error|1
7595420|NCT00750269|12001372|FG004|Overall Study|Site error|0
7595421|NCT00750269|12001368|FG000|Overall Study|SBRT plan could not be drawn|0
7595422|NCT00750269|12001369|FG001|Overall Study|SBRT plan could not be drawn|0
7595423|NCT00750269|12001370|FG002|Overall Study|SBRT plan could not be drawn|0
7595424|NCT00750269|12001371|FG003|Overall Study|SBRT plan could not be drawn|0
7595425|NCT00750269|12001372|FG004|Overall Study|SBRT plan could not be drawn|1
7595426|NCT00750269|12001368|FG000|Overall Study|Fiducials could not be placed|0
7595427|NCT00750269|12001369|FG001|Overall Study|Fiducials could not be placed|0
7595428|NCT00750269|12001370|FG002|Overall Study|Fiducials could not be placed|0
7595429|NCT00750269|12001371|FG003|Overall Study|Fiducials could not be placed|0
7595430|NCT00750269|12001372|FG004|Overall Study|Fiducials could not be placed|1
7595431|NCT00712322|12001394|FG000|Overall Study|Protocol deviation|0
7595432|NCT00712322|12001395|FG001|Overall Study|Protocol deviation|1
7595433|NCT00712322|12001396|FG002|Overall Study|Protocol deviation|0
7595434|NCT00323856|12001404|FG000|Overall Study|Withdrawal by Subject|1
7595435|NCT00323856|12001404|FG000|Overall Study|Was uncooperative and noncompliant|1
7595436|NCT00323856|12001404|FG000|Overall Study|Reason not specified|1
7595437|NCT00323856|12001404|FG000|Overall Study|Missing|2
7595438|NCT00103038|12001408|FG000|Overall Study|Withdrawal by Subject|8
7595439|NCT00103038|12001408|FG000|Overall Study|Screen failure|3
7595440|NCT00103038|12001408|FG000|Overall Study|Death|1
7595441|NCT00103038|12001408|FG000|Overall Study|Physician Decision|1
7595442|NCT04524663|12001424|FG000|Overall Study|Withdrawal by Subject|0
7595443|NCT04524663|12001425|FG001|Overall Study|Withdrawal by Subject|2
7771654|NCT00884286|12216038|FG001|Overall Study|Progressive disease|28
7771655|NCT00884286|12216037|FG000|Overall Study|Toxicity|4
7771656|NCT00884286|12216038|FG001|Overall Study|Toxicity|1
7771657|NCT00884286|12216037|FG000|Overall Study|Death|2
7771658|NCT00884286|12216038|FG001|Overall Study|Death|2
7771659|NCT00884286|12216037|FG000|Overall Study|Physician Decision|1
7771660|NCT00884286|12216038|FG001|Overall Study|Physician Decision|0
7771661|NCT00884286|12216037|FG000|Overall Study|Septic shock|1
7627751|NCT02919436|12040469|FG001|Overall Study|Enrolled before trial registration|33
7627752|NCT02028884|12040483|FG000|Double-blind Period|Adverse Event|5
7627753|NCT02028884|12040484|FG001|Double-blind Period|Adverse Event|3
7627754|NCT02028884|12040483|FG000|Double-blind Period|Eligibility Violation|1
7627755|NCT02028884|12040484|FG001|Double-blind Period|Eligibility Violation|0
7627756|NCT02028884|12040483|FG000|Double-blind Period|Non-Compliance With Study Drug|2
7627757|NCT02028884|12040484|FG001|Double-blind Period|Non-Compliance With Study Drug|0
7627758|NCT02028884|12040483|FG000|Double-blind Period|Withdrawal by Subject|2
7627759|NCT02028884|12040484|FG001|Double-blind Period|Withdrawal by Subject|0
7627760|NCT02028884|12040483|FG000|Double-blind Period|On-going in Study|8
7627761|NCT02028884|12040484|FG001|Double-blind Period|On-going in Study|20
7627762|NCT02028884|12040483|FG000|Open-label Extension Period|Adverse Event|2
7627763|NCT02028884|12040484|FG001|Open-label Extension Period|Adverse Event|1
7627764|NCT02028884|12040483|FG000|Open-label Extension Period|Lack of Efficacy|3
7771662|NCT00884286|12216038|FG001|Overall Study|Septic shock|0
7771663|NCT00884286|12216037|FG000|Overall Study|Thrombus in right auricle|1
7771664|NCT00884286|12216038|FG001|Overall Study|Thrombus in right auricle|0
7771665|NCT00884286|12216037|FG000|Overall Study|Not treated|2
7771666|NCT00884286|12216038|FG001|Overall Study|Not treated|1
7771667|NCT00884286|12216037|FG000|Overall Study|Comprised lung carcinoma|0
7771668|NCT00884286|12216038|FG001|Overall Study|Comprised lung carcinoma|1
7771669|NCT00884312|12216047|FG000|Overall Study|Non-fatal Progressive Disease|0
7595460|NCT03738423|12001481|FG000|Overall Study|Withdrawal by Subject|9
7595461|NCT03738423|12001482|FG001|Overall Study|Withdrawal by Subject|12
7595462|NCT03738423|12001483|FG002|Overall Study|Withdrawal by Subject|9
7595463|NCT03738423|12001484|FG003|Overall Study|Withdrawal by Subject|12
7595464|NCT03738423|12001485|FG004|Overall Study|Withdrawal by Subject|10
7595465|NCT03738423|12001481|FG000|Overall Study|Lack of Efficacy|3
7595466|NCT03738423|12001482|FG001|Overall Study|Lack of Efficacy|1
7595467|NCT03738423|12001483|FG002|Overall Study|Lack of Efficacy|1
7595468|NCT03738423|12001484|FG003|Overall Study|Lack of Efficacy|1
7595469|NCT03738423|12001485|FG004|Overall Study|Lack of Efficacy|2
7595470|NCT03738423|12001481|FG000|Overall Study|Lost to Follow-up|1
7595471|NCT03738423|12001482|FG001|Overall Study|Lost to Follow-up|0
7595472|NCT03738423|12001483|FG002|Overall Study|Lost to Follow-up|1
7595473|NCT03738423|12001484|FG003|Overall Study|Lost to Follow-up|1
7595474|NCT03738423|12001485|FG004|Overall Study|Lost to Follow-up|0
7595475|NCT03738423|12001481|FG000|Overall Study|Protocol Violation|1
7595476|NCT03738423|12001482|FG001|Overall Study|Protocol Violation|0
7595477|NCT03738423|12001483|FG002|Overall Study|Protocol Violation|0
7595478|NCT03738423|12001484|FG003|Overall Study|Protocol Violation|0
7595479|NCT03738423|12001485|FG004|Overall Study|Protocol Violation|1
7595480|NCT03738423|12001481|FG000|Overall Study|Physician Decision|0
7595481|NCT03738423|12001482|FG001|Overall Study|Physician Decision|0
7595482|NCT03738423|12001483|FG002|Overall Study|Physician Decision|1
7595483|NCT03738423|12001484|FG003|Overall Study|Physician Decision|0
7595484|NCT03738423|12001485|FG004|Overall Study|Physician Decision|1
7595485|NCT03738423|12001481|FG000|Overall Study|Death|0
7595486|NCT03738423|12001482|FG001|Overall Study|Death|0
7595487|NCT03738423|12001483|FG002|Overall Study|Death|0
7595488|NCT03738423|12001484|FG003|Overall Study|Death|0
7595489|NCT03738423|12001485|FG004|Overall Study|Death|1
7595490|NCT03738423|12001481|FG000|Overall Study|Randomized but never treated|0
7595491|NCT03738423|12001482|FG001|Overall Study|Randomized but never treated|0
7595492|NCT03738423|12001483|FG002|Overall Study|Randomized but never treated|1
7595493|NCT03738423|12001484|FG003|Overall Study|Randomized but never treated|1
7595494|NCT03738423|12001485|FG004|Overall Study|Randomized but never treated|0
7595495|NCT03600818|12001499|FG000|Overall Study|Adverse Event|4
7595496|NCT03600818|12001500|FG001|Overall Study|Adverse Event|7
7595497|NCT03600818|12001499|FG000|Overall Study|Lack of Efficacy|9
7595498|NCT03600818|12001500|FG001|Overall Study|Lack of Efficacy|4
7595499|NCT03600818|12001499|FG000|Overall Study|Withdrawal by Subject|4
7595500|NCT03600818|12001500|FG001|Overall Study|Withdrawal by Subject|3
7595501|NCT03600818|12001499|FG000|Overall Study|Other-unspecified|5
7595502|NCT03600818|12001500|FG001|Overall Study|Other-unspecified|3
7595503|NCT03600818|12001499|FG000|Overall Study|Randomized and not treated|0
7595504|NCT03600818|12001500|FG001|Overall Study|Randomized and not treated|1
7595505|NCT03578276|12001509|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2
7595506|NCT03578276|12001510|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2
7595507|NCT03035409|12001525|FG000|Overall Study|Adverse Event|5
7595508|NCT03035409|12001525|FG000|Overall Study|Death|2
7595509|NCT03035409|12001525|FG000|Overall Study|Withdrawal by Subject|2
7595510|NCT03035409|12001525|FG000|Overall Study|Non compliance|4
7595511|NCT03035409|12001525|FG000|Overall Study|Patient was jittery|1
7595512|NCT03035409|12001525|FG000|Overall Study|Did not like Questionnaire|1
7595513|NCT03035409|12001525|FG000|Overall Study|Aspartate Aminotransferase increased|1
7595514|NCT03035409|12001525|FG000|Overall Study|Did not like taking drugs|1
7595515|NCT02971761|12001529|FG000|Overall Study|GTx-024 drug supply was withdrawn|2
7627765|NCT02028884|12040484|FG001|Open-label Extension Period|Lack of Efficacy|0
7627766|NCT02028884|12040483|FG000|Open-label Extension Period|Non-Compliance With Study Drug|0
7627767|NCT02028884|12040484|FG001|Open-label Extension Period|Non-Compliance With Study Drug|1
7627768|NCT02028884|12040483|FG000|Open-label Extension Period|Withdrawal by Subject|0
7627769|NCT02028884|12040484|FG001|Open-label Extension Period|Withdrawal by Subject|2
7627770|NCT02028884|12040483|FG000|Open-label Extension Period|On-going in Study|19
7627771|NCT02028884|12040484|FG001|Open-label Extension Period|On-going in Study|14
7627772|NCT01983774|12040495|FG000|Overall Study|Lung Transplant|0
7627773|NCT01983774|12040496|FG001|Overall Study|Lung Transplant|1
7627774|NCT01983774|12040495|FG000|Overall Study|Lost to Follow-up|1
7627775|NCT01983774|12040496|FG001|Overall Study|Lost to Follow-up|0
7627776|NCT01974206|12040506|FG000|Overall Study|Did Not Take Study Drug|0
7627777|NCT01974206|12040507|FG001|Overall Study|Did Not Take Study Drug|1
7627778|NCT01974206|12040506|FG000|Overall Study|Physician Decision|1
7627779|NCT01974206|12040507|FG001|Overall Study|Physician Decision|0
7627780|NCT01974206|12040506|FG000|Overall Study|Withdrawal by Subject|3
7627781|NCT01974206|12040507|FG001|Overall Study|Withdrawal by Subject|0
7627782|NCT01974206|12040506|FG000|Overall Study|Lost to Follow-up|1
7627783|NCT01974206|12040507|FG001|Overall Study|Lost to Follow-up|0
7627784|NCT01974206|12040506|FG000|Overall Study|Death|1
7627785|NCT01974206|12040507|FG001|Overall Study|Death|0
7627786|NCT01970865|12040530|FG000|Overall Study|Death|3
7627787|NCT01970865|12040531|FG001|Overall Study|Death|1
7627788|NCT01970865|12040532|FG002|Overall Study|Death|3
7627789|NCT01970865|12040533|FG003|Overall Study|Death|4
7627790|NCT01970865|12040534|FG004|Overall Study|Death|6
7627791|NCT01970865|12040535|FG005|Overall Study|Death|3
7627792|NCT01970865|12040536|FG006|Overall Study|Death|1
7627793|NCT01970865|12040537|FG007|Overall Study|Death|3
7627794|NCT01970865|12040538|FG008|Overall Study|Death|2
7627795|NCT01970865|12040539|FG009|Overall Study|Death|1
7627796|NCT01970865|12040540|FG010|Overall Study|Death|1
7627797|NCT01970865|12040541|FG011|Overall Study|Death|4
7627798|NCT01970865|12040542|FG012|Overall Study|Death|14
7627799|NCT01970865|12040543|FG013|Overall Study|Death|19
7627800|NCT01970865|12040544|FG014|Overall Study|Death|15
7627801|NCT01970865|12040545|FG015|Overall Study|Death|10
7627802|NCT01970865|12040546|FG016|Overall Study|Death|1
7627803|NCT01970865|12040530|FG000|Overall Study|Lost to Follow-up|0
7627804|NCT01970865|12040531|FG001|Overall Study|Lost to Follow-up|0
7627805|NCT01970865|12040532|FG002|Overall Study|Lost to Follow-up|0
7627806|NCT01970865|12040533|FG003|Overall Study|Lost to Follow-up|1
7627807|NCT01970865|12040534|FG004|Overall Study|Lost to Follow-up|1
7627808|NCT01970865|12040535|FG005|Overall Study|Lost to Follow-up|0
7627809|NCT01970865|12040536|FG006|Overall Study|Lost to Follow-up|0
7627810|NCT01970865|12040537|FG007|Overall Study|Lost to Follow-up|0
7627811|NCT01970865|12040538|FG008|Overall Study|Lost to Follow-up|0
7627812|NCT01970865|12040539|FG009|Overall Study|Lost to Follow-up|0
7627813|NCT01970865|12040540|FG010|Overall Study|Lost to Follow-up|0
7627814|NCT01970865|12040541|FG011|Overall Study|Lost to Follow-up|0
7627815|NCT01970865|12040542|FG012|Overall Study|Lost to Follow-up|1
7627816|NCT01970865|12040543|FG013|Overall Study|Lost to Follow-up|0
7627817|NCT01970865|12040544|FG014|Overall Study|Lost to Follow-up|0
7627818|NCT01970865|12040545|FG015|Overall Study|Lost to Follow-up|0
7627819|NCT01970865|12040546|FG016|Overall Study|Lost to Follow-up|0
7771670|NCT00884312|12216048|FG001|Overall Study|Non-fatal Progressive Disease|8
7771671|NCT00884312|12216047|FG000|Overall Study|Fatal Progressive Disease|0
7771672|NCT00884312|12216048|FG001|Overall Study|Fatal Progressive Disease|1
7771673|NCT00884312|12216047|FG000|Overall Study|Non-fatal Adverse Event|1
7771674|NCT00884312|12216048|FG001|Overall Study|Non-fatal Adverse Event|0
7771675|NCT00884312|12216047|FG000|Overall Study|Fatal Adverse Event|1
7771676|NCT00884312|12216048|FG001|Overall Study|Fatal Adverse Event|4
7771677|NCT00884312|12216047|FG000|Overall Study|Withdrawal by Subject|0
7771678|NCT00884312|12216048|FG001|Overall Study|Withdrawal by Subject|6
7771679|NCT00884312|12216047|FG000|Overall Study|Physician Decision|0
7771680|NCT00884312|12216048|FG001|Overall Study|Physician Decision|1
7771681|NCT00884312|12216047|FG000|Overall Study|Other|0
7595528|NCT01968213|12001570|FG000|Overall Study|Ongoing|90
7595529|NCT01968213|12001571|FG001|Overall Study|Ongoing|9
7771682|NCT00884312|12216048|FG001|Overall Study|Other|4
7771683|NCT00884312|12216047|FG000|Overall Study|Did Not Receive Study Drug|0
7771684|NCT00884312|12216048|FG001|Overall Study|Did Not Receive Study Drug|1
7771685|NCT00884325|12216056|FG000|Overall Study|Lost to Follow-up|1
7771686|NCT00884325|12216057|FG001|Overall Study|Lost to Follow-up|2
7771687|NCT00884325|12216056|FG000|Overall Study|Lack of Efficacy|0
7595536|NCT01627574|12001595|FG000|Overall Study|Withdrawal by Subject|8
7595537|NCT01627574|12001596|FG001|Overall Study|Withdrawal by Subject|5
7595538|NCT01627574|12001595|FG000|Overall Study|Lost to Follow-up|13
7595539|NCT01627574|12001596|FG001|Overall Study|Lost to Follow-up|13
7595540|NCT01498458|12001602|FG000|Overall Study|Adverse Event|4
7595541|NCT01498458|12001602|FG000|Overall Study|Physician Decision|3
7595542|NCT01427712|12001611|FG000|Overall Study|Transfer to a different hospital|2
7595543|NCT01427712|12001611|FG000|Overall Study|Lost to Follow-up|1
7595544|NCT01427712|12001611|FG000|Overall Study|Aggravation of cystic fibrosis|3
7595545|NCT01427712|12001611|FG000|Overall Study|Failure to visit|1
7595546|NCT01369147|12001618|FG000|Overall Study|All collected data were unintentionally destroyed|0
7595547|NCT01369147|12001619|FG001|Overall Study|All collected data were unintentionally destroyed|1
7595548|NCT01369147|12001620|FG002|Overall Study|All collected data were unintentionally destroyed|0
7595549|NCT01097746|12001628|FG000|Overall Study|Adverse Event|4
7595550|NCT01097746|12001628|FG000|Overall Study|taken off study before any treatment given|1
7595551|NCT01079780|12001635|FG000|Overall Study|Disease progression|43
7595552|NCT01079780|12001636|FG001|Overall Study|Disease progression|7
7595553|NCT01079780|12001637|FG002|Overall Study|Disease progression|31
7595554|NCT01079780|12001635|FG000|Overall Study|Adverse Event|13
7595555|NCT01079780|12001636|FG001|Overall Study|Adverse Event|5
7595556|NCT01079780|12001637|FG002|Overall Study|Adverse Event|7
7595557|NCT01079780|12001635|FG000|Overall Study|Death|2
7595558|NCT01079780|12001636|FG001|Overall Study|Death|0
7595559|NCT01079780|12001637|FG002|Overall Study|Death|2
7595560|NCT01079780|12001635|FG000|Overall Study|Withdrawal by Subject|6
7595561|NCT01079780|12001636|FG001|Overall Study|Withdrawal by Subject|4
7595562|NCT01079780|12001637|FG002|Overall Study|Withdrawal by Subject|4
7595563|NCT01079780|12001635|FG000|Overall Study|Alternative therapy|2
7595564|NCT01079780|12001636|FG001|Overall Study|Alternative therapy|0
7595565|NCT01079780|12001637|FG002|Overall Study|Alternative therapy|2
7595566|NCT01079780|12001635|FG000|Overall Study|Physician Decision|1
7595567|NCT01079780|12001636|FG001|Overall Study|Physician Decision|0
7595568|NCT01079780|12001637|FG002|Overall Study|Physician Decision|1
7595569|NCT01079780|12001635|FG000|Overall Study|Error made in lesion measurement|1
7595570|NCT01079780|12001636|FG001|Overall Study|Error made in lesion measurement|0
7595571|NCT01079780|12001637|FG002|Overall Study|Error made in lesion measurement|0
7595572|NCT01079780|12001635|FG000|Overall Study|Patient had surgery|1
7595573|NCT01079780|12001636|FG001|Overall Study|Patient had surgery|0
7595574|NCT01079780|12001637|FG002|Overall Study|Patient had surgery|0
7595575|NCT01079780|12001635|FG000|Overall Study|Treatment cycle delay|0
7595576|NCT01079780|12001636|FG001|Overall Study|Treatment cycle delay|0
7595577|NCT01079780|12001637|FG002|Overall Study|Treatment cycle delay|1
7595578|NCT01079780|12001635|FG000|Overall Study|Never started treatment|1
7595579|NCT01079780|12001636|FG001|Overall Study|Never started treatment|0
7595580|NCT01079780|12001637|FG002|Overall Study|Never started treatment|2
7595581|NCT00075946|12001649|FG000|Overall Study|Path ineligible: undetermined histology|0
7595582|NCT00075946|12001650|FG001|Overall Study|Path ineligible: undetermined histology|0
7595583|NCT00075946|12001651|FG002|Overall Study|Path ineligible: undetermined histology|0
7595584|NCT00075946|12001652|FG003|Overall Study|Path ineligible: undetermined histology|0
7595585|NCT00075946|12001653|FG004|Overall Study|Path ineligible: undetermined histology|6
7595586|NCT00075946|12001649|FG000|Overall Study|Did not achieve response after induction|0
7595587|NCT00075946|12001650|FG001|Overall Study|Did not achieve response after induction|0
7595588|NCT00075946|12001651|FG002|Overall Study|Did not achieve response after induction|0
7595589|NCT00075946|12001652|FG003|Overall Study|Did not achieve response after induction|0
7595590|NCT00075946|12001653|FG004|Overall Study|Did not achieve response after induction|182
7595591|NCT00075946|12001649|FG000|Overall Study|Incorrectly randomized (no response)|5
7595592|NCT00075946|12001650|FG001|Overall Study|Incorrectly randomized (no response)|5
7595593|NCT00075946|12001651|FG002|Overall Study|Incorrectly randomized (no response)|5
7595594|NCT00075946|12001652|FG003|Overall Study|Incorrectly randomized (no response)|1
7595595|NCT00075946|12001653|FG004|Overall Study|Incorrectly randomized (no response)|0
7595596|NCT00075946|12001649|FG000|Overall Study|Still on treatment at time of analysis|52
7595597|NCT00075946|12001650|FG001|Overall Study|Still on treatment at time of analysis|19
7595598|NCT00075946|12001651|FG002|Overall Study|Still on treatment at time of analysis|3
7595599|NCT00075946|12001652|FG003|Overall Study|Still on treatment at time of analysis|9
7595600|NCT00075946|12001653|FG004|Overall Study|Still on treatment at time of analysis|0
7595601|NCT00075946|12001649|FG000|Overall Study|Adverse Event|2
7595602|NCT00075946|12001650|FG001|Overall Study|Adverse Event|10
7595603|NCT00075946|12001651|FG002|Overall Study|Adverse Event|0
7595604|NCT00075946|12001652|FG003|Overall Study|Adverse Event|2
7595605|NCT00075946|12001653|FG004|Overall Study|Adverse Event|0
7595606|NCT00075946|12001649|FG000|Overall Study|Death|0
7595607|NCT00075946|12001650|FG001|Overall Study|Death|1
7595608|NCT00075946|12001651|FG002|Overall Study|Death|0
7595609|NCT00075946|12001652|FG003|Overall Study|Death|0
7595610|NCT00075946|12001653|FG004|Overall Study|Death|0
7595611|NCT00075946|12001649|FG000|Overall Study|Withdrawal by Subject|23
7595612|NCT00075946|12001650|FG001|Overall Study|Withdrawal by Subject|58
7595613|NCT00075946|12001651|FG002|Overall Study|Withdrawal by Subject|4
7595614|NCT00075946|12001652|FG003|Overall Study|Withdrawal by Subject|9
7595615|NCT00075946|12001653|FG004|Overall Study|Withdrawal by Subject|0
7595616|NCT00075946|12001649|FG000|Overall Study|Alternative therapy|16
7595617|NCT00075946|12001650|FG001|Overall Study|Alternative therapy|2
7595618|NCT00075946|12001651|FG002|Overall Study|Alternative therapy|5
7595619|NCT00075946|12001652|FG003|Overall Study|Alternative therapy|0
7595620|NCT00075946|12001653|FG004|Overall Study|Alternative therapy|0
7595621|NCT00075946|12001649|FG000|Overall Study|Other complicating disease|7
7595622|NCT00075946|12001650|FG001|Overall Study|Other complicating disease|13
7595623|NCT00075946|12001651|FG002|Overall Study|Other complicating disease|1
7595624|NCT00075946|12001652|FG003|Overall Study|Other complicating disease|4
7595625|NCT00075946|12001653|FG004|Overall Study|Other complicating disease|0
7595626|NCT00075946|12001649|FG000|Overall Study|No response to retreatment|23
7595627|NCT00075946|12001650|FG001|Overall Study|No response to retreatment|0
7595628|NCT00075946|12001651|FG002|Overall Study|No response to retreatment|2
7595629|NCT00075946|12001652|FG003|Overall Study|No response to retreatment|0
7595630|NCT00075946|12001653|FG004|Overall Study|No response to retreatment|0
7595631|NCT00075946|12001649|FG000|Overall Study|Time to progression less than 6 months|15
7595632|NCT00075946|12001650|FG001|Overall Study|Time to progression less than 6 months|30
7595633|NCT00075946|12001651|FG002|Overall Study|Time to progression less than 6 months|8
7595634|NCT00075946|12001652|FG003|Overall Study|Time to progression less than 6 months|3
7595635|NCT00075946|12001653|FG004|Overall Study|Time to progression less than 6 months|0
7595636|NCT00075946|12001649|FG000|Overall Study|Other|5
7595637|NCT00075946|12001650|FG001|Overall Study|Other|13
7771688|NCT00884325|12216057|FG001|Overall Study|Lack of Efficacy|1
7595638|NCT00075946|12001651|FG002|Overall Study|Other|0
7595639|NCT00075946|12001652|FG003|Overall Study|Other|2
7595640|NCT00075946|12001653|FG004|Overall Study|Other|0
7595641|NCT00003641|12001666|FG000|Overall Study|Withdrawal by Subject|0
7595642|NCT00003641|12001667|FG001|Overall Study|Withdrawal by Subject|100
7595643|NCT00003641|12001666|FG000|Overall Study|Adverse Event|0
7595644|NCT00003641|12001667|FG001|Overall Study|Adverse Event|38
7595645|NCT00003641|12001666|FG000|Overall Study|Disease progression|0
7595646|NCT00003641|12001667|FG001|Overall Study|Disease progression|2
7595647|NCT00003641|12001666|FG000|Overall Study|Unknown/missing|0
7595648|NCT00003641|12001667|FG001|Overall Study|Unknown/missing|22
7595649|NCT00003641|12001666|FG000|Overall Study|Should not receive interferon therapy|2
7595650|NCT00003641|12001667|FG001|Overall Study|Should not receive interferon therapy|0
7595651|NCT00003641|12001666|FG000|Overall Study|Never started interferon|567
7595652|NCT00003641|12001667|FG001|Overall Study|Never started interferon|12
7627820|NCT01970865|12040530|FG000|Overall Study|Withdrawal by Subject|0
7627821|NCT01970865|12040531|FG001|Overall Study|Withdrawal by Subject|0
7627822|NCT01970865|12040532|FG002|Overall Study|Withdrawal by Subject|0
7627823|NCT01970865|12040533|FG003|Overall Study|Withdrawal by Subject|1
7627824|NCT01970865|12040534|FG004|Overall Study|Withdrawal by Subject|2
7627825|NCT01970865|12040535|FG005|Overall Study|Withdrawal by Subject|0
7627826|NCT01970865|12040536|FG006|Overall Study|Withdrawal by Subject|0
7627827|NCT01970865|12040537|FG007|Overall Study|Withdrawal by Subject|0
7627828|NCT01970865|12040538|FG008|Overall Study|Withdrawal by Subject|0
7627829|NCT01970865|12040539|FG009|Overall Study|Withdrawal by Subject|0
7627830|NCT01970865|12040540|FG010|Overall Study|Withdrawal by Subject|0
7627831|NCT01970865|12040541|FG011|Overall Study|Withdrawal by Subject|1
7627832|NCT01970865|12040542|FG012|Overall Study|Withdrawal by Subject|2
7627833|NCT01970865|12040543|FG013|Overall Study|Withdrawal by Subject|5
7627834|NCT01970865|12040544|FG014|Overall Study|Withdrawal by Subject|2
7627835|NCT01970865|12040545|FG015|Overall Study|Withdrawal by Subject|7
7627836|NCT01970865|12040546|FG016|Overall Study|Withdrawal by Subject|0
7627837|NCT01970865|12040530|FG000|Overall Study|Other|0
7627838|NCT01970865|12040531|FG001|Overall Study|Other|0
7627839|NCT01970865|12040532|FG002|Overall Study|Other|0
7627840|NCT01970865|12040533|FG003|Overall Study|Other|1
7627841|NCT01970865|12040534|FG004|Overall Study|Other|0
7627842|NCT01970865|12040535|FG005|Overall Study|Other|0
7627843|NCT01970865|12040536|FG006|Overall Study|Other|0
7627844|NCT01970865|12040537|FG007|Overall Study|Other|0
7627845|NCT01970865|12040538|FG008|Overall Study|Other|0
7627846|NCT01970865|12040539|FG009|Overall Study|Other|0
7627847|NCT01970865|12040540|FG010|Overall Study|Other|0
7627848|NCT01970865|12040541|FG011|Overall Study|Other|0
7627849|NCT01970865|12040542|FG012|Overall Study|Other|0
7627850|NCT01970865|12040543|FG013|Overall Study|Other|1
7627851|NCT01970865|12040544|FG014|Overall Study|Other|0
7627852|NCT01970865|12040545|FG015|Overall Study|Other|1
7627853|NCT01970865|12040546|FG016|Overall Study|Other|0
7627854|NCT01970865|12040530|FG000|Overall Study|Study ongoing|0
7627855|NCT01970865|12040531|FG001|Overall Study|Study ongoing|2
7627856|NCT01970865|12040532|FG002|Overall Study|Study ongoing|0
7627857|NCT01970865|12040533|FG003|Overall Study|Study ongoing|6
7627858|NCT01970865|12040534|FG004|Overall Study|Study ongoing|8
7627859|NCT01970865|12040535|FG005|Overall Study|Study ongoing|0
7627860|NCT01970865|12040536|FG006|Overall Study|Study ongoing|2
7627861|NCT01970865|12040537|FG007|Overall Study|Study ongoing|0
7627862|NCT01970865|12040538|FG008|Overall Study|Study ongoing|1
7627863|NCT01970865|12040539|FG009|Overall Study|Study ongoing|3
7627864|NCT01970865|12040540|FG010|Overall Study|Study ongoing|29
7627865|NCT01970865|12040541|FG011|Overall Study|Study ongoing|22
7627866|NCT01970865|12040542|FG012|Overall Study|Study ongoing|43
7627867|NCT01970865|12040543|FG013|Overall Study|Study ongoing|41
7627868|NCT01970865|12040544|FG014|Overall Study|Study ongoing|29
7627869|NCT01970865|12040545|FG015|Overall Study|Study ongoing|29
7627870|NCT01970865|12040546|FG016|Overall Study|Study ongoing|2
7627871|NCT00589420|12040607|FG000|Overall Study|screen failure|1
7595653|NCT01956669|12001680|FG000|Overall Study|Disease Progression|12
7595654|NCT01956669|12001681|FG001|Overall Study|Disease Progression|7
7595655|NCT01956669|12001682|FG002|Overall Study|Disease Progression|7
7771689|NCT00884325|12216056|FG000|Overall Study|Withdrawal by Subject|1
7771690|NCT00884325|12216057|FG001|Overall Study|Withdrawal by Subject|1
7771691|NCT00884325|12216056|FG000|Overall Study|Not provided|1
7771692|NCT00884325|12216057|FG001|Overall Study|Not provided|0
7771693|NCT00884377|12216065|FG000|Overall Study|Withdrawal by Subject|1
7595656|NCT01956669|12001683|FG003|Overall Study|Disease Progression|8
7595657|NCT01956669|12001684|FG004|Overall Study|Disease Progression|4
7595658|NCT01956669|12001685|FG005|Overall Study|Disease Progression|3
7595659|NCT01956669|12001686|FG006|Overall Study|Disease Progression|5
7595660|NCT01956669|12001680|FG000|Overall Study|Adverse Event|0
7595661|NCT01956669|12001681|FG001|Overall Study|Adverse Event|2
7595662|NCT01956669|12001682|FG002|Overall Study|Adverse Event|2
7595663|NCT01956669|12001683|FG003|Overall Study|Adverse Event|1
7595664|NCT01956669|12001684|FG004|Overall Study|Adverse Event|0
7595665|NCT01956669|12001685|FG005|Overall Study|Adverse Event|0
7595666|NCT01956669|12001686|FG006|Overall Study|Adverse Event|0
7595667|NCT01956669|12001680|FG000|Overall Study|Physician Decision|0
7595668|NCT01956669|12001681|FG001|Overall Study|Physician Decision|2
7595669|NCT01956669|12001682|FG002|Overall Study|Physician Decision|0
7595670|NCT01956669|12001683|FG003|Overall Study|Physician Decision|0
7595671|NCT01956669|12001684|FG004|Overall Study|Physician Decision|0
7595672|NCT01956669|12001685|FG005|Overall Study|Physician Decision|1
7595673|NCT01956669|12001686|FG006|Overall Study|Physician Decision|0
7595674|NCT01956669|12001680|FG000|Overall Study|Withdrawal by Subject|0
7595675|NCT01956669|12001681|FG001|Overall Study|Withdrawal by Subject|0
7595676|NCT01956669|12001682|FG002|Overall Study|Withdrawal by Subject|1
7595677|NCT01956669|12001683|FG003|Overall Study|Withdrawal by Subject|1
7595678|NCT01956669|12001684|FG004|Overall Study|Withdrawal by Subject|0
7595679|NCT01956669|12001685|FG005|Overall Study|Withdrawal by Subject|0
7595680|NCT01956669|12001686|FG006|Overall Study|Withdrawal by Subject|1
7595681|NCT01967823|12001711|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1
7595682|NCT01989676|12001721|FG000|Overall Study|Death|52
7595683|NCT01989676|12001722|FG001|Overall Study|Death|60
7595684|NCT01989676|12001721|FG000|Overall Study|Protocol Violation|2
7595685|NCT01989676|12001722|FG001|Overall Study|Protocol Violation|1
7595686|NCT01989676|12001721|FG000|Overall Study|Lost to Follow-up|8
7595687|NCT01989676|12001722|FG001|Overall Study|Lost to Follow-up|18
7595688|NCT01989676|12001721|FG000|Overall Study|No longer willing to participate in study|26
7595689|NCT01989676|12001722|FG001|Overall Study|No longer willing to participate in study|26
7595690|NCT01989676|12001721|FG000|Overall Study|Participants terminated from study by Sponsor|26
7595691|NCT01989676|12001722|FG001|Overall Study|Participants terminated from study by Sponsor|30
7595692|NCT01989676|12001721|FG000|Overall Study|Other|4
7595693|NCT01989676|12001722|FG001|Overall Study|Other|3
7595694|NCT01992653|12001737|FG000|Overall Study|Death|0
7595695|NCT01992653|12001738|FG001|Overall Study|Death|0
7595696|NCT01992653|12001739|FG002|Overall Study|Death|1
7595697|NCT01992653|12001740|FG003|Overall Study|Death|0
7595698|NCT01992653|12001741|FG004|Overall Study|Death|1
7595699|NCT01992653|12001742|FG005|Overall Study|Death|0
7595700|NCT01992653|12001743|FG006|Overall Study|Death|4
7595701|NCT01992653|12001744|FG007|Overall Study|Death|2
7595702|NCT01992653|12001737|FG000|Overall Study|Lost to Follow-up|0
7595703|NCT01992653|12001738|FG001|Overall Study|Lost to Follow-up|0
7595704|NCT01992653|12001739|FG002|Overall Study|Lost to Follow-up|0
7595705|NCT01992653|12001740|FG003|Overall Study|Lost to Follow-up|0
7595706|NCT01992653|12001741|FG004|Overall Study|Lost to Follow-up|0
7595707|NCT01992653|12001742|FG005|Overall Study|Lost to Follow-up|0
7595708|NCT01992653|12001743|FG006|Overall Study|Lost to Follow-up|0
7595709|NCT01992653|12001744|FG007|Overall Study|Lost to Follow-up|1
7595710|NCT01992653|12001737|FG000|Overall Study|Study Completed|0
7595711|NCT01992653|12001738|FG001|Overall Study|Study Completed|0
7595712|NCT01992653|12001739|FG002|Overall Study|Study Completed|0
7595713|NCT01992653|12001740|FG003|Overall Study|Study Completed|0
7595714|NCT01992653|12001741|FG004|Overall Study|Study Completed|0
7595715|NCT01992653|12001742|FG005|Overall Study|Study Completed|0
7595716|NCT01992653|12001743|FG006|Overall Study|Study Completed|0
7595717|NCT01992653|12001744|FG007|Overall Study|Study Completed|1
7595718|NCT01992653|12001737|FG000|Overall Study|Disease Progression|0
7595719|NCT01992653|12001738|FG001|Overall Study|Disease Progression|0
7595720|NCT01992653|12001739|FG002|Overall Study|Disease Progression|0
7595721|NCT01992653|12001740|FG003|Overall Study|Disease Progression|0
7595722|NCT01992653|12001741|FG004|Overall Study|Disease Progression|0
7595723|NCT01992653|12001742|FG005|Overall Study|Disease Progression|0
7595724|NCT01992653|12001743|FG006|Overall Study|Disease Progression|4
7595725|NCT01992653|12001744|FG007|Overall Study|Disease Progression|0
7627872|NCT04993339|12040617|FG000|Overall Study|Lost to Follow-up|0
7627873|NCT04993339|12040618|FG001|Overall Study|Lost to Follow-up|1
7627874|NCT04993339|12040617|FG000|Overall Study|no MRI scan|3
7627875|NCT04993339|12040618|FG001|Overall Study|no MRI scan|1
7627876|NCT04919161|12040660|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1
7627877|NCT04919161|12040661|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0
7627878|NCT04919161|12040660|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0
7627879|NCT04919161|12040661|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1
7627880|NCT04919161|12040660|FG000|Overall Study|Acute ankle sprain after session 1|0
7627881|NCT04919161|12040661|FG001|Overall Study|Acute ankle sprain after session 1|1
7627882|NCT04883541|12040752|FG000|Overall Study|Not attending regular yoga class|16
7627883|NCT04883541|12040753|FG001|Overall Study|Not attending regular yoga class|0
7627884|NCT04883541|12040752|FG000|Overall Study|Not attending the pregnancy school|0
7627885|NCT04883541|12040753|FG001|Overall Study|Not attending the pregnancy school|9
7627886|NCT04357782|12040769|FG000|Overall Study|Discharged from hospital|1
7627887|NCT04357782|12040770|FG001|Overall Study|Discharged from hospital|0
7627888|NCT04357782|12040769|FG000|Overall Study|Death|0
7627889|NCT04357782|12040770|FG001|Overall Study|Death|2
7627890|NCT03760068|12040797|FG000|Overall Study|Withdrawal by Subject|7
7627891|NCT03760068|12040798|FG001|Overall Study|Withdrawal by Subject|8
7627892|NCT03760068|12040797|FG000|Overall Study|Adverse Event|1
7627893|NCT03760068|12040798|FG001|Overall Study|Adverse Event|2
7627894|NCT03760068|12040797|FG000|Overall Study|Administrative Decision by Sponsor|0
7627895|NCT03760068|12040798|FG001|Overall Study|Administrative Decision by Sponsor|2
7627896|NCT03760068|12040797|FG000|Overall Study|Physician Decision|1
7627897|NCT03760068|12040798|FG001|Overall Study|Physician Decision|2
7627898|NCT03760068|12040797|FG000|Overall Study|Lost to Follow-up|4
7627899|NCT03760068|12040798|FG001|Overall Study|Lost to Follow-up|9
7627900|NCT03760068|12040797|FG000|Overall Study|Subject Moved Out of State|1
7627901|NCT03760068|12040798|FG001|Overall Study|Subject Moved Out of State|0
7627902|NCT03628781|12040816|FG000|Overall Study|Lost to Follow-up|16
7627903|NCT03628781|12040817|FG001|Overall Study|Lost to Follow-up|8
7627904|NCT03628781|12040816|FG000|Overall Study|Withdrawal by Subject|16
7627905|NCT03628781|12040817|FG001|Overall Study|Withdrawal by Subject|1
7627906|NCT03560206|12040825|FG000|Overall Study|Lost to Follow-up|19
7627907|NCT03560206|12040826|FG001|Overall Study|Lost to Follow-up|11
7627908|NCT03560206|12040825|FG000|Overall Study|Withdrawal by Subject|2
7627909|NCT03560206|12040826|FG001|Overall Study|Withdrawal by Subject|4
7627910|NCT03560206|12040825|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5
7627911|NCT03560206|12040826|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0
7627912|NCT03560206|12040825|FG000|Overall Study|Busy schedule|14
7627913|NCT03560206|12040826|FG001|Overall Study|Busy schedule|2
7627914|NCT03560206|12040825|FG000|Overall Study|patients' new health condition such as cancer|10
7627915|NCT03560206|12040826|FG001|Overall Study|patients' new health condition such as cancer|1
7627916|NCT03340766|12040835|FG000|Overall Study|Death|6
7627917|NCT03340766|12040836|FG001|Overall Study|Death|6
7627918|NCT03340766|12040837|FG002|Overall Study|Death|2
7627919|NCT03340766|12040835|FG000|Overall Study|Withdrawal by Subject|2
7627920|NCT03340766|12040836|FG001|Overall Study|Withdrawal by Subject|1
7627921|NCT03340766|12040837|FG002|Overall Study|Withdrawal by Subject|2
7627922|NCT03340766|12040835|FG000|Overall Study|Continuing Study|3
7627923|NCT03340766|12040836|FG001|Overall Study|Continuing Study|3
7627924|NCT03340766|12040837|FG002|Overall Study|Continuing Study|5
7627925|NCT02706847|12040858|FG000|Day 1 to Week 12|Adverse Event|2
7627926|NCT02706847|12040859|FG001|Day 1 to Week 12|Adverse Event|2
7627927|NCT02706847|12040860|FG002|Day 1 to Week 12|Adverse Event|1
7627928|NCT02706847|12040861|FG003|Day 1 to Week 12|Adverse Event|12
7627929|NCT02706847|12040858|FG000|Day 1 to Week 12|Withdrawal by Subject|2
7627930|NCT02706847|12040859|FG001|Day 1 to Week 12|Withdrawal by Subject|1
7627931|NCT02706847|12040860|FG002|Day 1 to Week 12|Withdrawal by Subject|4
7627932|NCT02706847|12040861|FG003|Day 1 to Week 12|Withdrawal by Subject|2
7627933|NCT02706847|12040858|FG000|Day 1 to Week 12|Lost to Follow-up|2
7627934|NCT02706847|12040859|FG001|Day 1 to Week 12|Lost to Follow-up|1
7627935|NCT02706847|12040860|FG002|Day 1 to Week 12|Lost to Follow-up|0
7627936|NCT02706847|12040861|FG003|Day 1 to Week 12|Lost to Follow-up|0
7627937|NCT02706847|12040858|FG000|Day 1 to Week 12|Other|4
7627938|NCT02706847|12040859|FG001|Day 1 to Week 12|Other|4
7627939|NCT02706847|12040860|FG002|Day 1 to Week 12|Other|2
7627940|NCT02706847|12040861|FG003|Day 1 to Week 12|Other|2
7627941|NCT02706847|12040858|FG000|Day 1 to Week 12|Randomized in Error|0
7627942|NCT02706847|12040859|FG001|Day 1 to Week 12|Randomized in Error|0
7627943|NCT02706847|12040860|FG002|Day 1 to Week 12|Randomized in Error|1
7595726|NCT02001974|12001765|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2
7595727|NCT02001974|12001766|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3
7595728|NCT02001974|12001767|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14
7595729|NCT02001974|12001765|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1
7595730|NCT02001974|12001766|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0
7595731|NCT02001974|12001767|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4
7595732|NCT02001974|12001765|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1
7595733|NCT02001974|12001766|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0
7595734|NCT02001974|12001767|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6
7595735|NCT02001974|12001765|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0
7595736|NCT02001974|12001766|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0
7595737|NCT02001974|12001767|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2
7595738|NCT02014558|12001788|FG000|Overall Study|Never Received Study Drug|0
7595739|NCT02014558|12001789|FG001|Overall Study|Never Received Study Drug|0
7595740|NCT02014558|12001790|FG002|Overall Study|Never Received Study Drug|0
7595741|NCT02014558|12001791|FG003|Overall Study|Never Received Study Drug|0
7595742|NCT02014558|12001792|FG004|Overall Study|Never Received Study Drug|1
7595743|NCT02014558|12001793|FG005|Overall Study|Never Received Study Drug|0
7595744|NCT02014558|12001794|FG006|Overall Study|Never Received Study Drug|1
7595745|NCT02014558|12001795|FG007|Overall Study|Never Received Study Drug|0
7595746|NCT02014558|12001796|FG008|Overall Study|Never Received Study Drug|2
7595747|NCT02014558|12001797|FG009|Overall Study|Never Received Study Drug|0
7595748|NCT02014558|12001798|FG010|Overall Study|Never Received Study Drug|2
7595749|NCT02014558|12001799|FG011|Overall Study|Never Received Study Drug|2
7595750|NCT02014558|12001800|FG012|Overall Study|Never Received Study Drug|0
7595751|NCT02014558|12001788|FG000|Overall Study|Adverse Event|0
7595752|NCT02014558|12001789|FG001|Overall Study|Adverse Event|0
7595753|NCT02014558|12001790|FG002|Overall Study|Adverse Event|0
7595754|NCT02014558|12001791|FG003|Overall Study|Adverse Event|0
7595755|NCT02014558|12001792|FG004|Overall Study|Adverse Event|1
7595756|NCT02014558|12001793|FG005|Overall Study|Adverse Event|0
7595757|NCT02014558|12001794|FG006|Overall Study|Adverse Event|0
7595758|NCT02014558|12001795|FG007|Overall Study|Adverse Event|0
7595759|NCT02014558|12001796|FG008|Overall Study|Adverse Event|2
7595760|NCT02014558|12001797|FG009|Overall Study|Adverse Event|2
7595761|NCT02014558|12001798|FG010|Overall Study|Adverse Event|5
7595762|NCT02014558|12001799|FG011|Overall Study|Adverse Event|21
7595763|NCT02014558|12001800|FG012|Overall Study|Adverse Event|3
7595764|NCT02014558|12001788|FG000|Overall Study|Death|1
7595765|NCT02014558|12001789|FG001|Overall Study|Death|0
7595766|NCT02014558|12001790|FG002|Overall Study|Death|0
7595767|NCT02014558|12001791|FG003|Overall Study|Death|0
7595768|NCT02014558|12001792|FG004|Overall Study|Death|0
7595769|NCT02014558|12001793|FG005|Overall Study|Death|0
7595770|NCT02014558|12001794|FG006|Overall Study|Death|1
7595771|NCT02014558|12001795|FG007|Overall Study|Death|1
7595772|NCT02014558|12001796|FG008|Overall Study|Death|2
7595773|NCT02014558|12001797|FG009|Overall Study|Death|5
7595774|NCT02014558|12001798|FG010|Overall Study|Death|5
7595775|NCT02014558|12001799|FG011|Overall Study|Death|19
7595776|NCT02014558|12001800|FG012|Overall Study|Death|2
7595777|NCT02014558|12001788|FG000|Overall Study|Lack of Efficacy|1
7595778|NCT02014558|12001789|FG001|Overall Study|Lack of Efficacy|2
7595779|NCT02014558|12001790|FG002|Overall Study|Lack of Efficacy|1
7595780|NCT02014558|12001791|FG003|Overall Study|Lack of Efficacy|1
7595781|NCT02014558|12001792|FG004|Overall Study|Lack of Efficacy|0
7595782|NCT02014558|12001793|FG005|Overall Study|Lack of Efficacy|0
7595783|NCT02014558|12001794|FG006|Overall Study|Lack of Efficacy|1
7595784|NCT02014558|12001795|FG007|Overall Study|Lack of Efficacy|3
7595785|NCT02014558|12001796|FG008|Overall Study|Lack of Efficacy|3
7595786|NCT02014558|12001797|FG009|Overall Study|Lack of Efficacy|3
7595787|NCT02014558|12001798|FG010|Overall Study|Lack of Efficacy|16
7595788|NCT02014558|12001799|FG011|Overall Study|Lack of Efficacy|8
7595789|NCT02014558|12001800|FG012|Overall Study|Lack of Efficacy|5
7595790|NCT02014558|12001788|FG000|Overall Study|Lost to Follow-up|0
7595791|NCT02014558|12001789|FG001|Overall Study|Lost to Follow-up|0
7595792|NCT02014558|12001790|FG002|Overall Study|Lost to Follow-up|0
7595793|NCT02014558|12001791|FG003|Overall Study|Lost to Follow-up|0
7595794|NCT02014558|12001792|FG004|Overall Study|Lost to Follow-up|0
7595795|NCT02014558|12001793|FG005|Overall Study|Lost to Follow-up|0
7595796|NCT02014558|12001794|FG006|Overall Study|Lost to Follow-up|0
7595797|NCT02014558|12001795|FG007|Overall Study|Lost to Follow-up|0
7595798|NCT02014558|12001796|FG008|Overall Study|Lost to Follow-up|0
7595799|NCT02014558|12001797|FG009|Overall Study|Lost to Follow-up|0
7595800|NCT02014558|12001798|FG010|Overall Study|Lost to Follow-up|1
7595801|NCT02014558|12001799|FG011|Overall Study|Lost to Follow-up|0
7595802|NCT02014558|12001800|FG012|Overall Study|Lost to Follow-up|0
7595803|NCT02014558|12001788|FG000|Overall Study|Progressive Disease|1
7595804|NCT02014558|12001789|FG001|Overall Study|Progressive Disease|0
7595805|NCT02014558|12001790|FG002|Overall Study|Progressive Disease|1
7595806|NCT02014558|12001791|FG003|Overall Study|Progressive Disease|1
7595807|NCT02014558|12001792|FG004|Overall Study|Progressive Disease|1
7595808|NCT02014558|12001793|FG005|Overall Study|Progressive Disease|2
7595809|NCT02014558|12001794|FG006|Overall Study|Progressive Disease|1
7595810|NCT02014558|12001795|FG007|Overall Study|Progressive Disease|6
7595811|NCT02014558|12001796|FG008|Overall Study|Progressive Disease|5
7595812|NCT02014558|12001797|FG009|Overall Study|Progressive Disease|6
7595813|NCT02014558|12001798|FG010|Overall Study|Progressive Disease|22
7595814|NCT02014558|12001799|FG011|Overall Study|Progressive Disease|31
7595815|NCT02014558|12001800|FG012|Overall Study|Progressive Disease|6
7595816|NCT02014558|12001788|FG000|Overall Study|Withdrawal by Subject|0
7595817|NCT02014558|12001789|FG001|Overall Study|Withdrawal by Subject|0
7595818|NCT02014558|12001790|FG002|Overall Study|Withdrawal by Subject|0
7595819|NCT02014558|12001791|FG003|Overall Study|Withdrawal by Subject|0
7595820|NCT02014558|12001792|FG004|Overall Study|Withdrawal by Subject|1
7595821|NCT02014558|12001793|FG005|Overall Study|Withdrawal by Subject|0
7595822|NCT02014558|12001794|FG006|Overall Study|Withdrawal by Subject|0
7595823|NCT02014558|12001795|FG007|Overall Study|Withdrawal by Subject|0
7595824|NCT02014558|12001796|FG008|Overall Study|Withdrawal by Subject|0
7595825|NCT02014558|12001797|FG009|Overall Study|Withdrawal by Subject|2
7595826|NCT02014558|12001798|FG010|Overall Study|Withdrawal by Subject|6
7595827|NCT02014558|12001799|FG011|Overall Study|Withdrawal by Subject|10
7595828|NCT02014558|12001800|FG012|Overall Study|Withdrawal by Subject|0
7595829|NCT02014558|12001788|FG000|Overall Study|Miscellaneous|2
7595830|NCT02014558|12001789|FG001|Overall Study|Miscellaneous|1
7595831|NCT02014558|12001790|FG002|Overall Study|Miscellaneous|1
7595832|NCT02014558|12001791|FG003|Overall Study|Miscellaneous|1
7595833|NCT02014558|12001792|FG004|Overall Study|Miscellaneous|0
7595834|NCT02014558|12001793|FG005|Overall Study|Miscellaneous|1
7595835|NCT02014558|12001794|FG006|Overall Study|Miscellaneous|0
7595836|NCT02014558|12001795|FG007|Overall Study|Miscellaneous|1
7595837|NCT02014558|12001796|FG008|Overall Study|Miscellaneous|1
7595838|NCT02014558|12001797|FG009|Overall Study|Miscellaneous|3
7595839|NCT02014558|12001798|FG010|Overall Study|Miscellaneous|12
7595840|NCT02014558|12001799|FG011|Overall Study|Miscellaneous|11
7595841|NCT02014558|12001800|FG012|Overall Study|Miscellaneous|1
7627944|NCT02706847|12040861|FG003|Day 1 to Week 12|Randomized in Error|0
7627945|NCT02706847|12040858|FG000|Week 12 to Week 24|Adverse Event|1
7627946|NCT02706847|12040859|FG001|Week 12 to Week 24|Adverse Event|2
7627947|NCT02706847|12040860|FG002|Week 12 to Week 24|Adverse Event|2
7627948|NCT02706847|12040861|FG003|Week 12 to Week 24|Adverse Event|5
7627949|NCT02706847|12040858|FG000|Week 12 to Week 24|Withdrawal by Subject|1
7627950|NCT02706847|12040859|FG001|Week 12 to Week 24|Withdrawal by Subject|0
7627951|NCT02706847|12040860|FG002|Week 12 to Week 24|Withdrawal by Subject|1
7627952|NCT02706847|12040861|FG003|Week 12 to Week 24|Withdrawal by Subject|4
7627953|NCT02706847|12040858|FG000|Week 12 to Week 24|Lost to Follow-up|0
7627954|NCT02706847|12040859|FG001|Week 12 to Week 24|Lost to Follow-up|0
7627955|NCT02706847|12040860|FG002|Week 12 to Week 24|Lost to Follow-up|0
7627956|NCT02706847|12040861|FG003|Week 12 to Week 24|Lost to Follow-up|1
7627957|NCT02706847|12040858|FG000|Week 12 to Week 24|Other|1
7627958|NCT02706847|12040859|FG001|Week 12 to Week 24|Other|0
7627959|NCT02706847|12040860|FG002|Week 12 to Week 24|Other|1
7627960|NCT02706847|12040861|FG003|Week 12 to Week 24|Other|4
7627961|NCT02564900|12040886|FG000|Dose Escalation|Progressive disease per RECIST|2
7627962|NCT02564900|12040887|FG001|Dose Escalation|Progressive disease per RECIST|3
7627963|NCT02564900|12040888|FG002|Dose Escalation|Progressive disease per RECIST|3
7627964|NCT02564900|12040889|FG003|Dose Escalation|Progressive disease per RECIST|3
7627965|NCT02564900|12040890|FG004|Dose Escalation|Progressive disease per RECIST|3
7627966|NCT02564900|12040891|FG005|Dose Escalation|Progressive disease per RECIST|1
7627967|NCT02564900|12040892|FG006|Dose Escalation|Progressive disease per RECIST|0
7627968|NCT02564900|12040893|FG007|Dose Escalation|Progressive disease per RECIST|0
7627969|NCT02564900|12040894|FG008|Dose Escalation|Progressive disease per RECIST|0
7627970|NCT02564900|12040895|FG009|Dose Escalation|Progressive disease per RECIST|0
7627971|NCT02564900|12040896|FG010|Dose Escalation|Progressive disease per RECIST|0
7627972|NCT02564900|12040897|FG011|Dose Escalation|Progressive disease per RECIST|0
7627973|NCT02564900|12040898|FG012|Dose Escalation|Progressive disease per RECIST|0
7627974|NCT02564900|12040899|FG013|Dose Escalation|Progressive disease per RECIST|0
7627975|NCT02564900|12040900|FG014|Dose Escalation|Progressive disease per RECIST|0
7627976|NCT02564900|12040886|FG000|Dose Escalation|Ongoing|1
7627977|NCT02564900|12040887|FG001|Dose Escalation|Ongoing|0
7627978|NCT02564900|12040888|FG002|Dose Escalation|Ongoing|0
7627979|NCT02564900|12040889|FG003|Dose Escalation|Ongoing|2
7627980|NCT02564900|12040890|FG004|Dose Escalation|Ongoing|2
7627981|NCT02564900|12040891|FG005|Dose Escalation|Ongoing|2
7627982|NCT02564900|12040892|FG006|Dose Escalation|Ongoing|0
7627983|NCT02564900|12040893|FG007|Dose Escalation|Ongoing|0
7627984|NCT02564900|12040894|FG008|Dose Escalation|Ongoing|0
7595842|NCT02024555|12001855|FG000|Overall Study|Lost to Follow-up|1
7595843|NCT02024555|12001856|FG001|Overall Study|Lost to Follow-up|1
7595844|NCT02024555|12001855|FG000|Overall Study|Withdrawal by Subject|5
7595845|NCT02024555|12001856|FG001|Overall Study|Withdrawal by Subject|1
7595846|NCT02034123|12001880|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595847|NCT02034123|12001881|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595848|NCT02034123|12001882|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595849|NCT02034123|12001883|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595850|NCT02034123|12001884|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
7595851|NCT02034123|12001885|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595852|NCT02034123|12001886|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595853|NCT02034123|12001887|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
7595854|NCT02034123|12001888|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
7595855|NCT02034123|12001889|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595856|NCT02034123|12001890|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595857|NCT02034123|12001891|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595858|NCT02034123|12001892|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595859|NCT02034123|12001893|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595860|NCT02034123|12001894|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595861|NCT02034123|12001895|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595862|NCT02034123|12001896|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595863|NCT02034123|12001897|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595864|NCT02034123|12001880|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595865|NCT02034123|12001881|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595866|NCT02034123|12001882|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595867|NCT02034123|12001883|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1
7595868|NCT02034123|12001884|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595869|NCT02034123|12001885|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595870|NCT02034123|12001886|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595871|NCT02034123|12001887|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595872|NCT02034123|12001888|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595873|NCT02034123|12001889|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595874|NCT02034123|12001890|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595875|NCT02034123|12001891|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595876|NCT02034123|12001892|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595877|NCT02034123|12001893|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595878|NCT02034123|12001894|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595879|NCT02034123|12001895|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595880|NCT02034123|12001896|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595881|NCT02034123|12001897|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595882|NCT02034123|12001880|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595883|NCT02034123|12001881|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595884|NCT02034123|12001882|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595885|NCT02034123|12001883|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595886|NCT02034123|12001884|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595887|NCT02034123|12001885|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595888|NCT02034123|12001886|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595889|NCT02034123|12001887|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595890|NCT02034123|12001888|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1
7595891|NCT02034123|12001889|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595892|NCT02034123|12001890|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595893|NCT02034123|12001891|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595894|NCT02034123|12001892|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595895|NCT02034123|12001893|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595896|NCT02034123|12001894|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595897|NCT02034123|12001895|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595898|NCT02034123|12001896|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595899|NCT02034123|12001897|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595900|NCT02034123|12001880|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595901|NCT02034123|12001881|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595902|NCT02034123|12001882|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595903|NCT02034123|12001883|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
7595904|NCT02034123|12001884|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
7595905|NCT02034123|12001885|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595906|NCT02034123|12001886|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595907|NCT02034123|12001887|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595908|NCT02034123|12001888|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595909|NCT02034123|12001889|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595910|NCT02034123|12001890|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595911|NCT02034123|12001891|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595912|NCT02034123|12001892|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595913|NCT02034123|12001893|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595914|NCT02034123|12001894|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595915|NCT02034123|12001895|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595916|NCT02034123|12001896|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595917|NCT02034123|12001897|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7627985|NCT02564900|12040895|FG009|Dose Escalation|Ongoing|0
7627986|NCT02564900|12040896|FG010|Dose Escalation|Ongoing|0
7627987|NCT02564900|12040897|FG011|Dose Escalation|Ongoing|0
7627988|NCT02564900|12040898|FG012|Dose Escalation|Ongoing|0
7627989|NCT02564900|12040899|FG013|Dose Escalation|Ongoing|0
7627990|NCT02564900|12040900|FG014|Dose Escalation|Ongoing|0
7627991|NCT02564900|12040886|FG000|Dose Escalation|Adverse Event|0
7627992|NCT02564900|12040887|FG001|Dose Escalation|Adverse Event|0
7627993|NCT02564900|12040888|FG002|Dose Escalation|Adverse Event|0
7627994|NCT02564900|12040889|FG003|Dose Escalation|Adverse Event|1
7627995|NCT02564900|12040890|FG004|Dose Escalation|Adverse Event|1
7627996|NCT02564900|12040891|FG005|Dose Escalation|Adverse Event|3
7627997|NCT02564900|12040892|FG006|Dose Escalation|Adverse Event|0
7627998|NCT02564900|12040893|FG007|Dose Escalation|Adverse Event|0
7627999|NCT02564900|12040894|FG008|Dose Escalation|Adverse Event|0
7628000|NCT02564900|12040895|FG009|Dose Escalation|Adverse Event|0
7628001|NCT02564900|12040896|FG010|Dose Escalation|Adverse Event|0
7628002|NCT02564900|12040897|FG011|Dose Escalation|Adverse Event|0
7628003|NCT02564900|12040898|FG012|Dose Escalation|Adverse Event|0
7628004|NCT02564900|12040899|FG013|Dose Escalation|Adverse Event|0
7628005|NCT02564900|12040900|FG014|Dose Escalation|Adverse Event|0
7628006|NCT02564900|12040886|FG000|Dose Expansion|Progressive disease per RECIST|0
7628007|NCT02564900|12040887|FG001|Dose Expansion|Progressive disease per RECIST|0
7628008|NCT02564900|12040888|FG002|Dose Expansion|Progressive disease per RECIST|0
7628009|NCT02564900|12040889|FG003|Dose Expansion|Progressive disease per RECIST|0
7628010|NCT02564900|12040890|FG004|Dose Expansion|Progressive disease per RECIST|0
7628011|NCT02564900|12040891|FG005|Dose Expansion|Progressive disease per RECIST|0
7628012|NCT02564900|12040892|FG006|Dose Expansion|Progressive disease per RECIST|19
7628013|NCT02564900|12040893|FG007|Dose Expansion|Progressive disease per RECIST|17
7628014|NCT02564900|12040894|FG008|Dose Expansion|Progressive disease per RECIST|8
7628015|NCT02564900|12040895|FG009|Dose Expansion|Progressive disease per RECIST|16
7628016|NCT02564900|12040896|FG010|Dose Expansion|Progressive disease per RECIST|13
7628017|NCT02564900|12040897|FG011|Dose Expansion|Progressive disease per RECIST|19
7628018|NCT02564900|12040898|FG012|Dose Expansion|Progressive disease per RECIST|10
7628019|NCT02564900|12040899|FG013|Dose Expansion|Progressive disease per RECIST|13
7628020|NCT02564900|12040900|FG014|Dose Expansion|Progressive disease per RECIST|11
7628021|NCT02564900|12040886|FG000|Dose Expansion|Clinical progression|0
7628022|NCT02564900|12040887|FG001|Dose Expansion|Clinical progression|0
7628023|NCT02564900|12040888|FG002|Dose Expansion|Clinical progression|0
7628024|NCT02564900|12040889|FG003|Dose Expansion|Clinical progression|0
7628025|NCT02564900|12040890|FG004|Dose Expansion|Clinical progression|0
7628026|NCT02564900|12040891|FG005|Dose Expansion|Clinical progression|0
7628027|NCT02564900|12040892|FG006|Dose Expansion|Clinical progression|5
7628028|NCT02564900|12040893|FG007|Dose Expansion|Clinical progression|12
7628029|NCT02564900|12040894|FG008|Dose Expansion|Clinical progression|0
7628030|NCT02564900|12040895|FG009|Dose Expansion|Clinical progression|3
7628031|NCT02564900|12040896|FG010|Dose Expansion|Clinical progression|2
7628032|NCT02564900|12040897|FG011|Dose Expansion|Clinical progression|0
7628033|NCT02564900|12040898|FG012|Dose Expansion|Clinical progression|1
7628034|NCT02564900|12040899|FG013|Dose Expansion|Clinical progression|3
7628035|NCT02564900|12040900|FG014|Dose Expansion|Clinical progression|1
7628036|NCT02564900|12040886|FG000|Dose Expansion|Adverse Event|0
7628037|NCT02564900|12040887|FG001|Dose Expansion|Adverse Event|0
7628038|NCT02564900|12040888|FG002|Dose Expansion|Adverse Event|0
7628039|NCT02564900|12040889|FG003|Dose Expansion|Adverse Event|0
7628040|NCT02564900|12040890|FG004|Dose Expansion|Adverse Event|0
7628041|NCT02564900|12040891|FG005|Dose Expansion|Adverse Event|0
7628042|NCT02564900|12040892|FG006|Dose Expansion|Adverse Event|9
7628043|NCT02564900|12040893|FG007|Dose Expansion|Adverse Event|22
7628044|NCT02564900|12040894|FG008|Dose Expansion|Adverse Event|0
7628045|NCT02564900|12040895|FG009|Dose Expansion|Adverse Event|11
7628046|NCT02564900|12040896|FG010|Dose Expansion|Adverse Event|0
7628047|NCT02564900|12040897|FG011|Dose Expansion|Adverse Event|5
7628048|NCT02564900|12040898|FG012|Dose Expansion|Adverse Event|2
7628049|NCT02564900|12040899|FG013|Dose Expansion|Adverse Event|2
7628050|NCT02564900|12040900|FG014|Dose Expansion|Adverse Event|1
7628051|NCT02564900|12040886|FG000|Dose Expansion|Ongoing|0
7628052|NCT02564900|12040887|FG001|Dose Expansion|Ongoing|0
7628053|NCT02564900|12040888|FG002|Dose Expansion|Ongoing|0
7628054|NCT02564900|12040889|FG003|Dose Expansion|Ongoing|0
7628055|NCT02564900|12040890|FG004|Dose Expansion|Ongoing|0
7628056|NCT02564900|12040891|FG005|Dose Expansion|Ongoing|0
7628057|NCT02564900|12040892|FG006|Dose Expansion|Ongoing|9
7595918|NCT02040584|12001942|FG000|Overall Study|Adverse Event|13
7595919|NCT02040584|12001943|FG001|Overall Study|Adverse Event|6
7595920|NCT02040584|12001942|FG000|Overall Study|Protocol Violation|9
7595921|NCT02040584|12001943|FG001|Overall Study|Protocol Violation|11
7595922|NCT02040584|12001942|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7595923|NCT02040584|12001943|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7595924|NCT02040584|12001942|FG000|Overall Study|Death|6
7595925|NCT02040584|12001943|FG001|Overall Study|Death|3
7595926|NCT02040584|12001942|FG000|Overall Study|Transplant rejection/retransplant|0
7595927|NCT02040584|12001943|FG001|Overall Study|Transplant rejection/retransplant|1
7595928|NCT02040584|12001942|FG000|Overall Study|Immunosuppressant/prohibited med use|7
7595929|NCT02040584|12001943|FG001|Overall Study|Immunosuppressant/prohibited med use|10
7595930|NCT02045797|12001962|FG000|Overall Study|Adverse Event|3
7595931|NCT02045797|12001963|FG001|Overall Study|Adverse Event|1
7595932|NCT02045797|12001964|FG002|Overall Study|Adverse Event|0
7595933|NCT02045797|12001962|FG000|Overall Study|Lack of Efficacy|1
7595934|NCT02045797|12001963|FG001|Overall Study|Lack of Efficacy|0
7595935|NCT02045797|12001964|FG002|Overall Study|Lack of Efficacy|0
7595936|NCT02045797|12001962|FG000|Overall Study|Lost to Follow-up|2
7595937|NCT02045797|12001963|FG001|Overall Study|Lost to Follow-up|3
7595938|NCT02045797|12001964|FG002|Overall Study|Lost to Follow-up|1
7595939|NCT02045797|12001962|FG000|Overall Study|Physician Decision|0
7595940|NCT02045797|12001963|FG001|Overall Study|Physician Decision|1
7771694|NCT00884377|12216066|FG001|Overall Study|Withdrawal by Subject|0
7771695|NCT00884377|12216065|FG000|Overall Study|Could not confirm diagnosis|1
7771696|NCT00884377|12216066|FG001|Overall Study|Could not confirm diagnosis|0
7771697|NCT00884377|12216065|FG000|Overall Study|Physician Decision|0
7771698|NCT00884377|12216066|FG001|Overall Study|Physician Decision|1
7771699|NCT00884390|12216080|FG000|Overall Study|Adverse Event|0
7771700|NCT00884390|12216081|FG001|Overall Study|Adverse Event|1
7771701|NCT00884390|12216080|FG000|Overall Study|Lost to Follow-up|0
7771702|NCT00884390|12216081|FG001|Overall Study|Lost to Follow-up|1
7771703|NCT00884390|12216080|FG000|Overall Study|Physician Decision|2
7771704|NCT00884390|12216081|FG001|Overall Study|Physician Decision|1
7771705|NCT00884390|12216080|FG000|Overall Study|Protocol Violation|4
7771706|NCT00884390|12216081|FG001|Overall Study|Protocol Violation|1
7771707|NCT00884390|12216080|FG000|Overall Study|Withdrawal by Subject|4
7771708|NCT00884390|12216081|FG001|Overall Study|Withdrawal by Subject|1
7771709|NCT00884390|12216080|FG000|Overall Study|Discontinuation of Study by Sponsor|2
7771710|NCT00884390|12216081|FG001|Overall Study|Discontinuation of Study by Sponsor|2
7771711|NCT00884390|12216080|FG000|Overall Study|Other|11
7771712|NCT00884390|12216081|FG001|Overall Study|Other|1
7771713|NCT00884650|12216116|FG000|Overall Study|Did not return complete pain diaries|7
7771714|NCT00884650|12216117|FG001|Overall Study|Did not return complete pain diaries|7
7771715|NCT00884650|12216116|FG000|Overall Study|Admitted Post-Op|1
7771716|NCT00884650|12216117|FG001|Overall Study|Admitted Post-Op|0
7771717|NCT00884650|12216116|FG000|Overall Study|Femoral Stress Fracture|1
7771718|NCT00884650|12216117|FG001|Overall Study|Femoral Stress Fracture|0
7771719|NCT00884650|12216116|FG000|Overall Study|Pain Pump Complication|0
7771720|NCT00884650|12216117|FG001|Overall Study|Pain Pump Complication|1
7771721|NCT00884741|12216127|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157
7771722|NCT00884741|12216128|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0
7771723|NCT00884741|12216129|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0
7771724|NCT00884741|12216130|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0
7771725|NCT00884741|12216127|FG000|Step 1 Registration: Tissue Screening|Death|3
7771726|NCT00884741|12216128|FG001|Step 1 Registration: Tissue Screening|Death|0
7595941|NCT02045797|12001964|FG002|Overall Study|Physician Decision|0
7595942|NCT02045797|12001962|FG000|Overall Study|Withdrawal by Subject|1
7595943|NCT02045797|12001963|FG001|Overall Study|Withdrawal by Subject|2
7595944|NCT02045797|12001964|FG002|Overall Study|Withdrawal by Subject|0
7628058|NCT02564900|12040893|FG007|Dose Expansion|Ongoing|10
7628059|NCT02564900|12040894|FG008|Dose Expansion|Ongoing|11
7628060|NCT02564900|12040895|FG009|Dose Expansion|Ongoing|3
7628061|NCT02564900|12040896|FG010|Dose Expansion|Ongoing|0
7628062|NCT02564900|12040897|FG011|Dose Expansion|Ongoing|0
7628063|NCT02564900|12040898|FG012|Dose Expansion|Ongoing|4
7628064|NCT02564900|12040899|FG013|Dose Expansion|Ongoing|0
7628065|NCT02564900|12040900|FG014|Dose Expansion|Ongoing|6
7628066|NCT02564900|12040886|FG000|Dose Expansion|Death|0
7628067|NCT02564900|12040887|FG001|Dose Expansion|Death|0
7628068|NCT02564900|12040888|FG002|Dose Expansion|Death|0
7628069|NCT02564900|12040889|FG003|Dose Expansion|Death|0
7628070|NCT02564900|12040890|FG004|Dose Expansion|Death|0
7628071|NCT02564900|12040891|FG005|Dose Expansion|Death|0
7628072|NCT02564900|12040892|FG006|Dose Expansion|Death|1
7771727|NCT00884741|12216129|FG002|Step 1 Registration: Tissue Screening|Death|0
7771728|NCT00884741|12216130|FG003|Step 1 Registration: Tissue Screening|Death|0
7771729|NCT00884741|12216127|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3
7771730|NCT00884741|12216128|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0
7771731|NCT00884741|12216129|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0
7771732|NCT00884741|12216130|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0
7771733|NCT00884741|12216127|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105
7771734|NCT00884741|12216128|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0
7771735|NCT00884741|12216129|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0
7771736|NCT00884741|12216130|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0
7771737|NCT00884741|12216127|FG000|Step 1 Registration: Tissue Screening|Disease progression|12
7771738|NCT00884741|12216128|FG001|Step 1 Registration: Tissue Screening|Disease progression|0
7771739|NCT00884741|12216129|FG002|Step 1 Registration: Tissue Screening|Disease progression|0
7771740|NCT00884741|12216130|FG003|Step 1 Registration: Tissue Screening|Disease progression|0
7771741|NCT00884741|12216127|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32
7771742|NCT00884741|12216128|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0
7771743|NCT00884741|12216129|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0
7771744|NCT00884741|12216130|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0
7771745|NCT00884741|12216127|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0
7771746|NCT00884741|12216128|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15
7771747|NCT00884741|12216129|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0
7771748|NCT00884741|12216130|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0
7771749|NCT00884741|12216127|FG000|Step 2 Registration: Tissue Analysis|Death|0
7771750|NCT00884741|12216128|FG001|Step 2 Registration: Tissue Analysis|Death|1
7771751|NCT00884741|12216129|FG002|Step 2 Registration: Tissue Analysis|Death|0
7771752|NCT00884741|12216130|FG003|Step 2 Registration: Tissue Analysis|Death|0
7771753|NCT00884741|12216127|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0
7771754|NCT00884741|12216128|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2
7771755|NCT00884741|12216129|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0
7771756|NCT00884741|12216130|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0
7771757|NCT00884741|12216127|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0
7771758|NCT00884741|12216128|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7
7771759|NCT00884741|12216129|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0
7771760|NCT00884741|12216130|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0
7771761|NCT00884741|12216127|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0
7799915|NCT01090323|12257098|FG001|Overall Study|Death|2
7628073|NCT02564900|12040893|FG007|Dose Expansion|Death|0
7628074|NCT02564900|12040894|FG008|Dose Expansion|Death|0
7595945|NCT02049710|12001974|FG000|Overall Study|Lost to Follow-up|319
7595946|NCT02049710|12001975|FG001|Overall Study|Lost to Follow-up|324
7595947|NCT02055547|12001981|FG000|Overall Study|Protocol Violation|0
7595948|NCT02055547|12001982|FG001|Overall Study|Protocol Violation|0
7595949|NCT02055547|12001983|FG002|Overall Study|Protocol Violation|1
7595950|NCT02055547|12001984|FG003|Overall Study|Protocol Violation|0
7595951|NCT02055547|12001985|FG004|Overall Study|Protocol Violation|0
7595952|NCT02055547|12001986|FG005|Overall Study|Protocol Violation|0
7595953|NCT02055547|12001987|FG006|Overall Study|Protocol Violation|1
7595954|NCT02055547|12001988|FG007|Overall Study|Protocol Violation|0
7595955|NCT02055547|12001989|FG008|Overall Study|Protocol Violation|0
7595956|NCT02055547|12001990|FG009|Overall Study|Protocol Violation|0
7595957|NCT02055547|12001991|FG010|Overall Study|Protocol Violation|0
7595958|NCT02055547|12001992|FG011|Overall Study|Protocol Violation|0
7595959|NCT02055547|12001993|FG012|Overall Study|Protocol Violation|0
7595960|NCT02055547|12001994|FG013|Overall Study|Protocol Violation|0
7595961|NCT02055547|12001995|FG014|Overall Study|Protocol Violation|0
7595962|NCT02055547|12001996|FG015|Overall Study|Protocol Violation|0
7595963|NCT02055547|12001997|FG016|Overall Study|Protocol Violation|0
7595964|NCT02055547|12001998|FG017|Overall Study|Protocol Violation|0
7595965|NCT02055547|12001999|FG018|Overall Study|Protocol Violation|0
7595966|NCT02055547|12001981|FG000|Overall Study|Physician Decision|0
7595967|NCT02055547|12001982|FG001|Overall Study|Physician Decision|1
7595968|NCT02055547|12001983|FG002|Overall Study|Physician Decision|1
7595969|NCT02055547|12001984|FG003|Overall Study|Physician Decision|0
7595970|NCT02055547|12001985|FG004|Overall Study|Physician Decision|1
7595971|NCT02055547|12001986|FG005|Overall Study|Physician Decision|0
7595972|NCT02055547|12001987|FG006|Overall Study|Physician Decision|0
7595973|NCT02055547|12001988|FG007|Overall Study|Physician Decision|0
7595974|NCT02055547|12001989|FG008|Overall Study|Physician Decision|0
7595975|NCT02055547|12001990|FG009|Overall Study|Physician Decision|1
7595976|NCT02055547|12001991|FG010|Overall Study|Physician Decision|1
7595977|NCT02055547|12001992|FG011|Overall Study|Physician Decision|0
7595978|NCT02055547|12001993|FG012|Overall Study|Physician Decision|0
7595979|NCT02055547|12001994|FG013|Overall Study|Physician Decision|0
7595980|NCT02055547|12001995|FG014|Overall Study|Physician Decision|0
7595981|NCT02055547|12001996|FG015|Overall Study|Physician Decision|0
7595982|NCT02055547|12001997|FG016|Overall Study|Physician Decision|0
7595983|NCT02055547|12001998|FG017|Overall Study|Physician Decision|0
7595984|NCT02055547|12001999|FG018|Overall Study|Physician Decision|0
7595985|NCT02055547|12001981|FG000|Overall Study|Adverse Event|0
7595986|NCT02055547|12001982|FG001|Overall Study|Adverse Event|0
7595987|NCT02055547|12001983|FG002|Overall Study|Adverse Event|0
7595988|NCT02055547|12001984|FG003|Overall Study|Adverse Event|0
7595989|NCT02055547|12001985|FG004|Overall Study|Adverse Event|0
7595990|NCT02055547|12001986|FG005|Overall Study|Adverse Event|0
7595991|NCT02055547|12001987|FG006|Overall Study|Adverse Event|1
7595992|NCT02055547|12001988|FG007|Overall Study|Adverse Event|0
7595993|NCT02055547|12001989|FG008|Overall Study|Adverse Event|1
7595994|NCT02055547|12001990|FG009|Overall Study|Adverse Event|0
7595995|NCT02055547|12001991|FG010|Overall Study|Adverse Event|0
7595996|NCT02055547|12001992|FG011|Overall Study|Adverse Event|0
7595997|NCT02055547|12001993|FG012|Overall Study|Adverse Event|0
7595998|NCT02055547|12001994|FG013|Overall Study|Adverse Event|0
7595999|NCT02055547|12001995|FG014|Overall Study|Adverse Event|0
7596000|NCT02055547|12001996|FG015|Overall Study|Adverse Event|0
7596001|NCT02055547|12001997|FG016|Overall Study|Adverse Event|0
7596002|NCT02055547|12001998|FG017|Overall Study|Adverse Event|0
7596003|NCT02055547|12001999|FG018|Overall Study|Adverse Event|0
7596004|NCT02055547|12001981|FG000|Overall Study|Withdrawal by Subject|0
7596005|NCT02055547|12001982|FG001|Overall Study|Withdrawal by Subject|0
7596006|NCT02055547|12001983|FG002|Overall Study|Withdrawal by Subject|0
7596007|NCT02055547|12001984|FG003|Overall Study|Withdrawal by Subject|0
7596008|NCT02055547|12001985|FG004|Overall Study|Withdrawal by Subject|0
7596009|NCT02055547|12001986|FG005|Overall Study|Withdrawal by Subject|1
7596010|NCT02055547|12001987|FG006|Overall Study|Withdrawal by Subject|0
7596011|NCT02055547|12001988|FG007|Overall Study|Withdrawal by Subject|0
7596012|NCT02055547|12001989|FG008|Overall Study|Withdrawal by Subject|1
7596013|NCT02055547|12001990|FG009|Overall Study|Withdrawal by Subject|0
7596014|NCT02055547|12001991|FG010|Overall Study|Withdrawal by Subject|0
7596015|NCT02055547|12001992|FG011|Overall Study|Withdrawal by Subject|0
7596016|NCT02055547|12001993|FG012|Overall Study|Withdrawal by Subject|0
7596017|NCT02055547|12001994|FG013|Overall Study|Withdrawal by Subject|1
7596018|NCT02055547|12001995|FG014|Overall Study|Withdrawal by Subject|0
7596019|NCT02055547|12001996|FG015|Overall Study|Withdrawal by Subject|1
7596020|NCT02055547|12001997|FG016|Overall Study|Withdrawal by Subject|0
7596021|NCT02055547|12001998|FG017|Overall Study|Withdrawal by Subject|0
7596022|NCT02055547|12001999|FG018|Overall Study|Withdrawal by Subject|0
7596023|NCT02055547|12001981|FG000|Overall Study|Lost to Follow-up|0
7596024|NCT02055547|12001982|FG001|Overall Study|Lost to Follow-up|0
7596025|NCT02055547|12001983|FG002|Overall Study|Lost to Follow-up|1
7596026|NCT02055547|12001984|FG003|Overall Study|Lost to Follow-up|0
7596027|NCT02055547|12001985|FG004|Overall Study|Lost to Follow-up|0
7596028|NCT02055547|12001986|FG005|Overall Study|Lost to Follow-up|0
7596029|NCT02055547|12001987|FG006|Overall Study|Lost to Follow-up|0
7596030|NCT02055547|12001988|FG007|Overall Study|Lost to Follow-up|0
7596031|NCT02055547|12001989|FG008|Overall Study|Lost to Follow-up|0
7596032|NCT02055547|12001990|FG009|Overall Study|Lost to Follow-up|0
7596033|NCT02055547|12001991|FG010|Overall Study|Lost to Follow-up|0
7596034|NCT02055547|12001992|FG011|Overall Study|Lost to Follow-up|0
7596035|NCT02055547|12001993|FG012|Overall Study|Lost to Follow-up|0
7596036|NCT02055547|12001994|FG013|Overall Study|Lost to Follow-up|0
7596037|NCT02055547|12001995|FG014|Overall Study|Lost to Follow-up|0
7596038|NCT02055547|12001996|FG015|Overall Study|Lost to Follow-up|0
7596039|NCT02055547|12001997|FG016|Overall Study|Lost to Follow-up|0
7596040|NCT02055547|12001998|FG017|Overall Study|Lost to Follow-up|0
7596041|NCT02055547|12001999|FG018|Overall Study|Lost to Follow-up|0
7628075|NCT02564900|12040895|FG009|Dose Expansion|Death|0
7628076|NCT02564900|12040896|FG010|Dose Expansion|Death|1
7628077|NCT02564900|12040897|FG011|Dose Expansion|Death|0
7628078|NCT02564900|12040898|FG012|Dose Expansion|Death|1
7628079|NCT02564900|12040899|FG013|Dose Expansion|Death|1
7628080|NCT02564900|12040900|FG014|Dose Expansion|Death|0
7628081|NCT02564900|12040886|FG000|Dose Expansion|Withdrawal by Subject|0
7628082|NCT02564900|12040887|FG001|Dose Expansion|Withdrawal by Subject|0
7628083|NCT02564900|12040888|FG002|Dose Expansion|Withdrawal by Subject|0
7628084|NCT02564900|12040889|FG003|Dose Expansion|Withdrawal by Subject|0
7628085|NCT02564900|12040890|FG004|Dose Expansion|Withdrawal by Subject|0
7628086|NCT02564900|12040891|FG005|Dose Expansion|Withdrawal by Subject|0
7628087|NCT02564900|12040892|FG006|Dose Expansion|Withdrawal by Subject|4
7628088|NCT02564900|12040893|FG007|Dose Expansion|Withdrawal by Subject|0
7628089|NCT02564900|12040894|FG008|Dose Expansion|Withdrawal by Subject|0
7628090|NCT02564900|12040895|FG009|Dose Expansion|Withdrawal by Subject|0
7628091|NCT02564900|12040896|FG010|Dose Expansion|Withdrawal by Subject|1
7628092|NCT02564900|12040897|FG011|Dose Expansion|Withdrawal by Subject|0
7628093|NCT02564900|12040898|FG012|Dose Expansion|Withdrawal by Subject|0
7628094|NCT02564900|12040899|FG013|Dose Expansion|Withdrawal by Subject|1
7628095|NCT02564900|12040900|FG014|Dose Expansion|Withdrawal by Subject|1
7628096|NCT02564900|12040886|FG000|Dose Expansion|Other|0
7628097|NCT02564900|12040887|FG001|Dose Expansion|Other|0
7628098|NCT02564900|12040888|FG002|Dose Expansion|Other|0
7628099|NCT02564900|12040889|FG003|Dose Expansion|Other|0
7628100|NCT02564900|12040890|FG004|Dose Expansion|Other|0
7628101|NCT02564900|12040891|FG005|Dose Expansion|Other|0
7628102|NCT02564900|12040892|FG006|Dose Expansion|Other|1
7628103|NCT02564900|12040893|FG007|Dose Expansion|Other|0
7628104|NCT02564900|12040894|FG008|Dose Expansion|Other|1
7628105|NCT02564900|12040895|FG009|Dose Expansion|Other|0
7628106|NCT02564900|12040896|FG010|Dose Expansion|Other|0
7771762|NCT00884741|12216128|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4
7771763|NCT00884741|12216129|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0
7771764|NCT00884741|12216130|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0
7628107|NCT02564900|12040897|FG011|Dose Expansion|Other|0
7628108|NCT02564900|12040898|FG012|Dose Expansion|Other|0
7628109|NCT02564900|12040899|FG013|Dose Expansion|Other|0
7628110|NCT02564900|12040900|FG014|Dose Expansion|Other|1
7628111|NCT02564900|12040886|FG000|Dose Expansion|Did not receive treatment|0
7628112|NCT02564900|12040887|FG001|Dose Expansion|Did not receive treatment|0
7628113|NCT02564900|12040888|FG002|Dose Expansion|Did not receive treatment|0
7628114|NCT02564900|12040889|FG003|Dose Expansion|Did not receive treatment|0
7596042|NCT02064387|12002045|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0
7596043|NCT02064387|12002046|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0
7596044|NCT02064387|12002047|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0
7596045|NCT02064387|12002048|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0
7596046|NCT02064387|12002049|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0
7596047|NCT02064387|12002050|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0
7596048|NCT02064387|12002051|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0
7596049|NCT02064387|12002052|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1
7596050|NCT02064387|12002053|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0
7596051|NCT02064387|12002054|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1
7596052|NCT02064387|12002055|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0
7596053|NCT02064387|12002056|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0
7596054|NCT02064387|12002045|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596055|NCT02064387|12002046|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596056|NCT02064387|12002047|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596057|NCT02064387|12002048|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596058|NCT02064387|12002049|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596059|NCT02064387|12002050|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596060|NCT02064387|12002051|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596061|NCT02064387|12002052|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1
7771765|NCT00884741|12216127|FG000|Randomization|Protocol Violation|0
7771766|NCT00884741|12216128|FG001|Randomization|Protocol Violation|0
7771767|NCT00884741|12216129|FG002|Randomization|Protocol Violation|8
7771768|NCT00884741|12216130|FG003|Randomization|Protocol Violation|8
7771769|NCT00884793|12216146|FG000|Overall Study|Withdrawal by Subject|1
7771770|NCT00884832|12216156|FG000|Overall Study|Withdrawal by Subject|0
7771771|NCT00884832|12216157|FG001|Overall Study|Withdrawal by Subject|1
7771772|NCT00884949|12216176|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
7771773|NCT00884949|12216176|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
7771774|NCT00885105|12216209|FG000|Overall Study|Withdrawal by Subject|0
7771775|NCT00885105|12216210|FG001|Overall Study|Withdrawal by Subject|8
7771776|NCT00885105|12216209|FG000|Overall Study|Adverse Event|1
7771777|NCT00885105|12216210|FG001|Overall Study|Adverse Event|0
7771778|NCT00885105|12216209|FG000|Overall Study|Protocol Violation|0
7771779|NCT00885105|12216210|FG001|Overall Study|Protocol Violation|2
7771780|NCT00885118|12216221|FG000|Overall Study|Adverse Event|1
7771781|NCT00885118|12216222|FG001|Overall Study|Adverse Event|0
7771782|NCT00885118|12216223|FG002|Overall Study|Adverse Event|0
7771783|NCT00885118|12216224|FG003|Overall Study|Adverse Event|0
7771784|NCT00885118|12216225|FG004|Overall Study|Adverse Event|0
7771785|NCT00885118|12216221|FG000|Overall Study|Withdrawal by Subject|0
7771786|NCT00885118|12216222|FG001|Overall Study|Withdrawal by Subject|0
7771787|NCT00885118|12216223|FG002|Overall Study|Withdrawal by Subject|0
7771788|NCT00885118|12216224|FG003|Overall Study|Withdrawal by Subject|0
7771789|NCT00885118|12216225|FG004|Overall Study|Withdrawal by Subject|1
7771790|NCT00885118|12216221|FG000|Overall Study|Other reason not defined above|0
7771791|NCT00885118|12216222|FG001|Overall Study|Other reason not defined above|0
7771792|NCT00885118|12216223|FG002|Overall Study|Other reason not defined above|1
7596062|NCT02064387|12002053|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596063|NCT02064387|12002054|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596064|NCT02064387|12002055|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596065|NCT02064387|12002056|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596066|NCT02064387|12002045|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596067|NCT02064387|12002046|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596068|NCT02064387|12002047|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596069|NCT02064387|12002048|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596070|NCT02064387|12002049|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596071|NCT02064387|12002050|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596072|NCT02064387|12002051|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596073|NCT02064387|12002052|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596074|NCT02064387|12002053|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1
7596075|NCT02064387|12002054|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596076|NCT02064387|12002055|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596077|NCT02064387|12002056|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596078|NCT02064387|12002045|FG000|Part 2 Max 35 Months Followup Duration|Death|0
7596079|NCT02064387|12002046|FG001|Part 2 Max 35 Months Followup Duration|Death|0
7596080|NCT02064387|12002047|FG002|Part 2 Max 35 Months Followup Duration|Death|0
7596081|NCT02064387|12002048|FG003|Part 2 Max 35 Months Followup Duration|Death|0
7596082|NCT02064387|12002049|FG004|Part 2 Max 35 Months Followup Duration|Death|0
7596083|NCT02064387|12002050|FG005|Part 2 Max 35 Months Followup Duration|Death|0
7596084|NCT02064387|12002051|FG006|Part 2 Max 35 Months Followup Duration|Death|0
7596085|NCT02064387|12002052|FG007|Part 2 Max 35 Months Followup Duration|Death|0
7596086|NCT02064387|12002053|FG008|Part 2 Max 35 Months Followup Duration|Death|0
7596087|NCT02064387|12002054|FG009|Part 2 Max 35 Months Followup Duration|Death|0
7596088|NCT02064387|12002055|FG010|Part 2 Max 35 Months Followup Duration|Death|5
7596089|NCT02064387|12002056|FG011|Part 2 Max 35 Months Followup Duration|Death|3
7596090|NCT02064387|12002045|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596091|NCT02064387|12002046|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596092|NCT02064387|12002047|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596093|NCT02064387|12002048|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596094|NCT02064387|12002049|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596095|NCT02064387|12002050|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596096|NCT02064387|12002051|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596097|NCT02064387|12002052|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596098|NCT02064387|12002053|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596099|NCT02064387|12002054|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596100|NCT02064387|12002055|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1
7596101|NCT02064387|12002056|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7628115|NCT02564900|12040890|FG004|Dose Expansion|Did not receive treatment|0
7628116|NCT02564900|12040891|FG005|Dose Expansion|Did not receive treatment|0
7628117|NCT02564900|12040892|FG006|Dose Expansion|Did not receive treatment|1
7628118|NCT02564900|12040893|FG007|Dose Expansion|Did not receive treatment|1
7628119|NCT02564900|12040894|FG008|Dose Expansion|Did not receive treatment|0
7628120|NCT02564900|12040895|FG009|Dose Expansion|Did not receive treatment|0
7628121|NCT02564900|12040896|FG010|Dose Expansion|Did not receive treatment|0
7628122|NCT02564900|12040897|FG011|Dose Expansion|Did not receive treatment|0
7628123|NCT02564900|12040898|FG012|Dose Expansion|Did not receive treatment|0
7628124|NCT02564900|12040899|FG013|Dose Expansion|Did not receive treatment|0
7628125|NCT02564900|12040900|FG014|Dose Expansion|Did not receive treatment|1
7628126|NCT02561299|12040943|FG000|Overall Study|Death|2
7628127|NCT02561299|12040944|FG001|Overall Study|Death|4
7628128|NCT02561299|12040943|FG000|Overall Study|Lost to Follow-up|1
7628129|NCT02561299|12040944|FG001|Overall Study|Lost to Follow-up|0
7628130|NCT02561299|12040943|FG000|Overall Study|Withdrawal by Subject|2
7628131|NCT02561299|12040944|FG001|Overall Study|Withdrawal by Subject|2
7628132|NCT02548143|12040952|FG000|Overall Study|Adverse Event|1
7628133|NCT02548143|12040953|FG001|Overall Study|Adverse Event|0
7628134|NCT02548143|12040952|FG000|Overall Study|Withdrawal by Subject|0
7628135|NCT02548143|12040953|FG001|Overall Study|Withdrawal by Subject|1
7628136|NCT02448680|12040961|FG000|Overall Study|Physician Decision|1
7628137|NCT02448680|12040962|FG001|Overall Study|Physician Decision|1
7628138|NCT02448680|12040961|FG000|Overall Study|Withdrawal by Subject|0
7628139|NCT02448680|12040962|FG001|Overall Study|Withdrawal by Subject|2
7628140|NCT02178358|12040995|FG000|Overall Study|Withdrawal by Subject|0
7628141|NCT02178358|12040996|FG001|Overall Study|Withdrawal by Subject|2
7628142|NCT02178358|12040997|FG002|Overall Study|Withdrawal by Subject|2
7628143|NCT02178358|12040995|FG000|Overall Study|Lost to Follow-up|1
7628144|NCT02178358|12040996|FG001|Overall Study|Lost to Follow-up|0
7628145|NCT02178358|12040997|FG002|Overall Study|Lost to Follow-up|0
7628146|NCT02073279|12041008|FG000|Double-blind Period|Adverse Event|1
7628147|NCT02073279|12041009|FG001|Double-blind Period|Adverse Event|1
7628148|NCT02073279|12041008|FG000|Double-blind Period|Protocol Deviation|0
7596102|NCT02076178|12002097|FG000|Oral Phase|Adverse Event|0
7596103|NCT02076178|12002098|FG001|Oral Phase|Adverse Event|7
7596104|NCT02076178|12002097|FG000|Oral Phase|Withdrawal by Subject|0
7596105|NCT02076178|12002098|FG001|Oral Phase|Withdrawal by Subject|4
7596106|NCT02076178|12002097|FG000|Oral Phase|Physician Decision|0
7596107|NCT02076178|12002098|FG001|Oral Phase|Physician Decision|1
7596108|NCT02076178|12002097|FG000|Injection Phase|Protocol defined stopping criteria|1
7596109|NCT02076178|12002098|FG001|Injection Phase|Protocol defined stopping criteria|0
7596110|NCT02076178|12002097|FG000|Injection Phase|Withdrawal by Subject|0
7596111|NCT02076178|12002098|FG001|Injection Phase|Withdrawal by Subject|3
7596112|NCT02076178|12002097|FG000|Injection Phase|Physician Decision|0
7596113|NCT02076178|12002098|FG001|Injection Phase|Physician Decision|3
7596114|NCT02076178|12002097|FG000|Injection Phase|Lost to Follow-up|0
7596115|NCT02076178|12002098|FG001|Injection Phase|Lost to Follow-up|1
7596116|NCT02079766|12002108|FG000|Overall Study|Physician Decision|1
7596117|NCT02079766|12002109|FG001|Overall Study|Physician Decision|0
7596118|NCT02079766|12002108|FG000|Overall Study|Withdrawal by Subject|1
7596119|NCT02079766|12002109|FG001|Overall Study|Withdrawal by Subject|0
7596168|NCT02087189|12002142|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2
7596169|NCT02112916|12002167|FG000|Overall Study|Adverse Event|6
7596170|NCT02112916|12002168|FG001|Overall Study|Adverse Event|9
7596171|NCT02112916|12002169|FG002|Overall Study|Adverse Event|3
7596172|NCT02112916|12002170|FG003|Overall Study|Adverse Event|2
7596173|NCT02112916|12002167|FG000|Overall Study|Death|9
7596174|NCT02112916|12002168|FG001|Overall Study|Death|9
7596175|NCT02112916|12002169|FG002|Overall Study|Death|3
7596176|NCT02112916|12002170|FG003|Overall Study|Death|4
7596177|NCT02112916|12002167|FG000|Overall Study|Lost to Follow-up|1
7596178|NCT02112916|12002168|FG001|Overall Study|Lost to Follow-up|0
7596179|NCT02112916|12002169|FG002|Overall Study|Lost to Follow-up|0
7596180|NCT02112916|12002170|FG003|Overall Study|Lost to Follow-up|0
7596181|NCT02112916|12002167|FG000|Overall Study|Physician Decision|94
7596182|NCT02112916|12002168|FG001|Overall Study|Physician Decision|72
7596183|NCT02112916|12002169|FG002|Overall Study|Physician Decision|24
7596184|NCT02112916|12002170|FG003|Overall Study|Physician Decision|15
7596185|NCT02112916|12002167|FG000|Overall Study|Withdrawal by Subject|5
7596186|NCT02112916|12002168|FG001|Overall Study|Withdrawal by Subject|3
7596187|NCT02112916|12002169|FG002|Overall Study|Withdrawal by Subject|1
7596188|NCT02112916|12002170|FG003|Overall Study|Withdrawal by Subject|1
7596189|NCT02112916|12002167|FG000|Overall Study|Ineligible|4
7596190|NCT02112916|12002168|FG001|Overall Study|Ineligible|8
7596191|NCT02112916|12002169|FG002|Overall Study|Ineligible|3
7596192|NCT02112916|12002170|FG003|Overall Study|Ineligible|8
7596193|NCT02112916|12002167|FG000|Overall Study|Inevaluable|6
7596194|NCT02112916|12002168|FG001|Overall Study|Inevaluable|4
7596195|NCT02112916|12002169|FG002|Overall Study|Inevaluable|5
7596196|NCT02112916|12002170|FG003|Overall Study|Inevaluable|5
7596197|NCT02112916|12002167|FG000|Overall Study|Refusal of further protocol therapy|19
7596198|NCT02112916|12002168|FG001|Overall Study|Refusal of further protocol therapy|16
7596199|NCT02112916|12002169|FG002|Overall Study|Refusal of further protocol therapy|1
7596200|NCT02112916|12002170|FG003|Overall Study|Refusal of further protocol therapy|7
7596201|NCT02112916|12002167|FG000|Overall Study|Development of SMN|1
7596202|NCT02112916|12002168|FG001|Overall Study|Development of SMN|0
7596203|NCT02112916|12002169|FG002|Overall Study|Development of SMN|0
7596204|NCT02112916|12002170|FG003|Overall Study|Development of SMN|1
7596205|NCT02112916|12002167|FG000|Overall Study|Relapse/Progression|10
7596206|NCT02112916|12002168|FG001|Overall Study|Relapse/Progression|18
7596207|NCT02112916|12002169|FG002|Overall Study|Relapse/Progression|15
7596208|NCT02112916|12002170|FG003|Overall Study|Relapse/Progression|2
7596209|NCT02112916|12002167|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5
7596210|NCT02112916|12002168|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5
7596211|NCT02112916|12002169|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0
7596212|NCT02112916|12002170|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0
7596213|NCT02112916|12002167|FG000|Overall Study|Still on Therapy|44
7596214|NCT02112916|12002168|FG001|Overall Study|Still on Therapy|47
7596215|NCT02112916|12002169|FG002|Overall Study|Still on Therapy|3
7596216|NCT02112916|12002170|FG003|Overall Study|Still on Therapy|2
7596217|NCT02112916|12002167|FG000|Overall Study|Identified to have Ph+ T-ALL|0
7596218|NCT02112916|12002168|FG001|Overall Study|Identified to have Ph+ T-ALL|1
7596219|NCT02112916|12002169|FG002|Overall Study|Identified to have Ph+ T-ALL|0
7596220|NCT02112916|12002170|FG003|Overall Study|Identified to have Ph+ T-ALL|0
7596221|NCT02112916|12002167|FG000|Overall Study|Identified to have Ph+ T-Lly|0
7596222|NCT02112916|12002168|FG001|Overall Study|Identified to have Ph+ T-Lly|0
7596223|NCT02112916|12002169|FG002|Overall Study|Identified to have Ph+ T-Lly|1
7596224|NCT02112916|12002170|FG003|Overall Study|Identified to have Ph+ T-Lly|0
7596227|NCT02135029|12002201|FG000|Overall Study|Adverse Event|2
7596228|NCT02135029|12002202|FG001|Overall Study|Adverse Event|2
7596229|NCT02135029|12002203|FG002|Overall Study|Adverse Event|2
7596230|NCT02135029|12002201|FG000|Overall Study|Lost to Follow-up|0
7596231|NCT02135029|12002202|FG001|Overall Study|Lost to Follow-up|1
7596232|NCT02135029|12002203|FG002|Overall Study|Lost to Follow-up|0
7596233|NCT02135029|12002201|FG000|Overall Study|Withdrawal by Subject|2
7596120|NCT02081391|12002119|FG000|12-hour Treatment|Withdrawal by Subject|3
7596121|NCT02081391|12002120|FG001|12-hour Treatment|Withdrawal by Subject|2
7596122|NCT02081391|12002121|FG002|12-hour Treatment|Withdrawal by Subject|0
7596123|NCT02081391|12002122|FG003|12-hour Treatment|Withdrawal by Subject|0
7596124|NCT02081391|12002119|FG000|12-hour Treatment|Physician Decision|4
7596125|NCT02081391|12002120|FG001|12-hour Treatment|Physician Decision|1
7596126|NCT02081391|12002121|FG002|12-hour Treatment|Physician Decision|0
7596127|NCT02081391|12002122|FG003|12-hour Treatment|Physician Decision|0
7596128|NCT02081391|12002119|FG000|12-hour Treatment|Lack of Efficacy|3
7596129|NCT02081391|12002120|FG001|12-hour Treatment|Lack of Efficacy|0
7596130|NCT02081391|12002121|FG002|12-hour Treatment|Lack of Efficacy|0
7596131|NCT02081391|12002122|FG003|12-hour Treatment|Lack of Efficacy|0
7596132|NCT02081391|12002119|FG000|12-hour Treatment|Adverse Event|4
7596133|NCT02081391|12002120|FG001|12-hour Treatment|Adverse Event|2
7596134|NCT02081391|12002121|FG002|12-hour Treatment|Adverse Event|0
7596135|NCT02081391|12002122|FG003|12-hour Treatment|Adverse Event|0
7596136|NCT02081391|12002119|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2
7596137|NCT02081391|12002120|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0
7596138|NCT02081391|12002121|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1
7596139|NCT02081391|12002122|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0
7596140|NCT02081391|12002119|FG000|12-hour Treatment|Further reasons|2
7596141|NCT02081391|12002120|FG001|12-hour Treatment|Further reasons|1
7596142|NCT02081391|12002121|FG002|12-hour Treatment|Further reasons|0
7596143|NCT02081391|12002122|FG003|12-hour Treatment|Further reasons|0
7596144|NCT02081391|12002119|FG000|24-hour Treatment and Trial Completion|Physician Decision|10
7596145|NCT02081391|12002120|FG001|24-hour Treatment and Trial Completion|Physician Decision|5
7596146|NCT02081391|12002121|FG002|24-hour Treatment and Trial Completion|Physician Decision|0
7596147|NCT02081391|12002122|FG003|24-hour Treatment and Trial Completion|Physician Decision|0
7596148|NCT02081391|12002119|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1
7596149|NCT02081391|12002120|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3
7596150|NCT02081391|12002121|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0
7596151|NCT02081391|12002122|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0
7596152|NCT02081391|12002119|FG000|24-hour Treatment and Trial Completion|Adverse Event|1
7596153|NCT02081391|12002120|FG001|24-hour Treatment and Trial Completion|Adverse Event|0
7596154|NCT02081391|12002121|FG002|24-hour Treatment and Trial Completion|Adverse Event|0
7596155|NCT02081391|12002122|FG003|24-hour Treatment and Trial Completion|Adverse Event|0
7596156|NCT02081391|12002119|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11
7596157|NCT02081391|12002120|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5
7596158|NCT02081391|12002121|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1
7596159|NCT02081391|12002122|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0
7596160|NCT02081391|12002119|FG000|24-hour Treatment and Trial Completion|Technical Problems|1
7596161|NCT02081391|12002120|FG001|24-hour Treatment and Trial Completion|Technical Problems|1
7596162|NCT02081391|12002121|FG002|24-hour Treatment and Trial Completion|Technical Problems|0
7596163|NCT02081391|12002122|FG003|24-hour Treatment and Trial Completion|Technical Problems|0
7596164|NCT02081391|12002119|FG000|24-hour Treatment and Trial Completion|Further reasons|3
7596165|NCT02081391|12002120|FG001|24-hour Treatment and Trial Completion|Further reasons|4
7596166|NCT02081391|12002121|FG002|24-hour Treatment and Trial Completion|Further reasons|0
7596167|NCT02081391|12002122|FG003|24-hour Treatment and Trial Completion|Further reasons|0
7596225|NCT02114697|12002187|FG000|Overall Study|Study terminated|5
7596226|NCT02114697|12002188|FG001|Overall Study|Study terminated|4
7596234|NCT02135029|12002202|FG001|Overall Study|Withdrawal by Subject|0
7596235|NCT02135029|12002203|FG002|Overall Study|Withdrawal by Subject|1
7596236|NCT02135029|12002201|FG000|Overall Study|Other|0
7596237|NCT02135029|12002202|FG001|Overall Study|Other|1
7596238|NCT02135029|12002203|FG002|Overall Study|Other|0
7596239|NCT02135029|12002201|FG000|Overall Study|Death|0
7596240|NCT02135029|12002202|FG001|Overall Study|Death|1
7596241|NCT02135029|12002203|FG002|Overall Study|Death|0
7628149|NCT02073279|12041009|FG001|Double-blind Period|Protocol Deviation|1
7628150|NCT02073279|12041008|FG000|Double-blind Period|Withdrawal by Subject|2
7628151|NCT02073279|12041009|FG001|Double-blind Period|Withdrawal by Subject|2
7628152|NCT02073279|12041008|FG000|Double-blind Period|Reason Not Specified|1
7628153|NCT02073279|12041009|FG001|Double-blind Period|Reason Not Specified|2
7628154|NCT02073279|12041008|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0
7628155|NCT02073279|12041009|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1
7628156|NCT02073279|12041008|FG000|Double-blind Period|On-going in Study|11
7628157|NCT02073279|12041009|FG001|Double-blind Period|On-going in Study|40
7628158|NCT02073279|12041008|FG000|Open-label Extension Period|Lack of Efficacy|1
7628159|NCT02073279|12041009|FG001|Open-label Extension Period|Lack of Efficacy|0
7628160|NCT02073279|12041008|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0
7628161|NCT02073279|12041009|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1
7628162|NCT02073279|12041008|FG000|Open-label Extension Period|Withdrawal by Subject|1
7628163|NCT02073279|12041009|FG001|Open-label Extension Period|Withdrawal by Subject|1
7628164|NCT02073279|12041008|FG000|Open-label Extension Period|Reason Not Specified|1
7628165|NCT02073279|12041009|FG001|Open-label Extension Period|Reason Not Specified|1
7628166|NCT02073279|12041008|FG000|Open-label Extension Period|On-going in Study|14
7596242|NCT02137239|12002214|FG000|Overall Study|Discontinued Study Treatment|0
7596243|NCT02137239|12002215|FG001|Overall Study|Discontinued Study Treatment|3
7596244|NCT02137239|12002214|FG000|Overall Study|Withdrew Consent|1
7596245|NCT02137239|12002215|FG001|Overall Study|Withdrew Consent|1
7596246|NCT02137239|12002214|FG000|Overall Study|Adverse Event|2
7596247|NCT02137239|12002215|FG001|Overall Study|Adverse Event|2
7628167|NCT02073279|12041009|FG001|Open-label Extension Period|On-going in Study|13
7628168|NCT01544127|12041021|FG000|Overall Study|Lost to Follow-up|4
7628169|NCT01544127|12041022|FG001|Overall Study|Lost to Follow-up|2
7628170|NCT01544127|12041023|FG002|Overall Study|Lost to Follow-up|9
7628171|NCT01544127|12041021|FG000|Overall Study|Withdrawal by Subject|2
7628172|NCT01544127|12041022|FG001|Overall Study|Withdrawal by Subject|2
7628173|NCT01544127|12041023|FG002|Overall Study|Withdrawal by Subject|1
7628174|NCT01544127|12041021|FG000|Overall Study|Discharged out of catchment area|1
7628175|NCT01544127|12041022|FG001|Overall Study|Discharged out of catchment area|1
7628176|NCT01544127|12041023|FG002|Overall Study|Discharged out of catchment area|1
7628177|NCT01544127|12041021|FG000|Overall Study|Death|1
7628178|NCT01544127|12041022|FG001|Overall Study|Death|0
7628179|NCT01544127|12041023|FG002|Overall Study|Death|0
7628180|NCT01544127|12041021|FG000|Overall Study|Jail or Prison|1
7628181|NCT01544127|12041022|FG001|Overall Study|Jail or Prison|1
7628182|NCT01544127|12041023|FG002|Overall Study|Jail or Prison|2
7628183|NCT01544127|12041021|FG000|Overall Study|Became Psychotic|1
7628184|NCT01544127|12041022|FG001|Overall Study|Became Psychotic|0
7628185|NCT01544127|12041023|FG002|Overall Study|Became Psychotic|0
7628186|NCT01544127|12041021|FG000|Overall Study|Researcher withdrew|1
7628187|NCT01544127|12041022|FG001|Overall Study|Researcher withdrew|0
7628188|NCT01544127|12041023|FG002|Overall Study|Researcher withdrew|0
7628189|NCT01544127|12041021|FG000|Overall Study|Went active duty|0
7628190|NCT01544127|12041022|FG001|Overall Study|Went active duty|0
7628191|NCT01544127|12041023|FG002|Overall Study|Went active duty|1
7628192|NCT00442559|12041050|FG000|Overall Study|Lost to Follow-up|32
7628193|NCT00442559|12041051|FG001|Overall Study|Lost to Follow-up|34
7628194|NCT00442559|12041050|FG000|Overall Study|Protocol Violation|1
7628195|NCT00442559|12041051|FG001|Overall Study|Protocol Violation|1
7628196|NCT00442559|12041050|FG000|Overall Study|Withdrawal by Subject|1
7628197|NCT00442559|12041051|FG001|Overall Study|Withdrawal by Subject|0
7628198|NCT00117338|12041065|FG000|Overall Study|Adverse Event|0
7628199|NCT00117338|12041066|FG001|Overall Study|Adverse Event|1
7628200|NCT00117338|12041065|FG000|Overall Study|Protocol Violation|3
7628201|NCT00117338|12041066|FG001|Overall Study|Protocol Violation|2
7628202|NCT00117338|12041065|FG000|Overall Study|Withdrawal by Subject|1
7628203|NCT00117338|12041066|FG001|Overall Study|Withdrawal by Subject|0
7628204|NCT00117338|12041065|FG000|Overall Study|Did not meet Inclusion Criteria|1
7628205|NCT00117338|12041066|FG001|Overall Study|Did not meet Inclusion Criteria|0
7628206|NCT00117338|12041065|FG000|Overall Study|Lack of Efficacy|0
7628207|NCT00117338|12041066|FG001|Overall Study|Lack of Efficacy|1
7596248|NCT02148133|12002221|FG000|Overall Study|Investigator discretion|1
7596249|NCT02148133|12002221|FG000|Overall Study|Lack of Efficacy|1
7596250|NCT02148133|12002221|FG000|Overall Study|Protocol deviation|1
7596251|NCT02148133|12002221|FG000|Overall Study|Protocol-defined stopping criteria|2
7596252|NCT02165215|12002241|FG000|Induction Phase|Adverse Event|1
7596253|NCT02165215|12002242|FG001|Induction Phase|Adverse Event|0
7596254|NCT02165215|12002243|FG002|Induction Phase|Adverse Event|0
7596255|NCT02165215|12002241|FG000|Induction Phase|Withdrawal by Subject|10
7596256|NCT02165215|12002242|FG001|Induction Phase|Withdrawal by Subject|0
7596257|NCT02165215|12002243|FG002|Induction Phase|Withdrawal by Subject|0
7596258|NCT02165215|12002241|FG000|Induction Phase|Protocol Violation|1
7596259|NCT02165215|12002242|FG001|Induction Phase|Protocol Violation|0
7596260|NCT02165215|12002243|FG002|Induction Phase|Protocol Violation|0
7596261|NCT02165215|12002241|FG000|Induction Phase|Physician Decision|1
7596262|NCT02165215|12002242|FG001|Induction Phase|Physician Decision|0
7596263|NCT02165215|12002243|FG002|Induction Phase|Physician Decision|0
7596264|NCT02165215|12002241|FG000|Induction Phase|Lack of Efficacy|2
7596265|NCT02165215|12002242|FG001|Induction Phase|Lack of Efficacy|0
7596266|NCT02165215|12002243|FG002|Induction Phase|Lack of Efficacy|0
7596267|NCT02165215|12002241|FG000|Induction Phase|Non-Compliance|2
7596268|NCT02165215|12002242|FG001|Induction Phase|Non-Compliance|0
7596269|NCT02165215|12002243|FG002|Induction Phase|Non-Compliance|0
7596270|NCT02165215|12002241|FG000|Induction Phase|Lost to Follow-up|6
7596271|NCT02165215|12002242|FG001|Induction Phase|Lost to Follow-up|0
7596272|NCT02165215|12002243|FG002|Induction Phase|Lost to Follow-up|0
7596273|NCT02165215|12002241|FG000|Maintenance Phase|Withdrawal by Subject|0
7596274|NCT02165215|12002242|FG001|Maintenance Phase|Withdrawal by Subject|7
7596275|NCT02165215|12002243|FG002|Maintenance Phase|Withdrawal by Subject|3
7596276|NCT02165215|12002241|FG000|Maintenance Phase|Multiple reasons|0
7596277|NCT02165215|12002242|FG001|Maintenance Phase|Multiple reasons|2
7596278|NCT02165215|12002243|FG002|Maintenance Phase|Multiple reasons|1
7596279|NCT02165215|12002241|FG000|Maintenance Phase|Lost to Follow-up|0
7596280|NCT02165215|12002242|FG001|Maintenance Phase|Lost to Follow-up|2
7596281|NCT02165215|12002243|FG002|Maintenance Phase|Lost to Follow-up|0
7596282|NCT02165215|12002241|FG000|Maintenance Phase|Adverse Event|0
7596283|NCT02165215|12002242|FG001|Maintenance Phase|Adverse Event|1
7596284|NCT02165215|12002243|FG002|Maintenance Phase|Adverse Event|1
7596285|NCT02180217|12002257|FG000|Overall Study|Adverse Event|3
7596286|NCT02180217|12002258|FG001|Overall Study|Adverse Event|2
7596287|NCT02180217|12002259|FG002|Overall Study|Adverse Event|22
7596288|NCT02180217|12002257|FG000|Overall Study|Death|1
7596289|NCT02180217|12002258|FG001|Overall Study|Death|1
7596290|NCT02180217|12002259|FG002|Overall Study|Death|0
7596291|NCT02180217|12002257|FG000|Overall Study|Withdrawal by Subject|1
7596292|NCT02180217|12002258|FG001|Overall Study|Withdrawal by Subject|1
7596293|NCT02180217|12002259|FG002|Overall Study|Withdrawal by Subject|4
7596294|NCT02180217|12002257|FG000|Overall Study|Subject/Guardian decision|5
7596295|NCT02180217|12002258|FG001|Overall Study|Subject/Guardian decision|3
7596296|NCT02180217|12002259|FG002|Overall Study|Subject/Guardian decision|6
7596297|NCT02180217|12002257|FG000|Overall Study|Physician Decision|1
7596298|NCT02180217|12002258|FG001|Overall Study|Physician Decision|1
7596299|NCT02180217|12002259|FG002|Overall Study|Physician Decision|6
7596300|NCT02180217|12002257|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7596301|NCT02180217|12002258|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7596302|NCT02180217|12002259|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7596303|NCT02193867|12002283|FG000|Overall Study|Death|2
7596304|NCT02193867|12002283|FG000|Overall Study|Sponsor Study Termination|2
7596305|NCT02215096|12002290|FG000|Run-In Period (Up to Week 2)|Adverse Event|1
7596306|NCT02215096|12002291|FG001|Run-In Period (Up to Week 2)|Adverse Event|0
7596307|NCT02215096|12002292|FG002|Run-In Period (Up to Week 2)|Adverse Event|0
7596308|NCT02215096|12002293|FG003|Run-In Period (Up to Week 2)|Adverse Event|0
7596309|NCT02215096|12002294|FG004|Run-In Period (Up to Week 2)|Adverse Event|0
7596310|NCT02215096|12002290|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7596311|NCT02215096|12002291|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7596312|NCT02215096|12002292|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7596313|NCT02215096|12002293|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7596314|NCT02215096|12002294|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1
7596315|NCT02215096|12002290|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7596316|NCT02215096|12002291|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7596317|NCT02215096|12002292|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7596318|NCT02215096|12002293|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1
7596319|NCT02215096|12002294|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7596320|NCT02215096|12002290|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
7596321|NCT02215096|12002291|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2
7596322|NCT02215096|12002292|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
7596323|NCT02215096|12002293|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
7596324|NCT02215096|12002294|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
7628208|NCT04851314|12041074|FG000|Overall Study|Unable to complete research set-up procedures|0
7628209|NCT04851314|12041075|FG001|Overall Study|Unable to complete research set-up procedures|2
7628210|NCT04851314|12041074|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3
7628211|NCT04851314|12041075|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2
7628212|NCT04823494|12041102|FG000|Overall Study|Programming software malfunction.|1
7628213|NCT04823494|12041103|FG001|Overall Study|Programming software malfunction.|0
7628214|NCT04823494|12041102|FG000|Overall Study|Withdrawal by Subject|1
7628215|NCT04823494|12041103|FG001|Overall Study|Withdrawal by Subject|0
7628216|NCT04823494|12041102|FG000|Overall Study|Devices lost|0
7628217|NCT04823494|12041103|FG001|Overall Study|Devices lost|1
7628221|NCT04799782|12041126|FG000|Washout|Physician Decision|2
7628222|NCT04799782|12041127|FG001|Washout|Physician Decision|0
7628223|NCT04799782|12041126|FG000|Washout|Withdrawal by Subject|0
7628224|NCT04799782|12041127|FG001|Washout|Withdrawal by Subject|2
7628225|NCT04799782|12041126|FG000|Washout|Lost to Follow-up|0
7628226|NCT04799782|12041127|FG001|Washout|Lost to Follow-up|1
7596325|NCT02218697|12002312|FG000|Overall Study|Adverse Event|0
7596326|NCT02218697|12002313|FG001|Overall Study|Adverse Event|2
7596327|NCT02218697|12002312|FG000|Overall Study|Unwilling to be vaccinated in left arm|0
7596328|NCT02218697|12002313|FG001|Overall Study|Unwilling to be vaccinated in left arm|1
7596329|NCT02218697|12002312|FG000|Overall Study|Withdrawal by Subject|2
7596330|NCT02218697|12002313|FG001|Overall Study|Withdrawal by Subject|3
7596331|NCT02221037|12002323|FG000|Overall Study|Physician Decision|0
7596332|NCT02221037|12002324|FG001|Overall Study|Physician Decision|0
7596333|NCT02221037|12002325|FG002|Overall Study|Physician Decision|1
7596334|NCT02221037|12002326|FG003|Overall Study|Physician Decision|0
7596335|NCT02224456|12002340|FG000|Overall Study|Lack of Efficacy|1
7596336|NCT02224456|12002340|FG000|Overall Study|Lost to Follow-up|15
7596337|NCT02224456|12002340|FG000|Overall Study|Withdrawal by Subject|9
7596338|NCT02224456|12002340|FG000|Overall Study|Physician Decision|3
7596339|NCT02224456|12002340|FG000|Overall Study|Death|2
7596340|NCT02224456|12002340|FG000|Overall Study|Pregnancy|4
7596341|NCT02224456|12002340|FG000|Overall Study|Protocol Violation|1
7596342|NCT02224456|12002340|FG000|Overall Study|Treatment Interruptions of ≥28 days|1
7596343|NCT02231762|12002344|FG000|Combination Phase|Adverse Event|10
7596344|NCT02231762|12002345|FG001|Combination Phase|Adverse Event|0
7596345|NCT02231762|12002346|FG002|Combination Phase|Adverse Event|0
7596346|NCT02231762|12002347|FG003|Combination Phase|Adverse Event|0
7596347|NCT02231762|12002344|FG000|Combination Phase|Withdrawal by Subject|2
7596348|NCT02231762|12002345|FG001|Combination Phase|Withdrawal by Subject|0
7596349|NCT02231762|12002346|FG002|Combination Phase|Withdrawal by Subject|0
7596350|NCT02231762|12002347|FG003|Combination Phase|Withdrawal by Subject|0
7596351|NCT02231762|12002344|FG000|Combination Phase|Disease Progression|6
7596352|NCT02231762|12002345|FG001|Combination Phase|Disease Progression|0
7596353|NCT02231762|12002346|FG002|Combination Phase|Disease Progression|0
7596354|NCT02231762|12002347|FG003|Combination Phase|Disease Progression|0
7596355|NCT02231762|12002344|FG000|Combination Phase|Did not meet inclusion criteria|1
7596356|NCT02231762|12002345|FG001|Combination Phase|Did not meet inclusion criteria|0
7596357|NCT02231762|12002346|FG002|Combination Phase|Did not meet inclusion criteria|0
7596358|NCT02231762|12002347|FG003|Combination Phase|Did not meet inclusion criteria|0
7596359|NCT02231762|12002344|FG000|Combination Phase|Protocol Violation|1
7596360|NCT02231762|12002345|FG001|Combination Phase|Protocol Violation|0
7596361|NCT02231762|12002346|FG002|Combination Phase|Protocol Violation|0
7596362|NCT02231762|12002347|FG003|Combination Phase|Protocol Violation|0
7596363|NCT02231762|12002344|FG000|Maintenance Phase|Disease progression|0
7596364|NCT02231762|12002345|FG001|Maintenance Phase|Disease progression|3
7596365|NCT02231762|12002346|FG002|Maintenance Phase|Disease progression|4
7596366|NCT02231762|12002347|FG003|Maintenance Phase|Disease progression|3
7596367|NCT02231762|12002344|FG000|Maintenance Phase|Adverse Event|0
7596368|NCT02231762|12002345|FG001|Maintenance Phase|Adverse Event|0
7596369|NCT02231762|12002346|FG002|Maintenance Phase|Adverse Event|1
7596370|NCT02231762|12002347|FG003|Maintenance Phase|Adverse Event|2
7596371|NCT02234843|12002371|FG000|Overall Study|Death|1
7596372|NCT02234843|12002372|FG001|Overall Study|Death|0
7596373|NCT02234843|12002373|FG002|Overall Study|Death|0
7596374|NCT02234843|12002374|FG003|Overall Study|Death|0
7596375|NCT02234843|12002375|FG004|Overall Study|Death|0
7596376|NCT02234843|12002376|FG005|Overall Study|Death|0
7596377|NCT02234843|12002377|FG006|Overall Study|Death|0
7596378|NCT02234843|12002378|FG007|Overall Study|Death|0
7596379|NCT02234843|12002379|FG008|Overall Study|Death|0
7596380|NCT02234843|12002380|FG009|Overall Study|Death|0
7596381|NCT02234843|12002371|FG000|Overall Study|Protocol Violation|1
7596382|NCT02234843|12002372|FG001|Overall Study|Protocol Violation|0
7596383|NCT02234843|12002373|FG002|Overall Study|Protocol Violation|1
7596384|NCT02234843|12002374|FG003|Overall Study|Protocol Violation|0
7596385|NCT02234843|12002375|FG004|Overall Study|Protocol Violation|0
7596386|NCT02234843|12002376|FG005|Overall Study|Protocol Violation|0
7596387|NCT02234843|12002377|FG006|Overall Study|Protocol Violation|0
7596388|NCT02234843|12002378|FG007|Overall Study|Protocol Violation|0
7596389|NCT02234843|12002379|FG008|Overall Study|Protocol Violation|0
7596390|NCT02234843|12002380|FG009|Overall Study|Protocol Violation|0
7596391|NCT02234843|12002371|FG000|Overall Study|Efficacy outcome reached|2
7596392|NCT02234843|12002372|FG001|Overall Study|Efficacy outcome reached|0
7596393|NCT02234843|12002373|FG002|Overall Study|Efficacy outcome reached|0
7596394|NCT02234843|12002374|FG003|Overall Study|Efficacy outcome reached|0
7596395|NCT02234843|12002375|FG004|Overall Study|Efficacy outcome reached|0
7596396|NCT02234843|12002376|FG005|Overall Study|Efficacy outcome reached|2
7596397|NCT02234843|12002377|FG006|Overall Study|Efficacy outcome reached|0
7596398|NCT02234843|12002378|FG007|Overall Study|Efficacy outcome reached|0
7596399|NCT02234843|12002379|FG008|Overall Study|Efficacy outcome reached|0
7596400|NCT02234843|12002380|FG009|Overall Study|Efficacy outcome reached|0
7596401|NCT02234843|12002371|FG000|Overall Study|Patient convenience|2
7596402|NCT02234843|12002372|FG001|Overall Study|Patient convenience|0
7596403|NCT02234843|12002373|FG002|Overall Study|Patient convenience|0
7596404|NCT02234843|12002374|FG003|Overall Study|Patient convenience|0
7596405|NCT02234843|12002375|FG004|Overall Study|Patient convenience|0
7596406|NCT02234843|12002376|FG005|Overall Study|Patient convenience|1
7596407|NCT02234843|12002377|FG006|Overall Study|Patient convenience|0
7596408|NCT02234843|12002378|FG007|Overall Study|Patient convenience|0
7596409|NCT02234843|12002379|FG008|Overall Study|Patient convenience|0
7596410|NCT02234843|12002380|FG009|Overall Study|Patient convenience|0
7596411|NCT02234843|12002371|FG000|Overall Study|Withdrawal by Subject|5
7596412|NCT02234843|12002372|FG001|Overall Study|Withdrawal by Subject|1
7596413|NCT02234843|12002373|FG002|Overall Study|Withdrawal by Subject|1
7596414|NCT02234843|12002374|FG003|Overall Study|Withdrawal by Subject|0
7596415|NCT02234843|12002375|FG004|Overall Study|Withdrawal by Subject|0
7596416|NCT02234843|12002376|FG005|Overall Study|Withdrawal by Subject|7
7596417|NCT02234843|12002377|FG006|Overall Study|Withdrawal by Subject|0
7596418|NCT02234843|12002378|FG007|Overall Study|Withdrawal by Subject|0
7596419|NCT02234843|12002379|FG008|Overall Study|Withdrawal by Subject|0
7596420|NCT02234843|12002380|FG009|Overall Study|Withdrawal by Subject|0
7596421|NCT02234843|12002371|FG000|Overall Study|Recovery|1
7596422|NCT02234843|12002372|FG001|Overall Study|Recovery|0
7596423|NCT02234843|12002373|FG002|Overall Study|Recovery|0
7596424|NCT02234843|12002374|FG003|Overall Study|Recovery|0
7596425|NCT02234843|12002375|FG004|Overall Study|Recovery|0
7596426|NCT02234843|12002376|FG005|Overall Study|Recovery|0
7596427|NCT02234843|12002377|FG006|Overall Study|Recovery|0
7596428|NCT02234843|12002378|FG007|Overall Study|Recovery|0
7596429|NCT02234843|12002379|FG008|Overall Study|Recovery|0
7596430|NCT02234843|12002380|FG009|Overall Study|Recovery|0
7596431|NCT02234843|12002371|FG000|Overall Study|Other|0
7596432|NCT02234843|12002372|FG001|Overall Study|Other|2
7596433|NCT02234843|12002373|FG002|Overall Study|Other|0
7596434|NCT02234843|12002374|FG003|Overall Study|Other|1
7596435|NCT02234843|12002375|FG004|Overall Study|Other|0
7596436|NCT02234843|12002376|FG005|Overall Study|Other|1
7596437|NCT02234843|12002377|FG006|Overall Study|Other|0
7596438|NCT02234843|12002378|FG007|Overall Study|Other|1
7596439|NCT02234843|12002379|FG008|Overall Study|Other|0
7596440|NCT02234843|12002380|FG009|Overall Study|Other|0
7596441|NCT02234843|12002371|FG000|Overall Study|Physician Decision|4
7596442|NCT02234843|12002372|FG001|Overall Study|Physician Decision|1
7596443|NCT02234843|12002373|FG002|Overall Study|Physician Decision|0
7596444|NCT02234843|12002374|FG003|Overall Study|Physician Decision|1
7596445|NCT02234843|12002375|FG004|Overall Study|Physician Decision|0
7596446|NCT02234843|12002376|FG005|Overall Study|Physician Decision|0
7596447|NCT02234843|12002377|FG006|Overall Study|Physician Decision|0
7596448|NCT02234843|12002378|FG007|Overall Study|Physician Decision|1
7596449|NCT02234843|12002379|FG008|Overall Study|Physician Decision|0
7596450|NCT02234843|12002380|FG009|Overall Study|Physician Decision|0
7596451|NCT02234843|12002371|FG000|Overall Study|Adverse Event|5
7596452|NCT02234843|12002372|FG001|Overall Study|Adverse Event|1
7771793|NCT00885118|12216224|FG003|Overall Study|Other reason not defined above|0
7771794|NCT00885118|12216225|FG004|Overall Study|Other reason not defined above|0
7771795|NCT00885170|12216243|FG000|Overall Study|Adverse Event|12
7771796|NCT00885170|12216244|FG001|Overall Study|Adverse Event|4
7771797|NCT00885170|12216243|FG000|Overall Study|Excessive bone loss|6
7771798|NCT00885170|12216244|FG001|Overall Study|Excessive bone loss|3
7596453|NCT02234843|12002373|FG002|Overall Study|Adverse Event|1
7596454|NCT02234843|12002374|FG003|Overall Study|Adverse Event|3
7596455|NCT02234843|12002375|FG004|Overall Study|Adverse Event|2
7771799|NCT00885170|12216243|FG000|Overall Study|Lost to Follow-up|2
7771800|NCT00885170|12216244|FG001|Overall Study|Lost to Follow-up|1
7771801|NCT00885170|12216243|FG000|Overall Study|Physician Decision|2
7771802|NCT00885170|12216244|FG001|Overall Study|Physician Decision|1
7771803|NCT00885170|12216243|FG000|Overall Study|Protocol Violation|3
7771804|NCT00885170|12216244|FG001|Overall Study|Protocol Violation|1
7771805|NCT00885170|12216243|FG000|Overall Study|Withdrawal by Subject|13
7771806|NCT00885170|12216244|FG001|Overall Study|Withdrawal by Subject|13
7771807|NCT00885352|12216252|FG000|Overall Study|Adverse Event|2
7771808|NCT00885352|12216253|FG001|Overall Study|Adverse Event|3
7771809|NCT00885352|12216252|FG000|Overall Study|Lost to Follow-up|2
7771810|NCT00885352|12216253|FG001|Overall Study|Lost to Follow-up|2
7771811|NCT00885352|12216252|FG000|Overall Study|Physician Decision|0
7771812|NCT00885352|12216253|FG001|Overall Study|Physician Decision|3
7771813|NCT00885352|12216252|FG000|Overall Study|Protocol Violation|0
7771814|NCT00885352|12216253|FG001|Overall Study|Protocol Violation|2
7771815|NCT00885352|12216252|FG000|Overall Study|Withdrawal by Subject|1
7771816|NCT00885352|12216253|FG001|Overall Study|Withdrawal by Subject|5
7771817|NCT00885352|12216252|FG000|Overall Study|Contradiction to study medication|0
7771818|NCT00885352|12216253|FG001|Overall Study|Contradiction to study medication|2
7771819|NCT00885352|12216252|FG000|Overall Study|Excluded medication|2
7771820|NCT00885352|12216253|FG001|Overall Study|Excluded medication|2
7771821|NCT00885352|12216252|FG000|Overall Study|Lab abnormalities|1
7771822|NCT00885352|12216253|FG001|Overall Study|Lab abnormalities|1
7771823|NCT00885365|12216261|FG000|4 Weeks ON Treatment|Adverse Event|2
7771824|NCT00885365|12216262|FG001|4 Weeks ON Treatment|Adverse Event|4
7771825|NCT00885365|12216261|FG000|4 Weeks ON Treatment|Protocol Violation|1
7771826|NCT00885365|12216262|FG001|4 Weeks ON Treatment|Protocol Violation|2
7771827|NCT00885365|12216261|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1
7596456|NCT02234843|12002376|FG005|Overall Study|Adverse Event|1
7596457|NCT02234843|12002377|FG006|Overall Study|Adverse Event|0
7596458|NCT02234843|12002378|FG007|Overall Study|Adverse Event|0
7596459|NCT02234843|12002379|FG008|Overall Study|Adverse Event|1
7596460|NCT02234843|12002380|FG009|Overall Study|Adverse Event|0
7596461|NCT02234843|12002371|FG000|Overall Study|Non-compliance with study drug|1
7596462|NCT02234843|12002372|FG001|Overall Study|Non-compliance with study drug|0
7596463|NCT02234843|12002373|FG002|Overall Study|Non-compliance with study drug|0
7596464|NCT02234843|12002374|FG003|Overall Study|Non-compliance with study drug|0
7596465|NCT02234843|12002375|FG004|Overall Study|Non-compliance with study drug|0
7596466|NCT02234843|12002376|FG005|Overall Study|Non-compliance with study drug|1
7596467|NCT02234843|12002377|FG006|Overall Study|Non-compliance with study drug|1
7596468|NCT02234843|12002378|FG007|Overall Study|Non-compliance with study drug|0
7596469|NCT02234843|12002379|FG008|Overall Study|Non-compliance with study drug|0
7596470|NCT02234843|12002380|FG009|Overall Study|Non-compliance with study drug|0
7596471|NCT02234843|12002371|FG000|Overall Study|Lost to Follow-up|0
7596472|NCT02234843|12002372|FG001|Overall Study|Lost to Follow-up|1
7596473|NCT02234843|12002373|FG002|Overall Study|Lost to Follow-up|0
7596474|NCT02234843|12002374|FG003|Overall Study|Lost to Follow-up|0
7596475|NCT02234843|12002375|FG004|Overall Study|Lost to Follow-up|0
7596476|NCT02234843|12002376|FG005|Overall Study|Lost to Follow-up|0
7596477|NCT02234843|12002377|FG006|Overall Study|Lost to Follow-up|1
7596478|NCT02234843|12002378|FG007|Overall Study|Lost to Follow-up|0
7596479|NCT02234843|12002379|FG008|Overall Study|Lost to Follow-up|0
7596480|NCT02234843|12002380|FG009|Overall Study|Lost to Follow-up|0
7628218|NCT04821245|12041111|FG000|Overall Study|Withdrawal by Subject|3
7628219|NCT04821245|12041111|FG000|Overall Study|Physician Decision|1
7771828|NCT00885365|12216262|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0
7771829|NCT00885378|12216270|FG000|Overall Study|Lack of Efficacy|2
7771830|NCT00885378|12216271|FG001|Overall Study|Lack of Efficacy|2
7771831|NCT00885378|12216270|FG000|Overall Study|Withdrawal by Subject|1
7771832|NCT00885378|12216271|FG001|Overall Study|Withdrawal by Subject|2
7771833|NCT00885378|12216270|FG000|Overall Study|Lost to Follow-up|1
7771834|NCT00885378|12216271|FG001|Overall Study|Lost to Follow-up|2
7771835|NCT00885378|12216270|FG000|Overall Study|Poor/Noncompliance|2
7771836|NCT00885378|12216271|FG001|Overall Study|Poor/Noncompliance|2
7771837|NCT00885378|12216270|FG000|Overall Study|Protocol Violation|2
7771838|NCT00885378|12216271|FG001|Overall Study|Protocol Violation|0
7771839|NCT00885482|12216277|FG000|Overall Study|Pregnancy|1
7771840|NCT00885482|12216277|FG000|Overall Study|Lack of Efficacy|1
7771841|NCT00885482|12216277|FG000|Overall Study|Death|1
7771842|NCT00885482|12216277|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1
7771843|NCT00885534|12216281|FG000|Overall Study|Patient deemed ineligible|1
7771844|NCT00885677|12216295|FG000|Overall Study|Death|40
7771845|NCT00885677|12216296|FG001|Overall Study|Death|34
7771846|NCT00885677|12216295|FG000|Overall Study|Lost to Follow-up|15
7771847|NCT00885677|12216296|FG001|Overall Study|Lost to Follow-up|13
7771848|NCT00885677|12216295|FG000|Overall Study|Protocol Violation|54
7771849|NCT00885677|12216296|FG001|Overall Study|Protocol Violation|54
7771850|NCT00885677|12216295|FG000|Overall Study|premature study closure|41
7771851|NCT00885677|12216296|FG001|Overall Study|premature study closure|44
7771852|NCT00885677|12216295|FG000|Overall Study|device/lead revision or replacement|7
7771853|NCT00885677|12216296|FG001|Overall Study|device/lead revision or replacement|6
7771854|NCT00885677|12216295|FG000|Overall Study|Heart transplantation|1
7771855|NCT00885677|12216296|FG001|Overall Study|Heart transplantation|0
7771856|NCT00885677|12216295|FG000|Overall Study|Inclusion/exclusion not met|25
7771857|NCT00885677|12216296|FG001|Overall Study|Inclusion/exclusion not met|27
7771858|NCT00885703|12216309|FG000|Overall Study|Death|9
7771859|NCT00885703|12216310|FG001|Overall Study|Death|7
7771860|NCT00885703|12216311|FG002|Overall Study|Death|8
7771861|NCT00885703|12216312|FG003|Overall Study|Death|7
7771862|NCT00885703|12216313|FG004|Overall Study|Death|7
7771863|NCT00885703|12216314|FG005|Overall Study|Death|8
7628220|NCT04821245|12041111|FG000|Overall Study|Protocol Violation|5
7596481|NCT02243306|12002415|FG000|Overall Study|Adverse Event|0
7596482|NCT02243306|12002416|FG001|Overall Study|Adverse Event|1
7596483|NCT02243306|12002415|FG000|Overall Study|Other: Reached stopping criteria|0
7596484|NCT02243306|12002416|FG001|Overall Study|Other: Reached stopping criteria|1
7596485|NCT02243306|12002415|FG000|Overall Study|Physician Decision|0
7596486|NCT02243306|12002416|FG001|Overall Study|Physician Decision|1
7771864|NCT00885703|12216315|FG006|Overall Study|Death|4
7771865|NCT00885703|12216309|FG000|Overall Study|Lost to Follow-up|0
7771866|NCT00885703|12216310|FG001|Overall Study|Lost to Follow-up|0
7771867|NCT00885703|12216311|FG002|Overall Study|Lost to Follow-up|1
7771868|NCT00885703|12216312|FG003|Overall Study|Lost to Follow-up|0
7771869|NCT00885703|12216313|FG004|Overall Study|Lost to Follow-up|0
7596493|NCT03926611|12002443|FG000|Overall Study|Adverse Event|0
7596494|NCT03926611|12002444|FG001|Overall Study|Adverse Event|0
7596495|NCT03926611|12002445|FG002|Overall Study|Adverse Event|0
7596496|NCT03926611|12002446|FG003|Overall Study|Adverse Event|3
7596497|NCT03926611|12002447|FG004|Overall Study|Adverse Event|1
7596498|NCT03926611|12002448|FG005|Overall Study|Adverse Event|3
7596499|NCT03926611|12002449|FG006|Overall Study|Adverse Event|0
7596500|NCT03926611|12002443|FG000|Overall Study|Lack of Efficacy|1
7596501|NCT03926611|12002444|FG001|Overall Study|Lack of Efficacy|2
7596502|NCT03926611|12002445|FG002|Overall Study|Lack of Efficacy|0
7596503|NCT03926611|12002446|FG003|Overall Study|Lack of Efficacy|0
7596504|NCT03926611|12002447|FG004|Overall Study|Lack of Efficacy|1
7596505|NCT03926611|12002448|FG005|Overall Study|Lack of Efficacy|0
7596506|NCT03926611|12002449|FG006|Overall Study|Lack of Efficacy|1
7596507|NCT03926611|12002443|FG000|Overall Study|Physician Decision|0
7596508|NCT03926611|12002444|FG001|Overall Study|Physician Decision|0
7596509|NCT03926611|12002445|FG002|Overall Study|Physician Decision|0
7596510|NCT03926611|12002446|FG003|Overall Study|Physician Decision|0
7596511|NCT03926611|12002447|FG004|Overall Study|Physician Decision|0
7596512|NCT03926611|12002448|FG005|Overall Study|Physician Decision|1
7596513|NCT03926611|12002449|FG006|Overall Study|Physician Decision|0
7596514|NCT03926611|12002443|FG000|Overall Study|Protocol Violation|1
7596515|NCT03926611|12002444|FG001|Overall Study|Protocol Violation|0
7596516|NCT03926611|12002445|FG002|Overall Study|Protocol Violation|0
7596517|NCT03926611|12002446|FG003|Overall Study|Protocol Violation|1
7596518|NCT03926611|12002447|FG004|Overall Study|Protocol Violation|1
7596519|NCT03926611|12002448|FG005|Overall Study|Protocol Violation|1
7596520|NCT03926611|12002449|FG006|Overall Study|Protocol Violation|1
7596521|NCT03926611|12002443|FG000|Overall Study|Technical problems|0
7596522|NCT03926611|12002444|FG001|Overall Study|Technical problems|0
7596523|NCT03926611|12002445|FG002|Overall Study|Technical problems|0
7596524|NCT03926611|12002446|FG003|Overall Study|Technical problems|0
7596525|NCT03926611|12002447|FG004|Overall Study|Technical problems|0
7596526|NCT03926611|12002448|FG005|Overall Study|Technical problems|1
7596527|NCT03926611|12002449|FG006|Overall Study|Technical problems|0
7596528|NCT03926611|12002443|FG000|Overall Study|Withdrawal by Subject|1
7596529|NCT03926611|12002444|FG001|Overall Study|Withdrawal by Subject|1
7596530|NCT03926611|12002445|FG002|Overall Study|Withdrawal by Subject|1
7596531|NCT03926611|12002446|FG003|Overall Study|Withdrawal by Subject|0
7596532|NCT03926611|12002447|FG004|Overall Study|Withdrawal by Subject|0
7596533|NCT03926611|12002448|FG005|Overall Study|Withdrawal by Subject|1
7596534|NCT03926611|12002449|FG006|Overall Study|Withdrawal by Subject|3
7596535|NCT03926611|12002443|FG000|Overall Study|Covid-19 pandemic|0
7596536|NCT03926611|12002444|FG001|Overall Study|Covid-19 pandemic|0
7596537|NCT03926611|12002445|FG002|Overall Study|Covid-19 pandemic|1
7596538|NCT03926611|12002446|FG003|Overall Study|Covid-19 pandemic|0
7596539|NCT03926611|12002447|FG004|Overall Study|Covid-19 pandemic|1
7596540|NCT03926611|12002448|FG005|Overall Study|Covid-19 pandemic|2
7596541|NCT03926611|12002449|FG006|Overall Study|Covid-19 pandemic|0
7596542|NCT03838484|12002473|FG000|Overall Study|Lost to Follow-up|0
7596543|NCT03838484|12002474|FG001|Overall Study|Lost to Follow-up|1
7596544|NCT03838484|12002475|FG002|Overall Study|Lost to Follow-up|0
7596545|NCT03838484|12002476|FG003|Overall Study|Lost to Follow-up|0
7596546|NCT03814720|12002497|FG000|Overall Study|Lost to Follow-up|0
7596547|NCT03814720|12002498|FG001|Overall Study|Lost to Follow-up|1
7596548|NCT03814720|12002499|FG002|Overall Study|Lost to Follow-up|0
7596549|NCT03814720|12002500|FG003|Overall Study|Lost to Follow-up|0
7596550|NCT03814720|12002501|FG004|Overall Study|Lost to Follow-up|0
7596551|NCT03635424|12002515|FG000|Overall Study|Adverse Event|1
7596552|NCT03635424|12002515|FG000|Overall Study|Death|1
7596553|NCT03635424|12002515|FG000|Overall Study|Device not implanted|1
7596554|NCT03529110|12002521|FG000|Overall Study|Progressive Disease|66
7596555|NCT03529110|12002522|FG001|Overall Study|Progressive Disease|158
7596556|NCT03529110|12002521|FG000|Overall Study|Clinical Progression|4
7596557|NCT03529110|12002522|FG001|Overall Study|Clinical Progression|12
7596558|NCT03529110|12002521|FG000|Overall Study|Adverse Event|35
7596559|NCT03529110|12002522|FG001|Overall Study|Adverse Event|17
7596560|NCT03529110|12002521|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13
7596561|NCT03529110|12002522|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11
7596562|NCT03529110|12002521|FG000|Overall Study|Lack of Efficacy|3
7596563|NCT03529110|12002522|FG001|Overall Study|Lack of Efficacy|3
7596564|NCT03529110|12002521|FG000|Overall Study|Physician Decision|2
7596565|NCT03529110|12002522|FG001|Overall Study|Physician Decision|8
7596566|NCT03529110|12002521|FG000|Overall Study|Miscellaneous|2
7596567|NCT03529110|12002522|FG001|Overall Study|Miscellaneous|5
7596568|NCT03517540|12002532|FG000|Overall Study|Protocol Violation|2
7596569|NCT03517540|12002533|FG001|Overall Study|Protocol Violation|0
7596570|NCT03517540|12002534|FG002|Overall Study|Protocol Violation|0
7596571|NCT03517540|12002535|FG003|Overall Study|Protocol Violation|1
7596572|NCT03517540|12002532|FG000|Overall Study|Adverse Event|9
7596573|NCT03517540|12002533|FG001|Overall Study|Adverse Event|3
7596574|NCT03517540|12002534|FG002|Overall Study|Adverse Event|8
7596575|NCT03517540|12002535|FG003|Overall Study|Adverse Event|1
7596576|NCT03517540|12002532|FG000|Overall Study|Withdrawal by Subject|3
7596577|NCT03517540|12002533|FG001|Overall Study|Withdrawal by Subject|4
7596578|NCT03517540|12002534|FG002|Overall Study|Withdrawal by Subject|1
7596579|NCT03517540|12002535|FG003|Overall Study|Withdrawal by Subject|3
7596580|NCT03437278|12002557|FG000|Overall Study|Adverse Event|0
7596581|NCT03437278|12002558|FG001|Overall Study|Adverse Event|0
7596582|NCT03437278|12002559|FG002|Overall Study|Adverse Event|1
7596583|NCT03437278|12002557|FG000|Overall Study|Progressive disease|1
7596584|NCT03437278|12002558|FG001|Overall Study|Progressive disease|0
7596585|NCT03437278|12002559|FG002|Overall Study|Progressive disease|0
7596586|NCT03437278|12002557|FG000|Overall Study|Physician Decision|1
7596587|NCT03437278|12002558|FG001|Overall Study|Physician Decision|0
7596588|NCT03437278|12002559|FG002|Overall Study|Physician Decision|1
7596589|NCT03350815|12002569|FG000|Period 1|Adverse Event|10
7596590|NCT03350815|12002570|FG001|Period 1|Adverse Event|0
7596591|NCT03350815|12002571|FG002|Period 1|Adverse Event|0
7596592|NCT03350815|12002572|FG003|Period 1|Adverse Event|0
7596593|NCT03350815|12002569|FG000|Period 1|Technical problems|1
7596594|NCT03350815|12002570|FG001|Period 1|Technical problems|0
7596595|NCT03350815|12002571|FG002|Period 1|Technical problems|0
7596596|NCT03350815|12002572|FG003|Period 1|Technical problems|0
7596597|NCT03350815|12002569|FG000|Period 1|Lost to Follow-up|3
7596598|NCT03350815|12002570|FG001|Period 1|Lost to Follow-up|0
7596599|NCT03350815|12002571|FG002|Period 1|Lost to Follow-up|0
7596600|NCT03350815|12002572|FG003|Period 1|Lost to Follow-up|0
7596601|NCT03350815|12002569|FG000|Period 1|Physician Decision|1
7596602|NCT03350815|12002570|FG001|Period 1|Physician Decision|0
7596603|NCT03350815|12002571|FG002|Period 1|Physician Decision|0
7596604|NCT03350815|12002572|FG003|Period 1|Physician Decision|0
7596605|NCT03350815|12002569|FG000|Period 1|Withdrawal by Subject|8
7596606|NCT03350815|12002570|FG001|Period 1|Withdrawal by Subject|0
7596607|NCT03350815|12002571|FG002|Period 1|Withdrawal by Subject|0
7596608|NCT03350815|12002572|FG003|Period 1|Withdrawal by Subject|0
7596609|NCT03350815|12002569|FG000|Period 1|Lack of Efficacy|15
7596610|NCT03350815|12002570|FG001|Period 1|Lack of Efficacy|0
7596611|NCT03350815|12002571|FG002|Period 1|Lack of Efficacy|0
7596612|NCT03350815|12002572|FG003|Period 1|Lack of Efficacy|0
7596613|NCT03350815|12002569|FG000|Period 1|Non-compliance with study treatment|2
7596614|NCT03350815|12002570|FG001|Period 1|Non-compliance with study treatment|0
7596615|NCT03350815|12002571|FG002|Period 1|Non-compliance with study treatment|0
7596616|NCT03350815|12002572|FG003|Period 1|Non-compliance with study treatment|0
7596617|NCT03350815|12002569|FG000|Period 1|Protocol Violation|3
7596618|NCT03350815|12002570|FG001|Period 1|Protocol Violation|0
7596619|NCT03350815|12002571|FG002|Period 1|Protocol Violation|0
7596620|NCT03350815|12002572|FG003|Period 1|Protocol Violation|0
7596621|NCT03350815|12002569|FG000|Period 2|Adverse Event|0
7596622|NCT03350815|12002570|FG001|Period 2|Adverse Event|3
7596623|NCT03350815|12002571|FG002|Period 2|Adverse Event|5
7596624|NCT03350815|12002572|FG003|Period 2|Adverse Event|0
7596625|NCT03350815|12002569|FG000|Period 2|Technical problem|0
7596626|NCT03350815|12002570|FG001|Period 2|Technical problem|1
7596627|NCT03350815|12002571|FG002|Period 2|Technical problem|0
7596628|NCT03350815|12002572|FG003|Period 2|Technical problem|0
7596629|NCT03350815|12002569|FG000|Period 2|Lost to Follow-up|0
7596630|NCT03350815|12002570|FG001|Period 2|Lost to Follow-up|3
7596631|NCT03350815|12002571|FG002|Period 2|Lost to Follow-up|3
7596632|NCT03350815|12002572|FG003|Period 2|Lost to Follow-up|0
7596633|NCT03350815|12002569|FG000|Period 2|Physician Decision|0
7596634|NCT03350815|12002570|FG001|Period 2|Physician Decision|0
7596635|NCT03350815|12002571|FG002|Period 2|Physician Decision|1
7596636|NCT03350815|12002572|FG003|Period 2|Physician Decision|0
7596637|NCT03350815|12002569|FG000|Period 2|Withdrawal by Subject|0
7596638|NCT03350815|12002570|FG001|Period 2|Withdrawal by Subject|3
7596639|NCT03350815|12002571|FG002|Period 2|Withdrawal by Subject|4
7596640|NCT03350815|12002572|FG003|Period 2|Withdrawal by Subject|0
7596641|NCT03350815|12002569|FG000|Period 2|Lack of Efficacy|0
7596642|NCT03350815|12002570|FG001|Period 2|Lack of Efficacy|6
7596643|NCT03350815|12002571|FG002|Period 2|Lack of Efficacy|2
7596644|NCT03350815|12002572|FG003|Period 2|Lack of Efficacy|0
7596645|NCT03350815|12002569|FG000|Period 2|Protocol Violation|0
7596646|NCT03350815|12002570|FG001|Period 2|Protocol Violation|0
7596647|NCT03350815|12002571|FG002|Period 2|Protocol Violation|1
7596648|NCT03350815|12002572|FG003|Period 2|Protocol Violation|0
7596649|NCT03350815|12002569|FG000|Period 2|New therapy for study indication|0
7596650|NCT03350815|12002570|FG001|Period 2|New therapy for study indication|0
7596651|NCT03350815|12002571|FG002|Period 2|New therapy for study indication|1
7596652|NCT03350815|12002572|FG003|Period 2|New therapy for study indication|0
7596653|NCT03249714|12002585|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1
7596654|NCT03249714|12002586|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1
7596655|NCT03249714|12002585|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1
7596656|NCT03249714|12002586|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1
7596657|NCT03249714|12002585|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1
7596658|NCT03249714|12002586|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0
7596659|NCT03249714|12002585|FG000|Open-label Treatment (Extension Part)|Adverse Event|2
7596660|NCT03249714|12002586|FG001|Open-label Treatment (Extension Part)|Adverse Event|0
7596661|NCT03170882|12002610|FG000|Overall Study|Ongoing|10
7596662|NCT03170882|12002611|FG001|Overall Study|Ongoing|14
7596663|NCT03170882|12002610|FG000|Overall Study|Death|15
7596664|NCT03170882|12002611|FG001|Overall Study|Death|29
7596665|NCT03170882|12002610|FG000|Overall Study|Lost to Follow-up|0
7596666|NCT03170882|12002611|FG001|Overall Study|Lost to Follow-up|1
7596667|NCT03170882|12002610|FG000|Overall Study|Withdrawal by Subject|4
7596668|NCT03170882|12002611|FG001|Overall Study|Withdrawal by Subject|6
7596669|NCT03170882|12002610|FG000|Overall Study|Reason not Specified|0
7596670|NCT03170882|12002611|FG001|Overall Study|Reason not Specified|1
7596671|NCT03074318|12002621|FG000|Overall Study|Adverse Event|0
7596672|NCT03074318|12002622|FG001|Overall Study|Adverse Event|1
7596673|NCT03074318|12002623|FG002|Overall Study|Adverse Event|1
7596674|NCT03074318|12002624|FG003|Overall Study|Adverse Event|1
7596675|NCT03074318|12002621|FG000|Overall Study|Death|1
7596676|NCT03074318|12002622|FG001|Overall Study|Death|0
7596677|NCT03074318|12002623|FG002|Overall Study|Death|0
7596678|NCT03074318|12002624|FG003|Overall Study|Death|0
7596679|NCT03074318|12002621|FG000|Overall Study|Withdrawal by Subject|1
7596680|NCT03074318|12002622|FG001|Overall Study|Withdrawal by Subject|2
7596681|NCT03074318|12002623|FG002|Overall Study|Withdrawal by Subject|2
7596682|NCT03074318|12002624|FG003|Overall Study|Withdrawal by Subject|4
7596683|NCT03074318|12002621|FG000|Overall Study|Trial Closure|2
7596684|NCT03074318|12002622|FG001|Overall Study|Trial Closure|2
7596685|NCT03074318|12002623|FG002|Overall Study|Trial Closure|3
7596686|NCT03074318|12002624|FG003|Overall Study|Trial Closure|11
7596687|NCT03010319|12002645|FG000|Overall Study|Adverse Event|15
7596688|NCT03010319|12002646|FG001|Overall Study|Adverse Event|9
7596689|NCT03010319|12002645|FG000|Overall Study|Withdrawal by Subject|1
7596690|NCT03010319|12002646|FG001|Overall Study|Withdrawal by Subject|6
7596691|NCT03010319|12002645|FG000|Overall Study|Physician Decision|2
7596692|NCT03010319|12002646|FG001|Overall Study|Physician Decision|4
7596693|NCT03010319|12002645|FG000|Overall Study|Sponsor requested withdrawal|2
7596694|NCT03010319|12002646|FG001|Overall Study|Sponsor requested withdrawal|2
7596695|NCT03010319|12002645|FG000|Overall Study|Death|1
7596696|NCT03010319|12002646|FG001|Overall Study|Death|0
7596697|NCT03010319|12002645|FG000|Overall Study|Lost to Follow-up|0
7596698|NCT03010319|12002646|FG001|Overall Study|Lost to Follow-up|1
7596699|NCT03010319|12002645|FG000|Overall Study|Other Reason|5
7596700|NCT03010319|12002646|FG001|Overall Study|Other Reason|7
7596701|NCT02915016|12002660|FG000|Overall Study|Lost to Follow-up|4
7596702|NCT02915016|12002661|FG001|Overall Study|Lost to Follow-up|2
7596703|NCT02915016|12002662|FG002|Overall Study|Lost to Follow-up|5
7596704|NCT02915016|12002663|FG003|Overall Study|Lost to Follow-up|3
7596705|NCT02915016|12002664|FG004|Overall Study|Lost to Follow-up|5
7596706|NCT02915016|12002665|FG005|Overall Study|Lost to Follow-up|2
7596707|NCT02915016|12002666|FG006|Overall Study|Lost to Follow-up|8
7596708|NCT02915016|12002667|FG007|Overall Study|Lost to Follow-up|2
7596709|NCT02915016|12002660|FG000|Overall Study|Physician Decision|0
7596710|NCT02915016|12002661|FG001|Overall Study|Physician Decision|0
7596711|NCT02915016|12002662|FG002|Overall Study|Physician Decision|1
7596712|NCT02915016|12002663|FG003|Overall Study|Physician Decision|0
7596713|NCT02915016|12002664|FG004|Overall Study|Physician Decision|0
7596714|NCT02915016|12002665|FG005|Overall Study|Physician Decision|1
7596715|NCT02915016|12002666|FG006|Overall Study|Physician Decision|2
7596716|NCT02915016|12002667|FG007|Overall Study|Physician Decision|0
7596717|NCT02915016|12002660|FG000|Overall Study|Withdrawal by Subject|2
7596718|NCT02915016|12002661|FG001|Overall Study|Withdrawal by Subject|0
7596719|NCT02915016|12002662|FG002|Overall Study|Withdrawal by Subject|1
7596720|NCT02915016|12002663|FG003|Overall Study|Withdrawal by Subject|0
7596721|NCT02915016|12002664|FG004|Overall Study|Withdrawal by Subject|1
7596722|NCT02915016|12002665|FG005|Overall Study|Withdrawal by Subject|3
7596723|NCT02915016|12002666|FG006|Overall Study|Withdrawal by Subject|1
7596724|NCT02915016|12002667|FG007|Overall Study|Withdrawal by Subject|1
7596725|NCT02915016|12002660|FG000|Overall Study|Elected not to continue|0
7596726|NCT02915016|12002661|FG001|Overall Study|Elected not to continue|0
7596727|NCT02915016|12002662|FG002|Overall Study|Elected not to continue|0
7596728|NCT02915016|12002663|FG003|Overall Study|Elected not to continue|1
7596729|NCT02915016|12002664|FG004|Overall Study|Elected not to continue|0
7596730|NCT02915016|12002665|FG005|Overall Study|Elected not to continue|0
7596731|NCT02915016|12002666|FG006|Overall Study|Elected not to continue|1
7596732|NCT02915016|12002667|FG007|Overall Study|Elected not to continue|0
7596733|NCT02915016|12002660|FG000|Overall Study|HIV infection|1
7596734|NCT02915016|12002661|FG001|Overall Study|HIV infection|1
7596735|NCT02915016|12002662|FG002|Overall Study|HIV infection|1
7596736|NCT02915016|12002663|FG003|Overall Study|HIV infection|0
7596737|NCT02915016|12002664|FG004|Overall Study|HIV infection|1
7596738|NCT02915016|12002665|FG005|Overall Study|HIV infection|0
7596739|NCT02915016|12002666|FG006|Overall Study|HIV infection|0
7596740|NCT02915016|12002667|FG007|Overall Study|HIV infection|0
7596741|NCT02915016|12002660|FG000|Overall Study|Participant unable to adhere|0
7596742|NCT02915016|12002661|FG001|Overall Study|Participant unable to adhere|0
7596743|NCT02915016|12002662|FG002|Overall Study|Participant unable to adhere|0
7596744|NCT02915016|12002663|FG003|Overall Study|Participant unable to adhere|0
7596745|NCT02915016|12002664|FG004|Overall Study|Participant unable to adhere|0
7596746|NCT02915016|12002665|FG005|Overall Study|Participant unable to adhere|0
7596747|NCT02915016|12002666|FG006|Overall Study|Participant unable to adhere|0
7596748|NCT02915016|12002667|FG007|Overall Study|Participant unable to adhere|1
7596749|NCT02871401|12002687|FG000|Overall Study|Adverse Event|1
7596750|NCT02871401|12002688|FG001|Overall Study|Adverse Event|0
7596751|NCT02701283|12002706|FG000|Overall Study|Death|25
7596752|NCT02701283|12002707|FG001|Overall Study|Death|29
7596753|NCT02701283|12002708|FG002|Overall Study|Death|19
7596754|NCT02701283|12002706|FG000|Overall Study|Lost to Follow-up|3
7596755|NCT02701283|12002707|FG001|Overall Study|Lost to Follow-up|8
7596756|NCT02701283|12002708|FG002|Overall Study|Lost to Follow-up|1
7596757|NCT02701283|12002706|FG000|Overall Study|Withdrawal by Subject|12
7596758|NCT02701283|12002707|FG001|Overall Study|Withdrawal by Subject|41
7596759|NCT02701283|12002708|FG002|Overall Study|Withdrawal by Subject|1
7596760|NCT02701283|12002706|FG000|Overall Study|Missed 2-year visit|22
7596761|NCT02701283|12002707|FG001|Overall Study|Missed 2-year visit|27
7596762|NCT02701283|12002708|FG002|Overall Study|Missed 2-year visit|0
7596763|NCT02701283|12002706|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7
7596764|NCT02701283|12002707|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57
7596765|NCT02701283|12002708|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0
7596766|NCT02696031|12002722|FG000|Up to Week 24|Adverse Event|2
7596767|NCT02696031|12002723|FG001|Up to Week 24|Adverse Event|4
7596768|NCT02696031|12002724|FG002|Up to Week 24|Adverse Event|2
7596769|NCT02696031|12002725|FG003|Up to Week 24|Adverse Event|0
7596770|NCT02696031|12002726|FG004|Up to Week 24|Adverse Event|0
7596771|NCT02696031|12002727|FG005|Up to Week 24|Adverse Event|0
7596772|NCT02696031|12002722|FG000|Up to Week 24|Lack of Efficacy|2
7596773|NCT02696031|12002723|FG001|Up to Week 24|Lack of Efficacy|1
7596774|NCT02696031|12002724|FG002|Up to Week 24|Lack of Efficacy|2
7596775|NCT02696031|12002725|FG003|Up to Week 24|Lack of Efficacy|0
7596776|NCT02696031|12002726|FG004|Up to Week 24|Lack of Efficacy|0
7596777|NCT02696031|12002727|FG005|Up to Week 24|Lack of Efficacy|0
7596778|NCT02696031|12002722|FG000|Up to Week 24|Lost to Follow-up|0
7596779|NCT02696031|12002723|FG001|Up to Week 24|Lost to Follow-up|1
7596780|NCT02696031|12002724|FG002|Up to Week 24|Lost to Follow-up|1
7596781|NCT02696031|12002725|FG003|Up to Week 24|Lost to Follow-up|0
7596782|NCT02696031|12002726|FG004|Up to Week 24|Lost to Follow-up|0
7596783|NCT02696031|12002727|FG005|Up to Week 24|Lost to Follow-up|0
7596784|NCT02696031|12002722|FG000|Up to Week 24|Physician Decision|1
7596785|NCT02696031|12002723|FG001|Up to Week 24|Physician Decision|0
7596786|NCT02696031|12002724|FG002|Up to Week 24|Physician Decision|1
7596787|NCT02696031|12002725|FG003|Up to Week 24|Physician Decision|0
7596788|NCT02696031|12002726|FG004|Up to Week 24|Physician Decision|0
7596789|NCT02696031|12002727|FG005|Up to Week 24|Physician Decision|0
7596790|NCT02696031|12002722|FG000|Up to Week 24|Protocol Violation|1
7596791|NCT02696031|12002723|FG001|Up to Week 24|Protocol Violation|0
7596792|NCT02696031|12002724|FG002|Up to Week 24|Protocol Violation|0
7596793|NCT02696031|12002725|FG003|Up to Week 24|Protocol Violation|0
7596794|NCT02696031|12002726|FG004|Up to Week 24|Protocol Violation|0
7596795|NCT02696031|12002727|FG005|Up to Week 24|Protocol Violation|0
7596796|NCT02696031|12002722|FG000|Up to Week 24|Withdrawal by Subject|4
7596797|NCT02696031|12002723|FG001|Up to Week 24|Withdrawal by Subject|1
7596798|NCT02696031|12002724|FG002|Up to Week 24|Withdrawal by Subject|5
7596799|NCT02696031|12002725|FG003|Up to Week 24|Withdrawal by Subject|0
7596800|NCT02696031|12002726|FG004|Up to Week 24|Withdrawal by Subject|0
7596801|NCT02696031|12002727|FG005|Up to Week 24|Withdrawal by Subject|0
7596802|NCT02696031|12002722|FG000|Up to Week 52|Adverse Event|4
7596803|NCT02696031|12002723|FG001|Up to Week 52|Adverse Event|5
7596804|NCT02696031|12002724|FG002|Up to Week 52|Adverse Event|3
7596805|NCT02696031|12002725|FG003|Up to Week 52|Adverse Event|0
7596806|NCT02696031|12002726|FG004|Up to Week 52|Adverse Event|0
7596807|NCT02696031|12002727|FG005|Up to Week 52|Adverse Event|0
7596808|NCT02696031|12002722|FG000|Up to Week 52|Lack of Efficacy|10
7596809|NCT02696031|12002723|FG001|Up to Week 52|Lack of Efficacy|7
7596810|NCT02696031|12002724|FG002|Up to Week 52|Lack of Efficacy|11
7596811|NCT02696031|12002725|FG003|Up to Week 52|Lack of Efficacy|0
7596812|NCT02696031|12002726|FG004|Up to Week 52|Lack of Efficacy|0
7596813|NCT02696031|12002727|FG005|Up to Week 52|Lack of Efficacy|0
7596814|NCT02696031|12002722|FG000|Up to Week 52|Lost to Follow-up|1
7596815|NCT02696031|12002723|FG001|Up to Week 52|Lost to Follow-up|1
7596816|NCT02696031|12002724|FG002|Up to Week 52|Lost to Follow-up|1
7596817|NCT02696031|12002725|FG003|Up to Week 52|Lost to Follow-up|0
7596818|NCT02696031|12002726|FG004|Up to Week 52|Lost to Follow-up|0
7596819|NCT02696031|12002727|FG005|Up to Week 52|Lost to Follow-up|0
7596820|NCT02696031|12002722|FG000|Up to Week 52|Physician Decision|1
7596821|NCT02696031|12002723|FG001|Up to Week 52|Physician Decision|1
7596822|NCT02696031|12002724|FG002|Up to Week 52|Physician Decision|2
7596823|NCT02696031|12002725|FG003|Up to Week 52|Physician Decision|0
7596824|NCT02696031|12002726|FG004|Up to Week 52|Physician Decision|0
7596825|NCT02696031|12002727|FG005|Up to Week 52|Physician Decision|0
7596826|NCT02696031|12002722|FG000|Up to Week 52|Pregnancy|0
7596827|NCT02696031|12002723|FG001|Up to Week 52|Pregnancy|2
7596828|NCT02696031|12002724|FG002|Up to Week 52|Pregnancy|0
7596829|NCT02696031|12002725|FG003|Up to Week 52|Pregnancy|0
7596830|NCT02696031|12002726|FG004|Up to Week 52|Pregnancy|0
7596831|NCT02696031|12002727|FG005|Up to Week 52|Pregnancy|0
7596832|NCT02696031|12002722|FG000|Up to Week 52|Protocol Violation|1
7596833|NCT02696031|12002723|FG001|Up to Week 52|Protocol Violation|0
7596834|NCT02696031|12002724|FG002|Up to Week 52|Protocol Violation|0
7596835|NCT02696031|12002725|FG003|Up to Week 52|Protocol Violation|0
7771870|NCT00885703|12216314|FG005|Overall Study|Lost to Follow-up|1
7771871|NCT00885703|12216315|FG006|Overall Study|Lost to Follow-up|0
7771872|NCT00885703|12216309|FG000|Overall Study|Withdrawal by Subject|0
7771873|NCT00885703|12216310|FG001|Overall Study|Withdrawal by Subject|0
7771874|NCT00885703|12216311|FG002|Overall Study|Withdrawal by Subject|0
7771875|NCT00885703|12216312|FG003|Overall Study|Withdrawal by Subject|1
7771876|NCT00885703|12216313|FG004|Overall Study|Withdrawal by Subject|3
7771877|NCT00885703|12216314|FG005|Overall Study|Withdrawal by Subject|1
7771878|NCT00885703|12216315|FG006|Overall Study|Withdrawal by Subject|1
7771879|NCT00885703|12216309|FG000|Overall Study|Ineligible (no CM)|1
7771880|NCT00885703|12216310|FG001|Overall Study|Ineligible (no CM)|3
7771881|NCT00885703|12216311|FG002|Overall Study|Ineligible (no CM)|2
7771882|NCT00885703|12216312|FG003|Overall Study|Ineligible (no CM)|1
7771883|NCT00885703|12216313|FG004|Overall Study|Ineligible (no CM)|2
7771884|NCT00885703|12216314|FG005|Overall Study|Ineligible (no CM)|3
7771885|NCT00885703|12216315|FG006|Overall Study|Ineligible (no CM)|1
7771886|NCT00885755|12216342|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1
7771887|NCT00885755|12216343|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0
7771888|NCT00885755|12216344|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0
7771889|NCT00885755|12216342|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16
7771890|NCT00885755|12216343|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0
7771891|NCT00885755|12216344|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0
7771892|NCT00885755|12216342|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
7771893|NCT00885755|12216343|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
7771894|NCT00885755|12216344|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
7771895|NCT00885755|12216342|FG000|Part I: Trastuzumab+Taxane|Death|0
7771896|NCT00885755|12216343|FG001|Part I: Trastuzumab+Taxane|Death|0
7771897|NCT00885755|12216344|FG002|Part I: Trastuzumab+Taxane|Death|1
7771898|NCT00885755|12216342|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
7771899|NCT00885755|12216343|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
7771900|NCT00885755|12216344|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
7771901|NCT00885846|12216359|FG000|Overall Study|Withdrawal by Subject|2
7771902|NCT00885846|12216360|FG001|Overall Study|Withdrawal by Subject|5
7771903|NCT00885846|12216361|FG002|Overall Study|Withdrawal by Subject|2
7771904|NCT00886015|12216371|FG000|Overall Study|Death|0
7771905|NCT00886015|12216372|FG001|Overall Study|Death|2
7771906|NCT00886119|12216378|FG000|Period 1|Did not meet inclusion criteria|1
7771907|NCT00886119|12216379|FG001|Period 1|Did not meet inclusion criteria|0
7771908|NCT00886288|12216415|FG000|Overall Study|no respect of the 12 weeks period|657
7771909|NCT00886288|12216416|FG001|Overall Study|no respect of the 12 weeks period|227
7771910|NCT00886288|12216415|FG000|Overall Study|Lost to Follow-up|86
7771911|NCT00886288|12216416|FG001|Overall Study|Lost to Follow-up|0
7771912|NCT00886340|12216426|FG000|Overall Study|Withdrawal by Subject|0
7596836|NCT02696031|12002726|FG004|Up to Week 52|Protocol Violation|0
7596837|NCT02696031|12002727|FG005|Up to Week 52|Protocol Violation|0
7596838|NCT02696031|12002722|FG000|Up to Week 52|Withdrawal by Subject|12
7596839|NCT02696031|12002723|FG001|Up to Week 52|Withdrawal by Subject|3
7596840|NCT02696031|12002724|FG002|Up to Week 52|Withdrawal by Subject|9
7596841|NCT02696031|12002725|FG003|Up to Week 52|Withdrawal by Subject|0
7596842|NCT02696031|12002726|FG004|Up to Week 52|Withdrawal by Subject|0
7596843|NCT02696031|12002727|FG005|Up to Week 52|Withdrawal by Subject|0
7596844|NCT02696031|12002722|FG000|Up to Week 104|Pregnancy|0
7596845|NCT02696031|12002723|FG001|Up to Week 104|Pregnancy|2
7596846|NCT02696031|12002724|FG002|Up to Week 104|Pregnancy|1
7596847|NCT02696031|12002725|FG003|Up to Week 104|Pregnancy|0
7596848|NCT02696031|12002726|FG004|Up to Week 104|Pregnancy|0
7596849|NCT02696031|12002727|FG005|Up to Week 104|Pregnancy|0
7596850|NCT02696031|12002722|FG000|Up to Week 104|Withdrawal by Subject|15
7596851|NCT02696031|12002723|FG001|Up to Week 104|Withdrawal by Subject|10
7596852|NCT02696031|12002724|FG002|Up to Week 104|Withdrawal by Subject|16
7596853|NCT02696031|12002725|FG003|Up to Week 104|Withdrawal by Subject|0
7596854|NCT02696031|12002726|FG004|Up to Week 104|Withdrawal by Subject|0
7596855|NCT02696031|12002727|FG005|Up to Week 104|Withdrawal by Subject|0
7596856|NCT02696031|12002722|FG000|Up to Week 104|Protocol Violation|1
7596857|NCT02696031|12002723|FG001|Up to Week 104|Protocol Violation|0
7596858|NCT02696031|12002724|FG002|Up to Week 104|Protocol Violation|0
7596859|NCT02696031|12002725|FG003|Up to Week 104|Protocol Violation|0
7596860|NCT02696031|12002726|FG004|Up to Week 104|Protocol Violation|0
7596861|NCT02696031|12002727|FG005|Up to Week 104|Protocol Violation|0
7596862|NCT02696031|12002722|FG000|Up to Week 104|Physician Decision|1
7596863|NCT02696031|12002723|FG001|Up to Week 104|Physician Decision|2
7596864|NCT02696031|12002724|FG002|Up to Week 104|Physician Decision|3
7596865|NCT02696031|12002725|FG003|Up to Week 104|Physician Decision|0
7596866|NCT02696031|12002726|FG004|Up to Week 104|Physician Decision|0
7596867|NCT02696031|12002727|FG005|Up to Week 104|Physician Decision|0
7596868|NCT02696031|12002722|FG000|Up to Week 104|Lost to Follow-up|2
7596869|NCT02696031|12002723|FG001|Up to Week 104|Lost to Follow-up|3
7596870|NCT02696031|12002724|FG002|Up to Week 104|Lost to Follow-up|1
7596871|NCT02696031|12002725|FG003|Up to Week 104|Lost to Follow-up|0
7596872|NCT02696031|12002726|FG004|Up to Week 104|Lost to Follow-up|0
7596873|NCT02696031|12002727|FG005|Up to Week 104|Lost to Follow-up|0
7596874|NCT02696031|12002722|FG000|Up to Week 104|Lack of Efficacy|13
7596875|NCT02696031|12002723|FG001|Up to Week 104|Lack of Efficacy|12
7596876|NCT02696031|12002724|FG002|Up to Week 104|Lack of Efficacy|11
7596877|NCT02696031|12002725|FG003|Up to Week 104|Lack of Efficacy|0
7596878|NCT02696031|12002726|FG004|Up to Week 104|Lack of Efficacy|0
7596879|NCT02696031|12002727|FG005|Up to Week 104|Lack of Efficacy|0
7596880|NCT02696031|12002722|FG000|Up to Week 104|Adverse Event|7
7596881|NCT02696031|12002723|FG001|Up to Week 104|Adverse Event|11
7771913|NCT00886340|12216427|FG001|Overall Study|Withdrawal by Subject|7
7771914|NCT00886379|12216438|FG000|Overall Study|Transferred Schools|0
7596882|NCT02696031|12002724|FG002|Up to Week 104|Adverse Event|5
7596883|NCT02696031|12002725|FG003|Up to Week 104|Adverse Event|0
7596884|NCT02696031|12002726|FG004|Up to Week 104|Adverse Event|0
7596885|NCT02696031|12002727|FG005|Up to Week 104|Adverse Event|0
7596886|NCT02696031|12002722|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
7596887|NCT02696031|12002723|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1
7596888|NCT02696031|12002724|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
7596889|NCT02696031|12002725|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
7596890|NCT02696031|12002726|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
7596891|NCT02696031|12002727|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
7596892|NCT02696031|12002722|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0
7596893|NCT02696031|12002723|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0
7596894|NCT02696031|12002724|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0
7596895|NCT02696031|12002725|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6
7596896|NCT02696031|12002726|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8
7596897|NCT02696031|12002727|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2
7596898|NCT02696031|12002722|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0
7596899|NCT02696031|12002723|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0
7596900|NCT02696031|12002724|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0
7596901|NCT02696031|12002725|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1
7596902|NCT02696031|12002726|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1
7596903|NCT02696031|12002727|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0
7596904|NCT02696031|12002722|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
7596905|NCT02696031|12002723|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
7596906|NCT02696031|12002724|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
7596907|NCT02696031|12002725|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1
7596908|NCT02696031|12002726|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
7596909|NCT02696031|12002727|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
7596910|NCT02696031|12002722|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
7596911|NCT02696031|12002723|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
7596912|NCT02696031|12002724|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
7596913|NCT02696031|12002725|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
7596914|NCT02696031|12002726|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1
7596915|NCT02696031|12002727|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
7596916|NCT02696031|12002722|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0
7596917|NCT02696031|12002723|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0
7596918|NCT02696031|12002724|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0
7596919|NCT02696031|12002725|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1
7596920|NCT02696031|12002726|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1
7596921|NCT02696031|12002727|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3
7596922|NCT02696031|12002722|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0
7596923|NCT02696031|12002723|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0
7596924|NCT02696031|12002724|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0
7596925|NCT02696031|12002725|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1
7596926|NCT02696031|12002726|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4
7596927|NCT02696031|12002727|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1
7596928|NCT02689453|12002739|FG000|Overall Study|Progressive disease|0
7596929|NCT02689453|12002740|FG001|Overall Study|Progressive disease|1
7596930|NCT02689453|12002741|FG002|Overall Study|Progressive disease|1
7596931|NCT02476851|12002753|FG000|Overall Study|Protocol Violation|1
7596932|NCT02476851|12002754|FG001|Overall Study|Protocol Violation|1
7596933|NCT02208024|12002779|FG000|Overall Study|Withdrawal by Subject|1
7596934|NCT01866111|12002787|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14
7596935|NCT01866111|12002788|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13
7596936|NCT01866111|12002789|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20
7596937|NCT01866111|12002790|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30
7596938|NCT01866111|12002787|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65
7596939|NCT01866111|12002788|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67
7596940|NCT01866111|12002789|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63
7596941|NCT01866111|12002790|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52
7596942|NCT01767129|12002800|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
7596943|NCT01767129|12002801|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
7596949|NCT01586910|12002832|FG000|Overall Study|Death|4
7596950|NCT01586910|12002833|FG001|Overall Study|Death|4
7596951|NCT01586910|12002832|FG000|Overall Study|Withdrawal by Subject|6
7596952|NCT01586910|12002833|FG001|Overall Study|Withdrawal by Subject|43
7596953|NCT01586910|12002832|FG000|Overall Study|Physician withdrew Subject|5
7596954|NCT01586910|12002833|FG001|Overall Study|Physician withdrew Subject|24
7771915|NCT00886379|12216439|FG001|Overall Study|Transferred Schools|0
7771916|NCT00886379|12216440|FG002|Overall Study|Transferred Schools|2
7771917|NCT00886379|12216441|FG003|Overall Study|Transferred Schools|1
7771918|NCT00886379|12216442|FG004|Overall Study|Transferred Schools|1
7771919|NCT00886379|12216438|FG000|Overall Study|Final blood draw not obtained|3
7771920|NCT00886379|12216439|FG001|Overall Study|Final blood draw not obtained|3
7771921|NCT00886379|12216440|FG002|Overall Study|Final blood draw not obtained|4
7771922|NCT00886379|12216441|FG003|Overall Study|Final blood draw not obtained|2
7771923|NCT00886379|12216442|FG004|Overall Study|Final blood draw not obtained|2
7799916|NCT01090323|12257097|FG000|Overall Study|Stopped end of core|7
7799917|NCT01090323|12257098|FG001|Overall Study|Stopped end of core|0
7799918|NCT01090323|12257097|FG000|Overall Study|Stopped end of extension 1#|3
7799919|NCT01090323|12257098|FG001|Overall Study|Stopped end of extension 1#|1
7799920|NCT01090414|12257108|FG000|Study 101-99|Progressive Disease|28
7799921|NCT01090414|12257109|FG001|Study 101-99|Progressive Disease|48
7799922|NCT01090414|12257110|FG002|Study 101-99|Progressive Disease|10
7799923|NCT01090414|12257111|FG003|Study 101-99|Progressive Disease|4
7799924|NCT01090414|12257108|FG000|Study 101-99|Adverse Event|10
7799925|NCT01090414|12257109|FG001|Study 101-99|Adverse Event|28
7799926|NCT01090414|12257110|FG002|Study 101-99|Adverse Event|18
7799927|NCT01090414|12257111|FG003|Study 101-99|Adverse Event|0
7799928|NCT01090414|12257108|FG000|Study 101-99|Investigator Request|1
7799929|NCT01090414|12257109|FG001|Study 101-99|Investigator Request|11
7596998|NCT00504582|12002900|FG000|Overall Study|Lost to Follow-up|1
7596999|NCT00504582|12002901|FG001|Overall Study|Lost to Follow-up|0
7597000|NCT00504582|12002902|FG002|Overall Study|Lost to Follow-up|0
7597001|NCT02257918|12002923|FG000|Overall Study|Lost to Follow-up|4
7597002|NCT02257918|12002924|FG001|Overall Study|Lost to Follow-up|1
7597003|NCT02257918|12002925|FG002|Overall Study|Lost to Follow-up|0
7597004|NCT02257918|12002923|FG000|Overall Study|Withdrawal by Subject|0
7597005|NCT02257918|12002924|FG001|Overall Study|Withdrawal by Subject|0
7597006|NCT02257918|12002925|FG002|Overall Study|Withdrawal by Subject|1
7597007|NCT02257918|12002923|FG000|Overall Study|Pregnancy|0
7597008|NCT02257918|12002924|FG001|Overall Study|Pregnancy|0
7597009|NCT02257918|12002925|FG002|Overall Study|Pregnancy|1
7597010|NCT02258542|12002937|FG000|Overall Study|eg. not made to the visit|7
7597011|NCT02258542|12002938|FG001|Overall Study|eg. not made to the visit|4
7597012|NCT02258542|12002939|FG002|Overall Study|eg. not made to the visit|0
7597013|NCT02258542|12002940|FG003|Overall Study|eg. not made to the visit|1
7597014|NCT02258542|12002937|FG000|Overall Study|study specific discount. criteria|1
7597015|NCT02258542|12002938|FG001|Overall Study|study specific discount. criteria|1
7597016|NCT02258542|12002939|FG002|Overall Study|study specific discount. criteria|0
7597017|NCT02258542|12002940|FG003|Overall Study|study specific discount. criteria|0
7597018|NCT02258542|12002937|FG000|Overall Study|Withdrawal by Subject|20
7597019|NCT02258542|12002938|FG001|Overall Study|Withdrawal by Subject|20
7597020|NCT02258542|12002939|FG002|Overall Study|Withdrawal by Subject|7
7597021|NCT02258542|12002940|FG003|Overall Study|Withdrawal by Subject|1
7597022|NCT02258542|12002937|FG000|Overall Study|Lost to Follow-up|5
7597023|NCT02258542|12002938|FG001|Overall Study|Lost to Follow-up|12
7597024|NCT02258542|12002939|FG002|Overall Study|Lost to Follow-up|1
7597025|NCT02258542|12002940|FG003|Overall Study|Lost to Follow-up|2
7799930|NCT01090414|12257110|FG002|Study 101-99|Investigator Request|4
7799931|NCT01090414|12257111|FG003|Study 101-99|Investigator Request|0
7799932|NCT01090414|12257108|FG000|Study 101-99|Death|3
7799933|NCT01090414|12257109|FG001|Study 101-99|Death|8
7799934|NCT01090414|12257110|FG002|Study 101-99|Death|1
7799935|NCT01090414|12257111|FG003|Study 101-99|Death|0
7799936|NCT01090414|12257108|FG000|Study 101-99|Sponsor Discontinued Study|0
7799937|NCT01090414|12257109|FG001|Study 101-99|Sponsor Discontinued Study|7
7799938|NCT01090414|12257110|FG002|Study 101-99|Sponsor Discontinued Study|5
7799939|NCT01090414|12257111|FG003|Study 101-99|Sponsor Discontinued Study|0
7799940|NCT01090414|12257108|FG000|Study 101-99|Other (Unknown Reasons)|3
7799941|NCT01090414|12257109|FG001|Study 101-99|Other (Unknown Reasons)|3
7799942|NCT01090414|12257110|FG002|Study 101-99|Other (Unknown Reasons)|0
7799943|NCT01090414|12257111|FG003|Study 101-99|Other (Unknown Reasons)|0
7799944|NCT01090414|12257108|FG000|Study 101-99|Withdrew Consent|0
7799945|NCT01090414|12257109|FG001|Study 101-99|Withdrew Consent|2
7799946|NCT01090414|12257110|FG002|Study 101-99|Withdrew Consent|3
7799947|NCT01090414|12257111|FG003|Study 101-99|Withdrew Consent|1
7799948|NCT01090414|12257108|FG000|Study 101-99|Participant Request|3
7799949|NCT01090414|12257109|FG001|Study 101-99|Participant Request|1
7799950|NCT01090414|12257110|FG002|Study 101-99|Participant Request|0
7799951|NCT01090414|12257111|FG003|Study 101-99|Participant Request|0
7799952|NCT01090427|12257136|FG000|After Controlled Period|Death|0
7799953|NCT01090427|12257137|FG001|After Controlled Period|Death|0
7799954|NCT01090427|12257138|FG002|After Controlled Period|Death|0
7799955|NCT01090427|12257139|FG003|After Controlled Period|Death|0
7799956|NCT01090427|12257140|FG004|After Controlled Period|Death|0
7799957|NCT01090427|12257141|FG005|After Controlled Period|Death|1
7799958|NCT01090427|12257142|FG006|After Controlled Period|Death|0
7799959|NCT01090427|12257136|FG000|After Controlled Period|Lack of Efficacy|0
7799960|NCT01090427|12257137|FG001|After Controlled Period|Lack of Efficacy|0
7799961|NCT01090427|12257138|FG002|After Controlled Period|Lack of Efficacy|0
7799962|NCT01090427|12257139|FG003|After Controlled Period|Lack of Efficacy|0
7799963|NCT01090427|12257140|FG004|After Controlled Period|Lack of Efficacy|0
7799964|NCT01090427|12257141|FG005|After Controlled Period|Lack of Efficacy|3
7771924|NCT00886483|12216456|FG000|Overall Study|Lost to Follow-up|0
7771925|NCT00886483|12216457|FG001|Overall Study|Lost to Follow-up|1
7771926|NCT00886483|12216456|FG000|Overall Study|Pursue medications|1
7771927|NCT00886483|12216457|FG001|Overall Study|Pursue medications|2
7771928|NCT00886483|12216456|FG000|Overall Study|Distance to center, poor grades|1
7771929|NCT00886483|12216457|FG001|Overall Study|Distance to center, poor grades|0
7771930|NCT00886587|12216473|FG000|Overall Study|Adverse Event|2
7771931|NCT00886587|12216474|FG001|Overall Study|Adverse Event|1
7771932|NCT00886587|12216473|FG000|Overall Study|Protocol Violation|2
7771933|NCT00886587|12216474|FG001|Overall Study|Protocol Violation|0
7771934|NCT00886587|12216473|FG000|Overall Study|Withdrawal by Subject|0
7771935|NCT00886587|12216474|FG001|Overall Study|Withdrawal by Subject|1
7771936|NCT00886613|12216483|FG000|Overall Study|Protocol deviation (Part B)|1
7771937|NCT00886613|12216484|FG001|Overall Study|Protocol deviation (Part B)|0
7771938|NCT00886613|12216485|FG002|Overall Study|Protocol deviation (Part B)|0
7597026|NCT02258542|12002937|FG000|Overall Study|Death|5
7597027|NCT02258542|12002938|FG001|Overall Study|Death|4
7597028|NCT02258542|12002939|FG002|Overall Study|Death|0
7771939|NCT00886613|12216483|FG000|Overall Study|Lost to follow-up (Part B)|1
7771940|NCT00886613|12216484|FG001|Overall Study|Lost to follow-up (Part B)|0
7771941|NCT00886613|12216485|FG002|Overall Study|Lost to follow-up (Part B)|1
7597029|NCT02258542|12002940|FG003|Overall Study|Death|1
7597030|NCT02258542|12002937|FG000|Overall Study|Adverse Event|3
7597031|NCT02258542|12002938|FG001|Overall Study|Adverse Event|4
7597032|NCT02258542|12002939|FG002|Overall Study|Adverse Event|0
7597033|NCT02258542|12002940|FG003|Overall Study|Adverse Event|0
7597034|NCT02258542|12002937|FG000|Overall Study|Protocol Violation|1
7597035|NCT02258542|12002938|FG001|Overall Study|Protocol Violation|2
7597036|NCT02258542|12002939|FG002|Overall Study|Protocol Violation|0
7597037|NCT02258542|12002940|FG003|Overall Study|Protocol Violation|0
7597038|NCT02258542|12002937|FG000|Overall Study|Eligibility criteria not fulfilled|0
7597039|NCT02258542|12002938|FG001|Overall Study|Eligibility criteria not fulfilled|2
7597040|NCT02258542|12002939|FG002|Overall Study|Eligibility criteria not fulfilled|0
7597041|NCT02258542|12002940|FG003|Overall Study|Eligibility criteria not fulfilled|0
7597042|NCT02290431|12002968|FG000|Overall Study|Adverse Event|20
7597043|NCT02290431|12002968|FG000|Overall Study|Progressive disease|4
7597044|NCT02290431|12002968|FG000|Overall Study|Study terminated by Sponsor|1
7597045|NCT02290431|12002968|FG000|Overall Study|Physician Decision|2
7597046|NCT02314923|12002982|FG000|Overall Study|Death|0
7597047|NCT02314923|12002983|FG001|Overall Study|Death|0
7597048|NCT02314923|12002984|FG002|Overall Study|Death|0
7597049|NCT02314923|12002985|FG003|Overall Study|Death|1
7597050|NCT02314923|12002986|FG004|Overall Study|Death|0
7597051|NCT02314923|12002987|FG005|Overall Study|Death|0
7597052|NCT02314923|12002988|FG006|Overall Study|Death|0
7597053|NCT02314923|12002989|FG007|Overall Study|Death|0
7597054|NCT02314923|12002990|FG008|Overall Study|Death|0
7597055|NCT02314923|12002991|FG009|Overall Study|Death|0
7597056|NCT02314923|12002982|FG000|Overall Study|Lost to Follow-up|2
7597057|NCT02314923|12002983|FG001|Overall Study|Lost to Follow-up|3
7597058|NCT02314923|12002984|FG002|Overall Study|Lost to Follow-up|1
7597059|NCT02314923|12002985|FG003|Overall Study|Lost to Follow-up|0
7597060|NCT02314923|12002986|FG004|Overall Study|Lost to Follow-up|0
7597061|NCT02314923|12002987|FG005|Overall Study|Lost to Follow-up|0
7597062|NCT02314923|12002988|FG006|Overall Study|Lost to Follow-up|3
7597063|NCT02314923|12002989|FG007|Overall Study|Lost to Follow-up|4
7597064|NCT02314923|12002990|FG008|Overall Study|Lost to Follow-up|2
7597065|NCT02314923|12002991|FG009|Overall Study|Lost to Follow-up|0
7597066|NCT02314923|12002982|FG000|Overall Study|Withdrawal by Subject|0
7597067|NCT02314923|12002983|FG001|Overall Study|Withdrawal by Subject|0
7597068|NCT02314923|12002984|FG002|Overall Study|Withdrawal by Subject|1
7597069|NCT02314923|12002985|FG003|Overall Study|Withdrawal by Subject|0
7597070|NCT02314923|12002986|FG004|Overall Study|Withdrawal by Subject|1
7597071|NCT02314923|12002987|FG005|Overall Study|Withdrawal by Subject|0
7597072|NCT02314923|12002988|FG006|Overall Study|Withdrawal by Subject|1
7597073|NCT02314923|12002989|FG007|Overall Study|Withdrawal by Subject|0
7597074|NCT02314923|12002990|FG008|Overall Study|Withdrawal by Subject|0
7597075|NCT02314923|12002991|FG009|Overall Study|Withdrawal by Subject|0
7597076|NCT02314923|12002982|FG000|Overall Study|Physician Decision|0
7597077|NCT02314923|12002983|FG001|Overall Study|Physician Decision|1
7597078|NCT02314923|12002984|FG002|Overall Study|Physician Decision|0
7597079|NCT02314923|12002985|FG003|Overall Study|Physician Decision|0
7597080|NCT02314923|12002986|FG004|Overall Study|Physician Decision|0
7597081|NCT02314923|12002987|FG005|Overall Study|Physician Decision|0
7597082|NCT02314923|12002988|FG006|Overall Study|Physician Decision|0
7597083|NCT02314923|12002989|FG007|Overall Study|Physician Decision|0
7597084|NCT02314923|12002990|FG008|Overall Study|Physician Decision|0
7597085|NCT02314923|12002991|FG009|Overall Study|Physician Decision|0
7597086|NCT02314923|12002982|FG000|Overall Study|Participant unavailable|0
7597087|NCT02314923|12002983|FG001|Overall Study|Participant unavailable|0
7597088|NCT02314923|12002984|FG002|Overall Study|Participant unavailable|0
7597089|NCT02314923|12002985|FG003|Overall Study|Participant unavailable|0
7597090|NCT02314923|12002986|FG004|Overall Study|Participant unavailable|0
7597091|NCT02314923|12002987|FG005|Overall Study|Participant unavailable|1
7597092|NCT02314923|12002988|FG006|Overall Study|Participant unavailable|0
7597093|NCT02314923|12002989|FG007|Overall Study|Participant unavailable|0
7597094|NCT02314923|12002990|FG008|Overall Study|Participant unavailable|0
7597095|NCT02314923|12002991|FG009|Overall Study|Participant unavailable|0
7597096|NCT02314923|12002982|FG000|Overall Study|Screen failure|0
7597097|NCT02314923|12002983|FG001|Overall Study|Screen failure|0
7597098|NCT02314923|12002984|FG002|Overall Study|Screen failure|0
7597099|NCT02314923|12002985|FG003|Overall Study|Screen failure|0
7597100|NCT02314923|12002986|FG004|Overall Study|Screen failure|0
7597101|NCT02314923|12002987|FG005|Overall Study|Screen failure|0
7597102|NCT02314923|12002988|FG006|Overall Study|Screen failure|1
7597103|NCT02314923|12002989|FG007|Overall Study|Screen failure|0
7597104|NCT02314923|12002990|FG008|Overall Study|Screen failure|0
7597105|NCT02314923|12002991|FG009|Overall Study|Screen failure|0
7597106|NCT02314923|12002982|FG000|Overall Study|Participant relocation|1
7597107|NCT02314923|12002983|FG001|Overall Study|Participant relocation|0
7597108|NCT02314923|12002984|FG002|Overall Study|Participant relocation|0
7597109|NCT02314923|12002985|FG003|Overall Study|Participant relocation|0
7597110|NCT02314923|12002986|FG004|Overall Study|Participant relocation|0
7597111|NCT02314923|12002987|FG005|Overall Study|Participant relocation|0
7597112|NCT02314923|12002988|FG006|Overall Study|Participant relocation|0
7597113|NCT02314923|12002989|FG007|Overall Study|Participant relocation|1
7597114|NCT02314923|12002990|FG008|Overall Study|Participant relocation|0
7597115|NCT02314923|12002991|FG009|Overall Study|Participant relocation|0
7597116|NCT04524507|12003032|FG000|Overall Study|Lost to Follow-up|2
7597117|NCT04524507|12003033|FG001|Overall Study|Lost to Follow-up|4
7597118|NCT04524507|12003032|FG000|Overall Study|Withdrawal by Subject|2
7597119|NCT04524507|12003033|FG001|Overall Study|Withdrawal by Subject|9
7597120|NCT04524507|12003032|FG000|Overall Study|Death|2
7597121|NCT04524507|12003033|FG001|Overall Study|Death|10
7597122|NCT04382924|12003042|FG000|Overall Study|Death|2
7597123|NCT04382924|12003043|FG001|Overall Study|Death|5
7597124|NCT04382924|12003044|FG002|Overall Study|Death|4
7597125|NCT04382924|12003042|FG000|Overall Study|Protocol Violation|0
7597126|NCT04382924|12003043|FG001|Overall Study|Protocol Violation|1
7597127|NCT04382924|12003044|FG002|Overall Study|Protocol Violation|1
7597128|NCT04382924|12003042|FG000|Overall Study|Transferred to other hospital/declined in person visits|0
7597129|NCT04382924|12003043|FG001|Overall Study|Transferred to other hospital/declined in person visits|1
7597130|NCT04382924|12003044|FG002|Overall Study|Transferred to other hospital/declined in person visits|1
7597131|NCT04382924|12003042|FG000|Overall Study|Withdrawal by Subject|6
7597132|NCT04382924|12003043|FG001|Overall Study|Withdrawal by Subject|3
7597133|NCT04382924|12003044|FG002|Overall Study|Withdrawal by Subject|6
7799965|NCT01090427|12257142|FG006|After Controlled Period|Lack of Efficacy|2
7597134|NCT03842436|12003075|FG000|Overall Study|Lost to Follow-up|1
7597135|NCT03462030|12003096|FG000|Overall Study|Withdrawal by Subject|1
7597136|NCT03462030|12003097|FG001|Overall Study|Withdrawal by Subject|1
7597137|NCT03446768|12003105|FG000|Overall Study|Withdrawal by Subject|0
7597138|NCT03446768|12003106|FG001|Overall Study|Withdrawal by Subject|1
7597139|NCT03253393|12003151|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6
7597140|NCT03253393|12003152|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7
7597141|NCT03253393|12003153|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0
7597142|NCT03188822|12003167|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6
7597143|NCT03188822|12003167|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1
7597144|NCT03128671|12003173|FG000|Allocation|ICU discharge prior to intervention initiation|4
7597145|NCT03128671|12003174|FG001|Allocation|ICU discharge prior to intervention initiation|0
7597146|NCT03128671|12003173|FG000|Allocation|Death|1
7597147|NCT03128671|12003174|FG001|Allocation|Death|0
7597148|NCT03128671|12003173|FG000|Allocation|Withdrawal by Subject|4
7597149|NCT03128671|12003174|FG001|Allocation|Withdrawal by Subject|0
7597150|NCT03128671|12003173|FG000|Intervention|Withdrawal by Subject|11
7597151|NCT03128671|12003174|FG001|Intervention|Withdrawal by Subject|10
7597152|NCT03128671|12003173|FG000|Intervention|Palliative/hospice care initiated|9
7597153|NCT03128671|12003174|FG001|Intervention|Palliative/hospice care initiated|10
7597154|NCT03128671|12003173|FG000|Intervention|Death|13
7597155|NCT03128671|12003174|FG001|Intervention|Death|11
7597156|NCT03128671|12003173|FG000|Intervention|Interrupted by hurricane|1
7597157|NCT03128671|12003174|FG001|Intervention|Interrupted by hurricane|0
7597158|NCT03128671|12003173|FG000|Intervention|Physician Decision|2
7597159|NCT03128671|12003174|FG001|Intervention|Physician Decision|3
7597160|NCT03111732|12003180|FG000|Overall Study|Enrolled in different study|1
7597161|NCT03111732|12003180|FG000|Overall Study|Progressive disease|3
7597162|NCT03111732|12003180|FG000|Overall Study|Withdrawal by Subject|1
7597163|NCT03065244|12003191|FG000|Overall Study|Lost to Follow-up|1
7597164|NCT03065244|12003192|FG001|Overall Study|Lost to Follow-up|1
7597165|NCT03065244|12003191|FG000|Overall Study|Diagnosed with a different disease|1
7597166|NCT03065244|12003192|FG001|Overall Study|Diagnosed with a different disease|1
7597167|NCT03065244|12003191|FG000|Overall Study|Protocol Violation|0
7597168|NCT03065244|12003192|FG001|Overall Study|Protocol Violation|1
7597169|NCT03065244|12003191|FG000|Overall Study|Withdrawal by Subject|1
7597170|NCT03065244|12003192|FG001|Overall Study|Withdrawal by Subject|1
7597171|NCT02879305|12003200|FG000|Overall Study|Investigator Site Closed|55
7597172|NCT02879305|12003201|FG001|Overall Study|Investigator Site Closed|57
7597173|NCT02879305|12003200|FG000|Overall Study|Withdrawal by Subject|44
7597174|NCT02879305|12003201|FG001|Overall Study|Withdrawal by Subject|42
7597175|NCT02879305|12003200|FG000|Overall Study|Lost to Follow-up|17
7597176|NCT02879305|12003201|FG001|Overall Study|Lost to Follow-up|12
7597177|NCT02879305|12003200|FG000|Overall Study|Other|1
7597178|NCT02879305|12003201|FG001|Overall Study|Other|0
7597179|NCT02787850|12003218|FG000|Overall Study|Withdrawal by Subject|0
7597180|NCT02787850|12003219|FG001|Overall Study|Withdrawal by Subject|1
7597181|NCT02676284|12003238|FG000|Overall Study|Withdrawal by Subject|1
7597182|NCT02431702|12003242|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7
7597183|NCT02431702|12003243|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7597184|NCT02431702|12003244|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7597185|NCT02431702|12003245|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7597186|NCT02431702|12003246|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7597187|NCT02431702|12003247|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7597188|NCT02431702|12003248|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7597189|NCT02431702|12003242|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11
7597190|NCT02431702|12003243|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7597191|NCT02431702|12003244|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7597192|NCT02431702|12003245|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7597193|NCT02431702|12003246|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7597194|NCT02431702|12003247|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7597195|NCT02431702|12003248|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23
7597196|NCT02431702|12003242|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9
7597197|NCT02431702|12003243|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7597198|NCT02431702|12003244|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7597199|NCT02431702|12003245|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7597200|NCT02431702|12003246|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7597201|NCT02431702|12003247|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7597202|NCT02431702|12003248|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6
7597203|NCT02431702|12003242|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5
7597204|NCT02431702|12003243|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0
7597205|NCT02431702|12003244|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0
7597206|NCT02431702|12003245|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0
7597207|NCT02431702|12003246|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0
7597208|NCT02431702|12003247|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0
7597209|NCT02431702|12003248|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3
7597210|NCT02431702|12003242|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2
7771942|NCT00886613|12216483|FG000|Overall Study|Subject withdrew consent (Part A)|0
7771943|NCT00886613|12216484|FG001|Overall Study|Subject withdrew consent (Part A)|0
7771944|NCT00886613|12216485|FG002|Overall Study|Subject withdrew consent (Part A)|2
7771945|NCT00886639|12216503|FG000|Overall Study|acute exacerbation|14
7771946|NCT00886639|12216503|FG000|Overall Study|non-compliance|2
7771947|NCT00886743|12216518|FG000|Overall Study|Adverse Event|3
7771948|NCT00886743|12216518|FG000|Overall Study|Other|1
7771949|NCT00886769|12216524|FG000|Overall Study|Unsatisfactory therapeutic effect|6
7771950|NCT00886769|12216525|FG001|Overall Study|Unsatisfactory therapeutic effect|37
7771951|NCT00886795|12216531|FG000|Overall Study|Lack of Efficacy|1
7771952|NCT00886821|12216550|FG000|Stage 2|Adverse Event|0
7771953|NCT00886821|12216551|FG001|Stage 2|Adverse Event|0
7771954|NCT00886821|12216552|FG002|Stage 2|Adverse Event|0
7771955|NCT00886821|12216553|FG003|Stage 2|Adverse Event|0
7771956|NCT00886821|12216554|FG004|Stage 2|Adverse Event|0
7771957|NCT00886821|12216555|FG005|Stage 2|Adverse Event|0
7771958|NCT00886821|12216556|FG006|Stage 2|Adverse Event|0
7771959|NCT00886821|12216557|FG007|Stage 2|Adverse Event|0
7771960|NCT00886821|12216558|FG008|Stage 2|Adverse Event|0
7771961|NCT00886821|12216559|FG009|Stage 2|Adverse Event|0
7771962|NCT00886821|12216560|FG010|Stage 2|Adverse Event|0
7771963|NCT00886821|12216561|FG011|Stage 2|Adverse Event|1
7771964|NCT00886821|12216562|FG012|Stage 2|Adverse Event|3
7771965|NCT00886821|12216563|FG013|Stage 2|Adverse Event|0
7771966|NCT00886821|12216550|FG000|Stage 2|Lost to Follow-up|0
7771967|NCT00886821|12216551|FG001|Stage 2|Lost to Follow-up|0
7771968|NCT00886821|12216552|FG002|Stage 2|Lost to Follow-up|0
7771969|NCT00886821|12216553|FG003|Stage 2|Lost to Follow-up|0
7771970|NCT00886821|12216554|FG004|Stage 2|Lost to Follow-up|0
7771971|NCT00886821|12216555|FG005|Stage 2|Lost to Follow-up|0
7771972|NCT00886821|12216556|FG006|Stage 2|Lost to Follow-up|0
7771973|NCT00886821|12216557|FG007|Stage 2|Lost to Follow-up|0
7771974|NCT00886821|12216558|FG008|Stage 2|Lost to Follow-up|0
7771975|NCT00886821|12216559|FG009|Stage 2|Lost to Follow-up|0
7771976|NCT00886821|12216560|FG010|Stage 2|Lost to Follow-up|0
7771977|NCT00886821|12216561|FG011|Stage 2|Lost to Follow-up|0
7771978|NCT00886821|12216562|FG012|Stage 2|Lost to Follow-up|2
7771979|NCT00886821|12216563|FG013|Stage 2|Lost to Follow-up|1
7771980|NCT00886834|12216609|FG000|Overall Study|Protocol Violation|0
7771981|NCT00886834|12216610|FG001|Overall Study|Protocol Violation|3
7771982|NCT00886938|12216620|FG000|Overall Study|Adverse Event|1
7771983|NCT00886938|12216620|FG000|Overall Study|Withdrawal by Subject|1
7771984|NCT00887068|12216626|FG000|Overall Study|Withdrawal by Subject|2
7771985|NCT00887068|12216627|FG001|Overall Study|Withdrawal by Subject|0
7771986|NCT00887068|12216626|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4
7771987|NCT00887068|12216627|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0
7771988|NCT00887159|12216636|FG000|Overall Study|Disease progression|6
7771989|NCT00887159|12216637|FG001|Overall Study|Disease progression|39
7771990|NCT00887159|12216638|FG002|Overall Study|Disease progression|33
7771991|NCT00887159|12216636|FG000|Overall Study|Adverse Event|3
7771992|NCT00887159|12216637|FG001|Overall Study|Adverse Event|4
7771993|NCT00887159|12216638|FG002|Overall Study|Adverse Event|17
7771994|NCT00887159|12216636|FG000|Overall Study|Death|2
7771995|NCT00887159|12216637|FG001|Overall Study|Death|2
7771996|NCT00887159|12216638|FG002|Overall Study|Death|0
7771997|NCT00887159|12216636|FG000|Overall Study|Withdrawal by Subject|4
7771998|NCT00887159|12216637|FG001|Overall Study|Withdrawal by Subject|4
7771999|NCT00887159|12216638|FG002|Overall Study|Withdrawal by Subject|2
7772000|NCT00887159|12216636|FG000|Overall Study|Alternative therapy|2
7772001|NCT00887159|12216637|FG001|Overall Study|Alternative therapy|0
7772002|NCT00887159|12216638|FG002|Overall Study|Alternative therapy|0
7772003|NCT00887159|12216636|FG000|Overall Study|Physician Decision|1
7772004|NCT00887159|12216637|FG001|Overall Study|Physician Decision|1
7772005|NCT00887159|12216638|FG002|Overall Study|Physician Decision|0
7772006|NCT00887159|12216636|FG000|Overall Study|Sympomatic deterioration|1
7772007|NCT00887159|12216637|FG001|Overall Study|Sympomatic deterioration|0
7772008|NCT00887159|12216638|FG002|Overall Study|Sympomatic deterioration|0
7597211|NCT02431702|12003243|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7597212|NCT02431702|12003244|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7597213|NCT02431702|12003245|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7597214|NCT02431702|12003246|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7597215|NCT02431702|12003247|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7597216|NCT02431702|12003248|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7597217|NCT02431702|12003242|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7597218|NCT02431702|12003243|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5
7597219|NCT02431702|12003244|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1
7597220|NCT02431702|12003245|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7597221|NCT02431702|12003246|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7597222|NCT02431702|12003247|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7597223|NCT02431702|12003248|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7597224|NCT02431702|12003242|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7597225|NCT02431702|12003243|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6
7597226|NCT02431702|12003244|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13
7597227|NCT02431702|12003245|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7597228|NCT02431702|12003246|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7597229|NCT02431702|12003247|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7597230|NCT02431702|12003248|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7597231|NCT02431702|12003242|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7597232|NCT02431702|12003243|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11
7597233|NCT02431702|12003244|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8
7597234|NCT02431702|12003245|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7772009|NCT00887159|12216636|FG000|Overall Study|Treatment delayed|1
7597235|NCT02431702|12003246|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7597236|NCT02431702|12003247|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7597237|NCT02431702|12003248|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7597238|NCT02431702|12003242|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7597239|NCT02431702|12003243|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2
7597240|NCT02431702|12003244|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7597241|NCT02431702|12003245|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7597242|NCT02431702|12003246|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7597243|NCT02431702|12003247|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7597244|NCT02431702|12003248|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7597245|NCT02431702|12003242|FG000|Part 2: 9Month Disease Progression Phase|Other|0
7597246|NCT02431702|12003243|FG001|Part 2: 9Month Disease Progression Phase|Other|2
7597247|NCT02431702|12003244|FG002|Part 2: 9Month Disease Progression Phase|Other|2
7597248|NCT02431702|12003245|FG003|Part 2: 9Month Disease Progression Phase|Other|0
7597249|NCT02431702|12003246|FG004|Part 2: 9Month Disease Progression Phase|Other|0
7597250|NCT02431702|12003247|FG005|Part 2: 9Month Disease Progression Phase|Other|0
7597251|NCT02431702|12003248|FG006|Part 2: 9Month Disease Progression Phase|Other|0
7597252|NCT02431702|12003242|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7597253|NCT02431702|12003243|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7597254|NCT02431702|12003244|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5
7597255|NCT02431702|12003245|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7597256|NCT02431702|12003246|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7597257|NCT02431702|12003247|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7772010|NCT00887159|12216637|FG001|Overall Study|Treatment delayed|1
7772011|NCT00887159|12216638|FG002|Overall Study|Treatment delayed|0
7772012|NCT00887159|12216636|FG000|Overall Study|Pt had PD but was SD when re-measured|0
7597258|NCT02431702|12003248|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7597259|NCT02431702|12003242|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7597260|NCT02431702|12003243|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7597261|NCT02431702|12003244|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7597262|NCT02431702|12003245|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2
7597263|NCT02431702|12003246|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3
7597264|NCT02431702|12003247|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7597265|NCT02431702|12003248|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7597266|NCT02431702|12003242|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7597267|NCT02431702|12003243|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7597268|NCT02431702|12003244|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7597269|NCT02431702|12003245|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1
7597270|NCT02431702|12003246|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7597271|NCT02431702|12003247|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5
7597272|NCT02431702|12003248|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7597273|NCT02431702|12003242|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7597274|NCT02431702|12003243|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7597275|NCT02431702|12003244|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7597276|NCT02431702|12003245|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5
7597277|NCT02431702|12003246|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
7597278|NCT02431702|12003247|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
7597279|NCT02431702|12003248|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7597280|NCT02431702|12003242|FG000|Part 3: 9 Month of Additional Treatment|Other|0
7597281|NCT02431702|12003243|FG001|Part 3: 9 Month of Additional Treatment|Other|0
7597282|NCT02431702|12003244|FG002|Part 3: 9 Month of Additional Treatment|Other|0
7597283|NCT02431702|12003245|FG003|Part 3: 9 Month of Additional Treatment|Other|1
7597284|NCT02431702|12003246|FG004|Part 3: 9 Month of Additional Treatment|Other|1
7597285|NCT02431702|12003247|FG005|Part 3: 9 Month of Additional Treatment|Other|6
7597286|NCT02431702|12003248|FG006|Part 3: 9 Month of Additional Treatment|Other|0
7597287|NCT02200770|12003285|FG000|Randomized-controlled Period (RCP)|Adverse Event|0
7597288|NCT02200770|12003286|FG001|Randomized-controlled Period (RCP)|Adverse Event|2
7597289|NCT02200770|12003285|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
7597290|NCT02200770|12003286|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
7597291|NCT02200770|12003285|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0
7597292|NCT02200770|12003286|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1
7597293|NCT02200770|12003285|FG000|Randomized-controlled Period (RCP)|Other|1
7597294|NCT02200770|12003286|FG001|Randomized-controlled Period (RCP)|Other|2
7597295|NCT02200770|12003285|FG000|Open-label Period (OLP)|Adverse Event|1
7597296|NCT02200770|12003286|FG001|Open-label Period (OLP)|Adverse Event|2
7597297|NCT02200770|12003285|FG000|Open-label Period (OLP)|Death|1
7597298|NCT02200770|12003286|FG001|Open-label Period (OLP)|Death|2
7597299|NCT02200770|12003285|FG000|Open-label Period (OLP)|Lost to Follow-up|0
7597300|NCT02200770|12003286|FG001|Open-label Period (OLP)|Lost to Follow-up|1
7597301|NCT02200770|12003285|FG000|Open-label Period (OLP)|Withdrawal by Subject|0
7597302|NCT02200770|12003286|FG001|Open-label Period (OLP)|Withdrawal by Subject|14
7597303|NCT02200770|12003285|FG000|Open-label Period (OLP)|Other|6
7597304|NCT02200770|12003286|FG001|Open-label Period (OLP)|Other|15
7597305|NCT02136069|12003296|FG000|Overall Study|UC flare-up|1
7597306|NCT02136069|12003297|FG001|Overall Study|UC flare-up|0
7597307|NCT02136069|12003296|FG000|Overall Study|Adverse Event|6
7597308|NCT02136069|12003297|FG001|Overall Study|Adverse Event|8
7597309|NCT02136069|12003296|FG000|Overall Study|Death|0
7597310|NCT02136069|12003297|FG001|Overall Study|Death|1
7597311|NCT02136069|12003296|FG000|Overall Study|Lack of Efficacy|10
7597312|NCT02136069|12003297|FG001|Overall Study|Lack of Efficacy|4
7597313|NCT02136069|12003296|FG000|Overall Study|Lost to Follow-up|1
7597314|NCT02136069|12003297|FG001|Overall Study|Lost to Follow-up|0
7597315|NCT02136069|12003296|FG000|Overall Study|Non-Compliance|1
7597316|NCT02136069|12003297|FG001|Overall Study|Non-Compliance|0
7597317|NCT02136069|12003296|FG000|Overall Study|Physician Decision|5
7597318|NCT02136069|12003297|FG001|Overall Study|Physician Decision|4
7597319|NCT02136069|12003296|FG000|Overall Study|Withdrawal by Subject|10
7597320|NCT02136069|12003297|FG001|Overall Study|Withdrawal by Subject|11
7597321|NCT02086552|12003303|FG000|Overall Study|Withdrawal by Subject|1
7597322|NCT01209767|12003312|FG000|Overall Study|Withdrawal by Subject|1
7597323|NCT01209767|12003312|FG000|Overall Study|Lost to Follow-up|3
7597324|NCT01186848|12003320|FG000|Overall Study|Lost to Follow-up|4
7597325|NCT01186848|12003320|FG000|Overall Study|Withdrawal by Subject|2
7597326|NCT01186848|12003320|FG000|Overall Study|Adverse Event|2
7597327|NCT01024608|12003337|FG000|Overall Study|Adverse Event|1
7597328|NCT01024608|12003338|FG001|Overall Study|Adverse Event|0
7597329|NCT01024608|12003337|FG000|Overall Study|Withdrawal by Subject|1
7597330|NCT01024608|12003338|FG001|Overall Study|Withdrawal by Subject|0
7597331|NCT01024608|12003337|FG000|Overall Study|Lost to Follow-up|0
7597332|NCT01024608|12003338|FG001|Overall Study|Lost to Follow-up|1
7597333|NCT01024608|12003337|FG000|Overall Study|Protocol Violation|0
7597334|NCT01024608|12003338|FG001|Overall Study|Protocol Violation|3
7597335|NCT01024608|12003337|FG000|Overall Study|Never received study treatment|2
7597336|NCT01024608|12003338|FG001|Overall Study|Never received study treatment|0
7597337|NCT00988247|12003346|FG000|Overall Study|Adverse Event|17
7597338|NCT00988247|12003347|FG001|Overall Study|Adverse Event|3
7597339|NCT00988247|12003346|FG000|Overall Study|Withdrawal by Subject|44
7597340|NCT00988247|12003347|FG001|Overall Study|Withdrawal by Subject|13
7597341|NCT00988247|12003346|FG000|Overall Study|Pregnancy|1
7597342|NCT00988247|12003347|FG001|Overall Study|Pregnancy|2
7597343|NCT00988247|12003346|FG000|Overall Study|Lost to Follow-up|11
7597344|NCT00988247|12003347|FG001|Overall Study|Lost to Follow-up|2
7597345|NCT00988247|12003346|FG000|Overall Study|Protocol Violation|4
7597346|NCT00988247|12003347|FG001|Overall Study|Protocol Violation|5
7597347|NCT00988247|12003346|FG000|Overall Study|Sponsor requested withdrawal|3
7597348|NCT00988247|12003347|FG001|Overall Study|Sponsor requested withdrawal|1
7597349|NCT00988247|12003346|FG000|Overall Study|Other|3
7597350|NCT00988247|12003347|FG001|Overall Study|Other|0
7597351|NCT00730639|12003379|FG000|Overall Study|Adverse Event|3
7597352|NCT00730639|12003380|FG001|Overall Study|Adverse Event|0
7597353|NCT00730639|12003381|FG002|Overall Study|Adverse Event|9
7597354|NCT00730639|12003382|FG003|Overall Study|Adverse Event|8
7597355|NCT00730639|12003383|FG004|Overall Study|Adverse Event|23
7597356|NCT00730639|12003379|FG000|Overall Study|Complete Response|0
7597357|NCT00730639|12003380|FG001|Overall Study|Complete Response|0
7597358|NCT00730639|12003381|FG002|Overall Study|Complete Response|2
7597359|NCT00730639|12003382|FG003|Overall Study|Complete Response|2
7597360|NCT00730639|12003383|FG004|Overall Study|Complete Response|1
7597361|NCT00730639|12003379|FG000|Overall Study|Completed Maximum Cycles|0
7597362|NCT00730639|12003380|FG001|Overall Study|Completed Maximum Cycles|0
7597363|NCT00730639|12003381|FG002|Overall Study|Completed Maximum Cycles|11
7772013|NCT00887159|12216637|FG001|Overall Study|Pt had PD but was SD when re-measured|1
7597364|NCT00730639|12003382|FG003|Overall Study|Completed Maximum Cycles|3
7597365|NCT00730639|12003383|FG004|Overall Study|Completed Maximum Cycles|6
7597366|NCT00730639|12003379|FG000|Overall Study|Death|0
7597367|NCT00730639|12003380|FG001|Overall Study|Death|0
7597368|NCT00730639|12003381|FG002|Overall Study|Death|0
7597369|NCT00730639|12003382|FG003|Overall Study|Death|0
7597370|NCT00730639|12003383|FG004|Overall Study|Death|2
7597371|NCT00730639|12003379|FG000|Overall Study|Disease Progression|12
7597372|NCT00730639|12003380|FG001|Overall Study|Disease Progression|13
7597373|NCT00730639|12003381|FG002|Overall Study|Disease Progression|48
7597374|NCT00730639|12003382|FG003|Overall Study|Disease Progression|32
7597375|NCT00730639|12003383|FG004|Overall Study|Disease Progression|88
7597376|NCT00730639|12003379|FG000|Overall Study|non-specified|0
7597377|NCT00730639|12003380|FG001|Overall Study|non-specified|0
7772014|NCT00887159|12216638|FG002|Overall Study|Pt had PD but was SD when re-measured|0
7772015|NCT00887159|12216636|FG000|Overall Study|Received more tx instead of observation|1
7772016|NCT00887159|12216637|FG001|Overall Study|Received more tx instead of observation|0
7772017|NCT00887159|12216638|FG002|Overall Study|Received more tx instead of observation|0
7772018|NCT00887159|12216636|FG000|Overall Study|Ineligible|5
7772019|NCT00887159|12216637|FG001|Overall Study|Ineligible|1
7772020|NCT00887159|12216638|FG002|Overall Study|Ineligible|0
7772021|NCT00887159|12216636|FG000|Overall Study|Never started assigned therapy|3
7597378|NCT00730639|12003381|FG002|Overall Study|non-specified|4
7597379|NCT00730639|12003382|FG003|Overall Study|non-specified|2
7597380|NCT00730639|12003383|FG004|Overall Study|non-specified|3
7597381|NCT00730639|12003379|FG000|Overall Study|Protocol Violation|0
7597382|NCT00730639|12003380|FG001|Overall Study|Protocol Violation|0
7597383|NCT00730639|12003381|FG002|Overall Study|Protocol Violation|1
7597384|NCT00730639|12003382|FG003|Overall Study|Protocol Violation|0
7597385|NCT00730639|12003383|FG004|Overall Study|Protocol Violation|0
7597386|NCT00730639|12003379|FG000|Overall Study|Withdrawal by Subject|0
7597387|NCT00730639|12003380|FG001|Overall Study|Withdrawal by Subject|0
7597388|NCT00730639|12003381|FG002|Overall Study|Withdrawal by Subject|6
7597389|NCT00730639|12003382|FG003|Overall Study|Withdrawal by Subject|3
7597390|NCT00730639|12003383|FG004|Overall Study|Withdrawal by Subject|4
7597391|NCT00730639|12003379|FG000|Overall Study|Treatment on-going|2
7597392|NCT00730639|12003380|FG001|Overall Study|Treatment on-going|5
7597393|NCT00730639|12003381|FG002|Overall Study|Treatment on-going|5
7597394|NCT00730639|12003382|FG003|Overall Study|Treatment on-going|4
7597395|NCT00730639|12003383|FG004|Overall Study|Treatment on-going|4
7597396|NCT04834362|12003412|FG000|Overall Study|Death|1
7597397|NCT04834362|12003413|FG001|Overall Study|Death|2
7597398|NCT04611789|12003439|FG000|Overall Study|Lost to Follow-up|1
7597399|NCT04611789|12003440|FG001|Overall Study|Lost to Follow-up|0
7597400|NCT04611789|12003441|FG002|Overall Study|Lost to Follow-up|0
7597401|NCT04254809|12003504|FG000|Overall Study|Lost to Follow-up|5
7597402|NCT04254809|12003505|FG001|Overall Study|Lost to Follow-up|10
7597403|NCT04230122|12003513|FG000|Overall Study|Lost to Follow-up|1
7597404|NCT04230122|12003514|FG001|Overall Study|Lost to Follow-up|0
7597405|NCT04033068|12003543|FG000|Overall Study|Withdrawal by Subject|0
7597406|NCT04033068|12003544|FG001|Overall Study|Withdrawal by Subject|0
7597407|NCT04033068|12003545|FG002|Overall Study|Withdrawal by Subject|1
7597408|NCT04033068|12003546|FG003|Overall Study|Withdrawal by Subject|0
7597409|NCT04033068|12003543|FG000|Overall Study|Lost to Follow-up|0
7597410|NCT04033068|12003544|FG001|Overall Study|Lost to Follow-up|1
7597411|NCT04033068|12003545|FG002|Overall Study|Lost to Follow-up|0
7597412|NCT04033068|12003546|FG003|Overall Study|Lost to Follow-up|0
7597413|NCT04033068|12003543|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0
7597414|NCT04033068|12003544|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0
7597415|NCT04033068|12003545|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0
7597416|NCT04033068|12003546|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1
7772022|NCT00887159|12216637|FG001|Overall Study|Never started assigned therapy|3
7597417|NCT03561597|12003556|FG000|Overall Study|Lost to Follow-up|20
7597418|NCT03350984|12003562|FG000|Overall Study|Death|1
7772023|NCT00887159|12216638|FG002|Overall Study|Never started assigned therapy|4
7772024|NCT00887198|12216650|FG000|Randomized Period|Ongoing|42
7772025|NCT00887198|12216651|FG001|Randomized Period|Ongoing|0
7772026|NCT00887198|12216652|FG002|Randomized Period|Ongoing|0
7772027|NCT00887198|12216650|FG000|Randomized Period|Adverse Event|50
7772028|NCT00887198|12216651|FG001|Randomized Period|Adverse Event|33
7772029|NCT00887198|12216652|FG002|Randomized Period|Adverse Event|0
7597419|NCT03350984|12003563|FG001|Overall Study|Death|0
7597420|NCT03350984|12003562|FG000|Overall Study|Lost to Follow-up|5
7597421|NCT03350984|12003563|FG001|Overall Study|Lost to Follow-up|6
7597422|NCT03350984|12003562|FG000|Overall Study|Protocol Violation|1
7597423|NCT03350984|12003563|FG001|Overall Study|Protocol Violation|2
7597424|NCT03350984|12003562|FG000|Overall Study|Physician Decision|1
7597425|NCT03350984|12003563|FG001|Overall Study|Physician Decision|0
7597426|NCT03277261|12003571|FG000|Overall Study|Adverse Event|17
7597427|NCT03277261|12003572|FG001|Overall Study|Adverse Event|1
7597428|NCT03277261|12003571|FG000|Overall Study|Participant Withdrawal of Consent|6
7597429|NCT03277261|12003572|FG001|Overall Study|Participant Withdrawal of Consent|15
7597430|NCT03277261|12003571|FG000|Overall Study|Investigator / Sponsor Decision|4
7597431|NCT03277261|12003572|FG001|Overall Study|Investigator / Sponsor Decision|2
7597432|NCT03277261|12003571|FG000|Overall Study|Pregnancy|2
7597433|NCT03277261|12003572|FG001|Overall Study|Pregnancy|0
7597434|NCT03277261|12003571|FG000|Overall Study|Lost to Follow-up|2
7597435|NCT03277261|12003572|FG001|Overall Study|Lost to Follow-up|2
7597436|NCT03277261|12003571|FG000|Overall Study|Lack of Efficacy|2
7597437|NCT03277261|12003572|FG001|Overall Study|Lack of Efficacy|2
7597438|NCT03277261|12003571|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1
7597439|NCT03277261|12003572|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1
7597440|NCT03277248|12003581|FG000|Overall Study|Adverse Event|3
7597441|NCT03277248|12003582|FG001|Overall Study|Adverse Event|1
7597442|NCT03277248|12003581|FG000|Overall Study|Subject Withdrawal of Consent|6
7597443|NCT03277248|12003582|FG001|Overall Study|Subject Withdrawal of Consent|23
7597444|NCT03277248|12003581|FG000|Overall Study|Investigator/Sponsor Decision|2
7597445|NCT03277248|12003582|FG001|Overall Study|Investigator/Sponsor Decision|2
7597446|NCT03277248|12003581|FG000|Overall Study|Pregnancy|4
7597447|NCT03277248|12003582|FG001|Overall Study|Pregnancy|1
7597448|NCT03277248|12003581|FG000|Overall Study|Lost to Follow-up|0
7597449|NCT03277248|12003582|FG001|Overall Study|Lost to Follow-up|2
7597450|NCT03277248|12003581|FG000|Overall Study|Lack of Efficacy|0
7597451|NCT03277248|12003582|FG001|Overall Study|Lack of Efficacy|2
7597452|NCT03277248|12003581|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3
7597453|NCT03277248|12003582|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3
7597454|NCT03179462|12003591|FG000|Overall Study|screening failure|1
7597455|NCT03179462|12003592|FG001|Overall Study|screening failure|2
7597456|NCT03179462|12003593|FG002|Overall Study|screening failure|0
7597457|NCT03099707|12003603|FG000|Overall Study|Withdrawal by Subject|0
7597458|NCT03099707|12003604|FG001|Overall Study|Withdrawal by Subject|3
7597459|NCT03099707|12003603|FG000|Overall Study|Lost to Follow-up|0
7597460|NCT03099707|12003604|FG001|Overall Study|Lost to Follow-up|1
7597461|NCT03064763|12003610|FG000|Overall Study|Ongoing in study|10
7597462|NCT03064763|12003610|FG000|Overall Study|Death|8
7597463|NCT02906033|12003635|FG000|Baseline|Protocol Violation|37
7597464|NCT02906033|12003636|FG001|Baseline|Protocol Violation|33
7597465|NCT02906033|12003635|FG000|Follow-up|Lost to Follow-up|46
7597466|NCT02906033|12003636|FG001|Follow-up|Lost to Follow-up|62
7597467|NCT02837783|12003644|FG000|Overall Study|Adverse Event|1
7597468|NCT02837783|12003645|FG001|Overall Study|Adverse Event|0
7597469|NCT02837783|12003644|FG000|Overall Study|Other, Not Specified|1
7597470|NCT02837783|12003645|FG001|Overall Study|Other, Not Specified|2
7597471|NCT02786537|12003657|FG000|As Randomized|Adverse Event|0
7597472|NCT02786537|12003658|FG001|As Randomized|Adverse Event|11
7772030|NCT00887198|12216650|FG000|Randomized Period|Lost to Follow-up|1
7772031|NCT00887198|12216651|FG001|Randomized Period|Lost to Follow-up|0
7597473|NCT02786537|12003659|FG002|As Randomized|Adverse Event|0
7597474|NCT02786537|12003660|FG003|As Randomized|Adverse Event|4
7597475|NCT02786537|12003661|FG004|As Randomized|Adverse Event|6
7597476|NCT02786537|12003662|FG005|As Randomized|Adverse Event|2
7597477|NCT02786537|12003657|FG000|As Randomized|Lack of Efficacy|0
7597478|NCT02786537|12003658|FG001|As Randomized|Lack of Efficacy|0
7597479|NCT02786537|12003659|FG002|As Randomized|Lack of Efficacy|0
7597480|NCT02786537|12003660|FG003|As Randomized|Lack of Efficacy|1
7597481|NCT02786537|12003661|FG004|As Randomized|Lack of Efficacy|0
7597482|NCT02786537|12003662|FG005|As Randomized|Lack of Efficacy|0
7597483|NCT02786537|12003657|FG000|As Randomized|Withdrawal by Subject|1
7597484|NCT02786537|12003658|FG001|As Randomized|Withdrawal by Subject|2
7597485|NCT02786537|12003659|FG002|As Randomized|Withdrawal by Subject|0
7597486|NCT02786537|12003660|FG003|As Randomized|Withdrawal by Subject|1
7597487|NCT02786537|12003661|FG004|As Randomized|Withdrawal by Subject|1
7597488|NCT02786537|12003662|FG005|As Randomized|Withdrawal by Subject|0
7597489|NCT02786537|12003657|FG000|As Randomized|Death|0
7597490|NCT02786537|12003658|FG001|As Randomized|Death|2
7597491|NCT02786537|12003659|FG002|As Randomized|Death|0
7597492|NCT02786537|12003660|FG003|As Randomized|Death|3
7597493|NCT02786537|12003661|FG004|As Randomized|Death|1
7597494|NCT02786537|12003662|FG005|As Randomized|Death|0
7597495|NCT02786537|12003657|FG000|As Randomized|Non-compliance with study drug|1
7597496|NCT02786537|12003658|FG001|As Randomized|Non-compliance with study drug|11
7597497|NCT02786537|12003659|FG002|As Randomized|Non-compliance with study drug|0
7597498|NCT02786537|12003660|FG003|As Randomized|Non-compliance with study drug|1
7597499|NCT02786537|12003661|FG004|As Randomized|Non-compliance with study drug|0
7597500|NCT02786537|12003662|FG005|As Randomized|Non-compliance with study drug|1
7597501|NCT02786537|12003657|FG000|As Randomized|Lost to treatment follow-up|4
7597502|NCT02786537|12003658|FG001|As Randomized|Lost to treatment follow-up|32
7597503|NCT02786537|12003659|FG002|As Randomized|Lost to treatment follow-up|0
7597504|NCT02786537|12003660|FG003|As Randomized|Lost to treatment follow-up|24
7597505|NCT02786537|12003661|FG004|As Randomized|Lost to treatment follow-up|4
7597506|NCT02786537|12003662|FG005|As Randomized|Lost to treatment follow-up|4
7597507|NCT02786537|12003657|FG000|As Randomized|Incarceration|0
7597508|NCT02786537|12003658|FG001|As Randomized|Incarceration|1
7597509|NCT02786537|12003659|FG002|As Randomized|Incarceration|0
7597510|NCT02786537|12003660|FG003|As Randomized|Incarceration|0
7597511|NCT02786537|12003661|FG004|As Randomized|Incarceration|0
7597512|NCT02786537|12003662|FG005|As Randomized|Incarceration|0
7597513|NCT02786537|12003657|FG000|As Randomized|Opiate Dependency Relapse|0
7597514|NCT02786537|12003658|FG001|As Randomized|Opiate Dependency Relapse|1
7597515|NCT02786537|12003659|FG002|As Randomized|Opiate Dependency Relapse|0
7597516|NCT02786537|12003660|FG003|As Randomized|Opiate Dependency Relapse|0
7597517|NCT02786537|12003661|FG004|As Randomized|Opiate Dependency Relapse|0
7597518|NCT02786537|12003662|FG005|As Randomized|Opiate Dependency Relapse|0
7597519|NCT02786537|12003657|FG000|As Randomized|HCV drugs stolen from pt|0
7597520|NCT02786537|12003658|FG001|As Randomized|HCV drugs stolen from pt|1
7597521|NCT02786537|12003659|FG002|As Randomized|HCV drugs stolen from pt|0
7597522|NCT02786537|12003660|FG003|As Randomized|HCV drugs stolen from pt|0
7597523|NCT02786537|12003661|FG004|As Randomized|HCV drugs stolen from pt|0
7597524|NCT02786537|12003662|FG005|As Randomized|HCV drugs stolen from pt|0
7597525|NCT02786537|12003657|FG000|As Randomized|Advised to stop after lapse in dosing|0
7597526|NCT02786537|12003658|FG001|As Randomized|Advised to stop after lapse in dosing|1
7597527|NCT02786537|12003659|FG002|As Randomized|Advised to stop after lapse in dosing|0
7597528|NCT02786537|12003660|FG003|As Randomized|Advised to stop after lapse in dosing|0
7597529|NCT02786537|12003661|FG004|As Randomized|Advised to stop after lapse in dosing|0
7597530|NCT02786537|12003662|FG005|As Randomized|Advised to stop after lapse in dosing|0
7597531|NCT02786537|12003657|FG000|As Randomized|Subject lost insurance|0
7597532|NCT02786537|12003658|FG001|As Randomized|Subject lost insurance|0
7597533|NCT02786537|12003659|FG002|As Randomized|Subject lost insurance|0
7597534|NCT02786537|12003660|FG003|As Randomized|Subject lost insurance|1
7597535|NCT02786537|12003661|FG004|As Randomized|Subject lost insurance|0
7597536|NCT02786537|12003662|FG005|As Randomized|Subject lost insurance|0
7597537|NCT02786537|12003657|FG000|As Treated|Adverse Event|0
7597538|NCT02786537|12003658|FG001|As Treated|Adverse Event|11
7597539|NCT02786537|12003659|FG002|As Treated|Adverse Event|0
7597540|NCT02786537|12003660|FG003|As Treated|Adverse Event|4
7597541|NCT02786537|12003661|FG004|As Treated|Adverse Event|6
7772032|NCT00887198|12216652|FG002|Randomized Period|Lost to Follow-up|0
7772033|NCT00887198|12216650|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0
7597542|NCT02786537|12003662|FG005|As Treated|Adverse Event|2
7597543|NCT02786537|12003657|FG000|As Treated|Death|0
7597544|NCT02786537|12003658|FG001|As Treated|Death|2
7597545|NCT02786537|12003659|FG002|As Treated|Death|0
7597546|NCT02786537|12003660|FG003|As Treated|Death|3
7597547|NCT02786537|12003661|FG004|As Treated|Death|1
7597548|NCT02786537|12003662|FG005|As Treated|Death|0
7597549|NCT02786537|12003657|FG000|As Treated|Lack of Efficacy|0
7597550|NCT02786537|12003658|FG001|As Treated|Lack of Efficacy|0
7597551|NCT02786537|12003659|FG002|As Treated|Lack of Efficacy|0
7597552|NCT02786537|12003660|FG003|As Treated|Lack of Efficacy|1
7597553|NCT02786537|12003661|FG004|As Treated|Lack of Efficacy|0
7597554|NCT02786537|12003662|FG005|As Treated|Lack of Efficacy|0
7597555|NCT02786537|12003657|FG000|As Treated|Lost to Follow-up|4
7597556|NCT02786537|12003658|FG001|As Treated|Lost to Follow-up|32
7597557|NCT02786537|12003659|FG002|As Treated|Lost to Follow-up|0
7597558|NCT02786537|12003660|FG003|As Treated|Lost to Follow-up|25
7597559|NCT02786537|12003661|FG004|As Treated|Lost to Follow-up|4
7597560|NCT02786537|12003662|FG005|As Treated|Lost to Follow-up|4
7597561|NCT02786537|12003657|FG000|As Treated|Non-compliance with study drug|1
7597562|NCT02786537|12003658|FG001|As Treated|Non-compliance with study drug|11
7597563|NCT02786537|12003659|FG002|As Treated|Non-compliance with study drug|0
7597564|NCT02786537|12003660|FG003|As Treated|Non-compliance with study drug|1
7597565|NCT02786537|12003661|FG004|As Treated|Non-compliance with study drug|0
7597566|NCT02786537|12003662|FG005|As Treated|Non-compliance with study drug|1
7597567|NCT02786537|12003657|FG000|As Treated|Lost insurance|0
7597568|NCT02786537|12003658|FG001|As Treated|Lost insurance|0
7597569|NCT02786537|12003659|FG002|As Treated|Lost insurance|0
7597570|NCT02786537|12003660|FG003|As Treated|Lost insurance|1
7597571|NCT02786537|12003661|FG004|As Treated|Lost insurance|0
7597572|NCT02786537|12003662|FG005|As Treated|Lost insurance|0
7597573|NCT02786537|12003657|FG000|As Treated|Withdrawal by Subject|1
7597574|NCT02786537|12003658|FG001|As Treated|Withdrawal by Subject|2
7597575|NCT02786537|12003659|FG002|As Treated|Withdrawal by Subject|0
7597576|NCT02786537|12003660|FG003|As Treated|Withdrawal by Subject|0
7597577|NCT02786537|12003661|FG004|As Treated|Withdrawal by Subject|1
7597578|NCT02786537|12003662|FG005|As Treated|Withdrawal by Subject|0
7597579|NCT02786537|12003657|FG000|As Treated|Incarceration|0
7597580|NCT02786537|12003658|FG001|As Treated|Incarceration|1
7597581|NCT02786537|12003659|FG002|As Treated|Incarceration|0
7597582|NCT02786537|12003660|FG003|As Treated|Incarceration|0
7597583|NCT02786537|12003661|FG004|As Treated|Incarceration|0
7597584|NCT02786537|12003662|FG005|As Treated|Incarceration|0
7597585|NCT02786537|12003657|FG000|As Treated|Opiate dependency relapse|0
7597586|NCT02786537|12003658|FG001|As Treated|Opiate dependency relapse|1
7597587|NCT02786537|12003659|FG002|As Treated|Opiate dependency relapse|0
7597588|NCT02786537|12003660|FG003|As Treated|Opiate dependency relapse|0
7597589|NCT02786537|12003661|FG004|As Treated|Opiate dependency relapse|0
7597590|NCT02786537|12003662|FG005|As Treated|Opiate dependency relapse|0
7597591|NCT02786537|12003657|FG000|As Treated|Drugs stolen from patient|0
7597592|NCT02786537|12003658|FG001|As Treated|Drugs stolen from patient|1
7597593|NCT02786537|12003659|FG002|As Treated|Drugs stolen from patient|0
7597594|NCT02786537|12003660|FG003|As Treated|Drugs stolen from patient|0
7597595|NCT02786537|12003661|FG004|As Treated|Drugs stolen from patient|0
7597596|NCT02786537|12003662|FG005|As Treated|Drugs stolen from patient|0
7597597|NCT02786537|12003657|FG000|As Treated|Advised to stop tx after loss of meds|0
7597598|NCT02786537|12003658|FG001|As Treated|Advised to stop tx after loss of meds|1
7597599|NCT02786537|12003659|FG002|As Treated|Advised to stop tx after loss of meds|0
7597600|NCT02786537|12003660|FG003|As Treated|Advised to stop tx after loss of meds|0
7597601|NCT02786537|12003661|FG004|As Treated|Advised to stop tx after loss of meds|0
7597602|NCT02786537|12003662|FG005|As Treated|Advised to stop tx after loss of meds|0
7597603|NCT02740231|12003772|FG000|Overall Study|Withdrawal by Subject|1
7597604|NCT02740231|12003773|FG001|Overall Study|Withdrawal by Subject|1
7597605|NCT02740231|12003774|FG002|Overall Study|Withdrawal by Subject|1
7597606|NCT02740231|12003775|FG003|Overall Study|Withdrawal by Subject|0
7597607|NCT02740231|12003772|FG000|Overall Study|Lack of Efficacy|0
7597608|NCT02740231|12003773|FG001|Overall Study|Lack of Efficacy|1
7597609|NCT02740231|12003774|FG002|Overall Study|Lack of Efficacy|0
7597610|NCT02740231|12003775|FG003|Overall Study|Lack of Efficacy|4
7597611|NCT02740231|12003772|FG000|Overall Study|Lost to Follow-up|1
7597612|NCT02740231|12003773|FG001|Overall Study|Lost to Follow-up|3
7597613|NCT02740231|12003774|FG002|Overall Study|Lost to Follow-up|0
7597614|NCT02740231|12003775|FG003|Overall Study|Lost to Follow-up|3
7597615|NCT02740231|12003772|FG000|Overall Study|Adverse Event|0
7597616|NCT02740231|12003773|FG001|Overall Study|Adverse Event|1
7597617|NCT02740231|12003774|FG002|Overall Study|Adverse Event|0
7597618|NCT02740231|12003775|FG003|Overall Study|Adverse Event|1
7597619|NCT02710084|12003787|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3
7597620|NCT02710084|12003788|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1
7597621|NCT02660034|12003809|FG000|Overall Study|Progressive Disease (Radiographic)|3
7597622|NCT02660034|12003810|FG001|Overall Study|Progressive Disease (Radiographic)|1
7597623|NCT02660034|12003811|FG002|Overall Study|Progressive Disease (Radiographic)|0
7597624|NCT02660034|12003812|FG003|Overall Study|Progressive Disease (Radiographic)|1
7597625|NCT02660034|12003813|FG004|Overall Study|Progressive Disease (Radiographic)|0
7597626|NCT02660034|12003814|FG005|Overall Study|Progressive Disease (Radiographic)|0
7597627|NCT02660034|12003815|FG006|Overall Study|Progressive Disease (Radiographic)|0
7597628|NCT02660034|12003816|FG007|Overall Study|Progressive Disease (Radiographic)|0
7597629|NCT02660034|12003817|FG008|Overall Study|Progressive Disease (Radiographic)|0
7597630|NCT02660034|12003818|FG009|Overall Study|Progressive Disease (Radiographic)|0
7597631|NCT02660034|12003819|FG010|Overall Study|Progressive Disease (Radiographic)|0
7597632|NCT02660034|12003820|FG011|Overall Study|Progressive Disease (Radiographic)|0
7597633|NCT02660034|12003821|FG012|Overall Study|Progressive Disease (Radiographic)|0
7597634|NCT02660034|12003822|FG013|Overall Study|Progressive Disease (Radiographic)|0
7597635|NCT02660034|12003809|FG000|Overall Study|Progressive Disease (Clinical)|7
7597636|NCT02660034|12003810|FG001|Overall Study|Progressive Disease (Clinical)|8
7597637|NCT02660034|12003811|FG002|Overall Study|Progressive Disease (Clinical)|3
7597638|NCT02660034|12003812|FG003|Overall Study|Progressive Disease (Clinical)|9
7597639|NCT02660034|12003813|FG004|Overall Study|Progressive Disease (Clinical)|3
7597640|NCT02660034|12003814|FG005|Overall Study|Progressive Disease (Clinical)|0
7597641|NCT02660034|12003815|FG006|Overall Study|Progressive Disease (Clinical)|0
7597642|NCT02660034|12003816|FG007|Overall Study|Progressive Disease (Clinical)|0
7597643|NCT02660034|12003817|FG008|Overall Study|Progressive Disease (Clinical)|0
7597644|NCT02660034|12003818|FG009|Overall Study|Progressive Disease (Clinical)|0
7597645|NCT02660034|12003819|FG010|Overall Study|Progressive Disease (Clinical)|0
7597646|NCT02660034|12003820|FG011|Overall Study|Progressive Disease (Clinical)|0
7597647|NCT02660034|12003821|FG012|Overall Study|Progressive Disease (Clinical)|0
7597648|NCT02660034|12003822|FG013|Overall Study|Progressive Disease (Clinical)|0
7597649|NCT02660034|12003809|FG000|Overall Study|Lost to Follow-up|0
7597650|NCT02660034|12003810|FG001|Overall Study|Lost to Follow-up|0
7597651|NCT02660034|12003811|FG002|Overall Study|Lost to Follow-up|1
7597652|NCT02660034|12003812|FG003|Overall Study|Lost to Follow-up|1
7597653|NCT02660034|12003813|FG004|Overall Study|Lost to Follow-up|0
7597654|NCT02660034|12003814|FG005|Overall Study|Lost to Follow-up|0
7597655|NCT02660034|12003815|FG006|Overall Study|Lost to Follow-up|0
7597656|NCT02660034|12003816|FG007|Overall Study|Lost to Follow-up|0
7597657|NCT02660034|12003817|FG008|Overall Study|Lost to Follow-up|0
7597658|NCT02660034|12003818|FG009|Overall Study|Lost to Follow-up|1
7597659|NCT02660034|12003819|FG010|Overall Study|Lost to Follow-up|1
7597660|NCT02660034|12003820|FG011|Overall Study|Lost to Follow-up|1
7597661|NCT02660034|12003821|FG012|Overall Study|Lost to Follow-up|0
7597662|NCT02660034|12003822|FG013|Overall Study|Lost to Follow-up|0
7597663|NCT02660034|12003809|FG000|Overall Study|Participant moved into special access scheme|1
7597664|NCT02660034|12003810|FG001|Overall Study|Participant moved into special access scheme|2
7597665|NCT02660034|12003811|FG002|Overall Study|Participant moved into special access scheme|0
7597666|NCT02660034|12003812|FG003|Overall Study|Participant moved into special access scheme|0
7597667|NCT02660034|12003813|FG004|Overall Study|Participant moved into special access scheme|0
7597668|NCT02660034|12003814|FG005|Overall Study|Participant moved into special access scheme|0
7597669|NCT02660034|12003815|FG006|Overall Study|Participant moved into special access scheme|0
7597670|NCT02660034|12003816|FG007|Overall Study|Participant moved into special access scheme|0
7597671|NCT02660034|12003817|FG008|Overall Study|Participant moved into special access scheme|0
7597672|NCT02660034|12003818|FG009|Overall Study|Participant moved into special access scheme|0
7597673|NCT02660034|12003819|FG010|Overall Study|Participant moved into special access scheme|0
7597674|NCT02660034|12003820|FG011|Overall Study|Participant moved into special access scheme|0
7597675|NCT02660034|12003821|FG012|Overall Study|Participant moved into special access scheme|0
7597676|NCT02660034|12003822|FG013|Overall Study|Participant moved into special access scheme|0
7597677|NCT02660034|12003809|FG000|Overall Study|Adverse Event|1
7597678|NCT02660034|12003810|FG001|Overall Study|Adverse Event|0
7597679|NCT02660034|12003811|FG002|Overall Study|Adverse Event|0
7597680|NCT02660034|12003812|FG003|Overall Study|Adverse Event|0
7597681|NCT02660034|12003813|FG004|Overall Study|Adverse Event|0
7597682|NCT02660034|12003814|FG005|Overall Study|Adverse Event|0
7597683|NCT02660034|12003815|FG006|Overall Study|Adverse Event|0
7597684|NCT02660034|12003816|FG007|Overall Study|Adverse Event|0
7597685|NCT02660034|12003817|FG008|Overall Study|Adverse Event|0
7597686|NCT02660034|12003818|FG009|Overall Study|Adverse Event|0
7597687|NCT02660034|12003819|FG010|Overall Study|Adverse Event|0
7597688|NCT02660034|12003820|FG011|Overall Study|Adverse Event|0
7597689|NCT02660034|12003821|FG012|Overall Study|Adverse Event|0
7597690|NCT02660034|12003822|FG013|Overall Study|Adverse Event|0
7597691|NCT02660034|12003809|FG000|Overall Study|Sponsor Decision|0
7597692|NCT02660034|12003810|FG001|Overall Study|Sponsor Decision|1
7597693|NCT02660034|12003811|FG002|Overall Study|Sponsor Decision|2
7597694|NCT02660034|12003812|FG003|Overall Study|Sponsor Decision|2
7597695|NCT02660034|12003813|FG004|Overall Study|Sponsor Decision|3
7597696|NCT02660034|12003814|FG005|Overall Study|Sponsor Decision|0
7597697|NCT02660034|12003815|FG006|Overall Study|Sponsor Decision|0
7597698|NCT02660034|12003816|FG007|Overall Study|Sponsor Decision|0
7597699|NCT02660034|12003817|FG008|Overall Study|Sponsor Decision|0
7597700|NCT02660034|12003818|FG009|Overall Study|Sponsor Decision|0
7597701|NCT02660034|12003819|FG010|Overall Study|Sponsor Decision|0
7597702|NCT02660034|12003820|FG011|Overall Study|Sponsor Decision|0
7597703|NCT02660034|12003821|FG012|Overall Study|Sponsor Decision|0
7597704|NCT02660034|12003822|FG013|Overall Study|Sponsor Decision|1
7597705|NCT02660034|12003809|FG000|Overall Study|Withdrawal by Subject|0
7597706|NCT02660034|12003810|FG001|Overall Study|Withdrawal by Subject|0
7597707|NCT02660034|12003811|FG002|Overall Study|Withdrawal by Subject|0
7597708|NCT02660034|12003812|FG003|Overall Study|Withdrawal by Subject|0
7597709|NCT02660034|12003813|FG004|Overall Study|Withdrawal by Subject|0
7597710|NCT02660034|12003814|FG005|Overall Study|Withdrawal by Subject|0
7597711|NCT02660034|12003815|FG006|Overall Study|Withdrawal by Subject|1
7597712|NCT02660034|12003816|FG007|Overall Study|Withdrawal by Subject|1
7597713|NCT02660034|12003817|FG008|Overall Study|Withdrawal by Subject|1
7597714|NCT02660034|12003818|FG009|Overall Study|Withdrawal by Subject|0
7597715|NCT02660034|12003819|FG010|Overall Study|Withdrawal by Subject|0
7597716|NCT02660034|12003820|FG011|Overall Study|Withdrawal by Subject|1
7597717|NCT02660034|12003821|FG012|Overall Study|Withdrawal by Subject|2
7597718|NCT02660034|12003822|FG013|Overall Study|Withdrawal by Subject|0
7597719|NCT02660034|12003809|FG000|Overall Study|Death|0
7597720|NCT02660034|12003810|FG001|Overall Study|Death|0
7597721|NCT02660034|12003811|FG002|Overall Study|Death|0
7597722|NCT02660034|12003812|FG003|Overall Study|Death|0
7597723|NCT02660034|12003813|FG004|Overall Study|Death|0
7597724|NCT02660034|12003814|FG005|Overall Study|Death|13
7597725|NCT02660034|12003815|FG006|Overall Study|Death|14
7597726|NCT02660034|12003816|FG007|Overall Study|Death|10
7597727|NCT02660034|12003817|FG008|Overall Study|Death|9
7597728|NCT02660034|12003818|FG009|Overall Study|Death|21
7597729|NCT02660034|12003819|FG010|Overall Study|Death|17
7597730|NCT02660034|12003820|FG011|Overall Study|Death|15
7597731|NCT02660034|12003821|FG012|Overall Study|Death|18
7597732|NCT02660034|12003822|FG013|Overall Study|Death|7
7597733|NCT02660034|12003809|FG000|Overall Study|Physician Decision|0
7597734|NCT02660034|12003810|FG001|Overall Study|Physician Decision|0
7597735|NCT02660034|12003811|FG002|Overall Study|Physician Decision|0
7597736|NCT02660034|12003812|FG003|Overall Study|Physician Decision|0
7597737|NCT02660034|12003813|FG004|Overall Study|Physician Decision|0
7597738|NCT02660034|12003814|FG005|Overall Study|Physician Decision|0
7597739|NCT02660034|12003815|FG006|Overall Study|Physician Decision|0
7597740|NCT02660034|12003816|FG007|Overall Study|Physician Decision|0
7597741|NCT02660034|12003817|FG008|Overall Study|Physician Decision|0
7597742|NCT02660034|12003818|FG009|Overall Study|Physician Decision|0
7597743|NCT02660034|12003819|FG010|Overall Study|Physician Decision|0
7597744|NCT02660034|12003820|FG011|Overall Study|Physician Decision|0
7597745|NCT02660034|12003821|FG012|Overall Study|Physician Decision|0
7597746|NCT02660034|12003822|FG013|Overall Study|Physician Decision|1
7597747|NCT02660034|12003809|FG000|Overall Study|Participants transferred to LTE|0
7597748|NCT02660034|12003810|FG001|Overall Study|Participants transferred to LTE|0
7597749|NCT02660034|12003811|FG002|Overall Study|Participants transferred to LTE|0
7597750|NCT02660034|12003812|FG003|Overall Study|Participants transferred to LTE|0
7597751|NCT02660034|12003813|FG004|Overall Study|Participants transferred to LTE|0
7597752|NCT02660034|12003814|FG005|Overall Study|Participants transferred to LTE|10
7597753|NCT02660034|12003815|FG006|Overall Study|Participants transferred to LTE|8
7597754|NCT02660034|12003816|FG007|Overall Study|Participants transferred to LTE|8
7597755|NCT02660034|12003817|FG008|Overall Study|Participants transferred to LTE|10
7597756|NCT02660034|12003818|FG009|Overall Study|Participants transferred to LTE|1
7597757|NCT02660034|12003819|FG010|Overall Study|Participants transferred to LTE|2
7597758|NCT02660034|12003820|FG011|Overall Study|Participants transferred to LTE|4
7597759|NCT02660034|12003821|FG012|Overall Study|Participants transferred to LTE|1
7597760|NCT02660034|12003822|FG013|Overall Study|Participants transferred to LTE|1
7597761|NCT02640625|12003856|FG000|Overall Study|Adverse Event|1
7597762|NCT02561962|12003870|FG000|Overall Study|Ongoing in study|1
7597763|NCT02561962|12003871|FG001|Overall Study|Ongoing in study|0
7597764|NCT02561962|12003872|FG002|Overall Study|Ongoing in study|0
7597765|NCT02561962|12003873|FG003|Overall Study|Ongoing in study|1
7597766|NCT02561962|12003874|FG004|Overall Study|Ongoing in study|0
7597767|NCT02561962|12003875|FG005|Overall Study|Ongoing in study|1
7597768|NCT02561962|12003876|FG006|Overall Study|Ongoing in study|0
7597769|NCT02561962|12003877|FG007|Overall Study|Ongoing in study|4
7597770|NCT02561962|12003878|FG008|Overall Study|Ongoing in study|1
7597771|NCT02561962|12003870|FG000|Overall Study|Withdrawal by Subject|1
7597772|NCT02561962|12003871|FG001|Overall Study|Withdrawal by Subject|0
7597773|NCT02561962|12003872|FG002|Overall Study|Withdrawal by Subject|0
7597774|NCT02561962|12003873|FG003|Overall Study|Withdrawal by Subject|0
7597775|NCT02561962|12003874|FG004|Overall Study|Withdrawal by Subject|1
7597776|NCT02561962|12003875|FG005|Overall Study|Withdrawal by Subject|1
7597777|NCT02561962|12003876|FG006|Overall Study|Withdrawal by Subject|2
7597778|NCT02561962|12003877|FG007|Overall Study|Withdrawal by Subject|1
7597779|NCT02561962|12003878|FG008|Overall Study|Withdrawal by Subject|0
7597780|NCT02561962|12003870|FG000|Overall Study|Decision by sponsor|0
7597781|NCT02561962|12003871|FG001|Overall Study|Decision by sponsor|0
7597782|NCT02561962|12003872|FG002|Overall Study|Decision by sponsor|0
7597783|NCT02561962|12003873|FG003|Overall Study|Decision by sponsor|0
7597784|NCT02561962|12003874|FG004|Overall Study|Decision by sponsor|1
7597785|NCT02561962|12003875|FG005|Overall Study|Decision by sponsor|1
7597786|NCT02561962|12003876|FG006|Overall Study|Decision by sponsor|0
7597787|NCT02561962|12003877|FG007|Overall Study|Decision by sponsor|3
7597788|NCT02561962|12003878|FG008|Overall Study|Decision by sponsor|0
7597789|NCT02561962|12003870|FG000|Overall Study|Lost to Follow-up|0
7597790|NCT02561962|12003871|FG001|Overall Study|Lost to Follow-up|0
7597791|NCT02561962|12003872|FG002|Overall Study|Lost to Follow-up|0
7597792|NCT02561962|12003873|FG003|Overall Study|Lost to Follow-up|0
7597793|NCT02561962|12003874|FG004|Overall Study|Lost to Follow-up|0
7772034|NCT00887198|12216651|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51
7772035|NCT00887198|12216652|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0
7772036|NCT00887198|12216650|FG000|Randomized Period|Withdrawal by Subject|41
7772037|NCT00887198|12216651|FG001|Randomized Period|Withdrawal by Subject|56
7772038|NCT00887198|12216652|FG002|Randomized Period|Withdrawal by Subject|0
7772039|NCT00887198|12216650|FG000|Randomized Period|Progressive disease|366
7772040|NCT00887198|12216651|FG001|Randomized Period|Progressive disease|370
7772041|NCT00887198|12216652|FG002|Randomized Period|Progressive disease|0
7597838|NCT01373151|12003958|FG003|Period 1|Withdrawal by Subject|1
7772042|NCT00887198|12216650|FG000|Randomized Period|Other|42
7772043|NCT00887198|12216651|FG001|Randomized Period|Other|30
7772044|NCT00887198|12216652|FG002|Randomized Period|Other|0
7772045|NCT00887198|12216650|FG000|Randomized Period|Randomized, Not treated|4
7772046|NCT00887198|12216651|FG001|Randomized Period|Randomized, Not treated|2
7772047|NCT00887198|12216652|FG002|Randomized Period|Randomized, Not treated|0
7772048|NCT00887198|12216650|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
7772049|NCT00887198|12216651|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
7772050|NCT00887198|12216652|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
7772051|NCT00887198|12216650|FG000|Cross Over (Placebo to AA)|Ongoing|0
7772052|NCT00887198|12216651|FG001|Cross Over (Placebo to AA)|Ongoing|0
7772053|NCT00887198|12216652|FG002|Cross Over (Placebo to AA)|Ongoing|35
7772054|NCT00887198|12216650|FG000|Cross Over (Placebo to AA)|Adverse Event|0
7772055|NCT00887198|12216651|FG001|Cross Over (Placebo to AA)|Adverse Event|0
7772056|NCT00887198|12216652|FG002|Cross Over (Placebo to AA)|Adverse Event|9
7772057|NCT00887198|12216650|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0
7772058|NCT00887198|12216651|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0
7772059|NCT00887198|12216652|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2
7772060|NCT00887198|12216650|FG000|Cross Over (Placebo to AA)|Progressive disease|0
7772061|NCT00887198|12216651|FG001|Cross Over (Placebo to AA)|Progressive disease|0
7772062|NCT00887198|12216652|FG002|Cross Over (Placebo to AA)|Progressive disease|20
7772063|NCT00887198|12216650|FG000|Cross Over (Placebo to AA)|Other|0
7772064|NCT00887198|12216651|FG001|Cross Over (Placebo to AA)|Other|0
7772065|NCT00887198|12216652|FG002|Cross Over (Placebo to AA)|Other|19
7772066|NCT00887224|12216663|FG000|Open-label Response (OLR) Phase|Adverse Event|46
7772067|NCT00887224|12216664|FG001|Open-label Response (OLR) Phase|Adverse Event|0
7772068|NCT00887224|12216665|FG002|Open-label Response (OLR) Phase|Adverse Event|0
7772069|NCT00887224|12216663|FG000|Open-label Response (OLR) Phase|Failed to return|6
7772070|NCT00887224|12216664|FG001|Open-label Response (OLR) Phase|Failed to return|0
7772071|NCT00887224|12216665|FG002|Open-label Response (OLR) Phase|Failed to return|0
7772072|NCT00887224|12216663|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26
7772073|NCT00887224|12216664|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0
7772074|NCT00887224|12216665|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0
7772075|NCT00887224|12216663|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16
7597794|NCT02561962|12003875|FG005|Overall Study|Lost to Follow-up|1
7597795|NCT02561962|12003876|FG006|Overall Study|Lost to Follow-up|0
7597796|NCT02561962|12003877|FG007|Overall Study|Lost to Follow-up|0
7597797|NCT02561962|12003878|FG008|Overall Study|Lost to Follow-up|0
7597798|NCT02500589|12003900|FG000|Overall Study|Withdrawal by Subject|11
7597799|NCT02500589|12003901|FG001|Overall Study|Withdrawal by Subject|14
7597800|NCT02500589|12003900|FG000|Overall Study|Lost to Follow-up|10
7597801|NCT02500589|12003901|FG001|Overall Study|Lost to Follow-up|12
7597802|NCT02500589|12003900|FG000|Overall Study|Excluded post rand: cognitive impairment|0
7597803|NCT02500589|12003901|FG001|Overall Study|Excluded post rand: cognitive impairment|1
7772076|NCT00887224|12216664|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0
7772077|NCT00887224|12216665|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0
7772078|NCT00887224|12216663|FG000|Open-label Response (OLR) Phase|Other|1
7772079|NCT00887224|12216664|FG001|Open-label Response (OLR) Phase|Other|0
7772080|NCT00887224|12216665|FG002|Open-label Response (OLR) Phase|Other|0
7597804|NCT02500589|12003900|FG000|Overall Study|Death|7
7597805|NCT02500589|12003901|FG001|Overall Study|Death|5
7597806|NCT02474329|12003911|FG000|Overall Study|Withdraw or did not contribute data.|13
7597807|NCT01388491|12003941|FG000|Overall Study|Adverse Event|10
7597808|NCT01388491|12003942|FG001|Overall Study|Adverse Event|9
7597809|NCT01388491|12003941|FG000|Overall Study|Sponsor Request|9
7597810|NCT01388491|12003942|FG001|Overall Study|Sponsor Request|7
7597811|NCT01388491|12003941|FG000|Overall Study|Withdrawal by Subject|6
7597812|NCT01388491|12003942|FG001|Overall Study|Withdrawal by Subject|10
7597813|NCT01388491|12003941|FG000|Overall Study|Lost to Follow-up|4
7597814|NCT01388491|12003942|FG001|Overall Study|Lost to Follow-up|3
7597815|NCT01388491|12003941|FG000|Overall Study|Protocol Violation|2
7597816|NCT01388491|12003942|FG001|Overall Study|Protocol Violation|0
7597817|NCT01388491|12003941|FG000|Overall Study|Noncompliance|2
7597818|NCT01388491|12003942|FG001|Overall Study|Noncompliance|0
7597819|NCT01388491|12003941|FG000|Overall Study|Pregnancy|1
7597820|NCT01388491|12003942|FG001|Overall Study|Pregnancy|0
7597821|NCT01373151|12003955|FG000|Period 1|Lack of Efficacy|3
7597822|NCT01373151|12003956|FG001|Period 1|Lack of Efficacy|0
7597823|NCT01373151|12003957|FG002|Period 1|Lack of Efficacy|0
7597824|NCT01373151|12003958|FG003|Period 1|Lack of Efficacy|0
7597825|NCT01373151|12003959|FG004|Period 1|Lack of Efficacy|1
7597826|NCT01373151|12003960|FG005|Period 1|Lack of Efficacy|0
7597827|NCT01373151|12003961|FG006|Period 1|Lack of Efficacy|0
7597828|NCT01373151|12003955|FG000|Period 1|Adverse Event|0
7597829|NCT01373151|12003956|FG001|Period 1|Adverse Event|0
7597830|NCT01373151|12003957|FG002|Period 1|Adverse Event|1
7597831|NCT01373151|12003958|FG003|Period 1|Adverse Event|0
7597832|NCT01373151|12003959|FG004|Period 1|Adverse Event|4
7597833|NCT01373151|12003960|FG005|Period 1|Adverse Event|3
7597834|NCT01373151|12003961|FG006|Period 1|Adverse Event|0
7597835|NCT01373151|12003955|FG000|Period 1|Withdrawal by Subject|2
7597836|NCT01373151|12003956|FG001|Period 1|Withdrawal by Subject|0
7597837|NCT01373151|12003957|FG002|Period 1|Withdrawal by Subject|3
7597839|NCT01373151|12003959|FG004|Period 1|Withdrawal by Subject|0
7597840|NCT01373151|12003960|FG005|Period 1|Withdrawal by Subject|1
7597841|NCT01373151|12003961|FG006|Period 1|Withdrawal by Subject|0
7597842|NCT01373151|12003955|FG000|Period 2|Lack of Efficacy|9
7597843|NCT01373151|12003956|FG001|Period 2|Lack of Efficacy|0
7597844|NCT01373151|12003957|FG002|Period 2|Lack of Efficacy|0
7597845|NCT01373151|12003958|FG003|Period 2|Lack of Efficacy|1
7597846|NCT01373151|12003959|FG004|Period 2|Lack of Efficacy|2
7597847|NCT01373151|12003960|FG005|Period 2|Lack of Efficacy|0
7597848|NCT01373151|12003961|FG006|Period 2|Lack of Efficacy|3
7597849|NCT01373151|12003955|FG000|Period 2|Adverse Event|0
7597850|NCT01373151|12003956|FG001|Period 2|Adverse Event|0
7597851|NCT01373151|12003957|FG002|Period 2|Adverse Event|3
7597852|NCT01373151|12003958|FG003|Period 2|Adverse Event|3
7597853|NCT01373151|12003959|FG004|Period 2|Adverse Event|0
7597854|NCT01373151|12003960|FG005|Period 2|Adverse Event|0
7597855|NCT01373151|12003961|FG006|Period 2|Adverse Event|1
7597856|NCT01373151|12003955|FG000|Period 2|subject request to discontinue|0
7597857|NCT01373151|12003956|FG001|Period 2|subject request to discontinue|1
7597858|NCT01373151|12003957|FG002|Period 2|subject request to discontinue|0
7597859|NCT01373151|12003958|FG003|Period 2|subject request to discontinue|0
7597860|NCT01373151|12003959|FG004|Period 2|subject request to discontinue|0
7597861|NCT01373151|12003960|FG005|Period 2|subject request to discontinue|0
7597862|NCT01373151|12003961|FG006|Period 2|subject request to discontinue|0
7597863|NCT01373151|12003955|FG000|Period 2|Withdrawal by Subject|0
7597864|NCT01373151|12003956|FG001|Period 2|Withdrawal by Subject|0
7597865|NCT01373151|12003957|FG002|Period 2|Withdrawal by Subject|0
7597866|NCT01373151|12003958|FG003|Period 2|Withdrawal by Subject|1
7597867|NCT01373151|12003959|FG004|Period 2|Withdrawal by Subject|0
7597868|NCT01373151|12003960|FG005|Period 2|Withdrawal by Subject|0
7597869|NCT01373151|12003961|FG006|Period 2|Withdrawal by Subject|0
7597870|NCT01373151|12003955|FG000|Period 2|Other|0
7597871|NCT01373151|12003956|FG001|Period 2|Other|0
7597872|NCT01373151|12003957|FG002|Period 2|Other|1
7597873|NCT01373151|12003958|FG003|Period 2|Other|0
7597874|NCT01373151|12003959|FG004|Period 2|Other|0
7597875|NCT01373151|12003960|FG005|Period 2|Other|0
7597876|NCT01373151|12003961|FG006|Period 2|Other|1
7597877|NCT01281644|12003990|FG000|Overall Study|Lost to Follow-up|3
7597878|NCT01281644|12003990|FG000|Overall Study|Withdrawal by Subject|2
7597879|NCT00960297|12004002|FG000|Overall Study|Physician Decision|1
7597880|NCT00960297|12004002|FG000|Overall Study|Venous port infection|1
7597881|NCT00960297|12004002|FG000|Overall Study|Disease progression|1
7597882|NCT00910650|12004006|FG000|Overall Study|Death|2
7597883|NCT00703326|12004016|FG000|Overall Study|Lost to Follow-up|47
7597884|NCT00703326|12004017|FG001|Overall Study|Lost to Follow-up|18
7597885|NCT00703326|12004016|FG000|Overall Study|Withdrawal by Subject|54
7597886|NCT00703326|12004017|FG001|Overall Study|Withdrawal by Subject|20
7597887|NCT00703326|12004016|FG000|Overall Study|Adverse Event|1
7597888|NCT00703326|12004017|FG001|Overall Study|Adverse Event|0
7597889|NCT00602667|12004027|FG000|Overall Study|Still on Therapy|0
7597890|NCT00602667|12004028|FG001|Overall Study|Still on Therapy|2
7597891|NCT00602667|12004029|FG002|Overall Study|Still on Therapy|2
7597892|NCT00602667|12004027|FG000|Overall Study|Death|0
7772081|NCT00887224|12216663|FG000|Open-label Response (OLR) Phase|Protocol Violation|12
7772082|NCT00887224|12216664|FG001|Open-label Response (OLR) Phase|Protocol Violation|0
7772083|NCT00887224|12216665|FG002|Open-label Response (OLR) Phase|Protocol Violation|0
7772084|NCT00887224|12216663|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15
7772085|NCT00887224|12216664|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0
7772086|NCT00887224|12216665|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0
7772087|NCT00887224|12216663|FG000|Open-label Stability (OLS) Phase|Adverse Event|22
7772088|NCT00887224|12216664|FG001|Open-label Stability (OLS) Phase|Adverse Event|0
7772089|NCT00887224|12216665|FG002|Open-label Stability (OLS) Phase|Adverse Event|0
7772090|NCT00887224|12216663|FG000|Open-label Stability (OLS) Phase|Failed to return|3
7597893|NCT00602667|12004028|FG001|Overall Study|Death|1
7597894|NCT00602667|12004029|FG002|Overall Study|Death|1
7597895|NCT00602667|12004027|FG000|Overall Study|Family request|3
7597896|NCT00602667|12004028|FG001|Overall Study|Family request|25
7597897|NCT00602667|12004029|FG002|Overall Study|Family request|6
7597898|NCT00602667|12004027|FG000|Overall Study|Excessive toxicity|1
7597899|NCT00602667|12004028|FG001|Overall Study|Excessive toxicity|1
7597900|NCT00602667|12004029|FG002|Overall Study|Excessive toxicity|0
7597901|NCT00602667|12004027|FG000|Overall Study|Second malignancy|0
7597902|NCT00602667|12004028|FG001|Overall Study|Second malignancy|1
7597903|NCT00602667|12004029|FG002|Overall Study|Second malignancy|0
7597904|NCT00602667|12004027|FG000|Overall Study|Physician Decision|2
7597905|NCT00602667|12004028|FG001|Overall Study|Physician Decision|3
7597906|NCT00602667|12004029|FG002|Overall Study|Physician Decision|8
7597907|NCT00602667|12004027|FG000|Overall Study|Progressive disease|13
7597908|NCT00602667|12004028|FG001|Overall Study|Progressive disease|48
7597909|NCT00602667|12004029|FG002|Overall Study|Progressive disease|45
7597910|NCT00602667|12004027|FG000|Overall Study|Progressive disease prior to therapy|0
7597911|NCT00602667|12004028|FG001|Overall Study|Progressive disease prior to therapy|0
7597912|NCT00602667|12004029|FG002|Overall Study|Progressive disease prior to therapy|1
7597913|NCT00472186|12004070|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1
7597914|NCT00472186|12004071|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0
7597915|NCT03996876|12004081|FG000|Overall Study|Incomplete Data|2
7597916|NCT03996876|12004082|FG001|Overall Study|Incomplete Data|4
7597917|NCT03589976|12004091|FG000|Overall Study|Death|5
7597918|NCT03589976|12004092|FG001|Overall Study|Death|1
7597919|NCT03589976|12004091|FG000|Overall Study|Adverse Event|5
7597920|NCT03589976|12004092|FG001|Overall Study|Adverse Event|1
7597921|NCT03589976|12004091|FG000|Overall Study|Withdrawal by Subject|4
7597922|NCT03589976|12004092|FG001|Overall Study|Withdrawal by Subject|1
7597923|NCT03589976|12004091|FG000|Overall Study|Lost to Follow-up|1
7597924|NCT03589976|12004092|FG001|Overall Study|Lost to Follow-up|0
7597925|NCT03589976|12004091|FG000|Overall Study|Other|4
7597926|NCT03589976|12004092|FG001|Overall Study|Other|3
7597927|NCT03135262|12004139|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1
7597928|NCT03135262|12004140|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7597929|NCT03135262|12004141|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7597930|NCT03135262|12004142|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7597931|NCT03135262|12004143|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7597932|NCT03135262|12004139|FG000|Overall Study|Progression of disease|0
7597933|NCT03135262|12004140|FG001|Overall Study|Progression of disease|0
7597934|NCT03135262|12004141|FG002|Overall Study|Progression of disease|0
7597935|NCT03135262|12004142|FG003|Overall Study|Progression of disease|1
7597936|NCT03135262|12004143|FG004|Overall Study|Progression of disease|0
7597937|NCT03135262|12004139|FG000|Overall Study|Death|6
7597938|NCT03135262|12004140|FG001|Overall Study|Death|2
7597939|NCT03135262|12004141|FG002|Overall Study|Death|2
7597940|NCT03135262|12004142|FG003|Overall Study|Death|2
7597941|NCT03135262|12004143|FG004|Overall Study|Death|0
7597942|NCT03135262|12004139|FG000|Overall Study|Withdrawal by Subject|0
7597943|NCT03135262|12004140|FG001|Overall Study|Withdrawal by Subject|0
7597944|NCT03135262|12004141|FG002|Overall Study|Withdrawal by Subject|1
7597945|NCT03135262|12004142|FG003|Overall Study|Withdrawal by Subject|0
7597946|NCT03135262|12004143|FG004|Overall Study|Withdrawal by Subject|1
7597947|NCT03135262|12004139|FG000|Overall Study|Study terminated by sponsor|2
7597948|NCT03135262|12004140|FG001|Overall Study|Study terminated by sponsor|4
7597949|NCT03135262|12004141|FG002|Overall Study|Study terminated by sponsor|4
7597950|NCT03135262|12004142|FG003|Overall Study|Study terminated by sponsor|3
7597951|NCT03135262|12004143|FG004|Overall Study|Study terminated by sponsor|0
7597952|NCT03104075|12004175|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1
7597953|NCT03104075|12004176|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0
7597954|NCT03038087|12004183|FG000|Overall Study|lost data|1
7597955|NCT02662985|12004223|FG000|Treatment Period 1|Adverse Event|0
7597956|NCT02662985|12004224|FG001|Treatment Period 1|Adverse Event|2
7597957|NCT02662985|12004223|FG000|Treatment Period 1|Protocol Violation|0
7597958|NCT02662985|12004224|FG001|Treatment Period 1|Protocol Violation|1
7597959|NCT02662985|12004223|FG000|Treatment Period 1|Physician Decision|1
7597960|NCT02662985|12004224|FG001|Treatment Period 1|Physician Decision|0
7597961|NCT02662985|12004223|FG000|Treatment Period 1|Withdrawal by Subject|0
7597962|NCT02662985|12004224|FG001|Treatment Period 1|Withdrawal by Subject|1
7597963|NCT02662985|12004223|FG000|Treatment Period 2|Lack of Efficacy|0
7597964|NCT02662985|12004224|FG001|Treatment Period 2|Lack of Efficacy|1
7597965|NCT02662985|12004223|FG000|Treatment Period 2|Lost to Follow-up|1
7597966|NCT02662985|12004224|FG001|Treatment Period 2|Lost to Follow-up|0
7597967|NCT02662985|12004223|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4
7597968|NCT02662985|12004224|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4
7597969|NCT02662985|12004223|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1
7597970|NCT02662985|12004224|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1
7597971|NCT02662985|12004223|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0
7597972|NCT02662985|12004224|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1
7597973|NCT02662985|12004223|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1
7597974|NCT02662985|12004224|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2
7597975|NCT02662985|12004223|FG000|Treatment Period 3 (Extension Period)|Death|0
7597976|NCT02662985|12004224|FG001|Treatment Period 3 (Extension Period)|Death|1
7597977|NCT02606461|12004234|FG000|Overall Study|Withdrawal by Subject|3
7597978|NCT02606461|12004235|FG001|Overall Study|Withdrawal by Subject|2
7597979|NCT02606461|12004236|FG002|Overall Study|Withdrawal by Subject|14
7597980|NCT02606461|12004237|FG003|Overall Study|Withdrawal by Subject|11
7597981|NCT02606461|12004234|FG000|Overall Study|Death|16
7597982|NCT02606461|12004235|FG001|Overall Study|Death|25
7597983|NCT02606461|12004236|FG002|Overall Study|Death|105
7597984|NCT02606461|12004237|FG003|Overall Study|Death|58
7597985|NCT02606461|12004234|FG000|Overall Study|Lost to Follow-up|2
7597986|NCT02606461|12004235|FG001|Overall Study|Lost to Follow-up|2
7597987|NCT02606461|12004236|FG002|Overall Study|Lost to Follow-up|4
7597988|NCT02606461|12004237|FG003|Overall Study|Lost to Follow-up|1
7597989|NCT02606461|12004234|FG000|Overall Study|Physician Decision|0
7597990|NCT02606461|12004235|FG001|Overall Study|Physician Decision|0
7597991|NCT02606461|12004236|FG002|Overall Study|Physician Decision|1
7597992|NCT02606461|12004237|FG003|Overall Study|Physician Decision|1
7597993|NCT02606461|12004234|FG000|Overall Study|Disease Progression|1
7597994|NCT02606461|12004235|FG001|Overall Study|Disease Progression|0
7597995|NCT02606461|12004236|FG002|Overall Study|Disease Progression|0
7597996|NCT02606461|12004237|FG003|Overall Study|Disease Progression|0
7597997|NCT02606461|12004234|FG000|Overall Study|No treatment|0
7597998|NCT02606461|12004235|FG001|Overall Study|No treatment|0
7597999|NCT02606461|12004236|FG002|Overall Study|No treatment|1
7598000|NCT02606461|12004237|FG003|Overall Study|No treatment|0
7598001|NCT02606461|12004234|FG000|Overall Study|Ongoing|5
7598002|NCT02606461|12004235|FG001|Overall Study|Ongoing|1
7598003|NCT02606461|12004236|FG002|Overall Study|Ongoing|63
7598004|NCT02606461|12004237|FG003|Overall Study|Ongoing|26
7598005|NCT02536339|12004250|FG000|Overall Study|Death|20
7598006|NCT02536339|12004250|FG000|Overall Study|Withdrawal by Subject|3
7598007|NCT02536339|12004250|FG000|Overall Study|Lost to Follow-up|2
7598008|NCT02536339|12004250|FG000|Overall Study|Treatment discontinued|2
7598009|NCT02536339|12004250|FG000|Overall Study|Physician Decision|1
7598010|NCT02323295|12004256|FG000|Overall Study|Adverse Event|0
7598011|NCT02323295|12004257|FG001|Overall Study|Adverse Event|1
7598012|NCT02323295|12004256|FG000|Overall Study|Withdrawal by Subject|0
7598013|NCT02323295|12004257|FG001|Overall Study|Withdrawal by Subject|1
7598014|NCT02323295|12004256|FG000|Overall Study|Patient did not have surgery as planned.|0
7598015|NCT02323295|12004257|FG001|Overall Study|Patient did not have surgery as planned.|1
7598016|NCT02036970|12004287|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0
7598017|NCT02036970|12004288|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0
7598018|NCT02036970|12004289|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3
7598019|NCT02036970|12004290|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2
7598020|NCT02036970|12004291|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0
7598021|NCT02036970|12004292|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1
7598022|NCT02036970|12004293|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0
7598023|NCT02036970|12004294|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1
7598024|NCT02036970|12004295|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3
7598025|NCT02036970|12004296|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1
7598026|NCT02036970|12004287|FG000|Part 1: Day 1 Through Week 16|Death|0
7598027|NCT02036970|12004288|FG001|Part 1: Day 1 Through Week 16|Death|0
7598028|NCT02036970|12004289|FG002|Part 1: Day 1 Through Week 16|Death|0
7598029|NCT02036970|12004290|FG003|Part 1: Day 1 Through Week 16|Death|0
7598030|NCT02036970|12004291|FG004|Part 1: Day 1 Through Week 16|Death|0
7598031|NCT02036970|12004292|FG005|Part 1: Day 1 Through Week 16|Death|0
7598032|NCT02036970|12004293|FG006|Part 1: Day 1 Through Week 16|Death|0
7598033|NCT02036970|12004294|FG007|Part 1: Day 1 Through Week 16|Death|0
7598034|NCT02036970|12004295|FG008|Part 1: Day 1 Through Week 16|Death|1
7598035|NCT02036970|12004296|FG009|Part 1: Day 1 Through Week 16|Death|0
7598036|NCT02036970|12004287|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1
7598037|NCT02036970|12004288|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0
7598038|NCT02036970|12004289|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1
7598039|NCT02036970|12004290|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0
7598040|NCT02036970|12004291|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0
7598041|NCT02036970|12004292|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0
7598042|NCT02036970|12004293|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0
7598043|NCT02036970|12004294|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0
7598044|NCT02036970|12004295|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2
7598045|NCT02036970|12004296|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0
7598046|NCT02036970|12004287|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7598047|NCT02036970|12004288|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7598048|NCT02036970|12004289|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7598049|NCT02036970|12004290|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7598050|NCT02036970|12004291|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1
7598051|NCT02036970|12004292|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7598052|NCT02036970|12004293|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7598053|NCT02036970|12004294|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7598054|NCT02036970|12004295|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2
7598055|NCT02036970|12004296|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4
7598056|NCT02036970|12004287|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598057|NCT02036970|12004288|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598058|NCT02036970|12004289|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598059|NCT02036970|12004290|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1
7598060|NCT02036970|12004291|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598061|NCT02036970|12004292|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598062|NCT02036970|12004293|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598063|NCT02036970|12004294|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598064|NCT02036970|12004295|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598065|NCT02036970|12004296|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598066|NCT02036970|12004287|FG000|Part 2: Week 16 Onwards|Adverse Event|0
7598067|NCT02036970|12004288|FG001|Part 2: Week 16 Onwards|Adverse Event|2
7598068|NCT02036970|12004289|FG002|Part 2: Week 16 Onwards|Adverse Event|1
7598069|NCT02036970|12004290|FG003|Part 2: Week 16 Onwards|Adverse Event|1
7598070|NCT02036970|12004291|FG004|Part 2: Week 16 Onwards|Adverse Event|1
7598071|NCT02036970|12004292|FG005|Part 2: Week 16 Onwards|Adverse Event|0
7598072|NCT02036970|12004293|FG006|Part 2: Week 16 Onwards|Adverse Event|1
7598073|NCT02036970|12004294|FG007|Part 2: Week 16 Onwards|Adverse Event|0
7598074|NCT02036970|12004295|FG008|Part 2: Week 16 Onwards|Adverse Event|6
7598075|NCT02036970|12004296|FG009|Part 2: Week 16 Onwards|Adverse Event|3
7598076|NCT02036970|12004287|FG000|Part 2: Week 16 Onwards|Protocol Violation|0
7598077|NCT02036970|12004288|FG001|Part 2: Week 16 Onwards|Protocol Violation|0
7598078|NCT02036970|12004289|FG002|Part 2: Week 16 Onwards|Protocol Violation|0
7598079|NCT02036970|12004290|FG003|Part 2: Week 16 Onwards|Protocol Violation|0
7598080|NCT02036970|12004291|FG004|Part 2: Week 16 Onwards|Protocol Violation|0
7598081|NCT02036970|12004292|FG005|Part 2: Week 16 Onwards|Protocol Violation|0
7598082|NCT02036970|12004293|FG006|Part 2: Week 16 Onwards|Protocol Violation|0
7598083|NCT02036970|12004294|FG007|Part 2: Week 16 Onwards|Protocol Violation|1
7598084|NCT02036970|12004295|FG008|Part 2: Week 16 Onwards|Protocol Violation|0
7598085|NCT02036970|12004296|FG009|Part 2: Week 16 Onwards|Protocol Violation|0
7598086|NCT02036970|12004287|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7598087|NCT02036970|12004288|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1
7598088|NCT02036970|12004289|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1
7598089|NCT02036970|12004290|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7598090|NCT02036970|12004291|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7598091|NCT02036970|12004292|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7598092|NCT02036970|12004293|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7598093|NCT02036970|12004294|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7598094|NCT02036970|12004295|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3
7598095|NCT02036970|12004296|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7598096|NCT02036970|12004287|FG000|Part 2: Week 16 Onwards|Progressive Disease|0
7598097|NCT02036970|12004288|FG001|Part 2: Week 16 Onwards|Progressive Disease|2
7598098|NCT02036970|12004289|FG002|Part 2: Week 16 Onwards|Progressive Disease|1
7598099|NCT02036970|12004290|FG003|Part 2: Week 16 Onwards|Progressive Disease|1
7598100|NCT02036970|12004291|FG004|Part 2: Week 16 Onwards|Progressive Disease|0
7598101|NCT02036970|12004292|FG005|Part 2: Week 16 Onwards|Progressive Disease|0
7598102|NCT02036970|12004293|FG006|Part 2: Week 16 Onwards|Progressive Disease|0
7598103|NCT02036970|12004294|FG007|Part 2: Week 16 Onwards|Progressive Disease|0
7598104|NCT02036970|12004295|FG008|Part 2: Week 16 Onwards|Progressive Disease|0
7598105|NCT02036970|12004296|FG009|Part 2: Week 16 Onwards|Progressive Disease|2
7598106|NCT01941719|12004330|FG000|Overall Study|Lost to Follow-up|20
7598107|NCT01941719|12004331|FG001|Overall Study|Lost to Follow-up|19
7598108|NCT00943618|12004357|FG000|Overall Study|Lost to Follow-up|38
7598109|NCT00943618|12004358|FG001|Overall Study|Lost to Follow-up|48
7598110|NCT00943618|12004359|FG002|Overall Study|Lost to Follow-up|20
7598111|NCT00943618|12004357|FG000|Overall Study|Discontinued Medication|17
7598112|NCT00943618|12004358|FG001|Overall Study|Discontinued Medication|29
7598113|NCT00943618|12004359|FG002|Overall Study|Discontinued Medication|11
7598114|NCT03938272|12004369|FG000|Overall Study|Withdrawal by Subject|1
7598115|NCT03938272|12004370|FG001|Overall Study|Withdrawal by Subject|0
7598116|NCT03938272|12004369|FG000|Overall Study|Physician Decision|0
7598117|NCT03938272|12004370|FG001|Overall Study|Physician Decision|2
7598118|NCT03938272|12004369|FG000|Overall Study|Study termination by sponsor|10
7598119|NCT03938272|12004370|FG001|Overall Study|Study termination by sponsor|8
7598120|NCT03641339|12004382|FG000|Overall Study|Physician Decision|1
7598121|NCT03641339|12004383|FG001|Overall Study|Physician Decision|0
7598122|NCT03641339|12004384|FG002|Overall Study|Physician Decision|0
7598123|NCT03641339|12004385|FG003|Overall Study|Physician Decision|0
7598124|NCT03641339|12004386|FG004|Overall Study|Physician Decision|0
7598125|NCT03641339|12004387|FG005|Overall Study|Physician Decision|0
7598126|NCT03641339|12004382|FG000|Overall Study|Withdrawal by Subject|0
7598127|NCT03641339|12004383|FG001|Overall Study|Withdrawal by Subject|2
7598128|NCT03641339|12004384|FG002|Overall Study|Withdrawal by Subject|0
7598129|NCT03641339|12004385|FG003|Overall Study|Withdrawal by Subject|2
7598130|NCT03641339|12004386|FG004|Overall Study|Withdrawal by Subject|0
7598131|NCT03641339|12004387|FG005|Overall Study|Withdrawal by Subject|1
7598132|NCT03625466|12004403|FG000|Overall Study|Adverse Event|0
7598133|NCT03625466|12004404|FG001|Overall Study|Adverse Event|1
7598134|NCT03625466|12004403|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
7598135|NCT03625466|12004404|FG001|Overall Study|Withdrawal of Consent (not due to AE)|1
7598136|NCT03317795|12004412|FG000|Overall Study|IUD Expulsion|1
7598137|NCT03317795|12004413|FG001|Overall Study|IUD Expulsion|0
7598138|NCT03317795|12004412|FG000|Overall Study|Lost to Follow-up|1
7598139|NCT03317795|12004413|FG001|Overall Study|Lost to Follow-up|3
7598140|NCT03317795|12004412|FG000|Overall Study|Treatment change|0
7598141|NCT03317795|12004413|FG001|Overall Study|Treatment change|3
7598142|NCT03317795|12004412|FG000|Overall Study|Intolerance of medication|0
7598143|NCT03317795|12004413|FG001|Overall Study|Intolerance of medication|1
7598144|NCT03287245|12004423|FG000|Overall Study|Study terminated by sponsor|3
7598145|NCT03287245|12004424|FG001|Overall Study|Study terminated by sponsor|0
7772091|NCT00887224|12216664|FG001|Open-label Stability (OLS) Phase|Failed to return|0
7772092|NCT00887224|12216665|FG002|Open-label Stability (OLS) Phase|Failed to return|0
7772093|NCT00887224|12216663|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16
7772094|NCT00887224|12216664|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0
7772095|NCT00887224|12216665|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0
7598146|NCT03287245|12004425|FG002|Overall Study|Study terminated by sponsor|3
7598147|NCT03287245|12004426|FG003|Overall Study|Study terminated by sponsor|1
7598148|NCT03287245|12004423|FG000|Overall Study|Adverse Event|1
7598149|NCT03287245|12004424|FG001|Overall Study|Adverse Event|0
7598150|NCT03287245|12004425|FG002|Overall Study|Adverse Event|0
7598151|NCT03287245|12004426|FG003|Overall Study|Adverse Event|0
7598152|NCT03287245|12004423|FG000|Overall Study|Withdrawal by Subject|8
7598153|NCT03287245|12004424|FG001|Overall Study|Withdrawal by Subject|3
7598154|NCT03287245|12004425|FG002|Overall Study|Withdrawal by Subject|3
7598155|NCT03287245|12004426|FG003|Overall Study|Withdrawal by Subject|0
7598156|NCT03287245|12004423|FG000|Overall Study|Physician Decision|3
7598157|NCT03287245|12004424|FG001|Overall Study|Physician Decision|2
7598158|NCT03287245|12004425|FG002|Overall Study|Physician Decision|0
7598159|NCT03287245|12004426|FG003|Overall Study|Physician Decision|0
7598160|NCT03092219|12004467|FG000|Overall Study|Protocol Violation|7
7598161|NCT03092219|12004468|FG001|Overall Study|Protocol Violation|4
7598162|NCT03033069|12004481|FG000|Overall Study|Adverse Event|6
7598163|NCT03033069|12004482|FG001|Overall Study|Adverse Event|7
7598164|NCT03033069|12004483|FG002|Overall Study|Adverse Event|4
7598165|NCT03033069|12004484|FG003|Overall Study|Adverse Event|6
7598166|NCT03033069|12004481|FG000|Overall Study|Lack of Efficacy|0
7598167|NCT03033069|12004482|FG001|Overall Study|Lack of Efficacy|0
7598168|NCT03033069|12004483|FG002|Overall Study|Lack of Efficacy|1
7598169|NCT03033069|12004484|FG003|Overall Study|Lack of Efficacy|0
7598170|NCT03033069|12004481|FG000|Overall Study|Lost to Follow-up|6
7772096|NCT00887224|12216663|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9
7598171|NCT03033069|12004482|FG001|Overall Study|Lost to Follow-up|5
7598172|NCT03033069|12004483|FG002|Overall Study|Lost to Follow-up|5
7598173|NCT03033069|12004484|FG003|Overall Study|Lost to Follow-up|6
7598174|NCT03033069|12004481|FG000|Overall Study|Non-Compliance With Study Drug|1
7598175|NCT03033069|12004482|FG001|Overall Study|Non-Compliance With Study Drug|1
7772097|NCT00887224|12216664|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0
7772098|NCT00887224|12216665|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0
7772099|NCT00887224|12216663|FG000|Open-label Stability (OLS) Phase|Other|1
7772100|NCT00887224|12216664|FG001|Open-label Stability (OLS) Phase|Other|0
7772101|NCT00887224|12216665|FG002|Open-label Stability (OLS) Phase|Other|0
7772102|NCT00887224|12216663|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13
7772103|NCT00887224|12216664|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0
7772104|NCT00887224|12216665|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0
7772105|NCT00887224|12216663|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
7772106|NCT00887224|12216664|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
7772107|NCT00887224|12216665|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
7772108|NCT00887224|12216663|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28
7598176|NCT03033069|12004483|FG002|Overall Study|Non-Compliance With Study Drug|1
7598177|NCT03033069|12004484|FG003|Overall Study|Non-Compliance With Study Drug|0
7598178|NCT03033069|12004481|FG000|Overall Study|Protocol Deviation|0
7598179|NCT03033069|12004482|FG001|Overall Study|Protocol Deviation|1
7598180|NCT03033069|12004483|FG002|Overall Study|Protocol Deviation|0
7598181|NCT03033069|12004484|FG003|Overall Study|Protocol Deviation|0
7598182|NCT03033069|12004481|FG000|Overall Study|Withdrawal by Subject|10
7598183|NCT03033069|12004482|FG001|Overall Study|Withdrawal by Subject|10
7598184|NCT03033069|12004483|FG002|Overall Study|Withdrawal by Subject|11
7598185|NCT03033069|12004484|FG003|Overall Study|Withdrawal by Subject|6
7598186|NCT03033069|12004481|FG000|Overall Study|Withdrawal By Caregiver|1
7598187|NCT03033069|12004482|FG001|Overall Study|Withdrawal By Caregiver|0
7598188|NCT03033069|12004483|FG002|Overall Study|Withdrawal By Caregiver|0
7598189|NCT03033069|12004484|FG003|Overall Study|Withdrawal By Caregiver|0
7598190|NCT03033069|12004481|FG000|Overall Study|Reason not Specified|0
7598191|NCT03033069|12004482|FG001|Overall Study|Reason not Specified|1
7598192|NCT03033069|12004483|FG002|Overall Study|Reason not Specified|0
7598193|NCT03033069|12004484|FG003|Overall Study|Reason not Specified|1
7598194|NCT02609503|12004509|FG000|Overall Study|Adverse Event|1
7598195|NCT02609503|12004509|FG000|Overall Study|Death|1
7598196|NCT02609503|12004509|FG000|Overall Study|Withdrawal by Subject|1
7598197|NCT02609503|12004509|FG000|Overall Study|Disease progression|1
7598198|NCT02587598|12004527|FG000|Overall Study|Death|4
7598199|NCT02587598|12004528|FG001|Overall Study|Death|8
7598200|NCT02587598|12004529|FG002|Overall Study|Death|4
7598201|NCT02587598|12004530|FG003|Overall Study|Death|16
7598202|NCT02587598|12004531|FG004|Overall Study|Death|9
7598203|NCT02587598|12004532|FG005|Overall Study|Death|4
7598204|NCT02587598|12004533|FG006|Overall Study|Death|6
7598205|NCT02587598|12004534|FG007|Overall Study|Death|7
7598206|NCT02587598|12004535|FG008|Overall Study|Death|9
7598207|NCT02587598|12004536|FG009|Overall Study|Death|1
7598208|NCT02587598|12004537|FG010|Overall Study|Death|3
7598209|NCT02587598|12004527|FG000|Overall Study|Study Terminated by the Sponsor|0
7598210|NCT02587598|12004528|FG001|Overall Study|Study Terminated by the Sponsor|1
7598211|NCT02587598|12004529|FG002|Overall Study|Study Terminated by the Sponsor|0
7598212|NCT02587598|12004530|FG003|Overall Study|Study Terminated by the Sponsor|3
7598213|NCT02587598|12004531|FG004|Overall Study|Study Terminated by the Sponsor|0
7598214|NCT02587598|12004532|FG005|Overall Study|Study Terminated by the Sponsor|1
7598215|NCT02587598|12004533|FG006|Overall Study|Study Terminated by the Sponsor|0
7598216|NCT02587598|12004534|FG007|Overall Study|Study Terminated by the Sponsor|0
7598217|NCT02587598|12004535|FG008|Overall Study|Study Terminated by the Sponsor|0
7598218|NCT02587598|12004536|FG009|Overall Study|Study Terminated by the Sponsor|1
7598219|NCT02587598|12004537|FG010|Overall Study|Study Terminated by the Sponsor|6
7772109|NCT00887224|12216664|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0
7598220|NCT02587598|12004527|FG000|Overall Study|Reason for study withdrawal not specified|0
7598221|NCT02587598|12004528|FG001|Overall Study|Reason for study withdrawal not specified|1
7598222|NCT02587598|12004529|FG002|Overall Study|Reason for study withdrawal not specified|0
7598223|NCT02587598|12004530|FG003|Overall Study|Reason for study withdrawal not specified|0
7598224|NCT02587598|12004531|FG004|Overall Study|Reason for study withdrawal not specified|0
7598225|NCT02587598|12004532|FG005|Overall Study|Reason for study withdrawal not specified|0
7598226|NCT02587598|12004533|FG006|Overall Study|Reason for study withdrawal not specified|0
7598227|NCT02587598|12004534|FG007|Overall Study|Reason for study withdrawal not specified|0
7598228|NCT02587598|12004535|FG008|Overall Study|Reason for study withdrawal not specified|0
7598229|NCT02587598|12004536|FG009|Overall Study|Reason for study withdrawal not specified|0
7598230|NCT02587598|12004537|FG010|Overall Study|Reason for study withdrawal not specified|0
7598231|NCT02587598|12004527|FG000|Overall Study|Withdrawal by Subject|0
7598232|NCT02587598|12004528|FG001|Overall Study|Withdrawal by Subject|1
7598233|NCT02587598|12004529|FG002|Overall Study|Withdrawal by Subject|0
7598234|NCT02587598|12004530|FG003|Overall Study|Withdrawal by Subject|2
7598235|NCT02587598|12004531|FG004|Overall Study|Withdrawal by Subject|3
7598236|NCT02587598|12004532|FG005|Overall Study|Withdrawal by Subject|1
7598237|NCT02587598|12004533|FG006|Overall Study|Withdrawal by Subject|0
7598238|NCT02587598|12004534|FG007|Overall Study|Withdrawal by Subject|0
7598239|NCT02587598|12004535|FG008|Overall Study|Withdrawal by Subject|0
7598240|NCT02587598|12004536|FG009|Overall Study|Withdrawal by Subject|1
7598241|NCT02587598|12004537|FG010|Overall Study|Withdrawal by Subject|2
7598242|NCT02587598|12004527|FG000|Overall Study|Physician Decision|0
7598243|NCT02587598|12004528|FG001|Overall Study|Physician Decision|0
7598244|NCT02587598|12004529|FG002|Overall Study|Physician Decision|0
7598245|NCT02587598|12004530|FG003|Overall Study|Physician Decision|0
7598246|NCT02587598|12004531|FG004|Overall Study|Physician Decision|0
7598247|NCT02587598|12004532|FG005|Overall Study|Physician Decision|0
7598248|NCT02587598|12004533|FG006|Overall Study|Physician Decision|0
7598249|NCT02587598|12004534|FG007|Overall Study|Physician Decision|0
7598250|NCT02587598|12004535|FG008|Overall Study|Physician Decision|0
7598251|NCT02587598|12004536|FG009|Overall Study|Physician Decision|0
7598252|NCT02587598|12004537|FG010|Overall Study|Physician Decision|3
7598253|NCT02485574|12004573|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4
7598275|NCT01460160|12004607|FG000|Treatment Phase|Lack of Efficacy|3
7598276|NCT01460160|12004607|FG000|Treatment Phase|Study Drug Toxicity|2
7598277|NCT01460160|12004607|FG000|Treatment Phase|Adverse Event|8
7598278|NCT01460160|12004607|FG000|Treatment Phase|Withdrawal by Subject|4
7598279|NCT01460160|12004607|FG000|Treatment Phase|Death|2
7598280|NCT01460160|12004607|FG000|Treatment Phase|Other reasons|9
7598281|NCT01460160|12004607|FG000|Follow-up Phase|Withdrawal by Subject|4
7772110|NCT00887224|12216665|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0
7772111|NCT00887224|12216663|FG000|OL Taper Phase / OL Follow Up|Failed to return|17
7772112|NCT00887224|12216664|FG001|OL Taper Phase / OL Follow Up|Failed to return|0
7772113|NCT00887224|12216665|FG002|OL Taper Phase / OL Follow Up|Failed to return|0
7772114|NCT00887224|12216663|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10
7772115|NCT00887224|12216664|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0
7772116|NCT00887224|12216665|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0
7772117|NCT00887224|12216663|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
7772118|NCT00887224|12216664|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
7772119|NCT00887224|12216665|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
7772120|NCT00887224|12216663|FG000|OL Taper Phase / OL Follow Up|Other|30
7772121|NCT00887224|12216664|FG001|OL Taper Phase / OL Follow Up|Other|0
7772122|NCT00887224|12216665|FG002|OL Taper Phase / OL Follow Up|Other|0
7772123|NCT00887224|12216663|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3
7772124|NCT00887224|12216664|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0
7772125|NCT00887224|12216665|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0
7772126|NCT00887224|12216663|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
7772127|NCT00887224|12216664|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
7772128|NCT00887224|12216665|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
7772129|NCT00887224|12216663|FG000|Double-blind (DB) Phase|Adverse Event|0
7772130|NCT00887224|12216664|FG001|Double-blind (DB) Phase|Adverse Event|7
7772131|NCT00887224|12216665|FG002|Double-blind (DB) Phase|Adverse Event|2
7772132|NCT00887224|12216663|FG000|Double-blind (DB) Phase|Failed to return|0
7772133|NCT00887224|12216664|FG001|Double-blind (DB) Phase|Failed to return|2
7772134|NCT00887224|12216665|FG002|Double-blind (DB) Phase|Failed to return|2
7772135|NCT00887224|12216663|FG000|Double-blind (DB) Phase|Lack of Efficacy|0
7772136|NCT00887224|12216664|FG001|Double-blind (DB) Phase|Lack of Efficacy|67
7772137|NCT00887224|12216665|FG002|Double-blind (DB) Phase|Lack of Efficacy|33
7772138|NCT00887224|12216663|FG000|Double-blind (DB) Phase|Lost to Follow-up|0
7772139|NCT00887224|12216664|FG001|Double-blind (DB) Phase|Lost to Follow-up|8
7772140|NCT00887224|12216665|FG002|Double-blind (DB) Phase|Lost to Follow-up|8
7772141|NCT00887224|12216663|FG000|Double-blind (DB) Phase|Other|0
7772142|NCT00887224|12216664|FG001|Double-blind (DB) Phase|Other|2
7772143|NCT00887224|12216665|FG002|Double-blind (DB) Phase|Other|0
7772144|NCT00887224|12216663|FG000|Double-blind (DB) Phase|Protocol Violation|0
7772145|NCT00887224|12216664|FG001|Double-blind (DB) Phase|Protocol Violation|8
7772146|NCT00887224|12216665|FG002|Double-blind (DB) Phase|Protocol Violation|5
7772147|NCT00887224|12216663|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0
7772148|NCT00887224|12216664|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6
7772149|NCT00887224|12216665|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12
7772150|NCT00887224|12216663|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0
7772151|NCT00887224|12216664|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5
7772152|NCT00887224|12216665|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0
7772153|NCT00887224|12216663|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0
7772154|NCT00887224|12216664|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5
7772155|NCT00887224|12216665|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4
7772156|NCT00887224|12216663|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0
7772157|NCT00887224|12216664|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6
7772158|NCT00887224|12216665|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0
7772159|NCT00887224|12216663|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
7772160|NCT00887224|12216664|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
7772161|NCT00887224|12216665|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
7772162|NCT00887224|12216663|FG000|DB Taper Phase / Post Study Follow Up|Other|0
7772163|NCT00887224|12216664|FG001|DB Taper Phase / Post Study Follow Up|Other|11
7772164|NCT00887224|12216665|FG002|DB Taper Phase / Post Study Follow Up|Other|12
7772165|NCT00887224|12216663|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
7772166|NCT00887224|12216664|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
7772167|NCT00887224|12216665|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
7772168|NCT00887224|12216663|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
7772169|NCT00887224|12216664|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
7772170|NCT00887224|12216665|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
7772171|NCT00887289|12216677|FG000|Overall Study|Lack of Efficacy|14
7772172|NCT00887289|12216677|FG000|Overall Study|Adverse Event|27
7598282|NCT01460160|12004607|FG000|Follow-up Phase|Death|14
7598283|NCT01460160|12004607|FG000|Follow-up Phase|Lost to Follow-up|7
7598284|NCT01460160|12004607|FG000|Follow-up Phase|Follow-up no longer required per protocol|70
7598285|NCT01460160|12004607|FG000|Follow-up Phase|Other and not reported reasons|5
7598286|NCT01170702|12004615|FG000|Overall Study|Exclusion criteria met after consent|1
7598287|NCT01170702|12004616|FG001|Overall Study|Exclusion criteria met after consent|2
7598288|NCT01170702|12004617|FG002|Overall Study|Exclusion criteria met after consent|0
7598289|NCT01170702|12004618|FG003|Overall Study|Exclusion criteria met after consent|2
7598290|NCT01018563|12004628|FG000|Overall Study|Termination of the study by Sponsor|2
7598291|NCT01018563|12004629|FG001|Overall Study|Termination of the study by Sponsor|1
7598292|NCT00805961|12004639|FG000|Modality Therapy|Withdrawal by Subject|1
7598293|NCT00805961|12004639|FG000|Modality Therapy|Adverse Event|1
7598294|NCT00805961|12004639|FG000|Modality Therapy|Disease Progression|2
7598295|NCT00805961|12004639|FG000|Treatment-Free Interval|Adverse Event|3
7598296|NCT00805961|12004639|FG000|Treatment-Free Interval|Intercurrent Illness|2
7598297|NCT00805961|12004639|FG000|Treatment-Free Interval|Physician Decision|1
7598298|NCT00805961|12004639|FG000|Treatment-Free Interval|Lack of Efficacy|1
7598299|NCT00805961|12004639|FG000|Maintenance Treatment|Lack of Efficacy|13
7598300|NCT00805961|12004639|FG000|Maintenance Treatment|Intercurrent Illness|7
7598301|NCT00805961|12004639|FG000|Maintenance Treatment|Adverse Event|6
7598302|NCT00805961|12004639|FG000|Maintenance Treatment|Withdrawal by Subject|5
7598303|NCT00805961|12004639|FG000|Maintenance Treatment|Symptomatic Deterioration|2
7598304|NCT00805961|12004639|FG000|Maintenance Treatment|Withdrawn Consent|1
7598305|NCT03921424|12004660|FG000|Overall Study|Lost to Follow-up|0
7598306|NCT03921424|12004661|FG001|Overall Study|Lost to Follow-up|1
7598307|NCT03921424|12004660|FG000|Overall Study|Withdrawal By Parent/Guardian|0
7598308|NCT03921424|12004661|FG001|Overall Study|Withdrawal By Parent/Guardian|2
7598309|NCT03598777|12004674|FG000|Overall Study|Study Terminated by Sponsor|3
7598310|NCT03598777|12004675|FG001|Overall Study|Study Terminated by Sponsor|0
7598311|NCT03598777|12004676|FG002|Overall Study|Study Terminated by Sponsor|0
7598312|NCT03598777|12004677|FG003|Overall Study|Study Terminated by Sponsor|0
7598313|NCT03598777|12004678|FG004|Overall Study|Study Terminated by Sponsor|15
7772173|NCT00887289|12216677|FG000|Overall Study|Withdrawal by Subject|26
7772174|NCT00887289|12216677|FG000|Overall Study|Lost to Follow-up|8
7598314|NCT03598777|12004674|FG000|Overall Study|Withdrawal by Subject|1
7598315|NCT03598777|12004675|FG001|Overall Study|Withdrawal by Subject|1
7598316|NCT03598777|12004676|FG002|Overall Study|Withdrawal by Subject|0
7598317|NCT03598777|12004677|FG003|Overall Study|Withdrawal by Subject|0
7598318|NCT03598777|12004678|FG004|Overall Study|Withdrawal by Subject|0
7598319|NCT03598777|12004674|FG000|Overall Study|Adverse Event|1
7598320|NCT03598777|12004675|FG001|Overall Study|Adverse Event|0
7598321|NCT03598777|12004676|FG002|Overall Study|Adverse Event|0
7598322|NCT03598777|12004677|FG003|Overall Study|Adverse Event|0
7598323|NCT03598777|12004678|FG004|Overall Study|Adverse Event|0
7598324|NCT03598777|12004674|FG000|Overall Study|Lost to Follow-up|1
7598325|NCT03598777|12004675|FG001|Overall Study|Lost to Follow-up|0
7598326|NCT03598777|12004676|FG002|Overall Study|Lost to Follow-up|0
7598327|NCT03598777|12004677|FG003|Overall Study|Lost to Follow-up|0
7598328|NCT03598777|12004678|FG004|Overall Study|Lost to Follow-up|0
7598329|NCT03406078|12004695|FG000|Overall Study|Death|1
7598330|NCT03406078|12004696|FG001|Overall Study|Death|0
7598331|NCT03406078|12004695|FG000|Overall Study|Lost to Follow-up|0
7598332|NCT03406078|12004696|FG001|Overall Study|Lost to Follow-up|1
7598333|NCT03406078|12004695|FG000|Overall Study|Withdrawal by Subject|5
7598334|NCT03406078|12004696|FG001|Overall Study|Withdrawal by Subject|2
7598335|NCT03345342|12004718|FG000|Open-Label Phase|Adverse Event|30
7598336|NCT03345342|12004719|FG001|Open-Label Phase|Adverse Event|0
7598337|NCT03345342|12004720|FG002|Open-Label Phase|Adverse Event|0
7598338|NCT03345342|12004721|FG003|Open-Label Phase|Adverse Event|0
7598339|NCT03345342|12004722|FG004|Open-Label Phase|Adverse Event|0
7598340|NCT03345342|12004718|FG000|Open-Label Phase|Death|1
7598341|NCT03345342|12004719|FG001|Open-Label Phase|Death|0
7598342|NCT03345342|12004720|FG002|Open-Label Phase|Death|0
7598343|NCT03345342|12004721|FG003|Open-Label Phase|Death|0
7598344|NCT03345342|12004722|FG004|Open-Label Phase|Death|0
7598345|NCT03345342|12004718|FG000|Open-Label Phase|Initiated Prohibited Medication|2
7598346|NCT03345342|12004719|FG001|Open-Label Phase|Initiated Prohibited Medication|0
7598347|NCT03345342|12004720|FG002|Open-Label Phase|Initiated Prohibited Medication|0
7598348|NCT03345342|12004721|FG003|Open-Label Phase|Initiated Prohibited Medication|0
7598349|NCT03345342|12004722|FG004|Open-Label Phase|Initiated Prohibited Medication|0
7598350|NCT03345342|12004718|FG000|Open-Label Phase|Lack of Efficacy|6
7598351|NCT03345342|12004719|FG001|Open-Label Phase|Lack of Efficacy|0
7598352|NCT03345342|12004720|FG002|Open-Label Phase|Lack of Efficacy|0
7598353|NCT03345342|12004721|FG003|Open-Label Phase|Lack of Efficacy|0
7598354|NCT03345342|12004722|FG004|Open-Label Phase|Lack of Efficacy|0
7598355|NCT03345342|12004718|FG000|Open-Label Phase|Lost to Follow-up|9
7598356|NCT03345342|12004719|FG001|Open-Label Phase|Lost to Follow-up|0
7598357|NCT03345342|12004720|FG002|Open-Label Phase|Lost to Follow-up|0
7598358|NCT03345342|12004721|FG003|Open-Label Phase|Lost to Follow-up|0
7598359|NCT03345342|12004722|FG004|Open-Label Phase|Lost to Follow-up|0
7598360|NCT03345342|12004718|FG000|Open-Label Phase|Non-Compliance with Study Drug|4
7598361|NCT03345342|12004719|FG001|Open-Label Phase|Non-Compliance with Study Drug|0
7598362|NCT03345342|12004720|FG002|Open-Label Phase|Non-Compliance with Study Drug|0
7598363|NCT03345342|12004721|FG003|Open-Label Phase|Non-Compliance with Study Drug|0
7598364|NCT03345342|12004722|FG004|Open-Label Phase|Non-Compliance with Study Drug|0
7598365|NCT03345342|12004718|FG000|Open-Label Phase|Physician Decision|4
7598366|NCT03345342|12004719|FG001|Open-Label Phase|Physician Decision|0
7598367|NCT03345342|12004720|FG002|Open-Label Phase|Physician Decision|0
7598368|NCT03345342|12004721|FG003|Open-Label Phase|Physician Decision|0
7598369|NCT03345342|12004722|FG004|Open-Label Phase|Physician Decision|0
7598370|NCT03345342|12004718|FG000|Open-Label Phase|Protocol Violation|8
7598371|NCT03345342|12004719|FG001|Open-Label Phase|Protocol Violation|0
7598372|NCT03345342|12004720|FG002|Open-Label Phase|Protocol Violation|0
7598373|NCT03345342|12004721|FG003|Open-Label Phase|Protocol Violation|0
7598374|NCT03345342|12004722|FG004|Open-Label Phase|Protocol Violation|0
7598375|NCT03345342|12004718|FG000|Open-Label Phase|Withdrawal by Subject|57
7598376|NCT03345342|12004719|FG001|Open-Label Phase|Withdrawal by Subject|0
7598377|NCT03345342|12004720|FG002|Open-Label Phase|Withdrawal by Subject|0
7598378|NCT03345342|12004721|FG003|Open-Label Phase|Withdrawal by Subject|0
7598379|NCT03345342|12004722|FG004|Open-Label Phase|Withdrawal by Subject|0
7598380|NCT03345342|12004718|FG000|Open-Label Phase|Other|15
7598381|NCT03345342|12004719|FG001|Open-Label Phase|Other|0
7598382|NCT03345342|12004720|FG002|Open-Label Phase|Other|0
7598383|NCT03345342|12004721|FG003|Open-Label Phase|Other|0
7598384|NCT03345342|12004722|FG004|Open-Label Phase|Other|0
7598385|NCT03345342|12004718|FG000|Double-Blind Phase|Adverse Event|0
7598386|NCT03345342|12004719|FG001|Double-Blind Phase|Adverse Event|1
7598387|NCT03345342|12004720|FG002|Double-Blind Phase|Adverse Event|6
7598388|NCT03345342|12004721|FG003|Double-Blind Phase|Adverse Event|0
7598389|NCT03345342|12004722|FG004|Double-Blind Phase|Adverse Event|0
7598390|NCT03345342|12004718|FG000|Double-Blind Phase|Death|0
7598391|NCT03345342|12004719|FG001|Double-Blind Phase|Death|2
7598392|NCT03345342|12004720|FG002|Double-Blind Phase|Death|1
7772175|NCT00887289|12216677|FG000|Overall Study|Other|20
7598393|NCT03345342|12004721|FG003|Double-Blind Phase|Death|0
7598394|NCT03345342|12004722|FG004|Double-Blind Phase|Death|0
7598395|NCT03345342|12004718|FG000|Double-Blind Phase|Initiated Prohibited Medication|0
7598396|NCT03345342|12004719|FG001|Double-Blind Phase|Initiated Prohibited Medication|0
7598397|NCT03345342|12004720|FG002|Double-Blind Phase|Initiated Prohibited Medication|2
7598398|NCT03345342|12004721|FG003|Double-Blind Phase|Initiated Prohibited Medication|0
7598399|NCT03345342|12004722|FG004|Double-Blind Phase|Initiated Prohibited Medication|0
7598400|NCT03345342|12004718|FG000|Double-Blind Phase|Lost to Follow-up|0
7598401|NCT03345342|12004719|FG001|Double-Blind Phase|Lost to Follow-up|1
7598402|NCT03345342|12004720|FG002|Double-Blind Phase|Lost to Follow-up|7
7598403|NCT03345342|12004721|FG003|Double-Blind Phase|Lost to Follow-up|0
7598404|NCT03345342|12004722|FG004|Double-Blind Phase|Lost to Follow-up|0
7598405|NCT03345342|12004718|FG000|Double-Blind Phase|Physician Decision|0
7598406|NCT03345342|12004719|FG001|Double-Blind Phase|Physician Decision|1
7598407|NCT03345342|12004720|FG002|Double-Blind Phase|Physician Decision|4
7598408|NCT03345342|12004721|FG003|Double-Blind Phase|Physician Decision|0
7598409|NCT03345342|12004722|FG004|Double-Blind Phase|Physician Decision|0
7598410|NCT03345342|12004718|FG000|Double-Blind Phase|Protocol Violation|0
7598411|NCT03345342|12004719|FG001|Double-Blind Phase|Protocol Violation|0
7598412|NCT03345342|12004720|FG002|Double-Blind Phase|Protocol Violation|1
7598413|NCT03345342|12004721|FG003|Double-Blind Phase|Protocol Violation|0
7598414|NCT03345342|12004722|FG004|Double-Blind Phase|Protocol Violation|0
7598415|NCT03345342|12004718|FG000|Double-Blind Phase|Withdrawal by Subject|0
7598416|NCT03345342|12004719|FG001|Double-Blind Phase|Withdrawal by Subject|16
7598417|NCT03345342|12004720|FG002|Double-Blind Phase|Withdrawal by Subject|38
7598418|NCT03345342|12004721|FG003|Double-Blind Phase|Withdrawal by Subject|0
7598419|NCT03345342|12004722|FG004|Double-Blind Phase|Withdrawal by Subject|0
7598420|NCT03345342|12004718|FG000|Double-Blind Phase|Other|0
7598421|NCT03345342|12004719|FG001|Double-Blind Phase|Other|1
7598422|NCT03345342|12004720|FG002|Double-Blind Phase|Other|3
7598423|NCT03345342|12004721|FG003|Double-Blind Phase|Other|0
7598424|NCT03345342|12004722|FG004|Double-Blind Phase|Other|0
7598425|NCT03345342|12004718|FG000|Follow-Up Phase|Adverse Event|0
7598426|NCT03345342|12004719|FG001|Follow-Up Phase|Adverse Event|0
7598427|NCT03345342|12004720|FG002|Follow-Up Phase|Adverse Event|0
7598428|NCT03345342|12004721|FG003|Follow-Up Phase|Adverse Event|0
7772176|NCT00887341|12216683|FG000|Overall Study|Refused treatment|1
7772177|NCT00887341|12216684|FG001|Overall Study|Refused treatment|0
7772178|NCT00887341|12216683|FG000|Overall Study|Withdrawal by Subject|1
7772179|NCT00887341|12216684|FG001|Overall Study|Withdrawal by Subject|1
7772180|NCT00887341|12216683|FG000|Overall Study|Adverse Event|0
7772181|NCT00887341|12216684|FG001|Overall Study|Adverse Event|1
7772182|NCT00887341|12216683|FG000|Overall Study|Lost to Follow-up|0
7772183|NCT00887341|12216684|FG001|Overall Study|Lost to Follow-up|1
7772184|NCT00887354|12216692|FG000|Treatment Phase (Week 0 to Week 26)|Death|0
7772185|NCT00887354|12216693|FG001|Treatment Phase (Week 0 to Week 26)|Death|1
7772186|NCT00887354|12216692|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
7772187|NCT00887354|12216693|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
7772188|NCT00887354|12216692|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
7772189|NCT00887354|12216693|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
7772190|NCT00887354|12216692|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
7772191|NCT00887354|12216693|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
7772192|NCT00887354|12216692|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
7772193|NCT00887354|12216693|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
7772194|NCT00887354|12216692|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
7772195|NCT00887354|12216693|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
7772196|NCT00887354|12216692|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
7772197|NCT00887354|12216693|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
7772198|NCT00887354|12216692|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
7772199|NCT00887354|12216693|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
7772200|NCT00887354|12216692|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
7772201|NCT00887354|12216693|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
7772202|NCT00887354|12216692|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5
7772203|NCT00887354|12216693|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3
7772204|NCT00887354|12216692|FG000|Open Label Phase (Week 26 to Week 78)|Death|0
7772205|NCT00887354|12216693|FG001|Open Label Phase (Week 26 to Week 78)|Death|2
7772206|NCT00887354|12216692|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
7772207|NCT00887354|12216693|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
7598429|NCT03345342|12004722|FG004|Follow-Up Phase|Adverse Event|4
7598430|NCT03345342|12004718|FG000|Follow-Up Phase|Lost to Follow-up|0
7598431|NCT03345342|12004719|FG001|Follow-Up Phase|Lost to Follow-up|0
7598432|NCT03345342|12004720|FG002|Follow-Up Phase|Lost to Follow-up|0
7598433|NCT03345342|12004721|FG003|Follow-Up Phase|Lost to Follow-up|0
7598434|NCT03345342|12004722|FG004|Follow-Up Phase|Lost to Follow-up|6
7598435|NCT03345342|12004718|FG000|Follow-Up Phase|Physician Decision|0
7598436|NCT03345342|12004719|FG001|Follow-Up Phase|Physician Decision|0
7598437|NCT03345342|12004720|FG002|Follow-Up Phase|Physician Decision|0
7598438|NCT03345342|12004721|FG003|Follow-Up Phase|Physician Decision|0
7598439|NCT03345342|12004722|FG004|Follow-Up Phase|Physician Decision|5
7598440|NCT03345342|12004718|FG000|Follow-Up Phase|Withdrawal by Subject|0
7598441|NCT03345342|12004719|FG001|Follow-Up Phase|Withdrawal by Subject|0
7598442|NCT03345342|12004720|FG002|Follow-Up Phase|Withdrawal by Subject|0
7598443|NCT03345342|12004721|FG003|Follow-Up Phase|Withdrawal by Subject|5
7598444|NCT03345342|12004722|FG004|Follow-Up Phase|Withdrawal by Subject|15
7598445|NCT03345342|12004718|FG000|Follow-Up Phase|Other|0
7598446|NCT03345342|12004719|FG001|Follow-Up Phase|Other|0
7598447|NCT03345342|12004720|FG002|Follow-Up Phase|Other|0
7598448|NCT03345342|12004721|FG003|Follow-Up Phase|Other|3
7598449|NCT03345342|12004722|FG004|Follow-Up Phase|Other|1
7598450|NCT02880241|12004755|FG000|Overall Study|Lack of Efficacy|1
7598451|NCT02880241|12004756|FG001|Overall Study|Lack of Efficacy|0
7598452|NCT02880241|12004757|FG002|Overall Study|Lack of Efficacy|0
7598453|NCT02880241|12004758|FG003|Overall Study|Lack of Efficacy|0
7598454|NCT02880241|12004759|FG004|Overall Study|Lack of Efficacy|0
7598455|NCT02880241|12004760|FG005|Overall Study|Lack of Efficacy|0
7598456|NCT02832687|12004778|FG000|Overall Study|Adverse Event|0
7598457|NCT02832687|12004779|FG001|Overall Study|Adverse Event|2
7598458|NCT02499900|12004791|FG000|Core Study Period|Other|1
7598459|NCT02499900|12004792|FG001|Core Study Period|Other|4
7598460|NCT02499900|12004791|FG000|Core Study Period|Lost to Follow-up|1
7598461|NCT02499900|12004792|FG001|Core Study Period|Lost to Follow-up|2
7598462|NCT02499900|12004791|FG000|Core Study Period|Per sponsor request|0
7598463|NCT02499900|12004792|FG001|Core Study Period|Per sponsor request|1
7598464|NCT02499900|12004791|FG000|Core Study Period|Pregnancy|1
7598465|NCT02499900|12004792|FG001|Core Study Period|Pregnancy|0
7598466|NCT02499900|12004791|FG000|Core Study Period|Protocol Violation|3
7598467|NCT02499900|12004792|FG001|Core Study Period|Protocol Violation|0
7598468|NCT02499900|12004791|FG000|Core Study Period|Withdrawal by Subject|11
7598469|NCT02499900|12004792|FG001|Core Study Period|Withdrawal by Subject|10
7598470|NCT02499900|12004791|FG000|Core Study Period|Adverse Event|18
7598471|NCT02499900|12004792|FG001|Core Study Period|Adverse Event|14
7598472|NCT02499900|12004791|FG000|Core Study Period|Death|0
7598473|NCT02499900|12004792|FG001|Core Study Period|Death|1
7598474|NCT02499900|12004791|FG000|Completed Core, Continued Into Extension|Physician Decision|1
7598475|NCT02499900|12004792|FG001|Completed Core, Continued Into Extension|Physician Decision|0
7598476|NCT02499900|12004791|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0
7598477|NCT02499900|12004792|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2
7598478|NCT02499900|12004791|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
7598479|NCT02499900|12004792|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
7598480|NCT02499900|12004791|FG000|Completed Core, Continued Into Extension|Personal motivation|1
7598481|NCT02499900|12004792|FG001|Completed Core, Continued Into Extension|Personal motivation|0
7598482|NCT02499900|12004791|FG000|Extension Study Period|Adverse Event|2
7598483|NCT02499900|12004792|FG001|Extension Study Period|Adverse Event|4
7598484|NCT02499900|12004791|FG000|Extension Study Period|Withdrawal by Subject|5
7598485|NCT02499900|12004792|FG001|Extension Study Period|Withdrawal by Subject|2
7598486|NCT02499900|12004791|FG000|Extension Study Period|Physician Decision|2
7598487|NCT02499900|12004792|FG001|Extension Study Period|Physician Decision|5
7772208|NCT00887354|12216692|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
7772209|NCT00887354|12216693|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
7772210|NCT00887354|12216692|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
7772211|NCT00887354|12216693|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
7772212|NCT00887354|12216692|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
7772213|NCT00887354|12216693|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
7772214|NCT00887432|12216702|FG000|Overall Study|Start Excluded Therapy|3
7772215|NCT00887432|12216703|FG001|Overall Study|Start Excluded Therapy|0
7772216|NCT00887432|12216702|FG000|Overall Study|Did not complete treatment|6
7772217|NCT00887432|12216703|FG001|Overall Study|Did not complete treatment|8
7772218|NCT00887432|12216702|FG000|Overall Study|Protocol Violation|2
7772219|NCT00887432|12216703|FG001|Overall Study|Protocol Violation|3
7772220|NCT00887432|12216702|FG000|Overall Study|Withdrawal by Subject|3
7772221|NCT00887432|12216703|FG001|Overall Study|Withdrawal by Subject|2
7772222|NCT00887432|12216702|FG000|Overall Study|Lost to Follow-up|1
7772223|NCT00887432|12216703|FG001|Overall Study|Lost to Follow-up|0
7772224|NCT00887432|12216702|FG000|Overall Study|No reason provided|0
7772225|NCT00887432|12216703|FG001|Overall Study|No reason provided|1
7772226|NCT00887484|12216729|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
7772227|NCT00887484|12216729|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
7772228|NCT00887484|12216729|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
7772229|NCT00887549|12216747|FG000|Induction Therapy|Adverse Event|8
7772230|NCT00887549|12216747|FG000|Induction Therapy|Physician Decision|1
7772231|NCT00887549|12216747|FG000|Induction Therapy|Progressive Disease|13
7772232|NCT00887549|12216747|FG000|Induction Therapy|Death due to Study Disease|4
7772233|NCT00887549|12216747|FG000|Induction Therapy|Death due to Study Drug Toxicity|1
7772234|NCT00887549|12216747|FG000|Maintenance Therapy|Adverse Event|16
7772235|NCT00887549|12216747|FG000|Maintenance Therapy|Physician Decision|1
7772236|NCT00887549|12216747|FG000|Maintenance Therapy|Progressive Disease|25
7772237|NCT00887549|12216747|FG000|Maintenance Therapy|Death due to adverse event|1
7772238|NCT00887588|12216775|FG000|Core Period|Death|1
7772239|NCT00887588|12216776|FG001|Core Period|Death|1
7772240|NCT00887588|12216775|FG000|Core Period|Lost to Follow-up|3
7772241|NCT00887588|12216776|FG001|Core Period|Lost to Follow-up|1
7772242|NCT00887588|12216775|FG000|Core Period|Withdrawal by Subject|6
7772243|NCT00887588|12216776|FG001|Core Period|Withdrawal by Subject|8
7772244|NCT00887588|12216775|FG000|Core Period|Adverse Event|9
7772245|NCT00887588|12216776|FG001|Core Period|Adverse Event|11
7772246|NCT00887588|12216775|FG000|Extension Period|Adverse Event|4
7772247|NCT00887588|12216776|FG001|Extension Period|Adverse Event|4
7772248|NCT00887588|12216775|FG000|Extension Period|Death|0
7772249|NCT00887588|12216776|FG001|Extension Period|Death|1
7772250|NCT00887588|12216775|FG000|Extension Period|Protocol deviation|1
7772251|NCT00887588|12216776|FG001|Extension Period|Protocol deviation|0
7772252|NCT00887588|12216775|FG000|Extension Period|Lost to Follow-up|1
7772253|NCT00887588|12216776|FG001|Extension Period|Lost to Follow-up|0
7772254|NCT00887679|12216790|FG000|Overall Study|Withdrawal by Subject|1
7772255|NCT00887679|12216790|FG000|Overall Study|Lost to Follow-up|4
7772256|NCT00887679|12216790|FG000|Overall Study|Physician Decision|5
7772257|NCT00887744|12216795|FG000|Overall Study|Adverse Event|3
7772258|NCT00887744|12216795|FG000|Overall Study|Death|1
7598488|NCT02499900|12004791|FG000|Extension Study Period|Pregnancy|1
7598489|NCT02499900|12004792|FG001|Extension Study Period|Pregnancy|2
7772259|NCT00887744|12216795|FG000|Overall Study|Lost to Follow-up|3
7598490|NCT02499900|12004791|FG000|Extension Study Period|Lost to Follow-up|2
7598491|NCT02499900|12004792|FG001|Extension Study Period|Lost to Follow-up|5
7598492|NCT02499900|12004791|FG000|Extension Study Period|Other|0
7598493|NCT02499900|12004792|FG001|Extension Study Period|Other|2
7598494|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25
7598495|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7
7598496|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0
7598497|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Other|19
7598498|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Other|4
7598499|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Other|0
7598500|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32
7598501|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10
7598502|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0
7598503|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24
7598504|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4
7598505|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0
7598506|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4
7598507|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0
7598508|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0
7598509|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4
7598510|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0
7598511|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0
7598512|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2
7598513|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1
7598514|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0
7598515|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Death|4
7598516|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Death|0
7598517|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Death|0
7598518|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3
7598519|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5
7598520|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0
7598521|NCT02269917|12004819|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0
7598522|NCT02269917|12004820|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0
7598523|NCT02269917|12004821|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1
7598524|NCT02269917|12004819|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
7598525|NCT02269917|12004820|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
7598526|NCT02269917|12004821|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10
7598527|NCT02269917|12004819|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
7598528|NCT02269917|12004820|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
7598529|NCT02269917|12004821|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11
7598530|NCT02269917|12004819|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
7598531|NCT02269917|12004820|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
7598532|NCT02269917|12004821|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1
7598533|NCT02269917|12004819|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0
7598534|NCT02269917|12004820|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0
7598535|NCT02269917|12004821|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2
7598536|NCT02269917|12004819|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
7598537|NCT02269917|12004820|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
7598538|NCT02269917|12004821|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5
7598539|NCT02269917|12004819|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0
7598540|NCT02269917|12004820|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0
7598541|NCT02269917|12004821|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8
7598542|NCT02225366|12004832|FG000|Overall Study|Lack of Efficacy|1
7598543|NCT02225366|12004833|FG001|Overall Study|Lack of Efficacy|0
7598544|NCT01530997|12004839|FG000|Overall Study|Physician Decision|1
7598545|NCT01530997|12004839|FG000|Overall Study|Withdrawal by Subject|1
7598546|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Death|0
7598547|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Death|1
7598548|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29
7598549|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6
7598550|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
7598551|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
7598552|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1
7598553|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1
7598554|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
7598555|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
7598556|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
7598557|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
7598558|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2
7772260|NCT00887744|12216795|FG000|Overall Study|Withdrawal by Subject|18
7598559|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0
7598560|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7
7598561|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4
7598562|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
7598563|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
7598564|NCT01067521|12004865|FG000|Open-Label Period|Death|3
7598565|NCT01067521|12004866|FG001|Open-Label Period|Death|1
7598566|NCT01067521|12004865|FG000|Open-Label Period|Adverse Event|30
7598567|NCT01067521|12004866|FG001|Open-Label Period|Adverse Event|28
7598568|NCT01067521|12004865|FG000|Open-Label Period|Withdrawal by Subject|160
7598569|NCT01067521|12004866|FG001|Open-Label Period|Withdrawal by Subject|88
7598570|NCT01067521|12004865|FG000|Open-Label Period|Physician Decision|13
7598571|NCT01067521|12004866|FG001|Open-Label Period|Physician Decision|11
7598572|NCT01067521|12004865|FG000|Open-Label Period|Non-compliance with study drug|5
7598573|NCT01067521|12004866|FG001|Open-Label Period|Non-compliance with study drug|0
7598574|NCT01067521|12004865|FG000|Open-Label Period|Protocol Violation|3
7598575|NCT01067521|12004866|FG001|Open-Label Period|Protocol Violation|0
7598576|NCT01067521|12004865|FG000|Open-Label Period|Pregnancy|14
7598577|NCT01067521|12004866|FG001|Open-Label Period|Pregnancy|8
7598578|NCT01067521|12004865|FG000|Open-Label Period|Teva requested subject to be withdrawn|5
7598579|NCT01067521|12004866|FG001|Open-Label Period|Teva requested subject to be withdrawn|2
7598580|NCT01067521|12004865|FG000|Open-Label Period|Lost to Follow-up|21
7598581|NCT01067521|12004866|FG001|Open-Label Period|Lost to Follow-up|20
7598582|NCT01047319|12004880|FG000|Overall Study|Teva requested participant withdrawal|3
7598583|NCT01047319|12004881|FG001|Overall Study|Teva requested participant withdrawal|0
7598584|NCT01047319|12004882|FG002|Overall Study|Teva requested participant withdrawal|1
7598585|NCT01047319|12004880|FG000|Overall Study|Protocol Violation|3
7598586|NCT01047319|12004881|FG001|Overall Study|Protocol Violation|2
7598587|NCT01047319|12004882|FG002|Overall Study|Protocol Violation|4
7598588|NCT01047319|12004880|FG000|Overall Study|Lack of Efficacy|4
7598589|NCT01047319|12004881|FG001|Overall Study|Lack of Efficacy|3
7598590|NCT01047319|12004882|FG002|Overall Study|Lack of Efficacy|3
7598591|NCT01047319|12004880|FG000|Overall Study|Death|5
7598592|NCT01047319|12004881|FG001|Overall Study|Death|1
7598593|NCT01047319|12004882|FG002|Overall Study|Death|5
7598594|NCT01047319|12004880|FG000|Overall Study|Pregnancy|13
7598595|NCT01047319|12004881|FG001|Overall Study|Pregnancy|8
7598596|NCT01047319|12004882|FG002|Overall Study|Pregnancy|8
7598597|NCT01047319|12004880|FG000|Overall Study|Physician Decision|12
7598598|NCT01047319|12004881|FG001|Overall Study|Physician Decision|9
7598599|NCT01047319|12004882|FG002|Overall Study|Physician Decision|10
7598600|NCT01047319|12004880|FG000|Overall Study|Lost to Follow-up|14
7598601|NCT01047319|12004881|FG001|Overall Study|Lost to Follow-up|10
7598602|NCT01047319|12004882|FG002|Overall Study|Lost to Follow-up|10
7598603|NCT01047319|12004880|FG000|Overall Study|Adverse Event|16
7598604|NCT01047319|12004881|FG001|Overall Study|Adverse Event|27
7598605|NCT01047319|12004882|FG002|Overall Study|Adverse Event|21
7598606|NCT01047319|12004880|FG000|Overall Study|Withdrawal by Subject|77
7598607|NCT01047319|12004881|FG001|Overall Study|Withdrawal by Subject|75
7598608|NCT01047319|12004882|FG002|Overall Study|Withdrawal by Subject|87
7598609|NCT01047319|12004880|FG000|Overall Study|Study terminated by Sponsor|198
7598610|NCT01047319|12004881|FG001|Overall Study|Study terminated by Sponsor|215
7598611|NCT01047319|12004882|FG002|Overall Study|Study terminated by Sponsor|203
7598612|NCT00988052|12004892|FG000|Overall Study|Missing|1
7598613|NCT00988052|12004893|FG001|Overall Study|Missing|0
7598614|NCT00988052|12004892|FG000|Overall Study|Teva requested subject withdrawal|3
7598615|NCT00988052|12004893|FG001|Overall Study|Teva requested subject withdrawal|1
7598616|NCT00988052|12004892|FG000|Overall Study|Death|1
7598617|NCT00988052|12004893|FG001|Overall Study|Death|3
7598618|NCT00988052|12004892|FG000|Overall Study|Protocol Violation|6
7598619|NCT00988052|12004893|FG001|Overall Study|Protocol Violation|5
7598620|NCT00988052|12004892|FG000|Overall Study|Pregnancy|6
7598621|NCT00988052|12004893|FG001|Overall Study|Pregnancy|6
7598622|NCT00988052|12004892|FG000|Overall Study|Lack of Efficacy|8
7598623|NCT00988052|12004893|FG001|Overall Study|Lack of Efficacy|7
7598624|NCT00988052|12004892|FG000|Overall Study|Lost to Follow-up|6
7598625|NCT00988052|12004893|FG001|Overall Study|Lost to Follow-up|11
7598626|NCT00988052|12004892|FG000|Overall Study|Physician Decision|27
7598627|NCT00988052|12004893|FG001|Overall Study|Physician Decision|28
7598628|NCT00988052|12004892|FG000|Overall Study|Adverse Event|35
7598629|NCT00988052|12004893|FG001|Overall Study|Adverse Event|28
7598630|NCT00988052|12004892|FG000|Overall Study|Withdrawal by Subject|90
7598631|NCT00988052|12004893|FG001|Overall Study|Withdrawal by Subject|91
7598632|NCT00988052|12004892|FG000|Overall Study|Study terminated by sponsor|240
7598633|NCT00988052|12004893|FG001|Overall Study|Study terminated by sponsor|236
7598634|NCT02021773|12004902|FG000|Overall Study|Adverse Event|1
7598635|NCT02021773|12004903|FG001|Overall Study|Adverse Event|4
7598636|NCT02021773|12004904|FG002|Overall Study|Adverse Event|3
7598637|NCT02021773|12004902|FG000|Overall Study|Lack of Efficacy|2
7598638|NCT02021773|12004903|FG001|Overall Study|Lack of Efficacy|2
7598639|NCT02021773|12004904|FG002|Overall Study|Lack of Efficacy|2
7598640|NCT02021773|12004902|FG000|Overall Study|Protocol Violation|2
7598641|NCT02021773|12004903|FG001|Overall Study|Protocol Violation|3
7598642|NCT02021773|12004904|FG002|Overall Study|Protocol Violation|1
7598643|NCT02021773|12004902|FG000|Overall Study|Withdrawal by Subject|3
7598644|NCT02021773|12004903|FG001|Overall Study|Withdrawal by Subject|4
7598645|NCT02021773|12004904|FG002|Overall Study|Withdrawal by Subject|5
7598646|NCT02021773|12004902|FG000|Overall Study|Lost to Follow-up|1
7598647|NCT02021773|12004903|FG001|Overall Study|Lost to Follow-up|3
7598648|NCT02021773|12004904|FG002|Overall Study|Lost to Follow-up|0
7598649|NCT02021773|12004902|FG000|Overall Study|Reason not specified|3
7598650|NCT02021773|12004903|FG001|Overall Study|Reason not specified|0
7598651|NCT02021773|12004904|FG002|Overall Study|Reason not specified|0
7598652|NCT04553406|12004928|FG000|Overall Study|Study Discontinuation|0
7598653|NCT04553406|12004929|FG001|Overall Study|Study Discontinuation|1
7598654|NCT03792750|12004935|FG000|Overall Study|Death|3
7598655|NCT03739138|12004956|FG000|Overall Study|Death|0
7598656|NCT03739138|12004957|FG001|Overall Study|Death|7
7598657|NCT03739138|12004958|FG002|Overall Study|Death|4
7598658|NCT03739138|12004959|FG003|Overall Study|Death|13
7598659|NCT03739138|12004960|FG004|Overall Study|Death|0
7598660|NCT03739138|12004956|FG000|Overall Study|Lost to Follow-up|0
7598661|NCT03739138|12004957|FG001|Overall Study|Lost to Follow-up|0
7598662|NCT03739138|12004958|FG002|Overall Study|Lost to Follow-up|1
7598663|NCT03739138|12004959|FG003|Overall Study|Lost to Follow-up|0
7598664|NCT03739138|12004960|FG004|Overall Study|Lost to Follow-up|0
7598665|NCT03739138|12004956|FG000|Overall Study|Study Terminated By Sponsor|0
7598666|NCT03739138|12004957|FG001|Overall Study|Study Terminated By Sponsor|0
7598667|NCT03739138|12004958|FG002|Overall Study|Study Terminated By Sponsor|0
7598668|NCT03739138|12004959|FG003|Overall Study|Study Terminated By Sponsor|4
7598669|NCT03739138|12004960|FG004|Overall Study|Study Terminated By Sponsor|0
7598670|NCT03739138|12004956|FG000|Overall Study|Withdrawal by Subject|0
7598671|NCT03739138|12004957|FG001|Overall Study|Withdrawal by Subject|0
7598672|NCT03739138|12004958|FG002|Overall Study|Withdrawal by Subject|0
7598673|NCT03739138|12004959|FG003|Overall Study|Withdrawal by Subject|1
7598674|NCT03739138|12004960|FG004|Overall Study|Withdrawal by Subject|0
7772261|NCT00887744|12216795|FG000|Overall Study|Various reasons|9
7772262|NCT00887809|12216801|FG000|Overall Study|Patient Not Treated|3
7772263|NCT00887809|12216802|FG001|Overall Study|Patient Not Treated|0
7772264|NCT00887809|12216801|FG000|Overall Study|Death|1
7772265|NCT00887809|12216802|FG001|Overall Study|Death|0
7772266|NCT00887822|12216810|FG000|Overall Study|Insufficient therapeutic response|53
7772267|NCT00887822|12216811|FG001|Overall Study|Insufficient therapeutic response|55
7772268|NCT00887822|12216810|FG000|Overall Study|Adverse Event|14
7772269|NCT00887822|12216811|FG001|Overall Study|Adverse Event|17
7772270|NCT00887822|12216810|FG000|Overall Study|Failure to return|11
7772271|NCT00887822|12216811|FG001|Overall Study|Failure to return|11
7772272|NCT00887822|12216810|FG000|Overall Study|Refused treatment/Did not cooperate|12
7772273|NCT00887822|12216811|FG001|Overall Study|Refused treatment/Did not cooperate|10
7772274|NCT00887822|12216810|FG000|Overall Study|Administrative/Other than specified|5
7772275|NCT00887822|12216811|FG001|Overall Study|Administrative/Other than specified|4
7772276|NCT00887822|12216810|FG000|Overall Study|Death|2
7772277|NCT00887822|12216811|FG001|Overall Study|Death|3
7772278|NCT00887822|12216810|FG000|Overall Study|Protocol Violation|0
7772279|NCT00887822|12216811|FG001|Overall Study|Protocol Violation|1
7772280|NCT00887822|12216810|FG000|Overall Study|Randomized but not treated|0
7772281|NCT00887822|12216811|FG001|Overall Study|Randomized but not treated|1
7772282|NCT00887913|12216817|FG000|Overall Study|Withdrawal by Subject|6
7772283|NCT00887926|12216825|FG000|Overall Study|Withdrawal by Subject|0
7772284|NCT00887926|12216826|FG001|Overall Study|Withdrawal by Subject|1
7772285|NCT00887926|12216827|FG002|Overall Study|Withdrawal by Subject|0
7772286|NCT00887926|12216828|FG003|Overall Study|Withdrawal by Subject|0
7772287|NCT00887978|12216846|FG000|Overall Study|Adverse Event|18
7772288|NCT00887978|12216847|FG001|Overall Study|Adverse Event|5
7772289|NCT00887978|12216846|FG000|Overall Study|Clinical Worsening|4
7772290|NCT00887978|12216847|FG001|Overall Study|Clinical Worsening|4
7772291|NCT00887978|12216846|FG000|Overall Study|Death|2
7772292|NCT00887978|12216847|FG001|Overall Study|Death|3
7772293|NCT00887978|12216846|FG000|Overall Study|Withdrawal by Subject|1
7772294|NCT00887978|12216847|FG001|Overall Study|Withdrawal by Subject|2
7772295|NCT00887978|12216846|FG000|Overall Study|Lost to Follow-up|0
7772296|NCT00887978|12216847|FG001|Overall Study|Lost to Follow-up|1
7598711|NCT03468309|12004980|FG000|Overall Study|Lost to Follow-up|4
7598712|NCT03468309|12004980|FG000|Overall Study|Withdrawal by Subject|2
7598713|NCT03347123|12004986|FG000|Overall Study|Death|1
7598714|NCT03347123|12004987|FG001|Overall Study|Death|2
7598715|NCT03347123|12004988|FG002|Overall Study|Death|0
7598716|NCT03347123|12004989|FG003|Overall Study|Death|0
7598717|NCT03347123|12004990|FG004|Overall Study|Death|0
7598718|NCT03347123|12004991|FG005|Overall Study|Death|0
7598719|NCT03347123|12004992|FG006|Overall Study|Death|0
7598720|NCT03347123|12004986|FG000|Overall Study|Withdrawal by Subject|1
7598721|NCT03347123|12004987|FG001|Overall Study|Withdrawal by Subject|0
7598722|NCT03347123|12004988|FG002|Overall Study|Withdrawal by Subject|0
7598723|NCT03347123|12004989|FG003|Overall Study|Withdrawal by Subject|0
7598724|NCT03347123|12004990|FG004|Overall Study|Withdrawal by Subject|0
7598725|NCT03347123|12004991|FG005|Overall Study|Withdrawal by Subject|0
7598726|NCT03347123|12004992|FG006|Overall Study|Withdrawal by Subject|0
7598727|NCT03347123|12004986|FG000|Overall Study|Reason not Specified|3
7772297|NCT00888134|12216853|FG000|Treatment With Study Drug|Withdrawal by Subject|1
7598728|NCT03347123|12004987|FG001|Overall Study|Reason not Specified|4
7598729|NCT03347123|12004988|FG002|Overall Study|Reason not Specified|0
7772298|NCT00888134|12216853|FG000|Follow-up|being followed for long-term survival|1
7598730|NCT03347123|12004989|FG003|Overall Study|Reason not Specified|0
7598731|NCT03347123|12004990|FG004|Overall Study|Reason not Specified|0
7598732|NCT03347123|12004991|FG005|Overall Study|Reason not Specified|0
7598733|NCT03347123|12004992|FG006|Overall Study|Reason not Specified|0
7598734|NCT03318523|12005007|FG000|PC Period: Up to Year 1|Adverse Event|1
7598735|NCT03318523|12005008|FG001|PC Period: Up to Year 1|Adverse Event|0
7598736|NCT03318523|12005009|FG002|PC Period: Up to Year 1|Adverse Event|2
7598737|NCT03318523|12005010|FG003|PC Period: Up to Year 1|Adverse Event|0
7598738|NCT03318523|12005011|FG004|PC Period: Up to Year 1|Adverse Event|0
7598739|NCT03318523|12005012|FG005|PC Period: Up to Year 1|Adverse Event|0
7598740|NCT03318523|12005013|FG006|PC Period: Up to Year 1|Adverse Event|0
7598741|NCT03318523|12005014|FG007|PC Period: Up to Year 1|Adverse Event|0
7598742|NCT03318523|12005015|FG008|PC Period: Up to Year 1|Adverse Event|0
7598743|NCT03318523|12005016|FG009|PC Period: Up to Year 1|Adverse Event|0
7598744|NCT03318523|12005007|FG000|PC Period: Up to Year 1|Consent Withdrawn|3
7598745|NCT03318523|12005008|FG001|PC Period: Up to Year 1|Consent Withdrawn|2
7598746|NCT03318523|12005009|FG002|PC Period: Up to Year 1|Consent Withdrawn|0
7598747|NCT03318523|12005010|FG003|PC Period: Up to Year 1|Consent Withdrawn|4
7598748|NCT03318523|12005011|FG004|PC Period: Up to Year 1|Consent Withdrawn|0
7598749|NCT03318523|12005012|FG005|PC Period: Up to Year 1|Consent Withdrawn|0
7598750|NCT03318523|12005013|FG006|PC Period: Up to Year 1|Consent Withdrawn|0
7598751|NCT03318523|12005014|FG007|PC Period: Up to Year 1|Consent Withdrawn|0
7598752|NCT03318523|12005015|FG008|PC Period: Up to Year 1|Consent Withdrawn|0
7598753|NCT03318523|12005016|FG009|PC Period: Up to Year 1|Consent Withdrawn|0
7598754|NCT03318523|12005007|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7598755|NCT03318523|12005008|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7598756|NCT03318523|12005009|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7598757|NCT03318523|12005010|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7598758|NCT03318523|12005011|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1
7598759|NCT03318523|12005012|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7598760|NCT03318523|12005013|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7598761|NCT03318523|12005014|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1
7598762|NCT03318523|12005015|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7598763|NCT03318523|12005016|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2
7598764|NCT03318523|12005007|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7598765|NCT03318523|12005008|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7598766|NCT03318523|12005009|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7598767|NCT03318523|12005010|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7598768|NCT03318523|12005011|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1
7598769|NCT03318523|12005012|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7598770|NCT03318523|12005013|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7598771|NCT03318523|12005014|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1
7598772|NCT03318523|12005015|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3
7598773|NCT03318523|12005016|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2
7598774|NCT03318523|12005007|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598775|NCT03318523|12005008|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598776|NCT03318523|12005009|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598777|NCT03318523|12005010|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598778|NCT03318523|12005011|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598779|NCT03318523|12005012|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1
7598780|NCT03318523|12005013|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598781|NCT03318523|12005014|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598782|NCT03318523|12005015|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598783|NCT03318523|12005016|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598784|NCT03318523|12005007|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598785|NCT03318523|12005008|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598786|NCT03318523|12005009|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598787|NCT03318523|12005010|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598788|NCT03318523|12005011|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598789|NCT03318523|12005012|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598790|NCT03318523|12005013|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598791|NCT03318523|12005014|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598792|NCT03318523|12005015|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598793|NCT03318523|12005016|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1
7598794|NCT03318523|12005007|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
7598795|NCT03318523|12005008|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
7598796|NCT03318523|12005009|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
7598797|NCT03318523|12005010|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
7598798|NCT03318523|12005011|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17
7598799|NCT03318523|12005012|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36
7598800|NCT03318523|12005013|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39
7598942|NCT02906020|12005050|FG000|Part 2: Long-term Follow-up Period|Other|0
7598801|NCT03318523|12005014|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48
7598802|NCT03318523|12005015|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94
7598803|NCT03318523|12005016|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91
7598804|NCT03318523|12005007|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7598805|NCT03318523|12005008|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7598806|NCT03318523|12005009|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7598807|NCT03318523|12005010|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7598808|NCT03318523|12005011|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1
7598809|NCT03318523|12005012|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7598810|NCT03318523|12005013|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7598811|NCT03318523|12005014|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2
7598812|NCT03318523|12005015|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3
7598813|NCT03318523|12005016|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7598814|NCT02906020|12005050|FG000|Part 1: Dose Escalation Period|Adverse Event|0
7598815|NCT02906020|12005051|FG001|Part 1: Dose Escalation Period|Adverse Event|1
7598816|NCT02906020|12005052|FG002|Part 1: Dose Escalation Period|Adverse Event|0
7598817|NCT02906020|12005053|FG003|Part 1: Dose Escalation Period|Adverse Event|1
7598818|NCT02906020|12005054|FG004|Part 1: Dose Escalation Period|Adverse Event|0
7598819|NCT02906020|12005055|FG005|Part 1: Dose Escalation Period|Adverse Event|0
7598820|NCT02906020|12005056|FG006|Part 1: Dose Escalation Period|Adverse Event|0
7598821|NCT02906020|12005057|FG007|Part 1: Dose Escalation Period|Adverse Event|0
7598822|NCT02906020|12005058|FG008|Part 1: Dose Escalation Period|Adverse Event|0
7598823|NCT02906020|12005059|FG009|Part 1: Dose Escalation Period|Adverse Event|0
7598824|NCT02906020|12005060|FG010|Part 1: Dose Escalation Period|Adverse Event|0
7598825|NCT02906020|12005061|FG011|Part 1: Dose Escalation Period|Adverse Event|0
7598826|NCT02906020|12005062|FG012|Part 1: Dose Escalation Period|Adverse Event|0
7598827|NCT02906020|12005063|FG013|Part 1: Dose Escalation Period|Adverse Event|0
7598828|NCT02906020|12005064|FG014|Part 1: Dose Escalation Period|Adverse Event|0
7598829|NCT02906020|12005065|FG015|Part 1: Dose Escalation Period|Adverse Event|0
7598830|NCT02906020|12005050|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0
7598831|NCT02906020|12005051|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0
7598832|NCT02906020|12005052|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0
7598833|NCT02906020|12005053|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0
7598834|NCT02906020|12005054|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0
7598835|NCT02906020|12005055|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0
7598836|NCT02906020|12005056|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0
7598837|NCT02906020|12005057|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0
7598838|NCT02906020|12005058|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6
7598839|NCT02906020|12005059|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15
7598840|NCT02906020|12005060|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0
7598841|NCT02906020|12005061|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0
7598842|NCT02906020|12005062|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0
7598843|NCT02906020|12005063|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0
7598844|NCT02906020|12005064|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0
7598845|NCT02906020|12005065|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0
7598846|NCT02906020|12005050|FG000|Part 2: Double-blind Treatment Period|Other|0
7598847|NCT02906020|12005051|FG001|Part 2: Double-blind Treatment Period|Other|0
7598848|NCT02906020|12005052|FG002|Part 2: Double-blind Treatment Period|Other|0
7598849|NCT02906020|12005053|FG003|Part 2: Double-blind Treatment Period|Other|0
7598850|NCT02906020|12005054|FG004|Part 2: Double-blind Treatment Period|Other|0
7598851|NCT02906020|12005055|FG005|Part 2: Double-blind Treatment Period|Other|0
7598852|NCT02906020|12005056|FG006|Part 2: Double-blind Treatment Period|Other|0
7598853|NCT02906020|12005057|FG007|Part 2: Double-blind Treatment Period|Other|0
7598854|NCT02906020|12005058|FG008|Part 2: Double-blind Treatment Period|Other|6
7598855|NCT02906020|12005059|FG009|Part 2: Double-blind Treatment Period|Other|10
7598856|NCT02906020|12005060|FG010|Part 2: Double-blind Treatment Period|Other|0
7598857|NCT02906020|12005061|FG011|Part 2: Double-blind Treatment Period|Other|0
7598858|NCT02906020|12005062|FG012|Part 2: Double-blind Treatment Period|Other|0
7598859|NCT02906020|12005063|FG013|Part 2: Double-blind Treatment Period|Other|0
7598860|NCT02906020|12005064|FG014|Part 2: Double-blind Treatment Period|Other|0
7598861|NCT02906020|12005065|FG015|Part 2: Double-blind Treatment Period|Other|0
7598862|NCT02906020|12005050|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0
7598863|NCT02906020|12005051|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0
7598864|NCT02906020|12005052|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0
7598865|NCT02906020|12005053|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0
7598866|NCT02906020|12005054|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0
7598867|NCT02906020|12005055|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0
7598868|NCT02906020|12005056|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0
7598869|NCT02906020|12005057|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0
7598870|NCT02906020|12005058|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0
7598871|NCT02906020|12005059|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0
7598872|NCT02906020|12005060|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0
7598873|NCT02906020|12005061|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0
7598874|NCT02906020|12005062|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10
7598875|NCT02906020|12005063|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4
7598876|NCT02906020|12005064|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0
7598877|NCT02906020|12005065|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0
7598878|NCT02906020|12005050|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598879|NCT02906020|12005051|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598880|NCT02906020|12005052|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598881|NCT02906020|12005053|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598882|NCT02906020|12005054|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598883|NCT02906020|12005055|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598884|NCT02906020|12005056|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598885|NCT02906020|12005057|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598886|NCT02906020|12005058|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598887|NCT02906020|12005059|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598888|NCT02906020|12005060|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598889|NCT02906020|12005061|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598890|NCT02906020|12005062|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7
7598891|NCT02906020|12005063|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4
7598892|NCT02906020|12005064|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598893|NCT02906020|12005065|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1
7598894|NCT02906020|12005050|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598895|NCT02906020|12005051|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598896|NCT02906020|12005052|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598897|NCT02906020|12005053|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598898|NCT02906020|12005054|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598899|NCT02906020|12005055|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598900|NCT02906020|12005056|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598901|NCT02906020|12005057|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598902|NCT02906020|12005058|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598903|NCT02906020|12005059|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598904|NCT02906020|12005060|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598905|NCT02906020|12005061|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598906|NCT02906020|12005062|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1
7598907|NCT02906020|12005063|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1
7598908|NCT02906020|12005064|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598909|NCT02906020|12005065|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598910|NCT02906020|12005050|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598911|NCT02906020|12005051|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598912|NCT02906020|12005052|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598913|NCT02906020|12005053|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598914|NCT02906020|12005054|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598915|NCT02906020|12005055|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598916|NCT02906020|12005056|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598917|NCT02906020|12005057|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598918|NCT02906020|12005058|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598919|NCT02906020|12005059|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598920|NCT02906020|12005060|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598921|NCT02906020|12005061|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598922|NCT02906020|12005062|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1
7598923|NCT02906020|12005063|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4
7598924|NCT02906020|12005064|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598925|NCT02906020|12005065|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598926|NCT02906020|12005050|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598927|NCT02906020|12005051|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598928|NCT02906020|12005052|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598929|NCT02906020|12005053|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598930|NCT02906020|12005054|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598931|NCT02906020|12005055|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598932|NCT02906020|12005056|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598933|NCT02906020|12005057|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598934|NCT02906020|12005058|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598935|NCT02906020|12005059|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598936|NCT02906020|12005060|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598937|NCT02906020|12005061|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598938|NCT02906020|12005062|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67
7598939|NCT02906020|12005063|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64
7598940|NCT02906020|12005064|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7
7598941|NCT02906020|12005065|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8
7598943|NCT02906020|12005051|FG001|Part 2: Long-term Follow-up Period|Other|0
7598944|NCT02906020|12005052|FG002|Part 2: Long-term Follow-up Period|Other|0
7598945|NCT02906020|12005053|FG003|Part 2: Long-term Follow-up Period|Other|0
7598946|NCT02906020|12005054|FG004|Part 2: Long-term Follow-up Period|Other|0
7598947|NCT02906020|12005055|FG005|Part 2: Long-term Follow-up Period|Other|0
7598948|NCT02906020|12005056|FG006|Part 2: Long-term Follow-up Period|Other|0
7598949|NCT02906020|12005057|FG007|Part 2: Long-term Follow-up Period|Other|0
7598950|NCT02906020|12005058|FG008|Part 2: Long-term Follow-up Period|Other|0
7598951|NCT02906020|12005059|FG009|Part 2: Long-term Follow-up Period|Other|0
7598952|NCT02906020|12005060|FG010|Part 2: Long-term Follow-up Period|Other|0
7598953|NCT02906020|12005061|FG011|Part 2: Long-term Follow-up Period|Other|0
7598954|NCT02906020|12005062|FG012|Part 2: Long-term Follow-up Period|Other|13
7598955|NCT02906020|12005063|FG013|Part 2: Long-term Follow-up Period|Other|8
7598956|NCT02906020|12005064|FG014|Part 2: Long-term Follow-up Period|Other|3
7598957|NCT02906020|12005065|FG015|Part 2: Long-term Follow-up Period|Other|2
7772299|NCT00888173|12216858|FG000|Overall Study|Wrong Primary|1
7772300|NCT00888173|12216858|FG000|Overall Study|Ineligible: required test not done|1
7772301|NCT00888238|12216862|FG000|Washout Period After Period 2|Adverse Event|0
7772302|NCT00888238|12216863|FG001|Washout Period After Period 2|Adverse Event|0
7772303|NCT00888238|12216864|FG002|Washout Period After Period 2|Adverse Event|1
7772304|NCT00888329|12216872|FG000|Overall Study|Physician Decision|6
7772305|NCT00888329|12216873|FG001|Overall Study|Physician Decision|9
7772306|NCT00888381|12216881|FG000|Overall Study|Lost to Follow-up|0
7772307|NCT00888381|12216882|FG001|Overall Study|Lost to Follow-up|1
7772308|NCT00888433|12216890|FG000|Overall Study|Withdrawal by Subject|1
7772309|NCT00888433|12216891|FG001|Overall Study|Withdrawal by Subject|2
7772310|NCT00888433|12216890|FG000|Overall Study|Missed Visit|2
7772311|NCT00888433|12216891|FG001|Overall Study|Missed Visit|1
7772312|NCT00888615|12216910|FG000|Overall Study|No treatment|2
7772313|NCT00888654|12216918|FG000|Overall Study|Problems swallowing oral meds.|1
7772314|NCT00888654|12216918|FG000|Overall Study|Not enough oral meds before surgery|3
7772315|NCT00888654|12216918|FG000|Overall Study|Surgery aborted|2
7772316|NCT00888654|12216918|FG000|Overall Study|Withdrawal by Subject|1
7772317|NCT00888654|12216918|FG000|Overall Study|Inelig. due to contraindication of med|1
7772318|NCT00888654|12216918|FG000|Overall Study|Change in surg date|1
7772319|NCT00888654|12216918|FG000|Overall Study|Stopped meds due to headaches|1
7772320|NCT00888849|12216924|FG000|Overall Study|Death|4
7599358|NCT02549092|12005145|FG000|Treatment Period|Adverse Event|2
7599359|NCT02549092|12005146|FG001|Treatment Period|Adverse Event|2
7599360|NCT02549092|12005145|FG000|Treatment Period|Withdrawal by Subject|1
7599361|NCT02549092|12005146|FG001|Treatment Period|Withdrawal by Subject|3
7599362|NCT02549092|12005145|FG000|Treatment Period|Lack of Efficacy|0
7599363|NCT02549092|12005146|FG001|Treatment Period|Lack of Efficacy|2
7599364|NCT02549092|12005145|FG000|Extension/Transition Period|Still in Extension/Transition Period|4
7599365|NCT02549092|12005146|FG001|Extension/Transition Period|Still in Extension/Transition Period|8
7599366|NCT02549092|12005145|FG000|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1
7599367|NCT02549092|12005146|FG001|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1
7599368|NCT02323126|12005167|FG000|Overall Study|Patient / guardian decision|0
7599369|NCT02323126|12005168|FG001|Overall Study|Patient / guardian decision|1
7599370|NCT02323126|12005169|FG002|Overall Study|Patient / guardian decision|2
7599371|NCT02323126|12005167|FG000|Overall Study|Progressive disease|14
7599372|NCT02323126|12005168|FG001|Overall Study|Progressive disease|8
7599373|NCT02323126|12005169|FG002|Overall Study|Progressive disease|14
7599374|NCT02323126|12005167|FG000|Overall Study|Physician Decision|0
7599375|NCT02323126|12005168|FG001|Overall Study|Physician Decision|1
7599376|NCT02323126|12005169|FG002|Overall Study|Physician Decision|3
7599377|NCT02323126|12005167|FG000|Overall Study|Death|1
7599378|NCT02323126|12005168|FG001|Overall Study|Death|1
7599379|NCT02323126|12005169|FG002|Overall Study|Death|4
7599380|NCT02323126|12005167|FG000|Overall Study|Adverse Event|3
7599381|NCT02323126|12005168|FG001|Overall Study|Adverse Event|5
7599382|NCT02323126|12005169|FG002|Overall Study|Adverse Event|7
7772321|NCT00888849|12216925|FG001|Overall Study|Death|7
7772322|NCT00888849|12216924|FG000|Overall Study|Lost to Follow-up|1
7772323|NCT00888849|12216925|FG001|Overall Study|Lost to Follow-up|2
7772324|NCT00888927|12216935|FG000|Overall Study|Adverse Event|0
7772325|NCT00888927|12216936|FG001|Overall Study|Adverse Event|0
7772326|NCT00888927|12216937|FG002|Overall Study|Adverse Event|0
7772327|NCT00888927|12216938|FG003|Overall Study|Adverse Event|1
7772328|NCT00888927|12216935|FG000|Overall Study|Withdrawal of consent|0
7599391|NCT01126749|12005194|FG000|Phase 1b|Other|0
7599392|NCT01126749|12005195|FG001|Phase 1b|Other|1
7599393|NCT01126749|12005196|FG002|Phase 1b|Other|0
7599394|NCT01126749|12005197|FG003|Phase 1b|Other|0
7599395|NCT01126749|12005194|FG000|Phase 1b|Withdrawal by Subject|0
7599396|NCT01126749|12005195|FG001|Phase 1b|Withdrawal by Subject|1
7599397|NCT01126749|12005196|FG002|Phase 1b|Withdrawal by Subject|0
7599398|NCT01126749|12005197|FG003|Phase 1b|Withdrawal by Subject|0
7599399|NCT01126749|12005194|FG000|Phase 1b|Death|3
7599400|NCT01126749|12005195|FG001|Phase 1b|Death|4
7599401|NCT01126749|12005196|FG002|Phase 1b|Death|0
7599402|NCT01126749|12005197|FG003|Phase 1b|Death|0
7772329|NCT00888927|12216936|FG001|Overall Study|Withdrawal of consent|0
7772330|NCT00888927|12216937|FG002|Overall Study|Withdrawal of consent|0
7599403|NCT01126749|12005194|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0
7599404|NCT01126749|12005195|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0
7599405|NCT01126749|12005196|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4
7599406|NCT01126749|12005197|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7
7599407|NCT01126749|12005194|FG000|Phase 2|Study Termination by Sponsor|0
7599408|NCT01126749|12005195|FG001|Phase 2|Study Termination by Sponsor|0
7599409|NCT01126749|12005196|FG002|Phase 2|Study Termination by Sponsor|12
7599410|NCT01126749|12005197|FG003|Phase 2|Study Termination by Sponsor|6
7599411|NCT01126749|12005194|FG000|Phase 2|Other|0
7599412|NCT01126749|12005195|FG001|Phase 2|Other|0
7599413|NCT01126749|12005196|FG002|Phase 2|Other|4
7599414|NCT01126749|12005197|FG003|Phase 2|Other|2
7599415|NCT01126749|12005194|FG000|Phase 2|Withdrawal by Subject|0
7599416|NCT01126749|12005195|FG001|Phase 2|Withdrawal by Subject|0
7599417|NCT01126749|12005196|FG002|Phase 2|Withdrawal by Subject|0
7599418|NCT01126749|12005197|FG003|Phase 2|Withdrawal by Subject|2
7599419|NCT01126749|12005194|FG000|Phase 2|Lost to Follow-up|0
7599420|NCT01126749|12005195|FG001|Phase 2|Lost to Follow-up|0
7599421|NCT01126749|12005196|FG002|Phase 2|Lost to Follow-up|0
7599422|NCT01126749|12005197|FG003|Phase 2|Lost to Follow-up|1
7599423|NCT01126749|12005194|FG000|Phase 2|Death|0
7599424|NCT01126749|12005195|FG001|Phase 2|Death|0
7599425|NCT01126749|12005196|FG002|Phase 2|Death|22
7599426|NCT01126749|12005197|FG003|Phase 2|Death|22
7599427|NCT01126749|12005194|FG000|Phase 2|Adverse Event|0
7599428|NCT01126749|12005195|FG001|Phase 2|Adverse Event|0
7599429|NCT01126749|12005196|FG002|Phase 2|Adverse Event|0
7599430|NCT01126749|12005197|FG003|Phase 2|Adverse Event|1
7599431|NCT01059448|12005220|FG000|Overall Study|Adverse Event|1
7599432|NCT01059448|12005221|FG001|Overall Study|Adverse Event|3
7599433|NCT01059448|12005222|FG002|Overall Study|Adverse Event|0
7599434|NCT01059448|12005223|FG003|Overall Study|Adverse Event|1
7599435|NCT01059448|12005220|FG000|Overall Study|Withdrawal by Subject|2
7599436|NCT01059448|12005221|FG001|Overall Study|Withdrawal by Subject|0
7599437|NCT01059448|12005222|FG002|Overall Study|Withdrawal by Subject|2
7599438|NCT01059448|12005223|FG003|Overall Study|Withdrawal by Subject|4
7599439|NCT01059448|12005220|FG000|Overall Study|Disease Progression|2
7599440|NCT01059448|12005221|FG001|Overall Study|Disease Progression|1
7599441|NCT01059448|12005222|FG002|Overall Study|Disease Progression|4
7599442|NCT01059448|12005223|FG003|Overall Study|Disease Progression|2
7599443|NCT01059448|12005220|FG000|Overall Study|Administrative Decision|43
7599444|NCT01059448|12005221|FG001|Overall Study|Administrative Decision|49
7599445|NCT01059448|12005222|FG002|Overall Study|Administrative Decision|45
7599446|NCT01059448|12005223|FG003|Overall Study|Administrative Decision|46
7599447|NCT01059448|12005220|FG000|Overall Study|Lost to Follow-up|0
7599448|NCT01059448|12005221|FG001|Overall Study|Lost to Follow-up|0
7599449|NCT01059448|12005222|FG002|Overall Study|Lost to Follow-up|2
7599450|NCT01059448|12005223|FG003|Overall Study|Lost to Follow-up|0
7599451|NCT01059448|12005220|FG000|Overall Study|Death|0
7599452|NCT01059448|12005221|FG001|Overall Study|Death|1
7599453|NCT01059448|12005222|FG002|Overall Study|Death|0
7599454|NCT01059448|12005223|FG003|Overall Study|Death|0
7599455|NCT01059448|12005220|FG000|Overall Study|Other|1
7599456|NCT01059448|12005221|FG001|Overall Study|Other|1
7599457|NCT01059448|12005222|FG002|Overall Study|Other|0
7599458|NCT01059448|12005223|FG003|Overall Study|Other|1
7599459|NCT00821587|12005235|FG000|Overall Study|Physician Decision|0
7599460|NCT00821587|12005236|FG001|Overall Study|Physician Decision|1
7599461|NCT00585195|12005263|FG000|Overall Study|Adverse Event|0
7599462|NCT00585195|12005264|FG001|Overall Study|Adverse Event|0
7599463|NCT00585195|12005265|FG002|Overall Study|Adverse Event|0
7599464|NCT00585195|12005266|FG003|Overall Study|Adverse Event|0
7599465|NCT00585195|12005267|FG004|Overall Study|Adverse Event|2
7599466|NCT00585195|12005268|FG005|Overall Study|Adverse Event|1
7599467|NCT00585195|12005269|FG006|Overall Study|Adverse Event|0
7599468|NCT00585195|12005270|FG007|Overall Study|Adverse Event|1
7599469|NCT00585195|12005271|FG008|Overall Study|Adverse Event|0
7599470|NCT00585195|12005272|FG009|Overall Study|Adverse Event|0
7599471|NCT00585195|12005273|FG010|Overall Study|Adverse Event|3
7599472|NCT00585195|12005274|FG011|Overall Study|Adverse Event|0
7599473|NCT00585195|12005275|FG012|Overall Study|Adverse Event|8
7599474|NCT00585195|12005276|FG013|Overall Study|Adverse Event|6
7599475|NCT00585195|12005277|FG014|Overall Study|Adverse Event|4
7599476|NCT00585195|12005278|FG015|Overall Study|Adverse Event|1
7599477|NCT00585195|12005279|FG016|Overall Study|Adverse Event|14
7599478|NCT00585195|12005280|FG017|Overall Study|Adverse Event|9
7599479|NCT00585195|12005281|FG018|Overall Study|Adverse Event|2
7599480|NCT00585195|12005282|FG019|Overall Study|Adverse Event|3
7599481|NCT00585195|12005283|FG020|Overall Study|Adverse Event|1
7599482|NCT00585195|12005263|FG000|Overall Study|Progressive Disease|2
7599483|NCT00585195|12005264|FG001|Overall Study|Progressive Disease|2
7599484|NCT00585195|12005265|FG002|Overall Study|Progressive Disease|5
7599485|NCT00585195|12005266|FG003|Overall Study|Progressive Disease|4
7599486|NCT00585195|12005267|FG004|Overall Study|Progressive Disease|6
7599487|NCT00585195|12005268|FG005|Overall Study|Progressive Disease|4
7599488|NCT00585195|12005269|FG006|Overall Study|Progressive Disease|6
7599489|NCT00585195|12005270|FG007|Overall Study|Progressive Disease|3
7599490|NCT00585195|12005271|FG008|Overall Study|Progressive Disease|0
7599491|NCT00585195|12005272|FG009|Overall Study|Progressive Disease|5
7599492|NCT00585195|12005273|FG010|Overall Study|Progressive Disease|2
7599493|NCT00585195|12005274|FG011|Overall Study|Progressive Disease|25
7599494|NCT00585195|12005275|FG012|Overall Study|Progressive Disease|29
7599495|NCT00585195|12005276|FG013|Overall Study|Progressive Disease|26
7599496|NCT00585195|12005277|FG014|Overall Study|Progressive Disease|21
7599497|NCT00585195|12005278|FG015|Overall Study|Progressive Disease|12
7599498|NCT00585195|12005279|FG016|Overall Study|Progressive Disease|94
7599499|NCT00585195|12005280|FG017|Overall Study|Progressive Disease|42
7599500|NCT00585195|12005281|FG018|Overall Study|Progressive Disease|4
7599501|NCT00585195|12005282|FG019|Overall Study|Progressive Disease|9
7599502|NCT00585195|12005283|FG020|Overall Study|Progressive Disease|8
7599503|NCT00585195|12005263|FG000|Overall Study|Withdrawal by Subject|1
7599504|NCT00585195|12005264|FG001|Overall Study|Withdrawal by Subject|1
7599505|NCT00585195|12005265|FG002|Overall Study|Withdrawal by Subject|2
7599506|NCT00585195|12005266|FG003|Overall Study|Withdrawal by Subject|2
7599507|NCT00585195|12005267|FG004|Overall Study|Withdrawal by Subject|0
7599508|NCT00585195|12005268|FG005|Overall Study|Withdrawal by Subject|0
7599509|NCT00585195|12005269|FG006|Overall Study|Withdrawal by Subject|0
7599510|NCT00585195|12005270|FG007|Overall Study|Withdrawal by Subject|1
7599511|NCT00585195|12005271|FG008|Overall Study|Withdrawal by Subject|0
7599512|NCT00585195|12005272|FG009|Overall Study|Withdrawal by Subject|0
7599513|NCT00585195|12005273|FG010|Overall Study|Withdrawal by Subject|3
7599514|NCT00585195|12005274|FG011|Overall Study|Withdrawal by Subject|8
7599515|NCT00585195|12005275|FG012|Overall Study|Withdrawal by Subject|15
7599516|NCT00585195|12005276|FG013|Overall Study|Withdrawal by Subject|0
7599517|NCT00585195|12005277|FG014|Overall Study|Withdrawal by Subject|3
7599518|NCT00585195|12005278|FG015|Overall Study|Withdrawal by Subject|0
7599519|NCT00585195|12005279|FG016|Overall Study|Withdrawal by Subject|7
7599520|NCT00585195|12005280|FG017|Overall Study|Withdrawal by Subject|1
7599521|NCT00585195|12005281|FG018|Overall Study|Withdrawal by Subject|2
7599522|NCT00585195|12005282|FG019|Overall Study|Withdrawal by Subject|2
7599523|NCT00585195|12005283|FG020|Overall Study|Withdrawal by Subject|0
7599524|NCT00585195|12005263|FG000|Overall Study|Other|0
7599525|NCT00585195|12005264|FG001|Overall Study|Other|1
7599526|NCT00585195|12005265|FG002|Overall Study|Other|1
7599527|NCT00585195|12005266|FG003|Overall Study|Other|1
7599528|NCT00585195|12005267|FG004|Overall Study|Other|0
7599529|NCT00585195|12005268|FG005|Overall Study|Other|1
7599530|NCT00585195|12005269|FG006|Overall Study|Other|0
7599531|NCT00585195|12005270|FG007|Overall Study|Other|0
7599532|NCT00585195|12005271|FG008|Overall Study|Other|2
7599533|NCT00585195|12005272|FG009|Overall Study|Other|1
7599534|NCT00585195|12005273|FG010|Overall Study|Other|0
7599535|NCT00585195|12005274|FG011|Overall Study|Other|19
7599536|NCT00585195|12005275|FG012|Overall Study|Other|23
7599537|NCT00585195|12005276|FG013|Overall Study|Other|7
7599538|NCT00585195|12005277|FG014|Overall Study|Other|11
7599539|NCT00585195|12005278|FG015|Overall Study|Other|3
7599540|NCT00585195|12005279|FG016|Overall Study|Other|28
7599541|NCT00585195|12005280|FG017|Overall Study|Other|12
7599542|NCT00585195|12005281|FG018|Overall Study|Other|10
7599543|NCT00585195|12005282|FG019|Overall Study|Other|4
7599544|NCT00585195|12005283|FG020|Overall Study|Other|2
7599545|NCT00585195|12005263|FG000|Overall Study|Randomized not treated|0
7599546|NCT00585195|12005264|FG001|Overall Study|Randomized not treated|0
7599547|NCT00585195|12005265|FG002|Overall Study|Randomized not treated|1
7599548|NCT00585195|12005266|FG003|Overall Study|Randomized not treated|0
7599549|NCT00585195|12005267|FG004|Overall Study|Randomized not treated|1
7599550|NCT00585195|12005268|FG005|Overall Study|Randomized not treated|0
7599551|NCT00585195|12005269|FG006|Overall Study|Randomized not treated|1
7599552|NCT00585195|12005270|FG007|Overall Study|Randomized not treated|0
7599553|NCT00585195|12005271|FG008|Overall Study|Randomized not treated|0
7599554|NCT00585195|12005272|FG009|Overall Study|Randomized not treated|0
7599555|NCT00585195|12005273|FG010|Overall Study|Randomized not treated|2
7599556|NCT00585195|12005274|FG011|Overall Study|Randomized not treated|0
7599557|NCT00585195|12005275|FG012|Overall Study|Randomized not treated|0
7599558|NCT00585195|12005276|FG013|Overall Study|Randomized not treated|0
7599559|NCT00585195|12005277|FG014|Overall Study|Randomized not treated|0
7599560|NCT00585195|12005278|FG015|Overall Study|Randomized not treated|1
7599561|NCT00585195|12005279|FG016|Overall Study|Randomized not treated|0
7599562|NCT00585195|12005280|FG017|Overall Study|Randomized not treated|1
7599563|NCT00585195|12005281|FG018|Overall Study|Randomized not treated|3
7599564|NCT00585195|12005282|FG019|Overall Study|Randomized not treated|0
7599565|NCT00585195|12005283|FG020|Overall Study|Randomized not treated|2
7599566|NCT00585195|12005263|FG000|Overall Study|Death|0
7599567|NCT00585195|12005264|FG001|Overall Study|Death|0
7599568|NCT00585195|12005265|FG002|Overall Study|Death|0
7599569|NCT00585195|12005266|FG003|Overall Study|Death|0
7599570|NCT00585195|12005267|FG004|Overall Study|Death|0
7599571|NCT00585195|12005268|FG005|Overall Study|Death|0
7599572|NCT00585195|12005269|FG006|Overall Study|Death|0
7599573|NCT00585195|12005270|FG007|Overall Study|Death|0
7599574|NCT00585195|12005271|FG008|Overall Study|Death|1
7599575|NCT00585195|12005272|FG009|Overall Study|Death|0
7599576|NCT00585195|12005273|FG010|Overall Study|Death|1
7599577|NCT00585195|12005274|FG011|Overall Study|Death|1
7599578|NCT00585195|12005275|FG012|Overall Study|Death|7
7599579|NCT00585195|12005276|FG013|Overall Study|Death|2
7599580|NCT00585195|12005277|FG014|Overall Study|Death|8
7599581|NCT00585195|12005278|FG015|Overall Study|Death|2
7599582|NCT00585195|12005279|FG016|Overall Study|Death|11
7599583|NCT00585195|12005280|FG017|Overall Study|Death|0
7599584|NCT00585195|12005281|FG018|Overall Study|Death|0
7599585|NCT00585195|12005282|FG019|Overall Study|Death|0
7599586|NCT00585195|12005283|FG020|Overall Study|Death|1
7599587|NCT00585195|12005263|FG000|Overall Study|Lost to Follow-up|0
7599588|NCT00585195|12005264|FG001|Overall Study|Lost to Follow-up|0
7599589|NCT00585195|12005265|FG002|Overall Study|Lost to Follow-up|0
7599590|NCT00585195|12005266|FG003|Overall Study|Lost to Follow-up|0
7599591|NCT00585195|12005267|FG004|Overall Study|Lost to Follow-up|0
7599592|NCT00585195|12005268|FG005|Overall Study|Lost to Follow-up|0
7599593|NCT00585195|12005269|FG006|Overall Study|Lost to Follow-up|0
7599594|NCT00585195|12005270|FG007|Overall Study|Lost to Follow-up|0
7599595|NCT00585195|12005271|FG008|Overall Study|Lost to Follow-up|0
7599596|NCT00585195|12005272|FG009|Overall Study|Lost to Follow-up|0
7599597|NCT00585195|12005273|FG010|Overall Study|Lost to Follow-up|0
7599598|NCT00585195|12005274|FG011|Overall Study|Lost to Follow-up|0
7599599|NCT00585195|12005275|FG012|Overall Study|Lost to Follow-up|1
7772331|NCT00888927|12216938|FG003|Overall Study|Withdrawal of consent|1
7772332|NCT00888940|12216950|FG000|Overall Study|Adverse Event|12
7772333|NCT00888940|12216951|FG001|Overall Study|Adverse Event|3
7772334|NCT00888940|12216950|FG000|Overall Study|Lost to Follow-up|5
7772335|NCT00888940|12216951|FG001|Overall Study|Lost to Follow-up|5
7772336|NCT00888940|12216950|FG000|Overall Study|Randomized Not Treated|11
7772337|NCT00888940|12216951|FG001|Overall Study|Randomized Not Treated|13
7772338|NCT00889005|12216963|FG000|Overall Study|Lost to Follow-up|4
7772339|NCT00889005|12216964|FG001|Overall Study|Lost to Follow-up|2
7772340|NCT00889005|12216963|FG000|Overall Study|Withdrawal by Subject|4
7772341|NCT00889005|12216964|FG001|Overall Study|Withdrawal by Subject|0
7772342|NCT00889252|12216998|FG000|Overall Study|Adverse Event|2
7772343|NCT00889252|12216999|FG001|Overall Study|Adverse Event|4
7772344|NCT00889252|12216998|FG000|Overall Study|Withdrawal by Subject|3
7772345|NCT00889252|12216999|FG001|Overall Study|Withdrawal by Subject|0
7772346|NCT00889252|12216998|FG000|Overall Study|Protocol Violation|2
7772347|NCT00889252|12216999|FG001|Overall Study|Protocol Violation|0
7772348|NCT00889265|12217005|FG000|Overall Study|Adverse Event|1
7772349|NCT00889265|12217005|FG000|Overall Study|Lost to Follow-up|5
7772350|NCT00889265|12217005|FG000|Overall Study|Protocol Violation|1
7772351|NCT00889603|12217027|FG000|Overall Study|Adverse Event|7
7772352|NCT00889603|12217027|FG000|Overall Study|Death|3
7772353|NCT00889603|12217027|FG000|Overall Study|Lost to Follow-up|19
7772354|NCT00889603|12217027|FG000|Overall Study|No longer willing to participant in stud|4
7772355|NCT00889603|12217027|FG000|Overall Study|Other|4
7772356|NCT00889681|12217031|FG000|Overall Study|Not meeting qualification Criteria|2
7772357|NCT00889681|12217031|FG000|Overall Study|Insurance disapproval|1
7772358|NCT00889707|12217037|FG000|Overall Study|Adverse Event|1
7772359|NCT00889707|12217038|FG001|Overall Study|Adverse Event|0
7772360|NCT00889707|12217037|FG000|Overall Study|Withdrawal by Subject|4
7772361|NCT00889707|12217038|FG001|Overall Study|Withdrawal by Subject|3
7772362|NCT00889707|12217037|FG000|Overall Study|Lost to Follow-up|0
7772363|NCT00889707|12217038|FG001|Overall Study|Lost to Follow-up|2
7772364|NCT00889707|12217037|FG000|Overall Study|Lack of Efficacy|2
7772365|NCT00889707|12217038|FG001|Overall Study|Lack of Efficacy|5
7772366|NCT00889720|12217044|FG000|Overall Study|Withdrawal by Subject|4
7772367|NCT00889720|12217044|FG000|Overall Study|Other|4
7772368|NCT00889863|12217052|FG000|Part I: Open Label|Death|1
7772369|NCT00889863|12217053|FG001|Part I: Open Label|Death|0
7772370|NCT00889863|12217052|FG000|Part I: Open Label|Adverse Event|4
7772371|NCT00889863|12217053|FG001|Part I: Open Label|Adverse Event|0
7772372|NCT00889863|12217052|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72
7772373|NCT00889863|12217053|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0
7772374|NCT00889863|12217052|FG000|Part II: Randomized Double Blind|Adverse Event|0
7772375|NCT00889863|12217053|FG001|Part II: Randomized Double Blind|Adverse Event|4
7772376|NCT00889863|12217052|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
7772377|NCT00889863|12217053|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
7772378|NCT00889863|12217052|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0
7772379|NCT00889863|12217053|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1
7772380|NCT00889863|12217052|FG000|Part II: Randomized Double Blind|Protocol deviation|0
7772381|NCT00889863|12217053|FG001|Part II: Randomized Double Blind|Protocol deviation|1
7599600|NCT00585195|12005276|FG013|Overall Study|Lost to Follow-up|0
7599601|NCT00585195|12005277|FG014|Overall Study|Lost to Follow-up|0
7599602|NCT00585195|12005278|FG015|Overall Study|Lost to Follow-up|0
7599603|NCT00585195|12005279|FG016|Overall Study|Lost to Follow-up|0
7599604|NCT00585195|12005280|FG017|Overall Study|Lost to Follow-up|2
7599605|NCT00585195|12005281|FG018|Overall Study|Lost to Follow-up|0
7599606|NCT00585195|12005282|FG019|Overall Study|Lost to Follow-up|0
7599607|NCT00585195|12005283|FG020|Overall Study|Lost to Follow-up|0
7599608|NCT00585195|12005263|FG000|Overall Study|Ongoing|0
7599609|NCT00585195|12005264|FG001|Overall Study|Ongoing|0
7599610|NCT00585195|12005265|FG002|Overall Study|Ongoing|0
7599611|NCT00585195|12005266|FG003|Overall Study|Ongoing|0
7599612|NCT00585195|12005267|FG004|Overall Study|Ongoing|0
7599613|NCT00585195|12005268|FG005|Overall Study|Ongoing|0
7599614|NCT00585195|12005269|FG006|Overall Study|Ongoing|0
7599615|NCT00585195|12005270|FG007|Overall Study|Ongoing|0
7599616|NCT00585195|12005271|FG008|Overall Study|Ongoing|0
7599617|NCT00585195|12005272|FG009|Overall Study|Ongoing|0
7599618|NCT00585195|12005273|FG010|Overall Study|Ongoing|0
7599619|NCT00585195|12005274|FG011|Overall Study|Ongoing|0
7599620|NCT00585195|12005275|FG012|Overall Study|Ongoing|2
7772382|NCT00890045|12217084|FG000|Overall Study|Death|0
7772383|NCT00890045|12217085|FG001|Overall Study|Death|1
7772384|NCT00890045|12217084|FG000|Overall Study|Did not receive HeRO Graft|0
7772385|NCT00890045|12217085|FG001|Overall Study|Did not receive HeRO Graft|2
7772386|NCT00890045|12217084|FG000|Overall Study|Lost to Follow-up|5
7772387|NCT00890045|12217085|FG001|Overall Study|Lost to Follow-up|7
7772388|NCT00890084|12217091|FG000|Overall Study|Adverse Event|16
7772389|NCT00890084|12217091|FG000|Overall Study|Lost to Follow-up|126
7772390|NCT00890097|12217098|FG000|Overall Study|Adverse Event|21
7772391|NCT00890097|12217099|FG001|Overall Study|Adverse Event|32
7772392|NCT00890097|12217100|FG002|Overall Study|Adverse Event|28
7772393|NCT00890097|12217098|FG000|Overall Study|Decision Unrelated to an Adverse Event|15
7772394|NCT00890097|12217099|FG001|Overall Study|Decision Unrelated to an Adverse Event|12
7772395|NCT00890097|12217100|FG002|Overall Study|Decision Unrelated to an Adverse Event|17
7772396|NCT00890097|12217098|FG000|Overall Study|Withdrew Consent|9
7772397|NCT00890097|12217099|FG001|Overall Study|Withdrew Consent|6
7772398|NCT00890097|12217100|FG002|Overall Study|Withdrew Consent|9
7772399|NCT00890097|12217098|FG000|Overall Study|Lost to Follow-up|5
7772400|NCT00890097|12217099|FG001|Overall Study|Lost to Follow-up|5
7772401|NCT00890097|12217100|FG002|Overall Study|Lost to Follow-up|5
7772402|NCT00890097|12217098|FG000|Overall Study|Noncompliance|0
7772403|NCT00890097|12217099|FG001|Overall Study|Noncompliance|4
7772404|NCT00890097|12217100|FG002|Overall Study|Noncompliance|4
7772405|NCT00890097|12217098|FG000|Overall Study|Sponsor Decision|7
7772406|NCT00890097|12217099|FG001|Overall Study|Sponsor Decision|11
7772407|NCT00890097|12217100|FG002|Overall Study|Sponsor Decision|7
7772408|NCT00890097|12217098|FG000|Overall Study|Did not attend final visit|2
7772409|NCT00890097|12217099|FG001|Overall Study|Did not attend final visit|3
7772410|NCT00890097|12217100|FG002|Overall Study|Did not attend final visit|0
7772411|NCT00890097|12217098|FG000|Overall Study|Subject Decision|3
7772412|NCT00890097|12217099|FG001|Overall Study|Subject Decision|2
7772413|NCT00890097|12217100|FG002|Overall Study|Subject Decision|6
7772414|NCT00890097|12217098|FG000|Overall Study|Randomization Error|2
7772415|NCT00890097|12217099|FG001|Overall Study|Randomization Error|0
7772416|NCT00890097|12217100|FG002|Overall Study|Randomization Error|0
7772417|NCT00890097|12217098|FG000|Overall Study|Failed inclusion criteria|3
7772418|NCT00890097|12217099|FG001|Overall Study|Failed inclusion criteria|4
7772419|NCT00890097|12217100|FG002|Overall Study|Failed inclusion criteria|0
7772420|NCT00890097|12217098|FG000|Overall Study|Transportation|0
7772421|NCT00890097|12217099|FG001|Overall Study|Transportation|2
7772422|NCT00890097|12217100|FG002|Overall Study|Transportation|0
7772423|NCT00890097|12217098|FG000|Overall Study|Subject Moved|0
7772424|NCT00890097|12217099|FG001|Overall Study|Subject Moved|4
7772425|NCT00890097|12217100|FG002|Overall Study|Subject Moved|0
7772426|NCT00890097|12217098|FG000|Overall Study|Protocol Deviation|1
7772427|NCT00890097|12217099|FG001|Overall Study|Protocol Deviation|1
7772428|NCT00890097|12217100|FG002|Overall Study|Protocol Deviation|1
7772429|NCT00890201|12217119|FG000|Overall Study|Protocol Violation|5
7772430|NCT00890201|12217120|FG001|Overall Study|Protocol Violation|56
7772431|NCT00890552|12217138|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1
7772432|NCT00890552|12217138|FG000|On-treatment|Early prog disease/ death|10
7772433|NCT00890695|12217161|FG000|Overall Study|Protocol Violation|1
7772434|NCT00890695|12217162|FG001|Overall Study|Protocol Violation|0
7772435|NCT00890825|12217179|FG000|Overall Study|Withdrawal by Subject|1
7772436|NCT00890825|12217180|FG001|Overall Study|Withdrawal by Subject|0
7772437|NCT00890825|12217179|FG000|Overall Study|Alive at data cut off (DCO)|13
7772438|NCT00890825|12217180|FG001|Overall Study|Alive at data cut off (DCO)|14
7772439|NCT00890929|12217190|FG000|Overall Study|Death before treatment|2
7599621|NCT00585195|12005276|FG013|Overall Study|Ongoing|0
7772440|NCT00890929|12217190|FG000|Overall Study|Withdrawal by Subject|3
7772441|NCT00890929|12217190|FG000|Overall Study|Physician Decision|1
7772442|NCT00891020|12217206|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11
7772443|NCT00891020|12217207|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32
7772444|NCT00891020|12217208|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17
7772445|NCT00891020|12217206|FG000|24 Week Treatment Period|Death|0
7599622|NCT00585195|12005277|FG014|Overall Study|Ongoing|0
7772446|NCT00891020|12217207|FG001|24 Week Treatment Period|Death|2
7772447|NCT00891020|12217208|FG002|24 Week Treatment Period|Death|0
7599623|NCT00585195|12005278|FG015|Overall Study|Ongoing|0
7599624|NCT00585195|12005279|FG016|Overall Study|Ongoing|0
7599625|NCT00585195|12005280|FG017|Overall Study|Ongoing|0
7599626|NCT00585195|12005281|FG018|Overall Study|Ongoing|0
7599627|NCT00585195|12005282|FG019|Overall Study|Ongoing|0
7599628|NCT00585195|12005283|FG020|Overall Study|Ongoing|0
7599629|NCT00585195|12005263|FG000|Overall Study|Withdrawn Due to Pregnancy|0
7599630|NCT00585195|12005264|FG001|Overall Study|Withdrawn Due to Pregnancy|0
7599631|NCT00585195|12005265|FG002|Overall Study|Withdrawn Due to Pregnancy|0
7599632|NCT00585195|12005266|FG003|Overall Study|Withdrawn Due to Pregnancy|0
7599633|NCT00585195|12005267|FG004|Overall Study|Withdrawn Due to Pregnancy|0
7599634|NCT00585195|12005268|FG005|Overall Study|Withdrawn Due to Pregnancy|0
7599635|NCT00585195|12005269|FG006|Overall Study|Withdrawn Due to Pregnancy|0
7599636|NCT00585195|12005270|FG007|Overall Study|Withdrawn Due to Pregnancy|0
7599637|NCT00585195|12005271|FG008|Overall Study|Withdrawn Due to Pregnancy|0
7599638|NCT00585195|12005272|FG009|Overall Study|Withdrawn Due to Pregnancy|0
7599639|NCT00585195|12005273|FG010|Overall Study|Withdrawn Due to Pregnancy|0
7599640|NCT00585195|12005274|FG011|Overall Study|Withdrawn Due to Pregnancy|0
7599641|NCT00585195|12005275|FG012|Overall Study|Withdrawn Due to Pregnancy|0
7599642|NCT00585195|12005276|FG013|Overall Study|Withdrawn Due to Pregnancy|0
7599643|NCT00585195|12005277|FG014|Overall Study|Withdrawn Due to Pregnancy|1
7599644|NCT00585195|12005278|FG015|Overall Study|Withdrawn Due to Pregnancy|0
7599645|NCT00585195|12005279|FG016|Overall Study|Withdrawn Due to Pregnancy|0
7599646|NCT00585195|12005280|FG017|Overall Study|Withdrawn Due to Pregnancy|0
7599647|NCT00585195|12005281|FG018|Overall Study|Withdrawn Due to Pregnancy|0
7599648|NCT00585195|12005282|FG019|Overall Study|Withdrawn Due to Pregnancy|0
7599649|NCT00585195|12005283|FG020|Overall Study|Withdrawn Due to Pregnancy|0
7599650|NCT04446429|12005368|FG000|Overall Study|Lost to Follow-up|6
7599651|NCT04446429|12005369|FG001|Overall Study|Lost to Follow-up|0
7599652|NCT04194528|12005392|FG000|Overall Study|Adverse Event|1
7772448|NCT00891020|12217206|FG000|24 Week Treatment Period|Insufficient therapeutic response|6
7599653|NCT03116685|12005424|FG000|Overall Study|Physician Decision|0
7599654|NCT03116685|12005425|FG001|Overall Study|Physician Decision|1
7599655|NCT03099304|12005436|FG000|DB Period Day 1 to Week 24|Adverse Event|1
7599656|NCT03099304|12005437|FG001|DB Period Day 1 to Week 24|Adverse Event|1
7599657|NCT03099304|12005438|FG002|DB Period Day 1 to Week 24|Adverse Event|0
7599658|NCT03099304|12005439|FG003|DB Period Day 1 to Week 24|Adverse Event|0
7599659|NCT03099304|12005440|FG004|DB Period Day 1 to Week 24|Adverse Event|1
7599660|NCT03099304|12005436|FG000|DB Period Day 1 to Week 24|Lost to Follow-up|1
7599661|NCT03099304|12005437|FG001|DB Period Day 1 to Week 24|Lost to Follow-up|1
7599662|NCT03099304|12005438|FG002|DB Period Day 1 to Week 24|Lost to Follow-up|0
7599663|NCT03099304|12005439|FG003|DB Period Day 1 to Week 24|Lost to Follow-up|0
7599664|NCT03099304|12005440|FG004|DB Period Day 1 to Week 24|Lost to Follow-up|0
7599665|NCT03099304|12005436|FG000|DB Period Day 1 to Week 24|Reason not specified|0
7599666|NCT03099304|12005437|FG001|DB Period Day 1 to Week 24|Reason not specified|0
7599667|NCT03099304|12005438|FG002|DB Period Day 1 to Week 24|Reason not specified|0
7599668|NCT03099304|12005439|FG003|DB Period Day 1 to Week 24|Reason not specified|1
7599669|NCT03099304|12005440|FG004|DB Period Day 1 to Week 24|Reason not specified|0
7599670|NCT03099304|12005436|FG000|DB Period Day 1 to Week 24|Withdrawal by Subject|3
7599671|NCT03099304|12005437|FG001|DB Period Day 1 to Week 24|Withdrawal by Subject|3
7599672|NCT03099304|12005438|FG002|DB Period Day 1 to Week 24|Withdrawal by Subject|0
7599673|NCT03099304|12005439|FG003|DB Period Day 1 to Week 24|Withdrawal by Subject|2
7599674|NCT03099304|12005440|FG004|DB Period Day 1 to Week 24|Withdrawal by Subject|2
7599675|NCT03099304|12005436|FG000|DB Period Day 1 to Week 24|Protocol Violation|0
7599676|NCT03099304|12005437|FG001|DB Period Day 1 to Week 24|Protocol Violation|0
7599677|NCT03099304|12005438|FG002|DB Period Day 1 to Week 24|Protocol Violation|1
7599678|NCT03099304|12005439|FG003|DB Period Day 1 to Week 24|Protocol Violation|1
7599679|NCT03099304|12005440|FG004|DB Period Day 1 to Week 24|Protocol Violation|0
7599680|NCT03099304|12005436|FG000|DB Period Weeks 24 to 52|Protocol Violation|0
7599681|NCT03099304|12005437|FG001|DB Period Weeks 24 to 52|Protocol Violation|0
7599682|NCT03099304|12005438|FG002|DB Period Weeks 24 to 52|Protocol Violation|1
7599683|NCT03099304|12005439|FG003|DB Period Weeks 24 to 52|Protocol Violation|0
7772449|NCT00891020|12217207|FG001|24 Week Treatment Period|Insufficient therapeutic response|9
7772450|NCT00891020|12217208|FG002|24 Week Treatment Period|Insufficient therapeutic response|15
7772451|NCT00891020|12217206|FG000|24 Week Treatment Period|Failure to return|4
7772452|NCT00891020|12217207|FG001|24 Week Treatment Period|Failure to return|5
7772453|NCT00891020|12217208|FG002|24 Week Treatment Period|Failure to return|5
7772454|NCT00891020|12217206|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1
7772455|NCT00891020|12217207|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0
7772456|NCT00891020|12217208|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2
7772457|NCT00891020|12217206|FG000|24 Week Treatment Period|Other protocol violation|1
7772458|NCT00891020|12217207|FG001|24 Week Treatment Period|Other protocol violation|1
7772459|NCT00891020|12217208|FG002|24 Week Treatment Period|Other protocol violation|2
7772460|NCT00891020|12217206|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3
7772461|NCT00891020|12217207|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2
7772462|NCT00891020|12217208|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1
7772463|NCT00891020|12217206|FG000|24 Week Treatment Period|Withdrew consent|6
7772464|NCT00891020|12217207|FG001|24 Week Treatment Period|Withdrew consent|3
7772465|NCT00891020|12217208|FG002|24 Week Treatment Period|Withdrew consent|15
7772466|NCT00891020|12217206|FG000|24 Week Treatment Period|Administrative/Other|5
7772467|NCT00891020|12217207|FG001|24 Week Treatment Period|Administrative/Other|6
7772468|NCT00891020|12217208|FG002|24 Week Treatment Period|Administrative/Other|1
7772469|NCT00891020|12217206|FG000|Long-term Extension Period|Adverse Event|1
7772470|NCT00891020|12217207|FG001|Long-term Extension Period|Adverse Event|11
7772471|NCT00891020|12217208|FG002|Long-term Extension Period|Adverse Event|10
7772472|NCT00891020|12217206|FG000|Long-term Extension Period|Death|0
7772473|NCT00891020|12217207|FG001|Long-term Extension Period|Death|0
7772474|NCT00891020|12217208|FG002|Long-term Extension Period|Death|1
7772475|NCT00891020|12217206|FG000|Long-term Extension Period|Insufficient therapeutic response|3
7772476|NCT00891020|12217207|FG001|Long-term Extension Period|Insufficient therapeutic response|2
7772477|NCT00891020|12217208|FG002|Long-term Extension Period|Insufficient therapeutic response|2
7772478|NCT00891020|12217206|FG000|Long-term Extension Period|Protocol Violation|0
7772479|NCT00891020|12217207|FG001|Long-term Extension Period|Protocol Violation|1
7772480|NCT00891020|12217208|FG002|Long-term Extension Period|Protocol Violation|1
7772481|NCT00891020|12217206|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1
7772482|NCT00891020|12217207|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6
7599684|NCT03099304|12005440|FG004|DB Period Weeks 24 to 52|Protocol Violation|0
7599685|NCT03099304|12005436|FG000|DB Period Weeks 24 to 52|Lost to Follow-up|0
7599686|NCT03099304|12005437|FG001|DB Period Weeks 24 to 52|Lost to Follow-up|1
7599687|NCT03099304|12005438|FG002|DB Period Weeks 24 to 52|Lost to Follow-up|1
7599688|NCT03099304|12005439|FG003|DB Period Weeks 24 to 52|Lost to Follow-up|1
7599689|NCT03099304|12005440|FG004|DB Period Weeks 24 to 52|Lost to Follow-up|0
7599690|NCT03099304|12005436|FG000|DB Period Weeks 24 to 52|Adverse Event|0
7599691|NCT03099304|12005437|FG001|DB Period Weeks 24 to 52|Adverse Event|0
7599692|NCT03099304|12005438|FG002|DB Period Weeks 24 to 52|Adverse Event|0
7599693|NCT03099304|12005439|FG003|DB Period Weeks 24 to 52|Adverse Event|1
7599694|NCT03099304|12005440|FG004|DB Period Weeks 24 to 52|Adverse Event|1
7599695|NCT03099304|12005436|FG000|DB Period Weeks 24 to 52|Withdrawal by Subject|0
7599696|NCT03099304|12005437|FG001|DB Period Weeks 24 to 52|Withdrawal by Subject|0
7599697|NCT03099304|12005438|FG002|DB Period Weeks 24 to 52|Withdrawal by Subject|0
7599698|NCT03099304|12005439|FG003|DB Period Weeks 24 to 52|Withdrawal by Subject|4
7599699|NCT03099304|12005440|FG004|DB Period Weeks 24 to 52|Withdrawal by Subject|1
7599700|NCT03099304|12005436|FG000|DB Period Weeks 24 to 52|Reason not specified|0
7599701|NCT03099304|12005437|FG001|DB Period Weeks 24 to 52|Reason not specified|0
7599702|NCT03099304|12005438|FG002|DB Period Weeks 24 to 52|Reason not specified|0
7599703|NCT03099304|12005439|FG003|DB Period Weeks 24 to 52|Reason not specified|1
7599704|NCT03099304|12005440|FG004|DB Period Weeks 24 to 52|Reason not specified|0
7599705|NCT02682901|12005486|FG000|Overall Study|Adverse Event|10
7599706|NCT02682901|12005487|FG001|Overall Study|Adverse Event|3
7599707|NCT02682901|12005486|FG000|Overall Study|Lack of Efficacy|0
7599708|NCT02682901|12005487|FG001|Overall Study|Lack of Efficacy|1
7599709|NCT02555657|12005495|FG000|Overall Study|Death|274
7599710|NCT02555657|12005496|FG001|Overall Study|Death|262
7599711|NCT02555657|12005495|FG000|Overall Study|Physician Decision|0
7599712|NCT02555657|12005496|FG001|Overall Study|Physician Decision|1
7599713|NCT02555657|12005495|FG000|Overall Study|Sponsor Decision|27
7599714|NCT02555657|12005496|FG001|Overall Study|Sponsor Decision|15
7599715|NCT02555657|12005495|FG000|Overall Study|Withdrawal by Subject|11
7599716|NCT02555657|12005496|FG001|Overall Study|Withdrawal by Subject|32
7599717|NCT02190721|12005506|FG000|Overall Study|Patient was out of the city|0
7599718|NCT02190721|12005507|FG001|Overall Study|Patient was out of the city|1
7599719|NCT02190721|12005508|FG002|Overall Study|Patient was out of the city|0
7599720|NCT00739401|12005541|FG000|Overall Study|patients were not due for the 2 year follow-up|34
7599721|NCT00739401|12005541|FG000|Overall Study|Death|3
7599722|NCT00739401|12005541|FG000|Overall Study|Withdrawal by Subject|4
7599723|NCT00651742|12005545|FG000|Overall Study|Objective Disease Progression|22
7599724|NCT00651742|12005545|FG000|Overall Study|Toxicity|3
7599725|NCT00651742|12005545|FG000|Overall Study|Investigator Judgment|1
7599726|NCT00651742|12005545|FG000|Overall Study|Withdrawal of Consent|1
7599727|NCT00651742|12005545|FG000|Overall Study|Enrolled but not treated|1
7599728|NCT04930263|12005564|FG000|Overall Study|Withdrawal by Subject|3
7599729|NCT04930263|12005565|FG001|Overall Study|Withdrawal by Subject|5
7599730|NCT04321252|12005580|FG000|Overall Study|Withdrawal by Subject|0
7599731|NCT04321252|12005581|FG001|Overall Study|Withdrawal by Subject|0
7599732|NCT04321252|12005582|FG002|Overall Study|Withdrawal by Subject|0
7599733|NCT04321252|12005583|FG003|Overall Study|Withdrawal by Subject|0
7599734|NCT04321252|12005584|FG004|Overall Study|Withdrawal by Subject|0
7599735|NCT04321252|12005585|FG005|Overall Study|Withdrawal by Subject|1
7599736|NCT04321252|12005586|FG006|Overall Study|Withdrawal by Subject|0
7599737|NCT04321252|12005587|FG007|Overall Study|Withdrawal by Subject|0
7599738|NCT04321252|12005588|FG008|Overall Study|Withdrawal by Subject|0
7599739|NCT04176445|12005618|FG000|Overall Study|Adverse Event|0
7599740|NCT04176445|12005619|FG001|Overall Study|Adverse Event|1
7599741|NCT04176445|12005618|FG000|Overall Study|change plans weaning after first intervention|0
7599742|NCT04176445|12005619|FG001|Overall Study|change plans weaning after first intervention|1
7599743|NCT04126213|12005631|FG000|Overall Study|Lost to Follow-up|9
7599744|NCT04126213|12005632|FG001|Overall Study|Lost to Follow-up|1
7599745|NCT04126213|12005633|FG002|Overall Study|Lost to Follow-up|5
7599746|NCT04126213|12005634|FG003|Overall Study|Lost to Follow-up|10
7599747|NCT04126213|12005635|FG004|Overall Study|Lost to Follow-up|4
7599748|NCT04126213|12005636|FG005|Overall Study|Lost to Follow-up|7
7599749|NCT04126213|12005631|FG000|Overall Study|Withdrawal by Subject|3
7599750|NCT04126213|12005632|FG001|Overall Study|Withdrawal by Subject|2
7599751|NCT04126213|12005633|FG002|Overall Study|Withdrawal by Subject|1
7599752|NCT04126213|12005634|FG003|Overall Study|Withdrawal by Subject|1
7599753|NCT04126213|12005635|FG004|Overall Study|Withdrawal by Subject|1
7599754|NCT04126213|12005636|FG005|Overall Study|Withdrawal by Subject|1
7599755|NCT04126213|12005631|FG000|Overall Study|Other|0
7599756|NCT04126213|12005632|FG001|Overall Study|Other|0
7599757|NCT04126213|12005633|FG002|Overall Study|Other|2
7599758|NCT04126213|12005634|FG003|Overall Study|Other|2
7599759|NCT04126213|12005635|FG004|Overall Study|Other|0
7599760|NCT04126213|12005636|FG005|Overall Study|Other|1
7599761|NCT04126213|12005631|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7599762|NCT04126213|12005632|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
7599763|NCT04126213|12005633|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7599764|NCT04126213|12005634|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7599765|NCT04126213|12005635|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7599766|NCT04126213|12005636|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
7599767|NCT03672188|12005672|FG000|Overall Study|Withdrawal by Subject|0
7599768|NCT03672188|12005673|FG001|Overall Study|Withdrawal by Subject|0
7599769|NCT03672188|12005674|FG002|Overall Study|Withdrawal by Subject|0
7599770|NCT03672188|12005675|FG003|Overall Study|Withdrawal by Subject|3
7599771|NCT03672188|12005676|FG004|Overall Study|Withdrawal by Subject|0
7599772|NCT03672188|12005677|FG005|Overall Study|Withdrawal by Subject|0
7599773|NCT03672188|12005678|FG006|Overall Study|Withdrawal by Subject|0
7599774|NCT03672188|12005679|FG007|Overall Study|Withdrawal by Subject|0
7599775|NCT03672188|12005680|FG008|Overall Study|Withdrawal by Subject|0
7599776|NCT03672188|12005681|FG009|Overall Study|Withdrawal by Subject|0
7599777|NCT03672188|12005682|FG010|Overall Study|Withdrawal by Subject|0
7772483|NCT00891020|12217208|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4
7772484|NCT00891020|12217206|FG000|Long-term Extension Period|Failure to return|0
7599778|NCT03672188|12005683|FG011|Overall Study|Withdrawal by Subject|0
7599779|NCT03672188|12005684|FG012|Overall Study|Withdrawal by Subject|0
7599780|NCT03672188|12005685|FG013|Overall Study|Withdrawal by Subject|0
7599781|NCT03672188|12005686|FG014|Overall Study|Withdrawal by Subject|0
7599782|NCT03672188|12005672|FG000|Overall Study|Death|0
7599783|NCT03672188|12005673|FG001|Overall Study|Death|0
7599784|NCT03672188|12005674|FG002|Overall Study|Death|0
7599785|NCT03672188|12005675|FG003|Overall Study|Death|0
7599786|NCT03672188|12005676|FG004|Overall Study|Death|0
7772485|NCT00891020|12217207|FG001|Long-term Extension Period|Failure to return|2
7772486|NCT00891020|12217208|FG002|Long-term Extension Period|Failure to return|3
7599787|NCT03672188|12005677|FG005|Overall Study|Death|0
7599788|NCT03672188|12005678|FG006|Overall Study|Death|0
7599789|NCT03672188|12005679|FG007|Overall Study|Death|0
7599790|NCT03672188|12005680|FG008|Overall Study|Death|0
7599791|NCT03672188|12005681|FG009|Overall Study|Death|0
7599792|NCT03672188|12005682|FG010|Overall Study|Death|0
7599793|NCT03672188|12005683|FG011|Overall Study|Death|0
7599794|NCT03672188|12005684|FG012|Overall Study|Death|1
7599795|NCT03672188|12005685|FG013|Overall Study|Death|0
7599796|NCT03672188|12005686|FG014|Overall Study|Death|0
7599797|NCT03672188|12005672|FG000|Overall Study|Lost to Follow-up|0
7599798|NCT03672188|12005673|FG001|Overall Study|Lost to Follow-up|0
7599799|NCT03672188|12005674|FG002|Overall Study|Lost to Follow-up|1
7599800|NCT03672188|12005675|FG003|Overall Study|Lost to Follow-up|0
7599801|NCT03672188|12005676|FG004|Overall Study|Lost to Follow-up|0
7599802|NCT03672188|12005677|FG005|Overall Study|Lost to Follow-up|0
7599803|NCT03672188|12005678|FG006|Overall Study|Lost to Follow-up|0
7599804|NCT03672188|12005679|FG007|Overall Study|Lost to Follow-up|0
7599805|NCT03672188|12005680|FG008|Overall Study|Lost to Follow-up|0
7599806|NCT03672188|12005681|FG009|Overall Study|Lost to Follow-up|0
7599807|NCT03672188|12005682|FG010|Overall Study|Lost to Follow-up|0
7599808|NCT03672188|12005683|FG011|Overall Study|Lost to Follow-up|0
7599809|NCT03672188|12005684|FG012|Overall Study|Lost to Follow-up|0
7599810|NCT03672188|12005685|FG013|Overall Study|Lost to Follow-up|0
7599811|NCT03672188|12005686|FG014|Overall Study|Lost to Follow-up|0
7599812|NCT03230916|12005767|FG000|Overall Study|Withdrawal by Subject|0
7599813|NCT03230916|12005768|FG001|Overall Study|Withdrawal by Subject|0
7599814|NCT03230916|12005769|FG002|Overall Study|Withdrawal by Subject|0
7599815|NCT03230916|12005770|FG003|Overall Study|Withdrawal by Subject|0
7599816|NCT03230916|12005771|FG004|Overall Study|Withdrawal by Subject|0
7599817|NCT03230916|12005772|FG005|Overall Study|Withdrawal by Subject|1
7599818|NCT03230916|12005773|FG006|Overall Study|Withdrawal by Subject|0
7599819|NCT03230916|12005774|FG007|Overall Study|Withdrawal by Subject|0
7599820|NCT03230916|12005775|FG008|Overall Study|Withdrawal by Subject|0
7599821|NCT03230916|12005776|FG009|Overall Study|Withdrawal by Subject|0
7599822|NCT03230916|12005777|FG010|Overall Study|Withdrawal by Subject|0
7599823|NCT03195894|12005820|FG000|Overall Study|"An example is Started other treatment."|4
7599824|NCT03195894|12005821|FG001|Overall Study|"An example is Started other treatment."|5
7599825|NCT03195894|12005820|FG000|Overall Study|Withdrawal by Subject|15
7599826|NCT03195894|12005821|FG001|Overall Study|Withdrawal by Subject|4
7599827|NCT03195894|12005820|FG000|Overall Study|Lost to Follow-up|14
7599828|NCT03195894|12005821|FG001|Overall Study|Lost to Follow-up|19
7599829|NCT03032705|12005832|FG000|Overall Study|Lost to Follow-up|16
7599830|NCT03032705|12005833|FG001|Overall Study|Lost to Follow-up|17
7599831|NCT03032705|12005832|FG000|Overall Study|did not quality|6
7599832|NCT03032705|12005833|FG001|Overall Study|did not quality|6
7599833|NCT02573259|12005846|FG000|Overall Study|Death|1
7599834|NCT02573259|12005847|FG001|Overall Study|Death|6
7599835|NCT02573259|12005848|FG002|Overall Study|Death|5
7599836|NCT02573259|12005849|FG003|Overall Study|Death|6
7599837|NCT02573259|12005850|FG004|Overall Study|Death|9
7599838|NCT02573259|12005851|FG005|Overall Study|Death|32
7599839|NCT02573259|12005852|FG006|Overall Study|Death|21
7599840|NCT02573259|12005846|FG000|Overall Study|Lost to Follow-up|0
7599841|NCT02573259|12005847|FG001|Overall Study|Lost to Follow-up|0
7599842|NCT02573259|12005848|FG002|Overall Study|Lost to Follow-up|0
7599843|NCT02573259|12005849|FG003|Overall Study|Lost to Follow-up|0
7599844|NCT02573259|12005850|FG004|Overall Study|Lost to Follow-up|0
7599845|NCT02573259|12005851|FG005|Overall Study|Lost to Follow-up|2
7599846|NCT02573259|12005852|FG006|Overall Study|Lost to Follow-up|1
7599847|NCT02573259|12005846|FG000|Overall Study|Participant refused further follow-up|0
7599848|NCT02573259|12005847|FG001|Overall Study|Participant refused further follow-up|2
7599849|NCT02573259|12005848|FG002|Overall Study|Participant refused further follow-up|1
7599850|NCT02573259|12005849|FG003|Overall Study|Participant refused further follow-up|0
7599851|NCT02573259|12005850|FG004|Overall Study|Participant refused further follow-up|3
7599852|NCT02573259|12005851|FG005|Overall Study|Participant refused further follow-up|20
7599853|NCT02573259|12005852|FG006|Overall Study|Participant refused further follow-up|7
7599854|NCT02573259|12005846|FG000|Overall Study|Other|0
7599855|NCT02573259|12005847|FG001|Overall Study|Other|0
7599856|NCT02573259|12005848|FG002|Overall Study|Other|0
7599857|NCT02573259|12005849|FG003|Overall Study|Other|0
7599858|NCT02573259|12005850|FG004|Overall Study|Other|1
7599859|NCT02573259|12005851|FG005|Overall Study|Other|4
7599860|NCT02573259|12005852|FG006|Overall Study|Other|5
7599861|NCT02318329|12005894|FG000|Overall Study|Progressive Disease|2
7599862|NCT02318329|12005895|FG001|Overall Study|Progressive Disease|3
7599863|NCT02318329|12005896|FG002|Overall Study|Progressive Disease|2
7599864|NCT02318329|12005897|FG003|Overall Study|Progressive Disease|3
7599865|NCT02318329|12005898|FG004|Overall Study|Progressive Disease|3
7599866|NCT02318329|12005899|FG005|Overall Study|Progressive Disease|3
7599867|NCT02318329|12005900|FG006|Overall Study|Progressive Disease|1
7599868|NCT02318329|12005901|FG007|Overall Study|Progressive Disease|1
7599869|NCT02318329|12005902|FG008|Overall Study|Progressive Disease|5
7599870|NCT02318329|12005903|FG009|Overall Study|Progressive Disease|39
7599871|NCT02318329|12005894|FG000|Overall Study|Death|0
7599872|NCT02318329|12005895|FG001|Overall Study|Death|0
7599873|NCT02318329|12005896|FG002|Overall Study|Death|0
7599874|NCT02318329|12005897|FG003|Overall Study|Death|0
7599875|NCT02318329|12005898|FG004|Overall Study|Death|0
7599876|NCT02318329|12005899|FG005|Overall Study|Death|0
7599877|NCT02318329|12005900|FG006|Overall Study|Death|0
7599878|NCT02318329|12005901|FG007|Overall Study|Death|0
7599879|NCT02318329|12005902|FG008|Overall Study|Death|0
7599880|NCT02318329|12005903|FG009|Overall Study|Death|5
7599881|NCT02318329|12005894|FG000|Overall Study|Lost to Follow-up|0
7599882|NCT02318329|12005895|FG001|Overall Study|Lost to Follow-up|0
7599883|NCT02318329|12005896|FG002|Overall Study|Lost to Follow-up|0
7599884|NCT02318329|12005897|FG003|Overall Study|Lost to Follow-up|0
7599885|NCT02318329|12005898|FG004|Overall Study|Lost to Follow-up|0
7599886|NCT02318329|12005899|FG005|Overall Study|Lost to Follow-up|0
7599887|NCT02318329|12005900|FG006|Overall Study|Lost to Follow-up|0
7599888|NCT02318329|12005901|FG007|Overall Study|Lost to Follow-up|0
7599889|NCT02318329|12005902|FG008|Overall Study|Lost to Follow-up|0
7599890|NCT02318329|12005903|FG009|Overall Study|Lost to Follow-up|1
7599891|NCT02318329|12005894|FG000|Overall Study|Withdrawal by Subject|0
7599892|NCT02318329|12005895|FG001|Overall Study|Withdrawal by Subject|0
7599893|NCT02318329|12005896|FG002|Overall Study|Withdrawal by Subject|0
7599894|NCT02318329|12005897|FG003|Overall Study|Withdrawal by Subject|0
7599895|NCT02318329|12005898|FG004|Overall Study|Withdrawal by Subject|0
7599896|NCT02318329|12005899|FG005|Overall Study|Withdrawal by Subject|0
7599897|NCT02318329|12005900|FG006|Overall Study|Withdrawal by Subject|0
7599898|NCT02318329|12005901|FG007|Overall Study|Withdrawal by Subject|0
7599899|NCT02318329|12005902|FG008|Overall Study|Withdrawal by Subject|0
7599900|NCT02318329|12005903|FG009|Overall Study|Withdrawal by Subject|6
7599901|NCT02318329|12005894|FG000|Overall Study|Other|1
7599902|NCT02318329|12005895|FG001|Overall Study|Other|1
7599903|NCT02318329|12005896|FG002|Overall Study|Other|1
7599904|NCT02318329|12005897|FG003|Overall Study|Other|0
7599905|NCT02318329|12005898|FG004|Overall Study|Other|0
7599906|NCT02318329|12005899|FG005|Overall Study|Other|0
7599907|NCT02318329|12005900|FG006|Overall Study|Other|0
7599908|NCT02318329|12005901|FG007|Overall Study|Other|0
7599909|NCT02318329|12005902|FG008|Overall Study|Other|1
7599910|NCT02318329|12005903|FG009|Overall Study|Other|1
7599911|NCT01602666|12005946|FG000|Induction Chemotherapy|Death|2
7599912|NCT01602666|12005947|FG001|Induction Chemotherapy|Death|1
7599913|NCT01602666|12005946|FG000|Induction Chemotherapy|Lack of Efficacy|16
7599914|NCT01602666|12005947|FG001|Induction Chemotherapy|Lack of Efficacy|7
7599915|NCT01602666|12005946|FG000|Induction Chemotherapy|Physician Decision|12
7599916|NCT01602666|12005947|FG001|Induction Chemotherapy|Physician Decision|5
7599917|NCT01602666|12005946|FG000|Induction Chemotherapy|Withdrawal by Subject|0
7599918|NCT01602666|12005947|FG001|Induction Chemotherapy|Withdrawal by Subject|2
7599919|NCT01602666|12005946|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5
7599920|NCT01602666|12005947|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6
7599921|NCT01602666|12005946|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2
7599922|NCT01602666|12005947|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3
7599923|NCT01602666|12005946|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4
7599924|NCT01602666|12005947|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5
7599925|NCT01602666|12005946|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2
7599926|NCT01602666|12005947|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3
7599927|NCT01602666|12005946|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4
7599928|NCT01602666|12005947|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0
7599929|NCT01602666|12005946|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0
7599930|NCT01602666|12005947|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14
7599931|NCT01602666|12005946|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0
7599932|NCT01602666|12005947|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9
7599933|NCT01375959|12005957|FG000|First Intervention (6 Weeks)|Adverse Event|2
7599934|NCT01375959|12005958|FG001|First Intervention (6 Weeks)|Adverse Event|3
7599935|NCT01375959|12005957|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0
7599936|NCT01375959|12005958|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1
7599937|NCT01375959|12005957|FG000|Second Intervention (6 Weeks)|Adverse Event|0
7599938|NCT01375959|12005958|FG001|Second Intervention (6 Weeks)|Adverse Event|2
7599939|NCT01224106|12005969|FG000|Double-Blind Treatment Phase|Death|3
7599940|NCT01224106|12005970|FG001|Double-Blind Treatment Phase|Death|0
7599941|NCT01224106|12005971|FG002|Double-Blind Treatment Phase|Death|0
7599942|NCT01224106|12005972|FG003|Double-Blind Treatment Phase|Death|0
7599943|NCT01224106|12005973|FG004|Double-Blind Treatment Phase|Death|0
7599944|NCT01224106|12005969|FG000|Double-Blind Treatment Phase|Physician Decision|6
7599945|NCT01224106|12005970|FG001|Double-Blind Treatment Phase|Physician Decision|5
7599946|NCT01224106|12005971|FG002|Double-Blind Treatment Phase|Physician Decision|4
7599947|NCT01224106|12005972|FG003|Double-Blind Treatment Phase|Physician Decision|0
7599948|NCT01224106|12005973|FG004|Double-Blind Treatment Phase|Physician Decision|0
7599949|NCT01224106|12005969|FG000|Double-Blind Treatment Phase|Adverse Event|0
7599950|NCT01224106|12005970|FG001|Double-Blind Treatment Phase|Adverse Event|5
7599951|NCT01224106|12005971|FG002|Double-Blind Treatment Phase|Adverse Event|3
7599952|NCT01224106|12005972|FG003|Double-Blind Treatment Phase|Adverse Event|0
7599953|NCT01224106|12005973|FG004|Double-Blind Treatment Phase|Adverse Event|0
7599954|NCT01224106|12005969|FG000|Double-Blind Treatment Phase|Other|0
7599955|NCT01224106|12005970|FG001|Double-Blind Treatment Phase|Other|0
7599956|NCT01224106|12005971|FG002|Double-Blind Treatment Phase|Other|1
7599957|NCT01224106|12005972|FG003|Double-Blind Treatment Phase|Other|0
7599958|NCT01224106|12005973|FG004|Double-Blind Treatment Phase|Other|0
7599959|NCT01224106|12005969|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7
7599960|NCT01224106|12005970|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8
7599961|NCT01224106|12005971|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8
7599962|NCT01224106|12005972|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0
7599963|NCT01224106|12005973|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0
7599964|NCT01224106|12005969|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62
7599965|NCT01224106|12005970|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68
7599966|NCT01224106|12005971|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63
7599967|NCT01224106|12005972|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0
7599968|NCT01224106|12005973|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0
7599969|NCT01224106|12005969|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1
7599970|NCT01224106|12005970|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
7599971|NCT01224106|12005971|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
7599972|NCT01224106|12005972|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0
7599973|NCT01224106|12005973|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0
7599974|NCT01224106|12005969|FG000|Open-Label Extension (OLE) Phase|Death|0
7599975|NCT01224106|12005970|FG001|Open-Label Extension (OLE) Phase|Death|0
7599976|NCT01224106|12005971|FG002|Open-Label Extension (OLE) Phase|Death|0
7599977|NCT01224106|12005972|FG003|Open-Label Extension (OLE) Phase|Death|1
7599978|NCT01224106|12005973|FG004|Open-Label Extension (OLE) Phase|Death|3
7599979|NCT01224106|12005969|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0
7599980|NCT01224106|12005970|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0
7599981|NCT01224106|12005971|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0
7599982|NCT01224106|12005972|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2
7599983|NCT01224106|12005973|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6
7599984|NCT01224106|12005969|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0
7599985|NCT01224106|12005970|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0
7599986|NCT01224106|12005971|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0
7599987|NCT01224106|12005972|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2
7599988|NCT01224106|12005973|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7
7599989|NCT01224106|12005969|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
7772487|NCT00891020|12217206|FG000|Long-term Extension Period|Administrative|1
7772488|NCT00891020|12217207|FG001|Long-term Extension Period|Administrative|2
7772489|NCT00891020|12217208|FG002|Long-term Extension Period|Administrative|2
7772490|NCT00891046|12217223|FG000|Overall Study|Protocol Violation|1
7772491|NCT00891046|12217224|FG001|Overall Study|Protocol Violation|1
7772492|NCT00891046|12217225|FG002|Overall Study|Protocol Violation|0
7772493|NCT00891046|12217226|FG003|Overall Study|Protocol Violation|0
7772494|NCT00891046|12217227|FG004|Overall Study|Protocol Violation|1
7772495|NCT00891046|12217223|FG000|Overall Study|Unsatisfactory therapeutic effect|5
7772496|NCT00891046|12217224|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7772497|NCT00891046|12217225|FG002|Overall Study|Unsatisfactory therapeutic effect|19
7772498|NCT00891046|12217226|FG003|Overall Study|Unsatisfactory therapeutic effect|2
7772499|NCT00891046|12217227|FG004|Overall Study|Unsatisfactory therapeutic effect|20
7772500|NCT00891046|12217223|FG000|Overall Study|Administrative problems|0
7772501|NCT00891046|12217224|FG001|Overall Study|Administrative problems|0
7772502|NCT00891046|12217225|FG002|Overall Study|Administrative problems|0
7772503|NCT00891046|12217226|FG003|Overall Study|Administrative problems|0
7772504|NCT00891046|12217227|FG004|Overall Study|Administrative problems|1
7772505|NCT00891046|12217223|FG000|Overall Study|Participant no longer required drug|0
7772506|NCT00891046|12217224|FG001|Overall Study|Participant no longer required drug|2
7772507|NCT00891046|12217225|FG002|Overall Study|Participant no longer required drug|0
7772508|NCT00891046|12217226|FG003|Overall Study|Participant no longer required drug|0
7772509|NCT00891046|12217227|FG004|Overall Study|Participant no longer required drug|1
7772510|NCT00891046|12217223|FG000|Overall Study|Adverse Event|4
7772511|NCT00891046|12217224|FG001|Overall Study|Adverse Event|3
7772512|NCT00891046|12217225|FG002|Overall Study|Adverse Event|2
7772513|NCT00891046|12217226|FG003|Overall Study|Adverse Event|0
7772514|NCT00891046|12217227|FG004|Overall Study|Adverse Event|14
7772515|NCT00891046|12217223|FG000|Overall Study|Withdrawal by Subject|2
7772516|NCT00891046|12217224|FG001|Overall Study|Withdrawal by Subject|1
7772517|NCT00891046|12217225|FG002|Overall Study|Withdrawal by Subject|2
7772518|NCT00891046|12217226|FG003|Overall Study|Withdrawal by Subject|1
7772519|NCT00891046|12217227|FG004|Overall Study|Withdrawal by Subject|1
7772520|NCT00891046|12217223|FG000|Overall Study|Lost to Follow-up|0
7772521|NCT00891046|12217224|FG001|Overall Study|Lost to Follow-up|0
7772522|NCT00891046|12217225|FG002|Overall Study|Lost to Follow-up|0
7772523|NCT00891046|12217226|FG003|Overall Study|Lost to Follow-up|0
7772524|NCT00891046|12217227|FG004|Overall Study|Lost to Follow-up|1
7772525|NCT00891202|12217279|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1
7772526|NCT00891202|12217280|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0
7772527|NCT00891202|12217281|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0
7772528|NCT00891202|12217282|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0
7772529|NCT00891202|12217279|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
7772530|NCT00891202|12217280|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
7772531|NCT00891202|12217281|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
7772532|NCT00891202|12217282|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
7772533|NCT00891202|12217279|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
7772534|NCT00891202|12217280|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
7772535|NCT00891202|12217281|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
7772536|NCT00891202|12217282|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
7772537|NCT00891202|12217279|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
7599990|NCT01224106|12005970|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
7599991|NCT01224106|12005971|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
7599992|NCT01224106|12005972|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6
7599993|NCT01224106|12005973|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15
7599994|NCT01224106|12005969|FG000|Open-Label Extension (OLE) Phase|Other|0
7599995|NCT01224106|12005970|FG001|Open-Label Extension (OLE) Phase|Other|0
7599996|NCT01224106|12005971|FG002|Open-Label Extension (OLE) Phase|Other|0
7599997|NCT01224106|12005972|FG003|Open-Label Extension (OLE) Phase|Other|5
7599998|NCT01224106|12005973|FG004|Open-Label Extension (OLE) Phase|Other|3
7599999|NCT00354835|12006002|FG000|Overall Study|Death|1
7600000|NCT00354835|12006003|FG001|Overall Study|Death|1
7600001|NCT00354835|12006002|FG000|Overall Study|Physician Decision|8
7600002|NCT00354835|12006003|FG001|Overall Study|Physician Decision|13
7600003|NCT00354835|12006002|FG000|Overall Study|Withdrawal by Subject|2
7600004|NCT00354835|12006003|FG001|Overall Study|Withdrawal by Subject|1
7600005|NCT00354835|12006002|FG000|Overall Study|Ineligible|17
7600006|NCT00354835|12006003|FG001|Overall Study|Ineligible|16
7600007|NCT00354835|12006002|FG000|Overall Study|Disease progression or relapse|15
7600008|NCT00354835|12006003|FG001|Overall Study|Disease progression or relapse|22
7600009|NCT00354835|12006002|FG000|Overall Study|Adverse Event|6
7600010|NCT00354835|12006003|FG001|Overall Study|Adverse Event|0
7600011|NCT00354835|12006002|FG000|Overall Study|Refusal of further therapy|3
7600012|NCT00354835|12006003|FG001|Overall Study|Refusal of further therapy|8
7600013|NCT04531241|12006024|FG000|Period 1|Withdrawal by Subject|2
7600014|NCT04531241|12006025|FG001|Period 1|Withdrawal by Subject|0
7600015|NCT04531241|12006024|FG000|Period 1|Dispesed incorrect lens power|1
7600016|NCT04531241|12006025|FG001|Period 1|Dispesed incorrect lens power|0
7600017|NCT04531241|12006024|FG000|Period 1|Protocol Violation|1
7600018|NCT04531241|12006025|FG001|Period 1|Protocol Violation|0
7600019|NCT04531241|12006024|FG000|Period 1|No longer eligible|0
7600020|NCT04531241|12006025|FG001|Period 1|No longer eligible|1
7600021|NCT04531241|12006024|FG000|Period 1|Lens Discomfort|0
7600022|NCT04531241|12006025|FG001|Period 1|Lens Discomfort|1
7600023|NCT04531241|12006024|FG000|Period 2|Covid-19 Related|1
7600024|NCT04531241|12006025|FG001|Period 2|Covid-19 Related|1
7600025|NCT04185220|12006070|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0
7600026|NCT04185220|12006071|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1
7600027|NCT04185220|12006070|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0
7600028|NCT04185220|12006071|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1
7600029|NCT03600714|12006088|FG000|Overall Study|Out of country and could not return for post-treatment visits|1
7600030|NCT03470441|12006109|FG000|Overall Study|Death|0
7600031|NCT03470441|12006110|FG001|Overall Study|Death|1
7600032|NCT03470441|12006111|FG002|Overall Study|Death|1
7600033|NCT03470441|12006112|FG003|Overall Study|Death|0
7600034|NCT03470441|12006109|FG000|Overall Study|Adverse Event|0
7600035|NCT03470441|12006110|FG001|Overall Study|Adverse Event|0
7600036|NCT03470441|12006111|FG002|Overall Study|Adverse Event|0
7600037|NCT03470441|12006112|FG003|Overall Study|Adverse Event|1
7600038|NCT03470441|12006109|FG000|Overall Study|Withdrawal by Subject|1
7600039|NCT03470441|12006110|FG001|Overall Study|Withdrawal by Subject|4
7600040|NCT03470441|12006111|FG002|Overall Study|Withdrawal by Subject|1
7600041|NCT03470441|12006112|FG003|Overall Study|Withdrawal by Subject|3
7600042|NCT03452397|12006126|FG000|Overall Study|Adverse Event|1
7772538|NCT00891202|12217280|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
7772539|NCT00891202|12217281|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
7772540|NCT00891202|12217282|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
7772541|NCT00891228|12217293|FG000|Overall Study|Adverse Event|0
7772542|NCT00891228|12217294|FG001|Overall Study|Adverse Event|2
7772543|NCT00891228|12217295|FG002|Overall Study|Adverse Event|3
7772544|NCT00891228|12217293|FG000|Overall Study|Withdrawal by Subject|2
7772545|NCT00891228|12217294|FG001|Overall Study|Withdrawal by Subject|4
7772546|NCT00891228|12217295|FG002|Overall Study|Withdrawal by Subject|5
7772547|NCT00891228|12217293|FG000|Overall Study|Protocol Violation|3
7772548|NCT00891228|12217294|FG001|Overall Study|Protocol Violation|1
7772549|NCT00891228|12217295|FG002|Overall Study|Protocol Violation|2
7772550|NCT00891228|12217293|FG000|Overall Study|Physician Decision|2
7600043|NCT03452397|12006127|FG001|Overall Study|Adverse Event|0
7600044|NCT03452397|12006128|FG002|Overall Study|Adverse Event|0
7600045|NCT03452397|12006129|FG003|Overall Study|Adverse Event|0
7600046|NCT03452397|12006126|FG000|Overall Study|Administrative reason|0
7600047|NCT03452397|12006127|FG001|Overall Study|Administrative reason|0
7600048|NCT03452397|12006128|FG002|Overall Study|Administrative reason|1
7600049|NCT03452397|12006129|FG003|Overall Study|Administrative reason|1
7600050|NCT03452397|12006126|FG000|Overall Study|Withdrawal by Subject|0
7600051|NCT03452397|12006127|FG001|Overall Study|Withdrawal by Subject|0
7600052|NCT03452397|12006128|FG002|Overall Study|Withdrawal by Subject|1
7600053|NCT03452397|12006129|FG003|Overall Study|Withdrawal by Subject|0
7600054|NCT03448939|12006143|FG000|Overall Study|Adverse Event|5
7600055|NCT03448939|12006144|FG001|Overall Study|Adverse Event|1
7600056|NCT03448939|12006143|FG000|Overall Study|Lost to Follow-up|6
7600057|NCT03448939|12006144|FG001|Overall Study|Lost to Follow-up|6
7600058|NCT03448939|12006143|FG000|Overall Study|Pregnancy|1
7600059|NCT03448939|12006144|FG001|Overall Study|Pregnancy|1
7600060|NCT03448939|12006143|FG000|Overall Study|Withdrawal by Subject|9
7600061|NCT03448939|12006144|FG001|Overall Study|Withdrawal by Subject|3
7600062|NCT03283371|12006161|FG000|Placebo-controlled|Adverse Event|1
7600063|NCT03283371|12006162|FG001|Placebo-controlled|Adverse Event|1
7600064|NCT03283371|12006163|FG002|Placebo-controlled|Adverse Event|0
7600065|NCT03283371|12006164|FG003|Placebo-controlled|Adverse Event|0
7600066|NCT03283371|12006161|FG000|Placebo-controlled|Lack of Efficacy|1
7600067|NCT03283371|12006162|FG001|Placebo-controlled|Lack of Efficacy|0
7600068|NCT03283371|12006163|FG002|Placebo-controlled|Lack of Efficacy|0
7600069|NCT03283371|12006164|FG003|Placebo-controlled|Lack of Efficacy|0
7600070|NCT03283371|12006161|FG000|Placebo-controlled|Withdrawal by Subject|1
7600071|NCT03283371|12006162|FG001|Placebo-controlled|Withdrawal by Subject|1
7600072|NCT03283371|12006163|FG002|Placebo-controlled|Withdrawal by Subject|0
7600073|NCT03283371|12006164|FG003|Placebo-controlled|Withdrawal by Subject|0
7600074|NCT03283371|12006161|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0
7600075|NCT03283371|12006162|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1
7600076|NCT03283371|12006163|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0
7600077|NCT03283371|12006164|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0
7772551|NCT00891228|12217294|FG001|Overall Study|Physician Decision|1
7600078|NCT03283371|12006161|FG000|Open-label Phase|Adverse Event|0
7600079|NCT03283371|12006162|FG001|Open-label Phase|Adverse Event|0
7600080|NCT03283371|12006163|FG002|Open-label Phase|Adverse Event|2
7600081|NCT03283371|12006164|FG003|Open-label Phase|Adverse Event|0
7600082|NCT03283371|12006161|FG000|Open-label Phase|Withdrawal by Subject|0
7600083|NCT03283371|12006162|FG001|Open-label Phase|Withdrawal by Subject|0
7600084|NCT03283371|12006163|FG002|Open-label Phase|Withdrawal by Subject|1
7600085|NCT03283371|12006164|FG003|Open-label Phase|Withdrawal by Subject|0
7600086|NCT03283371|12006161|FG000|Open-label Phase|Other|0
7600087|NCT03283371|12006162|FG001|Open-label Phase|Other|0
7772552|NCT00891228|12217295|FG002|Overall Study|Physician Decision|0
7772553|NCT00891228|12217293|FG000|Overall Study|Lost to Follow-up|4
7772554|NCT00891228|12217294|FG001|Overall Study|Lost to Follow-up|4
7772555|NCT00891228|12217295|FG002|Overall Study|Lost to Follow-up|5
7772556|NCT00891228|12217293|FG000|Overall Study|Pregnancy|0
7772557|NCT00891228|12217294|FG001|Overall Study|Pregnancy|1
7772558|NCT00891228|12217295|FG002|Overall Study|Pregnancy|0
7772559|NCT00891293|12217303|FG000|Overall Study|Adverse Event|2
7772560|NCT00891293|12217303|FG000|Overall Study|Protocol Violation|2
7772561|NCT00891293|12217303|FG000|Overall Study|Laboratory abnormality|4
7772562|NCT00891293|12217303|FG000|Overall Study|Lost to Follow-up|7
7772563|NCT00891293|12217303|FG000|Overall Study|Subject withdrew consent|7
7772564|NCT00891293|12217303|FG000|Overall Study|Sponsor termination|62
7772565|NCT00891371|12217316|FG000|Pre-assignment|Inclusion/exclusion|5
7772566|NCT00891371|12217316|FG000|Pre-assignment|Consent withdrawal|1
7772567|NCT00891371|12217316|FG000|Treatment|Lack of Efficacy|5
7772568|NCT00891371|12217316|FG000|Treatment|Adverse Event|2
7772569|NCT00891371|12217316|FG000|Treatment|Death|1
7772570|NCT00891371|12217316|FG000|Treatment|Lost to Follow-up|1
7772571|NCT00891462|12217332|FG000|Overall Study|Withdrawal by Subject|9
7772572|NCT00891462|12217333|FG001|Overall Study|Withdrawal by Subject|6
7772573|NCT00891462|12217334|FG002|Overall Study|Withdrawal by Subject|7
7772574|NCT00891462|12217332|FG000|Overall Study|Adverse Event|7
7772575|NCT00891462|12217333|FG001|Overall Study|Adverse Event|8
7772576|NCT00891462|12217334|FG002|Overall Study|Adverse Event|7
7772577|NCT00891462|12217332|FG000|Overall Study|Lack of Efficacy|10
7772578|NCT00891462|12217333|FG001|Overall Study|Lack of Efficacy|5
7772579|NCT00891462|12217334|FG002|Overall Study|Lack of Efficacy|1
7772580|NCT00891462|12217332|FG000|Overall Study|COPD exacerbation|7
7772581|NCT00891462|12217333|FG001|Overall Study|COPD exacerbation|4
7772582|NCT00891462|12217334|FG002|Overall Study|COPD exacerbation|1
7600088|NCT03283371|12006163|FG002|Open-label Phase|Other|1
7600089|NCT03283371|12006164|FG003|Open-label Phase|Other|1
7600090|NCT03257254|12006174|FG000|Overall Study|Withdrawal by Subject|7
7600091|NCT03257254|12006174|FG000|Overall Study|Lost to Follow-up|9
7600092|NCT03257254|12006174|FG000|Overall Study|Study discontinued by sponsor|5
7600093|NCT03084718|12006183|FG000|Overall Study|Withdrawal by Subject|4
7600094|NCT03084718|12006184|FG001|Overall Study|Withdrawal by Subject|3
7600095|NCT03084718|12006185|FG002|Overall Study|Withdrawal by Subject|4
7600096|NCT03084718|12006186|FG003|Overall Study|Withdrawal by Subject|0
7600097|NCT03084718|12006187|FG004|Overall Study|Withdrawal by Subject|0
7600098|NCT03084718|12006183|FG000|Overall Study|Physician Decision|1
7600099|NCT03084718|12006184|FG001|Overall Study|Physician Decision|0
7600100|NCT03084718|12006185|FG002|Overall Study|Physician Decision|0
7600101|NCT03084718|12006186|FG003|Overall Study|Physician Decision|0
7600102|NCT03084718|12006187|FG004|Overall Study|Physician Decision|0
7600103|NCT03084718|12006183|FG000|Overall Study|Adverse Event|3
7600104|NCT03084718|12006184|FG001|Overall Study|Adverse Event|5
7600105|NCT03084718|12006185|FG002|Overall Study|Adverse Event|5
7600106|NCT03084718|12006186|FG003|Overall Study|Adverse Event|8
7600107|NCT03084718|12006187|FG004|Overall Study|Adverse Event|2
7600108|NCT03084718|12006183|FG000|Overall Study|Lack of Efficacy|2
7600109|NCT03084718|12006184|FG001|Overall Study|Lack of Efficacy|0
7600110|NCT03084718|12006185|FG002|Overall Study|Lack of Efficacy|1
7600111|NCT03084718|12006186|FG003|Overall Study|Lack of Efficacy|4
7600112|NCT03084718|12006187|FG004|Overall Study|Lack of Efficacy|0
7600113|NCT03084718|12006183|FG000|Overall Study|Lost to Follow-up|0
7600114|NCT03084718|12006184|FG001|Overall Study|Lost to Follow-up|1
7600115|NCT03084718|12006185|FG002|Overall Study|Lost to Follow-up|0
7600116|NCT03084718|12006186|FG003|Overall Study|Lost to Follow-up|0
7600117|NCT03084718|12006187|FG004|Overall Study|Lost to Follow-up|2
7600118|NCT03084718|12006183|FG000|Overall Study|Protocol Violation|0
7600119|NCT03084718|12006184|FG001|Overall Study|Protocol Violation|0
7600120|NCT03084718|12006185|FG002|Overall Study|Protocol Violation|1
7600121|NCT03084718|12006186|FG003|Overall Study|Protocol Violation|0
7600122|NCT03084718|12006187|FG004|Overall Study|Protocol Violation|0
7600123|NCT03084718|12006183|FG000|Overall Study|Death|0
7600124|NCT03084718|12006184|FG001|Overall Study|Death|1
7600125|NCT03084718|12006185|FG002|Overall Study|Death|0
7600126|NCT03084718|12006186|FG003|Overall Study|Death|0
7600127|NCT03084718|12006187|FG004|Overall Study|Death|0
7600128|NCT03084718|12006183|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1
7600129|NCT03084718|12006184|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0
7600130|NCT03084718|12006185|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1
7600131|NCT03084718|12006186|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2
7600132|NCT03084718|12006187|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0
7600133|NCT03069417|12006204|FG000|Overall Study|Lost to Follow-up|2
7600134|NCT03069417|12006205|FG001|Overall Study|Lost to Follow-up|0
7600135|NCT03069417|12006204|FG000|Overall Study|Reason Unknown|4
7600136|NCT03069417|12006205|FG001|Overall Study|Reason Unknown|7
7600137|NCT02936323|12006234|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7600138|NCT02936323|12006235|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
7600139|NCT02936323|12006236|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7600140|NCT02936323|12006237|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
7600141|NCT02936323|12006238|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
7600142|NCT02936323|12006239|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
7600143|NCT02936323|12006240|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7600144|NCT02936323|12006241|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7600145|NCT02936323|12006242|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7600146|NCT02936323|12006243|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7600147|NCT02936323|12006234|FG000|Phase 1 Dose Escalation|Death|2
7600148|NCT02936323|12006235|FG001|Phase 1 Dose Escalation|Death|1
7600149|NCT02936323|12006236|FG002|Phase 1 Dose Escalation|Death|3
7600150|NCT02936323|12006237|FG003|Phase 1 Dose Escalation|Death|1
7600151|NCT02936323|12006238|FG004|Phase 1 Dose Escalation|Death|2
7600152|NCT02936323|12006239|FG005|Phase 1 Dose Escalation|Death|3
7600153|NCT02936323|12006240|FG006|Phase 1 Dose Escalation|Death|3
7600154|NCT02936323|12006241|FG007|Phase 1 Dose Escalation|Death|0
7600155|NCT02936323|12006242|FG008|Phase 1 Dose Escalation|Death|0
7600156|NCT02936323|12006243|FG009|Phase 1 Dose Escalation|Death|0
7600157|NCT02936323|12006234|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600158|NCT02936323|12006235|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600159|NCT02936323|12006236|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600160|NCT02936323|12006237|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600161|NCT02936323|12006238|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600162|NCT02936323|12006239|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1
7600163|NCT02936323|12006240|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600164|NCT02936323|12006241|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600165|NCT02936323|12006242|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600166|NCT02936323|12006243|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600167|NCT02936323|12006234|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7600168|NCT02936323|12006235|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7600169|NCT02936323|12006236|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7600170|NCT02936323|12006237|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7600171|NCT02936323|12006238|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7600172|NCT02936323|12006239|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7600173|NCT02936323|12006240|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7600174|NCT02936323|12006241|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11
7600175|NCT02936323|12006242|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4
7600176|NCT02936323|12006243|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2
7600177|NCT02936323|12006234|FG000|Phase 2a Dose Expansion|Physician Decision|0
7600178|NCT02936323|12006235|FG001|Phase 2a Dose Expansion|Physician Decision|0
7600179|NCT02936323|12006236|FG002|Phase 2a Dose Expansion|Physician Decision|0
7600180|NCT02936323|12006237|FG003|Phase 2a Dose Expansion|Physician Decision|0
7600181|NCT02936323|12006238|FG004|Phase 2a Dose Expansion|Physician Decision|0
7600182|NCT02936323|12006239|FG005|Phase 2a Dose Expansion|Physician Decision|0
7600183|NCT02936323|12006240|FG006|Phase 2a Dose Expansion|Physician Decision|0
7600184|NCT02936323|12006241|FG007|Phase 2a Dose Expansion|Physician Decision|0
7600185|NCT02936323|12006242|FG008|Phase 2a Dose Expansion|Physician Decision|0
7600186|NCT02936323|12006243|FG009|Phase 2a Dose Expansion|Physician Decision|1
7600187|NCT02936323|12006234|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0
7600188|NCT02936323|12006235|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0
7600189|NCT02936323|12006236|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0
7600190|NCT02936323|12006237|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0
7600191|NCT02936323|12006238|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0
7600192|NCT02936323|12006239|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0
7600193|NCT02936323|12006240|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0
7600194|NCT02936323|12006241|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2
7600195|NCT02936323|12006242|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1
7600196|NCT02936323|12006243|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0
7600197|NCT02936323|12006234|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600198|NCT02936323|12006235|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600199|NCT02936323|12006236|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600200|NCT02936323|12006237|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600201|NCT02936323|12006238|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600202|NCT02936323|12006239|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600203|NCT02936323|12006240|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600204|NCT02936323|12006241|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600205|NCT02936323|12006242|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600206|NCT02936323|12006243|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1
7600207|NCT02936323|12006234|FG000|Phase 2a Dose Expansion|Death|0
7600208|NCT02936323|12006235|FG001|Phase 2a Dose Expansion|Death|0
7600209|NCT02936323|12006236|FG002|Phase 2a Dose Expansion|Death|0
7600210|NCT02936323|12006237|FG003|Phase 2a Dose Expansion|Death|0
7600211|NCT02936323|12006238|FG004|Phase 2a Dose Expansion|Death|0
7600212|NCT02936323|12006239|FG005|Phase 2a Dose Expansion|Death|0
7600213|NCT02936323|12006240|FG006|Phase 2a Dose Expansion|Death|0
7600214|NCT02936323|12006241|FG007|Phase 2a Dose Expansion|Death|4
7600215|NCT02936323|12006242|FG008|Phase 2a Dose Expansion|Death|8
7600216|NCT02936323|12006243|FG009|Phase 2a Dose Expansion|Death|10
7772583|NCT00891462|12217332|FG000|Overall Study|Other Reason|2
7772584|NCT00891462|12217333|FG001|Overall Study|Other Reason|5
7772585|NCT00891462|12217334|FG002|Overall Study|Other Reason|3
7772586|NCT00891462|12217332|FG000|Overall Study|Protocol Violation|2
7772587|NCT00891462|12217333|FG001|Overall Study|Protocol Violation|1
7772588|NCT00891462|12217334|FG002|Overall Study|Protocol Violation|3
7772589|NCT00891462|12217332|FG000|Overall Study|Inclusion/exclusion criteria|0
7772590|NCT00891462|12217333|FG001|Overall Study|Inclusion/exclusion criteria|2
7772591|NCT00891462|12217334|FG002|Overall Study|Inclusion/exclusion criteria|2
7772592|NCT00891462|12217332|FG000|Overall Study|Lost to Follow-up|0
7772593|NCT00891462|12217333|FG001|Overall Study|Lost to Follow-up|2
7772594|NCT00891462|12217334|FG002|Overall Study|Lost to Follow-up|0
7772595|NCT00891527|12217344|FG000|Overall Study|Withdrawal by Subject|2
7600231|NCT02429791|12006295|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6
7600232|NCT02429791|12006296|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2
7600233|NCT02429791|12006295|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0
7600234|NCT02429791|12006296|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2
7600235|NCT02429791|12006295|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
7600236|NCT02429791|12006296|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
7600237|NCT02429791|12006295|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
7600238|NCT02429791|12006296|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2
7600239|NCT02429791|12006295|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1
7600240|NCT02429791|12006296|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4
7600241|NCT02429791|12006295|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3
7600242|NCT02429791|12006296|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
7600243|NCT02429791|12006295|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11
7600244|NCT02429791|12006296|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12
7600245|NCT02429791|12006295|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
7600246|NCT02429791|12006296|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4
7600247|NCT02429791|12006295|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4
7600248|NCT02429791|12006296|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
7600249|NCT02429791|12006295|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0
7600250|NCT02429791|12006296|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1
7600251|NCT02429791|12006295|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
7600252|NCT02429791|12006296|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
7600253|NCT02429791|12006295|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7
7600254|NCT02429791|12006296|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5
7600255|NCT02422797|12006311|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11
7600256|NCT02422797|12006312|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1
7600257|NCT02422797|12006311|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0
7600258|NCT02422797|12006312|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1
7600259|NCT02422797|12006311|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
7600260|NCT02422797|12006312|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
7600261|NCT02422797|12006311|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
7600262|NCT02422797|12006312|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
7600263|NCT02422797|12006311|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0
7600264|NCT02422797|12006312|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3
7600265|NCT02422797|12006311|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
7600266|NCT02422797|12006312|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
7600267|NCT02422797|12006311|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2
7600268|NCT02422797|12006312|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
7600269|NCT02422797|12006311|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
7600270|NCT02422797|12006312|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1
7600271|NCT02422797|12006311|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10
7600272|NCT02422797|12006312|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6
7600273|NCT02422797|12006311|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5
7600274|NCT02422797|12006312|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
7600275|NCT02422797|12006311|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
7600276|NCT02422797|12006312|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
7600277|NCT02422797|12006311|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2
7600278|NCT02422797|12006312|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6
7600279|NCT02422797|12006311|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1
7600280|NCT02422797|12006312|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0
7600281|NCT02422797|12006311|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
7600282|NCT02422797|12006312|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0
7600283|NCT02132611|12006341|FG000|Overall Study|Death|2
7600284|NCT01147822|12006347|FG000|Overall Study|Death|66
7600285|NCT01147822|12006348|FG001|Overall Study|Death|59
7600286|NCT01147822|12006347|FG000|Overall Study|Protocol Violation|0
7600287|NCT01147822|12006348|FG001|Overall Study|Protocol Violation|1
7600288|NCT01147822|12006347|FG000|Overall Study|Lost to Follow-up|3
7600289|NCT01147822|12006348|FG001|Overall Study|Lost to Follow-up|2
7600290|NCT01147822|12006347|FG000|Overall Study|Physician Decision|0
7600291|NCT01147822|12006348|FG001|Overall Study|Physician Decision|2
7600292|NCT01147822|12006347|FG000|Overall Study|Withdrawal by Subject|8
7600293|NCT01147822|12006348|FG001|Overall Study|Withdrawal by Subject|13
7600294|NCT01147822|12006347|FG000|Overall Study|Not Completed/Ongoing|111
7600295|NCT01147822|12006348|FG001|Overall Study|Not Completed/Ongoing|102
7772596|NCT00891618|12217349|FG000|Overall Study|Withdrawal by Subject|1
7772597|NCT00891657|12217355|FG000|Overall Study|Withdrawal by Subject|1
7772598|NCT00891657|12217356|FG001|Overall Study|Withdrawal by Subject|1
7772599|NCT00891735|12217366|FG000|Overall Study|Adverse Event|2
7772600|NCT00891735|12217367|FG001|Overall Study|Adverse Event|0
7772601|NCT00891735|12217368|FG002|Overall Study|Adverse Event|2
7772602|NCT00891735|12217369|FG003|Overall Study|Adverse Event|0
7772603|NCT00891735|12217366|FG000|Overall Study|Death|8
7772604|NCT00891735|12217367|FG001|Overall Study|Death|5
7772605|NCT00891735|12217368|FG002|Overall Study|Death|4
7772606|NCT00891735|12217369|FG003|Overall Study|Death|5
7772607|NCT00891735|12217366|FG000|Overall Study|Lost to Follow-up|2
7772608|NCT00891735|12217367|FG001|Overall Study|Lost to Follow-up|2
7772609|NCT00891735|12217368|FG002|Overall Study|Lost to Follow-up|2
7772610|NCT00891735|12217369|FG003|Overall Study|Lost to Follow-up|2
7772611|NCT00891735|12217366|FG000|Overall Study|Physician's decision to withdraw patient|1
7772612|NCT00891735|12217367|FG001|Overall Study|Physician's decision to withdraw patient|0
7772613|NCT00891735|12217368|FG002|Overall Study|Physician's decision to withdraw patient|0
7772614|NCT00891735|12217369|FG003|Overall Study|Physician's decision to withdraw patient|0
7772615|NCT00891735|12217366|FG000|Overall Study|Patient's decision to withdraw|4
7772616|NCT00891735|12217367|FG001|Overall Study|Patient's decision to withdraw|9
7772617|NCT00891735|12217368|FG002|Overall Study|Patient's decision to withdraw|4
7772618|NCT00891735|12217369|FG003|Overall Study|Patient's decision to withdraw|8
7799966|NCT01090427|12257136|FG000|After Controlled Period|Adverse Event|0
7799967|NCT01090427|12257137|FG001|After Controlled Period|Adverse Event|0
7799968|NCT01090427|12257138|FG002|After Controlled Period|Adverse Event|0
7799969|NCT01090427|12257139|FG003|After Controlled Period|Adverse Event|2
7799970|NCT01090427|12257140|FG004|After Controlled Period|Adverse Event|0
7799971|NCT01090427|12257141|FG005|After Controlled Period|Adverse Event|1
7799972|NCT01090427|12257142|FG006|After Controlled Period|Adverse Event|0
7799973|NCT01090453|12257156|FG000|Overall Study|Withdrawal by Subject|1
7799974|NCT01090453|12257157|FG001|Overall Study|Withdrawal by Subject|2
7799975|NCT01090453|12257156|FG000|Overall Study|Lost to Follow-up|7
7799976|NCT01090453|12257157|FG001|Overall Study|Lost to Follow-up|7
7600296|NCT04476251|12006369|FG000|Overall Study|Not treated|1
7600297|NCT03915860|12006377|FG000|Overall Study|Adverse Event|3
7600298|NCT03915860|12006377|FG000|Overall Study|Withdrawal by Subject|6
7600299|NCT03915860|12006377|FG000|Overall Study|Lost to Follow-up|2
7600300|NCT03915860|12006377|FG000|Overall Study|Other than specified|3
7600301|NCT03795233|12006396|FG000|Overall Study|Withdrawal by Subject|2
7600302|NCT03795233|12006397|FG001|Overall Study|Withdrawal by Subject|1
7600303|NCT03795233|12006396|FG000|Overall Study|Lost to Follow-up|1
7600304|NCT03795233|12006397|FG001|Overall Study|Lost to Follow-up|0
7600305|NCT03795233|12006396|FG000|Overall Study|Death|1
7600306|NCT03795233|12006397|FG001|Overall Study|Death|0
7600307|NCT03786380|12006408|FG000|Overall Study|Adverse Event|1
7600308|NCT03786380|12006409|FG001|Overall Study|Adverse Event|0
7600309|NCT03786380|12006410|FG002|Overall Study|Adverse Event|0
7600310|NCT03786380|12006411|FG003|Overall Study|Adverse Event|3
7600311|NCT03786380|12006412|FG004|Overall Study|Adverse Event|1
7600312|NCT03786380|12006408|FG000|Overall Study|Lack of Efficacy|0
7600313|NCT03786380|12006409|FG001|Overall Study|Lack of Efficacy|0
7600314|NCT03786380|12006410|FG002|Overall Study|Lack of Efficacy|0
7600315|NCT03786380|12006411|FG003|Overall Study|Lack of Efficacy|0
7600316|NCT03786380|12006412|FG004|Overall Study|Lack of Efficacy|1
7600317|NCT03786380|12006408|FG000|Overall Study|Withdrawal by Subject|1
7600318|NCT03786380|12006409|FG001|Overall Study|Withdrawal by Subject|2
7600319|NCT03786380|12006410|FG002|Overall Study|Withdrawal by Subject|2
7600320|NCT03786380|12006411|FG003|Overall Study|Withdrawal by Subject|1
7600321|NCT03786380|12006412|FG004|Overall Study|Withdrawal by Subject|2
7600322|NCT03786380|12006408|FG000|Overall Study|Lost to Follow-up|3
7600323|NCT03786380|12006409|FG001|Overall Study|Lost to Follow-up|0
7600324|NCT03786380|12006410|FG002|Overall Study|Lost to Follow-up|1
7600325|NCT03786380|12006411|FG003|Overall Study|Lost to Follow-up|2
7600326|NCT03786380|12006412|FG004|Overall Study|Lost to Follow-up|0
7600327|NCT03786380|12006408|FG000|Overall Study|Physician Decision|0
7600328|NCT03786380|12006409|FG001|Overall Study|Physician Decision|0
7600329|NCT03786380|12006410|FG002|Overall Study|Physician Decision|1
7600330|NCT03786380|12006411|FG003|Overall Study|Physician Decision|0
7600331|NCT03786380|12006412|FG004|Overall Study|Physician Decision|0
7600332|NCT03786380|12006408|FG000|Overall Study|Study Terminated by the Sponsor|30
7600333|NCT03786380|12006409|FG001|Overall Study|Study Terminated by the Sponsor|20
7600334|NCT03786380|12006410|FG002|Overall Study|Study Terminated by the Sponsor|50
7600335|NCT03786380|12006411|FG003|Overall Study|Study Terminated by the Sponsor|57
7600336|NCT03786380|12006412|FG004|Overall Study|Study Terminated by the Sponsor|23
7600337|NCT03786380|12006408|FG000|Overall Study|Reason Not Specified|0
7600338|NCT03786380|12006409|FG001|Overall Study|Reason Not Specified|0
7600339|NCT03786380|12006410|FG002|Overall Study|Reason Not Specified|0
7600340|NCT03786380|12006411|FG003|Overall Study|Reason Not Specified|0
7600341|NCT03786380|12006412|FG004|Overall Study|Reason Not Specified|1
7799977|NCT01090453|12257156|FG000|Overall Study|Non serious AEs|1
7799978|NCT01090453|12257157|FG001|Overall Study|Non serious AEs|0
7799979|NCT01090453|12257156|FG000|Overall Study|Protocol Violation|2
7600342|NCT03645863|12006436|FG000|Overall Study|Withdrawal by Subject|1
7600343|NCT03645863|12006437|FG001|Overall Study|Withdrawal by Subject|0
7600344|NCT03645863|12006438|FG002|Overall Study|Withdrawal by Subject|0
7600345|NCT03564145|12006446|FG000|Overall Study|Adverse Event|4
7600346|NCT03564145|12006446|FG000|Overall Study|Lost to Follow-up|21
7600347|NCT03564145|12006446|FG000|Overall Study|Protocol Violation|2
7600348|NCT03564145|12006446|FG000|Overall Study|Withdrawal by Subject|48
7600349|NCT03564145|12006446|FG000|Overall Study|Study Terminated by Sponsor|146
7600350|NCT03564145|12006446|FG000|Overall Study|Physician Decision|1
7600351|NCT03564145|12006446|FG000|Overall Study|Other Than Specified|1
7600352|NCT03564145|12006446|FG000|Overall Study|Pregnancy|1
7600353|NCT03564119|12006452|FG000|Overall Study|Adverse Event|4
7600354|NCT03564119|12006453|FG001|Overall Study|Adverse Event|0
7600355|NCT03564119|12006452|FG000|Overall Study|Lost to Follow-up|1
7600356|NCT03564119|12006453|FG001|Overall Study|Lost to Follow-up|4
7600357|NCT03564119|12006452|FG000|Overall Study|Protocol Violation|1
7600358|NCT03564119|12006453|FG001|Overall Study|Protocol Violation|0
7600359|NCT03564119|12006452|FG000|Overall Study|Withdrawal by Subject|9
7600360|NCT03564119|12006453|FG001|Overall Study|Withdrawal by Subject|4
7600361|NCT03564119|12006452|FG000|Overall Study|Other Than Specified|0
7600362|NCT03564119|12006453|FG001|Overall Study|Other Than Specified|1
7600363|NCT03181529|12006508|FG000|Overall Study|Withdrawal by Subject|1
7600364|NCT03181529|12006509|FG001|Overall Study|Withdrawal by Subject|1
7600365|NCT03181529|12006508|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1
7600366|NCT03181529|12006509|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0
7772619|NCT00891774|12217379|FG000|Overall Study|Lost to Follow-up|5
7772620|NCT00891774|12217379|FG000|Overall Study|Illness (Self/Mother)|3
7772621|NCT00891774|12217379|FG000|Overall Study|Withdrawal by Subject|2
7772622|NCT00891774|12217379|FG000|Overall Study|Protocol Violation|4
7772623|NCT00891813|12217383|FG000|Overall Study|Adverse Event|3
7772624|NCT00891813|12217383|FG000|Overall Study|Withdrawal by Subject|1
7772625|NCT00891813|12217383|FG000|Overall Study|Patient Noncompliance|6
7600374|NCT02779556|12006521|FG000|Baseline|Partial baseline interview completed|1
7600375|NCT02779556|12006522|FG001|Baseline|Partial baseline interview completed|0
7600376|NCT02779556|12006521|FG000|3 Months|Lost to Follow-up|40
7600377|NCT02779556|12006522|FG001|3 Months|Lost to Follow-up|29
7600378|NCT02779556|12006521|FG000|3 Months|Missed 3 month clinic visit|27
7600379|NCT02779556|12006522|FG001|3 Months|Missed 3 month clinic visit|19
7600380|NCT02779556|12006521|FG000|6 Month|Lost to Follow-up|33
7600381|NCT02779556|12006522|FG001|6 Month|Lost to Follow-up|39
7600382|NCT02779556|12006521|FG000|6 Month HbA1c|No value collected during window|69
7600383|NCT02779556|12006522|FG001|6 Month HbA1c|No value collected during window|50
7772626|NCT00891813|12217383|FG000|Overall Study|Protocol Violation|2
7772627|NCT00891839|12217387|FG000|Overall Study|Adverse Event|2
7772628|NCT00891839|12217387|FG000|Overall Study|Withdrawal by Subject|2
7772629|NCT00891839|12217387|FG000|Overall Study|Disease progression|3
7772630|NCT00891930|12217400|FG000|Part 1: Panitumumab +Irinotecan|Death|38
7772631|NCT00891930|12217400|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
7772632|NCT00891930|12217400|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
7772633|NCT00891930|12217400|FG000|Part 2: Panitumumab + Ganitumab|Death|30
7772634|NCT00891930|12217400|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
7600384|NCT02779556|12006521|FG000|12 Month HbA1c|No value collected during window|138
7600385|NCT02779556|12006522|FG001|12 Month HbA1c|No value collected during window|102
7600386|NCT02675751|12006537|FG000|Overall Study|Lost to Follow-up|16
7600387|NCT02621424|12006552|FG000|Overall Study|Withdrawal by Subject|1
7600388|NCT02621424|12006553|FG001|Overall Study|Withdrawal by Subject|2
7772635|NCT00892008|12217426|FG000|Overall Study|Death|5
7772636|NCT00892008|12217426|FG000|Overall Study|Lack of Efficacy|3
7772637|NCT00892008|12217426|FG000|Overall Study|Lost to Follow-up|142
7772638|NCT00892008|12217426|FG000|Overall Study|Other|378
7772639|NCT00892008|12217426|FG000|Overall Study|Adverse Event|37
7600389|NCT02595372|12006559|FG000|Overall Study|Adverse Event|6
7600390|NCT02595372|12006559|FG000|Overall Study|Physician Decision|2
7600391|NCT02595372|12006559|FG000|Overall Study|Disease Progression|1
7600392|NCT02334722|12006565|FG000|Overall Study|Lost to Follow-up|4
7600393|NCT02334722|12006566|FG001|Overall Study|Lost to Follow-up|0
7600394|NCT02334722|12006565|FG000|Overall Study|6 week questionnaire not completed|2
7600395|NCT02334722|12006566|FG001|Overall Study|6 week questionnaire not completed|0
7600396|NCT02334722|12006565|FG000|Overall Study|Unable to obtain medication|1
7600397|NCT02334722|12006566|FG001|Overall Study|Unable to obtain medication|1
7600398|NCT02334722|12006565|FG000|Overall Study|Withdrawal by Subject|0
7600399|NCT02334722|12006566|FG001|Overall Study|Withdrawal by Subject|3
7600400|NCT02334722|12006565|FG000|Overall Study|Adverse Event|0
7600401|NCT02334722|12006566|FG001|Overall Study|Adverse Event|2
7600402|NCT02334722|12006565|FG000|Overall Study|Physician Decision|0
7600403|NCT02334722|12006566|FG001|Overall Study|Physician Decision|1
7600404|NCT01966731|12006576|FG000|Overall Study|Death|2
7600405|NCT01966731|12006576|FG000|Overall Study|Lost to Follow-up|1
7600406|NCT01966731|12006576|FG000|Overall Study|Physician Decision|2
7600407|NCT01966731|12006576|FG000|Overall Study|Follow up is not complete|600
7600408|NCT01966731|12006576|FG000|Overall Study|Screening Failure|29
7772640|NCT00892047|12217432|FG000|Overall Study|Adverse Event|2
7772641|NCT00892047|12217433|FG001|Overall Study|Adverse Event|2
7600409|NCT01966731|12006576|FG000|Overall Study|Found to be ineligible|1
7772642|NCT00892047|12217432|FG000|Overall Study|subject burden|2
7772643|NCT00892047|12217433|FG001|Overall Study|subject burden|3
7772644|NCT00892047|12217432|FG000|Overall Study|Lack of Efficacy|0
7772645|NCT00892047|12217433|FG001|Overall Study|Lack of Efficacy|2
7772646|NCT00892099|12217444|FG000|Overall Study|Death|1
7772647|NCT00892099|12217445|FG001|Overall Study|Death|0
7772648|NCT00892099|12217446|FG002|Overall Study|Death|1
7772649|NCT00892099|12217444|FG000|Overall Study|Adverse Event|1
7772650|NCT00892099|12217445|FG001|Overall Study|Adverse Event|0
7772651|NCT00892099|12217446|FG002|Overall Study|Adverse Event|0
7772652|NCT00892099|12217444|FG000|Overall Study|replocated|1
7772653|NCT00892099|12217445|FG001|Overall Study|replocated|0
7772654|NCT00892099|12217446|FG002|Overall Study|replocated|2
7772655|NCT00892099|12217444|FG000|Overall Study|Prolonged hospitalization|1
7600424|NCT01675479|12006610|FG000|Overall Study|Lost to Follow-up|11
7600425|NCT00812708|12006614|FG000|Overall Study|Device could not be implanted|2
7600426|NCT00812708|12006614|FG000|Overall Study|Lack of medical insurance|1
7600427|NCT00812708|12006614|FG000|Overall Study|Switched to another study|1
7600428|NCT00812708|12006614|FG000|Overall Study|Surgery cancelled due to uveitis|1
7600429|NCT00812708|12006614|FG000|Overall Study|Signed consent but later withdrew|3
7600430|NCT00741988|12006621|FG000|Overall Study|Adverse Event|2
7600431|NCT00741988|12006622|FG001|Overall Study|Adverse Event|4
7600432|NCT00741988|12006621|FG000|Overall Study|Lack of Efficacy|2
7600433|NCT00741988|12006622|FG001|Overall Study|Lack of Efficacy|0
7600434|NCT00515671|12006639|FG000|Overall Study|Lost to Follow-up|13
7600435|NCT00515671|12006640|FG001|Overall Study|Lost to Follow-up|10
7600436|NCT00515671|12006639|FG000|Overall Study|Withdrawal by Subject|3
7600437|NCT00515671|12006640|FG001|Overall Study|Withdrawal by Subject|5
7600438|NCT00515671|12006639|FG000|Overall Study|incarcerated|1
7600439|NCT00515671|12006640|FG001|Overall Study|incarcerated|2
7600440|NCT00455403|12006648|FG000|Overall Study|Lost to Follow-up|2
7772656|NCT00892099|12217445|FG001|Overall Study|Prolonged hospitalization|0
7772657|NCT00892099|12217446|FG002|Overall Study|Prolonged hospitalization|1
7772658|NCT00892099|12217444|FG000|Overall Study|no further details|1
7772659|NCT00892099|12217445|FG001|Overall Study|no further details|0
7772660|NCT00892099|12217446|FG002|Overall Study|no further details|1
7772661|NCT00892099|12217444|FG000|Overall Study|kidney function recovered|0
7772662|NCT00892099|12217445|FG001|Overall Study|kidney function recovered|1
7772663|NCT00892099|12217446|FG002|Overall Study|kidney function recovered|0
7772664|NCT00892099|12217444|FG000|Overall Study|investigator decision|0
7772665|NCT00892099|12217445|FG001|Overall Study|investigator decision|0
7772666|NCT00892099|12217446|FG002|Overall Study|investigator decision|1
7772667|NCT00892099|12217444|FG000|Overall Study|Lost to Follow-up|0
7772668|NCT00892099|12217445|FG001|Overall Study|Lost to Follow-up|0
7772669|NCT00892099|12217446|FG002|Overall Study|Lost to Follow-up|1
7772670|NCT00892151|12217454|FG000|Overall Study|Protocol Violation|1
7772671|NCT00892177|12217461|FG000|Phase II|Ineligible|0
7772672|NCT00892177|12217462|FG001|Phase II|Ineligible|0
7772673|NCT00892177|12217463|FG002|Phase II|Ineligible|0
7772674|NCT00892177|12217464|FG003|Phase II|Ineligible|0
7772675|NCT00892177|12217465|FG004|Phase II|Ineligible|1
7772676|NCT00892177|12217466|FG005|Phase II|Ineligible|1
7772677|NCT00892177|12217461|FG000|Phase II|Withdrawal by Subject|0
7600441|NCT00455403|12006649|FG001|Overall Study|Lost to Follow-up|1
7600442|NCT00455403|12006648|FG000|Overall Study|Withdrawal by Subject|1
7600443|NCT00455403|12006649|FG001|Overall Study|Withdrawal by Subject|3
7600444|NCT00455403|12006648|FG000|Overall Study|Protocol Violation|0
7600445|NCT00455403|12006649|FG001|Overall Study|Protocol Violation|2
7600448|NCT04128319|12006673|FG000|Overall Study|Death|3
7600449|NCT03761810|12006679|FG000|Overall Study|Adverse Event|12
7600450|NCT03761810|12006680|FG001|Overall Study|Adverse Event|0
7600451|NCT03761810|12006679|FG000|Overall Study|Lost to Follow-up|15
7600452|NCT03761810|12006680|FG001|Overall Study|Lost to Follow-up|7
7600453|NCT03761810|12006679|FG000|Overall Study|Pregnancy|1
7600454|NCT03761810|12006680|FG001|Overall Study|Pregnancy|0
7600455|NCT03761810|12006679|FG000|Overall Study|Withdrawal by Subject|14
7600456|NCT03761810|12006680|FG001|Overall Study|Withdrawal by Subject|5
7600457|NCT03761810|12006679|FG000|Overall Study|Physician Decision|1
7600458|NCT03761810|12006680|FG001|Overall Study|Physician Decision|0
7600459|NCT03761810|12006679|FG000|Overall Study|Withdrawal by Parent/Guardian|4
7600460|NCT03761810|12006680|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7600461|NCT03761810|12006679|FG000|Overall Study|Other Than Specified|1
7600462|NCT03761810|12006680|FG001|Overall Study|Other Than Specified|0
7600463|NCT03761784|12006688|FG000|Overall Study|Adverse Event|4
7600464|NCT03761784|12006689|FG001|Overall Study|Adverse Event|0
7600465|NCT03761784|12006688|FG000|Overall Study|Lost to Follow-up|10
7600466|NCT03761784|12006689|FG001|Overall Study|Lost to Follow-up|7
7600467|NCT03761784|12006688|FG000|Overall Study|Pregnancy|1
7600468|NCT03761784|12006689|FG001|Overall Study|Pregnancy|0
7600469|NCT03761784|12006688|FG000|Overall Study|Protocol Violation|2
7600470|NCT03761784|12006689|FG001|Overall Study|Protocol Violation|0
7772678|NCT00892177|12217462|FG001|Phase II|Withdrawal by Subject|0
7772679|NCT00892177|12217463|FG002|Phase II|Withdrawal by Subject|0
7772680|NCT00892177|12217464|FG003|Phase II|Withdrawal by Subject|0
7772681|NCT00892177|12217465|FG004|Phase II|Withdrawal by Subject|4
7772682|NCT00892177|12217466|FG005|Phase II|Withdrawal by Subject|1
7600471|NCT03761784|12006688|FG000|Overall Study|Withdrawal by Parent or Guardian|4
7600472|NCT03761784|12006689|FG001|Overall Study|Withdrawal by Parent or Guardian|1
7600473|NCT03761784|12006688|FG000|Overall Study|Withdrawal by Subject|9
7600474|NCT03761784|12006689|FG001|Overall Study|Withdrawal by Subject|4
7600475|NCT03761784|12006688|FG000|Overall Study|Physician Decision|1
7600476|NCT03761784|12006689|FG001|Overall Study|Physician Decision|0
7600477|NCT03761784|12006688|FG000|Overall Study|Other Than Specified|1
7600478|NCT03761784|12006689|FG001|Overall Study|Other Than Specified|0
7600479|NCT03361865|12006697|FG000|Overall Study|Death|17
7600480|NCT03361865|12006698|FG001|Overall Study|Death|18
7600481|NCT03361865|12006697|FG000|Overall Study|Physician Decision|1
7600482|NCT03361865|12006698|FG001|Overall Study|Physician Decision|9
7600483|NCT03361865|12006697|FG000|Overall Study|Withdrawal by Subject|1
7600484|NCT03361865|12006698|FG001|Overall Study|Withdrawal by Subject|0
7600485|NCT02929056|12006724|FG000|Overall Study|Lost to Follow-up|0
7600486|NCT02929056|12006725|FG001|Overall Study|Lost to Follow-up|1
7600487|NCT02896855|12006733|FG000|Overall Study|Death|50
7600488|NCT02896855|12006734|FG001|Overall Study|Death|40
7600489|NCT02896855|12006733|FG000|Overall Study|Lost to Follow-up|15
7600490|NCT02896855|12006734|FG001|Overall Study|Lost to Follow-up|9
7600491|NCT02896855|12006733|FG000|Overall Study|Withdrawal by Subject|7
7600492|NCT02896855|12006734|FG001|Overall Study|Withdrawal by Subject|4
7600493|NCT02871778|12006747|FG000|Part A: Treatment Period 1|Adverse Event|1
7600494|NCT02871778|12006748|FG001|Part A: Treatment Period 1|Adverse Event|1
7600495|NCT02871778|12006749|FG002|Part A: Treatment Period 1|Adverse Event|1
7600496|NCT02871778|12006750|FG003|Part A: Treatment Period 1|Adverse Event|0
7600497|NCT02871778|12006751|FG004|Part A: Treatment Period 1|Adverse Event|0
7600498|NCT02871778|12006752|FG005|Part A: Treatment Period 1|Adverse Event|0
7600499|NCT02871778|12006753|FG006|Part A: Treatment Period 1|Adverse Event|0
7600500|NCT02871778|12006754|FG007|Part A: Treatment Period 1|Adverse Event|0
7600501|NCT02871778|12006747|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
7600502|NCT02871778|12006748|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
7600503|NCT02871778|12006749|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
7600504|NCT02871778|12006750|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
7600505|NCT02871778|12006751|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
7600506|NCT02871778|12006752|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
7600507|NCT02871778|12006753|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
7600508|NCT02871778|12006754|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
7600509|NCT02871778|12006747|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0
7600510|NCT02871778|12006748|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0
7600511|NCT02871778|12006749|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1
7600512|NCT02871778|12006750|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0
7600513|NCT02871778|12006751|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0
7600514|NCT02871778|12006752|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0
7600515|NCT02871778|12006753|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0
7600516|NCT02871778|12006754|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0
7600517|NCT02871778|12006747|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0
7600518|NCT02871778|12006748|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0
7600519|NCT02871778|12006749|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1
7600520|NCT02871778|12006750|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0
7600521|NCT02871778|12006751|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0
7600522|NCT02871778|12006752|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0
7600523|NCT02871778|12006753|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0
7600524|NCT02871778|12006754|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0
7600525|NCT02871778|12006747|FG000|Part A: Treatment Period 1|Wrong drug shipment|0
7600526|NCT02871778|12006748|FG001|Part A: Treatment Period 1|Wrong drug shipment|1
7600527|NCT02871778|12006749|FG002|Part A: Treatment Period 1|Wrong drug shipment|0
7600528|NCT02871778|12006750|FG003|Part A: Treatment Period 1|Wrong drug shipment|0
7600529|NCT02871778|12006751|FG004|Part A: Treatment Period 1|Wrong drug shipment|0
7600530|NCT02871778|12006752|FG005|Part A: Treatment Period 1|Wrong drug shipment|0
7600531|NCT02871778|12006753|FG006|Part A: Treatment Period 1|Wrong drug shipment|0
7600532|NCT02871778|12006754|FG007|Part A: Treatment Period 1|Wrong drug shipment|0
7600533|NCT02871778|12006747|FG000|Part A: Treatment Period 2|Adverse Event|2
7600534|NCT02871778|12006748|FG001|Part A: Treatment Period 2|Adverse Event|2
7600535|NCT02871778|12006749|FG002|Part A: Treatment Period 2|Adverse Event|0
7600536|NCT02871778|12006750|FG003|Part A: Treatment Period 2|Adverse Event|0
7600537|NCT02871778|12006751|FG004|Part A: Treatment Period 2|Adverse Event|0
7600538|NCT02871778|12006752|FG005|Part A: Treatment Period 2|Adverse Event|0
7600539|NCT02871778|12006753|FG006|Part A: Treatment Period 2|Adverse Event|0
7600540|NCT02871778|12006754|FG007|Part A: Treatment Period 2|Adverse Event|0
7600541|NCT02871778|12006747|FG000|Part A: Treatment Period 2|Lost to Follow-up|0
7600542|NCT02871778|12006748|FG001|Part A: Treatment Period 2|Lost to Follow-up|0
7600543|NCT02871778|12006749|FG002|Part A: Treatment Period 2|Lost to Follow-up|0
7600544|NCT02871778|12006750|FG003|Part A: Treatment Period 2|Lost to Follow-up|1
7600545|NCT02871778|12006751|FG004|Part A: Treatment Period 2|Lost to Follow-up|0
7600546|NCT02871778|12006752|FG005|Part A: Treatment Period 2|Lost to Follow-up|0
7600547|NCT02871778|12006753|FG006|Part A: Treatment Period 2|Lost to Follow-up|0
7600548|NCT02871778|12006754|FG007|Part A: Treatment Period 2|Lost to Follow-up|0
7600549|NCT02871778|12006747|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1
7600550|NCT02871778|12006748|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7600551|NCT02871778|12006749|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1
7600552|NCT02871778|12006750|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7600553|NCT02871778|12006751|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7600554|NCT02871778|12006752|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7600555|NCT02871778|12006753|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7600556|NCT02871778|12006754|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7600557|NCT02871778|12006747|FG000|Part B: Treatment Period 3|Adverse Event|0
7600558|NCT02871778|12006748|FG001|Part B: Treatment Period 3|Adverse Event|0
7600559|NCT02871778|12006749|FG002|Part B: Treatment Period 3|Adverse Event|0
7600560|NCT02871778|12006750|FG003|Part B: Treatment Period 3|Adverse Event|0
7600561|NCT02871778|12006751|FG004|Part B: Treatment Period 3|Adverse Event|1
7600562|NCT02871778|12006752|FG005|Part B: Treatment Period 3|Adverse Event|1
7600563|NCT02871778|12006753|FG006|Part B: Treatment Period 3|Adverse Event|1
7600564|NCT02871778|12006754|FG007|Part B: Treatment Period 3|Adverse Event|0
7600565|NCT02756208|12006787|FG000|Overall Study|Withdrawal by Subject|1
7600566|NCT02756208|12006788|FG001|Overall Study|Withdrawal by Subject|0
7600567|NCT02756208|12006789|FG002|Overall Study|Withdrawal by Subject|1
7600568|NCT02756208|12006790|FG003|Overall Study|Withdrawal by Subject|3
7600569|NCT02756208|12006787|FG000|Overall Study|Lost to Follow-up|3
7600570|NCT02756208|12006788|FG001|Overall Study|Lost to Follow-up|1
7600571|NCT02756208|12006789|FG002|Overall Study|Lost to Follow-up|1
7600572|NCT02756208|12006790|FG003|Overall Study|Lost to Follow-up|1
7600573|NCT02756208|12006787|FG000|Overall Study|Physician Decision|1
7600574|NCT02756208|12006788|FG001|Overall Study|Physician Decision|0
7600575|NCT02756208|12006789|FG002|Overall Study|Physician Decision|0
7600576|NCT02756208|12006790|FG003|Overall Study|Physician Decision|0
7600577|NCT02756208|12006787|FG000|Overall Study|Protocol Violation|0
7600578|NCT02756208|12006788|FG001|Overall Study|Protocol Violation|1
7600579|NCT02756208|12006789|FG002|Overall Study|Protocol Violation|0
7600580|NCT02756208|12006790|FG003|Overall Study|Protocol Violation|0
7600581|NCT02149121|12006807|FG000|Main Study Period|Lack of Efficacy|2
7600582|NCT02149121|12006808|FG001|Main Study Period|Lack of Efficacy|2
7600583|NCT02149121|12006809|FG002|Main Study Period|Lack of Efficacy|1
7600584|NCT02149121|12006810|FG003|Main Study Period|Lack of Efficacy|0
7600585|NCT02149121|12006811|FG004|Main Study Period|Lack of Efficacy|0
7772683|NCT00892437|12217483|FG000|Randomized Phase|Randomized but not treated|6
7772684|NCT00892437|12217484|FG001|Randomized Phase|Randomized but not treated|0
7772685|NCT00892437|12217483|FG000|Randomized Phase|Adverse Event|2
7772686|NCT00892437|12217484|FG001|Randomized Phase|Adverse Event|2
7772687|NCT00892437|12217483|FG000|Randomized Phase|Lost to Follow-up|1
7600586|NCT02149121|12006812|FG005|Main Study Period|Lack of Efficacy|0
7600587|NCT02149121|12006813|FG006|Main Study Period|Lack of Efficacy|0
7600588|NCT02149121|12006807|FG000|Main Study Period|Withdrawal by Subject|9
7600589|NCT02149121|12006808|FG001|Main Study Period|Withdrawal by Subject|5
7600590|NCT02149121|12006809|FG002|Main Study Period|Withdrawal by Subject|1
7600591|NCT02149121|12006810|FG003|Main Study Period|Withdrawal by Subject|0
7600592|NCT02149121|12006811|FG004|Main Study Period|Withdrawal by Subject|0
7600593|NCT02149121|12006812|FG005|Main Study Period|Withdrawal by Subject|0
7600594|NCT02149121|12006813|FG006|Main Study Period|Withdrawal by Subject|0
7600595|NCT02149121|12006807|FG000|Main Study Period|Adverse Event|2
7600596|NCT02149121|12006808|FG001|Main Study Period|Adverse Event|5
7600597|NCT02149121|12006809|FG002|Main Study Period|Adverse Event|1
7600598|NCT02149121|12006810|FG003|Main Study Period|Adverse Event|0
7600599|NCT02149121|12006811|FG004|Main Study Period|Adverse Event|0
7600600|NCT02149121|12006812|FG005|Main Study Period|Adverse Event|0
7600601|NCT02149121|12006813|FG006|Main Study Period|Adverse Event|0
7600602|NCT02149121|12006807|FG000|Main Study Period|Protocol Violation|2
7600603|NCT02149121|12006808|FG001|Main Study Period|Protocol Violation|0
7600604|NCT02149121|12006809|FG002|Main Study Period|Protocol Violation|0
7600605|NCT02149121|12006810|FG003|Main Study Period|Protocol Violation|0
7600606|NCT02149121|12006811|FG004|Main Study Period|Protocol Violation|0
7600607|NCT02149121|12006812|FG005|Main Study Period|Protocol Violation|0
7600608|NCT02149121|12006813|FG006|Main Study Period|Protocol Violation|0
7600609|NCT02149121|12006807|FG000|Main Study Period|Lost to Follow-up|2
7600610|NCT02149121|12006808|FG001|Main Study Period|Lost to Follow-up|1
7600611|NCT02149121|12006809|FG002|Main Study Period|Lost to Follow-up|0
7600612|NCT02149121|12006810|FG003|Main Study Period|Lost to Follow-up|0
7600613|NCT02149121|12006811|FG004|Main Study Period|Lost to Follow-up|0
7772688|NCT00892437|12217484|FG001|Randomized Phase|Lost to Follow-up|3
7772689|NCT00892437|12217483|FG000|Randomized Phase|Investigator's Discretion|1
7772690|NCT00892437|12217484|FG001|Randomized Phase|Investigator's Discretion|0
7772691|NCT00892437|12217483|FG000|Randomized Phase|Withdrew Consent|1
7772692|NCT00892437|12217484|FG001|Randomized Phase|Withdrew Consent|0
7772693|NCT00892437|12217483|FG000|Open-Label Extension Phase|Adverse Event|4
7772694|NCT00892437|12217484|FG001|Open-Label Extension Phase|Adverse Event|2
7772695|NCT00892437|12217483|FG000|Open-Label Extension Phase|Lack of Efficacy|1
7772696|NCT00892437|12217484|FG001|Open-Label Extension Phase|Lack of Efficacy|0
7772697|NCT00892437|12217483|FG000|Open-Label Extension Phase|Lost to Follow-up|3
7772698|NCT00892437|12217484|FG001|Open-Label Extension Phase|Lost to Follow-up|1
7772699|NCT00892437|12217483|FG000|Open-Label Extension Phase|Investigator's Discretion|1
7772700|NCT00892437|12217484|FG001|Open-Label Extension Phase|Investigator's Discretion|0
7772701|NCT00892437|12217483|FG000|Open-Label Extension Phase|Withdrew Consent|3
7772702|NCT00892437|12217484|FG001|Open-Label Extension Phase|Withdrew Consent|1
7772703|NCT00892723|12217521|FG000|Overall Study|Lost to Follow-up|1
7772704|NCT00892723|12217522|FG001|Overall Study|Lost to Follow-up|3
7772705|NCT00892723|12217523|FG002|Overall Study|Lost to Follow-up|1
7772706|NCT00892723|12217521|FG000|Overall Study|Withdrawal by Subject|1
7772707|NCT00892723|12217522|FG001|Overall Study|Withdrawal by Subject|1
7772708|NCT00892723|12217523|FG002|Overall Study|Withdrawal by Subject|1
7772709|NCT00892775|12217566|FG000|Overall Study|Protocol Violation|1
7772710|NCT00892775|12217567|FG001|Overall Study|Protocol Violation|0
7772711|NCT00892775|12217566|FG000|Overall Study|Subject difficulties with blood drawing|1
7772712|NCT00892775|12217567|FG001|Overall Study|Subject difficulties with blood drawing|0
7772713|NCT00892775|12217566|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
7772714|NCT00892775|12217567|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
7772715|NCT00892775|12217566|FG000|Overall Study|Migrated/ moved from study area|1
7772716|NCT00892775|12217567|FG001|Overall Study|Migrated/ moved from study area|0
7772717|NCT00892775|12217566|FG000|Overall Study|Withdrawal by Subject|0
7772718|NCT00892775|12217567|FG001|Overall Study|Withdrawal by Subject|1
7772719|NCT00892775|12217566|FG000|Overall Study|Lost to Follow-up|1
7772720|NCT00892775|12217567|FG001|Overall Study|Lost to Follow-up|0
7772721|NCT00892957|12217575|FG000|Between Postoperative Day 1 and Day 14|Death|0
7772722|NCT00892957|12217576|FG001|Between Postoperative Day 1 and Day 14|Death|2
7772723|NCT00892957|12217575|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
7772724|NCT00892957|12217576|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
7772725|NCT00893113|12217613|FG000|Overall Study|Lost to Follow-up|4
7772726|NCT00893113|12217614|FG001|Overall Study|Lost to Follow-up|8
7600614|NCT02149121|12006812|FG005|Main Study Period|Lost to Follow-up|0
7600615|NCT02149121|12006813|FG006|Main Study Period|Lost to Follow-up|0
7600616|NCT02149121|12006807|FG000|Main Study Period|Death|1
7600617|NCT02149121|12006808|FG001|Main Study Period|Death|0
7600618|NCT02149121|12006809|FG002|Main Study Period|Death|0
7600619|NCT02149121|12006810|FG003|Main Study Period|Death|0
7772727|NCT00893113|12217613|FG000|Overall Study|Early Termination|1
7772728|NCT00893113|12217614|FG001|Overall Study|Early Termination|1
7772729|NCT00893113|12217613|FG000|Overall Study|Withdrew Consent|8
7772730|NCT00893113|12217614|FG001|Overall Study|Withdrew Consent|7
7772731|NCT00893464|12217637|FG000|Overall Study|Did not complete therapy/experience PD|0
7772732|NCT00893464|12217638|FG001|Overall Study|Did not complete therapy/experience PD|0
7772733|NCT00893464|12217639|FG002|Overall Study|Did not complete therapy/experience PD|0
7772734|NCT00893464|12217640|FG003|Overall Study|Did not complete therapy/experience PD|0
7772735|NCT00893464|12217641|FG004|Overall Study|Did not complete therapy/experience PD|0
7772736|NCT00893464|12217642|FG005|Overall Study|Did not complete therapy/experience PD|0
7772737|NCT00893464|12217643|FG006|Overall Study|Did not complete therapy/experience PD|2
7772738|NCT00893464|12217644|FG007|Overall Study|Did not complete therapy/experience PD|2
7772739|NCT00893737|12217667|FG000|Overall Study|Adverse Event|4
7772740|NCT00893737|12217667|FG000|Overall Study|Withdrawal by Subject|2
7772741|NCT00893737|12217667|FG000|Overall Study|Lost to Follow-up|6
7772742|NCT00893763|12217673|FG000|Overall Study|extubated|110
7772743|NCT00893763|12217674|FG001|Overall Study|extubated|110
7772744|NCT00893971|12217682|FG000|Overall Study|Physician Decision|3
7772745|NCT00894166|12217715|FG000|Overall Study|Withdrew or Lost to Follow-Up|61
7772746|NCT00894166|12217716|FG001|Overall Study|Withdrew or Lost to Follow-Up|63
7772747|NCT00894166|12217717|FG002|Overall Study|Withdrew or Lost to Follow-Up|62
7772748|NCT00894166|12217718|FG003|Overall Study|Withdrew or Lost to Follow-Up|68
7772749|NCT00894166|12217719|FG004|Overall Study|Withdrew or Lost to Follow-Up|24
7772750|NCT00894166|12217720|FG005|Overall Study|Withdrew or Lost to Follow-Up|16
7772751|NCT00894166|12217721|FG006|Overall Study|Withdrew or Lost to Follow-Up|16
7772752|NCT00894166|12217722|FG007|Overall Study|Withdrew or Lost to Follow-Up|34
7772753|NCT00894166|12217715|FG000|Overall Study|Death|0
7772754|NCT00894166|12217716|FG001|Overall Study|Death|0
7772755|NCT00894166|12217717|FG002|Overall Study|Death|0
7772756|NCT00894166|12217718|FG003|Overall Study|Death|1
7772757|NCT00894166|12217719|FG004|Overall Study|Death|0
7772758|NCT00894166|12217720|FG005|Overall Study|Death|0
7772759|NCT00894166|12217721|FG006|Overall Study|Death|0
7772760|NCT00894166|12217722|FG007|Overall Study|Death|0
7772761|NCT00894322|12217748|FG000|Overall Study|Withdrawal by Subject|1
7772762|NCT00894322|12217749|FG001|Overall Study|Withdrawal by Subject|0
7772763|NCT00894322|12217750|FG002|Overall Study|Withdrawal by Subject|0
7600620|NCT02149121|12006811|FG004|Main Study Period|Death|0
7772764|NCT00894361|12217762|FG000|Overall Study|deaths and less than 2 years followup|24
7772765|NCT00894361|12217763|FG001|Overall Study|deaths and less than 2 years followup|64
7772766|NCT00894387|12217773|FG000|Overall Study|Adverse Event|44
7772767|NCT00894387|12217774|FG001|Overall Study|Adverse Event|45
7772768|NCT00894387|12217773|FG000|Overall Study|Abnormal Laboratory values|2
7772769|NCT00894387|12217774|FG001|Overall Study|Abnormal Laboratory values|2
7772770|NCT00894387|12217773|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7772771|NCT00894387|12217774|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7772772|NCT00894387|12217773|FG000|Overall Study|Lost to Follow-up|3
7772773|NCT00894387|12217774|FG001|Overall Study|Lost to Follow-up|5
7772774|NCT00894387|12217773|FG000|Overall Study|Administrative problems|2
7772775|NCT00894387|12217774|FG001|Overall Study|Administrative problems|2
7772776|NCT00894387|12217773|FG000|Overall Study|Death|77
7772777|NCT00894387|12217774|FG001|Overall Study|Death|76
7600621|NCT02149121|12006812|FG005|Main Study Period|Death|0
7600622|NCT02149121|12006813|FG006|Main Study Period|Death|0
7600623|NCT02149121|12006807|FG000|Main Study Period|Physician Decision|1
7600624|NCT02149121|12006808|FG001|Main Study Period|Physician Decision|0
7600625|NCT02149121|12006809|FG002|Main Study Period|Physician Decision|0
7600626|NCT02149121|12006810|FG003|Main Study Period|Physician Decision|0
7600627|NCT02149121|12006811|FG004|Main Study Period|Physician Decision|0
7600628|NCT02149121|12006812|FG005|Main Study Period|Physician Decision|0
7600629|NCT02149121|12006813|FG006|Main Study Period|Physician Decision|0
7600630|NCT02149121|12006807|FG000|Main Study Period|Developed any malignancy|0
7600631|NCT02149121|12006808|FG001|Main Study Period|Developed any malignancy|1
7600632|NCT02149121|12006809|FG002|Main Study Period|Developed any malignancy|1
7600633|NCT02149121|12006810|FG003|Main Study Period|Developed any malignancy|0
7600634|NCT02149121|12006811|FG004|Main Study Period|Developed any malignancy|0
7600635|NCT02149121|12006812|FG005|Main Study Period|Developed any malignancy|0
7600636|NCT02149121|12006813|FG006|Main Study Period|Developed any malignancy|0
7600637|NCT02149121|12006807|FG000|Main Study Period|Unmet predefined eligibility criteria|2
7600638|NCT02149121|12006808|FG001|Main Study Period|Unmet predefined eligibility criteria|2
7600639|NCT02149121|12006809|FG002|Main Study Period|Unmet predefined eligibility criteria|0
7600640|NCT02149121|12006810|FG003|Main Study Period|Unmet predefined eligibility criteria|0
7600641|NCT02149121|12006811|FG004|Main Study Period|Unmet predefined eligibility criteria|0
7600642|NCT02149121|12006812|FG005|Main Study Period|Unmet predefined eligibility criteria|0
7600643|NCT02149121|12006813|FG006|Main Study Period|Unmet predefined eligibility criteria|0
7600644|NCT02149121|12006807|FG000|Main Study Period|Disease progression|0
7600645|NCT02149121|12006808|FG001|Main Study Period|Disease progression|1
7600646|NCT02149121|12006809|FG002|Main Study Period|Disease progression|0
7600647|NCT02149121|12006810|FG003|Main Study Period|Disease progression|0
7600648|NCT02149121|12006811|FG004|Main Study Period|Disease progression|0
7600649|NCT02149121|12006812|FG005|Main Study Period|Disease progression|0
7600650|NCT02149121|12006813|FG006|Main Study Period|Disease progression|0
7600651|NCT02149121|12006807|FG000|Extension Study Period|Withdrawal by Subject|0
7600652|NCT02149121|12006808|FG001|Extension Study Period|Withdrawal by Subject|0
7600653|NCT02149121|12006809|FG002|Extension Study Period|Withdrawal by Subject|0
7600654|NCT02149121|12006810|FG003|Extension Study Period|Withdrawal by Subject|1
7600655|NCT02149121|12006811|FG004|Extension Study Period|Withdrawal by Subject|0
7600656|NCT02149121|12006812|FG005|Extension Study Period|Withdrawal by Subject|2
7600657|NCT02149121|12006813|FG006|Extension Study Period|Withdrawal by Subject|0
7600658|NCT01889186|12006836|FG000|Overall Study|Adverse event- not related to progression|18
7600659|NCT01889186|12006837|FG001|Overall Study|Adverse event- not related to progression|5
7600660|NCT01889186|12006836|FG000|Overall Study|Adverse event- related to progression|7
7600661|NCT01889186|12006837|FG001|Overall Study|Adverse event- related to progression|2
7600662|NCT01889186|12006836|FG000|Overall Study|COVID-19 logistical restrictions|1
7600663|NCT01889186|12006837|FG001|Overall Study|COVID-19 logistical restrictions|0
7600664|NCT01889186|12006836|FG000|Overall Study|Investigator request|1
7600665|NCT01889186|12006837|FG001|Overall Study|Investigator request|1
7600666|NCT01889186|12006836|FG000|Overall Study|Progressive disease- Richter's|12
7600667|NCT01889186|12006837|FG001|Overall Study|Progressive disease- Richter's|7
7600668|NCT01889186|12006836|FG000|Overall Study|Progressive disease per protocol|46
7600669|NCT01889186|12006837|FG001|Overall Study|Progressive disease per protocol|17
7600670|NCT01889186|12006836|FG000|Overall Study|Stem cell transplant|2
7600671|NCT01889186|12006837|FG001|Overall Study|Stem cell transplant|1
7600672|NCT01889186|12006836|FG000|Overall Study|Withdrew consent|2
7600673|NCT01889186|12006837|FG001|Overall Study|Withdrew consent|3
7600674|NCT01889186|12006836|FG000|Overall Study|Other, not specified|18
7600675|NCT01889186|12006837|FG001|Overall Study|Other, not specified|15
7600676|NCT01850004|12006845|FG000|Overall Study|Subject Moved|1
7600677|NCT01850004|12006845|FG000|Overall Study|Poor/Non-compliance|1
7600678|NCT01850004|12006845|FG000|Overall Study|Subject Withdrew Consent|4
7600679|NCT01850004|12006845|FG000|Overall Study|Subject Request to Discontinue Treatment|1
7600680|NCT01850004|12006845|FG000|Overall Study|AE Unrelated to Study Drug|1
7600681|NCT01510184|12006852|FG000|Overall Study|Sponsor discretion|28
7600682|NCT01510184|12006853|FG001|Overall Study|Sponsor discretion|28
7600683|NCT01510184|12006852|FG000|Overall Study|Death|1
7600684|NCT01510184|12006853|FG001|Overall Study|Death|2
7600685|NCT01510184|12006852|FG000|Overall Study|Withdrawal by Subject|1
7600686|NCT01510184|12006853|FG001|Overall Study|Withdrawal by Subject|4
7600687|NCT01510184|12006852|FG000|Overall Study|Other|0
7600688|NCT01510184|12006853|FG001|Overall Study|Other|1
7600689|NCT01471444|12006861|FG000|Overall Study|Physician Decision|3
7600690|NCT01471444|12006862|FG001|Overall Study|Physician Decision|2
7600691|NCT01471444|12006861|FG000|Overall Study|Withdrawal by Subject|0
7600692|NCT01471444|12006862|FG001|Overall Study|Withdrawal by Subject|1
7600693|NCT03745651|12006913|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
7600694|NCT03745651|12006914|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
7600695|NCT03745651|12006915|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600696|NCT03745651|12006916|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600697|NCT03745651|12006917|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600698|NCT03745651|12006918|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600699|NCT03745651|12006919|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600700|NCT03745651|12006913|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3
7600701|NCT03745651|12006914|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13
7600702|NCT03745651|12006915|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4
7600703|NCT03745651|12006916|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600704|NCT03745651|12006917|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600705|NCT03745651|12006918|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600706|NCT03745651|12006919|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600707|NCT03745651|12006913|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3
7600708|NCT03745651|12006914|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600709|NCT03745651|12006915|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
7600710|NCT03745651|12006916|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600711|NCT03745651|12006917|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600712|NCT03745651|12006918|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600713|NCT03745651|12006919|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600714|NCT03745651|12006913|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600715|NCT03745651|12006914|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2
7600716|NCT03745651|12006915|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600717|NCT03745651|12006916|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600718|NCT03745651|12006917|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600719|NCT03745651|12006918|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600720|NCT03745651|12006919|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600721|NCT03745651|12006913|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11
7600722|NCT03745651|12006914|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21
7600723|NCT03745651|12006915|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15
7600724|NCT03745651|12006916|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600725|NCT03745651|12006917|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600726|NCT03745651|12006918|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600727|NCT03745651|12006919|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600728|NCT03745651|12006913|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1
7600729|NCT03745651|12006914|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2
7600730|NCT03745651|12006915|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2
7600731|NCT03745651|12006916|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
7600732|NCT03745651|12006917|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
7600733|NCT03745651|12006918|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
7600734|NCT03745651|12006919|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
7600735|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600736|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600737|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600738|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600739|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600740|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4
7600741|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600742|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600743|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600744|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600745|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1
7600746|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600747|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4
7600748|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4
7600749|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7600750|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7600751|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7600752|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4
7600753|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2
7600754|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13
7600755|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10
7600756|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600757|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600758|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600759|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1
7600760|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600761|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4
7600762|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2
7600763|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
7600764|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
7600765|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
7600766|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1
7600767|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
7600768|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
7600769|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1
7600770|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600771|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600772|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600773|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600774|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600775|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1
7600776|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600777|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7600778|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7600779|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7600780|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12
7600781|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8
7600782|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26
7600783|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34
7600784|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
7600785|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
7600786|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
7600787|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
7600788|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
7600789|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
7600790|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
7600791|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4
7600792|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2
7600793|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
7600794|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600795|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600796|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600797|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600798|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1
7600799|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7600800|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7600801|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7600802|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7600803|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7600804|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7600805|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5
7600806|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12
7600807|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8
7600808|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600809|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600810|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600811|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600812|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
7600813|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
7600814|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600815|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600816|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600817|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600818|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600819|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1
7600820|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7600821|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7600822|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7600823|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7600824|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7600825|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7600826|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600827|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3
7600828|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600829|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600830|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600831|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600832|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600833|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17
7600834|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11
7600835|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19
7600836|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600837|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600838|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600839|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600840|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2
7600841|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1
7600842|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
7600843|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
7600844|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
7600845|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
7600846|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
7600847|NCT03745638|12006938|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600848|NCT03745638|12006939|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600849|NCT03745638|12006940|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600850|NCT03745638|12006941|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600851|NCT03745638|12006942|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600852|NCT03745638|12006943|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6
7772778|NCT00894387|12217773|FG000|Overall Study|Protocol Deviation|4
7772779|NCT00894387|12217774|FG001|Overall Study|Protocol Deviation|0
7772780|NCT00894387|12217773|FG000|Overall Study|Patient's request|25
7772781|NCT00894387|12217774|FG001|Overall Study|Patient's request|30
7772782|NCT00894387|12217773|FG000|Overall Study|Other (Missing)|5
7772783|NCT00894387|12217774|FG001|Overall Study|Other (Missing)|3
7772784|NCT00894387|12217773|FG000|Overall Study|Mis-randomized|13
7600853|NCT03745638|12006944|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1
7600854|NCT03745638|12006938|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600855|NCT03745638|12006939|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600856|NCT03745638|12006940|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600857|NCT03745638|12006941|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1
7600858|NCT03745638|12006942|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600859|NCT03745638|12006943|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2
7600860|NCT03745638|12006944|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2
7600861|NCT03745638|12006938|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7600862|NCT03745638|12006939|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7600863|NCT03745638|12006940|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7600864|NCT03745638|12006941|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3
7600865|NCT03745638|12006942|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5
7600866|NCT03745638|12006943|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13
7600867|NCT03745638|12006944|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24
7600868|NCT03745638|12006938|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600869|NCT03745638|12006939|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600870|NCT03745638|12006940|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600871|NCT03745638|12006941|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600872|NCT03745638|12006942|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1
7600873|NCT03745638|12006943|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3
7600874|NCT03745638|12006944|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600875|NCT03745638|12006938|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600876|NCT03745638|12006939|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600877|NCT03745638|12006940|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7772785|NCT00894387|12217774|FG001|Overall Study|Mis-randomized|9
7772786|NCT00894387|12217773|FG000|Overall Study|GCP non-compliance|0
7600878|NCT03745638|12006941|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600879|NCT03745638|12006942|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600880|NCT03745638|12006943|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1
7600881|NCT03745638|12006944|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600882|NCT03745638|12006938|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7600883|NCT03745638|12006939|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7600884|NCT03745638|12006940|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7600885|NCT03745638|12006941|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7
7600886|NCT03745638|12006942|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3
7600887|NCT03745638|12006943|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17
7600888|NCT03745638|12006944|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21
7600889|NCT03745638|12006938|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
7600890|NCT03745638|12006939|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
7600891|NCT03745638|12006940|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
7600892|NCT03745638|12006941|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
7600893|NCT03745638|12006942|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
7600894|NCT03745638|12006943|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4
7600895|NCT03745638|12006944|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3
7600896|NCT03715764|12006963|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2
7600897|NCT03715764|12006964|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3
7600898|NCT03715764|12006963|FG000|3 Month Follow-up|Lost to Follow-up|2
7600899|NCT03715764|12006964|FG001|3 Month Follow-up|Lost to Follow-up|2
7600900|NCT03715764|12006963|FG000|3 Month Follow-up|Withdrawal by Subject|1
7600901|NCT03715764|12006964|FG001|3 Month Follow-up|Withdrawal by Subject|1
7600902|NCT03715764|12006963|FG000|6 Month Follow-up|Lost to Follow-up|3
7600903|NCT03715764|12006964|FG001|6 Month Follow-up|Lost to Follow-up|0
7600904|NCT03715764|12006963|FG000|12 Month Follow-up|Lost to Follow-up|2
7600905|NCT03715764|12006964|FG001|12 Month Follow-up|Lost to Follow-up|3
7600906|NCT03715764|12006963|FG000|12 Month Follow-up|Pregnancy|0
7600907|NCT03715764|12006964|FG001|12 Month Follow-up|Pregnancy|1
7600908|NCT03715764|12006963|FG000|12 Month Follow-up|Surgery|2
7600909|NCT03715764|12006964|FG001|12 Month Follow-up|Surgery|0
7600910|NCT03715764|12006963|FG000|12 Month Follow-up|Wrong address|1
7600911|NCT03715764|12006964|FG001|12 Month Follow-up|Wrong address|0
7600912|NCT03715764|12006963|FG000|12 Month Follow-up|No symptoms|1
7600913|NCT03715764|12006964|FG001|12 Month Follow-up|No symptoms|0
7600914|NCT03715764|12006963|FG000|12 Month Follow-up|Changed primary care centre|0
7600915|NCT03715764|12006964|FG001|12 Month Follow-up|Changed primary care centre|1
7600916|NCT03654729|12006977|FG000|Overall Study|Death|9
7600917|NCT03654729|12006978|FG001|Overall Study|Death|9
7600918|NCT03654729|12006979|FG002|Overall Study|Death|16
7600919|NCT03654729|12006977|FG000|Overall Study|Withdrawal by Subject|8
7600920|NCT03654729|12006978|FG001|Overall Study|Withdrawal by Subject|6
7600921|NCT03654729|12006979|FG002|Overall Study|Withdrawal by Subject|4
7600922|NCT03654729|12006977|FG000|Overall Study|Study terminated by Sponsor|3
7600923|NCT03654729|12006978|FG001|Overall Study|Study terminated by Sponsor|5
7600924|NCT03654729|12006979|FG002|Overall Study|Study terminated by Sponsor|4
7600925|NCT03654729|12006977|FG000|Overall Study|Not reported|2
7600926|NCT03654729|12006978|FG001|Overall Study|Not reported|4
7600927|NCT03654729|12006979|FG002|Overall Study|Not reported|5
7600928|NCT03654729|12006977|FG000|Overall Study|Progressive disease|3
7600929|NCT03654729|12006978|FG001|Overall Study|Progressive disease|0
7600930|NCT03654729|12006979|FG002|Overall Study|Progressive disease|0
7600931|NCT03654729|12006977|FG000|Overall Study|Lost to Follow-up|2
7600932|NCT03654729|12006978|FG001|Overall Study|Lost to Follow-up|0
7600933|NCT03654729|12006979|FG002|Overall Study|Lost to Follow-up|0
7600934|NCT03654729|12006977|FG000|Overall Study|Physician Decision|2
7600935|NCT03654729|12006978|FG001|Overall Study|Physician Decision|0
7600936|NCT03654729|12006979|FG002|Overall Study|Physician Decision|0
7600937|NCT03654729|12006977|FG000|Overall Study|Protocol Violation|1
7600938|NCT03654729|12006978|FG001|Overall Study|Protocol Violation|1
7600939|NCT03654729|12006979|FG002|Overall Study|Protocol Violation|0
7600940|NCT03654729|12006977|FG000|Overall Study|Non-compliance with study drug|0
7600941|NCT03654729|12006978|FG001|Overall Study|Non-compliance with study drug|1
7600942|NCT03654729|12006979|FG002|Overall Study|Non-compliance with study drug|0
7600943|NCT03654729|12006977|FG000|Overall Study|Site terminated by Sponsor|1
7600944|NCT03654729|12006978|FG001|Overall Study|Site terminated by Sponsor|0
7600945|NCT03654729|12006979|FG002|Overall Study|Site terminated by Sponsor|0
7600946|NCT02976038|12007031|FG000|Overall Study|Physician Decision|22
7600947|NCT02976038|12007031|FG000|Overall Study|Withdrawal by Subject|3
7600948|NCT02976038|12007031|FG000|Overall Study|Lost to Follow-up|2
7600949|NCT02976038|12007031|FG000|Overall Study|Adverse Event|1
7600950|NCT02631070|12007047|FG000|Overall Study|Withdrawal by Subject|35
7600951|NCT02631070|12007048|FG001|Overall Study|Withdrawal by Subject|13
7600952|NCT02631070|12007047|FG000|Overall Study|Death|45
7600953|NCT02631070|12007048|FG001|Overall Study|Death|24
7600954|NCT02631070|12007047|FG000|Overall Study|Lost to Follow-up|5
7600955|NCT02631070|12007048|FG001|Overall Study|Lost to Follow-up|1
7600956|NCT02631070|12007047|FG000|Overall Study|Transition to rollover protocol|52
7600957|NCT02631070|12007048|FG001|Overall Study|Transition to rollover protocol|21
7600958|NCT02631070|12007047|FG000|Overall Study|Other reasons|12
7600959|NCT02631070|12007048|FG001|Overall Study|Other reasons|5
7600960|NCT02281955|12007054|FG000|Overall Study|Death|1
7600961|NCT02202434|12007062|FG000|Overall Study|Death|70
7600962|NCT02202434|12007063|FG001|Overall Study|Death|39
7600963|NCT02202434|12007064|FG002|Overall Study|Death|13
7600964|NCT02202434|12007065|FG003|Overall Study|Death|27
7600965|NCT02202434|12007062|FG000|Overall Study|Lost to Follow-up|1
7600966|NCT02202434|12007063|FG001|Overall Study|Lost to Follow-up|1
7600967|NCT02202434|12007064|FG002|Overall Study|Lost to Follow-up|1
7600968|NCT02202434|12007065|FG003|Overall Study|Lost to Follow-up|0
7600969|NCT02202434|12007062|FG000|Overall Study|Physician Decision|2
7600970|NCT02202434|12007063|FG001|Overall Study|Physician Decision|3
7600971|NCT02202434|12007064|FG002|Overall Study|Physician Decision|0
7600972|NCT02202434|12007065|FG003|Overall Study|Physician Decision|0
7600973|NCT02202434|12007062|FG000|Overall Study|Withdrawal by Subject|13
7600974|NCT02202434|12007063|FG001|Overall Study|Withdrawal by Subject|14
7600975|NCT02202434|12007064|FG002|Overall Study|Withdrawal by Subject|1
7600976|NCT02202434|12007065|FG003|Overall Study|Withdrawal by Subject|4
7600977|NCT02202434|12007062|FG000|Overall Study|Completed Study|1
7600978|NCT02202434|12007063|FG001|Overall Study|Completed Study|0
7600979|NCT02202434|12007064|FG002|Overall Study|Completed Study|0
7600980|NCT02202434|12007065|FG003|Overall Study|Completed Study|0
7600981|NCT02202434|12007062|FG000|Overall Study|Visit Missed|21
7600982|NCT02202434|12007063|FG001|Overall Study|Visit Missed|12
7600983|NCT02202434|12007064|FG002|Overall Study|Visit Missed|0
7600984|NCT02202434|12007065|FG003|Overall Study|Visit Missed|5
7600985|NCT02202434|12007062|FG000|Overall Study|Other|1
7600986|NCT02202434|12007063|FG001|Overall Study|Other|0
7600987|NCT02202434|12007064|FG002|Overall Study|Other|0
7600988|NCT02202434|12007065|FG003|Overall Study|Other|1
7600989|NCT01230242|12007079|FG000|Overall Study|Physician Decision|2
7600990|NCT01230242|12007079|FG000|Overall Study|Withdrawal by Subject|1
7600991|NCT00983437|12007083|FG000|Overall Study|Adverse Event|9
7600992|NCT00983437|12007083|FG000|Overall Study|Lack of Efficacy|1
7600993|NCT00983437|12007083|FG000|Overall Study|Withdrawal by Subject|8
7600994|NCT00983437|12007083|FG000|Overall Study|Noncompliance to Study Procedures|1
7600995|NCT00983437|12007083|FG000|Overall Study|Lost to Follow-up|2
7600996|NCT00983437|12007083|FG000|Overall Study|Other Reason|26
7600997|NCT00965757|12007089|FG000|Double-blind Phase|Progression of concomitant disease|1
7600998|NCT00965757|12007090|FG001|Double-blind Phase|Progression of concomitant disease|2
7600999|NCT00965757|12007091|FG002|Double-blind Phase|Progression of concomitant disease|0
7601000|NCT00965757|12007092|FG003|Double-blind Phase|Progression of concomitant disease|0
7601001|NCT00965757|12007089|FG000|Double-blind Phase|Adverse drug reaction|2
7601002|NCT00965757|12007090|FG001|Double-blind Phase|Adverse drug reaction|1
7601003|NCT00965757|12007091|FG002|Double-blind Phase|Adverse drug reaction|0
7601004|NCT00965757|12007092|FG003|Double-blind Phase|Adverse drug reaction|0
7601005|NCT00965757|12007089|FG000|Double-blind Phase|Abnormal Laboratory Value|2
7601006|NCT00965757|12007090|FG001|Double-blind Phase|Abnormal Laboratory Value|0
7601007|NCT00965757|12007091|FG002|Double-blind Phase|Abnormal Laboratory Value|0
7601008|NCT00965757|12007092|FG003|Double-blind Phase|Abnormal Laboratory Value|0
7601009|NCT00965757|12007089|FG000|Double-blind Phase|Lack of Efficacy|7
7601010|NCT00965757|12007090|FG001|Double-blind Phase|Lack of Efficacy|11
7601011|NCT00965757|12007091|FG002|Double-blind Phase|Lack of Efficacy|0
7601012|NCT00965757|12007092|FG003|Double-blind Phase|Lack of Efficacy|0
7601013|NCT00965757|12007089|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2
7601014|NCT00965757|12007090|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0
7772787|NCT00894387|12217774|FG001|Overall Study|GCP non-compliance|2
7772788|NCT00894413|12217782|FG000|Overall Study|Physician Decision|0
7772789|NCT00894413|12217783|FG001|Overall Study|Physician Decision|2
7772790|NCT00894413|12217782|FG000|Overall Study|Adverse Event|0
7772791|NCT00894413|12217783|FG001|Overall Study|Adverse Event|2
7772792|NCT00894413|12217782|FG000|Overall Study|Withdrawal by Subject|0
7772793|NCT00894413|12217783|FG001|Overall Study|Withdrawal by Subject|4
7772794|NCT00894543|12217825|FG000|Baseline to Week 4|No diary or lost or withdrew|3
7772795|NCT00894543|12217826|FG001|Baseline to Week 4|No diary or lost or withdrew|2
7772796|NCT00894543|12217825|FG000|Week 4 to Week 8|No diary or lost or withdrew|4
7772797|NCT00894543|12217826|FG001|Week 4 to Week 8|No diary or lost or withdrew|2
7772798|NCT00894647|12217834|FG000|Overall Study|Adverse Event|5
7772799|NCT00894647|12217835|FG001|Overall Study|Adverse Event|4
7772800|NCT00894647|12217834|FG000|Overall Study|Withdrawal by Subject|4
7772801|NCT00894647|12217835|FG001|Overall Study|Withdrawal by Subject|4
7772802|NCT00894647|12217834|FG000|Overall Study|Lost to Follow-up|0
7772803|NCT00894647|12217835|FG001|Overall Study|Lost to Follow-up|2
7772804|NCT00894647|12217834|FG000|Overall Study|Non-compliance with study procedures|0
7772805|NCT00894647|12217835|FG001|Overall Study|Non-compliance with study procedures|2
7772806|NCT00894647|12217834|FG000|Overall Study|Other, not due to AE|1
7772807|NCT00894647|12217835|FG001|Overall Study|Other, not due to AE|2
7772808|NCT00894686|12217841|FG000|Overall Study|Withdrawal by Subject|50
7772809|NCT00894686|12217841|FG000|Overall Study|Physician Decision|1
7772810|NCT00894686|12217841|FG000|Overall Study|Other|5
7772811|NCT00894803|12217865|FG000|Overall Study|Death|20
7772812|NCT00894803|12217866|FG001|Overall Study|Death|4
7772813|NCT00894803|12217865|FG000|Overall Study|Lost to Follow-up|0
7772814|NCT00894803|12217866|FG001|Overall Study|Lost to Follow-up|1
7772815|NCT00894933|12217872|FG000|Overall Study|Lost to Follow-up|2
7772816|NCT00894933|12217872|FG000|Overall Study|Cancelled Procedure|1
7601015|NCT00965757|12007091|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0
7601016|NCT00965757|12007092|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0
7601017|NCT00965757|12007089|FG000|Double-blind Phase|Lost to Follow-up|0
7772817|NCT00894933|12217872|FG000|Overall Study|Did not meeting incl/excl criteria|1
7772818|NCT00895011|12217879|FG000|Overall Study|Withdrawal by Subject|14
7772819|NCT00895011|12217880|FG001|Overall Study|Withdrawal by Subject|7
7772820|NCT00895011|12217881|FG002|Overall Study|Withdrawal by Subject|2
7772821|NCT00895011|12217879|FG000|Overall Study|Lost to Follow-up|5
7772822|NCT00895011|12217880|FG001|Overall Study|Lost to Follow-up|4
7772823|NCT00895011|12217881|FG002|Overall Study|Lost to Follow-up|1
7601018|NCT00965757|12007090|FG001|Double-blind Phase|Lost to Follow-up|1
7601019|NCT00965757|12007091|FG002|Double-blind Phase|Lost to Follow-up|0
7601020|NCT00965757|12007092|FG003|Double-blind Phase|Lost to Follow-up|0
7601021|NCT00965757|12007089|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2
7601022|NCT00965757|12007090|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3
7601023|NCT00965757|12007091|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0
7601024|NCT00965757|12007092|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0
7601025|NCT00965757|12007089|FG000|Double-blind Phase|Other|1
7601026|NCT00965757|12007090|FG001|Double-blind Phase|Other|0
7601027|NCT00965757|12007091|FG002|Double-blind Phase|Other|0
7601028|NCT00965757|12007092|FG003|Double-blind Phase|Other|0
7601029|NCT00965757|12007089|FG000|Extension Phase|Progression of concomitant disease|0
7601030|NCT00965757|12007090|FG001|Extension Phase|Progression of concomitant disease|0
7601031|NCT00965757|12007091|FG002|Extension Phase|Progression of concomitant disease|4
7601032|NCT00965757|12007092|FG003|Extension Phase|Progression of concomitant disease|2
7601033|NCT00965757|12007089|FG000|Extension Phase|Adverse drug reaction|0
7601034|NCT00965757|12007090|FG001|Extension Phase|Adverse drug reaction|0
7601035|NCT00965757|12007091|FG002|Extension Phase|Adverse drug reaction|6
7601036|NCT00965757|12007092|FG003|Extension Phase|Adverse drug reaction|3
7601037|NCT00965757|12007089|FG000|Extension Phase|Abnormal Laboratory Value|0
7601038|NCT00965757|12007090|FG001|Extension Phase|Abnormal Laboratory Value|0
7601039|NCT00965757|12007091|FG002|Extension Phase|Abnormal Laboratory Value|6
7601040|NCT00965757|12007092|FG003|Extension Phase|Abnormal Laboratory Value|1
7601041|NCT00965757|12007089|FG000|Extension Phase|Lack of Efficacy|0
7601042|NCT00965757|12007090|FG001|Extension Phase|Lack of Efficacy|0
7601043|NCT00965757|12007091|FG002|Extension Phase|Lack of Efficacy|8
7601044|NCT00965757|12007092|FG003|Extension Phase|Lack of Efficacy|12
7601045|NCT00965757|12007089|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0
7601046|NCT00965757|12007090|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0
7601047|NCT00965757|12007091|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4
7601048|NCT00965757|12007092|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0
7601049|NCT00965757|12007089|FG000|Extension Phase|Lost to Follow-up|0
7601050|NCT00965757|12007090|FG001|Extension Phase|Lost to Follow-up|0
7601051|NCT00965757|12007091|FG002|Extension Phase|Lost to Follow-up|0
7601052|NCT00965757|12007092|FG003|Extension Phase|Lost to Follow-up|1
7772824|NCT00895011|12217879|FG000|Overall Study|Protocol Violation|3
7772825|NCT00895011|12217880|FG001|Overall Study|Protocol Violation|1
7772826|NCT00895011|12217881|FG002|Overall Study|Protocol Violation|3
7772827|NCT00895011|12217879|FG000|Overall Study|Adverse Event|1
7772828|NCT00895011|12217880|FG001|Overall Study|Adverse Event|2
7772829|NCT00895011|12217881|FG002|Overall Study|Adverse Event|2
7772830|NCT00895011|12217879|FG000|Overall Study|schedule conflict|1
7772831|NCT00895011|12217880|FG001|Overall Study|schedule conflict|0
7772832|NCT00895011|12217881|FG002|Overall Study|schedule conflict|0
7772833|NCT00895037|12217893|FG000|Overall Study|Death|0
7772834|NCT00895037|12217894|FG001|Overall Study|Death|2
7772835|NCT00895037|12217895|FG002|Overall Study|Death|1
7772836|NCT00895154|12217905|FG000|Overall Study|Lost to Follow-up|1
7772837|NCT00895154|12217906|FG001|Overall Study|Lost to Follow-up|1
7772838|NCT00895154|12217905|FG000|Overall Study|Withdrawal by Subject|0
7772839|NCT00895154|12217906|FG001|Overall Study|Withdrawal by Subject|1
7772840|NCT00895245|12217953|FG000|Overall Study|Lack of Efficacy|6
7601053|NCT00965757|12007089|FG000|Extension Phase|Ineligible after Taking Study Drug|0
7601054|NCT00965757|12007090|FG001|Extension Phase|Ineligible after Taking Study Drug|0
7601055|NCT00965757|12007091|FG002|Extension Phase|Ineligible after Taking Study Drug|3
7601056|NCT00965757|12007092|FG003|Extension Phase|Ineligible after Taking Study Drug|3
7601057|NCT00965757|12007089|FG000|Extension Phase|Protocol Violation|0
7601058|NCT00965757|12007090|FG001|Extension Phase|Protocol Violation|0
7601059|NCT00965757|12007091|FG002|Extension Phase|Protocol Violation|0
7601060|NCT00965757|12007092|FG003|Extension Phase|Protocol Violation|1
7601061|NCT00965757|12007089|FG000|Extension Phase|Other|0
7601062|NCT00965757|12007090|FG001|Extension Phase|Other|0
7601063|NCT00965757|12007091|FG002|Extension Phase|Other|2
7772841|NCT00895310|12217957|FG000|Overall Study|Withdrawal by Subject|1
7772842|NCT00895414|12217961|FG000|First Intervention (14 Days)|Withdrawal by Subject|1
7772843|NCT00895414|12217962|FG001|First Intervention (14 Days)|Withdrawal by Subject|0
7772844|NCT00895414|12217961|FG000|First Intervention (14 Days)|Physician Decision|0
7772845|NCT00895414|12217962|FG001|First Intervention (14 Days)|Physician Decision|1
7772846|NCT00895453|12217971|FG000|Overall Study|Lost to Follow-up|25
7772847|NCT00895453|12217972|FG001|Overall Study|Lost to Follow-up|25
7601064|NCT00965757|12007092|FG003|Extension Phase|Other|1
7601065|NCT00928447|12007100|FG000|Overall Study|Withdrawal by Subject|1
7601066|NCT00928447|12007100|FG000|Overall Study|Investigator's decision|1
7601067|NCT00893789|12007108|FG000|Overall Study|Withdrawal by Subject|3
7601068|NCT00893789|12007109|FG001|Overall Study|Withdrawal by Subject|1
7601069|NCT00893789|12007110|FG002|Overall Study|Withdrawal by Subject|3
7601070|NCT00893789|12007111|FG003|Overall Study|Withdrawal by Subject|1
7601071|NCT00893789|12007108|FG000|Overall Study|Noncompliance With Study Drug|1
7601072|NCT00893789|12007109|FG001|Overall Study|Noncompliance With Study Drug|0
7772848|NCT00895453|12217973|FG002|Overall Study|Lost to Follow-up|23
7601073|NCT00893789|12007110|FG002|Overall Study|Noncompliance With Study Drug|1
7601074|NCT00893789|12007111|FG003|Overall Study|Noncompliance With Study Drug|2
7601075|NCT00893789|12007108|FG000|Overall Study|Noncompliance With Study Procedures|1
7601076|NCT00893789|12007109|FG001|Overall Study|Noncompliance With Study Procedures|0
7601077|NCT00893789|12007110|FG002|Overall Study|Noncompliance With Study Procedures|0
7601078|NCT00893789|12007111|FG003|Overall Study|Noncompliance With Study Procedures|0
7601079|NCT00893789|12007108|FG000|Overall Study|Taking Excluded Concomitant Medication|1
7601080|NCT00893789|12007109|FG001|Overall Study|Taking Excluded Concomitant Medication|0
7601081|NCT00893789|12007110|FG002|Overall Study|Taking Excluded Concomitant Medication|1
7601082|NCT00893789|12007111|FG003|Overall Study|Taking Excluded Concomitant Medication|0
7601083|NCT00893789|12007108|FG000|Overall Study|Adverse Event|0
7601084|NCT00893789|12007109|FG001|Overall Study|Adverse Event|2
7772849|NCT00895583|12217992|FG000|Overall Study|Adverse Event|28
7772850|NCT00895583|12217993|FG001|Overall Study|Adverse Event|4
7772851|NCT00895583|12217992|FG000|Overall Study|Death|2
7772852|NCT00895583|12217993|FG001|Overall Study|Death|1
7772853|NCT00895583|12217992|FG000|Overall Study|Physician Decision|3
7772854|NCT00895583|12217993|FG001|Overall Study|Physician Decision|1
7772855|NCT00895583|12217992|FG000|Overall Study|Lost to Follow-up|1
7772856|NCT00895583|12217993|FG001|Overall Study|Lost to Follow-up|3
7772857|NCT00895583|12217992|FG000|Overall Study|Protocol Violation|1
7772858|NCT00895583|12217993|FG001|Overall Study|Protocol Violation|0
7772859|NCT00895583|12217992|FG000|Overall Study|Withdrawal by Subject|4
7772860|NCT00895583|12217993|FG001|Overall Study|Withdrawal by Subject|2
7772861|NCT00895583|12217992|FG000|Overall Study|Lack of Efficacy|5
7772862|NCT00895583|12217993|FG001|Overall Study|Lack of Efficacy|0
7772863|NCT00895583|12217992|FG000|Overall Study|Other|0
7772864|NCT00895583|12217993|FG001|Overall Study|Other|1
7601085|NCT00893789|12007110|FG002|Overall Study|Adverse Event|1
7601086|NCT00893789|12007111|FG003|Overall Study|Adverse Event|5
7772865|NCT00895622|12218002|FG000|Overall Study|Protocol Violation|5
7772866|NCT00895622|12218003|FG001|Overall Study|Protocol Violation|4
7772867|NCT00895622|12218004|FG002|Overall Study|Protocol Violation|4
7601087|NCT00893789|12007108|FG000|Overall Study|Protocol Violation|0
7601088|NCT00893789|12007109|FG001|Overall Study|Protocol Violation|1
7601089|NCT00893789|12007110|FG002|Overall Study|Protocol Violation|1
7601090|NCT00893789|12007111|FG003|Overall Study|Protocol Violation|4
7601091|NCT00893789|12007108|FG000|Overall Study|Lost to Follow-up|0
7601092|NCT00893789|12007109|FG001|Overall Study|Lost to Follow-up|0
7601093|NCT00893789|12007110|FG002|Overall Study|Lost to Follow-up|0
7601094|NCT00893789|12007111|FG003|Overall Study|Lost to Follow-up|1
7772868|NCT00895661|12218020|FG000|Overall Study|Death|1
7772869|NCT00895661|12218020|FG000|Overall Study|reason unknown|2
7772870|NCT00895843|12218062|FG000|Overall Study|Protocol Violation|12
7601095|NCT03901144|12007129|FG000|Overall Study|Lost to Follow-up|1
7601096|NCT03901144|12007130|FG001|Overall Study|Lost to Follow-up|1
7601097|NCT03901144|12007131|FG002|Overall Study|Lost to Follow-up|1
7601098|NCT03901144|12007132|FG003|Overall Study|Lost to Follow-up|1
7601165|NCT03877926|12007485|FG000|Overall Study|Adverse Event|1
7601166|NCT03877926|12007486|FG001|Overall Study|Adverse Event|0
7601167|NCT03877926|12007487|FG002|Overall Study|Adverse Event|0
7601168|NCT03877926|12007488|FG003|Overall Study|Adverse Event|0
7601169|NCT03877926|12007485|FG000|Overall Study|Death|2
7601170|NCT03877926|12007486|FG001|Overall Study|Death|2
7601171|NCT03877926|12007487|FG002|Overall Study|Death|2
7601172|NCT03877926|12007488|FG003|Overall Study|Death|0
7601173|NCT03877926|12007485|FG000|Overall Study|Lost to Follow-up|41
7601174|NCT03877926|12007486|FG001|Overall Study|Lost to Follow-up|52
7601175|NCT03877926|12007487|FG002|Overall Study|Lost to Follow-up|45
7601176|NCT03877926|12007488|FG003|Overall Study|Lost to Follow-up|17
7601177|NCT03877926|12007485|FG000|Overall Study|Physician Decision|2
7601178|NCT03877926|12007486|FG001|Overall Study|Physician Decision|0
7601179|NCT03877926|12007487|FG002|Overall Study|Physician Decision|2
7601180|NCT03877926|12007488|FG003|Overall Study|Physician Decision|0
7601181|NCT03877926|12007485|FG000|Overall Study|Withdrawal by Subject|18
7601182|NCT03877926|12007486|FG001|Overall Study|Withdrawal by Subject|21
7772871|NCT00895843|12218063|FG001|Overall Study|Protocol Violation|12
7772872|NCT00895895|12218074|FG000|Period 1|Adverse Event|7
7772873|NCT00895895|12218075|FG001|Period 1|Adverse Event|6
7772874|NCT00895895|12218076|FG002|Period 1|Adverse Event|4
7772875|NCT00895895|12218077|FG003|Period 1|Adverse Event|6
7772876|NCT00895895|12218078|FG004|Period 1|Adverse Event|7
7772877|NCT00895895|12218074|FG000|Period 1|Death|0
7772878|NCT00895895|12218075|FG001|Period 1|Death|0
7772879|NCT00895895|12218076|FG002|Period 1|Death|0
7772880|NCT00895895|12218077|FG003|Period 1|Death|0
7772881|NCT00895895|12218078|FG004|Period 1|Death|1
7601183|NCT03877926|12007487|FG002|Overall Study|Withdrawal by Subject|12
7601184|NCT03877926|12007488|FG003|Overall Study|Withdrawal by Subject|4
7601185|NCT03877926|12007485|FG000|Overall Study|Other - Various|4
7601186|NCT03877926|12007486|FG001|Overall Study|Other - Various|1
7601187|NCT03877926|12007487|FG002|Overall Study|Other - Various|1
7601188|NCT03877926|12007488|FG003|Overall Study|Other - Various|0
7601189|NCT03877926|12007485|FG000|Overall Study|Not Treated|3
7601190|NCT03877926|12007486|FG001|Overall Study|Not Treated|1
7601191|NCT03877926|12007487|FG002|Overall Study|Not Treated|1
7772882|NCT00895895|12218074|FG000|Period 1|discontinued by sponsor|2
7772883|NCT00895895|12218075|FG001|Period 1|discontinued by sponsor|1
7601192|NCT03877926|12007488|FG003|Overall Study|Not Treated|0
7601193|NCT03862807|12007511|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1
7601194|NCT03857867|12007515|FG000|Overall Study|Physician Decision|1
7601195|NCT03691571|12007522|FG000|Overall Study|Withdrawal by Subject|9
7601196|NCT03691571|12007523|FG001|Overall Study|Withdrawal by Subject|2
7601197|NCT03436199|12007533|FG000|Overall Study|Adverse Event|15
7601198|NCT03436199|12007534|FG001|Overall Study|Adverse Event|40
7601199|NCT03436199|12007535|FG002|Overall Study|Adverse Event|7
7601099|NCT03461211|12007157|FG000|Overall Study|Adverse Event|1
7601100|NCT03461211|12007158|FG001|Overall Study|Adverse Event|1
7601101|NCT03461211|12007157|FG000|Overall Study|Lack of Efficacy|0
7601102|NCT03461211|12007158|FG001|Overall Study|Lack of Efficacy|1
7601103|NCT03276780|12007168|FG000|Overall Study|Withdrawal by Subject|5
7601104|NCT03276780|12007169|FG001|Overall Study|Withdrawal by Subject|3
7601105|NCT03276780|12007168|FG000|Overall Study|Lost to Follow-up|3
7601106|NCT03276780|12007169|FG001|Overall Study|Lost to Follow-up|5
7601107|NCT03276780|12007168|FG000|Overall Study|Moved out of state|1
7601108|NCT03276780|12007169|FG001|Overall Study|Moved out of state|1
7601109|NCT03276780|12007168|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1
7601110|NCT03276780|12007169|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0
7601111|NCT03276780|12007168|FG000|Overall Study|No show to appointments after baseline through Week 5|8
7601112|NCT03276780|12007169|FG001|Overall Study|No show to appointments after baseline through Week 5|1
7601113|NCT03050814|12007193|FG000|Overall Study|Screen failures|0
7601114|NCT03050814|12007194|FG001|Overall Study|Screen failures|0
7601115|NCT03050814|12007195|FG002|Overall Study|Screen failures|4
7601116|NCT02797262|12007203|FG000|Overall Study|Withdrawal by Subject|5
7601117|NCT02797262|12007204|FG001|Overall Study|Withdrawal by Subject|1
7601118|NCT02797262|12007203|FG000|Overall Study|Lost to Follow-up|10
7601119|NCT02797262|12007204|FG001|Overall Study|Lost to Follow-up|7
7601120|NCT02797262|12007203|FG000|Overall Study|Death|1
7601121|NCT02797262|12007204|FG001|Overall Study|Death|2
7601122|NCT02797262|12007203|FG000|Overall Study|Adverse Event|1
7601123|NCT02797262|12007204|FG001|Overall Study|Adverse Event|0
7601124|NCT02797262|12007203|FG000|Overall Study|COVID-19|2
7601125|NCT02797262|12007204|FG001|Overall Study|COVID-19|1
7601126|NCT02797262|12007203|FG000|Overall Study|Out-of-country|1
7601127|NCT02797262|12007204|FG001|Overall Study|Out-of-country|0
7601128|NCT02409368|12007222|FG000|Overall Study|Adverse event unrelated to study drug|16
7601129|NCT02409368|12007223|FG001|Overall Study|Adverse event unrelated to study drug|42
7601130|NCT02409368|12007224|FG002|Overall Study|Adverse event unrelated to study drug|10
7601131|NCT02409368|12007222|FG000|Overall Study|Death|5
7601132|NCT02409368|12007223|FG001|Overall Study|Death|17
7601133|NCT02409368|12007224|FG002|Overall Study|Death|5
7601134|NCT02409368|12007222|FG000|Overall Study|Disease Progression|101
7601135|NCT02409368|12007223|FG001|Overall Study|Disease Progression|346
7601136|NCT02409368|12007224|FG002|Overall Study|Disease Progression|63
7601137|NCT02409368|12007222|FG000|Overall Study|Lost to Follow-up|1
7601138|NCT02409368|12007223|FG001|Overall Study|Lost to Follow-up|5
7601139|NCT02409368|12007224|FG002|Overall Study|Lost to Follow-up|0
7601140|NCT02409368|12007222|FG000|Overall Study|maximum clinical benefit|3
7601141|NCT02409368|12007223|FG001|Overall Study|maximum clinical benefit|8
7601142|NCT02409368|12007224|FG002|Overall Study|maximum clinical benefit|1
7601143|NCT02409368|12007222|FG000|Overall Study|poor/non compliant|0
7601144|NCT02409368|12007223|FG001|Overall Study|poor/non compliant|2
7601145|NCT02409368|12007224|FG002|Overall Study|poor/non compliant|2
7601146|NCT02409368|12007222|FG000|Overall Study|study drug toxicity|12
7601147|NCT02409368|12007223|FG001|Overall Study|study drug toxicity|35
7601148|NCT02409368|12007224|FG002|Overall Study|study drug toxicity|6
7601149|NCT02409368|12007222|FG000|Overall Study|no longer meets study criteria|3
7601150|NCT02409368|12007223|FG001|Overall Study|no longer meets study criteria|9
7601151|NCT02409368|12007224|FG002|Overall Study|no longer meets study criteria|3
7601152|NCT02409368|12007222|FG000|Overall Study|Participant request to discontinue|3
7601153|NCT02409368|12007223|FG001|Overall Study|Participant request to discontinue|3
7601154|NCT02409368|12007224|FG002|Overall Study|Participant request to discontinue|3
7601155|NCT02409368|12007222|FG000|Overall Study|Participant withdrew consent|2
7601156|NCT02409368|12007223|FG001|Overall Study|Participant withdrew consent|4
7601157|NCT02409368|12007224|FG002|Overall Study|Participant withdrew consent|3
7601158|NCT02409368|12007222|FG000|Overall Study|Other Reasons|2
7601159|NCT02409368|12007223|FG001|Overall Study|Other Reasons|17
7601160|NCT02409368|12007224|FG002|Overall Study|Other Reasons|3
7601161|NCT02409368|12007222|FG000|Overall Study|Not Reported|0
7601162|NCT02409368|12007223|FG001|Overall Study|Not Reported|1
7601163|NCT02409368|12007224|FG002|Overall Study|Not Reported|0
7601164|NCT01285102|12007400|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4
7601200|NCT03436199|12007533|FG000|Overall Study|Withdrawal by Subject|4
7601201|NCT03436199|12007534|FG001|Overall Study|Withdrawal by Subject|10
7601202|NCT03436199|12007535|FG002|Overall Study|Withdrawal by Subject|3
7601203|NCT03436199|12007533|FG000|Overall Study|Lost to Follow-up|1
7601204|NCT03436199|12007534|FG001|Overall Study|Lost to Follow-up|0
7601205|NCT03436199|12007535|FG002|Overall Study|Lost to Follow-up|2
7601206|NCT03436199|12007533|FG000|Overall Study|Protocol Violation|1
7601207|NCT03436199|12007534|FG001|Overall Study|Protocol Violation|1
7601208|NCT03436199|12007535|FG002|Overall Study|Protocol Violation|0
7601209|NCT03436199|12007533|FG000|Overall Study|Physician Decision|0
7601210|NCT03436199|12007534|FG001|Overall Study|Physician Decision|1
7601211|NCT03436199|12007535|FG002|Overall Study|Physician Decision|0
7601212|NCT03436199|12007533|FG000|Overall Study|Could not return to clinic|1
7601213|NCT03436199|12007534|FG001|Overall Study|Could not return to clinic|0
7601214|NCT03436199|12007535|FG002|Overall Study|Could not return to clinic|0
7601215|NCT03436199|12007533|FG000|Overall Study|Withdrawn per physician|0
7601216|NCT03436199|12007534|FG001|Overall Study|Withdrawn per physician|1
7601217|NCT03436199|12007535|FG002|Overall Study|Withdrawn per physician|0
7772884|NCT00895895|12218076|FG002|Period 1|discontinued by sponsor|2
7772885|NCT00895895|12218077|FG003|Period 1|discontinued by sponsor|1
7772886|NCT00895895|12218078|FG004|Period 1|discontinued by sponsor|1
7772887|NCT00895895|12218074|FG000|Period 1|failed to return|0
7772888|NCT00895895|12218075|FG001|Period 1|failed to return|0
7772889|NCT00895895|12218076|FG002|Period 1|failed to return|1
7772890|NCT00895895|12218077|FG003|Period 1|failed to return|0
7772891|NCT00895895|12218078|FG004|Period 1|failed to return|1
7772892|NCT00895895|12218074|FG000|Period 1|investigator request|0
7772893|NCT00895895|12218075|FG001|Period 1|investigator request|1
7772894|NCT00895895|12218076|FG002|Period 1|investigator request|0
7772895|NCT00895895|12218077|FG003|Period 1|investigator request|0
7772896|NCT00895895|12218078|FG004|Period 1|investigator request|0
7772897|NCT00895895|12218074|FG000|Period 1|Lost to Follow-up|2
7772898|NCT00895895|12218075|FG001|Period 1|Lost to Follow-up|1
7772899|NCT00895895|12218076|FG002|Period 1|Lost to Follow-up|3
7772900|NCT00895895|12218077|FG003|Period 1|Lost to Follow-up|2
7772901|NCT00895895|12218078|FG004|Period 1|Lost to Follow-up|3
7772902|NCT00895895|12218074|FG000|Period 1|Other|1
7772903|NCT00895895|12218075|FG001|Period 1|Other|2
7772904|NCT00895895|12218076|FG002|Period 1|Other|1
7772905|NCT00895895|12218077|FG003|Period 1|Other|1
7772906|NCT00895895|12218078|FG004|Period 1|Other|1
7772907|NCT00895895|12218074|FG000|Period 1|Protocol Violation|0
7772908|NCT00895895|12218075|FG001|Period 1|Protocol Violation|1
7772909|NCT00895895|12218076|FG002|Period 1|Protocol Violation|0
7772910|NCT00895895|12218077|FG003|Period 1|Protocol Violation|0
7772911|NCT00895895|12218078|FG004|Period 1|Protocol Violation|0
7772912|NCT00895895|12218074|FG000|Period 1|Withdrawal by Subject|6
7772913|NCT00895895|12218075|FG001|Period 1|Withdrawal by Subject|6
7601226|NCT03217136|12007563|FG000|Overall Study|Lost to Follow-up|2
7601227|NCT03217136|12007564|FG001|Overall Study|Lost to Follow-up|1
7601228|NCT03217136|12007563|FG000|Overall Study|Site Randomized Participant in Error|0
7601229|NCT03217136|12007564|FG001|Overall Study|Site Randomized Participant in Error|1
7601230|NCT03217136|12007563|FG000|Overall Study|Did Not Meet Criteria after Randomization|0
7601231|NCT03217136|12007564|FG001|Overall Study|Did Not Meet Criteria after Randomization|1
7601232|NCT03217136|12007563|FG000|Overall Study|Dispensing Error|1
7601233|NCT03217136|12007564|FG001|Overall Study|Dispensing Error|0
7601234|NCT03217136|12007563|FG000|Overall Study|Withdrawal by Parent/Guardian|1
7601235|NCT03217136|12007564|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7601236|NCT03181542|12007572|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1
7601237|NCT03181542|12007573|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0
7601238|NCT03985293|12007628|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5
7601239|NCT03985293|12007629|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2
7772914|NCT00895895|12218076|FG002|Period 1|Withdrawal by Subject|8
7772915|NCT00895895|12218077|FG003|Period 1|Withdrawal by Subject|2
7772916|NCT00895895|12218078|FG004|Period 1|Withdrawal by Subject|4
7772917|NCT00895895|12218074|FG000|Period 1|unsatisfactory response-efficacy|2
7772918|NCT00895895|12218075|FG001|Period 1|unsatisfactory response-efficacy|0
7772919|NCT00895895|12218076|FG002|Period 1|unsatisfactory response-efficacy|0
7772920|NCT00895895|12218077|FG003|Period 1|unsatisfactory response-efficacy|0
7772921|NCT00895895|12218078|FG004|Period 1|unsatisfactory response-efficacy|0
7772922|NCT00895895|12218074|FG000|Period 1|randomized and not treated|1
7772923|NCT00895895|12218075|FG001|Period 1|randomized and not treated|3
7772924|NCT00895895|12218076|FG002|Period 1|randomized and not treated|1
7772925|NCT00895895|12218077|FG003|Period 1|randomized and not treated|1
7772926|NCT00895895|12218078|FG004|Period 1|randomized and not treated|2
7772927|NCT00895895|12218074|FG000|After Period 1, Prior to Period 2|Adverse Event|0
7772928|NCT00895895|12218075|FG001|After Period 1, Prior to Period 2|Adverse Event|0
7772929|NCT00895895|12218076|FG002|After Period 1, Prior to Period 2|Adverse Event|1
7772930|NCT00895895|12218077|FG003|After Period 1, Prior to Period 2|Adverse Event|0
7772931|NCT00895895|12218078|FG004|After Period 1, Prior to Period 2|Adverse Event|0
7772932|NCT00895895|12218074|FG000|After Period 1, Prior to Period 2|Other|0
7772933|NCT00895895|12218075|FG001|After Period 1, Prior to Period 2|Other|0
7772934|NCT00895895|12218076|FG002|After Period 1, Prior to Period 2|Other|1
7772935|NCT00895895|12218077|FG003|After Period 1, Prior to Period 2|Other|0
7772936|NCT00895895|12218078|FG004|After Period 1, Prior to Period 2|Other|0
7772937|NCT00895895|12218074|FG000|After Period 1, Prior to Period 2|Protocol Violation|0
7772938|NCT00895895|12218075|FG001|After Period 1, Prior to Period 2|Protocol Violation|0
7772939|NCT00895895|12218076|FG002|After Period 1, Prior to Period 2|Protocol Violation|0
7772940|NCT00895895|12218077|FG003|After Period 1, Prior to Period 2|Protocol Violation|0
7772941|NCT00895895|12218078|FG004|After Period 1, Prior to Period 2|Protocol Violation|1
7772942|NCT00895895|12218074|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0
7772943|NCT00895895|12218075|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0
7772944|NCT00895895|12218076|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0
7772945|NCT00895895|12218077|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0
7772946|NCT00895895|12218078|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1
7772947|NCT00895895|12218074|FG000|Period 2|Adverse Event|3
7772948|NCT00895895|12218075|FG001|Period 2|Adverse Event|3
7772949|NCT00895895|12218076|FG002|Period 2|Adverse Event|5
7772950|NCT00895895|12218077|FG003|Period 2|Adverse Event|2
7772951|NCT00895895|12218078|FG004|Period 2|Adverse Event|5
7772952|NCT00895895|12218074|FG000|Period 2|Death|0
7772953|NCT00895895|12218075|FG001|Period 2|Death|0
7772954|NCT00895895|12218076|FG002|Period 2|Death|1
7601240|NCT03985293|12007630|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3
7601241|NCT03985293|12007631|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8
7601242|NCT03985293|12007632|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15
7601243|NCT03985293|12007633|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24
7601244|NCT03985293|12007628|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1
7601245|NCT03985293|12007629|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3
7601246|NCT03985293|12007630|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0
7601247|NCT03985293|12007631|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3
7601248|NCT03985293|12007632|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3
7601249|NCT03985293|12007633|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1
7601250|NCT03985293|12007628|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1
7601251|NCT03985293|12007629|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1
7601252|NCT03985293|12007630|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0
7601253|NCT03985293|12007631|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1
7601254|NCT03985293|12007632|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0
7601255|NCT03985293|12007633|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0
7601256|NCT03985293|12007628|FG000|DOUBLE-BLIND TREATMENT|Other|1
7601257|NCT03985293|12007629|FG001|DOUBLE-BLIND TREATMENT|Other|2
7601258|NCT03985293|12007630|FG002|DOUBLE-BLIND TREATMENT|Other|0
7601259|NCT03985293|12007631|FG003|DOUBLE-BLIND TREATMENT|Other|2
7601260|NCT03985293|12007632|FG004|DOUBLE-BLIND TREATMENT|Other|1
7601261|NCT03985293|12007633|FG005|DOUBLE-BLIND TREATMENT|Other|0
7601262|NCT03985293|12007628|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1
7601263|NCT03985293|12007629|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2
7601264|NCT03985293|12007630|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0
7601265|NCT03985293|12007631|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0
7601266|NCT03985293|12007632|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0
7601267|NCT03985293|12007633|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1
7601268|NCT03985293|12007628|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0
7601269|NCT03985293|12007629|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4
7601270|NCT03985293|12007630|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2
7601271|NCT03985293|12007631|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0
7601272|NCT03985293|12007632|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1
7601273|NCT03985293|12007633|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7
7601274|NCT03985293|12007628|FG000|FOLLOW-UP|Lost to Follow-up|0
7601275|NCT03985293|12007629|FG001|FOLLOW-UP|Lost to Follow-up|0
7601276|NCT03985293|12007630|FG002|FOLLOW-UP|Lost to Follow-up|1
7601277|NCT03985293|12007631|FG003|FOLLOW-UP|Lost to Follow-up|0
7601278|NCT03985293|12007632|FG004|FOLLOW-UP|Lost to Follow-up|0
7601279|NCT03985293|12007633|FG005|FOLLOW-UP|Lost to Follow-up|0
7772955|NCT00895895|12218077|FG003|Period 2|Death|0
7772956|NCT00895895|12218078|FG004|Period 2|Death|0
7772957|NCT00895895|12218074|FG000|Period 2|discontinued by sponsor|44
7772958|NCT00895895|12218075|FG001|Period 2|discontinued by sponsor|44
7772959|NCT00895895|12218076|FG002|Period 2|discontinued by sponsor|38
7772960|NCT00895895|12218077|FG003|Period 2|discontinued by sponsor|46
7772961|NCT00895895|12218078|FG004|Period 2|discontinued by sponsor|37
7772962|NCT00895895|12218074|FG000|Period 2|failed to return|2
7772963|NCT00895895|12218075|FG001|Period 2|failed to return|0
7772964|NCT00895895|12218076|FG002|Period 2|failed to return|0
7772965|NCT00895895|12218077|FG003|Period 2|failed to return|0
7772966|NCT00895895|12218078|FG004|Period 2|failed to return|0
7772967|NCT00895895|12218074|FG000|Period 2|investigator request|2
7772968|NCT00895895|12218075|FG001|Period 2|investigator request|0
7772969|NCT00895895|12218076|FG002|Period 2|investigator request|0
7772970|NCT00895895|12218077|FG003|Period 2|investigator request|0
7772971|NCT00895895|12218078|FG004|Period 2|investigator request|0
7772972|NCT00895895|12218074|FG000|Period 2|Lost to Follow-up|1
7772973|NCT00895895|12218075|FG001|Period 2|Lost to Follow-up|2
7772974|NCT00895895|12218076|FG002|Period 2|Lost to Follow-up|1
7772975|NCT00895895|12218077|FG003|Period 2|Lost to Follow-up|1
7772976|NCT00895895|12218078|FG004|Period 2|Lost to Follow-up|0
7772977|NCT00895895|12218074|FG000|Period 2|Other|1
7772978|NCT00895895|12218075|FG001|Period 2|Other|1
7772979|NCT00895895|12218076|FG002|Period 2|Other|3
7772980|NCT00895895|12218077|FG003|Period 2|Other|1
7772981|NCT00895895|12218078|FG004|Period 2|Other|1
7772982|NCT00895895|12218074|FG000|Period 2|Protocol Violation|1
7772983|NCT00895895|12218075|FG001|Period 2|Protocol Violation|0
7772984|NCT00895895|12218076|FG002|Period 2|Protocol Violation|1
7772985|NCT00895895|12218077|FG003|Period 2|Protocol Violation|1
7772986|NCT00895895|12218078|FG004|Period 2|Protocol Violation|1
7772987|NCT00895895|12218074|FG000|Period 2|Withdrawal by Subject|0
7772988|NCT00895895|12218075|FG001|Period 2|Withdrawal by Subject|2
7772989|NCT00895895|12218076|FG002|Period 2|Withdrawal by Subject|0
7772990|NCT00895895|12218077|FG003|Period 2|Withdrawal by Subject|3
7772991|NCT00895895|12218078|FG004|Period 2|Withdrawal by Subject|5
7772992|NCT00895895|12218074|FG000|Period 2|unsatisfactory response-efficacy|2
7772993|NCT00895895|12218075|FG001|Period 2|unsatisfactory response-efficacy|1
7772994|NCT00895895|12218076|FG002|Period 2|unsatisfactory response-efficacy|0
7601280|NCT03846427|12007647|FG000|Overall Study|Death|7
7601281|NCT03846427|12007647|FG000|Overall Study|Withdrawal by Subject|2
7601282|NCT03846427|12007647|FG000|Overall Study|Remaining in study|59
7601285|NCT03776357|12007660|FG000|Overall Study|Lost to Follow-up|3
7772995|NCT00895895|12218077|FG003|Period 2|unsatisfactory response-efficacy|0
7772996|NCT00895895|12218078|FG004|Period 2|unsatisfactory response-efficacy|0
7772997|NCT00895947|12218123|FG000|Overall Study|Adverse Event|3
7772998|NCT00895947|12218124|FG001|Overall Study|Adverse Event|4
7772999|NCT00895947|12218123|FG000|Overall Study|Lost to Follow-up|3
7773000|NCT00895947|12218124|FG001|Overall Study|Lost to Follow-up|4
7773001|NCT00895947|12218123|FG000|Overall Study|Protocol Violation|4
7773002|NCT00895947|12218124|FG001|Overall Study|Protocol Violation|2
7773003|NCT00895947|12218123|FG000|Overall Study|Withdrawal by Subject|2
7773004|NCT00895947|12218124|FG001|Overall Study|Withdrawal by Subject|0
7773005|NCT00896051|12218150|FG000|Overall Study|Adverse Event|2
7773006|NCT00896051|12218151|FG001|Overall Study|Adverse Event|1
7773007|NCT00896051|12218150|FG000|Overall Study|Lost to Follow-up|3
7773008|NCT00896051|12218151|FG001|Overall Study|Lost to Follow-up|2
7773009|NCT00896051|12218150|FG000|Overall Study|Withdrawal by Subject|3
7773010|NCT00896051|12218151|FG001|Overall Study|Withdrawal by Subject|2
7773011|NCT00896051|12218150|FG000|Overall Study|Subject noncompliant|1
7773012|NCT00896051|12218151|FG001|Overall Study|Subject noncompliant|3
7773013|NCT00896051|12218150|FG000|Overall Study|Other|1
7773014|NCT00896051|12218151|FG001|Overall Study|Other|1
7773015|NCT00896168|12218177|FG000|Overall Study|Adverse Event|4
7773016|NCT00896168|12218178|FG001|Overall Study|Adverse Event|7
7773017|NCT00896168|12218177|FG000|Overall Study|Treatment failure|8
7773018|NCT00896168|12218178|FG001|Overall Study|Treatment failure|10
7773019|NCT00896168|12218177|FG000|Overall Study|Lost to Follow-up|1
7773020|NCT00896168|12218178|FG001|Overall Study|Lost to Follow-up|1
7773021|NCT00896168|12218177|FG000|Overall Study|Other|1
7773022|NCT00896168|12218178|FG001|Overall Study|Other|1
7773023|NCT00896233|12218188|FG000|Overall Study|Claustrophobia during MRI|1
7773024|NCT00896337|12218202|FG000|Overall Study|Death|7
7773025|NCT00896337|12218202|FG000|Overall Study|Withdrawal by Subject|7
7773026|NCT00896337|12218202|FG000|Overall Study|Lost to Follow-up|11
7773027|NCT00896363|12218214|FG000|Overall Study|Adverse Event|3
7773028|NCT00896363|12218215|FG001|Overall Study|Adverse Event|4
7773029|NCT00896363|12218216|FG002|Overall Study|Adverse Event|2
7773030|NCT00896363|12218214|FG000|Overall Study|Lack of Efficacy|0
7601286|NCT03656068|12007664|FG000|Overall Study|Withdrawal by Subject|4
7601287|NCT03656068|12007664|FG000|Overall Study|Adverse Event|1
7601288|NCT03400956|12007680|FG000|Treatment Period 1|Adverse Event|0
7601289|NCT03400956|12007681|FG001|Treatment Period 1|Adverse Event|1
7601290|NCT03400956|12007682|FG002|Treatment Period 1|Adverse Event|0
7601291|NCT03400956|12007680|FG000|Treatment Period 1|Lost to Follow-up|0
7601292|NCT03400956|12007681|FG001|Treatment Period 1|Lost to Follow-up|0
7601293|NCT03400956|12007682|FG002|Treatment Period 1|Lost to Follow-up|1
7601294|NCT03400956|12007680|FG000|Treatment Period 1|Protocol Violation|0
7601295|NCT03400956|12007681|FG001|Treatment Period 1|Protocol Violation|2
7601296|NCT03400956|12007682|FG002|Treatment Period 1|Protocol Violation|0
7601297|NCT03400956|12007680|FG000|Treatment Period 1|Study terminated by sponsor|3
7601298|NCT03400956|12007681|FG001|Treatment Period 1|Study terminated by sponsor|1
7601299|NCT03400956|12007682|FG002|Treatment Period 1|Study terminated by sponsor|1
7601300|NCT03400956|12007680|FG000|Treatment Period 1|Withdrawal by Subject|0
7601301|NCT03400956|12007681|FG001|Treatment Period 1|Withdrawal by Subject|2
7601302|NCT03400956|12007682|FG002|Treatment Period 1|Withdrawal by Subject|4
7601303|NCT03400956|12007680|FG000|Treatment Period 1|Other|1
7601304|NCT03400956|12007681|FG001|Treatment Period 1|Other|2
7601305|NCT03400956|12007682|FG002|Treatment Period 1|Other|3
7601306|NCT03400956|12007680|FG000|Post-treatment Period 1|Adverse Event|0
7601307|NCT03400956|12007681|FG001|Post-treatment Period 1|Adverse Event|0
7601308|NCT03400956|12007682|FG002|Post-treatment Period 1|Adverse Event|1
7601309|NCT03400956|12007680|FG000|Post-treatment Period 1|Physician Decision|2
7601310|NCT03400956|12007681|FG001|Post-treatment Period 1|Physician Decision|3
7601311|NCT03400956|12007682|FG002|Post-treatment Period 1|Physician Decision|0
7601312|NCT03400956|12007680|FG000|Post-treatment Period 1|Study terminated by sponsor|11
7601313|NCT03400956|12007681|FG001|Post-treatment Period 1|Study terminated by sponsor|10
7601314|NCT03400956|12007682|FG002|Post-treatment Period 1|Study terminated by sponsor|11
7601315|NCT03400956|12007680|FG000|Post-treatment Period 1|Withdrawal by Subject|5
7601316|NCT03400956|12007681|FG001|Post-treatment Period 1|Withdrawal by Subject|0
7601317|NCT03400956|12007682|FG002|Post-treatment Period 1|Withdrawal by Subject|0
7601318|NCT03400956|12007680|FG000|Post-treatment Period 1|Other|4
7773031|NCT00896363|12218215|FG001|Overall Study|Lack of Efficacy|2
7773032|NCT00896363|12218216|FG002|Overall Study|Lack of Efficacy|1
7773033|NCT00896363|12218214|FG000|Overall Study|Withdrawal by Subject|3
7773034|NCT00896363|12218215|FG001|Overall Study|Withdrawal by Subject|5
7773035|NCT00896363|12218216|FG002|Overall Study|Withdrawal by Subject|5
7773036|NCT00896454|12218235|FG000|Overall Study|Death|10
7773037|NCT00896454|12218235|FG000|Overall Study|Adverse Event|8
7773038|NCT00896454|12218235|FG000|Overall Study|Disease Progression|5
7773039|NCT00896454|12218235|FG000|Overall Study|Other|4
7773040|NCT00896454|12218235|FG000|Overall Study|Requirement for alternative therapy|3
7773041|NCT00896454|12218235|FG000|Overall Study|Ongoing in study|2
7773042|NCT00896454|12218235|FG000|Overall Study|Withdrawal by Subject|1
7773043|NCT00896480|12218239|FG000|Overall Study|Disease progression/recurrence|21
7773044|NCT00896649|12218246|FG000|Overall Study|Physician Decision|1
7773045|NCT00896649|12218246|FG000|Overall Study|Pregnancy|1
7773046|NCT00896649|12218246|FG000|Overall Study|missing documentation|1
7773047|NCT00896649|12218246|FG000|Overall Study|technical difficulties|2
7773048|NCT00897390|12218260|FG000|Overall Study|Adverse Event|2
7773049|NCT00897390|12218260|FG000|Overall Study|No Longer Met Study Criteria|1
7773050|NCT00897390|12218260|FG000|Overall Study|Personal Reasons|1
7773051|NCT00897390|12218260|FG000|Overall Study|Did not Return for the Clinic Visit|2
7773052|NCT00897715|12218287|FG000|Overall Study|Lost to Follow-up|0
7773053|NCT00897715|12218288|FG001|Overall Study|Lost to Follow-up|1
7773054|NCT00897715|12218287|FG000|Overall Study|Physician Decision|1
7773055|NCT00897715|12218288|FG001|Overall Study|Physician Decision|0
7773056|NCT00897715|12218287|FG000|Overall Study|increased risk of infection|1
7773057|NCT00897715|12218288|FG001|Overall Study|increased risk of infection|0
7773058|NCT00898443|12218304|FG000|Overall Study|Withdrawal by Subject|1
7773059|NCT00898443|12218305|FG001|Overall Study|Withdrawal by Subject|0
7773060|NCT00898807|12218319|FG000|Overall Study|Withdrawal by Subject|5
7773061|NCT00898807|12218320|FG001|Overall Study|Withdrawal by Subject|3
7773062|NCT00898807|12218319|FG000|Overall Study|Family pressure to discontinue|2
7773063|NCT00898807|12218320|FG001|Overall Study|Family pressure to discontinue|2
7773064|NCT00898807|12218319|FG000|Overall Study|Lost to Follow-up|1
7773065|NCT00898807|12218320|FG001|Overall Study|Lost to Follow-up|3
7773066|NCT00898807|12218319|FG000|Overall Study|Death|0
7773067|NCT00898807|12218320|FG001|Overall Study|Death|1
7773068|NCT00899353|12218339|FG000|Overall Study|Adverse Event|2
7773069|NCT00899353|12218339|FG000|Overall Study|Lost to Follow-up|1
7773070|NCT00899353|12218339|FG000|Overall Study|Withdrawal by Subject|2
7773071|NCT00899392|12218362|FG000|Overall Study|Subject didn't finish/partial pilot data|21
7773072|NCT00899392|12218363|FG001|Overall Study|Subject didn't finish/partial pilot data|24
7773073|NCT00899431|12218372|FG000|Overall Study|Physician Decision|1
7773074|NCT00899431|12218373|FG001|Overall Study|Physician Decision|0
7601319|NCT03400956|12007681|FG001|Post-treatment Period 1|Other|3
7601320|NCT03400956|12007682|FG002|Post-treatment Period 1|Other|4
7601321|NCT03400956|12007680|FG000|Treatment Period 2|Adverse Event|2
7601322|NCT03400956|12007681|FG001|Treatment Period 2|Adverse Event|1
7601323|NCT03400956|12007682|FG002|Treatment Period 2|Adverse Event|1
7601324|NCT03400956|12007680|FG000|Treatment Period 2|Lost to Follow-up|1
7601325|NCT03400956|12007681|FG001|Treatment Period 2|Lost to Follow-up|1
7601326|NCT03400956|12007682|FG002|Treatment Period 2|Lost to Follow-up|0
7601327|NCT03400956|12007680|FG000|Treatment Period 2|Withdrawal by Subject|0
7601328|NCT03400956|12007681|FG001|Treatment Period 2|Withdrawal by Subject|0
7601329|NCT03400956|12007682|FG002|Treatment Period 2|Withdrawal by Subject|3
7601330|NCT03400956|12007680|FG000|Treatment Period 2|Other|1
7601331|NCT03400956|12007681|FG001|Treatment Period 2|Other|1
7601332|NCT03400956|12007682|FG002|Treatment Period 2|Other|0
7601333|NCT03400956|12007680|FG000|Follow-up Period|Withdrawal by Subject|0
7601334|NCT03400956|12007681|FG001|Follow-up Period|Withdrawal by Subject|0
7601335|NCT03400956|12007682|FG002|Follow-up Period|Withdrawal by Subject|1
7601336|NCT03400956|12007680|FG000|Follow-up Period|Other|0
7601337|NCT03400956|12007681|FG001|Follow-up Period|Other|0
7601338|NCT03400956|12007682|FG002|Follow-up Period|Other|1
7601339|NCT03126539|12007695|FG000|Overall Study|Lost to Follow-up|1
7601340|NCT03126539|12007696|FG001|Overall Study|Lost to Follow-up|1
7601341|NCT03126539|12007697|FG002|Overall Study|Lost to Follow-up|1
7601342|NCT03126539|12007698|FG003|Overall Study|Lost to Follow-up|0
7601343|NCT03126539|12007699|FG004|Overall Study|Lost to Follow-up|0
7773075|NCT00899431|12218374|FG002|Overall Study|Physician Decision|0
7773076|NCT00899548|12218403|FG000|Overall Study|Physician Decision|3
7773077|NCT00899678|12218427|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6
7773078|NCT00899678|12218428|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0
7773079|NCT00899678|12218429|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0
7773080|NCT00899678|12218427|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
7773081|NCT00899678|12218428|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
7773082|NCT00899678|12218429|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
7773083|NCT00899678|12218427|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1
7773084|NCT00899678|12218428|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0
7773085|NCT00899678|12218429|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0
7773086|NCT00899678|12218427|FG000|Induction Period (Weeks 0 to 6)|Other reason|1
7773087|NCT00899678|12218428|FG001|Induction Period (Weeks 0 to 6)|Other reason|0
7773088|NCT00899678|12218429|FG002|Induction Period (Weeks 0 to 6)|Other reason|0
7773089|NCT00899678|12218427|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
7773090|NCT00899678|12218428|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
7773091|NCT00899678|12218429|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
7773092|NCT00899678|12218427|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
7773093|NCT00899678|12218428|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
7773094|NCT00899678|12218429|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
7773095|NCT00899678|12218427|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
7773096|NCT00899678|12218428|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
7773097|NCT00899678|12218429|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
7773098|NCT00899678|12218427|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
7773099|NCT00899678|12218428|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
7773100|NCT00899678|12218429|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
7773101|NCT00899678|12218427|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0
7773102|NCT00899678|12218428|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2
7773103|NCT00899678|12218429|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2
7773104|NCT00899847|12218452|FG000|Overall Study|Lack of suitable allogeneic donor|2
7799980|NCT01090453|12257157|FG001|Overall Study|Protocol Violation|0
7799981|NCT01090453|12257156|FG000|Overall Study|Other|2
7799982|NCT01090453|12257157|FG001|Overall Study|Other|4
7799983|NCT01090453|12257156|FG000|Overall Study|Eligibility Criteria|0
7799984|NCT01090453|12257157|FG001|Overall Study|Eligibility Criteria|1
7799985|NCT01090492|12257180|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1
7799986|NCT01090492|12257181|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1
7799987|NCT01090492|12257182|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1
7799988|NCT01090492|12257183|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2
7799989|NCT01090492|12257184|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0
7799990|NCT01090492|12257185|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0
7799991|NCT01090492|12257186|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1
7799992|NCT01090492|12257187|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0
7799993|NCT01090492|12257180|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7799994|NCT01090492|12257181|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
7799995|NCT01090492|12257182|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7601364|NCT02819635|12007750|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3
7601365|NCT02819635|12007751|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1
7601366|NCT02819635|12007752|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3
7601367|NCT02819635|12007753|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5
7601368|NCT02819635|12007754|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4
7601369|NCT02819635|12007755|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9
7601370|NCT02819635|12007756|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6
7601371|NCT02819635|12007757|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0
7601372|NCT02819635|12007758|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0
7601373|NCT02819635|12007759|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0
7601374|NCT02819635|12007760|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0
7601375|NCT02819635|12007761|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0
7601376|NCT02819635|12007750|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601377|NCT02819635|12007751|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601378|NCT02819635|12007752|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601379|NCT02819635|12007753|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601380|NCT02819635|12007754|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1
7601381|NCT02819635|12007755|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3
7601382|NCT02819635|12007756|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2
7601383|NCT02819635|12007757|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601384|NCT02819635|12007758|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601385|NCT02819635|12007759|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601386|NCT02819635|12007760|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601387|NCT02819635|12007761|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601388|NCT02819635|12007750|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601389|NCT02819635|12007751|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601390|NCT02819635|12007752|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601391|NCT02819635|12007753|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601392|NCT02819635|12007754|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601393|NCT02819635|12007755|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1
7601394|NCT02819635|12007756|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1
7601395|NCT02819635|12007757|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601396|NCT02819635|12007758|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601397|NCT02819635|12007759|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601398|NCT02819635|12007760|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601399|NCT02819635|12007761|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601400|NCT02819635|12007750|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601401|NCT02819635|12007751|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601402|NCT02819635|12007752|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601403|NCT02819635|12007753|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601404|NCT02819635|12007754|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601405|NCT02819635|12007755|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601406|NCT02819635|12007756|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1
7601407|NCT02819635|12007757|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601408|NCT02819635|12007758|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601409|NCT02819635|12007759|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601410|NCT02819635|12007760|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601411|NCT02819635|12007761|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601412|NCT02819635|12007750|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2
7601413|NCT02819635|12007751|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1
7601414|NCT02819635|12007752|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1
7601415|NCT02819635|12007753|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7
7601416|NCT02819635|12007754|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5
7601417|NCT02819635|12007755|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7
7601418|NCT02819635|12007756|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3
7601419|NCT02819635|12007757|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0
7601420|NCT02819635|12007758|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0
7601421|NCT02819635|12007759|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0
7601422|NCT02819635|12007760|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0
7601423|NCT02819635|12007761|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0
7601424|NCT02819635|12007750|FG000|Substudy 2, Part 2|Adverse Event|0
7601425|NCT02819635|12007751|FG001|Substudy 2, Part 2|Adverse Event|0
7601426|NCT02819635|12007752|FG002|Substudy 2, Part 2|Adverse Event|0
7601427|NCT02819635|12007753|FG003|Substudy 2, Part 2|Adverse Event|0
7601428|NCT02819635|12007754|FG004|Substudy 2, Part 2|Adverse Event|0
7601429|NCT02819635|12007755|FG005|Substudy 2, Part 2|Adverse Event|4
7601430|NCT02819635|12007756|FG006|Substudy 2, Part 2|Adverse Event|0
7601431|NCT02819635|12007757|FG007|Substudy 2, Part 2|Adverse Event|0
7601432|NCT02819635|12007758|FG008|Substudy 2, Part 2|Adverse Event|0
7601433|NCT02819635|12007759|FG009|Substudy 2, Part 2|Adverse Event|0
7601434|NCT02819635|12007760|FG010|Substudy 2, Part 2|Adverse Event|0
7601435|NCT02819635|12007761|FG011|Substudy 2, Part 2|Adverse Event|0
7601436|NCT02819635|12007750|FG000|Substudy 2, Part 2|Withdrew consent|0
7601437|NCT02819635|12007751|FG001|Substudy 2, Part 2|Withdrew consent|0
7601438|NCT02819635|12007752|FG002|Substudy 2, Part 2|Withdrew consent|0
7601439|NCT02819635|12007753|FG003|Substudy 2, Part 2|Withdrew consent|0
7601440|NCT02819635|12007754|FG004|Substudy 2, Part 2|Withdrew consent|0
7601441|NCT02819635|12007755|FG005|Substudy 2, Part 2|Withdrew consent|3
7601442|NCT02819635|12007756|FG006|Substudy 2, Part 2|Withdrew consent|1
7601443|NCT02819635|12007757|FG007|Substudy 2, Part 2|Withdrew consent|0
7601444|NCT02819635|12007758|FG008|Substudy 2, Part 2|Withdrew consent|0
7601445|NCT02819635|12007759|FG009|Substudy 2, Part 2|Withdrew consent|0
7601446|NCT02819635|12007760|FG010|Substudy 2, Part 2|Withdrew consent|0
7601447|NCT02819635|12007761|FG011|Substudy 2, Part 2|Withdrew consent|0
7601448|NCT02819635|12007750|FG000|Substudy 2, Part 2|Lost to Follow-up|0
7601449|NCT02819635|12007751|FG001|Substudy 2, Part 2|Lost to Follow-up|0
7601450|NCT02819635|12007752|FG002|Substudy 2, Part 2|Lost to Follow-up|0
7601451|NCT02819635|12007753|FG003|Substudy 2, Part 2|Lost to Follow-up|0
7601452|NCT02819635|12007754|FG004|Substudy 2, Part 2|Lost to Follow-up|0
7601453|NCT02819635|12007755|FG005|Substudy 2, Part 2|Lost to Follow-up|0
7601454|NCT02819635|12007756|FG006|Substudy 2, Part 2|Lost to Follow-up|1
7773105|NCT00900029|12218463|FG000|Overall Study|Lost to Follow-up|0
7773106|NCT00900029|12218464|FG001|Overall Study|Lost to Follow-up|2
7773107|NCT00900029|12218465|FG002|Overall Study|Lost to Follow-up|1
7773108|NCT00900029|12218466|FG003|Overall Study|Lost to Follow-up|4
7773109|NCT00900029|12218467|FG004|Overall Study|Lost to Follow-up|4
7773110|NCT00900029|12218463|FG000|Overall Study|Withdrawal by Subject|2
7773111|NCT00900029|12218464|FG001|Overall Study|Withdrawal by Subject|2
7773112|NCT00900029|12218465|FG002|Overall Study|Withdrawal by Subject|1
7773113|NCT00900029|12218466|FG003|Overall Study|Withdrawal by Subject|1
7773114|NCT00900029|12218467|FG004|Overall Study|Withdrawal by Subject|1
7773115|NCT00900029|12218463|FG000|Overall Study|Adverse Event|0
7773116|NCT00900029|12218464|FG001|Overall Study|Adverse Event|0
7773117|NCT00900029|12218465|FG002|Overall Study|Adverse Event|1
7601455|NCT02819635|12007757|FG007|Substudy 2, Part 2|Lost to Follow-up|0
7601456|NCT02819635|12007758|FG008|Substudy 2, Part 2|Lost to Follow-up|0
7601457|NCT02819635|12007759|FG009|Substudy 2, Part 2|Lost to Follow-up|0
7601458|NCT02819635|12007760|FG010|Substudy 2, Part 2|Lost to Follow-up|0
7601459|NCT02819635|12007761|FG011|Substudy 2, Part 2|Lost to Follow-up|0
7601460|NCT02819635|12007750|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601461|NCT02819635|12007751|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601462|NCT02819635|12007752|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601463|NCT02819635|12007753|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601464|NCT02819635|12007754|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601465|NCT02819635|12007755|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601466|NCT02819635|12007756|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2
7773118|NCT00900029|12218466|FG003|Overall Study|Adverse Event|1
7773119|NCT00900029|12218467|FG004|Overall Study|Adverse Event|1
7773120|NCT00900029|12218463|FG000|Overall Study|Death|1
7773121|NCT00900029|12218464|FG001|Overall Study|Death|0
7773122|NCT00900029|12218465|FG002|Overall Study|Death|0
7773123|NCT00900029|12218466|FG003|Overall Study|Death|1
7601467|NCT02819635|12007757|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601468|NCT02819635|12007758|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601469|NCT02819635|12007759|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601470|NCT02819635|12007760|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601471|NCT02819635|12007761|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601472|NCT02819635|12007750|FG000|Substudy 2, Part 2|Other, not specified|0
7601473|NCT02819635|12007751|FG001|Substudy 2, Part 2|Other, not specified|0
7601474|NCT02819635|12007752|FG002|Substudy 2, Part 2|Other, not specified|0
7601475|NCT02819635|12007753|FG003|Substudy 2, Part 2|Other, not specified|0
7601476|NCT02819635|12007754|FG004|Substudy 2, Part 2|Other, not specified|0
7601477|NCT02819635|12007755|FG005|Substudy 2, Part 2|Other, not specified|4
7601478|NCT02819635|12007756|FG006|Substudy 2, Part 2|Other, not specified|8
7601479|NCT02819635|12007757|FG007|Substudy 2, Part 2|Other, not specified|0
7601480|NCT02819635|12007758|FG008|Substudy 2, Part 2|Other, not specified|0
7601481|NCT02819635|12007759|FG009|Substudy 2, Part 2|Other, not specified|0
7601482|NCT02819635|12007760|FG010|Substudy 2, Part 2|Other, not specified|0
7601483|NCT02819635|12007761|FG011|Substudy 2, Part 2|Other, not specified|0
7601484|NCT02819635|12007750|FG000|Substudy 3|Adverse Event|0
7601485|NCT02819635|12007751|FG001|Substudy 3|Adverse Event|0
7601486|NCT02819635|12007752|FG002|Substudy 3|Adverse Event|0
7601487|NCT02819635|12007753|FG003|Substudy 3|Adverse Event|0
7601488|NCT02819635|12007754|FG004|Substudy 3|Adverse Event|0
7601489|NCT02819635|12007755|FG005|Substudy 3|Adverse Event|0
7601490|NCT02819635|12007756|FG006|Substudy 3|Adverse Event|0
7601491|NCT02819635|12007757|FG007|Substudy 3|Adverse Event|0
7601492|NCT02819635|12007758|FG008|Substudy 3|Adverse Event|32
7601493|NCT02819635|12007759|FG009|Substudy 3|Adverse Event|3
7601494|NCT02819635|12007760|FG010|Substudy 3|Adverse Event|12
7601495|NCT02819635|12007761|FG011|Substudy 3|Adverse Event|18
7601496|NCT02819635|12007750|FG000|Substudy 3|Withdrew consent|0
7601497|NCT02819635|12007751|FG001|Substudy 3|Withdrew consent|0
7601498|NCT02819635|12007752|FG002|Substudy 3|Withdrew consent|0
7601499|NCT02819635|12007753|FG003|Substudy 3|Withdrew consent|0
7601500|NCT02819635|12007754|FG004|Substudy 3|Withdrew consent|0
7601501|NCT02819635|12007755|FG005|Substudy 3|Withdrew consent|0
7601502|NCT02819635|12007756|FG006|Substudy 3|Withdrew consent|0
7601503|NCT02819635|12007757|FG007|Substudy 3|Withdrew consent|0
7601504|NCT02819635|12007758|FG008|Substudy 3|Withdrew consent|11
7601505|NCT02819635|12007759|FG009|Substudy 3|Withdrew consent|1
7601506|NCT02819635|12007760|FG010|Substudy 3|Withdrew consent|4
7601507|NCT02819635|12007761|FG011|Substudy 3|Withdrew consent|9
7601508|NCT02819635|12007750|FG000|Substudy 3|Lost to Follow-up|0
7601509|NCT02819635|12007751|FG001|Substudy 3|Lost to Follow-up|0
7601510|NCT02819635|12007752|FG002|Substudy 3|Lost to Follow-up|0
7601511|NCT02819635|12007753|FG003|Substudy 3|Lost to Follow-up|0
7601512|NCT02819635|12007754|FG004|Substudy 3|Lost to Follow-up|0
7601513|NCT02819635|12007755|FG005|Substudy 3|Lost to Follow-up|0
7601514|NCT02819635|12007756|FG006|Substudy 3|Lost to Follow-up|0
7601515|NCT02819635|12007757|FG007|Substudy 3|Lost to Follow-up|0
7601516|NCT02819635|12007758|FG008|Substudy 3|Lost to Follow-up|1
7601517|NCT02819635|12007759|FG009|Substudy 3|Lost to Follow-up|0
7601518|NCT02819635|12007760|FG010|Substudy 3|Lost to Follow-up|1
7601519|NCT02819635|12007761|FG011|Substudy 3|Lost to Follow-up|1
7601520|NCT02819635|12007750|FG000|Substudy 3|COVID-19 Logistical Restrictions|0
7773124|NCT00900029|12218467|FG004|Overall Study|Death|0
7773125|NCT00900146|12218484|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
7601521|NCT02819635|12007751|FG001|Substudy 3|COVID-19 Logistical Restrictions|0
7601522|NCT02819635|12007752|FG002|Substudy 3|COVID-19 Logistical Restrictions|0
7601523|NCT02819635|12007753|FG003|Substudy 3|COVID-19 Logistical Restrictions|0
7601524|NCT02819635|12007754|FG004|Substudy 3|COVID-19 Logistical Restrictions|0
7601525|NCT02819635|12007755|FG005|Substudy 3|COVID-19 Logistical Restrictions|0
7601526|NCT02819635|12007756|FG006|Substudy 3|COVID-19 Logistical Restrictions|0
7601527|NCT02819635|12007757|FG007|Substudy 3|COVID-19 Logistical Restrictions|0
7601528|NCT02819635|12007758|FG008|Substudy 3|COVID-19 Logistical Restrictions|0
7601529|NCT02819635|12007759|FG009|Substudy 3|COVID-19 Logistical Restrictions|0
7601530|NCT02819635|12007760|FG010|Substudy 3|COVID-19 Logistical Restrictions|0
7601531|NCT02819635|12007761|FG011|Substudy 3|COVID-19 Logistical Restrictions|1
7601532|NCT02819635|12007750|FG000|Substudy 3|Other, not specified|0
7601533|NCT02819635|12007751|FG001|Substudy 3|Other, not specified|0
7601534|NCT02819635|12007752|FG002|Substudy 3|Other, not specified|0
7601535|NCT02819635|12007753|FG003|Substudy 3|Other, not specified|0
7601536|NCT02819635|12007754|FG004|Substudy 3|Other, not specified|0
7601537|NCT02819635|12007755|FG005|Substudy 3|Other, not specified|0
7601538|NCT02819635|12007756|FG006|Substudy 3|Other, not specified|0
7601539|NCT02819635|12007757|FG007|Substudy 3|Other, not specified|0
7601540|NCT02819635|12007758|FG008|Substudy 3|Other, not specified|202
7601541|NCT02819635|12007759|FG009|Substudy 3|Other, not specified|5
7601542|NCT02819635|12007760|FG010|Substudy 3|Other, not specified|89
7601543|NCT02819635|12007761|FG011|Substudy 3|Other, not specified|39
7601544|NCT02756013|12007789|FG000|Overall Study|Adverse Event|1
7601545|NCT02756013|12007789|FG000|Overall Study|Hypersensitivity|1
7773126|NCT00900146|12218485|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
7773127|NCT00900146|12218486|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
7773128|NCT00900146|12218487|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
7773129|NCT00900146|12218488|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
7773130|NCT00900146|12218484|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
7773131|NCT00900146|12218485|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
7773132|NCT00900146|12218486|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
7773133|NCT00900146|12218487|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
7773134|NCT00900146|12218488|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
7773135|NCT00900146|12218484|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1
7773136|NCT00900146|12218485|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0
7773137|NCT00900146|12218486|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0
7773138|NCT00900146|12218487|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0
7773139|NCT00900146|12218488|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0
7773140|NCT00900146|12218484|FG000|Intermediate: Period III|Withdrawal by Subject|0
7773141|NCT00900146|12218485|FG001|Intermediate: Period III|Withdrawal by Subject|1
7773142|NCT00900146|12218486|FG002|Intermediate: Period III|Withdrawal by Subject|0
7773143|NCT00900146|12218487|FG003|Intermediate: Period III|Withdrawal by Subject|0
7773144|NCT00900146|12218488|FG004|Intermediate: Period III|Withdrawal by Subject|3
7773145|NCT00900146|12218484|FG000|Intermediate: Period III|Lost to Follow-up|2
7773146|NCT00900146|12218485|FG001|Intermediate: Period III|Lost to Follow-up|0
7773147|NCT00900146|12218486|FG002|Intermediate: Period III|Lost to Follow-up|0
7773148|NCT00900146|12218487|FG003|Intermediate: Period III|Lost to Follow-up|0
7773149|NCT00900146|12218488|FG004|Intermediate: Period III|Lost to Follow-up|1
7773150|NCT00900146|12218484|FG000|Intermediate: Period III|Administrative problems|85
7773151|NCT00900146|12218485|FG001|Intermediate: Period III|Administrative problems|92
7773152|NCT00900146|12218486|FG002|Intermediate: Period III|Administrative problems|84
7773153|NCT00900146|12218487|FG003|Intermediate: Period III|Administrative problems|90
7773154|NCT00900146|12218488|FG004|Intermediate: Period III|Administrative problems|163
7601564|NCT02419807|12007842|FG000|Overall Study|Withdrawal by Subject|4
7601565|NCT02419807|12007842|FG000|Overall Study|Physician Decision|1
7601566|NCT02419807|12007842|FG000|Overall Study|Protocol Violation|5
7773155|NCT00900159|12218502|FG000|Second Intervention|disempanelled for inappropriate behavior|1
7773156|NCT00900159|12218503|FG001|Second Intervention|disempanelled for inappropriate behavior|0
7773157|NCT00900562|12218520|FG000|Overall Study|Progressive disease|9
7773158|NCT00900562|12218521|FG001|Overall Study|Progressive disease|5
7773159|NCT00900562|12218520|FG000|Overall Study|Toxicity|1
7773160|NCT00900562|12218521|FG001|Overall Study|Toxicity|0
7773161|NCT00900562|12218520|FG000|Overall Study|Death|1
7773162|NCT00900562|12218521|FG001|Overall Study|Death|1
7773163|NCT00900562|12218520|FG000|Overall Study|Withdrawal by Subject|0
7773164|NCT00900562|12218521|FG001|Overall Study|Withdrawal by Subject|1
7773165|NCT00900562|12218520|FG000|Overall Study|Unrelated adverse event|1
7773166|NCT00900562|12218521|FG001|Overall Study|Unrelated adverse event|0
7773167|NCT00900601|12218528|FG000|Overall Study|Physician Decision|1
7773168|NCT00900627|12218538|FG000|Overall Study|Condition under investigation worsened|4
7601593|NCT02231749|12007872|FG000|Overall Study|Disease progression|229
7601594|NCT02231749|12007873|FG001|Overall Study|Disease progression|297
7601595|NCT02231749|12007872|FG000|Overall Study|Study Drug Toxicity|134
7601596|NCT02231749|12007873|FG001|Overall Study|Study Drug Toxicity|63
7601597|NCT02231749|12007872|FG000|Overall Study|Death|1
7601598|NCT02231749|12007873|FG001|Overall Study|Death|1
7773169|NCT00900627|12218539|FG001|Overall Study|Condition under investigation worsened|0
7773170|NCT00900627|12218540|FG002|Overall Study|Condition under investigation worsened|5
7773171|NCT00900627|12218541|FG003|Overall Study|Condition under investigation worsened|3
7773172|NCT00900627|12218542|FG004|Overall Study|Condition under investigation worsened|0
7601599|NCT02231749|12007872|FG000|Overall Study|AE unrelated to Study drug|32
7601600|NCT02231749|12007873|FG001|Overall Study|AE unrelated to Study drug|31
7601601|NCT02231749|12007872|FG000|Overall Study|Participant's request to discontinue|10
7601602|NCT02231749|12007873|FG001|Overall Study|Participant's request to discontinue|21
7601603|NCT02231749|12007872|FG000|Overall Study|Participant withdrew Consent|8
7601604|NCT02231749|12007873|FG001|Overall Study|Participant withdrew Consent|15
7601605|NCT02231749|12007872|FG000|Overall Study|Lost to Follow-up|1
7601606|NCT02231749|12007873|FG001|Overall Study|Lost to Follow-up|2
7601607|NCT02231749|12007872|FG000|Overall Study|Maximum Clinical Benefit|5
7601608|NCT02231749|12007873|FG001|Overall Study|Maximum Clinical Benefit|8
7601609|NCT02231749|12007872|FG000|Overall Study|Poor/Non-Compliance|0
7601610|NCT02231749|12007873|FG001|Overall Study|Poor/Non-Compliance|3
7601611|NCT02231749|12007872|FG000|Overall Study|Pregnancy|1
7601612|NCT02231749|12007873|FG001|Overall Study|Pregnancy|0
7601613|NCT02231749|12007872|FG000|Overall Study|other|0
7601614|NCT02231749|12007873|FG001|Overall Study|other|8
7601615|NCT02231749|12007872|FG000|Overall Study|No longer meets Study Criteria|1
7601616|NCT02231749|12007873|FG001|Overall Study|No longer meets Study Criteria|0
7601617|NCT02227199|12007882|FG000|Overall Study|Physician Decision|0
7601618|NCT02227199|12007883|FG001|Overall Study|Physician Decision|0
7601619|NCT02227199|12007884|FG002|Overall Study|Physician Decision|1
7601620|NCT02227199|12007882|FG000|Overall Study|Adverse Event|0
7601621|NCT02227199|12007883|FG001|Overall Study|Adverse Event|0
7601622|NCT02227199|12007884|FG002|Overall Study|Adverse Event|3
7601623|NCT02181413|12007898|FG000|Overall Study|Adverse Event|7
7601624|NCT02181413|12007899|FG001|Overall Study|Adverse Event|24
7601625|NCT02181413|12007898|FG000|Overall Study|Progressive Disease|121
7601626|NCT02181413|12007899|FG001|Overall Study|Progressive Disease|143
7601627|NCT02181413|12007898|FG000|Overall Study|Withdrawal by Subject|5
7601628|NCT02181413|12007899|FG001|Overall Study|Withdrawal by Subject|8
7601629|NCT02181413|12007898|FG000|Overall Study|Reason Not Specified|19
7601630|NCT02181413|12007899|FG001|Overall Study|Reason Not Specified|20
7601631|NCT02181413|12007898|FG000|Overall Study|Ongoing Study Treatment|0
7601632|NCT02181413|12007899|FG001|Overall Study|Ongoing Study Treatment|1
7601633|NCT02181413|12007898|FG000|Overall Study|Lost to Follow-up|0
7601634|NCT02181413|12007899|FG001|Overall Study|Lost to Follow-up|1
7601635|NCT02095678|12007907|FG000|Overall Study|Withdrawal by Subject|0
7601636|NCT02095678|12007908|FG001|Overall Study|Withdrawal by Subject|1
7601637|NCT02095678|12007907|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11
7601638|NCT02095678|12007908|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12
7601639|NCT02095678|12007907|FG000|Overall Study|lesion impacted by previous treatment|1
7601640|NCT02095678|12007908|FG001|Overall Study|lesion impacted by previous treatment|1
7601641|NCT02095678|12007907|FG000|Overall Study|No Confirmed Diagnosis|0
7601642|NCT02095678|12007908|FG001|Overall Study|No Confirmed Diagnosis|3
7601643|NCT02095678|12007907|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1
7601644|NCT02095678|12007908|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1
7601645|NCT02095678|12007907|FG000|Overall Study|No Visible Lesion or Pathological Finding|4
7601646|NCT02095678|12007908|FG001|Overall Study|No Visible Lesion or Pathological Finding|0
7773173|NCT00900627|12218543|FG005|Overall Study|Condition under investigation worsened|0
7773174|NCT00900627|12218538|FG000|Overall Study|Withdrawal by Subject|1
7773175|NCT00900627|12218539|FG001|Overall Study|Withdrawal by Subject|0
7773176|NCT00900627|12218540|FG002|Overall Study|Withdrawal by Subject|1
7773177|NCT00900627|12218541|FG003|Overall Study|Withdrawal by Subject|0
7773178|NCT00900627|12218542|FG004|Overall Study|Withdrawal by Subject|1
7773179|NCT00900627|12218543|FG005|Overall Study|Withdrawal by Subject|2
7773180|NCT00900627|12218538|FG000|Overall Study|Adverse Event|1
7773181|NCT00900627|12218539|FG001|Overall Study|Adverse Event|2
7773182|NCT00900627|12218540|FG002|Overall Study|Adverse Event|0
7773183|NCT00900627|12218541|FG003|Overall Study|Adverse Event|3
7773184|NCT00900627|12218542|FG004|Overall Study|Adverse Event|0
7601659|NCT01955109|12007937|FG000|Overall Study|Adverse Event|2
7601660|NCT01955109|12007938|FG001|Overall Study|Adverse Event|0
7601661|NCT01955109|12007937|FG000|Overall Study|Participant unwilling to continue|35
7601662|NCT01955109|12007938|FG001|Overall Study|Participant unwilling to continue|7
7601663|NCT01955109|12007937|FG000|Overall Study|Physician Decision|2
7601664|NCT01955109|12007938|FG001|Overall Study|Physician Decision|0
7601665|NCT01955109|12007937|FG000|Overall Study|Lost to Follow-up|3
7601666|NCT01955109|12007938|FG001|Overall Study|Lost to Follow-up|1
7601667|NCT01955109|12007937|FG000|Overall Study|Non-compliance|3
7601668|NCT01955109|12007938|FG001|Overall Study|Non-compliance|1
7773185|NCT00900627|12218543|FG005|Overall Study|Adverse Event|0
7773186|NCT00900627|12218538|FG000|Overall Study|Death|0
7773187|NCT00900627|12218539|FG001|Overall Study|Death|0
7773188|NCT00900627|12218540|FG002|Overall Study|Death|0
7773189|NCT00900627|12218541|FG003|Overall Study|Death|0
7773190|NCT00900627|12218542|FG004|Overall Study|Death|28
7773191|NCT00900627|12218543|FG005|Overall Study|Death|24
7773192|NCT00900731|12218568|FG000|Overall Study|Adverse Event|31
7773193|NCT00900731|12218569|FG001|Overall Study|Adverse Event|27
7773194|NCT00900731|12218568|FG000|Overall Study|Withdrawal by Subject|8
7773195|NCT00900731|12218569|FG001|Overall Study|Withdrawal by Subject|7
7773196|NCT00900731|12218568|FG000|Overall Study|Protocol Deviation|8
7773197|NCT00900731|12218569|FG001|Overall Study|Protocol Deviation|11
7773198|NCT00900731|12218568|FG000|Overall Study|Administrative Problems|5
7773199|NCT00900731|12218569|FG001|Overall Study|Administrative Problems|4
7773200|NCT00900731|12218568|FG000|Overall Study|Abnormal Test Procedure Result(s)|3
7773201|NCT00900731|12218569|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
7773202|NCT00900731|12218568|FG000|Overall Study|Abnormal Laboratory Value(s)|2
7773203|NCT00900731|12218569|FG001|Overall Study|Abnormal Laboratory Value(s)|4
7773204|NCT00900731|12218568|FG000|Overall Study|Lost to Follow-up|2
7773205|NCT00900731|12218569|FG001|Overall Study|Lost to Follow-up|3
7773206|NCT00900731|12218568|FG000|Overall Study|Lack of Efficacy|1
7773207|NCT00900731|12218569|FG001|Overall Study|Lack of Efficacy|3
7773208|NCT00900731|12218568|FG000|Overall Study|Death|0
7773209|NCT00900731|12218569|FG001|Overall Study|Death|2
7773210|NCT00900757|12218575|FG000|Overall Study|screen failure|19
7773211|NCT00900796|12218579|FG000|Phase 1|Lacked sufficient information|4
7773212|NCT00900796|12218579|FG000|Phase 1|Missing information at Week 16|7
7773213|NCT00900796|12218579|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
7773214|NCT00900796|12218579|FG000|Phase 2|Lost to Follow-up|5
7773215|NCT00901186|12218600|FG000|Overall Study|Lack of Efficacy|0
7773216|NCT00901186|12218601|FG001|Overall Study|Lack of Efficacy|1
7773217|NCT00901186|12218600|FG000|Overall Study|Abnormal laboratory values|0
7773218|NCT00901186|12218601|FG001|Overall Study|Abnormal laboratory values|1
7773219|NCT00901186|12218600|FG000|Overall Study|Lost to Follow-up|2
7773220|NCT00901186|12218601|FG001|Overall Study|Lost to Follow-up|0
7773221|NCT00901186|12218600|FG000|Overall Study|Adverse Event|2
7773222|NCT00901186|12218601|FG001|Overall Study|Adverse Event|4
7773223|NCT00901186|12218600|FG000|Overall Study|Administration problems|0
7773224|NCT00901186|12218601|FG001|Overall Study|Administration problems|1
7773225|NCT00901186|12218600|FG000|Overall Study|Protocol deviations|5
7773226|NCT00901186|12218601|FG001|Overall Study|Protocol deviations|4
7773227|NCT00901342|12218624|FG000|Overall Study|Adverse Event|1
7773228|NCT00901342|12218624|FG000|Overall Study|Death|4
7773229|NCT00901342|12218624|FG000|Overall Study|Disease progression|1
7773230|NCT00901342|12218624|FG000|Overall Study|Withdrawal by Subject|9
7773231|NCT00901394|12218631|FG000|Overall Study|Physician Decision|1
7773232|NCT00901394|12218632|FG001|Overall Study|Physician Decision|1
7773233|NCT00901394|12218633|FG002|Overall Study|Physician Decision|2
7773234|NCT00901459|12218641|FG000|Overall Study|Withdrawal by Subject|6
7773235|NCT00901485|12218652|FG000|Overall Study|Lack of Efficacy|0
7773236|NCT00901485|12218653|FG001|Overall Study|Lack of Efficacy|2
7773237|NCT00901485|12218652|FG000|Overall Study|Withdrawal by Subject|1
7773238|NCT00901485|12218653|FG001|Overall Study|Withdrawal by Subject|2
7773239|NCT00901576|12218665|FG000|Second Intervention|Withdrawal by Subject|0
7773240|NCT00901576|12218666|FG001|Second Intervention|Withdrawal by Subject|0
7773241|NCT00901576|12218667|FG002|Second Intervention|Withdrawal by Subject|0
7773242|NCT00901576|12218668|FG003|Second Intervention|Withdrawal by Subject|1
7773243|NCT00901576|12218669|FG004|Second Intervention|Withdrawal by Subject|0
7773244|NCT00901576|12218670|FG005|Second Intervention|Withdrawal by Subject|1
7773245|NCT00901576|12218665|FG000|Second Intervention|Physician Decision|1
7773246|NCT00901576|12218666|FG001|Second Intervention|Physician Decision|0
7773247|NCT00901576|12218667|FG002|Second Intervention|Physician Decision|0
7773248|NCT00901576|12218668|FG003|Second Intervention|Physician Decision|0
7773249|NCT00901576|12218669|FG004|Second Intervention|Physician Decision|0
7773250|NCT00901576|12218670|FG005|Second Intervention|Physician Decision|0
7773251|NCT00901628|12218680|FG000|Overall Study|disconnection of catheter|4
7773252|NCT00901628|12218681|FG001|Overall Study|disconnection of catheter|8
7773253|NCT00901628|12218680|FG000|Overall Study|disconnection of drain|0
7773254|NCT00901628|12218681|FG001|Overall Study|disconnection of drain|1
7773255|NCT00901628|12218680|FG000|Overall Study|peroneal nerve palsy|0
7773256|NCT00901628|12218681|FG001|Overall Study|peroneal nerve palsy|1
7773257|NCT00901901|12218689|FG000|Treatment Period|Adverse Event|120
7773258|NCT00901901|12218690|FG001|Treatment Period|Adverse Event|128
7773259|NCT00901901|12218689|FG000|Treatment Period|Withdrawal by Subject|26
7773260|NCT00901901|12218690|FG001|Treatment Period|Withdrawal by Subject|24
7773261|NCT00901901|12218689|FG000|Treatment Period|Physician Decision|2
7773262|NCT00901901|12218690|FG001|Treatment Period|Physician Decision|2
7773263|NCT00901901|12218689|FG000|Treatment Period|Lost to Follow-up|3
7773264|NCT00901901|12218690|FG001|Treatment Period|Lost to Follow-up|5
7773265|NCT00901901|12218689|FG000|Treatment Period|Noncompliance with study medication|4
7773266|NCT00901901|12218690|FG001|Treatment Period|Noncompliance with study medication|1
7773267|NCT00901901|12218689|FG000|Treatment Period|Missing|1
7773268|NCT00901901|12218690|FG001|Treatment Period|Missing|0
7773269|NCT00901901|12218689|FG000|Treatment Period|Never treated|0
7773270|NCT00901901|12218690|FG001|Treatment Period|Never treated|3
7773271|NCT00901901|12218689|FG000|Treatment Period|Protocol driven decision point|0
7773272|NCT00901901|12218690|FG001|Treatment Period|Protocol driven decision point|2
7773273|NCT00901901|12218689|FG000|Treatment Period|Study terminated by sponsor|2
7773274|NCT00901901|12218690|FG001|Treatment Period|Study terminated by sponsor|0
7773275|NCT00901901|12218689|FG000|Treatment Period|Protocol Violation|5
7773276|NCT00901901|12218690|FG001|Treatment Period|Protocol Violation|9
7773277|NCT00901901|12218689|FG000|Treatment Period|Switch to commercial drug|1
7773278|NCT00901901|12218690|FG001|Treatment Period|Switch to commercial drug|1
7773279|NCT00901901|12218689|FG000|Treatment Period|Transfer to treatment continuation study|5
7773280|NCT00901901|12218690|FG001|Treatment Period|Transfer to treatment continuation study|2
7773281|NCT00901901|12218689|FG000|Follow-up Period|Death|181
7773282|NCT00901901|12218690|FG001|Follow-up Period|Death|208
7773283|NCT00901901|12218689|FG000|Follow-up Period|Protocol driven decision point|47
7773284|NCT00901901|12218690|FG001|Follow-up Period|Protocol driven decision point|36
7773285|NCT00901901|12218689|FG000|Follow-up Period|Withdrawal by Subject|6
7773286|NCT00901901|12218690|FG001|Follow-up Period|Withdrawal by Subject|9
7773287|NCT00901901|12218689|FG000|Follow-up Period|Lost to Follow-up|12
7773288|NCT00901901|12218690|FG001|Follow-up Period|Lost to Follow-up|8
7773289|NCT00901901|12218689|FG000|Follow-up Period|Missing|94
7773290|NCT00901901|12218690|FG001|Follow-up Period|Missing|80
7773291|NCT00901927|12218698|FG000|Overall Study|Lack of Efficacy|1
7773292|NCT00901927|12218698|FG000|Overall Study|Protocol Violation|3
7773293|NCT00901927|12218698|FG000|Overall Study|Withdrawal by Subject|2
7773294|NCT00902174|12218737|FG000|Overall Study|Adverse Event|27
7773295|NCT00902174|12218738|FG001|Overall Study|Adverse Event|7
7773296|NCT00902174|12218737|FG000|Overall Study|Lack of Efficacy|1
7773297|NCT00902174|12218738|FG001|Overall Study|Lack of Efficacy|5
7773298|NCT00902174|12218737|FG000|Overall Study|Death|2
7773299|NCT00902174|12218738|FG001|Overall Study|Death|2
7773300|NCT00902174|12218737|FG000|Overall Study|Withdrawal by Subject|2
7773301|NCT00902174|12218738|FG001|Overall Study|Withdrawal by Subject|1
7773302|NCT00902174|12218737|FG000|Overall Study|Abnormal labs|1
7773303|NCT00902174|12218738|FG001|Overall Study|Abnormal labs|1
7773304|NCT00902174|12218737|FG000|Overall Study|Protocol Violation|1
7773305|NCT00902174|12218738|FG001|Overall Study|Protocol Violation|1
7773306|NCT00902174|12218737|FG000|Overall Study|Administration problem|0
7773307|NCT00902174|12218738|FG001|Overall Study|Administration problem|1
7773308|NCT00902265|12218751|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1
7773309|NCT00902265|12218751|FG000|Overall Study|Adverse Event|2
7773310|NCT00902265|12218751|FG000|Overall Study|Lack of Efficacy|2
7773311|NCT00902265|12218751|FG000|Overall Study|Protocol Violation|1
7601753|NCT01854775|12007987|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1
7601754|NCT01854775|12007988|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1
7601755|NCT01854775|12007989|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0
7601756|NCT01854775|12007987|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1
7601757|NCT01854775|12007988|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0
7601758|NCT01854775|12007989|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0
7601759|NCT01854775|12007987|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0
7601760|NCT01854775|12007988|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0
7601761|NCT01854775|12007989|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9
7601762|NCT01854775|12007987|FG000|Extension Phase|Pregnancy|3
7601763|NCT01854775|12007988|FG001|Extension Phase|Pregnancy|0
7601764|NCT01854775|12007989|FG002|Extension Phase|Pregnancy|0
7601765|NCT01854775|12007987|FG000|Extension Phase|Investigator's Discretion|1
7601766|NCT01854775|12007988|FG001|Extension Phase|Investigator's Discretion|0
7601767|NCT01854775|12007989|FG002|Extension Phase|Investigator's Discretion|0
7601768|NCT01854775|12007987|FG000|Extension Phase|Non-Compliance with Study Drug|1
7601769|NCT01854775|12007988|FG001|Extension Phase|Non-Compliance with Study Drug|0
7601770|NCT01854775|12007989|FG002|Extension Phase|Non-Compliance with Study Drug|0
7601771|NCT01854775|12007987|FG000|Extension Phase|Lost to Follow-up|2
7601772|NCT01854775|12007988|FG001|Extension Phase|Lost to Follow-up|0
7601773|NCT01854775|12007989|FG002|Extension Phase|Lost to Follow-up|0
7601774|NCT01854775|12007987|FG000|Extension Phase|Still on Study|32
7773312|NCT00902278|12218760|FG000|Overall Study|Physician Decision|1
7773313|NCT00902278|12218761|FG001|Overall Study|Physician Decision|0
7773314|NCT00902278|12218762|FG002|Overall Study|Physician Decision|2
7773315|NCT00902278|12218763|FG003|Overall Study|Physician Decision|0
7601775|NCT01854775|12007988|FG001|Extension Phase|Still on Study|47
7601776|NCT01854775|12007989|FG002|Extension Phase|Still on Study|18
7601777|NCT01839331|12008015|FG000|Overall Study|Early Termination|3
7601778|NCT01839331|12008016|FG001|Overall Study|Early Termination|0
7601779|NCT01839331|12008017|FG002|Overall Study|Early Termination|1
7601780|NCT01839331|12008018|FG003|Overall Study|Early Termination|2
7601781|NCT01839331|12008015|FG000|Overall Study|Protocol Violation|1
7601782|NCT01839331|12008016|FG001|Overall Study|Protocol Violation|6
7601783|NCT01839331|12008017|FG002|Overall Study|Protocol Violation|4
7601784|NCT01839331|12008018|FG003|Overall Study|Protocol Violation|3
7773316|NCT00902278|12218764|FG004|Overall Study|Physician Decision|1
7773317|NCT00902278|12218760|FG000|Overall Study|Lost to Follow-up|3
7601787|NCT01235234|12008057|FG000|Overall Study|Adverse Event|2
7601788|NCT01235234|12008058|FG001|Overall Study|Adverse Event|2
7601789|NCT01235234|12008059|FG002|Overall Study|Adverse Event|1
7773318|NCT00902278|12218761|FG001|Overall Study|Lost to Follow-up|2
7773319|NCT00902278|12218762|FG002|Overall Study|Lost to Follow-up|3
7773320|NCT00902278|12218763|FG003|Overall Study|Lost to Follow-up|0
7773321|NCT00902278|12218764|FG004|Overall Study|Lost to Follow-up|1
7773322|NCT00902304|12218779|FG000|Overall Study|Adverse Event|4
7773323|NCT00902304|12218780|FG001|Overall Study|Adverse Event|10
7773324|NCT00902304|12218781|FG002|Overall Study|Adverse Event|25
7773325|NCT00902304|12218779|FG000|Overall Study|Investigator discretion|3
7773326|NCT00902304|12218780|FG001|Overall Study|Investigator discretion|5
7773327|NCT00902304|12218781|FG002|Overall Study|Investigator discretion|13
7773328|NCT00902304|12218779|FG000|Overall Study|Lost to Follow-up|7
7773329|NCT00902304|12218780|FG001|Overall Study|Lost to Follow-up|7
7773330|NCT00902304|12218781|FG002|Overall Study|Lost to Follow-up|7
7773331|NCT00902304|12218779|FG000|Overall Study|Protocol Violation|9
7773332|NCT00902304|12218780|FG001|Overall Study|Protocol Violation|18
7773333|NCT00902304|12218781|FG002|Overall Study|Protocol Violation|20
7773334|NCT00902304|12218779|FG000|Overall Study|Withdrawal by Subject|32
7773335|NCT00902304|12218780|FG001|Overall Study|Withdrawal by Subject|22
7773336|NCT00902304|12218781|FG002|Overall Study|Withdrawal by Subject|43
7773337|NCT00902304|12218779|FG000|Overall Study|includes pregnancy|3
7773338|NCT00902304|12218780|FG001|Overall Study|includes pregnancy|9
7773339|NCT00902304|12218781|FG002|Overall Study|includes pregnancy|2
7773340|NCT00902330|12218792|FG000|Overall Study|Too overwhelmed by treatment|2
7601790|NCT01160211|12008070|FG000|Overall Study|ongoing|90
7601791|NCT01160211|12008071|FG001|Overall Study|ongoing|75
7601792|NCT01160211|12008072|FG002|Overall Study|ongoing|79
7601793|NCT01160211|12008070|FG000|Overall Study|Withdrawal by Subject|3
7601794|NCT01160211|12008071|FG001|Overall Study|Withdrawal by Subject|5
7601795|NCT01160211|12008072|FG002|Overall Study|Withdrawal by Subject|3
7601796|NCT01160211|12008070|FG000|Overall Study|Physician Decision|2
7601797|NCT01160211|12008071|FG001|Overall Study|Physician Decision|0
7601798|NCT01160211|12008072|FG002|Overall Study|Physician Decision|0
7601799|NCT01160211|12008070|FG000|Overall Study|Lost to Follow-up|4
7601800|NCT01160211|12008071|FG001|Overall Study|Lost to Follow-up|7
7601801|NCT01160211|12008072|FG002|Overall Study|Lost to Follow-up|5
7601802|NCT01093573|12008084|FG000|Overall Study|Physician Decision|0
7601803|NCT01093573|12008085|FG001|Overall Study|Physician Decision|0
7601804|NCT01093573|12008086|FG002|Overall Study|Physician Decision|1
7601805|NCT01093573|12008084|FG000|Overall Study|Insurance Denied|0
7601806|NCT01093573|12008085|FG001|Overall Study|Insurance Denied|0
7601807|NCT01093573|12008086|FG002|Overall Study|Insurance Denied|1
7601808|NCT00828854|12008097|FG000|Overall Study|Disease Progression|17
7601809|NCT00828854|12008097|FG000|Overall Study|Adverse Event|9
7601810|NCT00828854|12008097|FG000|Overall Study|Reason not Specified|1
7601811|NCT00753545|12008103|FG000|Overall Study|Death|98
7601812|NCT00753545|12008104|FG001|Overall Study|Death|112
7601813|NCT00753545|12008103|FG000|Overall Study|Lost to Follow-up|2
7601814|NCT00753545|12008104|FG001|Overall Study|Lost to Follow-up|3
7601815|NCT00753545|12008103|FG000|Overall Study|Protocol Violation|1
7601816|NCT00753545|12008104|FG001|Overall Study|Protocol Violation|0
7601817|NCT00753545|12008103|FG000|Overall Study|Voluntary Discontinuation of Patient|7
7601818|NCT00753545|12008104|FG001|Overall Study|Voluntary Discontinuation of Patient|3
7601819|NCT00494234|12008112|FG000|Overall Study|Lack of Efficacy|12
7601820|NCT00494234|12008113|FG001|Overall Study|Lack of Efficacy|9
7601821|NCT00494234|12008112|FG000|Overall Study|Withdrawal by Subject|1
7601822|NCT00494234|12008113|FG001|Overall Study|Withdrawal by Subject|0
7601823|NCT00494234|12008112|FG000|Overall Study|Death|2
7601824|NCT00494234|12008113|FG001|Overall Study|Death|1
7601825|NCT04600076|12008145|FG000|Overall Study|Lost to Follow-up|3
7601826|NCT04375397|12008151|FG000|Overall Study|Death|1
7601827|NCT04375397|12008152|FG001|Overall Study|Death|1
7601828|NCT04375397|12008151|FG000|Overall Study|Withdrew consent|2
7601829|NCT04375397|12008152|FG001|Overall Study|Withdrew consent|0
7601830|NCT04375397|12008151|FG000|Overall Study|Lost to Follow-up|6
7601831|NCT04375397|12008152|FG001|Overall Study|Lost to Follow-up|4
7601832|NCT04375397|12008151|FG000|Overall Study|Other, not specified|0
7601833|NCT04375397|12008152|FG001|Overall Study|Other, not specified|1
7601834|NCT04075734|12008177|FG000|Overall Study|Lost to Follow-up|1
7601835|NCT04075734|12008178|FG001|Overall Study|Lost to Follow-up|1
7601836|NCT04075734|12008179|FG002|Overall Study|Lost to Follow-up|0
7601837|NCT04075734|12008177|FG000|Overall Study|Withdrawal by Subject|3
7601838|NCT04075734|12008178|FG001|Overall Study|Withdrawal by Subject|0
7601839|NCT04075734|12008179|FG002|Overall Study|Withdrawal by Subject|0
7601840|NCT03915470|12008207|FG000|Overall Study|Death|3
7601841|NCT03915470|12008208|FG001|Overall Study|Death|1
7601842|NCT03915470|12008207|FG000|Overall Study|Adverse Event|1
7601843|NCT03915470|12008208|FG001|Overall Study|Adverse Event|0
7601844|NCT03915470|12008207|FG000|Overall Study|Physician Decision|1
7601845|NCT03915470|12008208|FG001|Overall Study|Physician Decision|0
7601846|NCT03915470|12008207|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1
7601847|NCT03915470|12008208|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1
7601848|NCT03881553|12008221|FG000|Overall Study|Discharged prior to participation|1
7601849|NCT03881553|12008222|FG001|Overall Study|Discharged prior to participation|1
7601850|NCT03881553|12008223|FG002|Overall Study|Discharged prior to participation|0
7601851|NCT03881553|12008221|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0
7601852|NCT03881553|12008222|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0
7601853|NCT03881553|12008223|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1
7773341|NCT00902330|12218793|FG001|Overall Study|Too overwhelmed by treatment|5
7601854|NCT03718000|12008312|FG000|Overall Study|Relocation|2
7601855|NCT03718000|12008313|FG001|Overall Study|Relocation|4
7601856|NCT03718000|12008312|FG000|Overall Study|Pregnancy|0
7601857|NCT03718000|12008313|FG001|Overall Study|Pregnancy|1
7773342|NCT00902330|12218792|FG000|Overall Study|Adverse Event|1
7773343|NCT00902330|12218793|FG001|Overall Study|Adverse Event|0
7773344|NCT00902330|12218792|FG000|Overall Study|No post baseline data|1
7773345|NCT00902330|12218793|FG001|Overall Study|No post baseline data|0
7773346|NCT00902486|12218806|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
7773347|NCT00902486|12218807|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
7773348|NCT00902486|12218808|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
7773349|NCT00902486|12218809|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
7773350|NCT00902486|12218810|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
7773351|NCT00902486|12218811|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
7773352|NCT00902486|12218806|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
7601870|NCT03654651|12008358|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1
7601871|NCT03654651|12008359|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0
7601872|NCT03633396|12008368|FG000|Overall Study|Withdrawal by Subject|4
7601873|NCT03633396|12008369|FG001|Overall Study|Withdrawal by Subject|4
7601874|NCT03633396|12008368|FG000|Overall Study|Adverse Event|1
7601875|NCT03633396|12008369|FG001|Overall Study|Adverse Event|1
7601876|NCT03633396|12008368|FG000|Overall Study|Lack of Efficacy|1
7601877|NCT03633396|12008369|FG001|Overall Study|Lack of Efficacy|0
7601878|NCT03633396|12008368|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0
7601879|NCT03633396|12008369|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1
7601880|NCT03612856|12008378|FG000|Pre-dose Period|Physician Decision|0
7601881|NCT03612856|12008379|FG001|Pre-dose Period|Physician Decision|1
7601882|NCT03612856|12008380|FG002|Pre-dose Period|Physician Decision|1
7601883|NCT03612856|12008378|FG000|Pre-dose Period|Withdrawal by Subject|0
7601884|NCT03612856|12008379|FG001|Pre-dose Period|Withdrawal by Subject|1
7601885|NCT03612856|12008380|FG002|Pre-dose Period|Withdrawal by Subject|0
7601886|NCT03607994|12008390|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1
7601887|NCT03607994|12008391|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1
7773353|NCT00902486|12218807|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
7773354|NCT00902486|12218808|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
7773355|NCT00902486|12218809|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
7773356|NCT00902486|12218810|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
7773357|NCT00902486|12218811|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
7773358|NCT00902486|12218806|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
7773359|NCT00902486|12218807|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
7773360|NCT00902486|12218808|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
7773361|NCT00902486|12218809|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
7773362|NCT00902486|12218810|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
7864081|NCT01609556|12353448|FG004|Dose Expansion: Maximum 124 Weeks|Death|0
7601899|NCT03505671|12008425|FG000|Overall Study|Withdrawal by Subject|2
7601900|NCT03505671|12008426|FG001|Overall Study|Withdrawal by Subject|1
7601901|NCT03505671|12008425|FG000|Overall Study|Lost to Follow-up|1
7601902|NCT03505671|12008426|FG001|Overall Study|Lost to Follow-up|0
7601903|NCT03469999|12008432|FG000|Overall Study|Lost to Follow-up|2
7601904|NCT03463993|12008439|FG000|Overall Study|Lost to Follow-up|7
7601905|NCT03463993|12008440|FG001|Overall Study|Lost to Follow-up|8
7601906|NCT03463993|12008439|FG000|Overall Study|Withdrawal by Subject|2
7601907|NCT03463993|12008440|FG001|Overall Study|Withdrawal by Subject|0
7601908|NCT03463993|12008439|FG000|Overall Study|Protocol Violation|4
7601909|NCT03463993|12008440|FG001|Overall Study|Protocol Violation|1
7601910|NCT03463993|12008439|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9
7601911|NCT03463993|12008440|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11
7601912|NCT03463993|12008439|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7
7601913|NCT03463993|12008440|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6
7601914|NCT03390101|12008449|FG000|Weeks 0-12|Withdrawal by Subject|0
7601915|NCT03390101|12008450|FG001|Weeks 0-12|Withdrawal by Subject|1
7601916|NCT03390101|12008451|FG002|Weeks 0-12|Withdrawal by Subject|1
7601917|NCT03390101|12008449|FG000|Weeks 0-12|Lost to Follow-up|0
7601918|NCT03390101|12008450|FG001|Weeks 0-12|Lost to Follow-up|1
7601919|NCT03390101|12008451|FG002|Weeks 0-12|Lost to Follow-up|0
7601920|NCT03390101|12008449|FG000|Weeks 12-54|Withdrawal by Subject|0
7601921|NCT03390101|12008450|FG001|Weeks 12-54|Withdrawal by Subject|3
7601922|NCT03390101|12008451|FG002|Weeks 12-54|Withdrawal by Subject|1
7601923|NCT03390101|12008449|FG000|Weeks 12-54|Pregnancy|1
7601924|NCT03390101|12008450|FG001|Weeks 12-54|Pregnancy|0
7601925|NCT03390101|12008451|FG002|Weeks 12-54|Pregnancy|0
7601926|NCT03390101|12008449|FG000|Weeks 12-54|Adverse Event|2
7601927|NCT03390101|12008450|FG001|Weeks 12-54|Adverse Event|1
7601928|NCT03390101|12008451|FG002|Weeks 12-54|Adverse Event|1
7601929|NCT03213158|12008459|FG000|Overall Study|Withdrawal by Subject|1
7601930|NCT03213158|12008459|FG000|Overall Study|Physician Decision|2
7601931|NCT03179605|12008463|FG000|Overall Study|Withdrawal by Subject|1
7601932|NCT03150862|12008484|FG000|Overall Study|Death|2
7601933|NCT03150862|12008485|FG001|Overall Study|Death|7
7601934|NCT03150862|12008486|FG002|Overall Study|Death|8
7601935|NCT03150862|12008487|FG003|Overall Study|Death|27
7601936|NCT03150862|12008488|FG004|Overall Study|Death|4
7601937|NCT03150862|12008489|FG005|Overall Study|Death|8
7601938|NCT03150862|12008490|FG006|Overall Study|Death|6
7601939|NCT03150862|12008491|FG007|Overall Study|Death|21
7601940|NCT03150862|12008484|FG000|Overall Study|Withdrawal by Subject|1
7601941|NCT03150862|12008485|FG001|Overall Study|Withdrawal by Subject|1
7601942|NCT03150862|12008486|FG002|Overall Study|Withdrawal by Subject|0
7601943|NCT03150862|12008487|FG003|Overall Study|Withdrawal by Subject|3
7601944|NCT03150862|12008488|FG004|Overall Study|Withdrawal by Subject|1
7601945|NCT03150862|12008489|FG005|Overall Study|Withdrawal by Subject|1
7601946|NCT03150862|12008490|FG006|Overall Study|Withdrawal by Subject|1
7601947|NCT03150862|12008491|FG007|Overall Study|Withdrawal by Subject|3
7601948|NCT03150862|12008484|FG000|Overall Study|Lost to Follow-up|0
7601949|NCT03150862|12008485|FG001|Overall Study|Lost to Follow-up|0
7601950|NCT03150862|12008486|FG002|Overall Study|Lost to Follow-up|1
7601951|NCT03150862|12008487|FG003|Overall Study|Lost to Follow-up|0
7601952|NCT03150862|12008488|FG004|Overall Study|Lost to Follow-up|0
7601953|NCT03150862|12008489|FG005|Overall Study|Lost to Follow-up|0
7601954|NCT03150862|12008490|FG006|Overall Study|Lost to Follow-up|0
7601955|NCT03150862|12008491|FG007|Overall Study|Lost to Follow-up|2
7601956|NCT03150862|12008484|FG000|Overall Study|Sponsor's decision|0
7601957|NCT03150862|12008485|FG001|Overall Study|Sponsor's decision|0
7601958|NCT03150862|12008486|FG002|Overall Study|Sponsor's decision|0
7601959|NCT03150862|12008487|FG003|Overall Study|Sponsor's decision|10
7601960|NCT03150862|12008488|FG004|Overall Study|Sponsor's decision|3
7601961|NCT03150862|12008489|FG005|Overall Study|Sponsor's decision|0
7601962|NCT03150862|12008490|FG006|Overall Study|Sponsor's decision|1
7601963|NCT03150862|12008491|FG007|Overall Study|Sponsor's decision|1
7773363|NCT00902486|12218811|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
7773364|NCT00902486|12218806|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
7773365|NCT00902486|12218807|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
7773366|NCT00902486|12218808|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
7773367|NCT00902486|12218809|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
7773368|NCT00902486|12218810|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
7773369|NCT00902486|12218811|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
7773370|NCT00902486|12218806|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
7773371|NCT00902486|12218807|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
7773372|NCT00902486|12218808|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
7773373|NCT00902486|12218809|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
7773374|NCT00902486|12218810|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
7773375|NCT00902486|12218811|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
7773376|NCT00902486|12218806|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0
7773377|NCT00902486|12218807|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0
7773378|NCT00902486|12218808|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0
7773379|NCT00902486|12218809|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0
7773380|NCT00902486|12218810|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1
7773381|NCT00902486|12218811|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2
7773382|NCT00902486|12218806|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
7773383|NCT00902486|12218807|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
7773384|NCT00902486|12218808|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
7773385|NCT00902486|12218809|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
7773386|NCT00902486|12218810|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
7773387|NCT00902486|12218811|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
7773388|NCT00902486|12218806|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
7773389|NCT00902486|12218807|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
7773390|NCT00902486|12218808|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
7773391|NCT00902486|12218809|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
7773392|NCT00902486|12218810|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
7773393|NCT00902486|12218811|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
7773394|NCT00902486|12218806|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7773395|NCT00902486|12218807|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7773396|NCT00902486|12218808|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7773397|NCT00902486|12218809|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1
7773398|NCT00902486|12218810|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7773399|NCT00902486|12218811|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7773400|NCT00902486|12218806|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7773401|NCT00902486|12218807|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7773402|NCT00902486|12218808|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
7773403|NCT00902486|12218809|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7773404|NCT00902486|12218810|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7773405|NCT00902486|12218811|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7773406|NCT00902486|12218806|FG000|Follow-up (After Week 24)|Lost to Follow-up|0
7773407|NCT00902486|12218807|FG001|Follow-up (After Week 24)|Lost to Follow-up|0
7773408|NCT00902486|12218808|FG002|Follow-up (After Week 24)|Lost to Follow-up|0
7773409|NCT00902486|12218809|FG003|Follow-up (After Week 24)|Lost to Follow-up|1
7773410|NCT00902486|12218810|FG004|Follow-up (After Week 24)|Lost to Follow-up|0
7773411|NCT00902486|12218811|FG005|Follow-up (After Week 24)|Lost to Follow-up|0
7773412|NCT00902538|12218844|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
7773413|NCT00902538|12218845|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
7773414|NCT00902538|12218846|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
7601964|NCT03150862|12008484|FG000|Overall Study|Change in Methylation status|0
7601965|NCT03150862|12008485|FG001|Overall Study|Change in Methylation status|0
7601966|NCT03150862|12008486|FG002|Overall Study|Change in Methylation status|0
7601967|NCT03150862|12008487|FG003|Overall Study|Change in Methylation status|0
7601968|NCT03150862|12008488|FG004|Overall Study|Change in Methylation status|1
7601969|NCT03150862|12008489|FG005|Overall Study|Change in Methylation status|0
7601970|NCT03150862|12008490|FG006|Overall Study|Change in Methylation status|0
7601971|NCT03150862|12008491|FG007|Overall Study|Change in Methylation status|0
7601972|NCT03150862|12008484|FG000|Overall Study|Roll over in to Long Term Extension|0
7601973|NCT03150862|12008485|FG001|Overall Study|Roll over in to Long Term Extension|0
7601974|NCT03150862|12008486|FG002|Overall Study|Roll over in to Long Term Extension|0
7601975|NCT03150862|12008487|FG003|Overall Study|Roll over in to Long Term Extension|0
7601976|NCT03150862|12008488|FG004|Overall Study|Roll over in to Long Term Extension|0
7601977|NCT03150862|12008489|FG005|Overall Study|Roll over in to Long Term Extension|0
7601978|NCT03150862|12008490|FG006|Overall Study|Roll over in to Long Term Extension|0
7601979|NCT03150862|12008491|FG007|Overall Study|Roll over in to Long Term Extension|1
7601980|NCT03150862|12008484|FG000|Overall Study|Progressive Disease|0
7601981|NCT03150862|12008485|FG001|Overall Study|Progressive Disease|0
7601982|NCT03150862|12008486|FG002|Overall Study|Progressive Disease|0
7601983|NCT03150862|12008487|FG003|Overall Study|Progressive Disease|0
7601984|NCT03150862|12008488|FG004|Overall Study|Progressive Disease|0
7601985|NCT03150862|12008489|FG005|Overall Study|Progressive Disease|0
7601986|NCT03150862|12008490|FG006|Overall Study|Progressive Disease|0
7601987|NCT03150862|12008491|FG007|Overall Study|Progressive Disease|2
7601988|NCT03074695|12008520|FG000|Overall Study|Delivered with caesarean before request for analgesia|1
7601989|NCT03074695|12008521|FG001|Overall Study|Delivered with caesarean before request for analgesia|1
7601990|NCT03074695|12008520|FG000|Overall Study|Research staff not available|1
7601991|NCT03074695|12008521|FG001|Overall Study|Research staff not available|2
7601992|NCT03074695|12008520|FG000|Overall Study|Did not receive neuraxial block|2
7601993|NCT03074695|12008521|FG001|Overall Study|Did not receive neuraxial block|2
7601994|NCT03052608|12008529|FG000|Treatment Phase|Adverse Event|10
7601995|NCT03052608|12008530|FG001|Treatment Phase|Adverse Event|12
7773415|NCT00902538|12218847|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
7773416|NCT00902538|12218848|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
7773417|NCT00902538|12218849|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
7773418|NCT00902538|12218844|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
7773419|NCT00902538|12218845|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
7773420|NCT00902538|12218846|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
7773421|NCT00902538|12218847|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
7773422|NCT00902538|12218848|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
7773423|NCT00902538|12218849|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
7773424|NCT00902538|12218844|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
7773425|NCT00902538|12218845|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
7773426|NCT00902538|12218846|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
7773427|NCT00902538|12218847|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
7773428|NCT00902538|12218848|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
7773429|NCT00902538|12218849|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
7773430|NCT00902538|12218844|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
7773431|NCT00902538|12218845|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
7773432|NCT00902538|12218846|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
7773433|NCT00902538|12218847|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
7773434|NCT00902538|12218848|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
7773435|NCT00902538|12218849|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
7773436|NCT00902538|12218844|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
7773437|NCT00902538|12218845|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
7773438|NCT00902538|12218846|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
7773439|NCT00902538|12218847|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
7601996|NCT03052608|12008529|FG000|Treatment Phase|Death|6
7601997|NCT03052608|12008530|FG001|Treatment Phase|Death|4
7601998|NCT03052608|12008529|FG000|Treatment Phase|Withdrawal by Subject|4
7601999|NCT03052608|12008530|FG001|Treatment Phase|Withdrawal by Subject|12
7773440|NCT00902538|12218848|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
7602000|NCT03052608|12008529|FG000|Treatment Phase|Global Deterioration of Health Status|0
7602001|NCT03052608|12008530|FG001|Treatment Phase|Global Deterioration of Health Status|3
7602002|NCT03052608|12008529|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0
7602003|NCT03052608|12008530|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1
7602004|NCT03052608|12008529|FG000|Treatment Phase|Subject didn't receive study treatment.|0
7602005|NCT03052608|12008530|FG001|Treatment Phase|Subject didn't receive study treatment.|1
7602006|NCT03052608|12008529|FG000|Treatment Phase|Ongoing|103
7602007|NCT03052608|12008530|FG001|Treatment Phase|Ongoing|31
7602008|NCT03052608|12008529|FG000|Long-Term Follow-up Phase|Death|23
7602009|NCT03052608|12008530|FG001|Long-Term Follow-up Phase|Death|28
7602010|NCT03052608|12008529|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0
7602011|NCT03052608|12008530|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2
7602012|NCT03052608|12008529|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4
7602013|NCT03052608|12008530|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18
7602014|NCT03052608|12008529|FG000|Long-Term Follow-up Phase|Ongoing|122
7602015|NCT03052608|12008530|FG001|Long-Term Follow-up Phase|Ongoing|99
7773441|NCT00902538|12218849|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
7773442|NCT00902538|12218844|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4
7773443|NCT00902538|12218845|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2
7773444|NCT00902538|12218846|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3
7773445|NCT00902538|12218847|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0
7773446|NCT00902538|12218848|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0
7773447|NCT00902538|12218849|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0
7773448|NCT00902538|12218844|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
7773449|NCT00902538|12218845|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
7602030|NCT02922725|12008551|FG000|Overall Study|Withdrawal by Subject|1
7602031|NCT02922725|12008552|FG001|Overall Study|Withdrawal by Subject|0
7602032|NCT02922725|12008553|FG002|Overall Study|Withdrawal by Subject|0
7602033|NCT02886572|12008560|FG000|Overall Study|Death|8
7602034|NCT02805257|12008566|FG000|Overall Study|Lost to Follow-up|7
7602035|NCT02805257|12008567|FG001|Overall Study|Lost to Follow-up|6
7602036|NCT02805257|12008566|FG000|Overall Study|Death|0
7602037|NCT02805257|12008567|FG001|Overall Study|Death|1
7602038|NCT02696564|12008606|FG000|Overall Study|Death|1
7602039|NCT02696564|12008607|FG001|Overall Study|Death|2
7602040|NCT02696564|12008606|FG000|Overall Study|Withdrawal by Subject|3
7602041|NCT02696564|12008607|FG001|Overall Study|Withdrawal by Subject|2
7602042|NCT02696564|12008606|FG000|Overall Study|Lost to Follow-up|3
7602043|NCT02696564|12008607|FG001|Overall Study|Lost to Follow-up|3
7602044|NCT02696564|12008606|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3
7602045|NCT02696564|12008607|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1
7602046|NCT02696564|12008606|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2
7602047|NCT02696564|12008607|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2
7602048|NCT02696564|12008606|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1
7602049|NCT02696564|12008607|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1
7602050|NCT02696564|12008606|FG000|Overall Study|Participant diagnosed with lung cancer|1
7602051|NCT02696564|12008607|FG001|Overall Study|Participant diagnosed with lung cancer|0
7602052|NCT02696564|12008606|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0
7602053|NCT02696564|12008607|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2
7773450|NCT00902538|12218846|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
7773451|NCT00902538|12218847|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
7773452|NCT00902538|12218848|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
7773453|NCT00902538|12218849|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
7773454|NCT00902538|12218844|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
7773455|NCT00902538|12218845|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
7773456|NCT00902538|12218846|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
7773457|NCT00902538|12218847|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
7773458|NCT00902538|12218848|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
7773459|NCT00902538|12218849|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
7773460|NCT00902538|12218844|FG000|2-Randomized Double-blind 3 Treatments|Other|2
7773461|NCT00902538|12218845|FG001|2-Randomized Double-blind 3 Treatments|Other|1
7602066|NCT02640950|12008626|FG000|Overall Study|Adverse Event|1
7602067|NCT02640950|12008626|FG000|Overall Study|Withdrawal by Subject|1
7602068|NCT02639065|12008630|FG000|Study Treatment|Disease Progression|11
7602069|NCT02639065|12008630|FG000|Study Treatment|Adverse Event|8
7602070|NCT02639065|12008630|FG000|Study Treatment|Withdrawal by Subject|1
7602071|NCT02639065|12008630|FG000|Follow up|Withdrawal by Subject|1
7602072|NCT02639065|12008630|FG000|Follow up|Symptomatic Deterioration|2
7602073|NCT02639065|12008630|FG000|Follow up|Death|2
7602074|NCT02639065|12008630|FG000|Follow up|Study Terminated|1
7602075|NCT02639065|12008630|FG000|Follow up|Disease Progression|3
7602076|NCT02564263|12008636|FG000|Overall Study|Adverse Event|31
7602077|NCT02564263|12008637|FG001|Overall Study|Adverse Event|29
7602078|NCT02564263|12008636|FG000|Overall Study|Death|236
7773462|NCT00902538|12218846|FG002|2-Randomized Double-blind 3 Treatments|Other|0
7773463|NCT00902538|12218847|FG003|2-Randomized Double-blind 3 Treatments|Other|0
7773464|NCT00902538|12218848|FG004|2-Randomized Double-blind 3 Treatments|Other|0
7773465|NCT00902538|12218849|FG005|2-Randomized Double-blind 3 Treatments|Other|0
7773466|NCT00902538|12218844|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
7773467|NCT00902538|12218845|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
7773468|NCT00902538|12218846|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
7773469|NCT00902538|12218847|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
7773470|NCT00902538|12218848|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
7773471|NCT00902538|12218849|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
7773472|NCT00902538|12218844|FG000|3-Single-blind, Single Treatment|Adverse Event|0
7773473|NCT00902538|12218845|FG001|3-Single-blind, Single Treatment|Adverse Event|5
7602079|NCT02564263|12008637|FG001|Overall Study|Death|242
7602080|NCT02564263|12008636|FG000|Overall Study|Withdrawal by Subject|5
7602081|NCT02564263|12008637|FG001|Overall Study|Withdrawal by Subject|18
7602082|NCT02564263|12008636|FG000|Overall Study|Ongoing in Study|42
7773474|NCT00902538|12218846|FG002|3-Single-blind, Single Treatment|Adverse Event|0
7602083|NCT02564263|12008637|FG001|Overall Study|Ongoing in Study|25
7773475|NCT00902538|12218847|FG003|3-Single-blind, Single Treatment|Adverse Event|0
7773476|NCT00902538|12218848|FG004|3-Single-blind, Single Treatment|Adverse Event|0
7773477|NCT00902538|12218849|FG005|3-Single-blind, Single Treatment|Adverse Event|0
7773478|NCT00902538|12218844|FG000|3-Single-blind, Single Treatment|Protocol Violation|0
7773479|NCT00902538|12218845|FG001|3-Single-blind, Single Treatment|Protocol Violation|5
7773480|NCT00902538|12218846|FG002|3-Single-blind, Single Treatment|Protocol Violation|0
7773481|NCT00902538|12218847|FG003|3-Single-blind, Single Treatment|Protocol Violation|0
7773482|NCT00902538|12218848|FG004|3-Single-blind, Single Treatment|Protocol Violation|0
7773483|NCT00902538|12218849|FG005|3-Single-blind, Single Treatment|Protocol Violation|0
7773484|NCT00902538|12218844|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0
7773485|NCT00902538|12218845|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4
7773486|NCT00902538|12218846|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0
7773487|NCT00902538|12218847|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0
7773488|NCT00902538|12218848|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0
7602098|NCT02372136|12008654|FG000|Overall Study|Death|3
7602099|NCT02372136|12008655|FG001|Overall Study|Death|1
7602100|NCT02367456|12008666|FG000|Overall Study|Death|8
7602101|NCT02367456|12008667|FG001|Overall Study|Death|21
7602102|NCT02367456|12008668|FG002|Overall Study|Death|14
7602103|NCT02367456|12008666|FG000|Overall Study|Lost to Follow-up|1
7602104|NCT02367456|12008667|FG001|Overall Study|Lost to Follow-up|3
7602105|NCT02367456|12008668|FG002|Overall Study|Lost to Follow-up|1
7602106|NCT02367456|12008666|FG000|Overall Study|Ongoing|0
7602107|NCT02367456|12008667|FG001|Overall Study|Ongoing|6
7602108|NCT02367456|12008668|FG002|Overall Study|Ongoing|15
7602109|NCT02367456|12008666|FG000|Overall Study|Other reason|3
7602110|NCT02367456|12008667|FG001|Overall Study|Other reason|0
7602111|NCT02367456|12008668|FG002|Overall Study|Other reason|0
7773489|NCT00902538|12218849|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0
7773490|NCT00902538|12218844|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0
7773491|NCT00902538|12218845|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1
7773492|NCT00902538|12218846|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0
7602116|NCT02022033|12008685|FG000|Overall Study|Physician Decision|1
7773493|NCT00902538|12218847|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0
7773494|NCT00902538|12218848|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0
7773495|NCT00902538|12218849|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0
7773496|NCT00902538|12218844|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0
7773497|NCT00902538|12218845|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0
7773498|NCT00902538|12218846|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0
7773499|NCT00902538|12218847|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3
7773500|NCT00902538|12218848|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1
7773501|NCT00902538|12218849|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1
7773502|NCT00902538|12218844|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
7773503|NCT00902538|12218845|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
7773504|NCT00902538|12218846|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
7773505|NCT00902538|12218847|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
7773506|NCT00902538|12218848|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
7773507|NCT00902538|12218849|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
7773508|NCT00902538|12218844|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
7773509|NCT00902538|12218845|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
7773510|NCT00902538|12218846|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
7773511|NCT00902538|12218847|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
7773512|NCT00902538|12218848|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
7773513|NCT00902538|12218849|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
7773514|NCT00902564|12218861|FG000|Overall Study|Withdrawal by Subject|2
7773515|NCT00902577|12218865|FG000|Overall Study|Withdrawal by Subject|6
7773516|NCT00902577|12218865|FG000|Overall Study|FMISO production failure|2
7773517|NCT00902746|12218888|FG000|Overall Study|Protocol Violation|7
7773518|NCT00902746|12218888|FG000|Overall Study|Withdrawal by Subject|16
7773519|NCT00902746|12218888|FG000|Overall Study|Adverse Event|8
7773520|NCT00902746|12218888|FG000|Overall Study|Lost to Follow-up|3
7773521|NCT00902746|12218888|FG000|Overall Study|Physician Decision|2
7773522|NCT00902850|12218894|FG000|Overall Study|Physician Decision|2
7773523|NCT00902850|12218895|FG001|Overall Study|Physician Decision|2
7773524|NCT00903032|12218903|FG000|Overall Study|Withdrawal by Subject|5
7773525|NCT00903032|12218904|FG001|Overall Study|Withdrawal by Subject|3
7773526|NCT00903032|12218903|FG000|Overall Study|Lost to Follow-up|2
7773527|NCT00903032|12218904|FG001|Overall Study|Lost to Follow-up|2
7773528|NCT00903175|12218916|FG000|Period 1 - First Line|Adverse Event|36
7773529|NCT00903175|12218917|FG001|Period 1 - First Line|Adverse Event|50
7773530|NCT00903175|12218916|FG000|Period 1 - First Line|Abnormal lab value(s)|0
7773531|NCT00903175|12218917|FG001|Period 1 - First Line|Abnormal lab value(s)|1
7773532|NCT00903175|12218916|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1
7773533|NCT00903175|12218917|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0
7773534|NCT00903175|12218916|FG000|Period 1 - First Line|Protocol Violation|3
7773535|NCT00903175|12218917|FG001|Period 1 - First Line|Protocol Violation|3
7773536|NCT00903175|12218916|FG000|Period 1 - First Line|Withdrawal by Subject|8
7602133|NCT01434602|12008703|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
7602134|NCT01434602|12008704|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1
7602135|NCT01434602|12008705|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
7602136|NCT01434602|12008706|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
7602137|NCT01434602|12008707|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
7602138|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
7602139|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
7602140|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
7602141|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1
7602142|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
7602143|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
7773537|NCT00903175|12218917|FG001|Period 1 - First Line|Withdrawal by Subject|12
7773538|NCT00903175|12218916|FG000|Period 1 - First Line|Administrative problems|12
7773539|NCT00903175|12218917|FG001|Period 1 - First Line|Administrative problems|13
7773540|NCT00903175|12218916|FG000|Period 1 - First Line|Death|17
7773541|NCT00903175|12218917|FG001|Period 1 - First Line|Death|10
7773542|NCT00903175|12218916|FG000|Period 2 - Second Line|Missing|1
7773543|NCT00903175|12218917|FG001|Period 2 - Second Line|Missing|0
7773544|NCT00903175|12218916|FG000|Period 2 - Second Line|Adverse Event|16
7773545|NCT00903175|12218917|FG001|Period 2 - Second Line|Adverse Event|20
7773546|NCT00903175|12218916|FG000|Period 2 - Second Line|Withdrawal by Subject|7
7773547|NCT00903175|12218917|FG001|Period 2 - Second Line|Withdrawal by Subject|5
7773548|NCT00903175|12218916|FG000|Period 2 - Second Line|Lost to Follow-up|1
7773549|NCT00903175|12218917|FG001|Period 2 - Second Line|Lost to Follow-up|0
7773550|NCT00903175|12218916|FG000|Period 2 - Second Line|Administrative problems|19
7773551|NCT00903175|12218917|FG001|Period 2 - Second Line|Administrative problems|9
7773552|NCT00903175|12218916|FG000|Period 2 - Second Line|Death|5
7773553|NCT00903175|12218917|FG001|Period 2 - Second Line|Death|2
7773554|NCT00903201|12218926|FG000|Overall Study|Adverse Event|1
7773555|NCT00903201|12218927|FG001|Overall Study|Adverse Event|4
7773556|NCT00903201|12218928|FG002|Overall Study|Adverse Event|0
7773557|NCT00903201|12218926|FG000|Overall Study|Protocol Violation|2
7773558|NCT00903201|12218927|FG001|Overall Study|Protocol Violation|1
7773559|NCT00903201|12218928|FG002|Overall Study|Protocol Violation|0
7773560|NCT00903201|12218926|FG000|Overall Study|Lost to Follow-up|0
7773561|NCT00903201|12218927|FG001|Overall Study|Lost to Follow-up|1
7773562|NCT00903201|12218928|FG002|Overall Study|Lost to Follow-up|0
7773563|NCT00903201|12218926|FG000|Overall Study|Physician Decision|1
7773564|NCT00903201|12218927|FG001|Overall Study|Physician Decision|0
7773565|NCT00903201|12218928|FG002|Overall Study|Physician Decision|1
7773566|NCT00903201|12218926|FG000|Overall Study|Withdrawal by Subject|1
7773567|NCT00903201|12218927|FG001|Overall Study|Withdrawal by Subject|0
7773568|NCT00903201|12218928|FG002|Overall Study|Withdrawal by Subject|1
7773569|NCT00903331|12218940|FG000|Overall Study|Death|4
7773570|NCT00903331|12218941|FG001|Overall Study|Death|8
7773571|NCT00903331|12218940|FG000|Overall Study|Withdrawal of consent|1
7773572|NCT00903331|12218941|FG001|Overall Study|Withdrawal of consent|8
7773573|NCT00903331|12218940|FG000|Overall Study|Lung transplant|0
7773574|NCT00903331|12218941|FG001|Overall Study|Lung transplant|2
7773575|NCT00903344|12218949|FG000|Overall Study|Pregnancy|2
7773576|NCT00903344|12218950|FG001|Overall Study|Pregnancy|3
7773577|NCT00903344|12218949|FG000|Overall Study|Lost to Follow-up|3
7773578|NCT00903344|12218950|FG001|Overall Study|Lost to Follow-up|0
7773579|NCT00903357|12218956|FG000|First Intervention|Withdrawal by Subject|5
7773580|NCT00903357|12218957|FG001|First Intervention|Withdrawal by Subject|3
7773581|NCT00903357|12218956|FG000|First Intervention|Flu|0
7773582|NCT00903357|12218957|FG001|First Intervention|Flu|1
7773583|NCT00903357|12218956|FG000|Wash Out Period of 2 Weeks|Flu|0
7773584|NCT00903357|12218957|FG001|Wash Out Period of 2 Weeks|Flu|1
7773585|NCT00903357|12218956|FG000|Second Intervention|Lost to Follow-up|1
7773586|NCT00903357|12218957|FG001|Second Intervention|Lost to Follow-up|0
7602144|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
7602145|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
7602146|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1
7602147|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
7602148|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0
7773587|NCT00903370|12218969|FG000|Overall Study|Death|13
7773588|NCT00903370|12218970|FG001|Overall Study|Death|10
7773589|NCT00903370|12218969|FG000|Overall Study|Withdrawal by Subject|9
7773590|NCT00903370|12218970|FG001|Overall Study|Withdrawal by Subject|6
7773591|NCT00903370|12218969|FG000|Overall Study|Lost to Follow-up|6
7602149|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0
7602150|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0
7602151|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1
7602152|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0
7602153|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
7602154|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
7602155|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
7602156|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1
7602157|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
7602158|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0
7602159|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0
7602160|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0
7602161|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1
7602162|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0
7602163|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
7602164|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
7602165|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
7602166|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
7602167|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1
7602168|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0
7602169|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0
7602170|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0
7602171|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1
7602172|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1
7602173|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
7602174|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
7602175|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
7602176|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1
7602177|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
7602178|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0
7602179|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0
7602180|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0
7602181|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2
7602182|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0
7602183|NCT01358877|12008731|FG000|Overall Study|Death|80
7602184|NCT01358877|12008732|FG001|Overall Study|Death|89
7602185|NCT01358877|12008731|FG000|Overall Study|Ongoing follow-up for post-recurrence|87
7602186|NCT01358877|12008732|FG001|Overall Study|Ongoing follow-up for post-recurrence|108
7602187|NCT01358877|12008731|FG000|Overall Study|Ongoing follow-up for IDFS event|2084
7602188|NCT01358877|12008732|FG001|Overall Study|Ongoing follow-up for IDFS event|2073
7602189|NCT01358877|12008731|FG000|Overall Study|Ongoing follow-up for overall survival|7
7602190|NCT01358877|12008732|FG001|Overall Study|Ongoing follow-up for overall survival|5
7602191|NCT01358877|12008731|FG000|Overall Study|Other|142
7602192|NCT01358877|12008732|FG001|Overall Study|Other|129
7602193|NCT01239797|12008740|FG000|Randomized Participants|Participant no longer meets study criteria|1
7602194|NCT01239797|12008741|FG001|Randomized Participants|Participant no longer meets study criteria|1
7602195|NCT01239797|12008740|FG000|Randomized Participants|Participant withdrew consent|1
7602196|NCT01239797|12008741|FG001|Randomized Participants|Participant withdrew consent|7
7602197|NCT01239797|12008740|FG000|Randomized Participants|Adverse event unrelated to study drug|0
7602198|NCT01239797|12008741|FG001|Randomized Participants|Adverse event unrelated to study drug|1
7602199|NCT01239797|12008740|FG000|Treated Participants|Disease progression|185
7602200|NCT01239797|12008741|FG001|Treated Participants|Disease progression|185
7602201|NCT01239797|12008740|FG000|Treated Participants|Study drug toxicity|39
7602202|NCT01239797|12008741|FG001|Treated Participants|Study drug toxicity|45
7602203|NCT01239797|12008740|FG000|Treated Participants|Adverse event unrelated to study drug|31
7602204|NCT01239797|12008741|FG001|Treated Participants|Adverse event unrelated to study drug|37
7602205|NCT01239797|12008740|FG000|Treated Participants|Participants request to discontinue study treatment|28
7602206|NCT01239797|12008741|FG001|Treated Participants|Participants request to discontinue study treatment|18
7602207|NCT01239797|12008740|FG000|Treated Participants|Administrative reason by sponsor|13
7602208|NCT01239797|12008741|FG001|Treated Participants|Administrative reason by sponsor|4
7602209|NCT01239797|12008740|FG000|Treated Participants|Other reasons|14
7602210|NCT01239797|12008741|FG001|Treated Participants|Other reasons|14
7602211|NCT01239797|12008740|FG000|Treated Participants|Participant withdrew consent|6
7602212|NCT01239797|12008741|FG001|Treated Participants|Participant withdrew consent|11
7602213|NCT01239797|12008740|FG000|Treated Participants|Death|1
7602214|NCT01239797|12008741|FG001|Treated Participants|Death|1
7602215|NCT01239797|12008740|FG000|Treated Participants|Participant no longer meets study criteria|1
7602216|NCT01239797|12008741|FG001|Treated Participants|Participant no longer meets study criteria|1
7602217|NCT01239797|12008740|FG000|Treated Participants|Poor/non-compliance|0
7602218|NCT01239797|12008741|FG001|Treated Participants|Poor/non-compliance|1
7602219|NCT01236521|12008749|FG000|Overall Study|Withdrawal by Subject|12
7602220|NCT01236521|12008750|FG001|Overall Study|Withdrawal by Subject|17
7602221|NCT01236521|12008749|FG000|Overall Study|Death|2
7602222|NCT01236521|12008750|FG001|Overall Study|Death|1
7602223|NCT01236521|12008749|FG000|Overall Study|Lost to Follow-up|9
7602224|NCT01236521|12008750|FG001|Overall Study|Lost to Follow-up|7
7602225|NCT01103349|12008759|FG000|Overall Study|Adverse Event|8
7602226|NCT01103349|12008760|FG001|Overall Study|Adverse Event|5
7602227|NCT01103349|12008761|FG002|Overall Study|Adverse Event|3
7602228|NCT01103349|12008759|FG000|Overall Study|Consent withdrawn|1
7602229|NCT01103349|12008760|FG001|Overall Study|Consent withdrawn|0
7602230|NCT01103349|12008761|FG002|Overall Study|Consent withdrawn|0
7602231|NCT01103349|12008759|FG000|Overall Study|Incorrectly included in the trial|1
7602232|NCT01103349|12008760|FG001|Overall Study|Incorrectly included in the trial|0
7602233|NCT01103349|12008761|FG002|Overall Study|Incorrectly included in the trial|0
7602234|NCT01103349|12008759|FG000|Overall Study|Withdrawal by Subject|1
7602235|NCT01103349|12008760|FG001|Overall Study|Withdrawal by Subject|1
7602236|NCT01103349|12008761|FG002|Overall Study|Withdrawal by Subject|0
7602237|NCT01103349|12008759|FG000|Overall Study|did not want to take trial medication|0
7602238|NCT01103349|12008760|FG001|Overall Study|did not want to take trial medication|1
7602239|NCT01103349|12008761|FG002|Overall Study|did not want to take trial medication|0
7602240|NCT01103349|12008759|FG000|Overall Study|forgot to take medication|0
7602241|NCT01103349|12008760|FG001|Overall Study|forgot to take medication|0
7602242|NCT01103349|12008761|FG002|Overall Study|forgot to take medication|1
7602243|NCT01092143|12008774|FG000|Overall Study|Adverse Event|10
7602244|NCT01092143|12008775|FG001|Overall Study|Adverse Event|5
7602245|NCT01092143|12008776|FG002|Overall Study|Adverse Event|1
7602246|NCT01092143|12008777|FG003|Overall Study|Adverse Event|4
7602247|NCT01092143|12008778|FG004|Overall Study|Adverse Event|3
7602248|NCT01092143|12008774|FG000|Overall Study|Lost to Follow-up|1
7602249|NCT01092143|12008775|FG001|Overall Study|Lost to Follow-up|0
7602250|NCT01092143|12008776|FG002|Overall Study|Lost to Follow-up|1
7602251|NCT01092143|12008777|FG003|Overall Study|Lost to Follow-up|0
7602252|NCT01092143|12008778|FG004|Overall Study|Lost to Follow-up|0
7602253|NCT01092143|12008774|FG000|Overall Study|Consent withdrawn|2
7602254|NCT01092143|12008775|FG001|Overall Study|Consent withdrawn|1
7602255|NCT01092143|12008776|FG002|Overall Study|Consent withdrawn|0
7602256|NCT01092143|12008777|FG003|Overall Study|Consent withdrawn|1
7602257|NCT01092143|12008778|FG004|Overall Study|Consent withdrawn|3
7602258|NCT01092143|12008774|FG000|Overall Study|Not treated|0
7602259|NCT01092143|12008775|FG001|Overall Study|Not treated|0
7602260|NCT01092143|12008776|FG002|Overall Study|Not treated|1
7602261|NCT01092143|12008777|FG003|Overall Study|Not treated|0
7602262|NCT01092143|12008778|FG004|Overall Study|Not treated|0
7602263|NCT01092143|12008774|FG000|Overall Study|did not reversibility criteria|0
7602264|NCT01092143|12008775|FG001|Overall Study|did not reversibility criteria|0
7602265|NCT01092143|12008776|FG002|Overall Study|did not reversibility criteria|1
7602266|NCT01092143|12008777|FG003|Overall Study|did not reversibility criteria|0
7602267|NCT01092143|12008778|FG004|Overall Study|did not reversibility criteria|0
7602268|NCT01092143|12008774|FG000|Overall Study|Increased Albuterol use for >2 days|0
7602269|NCT01092143|12008775|FG001|Overall Study|Increased Albuterol use for >2 days|1
7602270|NCT01092143|12008776|FG002|Overall Study|Increased Albuterol use for >2 days|0
7602271|NCT01092143|12008777|FG003|Overall Study|Increased Albuterol use for >2 days|0
7602272|NCT01092143|12008778|FG004|Overall Study|Increased Albuterol use for >2 days|0
7602273|NCT01092143|12008774|FG000|Overall Study|Ineligible patient|1
7602274|NCT01092143|12008775|FG001|Overall Study|Ineligible patient|0
7602275|NCT01092143|12008776|FG002|Overall Study|Ineligible patient|0
7602276|NCT01092143|12008777|FG003|Overall Study|Ineligible patient|0
7602277|NCT01092143|12008778|FG004|Overall Study|Ineligible patient|0
7602278|NCT01092143|12008774|FG000|Overall Study|Drop in FEV1 at visit 9|1
7602279|NCT01092143|12008775|FG001|Overall Study|Drop in FEV1 at visit 9|0
7602280|NCT01092143|12008776|FG002|Overall Study|Drop in FEV1 at visit 9|0
7602281|NCT01092143|12008777|FG003|Overall Study|Drop in FEV1 at visit 9|0
7602282|NCT01092143|12008778|FG004|Overall Study|Drop in FEV1 at visit 9|0
7602283|NCT01092143|12008774|FG000|Overall Study|Patient travel|0
7602284|NCT01092143|12008775|FG001|Overall Study|Patient travel|0
7602285|NCT01092143|12008776|FG002|Overall Study|Patient travel|0
7602286|NCT01092143|12008777|FG003|Overall Study|Patient travel|0
7602287|NCT01092143|12008778|FG004|Overall Study|Patient travel|1
7602288|NCT01092143|12008774|FG000|Overall Study|Non compliance with study medication|0
7602289|NCT01092143|12008775|FG001|Overall Study|Non compliance with study medication|0
7602290|NCT01092143|12008776|FG002|Overall Study|Non compliance with study medication|0
7602291|NCT01092143|12008777|FG003|Overall Study|Non compliance with study medication|0
7602292|NCT01092143|12008778|FG004|Overall Study|Non compliance with study medication|1
7602293|NCT01092143|12008774|FG000|Overall Study|Randomized by mistake|0
7602294|NCT01092143|12008775|FG001|Overall Study|Randomized by mistake|0
7602295|NCT01092143|12008776|FG002|Overall Study|Randomized by mistake|0
7602296|NCT01092143|12008777|FG003|Overall Study|Randomized by mistake|1
7602297|NCT01092143|12008778|FG004|Overall Study|Randomized by mistake|0
7602298|NCT01092143|12008774|FG000|Overall Study|Pregnancy|0
7602299|NCT01092143|12008775|FG001|Overall Study|Pregnancy|0
7602300|NCT01092143|12008776|FG002|Overall Study|Pregnancy|0
7602301|NCT01092143|12008777|FG003|Overall Study|Pregnancy|1
7602302|NCT01092143|12008778|FG004|Overall Study|Pregnancy|0
7602303|NCT00640133|12008802|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1
7602304|NCT00640133|12008803|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0
7602305|NCT00640133|12008802|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1
7602306|NCT00640133|12008803|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0
7602307|NCT00640133|12008802|FG000|Open Label Phase (Month 4-12)|Adverse Event|1
7602308|NCT00640133|12008803|FG001|Open Label Phase (Month 4-12)|Adverse Event|0
7602309|NCT00593567|12008813|FG000|Overall Study|Adverse Event|2
7602310|NCT00593567|12008814|FG001|Overall Study|Adverse Event|0
7602311|NCT00593567|12008813|FG000|Overall Study|Physician Decision|2
7602312|NCT00593567|12008814|FG001|Overall Study|Physician Decision|0
7602313|NCT00593567|12008813|FG000|Overall Study|Protocol Violation|13
7602314|NCT00593567|12008814|FG001|Overall Study|Protocol Violation|7
7602315|NCT00593567|12008813|FG000|Overall Study|Lack of Efficacy|2
7602316|NCT00593567|12008814|FG001|Overall Study|Lack of Efficacy|1
7602317|NCT00593567|12008813|FG000|Overall Study|Withdrawal by Subject|1
7602318|NCT00593567|12008814|FG001|Overall Study|Withdrawal by Subject|2
7602339|NCT02983617|12008831|FG000|Overall Study|Adverse Event|0
7602340|NCT02983617|12008832|FG001|Overall Study|Adverse Event|7
7602341|NCT02983617|12008831|FG000|Overall Study|Death|0
7602342|NCT02983617|12008832|FG001|Overall Study|Death|1
7602343|NCT02983617|12008831|FG000|Overall Study|Investigator's Discretion|0
7602344|NCT02983617|12008832|FG001|Overall Study|Investigator's Discretion|1
7602345|NCT02649946|12008866|FG000|Overall Study|Withdrawal by Subject|1
7602346|NCT02649946|12008867|FG001|Overall Study|Withdrawal by Subject|1
7602347|NCT02649946|12008866|FG000|Overall Study|Death|7
7602348|NCT02649946|12008867|FG001|Overall Study|Death|9
7602349|NCT02649946|12008866|FG000|Overall Study|Physician Decision|1
7602350|NCT02649946|12008867|FG001|Overall Study|Physician Decision|0
7602351|NCT02649946|12008866|FG000|Overall Study|Lost to Follow-up|2
7602352|NCT02649946|12008867|FG001|Overall Study|Lost to Follow-up|1
7602353|NCT02649946|12008866|FG000|Overall Study|Erroneously enrolled|1
7602354|NCT02649946|12008867|FG001|Overall Study|Erroneously enrolled|0
7602355|NCT02649946|12008866|FG000|Overall Study|Missed 6-month follow-up visit|0
7602356|NCT02649946|12008867|FG001|Overall Study|Missed 6-month follow-up visit|4
7773592|NCT00903370|12218970|FG001|Overall Study|Lost to Follow-up|8
7773593|NCT00903383|12218980|FG000|Overall Study|Adverse Event|1
7773594|NCT00903383|12218981|FG001|Overall Study|Adverse Event|2
7773595|NCT00903383|12218982|FG002|Overall Study|Adverse Event|3
7773596|NCT00903383|12218983|FG003|Overall Study|Adverse Event|1
7773597|NCT00903383|12218980|FG000|Overall Study|Physician Decision|1
7773598|NCT00903383|12218981|FG001|Overall Study|Physician Decision|2
7773599|NCT00903383|12218982|FG002|Overall Study|Physician Decision|0
7773600|NCT00903383|12218983|FG003|Overall Study|Physician Decision|0
7773601|NCT00903383|12218980|FG000|Overall Study|Lost to Follow-up|0
7773602|NCT00903383|12218981|FG001|Overall Study|Lost to Follow-up|0
7773603|NCT00903383|12218982|FG002|Overall Study|Lost to Follow-up|0
7773604|NCT00903383|12218983|FG003|Overall Study|Lost to Follow-up|1
7773605|NCT00903383|12218980|FG000|Overall Study|Decision of Sponsor|1
7773606|NCT00903383|12218981|FG001|Overall Study|Decision of Sponsor|0
7773607|NCT00903383|12218982|FG002|Overall Study|Decision of Sponsor|0
7773608|NCT00903383|12218983|FG003|Overall Study|Decision of Sponsor|0
7773609|NCT00903383|12218980|FG000|Overall Study|Withdrawal by Subject|4
7773610|NCT00903383|12218981|FG001|Overall Study|Withdrawal by Subject|1
7773611|NCT00903383|12218982|FG002|Overall Study|Withdrawal by Subject|0
7773612|NCT00903383|12218983|FG003|Overall Study|Withdrawal by Subject|2
7773613|NCT00903383|12218980|FG000|Overall Study|Patient Decision - Lack of Efficacy|0
7773614|NCT00903383|12218981|FG001|Overall Study|Patient Decision - Lack of Efficacy|1
7773615|NCT00903383|12218982|FG002|Overall Study|Patient Decision - Lack of Efficacy|0
7773616|NCT00903383|12218983|FG003|Overall Study|Patient Decision - Lack of Efficacy|0
7773617|NCT00903383|12218980|FG000|Overall Study|Patient Decision|0
7773618|NCT00903383|12218981|FG001|Overall Study|Patient Decision|0
7773619|NCT00903383|12218982|FG002|Overall Study|Patient Decision|0
7773620|NCT00903383|12218983|FG003|Overall Study|Patient Decision|1
7773621|NCT00903409|12218995|FG000|Overall Study|Adverse Event|11
7773622|NCT00903409|12218996|FG001|Overall Study|Adverse Event|9
7773623|NCT00903409|12218995|FG000|Overall Study|Non-compliance with Protocol|1
7773624|NCT00903409|12218996|FG001|Overall Study|Non-compliance with Protocol|1
7773625|NCT00903409|12218995|FG000|Overall Study|Laboratory Abnormality|2
7773626|NCT00903409|12218996|FG001|Overall Study|Laboratory Abnormality|0
7773627|NCT00903409|12218995|FG000|Overall Study|Withdrawal by Subject|8
7773628|NCT00903409|12218996|FG001|Overall Study|Withdrawal by Subject|8
7773629|NCT00903409|12218995|FG000|Overall Study|Other|2
7773630|NCT00903409|12218996|FG001|Overall Study|Other|3
7773631|NCT00903409|12218995|FG000|Overall Study|Lost to Follow-up|2
7773632|NCT00903409|12218996|FG001|Overall Study|Lost to Follow-up|6
7773633|NCT00903617|12219015|FG000|Overall Study|Adverse Event|0
7773634|NCT00903617|12219016|FG001|Overall Study|Adverse Event|1
7773635|NCT00903617|12219017|FG002|Overall Study|Adverse Event|1
7773636|NCT00903617|12219018|FG003|Overall Study|Adverse Event|0
7773637|NCT00903617|12219015|FG000|Overall Study|Protocol-defined stopping criteria|0
7773638|NCT00903617|12219016|FG001|Overall Study|Protocol-defined stopping criteria|2
7773639|NCT00903617|12219017|FG002|Overall Study|Protocol-defined stopping criteria|0
7773640|NCT00903617|12219018|FG003|Overall Study|Protocol-defined stopping criteria|0
7602399|NCT02345850|12008892|FG000|Overall Study|Not transplanted|10
7602400|NCT02345850|12008893|FG001|Overall Study|Not transplanted|5
7602401|NCT02345850|12008894|FG002|Overall Study|Not transplanted|4
7602402|NCT02345850|12008892|FG000|Overall Study|Lost to Follow-up|2
7602403|NCT02345850|12008893|FG001|Overall Study|Lost to Follow-up|3
7602404|NCT02345850|12008894|FG002|Overall Study|Lost to Follow-up|2
7602405|NCT02345850|12008892|FG000|Overall Study|Withdrawal by Subject|1
7602406|NCT02345850|12008893|FG001|Overall Study|Withdrawal by Subject|0
7602407|NCT02345850|12008894|FG002|Overall Study|Withdrawal by Subject|0
7602408|NCT02343302|12008904|FG000|Overall Study|Physician Decision|1
7602409|NCT02343302|12008905|FG001|Overall Study|Physician Decision|1
7602410|NCT01464164|12008947|FG000|Overall Study|Screen failure|0
7602411|NCT01464164|12008948|FG001|Overall Study|Screen failure|1
7602412|NCT01464164|12008949|FG002|Overall Study|Screen failure|2
7602413|NCT01464164|12008950|FG003|Overall Study|Screen failure|0
7602414|NCT01464164|12008951|FG004|Overall Study|Screen failure|0
7602415|NCT01464164|12008952|FG005|Overall Study|Screen failure|0
7602416|NCT01464164|12008953|FG006|Overall Study|Screen failure|0
7602417|NCT01464164|12008947|FG000|Overall Study|Physician Decision|0
7602418|NCT01464164|12008948|FG001|Overall Study|Physician Decision|0
7602419|NCT01464164|12008949|FG002|Overall Study|Physician Decision|0
7602420|NCT01464164|12008950|FG003|Overall Study|Physician Decision|0
7602421|NCT01464164|12008951|FG004|Overall Study|Physician Decision|0
7602422|NCT01464164|12008952|FG005|Overall Study|Physician Decision|0
7602423|NCT01464164|12008953|FG006|Overall Study|Physician Decision|2
7602424|NCT01111565|12008983|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3
7602425|NCT01111565|12008984|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
7602426|NCT01111565|12008985|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
7773641|NCT00903617|12219015|FG000|Overall Study|Lost to Follow-up|2
7773642|NCT00903617|12219016|FG001|Overall Study|Lost to Follow-up|0
7773643|NCT00903617|12219017|FG002|Overall Study|Lost to Follow-up|1
7602427|NCT01111565|12008986|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
7602428|NCT01111565|12008987|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
7602429|NCT01111565|12008983|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1
7602430|NCT01111565|12008984|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0
7602431|NCT01111565|12008985|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0
7602432|NCT01111565|12008986|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0
7773644|NCT00903617|12219018|FG003|Overall Study|Lost to Follow-up|1
7602433|NCT01111565|12008987|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0
7602434|NCT01111565|12008983|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58
7602435|NCT01111565|12008984|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
7602436|NCT01111565|12008985|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
7602437|NCT01111565|12008986|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
7602438|NCT01111565|12008987|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
7602439|NCT01111565|12008983|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1
7602440|NCT01111565|12008984|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
7602441|NCT01111565|12008985|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
7602442|NCT01111565|12008986|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
7602443|NCT01111565|12008987|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
7602444|NCT01111565|12008983|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1
7602445|NCT01111565|12008984|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
7602446|NCT01111565|12008985|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
7602447|NCT01111565|12008986|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
7602448|NCT01111565|12008987|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
7602449|NCT01111565|12008983|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1
7602450|NCT01111565|12008984|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0
7602451|NCT01111565|12008985|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0
7602452|NCT01111565|12008986|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0
7602453|NCT01111565|12008987|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0
7602454|NCT01111565|12008983|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1
7602455|NCT01111565|12008984|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
7602456|NCT01111565|12008985|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
7602457|NCT01111565|12008986|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
7602458|NCT01111565|12008987|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
7602459|NCT01111565|12008983|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7602460|NCT01111565|12008984|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7602461|NCT01111565|12008985|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7602462|NCT01111565|12008986|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
7602463|NCT01111565|12008987|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7602464|NCT01111565|12008983|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
7602465|NCT01111565|12008984|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
7602466|NCT01111565|12008985|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2
7602467|NCT01111565|12008986|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
7602468|NCT01111565|12008987|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
7602469|NCT01111565|12008983|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
7602470|NCT01111565|12008984|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7
7602471|NCT01111565|12008985|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
7773645|NCT00903617|12219015|FG000|Overall Study|Withdrawal by Subject|1
7602472|NCT01111565|12008986|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2
7602473|NCT01111565|12008987|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
7602474|NCT01111565|12008983|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
7602475|NCT01111565|12008984|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
7602476|NCT01111565|12008985|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
7602477|NCT01111565|12008986|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1
7602478|NCT01111565|12008987|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
7602479|NCT01111565|12008983|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
7602480|NCT01111565|12008984|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
7602481|NCT01111565|12008985|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
7602482|NCT01111565|12008986|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
7602483|NCT01111565|12008987|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1
7773646|NCT00903617|12219016|FG001|Overall Study|Withdrawal by Subject|2
7773647|NCT00903617|12219017|FG002|Overall Study|Withdrawal by Subject|3
7773648|NCT00903617|12219018|FG003|Overall Study|Withdrawal by Subject|0
7773649|NCT00903630|12219032|FG000|Phase 2|Adverse Event|0
7773650|NCT00903630|12219033|FG001|Phase 2|Adverse Event|0
7773651|NCT00903630|12219034|FG002|Phase 2|Adverse Event|1
7773652|NCT00903682|12219046|FG000|Overall Study|Adverse Event|6
7773653|NCT00903682|12219047|FG001|Overall Study|Adverse Event|13
7773654|NCT00903682|12219046|FG000|Overall Study|Lost to Follow-up|1
7773655|NCT00903682|12219047|FG001|Overall Study|Lost to Follow-up|0
7773656|NCT00903682|12219046|FG000|Overall Study|Withdrawal by Subject|5
7773657|NCT00903682|12219047|FG001|Overall Study|Withdrawal by Subject|0
7773658|NCT00903682|12219046|FG000|Overall Study|Pregnancy|0
7773659|NCT00903682|12219047|FG001|Overall Study|Pregnancy|1
7773660|NCT00903682|12219046|FG000|Overall Study|Subject Reached A Virologic Endpoint|1
7773661|NCT00903682|12219047|FG001|Overall Study|Subject Reached A Virologic Endpoint|1
7773662|NCT00903682|12219046|FG000|Overall Study|Subject Non-Compliant|1
7773663|NCT00903682|12219047|FG001|Overall Study|Subject Non-Compliant|0
7773664|NCT00903682|12219046|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1
7773665|NCT00903682|12219047|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0
7773666|NCT00903682|12219046|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
7773667|NCT00903682|12219047|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
7773668|NCT00903695|12219055|FG000|Overall Study|medical exclusion after 1st testing|1
7602484|NCT01092117|12008997|FG000|Index Procedure to 1 Month|Death|1
7602485|NCT01092117|12008997|FG000|1 Month|Death|1
7602486|NCT01092117|12008997|FG000|1 Month|Withdrawal by Subject|1
7602487|NCT01092117|12008997|FG000|1 Month|Lost to Follow-up|1
7602488|NCT01092117|12008997|FG000|6 Months|Death|2
7602489|NCT01092117|12008997|FG000|6 Months|Withdrawal by Subject|3
7602490|NCT01092117|12008997|FG000|12 Month|Death|11
7602491|NCT01092117|12008997|FG000|12 Month|Withdrawal by Subject|2
7602492|NCT01092117|12008997|FG000|12 Month|Lost to Follow-up|1
7602493|NCT01092117|12008997|FG000|Year 2|Death|5
7602494|NCT01092117|12008997|FG000|Year 2|Withdrawal by Subject|4
7602495|NCT01092117|12008997|FG000|Year 2|Lost to Follow-up|1
7602496|NCT01092117|12008997|FG000|Year 3|Death|7
7773669|NCT00903695|12219056|FG001|Overall Study|medical exclusion after 1st testing|0
7773670|NCT00903695|12219055|FG000|Overall Study|lung cancer|1
7773671|NCT00903695|12219056|FG001|Overall Study|lung cancer|0
7602497|NCT01092117|12008997|FG000|Year 3|Withdrawal by Subject|9
7602498|NCT01092117|12008997|FG000|Year 3|Lost to Follow-up|3
7602499|NCT01092117|12008997|FG000|Year 4|Death|8
7602500|NCT01092117|12008997|FG000|Year 4|Withdrawal by Subject|4
7602501|NCT01092117|12008997|FG000|Year 4|Lost to Follow-up|4
7602502|NCT00950989|12009005|FG000|Overall Study|Death|0
7602503|NCT00950989|12009006|FG001|Overall Study|Death|0
7602504|NCT00950989|12009007|FG002|Overall Study|Death|1
7602505|NCT00950989|12009008|FG003|Overall Study|Death|0
7602506|NCT00950989|12009005|FG000|Overall Study|Administrative Decision|0
7602507|NCT00950989|12009006|FG001|Overall Study|Administrative Decision|1
7602508|NCT00950989|12009007|FG002|Overall Study|Administrative Decision|0
7602509|NCT00950989|12009008|FG003|Overall Study|Administrative Decision|0
7602510|NCT00950989|12009005|FG000|Overall Study|Disease Progression|0
7602511|NCT00950989|12009006|FG001|Overall Study|Disease Progression|0
7602512|NCT00950989|12009007|FG002|Overall Study|Disease Progression|1
7602513|NCT00950989|12009008|FG003|Overall Study|Disease Progression|0
7602514|NCT00950989|12009005|FG000|Overall Study|Withdrawal by Subject|2
7602515|NCT00950989|12009006|FG001|Overall Study|Withdrawal by Subject|1
7602516|NCT00950989|12009007|FG002|Overall Study|Withdrawal by Subject|0
7602517|NCT00950989|12009008|FG003|Overall Study|Withdrawal by Subject|0
7602518|NCT00950989|12009005|FG000|Overall Study|Adverse Event|2
7602519|NCT00950989|12009006|FG001|Overall Study|Adverse Event|1
7602520|NCT00950989|12009007|FG002|Overall Study|Adverse Event|1
7602521|NCT00950989|12009008|FG003|Overall Study|Adverse Event|0
7773672|NCT00903760|12219066|FG000|Overall Study|Disease Progression/Death|8
7773673|NCT00903760|12219067|FG001|Overall Study|Disease Progression/Death|6
7773674|NCT00903760|12219066|FG000|Overall Study|Stem Cell Transplant|8
7773675|NCT00903760|12219067|FG001|Overall Study|Stem Cell Transplant|4
7773676|NCT00903760|12219066|FG000|Overall Study|Physician Decision|1
7773677|NCT00903760|12219067|FG001|Overall Study|Physician Decision|2
7773678|NCT00903760|12219066|FG000|Overall Study|Death|0
7773679|NCT00903760|12219067|FG001|Overall Study|Death|1
7773680|NCT00903760|12219066|FG000|Overall Study|Lost to Follow-up|1
7773681|NCT00903760|12219067|FG001|Overall Study|Lost to Follow-up|0
7773682|NCT00903760|12219066|FG000|Overall Study|Withdrawal by Subject|1
7773683|NCT00903760|12219067|FG001|Overall Study|Withdrawal by Subject|2
7773684|NCT00903760|12219066|FG000|Overall Study|Off treatment for long period|0
7773685|NCT00903760|12219067|FG001|Overall Study|Off treatment for long period|1
7773686|NCT00903786|12219073|FG000|Overall Study|Physician Decision|6
7773687|NCT00903786|12219073|FG000|Overall Study|Lack of Efficacy|5
7773688|NCT00903786|12219073|FG000|Overall Study|Reason other than lack of efficacy|4
7773689|NCT00903877|12219078|FG000|Overall Study|Did not meet study criteria|33
7773690|NCT00903877|12219078|FG000|Overall Study|Withdrawal by Subject|3
7773691|NCT00903877|12219078|FG000|Overall Study|Adverse Event|2
7773692|NCT00903877|12219078|FG000|Overall Study|Lost to Follow-up|1
7773693|NCT00903877|12219078|FG000|Overall Study|Participation put on hold|4
7773694|NCT00903929|12219082|FG000|Overall Study|Withdrawal by Subject|0
7773695|NCT00903929|12219083|FG001|Overall Study|Withdrawal by Subject|0
7773696|NCT00903929|12219084|FG002|Overall Study|Withdrawal by Subject|1
7773697|NCT00903929|12219085|FG003|Overall Study|Withdrawal by Subject|2
7773698|NCT00903929|12219082|FG000|Overall Study|Adverse Event|0
7773699|NCT00903929|12219083|FG001|Overall Study|Adverse Event|0
7602522|NCT00489307|12009023|FG000|Overall Study|Death|1
7602523|NCT00489307|12009024|FG001|Overall Study|Death|1
7602524|NCT00489307|12009023|FG000|Overall Study|Lost to Follow-up|2
7602525|NCT00489307|12009024|FG001|Overall Study|Lost to Follow-up|2
7602526|NCT00489307|12009023|FG000|Overall Study|Physician Decision|1
7602527|NCT00489307|12009024|FG001|Overall Study|Physician Decision|0
7602528|NCT00489307|12009023|FG000|Overall Study|Withdrawal by Subject|2
7602529|NCT00489307|12009024|FG001|Overall Study|Withdrawal by Subject|4
7602530|NCT00489307|12009023|FG000|Overall Study|Hospitalization unrelated to treatment|10
7602531|NCT00489307|12009024|FG001|Overall Study|Hospitalization unrelated to treatment|7
7602532|NCT00489307|12009023|FG000|Overall Study|Surgery after assignment|1
7602533|NCT00489307|12009024|FG001|Overall Study|Surgery after assignment|0
7602534|NCT00489307|12009023|FG000|Overall Study|Did not fill up the forms|2
7602535|NCT00489307|12009024|FG001|Overall Study|Did not fill up the forms|1
7602536|NCT00489307|12009023|FG000|Overall Study|Patient or family refusal|5
7602537|NCT00489307|12009024|FG001|Overall Study|Patient or family refusal|9
7602538|NCT00072410|12009032|FG000|Overall Study|Progressive disease|0
7602539|NCT00072410|12009033|FG001|Overall Study|Progressive disease|3
7773700|NCT00903929|12219084|FG002|Overall Study|Adverse Event|0
7773701|NCT00903929|12219085|FG003|Overall Study|Adverse Event|1
7773702|NCT00903968|12219092|FG000|Overall Study|Adverse Event|0
7773703|NCT00903968|12219093|FG001|Overall Study|Adverse Event|0
7773704|NCT00903968|12219094|FG002|Overall Study|Adverse Event|0
7773705|NCT00903968|12219095|FG003|Overall Study|Adverse Event|0
7773706|NCT00903968|12219096|FG004|Overall Study|Adverse Event|0
7773707|NCT00903968|12219097|FG005|Overall Study|Adverse Event|0
7773708|NCT00903968|12219098|FG006|Overall Study|Adverse Event|1
7773709|NCT00903968|12219099|FG007|Overall Study|Adverse Event|8
7773710|NCT00903968|12219092|FG000|Overall Study|DLT|0
7773711|NCT00903968|12219093|FG001|Overall Study|DLT|0
7773712|NCT00903968|12219094|FG002|Overall Study|DLT|0
7773713|NCT00903968|12219095|FG003|Overall Study|DLT|0
7773714|NCT00903968|12219096|FG004|Overall Study|DLT|0
7773715|NCT00903968|12219097|FG005|Overall Study|DLT|0
7773716|NCT00903968|12219098|FG006|Overall Study|DLT|2
7773717|NCT00903968|12219099|FG007|Overall Study|DLT|0
7773718|NCT00903968|12219092|FG000|Overall Study|Withdrawal by Subject|1
7773719|NCT00903968|12219093|FG001|Overall Study|Withdrawal by Subject|0
7773720|NCT00903968|12219094|FG002|Overall Study|Withdrawal by Subject|1
7773721|NCT00903968|12219095|FG003|Overall Study|Withdrawal by Subject|0
7773722|NCT00903968|12219096|FG004|Overall Study|Withdrawal by Subject|1
7773723|NCT00903968|12219097|FG005|Overall Study|Withdrawal by Subject|1
7773724|NCT00903968|12219098|FG006|Overall Study|Withdrawal by Subject|0
7773725|NCT00903968|12219099|FG007|Overall Study|Withdrawal by Subject|4
7773726|NCT00903968|12219092|FG000|Overall Study|Non-Compliance|0
7773727|NCT00903968|12219093|FG001|Overall Study|Non-Compliance|0
7773728|NCT00903968|12219094|FG002|Overall Study|Non-Compliance|0
7773729|NCT00903968|12219095|FG003|Overall Study|Non-Compliance|0
7773730|NCT00903968|12219096|FG004|Overall Study|Non-Compliance|0
7773731|NCT00903968|12219097|FG005|Overall Study|Non-Compliance|1
7773732|NCT00903968|12219098|FG006|Overall Study|Non-Compliance|0
7602540|NCT04498247|12009080|FG000|Overall Study|Lost to Follow-up|0
7602541|NCT04498247|12009081|FG001|Overall Study|Lost to Follow-up|0
7602542|NCT04498247|12009082|FG002|Overall Study|Lost to Follow-up|0
7602543|NCT04498247|12009083|FG003|Overall Study|Lost to Follow-up|1
7602544|NCT04498247|12009084|FG004|Overall Study|Lost to Follow-up|0
7602545|NCT04498247|12009085|FG005|Overall Study|Lost to Follow-up|0
7602546|NCT04498247|12009086|FG006|Overall Study|Lost to Follow-up|0
7602547|NCT04498247|12009087|FG007|Overall Study|Lost to Follow-up|0
7602548|NCT04498247|12009080|FG000|Overall Study|Mistakenly Randomized; Not Treated|1
7773733|NCT00903968|12219099|FG007|Overall Study|Non-Compliance|0
7773734|NCT00903968|12219092|FG000|Overall Study|Physician Decision|0
7773735|NCT00903968|12219093|FG001|Overall Study|Physician Decision|0
7773736|NCT00903968|12219094|FG002|Overall Study|Physician Decision|0
7773737|NCT00903968|12219095|FG003|Overall Study|Physician Decision|0
7773738|NCT00903968|12219096|FG004|Overall Study|Physician Decision|0
7602549|NCT04498247|12009081|FG001|Overall Study|Mistakenly Randomized; Not Treated|0
7602550|NCT04498247|12009082|FG002|Overall Study|Mistakenly Randomized; Not Treated|0
7602551|NCT04498247|12009083|FG003|Overall Study|Mistakenly Randomized; Not Treated|0
7602552|NCT04498247|12009084|FG004|Overall Study|Mistakenly Randomized; Not Treated|0
7602553|NCT04498247|12009085|FG005|Overall Study|Mistakenly Randomized; Not Treated|0
7602554|NCT04498247|12009086|FG006|Overall Study|Mistakenly Randomized; Not Treated|0
7602555|NCT04498247|12009087|FG007|Overall Study|Mistakenly Randomized; Not Treated|0
7602556|NCT04498247|12009080|FG000|Overall Study|Withdrawal by Subject|0
7602557|NCT04498247|12009081|FG001|Overall Study|Withdrawal by Subject|8
7602558|NCT04498247|12009082|FG002|Overall Study|Withdrawal by Subject|0
7602559|NCT04498247|12009083|FG003|Overall Study|Withdrawal by Subject|7
7602560|NCT04498247|12009084|FG004|Overall Study|Withdrawal by Subject|0
7602561|NCT04498247|12009085|FG005|Overall Study|Withdrawal by Subject|0
7602562|NCT04498247|12009086|FG006|Overall Study|Withdrawal by Subject|1
7602563|NCT04498247|12009087|FG007|Overall Study|Withdrawal by Subject|0
7602564|NCT04498247|12009080|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0
7602565|NCT04498247|12009081|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4
7602566|NCT04498247|12009082|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0
7602567|NCT04498247|12009083|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3
7602568|NCT04498247|12009084|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0
7773739|NCT00903968|12219097|FG005|Overall Study|Physician Decision|1
7773740|NCT00903968|12219098|FG006|Overall Study|Physician Decision|0
7773741|NCT00903968|12219099|FG007|Overall Study|Physician Decision|0
7773742|NCT00903968|12219092|FG000|Overall Study|Progressive Disease|2
7602569|NCT04498247|12009085|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0
7773743|NCT00903968|12219093|FG001|Overall Study|Progressive Disease|3
7602570|NCT04498247|12009086|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7
7602571|NCT04498247|12009087|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0
7602572|NCT04472650|12009104|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1
7602573|NCT04472650|12009105|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0
7602574|NCT04151290|12009122|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286
7602575|NCT04038385|12009128|FG000|Overall Study|Completed baseline assessment only|7
7602576|NCT04038385|12009129|FG001|Overall Study|Completed baseline assessment only|4
7602577|NCT04038385|12009128|FG000|Overall Study|Moved out of area|4
7602578|NCT04038385|12009129|FG001|Overall Study|Moved out of area|2
7602579|NCT04038385|12009128|FG000|Overall Study|Discontinued study involvement|6
7602580|NCT04038385|12009129|FG001|Overall Study|Discontinued study involvement|1
7773744|NCT00903968|12219094|FG002|Overall Study|Progressive Disease|2
7773745|NCT00903968|12219095|FG003|Overall Study|Progressive Disease|3
7773746|NCT00903968|12219096|FG004|Overall Study|Progressive Disease|3
7773747|NCT00903968|12219097|FG005|Overall Study|Progressive Disease|3
7773748|NCT00903968|12219098|FG006|Overall Study|Progressive Disease|0
7773749|NCT00903968|12219099|FG007|Overall Study|Progressive Disease|18
7773750|NCT00903968|12219092|FG000|Overall Study|Lack of Efficacy|0
7773751|NCT00903968|12219093|FG001|Overall Study|Lack of Efficacy|0
7773752|NCT00903968|12219094|FG002|Overall Study|Lack of Efficacy|0
7773753|NCT00903968|12219095|FG003|Overall Study|Lack of Efficacy|0
7773754|NCT00903968|12219096|FG004|Overall Study|Lack of Efficacy|0
7773755|NCT00903968|12219097|FG005|Overall Study|Lack of Efficacy|0
7773756|NCT00903968|12219098|FG006|Overall Study|Lack of Efficacy|0
7773757|NCT00903968|12219099|FG007|Overall Study|Lack of Efficacy|3
7773758|NCT00904033|12219135|FG000|Overall Study|Withdrawal by Subject|1
7773759|NCT00904033|12219136|FG001|Overall Study|Withdrawal by Subject|1
7773760|NCT00904033|12219137|FG002|Overall Study|Withdrawal by Subject|0
7773761|NCT00904033|12219138|FG003|Overall Study|Withdrawal by Subject|0
7773762|NCT00904033|12219135|FG000|Overall Study|Physician Decision|0
7773763|NCT00904033|12219136|FG001|Overall Study|Physician Decision|0
7773764|NCT00904033|12219137|FG002|Overall Study|Physician Decision|1
7773765|NCT00904033|12219138|FG003|Overall Study|Physician Decision|0
7773766|NCT00904033|12219135|FG000|Overall Study|Unable to obtain final blood draw|0
7773767|NCT00904033|12219136|FG001|Overall Study|Unable to obtain final blood draw|0
7773768|NCT00904033|12219137|FG002|Overall Study|Unable to obtain final blood draw|0
7773769|NCT00904033|12219138|FG003|Overall Study|Unable to obtain final blood draw|2
7773770|NCT00904150|12219151|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3
7773771|NCT00904150|12219152|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0
7773772|NCT00904150|12219151|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0
7602581|NCT03923738|12009135|FG000|Period 1|Adverse Event|1
7602582|NCT03923738|12009135|FG000|Period 1|Withdrawal by Subject|1
7602583|NCT03887117|12009145|FG000|Overall Study|Discontinued prematurely|0
7602584|NCT03887117|12009146|FG001|Overall Study|Discontinued prematurely|1
7602585|NCT03887117|12009147|FG002|Overall Study|Discontinued prematurely|1
7602586|NCT03887117|12009148|FG003|Overall Study|Discontinued prematurely|2
7602587|NCT03858634|12009169|FG000|Overall Study|Withdrawal by Subject|1
7602588|NCT03858634|12009170|FG001|Overall Study|Withdrawal by Subject|0
7602589|NCT03858634|12009169|FG000|Overall Study|Adverse Event|1
7602590|NCT03858634|12009170|FG001|Overall Study|Adverse Event|0
7602591|NCT03858634|12009169|FG000|Overall Study|Lost to Follow-up|0
7602592|NCT03858634|12009170|FG001|Overall Study|Lost to Follow-up|1
7602593|NCT03858634|12009169|FG000|Overall Study|Other, Not Specified|1
7773773|NCT00904150|12219152|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145
7602594|NCT03858634|12009170|FG001|Overall Study|Other, Not Specified|1
7602595|NCT03819114|12009188|FG000|Overall Study|Protocol Violation|0
7602596|NCT03819114|12009189|FG001|Overall Study|Protocol Violation|1
7602597|NCT03819114|12009190|FG002|Overall Study|Protocol Violation|1
7602598|NCT03819114|12009191|FG003|Overall Study|Protocol Violation|0
7602599|NCT03819114|12009188|FG000|Overall Study|Lost to Follow-up|0
7602600|NCT03819114|12009189|FG001|Overall Study|Lost to Follow-up|0
7602601|NCT03819114|12009190|FG002|Overall Study|Lost to Follow-up|1
7602602|NCT03819114|12009191|FG003|Overall Study|Lost to Follow-up|0
7602603|NCT03804268|12009205|FG000|Overall Study|Adverse Event|2
7602604|NCT03804268|12009206|FG001|Overall Study|Adverse Event|2
7602605|NCT03804268|12009205|FG000|Overall Study|Withdrawal by Subject|2
7602606|NCT03804268|12009206|FG001|Overall Study|Withdrawal by Subject|0
7602607|NCT03804268|12009205|FG000|Overall Study|Lost to Follow-up|1
7602608|NCT03804268|12009206|FG001|Overall Study|Lost to Follow-up|0
7602609|NCT03804268|12009205|FG000|Overall Study|Physician Decision|2
7602610|NCT03804268|12009206|FG001|Overall Study|Physician Decision|0
7602611|NCT04435808|12009215|FG000|Overall Study|Study stopped by DSMB|0
7602612|NCT04435808|12009216|FG001|Overall Study|Study stopped by DSMB|1
7602613|NCT04409262|12009224|FG000|Overall Study|Adverse Event|0
7602614|NCT04409262|12009225|FG001|Overall Study|Adverse Event|2
7602615|NCT04409262|12009224|FG000|Overall Study|Death|55
7602616|NCT04409262|12009225|FG001|Overall Study|Death|97
7602617|NCT04409262|12009224|FG000|Overall Study|Lost to Follow-up|12
7602618|NCT04409262|12009225|FG001|Overall Study|Lost to Follow-up|23
7602619|NCT04409262|12009224|FG000|Overall Study|Lack of Staff|0
7602620|NCT04409262|12009225|FG001|Overall Study|Lack of Staff|1
7602621|NCT04409262|12009224|FG000|Overall Study|Protocol Violation|3
7602622|NCT04409262|12009225|FG001|Overall Study|Protocol Violation|1
7602623|NCT04409262|12009224|FG000|Overall Study|Withdrawal by Subject|5
7602624|NCT04409262|12009225|FG001|Overall Study|Withdrawal by Subject|10
7602625|NCT04305912|12009234|FG000|First Intervention|COVID-19 Suspension|2
7602626|NCT04305912|12009235|FG001|First Intervention|COVID-19 Suspension|0
7602627|NCT04305912|12009234|FG000|First Intervention|Withdrawal by Subject|0
7602628|NCT04305912|12009235|FG001|First Intervention|Withdrawal by Subject|1
7602629|NCT04305912|12009234|FG000|Second Intervention|Adverse Event|0
7602630|NCT04305912|12009235|FG001|Second Intervention|Adverse Event|1
7602631|NCT03987919|12009254|FG000|Overall Study|Adverse Event|1
7602632|NCT03987919|12009255|FG001|Overall Study|Adverse Event|4
7602633|NCT03987919|12009256|FG002|Overall Study|Adverse Event|1
7602634|NCT03987919|12009257|FG003|Overall Study|Adverse Event|3
7602635|NCT03987919|12009254|FG000|Overall Study|Death|4
7602636|NCT03987919|12009255|FG001|Overall Study|Death|4
7602637|NCT03987919|12009256|FG002|Overall Study|Death|4
7602638|NCT03987919|12009257|FG003|Overall Study|Death|1
7602639|NCT03987919|12009254|FG000|Overall Study|Lost to Follow-up|5
7602640|NCT03987919|12009255|FG001|Overall Study|Lost to Follow-up|6
7602641|NCT03987919|12009256|FG002|Overall Study|Lost to Follow-up|8
7773774|NCT00904215|12219158|FG000|Overall Study|Adverse Event|25
7773775|NCT00904215|12219158|FG000|Overall Study|Protocol Violation|10
7773776|NCT00904215|12219158|FG000|Overall Study|Lost to Follow-up|63
7773777|NCT00904215|12219158|FG000|Overall Study|Withdrawal by Subject|9
7602642|NCT03987919|12009257|FG003|Overall Study|Lost to Follow-up|12
7602643|NCT03987919|12009254|FG000|Overall Study|Physician Decision|0
7602644|NCT03987919|12009255|FG001|Overall Study|Physician Decision|2
7602645|NCT03987919|12009256|FG002|Overall Study|Physician Decision|0
7602646|NCT03987919|12009257|FG003|Overall Study|Physician Decision|4
7602647|NCT03987919|12009254|FG000|Overall Study|Pregnancy|1
7602648|NCT03987919|12009255|FG001|Overall Study|Pregnancy|0
7602649|NCT03987919|12009256|FG002|Overall Study|Pregnancy|1
7602650|NCT03987919|12009257|FG003|Overall Study|Pregnancy|1
7602651|NCT03987919|12009254|FG000|Overall Study|Protocol Violation|0
7602652|NCT03987919|12009255|FG001|Overall Study|Protocol Violation|1
7602653|NCT03987919|12009256|FG002|Overall Study|Protocol Violation|0
7602654|NCT03987919|12009257|FG003|Overall Study|Protocol Violation|0
7602655|NCT03987919|12009254|FG000|Overall Study|Site terminated by Sponsor|0
7602656|NCT03987919|12009255|FG001|Overall Study|Site terminated by Sponsor|0
7602657|NCT03987919|12009256|FG002|Overall Study|Site terminated by Sponsor|0
7602658|NCT03987919|12009257|FG003|Overall Study|Site terminated by Sponsor|1
7602659|NCT03987919|12009254|FG000|Overall Study|Withdrawal by Subject|7
7602660|NCT03987919|12009255|FG001|Overall Study|Withdrawal by Subject|7
7602661|NCT03987919|12009256|FG002|Overall Study|Withdrawal by Subject|8
7602662|NCT03987919|12009257|FG003|Overall Study|Withdrawal by Subject|4
7602663|NCT03987919|12009254|FG000|Overall Study|Other - as reported by the investigator|1
7602664|NCT03987919|12009255|FG001|Overall Study|Other - as reported by the investigator|3
7602665|NCT03987919|12009256|FG002|Overall Study|Other - as reported by the investigator|2
7602666|NCT03987919|12009257|FG003|Overall Study|Other - as reported by the investigator|0
7602667|NCT03861039|12009286|FG000|Overall Study|Adverse Event|2
7602668|NCT03861039|12009287|FG001|Overall Study|Adverse Event|5
7602669|NCT03861039|12009288|FG002|Overall Study|Adverse Event|11
7602670|NCT03861039|12009286|FG000|Overall Study|Withdrawal by Subject|1
7602671|NCT03861039|12009287|FG001|Overall Study|Withdrawal by Subject|3
7602672|NCT03861039|12009288|FG002|Overall Study|Withdrawal by Subject|4
7602673|NCT03759587|12009298|FG000|Overall Study|Ongoing|19
7773778|NCT00904215|12219158|FG000|Overall Study|Other|28
7602674|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Adverse Event|3
7602675|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Adverse Event|2
7602676|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Adverse Event|0
7602677|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Adverse Event|3
7602678|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Screen Failure|0
7602679|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Screen Failure|1
7602680|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Screen Failure|0
7602681|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Screen Failure|0
7602682|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Death|6
7602683|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Death|2
7602684|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Death|2
7602685|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Death|9
7602686|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4
7602687|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2
7602688|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2
7602689|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11
7602690|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Physician Decision|1
7602691|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Physician Decision|1
7602692|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Physician Decision|0
7602693|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Physician Decision|3
7602694|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Protocol Violation|0
7602695|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Protocol Violation|1
7602696|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Protocol Violation|0
7602697|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Protocol Violation|1
7602698|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5
7602699|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0
7602700|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5
7602701|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23
7602702|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Personal Reason|2
7602703|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Personal Reason|2
7602704|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Personal Reason|0
7602705|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Personal Reason|2
7602706|NCT03730662|12009306|FG000|Variable Treatment Period|Adverse Event|1
7602707|NCT03730662|12009307|FG001|Variable Treatment Period|Adverse Event|2
7602708|NCT03730662|12009308|FG002|Variable Treatment Period|Adverse Event|0
7602709|NCT03730662|12009309|FG003|Variable Treatment Period|Adverse Event|7
7602710|NCT03730662|12009306|FG000|Variable Treatment Period|Death|9
7602711|NCT03730662|12009307|FG001|Variable Treatment Period|Death|0
7602712|NCT03730662|12009308|FG002|Variable Treatment Period|Death|6
7602713|NCT03730662|12009309|FG003|Variable Treatment Period|Death|26
7602714|NCT03730662|12009306|FG000|Variable Treatment Period|Lost to Follow-up|2
7602715|NCT03730662|12009307|FG001|Variable Treatment Period|Lost to Follow-up|1
7602716|NCT03730662|12009308|FG002|Variable Treatment Period|Lost to Follow-up|4
7602717|NCT03730662|12009309|FG003|Variable Treatment Period|Lost to Follow-up|11
7602718|NCT03730662|12009306|FG000|Variable Treatment Period|Personal Reason|0
7602719|NCT03730662|12009307|FG001|Variable Treatment Period|Personal Reason|2
7602720|NCT03730662|12009308|FG002|Variable Treatment Period|Personal Reason|1
7602721|NCT03730662|12009309|FG003|Variable Treatment Period|Personal Reason|6
7602722|NCT03730662|12009306|FG000|Variable Treatment Period|Physician Decision|0
7602723|NCT03730662|12009307|FG001|Variable Treatment Period|Physician Decision|0
7602724|NCT03730662|12009308|FG002|Variable Treatment Period|Physician Decision|0
7602725|NCT03730662|12009309|FG003|Variable Treatment Period|Physician Decision|3
7602726|NCT03730662|12009306|FG000|Variable Treatment Period|Protocol Violation|0
7602727|NCT03730662|12009307|FG001|Variable Treatment Period|Protocol Violation|1
7602728|NCT03730662|12009308|FG002|Variable Treatment Period|Protocol Violation|1
7602729|NCT03730662|12009309|FG003|Variable Treatment Period|Protocol Violation|1
7602730|NCT03730662|12009306|FG000|Variable Treatment Period|Withdrawal by Subject|2
7602731|NCT03730662|12009307|FG001|Variable Treatment Period|Withdrawal by Subject|1
7602732|NCT03730662|12009308|FG002|Variable Treatment Period|Withdrawal by Subject|4
7602733|NCT03730662|12009309|FG003|Variable Treatment Period|Withdrawal by Subject|17
7602734|NCT03538444|12009325|FG000|Overall Study|opioid withdrawal|1
7602735|NCT03538444|12009326|FG001|Overall Study|opioid withdrawal|0
7773779|NCT00904371|12219166|FG000|Overall Study|Adverse Event|2
7773780|NCT00904371|12219166|FG000|Overall Study|Lost to Follow-up|4
7773781|NCT00904371|12219166|FG000|Overall Study|Discontinued at target blood pressure|2
7773782|NCT00904371|12219166|FG000|Overall Study|Continued with Tritace|1
7773783|NCT00904670|12219186|FG000|Open Label Phase|Withdrawal by Subject|2
7773784|NCT00904670|12219187|FG001|Open Label Phase|Withdrawal by Subject|0
7773785|NCT00904670|12219186|FG000|Open Label Phase|Adverse Event|2
7773786|NCT00904670|12219187|FG001|Open Label Phase|Adverse Event|0
7773787|NCT00904670|12219186|FG000|Open Label Phase|Lack of Efficacy|1
7773788|NCT00904670|12219187|FG001|Open Label Phase|Lack of Efficacy|0
7773789|NCT00904670|12219186|FG000|Open Label Phase|Lost to Follow-up|1
7773790|NCT00904670|12219187|FG001|Open Label Phase|Lost to Follow-up|0
7773791|NCT00904722|12219195|FG000|Overall Study|Physician Decision|1
7773792|NCT00904748|12219199|FG000|Overall Study|Withdrawal by Subject|1
7773793|NCT00904748|12219200|FG001|Overall Study|Withdrawal by Subject|1
7773794|NCT00904748|12219201|FG002|Overall Study|Withdrawal by Subject|1
7773795|NCT00904748|12219202|FG003|Overall Study|Withdrawal by Subject|2
7773796|NCT00904748|12219203|FG004|Overall Study|Withdrawal by Subject|0
7773797|NCT00904748|12219204|FG005|Overall Study|Withdrawal by Subject|0
7773798|NCT00904748|12219199|FG000|Overall Study|Adverse Event|0
7773799|NCT00904748|12219200|FG001|Overall Study|Adverse Event|0
7602756|NCT03252925|12009362|FG000|Overall Study|Withdrawal by Subject|1
7602757|NCT03252925|12009363|FG001|Overall Study|Withdrawal by Subject|0
7602758|NCT03252925|12009362|FG000|Overall Study|Protocol Violation|6
7602759|NCT03252925|12009363|FG001|Overall Study|Protocol Violation|0
7602760|NCT03252925|12009362|FG000|Overall Study|Adverse Event|1
7602761|NCT03252925|12009363|FG001|Overall Study|Adverse Event|0
7602762|NCT03252925|12009362|FG000|Overall Study|Lost to Follow-up|6
7602763|NCT03252925|12009363|FG001|Overall Study|Lost to Follow-up|6
7602764|NCT03185832|12009373|FG000|Overall Study|Death|9
7602765|NCT03185832|12009374|FG001|Overall Study|Death|14
7602766|NCT03185832|12009375|FG002|Overall Study|Death|9
7602767|NCT03185832|12009376|FG003|Overall Study|Death|7
7602768|NCT03185832|12009373|FG000|Overall Study|Withdrawn - vital status available|0
7602769|NCT03185832|12009374|FG001|Overall Study|Withdrawn - vital status available|1
7602770|NCT03185832|12009375|FG002|Overall Study|Withdrawn - vital status available|1
7602771|NCT03185832|12009376|FG003|Overall Study|Withdrawn - vital status available|4
7602772|NCT02959918|12009407|FG000|Overall Study|Adverse Event|1
7602773|NCT02959918|12009408|FG001|Overall Study|Adverse Event|1
7602774|NCT02959918|12009409|FG002|Overall Study|Adverse Event|2
7602775|NCT02959918|12009410|FG003|Overall Study|Adverse Event|0
7602776|NCT02959918|12009411|FG004|Overall Study|Adverse Event|0
7602777|NCT02959918|12009412|FG005|Overall Study|Adverse Event|2
7602778|NCT02959918|12009413|FG006|Overall Study|Adverse Event|2
7602779|NCT02959918|12009414|FG007|Overall Study|Adverse Event|1
7602780|NCT02959918|12009415|FG008|Overall Study|Adverse Event|2
7602781|NCT02959918|12009416|FG009|Overall Study|Adverse Event|1
7602782|NCT02959918|12009417|FG010|Overall Study|Adverse Event|1
7602783|NCT02959918|12009418|FG011|Overall Study|Adverse Event|3
7602784|NCT02959918|12009419|FG012|Overall Study|Adverse Event|2
7602785|NCT02959918|12009420|FG013|Overall Study|Adverse Event|4
7602786|NCT02959918|12009407|FG000|Overall Study|Lost to Follow-up|0
7602787|NCT02959918|12009408|FG001|Overall Study|Lost to Follow-up|0
7602788|NCT02959918|12009409|FG002|Overall Study|Lost to Follow-up|0
7602789|NCT02959918|12009410|FG003|Overall Study|Lost to Follow-up|0
7602790|NCT02959918|12009411|FG004|Overall Study|Lost to Follow-up|0
7602791|NCT02959918|12009412|FG005|Overall Study|Lost to Follow-up|0
7602792|NCT02959918|12009413|FG006|Overall Study|Lost to Follow-up|0
7602793|NCT02959918|12009414|FG007|Overall Study|Lost to Follow-up|0
7602794|NCT02959918|12009415|FG008|Overall Study|Lost to Follow-up|0
7602795|NCT02959918|12009416|FG009|Overall Study|Lost to Follow-up|1
7602796|NCT02959918|12009417|FG010|Overall Study|Lost to Follow-up|0
7602797|NCT02959918|12009418|FG011|Overall Study|Lost to Follow-up|0
7602798|NCT02959918|12009419|FG012|Overall Study|Lost to Follow-up|1
7602799|NCT02959918|12009420|FG013|Overall Study|Lost to Follow-up|0
7602800|NCT02959918|12009407|FG000|Overall Study|Withdrawal by Subject|0
7602801|NCT02959918|12009408|FG001|Overall Study|Withdrawal by Subject|0
7602802|NCT02959918|12009409|FG002|Overall Study|Withdrawal by Subject|1
7602803|NCT02959918|12009410|FG003|Overall Study|Withdrawal by Subject|2
7602804|NCT02959918|12009411|FG004|Overall Study|Withdrawal by Subject|0
7602805|NCT02959918|12009412|FG005|Overall Study|Withdrawal by Subject|0
7602806|NCT02959918|12009413|FG006|Overall Study|Withdrawal by Subject|1
7602807|NCT02959918|12009414|FG007|Overall Study|Withdrawal by Subject|0
7602808|NCT02959918|12009415|FG008|Overall Study|Withdrawal by Subject|1
7602809|NCT02959918|12009416|FG009|Overall Study|Withdrawal by Subject|1
7602810|NCT02959918|12009417|FG010|Overall Study|Withdrawal by Subject|2
7602811|NCT02959918|12009418|FG011|Overall Study|Withdrawal by Subject|3
7602812|NCT02959918|12009419|FG012|Overall Study|Withdrawal by Subject|1
7602813|NCT02959918|12009420|FG013|Overall Study|Withdrawal by Subject|1
7602814|NCT02959918|12009407|FG000|Overall Study|Protocol Violation|0
7602815|NCT02959918|12009408|FG001|Overall Study|Protocol Violation|0
7602816|NCT02959918|12009409|FG002|Overall Study|Protocol Violation|1
7602817|NCT02959918|12009410|FG003|Overall Study|Protocol Violation|0
7602818|NCT02959918|12009411|FG004|Overall Study|Protocol Violation|0
7602819|NCT02959918|12009412|FG005|Overall Study|Protocol Violation|1
7602820|NCT02959918|12009413|FG006|Overall Study|Protocol Violation|0
7602821|NCT02959918|12009414|FG007|Overall Study|Protocol Violation|0
7602822|NCT02959918|12009415|FG008|Overall Study|Protocol Violation|2
7602823|NCT02959918|12009416|FG009|Overall Study|Protocol Violation|1
7602824|NCT02959918|12009417|FG010|Overall Study|Protocol Violation|0
7602825|NCT02959918|12009418|FG011|Overall Study|Protocol Violation|1
7602826|NCT02959918|12009419|FG012|Overall Study|Protocol Violation|1
7602827|NCT02959918|12009420|FG013|Overall Study|Protocol Violation|0
7602828|NCT02959918|12009407|FG000|Overall Study|Stopping Rule Met|1
7602829|NCT02959918|12009408|FG001|Overall Study|Stopping Rule Met|0
7602830|NCT02959918|12009409|FG002|Overall Study|Stopping Rule Met|3
7602831|NCT02959918|12009410|FG003|Overall Study|Stopping Rule Met|4
7602832|NCT02959918|12009411|FG004|Overall Study|Stopping Rule Met|5
7602833|NCT02959918|12009412|FG005|Overall Study|Stopping Rule Met|3
7773800|NCT00904748|12219201|FG002|Overall Study|Adverse Event|0
7773801|NCT00904748|12219202|FG003|Overall Study|Adverse Event|0
7773802|NCT00904748|12219203|FG004|Overall Study|Adverse Event|1
7773803|NCT00904748|12219204|FG005|Overall Study|Adverse Event|0
7773804|NCT00904839|12219251|FG000|Overall Study|Adverse Event|0
7773805|NCT00904839|12219252|FG001|Overall Study|Adverse Event|5
7773806|NCT00904839|12219253|FG002|Overall Study|Adverse Event|4
7773807|NCT00904839|12219251|FG000|Overall Study|Protocol Violation|0
7773808|NCT00904839|12219252|FG001|Overall Study|Protocol Violation|1
7773809|NCT00904839|12219253|FG002|Overall Study|Protocol Violation|1
7773810|NCT00904839|12219251|FG000|Overall Study|Lost to Follow-up|0
7773811|NCT00904839|12219252|FG001|Overall Study|Lost to Follow-up|1
7773812|NCT00904839|12219253|FG002|Overall Study|Lost to Follow-up|2
7773813|NCT00904839|12219251|FG000|Overall Study|Withdrawal by Subject|0
7773814|NCT00904839|12219252|FG001|Overall Study|Withdrawal by Subject|2
7773815|NCT00904839|12219253|FG002|Overall Study|Withdrawal by Subject|0
7773816|NCT00904839|12219251|FG000|Overall Study|Not treated|1
7773817|NCT00904839|12219252|FG001|Overall Study|Not treated|0
7773818|NCT00904839|12219253|FG002|Overall Study|Not treated|1
7773819|NCT00904839|12219251|FG000|Overall Study|Other than above|0
7773820|NCT00904839|12219252|FG001|Overall Study|Other than above|9
7773821|NCT00904839|12219253|FG002|Overall Study|Other than above|7
7773822|NCT00904917|12219268|FG000|Overall Study|Lost to Follow-up|2
7773823|NCT00904917|12219269|FG001|Overall Study|Lost to Follow-up|2
7773824|NCT00904917|12219270|FG002|Overall Study|Lost to Follow-up|2
7773825|NCT00904917|12219271|FG003|Overall Study|Lost to Follow-up|2
7773826|NCT00904969|12219284|FG000|Overall Study|Lost to Follow-up|4
7773827|NCT00904969|12219284|FG000|Overall Study|Withdrawal by Subject|3
7773828|NCT00904969|12219284|FG000|Overall Study|Additional Treatments|11
7773829|NCT00904969|12219284|FG000|Overall Study|Case Aborted; Subject Exited|1
7602834|NCT02959918|12009413|FG006|Overall Study|Stopping Rule Met|2
7602835|NCT02959918|12009414|FG007|Overall Study|Stopping Rule Met|4
7602836|NCT02959918|12009415|FG008|Overall Study|Stopping Rule Met|1
7602837|NCT02959918|12009416|FG009|Overall Study|Stopping Rule Met|1
7602838|NCT02959918|12009417|FG010|Overall Study|Stopping Rule Met|3
7602839|NCT02959918|12009418|FG011|Overall Study|Stopping Rule Met|5
7602840|NCT02959918|12009419|FG012|Overall Study|Stopping Rule Met|2
7602841|NCT02959918|12009420|FG013|Overall Study|Stopping Rule Met|1
7602842|NCT02959918|12009407|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1
7602843|NCT02959918|12009408|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2
7602844|NCT02959918|12009409|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1
7602845|NCT02959918|12009410|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3
7602846|NCT02959918|12009411|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602847|NCT02959918|12009412|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602848|NCT02959918|12009413|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7773830|NCT00904982|12219307|FG000|Overall Study|Withdrawal by Subject|2
7773831|NCT00904982|12219308|FG001|Overall Study|Withdrawal by Subject|0
7773832|NCT00904982|12219309|FG002|Overall Study|Withdrawal by Subject|0
7773833|NCT00904982|12219310|FG003|Overall Study|Withdrawal by Subject|0
7773834|NCT00905021|12219329|FG000|Overall Study|Adverse Event|2
7773835|NCT00905034|12219334|FG000|Overall Study|Withdrawal by Subject|1
7773836|NCT00905255|12219357|FG000|Overall Study|Adverse Event|7
7773837|NCT00905255|12219358|FG001|Overall Study|Adverse Event|5
7602849|NCT02959918|12009414|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7773838|NCT00905255|12219357|FG000|Overall Study|Withdrawal by Subject|5
7773839|NCT00905255|12219358|FG001|Overall Study|Withdrawal by Subject|4
7602850|NCT02959918|12009415|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602851|NCT02959918|12009416|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602852|NCT02959918|12009417|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602853|NCT02959918|12009418|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602854|NCT02959918|12009419|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602855|NCT02959918|12009420|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602856|NCT02959918|12009407|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602857|NCT02959918|12009408|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602858|NCT02959918|12009409|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602859|NCT02959918|12009410|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602860|NCT02959918|12009411|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602861|NCT02959918|12009412|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602862|NCT02959918|12009413|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602863|NCT02959918|12009414|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1
7602864|NCT02959918|12009415|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602865|NCT02959918|12009416|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602866|NCT02959918|12009417|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602867|NCT02959918|12009418|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602868|NCT02959918|12009419|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602869|NCT02959918|12009420|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602870|NCT02959918|12009407|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0
7602871|NCT02959918|12009408|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0
7602872|NCT02959918|12009409|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0
7602873|NCT02959918|12009410|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0
7602874|NCT02959918|12009411|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0
7602875|NCT02959918|12009412|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0
7602876|NCT02959918|12009413|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0
7602877|NCT02959918|12009414|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0
7602878|NCT02959918|12009415|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1
7602879|NCT02959918|12009416|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0
7602880|NCT02959918|12009417|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0
7602881|NCT02959918|12009418|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0
7602882|NCT02959918|12009419|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0
7602883|NCT02959918|12009420|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0
7602884|NCT02959918|12009407|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602885|NCT02959918|12009408|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602886|NCT02959918|12009409|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602887|NCT02959918|12009410|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602888|NCT02959918|12009411|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602889|NCT02959918|12009412|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602890|NCT02959918|12009413|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602891|NCT02959918|12009414|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602892|NCT02959918|12009415|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602893|NCT02959918|12009416|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1
7602894|NCT02959918|12009417|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602895|NCT02959918|12009418|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602896|NCT02959918|12009419|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602897|NCT02959918|12009420|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602898|NCT02472964|12009455|FG000|Part 1 (up to Week 24)|Adverse Event|2
7602899|NCT02472964|12009456|FG001|Part 1 (up to Week 24)|Adverse Event|4
7773840|NCT00905255|12219357|FG000|Overall Study|Familial and Personal Reasons|1
7773841|NCT00905255|12219358|FG001|Overall Study|Familial and Personal Reasons|0
7773842|NCT00905307|12219388|FG000|Overall Study|Switched to Open Label Rescue|7
7773843|NCT00905307|12219389|FG001|Overall Study|Switched to Open Label Rescue|17
7773844|NCT00905307|12219390|FG002|Overall Study|Switched to Open Label Rescue|11
7602900|NCT02472964|12009455|FG000|Part 1 (up to Week 24)|disease progression|58
7602901|NCT02472964|12009456|FG001|Part 1 (up to Week 24)|disease progression|47
7602902|NCT02472964|12009455|FG000|Part 1 (up to Week 24)|Death|3
7602903|NCT02472964|12009456|FG001|Part 1 (up to Week 24)|Death|6
7602904|NCT02472964|12009455|FG000|Part 1 (up to Week 24)|Physician Decision|3
7602905|NCT02472964|12009456|FG001|Part 1 (up to Week 24)|Physician Decision|1
7602906|NCT02472964|12009455|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0
7602907|NCT02472964|12009456|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1
7602908|NCT02472964|12009455|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7
7602909|NCT02472964|12009456|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2
7602910|NCT02472964|12009455|FG000|Part 1 (up to Week 24)|Other|2
7602911|NCT02472964|12009456|FG001|Part 1 (up to Week 24)|Other|1
7602912|NCT02472964|12009455|FG000|Part 2 (Week 24-week 48)|Adverse Event|4
7602913|NCT02472964|12009456|FG001|Part 2 (Week 24-week 48)|Adverse Event|2
7602914|NCT02472964|12009455|FG000|Part 2 (Week 24-week 48)|Disease Progression|52
7602915|NCT02472964|12009456|FG001|Part 2 (Week 24-week 48)|Disease Progression|56
7602916|NCT02472964|12009455|FG000|Part 2 (Week 24-week 48)|Death|0
7602917|NCT02472964|12009456|FG001|Part 2 (Week 24-week 48)|Death|1
7602918|NCT02472964|12009455|FG000|Part 2 (Week 24-week 48)|Physician Decision|1
7602919|NCT02472964|12009456|FG001|Part 2 (Week 24-week 48)|Physician Decision|1
7602920|NCT02472964|12009455|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2
7602921|NCT02472964|12009456|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1
7602922|NCT02472964|12009455|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
7602923|NCT02472964|12009456|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
7602924|NCT02472964|12009455|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3
7602925|NCT02472964|12009456|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1
7602926|NCT02178722|12009467|FG000|Overall Study|Withdrawal by Subject|0
7602927|NCT02178722|12009468|FG001|Overall Study|Withdrawal by Subject|0
7602928|NCT02178722|12009469|FG002|Overall Study|Withdrawal by Subject|0
7602929|NCT02178722|12009470|FG003|Overall Study|Withdrawal by Subject|2
7602930|NCT02178722|12009471|FG004|Overall Study|Withdrawal by Subject|33
7602931|NCT02178722|12009467|FG000|Overall Study|Death|2
7602932|NCT02178722|12009468|FG001|Overall Study|Death|13
7602933|NCT02178722|12009469|FG002|Overall Study|Death|12
7602934|NCT02178722|12009470|FG003|Overall Study|Death|12
7602935|NCT02178722|12009471|FG004|Overall Study|Death|205
7602936|NCT02178722|12009467|FG000|Overall Study|Lost to Follow-up|0
7602937|NCT02178722|12009468|FG001|Overall Study|Lost to Follow-up|0
7602938|NCT02178722|12009469|FG002|Overall Study|Lost to Follow-up|0
7602939|NCT02178722|12009470|FG003|Overall Study|Lost to Follow-up|2
7602940|NCT02178722|12009471|FG004|Overall Study|Lost to Follow-up|11
7602941|NCT02178722|12009467|FG000|Overall Study|Study terminated by Sponsor|2
7602942|NCT02178722|12009468|FG001|Overall Study|Study terminated by Sponsor|7
7602943|NCT02178722|12009469|FG002|Overall Study|Study terminated by Sponsor|6
7602944|NCT02178722|12009470|FG003|Overall Study|Study terminated by Sponsor|4
7602945|NCT02178722|12009471|FG004|Overall Study|Study terminated by Sponsor|128
7602946|NCT02178722|12009467|FG000|Overall Study|Physician Decision|0
7602947|NCT02178722|12009468|FG001|Overall Study|Physician Decision|0
7602948|NCT02178722|12009469|FG002|Overall Study|Physician Decision|0
7602949|NCT02178722|12009470|FG003|Overall Study|Physician Decision|0
7602950|NCT02178722|12009471|FG004|Overall Study|Physician Decision|3
7602951|NCT02178722|12009467|FG000|Overall Study|Other|0
7602952|NCT02178722|12009468|FG001|Overall Study|Other|0
7602953|NCT02178722|12009469|FG002|Overall Study|Other|0
7602954|NCT02178722|12009470|FG003|Overall Study|Other|0
7602955|NCT02178722|12009471|FG004|Overall Study|Other|2
7602956|NCT01258803|12009486|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1
7602957|NCT01258803|12009487|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1
7602958|NCT01258803|12009488|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0
7602959|NCT01258803|12009489|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0
7602960|NCT01258803|12009490|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0
7602961|NCT01258803|12009491|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1
7602962|NCT01258803|12009486|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
7602963|NCT01258803|12009487|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
7602964|NCT01258803|12009488|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
7602965|NCT01258803|12009489|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
7602966|NCT01258803|12009490|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
7602967|NCT01258803|12009491|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
7602968|NCT01258803|12009486|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0
7602969|NCT01258803|12009487|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0
7602970|NCT01258803|12009488|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1
7602971|NCT01258803|12009489|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0
7602972|NCT01258803|12009490|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0
7602973|NCT01258803|12009491|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0
7602974|NCT00862251|12009512|FG000|Overall Study|Adverse Event|8
7602975|NCT00862251|12009513|FG001|Overall Study|Adverse Event|3
7602976|NCT00862251|12009514|FG002|Overall Study|Adverse Event|1
7602977|NCT00862251|12009512|FG000|Overall Study|Lost to Follow-up|0
7602978|NCT00862251|12009513|FG001|Overall Study|Lost to Follow-up|0
7602979|NCT00862251|12009514|FG002|Overall Study|Lost to Follow-up|1
7602980|NCT00862251|12009512|FG000|Overall Study|Protocol Violation|2
7602981|NCT00862251|12009513|FG001|Overall Study|Protocol Violation|0
7602982|NCT00862251|12009514|FG002|Overall Study|Protocol Violation|1
7602983|NCT00862251|12009512|FG000|Overall Study|Withdrawal by Subject|9
7602984|NCT00862251|12009513|FG001|Overall Study|Withdrawal by Subject|2
7602985|NCT00862251|12009514|FG002|Overall Study|Withdrawal by Subject|6
7602986|NCT00783263|12009529|FG000|Overall Study|Adverse Event|3
7602987|NCT00783263|12009530|FG001|Overall Study|Adverse Event|0
7602988|NCT00783263|12009531|FG002|Overall Study|Adverse Event|2
7602989|NCT00783263|12009532|FG003|Overall Study|Adverse Event|1
7602990|NCT00783263|12009529|FG000|Overall Study|Lost to Follow-up|1
7602991|NCT00783263|12009530|FG001|Overall Study|Lost to Follow-up|1
7602992|NCT00783263|12009531|FG002|Overall Study|Lost to Follow-up|0
7602993|NCT00783263|12009532|FG003|Overall Study|Lost to Follow-up|0
7602994|NCT00783263|12009529|FG000|Overall Study|Withdrawal by Subject|0
7773845|NCT00905307|12219391|FG003|Overall Study|Switched to Open Label Rescue|11
7773846|NCT00905307|12219392|FG004|Overall Study|Switched to Open Label Rescue|4
7773847|NCT00905307|12219393|FG005|Overall Study|Switched to Open Label Rescue|15
7773848|NCT00905307|12219388|FG000|Overall Study|Lost to Follow-up|0
7773849|NCT00905307|12219389|FG001|Overall Study|Lost to Follow-up|0
7773850|NCT00905307|12219390|FG002|Overall Study|Lost to Follow-up|0
7773851|NCT00905307|12219391|FG003|Overall Study|Lost to Follow-up|0
7773852|NCT00905307|12219392|FG004|Overall Study|Lost to Follow-up|1
7773853|NCT00905307|12219393|FG005|Overall Study|Lost to Follow-up|1
7773854|NCT00905307|12219388|FG000|Overall Study|Adverse Event|3
7773855|NCT00905307|12219389|FG001|Overall Study|Adverse Event|4
7773856|NCT00905307|12219390|FG002|Overall Study|Adverse Event|5
7773857|NCT00905307|12219391|FG003|Overall Study|Adverse Event|11
7773858|NCT00905307|12219392|FG004|Overall Study|Adverse Event|3
7773859|NCT00905307|12219393|FG005|Overall Study|Adverse Event|5
7773860|NCT00905307|12219388|FG000|Overall Study|Withdrawal by Subject|5
7773861|NCT00905307|12219389|FG001|Overall Study|Withdrawal by Subject|13
7773862|NCT00905307|12219390|FG002|Overall Study|Withdrawal by Subject|15
7773863|NCT00905307|12219391|FG003|Overall Study|Withdrawal by Subject|11
7773864|NCT00905307|12219392|FG004|Overall Study|Withdrawal by Subject|4
7773865|NCT00905307|12219393|FG005|Overall Study|Withdrawal by Subject|13
7773866|NCT00905307|12219388|FG000|Overall Study|Protocol Violation|1
7773867|NCT00905307|12219389|FG001|Overall Study|Protocol Violation|0
7773868|NCT00905307|12219390|FG002|Overall Study|Protocol Violation|1
7773869|NCT00905307|12219391|FG003|Overall Study|Protocol Violation|0
7773870|NCT00905307|12219392|FG004|Overall Study|Protocol Violation|0
7773871|NCT00905307|12219393|FG005|Overall Study|Protocol Violation|0
7773872|NCT00905307|12219388|FG000|Overall Study|Lack of Efficacy|6
7773873|NCT00905307|12219389|FG001|Overall Study|Lack of Efficacy|3
7773874|NCT00905307|12219390|FG002|Overall Study|Lack of Efficacy|5
7773875|NCT00905307|12219391|FG003|Overall Study|Lack of Efficacy|4
7773876|NCT00905307|12219392|FG004|Overall Study|Lack of Efficacy|4
7773877|NCT00905307|12219393|FG005|Overall Study|Lack of Efficacy|8
7773878|NCT00905359|12219422|FG000|Overall Study|Lost to Follow-up|17
7773879|NCT00905359|12219423|FG001|Overall Study|Lost to Follow-up|10
7773880|NCT00905359|12219422|FG000|Overall Study|Death|2
7773881|NCT00905359|12219423|FG001|Overall Study|Death|0
7773882|NCT00905359|12219422|FG000|Overall Study|Withdrawal consent|5
7773883|NCT00905359|12219423|FG001|Overall Study|Withdrawal consent|6
7773884|NCT00905424|12219431|FG000|Overall Study|Lost to Follow-up|3
7773885|NCT00905424|12219432|FG001|Overall Study|Lost to Follow-up|3
7773886|NCT00905424|12219431|FG000|Overall Study|Withdrawal by Subject|1
7773887|NCT00905424|12219432|FG001|Overall Study|Withdrawal by Subject|2
7773888|NCT00905424|12219431|FG000|Overall Study|Adverse Event|4
7773889|NCT00905424|12219432|FG001|Overall Study|Adverse Event|2
7773890|NCT00905424|12219431|FG000|Overall Study|Non-compliance with study medication|2
7773891|NCT00905424|12219432|FG001|Overall Study|Non-compliance with study medication|0
7773892|NCT00905424|12219431|FG000|Overall Study|Sponsor decision|1
7773893|NCT00905424|12219432|FG001|Overall Study|Sponsor decision|0
7773894|NCT00905424|12219431|FG000|Overall Study|Positive urine drug screen|0
7773895|NCT00905424|12219432|FG001|Overall Study|Positive urine drug screen|1
7773896|NCT00905424|12219431|FG000|Overall Study|Non-adherence to visit schedule|0
7773897|NCT00905424|12219432|FG001|Overall Study|Non-adherence to visit schedule|1
7602995|NCT00783263|12009530|FG001|Overall Study|Withdrawal by Subject|1
7602996|NCT00783263|12009531|FG002|Overall Study|Withdrawal by Subject|1
7602997|NCT00783263|12009532|FG003|Overall Study|Withdrawal by Subject|2
7602998|NCT00782184|12009557|FG000|Overall Study|Adverse Event|1
7602999|NCT00782184|12009558|FG001|Overall Study|Adverse Event|2
7603000|NCT00782184|12009557|FG000|Overall Study|Protocol Violation|0
7773898|NCT00905437|12219442|FG000|Overall Study|Adverse Event|3
7773899|NCT00905437|12219443|FG001|Overall Study|Adverse Event|2
7773900|NCT00905437|12219442|FG000|Overall Study|Lost to Follow-up|0
7773901|NCT00905437|12219443|FG001|Overall Study|Lost to Follow-up|1
7773902|NCT00905437|12219442|FG000|Overall Study|Withdrawal by Subject|0
7773903|NCT00905437|12219443|FG001|Overall Study|Withdrawal by Subject|1
7773904|NCT00905437|12219442|FG000|Overall Study|Other|5
7773905|NCT00905437|12219443|FG001|Overall Study|Other|6
7773906|NCT00905489|12219482|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
7773907|NCT00905489|12219482|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
7773908|NCT00905489|12219482|FG000|Optional Extension Phase (OEP)|Adverse Event|1
7773909|NCT00905632|12219529|FG000|Overall Study|Adverse Event|0
7773910|NCT00905632|12219530|FG001|Overall Study|Adverse Event|0
7773911|NCT00905632|12219531|FG002|Overall Study|Adverse Event|0
7773912|NCT00905632|12219532|FG003|Overall Study|Adverse Event|0
7773913|NCT00905632|12219533|FG004|Overall Study|Adverse Event|0
7773914|NCT00905632|12219534|FG005|Overall Study|Adverse Event|1
7773915|NCT00905632|12219535|FG006|Overall Study|Adverse Event|4
7773916|NCT00905840|12219571|FG000|Overall Study|Lost to Follow-up|11
7773917|NCT00905840|12219571|FG000|Overall Study|Death|3
7773918|NCT00905840|12219571|FG000|Overall Study|Withdrawal by Subject|1
7773919|NCT00905840|12219571|FG000|Overall Study|Adverse Event|1
7773920|NCT00906087|12219587|FG000|Initial Washout|Withdrawal by Subject|1
7773921|NCT00906087|12219587|FG000|Initial Washout|Physician Decision|1
7799996|NCT01090492|12257183|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7799997|NCT01090492|12257184|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7799998|NCT01090492|12257185|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7799999|NCT01090492|12257186|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7800000|NCT01090492|12257187|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
7800001|NCT01090492|12257180|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7800002|NCT01090492|12257181|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7800003|NCT01090492|12257182|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1
7800004|NCT01090492|12257183|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7800005|NCT01090492|12257184|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7800006|NCT01090492|12257185|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7800007|NCT01090492|12257186|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7800008|NCT01090492|12257187|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7800009|NCT01090492|12257180|FG000|First Intervention Period (4 Weeks)|Other|0
7800010|NCT01090492|12257181|FG001|First Intervention Period (4 Weeks)|Other|0
7800011|NCT01090492|12257182|FG002|First Intervention Period (4 Weeks)|Other|1
7800012|NCT01090492|12257183|FG003|First Intervention Period (4 Weeks)|Other|1
7800013|NCT01090492|12257184|FG004|First Intervention Period (4 Weeks)|Other|2
7800014|NCT01090492|12257185|FG005|First Intervention Period (4 Weeks)|Other|0
7800015|NCT01090492|12257186|FG006|First Intervention Period (4 Weeks)|Other|0
7800016|NCT01090492|12257187|FG007|First Intervention Period (4 Weeks)|Other|0
7800017|NCT01090492|12257180|FG000|First Intervention Period (4 Weeks)|Pregnancy|0
7800018|NCT01090492|12257181|FG001|First Intervention Period (4 Weeks)|Pregnancy|0
7800019|NCT01090492|12257182|FG002|First Intervention Period (4 Weeks)|Pregnancy|0
7800020|NCT01090492|12257183|FG003|First Intervention Period (4 Weeks)|Pregnancy|0
7800021|NCT01090492|12257184|FG004|First Intervention Period (4 Weeks)|Pregnancy|1
7800022|NCT01090492|12257185|FG005|First Intervention Period (4 Weeks)|Pregnancy|0
7800023|NCT01090492|12257186|FG006|First Intervention Period (4 Weeks)|Pregnancy|0
7800024|NCT01090492|12257187|FG007|First Intervention Period (4 Weeks)|Pregnancy|0
7800025|NCT01090492|12257180|FG000|First Intervention Period (4 Weeks)|Adverse Event|0
7773922|NCT00906204|12219614|FG000|Primary Endpoint (Early Safety)|Physician Decision|1
7773923|NCT00906204|12219615|FG001|Primary Endpoint (Early Safety)|Physician Decision|0
7773924|NCT00906204|12219614|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
7773925|NCT00906204|12219615|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
7773926|NCT00906204|12219614|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
7603001|NCT00782184|12009558|FG001|Overall Study|Protocol Violation|1
7603002|NCT00782184|12009557|FG000|Overall Study|Withdrawal by Subject|3
7603003|NCT00782184|12009558|FG001|Overall Study|Withdrawal by Subject|2
7603004|NCT00635882|12009571|FG000|Overall Study|Protocol Violation|1
7603005|NCT00635882|12009572|FG001|Overall Study|Protocol Violation|0
7603006|NCT00635882|12009573|FG002|Overall Study|Protocol Violation|0
7603007|NCT00635882|12009574|FG003|Overall Study|Protocol Violation|0
7603008|NCT00635882|12009575|FG004|Overall Study|Protocol Violation|0
7603009|NCT00635882|12009576|FG005|Overall Study|Protocol Violation|0
7773927|NCT00906204|12219615|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
7773928|NCT00906204|12219614|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2
7773929|NCT00906204|12219615|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2
7773930|NCT00906204|12219614|FG000|Secondary Endpoints (Long-term Safety)|Death|0
7773931|NCT00906204|12219615|FG001|Secondary Endpoints (Long-term Safety)|Death|1
7773932|NCT00906282|12219625|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2
7773933|NCT00906282|12219625|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10
7773934|NCT00906282|12219625|FG000|Preoperative Chemotherapy|Progressive disease|6
7773935|NCT00906282|12219625|FG000|Preoperative Chemotherapy|Toxicity|1
7773936|NCT00906347|12219632|FG000|Received Study Drug|8 cm prior to initiation of study drug|18
7773937|NCT00906347|12219633|FG001|Received Study Drug|8 cm prior to initiation of study drug|30
7773938|NCT00906347|12219632|FG000|Received Study Drug|Nonreassuring fetal heart rate|13
7773939|NCT00906347|12219633|FG001|Received Study Drug|Nonreassuring fetal heart rate|1
7773940|NCT00906347|12219632|FG000|Received Study Drug|Refused study drug|1
7603010|NCT00535405|12009604|FG000|Overall Study|Adverse Event|6
7603011|NCT00535405|12009605|FG001|Overall Study|Adverse Event|8
7603012|NCT00535405|12009606|FG002|Overall Study|Adverse Event|3
7603013|NCT00535405|12009607|FG003|Overall Study|Adverse Event|8
7603014|NCT00535405|12009608|FG004|Overall Study|Adverse Event|6
7603015|NCT00535405|12009604|FG000|Overall Study|Lost to Follow-up|1
7603016|NCT00535405|12009605|FG001|Overall Study|Lost to Follow-up|3
7603017|NCT00535405|12009606|FG002|Overall Study|Lost to Follow-up|3
7603018|NCT00535405|12009607|FG003|Overall Study|Lost to Follow-up|2
7603019|NCT00535405|12009608|FG004|Overall Study|Lost to Follow-up|1
7603020|NCT00535405|12009604|FG000|Overall Study|Physician Decision|3
7603021|NCT00535405|12009605|FG001|Overall Study|Physician Decision|2
7603022|NCT00535405|12009606|FG002|Overall Study|Physician Decision|0
7603023|NCT00535405|12009607|FG003|Overall Study|Physician Decision|1
7603024|NCT00535405|12009608|FG004|Overall Study|Physician Decision|1
7603025|NCT00535405|12009604|FG000|Overall Study|Protocol Violation|2
7603026|NCT00535405|12009605|FG001|Overall Study|Protocol Violation|2
7603027|NCT00535405|12009606|FG002|Overall Study|Protocol Violation|2
7603028|NCT00535405|12009607|FG003|Overall Study|Protocol Violation|1
7603029|NCT00535405|12009608|FG004|Overall Study|Protocol Violation|0
7603030|NCT00535405|12009604|FG000|Overall Study|Withdrawal by Subject|5
7603031|NCT00535405|12009605|FG001|Overall Study|Withdrawal by Subject|11
7603032|NCT00535405|12009606|FG002|Overall Study|Withdrawal by Subject|10
7603033|NCT00535405|12009607|FG003|Overall Study|Withdrawal by Subject|10
7603034|NCT00535405|12009608|FG004|Overall Study|Withdrawal by Subject|8
7603035|NCT00496730|12009622|FG000|Overall Study|Lost to Follow-up|4
7603036|NCT00496730|12009623|FG001|Overall Study|Lost to Follow-up|3
7603037|NCT00496730|12009622|FG000|Overall Study|Withdrawal by Subject|2
7603038|NCT00496730|12009623|FG001|Overall Study|Withdrawal by Subject|2
7603039|NCT00462748|12009632|FG000|Overall Study|Adverse Event|7
7603040|NCT00462748|12009633|FG001|Overall Study|Adverse Event|5
7603041|NCT00462748|12009634|FG002|Overall Study|Adverse Event|9
7603042|NCT00462748|12009632|FG000|Overall Study|Protocol Violation|0
7603043|NCT00462748|12009633|FG001|Overall Study|Protocol Violation|2
7603044|NCT00462748|12009634|FG002|Overall Study|Protocol Violation|1
7603045|NCT00462748|12009632|FG000|Overall Study|Withdrew consent|3
7603046|NCT00462748|12009633|FG001|Overall Study|Withdrew consent|3
7603047|NCT00462748|12009634|FG002|Overall Study|Withdrew consent|0
7603048|NCT00462748|12009632|FG000|Overall Study|Lost to Follow-up|1
7603049|NCT00462748|12009633|FG001|Overall Study|Lost to Follow-up|1
7603050|NCT00462748|12009634|FG002|Overall Study|Lost to Follow-up|1
7603051|NCT00462748|12009632|FG000|Overall Study|Discontinued after 41 days Rx|1
7603052|NCT00462748|12009633|FG001|Overall Study|Discontinued after 41 days Rx|0
7603053|NCT00462748|12009634|FG002|Overall Study|Discontinued after 41 days Rx|0
7603054|NCT00418834|12009644|FG000|Overall Study|Adverse Event|16
7603055|NCT00418834|12009645|FG001|Overall Study|Adverse Event|9
7603056|NCT00418834|12009644|FG000|Overall Study|Lost to Follow-up|0
7603057|NCT00418834|12009645|FG001|Overall Study|Lost to Follow-up|1
7603058|NCT00418834|12009644|FG000|Overall Study|Protocol Violation|4
7603059|NCT00418834|12009645|FG001|Overall Study|Protocol Violation|3
7603060|NCT00418834|12009644|FG000|Overall Study|Withdrawal by Subject|3
7603061|NCT00418834|12009645|FG001|Overall Study|Withdrawal by Subject|7
7603062|NCT00409773|12009656|FG000|Overall Study|Adverse Event|3
7603063|NCT00409773|12009657|FG001|Overall Study|Adverse Event|4
7603064|NCT00409773|12009658|FG002|Overall Study|Adverse Event|4
7603065|NCT00409773|12009659|FG003|Overall Study|Adverse Event|2
7603066|NCT00409773|12009660|FG004|Overall Study|Adverse Event|6
7603067|NCT00409773|12009656|FG000|Overall Study|Lost to Follow-up|6
7603068|NCT00409773|12009657|FG001|Overall Study|Lost to Follow-up|1
7603069|NCT00409773|12009658|FG002|Overall Study|Lost to Follow-up|2
7603070|NCT00409773|12009659|FG003|Overall Study|Lost to Follow-up|3
7603071|NCT00409773|12009660|FG004|Overall Study|Lost to Follow-up|1
7603072|NCT00409773|12009656|FG000|Overall Study|Physician Decision|0
7603073|NCT00409773|12009657|FG001|Overall Study|Physician Decision|0
7603074|NCT00409773|12009658|FG002|Overall Study|Physician Decision|0
7603075|NCT00409773|12009659|FG003|Overall Study|Physician Decision|2
7603076|NCT00409773|12009660|FG004|Overall Study|Physician Decision|0
7603077|NCT00409773|12009656|FG000|Overall Study|Protocol Violation|0
7603078|NCT00409773|12009657|FG001|Overall Study|Protocol Violation|2
7603079|NCT00409773|12009658|FG002|Overall Study|Protocol Violation|3
7603080|NCT00409773|12009659|FG003|Overall Study|Protocol Violation|3
7603081|NCT00409773|12009660|FG004|Overall Study|Protocol Violation|1
7603082|NCT00409773|12009656|FG000|Overall Study|Withdrawal by Subject|0
7603083|NCT00409773|12009657|FG001|Overall Study|Withdrawal by Subject|0
7603084|NCT00409773|12009658|FG002|Overall Study|Withdrawal by Subject|0
7603085|NCT00409773|12009659|FG003|Overall Study|Withdrawal by Subject|2
7603086|NCT00409773|12009660|FG004|Overall Study|Withdrawal by Subject|1
7603087|NCT00409773|12009656|FG000|Overall Study|Lack of Eligibility|0
7603088|NCT00409773|12009657|FG001|Overall Study|Lack of Eligibility|0
7603089|NCT00409773|12009658|FG002|Overall Study|Lack of Eligibility|0
7603090|NCT00409773|12009659|FG003|Overall Study|Lack of Eligibility|0
7603091|NCT00409773|12009660|FG004|Overall Study|Lack of Eligibility|1
7603092|NCT00276484|12009674|FG000|Overall Study|Adverse Event|4
7603093|NCT00276484|12009675|FG001|Overall Study|Adverse Event|7
7603094|NCT00276484|12009674|FG000|Overall Study|Lost to Follow-up|1
7603095|NCT00276484|12009675|FG001|Overall Study|Lost to Follow-up|1
7603096|NCT00276484|12009674|FG000|Overall Study|Protocol Violation|0
7603097|NCT00276484|12009675|FG001|Overall Study|Protocol Violation|1
7603098|NCT00276484|12009674|FG000|Overall Study|Withdrawal by Subject|4
7603099|NCT00276484|12009675|FG001|Overall Study|Withdrawal by Subject|3
7603100|NCT00276484|12009674|FG000|Overall Study|Could not take time off work|0
7603101|NCT00276484|12009675|FG001|Overall Study|Could not take time off work|1
7603102|NCT00276458|12009683|FG000|Overall Study|Adverse Event|0
7603103|NCT00276458|12009684|FG001|Overall Study|Adverse Event|2
7603104|NCT00276458|12009683|FG000|Overall Study|Lost to Follow-up|2
7603105|NCT00276458|12009684|FG001|Overall Study|Lost to Follow-up|2
7603106|NCT00276458|12009683|FG000|Overall Study|Protocol Violation|4
7603107|NCT00276458|12009684|FG001|Overall Study|Protocol Violation|3
7603108|NCT00271817|12009693|FG000|Part 1|Adverse Event|68
7603109|NCT00271817|12009694|FG001|Part 1|Adverse Event|25
7603110|NCT00271817|12009695|FG002|Part 1|Adverse Event|156
7603111|NCT00271817|12009693|FG000|Part 1|Lost to Follow-up|6
7603112|NCT00271817|12009694|FG001|Part 1|Lost to Follow-up|8
7603113|NCT00271817|12009695|FG002|Part 1|Lost to Follow-up|24
7773941|NCT00906347|12219633|FG001|Received Study Drug|Refused study drug|0
7773942|NCT00906347|12219632|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8
7773943|NCT00906347|12219633|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0
7773944|NCT00906373|12219641|FG000|Overall Study|Withdrawal by Subject|0
7773945|NCT00906373|12219642|FG001|Overall Study|Withdrawal by Subject|5
7773946|NCT00906373|12219641|FG000|Overall Study|Other|0
7773947|NCT00906373|12219642|FG001|Overall Study|Other|1
7773948|NCT00906373|12219641|FG000|Overall Study|Still on treatment at cutoff date|0
7773949|NCT00906373|12219642|FG001|Overall Study|Still on treatment at cutoff date|2
7773950|NCT00906399|12219652|FG000|Year 1|Randomized But Not Treated|0
7773951|NCT00906399|12219653|FG001|Year 1|Randomized But Not Treated|1
7773952|NCT00906399|12219654|FG002|Year 1|Randomized But Not Treated|3
7773953|NCT00906399|12219655|FG003|Year 1|Randomized But Not Treated|0
7773954|NCT00906399|12219656|FG004|Year 1|Randomized But Not Treated|0
7773955|NCT00906399|12219657|FG005|Year 1|Randomized But Not Treated|0
7773956|NCT00906399|12219658|FG006|Year 1|Randomized But Not Treated|0
7773957|NCT00906399|12219652|FG000|Year 1|Adverse Event|4
7773958|NCT00906399|12219653|FG001|Year 1|Adverse Event|22
7773959|NCT00906399|12219654|FG002|Year 1|Adverse Event|24
7773960|NCT00906399|12219655|FG003|Year 1|Adverse Event|0
7773961|NCT00906399|12219656|FG004|Year 1|Adverse Event|0
7773962|NCT00906399|12219657|FG005|Year 1|Adverse Event|0
7773963|NCT00906399|12219658|FG006|Year 1|Adverse Event|0
7773964|NCT00906399|12219652|FG000|Year 1|Lost to Follow-up|4
7603114|NCT00271817|12009693|FG000|Part 1|Protocol Violation|5
7603115|NCT00271817|12009694|FG001|Part 1|Protocol Violation|4
7603116|NCT00271817|12009695|FG002|Part 1|Protocol Violation|7
7603117|NCT00271817|12009693|FG000|Part 1|Patient Moved|3
7603118|NCT00271817|12009694|FG001|Part 1|Patient Moved|1
7603119|NCT00271817|12009695|FG002|Part 1|Patient Moved|5
7603120|NCT00271817|12009693|FG000|Part 1|Withdrawal by Subject|23
7603121|NCT00271817|12009694|FG001|Part 1|Withdrawal by Subject|17
7773965|NCT00906399|12219653|FG001|Year 1|Lost to Follow-up|4
7773966|NCT00906399|12219654|FG002|Year 1|Lost to Follow-up|2
7773967|NCT00906399|12219655|FG003|Year 1|Lost to Follow-up|0
7773968|NCT00906399|12219656|FG004|Year 1|Lost to Follow-up|0
7773969|NCT00906399|12219657|FG005|Year 1|Lost to Follow-up|0
7773970|NCT00906399|12219658|FG006|Year 1|Lost to Follow-up|0
7773971|NCT00906399|12219652|FG000|Year 1|Withdrawal by Subject|30
7773972|NCT00906399|12219653|FG001|Year 1|Withdrawal by Subject|32
7773973|NCT00906399|12219654|FG002|Year 1|Withdrawal by Subject|36
7773974|NCT00906399|12219655|FG003|Year 1|Withdrawal by Subject|0
7773975|NCT00906399|12219656|FG004|Year 1|Withdrawal by Subject|0
7773976|NCT00906399|12219657|FG005|Year 1|Withdrawal by Subject|0
7773977|NCT00906399|12219658|FG006|Year 1|Withdrawal by Subject|0
7773978|NCT00906399|12219652|FG000|Year 1|Physician Decision|0
7773979|NCT00906399|12219653|FG001|Year 1|Physician Decision|1
7773980|NCT00906399|12219654|FG002|Year 1|Physician Decision|3
7773981|NCT00906399|12219655|FG003|Year 1|Physician Decision|0
7773982|NCT00906399|12219656|FG004|Year 1|Physician Decision|0
7773983|NCT00906399|12219657|FG005|Year 1|Physician Decision|0
7773984|NCT00906399|12219658|FG006|Year 1|Physician Decision|0
7603122|NCT00271817|12009695|FG002|Part 1|Withdrawal by Subject|45
7603123|NCT00271817|12009693|FG000|Part 1|LDL < 50 mg/dL|1
7603124|NCT00271817|12009694|FG001|Part 1|LDL < 50 mg/dL|4
7603125|NCT00271817|12009695|FG002|Part 1|LDL < 50 mg/dL|48
7603126|NCT00271817|12009693|FG000|Part 2|Adverse Event|0
7603127|NCT00271817|12009694|FG001|Part 2|Adverse Event|17
7603128|NCT00271817|12009695|FG002|Part 2|Adverse Event|33
7603129|NCT00271817|12009693|FG000|Part 2|Lack of Efficacy|0
7603130|NCT00271817|12009694|FG001|Part 2|Lack of Efficacy|1
7603131|NCT00271817|12009695|FG002|Part 2|Lack of Efficacy|6
7603132|NCT00271817|12009693|FG000|Part 2|Lost to Follow-up|0
7603133|NCT00271817|12009694|FG001|Part 2|Lost to Follow-up|6
7603134|NCT00271817|12009695|FG002|Part 2|Lost to Follow-up|18
7603135|NCT00271817|12009693|FG000|Part 2|Protocol Violation|0
7603136|NCT00271817|12009694|FG001|Part 2|Protocol Violation|3
7603137|NCT00271817|12009695|FG002|Part 2|Protocol Violation|5
7603138|NCT00271817|12009693|FG000|Part 2|Patient Moved|0
7603139|NCT00271817|12009694|FG001|Part 2|Patient Moved|0
7603140|NCT00271817|12009695|FG002|Part 2|Patient Moved|5
7603141|NCT00271817|12009693|FG000|Part 2|Withdrawal by Subject|0
7603142|NCT00271817|12009694|FG001|Part 2|Withdrawal by Subject|2
7603143|NCT00271817|12009695|FG002|Part 2|Withdrawal by Subject|13
7603144|NCT00271817|12009693|FG000|Part 2|LDL < 50 mg/dL|0
7603145|NCT00271817|12009694|FG001|Part 2|LDL < 50 mg/dL|3
7603146|NCT00271817|12009695|FG002|Part 2|LDL < 50 mg/dL|4
7603147|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Adverse Event|1
7603148|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Adverse Event|6
7603149|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Adverse Event|0
7603150|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Adverse Event|0
7603151|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Adverse Event|0
7603152|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1
7603153|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1
7603154|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0
7603155|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0
7603156|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0
7603157|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22
7603158|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16
7603159|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0
7603160|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0
7603161|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0
7603162|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10
7773985|NCT00906399|12219652|FG000|Year 1|Death|2
7773986|NCT00906399|12219653|FG001|Year 1|Death|1
7773987|NCT00906399|12219654|FG002|Year 1|Death|1
7773988|NCT00906399|12219655|FG003|Year 1|Death|0
7773989|NCT00906399|12219656|FG004|Year 1|Death|0
7773990|NCT00906399|12219657|FG005|Year 1|Death|0
7773991|NCT00906399|12219658|FG006|Year 1|Death|0
7773992|NCT00906399|12219652|FG000|Year 1|Other|4
7773993|NCT00906399|12219653|FG001|Year 1|Other|2
7773994|NCT00906399|12219654|FG002|Year 1|Other|7
7773995|NCT00906399|12219655|FG003|Year 1|Other|0
7773996|NCT00906399|12219656|FG004|Year 1|Other|0
7773997|NCT00906399|12219657|FG005|Year 1|Other|0
7773998|NCT00906399|12219658|FG006|Year 1|Other|0
7773999|NCT00906399|12219652|FG000|Year 2|Adverse Event|0
7774000|NCT00906399|12219653|FG001|Year 2|Adverse Event|0
7774001|NCT00906399|12219654|FG002|Year 2|Adverse Event|0
7774002|NCT00906399|12219655|FG003|Year 2|Adverse Event|9
7774003|NCT00906399|12219656|FG004|Year 2|Adverse Event|8
7774004|NCT00906399|12219657|FG005|Year 2|Adverse Event|11
7774005|NCT00906399|12219658|FG006|Year 2|Adverse Event|6
7774006|NCT00906399|12219652|FG000|Year 2|Lost to Follow-up|0
7774007|NCT00906399|12219653|FG001|Year 2|Lost to Follow-up|0
7774008|NCT00906399|12219654|FG002|Year 2|Lost to Follow-up|0
7774009|NCT00906399|12219655|FG003|Year 2|Lost to Follow-up|1
7774010|NCT00906399|12219656|FG004|Year 2|Lost to Follow-up|4
7774011|NCT00906399|12219657|FG005|Year 2|Lost to Follow-up|2
7774012|NCT00906399|12219658|FG006|Year 2|Lost to Follow-up|4
7603163|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6
7603164|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0
7774013|NCT00906399|12219652|FG000|Year 2|Withdrawal by Subject|0
7774014|NCT00906399|12219653|FG001|Year 2|Withdrawal by Subject|0
7774015|NCT00906399|12219654|FG002|Year 2|Withdrawal by Subject|0
7774016|NCT00906399|12219655|FG003|Year 2|Withdrawal by Subject|17
7774017|NCT00906399|12219656|FG004|Year 2|Withdrawal by Subject|18
7774018|NCT00906399|12219657|FG005|Year 2|Withdrawal by Subject|27
7774019|NCT00906399|12219658|FG006|Year 2|Withdrawal by Subject|13
7774020|NCT00906399|12219652|FG000|Year 2|Physician Decision|0
7603165|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0
7603166|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0
7603167|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Death|2
7603168|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Death|2
7603169|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Death|0
7603170|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Death|0
7603171|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Death|0
7603172|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Physician Decision|3
7603173|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Physician Decision|4
7603174|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Physician Decision|0
7603175|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Physician Decision|0
7603176|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Physician Decision|0
7603177|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0
7603178|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2
7603179|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0
7603180|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0
7603181|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0
7603182|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101
7603183|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89
7603184|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
7603185|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
7603186|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
7603187|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1
7603188|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
7774021|NCT00906399|12219653|FG001|Year 2|Physician Decision|0
7774022|NCT00906399|12219654|FG002|Year 2|Physician Decision|0
7774023|NCT00906399|12219655|FG003|Year 2|Physician Decision|0
7774024|NCT00906399|12219656|FG004|Year 2|Physician Decision|2
7774025|NCT00906399|12219657|FG005|Year 2|Physician Decision|6
7774026|NCT00906399|12219658|FG006|Year 2|Physician Decision|3
7774027|NCT00906399|12219652|FG000|Year 2|Death|0
7774028|NCT00906399|12219653|FG001|Year 2|Death|0
7774029|NCT00906399|12219654|FG002|Year 2|Death|0
7774030|NCT00906399|12219655|FG003|Year 2|Death|1
7774031|NCT00906399|12219656|FG004|Year 2|Death|0
7774032|NCT00906399|12219657|FG005|Year 2|Death|0
7774033|NCT00906399|12219658|FG006|Year 2|Death|3
7774034|NCT00906399|12219652|FG000|Year 2|Other|0
7774035|NCT00906399|12219653|FG001|Year 2|Other|0
7774036|NCT00906399|12219654|FG002|Year 2|Other|0
7774037|NCT00906399|12219655|FG003|Year 2|Other|2
7774038|NCT00906399|12219656|FG004|Year 2|Other|3
7774039|NCT00906399|12219657|FG005|Year 2|Other|1
7774040|NCT00906399|12219658|FG006|Year 2|Other|0
7774041|NCT00906698|12219689|FG000|Overall Study|Dose-limiting toxicity (DLT)|0
7774042|NCT00906698|12219690|FG001|Overall Study|Dose-limiting toxicity (DLT)|6
7774043|NCT00906698|12219691|FG002|Overall Study|Dose-limiting toxicity (DLT)|0
7774044|NCT00906698|12219692|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
7774045|NCT00906698|12219693|FG004|Overall Study|Dose-limiting toxicity (DLT)|1
7774046|NCT00906698|12219694|FG005|Overall Study|Dose-limiting toxicity (DLT)|0
7774047|NCT00906698|12219689|FG000|Overall Study|Adverse Event|0
7774048|NCT00906698|12219690|FG001|Overall Study|Adverse Event|0
7774049|NCT00906698|12219691|FG002|Overall Study|Adverse Event|2
7774050|NCT00906698|12219692|FG003|Overall Study|Adverse Event|0
7774051|NCT00906698|12219693|FG004|Overall Study|Adverse Event|4
7774052|NCT00906698|12219694|FG005|Overall Study|Adverse Event|1
7774053|NCT00906698|12219689|FG000|Overall Study|Disease progression|3
7774054|NCT00906698|12219690|FG001|Overall Study|Disease progression|12
7774055|NCT00906698|12219691|FG002|Overall Study|Disease progression|4
7774056|NCT00906698|12219692|FG003|Overall Study|Disease progression|4
7774057|NCT00906698|12219693|FG004|Overall Study|Disease progression|12
7774058|NCT00906698|12219694|FG005|Overall Study|Disease progression|4
7774059|NCT00906698|12219689|FG000|Overall Study|Withdrawal by Subject|0
7774060|NCT00906698|12219690|FG001|Overall Study|Withdrawal by Subject|0
7774061|NCT00906698|12219691|FG002|Overall Study|Withdrawal by Subject|0
7774062|NCT00906698|12219692|FG003|Overall Study|Withdrawal by Subject|0
7603189|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
7603190|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
7603191|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
7603192|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3
7603193|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0
7603194|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0
7603195|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0
7603196|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0
7603197|NCT03420781|12009727|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
7774063|NCT00906698|12219693|FG004|Overall Study|Withdrawal by Subject|1
7774064|NCT00906698|12219694|FG005|Overall Study|Withdrawal by Subject|0
7774065|NCT00906698|12219689|FG000|Overall Study|incl. non compliance, lost to follow-up|0
7774066|NCT00906698|12219690|FG001|Overall Study|incl. non compliance, lost to follow-up|1
7774067|NCT00906698|12219691|FG002|Overall Study|incl. non compliance, lost to follow-up|0
7774068|NCT00906698|12219692|FG003|Overall Study|incl. non compliance, lost to follow-up|0
7774069|NCT00906698|12219693|FG004|Overall Study|incl. non compliance, lost to follow-up|0
7603198|NCT03420781|12009728|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
7603199|NCT03420781|12009729|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
7603200|NCT03420781|12009730|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2
7603201|NCT03420781|12009731|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
7774070|NCT00906698|12219694|FG005|Overall Study|incl. non compliance, lost to follow-up|0
7774071|NCT00906945|12219746|FG000|Overall Study|Found to be not eligible|0
7774072|NCT00906945|12219747|FG001|Overall Study|Found to be not eligible|0
7774073|NCT00906945|12219748|FG002|Overall Study|Found to be not eligible|0
7774074|NCT00906945|12219749|FG003|Overall Study|Found to be not eligible|1
7774075|NCT00906945|12219750|FG004|Overall Study|Found to be not eligible|1
7774076|NCT00906945|12219751|FG005|Overall Study|Found to be not eligible|1
7774077|NCT00906945|12219746|FG000|Overall Study|Physician Decision|0
7774078|NCT00906945|12219747|FG001|Overall Study|Physician Decision|0
7774079|NCT00906945|12219748|FG002|Overall Study|Physician Decision|0
7774080|NCT00906945|12219749|FG003|Overall Study|Physician Decision|0
7774081|NCT00906945|12219750|FG004|Overall Study|Physician Decision|0
7774082|NCT00906945|12219751|FG005|Overall Study|Physician Decision|1
7774083|NCT00906971|12219778|FG000|Overall Study|Withdrawal by Subject|8
7774084|NCT00906971|12219779|FG001|Overall Study|Withdrawal by Subject|2
7774085|NCT00906971|12219778|FG000|Overall Study|Lost to Follow-up|0
7774086|NCT00906971|12219779|FG001|Overall Study|Lost to Follow-up|1
7774087|NCT00907153|12219796|FG000|Overall Study|Lost to Follow-up|1
7774088|NCT00907153|12219797|FG001|Overall Study|Lost to Follow-up|1
7774089|NCT00907153|12219796|FG000|Overall Study|Withdrawal by Subject|1
7774090|NCT00907153|12219797|FG001|Overall Study|Withdrawal by Subject|3
7774091|NCT00907257|12219805|FG000|Overall Study|Adverse Event|0
7774092|NCT00907257|12219806|FG001|Overall Study|Adverse Event|4
7774093|NCT00907257|12219805|FG000|Overall Study|Protocol Violation|1
7774094|NCT00907257|12219806|FG001|Overall Study|Protocol Violation|2
7774095|NCT00907257|12219805|FG000|Overall Study|Lost to Follow-up|3
7774096|NCT00907257|12219806|FG001|Overall Study|Lost to Follow-up|3
7774097|NCT00907257|12219805|FG000|Overall Study|Withdrawal by Subject|1
7774098|NCT00907257|12219806|FG001|Overall Study|Withdrawal by Subject|2
7774099|NCT00907257|12219805|FG000|Overall Study|Per IRB-Subject became vulnerable|1
7774100|NCT00907257|12219806|FG001|Overall Study|Per IRB-Subject became vulnerable|0
7774101|NCT00907257|12219805|FG000|Overall Study|Moved|1
7774102|NCT00907257|12219806|FG001|Overall Study|Moved|0
7774103|NCT00907257|12219805|FG000|Overall Study|Personal Reasons|6
7774104|NCT00907257|12219806|FG001|Overall Study|Personal Reasons|1
7774105|NCT00907335|12219814|FG000|Overall Study|Withdrawal by Subject|2
7774106|NCT00907335|12219815|FG001|Overall Study|Withdrawal by Subject|0
7774107|NCT00907335|12219814|FG000|Overall Study|Adverse Event|4
7774108|NCT00907335|12219815|FG001|Overall Study|Adverse Event|1
7774109|NCT00907335|12219814|FG000|Overall Study|Lost to Follow-up|2
7774110|NCT00907335|12219815|FG001|Overall Study|Lost to Follow-up|0
7774111|NCT00907374|12219823|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2
7774112|NCT00907374|12219824|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2
7774113|NCT00907517|12219847|FG000|Overall Study|Progressive Disease|3
7603202|NCT03420781|12009727|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
7603203|NCT03420781|12009728|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
7603204|NCT03420781|12009729|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
7603205|NCT03420781|12009730|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
7603206|NCT03420781|12009731|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2
7603207|NCT03420781|12009727|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0
7603208|NCT03420781|12009728|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0
7603209|NCT03420781|12009729|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6
7603210|NCT03420781|12009730|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3
7603211|NCT03420781|12009731|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3
7603212|NCT03316586|12009747|FG000|Overall Study|Adverse Event|2
7603213|NCT03316586|12009747|FG000|Overall Study|Physician Decision|3
7603214|NCT03316586|12009747|FG000|Overall Study|Lack of Efficacy|10
7603215|NCT03316586|12009747|FG000|Overall Study|still on treatment|1
7603216|NCT03316586|12009747|FG000|Overall Study|Patient needed radiation therapy|1
7603217|NCT03316586|12009747|FG000|Overall Study|Physician Decision to send patient for breast surgery|1
7774114|NCT00907517|12219848|FG001|Overall Study|Progressive Disease|3
7774115|NCT00907517|12219849|FG002|Overall Study|Progressive Disease|4
7774116|NCT00907517|12219850|FG003|Overall Study|Progressive Disease|4
7774117|NCT00907517|12219851|FG004|Overall Study|Progressive Disease|4
7774118|NCT00907517|12219847|FG000|Overall Study|Symptomatic Deterioration|0
7774119|NCT00907517|12219848|FG001|Overall Study|Symptomatic Deterioration|0
7774120|NCT00907517|12219849|FG002|Overall Study|Symptomatic Deterioration|0
7774121|NCT00907517|12219850|FG003|Overall Study|Symptomatic Deterioration|0
7774122|NCT00907517|12219851|FG004|Overall Study|Symptomatic Deterioration|1
7774123|NCT00907621|12219865|FG000|Overall Study|Lost to Follow-up|6
7774124|NCT00907621|12219866|FG001|Overall Study|Lost to Follow-up|3
7774125|NCT00907621|12219865|FG000|Overall Study|intercurrent febrile illness|1
7774126|NCT00907621|12219866|FG001|Overall Study|intercurrent febrile illness|1
7774127|NCT00907738|12219877|FG000|Overall Study|Adverse Event|2
7774128|NCT00907738|12219878|FG001|Overall Study|Adverse Event|0
7774129|NCT00907738|12219879|FG002|Overall Study|Adverse Event|1
7774130|NCT00907738|12219880|FG003|Overall Study|Adverse Event|0
7774131|NCT00907738|12219881|FG004|Overall Study|Adverse Event|0
7774132|NCT00907738|12219877|FG000|Overall Study|not specified or withdrew consent|3
7774133|NCT00907738|12219878|FG001|Overall Study|not specified or withdrew consent|0
7774134|NCT00907738|12219879|FG002|Overall Study|not specified or withdrew consent|0
7774135|NCT00907738|12219880|FG003|Overall Study|not specified or withdrew consent|0
7774136|NCT00907738|12219881|FG004|Overall Study|not specified or withdrew consent|0
7774137|NCT00907738|12219877|FG000|Overall Study|Disease progression|8
7774138|NCT00907738|12219878|FG001|Overall Study|Disease progression|1
7774139|NCT00907738|12219879|FG002|Overall Study|Disease progression|6
7774140|NCT00907738|12219880|FG003|Overall Study|Disease progression|4
7774141|NCT00907738|12219881|FG004|Overall Study|Disease progression|2
7774142|NCT00907777|12219899|FG000|Overall Study|Withdrawal by Subject|0
7774143|NCT00907777|12219900|FG001|Overall Study|Withdrawal by Subject|1
7774144|NCT00907803|12219909|FG000|Overall Study|Withdrawal of consent - long commute|1
7774145|NCT00907803|12219910|FG001|Overall Study|Withdrawal of consent - long commute|0
7774146|NCT00907803|12219911|FG002|Overall Study|Withdrawal of consent - long commute|0
7774147|NCT00907803|12219909|FG000|Overall Study|Adverse Event|2
7774148|NCT00907803|12219910|FG001|Overall Study|Adverse Event|0
7774149|NCT00907803|12219911|FG002|Overall Study|Adverse Event|0
7774150|NCT00907803|12219909|FG000|Overall Study|Withdrawal by Subject|0
7774151|NCT00907803|12219910|FG001|Overall Study|Withdrawal by Subject|1
7774152|NCT00907803|12219911|FG002|Overall Study|Withdrawal by Subject|0
7774153|NCT00907803|12219909|FG000|Overall Study|Lost to Follow-up|0
7774154|NCT00907803|12219910|FG001|Overall Study|Lost to Follow-up|1
7774155|NCT00907803|12219911|FG002|Overall Study|Lost to Follow-up|0
7774156|NCT00907803|12219909|FG000|Overall Study|Protocol Violation|0
7774157|NCT00907803|12219910|FG001|Overall Study|Protocol Violation|1
7603218|NCT03269695|12009766|FG000|Overall Study|Adverse Event|2
7603219|NCT03269695|12009767|FG001|Overall Study|Adverse Event|1
7603220|NCT03269695|12009766|FG000|Overall Study|Lack of Efficacy|0
7603221|NCT03269695|12009767|FG001|Overall Study|Lack of Efficacy|1
7603222|NCT03269695|12009766|FG000|Overall Study|Withdrawal by Subject|0
7603223|NCT03269695|12009767|FG001|Overall Study|Withdrawal by Subject|1
7603224|NCT03268811|12009776|FG000|Overall Study|Adverse Event|0
7603225|NCT03268811|12009777|FG001|Overall Study|Adverse Event|1
7603226|NCT03227757|12009784|FG000|Overall Study|Death|7
7603227|NCT03227757|12009784|FG000|Overall Study|Withdrawal|5
7603228|NCT03227757|12009784|FG000|Overall Study|Missed visits|4
7603229|NCT03142334|12009794|FG000|Overall Study|Death|18
7603230|NCT03142334|12009795|FG001|Overall Study|Death|33
7603231|NCT03142334|12009794|FG000|Overall Study|Withdrawal by Subject|15
7603232|NCT03142334|12009795|FG001|Overall Study|Withdrawal by Subject|11
7603233|NCT03142334|12009794|FG000|Overall Study|Ongoing on trial follow up|463
7603234|NCT03142334|12009795|FG001|Overall Study|Ongoing on trial follow up|454
7603235|NCT02857426|12009875|FG000|Overall Study|Disease progression|34
7603236|NCT02857426|12009876|FG001|Overall Study|Disease progression|13
7603237|NCT02857426|12009875|FG000|Overall Study|Study drug toxicity|4
7603238|NCT02857426|12009876|FG001|Overall Study|Study drug toxicity|1
7603239|NCT02857426|12009875|FG000|Overall Study|Death|1
7603240|NCT02857426|12009876|FG001|Overall Study|Death|0
7603241|NCT02857426|12009875|FG000|Overall Study|Adverse event unrelated to study drug|6
7603242|NCT02857426|12009876|FG001|Overall Study|Adverse event unrelated to study drug|2
7603243|NCT02857426|12009875|FG000|Overall Study|Participant withdrew consent|1
7603244|NCT02857426|12009876|FG001|Overall Study|Participant withdrew consent|1
7603245|NCT02857426|12009875|FG000|Overall Study|Maximum clinical benefit|1
7603246|NCT02857426|12009876|FG001|Overall Study|Maximum clinical benefit|0
7603247|NCT02857426|12009875|FG000|Overall Study|Completed treatment|0
7603248|NCT02857426|12009876|FG001|Overall Study|Completed treatment|2
7603249|NCT02855125|12009884|FG000|Overall Study|Withdrawal by Subject|2
7603250|NCT02855125|12009885|FG001|Overall Study|Withdrawal by Subject|2
7603251|NCT02855125|12009884|FG000|Overall Study|Clinical Disease Progression|5
7603252|NCT02855125|12009885|FG001|Overall Study|Clinical Disease Progression|4
7603253|NCT02855125|12009884|FG000|Overall Study|Radiologic Disease Progression|36
7603254|NCT02855125|12009885|FG001|Overall Study|Radiologic Disease Progression|39
7603255|NCT02855125|12009884|FG000|Overall Study|Adverse Event|11
7603256|NCT02855125|12009885|FG001|Overall Study|Adverse Event|7
7603257|NCT02855125|12009884|FG000|Overall Study|Physician Decision|1
7603258|NCT02855125|12009885|FG001|Overall Study|Physician Decision|0
7603259|NCT02855125|12009884|FG000|Overall Study|On Treatment|9
7603260|NCT02855125|12009885|FG001|Overall Study|On Treatment|11
7603261|NCT02855125|12009884|FG000|Overall Study|Randomized but not treated|0
7603262|NCT02855125|12009885|FG001|Overall Study|Randomized but not treated|1
7774158|NCT00907803|12219911|FG002|Overall Study|Protocol Violation|0
7603265|NCT02527798|12009931|FG000|Overall Study|Physician Decision|1
7603266|NCT02527798|12009932|FG001|Overall Study|Physician Decision|0
7603267|NCT02527798|12009933|FG002|Overall Study|Physician Decision|1
7603268|NCT02527798|12009934|FG003|Overall Study|Physician Decision|1
7603269|NCT02527798|12009935|FG004|Overall Study|Physician Decision|0
7603270|NCT02527798|12009936|FG005|Overall Study|Physician Decision|0
7603271|NCT02527798|12009931|FG000|Overall Study|Death|0
7603272|NCT02527798|12009932|FG001|Overall Study|Death|0
7603273|NCT02527798|12009933|FG002|Overall Study|Death|1
7603274|NCT02527798|12009934|FG003|Overall Study|Death|0
7603275|NCT02527798|12009935|FG004|Overall Study|Death|0
7603276|NCT02527798|12009936|FG005|Overall Study|Death|0
7603277|NCT02527798|12009931|FG000|Overall Study|Withdrawal by Subject|0
7603278|NCT02527798|12009932|FG001|Overall Study|Withdrawal by Subject|1
7603279|NCT02527798|12009933|FG002|Overall Study|Withdrawal by Subject|2
7603280|NCT02527798|12009934|FG003|Overall Study|Withdrawal by Subject|0
7603281|NCT02527798|12009935|FG004|Overall Study|Withdrawal by Subject|0
7603282|NCT02527798|12009936|FG005|Overall Study|Withdrawal by Subject|0
7603283|NCT02527798|12009931|FG000|Overall Study|Reason undisclosed|1
7603284|NCT02527798|12009932|FG001|Overall Study|Reason undisclosed|0
7603285|NCT02527798|12009933|FG002|Overall Study|Reason undisclosed|1
7603286|NCT02527798|12009934|FG003|Overall Study|Reason undisclosed|0
7603287|NCT02527798|12009935|FG004|Overall Study|Reason undisclosed|0
7603288|NCT02527798|12009936|FG005|Overall Study|Reason undisclosed|0
7603289|NCT02527798|12009931|FG000|Overall Study|Did not receive intervention|1
7603290|NCT02527798|12009932|FG001|Overall Study|Did not receive intervention|1
7603291|NCT02527798|12009933|FG002|Overall Study|Did not receive intervention|0
7603292|NCT02527798|12009934|FG003|Overall Study|Did not receive intervention|0
7603293|NCT02527798|12009935|FG004|Overall Study|Did not receive intervention|0
7603294|NCT02527798|12009936|FG005|Overall Study|Did not receive intervention|0
7603295|NCT02279745|12009987|FG000|Overall Study|Adverse Event|7
7603296|NCT02279745|12009987|FG000|Overall Study|Death|6
7603297|NCT02279745|12009987|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2
7603298|NCT02279745|12009987|FG000|Overall Study|Withdrawal by Subject|2
7603299|NCT02279745|12009987|FG000|Overall Study|Pregnancy|1
7603300|NCT02279745|12009987|FG000|Overall Study|Study Non-compliance|1
7603301|NCT02279745|12009987|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1
7603302|NCT02030938|12010010|FG000|Overall Study|Lost to Follow-up|4
7603303|NCT02030938|12010010|FG000|Overall Study|Withdrawal by Subject|1
7603304|NCT02006147|12010022|FG000|Overall Study|Protocol Violation|1
7603305|NCT02006147|12010023|FG001|Overall Study|Protocol Violation|1
7603306|NCT02006147|12010024|FG002|Overall Study|Protocol Violation|0
7603307|NCT02006147|12010025|FG003|Overall Study|Protocol Violation|0
7603308|NCT02006147|12010022|FG000|Overall Study|Withdrawal by Subject|0
7603309|NCT02006147|12010023|FG001|Overall Study|Withdrawal by Subject|1
7603310|NCT02006147|12010024|FG002|Overall Study|Withdrawal by Subject|0
7603311|NCT02006147|12010025|FG003|Overall Study|Withdrawal by Subject|0
7603312|NCT02006147|12010022|FG000|Overall Study|Withdrawal by Sponsor|1
7603313|NCT02006147|12010023|FG001|Overall Study|Withdrawal by Sponsor|0
7603314|NCT02006147|12010024|FG002|Overall Study|Withdrawal by Sponsor|0
7603315|NCT02006147|12010025|FG003|Overall Study|Withdrawal by Sponsor|0
7603316|NCT01925794|12010031|FG000|180 Days|Death|2
7603317|NCT01925794|12010031|FG000|180 Days|Withdrawal by Subject|2
7603318|NCT01925794|12010031|FG000|270 Days|Death|2
7603319|NCT01925794|12010031|FG000|270 Days|Protocol Violation|3
7603320|NCT01849250|12010054|FG000|Overall Study|Withdrawal by Subject|1
7603321|NCT01849250|12010055|FG001|Overall Study|Withdrawal by Subject|0
7603322|NCT01849250|12010054|FG000|Overall Study|Not Evaluable|5
7603323|NCT01849250|12010055|FG001|Overall Study|Not Evaluable|3
7603324|NCT01849250|12010054|FG000|Overall Study|Screen Failure|1
7603325|NCT01849250|12010055|FG001|Overall Study|Screen Failure|0
7603326|NCT01441115|12010066|FG000|Overall Study|Taken off study - Principal Investigator discretion|1
7603327|NCT01199302|12010077|FG000|Overall Study|Adverse Event|1
7603328|NCT01199302|12010078|FG001|Overall Study|Adverse Event|1
7603329|NCT01199302|12010079|FG002|Overall Study|Adverse Event|2
7603330|NCT01199302|12010080|FG003|Overall Study|Adverse Event|0
7603331|NCT01199302|12010077|FG000|Overall Study|Withdrawal by Subject|2
7603332|NCT01199302|12010078|FG001|Overall Study|Withdrawal by Subject|2
7603333|NCT01199302|12010079|FG002|Overall Study|Withdrawal by Subject|3
7603334|NCT01199302|12010080|FG003|Overall Study|Withdrawal by Subject|0
7603335|NCT01199302|12010077|FG000|Overall Study|Disease Progression|3
7603336|NCT01199302|12010078|FG001|Overall Study|Disease Progression|4
7603337|NCT01199302|12010079|FG002|Overall Study|Disease Progression|4
7603338|NCT01199302|12010080|FG003|Overall Study|Disease Progression|2
7603339|NCT01199302|12010077|FG000|Overall Study|Study Termination|13
7603340|NCT01199302|12010078|FG001|Overall Study|Study Termination|8
7603341|NCT01199302|12010079|FG002|Overall Study|Study Termination|11
7603342|NCT01199302|12010080|FG003|Overall Study|Study Termination|9
7603343|NCT01199302|12010077|FG000|Overall Study|Lost to Follow-up|0
7603344|NCT01199302|12010078|FG001|Overall Study|Lost to Follow-up|1
7603345|NCT01199302|12010079|FG002|Overall Study|Lost to Follow-up|0
7603346|NCT01199302|12010080|FG003|Overall Study|Lost to Follow-up|0
7603347|NCT01199302|12010077|FG000|Overall Study|Other|1
7603348|NCT01199302|12010078|FG001|Overall Study|Other|0
7603349|NCT01199302|12010079|FG002|Overall Study|Other|0
7603350|NCT01199302|12010080|FG003|Overall Study|Other|0
7603351|NCT01123707|12010091|FG000|Overall Study|Lost to Follow-up|3
7774159|NCT00907881|12219919|FG000|Overall Study|Lost to Follow-up|59
7774160|NCT00907881|12219919|FG000|Overall Study|Noncompliance|5
7774161|NCT00907881|12219919|FG000|Overall Study|Withdrawal by Subject|5
7774162|NCT00907881|12219919|FG000|Overall Study|Protocol Violation|1
7774163|NCT00907881|12219919|FG000|Overall Study|Missing discontinuation information|15
7774164|NCT00908011|12219925|FG000|Overall Study|Withdrawal by Subject|2
7774165|NCT00908011|12219926|FG001|Overall Study|Withdrawal by Subject|2
7774166|NCT00908037|12219939|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7774167|NCT00908037|12219940|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7774168|NCT00908037|12219941|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7774169|NCT00908037|12219942|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7774170|NCT00908037|12219943|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1
7774171|NCT00908037|12219944|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7774172|NCT00908037|12219945|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3
7774173|NCT00908037|12219946|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7774174|NCT00908037|12219947|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1
7774175|NCT00908037|12219948|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7774176|NCT00908037|12219949|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7774177|NCT00908037|12219950|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7774178|NCT00908037|12219939|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7774179|NCT00908037|12219940|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7774180|NCT00908037|12219941|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7774181|NCT00908037|12219942|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7774182|NCT00908037|12219943|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
7774183|NCT00908037|12219944|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7774184|NCT00908037|12219945|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7774185|NCT00908037|12219946|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7774186|NCT00908037|12219947|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
7774187|NCT00908037|12219948|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7774188|NCT00908037|12219949|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7774189|NCT00908037|12219950|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7774190|NCT00908037|12219939|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7774191|NCT00908037|12219940|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7774192|NCT00908037|12219941|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7774193|NCT00908037|12219942|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
7774194|NCT00908037|12219943|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7774195|NCT00908037|12219944|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7774196|NCT00908037|12219945|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
7774197|NCT00908037|12219946|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7774198|NCT00908037|12219947|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7774199|NCT00908037|12219948|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7774200|NCT00908037|12219949|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7774201|NCT00908037|12219950|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7774202|NCT00908037|12219939|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7774203|NCT00908037|12219940|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7774204|NCT00908037|12219941|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7774205|NCT00908037|12219942|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7774206|NCT00908037|12219943|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7603352|NCT01123707|12010092|FG001|Overall Study|Lost to Follow-up|1
7603353|NCT01123707|12010093|FG002|Overall Study|Lost to Follow-up|3
7603354|NCT01123707|12010094|FG003|Overall Study|Lost to Follow-up|2
7603355|NCT01123707|12010091|FG000|Overall Study|Adverse Event|5
7603356|NCT01123707|12010092|FG001|Overall Study|Adverse Event|7
7603357|NCT01123707|12010093|FG002|Overall Study|Adverse Event|5
7603358|NCT01123707|12010094|FG003|Overall Study|Adverse Event|3
7603359|NCT01123707|12010091|FG000|Overall Study|Sponsor Discontinued Study|30
7603360|NCT01123707|12010092|FG001|Overall Study|Sponsor Discontinued Study|24
7603361|NCT01123707|12010093|FG002|Overall Study|Sponsor Discontinued Study|25
7603362|NCT01123707|12010094|FG003|Overall Study|Sponsor Discontinued Study|40
7603363|NCT01123707|12010091|FG000|Overall Study|Participant Met Withdrawal Criteria|1
7603364|NCT01123707|12010092|FG001|Overall Study|Participant Met Withdrawal Criteria|1
7603365|NCT01123707|12010093|FG002|Overall Study|Participant Met Withdrawal Criteria|0
7603366|NCT01123707|12010094|FG003|Overall Study|Participant Met Withdrawal Criteria|1
7603367|NCT01123707|12010091|FG000|Overall Study|Investigator Withdrew Participant|0
7603368|NCT01123707|12010092|FG001|Overall Study|Investigator Withdrew Participant|1
7603369|NCT01123707|12010093|FG002|Overall Study|Investigator Withdrew Participant|1
7603370|NCT01123707|12010094|FG003|Overall Study|Investigator Withdrew Participant|1
7603371|NCT01123707|12010091|FG000|Overall Study|Subject Withdrew Consent|4
7603372|NCT01123707|12010092|FG001|Overall Study|Subject Withdrew Consent|5
7603373|NCT01123707|12010093|FG002|Overall Study|Subject Withdrew Consent|1
7603374|NCT01123707|12010094|FG003|Overall Study|Subject Withdrew Consent|2
7603375|NCT01123707|12010091|FG000|Overall Study|Lack of Efficacy|1
7603376|NCT01123707|12010092|FG001|Overall Study|Lack of Efficacy|2
7603377|NCT01123707|12010093|FG002|Overall Study|Lack of Efficacy|1
7603378|NCT01123707|12010094|FG003|Overall Study|Lack of Efficacy|0
7603379|NCT01123707|12010091|FG000|Overall Study|Subject Met Exclusion Criteria|0
7603380|NCT01123707|12010092|FG001|Overall Study|Subject Met Exclusion Criteria|0
7603381|NCT01123707|12010093|FG002|Overall Study|Subject Met Exclusion Criteria|2
7603382|NCT01123707|12010094|FG003|Overall Study|Subject Met Exclusion Criteria|1
7603383|NCT00462943|12010111|FG000|Overall Study|Failure to achieve a response|5
7603384|NCT00462943|12010112|FG001|Overall Study|Failure to achieve a response|5
7603385|NCT00462943|12010113|FG002|Overall Study|Failure to achieve a response|1
7603386|NCT00462943|12010111|FG000|Overall Study|Adverse Event|6
7603387|NCT00462943|12010112|FG001|Overall Study|Adverse Event|4
7603388|NCT00462943|12010113|FG002|Overall Study|Adverse Event|1
7603389|NCT00462943|12010111|FG000|Overall Study|Protocol Violation|1
7603390|NCT00462943|12010112|FG001|Overall Study|Protocol Violation|0
7603391|NCT00462943|12010113|FG002|Overall Study|Protocol Violation|0
7603392|NCT00462943|12010111|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8
7603393|NCT00462943|12010112|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2
7603394|NCT00462943|12010113|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4
7603395|NCT00462943|12010111|FG000|Overall Study|Disease Progression|15
7603396|NCT00462943|12010112|FG001|Overall Study|Disease Progression|15
7603397|NCT00462943|12010113|FG002|Overall Study|Disease Progression|9
7603398|NCT00462943|12010111|FG000|Overall Study|Death|5
7603399|NCT00462943|12010112|FG001|Overall Study|Death|2
7603400|NCT00462943|12010113|FG002|Overall Study|Death|7
7603401|NCT00462943|12010111|FG000|Overall Study|Stem Cell Transplant|1
7603402|NCT00462943|12010112|FG001|Overall Study|Stem Cell Transplant|1
7603403|NCT00462943|12010113|FG002|Overall Study|Stem Cell Transplant|0
7603404|NCT00462943|12010111|FG000|Overall Study|Bone Marrow Transplant|1
7603405|NCT00462943|12010112|FG001|Overall Study|Bone Marrow Transplant|0
7603406|NCT00462943|12010113|FG002|Overall Study|Bone Marrow Transplant|0
7603407|NCT00462943|12010111|FG000|Overall Study|Required Lymphocyte Infusion|1
7603408|NCT00462943|12010112|FG001|Overall Study|Required Lymphocyte Infusion|0
7603409|NCT00462943|12010113|FG002|Overall Study|Required Lymphocyte Infusion|0
7603410|NCT00462943|12010111|FG000|Overall Study|Transplant - not specified|1
7603411|NCT00462943|12010112|FG001|Overall Study|Transplant - not specified|0
7603412|NCT00462943|12010113|FG002|Overall Study|Transplant - not specified|1
7603413|NCT00462943|12010111|FG000|Overall Study|Physician Decision|1
7603414|NCT00462943|12010112|FG001|Overall Study|Physician Decision|0
7603415|NCT00462943|12010113|FG002|Overall Study|Physician Decision|0
7603416|NCT00462943|12010111|FG000|Overall Study|Withdrawal by Subject|0
7603417|NCT00462943|12010112|FG001|Overall Study|Withdrawal by Subject|1
7603418|NCT00462943|12010113|FG002|Overall Study|Withdrawal by Subject|0
7603419|NCT00248287|12010123|FG000|Overall Study|Adverse Event|11
7774207|NCT00908037|12219944|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7603420|NCT00248287|12010124|FG001|Overall Study|Adverse Event|10
7603421|NCT00248287|12010123|FG000|Overall Study|Death|1
7603422|NCT00248287|12010124|FG001|Overall Study|Death|0
7603423|NCT00248287|12010123|FG000|Overall Study|Lost to Follow-up|0
7603424|NCT00248287|12010124|FG001|Overall Study|Lost to Follow-up|1
7603425|NCT00248287|12010123|FG000|Overall Study|Investigator Request|4
7603426|NCT00248287|12010124|FG001|Overall Study|Investigator Request|3
7603427|NCT00248287|12010123|FG000|Overall Study|Patient Request|5
7603428|NCT00248287|12010124|FG001|Overall Study|Patient Request|3
7603429|NCT00248287|12010123|FG000|Overall Study|Other|3
7603430|NCT00248287|12010124|FG001|Overall Study|Other|2
7603431|NCT00105560|12010134|FG000|Overall Study|Lost to Follow-up|1
7603432|NCT04569786|12010168|FG000|Overall Study|Lost to Follow-up|1
7603433|NCT04569786|12010169|FG001|Overall Study|Lost to Follow-up|0
7603434|NCT04569786|12010170|FG002|Overall Study|Lost to Follow-up|4
7603435|NCT04569786|12010171|FG003|Overall Study|Lost to Follow-up|1
7603436|NCT04569786|12010172|FG004|Overall Study|Lost to Follow-up|0
7603437|NCT04569786|12010168|FG000|Overall Study|Withdrawal by Subject|0
7603438|NCT04569786|12010169|FG001|Overall Study|Withdrawal by Subject|0
7603439|NCT04569786|12010170|FG002|Overall Study|Withdrawal by Subject|0
7603440|NCT04569786|12010171|FG003|Overall Study|Withdrawal by Subject|5
7603441|NCT04569786|12010172|FG004|Overall Study|Withdrawal by Subject|1
7603442|NCT04569786|12010168|FG000|Overall Study|Physician Decision|0
7603443|NCT04569786|12010169|FG001|Overall Study|Physician Decision|0
7603444|NCT04569786|12010170|FG002|Overall Study|Physician Decision|0
7603445|NCT04569786|12010171|FG003|Overall Study|Physician Decision|1
7603446|NCT04569786|12010172|FG004|Overall Study|Physician Decision|0
7603447|NCT04129944|12010193|FG000|Overall Study|Death|0
7603448|NCT04129944|12010194|FG001|Overall Study|Death|0
7603449|NCT04129944|12010195|FG002|Overall Study|Death|0
7603450|NCT04129944|12010196|FG003|Overall Study|Death|1
7603451|NCT04129944|12010193|FG000|Overall Study|Lost to Follow-up|1
7603452|NCT04129944|12010194|FG001|Overall Study|Lost to Follow-up|0
7603453|NCT04129944|12010195|FG002|Overall Study|Lost to Follow-up|0
7603454|NCT04129944|12010196|FG003|Overall Study|Lost to Follow-up|0
7603455|NCT04129944|12010193|FG000|Overall Study|Withdrawal by Subject|1
7603456|NCT04129944|12010194|FG001|Overall Study|Withdrawal by Subject|0
7603457|NCT04129944|12010195|FG002|Overall Study|Withdrawal by Subject|1
7603458|NCT04129944|12010196|FG003|Overall Study|Withdrawal by Subject|2
7603459|NCT03857542|12010217|FG000|Overall Study|Adverse Event|1
7603460|NCT03857542|12010218|FG001|Overall Study|Adverse Event|3
7603461|NCT03857542|12010217|FG000|Overall Study|Withdrawal by Subject|2
7603462|NCT03857542|12010218|FG001|Overall Study|Withdrawal by Subject|1
7603463|NCT03857542|12010217|FG000|Overall Study|Lost to Follow-up|2
7603464|NCT03857542|12010218|FG001|Overall Study|Lost to Follow-up|1
7603465|NCT03857542|12010217|FG000|Overall Study|Reason not Specified|1
7603466|NCT03857542|12010218|FG001|Overall Study|Reason not Specified|0
7774208|NCT00908037|12219945|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7774209|NCT00908037|12219946|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7774210|NCT00908037|12219947|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7774211|NCT00908037|12219948|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7774212|NCT00908037|12219949|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7774213|NCT00908037|12219950|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
7774214|NCT00908037|12219939|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7774215|NCT00908037|12219940|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7774216|NCT00908037|12219941|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7774217|NCT00908037|12219942|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7774218|NCT00908037|12219943|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7774219|NCT00908037|12219944|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7774220|NCT00908037|12219945|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7774221|NCT00908037|12219946|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7774222|NCT00908037|12219947|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7774223|NCT00908037|12219948|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
7774224|NCT00908037|12219949|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7774225|NCT00908037|12219950|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
7603485|NCT03656744|12010252|FG000|Overall Study|Adverse Event|1
7603486|NCT03656744|12010253|FG001|Overall Study|Adverse Event|4
7603487|NCT03656744|12010254|FG002|Overall Study|Adverse Event|1
7603488|NCT03656744|12010252|FG000|Overall Study|Protocol Violation|1
7603489|NCT03656744|12010253|FG001|Overall Study|Protocol Violation|0
7603490|NCT03656744|12010254|FG002|Overall Study|Protocol Violation|0
7603491|NCT03656744|12010252|FG000|Overall Study|Lost to Follow-up|2
7603492|NCT03656744|12010253|FG001|Overall Study|Lost to Follow-up|2
7603493|NCT03656744|12010254|FG002|Overall Study|Lost to Follow-up|0
7603494|NCT03656744|12010252|FG000|Overall Study|Withdrawal by Subject|0
7603495|NCT03656744|12010253|FG001|Overall Study|Withdrawal by Subject|1
7603496|NCT03656744|12010254|FG002|Overall Study|Withdrawal by Subject|0
7603497|NCT03656744|12010252|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1
7603498|NCT03656744|12010253|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0
7603499|NCT03656744|12010254|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0
7603500|NCT03510598|12010262|FG000|Overall Study|Withdrawal by Subject|1
7603501|NCT03487796|12010270|FG000|Overall Study|Lost to Follow-up|18
7603502|NCT03487796|12010271|FG001|Overall Study|Lost to Follow-up|6
7603503|NCT03446612|12010285|FG000|Overall Study|Protocol defined stopping criteria|0
7603504|NCT03446612|12010286|FG001|Overall Study|Protocol defined stopping criteria|1
7603505|NCT03370120|12010307|FG000|Overall Study|Adverse event, non-fatal|24
7603506|NCT03370120|12010307|FG000|Overall Study|Withdrawal by Subject|6
7603507|NCT03370120|12010307|FG000|Overall Study|Lost to Follow-up|1
7603508|NCT03370120|12010307|FG000|Overall Study|Lack of Efficacy|37
7603509|NCT03370120|12010307|FG000|Overall Study|Per sponsor's instructions|1
7603510|NCT03370120|12010307|FG000|Overall Study|Study was terminated by parent company UCB|2
7603511|NCT03370120|12010307|FG000|Overall Study|The study was ended by the promoter|3
7774226|NCT00908037|12219939|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7774227|NCT00908037|12219940|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7774228|NCT00908037|12219941|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7774229|NCT00908037|12219942|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7774230|NCT00908037|12219943|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7774231|NCT00908037|12219944|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7774232|NCT00908037|12219945|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7774233|NCT00908037|12219946|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7774234|NCT00908037|12219947|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7774235|NCT00908037|12219948|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
7774236|NCT00908037|12219949|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7774237|NCT00908037|12219950|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7774238|NCT00908037|12219939|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7774239|NCT00908037|12219940|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7774240|NCT00908037|12219941|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7774241|NCT00908037|12219942|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7774242|NCT00908037|12219943|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7774243|NCT00908037|12219944|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7774244|NCT00908037|12219945|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7774245|NCT00908037|12219946|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7774246|NCT00908037|12219947|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7774247|NCT00908037|12219948|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7774248|NCT00908037|12219949|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
7774249|NCT00908037|12219950|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7774250|NCT00908037|12219939|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7774251|NCT00908037|12219940|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7603512|NCT03370120|12010307|FG000|Overall Study|Discontinuation of drug development|3
7603513|NCT03370120|12010307|FG000|Overall Study|End of project|2
7603514|NCT03370120|12010307|FG000|Overall Study|Premature study closure|2
7603515|NCT03370120|12010307|FG000|Overall Study|Premature program termination|1
7603516|NCT03370120|12010307|FG000|Overall Study|Premature study termination|7
7603517|NCT03370120|12010307|FG000|Overall Study|Trial terminated by sponsor|2
7603518|NCT03370120|12010307|FG000|Overall Study|Trial discontinued by sponsor|2
7603519|NCT03370120|12010307|FG000|Overall Study|Study ended|15
7603520|NCT03370120|12010307|FG000|Overall Study|Clinical trial has been cancelled|1
7603521|NCT03370120|12010307|FG000|Overall Study|End of study per sponsor decision|2
7603522|NCT03370120|12010307|FG000|Overall Study|Promoter's decision|2
7603523|NCT03370120|12010307|FG000|Overall Study|The trial has been suspended|3
7603524|NCT03370120|12010307|FG000|Overall Study|Sponsor stopped PSL development based on data|3
7603525|NCT03370120|12010307|FG000|Overall Study|Early termination by order of sponsor|2
7603526|NCT03370120|12010307|FG000|Overall Study|Discontinuation of the study|5
7603527|NCT03370120|12010307|FG000|Overall Study|End of clinical trial discontinuation|1
7603528|NCT03370120|12010307|FG000|Overall Study|Because the clinical trial ended halfway|4
7603529|NCT03370120|12010307|FG000|Overall Study|Development discontinued|5
7603530|NCT03370120|12010307|FG000|Overall Study|Padsenovil program closed|3
7603531|NCT03370120|12010307|FG000|Overall Study|End of project|2
7603532|NCT03370120|12010307|FG000|Overall Study|Termination of project|1
7603533|NCT03370120|12010307|FG000|Overall Study|The study was interrupted by sponsor|4
7603534|NCT03370120|12010307|FG000|Overall Study|The protocol was interrupted by sponsor|1
7603535|NCT03370120|12010307|FG000|Overall Study|End of sponsor decision|1
7603536|NCT03370120|12010307|FG000|Overall Study|The study was terminated prematurely by study lead|1
7603537|NCT03370120|12010307|FG000|Overall Study|Early termination of studies|5
7603538|NCT03370120|12010307|FG000|Overall Study|This study is ended early|1
7603539|NCT03370120|12010307|FG000|Overall Study|End of padsevonil program|2
7603540|NCT03370120|12010307|FG000|Overall Study|Decision of sponsor|6
7603541|NCT03370120|12010307|FG000|Overall Study|Asked by the sponsor|3
7603542|NCT03370120|12010307|FG000|Overall Study|Sponsor decision to stop the protocol|1
7603543|NCT03370120|12010307|FG000|Overall Study|PI decision poor compliance from participant|1
7603544|NCT03370120|12010307|FG000|Overall Study|Promoter ended the study|3
7603545|NCT03370120|12010307|FG000|Overall Study|Premature study close by sponsor's decision|4
7603546|NCT03370120|12010307|FG000|Overall Study|Study terminated by sponsor|33
7603547|NCT03370120|12010307|FG000|Overall Study|Sponsor prematurely terminated this study|2
7603548|NCT03370120|12010307|FG000|Overall Study|Sponsor decision to terminate study|63
7603549|NCT03370120|12010307|FG000|Overall Study|Program closure|3
7603550|NCT03370120|12010307|FG000|Overall Study|Study ended prematurely|1
7603551|NCT03370120|12010307|FG000|Overall Study|Study stopped by sponsor|2
7603552|NCT03370120|12010307|FG000|Overall Study|Program termination|55
7603553|NCT03370120|12010307|FG000|Overall Study|Sponsor decision|62
7603554|NCT03370120|12010307|FG000|Overall Study|Sponsor study closure|10
7603555|NCT03143829|12010330|FG000|Overall Study|Withdrawal by Subject|2
7603556|NCT03143829|12010331|FG001|Overall Study|Withdrawal by Subject|5
7603557|NCT03143829|12010330|FG000|Overall Study|Lost to Follow-up|0
7603558|NCT03143829|12010331|FG001|Overall Study|Lost to Follow-up|2
7603559|NCT03143829|12010330|FG000|Overall Study|Death|1
7603560|NCT03143829|12010331|FG001|Overall Study|Death|1
7603561|NCT03143829|12010330|FG000|Overall Study|changed treatment, no longer eligible|2
7603562|NCT03143829|12010331|FG001|Overall Study|changed treatment, no longer eligible|2
7603563|NCT02963610|12010346|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3
7603564|NCT02766335|12010353|FG000|Initial Registration|Adverse Event|6
7603565|NCT02766335|12010354|FG001|Initial Registration|Adverse Event|3
7603566|NCT02766335|12010355|FG002|Initial Registration|Adverse Event|0
7603567|NCT02766335|12010353|FG000|Initial Registration|Refusal unrelated to adverse event|1
7603568|NCT02766335|12010354|FG001|Initial Registration|Refusal unrelated to adverse event|0
7603569|NCT02766335|12010355|FG002|Initial Registration|Refusal unrelated to adverse event|0
7603570|NCT02766335|12010353|FG000|Initial Registration|Progression/relapse|49
7603571|NCT02766335|12010354|FG001|Initial Registration|Progression/relapse|15
7603572|NCT02766335|12010355|FG002|Initial Registration|Progression/relapse|0
7603573|NCT02766335|12010353|FG000|Initial Registration|Death|1
7603574|NCT02766335|12010354|FG001|Initial Registration|Death|3
7603575|NCT02766335|12010355|FG002|Initial Registration|Death|0
7603576|NCT02766335|12010353|FG000|Initial Registration|not protocol specified|1
7603577|NCT02766335|12010354|FG001|Initial Registration|not protocol specified|9
7603578|NCT02766335|12010355|FG002|Initial Registration|not protocol specified|0
7603579|NCT02766335|12010353|FG000|Re-registration of Arm I to MEDI4738|Death|0
7603580|NCT02766335|12010354|FG001|Re-registration of Arm I to MEDI4738|Death|0
7603581|NCT02766335|12010355|FG002|Re-registration of Arm I to MEDI4738|Death|1
7603582|NCT02766335|12010353|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0
7603583|NCT02766335|12010354|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0
7603584|NCT02766335|12010355|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1
7603585|NCT02606136|12010361|FG000|Overall Study|Participant/Legal Guardian Decision|5
7603586|NCT02606136|12010361|FG000|Overall Study|Withdrawal by Subject|1
7603587|NCT02228382|12010370|FG000|Overall Study|Death|5
7603588|NCT02228382|12010371|FG001|Overall Study|Death|7
7603589|NCT02228382|12010372|FG002|Overall Study|Death|5
7603590|NCT02228382|12010373|FG003|Overall Study|Death|0
7603591|NCT02228382|12010374|FG004|Overall Study|Death|2
7603592|NCT02228382|12010370|FG000|Overall Study|Participant refused further follow-up|0
7603593|NCT02228382|12010371|FG001|Overall Study|Participant refused further follow-up|0
7603594|NCT02228382|12010372|FG002|Overall Study|Participant refused further follow-up|1
7603595|NCT02228382|12010373|FG003|Overall Study|Participant refused further follow-up|0
7603596|NCT02228382|12010374|FG004|Overall Study|Participant refused further follow-up|0
7603597|NCT02228382|12010370|FG000|Overall Study|Study terminated by sponsor|3
7603598|NCT02228382|12010371|FG001|Overall Study|Study terminated by sponsor|5
7603599|NCT02228382|12010372|FG002|Overall Study|Study terminated by sponsor|7
7603600|NCT02228382|12010373|FG003|Overall Study|Study terminated by sponsor|0
7603601|NCT02228382|12010374|FG004|Overall Study|Study terminated by sponsor|0
7603602|NCT02228382|12010370|FG000|Overall Study|Lost to Follow-up|0
7603603|NCT02228382|12010371|FG001|Overall Study|Lost to Follow-up|0
7603604|NCT02228382|12010372|FG002|Overall Study|Lost to Follow-up|3
7603605|NCT02228382|12010373|FG003|Overall Study|Lost to Follow-up|1
7603606|NCT02228382|12010374|FG004|Overall Study|Lost to Follow-up|0
7603607|NCT02228382|12010370|FG000|Overall Study|Withdrawal by Subject|0
7603608|NCT02228382|12010371|FG001|Overall Study|Withdrawal by Subject|3
7603609|NCT02228382|12010372|FG002|Overall Study|Withdrawal by Subject|2
7603610|NCT02228382|12010373|FG003|Overall Study|Withdrawal by Subject|1
7603611|NCT02228382|12010374|FG004|Overall Study|Withdrawal by Subject|0
7603612|NCT02228382|12010370|FG000|Overall Study|Other|2
7603613|NCT02228382|12010371|FG001|Overall Study|Other|3
7603614|NCT02228382|12010372|FG002|Overall Study|Other|3
7603615|NCT02228382|12010373|FG003|Overall Study|Other|0
7774252|NCT00908037|12219941|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7774253|NCT00908037|12219942|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7774254|NCT00908037|12219943|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7774255|NCT00908037|12219944|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7774256|NCT00908037|12219945|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7774257|NCT00908037|12219946|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7774258|NCT00908037|12219947|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7774259|NCT00908037|12219948|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
7774260|NCT00908037|12219949|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7774261|NCT00908037|12219950|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7774262|NCT00908037|12219939|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7774263|NCT00908037|12219940|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7774264|NCT00908037|12219941|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7774265|NCT00908037|12219942|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7774266|NCT00908037|12219943|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7774267|NCT00908037|12219944|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7774268|NCT00908037|12219945|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7774269|NCT00908037|12219946|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7774270|NCT00908037|12219947|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7774271|NCT00908037|12219948|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7774272|NCT00908037|12219949|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
7774273|NCT00908037|12219950|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7774274|NCT00908076|12220004|FG000|Overall Study|Lack of Efficacy|1
7774275|NCT00908076|12220005|FG001|Overall Study|Lack of Efficacy|1
7774276|NCT00908115|12220011|FG000|Overall Study|Other|14
7774277|NCT00908141|12220017|FG000|Overall Study|Withdrawal by Subject|0
7774278|NCT00908141|12220018|FG001|Overall Study|Withdrawal by Subject|1
7774279|NCT00908232|12220024|FG000|Cycle 1 to 4|Death|5
7774280|NCT00908232|12220025|FG001|Cycle 1 to 4|Death|0
7774281|NCT00908232|12220026|FG002|Cycle 1 to 4|Death|0
7774282|NCT00908232|12220027|FG003|Cycle 1 to 4|Death|0
7603616|NCT02228382|12010374|FG004|Overall Study|Other|0
7603617|NCT02001623|12010424|FG000|Overall Study|Disease Progression|2
7603618|NCT02001623|12010425|FG001|Overall Study|Disease Progression|2
7603619|NCT02001623|12010426|FG002|Overall Study|Disease Progression|3
7603620|NCT02001623|12010427|FG003|Overall Study|Disease Progression|2
7603621|NCT02001623|12010428|FG004|Overall Study|Disease Progression|3
7603622|NCT02001623|12010429|FG005|Overall Study|Disease Progression|2
7603623|NCT02001623|12010430|FG006|Overall Study|Disease Progression|3
7603624|NCT02001623|12010431|FG007|Overall Study|Disease Progression|3
7603625|NCT02001623|12010432|FG008|Overall Study|Disease Progression|7
7603626|NCT02001623|12010433|FG009|Overall Study|Disease Progression|40
7603627|NCT02001623|12010434|FG010|Overall Study|Disease Progression|5
7603628|NCT02001623|12010435|FG011|Overall Study|Disease Progression|9
7603629|NCT02001623|12010436|FG012|Overall Study|Disease Progression|9
7603630|NCT02001623|12010437|FG013|Overall Study|Disease Progression|20
7603631|NCT02001623|12010438|FG014|Overall Study|Disease Progression|9
7603632|NCT02001623|12010424|FG000|Overall Study|Physician Decision|0
7603633|NCT02001623|12010425|FG001|Overall Study|Physician Decision|0
7603634|NCT02001623|12010426|FG002|Overall Study|Physician Decision|0
7603635|NCT02001623|12010427|FG003|Overall Study|Physician Decision|0
7603636|NCT02001623|12010428|FG004|Overall Study|Physician Decision|0
7603637|NCT02001623|12010429|FG005|Overall Study|Physician Decision|0
7603638|NCT02001623|12010430|FG006|Overall Study|Physician Decision|0
7603639|NCT02001623|12010431|FG007|Overall Study|Physician Decision|0
7603640|NCT02001623|12010432|FG008|Overall Study|Physician Decision|3
7603641|NCT02001623|12010433|FG009|Overall Study|Physician Decision|2
7603642|NCT02001623|12010434|FG010|Overall Study|Physician Decision|3
7603643|NCT02001623|12010435|FG011|Overall Study|Physician Decision|3
7603644|NCT02001623|12010436|FG012|Overall Study|Physician Decision|1
7603645|NCT02001623|12010437|FG013|Overall Study|Physician Decision|2
7603646|NCT02001623|12010438|FG014|Overall Study|Physician Decision|1
7603647|NCT02001623|12010424|FG000|Overall Study|Death|0
7603648|NCT02001623|12010425|FG001|Overall Study|Death|1
7603649|NCT02001623|12010426|FG002|Overall Study|Death|0
7603650|NCT02001623|12010427|FG003|Overall Study|Death|0
7603651|NCT02001623|12010428|FG004|Overall Study|Death|0
7603652|NCT02001623|12010429|FG005|Overall Study|Death|0
7603653|NCT02001623|12010430|FG006|Overall Study|Death|0
7603654|NCT02001623|12010431|FG007|Overall Study|Death|0
7603655|NCT02001623|12010432|FG008|Overall Study|Death|0
7603656|NCT02001623|12010433|FG009|Overall Study|Death|0
7603657|NCT02001623|12010434|FG010|Overall Study|Death|0
7603658|NCT02001623|12010435|FG011|Overall Study|Death|0
7603659|NCT02001623|12010436|FG012|Overall Study|Death|0
7603660|NCT02001623|12010437|FG013|Overall Study|Death|0
7603661|NCT02001623|12010438|FG014|Overall Study|Death|0
7603662|NCT02001623|12010424|FG000|Overall Study|Adverse Event|0
7603663|NCT02001623|12010425|FG001|Overall Study|Adverse Event|0
7603664|NCT02001623|12010426|FG002|Overall Study|Adverse Event|0
7603665|NCT02001623|12010427|FG003|Overall Study|Adverse Event|0
7603666|NCT02001623|12010428|FG004|Overall Study|Adverse Event|0
7603667|NCT02001623|12010429|FG005|Overall Study|Adverse Event|1
7603668|NCT02001623|12010430|FG006|Overall Study|Adverse Event|0
7603669|NCT02001623|12010431|FG007|Overall Study|Adverse Event|3
7603670|NCT02001623|12010432|FG008|Overall Study|Adverse Event|4
7603671|NCT02001623|12010433|FG009|Overall Study|Adverse Event|6
7603672|NCT02001623|12010434|FG010|Overall Study|Adverse Event|4
7603673|NCT02001623|12010435|FG011|Overall Study|Adverse Event|0
7603674|NCT02001623|12010436|FG012|Overall Study|Adverse Event|3
7603675|NCT02001623|12010437|FG013|Overall Study|Adverse Event|5
7603676|NCT02001623|12010438|FG014|Overall Study|Adverse Event|6
7603677|NCT02001623|12010424|FG000|Overall Study|Other - Miscellaneous|0
7603678|NCT02001623|12010425|FG001|Overall Study|Other - Miscellaneous|0
7603679|NCT02001623|12010426|FG002|Overall Study|Other - Miscellaneous|0
7603680|NCT02001623|12010427|FG003|Overall Study|Other - Miscellaneous|0
7603681|NCT02001623|12010428|FG004|Overall Study|Other - Miscellaneous|0
7603682|NCT02001623|12010429|FG005|Overall Study|Other - Miscellaneous|0
7603683|NCT02001623|12010430|FG006|Overall Study|Other - Miscellaneous|0
7603684|NCT02001623|12010431|FG007|Overall Study|Other - Miscellaneous|0
7603685|NCT02001623|12010432|FG008|Overall Study|Other - Miscellaneous|0
7603686|NCT02001623|12010433|FG009|Overall Study|Other - Miscellaneous|1
7603687|NCT02001623|12010434|FG010|Overall Study|Other - Miscellaneous|0
7603688|NCT02001623|12010435|FG011|Overall Study|Other - Miscellaneous|0
7603689|NCT02001623|12010436|FG012|Overall Study|Other - Miscellaneous|0
7603690|NCT02001623|12010437|FG013|Overall Study|Other - Miscellaneous|1
7603691|NCT02001623|12010438|FG014|Overall Study|Other - Miscellaneous|0
7603692|NCT02001623|12010424|FG000|Overall Study|Withdrawal by Subject|1
7603693|NCT02001623|12010425|FG001|Overall Study|Withdrawal by Subject|0
7603694|NCT02001623|12010426|FG002|Overall Study|Withdrawal by Subject|0
7603695|NCT02001623|12010427|FG003|Overall Study|Withdrawal by Subject|0
7603696|NCT02001623|12010428|FG004|Overall Study|Withdrawal by Subject|0
7603697|NCT02001623|12010429|FG005|Overall Study|Withdrawal by Subject|0
7603698|NCT02001623|12010430|FG006|Overall Study|Withdrawal by Subject|0
7603699|NCT02001623|12010431|FG007|Overall Study|Withdrawal by Subject|0
7603700|NCT02001623|12010432|FG008|Overall Study|Withdrawal by Subject|1
7603701|NCT02001623|12010433|FG009|Overall Study|Withdrawal by Subject|3
7603702|NCT02001623|12010434|FG010|Overall Study|Withdrawal by Subject|2
7603703|NCT02001623|12010435|FG011|Overall Study|Withdrawal by Subject|2
7603704|NCT02001623|12010436|FG012|Overall Study|Withdrawal by Subject|1
7603705|NCT02001623|12010437|FG013|Overall Study|Withdrawal by Subject|5
7603706|NCT02001623|12010438|FG014|Overall Study|Withdrawal by Subject|2
7603707|NCT02001623|12010424|FG000|Overall Study|Lost to Follow-up|0
7603708|NCT02001623|12010425|FG001|Overall Study|Lost to Follow-up|0
7603709|NCT02001623|12010426|FG002|Overall Study|Lost to Follow-up|0
7603710|NCT02001623|12010427|FG003|Overall Study|Lost to Follow-up|0
7603711|NCT02001623|12010428|FG004|Overall Study|Lost to Follow-up|0
7603712|NCT02001623|12010429|FG005|Overall Study|Lost to Follow-up|0
7603713|NCT02001623|12010430|FG006|Overall Study|Lost to Follow-up|0
7603714|NCT02001623|12010431|FG007|Overall Study|Lost to Follow-up|0
7603715|NCT02001623|12010432|FG008|Overall Study|Lost to Follow-up|0
7603716|NCT02001623|12010433|FG009|Overall Study|Lost to Follow-up|1
7603717|NCT02001623|12010434|FG010|Overall Study|Lost to Follow-up|0
7603718|NCT02001623|12010435|FG011|Overall Study|Lost to Follow-up|0
7603719|NCT02001623|12010436|FG012|Overall Study|Lost to Follow-up|0
7603720|NCT02001623|12010437|FG013|Overall Study|Lost to Follow-up|0
7603721|NCT02001623|12010438|FG014|Overall Study|Lost to Follow-up|0
7603722|NCT02001623|12010424|FG000|Overall Study|Start of New Anti-cancer Treatment|0
7603723|NCT02001623|12010425|FG001|Overall Study|Start of New Anti-cancer Treatment|0
7603859|NCT03215706|12010659|FG001|Randomization|other reasons|2
7603724|NCT02001623|12010426|FG002|Overall Study|Start of New Anti-cancer Treatment|0
7603725|NCT02001623|12010427|FG003|Overall Study|Start of New Anti-cancer Treatment|0
7603726|NCT02001623|12010428|FG004|Overall Study|Start of New Anti-cancer Treatment|0
7603727|NCT02001623|12010429|FG005|Overall Study|Start of New Anti-cancer Treatment|0
7603728|NCT02001623|12010430|FG006|Overall Study|Start of New Anti-cancer Treatment|0
7603729|NCT02001623|12010431|FG007|Overall Study|Start of New Anti-cancer Treatment|0
7603730|NCT02001623|12010432|FG008|Overall Study|Start of New Anti-cancer Treatment|0
7603731|NCT02001623|12010433|FG009|Overall Study|Start of New Anti-cancer Treatment|0
7603732|NCT02001623|12010434|FG010|Overall Study|Start of New Anti-cancer Treatment|0
7603733|NCT02001623|12010435|FG011|Overall Study|Start of New Anti-cancer Treatment|1
7603734|NCT02001623|12010436|FG012|Overall Study|Start of New Anti-cancer Treatment|0
7603735|NCT02001623|12010437|FG013|Overall Study|Start of New Anti-cancer Treatment|1
7603736|NCT02001623|12010438|FG014|Overall Study|Start of New Anti-cancer Treatment|0
7603737|NCT02001623|12010424|FG000|Overall Study|Dose Delay Due to Toxicity|0
7603738|NCT02001623|12010425|FG001|Overall Study|Dose Delay Due to Toxicity|0
7603739|NCT02001623|12010426|FG002|Overall Study|Dose Delay Due to Toxicity|0
7603740|NCT02001623|12010427|FG003|Overall Study|Dose Delay Due to Toxicity|0
7603741|NCT02001623|12010428|FG004|Overall Study|Dose Delay Due to Toxicity|0
7603742|NCT02001623|12010429|FG005|Overall Study|Dose Delay Due to Toxicity|0
7603743|NCT02001623|12010430|FG006|Overall Study|Dose Delay Due to Toxicity|0
7603744|NCT02001623|12010431|FG007|Overall Study|Dose Delay Due to Toxicity|0
7603745|NCT02001623|12010432|FG008|Overall Study|Dose Delay Due to Toxicity|0
7603746|NCT02001623|12010433|FG009|Overall Study|Dose Delay Due to Toxicity|0
7603747|NCT02001623|12010434|FG010|Overall Study|Dose Delay Due to Toxicity|0
7603748|NCT02001623|12010435|FG011|Overall Study|Dose Delay Due to Toxicity|0
7603749|NCT02001623|12010436|FG012|Overall Study|Dose Delay Due to Toxicity|0
7603750|NCT02001623|12010437|FG013|Overall Study|Dose Delay Due to Toxicity|1
7603751|NCT02001623|12010438|FG014|Overall Study|Dose Delay Due to Toxicity|0
7603752|NCT01900002|12010487|FG000|Overall Study|Withdrawal by Subject|2
7603753|NCT01900002|12010487|FG000|Overall Study|ineligible for Y-90|4
7603754|NCT01595061|12010491|FG000|Overall Study|Never Treated|3
7603755|NCT01595061|12010491|FG000|Overall Study|Inadequate Pathology|1
7774283|NCT00908232|12220024|FG000|Cycle 1 to 4|Withdrawal by Subject|4
7774284|NCT00908232|12220025|FG001|Cycle 1 to 4|Withdrawal by Subject|0
7774285|NCT00908232|12220026|FG002|Cycle 1 to 4|Withdrawal by Subject|0
7774286|NCT00908232|12220027|FG003|Cycle 1 to 4|Withdrawal by Subject|0
7774287|NCT00908232|12220024|FG000|Cycle 1 to 4|Progressive Disease|6
7774288|NCT00908232|12220025|FG001|Cycle 1 to 4|Progressive Disease|0
7774289|NCT00908232|12220026|FG002|Cycle 1 to 4|Progressive Disease|0
7774290|NCT00908232|12220027|FG003|Cycle 1 to 4|Progressive Disease|0
7774291|NCT00908232|12220024|FG000|Cycle 1 to 4|Adverse Event|12
7774292|NCT00908232|12220025|FG001|Cycle 1 to 4|Adverse Event|0
7774293|NCT00908232|12220026|FG002|Cycle 1 to 4|Adverse Event|0
7774294|NCT00908232|12220027|FG003|Cycle 1 to 4|Adverse Event|0
7774295|NCT00908232|12220024|FG000|Cycle 1 to 4|Other|1
7774296|NCT00908232|12220025|FG001|Cycle 1 to 4|Other|0
7774297|NCT00908232|12220026|FG002|Cycle 1 to 4|Other|0
7774298|NCT00908232|12220027|FG003|Cycle 1 to 4|Other|0
7774299|NCT00908232|12220024|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
7774300|NCT00908232|12220025|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
7774301|NCT00908232|12220026|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
7774302|NCT00908232|12220027|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
7774303|NCT00908232|12220024|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
7774304|NCT00908232|12220025|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
7774305|NCT00908232|12220026|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
7774306|NCT00908232|12220027|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
7774307|NCT00908232|12220024|FG000|Randomization (Cycle 5) to Cycle 8|Death|2
7774308|NCT00908232|12220025|FG001|Randomization (Cycle 5) to Cycle 8|Death|0
7774309|NCT00908232|12220026|FG002|Randomization (Cycle 5) to Cycle 8|Death|0
7774310|NCT00908232|12220027|FG003|Randomization (Cycle 5) to Cycle 8|Death|0
7603756|NCT04502212|12010495|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1
7603757|NCT04502212|12010495|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1
7603758|NCT04794803|12010511|FG000|Overall Study|Death|1
7603759|NCT04794803|12010512|FG001|Overall Study|Death|3
7603760|NCT04794803|12010511|FG000|Overall Study|Lost to Follow-up|2
7603761|NCT04794803|12010512|FG001|Overall Study|Lost to Follow-up|2
7603762|NCT04794803|12010511|FG000|Overall Study|Withdrawal by Subject|1
7603763|NCT04794803|12010512|FG001|Overall Study|Withdrawal by Subject|0
7603764|NCT04794803|12010511|FG000|Overall Study|Physician Decision|1
7603765|NCT04794803|12010512|FG001|Overall Study|Physician Decision|1
7603766|NCT04794803|12010511|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4
7603767|NCT04794803|12010512|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1
7603768|NCT04794803|12010511|FG000|Overall Study|Refused to continue the treatment|1
7603769|NCT04794803|12010512|FG001|Overall Study|Refused to continue the treatment|0
7603770|NCT04794803|12010511|FG000|Overall Study|Patient admitted to ICU|0
7603771|NCT04794803|12010512|FG001|Overall Study|Patient admitted to ICU|1
7603772|NCT04706403|12010523|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0
7603773|NCT04706403|12010524|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0
7603774|NCT04706403|12010525|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1
7603775|NCT04706403|12010526|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1
7603776|NCT04706403|12010527|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2
7603777|NCT04440449|12010541|FG000|Overall Study|Lost to Follow-up|2
7603778|NCT04440449|12010542|FG001|Overall Study|Lost to Follow-up|0
7603779|NCT04369469|12010551|FG000|Overall Study|Lost to Follow-up|2
7603780|NCT04369469|12010552|FG001|Overall Study|Lost to Follow-up|4
7603781|NCT04369469|12010551|FG000|Overall Study|Physician Decision|2
7603782|NCT04369469|12010552|FG001|Overall Study|Physician Decision|1
7603783|NCT04369469|12010551|FG000|Overall Study|Withdrawal by Subject|2
7603784|NCT04369469|12010552|FG001|Overall Study|Withdrawal by Subject|3
7603785|NCT04369469|12010551|FG000|Overall Study|Adverse Event|1
7603786|NCT04369469|12010552|FG001|Overall Study|Adverse Event|0
7603787|NCT04369469|12010551|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2
7603788|NCT04369469|12010552|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0
7603789|NCT04369469|12010551|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1
7603790|NCT04369469|12010552|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0
7603791|NCT04369469|12010551|FG000|Overall Study|Unable to Provide Consent|0
7603792|NCT04369469|12010552|FG001|Overall Study|Unable to Provide Consent|1
7603809|NCT03772574|12010582|FG000|Overall Study|Protocol Violation|2
7603810|NCT03772574|12010583|FG001|Overall Study|Protocol Violation|0
7603811|NCT03772574|12010584|FG002|Overall Study|Protocol Violation|0
7603812|NCT03772574|12010582|FG000|Overall Study|Discomfort|0
7603813|NCT03772574|12010583|FG001|Overall Study|Discomfort|5
7603814|NCT03772574|12010584|FG002|Overall Study|Discomfort|4
7603815|NCT03594955|12010592|FG000|Overall Study|Adverse Event|1
7603816|NCT03594955|12010592|FG000|Overall Study|Progressive disease|5
7603817|NCT03594955|12010592|FG000|Overall Study|Sponsor's decision|1
7603818|NCT03548220|12010600|FG000|Overall Study|Lost to Follow-up|1
7603819|NCT03548220|12010601|FG001|Overall Study|Lost to Follow-up|0
7603820|NCT03548220|12010602|FG002|Overall Study|Lost to Follow-up|0
7603821|NCT03548220|12010603|FG003|Overall Study|Lost to Follow-up|0
7774311|NCT00908232|12220024|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
7603822|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1
7603823|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0
7603824|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2
7603825|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1
7603826|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3
7603827|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14
7603828|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7
7603829|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2
7603830|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1
7603831|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0
7603832|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2
7603833|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2
7603834|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0
7603835|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1
7603836|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2
7603837|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0
7603838|NCT03434041|12010629|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4
7603839|NCT03434041|12010630|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3
7603840|NCT03434041|12010629|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2
7603841|NCT03434041|12010630|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0
7603842|NCT03434041|12010629|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1
7603843|NCT03434041|12010630|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0
7603844|NCT03420222|12010640|FG000|Overall Study|Withdrawal by Subject|5
7603845|NCT03420222|12010641|FG001|Overall Study|Withdrawal by Subject|0
7603846|NCT03420222|12010640|FG000|Overall Study|Physician Decision|0
7603847|NCT03420222|12010641|FG001|Overall Study|Physician Decision|1
7603848|NCT03409796|12010649|FG000|Overall Study|Adverse Event|2
7603849|NCT03409796|12010650|FG001|Overall Study|Adverse Event|0
7603850|NCT03409796|12010649|FG000|Overall Study|Other|0
7603851|NCT03409796|12010650|FG001|Overall Study|Other|1
7774312|NCT00908232|12220025|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
7774313|NCT00908232|12220026|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
7774314|NCT00908232|12220027|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
7603852|NCT03215706|12010658|FG000|Randomization|Adverse Event unrelated to study drug|1
7603853|NCT03215706|12010659|FG001|Randomization|Adverse Event unrelated to study drug|0
7603854|NCT03215706|12010658|FG000|Randomization|participant withdrew consent|1
7603855|NCT03215706|12010659|FG001|Randomization|participant withdrew consent|3
7603856|NCT03215706|12010658|FG000|Randomization|no longer meets study criteria|1
7603857|NCT03215706|12010659|FG001|Randomization|no longer meets study criteria|4
7603858|NCT03215706|12010658|FG000|Randomization|other reasons|0
7603860|NCT03215706|12010658|FG000|Treatment Period|Disease Progression|150
7603861|NCT03215706|12010659|FG001|Treatment Period|Disease Progression|142
7603862|NCT03215706|12010658|FG000|Treatment Period|Study Drug Toxicity|53
7603863|NCT03215706|12010659|FG001|Treatment Period|Study Drug Toxicity|21
7603864|NCT03215706|12010658|FG000|Treatment Period|Death|2
7603865|NCT03215706|12010659|FG001|Treatment Period|Death|1
7603866|NCT03215706|12010658|FG000|Treatment Period|Adverse event unrelated to study drug|24
7603867|NCT03215706|12010659|FG001|Treatment Period|Adverse event unrelated to study drug|23
7603868|NCT03215706|12010658|FG000|Treatment Period|Request to D/C treatment|1
7603869|NCT03215706|12010659|FG001|Treatment Period|Request to D/C treatment|6
7603870|NCT03215706|12010658|FG000|Treatment Period|Participant withdrew consent|3
7603871|NCT03215706|12010659|FG001|Treatment Period|Participant withdrew consent|4
7603872|NCT03215706|12010658|FG000|Treatment Period|Lost to Follow-up|0
7603873|NCT03215706|12010659|FG001|Treatment Period|Lost to Follow-up|1
7603874|NCT03215706|12010658|FG000|Treatment Period|Other Reasons|4
7603875|NCT03215706|12010659|FG001|Treatment Period|Other Reasons|5
7603876|NCT03215706|12010658|FG000|Treatment Period|Ongoing in the treatment period|105
7603877|NCT03215706|12010659|FG001|Treatment Period|Ongoing in the treatment period|43
7774315|NCT00908232|12220024|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
7774316|NCT00908232|12220025|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
7774317|NCT00908232|12220026|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
7774318|NCT00908232|12220027|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
7774319|NCT00908232|12220024|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
7774320|NCT00908232|12220025|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
7774321|NCT00908232|12220026|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
7774322|NCT00908232|12220027|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
7774323|NCT00908232|12220024|FG000|Randomization (Cycle 5) to Cycle 8|Other|3
7774324|NCT00908232|12220025|FG001|Randomization (Cycle 5) to Cycle 8|Other|1
7774325|NCT00908232|12220026|FG002|Randomization (Cycle 5) to Cycle 8|Other|0
7774326|NCT00908232|12220027|FG003|Randomization (Cycle 5) to Cycle 8|Other|0
7774327|NCT00908232|12220024|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
7774328|NCT00908232|12220025|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
7774329|NCT00908232|12220026|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
7774330|NCT00908232|12220027|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
7774331|NCT00908310|12220033|FG000|Overall Study|Death|37
7774332|NCT00908310|12220033|FG000|Overall Study|Withdrawal by Subject|7
7774333|NCT00908310|12220033|FG000|Overall Study|Lost to Follow-up|7
7774334|NCT00908310|12220033|FG000|Overall Study|Screening failure|5
7774335|NCT00908310|12220033|FG000|Overall Study|Other reasons|4
7774336|NCT00908349|12220037|FG000|Overall Study|Adverse Event|10
7603898|NCT03093350|12010700|FG000|Overall Study|Death|1
7603899|NCT03093350|12010700|FG000|Overall Study|Signed consent, never began treartment|1
7603900|NCT02999854|12010713|FG000|Active Study Phase (up to 18 Months)|Screen failures|7
7603901|NCT02999854|12010714|FG001|Active Study Phase (up to 18 Months)|Screen failures|2
7603902|NCT02999854|12010713|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8
7603903|NCT02999854|12010714|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2
7603904|NCT02999854|12010713|FG000|Active Study Phase (up to 18 Months)|Death|7
7603905|NCT02999854|12010714|FG001|Active Study Phase (up to 18 Months)|Death|5
7603906|NCT02999854|12010713|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1
7603907|NCT02999854|12010714|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0
7603908|NCT02999854|12010713|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1
7603909|NCT02999854|12010714|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0
7603910|NCT02999854|12010713|FG000|Long Term Safety FU (up to 24 Months)|Death|1
7603911|NCT02999854|12010714|FG001|Long Term Safety FU (up to 24 Months)|Death|1
7603912|NCT02999854|12010713|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1
7603913|NCT02999854|12010714|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1
7603914|NCT02999854|12010713|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1
7603915|NCT02999854|12010714|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1
7603916|NCT02960763|12010725|FG000|Step 1|Withdrawal by Subject|10
7603917|NCT02960763|12010726|FG001|Step 1|Withdrawal by Subject|8
7603918|NCT02960763|12010727|FG002|Step 1|Withdrawal by Subject|13
7603919|NCT02960763|12010728|FG003|Step 1|Withdrawal by Subject|0
7603920|NCT02960763|12010729|FG004|Step 1|Withdrawal by Subject|0
7603921|NCT02960763|12010725|FG000|Step 1|Lost to Follow-up|7
7603922|NCT02960763|12010726|FG001|Step 1|Lost to Follow-up|9
7603923|NCT02960763|12010727|FG002|Step 1|Lost to Follow-up|13
7603924|NCT02960763|12010728|FG003|Step 1|Lost to Follow-up|0
7603925|NCT02960763|12010729|FG004|Step 1|Lost to Follow-up|0
7603926|NCT02960763|12010725|FG000|Step 1|Death|1
7603927|NCT02960763|12010726|FG001|Step 1|Death|1
7603928|NCT02960763|12010727|FG002|Step 1|Death|1
7603929|NCT02960763|12010728|FG003|Step 1|Death|0
7603930|NCT02960763|12010729|FG004|Step 1|Death|0
7603931|NCT02960763|12010725|FG000|Step 1|Investigator discretion|1
7603932|NCT02960763|12010726|FG001|Step 1|Investigator discretion|0
7603933|NCT02960763|12010727|FG002|Step 1|Investigator discretion|1
7603934|NCT02960763|12010728|FG003|Step 1|Investigator discretion|0
7603935|NCT02960763|12010729|FG004|Step 1|Investigator discretion|0
7603936|NCT02960763|12010725|FG000|Step 2|Withdrawal by Subject|0
7603937|NCT02960763|12010726|FG001|Step 2|Withdrawal by Subject|0
7603938|NCT02960763|12010727|FG002|Step 2|Withdrawal by Subject|0
7603939|NCT02960763|12010728|FG003|Step 2|Withdrawal by Subject|7
7603940|NCT02960763|12010729|FG004|Step 2|Withdrawal by Subject|3
7603941|NCT02960763|12010725|FG000|Step 2|Lost to Follow-up|0
7603942|NCT02960763|12010726|FG001|Step 2|Lost to Follow-up|0
7603943|NCT02960763|12010727|FG002|Step 2|Lost to Follow-up|0
7603944|NCT02960763|12010728|FG003|Step 2|Lost to Follow-up|4
7603945|NCT02960763|12010729|FG004|Step 2|Lost to Follow-up|1
7603946|NCT02960763|12010725|FG000|Step 2|Investigator discretion|0
7603947|NCT02960763|12010726|FG001|Step 2|Investigator discretion|0
7603948|NCT02960763|12010727|FG002|Step 2|Investigator discretion|0
7603949|NCT02960763|12010728|FG003|Step 2|Investigator discretion|0
7603950|NCT02960763|12010729|FG004|Step 2|Investigator discretion|1
7603951|NCT02839343|12010743|FG000|Overall Study|Withdrawal by Subject|3
7603952|NCT02839343|12010744|FG001|Overall Study|Withdrawal by Subject|1
7603953|NCT02839343|12010743|FG000|Overall Study|Disease Progression Prior to Treatment|1
7603954|NCT02839343|12010744|FG001|Overall Study|Disease Progression Prior to Treatment|0
7603955|NCT02839343|12010743|FG000|Overall Study|Adverse Event|1
7603956|NCT02839343|12010744|FG001|Overall Study|Adverse Event|0
7603957|NCT02819479|12010750|FG000|Overall Study|Adverse Event|2
7603958|NCT02601313|12010758|FG000|Overall Study|Death|2
7603959|NCT02601313|12010759|FG001|Overall Study|Death|16
7603960|NCT02601313|12010760|FG002|Overall Study|Death|4
7603961|NCT02601313|12010758|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0
7603962|NCT02601313|12010759|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5
7603963|NCT02601313|12010760|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2
7603964|NCT02601313|12010758|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0
7603965|NCT02601313|12010759|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1
7603966|NCT02601313|12010760|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1
7603967|NCT02601313|12010758|FG000|Overall Study|Still on study|0
7603968|NCT02601313|12010759|FG001|Overall Study|Still on study|52
7603969|NCT02601313|12010760|FG002|Overall Study|Still on study|10
7603970|NCT02601313|12010758|FG000|Overall Study|Enrolled, did not initiate AC|4
7603971|NCT02601313|12010759|FG001|Overall Study|Enrolled, did not initiate AC|0
7603972|NCT02601313|12010760|FG002|Overall Study|Enrolled, did not initiate AC|0
7774337|NCT00908349|12220037|FG000|Overall Study|Withdrawal by Subject|9
7774338|NCT00908349|12220037|FG000|Overall Study|Physician Decision|5
7774339|NCT00908349|12220037|FG000|Overall Study|Lost to Follow-up|5
7774340|NCT00908349|12220037|FG000|Overall Study|Various|6
7603977|NCT02438722|12010790|FG000|Overall Study|Adverse Event|12
7603978|NCT02438722|12010791|FG001|Overall Study|Adverse Event|9
7603979|NCT02438722|12010790|FG000|Overall Study|Refusal unrelated to AE|2
7603980|NCT02438722|12010791|FG001|Overall Study|Refusal unrelated to AE|5
7603981|NCT02438722|12010790|FG000|Overall Study|Disease progression/relapse|46
7603982|NCT02438722|12010791|FG001|Overall Study|Disease progression/relapse|51
7603983|NCT02438722|12010790|FG000|Overall Study|Death|0
7603984|NCT02438722|12010791|FG001|Overall Study|Death|3
7603985|NCT02438722|12010790|FG000|Overall Study|Physician Decision|2
7603986|NCT02438722|12010791|FG001|Overall Study|Physician Decision|2
7603987|NCT02438722|12010790|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1
7603988|NCT02438722|12010791|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0
7603989|NCT02438722|12010790|FG000|Overall Study|Withdrawal by Subject|0
7603990|NCT02438722|12010791|FG001|Overall Study|Withdrawal by Subject|1
7603991|NCT02438722|12010790|FG000|Overall Study|On protocol treatment|15
7603992|NCT02438722|12010791|FG001|Overall Study|On protocol treatment|14
7603993|NCT02438722|12010790|FG000|Overall Study|Did not receive protocol treatment|5
7603994|NCT02438722|12010791|FG001|Overall Study|Did not receive protocol treatment|0
7774341|NCT00908375|12220043|FG000|Overall Study|Withdrawal by Subject|2
7774342|NCT00908375|12220044|FG001|Overall Study|Withdrawal by Subject|4
7774343|NCT00908375|12220043|FG000|Overall Study|Lost to Follow-up|8
7774344|NCT00908375|12220044|FG001|Overall Study|Lost to Follow-up|6
7774345|NCT00908544|12220065|FG000|Overall Study|Withdrawal by Subject|2
7774346|NCT00908544|12220066|FG001|Overall Study|Withdrawal by Subject|4
7774347|NCT00908544|12220065|FG000|Overall Study|Lack of Efficacy|0
7774348|NCT00908544|12220066|FG001|Overall Study|Lack of Efficacy|1
7774349|NCT00908544|12220065|FG000|Overall Study|Pregnancy|1
7774350|NCT00908544|12220066|FG001|Overall Study|Pregnancy|0
7774351|NCT00908544|12220065|FG000|Overall Study|Relocation abroad|1
7774352|NCT00908544|12220066|FG001|Overall Study|Relocation abroad|1
7774353|NCT00908544|12220065|FG000|Overall Study|Unable to visit sutdy center|1
7774354|NCT00908544|12220066|FG001|Overall Study|Unable to visit sutdy center|0
7774355|NCT00908583|12220072|FG000|Phase 1|Withdrawal by Subject|1
7774356|NCT00908583|12220072|FG000|Phase 1|Adverse Event|4
7774357|NCT00908583|12220072|FG000|Phase 2|Physician Decision|1
7774358|NCT00908583|12220072|FG000|Phase 2|Adverse Event|1
7774359|NCT00908583|12220072|FG000|Phase 3|Adverse Event|2
7774360|NCT00908583|12220072|FG000|Phase 4|Adverse Event|1
7774361|NCT00908583|12220072|FG000|Phase 4|Physician Decision|1
7774362|NCT00908583|12220072|FG000|Phase 5|Adverse Event|3
7774363|NCT00908596|12220094|FG000|Overall Study|Other reasons|46
7774364|NCT00908596|12220095|FG001|Overall Study|Other reasons|6
7774365|NCT00908596|12220096|FG002|Overall Study|Other reasons|2
7774366|NCT00908596|12220097|FG003|Overall Study|Other reasons|0
7774367|NCT00908596|12220094|FG000|Overall Study|Lost to Follow-up|0
7774368|NCT00908596|12220095|FG001|Overall Study|Lost to Follow-up|1
7774369|NCT00908596|12220096|FG002|Overall Study|Lost to Follow-up|12
7774370|NCT00908596|12220097|FG003|Overall Study|Lost to Follow-up|4
7774371|NCT00908596|12220094|FG000|Overall Study|Death|0
7774372|NCT00908596|12220095|FG001|Overall Study|Death|5
7774373|NCT00908596|12220096|FG002|Overall Study|Death|57
7774374|NCT00908596|12220097|FG003|Overall Study|Death|32
7774375|NCT00908596|12220094|FG000|Overall Study|Protocol Violation|1
7774376|NCT00908596|12220095|FG001|Overall Study|Protocol Violation|0
7774377|NCT00908596|12220096|FG002|Overall Study|Protocol Violation|0
7774378|NCT00908596|12220097|FG003|Overall Study|Protocol Violation|0
7774379|NCT00908596|12220094|FG000|Overall Study|Withdrawal by Subject|0
7774380|NCT00908596|12220095|FG001|Overall Study|Withdrawal by Subject|1
7774381|NCT00908596|12220096|FG002|Overall Study|Withdrawal by Subject|3
7774382|NCT00908596|12220097|FG003|Overall Study|Withdrawal by Subject|1
7774383|NCT00908895|12220140|FG000|Overall Study|Lost to Follow-up|1
7774384|NCT00908895|12220141|FG001|Overall Study|Lost to Follow-up|3
7774385|NCT00908895|12220140|FG000|Overall Study|algodystrophy|2
7774386|NCT00908895|12220141|FG001|Overall Study|algodystrophy|2
7774387|NCT00908895|12220140|FG000|Overall Study|Adverse Event|1
7774388|NCT00908895|12220141|FG001|Overall Study|Adverse Event|1
7774389|NCT00908960|12220159|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1
7774390|NCT00908960|12220160|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1
7774391|NCT00908960|12220161|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2
7774392|NCT00909038|12220169|FG000|Overall Study|Protocol Violation|187
7774393|NCT00909038|12220169|FG000|Overall Study|Non-evaluable Subjects|230
7774394|NCT00909090|12220179|FG000|Overall Study|Lost to Follow-up|17
7774395|NCT00909090|12220180|FG001|Overall Study|Lost to Follow-up|17
7774396|NCT00909181|12220208|FG000|Overall Study|Lost to Follow-up|39
7774397|NCT00909181|12220209|FG001|Overall Study|Lost to Follow-up|18
7774398|NCT00909181|12220210|FG002|Overall Study|Lost to Follow-up|33
7774399|NCT00909363|12220241|FG000|Overall Study|Withdrawal by Subject|1
7774400|NCT00909363|12220242|FG001|Overall Study|Withdrawal by Subject|0
7604051|NCT02004691|12010838|FG000|PAP: Up to 52 Weeks|Poor compliance|1
7604052|NCT02004691|12010839|FG001|PAP: Up to 52 Weeks|Poor compliance|0
7604053|NCT02004691|12010838|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1
7604054|NCT02004691|12010839|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0
7604055|NCT02004691|12010838|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0
7604056|NCT02004691|12010839|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1
7604057|NCT02004691|12010838|FG000|ETP: Ongoing From Week 52|Other|0
7604058|NCT02004691|12010839|FG001|ETP: Ongoing From Week 52|Other|1
7604059|NCT02004691|12010838|FG000|ETP: Ongoing From Week 52|Ongoing|16
7604060|NCT02004691|12010839|FG001|ETP: Ongoing From Week 52|Ongoing|16
7774401|NCT00909363|12220243|FG002|Overall Study|Withdrawal by Subject|0
7774402|NCT00909363|12220241|FG000|Overall Study|Lack of Efficacy|1
7774403|NCT00909363|12220242|FG001|Overall Study|Lack of Efficacy|0
7774404|NCT00909363|12220243|FG002|Overall Study|Lack of Efficacy|0
7774405|NCT00909428|12220257|FG000|Overall Study|Lost to Follow-up|13
7774406|NCT00909428|12220258|FG001|Overall Study|Lost to Follow-up|10
7774407|NCT00909428|12220259|FG002|Overall Study|Lost to Follow-up|9
7774408|NCT00909480|12220268|FG000|Overall Study|Adverse Event|5
7774409|NCT00909480|12220269|FG001|Overall Study|Adverse Event|3
7774410|NCT00909480|12220268|FG000|Overall Study|Protocol Violation|6
7774411|NCT00909480|12220269|FG001|Overall Study|Protocol Violation|8
7774412|NCT00909480|12220268|FG000|Overall Study|Withdrawal criteria|9
7774413|NCT00909480|12220269|FG001|Overall Study|Withdrawal criteria|11
7774414|NCT00909480|12220268|FG000|Overall Study|Unclassified|18
7774415|NCT00909480|12220269|FG001|Overall Study|Unclassified|19
7774416|NCT00909532|12220277|FG000|Overall Study|Adverse Event|4
7774417|NCT00909532|12220278|FG001|Overall Study|Adverse Event|1
7774418|NCT00909532|12220277|FG000|Overall Study|Pregnancy|0
7774419|NCT00909532|12220278|FG001|Overall Study|Pregnancy|1
7774420|NCT00909532|12220277|FG000|Overall Study|Prohibited Medication|2
7774421|NCT00909532|12220278|FG001|Overall Study|Prohibited Medication|1
7774422|NCT00909532|12220277|FG000|Overall Study|Withdrawal of Consent|1
7774423|NCT00909532|12220278|FG001|Overall Study|Withdrawal of Consent|1
7774424|NCT00909532|12220277|FG000|Overall Study|Noncompliance with Study Requirements|0
7774425|NCT00909532|12220278|FG001|Overall Study|Noncompliance with Study Requirements|2
7774426|NCT00909532|12220277|FG000|Overall Study|Physician Decision|1
7774427|NCT00909532|12220278|FG001|Overall Study|Physician Decision|0
7774428|NCT00909532|12220277|FG000|Overall Study|Wrong Genotype|1
7774429|NCT00909532|12220278|FG001|Overall Study|Wrong Genotype|0
7774430|NCT00909532|12220277|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
7774431|NCT00909532|12220278|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
7604091|NCT01668719|12010871|FG000|Phase I|On treatment|1
7604092|NCT01668719|12010872|FG001|Phase I|On treatment|0
7774432|NCT00909727|12220305|FG000|Overall Study|Adverse Event|1
7774433|NCT00909727|12220306|FG001|Overall Study|Adverse Event|0
7774434|NCT00909727|12220305|FG000|Overall Study|Wrong Genotype|1
7774435|NCT00909727|12220306|FG001|Overall Study|Wrong Genotype|0
7774436|NCT00909727|12220305|FG000|Overall Study|Withdrawal of Consent|1
7774437|NCT00909727|12220306|FG001|Overall Study|Withdrawal of Consent|0
7774438|NCT00909727|12220305|FG000|Overall Study|Prohibited Medication|1
7774439|NCT00909727|12220306|FG001|Overall Study|Prohibited Medication|0
7774440|NCT00909779|12220314|FG000|Overall Study|Adverse Event|53
7604093|NCT01668719|12010873|FG002|Phase I|On treatment|0
7604094|NCT01668719|12010871|FG000|Phase I|Adverse Event|2
7604095|NCT01668719|12010872|FG001|Phase I|Adverse Event|0
7604096|NCT01668719|12010873|FG002|Phase I|Adverse Event|0
7604097|NCT01668719|12010871|FG000|Phase I|Progression/relapse|1
7604098|NCT01668719|12010872|FG001|Phase I|Progression/relapse|0
7604099|NCT01668719|12010873|FG002|Phase I|Progression/relapse|0
7604100|NCT01668719|12010871|FG000|Phase I|not protocol specified|2
7604101|NCT01668719|12010872|FG001|Phase I|not protocol specified|0
7604102|NCT01668719|12010873|FG002|Phase I|not protocol specified|0
7604103|NCT01668719|12010871|FG000|Phase II|On treatment|0
7604104|NCT01668719|12010872|FG001|Phase II|On treatment|4
7604105|NCT01668719|12010873|FG002|Phase II|On treatment|3
7604106|NCT01668719|12010871|FG000|Phase II|Adverse Event|0
7604107|NCT01668719|12010872|FG001|Phase II|Adverse Event|18
7604108|NCT01668719|12010873|FG002|Phase II|Adverse Event|18
7604109|NCT01668719|12010871|FG000|Phase II|Refusal unrelated to adverse event|0
7604110|NCT01668719|12010872|FG001|Phase II|Refusal unrelated to adverse event|4
7604111|NCT01668719|12010873|FG002|Phase II|Refusal unrelated to adverse event|1
7604112|NCT01668719|12010871|FG000|Phase II|Progression/relapse|0
7604113|NCT01668719|12010872|FG001|Phase II|Progression/relapse|13
7604114|NCT01668719|12010873|FG002|Phase II|Progression/relapse|17
7604115|NCT01668719|12010871|FG000|Phase II|Death|0
7604116|NCT01668719|12010872|FG001|Phase II|Death|0
7604117|NCT01668719|12010873|FG002|Phase II|Death|2
7604118|NCT01668719|12010871|FG000|Phase II|not protocol specified|0
7604119|NCT01668719|12010872|FG001|Phase II|not protocol specified|13
7604120|NCT01668719|12010873|FG002|Phase II|not protocol specified|7
7774441|NCT00909779|12220315|FG001|Overall Study|Adverse Event|55
7774442|NCT00909779|12220314|FG000|Overall Study|Lack of Efficacy|7
7774443|NCT00909779|12220315|FG001|Overall Study|Lack of Efficacy|4
7774444|NCT00909779|12220314|FG000|Overall Study|Lost to Follow-up|19
7774445|NCT00909779|12220315|FG001|Overall Study|Lost to Follow-up|15
7774446|NCT00909779|12220314|FG000|Overall Study|Physician Decision|8
7774447|NCT00909779|12220315|FG001|Overall Study|Physician Decision|2
7774448|NCT00909779|12220314|FG000|Overall Study|Protocol Violation|2
7774449|NCT00909779|12220315|FG001|Overall Study|Protocol Violation|5
7774450|NCT00909779|12220314|FG000|Overall Study|Withdrawal by Subject|116
7774451|NCT00909779|12220315|FG001|Overall Study|Withdrawal by Subject|80
7774452|NCT00909779|12220314|FG000|Overall Study|Site Ceasing Operation|2
7774453|NCT00909779|12220315|FG001|Overall Study|Site Ceasing Operation|2
7774454|NCT00909779|12220314|FG000|Overall Study|Medical Monitor Decision|1
7774455|NCT00909779|12220315|FG001|Overall Study|Medical Monitor Decision|0
7774456|NCT00909779|12220314|FG000|Overall Study|Noncompliance|1
7774457|NCT00909779|12220315|FG001|Overall Study|Noncompliance|1
7774458|NCT00909779|12220314|FG000|Overall Study|Randomized in error|1
7774459|NCT00909779|12220315|FG001|Overall Study|Randomized in error|1
7774460|NCT00909792|12220323|FG000|Period 1|Did not meet inclusion criteria|0
7774461|NCT00909792|12220324|FG001|Period 1|Did not meet inclusion criteria|1
7774462|NCT00909792|12220323|FG000|Period 2|Biomicroscopy|1
7774463|NCT00909792|12220324|FG001|Period 2|Biomicroscopy|0
7774464|NCT00909792|12220323|FG000|Period 2|Lost to Follow-up|0
7774465|NCT00909792|12220324|FG001|Period 2|Lost to Follow-up|1
7774466|NCT00909844|12220330|FG000|Overall Study|Adverse Event|1
7774467|NCT00909844|12220330|FG000|Overall Study|Withdrawal by Subject|1
7774468|NCT00909844|12220330|FG000|Overall Study|Lost to Follow-up|2
7774469|NCT00909857|12220337|FG000|Overall Study|Withdrawal by Subject|6
7774470|NCT00909857|12220338|FG001|Overall Study|Withdrawal by Subject|10
7774471|NCT00909857|12220337|FG000|Overall Study|Adverse Event|5
7774472|NCT00909857|12220338|FG001|Overall Study|Adverse Event|5
7774473|NCT00909857|12220337|FG000|Overall Study|Lost to Follow-up|2
7774474|NCT00909857|12220338|FG001|Overall Study|Lost to Follow-up|5
7774475|NCT00909857|12220337|FG000|Overall Study|Protocol Violation|2
7774476|NCT00909857|12220338|FG001|Overall Study|Protocol Violation|1
7774477|NCT00909857|12220337|FG000|Overall Study|Pregnancy|1
7774478|NCT00909857|12220338|FG001|Overall Study|Pregnancy|0
7774479|NCT00909857|12220337|FG000|Overall Study|Other|1
7774480|NCT00909857|12220338|FG001|Overall Study|Other|0
7774481|NCT00909857|12220337|FG000|Overall Study|Did not receive study medication|19
7774482|NCT00909857|12220338|FG001|Overall Study|Did not receive study medication|24
7774483|NCT00909870|12220346|FG000|Overall Study|Adverse Event|13
7774484|NCT00909870|12220347|FG001|Overall Study|Adverse Event|7
7774485|NCT00909870|12220346|FG000|Overall Study|Protocol Violation|1
7774486|NCT00909870|12220347|FG001|Overall Study|Protocol Violation|2
7774487|NCT00909870|12220346|FG000|Overall Study|Withdrawal by Subject|5
7774488|NCT00909870|12220347|FG001|Overall Study|Withdrawal by Subject|8
7774489|NCT00909870|12220346|FG000|Overall Study|Lost to Follow-up|3
7774490|NCT00909870|12220347|FG001|Overall Study|Lost to Follow-up|3
7774491|NCT00909870|12220346|FG000|Overall Study|Physician Decision|0
7774492|NCT00909870|12220347|FG001|Overall Study|Physician Decision|2
7774493|NCT00909870|12220346|FG000|Overall Study|Other|1
7774494|NCT00909870|12220347|FG001|Overall Study|Other|5
7774495|NCT00910000|12220360|FG000|Overall Study|Adverse Event|0
7774496|NCT00910000|12220361|FG001|Overall Study|Adverse Event|3
7774497|NCT00910000|12220362|FG002|Overall Study|Adverse Event|2
7774498|NCT00910000|12220363|FG003|Overall Study|Adverse Event|2
7774499|NCT00910000|12220364|FG004|Overall Study|Adverse Event|0
7774500|NCT00910000|12220365|FG005|Overall Study|Adverse Event|1
7774501|NCT00910000|12220360|FG000|Overall Study|Withdrawal by Subject|0
7774502|NCT00910000|12220361|FG001|Overall Study|Withdrawal by Subject|0
7774503|NCT00910000|12220362|FG002|Overall Study|Withdrawal by Subject|1
7774504|NCT00910000|12220363|FG003|Overall Study|Withdrawal by Subject|0
7774505|NCT00910000|12220364|FG004|Overall Study|Withdrawal by Subject|1
7774506|NCT00910000|12220365|FG005|Overall Study|Withdrawal by Subject|0
7774507|NCT00910039|12220375|FG000|Overall Study|Physician Decision|1
7774508|NCT00910091|12220382|FG000|Pre-assignment|Withdrawal by Subject|0
7774509|NCT00910091|12220383|FG001|Pre-assignment|Withdrawal by Subject|2
7774510|NCT00910091|12220382|FG000|Treatment and Survival|Withdrawal by Subject|3
7774511|NCT00910091|12220383|FG001|Treatment and Survival|Withdrawal by Subject|4
7774512|NCT00910091|12220382|FG000|Treatment and Survival|Adverse Event|1
7774513|NCT00910091|12220383|FG001|Treatment and Survival|Adverse Event|0
7604177|NCT01515748|12010914|FG000|Overall Study|Withdrawal by Subject|32
7604178|NCT01515748|12010915|FG001|Overall Study|Withdrawal by Subject|41
7604179|NCT01515748|12010914|FG000|Overall Study|Lost to Follow-up|2
7604180|NCT01515748|12010915|FG001|Overall Study|Lost to Follow-up|4
7604181|NCT01515748|12010914|FG000|Overall Study|Ongoing|86
7604182|NCT01515748|12010915|FG001|Overall Study|Ongoing|90
7604183|NCT01261247|12010922|FG000|Overall Study|Ineligible|2
7604184|NCT00790933|12010954|FG000|Overall Study|Adverse Event|94
7604185|NCT00790933|12010955|FG001|Overall Study|Adverse Event|119
7604186|NCT00790933|12010956|FG002|Overall Study|Adverse Event|65
7604187|NCT00790933|12010957|FG003|Overall Study|Adverse Event|5
7604188|NCT00790933|12010958|FG004|Overall Study|Adverse Event|69
7604189|NCT00790933|12010954|FG000|Overall Study|Protocol Violation(s)|8
7604190|NCT00790933|12010955|FG001|Overall Study|Protocol Violation(s)|18
7604191|NCT00790933|12010956|FG002|Overall Study|Protocol Violation(s)|7
7604192|NCT00790933|12010957|FG003|Overall Study|Protocol Violation(s)|0
7604193|NCT00790933|12010958|FG004|Overall Study|Protocol Violation(s)|12
7604194|NCT00790933|12010954|FG000|Overall Study|Lack of Efficacy|192
7604195|NCT00790933|12010955|FG001|Overall Study|Lack of Efficacy|176
7604196|NCT00790933|12010956|FG002|Overall Study|Lack of Efficacy|130
7604197|NCT00790933|12010957|FG003|Overall Study|Lack of Efficacy|1
7604198|NCT00790933|12010958|FG004|Overall Study|Lack of Efficacy|121
7604199|NCT00790933|12010954|FG000|Overall Study|Study Terminated by Sponsor|0
7604200|NCT00790933|12010955|FG001|Overall Study|Study Terminated by Sponsor|0
7604201|NCT00790933|12010956|FG002|Overall Study|Study Terminated by Sponsor|1
7604202|NCT00790933|12010957|FG003|Overall Study|Study Terminated by Sponsor|0
7604203|NCT00790933|12010958|FG004|Overall Study|Study Terminated by Sponsor|0
7604204|NCT00790933|12010954|FG000|Overall Study|Withdrawal by Subject|123
7604205|NCT00790933|12010955|FG001|Overall Study|Withdrawal by Subject|120
7604206|NCT00790933|12010956|FG002|Overall Study|Withdrawal by Subject|52
7604207|NCT00790933|12010957|FG003|Overall Study|Withdrawal by Subject|6
7604208|NCT00790933|12010958|FG004|Overall Study|Withdrawal by Subject|50
7604209|NCT00790933|12010954|FG000|Overall Study|Lost to Follow-up|13
7604210|NCT00790933|12010955|FG001|Overall Study|Lost to Follow-up|31
7604211|NCT00790933|12010956|FG002|Overall Study|Lost to Follow-up|10
7604212|NCT00790933|12010957|FG003|Overall Study|Lost to Follow-up|1
7604213|NCT00790933|12010958|FG004|Overall Study|Lost to Follow-up|15
7604214|NCT00790933|12010954|FG000|Overall Study|Reason Not Specified|8
7604215|NCT00790933|12010955|FG001|Overall Study|Reason Not Specified|16
7604216|NCT00790933|12010956|FG002|Overall Study|Reason Not Specified|4
7604217|NCT00790933|12010957|FG003|Overall Study|Reason Not Specified|1
7604218|NCT00790933|12010958|FG004|Overall Study|Reason Not Specified|9
7604219|NCT04388527|12011020|FG000|Overall Study|Death|14
7604220|NCT04388527|12011020|FG000|Overall Study|Withdrawal by Subject|2
7604221|NCT04388527|12011020|FG000|Overall Study|Lost to Follow-up|1
7604222|NCT04280081|12011028|FG000|Overall Study|Adverse Event|4
7604223|NCT04280081|12011028|FG000|Overall Study|Death|2
7604224|NCT04280081|12011028|FG000|Overall Study|Progressive Disease|6
7604225|NCT04126083|12011050|FG000|Overall Study|Withdrawal by Subject|1
7604226|NCT03444038|12011173|FG000|Overall Study|Adverse Event|12
7604227|NCT03444038|12011173|FG000|Overall Study|Withdrawal by Subject|7
7604228|NCT03444038|12011173|FG000|Overall Study|Lost to Follow-up|1
7604229|NCT03444038|12011173|FG000|Overall Study|Physician Decision|2
7604230|NCT03444038|12011173|FG000|Overall Study|Lack of Efficacy|7
7604231|NCT03265665|12011183|FG000|24-week Data Collection|Withdrawal by Subject|2
7604232|NCT03265665|12011184|FG001|24-week Data Collection|Withdrawal by Subject|2
7604233|NCT03265665|12011183|FG000|24-week Data Collection|Lost to Follow-up|4
7604234|NCT03265665|12011184|FG001|24-week Data Collection|Lost to Follow-up|5
7604235|NCT03265665|12011183|FG000|36-week Data Collection|Lost to Follow-up|6
7604236|NCT03265665|12011184|FG001|36-week Data Collection|Lost to Follow-up|8
7604237|NCT02725593|12011198|FG000|Blinded Treatment Period|Withdrawal by Subject|4
7604238|NCT02725593|12011199|FG001|Blinded Treatment Period|Withdrawal by Subject|3
7604239|NCT02725593|12011198|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0
7604240|NCT02725593|12011199|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2
7604241|NCT02725593|12011198|FG000|Blinded Treatment Period|Lost to Follow-up|1
7604242|NCT02725593|12011199|FG001|Blinded Treatment Period|Lost to Follow-up|1
7604243|NCT02725593|12011198|FG000|Long Term Extension|Withdrawal by Subject|1
7604244|NCT02725593|12011199|FG001|Long Term Extension|Withdrawal by Subject|3
7604245|NCT02716675|12011208|FG000|Overall Study|Death|2
7604246|NCT02716675|12011209|FG001|Overall Study|Death|3
7604247|NCT02716675|12011210|FG002|Overall Study|Death|0
7604248|NCT02716675|12011208|FG000|Overall Study|Physician Decision|2
7604249|NCT02716675|12011209|FG001|Overall Study|Physician Decision|1
7604250|NCT02716675|12011210|FG002|Overall Study|Physician Decision|1
7604251|NCT02716675|12011208|FG000|Overall Study|Lost to Follow-up|100
7604252|NCT02716675|12011209|FG001|Overall Study|Lost to Follow-up|87
7604253|NCT02716675|12011210|FG002|Overall Study|Lost to Follow-up|99
7604254|NCT02716675|12011208|FG000|Overall Study|Withdrawal by Subject|22
7604255|NCT02716675|12011209|FG001|Overall Study|Withdrawal by Subject|25
7604256|NCT02716675|12011210|FG002|Overall Study|Withdrawal by Subject|20
7604257|NCT02716675|12011208|FG000|Overall Study|Protocol Violation|0
7604258|NCT02716675|12011209|FG001|Overall Study|Protocol Violation|3
7604259|NCT02716675|12011210|FG002|Overall Study|Protocol Violation|1
7604260|NCT02716675|12011208|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36
7604261|NCT02716675|12011209|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31
7604262|NCT02716675|12011210|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42
7604263|NCT02716675|12011208|FG000|Overall Study|Other|38
7604264|NCT02716675|12011209|FG001|Overall Study|Other|47
7604265|NCT02716675|12011210|FG002|Overall Study|Other|48
7604266|NCT02636946|12011225|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0
7604267|NCT02636946|12011226|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1
7604268|NCT02636946|12011225|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1
7604269|NCT02636946|12011226|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0
7604270|NCT02636946|12011225|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0
7604271|NCT02636946|12011226|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1
7604272|NCT02636946|12011225|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0
7604273|NCT02636946|12011226|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1
7774514|NCT00910247|12220403|FG000|Overall Study|Adverse Event|15
7774515|NCT00910247|12220403|FG000|Overall Study|Death|2
7774516|NCT00910247|12220403|FG000|Overall Study|Lost to Follow-up|10
7774517|NCT00910247|12220403|FG000|Overall Study|Physician Decision|3
7774518|NCT00910247|12220403|FG000|Overall Study|Protocol Violation|10
7774519|NCT00910247|12220403|FG000|Overall Study|Withdrawal by Subject|25
7774520|NCT00910247|12220403|FG000|Overall Study|Not collected|4
7774521|NCT00910273|12220409|FG000|Overall Study|Lack of Efficacy|6
7774522|NCT00910273|12220410|FG001|Overall Study|Lack of Efficacy|9
7774523|NCT00910273|12220409|FG000|Overall Study|Adverse Event|1
7774524|NCT00910273|12220410|FG001|Overall Study|Adverse Event|1
7774525|NCT00910273|12220409|FG000|Overall Study|Withdrawal by Subject|1
7604274|NCT02636946|12011225|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0
7604275|NCT02636946|12011226|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2
7604276|NCT02636946|12011225|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2
7604277|NCT02636946|12011226|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1
7604278|NCT02631941|12011242|FG000|Overall Study|Physician Decision|0
7604279|NCT02631941|12011243|FG001|Overall Study|Physician Decision|1
7604280|NCT02631941|12011244|FG002|Overall Study|Physician Decision|0
7604281|NCT02631941|12011245|FG003|Overall Study|Physician Decision|0
7604282|NCT02631941|12011246|FG004|Overall Study|Physician Decision|0
7604283|NCT02631941|12011247|FG005|Overall Study|Physician Decision|0
7604284|NCT02631941|12011248|FG006|Overall Study|Physician Decision|0
7604285|NCT02631941|12011249|FG007|Overall Study|Physician Decision|0
7604286|NCT02631941|12011250|FG008|Overall Study|Physician Decision|0
7604287|NCT02631941|12011251|FG009|Overall Study|Physician Decision|0
7604288|NCT02631941|12011242|FG000|Overall Study|Adverse Event|0
7604289|NCT02631941|12011243|FG001|Overall Study|Adverse Event|1
7604290|NCT02631941|12011244|FG002|Overall Study|Adverse Event|0
7604291|NCT02631941|12011245|FG003|Overall Study|Adverse Event|0
7604292|NCT02631941|12011246|FG004|Overall Study|Adverse Event|0
7604293|NCT02631941|12011247|FG005|Overall Study|Adverse Event|0
7604294|NCT02631941|12011248|FG006|Overall Study|Adverse Event|0
7604295|NCT02631941|12011249|FG007|Overall Study|Adverse Event|0
7604296|NCT02631941|12011250|FG008|Overall Study|Adverse Event|0
7604297|NCT02631941|12011251|FG009|Overall Study|Adverse Event|0
7604298|NCT02631941|12011242|FG000|Overall Study|Withdrawal by Subject|0
7604299|NCT02631941|12011243|FG001|Overall Study|Withdrawal by Subject|0
7604300|NCT02631941|12011244|FG002|Overall Study|Withdrawal by Subject|0
7604301|NCT02631941|12011245|FG003|Overall Study|Withdrawal by Subject|0
7604302|NCT02631941|12011246|FG004|Overall Study|Withdrawal by Subject|1
7604303|NCT02631941|12011247|FG005|Overall Study|Withdrawal by Subject|0
7604304|NCT02631941|12011248|FG006|Overall Study|Withdrawal by Subject|0
7604305|NCT02631941|12011249|FG007|Overall Study|Withdrawal by Subject|1
7604306|NCT02631941|12011250|FG008|Overall Study|Withdrawal by Subject|0
7604307|NCT02631941|12011251|FG009|Overall Study|Withdrawal by Subject|0
7604308|NCT02631941|12011242|FG000|Overall Study|Lost to Follow-up|0
7604309|NCT02631941|12011243|FG001|Overall Study|Lost to Follow-up|0
7604310|NCT02631941|12011244|FG002|Overall Study|Lost to Follow-up|0
7604311|NCT02631941|12011245|FG003|Overall Study|Lost to Follow-up|0
7604312|NCT02631941|12011246|FG004|Overall Study|Lost to Follow-up|0
7604313|NCT02631941|12011247|FG005|Overall Study|Lost to Follow-up|0
7604314|NCT02631941|12011248|FG006|Overall Study|Lost to Follow-up|0
7604315|NCT02631941|12011249|FG007|Overall Study|Lost to Follow-up|0
7774526|NCT00910273|12220410|FG001|Overall Study|Withdrawal by Subject|0
7774527|NCT00910273|12220409|FG000|Overall Study|Discontinuation of study by sponsor|8
7774528|NCT00910273|12220410|FG001|Overall Study|Discontinuation of study by sponsor|2
7604316|NCT02631941|12011250|FG008|Overall Study|Lost to Follow-up|1
7604317|NCT02631941|12011251|FG009|Overall Study|Lost to Follow-up|0
7604318|NCT02568215|12011264|FG000|Overall Study|Death|1
7604319|NCT02568215|12011265|FG001|Overall Study|Death|2
7604320|NCT02568215|12011266|FG002|Overall Study|Death|0
7604321|NCT02568215|12011264|FG000|Overall Study|Physician Decision|2
7604322|NCT02568215|12011265|FG001|Overall Study|Physician Decision|2
7604323|NCT02568215|12011266|FG002|Overall Study|Physician Decision|2
7604324|NCT02568215|12011264|FG000|Overall Study|Lost to Follow-up|29
7604325|NCT02568215|12011265|FG001|Overall Study|Lost to Follow-up|32
7604326|NCT02568215|12011266|FG002|Overall Study|Lost to Follow-up|41
7604327|NCT02568215|12011264|FG000|Overall Study|Withdrawal by Subject|21
7604328|NCT02568215|12011265|FG001|Overall Study|Withdrawal by Subject|19
7604329|NCT02568215|12011266|FG002|Overall Study|Withdrawal by Subject|22
7604330|NCT02568215|12011264|FG000|Overall Study|Protocol Violation|1
7604331|NCT02568215|12011265|FG001|Overall Study|Protocol Violation|1
7604332|NCT02568215|12011266|FG002|Overall Study|Protocol Violation|0
7774529|NCT00910273|12220409|FG000|Overall Study|Protocol Violation|1
7774530|NCT00910273|12220410|FG001|Overall Study|Protocol Violation|0
7774531|NCT00910273|12220409|FG000|Overall Study|Lost to Follow-up|1
7774532|NCT00910273|12220410|FG001|Overall Study|Lost to Follow-up|1
7774533|NCT00910299|12220418|FG000|Overall Study|Withdrawal by Subject|16
7774534|NCT00910299|12220419|FG001|Overall Study|Withdrawal by Subject|13
7774535|NCT00910299|12220418|FG000|Overall Study|Sponsor Decision|58
7774536|NCT00910299|12220419|FG001|Overall Study|Sponsor Decision|60
7774537|NCT00910299|12220418|FG000|Overall Study|Didn't receive any study drug|2
7774538|NCT00910299|12220419|FG001|Overall Study|Didn't receive any study drug|1
7774539|NCT00910429|12220427|FG000|Overall Study|Death|18
7774540|NCT00910429|12220428|FG001|Overall Study|Death|12
7774541|NCT00910429|12220427|FG000|Overall Study|Withdrawal by Subject|3
7774542|NCT00910429|12220428|FG001|Overall Study|Withdrawal by Subject|2
7774543|NCT00910429|12220427|FG000|Overall Study|Protocol Violation|1
7774544|NCT00910429|12220428|FG001|Overall Study|Protocol Violation|0
7774545|NCT00910429|12220427|FG000|Overall Study|Lost to Follow-up|2
7774546|NCT00910429|12220428|FG001|Overall Study|Lost to Follow-up|1
7774547|NCT00910429|12220427|FG000|Overall Study|Adverse Event|10
7774548|NCT00910429|12220428|FG001|Overall Study|Adverse Event|5
7774549|NCT00910429|12220427|FG000|Overall Study|Drug non-compliance|1
7774550|NCT00910429|12220428|FG001|Overall Study|Drug non-compliance|0
7774551|NCT00910429|12220427|FG000|Overall Study|Lack of Efficacy|4
7774552|NCT00910429|12220428|FG001|Overall Study|Lack of Efficacy|1
7774553|NCT00910624|12220456|FG000|Treatment Phase|Adverse Event|2
7774554|NCT00910624|12220457|FG001|Treatment Phase|Adverse Event|6
7774555|NCT00910624|12220458|FG002|Treatment Phase|Adverse Event|6
7774556|NCT00910624|12220459|FG003|Treatment Phase|Adverse Event|0
7774557|NCT00910624|12220456|FG000|Treatment Phase|Treatment Failure|23
7774558|NCT00910624|12220457|FG001|Treatment Phase|Treatment Failure|10
7774559|NCT00910624|12220458|FG002|Treatment Phase|Treatment Failure|0
7774560|NCT00910624|12220459|FG003|Treatment Phase|Treatment Failure|0
7774561|NCT00910624|12220456|FG000|Treatment Phase|Lost to Follow-up|0
7774562|NCT00910624|12220457|FG001|Treatment Phase|Lost to Follow-up|0
7774563|NCT00910624|12220458|FG002|Treatment Phase|Lost to Follow-up|1
7774564|NCT00910624|12220459|FG003|Treatment Phase|Lost to Follow-up|0
7774565|NCT00910624|12220456|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
7774566|NCT00910624|12220457|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
7774567|NCT00910624|12220458|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
7774568|NCT00910624|12220459|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
7774569|NCT00910624|12220456|FG000|Treatment Phase|Withdrawal by Subject|2
7774570|NCT00910624|12220457|FG001|Treatment Phase|Withdrawal by Subject|1
7774571|NCT00910624|12220458|FG002|Treatment Phase|Withdrawal by Subject|0
7774572|NCT00910624|12220459|FG003|Treatment Phase|Withdrawal by Subject|0
7774573|NCT00910624|12220456|FG000|Treatment Phase|Non-Compliance With Protocol|0
7774574|NCT00910624|12220457|FG001|Treatment Phase|Non-Compliance With Protocol|1
7774575|NCT00910624|12220458|FG002|Treatment Phase|Non-Compliance With Protocol|1
7774576|NCT00910624|12220459|FG003|Treatment Phase|Non-Compliance With Protocol|0
7604333|NCT02568215|12011264|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25
7604334|NCT02568215|12011265|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23
7604335|NCT02568215|12011266|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21
7604336|NCT02568215|12011264|FG000|Overall Study|Other|0
7604337|NCT02568215|12011265|FG001|Overall Study|Other|1
7604338|NCT02568215|12011266|FG002|Overall Study|Other|4
7604339|NCT02528643|12011294|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5
7604340|NCT02528643|12011295|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8
7604341|NCT02528643|12011294|FG000|DB (Median Duration up to 14.65 Months)|Death|1
7604342|NCT02528643|12011295|FG001|DB (Median Duration up to 14.65 Months)|Death|6
7604343|NCT02528643|12011294|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0
7604344|NCT02528643|12011295|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1
7604345|NCT02528643|12011294|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44
7604346|NCT02528643|12011295|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82
7604347|NCT02528643|12011294|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2
7774577|NCT00910624|12220456|FG000|Follow-Up Phase|Adverse Event|0
7774578|NCT00910624|12220457|FG001|Follow-Up Phase|Adverse Event|0
7604348|NCT02528643|12011295|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8
7604349|NCT02528643|12011294|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3
7774579|NCT00910624|12220458|FG002|Follow-Up Phase|Adverse Event|1
7774580|NCT00910624|12220459|FG003|Follow-Up Phase|Adverse Event|0
7774581|NCT00910624|12220456|FG000|Follow-Up Phase|Lost to Follow-up|3
7774582|NCT00910624|12220457|FG001|Follow-Up Phase|Lost to Follow-up|1
7774583|NCT00910624|12220458|FG002|Follow-Up Phase|Lost to Follow-up|2
7774584|NCT00910624|12220459|FG003|Follow-Up Phase|Lost to Follow-up|0
7774585|NCT00910624|12220456|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
7774586|NCT00910624|12220457|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
7774587|NCT00910624|12220458|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
7774588|NCT00910624|12220459|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
7604350|NCT02528643|12011295|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5
7604351|NCT02528643|12011294|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0
7604352|NCT02528643|12011295|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1
7604353|NCT02237508|12011339|FG000|Overall Study|Withdrawal by Subject|0
7604354|NCT02237508|12011340|FG001|Overall Study|Withdrawal by Subject|2
7604355|NCT02237508|12011341|FG002|Overall Study|Withdrawal by Subject|0
7604356|NCT02237508|12011342|FG003|Overall Study|Withdrawal by Subject|1
7604357|NCT02237508|12011343|FG004|Overall Study|Withdrawal by Subject|0
7604358|NCT02237508|12011344|FG005|Overall Study|Withdrawal by Subject|1
7604359|NCT02237508|12011345|FG006|Overall Study|Withdrawal by Subject|1
7604360|NCT02237508|12011346|FG007|Overall Study|Withdrawal by Subject|0
7604361|NCT02237508|12011347|FG008|Overall Study|Withdrawal by Subject|1
7604362|NCT02237508|12011348|FG009|Overall Study|Withdrawal by Subject|0
7774589|NCT00910624|12220456|FG000|Follow-Up Phase|Withdrawal by Subject|1
7774590|NCT00910624|12220457|FG001|Follow-Up Phase|Withdrawal by Subject|0
7774591|NCT00910624|12220458|FG002|Follow-Up Phase|Withdrawal by Subject|0
7774592|NCT00910624|12220459|FG003|Follow-Up Phase|Withdrawal by Subject|0
7774593|NCT00910624|12220456|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
7774594|NCT00910624|12220457|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
7774595|NCT00910624|12220458|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
7774596|NCT00910624|12220459|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
7774597|NCT00910624|12220456|FG000|Follow-Up Phase|Administrative|0
7774598|NCT00910624|12220457|FG001|Follow-Up Phase|Administrative|1
7774599|NCT00910624|12220458|FG002|Follow-Up Phase|Administrative|1
7774600|NCT00910624|12220459|FG003|Follow-Up Phase|Administrative|0
7774601|NCT00910663|12220469|FG000|Period 1|Withdrawal by Subject|0
7774602|NCT00910663|12220470|FG001|Period 1|Withdrawal by Subject|1
7774603|NCT00910689|12220480|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
7774604|NCT00910689|12220481|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
7774605|NCT00910689|12220482|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
7774606|NCT00910689|12220483|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
7774607|NCT00910689|12220480|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3
7774608|NCT00910689|12220481|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4
7774609|NCT00910689|12220482|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1
7774610|NCT00910689|12220483|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3
7774611|NCT00910689|12220480|FG000|Month 2- 4: Treatment Period|Adverse Event|2
7774612|NCT00910689|12220481|FG001|Month 2- 4: Treatment Period|Adverse Event|3
7774613|NCT00910689|12220482|FG002|Month 2- 4: Treatment Period|Adverse Event|2
7774614|NCT00910689|12220483|FG003|Month 2- 4: Treatment Period|Adverse Event|0
7774615|NCT00910689|12220480|FG000|Month 2- 4: Treatment Period|Time Demands|1
7774616|NCT00910689|12220481|FG001|Month 2- 4: Treatment Period|Time Demands|0
7774617|NCT00910689|12220482|FG002|Month 2- 4: Treatment Period|Time Demands|4
7774618|NCT00910689|12220483|FG003|Month 2- 4: Treatment Period|Time Demands|8
7774619|NCT00910689|12220480|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2
7774620|NCT00910689|12220481|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1
7774621|NCT00910689|12220482|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0
7774622|NCT00910689|12220483|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0
7774623|NCT00910689|12220480|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0
7774624|NCT00910689|12220481|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0
7774625|NCT00910689|12220482|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1
7774626|NCT00910689|12220483|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0
7774627|NCT00910689|12220480|FG000|Month 2- 4: Treatment Period|Pregnancy|0
7604363|NCT02237508|12011339|FG000|Overall Study|Physician Decision|0
7774628|NCT00910689|12220481|FG001|Month 2- 4: Treatment Period|Pregnancy|2
7774629|NCT00910689|12220482|FG002|Month 2- 4: Treatment Period|Pregnancy|0
7774630|NCT00910689|12220483|FG003|Month 2- 4: Treatment Period|Pregnancy|0
7774631|NCT00910689|12220480|FG000|Month 2- 4: Treatment Period|Protocol Violation|1
7774632|NCT00910689|12220481|FG001|Month 2- 4: Treatment Period|Protocol Violation|0
7774633|NCT00910689|12220482|FG002|Month 2- 4: Treatment Period|Protocol Violation|0
7774634|NCT00910689|12220483|FG003|Month 2- 4: Treatment Period|Protocol Violation|0
7774635|NCT00910689|12220480|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
7774636|NCT00910689|12220481|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
7774637|NCT00910689|12220482|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
7774638|NCT00910689|12220483|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
7774639|NCT00910689|12220480|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1
7774640|NCT00910689|12220481|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0
7604364|NCT02237508|12011340|FG001|Overall Study|Physician Decision|1
7604365|NCT02237508|12011341|FG002|Overall Study|Physician Decision|0
7604366|NCT02237508|12011342|FG003|Overall Study|Physician Decision|0
7604367|NCT02237508|12011343|FG004|Overall Study|Physician Decision|0
7604368|NCT02237508|12011344|FG005|Overall Study|Physician Decision|0
7604369|NCT02237508|12011345|FG006|Overall Study|Physician Decision|0
7604370|NCT02237508|12011346|FG007|Overall Study|Physician Decision|0
7604371|NCT02237508|12011347|FG008|Overall Study|Physician Decision|0
7604372|NCT02237508|12011348|FG009|Overall Study|Physician Decision|0
7604373|NCT02237508|12011339|FG000|Overall Study|Protocol Violation|0
7604374|NCT02237508|12011340|FG001|Overall Study|Protocol Violation|0
7604375|NCT02237508|12011341|FG002|Overall Study|Protocol Violation|1
7604376|NCT02237508|12011342|FG003|Overall Study|Protocol Violation|0
7604377|NCT02237508|12011343|FG004|Overall Study|Protocol Violation|0
7604378|NCT02237508|12011344|FG005|Overall Study|Protocol Violation|0
7604379|NCT02237508|12011345|FG006|Overall Study|Protocol Violation|0
7604380|NCT02237508|12011346|FG007|Overall Study|Protocol Violation|0
7604381|NCT02237508|12011347|FG008|Overall Study|Protocol Violation|0
7604382|NCT02237508|12011348|FG009|Overall Study|Protocol Violation|0
7604383|NCT01706705|12011366|FG000|Overall Study|Death|1
7604384|NCT01706705|12011366|FG000|Overall Study|Lack of Efficacy|13
7604385|NCT01706705|12011366|FG000|Overall Study|Non-clinical|6
7604386|NCT01609842|12011375|FG000|Concurrent Intervention Control|pharmacy data not available|2
7604387|NCT01609842|12011376|FG001|Concurrent Intervention Control|pharmacy data not available|0
7604388|NCT00003479|12011408|FG000|Overall Study|Not evaluable|3
7604389|NCT04160195|12011414|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1
7604390|NCT04160195|12011415|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0
7604417|NCT04152447|12011438|FG000|Overall Study|Lost to Follow-up|1
7774641|NCT00910689|12220482|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2
7774642|NCT00910689|12220483|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4
7774643|NCT00910689|12220480|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
7774644|NCT00910689|12220481|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
7774645|NCT00910689|12220482|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
7774646|NCT00910689|12220483|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
7774647|NCT00910689|12220480|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1
7774648|NCT00910689|12220481|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1
7774649|NCT00910689|12220482|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0
7774650|NCT00910689|12220483|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0
7774651|NCT00910689|12220480|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0
7774652|NCT00910689|12220481|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0
7774653|NCT00910689|12220482|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2
7774654|NCT00910689|12220483|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0
7774655|NCT00910689|12220480|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0
7774656|NCT00910689|12220481|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0
7774657|NCT00910689|12220482|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1
7774658|NCT00910689|12220483|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1
7774659|NCT00910689|12220480|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
7774660|NCT00910689|12220481|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
7774661|NCT00910689|12220482|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
7774662|NCT00910689|12220483|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
7774663|NCT00910689|12220480|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2
7774664|NCT00910689|12220481|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4
7774665|NCT00910689|12220482|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2
7774666|NCT00910689|12220483|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2
7774667|NCT00910689|12220480|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1
7774668|NCT00910689|12220481|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0
7774669|NCT00910689|12220482|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0
7774670|NCT00910689|12220483|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0
7774671|NCT00910689|12220480|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
7774672|NCT00910689|12220481|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
7774673|NCT00910689|12220482|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
7774674|NCT00910689|12220483|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
7774675|NCT00910689|12220480|FG000|Months 11- 16: Evaluation Period II|Time Demands|2
7774676|NCT00910689|12220481|FG001|Months 11- 16: Evaluation Period II|Time Demands|1
7774677|NCT00910689|12220482|FG002|Months 11- 16: Evaluation Period II|Time Demands|0
7774678|NCT00910689|12220483|FG003|Months 11- 16: Evaluation Period II|Time Demands|0
7774679|NCT00910689|12220480|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0
7774680|NCT00910689|12220481|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0
7774681|NCT00910689|12220482|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0
7774682|NCT00910689|12220483|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1
7774683|NCT00910689|12220480|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0
7774684|NCT00910689|12220481|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2
7774685|NCT00910689|12220482|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1
7774686|NCT00910689|12220483|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0
7774687|NCT00910715|12220496|FG000|Overall Study|Lost to Follow-up|22
7774688|NCT00910715|12220497|FG001|Overall Study|Lost to Follow-up|26
7774689|NCT00910715|12220498|FG002|Overall Study|Lost to Follow-up|0
7774690|NCT00910728|12220517|FG000|Overall Study|Lack of Efficacy|2
7774691|NCT00910728|12220518|FG001|Overall Study|Lack of Efficacy|3
7774692|NCT00910728|12220519|FG002|Overall Study|Lack of Efficacy|1
7774693|NCT00910728|12220520|FG003|Overall Study|Lack of Efficacy|2
7774694|NCT00910728|12220521|FG004|Overall Study|Lack of Efficacy|1
7774695|NCT00910728|12220522|FG005|Overall Study|Lack of Efficacy|0
7774696|NCT00910728|12220523|FG006|Overall Study|Lack of Efficacy|2
7774697|NCT00910728|12220524|FG007|Overall Study|Lack of Efficacy|2
7774698|NCT00910728|12220525|FG008|Overall Study|Lack of Efficacy|2
7604418|NCT04152447|12011439|FG001|Overall Study|Lost to Follow-up|0
7604419|NCT04152447|12011438|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1
7604420|NCT04152447|12011439|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1
7604421|NCT04152447|12011438|FG000|Overall Study|Withdrawal by Subject|0
7604422|NCT04152447|12011439|FG001|Overall Study|Withdrawal by Subject|1
7604423|NCT04152447|12011438|FG000|Overall Study|Found ineligible after enrolling|1
7604424|NCT04152447|12011439|FG001|Overall Study|Found ineligible after enrolling|1
7604425|NCT04152447|12011438|FG000|Overall Study|Did not receive VR headset in time.|0
7604426|NCT04152447|12011439|FG001|Overall Study|Did not receive VR headset in time.|2
7604391|NCT04159701|12011425|FG000|Period 1: Treatment Period|Pregnancy|1
7604392|NCT04159701|12011426|FG001|Period 1: Treatment Period|Pregnancy|0
7604393|NCT04159701|12011425|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4
7604394|NCT04159701|12011426|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1
7604395|NCT04159701|12011425|FG000|Period 1: Treatment Period|Withdrawal by Subject|3
7604396|NCT04159701|12011426|FG001|Period 1: Treatment Period|Withdrawal by Subject|0
7604397|NCT04159701|12011425|FG000|Washout Period|site terminated by sponsor|0
7604398|NCT04159701|12011426|FG001|Washout Period|site terminated by sponsor|1
7604399|NCT04159701|12011425|FG000|Washout Period|study terminated by sponsor|10
7604400|NCT04159701|12011426|FG001|Washout Period|study terminated by sponsor|3
7604401|NCT04159701|12011425|FG000|Washout Period|Withdrawal by Subject|1
7604402|NCT04159701|12011426|FG001|Washout Period|Withdrawal by Subject|0
7604403|NCT04159701|12011425|FG000|Washout Period|Inadvertent Enrollment|1
7604404|NCT04159701|12011426|FG001|Washout Period|Inadvertent Enrollment|0
7604405|NCT04159701|12011425|FG000|Washout Period|Miscellaneous|1
7604406|NCT04159701|12011426|FG001|Washout Period|Miscellaneous|0
7604407|NCT04159701|12011425|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0
7604408|NCT04159701|12011426|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2
7604409|NCT04159701|12011425|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0
7604410|NCT04159701|12011426|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1
7604411|NCT04159701|12011425|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6
7604412|NCT04159701|12011426|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3
7604413|NCT04159701|12011425|FG000|Post-treatment Follow-up|Withdrawal by Subject|3
7604414|NCT04159701|12011426|FG001|Post-treatment Follow-up|Withdrawal by Subject|0
7604415|NCT04159701|12011425|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1
7604416|NCT04159701|12011426|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0
7604427|NCT04150107|12011447|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2
7604428|NCT04150107|12011448|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0
7604429|NCT04150107|12011447|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0
7604430|NCT04150107|12011448|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1
7604431|NCT04006847|12011456|FG000|Overall Study|Product issue|1
7604432|NCT03922711|12011463|FG000|Overall Study|Adverse Event|3
7604433|NCT03922711|12011464|FG001|Overall Study|Adverse Event|2
7604434|NCT03922711|12011465|FG002|Overall Study|Adverse Event|2
7604435|NCT03922711|12011463|FG000|Overall Study|Protocol Violation|1
7604436|NCT03922711|12011464|FG001|Overall Study|Protocol Violation|0
7604437|NCT03922711|12011465|FG002|Overall Study|Protocol Violation|0
7604438|NCT03922711|12011463|FG000|Overall Study|Withdrawal by Subject|0
7604439|NCT03922711|12011464|FG001|Overall Study|Withdrawal by Subject|3
7604440|NCT03922711|12011465|FG002|Overall Study|Withdrawal by Subject|1
7604441|NCT03922711|12011463|FG000|Overall Study|Not further specified|0
7604442|NCT03922711|12011464|FG001|Overall Study|Not further specified|0
7604443|NCT03922711|12011465|FG002|Overall Study|Not further specified|1
7604444|NCT04460183|12011474|FG000|Overall Study|Lost to Follow-up|3
7604445|NCT04460183|12011475|FG001|Overall Study|Lost to Follow-up|1
7604446|NCT04460183|12011474|FG000|Overall Study|Withdrawal by Subject|1
7604447|NCT04460183|12011475|FG001|Overall Study|Withdrawal by Subject|0
7774699|NCT00910728|12220517|FG000|Overall Study|Withdrawal by Subject|0
7774700|NCT00910728|12220518|FG001|Overall Study|Withdrawal by Subject|0
7774701|NCT00910728|12220519|FG002|Overall Study|Withdrawal by Subject|0
7774702|NCT00910728|12220520|FG003|Overall Study|Withdrawal by Subject|0
7774703|NCT00910728|12220521|FG004|Overall Study|Withdrawal by Subject|3
7774704|NCT00910728|12220522|FG005|Overall Study|Withdrawal by Subject|1
7774705|NCT00910728|12220523|FG006|Overall Study|Withdrawal by Subject|2
7774706|NCT00910728|12220524|FG007|Overall Study|Withdrawal by Subject|0
7774707|NCT00910728|12220525|FG008|Overall Study|Withdrawal by Subject|0
7774708|NCT00910728|12220517|FG000|Overall Study|(not specified)|2
7774709|NCT00910728|12220518|FG001|Overall Study|(not specified)|0
7774710|NCT00910728|12220519|FG002|Overall Study|(not specified)|1
7774711|NCT00910728|12220520|FG003|Overall Study|(not specified)|0
7604462|NCT03829332|12011503|FG000|Overall Study|Death|145
7604463|NCT03829332|12011504|FG001|Overall Study|Death|135
7604464|NCT03829332|12011503|FG000|Overall Study|Withdrawal by Subject|10
7604465|NCT03829332|12011504|FG001|Overall Study|Withdrawal by Subject|4
7604466|NCT03829332|12011503|FG000|Overall Study|Ongoing in Study|154
7604467|NCT03829332|12011504|FG001|Overall Study|Ongoing in Study|175
7774712|NCT00910728|12220521|FG004|Overall Study|(not specified)|1
7774713|NCT00910728|12220522|FG005|Overall Study|(not specified)|0
7774714|NCT00910728|12220523|FG006|Overall Study|(not specified)|0
7774715|NCT00910728|12220524|FG007|Overall Study|(not specified)|0
7774716|NCT00910728|12220525|FG008|Overall Study|(not specified)|0
7774717|NCT00910728|12220517|FG000|Overall Study|Adverse Event|2
7774718|NCT00910728|12220518|FG001|Overall Study|Adverse Event|0
7774719|NCT00910728|12220519|FG002|Overall Study|Adverse Event|1
7774720|NCT00910728|12220520|FG003|Overall Study|Adverse Event|1
7774721|NCT00910728|12220521|FG004|Overall Study|Adverse Event|0
7774722|NCT00910728|12220522|FG005|Overall Study|Adverse Event|0
7774723|NCT00910728|12220523|FG006|Overall Study|Adverse Event|2
7774724|NCT00910728|12220524|FG007|Overall Study|Adverse Event|1
7774725|NCT00910728|12220525|FG008|Overall Study|Adverse Event|1
7774726|NCT00910858|12220557|FG000|Pharmacokinetic Phase|Adverse Event|1
7774727|NCT00910858|12220558|FG001|Pharmacokinetic Phase|Adverse Event|0
7774728|NCT00910858|12220559|FG002|Pharmacokinetic Phase|Adverse Event|0
7774729|NCT00910858|12220557|FG000|Monotherapy Phase|Adverse Event|3
7774730|NCT00910858|12220558|FG001|Monotherapy Phase|Adverse Event|2
7774731|NCT00910858|12220559|FG002|Monotherapy Phase|Adverse Event|0
7774732|NCT00910858|12220557|FG000|Monotherapy Phase|Lack of therapeutic effect|9
7774733|NCT00910858|12220558|FG001|Monotherapy Phase|Lack of therapeutic effect|6
7774734|NCT00910858|12220559|FG002|Monotherapy Phase|Lack of therapeutic effect|4
7774735|NCT00910858|12220557|FG000|Monotherapy Phase|Withdrawal by Subject|1
7774736|NCT00910858|12220558|FG001|Monotherapy Phase|Withdrawal by Subject|3
7774737|NCT00910858|12220559|FG002|Monotherapy Phase|Withdrawal by Subject|1
7774738|NCT00910858|12220557|FG000|Monotherapy Phase|Protocol Violation|1
7774739|NCT00910858|12220558|FG001|Monotherapy Phase|Protocol Violation|0
7774740|NCT00910858|12220559|FG002|Monotherapy Phase|Protocol Violation|0
7774741|NCT00910858|12220557|FG000|Monotherapy Phase|Other|3
7774742|NCT00910858|12220558|FG001|Monotherapy Phase|Other|4
7774743|NCT00910858|12220559|FG002|Monotherapy Phase|Other|2
7774744|NCT00910858|12220557|FG000|Combined Treatment Phase|Lack of therapeutic effect|8
7774745|NCT00910858|12220558|FG001|Combined Treatment Phase|Lack of therapeutic effect|6
7774746|NCT00910858|12220559|FG002|Combined Treatment Phase|Lack of therapeutic effect|3
7774747|NCT00910858|12220557|FG000|Combined Treatment Phase|Withdrawal by Subject|0
7774748|NCT00910858|12220558|FG001|Combined Treatment Phase|Withdrawal by Subject|2
7774749|NCT00910858|12220559|FG002|Combined Treatment Phase|Withdrawal by Subject|0
7774750|NCT00910858|12220557|FG000|Combined Treatment Phase|Protocol Violation|1
7774751|NCT00910858|12220558|FG001|Combined Treatment Phase|Protocol Violation|0
7774752|NCT00910858|12220559|FG002|Combined Treatment Phase|Protocol Violation|0
7774753|NCT00910858|12220557|FG000|Combined Treatment Phase|Other|0
7774754|NCT00910858|12220558|FG001|Combined Treatment Phase|Other|2
7774755|NCT00910858|12220559|FG002|Combined Treatment Phase|Other|1
7774756|NCT00910871|12220575|FG000|Overall Study|Adverse Event|5
7774757|NCT00910871|12220575|FG000|Overall Study|Death|12
7774758|NCT00910871|12220575|FG000|Overall Study|Lost to Follow-up|8
7774759|NCT00910871|12220575|FG000|Overall Study|Protocol Violation|11
7774760|NCT00910871|12220575|FG000|Overall Study|Withdrawal by Subject|12
7774761|NCT00910871|12220575|FG000|Overall Study|Subject didn't meet eligibility criteria|5
7774762|NCT00910871|12220575|FG000|Overall Study|Undefined|1
7774763|NCT00910910|12220581|FG000|Overall Study|Adverse Event|63
7774764|NCT00910910|12220582|FG001|Overall Study|Adverse Event|35
7774765|NCT00910910|12220581|FG000|Overall Study|PD without histologic change|27
7774766|NCT00910910|12220582|FG001|Overall Study|PD without histologic change|23
7774767|NCT00910910|12220581|FG000|Overall Study|PD with histologic change|0
7774768|NCT00910910|12220582|FG001|Overall Study|PD with histologic change|2
7774769|NCT00910910|12220581|FG000|Overall Study|Withdrawal by Subject|7
7774770|NCT00910910|12220582|FG001|Overall Study|Withdrawal by Subject|5
7774771|NCT00910910|12220581|FG000|Overall Study|Lost to Follow-up|2
7774772|NCT00910910|12220582|FG001|Overall Study|Lost to Follow-up|2
7774773|NCT00910910|12220581|FG000|Overall Study|Death|9
7774774|NCT00910910|12220582|FG001|Overall Study|Death|3
7774775|NCT00910910|12220581|FG000|Overall Study|Protocol Violation|2
7774776|NCT00910910|12220582|FG001|Overall Study|Protocol Violation|2
7774777|NCT00910910|12220581|FG000|Overall Study|Completed 13 cycles of treatment|0
7774778|NCT00910910|12220582|FG001|Overall Study|Completed 13 cycles of treatment|118
7774779|NCT00910910|12220581|FG000|Overall Study|Other|114
7774780|NCT00910910|12220582|FG001|Overall Study|Other|32
7774781|NCT00910910|12220581|FG000|Overall Study|Untreated before cycle 1|1
7774782|NCT00910910|12220582|FG001|Overall Study|Untreated before cycle 1|2
7774783|NCT00910962|12220591|FG000|Overall Study|Adverse Event|5
7774784|NCT00910962|12220592|FG001|Overall Study|Adverse Event|20
7774785|NCT00910962|12220593|FG002|Overall Study|Adverse Event|17
7774786|NCT00910962|12220591|FG000|Overall Study|Protocol Violation|1
7774787|NCT00910962|12220592|FG001|Overall Study|Protocol Violation|3
7774788|NCT00910962|12220593|FG002|Overall Study|Protocol Violation|3
7774789|NCT00910962|12220591|FG000|Overall Study|Lost to Follow-up|0
7774790|NCT00910962|12220592|FG001|Overall Study|Lost to Follow-up|3
7774791|NCT00910962|12220593|FG002|Overall Study|Lost to Follow-up|1
7774792|NCT00910962|12220591|FG000|Overall Study|Physician Decision|0
7774793|NCT00910962|12220592|FG001|Overall Study|Physician Decision|6
7774794|NCT00910962|12220593|FG002|Overall Study|Physician Decision|6
7774795|NCT00910962|12220591|FG000|Overall Study|Withdrawal by Subject|25
7774796|NCT00910962|12220592|FG001|Overall Study|Withdrawal by Subject|32
7774797|NCT00910962|12220593|FG002|Overall Study|Withdrawal by Subject|32
7774798|NCT00910962|12220591|FG000|Overall Study|Reached defined stopping criteria|12
7774799|NCT00910962|12220592|FG001|Overall Study|Reached defined stopping criteria|14
7774800|NCT00910962|12220593|FG002|Overall Study|Reached defined stopping criteria|17
7774801|NCT00910988|12220607|FG000|Overall Study|Lost to Follow-up|2
7774802|NCT00910988|12220608|FG001|Overall Study|Lost to Follow-up|4
7774803|NCT00910988|12220609|FG002|Overall Study|Lost to Follow-up|3
7774804|NCT00910988|12220610|FG003|Overall Study|Lost to Follow-up|0
7774805|NCT00911144|12220638|FG000|Overall Study|Withdrawal by Subject|16
7774806|NCT00911144|12220639|FG001|Overall Study|Withdrawal by Subject|5
7774807|NCT00911157|12220647|FG000|Overall Study|Adverse Event|4
7774808|NCT00911157|12220648|FG001|Overall Study|Adverse Event|1
7774809|NCT00911157|12220647|FG000|Overall Study|Withdrawal by Subject|1
7774810|NCT00911157|12220648|FG001|Overall Study|Withdrawal by Subject|1
7774811|NCT00911157|12220647|FG000|Overall Study|Need for prohibited drug (heparin)|1
7774812|NCT00911157|12220648|FG001|Overall Study|Need for prohibited drug (heparin)|0
7774813|NCT00911157|12220647|FG000|Overall Study|Need to treat for lung cancer|1
7774814|NCT00911157|12220648|FG001|Overall Study|Need to treat for lung cancer|0
7774815|NCT00911170|12220656|FG000|Treatment Period|Randomized in error|1
7774816|NCT00911170|12220657|FG001|Treatment Period|Randomized in error|1
7774817|NCT00911170|12220656|FG000|Treatment Period|Ineligibility determined|1
7774818|NCT00911170|12220657|FG001|Treatment Period|Ineligibility determined|3
7774819|NCT00911170|12220656|FG000|Treatment Period|Protocol deviation|1
7774820|NCT00911170|12220657|FG001|Treatment Period|Protocol deviation|2
7774821|NCT00911170|12220656|FG000|Treatment Period|Adverse Event|9
7774822|NCT00911170|12220657|FG001|Treatment Period|Adverse Event|10
7774823|NCT00911170|12220656|FG000|Treatment Period|Withdrawal by Subject|4
7774824|NCT00911170|12220657|FG001|Treatment Period|Withdrawal by Subject|4
7774825|NCT00911170|12220656|FG000|Treatment Period|Disease progression|0
7774826|NCT00911170|12220657|FG001|Treatment Period|Disease progression|2
7774827|NCT00911170|12220656|FG000|Treatment Period|Physician Decision|5
7774828|NCT00911170|12220657|FG001|Treatment Period|Physician Decision|5
7774829|NCT00911170|12220656|FG000|Treatment Period|Lost to Follow-up|0
7774830|NCT00911170|12220657|FG001|Treatment Period|Lost to Follow-up|1
7774831|NCT00911170|12220656|FG000|Treatment Period|Death|6
7774832|NCT00911170|12220657|FG001|Treatment Period|Death|9
7774833|NCT00911170|12220656|FG000|Long Term Follow-Up|Continuing in study|274
7774834|NCT00911170|12220657|FG001|Long Term Follow-Up|Continuing in study|269
7774835|NCT00911170|12220656|FG000|Long Term Follow-Up|Withdrawal by Subject|20
7774836|NCT00911170|12220657|FG001|Long Term Follow-Up|Withdrawal by Subject|21
7774837|NCT00911170|12220656|FG000|Long Term Follow-Up|Physician Decision|5
7774838|NCT00911170|12220657|FG001|Long Term Follow-Up|Physician Decision|4
7774839|NCT00911170|12220656|FG000|Long Term Follow-Up|Lost to Follow-up|8
7774840|NCT00911170|12220657|FG001|Long Term Follow-Up|Lost to Follow-up|7
7774841|NCT00911170|12220656|FG000|Long Term Follow-Up|Death|116
7774842|NCT00911170|12220657|FG001|Long Term Follow-Up|Death|121
7774843|NCT00911300|12220665|FG000|Overall Study|Primary Endpoint Component Occurred|1
7774844|NCT00911300|12220666|FG001|Overall Study|Primary Endpoint Component Occurred|2
7774845|NCT00911300|12220665|FG000|Overall Study|Death|1
7774846|NCT00911300|12220666|FG001|Overall Study|Death|0
7774847|NCT00911300|12220665|FG000|Overall Study|Thrombus Persistant in Second TEE|3
7774848|NCT00911300|12220666|FG001|Overall Study|Thrombus Persistant in Second TEE|7
7774849|NCT00911300|12220665|FG000|Overall Study|Adverse Event|14
7774850|NCT00911300|12220666|FG001|Overall Study|Adverse Event|6
7774851|NCT00911300|12220665|FG000|Overall Study|Protocol Violation|3
7774852|NCT00911300|12220666|FG001|Overall Study|Protocol Violation|2
7774853|NCT00911300|12220665|FG000|Overall Study|Consent Withdrawn|4
7774854|NCT00911300|12220666|FG001|Overall Study|Consent Withdrawn|12
7774855|NCT00911300|12220665|FG000|Overall Study|Coronary Angiography Performed|1
7774856|NCT00911300|12220666|FG001|Overall Study|Coronary Angiography Performed|0
7774857|NCT00911300|12220665|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3
7774858|NCT00911300|12220666|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3
7774859|NCT00911300|12220665|FG000|Overall Study|Received Commercial Treatment|1
7774860|NCT00911300|12220666|FG001|Overall Study|Received Commercial Treatment|0
7774861|NCT00911300|12220665|FG000|Overall Study|Recurrent Tachyarrhythmia|1
7774862|NCT00911300|12220666|FG001|Overall Study|Recurrent Tachyarrhythmia|1
7774863|NCT00911300|12220665|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
7774864|NCT00911300|12220666|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
7774865|NCT00911300|12220665|FG000|Overall Study|Nurse Unavailable in Participant's City|1
7774866|NCT00911300|12220666|FG001|Overall Study|Nurse Unavailable in Participant's City|0
7774867|NCT00911300|12220665|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
7774868|NCT00911300|12220666|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
7774869|NCT00911300|12220665|FG000|Overall Study|Participant Could Not Stay in Hospital|0
7774870|NCT00911300|12220666|FG001|Overall Study|Participant Could Not Stay in Hospital|1
7774871|NCT00911300|12220665|FG000|Overall Study|Investigator's Decision; New AF Episode|0
7774872|NCT00911300|12220666|FG001|Overall Study|Investigator's Decision; New AF Episode|1
7774873|NCT00911300|12220665|FG000|Overall Study|International Normalized Ratio Too High|0
7774874|NCT00911300|12220666|FG001|Overall Study|International Normalized Ratio Too High|1
7774875|NCT00911300|12220665|FG000|Overall Study|Participant Refused Hospital Consulation|0
7774876|NCT00911300|12220666|FG001|Overall Study|Participant Refused Hospital Consulation|1
7774877|NCT00911300|12220665|FG000|Overall Study|Underlying Disease (Myocarditis)|0
7774878|NCT00911300|12220666|FG001|Overall Study|Underlying Disease (Myocarditis)|1
7774879|NCT00911300|12220665|FG000|Overall Study|Physician Decision|0
7774880|NCT00911300|12220666|FG001|Overall Study|Physician Decision|1
7774881|NCT00911300|12220665|FG000|Overall Study|Treatment Stopped by Mistake|0
7774882|NCT00911300|12220666|FG001|Overall Study|Treatment Stopped by Mistake|1
7774883|NCT00911300|12220665|FG000|Overall Study|Randomized; No Study Medication Received|0
7774884|NCT00911300|12220666|FG001|Overall Study|Randomized; No Study Medication Received|2
7774885|NCT00911508|12220683|FG000|Overall Study|Lost to Follow-up|27
7604572|NCT03543046|12011562|FG000|Overall Study|Adverse Event|1
7604573|NCT03543046|12011563|FG001|Overall Study|Adverse Event|1
7604574|NCT03543046|12011562|FG000|Overall Study|Physician Decision|1
7604575|NCT03543046|12011563|FG001|Overall Study|Physician Decision|1
7604576|NCT03543046|12011562|FG000|Overall Study|Protocol Violation|1
7604577|NCT03543046|12011563|FG001|Overall Study|Protocol Violation|0
7774886|NCT00911508|12220684|FG001|Overall Study|Lost to Follow-up|18
7774887|NCT00911508|12220683|FG000|Overall Study|Withdrawal by Subject|79
7774888|NCT00911508|12220684|FG001|Overall Study|Withdrawal by Subject|112
7774889|NCT00911534|12220692|FG000|Overall Study|Adverse Event|4
7774890|NCT00911534|12220693|FG001|Overall Study|Adverse Event|4
7774891|NCT00911534|12220692|FG000|Overall Study|Lost to Follow-up|2
7774892|NCT00911534|12220693|FG001|Overall Study|Lost to Follow-up|4
7774893|NCT00911534|12220692|FG000|Overall Study|Withdrawal by Subject|2
7774894|NCT00911534|12220693|FG001|Overall Study|Withdrawal by Subject|1
7604587|NCT03063203|12011613|FG000|Overall Study|Chose alternative therapy|3
7604588|NCT03063203|12011613|FG000|Overall Study|Death|2
7604589|NCT03063203|12011613|FG000|Overall Study|Disease progression|4
7604590|NCT03063203|12011613|FG000|Overall Study|Physician Decision|5
7774895|NCT00911534|12220692|FG000|Overall Study|Lack of Efficacy|4
7774896|NCT00911534|12220693|FG001|Overall Study|Lack of Efficacy|1
7774897|NCT00911534|12220692|FG000|Overall Study|Withdrawal of consent|1
7774898|NCT00911534|12220693|FG001|Overall Study|Withdrawal of consent|4
7774899|NCT00911534|12220692|FG000|Overall Study|Other|2
7774900|NCT00911534|12220693|FG001|Overall Study|Other|2
7774901|NCT00911625|12220715|FG000|Overall Study|Lost to Follow-up|7
7774902|NCT00911625|12220716|FG001|Overall Study|Lost to Follow-up|0
7774903|NCT00911768|12220733|FG000|Overall Study|Protocol Violation|5
7774904|NCT00911768|12220734|FG001|Overall Study|Protocol Violation|4
7774905|NCT00911768|12220733|FG000|Overall Study|Withdrawal by Subject|1
7774906|NCT00911768|12220734|FG001|Overall Study|Withdrawal by Subject|0
7774907|NCT00911807|12220743|FG000|Overall Study|Adverse Event|2
7774908|NCT00911807|12220744|FG001|Overall Study|Adverse Event|1
7774909|NCT00911807|12220745|FG002|Overall Study|Adverse Event|5
7774910|NCT00911807|12220743|FG000|Overall Study|Death|0
7774911|NCT00911807|12220744|FG001|Overall Study|Death|0
7604607|NCT02623205|12011657|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4
7774912|NCT00911807|12220745|FG002|Overall Study|Death|1
7774913|NCT00911807|12220743|FG000|Overall Study|Protocol Violation|6
7774914|NCT00911807|12220744|FG001|Overall Study|Protocol Violation|4
7774915|NCT00911807|12220745|FG002|Overall Study|Protocol Violation|9
7774916|NCT00911807|12220743|FG000|Overall Study|Withdrawal by Subject|8
7774917|NCT00911807|12220744|FG001|Overall Study|Withdrawal by Subject|10
7774918|NCT00911807|12220745|FG002|Overall Study|Withdrawal by Subject|7
7774919|NCT00911807|12220743|FG000|Overall Study|Organizational reasons|1
7774920|NCT00911807|12220744|FG001|Overall Study|Organizational reasons|3
7774921|NCT00911807|12220745|FG002|Overall Study|Organizational reasons|1
7800026|NCT01090492|12257181|FG001|First Intervention Period (4 Weeks)|Adverse Event|2
7800027|NCT01090492|12257182|FG002|First Intervention Period (4 Weeks)|Adverse Event|0
7604608|NCT02623205|12011658|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3
7800028|NCT01090492|12257183|FG003|First Intervention Period (4 Weeks)|Adverse Event|3
7800029|NCT01090492|12257184|FG004|First Intervention Period (4 Weeks)|Adverse Event|1
7800030|NCT01090492|12257185|FG005|First Intervention Period (4 Weeks)|Adverse Event|2
7800031|NCT01090492|12257186|FG006|First Intervention Period (4 Weeks)|Adverse Event|0
7800032|NCT01090492|12257187|FG007|First Intervention Period (4 Weeks)|Adverse Event|5
7774922|NCT00911820|12220755|FG000|Overall Study|RECIST progression|12
7774923|NCT00911820|12220756|FG001|Overall Study|RECIST progression|8
7774924|NCT00911820|12220755|FG000|Overall Study|Adverse Event|8
7774925|NCT00911820|12220756|FG001|Overall Study|Adverse Event|8
7774926|NCT00911820|12220755|FG000|Overall Study|Clinical Progression|7
7774927|NCT00911820|12220756|FG001|Overall Study|Clinical Progression|5
7774928|NCT00911820|12220755|FG000|Overall Study|Physician Decision|5
7774929|NCT00911820|12220756|FG001|Overall Study|Physician Decision|9
7774930|NCT00911820|12220755|FG000|Overall Study|Decline in Performance Status|4
7774931|NCT00911820|12220756|FG001|Overall Study|Decline in Performance Status|2
7774932|NCT00911820|12220755|FG000|Overall Study|Withdrawal by Subject|3
7774933|NCT00911820|12220756|FG001|Overall Study|Withdrawal by Subject|4
7774934|NCT00911820|12220755|FG000|Overall Study|Death|1
7774935|NCT00911820|12220756|FG001|Overall Study|Death|2
7774936|NCT00911820|12220755|FG000|Overall Study|Pursue surgery|1
7774937|NCT00911820|12220756|FG001|Overall Study|Pursue surgery|1
7774938|NCT00911820|12220755|FG000|Overall Study|Pursue Radiation|1
7774939|NCT00911820|12220756|FG001|Overall Study|Pursue Radiation|0
7774940|NCT00911820|12220755|FG000|Overall Study|Still on Therapy|2
7774941|NCT00911820|12220756|FG001|Overall Study|Still on Therapy|2
7774942|NCT00911820|12220755|FG000|Overall Study|Pathology Not Confirmed|1
7774943|NCT00911820|12220756|FG001|Overall Study|Pathology Not Confirmed|0
7774944|NCT00911820|12220755|FG000|Overall Study|Withdraw before Receive Treatment|0
7774945|NCT00911820|12220756|FG001|Overall Study|Withdraw before Receive Treatment|2
7774946|NCT00911859|12220765|FG000|Treatment Period|Adverse Event|3
7774947|NCT00911859|12220766|FG001|Treatment Period|Adverse Event|3
7774948|NCT00911859|12220767|FG002|Treatment Period|Adverse Event|7
7774949|NCT00911859|12220765|FG000|Treatment Period|Death|1
7774950|NCT00911859|12220766|FG001|Treatment Period|Death|3
7774951|NCT00911859|12220767|FG002|Treatment Period|Death|5
7774952|NCT00911859|12220765|FG000|Treatment Period|Lack of Efficacy|1
7774953|NCT00911859|12220766|FG001|Treatment Period|Lack of Efficacy|7
7774954|NCT00911859|12220767|FG002|Treatment Period|Lack of Efficacy|5
7774955|NCT00911859|12220765|FG000|Treatment Period|Physician Decision|3
7774956|NCT00911859|12220766|FG001|Treatment Period|Physician Decision|3
7774957|NCT00911859|12220767|FG002|Treatment Period|Physician Decision|3
7774958|NCT00911859|12220765|FG000|Treatment Period|Withdrawal by Subject|0
7774959|NCT00911859|12220766|FG001|Treatment Period|Withdrawal by Subject|4
7774960|NCT00911859|12220767|FG002|Treatment Period|Withdrawal by Subject|5
7774961|NCT00911859|12220765|FG000|Treatment Period|Did not receive study treatment|0
7774962|NCT00911859|12220766|FG001|Treatment Period|Did not receive study treatment|1
7774963|NCT00911859|12220767|FG002|Treatment Period|Did not receive study treatment|0
7774964|NCT00911859|12220765|FG000|Maintainance Period|Lack of Efficacy|0
7774965|NCT00911859|12220766|FG001|Maintainance Period|Lack of Efficacy|0
7774966|NCT00911859|12220767|FG002|Maintainance Period|Lack of Efficacy|9
7774967|NCT00911859|12220765|FG000|Maintainance Period|Physician Decision|0
7774968|NCT00911859|12220766|FG001|Maintainance Period|Physician Decision|0
7604647|NCT01560637|12011698|FG000|Overall Study|Adverse Event|63
7604648|NCT01560637|12011698|FG000|Overall Study|Death|69
7604649|NCT01560637|12011698|FG000|Overall Study|Lost to Follow-up|8
7604650|NCT01560637|12011698|FG000|Overall Study|Protocol Violation|8
7604651|NCT01560637|12011698|FG000|Overall Study|Withdrawal by Subject|24
7604652|NCT01560637|12011698|FG000|Overall Study|Progressive Disease|20
7604653|NCT01560637|12011698|FG000|Overall Study|Other Reason Not Specified|6
7604654|NCT00999804|12011704|FG000|Overall Study|Lack of Efficacy|9
7604655|NCT00999804|12011705|FG001|Overall Study|Lack of Efficacy|2
7604656|NCT00999804|12011704|FG000|Overall Study|Adverse Event|4
7604657|NCT00999804|12011705|FG001|Overall Study|Adverse Event|3
7604658|NCT00999804|12011704|FG000|Overall Study|Withdrawal by Subject|4
7604659|NCT00999804|12011705|FG001|Overall Study|Withdrawal by Subject|0
7604660|NCT00999804|12011704|FG000|Overall Study|Death|1
7604661|NCT00999804|12011705|FG001|Overall Study|Death|0
7604662|NCT00999804|12011704|FG000|Overall Study|Ineligible|3
7604663|NCT00999804|12011705|FG001|Overall Study|Ineligible|0
7604664|NCT00458003|12011713|FG000|Overall Study|Non protocol spinal anesthesia|1
7604665|NCT00458003|12011714|FG001|Overall Study|Non protocol spinal anesthesia|1
7774969|NCT00911859|12220767|FG002|Maintainance Period|Physician Decision|9
7774970|NCT00911859|12220765|FG000|Maintainance Period|Withdrawal by Subject|0
7774971|NCT00911859|12220766|FG001|Maintainance Period|Withdrawal by Subject|0
7774972|NCT00911859|12220767|FG002|Maintainance Period|Withdrawal by Subject|3
7774973|NCT00911859|12220765|FG000|Follow-up Period|Death|5
7774974|NCT00911859|12220766|FG001|Follow-up Period|Death|8
7774975|NCT00911859|12220767|FG002|Follow-up Period|Death|10
7774976|NCT00911859|12220765|FG000|Follow-up Period|Lost to Follow-up|1
7774977|NCT00911859|12220766|FG001|Follow-up Period|Lost to Follow-up|1
7774978|NCT00911859|12220767|FG002|Follow-up Period|Lost to Follow-up|0
7774979|NCT00911859|12220765|FG000|Follow-up Period|Withdrawal by Subject|0
7774980|NCT00911859|12220766|FG001|Follow-up Period|Withdrawal by Subject|4
7774981|NCT00911859|12220767|FG002|Follow-up Period|Withdrawal by Subject|4
7774982|NCT00911859|12220765|FG000|Follow-up Period|Study terminated by sponsor|5
7774983|NCT00911859|12220766|FG001|Follow-up Period|Study terminated by sponsor|33
7774984|NCT00911859|12220767|FG002|Follow-up Period|Study terminated by sponsor|27
7604666|NCT03794544|12011756|FG000|Overall Study|Withdrawal by Subject|1
7604667|NCT03794544|12011757|FG001|Overall Study|Withdrawal by Subject|1
7604668|NCT03794544|12011758|FG002|Overall Study|Withdrawal by Subject|0
7604669|NCT03794544|12011759|FG003|Overall Study|Withdrawal by Subject|0
7604670|NCT03794544|12011756|FG000|Overall Study|Death|0
7604671|NCT03794544|12011757|FG001|Overall Study|Death|0
7604672|NCT03794544|12011758|FG002|Overall Study|Death|0
7604673|NCT03794544|12011759|FG003|Overall Study|Death|1
7604674|NCT03794544|12011756|FG000|Overall Study|Lost to Follow-up|0
7604675|NCT03794544|12011757|FG001|Overall Study|Lost to Follow-up|1
7604676|NCT03794544|12011758|FG002|Overall Study|Lost to Follow-up|1
7604677|NCT03794544|12011759|FG003|Overall Study|Lost to Follow-up|0
7604678|NCT03794544|12011756|FG000|Overall Study|Other|0
7604679|NCT03794544|12011757|FG001|Overall Study|Other|1
7604680|NCT03794544|12011758|FG002|Overall Study|Other|0
7774985|NCT00911937|12220781|FG000|Overall Study|Death|1
7774986|NCT00911937|12220782|FG001|Overall Study|Death|0
7774987|NCT00911937|12220781|FG000|Overall Study|Lost to Follow-up|8
7774988|NCT00911937|12220782|FG001|Overall Study|Lost to Follow-up|5
7774989|NCT00911937|12220781|FG000|Overall Study|Withdrawal by Subject|10
7774990|NCT00911937|12220782|FG001|Overall Study|Withdrawal by Subject|7
7774991|NCT00911937|12220781|FG000|Overall Study|Withdrawn due to pregnancy|1
7774992|NCT00911937|12220782|FG001|Overall Study|Withdrawn due to pregnancy|0
7774993|NCT00911937|12220781|FG000|Overall Study|Adverse Event|11
7774994|NCT00911937|12220782|FG001|Overall Study|Adverse Event|25
7774995|NCT00911937|12220781|FG000|Overall Study|Lack of Efficacy|11
7774996|NCT00911937|12220782|FG001|Overall Study|Lack of Efficacy|6
7774997|NCT00911937|12220781|FG000|Overall Study|Did not meet inclusion criteria|9
7774998|NCT00911937|12220782|FG001|Overall Study|Did not meet inclusion criteria|11
7774999|NCT00911937|12220781|FG000|Overall Study|Protocol Violation|14
7775000|NCT00911937|12220782|FG001|Overall Study|Protocol Violation|23
7775001|NCT00911937|12220781|FG000|Overall Study|Randomized but not treated|13
7775002|NCT00911937|12220782|FG001|Overall Study|Randomized but not treated|13
7775003|NCT00911937|12220781|FG000|Overall Study|Other|9
7775004|NCT00911937|12220782|FG001|Overall Study|Other|5
7775005|NCT00911989|12220788|FG000|Overall Study|Adverse Event|1
7775006|NCT00912015|12220801|FG000|Overall Study|Lack of Efficacy|1
7775007|NCT00912015|12220802|FG001|Overall Study|Lack of Efficacy|0
7775008|NCT00912015|12220803|FG002|Overall Study|Lack of Efficacy|0
7775009|NCT00912015|12220804|FG003|Overall Study|Lack of Efficacy|0
7775010|NCT00912015|12220801|FG000|Overall Study|Withdrawal by Subject|8
7775011|NCT00912015|12220802|FG001|Overall Study|Withdrawal by Subject|8
7775012|NCT00912015|12220803|FG002|Overall Study|Withdrawal by Subject|3
7775013|NCT00912015|12220804|FG003|Overall Study|Withdrawal by Subject|0
7775014|NCT00912015|12220801|FG000|Overall Study|Protocol Violation|1
7775015|NCT00912015|12220802|FG001|Overall Study|Protocol Violation|0
7775016|NCT00912015|12220803|FG002|Overall Study|Protocol Violation|0
7775017|NCT00912015|12220804|FG003|Overall Study|Protocol Violation|1
7775018|NCT00912015|12220801|FG000|Overall Study|Adverse Event|6
7775019|NCT00912015|12220802|FG001|Overall Study|Adverse Event|0
7775020|NCT00912015|12220803|FG002|Overall Study|Adverse Event|0
7775021|NCT00912015|12220804|FG003|Overall Study|Adverse Event|1
7775022|NCT00912028|12220817|FG000|Overall Study|Lost to Follow-up|2
7775023|NCT00912028|12220818|FG001|Overall Study|Lost to Follow-up|3
7775024|NCT00912028|12220819|FG002|Overall Study|Lost to Follow-up|0
7775025|NCT00912028|12220820|FG003|Overall Study|Lost to Follow-up|1
7775026|NCT00912028|12220821|FG004|Overall Study|Lost to Follow-up|3
7775027|NCT00912028|12220817|FG000|Overall Study|Withdrawal by Subject|3
7775028|NCT00912028|12220818|FG001|Overall Study|Withdrawal by Subject|0
7775029|NCT00912028|12220819|FG002|Overall Study|Withdrawal by Subject|0
7775030|NCT00912028|12220820|FG003|Overall Study|Withdrawal by Subject|0
7775031|NCT00912028|12220821|FG004|Overall Study|Withdrawal by Subject|0
7775032|NCT00912093|12220836|FG000|The Controlled Phase|Death|0
7775033|NCT00912093|12220837|FG001|The Controlled Phase|Death|1
7775034|NCT00912093|12220838|FG002|The Controlled Phase|Death|0
7775035|NCT00912093|12220839|FG003|The Controlled Phase|Death|0
7775036|NCT00912093|12220840|FG004|The Controlled Phase|Death|0
7775037|NCT00912093|12220836|FG000|The Controlled Phase|Medical Condition|0
7775038|NCT00912093|12220837|FG001|The Controlled Phase|Medical Condition|1
7775039|NCT00912093|12220838|FG002|The Controlled Phase|Medical Condition|0
7775040|NCT00912093|12220839|FG003|The Controlled Phase|Medical Condition|0
7775041|NCT00912093|12220840|FG004|The Controlled Phase|Medical Condition|0
7604681|NCT03794544|12011759|FG003|Overall Study|Other|0
7604682|NCT03732807|12011776|FG000|Treatment Period (up to Week 24)|Adverse Event|3
7604683|NCT03732807|12011777|FG001|Treatment Period (up to Week 24)|Adverse Event|0
7604684|NCT03732807|12011778|FG002|Treatment Period (up to Week 24)|Adverse Event|2
7604685|NCT03732807|12011779|FG003|Treatment Period (up to Week 24)|Adverse Event|4
7604686|NCT03732807|12011780|FG004|Treatment Period (up to Week 24)|Adverse Event|2
7604687|NCT03732807|12011781|FG005|Treatment Period (up to Week 24)|Adverse Event|0
7604688|NCT03732807|12011782|FG006|Treatment Period (up to Week 24)|Adverse Event|1
7604689|NCT03732807|12011776|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1
7604690|NCT03732807|12011777|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0
7604691|NCT03732807|12011778|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1
7775042|NCT00912093|12220836|FG000|The Controlled Phase|Lost to Follow-up|0
7775043|NCT00912093|12220837|FG001|The Controlled Phase|Lost to Follow-up|0
7775044|NCT00912093|12220838|FG002|The Controlled Phase|Lost to Follow-up|0
7775045|NCT00912093|12220839|FG003|The Controlled Phase|Lost to Follow-up|0
7775046|NCT00912093|12220840|FG004|The Controlled Phase|Lost to Follow-up|1
7775047|NCT00912197|12220850|FG000|Overall Study|Withdrawal by Subject|3
7775048|NCT00912197|12220851|FG001|Overall Study|Withdrawal by Subject|3
7775049|NCT00912288|12220861|FG000|Overall Study|Death|0
7775050|NCT00912288|12220862|FG001|Overall Study|Death|1
7775051|NCT00912288|12220861|FG000|Overall Study|Adverse Event|1
7775052|NCT00912288|12220862|FG001|Overall Study|Adverse Event|1
7775053|NCT00912288|12220861|FG000|Overall Study|Lost to Follow-up|1
7775054|NCT00912288|12220862|FG001|Overall Study|Lost to Follow-up|0
7775055|NCT00912288|12220861|FG000|Overall Study|Protocol Violation|1
7604692|NCT03732807|12011779|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2
7604693|NCT03732807|12011780|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1
7604694|NCT03732807|12011781|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0
7775056|NCT00912288|12220862|FG001|Overall Study|Protocol Violation|0
7775057|NCT00912288|12220861|FG000|Overall Study|Withdrawal by Subject|3
7775058|NCT00912288|12220862|FG001|Overall Study|Withdrawal by Subject|3
7775059|NCT00912288|12220861|FG000|Overall Study|Study terminated by sponsor|34
7775060|NCT00912288|12220862|FG001|Overall Study|Study terminated by sponsor|35
7775061|NCT00912288|12220861|FG000|Overall Study|Other|1
7775062|NCT00912288|12220862|FG001|Overall Study|Other|0
7775063|NCT00912340|12220884|FG000|Overall Study|Adverse Event|2
7775064|NCT00912340|12220885|FG001|Overall Study|Adverse Event|4
7775065|NCT00912340|12220886|FG002|Overall Study|Adverse Event|0
7775066|NCT00912340|12220884|FG000|Overall Study|Protocol revised to remove arm|0
7775067|NCT00912340|12220885|FG001|Overall Study|Protocol revised to remove arm|0
7775068|NCT00912340|12220886|FG002|Overall Study|Protocol revised to remove arm|4
7775069|NCT00912405|12220894|FG000|Overall Study|Lost to Follow-up|5
7775070|NCT00912509|12220900|FG000|Overall Study|Lost to Follow-up|1
7775071|NCT00912509|12220901|FG001|Overall Study|Lost to Follow-up|0
7775072|NCT00912509|12220900|FG000|Overall Study|Lack of Efficacy|4
7775073|NCT00912509|12220901|FG001|Overall Study|Lack of Efficacy|3
7775074|NCT00912743|12220910|FG000|Overall Study|Adverse Event|3
7775075|NCT00912743|12220911|FG001|Overall Study|Adverse Event|1
7775076|NCT00912743|12220910|FG000|Overall Study|Lack of Efficacy|9
7775077|NCT00912743|12220911|FG001|Overall Study|Lack of Efficacy|18
7775078|NCT00912743|12220910|FG000|Overall Study|Toxicity|0
7775079|NCT00912743|12220911|FG001|Overall Study|Toxicity|1
7775080|NCT00912743|12220910|FG000|Overall Study|End of treatment form was not collected|1
7775081|NCT00912743|12220911|FG001|Overall Study|End of treatment form was not collected|0
7775082|NCT00912782|12220919|FG000|Overall Study|Death|2
7775083|NCT00912782|12220920|FG001|Overall Study|Death|1
7775084|NCT00912782|12220919|FG000|Overall Study|Lost to Follow-up|0
7775085|NCT00912782|12220920|FG001|Overall Study|Lost to Follow-up|1
7775086|NCT00912782|12220919|FG000|Overall Study|Did not receive vascular access type|1
7775087|NCT00912782|12220920|FG001|Overall Study|Did not receive vascular access type|2
7775088|NCT00912782|12220919|FG000|Overall Study|Relocated before study completion|0
7775089|NCT00912782|12220920|FG001|Overall Study|Relocated before study completion|1
7775090|NCT00912808|12220937|FG000|First Intervention (6 Weeks)|Adverse Event|2
7775091|NCT00912808|12220938|FG001|First Intervention (6 Weeks)|Adverse Event|1
7775092|NCT00912808|12220937|FG000|Washout|Withdrawal by Subject|0
7775093|NCT00912808|12220938|FG001|Washout|Withdrawal by Subject|1
7775094|NCT00912808|12220937|FG000|Second Intervention (6 Weeks)|Adverse Event|0
7775095|NCT00912808|12220938|FG001|Second Intervention (6 Weeks)|Adverse Event|1
7775096|NCT00912808|12220937|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1
7775097|NCT00912808|12220938|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0
7775098|NCT00912912|12220958|FG000|Overall Study|Withdrawal by Subject|1
7775099|NCT00912912|12220958|FG000|Overall Study|Disease Progression|3
7775100|NCT00912964|12220974|FG000|Overall Study|Eligibility criterion not met|1
7775101|NCT00912964|12220975|FG001|Overall Study|Eligibility criterion not met|1
7775102|NCT00912964|12220976|FG002|Overall Study|Eligibility criterion not met|0
7775103|NCT00912964|12220974|FG000|Overall Study|Adverse Event|15
7775104|NCT00912964|12220975|FG001|Overall Study|Adverse Event|18
7775105|NCT00912964|12220976|FG002|Overall Study|Adverse Event|12
7775106|NCT00912964|12220974|FG000|Overall Study|Lack of Efficacy|11
7775107|NCT00912964|12220975|FG001|Overall Study|Lack of Efficacy|4
7775108|NCT00912964|12220976|FG002|Overall Study|Lack of Efficacy|3
7775109|NCT00912964|12220974|FG000|Overall Study|Withdrawal by Subject|20
7775110|NCT00912964|12220975|FG001|Overall Study|Withdrawal by Subject|12
7775111|NCT00912964|12220976|FG002|Overall Study|Withdrawal by Subject|18
7604695|NCT03732807|12011782|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0
7604696|NCT03732807|12011776|FG000|Treatment Period (up to Week 24)|Physician Decision|0
7604697|NCT03732807|12011777|FG001|Treatment Period (up to Week 24)|Physician Decision|1
7604698|NCT03732807|12011778|FG002|Treatment Period (up to Week 24)|Physician Decision|2
7604699|NCT03732807|12011779|FG003|Treatment Period (up to Week 24)|Physician Decision|5
7604700|NCT03732807|12011780|FG004|Treatment Period (up to Week 24)|Physician Decision|0
7604701|NCT03732807|12011781|FG005|Treatment Period (up to Week 24)|Physician Decision|0
7604702|NCT03732807|12011782|FG006|Treatment Period (up to Week 24)|Physician Decision|1
7604703|NCT03732807|12011776|FG000|Treatment Period (up to Week 24)|Pregnancy|1
7604704|NCT03732807|12011777|FG001|Treatment Period (up to Week 24)|Pregnancy|0
7775112|NCT00912964|12220974|FG000|Overall Study|Lost to Follow-up|4
7604705|NCT03732807|12011778|FG002|Treatment Period (up to Week 24)|Pregnancy|0
7604706|NCT03732807|12011779|FG003|Treatment Period (up to Week 24)|Pregnancy|0
7604707|NCT03732807|12011780|FG004|Treatment Period (up to Week 24)|Pregnancy|1
7604708|NCT03732807|12011781|FG005|Treatment Period (up to Week 24)|Pregnancy|0
7604709|NCT03732807|12011782|FG006|Treatment Period (up to Week 24)|Pregnancy|1
7604710|NCT03732807|12011776|FG000|Treatment Period (up to Week 24)|Protocol Violation|1
7604711|NCT03732807|12011777|FG001|Treatment Period (up to Week 24)|Protocol Violation|1
7775113|NCT00912964|12220975|FG001|Overall Study|Lost to Follow-up|3
7775114|NCT00912964|12220976|FG002|Overall Study|Lost to Follow-up|3
7775115|NCT00912964|12220974|FG000|Overall Study|Protocol Violation|5
7775116|NCT00912964|12220975|FG001|Overall Study|Protocol Violation|3
7775117|NCT00912964|12220976|FG002|Overall Study|Protocol Violation|8
7775118|NCT00912964|12220974|FG000|Overall Study|Taking exclusionary medications|7
7775119|NCT00912964|12220975|FG001|Overall Study|Taking exclusionary medications|4
7775120|NCT00912964|12220976|FG002|Overall Study|Taking exclusionary medications|8
7775121|NCT00912964|12220974|FG000|Overall Study|Medical History|1
7775122|NCT00912964|12220975|FG001|Overall Study|Medical History|0
7775123|NCT00912964|12220976|FG002|Overall Study|Medical History|0
7775124|NCT00912964|12220974|FG000|Overall Study|Non-compliance with study procedures|2
7775125|NCT00912964|12220975|FG001|Overall Study|Non-compliance with study procedures|0
7775126|NCT00912964|12220976|FG002|Overall Study|Non-compliance with study procedures|0
7775127|NCT00912964|12220974|FG000|Overall Study|Violation of exclusion criterion|0
7775128|NCT00912964|12220975|FG001|Overall Study|Violation of exclusion criterion|0
7775129|NCT00912964|12220976|FG002|Overall Study|Violation of exclusion criterion|2
7775130|NCT00912964|12220974|FG000|Overall Study|Randomized but never received study drug|0
7775131|NCT00912964|12220975|FG001|Overall Study|Randomized but never received study drug|1
7775132|NCT00912964|12220976|FG002|Overall Study|Randomized but never received study drug|0
7775133|NCT00913380|12221035|FG000|Clinical Outcomes|Lost to Follow-up|6
7775134|NCT00913380|12221036|FG001|Clinical Outcomes|Lost to Follow-up|6
7775135|NCT00913458|12221042|FG000|Phase 1|Non-Responder|54
7775136|NCT00913458|12221043|FG001|Phase 1|Non-Responder|0
7775137|NCT00913458|12221044|FG002|Phase 1|Non-Responder|0
7775138|NCT00913458|12221045|FG003|Phase 1|Non-Responder|0
7775139|NCT00913458|12221046|FG004|Phase 1|Non-Responder|0
7775140|NCT00913458|12221047|FG005|Phase 1|Non-Responder|0
7775141|NCT00913458|12221048|FG006|Phase 1|Non-Responder|0
7775142|NCT00913458|12221042|FG000|Phase 1|Subject Request|17
7775143|NCT00913458|12221043|FG001|Phase 1|Subject Request|0
7775144|NCT00913458|12221044|FG002|Phase 1|Subject Request|0
7775145|NCT00913458|12221045|FG003|Phase 1|Subject Request|0
7775146|NCT00913458|12221046|FG004|Phase 1|Subject Request|0
7775147|NCT00913458|12221047|FG005|Phase 1|Subject Request|0
7775148|NCT00913458|12221048|FG006|Phase 1|Subject Request|0
7775149|NCT00913458|12221042|FG000|Phase 1|Adverse Event|20
7775150|NCT00913458|12221043|FG001|Phase 1|Adverse Event|0
7775151|NCT00913458|12221044|FG002|Phase 1|Adverse Event|0
7775152|NCT00913458|12221045|FG003|Phase 1|Adverse Event|0
7775153|NCT00913458|12221046|FG004|Phase 1|Adverse Event|0
7775154|NCT00913458|12221047|FG005|Phase 1|Adverse Event|0
7775155|NCT00913458|12221048|FG006|Phase 1|Adverse Event|0
7775156|NCT00913458|12221042|FG000|Phase 1|Lost to Follow-up|2
7775157|NCT00913458|12221043|FG001|Phase 1|Lost to Follow-up|0
7775158|NCT00913458|12221044|FG002|Phase 1|Lost to Follow-up|0
7775159|NCT00913458|12221045|FG003|Phase 1|Lost to Follow-up|0
7775160|NCT00913458|12221046|FG004|Phase 1|Lost to Follow-up|0
7775161|NCT00913458|12221047|FG005|Phase 1|Lost to Follow-up|0
7775162|NCT00913458|12221048|FG006|Phase 1|Lost to Follow-up|0
7775163|NCT00913458|12221042|FG000|Phase 1|Protocol Violation|10
7775164|NCT00913458|12221043|FG001|Phase 1|Protocol Violation|0
7604712|NCT03732807|12011778|FG002|Treatment Period (up to Week 24)|Protocol Violation|0
7604713|NCT03732807|12011779|FG003|Treatment Period (up to Week 24)|Protocol Violation|0
7604714|NCT03732807|12011780|FG004|Treatment Period (up to Week 24)|Protocol Violation|0
7604715|NCT03732807|12011781|FG005|Treatment Period (up to Week 24)|Protocol Violation|0
7604716|NCT03732807|12011782|FG006|Treatment Period (up to Week 24)|Protocol Violation|0
7604717|NCT03732807|12011776|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4
7604718|NCT03732807|12011777|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4
7604719|NCT03732807|12011778|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4
7604720|NCT03732807|12011779|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4
7604721|NCT03732807|12011780|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1
7604722|NCT03732807|12011781|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1
7604723|NCT03732807|12011782|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2
7604724|NCT03732807|12011776|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0
7604725|NCT03732807|12011777|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0
7604726|NCT03732807|12011778|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0
7604727|NCT03732807|12011779|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0
7775165|NCT00913458|12221044|FG002|Phase 1|Protocol Violation|0
7775166|NCT00913458|12221045|FG003|Phase 1|Protocol Violation|0
7775167|NCT00913458|12221046|FG004|Phase 1|Protocol Violation|0
7775168|NCT00913458|12221047|FG005|Phase 1|Protocol Violation|0
7775169|NCT00913458|12221048|FG006|Phase 1|Protocol Violation|0
7775170|NCT00913458|12221042|FG000|Phase 1|Sponsor|2
7775171|NCT00913458|12221043|FG001|Phase 1|Sponsor|0
7775172|NCT00913458|12221044|FG002|Phase 1|Sponsor|0
7775173|NCT00913458|12221045|FG003|Phase 1|Sponsor|0
7775174|NCT00913458|12221046|FG004|Phase 1|Sponsor|0
7604728|NCT03732807|12011780|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0
7604729|NCT03732807|12011781|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1
7604730|NCT03732807|12011782|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0
7604731|NCT03732807|12011776|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0
7604732|NCT03732807|12011777|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2
7604733|NCT03732807|12011778|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2
7604734|NCT03732807|12011779|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1
7604735|NCT03732807|12011780|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0
7604736|NCT03732807|12011781|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0
7604737|NCT03732807|12011782|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2
7604738|NCT03732807|12011776|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2
7604739|NCT03732807|12011777|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1
7604740|NCT03732807|12011778|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0
7604741|NCT03732807|12011779|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3
7604742|NCT03732807|12011780|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3
7604743|NCT03732807|12011781|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0
7604744|NCT03732807|12011782|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1
7775175|NCT00913458|12221047|FG005|Phase 1|Sponsor|0
7775176|NCT00913458|12221048|FG006|Phase 1|Sponsor|0
7775177|NCT00913458|12221042|FG000|Phase 1|Unsatisfactory Response per Investigator|7
7775178|NCT00913458|12221043|FG001|Phase 1|Unsatisfactory Response per Investigator|0
7775179|NCT00913458|12221044|FG002|Phase 1|Unsatisfactory Response per Investigator|0
7775180|NCT00913458|12221045|FG003|Phase 1|Unsatisfactory Response per Investigator|0
7775181|NCT00913458|12221046|FG004|Phase 1|Unsatisfactory Response per Investigator|0
7775182|NCT00913458|12221047|FG005|Phase 1|Unsatisfactory Response per Investigator|0
7775183|NCT00913458|12221048|FG006|Phase 1|Unsatisfactory Response per Investigator|0
7775184|NCT00913458|12221042|FG000|Phase 2|Non-Responder|0
7775185|NCT00913458|12221043|FG001|Phase 2|Non-Responder|5
7775186|NCT00913458|12221044|FG002|Phase 2|Non-Responder|7
7775187|NCT00913458|12221045|FG003|Phase 2|Non-Responder|12
7775188|NCT00913458|12221046|FG004|Phase 2|Non-Responder|0
7775189|NCT00913458|12221047|FG005|Phase 2|Non-Responder|0
7775190|NCT00913458|12221048|FG006|Phase 2|Non-Responder|0
7775191|NCT00913458|12221042|FG000|Phase 2|Subject Request|0
7775192|NCT00913458|12221043|FG001|Phase 2|Subject Request|0
7775193|NCT00913458|12221044|FG002|Phase 2|Subject Request|1
7775194|NCT00913458|12221045|FG003|Phase 2|Subject Request|2
7775195|NCT00913458|12221046|FG004|Phase 2|Subject Request|0
7775196|NCT00913458|12221047|FG005|Phase 2|Subject Request|0
7775197|NCT00913458|12221048|FG006|Phase 2|Subject Request|0
7775198|NCT00913458|12221042|FG000|Phase 2|Adverse Event|0
7775199|NCT00913458|12221043|FG001|Phase 2|Adverse Event|3
7775200|NCT00913458|12221044|FG002|Phase 2|Adverse Event|0
7775201|NCT00913458|12221045|FG003|Phase 2|Adverse Event|1
7604745|NCT03732807|12011776|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0
7604746|NCT03732807|12011777|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0
7604747|NCT03732807|12011778|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2
7604748|NCT03732807|12011779|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1
7604749|NCT03732807|12011780|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1
7604750|NCT03732807|12011781|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2
7604751|NCT03732807|12011782|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0
7604752|NCT03732807|12011776|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
7604753|NCT03732807|12011777|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1
7604754|NCT03732807|12011778|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
7604755|NCT03732807|12011779|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
7604756|NCT03732807|12011780|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
7604757|NCT03732807|12011781|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
7604758|NCT03732807|12011782|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
7604759|NCT03732807|12011776|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0
7775202|NCT00913458|12221046|FG004|Phase 2|Adverse Event|0
7775203|NCT00913458|12221047|FG005|Phase 2|Adverse Event|0
7775204|NCT00913458|12221048|FG006|Phase 2|Adverse Event|0
7775205|NCT00913458|12221042|FG000|Phase 2|Lost to Follow-up|0
7775206|NCT00913458|12221043|FG001|Phase 2|Lost to Follow-up|0
7775207|NCT00913458|12221044|FG002|Phase 2|Lost to Follow-up|0
7775208|NCT00913458|12221045|FG003|Phase 2|Lost to Follow-up|1
7775209|NCT00913458|12221046|FG004|Phase 2|Lost to Follow-up|0
7604760|NCT03732807|12011777|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1
7604761|NCT03732807|12011778|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0
7604762|NCT03732807|12011779|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1
7604763|NCT03732807|12011780|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1
7604764|NCT03732807|12011781|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0
7604765|NCT03732807|12011782|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0
7604766|NCT03732807|12011776|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3
7604767|NCT03732807|12011777|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2
7604768|NCT03732807|12011778|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
7775210|NCT00913458|12221047|FG005|Phase 2|Lost to Follow-up|0
7775211|NCT00913458|12221048|FG006|Phase 2|Lost to Follow-up|0
7604769|NCT03732807|12011779|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
7604770|NCT03732807|12011780|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0
7604771|NCT03732807|12011781|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
7604772|NCT03732807|12011782|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
7604773|NCT03732807|12011776|FG000|Treatment Extension (Week 25 up to 48)|Other|1
7604774|NCT03732807|12011777|FG001|Treatment Extension (Week 25 up to 48)|Other|4
7604775|NCT03732807|12011778|FG002|Treatment Extension (Week 25 up to 48)|Other|0
7604776|NCT03732807|12011779|FG003|Treatment Extension (Week 25 up to 48)|Other|2
7604777|NCT03732807|12011780|FG004|Treatment Extension (Week 25 up to 48)|Other|0
7604778|NCT03732807|12011781|FG005|Treatment Extension (Week 25 up to 48)|Other|0
7604779|NCT03732807|12011782|FG006|Treatment Extension (Week 25 up to 48)|Other|0
7775212|NCT00913458|12221042|FG000|Phase 2|Protocol Violation|0
7775213|NCT00913458|12221043|FG001|Phase 2|Protocol Violation|2
7775214|NCT00913458|12221044|FG002|Phase 2|Protocol Violation|0
7775215|NCT00913458|12221045|FG003|Phase 2|Protocol Violation|0
7775216|NCT00913458|12221046|FG004|Phase 2|Protocol Violation|0
7775217|NCT00913458|12221047|FG005|Phase 2|Protocol Violation|0
7775218|NCT00913458|12221048|FG006|Phase 2|Protocol Violation|0
7775219|NCT00913458|12221042|FG000|Phase 2|Unsatisfactory Response per Investigator|0
7775220|NCT00913458|12221043|FG001|Phase 2|Unsatisfactory Response per Investigator|0
7775221|NCT00913458|12221044|FG002|Phase 2|Unsatisfactory Response per Investigator|11
7775222|NCT00913458|12221045|FG003|Phase 2|Unsatisfactory Response per Investigator|17
7775223|NCT00913458|12221046|FG004|Phase 2|Unsatisfactory Response per Investigator|0
7775224|NCT00913458|12221047|FG005|Phase 2|Unsatisfactory Response per Investigator|0
7775225|NCT00913458|12221048|FG006|Phase 2|Unsatisfactory Response per Investigator|0
7775226|NCT00913458|12221042|FG000|Phase 3|Adverse Event|0
7775227|NCT00913458|12221043|FG001|Phase 3|Adverse Event|0
7775228|NCT00913458|12221044|FG002|Phase 3|Adverse Event|0
7775229|NCT00913458|12221045|FG003|Phase 3|Adverse Event|0
7775230|NCT00913458|12221046|FG004|Phase 3|Adverse Event|5
7775231|NCT00913458|12221047|FG005|Phase 3|Adverse Event|4
7775232|NCT00913458|12221048|FG006|Phase 3|Adverse Event|1
7604780|NCT03731364|12011804|FG000|Overall Study|Adverse Event|0
7604781|NCT03731364|12011805|FG001|Overall Study|Adverse Event|0
7604782|NCT03731364|12011806|FG002|Overall Study|Adverse Event|1
7604783|NCT03731364|12011807|FG003|Overall Study|Adverse Event|2
7604784|NCT03731364|12011808|FG004|Overall Study|Adverse Event|1
7604785|NCT04598152|12011860|FG000|Overall Study|Lost to Follow-up|0
7604786|NCT04598152|12011861|FG001|Overall Study|Lost to Follow-up|1
7604787|NCT04570670|12011895|FG000|Overall Study|Withdrawal by Subject|1
7604788|NCT04570670|12011896|FG001|Overall Study|Withdrawal by Subject|0
7604789|NCT04546581|12011912|FG000|Overall Study|Adverse Event|9
7604790|NCT04546581|12011913|FG001|Overall Study|Adverse Event|3
7604791|NCT04546581|12011912|FG000|Overall Study|Physician Decision|0
7604792|NCT04546581|12011913|FG001|Overall Study|Physician Decision|1
7604793|NCT04546581|12011912|FG000|Overall Study|Protocol Violation|1
7604794|NCT04546581|12011913|FG001|Overall Study|Protocol Violation|2
7604795|NCT04546581|12011912|FG000|Overall Study|Withdrawal by Subject|3
7604796|NCT04546581|12011913|FG001|Overall Study|Withdrawal by Subject|7
7604797|NCT04021290|12011925|FG000|Overall Study|Adverse Event|4
7604798|NCT04021290|12011926|FG001|Overall Study|Adverse Event|3
7604799|NCT04021290|12011925|FG000|Overall Study|Lack of Efficacy|0
7604800|NCT04021290|12011926|FG001|Overall Study|Lack of Efficacy|3
7604801|NCT04021290|12011925|FG000|Overall Study|Lost to Follow-up|2
7604802|NCT04021290|12011926|FG001|Overall Study|Lost to Follow-up|1
7604803|NCT04021290|12011925|FG000|Overall Study|Death|1
7604804|NCT04021290|12011926|FG001|Overall Study|Death|0
7604805|NCT04021290|12011925|FG000|Overall Study|Physician Decision|1
7604806|NCT04021290|12011926|FG001|Overall Study|Physician Decision|2
7604807|NCT04021290|12011925|FG000|Overall Study|Withdrawal by Subject|1
7604808|NCT04021290|12011926|FG001|Overall Study|Withdrawal by Subject|5
7604809|NCT04021290|12011925|FG000|Overall Study|Ongoing|89
7604810|NCT04021290|12011926|FG001|Overall Study|Ongoing|0
7604811|NCT04021290|12011925|FG000|Overall Study|Protocol Deviation|5
7604812|NCT04021290|12011926|FG001|Overall Study|Protocol Deviation|4
7604813|NCT03915626|12011932|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1
7604814|NCT03698279|12011948|FG000|Overall Study|Withdrawal by parent/guardian|1
7604815|NCT03698279|12011949|FG001|Overall Study|Withdrawal by parent/guardian|1
7604816|NCT03698279|12011950|FG002|Overall Study|Withdrawal by parent/guardian|1
7604817|NCT03698279|12011951|FG003|Overall Study|Withdrawal by parent/guardian|1
7604818|NCT03698279|12011952|FG004|Overall Study|Withdrawal by parent/guardian|0
7604819|NCT03698279|12011953|FG005|Overall Study|Withdrawal by parent/guardian|0
7604820|NCT03698279|12011948|FG000|Overall Study|Protocol deviation|1
7604821|NCT03698279|12011949|FG001|Overall Study|Protocol deviation|0
7604822|NCT03698279|12011950|FG002|Overall Study|Protocol deviation|1
7604823|NCT03698279|12011951|FG003|Overall Study|Protocol deviation|0
7775233|NCT00913458|12221042|FG000|Phase 3|Lost to Follow-up|0
7775234|NCT00913458|12221043|FG001|Phase 3|Lost to Follow-up|0
7775235|NCT00913458|12221044|FG002|Phase 3|Lost to Follow-up|0
7775236|NCT00913458|12221045|FG003|Phase 3|Lost to Follow-up|0
7775237|NCT00913458|12221046|FG004|Phase 3|Lost to Follow-up|2
7775238|NCT00913458|12221047|FG005|Phase 3|Lost to Follow-up|0
7775239|NCT00913458|12221048|FG006|Phase 3|Lost to Follow-up|0
7775240|NCT00913458|12221042|FG000|Phase 3|Non-Responder|0
7775241|NCT00913458|12221043|FG001|Phase 3|Non-Responder|0
7775242|NCT00913458|12221044|FG002|Phase 3|Non-Responder|0
7775243|NCT00913458|12221045|FG003|Phase 3|Non-Responder|0
7775244|NCT00913458|12221046|FG004|Phase 3|Non-Responder|0
7775245|NCT00913458|12221047|FG005|Phase 3|Non-Responder|1
7775246|NCT00913458|12221048|FG006|Phase 3|Non-Responder|3
7775247|NCT00913458|12221042|FG000|Phase 3|Withdrawal by Subject|0
7604824|NCT03698279|12011952|FG004|Overall Study|Protocol deviation|0
7604825|NCT03698279|12011953|FG005|Overall Study|Protocol deviation|0
7604826|NCT03698279|12011948|FG000|Overall Study|Withdrawal by Subject|0
7604827|NCT03698279|12011949|FG001|Overall Study|Withdrawal by Subject|0
7604828|NCT03698279|12011950|FG002|Overall Study|Withdrawal by Subject|1
7775248|NCT00913458|12221043|FG001|Phase 3|Withdrawal by Subject|0
7775249|NCT00913458|12221044|FG002|Phase 3|Withdrawal by Subject|0
7775250|NCT00913458|12221045|FG003|Phase 3|Withdrawal by Subject|0
7604829|NCT03698279|12011951|FG003|Overall Study|Withdrawal by Subject|0
7604830|NCT03698279|12011952|FG004|Overall Study|Withdrawal by Subject|0
7604831|NCT03698279|12011953|FG005|Overall Study|Withdrawal by Subject|0
7604832|NCT03698279|12011948|FG000|Overall Study|Lost to Follow-up|3
7604833|NCT03698279|12011949|FG001|Overall Study|Lost to Follow-up|1
7604834|NCT03698279|12011950|FG002|Overall Study|Lost to Follow-up|4
7604835|NCT03698279|12011951|FG003|Overall Study|Lost to Follow-up|5
7604836|NCT03698279|12011952|FG004|Overall Study|Lost to Follow-up|0
7604837|NCT03698279|12011953|FG005|Overall Study|Lost to Follow-up|0
7604838|NCT03478930|12011983|FG000|Overall Study|Adverse Event|0
7604839|NCT03478930|12011984|FG001|Overall Study|Adverse Event|1
7604840|NCT03478930|12011983|FG000|Overall Study|Lack of Efficacy|3
7604841|NCT03478930|12011984|FG001|Overall Study|Lack of Efficacy|3
7604842|NCT03478930|12011983|FG000|Overall Study|Withdrawal by Subject|6
7604843|NCT03478930|12011984|FG001|Overall Study|Withdrawal by Subject|5
7604844|NCT03434353|12011995|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10
7604845|NCT03434353|12011996|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3
7604846|NCT03434353|12011997|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11
7604847|NCT03434353|12011998|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3
7604848|NCT03434353|12011999|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17
7604849|NCT03434353|12011995|FG000|Overall Study|Withdrew consent|1
7604850|NCT03434353|12011996|FG001|Overall Study|Withdrew consent|0
7604851|NCT03434353|12011997|FG002|Overall Study|Withdrew consent|3
7604852|NCT03434353|12011998|FG003|Overall Study|Withdrew consent|0
7604853|NCT03434353|12011999|FG004|Overall Study|Withdrew consent|0
7604854|NCT03434353|12011995|FG000|Overall Study|Adverse Event|1
7604855|NCT03434353|12011996|FG001|Overall Study|Adverse Event|0
7604856|NCT03434353|12011997|FG002|Overall Study|Adverse Event|0
7604857|NCT03434353|12011998|FG003|Overall Study|Adverse Event|0
7604858|NCT03434353|12011999|FG004|Overall Study|Adverse Event|1
7604859|NCT03434353|12011995|FG000|Overall Study|Lost to Follow-up|2
7604860|NCT03434353|12011996|FG001|Overall Study|Lost to Follow-up|0
7775251|NCT00913458|12221046|FG004|Phase 3|Withdrawal by Subject|1
7775252|NCT00913458|12221047|FG005|Phase 3|Withdrawal by Subject|2
7775253|NCT00913458|12221048|FG006|Phase 3|Withdrawal by Subject|0
7775254|NCT00913458|12221042|FG000|Phase 3|Unsatisfactory Response per Investigator|0
7775255|NCT00913458|12221043|FG001|Phase 3|Unsatisfactory Response per Investigator|0
7775256|NCT00913458|12221044|FG002|Phase 3|Unsatisfactory Response per Investigator|0
7775257|NCT00913458|12221045|FG003|Phase 3|Unsatisfactory Response per Investigator|0
7775258|NCT00913458|12221046|FG004|Phase 3|Unsatisfactory Response per Investigator|14
7775259|NCT00913458|12221047|FG005|Phase 3|Unsatisfactory Response per Investigator|11
7775260|NCT00913458|12221048|FG006|Phase 3|Unsatisfactory Response per Investigator|4
7775261|NCT00913523|12221077|FG000|Overall Study|Withdrawal by Subject|3
7775262|NCT00913523|12221078|FG001|Overall Study|Withdrawal by Subject|2
7775263|NCT00913523|12221079|FG002|Overall Study|Withdrawal by Subject|2
7775264|NCT00913523|12221077|FG000|Overall Study|Lost to Follow-up|1
7775265|NCT00913523|12221078|FG001|Overall Study|Lost to Follow-up|1
7775266|NCT00913523|12221079|FG002|Overall Study|Lost to Follow-up|1
7775267|NCT00913523|12221077|FG000|Overall Study|Adverse Event|1
7775268|NCT00913523|12221078|FG001|Overall Study|Adverse Event|0
7775269|NCT00913523|12221079|FG002|Overall Study|Adverse Event|0
7775270|NCT00913523|12221077|FG000|Overall Study|Protocol Violation|5
7775271|NCT00913523|12221078|FG001|Overall Study|Protocol Violation|8
7775272|NCT00913523|12221079|FG002|Overall Study|Protocol Violation|8
7775273|NCT00913523|12221077|FG000|Overall Study|Pregnancy|1
7775274|NCT00913523|12221078|FG001|Overall Study|Pregnancy|3
7775275|NCT00913523|12221079|FG002|Overall Study|Pregnancy|0
7775276|NCT00913523|12221077|FG000|Overall Study|Inadequate Number of Tampons Used|7
7775277|NCT00913523|12221078|FG001|Overall Study|Inadequate Number of Tampons Used|2
7775278|NCT00913523|12221079|FG002|Overall Study|Inadequate Number of Tampons Used|3
7775279|NCT00913744|12221106|FG000|Overall Study|Adverse Event|2
7775280|NCT00913744|12221107|FG001|Overall Study|Adverse Event|0
7775281|NCT00913744|12221106|FG000|Overall Study|Withdrawal by Subject|2
7775282|NCT00913744|12221107|FG001|Overall Study|Withdrawal by Subject|1
7775283|NCT00913744|12221106|FG000|Overall Study|Death|1
7775284|NCT00913744|12221107|FG001|Overall Study|Death|0
7775285|NCT00913770|12221116|FG000|Overall Study|Unable to contact|24
7775286|NCT00913770|12221117|FG001|Overall Study|Unable to contact|19
7775287|NCT00913770|12221118|FG002|Overall Study|Unable to contact|13
7775288|NCT00913770|12221116|FG000|Overall Study|Refused|11
7775289|NCT00913770|12221117|FG001|Overall Study|Refused|10
7775290|NCT00913770|12221118|FG002|Overall Study|Refused|8
7775291|NCT00913835|12221128|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
7775292|NCT00913835|12221129|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
7775293|NCT00913835|12221128|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
7775294|NCT00913835|12221129|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
7775295|NCT00913835|12221128|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4
7775296|NCT00913835|12221129|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3
7775297|NCT00913835|12221128|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
7775298|NCT00913835|12221129|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
7775299|NCT00913835|12221128|FG000|Lip Dox: Olaratumab Monotherapy|Other|0
7775300|NCT00913835|12221129|FG001|Lip Dox: Olaratumab Monotherapy|Other|3
7604861|NCT03434353|12011997|FG002|Overall Study|Lost to Follow-up|0
7604862|NCT03434353|12011998|FG003|Overall Study|Lost to Follow-up|0
7604863|NCT03434353|12011999|FG004|Overall Study|Lost to Follow-up|0
7604864|NCT03415022|12012013|FG000|Overall Study|Withdrawal by Subject|1
7604865|NCT03415022|12012014|FG001|Overall Study|Withdrawal by Subject|2
7775301|NCT00913978|12221148|FG000|Overall Study|Surgeon choice|1
7775302|NCT00913978|12221149|FG001|Overall Study|Surgeon choice|3
7775303|NCT00914316|12221186|FG000|Phase 1|Physician Decision|4
7775304|NCT00914316|12221187|FG001|Phase 1|Physician Decision|0
7604866|NCT03415022|12012013|FG000|Overall Study|COVID-19 Suspension|2
7604867|NCT03415022|12012014|FG001|Overall Study|COVID-19 Suspension|3
7604868|NCT03415022|12012013|FG000|Overall Study|Lost to Follow-up|2
7604869|NCT03415022|12012014|FG001|Overall Study|Lost to Follow-up|0
7604870|NCT03283670|12012020|FG000|Placebo Gas|Withdrawal by Subject|2
7604871|NCT03283670|12012020|FG000|25% Nitrous Oxide|Withdrawal by Subject|4
7604872|NCT03283670|12012020|FG000|50% Nitrous Oxide|Withdrawal by Subject|1
7604873|NCT03219567|12012051|FG000|Overall Study|Withdrawal by Subject|0
7604874|NCT03219567|12012052|FG001|Overall Study|Withdrawal by Subject|1
7604875|NCT03153111|12012070|FG000|Overall Study|Death|2
7604876|NCT03153111|12012071|FG001|Overall Study|Death|5
7604877|NCT03153111|12012070|FG000|Overall Study|Lost to Follow-up|1
7604878|NCT03153111|12012071|FG001|Overall Study|Lost to Follow-up|0
7604879|NCT03153111|12012070|FG000|Overall Study|Physician Decision|5
7604880|NCT03153111|12012071|FG001|Overall Study|Physician Decision|1
7604881|NCT03153111|12012070|FG000|Overall Study|Withdrawal by Subject|3
7604882|NCT03153111|12012071|FG001|Overall Study|Withdrawal by Subject|3
7604883|NCT03073733|12012080|FG000|Overall Study|Lost to Follow-up|1
7604884|NCT03073733|12012081|FG001|Overall Study|Lost to Follow-up|0
7604885|NCT03073733|12012082|FG002|Overall Study|Lost to Follow-up|0
7604886|NCT03073733|12012080|FG000|Overall Study|Physician Decision|0
7604887|NCT03073733|12012081|FG001|Overall Study|Physician Decision|1
7604888|NCT03073733|12012082|FG002|Overall Study|Physician Decision|0
7604889|NCT03073733|12012080|FG000|Overall Study|Withdrawal by Subject|0
7604890|NCT03073733|12012081|FG001|Overall Study|Withdrawal by Subject|0
7604891|NCT03073733|12012082|FG002|Overall Study|Withdrawal by Subject|1
7775305|NCT00914316|12221188|FG002|Phase 1|Physician Decision|1
7775306|NCT00914316|12221189|FG003|Phase 1|Physician Decision|2
7864082|NCT01609556|12353449|FG005|Dose Expansion: Maximum 124 Weeks|Death|0
7604895|NCT02702414|12012120|FG000|Overall Study|Death|77
7604896|NCT02702414|12012121|FG001|Overall Study|Death|34
7604897|NCT02702414|12012120|FG000|Overall Study|Lost to Follow-up|0
7604898|NCT02702414|12012121|FG001|Overall Study|Lost to Follow-up|1
7604899|NCT02702414|12012120|FG000|Overall Study|Withdrawal by Subject|0
7604900|NCT02702414|12012121|FG001|Overall Study|Withdrawal by Subject|1
7604901|NCT02702414|12012120|FG000|Overall Study|Participants Ongoing in Study|27
7604902|NCT02702414|12012121|FG001|Overall Study|Participants Ongoing in Study|15
7604903|NCT02702414|12012120|FG000|Overall Study|Not Treated|1
7604904|NCT02702414|12012121|FG001|Overall Study|Not Treated|0
7864083|NCT01609556|12353450|FG006|Dose Expansion: Maximum 124 Weeks|Death|0
7864084|NCT01609556|12353451|FG007|Dose Expansion: Maximum 124 Weeks|Death|0
7864085|NCT01609556|12353452|FG008|Dose Expansion: Maximum 124 Weeks|Death|0
7864086|NCT01609556|12353453|FG009|Dose Expansion: Maximum 124 Weeks|Death|0
7864087|NCT01609556|12353454|FG010|Dose Expansion: Maximum 124 Weeks|Death|0
7604911|NCT02420795|12012161|FG000|Overall Study|Withdrawal by Subject|1
7604912|NCT02420795|12012162|FG001|Overall Study|Withdrawal by Subject|0
7604913|NCT02420795|12012163|FG002|Overall Study|Withdrawal by Subject|0
7604914|NCT02420795|12012161|FG000|Overall Study|Adverse Event|1
7604915|NCT02420795|12012162|FG001|Overall Study|Adverse Event|0
7604916|NCT02420795|12012163|FG002|Overall Study|Adverse Event|0
7604917|NCT02420795|12012161|FG000|Overall Study|Progressive disease|2
7604918|NCT02420795|12012162|FG001|Overall Study|Progressive disease|2
7604919|NCT02420795|12012163|FG002|Overall Study|Progressive disease|4
7604920|NCT02420795|12012161|FG000|Overall Study|Death|0
7604921|NCT02420795|12012162|FG001|Overall Study|Death|0
7604922|NCT02420795|12012163|FG002|Overall Study|Death|1
7604923|NCT02240485|12012175|FG000|3 Months Post-admission|Lost to Follow-up|1
7604924|NCT02240485|12012176|FG001|3 Months Post-admission|Lost to Follow-up|5
7604925|NCT02240485|12012175|FG000|3 Months Post-admission|Withdrawal by Subject|2
7604926|NCT02240485|12012176|FG001|3 Months Post-admission|Withdrawal by Subject|1
7604927|NCT02240485|12012175|FG000|9 Months Post-admission|Lost to Follow-up|3
7604928|NCT02240485|12012176|FG001|9 Months Post-admission|Lost to Follow-up|1
7604929|NCT02240485|12012175|FG000|9 Months Post-admission|Withdrawal by Subject|0
7604930|NCT02240485|12012176|FG001|9 Months Post-admission|Withdrawal by Subject|3
7604931|NCT02240485|12012175|FG000|18 Months Post-admission|Lost to Follow-up|1
7604932|NCT02240485|12012176|FG001|18 Months Post-admission|Lost to Follow-up|1
7604933|NCT02240485|12012175|FG000|18 Months Post-admission|Withdrawal by Subject|2
7604934|NCT02240485|12012176|FG001|18 Months Post-admission|Withdrawal by Subject|4
7604935|NCT02227147|12012188|FG000|Controlled Treatment Period|Adverse Event|4
7604936|NCT02227147|12012189|FG001|Controlled Treatment Period|Adverse Event|3
7604937|NCT02227147|12012188|FG000|Controlled Treatment Period|Other|2
7604938|NCT02227147|12012189|FG001|Controlled Treatment Period|Other|0
7604939|NCT02227147|12012188|FG000|Follow-up Period|Other|3
7604940|NCT02227147|12012189|FG001|Follow-up Period|Other|5
7604941|NCT02199691|12012203|FG000|Overall Study|Protocol Violation|3
7604942|NCT02199691|12012204|FG001|Overall Study|Protocol Violation|3
7604943|NCT02199691|12012205|FG002|Overall Study|Protocol Violation|6
7604944|NCT02199691|12012206|FG003|Overall Study|Protocol Violation|7
7604945|NCT02199691|12012203|FG000|Overall Study|Withdrawal by Subject|5
7604946|NCT02199691|12012204|FG001|Overall Study|Withdrawal by Subject|3
7775307|NCT00914316|12221186|FG000|Phase 1|Withdrawal by Subject|0
7604947|NCT02199691|12012205|FG002|Overall Study|Withdrawal by Subject|12
7604948|NCT02199691|12012206|FG003|Overall Study|Withdrawal by Subject|13
7604949|NCT02199691|12012203|FG000|Overall Study|Lost to Follow-up|2
7604950|NCT02199691|12012204|FG001|Overall Study|Lost to Follow-up|1
7604951|NCT02199691|12012205|FG002|Overall Study|Lost to Follow-up|9
7604952|NCT02199691|12012206|FG003|Overall Study|Lost to Follow-up|10
7775308|NCT00914316|12221187|FG001|Phase 1|Withdrawal by Subject|2
7775309|NCT00914316|12221188|FG002|Phase 1|Withdrawal by Subject|4
7775310|NCT00914316|12221189|FG003|Phase 1|Withdrawal by Subject|0
7775311|NCT00914316|12221186|FG000|Phase 1|Adverse Event|1
7775312|NCT00914316|12221187|FG001|Phase 1|Adverse Event|0
7775313|NCT00914316|12221188|FG002|Phase 1|Adverse Event|0
7775314|NCT00914316|12221189|FG003|Phase 1|Adverse Event|0
7775315|NCT00914316|12221186|FG000|Phase 2|Withdrawal by Subject|1
7775316|NCT00914316|12221187|FG001|Phase 2|Withdrawal by Subject|0
7775317|NCT00914316|12221188|FG002|Phase 2|Withdrawal by Subject|1
7775318|NCT00914316|12221189|FG003|Phase 2|Withdrawal by Subject|0
7775319|NCT00914459|12221201|FG000|Overall Study|Protocol Violation|0
7775320|NCT00914459|12221202|FG001|Overall Study|Protocol Violation|1
7775321|NCT00914459|12221201|FG000|Overall Study|Parent/Legal guardian request|1
7775322|NCT00914459|12221202|FG001|Overall Study|Parent/Legal guardian request|0
7775323|NCT00914589|12221217|FG000|Overall Study|Adverse Event|1
7775324|NCT00914589|12221218|FG001|Overall Study|Adverse Event|0
7775325|NCT00914589|12221219|FG002|Overall Study|Adverse Event|1
7775326|NCT00914589|12221217|FG000|Overall Study|Protocol Violation|8
7775327|NCT00914589|12221218|FG001|Overall Study|Protocol Violation|6
7775328|NCT00914589|12221219|FG002|Overall Study|Protocol Violation|3
7775329|NCT00914589|12221217|FG000|Overall Study|unclassified|16
7775330|NCT00914589|12221218|FG001|Overall Study|unclassified|9
7775331|NCT00914589|12221219|FG002|Overall Study|unclassified|7
7775332|NCT00914589|12221217|FG000|Overall Study|Death|0
7775333|NCT00914589|12221218|FG001|Overall Study|Death|1
7775334|NCT00914589|12221219|FG002|Overall Study|Death|1
7775335|NCT00914628|12221229|FG000|Overall Study|Death|35
7775336|NCT00914628|12221230|FG001|Overall Study|Death|17
7775337|NCT00914628|12221229|FG000|Overall Study|Medical decision|4
7775338|NCT00914628|12221230|FG001|Overall Study|Medical decision|0
7775339|NCT00914628|12221229|FG000|Overall Study|Protocol Violation|1
7775340|NCT00914628|12221230|FG001|Overall Study|Protocol Violation|0
7775341|NCT00914628|12221229|FG000|Overall Study|Lack of Efficacy|1
7775342|NCT00914628|12221230|FG001|Overall Study|Lack of Efficacy|0
7775343|NCT00914628|12221229|FG000|Overall Study|non-randomized|1
7775344|NCT00914628|12221230|FG001|Overall Study|non-randomized|0
7775345|NCT00914628|12221229|FG000|Overall Study|Relapse|1
7775346|NCT00914628|12221230|FG001|Overall Study|Relapse|2
7775347|NCT00914628|12221229|FG000|Overall Study|Study terminated by Sponsor|14
7775348|NCT00914628|12221230|FG001|Overall Study|Study terminated by Sponsor|8
7775349|NCT00914628|12221229|FG000|Overall Study|Patients who did not receive a single dose|7
7775350|NCT00914628|12221230|FG001|Overall Study|Patients who did not receive a single dose|1
7775351|NCT00914732|12221243|FG000|Overall Study|Lost to Follow-up|6
7775352|NCT00914732|12221244|FG001|Overall Study|Lost to Follow-up|7
7775353|NCT00914732|12221245|FG002|Overall Study|Lost to Follow-up|9
7775354|NCT00914732|12221243|FG000|Overall Study|Withdrawal by Subject|3
7775355|NCT00914732|12221244|FG001|Overall Study|Withdrawal by Subject|0
7604953|NCT01751984|12012243|FG000|Overall Study|Adverse Event|5
7604954|NCT01751984|12012244|FG001|Overall Study|Adverse Event|3
7604955|NCT01751984|12012243|FG000|Overall Study|Withdrawal by Subject|0
7604956|NCT01751984|12012244|FG001|Overall Study|Withdrawal by Subject|1
7604957|NCT01751984|12012243|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1
7775356|NCT00914732|12221245|FG002|Overall Study|Withdrawal by Subject|2
7775357|NCT00914732|12221243|FG000|Overall Study|Adverse Event|1
7775358|NCT00914732|12221244|FG001|Overall Study|Adverse Event|0
7775359|NCT00914732|12221245|FG002|Overall Study|Adverse Event|0
7775360|NCT00914810|12221256|FG000|Overall Study|Withdrawal by Subject|1
7775361|NCT00914810|12221257|FG001|Overall Study|Withdrawal by Subject|0
7775362|NCT00914810|12221256|FG000|Overall Study|Relocated out of state|1
7775363|NCT00914810|12221257|FG001|Overall Study|Relocated out of state|0
7775364|NCT00914810|12221256|FG000|Overall Study|Hospitalized and unable to follow up.|0
7604958|NCT01751984|12012244|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
7604959|NCT01732627|12012252|FG000|Overall Study|Withdrawal by Subject|1
7604960|NCT01732627|12012253|FG001|Overall Study|Withdrawal by Subject|0
7604961|NCT01702571|12012261|FG000|Overall Study|Death|1067
7604962|NCT01702571|12012262|FG001|Overall Study|Death|76
7604963|NCT01702571|12012261|FG000|Overall Study|Lost to Follow-up|144
7604964|NCT01702571|12012262|FG001|Overall Study|Lost to Follow-up|10
7604965|NCT01702571|12012261|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4
7604966|NCT01702571|12012262|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0
7604967|NCT01702571|12012261|FG000|Overall Study|Investigator Decision|5
7604968|NCT01702571|12012262|FG001|Overall Study|Investigator Decision|0
7604969|NCT01702571|12012261|FG000|Overall Study|Not Classifiable|1
7604970|NCT01702571|12012262|FG001|Overall Study|Not Classifiable|0
7604971|NCT01702571|12012261|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93
7604972|NCT01702571|12012262|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0
7604973|NCT01702571|12012261|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0
7604974|NCT01702571|12012262|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1
7604975|NCT01702571|12012261|FG000|Overall Study|Progressive Disease|3
7604976|NCT01702571|12012262|FG001|Overall Study|Progressive Disease|0
7604977|NCT01702571|12012261|FG000|Overall Study|Protocol Violation|2
7604978|NCT01702571|12012262|FG001|Overall Study|Protocol Violation|0
7604979|NCT01702571|12012261|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9
7604980|NCT01702571|12012262|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1
7604981|NCT01702571|12012261|FG000|Overall Study|Termination By Sponsor|4
7604982|NCT01702571|12012262|FG001|Overall Study|Termination By Sponsor|0
7604983|NCT01702571|12012261|FG000|Overall Study|Withdrawal by Subject|177
7604984|NCT01702571|12012262|FG001|Overall Study|Withdrawal by Subject|29
7604985|NCT01578239|12012270|FG000|Treatment Period|Progressive Disease|19
7604986|NCT01578239|12012271|FG001|Treatment Period|Progressive Disease|64
7604987|NCT01578239|12012270|FG000|Treatment Period|Physician Decision|17
7604988|NCT01578239|12012271|FG001|Treatment Period|Physician Decision|17
7604989|NCT01578239|12012270|FG000|Treatment Period|Adverse Event|13
7604990|NCT01578239|12012271|FG001|Treatment Period|Adverse Event|10
7604991|NCT01578239|12012270|FG000|Treatment Period|Non-compliance|2
7604992|NCT01578239|12012271|FG001|Treatment Period|Non-compliance|0
7604993|NCT01578239|12012270|FG000|Treatment Period|Withdrawal by Subject|10
7604994|NCT01578239|12012271|FG001|Treatment Period|Withdrawal by Subject|9
7604995|NCT01578239|12012270|FG000|Treatment Period|Other|6
7604996|NCT01578239|12012271|FG001|Treatment Period|Other|1
7604997|NCT01578239|12012270|FG000|Long-term Follow-Up Period|Death|69
7604998|NCT01578239|12012271|FG001|Long-term Follow-Up Period|Death|64
7604999|NCT01578239|12012270|FG000|Long-term Follow-Up Period|Consent withdrawal|4
7605000|NCT01578239|12012271|FG001|Long-term Follow-Up Period|Consent withdrawal|10
7605001|NCT01578239|12012270|FG000|Long-term Follow-Up Period|Lost to Follow-up|2
7605002|NCT01578239|12012271|FG001|Long-term Follow-Up Period|Lost to Follow-up|4
7605003|NCT01578239|12012270|FG000|Long-term Follow-Up Period|Other|2
7605004|NCT01578239|12012271|FG001|Long-term Follow-Up Period|Other|2
7605005|NCT01458340|12012280|FG000|Overall Study|Adverse Event|5
7605006|NCT01458340|12012281|FG001|Overall Study|Adverse Event|4
7605007|NCT01458340|12012282|FG002|Overall Study|Adverse Event|2
7605008|NCT01458340|12012280|FG000|Overall Study|Lost to Follow-up|3
7605009|NCT01458340|12012281|FG001|Overall Study|Lost to Follow-up|3
7605010|NCT01458340|12012282|FG002|Overall Study|Lost to Follow-up|10
7605011|NCT01458340|12012280|FG000|Overall Study|Miscellaneous|0
7605012|NCT01458340|12012281|FG001|Overall Study|Miscellaneous|1
7605013|NCT01458340|12012282|FG002|Overall Study|Miscellaneous|0
7605014|NCT01458340|12012280|FG000|Overall Study|Physician Decision|1
7605015|NCT01458340|12012281|FG001|Overall Study|Physician Decision|1
7605016|NCT01458340|12012282|FG002|Overall Study|Physician Decision|2
7605017|NCT01458340|12012280|FG000|Overall Study|Protocol Violation|6
7605018|NCT01458340|12012281|FG001|Overall Study|Protocol Violation|6
7605019|NCT01458340|12012282|FG002|Overall Study|Protocol Violation|5
7605020|NCT01458340|12012280|FG000|Overall Study|Withdrawal by Subject|12
7605021|NCT01458340|12012281|FG001|Overall Study|Withdrawal by Subject|6
7605022|NCT01458340|12012282|FG002|Overall Study|Withdrawal by Subject|4
7605023|NCT01336634|12012330|FG000|Overall Study|Study closed/terminated|5
7605024|NCT01336634|12012331|FG001|Overall Study|Study closed/terminated|6
7605025|NCT01336634|12012332|FG002|Overall Study|Study closed/terminated|6
7605026|NCT01336634|12012330|FG000|Overall Study|Lost to Follow-up|2
7605027|NCT01336634|12012331|FG001|Overall Study|Lost to Follow-up|1
7605028|NCT01336634|12012332|FG002|Overall Study|Lost to Follow-up|1
7605029|NCT01336634|12012330|FG000|Overall Study|Physician Decision|1
7605030|NCT01336634|12012331|FG001|Overall Study|Physician Decision|1
7605031|NCT01336634|12012332|FG002|Overall Study|Physician Decision|0
7605032|NCT01336634|12012330|FG000|Overall Study|Withdrawal by Subject|6
7605033|NCT01336634|12012331|FG001|Overall Study|Withdrawal by Subject|0
7605034|NCT01336634|12012332|FG002|Overall Study|Withdrawal by Subject|2
7605035|NCT01155375|12012345|FG000|Overall Study|Adverse Event|1
7605036|NCT01155375|12012346|FG001|Overall Study|Adverse Event|0
7605037|NCT00628095|12012359|FG000|Overall Study|Adverse Event|5
7605038|NCT00628095|12012360|FG001|Overall Study|Adverse Event|3
7605039|NCT00628095|12012359|FG000|Overall Study|Lack of Efficacy|0
7605040|NCT00628095|12012360|FG001|Overall Study|Lack of Efficacy|3
7605041|NCT00628095|12012359|FG000|Overall Study|Withdrawal by Subject|2
7605042|NCT00628095|12012360|FG001|Overall Study|Withdrawal by Subject|0
7605043|NCT00628095|12012359|FG000|Overall Study|Other|0
7605044|NCT00628095|12012360|FG001|Overall Study|Other|1
7605045|NCT03945825|12012392|FG000|Overall Study|Enrolled but treatment not administered|0
7605046|NCT03945825|12012393|FG001|Overall Study|Enrolled but treatment not administered|0
7605047|NCT03945825|12012394|FG002|Overall Study|Enrolled but treatment not administered|0
7605048|NCT03945825|12012395|FG003|Overall Study|Enrolled but treatment not administered|0
7605049|NCT03945825|12012396|FG004|Overall Study|Enrolled but treatment not administered|1
7605050|NCT03945825|12012397|FG005|Overall Study|Enrolled but treatment not administered|0
7605051|NCT03945825|12012392|FG000|Overall Study|Lost to Follow-up|1
7605052|NCT03945825|12012393|FG001|Overall Study|Lost to Follow-up|5
7605053|NCT03945825|12012394|FG002|Overall Study|Lost to Follow-up|0
7605054|NCT03945825|12012395|FG003|Overall Study|Lost to Follow-up|1
7605055|NCT03945825|12012396|FG004|Overall Study|Lost to Follow-up|2
7605056|NCT03945825|12012397|FG005|Overall Study|Lost to Follow-up|2
7605057|NCT03945825|12012392|FG000|Overall Study|Withdrawal by Subject|1
7605058|NCT03945825|12012393|FG001|Overall Study|Withdrawal by Subject|0
7605059|NCT03945825|12012394|FG002|Overall Study|Withdrawal by Subject|1
7605060|NCT03945825|12012395|FG003|Overall Study|Withdrawal by Subject|1
7605061|NCT03945825|12012396|FG004|Overall Study|Withdrawal by Subject|0
7605062|NCT03945825|12012397|FG005|Overall Study|Withdrawal by Subject|1
7605063|NCT03562767|12012444|FG000|Overall Study|Physician Decision|2
7605064|NCT03562767|12012445|FG001|Overall Study|Physician Decision|0
7605065|NCT03562767|12012446|FG002|Overall Study|Physician Decision|0
7605066|NCT03562767|12012444|FG000|Overall Study|Logistic Reason|1
7605067|NCT03562767|12012445|FG001|Overall Study|Logistic Reason|3
7605068|NCT03562767|12012446|FG002|Overall Study|Logistic Reason|0
7605069|NCT03559699|12012458|FG000|Overall Study|Withdrawal by Subject|6
7605070|NCT03559699|12012458|FG000|Overall Study|Lost to Follow-up|1
7605071|NCT03305016|12012475|FG000|Overall Study|Withdrawal by Subject|2
7605072|NCT03291067|12012492|FG000|Overall Study|Adverse Event|0
7605073|NCT03291067|12012493|FG001|Overall Study|Adverse Event|2
7775365|NCT00914810|12221257|FG001|Overall Study|Hospitalized and unable to follow up.|1
7775366|NCT00914849|12221265|FG000|Overall Study|Withdrawal by Subject|1
7775367|NCT00914849|12221266|FG001|Overall Study|Withdrawal by Subject|0
7775368|NCT00914849|12221265|FG000|Overall Study|Not eligible|0
7775369|NCT00914849|12221266|FG001|Overall Study|Not eligible|1
7775370|NCT00914927|12221300|FG000|Overall Study|Adverse Event|0
7775371|NCT00914927|12221301|FG001|Overall Study|Adverse Event|0
7775372|NCT00914927|12221302|FG002|Overall Study|Adverse Event|0
7775373|NCT00914927|12221303|FG003|Overall Study|Adverse Event|0
7775374|NCT00914927|12221304|FG004|Overall Study|Adverse Event|1
7775375|NCT00914927|12221305|FG005|Overall Study|Adverse Event|0
7775376|NCT00914927|12221306|FG006|Overall Study|Adverse Event|0
7775377|NCT00914927|12221300|FG000|Overall Study|Withdrawal by Subject|0
7775378|NCT00914927|12221301|FG001|Overall Study|Withdrawal by Subject|1
7775379|NCT00914927|12221302|FG002|Overall Study|Withdrawal by Subject|0
7775380|NCT00914927|12221303|FG003|Overall Study|Withdrawal by Subject|1
7775381|NCT00914927|12221304|FG004|Overall Study|Withdrawal by Subject|0
7775382|NCT00914927|12221305|FG005|Overall Study|Withdrawal by Subject|0
7775383|NCT00914927|12221306|FG006|Overall Study|Withdrawal by Subject|0
7775384|NCT00914927|12221300|FG000|Overall Study|Lost to Follow-up|0
7775385|NCT00914927|12221301|FG001|Overall Study|Lost to Follow-up|0
7775386|NCT00914927|12221302|FG002|Overall Study|Lost to Follow-up|0
7775387|NCT00914927|12221303|FG003|Overall Study|Lost to Follow-up|1
7775388|NCT00914927|12221304|FG004|Overall Study|Lost to Follow-up|0
7775389|NCT00914927|12221305|FG005|Overall Study|Lost to Follow-up|0
7775390|NCT00914927|12221306|FG006|Overall Study|Lost to Follow-up|0
7775391|NCT00914927|12221300|FG000|Overall Study|Administrative/Other|2
7775392|NCT00914927|12221301|FG001|Overall Study|Administrative/Other|1
7775393|NCT00914927|12221302|FG002|Overall Study|Administrative/Other|0
7775394|NCT00914927|12221303|FG003|Overall Study|Administrative/Other|0
7775395|NCT00914927|12221304|FG004|Overall Study|Administrative/Other|1
7775396|NCT00914927|12221305|FG005|Overall Study|Administrative/Other|0
7775397|NCT00914927|12221306|FG006|Overall Study|Administrative/Other|0
7775398|NCT00914940|12221331|FG000|D0 to D100 Post-transplant|Death|2
7775399|NCT00914940|12221331|FG000|D101 to 2 Years Post-transplant|Death|8
7775400|NCT00914940|12221331|FG000|2 Years to 5 Years Post-transplant|Death|3
7775401|NCT00914966|12221335|FG000|Step 1: 1500 Units|Withdrawal by Subject|1
7775402|NCT00914966|12221335|FG000|Step 1: 1500 Units|Physician Decision|1
7775403|NCT00914966|12221335|FG000|Step 2: 2000 Units|Withdrawal by Subject|1
7775404|NCT00915005|12221346|FG000|Overall Study|Withdrawal by Subject|4
7775405|NCT00915005|12221347|FG001|Overall Study|Withdrawal by Subject|4
7775406|NCT00915005|12221346|FG000|Overall Study|Patient preferred protons therapy|6
7775407|NCT00915005|12221347|FG001|Overall Study|Patient preferred protons therapy|0
7775408|NCT00915005|12221346|FG000|Overall Study|Insurance denial|3
7775409|NCT00915005|12221347|FG001|Overall Study|Insurance denial|15
7775410|NCT00915018|12221355|FG000|Overall Study|Death|75
7605074|NCT03291067|12012494|FG002|Overall Study|Adverse Event|17
7605075|NCT03291067|12012495|FG003|Overall Study|Adverse Event|3
7605076|NCT03291067|12012492|FG000|Overall Study|Lost to Follow-up|2
7605077|NCT03291067|12012493|FG001|Overall Study|Lost to Follow-up|1
7775411|NCT00915018|12221356|FG001|Overall Study|Death|70
7775412|NCT00915018|12221355|FG000|Overall Study|Lost to Follow-up|10
7605078|NCT03291067|12012494|FG002|Overall Study|Lost to Follow-up|0
7605079|NCT03291067|12012495|FG003|Overall Study|Lost to Follow-up|1
7605080|NCT03291067|12012492|FG000|Overall Study|Physician Decision|0
7605081|NCT03291067|12012493|FG001|Overall Study|Physician Decision|0
7605082|NCT03291067|12012494|FG002|Overall Study|Physician Decision|1
7605083|NCT03291067|12012495|FG003|Overall Study|Physician Decision|0
7605084|NCT03291067|12012492|FG000|Overall Study|Protocol Violation|5
7775413|NCT00915018|12221356|FG001|Overall Study|Lost to Follow-up|5
7775414|NCT00915018|12221355|FG000|Overall Study|Withdrawal by Subject|38
7775415|NCT00915018|12221356|FG001|Overall Study|Withdrawal by Subject|27
7775416|NCT00915018|12221355|FG000|Overall Study|By Sponsor due to Protocol Amendment|92
7775417|NCT00915018|12221356|FG001|Overall Study|By Sponsor due to Protocol Amendment|105
7775418|NCT00915278|12221381|FG000|Overall Study|Death|1
7775419|NCT00915278|12221382|FG001|Overall Study|Death|0
7775420|NCT00915278|12221383|FG002|Overall Study|Death|0
7775421|NCT00915278|12221384|FG003|Overall Study|Death|0
7775422|NCT00915278|12221385|FG004|Overall Study|Death|0
7775423|NCT00915278|12221386|FG005|Overall Study|Death|0
7775424|NCT00915278|12221381|FG000|Overall Study|Lost to Follow-up|0
7775425|NCT00915278|12221382|FG001|Overall Study|Lost to Follow-up|1
7775426|NCT00915278|12221383|FG002|Overall Study|Lost to Follow-up|0
7775427|NCT00915278|12221384|FG003|Overall Study|Lost to Follow-up|0
7775428|NCT00915278|12221385|FG004|Overall Study|Lost to Follow-up|0
7775429|NCT00915278|12221386|FG005|Overall Study|Lost to Follow-up|0
7775430|NCT00915278|12221381|FG000|Overall Study|Withdrawal by Subject|0
7775431|NCT00915278|12221382|FG001|Overall Study|Withdrawal by Subject|1
7775432|NCT00915278|12221383|FG002|Overall Study|Withdrawal by Subject|0
7775433|NCT00915278|12221384|FG003|Overall Study|Withdrawal by Subject|0
7775434|NCT00915278|12221385|FG004|Overall Study|Withdrawal by Subject|1
7775435|NCT00915278|12221386|FG005|Overall Study|Withdrawal by Subject|4
7775436|NCT00915278|12221381|FG000|Overall Study|Adverse Event|4
7775437|NCT00915278|12221382|FG001|Overall Study|Adverse Event|1
7775438|NCT00915278|12221383|FG002|Overall Study|Adverse Event|0
7775439|NCT00915278|12221384|FG003|Overall Study|Adverse Event|0
7775440|NCT00915278|12221385|FG004|Overall Study|Adverse Event|0
7775441|NCT00915278|12221386|FG005|Overall Study|Adverse Event|0
7775442|NCT00915278|12221381|FG000|Overall Study|Progressive disease/clinical progression|0
7775443|NCT00915278|12221382|FG001|Overall Study|Progressive disease/clinical progression|0
7775444|NCT00915278|12221383|FG002|Overall Study|Progressive disease/clinical progression|0
7775445|NCT00915278|12221384|FG003|Overall Study|Progressive disease/clinical progression|3
7775446|NCT00915278|12221385|FG004|Overall Study|Progressive disease/clinical progression|1
7775447|NCT00915278|12221386|FG005|Overall Study|Progressive disease/clinical progression|2
7775448|NCT00915278|12221381|FG000|Overall Study|Infusion related AEs|0
7775449|NCT00915278|12221382|FG001|Overall Study|Infusion related AEs|0
7775450|NCT00915278|12221383|FG002|Overall Study|Infusion related AEs|0
7775451|NCT00915278|12221384|FG003|Overall Study|Infusion related AEs|0
7775452|NCT00915278|12221385|FG004|Overall Study|Infusion related AEs|0
7775453|NCT00915278|12221386|FG005|Overall Study|Infusion related AEs|2
7775454|NCT00915278|12221381|FG000|Overall Study|Admission to hospice|0
7775455|NCT00915278|12221382|FG001|Overall Study|Admission to hospice|0
7775456|NCT00915278|12221383|FG002|Overall Study|Admission to hospice|1
7775457|NCT00915278|12221384|FG003|Overall Study|Admission to hospice|0
7775458|NCT00915278|12221385|FG004|Overall Study|Admission to hospice|0
7775459|NCT00915278|12221386|FG005|Overall Study|Admission to hospice|0
7775460|NCT00915343|12221400|FG000|Part B - Open Label Period|Treatment switch|0
7775461|NCT00915343|12221401|FG001|Part B - Open Label Period|Treatment switch|0
7775462|NCT00915343|12221402|FG002|Part B - Open Label Period|Treatment switch|1
7605085|NCT03291067|12012493|FG001|Overall Study|Protocol Violation|3
7605086|NCT03291067|12012494|FG002|Overall Study|Protocol Violation|4
7605087|NCT03291067|12012495|FG003|Overall Study|Protocol Violation|2
7605088|NCT03291067|12012492|FG000|Overall Study|Withdrawal by Subject|3
7605089|NCT03291067|12012493|FG001|Overall Study|Withdrawal by Subject|4
7775463|NCT00915343|12221400|FG000|Part B - Open Label Period|Did not attend the last visit|0
7775464|NCT00915343|12221401|FG001|Part B - Open Label Period|Did not attend the last visit|0
7775465|NCT00915343|12221402|FG002|Part B - Open Label Period|Did not attend the last visit|1
7775466|NCT00915356|12221419|FG000|Overall Study|Withdrawal by Subject|1
7775467|NCT00915356|12221420|FG001|Overall Study|Withdrawal by Subject|0
7775468|NCT00915356|12221421|FG002|Overall Study|Withdrawal by Subject|0
7775469|NCT00915356|12221422|FG003|Overall Study|Withdrawal by Subject|0
7775470|NCT00915356|12221423|FG004|Overall Study|Withdrawal by Subject|0
7775471|NCT00915473|12221437|FG000|Screening|Withdrawal by Subject|1
7775472|NCT00915473|12221438|FG001|Screening|Withdrawal by Subject|0
7775473|NCT00915473|12221437|FG000|4-week Follow Up|Lost to Follow-up|1
7775474|NCT00915473|12221438|FG001|4-week Follow Up|Lost to Follow-up|5
7775475|NCT00915525|12221455|FG000|Overall Study|Protocol Violation|9
7775476|NCT00915525|12221456|FG001|Overall Study|Protocol Violation|4
7775477|NCT00915525|12221455|FG000|Overall Study|Withdrawal by Subject|59
7775478|NCT00915525|12221456|FG001|Overall Study|Withdrawal by Subject|21
7775479|NCT00915525|12221455|FG000|Overall Study|Lost to Follow-up|27
7775480|NCT00915525|12221456|FG001|Overall Study|Lost to Follow-up|16
7775481|NCT00915525|12221455|FG000|Overall Study|Pregnancy|2
7775482|NCT00915525|12221456|FG001|Overall Study|Pregnancy|0
7775483|NCT00915525|12221455|FG000|Overall Study|Lack of Efficacy|15
7775484|NCT00915525|12221456|FG001|Overall Study|Lack of Efficacy|32
7775485|NCT00915525|12221455|FG000|Overall Study|Adverse Event|29
7775486|NCT00915525|12221456|FG001|Overall Study|Adverse Event|13
7775487|NCT00915525|12221455|FG000|Overall Study|Missing|12
7775488|NCT00915525|12221456|FG001|Overall Study|Missing|1
7605090|NCT03291067|12012494|FG002|Overall Study|Withdrawal by Subject|7
7605091|NCT03291067|12012495|FG003|Overall Study|Withdrawal by Subject|5
7605092|NCT03291067|12012492|FG000|Overall Study|Other|0
7605093|NCT03291067|12012493|FG001|Overall Study|Other|4
7605094|NCT03291067|12012494|FG002|Overall Study|Other|4
7605095|NCT03291067|12012495|FG003|Overall Study|Other|6
7605096|NCT03271047|12012509|FG000|Phase 1b: Dose Finding Period|Death|8
7605097|NCT03271047|12012510|FG001|Phase 1b: Dose Finding Period|Death|8
7605098|NCT03271047|12012511|FG002|Phase 1b: Dose Finding Period|Death|0
7605099|NCT03271047|12012512|FG003|Phase 1b: Dose Finding Period|Death|0
7605100|NCT03271047|12012509|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1
7605101|NCT03271047|12012510|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0
7605102|NCT03271047|12012511|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0
7605103|NCT03271047|12012512|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0
7605104|NCT03271047|12012509|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
7605105|NCT03271047|12012510|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2
7605106|NCT03271047|12012511|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
7605107|NCT03271047|12012512|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
7605108|NCT03271047|12012509|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1
7605109|NCT03271047|12012510|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1
7605110|NCT03271047|12012511|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0
7605111|NCT03271047|12012512|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0
7605112|NCT03271047|12012509|FG000|Randomized Phase 2 Period|Other|0
7605113|NCT03271047|12012510|FG001|Randomized Phase 2 Period|Other|0
7605114|NCT03271047|12012511|FG002|Randomized Phase 2 Period|Other|0
7605115|NCT03271047|12012512|FG003|Randomized Phase 2 Period|Other|1
7605116|NCT03271047|12012509|FG000|Randomized Phase 2 Period|Death|0
7775489|NCT00915525|12221455|FG000|Overall Study|Other Reason|35
7775490|NCT00915525|12221456|FG001|Overall Study|Other Reason|12
7775491|NCT00915525|12221455|FG000|Overall Study|Site Closed|27
7775492|NCT00915525|12221456|FG001|Overall Study|Site Closed|9
7775493|NCT00915525|12221455|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
7775494|NCT00915525|12221456|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
7775495|NCT00915525|12221455|FG000|Overall Study|Study Burden|28
7605117|NCT03271047|12012510|FG001|Randomized Phase 2 Period|Death|0
7605118|NCT03271047|12012511|FG002|Randomized Phase 2 Period|Death|20
7605119|NCT03271047|12012512|FG003|Randomized Phase 2 Period|Death|21
7605120|NCT03271047|12012509|FG000|Randomized Phase 2 Period|Lost to Follow-up|0
7605121|NCT03271047|12012510|FG001|Randomized Phase 2 Period|Lost to Follow-up|0
7605122|NCT03271047|12012511|FG002|Randomized Phase 2 Period|Lost to Follow-up|2
7605123|NCT03271047|12012512|FG003|Randomized Phase 2 Period|Lost to Follow-up|1
7605124|NCT03271047|12012509|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0
7605125|NCT03271047|12012510|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0
7605126|NCT03271047|12012511|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5
7605127|NCT03271047|12012512|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0
7605128|NCT03271047|12012509|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0
7605129|NCT03271047|12012510|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0
7605130|NCT03271047|12012511|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0
7605131|NCT03271047|12012512|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4
7605132|NCT03257436|12012524|FG000|Overall Study|Withdrawal by Subject|76
7605133|NCT03257436|12012524|FG000|Overall Study|Death|19
7605134|NCT03158285|12012541|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4
7605135|NCT03158285|12012542|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2
7605136|NCT03158285|12012543|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6
7605137|NCT03158285|12012541|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0
7605138|NCT03158285|12012542|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
7605139|NCT03158285|12012543|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
7775496|NCT00915525|12221456|FG001|Overall Study|Study Burden|12
7775497|NCT00915525|12221455|FG000|Overall Study|Non-Compliance|3
7775498|NCT00915525|12221456|FG001|Overall Study|Non-Compliance|1
7775499|NCT00915525|12221455|FG000|Overall Study|Patient Moved|15
7775500|NCT00915525|12221456|FG001|Overall Study|Patient Moved|9
7775501|NCT00915551|12221495|FG000|Overall Study|Withdrawal by Subject|0
7775502|NCT00915551|12221496|FG001|Overall Study|Withdrawal by Subject|1
7775503|NCT00915772|12221542|FG000|Overall Study|Adverse Event|12
7775504|NCT00915772|12221543|FG001|Overall Study|Adverse Event|13
7775505|NCT00915772|12221544|FG002|Overall Study|Adverse Event|11
7775506|NCT00915772|12221542|FG000|Overall Study|Protocol Violation|4
7775507|NCT00915772|12221543|FG001|Overall Study|Protocol Violation|1
7775508|NCT00915772|12221544|FG002|Overall Study|Protocol Violation|2
7775509|NCT00915772|12221542|FG000|Overall Study|Lost to Follow-up|1
7775510|NCT00915772|12221543|FG001|Overall Study|Lost to Follow-up|2
7775511|NCT00915772|12221544|FG002|Overall Study|Lost to Follow-up|2
7775512|NCT00915772|12221542|FG000|Overall Study|Lack of Efficacy|9
7775513|NCT00915772|12221543|FG001|Overall Study|Lack of Efficacy|15
7775514|NCT00915772|12221544|FG002|Overall Study|Lack of Efficacy|3
7775515|NCT00915772|12221542|FG000|Overall Study|Refused to continue trial medication|6
7775516|NCT00915772|12221543|FG001|Overall Study|Refused to continue trial medication|8
7775517|NCT00915772|12221544|FG002|Overall Study|Refused to continue trial medication|4
7775518|NCT00915772|12221542|FG000|Overall Study|Any other reason|4
7775519|NCT00915772|12221543|FG001|Overall Study|Any other reason|7
7775520|NCT00915772|12221544|FG002|Overall Study|Any other reason|7
7775521|NCT00915876|12221582|FG000|Overall Study|Adverse Event|0
7775522|NCT00915876|12221583|FG001|Overall Study|Adverse Event|1
7775523|NCT00916006|12221634|FG000|Overall Study|Adverse Event|1
7775524|NCT00916006|12221635|FG001|Overall Study|Adverse Event|1
7775525|NCT00916006|12221634|FG000|Overall Study|Withdrawal by Subject|2
7775526|NCT00916006|12221635|FG001|Overall Study|Withdrawal by Subject|5
7775527|NCT00916006|12221634|FG000|Overall Study|Protocol Violation|0
7605140|NCT03158285|12012541|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
7605141|NCT03158285|12012542|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
7605142|NCT03158285|12012543|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0
7605143|NCT03158285|12012541|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
7605144|NCT03158285|12012542|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1
7605145|NCT03158285|12012543|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
7605146|NCT03158285|12012541|FG000|Placebo-controlled Period: Week 0 - 24|Other|1
7605147|NCT03158285|12012542|FG001|Placebo-controlled Period: Week 0 - 24|Other|1
7605148|NCT03158285|12012543|FG002|Placebo-controlled Period: Week 0 - 24|Other|0
7605149|NCT03158285|12012541|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3
7605150|NCT03158285|12012542|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0
7605151|NCT03158285|12012543|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1
7605152|NCT03158285|12012541|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5
7605153|NCT03158285|12012542|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
7605154|NCT03158285|12012543|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
7605155|NCT03158285|12012541|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
7605156|NCT03158285|12012542|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
7605157|NCT03158285|12012543|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
7605158|NCT03158285|12012541|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0
7605159|NCT03158285|12012542|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0
7605160|NCT03158285|12012543|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1
7605161|NCT03158285|12012541|FG000|Active Treatment Period: Week 24 - 52|Other|1
7605162|NCT03158285|12012542|FG001|Active Treatment Period: Week 24 - 52|Other|1
7605163|NCT03158285|12012543|FG002|Active Treatment Period: Week 24 - 52|Other|0
7605164|NCT03158285|12012541|FG000|Active Treatment Period: Week 52-100|Adverse Event|7
7605165|NCT03158285|12012542|FG001|Active Treatment Period: Week 52-100|Adverse Event|5
7775528|NCT00916006|12221635|FG001|Overall Study|Protocol Violation|1
7775529|NCT00916058|12221655|FG000|Phase 1|Screen Failure|0
7605166|NCT03158285|12012543|FG002|Active Treatment Period: Week 52-100|Adverse Event|3
7605167|NCT03158285|12012541|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1
7605168|NCT03158285|12012542|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1
7605169|NCT03158285|12012543|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3
7605170|NCT03158285|12012541|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5
7605171|NCT03158285|12012542|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2
7775530|NCT00916058|12221656|FG001|Phase 1|Screen Failure|0
7775531|NCT00916058|12221657|FG002|Phase 1|Screen Failure|0
7775532|NCT00916058|12221658|FG003|Phase 1|Screen Failure|0
7775533|NCT00916058|12221659|FG004|Phase 1|Screen Failure|0
7775534|NCT00916058|12221660|FG005|Phase 1|Screen Failure|1
7775535|NCT00916058|12221661|FG006|Phase 1|Screen Failure|0
7775536|NCT00916058|12221655|FG000|Phase 2|Screen Failure|0
7775537|NCT00916058|12221656|FG001|Phase 2|Screen Failure|0
7775538|NCT00916058|12221657|FG002|Phase 2|Screen Failure|0
7775539|NCT00916058|12221658|FG003|Phase 2|Screen Failure|0
7775540|NCT00916058|12221659|FG004|Phase 2|Screen Failure|0
7775541|NCT00916058|12221660|FG005|Phase 2|Screen Failure|0
7775542|NCT00916058|12221661|FG006|Phase 2|Screen Failure|3
7775543|NCT00916149|12221691|FG000|Overall Study|Lost to Follow-up|3
7775544|NCT00916149|12221692|FG001|Overall Study|Lost to Follow-up|2
7775545|NCT00916149|12221693|FG002|Overall Study|Lost to Follow-up|0
7775546|NCT00916149|12221691|FG000|Overall Study|Unable to place scalp EEG leads|1
7775547|NCT00916149|12221692|FG001|Overall Study|Unable to place scalp EEG leads|0
7775548|NCT00916149|12221693|FG002|Overall Study|Unable to place scalp EEG leads|0
7775549|NCT00916279|12221700|FG000|Overall Study|Death|2
7775550|NCT00916279|12221700|FG000|Overall Study|Lost to Follow-up|2
7775551|NCT00916305|12221709|FG000|Overall Study|Lost to Follow-up|21
7775552|NCT00916305|12221710|FG001|Overall Study|Lost to Follow-up|27
7775553|NCT00916305|12221709|FG000|Overall Study|Withdrawal by Subject|0
7775554|NCT00916305|12221710|FG001|Overall Study|Withdrawal by Subject|1
7775555|NCT00916344|12221716|FG000|Overall Study|Death|2
7775556|NCT00916344|12221716|FG000|Overall Study|ICD upgrade|1
7775557|NCT00916344|12221716|FG000|Overall Study|Drop-out|5
7775558|NCT00916357|12221720|FG000|Period 1|Withdrawal by Subject|1
7775559|NCT00916357|12221721|FG001|Period 1|Withdrawal by Subject|0
7775560|NCT00916357|12221722|FG002|Period 1|Withdrawal by Subject|0
7775561|NCT00916357|12221723|FG003|Period 1|Withdrawal by Subject|0
7775562|NCT00916357|12221724|FG004|Period 1|Withdrawal by Subject|0
7775563|NCT00916357|12221725|FG005|Period 1|Withdrawal by Subject|0
7775564|NCT00916357|12221720|FG000|Period 2|Weight loss > 3 kilograms (kg)|0
7775565|NCT00916357|12221721|FG001|Period 2|Weight loss > 3 kilograms (kg)|0
7775566|NCT00916357|12221722|FG002|Period 2|Weight loss > 3 kilograms (kg)|0
7605172|NCT03158285|12012543|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1
7605173|NCT03158285|12012541|FG000|Active Treatment Period: Week 52-100|Pregnancy|0
7775567|NCT00916357|12221723|FG003|Period 2|Weight loss > 3 kilograms (kg)|1
7775568|NCT00916357|12221724|FG004|Period 2|Weight loss > 3 kilograms (kg)|0
7775569|NCT00916357|12221725|FG005|Period 2|Weight loss > 3 kilograms (kg)|0
7775570|NCT00916370|12221736|FG000|Overall Study|Death|3
7775571|NCT00916370|12221737|FG001|Overall Study|Death|1
7775572|NCT00916370|12221736|FG000|Overall Study|Withdrawal by Subject|2
7775573|NCT00916370|12221737|FG001|Overall Study|Withdrawal by Subject|0
7775574|NCT00916370|12221736|FG000|Overall Study|Physician Decision|0
7775575|NCT00916370|12221737|FG001|Overall Study|Physician Decision|1
7605174|NCT03158285|12012542|FG001|Active Treatment Period: Week 52-100|Pregnancy|0
7605175|NCT03158285|12012543|FG002|Active Treatment Period: Week 52-100|Pregnancy|1
7605176|NCT03158285|12012541|FG000|Active Treatment Period: Week 52-100|Death|1
7605177|NCT03158285|12012542|FG001|Active Treatment Period: Week 52-100|Death|0
7605178|NCT03158285|12012543|FG002|Active Treatment Period: Week 52-100|Death|0
7605179|NCT03158285|12012541|FG000|Active Treatment Period: Week 52-100|Other|4
7605180|NCT03158285|12012542|FG001|Active Treatment Period: Week 52-100|Other|1
7605181|NCT03158285|12012543|FG002|Active Treatment Period: Week 52-100|Other|0
7605182|NCT04723173|12012556|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1
7605183|NCT03683823|12012600|FG000|Post-treatment Assessment|Withdrawal by Subject|1
7605184|NCT03683823|12012601|FG001|Post-treatment Assessment|Withdrawal by Subject|1
7605185|NCT03683823|12012600|FG000|Post-treatment Assessment|Lost to Follow-up|0
7605186|NCT03683823|12012601|FG001|Post-treatment Assessment|Lost to Follow-up|1
7605187|NCT03683823|12012600|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1
7605188|NCT03683823|12012601|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1
7605189|NCT03515551|12012627|FG000|Overall Study|Death|4
7605190|NCT03515551|12012628|FG001|Overall Study|Death|1
7605191|NCT03515551|12012629|FG002|Overall Study|Death|2
7605192|NCT03515551|12012630|FG003|Overall Study|Death|2
7605193|NCT03515551|12012631|FG004|Overall Study|Death|2
7605194|NCT03515551|12012632|FG005|Overall Study|Death|4
7605195|NCT03515551|12012633|FG006|Overall Study|Death|1
7605196|NCT03515551|12012627|FG000|Overall Study|Lost to Follow-up|0
7605197|NCT03515551|12012628|FG001|Overall Study|Lost to Follow-up|0
7605198|NCT03515551|12012629|FG002|Overall Study|Lost to Follow-up|1
7605199|NCT03515551|12012630|FG003|Overall Study|Lost to Follow-up|0
7605200|NCT03515551|12012631|FG004|Overall Study|Lost to Follow-up|0
7605201|NCT03515551|12012632|FG005|Overall Study|Lost to Follow-up|0
7605202|NCT03515551|12012633|FG006|Overall Study|Lost to Follow-up|0
7605203|NCT03515551|12012627|FG000|Overall Study|Withdrawal by Subject|0
7605204|NCT03515551|12012628|FG001|Overall Study|Withdrawal by Subject|1
7605205|NCT03515551|12012629|FG002|Overall Study|Withdrawal by Subject|0
7605206|NCT03515551|12012630|FG003|Overall Study|Withdrawal by Subject|0
7605207|NCT03515551|12012631|FG004|Overall Study|Withdrawal by Subject|0
7605208|NCT03515551|12012632|FG005|Overall Study|Withdrawal by Subject|0
7605209|NCT03515551|12012633|FG006|Overall Study|Withdrawal by Subject|1
7605210|NCT03515551|12012627|FG000|Overall Study|Study ended by sponsor|0
7605211|NCT03515551|12012628|FG001|Overall Study|Study ended by sponsor|0
7605212|NCT03515551|12012629|FG002|Overall Study|Study ended by sponsor|2
7605213|NCT03515551|12012630|FG003|Overall Study|Study ended by sponsor|1
7605214|NCT03515551|12012631|FG004|Overall Study|Study ended by sponsor|3
7605215|NCT03515551|12012632|FG005|Overall Study|Study ended by sponsor|0
7605216|NCT03515551|12012633|FG006|Overall Study|Study ended by sponsor|3
7605217|NCT03515551|12012627|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
7605218|NCT03515551|12012628|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1
7605219|NCT03515551|12012629|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
7605220|NCT03515551|12012630|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
7605221|NCT03515551|12012631|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
7605222|NCT03515551|12012632|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
7605223|NCT03515551|12012633|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
7605224|NCT03385265|12012658|FG000|Overall Study|Withdrawal by Subject|5
7605225|NCT03385265|12012659|FG001|Overall Study|Withdrawal by Subject|2
7605226|NCT03385265|12012660|FG002|Overall Study|Withdrawal by Subject|5
7605227|NCT03385265|12012661|FG003|Overall Study|Withdrawal by Subject|2
7605228|NCT02919306|12012714|FG000|Overall Study|Withdrawal by Subject|1
7605229|NCT02919306|12012715|FG001|Overall Study|Withdrawal by Subject|0
7605230|NCT02919306|12012714|FG000|Overall Study|Protocol Violation|1
7605231|NCT02919306|12012715|FG001|Overall Study|Protocol Violation|0
7605232|NCT02763189|12012723|FG000|Overall Study|Device failure|0
7605233|NCT02763189|12012724|FG001|Overall Study|Device failure|2
7605234|NCT02659514|12012741|FG000|Overall Study|Adverse Event|3
7605235|NCT02659514|12012742|FG001|Overall Study|Adverse Event|12
7605236|NCT02659514|12012741|FG000|Overall Study|Disease Progression|23
7605237|NCT02659514|12012742|FG001|Overall Study|Disease Progression|13
7605238|NCT02659514|12012741|FG000|Overall Study|Withdrawal by Subject|0
7605239|NCT02659514|12012742|FG001|Overall Study|Withdrawal by Subject|4
7605240|NCT02659514|12012741|FG000|Overall Study|Lost to Follow-up|0
7605241|NCT02659514|12012742|FG001|Overall Study|Lost to Follow-up|1
7605242|NCT02659514|12012741|FG000|Overall Study|Death|6
7605243|NCT02659514|12012742|FG001|Overall Study|Death|1
7605244|NCT02659514|12012741|FG000|Overall Study|Reason Unspecified|0
7605245|NCT02659514|12012742|FG001|Overall Study|Reason Unspecified|3
7775576|NCT00916383|12221744|FG000|Overall Study|Adverse Event|1
7775577|NCT00916383|12221744|FG000|Overall Study|Death|1
7775578|NCT00916383|12221744|FG000|Overall Study|Protocol Violation|1
7775579|NCT00916578|12221761|FG000|Overall Study|Physician Decision|2
7775580|NCT00916578|12221761|FG000|Overall Study|Withdrawal by Subject|3
7775581|NCT00916578|12221761|FG000|Overall Study|Insurance Denial|2
7775582|NCT00916617|12221769|FG000|Overall Study|Adverse Event|3
7775583|NCT00916617|12221770|FG001|Overall Study|Adverse Event|2
7605254|NCT01673867|12012790|FG000|Randomization|AE unrelated to study drug|1
7605255|NCT01673867|12012791|FG001|Randomization|AE unrelated to study drug|0
7605256|NCT01673867|12012790|FG000|Randomization|Requested treatment discontinuation|0
7605257|NCT01673867|12012791|FG001|Randomization|Requested treatment discontinuation|4
7605258|NCT01673867|12012790|FG000|Randomization|Withdrawal by Subject|0
7605259|NCT01673867|12012791|FG001|Randomization|Withdrawal by Subject|12
7605260|NCT01673867|12012790|FG000|Randomization|Lost to Follow-up|0
7605261|NCT01673867|12012791|FG001|Randomization|Lost to Follow-up|1
7605262|NCT01673867|12012790|FG000|Randomization|No longer meets criteria|4
7605263|NCT01673867|12012791|FG001|Randomization|No longer meets criteria|5
7605264|NCT01673867|12012790|FG000|Treatment|Disease Progression|194
7605265|NCT01673867|12012791|FG001|Treatment|Disease Progression|179
7605266|NCT01673867|12012790|FG000|Treatment|Study Drug Toxicity|17
7605267|NCT01673867|12012791|FG001|Treatment|Study Drug Toxicity|42
7605268|NCT01673867|12012790|FG000|Treatment|Death|1
7605269|NCT01673867|12012791|FG001|Treatment|Death|1
7605270|NCT01673867|12012790|FG000|Treatment|AE unrelated to study drug|19
7605271|NCT01673867|12012791|FG001|Treatment|AE unrelated to study drug|11
7605272|NCT01673867|12012790|FG000|Treatment|Requested treatment discontinuation|5
7605273|NCT01673867|12012791|FG001|Treatment|Requested treatment discontinuation|16
7605274|NCT01673867|12012790|FG000|Treatment|Withdrawal by Subject|4
7605275|NCT01673867|12012791|FG001|Treatment|Withdrawal by Subject|6
7605276|NCT01673867|12012790|FG000|Treatment|Maximum clinical benefit|0
7605277|NCT01673867|12012791|FG001|Treatment|Maximum clinical benefit|10
7605278|NCT01673867|12012790|FG000|Treatment|No longer meets criteria|2
7605279|NCT01673867|12012791|FG001|Treatment|No longer meets criteria|0
7605280|NCT01673867|12012790|FG000|Treatment|Required steroid therapy|1
7605281|NCT01673867|12012791|FG001|Treatment|Required steroid therapy|0
7605282|NCT01673867|12012790|FG000|Treatment|Health status not improved|1
7605283|NCT01673867|12012791|FG001|Treatment|Health status not improved|0
7605284|NCT01673867|12012790|FG000|Treatment|Required prolonged hospitalization|0
7605285|NCT01673867|12012791|FG001|Treatment|Required prolonged hospitalization|1
7605286|NCT01673867|12012790|FG000|Treatment|Symptomatic deterioration|0
7605287|NCT01673867|12012791|FG001|Treatment|Symptomatic deterioration|1
7775584|NCT00916617|12221771|FG002|Overall Study|Adverse Event|6
7605288|NCT01673867|12012790|FG000|Treatment|Physician Decision|0
7605289|NCT01673867|12012791|FG001|Treatment|Physician Decision|1
7605290|NCT00335777|12012801|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
7605291|NCT00335777|12012801|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
7605292|NCT00335777|12012801|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
7605293|NCT00335777|12012801|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
7775585|NCT00916617|12221772|FG003|Overall Study|Adverse Event|3
7775586|NCT00916617|12221769|FG000|Overall Study|Withdrawal by Subject|3
7775587|NCT00916617|12221770|FG001|Overall Study|Withdrawal by Subject|2
7775588|NCT00916617|12221771|FG002|Overall Study|Withdrawal by Subject|0
7775589|NCT00916617|12221772|FG003|Overall Study|Withdrawal by Subject|1
7775590|NCT00916617|12221769|FG000|Overall Study|Caregiver Request|3
7775591|NCT00916617|12221770|FG001|Overall Study|Caregiver Request|2
7775592|NCT00916617|12221771|FG002|Overall Study|Caregiver Request|1
7775593|NCT00916617|12221772|FG003|Overall Study|Caregiver Request|0
7775594|NCT00916617|12221769|FG000|Overall Study|Physician Decision|1
7775595|NCT00916617|12221770|FG001|Overall Study|Physician Decision|1
7775596|NCT00916617|12221771|FG002|Overall Study|Physician Decision|0
7775597|NCT00916617|12221772|FG003|Overall Study|Physician Decision|0
7775598|NCT00916617|12221769|FG000|Overall Study|Discontinuation of Study by Sponsor|8
7775599|NCT00916617|12221770|FG001|Overall Study|Discontinuation of Study by Sponsor|13
7775600|NCT00916617|12221771|FG002|Overall Study|Discontinuation of Study by Sponsor|3
7775601|NCT00916617|12221772|FG003|Overall Study|Discontinuation of Study by Sponsor|1
7775602|NCT00916617|12221769|FG000|Overall Study|Lost to Follow-up|2
7775603|NCT00916617|12221770|FG001|Overall Study|Lost to Follow-up|1
7775604|NCT00916617|12221771|FG002|Overall Study|Lost to Follow-up|0
7775605|NCT00916617|12221772|FG003|Overall Study|Lost to Follow-up|0
7605294|NCT00335777|12012801|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12
7605295|NCT00159588|12012809|FG000|5 Month Follow-up|Withdrawal by Subject|2
7605296|NCT00159588|12012810|FG001|5 Month Follow-up|Withdrawal by Subject|4
7775606|NCT00916617|12221769|FG000|Overall Study|Lack of Efficacy|1
7775607|NCT00916617|12221770|FG001|Overall Study|Lack of Efficacy|0
7775608|NCT00916617|12221771|FG002|Overall Study|Lack of Efficacy|0
7605297|NCT00159588|12012811|FG002|5 Month Follow-up|Withdrawal by Subject|2
7605298|NCT03051217|12012825|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2
7605299|NCT03051217|12012826|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0
7605300|NCT03051217|12012827|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
7605301|NCT03051217|12012828|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
7605302|NCT03051217|12012829|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
7605303|NCT03051217|12012830|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
7605304|NCT03051217|12012831|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
7605305|NCT03051217|12012825|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7605306|NCT03051217|12012826|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1
7605307|NCT03051217|12012827|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7605308|NCT03051217|12012828|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7605309|NCT03051217|12012829|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7605310|NCT03051217|12012830|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7605311|NCT03051217|12012831|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7605312|NCT03051217|12012825|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
7605313|NCT03051217|12012826|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
7605314|NCT03051217|12012827|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
7605315|NCT03051217|12012828|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7605316|NCT03051217|12012829|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7605317|NCT03051217|12012830|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7605318|NCT03051217|12012831|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7605319|NCT03051217|12012825|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
7605320|NCT03051217|12012826|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
7605321|NCT03051217|12012827|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
7605322|NCT03051217|12012828|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
7605323|NCT03051217|12012829|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2
7605324|NCT03051217|12012830|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
7605325|NCT03051217|12012831|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
7605326|NCT03051217|12012825|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7605327|NCT03051217|12012826|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7605328|NCT03051217|12012827|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7605329|NCT03051217|12012828|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1
7605330|NCT03051217|12012829|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7605331|NCT03051217|12012830|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7605332|NCT03051217|12012831|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7605333|NCT03051217|12012825|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7605334|NCT03051217|12012826|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7605335|NCT03051217|12012827|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7605336|NCT03051217|12012828|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1
7605337|NCT03051217|12012829|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7605338|NCT03051217|12012830|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7605339|NCT03051217|12012831|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7605340|NCT03051217|12012825|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7605341|NCT03051217|12012826|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7605342|NCT03051217|12012827|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7605343|NCT03051217|12012828|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7605344|NCT03051217|12012829|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1
7605345|NCT03051217|12012830|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7605346|NCT03051217|12012831|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7605347|NCT03051217|12012825|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7605348|NCT03051217|12012826|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7605349|NCT03051217|12012827|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7605350|NCT03051217|12012828|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7605351|NCT03051217|12012829|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7605352|NCT03051217|12012830|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1
7605353|NCT03051217|12012831|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7605360|NCT02889809|12012884|FG000|Overall Study|Withdrawal by Subject|30
7605361|NCT02889809|12012885|FG001|Overall Study|Withdrawal by Subject|21
7605362|NCT02889809|12012884|FG000|Overall Study|Lost to Follow-up|1
7605363|NCT02889809|12012885|FG001|Overall Study|Lost to Follow-up|1
7605364|NCT02889809|12012884|FG000|Overall Study|Site Closed|12
7605365|NCT02889809|12012885|FG001|Overall Study|Site Closed|11
7775609|NCT00916617|12221772|FG003|Overall Study|Lack of Efficacy|0
7775610|NCT00916617|12221769|FG000|Overall Study|Other|2
7775611|NCT00916617|12221770|FG001|Overall Study|Other|0
7775612|NCT00916617|12221771|FG002|Overall Study|Other|0
7775613|NCT00916617|12221772|FG003|Overall Study|Other|2
7775614|NCT00916721|12221788|FG000|Overall Study|Lost to Follow-up|0
7775615|NCT00916721|12221789|FG001|Overall Study|Lost to Follow-up|1
7775616|NCT00916721|12221788|FG000|Overall Study|Adverse Event|6
7775617|NCT00916721|12221789|FG001|Overall Study|Adverse Event|3
7775618|NCT00916721|12221788|FG000|Overall Study|Withdrawal by Subject|2
7775619|NCT00916721|12221789|FG001|Overall Study|Withdrawal by Subject|2
7775620|NCT00916721|12221788|FG000|Overall Study|Protocol Violation|2
7775621|NCT00916721|12221789|FG001|Overall Study|Protocol Violation|4
7775622|NCT00916929|12221797|FG000|Overall Study|Lost to Follow-up|1
7775623|NCT00916929|12221798|FG001|Overall Study|Lost to Follow-up|3
7775624|NCT00916929|12221797|FG000|Overall Study|Death|5
7775625|NCT00916929|12221798|FG001|Overall Study|Death|10
7775626|NCT00916929|12221797|FG000|Overall Study|Withdrawal by Subject|1
7775627|NCT00916929|12221798|FG001|Overall Study|Withdrawal by Subject|5
7775628|NCT00916929|12221797|FG000|Overall Study|Left ventricular epicardial lead|1
7775629|NCT00916929|12221798|FG001|Overall Study|Left ventricular epicardial lead|2
7775630|NCT00916929|12221797|FG000|Overall Study|Transferred to hospice care|1
7775631|NCT00916929|12221798|FG001|Overall Study|Transferred to hospice care|1
7775632|NCT00916929|12221797|FG000|Overall Study|System explant|1
7775633|NCT00916929|12221798|FG001|Overall Study|System explant|0
7775634|NCT00916929|12221797|FG000|Overall Study|Moved to another state|0
7775635|NCT00916929|12221798|FG001|Overall Study|Moved to another state|1
7775636|NCT00916929|12221797|FG000|Overall Study|Device unable to process impedance data|0
7775637|NCT00916929|12221798|FG001|Overall Study|Device unable to process impedance data|7
7775638|NCT00917124|12221808|FG000|Overall Study|Protocol Violation|4
7775639|NCT00917124|12221809|FG001|Overall Study|Protocol Violation|6
7775640|NCT00917150|12221819|FG000|Overall Study|Adverse Event|12
7775641|NCT00917150|12221820|FG001|Overall Study|Adverse Event|7
7605366|NCT02849587|12012894|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2
7605367|NCT02849587|12012895|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3
7605368|NCT02849587|12012896|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2
7605369|NCT02849587|12012894|FG000|Overall Study|Withdrawal by Subject|0
7605370|NCT02849587|12012895|FG001|Overall Study|Withdrawal by Subject|1
7605371|NCT02849587|12012896|FG002|Overall Study|Withdrawal by Subject|0
7775642|NCT00917150|12221821|FG002|Overall Study|Adverse Event|12
7605373|NCT02781727|12012943|FG000|Pre-dosing Period|Withdrawal by Subject|1
7605374|NCT02781727|12012944|FG001|Pre-dosing Period|Withdrawal by Subject|0
7605375|NCT02781727|12012943|FG000|Treatment Period|Withdrawal by Subject|1
7605376|NCT02781727|12012944|FG001|Treatment Period|Withdrawal by Subject|0
7605377|NCT02781727|12012943|FG000|Treatment Period|Lost to Follow-up|0
7605378|NCT02781727|12012944|FG001|Treatment Period|Lost to Follow-up|1
7605379|NCT02778204|12012954|FG000|Overall Study|Adverse Event|1
7605380|NCT02778204|12012955|FG001|Overall Study|Adverse Event|0
7605381|NCT02778204|12012956|FG002|Overall Study|Adverse Event|0
7605382|NCT02778204|12012957|FG003|Overall Study|Adverse Event|0
7605383|NCT02778204|12012954|FG000|Overall Study|Withdrawal by Subject|0
7605384|NCT02778204|12012955|FG001|Overall Study|Withdrawal by Subject|0
7605385|NCT02778204|12012956|FG002|Overall Study|Withdrawal by Subject|1
7605386|NCT02778204|12012957|FG003|Overall Study|Withdrawal by Subject|2
7605387|NCT02778204|12012954|FG000|Overall Study|Lost to Follow-up|1
7605388|NCT02778204|12012955|FG001|Overall Study|Lost to Follow-up|0
7605389|NCT02778204|12012956|FG002|Overall Study|Lost to Follow-up|2
7605390|NCT02778204|12012957|FG003|Overall Study|Lost to Follow-up|1
7605391|NCT02778204|12012954|FG000|Overall Study|Protocol Violation|0
7605392|NCT02778204|12012955|FG001|Overall Study|Protocol Violation|0
7605393|NCT02778204|12012956|FG002|Overall Study|Protocol Violation|1
7605394|NCT02778204|12012957|FG003|Overall Study|Protocol Violation|0
7605395|NCT02778204|12012954|FG000|Overall Study|Eligibility Violation|0
7605396|NCT02778204|12012955|FG001|Overall Study|Eligibility Violation|0
7605397|NCT02778204|12012956|FG002|Overall Study|Eligibility Violation|0
7605398|NCT02778204|12012957|FG003|Overall Study|Eligibility Violation|1
7605399|NCT02496611|12012980|FG000|Overall Study|Lost to Follow-up|2
7605400|NCT02496611|12012981|FG001|Overall Study|Lost to Follow-up|1
7605401|NCT02496611|12012980|FG000|Overall Study|Withdrawal by Subject|5
7605402|NCT02496611|12012981|FG001|Overall Study|Withdrawal by Subject|2
7605403|NCT02177695|12012999|FG000|ITT Analysis|Ineligible|5
7605404|NCT02177695|12013000|FG001|ITT Analysis|Ineligible|5
7605405|NCT02177695|12012999|FG000|Primary COXEN Analysis|inadequate tissue submitted|5
7605406|NCT02177695|12013000|FG001|Primary COXEN Analysis|inadequate tissue submitted|6
7605407|NCT02177695|12012999|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15
7605408|NCT02177695|12013000|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8
7605409|NCT02177695|12012999|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13
7605410|NCT02177695|12013000|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13
7605411|NCT02105636|12013030|FG000|Overall Study|Disease Progression|162
7605412|NCT02105636|12013031|FG001|Overall Study|Disease Progression|83
7605413|NCT02105636|12013030|FG000|Overall Study|Study Drug Toxicity|9
7605414|NCT02105636|12013031|FG001|Overall Study|Study Drug Toxicity|11
7605415|NCT02105636|12013030|FG000|Overall Study|Adverse Event Unrelated to Study Drug|12
7605416|NCT02105636|12013031|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
7605506|NCT01150890|12013077|FG000|Overall Study|Withdrawal by Subject|0
7775643|NCT00917150|12221822|FG003|Overall Study|Adverse Event|11
7775644|NCT00917150|12221819|FG000|Overall Study|Death|1
7775645|NCT00917150|12221820|FG001|Overall Study|Death|4
7775646|NCT00917150|12221821|FG002|Overall Study|Death|3
7775647|NCT00917150|12221822|FG003|Overall Study|Death|2
7775648|NCT00917150|12221819|FG000|Overall Study|Lost to Follow-up|1
7605417|NCT02105636|12013030|FG000|Overall Study|Subject Request to Discontinue Treatment|4
7605418|NCT02105636|12013031|FG001|Overall Study|Subject Request to Discontinue Treatment|6
7605419|NCT02105636|12013030|FG000|Overall Study|Subject Withdrew Consent|4
7605420|NCT02105636|12013031|FG001|Overall Study|Subject Withdrew Consent|1
7605421|NCT02105636|12013030|FG000|Overall Study|Maximum Clinical Benefit|1
7605422|NCT02105636|12013031|FG001|Overall Study|Maximum Clinical Benefit|1
7605423|NCT02105636|12013030|FG000|Overall Study|Poor/Non-compliance|0
7605424|NCT02105636|12013031|FG001|Overall Study|Poor/Non-compliance|1
7605425|NCT02105636|12013030|FG000|Overall Study|Reason Not Specified|0
7605426|NCT02105636|12013031|FG001|Overall Study|Reason Not Specified|2
7605427|NCT02105636|12013030|FG000|Overall Study|Not Reported|3
7605428|NCT02105636|12013031|FG001|Overall Study|Not Reported|0
7605429|NCT02038946|12013038|FG000|Overall Study|Death|5
7605430|NCT02038946|12013038|FG000|Overall Study|Withdrawal by Subject|3
7605431|NCT02038946|12013038|FG000|Overall Study|Lost to Follow-up|2
7605432|NCT02038946|12013038|FG000|Overall Study|Other reasons|2
7605433|NCT01988571|12013044|FG000|Overall Study|Death|3
7605434|NCT01988571|12013045|FG001|Overall Study|Death|1
7605435|NCT01988571|12013044|FG000|Overall Study|Physician Decision|2
7605436|NCT01988571|12013045|FG001|Overall Study|Physician Decision|1
7605437|NCT01988571|12013044|FG000|Overall Study|Lost to Follow-up|3
7605438|NCT01988571|12013045|FG001|Overall Study|Lost to Follow-up|0
7605439|NCT01988571|12013044|FG000|Overall Study|Withdrawal by Subject|31
7605440|NCT01988571|12013045|FG001|Overall Study|Withdrawal by Subject|33
7605441|NCT01332266|12013056|FG000|Phase 1b|Death|3
7605442|NCT01332266|12013057|FG001|Phase 1b|Death|3
7605443|NCT01332266|12013058|FG002|Phase 1b|Death|2
7605444|NCT01332266|12013059|FG003|Phase 1b|Death|0
7605445|NCT01332266|12013060|FG004|Phase 1b|Death|0
7605446|NCT01332266|12013056|FG000|Phase 1b|Lost to Follow-up|0
7605447|NCT01332266|12013057|FG001|Phase 1b|Lost to Follow-up|1
7605448|NCT01332266|12013058|FG002|Phase 1b|Lost to Follow-up|0
7605449|NCT01332266|12013059|FG003|Phase 1b|Lost to Follow-up|0
7605450|NCT01332266|12013060|FG004|Phase 1b|Lost to Follow-up|0
7605451|NCT01332266|12013056|FG000|Phase 1b|Withdrawal by Subject|1
7605452|NCT01332266|12013057|FG001|Phase 1b|Withdrawal by Subject|1
7605453|NCT01332266|12013058|FG002|Phase 1b|Withdrawal by Subject|1
7605454|NCT01332266|12013059|FG003|Phase 1b|Withdrawal by Subject|0
7605455|NCT01332266|12013060|FG004|Phase 1b|Withdrawal by Subject|0
7605456|NCT01332266|12013056|FG000|Phase 2|Death|0
7605457|NCT01332266|12013057|FG001|Phase 2|Death|0
7605458|NCT01332266|12013058|FG002|Phase 2|Death|0
7605459|NCT01332266|12013059|FG003|Phase 2|Death|33
7605460|NCT01332266|12013060|FG004|Phase 2|Death|36
7605461|NCT01332266|12013056|FG000|Phase 2|Lost to Follow-up|0
7605462|NCT01332266|12013057|FG001|Phase 2|Lost to Follow-up|0
7605463|NCT01332266|12013058|FG002|Phase 2|Lost to Follow-up|0
7605464|NCT01332266|12013059|FG003|Phase 2|Lost to Follow-up|2
7605465|NCT01332266|12013060|FG004|Phase 2|Lost to Follow-up|0
7605466|NCT01332266|12013056|FG000|Phase 2|Physician Decision|0
7605467|NCT01332266|12013057|FG001|Phase 2|Physician Decision|0
7605468|NCT01332266|12013058|FG002|Phase 2|Physician Decision|0
7605469|NCT01332266|12013059|FG003|Phase 2|Physician Decision|3
7605470|NCT01332266|12013060|FG004|Phase 2|Physician Decision|1
7605471|NCT01332266|12013056|FG000|Phase 2|Symptomatic deterioration|0
7605472|NCT01332266|12013057|FG001|Phase 2|Symptomatic deterioration|0
7605473|NCT01332266|12013058|FG002|Phase 2|Symptomatic deterioration|0
7605474|NCT01332266|12013059|FG003|Phase 2|Symptomatic deterioration|0
7605475|NCT01332266|12013060|FG004|Phase 2|Symptomatic deterioration|1
7605476|NCT01332266|12013056|FG000|Phase 2|Progression Disease|0
7605477|NCT01332266|12013057|FG001|Phase 2|Progression Disease|0
7605478|NCT01332266|12013058|FG002|Phase 2|Progression Disease|0
7605479|NCT01332266|12013059|FG003|Phase 2|Progression Disease|2
7605480|NCT01332266|12013060|FG004|Phase 2|Progression Disease|1
7605481|NCT01332266|12013056|FG000|Phase 2|Withdrawal by Subject|0
7605482|NCT01332266|12013057|FG001|Phase 2|Withdrawal by Subject|0
7605483|NCT01332266|12013058|FG002|Phase 2|Withdrawal by Subject|0
7605484|NCT01332266|12013059|FG003|Phase 2|Withdrawal by Subject|2
7605485|NCT01332266|12013060|FG004|Phase 2|Withdrawal by Subject|2
7605486|NCT01150890|12013077|FG000|Overall Study|Other|0
7605487|NCT01150890|12013078|FG001|Overall Study|Other|1
7605488|NCT01150890|12013079|FG002|Overall Study|Other|0
7605489|NCT01150890|12013080|FG003|Overall Study|Other|2
7605490|NCT01150890|12013077|FG000|Overall Study|Pregnancy|0
7605491|NCT01150890|12013078|FG001|Overall Study|Pregnancy|0
7605492|NCT01150890|12013079|FG002|Overall Study|Pregnancy|0
7605493|NCT01150890|12013080|FG003|Overall Study|Pregnancy|1
7605494|NCT01150890|12013077|FG000|Overall Study|Administrative Decision|4
7605495|NCT01150890|12013078|FG001|Overall Study|Administrative Decision|4
7605496|NCT01150890|12013079|FG002|Overall Study|Administrative Decision|5
7605497|NCT01150890|12013080|FG003|Overall Study|Administrative Decision|6
7605498|NCT01150890|12013077|FG000|Overall Study|Ineligibility determined|0
7605499|NCT01150890|12013078|FG001|Overall Study|Ineligibility determined|1
7605500|NCT01150890|12013079|FG002|Overall Study|Ineligibility determined|0
7605501|NCT01150890|12013080|FG003|Overall Study|Ineligibility determined|0
7605502|NCT01150890|12013077|FG000|Overall Study|Adverse Event|0
7605503|NCT01150890|12013078|FG001|Overall Study|Adverse Event|0
7605504|NCT01150890|12013079|FG002|Overall Study|Adverse Event|2
7605505|NCT01150890|12013080|FG003|Overall Study|Adverse Event|0
7605507|NCT01150890|12013078|FG001|Overall Study|Withdrawal by Subject|0
7605508|NCT01150890|12013079|FG002|Overall Study|Withdrawal by Subject|2
7605509|NCT01150890|12013080|FG003|Overall Study|Withdrawal by Subject|1
7605510|NCT01150890|12013077|FG000|Overall Study|Disease progression|0
7605511|NCT01150890|12013078|FG001|Overall Study|Disease progression|7
7605512|NCT01150890|12013079|FG002|Overall Study|Disease progression|3
7605513|NCT01150890|12013080|FG003|Overall Study|Disease progression|7
7605514|NCT01140867|12013093|FG000|Overall Study|Adverse Event|22
7605515|NCT01140867|12013093|FG000|Overall Study|Lack of Efficacy|3
7605516|NCT01140867|12013093|FG000|Overall Study|Lost to Follow-up|2
7605517|NCT01140867|12013093|FG000|Overall Study|Withdrawal by Subject|1
7605518|NCT01140867|12013093|FG000|Overall Study|Protocol Violation|1
7605519|NCT01140867|12013093|FG000|Overall Study|Uncooperative patient|2
7605520|NCT01140867|12013093|FG000|Overall Study|Medication Noncompliance|2
7605521|NCT01137773|12013099|FG000|Overall Study|Death|3
7605522|NCT01137773|12013100|FG001|Overall Study|Death|3
7605523|NCT01137773|12013099|FG000|Overall Study|Lost to Follow-up|6
7605524|NCT01137773|12013100|FG001|Overall Study|Lost to Follow-up|0
7605525|NCT01127256|12013110|FG000|Overall Study|Adverse Event|13
7605526|NCT01127256|12013111|FG001|Overall Study|Adverse Event|13
7605527|NCT01127256|12013110|FG000|Overall Study|Lack of Efficacy|4
7605528|NCT01127256|12013111|FG001|Overall Study|Lack of Efficacy|0
7605529|NCT01127256|12013110|FG000|Overall Study|Lost to Follow-up|16
7605530|NCT01127256|12013111|FG001|Overall Study|Lost to Follow-up|17
7605531|NCT01127256|12013110|FG000|Overall Study|Withdrawal by Subject|5
7605532|NCT01127256|12013111|FG001|Overall Study|Withdrawal by Subject|9
7605533|NCT01127256|12013110|FG000|Overall Study|Protocol Violation|1
7605534|NCT01127256|12013111|FG001|Overall Study|Protocol Violation|0
7605535|NCT01004861|12013130|FG000|Overall Study|Disease progression|3
7605536|NCT01004861|12013131|FG001|Overall Study|Disease progression|4
7605537|NCT01004861|12013132|FG002|Overall Study|Disease progression|5
7605538|NCT01004861|12013133|FG003|Overall Study|Disease progression|4
7605539|NCT01004861|12013134|FG004|Overall Study|Disease progression|4
7605540|NCT01004861|12013135|FG005|Overall Study|Disease progression|4
7605541|NCT01004861|12013136|FG006|Overall Study|Disease progression|5
7605542|NCT01004861|12013137|FG007|Overall Study|Disease progression|1
7605543|NCT01004861|12013138|FG008|Overall Study|Disease progression|4
7605544|NCT01004861|12013139|FG009|Overall Study|Disease progression|7
7605545|NCT01004861|12013140|FG010|Overall Study|Disease progression|6
7605546|NCT01004861|12013141|FG011|Overall Study|Disease progression|3
7605547|NCT01004861|12013142|FG012|Overall Study|Disease progression|8
7605548|NCT01004861|12013130|FG000|Overall Study|Physician Decision|0
7605549|NCT01004861|12013131|FG001|Overall Study|Physician Decision|2
7605550|NCT01004861|12013132|FG002|Overall Study|Physician Decision|1
7605551|NCT01004861|12013133|FG003|Overall Study|Physician Decision|1
7605552|NCT01004861|12013134|FG004|Overall Study|Physician Decision|1
7605553|NCT01004861|12013135|FG005|Overall Study|Physician Decision|0
7605554|NCT01004861|12013136|FG006|Overall Study|Physician Decision|0
7605555|NCT01004861|12013137|FG007|Overall Study|Physician Decision|1
7605556|NCT01004861|12013138|FG008|Overall Study|Physician Decision|0
7605557|NCT01004861|12013139|FG009|Overall Study|Physician Decision|0
7605558|NCT01004861|12013140|FG010|Overall Study|Physician Decision|0
7605559|NCT01004861|12013141|FG011|Overall Study|Physician Decision|0
7605560|NCT01004861|12013142|FG012|Overall Study|Physician Decision|3
7605561|NCT01004861|12013130|FG000|Overall Study|Adverse Event|0
7605562|NCT01004861|12013131|FG001|Overall Study|Adverse Event|0
7605563|NCT01004861|12013132|FG002|Overall Study|Adverse Event|0
7605564|NCT01004861|12013133|FG003|Overall Study|Adverse Event|1
7605565|NCT01004861|12013134|FG004|Overall Study|Adverse Event|0
7605566|NCT01004861|12013135|FG005|Overall Study|Adverse Event|2
7605567|NCT01004861|12013136|FG006|Overall Study|Adverse Event|1
7605568|NCT01004861|12013137|FG007|Overall Study|Adverse Event|1
7605569|NCT01004861|12013138|FG008|Overall Study|Adverse Event|13
7605570|NCT01004861|12013139|FG009|Overall Study|Adverse Event|1
7605571|NCT01004861|12013140|FG010|Overall Study|Adverse Event|1
7605572|NCT01004861|12013141|FG011|Overall Study|Adverse Event|0
7605573|NCT01004861|12013142|FG012|Overall Study|Adverse Event|2
7605574|NCT01004861|12013130|FG000|Overall Study|Protocol Violation|0
7605575|NCT01004861|12013131|FG001|Overall Study|Protocol Violation|0
7605576|NCT01004861|12013132|FG002|Overall Study|Protocol Violation|0
7605577|NCT01004861|12013133|FG003|Overall Study|Protocol Violation|0
7605578|NCT01004861|12013134|FG004|Overall Study|Protocol Violation|1
7605579|NCT01004861|12013135|FG005|Overall Study|Protocol Violation|0
7605580|NCT01004861|12013136|FG006|Overall Study|Protocol Violation|0
7605581|NCT01004861|12013137|FG007|Overall Study|Protocol Violation|0
7605582|NCT01004861|12013138|FG008|Overall Study|Protocol Violation|0
7605583|NCT01004861|12013139|FG009|Overall Study|Protocol Violation|0
7605584|NCT01004861|12013140|FG010|Overall Study|Protocol Violation|0
7605585|NCT01004861|12013141|FG011|Overall Study|Protocol Violation|0
7605586|NCT01004861|12013142|FG012|Overall Study|Protocol Violation|0
7605587|NCT01004861|12013130|FG000|Overall Study|Lost to Follow-up|0
7605588|NCT01004861|12013131|FG001|Overall Study|Lost to Follow-up|0
7605589|NCT01004861|12013132|FG002|Overall Study|Lost to Follow-up|0
7605590|NCT01004861|12013133|FG003|Overall Study|Lost to Follow-up|0
7605591|NCT01004861|12013134|FG004|Overall Study|Lost to Follow-up|0
7605592|NCT01004861|12013135|FG005|Overall Study|Lost to Follow-up|0
7605593|NCT01004861|12013136|FG006|Overall Study|Lost to Follow-up|0
7605594|NCT01004861|12013137|FG007|Overall Study|Lost to Follow-up|1
7605595|NCT01004861|12013138|FG008|Overall Study|Lost to Follow-up|3
7605596|NCT01004861|12013139|FG009|Overall Study|Lost to Follow-up|0
7605597|NCT01004861|12013140|FG010|Overall Study|Lost to Follow-up|0
7605598|NCT01004861|12013141|FG011|Overall Study|Lost to Follow-up|1
7605599|NCT01004861|12013142|FG012|Overall Study|Lost to Follow-up|0
7605600|NCT01004861|12013130|FG000|Overall Study|Non-compliance|0
7605601|NCT01004861|12013131|FG001|Overall Study|Non-compliance|0
7605602|NCT01004861|12013132|FG002|Overall Study|Non-compliance|0
7605603|NCT01004861|12013133|FG003|Overall Study|Non-compliance|0
7605604|NCT01004861|12013134|FG004|Overall Study|Non-compliance|0
7605605|NCT01004861|12013135|FG005|Overall Study|Non-compliance|0
7605606|NCT01004861|12013136|FG006|Overall Study|Non-compliance|0
7605607|NCT01004861|12013137|FG007|Overall Study|Non-compliance|0
7605608|NCT01004861|12013138|FG008|Overall Study|Non-compliance|5
7605609|NCT01004861|12013139|FG009|Overall Study|Non-compliance|0
7605610|NCT01004861|12013140|FG010|Overall Study|Non-compliance|0
7605611|NCT01004861|12013141|FG011|Overall Study|Non-compliance|0
7605612|NCT01004861|12013142|FG012|Overall Study|Non-compliance|1
7605613|NCT01004861|12013130|FG000|Overall Study|Other|0
7605614|NCT01004861|12013131|FG001|Overall Study|Other|0
7605615|NCT01004861|12013132|FG002|Overall Study|Other|0
7605616|NCT01004861|12013133|FG003|Overall Study|Other|0
7605617|NCT01004861|12013134|FG004|Overall Study|Other|0
7605618|NCT01004861|12013135|FG005|Overall Study|Other|0
7605619|NCT01004861|12013136|FG006|Overall Study|Other|0
7605620|NCT01004861|12013137|FG007|Overall Study|Other|0
7605621|NCT01004861|12013138|FG008|Overall Study|Other|0
7605622|NCT01004861|12013139|FG009|Overall Study|Other|2
7605623|NCT01004861|12013140|FG010|Overall Study|Other|1
7605624|NCT01004861|12013141|FG011|Overall Study|Other|2
7605625|NCT01004861|12013142|FG012|Overall Study|Other|3
7605626|NCT01004861|12013130|FG000|Overall Study|Patient decision|0
7775649|NCT00917150|12221820|FG001|Overall Study|Lost to Follow-up|0
7775650|NCT00917150|12221821|FG002|Overall Study|Lost to Follow-up|4
7775651|NCT00917150|12221822|FG003|Overall Study|Lost to Follow-up|2
7775652|NCT00917150|12221819|FG000|Overall Study|Physician Decision|0
7775653|NCT00917150|12221820|FG001|Overall Study|Physician Decision|2
7775654|NCT00917150|12221821|FG002|Overall Study|Physician Decision|0
7775655|NCT00917150|12221822|FG003|Overall Study|Physician Decision|1
7775656|NCT00917150|12221819|FG000|Overall Study|Protocol Violation|5
7775657|NCT00917150|12221820|FG001|Overall Study|Protocol Violation|5
7775658|NCT00917150|12221821|FG002|Overall Study|Protocol Violation|3
7775659|NCT00917150|12221822|FG003|Overall Study|Protocol Violation|5
7775660|NCT00917150|12221819|FG000|Overall Study|Withdrawal by Subject|15
7775661|NCT00917150|12221820|FG001|Overall Study|Withdrawal by Subject|16
7775662|NCT00917150|12221821|FG002|Overall Study|Withdrawal by Subject|18
7775663|NCT00917150|12221822|FG003|Overall Study|Withdrawal by Subject|11
7775664|NCT00917150|12221819|FG000|Overall Study|Other than specified|3
7775665|NCT00917150|12221820|FG001|Overall Study|Other than specified|3
7775666|NCT00917150|12221821|FG002|Overall Study|Other than specified|2
7775667|NCT00917150|12221822|FG003|Overall Study|Other than specified|2
7775668|NCT00917267|12221834|FG000|Overall Study|Adverse Event|15
7775669|NCT00917267|12221835|FG001|Overall Study|Adverse Event|36
7775670|NCT00917267|12221834|FG000|Overall Study|Physician Decision|2
7775671|NCT00917267|12221835|FG001|Overall Study|Physician Decision|4
7775672|NCT00917267|12221834|FG000|Overall Study|Protocol Violation|9
7775673|NCT00917267|12221835|FG001|Overall Study|Protocol Violation|18
7775674|NCT00917267|12221834|FG000|Overall Study|Withdrawal by Subject|5
7775675|NCT00917267|12221835|FG001|Overall Study|Withdrawal by Subject|12
7775676|NCT00917267|12221834|FG000|Overall Study|Lost to follow up|0
7775677|NCT00917267|12221835|FG001|Overall Study|Lost to follow up|2
7775678|NCT00917267|12221834|FG000|Overall Study|Entry Criteria Not Met|1
7775679|NCT00917267|12221835|FG001|Overall Study|Entry Criteria Not Met|0
7775680|NCT00917267|12221834|FG000|Overall Study|Sponsor Decision|5
7775681|NCT00917267|12221835|FG001|Overall Study|Sponsor Decision|5
7775682|NCT00917267|12221834|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
7775683|NCT00917267|12221835|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
7775684|NCT00917384|12221847|FG000|Overall Study|Lost to Follow-up|4
7775685|NCT00917384|12221848|FG001|Overall Study|Lost to Follow-up|2
7605627|NCT01004861|12013131|FG001|Overall Study|Patient decision|0
7605628|NCT01004861|12013132|FG002|Overall Study|Patient decision|0
7605629|NCT01004861|12013133|FG003|Overall Study|Patient decision|0
7605630|NCT01004861|12013134|FG004|Overall Study|Patient decision|1
7605631|NCT01004861|12013135|FG005|Overall Study|Patient decision|0
7605632|NCT01004861|12013136|FG006|Overall Study|Patient decision|1
7605633|NCT01004861|12013137|FG007|Overall Study|Patient decision|0
7605634|NCT01004861|12013138|FG008|Overall Study|Patient decision|7
7605635|NCT01004861|12013139|FG009|Overall Study|Patient decision|1
7605636|NCT01004861|12013140|FG010|Overall Study|Patient decision|1
7605637|NCT01004861|12013141|FG011|Overall Study|Patient decision|2
7605638|NCT01004861|12013142|FG012|Overall Study|Patient decision|3
7605639|NCT01004861|12013130|FG000|Overall Study|Transitioned to Phase 4 study|0
7605640|NCT01004861|12013131|FG001|Overall Study|Transitioned to Phase 4 study|0
7605641|NCT01004861|12013132|FG002|Overall Study|Transitioned to Phase 4 study|0
7775686|NCT00917384|12221847|FG000|Overall Study|Withdrawal by Subject|10
7775687|NCT00917384|12221848|FG001|Overall Study|Withdrawal by Subject|2
7605642|NCT01004861|12013133|FG003|Overall Study|Transitioned to Phase 4 study|0
7605643|NCT01004861|12013134|FG004|Overall Study|Transitioned to Phase 4 study|0
7605644|NCT01004861|12013135|FG005|Overall Study|Transitioned to Phase 4 study|0
7605645|NCT01004861|12013136|FG006|Overall Study|Transitioned to Phase 4 study|0
7605646|NCT01004861|12013137|FG007|Overall Study|Transitioned to Phase 4 study|0
7605647|NCT01004861|12013138|FG008|Overall Study|Transitioned to Phase 4 study|2
7605648|NCT01004861|12013139|FG009|Overall Study|Transitioned to Phase 4 study|0
7605649|NCT01004861|12013140|FG010|Overall Study|Transitioned to Phase 4 study|0
7605650|NCT01004861|12013141|FG011|Overall Study|Transitioned to Phase 4 study|0
7605651|NCT01004861|12013142|FG012|Overall Study|Transitioned to Phase 4 study|0
7605652|NCT01004861|12013130|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605653|NCT01004861|12013131|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605654|NCT01004861|12013132|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605655|NCT01004861|12013133|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605656|NCT01004861|12013134|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605657|NCT01004861|12013135|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605658|NCT01004861|12013136|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605659|NCT01004861|12013137|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605660|NCT01004861|12013138|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1
7605661|NCT01004861|12013139|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605662|NCT01004861|12013140|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605663|NCT01004861|12013141|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605664|NCT01004861|12013142|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605665|NCT01004861|12013130|FG000|Overall Study|Patient withdrew|0
7605666|NCT01004861|12013131|FG001|Overall Study|Patient withdrew|0
7605667|NCT01004861|12013132|FG002|Overall Study|Patient withdrew|0
7605668|NCT01004861|12013133|FG003|Overall Study|Patient withdrew|0
7605669|NCT01004861|12013134|FG004|Overall Study|Patient withdrew|0
7605670|NCT01004861|12013135|FG005|Overall Study|Patient withdrew|0
7605671|NCT01004861|12013136|FG006|Overall Study|Patient withdrew|0
7605672|NCT01004861|12013137|FG007|Overall Study|Patient withdrew|0
7605673|NCT01004861|12013138|FG008|Overall Study|Patient withdrew|1
7605674|NCT01004861|12013139|FG009|Overall Study|Patient withdrew|0
7605675|NCT01004861|12013140|FG010|Overall Study|Patient withdrew|0
7605676|NCT01004861|12013141|FG011|Overall Study|Patient withdrew|0
7605677|NCT01004861|12013142|FG012|Overall Study|Patient withdrew|0
7605678|NCT01004861|12013130|FG000|Overall Study|Surgical resection|0
7605679|NCT01004861|12013131|FG001|Overall Study|Surgical resection|0
7605680|NCT01004861|12013132|FG002|Overall Study|Surgical resection|0
7605681|NCT01004861|12013133|FG003|Overall Study|Surgical resection|0
7605682|NCT01004861|12013134|FG004|Overall Study|Surgical resection|0
7605683|NCT01004861|12013135|FG005|Overall Study|Surgical resection|0
7605684|NCT01004861|12013136|FG006|Overall Study|Surgical resection|0
7605685|NCT01004861|12013137|FG007|Overall Study|Surgical resection|0
7605686|NCT01004861|12013138|FG008|Overall Study|Surgical resection|1
7605687|NCT01004861|12013139|FG009|Overall Study|Surgical resection|0
7605688|NCT01004861|12013140|FG010|Overall Study|Surgical resection|0
7605689|NCT01004861|12013141|FG011|Overall Study|Surgical resection|0
7605690|NCT01004861|12013142|FG012|Overall Study|Surgical resection|0
7605691|NCT01004861|12013130|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605692|NCT01004861|12013131|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605693|NCT01004861|12013132|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605694|NCT01004861|12013133|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605695|NCT01004861|12013134|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605696|NCT01004861|12013135|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605697|NCT01004861|12013136|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605698|NCT01004861|12013137|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605699|NCT01004861|12013138|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1
7605700|NCT01004861|12013139|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605701|NCT01004861|12013140|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605702|NCT01004861|12013141|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605703|NCT01004861|12013142|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605704|NCT01004861|12013130|FG000|Overall Study|Study termination by Sponsor|0
7605705|NCT01004861|12013131|FG001|Overall Study|Study termination by Sponsor|0
7605706|NCT01004861|12013132|FG002|Overall Study|Study termination by Sponsor|0
7605707|NCT01004861|12013133|FG003|Overall Study|Study termination by Sponsor|0
7605708|NCT01004861|12013134|FG004|Overall Study|Study termination by Sponsor|0
7605709|NCT01004861|12013135|FG005|Overall Study|Study termination by Sponsor|0
7605710|NCT01004861|12013136|FG006|Overall Study|Study termination by Sponsor|0
7605711|NCT01004861|12013137|FG007|Overall Study|Study termination by Sponsor|0
7605712|NCT01004861|12013138|FG008|Overall Study|Study termination by Sponsor|1
7605713|NCT01004861|12013139|FG009|Overall Study|Study termination by Sponsor|0
7605714|NCT01004861|12013140|FG010|Overall Study|Study termination by Sponsor|0
7605715|NCT01004861|12013141|FG011|Overall Study|Study termination by Sponsor|0
7605716|NCT01004861|12013142|FG012|Overall Study|Study termination by Sponsor|0
7605717|NCT00912223|12013174|FG000|Overall Study|Withdrawal by Subject|1
7605718|NCT00912223|12013174|FG000|Overall Study|Not transplanted|1
7605719|NCT00912223|12013174|FG000|Overall Study|Transformed disease|1
7605720|NCT00381381|12013178|FG000|Overall Study|Adverse Event|3
7605721|NCT00381381|12013178|FG000|Overall Study|Lost to Follow-up|52
7605722|NCT00381381|12013178|FG000|Overall Study|Withdrawal by Subject|9
7605723|NCT03712124|12013198|FG000|Overall Study|Protocol Violation|1
7605724|NCT03712124|12013199|FG001|Overall Study|Protocol Violation|0
7605725|NCT03535740|12013211|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55
7605726|NCT03535740|12013211|FG000|Overall Study|Death|34
7605727|NCT03535740|12013211|FG000|Overall Study|Lost to Follow-up|1
7605728|NCT03535740|12013211|FG000|Overall Study|Withdrawal by Subject|13
7605729|NCT02896257|12013248|FG000|Providers|Without eligible patients|21
7605730|NCT02896257|12013249|FG001|Providers|Without eligible patients|28
7605731|NCT02896257|12013248|FG000|Patients|PFT entry criteria not met|43
7605732|NCT02896257|12013249|FG001|Patients|PFT entry criteria not met|50
7605733|NCT02896257|12013248|FG000|Patients|No capacity to review|8
7605734|NCT02896257|12013249|FG001|Patients|No capacity to review|11
7605735|NCT02896257|12013248|FG000|Patients|Appointment rescheduled/cancelled|5
7605736|NCT02896257|12013249|FG001|Patients|Appointment rescheduled/cancelled|7
7605737|NCT02896257|12013248|FG000|Patients|PCP not assigned a clinic|4
7605738|NCT02896257|12013249|FG001|Patients|PCP not assigned a clinic|0
7605739|NCT02896257|12013248|FG000|Patients|No history of COPD|0
7605740|NCT02896257|12013249|FG001|Patients|No history of COPD|1
7605741|NCT02896257|12013248|FG000|Patients|Deceased between review and index date|0
7605742|NCT02896257|12013249|FG001|Patients|Deceased between review and index date|1
7605743|NCT02896257|12013248|FG000|Patients|No ICS Rx upon review|1
7605744|NCT02896257|12013249|FG001|Patients|No ICS Rx upon review|1
7605745|NCT02896257|12013248|FG000|Patients|Protocol Violation|2
7605746|NCT02896257|12013249|FG001|Patients|Protocol Violation|1
7605747|NCT02896257|12013248|FG000|Patients|Hospice care|0
7605748|NCT02896257|12013249|FG001|Patients|Hospice care|1
7605749|NCT02736617|12013265|FG000|Treatment|Adverse Event|1
7605750|NCT02736617|12013265|FG000|Treatment|Lack of Efficacy|1
7605751|NCT02736617|12013265|FG000|Treatment|Withdrawal by Subject|1
7605752|NCT02736617|12013265|FG000|Maintenance|Lack of Efficacy|4
7775688|NCT00917462|12221854|FG000|Overall Study|Clinical Deterioration|1
7775689|NCT00917501|12221860|FG000|Overall Study|Lost to Follow-up|4
7775690|NCT00917501|12221861|FG001|Overall Study|Lost to Follow-up|1
7775691|NCT00917501|12221860|FG000|Overall Study|Withdrawal by Subject|3
7775692|NCT00917501|12221861|FG001|Overall Study|Withdrawal by Subject|1
7775693|NCT00917501|12221860|FG000|Overall Study|Lack of Efficacy|1
7775694|NCT00917501|12221861|FG001|Overall Study|Lack of Efficacy|2
7775695|NCT00917501|12221860|FG000|Overall Study|trouble swollowing capsules|0
7775696|NCT00917501|12221861|FG001|Overall Study|trouble swollowing capsules|1
7775697|NCT00917553|12221869|FG000|Overall Study|Lost to Follow-up|2
7775698|NCT00917553|12221870|FG001|Overall Study|Lost to Follow-up|1
7800033|NCT01090492|12257180|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1
7800034|NCT01090492|12257181|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0
7800035|NCT01090492|12257182|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0
7800036|NCT01090492|12257183|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0
7800037|NCT01090492|12257184|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1
7800038|NCT01090492|12257185|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0
7800039|NCT01090492|12257186|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1
7605753|NCT02736617|12013265|FG000|Maintenance|Physician Decision|1
7605754|NCT02579265|12013276|FG000|Overall Study|Weaned off earlier than 28 days|44
7605755|NCT02579265|12013277|FG001|Overall Study|Weaned off earlier than 28 days|43
7605756|NCT02579265|12013276|FG000|Overall Study|Adverse Event|2
7605757|NCT02579265|12013277|FG001|Overall Study|Adverse Event|0
7605758|NCT02579265|12013276|FG000|Overall Study|Any other reason not specified|0
7605759|NCT02579265|12013277|FG001|Overall Study|Any other reason not specified|2
7605760|NCT02579265|12013276|FG000|Overall Study|Withdrawal by Subject|2
7605761|NCT02579265|12013277|FG001|Overall Study|Withdrawal by Subject|0
7605762|NCT02579265|12013276|FG000|Overall Study|Physician Decision|1
7605763|NCT02579265|12013277|FG001|Overall Study|Physician Decision|0
7605764|NCT02579265|12013276|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1
7605765|NCT02579265|12013277|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0
7605766|NCT02013167|12013285|FG000|Overall Study|Withdrawal by Subject|15
7605767|NCT02013167|12013286|FG001|Overall Study|Withdrawal by Subject|14
7800040|NCT01090492|12257187|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1
7800041|NCT01090492|12257180|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0
7800042|NCT01090492|12257181|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1
7800043|NCT01090492|12257182|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0
7800044|NCT01090492|12257183|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0
7800045|NCT01090492|12257184|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0
7775699|NCT00917579|12221876|FG000|Washout >= 2 Weeks|Adverse Event|1
7775700|NCT00917579|12221877|FG001|Washout >= 2 Weeks|Adverse Event|0
7775701|NCT00917579|12221876|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1
7775702|NCT00917579|12221877|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0
7775703|NCT00917644|12221883|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
7605768|NCT02013167|12013285|FG000|Overall Study|Sponsor Decision|1
7605769|NCT02013167|12013286|FG001|Overall Study|Sponsor Decision|3
7605770|NCT02013167|12013285|FG000|Overall Study|Lost to Follow-up|0
7605771|NCT02013167|12013286|FG001|Overall Study|Lost to Follow-up|1
7605772|NCT02013167|12013285|FG000|Overall Study|Death|85
7605773|NCT02013167|12013286|FG001|Overall Study|Death|160
7605774|NCT02004522|12013295|FG000|Overall Study|Adverse Event|55
7605775|NCT02004522|12013296|FG001|Overall Study|Adverse Event|6
7605776|NCT02004522|12013295|FG000|Overall Study|Withdrawal by Subject|13
7605777|NCT02004522|12013296|FG001|Overall Study|Withdrawal by Subject|7
7605778|NCT02004522|12013295|FG000|Overall Study|Death|12
7605779|NCT02004522|12013296|FG001|Overall Study|Death|3
7605780|NCT02004522|12013295|FG000|Overall Study|Physician Decision|3
7605781|NCT02004522|12013296|FG001|Overall Study|Physician Decision|4
7605782|NCT02004522|12013295|FG000|Overall Study|Protocol Violation|1
7605783|NCT02004522|12013296|FG001|Overall Study|Protocol Violation|0
7605784|NCT02004522|12013295|FG000|Overall Study|Other is reason listed by PI.|4
7605785|NCT02004522|12013296|FG001|Overall Study|Other is reason listed by PI.|1
7605786|NCT02004522|12013295|FG000|Overall Study|Never Dosed|2
7605787|NCT02004522|12013296|FG001|Overall Study|Never Dosed|4
7775704|NCT00917644|12221884|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
7775705|NCT00917644|12221883|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
7775706|NCT00917644|12221884|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
7775707|NCT00917644|12221883|FG000|Period 2: Second Intervention|family emergency|1
7775708|NCT00917644|12221884|FG001|Period 2: Second Intervention|family emergency|0
7775709|NCT00917852|12221899|FG000|Overall Study|Death|6
7775710|NCT00918138|12221929|FG000|Overall Study|Subject withdrew consent|1
7775711|NCT00918138|12221930|FG001|Overall Study|Subject withdrew consent|1
7775712|NCT00918138|12221929|FG000|Overall Study|Death|1
7775713|NCT00918138|12221930|FG001|Overall Study|Death|0
7775714|NCT00918203|12221938|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1
7775715|NCT00918203|12221939|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1
7775716|NCT00918203|12221940|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0
7775717|NCT00918203|12221938|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2
7775718|NCT00918203|12221939|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8
7775719|NCT00918203|12221940|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0
7605788|NCT02004522|12013295|FG000|Overall Study|Disease Progression|35
7605789|NCT02004522|12013296|FG001|Overall Study|Disease Progression|31
7605790|NCT02004522|12013295|FG000|Overall Study|Completed Treatrment Cycles Per Protocol|1
7605791|NCT02004522|12013296|FG001|Overall Study|Completed Treatrment Cycles Per Protocol|103
7775720|NCT00918203|12221938|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2
7605793|NCT01981850|12013313|FG000|Main Phase Stage 1|Death|2
7605794|NCT01981850|12013314|FG001|Main Phase Stage 1|Death|0
7605795|NCT01981850|12013315|FG002|Main Phase Stage 1|Death|0
7605796|NCT01981850|12013316|FG003|Main Phase Stage 1|Death|0
7605797|NCT01981850|12013317|FG004|Main Phase Stage 1|Death|0
7605798|NCT01981850|12013318|FG005|Main Phase Stage 1|Death|0
7605799|NCT01981850|12013319|FG006|Main Phase Stage 1|Death|0
7605800|NCT01981850|12013320|FG007|Main Phase Stage 1|Death|0
7605801|NCT01981850|12013321|FG008|Main Phase Stage 1|Death|0
7605802|NCT01981850|12013322|FG009|Main Phase Stage 1|Death|0
7605803|NCT01981850|12013313|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1
7605804|NCT01981850|12013314|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0
7605805|NCT01981850|12013315|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0
7605806|NCT01981850|12013316|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0
7605807|NCT01981850|12013317|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0
7605808|NCT01981850|12013318|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0
7605809|NCT01981850|12013319|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0
7605810|NCT01981850|12013320|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0
7605811|NCT01981850|12013321|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0
7605812|NCT01981850|12013322|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0
7605813|NCT01981850|12013313|FG000|Main Phase Stage 1|Lack of Efficacy|0
7605814|NCT01981850|12013314|FG001|Main Phase Stage 1|Lack of Efficacy|2
7605815|NCT01981850|12013315|FG002|Main Phase Stage 1|Lack of Efficacy|0
7605816|NCT01981850|12013316|FG003|Main Phase Stage 1|Lack of Efficacy|0
7775721|NCT00918203|12221939|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1
7775722|NCT00918203|12221940|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0
7775723|NCT00918203|12221938|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1
7775724|NCT00918203|12221939|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0
7775725|NCT00918203|12221940|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0
7775726|NCT00918255|12221959|FG000|Overall Study|Adverse Event|1
7775727|NCT00918255|12221960|FG001|Overall Study|Adverse Event|0
7775728|NCT00918255|12221961|FG002|Overall Study|Adverse Event|0
7775729|NCT00918255|12221959|FG000|Overall Study|Withdrawal by Subject|1
7775730|NCT00918255|12221960|FG001|Overall Study|Withdrawal by Subject|0
7775731|NCT00918255|12221961|FG002|Overall Study|Withdrawal by Subject|2
7775732|NCT00918255|12221959|FG000|Overall Study|Lack of Efficacy|1
7775733|NCT00918255|12221960|FG001|Overall Study|Lack of Efficacy|0
7775734|NCT00918255|12221961|FG002|Overall Study|Lack of Efficacy|0
7775735|NCT00918255|12221959|FG000|Overall Study|Lost to Follow-up|1
7775736|NCT00918255|12221960|FG001|Overall Study|Lost to Follow-up|0
7775737|NCT00918255|12221961|FG002|Overall Study|Lost to Follow-up|2
7775738|NCT00918255|12221959|FG000|Overall Study|Exceeded allowed number of interventions|0
7775739|NCT00918255|12221960|FG001|Overall Study|Exceeded allowed number of interventions|0
7775740|NCT00918255|12221961|FG002|Overall Study|Exceeded allowed number of interventions|1
7775741|NCT00918255|12221959|FG000|Overall Study|Non-compliance|1
7775742|NCT00918255|12221960|FG001|Overall Study|Non-compliance|0
7775743|NCT00918255|12221961|FG002|Overall Study|Non-compliance|0
7775744|NCT00918255|12221959|FG000|Overall Study|Investigator discretion|1
7775745|NCT00918255|12221960|FG001|Overall Study|Investigator discretion|0
7775746|NCT00918255|12221961|FG002|Overall Study|Investigator discretion|0
7775747|NCT00918281|12221969|FG000|Overall Study|Physician Decision|29
7775748|NCT00918333|12221978|FG000|Overall Study|Drug not taken per protocol|1
7775749|NCT00918333|12221979|FG001|Overall Study|Drug not taken per protocol|0
7775750|NCT00918333|12221978|FG000|Overall Study|Inadequate amount of drugs provided|1
7775751|NCT00918333|12221979|FG001|Overall Study|Inadequate amount of drugs provided|4
7775752|NCT00918333|12221978|FG000|Overall Study|Ineligible|1
7775753|NCT00918333|12221979|FG001|Overall Study|Ineligible|0
7775754|NCT00918333|12221978|FG000|Overall Study|Withdrawal by Subject|0
7775755|NCT00918333|12221979|FG001|Overall Study|Withdrawal by Subject|1
7775756|NCT00918346|12221988|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0
7775757|NCT00918346|12221989|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1
7775758|NCT00918385|12222000|FG000|Monotherapy|Adverse Event|1
7775759|NCT00918385|12222001|FG001|Monotherapy|Adverse Event|6
7775760|NCT00918385|12222000|FG000|Monotherapy|Complicating illness|1
7605817|NCT01981850|12013317|FG004|Main Phase Stage 1|Lack of Efficacy|0
7605818|NCT01981850|12013318|FG005|Main Phase Stage 1|Lack of Efficacy|0
7605819|NCT01981850|12013319|FG006|Main Phase Stage 1|Lack of Efficacy|0
7605820|NCT01981850|12013320|FG007|Main Phase Stage 1|Lack of Efficacy|0
7605821|NCT01981850|12013321|FG008|Main Phase Stage 1|Lack of Efficacy|0
7605822|NCT01981850|12013322|FG009|Main Phase Stage 1|Lack of Efficacy|0
7605823|NCT01981850|12013313|FG000|Main Phase Stage 1|Various reasons|0
7605824|NCT01981850|12013314|FG001|Main Phase Stage 1|Various reasons|0
7605825|NCT01981850|12013315|FG002|Main Phase Stage 1|Various reasons|2
7605826|NCT01981850|12013316|FG003|Main Phase Stage 1|Various reasons|0
7605827|NCT01981850|12013317|FG004|Main Phase Stage 1|Various reasons|0
7605828|NCT01981850|12013318|FG005|Main Phase Stage 1|Various reasons|0
7605829|NCT01981850|12013319|FG006|Main Phase Stage 1|Various reasons|0
7605830|NCT01981850|12013320|FG007|Main Phase Stage 1|Various reasons|0
7605831|NCT01981850|12013321|FG008|Main Phase Stage 1|Various reasons|0
7605832|NCT01981850|12013322|FG009|Main Phase Stage 1|Various reasons|0
7605833|NCT01981850|12013313|FG000|Main Phase Stage 2|Adverse Event|0
7605834|NCT01981850|12013314|FG001|Main Phase Stage 2|Adverse Event|0
7605835|NCT01981850|12013315|FG002|Main Phase Stage 2|Adverse Event|0
7605836|NCT01981850|12013316|FG003|Main Phase Stage 2|Adverse Event|0
7605837|NCT01981850|12013317|FG004|Main Phase Stage 2|Adverse Event|6
7605838|NCT01981850|12013318|FG005|Main Phase Stage 2|Adverse Event|5
7605839|NCT01981850|12013319|FG006|Main Phase Stage 2|Adverse Event|7
7605840|NCT01981850|12013320|FG007|Main Phase Stage 2|Adverse Event|0
7605841|NCT01981850|12013321|FG008|Main Phase Stage 2|Adverse Event|0
7605842|NCT01981850|12013322|FG009|Main Phase Stage 2|Adverse Event|0
7605843|NCT01981850|12013313|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0
7605844|NCT01981850|12013314|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0
7605845|NCT01981850|12013315|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0
7605846|NCT01981850|12013316|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0
7605847|NCT01981850|12013317|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4
7605848|NCT01981850|12013318|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3
7605849|NCT01981850|12013319|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3
7605850|NCT01981850|12013320|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0
7605851|NCT01981850|12013321|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0
7605852|NCT01981850|12013322|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0
7605853|NCT01981850|12013313|FG000|Main Phase Stage 2|Lack of Efficacy|0
7605854|NCT01981850|12013314|FG001|Main Phase Stage 2|Lack of Efficacy|0
7605855|NCT01981850|12013315|FG002|Main Phase Stage 2|Lack of Efficacy|0
7775761|NCT00918385|12222001|FG001|Monotherapy|Complicating illness|0
7775762|NCT00918385|12222000|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1
7775763|NCT00918385|12222001|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1
7775764|NCT00918385|12222000|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
7775765|NCT00918385|12222001|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
7775766|NCT00918385|12222000|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1
7775767|NCT00918385|12222001|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0
7605856|NCT01981850|12013316|FG003|Main Phase Stage 2|Lack of Efficacy|0
7605857|NCT01981850|12013317|FG004|Main Phase Stage 2|Lack of Efficacy|1
7605858|NCT01981850|12013318|FG005|Main Phase Stage 2|Lack of Efficacy|2
7605859|NCT01981850|12013319|FG006|Main Phase Stage 2|Lack of Efficacy|0
7775768|NCT00918385|12222000|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
7864088|NCT01609556|12353455|FG011|Dose Expansion: Maximum 124 Weeks|Death|0
7605860|NCT01981850|12013320|FG007|Main Phase Stage 2|Lack of Efficacy|0
7605861|NCT01981850|12013321|FG008|Main Phase Stage 2|Lack of Efficacy|0
7605862|NCT01981850|12013322|FG009|Main Phase Stage 2|Lack of Efficacy|0
7605863|NCT01981850|12013313|FG000|Main Phase Stage 2|Various reasons|0
7605864|NCT01981850|12013314|FG001|Main Phase Stage 2|Various reasons|0
7605865|NCT01981850|12013315|FG002|Main Phase Stage 2|Various reasons|0
7775769|NCT00918385|12222001|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
7775770|NCT00918567|12222011|FG000|Overall Study|Lack of Efficacy|3
7775771|NCT00918567|12222012|FG001|Overall Study|Lack of Efficacy|1
7775772|NCT00918567|12222011|FG000|Overall Study|Withdrawal by Subject|1
7775773|NCT00918567|12222012|FG001|Overall Study|Withdrawal by Subject|1
7775774|NCT00918567|12222011|FG000|Overall Study|Adverse Event|1
7775775|NCT00918567|12222012|FG001|Overall Study|Adverse Event|0
7775776|NCT00918580|12222018|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1
7775777|NCT00918580|12222018|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
7775778|NCT00918580|12222018|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
7775779|NCT00918580|12222018|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
7775780|NCT00918580|12222018|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1
7775781|NCT00918580|12222018|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
7775782|NCT00918580|12222018|FG000|After 6-month FU to 1-year FU|Failed to Return|2
7775783|NCT00918684|12222029|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
7775784|NCT00918684|12222029|FG000|Treatment Phase|Lack of Efficacy|6
7775785|NCT00918684|12222029|FG000|Treatment Phase|Lost to Follow-up|2
7775786|NCT00918684|12222029|FG000|Treatment Phase|Physician Decision|8
7775787|NCT00918684|12222029|FG000|Treatment Phase|Protocol Violation|1
7775788|NCT00918684|12222029|FG000|Treatment Phase|Withdrawal by Subject|8
7775789|NCT00918736|12222039|FG000|Overall Study|Withdrawal by Subject|4
7775790|NCT00918749|12222046|FG000|Overall Study|Adverse Event|1
7775791|NCT00918749|12222047|FG001|Overall Study|Adverse Event|0
7775792|NCT00918749|12222048|FG002|Overall Study|Adverse Event|1
7775793|NCT00918749|12222046|FG000|Overall Study|Lost to Follow-up|0
7775794|NCT00918749|12222047|FG001|Overall Study|Lost to Follow-up|0
7775795|NCT00918749|12222048|FG002|Overall Study|Lost to Follow-up|1
7775796|NCT00918749|12222046|FG000|Overall Study|Withdrawal by Subject|5
7775797|NCT00918749|12222047|FG001|Overall Study|Withdrawal by Subject|3
7775798|NCT00918749|12222048|FG002|Overall Study|Withdrawal by Subject|5
7775799|NCT00918749|12222046|FG000|Overall Study|No Study Medication Taken|1
7775800|NCT00918749|12222047|FG001|Overall Study|No Study Medication Taken|0
7775801|NCT00918749|12222048|FG002|Overall Study|No Study Medication Taken|0
7775802|NCT00918879|12222067|FG000|Overall Study|Withdrawal by Subject|4
7605866|NCT01981850|12013316|FG003|Main Phase Stage 2|Various reasons|0
7605867|NCT01981850|12013317|FG004|Main Phase Stage 2|Various reasons|2
7605868|NCT01981850|12013318|FG005|Main Phase Stage 2|Various reasons|0
7605869|NCT01981850|12013319|FG006|Main Phase Stage 2|Various reasons|1
7605870|NCT01981850|12013320|FG007|Main Phase Stage 2|Various reasons|0
7605871|NCT01981850|12013321|FG008|Main Phase Stage 2|Various reasons|0
7605872|NCT01981850|12013322|FG009|Main Phase Stage 2|Various reasons|0
7605873|NCT01981850|12013313|FG000|Main Phase Stage 2|Progressive Disease|0
7605874|NCT01981850|12013314|FG001|Main Phase Stage 2|Progressive Disease|0
7605875|NCT01981850|12013315|FG002|Main Phase Stage 2|Progressive Disease|0
7605876|NCT01981850|12013316|FG003|Main Phase Stage 2|Progressive Disease|0
7605877|NCT01981850|12013317|FG004|Main Phase Stage 2|Progressive Disease|0
7605878|NCT01981850|12013318|FG005|Main Phase Stage 2|Progressive Disease|6
7605879|NCT01981850|12013319|FG006|Main Phase Stage 2|Progressive Disease|6
7605880|NCT01981850|12013320|FG007|Main Phase Stage 2|Progressive Disease|0
7605881|NCT01981850|12013321|FG008|Main Phase Stage 2|Progressive Disease|0
7605882|NCT01981850|12013322|FG009|Main Phase Stage 2|Progressive Disease|0
7605883|NCT01981850|12013313|FG000|Open Label Extension (OLE)|Adverse Event|0
7605884|NCT01981850|12013314|FG001|Open Label Extension (OLE)|Adverse Event|0
7605885|NCT01981850|12013315|FG002|Open Label Extension (OLE)|Adverse Event|0
7605886|NCT01981850|12013316|FG003|Open Label Extension (OLE)|Adverse Event|0
7605887|NCT01981850|12013317|FG004|Open Label Extension (OLE)|Adverse Event|0
7605888|NCT01981850|12013318|FG005|Open Label Extension (OLE)|Adverse Event|0
7605889|NCT01981850|12013319|FG006|Open Label Extension (OLE)|Adverse Event|0
7605890|NCT01981850|12013320|FG007|Open Label Extension (OLE)|Adverse Event|2
7605891|NCT01981850|12013321|FG008|Open Label Extension (OLE)|Adverse Event|1
7605892|NCT01981850|12013322|FG009|Open Label Extension (OLE)|Adverse Event|8
7605893|NCT01981850|12013313|FG000|Open Label Extension (OLE)|Lack of Efficacy|0
7605894|NCT01981850|12013314|FG001|Open Label Extension (OLE)|Lack of Efficacy|0
7605895|NCT01981850|12013315|FG002|Open Label Extension (OLE)|Lack of Efficacy|0
7775803|NCT00918879|12222068|FG001|Overall Study|Withdrawal by Subject|4
7775804|NCT00918879|12222067|FG000|Overall Study|Lost to Follow-up|1
7775805|NCT00918879|12222068|FG001|Overall Study|Lost to Follow-up|1
7775806|NCT00918879|12222067|FG000|Overall Study|Severe non-compliance to protocol|1
7775807|NCT00918879|12222068|FG001|Overall Study|Severe non-compliance to protocol|1
7775808|NCT00918957|12222080|FG000|Overall Study|Adverse Event|2
7775809|NCT00918957|12222081|FG001|Overall Study|Adverse Event|0
7775810|NCT00918957|12222080|FG000|Overall Study|Withdrawal by Subject|1
7775811|NCT00918957|12222081|FG001|Overall Study|Withdrawal by Subject|0
7775812|NCT00919061|12222091|FG000|Overall Study|Adverse Event|1
7775813|NCT00919061|12222091|FG000|Overall Study|Withdrawal by Subject|1
7775814|NCT00919633|12222146|FG000|Overall Study|Adverse Event|1
7775815|NCT00919633|12222147|FG001|Overall Study|Adverse Event|9
7775816|NCT00919633|12222148|FG002|Overall Study|Adverse Event|12
7775817|NCT00919633|12222149|FG003|Overall Study|Adverse Event|10
7775818|NCT00919633|12222146|FG000|Overall Study|Death|0
7775819|NCT00919633|12222147|FG001|Overall Study|Death|0
7775820|NCT00919633|12222148|FG002|Overall Study|Death|2
7775821|NCT00919633|12222149|FG003|Overall Study|Death|0
7775822|NCT00919633|12222146|FG000|Overall Study|Lack of Efficacy|17
7775823|NCT00919633|12222147|FG001|Overall Study|Lack of Efficacy|3
7775824|NCT00919633|12222148|FG002|Overall Study|Lack of Efficacy|2
7775825|NCT00919633|12222149|FG003|Overall Study|Lack of Efficacy|3
7775826|NCT00919633|12222146|FG000|Overall Study|Withdrawal by Subject|1
7775827|NCT00919633|12222147|FG001|Overall Study|Withdrawal by Subject|2
7775828|NCT00919633|12222148|FG002|Overall Study|Withdrawal by Subject|4
7775829|NCT00919633|12222149|FG003|Overall Study|Withdrawal by Subject|3
7775830|NCT00919633|12222146|FG000|Overall Study|Lost to Follow-up|3
7775831|NCT00919633|12222147|FG001|Overall Study|Lost to Follow-up|1
7775832|NCT00919633|12222148|FG002|Overall Study|Lost to Follow-up|0
7775833|NCT00919633|12222149|FG003|Overall Study|Lost to Follow-up|2
7775834|NCT00919633|12222146|FG000|Overall Study|Withdraw consent post transition to SOC|0
7775835|NCT00919633|12222147|FG001|Overall Study|Withdraw consent post transition to SOC|0
7775836|NCT00919633|12222148|FG002|Overall Study|Withdraw consent post transition to SOC|1
7775837|NCT00919633|12222149|FG003|Overall Study|Withdraw consent post transition to SOC|1
7775838|NCT00919633|12222146|FG000|Overall Study|Protocol Violation|0
7775839|NCT00919633|12222147|FG001|Overall Study|Protocol Violation|0
7775840|NCT00919633|12222148|FG002|Overall Study|Protocol Violation|0
7775841|NCT00919633|12222149|FG003|Overall Study|Protocol Violation|1
7775842|NCT00919633|12222146|FG000|Overall Study|Physician Decision|0
7775843|NCT00919633|12222147|FG001|Overall Study|Physician Decision|0
7775844|NCT00919633|12222148|FG002|Overall Study|Physician Decision|0
7775845|NCT00919633|12222149|FG003|Overall Study|Physician Decision|1
7775846|NCT00919633|12222146|FG000|Overall Study|Request of withdrawal w/o future contact|0
7775847|NCT00919633|12222147|FG001|Overall Study|Request of withdrawal w/o future contact|0
7775848|NCT00919633|12222148|FG002|Overall Study|Request of withdrawal w/o future contact|1
7775849|NCT00919633|12222149|FG003|Overall Study|Request of withdrawal w/o future contact|0
7775850|NCT00919633|12222146|FG000|Overall Study|Viral rebound outside protocol timepoint|0
7775851|NCT00919633|12222147|FG001|Overall Study|Viral rebound outside protocol timepoint|0
7605896|NCT01981850|12013316|FG003|Open Label Extension (OLE)|Lack of Efficacy|0
7605897|NCT01981850|12013317|FG004|Open Label Extension (OLE)|Lack of Efficacy|0
7605898|NCT01981850|12013318|FG005|Open Label Extension (OLE)|Lack of Efficacy|0
7605899|NCT01981850|12013319|FG006|Open Label Extension (OLE)|Lack of Efficacy|0
7605900|NCT01981850|12013320|FG007|Open Label Extension (OLE)|Lack of Efficacy|4
7605901|NCT01981850|12013321|FG008|Open Label Extension (OLE)|Lack of Efficacy|1
7605902|NCT01981850|12013322|FG009|Open Label Extension (OLE)|Lack of Efficacy|19
7605903|NCT01981850|12013313|FG000|Open Label Extension (OLE)|Various reasons|0
7605904|NCT01981850|12013314|FG001|Open Label Extension (OLE)|Various reasons|0
7605905|NCT01981850|12013315|FG002|Open Label Extension (OLE)|Various reasons|0
7605906|NCT01981850|12013316|FG003|Open Label Extension (OLE)|Various reasons|0
7605907|NCT01981850|12013317|FG004|Open Label Extension (OLE)|Various reasons|0
7605908|NCT01981850|12013318|FG005|Open Label Extension (OLE)|Various reasons|0
7605909|NCT01981850|12013319|FG006|Open Label Extension (OLE)|Various reasons|0
7605910|NCT01981850|12013320|FG007|Open Label Extension (OLE)|Various reasons|3
7605911|NCT01981850|12013321|FG008|Open Label Extension (OLE)|Various reasons|1
7605912|NCT01981850|12013322|FG009|Open Label Extension (OLE)|Various reasons|3
7605913|NCT01981850|12013313|FG000|Open Label Extension (OLE)|Progressive Disease|0
7605914|NCT01981850|12013314|FG001|Open Label Extension (OLE)|Progressive Disease|0
7775852|NCT00919633|12222148|FG002|Overall Study|Viral rebound outside protocol timepoint|1
7775853|NCT00919633|12222149|FG003|Overall Study|Viral rebound outside protocol timepoint|0
7775854|NCT00919711|12222161|FG000|Overall Study|Withdrawal by Subject|15
7605915|NCT01981850|12013315|FG002|Open Label Extension (OLE)|Progressive Disease|0
7605916|NCT01981850|12013316|FG003|Open Label Extension (OLE)|Progressive Disease|0
7605917|NCT01981850|12013317|FG004|Open Label Extension (OLE)|Progressive Disease|0
7605918|NCT01981850|12013318|FG005|Open Label Extension (OLE)|Progressive Disease|0
7605919|NCT01981850|12013319|FG006|Open Label Extension (OLE)|Progressive Disease|0
7605920|NCT01981850|12013320|FG007|Open Label Extension (OLE)|Progressive Disease|3
7605921|NCT01981850|12013321|FG008|Open Label Extension (OLE)|Progressive Disease|2
7605922|NCT01981850|12013322|FG009|Open Label Extension (OLE)|Progressive Disease|9
7605923|NCT01981850|12013313|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7605924|NCT01981850|12013314|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7605925|NCT01981850|12013315|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7605926|NCT01981850|12013316|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7605927|NCT01981850|12013317|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7775855|NCT00919711|12222162|FG001|Overall Study|Withdrawal by Subject|7
7775856|NCT00919711|12222161|FG000|Overall Study|Adverse Event|13
7775857|NCT00919711|12222162|FG001|Overall Study|Adverse Event|3
7775858|NCT00919711|12222161|FG000|Overall Study|Other|1
7775859|NCT00919711|12222162|FG001|Overall Study|Other|2
7775860|NCT00919711|12222161|FG000|Overall Study|Administrative Decision|0
7605928|NCT01981850|12013318|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7775861|NCT00919711|12222162|FG001|Overall Study|Administrative Decision|1
7605929|NCT01981850|12013319|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7605930|NCT01981850|12013320|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7605931|NCT01981850|12013321|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7605932|NCT01981850|12013322|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8
7605933|NCT01981850|12013313|FG000|Open Label Extension (OLE)|Lost to Follow-up|0
7605934|NCT01981850|12013314|FG001|Open Label Extension (OLE)|Lost to Follow-up|0
7605935|NCT01981850|12013315|FG002|Open Label Extension (OLE)|Lost to Follow-up|0
7605936|NCT01981850|12013316|FG003|Open Label Extension (OLE)|Lost to Follow-up|0
7605937|NCT01981850|12013317|FG004|Open Label Extension (OLE)|Lost to Follow-up|0
7605938|NCT01981850|12013318|FG005|Open Label Extension (OLE)|Lost to Follow-up|0
7605939|NCT01981850|12013319|FG006|Open Label Extension (OLE)|Lost to Follow-up|0
7605940|NCT01981850|12013320|FG007|Open Label Extension (OLE)|Lost to Follow-up|0
7605941|NCT01981850|12013321|FG008|Open Label Extension (OLE)|Lost to Follow-up|0
7605942|NCT01981850|12013322|FG009|Open Label Extension (OLE)|Lost to Follow-up|1
7605943|NCT01804816|12013354|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3
7605944|NCT01804816|12013354|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1
7605945|NCT01519960|12013388|FG000|Overall Study|Ongoing in Follow-Up|101
7605946|NCT01519960|12013389|FG001|Overall Study|Ongoing in Follow-Up|11
7605947|NCT01519960|12013390|FG002|Overall Study|Ongoing in Follow-Up|10
7605948|NCT01519960|12013388|FG000|Overall Study|Ongoing/Switched to PEG-IFN|0
7605949|NCT01519960|12013389|FG001|Overall Study|Ongoing/Switched to PEG-IFN|33
7605950|NCT01519960|12013390|FG002|Overall Study|Ongoing/Switched to PEG-IFN|0
7605951|NCT01519960|12013388|FG000|Overall Study|Adverse Event|0
7605952|NCT01519960|12013389|FG001|Overall Study|Adverse Event|1
7605953|NCT01519960|12013390|FG002|Overall Study|Adverse Event|0
7605954|NCT01519960|12013388|FG000|Overall Study|Withdrawal by Subject|0
7605955|NCT01519960|12013389|FG001|Overall Study|Withdrawal by Subject|4
7605956|NCT01519960|12013390|FG002|Overall Study|Withdrawal by Subject|0
7605957|NCT01519960|12013388|FG000|Overall Study|Lost to Follow-up|0
7605958|NCT01519960|12013389|FG001|Overall Study|Lost to Follow-up|1
7605959|NCT01519960|12013390|FG002|Overall Study|Lost to Follow-up|0
7605960|NCT00688376|12013403|FG000|Double-Blind Phase|Adverse Event|4
7605961|NCT00688376|12013404|FG001|Double-Blind Phase|Adverse Event|4
7605962|NCT00688376|12013403|FG000|Double-Blind Phase|Protocol Violation|1
7605963|NCT00688376|12013404|FG001|Double-Blind Phase|Protocol Violation|2
7605964|NCT00688376|12013403|FG000|Double-Blind Phase|Withdrawal by Subject|1
7605965|NCT00688376|12013404|FG001|Double-Blind Phase|Withdrawal by Subject|0
7605966|NCT00688376|12013403|FG000|Double-Blind Phase|Not treated|0
7605967|NCT00688376|12013404|FG001|Double-Blind Phase|Not treated|1
7605968|NCT00688376|12013403|FG000|Blinded Extension Phase|Adverse Event|3
7605969|NCT00688376|12013404|FG001|Blinded Extension Phase|Adverse Event|4
7605970|NCT00688376|12013403|FG000|Blinded Extension Phase|Withdrawal by Subject|0
7605971|NCT00688376|12013404|FG001|Blinded Extension Phase|Withdrawal by Subject|1
7605972|NCT00688376|12013403|FG000|Blinded Extension Phase|Physician Decision|1
7605973|NCT00688376|12013404|FG001|Blinded Extension Phase|Physician Decision|0
7605974|NCT00688376|12013403|FG000|Blinded Extension Phase|Other|1
7605975|NCT00688376|12013404|FG001|Blinded Extension Phase|Other|0
7775862|NCT00919711|12222161|FG000|Overall Study|Lost to Follow-up|2
7775863|NCT00919711|12222162|FG001|Overall Study|Lost to Follow-up|0
7775864|NCT00919711|12222161|FG000|Overall Study|Death|1
7775865|NCT00919711|12222162|FG001|Overall Study|Death|0
7775866|NCT00919711|12222161|FG000|Overall Study|Noncompliance|1
7775867|NCT00919711|12222162|FG001|Overall Study|Noncompliance|0
7775868|NCT00919854|12222184|FG000|Overall Study|Adverse Event|1
7775869|NCT00919867|12222194|FG000|First Intervention|Withdrawal by Subject|0
7775870|NCT00919867|12222195|FG001|First Intervention|Withdrawal by Subject|0
7775871|NCT00919867|12222196|FG002|First Intervention|Withdrawal by Subject|1
7775872|NCT00919867|12222197|FG003|First Intervention|Withdrawal by Subject|0
7775873|NCT00919867|12222198|FG004|First Intervention|Withdrawal by Subject|0
7605976|NCT00121108|12013431|FG000|Overall Study|Lost to Follow-up|10
7605977|NCT00121108|12013432|FG001|Overall Study|Lost to Follow-up|22
7605978|NCT00121108|12013431|FG000|Overall Study|Withdrawal by Subject|106
7775874|NCT00919867|12222199|FG005|First Intervention|Withdrawal by Subject|0
7775875|NCT00919867|12222194|FG000|First Intervention|Physician Decision|0
7775876|NCT00919867|12222195|FG001|First Intervention|Physician Decision|0
7605979|NCT00121108|12013432|FG001|Overall Study|Withdrawal by Subject|195
7605980|NCT00121108|12013431|FG000|Overall Study|Death|5
7605981|NCT00121108|12013432|FG001|Overall Study|Death|8
7605982|NCT00003102|12013442|FG000|Overall Study|Physician Decision|1
7605983|NCT00003102|12013443|FG001|Overall Study|Physician Decision|1
7605984|NCT00003102|12013444|FG002|Overall Study|Physician Decision|0
7605985|NCT00003102|12013442|FG000|Overall Study|Progressive Disease|0
7605986|NCT00003102|12013443|FG001|Overall Study|Progressive Disease|1
7605987|NCT00003102|12013444|FG002|Overall Study|Progressive Disease|0
7605988|NCT00003102|12013442|FG000|Overall Study|Adverse Event|0
7605989|NCT00003102|12013443|FG001|Overall Study|Adverse Event|1
7605990|NCT00003102|12013444|FG002|Overall Study|Adverse Event|1
7605991|NCT00003102|12013442|FG000|Overall Study|Death|0
7605992|NCT00003102|12013443|FG001|Overall Study|Death|0
7605993|NCT00003102|12013444|FG002|Overall Study|Death|1
7605994|NCT04633837|12013454|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5
7605995|NCT04633837|12013455|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0
7605996|NCT04057937|12013463|FG000|Placebo-controlled Phase|Adverse Event|3
7605997|NCT04057937|12013464|FG001|Placebo-controlled Phase|Adverse Event|0
7605998|NCT04057937|12013463|FG000|Active-treatment Phase|Withdrawal by Subject|1
7605999|NCT04057937|12013464|FG001|Active-treatment Phase|Withdrawal by Subject|0
7606000|NCT04057937|12013463|FG000|Active-treatment Phase|Pregnancy|0
7606001|NCT04057937|12013464|FG001|Active-treatment Phase|Pregnancy|1
7606002|NCT04057937|12013463|FG000|Active-treatment Phase|Physician Decision|0
7606003|NCT04057937|12013464|FG001|Active-treatment Phase|Physician Decision|1
7606004|NCT03032510|12013477|FG000|Overall Study|Adverse Event|5
7606005|NCT03032510|12013478|FG001|Overall Study|Adverse Event|2
7606006|NCT03032510|12013477|FG000|Overall Study|Lost to Follow-up|8
7606007|NCT03032510|12013478|FG001|Overall Study|Lost to Follow-up|7
7606008|NCT03032510|12013477|FG000|Overall Study|Withdrawal by Subject|8
7606009|NCT03032510|12013478|FG001|Overall Study|Withdrawal by Subject|7
7606010|NCT03032510|12013477|FG000|Overall Study|Subject noncompliance|4
7606011|NCT03032510|12013478|FG001|Overall Study|Subject noncompliance|2
7606012|NCT03032510|12013477|FG000|Overall Study|Physician Decision|2
7606013|NCT03032510|12013478|FG001|Overall Study|Physician Decision|0
7606014|NCT02946047|12013509|FG000|Overall Study|Adverse Event|1
7606015|NCT02946047|12013510|FG001|Overall Study|Adverse Event|0
7606016|NCT02946047|12013511|FG002|Overall Study|Adverse Event|0
7606017|NCT02946047|12013512|FG003|Overall Study|Adverse Event|0
7606018|NCT02784704|12013530|FG000|Overall Study|Adverse Event|4
7606019|NCT02784704|12013531|FG001|Overall Study|Adverse Event|2
7606020|NCT02784704|12013530|FG000|Overall Study|Lost to Follow-up|6
7606021|NCT02784704|12013531|FG001|Overall Study|Lost to Follow-up|4
7606022|NCT02784704|12013530|FG000|Overall Study|Withdrawal by Subject|1
7606023|NCT02784704|12013531|FG001|Overall Study|Withdrawal by Subject|3
7606024|NCT02784704|12013530|FG000|Overall Study|Subject Non Compliance|2
7606025|NCT02784704|12013531|FG001|Overall Study|Subject Non Compliance|0
7606026|NCT04831515|12013539|FG000|First Intervention|Adverse Event|0
7606027|NCT04831515|12013540|FG001|First Intervention|Adverse Event|1
7606028|NCT04634409|12013573|FG000|Overall Study|Death|0
7606029|NCT04634409|12013574|FG001|Overall Study|Death|0
7606030|NCT04634409|12013575|FG002|Overall Study|Death|0
7606031|NCT04634409|12013576|FG003|Overall Study|Death|0
7606032|NCT04634409|12013577|FG004|Overall Study|Death|0
7606033|NCT04634409|12013578|FG005|Overall Study|Death|0
7606034|NCT04634409|12013579|FG006|Overall Study|Death|0
7606035|NCT04634409|12013580|FG007|Overall Study|Death|0
7606036|NCT04634409|12013581|FG008|Overall Study|Death|0
7606037|NCT04634409|12013582|FG009|Overall Study|Death|0
7606038|NCT04634409|12013583|FG010|Overall Study|Death|1
7606039|NCT04634409|12013584|FG011|Overall Study|Death|0
7606040|NCT04634409|12013585|FG012|Overall Study|Death|1
7606041|NCT04634409|12013586|FG013|Overall Study|Death|0
7606042|NCT04634409|12013587|FG014|Overall Study|Death|0
7606043|NCT04634409|12013588|FG015|Overall Study|Death|0
7606044|NCT04634409|12013589|FG016|Overall Study|Death|0
7606045|NCT04634409|12013590|FG017|Overall Study|Death|0
7606046|NCT04634409|12013591|FG018|Overall Study|Death|0
7606047|NCT04634409|12013592|FG019|Overall Study|Death|0
7606048|NCT04634409|12013593|FG020|Overall Study|Death|0
7606049|NCT04634409|12013594|FG021|Overall Study|Death|0
7606050|NCT04634409|12013595|FG022|Overall Study|Death|0
7606051|NCT04634409|12013596|FG023|Overall Study|Death|0
7606052|NCT04634409|12013597|FG024|Overall Study|Death|0
7606053|NCT04634409|12013598|FG025|Overall Study|Death|0
7606054|NCT04634409|12013599|FG026|Overall Study|Death|0
7606055|NCT04634409|12013573|FG000|Overall Study|Adverse Event|0
7606056|NCT04634409|12013574|FG001|Overall Study|Adverse Event|0
7606057|NCT04634409|12013575|FG002|Overall Study|Adverse Event|1
7606058|NCT04634409|12013576|FG003|Overall Study|Adverse Event|0
7606059|NCT04634409|12013577|FG004|Overall Study|Adverse Event|0
7606060|NCT04634409|12013578|FG005|Overall Study|Adverse Event|1
7606061|NCT04634409|12013579|FG006|Overall Study|Adverse Event|0
7606062|NCT04634409|12013580|FG007|Overall Study|Adverse Event|0
7606063|NCT04634409|12013581|FG008|Overall Study|Adverse Event|0
7606064|NCT04634409|12013582|FG009|Overall Study|Adverse Event|0
7606065|NCT04634409|12013583|FG010|Overall Study|Adverse Event|0
7606066|NCT04634409|12013584|FG011|Overall Study|Adverse Event|0
7606067|NCT04634409|12013585|FG012|Overall Study|Adverse Event|0
7606068|NCT04634409|12013586|FG013|Overall Study|Adverse Event|0
7606069|NCT04634409|12013587|FG014|Overall Study|Adverse Event|0
7606070|NCT04634409|12013588|FG015|Overall Study|Adverse Event|0
7606071|NCT04634409|12013589|FG016|Overall Study|Adverse Event|0
7606072|NCT04634409|12013590|FG017|Overall Study|Adverse Event|0
7606073|NCT04634409|12013591|FG018|Overall Study|Adverse Event|0
7606074|NCT04634409|12013592|FG019|Overall Study|Adverse Event|0
7606075|NCT04634409|12013593|FG020|Overall Study|Adverse Event|0
7606076|NCT04634409|12013594|FG021|Overall Study|Adverse Event|0
7606077|NCT04634409|12013595|FG022|Overall Study|Adverse Event|0
7606078|NCT04634409|12013596|FG023|Overall Study|Adverse Event|0
7606079|NCT04634409|12013597|FG024|Overall Study|Adverse Event|0
7606080|NCT04634409|12013598|FG025|Overall Study|Adverse Event|0
7606081|NCT04634409|12013599|FG026|Overall Study|Adverse Event|0
7606082|NCT04634409|12013573|FG000|Overall Study|Lost to Follow-up|3
7606083|NCT04634409|12013574|FG001|Overall Study|Lost to Follow-up|1
7606084|NCT04634409|12013575|FG002|Overall Study|Lost to Follow-up|1
7606085|NCT04634409|12013576|FG003|Overall Study|Lost to Follow-up|3
7606086|NCT04634409|12013577|FG004|Overall Study|Lost to Follow-up|1
7775877|NCT00919867|12222196|FG002|First Intervention|Physician Decision|0
7775878|NCT00919867|12222197|FG003|First Intervention|Physician Decision|0
7775879|NCT00919867|12222198|FG004|First Intervention|Physician Decision|0
7775880|NCT00919867|12222199|FG005|First Intervention|Physician Decision|1
7775881|NCT00920140|12222229|FG000|Phase 1 (Dose Escalation)|Adverse Event|3
7775882|NCT00920140|12222230|FG001|Phase 1 (Dose Escalation)|Adverse Event|3
7775883|NCT00920140|12222231|FG002|Phase 1 (Dose Escalation)|Adverse Event|0
7775884|NCT00920140|12222232|FG003|Phase 1 (Dose Escalation)|Adverse Event|0
7775885|NCT00920140|12222233|FG004|Phase 1 (Dose Escalation)|Adverse Event|0
7775886|NCT00920140|12222229|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2
7775887|NCT00920140|12222230|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4
7775888|NCT00920140|12222231|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0
7775889|NCT00920140|12222232|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0
7775890|NCT00920140|12222233|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0
7775891|NCT00920140|12222229|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
7775892|NCT00920140|12222230|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
7775893|NCT00920140|12222231|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
7775894|NCT00920140|12222232|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
7775895|NCT00920140|12222233|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
7775896|NCT00920140|12222229|FG000|Phase 2|Adverse Event|0
7775897|NCT00920140|12222230|FG001|Phase 2|Adverse Event|0
7775898|NCT00920140|12222231|FG002|Phase 2|Adverse Event|14
7775899|NCT00920140|12222232|FG003|Phase 2|Adverse Event|2
7775900|NCT00920140|12222233|FG004|Phase 2|Adverse Event|3
7775901|NCT00920140|12222229|FG000|Phase 2|Lack of Efficacy|0
7775902|NCT00920140|12222230|FG001|Phase 2|Lack of Efficacy|0
7775903|NCT00920140|12222231|FG002|Phase 2|Lack of Efficacy|29
7775904|NCT00920140|12222232|FG003|Phase 2|Lack of Efficacy|14
7775905|NCT00920140|12222233|FG004|Phase 2|Lack of Efficacy|5
7775906|NCT00920140|12222229|FG000|Phase 2|Lost to Follow-up|0
7775907|NCT00920140|12222230|FG001|Phase 2|Lost to Follow-up|0
7775908|NCT00920140|12222231|FG002|Phase 2|Lost to Follow-up|0
7775909|NCT00920140|12222232|FG003|Phase 2|Lost to Follow-up|1
7775910|NCT00920140|12222233|FG004|Phase 2|Lost to Follow-up|0
7775911|NCT00920140|12222229|FG000|Phase 2|Physician Decision|0
7775912|NCT00920140|12222230|FG001|Phase 2|Physician Decision|0
7775913|NCT00920140|12222231|FG002|Phase 2|Physician Decision|3
7775914|NCT00920140|12222232|FG003|Phase 2|Physician Decision|3
7775915|NCT00920140|12222233|FG004|Phase 2|Physician Decision|2
7775916|NCT00920140|12222229|FG000|Phase 2|Withdrawal by Subject|0
7775917|NCT00920140|12222230|FG001|Phase 2|Withdrawal by Subject|0
7775918|NCT00920140|12222231|FG002|Phase 2|Withdrawal by Subject|4
7775919|NCT00920140|12222232|FG003|Phase 2|Withdrawal by Subject|2
7775920|NCT00920140|12222233|FG004|Phase 2|Withdrawal by Subject|1
7775921|NCT00920218|12222250|FG000|Overall Study|Serious Adverse Event|2
7775922|NCT00920218|12222251|FG001|Overall Study|Serious Adverse Event|0
7775923|NCT00920218|12222252|FG002|Overall Study|Serious Adverse Event|2
7775924|NCT00920218|12222253|FG003|Overall Study|Serious Adverse Event|1
7775925|NCT00920218|12222250|FG000|Overall Study|Withdrawal by Subject|0
7775926|NCT00920218|12222251|FG001|Overall Study|Withdrawal by Subject|3
7775927|NCT00920218|12222252|FG002|Overall Study|Withdrawal by Subject|2
7775928|NCT00920218|12222253|FG003|Overall Study|Withdrawal by Subject|0
7775929|NCT00920218|12222250|FG000|Overall Study|Migrated/moved from study area|0
7775930|NCT00920218|12222251|FG001|Overall Study|Migrated/moved from study area|0
7775931|NCT00920218|12222252|FG002|Overall Study|Migrated/moved from study area|1
7775932|NCT00920218|12222253|FG003|Overall Study|Migrated/moved from study area|0
7775933|NCT00920218|12222250|FG000|Overall Study|Lost to Follow-up|0
7775934|NCT00920218|12222251|FG001|Overall Study|Lost to Follow-up|1
7775935|NCT00920218|12222252|FG002|Overall Study|Lost to Follow-up|0
7606087|NCT04634409|12013578|FG005|Overall Study|Lost to Follow-up|1
7775936|NCT00920218|12222253|FG003|Overall Study|Lost to Follow-up|3
7864089|NCT01609556|12353456|FG012|Dose Expansion: Maximum 124 Weeks|Death|4
7606088|NCT04634409|12013579|FG006|Overall Study|Lost to Follow-up|1
7606089|NCT04634409|12013580|FG007|Overall Study|Lost to Follow-up|3
7606090|NCT04634409|12013581|FG008|Overall Study|Lost to Follow-up|3
7606091|NCT04634409|12013582|FG009|Overall Study|Lost to Follow-up|11
7606092|NCT04634409|12013583|FG010|Overall Study|Lost to Follow-up|8
7606093|NCT04634409|12013584|FG011|Overall Study|Lost to Follow-up|15
7606094|NCT04634409|12013585|FG012|Overall Study|Lost to Follow-up|3
7606095|NCT04634409|12013586|FG013|Overall Study|Lost to Follow-up|2
7775937|NCT00920218|12222250|FG000|Overall Study|Transplant failed/malignancy recurrence|0
7775938|NCT00920218|12222251|FG001|Overall Study|Transplant failed/malignancy recurrence|1
7606096|NCT04634409|12013587|FG014|Overall Study|Lost to Follow-up|7
7606097|NCT04634409|12013588|FG015|Overall Study|Lost to Follow-up|0
7606098|NCT04634409|12013589|FG016|Overall Study|Lost to Follow-up|0
7606099|NCT04634409|12013590|FG017|Overall Study|Lost to Follow-up|0
7606100|NCT04634409|12013591|FG018|Overall Study|Lost to Follow-up|0
7606101|NCT04634409|12013592|FG019|Overall Study|Lost to Follow-up|0
7606102|NCT04634409|12013593|FG020|Overall Study|Lost to Follow-up|0
7606103|NCT04634409|12013594|FG021|Overall Study|Lost to Follow-up|0
7606104|NCT04634409|12013595|FG022|Overall Study|Lost to Follow-up|0
7606105|NCT04634409|12013596|FG023|Overall Study|Lost to Follow-up|0
7606106|NCT04634409|12013597|FG024|Overall Study|Lost to Follow-up|0
7606107|NCT04634409|12013598|FG025|Overall Study|Lost to Follow-up|0
7606108|NCT04634409|12013599|FG026|Overall Study|Lost to Follow-up|0
7606109|NCT04634409|12013573|FG000|Overall Study|Withdrawal by Subject|3
7606110|NCT04634409|12013574|FG001|Overall Study|Withdrawal by Subject|1
7606111|NCT04634409|12013575|FG002|Overall Study|Withdrawal by Subject|6
7606112|NCT04634409|12013576|FG003|Overall Study|Withdrawal by Subject|4
7606113|NCT04634409|12013577|FG004|Overall Study|Withdrawal by Subject|2
7606114|NCT04634409|12013578|FG005|Overall Study|Withdrawal by Subject|0
7606115|NCT04634409|12013579|FG006|Overall Study|Withdrawal by Subject|0
7606116|NCT04634409|12013580|FG007|Overall Study|Withdrawal by Subject|2
7606117|NCT04634409|12013581|FG008|Overall Study|Withdrawal by Subject|3
7606118|NCT04634409|12013582|FG009|Overall Study|Withdrawal by Subject|2
7606119|NCT04634409|12013583|FG010|Overall Study|Withdrawal by Subject|3
7606120|NCT04634409|12013584|FG011|Overall Study|Withdrawal by Subject|2
7606121|NCT04634409|12013585|FG012|Overall Study|Withdrawal by Subject|2
7606122|NCT04634409|12013586|FG013|Overall Study|Withdrawal by Subject|1
7775939|NCT00920218|12222252|FG002|Overall Study|Transplant failed/malignancy recurrence|2
7775940|NCT00920218|12222253|FG003|Overall Study|Transplant failed/malignancy recurrence|3
7775941|NCT00920218|12222250|FG000|Overall Study|Other|0
7775942|NCT00920218|12222251|FG001|Overall Study|Other|0
7775943|NCT00920218|12222252|FG002|Overall Study|Other|1
7775944|NCT00920218|12222253|FG003|Overall Study|Other|0
7775945|NCT00920426|12222290|FG000|ITZ111451|Adverse Event|1
7775946|NCT00920426|12222291|FG001|ITZ111451|Adverse Event|0
7775947|NCT00920426|12222292|FG002|ITZ111451|Adverse Event|0
7775948|NCT00920426|12222293|FG003|ITZ111451|Adverse Event|0
7775949|NCT00920556|12222309|FG000|Overall Study|Adverse Event|16
7775950|NCT00920556|12222309|FG000|Overall Study|Physician Decision|7
7606123|NCT04634409|12013587|FG014|Overall Study|Withdrawal by Subject|5
7606124|NCT04634409|12013588|FG015|Overall Study|Withdrawal by Subject|0
7606125|NCT04634409|12013589|FG016|Overall Study|Withdrawal by Subject|0
7606126|NCT04634409|12013590|FG017|Overall Study|Withdrawal by Subject|1
7606127|NCT04634409|12013591|FG018|Overall Study|Withdrawal by Subject|0
7606128|NCT04634409|12013592|FG019|Overall Study|Withdrawal by Subject|0
7606129|NCT04634409|12013593|FG020|Overall Study|Withdrawal by Subject|0
7606130|NCT04634409|12013594|FG021|Overall Study|Withdrawal by Subject|0
7606131|NCT04634409|12013595|FG022|Overall Study|Withdrawal by Subject|0
7606132|NCT04634409|12013596|FG023|Overall Study|Withdrawal by Subject|1
7606133|NCT04634409|12013597|FG024|Overall Study|Withdrawal by Subject|0
7606134|NCT04634409|12013598|FG025|Overall Study|Withdrawal by Subject|0
7606135|NCT04634409|12013599|FG026|Overall Study|Withdrawal by Subject|0
7775951|NCT00920556|12222309|FG000|Overall Study|Withdrawal by Subject|1
7775952|NCT00920686|12222347|FG000|Overall Study|Lost to Follow-up|2
7775953|NCT00920686|12222348|FG001|Overall Study|Lost to Follow-up|3
7775954|NCT00920686|12222349|FG002|Overall Study|Lost to Follow-up|1
7606136|NCT04634409|12013573|FG000|Overall Study|Other - As reported by Investigator|1
7606137|NCT04634409|12013574|FG001|Overall Study|Other - As reported by Investigator|0
7606138|NCT04634409|12013575|FG002|Overall Study|Other - As reported by Investigator|0
7775955|NCT00920686|12222347|FG000|Overall Study|Study drug dosing criteria not met|17
7775956|NCT00920686|12222348|FG001|Overall Study|Study drug dosing criteria not met|19
7606139|NCT04634409|12013576|FG003|Overall Study|Other - As reported by Investigator|0
7606140|NCT04634409|12013577|FG004|Overall Study|Other - As reported by Investigator|0
7606141|NCT04634409|12013578|FG005|Overall Study|Other - As reported by Investigator|0
7606142|NCT04634409|12013579|FG006|Overall Study|Other - As reported by Investigator|0
7606143|NCT04634409|12013580|FG007|Overall Study|Other - As reported by Investigator|6
7606144|NCT04634409|12013581|FG008|Overall Study|Other - As reported by Investigator|4
7606145|NCT04634409|12013582|FG009|Overall Study|Other - As reported by Investigator|0
7606146|NCT04634409|12013583|FG010|Overall Study|Other - As reported by Investigator|1
7606147|NCT04634409|12013584|FG011|Overall Study|Other - As reported by Investigator|2
7606148|NCT04634409|12013585|FG012|Overall Study|Other - As reported by Investigator|2
7606149|NCT04634409|12013586|FG013|Overall Study|Other - As reported by Investigator|1
7606211|NCT03284424|12013765|FG001|Overall Study|Lost to Follow-up|0
7606150|NCT04634409|12013587|FG014|Overall Study|Other - As reported by Investigator|0
7606151|NCT04634409|12013588|FG015|Overall Study|Other - As reported by Investigator|0
7606152|NCT04634409|12013589|FG016|Overall Study|Other - As reported by Investigator|0
7606153|NCT04634409|12013590|FG017|Overall Study|Other - As reported by Investigator|0
7775957|NCT00920686|12222349|FG002|Overall Study|Study drug dosing criteria not met|12
7775958|NCT00920699|12222364|FG000|Overall Study|Withdrawal by Subject|2
7775959|NCT00920699|12222365|FG001|Overall Study|Withdrawal by Subject|0
7775960|NCT00920699|12222366|FG002|Overall Study|Withdrawal by Subject|2
7775961|NCT00920699|12222364|FG000|Overall Study|no longer met eligibility|0
7775962|NCT00920699|12222365|FG001|Overall Study|no longer met eligibility|1
7775963|NCT00920699|12222366|FG002|Overall Study|no longer met eligibility|0
7775964|NCT00920699|12222364|FG000|Overall Study|Lost to Follow-up|0
7775965|NCT00920699|12222365|FG001|Overall Study|Lost to Follow-up|0
7775966|NCT00920699|12222366|FG002|Overall Study|Lost to Follow-up|2
7775967|NCT00920790|12222374|FG000|Overall Study|aggravation of general condition|14
7775968|NCT00920829|12222382|FG000|Allocation|No post randomization data|3
7775969|NCT00920829|12222383|FG001|Allocation|No post randomization data|1
7775970|NCT00920829|12222384|FG002|Allocation|No post randomization data|0
7775971|NCT00920829|12222385|FG003|Allocation|No post randomization data|2
7775972|NCT00920829|12222382|FG000|Available for Analysis|Withdrawal by Subject|6
7775973|NCT00920829|12222383|FG001|Available for Analysis|Withdrawal by Subject|6
7775974|NCT00920829|12222384|FG002|Available for Analysis|Withdrawal by Subject|6
7775975|NCT00920829|12222385|FG003|Available for Analysis|Withdrawal by Subject|10
7775976|NCT00920829|12222382|FG000|Available for Analysis|Required Medical Treatment|0
7775977|NCT00920829|12222383|FG001|Available for Analysis|Required Medical Treatment|1
7775978|NCT00920829|12222384|FG002|Available for Analysis|Required Medical Treatment|2
7606154|NCT04634409|12013591|FG018|Overall Study|Other - As reported by Investigator|0
7606155|NCT04634409|12013592|FG019|Overall Study|Other - As reported by Investigator|0
7606156|NCT04634409|12013593|FG020|Overall Study|Other - As reported by Investigator|0
7606157|NCT04634409|12013594|FG021|Overall Study|Other - As reported by Investigator|0
7606158|NCT04634409|12013595|FG022|Overall Study|Other - As reported by Investigator|0
7606159|NCT04634409|12013596|FG023|Overall Study|Other - As reported by Investigator|0
7606160|NCT04634409|12013597|FG024|Overall Study|Other - As reported by Investigator|0
7606161|NCT04634409|12013598|FG025|Overall Study|Other - As reported by Investigator|0
7606162|NCT04634409|12013599|FG026|Overall Study|Other - As reported by Investigator|0
7606163|NCT03502681|12013704|FG000|Overall Study|Adverse Event|1
7606164|NCT03502681|12013705|FG001|Overall Study|Adverse Event|1
7606165|NCT03502681|12013704|FG000|Overall Study|Disease Progression|2
7606166|NCT03502681|12013705|FG001|Overall Study|Disease Progression|1
7606167|NCT03405662|12013712|FG000|Overall Study|COVID-19 restriction|1
7606168|NCT03405662|12013713|FG001|Overall Study|COVID-19 restriction|0
7606169|NCT03405662|12013712|FG000|Overall Study|unblinding|0
7606170|NCT03405662|12013713|FG001|Overall Study|unblinding|1
7606171|NCT03405662|12013712|FG000|Overall Study|placement in memory care facility|0
7606172|NCT03405662|12013713|FG001|Overall Study|placement in memory care facility|2
7606173|NCT03334435|12013728|FG000|Overall Study|Ongoing as of Week 52|70
7606174|NCT03334435|12013729|FG001|Overall Study|Ongoing as of Week 52|32
7606175|NCT03334435|12013730|FG002|Overall Study|Ongoing as of Week 52|379
7606176|NCT03334435|12013731|FG003|Overall Study|Ongoing as of Week 52|519
7606177|NCT03334435|12013732|FG004|Overall Study|Ongoing as of Week 52|146
7606178|NCT03334435|12013728|FG000|Overall Study|Lack of Efficacy|3
7606179|NCT03334435|12013729|FG001|Overall Study|Lack of Efficacy|5
7606180|NCT03334435|12013730|FG002|Overall Study|Lack of Efficacy|76
7606181|NCT03334435|12013731|FG003|Overall Study|Lack of Efficacy|140
7606182|NCT03334435|12013732|FG004|Overall Study|Lack of Efficacy|61
7606183|NCT03334435|12013728|FG000|Overall Study|Adverse Event|2
7606184|NCT03334435|12013729|FG001|Overall Study|Adverse Event|1
7606185|NCT03334435|12013730|FG002|Overall Study|Adverse Event|9
7606186|NCT03334435|12013731|FG003|Overall Study|Adverse Event|23
7606187|NCT03334435|12013732|FG004|Overall Study|Adverse Event|13
7606188|NCT03334435|12013728|FG000|Overall Study|Withdrawal by Subject|11
7606189|NCT03334435|12013729|FG001|Overall Study|Withdrawal by Subject|4
7606190|NCT03334435|12013730|FG002|Overall Study|Withdrawal by Subject|38
7606191|NCT03334435|12013731|FG003|Overall Study|Withdrawal by Subject|42
7606192|NCT03334435|12013732|FG004|Overall Study|Withdrawal by Subject|20
7606193|NCT03334435|12013728|FG000|Overall Study|Lost to Follow-up|3
7606194|NCT03334435|12013729|FG001|Overall Study|Lost to Follow-up|0
7606195|NCT03334435|12013730|FG002|Overall Study|Lost to Follow-up|2
7606196|NCT03334435|12013731|FG003|Overall Study|Lost to Follow-up|1
7606197|NCT03334435|12013732|FG004|Overall Study|Lost to Follow-up|1
7606198|NCT03334435|12013728|FG000|Overall Study|Death|0
7606199|NCT03334435|12013729|FG001|Overall Study|Death|0
7606200|NCT03334435|12013730|FG002|Overall Study|Death|0
7606201|NCT03334435|12013731|FG003|Overall Study|Death|1
7606202|NCT03334435|12013732|FG004|Overall Study|Death|0
7606203|NCT03334435|12013728|FG000|Overall Study|Other|0
7606204|NCT03334435|12013729|FG001|Overall Study|Other|1
7606205|NCT03334435|12013730|FG002|Overall Study|Other|3
7606206|NCT03334435|12013731|FG003|Overall Study|Other|2
7606207|NCT03334435|12013732|FG004|Overall Study|Other|1
7606208|NCT03284424|12013764|FG000|Overall Study|Death|56
7606209|NCT03284424|12013765|FG001|Overall Study|Death|13
7606210|NCT03284424|12013764|FG000|Overall Study|Lost to Follow-up|1
7606212|NCT03284424|12013764|FG000|Overall Study|Physician Decision|1
7606213|NCT03284424|12013765|FG001|Overall Study|Physician Decision|0
7606214|NCT03284424|12013764|FG000|Overall Study|Withdrawal by Subject|3
7606215|NCT03284424|12013765|FG001|Overall Study|Withdrawal by Subject|2
7606216|NCT03284424|12013764|FG000|Overall Study|Ongoing in study|44
7606217|NCT03284424|12013765|FG001|Overall Study|Ongoing in study|39
7775979|NCT00920829|12222385|FG003|Available for Analysis|Required Medical Treatment|0
7775980|NCT00920829|12222382|FG000|Available for Analysis|Adverse Event|1
7775981|NCT00920829|12222383|FG001|Available for Analysis|Adverse Event|2
7775982|NCT00920829|12222384|FG002|Available for Analysis|Adverse Event|1
7775983|NCT00920829|12222385|FG003|Available for Analysis|Adverse Event|0
7775984|NCT00920829|12222382|FG000|Available for Analysis|Death|1
7775985|NCT00920829|12222383|FG001|Available for Analysis|Death|0
7775986|NCT00920829|12222384|FG002|Available for Analysis|Death|0
7775987|NCT00920829|12222385|FG003|Available for Analysis|Death|0
7775988|NCT00920829|12222382|FG000|Available for Analysis|Protocol Violation|0
7775989|NCT00920829|12222383|FG001|Available for Analysis|Protocol Violation|0
7775990|NCT00920829|12222384|FG002|Available for Analysis|Protocol Violation|1
7775991|NCT00920829|12222385|FG003|Available for Analysis|Protocol Violation|0
7775992|NCT00920829|12222382|FG000|Available for Analysis|Required more treatment|0
7775993|NCT00920829|12222383|FG001|Available for Analysis|Required more treatment|2
7775994|NCT00920829|12222384|FG002|Available for Analysis|Required more treatment|0
7775995|NCT00920829|12222385|FG003|Available for Analysis|Required more treatment|1
7775996|NCT00920855|12222398|FG000|Overall Study|Adverse Event|1
7775997|NCT00920855|12222399|FG001|Overall Study|Adverse Event|1
7775998|NCT00920855|12222400|FG002|Overall Study|Adverse Event|4
7775999|NCT00920855|12222398|FG000|Overall Study|Withdrawal by Subject|2
7776000|NCT00920855|12222399|FG001|Overall Study|Withdrawal by Subject|1
7776001|NCT00920855|12222400|FG002|Overall Study|Withdrawal by Subject|6
7776002|NCT00920855|12222398|FG000|Overall Study|Disease progression|2
7776003|NCT00920855|12222399|FG001|Overall Study|Disease progression|1
7776004|NCT00920855|12222400|FG002|Overall Study|Disease progression|10
7776005|NCT00920855|12222398|FG000|Overall Study|Noncompliance to study medication|0
7776006|NCT00920855|12222399|FG001|Overall Study|Noncompliance to study medication|0
7776007|NCT00920855|12222400|FG002|Overall Study|Noncompliance to study medication|1
7776008|NCT00920855|12222398|FG000|Overall Study|Response plateau; started maintenance|0
7776009|NCT00920855|12222399|FG001|Overall Study|Response plateau; started maintenance|0
7776010|NCT00920855|12222400|FG002|Overall Study|Response plateau; started maintenance|1
7776011|NCT00920907|12222411|FG000|Induction Period|Adverse Event|0
7776012|NCT00920907|12222412|FG001|Induction Period|Adverse Event|2
7776013|NCT00920907|12222411|FG000|Induction Period|Death|1
7776014|NCT00920907|12222412|FG001|Induction Period|Death|1
7776015|NCT00920907|12222411|FG000|Induction Period|Disease Progression|12
7776016|NCT00920907|12222412|FG001|Induction Period|Disease Progression|11
7776017|NCT00920907|12222411|FG000|Induction Period|Study Drug Toxicity|8
7776018|NCT00920907|12222412|FG001|Induction Period|Study Drug Toxicity|6
7776019|NCT00920907|12222411|FG000|Induction Period|No longer meets study criteria|0
7776020|NCT00920907|12222412|FG001|Induction Period|No longer meets study criteria|1
7776021|NCT00920907|12222411|FG000|Induction Period|Withdrawal by Subject|1
7776022|NCT00920907|12222412|FG001|Induction Period|Withdrawal by Subject|1
7776023|NCT00920907|12222411|FG000|Maintenance Period|Disease Progression|3
7776024|NCT00920907|12222412|FG001|Maintenance Period|Disease Progression|7
7776025|NCT00920907|12222411|FG000|Maintenance Period|Administrative (study closure)|7
7776026|NCT00920907|12222412|FG001|Maintenance Period|Administrative (study closure)|2
7606266|NCT02963766|12013795|FG000|Double-Blind Period|Adverse Event|1
7776027|NCT00920907|12222411|FG000|Maintenance Period|Study Drug Toxicity|0
7776028|NCT00920907|12222412|FG001|Maintenance Period|Study Drug Toxicity|2
7776029|NCT00920907|12222411|FG000|Maintenance Period|Death|1
7776030|NCT00920907|12222412|FG001|Maintenance Period|Death|1
7776031|NCT00920907|12222411|FG000|Maintenance Period|Withdrawal by Subject|1
7776032|NCT00920907|12222412|FG001|Maintenance Period|Withdrawal by Subject|0
7776033|NCT00920907|12222411|FG000|Maintenance Period|Adverse Event|0
7776034|NCT00920907|12222412|FG001|Maintenance Period|Adverse Event|1
7776035|NCT00921024|12222422|FG000|Overall Study|Lost to Follow-up|2
7776036|NCT00921024|12222423|FG001|Overall Study|Lost to Follow-up|0
7776037|NCT00921024|12222422|FG000|Overall Study|Received concomittant therapy|2
7776038|NCT00921024|12222423|FG001|Overall Study|Received concomittant therapy|0
7776039|NCT00921024|12222422|FG000|Overall Study|Withdrawal by Subject|0
7776040|NCT00921024|12222423|FG001|Overall Study|Withdrawal by Subject|3
7776041|NCT00921557|12222457|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
7776042|NCT00921557|12222458|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
7776043|NCT00921557|12222459|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
7776044|NCT00921557|12222457|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0
7776045|NCT00921557|12222458|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1
7776046|NCT00921557|12222459|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0
7776047|NCT00921557|12222457|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
7776048|NCT00921557|12222458|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
7776049|NCT00921557|12222459|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
7776050|NCT00921557|12222457|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1
7606267|NCT02963766|12013796|FG001|Double-Blind Period|Adverse Event|0
7606268|NCT02963766|12013797|FG002|Double-Blind Period|Adverse Event|1
7606269|NCT02963766|12013795|FG000|Double-Blind Period|Physician Decision|1
7606270|NCT02963766|12013796|FG001|Double-Blind Period|Physician Decision|0
7606271|NCT02963766|12013797|FG002|Double-Blind Period|Physician Decision|0
7776051|NCT00921557|12222458|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0
7776052|NCT00921557|12222459|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0
7776053|NCT00921557|12222457|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
7776054|NCT00921557|12222458|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
7776055|NCT00921557|12222459|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
7776056|NCT00922116|12222516|FG000|Overall Study|Adverse Event|4
7776057|NCT00922116|12222516|FG000|Overall Study|Death|1
7606272|NCT02963766|12013795|FG000|Double-Blind Period|Withdrawal by Subject|1
7606273|NCT02963766|12013796|FG001|Double-Blind Period|Withdrawal by Subject|1
7606274|NCT02963766|12013797|FG002|Double-Blind Period|Withdrawal by Subject|0
7776058|NCT00922116|12222516|FG000|Overall Study|Lost to Follow-up|1
7606275|NCT02963766|12013795|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0
7606276|NCT02963766|12013796|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0
7606277|NCT02963766|12013797|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1
7606278|NCT02963766|12013795|FG000|Double-Blind Period|Protocol Violation|1
7606279|NCT02963766|12013796|FG001|Double-Blind Period|Protocol Violation|0
7606280|NCT02963766|12013797|FG002|Double-Blind Period|Protocol Violation|0
7606281|NCT02963766|12013795|FG000|Double-Blind Period|Lost to Follow-up|0
7606282|NCT02963766|12013796|FG001|Double-Blind Period|Lost to Follow-up|1
7606283|NCT02963766|12013797|FG002|Double-Blind Period|Lost to Follow-up|0
7606284|NCT02963766|12013795|FG000|Open Label Extension (OLE)|Physician Decision|1
7606285|NCT02963766|12013796|FG001|Open Label Extension (OLE)|Physician Decision|2
7606286|NCT02963766|12013797|FG002|Open Label Extension (OLE)|Physician Decision|2
7606287|NCT02963766|12013795|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1
7606288|NCT02963766|12013796|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1
7606289|NCT02963766|12013797|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0
7606290|NCT02795182|12013819|FG000|Overall Study|Death|5
7606291|NCT02795182|12013820|FG001|Overall Study|Death|4
7776059|NCT00922116|12222516|FG000|Overall Study|Withdrawal by Subject|4
7776060|NCT00922116|12222516|FG000|Overall Study|Other|5
7776061|NCT00922207|12222527|FG000|Overall Study|Adverse Event/Intercurrent Illness|3
7776062|NCT00922207|12222528|FG001|Overall Study|Adverse Event/Intercurrent Illness|0
7776063|NCT00922207|12222529|FG002|Overall Study|Adverse Event/Intercurrent Illness|0
7776064|NCT00922207|12222527|FG000|Overall Study|Insufficient Therapeutic Response|0
7776065|NCT00922207|12222528|FG001|Overall Study|Insufficient Therapeutic Response|0
7776066|NCT00922207|12222529|FG002|Overall Study|Insufficient Therapeutic Response|1
7776067|NCT00922207|12222527|FG000|Overall Study|Violation of Selection Criteria at Entry|0
7776068|NCT00922207|12222528|FG001|Overall Study|Violation of Selection Criteria at Entry|1
7776069|NCT00922207|12222529|FG002|Overall Study|Violation of Selection Criteria at Entry|0
7776070|NCT00922207|12222527|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1
7776071|NCT00922207|12222528|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
7776072|NCT00922207|12222529|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0
7776073|NCT00922207|12222527|FG000|Overall Study|Withdrew Consent|2
7776074|NCT00922207|12222528|FG001|Overall Study|Withdrew Consent|5
7776075|NCT00922207|12222529|FG002|Overall Study|Withdrew Consent|2
7776076|NCT00922207|12222527|FG000|Overall Study|Abnormality of Laboratory Test|0
7776077|NCT00922207|12222528|FG001|Overall Study|Abnormality of Laboratory Test|1
7776078|NCT00922207|12222529|FG002|Overall Study|Abnormality of Laboratory Test|1
7776079|NCT00922272|12222542|FG000|Open-label Phase|Adverse Event|5
7776080|NCT00922272|12222543|FG001|Open-label Phase|Adverse Event|0
7776081|NCT00922272|12222542|FG000|Open-label Phase|Protocol Violation|1
7776082|NCT00922272|12222543|FG001|Open-label Phase|Protocol Violation|0
7776083|NCT00922272|12222542|FG000|Open-label Phase|Withdrawal by Subject|11
7776084|NCT00922272|12222543|FG001|Open-label Phase|Withdrawal by Subject|0
7776085|NCT00922272|12222542|FG000|Open-label Phase|Failure to meet randomization criteria|1
7776086|NCT00922272|12222543|FG001|Open-label Phase|Failure to meet randomization criteria|0
7776087|NCT00922272|12222542|FG000|Open-label Phase|Withdrawal criteria met|5
7606292|NCT02795182|12013821|FG002|Overall Study|Death|4
7606293|NCT02795182|12013822|FG003|Overall Study|Death|18
7606294|NCT02795182|12013819|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0
7606295|NCT02795182|12013820|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0
7606296|NCT02795182|12013821|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0
7606297|NCT02795182|12013822|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1
7606298|NCT02795182|12013819|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0
7606299|NCT02795182|12013820|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0
7606300|NCT02795182|12013821|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0
7606301|NCT02795182|12013822|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2
7606302|NCT02795182|12013819|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3
7606303|NCT02795182|12013820|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2
7606304|NCT02795182|12013821|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0
7606305|NCT02795182|12013822|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8
7606306|NCT02795182|12013819|FG000|Overall Study|Withdrawal by Subject|4
7606307|NCT02795182|12013820|FG001|Overall Study|Withdrawal by Subject|0
7606308|NCT02795182|12013821|FG002|Overall Study|Withdrawal by Subject|0
7776088|NCT00922272|12222543|FG001|Open-label Phase|Withdrawal criteria met|0
7776089|NCT00922272|12222542|FG000|Double-blind Phase|Adverse Event|1
7776090|NCT00922272|12222543|FG001|Double-blind Phase|Adverse Event|1
7776091|NCT00922272|12222542|FG000|Double-blind Phase|Withdrawal by Subject|1
7606309|NCT02795182|12013822|FG003|Overall Study|Withdrawal by Subject|3
7606310|NCT02795182|12013819|FG000|Overall Study|Lost to Follow-up|0
7606311|NCT02795182|12013820|FG001|Overall Study|Lost to Follow-up|0
7606312|NCT02795182|12013821|FG002|Overall Study|Lost to Follow-up|1
7776092|NCT00922272|12222543|FG001|Double-blind Phase|Withdrawal by Subject|1
7776093|NCT00922272|12222542|FG000|Double-blind Phase|Lost to Follow-up|2
7776094|NCT00922272|12222543|FG001|Double-blind Phase|Lost to Follow-up|1
7606313|NCT02795182|12013822|FG003|Overall Study|Lost to Follow-up|1
7606314|NCT02795182|12013819|FG000|Overall Study|Roll Over to Long Term Extension|3
7606315|NCT02795182|12013820|FG001|Overall Study|Roll Over to Long Term Extension|3
7606316|NCT02795182|12013821|FG002|Overall Study|Roll Over to Long Term Extension|2
7606317|NCT02795182|12013822|FG003|Overall Study|Roll Over to Long Term Extension|5
7606318|NCT02795182|12013819|FG000|Overall Study|Progressive Disease|0
7606319|NCT02795182|12013820|FG001|Overall Study|Progressive Disease|1
7606320|NCT02795182|12013821|FG002|Overall Study|Progressive Disease|0
7606321|NCT02795182|12013822|FG003|Overall Study|Progressive Disease|4
7606322|NCT02795182|12013819|FG000|Overall Study|Physician Decision|0
7606323|NCT02795182|12013820|FG001|Overall Study|Physician Decision|0
7606324|NCT02795182|12013821|FG002|Overall Study|Physician Decision|0
7606325|NCT02795182|12013822|FG003|Overall Study|Physician Decision|1
7606326|NCT02674464|12013857|FG000|Overall Study|Death|10
7606327|NCT02674464|12013858|FG001|Overall Study|Death|21
7606328|NCT02674464|12013857|FG000|Overall Study|Withdrawal by Subject|24
7606329|NCT02674464|12013858|FG001|Overall Study|Withdrawal by Subject|44
7606330|NCT02674464|12013857|FG000|Overall Study|Lost to Follow-up|97
7606331|NCT02674464|12013858|FG001|Overall Study|Lost to Follow-up|92
7606332|NCT02674464|12013857|FG000|Overall Study|Outside survey window|6
7606333|NCT02674464|12013858|FG001|Overall Study|Outside survey window|3
7606334|NCT02318784|12013864|FG000|Overall Study|Adverse Event|13
7776095|NCT00922272|12222542|FG000|Double-blind Phase|Withdrawal criteria met|1
7776096|NCT00922272|12222543|FG001|Double-blind Phase|Withdrawal criteria met|1
7776097|NCT00922272|12222542|FG000|Double-blind Phase|Noncompliance|1
7776098|NCT00922272|12222543|FG001|Double-blind Phase|Noncompliance|1
7776099|NCT00922272|12222542|FG000|Double-blind Phase|Positive urine drug screen|1
7776100|NCT00922272|12222543|FG001|Double-blind Phase|Positive urine drug screen|1
7776101|NCT00922428|12222551|FG000|Overall Study|retrospective/extremely implausible data|2
7776102|NCT00922428|12222551|FG000|Overall Study|no medication use or questionable use|13
7776103|NCT00922441|12222564|FG000|Overall Study|Protocol Violation|0
7776104|NCT00922441|12222565|FG001|Overall Study|Protocol Violation|0
7776105|NCT00922441|12222566|FG002|Overall Study|Protocol Violation|2
7776106|NCT00922441|12222564|FG000|Overall Study|Withdrawal by Subject|0
7776107|NCT00922441|12222565|FG001|Overall Study|Withdrawal by Subject|0
7776108|NCT00922441|12222566|FG002|Overall Study|Withdrawal by Subject|1
7606335|NCT02318784|12013864|FG000|Overall Study|Death|2
7606336|NCT02318784|12013864|FG000|Overall Study|Progressive Disease|37
7606337|NCT02318784|12013864|FG000|Overall Study|Withdrawal by Subject|10
7606338|NCT02317991|12013868|FG000|Overall Study|Adverse Event|12
7606339|NCT02317991|12013868|FG000|Overall Study|Death|4
7606340|NCT02317991|12013868|FG000|Overall Study|Withdrawal by Subject|8
7606341|NCT02317991|12013868|FG000|Overall Study|Progressive Disease|41
7776109|NCT00922480|12222576|FG000|Main Study|Protocol Violation|3
7776110|NCT00922480|12222577|FG001|Main Study|Protocol Violation|6
7776111|NCT00922480|12222576|FG000|Main Study|Adverse Event|6
7776112|NCT00922480|12222577|FG001|Main Study|Adverse Event|7
7776113|NCT00922480|12222576|FG000|Main Study|Lack of Efficacy|3
7776114|NCT00922480|12222577|FG001|Main Study|Lack of Efficacy|0
7776115|NCT00922480|12222576|FG000|Main Study|Withdrawal by Subject|20
7776116|NCT00922480|12222577|FG001|Main Study|Withdrawal by Subject|15
7776117|NCT00922480|12222576|FG000|Main Study|Lost to Follow-up|5
7776118|NCT00922480|12222577|FG001|Main Study|Lost to Follow-up|0
7776119|NCT00922480|12222576|FG000|Main Study|Physician Decision|0
7776120|NCT00922480|12222577|FG001|Main Study|Physician Decision|1
7776121|NCT00922480|12222576|FG000|Extension Study|Protocol Violation|3
7776122|NCT00922480|12222577|FG001|Extension Study|Protocol Violation|0
7776123|NCT00922480|12222576|FG000|Extension Study|Adverse Event|1
7776124|NCT00922480|12222577|FG001|Extension Study|Adverse Event|1
7776125|NCT00922480|12222576|FG000|Extension Study|Withdrawal by Subject|1
7776126|NCT00922480|12222577|FG001|Extension Study|Withdrawal by Subject|1
7776127|NCT00922480|12222576|FG000|Extension Study|Others|0
7776128|NCT00922480|12222577|FG001|Extension Study|Others|1
7776129|NCT00922623|12222585|FG000|Overall Study|Other|4
7776130|NCT00922623|12222585|FG000|Overall Study|Lost to Follow-up|1
7776131|NCT00922636|12222596|FG000|Overall Study|Adverse Event|3
7776132|NCT00922636|12222597|FG001|Overall Study|Adverse Event|3
7776133|NCT00922636|12222598|FG002|Overall Study|Adverse Event|2
7776134|NCT00922636|12222599|FG003|Overall Study|Adverse Event|3
7776135|NCT00922636|12222600|FG004|Overall Study|Adverse Event|2
7776136|NCT00922636|12222596|FG000|Overall Study|Lack of Efficacy|1
7776137|NCT00922636|12222597|FG001|Overall Study|Lack of Efficacy|7
7776138|NCT00922636|12222598|FG002|Overall Study|Lack of Efficacy|3
7776139|NCT00922636|12222599|FG003|Overall Study|Lack of Efficacy|2
7776140|NCT00922636|12222600|FG004|Overall Study|Lack of Efficacy|4
7776141|NCT00922636|12222596|FG000|Overall Study|Sponsor Decision|0
7776142|NCT00922636|12222597|FG001|Overall Study|Sponsor Decision|0
7776143|NCT00922636|12222598|FG002|Overall Study|Sponsor Decision|2
7776144|NCT00922636|12222599|FG003|Overall Study|Sponsor Decision|0
7776145|NCT00922636|12222600|FG004|Overall Study|Sponsor Decision|0
7606372|NCT02260193|12013907|FG000|Overall Study|Lack of Efficacy|0
7606373|NCT02260193|12013908|FG001|Overall Study|Lack of Efficacy|1
7606374|NCT02260193|12013909|FG002|Overall Study|Lack of Efficacy|6
7606375|NCT02260193|12013907|FG000|Overall Study|Adverse Event|3
7606376|NCT02260193|12013908|FG001|Overall Study|Adverse Event|4
7606377|NCT02260193|12013909|FG002|Overall Study|Adverse Event|1
7606378|NCT02260193|12013907|FG000|Overall Study|Protocol Violation|0
7606379|NCT02260193|12013908|FG001|Overall Study|Protocol Violation|4
7606380|NCT02260193|12013909|FG002|Overall Study|Protocol Violation|0
7606381|NCT02260193|12013907|FG000|Overall Study|Withdrawal by Subject|3
7606382|NCT02260193|12013908|FG001|Overall Study|Withdrawal by Subject|0
7606383|NCT02260193|12013909|FG002|Overall Study|Withdrawal by Subject|2
7606384|NCT02260193|12013907|FG000|Overall Study|Kidney Transplantation|0
7606385|NCT02260193|12013908|FG001|Overall Study|Kidney Transplantation|0
7606386|NCT02260193|12013909|FG002|Overall Study|Kidney Transplantation|1
7776146|NCT00922636|12222596|FG000|Overall Study|Withdrawal by Subject|0
7776147|NCT00922636|12222597|FG001|Overall Study|Withdrawal by Subject|0
7776148|NCT00922636|12222598|FG002|Overall Study|Withdrawal by Subject|5
7776149|NCT00922636|12222599|FG003|Overall Study|Withdrawal by Subject|2
7776150|NCT00922636|12222600|FG004|Overall Study|Withdrawal by Subject|4
7776151|NCT00922636|12222596|FG000|Overall Study|Protocol Violation|0
7776152|NCT00922636|12222597|FG001|Overall Study|Protocol Violation|0
7776153|NCT00922636|12222598|FG002|Overall Study|Protocol Violation|2
7776154|NCT00922636|12222599|FG003|Overall Study|Protocol Violation|2
7776155|NCT00922636|12222600|FG004|Overall Study|Protocol Violation|0
7776156|NCT00922636|12222596|FG000|Overall Study|Entry Criteria Not Met|0
7776157|NCT00922636|12222597|FG001|Overall Study|Entry Criteria Not Met|0
7776158|NCT00922636|12222598|FG002|Overall Study|Entry Criteria Not Met|1
7776159|NCT00922636|12222599|FG003|Overall Study|Entry Criteria Not Met|1
7776160|NCT00922636|12222600|FG004|Overall Study|Entry Criteria Not Met|0
7776161|NCT00922636|12222596|FG000|Overall Study|Parent/Caregiver Decision|2
7776162|NCT00922636|12222597|FG001|Overall Study|Parent/Caregiver Decision|4
7776163|NCT00922636|12222598|FG002|Overall Study|Parent/Caregiver Decision|3
7776164|NCT00922636|12222599|FG003|Overall Study|Parent/Caregiver Decision|5
7776165|NCT00922636|12222600|FG004|Overall Study|Parent/Caregiver Decision|2
7776166|NCT00922636|12222596|FG000|Overall Study|Lost to Follow-up|1
7776167|NCT00922636|12222597|FG001|Overall Study|Lost to Follow-up|2
7776168|NCT00922636|12222598|FG002|Overall Study|Lost to Follow-up|2
7776169|NCT00922636|12222599|FG003|Overall Study|Lost to Follow-up|2
7776170|NCT00922636|12222600|FG004|Overall Study|Lost to Follow-up|4
7776171|NCT00922766|12222621|FG000|Overall Study|Death|3
7776172|NCT00922766|12222621|FG000|Overall Study|Withdrawal by Subject|2
7776173|NCT00922766|12222621|FG000|Overall Study|Other|1
7776174|NCT00922766|12222621|FG000|Overall Study|Adverse Event|1
7776175|NCT00922779|12222625|FG000|Overall Study|Adverse Event|67
7776176|NCT00922779|12222625|FG000|Overall Study|Pregnancy|7
7776177|NCT00922779|12222625|FG000|Overall Study|Withdrawal by Subject|308
7776178|NCT00922779|12222625|FG000|Overall Study|Lost to Follow-up|44
7776179|NCT00922779|12222625|FG000|Overall Study|Other|27
7776180|NCT00922779|12222625|FG000|Overall Study|Missing|1874
7776181|NCT00922935|12222636|FG000|Overall Study|Protocol Violation|0
7776182|NCT00922935|12222637|FG001|Overall Study|Protocol Violation|3
7776183|NCT00922935|12222638|FG002|Overall Study|Protocol Violation|0
7776184|NCT00922935|12222636|FG000|Overall Study|Physician Decision|1
7776185|NCT00922935|12222637|FG001|Overall Study|Physician Decision|1
7776186|NCT00922935|12222638|FG002|Overall Study|Physician Decision|0
7776187|NCT00922935|12222636|FG000|Overall Study|Lost to Follow-up|0
7776188|NCT00922935|12222637|FG001|Overall Study|Lost to Follow-up|1
7776189|NCT00922935|12222638|FG002|Overall Study|Lost to Follow-up|0
7776190|NCT00922974|12222649|FG000|Phase II Component|Protocol Violation|2
7776191|NCT00922974|12222650|FG001|Phase II Component|Protocol Violation|0
7776192|NCT00922974|12222649|FG000|Phase II Component|Not evaluable for treatment review|5
7776193|NCT00922974|12222650|FG001|Phase II Component|Not evaluable for treatment review|0
7776194|NCT00922974|12222649|FG000|Phase III Component|Protocol Violation|8
7776195|NCT00922974|12222650|FG001|Phase III Component|Protocol Violation|6
7776196|NCT00922987|12222658|FG000|Overall Study|Insufficient clinical response|1
7776197|NCT00922987|12222658|FG000|Overall Study|Protocol Violation|2
7776198|NCT00922987|12222658|FG000|Overall Study|Adverse Event|1
7776199|NCT00923078|12222665|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
7776200|NCT00923078|12222666|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
7776201|NCT00923078|12222667|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
7776202|NCT00923078|12222665|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0
7776203|NCT00923078|12222666|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0
7776204|NCT00923078|12222667|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20
7776205|NCT00923091|12222682|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
7776206|NCT00923091|12222683|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
7776207|NCT00923091|12222684|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
7776208|NCT00923091|12222685|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
7776209|NCT00923091|12222686|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
7776210|NCT00923091|12222687|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
7776211|NCT00923091|12222688|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
7776212|NCT00923091|12222689|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
7776213|NCT00923091|12222690|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
7776214|NCT00923091|12222691|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
7776215|NCT00923091|12222692|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
7776216|NCT00923091|12222693|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
7776217|NCT00923091|12222694|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
7776218|NCT00923091|12222682|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
7776219|NCT00923091|12222683|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
7776220|NCT00923091|12222684|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
7776221|NCT00923091|12222685|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
7776222|NCT00923091|12222686|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
7776223|NCT00923091|12222687|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
7776224|NCT00923091|12222688|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
7776225|NCT00923091|12222689|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
7776226|NCT00923091|12222690|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
7776227|NCT00923091|12222691|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
7776228|NCT00923091|12222692|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
7776229|NCT00923091|12222693|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
7776230|NCT00923091|12222694|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
7776231|NCT00923091|12222682|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
7776232|NCT00923091|12222683|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
7776233|NCT00923091|12222684|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
7776234|NCT00923091|12222685|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
7776235|NCT00923091|12222686|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
7776236|NCT00923091|12222687|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
7776237|NCT00923091|12222688|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
7776238|NCT00923091|12222689|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
7776239|NCT00923091|12222690|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
7776240|NCT00923091|12222691|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
7776241|NCT00923091|12222692|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
7776242|NCT00923091|12222693|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
7776243|NCT00923091|12222694|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
7776244|NCT00923091|12222682|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7776245|NCT00923091|12222683|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7606478|NCT01832402|12014012|FG000|Overall Study|Lost to Follow-up|2
7606479|NCT01832402|12014013|FG001|Overall Study|Lost to Follow-up|0
7606480|NCT01832402|12014012|FG000|Overall Study|Withdrawal by Subject|3
7606481|NCT01832402|12014013|FG001|Overall Study|Withdrawal by Subject|3
7606482|NCT01832402|12014012|FG000|Overall Study|Declining Performance status|2
7606483|NCT01832402|12014013|FG001|Overall Study|Declining Performance status|1
7606484|NCT01468922|12014032|FG000|Overall Study|Screening failure|0
7606485|NCT01468922|12014033|FG001|Overall Study|Screening failure|0
7606486|NCT01468922|12014034|FG002|Overall Study|Screening failure|0
7606487|NCT01468922|12014035|FG003|Overall Study|Screening failure|0
7606488|NCT01468922|12014036|FG004|Overall Study|Screening failure|0
7606489|NCT01468922|12014037|FG005|Overall Study|Screening failure|0
7606490|NCT01468922|12014038|FG006|Overall Study|Screening failure|0
7606491|NCT01468922|12014039|FG007|Overall Study|Screening failure|0
7606492|NCT01468922|12014040|FG008|Overall Study|Screening failure|1
7606493|NCT01468922|12014032|FG000|Overall Study|Per patient choice|1
7606494|NCT01468922|12014033|FG001|Overall Study|Per patient choice|0
7606495|NCT01468922|12014034|FG002|Overall Study|Per patient choice|0
7606496|NCT01468922|12014035|FG003|Overall Study|Per patient choice|0
7606497|NCT01468922|12014036|FG004|Overall Study|Per patient choice|0
7606498|NCT01468922|12014037|FG005|Overall Study|Per patient choice|0
7606499|NCT01468922|12014038|FG006|Overall Study|Per patient choice|0
7606500|NCT01468922|12014039|FG007|Overall Study|Per patient choice|0
7606501|NCT01468922|12014040|FG008|Overall Study|Per patient choice|0
7606502|NCT01468922|12014032|FG000|Overall Study|Switched to alternative treatment|1
7606503|NCT01468922|12014033|FG001|Overall Study|Switched to alternative treatment|0
7606504|NCT01468922|12014034|FG002|Overall Study|Switched to alternative treatment|0
7606505|NCT01468922|12014035|FG003|Overall Study|Switched to alternative treatment|0
7606506|NCT01468922|12014036|FG004|Overall Study|Switched to alternative treatment|1
7606507|NCT01468922|12014037|FG005|Overall Study|Switched to alternative treatment|0
7606508|NCT01468922|12014038|FG006|Overall Study|Switched to alternative treatment|0
7606509|NCT01468922|12014039|FG007|Overall Study|Switched to alternative treatment|0
7606510|NCT01468922|12014040|FG008|Overall Study|Switched to alternative treatment|0
7606511|NCT01468922|12014032|FG000|Overall Study|Enrolled on new protocol|0
7606512|NCT01468922|12014033|FG001|Overall Study|Enrolled on new protocol|0
7606513|NCT01468922|12014034|FG002|Overall Study|Enrolled on new protocol|0
7776246|NCT00923091|12222684|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7776247|NCT00923091|12222685|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7776248|NCT00923091|12222686|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7776249|NCT00923091|12222687|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
7776250|NCT00923091|12222688|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7776251|NCT00923091|12222689|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7776252|NCT00923091|12222690|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7776253|NCT00923091|12222691|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7776254|NCT00923091|12222692|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7776255|NCT00923091|12222693|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7776256|NCT00923091|12222694|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7776257|NCT00923091|12222682|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7776258|NCT00923091|12222683|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
7776259|NCT00923091|12222684|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7776260|NCT00923091|12222685|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
7606514|NCT01468922|12014035|FG003|Overall Study|Enrolled on new protocol|0
7606515|NCT01468922|12014036|FG004|Overall Study|Enrolled on new protocol|1
7606516|NCT01468922|12014037|FG005|Overall Study|Enrolled on new protocol|0
7606517|NCT01468922|12014038|FG006|Overall Study|Enrolled on new protocol|0
7606518|NCT01468922|12014039|FG007|Overall Study|Enrolled on new protocol|0
7606519|NCT01468922|12014040|FG008|Overall Study|Enrolled on new protocol|0
7606520|NCT01468922|12014032|FG000|Overall Study|Adverse Event|0
7606521|NCT01468922|12014033|FG001|Overall Study|Adverse Event|0
7606522|NCT01468922|12014034|FG002|Overall Study|Adverse Event|0
7606523|NCT01468922|12014035|FG003|Overall Study|Adverse Event|0
7606524|NCT01468922|12014036|FG004|Overall Study|Adverse Event|0
7606525|NCT01468922|12014037|FG005|Overall Study|Adverse Event|0
7606526|NCT01468922|12014038|FG006|Overall Study|Adverse Event|0
7776261|NCT00923091|12222686|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7776262|NCT00923091|12222687|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
7776263|NCT00923091|12222688|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7776264|NCT00923091|12222689|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7776265|NCT00923091|12222690|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7776266|NCT00923091|12222691|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7776267|NCT00923091|12222692|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7776268|NCT00923091|12222693|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7776269|NCT00923091|12222694|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7776270|NCT00923091|12222682|FG000|Period III (Single-Blind)|Adverse Event|5
7776271|NCT00923091|12222683|FG001|Period III (Single-Blind)|Adverse Event|0
7776272|NCT00923091|12222684|FG002|Period III (Single-Blind)|Adverse Event|0
7776273|NCT00923091|12222685|FG003|Period III (Single-Blind)|Adverse Event|0
7776274|NCT00923091|12222686|FG004|Period III (Single-Blind)|Adverse Event|0
7776275|NCT00923091|12222687|FG005|Period III (Single-Blind)|Adverse Event|0
7606527|NCT01468922|12014039|FG007|Overall Study|Adverse Event|1
7776276|NCT00923091|12222688|FG006|Period III (Single-Blind)|Adverse Event|0
7776277|NCT00923091|12222689|FG007|Period III (Single-Blind)|Adverse Event|0
7606528|NCT01468922|12014040|FG008|Overall Study|Adverse Event|0
7606529|NCT01468922|12014032|FG000|Overall Study|Infection of blood|0
7606530|NCT01468922|12014033|FG001|Overall Study|Infection of blood|0
7606531|NCT01468922|12014034|FG002|Overall Study|Infection of blood|0
7606532|NCT01468922|12014035|FG003|Overall Study|Infection of blood|0
7606533|NCT01468922|12014036|FG004|Overall Study|Infection of blood|0
7606534|NCT01468922|12014037|FG005|Overall Study|Infection of blood|0
7606535|NCT01468922|12014038|FG006|Overall Study|Infection of blood|0
7606536|NCT01468922|12014039|FG007|Overall Study|Infection of blood|1
7606537|NCT01468922|12014040|FG008|Overall Study|Infection of blood|0
7606538|NCT01468922|12014032|FG000|Overall Study|Patient choice - surgery|0
7606539|NCT01468922|12014033|FG001|Overall Study|Patient choice - surgery|0
7606540|NCT01468922|12014034|FG002|Overall Study|Patient choice - surgery|0
7606541|NCT01468922|12014035|FG003|Overall Study|Patient choice - surgery|0
7606542|NCT01468922|12014036|FG004|Overall Study|Patient choice - surgery|0
7606543|NCT01468922|12014037|FG005|Overall Study|Patient choice - surgery|0
7606544|NCT01468922|12014038|FG006|Overall Study|Patient choice - surgery|0
7606545|NCT01468922|12014039|FG007|Overall Study|Patient choice - surgery|1
7606546|NCT01468922|12014040|FG008|Overall Study|Patient choice - surgery|0
7606547|NCT01468922|12014032|FG000|Overall Study|Refused further treatment|0
7606548|NCT01468922|12014033|FG001|Overall Study|Refused further treatment|0
7606549|NCT01468922|12014034|FG002|Overall Study|Refused further treatment|0
7606550|NCT01468922|12014035|FG003|Overall Study|Refused further treatment|0
7606551|NCT01468922|12014036|FG004|Overall Study|Refused further treatment|0
7606552|NCT01468922|12014037|FG005|Overall Study|Refused further treatment|0
7606553|NCT01468922|12014038|FG006|Overall Study|Refused further treatment|0
7606554|NCT01468922|12014039|FG007|Overall Study|Refused further treatment|1
7606555|NCT01468922|12014040|FG008|Overall Study|Refused further treatment|0
7606556|NCT01381094|12014063|FG000|Overall Study|Adverse Event|1
7606557|NCT01381094|12014064|FG001|Overall Study|Adverse Event|2
7776278|NCT00923091|12222690|FG008|Period III (Single-Blind)|Adverse Event|0
7776279|NCT00923091|12222691|FG009|Period III (Single-Blind)|Adverse Event|0
7776280|NCT00923091|12222692|FG010|Period III (Single-Blind)|Adverse Event|0
7776281|NCT00923091|12222693|FG011|Period III (Single-Blind)|Adverse Event|0
7776282|NCT00923091|12222694|FG012|Period III (Single-Blind)|Adverse Event|0
7776283|NCT00923091|12222682|FG000|Period III (Single-Blind)|Withdrawal by Subject|10
7776284|NCT00923091|12222683|FG001|Period III (Single-Blind)|Withdrawal by Subject|0
7776285|NCT00923091|12222684|FG002|Period III (Single-Blind)|Withdrawal by Subject|0
7776286|NCT00923091|12222685|FG003|Period III (Single-Blind)|Withdrawal by Subject|0
7776287|NCT00923091|12222686|FG004|Period III (Single-Blind)|Withdrawal by Subject|0
7776288|NCT00923091|12222687|FG005|Period III (Single-Blind)|Withdrawal by Subject|0
7776289|NCT00923091|12222688|FG006|Period III (Single-Blind)|Withdrawal by Subject|0
7776290|NCT00923091|12222689|FG007|Period III (Single-Blind)|Withdrawal by Subject|0
7776291|NCT00923091|12222690|FG008|Period III (Single-Blind)|Withdrawal by Subject|0
7776292|NCT00923091|12222691|FG009|Period III (Single-Blind)|Withdrawal by Subject|0
7776293|NCT00923091|12222692|FG010|Period III (Single-Blind)|Withdrawal by Subject|0
7776294|NCT00923091|12222693|FG011|Period III (Single-Blind)|Withdrawal by Subject|0
7776295|NCT00923091|12222694|FG012|Period III (Single-Blind)|Withdrawal by Subject|0
7776296|NCT00923091|12222682|FG000|Period III (Single-Blind)|Protocol Violation|3
7606558|NCT01381094|12014065|FG002|Overall Study|Adverse Event|0
7606559|NCT01381094|12014066|FG003|Overall Study|Adverse Event|1
7606560|NCT01381094|12014067|FG004|Overall Study|Adverse Event|0
7606561|NCT01381094|12014063|FG000|Overall Study|Lost to Follow-up|0
7606562|NCT01381094|12014064|FG001|Overall Study|Lost to Follow-up|0
7776297|NCT00923091|12222683|FG001|Period III (Single-Blind)|Protocol Violation|0
7776298|NCT00923091|12222684|FG002|Period III (Single-Blind)|Protocol Violation|0
7776299|NCT00923091|12222685|FG003|Period III (Single-Blind)|Protocol Violation|0
7776300|NCT00923091|12222686|FG004|Period III (Single-Blind)|Protocol Violation|0
7606563|NCT01381094|12014065|FG002|Overall Study|Lost to Follow-up|0
7606564|NCT01381094|12014066|FG003|Overall Study|Lost to Follow-up|0
7606565|NCT01381094|12014067|FG004|Overall Study|Lost to Follow-up|1
7606566|NCT01381094|12014063|FG000|Overall Study|Withdrawal of informed consent|0
7606567|NCT01381094|12014064|FG001|Overall Study|Withdrawal of informed consent|1
7606568|NCT01381094|12014065|FG002|Overall Study|Withdrawal of informed consent|0
7606569|NCT01381094|12014066|FG003|Overall Study|Withdrawal of informed consent|0
7606570|NCT01381094|12014067|FG004|Overall Study|Withdrawal of informed consent|0
7606571|NCT01381094|12014063|FG000|Overall Study|Participant given Aranesp injection|1
7606572|NCT01381094|12014064|FG001|Overall Study|Participant given Aranesp injection|0
7606573|NCT01381094|12014065|FG002|Overall Study|Participant given Aranesp injection|0
7606574|NCT01381094|12014066|FG003|Overall Study|Participant given Aranesp injection|0
7606575|NCT01381094|12014067|FG004|Overall Study|Participant given Aranesp injection|0
7776301|NCT00923091|12222687|FG005|Period III (Single-Blind)|Protocol Violation|0
7606577|NCT01081951|12014089|FG000|Overall Study|Death|54
7606578|NCT01081951|12014090|FG001|Overall Study|Death|47
7606579|NCT01081951|12014089|FG000|Overall Study|Withdrawal by Subject|2
7606580|NCT01081951|12014090|FG001|Overall Study|Withdrawal by Subject|6
7606581|NCT01081951|12014089|FG000|Overall Study|Allocated treatment but did not take it|0
7606582|NCT01081951|12014090|FG001|Overall Study|Allocated treatment but did not take it|1
7606583|NCT01081951|12014089|FG000|Overall Study|Lost to Follow-up|0
7606584|NCT01081951|12014090|FG001|Overall Study|Lost to Follow-up|1
7776302|NCT00923091|12222688|FG006|Period III (Single-Blind)|Protocol Violation|0
7776303|NCT00923091|12222689|FG007|Period III (Single-Blind)|Protocol Violation|0
7776304|NCT00923091|12222690|FG008|Period III (Single-Blind)|Protocol Violation|0
7776305|NCT00923091|12222691|FG009|Period III (Single-Blind)|Protocol Violation|0
7776306|NCT00923091|12222692|FG010|Period III (Single-Blind)|Protocol Violation|0
7776307|NCT00923091|12222693|FG011|Period III (Single-Blind)|Protocol Violation|0
7776308|NCT00923091|12222694|FG012|Period III (Single-Blind)|Protocol Violation|0
7776309|NCT00923091|12222682|FG000|Period III (Single-Blind)|Lost to Follow-up|2
7606639|NCT00788671|12014119|FG000|Overall Study|Death|2
7606640|NCT00788671|12014119|FG000|Overall Study|Unable to biopsy|1
7606641|NCT00788671|12014119|FG000|Overall Study|Withdrawal by Subject|4
7606642|NCT00788671|12014119|FG000|Overall Study|IUD expulsed|1
7606643|NCT00788671|12014119|FG000|Overall Study|Lost to follow up|2
7776310|NCT00923091|12222683|FG001|Period III (Single-Blind)|Lost to Follow-up|0
7776311|NCT00923091|12222684|FG002|Period III (Single-Blind)|Lost to Follow-up|0
7776312|NCT00923091|12222685|FG003|Period III (Single-Blind)|Lost to Follow-up|0
7776313|NCT00923091|12222686|FG004|Period III (Single-Blind)|Lost to Follow-up|0
7776314|NCT00923091|12222687|FG005|Period III (Single-Blind)|Lost to Follow-up|0
7776315|NCT00923091|12222688|FG006|Period III (Single-Blind)|Lost to Follow-up|0
7776316|NCT00923091|12222689|FG007|Period III (Single-Blind)|Lost to Follow-up|0
7776317|NCT00923091|12222690|FG008|Period III (Single-Blind)|Lost to Follow-up|0
7864090|NCT01609556|12353457|FG013|Dose Expansion: Maximum 124 Weeks|Death|2
7606644|NCT03881059|12014139|FG000|Treatment Period - Part A|Adverse Event|1
7606645|NCT03881059|12014140|FG001|Treatment Period - Part A|Adverse Event|3
7606646|NCT03881059|12014141|FG002|Treatment Period - Part A|Adverse Event|4
7606647|NCT03881059|12014139|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0
7606648|NCT03881059|12014140|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1
7606649|NCT03881059|12014141|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1
7606650|NCT03881059|12014139|FG000|Treatment Period - Part A|Withdrawal by Subject|5
7606651|NCT03881059|12014140|FG001|Treatment Period - Part A|Withdrawal by Subject|2
7606652|NCT03881059|12014141|FG002|Treatment Period - Part A|Withdrawal by Subject|3
7606653|NCT03881059|12014139|FG000|Treatment Period - Part A|Other reasons|2
7606654|NCT03881059|12014140|FG001|Treatment Period - Part A|Other reasons|1
7606655|NCT03881059|12014141|FG002|Treatment Period - Part A|Other reasons|0
7606656|NCT03881059|12014139|FG000|Treatment Period - Part B|Adverse Event|0
7606657|NCT03881059|12014140|FG001|Treatment Period - Part B|Adverse Event|0
7606658|NCT03881059|12014141|FG002|Treatment Period - Part B|Adverse Event|3
7606659|NCT03881059|12014139|FG000|Treatment Period - Part B|Death|0
7606660|NCT03881059|12014140|FG001|Treatment Period - Part B|Death|1
7606661|NCT03881059|12014141|FG002|Treatment Period - Part B|Death|1
7606662|NCT03881059|12014139|FG000|Treatment Period - Part B|Lack of Efficacy|1
7606663|NCT03881059|12014140|FG001|Treatment Period - Part B|Lack of Efficacy|1
7606664|NCT03881059|12014141|FG002|Treatment Period - Part B|Lack of Efficacy|0
7606665|NCT03881059|12014139|FG000|Treatment Period - Part B|Lost to Follow-up|1
7606666|NCT03881059|12014140|FG001|Treatment Period - Part B|Lost to Follow-up|1
7606667|NCT03881059|12014141|FG002|Treatment Period - Part B|Lost to Follow-up|0
7606668|NCT03881059|12014139|FG000|Treatment Period - Part B|Site terminated by sponsor|1
7606669|NCT03881059|12014140|FG001|Treatment Period - Part B|Site terminated by sponsor|0
7606670|NCT03881059|12014141|FG002|Treatment Period - Part B|Site terminated by sponsor|3
7606671|NCT03881059|12014139|FG000|Treatment Period - Part B|Withdrawal by Subject|1
7606672|NCT03881059|12014140|FG001|Treatment Period - Part B|Withdrawal by Subject|0
7606673|NCT03881059|12014141|FG002|Treatment Period - Part B|Withdrawal by Subject|1
7606674|NCT03881059|12014139|FG000|Treatment Period - Part B|Other reasons|4
7606675|NCT03881059|12014140|FG001|Treatment Period - Part B|Other reasons|3
7606676|NCT03881059|12014141|FG002|Treatment Period - Part B|Other reasons|3
7606677|NCT03450629|12014160|FG000|Overall Study|Adverse Event|15
7606678|NCT03450629|12014161|FG001|Overall Study|Adverse Event|14
7606679|NCT03450629|12014160|FG000|Overall Study|Physician Decision|2
7606680|NCT03450629|12014161|FG001|Overall Study|Physician Decision|2
7606681|NCT03450629|12014160|FG000|Overall Study|Lack of Efficacy|2
7606682|NCT03450629|12014161|FG001|Overall Study|Lack of Efficacy|0
7606683|NCT03450629|12014160|FG000|Overall Study|Lost to Follow-up|4
7606684|NCT03450629|12014161|FG001|Overall Study|Lost to Follow-up|2
7606685|NCT03450629|12014160|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7606686|NCT03450629|12014161|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
7606687|NCT03450629|12014160|FG000|Overall Study|Non-Compliance With Study Drug|2
7606688|NCT03450629|12014161|FG001|Overall Study|Non-Compliance With Study Drug|1
7606689|NCT03450629|12014160|FG000|Overall Study|Protocol Violation|11
7606690|NCT03450629|12014161|FG001|Overall Study|Protocol Violation|8
7606691|NCT03450629|12014160|FG000|Overall Study|Withdrawal by Subject|12
7606692|NCT03450629|12014161|FG001|Overall Study|Withdrawal by Subject|6
7606693|NCT03367403|12014170|FG000|Overall Study|Adverse Event|20
7606694|NCT03367403|12014171|FG001|Overall Study|Adverse Event|6
7606695|NCT03367403|12014172|FG002|Overall Study|Adverse Event|2
7606696|NCT03367403|12014170|FG000|Overall Study|Withdrawal by Subject|12
7606697|NCT03367403|12014171|FG001|Overall Study|Withdrawal by Subject|12
7606698|NCT03367403|12014172|FG002|Overall Study|Withdrawal by Subject|1
7606699|NCT03367403|12014170|FG000|Overall Study|Death|1
7606700|NCT03367403|12014171|FG001|Overall Study|Death|2
7606701|NCT03367403|12014172|FG002|Overall Study|Death|0
7606702|NCT03367403|12014170|FG000|Overall Study|Physician Decision|0
7606703|NCT03367403|12014171|FG001|Overall Study|Physician Decision|1
7606704|NCT03367403|12014172|FG002|Overall Study|Physician Decision|0
7606705|NCT03367403|12014170|FG000|Overall Study|Protocol Violation|1
7606706|NCT03367403|12014171|FG001|Overall Study|Protocol Violation|1
7606707|NCT03367403|12014172|FG002|Overall Study|Protocol Violation|0
7606708|NCT03367403|12014170|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0
7606709|NCT03367403|12014171|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2
7606710|NCT03367403|12014172|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0
7606711|NCT03367403|12014170|FG000|Overall Study|COVID-19|3
7606712|NCT03367403|12014171|FG001|Overall Study|COVID-19|7
7606713|NCT03367403|12014172|FG002|Overall Study|COVID-19|0
7606714|NCT03367403|12014170|FG000|Overall Study|Abuse of Alcohol Intake|0
7606715|NCT03367403|12014171|FG001|Overall Study|Abuse of Alcohol Intake|1
7606716|NCT03367403|12014172|FG002|Overall Study|Abuse of Alcohol Intake|0
7606717|NCT03367403|12014170|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0
7606718|NCT03367403|12014171|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1
7606719|NCT03367403|12014172|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0
7606720|NCT03286426|12014180|FG000|Overall Study|Physician Decision|3
7606721|NCT02809677|12014197|FG000|Overall Study|Withdrawal by Subject|8
7776318|NCT00923091|12222691|FG009|Period III (Single-Blind)|Lost to Follow-up|0
7776319|NCT00923091|12222692|FG010|Period III (Single-Blind)|Lost to Follow-up|0
7776320|NCT00923091|12222693|FG011|Period III (Single-Blind)|Lost to Follow-up|0
7776321|NCT00923091|12222694|FG012|Period III (Single-Blind)|Lost to Follow-up|0
7776322|NCT00923091|12222682|FG000|Period IV (Double-Blind)|Adverse Event|2
7776323|NCT00923091|12222683|FG001|Period IV (Double-Blind)|Adverse Event|0
7776324|NCT00923091|12222684|FG002|Period IV (Double-Blind)|Adverse Event|0
7776325|NCT00923091|12222685|FG003|Period IV (Double-Blind)|Adverse Event|0
7776326|NCT00923091|12222686|FG004|Period IV (Double-Blind)|Adverse Event|0
7776327|NCT00923091|12222687|FG005|Period IV (Double-Blind)|Adverse Event|0
7776328|NCT00923091|12222688|FG006|Period IV (Double-Blind)|Adverse Event|0
7776329|NCT00923091|12222689|FG007|Period IV (Double-Blind)|Adverse Event|0
7776330|NCT00923091|12222690|FG008|Period IV (Double-Blind)|Adverse Event|0
7776331|NCT00923091|12222691|FG009|Period IV (Double-Blind)|Adverse Event|0
7776332|NCT00923091|12222692|FG010|Period IV (Double-Blind)|Adverse Event|0
7776333|NCT00923091|12222693|FG011|Period IV (Double-Blind)|Adverse Event|0
7776334|NCT00923091|12222694|FG012|Period IV (Double-Blind)|Adverse Event|0
7606722|NCT02554253|12014208|FG000|Overall Study|ineligible after enrollment|1
7606723|NCT02554253|12014209|FG001|Overall Study|ineligible after enrollment|0
7606724|NCT02554253|12014208|FG000|Overall Study|converted to transcatheter procedure|0
7606725|NCT02554253|12014209|FG001|Overall Study|converted to transcatheter procedure|1
7606726|NCT02554253|12014208|FG000|Overall Study|received both drugs|0
7606727|NCT02554253|12014209|FG001|Overall Study|received both drugs|1
7606728|NCT01307046|12014228|FG000|Overall Study|Adverse Event|3
7606729|NCT01307046|12014229|FG001|Overall Study|Adverse Event|3
7606730|NCT01307046|12014228|FG000|Overall Study|Lack of Efficacy|0
7606731|NCT01307046|12014229|FG001|Overall Study|Lack of Efficacy|2
7606732|NCT01307046|12014228|FG000|Overall Study|Physician Decision|2
7606733|NCT01307046|12014229|FG001|Overall Study|Physician Decision|0
7606734|NCT01307046|12014228|FG000|Overall Study|Withdrawal by Subject|1
7606735|NCT01307046|12014229|FG001|Overall Study|Withdrawal by Subject|1
7606736|NCT01307046|12014228|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4
7606737|NCT01307046|12014229|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2
7606738|NCT01307046|12014228|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2
7606739|NCT01307046|12014229|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3
7776335|NCT00923091|12222682|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0
7776336|NCT00923091|12222683|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1
7776337|NCT00923091|12222684|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0
7776338|NCT00923091|12222685|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0
7776339|NCT00923091|12222686|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0
7776340|NCT00923091|12222687|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0
7776341|NCT00923091|12222688|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0
7776342|NCT00923091|12222689|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0
7776343|NCT00923091|12222690|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0
7776344|NCT00923091|12222691|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0
7776345|NCT00923091|12222692|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0
7776346|NCT00923091|12222693|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0
7776347|NCT00923091|12222694|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0
7776348|NCT00923091|12222682|FG000|Period IV (Double-Blind)|Protocol Violation|0
7776349|NCT00923091|12222683|FG001|Period IV (Double-Blind)|Protocol Violation|1
7776350|NCT00923091|12222684|FG002|Period IV (Double-Blind)|Protocol Violation|0
7776351|NCT00923091|12222685|FG003|Period IV (Double-Blind)|Protocol Violation|0
7776352|NCT00923091|12222686|FG004|Period IV (Double-Blind)|Protocol Violation|0
7776353|NCT00923091|12222687|FG005|Period IV (Double-Blind)|Protocol Violation|0
7776354|NCT00923091|12222688|FG006|Period IV (Double-Blind)|Protocol Violation|0
7776355|NCT00923091|12222689|FG007|Period IV (Double-Blind)|Protocol Violation|0
7776356|NCT00923091|12222690|FG008|Period IV (Double-Blind)|Protocol Violation|0
7776357|NCT00923091|12222691|FG009|Period IV (Double-Blind)|Protocol Violation|0
7776358|NCT00923091|12222692|FG010|Period IV (Double-Blind)|Protocol Violation|0
7776359|NCT00923091|12222693|FG011|Period IV (Double-Blind)|Protocol Violation|0
7776360|NCT00923091|12222694|FG012|Period IV (Double-Blind)|Protocol Violation|0
7776361|NCT00923091|12222682|FG000|Period V (Double -Blind)|Withdrawal by Subject|0
7776362|NCT00923091|12222683|FG001|Period V (Double -Blind)|Withdrawal by Subject|0
7776363|NCT00923091|12222684|FG002|Period V (Double -Blind)|Withdrawal by Subject|0
7776364|NCT00923091|12222685|FG003|Period V (Double -Blind)|Withdrawal by Subject|0
7776365|NCT00923091|12222686|FG004|Period V (Double -Blind)|Withdrawal by Subject|0
7776366|NCT00923091|12222687|FG005|Period V (Double -Blind)|Withdrawal by Subject|0
7776367|NCT00923091|12222688|FG006|Period V (Double -Blind)|Withdrawal by Subject|0
7776368|NCT00923091|12222689|FG007|Period V (Double -Blind)|Withdrawal by Subject|0
7776369|NCT00923091|12222690|FG008|Period V (Double -Blind)|Withdrawal by Subject|1
7776370|NCT00923091|12222691|FG009|Period V (Double -Blind)|Withdrawal by Subject|0
7776371|NCT00923091|12222692|FG010|Period V (Double -Blind)|Withdrawal by Subject|0
7776372|NCT00923091|12222693|FG011|Period V (Double -Blind)|Withdrawal by Subject|0
7776373|NCT00923091|12222694|FG012|Period V (Double -Blind)|Withdrawal by Subject|1
7776374|NCT00923091|12222682|FG000|Period V (Double -Blind)|Protocol Violation|0
7606740|NCT01307033|12014237|FG000|8-week Double-blind Period|Adverse Event|2
7606741|NCT01307033|12014238|FG001|8-week Double-blind Period|Adverse Event|0
7606742|NCT01307033|12014239|FG002|8-week Double-blind Period|Adverse Event|0
7606743|NCT01307033|12014240|FG003|8-week Double-blind Period|Adverse Event|0
7606744|NCT01307033|12014237|FG000|8-week Double-blind Period|Withdrawal by Subject|4
7606745|NCT01307033|12014238|FG001|8-week Double-blind Period|Withdrawal by Subject|1
7606746|NCT01307033|12014239|FG002|8-week Double-blind Period|Withdrawal by Subject|0
7606747|NCT01307033|12014240|FG003|8-week Double-blind Period|Withdrawal by Subject|0
7606748|NCT01307033|12014237|FG000|8-week Double-blind Period|Lack of Efficacy|1
7606749|NCT01307033|12014238|FG001|8-week Double-blind Period|Lack of Efficacy|0
7606750|NCT01307033|12014239|FG002|8-week Double-blind Period|Lack of Efficacy|0
7606751|NCT01307033|12014240|FG003|8-week Double-blind Period|Lack of Efficacy|0
7606752|NCT01307033|12014237|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
7606753|NCT01307033|12014238|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
7606754|NCT01307033|12014239|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
7606755|NCT01307033|12014240|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
7606756|NCT01307033|12014237|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
7606757|NCT01307033|12014238|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
7776375|NCT00923091|12222683|FG001|Period V (Double -Blind)|Protocol Violation|0
7606758|NCT01307033|12014239|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
7606759|NCT01307033|12014240|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
7606760|NCT01307033|12014237|FG000|44-week Open-label Extension|Adverse Event|0
7606761|NCT01307033|12014238|FG001|44-week Open-label Extension|Adverse Event|0
7606762|NCT01307033|12014239|FG002|44-week Open-label Extension|Adverse Event|2
7606763|NCT01307033|12014240|FG003|44-week Open-label Extension|Adverse Event|1
7606764|NCT01307033|12014237|FG000|44-week Open-label Extension|Withdrawal by Subject|0
7606765|NCT01307033|12014238|FG001|44-week Open-label Extension|Withdrawal by Subject|0
7606766|NCT01307033|12014239|FG002|44-week Open-label Extension|Withdrawal by Subject|2
7606767|NCT01307033|12014240|FG003|44-week Open-label Extension|Withdrawal by Subject|1
7606768|NCT01307033|12014237|FG000|44-week Open-label Extension|Physician Decision|0
7606769|NCT01307033|12014238|FG001|44-week Open-label Extension|Physician Decision|0
7606770|NCT01307033|12014239|FG002|44-week Open-label Extension|Physician Decision|1
7606771|NCT01307033|12014240|FG003|44-week Open-label Extension|Physician Decision|0
7606772|NCT01307033|12014237|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
7606773|NCT01307033|12014238|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
7606774|NCT01307033|12014239|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
7606775|NCT01307033|12014240|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
7606776|NCT01307033|12014237|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
7606777|NCT01307033|12014238|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
7606778|NCT01307033|12014239|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
7606779|NCT01307033|12014240|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
7606780|NCT01307033|12014237|FG000|44-week Open-label Extension|Death|0
7606781|NCT01307033|12014238|FG001|44-week Open-label Extension|Death|0
7606782|NCT01307033|12014239|FG002|44-week Open-label Extension|Death|0
7606783|NCT01307033|12014240|FG003|44-week Open-label Extension|Death|1
7606784|NCT00739674|12014254|FG000|Overall Study|Screening failures|19
7606785|NCT00739674|12014255|FG001|Overall Study|Screening failures|17
7606786|NCT00739674|12014254|FG000|Overall Study|Site 212 removal|19
7606787|NCT00739674|12014255|FG001|Overall Study|Site 212 removal|13
7606788|NCT00739674|12014254|FG000|Overall Study|No follow-up data|33
7606789|NCT00739674|12014255|FG001|Overall Study|No follow-up data|18
7606790|NCT00739674|12014254|FG000|Overall Study|Dietician consultation >30 days|1
7606791|NCT00739674|12014255|FG001|Overall Study|Dietician consultation >30 days|9
7606792|NCT00739674|12014254|FG000|Overall Study|Adverse Event|22
7606793|NCT00739674|12014255|FG001|Overall Study|Adverse Event|13
7606794|NCT00739674|12014254|FG000|Overall Study|Death|1
7606795|NCT00739674|12014255|FG001|Overall Study|Death|0
7606796|NCT00739674|12014254|FG000|Overall Study|Lack of Efficacy|1
7606797|NCT00739674|12014255|FG001|Overall Study|Lack of Efficacy|0
7606798|NCT00739674|12014254|FG000|Overall Study|Lost to Follow-up|52
7606799|NCT00739674|12014255|FG001|Overall Study|Lost to Follow-up|30
7606800|NCT00739674|12014254|FG000|Overall Study|Protocol Violation|5
7606801|NCT00739674|12014255|FG001|Overall Study|Protocol Violation|5
7606802|NCT00739674|12014254|FG000|Overall Study|Withdrawal by Subject|9
7606803|NCT00739674|12014255|FG001|Overall Study|Withdrawal by Subject|9
7606804|NCT00739674|12014254|FG000|Overall Study|Reason missing|2
7606805|NCT00739674|12014255|FG001|Overall Study|Reason missing|0
7606806|NCT00739674|12014254|FG000|Overall Study|Clinic closed|6
7606807|NCT00739674|12014255|FG001|Overall Study|Clinic closed|4
7606808|NCT00739674|12014254|FG000|Overall Study|Patient moved|3
7606809|NCT00739674|12014255|FG001|Overall Study|Patient moved|2
7606810|NCT00739674|12014254|FG000|Overall Study|Non compliant|4
7606811|NCT00739674|12014255|FG001|Overall Study|Non compliant|0
7606812|NCT00739674|12014254|FG000|Overall Study|Unable to attend visit|3
7606813|NCT00739674|12014255|FG001|Overall Study|Unable to attend visit|1
7606814|NCT00739674|12014254|FG000|Overall Study|Home monitoring off meds|1
7606815|NCT00739674|12014255|FG001|Overall Study|Home monitoring off meds|0
7606816|NCT00739674|12014254|FG000|Overall Study|Erectile dysfunction|0
7606817|NCT00739674|12014255|FG001|Overall Study|Erectile dysfunction|1
7606818|NCT00546754|12014263|FG000|Overall Study|Serious Adverse Event|1
7606819|NCT00546754|12014264|FG001|Overall Study|Serious Adverse Event|1
7606820|NCT00546754|12014263|FG000|Overall Study|Adverse Event|11
7606821|NCT00546754|12014264|FG001|Overall Study|Adverse Event|16
7606822|NCT00546754|12014263|FG000|Overall Study|Lack of Efficacy|1
7606823|NCT00546754|12014264|FG001|Overall Study|Lack of Efficacy|1
7606824|NCT00546754|12014263|FG000|Overall Study|Lost to Follow-up|9
7606825|NCT00546754|12014264|FG001|Overall Study|Lost to Follow-up|15
7606826|NCT00546754|12014263|FG000|Overall Study|Protocol Violation|3
7606827|NCT00546754|12014264|FG001|Overall Study|Protocol Violation|0
7606828|NCT00546754|12014263|FG000|Overall Study|Withdrawal by Subject|6
7606829|NCT00546754|12014264|FG001|Overall Study|Withdrawal by Subject|7
7606830|NCT00546754|12014263|FG000|Overall Study|Dyspnea|1
7606831|NCT00546754|12014264|FG001|Overall Study|Dyspnea|0
7606832|NCT00546754|12014263|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
7776376|NCT00923091|12222684|FG002|Period V (Double -Blind)|Protocol Violation|0
7606833|NCT00546754|12014264|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
7606834|NCT00546754|12014263|FG000|Overall Study|Hip Replacement|1
7606835|NCT00546754|12014264|FG001|Overall Study|Hip Replacement|0
7606836|NCT00546754|12014263|FG000|Overall Study|Suicide|1
7606837|NCT00546754|12014264|FG001|Overall Study|Suicide|0
7606838|NCT00546754|12014263|FG000|Overall Study|Missing Cooperation|1
7606839|NCT00546754|12014264|FG001|Overall Study|Missing Cooperation|0
7606840|NCT00546754|12014263|FG000|Overall Study|Elevated Creatinine and Potassium levels|0
7606841|NCT00546754|12014264|FG001|Overall Study|Elevated Creatinine and Potassium levels|1
7606842|NCT00546754|12014263|FG000|Overall Study|Patient's Decision|0
7606843|NCT00546754|12014264|FG001|Overall Study|Patient's Decision|1
7606844|NCT00546754|12014263|FG000|Overall Study|Missing|14
7606845|NCT00546754|12014264|FG001|Overall Study|Missing|7
7606846|NCT00479713|12014272|FG000|Overall Study|Adverse Event|8
7776377|NCT00923091|12222685|FG003|Period V (Double -Blind)|Protocol Violation|0
7776378|NCT00923091|12222686|FG004|Period V (Double -Blind)|Protocol Violation|0
7776379|NCT00923091|12222687|FG005|Period V (Double -Blind)|Protocol Violation|0
7776380|NCT00923091|12222688|FG006|Period V (Double -Blind)|Protocol Violation|0
7776381|NCT00923091|12222689|FG007|Period V (Double -Blind)|Protocol Violation|0
7776382|NCT00923091|12222690|FG008|Period V (Double -Blind)|Protocol Violation|0
7776383|NCT00923091|12222691|FG009|Period V (Double -Blind)|Protocol Violation|0
7776384|NCT00923091|12222692|FG010|Period V (Double -Blind)|Protocol Violation|0
7776385|NCT00923091|12222693|FG011|Period V (Double -Blind)|Protocol Violation|0
7776386|NCT00923091|12222694|FG012|Period V (Double -Blind)|Protocol Violation|1
7776387|NCT00923091|12222682|FG000|Period V (Double -Blind)|Lost to Follow-up|0
7776388|NCT00923091|12222683|FG001|Period V (Double -Blind)|Lost to Follow-up|0
7776389|NCT00923091|12222684|FG002|Period V (Double -Blind)|Lost to Follow-up|0
7776390|NCT00923091|12222685|FG003|Period V (Double -Blind)|Lost to Follow-up|0
7776391|NCT00923091|12222686|FG004|Period V (Double -Blind)|Lost to Follow-up|0
7776392|NCT00923091|12222687|FG005|Period V (Double -Blind)|Lost to Follow-up|0
7776393|NCT00923091|12222688|FG006|Period V (Double -Blind)|Lost to Follow-up|0
7606847|NCT00479713|12014273|FG001|Overall Study|Adverse Event|6
7606848|NCT00479713|12014272|FG000|Overall Study|Death|1
7606849|NCT00479713|12014273|FG001|Overall Study|Death|0
7606850|NCT00479713|12014272|FG000|Overall Study|Lost to Follow-up|0
7606851|NCT00479713|12014273|FG001|Overall Study|Lost to Follow-up|1
7606852|NCT00479713|12014272|FG000|Overall Study|Protocol Violation|0
7606853|NCT00479713|12014273|FG001|Overall Study|Protocol Violation|1
7606854|NCT00479713|12014272|FG000|Overall Study|Withdrawal by Subject|4
7606855|NCT00479713|12014273|FG001|Overall Study|Withdrawal by Subject|1
7606856|NCT00406783|12014281|FG000|Overall Study|Adverse Event|4
7606857|NCT00406783|12014282|FG001|Overall Study|Adverse Event|4
7606858|NCT00406783|12014281|FG000|Overall Study|Treatment Failure|2
7606859|NCT00406783|12014282|FG001|Overall Study|Treatment Failure|3
7606860|NCT00406783|12014281|FG000|Overall Study|Lost to Follow-up|3
7606861|NCT00406783|12014282|FG001|Overall Study|Lost to Follow-up|0
7606862|NCT00406783|12014281|FG000|Overall Study|Withdrawal by Subject|1
7606863|NCT00406783|12014282|FG001|Overall Study|Withdrawal by Subject|4
7606864|NCT00406783|12014281|FG000|Overall Study|Protocol Violation|4
7606865|NCT00406783|12014282|FG001|Overall Study|Protocol Violation|4
7606866|NCT00405964|12014290|FG000|Overall Study|Treatment Failure|17
7606867|NCT00405964|12014291|FG001|Overall Study|Treatment Failure|45
7606868|NCT00405964|12014290|FG000|Overall Study|Adverse Event|7
7606869|NCT00405964|12014291|FG001|Overall Study|Adverse Event|16
7606870|NCT00405964|12014290|FG000|Overall Study|Lost to Follow-up|5
7606871|NCT00405964|12014291|FG001|Overall Study|Lost to Follow-up|5
7606872|NCT00405964|12014290|FG000|Overall Study|Withdrawal by Subject|19
7606873|NCT00405964|12014291|FG001|Overall Study|Withdrawal by Subject|23
7606874|NCT00405964|12014290|FG000|Overall Study|Protocol Violation|11
7606875|NCT00405964|12014291|FG001|Overall Study|Protocol Violation|6
7606876|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11
7606877|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5
7606878|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7
7606879|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14
7606880|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13
7606881|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
7606882|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
7606883|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
7606884|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
7606885|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
7606886|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
7606887|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
7606888|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
7606889|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
7606890|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
7606891|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
7606892|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
7606893|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
7606894|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
7606895|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
7606896|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
7606897|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
7606898|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
7606899|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
7606900|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
7606901|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
7606902|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
7606903|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
7606904|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
7606905|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
7606906|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
7606907|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
7606908|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
7606909|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
7606910|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
7606911|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Administrative|1
7606912|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Administrative|3
7606913|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Administrative|3
7606914|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Administrative|3
7606915|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Administrative|3
7606916|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Ongoing|1
7606917|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Ongoing|0
7606918|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Ongoing|0
7606919|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Ongoing|0
7606920|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Ongoing|0
7606921|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Adverse Event|6
7606922|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Adverse Event|7
7606923|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Adverse Event|10
7606924|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Adverse Event|1
7606925|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Adverse Event|0
7606926|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0
7606927|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2
7606928|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4
7606929|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1
7606930|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0
7606931|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2
7606932|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0
7606933|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1
7606934|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1
7606935|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0
7606936|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
7606937|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
7606938|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
7606939|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
7606940|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
7606941|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1
7606942|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1
7606943|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1
7606944|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1
7606945|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0
7606946|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2
7606947|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1
7606948|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1
7606949|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4
7606950|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0
7606951|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
7606952|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
7606953|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
7606954|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
7606955|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
7606956|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Administrative|1
7606957|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Administrative|2
7606958|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Administrative|3
7606959|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Administrative|1
7606960|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Administrative|0
7606961|NCT00383552|12014322|FG000|Overall Study|Adverse Event|7
7606962|NCT00383552|12014323|FG001|Overall Study|Adverse Event|6
7606963|NCT00383552|12014324|FG002|Overall Study|Adverse Event|9
7606964|NCT00383552|12014325|FG003|Overall Study|Adverse Event|6
7606965|NCT00383552|12014322|FG000|Overall Study|Lack of Efficacy|4
7606966|NCT00383552|12014323|FG001|Overall Study|Lack of Efficacy|13
7606967|NCT00383552|12014324|FG002|Overall Study|Lack of Efficacy|29
7606968|NCT00383552|12014325|FG003|Overall Study|Lack of Efficacy|42
7606969|NCT00383552|12014322|FG000|Overall Study|Lost to Follow-up|0
7606970|NCT00383552|12014323|FG001|Overall Study|Lost to Follow-up|1
7606971|NCT00383552|12014324|FG002|Overall Study|Lost to Follow-up|5
7606972|NCT00383552|12014325|FG003|Overall Study|Lost to Follow-up|1
7606973|NCT00383552|12014322|FG000|Overall Study|Did not wish to continue (unrelated)|4
7606974|NCT00383552|12014323|FG001|Overall Study|Did not wish to continue (unrelated)|9
7606975|NCT00383552|12014324|FG002|Overall Study|Did not wish to continue (unrelated)|5
7606976|NCT00383552|12014325|FG003|Overall Study|Did not wish to continue (unrelated)|6
7606977|NCT00383552|12014322|FG000|Overall Study|Did not wish to continue (related)|1
7606978|NCT00383552|12014323|FG001|Overall Study|Did not wish to continue (related)|0
7606979|NCT00383552|12014324|FG002|Overall Study|Did not wish to continue (related)|2
7606980|NCT00383552|12014325|FG003|Overall Study|Did not wish to continue (related)|3
7606981|NCT00383552|12014322|FG000|Overall Study|Noncompliance with the protocol|11
7606982|NCT00383552|12014323|FG001|Overall Study|Noncompliance with the protocol|6
7606983|NCT00383552|12014324|FG002|Overall Study|Noncompliance with the protocol|8
7606984|NCT00383552|12014325|FG003|Overall Study|Noncompliance with the protocol|10
7606985|NCT00383552|12014322|FG000|Overall Study|Did not meet protocol eligibility|8
7606986|NCT00383552|12014323|FG001|Overall Study|Did not meet protocol eligibility|6
7606987|NCT00383552|12014324|FG002|Overall Study|Did not meet protocol eligibility|2
7606988|NCT00383552|12014325|FG003|Overall Study|Did not meet protocol eligibility|3
7606989|NCT00383552|12014322|FG000|Overall Study|Administrative|1
7606990|NCT00383552|12014323|FG001|Overall Study|Administrative|0
7606991|NCT00383552|12014324|FG002|Overall Study|Administrative|1
7606992|NCT00383552|12014325|FG003|Overall Study|Administrative|1
7606993|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10
7606994|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2
7606995|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8
7606996|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6
7606997|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8
7606998|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
7606999|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
7607000|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
7607001|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
7607002|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
7607003|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
7607004|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
7607005|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
7607006|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
7607007|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
7607008|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
7607009|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
7607010|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
7607011|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
7607012|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
7607013|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
7607014|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
7607015|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
7607016|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
7607017|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
7607018|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
7607019|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
7607020|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
7607021|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
7607022|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
7776394|NCT00923091|12222689|FG007|Period V (Double -Blind)|Lost to Follow-up|0
7776395|NCT00923091|12222690|FG008|Period V (Double -Blind)|Lost to Follow-up|0
7776396|NCT00923091|12222691|FG009|Period V (Double -Blind)|Lost to Follow-up|0
7776397|NCT00923091|12222692|FG010|Period V (Double -Blind)|Lost to Follow-up|1
7776398|NCT00923091|12222693|FG011|Period V (Double -Blind)|Lost to Follow-up|0
7776399|NCT00923091|12222694|FG012|Period V (Double -Blind)|Lost to Follow-up|0
7776400|NCT00923091|12222682|FG000|Period VI (Open-Label)|Adverse Event|17
7776401|NCT00923091|12222683|FG001|Period VI (Open-Label)|Adverse Event|0
7776402|NCT00923091|12222684|FG002|Period VI (Open-Label)|Adverse Event|4
7776403|NCT00923091|12222685|FG003|Period VI (Open-Label)|Adverse Event|1
7776404|NCT00923091|12222686|FG004|Period VI (Open-Label)|Adverse Event|1
7776405|NCT00923091|12222687|FG005|Period VI (Open-Label)|Adverse Event|0
7776406|NCT00923091|12222688|FG006|Period VI (Open-Label)|Adverse Event|0
7776407|NCT00923091|12222689|FG007|Period VI (Open-Label)|Adverse Event|0
7776408|NCT00923091|12222690|FG008|Period VI (Open-Label)|Adverse Event|0
7776409|NCT00923091|12222691|FG009|Period VI (Open-Label)|Adverse Event|0
7776410|NCT00923091|12222692|FG010|Period VI (Open-Label)|Adverse Event|0
7776411|NCT00923091|12222693|FG011|Period VI (Open-Label)|Adverse Event|0
7776412|NCT00923091|12222694|FG012|Period VI (Open-Label)|Adverse Event|0
7776413|NCT00923091|12222682|FG000|Period VI (Open-Label)|Withdrawal by Subject|15
7776414|NCT00923091|12222683|FG001|Period VI (Open-Label)|Withdrawal by Subject|7
7607023|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
7607024|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
7607025|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
7607026|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
7607027|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
7607028|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Administrative|5
7607029|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Administrative|3
7607030|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Administrative|1
7607031|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Administrative|1
7607032|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Administrative|1
7607033|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Adverse Event|4
7607034|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Adverse Event|2
7607035|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Adverse Event|5
7607036|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Adverse Event|5
7607037|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Adverse Event|1
7607038|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1
7607039|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1
7607040|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1
7607041|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1
7607042|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0
7607043|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0
7607044|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2
7607045|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1
7607046|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0
7607047|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1
7607048|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
7607049|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
7607050|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
7607051|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
7607052|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
7607053|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1
7607054|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0
7607055|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2
7607056|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0
7607057|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1
7607058|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4
7607059|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1
7607060|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1
7607061|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1
7607062|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0
7607063|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
7607064|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
7607065|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
7607066|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
7607067|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
7607068|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Administrative|1
7607069|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Administrative|1
7776415|NCT00923091|12222684|FG002|Period VI (Open-Label)|Withdrawal by Subject|5
7776416|NCT00923091|12222685|FG003|Period VI (Open-Label)|Withdrawal by Subject|0
7776417|NCT00923091|12222686|FG004|Period VI (Open-Label)|Withdrawal by Subject|1
7776418|NCT00923091|12222687|FG005|Period VI (Open-Label)|Withdrawal by Subject|0
7776419|NCT00923091|12222688|FG006|Period VI (Open-Label)|Withdrawal by Subject|0
7776420|NCT00923091|12222689|FG007|Period VI (Open-Label)|Withdrawal by Subject|0
7776421|NCT00923091|12222690|FG008|Period VI (Open-Label)|Withdrawal by Subject|0
7776422|NCT00923091|12222691|FG009|Period VI (Open-Label)|Withdrawal by Subject|0
7776423|NCT00923091|12222692|FG010|Period VI (Open-Label)|Withdrawal by Subject|0
7776424|NCT00923091|12222693|FG011|Period VI (Open-Label)|Withdrawal by Subject|0
7776425|NCT00923091|12222694|FG012|Period VI (Open-Label)|Withdrawal by Subject|0
7776426|NCT00923091|12222682|FG000|Period VI (Open-Label)|Protocol Violation|6
7776427|NCT00923091|12222683|FG001|Period VI (Open-Label)|Protocol Violation|1
7776428|NCT00923091|12222684|FG002|Period VI (Open-Label)|Protocol Violation|3
7776429|NCT00923091|12222685|FG003|Period VI (Open-Label)|Protocol Violation|1
7776430|NCT00923091|12222686|FG004|Period VI (Open-Label)|Protocol Violation|4
7776431|NCT00923091|12222687|FG005|Period VI (Open-Label)|Protocol Violation|0
7776432|NCT00923091|12222688|FG006|Period VI (Open-Label)|Protocol Violation|0
7776433|NCT00923091|12222689|FG007|Period VI (Open-Label)|Protocol Violation|0
7776434|NCT00923091|12222690|FG008|Period VI (Open-Label)|Protocol Violation|0
7776435|NCT00923091|12222691|FG009|Period VI (Open-Label)|Protocol Violation|0
7776436|NCT00923091|12222692|FG010|Period VI (Open-Label)|Protocol Violation|0
7776437|NCT00923091|12222693|FG011|Period VI (Open-Label)|Protocol Violation|0
7776438|NCT00923091|12222694|FG012|Period VI (Open-Label)|Protocol Violation|0
7776439|NCT00923091|12222682|FG000|Period VI (Open-Label)|Lost to Follow-up|1
7776440|NCT00923091|12222683|FG001|Period VI (Open-Label)|Lost to Follow-up|0
7776441|NCT00923091|12222684|FG002|Period VI (Open-Label)|Lost to Follow-up|1
7776442|NCT00923091|12222685|FG003|Period VI (Open-Label)|Lost to Follow-up|0
7776443|NCT00923091|12222686|FG004|Period VI (Open-Label)|Lost to Follow-up|0
7776444|NCT00923091|12222687|FG005|Period VI (Open-Label)|Lost to Follow-up|0
7776445|NCT00923091|12222688|FG006|Period VI (Open-Label)|Lost to Follow-up|0
7776446|NCT00923091|12222689|FG007|Period VI (Open-Label)|Lost to Follow-up|0
7776447|NCT00923091|12222690|FG008|Period VI (Open-Label)|Lost to Follow-up|0
7776448|NCT00923091|12222691|FG009|Period VI (Open-Label)|Lost to Follow-up|0
7607070|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Administrative|0
7607071|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Administrative|1
7607072|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Administrative|0
7607073|NCT00381485|12014364|FG000|Open-Label Run-In Period|Adverse Event|9
7607074|NCT00381485|12014365|FG001|Open-Label Run-In Period|Adverse Event|0
7607075|NCT00381485|12014366|FG002|Open-Label Run-In Period|Adverse Event|0
7607076|NCT00381485|12014367|FG003|Open-Label Run-In Period|Adverse Event|0
7607077|NCT00381485|12014364|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76
7607078|NCT00381485|12014365|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0
7607079|NCT00381485|12014366|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0
7607080|NCT00381485|12014367|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0
7607081|NCT00381485|12014364|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
7607082|NCT00381485|12014365|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
7607083|NCT00381485|12014366|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
7607084|NCT00381485|12014367|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
7607085|NCT00381485|12014364|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
7607086|NCT00381485|12014365|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
7607087|NCT00381485|12014366|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
7607088|NCT00381485|12014367|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
7607089|NCT00381485|12014364|FG000|Open-Label Run-In Period|Lost to Follow-up|3
7607090|NCT00381485|12014365|FG001|Open-Label Run-In Period|Lost to Follow-up|0
7607091|NCT00381485|12014366|FG002|Open-Label Run-In Period|Lost to Follow-up|0
7607092|NCT00381485|12014367|FG003|Open-Label Run-In Period|Lost to Follow-up|0
7607093|NCT00381485|12014364|FG000|Open-Label Run-In Period|Treatment failure|1
7607094|NCT00381485|12014365|FG001|Open-Label Run-In Period|Treatment failure|0
7607095|NCT00381485|12014366|FG002|Open-Label Run-In Period|Treatment failure|0
7607096|NCT00381485|12014367|FG003|Open-Label Run-In Period|Treatment failure|0
7607097|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Adverse Event|0
7607098|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Adverse Event|2
7607099|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Adverse Event|2
7607100|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Adverse Event|5
7607101|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
7607102|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Lack of Efficacy|8
7607103|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Lack of Efficacy|11
7607104|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Lack of Efficacy|13
7607105|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7607106|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
7607107|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Lost to Follow-up|1
7607108|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
7607109|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0
7607110|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9
7607111|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3
7607112|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3
7607113|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0
7607114|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5
7607115|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7
7607116|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5
7607117|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
7607118|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
7607119|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
7607120|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
7607121|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
7607122|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
7607123|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
7776449|NCT00923091|12222692|FG010|Period VI (Open-Label)|Lost to Follow-up|0
7607124|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
7607125|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Administrative|0
7607126|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Administrative|1
7607127|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Administrative|0
7607128|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Administrative|1
7607129|NCT00379288|12014380|FG000|Overall Study|Adverse Event|5
7607130|NCT00379288|12014381|FG001|Overall Study|Adverse Event|6
7607131|NCT00379288|12014382|FG002|Overall Study|Adverse Event|2
7607132|NCT00379288|12014383|FG003|Overall Study|Adverse Event|0
7607133|NCT00379288|12014380|FG000|Overall Study|Treatment Failure|0
7607134|NCT00379288|12014381|FG001|Overall Study|Treatment Failure|1
7607135|NCT00379288|12014382|FG002|Overall Study|Treatment Failure|0
7607136|NCT00379288|12014383|FG003|Overall Study|Treatment Failure|1
7607137|NCT00379288|12014380|FG000|Overall Study|Lost to Follow-up|3
7607138|NCT00379288|12014381|FG001|Overall Study|Lost to Follow-up|3
7607139|NCT00379288|12014382|FG002|Overall Study|Lost to Follow-up|2
7607140|NCT00379288|12014383|FG003|Overall Study|Lost to Follow-up|0
7607141|NCT00379288|12014380|FG000|Overall Study|Subject withdrew-unrelated to study drug|0
7607142|NCT00379288|12014381|FG001|Overall Study|Subject withdrew-unrelated to study drug|3
7607143|NCT00379288|12014382|FG002|Overall Study|Subject withdrew-unrelated to study drug|4
7607144|NCT00379288|12014383|FG003|Overall Study|Subject withdrew-unrelated to study drug|2
7607145|NCT00379288|12014380|FG000|Overall Study|Subject withdrew-related to study drug|1
7607146|NCT00379288|12014381|FG001|Overall Study|Subject withdrew-related to study drug|0
7607147|NCT00379288|12014382|FG002|Overall Study|Subject withdrew-related to study drug|0
7607148|NCT00379288|12014383|FG003|Overall Study|Subject withdrew-related to study drug|1
7607149|NCT00379288|12014380|FG000|Overall Study|Noncompliance with protocol|8
7607150|NCT00379288|12014381|FG001|Overall Study|Noncompliance with protocol|6
7607151|NCT00379288|12014382|FG002|Overall Study|Noncompliance with protocol|2
7776450|NCT00923091|12222693|FG011|Period VI (Open-Label)|Lost to Follow-up|0
7776451|NCT00923091|12222694|FG012|Period VI (Open-Label)|Lost to Follow-up|0
7776452|NCT00923091|12222682|FG000|Period VI (Open-Label)|Other Reason|0
7776453|NCT00923091|12222683|FG001|Period VI (Open-Label)|Other Reason|0
7607152|NCT00379288|12014383|FG003|Overall Study|Noncompliance with protocol|1
7607153|NCT00379288|12014380|FG000|Overall Study|Did not meet protocol eligibility|0
7607154|NCT00379288|12014381|FG001|Overall Study|Did not meet protocol eligibility|1
7607155|NCT00379288|12014382|FG002|Overall Study|Did not meet protocol eligibility|0
7607156|NCT00379288|12014383|FG003|Overall Study|Did not meet protocol eligibility|2
7607157|NCT00379288|12014380|FG000|Overall Study|Administrative|2
7607158|NCT00379288|12014381|FG001|Overall Study|Administrative|2
7607159|NCT00379288|12014382|FG002|Overall Study|Administrative|0
7607160|NCT00379288|12014383|FG003|Overall Study|Administrative|1
7607161|NCT00378378|12014396|FG000|Overall Study|Withdrawal by Subject|0
7607162|NCT00378378|12014397|FG001|Overall Study|Withdrawal by Subject|1
7607163|NCT00378378|12014398|FG002|Overall Study|Withdrawal by Subject|0
7607164|NCT00378378|12014396|FG000|Overall Study|Treatment Failure|0
7607165|NCT00378378|12014397|FG001|Overall Study|Treatment Failure|0
7607166|NCT00378378|12014398|FG002|Overall Study|Treatment Failure|1
7607167|NCT00378378|12014396|FG000|Overall Study|Non-compliance with protocol|0
7607168|NCT00378378|12014397|FG001|Overall Study|Non-compliance with protocol|0
7607169|NCT00378378|12014398|FG002|Overall Study|Non-compliance with protocol|1
7607170|NCT00089895|12014408|FG000|Overall Study|Consent Withdrawn|11
7607171|NCT00089895|12014409|FG001|Overall Study|Consent Withdrawn|14
7607172|NCT00089895|12014408|FG000|Overall Study|Technical reason|7
7607173|NCT00089895|12014409|FG001|Overall Study|Technical reason|2
7607174|NCT00089895|12014408|FG000|Overall Study|Surgery|0
7607175|NCT00089895|12014409|FG001|Overall Study|Surgery|1
7607176|NCT00089895|12014408|FG000|Overall Study|Bleeding|0
7607177|NCT00089895|12014409|FG001|Overall Study|Bleeding|2
7607178|NCT00089895|12014408|FG000|Overall Study|Physician Decision|3
7607179|NCT00089895|12014409|FG001|Overall Study|Physician Decision|7
7607180|NCT00089895|12014408|FG000|Overall Study|Exclusion criteria met|6
7776454|NCT00923091|12222684|FG002|Period VI (Open-Label)|Other Reason|0
7776455|NCT00923091|12222685|FG003|Period VI (Open-Label)|Other Reason|1
7776456|NCT00923091|12222686|FG004|Period VI (Open-Label)|Other Reason|1
7776457|NCT00923091|12222687|FG005|Period VI (Open-Label)|Other Reason|0
7776458|NCT00923091|12222688|FG006|Period VI (Open-Label)|Other Reason|0
7776459|NCT00923091|12222689|FG007|Period VI (Open-Label)|Other Reason|0
7776460|NCT00923091|12222690|FG008|Period VI (Open-Label)|Other Reason|0
7776461|NCT00923091|12222691|FG009|Period VI (Open-Label)|Other Reason|0
7776462|NCT00923091|12222692|FG010|Period VI (Open-Label)|Other Reason|0
7776463|NCT00923091|12222693|FG011|Period VI (Open-Label)|Other Reason|0
7776464|NCT00923091|12222694|FG012|Period VI (Open-Label)|Other Reason|0
7776465|NCT00923130|12222728|FG000|Overall Study|Stopped treatment due to progression|17
7776466|NCT00923130|12222728|FG000|Overall Study|Death|1
7776467|NCT00923130|12222728|FG000|Overall Study|Discontinued treatment due to toxicities|3
7776468|NCT00923130|12222728|FG000|Overall Study|Switched to alternative treatment|2
7776469|NCT00923130|12222728|FG000|Overall Study|Refused further treatment|2
7776470|NCT00923156|12222735|FG000|Overall Study|Adverse Event|0
7776471|NCT00923156|12222736|FG001|Overall Study|Adverse Event|2
7776472|NCT00923156|12222737|FG002|Overall Study|Adverse Event|1
7776473|NCT00923156|12222735|FG000|Overall Study|Abnormal laboratory values|0
7776474|NCT00923156|12222736|FG001|Overall Study|Abnormal laboratory values|0
7776475|NCT00923156|12222737|FG002|Overall Study|Abnormal laboratory values|1
7776476|NCT00923156|12222735|FG000|Overall Study|Withdrawal by Subject|0
7776477|NCT00923156|12222736|FG001|Overall Study|Withdrawal by Subject|1
7776478|NCT00923156|12222737|FG002|Overall Study|Withdrawal by Subject|0
7607181|NCT00089895|12014409|FG001|Overall Study|Exclusion criteria met|6
7776479|NCT00923156|12222735|FG000|Overall Study|Death|0
7776480|NCT00923156|12222736|FG001|Overall Study|Death|1
7776481|NCT00923156|12222737|FG002|Overall Study|Death|0
7776482|NCT00923156|12222735|FG000|Overall Study|Lack of Efficacy|0
7776483|NCT00923156|12222736|FG001|Overall Study|Lack of Efficacy|0
7607182|NCT00089895|12014408|FG000|Overall Study|Not otherwise specified|4
7607183|NCT00089895|12014409|FG001|Overall Study|Not otherwise specified|8
7607184|NCT00089895|12014408|FG000|Overall Study|Missing|4
7607185|NCT00089895|12014409|FG001|Overall Study|Missing|2
7607186|NCT02577354|12014417|FG000|Overall Study|Lack of Efficacy|4
7607187|NCT02577354|12014418|FG001|Overall Study|Lack of Efficacy|4
7607188|NCT02577354|12014417|FG000|Overall Study|Lost to Follow-up|3
7607189|NCT02577354|12014418|FG001|Overall Study|Lost to Follow-up|1
7607190|NCT02577354|12014417|FG000|Overall Study|Missed Visit|4
7607191|NCT02577354|12014418|FG001|Overall Study|Missed Visit|3
7607192|NCT02577354|12014417|FG000|Overall Study|Adverse Event|4
7607193|NCT02577354|12014418|FG001|Overall Study|Adverse Event|5
7607194|NCT02471807|12014434|FG000|Overall Study|Death|14
7607195|NCT02471807|12014434|FG000|Overall Study|Withdrawal by Subject|1
7607196|NCT02471807|12014434|FG000|Overall Study|Explant|5
7607197|NCT02471807|12014434|FG000|Overall Study|Visits not yet due|2
7607198|NCT02471807|12014434|FG000|Overall Study|Missed Visit|1
7776484|NCT00923156|12222737|FG002|Overall Study|Lack of Efficacy|1
7776485|NCT00923195|12222747|FG000|Overall Study|Death|0
7607202|NCT01453946|12014460|FG000|Overall Study|Did not receive drug for the taper phase|1
7607203|NCT01453946|12014460|FG000|Overall Study|Protocol Violation|2
7607204|NCT01453946|12014460|FG000|Overall Study|Lack of Efficacy|3
7607205|NCT01453946|12014460|FG000|Overall Study|Adverse Event|3
7607206|NCT01444092|12014464|FG000|Overall Study|Adverse Event|8
7607207|NCT01444092|12014464|FG000|Overall Study|Protocol Violation|1
7607208|NCT01444092|12014464|FG000|Overall Study|Withdrawal by Subject|1
7607209|NCT01444092|12014464|FG000|Overall Study|Other Eligibility criteria|7
7607210|NCT01265784|12014471|FG000|Overall Study|Lost to Follow-up|5
7607211|NCT01265784|12014472|FG001|Overall Study|Lost to Follow-up|3
7607212|NCT01265784|12014473|FG002|Overall Study|Lost to Follow-up|2
7607213|NCT01265784|12014471|FG000|Overall Study|Withdrawal by Subject|0
7607214|NCT01265784|12014472|FG001|Overall Study|Withdrawal by Subject|5
7607215|NCT01265784|12014473|FG002|Overall Study|Withdrawal by Subject|0
7607216|NCT01265784|12014471|FG000|Overall Study|Physician Decision|1
7607217|NCT01265784|12014472|FG001|Overall Study|Physician Decision|0
7607218|NCT01265784|12014473|FG002|Overall Study|Physician Decision|1
7607219|NCT01265784|12014471|FG000|Overall Study|Adverse Event|1
7607220|NCT01265784|12014472|FG001|Overall Study|Adverse Event|0
7607221|NCT01265784|12014473|FG002|Overall Study|Adverse Event|0
7607222|NCT01265784|12014471|FG000|Overall Study|Death|3
7607223|NCT01265784|12014472|FG001|Overall Study|Death|0
7607224|NCT01265784|12014473|FG002|Overall Study|Death|0
7607225|NCT01265784|12014471|FG000|Overall Study|Protocol Violation|2
7607226|NCT01265784|12014472|FG001|Overall Study|Protocol Violation|0
7607227|NCT01265784|12014473|FG002|Overall Study|Protocol Violation|0
7607228|NCT01265784|12014471|FG000|Overall Study|Incorrectly Randomized|0
7607229|NCT01265784|12014472|FG001|Overall Study|Incorrectly Randomized|0
7607230|NCT01265784|12014473|FG002|Overall Study|Incorrectly Randomized|1
7607231|NCT00577577|12014483|FG000|Overall Study|Adverse Event|3
7607232|NCT00577577|12014484|FG001|Overall Study|Adverse Event|2
7607233|NCT00577577|12014483|FG000|Overall Study|Lost to Follow-up|1
7607234|NCT00577577|12014484|FG001|Overall Study|Lost to Follow-up|0
7607235|NCT00577577|12014483|FG000|Overall Study|Protocol Violation|0
7607236|NCT00577577|12014484|FG001|Overall Study|Protocol Violation|3
7607237|NCT00577577|12014483|FG000|Overall Study|Transportation|1
7607238|NCT00577577|12014484|FG001|Overall Study|Transportation|0
7607239|NCT00392327|12014498|FG000|Overall Study|Death|1
7607240|NCT00392327|12014499|FG001|Overall Study|Death|0
7607241|NCT00392327|12014500|FG002|Overall Study|Death|1
7607242|NCT00392327|12014501|FG003|Overall Study|Death|0
7607243|NCT00392327|12014502|FG004|Overall Study|Death|0
7607244|NCT00392327|12014503|FG005|Overall Study|Death|0
7607245|NCT00392327|12014504|FG006|Overall Study|Death|0
7607246|NCT00392327|12014505|FG007|Overall Study|Death|0
7607247|NCT00392327|12014498|FG000|Overall Study|Lack of Efficacy|8
7607248|NCT00392327|12014499|FG001|Overall Study|Lack of Efficacy|8
7607249|NCT00392327|12014500|FG002|Overall Study|Lack of Efficacy|9
7607250|NCT00392327|12014501|FG003|Overall Study|Lack of Efficacy|6
7607251|NCT00392327|12014502|FG004|Overall Study|Lack of Efficacy|3
7607252|NCT00392327|12014503|FG005|Overall Study|Lack of Efficacy|3
7607253|NCT00392327|12014504|FG006|Overall Study|Lack of Efficacy|3
7607254|NCT00392327|12014505|FG007|Overall Study|Lack of Efficacy|3
7607255|NCT00392327|12014498|FG000|Overall Study|Physician Decision|3
7607256|NCT00392327|12014499|FG001|Overall Study|Physician Decision|5
7607257|NCT00392327|12014500|FG002|Overall Study|Physician Decision|2
7607258|NCT00392327|12014501|FG003|Overall Study|Physician Decision|2
7607259|NCT00392327|12014502|FG004|Overall Study|Physician Decision|0
7607260|NCT00392327|12014503|FG005|Overall Study|Physician Decision|1
7607261|NCT00392327|12014504|FG006|Overall Study|Physician Decision|5
7607262|NCT00392327|12014505|FG007|Overall Study|Physician Decision|3
7607263|NCT00392327|12014498|FG000|Overall Study|Protocol Violation|0
7607264|NCT00392327|12014499|FG001|Overall Study|Protocol Violation|0
7607265|NCT00392327|12014500|FG002|Overall Study|Protocol Violation|1
7607266|NCT00392327|12014501|FG003|Overall Study|Protocol Violation|0
7607267|NCT00392327|12014502|FG004|Overall Study|Protocol Violation|0
7607268|NCT00392327|12014503|FG005|Overall Study|Protocol Violation|0
7607269|NCT00392327|12014504|FG006|Overall Study|Protocol Violation|0
7607270|NCT00392327|12014505|FG007|Overall Study|Protocol Violation|0
7607271|NCT00392327|12014498|FG000|Overall Study|Withdrawal by Subject|3
7607272|NCT00392327|12014499|FG001|Overall Study|Withdrawal by Subject|2
7607273|NCT00392327|12014500|FG002|Overall Study|Withdrawal by Subject|4
7607274|NCT00392327|12014501|FG003|Overall Study|Withdrawal by Subject|6
7607275|NCT00392327|12014502|FG004|Overall Study|Withdrawal by Subject|0
7607276|NCT00392327|12014503|FG005|Overall Study|Withdrawal by Subject|1
7607277|NCT00392327|12014504|FG006|Overall Study|Withdrawal by Subject|1
7607278|NCT00392327|12014505|FG007|Overall Study|Withdrawal by Subject|5
7607279|NCT00392327|12014498|FG000|Overall Study|Ineligible|0
7607280|NCT00392327|12014499|FG001|Overall Study|Ineligible|4
7607281|NCT00392327|12014500|FG002|Overall Study|Ineligible|3
7607282|NCT00392327|12014501|FG003|Overall Study|Ineligible|2
7607283|NCT00392327|12014502|FG004|Overall Study|Ineligible|0
7607284|NCT00392327|12014503|FG005|Overall Study|Ineligible|0
7607285|NCT00392327|12014504|FG006|Overall Study|Ineligible|0
7607286|NCT00392327|12014505|FG007|Overall Study|Ineligible|0
7607287|NCT00085202|12014525|FG000|Overall Study|Still on therapy|2
7607288|NCT00085202|12014526|FG001|Overall Study|Still on therapy|0
7607289|NCT00085202|12014525|FG000|Overall Study|Bone involvement confirmed by bone scan|0
7607290|NCT00085202|12014526|FG001|Overall Study|Bone involvement confirmed by bone scan|1
7776486|NCT00923195|12222748|FG001|Overall Study|Death|1
7776487|NCT00923260|12222756|FG000|Overall Study|Lost to Follow-up|1
7776488|NCT00923260|12222757|FG001|Overall Study|Lost to Follow-up|1
7776489|NCT00923273|12222768|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
7776490|NCT00923273|12222769|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
7776491|NCT00923273|12222770|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
7776492|NCT00923273|12222771|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
7776493|NCT00923273|12222772|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
7776494|NCT00923273|12222768|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
7776495|NCT00923273|12222769|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
7776496|NCT00923273|12222770|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
7776497|NCT00923273|12222771|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
7776498|NCT00923273|12222772|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
7776499|NCT00923351|12222792|FG000|Overall Study|no apheresis/adequate tumor sample|0
7776500|NCT00923351|12222793|FG001|Overall Study|no apheresis/adequate tumor sample|0
7776501|NCT00923351|12222794|FG002|Overall Study|no apheresis/adequate tumor sample|12
7776502|NCT00923364|12222800|FG000|Overall Study|Death|3
7776503|NCT00923364|12222801|FG001|Overall Study|Death|0
7776504|NCT00923364|12222800|FG000|Overall Study|Did not go to transplant|1
7776505|NCT00923364|12222801|FG001|Overall Study|Did not go to transplant|0
7776506|NCT00923559|12222812|FG000|Overall Study|Lost to Follow-up|2
7776507|NCT00923559|12222813|FG001|Overall Study|Lost to Follow-up|3
7776508|NCT00923845|12222832|FG000|Induction Therapy|Poor performance status|0
7776509|NCT00923845|12222833|FG001|Induction Therapy|Poor performance status|2
7776510|NCT00923936|12222850|FG000|Overall Study|progressive disease on study|2
7776511|NCT00923936|12222851|FG001|Overall Study|progressive disease on study|1
7776512|NCT00923936|12222850|FG000|Overall Study|Adverse Event|2
7776513|NCT00923936|12222851|FG001|Overall Study|Adverse Event|1
7776514|NCT00923936|12222850|FG000|Overall Study|Lost to follow up|2
7776515|NCT00923936|12222851|FG001|Overall Study|Lost to follow up|0
7607291|NCT00085202|12014525|FG000|Overall Study|Excessive toxicity|6
7607292|NCT00085202|12014526|FG001|Overall Study|Excessive toxicity|5
7776516|NCT00923936|12222850|FG000|Overall Study|Continuing in follow up period|2
7776517|NCT00923936|12222851|FG001|Overall Study|Continuing in follow up period|1
7776518|NCT00923975|12222863|FG000|Overall Study|Did not meet inclusion criteria|1
7800046|NCT01090492|12257185|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0
7800047|NCT01090492|12257186|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0
7800048|NCT01090492|12257187|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0
7607293|NCT00085202|12014525|FG000|Overall Study|Non-specified|3
7776519|NCT00924287|12222910|FG000|Overall Study|Death|1
7776520|NCT00924313|12222914|FG000|Overall Study|not imaged due to failed tracer imaging|1
7607294|NCT00085202|12014526|FG001|Overall Study|Non-specified|5
7607295|NCT00085202|12014525|FG000|Overall Study|Withdrawal by Subject|2
7607296|NCT00085202|12014526|FG001|Overall Study|Withdrawal by Subject|1
7607297|NCT00085202|12014525|FG000|Overall Study|Physician Decision|4
7607298|NCT00085202|12014526|FG001|Overall Study|Physician Decision|1
7607299|NCT00085202|12014525|FG000|Overall Study|Progressive disease|1
7607300|NCT00085202|12014526|FG001|Overall Study|Progressive disease|11
7776521|NCT00924404|12222928|FG000|Overall Study|Lost to Follow-up|6
7776522|NCT00924404|12222929|FG001|Overall Study|Lost to Follow-up|4
7776523|NCT00924443|12222935|FG000|Overall Study|Physician Decision|2
7776524|NCT00924443|12222935|FG000|Overall Study|Protocol Violation|1
7607301|NCT04386616|12014627|FG000|Overall Study|Death|22
7607302|NCT04386616|12014628|FG001|Overall Study|Death|22
7607303|NCT04386616|12014629|FG002|Overall Study|Death|21
7607304|NCT04386616|12014627|FG000|Overall Study|Lost to Follow-up|5
7607305|NCT04386616|12014628|FG001|Overall Study|Lost to Follow-up|8
7607306|NCT04386616|12014629|FG002|Overall Study|Lost to Follow-up|6
7607307|NCT04386616|12014627|FG000|Overall Study|Withdrawal by Subject|2
7607308|NCT04386616|12014628|FG001|Overall Study|Withdrawal by Subject|4
7776525|NCT00924469|12222941|FG000|Overall Study|Adverse Event|2
7776526|NCT00924469|12222942|FG001|Overall Study|Adverse Event|0
7776527|NCT00924469|12222941|FG000|Overall Study|Withdrawal by Subject|0
7776528|NCT00924469|12222942|FG001|Overall Study|Withdrawal by Subject|1
7776529|NCT00924469|12222941|FG000|Overall Study|Lost to Follow-up|0
7776530|NCT00924469|12222942|FG001|Overall Study|Lost to Follow-up|1
7776531|NCT00924508|12222953|FG000|Overall Study|Withdrawal by Subject|3
7776532|NCT00924560|12222963|FG000|Overall Study|Did Not Meet Protocol Requirements|4
7776533|NCT00924560|12222964|FG001|Overall Study|Did Not Meet Protocol Requirements|2
7776534|NCT00924560|12222965|FG002|Overall Study|Did Not Meet Protocol Requirements|1
7776535|NCT00924560|12222963|FG000|Overall Study|Non Compliance with the Protocol|20
7776536|NCT00924560|12222964|FG001|Overall Study|Non Compliance with the Protocol|15
7776537|NCT00924560|12222965|FG002|Overall Study|Non Compliance with the Protocol|4
7776538|NCT00924560|12222963|FG000|Overall Study|Physician Decision|2
7776539|NCT00924560|12222964|FG001|Overall Study|Physician Decision|3
7776540|NCT00924560|12222965|FG002|Overall Study|Physician Decision|4
7776541|NCT00924560|12222963|FG000|Overall Study|Withdrawal by Subject|50
7776542|NCT00924560|12222964|FG001|Overall Study|Withdrawal by Subject|44
7776543|NCT00924560|12222965|FG002|Overall Study|Withdrawal by Subject|18
7776544|NCT00924560|12222963|FG000|Overall Study|Adverse Event|39
7776545|NCT00924560|12222964|FG001|Overall Study|Adverse Event|33
7776546|NCT00924560|12222965|FG002|Overall Study|Adverse Event|0
7776547|NCT00924560|12222963|FG000|Overall Study|Pregnancy|5
7776548|NCT00924560|12222964|FG001|Overall Study|Pregnancy|7
7776549|NCT00924560|12222965|FG002|Overall Study|Pregnancy|1
7776550|NCT00924560|12222963|FG000|Overall Study|Lost to Follow-up|78
7776551|NCT00924560|12222964|FG001|Overall Study|Lost to Follow-up|94
7776552|NCT00924560|12222965|FG002|Overall Study|Lost to Follow-up|45
7776553|NCT00924560|12222963|FG000|Overall Study|Miscellaneous Reasons|13
7776554|NCT00924560|12222964|FG001|Overall Study|Miscellaneous Reasons|10
7776555|NCT00924560|12222965|FG002|Overall Study|Miscellaneous Reasons|10
7776556|NCT00924638|12222992|FG000|Overall Study|Death|3
7776557|NCT00924638|12222993|FG001|Overall Study|Death|2
7776558|NCT00924638|12222992|FG000|Overall Study|Lost to Follow-up|1
7776559|NCT00924638|12222993|FG001|Overall Study|Lost to Follow-up|1
7776560|NCT00924638|12222992|FG000|Overall Study|Withdrawal by Subject|5
7776561|NCT00924638|12222993|FG001|Overall Study|Withdrawal by Subject|7
7776562|NCT00924638|12222992|FG000|Overall Study|Physician Decision|3
7776563|NCT00924638|12222993|FG001|Overall Study|Physician Decision|3
7776564|NCT00924651|12223001|FG000|Overall Study|Chemo started too soon|2
7776565|NCT00924651|12223002|FG001|Overall Study|Chemo started too soon|3
7776566|NCT00924651|12223001|FG000|Overall Study|No Reason|3
7776567|NCT00924651|12223002|FG001|Overall Study|No Reason|7
7776568|NCT00924651|12223001|FG000|Overall Study|Overwhelmed|6
7776569|NCT00924651|12223002|FG001|Overall Study|Overwhelmed|6
7776570|NCT00924651|12223001|FG000|Overall Study|Noncompliant|1
7776571|NCT00924651|12223002|FG001|Overall Study|Noncompliant|4
7776572|NCT00924651|12223001|FG000|Overall Study|Medical|1
7776573|NCT00924651|12223002|FG001|Overall Study|Medical|3
7776574|NCT00924651|12223001|FG000|Overall Study|Changed Mind|10
7776575|NCT00924651|12223002|FG001|Overall Study|Changed Mind|1
7776576|NCT00924651|12223001|FG000|Overall Study|Incomplete Form|2
7776577|NCT00924651|12223002|FG001|Overall Study|Incomplete Form|1
7776578|NCT00924664|12223010|FG000|Overall Study|Adverse Event|23
7776579|NCT00924664|12223011|FG001|Overall Study|Adverse Event|39
7776580|NCT00924664|12223010|FG000|Overall Study|Lack of Efficacy|10
7776581|NCT00924664|12223011|FG001|Overall Study|Lack of Efficacy|15
7776582|NCT00924664|12223010|FG000|Overall Study|Lost to Follow-up|10
7776583|NCT00924664|12223011|FG001|Overall Study|Lost to Follow-up|12
7776584|NCT00924664|12223010|FG000|Overall Study|Withdrawal by Subject|47
7607309|NCT04386616|12014629|FG002|Overall Study|Withdrawal by Subject|1
7776585|NCT00924664|12223011|FG001|Overall Study|Withdrawal by Subject|71
7776586|NCT00924664|12223010|FG000|Overall Study|Protocol Violation|2
7776587|NCT00924664|12223011|FG001|Overall Study|Protocol Violation|5
7776588|NCT00924664|12223010|FG000|Overall Study|Pregnancy|1
7776589|NCT00924664|12223011|FG001|Overall Study|Pregnancy|1
7607310|NCT04386616|12014627|FG000|Overall Study|Adverse Event|1
7607311|NCT04386616|12014628|FG001|Overall Study|Adverse Event|1
7607312|NCT04386616|12014629|FG002|Overall Study|Adverse Event|0
7607313|NCT04296942|12014662|FG000|Overall Study|Study closure by sponsor|1
7607314|NCT04296942|12014663|FG001|Overall Study|Study closure by sponsor|0
7607315|NCT04296942|12014664|FG002|Overall Study|Study closure by sponsor|0
7607316|NCT04278872|12014676|FG000|Overall Study|Adverse Event|1
7607317|NCT04278872|12014677|FG001|Overall Study|Adverse Event|0
7607318|NCT04278872|12014676|FG000|Overall Study|Protocol Violation|0
7607319|NCT04278872|12014677|FG001|Overall Study|Protocol Violation|1
7607320|NCT04278872|12014676|FG000|Overall Study|Study Termination|2
7607321|NCT04278872|12014677|FG001|Overall Study|Study Termination|0
7607322|NCT04213807|12014686|FG000|Overall Study|Physician Decision|0
7607323|NCT04213807|12014687|FG001|Overall Study|Physician Decision|0
7607324|NCT04213807|12014688|FG002|Overall Study|Physician Decision|1
7607325|NCT03721107|12014765|FG000|Overall Study|Adverse Event|1
7607326|NCT03721107|12014766|FG001|Overall Study|Adverse Event|1
7607327|NCT03721107|12014767|FG002|Overall Study|Adverse Event|6
7607328|NCT03721107|12014768|FG003|Overall Study|Adverse Event|5
7776590|NCT00924664|12223010|FG000|Overall Study|Death|0
7776591|NCT00924664|12223011|FG001|Overall Study|Death|2
7776592|NCT00924664|12223010|FG000|Overall Study|Study terminated by sponsor|199
7776593|NCT00924664|12223011|FG001|Overall Study|Study terminated by sponsor|330
7776594|NCT00924664|12223010|FG000|Overall Study|Other|29
7776595|NCT00924664|12223011|FG001|Overall Study|Other|52
7776596|NCT00924664|12223010|FG000|Overall Study|Randomized but not Treated|1
7776597|NCT00924664|12223011|FG001|Overall Study|Randomized but not Treated|0
7776598|NCT00924703|12223017|FG000|Overall Study|Withdrawal by Subject|11
7776599|NCT00924703|12223017|FG000|Overall Study|Physician Decision|5
7776600|NCT00924703|12223017|FG000|Overall Study|Lost to Follow-up|3
7776601|NCT00924703|12223017|FG000|Overall Study|Adverse Event|2
7776602|NCT00924703|12223017|FG000|Overall Study|Withdrawal by Sponsor|1
7776603|NCT00924729|12223023|FG000|Overall Study|insufficient volume for analysis|1
7776604|NCT00924729|12223024|FG001|Overall Study|insufficient volume for analysis|0
7607329|NCT03721107|12014765|FG000|Overall Study|Lost to Follow-up|2
7607330|NCT03721107|12014766|FG001|Overall Study|Lost to Follow-up|0
7607331|NCT03721107|12014767|FG002|Overall Study|Lost to Follow-up|3
7607332|NCT03721107|12014768|FG003|Overall Study|Lost to Follow-up|0
7607333|NCT03721107|12014765|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0
7607334|NCT03721107|12014766|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0
7607335|NCT03721107|12014767|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0
7607336|NCT03721107|12014768|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1
7607337|NCT03721107|12014765|FG000|Overall Study|Physician Decision|0
7607338|NCT03721107|12014766|FG001|Overall Study|Physician Decision|1
7607339|NCT03721107|12014767|FG002|Overall Study|Physician Decision|0
7607340|NCT03721107|12014768|FG003|Overall Study|Physician Decision|0
7607341|NCT03721107|12014765|FG000|Overall Study|Pregnancy|0
7607342|NCT03721107|12014766|FG001|Overall Study|Pregnancy|0
7607343|NCT03721107|12014767|FG002|Overall Study|Pregnancy|1
7607344|NCT03721107|12014768|FG003|Overall Study|Pregnancy|0
7607345|NCT03721107|12014765|FG000|Overall Study|Withdrawal by Subject|1
7607346|NCT03721107|12014766|FG001|Overall Study|Withdrawal by Subject|1
7607347|NCT03721107|12014767|FG002|Overall Study|Withdrawal by Subject|5
7607348|NCT03721107|12014768|FG003|Overall Study|Withdrawal by Subject|5
7607349|NCT03721107|12014765|FG000|Overall Study|Other|1
7607350|NCT03721107|12014766|FG001|Overall Study|Other|0
7607351|NCT03721107|12014767|FG002|Overall Study|Other|0
7607352|NCT03721107|12014768|FG003|Overall Study|Other|1
7607403|NCT03294109|12014915|FG000|Overall Study|Withdrawal by Subject|6
7607404|NCT03294109|12014916|FG001|Overall Study|Withdrawal by Subject|5
7607405|NCT03268005|12014925|FG000|Overall Study|Death|2
7607406|NCT03268005|12014926|FG001|Overall Study|Death|1
7607407|NCT03268005|12014925|FG000|Overall Study|Lost to Follow-up|2
7607408|NCT03268005|12014926|FG001|Overall Study|Lost to Follow-up|2
7607409|NCT03268005|12014925|FG000|Overall Study|Withdrawal by Subject|11
7607410|NCT03268005|12014926|FG001|Overall Study|Withdrawal by Subject|11
7607411|NCT03225170|12014935|FG000|Overall Study|Lost to Follow-up|4
7607412|NCT03225170|12014936|FG001|Overall Study|Lost to Follow-up|4
7607413|NCT03225170|12014937|FG002|Overall Study|Lost to Follow-up|0
7607414|NCT03225170|12014935|FG000|Overall Study|Did not complete intervention/control writing exercise|0
7607415|NCT03225170|12014936|FG001|Overall Study|Did not complete intervention/control writing exercise|1
7607416|NCT03225170|12014937|FG002|Overall Study|Did not complete intervention/control writing exercise|0
7607417|NCT03219034|12014961|FG000|Overall Study|Lost to Follow-up|9
7607418|NCT03219034|12014962|FG001|Overall Study|Lost to Follow-up|13
7607419|NCT03219034|12014961|FG000|Overall Study|Additional dental work needed|1
7607420|NCT03219034|12014962|FG001|Overall Study|Additional dental work needed|0
7607421|NCT03219034|12014961|FG000|Overall Study|UPPP Surgery|1
7607422|NCT03219034|12014962|FG001|Overall Study|UPPP Surgery|0
7607423|NCT03219034|12014961|FG000|Overall Study|Dental sensitivity|0
7607424|NCT03219034|12014962|FG001|Overall Study|Dental sensitivity|1
7607425|NCT03219034|12014961|FG000|Overall Study|Death in family|0
7607426|NCT03219034|12014962|FG001|Overall Study|Death in family|1
7607496|NCT02785952|12015055|FG001|Overall Study|Adverse Event|19
7776605|NCT00924729|12223023|FG000|Overall Study|Protocol Violation|1
7607427|NCT03168438|12014972|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0
7607428|NCT03168438|12014973|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1
7607429|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Withdrew Consent|10
7607430|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Withdrew Consent|16
7607431|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Withdrew Consent|0
7607432|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Withdrew Consent|0
7607433|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4
7607434|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3
7607435|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0
7607436|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0
7607437|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Adverse Event|3
7607353|NCT03644849|12014808|FG000|Overall Study|Lost to Follow-up|1
7607354|NCT03644849|12014809|FG001|Overall Study|Lost to Follow-up|3
7607355|NCT03604159|12014817|FG000|Overall Study|Lost to Follow-up|6
7607356|NCT03604159|12014818|FG001|Overall Study|Lost to Follow-up|7
7607357|NCT03602885|12014826|FG000|Overall Study|Lost to Follow-up|3
7607358|NCT03602885|12014827|FG001|Overall Study|Lost to Follow-up|0
7607359|NCT03539601|12014837|FG000|Overall Study|Withdraw by parent/guardian|1
7607360|NCT03539601|12014838|FG001|Overall Study|Withdraw by parent/guardian|0
7607361|NCT03539601|12014839|FG002|Overall Study|Withdraw by parent/guardian|1
7607362|NCT03539601|12014840|FG003|Overall Study|Withdraw by parent/guardian|0
7607363|NCT03539601|12014837|FG000|Overall Study|Adverse Event|0
7607364|NCT03539601|12014838|FG001|Overall Study|Adverse Event|2
7607365|NCT03539601|12014839|FG002|Overall Study|Adverse Event|0
7607366|NCT03539601|12014840|FG003|Overall Study|Adverse Event|0
7607367|NCT03539601|12014837|FG000|Overall Study|Lost to Follow-up|2
7607368|NCT03539601|12014838|FG001|Overall Study|Lost to Follow-up|4
7607369|NCT03539601|12014839|FG002|Overall Study|Lost to Follow-up|5
7607370|NCT03539601|12014840|FG003|Overall Study|Lost to Follow-up|0
7607371|NCT03539601|12014837|FG000|Overall Study|Withdrawal by Subject|2
7607372|NCT03539601|12014838|FG001|Overall Study|Withdrawal by Subject|0
7607373|NCT03539601|12014839|FG002|Overall Study|Withdrawal by Subject|0
7607374|NCT03539601|12014840|FG003|Overall Study|Withdrawal by Subject|1
7607375|NCT03539601|12014837|FG000|Overall Study|Randomized but not treated|1
7607376|NCT03539601|12014838|FG001|Overall Study|Randomized but not treated|1
7607377|NCT03539601|12014839|FG002|Overall Study|Randomized but not treated|0
7607378|NCT03539601|12014840|FG003|Overall Study|Randomized but not treated|0
7607379|NCT03539458|12014858|FG000|Overall Study|Death|1
7607380|NCT03532451|12014864|FG000|Overall Study|Withdrawal by Subject|0
7607381|NCT03532451|12014865|FG001|Overall Study|Withdrawal by Subject|1
7607382|NCT03532451|12014864|FG000|Overall Study|Progression prior to the surgery|1
7607383|NCT03532451|12014865|FG001|Overall Study|Progression prior to the surgery|0
7607384|NCT03439657|12014891|FG000|Overall Study|Adverse Event|2
7607385|NCT03439657|12014892|FG001|Overall Study|Adverse Event|3
7607386|NCT03439657|12014891|FG000|Overall Study|Lost to Follow-up|1
7607387|NCT03439657|12014892|FG001|Overall Study|Lost to Follow-up|0
7607388|NCT03439657|12014891|FG000|Overall Study|Protocol Violation|1
7607389|NCT03439657|12014892|FG001|Overall Study|Protocol Violation|1
7607390|NCT03439657|12014891|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3
7607391|NCT03439657|12014892|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0
7607392|NCT03377790|12014902|FG000|Overall Study|Withdrawal by Subject|1
7607393|NCT03377790|12014903|FG001|Overall Study|Withdrawal by Subject|0
7607394|NCT03377790|12014902|FG000|Overall Study|Adverse Event|1
7607395|NCT03377790|12014903|FG001|Overall Study|Adverse Event|0
7607396|NCT03377790|12014902|FG000|Overall Study|Lost to Follow-up|0
7607397|NCT03377790|12014903|FG001|Overall Study|Lost to Follow-up|2
7607398|NCT03377790|12014902|FG000|Overall Study|Randomized but not treated|1
7607399|NCT03377790|12014903|FG001|Overall Study|Randomized but not treated|0
7607400|NCT03377790|12014902|FG000|Overall Study|Withdrawn by Parent/Guardian|7
7607401|NCT03377790|12014903|FG001|Overall Study|Withdrawn by Parent/Guardian|4
7607402|NCT03353675|12014909|FG000|Overall Study|Adverse Event|4
7607438|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Adverse Event|3
7607439|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Adverse Event|0
7607440|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Adverse Event|0
7607441|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1
7607442|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3
7607443|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0
7607444|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0
7607445|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Death|2
7607446|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Death|1
7607447|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Death|0
7607448|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Death|0
7607449|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1
7607450|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1
7607451|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0
7607452|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0
7607453|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Protocol Violation|0
7607454|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Protocol Violation|1
7607455|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Protocol Violation|0
7607456|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Protocol Violation|0
7607457|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0
7607458|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2
7607459|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0
7607460|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0
7607461|NCT03110380|12014982|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0
7607462|NCT03110380|12014983|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0
7607463|NCT03110380|12014984|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3
7607464|NCT03110380|12014985|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1
7607465|NCT03110380|12014982|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0
7607466|NCT03110380|12014983|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0
7607467|NCT03110380|12014984|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1
7607468|NCT03110380|12014985|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1
7607469|NCT03110380|12014982|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0
7607470|NCT03110380|12014983|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0
7607471|NCT03110380|12014984|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0
7607472|NCT03110380|12014985|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1
7607473|NCT03078478|12015001|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
7607474|NCT03078478|12015002|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
7607475|NCT03078478|12015001|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7
7607476|NCT03078478|12015002|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4
7607477|NCT03078478|12015001|FG000|Maintenance Period 1 (36 Weeks)|Death|3
7607478|NCT03078478|12015002|FG001|Maintenance Period 1 (36 Weeks)|Death|3
7607479|NCT03078478|12015001|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1
7607480|NCT03078478|12015002|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0
7607481|NCT03078478|12015001|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18
7607482|NCT03078478|12015002|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13
7607483|NCT03078478|12015001|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3
7607484|NCT03078478|12015002|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6
7607485|NCT03078478|12015001|FG000|Maintencance Period 2 (36 Weeks)|Death|4
7607486|NCT03078478|12015002|FG001|Maintencance Period 2 (36 Weeks)|Death|6
7607487|NCT03078478|12015001|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0
7607488|NCT03078478|12015002|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2
7607489|NCT02993263|12015017|FG000|Overall Study|Equipment Software failed and results were lost.|323
7607490|NCT02985684|12015021|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5
7607491|NCT02985684|12015021|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5
7607492|NCT02985684|12015021|FG000|6-Month Closure Success Evaluation|Device Removal|3
7776606|NCT00924729|12223024|FG001|Overall Study|Protocol Violation|0
7776607|NCT00924781|12223036|FG000|Overall Study|Study terminated by sponsor|12
7776608|NCT00924781|12223037|FG001|Overall Study|Study terminated by sponsor|10
7776609|NCT00924820|12223053|FG000|Overall Study|Death|2
7776610|NCT00924820|12223053|FG000|Overall Study|Ineligible, Screen Failure|5
7776611|NCT00924898|12223068|FG000|Overall Study|Withdrawal by Subject|2
7776612|NCT00924950|12223077|FG000|Overall Study|Lost to Follow-up|2
7776613|NCT00925002|12223087|FG000|Overall Study|Other|1
7776614|NCT00925002|12223088|FG001|Overall Study|Other|4
7776615|NCT00925002|12223089|FG002|Overall Study|Other|0
7776616|NCT00925002|12223087|FG000|Overall Study|Death|1
7776617|NCT00925002|12223088|FG001|Overall Study|Death|1
7776618|NCT00925002|12223089|FG002|Overall Study|Death|5
7776619|NCT00925002|12223087|FG000|Overall Study|Adverse Event|3
7776620|NCT00925002|12223088|FG001|Overall Study|Adverse Event|1
7776621|NCT00925002|12223089|FG002|Overall Study|Adverse Event|2
7776622|NCT00925002|12223087|FG000|Overall Study|Participant withdrew consent|1
7776623|NCT00925002|12223088|FG001|Overall Study|Participant withdrew consent|3
7776624|NCT00925002|12223089|FG002|Overall Study|Participant withdrew consent|3
7776625|NCT00925015|12223101|FG000|Overall Study|Adverse Event|1
7776626|NCT00925015|12223102|FG001|Overall Study|Adverse Event|2
7776627|NCT00925015|12223103|FG002|Overall Study|Adverse Event|1
7776628|NCT00925015|12223101|FG000|Overall Study|Physician Decision|0
7776629|NCT00925015|12223102|FG001|Overall Study|Physician Decision|1
7776630|NCT00925015|12223103|FG002|Overall Study|Physician Decision|0
7776631|NCT00925015|12223101|FG000|Overall Study|Progressive Disease|7
7776632|NCT00925015|12223102|FG001|Overall Study|Progressive Disease|3
7776633|NCT00925015|12223103|FG002|Overall Study|Progressive Disease|4
7776634|NCT00925015|12223101|FG000|Overall Study|Withdrawal by Subject|0
7776635|NCT00925015|12223102|FG001|Overall Study|Withdrawal by Subject|0
7776636|NCT00925015|12223103|FG002|Overall Study|Withdrawal by Subject|1
7776637|NCT00925132|12223141|FG000|Overall Study|Withdrawal by Subject|2
7776638|NCT00925132|12223142|FG001|Overall Study|Withdrawal by Subject|0
7776639|NCT00925132|12223143|FG002|Overall Study|Withdrawal by Subject|0
7776640|NCT00925132|12223144|FG003|Overall Study|Withdrawal by Subject|0
7776641|NCT00925132|12223145|FG004|Overall Study|Withdrawal by Subject|1
7776642|NCT00925132|12223141|FG000|Overall Study|Removed due to disease progression|0
7776643|NCT00925132|12223142|FG001|Overall Study|Removed due to disease progression|0
7607493|NCT02873195|12015036|FG000|Overall Study|Ineligible|5
7607494|NCT02873195|12015037|FG001|Overall Study|Ineligible|0
7607495|NCT02785952|12015054|FG000|Overall Study|Adverse Event|31
7607497|NCT02785952|12015054|FG000|Overall Study|Refusal unrelated to adverse events|10
7607498|NCT02785952|12015055|FG001|Overall Study|Refusal unrelated to adverse events|5
7607499|NCT02785952|12015054|FG000|Overall Study|Disease progression/relapse|61
7607500|NCT02785952|12015055|FG001|Overall Study|Disease progression/relapse|89
7607501|NCT02785952|12015054|FG000|Overall Study|Death|11
7607502|NCT02785952|12015055|FG001|Overall Study|Death|7
7607503|NCT02785952|12015054|FG000|Overall Study|Other- not protocol specified|6
7607504|NCT02785952|12015055|FG001|Overall Study|Other- not protocol specified|4
7607505|NCT02785952|12015054|FG000|Overall Study|On protocol treatment|6
7607506|NCT02785952|12015055|FG001|Overall Study|On protocol treatment|3
7607507|NCT02748616|12015067|FG000|Overall Study|Lost to Follow-up|1
7607508|NCT02748616|12015067|FG000|Overall Study|Withdrawal by Subject|2
7607509|NCT02748616|12015067|FG000|Overall Study|Physician Decision|2
7607510|NCT02748616|12015067|FG000|Overall Study|Did Not Complete Ursodial Course|2
7607592|NCT01978938|12015292|FG001|Overall Study|Previously scheduled procedure|1
7607511|NCT02719522|12015071|FG000|Overall Study|Implant Failure|4
7607512|NCT02719522|12015071|FG000|Overall Study|Death|2
7607513|NCT02719522|12015071|FG000|Overall Study|Lost to Follow-up|5
7607514|NCT02585232|12015092|FG000|Overall Study|Lost to Follow-up|8
7607515|NCT02585232|12015093|FG001|Overall Study|Lost to Follow-up|8
7607516|NCT02585232|12015092|FG000|Overall Study|Withdrawal by Subject|4
7607517|NCT02585232|12015093|FG001|Overall Study|Withdrawal by Subject|8
7607523|NCT02545283|12015144|FG000|Overall Study|Lost to Follow-up|2
7607524|NCT02545283|12015145|FG001|Overall Study|Lost to Follow-up|4
7607525|NCT02545283|12015144|FG000|Overall Study|Withdrawal by Subject|5
7607526|NCT02545283|12015145|FG001|Overall Study|Withdrawal by Subject|9
7607527|NCT02545283|12015144|FG000|Overall Study|Death|109
7607528|NCT02545283|12015145|FG001|Overall Study|Death|211
7607529|NCT02545283|12015144|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0
7607530|NCT02545283|12015145|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3
7607531|NCT02545283|12015144|FG000|Overall Study|Study Terminated By Sponsor|33
7607532|NCT02545283|12015145|FG001|Overall Study|Study Terminated By Sponsor|71
7607533|NCT02524171|12015155|FG000|6-month Follow-up|Lost to Follow-up|53
7607534|NCT02524171|12015156|FG001|6-month Follow-up|Lost to Follow-up|45
7607535|NCT02524171|12015155|FG000|12-month Follow-up Interview|Lost to Follow-up|45
7607536|NCT02524171|12015156|FG001|12-month Follow-up Interview|Lost to Follow-up|41
7776644|NCT00925132|12223143|FG002|Overall Study|Removed due to disease progression|0
7776645|NCT00925132|12223144|FG003|Overall Study|Removed due to disease progression|0
7776646|NCT00925132|12223145|FG004|Overall Study|Removed due to disease progression|4
7776647|NCT00925288|12223153|FG000|Overall Study|Lost to Follow-up|9
7776648|NCT00925288|12223154|FG001|Overall Study|Lost to Follow-up|7
7776649|NCT00925301|12223164|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
7776650|NCT00925301|12223165|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
7776651|NCT00925301|12223166|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
7776652|NCT00925301|12223167|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
7776653|NCT00925301|12223164|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0
7776654|NCT00925301|12223165|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1
7776655|NCT00925301|12223166|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0
7776656|NCT00925301|12223167|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0
7607552|NCT02306122|12015211|FG000|Initial Physician Randomization|Physician Decision|0
7607553|NCT02306122|12015212|FG001|Initial Physician Randomization|Physician Decision|0
7607554|NCT02306122|12015213|FG002|Initial Physician Randomization|Physician Decision|0
7607555|NCT02306122|12015214|FG003|Initial Physician Randomization|Physician Decision|0
7607556|NCT02306122|12015215|FG004|Initial Physician Randomization|Physician Decision|0
7607557|NCT02306122|12015216|FG005|Initial Physician Randomization|Physician Decision|0
7607558|NCT02306122|12015217|FG006|Initial Physician Randomization|Physician Decision|0
7607559|NCT02306122|12015218|FG007|Initial Physician Randomization|Physician Decision|0
7607560|NCT02306122|12015219|FG008|Initial Physician Randomization|Physician Decision|1
7607561|NCT02306122|12015220|FG009|Initial Physician Randomization|Physician Decision|0
7607562|NCT02306122|12015221|FG010|Initial Physician Randomization|Physician Decision|0
7607563|NCT02147184|12015259|FG000|Overall Study|Lost to Follow-up|28
7607564|NCT02147184|12015260|FG001|Overall Study|Lost to Follow-up|15
7607565|NCT02147184|12015259|FG000|Overall Study|Study Burden|11
7607566|NCT02147184|12015260|FG001|Overall Study|Study Burden|7
7607567|NCT02147184|12015259|FG000|Overall Study|Pregnancy|6
7607568|NCT02147184|12015260|FG001|Overall Study|Pregnancy|0
7607569|NCT02147184|12015259|FG000|Overall Study|Moved out of state|3
7607570|NCT02147184|12015260|FG001|Overall Study|Moved out of state|3
7607571|NCT02147184|12015259|FG000|Overall Study|Physician Decision|0
7607572|NCT02147184|12015260|FG001|Overall Study|Physician Decision|2
7607573|NCT02147184|12015259|FG000|Overall Study|Other|1
7607574|NCT02147184|12015260|FG001|Overall Study|Other|0
7607575|NCT02000219|12015285|FG000|14-Week Study Period|Physician Decision|1
7607576|NCT02000219|12015285|FG000|14-Week Study Period|Adverse Event|1
7607577|NCT02000219|12015285|FG000|14-Week Study Period|Underwent transplantation|1
7607578|NCT02000219|12015285|FG000|Continuation Period|Withdrawal by Subject|1
7607579|NCT02000219|12015285|FG000|Continuation Period|Had liver transplant|2
7607580|NCT02000219|12015285|FG000|Continuation Period|Non-compliance with study drug|2
7607581|NCT01978938|12015291|FG000|Overall Study|Lost to Follow-up|12
7607582|NCT01978938|12015292|FG001|Overall Study|Lost to Follow-up|6
7607583|NCT01978938|12015291|FG000|Overall Study|Withdrawal by Subject|8
7607584|NCT01978938|12015292|FG001|Overall Study|Withdrawal by Subject|4
7607585|NCT01978938|12015291|FG000|Overall Study|Adverse Event, non-fatal|2
7607586|NCT01978938|12015292|FG001|Overall Study|Adverse Event, non-fatal|1
7607587|NCT01978938|12015291|FG000|Overall Study|Participant noncompliance|1
7607588|NCT01978938|12015292|FG001|Overall Study|Participant noncompliance|1
7607589|NCT01978938|12015291|FG000|Overall Study|Did not meet inclusion criteria|0
7607590|NCT01978938|12015292|FG001|Overall Study|Did not meet inclusion criteria|1
7607591|NCT01978938|12015291|FG000|Overall Study|Previously scheduled procedure|0
7607593|NCT01854385|12015298|FG000|Pre-Treatment|Withdrawal by Subject|4
7607594|NCT01854385|12015298|FG000|Pre-Treatment|Did not meet criteria based on headache number|15
7607595|NCT01854385|12015298|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3
7607596|NCT01854385|12015298|FG000|Pre-Treatment|Unable to come for study visits|1
7607597|NCT01854385|12015298|FG000|Treatment|Lost to Follow-up|1
7607598|NCT01844856|12015304|FG000|Overall Study|Lost to Follow-up|15
7607599|NCT01844856|12015305|FG001|Overall Study|Lost to Follow-up|3
7607600|NCT01844856|12015304|FG000|Overall Study|Adverse Event|3
7607601|NCT01844856|12015305|FG001|Overall Study|Adverse Event|6
7607602|NCT01844856|12015304|FG000|Overall Study|Withdrawal by Subject|3
7607603|NCT01844856|12015305|FG001|Overall Study|Withdrawal by Subject|2
7607604|NCT01844856|12015304|FG000|Overall Study|Noncompliance|2
7607605|NCT01844856|12015305|FG001|Overall Study|Noncompliance|3
7607606|NCT01844856|12015304|FG000|Overall Study|Enterococcus Resistant|0
7607607|NCT01844856|12015305|FG001|Overall Study|Enterococcus Resistant|1
7607608|NCT01844856|12015304|FG000|Overall Study|Inadvertently Not Scheduled|1
7607609|NCT01844856|12015305|FG001|Overall Study|Inadvertently Not Scheduled|0
7607610|NCT01844856|12015304|FG000|Overall Study|Randomized but was a Screen Failure|0
7607611|NCT01844856|12015305|FG001|Overall Study|Randomized but was a Screen Failure|1
7607612|NCT01712789|12015344|FG000|Overall Study|Lack of Efficacy|2
7607613|NCT01712789|12015344|FG000|Overall Study|Lost to Follow-up|1
7607614|NCT01712789|12015344|FG000|Overall Study|Progressive Disease|504
7607615|NCT01712789|12015344|FG000|Overall Study|Death|57
7607616|NCT01712789|12015344|FG000|Overall Study|Adverse Event|52
7607617|NCT01712789|12015344|FG000|Overall Study|Miscellaneous|31
7607618|NCT01712789|12015344|FG000|Overall Study|Withdrawal by Subject|21
7607619|NCT01712789|12015344|FG000|Overall Study|Transition to Commercial Treatment|8
7607620|NCT01712789|12015344|FG000|Overall Study|Participants Did Not Receive Study Drug|6
7776657|NCT00925301|12223164|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
7607633|NCT01542736|12015366|FG000|Overall Study|Death|1
7607634|NCT01535807|12015372|FG000|Overall Study|Withdrawal by Subject|1
7607635|NCT01535807|12015373|FG001|Overall Study|Withdrawal by Subject|1
7607636|NCT01535807|12015372|FG000|Overall Study|Data collection error|1
7607637|NCT01535807|12015373|FG001|Overall Study|Data collection error|1
7607638|NCT01147666|12015394|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1
7607639|NCT01147666|12015395|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1
7607640|NCT01147666|12015396|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1
7607641|NCT01147666|12015397|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607642|NCT01147666|12015398|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607643|NCT01147666|12015399|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607644|NCT01147666|12015400|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607645|NCT01147666|12015401|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607646|NCT01147666|12015402|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607647|NCT01147666|12015403|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607648|NCT01147666|12015404|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7776658|NCT00925301|12223165|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
7776659|NCT00925301|12223166|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
7607649|NCT01147666|12015405|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607650|NCT01147666|12015406|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1
7607651|NCT01147666|12015407|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607652|NCT01147666|12015408|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607653|NCT01147666|12015394|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
7607654|NCT01147666|12015395|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
7607655|NCT01147666|12015396|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
7776660|NCT00925301|12223167|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
7776661|NCT00925301|12223164|FG000|6-Month Open-label (Stage 2)|Adverse Event|0
7776662|NCT00925301|12223165|FG001|6-Month Open-label (Stage 2)|Adverse Event|0
7776663|NCT00925301|12223166|FG002|6-Month Open-label (Stage 2)|Adverse Event|2
7776664|NCT00925301|12223167|FG003|6-Month Open-label (Stage 2)|Adverse Event|0
7776665|NCT00925301|12223164|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
7776666|NCT00925301|12223165|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
7776667|NCT00925301|12223166|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
7776668|NCT00925301|12223167|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
7776669|NCT00925301|12223164|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0
7776670|NCT00925301|12223165|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0
7776671|NCT00925301|12223166|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0
7776672|NCT00925301|12223167|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1
7776673|NCT00925301|12223164|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
7776674|NCT00925301|12223165|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
7776675|NCT00925301|12223166|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
7776676|NCT00925301|12223167|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
7776677|NCT00925353|12223178|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3
7776678|NCT00925522|12223182|FG000|Overall Study|study closed -- business decision|20
7776679|NCT00925587|12223188|FG000|Overall Study|Protocol Specified Criteria|6
7776680|NCT00925587|12223189|FG001|Overall Study|Protocol Specified Criteria|6
7776681|NCT00925587|12223188|FG000|Overall Study|Physician Decision|4
7776682|NCT00925587|12223189|FG001|Overall Study|Physician Decision|1
7776683|NCT00925587|12223188|FG000|Overall Study|Protocol Violation|6
7776684|NCT00925587|12223189|FG001|Overall Study|Protocol Violation|4
7776685|NCT00925587|12223188|FG000|Overall Study|Withdrawal by Subject|9
7776686|NCT00925587|12223189|FG001|Overall Study|Withdrawal by Subject|6
7776687|NCT00925587|12223188|FG000|Overall Study|Death|5
7776688|NCT00925587|12223189|FG001|Overall Study|Death|5
7776689|NCT00925587|12223188|FG000|Overall Study|Adverse Event|6
7776690|NCT00925587|12223189|FG001|Overall Study|Adverse Event|2
7776691|NCT00925587|12223188|FG000|Overall Study|Lost to Follow-up|0
7776692|NCT00925587|12223189|FG001|Overall Study|Lost to Follow-up|1
7776693|NCT00925600|12223197|FG000|Overall Study|Withdrawal by Subject|16
7776694|NCT00925600|12223198|FG001|Overall Study|Withdrawal by Subject|14
7776695|NCT00925600|12223197|FG000|Overall Study|Death|4
7776696|NCT00925600|12223198|FG001|Overall Study|Death|3
7776697|NCT00925600|12223197|FG000|Overall Study|Lost to Follow-up|2
7776698|NCT00925600|12223198|FG001|Overall Study|Lost to Follow-up|2
7776699|NCT00925600|12223197|FG000|Overall Study|Disease Progression|1
7776700|NCT00925600|12223198|FG001|Overall Study|Disease Progression|3
7776701|NCT00925600|12223197|FG000|Overall Study|Administrative Decision|1
7776702|NCT00925600|12223198|FG001|Overall Study|Administrative Decision|1
7776703|NCT00925600|12223197|FG000|Overall Study|Noncompliance|2
7776704|NCT00925600|12223198|FG001|Overall Study|Noncompliance|0
7776705|NCT00925600|12223197|FG000|Overall Study|Ineligibility Determined|2
7776706|NCT00925600|12223198|FG001|Overall Study|Ineligibility Determined|0
7607656|NCT01147666|12015397|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
7607657|NCT01147666|12015398|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3
7607658|NCT01147666|12015399|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
7607659|NCT01147666|12015400|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2
7607660|NCT01147666|12015401|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2
7607661|NCT01147666|12015402|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
7607662|NCT01147666|12015403|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
7607663|NCT01147666|12015404|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
7607664|NCT01147666|12015405|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
7607665|NCT01147666|12015406|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
7607666|NCT01147666|12015407|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
7607667|NCT01147666|12015408|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3
7607668|NCT01147666|12015394|FG000|Dosing Period 1: 6-Week Treatment|Death|0
7607669|NCT01147666|12015395|FG001|Dosing Period 1: 6-Week Treatment|Death|0
7607670|NCT01147666|12015396|FG002|Dosing Period 1: 6-Week Treatment|Death|0
7607671|NCT01147666|12015397|FG003|Dosing Period 1: 6-Week Treatment|Death|0
7607672|NCT01147666|12015398|FG004|Dosing Period 1: 6-Week Treatment|Death|1
7607673|NCT01147666|12015399|FG005|Dosing Period 1: 6-Week Treatment|Death|1
7607674|NCT01147666|12015400|FG006|Dosing Period 1: 6-Week Treatment|Death|1
7607675|NCT01147666|12015401|FG007|Dosing Period 1: 6-Week Treatment|Death|0
7607676|NCT01147666|12015402|FG008|Dosing Period 1: 6-Week Treatment|Death|0
7607677|NCT01147666|12015403|FG009|Dosing Period 1: 6-Week Treatment|Death|0
7607678|NCT01147666|12015404|FG010|Dosing Period 1: 6-Week Treatment|Death|0
7607679|NCT01147666|12015405|FG011|Dosing Period 1: 6-Week Treatment|Death|0
7607680|NCT01147666|12015406|FG012|Dosing Period 1: 6-Week Treatment|Death|1
7607681|NCT01147666|12015407|FG013|Dosing Period 1: 6-Week Treatment|Death|0
7607682|NCT01147666|12015408|FG014|Dosing Period 1: 6-Week Treatment|Death|0
7607683|NCT01147666|12015394|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
7607684|NCT01147666|12015395|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607685|NCT01147666|12015396|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607686|NCT01147666|12015397|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
7607687|NCT01147666|12015398|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607688|NCT01147666|12015399|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607689|NCT01147666|12015400|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607690|NCT01147666|12015401|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607691|NCT01147666|12015402|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607692|NCT01147666|12015403|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607693|NCT01147666|12015404|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
7607694|NCT01147666|12015405|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607695|NCT01147666|12015406|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607696|NCT01147666|12015407|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607697|NCT01147666|12015408|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607698|NCT01147666|12015394|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607699|NCT01147666|12015395|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607700|NCT01147666|12015396|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607701|NCT01147666|12015397|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607702|NCT01147666|12015398|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
7607703|NCT01147666|12015399|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
7607704|NCT01147666|12015400|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607705|NCT01147666|12015401|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
7607706|NCT01147666|12015402|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607707|NCT01147666|12015403|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
7607708|NCT01147666|12015404|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607709|NCT01147666|12015405|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
7607710|NCT01147666|12015406|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607711|NCT01147666|12015407|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
7607712|NCT01147666|12015408|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607713|NCT01147666|12015394|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607714|NCT01147666|12015395|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607715|NCT01147666|12015396|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607716|NCT01147666|12015397|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1
7607717|NCT01147666|12015398|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607718|NCT01147666|12015399|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607719|NCT01147666|12015400|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607720|NCT01147666|12015401|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607721|NCT01147666|12015402|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607722|NCT01147666|12015403|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607723|NCT01147666|12015404|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2
7607724|NCT01147666|12015405|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607725|NCT01147666|12015406|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607726|NCT01147666|12015407|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607727|NCT01147666|12015408|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607728|NCT01147666|12015394|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607729|NCT01147666|12015395|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607730|NCT01147666|12015396|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607731|NCT01147666|12015397|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607732|NCT01147666|12015398|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607733|NCT01147666|12015399|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607734|NCT01147666|12015400|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607735|NCT01147666|12015401|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607736|NCT01147666|12015402|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607737|NCT01147666|12015403|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607738|NCT01147666|12015404|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607739|NCT01147666|12015405|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
7607740|NCT01147666|12015406|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
7607741|NCT01147666|12015407|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607742|NCT01147666|12015408|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
7607743|NCT01147666|12015394|FG000|Dosing Period 2: 19-Week Treatment|Death|0
7607744|NCT01147666|12015395|FG001|Dosing Period 2: 19-Week Treatment|Death|0
7607745|NCT01147666|12015396|FG002|Dosing Period 2: 19-Week Treatment|Death|0
7607746|NCT01147666|12015397|FG003|Dosing Period 2: 19-Week Treatment|Death|0
7607747|NCT01147666|12015398|FG004|Dosing Period 2: 19-Week Treatment|Death|1
7607748|NCT01147666|12015399|FG005|Dosing Period 2: 19-Week Treatment|Death|1
7607749|NCT01147666|12015400|FG006|Dosing Period 2: 19-Week Treatment|Death|1
7607750|NCT01147666|12015401|FG007|Dosing Period 2: 19-Week Treatment|Death|0
7607751|NCT01147666|12015402|FG008|Dosing Period 2: 19-Week Treatment|Death|0
7607752|NCT01147666|12015403|FG009|Dosing Period 2: 19-Week Treatment|Death|0
7607753|NCT01147666|12015404|FG010|Dosing Period 2: 19-Week Treatment|Death|0
7607754|NCT01147666|12015405|FG011|Dosing Period 2: 19-Week Treatment|Death|0
7776707|NCT00925600|12223197|FG000|Overall Study|Protocol Deviation|0
7776708|NCT00925600|12223198|FG001|Overall Study|Protocol Deviation|1
7776709|NCT00925600|12223197|FG000|Overall Study|Requirement for Alternative Therapy|0
7776710|NCT00925600|12223198|FG001|Overall Study|Requirement for Alternative Therapy|1
7776711|NCT00925600|12223197|FG000|Overall Study|Other|3
7776712|NCT00925600|12223198|FG001|Overall Study|Other|1
7776713|NCT00925600|12223197|FG000|Overall Study|Adverse Event|1
7776714|NCT00925600|12223198|FG001|Overall Study|Adverse Event|2
7776715|NCT00925704|12223214|FG000|First Intervention|Withdrew consent|0
7776716|NCT00925704|12223215|FG001|First Intervention|Withdrew consent|0
7776717|NCT00925704|12223216|FG002|First Intervention|Withdrew consent|0
7776718|NCT00925704|12223217|FG003|First Intervention|Withdrew consent|1
7776719|NCT00925704|12223218|FG004|First Intervention|Withdrew consent|1
7776720|NCT00925704|12223219|FG005|First Intervention|Withdrew consent|0
7776721|NCT00925704|12223214|FG000|Second Intervention|Withdrawal by Subject|1
7776722|NCT00925704|12223215|FG001|Second Intervention|Withdrawal by Subject|0
7776723|NCT00925704|12223216|FG002|Second Intervention|Withdrawal by Subject|0
7776724|NCT00925704|12223217|FG003|Second Intervention|Withdrawal by Subject|0
7776725|NCT00925704|12223218|FG004|Second Intervention|Withdrawal by Subject|1
7776726|NCT00925704|12223219|FG005|Second Intervention|Withdrawal by Subject|0
7776727|NCT00925704|12223214|FG000|Third Intervention|Withdrew consent|0
7776728|NCT00925704|12223215|FG001|Third Intervention|Withdrew consent|0
7776729|NCT00925704|12223216|FG002|Third Intervention|Withdrew consent|0
7776730|NCT00925704|12223217|FG003|Third Intervention|Withdrew consent|0
7776731|NCT00925704|12223218|FG004|Third Intervention|Withdrew consent|0
7776732|NCT00925704|12223219|FG005|Third Intervention|Withdrew consent|1
7776733|NCT00925769|12223234|FG000|Overall Study|Major toxicity|1
7776734|NCT00925769|12223235|FG001|Overall Study|Major toxicity|0
7607755|NCT01147666|12015406|FG012|Dosing Period 2: 19-Week Treatment|Death|1
7607756|NCT01147666|12015407|FG013|Dosing Period 2: 19-Week Treatment|Death|0
7607757|NCT01147666|12015408|FG014|Dosing Period 2: 19-Week Treatment|Death|0
7607758|NCT01147666|12015394|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607759|NCT01147666|12015395|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607760|NCT01147666|12015396|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607761|NCT01147666|12015397|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607762|NCT01147666|12015398|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3
7607763|NCT01147666|12015399|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
7607764|NCT01147666|12015400|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
7607765|NCT01147666|12015401|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
7607766|NCT01147666|12015402|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607767|NCT01147666|12015403|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
7607768|NCT01147666|12015404|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607769|NCT01147666|12015405|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607770|NCT01147666|12015406|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
7607771|NCT01147666|12015407|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607772|NCT01147666|12015408|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
7607773|NCT01147666|12015394|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607774|NCT01147666|12015395|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607775|NCT01147666|12015396|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607776|NCT01147666|12015397|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1
7607777|NCT01147666|12015398|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607778|NCT01147666|12015399|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607779|NCT01147666|12015400|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607780|NCT01147666|12015401|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607781|NCT01147666|12015402|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607782|NCT01147666|12015403|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607783|NCT01147666|12015404|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607784|NCT01147666|12015405|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607785|NCT01147666|12015406|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607786|NCT01147666|12015407|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607787|NCT01147666|12015408|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607788|NCT01147666|12015394|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607789|NCT01147666|12015395|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607790|NCT01147666|12015396|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607791|NCT01147666|12015397|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607792|NCT01147666|12015398|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
7607793|NCT01147666|12015399|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
7607794|NCT01147666|12015400|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607795|NCT01147666|12015401|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
7607796|NCT01147666|12015402|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7776735|NCT00925769|12223236|FG002|Overall Study|Major toxicity|1
7776736|NCT00925769|12223237|FG003|Overall Study|Major toxicity|1
7776737|NCT00925769|12223238|FG004|Overall Study|Major toxicity|0
7776738|NCT00925769|12223239|FG005|Overall Study|Major toxicity|0
7776739|NCT00925769|12223234|FG000|Overall Study|Disease progression|4
7776740|NCT00925769|12223235|FG001|Overall Study|Disease progression|5
7776741|NCT00925769|12223236|FG002|Overall Study|Disease progression|3
7776742|NCT00925769|12223237|FG003|Overall Study|Disease progression|4
7776743|NCT00925769|12223238|FG004|Overall Study|Disease progression|2
7776744|NCT00925769|12223239|FG005|Overall Study|Disease progression|3
7776745|NCT00925769|12223234|FG000|Overall Study|Death|0
7776746|NCT00925769|12223235|FG001|Overall Study|Death|0
7776747|NCT00925769|12223236|FG002|Overall Study|Death|1
7607797|NCT01147666|12015403|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
7607798|NCT01147666|12015404|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607799|NCT01147666|12015405|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607800|NCT01147666|12015406|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607801|NCT01147666|12015407|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
7607802|NCT01147666|12015408|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607803|NCT01147666|12015394|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0
7776748|NCT00925769|12223237|FG003|Overall Study|Death|0
7776749|NCT00925769|12223238|FG004|Overall Study|Death|0
7776750|NCT00925769|12223239|FG005|Overall Study|Death|0
7776751|NCT00925769|12223234|FG000|Overall Study|Physician Decision|1
7607804|NCT01147666|12015395|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607805|NCT01147666|12015396|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607806|NCT01147666|12015397|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1
7607807|NCT01147666|12015398|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607808|NCT01147666|12015399|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607809|NCT01147666|12015400|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607810|NCT01147666|12015401|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607811|NCT01147666|12015402|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607812|NCT01147666|12015403|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607813|NCT01147666|12015404|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2
7607814|NCT01147666|12015405|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607815|NCT01147666|12015406|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607816|NCT01147666|12015407|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607817|NCT01147666|12015408|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607818|NCT01147666|12015394|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607819|NCT01147666|12015395|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607820|NCT01147666|12015396|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607821|NCT01147666|12015397|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607822|NCT01147666|12015398|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607823|NCT01147666|12015399|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607824|NCT01147666|12015400|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607825|NCT01147666|12015401|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607826|NCT01147666|12015402|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607827|NCT01147666|12015403|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607828|NCT01147666|12015404|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607829|NCT01147666|12015405|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607830|NCT01147666|12015406|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1
7607831|NCT01147666|12015407|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607832|NCT01147666|12015408|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607833|NCT01147666|12015394|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607834|NCT01147666|12015395|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607835|NCT01147666|12015396|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607836|NCT01147666|12015397|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607837|NCT01147666|12015398|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607838|NCT01147666|12015399|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607839|NCT01147666|12015400|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607840|NCT01147666|12015401|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607841|NCT01147666|12015402|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607842|NCT01147666|12015403|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607843|NCT01147666|12015404|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607844|NCT01147666|12015405|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607845|NCT01147666|12015406|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1
7607846|NCT01147666|12015407|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607847|NCT01147666|12015408|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1
7607848|NCT00982111|12015472|FG000|Overall Study|Adverse Event|1
7607849|NCT00982111|12015473|FG001|Overall Study|Adverse Event|1
7607850|NCT00982111|12015472|FG000|Overall Study|Progressive Disease|46
7607851|NCT00982111|12015473|FG001|Overall Study|Progressive Disease|39
7607852|NCT00982111|12015472|FG000|Overall Study|Lost to Follow-up|9
7607853|NCT00982111|12015473|FG001|Overall Study|Lost to Follow-up|6
7776752|NCT00925769|12223235|FG001|Overall Study|Physician Decision|0
7776753|NCT00925769|12223236|FG002|Overall Study|Physician Decision|0
7776754|NCT00925769|12223237|FG003|Overall Study|Physician Decision|0
7776755|NCT00925769|12223238|FG004|Overall Study|Physician Decision|0
7776756|NCT00925769|12223239|FG005|Overall Study|Physician Decision|0
7776757|NCT00925769|12223234|FG000|Overall Study|Missing documentation|0
7776758|NCT00925769|12223235|FG001|Overall Study|Missing documentation|1
7776759|NCT00925769|12223236|FG002|Overall Study|Missing documentation|0
7776760|NCT00925769|12223237|FG003|Overall Study|Missing documentation|0
7776761|NCT00925769|12223238|FG004|Overall Study|Missing documentation|0
7776762|NCT00925769|12223239|FG005|Overall Study|Missing documentation|0
7776763|NCT00925769|12223234|FG000|Overall Study|End of study visit not done|0
7776764|NCT00925769|12223235|FG001|Overall Study|End of study visit not done|0
7776765|NCT00925769|12223236|FG002|Overall Study|End of study visit not done|1
7776766|NCT00925769|12223237|FG003|Overall Study|End of study visit not done|0
7776767|NCT00925769|12223238|FG004|Overall Study|End of study visit not done|0
7776768|NCT00925769|12223239|FG005|Overall Study|End of study visit not done|0
7776769|NCT00925769|12223234|FG000|Overall Study|Participant is unable to swallow drug|0
7776770|NCT00925769|12223235|FG001|Overall Study|Participant is unable to swallow drug|0
7776771|NCT00925769|12223236|FG002|Overall Study|Participant is unable to swallow drug|0
7776772|NCT00925769|12223237|FG003|Overall Study|Participant is unable to swallow drug|1
7776773|NCT00925769|12223238|FG004|Overall Study|Participant is unable to swallow drug|0
7776774|NCT00925769|12223239|FG005|Overall Study|Participant is unable to swallow drug|0
7776775|NCT00925769|12223234|FG000|Overall Study|Adverse Event|0
7776776|NCT00925769|12223235|FG001|Overall Study|Adverse Event|0
7776777|NCT00925769|12223236|FG002|Overall Study|Adverse Event|0
7776778|NCT00925769|12223237|FG003|Overall Study|Adverse Event|0
7776779|NCT00925769|12223238|FG004|Overall Study|Adverse Event|1
7776780|NCT00925769|12223239|FG005|Overall Study|Adverse Event|0
7776781|NCT00925899|12223265|FG000|Part 1|Death|1
7776782|NCT00925899|12223266|FG001|Part 1|Death|2
7776783|NCT00925899|12223265|FG000|Part 1|Withdrawal by Subject|10
7776784|NCT00925899|12223266|FG001|Part 1|Withdrawal by Subject|9
7776785|NCT00925990|12223288|FG000|Overall Study|Adverse Event|1
7776786|NCT00925990|12223289|FG001|Overall Study|Adverse Event|3
7776787|NCT00925990|12223288|FG000|Overall Study|Withdrawal by Subject|2
7776788|NCT00925990|12223289|FG001|Overall Study|Withdrawal by Subject|2
7776789|NCT00925990|12223288|FG000|Overall Study|Lost to Follow-up|1
7776790|NCT00925990|12223289|FG001|Overall Study|Lost to Follow-up|3
7776791|NCT00925990|12223288|FG000|Overall Study|Physician Decision|1
7776792|NCT00925990|12223289|FG001|Overall Study|Physician Decision|1
7776793|NCT00925990|12223288|FG000|Overall Study|moved out of state, missed medication|0
7776794|NCT00925990|12223289|FG001|Overall Study|moved out of state, missed medication|2
7776795|NCT00926003|12223298|FG000|Post-Training Evaluation|Withdrawal by Subject|1
7776796|NCT00926003|12223299|FG001|Post-Training Evaluation|Withdrawal by Subject|0
7776797|NCT00926003|12223300|FG002|Post-Training Evaluation|Withdrawal by Subject|0
7776798|NCT00926003|12223298|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1
7776799|NCT00926003|12223299|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0
7776800|NCT00926003|12223300|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0
7776801|NCT00926029|12223311|FG000|Overall Study|Lost to Follow-up|2
7776802|NCT00926029|12223312|FG001|Overall Study|Lost to Follow-up|1
7776803|NCT00926029|12223313|FG002|Overall Study|Lost to Follow-up|1
7776804|NCT00926211|12223340|FG000|Overall Study|Lost to Follow-up|1
7607854|NCT00982111|12015472|FG000|Overall Study|New Anti-Cancer Therapy|5
7607855|NCT00982111|12015473|FG001|Overall Study|New Anti-Cancer Therapy|5
7607856|NCT00982111|12015472|FG000|Overall Study|Medical Decision|1
7607857|NCT00982111|12015473|FG001|Overall Study|Medical Decision|0
7607858|NCT00982111|12015472|FG000|Overall Study|Withdrawal by Subject|17
7607859|NCT00982111|12015473|FG001|Overall Study|Withdrawal by Subject|19
7607860|NCT00982111|12015472|FG000|Overall Study|Global Study End|0
7607861|NCT00982111|12015473|FG001|Overall Study|Global Study End|1
7607862|NCT00982111|12015472|FG000|Overall Study|Sponsor's Decision|0
7607863|NCT00982111|12015473|FG001|Overall Study|Sponsor's Decision|1
7607864|NCT00116142|12015487|FG000|Overall Study|Adverse Event|8
7607865|NCT00116142|12015488|FG001|Overall Study|Adverse Event|7
7607866|NCT00116142|12015487|FG000|Overall Study|Protocol Violation|2
7607867|NCT00116142|12015488|FG001|Overall Study|Protocol Violation|1
7607868|NCT00116142|12015487|FG000|Overall Study|Withdrawal by Subject|5
7607869|NCT00116142|12015488|FG001|Overall Study|Withdrawal by Subject|5
7607870|NCT00116142|12015487|FG000|Overall Study|Physician Decision|3
7607871|NCT00116142|12015488|FG001|Overall Study|Physician Decision|1
7607872|NCT00116142|12015487|FG000|Overall Study|Delayed Radiation Therapy|1
7607873|NCT00116142|12015488|FG001|Overall Study|Delayed Radiation Therapy|0
7607874|NCT00116142|12015487|FG000|Overall Study|Patient could not tolerate docetaxel|0
7607875|NCT00116142|12015488|FG001|Overall Study|Patient could not tolerate docetaxel|2
7607876|NCT00116142|12015487|FG000|Overall Study|Patient stopped due to depression|0
7607877|NCT00116142|12015488|FG001|Overall Study|Patient stopped due to depression|1
7607878|NCT00116142|12015487|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0
7607879|NCT00116142|12015488|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1
7607880|NCT00116142|12015487|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0
7607881|NCT00116142|12015488|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1
7607882|NCT00116142|12015487|FG000|Overall Study|Patient didn't start due to low platelet counts|0
7607883|NCT00116142|12015488|FG001|Overall Study|Patient didn't start due to low platelet counts|1
7607884|NCT00070018|12015497|FG000|Overall Study|Adverse Event|2
7607885|NCT00070018|12015497|FG000|Overall Study|Lack of Efficacy|1
7607886|NCT00070018|12015497|FG000|Overall Study|Withdrawal by Subject|1
7607887|NCT04447287|12015510|FG000|Period 1: Run-in Period|Adverse Event|3
7607888|NCT04447287|12015511|FG001|Period 1: Run-in Period|Adverse Event|0
7607889|NCT04447287|12015512|FG002|Period 1: Run-in Period|Adverse Event|0
7607890|NCT04447287|12015510|FG000|Period 1: Run-in Period|Withdrawal by Subject|1
7607891|NCT04447287|12015511|FG001|Period 1: Run-in Period|Withdrawal by Subject|0
7607892|NCT04447287|12015512|FG002|Period 1: Run-in Period|Withdrawal by Subject|0
7607893|NCT04447287|12015510|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1
7607894|NCT04447287|12015511|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0
7607895|NCT04447287|12015512|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0
7607896|NCT04039503|12015568|FG000|Overall Study|Adverse Event|3
7776805|NCT00926237|12223345|FG000|Overall Study|Withdrawal by Subject|2
7776806|NCT00926237|12223346|FG001|Overall Study|Withdrawal by Subject|1
7776807|NCT00926289|12223368|FG000|Overall Study|Adverse Event|9
7776808|NCT00926289|12223369|FG001|Overall Study|Adverse Event|11
7776809|NCT00926289|12223368|FG000|Overall Study|Protocol Violation|8
7776810|NCT00926289|12223369|FG001|Overall Study|Protocol Violation|12
7776811|NCT00926289|12223368|FG000|Overall Study|Lost to Follow-up|3
7776812|NCT00926289|12223369|FG001|Overall Study|Lost to Follow-up|6
7776813|NCT00926289|12223368|FG000|Overall Study|Withdrawal by Subject|4
7776814|NCT00926289|12223369|FG001|Overall Study|Withdrawal by Subject|4
7776815|NCT00926289|12223368|FG000|Overall Study|Other|1
7776816|NCT00926289|12223369|FG001|Overall Study|Other|3
7776817|NCT00926328|12223377|FG000|Overall Study|Lost to Follow-up|12
7776818|NCT00926328|12223378|FG001|Overall Study|Lost to Follow-up|14
7776819|NCT00926367|12223386|FG000|Overall Study|Withdrawal by Subject|0
7776820|NCT00926367|12223387|FG001|Overall Study|Withdrawal by Subject|1
7776821|NCT00926367|12223386|FG000|Overall Study|Lost to Follow-up|1
7776822|NCT00926367|12223387|FG001|Overall Study|Lost to Follow-up|0
7776823|NCT00926367|12223386|FG000|Overall Study|Skin Irritation|1
7776824|NCT00926367|12223387|FG001|Overall Study|Skin Irritation|2
7776825|NCT00926393|12223410|FG000|Overall Study|Withdrawal by Subject|1
7776826|NCT00926393|12223411|FG001|Overall Study|Withdrawal by Subject|2
7776827|NCT00926393|12223410|FG000|Overall Study|Adverse Event|1
7776828|NCT00926393|12223411|FG001|Overall Study|Adverse Event|1
7776829|NCT00926536|12223428|FG000|Overall Study|Physician Decision|1
7776830|NCT00926536|12223429|FG001|Overall Study|Physician Decision|2
7776831|NCT00926783|12223446|FG000|Overall Study|Incomplete CFAE Procedures|3
7776832|NCT00926783|12223447|FG001|Overall Study|Incomplete CFAE Procedures|3
7776833|NCT00926796|12223455|FG000|Overall Study|Did not receive randomized treatment|4
7776834|NCT00926796|12223456|FG001|Overall Study|Did not receive randomized treatment|7
7776835|NCT00926796|12223455|FG000|Overall Study|Ineligible, negative for gonorrhea|57
7776836|NCT00926796|12223456|FG001|Overall Study|Ineligible, negative for gonorrhea|60
7607897|NCT04039503|12015569|FG001|Overall Study|Adverse Event|0
7607898|NCT04039503|12015570|FG002|Overall Study|Adverse Event|2
7607899|NCT04039503|12015571|FG003|Overall Study|Adverse Event|0
7607900|NCT04039503|12015568|FG000|Overall Study|Lost to Follow-up|0
7607901|NCT04039503|12015569|FG001|Overall Study|Lost to Follow-up|0
7607902|NCT04039503|12015570|FG002|Overall Study|Lost to Follow-up|1
7607903|NCT04039503|12015571|FG003|Overall Study|Lost to Follow-up|0
7607904|NCT04039503|12015568|FG000|Overall Study|Protocol Violation|0
7607905|NCT04039503|12015569|FG001|Overall Study|Protocol Violation|1
7607906|NCT04039503|12015570|FG002|Overall Study|Protocol Violation|2
7607907|NCT04039503|12015571|FG003|Overall Study|Protocol Violation|1
7607908|NCT04039503|12015568|FG000|Overall Study|Withdrawal by Subject|4
7607909|NCT04039503|12015569|FG001|Overall Study|Withdrawal by Subject|3
7607910|NCT04039503|12015570|FG002|Overall Study|Withdrawal by Subject|5
7607911|NCT04039503|12015571|FG003|Overall Study|Withdrawal by Subject|2
7607912|NCT03695172|12015589|FG000|Overall Study|Withdrawal by Subject|1
7607913|NCT03695172|12015590|FG001|Overall Study|Withdrawal by Subject|1
7607914|NCT03695172|12015591|FG002|Overall Study|Withdrawal by Subject|0
7776837|NCT00926796|12223455|FG000|Overall Study|Ineligible, but positive for gonorrhea|1
7776838|NCT00926796|12223456|FG001|Overall Study|Ineligible, but positive for gonorrhea|1
7776839|NCT00926796|12223455|FG000|Overall Study|Adverse Event|7
7776840|NCT00926796|12223456|FG001|Overall Study|Adverse Event|14
7776841|NCT00926796|12223455|FG000|Overall Study|Lost to Follow-up|22
7776842|NCT00926796|12223456|FG001|Overall Study|Lost to Follow-up|13
7776843|NCT00926796|12223455|FG000|Overall Study|Protocol Violation|15
7607921|NCT03357952|12015645|FG000|Overall Study|Withdrawal by Subject|0
7607922|NCT03357952|12015646|FG001|Overall Study|Withdrawal by Subject|1
7607923|NCT03357952|12015645|FG000|Overall Study|Sponsor Decision|9
7607924|NCT03357952|12015646|FG001|Overall Study|Sponsor Decision|0
7607925|NCT03170869|12015661|FG000|Overall Study|Protocol Violation|5
7607926|NCT03170869|12015661|FG000|Overall Study|Early study termination|3
7607927|NCT03066622|12015668|FG000|Overall Study|Lost to Follow-up|24
7607928|NCT03066622|12015669|FG001|Overall Study|Lost to Follow-up|25
7607929|NCT03066622|12015668|FG000|Overall Study|Withdrawal by Subject|2
7607930|NCT03066622|12015669|FG001|Overall Study|Withdrawal by Subject|1
7607931|NCT03052920|12015675|FG000|Overall Study|Withdrawal by Subject|1
7776844|NCT00926796|12223456|FG001|Overall Study|Protocol Violation|11
7776845|NCT00926796|12223455|FG000|Overall Study|Withdrawal by Subject|1
7776846|NCT00926796|12223456|FG001|Overall Study|Withdrawal by Subject|0
7776847|NCT00927069|12223498|FG000|Week 0 to Week 12|Worsening of psoriasis|1
7776848|NCT00927069|12223499|FG001|Week 0 to Week 12|Worsening of psoriasis|1
7776849|NCT00927069|12223500|FG002|Week 0 to Week 12|Worsening of psoriasis|0
7776850|NCT00927069|12223501|FG003|Week 0 to Week 12|Worsening of psoriasis|0
7776851|NCT00927069|12223498|FG000|Week 12 to Week 24|Lack of Efficacy|0
7776852|NCT00927069|12223499|FG001|Week 12 to Week 24|Lack of Efficacy|0
7776853|NCT00927069|12223500|FG002|Week 12 to Week 24|Lack of Efficacy|2
7607942|NCT02722434|12015703|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1
7607943|NCT02722434|12015704|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0
7607944|NCT02722434|12015703|FG000|Overall Study|Withdrawal After Beginning Treatment|0
7607945|NCT02722434|12015704|FG001|Overall Study|Withdrawal After Beginning Treatment|3
7776854|NCT00927069|12223501|FG003|Week 12 to Week 24|Lack of Efficacy|3
7776855|NCT00927069|12223498|FG000|Week 12 to Week 24|Lost to Follow-up|0
7776856|NCT00927069|12223499|FG001|Week 12 to Week 24|Lost to Follow-up|0
7776857|NCT00927069|12223500|FG002|Week 12 to Week 24|Lost to Follow-up|1
7776858|NCT00927069|12223501|FG003|Week 12 to Week 24|Lost to Follow-up|0
7776859|NCT00927069|12223498|FG000|Week 12 to Week 24|Withdrawal by Subject|1
7776860|NCT00927069|12223499|FG001|Week 12 to Week 24|Withdrawal by Subject|0
7776861|NCT00927069|12223500|FG002|Week 12 to Week 24|Withdrawal by Subject|0
7776862|NCT00927069|12223501|FG003|Week 12 to Week 24|Withdrawal by Subject|0
7776863|NCT00927069|12223498|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1
7607953|NCT01248247|12015767|FG000|Overall Study|Adverse Event|2
7607954|NCT01248247|12015768|FG001|Overall Study|Adverse Event|4
7607955|NCT01248247|12015769|FG002|Overall Study|Adverse Event|4
7607956|NCT01248247|12015770|FG003|Overall Study|Adverse Event|2
7776864|NCT00927069|12223499|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0
7607957|NCT01248247|12015767|FG000|Overall Study|Death|0
7607958|NCT01248247|12015768|FG001|Overall Study|Death|1
7607959|NCT01248247|12015769|FG002|Overall Study|Death|4
7607960|NCT01248247|12015770|FG003|Overall Study|Death|7
7607961|NCT01248247|12015767|FG000|Overall Study|Lost to Follow-up|0
7607962|NCT01248247|12015768|FG001|Overall Study|Lost to Follow-up|1
7607963|NCT01248247|12015769|FG002|Overall Study|Lost to Follow-up|1
7607964|NCT01248247|12015770|FG003|Overall Study|Lost to Follow-up|0
7607965|NCT01248247|12015767|FG000|Overall Study|Alternative treatment|0
7607966|NCT01248247|12015768|FG001|Overall Study|Alternative treatment|1
7607967|NCT01248247|12015769|FG002|Overall Study|Alternative treatment|0
7607968|NCT01248247|12015770|FG003|Overall Study|Alternative treatment|0
7607969|NCT01248247|12015767|FG000|Overall Study|Other|2
7607970|NCT01248247|12015768|FG001|Overall Study|Other|8
7607971|NCT01248247|12015769|FG002|Overall Study|Other|8
7607972|NCT01248247|12015770|FG003|Overall Study|Other|5
7607973|NCT01248247|12015767|FG000|Overall Study|Progression|18
7607974|NCT01248247|12015768|FG001|Overall Study|Progression|27
7607975|NCT01248247|12015769|FG002|Overall Study|Progression|56
7607976|NCT01248247|12015770|FG003|Overall Study|Progression|44
7607977|NCT01248247|12015767|FG000|Overall Study|Refuse further treatment|0
7607978|NCT01248247|12015768|FG001|Overall Study|Refuse further treatment|0
7607979|NCT01248247|12015769|FG002|Overall Study|Refuse further treatment|1
7607980|NCT01248247|12015770|FG003|Overall Study|Refuse further treatment|2
7607981|NCT01248247|12015767|FG000|Overall Study|Complicating disease|0
7607982|NCT01248247|12015768|FG001|Overall Study|Complicating disease|0
7607983|NCT01248247|12015769|FG002|Overall Study|Complicating disease|1
7607984|NCT01248247|12015770|FG003|Overall Study|Complicating disease|1
7607985|NCT01164228|12015782|FG000|Overall Study|Progression|24
7607986|NCT01164228|12015783|FG001|Overall Study|Progression|25
7607987|NCT01164228|12015782|FG000|Overall Study|Adverse Event|13
7607988|NCT01164228|12015783|FG001|Overall Study|Adverse Event|7
7607989|NCT01164228|12015782|FG000|Overall Study|Death|1
7607990|NCT01164228|12015783|FG001|Overall Study|Death|1
7607991|NCT01164228|12015782|FG000|Overall Study|Withdrawal by Subject|2
7607992|NCT01164228|12015783|FG001|Overall Study|Withdrawal by Subject|0
7607993|NCT01164228|12015782|FG000|Overall Study|Physician Decision|1
7607994|NCT01164228|12015783|FG001|Overall Study|Physician Decision|2
7607995|NCT01164228|12015782|FG000|Overall Study|Symptomatic deterioration|1
7607996|NCT01164228|12015783|FG001|Overall Study|Symptomatic deterioration|0
7607997|NCT01164228|12015782|FG000|Overall Study|Never started treatment|1
7607998|NCT01164228|12015783|FG001|Overall Study|Never started treatment|3
7607999|NCT01164228|12015782|FG000|Overall Study|Ineligible|1
7608000|NCT01164228|12015783|FG001|Overall Study|Ineligible|0
7608001|NCT00591318|12015850|FG000|Overall Study|Lack of Efficacy|2
7608002|NCT00591318|12015851|FG001|Overall Study|Lack of Efficacy|0
7608003|NCT00591318|12015850|FG000|Overall Study|Adverse Event|2
7608004|NCT00591318|12015851|FG001|Overall Study|Adverse Event|0
7608005|NCT04534517|12015872|FG000|Overall Study|Adverse Event|1
7608006|NCT04534517|12015872|FG000|Overall Study|Withdrawal by Subject|1
7608007|NCT04534517|12015872|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1
7608008|NCT04534517|12015872|FG000|Overall Study|COVID-19 Related|1
7608009|NCT04494646|12015878|FG000|Overall Study|Adverse Event|0
7608010|NCT04494646|12015879|FG001|Overall Study|Adverse Event|1
7608011|NCT04494646|12015878|FG000|Overall Study|Withdrawal by Subject|0
7608012|NCT04494646|12015879|FG001|Overall Study|Withdrawal by Subject|1
7776865|NCT00927069|12223500|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0
7776866|NCT00927069|12223501|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0
7776867|NCT00927082|12223515|FG000|Overall Study|Lost to Follow-up|9
7776868|NCT00927082|12223516|FG001|Overall Study|Lost to Follow-up|8
7776869|NCT00927082|12223517|FG002|Overall Study|Lost to Follow-up|12
7776870|NCT00927082|12223518|FG003|Overall Study|Lost to Follow-up|16
7776871|NCT00927082|12223515|FG000|Overall Study|Withdrawal by Subject|3
7776872|NCT00927082|12223516|FG001|Overall Study|Withdrawal by Subject|2
7776873|NCT00927082|12223517|FG002|Overall Study|Withdrawal by Subject|7
7776874|NCT00927082|12223518|FG003|Overall Study|Withdrawal by Subject|2
7776875|NCT00927082|12223515|FG000|Overall Study|Death|0
7776876|NCT00927082|12223516|FG001|Overall Study|Death|0
7608013|NCT04258020|12015887|FG000|Overall Study|Withdrawal by Subject|1
7608014|NCT04258020|12015888|FG001|Overall Study|Withdrawal by Subject|0
7608015|NCT04234464|12015896|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1
7608016|NCT04234464|12015897|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0
7608017|NCT03852316|12015903|FG000|Overall Study|Protocol Violation|1
7608018|NCT03852316|12015903|FG000|Overall Study|Withdrawal by Subject|2
7608019|NCT03852316|12015903|FG000|Overall Study|Enrolled but Device not Utilized|1
7608020|NCT03789318|12015912|FG000|Overall Study|Adverse Event|0
7608021|NCT03789318|12015913|FG001|Overall Study|Adverse Event|0
7608022|NCT03789318|12015914|FG002|Overall Study|Adverse Event|1
7608023|NCT03789318|12015915|FG003|Overall Study|Adverse Event|1
7608024|NCT03789318|12015916|FG004|Overall Study|Adverse Event|0
7776877|NCT00927082|12223517|FG002|Overall Study|Death|1
7776878|NCT00927082|12223518|FG003|Overall Study|Death|0
7776879|NCT00927082|12223515|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0
7776880|NCT00927082|12223516|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0
7776881|NCT00927082|12223517|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2
7776882|NCT00927082|12223518|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1
7776883|NCT00927095|12223535|FG000|Overall Study|Adverse Event|3
7776884|NCT00927095|12223536|FG001|Overall Study|Adverse Event|1
7776885|NCT00927095|12223537|FG002|Overall Study|Adverse Event|0
7776886|NCT00927095|12223535|FG000|Overall Study|Withdrawal by Subject|2
7776887|NCT00927095|12223536|FG001|Overall Study|Withdrawal by Subject|1
7776888|NCT00927095|12223537|FG002|Overall Study|Withdrawal by Subject|1
7776889|NCT00927095|12223535|FG000|Overall Study|Physician Decision|1
7776890|NCT00927095|12223536|FG001|Overall Study|Physician Decision|2
7776891|NCT00927095|12223537|FG002|Overall Study|Physician Decision|1
7776892|NCT00927186|12223556|FG000|12 Months Primary Study|Adverse Event|5
7776893|NCT00927186|12223557|FG001|12 Months Primary Study|Adverse Event|2
7776894|NCT00927186|12223556|FG000|12 Months Primary Study|Lost to Follow-up|1
7776895|NCT00927186|12223557|FG001|12 Months Primary Study|Lost to Follow-up|0
7776896|NCT00927186|12223556|FG000|12 Months Primary Study|Protocol Violation|0
7776897|NCT00927186|12223557|FG001|12 Months Primary Study|Protocol Violation|1
7776898|NCT00927186|12223556|FG000|12 Months Primary Study|Withdrawal by Subject|1
7776899|NCT00927186|12223557|FG001|12 Months Primary Study|Withdrawal by Subject|1
7776900|NCT00927251|12223566|FG000|Overall Study|Patients not implanted with 4296 lead|8
7608025|NCT03789318|12015912|FG000|Overall Study|Lost to Follow-up|0
7608026|NCT03789318|12015913|FG001|Overall Study|Lost to Follow-up|0
7608027|NCT03789318|12015914|FG002|Overall Study|Lost to Follow-up|1
7608028|NCT03789318|12015915|FG003|Overall Study|Lost to Follow-up|0
7608029|NCT03789318|12015916|FG004|Overall Study|Lost to Follow-up|0
7608030|NCT03789318|12015912|FG000|Overall Study|Withdrawal by Subject|0
7608031|NCT03789318|12015913|FG001|Overall Study|Withdrawal by Subject|0
7608032|NCT03789318|12015914|FG002|Overall Study|Withdrawal by Subject|1
7608033|NCT03789318|12015915|FG003|Overall Study|Withdrawal by Subject|0
7608034|NCT03789318|12015916|FG004|Overall Study|Withdrawal by Subject|0
7776901|NCT00927355|12223583|FG000|Overall Study|Adverse Event|1
7776902|NCT00927355|12223584|FG001|Overall Study|Adverse Event|1
7776903|NCT00927368|12223605|FG000|Overall Study|enrollment in another study|1
7776904|NCT00927368|12223606|FG001|Overall Study|enrollment in another study|1
7776905|NCT00927368|12223607|FG002|Overall Study|enrollment in another study|2
7776906|NCT00927368|12223605|FG000|Overall Study|Lost to Follow-up|4
7776907|NCT00927368|12223606|FG001|Overall Study|Lost to Follow-up|0
7776908|NCT00927368|12223607|FG002|Overall Study|Lost to Follow-up|0
7776909|NCT00927368|12223605|FG000|Overall Study|equipment failure|1
7776910|NCT00927368|12223606|FG001|Overall Study|equipment failure|0
7776911|NCT00927368|12223607|FG002|Overall Study|equipment failure|0
7776912|NCT00927368|12223605|FG000|Overall Study|ineligible post randomization|0
7776913|NCT00927368|12223606|FG001|Overall Study|ineligible post randomization|3
7776914|NCT00927368|12223607|FG002|Overall Study|ineligible post randomization|1
7776915|NCT00927368|12223605|FG000|Overall Study|cancellation of surgery|0
7776916|NCT00927368|12223606|FG001|Overall Study|cancellation of surgery|1
7776917|NCT00927368|12223607|FG002|Overall Study|cancellation of surgery|2
7776918|NCT00927394|12223617|FG000|Overall Study|Adverse Event|14
7776919|NCT00927394|12223618|FG001|Overall Study|Adverse Event|9
7776920|NCT00927394|12223617|FG000|Overall Study|Unsatisfactory therapeutic effect|17
7776921|NCT00927394|12223618|FG001|Overall Study|Unsatisfactory therapeutic effect|23
7776922|NCT00927394|12223617|FG000|Overall Study|Withdrawal by Subject|20
7608057|NCT03103321|12015971|FG000|Overall Study|Protocol Violation|1
7608058|NCT03103321|12015972|FG001|Overall Study|Protocol Violation|1
7608059|NCT03103321|12015973|FG002|Overall Study|Protocol Violation|1
7608060|NCT03103321|12015974|FG003|Overall Study|Protocol Violation|0
7608061|NCT03079869|12015986|FG000|Overall Study|Adverse Event|6
7608062|NCT03079869|12015987|FG001|Overall Study|Adverse Event|8
7608063|NCT03079869|12015986|FG000|Overall Study|Withdrawal by Subject|4
7608064|NCT03079869|12015987|FG001|Overall Study|Withdrawal by Subject|1
7608065|NCT03079869|12015986|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3
7608066|NCT03079869|12015987|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2
7608067|NCT03033875|12015996|FG000|Overall Study|Withdrawal by Subject|5
7608068|NCT03033875|12015997|FG001|Overall Study|Withdrawal by Subject|9
7608069|NCT03033875|12015998|FG002|Overall Study|Withdrawal by Subject|4
7608070|NCT03033875|12015996|FG000|Overall Study|Other|14
7608071|NCT03033875|12015997|FG001|Overall Study|Other|15
7608072|NCT03033875|12015998|FG002|Overall Study|Other|8
7608073|NCT02887248|12016010|FG000|Overall Study|Withdrawal by Subject|1
7608074|NCT02887248|12016010|FG000|Overall Study|Adverse Event|1
7608075|NCT02887248|12016010|FG000|Overall Study|Progressive Disease|1
7608076|NCT02849990|12016014|FG000|Overall Study|Adverse Event|1
7776923|NCT00927394|12223618|FG001|Overall Study|Withdrawal by Subject|24
7776924|NCT00927394|12223617|FG000|Overall Study|Lost to Follow-up|8
7776925|NCT00927394|12223618|FG001|Overall Study|Lost to Follow-up|14
7776926|NCT00927394|12223617|FG000|Overall Study|Administrative Problem|1
7776927|NCT00927394|12223618|FG001|Overall Study|Administrative Problem|0
7776928|NCT00927394|12223617|FG000|Overall Study|Death|1
7776929|NCT00927394|12223618|FG001|Overall Study|Death|1
7776930|NCT00927394|12223617|FG000|Overall Study|Protocol deviation|16
7776931|NCT00927394|12223618|FG001|Overall Study|Protocol deviation|13
7776932|NCT00927394|12223617|FG000|Overall Study|Randomized in error|0
7776933|NCT00927394|12223618|FG001|Overall Study|Randomized in error|1
7776934|NCT00927472|12223627|FG000|Overall Study|Withdrawal by Subject|10
7608077|NCT02849990|12016014|FG000|Overall Study|Withdrawal by Subject|1
7608078|NCT02467270|12016047|FG000|Overall Study|Participants Never Treated|0
7608079|NCT02467270|12016048|FG001|Overall Study|Participants Never Treated|1
7608080|NCT02467270|12016049|FG002|Overall Study|Participants Never Treated|0
7608081|NCT02467270|12016047|FG000|Overall Study|Ongoing|50
7608082|NCT02467270|12016048|FG001|Overall Study|Ongoing|41
7608083|NCT02467270|12016049|FG002|Overall Study|Ongoing|43
7608084|NCT02467270|12016047|FG000|Overall Study|Adverse Event|16
7608085|NCT02467270|12016048|FG001|Overall Study|Adverse Event|15
7608086|NCT02467270|12016049|FG002|Overall Study|Adverse Event|14
7608087|NCT02467270|12016047|FG000|Overall Study|Progressive Disease|7
7608088|NCT02467270|12016048|FG001|Overall Study|Progressive Disease|7
7608089|NCT02467270|12016049|FG002|Overall Study|Progressive Disease|4
7608090|NCT02467270|12016047|FG000|Overall Study|Death|2
7608091|NCT02467270|12016048|FG001|Overall Study|Death|0
7608092|NCT02467270|12016049|FG002|Overall Study|Death|2
7608093|NCT02467270|12016047|FG000|Overall Study|Lack of Efficacy|12
7608094|NCT02467270|12016048|FG001|Overall Study|Lack of Efficacy|18
7608095|NCT02467270|12016049|FG002|Overall Study|Lack of Efficacy|23
7608096|NCT02467270|12016047|FG000|Overall Study|Non-compliance With Study Drug|0
7608097|NCT02467270|12016048|FG001|Overall Study|Non-compliance With Study Drug|2
7608098|NCT02467270|12016049|FG002|Overall Study|Non-compliance With Study Drug|1
7608099|NCT02467270|12016047|FG000|Overall Study|Lost to Follow-up|2
7608100|NCT02467270|12016048|FG001|Overall Study|Lost to Follow-up|1
7608101|NCT02467270|12016049|FG002|Overall Study|Lost to Follow-up|0
7608102|NCT02467270|12016047|FG000|Overall Study|Pregnancy|0
7608103|NCT02467270|12016048|FG001|Overall Study|Pregnancy|1
7608104|NCT02467270|12016049|FG002|Overall Study|Pregnancy|0
7608105|NCT02467270|12016047|FG000|Overall Study|Physician Decision|0
7608106|NCT02467270|12016048|FG001|Overall Study|Physician Decision|4
7608107|NCT02467270|12016049|FG002|Overall Study|Physician Decision|1
7608108|NCT02467270|12016047|FG000|Overall Study|Withdrawal by Subject|4
7608109|NCT02467270|12016048|FG001|Overall Study|Withdrawal by Subject|3
7608110|NCT02467270|12016049|FG002|Overall Study|Withdrawal by Subject|5
7608111|NCT02467270|12016047|FG000|Overall Study|Reason not Specified|1
7608112|NCT02467270|12016048|FG001|Overall Study|Reason not Specified|2
7608113|NCT02467270|12016049|FG002|Overall Study|Reason not Specified|1
7608114|NCT02452554|12016063|FG000|Overall Study|Death|2
7608115|NCT02452554|12016064|FG001|Overall Study|Death|1
7608116|NCT02452554|12016065|FG002|Overall Study|Death|0
7608117|NCT02452554|12016066|FG003|Overall Study|Death|0
7608118|NCT02452554|12016067|FG004|Overall Study|Death|0
7608119|NCT02452554|12016068|FG005|Overall Study|Death|0
7608120|NCT02452554|12016063|FG000|Overall Study|Lack of Efficacy|13
7608121|NCT02452554|12016064|FG001|Overall Study|Lack of Efficacy|14
7608122|NCT02452554|12016065|FG002|Overall Study|Lack of Efficacy|9
7776935|NCT00927472|12223628|FG001|Overall Study|Withdrawal by Subject|11
7776936|NCT00927472|12223627|FG000|Overall Study|Lost to Follow-up|1
7776937|NCT00927472|12223628|FG001|Overall Study|Lost to Follow-up|6
7776938|NCT00927472|12223627|FG000|Overall Study|Protocol Violation|0
7776939|NCT00927472|12223628|FG001|Overall Study|Protocol Violation|1
7776940|NCT00927472|12223627|FG000|Overall Study|Post treatment Assessment out of window|0
7776941|NCT00927472|12223628|FG001|Overall Study|Post treatment Assessment out of window|4
7776942|NCT00927485|12223636|FG000|Overall Study|Adverse Event|4
7776943|NCT00927485|12223637|FG001|Overall Study|Adverse Event|2
7776944|NCT00927485|12223636|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2
7776945|NCT00927485|12223637|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2
7776946|NCT00927563|12223643|FG000|Overall Study|Lost to Follow-up|1
7776947|NCT00927563|12223643|FG000|Overall Study|Withdrawal by Subject|1
7776948|NCT00927589|12223655|FG000|Overall Study|Death|1
7608123|NCT02452554|12016066|FG003|Overall Study|Lack of Efficacy|1
7608124|NCT02452554|12016067|FG004|Overall Study|Lack of Efficacy|5
7608125|NCT02452554|12016068|FG005|Overall Study|Lack of Efficacy|8
7608126|NCT02452554|12016063|FG000|Overall Study|Physician Decision|0
7608127|NCT02452554|12016064|FG001|Overall Study|Physician Decision|1
7608128|NCT02452554|12016065|FG002|Overall Study|Physician Decision|0
7608129|NCT02452554|12016066|FG003|Overall Study|Physician Decision|0
7608130|NCT02452554|12016067|FG004|Overall Study|Physician Decision|0
7608131|NCT02452554|12016068|FG005|Overall Study|Physician Decision|0
7608132|NCT02452554|12016063|FG000|Overall Study|Withdrawal by Subject|1
7608133|NCT02452554|12016064|FG001|Overall Study|Withdrawal by Subject|0
7608134|NCT02452554|12016065|FG002|Overall Study|Withdrawal by Subject|2
7608135|NCT02452554|12016066|FG003|Overall Study|Withdrawal by Subject|0
7608136|NCT02452554|12016067|FG004|Overall Study|Withdrawal by Subject|0
7608137|NCT02452554|12016068|FG005|Overall Study|Withdrawal by Subject|1
7608138|NCT02452554|12016063|FG000|Overall Study|Ineligible|0
7608139|NCT02452554|12016064|FG001|Overall Study|Ineligible|1
7608140|NCT02452554|12016065|FG002|Overall Study|Ineligible|0
7608141|NCT02452554|12016066|FG003|Overall Study|Ineligible|0
7608142|NCT02452554|12016067|FG004|Overall Study|Ineligible|0
7608143|NCT02452554|12016068|FG005|Overall Study|Ineligible|0
7608144|NCT02452554|12016063|FG000|Overall Study|Never Received Treatment|1
7608145|NCT02452554|12016064|FG001|Overall Study|Never Received Treatment|0
7608146|NCT02452554|12016065|FG002|Overall Study|Never Received Treatment|0
7608147|NCT02452554|12016066|FG003|Overall Study|Never Received Treatment|0
7608148|NCT02452554|12016067|FG004|Overall Study|Never Received Treatment|0
7608149|NCT02452554|12016068|FG005|Overall Study|Never Received Treatment|0
7608150|NCT02318277|12016091|FG000|Overall Study|Physician Decision|0
7608151|NCT02318277|12016092|FG001|Overall Study|Physician Decision|0
7608152|NCT02318277|12016093|FG002|Overall Study|Physician Decision|0
7608153|NCT02318277|12016094|FG003|Overall Study|Physician Decision|0
7608154|NCT02318277|12016095|FG004|Overall Study|Physician Decision|0
7608155|NCT02318277|12016096|FG005|Overall Study|Physician Decision|0
7608156|NCT02318277|12016097|FG006|Overall Study|Physician Decision|0
7608157|NCT02318277|12016098|FG007|Overall Study|Physician Decision|1
7608158|NCT02318277|12016091|FG000|Overall Study|Other|0
7608159|NCT02318277|12016092|FG001|Overall Study|Other|0
7608160|NCT02318277|12016093|FG002|Overall Study|Other|0
7608161|NCT02318277|12016094|FG003|Overall Study|Other|0
7608162|NCT02318277|12016095|FG004|Overall Study|Other|0
7608163|NCT02318277|12016096|FG005|Overall Study|Other|0
7608164|NCT02318277|12016097|FG006|Overall Study|Other|1
7608165|NCT02318277|12016098|FG007|Overall Study|Other|0
7608166|NCT02318277|12016091|FG000|Overall Study|Withdrawal by Subject|0
7608167|NCT02318277|12016092|FG001|Overall Study|Withdrawal by Subject|0
7608168|NCT02318277|12016093|FG002|Overall Study|Withdrawal by Subject|1
7608169|NCT02318277|12016094|FG003|Overall Study|Withdrawal by Subject|0
7608170|NCT02318277|12016095|FG004|Overall Study|Withdrawal by Subject|1
7608171|NCT02318277|12016096|FG005|Overall Study|Withdrawal by Subject|1
7608172|NCT02318277|12016097|FG006|Overall Study|Withdrawal by Subject|6
7608173|NCT02318277|12016098|FG007|Overall Study|Withdrawal by Subject|14
7608174|NCT02318277|12016091|FG000|Overall Study|Participant trial terminated by sponsor|0
7608175|NCT02318277|12016092|FG001|Overall Study|Participant trial terminated by sponsor|0
7608176|NCT02318277|12016093|FG002|Overall Study|Participant trial terminated by sponsor|1
7608177|NCT02318277|12016094|FG003|Overall Study|Participant trial terminated by sponsor|0
7608178|NCT02318277|12016095|FG004|Overall Study|Participant trial terminated by sponsor|1
7608179|NCT02318277|12016096|FG005|Overall Study|Participant trial terminated by sponsor|2
7608180|NCT02318277|12016097|FG006|Overall Study|Participant trial terminated by sponsor|5
7608181|NCT02318277|12016098|FG007|Overall Study|Participant trial terminated by sponsor|16
7608182|NCT02318277|12016091|FG000|Overall Study|Lost to Follow-up|1
7608183|NCT02318277|12016092|FG001|Overall Study|Lost to Follow-up|0
7608184|NCT02318277|12016093|FG002|Overall Study|Lost to Follow-up|1
7608185|NCT02318277|12016094|FG003|Overall Study|Lost to Follow-up|0
7608186|NCT02318277|12016095|FG004|Overall Study|Lost to Follow-up|0
7608187|NCT02318277|12016096|FG005|Overall Study|Lost to Follow-up|0
7608188|NCT02318277|12016097|FG006|Overall Study|Lost to Follow-up|3
7608189|NCT02318277|12016098|FG007|Overall Study|Lost to Follow-up|4
7608190|NCT02318277|12016091|FG000|Overall Study|Death|5
7608191|NCT02318277|12016092|FG001|Overall Study|Death|3
7608192|NCT02318277|12016093|FG002|Overall Study|Death|1
7608193|NCT02318277|12016094|FG003|Overall Study|Death|4
7608194|NCT02318277|12016095|FG004|Overall Study|Death|6
7608195|NCT02318277|12016096|FG005|Overall Study|Death|5
7608196|NCT02318277|12016097|FG006|Overall Study|Death|34
7608197|NCT02318277|12016098|FG007|Overall Study|Death|58
7608198|NCT02318277|12016091|FG000|Overall Study|Transitioned to Hospice|0
7608199|NCT02318277|12016092|FG001|Overall Study|Transitioned to Hospice|0
7608200|NCT02318277|12016093|FG002|Overall Study|Transitioned to Hospice|0
7608201|NCT02318277|12016094|FG003|Overall Study|Transitioned to Hospice|0
7608202|NCT02318277|12016095|FG004|Overall Study|Transitioned to Hospice|0
7608203|NCT02318277|12016096|FG005|Overall Study|Transitioned to Hospice|1
7608204|NCT02318277|12016097|FG006|Overall Study|Transitioned to Hospice|0
7608205|NCT02318277|12016098|FG007|Overall Study|Transitioned to Hospice|0
7608206|NCT02143063|12016154|FG000|Overall Study|Lost to Follow-up|16
7608207|NCT02143063|12016155|FG001|Overall Study|Lost to Follow-up|28
7608208|NCT02143063|12016156|FG002|Overall Study|Lost to Follow-up|29
7608209|NCT02143063|12016154|FG000|Overall Study|Withdrawal by Subject|0
7608210|NCT02143063|12016155|FG001|Overall Study|Withdrawal by Subject|1
7608211|NCT02143063|12016156|FG002|Overall Study|Withdrawal by Subject|0
7608212|NCT02143063|12016154|FG000|Overall Study|Death|0
7608213|NCT02143063|12016155|FG001|Overall Study|Death|1
7608214|NCT02143063|12016156|FG002|Overall Study|Death|1
7608215|NCT02017964|12016164|FG000|Overall Study|Patient deemed ineligible|1
7608216|NCT01968785|12016170|FG000|Overall Study|Withdrawal by Subject|1
7608217|NCT01968785|12016171|FG001|Overall Study|Withdrawal by Subject|0
7776949|NCT00927589|12223655|FG000|Overall Study|Physician Decision|1
7776950|NCT00927589|12223655|FG000|Overall Study|Withdrawal by Subject|3
7776951|NCT00927589|12223655|FG000|Overall Study|Adverse Event|2
7776952|NCT00927589|12223655|FG000|Overall Study|Disease Progression|8
7776953|NCT00927589|12223655|FG000|Overall Study|Non-compliance|1
7776954|NCT00927758|12223659|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
7776955|NCT00927758|12223660|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
7776956|NCT00927758|12223661|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
7776957|NCT00927758|12223662|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
7776958|NCT00927758|12223663|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
7776959|NCT00927758|12223664|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
7776960|NCT00927758|12223659|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
7776961|NCT00927758|12223660|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
7776962|NCT00927758|12223661|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
7776963|NCT00927758|12223662|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
7776964|NCT00927758|12223663|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
7776965|NCT00927758|12223664|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
7776966|NCT00927784|12223674|FG000|Overall Study|Death|1
7776967|NCT00927784|12223675|FG001|Overall Study|Death|0
7776968|NCT00927784|12223674|FG000|Overall Study|Withdrawal by Subject|1
7776969|NCT00927784|12223675|FG001|Overall Study|Withdrawal by Subject|0
7776970|NCT00927810|12223685|FG000|Overall Study|Withdrawal by Subject|0
7776971|NCT00927810|12223686|FG001|Overall Study|Withdrawal by Subject|3
7776972|NCT00927810|12223687|FG002|Overall Study|Withdrawal by Subject|0
7776973|NCT00927810|12223688|FG003|Overall Study|Withdrawal by Subject|1
7776974|NCT00927810|12223685|FG000|Overall Study|Lost to Follow-up|0
7776975|NCT00927810|12223686|FG001|Overall Study|Lost to Follow-up|2
7776976|NCT00927810|12223687|FG002|Overall Study|Lost to Follow-up|1
7776977|NCT00927810|12223688|FG003|Overall Study|Lost to Follow-up|1
7776978|NCT00927810|12223685|FG000|Overall Study|Death|0
7776979|NCT00927810|12223686|FG001|Overall Study|Death|2
7776980|NCT00927810|12223687|FG002|Overall Study|Death|0
7776981|NCT00927810|12223688|FG003|Overall Study|Death|0
7776982|NCT00927810|12223685|FG000|Overall Study|Abnormal laboratory value(s)|0
7776983|NCT00927810|12223686|FG001|Overall Study|Abnormal laboratory value(s)|1
7776984|NCT00927810|12223687|FG002|Overall Study|Abnormal laboratory value(s)|0
7776985|NCT00927810|12223688|FG003|Overall Study|Abnormal laboratory value(s)|0
7776986|NCT00927823|12223706|FG000|Continuous Dosing Period|Death|0
7776987|NCT00927823|12223707|FG001|Continuous Dosing Period|Death|0
7608218|NCT01956110|12016179|FG000|Overall Study|Protocol Violation|25
7608219|NCT01956110|12016180|FG001|Overall Study|Protocol Violation|11
7608220|NCT01956110|12016179|FG000|Overall Study|Adverse Event|9
7608221|NCT01956110|12016180|FG001|Overall Study|Adverse Event|10
7608222|NCT01956110|12016179|FG000|Overall Study|Personal reasons|1
7608223|NCT01956110|12016180|FG001|Overall Study|Personal reasons|1
7608224|NCT01648023|12016189|FG000|Overall Study|Screen Fail Post Randomization|1
7608225|NCT01648023|12016190|FG001|Overall Study|Screen Fail Post Randomization|2
7608226|NCT01083433|12016213|FG000|Overall Study|Lost to Follow-up|2
7608227|NCT01083433|12016214|FG001|Overall Study|Lost to Follow-up|1
7608228|NCT01083433|12016215|FG002|Overall Study|Lost to Follow-up|1
7608229|NCT01083433|12016213|FG000|Overall Study|Withdrawal by Subject|0
7776988|NCT00927823|12223708|FG002|Continuous Dosing Period|Death|6
7776989|NCT00927823|12223709|FG003|Continuous Dosing Period|Death|0
7776990|NCT00927823|12223706|FG000|Continuous Dosing Period|Lost to Follow-up|1
7776991|NCT00927823|12223707|FG001|Continuous Dosing Period|Lost to Follow-up|1
7776992|NCT00927823|12223708|FG002|Continuous Dosing Period|Lost to Follow-up|9
7776993|NCT00927823|12223709|FG003|Continuous Dosing Period|Lost to Follow-up|0
7776994|NCT00927823|12223706|FG000|Continuous Dosing Period|Withdrawal by Subject|1
7776995|NCT00927823|12223707|FG001|Continuous Dosing Period|Withdrawal by Subject|0
7776996|NCT00927823|12223708|FG002|Continuous Dosing Period|Withdrawal by Subject|2
7776997|NCT00927823|12223709|FG003|Continuous Dosing Period|Withdrawal by Subject|2
7776998|NCT00927823|12223706|FG000|Continuous Dosing Period|Other|1
7776999|NCT00927823|12223707|FG001|Continuous Dosing Period|Other|2
7777000|NCT00927823|12223708|FG002|Continuous Dosing Period|Other|9
7777001|NCT00927823|12223709|FG003|Continuous Dosing Period|Other|3
7777002|NCT00927862|12223741|FG000|Overall Study|Missing data needed for endpt analyses|27
7777003|NCT00927862|12223742|FG001|Overall Study|Missing data needed for endpt analyses|45
7777004|NCT00927901|12223761|FG000|Treatment Period 1|Subject withdrew consent|0
7777005|NCT00927901|12223762|FG001|Treatment Period 1|Subject withdrew consent|0
7777006|NCT00927901|12223763|FG002|Treatment Period 1|Subject withdrew consent|1
7777007|NCT00927901|12223764|FG003|Treatment Period 1|Subject withdrew consent|0
7777008|NCT00927901|12223761|FG000|Treatment Period 4|Adverse Event|0
7777009|NCT00927901|12223762|FG001|Treatment Period 4|Adverse Event|0
7777010|NCT00927901|12223763|FG002|Treatment Period 4|Adverse Event|0
7777011|NCT00927901|12223764|FG003|Treatment Period 4|Adverse Event|1
7777012|NCT00927901|12223761|FG000|Treatment Period 4|Subject withdrew consent|0
7777013|NCT00927901|12223762|FG001|Treatment Period 4|Subject withdrew consent|0
7777014|NCT00927901|12223763|FG002|Treatment Period 4|Subject withdrew consent|1
7608230|NCT01083433|12016214|FG001|Overall Study|Withdrawal by Subject|5
7608231|NCT01083433|12016215|FG002|Overall Study|Withdrawal by Subject|3
7608232|NCT01083433|12016213|FG000|Overall Study|Pregnancy|0
7608233|NCT01083433|12016214|FG001|Overall Study|Pregnancy|0
7608234|NCT01083433|12016215|FG002|Overall Study|Pregnancy|1
7608235|NCT00787176|12016231|FG000|Overall Study|Low quality fetal heart rate tracing|7
7777015|NCT00927901|12223764|FG003|Treatment Period 4|Subject withdrew consent|0
7608236|NCT00787176|12016232|FG001|Overall Study|Low quality fetal heart rate tracing|3
7608237|NCT00787176|12016233|FG002|Overall Study|Low quality fetal heart rate tracing|6
7608238|NCT00787176|12016234|FG003|Overall Study|Low quality fetal heart rate tracing|5
7608239|NCT00352534|12016247|FG000|Initial Staging|Ineligible|8
7608240|NCT00352534|12016248|FG001|Initial Staging|Ineligible|9
7608241|NCT00352534|12016249|FG002|Initial Staging|Ineligible|0
7608242|NCT00352534|12016250|FG003|Initial Staging|Ineligible|0
7608243|NCT00352534|12016251|FG004|Initial Staging|Ineligible|0
7608244|NCT00352534|12016252|FG005|Initial Staging|Ineligible|0
7608245|NCT00352534|12016253|FG006|Initial Staging|Ineligible|0
7608246|NCT00352534|12016247|FG000|Final Risk Group Assignment|Lack of Efficacy|0
7608247|NCT00352534|12016248|FG001|Final Risk Group Assignment|Lack of Efficacy|0
7608248|NCT00352534|12016249|FG002|Final Risk Group Assignment|Lack of Efficacy|0
7608249|NCT00352534|12016250|FG003|Final Risk Group Assignment|Lack of Efficacy|2
7608250|NCT00352534|12016251|FG004|Final Risk Group Assignment|Lack of Efficacy|1
7608251|NCT00352534|12016252|FG005|Final Risk Group Assignment|Lack of Efficacy|19
7608252|NCT00352534|12016253|FG006|Final Risk Group Assignment|Lack of Efficacy|0
7608253|NCT00352534|12016247|FG000|Final Risk Group Assignment|Physician Decision|0
7608254|NCT00352534|12016248|FG001|Final Risk Group Assignment|Physician Decision|0
7608255|NCT00352534|12016249|FG002|Final Risk Group Assignment|Physician Decision|0
7608256|NCT00352534|12016250|FG003|Final Risk Group Assignment|Physician Decision|0
7608257|NCT00352534|12016251|FG004|Final Risk Group Assignment|Physician Decision|0
7608258|NCT00352534|12016252|FG005|Final Risk Group Assignment|Physician Decision|8
7608259|NCT00352534|12016253|FG006|Final Risk Group Assignment|Physician Decision|0
7608260|NCT00352534|12016247|FG000|Final Risk Group Assignment|Withdrawal by Subject|0
7608261|NCT00352534|12016248|FG001|Final Risk Group Assignment|Withdrawal by Subject|0
7608262|NCT00352534|12016249|FG002|Final Risk Group Assignment|Withdrawal by Subject|0
7608263|NCT00352534|12016250|FG003|Final Risk Group Assignment|Withdrawal by Subject|0
7608264|NCT00352534|12016251|FG004|Final Risk Group Assignment|Withdrawal by Subject|0
7608265|NCT00352534|12016252|FG005|Final Risk Group Assignment|Withdrawal by Subject|3
7608266|NCT00352534|12016253|FG006|Final Risk Group Assignment|Withdrawal by Subject|0
7608267|NCT00352534|12016247|FG000|Final Risk Group Assignment|Ineligible|0
7608268|NCT00352534|12016248|FG001|Final Risk Group Assignment|Ineligible|0
7608269|NCT00352534|12016249|FG002|Final Risk Group Assignment|Ineligible|3
7608270|NCT00352534|12016250|FG003|Final Risk Group Assignment|Ineligible|1
7608271|NCT00352534|12016251|FG004|Final Risk Group Assignment|Ineligible|0
7608272|NCT00352534|12016252|FG005|Final Risk Group Assignment|Ineligible|13
7608273|NCT00352534|12016253|FG006|Final Risk Group Assignment|Ineligible|0
7608274|NCT00352534|12016247|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0
7608275|NCT00352534|12016248|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0
7608276|NCT00352534|12016249|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0
7608277|NCT00352534|12016250|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0
7608278|NCT00352534|12016251|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0
7608279|NCT00352534|12016252|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0
7608280|NCT00352534|12016253|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28
7608281|NCT00352534|12016247|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7777016|NCT00927927|12223792|FG000|Overall Study|Withdrawal by Subject|0
7777017|NCT00927927|12223793|FG001|Overall Study|Withdrawal by Subject|0
7777018|NCT00927927|12223794|FG002|Overall Study|Withdrawal by Subject|0
7608282|NCT00352534|12016248|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7608283|NCT00352534|12016249|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7777019|NCT00927927|12223795|FG003|Overall Study|Withdrawal by Subject|0
7777020|NCT00927927|12223796|FG004|Overall Study|Withdrawal by Subject|0
7777021|NCT00927927|12223797|FG005|Overall Study|Withdrawal by Subject|0
7777022|NCT00927927|12223798|FG006|Overall Study|Withdrawal by Subject|0
7777023|NCT00927927|12223799|FG007|Overall Study|Withdrawal by Subject|2
7777024|NCT00927927|12223800|FG008|Overall Study|Withdrawal by Subject|0
7777025|NCT00927927|12223801|FG009|Overall Study|Withdrawal by Subject|0
7777026|NCT00927927|12223802|FG010|Overall Study|Withdrawal by Subject|0
7777027|NCT00927927|12223803|FG011|Overall Study|Withdrawal by Subject|2
7777028|NCT00927927|12223804|FG012|Overall Study|Withdrawal by Subject|0
7777029|NCT00927927|12223805|FG013|Overall Study|Withdrawal by Subject|0
7777030|NCT00927927|12223806|FG014|Overall Study|Withdrawal by Subject|0
7777031|NCT00927940|12223838|FG000|Overall Study|Death|1
7777032|NCT00928018|12223849|FG000|Overall Study|Withdrawal by Subject|1
7777033|NCT00928018|12223850|FG001|Overall Study|Withdrawal by Subject|0
7777034|NCT00928057|12223862|FG000|Overall Study|Adverse Event|1
7777035|NCT00928057|12223863|FG001|Overall Study|Adverse Event|2
7777036|NCT00928057|12223862|FG000|Overall Study|Withdrawal by Subject|1
7777037|NCT00928057|12223863|FG001|Overall Study|Withdrawal by Subject|0
7777038|NCT00928057|12223862|FG000|Overall Study|Lost to Follow-up|0
7608284|NCT00352534|12016250|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7608285|NCT00352534|12016251|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7608286|NCT00352534|12016252|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7608287|NCT00352534|12016253|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
7608288|NCT00352534|12016247|FG000|Final Risk Group Assignment|Death|0
7777039|NCT00928057|12223863|FG001|Overall Study|Lost to Follow-up|1
7608289|NCT00352534|12016248|FG001|Final Risk Group Assignment|Death|0
7608290|NCT00352534|12016249|FG002|Final Risk Group Assignment|Death|0
7608291|NCT00352534|12016250|FG003|Final Risk Group Assignment|Death|0
7608292|NCT00352534|12016251|FG004|Final Risk Group Assignment|Death|0
7608293|NCT00352534|12016252|FG005|Final Risk Group Assignment|Death|2
7608294|NCT00352534|12016253|FG006|Final Risk Group Assignment|Death|0
7608295|NCT00033293|12016265|FG000|Overall Study|Death|0
7608296|NCT00033293|12016266|FG001|Overall Study|Death|1
7608297|NCT00033293|12016265|FG000|Overall Study|Lack of Efficacy|5
7608298|NCT00033293|12016266|FG001|Overall Study|Lack of Efficacy|8
7608299|NCT00033293|12016265|FG000|Overall Study|Lost to Follow-up|0
7608300|NCT00033293|12016266|FG001|Overall Study|Lost to Follow-up|1
7608301|NCT00033293|12016265|FG000|Overall Study|Physician Decision|3
7608302|NCT00033293|12016266|FG001|Overall Study|Physician Decision|1
7608303|NCT00033293|12016265|FG000|Overall Study|Withdrawal by Subject|1
7608304|NCT00033293|12016266|FG001|Overall Study|Withdrawal by Subject|0
7608305|NCT00033293|12016265|FG000|Overall Study|Could not be weaned from steroid therapy|1
7608306|NCT00033293|12016266|FG001|Overall Study|Could not be weaned from steroid therapy|1
7608307|NCT00033293|12016265|FG000|Overall Study|Treatment refused|0
7608308|NCT00033293|12016266|FG001|Overall Study|Treatment refused|6
7777040|NCT00928057|12223862|FG000|Overall Study|Protocol Violation|0
7777041|NCT00928057|12223863|FG001|Overall Study|Protocol Violation|1
7777042|NCT00928070|12223881|FG000|Overall Study|Lost to Follow-up|1
7777043|NCT00928070|12223882|FG001|Overall Study|Lost to Follow-up|2
7777044|NCT00928070|12223881|FG000|Overall Study|Withdrawal by Subject|10
7777045|NCT00928070|12223882|FG001|Overall Study|Withdrawal by Subject|3
7777046|NCT00928070|12223881|FG000|Overall Study|Adverse Event|14
7777047|NCT00928070|12223882|FG001|Overall Study|Adverse Event|26
7777048|NCT00928070|12223881|FG000|Overall Study|Lack of Efficacy|9
7777049|NCT00928070|12223882|FG001|Overall Study|Lack of Efficacy|5
7777050|NCT00928070|12223881|FG000|Overall Study|Did not meet entrance criteria|16
7777051|NCT00928070|12223882|FG001|Overall Study|Did not meet entrance criteria|9
7777052|NCT00928070|12223881|FG000|Overall Study|Protocol Violation|6
7777053|NCT00928070|12223882|FG001|Overall Study|Protocol Violation|5
7777054|NCT00928070|12223881|FG000|Overall Study|Randomized but not treated|2
7777055|NCT00928070|12223882|FG001|Overall Study|Randomized but not treated|2
7777056|NCT00928070|12223881|FG000|Overall Study|Other|5
7777057|NCT00928070|12223882|FG001|Overall Study|Other|5
7777058|NCT00928135|12223950|FG000|Overall Study|Withdrawal by Subject|1
7777059|NCT00928135|12223951|FG001|Overall Study|Withdrawal by Subject|0
7777060|NCT00928187|12223964|FG000|Overall Study|Death|1
7777061|NCT00928187|12223965|FG001|Overall Study|Death|2
7777062|NCT00928187|12223966|FG002|Overall Study|Death|3
7777063|NCT00928187|12223964|FG000|Overall Study|Lost to Follow-up|1
7777064|NCT00928187|12223965|FG001|Overall Study|Lost to Follow-up|2
7777065|NCT00928187|12223966|FG002|Overall Study|Lost to Follow-up|1
7777066|NCT00928187|12223964|FG000|Overall Study|Withdrawal by Subject|0
7777067|NCT00928187|12223965|FG001|Overall Study|Withdrawal by Subject|1
7777068|NCT00928187|12223966|FG002|Overall Study|Withdrawal by Subject|1
7777069|NCT00928187|12223964|FG000|Overall Study|Protocol Violation|0
7777070|NCT00928187|12223965|FG001|Overall Study|Protocol Violation|1
7777071|NCT00928187|12223966|FG002|Overall Study|Protocol Violation|0
7777072|NCT00928252|12223978|FG000|Overall Study|Physician Decision|3
7777073|NCT00928408|12224001|FG000|Overall Study|Other|2
7777074|NCT00928408|12224001|FG000|Overall Study|Withdrawal by Subject|4
7777075|NCT00928408|12224001|FG000|Overall Study|Death|5
7777076|NCT00928408|12224001|FG000|Overall Study|Lost to Follow-up|12
7800049|NCT01090492|12257180|FG000|Second Intervention Period (4 Weeks)|Other|0
7800050|NCT01090492|12257181|FG001|Second Intervention Period (4 Weeks)|Other|1
7800051|NCT01090492|12257182|FG002|Second Intervention Period (4 Weeks)|Other|1
7800052|NCT01090492|12257183|FG003|Second Intervention Period (4 Weeks)|Other|0
7800053|NCT01090492|12257184|FG004|Second Intervention Period (4 Weeks)|Other|0
7800054|NCT01090492|12257185|FG005|Second Intervention Period (4 Weeks)|Other|0
7800055|NCT01090492|12257186|FG006|Second Intervention Period (4 Weeks)|Other|0
7800056|NCT01090492|12257187|FG007|Second Intervention Period (4 Weeks)|Other|0
7800057|NCT01090492|12257180|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0
7800058|NCT01090492|12257181|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0
7800059|NCT01090492|12257182|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1
7800060|NCT01090492|12257183|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0
7800061|NCT01090492|12257184|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1
7800062|NCT01090492|12257185|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1
7800063|NCT01090492|12257186|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7
7800064|NCT01090492|12257187|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1
7800065|NCT01090492|12257180|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7800066|NCT01090492|12257181|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7800067|NCT01090492|12257182|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7800068|NCT01090492|12257183|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7800069|NCT01090492|12257184|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7800070|NCT01090492|12257185|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7800071|NCT01090492|12257186|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
7800072|NCT01090492|12257187|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7777077|NCT00928434|12224012|FG000|Overall Study|Adverse Event|14
7777078|NCT00928434|12224013|FG001|Overall Study|Adverse Event|5
7777079|NCT00928434|12224014|FG002|Overall Study|Adverse Event|18
7608309|NCT04497415|12016276|FG000|Overall Study|Lost to Follow-up|43
7608310|NCT04497415|12016277|FG001|Overall Study|Lost to Follow-up|27
7608311|NCT04594759|12016318|FG000|Overall Study|Lost to Follow-up|3
7608312|NCT04463069|12016324|FG000|Overall Study|Withdrawal by Subject|2
7608313|NCT04463069|12016325|FG001|Overall Study|Withdrawal by Subject|10
7608314|NCT04463069|12016324|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0
7608315|NCT04463069|12016325|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13
7608316|NCT04250337|12016333|FG000|Overall Study|Adverse Event|0
7608317|NCT04250337|12016334|FG001|Overall Study|Adverse Event|3
7608318|NCT04250337|12016333|FG000|Overall Study|Lack of Efficacy|1
7608319|NCT04250337|12016334|FG001|Overall Study|Lack of Efficacy|3
7608320|NCT04250337|12016333|FG000|Overall Study|Physician Decision|1
7608321|NCT04250337|12016334|FG001|Overall Study|Physician Decision|0
7608322|NCT04250337|12016333|FG000|Overall Study|Protocol Deviation|2
7608323|NCT04250337|12016334|FG001|Overall Study|Protocol Deviation|2
7608324|NCT04250337|12016333|FG000|Overall Study|Withdrawal by Subject|4
7608325|NCT04250337|12016334|FG001|Overall Study|Withdrawal by Subject|3
7608326|NCT04126733|12016341|FG000|Treatment Period|Other Reason|1
7608327|NCT04126733|12016341|FG000|Treatment Period|Death|1
7608328|NCT04126733|12016341|FG000|Treatment Period|Physician Decision|3
7608329|NCT04126733|12016341|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7
7608330|NCT04126733|12016341|FG000|Treatment Period|Adverse Event|7
7608331|NCT04126733|12016341|FG000|Treatment Period|Progressive Disease - Radiological Progression|44
7608332|NCT04126733|12016341|FG000|Treatment Period|Ongoing with Study Treatment|7
7608333|NCT04126733|12016341|FG000|Active Follow-up Period|Death|13
7608334|NCT04126733|12016341|FG000|Active Follow-up Period|Other Reason|1
7608335|NCT04126733|12016341|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4
7608336|NCT04126733|12016341|FG000|Active Follow-up Period|Withdrawal by Subject|2
7608337|NCT04126733|12016341|FG000|Long-term Follow-up Period|Withdrawal by Subject|1
7608338|NCT04126733|12016341|FG000|Long-term Follow-up Period|Death|5
7777080|NCT00928434|12224012|FG000|Overall Study|Protocol Violation|5
7777081|NCT00928434|12224013|FG001|Overall Study|Protocol Violation|0
7777082|NCT00928434|12224014|FG002|Overall Study|Protocol Violation|8
7777083|NCT00928434|12224012|FG000|Overall Study|Physician Decision|2
7777084|NCT00928434|12224013|FG001|Overall Study|Physician Decision|0
7777085|NCT00928434|12224014|FG002|Overall Study|Physician Decision|3
7777086|NCT00928434|12224012|FG000|Overall Study|Lost to Follow-up|1
7777087|NCT00928434|12224013|FG001|Overall Study|Lost to Follow-up|0
7777088|NCT00928434|12224014|FG002|Overall Study|Lost to Follow-up|3
7777089|NCT00928434|12224012|FG000|Overall Study|Withdrawal by Subject|5
7777090|NCT00928434|12224013|FG001|Overall Study|Withdrawal by Subject|3
7777091|NCT00928434|12224014|FG002|Overall Study|Withdrawal by Subject|2
7777092|NCT00928434|12224012|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
7777093|NCT00928434|12224013|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
7777094|NCT00928434|12224014|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
7777095|NCT00928434|12224012|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2
7777096|NCT00928434|12224013|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1
7777097|NCT00928434|12224014|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1
7777098|NCT00928434|12224012|FG000|Overall Study|Other (not meeting above criteria)|5
7777099|NCT00928434|12224013|FG001|Overall Study|Other (not meeting above criteria)|1
7777100|NCT00928434|12224014|FG002|Overall Study|Other (not meeting above criteria)|2
7777101|NCT00928486|12224030|FG000|Overall Study|Adverse Event|2
7777102|NCT00928486|12224030|FG000|Overall Study|Disease Progression|7
7608361|NCT03575572|12016371|FG000|Overall Study|Withdrawal by Subject|2
7608362|NCT03575572|12016371|FG000|Overall Study|Physician Decision|2
7608363|NCT03521687|12016384|FG000|Overall Study|Adverse Event|4
7608364|NCT03521687|12016384|FG000|Overall Study|Physician Decision|1
7777103|NCT00928486|12224030|FG000|Overall Study|Withdrawal by Subject|1
7777104|NCT00928512|12224039|FG000|Overall Study|Adverse Event|4
7777105|NCT00928512|12224040|FG001|Overall Study|Adverse Event|3
7777106|NCT00928512|12224041|FG002|Overall Study|Adverse Event|2
7777107|NCT00928512|12224042|FG003|Overall Study|Adverse Event|8
7777108|NCT00928512|12224043|FG004|Overall Study|Adverse Event|6
7777109|NCT00928512|12224039|FG000|Overall Study|Lack of Efficacy|2
7777110|NCT00928512|12224040|FG001|Overall Study|Lack of Efficacy|0
7777111|NCT00928512|12224041|FG002|Overall Study|Lack of Efficacy|4
7777112|NCT00928512|12224042|FG003|Overall Study|Lack of Efficacy|7
7777113|NCT00928512|12224043|FG004|Overall Study|Lack of Efficacy|3
7777114|NCT00928512|12224039|FG000|Overall Study|Protocol Violation|0
7777115|NCT00928512|12224040|FG001|Overall Study|Protocol Violation|1
7777116|NCT00928512|12224041|FG002|Overall Study|Protocol Violation|0
7777117|NCT00928512|12224042|FG003|Overall Study|Protocol Violation|1
7608380|NCT02966301|12016428|FG000|Overall Study|Death|2
7608381|NCT02966301|12016428|FG000|Overall Study|Withdrawal by Subject|1
7608382|NCT02832167|12016441|FG000|Treatment Period 1|Disease progression|90
7608383|NCT02832167|12016441|FG000|Treatment Period 1|Adverse event unrelated to study drug|12
7608384|NCT02832167|12016441|FG000|Treatment Period 1|Death|2
7608385|NCT02832167|12016441|FG000|Treatment Period 1|Study Drug Toxicity|6
7608413|NCT02659020|12016460|FG004|Overall Study|Lost to Follow-up|1
7608386|NCT02832167|12016441|FG000|Treatment Period 1|Participant request to discontinue|9
7608387|NCT02832167|12016441|FG000|Treatment Period 1|No longer meet study criteria|1
7608388|NCT02832167|12016441|FG000|Treatment Period 1|Participant withdrew consent|3
7608389|NCT02832167|12016441|FG000|Treatment Period 1|Other reasons|6
7608390|NCT02832167|12016441|FG000|Transition From Period 1 to Period 2|Other reasons|1
7777118|NCT00928512|12224043|FG004|Overall Study|Protocol Violation|3
7777119|NCT00928512|12224039|FG000|Overall Study|Withdrawal by Subject|3
7777120|NCT00928512|12224040|FG001|Overall Study|Withdrawal by Subject|0
7777121|NCT00928512|12224041|FG002|Overall Study|Withdrawal by Subject|3
7777122|NCT00928512|12224042|FG003|Overall Study|Withdrawal by Subject|4
7777123|NCT00928512|12224043|FG004|Overall Study|Withdrawal by Subject|0
7777124|NCT00928512|12224039|FG000|Overall Study|Lost to Follow-up|1
7777125|NCT00928512|12224040|FG001|Overall Study|Lost to Follow-up|1
7777126|NCT00928512|12224041|FG002|Overall Study|Lost to Follow-up|2
7777127|NCT00928512|12224042|FG003|Overall Study|Lost to Follow-up|1
7777128|NCT00928512|12224043|FG004|Overall Study|Lost to Follow-up|3
7777129|NCT00928512|12224039|FG000|Overall Study|Administrative Problems|0
7777130|NCT00928512|12224040|FG001|Overall Study|Administrative Problems|1
7777131|NCT00928512|12224041|FG002|Overall Study|Administrative Problems|0
7777132|NCT00928512|12224042|FG003|Overall Study|Administrative Problems|0
7777133|NCT00928512|12224043|FG004|Overall Study|Administrative Problems|0
7777134|NCT00928564|12224061|FG000|Overall Study|Lost to Follow-up|6
7777135|NCT00928564|12224062|FG001|Overall Study|Lost to Follow-up|0
7777136|NCT00928668|12224075|FG000|Overall Study|Adverse Event|1
7777137|NCT00928668|12224076|FG001|Overall Study|Adverse Event|0
7777138|NCT00928668|12224077|FG002|Overall Study|Adverse Event|0
7777139|NCT00928668|12224078|FG003|Overall Study|Adverse Event|0
7777140|NCT00928668|12224079|FG004|Overall Study|Adverse Event|0
7777141|NCT00928668|12224075|FG000|Overall Study|Protocol Violation|0
7777142|NCT00928668|12224076|FG001|Overall Study|Protocol Violation|0
7777143|NCT00928668|12224077|FG002|Overall Study|Protocol Violation|0
7777144|NCT00928668|12224078|FG003|Overall Study|Protocol Violation|0
7777145|NCT00928668|12224079|FG004|Overall Study|Protocol Violation|1
7777146|NCT00928668|12224075|FG000|Overall Study|Withdrawal by Subject|0
7777147|NCT00928668|12224076|FG001|Overall Study|Withdrawal by Subject|1
7777148|NCT00928668|12224077|FG002|Overall Study|Withdrawal by Subject|1
7777149|NCT00928668|12224078|FG003|Overall Study|Withdrawal by Subject|0
7777150|NCT00928668|12224079|FG004|Overall Study|Withdrawal by Subject|0
7777151|NCT00928668|12224075|FG000|Overall Study|Other reasons not listed above|0
7777152|NCT00928668|12224076|FG001|Overall Study|Other reasons not listed above|0
7777153|NCT00928668|12224077|FG002|Overall Study|Other reasons not listed above|0
7777154|NCT00928668|12224078|FG003|Overall Study|Other reasons not listed above|1
7777155|NCT00928668|12224079|FG004|Overall Study|Other reasons not listed above|0
7777156|NCT00928707|12224105|FG000|Overall Study|Protocol Violation|1
7777157|NCT00928707|12224106|FG001|Overall Study|Protocol Violation|0
7777158|NCT00928746|12224128|FG000|Overall Study|Adverse Event|2
7777159|NCT00928746|12224128|FG000|Overall Study|Protocol Violation|1
7777160|NCT00928746|12224128|FG000|Overall Study|Withdrawal by Subject|1
7777161|NCT00928746|12224128|FG000|Overall Study|Other|2
7777162|NCT00928889|12224149|FG000|Overall Study|Lost to Follow-up|3
7777163|NCT00928889|12224150|FG001|Overall Study|Lost to Follow-up|1
7777164|NCT00928889|12224149|FG000|Overall Study|Protocol Violation|0
7777165|NCT00928889|12224150|FG001|Overall Study|Protocol Violation|1
7777166|NCT00928889|12224149|FG000|Overall Study|Adverse Event|1
7777167|NCT00928889|12224150|FG001|Overall Study|Adverse Event|0
7777168|NCT00928889|12224149|FG000|Overall Study|Other|1
7777169|NCT00928889|12224150|FG001|Overall Study|Other|0
7777170|NCT00929110|12224173|FG000|Overall Study|Adverse Event|40
7777171|NCT00929110|12224174|FG001|Overall Study|Adverse Event|29
7777172|NCT00929110|12224175|FG002|Overall Study|Adverse Event|18
7608391|NCT02832167|12016441|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1
7608392|NCT02832167|12016441|FG000|Transition From Period 1 to Period 2|Death|2
7608393|NCT02832167|12016441|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3
7608394|NCT02832167|12016441|FG000|Treatment Period 2|Disease progression|69
7608395|NCT02832167|12016441|FG000|Treatment Period 2|Adverse event unrelated to study drug|1
7608396|NCT02832167|12016441|FG000|Treatment Period 2|Maximum clinical benefit|1
7608397|NCT02832167|12016441|FG000|Treatment Period 2|Study Drug Toxicity|5
7608398|NCT02832167|12016441|FG000|Treatment Period 2|Participant request to discontinue|2
7608399|NCT02832167|12016441|FG000|Treatment Period 2|Participant withdrew consent|3
7608400|NCT02832167|12016441|FG000|Treatment Period 2|Other reasons|3
7608401|NCT02699554|12016445|FG000|Overall Study|Lost to Follow-up|9
7608402|NCT02659020|12016456|FG000|Overall Study|Adverse Event|0
7608403|NCT02659020|12016457|FG001|Overall Study|Adverse Event|0
7608404|NCT02659020|12016458|FG002|Overall Study|Adverse Event|0
7608405|NCT02659020|12016459|FG003|Overall Study|Adverse Event|2
7608406|NCT02659020|12016460|FG004|Overall Study|Adverse Event|0
7608407|NCT02659020|12016461|FG005|Overall Study|Adverse Event|0
7608408|NCT02659020|12016462|FG006|Overall Study|Adverse Event|2
7608409|NCT02659020|12016456|FG000|Overall Study|Lost to Follow-up|1
7608410|NCT02659020|12016457|FG001|Overall Study|Lost to Follow-up|2
7608411|NCT02659020|12016458|FG002|Overall Study|Lost to Follow-up|1
7608412|NCT02659020|12016459|FG003|Overall Study|Lost to Follow-up|6
7777173|NCT00929110|12224173|FG000|Overall Study|Subject withdrew consent|40
7608414|NCT02659020|12016461|FG005|Overall Study|Lost to Follow-up|5
7608415|NCT02659020|12016462|FG006|Overall Study|Lost to Follow-up|0
7608416|NCT02659020|12016456|FG000|Overall Study|Physician Decision|0
7608417|NCT02659020|12016457|FG001|Overall Study|Physician Decision|0
7608418|NCT02659020|12016458|FG002|Overall Study|Physician Decision|0
7777174|NCT00929110|12224174|FG001|Overall Study|Subject withdrew consent|23
7777175|NCT00929110|12224175|FG002|Overall Study|Subject withdrew consent|26
7777176|NCT00929110|12224173|FG000|Overall Study|Unsatisfactory therapeutic effect|20
7777177|NCT00929110|12224174|FG001|Overall Study|Unsatisfactory therapeutic effect|9
7777178|NCT00929110|12224175|FG002|Overall Study|Unsatisfactory therapeutic effect|6
7777179|NCT00929110|12224173|FG000|Overall Study|Lost to Follow-up|7
7777180|NCT00929110|12224174|FG001|Overall Study|Lost to Follow-up|7
7777181|NCT00929110|12224175|FG002|Overall Study|Lost to Follow-up|3
7777182|NCT00929110|12224173|FG000|Overall Study|Protocol deviation|5
7777183|NCT00929110|12224174|FG001|Overall Study|Protocol deviation|2
7777184|NCT00929110|12224175|FG002|Overall Study|Protocol deviation|4
7777185|NCT00929110|12224173|FG000|Overall Study|Administrative problems|4
7777186|NCT00929110|12224174|FG001|Overall Study|Administrative problems|1
7777187|NCT00929110|12224175|FG002|Overall Study|Administrative problems|2
7777188|NCT00929110|12224173|FG000|Overall Study|Death|2
7777189|NCT00929110|12224174|FG001|Overall Study|Death|2
7777190|NCT00929110|12224175|FG002|Overall Study|Death|2
7608419|NCT02659020|12016459|FG003|Overall Study|Physician Decision|1
7608420|NCT02659020|12016460|FG004|Overall Study|Physician Decision|1
7608421|NCT02659020|12016461|FG005|Overall Study|Physician Decision|0
7608422|NCT02659020|12016462|FG006|Overall Study|Physician Decision|1
7608423|NCT02659020|12016456|FG000|Overall Study|Withdrawal by Subject|2
7608424|NCT02659020|12016457|FG001|Overall Study|Withdrawal by Subject|1
7608425|NCT02659020|12016458|FG002|Overall Study|Withdrawal by Subject|0
7777191|NCT00929110|12224173|FG000|Overall Study|Abnormal laboratory value(s)|0
7777192|NCT00929110|12224174|FG001|Overall Study|Abnormal laboratory value(s)|1
7777193|NCT00929110|12224175|FG002|Overall Study|Abnormal laboratory value(s)|0
7777194|NCT00929110|12224173|FG000|Overall Study|Abnormal test procedure result(s)|0
7777195|NCT00929110|12224174|FG001|Overall Study|Abnormal test procedure result(s)|1
7777196|NCT00929110|12224175|FG002|Overall Study|Abnormal test procedure result(s)|1
7777197|NCT00929110|12224173|FG000|Overall Study|Patient inability to use the device|0
7777198|NCT00929110|12224174|FG001|Overall Study|Patient inability to use the device|1
7777199|NCT00929110|12224175|FG002|Overall Study|Patient inability to use the device|0
7777200|NCT00929162|12224185|FG000|Overall Study|Adverse Event|8
7777201|NCT00929162|12224186|FG001|Overall Study|Adverse Event|5
7777202|NCT00929162|12224185|FG000|Overall Study|Withdrawal by Subject|3
7777203|NCT00929162|12224186|FG001|Overall Study|Withdrawal by Subject|1
7777204|NCT00929162|12224185|FG000|Overall Study|Protocol Violation|32
7777205|NCT00929162|12224186|FG001|Overall Study|Protocol Violation|30
7777206|NCT00929162|12224185|FG000|Overall Study|Other termination reason|5
7777207|NCT00929162|12224186|FG001|Overall Study|Other termination reason|6
7777208|NCT00929201|12224192|FG000|Period 1|Withdrawal by Subject|0
7777209|NCT00929201|12224193|FG001|Period 1|Withdrawal by Subject|1
7608426|NCT02659020|12016459|FG003|Overall Study|Withdrawal by Subject|3
7608427|NCT02659020|12016460|FG004|Overall Study|Withdrawal by Subject|3
7608428|NCT02659020|12016461|FG005|Overall Study|Withdrawal by Subject|6
7608429|NCT02659020|12016462|FG006|Overall Study|Withdrawal by Subject|3
7608430|NCT02659020|12016456|FG000|Overall Study|Progressive Disease|0
7608431|NCT02659020|12016457|FG001|Overall Study|Progressive Disease|0
7608432|NCT02659020|12016458|FG002|Overall Study|Progressive Disease|0
7608433|NCT02659020|12016459|FG003|Overall Study|Progressive Disease|4
7608434|NCT02659020|12016460|FG004|Overall Study|Progressive Disease|1
7608435|NCT02659020|12016461|FG005|Overall Study|Progressive Disease|0
7608436|NCT02659020|12016462|FG006|Overall Study|Progressive Disease|2
7608437|NCT02626949|12016487|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15
7608438|NCT02626949|12016488|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11
7608439|NCT02626949|12016487|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1
7608440|NCT02626949|12016488|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3
7608441|NCT02626949|12016487|FG000|Enrolled|Lost to Follow-up|7
7608442|NCT02626949|12016488|FG001|Enrolled|Lost to Follow-up|6
7608443|NCT02626949|12016487|FG000|Enrolled|Withdrawal by Subject|3
7777210|NCT00929240|12224200|FG000|Initial Treatment Phase|Adverse Event|31
7777211|NCT00929240|12224201|FG001|Initial Treatment Phase|Adverse Event|0
7777212|NCT00929240|12224202|FG002|Initial Treatment Phase|Adverse Event|0
7777213|NCT00929240|12224200|FG000|Initial Treatment Phase|Disease progression|41
7777214|NCT00929240|12224201|FG001|Initial Treatment Phase|Disease progression|0
7777215|NCT00929240|12224202|FG002|Initial Treatment Phase|Disease progression|0
7608444|NCT02626949|12016488|FG001|Enrolled|Withdrawal by Subject|2
7608445|NCT02565914|12016503|FG000|Overall Study|Adverse Event|17
7608446|NCT02565914|12016503|FG000|Overall Study|Withdrawal of consent (not due to AE)|25
7608447|NCT02565914|12016503|FG000|Overall Study|Lost to Follow-up|12
7608448|NCT02565914|12016503|FG000|Overall Study|Death (not treatment emergent)|1
7608449|NCT02565914|12016503|FG000|Overall Study|Other noncompliance|6
7608450|NCT02565914|12016503|FG000|Overall Study|Physician Decision|6
7608451|NCT02565914|12016503|FG000|Overall Study|Parent study termination by sponsor|1
7608452|NCT02565914|12016503|FG000|Overall Study|Commercial drug available|5
7608453|NCT02565914|12016503|FG000|Overall Study|Other|18
7608454|NCT02565914|12016503|FG000|Overall Study|Enrolled, but did not receive study drug|2
7608455|NCT02385045|12016515|FG000|Overall Study|Endoscopy could not be completed|4
7777216|NCT00929240|12224200|FG000|Initial Treatment Phase|Withdrawal by Subject|13
7777217|NCT00929240|12224201|FG001|Initial Treatment Phase|Withdrawal by Subject|0
7777218|NCT00929240|12224202|FG002|Initial Treatment Phase|Withdrawal by Subject|0
7777219|NCT00929240|12224200|FG000|Initial Treatment Phase|Protocol Violation|5
7777220|NCT00929240|12224201|FG001|Initial Treatment Phase|Protocol Violation|0
7777221|NCT00929240|12224202|FG002|Initial Treatment Phase|Protocol Violation|0
7777222|NCT00929240|12224200|FG000|Initial Treatment Phase|Death|2
7777223|NCT00929240|12224201|FG001|Initial Treatment Phase|Death|0
7777224|NCT00929240|12224202|FG002|Initial Treatment Phase|Death|0
7777225|NCT00929240|12224200|FG000|Initial Treatment Phase|Health authority/Study termination|3
7777226|NCT00929240|12224201|FG001|Initial Treatment Phase|Health authority/Study termination|0
7777227|NCT00929240|12224202|FG002|Initial Treatment Phase|Health authority/Study termination|0
7777228|NCT00929240|12224200|FG000|Initial Treatment Phase|Physician Decision|4
7777229|NCT00929240|12224201|FG001|Initial Treatment Phase|Physician Decision|0
7777230|NCT00929240|12224202|FG002|Initial Treatment Phase|Physician Decision|0
7777231|NCT00929240|12224200|FG000|Maintenance Phase|Disease progression|0
7777232|NCT00929240|12224201|FG001|Maintenance Phase|Disease progression|73
7777233|NCT00929240|12224202|FG002|Maintenance Phase|Disease progression|60
7777234|NCT00929240|12224200|FG000|Maintenance Phase|Adverse Event|0
7777235|NCT00929240|12224201|FG001|Maintenance Phase|Adverse Event|9
7777236|NCT00929240|12224202|FG002|Maintenance Phase|Adverse Event|12
7777237|NCT00929240|12224200|FG000|Maintenance Phase|Withdrawal by Subject|0
7777238|NCT00929240|12224201|FG001|Maintenance Phase|Withdrawal by Subject|2
7777239|NCT00929240|12224202|FG002|Maintenance Phase|Withdrawal by Subject|6
7777240|NCT00929240|12224200|FG000|Maintenance Phase|Protocol Violation|0
7777241|NCT00929240|12224201|FG001|Maintenance Phase|Protocol Violation|1
7777242|NCT00929240|12224202|FG002|Maintenance Phase|Protocol Violation|0
7777243|NCT00929240|12224200|FG000|Maintenance Phase|Health authority/Study termination|0
7608456|NCT01845649|12016530|FG000|Overall Study|Adverse Event|7
7608457|NCT01845649|12016531|FG001|Overall Study|Adverse Event|10
7777244|NCT00929240|12224201|FG001|Maintenance Phase|Health authority/Study termination|1
7777245|NCT00929240|12224202|FG002|Maintenance Phase|Health authority/Study termination|2
7777246|NCT00929240|12224200|FG000|Maintenance Phase|Physician Decision|0
7777247|NCT00929240|12224201|FG001|Maintenance Phase|Physician Decision|2
7777248|NCT00929240|12224202|FG002|Maintenance Phase|Physician Decision|1
7777249|NCT00929240|12224200|FG000|Maintenance Phase|Change of treatment|0
7777250|NCT00929240|12224201|FG001|Maintenance Phase|Change of treatment|4
7777251|NCT00929240|12224202|FG002|Maintenance Phase|Change of treatment|0
7777252|NCT00929240|12224200|FG000|Maintenance Phase|Treatment ongoing at study closure|0
7777253|NCT00929240|12224201|FG001|Maintenance Phase|Treatment ongoing at study closure|0
7608458|NCT01845649|12016530|FG000|Overall Study|Lack of Efficacy|1
7608459|NCT01845649|12016531|FG001|Overall Study|Lack of Efficacy|1
7608460|NCT01845649|12016530|FG000|Overall Study|Lost to Follow-up|2
7608461|NCT01845649|12016531|FG001|Overall Study|Lost to Follow-up|2
7608462|NCT01845649|12016530|FG000|Overall Study|Withdrew Consent|12
7608463|NCT01845649|12016531|FG001|Overall Study|Withdrew Consent|4
7608464|NCT01845649|12016530|FG000|Overall Study|Protocol Deviation|7
7608465|NCT01845649|12016531|FG001|Overall Study|Protocol Deviation|4
7608466|NCT01845649|12016530|FG000|Overall Study|Reason not Specified|2
7608467|NCT01845649|12016531|FG001|Overall Study|Reason not Specified|1
7777254|NCT00929240|12224202|FG002|Maintenance Phase|Treatment ongoing at study closure|10
7777255|NCT00929240|12224200|FG000|Maintenance Phase|Participant not treated|0
7777256|NCT00929240|12224201|FG001|Maintenance Phase|Participant not treated|2
7777257|NCT00929240|12224202|FG002|Maintenance Phase|Participant not treated|0
7777258|NCT00929526|12224267|FG000|Overall Study|Withdrawal by Subject|1
7777259|NCT00929526|12224268|FG001|Overall Study|Withdrawal by Subject|11
7777260|NCT00929526|12224267|FG000|Overall Study|Lost to Follow-up|8
7777261|NCT00929526|12224268|FG001|Overall Study|Lost to Follow-up|12
7777262|NCT00929526|12224267|FG000|Overall Study|Other|8
7777263|NCT00929526|12224268|FG001|Overall Study|Other|6
7777264|NCT00929643|12224283|FG000|Overall Study|Protocol Violation|2
7777265|NCT00929656|12224289|FG000|Overall Study|Lost to Follow-up|0
7777266|NCT00929656|12224290|FG001|Overall Study|Lost to Follow-up|1
7777267|NCT00929669|12224296|FG000|Overall Study|elevated glucose levels|1
7777268|NCT00929695|12224302|FG000|Overall Study|Death|2
7777269|NCT00929695|12224303|FG001|Overall Study|Death|1
7777270|NCT00929695|12224302|FG000|Overall Study|Withdrawal by Subject|0
7608474|NCT01816139|12016548|FG000|Overall Study|Adverse Event|6
7608475|NCT01816139|12016549|FG001|Overall Study|Adverse Event|8
7608476|NCT01816139|12016548|FG000|Overall Study|Lack of Efficacy|1
7608477|NCT01816139|12016549|FG001|Overall Study|Lack of Efficacy|2
7608478|NCT01816139|12016548|FG000|Overall Study|Lost to Follow-up|5
7608479|NCT01816139|12016549|FG001|Overall Study|Lost to Follow-up|3
7608480|NCT01816139|12016548|FG000|Overall Study|Withdrew Consent|6
7608481|NCT01816139|12016549|FG001|Overall Study|Withdrew Consent|4
7608482|NCT01816139|12016548|FG000|Overall Study|Protocol Violation|6
7608483|NCT01816139|12016549|FG001|Overall Study|Protocol Violation|3
7608484|NCT01816139|12016548|FG000|Overall Study|Reason not Specified|4
7608485|NCT01816139|12016549|FG001|Overall Study|Reason not Specified|2
7608486|NCT01455597|12016555|FG000|Overall Study|Adverse Event|7
7608487|NCT01455597|12016556|FG001|Overall Study|Adverse Event|0
7608488|NCT01455597|12016557|FG002|Overall Study|Adverse Event|5
7608489|NCT01455597|12016558|FG003|Overall Study|Adverse Event|1
7608490|NCT01455597|12016555|FG000|Overall Study|Lack of Efficacy|0
7608491|NCT01455597|12016556|FG001|Overall Study|Lack of Efficacy|1
7608492|NCT01455597|12016557|FG002|Overall Study|Lack of Efficacy|2
7608493|NCT01455597|12016558|FG003|Overall Study|Lack of Efficacy|0
7608494|NCT01455597|12016555|FG000|Overall Study|Lost to Follow-up|3
7777271|NCT00929695|12224303|FG001|Overall Study|Withdrawal by Subject|2
7777272|NCT00929695|12224302|FG000|Overall Study|discharge home|4
7777273|NCT00929695|12224303|FG001|Overall Study|discharge home|3
7777274|NCT00929695|12224302|FG000|Overall Study|incorrect stratification|2
7777275|NCT00929695|12224303|FG001|Overall Study|incorrect stratification|0
7777276|NCT00929708|12224319|FG000|Overall Study|Protocol Violation|2
7777277|NCT00929708|12224320|FG001|Overall Study|Protocol Violation|1
7777278|NCT00929708|12224321|FG002|Overall Study|Protocol Violation|1
7777279|NCT00929708|12224322|FG003|Overall Study|Protocol Violation|1
7608495|NCT01455597|12016556|FG001|Overall Study|Lost to Follow-up|0
7608496|NCT01455597|12016557|FG002|Overall Study|Lost to Follow-up|2
7608497|NCT01455597|12016558|FG003|Overall Study|Lost to Follow-up|1
7608498|NCT01455597|12016555|FG000|Overall Study|Withdrew Consent|6
7608499|NCT01455597|12016556|FG001|Overall Study|Withdrew Consent|5
7608500|NCT01455597|12016557|FG002|Overall Study|Withdrew Consent|8
7608501|NCT01455597|12016558|FG003|Overall Study|Withdrew Consent|5
7608502|NCT01455597|12016555|FG000|Overall Study|Reason not Specified|1
7608503|NCT01455597|12016556|FG001|Overall Study|Reason not Specified|2
7608504|NCT01455597|12016557|FG002|Overall Study|Reason not Specified|3
7608505|NCT01455597|12016558|FG003|Overall Study|Reason not Specified|3
7608506|NCT01400776|12016574|FG000|Overall Study|Adverse Event|7
7608507|NCT01400776|12016575|FG001|Overall Study|Adverse Event|2
7608508|NCT01400776|12016576|FG002|Overall Study|Adverse Event|9
7608509|NCT01400776|12016577|FG003|Overall Study|Adverse Event|2
7608510|NCT01400776|12016574|FG000|Overall Study|Lost to Follow-up|1
7608511|NCT01400776|12016575|FG001|Overall Study|Lost to Follow-up|0
7608512|NCT01400776|12016576|FG002|Overall Study|Lost to Follow-up|4
7608513|NCT01400776|12016577|FG003|Overall Study|Lost to Follow-up|1
7608514|NCT01400776|12016574|FG000|Overall Study|Withdrew Consent|4
7608515|NCT01400776|12016575|FG001|Overall Study|Withdrew Consent|2
7608516|NCT01400776|12016576|FG002|Overall Study|Withdrew Consent|6
7608517|NCT01400776|12016577|FG003|Overall Study|Withdrew Consent|1
7608518|NCT01400776|12016574|FG000|Overall Study|Protocol Deviation|6
7777280|NCT00929708|12224323|FG004|Overall Study|Protocol Violation|1
7777281|NCT00929708|12224319|FG000|Overall Study|Withdrawal by Subject|2
7777282|NCT00929708|12224320|FG001|Overall Study|Withdrawal by Subject|0
7777283|NCT00929708|12224321|FG002|Overall Study|Withdrawal by Subject|0
7777284|NCT00929708|12224322|FG003|Overall Study|Withdrawal by Subject|2
7777285|NCT00929708|12224323|FG004|Overall Study|Withdrawal by Subject|1
7777286|NCT00929708|12224319|FG000|Overall Study|Adverse Event|0
7777287|NCT00929708|12224320|FG001|Overall Study|Adverse Event|0
7777288|NCT00929708|12224321|FG002|Overall Study|Adverse Event|0
7777289|NCT00929708|12224322|FG003|Overall Study|Adverse Event|0
7777290|NCT00929708|12224323|FG004|Overall Study|Adverse Event|3
7777291|NCT00929708|12224319|FG000|Overall Study|Physician Decision|0
7777292|NCT00929708|12224320|FG001|Overall Study|Physician Decision|2
7777293|NCT00929708|12224321|FG002|Overall Study|Physician Decision|2
7777294|NCT00929708|12224322|FG003|Overall Study|Physician Decision|2
7777295|NCT00929708|12224323|FG004|Overall Study|Physician Decision|1
7777296|NCT00929708|12224319|FG000|Overall Study|Lost to Follow-up|0
7608519|NCT01400776|12016575|FG001|Overall Study|Protocol Deviation|1
7777297|NCT00929708|12224320|FG001|Overall Study|Lost to Follow-up|0
7777298|NCT00929708|12224321|FG002|Overall Study|Lost to Follow-up|0
7608520|NCT01400776|12016576|FG002|Overall Study|Protocol Deviation|5
7608521|NCT01400776|12016577|FG003|Overall Study|Protocol Deviation|2
7608522|NCT01400776|12016574|FG000|Overall Study|Reason not Specified|3
7608523|NCT01400776|12016575|FG001|Overall Study|Reason not Specified|0
7608524|NCT01400776|12016576|FG002|Overall Study|Reason not Specified|4
7608525|NCT01400776|12016577|FG003|Overall Study|Reason not Specified|3
7608526|NCT00511134|12016589|FG000|Overall Study|Withdrawal by Subject|0
7608527|NCT00511134|12016590|FG001|Overall Study|Withdrawal by Subject|2
7777299|NCT00929708|12224322|FG003|Overall Study|Lost to Follow-up|1
7777300|NCT00929708|12224323|FG004|Overall Study|Lost to Follow-up|0
7777301|NCT00929734|12224337|FG000|Overall Study|Lost to Follow-up|2
7777302|NCT00929734|12224338|FG001|Overall Study|Lost to Follow-up|1
7777303|NCT00929734|12224337|FG000|Overall Study|Withdrawal by Subject|0
7777304|NCT00929734|12224338|FG001|Overall Study|Withdrawal by Subject|2
7777305|NCT00929864|12224373|FG000|Overall Study|Death|1
7777306|NCT00929864|12224374|FG001|Overall Study|Death|1
7777307|NCT00929864|12224373|FG000|Overall Study|Adverse Event|11
7777308|NCT00929864|12224374|FG001|Overall Study|Adverse Event|30
7777309|NCT00929864|12224373|FG000|Overall Study|Lack of Efficacy|19
7777310|NCT00929864|12224374|FG001|Overall Study|Lack of Efficacy|16
7777311|NCT00929864|12224373|FG000|Overall Study|Lost to Follow-up|7
7777312|NCT00929864|12224374|FG001|Overall Study|Lost to Follow-up|12
7777313|NCT00929864|12224373|FG000|Overall Study|Withdrawal by Subject|20
7777314|NCT00929864|12224374|FG001|Overall Study|Withdrawal by Subject|9
7777315|NCT00929864|12224373|FG000|Overall Study|No longer met criteria|2
7777316|NCT00929864|12224374|FG001|Overall Study|No longer met criteria|1
7777317|NCT00929864|12224373|FG000|Overall Study|Poor or non-compliance|3
7777318|NCT00929864|12224374|FG001|Overall Study|Poor or non-compliance|3
7777319|NCT00929864|12224373|FG000|Overall Study|Pregnancy|0
7777320|NCT00929864|12224374|FG001|Overall Study|Pregnancy|3
7777321|NCT00929864|12224373|FG000|Overall Study|Administrative reason by Sponsor|1
7777322|NCT00929864|12224374|FG001|Overall Study|Administrative reason by Sponsor|1
7777323|NCT00929864|12224373|FG000|Overall Study|Non-specified|2
7777324|NCT00929864|12224374|FG001|Overall Study|Non-specified|7
7777325|NCT00929994|12224384|FG000|Overall Study|Withdrawal by Subject|1
7777326|NCT00929994|12224384|FG000|Overall Study|medical issue unrelated to intervention|4
7777327|NCT00929994|12224384|FG000|Overall Study|employment|1
7777328|NCT00930046|12224393|FG000|Overall Study|Wound catheter malfunctioned|1
7777329|NCT00930046|12224394|FG001|Overall Study|Wound catheter malfunctioned|2
7777330|NCT00930059|12224402|FG000|Overall Study|Death|1
7777331|NCT00930059|12224403|FG001|Overall Study|Death|0
7777332|NCT00930059|12224402|FG000|Overall Study|Did not meet entrance criteria|1
7777333|NCT00930059|12224403|FG001|Overall Study|Did not meet entrance criteria|1
7777334|NCT00930059|12224402|FG000|Overall Study|Withdrawal by Subject|3
7777335|NCT00930059|12224403|FG001|Overall Study|Withdrawal by Subject|4
7777336|NCT00930059|12224402|FG000|Overall Study|Other|1
7777337|NCT00930059|12224403|FG001|Overall Study|Other|0
7777338|NCT00930059|12224402|FG000|Overall Study|1 site terminated by sponsor|1
7777339|NCT00930059|12224403|FG001|Overall Study|1 site terminated by sponsor|1
7777340|NCT00930059|12224402|FG000|Overall Study|Adverse Event|1
7777341|NCT00930059|12224403|FG001|Overall Study|Adverse Event|6
7777342|NCT00930176|12224409|FG000|Overall Study|Death|1
7777343|NCT00930553|12224422|FG000|Overall Study|Adverse Event|1
7777344|NCT00930553|12224422|FG000|Overall Study|Lack of Efficacy|7
7777345|NCT00930553|12224422|FG000|Overall Study|Physician Decision|39
7777346|NCT00930553|12224422|FG000|Overall Study|Protocol Violation|1
7777347|NCT00930553|12224422|FG000|Overall Study|Pregnancy|1
7777348|NCT00930553|12224422|FG000|Overall Study|Withdrawal by Subject|88
7608558|NCT03725293|12016642|FG000|Overall Study|Physician Decision|9
7608559|NCT03725293|12016643|FG001|Overall Study|Physician Decision|6
7608560|NCT03725293|12016642|FG000|Overall Study|alternative vascular access needs|1
7608561|NCT03725293|12016643|FG001|Overall Study|alternative vascular access needs|2
7608562|NCT03725293|12016642|FG000|Overall Study|venous anatomy screen failures|2
7608563|NCT03725293|12016643|FG001|Overall Study|venous anatomy screen failures|1
7608564|NCT03702231|12016652|FG000|Overall Study|Withdrawal by Subject|1
7608565|NCT03702231|12016653|FG001|Overall Study|Withdrawal by Subject|0
7608566|NCT03702231|12016654|FG002|Overall Study|Withdrawal by Subject|0
7608567|NCT03702231|12016652|FG000|Overall Study|Protocol Violation|0
7608568|NCT03702231|12016653|FG001|Overall Study|Protocol Violation|0
7608569|NCT03702231|12016654|FG002|Overall Study|Protocol Violation|1
7608570|NCT03702231|12016652|FG000|Overall Study|COVID Pandemic|3
7608571|NCT03702231|12016653|FG001|Overall Study|COVID Pandemic|4
7608572|NCT03702231|12016654|FG002|Overall Study|COVID Pandemic|1
7608573|NCT03556358|12016685|FG000|Overall Study|Subjects Randomized that did not Treat|3
7608574|NCT03556358|12016686|FG001|Overall Study|Subjects Randomized that did not Treat|0
7608575|NCT03556358|12016685|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7
7608576|NCT03556358|12016686|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5
7608577|NCT03556358|12016685|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0
7608578|NCT03556358|12016686|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1
7608579|NCT03556358|12016685|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0
7608580|NCT03556358|12016686|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1
7608581|NCT03556358|12016685|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0
7608582|NCT03556358|12016686|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2
7608583|NCT03556358|12016685|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0
7608584|NCT03556358|12016686|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1
7608585|NCT03556358|12016685|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1
7608586|NCT03556358|12016686|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2
7608587|NCT03290781|12016699|FG000|Overall Study|Adverse Event|5
7608588|NCT03290781|12016700|FG001|Overall Study|Adverse Event|7
7608589|NCT03290781|12016701|FG002|Overall Study|Adverse Event|4
7608590|NCT03290781|12016702|FG003|Overall Study|Adverse Event|1
7608591|NCT03290781|12016703|FG004|Overall Study|Adverse Event|0
7608592|NCT03290781|12016704|FG005|Overall Study|Adverse Event|0
7608593|NCT03290781|12016705|FG006|Overall Study|Adverse Event|0
7608594|NCT03290781|12016699|FG000|Overall Study|Death|0
7608595|NCT03290781|12016700|FG001|Overall Study|Death|0
7608596|NCT03290781|12016701|FG002|Overall Study|Death|1
7777349|NCT00930553|12224422|FG000|Overall Study|Lost to Follow-up|25
7777350|NCT00930553|12224422|FG000|Overall Study|Death|9
7777351|NCT00930553|12224422|FG000|Overall Study|Study terminated by sponsor|24
7777352|NCT00930553|12224422|FG000|Overall Study|Other than specified above|28
7777353|NCT00930644|12224444|FG000|Overall Study|Withdrawal by Subject|4
7777354|NCT00930644|12224444|FG000|Overall Study|Physician Decision|2
7777355|NCT00930644|12224444|FG000|Overall Study|Death|1
7777356|NCT00930644|12224444|FG000|Overall Study|Adverse Event|16
7777357|NCT00930761|12224453|FG000|Overall Study|3 newborns died; 1 mother quit the study|4
7777358|NCT00930761|12224454|FG001|Overall Study|3 newborns died; 1 mother quit the study|0
7777359|NCT00930761|12224453|FG000|Overall Study|less than 3 music therapy sessions|0
7777360|NCT00930761|12224454|FG001|Overall Study|less than 3 music therapy sessions|3
7777361|NCT00930774|12224464|FG000|Overall Study|Withdrawal by Subject|1
7608597|NCT03290781|12016702|FG003|Overall Study|Death|0
7608598|NCT03290781|12016703|FG004|Overall Study|Death|1
7608599|NCT03290781|12016704|FG005|Overall Study|Death|0
7608600|NCT03290781|12016705|FG006|Overall Study|Death|0
7608601|NCT03290781|12016699|FG000|Overall Study|Withdrawal by Subject|6
7608602|NCT03290781|12016700|FG001|Overall Study|Withdrawal by Subject|5
7777362|NCT00930774|12224465|FG001|Overall Study|Withdrawal by Subject|9
7608603|NCT03290781|12016701|FG002|Overall Study|Withdrawal by Subject|9
7608604|NCT03290781|12016702|FG003|Overall Study|Withdrawal by Subject|10
7608605|NCT03290781|12016703|FG004|Overall Study|Withdrawal by Subject|1
7608606|NCT03290781|12016704|FG005|Overall Study|Withdrawal by Subject|2
7608607|NCT03290781|12016705|FG006|Overall Study|Withdrawal by Subject|0
7608608|NCT03290781|12016699|FG000|Overall Study|Physician Decision|0
7608609|NCT03290781|12016700|FG001|Overall Study|Physician Decision|1
7608610|NCT03290781|12016701|FG002|Overall Study|Physician Decision|0
7608611|NCT03290781|12016702|FG003|Overall Study|Physician Decision|0
7608612|NCT03290781|12016703|FG004|Overall Study|Physician Decision|0
7608613|NCT03290781|12016704|FG005|Overall Study|Physician Decision|0
7608614|NCT03290781|12016705|FG006|Overall Study|Physician Decision|0
7608615|NCT03290781|12016699|FG000|Overall Study|Site Terminated by Sponsor|1
7608616|NCT03290781|12016700|FG001|Overall Study|Site Terminated by Sponsor|0
7608617|NCT03290781|12016701|FG002|Overall Study|Site Terminated by Sponsor|2
7608618|NCT03290781|12016702|FG003|Overall Study|Site Terminated by Sponsor|1
7608619|NCT03290781|12016703|FG004|Overall Study|Site Terminated by Sponsor|0
7608620|NCT03290781|12016704|FG005|Overall Study|Site Terminated by Sponsor|0
7608621|NCT03290781|12016705|FG006|Overall Study|Site Terminated by Sponsor|0
7608622|NCT03290781|12016699|FG000|Overall Study|Lost to Follow-up|0
7608623|NCT03290781|12016700|FG001|Overall Study|Lost to Follow-up|0
7608624|NCT03290781|12016701|FG002|Overall Study|Lost to Follow-up|0
7608625|NCT03290781|12016702|FG003|Overall Study|Lost to Follow-up|1
7608626|NCT03290781|12016703|FG004|Overall Study|Lost to Follow-up|0
7608627|NCT03290781|12016704|FG005|Overall Study|Lost to Follow-up|0
7608628|NCT03290781|12016705|FG006|Overall Study|Lost to Follow-up|0
7608629|NCT03290781|12016699|FG000|Overall Study|Protocol Deviation|2
7608630|NCT03290781|12016700|FG001|Overall Study|Protocol Deviation|0
7608631|NCT03290781|12016701|FG002|Overall Study|Protocol Deviation|0
7608632|NCT03290781|12016702|FG003|Overall Study|Protocol Deviation|1
7608633|NCT03290781|12016703|FG004|Overall Study|Protocol Deviation|0
7608634|NCT03290781|12016704|FG005|Overall Study|Protocol Deviation|0
7608635|NCT03290781|12016705|FG006|Overall Study|Protocol Deviation|0
7608636|NCT03290781|12016699|FG000|Overall Study|Disease Relapse|32
7608637|NCT03290781|12016700|FG001|Overall Study|Disease Relapse|5
7608638|NCT03290781|12016701|FG002|Overall Study|Disease Relapse|38
7608639|NCT03290781|12016702|FG003|Overall Study|Disease Relapse|7
7608640|NCT03290781|12016703|FG004|Overall Study|Disease Relapse|3
7608641|NCT03290781|12016704|FG005|Overall Study|Disease Relapse|1
7608642|NCT03290781|12016705|FG006|Overall Study|Disease Relapse|4
7608643|NCT03290781|12016699|FG000|Overall Study|Other|3
7608644|NCT03290781|12016700|FG001|Overall Study|Other|0
7608645|NCT03290781|12016701|FG002|Overall Study|Other|2
7608646|NCT03290781|12016702|FG003|Overall Study|Other|2
7608647|NCT03290781|12016703|FG004|Overall Study|Other|0
7608648|NCT03290781|12016704|FG005|Overall Study|Other|0
7608649|NCT03290781|12016705|FG006|Overall Study|Other|0
7608650|NCT03228680|12016764|FG000|Overall Study|Adverse Event|13
7608651|NCT03228680|12016765|FG001|Overall Study|Adverse Event|18
7608652|NCT03228680|12016764|FG000|Overall Study|Randomization failure|0
7608653|NCT03228680|12016765|FG001|Overall Study|Randomization failure|1
7608654|NCT03228680|12016764|FG000|Overall Study|Withdrawal by Subject|1
7608655|NCT03228680|12016765|FG001|Overall Study|Withdrawal by Subject|0
7608656|NCT03228680|12016764|FG000|Overall Study|Other|9
7608657|NCT03228680|12016765|FG001|Overall Study|Other|16
7608658|NCT02679781|12016805|FG000|Overall Study|Lost to Follow-up|1
7608659|NCT02679781|12016806|FG001|Overall Study|Lost to Follow-up|2
7608660|NCT02679781|12016805|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6
7608661|NCT02679781|12016806|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1
7608662|NCT02624869|12016815|FG000|Overall Study|Lost to Follow-up|0
7608663|NCT02624869|12016816|FG001|Overall Study|Lost to Follow-up|0
7608664|NCT02624869|12016817|FG002|Overall Study|Lost to Follow-up|1
7608665|NCT02624869|12016815|FG000|Overall Study|Withdrawal by Subject|1
7608666|NCT02624869|12016816|FG001|Overall Study|Withdrawal by Subject|3
7608667|NCT02624869|12016817|FG002|Overall Study|Withdrawal by Subject|1
7608668|NCT02435433|12016856|FG000|Overall Study|On Treatment|11
7608669|NCT02435433|12016857|FG001|Overall Study|On Treatment|0
7608670|NCT02435433|12016858|FG002|Overall Study|On Treatment|0
7608671|NCT02435433|12016859|FG003|Overall Study|On Treatment|0
7608672|NCT02435433|12016860|FG004|Overall Study|On Treatment|0
7608673|NCT02435433|12016856|FG000|Overall Study|Withdrawal by Subject|2
7608674|NCT02435433|12016857|FG001|Overall Study|Withdrawal by Subject|3
7777363|NCT00930774|12224466|FG002|Overall Study|Withdrawal by Subject|2
7608675|NCT02435433|12016858|FG002|Overall Study|Withdrawal by Subject|0
7608676|NCT02435433|12016859|FG003|Overall Study|Withdrawal by Subject|0
7608677|NCT02435433|12016860|FG004|Overall Study|Withdrawal by Subject|0
7608678|NCT02435433|12016856|FG000|Overall Study|Lost to Follow-up|2
7608679|NCT02435433|12016857|FG001|Overall Study|Lost to Follow-up|2
7608680|NCT02435433|12016858|FG002|Overall Study|Lost to Follow-up|0
7608681|NCT02435433|12016859|FG003|Overall Study|Lost to Follow-up|0
7608682|NCT02435433|12016860|FG004|Overall Study|Lost to Follow-up|0
7777364|NCT00930774|12224467|FG003|Overall Study|Withdrawal by Subject|0
7777365|NCT00930813|12224480|FG000|Overall Study|Death|4
7777366|NCT00930813|12224481|FG001|Overall Study|Death|5
7777367|NCT00930813|12224480|FG000|Overall Study|Withdrawal by Subject|2
7777368|NCT00930813|12224481|FG001|Overall Study|Withdrawal by Subject|5
7777369|NCT00930813|12224480|FG000|Overall Study|Lost to Follow-up|2
7777370|NCT00930813|12224481|FG001|Overall Study|Lost to Follow-up|4
7777371|NCT00930930|12224491|FG000|Overall Study|Death|1
7777372|NCT00930930|12224492|FG001|Overall Study|Death|0
7777373|NCT00930930|12224491|FG000|Overall Study|Physician Decision|1
7777374|NCT00930930|12224492|FG001|Overall Study|Physician Decision|0
7777375|NCT00930930|12224491|FG000|Overall Study|Adverse Event|13
7777376|NCT00930930|12224492|FG001|Overall Study|Adverse Event|3
7777377|NCT00930930|12224491|FG000|Overall Study|Withdrawal by Subject|3
7777378|NCT00930930|12224492|FG001|Overall Study|Withdrawal by Subject|1
7777379|NCT00930930|12224491|FG000|Overall Study|Disease progression|2
7777380|NCT00930930|12224492|FG001|Overall Study|Disease progression|3
7777381|NCT00930930|12224491|FG000|Overall Study|excessive lapse btw txs, not eligible|0
7777382|NCT00930930|12224492|FG001|Overall Study|excessive lapse btw txs, not eligible|1
7777383|NCT00930930|12224491|FG000|Overall Study|patients not compliant|1
7777384|NCT00930930|12224492|FG001|Overall Study|patients not compliant|1
7777385|NCT00930969|12224498|FG000|Overall Study|Death|5
7777386|NCT00930969|12224498|FG000|Overall Study|Lost to Follow-up|1
7777387|NCT00930969|12224498|FG000|Overall Study|Physician Decision|13
7777388|NCT00930969|12224498|FG000|Overall Study|Withdrawal by Subject|19
7777389|NCT00930982|12224504|FG000|Overall Study|Adverse Event|19
7777390|NCT00930982|12224505|FG001|Overall Study|Adverse Event|23
7777391|NCT00930982|12224504|FG000|Overall Study|Protocol Violation|1
7777392|NCT00930982|12224505|FG001|Overall Study|Protocol Violation|5
7777393|NCT00930982|12224504|FG000|Overall Study|Withdrawal by Subject|1
7777394|NCT00930982|12224505|FG001|Overall Study|Withdrawal by Subject|1
7777395|NCT00931307|12224522|FG000|Overall Study|Lack of Efficacy|12
7608689|NCT02368886|12016892|FG000|Overall Study|Cancel|1
7608690|NCT02368886|12016893|FG001|Overall Study|Cancel|1
7608691|NCT02368886|12016894|FG002|Overall Study|Cancel|1
7608692|NCT02368886|12016895|FG003|Overall Study|Cancel|3
7608693|NCT02368886|12016892|FG000|Overall Study|Ineligible|0
7608694|NCT02368886|12016893|FG001|Overall Study|Ineligible|0
7608695|NCT02368886|12016894|FG002|Overall Study|Ineligible|0
7608696|NCT02368886|12016895|FG003|Overall Study|Ineligible|1
7608697|NCT02354703|12016907|FG000|Overall Study|Withdrawal by Subject|1
7608698|NCT02354703|12016908|FG001|Overall Study|Withdrawal by Subject|1
7608699|NCT02354703|12016909|FG002|Overall Study|Withdrawal by Subject|1
7608700|NCT02354703|12016910|FG003|Overall Study|Withdrawal by Subject|1
7608701|NCT02354703|12016907|FG000|Overall Study|Lost to Follow-up|2
7608702|NCT02354703|12016908|FG001|Overall Study|Lost to Follow-up|7
7608703|NCT02354703|12016909|FG002|Overall Study|Lost to Follow-up|9
7608704|NCT02354703|12016910|FG003|Overall Study|Lost to Follow-up|2
7608705|NCT02354703|12016907|FG000|Overall Study|Adverse Event|0
7608706|NCT02354703|12016908|FG001|Overall Study|Adverse Event|0
7608707|NCT02354703|12016909|FG002|Overall Study|Adverse Event|1
7608708|NCT02354703|12016910|FG003|Overall Study|Adverse Event|0
7608709|NCT01981551|12016922|FG000|Overall Study|Refused further treatment|8
7608710|NCT01981551|12016922|FG000|Overall Study|Adverse Event|1
7777396|NCT00931307|12224522|FG000|Overall Study|Biomicroscopy|1
7608711|NCT00468130|12016932|FG000|Overall Study|Adverse Event|2
7608712|NCT00468130|12016933|FG001|Overall Study|Adverse Event|1
7608713|NCT00468130|12016932|FG000|Overall Study|Withdrawal by Subject|0
7608714|NCT00468130|12016933|FG001|Overall Study|Withdrawal by Subject|1
7608715|NCT00384111|12016941|FG000|Overall Study|Disease Progression|3
7608716|NCT00384111|12016941|FG000|Overall Study|Adverse Event|1
7608717|NCT00384111|12016941|FG000|Overall Study|Investigator Decision|3
7608718|NCT00384111|12016941|FG000|Overall Study|Study Terminated by the Sponsor|19
7777397|NCT00931385|12224535|FG000|Overall Study|Adverse Event|2
7777398|NCT00931385|12224536|FG001|Overall Study|Adverse Event|1
7777399|NCT00931385|12224537|FG002|Overall Study|Adverse Event|0
7777400|NCT00931385|12224538|FG003|Overall Study|Adverse Event|3
7777401|NCT00931385|12224535|FG000|Overall Study|Protocol Violation|0
7777402|NCT00931385|12224536|FG001|Overall Study|Protocol Violation|0
7777403|NCT00931385|12224537|FG002|Overall Study|Protocol Violation|1
7777404|NCT00931385|12224538|FG003|Overall Study|Protocol Violation|0
7777405|NCT00931385|12224535|FG000|Overall Study|Withdrawal by Subject|0
7777406|NCT00931385|12224536|FG001|Overall Study|Withdrawal by Subject|1
7777407|NCT00931385|12224537|FG002|Overall Study|Withdrawal by Subject|0
7777408|NCT00931385|12224538|FG003|Overall Study|Withdrawal by Subject|1
7608719|NCT04854642|12016945|FG000|Overall Study|Adverse Event|1
7777409|NCT00931385|12224535|FG000|Overall Study|Lost to Follow-up|0
7777410|NCT00931385|12224536|FG001|Overall Study|Lost to Follow-up|0
7777411|NCT00931385|12224537|FG002|Overall Study|Lost to Follow-up|0
7608720|NCT04854642|12016946|FG001|Overall Study|Adverse Event|2
7608721|NCT04854642|12016945|FG000|Overall Study|Withdrawal by Subject|0
7608722|NCT04854642|12016946|FG001|Overall Study|Withdrawal by Subject|1
7608723|NCT04388787|12016967|FG000|Blinded Period|Patient could not follow instructions|1
7608724|NCT04388787|12016967|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9
7608725|NCT04377620|12016991|FG000|Overall Study|Death|42
7608726|NCT04377620|12016992|FG001|Overall Study|Death|48
7608727|NCT04377620|12016993|FG002|Overall Study|Death|36
7608728|NCT04377620|12016991|FG000|Overall Study|Withdrawal by Subject|0
7608729|NCT04377620|12016992|FG001|Overall Study|Withdrawal by Subject|2
7608730|NCT04377620|12016993|FG002|Overall Study|Withdrawal by Subject|0
7608731|NCT04310566|12017024|FG000|Period 1|Study Termination due to COVID-19|15
7608732|NCT04310566|12017025|FG001|Period 1|Study Termination due to COVID-19|17
7608733|NCT04310566|12017024|FG000|Period 1|Protocol Violation|0
7608734|NCT04310566|12017025|FG001|Period 1|Protocol Violation|1
7608735|NCT04310566|12017024|FG000|Period 1|Subject no longer meets eligbility criteria|0
7608736|NCT04310566|12017025|FG001|Period 1|Subject no longer meets eligbility criteria|1
7608737|NCT04310566|12017024|FG000|Period 1|Lost to Follow-up|1
7608738|NCT04310566|12017025|FG001|Period 1|Lost to Follow-up|0
7608739|NCT04310566|12017024|FG000|Period 1|Withdrawal by Subject|0
7608740|NCT04310566|12017025|FG001|Period 1|Withdrawal by Subject|1
7608741|NCT04310566|12017024|FG000|Period 2|Study Termination|7
7608742|NCT04310566|12017025|FG001|Period 2|Study Termination|5
7608743|NCT04206020|12017033|FG000|Overall Study|Adverse Event|1
7608744|NCT04206020|12017034|FG001|Overall Study|Adverse Event|4
7608745|NCT04206020|12017033|FG000|Overall Study|Protocol Violation|2
7608746|NCT04206020|12017034|FG001|Overall Study|Protocol Violation|0
7608747|NCT04206020|12017033|FG000|Overall Study|Withdrawal by Subject|2
7608748|NCT04206020|12017034|FG001|Overall Study|Withdrawal by Subject|0
7608749|NCT04206020|12017033|FG000|Overall Study|Lost to Follow-up|2
7608750|NCT04206020|12017034|FG001|Overall Study|Lost to Follow-up|0
7608751|NCT04206020|12017033|FG000|Overall Study|Pregnancy|0
7608752|NCT04206020|12017034|FG001|Overall Study|Pregnancy|1
7608753|NCT04206020|12017033|FG000|Overall Study|Unable to attend visits|1
7608754|NCT04206020|12017034|FG001|Overall Study|Unable to attend visits|2
7608755|NCT04097301|12017040|FG000|Overall Study|Death|1
7608756|NCT04097301|12017040|FG000|Overall Study|Withdrawal by Subject|1
7608757|NCT04097301|12017040|FG000|Overall Study|Screening Failure|5
7608758|NCT03953079|12017053|FG000|Core Study|Withdrawal by Subject|1
7608759|NCT03953079|12017054|FG001|Core Study|Withdrawal by Subject|2
7608760|NCT03953079|12017055|FG002|Core Study|Withdrawal by Subject|1
7608761|NCT03953079|12017053|FG000|Core Study|COVID-19|0
7608762|NCT03953079|12017054|FG001|Core Study|COVID-19|1
7608763|NCT03953079|12017055|FG002|Core Study|COVID-19|0
7608764|NCT03953079|12017053|FG000|Core Study|Difficulties leaving the house|0
7608765|NCT03953079|12017054|FG001|Core Study|Difficulties leaving the house|1
7608766|NCT03953079|12017055|FG002|Core Study|Difficulties leaving the house|0
7608767|NCT03953079|12017053|FG000|Extension Study|Withdrawal by Subject|1
7608768|NCT03953079|12017054|FG001|Extension Study|Withdrawal by Subject|0
7608769|NCT03953079|12017055|FG002|Extension Study|Withdrawal by Subject|0
7608770|NCT03953079|12017053|FG000|Extension Study|Received Rescue Treatment|5
7608771|NCT03953079|12017054|FG001|Extension Study|Received Rescue Treatment|6
7608772|NCT03953079|12017055|FG002|Extension Study|Received Rescue Treatment|5
7608773|NCT03922750|12017067|FG000|Overall Study|Unclassified|0
7608774|NCT03922750|12017068|FG001|Overall Study|Unclassified|0
7608775|NCT03922750|12017069|FG002|Overall Study|Unclassified|1
7608776|NCT03922750|12017067|FG000|Overall Study|Adverse Event|0
7608777|NCT03922750|12017068|FG001|Overall Study|Adverse Event|1
7608778|NCT03922750|12017069|FG002|Overall Study|Adverse Event|0
7608779|NCT03910673|12017082|FG000|Overall Study|Adverse Event|0
7608780|NCT03910673|12017083|FG001|Overall Study|Adverse Event|0
7608781|NCT03910673|12017084|FG002|Overall Study|Adverse Event|0
7608782|NCT03910673|12017085|FG003|Overall Study|Adverse Event|2
7608783|NCT03910673|12017086|FG004|Overall Study|Adverse Event|0
7608784|NCT03885999|12017090|FG000|Overall Study|Adverse Event|1
7608785|NCT03882970|12017098|FG000|Overall Study|Adverse Event|5
7608786|NCT03882970|12017099|FG001|Overall Study|Adverse Event|7
7608787|NCT03882970|12017100|FG002|Overall Study|Adverse Event|3
7608788|NCT03882970|12017101|FG003|Overall Study|Adverse Event|1
7608789|NCT03882970|12017098|FG000|Overall Study|Death|1
7608790|NCT03882970|12017099|FG001|Overall Study|Death|2
7608791|NCT03882970|12017100|FG002|Overall Study|Death|1
7608792|NCT03882970|12017101|FG003|Overall Study|Death|1
7608793|NCT03882970|12017098|FG000|Overall Study|Lost to Follow-up|8
7608794|NCT03882970|12017099|FG001|Overall Study|Lost to Follow-up|9
7608795|NCT03882970|12017100|FG002|Overall Study|Lost to Follow-up|5
7608796|NCT03882970|12017101|FG003|Overall Study|Lost to Follow-up|5
7608797|NCT03882970|12017098|FG000|Overall Study|Physician Decision|0
7608798|NCT03882970|12017099|FG001|Overall Study|Physician Decision|2
7608799|NCT03882970|12017100|FG002|Overall Study|Physician Decision|2
7608800|NCT03882970|12017101|FG003|Overall Study|Physician Decision|2
7608801|NCT03882970|12017098|FG000|Overall Study|Protocol Violation|2
7608802|NCT03882970|12017099|FG001|Overall Study|Protocol Violation|0
7608803|NCT03882970|12017100|FG002|Overall Study|Protocol Violation|0
7608804|NCT03882970|12017101|FG003|Overall Study|Protocol Violation|0
7608805|NCT03882970|12017098|FG000|Overall Study|Withdrawal by Subject|8
7608806|NCT03882970|12017099|FG001|Overall Study|Withdrawal by Subject|17
7608807|NCT03882970|12017100|FG002|Overall Study|Withdrawal by Subject|7
7608808|NCT03882970|12017101|FG003|Overall Study|Withdrawal by Subject|22
7608809|NCT03882970|12017098|FG000|Overall Study|Personal Reason|2
7608810|NCT03882970|12017099|FG001|Overall Study|Personal Reason|3
7608811|NCT03882970|12017100|FG002|Overall Study|Personal Reason|1
7608812|NCT03882970|12017101|FG003|Overall Study|Personal Reason|3
7608813|NCT03867734|12017125|FG000|Overall Study|Lost to Follow-up|2
7608814|NCT03781778|12017135|FG000|Overall Study|Withdrawal by Subject|2
7608815|NCT03781778|12017136|FG001|Overall Study|Withdrawal by Subject|2
7777412|NCT00931385|12224538|FG003|Overall Study|Lost to Follow-up|1
7777413|NCT00931411|12224554|FG000|First Intervention - 42 Days|Adverse Event|2
7777414|NCT00931411|12224555|FG001|First Intervention - 42 Days|Adverse Event|3
7777415|NCT00931411|12224554|FG000|First Intervention - 42 Days|Lost to Follow-up|2
7777416|NCT00931411|12224555|FG001|First Intervention - 42 Days|Lost to Follow-up|0
7777417|NCT00931411|12224554|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
7777418|NCT00931411|12224555|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
7777419|NCT00931463|12224567|FG000|Overall Study|Death|8
7777420|NCT00931463|12224568|FG001|Overall Study|Death|4
7777421|NCT00931463|12224567|FG000|Overall Study|Withdrawal by Subject|5
7777422|NCT00931463|12224568|FG001|Overall Study|Withdrawal by Subject|0
7777423|NCT00931463|12224567|FG000|Overall Study|Lost to Follow-up|4
7777424|NCT00931463|12224568|FG001|Overall Study|Lost to Follow-up|1
7777425|NCT00931515|12224596|FG000|Overall Study|Lost to Follow-up|2
7777426|NCT00931515|12224597|FG001|Overall Study|Lost to Follow-up|5
7777427|NCT00931528|12224605|FG000|Overall Study|Protocol Violation|9
7777428|NCT00931528|12224606|FG001|Overall Study|Protocol Violation|12
7777429|NCT00931528|12224605|FG000|Overall Study|Withdrawal by Subject|4
7777430|NCT00931528|12224606|FG001|Overall Study|Withdrawal by Subject|12
7777431|NCT00931528|12224605|FG000|Overall Study|Lost to Follow-up|6
7777432|NCT00931528|12224606|FG001|Overall Study|Lost to Follow-up|13
7777433|NCT00931528|12224605|FG000|Overall Study|Assessment outside of Time Frame|22
7777434|NCT00931528|12224606|FG001|Overall Study|Assessment outside of Time Frame|23
7777435|NCT00931632|12224615|FG000|Overall Study|Withdrawal by Subject|2
7777436|NCT00931632|12224616|FG001|Overall Study|Withdrawal by Subject|3
7777437|NCT00931632|12224615|FG000|Overall Study|Adverse Event|19
7777438|NCT00931632|12224616|FG001|Overall Study|Adverse Event|15
7777439|NCT00931710|12224624|FG000|Overall Study|Adverse Event|16
7777440|NCT00931710|12224625|FG001|Overall Study|Adverse Event|10
7777441|NCT00931710|12224624|FG000|Overall Study|Abnormal test procedure results|2
7777442|NCT00931710|12224625|FG001|Overall Study|Abnormal test procedure results|0
7777443|NCT00931710|12224624|FG000|Overall Study|Unsatisfactory therapeutic effects|5
7777444|NCT00931710|12224625|FG001|Overall Study|Unsatisfactory therapeutic effects|12
7777445|NCT00931710|12224624|FG000|Overall Study|Patient withdrew consent|4
7777446|NCT00931710|12224625|FG001|Overall Study|Patient withdrew consent|9
7777447|NCT00931710|12224624|FG000|Overall Study|Lost to Follow-up|6
7777448|NCT00931710|12224625|FG001|Overall Study|Lost to Follow-up|5
7777449|NCT00931710|12224624|FG000|Overall Study|Protocol deviation|1
7608816|NCT03730480|12017155|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1
7608817|NCT03713034|12017168|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5
7608818|NCT03713034|12017169|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4
7608819|NCT03654404|12017177|FG000|Overall Study|Death|1
7608820|NCT03654404|12017177|FG000|Overall Study|Lost to Follow-up|2
7608821|NCT03654404|12017177|FG000|Overall Study|Withdrawal by Subject|5
7608822|NCT03567057|12017184|FG000|Overall Study|Adverse Event|56
7608823|NCT03567057|12017185|FG001|Overall Study|Adverse Event|53
7608824|NCT03567057|12017186|FG002|Overall Study|Adverse Event|28
7608825|NCT03567057|12017184|FG000|Overall Study|Withdrawal by Subject|22
7777450|NCT00931710|12224625|FG001|Overall Study|Protocol deviation|2
7777451|NCT00931723|12224633|FG000|Overall Study|Withdrawal by Subject|11
7777452|NCT00931723|12224634|FG001|Overall Study|Withdrawal by Subject|13
7777453|NCT00931723|12224633|FG000|Overall Study|Adverse Event|6
7777454|NCT00931723|12224634|FG001|Overall Study|Adverse Event|13
7777455|NCT00931723|12224633|FG000|Overall Study|Lithium found in blood|0
7777456|NCT00931723|12224634|FG001|Overall Study|Lithium found in blood|1
7777457|NCT00931723|12224633|FG000|Overall Study|Condition under investigation worsened|1
7777458|NCT00931723|12224634|FG001|Overall Study|Condition under investigation worsened|2
7777459|NCT00931723|12224633|FG000|Overall Study|Lost to Follow-up|1
7777460|NCT00931723|12224634|FG001|Overall Study|Lost to Follow-up|2
7777461|NCT00931723|12224633|FG000|Overall Study|Study-specific discontinuation criteria|1
7777462|NCT00931723|12224634|FG001|Overall Study|Study-specific discontinuation criteria|1
7777463|NCT00931723|12224633|FG000|Overall Study|Severe non-compliance to protocol|2
7777464|NCT00931723|12224634|FG001|Overall Study|Severe non-compliance to protocol|0
7777465|NCT00931723|12224633|FG000|Overall Study|Safety reasons|0
7777466|NCT00931723|12224634|FG001|Overall Study|Safety reasons|1
7777467|NCT00931723|12224633|FG000|Overall Study|Took prohibited concomitant medication|0
7777468|NCT00931723|12224634|FG001|Overall Study|Took prohibited concomitant medication|1
7777469|NCT00931723|12224633|FG000|Overall Study|Lack or insufficient theraputic response|2
7777470|NCT00931723|12224634|FG001|Overall Study|Lack or insufficient theraputic response|5
7777471|NCT00931723|12224633|FG000|Overall Study|Sponsor decision|1
7777472|NCT00931723|12224634|FG001|Overall Study|Sponsor decision|0
7777473|NCT00931723|12224633|FG000|Overall Study|Late hospital discharge|1
7777474|NCT00931723|12224634|FG001|Overall Study|Late hospital discharge|0
7608826|NCT03567057|12017185|FG001|Overall Study|Withdrawal by Subject|24
7608827|NCT03567057|12017186|FG002|Overall Study|Withdrawal by Subject|13
7608828|NCT03567057|12017184|FG000|Overall Study|Lost to Follow-up|3
7608829|NCT03567057|12017185|FG001|Overall Study|Lost to Follow-up|5
7777475|NCT00931762|12224640|FG000|Overall Study|Abnormal Laboratory Value (s)|2
7777476|NCT00931762|12224640|FG000|Overall Study|Administrative Problems|5
7777477|NCT00931762|12224640|FG000|Overall Study|Death|1
7777478|NCT00931762|12224640|FG000|Overall Study|Disease Progression|3
7777479|NCT00931762|12224640|FG000|Overall Study|Adverse Event (s)|11
7777480|NCT00931762|12224640|FG000|Overall Study|Subject withdrew consent|13
7777481|NCT00931801|12224647|FG000|Overall Study|Adverse Event|0
7777482|NCT00931801|12224648|FG001|Overall Study|Adverse Event|0
7608830|NCT03567057|12017186|FG002|Overall Study|Lost to Follow-up|2
7608831|NCT03567057|12017184|FG000|Overall Study|COVID-19 pandemic|4
7608832|NCT03567057|12017185|FG001|Overall Study|COVID-19 pandemic|3
7608833|NCT03567057|12017186|FG002|Overall Study|COVID-19 pandemic|0
7608834|NCT03567057|12017184|FG000|Overall Study|Non-compliance with study drug|4
7608835|NCT03567057|12017185|FG001|Overall Study|Non-compliance with study drug|2
7608836|NCT03567057|12017186|FG002|Overall Study|Non-compliance with study drug|0
7608837|NCT03567057|12017184|FG000|Overall Study|Lack of Efficacy|3
7608838|NCT03567057|12017185|FG001|Overall Study|Lack of Efficacy|0
7608839|NCT03567057|12017186|FG002|Overall Study|Lack of Efficacy|1
7608840|NCT03567057|12017184|FG000|Overall Study|Death|1
7608841|NCT03567057|12017185|FG001|Overall Study|Death|0
7608842|NCT03567057|12017186|FG002|Overall Study|Death|0
7608843|NCT03567057|12017184|FG000|Overall Study|Physician Decision|1
7608844|NCT03567057|12017185|FG001|Overall Study|Physician Decision|0
7608845|NCT03567057|12017186|FG002|Overall Study|Physician Decision|0
7608846|NCT03567057|12017184|FG000|Overall Study|Unstable medical condition|1
7608847|NCT03567057|12017185|FG001|Overall Study|Unstable medical condition|0
7608848|NCT03567057|12017186|FG002|Overall Study|Unstable medical condition|0
7608849|NCT03567057|12017184|FG000|Overall Study|Medical history event|0
7608850|NCT03567057|12017185|FG001|Overall Study|Medical history event|0
7608851|NCT03567057|12017186|FG002|Overall Study|Medical history event|1
7608852|NCT03567057|12017184|FG000|Overall Study|Other|0
7608853|NCT03567057|12017185|FG001|Overall Study|Other|0
7608854|NCT03567057|12017186|FG002|Overall Study|Other|1
7608855|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Other|9
7608856|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Other|0
7608857|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8
7608858|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0
7608859|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11
7608860|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0
7608861|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2
7608862|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0
7608863|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19
7608864|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0
7608865|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1
7608866|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0
7608867|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1
7608868|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0
7608869|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48
7608870|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0
7608871|NCT03548987|12017196|FG000|Maintenance Period (Week 20 to Week 68)|other|12
7608872|NCT03548987|12017197|FG001|Maintenance Period (Week 20 to Week 68)|other|23
7608873|NCT03548987|12017196|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2
7608874|NCT03548987|12017197|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1
7608875|NCT03548987|12017196|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1
7608876|NCT03548987|12017197|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1
7608877|NCT03548987|12017196|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2
7608878|NCT03548987|12017197|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0
7608879|NCT03548987|12017196|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1
7608880|NCT03548987|12017197|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0
7608881|NCT03548987|12017196|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13
7608882|NCT03548987|12017197|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6
7608883|NCT03548064|12017212|FG000|Overall Study|Withdrawal by Subject|0
7608884|NCT03548064|12017213|FG001|Overall Study|Withdrawal by Subject|0
7608885|NCT03548064|12017214|FG002|Overall Study|Withdrawal by Subject|0
7608886|NCT03548064|12017215|FG003|Overall Study|Withdrawal by Subject|1
7608887|NCT03548064|12017216|FG004|Overall Study|Withdrawal by Subject|0
7608888|NCT03548064|12017217|FG005|Overall Study|Withdrawal by Subject|0
7608889|NCT03548064|12017218|FG006|Overall Study|Withdrawal by Subject|0
7608890|NCT03548064|12017219|FG007|Overall Study|Withdrawal by Subject|0
7608891|NCT03548064|12017212|FG000|Overall Study|Lost to Follow-up|0
7777483|NCT00931801|12224649|FG002|Overall Study|Adverse Event|1
7777484|NCT00931801|12224647|FG000|Overall Study|Lost to Follow-up|0
7777485|NCT00931801|12224648|FG001|Overall Study|Lost to Follow-up|1
7777486|NCT00931801|12224649|FG002|Overall Study|Lost to Follow-up|0
7608892|NCT03548064|12017213|FG001|Overall Study|Lost to Follow-up|0
7608893|NCT03548064|12017214|FG002|Overall Study|Lost to Follow-up|0
7608894|NCT03548064|12017215|FG003|Overall Study|Lost to Follow-up|0
7608895|NCT03548064|12017216|FG004|Overall Study|Lost to Follow-up|2
7608896|NCT03548064|12017217|FG005|Overall Study|Lost to Follow-up|0
7608897|NCT03548064|12017218|FG006|Overall Study|Lost to Follow-up|0
7608898|NCT03548064|12017219|FG007|Overall Study|Lost to Follow-up|0
7608899|NCT03548064|12017212|FG000|Overall Study|Covid-19 Pandemic|0
7608900|NCT03548064|12017213|FG001|Overall Study|Covid-19 Pandemic|0
7608901|NCT03548064|12017214|FG002|Overall Study|Covid-19 Pandemic|0
7608902|NCT03548064|12017215|FG003|Overall Study|Covid-19 Pandemic|0
7608903|NCT03548064|12017216|FG004|Overall Study|Covid-19 Pandemic|10
7608904|NCT03548064|12017217|FG005|Overall Study|Covid-19 Pandemic|3
7608905|NCT03548064|12017218|FG006|Overall Study|Covid-19 Pandemic|0
7608906|NCT03548064|12017219|FG007|Overall Study|Covid-19 Pandemic|0
7608907|NCT03446456|12017245|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1
7608908|NCT03446456|12017246|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1
7777487|NCT00931801|12224647|FG000|Overall Study|Withdrawal by Subject|1
7777488|NCT00931801|12224648|FG001|Overall Study|Withdrawal by Subject|0
7777489|NCT00931801|12224649|FG002|Overall Study|Withdrawal by Subject|0
7777490|NCT00931801|12224647|FG000|Overall Study|Confirmed Virologic Failure|0
7777491|NCT00931801|12224648|FG001|Overall Study|Confirmed Virologic Failure|0
7777492|NCT00931801|12224649|FG002|Overall Study|Confirmed Virologic Failure|3
7777493|NCT00931892|12224673|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0
7777494|NCT00931892|12224674|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1
7777495|NCT00931918|12224722|FG000|Overall Study|Adverse Event|4
7777496|NCT00931918|12224723|FG001|Overall Study|Adverse Event|6
7608909|NCT03446456|12017245|FG000|Overall Study|Lost to Follow-up|1
7608910|NCT03446456|12017246|FG001|Overall Study|Lost to Follow-up|3
7608911|NCT03446456|12017245|FG000|Overall Study|Participant failed the toxicology test|1
7608912|NCT03446456|12017246|FG001|Overall Study|Participant failed the toxicology test|0
7608913|NCT03446456|12017245|FG000|Overall Study|Break down of the experimental equipment|1
7608914|NCT03446456|12017246|FG001|Overall Study|Break down of the experimental equipment|0
7608915|NCT03382834|12017254|FG000|Overall Study|Lost to Follow-up|1
7608916|NCT03382834|12017255|FG001|Overall Study|Lost to Follow-up|0
7608917|NCT03382834|12017254|FG000|Overall Study|Withdrawal by Subject|0
7608918|NCT03382834|12017255|FG001|Overall Study|Withdrawal by Subject|1
7608919|NCT03371823|12017263|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1
7608920|NCT03371823|12017264|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0
7608921|NCT03353350|12017274|FG000|30-week Core Treatment Period|Protocol Violation|1
7608922|NCT03353350|12017275|FG001|30-week Core Treatment Period|Protocol Violation|1
7608923|NCT03353350|12017276|FG002|30-week Core Treatment Period|Protocol Violation|1
7608924|NCT03353350|12017277|FG003|30-week Core Treatment Period|Protocol Violation|0
7608925|NCT03353350|12017274|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2
7608926|NCT03353350|12017275|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2
7608927|NCT03353350|12017276|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2
7608928|NCT03353350|12017277|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0
7608929|NCT03353350|12017274|FG000|30-week Core Treatment Period|Adverse Event|0
7608930|NCT03353350|12017275|FG001|30-week Core Treatment Period|Adverse Event|4
7608931|NCT03353350|12017276|FG002|30-week Core Treatment Period|Adverse Event|2
7608932|NCT03353350|12017277|FG003|30-week Core Treatment Period|Adverse Event|3
7608933|NCT03353350|12017274|FG000|30-week Core Treatment Period|Withdrawal by Subject|19
7608934|NCT03353350|12017275|FG001|30-week Core Treatment Period|Withdrawal by Subject|12
7608935|NCT03353350|12017276|FG002|30-week Core Treatment Period|Withdrawal by Subject|19
7608936|NCT03353350|12017277|FG003|30-week Core Treatment Period|Withdrawal by Subject|19
7608937|NCT03353350|12017274|FG000|26-week Treatment Extension Period|Protocol Violation|2
7608938|NCT03353350|12017275|FG001|26-week Treatment Extension Period|Protocol Violation|0
7608939|NCT03353350|12017276|FG002|26-week Treatment Extension Period|Protocol Violation|0
7608940|NCT03353350|12017277|FG003|26-week Treatment Extension Period|Protocol Violation|0
7608941|NCT03353350|12017274|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0
7608942|NCT03353350|12017275|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0
7608943|NCT03353350|12017276|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1
7608944|NCT03353350|12017277|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1
7608945|NCT03353350|12017274|FG000|26-week Treatment Extension Period|Adverse Event|1
7608946|NCT03353350|12017275|FG001|26-week Treatment Extension Period|Adverse Event|0
7608947|NCT03353350|12017276|FG002|26-week Treatment Extension Period|Adverse Event|0
7608948|NCT03353350|12017277|FG003|26-week Treatment Extension Period|Adverse Event|1
7608949|NCT03353350|12017274|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2
7608950|NCT03353350|12017275|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3
7608951|NCT03353350|12017276|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3
7608952|NCT03353350|12017277|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12
7608953|NCT03350503|12017287|FG000|Overall Study|Adverse Event|1
7608954|NCT03350503|12017287|FG000|Overall Study|Hospital Transfer or Removal|2
7608955|NCT03350503|12017287|FG000|Overall Study|Subject Wishes|2
7608959|NCT03282565|12017307|FG000|Overall Study|COVID-19 Research Shutdown|0
7608960|NCT03282565|12017308|FG001|Overall Study|COVID-19 Research Shutdown|2
7608961|NCT03282565|12017309|FG002|Overall Study|COVID-19 Research Shutdown|2
7608962|NCT03276936|12017319|FG000|Overall Study|Adverse Event|4
7608963|NCT03276936|12017320|FG001|Overall Study|Adverse Event|2
7608964|NCT03276936|12017319|FG000|Overall Study|Lost to Follow-up|16
7608965|NCT03276936|12017320|FG001|Overall Study|Lost to Follow-up|13
7608966|NCT03276936|12017319|FG000|Overall Study|Withdrawal by Subject|30
7608967|NCT03276936|12017320|FG001|Overall Study|Withdrawal by Subject|20
7608968|NCT03276936|12017319|FG000|Overall Study|Not mentioned|6
7608969|NCT03276936|12017320|FG001|Overall Study|Not mentioned|3
7608970|NCT03271021|12017328|FG000|Overall Study|Adverse Event|3
7608971|NCT03271021|12017329|FG001|Overall Study|Adverse Event|2
7608972|NCT03271021|12017328|FG000|Overall Study|Withdrawal by Subject|36
7608973|NCT03271021|12017329|FG001|Overall Study|Withdrawal by Subject|53
7608974|NCT03271021|12017328|FG000|Overall Study|Lost to Follow-up|34
7608975|NCT03271021|12017329|FG001|Overall Study|Lost to Follow-up|39
7608976|NCT03271021|12017328|FG000|Overall Study|Protocol Violation|6
7608977|NCT03271021|12017329|FG001|Overall Study|Protocol Violation|4
7608978|NCT03271021|12017328|FG000|Overall Study|Abnormal Lab Results|1
7608979|NCT03271021|12017329|FG001|Overall Study|Abnormal Lab Results|0
7608980|NCT03271021|12017328|FG000|Overall Study|Miscellaneous|9
7608981|NCT03271021|12017329|FG001|Overall Study|Miscellaneous|8
7608982|NCT03255083|12017339|FG000|Overall Study|Clinical progression|1
7608983|NCT03255083|12017340|FG001|Overall Study|Clinical progression|0
7608984|NCT03255083|12017341|FG002|Overall Study|Clinical progression|0
7608985|NCT03255083|12017342|FG003|Overall Study|Clinical progression|0
7608986|NCT03255083|12017339|FG000|Overall Study|Adverse Event|0
7608987|NCT03255083|12017340|FG001|Overall Study|Adverse Event|1
7608988|NCT03255083|12017341|FG002|Overall Study|Adverse Event|0
7608989|NCT03255083|12017342|FG003|Overall Study|Adverse Event|0
7608990|NCT03255083|12017339|FG000|Overall Study|Progressive disease by RECIST version 1.1|4
7608991|NCT03255083|12017340|FG001|Overall Study|Progressive disease by RECIST version 1.1|1
7608992|NCT03255083|12017341|FG002|Overall Study|Progressive disease by RECIST version 1.1|2
7608993|NCT03255083|12017342|FG003|Overall Study|Progressive disease by RECIST version 1.1|1
7608994|NCT03255083|12017339|FG000|Overall Study|Withdrawal by Subject|1
7608995|NCT03255083|12017340|FG001|Overall Study|Withdrawal by Subject|1
7608996|NCT03255083|12017341|FG002|Overall Study|Withdrawal by Subject|1
7608997|NCT03255083|12017342|FG003|Overall Study|Withdrawal by Subject|0
7608998|NCT03227471|12017367|FG000|Overall Study|Withdrawal by Subject|0
7608999|NCT03227471|12017368|FG001|Overall Study|Withdrawal by Subject|0
7609000|NCT03227471|12017369|FG002|Overall Study|Withdrawal by Subject|0
7609001|NCT03227471|12017370|FG003|Overall Study|Withdrawal by Subject|0
7609002|NCT03227471|12017371|FG004|Overall Study|Withdrawal by Subject|1
7609003|NCT03227471|12017372|FG005|Overall Study|Withdrawal by Subject|0
7609004|NCT03227471|12017373|FG006|Overall Study|Withdrawal by Subject|0
7609005|NCT03227471|12017374|FG007|Overall Study|Withdrawal by Subject|0
7609006|NCT03227471|12017375|FG008|Overall Study|Withdrawal by Subject|0
7609007|NCT03227471|12017376|FG009|Overall Study|Withdrawal by Subject|0
7609008|NCT03227471|12017377|FG010|Overall Study|Withdrawal by Subject|0
7609009|NCT03227471|12017378|FG011|Overall Study|Withdrawal by Subject|0
7609010|NCT03227471|12017379|FG012|Overall Study|Withdrawal by Subject|1
7609011|NCT03227471|12017380|FG013|Overall Study|Withdrawal by Subject|0
7609012|NCT03227471|12017381|FG014|Overall Study|Withdrawal by Subject|0
7609013|NCT03227471|12017367|FG000|Overall Study|Randomized, Never Dosed|0
7609014|NCT03227471|12017368|FG001|Overall Study|Randomized, Never Dosed|0
7609015|NCT03227471|12017369|FG002|Overall Study|Randomized, Never Dosed|0
7609016|NCT03227471|12017370|FG003|Overall Study|Randomized, Never Dosed|0
7609017|NCT03227471|12017371|FG004|Overall Study|Randomized, Never Dosed|0
7609018|NCT03227471|12017372|FG005|Overall Study|Randomized, Never Dosed|0
7609019|NCT03227471|12017373|FG006|Overall Study|Randomized, Never Dosed|0
7609020|NCT03227471|12017374|FG007|Overall Study|Randomized, Never Dosed|0
7609021|NCT03227471|12017375|FG008|Overall Study|Randomized, Never Dosed|0
7609022|NCT03227471|12017376|FG009|Overall Study|Randomized, Never Dosed|0
7609023|NCT03227471|12017377|FG010|Overall Study|Randomized, Never Dosed|0
7609024|NCT03227471|12017378|FG011|Overall Study|Randomized, Never Dosed|0
7609025|NCT03227471|12017379|FG012|Overall Study|Randomized, Never Dosed|0
7609026|NCT03227471|12017380|FG013|Overall Study|Randomized, Never Dosed|0
7609027|NCT03227471|12017381|FG014|Overall Study|Randomized, Never Dosed|1
7777497|NCT00931918|12224722|FG000|Overall Study|Progressive Disease|2
7777498|NCT00931918|12224723|FG001|Overall Study|Progressive Disease|1
7777499|NCT00931918|12224722|FG000|Overall Study|Symptomatic Deterioration|1
7777500|NCT00931918|12224723|FG001|Overall Study|Symptomatic Deterioration|0
7777501|NCT00931918|12224722|FG000|Overall Study|Withdrawal by Patient|3
7777502|NCT00931918|12224723|FG001|Overall Study|Withdrawal by Patient|4
7777503|NCT00931918|12224722|FG000|Overall Study|Other Reason not Specified|4
7777504|NCT00931918|12224723|FG001|Overall Study|Other Reason not Specified|4
7777505|NCT00931918|12224722|FG000|Overall Study|Did not receive study drug|3
7777506|NCT00931918|12224723|FG001|Overall Study|Did not receive study drug|2
7777507|NCT00931944|12224729|FG000|Overall Study|Adverse Event|4
7777508|NCT00931944|12224729|FG000|Overall Study|W/D Consent (due to ALS progression))|19
7777509|NCT00931944|12224729|FG000|Overall Study|Withdrawal Consent (due to other)|2
7777510|NCT00931944|12224729|FG000|Overall Study|Death|28
7609042|NCT03194321|12017453|FG000|Overall Study|Withdrawal by Subject|1
7609043|NCT03194321|12017453|FG000|Overall Study|Lost to Follow-up|1
7609044|NCT03194321|12017453|FG000|Overall Study|Travel for Follow-up|1
7609045|NCT03085095|12017459|FG000|Overall Study|Adverse Event|23
7777511|NCT00931944|12224729|FG000|Overall Study|Other|2
7777512|NCT00932113|12224757|FG000|Overall Study|Lost to Follow-up|1
7777513|NCT00932113|12224758|FG001|Overall Study|Lost to Follow-up|0
7777514|NCT00932126|12224764|FG000|Overall Study|Adverse Event|0
7777515|NCT00932126|12224765|FG001|Overall Study|Adverse Event|0
7777516|NCT00932126|12224766|FG002|Overall Study|Adverse Event|0
7777517|NCT00932126|12224767|FG003|Overall Study|Adverse Event|0
7777518|NCT00932126|12224768|FG004|Overall Study|Adverse Event|0
7777519|NCT00932126|12224769|FG005|Overall Study|Adverse Event|0
7777520|NCT00932126|12224770|FG006|Overall Study|Adverse Event|1
7777521|NCT00932126|12224771|FG007|Overall Study|Adverse Event|2
7777522|NCT00932126|12224764|FG000|Overall Study|Protocol Violation|0
7777523|NCT00932126|12224765|FG001|Overall Study|Protocol Violation|0
7777524|NCT00932126|12224766|FG002|Overall Study|Protocol Violation|0
7777525|NCT00932126|12224767|FG003|Overall Study|Protocol Violation|0
7777526|NCT00932126|12224768|FG004|Overall Study|Protocol Violation|1
7777527|NCT00932126|12224769|FG005|Overall Study|Protocol Violation|0
7777528|NCT00932126|12224770|FG006|Overall Study|Protocol Violation|0
7777529|NCT00932126|12224771|FG007|Overall Study|Protocol Violation|0
7777530|NCT00932126|12224764|FG000|Overall Study|Withdrawal by Subject|0
7777531|NCT00932126|12224765|FG001|Overall Study|Withdrawal by Subject|0
7777532|NCT00932126|12224766|FG002|Overall Study|Withdrawal by Subject|1
7609046|NCT03085095|12017460|FG001|Overall Study|Adverse Event|8
7777533|NCT00932126|12224767|FG003|Overall Study|Withdrawal by Subject|0
7609047|NCT03085095|12017459|FG000|Overall Study|Protocol Violation|0
7609048|NCT03085095|12017460|FG001|Overall Study|Protocol Violation|1
7609049|NCT03085095|12017459|FG000|Overall Study|Lost to Follow-up|2
7609050|NCT03085095|12017460|FG001|Overall Study|Lost to Follow-up|1
7777534|NCT00932126|12224768|FG004|Overall Study|Withdrawal by Subject|0
7777535|NCT00932126|12224769|FG005|Overall Study|Withdrawal by Subject|0
7777536|NCT00932126|12224770|FG006|Overall Study|Withdrawal by Subject|0
7609051|NCT03085095|12017459|FG000|Overall Study|Withdrawal by Subject|17
7609052|NCT03085095|12017460|FG001|Overall Study|Withdrawal by Subject|6
7609053|NCT03085095|12017459|FG000|Overall Study|Physician Decision|9
7609054|NCT03085095|12017460|FG001|Overall Study|Physician Decision|3
7609055|NCT03085095|12017459|FG000|Overall Study|Testosterone Suppression Level Not Met|7
7609056|NCT03085095|12017460|FG001|Overall Study|Testosterone Suppression Level Not Met|13
7609057|NCT03085095|12017459|FG000|Overall Study|Did not Receive Study Drug|2
7609058|NCT03085095|12017460|FG001|Overall Study|Did not Receive Study Drug|2
7777537|NCT00932126|12224771|FG007|Overall Study|Withdrawal by Subject|1
7777538|NCT00932126|12224764|FG000|Overall Study|Objective progression or relapse|3
7777539|NCT00932126|12224765|FG001|Overall Study|Objective progression or relapse|3
7777540|NCT00932126|12224766|FG002|Overall Study|Objective progression or relapse|2
7777541|NCT00932126|12224767|FG003|Overall Study|Objective progression or relapse|3
7777542|NCT00932126|12224768|FG004|Overall Study|Objective progression or relapse|3
7777543|NCT00932126|12224769|FG005|Overall Study|Objective progression or relapse|3
7777544|NCT00932126|12224770|FG006|Overall Study|Objective progression or relapse|3
7777545|NCT00932126|12224771|FG007|Overall Study|Objective progression or relapse|5
7777546|NCT00932126|12224764|FG000|Overall Study|Other|0
7777547|NCT00932126|12224765|FG001|Overall Study|Other|0
7777548|NCT00932126|12224766|FG002|Overall Study|Other|0
7777549|NCT00932126|12224767|FG003|Overall Study|Other|0
7777550|NCT00932126|12224768|FG004|Overall Study|Other|1
7777551|NCT00932126|12224769|FG005|Overall Study|Other|0
7777552|NCT00932126|12224770|FG006|Overall Study|Other|1
7777553|NCT00932126|12224771|FG007|Overall Study|Other|2
7777554|NCT00932165|12224791|FG000|Overall Study|Lost to Follow-up|1
7777555|NCT00932360|12224814|FG000|Washout (One Week)|Withdrawal by Subject|0
7777556|NCT00932360|12224815|FG001|Washout (One Week)|Withdrawal by Subject|0
7777557|NCT00932360|12224816|FG002|Washout (One Week)|Withdrawal by Subject|0
7777558|NCT00932360|12224817|FG003|Washout (One Week)|Withdrawal by Subject|0
7777559|NCT00932360|12224818|FG004|Washout (One Week)|Withdrawal by Subject|2
7777560|NCT00932360|12224819|FG005|Washout (One Week)|Withdrawal by Subject|0
7777561|NCT00932373|12224844|FG000|Overall Study|Progressive disease|3
7777562|NCT00932373|12224845|FG001|Overall Study|Progressive disease|1
7777563|NCT00932373|12224846|FG002|Overall Study|Progressive disease|0
7777564|NCT00932373|12224847|FG003|Overall Study|Progressive disease|0
7777565|NCT00932373|12224848|FG004|Overall Study|Progressive disease|10
7777566|NCT00932373|12224849|FG005|Overall Study|Progressive disease|1
7777567|NCT00932373|12224850|FG006|Overall Study|Progressive disease|0
7777568|NCT00932373|12224851|FG007|Overall Study|Progressive disease|2
7777569|NCT00932373|12224852|FG008|Overall Study|Progressive disease|1
7777570|NCT00932373|12224853|FG009|Overall Study|Progressive disease|9
7777571|NCT00932373|12224854|FG010|Overall Study|Progressive disease|2
7777572|NCT00932373|12224844|FG000|Overall Study|Adverse Event|0
7777573|NCT00932373|12224845|FG001|Overall Study|Adverse Event|0
7777574|NCT00932373|12224846|FG002|Overall Study|Adverse Event|0
7777575|NCT00932373|12224847|FG003|Overall Study|Adverse Event|0
7777576|NCT00932373|12224848|FG004|Overall Study|Adverse Event|2
7777577|NCT00932373|12224849|FG005|Overall Study|Adverse Event|1
7777578|NCT00932373|12224850|FG006|Overall Study|Adverse Event|0
7609059|NCT03085095|12017459|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1
7609060|NCT03085095|12017460|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0
7777579|NCT00932373|12224851|FG007|Overall Study|Adverse Event|1
7777580|NCT00932373|12224852|FG008|Overall Study|Adverse Event|0
7777581|NCT00932373|12224853|FG009|Overall Study|Adverse Event|2
7777582|NCT00932373|12224854|FG010|Overall Study|Adverse Event|1
7777583|NCT00932373|12224844|FG000|Overall Study|Physician Decision|0
7777584|NCT00932373|12224845|FG001|Overall Study|Physician Decision|0
7777585|NCT00932373|12224846|FG002|Overall Study|Physician Decision|1
7777586|NCT00932373|12224847|FG003|Overall Study|Physician Decision|0
7777587|NCT00932373|12224848|FG004|Overall Study|Physician Decision|2
7609061|NCT03048422|12017472|FG000|Overall Study|Death|1
7609062|NCT03048422|12017473|FG001|Overall Study|Death|0
7609063|NCT03048422|12017474|FG002|Overall Study|Death|0
7609064|NCT03048422|12017472|FG000|Overall Study|Lost to Follow-up|5
7609065|NCT03048422|12017473|FG001|Overall Study|Lost to Follow-up|0
7609066|NCT03048422|12017474|FG002|Overall Study|Lost to Follow-up|1
7609067|NCT03048422|12017472|FG000|Overall Study|Withdrawal by Subject|5
7609068|NCT03048422|12017473|FG001|Overall Study|Withdrawal by Subject|7
7609069|NCT03048422|12017474|FG002|Overall Study|Withdrawal by Subject|4
7609070|NCT03048422|12017472|FG000|Overall Study|Moved|3
7609071|NCT03048422|12017473|FG001|Overall Study|Moved|2
7609072|NCT03048422|12017474|FG002|Overall Study|Moved|2
7609073|NCT03048422|12017472|FG000|Overall Study|Noncompliant with Study Requirements|2
7609074|NCT03048422|12017473|FG001|Overall Study|Noncompliant with Study Requirements|1
7777588|NCT00932373|12224849|FG005|Overall Study|Physician Decision|0
7777589|NCT00932373|12224850|FG006|Overall Study|Physician Decision|0
7777590|NCT00932373|12224851|FG007|Overall Study|Physician Decision|0
7777591|NCT00932373|12224852|FG008|Overall Study|Physician Decision|0
7777592|NCT00932373|12224853|FG009|Overall Study|Physician Decision|1
7777593|NCT00932373|12224854|FG010|Overall Study|Physician Decision|0
7777594|NCT00932373|12224844|FG000|Overall Study|Dose limiting toxicity|0
7777595|NCT00932373|12224845|FG001|Overall Study|Dose limiting toxicity|0
7777596|NCT00932373|12224846|FG002|Overall Study|Dose limiting toxicity|0
7777597|NCT00932373|12224847|FG003|Overall Study|Dose limiting toxicity|0
7777598|NCT00932373|12224848|FG004|Overall Study|Dose limiting toxicity|0
7777599|NCT00932373|12224849|FG005|Overall Study|Dose limiting toxicity|1
7777600|NCT00932373|12224850|FG006|Overall Study|Dose limiting toxicity|0
7777601|NCT00932373|12224851|FG007|Overall Study|Dose limiting toxicity|0
7777602|NCT00932373|12224852|FG008|Overall Study|Dose limiting toxicity|0
7777603|NCT00932373|12224853|FG009|Overall Study|Dose limiting toxicity|0
7777604|NCT00932373|12224854|FG010|Overall Study|Dose limiting toxicity|0
7777605|NCT00932373|12224844|FG000|Overall Study|Withdrawal by Subject|0
7777606|NCT00932373|12224845|FG001|Overall Study|Withdrawal by Subject|0
7777607|NCT00932373|12224846|FG002|Overall Study|Withdrawal by Subject|0
7777608|NCT00932373|12224847|FG003|Overall Study|Withdrawal by Subject|0
7777609|NCT00932373|12224848|FG004|Overall Study|Withdrawal by Subject|0
7777610|NCT00932373|12224849|FG005|Overall Study|Withdrawal by Subject|0
7777611|NCT00932373|12224850|FG006|Overall Study|Withdrawal by Subject|0
7777612|NCT00932373|12224851|FG007|Overall Study|Withdrawal by Subject|0
7777613|NCT00932373|12224852|FG008|Overall Study|Withdrawal by Subject|1
7777614|NCT00932373|12224853|FG009|Overall Study|Withdrawal by Subject|0
7777615|NCT00932373|12224854|FG010|Overall Study|Withdrawal by Subject|0
7777616|NCT00932373|12224844|FG000|Overall Study|Clinical progression|0
7777617|NCT00932373|12224845|FG001|Overall Study|Clinical progression|0
7777618|NCT00932373|12224846|FG002|Overall Study|Clinical progression|0
7777619|NCT00932373|12224847|FG003|Overall Study|Clinical progression|0
7777620|NCT00932373|12224848|FG004|Overall Study|Clinical progression|0
7777621|NCT00932373|12224849|FG005|Overall Study|Clinical progression|0
7777622|NCT00932373|12224850|FG006|Overall Study|Clinical progression|1
7777623|NCT00932373|12224851|FG007|Overall Study|Clinical progression|0
7777624|NCT00932373|12224852|FG008|Overall Study|Clinical progression|0
7777625|NCT00932373|12224853|FG009|Overall Study|Clinical progression|0
7777626|NCT00932373|12224854|FG010|Overall Study|Clinical progression|0
7777627|NCT00932373|12224844|FG000|Overall Study|Lack of Efficacy|0
7777628|NCT00932373|12224845|FG001|Overall Study|Lack of Efficacy|0
7777629|NCT00932373|12224846|FG002|Overall Study|Lack of Efficacy|0
7777630|NCT00932373|12224847|FG003|Overall Study|Lack of Efficacy|0
7777631|NCT00932373|12224848|FG004|Overall Study|Lack of Efficacy|0
7777632|NCT00932373|12224849|FG005|Overall Study|Lack of Efficacy|0
7609075|NCT03048422|12017474|FG002|Overall Study|Noncompliant with Study Requirements|2
7609076|NCT03048422|12017472|FG000|Overall Study|Not Able to Get to Clinic|1
7609077|NCT03048422|12017473|FG001|Overall Study|Not Able to Get to Clinic|0
7609078|NCT03048422|12017474|FG002|Overall Study|Not Able to Get to Clinic|0
7777633|NCT00932373|12224850|FG006|Overall Study|Lack of Efficacy|0
7777634|NCT00932373|12224851|FG007|Overall Study|Lack of Efficacy|0
7777635|NCT00932373|12224852|FG008|Overall Study|Lack of Efficacy|0
7777636|NCT00932373|12224853|FG009|Overall Study|Lack of Efficacy|1
7777637|NCT00932373|12224854|FG010|Overall Study|Lack of Efficacy|0
7777638|NCT00932425|12224897|FG000|Overall Study|Lost to Follow-up|0
7777639|NCT00932425|12224898|FG001|Overall Study|Lost to Follow-up|1
7777640|NCT00932425|12224897|FG000|Overall Study|Withdrawal by Subject|0
7777641|NCT00932425|12224898|FG001|Overall Study|Withdrawal by Subject|1
7777642|NCT00932451|12224915|FG000|Overall Study|Withdrawal by Subject|69
7777643|NCT00932451|12224915|FG000|Overall Study|Lost to Follow-up|22
7609079|NCT03032068|12017492|FG000|Overall Study|Adverse Event|1
7609080|NCT02835690|12017512|FG000|Overall Study|Death|4
7609081|NCT02835690|12017513|FG001|Overall Study|Death|6
7609082|NCT02835690|12017514|FG002|Overall Study|Death|6
7609083|NCT02835690|12017512|FG000|Overall Study|Ongoing in Study (Follow-up)|10
7609084|NCT02835690|12017513|FG001|Overall Study|Ongoing in Study (Follow-up)|7
7609085|NCT02835690|12017514|FG002|Overall Study|Ongoing in Study (Follow-up)|9
7609086|NCT02835690|12017512|FG000|Overall Study|Not Treated|0
7609087|NCT02835690|12017513|FG001|Overall Study|Not Treated|2
7609088|NCT02835690|12017514|FG002|Overall Study|Not Treated|0
7609089|NCT02828982|12017522|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
7609090|NCT02828982|12017523|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
7609091|NCT02815280|12017537|FG000|Double-Blind Phase|Adverse Event|1
7609092|NCT02815280|12017538|FG001|Double-Blind Phase|Adverse Event|1
7609093|NCT02815280|12017537|FG000|Double-Blind Phase|Lost to Follow-up|10
7609094|NCT02815280|12017538|FG001|Double-Blind Phase|Lost to Follow-up|9
7609095|NCT02815280|12017537|FG000|Double-Blind Phase|Withdrawal by Subject|20
7609096|NCT02815280|12017538|FG001|Double-Blind Phase|Withdrawal by Subject|11
7609097|NCT02815280|12017537|FG000|Double-Blind Phase|Protocol Violation|2
7609098|NCT02815280|12017538|FG001|Double-Blind Phase|Protocol Violation|2
7609099|NCT02815280|12017537|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3
7609100|NCT02815280|12017538|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2
7609101|NCT02815280|12017537|FG000|Open-Label Phase|Adverse Event|2
7609102|NCT02815280|12017538|FG001|Open-Label Phase|Adverse Event|3
7609103|NCT02815280|12017537|FG000|Open-Label Phase|Lost to Follow-up|18
7609104|NCT02815280|12017538|FG001|Open-Label Phase|Lost to Follow-up|9
7609105|NCT02815280|12017537|FG000|Open-Label Phase|Withdrawal by Subject|33
7609106|NCT02815280|12017538|FG001|Open-Label Phase|Withdrawal by Subject|18
7777644|NCT00932451|12224915|FG000|Overall Study|Death|726
7777645|NCT00932451|12224915|FG000|Overall Study|Other reasons|5
7777646|NCT00932646|12224947|FG000|Overall Study|Adverse Event|2
7777647|NCT00932646|12224948|FG001|Overall Study|Adverse Event|1
7777648|NCT00932646|12224949|FG002|Overall Study|Adverse Event|1
7777649|NCT00932646|12224950|FG003|Overall Study|Adverse Event|1
7777650|NCT00932646|12224947|FG000|Overall Study|Lost to Follow-up|2
7777651|NCT00932646|12224948|FG001|Overall Study|Lost to Follow-up|1
7777652|NCT00932646|12224949|FG002|Overall Study|Lost to Follow-up|0
7777653|NCT00932646|12224950|FG003|Overall Study|Lost to Follow-up|0
7777654|NCT00932646|12224947|FG000|Overall Study|Withdrawal by Subject|1
7777655|NCT00932646|12224948|FG001|Overall Study|Withdrawal by Subject|1
7777656|NCT00932646|12224949|FG002|Overall Study|Withdrawal by Subject|3
7777657|NCT00932646|12224950|FG003|Overall Study|Withdrawal by Subject|0
7777658|NCT00932698|12224979|FG000|Part 1 (Dose Escalation)|Progressive Disease|3
7777659|NCT00932698|12224980|FG001|Part 1 (Dose Escalation)|Progressive Disease|2
7777660|NCT00932698|12224981|FG002|Part 1 (Dose Escalation)|Progressive Disease|2
7777661|NCT00932698|12224982|FG003|Part 1 (Dose Escalation)|Progressive Disease|2
7777662|NCT00932698|12224983|FG004|Part 1 (Dose Escalation)|Progressive Disease|3
7777663|NCT00932698|12224984|FG005|Part 1 (Dose Escalation)|Progressive Disease|5
7777664|NCT00932698|12224985|FG006|Part 1 (Dose Escalation)|Progressive Disease|2
7777665|NCT00932698|12224986|FG007|Part 1 (Dose Escalation)|Progressive Disease|0
7777666|NCT00932698|12224987|FG008|Part 1 (Dose Escalation)|Progressive Disease|0
7777667|NCT00932698|12224988|FG009|Part 1 (Dose Escalation)|Progressive Disease|0
7777668|NCT00932698|12224989|FG010|Part 1 (Dose Escalation)|Progressive Disease|0
7777669|NCT00932698|12224979|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7777670|NCT00932698|12224980|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1
7777671|NCT00932698|12224981|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7777672|NCT00932698|12224982|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1
7777673|NCT00932698|12224983|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7777674|NCT00932698|12224984|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1
7777675|NCT00932698|12224985|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1
7777676|NCT00932698|12224986|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7777677|NCT00932698|12224987|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7777678|NCT00932698|12224988|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7777679|NCT00932698|12224989|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7777680|NCT00932698|12224979|FG000|Part 1 (Dose Escalation)|Adverse Event|0
7777681|NCT00932698|12224980|FG001|Part 1 (Dose Escalation)|Adverse Event|0
7777682|NCT00932698|12224981|FG002|Part 1 (Dose Escalation)|Adverse Event|0
7777683|NCT00932698|12224982|FG003|Part 1 (Dose Escalation)|Adverse Event|0
7777684|NCT00932698|12224983|FG004|Part 1 (Dose Escalation)|Adverse Event|0
7777685|NCT00932698|12224984|FG005|Part 1 (Dose Escalation)|Adverse Event|1
7777686|NCT00932698|12224985|FG006|Part 1 (Dose Escalation)|Adverse Event|0
7777687|NCT00932698|12224986|FG007|Part 1 (Dose Escalation)|Adverse Event|0
7777688|NCT00932698|12224987|FG008|Part 1 (Dose Escalation)|Adverse Event|0
7777689|NCT00932698|12224988|FG009|Part 1 (Dose Escalation)|Adverse Event|0
7777690|NCT00932698|12224989|FG010|Part 1 (Dose Escalation)|Adverse Event|0
7777691|NCT00932698|12224979|FG000|Part 1 (Dose Escalation)|Other|0
7609107|NCT02815280|12017537|FG000|Open-Label Phase|Protocol Violation|3
7609108|NCT02815280|12017538|FG001|Open-Label Phase|Protocol Violation|0
7609109|NCT02815280|12017537|FG000|Open-Label Phase|Administrative|26
7609110|NCT02815280|12017538|FG001|Open-Label Phase|Administrative|12
7609111|NCT02815280|12017537|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5
7609112|NCT02815280|12017538|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2
7609113|NCT02815267|12017550|FG000|Double-Blind Phase|Adverse Event|0
7609114|NCT02815267|12017551|FG001|Double-Blind Phase|Adverse Event|3
7609115|NCT02815267|12017550|FG000|Double-Blind Phase|Lost to Follow-up|17
7609116|NCT02815267|12017551|FG001|Double-Blind Phase|Lost to Follow-up|9
7609117|NCT02815267|12017550|FG000|Double-Blind Phase|Withdrawal by Subject|11
7609118|NCT02815267|12017551|FG001|Double-Blind Phase|Withdrawal by Subject|10
7609119|NCT02815267|12017550|FG000|Double-Blind Phase|Protocol Violation|3
7609120|NCT02815267|12017551|FG001|Double-Blind Phase|Protocol Violation|2
7609121|NCT02815267|12017550|FG000|Double-Blind Phase|Site withdrawal|1
7609122|NCT02815267|12017551|FG001|Double-Blind Phase|Site withdrawal|6
7609123|NCT02815267|12017550|FG000|Double-Blind Phase|Received a disallowed medication|1
7777692|NCT00932698|12224980|FG001|Part 1 (Dose Escalation)|Other|0
7777693|NCT00932698|12224981|FG002|Part 1 (Dose Escalation)|Other|1
7777694|NCT00932698|12224982|FG003|Part 1 (Dose Escalation)|Other|0
7777695|NCT00932698|12224983|FG004|Part 1 (Dose Escalation)|Other|0
7777696|NCT00932698|12224984|FG005|Part 1 (Dose Escalation)|Other|0
7777697|NCT00932698|12224985|FG006|Part 1 (Dose Escalation)|Other|1
7609124|NCT02815267|12017551|FG001|Double-Blind Phase|Received a disallowed medication|1
7609125|NCT02815267|12017550|FG000|Open-Label Phase|Adverse Event|1
7609126|NCT02815267|12017551|FG001|Open-Label Phase|Adverse Event|1
7609127|NCT02815267|12017550|FG000|Open-Label Phase|Lost to Follow-up|23
7609128|NCT02815267|12017551|FG001|Open-Label Phase|Lost to Follow-up|9
7609129|NCT02815267|12017550|FG000|Open-Label Phase|Withdrawal by Subject|24
7609130|NCT02815267|12017551|FG001|Open-Label Phase|Withdrawal by Subject|13
7609131|NCT02815267|12017550|FG000|Open-Label Phase|Protocol Violation|0
7609132|NCT02815267|12017551|FG001|Open-Label Phase|Protocol Violation|1
7609133|NCT02815267|12017550|FG000|Open-Label Phase|Administrative|21
7609134|NCT02815267|12017551|FG001|Open-Label Phase|Administrative|12
7609135|NCT02815267|12017550|FG000|Open-Label Phase|Other|2
7777698|NCT00932698|12224986|FG007|Part 1 (Dose Escalation)|Other|0
7777699|NCT00932698|12224987|FG008|Part 1 (Dose Escalation)|Other|0
7777700|NCT00932698|12224988|FG009|Part 1 (Dose Escalation)|Other|0
7777701|NCT00932698|12224989|FG010|Part 1 (Dose Escalation)|Other|0
7777702|NCT00932698|12224979|FG000|Part 2 (Dose Expansion)|Progressive Disease|0
7777703|NCT00932698|12224980|FG001|Part 2 (Dose Expansion)|Progressive Disease|0
7777704|NCT00932698|12224981|FG002|Part 2 (Dose Expansion)|Progressive Disease|0
7777705|NCT00932698|12224982|FG003|Part 2 (Dose Expansion)|Progressive Disease|0
7777706|NCT00932698|12224983|FG004|Part 2 (Dose Expansion)|Progressive Disease|0
7777707|NCT00932698|12224984|FG005|Part 2 (Dose Expansion)|Progressive Disease|0
7777708|NCT00932698|12224985|FG006|Part 2 (Dose Expansion)|Progressive Disease|0
7777709|NCT00932698|12224986|FG007|Part 2 (Dose Expansion)|Progressive Disease|14
7777710|NCT00932698|12224987|FG008|Part 2 (Dose Expansion)|Progressive Disease|8
7777711|NCT00932698|12224988|FG009|Part 2 (Dose Expansion)|Progressive Disease|3
7777712|NCT00932698|12224989|FG010|Part 2 (Dose Expansion)|Progressive Disease|2
7777713|NCT00932698|12224979|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7777714|NCT00932698|12224980|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7777715|NCT00932698|12224981|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7777716|NCT00932698|12224982|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7777717|NCT00932698|12224983|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7609136|NCT02815267|12017551|FG001|Open-Label Phase|Other|5
7609137|NCT02802228|12017563|FG000|Overall Study|Withdrawal by Subject|2
7609138|NCT02802228|12017564|FG001|Overall Study|Withdrawal by Subject|0
7777718|NCT00932698|12224984|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7777719|NCT00932698|12224985|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7777720|NCT00932698|12224986|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1
7777721|NCT00932698|12224987|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3
7609139|NCT02802228|12017563|FG000|Overall Study|Lost to Follow-up|1
7609140|NCT02802228|12017564|FG001|Overall Study|Lost to Follow-up|0
7609141|NCT02802228|12017563|FG000|Overall Study|Adverse Event|1
7609142|NCT02802228|12017564|FG001|Overall Study|Adverse Event|0
7609143|NCT02802228|12017563|FG000|Overall Study|Physician Decision|1
7609144|NCT02802228|12017564|FG001|Overall Study|Physician Decision|0
7609145|NCT02674516|12017595|FG000|Overall Study|Lost to Follow-up|3
7609146|NCT02674516|12017596|FG001|Overall Study|Lost to Follow-up|0
7609147|NCT02674516|12017595|FG000|Overall Study|Protocol Violation|0
7609148|NCT02674516|12017596|FG001|Overall Study|Protocol Violation|4
7609149|NCT02674516|12017595|FG000|Overall Study|Knowledge of study hypothesis|1
7609150|NCT02674516|12017596|FG001|Overall Study|Knowledge of study hypothesis|0
7609151|NCT02505425|12017615|FG000|Overall Study|Lost to Follow-up|41
7609152|NCT02505425|12017616|FG001|Overall Study|Lost to Follow-up|61
7609153|NCT02505425|12017617|FG002|Overall Study|Lost to Follow-up|31
7609154|NCT02505425|12017618|FG003|Overall Study|Lost to Follow-up|19
7777722|NCT00932698|12224988|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2
7777723|NCT00932698|12224989|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7777724|NCT00932698|12224979|FG000|Part 2 (Dose Expansion)|Adverse Event|0
7777725|NCT00932698|12224980|FG001|Part 2 (Dose Expansion)|Adverse Event|0
7609155|NCT02505425|12017615|FG000|Overall Study|Withdrawal by Subject|39
7609156|NCT02505425|12017616|FG001|Overall Study|Withdrawal by Subject|9
7609157|NCT02505425|12017617|FG002|Overall Study|Withdrawal by Subject|19
7609158|NCT02505425|12017618|FG003|Overall Study|Withdrawal by Subject|7
7609159|NCT02505425|12017615|FG000|Overall Study|Death|8
7609160|NCT02505425|12017616|FG001|Overall Study|Death|12
7609161|NCT02505425|12017617|FG002|Overall Study|Death|0
7609162|NCT02505425|12017618|FG003|Overall Study|Death|0
7609163|NCT02487979|12017628|FG000|Overall Study|Physician Decision|2
7609164|NCT02487979|12017628|FG000|Overall Study|Withdrawal by Subject|2
7609165|NCT02487979|12017628|FG000|Overall Study|Progressive Disease|17
7609166|NCT02463448|12017632|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3
7609167|NCT02463448|12017632|FG000|6 Months Through 12 Months|Lost to Follow-up|1
7777726|NCT00932698|12224981|FG002|Part 2 (Dose Expansion)|Adverse Event|0
7777727|NCT00932698|12224982|FG003|Part 2 (Dose Expansion)|Adverse Event|0
7777728|NCT00932698|12224983|FG004|Part 2 (Dose Expansion)|Adverse Event|0
7777729|NCT00932698|12224984|FG005|Part 2 (Dose Expansion)|Adverse Event|0
7777730|NCT00932698|12224985|FG006|Part 2 (Dose Expansion)|Adverse Event|0
7777731|NCT00932698|12224986|FG007|Part 2 (Dose Expansion)|Adverse Event|5
7777732|NCT00932698|12224987|FG008|Part 2 (Dose Expansion)|Adverse Event|1
7609168|NCT02463448|12017632|FG000|6 Months Through 12 Months|Withdrawal by Subject|1
7609169|NCT02463448|12017632|FG000|12 Months Through End of Study|Lost to Follow-up|1
7609170|NCT02276547|12017645|FG000|Overall Study|Death|2
7609171|NCT02276547|12017645|FG000|Overall Study|Explant|2
7609172|NCT02263885|12017649|FG000|Overall Study|Withdrawal by Subject|7
7609173|NCT02263885|12017649|FG000|Overall Study|Alternative Treatment|3
7777733|NCT00932698|12224988|FG009|Part 2 (Dose Expansion)|Adverse Event|1
7777734|NCT00932698|12224989|FG010|Part 2 (Dose Expansion)|Adverse Event|0
7777735|NCT00932893|12225021|FG000|Overall Study|Death|115
7777736|NCT00932893|12225022|FG001|Overall Study|Death|24
7777737|NCT00932893|12225021|FG000|Overall Study|Lost to Follow-up|8
7777738|NCT00932893|12225022|FG001|Overall Study|Lost to Follow-up|0
7609179|NCT01995175|12017658|FG000|Overall Study|Withdrawal by Subject|35
7609180|NCT01995175|12017658|FG000|Overall Study|Lost to Follow-up|102
7609181|NCT01995175|12017658|FG000|Overall Study|Other|67
7609182|NCT01995175|12017658|FG000|Overall Study|Migrated / moved from the study area|49
7609183|NCT01804270|12017672|FG000|Overall Study|Withdrawal by Subject|1
7609184|NCT01804270|12017673|FG001|Overall Study|Withdrawal by Subject|1
7609185|NCT01338636|12017679|FG000|Overall Study|Withdrawn due to lack of improvement|8
7609186|NCT01208974|12017683|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1
7609187|NCT01208974|12017684|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
7609188|NCT01208974|12017685|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
7609189|NCT01208974|12017686|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
7609190|NCT01208974|12017683|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1
7609191|NCT01208974|12017684|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
7609192|NCT01208974|12017685|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
7609193|NCT01208974|12017686|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
7609194|NCT01208974|12017683|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1
7609195|NCT01208974|12017684|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
7609196|NCT01208974|12017685|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
7609197|NCT01208974|12017686|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
7609198|NCT00938912|12017693|FG000|Overall Study|Withdrawal by Subject|28
7609199|NCT00938912|12017693|FG000|Overall Study|Lost to Follow-up|4
7609200|NCT00938912|12017693|FG000|Overall Study|Lack of Efficacy|43
7609201|NCT00938912|12017693|FG000|Overall Study|Adverse event, non-fatal|24
7609202|NCT00938912|12017693|FG000|Overall Study|Adverse event, fatal|1
7609203|NCT00938912|12017693|FG000|Overall Study|Participant self adjusted antiepileptic medication|1
7609204|NCT00938912|12017693|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1
7609205|NCT00938912|12017693|FG000|Overall Study|Participant needed prohibit medication|1
7609206|NCT00938912|12017693|FG000|Overall Study|Participant was scheduled for lobal resection|1
7609207|NCT00938912|12017693|FG000|Overall Study|Did not meet Eligibility criteria|1
7609208|NCT00938912|12017693|FG000|Overall Study|Participant relocated not related to AE|1
7609209|NCT00938912|12017693|FG000|Overall Study|Participant moved to another city|1
7609210|NCT00938912|12017693|FG000|Overall Study|Participant experienced break through seizures|1
7609211|NCT00938912|12017693|FG000|Overall Study|No longer wished to participate in the study|1
7609212|NCT00938912|12017693|FG000|Overall Study|Protocol Deviation|2
7777739|NCT00932893|12225021|FG000|Overall Study|Withdrawal by Subject|5
7777740|NCT00932893|12225022|FG001|Overall Study|Withdrawal by Subject|2
7777741|NCT00932893|12225021|FG000|Overall Study|Other|5
7777742|NCT00932893|12225022|FG001|Overall Study|Other|144
7777743|NCT00933166|12225029|FG000|Overall Study|Lost to Follow-up|4
7777744|NCT00933166|12225029|FG000|Overall Study|Lack of Efficacy|9
7777745|NCT00933166|12225029|FG000|Overall Study|Unavailable|4
7777746|NCT00933166|12225029|FG000|Overall Study|Withdrawal by Subject|1
7777747|NCT00933244|12225036|FG000|Overall Study|Withdrawal by Subject|5
7777748|NCT00933244|12225037|FG001|Overall Study|Withdrawal by Subject|1
7777749|NCT00933244|12225038|FG002|Overall Study|Withdrawal by Subject|3
7777750|NCT00933270|12225046|FG000|Overall Study|Withdrawal by Subject|26
7777751|NCT00933270|12225046|FG000|Overall Study|Insufficient Follow-up|10
7777752|NCT00933270|12225046|FG000|Overall Study|Lost to Follow-up|14
7777753|NCT00933270|12225046|FG000|Overall Study|Adverse Event|1
7777754|NCT00933270|12225046|FG000|Overall Study|Missed Visit|2
7777755|NCT00933270|12225046|FG000|Overall Study|Death|24
7777756|NCT00933270|12225046|FG000|Overall Study|Moved or would not return|10
7777757|NCT00933335|12225053|FG000|Overall Study|Lost to Follow-up|1
7777758|NCT00933335|12225054|FG001|Overall Study|Lost to Follow-up|3
7777759|NCT00933335|12225053|FG000|Overall Study|Withdrawal by Subject|0
7777760|NCT00933335|12225054|FG001|Overall Study|Withdrawal by Subject|1
7777761|NCT00933335|12225053|FG000|Overall Study|Progressive Disease|0
7609237|NCT00579826|12017744|FG000|Overall Study|Withdrawal by Subject|5
7609238|NCT00579826|12017745|FG001|Overall Study|Withdrawal by Subject|3
7609239|NCT00322218|12017753|FG000|Overall Study|Death|3
7609240|NCT00322218|12017754|FG001|Overall Study|Death|6
7609241|NCT00186888|12017763|FG000|Overall Study|Toxicity|0
7609242|NCT00186888|12017764|FG001|Overall Study|Toxicity|1
7609243|NCT00186888|12017765|FG002|Overall Study|Toxicity|0
7609244|NCT00186888|12017763|FG000|Overall Study|Relapse or progression of disease|4
7609245|NCT00186888|12017764|FG001|Overall Study|Relapse or progression of disease|2
7609246|NCT00186888|12017765|FG002|Overall Study|Relapse or progression of disease|0
7609247|NCT04066491|12017811|FG000|Overall Study|Treatment ongoing|2
7609248|NCT04066491|12017812|FG001|Overall Study|Treatment ongoing|72
7609249|NCT04066491|12017813|FG002|Overall Study|Treatment ongoing|66
7609250|NCT04066491|12017811|FG000|Overall Study|Treatment completed/discontinued and in follow-up,|2
7609251|NCT04066491|12017812|FG001|Overall Study|Treatment completed/discontinued and in follow-up,|39
7609252|NCT04066491|12017813|FG002|Overall Study|Treatment completed/discontinued and in follow-up,|41
7609253|NCT04066491|12017811|FG000|Overall Study|Randomized, not treated|0
7609254|NCT04066491|12017812|FG001|Overall Study|Randomized, not treated|0
7609255|NCT04066491|12017813|FG002|Overall Study|Randomized, not treated|2
7609256|NCT03259425|12017822|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1
7609257|NCT03129100|12017831|FG000|Lead-In Period (Period 1)|Adverse Event|2
7609258|NCT03129100|12017832|FG001|Lead-In Period (Period 1)|Adverse Event|6
7609259|NCT03129100|12017833|FG002|Lead-In Period (Period 1)|Adverse Event|0
7609260|NCT03129100|12017834|FG003|Lead-In Period (Period 1)|Adverse Event|0
7609261|NCT03129100|12017835|FG004|Lead-In Period (Period 1)|Adverse Event|0
7609262|NCT03129100|12017836|FG005|Lead-In Period (Period 1)|Adverse Event|0
7609263|NCT03129100|12017837|FG006|Lead-In Period (Period 1)|Adverse Event|0
7609264|NCT03129100|12017838|FG007|Lead-In Period (Period 1)|Adverse Event|0
7609265|NCT03129100|12017839|FG008|Lead-In Period (Period 1)|Adverse Event|0
7609266|NCT03129100|12017840|FG009|Lead-In Period (Period 1)|Adverse Event|0
7609267|NCT03129100|12017841|FG010|Lead-In Period (Period 1)|Adverse Event|0
7609268|NCT03129100|12017842|FG011|Lead-In Period (Period 1)|Adverse Event|0
7609269|NCT03129100|12017843|FG012|Lead-In Period (Period 1)|Adverse Event|0
7609270|NCT03129100|12017844|FG013|Lead-In Period (Period 1)|Adverse Event|0
7609271|NCT03129100|12017845|FG014|Lead-In Period (Period 1)|Adverse Event|0
7609272|NCT03129100|12017846|FG015|Lead-In Period (Period 1)|Adverse Event|0
7609273|NCT03129100|12017847|FG016|Lead-In Period (Period 1)|Adverse Event|0
7609274|NCT03129100|12017848|FG017|Lead-In Period (Period 1)|Adverse Event|0
7609275|NCT03129100|12017849|FG018|Lead-In Period (Period 1)|Adverse Event|0
7609276|NCT03129100|12017850|FG019|Lead-In Period (Period 1)|Adverse Event|0
7609277|NCT03129100|12017851|FG020|Lead-In Period (Period 1)|Adverse Event|0
7609278|NCT03129100|12017852|FG021|Lead-In Period (Period 1)|Adverse Event|0
7609279|NCT03129100|12017853|FG022|Lead-In Period (Period 1)|Adverse Event|0
7609280|NCT03129100|12017854|FG023|Lead-In Period (Period 1)|Adverse Event|0
7609281|NCT03129100|12017855|FG024|Lead-In Period (Period 1)|Adverse Event|0
7777762|NCT00933335|12225054|FG001|Overall Study|Progressive Disease|11
7777763|NCT00933335|12225053|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
7777764|NCT00933335|12225054|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
7777765|NCT00933335|12225053|FG000|Overall Study|Co-morbid Illness|1
7777766|NCT00933335|12225054|FG001|Overall Study|Co-morbid Illness|0
7777767|NCT00933543|12225077|FG000|Overall Study|Adverse Event|2
7777768|NCT00933543|12225078|FG001|Overall Study|Adverse Event|1
7777769|NCT00933543|12225077|FG000|Overall Study|Lost to Follow-up|0
7777770|NCT00933543|12225078|FG001|Overall Study|Lost to Follow-up|1
7777771|NCT00933543|12225077|FG000|Overall Study|Withdrawal by Subject|0
7777772|NCT00933543|12225078|FG001|Overall Study|Withdrawal by Subject|1
7777773|NCT00933543|12225077|FG000|Overall Study|Lack of Efficacy|0
7777774|NCT00933543|12225078|FG001|Overall Study|Lack of Efficacy|3
7777775|NCT00933543|12225077|FG000|Overall Study|Other|1
7777776|NCT00933543|12225078|FG001|Overall Study|Other|1
7777777|NCT00933608|12225086|FG000|Overall Study|Adverse Event|4
7777778|NCT00933608|12225087|FG001|Overall Study|Adverse Event|2
7777779|NCT00933608|12225086|FG000|Overall Study|Physician Decision|1
7777780|NCT00933608|12225087|FG001|Overall Study|Physician Decision|0
7777781|NCT00933686|12225095|FG000|Overall Study|Protocol Violation|0
7777782|NCT00933686|12225096|FG001|Overall Study|Protocol Violation|1
7777783|NCT00933686|12225095|FG000|Overall Study|Lost to Follow-up|2
7777784|NCT00933686|12225096|FG001|Overall Study|Lost to Follow-up|2
7777785|NCT00933686|12225095|FG000|Overall Study|Withdrawal by Subject|6
7777786|NCT00933686|12225096|FG001|Overall Study|Withdrawal by Subject|5
7777787|NCT00933686|12225095|FG000|Overall Study|Adverse Event|1
7777788|NCT00933686|12225096|FG001|Overall Study|Adverse Event|1
7777789|NCT00933686|12225095|FG000|Overall Study|Physician Decision|1
7777790|NCT00933686|12225096|FG001|Overall Study|Physician Decision|0
7777791|NCT00933686|12225095|FG000|Overall Study|Failure to show up at endpoint visits|0
7777792|NCT00933686|12225096|FG001|Overall Study|Failure to show up at endpoint visits|2
7777793|NCT00933933|12225107|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
7777794|NCT00933933|12225108|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
7777795|NCT00933933|12225109|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
7777796|NCT00933933|12225107|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
7777797|NCT00933933|12225108|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
7777798|NCT00933933|12225109|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
7800073|NCT01090739|12257206|FG000|Enrollment|Withdrawal by Subject|24
7800074|NCT01090739|12257206|FG000|Enrollment|Protocol Violation|14
7800075|NCT01090739|12257206|FG000|Enrollment|Lost to Follow-up|5
7800076|NCT01090739|12257206|FG000|Enrollment|Physician Decision|5
7800077|NCT01090739|12257206|FG000|Enrollment|Sponsor termination of site|4
7800078|NCT01090739|12257206|FG000|Enrollment|Study implant limit reached|2
7800079|NCT01090739|12257206|FG000|Enrollment|Adverse Event|1
7800080|NCT01090739|12257206|FG000|12 Month Follow-up|Withdrawal by Subject|2
7800081|NCT01090739|12257206|FG000|12 Month Follow-up|Lost to Follow-up|1
7800082|NCT01090739|12257206|FG000|12 Month Follow-up|Physician Decision|1
7800083|NCT01090739|12257206|FG000|12 Month Follow-up|Death|1
7800084|NCT01090739|12257206|FG000|24 Month Follow-up|Withdrawal by Subject|7
7800085|NCT01090739|12257206|FG000|24 Month Follow-up|Lost to Follow-up|1
7609282|NCT03129100|12017856|FG025|Lead-In Period (Period 1)|Adverse Event|0
7609283|NCT03129100|12017831|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2
7800086|NCT01090739|12257206|FG000|24 Month Follow-up|Death|1
7800087|NCT01090739|12257206|FG000|36 Month Follow-up|Withdrawal by Subject|6
7800088|NCT01090739|12257206|FG000|36 Month Follow-up|Visit still pending|17
7800089|NCT01090765|12257226|FG000|Overall Study|Patient withdrew consent|0
7609284|NCT03129100|12017832|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0
7609285|NCT03129100|12017833|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0
7609286|NCT03129100|12017834|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0
7609287|NCT03129100|12017835|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0
7609288|NCT03129100|12017836|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0
7609289|NCT03129100|12017837|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0
7609290|NCT03129100|12017838|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0
7609291|NCT03129100|12017839|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0
7609292|NCT03129100|12017840|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0
7609293|NCT03129100|12017841|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0
7609294|NCT03129100|12017842|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0
7609295|NCT03129100|12017843|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0
7609296|NCT03129100|12017844|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0
7609297|NCT03129100|12017845|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0
7609298|NCT03129100|12017846|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0
7609299|NCT03129100|12017847|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0
7609300|NCT03129100|12017848|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0
7609301|NCT03129100|12017849|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0
7609302|NCT03129100|12017850|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0
7609303|NCT03129100|12017851|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0
7609304|NCT03129100|12017852|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0
7609305|NCT03129100|12017853|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0
7609306|NCT03129100|12017854|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0
7609307|NCT03129100|12017855|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0
7609308|NCT03129100|12017856|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0
7609309|NCT03129100|12017831|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8
7609310|NCT03129100|12017832|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8
7609311|NCT03129100|12017833|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609312|NCT03129100|12017834|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609313|NCT03129100|12017835|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609314|NCT03129100|12017836|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609315|NCT03129100|12017837|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609316|NCT03129100|12017838|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609317|NCT03129100|12017839|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609318|NCT03129100|12017840|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609319|NCT03129100|12017841|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609320|NCT03129100|12017842|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609321|NCT03129100|12017843|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609322|NCT03129100|12017844|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609323|NCT03129100|12017845|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609324|NCT03129100|12017846|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609325|NCT03129100|12017847|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609326|NCT03129100|12017848|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609327|NCT03129100|12017849|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609328|NCT03129100|12017850|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609329|NCT03129100|12017851|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609330|NCT03129100|12017852|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609331|NCT03129100|12017853|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609332|NCT03129100|12017854|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609333|NCT03129100|12017855|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609334|NCT03129100|12017856|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609335|NCT03129100|12017831|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3
7609336|NCT03129100|12017832|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2
7609337|NCT03129100|12017833|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0
7609338|NCT03129100|12017834|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0
7609339|NCT03129100|12017835|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0
7609340|NCT03129100|12017836|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0
7609341|NCT03129100|12017837|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0
7609342|NCT03129100|12017838|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0
7609343|NCT03129100|12017839|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0
7609344|NCT03129100|12017840|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0
7609345|NCT03129100|12017841|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0
7609346|NCT03129100|12017842|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0
7609347|NCT03129100|12017843|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0
7609348|NCT03129100|12017844|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0
7609349|NCT03129100|12017845|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0
7609350|NCT03129100|12017846|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0
7609351|NCT03129100|12017847|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0
7609352|NCT03129100|12017848|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0
7609353|NCT03129100|12017849|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0
7609354|NCT03129100|12017850|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0
7609355|NCT03129100|12017851|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0
7609356|NCT03129100|12017852|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0
7609357|NCT03129100|12017853|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0
7609358|NCT03129100|12017854|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0
7609359|NCT03129100|12017855|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0
7609360|NCT03129100|12017856|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0
7609361|NCT03129100|12017831|FG000|Lead-In Period (Period 1)|Surgery Programmed|0
7609362|NCT03129100|12017832|FG001|Lead-In Period (Period 1)|Surgery Programmed|1
7609363|NCT03129100|12017833|FG002|Lead-In Period (Period 1)|Surgery Programmed|0
7609364|NCT03129100|12017834|FG003|Lead-In Period (Period 1)|Surgery Programmed|0
7609365|NCT03129100|12017835|FG004|Lead-In Period (Period 1)|Surgery Programmed|0
7777799|NCT00934050|12225139|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1
7777800|NCT00934050|12225140|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0
7777801|NCT00934050|12225141|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0
7609366|NCT03129100|12017836|FG005|Lead-In Period (Period 1)|Surgery Programmed|0
7609367|NCT03129100|12017837|FG006|Lead-In Period (Period 1)|Surgery Programmed|0
7609368|NCT03129100|12017838|FG007|Lead-In Period (Period 1)|Surgery Programmed|0
7609369|NCT03129100|12017839|FG008|Lead-In Period (Period 1)|Surgery Programmed|0
7609370|NCT03129100|12017840|FG009|Lead-In Period (Period 1)|Surgery Programmed|0
7609371|NCT03129100|12017841|FG010|Lead-In Period (Period 1)|Surgery Programmed|0
7609372|NCT03129100|12017842|FG011|Lead-In Period (Period 1)|Surgery Programmed|0
7609373|NCT03129100|12017843|FG012|Lead-In Period (Period 1)|Surgery Programmed|0
7609374|NCT03129100|12017844|FG013|Lead-In Period (Period 1)|Surgery Programmed|0
7609375|NCT03129100|12017845|FG014|Lead-In Period (Period 1)|Surgery Programmed|0
7609376|NCT03129100|12017846|FG015|Lead-In Period (Period 1)|Surgery Programmed|0
7609377|NCT03129100|12017847|FG016|Lead-In Period (Period 1)|Surgery Programmed|0
7609378|NCT03129100|12017848|FG017|Lead-In Period (Period 1)|Surgery Programmed|0
7777802|NCT00934050|12225142|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1
7777803|NCT00934050|12225143|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0
7777804|NCT00934050|12225144|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0
7777805|NCT00934050|12225139|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
7777806|NCT00934050|12225140|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
7777807|NCT00934050|12225141|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
7777808|NCT00934050|12225142|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
7777809|NCT00934050|12225143|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
7777810|NCT00934050|12225144|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
7777811|NCT00934050|12225139|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
7777812|NCT00934050|12225140|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
7777813|NCT00934050|12225141|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
7777814|NCT00934050|12225142|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
7777815|NCT00934050|12225143|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
7777816|NCT00934050|12225144|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
7777817|NCT00934050|12225139|FG000|Enrolled After 15 Dec 2009|Adverse Event|0
7609379|NCT03129100|12017849|FG018|Lead-In Period (Period 1)|Surgery Programmed|0
7609380|NCT03129100|12017850|FG019|Lead-In Period (Period 1)|Surgery Programmed|0
7609381|NCT03129100|12017851|FG020|Lead-In Period (Period 1)|Surgery Programmed|0
7609382|NCT03129100|12017852|FG021|Lead-In Period (Period 1)|Surgery Programmed|0
7609383|NCT03129100|12017853|FG022|Lead-In Period (Period 1)|Surgery Programmed|0
7609384|NCT03129100|12017854|FG023|Lead-In Period (Period 1)|Surgery Programmed|0
7609385|NCT03129100|12017855|FG024|Lead-In Period (Period 1)|Surgery Programmed|0
7609386|NCT03129100|12017856|FG025|Lead-In Period (Period 1)|Surgery Programmed|0
7609387|NCT03129100|12017831|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0
7609388|NCT03129100|12017832|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0
7609389|NCT03129100|12017833|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2
7609390|NCT03129100|12017834|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1
7609391|NCT03129100|12017835|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0
7609392|NCT03129100|12017836|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2
7609393|NCT03129100|12017837|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0
7609394|NCT03129100|12017838|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0
7609395|NCT03129100|12017839|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0
7609396|NCT03129100|12017840|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0
7609397|NCT03129100|12017841|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0
7609398|NCT03129100|12017842|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0
7609399|NCT03129100|12017843|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0
7609400|NCT03129100|12017844|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0
7609401|NCT03129100|12017845|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0
7609402|NCT03129100|12017846|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0
7609403|NCT03129100|12017847|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0
7609404|NCT03129100|12017848|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0
7777818|NCT00934050|12225140|FG001|Enrolled After 15 Dec 2009|Adverse Event|0
7777819|NCT00934050|12225141|FG002|Enrolled After 15 Dec 2009|Adverse Event|0
7777820|NCT00934050|12225142|FG003|Enrolled After 15 Dec 2009|Adverse Event|0
7777821|NCT00934050|12225143|FG004|Enrolled After 15 Dec 2009|Adverse Event|3
7777822|NCT00934050|12225144|FG005|Enrolled After 15 Dec 2009|Adverse Event|0
7777823|NCT00934050|12225139|FG000|Enrolled After 15 Dec 2009|Death|0
7777824|NCT00934050|12225140|FG001|Enrolled After 15 Dec 2009|Death|0
7777825|NCT00934050|12225141|FG002|Enrolled After 15 Dec 2009|Death|0
7777826|NCT00934050|12225142|FG003|Enrolled After 15 Dec 2009|Death|0
7777827|NCT00934050|12225143|FG004|Enrolled After 15 Dec 2009|Death|0
7777828|NCT00934050|12225144|FG005|Enrolled After 15 Dec 2009|Death|1
7777829|NCT00934050|12225139|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0
7777830|NCT00934050|12225140|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0
7777831|NCT00934050|12225141|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0
7777832|NCT00934050|12225142|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0
7777833|NCT00934050|12225143|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0
7777834|NCT00934050|12225144|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1
7777835|NCT00934050|12225139|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
7777836|NCT00934050|12225140|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
7777837|NCT00934050|12225141|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
7777838|NCT00934050|12225142|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
7777839|NCT00934050|12225143|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
7777840|NCT00934050|12225144|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
7777841|NCT00934089|12225156|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1
7777842|NCT00934089|12225157|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0
7777843|NCT00934089|12225156|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1
7777844|NCT00934089|12225157|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0
7777845|NCT00934102|12225163|FG000|Period 1, One Night of Wear|Personal Reasons|1
7777846|NCT00934102|12225164|FG001|Period 1, One Night of Wear|Personal Reasons|0
7777847|NCT00934102|12225165|FG002|Period 1, One Night of Wear|Personal Reasons|0
7777848|NCT00934128|12225175|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0
7777849|NCT00934128|12225176|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1
7777850|NCT00934128|12225175|FG000|First Intervention (2 Hours)|Adverse Event|4
7777851|NCT00934128|12225176|FG001|First Intervention (2 Hours)|Adverse Event|1
7777852|NCT00934128|12225175|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
7777853|NCT00934128|12225176|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
7777854|NCT00934128|12225175|FG000|Washout Period (1 Hour)|Patient preference|1
7777855|NCT00934128|12225176|FG001|Washout Period (1 Hour)|Patient preference|3
7609405|NCT03129100|12017849|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0
7609406|NCT03129100|12017850|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0
7609407|NCT03129100|12017851|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0
7609408|NCT03129100|12017852|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0
7609409|NCT03129100|12017853|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0
7609410|NCT03129100|12017854|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0
7609411|NCT03129100|12017855|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0
7609412|NCT03129100|12017856|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0
7609413|NCT03129100|12017831|FG000|Period2 Extension Period (Group A and B)|Death|0
7609414|NCT03129100|12017832|FG001|Period2 Extension Period (Group A and B)|Death|0
7609415|NCT03129100|12017833|FG002|Period2 Extension Period (Group A and B)|Death|1
7609416|NCT03129100|12017834|FG003|Period2 Extension Period (Group A and B)|Death|0
7609417|NCT03129100|12017835|FG004|Period2 Extension Period (Group A and B)|Death|0
7609418|NCT03129100|12017836|FG005|Period2 Extension Period (Group A and B)|Death|0
7609419|NCT03129100|12017837|FG006|Period2 Extension Period (Group A and B)|Death|0
7609420|NCT03129100|12017838|FG007|Period2 Extension Period (Group A and B)|Death|0
7609421|NCT03129100|12017839|FG008|Period2 Extension Period (Group A and B)|Death|0
7609422|NCT03129100|12017840|FG009|Period2 Extension Period (Group A and B)|Death|0
7609423|NCT03129100|12017841|FG010|Period2 Extension Period (Group A and B)|Death|0
7609424|NCT03129100|12017842|FG011|Period2 Extension Period (Group A and B)|Death|0
7609425|NCT03129100|12017843|FG012|Period2 Extension Period (Group A and B)|Death|0
7609426|NCT03129100|12017844|FG013|Period2 Extension Period (Group A and B)|Death|0
7609427|NCT03129100|12017845|FG014|Period2 Extension Period (Group A and B)|Death|0
7609428|NCT03129100|12017846|FG015|Period2 Extension Period (Group A and B)|Death|0
7609429|NCT03129100|12017847|FG016|Period2 Extension Period (Group A and B)|Death|0
7609430|NCT03129100|12017848|FG017|Period2 Extension Period (Group A and B)|Death|0
7609431|NCT03129100|12017849|FG018|Period2 Extension Period (Group A and B)|Death|0
7609432|NCT03129100|12017850|FG019|Period2 Extension Period (Group A and B)|Death|0
7609433|NCT03129100|12017851|FG020|Period2 Extension Period (Group A and B)|Death|0
7609434|NCT03129100|12017852|FG021|Period2 Extension Period (Group A and B)|Death|0
7609435|NCT03129100|12017853|FG022|Period2 Extension Period (Group A and B)|Death|0
7609436|NCT03129100|12017854|FG023|Period2 Extension Period (Group A and B)|Death|0
7609437|NCT03129100|12017855|FG024|Period2 Extension Period (Group A and B)|Death|0
7609438|NCT03129100|12017856|FG025|Period2 Extension Period (Group A and B)|Death|0
7609439|NCT03129100|12017831|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609440|NCT03129100|12017832|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609441|NCT03129100|12017833|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13
7609442|NCT03129100|12017834|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5
7609443|NCT03129100|12017835|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1
7609444|NCT03129100|12017836|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1
7609445|NCT03129100|12017837|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2
7609446|NCT03129100|12017838|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609447|NCT03129100|12017839|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609448|NCT03129100|12017840|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609449|NCT03129100|12017841|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609450|NCT03129100|12017842|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609451|NCT03129100|12017843|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609452|NCT03129100|12017844|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609453|NCT03129100|12017845|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609454|NCT03129100|12017846|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609455|NCT03129100|12017847|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609456|NCT03129100|12017848|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609457|NCT03129100|12017849|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609458|NCT03129100|12017850|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609459|NCT03129100|12017851|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609460|NCT03129100|12017852|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609461|NCT03129100|12017853|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609462|NCT03129100|12017854|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609463|NCT03129100|12017855|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609464|NCT03129100|12017856|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609465|NCT03129100|12017831|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0
7609466|NCT03129100|12017832|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0
7609467|NCT03129100|12017833|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1
7609468|NCT03129100|12017834|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0
7609469|NCT03129100|12017835|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0
7609470|NCT03129100|12017836|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0
7609471|NCT03129100|12017837|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0
7609472|NCT03129100|12017838|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0
7609473|NCT03129100|12017839|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0
7609474|NCT03129100|12017840|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0
7609475|NCT03129100|12017841|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0
7609476|NCT03129100|12017842|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0
7609477|NCT03129100|12017843|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0
7609478|NCT03129100|12017844|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0
7609479|NCT03129100|12017845|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0
7609480|NCT03129100|12017846|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0
7609481|NCT03129100|12017847|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0
7609482|NCT03129100|12017848|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0
7609483|NCT03129100|12017849|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0
7609484|NCT03129100|12017850|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0
7609485|NCT03129100|12017851|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0
7609486|NCT03129100|12017852|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0
7609487|NCT03129100|12017853|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0
7609488|NCT03129100|12017854|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0
7609489|NCT03129100|12017855|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0
7609490|NCT03129100|12017856|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0
7777856|NCT00934128|12225175|FG000|Washout Period (1 Hour)|Pain|1
7777857|NCT00934128|12225176|FG001|Washout Period (1 Hour)|Pain|0
7777858|NCT00934128|12225175|FG000|Washout Period (1 Hour)|Too tired|1
7777859|NCT00934128|12225176|FG001|Washout Period (1 Hour)|Too tired|0
7777860|NCT00934128|12225175|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4
7777861|NCT00934128|12225176|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2
7777862|NCT00934128|12225175|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
7777863|NCT00934128|12225176|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
7777864|NCT00934362|12225203|FG000|Overall Study|Adverse Event|1
7777865|NCT00934362|12225204|FG001|Overall Study|Adverse Event|0
7777866|NCT00934440|12225219|FG000|Overall Study|Lost to Follow-up|1
7777867|NCT00934544|12225226|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12
7777868|NCT00934544|12225227|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4
7777869|NCT00934544|12225228|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0
7777870|NCT00934544|12225226|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2
7777871|NCT00934544|12225227|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9
7777872|NCT00934544|12225228|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0
7777873|NCT00934544|12225226|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2
7777874|NCT00934544|12225227|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0
7777875|NCT00934544|12225228|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0
7777876|NCT00934544|12225226|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1
7777877|NCT00934544|12225227|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3
7777878|NCT00934544|12225228|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0
7609491|NCT03129100|12017831|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609492|NCT03129100|12017832|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609493|NCT03129100|12017833|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2
7609494|NCT03129100|12017834|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609495|NCT03129100|12017835|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609496|NCT03129100|12017836|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609497|NCT03129100|12017837|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609498|NCT03129100|12017838|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609499|NCT03129100|12017839|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609500|NCT03129100|12017840|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609501|NCT03129100|12017841|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609502|NCT03129100|12017842|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609503|NCT03129100|12017843|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609504|NCT03129100|12017844|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609505|NCT03129100|12017845|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609506|NCT03129100|12017846|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609507|NCT03129100|12017847|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609508|NCT03129100|12017848|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609509|NCT03129100|12017849|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609510|NCT03129100|12017850|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609511|NCT03129100|12017851|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609512|NCT03129100|12017852|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609513|NCT03129100|12017853|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609514|NCT03129100|12017854|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609515|NCT03129100|12017855|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609516|NCT03129100|12017856|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609517|NCT03129100|12017831|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609518|NCT03129100|12017832|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609519|NCT03129100|12017833|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2
7609520|NCT03129100|12017834|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609521|NCT03129100|12017835|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609522|NCT03129100|12017836|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609523|NCT03129100|12017837|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609524|NCT03129100|12017838|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609525|NCT03129100|12017839|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7777879|NCT00934544|12225226|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2
7777880|NCT00934544|12225227|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
7777881|NCT00934544|12225228|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
7777882|NCT00934544|12225226|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
7609526|NCT03129100|12017840|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609527|NCT03129100|12017841|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609528|NCT03129100|12017842|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609529|NCT03129100|12017843|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609530|NCT03129100|12017844|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609531|NCT03129100|12017845|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609532|NCT03129100|12017846|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609533|NCT03129100|12017847|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609534|NCT03129100|12017848|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609535|NCT03129100|12017849|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609536|NCT03129100|12017850|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609537|NCT03129100|12017851|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609538|NCT03129100|12017852|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609539|NCT03129100|12017853|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609540|NCT03129100|12017854|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609541|NCT03129100|12017855|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609542|NCT03129100|12017856|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609543|NCT03129100|12017831|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609544|NCT03129100|12017832|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609545|NCT03129100|12017833|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609546|NCT03129100|12017834|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609547|NCT03129100|12017835|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5
7609548|NCT03129100|12017836|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6
7609549|NCT03129100|12017837|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19
7609550|NCT03129100|12017838|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609551|NCT03129100|12017839|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609552|NCT03129100|12017840|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609553|NCT03129100|12017841|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609554|NCT03129100|12017842|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609555|NCT03129100|12017843|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609556|NCT03129100|12017844|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609557|NCT03129100|12017845|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609558|NCT03129100|12017846|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609559|NCT03129100|12017847|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609560|NCT03129100|12017848|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609561|NCT03129100|12017849|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609562|NCT03129100|12017850|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609563|NCT03129100|12017851|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609564|NCT03129100|12017852|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609565|NCT03129100|12017853|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609566|NCT03129100|12017854|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609567|NCT03129100|12017855|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609568|NCT03129100|12017856|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609569|NCT03129100|12017831|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609570|NCT03129100|12017832|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609571|NCT03129100|12017833|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609572|NCT03129100|12017834|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609573|NCT03129100|12017835|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609574|NCT03129100|12017836|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609575|NCT03129100|12017837|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609576|NCT03129100|12017838|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609577|NCT03129100|12017839|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609578|NCT03129100|12017840|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1
7609579|NCT03129100|12017841|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7777883|NCT00934544|12225227|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1
7609580|NCT03129100|12017842|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609581|NCT03129100|12017843|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609582|NCT03129100|12017844|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609583|NCT03129100|12017845|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609584|NCT03129100|12017846|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609585|NCT03129100|12017847|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609586|NCT03129100|12017848|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609587|NCT03129100|12017849|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609588|NCT03129100|12017850|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609589|NCT03129100|12017851|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609590|NCT03129100|12017852|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609591|NCT03129100|12017853|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609592|NCT03129100|12017854|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609593|NCT03129100|12017855|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609594|NCT03129100|12017856|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609595|NCT03129100|12017831|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609596|NCT03129100|12017832|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609597|NCT03129100|12017833|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609598|NCT03129100|12017834|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609599|NCT03129100|12017835|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609600|NCT03129100|12017836|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609601|NCT03129100|12017837|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609602|NCT03129100|12017838|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609603|NCT03129100|12017839|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609604|NCT03129100|12017840|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609605|NCT03129100|12017841|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609606|NCT03129100|12017842|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6
7609607|NCT03129100|12017843|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609608|NCT03129100|12017844|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609609|NCT03129100|12017845|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609610|NCT03129100|12017846|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609611|NCT03129100|12017847|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609612|NCT03129100|12017848|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609613|NCT03129100|12017849|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609614|NCT03129100|12017850|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609615|NCT03129100|12017851|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609616|NCT03129100|12017852|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609617|NCT03129100|12017853|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609618|NCT03129100|12017854|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609619|NCT03129100|12017855|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609620|NCT03129100|12017856|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609621|NCT03129100|12017831|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609622|NCT03129100|12017832|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609623|NCT03129100|12017833|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609624|NCT03129100|12017834|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609625|NCT03129100|12017835|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609626|NCT03129100|12017836|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609627|NCT03129100|12017837|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609628|NCT03129100|12017838|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609629|NCT03129100|12017839|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609630|NCT03129100|12017840|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609631|NCT03129100|12017841|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609632|NCT03129100|12017842|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12
7609633|NCT03129100|12017843|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7
7609634|NCT03129100|12017844|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4
7609635|NCT03129100|12017845|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2
7609636|NCT03129100|12017846|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609637|NCT03129100|12017847|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609638|NCT03129100|12017848|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609639|NCT03129100|12017849|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609640|NCT03129100|12017850|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609641|NCT03129100|12017851|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609642|NCT03129100|12017852|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609643|NCT03129100|12017853|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609644|NCT03129100|12017854|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609645|NCT03129100|12017855|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609646|NCT03129100|12017856|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609647|NCT03129100|12017831|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609648|NCT03129100|12017832|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609649|NCT03129100|12017833|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609650|NCT03129100|12017834|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609651|NCT03129100|12017835|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609652|NCT03129100|12017836|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609653|NCT03129100|12017837|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609654|NCT03129100|12017838|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609655|NCT03129100|12017839|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609656|NCT03129100|12017840|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609657|NCT03129100|12017841|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609658|NCT03129100|12017842|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1
7609659|NCT03129100|12017843|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609660|NCT03129100|12017844|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1
7609661|NCT03129100|12017845|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1
7609662|NCT03129100|12017846|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609663|NCT03129100|12017847|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609664|NCT03129100|12017848|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609665|NCT03129100|12017849|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609666|NCT03129100|12017850|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609667|NCT03129100|12017851|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609668|NCT03129100|12017852|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609669|NCT03129100|12017853|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609670|NCT03129100|12017854|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609671|NCT03129100|12017855|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609672|NCT03129100|12017856|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609673|NCT03129100|12017831|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609674|NCT03129100|12017832|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609675|NCT03129100|12017833|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609676|NCT03129100|12017834|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609677|NCT03129100|12017835|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609678|NCT03129100|12017836|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7777884|NCT00934544|12225228|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
7777885|NCT00934544|12225226|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7
7777886|NCT00934544|12225227|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7
7777887|NCT00934544|12225228|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0
7777888|NCT00934544|12225226|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29
7777889|NCT00934544|12225227|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18
7777890|NCT00934544|12225228|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0
7777891|NCT00934544|12225226|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16
7777892|NCT00934544|12225227|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9
7777893|NCT00934544|12225228|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6
7777894|NCT00934544|12225226|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35
7777895|NCT00934544|12225227|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5
7777896|NCT00934544|12225228|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10
7777897|NCT00934544|12225226|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10
7777898|NCT00934544|12225227|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9
7777899|NCT00934544|12225228|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0
7777900|NCT00934544|12225226|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2
7777901|NCT00934544|12225227|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0
7777902|NCT00934544|12225228|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5
7777903|NCT00934544|12225226|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32
7777904|NCT00934544|12225227|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4
7777905|NCT00934544|12225228|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7
7777906|NCT00934544|12225226|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4
7777907|NCT00934544|12225227|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0
7777908|NCT00934544|12225228|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1
7777909|NCT00934544|12225226|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
7609679|NCT03129100|12017837|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609680|NCT03129100|12017838|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609681|NCT03129100|12017839|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609682|NCT03129100|12017840|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609683|NCT03129100|12017841|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609684|NCT03129100|12017842|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609685|NCT03129100|12017843|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609686|NCT03129100|12017844|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609687|NCT03129100|12017845|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609688|NCT03129100|12017846|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1
7609689|NCT03129100|12017847|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609690|NCT03129100|12017848|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609691|NCT03129100|12017849|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609692|NCT03129100|12017850|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609693|NCT03129100|12017851|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609694|NCT03129100|12017852|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609695|NCT03129100|12017853|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609696|NCT03129100|12017854|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609697|NCT03129100|12017855|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609698|NCT03129100|12017856|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609699|NCT03129100|12017831|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609700|NCT03129100|12017832|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609701|NCT03129100|12017833|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609702|NCT03129100|12017834|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609703|NCT03129100|12017835|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609704|NCT03129100|12017836|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609836|NCT03129100|12017838|FG007|Period 4 (Post Treatment Follow-up)|Death|0
7609705|NCT03129100|12017837|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609706|NCT03129100|12017838|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609707|NCT03129100|12017839|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609708|NCT03129100|12017840|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609709|NCT03129100|12017841|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609710|NCT03129100|12017842|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609711|NCT03129100|12017843|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24
7609712|NCT03129100|12017844|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609713|NCT03129100|12017845|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2
7609714|NCT03129100|12017846|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8
7609715|NCT03129100|12017847|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609716|NCT03129100|12017848|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609717|NCT03129100|12017849|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609718|NCT03129100|12017850|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609719|NCT03129100|12017851|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609720|NCT03129100|12017852|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609721|NCT03129100|12017853|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609722|NCT03129100|12017854|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609723|NCT03129100|12017855|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609724|NCT03129100|12017856|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609725|NCT03129100|12017831|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609726|NCT03129100|12017832|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609727|NCT03129100|12017833|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609728|NCT03129100|12017834|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609729|NCT03129100|12017835|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609730|NCT03129100|12017836|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609731|NCT03129100|12017837|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609732|NCT03129100|12017838|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609733|NCT03129100|12017839|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609734|NCT03129100|12017840|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609735|NCT03129100|12017841|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609736|NCT03129100|12017842|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609737|NCT03129100|12017843|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609738|NCT03129100|12017844|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609739|NCT03129100|12017845|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609740|NCT03129100|12017846|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609741|NCT03129100|12017847|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609742|NCT03129100|12017848|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2
7609743|NCT03129100|12017849|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609744|NCT03129100|12017850|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3
7609745|NCT03129100|12017851|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609746|NCT03129100|12017852|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609747|NCT03129100|12017853|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609748|NCT03129100|12017854|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609749|NCT03129100|12017855|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609750|NCT03129100|12017856|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609751|NCT03129100|12017831|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609752|NCT03129100|12017832|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609753|NCT03129100|12017833|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609754|NCT03129100|12017834|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609755|NCT03129100|12017835|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609756|NCT03129100|12017836|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609757|NCT03129100|12017837|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609758|NCT03129100|12017838|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609759|NCT03129100|12017839|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609760|NCT03129100|12017840|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609761|NCT03129100|12017841|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609762|NCT03129100|12017842|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609763|NCT03129100|12017843|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609764|NCT03129100|12017844|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609765|NCT03129100|12017845|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609766|NCT03129100|12017846|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609767|NCT03129100|12017847|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609768|NCT03129100|12017848|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609769|NCT03129100|12017849|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609770|NCT03129100|12017850|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609771|NCT03129100|12017851|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2
7609772|NCT03129100|12017852|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609773|NCT03129100|12017853|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609774|NCT03129100|12017854|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609775|NCT03129100|12017855|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609776|NCT03129100|12017856|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609777|NCT03129100|12017831|FG000|Period 3 (Dose Escalation)|Physician Decision|0
7609778|NCT03129100|12017832|FG001|Period 3 (Dose Escalation)|Physician Decision|0
7609779|NCT03129100|12017833|FG002|Period 3 (Dose Escalation)|Physician Decision|0
7609780|NCT03129100|12017834|FG003|Period 3 (Dose Escalation)|Physician Decision|0
7609781|NCT03129100|12017835|FG004|Period 3 (Dose Escalation)|Physician Decision|0
7609782|NCT03129100|12017836|FG005|Period 3 (Dose Escalation)|Physician Decision|0
7609783|NCT03129100|12017837|FG006|Period 3 (Dose Escalation)|Physician Decision|0
7609784|NCT03129100|12017838|FG007|Period 3 (Dose Escalation)|Physician Decision|0
7609785|NCT03129100|12017839|FG008|Period 3 (Dose Escalation)|Physician Decision|0
7609786|NCT03129100|12017840|FG009|Period 3 (Dose Escalation)|Physician Decision|0
7609787|NCT03129100|12017841|FG010|Period 3 (Dose Escalation)|Physician Decision|0
7609788|NCT03129100|12017842|FG011|Period 3 (Dose Escalation)|Physician Decision|0
7609789|NCT03129100|12017843|FG012|Period 3 (Dose Escalation)|Physician Decision|0
7609790|NCT03129100|12017844|FG013|Period 3 (Dose Escalation)|Physician Decision|0
7609791|NCT03129100|12017845|FG014|Period 3 (Dose Escalation)|Physician Decision|0
7609792|NCT03129100|12017846|FG015|Period 3 (Dose Escalation)|Physician Decision|0
7777910|NCT00934544|12225227|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1
7777911|NCT00934544|12225228|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
7777912|NCT00934544|12225226|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8
7777913|NCT00934544|12225227|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0
7777914|NCT00934544|12225228|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5
7777915|NCT00934622|12225258|FG000|Overall Study|Lost to Follow-up|7
7609793|NCT03129100|12017847|FG016|Period 3 (Dose Escalation)|Physician Decision|0
7609794|NCT03129100|12017848|FG017|Period 3 (Dose Escalation)|Physician Decision|0
7609795|NCT03129100|12017849|FG018|Period 3 (Dose Escalation)|Physician Decision|0
7609796|NCT03129100|12017850|FG019|Period 3 (Dose Escalation)|Physician Decision|0
7609797|NCT03129100|12017851|FG020|Period 3 (Dose Escalation)|Physician Decision|1
7609798|NCT03129100|12017852|FG021|Period 3 (Dose Escalation)|Physician Decision|0
7609799|NCT03129100|12017853|FG022|Period 3 (Dose Escalation)|Physician Decision|0
7609800|NCT03129100|12017854|FG023|Period 3 (Dose Escalation)|Physician Decision|0
7609801|NCT03129100|12017855|FG024|Period 3 (Dose Escalation)|Physician Decision|0
7609802|NCT03129100|12017856|FG025|Period 3 (Dose Escalation)|Physician Decision|0
7609803|NCT03129100|12017831|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609804|NCT03129100|12017832|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609805|NCT03129100|12017833|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609806|NCT03129100|12017834|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609807|NCT03129100|12017835|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609808|NCT03129100|12017836|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609809|NCT03129100|12017837|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609810|NCT03129100|12017838|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609811|NCT03129100|12017839|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609812|NCT03129100|12017840|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609813|NCT03129100|12017841|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609814|NCT03129100|12017842|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609815|NCT03129100|12017843|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609816|NCT03129100|12017844|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609817|NCT03129100|12017845|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609818|NCT03129100|12017846|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609819|NCT03129100|12017847|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609820|NCT03129100|12017848|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609821|NCT03129100|12017849|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609822|NCT03129100|12017850|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609823|NCT03129100|12017851|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1
7609824|NCT03129100|12017852|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0
7777916|NCT00934622|12225258|FG000|Overall Study|2nd Intraoperative exclusion criteria|1
7777917|NCT00934648|12225299|FG000|Overall Study|Failure to return|8
7777918|NCT00934648|12225299|FG000|Overall Study|Withdrawal by Subject|1
7777919|NCT00934661|12225305|FG000|Overall Study|Failure of Combined/Spinal Epidural|1
7777920|NCT00934661|12225306|FG001|Overall Study|Failure of Combined/Spinal Epidural|0
7777921|NCT00934843|12225314|FG000|Overall Study|Protocol Violation|0
7777922|NCT00934843|12225315|FG001|Overall Study|Protocol Violation|1
7777923|NCT00934856|12225327|FG000|Feasibility Part|Progressive disease|4
7777924|NCT00934856|12225328|FG001|Feasibility Part|Progressive disease|4
7777925|NCT00934856|12225329|FG002|Feasibility Part|Progressive disease|2
7777926|NCT00934856|12225330|FG003|Feasibility Part|Progressive disease|3
7609825|NCT03129100|12017853|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609826|NCT03129100|12017854|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609827|NCT03129100|12017855|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609828|NCT03129100|12017856|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609829|NCT03129100|12017831|FG000|Period 4 (Post Treatment Follow-up)|Death|0
7609830|NCT03129100|12017832|FG001|Period 4 (Post Treatment Follow-up)|Death|0
7609831|NCT03129100|12017833|FG002|Period 4 (Post Treatment Follow-up)|Death|0
7609832|NCT03129100|12017834|FG003|Period 4 (Post Treatment Follow-up)|Death|0
7609833|NCT03129100|12017835|FG004|Period 4 (Post Treatment Follow-up)|Death|0
7609834|NCT03129100|12017836|FG005|Period 4 (Post Treatment Follow-up)|Death|0
7609835|NCT03129100|12017837|FG006|Period 4 (Post Treatment Follow-up)|Death|0
7609837|NCT03129100|12017839|FG008|Period 4 (Post Treatment Follow-up)|Death|0
7609838|NCT03129100|12017840|FG009|Period 4 (Post Treatment Follow-up)|Death|0
7609839|NCT03129100|12017841|FG010|Period 4 (Post Treatment Follow-up)|Death|0
7609840|NCT03129100|12017842|FG011|Period 4 (Post Treatment Follow-up)|Death|0
7609841|NCT03129100|12017843|FG012|Period 4 (Post Treatment Follow-up)|Death|0
7609842|NCT03129100|12017844|FG013|Period 4 (Post Treatment Follow-up)|Death|0
7609843|NCT03129100|12017845|FG014|Period 4 (Post Treatment Follow-up)|Death|0
7609844|NCT03129100|12017846|FG015|Period 4 (Post Treatment Follow-up)|Death|0
7609845|NCT03129100|12017847|FG016|Period 4 (Post Treatment Follow-up)|Death|0
7609846|NCT03129100|12017848|FG017|Period 4 (Post Treatment Follow-up)|Death|0
7609847|NCT03129100|12017849|FG018|Period 4 (Post Treatment Follow-up)|Death|0
7609848|NCT03129100|12017850|FG019|Period 4 (Post Treatment Follow-up)|Death|0
7609849|NCT03129100|12017851|FG020|Period 4 (Post Treatment Follow-up)|Death|0
7609850|NCT03129100|12017852|FG021|Period 4 (Post Treatment Follow-up)|Death|0
7609851|NCT03129100|12017853|FG022|Period 4 (Post Treatment Follow-up)|Death|0
7609852|NCT03129100|12017854|FG023|Period 4 (Post Treatment Follow-up)|Death|0
7609853|NCT03129100|12017855|FG024|Period 4 (Post Treatment Follow-up)|Death|1
7609854|NCT03129100|12017856|FG025|Period 4 (Post Treatment Follow-up)|Death|0
7609855|NCT03129100|12017831|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609856|NCT03129100|12017832|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609857|NCT03129100|12017833|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609858|NCT03129100|12017834|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609859|NCT03129100|12017835|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609860|NCT03129100|12017836|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609861|NCT03129100|12017837|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609862|NCT03129100|12017838|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609863|NCT03129100|12017839|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609864|NCT03129100|12017840|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609865|NCT03129100|12017841|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609866|NCT03129100|12017842|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609867|NCT03129100|12017843|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609868|NCT03129100|12017844|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609869|NCT03129100|12017845|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609870|NCT03129100|12017846|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609871|NCT03129100|12017847|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609872|NCT03129100|12017848|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609873|NCT03129100|12017849|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609874|NCT03129100|12017850|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609875|NCT03129100|12017851|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609876|NCT03129100|12017852|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609877|NCT03129100|12017853|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609878|NCT03129100|12017854|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609879|NCT03129100|12017855|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2
7609880|NCT03129100|12017856|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2
7609881|NCT03129100|12017831|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609882|NCT03129100|12017832|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609883|NCT03129100|12017833|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609884|NCT03129100|12017834|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609885|NCT03129100|12017835|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609886|NCT03129100|12017836|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609887|NCT03129100|12017837|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609888|NCT03129100|12017838|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609889|NCT03129100|12017839|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609890|NCT03129100|12017840|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609891|NCT03129100|12017841|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609892|NCT03129100|12017842|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609893|NCT03129100|12017843|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609894|NCT03129100|12017844|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609895|NCT03129100|12017845|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609896|NCT03129100|12017846|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609897|NCT03129100|12017847|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609898|NCT03129100|12017848|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609899|NCT03129100|12017849|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609900|NCT03129100|12017850|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609901|NCT03129100|12017851|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609902|NCT03129100|12017852|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609903|NCT03129100|12017853|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609904|NCT03129100|12017854|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3
7609905|NCT03129100|12017855|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20
7609906|NCT03129100|12017856|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37
7609907|NCT03129100|12017831|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609908|NCT03129100|12017832|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609982|NCT03129100|12017854|FG023|Period 4 (Post Treatment Follow-up)|Other|0
7609909|NCT03129100|12017833|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609910|NCT03129100|12017834|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609911|NCT03129100|12017835|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609912|NCT03129100|12017836|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609913|NCT03129100|12017837|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609914|NCT03129100|12017838|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609915|NCT03129100|12017839|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609916|NCT03129100|12017840|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609917|NCT03129100|12017841|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609918|NCT03129100|12017842|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609919|NCT03129100|12017843|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609920|NCT03129100|12017844|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609921|NCT03129100|12017845|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609922|NCT03129100|12017846|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609923|NCT03129100|12017847|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609924|NCT03129100|12017848|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609925|NCT03129100|12017849|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609926|NCT03129100|12017850|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609927|NCT03129100|12017851|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609928|NCT03129100|12017852|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609929|NCT03129100|12017853|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609930|NCT03129100|12017854|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609931|NCT03129100|12017855|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2
7609932|NCT03129100|12017856|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609933|NCT03129100|12017831|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609934|NCT03129100|12017832|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609935|NCT03129100|12017833|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609936|NCT03129100|12017834|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609937|NCT03129100|12017835|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609938|NCT03129100|12017836|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609939|NCT03129100|12017837|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609940|NCT03129100|12017838|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609941|NCT03129100|12017839|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609942|NCT03129100|12017840|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609943|NCT03129100|12017841|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609944|NCT03129100|12017842|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609945|NCT03129100|12017843|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609946|NCT03129100|12017844|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609947|NCT03129100|12017845|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609948|NCT03129100|12017846|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609949|NCT03129100|12017847|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609950|NCT03129100|12017848|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609951|NCT03129100|12017849|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609952|NCT03129100|12017850|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609953|NCT03129100|12017851|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609954|NCT03129100|12017852|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609955|NCT03129100|12017853|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609956|NCT03129100|12017854|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609957|NCT03129100|12017855|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609958|NCT03129100|12017856|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1
7609959|NCT03129100|12017831|FG000|Period 4 (Post Treatment Follow-up)|Other|0
7609960|NCT03129100|12017832|FG001|Period 4 (Post Treatment Follow-up)|Other|0
7609961|NCT03129100|12017833|FG002|Period 4 (Post Treatment Follow-up)|Other|0
7609962|NCT03129100|12017834|FG003|Period 4 (Post Treatment Follow-up)|Other|0
7609963|NCT03129100|12017835|FG004|Period 4 (Post Treatment Follow-up)|Other|0
7609964|NCT03129100|12017836|FG005|Period 4 (Post Treatment Follow-up)|Other|0
7609965|NCT03129100|12017837|FG006|Period 4 (Post Treatment Follow-up)|Other|0
7609966|NCT03129100|12017838|FG007|Period 4 (Post Treatment Follow-up)|Other|0
7609967|NCT03129100|12017839|FG008|Period 4 (Post Treatment Follow-up)|Other|0
7609968|NCT03129100|12017840|FG009|Period 4 (Post Treatment Follow-up)|Other|0
7609969|NCT03129100|12017841|FG010|Period 4 (Post Treatment Follow-up)|Other|0
7609970|NCT03129100|12017842|FG011|Period 4 (Post Treatment Follow-up)|Other|0
7609971|NCT03129100|12017843|FG012|Period 4 (Post Treatment Follow-up)|Other|0
7609972|NCT03129100|12017844|FG013|Period 4 (Post Treatment Follow-up)|Other|0
7609973|NCT03129100|12017845|FG014|Period 4 (Post Treatment Follow-up)|Other|0
7609974|NCT03129100|12017846|FG015|Period 4 (Post Treatment Follow-up)|Other|0
7609975|NCT03129100|12017847|FG016|Period 4 (Post Treatment Follow-up)|Other|0
7609976|NCT03129100|12017848|FG017|Period 4 (Post Treatment Follow-up)|Other|0
7609977|NCT03129100|12017849|FG018|Period 4 (Post Treatment Follow-up)|Other|0
7609978|NCT03129100|12017850|FG019|Period 4 (Post Treatment Follow-up)|Other|0
7609979|NCT03129100|12017851|FG020|Period 4 (Post Treatment Follow-up)|Other|0
7609980|NCT03129100|12017852|FG021|Period 4 (Post Treatment Follow-up)|Other|0
7609981|NCT03129100|12017853|FG022|Period 4 (Post Treatment Follow-up)|Other|0
7609983|NCT03129100|12017855|FG024|Period 4 (Post Treatment Follow-up)|Other|0
7609984|NCT03129100|12017856|FG025|Period 4 (Post Treatment Follow-up)|Other|2
7609985|NCT02831257|12017893|FG000|Overall Study|Lack of Efficacy|3
7609986|NCT02831257|12017893|FG000|Overall Study|Adverse Event|2
7609987|NCT02831257|12017893|FG000|Overall Study|Physician Decision|1
7609988|NCT02831257|12017893|FG000|Overall Study|Withdrawal by Subject|6
7777927|NCT00934856|12225331|FG004|Feasibility Part|Progressive disease|0
7777928|NCT00934856|12225332|FG005|Feasibility Part|Progressive disease|0
7777929|NCT00934856|12225327|FG000|Feasibility Part|Physician Decision|0
7777930|NCT00934856|12225328|FG001|Feasibility Part|Physician Decision|0
7777931|NCT00934856|12225329|FG002|Feasibility Part|Physician Decision|1
7777932|NCT00934856|12225330|FG003|Feasibility Part|Physician Decision|0
7777933|NCT00934856|12225331|FG004|Feasibility Part|Physician Decision|0
7777934|NCT00934856|12225332|FG005|Feasibility Part|Physician Decision|0
7777935|NCT00934856|12225327|FG000|Feasibility Part|Adverse Event|1
7777936|NCT00934856|12225328|FG001|Feasibility Part|Adverse Event|1
7777937|NCT00934856|12225329|FG002|Feasibility Part|Adverse Event|0
7777938|NCT00934856|12225330|FG003|Feasibility Part|Adverse Event|1
7777939|NCT00934856|12225331|FG004|Feasibility Part|Adverse Event|0
7777940|NCT00934856|12225332|FG005|Feasibility Part|Adverse Event|2
7777941|NCT00934856|12225327|FG000|Feasibility Part|Withdrawal by Subject|0
7777942|NCT00934856|12225328|FG001|Feasibility Part|Withdrawal by Subject|0
7777943|NCT00934856|12225329|FG002|Feasibility Part|Withdrawal by Subject|0
7777944|NCT00934856|12225330|FG003|Feasibility Part|Withdrawal by Subject|1
7777945|NCT00934856|12225331|FG004|Feasibility Part|Withdrawal by Subject|0
7777946|NCT00934856|12225332|FG005|Feasibility Part|Withdrawal by Subject|1
7777947|NCT00934856|12225327|FG000|Extension Part|Adverse Event|0
7777948|NCT00934856|12225328|FG001|Extension Part|Adverse Event|0
7777949|NCT00934856|12225329|FG002|Extension Part|Adverse Event|0
7777950|NCT00934856|12225330|FG003|Extension Part|Adverse Event|1
7777951|NCT00934856|12225331|FG004|Extension Part|Adverse Event|4
7777952|NCT00934856|12225332|FG005|Extension Part|Adverse Event|4
7777953|NCT00934856|12225327|FG000|Extension Part|Progressive disease|0
7777954|NCT00934856|12225328|FG001|Extension Part|Progressive disease|0
7777955|NCT00934856|12225329|FG002|Extension Part|Progressive disease|0
7777956|NCT00934856|12225330|FG003|Extension Part|Progressive disease|1
7777957|NCT00934856|12225331|FG004|Extension Part|Progressive disease|0
7777958|NCT00934856|12225332|FG005|Extension Part|Progressive disease|0
7777959|NCT00934856|12225327|FG000|Extension Part|Non-compliance with drug|0
7777960|NCT00934856|12225328|FG001|Extension Part|Non-compliance with drug|0
7610023|NCT02406027|12017931|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0
7610024|NCT02406027|12017932|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2
7610025|NCT02406027|12017933|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1
7610026|NCT02406027|12017934|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0
7610027|NCT02406027|12017935|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0
7610028|NCT02406027|12017936|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0
7610029|NCT02406027|12017937|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0
7610030|NCT02406027|12017931|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3
7610031|NCT02406027|12017932|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0
7610032|NCT02406027|12017933|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1
7610033|NCT02406027|12017934|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0
7610034|NCT02406027|12017935|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0
7610035|NCT02406027|12017936|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0
7610036|NCT02406027|12017937|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0
7610037|NCT02406027|12017931|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2
7610038|NCT02406027|12017932|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
7610039|NCT02406027|12017933|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
7610040|NCT02406027|12017934|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
7610041|NCT02406027|12017935|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
7610042|NCT02406027|12017936|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
7610043|NCT02406027|12017937|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
7610044|NCT02406027|12017931|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
7610045|NCT02406027|12017932|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
7610046|NCT02406027|12017933|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
7610047|NCT02406027|12017934|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
7610048|NCT02406027|12017935|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
7610049|NCT02406027|12017936|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
7610050|NCT02406027|12017937|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
7610051|NCT02406027|12017931|FG000|Open-label Phase (Period 2)|Adverse Event|0
7610052|NCT02406027|12017932|FG001|Open-label Phase (Period 2)|Adverse Event|0
7610053|NCT02406027|12017933|FG002|Open-label Phase (Period 2)|Adverse Event|0
7610054|NCT02406027|12017934|FG003|Open-label Phase (Period 2)|Adverse Event|2
7610055|NCT02406027|12017935|FG004|Open-label Phase (Period 2)|Adverse Event|2
7610056|NCT02406027|12017936|FG005|Open-label Phase (Period 2)|Adverse Event|0
7610057|NCT02406027|12017937|FG006|Open-label Phase (Period 2)|Adverse Event|0
7610058|NCT02406027|12017931|FG000|Open-label Phase (Period 2)|Physician Decision|0
7610059|NCT02406027|12017932|FG001|Open-label Phase (Period 2)|Physician Decision|0
7610060|NCT02406027|12017933|FG002|Open-label Phase (Period 2)|Physician Decision|0
7610061|NCT02406027|12017934|FG003|Open-label Phase (Period 2)|Physician Decision|0
7610062|NCT02406027|12017935|FG004|Open-label Phase (Period 2)|Physician Decision|0
7610063|NCT02406027|12017936|FG005|Open-label Phase (Period 2)|Physician Decision|1
7610064|NCT02406027|12017937|FG006|Open-label Phase (Period 2)|Physician Decision|1
7610065|NCT02406027|12017931|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0
7610066|NCT02406027|12017932|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0
7610067|NCT02406027|12017933|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0
7610068|NCT02406027|12017934|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2
7610069|NCT02406027|12017935|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4
7610070|NCT02406027|12017936|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0
7610071|NCT02406027|12017937|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2
7610072|NCT02406027|12017931|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
7610073|NCT02406027|12017932|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
7610074|NCT02406027|12017933|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
7610075|NCT02406027|12017934|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11
7610076|NCT02406027|12017935|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7
7610077|NCT02406027|12017936|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24
7610078|NCT02406027|12017937|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19
7610079|NCT02406027|12017931|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7610080|NCT02406027|12017932|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7610081|NCT02406027|12017933|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7610082|NCT02406027|12017934|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7610083|NCT02406027|12017935|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7610084|NCT02406027|12017936|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1
7610085|NCT02406027|12017937|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7610086|NCT02406027|12017931|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7610087|NCT02406027|12017932|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7610088|NCT02406027|12017933|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7610089|NCT02406027|12017934|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7610090|NCT02406027|12017935|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1
7610091|NCT02406027|12017936|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7610092|NCT02406027|12017937|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7610093|NCT02374814|12017959|FG000|Overall Study|Lost to Follow-up|1
7610094|NCT02374814|12017960|FG001|Overall Study|Lost to Follow-up|1
7610095|NCT02374814|12017961|FG002|Overall Study|Lost to Follow-up|0
7610096|NCT02374814|12017962|FG003|Overall Study|Lost to Follow-up|1
7610097|NCT02374814|12017963|FG004|Overall Study|Lost to Follow-up|0
7610098|NCT02374814|12017964|FG005|Overall Study|Lost to Follow-up|0
7610099|NCT02374814|12017959|FG000|Overall Study|Withdrawal by Subject|0
7610100|NCT02374814|12017960|FG001|Overall Study|Withdrawal by Subject|0
7610101|NCT02374814|12017961|FG002|Overall Study|Withdrawal by Subject|1
7610102|NCT02374814|12017962|FG003|Overall Study|Withdrawal by Subject|1
7610103|NCT02374814|12017963|FG004|Overall Study|Withdrawal by Subject|0
7610104|NCT02374814|12017964|FG005|Overall Study|Withdrawal by Subject|0
7610105|NCT02142738|12017988|FG000|Overall Study|Adverse Event|13
7610106|NCT02142738|12017989|FG001|Overall Study|Adverse Event|9
7610107|NCT02142738|12017988|FG000|Overall Study|Death|92
7610108|NCT02142738|12017989|FG001|Overall Study|Death|112
7610109|NCT02142738|12017988|FG000|Overall Study|Lost to Follow-up|0
7610110|NCT02142738|12017989|FG001|Overall Study|Lost to Follow-up|3
7610111|NCT02142738|12017988|FG000|Overall Study|Withdrawal by Subject|6
7610112|NCT02142738|12017989|FG001|Overall Study|Withdrawal by Subject|7
7610113|NCT02142738|12017988|FG000|Overall Study|Follow up ended by sponsor|43
7610114|NCT02142738|12017989|FG001|Overall Study|Follow up ended by sponsor|20
7777961|NCT00934856|12225329|FG002|Extension Part|Non-compliance with drug|0
7777962|NCT00934856|12225330|FG003|Extension Part|Non-compliance with drug|0
7777963|NCT00934856|12225331|FG004|Extension Part|Non-compliance with drug|0
7777964|NCT00934856|12225332|FG005|Extension Part|Non-compliance with drug|1
7777965|NCT00934947|12225378|FG000|Overall Study|Adverse Event|0
7777966|NCT00934947|12225379|FG001|Overall Study|Adverse Event|2
7777967|NCT00935012|12225387|FG000|Overall Study|Death|19
7777968|NCT00935012|12225387|FG000|Overall Study|Withdrawal by Subject|3
7777969|NCT00935012|12225387|FG000|Overall Study|Other|5
7777970|NCT00935012|12225387|FG000|Overall Study|Adverse Event|2
7610125|NCT01667133|12018030|FG000|Phase 1: Dose-escalation|Adverse Event|0
7610126|NCT01667133|12018031|FG001|Phase 1: Dose-escalation|Adverse Event|0
7610127|NCT01667133|12018032|FG002|Phase 1: Dose-escalation|Adverse Event|1
7610128|NCT01667133|12018033|FG003|Phase 1: Dose-escalation|Adverse Event|0
7610129|NCT01667133|12018034|FG004|Phase 1: Dose-escalation|Adverse Event|0
7610130|NCT01667133|12018035|FG005|Phase 1: Dose-escalation|Adverse Event|0
7610131|NCT01667133|12018036|FG006|Phase 1: Dose-escalation|Adverse Event|0
7610132|NCT01667133|12018037|FG007|Phase 1: Dose-escalation|Adverse Event|0
7610133|NCT01667133|12018038|FG008|Phase 1: Dose-escalation|Adverse Event|0
7610134|NCT01667133|12018039|FG009|Phase 1: Dose-escalation|Adverse Event|0
7610135|NCT01667133|12018040|FG010|Phase 1: Dose-escalation|Adverse Event|0
7610136|NCT01667133|12018041|FG011|Phase 1: Dose-escalation|Adverse Event|0
7610137|NCT01667133|12018030|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0
7610138|NCT01667133|12018031|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0
7610139|NCT01667133|12018032|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1
7610140|NCT01667133|12018033|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0
7610141|NCT01667133|12018034|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0
7610142|NCT01667133|12018035|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0
7610143|NCT01667133|12018036|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0
7610144|NCT01667133|12018037|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0
7610145|NCT01667133|12018038|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0
7610146|NCT01667133|12018039|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0
7610147|NCT01667133|12018040|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0
7610148|NCT01667133|12018041|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0
7610149|NCT01667133|12018030|FG000|Phase 1: Dose-escalation|Progressive Disease|0
7610150|NCT01667133|12018031|FG001|Phase 1: Dose-escalation|Progressive Disease|1
7610151|NCT01667133|12018032|FG002|Phase 1: Dose-escalation|Progressive Disease|2
7610152|NCT01667133|12018033|FG003|Phase 1: Dose-escalation|Progressive Disease|0
7610153|NCT01667133|12018034|FG004|Phase 1: Dose-escalation|Progressive Disease|1
7610154|NCT01667133|12018035|FG005|Phase 1: Dose-escalation|Progressive Disease|1
7610155|NCT01667133|12018036|FG006|Phase 1: Dose-escalation|Progressive Disease|1
7610156|NCT01667133|12018037|FG007|Phase 1: Dose-escalation|Progressive Disease|0
7610157|NCT01667133|12018038|FG008|Phase 1: Dose-escalation|Progressive Disease|0
7610158|NCT01667133|12018039|FG009|Phase 1: Dose-escalation|Progressive Disease|0
7610159|NCT01667133|12018040|FG010|Phase 1: Dose-escalation|Progressive Disease|0
7610160|NCT01667133|12018041|FG011|Phase 1: Dose-escalation|Progressive Disease|0
7610161|NCT01667133|12018030|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610162|NCT01667133|12018031|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610163|NCT01667133|12018032|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610164|NCT01667133|12018033|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1
7610165|NCT01667133|12018034|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610166|NCT01667133|12018035|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610167|NCT01667133|12018036|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0
7777971|NCT00935220|12225400|FG000|Overall Study|Adverse Event|1
7610168|NCT01667133|12018037|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610169|NCT01667133|12018038|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610170|NCT01667133|12018039|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610171|NCT01667133|12018040|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610172|NCT01667133|12018041|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610173|NCT01667133|12018030|FG000|Phase 2: Dose-expansion|Adverse Event|0
7610174|NCT01667133|12018031|FG001|Phase 2: Dose-expansion|Adverse Event|0
7610175|NCT01667133|12018032|FG002|Phase 2: Dose-expansion|Adverse Event|0
7610176|NCT01667133|12018033|FG003|Phase 2: Dose-expansion|Adverse Event|0
7610177|NCT01667133|12018034|FG004|Phase 2: Dose-expansion|Adverse Event|0
7610178|NCT01667133|12018035|FG005|Phase 2: Dose-expansion|Adverse Event|0
7610179|NCT01667133|12018036|FG006|Phase 2: Dose-expansion|Adverse Event|0
7610180|NCT01667133|12018037|FG007|Phase 2: Dose-expansion|Adverse Event|2
7610181|NCT01667133|12018038|FG008|Phase 2: Dose-expansion|Adverse Event|1
7610182|NCT01667133|12018039|FG009|Phase 2: Dose-expansion|Adverse Event|1
7610183|NCT01667133|12018040|FG010|Phase 2: Dose-expansion|Adverse Event|0
7610184|NCT01667133|12018041|FG011|Phase 2: Dose-expansion|Adverse Event|0
7610185|NCT01667133|12018030|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0
7610186|NCT01667133|12018031|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0
7610187|NCT01667133|12018032|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0
7610188|NCT01667133|12018033|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0
7777972|NCT00935220|12225400|FG000|Overall Study|Other reason (not specified)|1
7777973|NCT00935259|12225404|FG000|Period 1|Administrative (scheduling conflict)|1
7777974|NCT00935259|12225405|FG001|Period 1|Administrative (scheduling conflict)|1
7777975|NCT00935272|12225415|FG000|Overall Study|Lost to Follow-up|10
7777976|NCT00935272|12225416|FG001|Overall Study|Lost to Follow-up|3
7777977|NCT00935272|12225415|FG000|Overall Study|Withdrawal by Subject|8
7777978|NCT00935272|12225416|FG001|Overall Study|Withdrawal by Subject|2
7777979|NCT00935272|12225415|FG000|Overall Study|Physician Decision|1
7777980|NCT00935272|12225416|FG001|Overall Study|Physician Decision|0
7777981|NCT00935272|12225415|FG000|Overall Study|Protocol Violation|0
7777982|NCT00935272|12225416|FG001|Overall Study|Protocol Violation|1
7777983|NCT00935493|12225449|FG000|Overall Study|Lost to Follow-up|1
7777984|NCT00935493|12225450|FG001|Overall Study|Lost to Follow-up|1
7777985|NCT00935493|12225451|FG002|Overall Study|Lost to Follow-up|1
7777986|NCT00935493|12225449|FG000|Overall Study|Treatment Discontinued|0
7777987|NCT00935493|12225450|FG001|Overall Study|Treatment Discontinued|1
7777988|NCT00935493|12225451|FG002|Overall Study|Treatment Discontinued|0
7777989|NCT00935532|12225461|FG000|Overall Study|Adverse Event|11
7777990|NCT00935532|12225462|FG001|Overall Study|Adverse Event|6
7777991|NCT00935532|12225461|FG000|Overall Study|Death|1
7777992|NCT00935532|12225462|FG001|Overall Study|Death|0
7777993|NCT00935532|12225461|FG000|Overall Study|Lost to Follow-up|1
7777994|NCT00935532|12225462|FG001|Overall Study|Lost to Follow-up|0
7777995|NCT00935532|12225461|FG000|Overall Study|Physician Decision|1
7610189|NCT01667133|12018034|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0
7610190|NCT01667133|12018035|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0
7610191|NCT01667133|12018036|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0
7610192|NCT01667133|12018037|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0
7610193|NCT01667133|12018038|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0
7610194|NCT01667133|12018039|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2
7777996|NCT00935532|12225462|FG001|Overall Study|Physician Decision|2
7777997|NCT00935532|12225461|FG000|Overall Study|Protocol Violation|2
7777998|NCT00935532|12225462|FG001|Overall Study|Protocol Violation|1
7777999|NCT00935532|12225461|FG000|Overall Study|Subject Decision|2
7778000|NCT00935532|12225462|FG001|Overall Study|Subject Decision|1
7778001|NCT00935532|12225461|FG000|Overall Study|Sponsor Decision|0
7778002|NCT00935532|12225462|FG001|Overall Study|Sponsor Decision|1
7610195|NCT01667133|12018040|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0
7610196|NCT01667133|12018041|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0
7610197|NCT01667133|12018030|FG000|Phase 2: Dose-expansion|Progressive Disease|0
7610198|NCT01667133|12018031|FG001|Phase 2: Dose-expansion|Progressive Disease|0
7610199|NCT01667133|12018032|FG002|Phase 2: Dose-expansion|Progressive Disease|0
7610200|NCT01667133|12018033|FG003|Phase 2: Dose-expansion|Progressive Disease|0
7610201|NCT01667133|12018034|FG004|Phase 2: Dose-expansion|Progressive Disease|0
7610202|NCT01667133|12018035|FG005|Phase 2: Dose-expansion|Progressive Disease|0
7610203|NCT01667133|12018036|FG006|Phase 2: Dose-expansion|Progressive Disease|0
7610204|NCT01667133|12018037|FG007|Phase 2: Dose-expansion|Progressive Disease|0
7610205|NCT01667133|12018038|FG008|Phase 2: Dose-expansion|Progressive Disease|0
7610206|NCT01667133|12018039|FG009|Phase 2: Dose-expansion|Progressive Disease|0
7610207|NCT01667133|12018040|FG010|Phase 2: Dose-expansion|Progressive Disease|3
7610208|NCT01667133|12018041|FG011|Phase 2: Dose-expansion|Progressive Disease|5
7610209|NCT01667133|12018030|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610210|NCT01667133|12018031|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610211|NCT01667133|12018032|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610212|NCT01667133|12018033|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610213|NCT01667133|12018034|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610214|NCT01667133|12018035|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610215|NCT01667133|12018036|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610216|NCT01667133|12018037|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610217|NCT01667133|12018038|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610218|NCT01667133|12018039|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2
7610219|NCT01667133|12018040|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610220|NCT01667133|12018041|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610221|NCT01667133|12018030|FG000|Phase 2: Dose-expansion|Death|0
7610222|NCT01667133|12018031|FG001|Phase 2: Dose-expansion|Death|0
7610223|NCT01667133|12018032|FG002|Phase 2: Dose-expansion|Death|0
7610224|NCT01667133|12018033|FG003|Phase 2: Dose-expansion|Death|0
7610225|NCT01667133|12018034|FG004|Phase 2: Dose-expansion|Death|0
7610226|NCT01667133|12018035|FG005|Phase 2: Dose-expansion|Death|0
7610227|NCT01667133|12018036|FG006|Phase 2: Dose-expansion|Death|0
7610228|NCT01667133|12018037|FG007|Phase 2: Dose-expansion|Death|0
7610229|NCT01667133|12018038|FG008|Phase 2: Dose-expansion|Death|0
7610230|NCT01667133|12018039|FG009|Phase 2: Dose-expansion|Death|1
7610231|NCT01667133|12018040|FG010|Phase 2: Dose-expansion|Death|0
7610232|NCT01667133|12018041|FG011|Phase 2: Dose-expansion|Death|0
7610233|NCT01667133|12018030|FG000|Phase 2: Dose-expansion|Other|0
7610234|NCT01667133|12018031|FG001|Phase 2: Dose-expansion|Other|0
7610235|NCT01667133|12018032|FG002|Phase 2: Dose-expansion|Other|0
7610236|NCT01667133|12018033|FG003|Phase 2: Dose-expansion|Other|0
7610237|NCT01667133|12018034|FG004|Phase 2: Dose-expansion|Other|0
7610238|NCT01667133|12018035|FG005|Phase 2: Dose-expansion|Other|0
7610239|NCT01667133|12018036|FG006|Phase 2: Dose-expansion|Other|0
7610240|NCT01667133|12018037|FG007|Phase 2: Dose-expansion|Other|0
7610241|NCT01667133|12018038|FG008|Phase 2: Dose-expansion|Other|0
7610242|NCT01667133|12018039|FG009|Phase 2: Dose-expansion|Other|0
7610243|NCT01667133|12018040|FG010|Phase 2: Dose-expansion|Other|0
7610244|NCT01667133|12018041|FG011|Phase 2: Dose-expansion|Other|1
7610245|NCT01585103|12018102|FG000|Overall Study|Unable to swallow Cytosponge|6
7610246|NCT01427725|12018106|FG000|Overall Study|Lost to Follow-up|17
7610247|NCT01427725|12018106|FG000|Overall Study|Protocol Violation|1
7610248|NCT01427725|12018106|FG000|Overall Study|Drug not administered|1
7610249|NCT01427725|12018106|FG000|Overall Study|Failure to visit|7
7610250|NCT01427725|12018106|FG000|Overall Study|Adverse Event|46
7778003|NCT00935532|12225461|FG000|Overall Study|Loss Glucose Control|4
7778004|NCT00935532|12225462|FG001|Overall Study|Loss Glucose Control|0
7778005|NCT00935584|12225470|FG000|Overall Study|Withdrawal by Subject|9
7610251|NCT01427725|12018106|FG000|Overall Study|Failure to visit after administration|40
7610252|NCT01427725|12018106|FG000|Overall Study|Patient's rejection|27
7610253|NCT01427725|12018106|FG000|Overall Study|Transfer to a different hospital|17
7610254|NCT01427725|12018106|FG000|Overall Study|Lack of Efficacy|8
7610255|NCT01427725|12018106|FG000|Overall Study|Death|7
7610256|NCT01427725|12018106|FG000|Overall Study|Symptom improvement|6
7610257|NCT01427725|12018106|FG000|Overall Study|AE and Patient's rejection|5
7610258|NCT01427725|12018106|FG000|Overall Study|Physician Decision|5
7610259|NCT01427725|12018106|FG000|Overall Study|Exacerbation of underlying disease|5
7610260|NCT01427725|12018106|FG000|Overall Study|Oral feeding difficulty|5
7610261|NCT01427725|12018106|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1
7610262|NCT01427725|12018106|FG000|Overall Study|Forgetting prescription|1
7610263|NCT01427725|12018106|FG000|Overall Study|Other|2
7778006|NCT00935584|12225471|FG001|Overall Study|Withdrawal by Subject|0
7610264|NCT04608344|12018117|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0
7610265|NCT04608344|12018118|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1
7610266|NCT04608344|12018117|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1
7610267|NCT04608344|12018118|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0
7610268|NCT04350372|12018137|FG000|Overall Study|Death|1
7778007|NCT00935584|12225470|FG000|Overall Study|Death|3
7778008|NCT00935584|12225471|FG001|Overall Study|Death|0
7778009|NCT00935584|12225470|FG000|Overall Study|Lost to Follow-up|8
7778010|NCT00935584|12225471|FG001|Overall Study|Lost to Follow-up|0
7778011|NCT00935584|12225470|FG000|Overall Study|No show|9
7778012|NCT00935584|12225471|FG001|Overall Study|No show|0
7778013|NCT00935584|12225470|FG000|Overall Study|Relocated|3
7778014|NCT00935584|12225471|FG001|Overall Study|Relocated|0
7778015|NCT00935584|12225470|FG000|Overall Study|Patient changed provider|3
7778016|NCT00935584|12225471|FG001|Overall Study|Patient changed provider|0
7778017|NCT00935584|12225470|FG000|Overall Study|Provider dropped out of study|14
7778018|NCT00935584|12225471|FG001|Overall Study|Provider dropped out of study|4
7778019|NCT00935701|12225475|FG000|Overall Study|Failure to Transition to Acupuncture|1
7778020|NCT00935818|12225506|FG000|Overall Study|Withdrawal by Subject|45
7778021|NCT00935818|12225507|FG001|Overall Study|Withdrawal by Subject|50
7778022|NCT00935818|12225506|FG000|Overall Study|Lost to Follow-up|40
7778023|NCT00935818|12225507|FG001|Overall Study|Lost to Follow-up|42
7778024|NCT00935818|12225506|FG000|Overall Study|Adverse Event|6
7778025|NCT00935818|12225507|FG001|Overall Study|Adverse Event|7
7778026|NCT00935818|12225506|FG000|Overall Study|Physician Decision|0
7778027|NCT00935818|12225507|FG001|Overall Study|Physician Decision|1
7778028|NCT00935883|12225524|FG000|Treatment Period|Physician Decision|1
7778029|NCT00935883|12225525|FG001|Treatment Period|Physician Decision|0
7778030|NCT00935883|12225524|FG000|Treatment Period|Withdrawal by Subject|0
7778031|NCT00935883|12225525|FG001|Treatment Period|Withdrawal by Subject|2
7778032|NCT00936065|12225534|FG000|Overall Study|Adverse Event|1
7778033|NCT00936065|12225535|FG001|Overall Study|Adverse Event|0
7778034|NCT00936065|12225536|FG002|Overall Study|Adverse Event|1
7778035|NCT00936065|12225534|FG000|Overall Study|Lack of Efficacy|1
7778036|NCT00936065|12225535|FG001|Overall Study|Lack of Efficacy|0
7778037|NCT00936065|12225536|FG002|Overall Study|Lack of Efficacy|1
7778038|NCT00936065|12225534|FG000|Overall Study|Lost to Follow-up|1
7778039|NCT00936065|12225535|FG001|Overall Study|Lost to Follow-up|0
7778040|NCT00936065|12225536|FG002|Overall Study|Lost to Follow-up|0
7778041|NCT00936065|12225534|FG000|Overall Study|Protocol Violation|1
7778042|NCT00936065|12225535|FG001|Overall Study|Protocol Violation|2
7610277|NCT04234984|12018188|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2
7610278|NCT04234984|12018188|FG000|Follow-up at the Second Time Point|Death|1
7610279|NCT04234984|12018188|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1
7610280|NCT04227197|12018196|FG000|Randomization|Protocol Violation|1
7610281|NCT04227197|12018197|FG001|Randomization|Protocol Violation|0
7610282|NCT04227197|12018196|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1
7610283|NCT04227197|12018197|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0
7610284|NCT04227197|12018196|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2
7610285|NCT04227197|12018197|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0
7610286|NCT04227197|12018196|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7
7610287|NCT04227197|12018197|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5
7610288|NCT04227197|12018196|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5
7610289|NCT04227197|12018197|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0
7778043|NCT00936065|12225536|FG002|Overall Study|Protocol Violation|1
7778044|NCT00936065|12225534|FG000|Overall Study|Withdrawal by Subject|0
7778045|NCT00936065|12225535|FG001|Overall Study|Withdrawal by Subject|2
7778046|NCT00936065|12225536|FG002|Overall Study|Withdrawal by Subject|4
7778047|NCT00936117|12225544|FG000|Overall Study|Adverse Event|7
7610290|NCT04227197|12018196|FG000|2-week Follow-up Survey for PCP's|Not responsive|20
7610291|NCT04227197|12018197|FG001|2-week Follow-up Survey for PCP's|Not responsive|25
7610292|NCT04227197|12018196|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11
7610293|NCT04227197|12018197|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3
7610294|NCT04105725|12018208|FG000|Primary Intervention|Lost to Follow-up|0
7610295|NCT04105725|12018209|FG001|Primary Intervention|Lost to Follow-up|2
7610296|NCT04105725|12018208|FG000|Primary Intervention|Withdrawal by Subject|0
7610297|NCT04105725|12018209|FG001|Primary Intervention|Withdrawal by Subject|1
7610298|NCT04066023|12018218|FG000|Overall Study|Adverse Event|0
7610299|NCT04066023|12018219|FG001|Overall Study|Adverse Event|0
7610300|NCT04066023|12018220|FG002|Overall Study|Adverse Event|1
7610301|NCT04066023|12018218|FG000|Overall Study|Sponsor decision|3
7610302|NCT04066023|12018219|FG001|Overall Study|Sponsor decision|6
7610303|NCT04066023|12018220|FG002|Overall Study|Sponsor decision|2
7610304|NCT04066023|12018218|FG000|Overall Study|Physician Decision|0
7610305|NCT04066023|12018219|FG001|Overall Study|Physician Decision|0
7610306|NCT04066023|12018220|FG002|Overall Study|Physician Decision|1
7610307|NCT04066023|12018218|FG000|Overall Study|Lost to Follow-up|0
7610308|NCT04066023|12018219|FG001|Overall Study|Lost to Follow-up|1
7610309|NCT04066023|12018220|FG002|Overall Study|Lost to Follow-up|1
7610310|NCT04066023|12018218|FG000|Overall Study|Noncompliance|0
7610311|NCT04066023|12018219|FG001|Overall Study|Noncompliance|1
7610312|NCT04066023|12018220|FG002|Overall Study|Noncompliance|1
7610313|NCT03882957|12018241|FG000|Overall Study|Did not complete all three arms|1
7778048|NCT00936117|12225544|FG000|Overall Study|Unable to continue oral medication|3
7778049|NCT00936208|12225551|FG000|Overall Study|Protocol Violation|37
7778050|NCT00936208|12225552|FG001|Overall Study|Protocol Violation|22
7778051|NCT00936221|12225560|FG000|Overall Study|Withdrawal by Subject|1
7778052|NCT00936221|12225561|FG001|Overall Study|Withdrawal by Subject|1
7778053|NCT00936611|12225624|FG000|Overall Study|Progressive Disease|3
7778054|NCT00936611|12225624|FG000|Overall Study|New Systemic Therapy|22
7778055|NCT00936611|12225624|FG000|Overall Study|Lost to Follow-up|1
7778056|NCT00936611|12225624|FG000|Overall Study|Withdrawal by Subject|2
7778057|NCT00936611|12225624|FG000|Overall Study|Still on Follow-up|1
7778058|NCT00936611|12225624|FG000|Overall Study|Still on Active Therapy|7
7778059|NCT00936611|12225624|FG000|Overall Study|Ineligible for Study Drug|3
7778060|NCT00936702|12225637|FG000|Overall Study|Disease progression|34
7778061|NCT00936702|12225637|FG000|Overall Study|Adverse Event|8
7778062|NCT00936702|12225637|FG000|Overall Study|Withdrawal by Subject|2
7610314|NCT03387852|12018289|FG000|Overall Study|Adverse event (AE)|3
7610315|NCT03387852|12018290|FG001|Overall Study|Adverse event (AE)|0
7610316|NCT03387852|12018291|FG002|Overall Study|Adverse event (AE)|2
7610317|NCT03387852|12018292|FG003|Overall Study|Adverse event (AE)|0
7610318|NCT03387852|12018289|FG000|Overall Study|Loss of asthma control (LOAC)|28
7610319|NCT03387852|12018290|FG001|Overall Study|Loss of asthma control (LOAC)|16
7610320|NCT03387852|12018291|FG002|Overall Study|Loss of asthma control (LOAC)|20
7610321|NCT03387852|12018292|FG003|Overall Study|Loss of asthma control (LOAC)|14
7610322|NCT03387852|12018289|FG000|Overall Study|Withdrawal by participant|1
7610323|NCT03387852|12018290|FG001|Overall Study|Withdrawal by participant|1
7610324|NCT03387852|12018291|FG002|Overall Study|Withdrawal by participant|3
7610325|NCT03387852|12018292|FG003|Overall Study|Withdrawal by participant|2
7610326|NCT03387852|12018289|FG000|Overall Study|Other- Unspecified|1
7610327|NCT03387852|12018290|FG001|Overall Study|Other- Unspecified|1
7610328|NCT03387852|12018291|FG002|Overall Study|Other- Unspecified|2
7610329|NCT03387852|12018292|FG003|Overall Study|Other- Unspecified|1
7610330|NCT03387852|12018289|FG000|Overall Study|Poor compliance to protocol|0
7610331|NCT03387852|12018290|FG001|Overall Study|Poor compliance to protocol|0
7610332|NCT03387852|12018291|FG002|Overall Study|Poor compliance to protocol|0
7610333|NCT03387852|12018292|FG003|Overall Study|Poor compliance to protocol|1
7610334|NCT03387852|12018289|FG000|Overall Study|Randomized and not treated|0
7610335|NCT03387852|12018290|FG001|Overall Study|Randomized and not treated|0
7610336|NCT03387852|12018291|FG002|Overall Study|Randomized and not treated|0
7610337|NCT03387852|12018292|FG003|Overall Study|Randomized and not treated|1
7610338|NCT03364673|12018309|FG000|Overall Study|Withdrawal by Subject|2
7610339|NCT03364673|12018309|FG000|Overall Study|Injury unrelated to study|3
7610340|NCT03343704|12018315|FG000|Overall Study|Refused to complete follow up|0
7610341|NCT03343704|12018316|FG001|Overall Study|Refused to complete follow up|1
7610342|NCT03343704|12018315|FG000|Overall Study|Death|0
7610343|NCT03343704|12018316|FG001|Overall Study|Death|1
7610344|NCT03343704|12018315|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1
7610345|NCT03343704|12018316|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0
7610346|NCT03265145|12018326|FG000|Overall Study|Protocol Violation|2
7610347|NCT03265145|12018327|FG001|Overall Study|Protocol Violation|0
7610348|NCT03265145|12018326|FG000|Overall Study|Adverse Event|1
7610349|NCT03265145|12018327|FG001|Overall Study|Adverse Event|0
7610350|NCT03265145|12018326|FG000|Overall Study|Withdrawal by Subject|23
7610351|NCT03265145|12018327|FG001|Overall Study|Withdrawal by Subject|19
7610352|NCT03265145|12018326|FG000|Overall Study|Death|12
7610353|NCT03265145|12018327|FG001|Overall Study|Death|12
7610354|NCT03265145|12018326|FG000|Overall Study|Lost to Follow-up|13
7610355|NCT03265145|12018327|FG001|Overall Study|Lost to Follow-up|9
7610356|NCT03265145|12018326|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0
7610357|NCT03265145|12018327|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1
7610358|NCT03265145|12018326|FG000|Overall Study|Switched back to previous medication|1
7610359|NCT03265145|12018327|FG001|Overall Study|Switched back to previous medication|0
7610360|NCT03265145|12018326|FG000|Overall Study|Did not want to take medication|1
7610361|NCT03265145|12018327|FG001|Overall Study|Did not want to take medication|0
7610362|NCT03265145|12018326|FG000|Overall Study|Subject could not afford medication|0
7610363|NCT03265145|12018327|FG001|Overall Study|Subject could not afford medication|1
7610364|NCT03265145|12018326|FG000|Overall Study|Site closed|2
7610365|NCT03265145|12018327|FG001|Overall Study|Site closed|3
7610366|NCT03265145|12018326|FG000|Overall Study|Incorrectly randomized|16
7610367|NCT03265145|12018327|FG001|Overall Study|Incorrectly randomized|6
7610368|NCT03265145|12018326|FG000|Overall Study|Entered into Electronic Data Capture in error|0
7610369|NCT03265145|12018327|FG001|Overall Study|Entered into Electronic Data Capture in error|1
7610370|NCT03265145|12018326|FG000|Overall Study|Physician Decision|0
7610371|NCT03265145|12018327|FG001|Overall Study|Physician Decision|3
7610372|NCT03265145|12018326|FG000|Overall Study|Subject transferred to another facility|0
7610373|NCT03265145|12018327|FG001|Overall Study|Subject transferred to another facility|1
7610374|NCT03219164|12018336|FG000|Overall Study|Study Terminated by Sponsor|16
7610375|NCT03219164|12018337|FG001|Overall Study|Study Terminated by Sponsor|12
7610376|NCT03219164|12018336|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5
7610377|NCT03219164|12018337|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4
7610378|NCT03219164|12018336|FG000|Overall Study|Lost to Follow-up|1
7610379|NCT03219164|12018337|FG001|Overall Study|Lost to Follow-up|1
7610380|NCT03219164|12018336|FG000|Overall Study|Adverse Event|1
7610381|NCT03219164|12018337|FG001|Overall Study|Adverse Event|0
7610382|NCT03219164|12018336|FG000|Overall Study|Non-Compliance with Study Drug|1
7610383|NCT03219164|12018337|FG001|Overall Study|Non-Compliance with Study Drug|0
7778063|NCT00936702|12225637|FG000|Overall Study|Alternative Treatment|1
7778064|NCT00936702|12225637|FG000|Overall Study|Other|1
7778065|NCT00936715|12225641|FG000|Overall Study|Investigators Discretion|1
7778066|NCT00936715|12225641|FG000|Overall Study|Protocol Violation|1
7778067|NCT00936715|12225641|FG000|Overall Study|Safety or Tolerability Reasons|4
7778068|NCT00936858|12225649|FG000|Overall Study|Death|3
7778069|NCT00936858|12225649|FG000|Overall Study|Progression|29
7778070|NCT00936858|12225649|FG000|Overall Study|Withdrawal by Subject|5
7778071|NCT00936858|12225649|FG000|Overall Study|Adverse Event|1
7778072|NCT00936858|12225649|FG000|Overall Study|Physician Decision|7
7778073|NCT00936858|12225649|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4
7778074|NCT00936858|12225649|FG000|Overall Study|Lost to Follow-up|1
7778075|NCT00936884|12225656|FG000|Double-blind|Withdrawal by Subject|6
7778076|NCT00936884|12225657|FG001|Double-blind|Withdrawal by Subject|4
7778077|NCT00936884|12225658|FG002|Double-blind|Withdrawal by Subject|0
7778078|NCT00936884|12225656|FG000|Double-blind|Death|2
7778079|NCT00936884|12225657|FG001|Double-blind|Death|1
7778080|NCT00936884|12225658|FG002|Double-blind|Death|0
7778081|NCT00936884|12225656|FG000|Double-blind|Lack of Efficacy|1
7778082|NCT00936884|12225657|FG001|Double-blind|Lack of Efficacy|1
7778083|NCT00936884|12225658|FG002|Double-blind|Lack of Efficacy|0
7778084|NCT00936884|12225656|FG000|Double-blind|Adverse Event|1
7778085|NCT00936884|12225657|FG001|Double-blind|Adverse Event|0
7778086|NCT00936884|12225658|FG002|Double-blind|Adverse Event|0
7778087|NCT00936884|12225656|FG000|Double-blind|Physician Decision|1
7778088|NCT00936884|12225657|FG001|Double-blind|Physician Decision|0
7778089|NCT00936884|12225658|FG002|Double-blind|Physician Decision|0
7778090|NCT00936884|12225656|FG000|Double-blind|No post baseline diary entry|1
7778091|NCT00936884|12225657|FG001|Double-blind|No post baseline diary entry|0
7778092|NCT00936884|12225658|FG002|Double-blind|No post baseline diary entry|0
7778093|NCT00936884|12225656|FG000|Double-blind|Did not receive study drug|0
7778094|NCT00936884|12225657|FG001|Double-blind|Did not receive study drug|1
7778095|NCT00936884|12225658|FG002|Double-blind|Did not receive study drug|0
7778096|NCT00936897|12225667|FG000|Overall Study|Withdrawal by Subject|9
7778097|NCT00936897|12225668|FG001|Overall Study|Withdrawal by Subject|19
7778098|NCT00936897|12225667|FG000|Overall Study|Adverse Event|4
7778099|NCT00936897|12225668|FG001|Overall Study|Adverse Event|13
7778100|NCT00936897|12225667|FG000|Overall Study|Other|3
7778101|NCT00936897|12225668|FG001|Overall Study|Other|9
7778102|NCT00936897|12225667|FG000|Overall Study|Lost to Follow-up|1
7778103|NCT00936897|12225668|FG001|Overall Study|Lost to Follow-up|10
7778104|NCT00936897|12225667|FG000|Overall Study|Administrative Decision|1
7778105|NCT00936897|12225668|FG001|Overall Study|Administrative Decision|2
7778106|NCT00936897|12225667|FG000|Overall Study|Protocol Violation|1
7778107|NCT00936897|12225668|FG001|Overall Study|Protocol Violation|1
7778108|NCT00936897|12225667|FG000|Overall Study|Ineligibility Determined|0
7778109|NCT00936897|12225668|FG001|Overall Study|Ineligibility Determined|3
7778110|NCT00936897|12225667|FG000|Overall Study|Noncompliance|0
7778111|NCT00936897|12225668|FG001|Overall Study|Noncompliance|2
7778112|NCT00936897|12225667|FG000|Overall Study|Death|0
7778113|NCT00936897|12225668|FG001|Overall Study|Death|1
7778114|NCT00936910|12225674|FG000|Overall Study|Lack of Efficacy|3
7778115|NCT00936975|12225679|FG000|Overall Study|Withdrawal by Subject|1
7778116|NCT00936975|12225679|FG000|Overall Study|Disease progression|3
7778117|NCT00936975|12225679|FG000|Overall Study|Post-Tx scan uninterpretable|2
7778118|NCT00937040|12225686|FG000|Overall Study|Adverse Event|5
7778119|NCT00937040|12225687|FG001|Overall Study|Adverse Event|8
7610384|NCT03219164|12018336|FG000|Overall Study|Protocol Violation|0
7610385|NCT03219164|12018337|FG001|Overall Study|Protocol Violation|1
7610386|NCT03219164|12018336|FG000|Overall Study|Withdrew Assent|1
7610387|NCT03219164|12018337|FG001|Overall Study|Withdrew Assent|0
7610388|NCT03143153|12018346|FG000|Pre-Treatment|Participant request to discontinue study treatment|0
7610389|NCT03143153|12018347|FG001|Pre-Treatment|Participant request to discontinue study treatment|0
7610390|NCT03143153|12018348|FG002|Pre-Treatment|Participant request to discontinue study treatment|2
7610391|NCT03143153|12018346|FG000|Pre-Treatment|Participant withdrew consent|0
7610392|NCT03143153|12018347|FG001|Pre-Treatment|Participant withdrew consent|1
7610393|NCT03143153|12018348|FG002|Pre-Treatment|Participant withdrew consent|12
7610394|NCT03143153|12018346|FG000|Pre-Treatment|Participant no longer meets study criteria|0
7610395|NCT03143153|12018347|FG001|Pre-Treatment|Participant no longer meets study criteria|4
7610396|NCT03143153|12018348|FG002|Pre-Treatment|Participant no longer meets study criteria|2
7610397|NCT03143153|12018346|FG000|Pre-Treatment|Other Reasons|1
7610398|NCT03143153|12018347|FG001|Pre-Treatment|Other Reasons|2
7610399|NCT03143153|12018348|FG002|Pre-Treatment|Other Reasons|1
7610400|NCT03143153|12018346|FG000|Pre-Treatment|Disease Progression|1
7610401|NCT03143153|12018347|FG001|Pre-Treatment|Disease Progression|1
7610402|NCT03143153|12018348|FG002|Pre-Treatment|Disease Progression|2
7610403|NCT03143153|12018346|FG000|Pre-Treatment|Adverse event unrelated to study drug|1
7610404|NCT03143153|12018347|FG001|Pre-Treatment|Adverse event unrelated to study drug|3
7610405|NCT03143153|12018348|FG002|Pre-Treatment|Adverse event unrelated to study drug|1
7610406|NCT03143153|12018346|FG000|Treatment|Disease progression|174
7610407|NCT03143153|12018347|FG001|Treatment|Disease progression|184
7610408|NCT03143153|12018348|FG002|Treatment|Disease progression|193
7610409|NCT03143153|12018346|FG000|Treatment|Study drug toxicity|59
7610410|NCT03143153|12018347|FG001|Treatment|Study drug toxicity|33
7610411|NCT03143153|12018348|FG002|Treatment|Study drug toxicity|40
7610412|NCT03143153|12018346|FG000|Treatment|Death|5
7610413|NCT03143153|12018347|FG001|Treatment|Death|3
7610414|NCT03143153|12018348|FG002|Treatment|Death|4
7610415|NCT03143153|12018346|FG000|Treatment|Adverse event unrelated to study drug|19
7610416|NCT03143153|12018347|FG001|Treatment|Adverse event unrelated to study drug|28
7610417|NCT03143153|12018348|FG002|Treatment|Adverse event unrelated to study drug|12
7610418|NCT03143153|12018346|FG000|Treatment|Participant request to discontinue study treatment|13
7610419|NCT03143153|12018347|FG001|Treatment|Participant request to discontinue study treatment|15
7610420|NCT03143153|12018348|FG002|Treatment|Participant request to discontinue study treatment|20
7610421|NCT03143153|12018346|FG000|Treatment|Participant withdrew consent|3
7610422|NCT03143153|12018347|FG001|Treatment|Participant withdrew consent|4
7610423|NCT03143153|12018348|FG002|Treatment|Participant withdrew consent|12
7610424|NCT03143153|12018346|FG000|Treatment|Pregnancy|1
7610425|NCT03143153|12018347|FG001|Treatment|Pregnancy|0
7778120|NCT00937040|12225686|FG000|Overall Study|Lost to Follow-up|12
7778121|NCT00937040|12225687|FG001|Overall Study|Lost to Follow-up|12
7778122|NCT00937040|12225686|FG000|Overall Study|Protocol Violation|3
7778123|NCT00937040|12225687|FG001|Overall Study|Protocol Violation|0
7778124|NCT00937040|12225686|FG000|Overall Study|Withdrawal by Subject|13
7778125|NCT00937040|12225687|FG001|Overall Study|Withdrawal by Subject|7
7778126|NCT00937040|12225686|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
7778127|NCT00937040|12225687|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
7778128|NCT00937040|12225686|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
7778129|NCT00937040|12225687|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
7778130|NCT00937157|12225718|FG000|Overall Study|Pregnancy|1
7778131|NCT00937157|12225718|FG000|Overall Study|Lost to Follow-up|3
7778132|NCT00937326|12225736|FG000|Overall Study|Adverse Event|0
7778133|NCT00937326|12225737|FG001|Overall Study|Adverse Event|3
7778134|NCT00937326|12225738|FG002|Overall Study|Adverse Event|1
7778135|NCT00937326|12225739|FG003|Overall Study|Adverse Event|1
7778136|NCT00937326|12225740|FG004|Overall Study|Adverse Event|2
7778137|NCT00937326|12225736|FG000|Overall Study|Death|0
7778138|NCT00937326|12225737|FG001|Overall Study|Death|0
7778139|NCT00937326|12225738|FG002|Overall Study|Death|1
7778140|NCT00937326|12225739|FG003|Overall Study|Death|0
7778141|NCT00937326|12225740|FG004|Overall Study|Death|0
7610426|NCT03143153|12018348|FG002|Treatment|Pregnancy|0
7610427|NCT03143153|12018346|FG000|Treatment|Maximum clinical benefit|1
7610428|NCT03143153|12018347|FG001|Treatment|Maximum clinical benefit|3
7610429|NCT03143153|12018348|FG002|Treatment|Maximum clinical benefit|4
7610430|NCT03143153|12018346|FG000|Treatment|Completed treatment as per Protocol|13
7610431|NCT03143153|12018347|FG001|Treatment|Completed treatment as per Protocol|8
7610432|NCT03143153|12018348|FG002|Treatment|Completed treatment as per Protocol|0
7610433|NCT03143153|12018346|FG000|Treatment|Other reasons|12
7610434|NCT03143153|12018347|FG001|Treatment|Other reasons|7
7610435|NCT03143153|12018348|FG002|Treatment|Other reasons|15
7610436|NCT03143153|12018346|FG000|Treatment|Not reported|1
7610437|NCT03143153|12018347|FG001|Treatment|Not reported|0
7610438|NCT03143153|12018348|FG002|Treatment|Not reported|0
7610439|NCT02921789|12018396|FG000|Overall Study|Adverse Event|0
7610440|NCT02921789|12018397|FG001|Overall Study|Adverse Event|1
7778142|NCT00937326|12225736|FG000|Overall Study|Withdrawal by Subject|3
7778143|NCT00937326|12225737|FG001|Overall Study|Withdrawal by Subject|4
7778144|NCT00937326|12225738|FG002|Overall Study|Withdrawal by Subject|1
7778145|NCT00937326|12225739|FG003|Overall Study|Withdrawal by Subject|4
7778146|NCT00937326|12225740|FG004|Overall Study|Withdrawal by Subject|3
7778147|NCT00937326|12225736|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0
7778148|NCT00937326|12225737|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0
7778149|NCT00937326|12225738|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1
7778150|NCT00937326|12225739|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0
7778151|NCT00937326|12225740|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0
7778152|NCT00937391|12225768|FG000|Stage 2|Withdrawal by Subject|1
7778153|NCT00937404|12225785|FG000|Overall Study|Protocol Violation|1
7778154|NCT00937404|12225785|FG000|Overall Study|Withdrawal by Subject|1
7778155|NCT00937495|12225789|FG000|Overall Study|Protocol Violation|2
7778156|NCT00937521|12225801|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0
7778157|NCT00937521|12225802|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0
7778158|NCT00937521|12225803|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2
7778159|NCT00937521|12225804|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0
7778160|NCT00937521|12225805|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0
7778161|NCT00937521|12225806|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0
7778162|NCT00937521|12225807|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1
7778163|NCT00937521|12225808|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0
7778164|NCT00937521|12225801|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
7778165|NCT00937521|12225802|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
7778166|NCT00937521|12225803|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
7610441|NCT02921789|12018396|FG000|Overall Study|Lost to Follow-up|1
7610442|NCT02921789|12018397|FG001|Overall Study|Lost to Follow-up|0
7610443|NCT02921789|12018396|FG000|Overall Study|Protocol Deviation|2
7610444|NCT02921789|12018397|FG001|Overall Study|Protocol Deviation|0
7610445|NCT02921789|12018396|FG000|Overall Study|Withdrawal by Subject|2
7610446|NCT02921789|12018397|FG001|Overall Study|Withdrawal by Subject|1
7610447|NCT02921789|12018396|FG000|Overall Study|Miscellaneous|3
7610448|NCT02921789|12018397|FG001|Overall Study|Miscellaneous|2
7610449|NCT02898077|12018405|FG000|Overall Study|Enrolled/randomized, but never treated|1
7610450|NCT02898077|12018406|FG001|Overall Study|Enrolled/randomized, but never treated|1
7610451|NCT02898077|12018405|FG000|Overall Study|Lost to Follow-up|4
7610452|NCT02898077|12018406|FG001|Overall Study|Lost to Follow-up|3
7610453|NCT02898077|12018405|FG000|Overall Study|Physician Decision|0
7610454|NCT02898077|12018406|FG001|Overall Study|Physician Decision|2
7610455|NCT02898077|12018405|FG000|Overall Study|Sponsor Decision|32
7610456|NCT02898077|12018406|FG001|Overall Study|Sponsor Decision|13
7610457|NCT02898077|12018405|FG000|Overall Study|Withdrawal by Subject|6
7610458|NCT02898077|12018406|FG001|Overall Study|Withdrawal by Subject|3
7610459|NCT02898077|12018405|FG000|Overall Study|Discontinued from treatment but refused follow-up|2
7610460|NCT02898077|12018406|FG001|Overall Study|Discontinued from treatment but refused follow-up|1
7610461|NCT02898077|12018405|FG000|Overall Study|Ended extension period|3
7610462|NCT02898077|12018406|FG001|Overall Study|Ended extension period|0
7610463|NCT02702271|12018414|FG000|Overall Study|Death|36
7610464|NCT02702271|12018415|FG001|Overall Study|Death|7
7610465|NCT02702271|12018414|FG000|Overall Study|Lost to Follow-up|12
7610466|NCT02702271|12018415|FG001|Overall Study|Lost to Follow-up|0
7610467|NCT02702271|12018414|FG000|Overall Study|Withdrawal by Subject|8
7610468|NCT02702271|12018415|FG001|Overall Study|Withdrawal by Subject|1
7610469|NCT02702271|12018414|FG000|Overall Study|Physician Decision|2
7610470|NCT02702271|12018415|FG001|Overall Study|Physician Decision|0
7610471|NCT02702271|12018414|FG000|Overall Study|Unsuccessful Implant Attempt|5
7610472|NCT02702271|12018415|FG001|Overall Study|Unsuccessful Implant Attempt|1
7610473|NCT02471339|12018439|FG000|Overall Study|Did not provide follow-up data|2
7610474|NCT02471339|12018440|FG001|Overall Study|Did not provide follow-up data|0
7610475|NCT02470585|12018449|FG000|Overall Study|Death|82
7610476|NCT02470585|12018450|FG001|Overall Study|Death|87
7610477|NCT02470585|12018451|FG002|Overall Study|Death|86
7610478|NCT02470585|12018449|FG000|Overall Study|Withdrawal by Subject|19
7610479|NCT02470585|12018450|FG001|Overall Study|Withdrawal by Subject|21
7610480|NCT02470585|12018451|FG002|Overall Study|Withdrawal by Subject|29
7610481|NCT02470585|12018449|FG000|Overall Study|Lost to Follow-up|2
7610482|NCT02470585|12018450|FG001|Overall Study|Lost to Follow-up|5
7610483|NCT02470585|12018451|FG002|Overall Study|Lost to Follow-up|4
7610484|NCT02470585|12018449|FG000|Overall Study|Other|4
7610485|NCT02470585|12018450|FG001|Overall Study|Other|4
7610486|NCT02470585|12018451|FG002|Overall Study|Other|6
7778167|NCT00937521|12225804|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
7778168|NCT00937521|12225805|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
7778169|NCT00937521|12225806|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
7778170|NCT00937521|12225807|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
7610487|NCT02163694|12018482|FG000|Overall Study|Adverse event- related to progression|3
7610488|NCT02163694|12018483|FG001|Overall Study|Adverse event- related to progression|8
7610489|NCT02163694|12018482|FG000|Overall Study|Adverse event- not related to progression|7
7610490|NCT02163694|12018483|FG001|Overall Study|Adverse event- not related to progression|17
7610491|NCT02163694|12018482|FG000|Overall Study|Withdrew consent|8
7610492|NCT02163694|12018483|FG001|Overall Study|Withdrew consent|21
7610493|NCT02163694|12018482|FG000|Overall Study|Lost to Follow-up|1
7610494|NCT02163694|12018483|FG001|Overall Study|Lost to Follow-up|2
7610495|NCT02163694|12018482|FG000|Overall Study|Progressive disease per protocol|122
7610496|NCT02163694|12018483|FG001|Overall Study|Progressive disease per protocol|197
7610497|NCT02163694|12018482|FG000|Overall Study|Other, not specified|13
7610498|NCT02163694|12018483|FG001|Overall Study|Other, not specified|22
7610499|NCT01966471|12018491|FG000|Overall Study|Death|44
7610500|NCT01966471|12018492|FG001|Overall Study|Death|56
7610501|NCT01966471|12018491|FG000|Overall Study|Lost to Follow-up|46
7610502|NCT01966471|12018492|FG001|Overall Study|Lost to Follow-up|39
7610503|NCT01966471|12018491|FG000|Overall Study|Various reasons|4
7610504|NCT01966471|12018492|FG001|Overall Study|Various reasons|4
7610505|NCT01966471|12018491|FG000|Overall Study|Physician Decision|7
7610506|NCT01966471|12018492|FG001|Overall Study|Physician Decision|5
7610507|NCT01966471|12018491|FG000|Overall Study|Study Terminated By Sponsor|758
7610508|NCT01966471|12018492|FG001|Overall Study|Study Terminated By Sponsor|773
7610509|NCT01966471|12018491|FG000|Overall Study|Withdrawal by Subject|59
7610510|NCT01966471|12018492|FG001|Overall Study|Withdrawal by Subject|51
7610511|NCT01465334|12018522|FG000|Overall Study|Disease Progression|1
7610512|NCT01465334|12018523|FG001|Overall Study|Disease Progression|0
7610513|NCT01465334|12018522|FG000|Overall Study|Adverse Event|1
7610514|NCT01465334|12018523|FG001|Overall Study|Adverse Event|0
7610515|NCT01465334|12018522|FG000|Overall Study|Richter's transformation|0
7610516|NCT01465334|12018523|FG001|Overall Study|Richter's transformation|3
7610517|NCT01465334|12018522|FG000|Overall Study|Refractory Disease|0
7610518|NCT01465334|12018523|FG001|Overall Study|Refractory Disease|3
7610519|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
7610520|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
7610521|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
7610522|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7610523|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7610524|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7610525|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7610526|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7610527|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7610528|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
7610529|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
7610530|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
7610531|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7610532|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7610533|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7610534|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7610535|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7610536|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7610537|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
7610538|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
7610539|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
7610540|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7610541|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7610542|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7610543|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7610544|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7610545|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7610546|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610547|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610548|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
7610549|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610550|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610551|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610552|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610553|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610554|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610555|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
7610556|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7610557|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
7610558|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7610559|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7610560|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7610561|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7610562|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7610563|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7610564|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7610565|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610566|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610567|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610568|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610569|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610570|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610571|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610572|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610573|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1
7610574|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2
7610575|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0
7610576|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0
7610577|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0
7610578|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0
7610579|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0
7610580|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0
7610581|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0
7610582|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7610583|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
7610584|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
7610585|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7610586|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7610587|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7610588|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7610589|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7610590|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7610591|NCT01307423|12018532|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0
7610592|NCT01307423|12018533|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3
7610593|NCT01307423|12018534|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2
7610594|NCT01307423|12018535|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2
7610595|NCT01307423|12018536|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2
7610596|NCT01307423|12018537|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0
7610597|NCT01307423|12018538|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0
7610598|NCT01307423|12018539|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0
7610599|NCT01307423|12018540|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0
7610600|NCT01307423|12018532|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
7610601|NCT01307423|12018533|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
7610602|NCT01307423|12018534|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
7610603|NCT01307423|12018535|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
7610604|NCT01307423|12018536|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
7610605|NCT01307423|12018537|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
7610606|NCT01307423|12018538|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
7610607|NCT01307423|12018539|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
7610608|NCT01307423|12018540|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
7610609|NCT01307423|12018532|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610610|NCT01307423|12018533|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610611|NCT01307423|12018534|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610612|NCT01307423|12018535|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610613|NCT01307423|12018536|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610614|NCT01307423|12018537|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
7610615|NCT01307423|12018538|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610616|NCT01307423|12018539|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610617|NCT01307423|12018540|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610618|NCT01307423|12018532|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
7610619|NCT01307423|12018533|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
7610620|NCT01307423|12018534|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
7610621|NCT01307423|12018535|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
7610622|NCT01307423|12018536|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
7610623|NCT01307423|12018537|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
7610624|NCT01307423|12018538|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
7610625|NCT01307423|12018539|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
7610626|NCT01307423|12018540|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
7610627|NCT01307423|12018532|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610628|NCT01307423|12018533|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610629|NCT01307423|12018534|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610630|NCT01307423|12018535|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
7610631|NCT01307423|12018536|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610632|NCT01307423|12018537|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610633|NCT01307423|12018538|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610634|NCT01307423|12018539|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610635|NCT01307423|12018540|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610636|NCT01307423|12018532|FG000|Active Treatment Phase (Week 25-52)|Other|0
7610637|NCT01307423|12018533|FG001|Active Treatment Phase (Week 25-52)|Other|0
7610638|NCT01307423|12018534|FG002|Active Treatment Phase (Week 25-52)|Other|0
7610639|NCT01307423|12018535|FG003|Active Treatment Phase (Week 25-52)|Other|1
7610640|NCT01307423|12018536|FG004|Active Treatment Phase (Week 25-52)|Other|0
7610641|NCT01307423|12018537|FG005|Active Treatment Phase (Week 25-52)|Other|0
7610642|NCT01307423|12018538|FG006|Active Treatment Phase (Week 25-52)|Other|0
7610643|NCT01307423|12018539|FG007|Active Treatment Phase (Week 25-52)|Other|0
7610644|NCT01307423|12018540|FG008|Active Treatment Phase (Week 25-52)|Other|0
7610645|NCT01307423|12018532|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610646|NCT01307423|12018533|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610647|NCT01307423|12018534|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610648|NCT01307423|12018535|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610649|NCT01307423|12018536|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610650|NCT01307423|12018537|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1
7610651|NCT01307423|12018538|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610652|NCT01307423|12018539|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610653|NCT01307423|12018540|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610654|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0
7610655|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2
7610656|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7
7610657|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0
7610658|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0
7610659|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0
7610660|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0
7610661|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1
7610662|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1
7610663|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7610664|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
7610665|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
7610666|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7610667|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7610668|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7610669|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7610670|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
7610671|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
7610672|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610673|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610674|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
7610675|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610676|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610677|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610678|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610679|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610680|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610681|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7610682|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
7610683|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
7610684|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7610685|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7610686|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7610687|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7610688|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
7610689|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
7610690|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0
7610691|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1
7610692|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0
7610693|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0
7610694|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0
7610695|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0
7610696|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0
7610697|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1
7610698|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1
7610699|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0
7610700|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1
7610701|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2
7610702|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0
7610703|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0
7610704|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0
7610705|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0
7610706|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3
7610707|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4
7610708|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7610709|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
7610710|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
7610711|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7610712|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7610713|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7610714|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7610715|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
7610716|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
7610717|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7610718|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
7610719|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
7610720|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7610721|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7610722|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7610723|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7610724|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7610725|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7610726|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7610727|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
7610728|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
7610729|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7610730|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7610731|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7610732|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7610733|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
7610734|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
7610735|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7778171|NCT00937521|12225808|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
7778172|NCT00937521|12225801|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7778173|NCT00937521|12225802|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7778174|NCT00937521|12225803|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
7778175|NCT00937521|12225804|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
7778176|NCT00937521|12225805|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7778177|NCT00937521|12225806|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7778178|NCT00937521|12225807|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7778179|NCT00937521|12225808|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7778180|NCT00937521|12225801|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
7778181|NCT00937521|12225802|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
7778182|NCT00937521|12225803|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
7778183|NCT00937521|12225804|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
7778184|NCT00937521|12225805|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
7778185|NCT00937521|12225806|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
7778186|NCT00937521|12225807|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
7778187|NCT00937521|12225808|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
7778188|NCT00937521|12225801|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1
7778189|NCT00937521|12225802|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7800090|NCT01090765|12257227|FG001|Overall Study|Patient withdrew consent|0
7778190|NCT00937521|12225803|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7610736|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
7610737|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
7610738|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7610739|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7610740|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7610741|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7610742|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
7610743|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
7610744|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0
7610745|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1
7610746|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0
7610747|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0
7610748|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0
7610749|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0
7610750|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0
7610751|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1
7610752|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0
7610753|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0
7610754|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2
7610755|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0
7610756|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0
7610757|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0
7610758|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0
7610759|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0
7610760|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0
7778191|NCT00937521|12225804|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7778192|NCT00937521|12225805|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7778193|NCT00937521|12225806|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7778194|NCT00937521|12225807|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1
7778195|NCT00937521|12225808|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7778196|NCT00937521|12225801|FG000|Booster Phase|Adverse Event|0
7778197|NCT00937521|12225802|FG001|Booster Phase|Adverse Event|0
7610761|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0
7778198|NCT00937521|12225803|FG002|Booster Phase|Adverse Event|0
7778199|NCT00937521|12225804|FG003|Booster Phase|Adverse Event|0
7778200|NCT00937521|12225805|FG004|Booster Phase|Adverse Event|0
7778201|NCT00937521|12225806|FG005|Booster Phase|Adverse Event|0
7778202|NCT00937521|12225807|FG006|Booster Phase|Adverse Event|1
7778203|NCT00937521|12225808|FG007|Booster Phase|Adverse Event|0
7610762|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7610763|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
7610764|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7610765|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7610766|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7610767|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7610768|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7610769|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7610770|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
7610771|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7610772|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
7610773|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
7610774|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7610775|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7610776|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7610777|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7610778|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
7610779|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
7610780|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610781|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610782|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
7610783|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610784|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610785|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610786|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610787|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610788|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610789|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0
7778204|NCT00937521|12225801|FG000|Booster Phase|Withdrawal by Subject|1
7778205|NCT00937521|12225802|FG001|Booster Phase|Withdrawal by Subject|0
7778206|NCT00937521|12225803|FG002|Booster Phase|Withdrawal by Subject|0
7778207|NCT00937521|12225804|FG003|Booster Phase|Withdrawal by Subject|1
7778208|NCT00937521|12225805|FG004|Booster Phase|Withdrawal by Subject|0
7778209|NCT00937521|12225806|FG005|Booster Phase|Withdrawal by Subject|0
7778210|NCT00937521|12225807|FG006|Booster Phase|Withdrawal by Subject|0
7778211|NCT00937521|12225808|FG007|Booster Phase|Withdrawal by Subject|2
7778212|NCT00937521|12225801|FG000|Booster Phase|Lost to Follow-up|2
7778213|NCT00937521|12225802|FG001|Booster Phase|Lost to Follow-up|2
7778214|NCT00937521|12225803|FG002|Booster Phase|Lost to Follow-up|4
7778215|NCT00937521|12225804|FG003|Booster Phase|Lost to Follow-up|2
7778216|NCT00937521|12225805|FG004|Booster Phase|Lost to Follow-up|4
7778217|NCT00937521|12225806|FG005|Booster Phase|Lost to Follow-up|4
7778218|NCT00937521|12225807|FG006|Booster Phase|Lost to Follow-up|3
7778219|NCT00937521|12225808|FG007|Booster Phase|Lost to Follow-up|0
7778220|NCT00937521|12225801|FG000|Booster Phase|Administrative Reason|0
7778221|NCT00937521|12225802|FG001|Booster Phase|Administrative Reason|0
7778222|NCT00937521|12225803|FG002|Booster Phase|Administrative Reason|1
7778223|NCT00937521|12225804|FG003|Booster Phase|Administrative Reason|0
7778224|NCT00937521|12225805|FG004|Booster Phase|Administrative Reason|1
7778225|NCT00937521|12225806|FG005|Booster Phase|Administrative Reason|1
7610790|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0
7610791|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0
7610792|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0
7610793|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0
7610794|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0
7610795|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0
7610796|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1
7610797|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0
7610798|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0
7610799|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1
7610800|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1
7610801|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0
7610802|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0
7610803|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0
7610804|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0
7610805|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0
7610806|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1
7610807|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7610808|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
7778226|NCT00937521|12225807|FG006|Booster Phase|Administrative Reason|0
7610809|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
7610810|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7610811|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7610812|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7610813|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7610814|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7610815|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7610816|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7610817|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
7610818|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
7610819|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7610820|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7610821|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7610822|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7610823|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7610824|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
7610825|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610826|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
7610827|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610828|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610829|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610830|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610831|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610832|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610833|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610834|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0
7610835|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0
7610836|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2
7610837|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0
7610838|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0
7610839|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0
7610840|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0
7610841|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1
7610842|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1
7610843|NCT00655876|12018601|FG000|Overall Study|Protocol Violation|9
7610844|NCT00655876|12018602|FG001|Overall Study|Protocol Violation|7
7610845|NCT00265941|12018627|FG000|Overall Study|Protocol Violation|22
7610846|NCT00265941|12018628|FG001|Overall Study|Protocol Violation|25
7610847|NCT00265941|12018627|FG000|Overall Study|Lost to Follow-up|1
7610848|NCT00265941|12018628|FG001|Overall Study|Lost to Follow-up|1
7610849|NCT00114140|12018642|FG000|Overall Study|Protocol Violation|7
7610850|NCT00047008|12018655|FG000|Overall Study|Withdrawn consent|2
7778227|NCT00937521|12225808|FG007|Booster Phase|Administrative Reason|0
7778228|NCT00937521|12225801|FG000|Booster Phase|Protocol Deviation|0
7610851|NCT00047008|12018656|FG001|Overall Study|Withdrawn consent|3
7610852|NCT00047008|12018655|FG000|Overall Study|Ineligible|9
7610853|NCT00047008|12018656|FG001|Overall Study|Ineligible|8
7778229|NCT00937521|12225802|FG001|Booster Phase|Protocol Deviation|0
7778230|NCT00937521|12225803|FG002|Booster Phase|Protocol Deviation|0
7778231|NCT00937521|12225804|FG003|Booster Phase|Protocol Deviation|0
7778232|NCT00937521|12225805|FG004|Booster Phase|Protocol Deviation|0
7778233|NCT00937521|12225806|FG005|Booster Phase|Protocol Deviation|0
7778234|NCT00937521|12225807|FG006|Booster Phase|Protocol Deviation|1
7778235|NCT00937521|12225808|FG007|Booster Phase|Protocol Deviation|0
7778236|NCT00937547|12225844|FG000|Overall Study|misdiagnosis|1
7778237|NCT00937547|12225845|FG001|Overall Study|misdiagnosis|6
7778238|NCT00937547|12225846|FG002|Overall Study|misdiagnosis|7
7778239|NCT00937560|12225854|FG000|Initial Treatment|Death|6
7610854|NCT04392583|12018666|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1
7778240|NCT00937560|12225854|FG000|Initial Treatment|Withdraw consent|3
7778241|NCT00937560|12225854|FG000|Initial Treatment|Adverse Event|1
7778242|NCT00937560|12225854|FG000|Initial Treatment|Lost to Follow-up|1
7778243|NCT00937560|12225854|FG000|Initial Treatment|No end of study page|10
7778244|NCT00937560|12225854|FG000|Maintenance Treatment|Death|12
7778245|NCT00937560|12225854|FG000|Maintenance Treatment|Withdraw consent|5
7778246|NCT00937560|12225854|FG000|Maintenance Treatment|According to protocol|1
7778247|NCT00937768|12225860|FG000|Overall Study|Refused Further Treatment|3
7778248|NCT00937768|12225861|FG001|Overall Study|Refused Further Treatment|2
7778249|NCT00937768|12225860|FG000|Overall Study|Disease Progression|1
7778250|NCT00937768|12225861|FG001|Overall Study|Disease Progression|1
7778251|NCT00937768|12225860|FG000|Overall Study|Alternate Treatment|0
7778252|NCT00937768|12225861|FG001|Overall Study|Alternate Treatment|1
7778253|NCT00937768|12225860|FG000|Overall Study|No Further Funding|4
7778254|NCT00937768|12225861|FG001|Overall Study|No Further Funding|4
7778255|NCT00937833|12225873|FG000|Overall Study|Protocol Violation|1
7778256|NCT00937833|12225874|FG001|Overall Study|Protocol Violation|2
7778257|NCT00937833|12225873|FG000|Overall Study|Procedure delayed; enrollment closed|0
7778258|NCT00937833|12225874|FG001|Overall Study|Procedure delayed; enrollment closed|1
7778259|NCT00937833|12225873|FG000|Overall Study|Lost to Follow-up|10
7778260|NCT00937833|12225874|FG001|Overall Study|Lost to Follow-up|8
7778261|NCT00937833|12225873|FG000|Overall Study|Withdrawal by Subject|4
7778262|NCT00937833|12225874|FG001|Overall Study|Withdrawal by Subject|6
7778263|NCT00937950|12225889|FG000|Overall Study|Withdrawal by Subject|23
7778264|NCT00937950|12225889|FG000|Overall Study|Migrated/moved from study area|27
7778265|NCT00937950|12225889|FG000|Overall Study|Lost to Follow-up|144
7778266|NCT00937950|12225889|FG000|Overall Study|Missing confirmed|4
7778267|NCT00937950|12225889|FG000|Overall Study|Other|18
7778268|NCT00938015|12225893|FG000|Overall Study|Death|2
7778269|NCT00938015|12225893|FG000|Overall Study|Lost to Follow-up|32
7778270|NCT00938015|12225893|FG000|Overall Study|Adverse Event|32
7778271|NCT00938015|12225893|FG000|Overall Study|Non-responder|52
7778272|NCT00938015|12225893|FG000|Overall Study|Reason not related to Etanercept|29
7778273|NCT00938041|12225897|FG000|Overall Study|Lost to Follow-up|6
7778274|NCT00938041|12225897|FG000|Overall Study|Received Alternative Therapy|1
7778275|NCT00938041|12225897|FG000|Overall Study|Progressive Disease|5
7778276|NCT00938041|12225897|FG000|Overall Study|Death|12
7778277|NCT00938041|12225897|FG000|Overall Study|Adrenal Insufficiency|3
7778278|NCT00938327|12225918|FG000|Overall Study|Adverse Event|2
7778279|NCT00938327|12225918|FG000|Overall Study|Protocol Violation|1
7778280|NCT00938327|12225918|FG000|Overall Study|Withdrawal by Subject|4
7778281|NCT00938327|12225918|FG000|Overall Study|Lost to Follow-up|37
7778282|NCT00938327|12225918|FG000|Overall Study|2nd dose received outside of the study|7
7778283|NCT00938327|12225918|FG000|Overall Study|Vaccine not received as out of stock|9
7778284|NCT00938340|12225922|FG000|Overall Study|Withdrawal by Subject|3
7610855|NCT04326439|12018676|FG000|Overall Study|Withdrawal by Subject|1
7610856|NCT04326439|12018677|FG001|Overall Study|Withdrawal by Subject|0
7610857|NCT04326439|12018676|FG000|Overall Study|Proceeded to HSCT after Induction 2|0
7610858|NCT04326439|12018677|FG001|Overall Study|Proceeded to HSCT after Induction 2|2
7610859|NCT04326439|12018676|FG000|Overall Study|Relapse after Induction 2|0
7610860|NCT04326439|12018677|FG001|Overall Study|Relapse after Induction 2|1
7610861|NCT04326439|12018676|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1
7610862|NCT04326439|12018677|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0
7610863|NCT04003142|12018706|FG000|Double-blind Period (12 Weeks)|Adverse Event|1
7610864|NCT04003142|12018707|FG001|Double-blind Period (12 Weeks)|Adverse Event|1
7610865|NCT04003142|12018708|FG002|Double-blind Period (12 Weeks)|Adverse Event|2
7610866|NCT04003142|12018709|FG003|Double-blind Period (12 Weeks)|Adverse Event|0
7610867|NCT04003142|12018710|FG004|Double-blind Period (12 Weeks)|Adverse Event|0
7610868|NCT04003142|12018706|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2
7610869|NCT04003142|12018707|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1
7610870|NCT04003142|12018708|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2
7610871|NCT04003142|12018709|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0
7610872|NCT04003142|12018710|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0
7610873|NCT04003142|12018706|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1
7610874|NCT04003142|12018707|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5
7610875|NCT04003142|12018708|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0
7778285|NCT00938340|12225922|FG000|Overall Study|Protocol Violation|1
7610876|NCT04003142|12018709|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0
7610877|NCT04003142|12018710|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0
7610878|NCT04003142|12018706|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11
7610879|NCT04003142|12018707|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6
7610880|NCT04003142|12018708|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6
7610881|NCT04003142|12018709|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0
7610882|NCT04003142|12018710|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0
7610883|NCT04003142|12018706|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2
7610884|NCT04003142|12018707|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1
7778286|NCT00938340|12225922|FG000|Overall Study|Adverse Event|1
7610885|NCT04003142|12018708|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2
7610886|NCT04003142|12018709|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0
7610887|NCT04003142|12018710|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0
7610888|NCT04003142|12018706|FG000|Extension Period (40 Weeks)|Adverse Event|0
7610889|NCT04003142|12018707|FG001|Extension Period (40 Weeks)|Adverse Event|4
7610890|NCT04003142|12018708|FG002|Extension Period (40 Weeks)|Adverse Event|4
7610891|NCT04003142|12018709|FG003|Extension Period (40 Weeks)|Adverse Event|2
7610892|NCT04003142|12018710|FG004|Extension Period (40 Weeks)|Adverse Event|3
7610893|NCT04003142|12018706|FG000|Extension Period (40 Weeks)|Death|0
7610894|NCT04003142|12018707|FG001|Extension Period (40 Weeks)|Death|0
7610895|NCT04003142|12018708|FG002|Extension Period (40 Weeks)|Death|0
7610896|NCT04003142|12018709|FG003|Extension Period (40 Weeks)|Death|0
7610897|NCT04003142|12018710|FG004|Extension Period (40 Weeks)|Death|1
7610898|NCT04003142|12018706|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0
7610899|NCT04003142|12018707|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2
7610900|NCT04003142|12018708|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1
7610901|NCT04003142|12018709|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2
7610902|NCT04003142|12018710|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1
7610903|NCT04003142|12018706|FG000|Extension Period (40 Weeks)|Protocol Deviation|0
7610904|NCT04003142|12018707|FG001|Extension Period (40 Weeks)|Protocol Deviation|0
7610905|NCT04003142|12018708|FG002|Extension Period (40 Weeks)|Protocol Deviation|2
7610906|NCT04003142|12018709|FG003|Extension Period (40 Weeks)|Protocol Deviation|0
7610907|NCT04003142|12018710|FG004|Extension Period (40 Weeks)|Protocol Deviation|0
7610908|NCT04003142|12018706|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0
7610909|NCT04003142|12018707|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17
7610910|NCT04003142|12018708|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14
7610911|NCT04003142|12018709|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9
7610912|NCT04003142|12018710|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5
7610913|NCT04003142|12018706|FG000|Extension Period (40 Weeks)|Miscellaneous|0
7610914|NCT04003142|12018707|FG001|Extension Period (40 Weeks)|Miscellaneous|4
7610915|NCT04003142|12018708|FG002|Extension Period (40 Weeks)|Miscellaneous|1
7610916|NCT04003142|12018709|FG003|Extension Period (40 Weeks)|Miscellaneous|0
7610917|NCT04003142|12018710|FG004|Extension Period (40 Weeks)|Miscellaneous|2
7778287|NCT00938366|12225970|FG000|Overall Study|Withdrawal by Subject|1
7610918|NCT03402841|12018745|FG000|Overall Study|Withdrawal by Subject|4
7610919|NCT03402841|12018745|FG000|Overall Study|Lost to Follow-up|3
7610920|NCT03402841|12018745|FG000|Overall Study|Death|85
7610921|NCT03383666|12018749|FG000|Overall Study|Withdrawal by Subject|2
7610922|NCT03383666|12018749|FG000|Overall Study|Lost to Follow-up|2
7778288|NCT00938366|12225971|FG001|Overall Study|Withdrawal by Subject|0
7778289|NCT00938392|12225979|FG000|Overall Study|Adverse Event|0
7778290|NCT00938392|12225980|FG001|Overall Study|Adverse Event|1
7778291|NCT00938392|12225979|FG000|Overall Study|Withdrawal by Subject|0
7778292|NCT00938392|12225980|FG001|Overall Study|Withdrawal by Subject|1
7778293|NCT00938392|12225979|FG000|Overall Study|Lost to Follow-up|2
7778294|NCT00938392|12225980|FG001|Overall Study|Lost to Follow-up|2
7778295|NCT00938431|12225989|FG000|Overall Study|Adverse Event|5
7778296|NCT00938431|12225990|FG001|Overall Study|Adverse Event|8
7778297|NCT00938431|12225991|FG002|Overall Study|Adverse Event|6
7778298|NCT00938431|12225989|FG000|Overall Study|Lack of Efficacy|0
7778299|NCT00938431|12225990|FG001|Overall Study|Lack of Efficacy|1
7778300|NCT00938431|12225991|FG002|Overall Study|Lack of Efficacy|0
7778301|NCT00938431|12225989|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1
7778302|NCT00938431|12225990|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0
7778303|NCT00938431|12225991|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0
7610939|NCT03219333|12018771|FG000|Overall Study|Withdrawal by Subject|8
7610940|NCT03219333|12018772|FG001|Overall Study|Withdrawal by Subject|3
7610941|NCT03219333|12018771|FG000|Overall Study|Lost to Follow-up|1
7610942|NCT03219333|12018772|FG001|Overall Study|Lost to Follow-up|0
7610943|NCT03219333|12018771|FG000|Overall Study|Death|94
7610944|NCT03219333|12018772|FG001|Overall Study|Death|44
7610945|NCT03219333|12018771|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2
7610946|NCT03219333|12018772|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2
7778304|NCT00938431|12225989|FG000|Overall Study|Dosing compliance issue|0
7778305|NCT00938431|12225990|FG001|Overall Study|Dosing compliance issue|0
7778306|NCT00938431|12225991|FG002|Overall Study|Dosing compliance issue|1
7778307|NCT00938431|12225989|FG000|Overall Study|Reached maximum dose early|0
7778308|NCT00938431|12225990|FG001|Overall Study|Reached maximum dose early|0
7778309|NCT00938431|12225991|FG002|Overall Study|Reached maximum dose early|1
7778310|NCT00938470|12226009|FG000|Overall Study|Disease Progression|3
7778311|NCT00938470|12226010|FG001|Overall Study|Disease Progression|0
7778312|NCT00938470|12226009|FG000|Overall Study|Alternate Treatment|1
7778313|NCT00938470|12226010|FG001|Overall Study|Alternate Treatment|0
7778314|NCT00938470|12226009|FG000|Overall Study|Death|3
7778315|NCT00938470|12226010|FG001|Overall Study|Death|2
7778316|NCT00938470|12226009|FG000|Overall Study|Other Reason|0
7778317|NCT00938470|12226010|FG001|Overall Study|Other Reason|1
7778318|NCT00938639|12226027|FG000|Overall Study|Moved away from study area|0
7778319|NCT00938639|12226028|FG001|Overall Study|Moved away from study area|1
7778320|NCT00938639|12226027|FG000|Overall Study|Lost to Follow-up|1
7778321|NCT00938639|12226028|FG001|Overall Study|Lost to Follow-up|2
7778322|NCT00938639|12226027|FG000|Overall Study|Family issues|1
7778323|NCT00938639|12226028|FG001|Overall Study|Family issues|1
7778324|NCT00938639|12226027|FG000|Overall Study|Participant noncompliance|1
7778325|NCT00938639|12226028|FG001|Overall Study|Participant noncompliance|0
7778326|NCT00938717|12226049|FG000|Overall Study|Adverse Event|10
7778327|NCT00938717|12226050|FG001|Overall Study|Adverse Event|41
7778328|NCT00938717|12226049|FG000|Overall Study|Protocol Violation|11
7778329|NCT00938717|12226050|FG001|Overall Study|Protocol Violation|8
7778330|NCT00938717|12226049|FG000|Overall Study|Withdrawal by Subject|26
7778331|NCT00938717|12226050|FG001|Overall Study|Withdrawal by Subject|24
7778332|NCT00938717|12226049|FG000|Overall Study|Lost to Follow-up|13
7778333|NCT00938717|12226050|FG001|Overall Study|Lost to Follow-up|18
7778334|NCT00938717|12226049|FG000|Overall Study|Lack of Efficacy|33
7778335|NCT00938717|12226050|FG001|Overall Study|Lack of Efficacy|15
7778336|NCT00938717|12226049|FG000|Overall Study|Other reason|5
7778337|NCT00938717|12226050|FG001|Overall Study|Other reason|2
7778338|NCT00938860|12226067|FG000|Overall Study|Adverse Event|2
7778339|NCT00938860|12226068|FG001|Overall Study|Adverse Event|1
7778340|NCT00938860|12226067|FG000|Overall Study|Abnormal laboratory values|2
7778341|NCT00938860|12226068|FG001|Overall Study|Abnormal laboratory values|2
7778342|NCT00938860|12226067|FG000|Overall Study|Withdrawal by Subject|11
7778343|NCT00938860|12226068|FG001|Overall Study|Withdrawal by Subject|8
7778344|NCT00938860|12226067|FG000|Overall Study|Lost to Follow-up|4
7778345|NCT00938860|12226068|FG001|Overall Study|Lost to Follow-up|4
7778346|NCT00938860|12226067|FG000|Overall Study|Administration problems|2
7778347|NCT00938860|12226068|FG001|Overall Study|Administration problems|0
7778348|NCT00938860|12226067|FG000|Overall Study|Death|1
7778349|NCT00938860|12226068|FG001|Overall Study|Death|1
7778350|NCT00938860|12226067|FG000|Overall Study|Protocol Violation|3
7778351|NCT00938860|12226068|FG001|Overall Study|Protocol Violation|1
7778352|NCT00938886|12226076|FG000|Overall Study|Death|0
7778353|NCT00938886|12226077|FG001|Overall Study|Death|1
7778354|NCT00938886|12226076|FG000|Overall Study|Withdrawal by Subject|4
7778355|NCT00938886|12226077|FG001|Overall Study|Withdrawal by Subject|7
7778356|NCT00938886|12226076|FG000|Overall Study|Lost to Follow-up|3
7778357|NCT00938886|12226077|FG001|Overall Study|Lost to Follow-up|2
7778358|NCT00938964|12226085|FG000|Overall Study|Death|3
7778359|NCT00938964|12226086|FG001|Overall Study|Death|3
7778360|NCT00938964|12226085|FG000|Overall Study|Lost to Follow-up|2
7778361|NCT00938964|12226086|FG001|Overall Study|Lost to Follow-up|3
7778362|NCT00938964|12226085|FG000|Overall Study|Withdrawal by Subject|22
7778363|NCT00938964|12226086|FG001|Overall Study|Withdrawal by Subject|18
7778364|NCT00938964|12226085|FG000|Overall Study|Found to Meet Exclusion Criteria|3
7778365|NCT00938964|12226086|FG001|Overall Study|Found to Meet Exclusion Criteria|4
7778366|NCT00939003|12226094|FG000|Double-blind Treatment Period|Adverse Event|1
7778367|NCT00939003|12226095|FG001|Double-blind Treatment Period|Adverse Event|1
7778368|NCT00939003|12226094|FG000|Double-blind Treatment Period|Lack of Efficacy|0
7778369|NCT00939003|12226095|FG001|Double-blind Treatment Period|Lack of Efficacy|1
7611015|NCT02881957|12018833|FG000|Overall Study|Comfort care|0
7611016|NCT02881957|12018834|FG001|Overall Study|Comfort care|1
7611017|NCT02881957|12018833|FG000|Overall Study|Concurrent trial enrollment|0
7611018|NCT02881957|12018834|FG001|Overall Study|Concurrent trial enrollment|1
7611019|NCT02881957|12018833|FG000|Overall Study|Discharged within 48 hours|0
7611020|NCT02881957|12018834|FG001|Overall Study|Discharged within 48 hours|1
7611021|NCT02881957|12018833|FG000|Overall Study|Withdrawal by Subject|2
7611022|NCT02881957|12018834|FG001|Overall Study|Withdrawal by Subject|1
7611023|NCT02881957|12018833|FG000|Overall Study|Protocol Violation|1
7611024|NCT02881957|12018834|FG001|Overall Study|Protocol Violation|0
7778370|NCT00939003|12226094|FG000|Double-blind Treatment Period|Pregnancy|0
7778371|NCT00939003|12226095|FG001|Double-blind Treatment Period|Pregnancy|1
7778372|NCT00939003|12226094|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1
7778373|NCT00939003|12226095|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1
7778374|NCT00939003|12226094|FG000|Open-label Treatment Period|Adverse Event|4
7778375|NCT00939003|12226095|FG001|Open-label Treatment Period|Adverse Event|8
7778376|NCT00939003|12226094|FG000|Open-label Treatment Period|Withdrawal by Subject|14
7778377|NCT00939003|12226095|FG001|Open-label Treatment Period|Withdrawal by Subject|7
7778378|NCT00939003|12226094|FG000|Open-label Treatment Period|Lack of Efficacy|6
7778379|NCT00939003|12226095|FG001|Open-label Treatment Period|Lack of Efficacy|9
7778380|NCT00939003|12226094|FG000|Open-label Treatment Period|Pregnancy|1
7778381|NCT00939003|12226095|FG001|Open-label Treatment Period|Pregnancy|1
7778382|NCT00939003|12226094|FG000|Open-label Treatment Period|Exclusion Criteria|1
7778383|NCT00939003|12226095|FG001|Open-label Treatment Period|Exclusion Criteria|0
7778384|NCT00939003|12226094|FG000|Open-label Treatment Period|Site Closure|3
7778385|NCT00939003|12226095|FG001|Open-label Treatment Period|Site Closure|4
7778386|NCT00939029|12226106|FG000|Overall Study|Withdrawal by Subject|3
7778387|NCT00939029|12226107|FG001|Overall Study|Withdrawal by Subject|7
7611025|NCT02761694|12018856|FG000|Overall Study|Lack of Efficacy|0
7611026|NCT02761694|12018857|FG001|Overall Study|Lack of Efficacy|0
7611027|NCT02761694|12018858|FG002|Overall Study|Lack of Efficacy|0
7611028|NCT02761694|12018859|FG003|Overall Study|Lack of Efficacy|0
7611029|NCT02761694|12018860|FG004|Overall Study|Lack of Efficacy|0
7611030|NCT02761694|12018861|FG005|Overall Study|Lack of Efficacy|0
7611031|NCT02761694|12018862|FG006|Overall Study|Lack of Efficacy|6
7611032|NCT02761694|12018863|FG007|Overall Study|Lack of Efficacy|0
7611033|NCT02761694|12018864|FG008|Overall Study|Lack of Efficacy|0
7778388|NCT00939029|12226106|FG000|Overall Study|Lost to Follow-up|3
7778389|NCT00939029|12226107|FG001|Overall Study|Lost to Follow-up|4
7778390|NCT00939029|12226106|FG000|Overall Study|Adverse Event|0
7778391|NCT00939029|12226107|FG001|Overall Study|Adverse Event|1
7611034|NCT02761694|12018865|FG009|Overall Study|Lack of Efficacy|1
7611035|NCT02761694|12018866|FG010|Overall Study|Lack of Efficacy|1
7611036|NCT02761694|12018867|FG011|Overall Study|Lack of Efficacy|4
7611037|NCT02761694|12018856|FG000|Overall Study|Death|0
7611038|NCT02761694|12018857|FG001|Overall Study|Death|0
7611039|NCT02761694|12018858|FG002|Overall Study|Death|0
7611040|NCT02761694|12018859|FG003|Overall Study|Death|0
7611041|NCT02761694|12018860|FG004|Overall Study|Death|0
7611042|NCT02761694|12018861|FG005|Overall Study|Death|0
7611043|NCT02761694|12018862|FG006|Overall Study|Death|2
7611044|NCT02761694|12018863|FG007|Overall Study|Death|0
7611045|NCT02761694|12018864|FG008|Overall Study|Death|2
7611046|NCT02761694|12018865|FG009|Overall Study|Death|2
7611047|NCT02761694|12018866|FG010|Overall Study|Death|1
7611048|NCT02761694|12018867|FG011|Overall Study|Death|0
7611049|NCT02761694|12018856|FG000|Overall Study|Physician Decision|0
7778392|NCT00939055|12226115|FG000|Overall Study|Discontinuation prior to procedure|4
7778393|NCT00939055|12226116|FG001|Overall Study|Discontinuation prior to procedure|0
7778394|NCT00939094|12226125|FG000|Overall Study|Adverse Event|9
7778395|NCT00939094|12226126|FG001|Overall Study|Adverse Event|0
7778396|NCT00939094|12226125|FG000|Overall Study|Withdrawal by Subject|1
7778397|NCT00939094|12226126|FG001|Overall Study|Withdrawal by Subject|6
7778398|NCT00939094|12226125|FG000|Overall Study|Lost to Follow-up|1
7778399|NCT00939094|12226126|FG001|Overall Study|Lost to Follow-up|1
7778400|NCT00939094|12226125|FG000|Overall Study|Eligibility criteria not fulfilled|2
7778401|NCT00939094|12226126|FG001|Overall Study|Eligibility criteria not fulfilled|0
7778402|NCT00939094|12226125|FG000|Overall Study|Severe non-compliance to protocol|0
7778403|NCT00939094|12226126|FG001|Overall Study|Severe non-compliance to protocol|1
7778404|NCT00939094|12226125|FG000|Overall Study|Study stopped by sponsor|0
7778405|NCT00939094|12226126|FG001|Overall Study|Study stopped by sponsor|2
7778406|NCT00939094|12226125|FG000|Overall Study|Abnormal ECG findings|1
7778407|NCT00939094|12226126|FG001|Overall Study|Abnormal ECG findings|0
7778408|NCT00939107|12226134|FG000|Overall Study|Lost to Follow-up|14
7778409|NCT00939107|12226135|FG001|Overall Study|Lost to Follow-up|12
7800091|NCT01090765|12257228|FG002|Overall Study|Patient withdrew consent|0
7800092|NCT01090765|12257229|FG003|Overall Study|Patient withdrew consent|0
7800093|NCT01090765|12257230|FG004|Overall Study|Patient withdrew consent|1
7800094|NCT01090765|12257231|FG005|Overall Study|Patient withdrew consent|1
7800095|NCT01090765|12257226|FG000|Overall Study|Developed a DVT, needed anticoagulation|0
7800096|NCT01090765|12257227|FG001|Overall Study|Developed a DVT, needed anticoagulation|0
7800097|NCT01090765|12257228|FG002|Overall Study|Developed a DVT, needed anticoagulation|0
7800098|NCT01090765|12257229|FG003|Overall Study|Developed a DVT, needed anticoagulation|1
7800099|NCT01090765|12257230|FG004|Overall Study|Developed a DVT, needed anticoagulation|0
7800100|NCT01090765|12257231|FG005|Overall Study|Developed a DVT, needed anticoagulation|0
7800101|NCT01090765|12257226|FG000|Overall Study|Vasovagal reaction with first infusion|0
7800102|NCT01090765|12257227|FG001|Overall Study|Vasovagal reaction with first infusion|0
7800103|NCT01090765|12257228|FG002|Overall Study|Vasovagal reaction with first infusion|0
7800104|NCT01090765|12257229|FG003|Overall Study|Vasovagal reaction with first infusion|0
7800105|NCT01090765|12257230|FG004|Overall Study|Vasovagal reaction with first infusion|1
7800106|NCT01090765|12257231|FG005|Overall Study|Vasovagal reaction with first infusion|0
7800107|NCT01090973|12257250|FG000|Overall Study|Disease progression|1
7800108|NCT01091103|12257254|FG000|Overall Study|Adverse Event|1
7611050|NCT02761694|12018857|FG001|Overall Study|Physician Decision|0
7611051|NCT02761694|12018858|FG002|Overall Study|Physician Decision|0
7611052|NCT02761694|12018859|FG003|Overall Study|Physician Decision|0
7611053|NCT02761694|12018860|FG004|Overall Study|Physician Decision|0
7611054|NCT02761694|12018861|FG005|Overall Study|Physician Decision|0
7611055|NCT02761694|12018862|FG006|Overall Study|Physician Decision|1
7611056|NCT02761694|12018863|FG007|Overall Study|Physician Decision|0
7611057|NCT02761694|12018864|FG008|Overall Study|Physician Decision|0
7611058|NCT02761694|12018865|FG009|Overall Study|Physician Decision|0
7611059|NCT02761694|12018866|FG010|Overall Study|Physician Decision|0
7611060|NCT02761694|12018867|FG011|Overall Study|Physician Decision|0
7611061|NCT02761694|12018856|FG000|Overall Study|Withdrawal by Subject|0
7611062|NCT02761694|12018857|FG001|Overall Study|Withdrawal by Subject|0
7611063|NCT02761694|12018858|FG002|Overall Study|Withdrawal by Subject|0
7611064|NCT02761694|12018859|FG003|Overall Study|Withdrawal by Subject|1
7611065|NCT02761694|12018860|FG004|Overall Study|Withdrawal by Subject|0
7611066|NCT02761694|12018861|FG005|Overall Study|Withdrawal by Subject|0
7611067|NCT02761694|12018862|FG006|Overall Study|Withdrawal by Subject|4
7611068|NCT02761694|12018863|FG007|Overall Study|Withdrawal by Subject|0
7611069|NCT02761694|12018864|FG008|Overall Study|Withdrawal by Subject|2
7611070|NCT02761694|12018865|FG009|Overall Study|Withdrawal by Subject|1
7611071|NCT02761694|12018866|FG010|Overall Study|Withdrawal by Subject|0
7611072|NCT02761694|12018867|FG011|Overall Study|Withdrawal by Subject|0
7611073|NCT02761694|12018856|FG000|Overall Study|Lost to Follow-up|0
7611074|NCT02761694|12018857|FG001|Overall Study|Lost to Follow-up|0
7611075|NCT02761694|12018858|FG002|Overall Study|Lost to Follow-up|0
7611076|NCT02761694|12018859|FG003|Overall Study|Lost to Follow-up|0
7611077|NCT02761694|12018860|FG004|Overall Study|Lost to Follow-up|0
7611078|NCT02761694|12018861|FG005|Overall Study|Lost to Follow-up|0
7611079|NCT02761694|12018862|FG006|Overall Study|Lost to Follow-up|1
7611080|NCT02761694|12018863|FG007|Overall Study|Lost to Follow-up|0
7611081|NCT02761694|12018864|FG008|Overall Study|Lost to Follow-up|0
7611082|NCT02761694|12018865|FG009|Overall Study|Lost to Follow-up|0
7611083|NCT02761694|12018866|FG010|Overall Study|Lost to Follow-up|0
7611084|NCT02761694|12018867|FG011|Overall Study|Lost to Follow-up|1
7611085|NCT02761694|12018856|FG000|Overall Study|Adverse Event|0
7611086|NCT02761694|12018857|FG001|Overall Study|Adverse Event|0
7611087|NCT02761694|12018858|FG002|Overall Study|Adverse Event|0
7611088|NCT02761694|12018859|FG003|Overall Study|Adverse Event|0
7778410|NCT00939185|12226154|FG000|Overall Study|Adverse Event|3
7778411|NCT00939185|12226154|FG000|Overall Study|Lack of Efficacy|1
7778412|NCT00939185|12226154|FG000|Overall Study|Lost to Follow-up|6
7778413|NCT00939185|12226154|FG000|Overall Study|Other|3
7778414|NCT00939185|12226154|FG000|Overall Study|Withdrawal by Subject|2
7778415|NCT00939185|12226154|FG000|Overall Study|Randomized But Did Not Receive Treatment|10
7778416|NCT00939341|12226175|FG000|Overall Study|Adverse Event|15
7778417|NCT00939341|12226175|FG000|Overall Study|Pregnancy|1
7778418|NCT00939341|12226175|FG000|Overall Study|Lost to Follow-up|23
7778419|NCT00939341|12226175|FG000|Overall Study|Withdrawal by Subject|13
7778420|NCT00939341|12226175|FG000|Overall Study|Protocol Violation|6
7778421|NCT00939341|12226175|FG000|Overall Study|Incorrect enrolment|8
7800109|NCT01091103|12257254|FG000|Overall Study|Progressive Disease|3
7800110|NCT01091168|12257287|FG000|Overall Study|Progressive disease|250
7800111|NCT01091168|12257288|FG001|Overall Study|Progressive disease|234
7800112|NCT01091168|12257287|FG000|Overall Study|Adverse Event|21
7800113|NCT01091168|12257288|FG001|Overall Study|Adverse Event|24
7800114|NCT01091168|12257287|FG000|Overall Study|Lost to Follow-up|0
7800115|NCT01091168|12257288|FG001|Overall Study|Lost to Follow-up|1
7800116|NCT01091168|12257287|FG000|Overall Study|Physician, patient's decision, other|27
7800117|NCT01091168|12257288|FG001|Overall Study|Physician, patient's decision, other|37
7800118|NCT01091246|12257297|FG000|Overall Study|Lost to Follow-up|23
7800119|NCT01091246|12257298|FG001|Overall Study|Lost to Follow-up|11
7800120|NCT01091246|12257299|FG002|Overall Study|Lost to Follow-up|7
7800121|NCT01091246|12257297|FG000|Overall Study|Adverse Event|1
7800122|NCT01091246|12257298|FG001|Overall Study|Adverse Event|0
7800123|NCT01091246|12257299|FG002|Overall Study|Adverse Event|1
7800124|NCT01091246|12257297|FG000|Overall Study|Withdrawal by Subject|9
7800125|NCT01091246|12257298|FG001|Overall Study|Withdrawal by Subject|5
7800126|NCT01091246|12257299|FG002|Overall Study|Withdrawal by Subject|4
7800127|NCT01091246|12257297|FG000|Overall Study|Subject not dosed|2
7800128|NCT01091246|12257298|FG001|Overall Study|Subject not dosed|0
7800129|NCT01091246|12257299|FG002|Overall Study|Subject not dosed|1
7800130|NCT01091259|12257309|FG000|Overall Study|Adverse Event|3
7800131|NCT01091259|12257309|FG000|Overall Study|Lack of Efficacy|2
7800132|NCT01091363|12257315|FG000|Overall Study|Withdrawal by Subject|11
7800133|NCT01091363|12257316|FG001|Overall Study|Withdrawal by Subject|15
7800134|NCT01091363|12257315|FG000|Overall Study|Lost to Follow-up|2
7800135|NCT01091363|12257316|FG001|Overall Study|Lost to Follow-up|2
7611089|NCT02761694|12018860|FG004|Overall Study|Adverse Event|0
7611090|NCT02761694|12018861|FG005|Overall Study|Adverse Event|0
7611091|NCT02761694|12018862|FG006|Overall Study|Adverse Event|1
7800136|NCT01091428|12257326|FG000|Phase 1|Progressive Disease|24
7800137|NCT01091428|12257327|FG001|Phase 1|Progressive Disease|8
7800138|NCT01091428|12257328|FG002|Phase 1|Progressive Disease|0
7800139|NCT01091428|12257329|FG003|Phase 1|Progressive Disease|0
7800140|NCT01091428|12257326|FG000|Phase 1|Symptomatic Deterioration|3
7800141|NCT01091428|12257327|FG001|Phase 1|Symptomatic Deterioration|2
7611092|NCT02761694|12018863|FG007|Overall Study|Adverse Event|0
7611093|NCT02761694|12018864|FG008|Overall Study|Adverse Event|1
7611094|NCT02761694|12018865|FG009|Overall Study|Adverse Event|0
7611095|NCT02761694|12018866|FG010|Overall Study|Adverse Event|0
7611096|NCT02761694|12018867|FG011|Overall Study|Adverse Event|1
7611097|NCT02761694|12018856|FG000|Overall Study|Other|4
7611098|NCT02761694|12018857|FG001|Overall Study|Other|4
7611099|NCT02761694|12018858|FG002|Overall Study|Other|1
7611100|NCT02761694|12018859|FG003|Overall Study|Other|2
7611101|NCT02761694|12018860|FG004|Overall Study|Other|3
7611102|NCT02761694|12018861|FG005|Overall Study|Other|3
7611103|NCT02761694|12018862|FG006|Overall Study|Other|18
7611104|NCT02761694|12018863|FG007|Overall Study|Other|8
7800142|NCT01091428|12257328|FG002|Phase 1|Symptomatic Deterioration|0
7611105|NCT02761694|12018864|FG008|Overall Study|Other|0
7611106|NCT02761694|12018865|FG009|Overall Study|Other|1
7611107|NCT02761694|12018866|FG010|Overall Study|Other|1
7611108|NCT02761694|12018867|FG011|Overall Study|Other|0
7611109|NCT02611960|12018896|FG000|Overall Study|COVID-19 Association Unspecified Adverse Event|7
7611110|NCT02611960|12018897|FG001|Overall Study|COVID-19 Association Unspecified Adverse Event|8
7611111|NCT02611960|12018896|FG000|Overall Study|Death|87
7611112|NCT02611960|12018897|FG001|Overall Study|Death|85
7611113|NCT02611960|12018896|FG000|Overall Study|Withdrawal by Subject|0
7611114|NCT02611960|12018897|FG001|Overall Study|Withdrawal by Subject|1
7611115|NCT02611960|12018896|FG000|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|1
7611116|NCT02611960|12018897|FG001|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|4
7611117|NCT02611960|12018896|FG000|Overall Study|Participants Ongoing|22
7611118|NCT02611960|12018897|FG001|Overall Study|Participants Ongoing|18
7611119|NCT02574455|12018906|FG000|Overall Study|Death|197
7611120|NCT02574455|12018907|FG001|Overall Study|Death|210
7611121|NCT02574455|12018906|FG000|Overall Study|Withdrawal of Consent|11
7611122|NCT02574455|12018907|FG001|Overall Study|Withdrawal of Consent|28
7611123|NCT02574455|12018906|FG000|Overall Study|Lost to Follow-up|4
7611124|NCT02574455|12018907|FG001|Overall Study|Lost to Follow-up|4
7611125|NCT02574455|12018906|FG000|Overall Study|Sponsor's Decision|55
7611126|NCT02574455|12018907|FG001|Overall Study|Sponsor's Decision|20
7611127|NCT02493660|12018915|FG000|Overall Study|Physician Decision|0
7611128|NCT02493660|12018916|FG001|Overall Study|Physician Decision|1
7611129|NCT02493660|12018915|FG000|Overall Study|Adverse Event|4
7611130|NCT02493660|12018916|FG001|Overall Study|Adverse Event|2
7611131|NCT02493660|12018915|FG000|Overall Study|Withdrawal by Subject|2
7611132|NCT02493660|12018916|FG001|Overall Study|Withdrawal by Subject|3
7611133|NCT02493660|12018915|FG000|Overall Study|Subject unable to return for follow-up visits|2
7611134|NCT02493660|12018916|FG001|Overall Study|Subject unable to return for follow-up visits|0
7611135|NCT02493660|12018915|FG000|Overall Study|Protocol Violation|0
7611136|NCT02493660|12018916|FG001|Overall Study|Protocol Violation|1
7611137|NCT02493660|12018915|FG000|Overall Study|Death|0
7611138|NCT02493660|12018916|FG001|Overall Study|Death|1
7611139|NCT02493660|12018915|FG000|Overall Study|Lost to Follow-up|2
7611140|NCT02493660|12018916|FG001|Overall Study|Lost to Follow-up|4
7611141|NCT02232087|12018924|FG000|Overall Study|Withdrawal by Subject|2
7611142|NCT02232087|12018925|FG001|Overall Study|Withdrawal by Subject|0
7611143|NCT02232087|12018926|FG002|Overall Study|Withdrawal by Subject|0
7611144|NCT02232087|12018927|FG003|Overall Study|Withdrawal by Subject|0
7611145|NCT02232087|12018928|FG004|Overall Study|Withdrawal by Subject|0
7611146|NCT02232087|12018929|FG005|Overall Study|Withdrawal by Subject|1
7611147|NCT02232087|12018924|FG000|Overall Study|poor inhalation technique|0
7611148|NCT02232087|12018925|FG001|Overall Study|poor inhalation technique|1
7611149|NCT02232087|12018926|FG002|Overall Study|poor inhalation technique|0
7611150|NCT02232087|12018927|FG003|Overall Study|poor inhalation technique|0
7611151|NCT02232087|12018928|FG004|Overall Study|poor inhalation technique|0
7611152|NCT02232087|12018929|FG005|Overall Study|poor inhalation technique|2
7611153|NCT02232087|12018924|FG000|Overall Study|protocol stop criteria|0
7611154|NCT02232087|12018925|FG001|Overall Study|protocol stop criteria|1
7611155|NCT02232087|12018926|FG002|Overall Study|protocol stop criteria|0
7611156|NCT02232087|12018927|FG003|Overall Study|protocol stop criteria|1
7611157|NCT02232087|12018928|FG004|Overall Study|protocol stop criteria|0
7611158|NCT02232087|12018929|FG005|Overall Study|protocol stop criteria|0
7611159|NCT02232087|12018924|FG000|Overall Study|Adverse Event|0
7611160|NCT02232087|12018925|FG001|Overall Study|Adverse Event|0
7611161|NCT02232087|12018926|FG002|Overall Study|Adverse Event|0
7611162|NCT02232087|12018927|FG003|Overall Study|Adverse Event|0
7611163|NCT02232087|12018928|FG004|Overall Study|Adverse Event|1
7611164|NCT02232087|12018929|FG005|Overall Study|Adverse Event|0
7611165|NCT01952847|12018956|FG000|Overall Study|Ineligible|1
7611166|NCT01952847|12018957|FG001|Overall Study|Ineligible|0
7611167|NCT01952847|12018958|FG002|Overall Study|Ineligible|0
7611168|NCT01952847|12018959|FG003|Overall Study|Ineligible|0
7611169|NCT01952847|12018956|FG000|Overall Study|Lack of Insurance Coverage|0
7611170|NCT01952847|12018957|FG001|Overall Study|Lack of Insurance Coverage|1
7611171|NCT01952847|12018958|FG002|Overall Study|Lack of Insurance Coverage|0
7611172|NCT01952847|12018959|FG003|Overall Study|Lack of Insurance Coverage|0
7611173|NCT01952847|12018956|FG000|Overall Study|Withdrawal by Subject|1
7611174|NCT01952847|12018957|FG001|Overall Study|Withdrawal by Subject|1
7611175|NCT01952847|12018958|FG002|Overall Study|Withdrawal by Subject|0
7611176|NCT01952847|12018959|FG003|Overall Study|Withdrawal by Subject|1
7611177|NCT01889238|12018971|FG000|Overall Study|Treatment ongoing|9
7778422|NCT00939393|12226188|FG000|Overall Study|Withdrawal by Subject|1
7778423|NCT00939393|12226189|FG001|Overall Study|Withdrawal by Subject|0
7778424|NCT00939393|12226188|FG000|Overall Study|Lost to Follow-up|3
7778425|NCT00939393|12226189|FG001|Overall Study|Lost to Follow-up|0
7778426|NCT00939484|12226204|FG000|Overall Study|Progression/Relapse|8
7778427|NCT00939484|12226205|FG001|Overall Study|Progression/Relapse|20
7778428|NCT00939484|12226206|FG002|Overall Study|Progression/Relapse|3
7778429|NCT00939510|12226216|FG000|Overall Study|Withdrawal by Subject|1
7778430|NCT00939523|12226220|FG000|Overall Study|Lack of Efficacy|1
7778431|NCT00939523|12226220|FG000|Overall Study|Physician Decision|2
7778432|NCT00939627|12226242|FG000|Overall Study|Disease Progression|16
7778433|NCT00939627|12226243|FG001|Overall Study|Disease Progression|12
7778434|NCT00939627|12226244|FG002|Overall Study|Disease Progression|0
7778435|NCT00939627|12226242|FG000|Overall Study|Adverse Event|6
7778436|NCT00939627|12226243|FG001|Overall Study|Adverse Event|7
7778437|NCT00939627|12226244|FG002|Overall Study|Adverse Event|0
7778438|NCT00939627|12226242|FG000|Overall Study|Death|0
7778439|NCT00939627|12226243|FG001|Overall Study|Death|2
7778440|NCT00939627|12226244|FG002|Overall Study|Death|0
7778441|NCT00939627|12226242|FG000|Overall Study|Withdrawal by Subject|2
7778442|NCT00939627|12226243|FG001|Overall Study|Withdrawal by Subject|4
7778443|NCT00939627|12226244|FG002|Overall Study|Withdrawal by Subject|0
7778444|NCT00939627|12226242|FG000|Overall Study|Other complicating disease|1
7778445|NCT00939627|12226243|FG001|Overall Study|Other complicating disease|1
7778446|NCT00939627|12226244|FG002|Overall Study|Other complicating disease|0
7778447|NCT00939627|12226242|FG000|Overall Study|Not compliant|2
7778448|NCT00939627|12226243|FG001|Overall Study|Not compliant|0
7778449|NCT00939627|12226244|FG002|Overall Study|Not compliant|0
7778450|NCT00939627|12226242|FG000|Overall Study|No off-tx reason given|0
7778451|NCT00939627|12226243|FG001|Overall Study|No off-tx reason given|2
7778452|NCT00939627|12226244|FG002|Overall Study|No off-tx reason given|0
7778453|NCT00939640|12226250|FG000|Overall Study|Physician Decision|1
7778454|NCT00939692|12226266|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
7778455|NCT00939692|12226267|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
7778456|NCT00939692|12226266|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
7778457|NCT00939692|12226267|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
7778458|NCT00939770|12226297|FG000|Overall Study|Adverse Event|1
7778459|NCT00939770|12226298|FG001|Overall Study|Adverse Event|1
7778460|NCT00939770|12226299|FG002|Overall Study|Adverse Event|0
7778461|NCT00939770|12226300|FG003|Overall Study|Adverse Event|0
7778462|NCT00939770|12226301|FG004|Overall Study|Adverse Event|6
7778463|NCT00939770|12226302|FG005|Overall Study|Adverse Event|2
7778464|NCT00939770|12226303|FG006|Overall Study|Adverse Event|1
7778465|NCT00939770|12226304|FG007|Overall Study|Adverse Event|1
7778466|NCT00939770|12226297|FG000|Overall Study|Lack of Efficacy|4
7778467|NCT00939770|12226298|FG001|Overall Study|Lack of Efficacy|6
7778468|NCT00939770|12226299|FG002|Overall Study|Lack of Efficacy|13
7778469|NCT00939770|12226300|FG003|Overall Study|Lack of Efficacy|9
7778470|NCT00939770|12226301|FG004|Overall Study|Lack of Efficacy|16
7778471|NCT00939770|12226302|FG005|Overall Study|Lack of Efficacy|8
7778472|NCT00939770|12226303|FG006|Overall Study|Lack of Efficacy|11
7778473|NCT00939770|12226304|FG007|Overall Study|Lack of Efficacy|1
7778474|NCT00939770|12226297|FG000|Overall Study|Lost to Follow-up|0
7778475|NCT00939770|12226298|FG001|Overall Study|Lost to Follow-up|0
7778476|NCT00939770|12226299|FG002|Overall Study|Lost to Follow-up|0
7778477|NCT00939770|12226300|FG003|Overall Study|Lost to Follow-up|0
7778478|NCT00939770|12226301|FG004|Overall Study|Lost to Follow-up|1
7778479|NCT00939770|12226302|FG005|Overall Study|Lost to Follow-up|0
7778480|NCT00939770|12226303|FG006|Overall Study|Lost to Follow-up|0
7778481|NCT00939770|12226304|FG007|Overall Study|Lost to Follow-up|0
7778482|NCT00939770|12226297|FG000|Overall Study|Physician Decision|0
7778483|NCT00939770|12226298|FG001|Overall Study|Physician Decision|0
7778484|NCT00939770|12226299|FG002|Overall Study|Physician Decision|2
7778485|NCT00939770|12226300|FG003|Overall Study|Physician Decision|0
7778486|NCT00939770|12226301|FG004|Overall Study|Physician Decision|7
7778487|NCT00939770|12226302|FG005|Overall Study|Physician Decision|1
7778488|NCT00939770|12226303|FG006|Overall Study|Physician Decision|0
7778489|NCT00939770|12226304|FG007|Overall Study|Physician Decision|6
7778490|NCT00939770|12226297|FG000|Overall Study|Protocol Violation|0
7778491|NCT00939770|12226298|FG001|Overall Study|Protocol Violation|0
7778492|NCT00939770|12226299|FG002|Overall Study|Protocol Violation|0
7778493|NCT00939770|12226300|FG003|Overall Study|Protocol Violation|0
7778494|NCT00939770|12226301|FG004|Overall Study|Protocol Violation|1
7778495|NCT00939770|12226302|FG005|Overall Study|Protocol Violation|0
7778496|NCT00939770|12226303|FG006|Overall Study|Protocol Violation|0
7611198|NCT01672892|12018986|FG000|Overall Study|Protocol Violation|7
7611199|NCT01672892|12018987|FG001|Overall Study|Protocol Violation|3
7611200|NCT01560585|12018996|FG000|Overall Study|Physician Decision|3
7611201|NCT00979212|12019003|FG000|Overall Study|Protocol Violation|1
7611202|NCT00979212|12019004|FG001|Overall Study|Protocol Violation|8
7611203|NCT00979212|12019003|FG000|Overall Study|No protocol therapy received|1
7611204|NCT00979212|12019004|FG001|Overall Study|No protocol therapy received|0
7611205|NCT00777491|12019012|FG000|Overall Study|Protocol Violation|0
7611206|NCT00777491|12019013|FG001|Overall Study|Protocol Violation|2
7611207|NCT00777491|12019012|FG000|Overall Study|Did not receive any protocol treatment|2
7611208|NCT00777491|12019013|FG001|Overall Study|Did not receive any protocol treatment|0
7611209|NCT00759655|12019019|FG000|Overall Study|Termination of the study by sponsor|1
7611210|NCT00145795|12019025|FG000|Overall Study|Adverse Event|1
7611211|NCT00145795|12019026|FG001|Overall Study|Adverse Event|0
7611212|NCT00005044|12019034|FG000|Overall Study|Protocol Violation|37
7611213|NCT00005044|12019035|FG001|Overall Study|Protocol Violation|46
7611214|NCT00005044|12019034|FG000|Overall Study|Withdrawal by Subject|1
7611215|NCT00005044|12019035|FG001|Overall Study|Withdrawal by Subject|5
7611216|NCT00005044|12019034|FG000|Overall Study|No protocol treatment|0
7611217|NCT00005044|12019035|FG001|Overall Study|No protocol treatment|1
7611218|NCT00002874|12019043|FG000|Overall Study|Withdrawal by Subject|1
7778497|NCT00939770|12226304|FG007|Overall Study|Protocol Violation|0
7611219|NCT00002874|12019044|FG001|Overall Study|Withdrawal by Subject|1
7611220|NCT00002874|12019043|FG000|Overall Study|Protocol Violation|44
7611221|NCT00002874|12019044|FG001|Overall Study|Protocol Violation|34
7611222|NCT04391894|12019055|FG000|Overall Study|Adverse Event|1
7611223|NCT04391894|12019056|FG001|Overall Study|Adverse Event|1
7611224|NCT04391894|12019057|FG002|Overall Study|Adverse Event|1
7611225|NCT04391894|12019058|FG003|Overall Study|Adverse Event|1
7611226|NCT04391894|12019059|FG004|Overall Study|Adverse Event|1
7611227|NCT04391894|12019055|FG000|Overall Study|Lost to Follow-up|1
7611228|NCT04391894|12019056|FG001|Overall Study|Lost to Follow-up|0
7611229|NCT04391894|12019057|FG002|Overall Study|Lost to Follow-up|0
7611230|NCT04391894|12019058|FG003|Overall Study|Lost to Follow-up|0
7611231|NCT04391894|12019059|FG004|Overall Study|Lost to Follow-up|0
7611232|NCT04391894|12019055|FG000|Overall Study|Protocol Violation|0
7611233|NCT04391894|12019056|FG001|Overall Study|Protocol Violation|0
7611234|NCT04391894|12019057|FG002|Overall Study|Protocol Violation|0
7611235|NCT04391894|12019058|FG003|Overall Study|Protocol Violation|1
7611236|NCT04391894|12019059|FG004|Overall Study|Protocol Violation|0
7611237|NCT04391894|12019055|FG000|Overall Study|Withdrawal by Subject|2
7611238|NCT04391894|12019056|FG001|Overall Study|Withdrawal by Subject|0
7611239|NCT04391894|12019057|FG002|Overall Study|Withdrawal by Subject|3
7611240|NCT04391894|12019058|FG003|Overall Study|Withdrawal by Subject|0
7611241|NCT04391894|12019059|FG004|Overall Study|Withdrawal by Subject|1
7611242|NCT04391894|12019055|FG000|Overall Study|Unsatisfactory Therapeutic effect|0
7611243|NCT04391894|12019056|FG001|Overall Study|Unsatisfactory Therapeutic effect|0
7611244|NCT04391894|12019057|FG002|Overall Study|Unsatisfactory Therapeutic effect|0
7611245|NCT04391894|12019058|FG003|Overall Study|Unsatisfactory Therapeutic effect|0
7611246|NCT04391894|12019059|FG004|Overall Study|Unsatisfactory Therapeutic effect|1
7611247|NCT03428100|12019102|FG000|Overall Study|Adverse Event|1
7611248|NCT03428100|12019103|FG001|Overall Study|Adverse Event|0
7611249|NCT03428100|12019104|FG002|Overall Study|Adverse Event|3
7611250|NCT03428100|12019105|FG003|Overall Study|Adverse Event|1
7611251|NCT03428100|12019102|FG000|Overall Study|Lack of Efficacy|16
7611252|NCT03428100|12019103|FG001|Overall Study|Lack of Efficacy|10
7611253|NCT03428100|12019104|FG002|Overall Study|Lack of Efficacy|7
7611254|NCT03428100|12019105|FG003|Overall Study|Lack of Efficacy|6
7611255|NCT03428100|12019102|FG000|Overall Study|Protocol Deviation|0
7611256|NCT03428100|12019103|FG001|Overall Study|Protocol Deviation|2
7611257|NCT03428100|12019104|FG002|Overall Study|Protocol Deviation|2
7611258|NCT03428100|12019105|FG003|Overall Study|Protocol Deviation|0
7611259|NCT03428100|12019102|FG000|Overall Study|Withdrawal by Subject|4
7611260|NCT03428100|12019103|FG001|Overall Study|Withdrawal by Subject|0
7611261|NCT03428100|12019104|FG002|Overall Study|Withdrawal by Subject|0
7611262|NCT03428100|12019105|FG003|Overall Study|Withdrawal by Subject|0
7611263|NCT03428100|12019102|FG000|Overall Study|Physician Decision|0
7611264|NCT03428100|12019103|FG001|Overall Study|Physician Decision|1
7611265|NCT03428100|12019104|FG002|Overall Study|Physician Decision|0
7611266|NCT03428100|12019105|FG003|Overall Study|Physician Decision|0
7611267|NCT03341936|12019125|FG000|Overall Study|Ineligible|1
7611268|NCT03341936|12019125|FG000|Overall Study|Disease Progression|2
7611269|NCT03341936|12019125|FG000|Overall Study|Withdrew Consent|4
7611270|NCT03341936|12019125|FG000|Overall Study|Non-Compliance|1
7611271|NCT03341936|12019125|FG000|Overall Study|Physician Decision|1
7611272|NCT03341936|12019125|FG000|Overall Study|Withdrawal by Subject|1
7611273|NCT03341936|12019125|FG000|Overall Study|Other|1
7611274|NCT03144687|12019135|FG000|Overall Study|Death|0
7611275|NCT03144687|12019136|FG001|Overall Study|Death|2
7611276|NCT03144687|12019135|FG000|Overall Study|Lost to Follow-up|0
7611277|NCT03144687|12019136|FG001|Overall Study|Lost to Follow-up|1
7611278|NCT03144687|12019135|FG000|Overall Study|Physician Decision|0
7611279|NCT03144687|12019136|FG001|Overall Study|Physician Decision|1
7611280|NCT03144687|12019135|FG000|Overall Study|Withdrawal by Subject|1
7611281|NCT03144687|12019136|FG001|Overall Study|Withdrawal by Subject|3
7611282|NCT03144687|12019135|FG000|Overall Study|Not Reported|2
7611283|NCT03144687|12019136|FG001|Overall Study|Not Reported|0
7611286|NCT02880371|12019158|FG000|Phase 1b|Lost to Follow-up|1
7611287|NCT02880371|12019159|FG001|Phase 1b|Lost to Follow-up|0
7611288|NCT02880371|12019160|FG002|Phase 1b|Lost to Follow-up|0
7611289|NCT02880371|12019161|FG003|Phase 1b|Lost to Follow-up|0
7611290|NCT02880371|12019162|FG004|Phase 1b|Lost to Follow-up|0
7611291|NCT02880371|12019163|FG005|Phase 1b|Lost to Follow-up|0
7611292|NCT02880371|12019164|FG006|Phase 1b|Lost to Follow-up|0
7611293|NCT02880371|12019165|FG007|Phase 1b|Lost to Follow-up|0
7611294|NCT02880371|12019158|FG000|Phase 1b|Participants terminated by Sponsor|1
7611295|NCT02880371|12019159|FG001|Phase 1b|Participants terminated by Sponsor|0
7611296|NCT02880371|12019160|FG002|Phase 1b|Participants terminated by Sponsor|0
7611297|NCT02880371|12019161|FG003|Phase 1b|Participants terminated by Sponsor|0
7611298|NCT02880371|12019162|FG004|Phase 1b|Participants terminated by Sponsor|0
7778498|NCT00939770|12226297|FG000|Overall Study|Withdrawal by Subject|0
7611299|NCT02880371|12019163|FG005|Phase 1b|Participants terminated by Sponsor|0
7611300|NCT02880371|12019164|FG006|Phase 1b|Participants terminated by Sponsor|0
7611301|NCT02880371|12019165|FG007|Phase 1b|Participants terminated by Sponsor|0
7611302|NCT02880371|12019158|FG000|Phase 1b|Withdrawal by Subject|0
7611303|NCT02880371|12019159|FG001|Phase 1b|Withdrawal by Subject|0
7611304|NCT02880371|12019160|FG002|Phase 1b|Withdrawal by Subject|1
7611305|NCT02880371|12019161|FG003|Phase 1b|Withdrawal by Subject|0
7611306|NCT02880371|12019162|FG004|Phase 1b|Withdrawal by Subject|0
7611307|NCT02880371|12019163|FG005|Phase 1b|Withdrawal by Subject|0
7611308|NCT02880371|12019164|FG006|Phase 1b|Withdrawal by Subject|0
7611309|NCT02880371|12019165|FG007|Phase 1b|Withdrawal by Subject|0
7611310|NCT02880371|12019158|FG000|Phase 1b|Death|4
7611311|NCT02880371|12019159|FG001|Phase 1b|Death|6
7611312|NCT02880371|12019160|FG002|Phase 1b|Death|5
7611313|NCT02880371|12019161|FG003|Phase 1b|Death|1
7611314|NCT02880371|12019162|FG004|Phase 1b|Death|0
7611315|NCT02880371|12019163|FG005|Phase 1b|Death|0
7611316|NCT02880371|12019164|FG006|Phase 1b|Death|0
7611317|NCT02880371|12019165|FG007|Phase 1b|Death|0
7611318|NCT02880371|12019158|FG000|Phase 1b|Enrolled but not Treated|0
7611319|NCT02880371|12019159|FG001|Phase 1b|Enrolled but not Treated|1
7611320|NCT02880371|12019160|FG002|Phase 1b|Enrolled but not Treated|0
7611321|NCT02880371|12019161|FG003|Phase 1b|Enrolled but not Treated|0
7611322|NCT02880371|12019162|FG004|Phase 1b|Enrolled but not Treated|0
7611323|NCT02880371|12019163|FG005|Phase 1b|Enrolled but not Treated|0
7611324|NCT02880371|12019164|FG006|Phase 1b|Enrolled but not Treated|0
7611325|NCT02880371|12019165|FG007|Phase 1b|Enrolled but not Treated|0
7611326|NCT02880371|12019158|FG000|Phase 2|Enrolled but not Treated|0
7611327|NCT02880371|12019159|FG001|Phase 2|Enrolled but not Treated|0
7611328|NCT02880371|12019160|FG002|Phase 2|Enrolled but not Treated|0
7611329|NCT02880371|12019161|FG003|Phase 2|Enrolled but not Treated|0
7611330|NCT02880371|12019162|FG004|Phase 2|Enrolled but not Treated|0
7611331|NCT02880371|12019163|FG005|Phase 2|Enrolled but not Treated|1
7611332|NCT02880371|12019164|FG006|Phase 2|Enrolled but not Treated|1
7611333|NCT02880371|12019165|FG007|Phase 2|Enrolled but not Treated|0
7611334|NCT02880371|12019158|FG000|Phase 2|Other|0
7611335|NCT02880371|12019159|FG001|Phase 2|Other|0
7611336|NCT02880371|12019160|FG002|Phase 2|Other|0
7611337|NCT02880371|12019161|FG003|Phase 2|Other|0
7611338|NCT02880371|12019162|FG004|Phase 2|Other|0
7611339|NCT02880371|12019163|FG005|Phase 2|Other|1
7611340|NCT02880371|12019164|FG006|Phase 2|Other|2
7611341|NCT02880371|12019165|FG007|Phase 2|Other|1
7611342|NCT02880371|12019158|FG000|Phase 2|Participants terminated by Sponsor|0
7611343|NCT02880371|12019159|FG001|Phase 2|Participants terminated by Sponsor|0
7611344|NCT02880371|12019160|FG002|Phase 2|Participants terminated by Sponsor|0
7611345|NCT02880371|12019161|FG003|Phase 2|Participants terminated by Sponsor|0
7611346|NCT02880371|12019162|FG004|Phase 2|Participants terminated by Sponsor|1
7611347|NCT02880371|12019163|FG005|Phase 2|Participants terminated by Sponsor|6
7611348|NCT02880371|12019164|FG006|Phase 2|Participants terminated by Sponsor|1
7611349|NCT02880371|12019165|FG007|Phase 2|Participants terminated by Sponsor|5
7611350|NCT02880371|12019158|FG000|Phase 2|Death|0
7611351|NCT02880371|12019159|FG001|Phase 2|Death|0
7611352|NCT02880371|12019160|FG002|Phase 2|Death|0
7611353|NCT02880371|12019161|FG003|Phase 2|Death|0
7611354|NCT02880371|12019162|FG004|Phase 2|Death|1
7611355|NCT02880371|12019163|FG005|Phase 2|Death|10
7611356|NCT02880371|12019164|FG006|Phase 2|Death|20
7611357|NCT02880371|12019165|FG007|Phase 2|Death|5
7611358|NCT02880371|12019158|FG000|Phase 2|Lost to Follow-up|0
7611359|NCT02880371|12019159|FG001|Phase 2|Lost to Follow-up|0
7611360|NCT02880371|12019160|FG002|Phase 2|Lost to Follow-up|0
7611361|NCT02880371|12019161|FG003|Phase 2|Lost to Follow-up|0
7611362|NCT02880371|12019162|FG004|Phase 2|Lost to Follow-up|0
7611363|NCT02880371|12019163|FG005|Phase 2|Lost to Follow-up|0
7611364|NCT02880371|12019164|FG006|Phase 2|Lost to Follow-up|3
7611365|NCT02880371|12019165|FG007|Phase 2|Lost to Follow-up|0
7611366|NCT02880371|12019158|FG000|Phase 2|Withdrawal by Subject|0
7611367|NCT02880371|12019159|FG001|Phase 2|Withdrawal by Subject|0
7611368|NCT02880371|12019160|FG002|Phase 2|Withdrawal by Subject|0
7611369|NCT02880371|12019161|FG003|Phase 2|Withdrawal by Subject|0
7611370|NCT02880371|12019162|FG004|Phase 2|Withdrawal by Subject|0
7611371|NCT02880371|12019163|FG005|Phase 2|Withdrawal by Subject|1
7611372|NCT02880371|12019164|FG006|Phase 2|Withdrawal by Subject|1
7611373|NCT02880371|12019165|FG007|Phase 2|Withdrawal by Subject|0
7611374|NCT02880371|12019158|FG000|Phase 2|End of Study page not completed by error|0
7611375|NCT02880371|12019159|FG001|Phase 2|End of Study page not completed by error|0
7611376|NCT02880371|12019160|FG002|Phase 2|End of Study page not completed by error|0
7611377|NCT02880371|12019161|FG003|Phase 2|End of Study page not completed by error|0
7611378|NCT02880371|12019162|FG004|Phase 2|End of Study page not completed by error|0
7611379|NCT02880371|12019163|FG005|Phase 2|End of Study page not completed by error|1
7611380|NCT02880371|12019164|FG006|Phase 2|End of Study page not completed by error|0
7611381|NCT02880371|12019165|FG007|Phase 2|End of Study page not completed by error|0
7778499|NCT00939770|12226298|FG001|Overall Study|Withdrawal by Subject|1
7778500|NCT00939770|12226299|FG002|Overall Study|Withdrawal by Subject|5
7778501|NCT00939770|12226300|FG003|Overall Study|Withdrawal by Subject|2
7778502|NCT00939770|12226301|FG004|Overall Study|Withdrawal by Subject|6
7778503|NCT00939770|12226302|FG005|Overall Study|Withdrawal by Subject|0
7778504|NCT00939770|12226303|FG006|Overall Study|Withdrawal by Subject|2
7778505|NCT00939770|12226304|FG007|Overall Study|Withdrawal by Subject|2
7778506|NCT00939783|12226335|FG000|Overall Study|Death|6
7778507|NCT00939783|12226335|FG000|Overall Study|Adverse Event|39
7778508|NCT00939783|12226335|FG000|Overall Study|Study Terminated by Sponsor|498
7778509|NCT00939783|12226335|FG000|Overall Study|Withdrawal by Subject|78
7778510|NCT00939783|12226335|FG000|Overall Study|Other|16
7778511|NCT00939783|12226335|FG000|Overall Study|Lost to Follow-up|8
7611394|NCT02434354|12019194|FG000|Overall Study|screen fail|3
7611395|NCT02419417|12019209|FG000|Overall Study|Disease progression|5
7611396|NCT02419417|12019210|FG001|Overall Study|Disease progression|4
7611397|NCT02419417|12019211|FG002|Overall Study|Disease progression|13
7611398|NCT02419417|12019212|FG003|Overall Study|Disease progression|10
7611399|NCT02419417|12019213|FG004|Overall Study|Disease progression|10
7611400|NCT02419417|12019214|FG005|Overall Study|Disease progression|3
7611401|NCT02419417|12019215|FG006|Overall Study|Disease progression|4
7611402|NCT02419417|12019216|FG007|Overall Study|Disease progression|5
7611403|NCT02419417|12019217|FG008|Overall Study|Disease progression|13
7611404|NCT02419417|12019218|FG009|Overall Study|Disease progression|9
7611405|NCT02419417|12019219|FG010|Overall Study|Disease progression|0
7611406|NCT02419417|12019209|FG000|Overall Study|Study drug toxicity|0
7611407|NCT02419417|12019210|FG001|Overall Study|Study drug toxicity|0
7611408|NCT02419417|12019211|FG002|Overall Study|Study drug toxicity|0
7611409|NCT02419417|12019212|FG003|Overall Study|Study drug toxicity|0
7611410|NCT02419417|12019213|FG004|Overall Study|Study drug toxicity|1
7611411|NCT02419417|12019214|FG005|Overall Study|Study drug toxicity|0
7611412|NCT02419417|12019215|FG006|Overall Study|Study drug toxicity|0
7611413|NCT02419417|12019216|FG007|Overall Study|Study drug toxicity|0
7611414|NCT02419417|12019217|FG008|Overall Study|Study drug toxicity|0
7611415|NCT02419417|12019218|FG009|Overall Study|Study drug toxicity|0
7611416|NCT02419417|12019219|FG010|Overall Study|Study drug toxicity|0
7611417|NCT02419417|12019209|FG000|Overall Study|Adverse event unrelated to study drug|0
7611418|NCT02419417|12019210|FG001|Overall Study|Adverse event unrelated to study drug|0
7611419|NCT02419417|12019211|FG002|Overall Study|Adverse event unrelated to study drug|0
7611420|NCT02419417|12019212|FG003|Overall Study|Adverse event unrelated to study drug|0
7611421|NCT02419417|12019213|FG004|Overall Study|Adverse event unrelated to study drug|2
7611422|NCT02419417|12019214|FG005|Overall Study|Adverse event unrelated to study drug|1
7611423|NCT02419417|12019215|FG006|Overall Study|Adverse event unrelated to study drug|0
7611424|NCT02419417|12019216|FG007|Overall Study|Adverse event unrelated to study drug|1
7611425|NCT02419417|12019217|FG008|Overall Study|Adverse event unrelated to study drug|0
7611426|NCT02419417|12019218|FG009|Overall Study|Adverse event unrelated to study drug|0
7611427|NCT02419417|12019219|FG010|Overall Study|Adverse event unrelated to study drug|0
7611428|NCT02419417|12019209|FG000|Overall Study|Participant request to discontinue|0
7611429|NCT02419417|12019210|FG001|Overall Study|Participant request to discontinue|0
7611430|NCT02419417|12019211|FG002|Overall Study|Participant request to discontinue|0
7611431|NCT02419417|12019212|FG003|Overall Study|Participant request to discontinue|0
7611432|NCT02419417|12019213|FG004|Overall Study|Participant request to discontinue|0
7611433|NCT02419417|12019214|FG005|Overall Study|Participant request to discontinue|0
7611434|NCT02419417|12019215|FG006|Overall Study|Participant request to discontinue|0
7611435|NCT02419417|12019216|FG007|Overall Study|Participant request to discontinue|0
7611436|NCT02419417|12019217|FG008|Overall Study|Participant request to discontinue|0
7611437|NCT02419417|12019218|FG009|Overall Study|Participant request to discontinue|1
7611438|NCT02419417|12019219|FG010|Overall Study|Participant request to discontinue|0
7611439|NCT02419417|12019209|FG000|Overall Study|Withdrawal by Subject|0
7611440|NCT02419417|12019210|FG001|Overall Study|Withdrawal by Subject|0
7611441|NCT02419417|12019211|FG002|Overall Study|Withdrawal by Subject|0
7611442|NCT02419417|12019212|FG003|Overall Study|Withdrawal by Subject|0
7611443|NCT02419417|12019213|FG004|Overall Study|Withdrawal by Subject|0
7611444|NCT02419417|12019214|FG005|Overall Study|Withdrawal by Subject|0
7611445|NCT02419417|12019215|FG006|Overall Study|Withdrawal by Subject|0
7611446|NCT02419417|12019216|FG007|Overall Study|Withdrawal by Subject|0
7778512|NCT00939783|12226335|FG000|Overall Study|Protocol Violation|3
7611447|NCT02419417|12019217|FG008|Overall Study|Withdrawal by Subject|0
7611448|NCT02419417|12019218|FG009|Overall Study|Withdrawal by Subject|0
7611449|NCT02419417|12019219|FG010|Overall Study|Withdrawal by Subject|1
7611450|NCT02395120|12019253|FG000|Overall Study|Missed follow-up dental exam|57
7611451|NCT02395120|12019254|FG001|Overall Study|Missed follow-up dental exam|62
7611452|NCT02395120|12019255|FG002|Overall Study|Missed follow-up dental exam|6
7611453|NCT02395120|12019256|FG003|Overall Study|Missed follow-up dental exam|6
7611454|NCT02395120|12019257|FG004|Overall Study|Missed follow-up dental exam|51
7778513|NCT00939783|12226335|FG000|Overall Study|Enrolled but not treated|1
7778514|NCT00939809|12226343|FG000|Overall Study|Adverse Event|2
7778515|NCT00939809|12226343|FG000|Overall Study|Death|1
7778516|NCT00939822|12226349|FG000|Overall Study|Lost to Follow-up|1
7778517|NCT00939822|12226350|FG001|Overall Study|Lost to Follow-up|0
7778518|NCT00939822|12226349|FG000|Overall Study|withdrew from study due to busy schedule|1
7778519|NCT00939822|12226350|FG001|Overall Study|withdrew from study due to busy schedule|1
7778520|NCT00939822|12226349|FG000|Overall Study|Mental health issues|0
7778521|NCT00939822|12226350|FG001|Overall Study|Mental health issues|2
7778522|NCT00940017|12226382|FG000|Overall Study|did not meet entrance criteria|3
7778523|NCT00940017|12226382|FG000|Overall Study|Adverse Event|1
7778524|NCT00940108|12226390|FG000|Overall Study|Adverse Event|2
7778525|NCT00940108|12226391|FG001|Overall Study|Adverse Event|4
7778526|NCT00940108|12226392|FG002|Overall Study|Adverse Event|0
7778527|NCT00940108|12226393|FG003|Overall Study|Adverse Event|2
7611469|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Death|3
7611470|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Death|3
7611471|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Death|0
7611472|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Death|0
7611473|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Adverse Event|2
7611474|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Adverse Event|8
7611475|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Adverse Event|0
7611476|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Adverse Event|0
7611477|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42
7611478|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29
7611479|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0
7611480|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0
7611481|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Physician Decision|2
7611482|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Physician Decision|4
7611483|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Physician Decision|0
7611484|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Physician Decision|0
7611485|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1
7611486|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2
7611487|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0
7611488|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0
7611489|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Protocol Violation|0
7611490|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Protocol Violation|1
7611491|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Protocol Violation|0
7611492|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Protocol Violation|0
7611493|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Non-Compliance|2
7611494|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Non-Compliance|4
7611495|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Non-Compliance|0
7611496|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Non-Compliance|0
7611497|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Other|6
7611498|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Other|3
7611499|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Other|0
7611500|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Other|0
7611501|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3
7611502|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2
7778528|NCT00940108|12226390|FG000|Overall Study|Withdrew Consent|2
7778529|NCT00940108|12226391|FG001|Overall Study|Withdrew Consent|1
7611503|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0
7611504|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0
7611505|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Adverse Event|0
7611506|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Adverse Event|0
7611507|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Adverse Event|6
7611508|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Adverse Event|8
7611509|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Death|0
7611510|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Death|0
7611511|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Death|7
7611512|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Death|4
7611513|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Lost to Follow-up|0
7611514|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Lost to Follow-up|0
7611515|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Lost to Follow-up|0
7611516|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Lost to Follow-up|1
7611517|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Non-Compliance|0
7611518|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Non-Compliance|0
7611519|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Non-Compliance|1
7611520|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Non-Compliance|1
7611521|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0
7611522|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0
7611523|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39
7611524|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32
7611525|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0
7611526|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0
7778530|NCT00940108|12226392|FG002|Overall Study|Withdrew Consent|0
7778531|NCT00940108|12226393|FG003|Overall Study|Withdrew Consent|1
7778532|NCT00940108|12226390|FG000|Overall Study|Dose 2 contraindicated|1
7778533|NCT00940108|12226391|FG001|Overall Study|Dose 2 contraindicated|1
7778534|NCT00940108|12226392|FG002|Overall Study|Dose 2 contraindicated|0
7778535|NCT00940108|12226393|FG003|Overall Study|Dose 2 contraindicated|1
7778536|NCT00940108|12226390|FG000|Overall Study|Declined further vaccination|0
7778537|NCT00940108|12226391|FG001|Overall Study|Declined further vaccination|1
7778538|NCT00940108|12226392|FG002|Overall Study|Declined further vaccination|3
7778539|NCT00940108|12226393|FG003|Overall Study|Declined further vaccination|0
7611527|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0
7611528|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1
7611529|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Physician Decision|0
7611530|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Physician Decision|0
7611531|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Physician Decision|8
7611532|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Physician Decision|5
7611533|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Other|0
7611534|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Other|0
7611535|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Other|9
7611536|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Other|9
7778540|NCT00940108|12226390|FG000|Overall Study|Refused - pyrexia after Dose 1|0
7778541|NCT00940108|12226391|FG001|Overall Study|Refused - pyrexia after Dose 1|1
7778542|NCT00940108|12226392|FG002|Overall Study|Refused - pyrexia after Dose 1|0
7778543|NCT00940108|12226393|FG003|Overall Study|Refused - pyrexia after Dose 1|0
7778544|NCT00940108|12226390|FG000|Overall Study|Viral illness after Dose 1|0
7778545|NCT00940108|12226391|FG001|Overall Study|Viral illness after Dose 1|1
7778546|NCT00940108|12226392|FG002|Overall Study|Viral illness after Dose 1|0
7778547|NCT00940108|12226393|FG003|Overall Study|Viral illness after Dose 1|0
7778548|NCT00940108|12226390|FG000|Overall Study|Diagnosed with H1N1|0
7778549|NCT00940108|12226391|FG001|Overall Study|Diagnosed with H1N1|0
7778550|NCT00940108|12226392|FG002|Overall Study|Diagnosed with H1N1|0
7778551|NCT00940108|12226393|FG003|Overall Study|Diagnosed with H1N1|1
7778552|NCT00940316|12226423|FG000|Reached First Response at 8 Weeks|Adverse Event|2
7778553|NCT00940316|12226424|FG001|Reached First Response at 8 Weeks|Adverse Event|1
7778554|NCT00940316|12226425|FG002|Reached First Response at 8 Weeks|Adverse Event|0
7778555|NCT00940316|12226423|FG000|Reached First Response at 8 Weeks|Progressive disease|1
7778556|NCT00940316|12226424|FG001|Reached First Response at 8 Weeks|Progressive disease|3
7778557|NCT00940316|12226425|FG002|Reached First Response at 8 Weeks|Progressive disease|0
7778558|NCT00940316|12226423|FG000|Moved on to be Treated Cycle 5|Adverse Event|2
7778559|NCT00940316|12226424|FG001|Moved on to be Treated Cycle 5|Adverse Event|0
7778560|NCT00940316|12226425|FG002|Moved on to be Treated Cycle 5|Adverse Event|0
7778561|NCT00940316|12226423|FG000|Treated After Cycle 5|Adverse Event|0
7778562|NCT00940316|12226424|FG001|Treated After Cycle 5|Adverse Event|0
7778563|NCT00940316|12226425|FG002|Treated After Cycle 5|Adverse Event|1
7778564|NCT00940316|12226423|FG000|Treated After Cycle 5|Progressive disease|0
7778565|NCT00940316|12226424|FG001|Treated After Cycle 5|Progressive disease|1
7778566|NCT00940316|12226425|FG002|Treated After Cycle 5|Progressive disease|0
7778567|NCT00940342|12226444|FG000|Overall Study|Adverse Event|0
7778568|NCT00940342|12226445|FG001|Overall Study|Adverse Event|2
7778569|NCT00940342|12226446|FG002|Overall Study|Adverse Event|1
7778570|NCT00940485|12226467|FG000|Overall Study|HBeAb positive at Baseline|3
7778571|NCT00940485|12226468|FG001|Overall Study|HBeAb positive at Baseline|2
7611567|NCT00726596|12019376|FG000|Overall Study|Adverse Event|2
7611568|NCT00726596|12019377|FG001|Overall Study|Adverse Event|1
7611569|NCT00726596|12019376|FG000|Overall Study|Withdrawal by Subject|3
7611570|NCT00726596|12019377|FG001|Overall Study|Withdrawal by Subject|3
7611571|NCT00489827|12019385|FG000|Overall Study|Intraoperative exclusion criteria|1
7611572|NCT00489827|12019386|FG001|Overall Study|Intraoperative exclusion criteria|1
7611573|NCT00489827|12019385|FG000|Overall Study|Intraoperative exclusion criteria|1
7611574|NCT00489827|12019386|FG001|Overall Study|Intraoperative exclusion criteria|1
7778572|NCT00940485|12226467|FG000|Overall Study|Lost to Follow-up|2
7611576|NCT04311463|12019442|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1
7611577|NCT04311463|12019443|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0
7611578|NCT04311463|12019442|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1
7611579|NCT04311463|12019443|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1
7611580|NCT04311463|12019442|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2
7611581|NCT04311463|12019443|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1
7611582|NCT03930186|12019459|FG000|Weeks 0 to 16|Adverse Event|6
7611583|NCT03930186|12019459|FG000|Weeks 0 to 16|Withdrawal by Subject|6
7611584|NCT03930186|12019459|FG000|Weeks 16 to 32|Adverse Event|1
7611585|NCT03930186|12019459|FG000|Weeks 16 to 32|Withdrawal by Subject|3
7611586|NCT03740100|12019463|FG000|Overall Study|Adverse Event|1
7611587|NCT03740100|12019463|FG000|Overall Study|Death|1
7611588|NCT03597295|12019467|FG000|Overall Study|Death|37
7611589|NCT03597295|12019467|FG000|Overall Study|Lost to Follow-up|3
7611590|NCT03597295|12019467|FG000|Overall Study|Participants ongoing in the study|54
7611591|NCT04808609|12019495|FG000|Overall Study|Lost to Follow-up|0
7611592|NCT04808609|12019496|FG001|Overall Study|Lost to Follow-up|2
7611593|NCT04808609|12019495|FG000|Overall Study|Administrative Withdrawal|0
7778573|NCT00940485|12226468|FG001|Overall Study|Lost to Follow-up|3
7778574|NCT00940485|12226467|FG000|Overall Study|Adverse Event|8
7778575|NCT00940485|12226468|FG001|Overall Study|Adverse Event|0
7778576|NCT00940485|12226467|FG000|Overall Study|Withdrawal by Subject|1
7611594|NCT04808609|12019496|FG001|Overall Study|Administrative Withdrawal|1
7611595|NCT04577781|12019504|FG000|Overall Study|Adverse Event|2
7611596|NCT04577781|12019505|FG001|Overall Study|Adverse Event|2
7611597|NCT04577781|12019504|FG000|Overall Study|Physician Decision|1
7611598|NCT04577781|12019505|FG001|Overall Study|Physician Decision|0
7611599|NCT04524598|12019516|FG000|Phase I - Feasibility|Lost to Follow-up|2
7611600|NCT04524598|12019517|FG001|Phase I - Feasibility|Lost to Follow-up|4
7611601|NCT04524598|12019518|FG002|Phase I - Feasibility|Lost to Follow-up|0
7611602|NCT04524598|12019519|FG003|Phase I - Feasibility|Lost to Follow-up|0
7611603|NCT04524598|12019520|FG004|Phase I - Feasibility|Lost to Follow-up|0
7611604|NCT04524598|12019516|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2
7611605|NCT04524598|12019517|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1
7611606|NCT04524598|12019518|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
7611607|NCT04524598|12019519|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
7611608|NCT04524598|12019520|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
7611609|NCT04524598|12019516|FG000|Phase II - Outcomes|Lost to Follow-up|0
7611610|NCT04524598|12019517|FG001|Phase II - Outcomes|Lost to Follow-up|0
7611611|NCT04524598|12019518|FG002|Phase II - Outcomes|Lost to Follow-up|16
7611612|NCT04524598|12019519|FG003|Phase II - Outcomes|Lost to Follow-up|8
7611613|NCT04524598|12019520|FG004|Phase II - Outcomes|Lost to Follow-up|0
7611614|NCT04524598|12019516|FG000|Phase II - Outcomes|Withdrawal by Subject|0
7611615|NCT04524598|12019517|FG001|Phase II - Outcomes|Withdrawal by Subject|0
7611616|NCT04524598|12019518|FG002|Phase II - Outcomes|Withdrawal by Subject|2
7611617|NCT04524598|12019519|FG003|Phase II - Outcomes|Withdrawal by Subject|0
7611618|NCT04524598|12019520|FG004|Phase II - Outcomes|Withdrawal by Subject|0
7611619|NCT04524598|12019516|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
7611620|NCT04524598|12019517|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
7611621|NCT04524598|12019518|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8
7778577|NCT00940485|12226468|FG001|Overall Study|Withdrawal by Subject|1
7778578|NCT00940485|12226467|FG000|Overall Study|Others|1
7778579|NCT00940485|12226468|FG001|Overall Study|Others|1
7778580|NCT00940602|12226503|FG000|Overall Study|Administrative problems|1
7778581|NCT00940602|12226504|FG001|Overall Study|Administrative problems|1
7778582|NCT00940602|12226503|FG000|Overall Study|Patient/guardian decision|13
7778583|NCT00940602|12226504|FG001|Overall Study|Patient/guardian decision|28
7778584|NCT00940602|12226503|FG000|Overall Study|Physician Decision|8
7611622|NCT04524598|12019519|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5
7611623|NCT04524598|12019520|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
7778585|NCT00940602|12226504|FG001|Overall Study|Physician Decision|5
7778586|NCT00940602|12226503|FG000|Overall Study|Pregnancy|1
7778587|NCT00940602|12226504|FG001|Overall Study|Pregnancy|0
7778588|NCT00940602|12226503|FG000|Overall Study|Protocol Deviation (untreated)|1
7778589|NCT00940602|12226504|FG001|Overall Study|Protocol Deviation (untreated)|0
7778590|NCT00940602|12226503|FG000|Overall Study|Disease progression|8
7778591|NCT00940602|12226504|FG001|Overall Study|Disease progression|2
7778592|NCT00940602|12226503|FG000|Overall Study|Death|38
7778593|NCT00940602|12226504|FG001|Overall Study|Death|19
7778594|NCT00940602|12226503|FG000|Overall Study|Lost to Follow-up|3
7778595|NCT00940602|12226504|FG001|Overall Study|Lost to Follow-up|1
7778596|NCT00940602|12226503|FG000|Overall Study|Patient withdrew consent|26
7611624|NCT04524598|12019516|FG000|Phase II - Control Extension|Lost to Follow-up|0
7778597|NCT00940602|12226504|FG001|Overall Study|Patient withdrew consent|13
7611625|NCT04524598|12019517|FG001|Phase II - Control Extension|Lost to Follow-up|0
7611626|NCT04524598|12019518|FG002|Phase II - Control Extension|Lost to Follow-up|0
7611627|NCT04524598|12019519|FG003|Phase II - Control Extension|Lost to Follow-up|0
7611628|NCT04524598|12019520|FG004|Phase II - Control Extension|Lost to Follow-up|6
7611629|NCT04524598|12019516|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
7611630|NCT04524598|12019517|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
7611631|NCT04524598|12019518|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
7611632|NCT04524598|12019519|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
7611633|NCT04524598|12019520|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6
7611634|NCT04518462|12019537|FG000|Overall Study|Withdrawal by Subject|0
7611635|NCT04518462|12019538|FG001|Overall Study|Withdrawal by Subject|0
7611636|NCT04518462|12019539|FG002|Overall Study|Withdrawal by Subject|1
7611637|NCT04518462|12019537|FG000|Overall Study|Physician Decision|1
7611638|NCT04518462|12019538|FG001|Overall Study|Physician Decision|1
7611639|NCT04518462|12019539|FG002|Overall Study|Physician Decision|0
7611640|NCT04432298|12019549|FG000|Overall Study|Other than specified|1
7611641|NCT04432298|12019550|FG001|Overall Study|Other than specified|0
7611642|NCT04432298|12019549|FG000|Overall Study|Lost to Follow-up|0
7611643|NCT04432298|12019550|FG001|Overall Study|Lost to Follow-up|1
7611644|NCT04432298|12019549|FG000|Overall Study|Death|3
7611645|NCT04432298|12019550|FG001|Overall Study|Death|2
7611646|NCT04432298|12019549|FG000|Overall Study|Withdrawal by Subject|2
7778598|NCT00940602|12226503|FG000|Overall Study|Adverse Event|7
7778599|NCT00940602|12226504|FG001|Overall Study|Adverse Event|2
7778600|NCT00940602|12226503|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43
7778601|NCT00940602|12226504|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5
7778602|NCT00940823|12226517|FG000|Overall Study|Death|8
7778603|NCT00940823|12226518|FG001|Overall Study|Death|12
7778604|NCT00940823|12226517|FG000|Overall Study|Lost to Follow-up|27
7778605|NCT00940823|12226518|FG001|Overall Study|Lost to Follow-up|20
7778606|NCT00940875|12226528|FG000|Treatment Phase|Adverse Event|9
7778607|NCT00940875|12226529|FG001|Treatment Phase|Adverse Event|3
7778608|NCT00940875|12226528|FG000|Treatment Phase|Death|3
7778609|NCT00940875|12226529|FG001|Treatment Phase|Death|5
7778610|NCT00940875|12226528|FG000|Treatment Phase|Lack of Efficacy|1
7778611|NCT00940875|12226529|FG001|Treatment Phase|Lack of Efficacy|0
7778612|NCT00940875|12226528|FG000|Treatment Phase|Withdrawal by Subject|3
7778613|NCT00940875|12226529|FG001|Treatment Phase|Withdrawal by Subject|0
7778614|NCT00940875|12226528|FG000|Treatment Phase|Disease progression|9
7778615|NCT00940875|12226529|FG001|Treatment Phase|Disease progression|11
7778616|NCT00940875|12226528|FG000|Treatment Phase|Physician Decision|1
7778617|NCT00940875|12226529|FG001|Treatment Phase|Physician Decision|0
7778618|NCT00940875|12226528|FG000|Post-Study Treatment|Death|0
7778619|NCT00940875|12226529|FG001|Post-Study Treatment|Death|1
7778620|NCT00940875|12226528|FG000|Post-Study Treatment|Disease Progression|0
7778621|NCT00940875|12226529|FG001|Post-Study Treatment|Disease Progression|2
7778622|NCT00940888|12226536|FG000|Overall Study|Unsuccessful Implant|4
7778623|NCT00940888|12226536|FG000|Overall Study|Death|461
7778624|NCT00940888|12226536|FG000|Overall Study|Withdrawn - Non-Death|364
7778625|NCT00940888|12226536|FG000|Overall Study|Lost to Follow-up|6
7778626|NCT00940992|12226558|FG000|Overall Study|Adverse Event|2
7778627|NCT00940992|12226559|FG001|Overall Study|Adverse Event|0
7778628|NCT00940992|12226560|FG002|Overall Study|Adverse Event|1
7778629|NCT00940992|12226558|FG000|Overall Study|subject request|2
7778630|NCT00940992|12226559|FG001|Overall Study|subject request|1
7778631|NCT00940992|12226560|FG002|Overall Study|subject request|0
7778632|NCT00940992|12226558|FG000|Overall Study|Lost to Follow-up|0
7778633|NCT00940992|12226559|FG001|Overall Study|Lost to Follow-up|1
7778634|NCT00940992|12226560|FG002|Overall Study|Lost to Follow-up|1
7778635|NCT00941031|12226583|FG000|Induction Period|Lack of Efficacy|2
7778636|NCT00941031|12226584|FG001|Induction Period|Lack of Efficacy|1
7778637|NCT00941031|12226585|FG002|Induction Period|Lack of Efficacy|0
7778638|NCT00941031|12226586|FG003|Induction Period|Lack of Efficacy|5
7778639|NCT00941031|12226587|FG004|Induction Period|Lack of Efficacy|0
7778640|NCT00941031|12226588|FG005|Induction Period|Lack of Efficacy|0
7778641|NCT00941031|12226589|FG006|Induction Period|Lack of Efficacy|0
7778642|NCT00941031|12226583|FG000|Induction Period|Withdrawal by Subject|1
7778643|NCT00941031|12226584|FG001|Induction Period|Withdrawal by Subject|2
7611647|NCT04432298|12019550|FG001|Overall Study|Withdrawal by Subject|0
7611648|NCT04428034|12019556|FG000|Enrollment to Intervention Completion|Protocol Violation|9
7611649|NCT04428034|12019556|FG000|Enrollment to Intervention Completion|Suspected Fraudulent Case|1
7611650|NCT03853694|12019576|FG000|Overall Study|Protocol Violation|3
7611651|NCT03853694|12019577|FG001|Overall Study|Protocol Violation|5
7611652|NCT03853694|12019578|FG002|Overall Study|Protocol Violation|3
7611653|NCT03853694|12019576|FG000|Overall Study|Delivered early|0
7611654|NCT03853694|12019577|FG001|Overall Study|Delivered early|1
7611655|NCT03853694|12019578|FG002|Overall Study|Delivered early|0
7611656|NCT03853694|12019576|FG000|Overall Study|not suitable to proceed|0
7611657|NCT03853694|12019577|FG001|Overall Study|not suitable to proceed|1
7611658|NCT03853694|12019578|FG002|Overall Study|not suitable to proceed|0
7611659|NCT03853694|12019576|FG000|Overall Study|difficult surgery|0
7611660|NCT03853694|12019577|FG001|Overall Study|difficult surgery|0
7611661|NCT03853694|12019578|FG002|Overall Study|difficult surgery|1
7611662|NCT03853694|12019576|FG000|Overall Study|Lost to Follow-up|0
7611663|NCT03853694|12019577|FG001|Overall Study|Lost to Follow-up|1
7611664|NCT03853694|12019578|FG002|Overall Study|Lost to Follow-up|0
7611665|NCT03853694|12019576|FG000|Overall Study|Withdrawal by Subject|0
7611666|NCT03853694|12019577|FG001|Overall Study|Withdrawal by Subject|1
7611667|NCT03853694|12019578|FG002|Overall Study|Withdrawal by Subject|0
7611668|NCT03785340|12019588|FG000|Overall Study|Lost to Follow-up|2
7611669|NCT03785340|12019589|FG001|Overall Study|Lost to Follow-up|0
7611670|NCT03785340|12019588|FG000|Overall Study|Adverse Event|1
7611671|NCT03785340|12019589|FG001|Overall Study|Adverse Event|0
7778644|NCT00941031|12226585|FG002|Induction Period|Withdrawal by Subject|2
7778645|NCT00941031|12226586|FG003|Induction Period|Withdrawal by Subject|2
7778646|NCT00941031|12226587|FG004|Induction Period|Withdrawal by Subject|0
7778647|NCT00941031|12226588|FG005|Induction Period|Withdrawal by Subject|0
7778648|NCT00941031|12226589|FG006|Induction Period|Withdrawal by Subject|0
7778649|NCT00941031|12226583|FG000|Induction Period|Adminstative Problems|1
7778650|NCT00941031|12226584|FG001|Induction Period|Adminstative Problems|1
7778651|NCT00941031|12226585|FG002|Induction Period|Adminstative Problems|1
7611682|NCT03173560|12019670|FG000|Overall Study|Ongoing on Treatment|38
7611683|NCT03173560|12019671|FG001|Overall Study|Ongoing on Treatment|50
7611684|NCT03173560|12019670|FG000|Overall Study|Ongoing Survival Follow-up|56
7611685|NCT03173560|12019671|FG001|Overall Study|Ongoing Survival Follow-up|57
7611686|NCT03173560|12019670|FG000|Overall Study|Lost to Follow-up|1
7611687|NCT03173560|12019671|FG001|Overall Study|Lost to Follow-up|4
7611688|NCT03173560|12019670|FG000|Overall Study|Withdrawal by Subject|10
7611689|NCT03173560|12019671|FG001|Overall Study|Withdrawal by Subject|5
7611690|NCT03173560|12019670|FG000|Overall Study|Other|0
7611691|NCT03173560|12019671|FG001|Overall Study|Other|1
7611692|NCT02865850|12019693|FG000|Overall Study|Death|15
7611693|NCT02865850|12019694|FG001|Overall Study|Death|19
7611694|NCT02865850|12019693|FG000|Overall Study|Withdrawal by Subject|3
7611695|NCT02865850|12019694|FG001|Overall Study|Withdrawal by Subject|2
7611696|NCT02865850|12019693|FG000|Overall Study|Lost to Follow-up|3
7611697|NCT02865850|12019694|FG001|Overall Study|Lost to Follow-up|2
7611698|NCT02763579|12019702|FG000|Overall Study|Death|101
7611699|NCT02763579|12019703|FG001|Overall Study|Death|132
7611700|NCT02763579|12019702|FG000|Overall Study|Lost to Follow-up|3
7611701|NCT02763579|12019703|FG001|Overall Study|Lost to Follow-up|1
7611702|NCT02763579|12019702|FG000|Overall Study|Withdrawal by Subject|18
7611703|NCT02763579|12019703|FG001|Overall Study|Withdrawal by Subject|9
7611704|NCT02763579|12019702|FG000|Overall Study|Physician Decision|2
7611705|NCT02763579|12019703|FG001|Overall Study|Physician Decision|0
7611706|NCT02763579|12019702|FG000|Overall Study|On-going in study|77
7611707|NCT02763579|12019703|FG001|Overall Study|On-going in study|60
7611708|NCT02746471|12019709|FG000|Overall Study|Death|43
7611709|NCT02746471|12019709|FG000|Overall Study|Exited before 36 months|1119
7778652|NCT00941031|12226586|FG003|Induction Period|Adminstative Problems|0
7778653|NCT00941031|12226587|FG004|Induction Period|Adminstative Problems|0
7778654|NCT00941031|12226588|FG005|Induction Period|Adminstative Problems|0
7778655|NCT00941031|12226589|FG006|Induction Period|Adminstative Problems|0
7778656|NCT00941031|12226583|FG000|Induction Period|Adverse Event|1
7778657|NCT00941031|12226584|FG001|Induction Period|Adverse Event|0
7778658|NCT00941031|12226585|FG002|Induction Period|Adverse Event|3
7778659|NCT00941031|12226586|FG003|Induction Period|Adverse Event|2
7778660|NCT00941031|12226587|FG004|Induction Period|Adverse Event|0
7778661|NCT00941031|12226588|FG005|Induction Period|Adverse Event|0
7778662|NCT00941031|12226589|FG006|Induction Period|Adverse Event|0
7778663|NCT00941031|12226583|FG000|Maintenance Period|Withdrawal by Subject|0
7778664|NCT00941031|12226584|FG001|Maintenance Period|Withdrawal by Subject|0
7778665|NCT00941031|12226585|FG002|Maintenance Period|Withdrawal by Subject|0
7778666|NCT00941031|12226586|FG003|Maintenance Period|Withdrawal by Subject|0
7778667|NCT00941031|12226587|FG004|Maintenance Period|Withdrawal by Subject|6
7778668|NCT00941031|12226588|FG005|Maintenance Period|Withdrawal by Subject|2
7778669|NCT00941031|12226589|FG006|Maintenance Period|Withdrawal by Subject|13
7778670|NCT00941031|12226583|FG000|Maintenance Period|Administrative Problems|0
7778671|NCT00941031|12226584|FG001|Maintenance Period|Administrative Problems|0
7778672|NCT00941031|12226585|FG002|Maintenance Period|Administrative Problems|0
7778673|NCT00941031|12226586|FG003|Maintenance Period|Administrative Problems|0
7778674|NCT00941031|12226587|FG004|Maintenance Period|Administrative Problems|1
7778675|NCT00941031|12226588|FG005|Maintenance Period|Administrative Problems|0
7778676|NCT00941031|12226589|FG006|Maintenance Period|Administrative Problems|1
7778677|NCT00941031|12226583|FG000|Maintenance Period|Protocol Violation|0
7778678|NCT00941031|12226584|FG001|Maintenance Period|Protocol Violation|0
7778679|NCT00941031|12226585|FG002|Maintenance Period|Protocol Violation|0
7778680|NCT00941031|12226586|FG003|Maintenance Period|Protocol Violation|0
7778681|NCT00941031|12226587|FG004|Maintenance Period|Protocol Violation|0
7778682|NCT00941031|12226588|FG005|Maintenance Period|Protocol Violation|0
7778683|NCT00941031|12226589|FG006|Maintenance Period|Protocol Violation|1
7778684|NCT00941031|12226583|FG000|Maintenance Period|Adverse Event|0
7778685|NCT00941031|12226584|FG001|Maintenance Period|Adverse Event|0
7778686|NCT00941031|12226585|FG002|Maintenance Period|Adverse Event|0
7778687|NCT00941031|12226586|FG003|Maintenance Period|Adverse Event|0
7778688|NCT00941031|12226587|FG004|Maintenance Period|Adverse Event|0
7778689|NCT00941031|12226588|FG005|Maintenance Period|Adverse Event|2
7778690|NCT00941031|12226589|FG006|Maintenance Period|Adverse Event|8
7778691|NCT00941031|12226583|FG000|Maintenance Period|Lost to Follow-up|0
7778692|NCT00941031|12226584|FG001|Maintenance Period|Lost to Follow-up|0
7778693|NCT00941031|12226585|FG002|Maintenance Period|Lost to Follow-up|0
7778694|NCT00941031|12226586|FG003|Maintenance Period|Lost to Follow-up|0
7778695|NCT00941031|12226587|FG004|Maintenance Period|Lost to Follow-up|2
7778696|NCT00941031|12226588|FG005|Maintenance Period|Lost to Follow-up|2
7778697|NCT00941031|12226589|FG006|Maintenance Period|Lost to Follow-up|7
7778698|NCT00941031|12226583|FG000|Maintenance Period|Lack of Efficacy|0
7778699|NCT00941031|12226584|FG001|Maintenance Period|Lack of Efficacy|0
7778700|NCT00941031|12226585|FG002|Maintenance Period|Lack of Efficacy|0
7778701|NCT00941031|12226586|FG003|Maintenance Period|Lack of Efficacy|0
7778702|NCT00941031|12226587|FG004|Maintenance Period|Lack of Efficacy|0
7778703|NCT00941031|12226588|FG005|Maintenance Period|Lack of Efficacy|0
7778704|NCT00941031|12226589|FG006|Maintenance Period|Lack of Efficacy|13
7778705|NCT00941070|12226608|FG000|Overall Study|Patient non-compliant|1
7778706|NCT00941304|12226619|FG000|Overall Study|Lost to Follow-up|1
7778707|NCT00941304|12226620|FG001|Overall Study|Lost to Follow-up|0
7778708|NCT00941304|12226621|FG002|Overall Study|Lost to Follow-up|0
7778709|NCT00941304|12226622|FG003|Overall Study|Lost to Follow-up|0
7778710|NCT00941304|12226623|FG004|Overall Study|Lost to Follow-up|0
7778711|NCT00941330|12226637|FG000|Overall Study|Other|1
7778712|NCT00941330|12226638|FG001|Overall Study|Other|0
7778713|NCT00941330|12226637|FG000|Overall Study|Physician Decision|0
7611748|NCT02706873|12019727|FG000|Overall Study|Adverse Event|13
7611749|NCT02706873|12019728|FG001|Overall Study|Adverse Event|3
7611750|NCT02706873|12019729|FG002|Overall Study|Adverse Event|13
7778714|NCT00941330|12226638|FG001|Overall Study|Physician Decision|2
7778715|NCT00941603|12226650|FG000|Overall Study|Adverse Event|10
7778716|NCT00941603|12226651|FG001|Overall Study|Adverse Event|15
7778717|NCT00941603|12226652|FG002|Overall Study|Adverse Event|5
7611751|NCT02706873|12019730|FG003|Overall Study|Adverse Event|12
7611752|NCT02706873|12019727|FG000|Overall Study|Withdrawal by Subject|15
7611753|NCT02706873|12019728|FG001|Overall Study|Withdrawal by Subject|0
7611754|NCT02706873|12019729|FG002|Overall Study|Withdrawal by Subject|8
7611755|NCT02706873|12019730|FG003|Overall Study|Withdrawal by Subject|11
7611756|NCT02706873|12019727|FG000|Overall Study|Lost to Follow-up|3
7611757|NCT02706873|12019728|FG001|Overall Study|Lost to Follow-up|0
7611758|NCT02706873|12019729|FG002|Overall Study|Lost to Follow-up|4
7611759|NCT02706873|12019730|FG003|Overall Study|Lost to Follow-up|2
7611760|NCT02706873|12019727|FG000|Overall Study|Lack of Efficacy|10
7778718|NCT00941603|12226653|FG003|Overall Study|Adverse Event|1
7611761|NCT02706873|12019728|FG001|Overall Study|Lack of Efficacy|0
7611762|NCT02706873|12019729|FG002|Overall Study|Lack of Efficacy|0
7611763|NCT02706873|12019730|FG003|Overall Study|Lack of Efficacy|3
7611764|NCT02706873|12019727|FG000|Overall Study|Other|5
7611765|NCT02706873|12019728|FG001|Overall Study|Other|1
7611766|NCT02706873|12019729|FG002|Overall Study|Other|2
7611767|NCT02706873|12019730|FG003|Overall Study|Other|3
7611768|NCT02706873|12019727|FG000|Overall Study|Not Dosed|1
7611769|NCT02706873|12019728|FG001|Overall Study|Not Dosed|0
7611770|NCT02706873|12019729|FG002|Overall Study|Not Dosed|0
7611771|NCT02706873|12019730|FG003|Overall Study|Not Dosed|1
7611772|NCT02706873|12019727|FG000|Overall Study|Ongoing|0
7611773|NCT02706873|12019728|FG001|Overall Study|Ongoing|0
7611774|NCT02706873|12019729|FG002|Overall Study|Ongoing|0
7611775|NCT02706873|12019730|FG003|Overall Study|Ongoing|1
7611776|NCT02591953|12019744|FG000|Overall Study|Lost to Follow-up|6
7611777|NCT02591953|12019745|FG001|Overall Study|Lost to Follow-up|6
7611778|NCT02509494|12019759|FG000|Overall Study|Lost to Follow-up|8
7611779|NCT02509494|12019760|FG001|Overall Study|Lost to Follow-up|47
7611780|NCT02509494|12019761|FG002|Overall Study|Lost to Follow-up|19
7611781|NCT02509494|12019762|FG003|Overall Study|Lost to Follow-up|6
7611782|NCT02509494|12019763|FG004|Overall Study|Lost to Follow-up|3
7611783|NCT02509494|12019764|FG005|Overall Study|Lost to Follow-up|3
7611784|NCT02509494|12019765|FG006|Overall Study|Lost to Follow-up|1
7611785|NCT02509494|12019766|FG007|Overall Study|Lost to Follow-up|3
7611786|NCT02509494|12019767|FG008|Overall Study|Lost to Follow-up|1
7611787|NCT02509494|12019759|FG000|Overall Study|Physician Decision|2
7611788|NCT02509494|12019760|FG001|Overall Study|Physician Decision|1
7611789|NCT02509494|12019761|FG002|Overall Study|Physician Decision|0
7611790|NCT02509494|12019762|FG003|Overall Study|Physician Decision|0
7611791|NCT02509494|12019763|FG004|Overall Study|Physician Decision|0
7611792|NCT02509494|12019764|FG005|Overall Study|Physician Decision|0
7611793|NCT02509494|12019765|FG006|Overall Study|Physician Decision|0
7611794|NCT02509494|12019766|FG007|Overall Study|Physician Decision|0
7611795|NCT02509494|12019767|FG008|Overall Study|Physician Decision|0
7611796|NCT02509494|12019759|FG000|Overall Study|Withdrawal by Subject|4
7611797|NCT02509494|12019760|FG001|Overall Study|Withdrawal by Subject|17
7611798|NCT02509494|12019761|FG002|Overall Study|Withdrawal by Subject|7
7611799|NCT02509494|12019762|FG003|Overall Study|Withdrawal by Subject|5
7611800|NCT02509494|12019763|FG004|Overall Study|Withdrawal by Subject|0
7611801|NCT02509494|12019764|FG005|Overall Study|Withdrawal by Subject|6
7611802|NCT02509494|12019765|FG006|Overall Study|Withdrawal by Subject|1
7611803|NCT02509494|12019766|FG007|Overall Study|Withdrawal by Subject|2
7611804|NCT02509494|12019767|FG008|Overall Study|Withdrawal by Subject|1
7611805|NCT02509494|12019759|FG000|Overall Study|Death|0
7611806|NCT02509494|12019760|FG001|Overall Study|Death|1
7611807|NCT02509494|12019761|FG002|Overall Study|Death|0
7611808|NCT02509494|12019762|FG003|Overall Study|Death|0
7611809|NCT02509494|12019763|FG004|Overall Study|Death|1
7611810|NCT02509494|12019764|FG005|Overall Study|Death|0
7611811|NCT02509494|12019765|FG006|Overall Study|Death|0
7611812|NCT02509494|12019766|FG007|Overall Study|Death|1
7611813|NCT02509494|12019767|FG008|Overall Study|Death|0
7611814|NCT02509494|12019759|FG000|Overall Study|Other|0
7611815|NCT02509494|12019760|FG001|Overall Study|Other|4
7611816|NCT02509494|12019761|FG002|Overall Study|Other|5
7611817|NCT02509494|12019762|FG003|Overall Study|Other|0
7611818|NCT02509494|12019763|FG004|Overall Study|Other|0
7611819|NCT02509494|12019764|FG005|Overall Study|Other|0
7611820|NCT02509494|12019765|FG006|Overall Study|Other|0
7611821|NCT02509494|12019766|FG007|Overall Study|Other|0
7611822|NCT02509494|12019767|FG008|Overall Study|Other|0
7611823|NCT02509494|12019759|FG000|Overall Study|Non-Compliance With Study Drug|1
7611824|NCT02509494|12019760|FG001|Overall Study|Non-Compliance With Study Drug|11
7611825|NCT02509494|12019761|FG002|Overall Study|Non-Compliance With Study Drug|7
7611826|NCT02509494|12019762|FG003|Overall Study|Non-Compliance With Study Drug|0
7611827|NCT02509494|12019763|FG004|Overall Study|Non-Compliance With Study Drug|1
7611828|NCT02509494|12019764|FG005|Overall Study|Non-Compliance With Study Drug|2
7611829|NCT02509494|12019765|FG006|Overall Study|Non-Compliance With Study Drug|1
7611830|NCT02509494|12019766|FG007|Overall Study|Non-Compliance With Study Drug|1
7611831|NCT02509494|12019767|FG008|Overall Study|Non-Compliance With Study Drug|0
7611832|NCT02151981|12019812|FG000|Overall Study|Death|184
7611833|NCT02151981|12019813|FG001|Overall Study|Death|88
7611834|NCT02151981|12019812|FG000|Overall Study|Lost to Follow-up|7
7611835|NCT02151981|12019813|FG001|Overall Study|Lost to Follow-up|1
7611836|NCT02151981|12019812|FG000|Overall Study|Withdrawal by Subject|27
7611837|NCT02151981|12019813|FG001|Overall Study|Withdrawal by Subject|21
7611838|NCT02151981|12019812|FG000|Overall Study|Ongoing Study at Data Cut-off|60
7611839|NCT02151981|12019813|FG001|Overall Study|Ongoing Study at Data Cut-off|27
7611840|NCT02151981|12019812|FG000|Overall Study|Eligibility criteria not fulfilled|0
7611841|NCT02151981|12019813|FG001|Overall Study|Eligibility criteria not fulfilled|1
7611842|NCT02151981|12019812|FG000|Overall Study|Patient had no clinical benefit|1
7611843|NCT02151981|12019813|FG001|Overall Study|Patient had no clinical benefit|0
7611844|NCT02151981|12019812|FG000|Overall Study|Unwilling to continue to follow up visit|0
7611845|NCT02151981|12019813|FG001|Overall Study|Unwilling to continue to follow up visit|1
7611846|NCT02151981|12019812|FG000|Overall Study|Study terminated|0
7611847|NCT02151981|12019813|FG001|Overall Study|Study terminated|1
7611848|NCT02087423|12019822|FG000|Overall Study|Withdrawal by Subject|20
7611849|NCT02087423|12019823|FG001|Overall Study|Withdrawal by Subject|20
7611850|NCT02087423|12019824|FG002|Overall Study|Withdrawal by Subject|3
7611851|NCT02087423|12019822|FG000|Overall Study|Death|68
7611852|NCT02087423|12019823|FG001|Overall Study|Death|207
7611853|NCT02087423|12019824|FG002|Overall Study|Death|40
7611854|NCT02087423|12019822|FG000|Overall Study|Lost to Follow-up|0
7611855|NCT02087423|12019823|FG001|Overall Study|Lost to Follow-up|2
7611856|NCT02087423|12019824|FG002|Overall Study|Lost to Follow-up|0
7611857|NCT02087423|12019822|FG000|Overall Study|Terminated from study at final DCO|23
7611858|NCT02087423|12019823|FG001|Overall Study|Terminated from study at final DCO|36
7611859|NCT02087423|12019824|FG002|Overall Study|Terminated from study at final DCO|25
7778719|NCT00941603|12226654|FG004|Overall Study|Adverse Event|4
7778720|NCT00941603|12226655|FG005|Overall Study|Adverse Event|0
7778721|NCT00941603|12226650|FG000|Overall Study|Lost to Follow-up|0
7778722|NCT00941603|12226651|FG001|Overall Study|Lost to Follow-up|0
7778723|NCT00941603|12226652|FG002|Overall Study|Lost to Follow-up|0
7778724|NCT00941603|12226653|FG003|Overall Study|Lost to Follow-up|1
7778725|NCT00941603|12226654|FG004|Overall Study|Lost to Follow-up|0
7778726|NCT00941603|12226655|FG005|Overall Study|Lost to Follow-up|2
7778727|NCT00941603|12226650|FG000|Overall Study|Withdrawal by Subject|0
7778728|NCT00941603|12226651|FG001|Overall Study|Withdrawal by Subject|0
7778729|NCT00941603|12226652|FG002|Overall Study|Withdrawal by Subject|0
7778730|NCT00941603|12226653|FG003|Overall Study|Withdrawal by Subject|2
7778731|NCT00941603|12226654|FG004|Overall Study|Withdrawal by Subject|0
7778732|NCT00941603|12226655|FG005|Overall Study|Withdrawal by Subject|1
7611874|NCT01874353|12019845|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2
7611875|NCT01874353|12019846|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0
7611876|NCT01874353|12019847|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0
7611877|NCT01874353|12019848|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0
7611878|NCT01874353|12019845|FG000|Overall Study|Lost to Follow-up|2
7611879|NCT01874353|12019846|FG001|Overall Study|Lost to Follow-up|2
7611880|NCT01874353|12019847|FG002|Overall Study|Lost to Follow-up|2
7778733|NCT00941603|12226650|FG000|Overall Study|Protocol Violation|0
7611881|NCT01874353|12019848|FG003|Overall Study|Lost to Follow-up|0
7611882|NCT01874353|12019845|FG000|Overall Study|Death|110
7611883|NCT01874353|12019846|FG001|Overall Study|Death|60
7611884|NCT01874353|12019847|FG002|Overall Study|Death|13
7611885|NCT01874353|12019848|FG003|Overall Study|Death|7
7611886|NCT01874353|12019845|FG000|Overall Study|Withdrawal by Subject|13
7611887|NCT01874353|12019846|FG001|Overall Study|Withdrawal by Subject|11
7611888|NCT01874353|12019847|FG002|Overall Study|Withdrawal by Subject|0
7611889|NCT01874353|12019848|FG003|Overall Study|Withdrawal by Subject|0
7778734|NCT00941603|12226651|FG001|Overall Study|Protocol Violation|1
7778735|NCT00941603|12226652|FG002|Overall Study|Protocol Violation|0
7778736|NCT00941603|12226653|FG003|Overall Study|Protocol Violation|0
7778737|NCT00941603|12226654|FG004|Overall Study|Protocol Violation|0
7778738|NCT00941603|12226655|FG005|Overall Study|Protocol Violation|0
7778739|NCT00941603|12226650|FG000|Overall Study|Did not meet protocol eligibility|1
7778740|NCT00941603|12226651|FG001|Overall Study|Did not meet protocol eligibility|0
7778741|NCT00941603|12226652|FG002|Overall Study|Did not meet protocol eligibility|0
7778742|NCT00941603|12226653|FG003|Overall Study|Did not meet protocol eligibility|0
7778743|NCT00941603|12226654|FG004|Overall Study|Did not meet protocol eligibility|0
7778744|NCT00941603|12226655|FG005|Overall Study|Did not meet protocol eligibility|0
7778745|NCT00941655|12226671|FG000|Overall Study|received some chemo, 4 and 9 cycles|1
7778746|NCT00941655|12226672|FG001|Overall Study|received some chemo, 4 and 9 cycles|0
7778747|NCT00941655|12226671|FG000|Overall Study|not meet criteria for chemo foll surgery|4
7778748|NCT00941655|12226672|FG001|Overall Study|not meet criteria for chemo foll surgery|0
7778749|NCT00941655|12226671|FG000|Overall Study|progressed while on chemo|0
7778750|NCT00941655|12226672|FG001|Overall Study|progressed while on chemo|2
7778751|NCT00941655|12226671|FG000|Overall Study|refused further treatment|0
7778752|NCT00941655|12226672|FG001|Overall Study|refused further treatment|1
7778753|NCT00941655|12226671|FG000|Overall Study|withdrew consent|0
7778754|NCT00941655|12226672|FG001|Overall Study|withdrew consent|1
7778755|NCT00941655|12226671|FG000|Overall Study|non-compliant|0
7778756|NCT00941655|12226672|FG001|Overall Study|non-compliant|1
7778757|NCT00941720|12226701|FG000|Overall Study|Withdrawal by Subject|1
7778758|NCT00941720|12226701|FG000|Overall Study|Insurance denied participation|11
7778759|NCT00941720|12226701|FG000|Overall Study|ineligible|2
7778760|NCT00941733|12226707|FG000|Overall Study|Death|24
7778761|NCT00941733|12226708|FG001|Overall Study|Death|10
7778762|NCT00941733|12226707|FG000|Overall Study|Withdrawal by Subject|14
7778763|NCT00941733|12226708|FG001|Overall Study|Withdrawal by Subject|6
7778764|NCT00941733|12226707|FG000|Overall Study|Adverse Event|20
7778765|NCT00941733|12226708|FG001|Overall Study|Adverse Event|4
7778766|NCT00941733|12226707|FG000|Overall Study|Lost to Follow-up|1
7778767|NCT00941733|12226708|FG001|Overall Study|Lost to Follow-up|2
7778768|NCT00941733|12226707|FG000|Overall Study|Protocol Violation|15
7778769|NCT00941733|12226708|FG001|Overall Study|Protocol Violation|6
7778770|NCT00941798|12226716|FG000|Overall Study|Withdrawal by Subject|72
7778771|NCT00941798|12226717|FG001|Overall Study|Withdrawal by Subject|74
7778772|NCT00941798|12226716|FG000|Overall Study|Adverse Event|43
7778773|NCT00941798|12226717|FG001|Overall Study|Adverse Event|23
7778774|NCT00941798|12226716|FG000|Overall Study|Lost to Follow-up|29
7778775|NCT00941798|12226717|FG001|Overall Study|Lost to Follow-up|23
7778776|NCT00941798|12226716|FG000|Overall Study|Protocol Violation|17
7778777|NCT00941798|12226717|FG001|Overall Study|Protocol Violation|20
7778778|NCT00941798|12226716|FG000|Overall Study|Administrative problems|13
7778779|NCT00941798|12226717|FG001|Overall Study|Administrative problems|23
7778780|NCT00941798|12226716|FG000|Overall Study|Lack of Efficacy|10
7778781|NCT00941798|12226717|FG001|Overall Study|Lack of Efficacy|17
7778782|NCT00941798|12226716|FG000|Overall Study|Patient's inability to use device|6
7778783|NCT00941798|12226717|FG001|Overall Study|Patient's inability to use device|1
7778784|NCT00941798|12226716|FG000|Overall Study|Abnormal test procedure results|3
7778785|NCT00941798|12226717|FG001|Overall Study|Abnormal test procedure results|1
7778786|NCT00941798|12226716|FG000|Overall Study|Abnormal laboratory values|1
7778787|NCT00941798|12226717|FG001|Overall Study|Abnormal laboratory values|2
7778788|NCT00941798|12226716|FG000|Overall Study|Death|0
7778789|NCT00941798|12226717|FG001|Overall Study|Death|1
7778790|NCT00941863|12226728|FG000|Until Primary Completion Date (PCD)|Adverse Event|1
7778791|NCT00941863|12226729|FG001|Until Primary Completion Date (PCD)|Adverse Event|2
7778792|NCT00941863|12226730|FG002|Until Primary Completion Date (PCD)|Adverse Event|2
7778793|NCT00941863|12226731|FG003|Until Primary Completion Date (PCD)|Adverse Event|1
7778794|NCT00941863|12226732|FG004|Until Primary Completion Date (PCD)|Adverse Event|5
7778795|NCT00941863|12226728|FG000|Until Primary Completion Date (PCD)|Physician Decision|0
7778796|NCT00941863|12226729|FG001|Until Primary Completion Date (PCD)|Physician Decision|0
7778797|NCT00941863|12226730|FG002|Until Primary Completion Date (PCD)|Physician Decision|0
7778798|NCT00941863|12226731|FG003|Until Primary Completion Date (PCD)|Physician Decision|0
7778799|NCT00941863|12226732|FG004|Until Primary Completion Date (PCD)|Physician Decision|1
7778800|NCT00941863|12226728|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
7778801|NCT00941863|12226729|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
7778802|NCT00941863|12226730|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
7778803|NCT00941863|12226731|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
7778804|NCT00941863|12226732|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
7778805|NCT00941863|12226728|FG000|Until Primary Completion Date (PCD)|Death|0
7778806|NCT00941863|12226729|FG001|Until Primary Completion Date (PCD)|Death|0
7778807|NCT00941863|12226730|FG002|Until Primary Completion Date (PCD)|Death|1
7778808|NCT00941863|12226731|FG003|Until Primary Completion Date (PCD)|Death|2
7778809|NCT00941863|12226732|FG004|Until Primary Completion Date (PCD)|Death|7
7778810|NCT00941863|12226728|FG000|Until Primary Completion Date (PCD)|Disease progression|6
7778811|NCT00941863|12226729|FG001|Until Primary Completion Date (PCD)|Disease progression|1
7778812|NCT00941863|12226730|FG002|Until Primary Completion Date (PCD)|Disease progression|8
7778813|NCT00941863|12226731|FG003|Until Primary Completion Date (PCD)|Disease progression|14
7778814|NCT00941863|12226732|FG004|Until Primary Completion Date (PCD)|Disease progression|73
7778815|NCT00941863|12226728|FG000|Continued After PCD|Withdrawal by Subject|0
7778816|NCT00941863|12226729|FG001|Continued After PCD|Withdrawal by Subject|0
7778817|NCT00941863|12226730|FG002|Continued After PCD|Withdrawal by Subject|0
7778818|NCT00941863|12226731|FG003|Continued After PCD|Withdrawal by Subject|0
7778819|NCT00941863|12226732|FG004|Continued After PCD|Withdrawal by Subject|1
7778820|NCT00941863|12226728|FG000|Continued After PCD|Disease progression, recurrence, relapse|0
7611923|NCT02849626|12019932|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11
7611924|NCT02849626|12019933|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3
7611925|NCT02849626|12019932|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7
7611926|NCT02849626|12019933|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2
7611927|NCT02849626|12019932|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6
7611928|NCT02849626|12019933|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2
7611929|NCT02849626|12019932|FG000|Core Phase (up to 23 Weeks)|Non-specified|3
7611930|NCT02849626|12019933|FG001|Core Phase (up to 23 Weeks)|Non-specified|0
7611931|NCT02849626|12019932|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3
7611932|NCT02849626|12019933|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2
7611933|NCT02849626|12019932|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4
7611934|NCT02849626|12019933|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0
7611935|NCT02849626|12019932|FG000|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|3
7611936|NCT02849626|12019933|FG001|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|1
7611937|NCT02849626|12019932|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1
7611938|NCT02849626|12019933|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0
7611939|NCT02654132|12019951|FG000|Overall Study|Disease Progression|26
7611940|NCT02654132|12019952|FG001|Overall Study|Disease Progression|31
7611941|NCT02654132|12019951|FG000|Overall Study|Adverse Event Unrelated to Study Drug|5
7611942|NCT02654132|12019952|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5
7611943|NCT02654132|12019951|FG000|Overall Study|Switched to another tx|0
7611944|NCT02654132|12019952|FG001|Overall Study|Switched to another tx|1
7611945|NCT02654132|12019951|FG000|Overall Study|Study Drug Toxicity|1
7611946|NCT02654132|12019952|FG001|Overall Study|Study Drug Toxicity|2
7778821|NCT00941863|12226729|FG001|Continued After PCD|Disease progression, recurrence, relapse|0
7778822|NCT00941863|12226730|FG002|Continued After PCD|Disease progression, recurrence, relapse|0
7611947|NCT02654132|12019951|FG000|Overall Study|Maximum Clinical Benefit|0
7611948|NCT02654132|12019952|FG001|Overall Study|Maximum Clinical Benefit|2
7611949|NCT02654132|12019951|FG000|Overall Study|Subj Request to Discontinue Treatment|1
7611950|NCT02654132|12019952|FG001|Overall Study|Subj Request to Discontinue Treatment|0
7611951|NCT02654132|12019951|FG000|Overall Study|Not Reported|0
7611952|NCT02654132|12019952|FG001|Overall Study|Not Reported|1
7611953|NCT02654132|12019951|FG000|Overall Study|Subject Withdrew Consent|2
7611954|NCT02654132|12019952|FG001|Overall Study|Subject Withdrew Consent|1
7611955|NCT02654132|12019951|FG000|Overall Study|Inadequate response to therapy|1
7611956|NCT02654132|12019952|FG001|Overall Study|Inadequate response to therapy|0
7611957|NCT02654132|12019951|FG000|Overall Study|Clinical Progression (not protocol)|0
7611958|NCT02654132|12019952|FG001|Overall Study|Clinical Progression (not protocol)|1
7611959|NCT02654132|12019951|FG000|Overall Study|Never treated|0
7611960|NCT02654132|12019952|FG001|Overall Study|Never treated|2
7611977|NCT02600923|12019968|FG000|Overall Study|Death|10
7611978|NCT02600923|12019968|FG000|Overall Study|Adverse Event|3
7611979|NCT02600923|12019968|FG000|Overall Study|Global deterioration of health status|2
7611980|NCT02600923|12019968|FG000|Overall Study|Insufficient clinical response|6
7611981|NCT02600923|12019968|FG000|Overall Study|Lost to Follow-up|1
7611982|NCT02600923|12019968|FG000|Overall Study|Withdrawal by Subject|5
7611983|NCT02600923|12019968|FG000|Overall Study|Objective progression or relapse|50
7611984|NCT02600923|12019968|FG000|Overall Study|Study terminated by Sponsor|53
7611985|NCT02600923|12019968|FG000|Overall Study|Not treated|1
7611986|NCT02412735|12019993|FG000|Overall Study|Adverse Event|0
7611987|NCT02412735|12019994|FG001|Overall Study|Adverse Event|1
7611988|NCT02412735|12019995|FG002|Overall Study|Adverse Event|2
7611989|NCT02412735|12019993|FG000|Overall Study|Withdrawal by Subject|23
7611990|NCT02412735|12019994|FG001|Overall Study|Withdrawal by Subject|27
7611991|NCT02412735|12019995|FG002|Overall Study|Withdrawal by Subject|22
7611992|NCT02412735|12019993|FG000|Overall Study|Investigator Decision|3
7611993|NCT02412735|12019994|FG001|Overall Study|Investigator Decision|3
7611994|NCT02412735|12019995|FG002|Overall Study|Investigator Decision|2
7611995|NCT02412735|12019993|FG000|Overall Study|Lost to Follow-up|17
7611996|NCT02412735|12019994|FG001|Overall Study|Lost to Follow-up|11
7611997|NCT02412735|12019995|FG002|Overall Study|Lost to Follow-up|18
7611998|NCT02412735|12019993|FG000|Overall Study|Reason not Specified|3
7611999|NCT02412735|12019994|FG001|Overall Study|Reason not Specified|2
7612000|NCT02412735|12019995|FG002|Overall Study|Reason not Specified|2
7612001|NCT02371889|12020005|FG000|Overall Study|Adverse medication effect|11
7612002|NCT02371889|12020006|FG001|Overall Study|Adverse medication effect|2
7612003|NCT02371889|12020005|FG000|Overall Study|Lost to Follow-up|6
7612004|NCT02371889|12020006|FG001|Overall Study|Lost to Follow-up|5
7612005|NCT02371889|12020005|FG000|Overall Study|Personal time constraints|2
7612006|NCT02371889|12020006|FG001|Overall Study|Personal time constraints|4
7612007|NCT02371889|12020005|FG000|Overall Study|Lack of Efficacy|0
7612008|NCT02371889|12020006|FG001|Overall Study|Lack of Efficacy|2
7612009|NCT02371889|12020005|FG000|Overall Study|Relapse|0
7612010|NCT02371889|12020006|FG001|Overall Study|Relapse|1
7612011|NCT02100722|12020027|FG000|Overall Study|Withdrawal pre-procedure|4
7612012|NCT02100722|12020028|FG001|Overall Study|Withdrawal pre-procedure|9
7612013|NCT02100722|12020027|FG000|Overall Study|Withdrawal post-procedure|0
7612014|NCT02100722|12020028|FG001|Overall Study|Withdrawal post-procedure|3
7612015|NCT02100722|12020027|FG000|Overall Study|Lost to Follow-up|2
7612016|NCT02100722|12020028|FG001|Overall Study|Lost to Follow-up|2
7612017|NCT02100722|12020027|FG000|Overall Study|Continuing on study|751
7612018|NCT02100722|12020028|FG001|Overall Study|Continuing on study|729
7612019|NCT02046096|12020037|FG000|Overall Study|Death|28
7612020|NCT02046096|12020038|FG001|Overall Study|Death|45
7612021|NCT02046096|12020037|FG000|Overall Study|Lost to Follow-up|9
7612022|NCT02046096|12020038|FG001|Overall Study|Lost to Follow-up|20
7612023|NCT02046096|12020037|FG000|Overall Study|Withdrawal by Subject|5
7612024|NCT02046096|12020038|FG001|Overall Study|Withdrawal by Subject|17
7612025|NCT02046096|12020037|FG000|Overall Study|Other endpoint|2
7612026|NCT02046096|12020038|FG001|Overall Study|Other endpoint|19
7612027|NCT01945775|12020048|FG000|Overall Study|Death|214
7612028|NCT01945775|12020049|FG001|Overall Study|Death|98
7612029|NCT01945775|12020048|FG000|Overall Study|Lost to Follow-up|12
7612030|NCT01945775|12020049|FG001|Overall Study|Lost to Follow-up|7
7612031|NCT01945775|12020048|FG000|Overall Study|Withdrawal by Subject|11
7612032|NCT01945775|12020049|FG001|Overall Study|Withdrawal by Subject|21
7612033|NCT01945775|12020048|FG000|Overall Study|Other|50
7612034|NCT01945775|12020049|FG001|Overall Study|Other|18
7612035|NCT01781637|12020057|FG000|Overall Study|Adverse Event|1
7612036|NCT01781637|12020058|FG001|Overall Study|Adverse Event|0
7612037|NCT01781637|12020057|FG000|Overall Study|Lack of Efficacy|2
7612038|NCT01781637|12020058|FG001|Overall Study|Lack of Efficacy|6
7612039|NCT01781637|12020057|FG000|Overall Study|Withdrawal by Subject|1
7612040|NCT01781637|12020058|FG001|Overall Study|Withdrawal by Subject|0
7612041|NCT01670539|12020064|FG000|Overall Study|Death|3
7612042|NCT01670539|12020065|FG001|Overall Study|Death|5
7612043|NCT01670539|12020064|FG000|Overall Study|Withdrawal by Subject|3
7612044|NCT01670539|12020065|FG001|Overall Study|Withdrawal by Subject|0
7612045|NCT00407602|12020072|FG000|Overall Study|Death - unrelated to device|1
7612046|NCT00407602|12020072|FG000|Overall Study|Device explanted|5
7612047|NCT00407602|12020072|FG000|Overall Study|Withdrawal by Subject|1
7612048|NCT04567186|12020092|FG000|Period 1|COVID-19 related|1
7612049|NCT04567186|12020093|FG001|Period 1|COVID-19 related|0
7778823|NCT00941863|12226731|FG003|Continued After PCD|Disease progression, recurrence, relapse|0
7778824|NCT00941863|12226732|FG004|Continued After PCD|Disease progression, recurrence, relapse|18
7778825|NCT00942084|12226762|FG000|Overall Study|Death|2
7778826|NCT00942162|12226773|FG000|Overall Study|Death|45
7778827|NCT00942162|12226774|FG001|Overall Study|Death|35
7778828|NCT00942162|12226775|FG002|Overall Study|Death|0
7778829|NCT00942162|12226773|FG000|Overall Study|Withdrawal by Subject|7
7778830|NCT00942162|12226774|FG001|Overall Study|Withdrawal by Subject|2
7778831|NCT00942162|12226775|FG002|Overall Study|Withdrawal by Subject|0
7778832|NCT00942162|12226773|FG000|Overall Study|Lost to Follow-up|4
7778833|NCT00942162|12226774|FG001|Overall Study|Lost to Follow-up|0
7778834|NCT00942162|12226775|FG002|Overall Study|Lost to Follow-up|0
7778835|NCT00942162|12226773|FG000|Overall Study|Other|14
7778836|NCT00942162|12226774|FG001|Overall Study|Other|13
7778837|NCT00942162|12226775|FG002|Overall Study|Other|2
7778838|NCT00942175|12226789|FG000|Overall Study|Adverse Event|2
7778839|NCT00942175|12226790|FG001|Overall Study|Adverse Event|1
7778840|NCT00942175|12226791|FG002|Overall Study|Adverse Event|0
7778841|NCT00942175|12226792|FG003|Overall Study|Adverse Event|0
7778842|NCT00942175|12226789|FG000|Overall Study|Protocol Violation|0
7778843|NCT00942175|12226790|FG001|Overall Study|Protocol Violation|1
7778844|NCT00942175|12226791|FG002|Overall Study|Protocol Violation|2
7778845|NCT00942175|12226792|FG003|Overall Study|Protocol Violation|0
7778846|NCT00942175|12226789|FG000|Overall Study|Pregnancy|0
7612050|NCT04567186|12020092|FG000|Period 1|Protocol Violation|0
7612051|NCT04567186|12020093|FG001|Period 1|Protocol Violation|1
7612052|NCT04567186|12020092|FG000|Period 1|Adverse Event|0
7612053|NCT04567186|12020093|FG001|Period 1|Adverse Event|2
7612054|NCT04567186|12020092|FG000|Period 2|COVID-19 Related|0
7612055|NCT04567186|12020093|FG001|Period 2|COVID-19 Related|1
7612056|NCT04567186|12020092|FG000|Period 2|Protocol Violation|0
7612057|NCT04567186|12020093|FG001|Period 2|Protocol Violation|1
7612058|NCT04567186|12020092|FG000|Period 2|Lost to Follow-up|0
7612059|NCT04567186|12020093|FG001|Period 2|Lost to Follow-up|1
7612060|NCT04567186|12020092|FG000|Period 3|Subject no longer meets eligibilty criteria|1
7778847|NCT00942175|12226790|FG001|Overall Study|Pregnancy|0
7778848|NCT00942175|12226791|FG002|Overall Study|Pregnancy|0
7778849|NCT00942175|12226792|FG003|Overall Study|Pregnancy|1
7778850|NCT00942175|12226789|FG000|Overall Study|Elevated Alanine Amino Transferase|0
7778851|NCT00942175|12226790|FG001|Overall Study|Elevated Alanine Amino Transferase|0
7778852|NCT00942175|12226791|FG002|Overall Study|Elevated Alanine Amino Transferase|0
7778853|NCT00942175|12226792|FG003|Overall Study|Elevated Alanine Amino Transferase|1
7778854|NCT00942175|12226789|FG000|Overall Study|Low Platelet Count|0
7778855|NCT00942175|12226790|FG001|Overall Study|Low Platelet Count|2
7778856|NCT00942175|12226791|FG002|Overall Study|Low Platelet Count|0
7612061|NCT04567186|12020093|FG001|Period 3|Subject no longer meets eligibilty criteria|0
7612062|NCT04065074|12020099|FG000|Overall Study|Adverse Event|1
7612063|NCT04065074|12020099|FG000|Overall Study|Protocol Non-Compliance after injection|1
7612064|NCT03980730|12020105|FG000|Overall Study|Study Terminated by Sponsor|0
7612065|NCT03980730|12020106|FG001|Overall Study|Study Terminated by Sponsor|3
7612066|NCT03980730|12020105|FG000|Overall Study|Adverse Event|2
7612067|NCT03980730|12020106|FG001|Overall Study|Adverse Event|0
7612068|NCT03980730|12020105|FG000|Overall Study|Sponsor Request|0
7612069|NCT03980730|12020106|FG001|Overall Study|Sponsor Request|1
7612070|NCT03793010|12020114|FG000|Overall Study|Withdrawal by Subject|5
7612071|NCT03793010|12020115|FG001|Overall Study|Withdrawal by Subject|7
7612072|NCT03793010|12020114|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19
7612073|NCT03793010|12020115|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18
7612074|NCT03793010|12020114|FG000|Overall Study|Lost to Follow-up|1
7612075|NCT03793010|12020115|FG001|Overall Study|Lost to Follow-up|2
7612076|NCT03793010|12020114|FG000|Overall Study|Patient couldn't sit still for injection|1
7612077|NCT03793010|12020115|FG001|Overall Study|Patient couldn't sit still for injection|0
7612078|NCT03793010|12020114|FG000|Overall Study|Withdrew to pursue other treatment|1
7612079|NCT03793010|12020115|FG001|Overall Study|Withdrew to pursue other treatment|0
7612080|NCT03793010|12020114|FG000|Overall Study|Did not meet eligibility criteria|1
7612081|NCT03793010|12020115|FG001|Overall Study|Did not meet eligibility criteria|0
7612082|NCT03644017|12020121|FG000|Overall Study|Access Abandonment|5
7612083|NCT03644017|12020121|FG000|Overall Study|Kidney Transplant|2
7612084|NCT03592186|12020127|FG000|Overall Study|Withdrawal by Subject|1
7612085|NCT03592186|12020128|FG001|Overall Study|Withdrawal by Subject|0
7612086|NCT03592186|12020127|FG000|Overall Study|Lost to Follow-up|16
7612087|NCT03592186|12020128|FG001|Overall Study|Lost to Follow-up|11
7612088|NCT03529942|12020134|FG000|Overall Study|Withdrawal by Subject|13
7612089|NCT03529942|12020134|FG000|Overall Study|Physician Decision|1
7612090|NCT03529942|12020134|FG000|Overall Study|Lost to Follow-up|7
7612091|NCT03529942|12020134|FG000|Overall Study|Needle inserted but no drug administered|1
7612092|NCT03529942|12020134|FG000|Overall Study|Personal reasons|1
7778857|NCT00942175|12226792|FG003|Overall Study|Low Platelet Count|0
7778858|NCT00942188|12226814|FG000|Overall Study|Adverse Event|0
7778859|NCT00942188|12226815|FG001|Overall Study|Adverse Event|3
7778860|NCT00942188|12226816|FG002|Overall Study|Adverse Event|2
7778861|NCT00942188|12226817|FG003|Overall Study|Adverse Event|0
7778862|NCT00942188|12226814|FG000|Overall Study|Lack of Efficacy|0
7612093|NCT03349775|12020143|FG000|Overall Study|Side Effects|1
7612094|NCT03349775|12020144|FG001|Overall Study|Side Effects|2
7612095|NCT03349775|12020143|FG000|Overall Study|Withdrawal by Subject|1
7612096|NCT03349775|12020144|FG001|Overall Study|Withdrawal by Subject|1
7612097|NCT03349775|12020143|FG000|Overall Study|No primary outcome measurements|0
7612098|NCT03349775|12020144|FG001|Overall Study|No primary outcome measurements|1
7612099|NCT03256344|12020161|FG000|Overall Study|Ongoing on study|3
7612100|NCT03256344|12020162|FG001|Overall Study|Ongoing on study|3
7612101|NCT03256344|12020161|FG000|Overall Study|Death|5
7612102|NCT03256344|12020162|FG001|Overall Study|Death|19
7612103|NCT03256344|12020161|FG000|Overall Study|Withdrawal by Subject|3
7612104|NCT03256344|12020162|FG001|Overall Study|Withdrawal by Subject|3
7612105|NCT03207815|12020170|FG000|Overall Study|Protocol Violation|3
7612106|NCT03207815|12020171|FG001|Overall Study|Protocol Violation|1
7612107|NCT03207815|12020170|FG000|Overall Study|Adverse Event|1
7612108|NCT03207815|12020171|FG001|Overall Study|Adverse Event|2
7612109|NCT03207815|12020170|FG000|Overall Study|Lost to Follow-up|1
7612110|NCT03207815|12020171|FG001|Overall Study|Lost to Follow-up|2
7612111|NCT03207815|12020170|FG000|Overall Study|Investigator's Discretion|1
7612112|NCT03207815|12020171|FG001|Overall Study|Investigator's Discretion|1
7612113|NCT03207815|12020170|FG000|Overall Study|Lack of Efficacy|0
7612114|NCT03207815|12020171|FG001|Overall Study|Lack of Efficacy|1
7612115|NCT03207815|12020170|FG000|Overall Study|Pregnancy/Partner Pregnancy|1
7612116|NCT03207815|12020171|FG001|Overall Study|Pregnancy/Partner Pregnancy|0
7612117|NCT03207815|12020170|FG000|Overall Study|Withdrew Consent|1
7612118|NCT03207815|12020171|FG001|Overall Study|Withdrew Consent|0
7612119|NCT02968563|12020197|FG000|Overall Study|Adverse Event|0
7612120|NCT02968563|12020198|FG001|Overall Study|Adverse Event|6
7612121|NCT02968563|12020197|FG000|Overall Study|Death|1
7612122|NCT02968563|12020198|FG001|Overall Study|Death|1
7612123|NCT02968563|12020197|FG000|Overall Study|Lost to Follow-up|0
7612124|NCT02968563|12020198|FG001|Overall Study|Lost to Follow-up|1
7612125|NCT02915783|12020204|FG000|Overall Study|Ongoing: Receiving Treatment|6
7612126|NCT02915783|12020204|FG000|Overall Study|Ongoing: In Survival Follow Up|8
7612127|NCT02913482|12020211|FG000|Overall Study|Death|0
7612128|NCT02913482|12020212|FG001|Overall Study|Death|2
7612129|NCT02913482|12020213|FG002|Overall Study|Death|2
7612130|NCT02913482|12020211|FG000|Overall Study|Progressive Disease|1
7612131|NCT02913482|12020212|FG001|Overall Study|Progressive Disease|1
7612132|NCT02913482|12020213|FG002|Overall Study|Progressive Disease|1
7612133|NCT02787044|12020225|FG000|Overall Study|Lost to Follow-up|15
7612134|NCT02787044|12020226|FG001|Overall Study|Lost to Follow-up|19
7612135|NCT02698163|12020238|FG000|Overall Study|Lost to Follow-up|0
7612136|NCT02698163|12020239|FG001|Overall Study|Lost to Follow-up|1
7612137|NCT01816165|12020266|FG000|Overall Study|Adverse Event|1
7612138|NCT01816165|12020267|FG001|Overall Study|Adverse Event|0
7612139|NCT01816165|12020268|FG002|Overall Study|Adverse Event|0
7612140|NCT01816165|12020269|FG003|Overall Study|Adverse Event|0
7612141|NCT01813929|12020291|FG000|Overall Study|Withdrawal by Subject|0
7612142|NCT01813929|12020292|FG001|Overall Study|Withdrawal by Subject|1
7612143|NCT00882050|12020313|FG000|Overall Study|Physician Decision|1
7612144|NCT00882050|12020314|FG001|Overall Study|Physician Decision|0
7612145|NCT00882050|12020315|FG002|Overall Study|Physician Decision|0
7612146|NCT00070564|12020329|FG000|Overall Study|Progression|2
7612147|NCT00070564|12020330|FG001|Overall Study|Progression|4
7612148|NCT00070564|12020331|FG002|Overall Study|Progression|7
7612149|NCT00070564|12020332|FG003|Overall Study|Progression|7
7612150|NCT00070564|12020333|FG004|Overall Study|Progression|1
7612151|NCT00070564|12020334|FG005|Overall Study|Progression|0
7612152|NCT00070564|12020329|FG000|Overall Study|Delinquent|1
7612153|NCT00070564|12020330|FG001|Overall Study|Delinquent|4
7612154|NCT00070564|12020331|FG002|Overall Study|Delinquent|2
7612155|NCT00070564|12020332|FG003|Overall Study|Delinquent|0
7612156|NCT00070564|12020333|FG004|Overall Study|Delinquent|0
7612157|NCT00070564|12020334|FG005|Overall Study|Delinquent|0
7612158|NCT00070564|12020329|FG000|Overall Study|Adverse Event|150
7612159|NCT00070564|12020330|FG001|Overall Study|Adverse Event|142
7612160|NCT00070564|12020331|FG002|Overall Study|Adverse Event|120
7612161|NCT00070564|12020332|FG003|Overall Study|Adverse Event|108
7612162|NCT00070564|12020333|FG004|Overall Study|Adverse Event|63
7612163|NCT00070564|12020334|FG005|Overall Study|Adverse Event|36
7612164|NCT00070564|12020329|FG000|Overall Study|Death|4
7612165|NCT00070564|12020330|FG001|Overall Study|Death|1
7612166|NCT00070564|12020331|FG002|Overall Study|Death|5
7612167|NCT00070564|12020332|FG003|Overall Study|Death|3
7612168|NCT00070564|12020333|FG004|Overall Study|Death|0
7612169|NCT00070564|12020334|FG005|Overall Study|Death|1
7612170|NCT00070564|12020329|FG000|Overall Study|Other, not protocol specified|17
7612171|NCT00070564|12020330|FG001|Overall Study|Other, not protocol specified|15
7612172|NCT00070564|12020331|FG002|Overall Study|Other, not protocol specified|14
7612173|NCT00070564|12020332|FG003|Overall Study|Other, not protocol specified|19
7612174|NCT00070564|12020333|FG004|Overall Study|Other, not protocol specified|6
7612175|NCT00070564|12020334|FG005|Overall Study|Other, not protocol specified|7
7612176|NCT00070564|12020329|FG000|Overall Study|Withdrawal by Subject|26
7612177|NCT00070564|12020330|FG001|Overall Study|Withdrawal by Subject|37
7612178|NCT00070564|12020331|FG002|Overall Study|Withdrawal by Subject|23
7612179|NCT00070564|12020332|FG003|Overall Study|Withdrawal by Subject|30
7612180|NCT00070564|12020333|FG004|Overall Study|Withdrawal by Subject|8
7612181|NCT00070564|12020334|FG005|Overall Study|Withdrawal by Subject|8
7612182|NCT00070564|12020329|FG000|Overall Study|Not reported|0
7612183|NCT00070564|12020330|FG001|Overall Study|Not reported|0
7612184|NCT00070564|12020331|FG002|Overall Study|Not reported|0
7612185|NCT00070564|12020332|FG003|Overall Study|Not reported|0
7612186|NCT00070564|12020333|FG004|Overall Study|Not reported|1
7612187|NCT00070564|12020334|FG005|Overall Study|Not reported|0
7612188|NCT04425720|12020365|FG000|Overall Study|Withdrawal by Subject|0
7612189|NCT04425720|12020366|FG001|Overall Study|Withdrawal by Subject|20
7612190|NCT04409509|12020375|FG000|Overall Study|Failure to meet randomization requirement|1
7612191|NCT04409509|12020376|FG001|Overall Study|Failure to meet randomization requirement|0
7612192|NCT04409509|12020375|FG000|Overall Study|Adverse Event|0
7612193|NCT04409509|12020376|FG001|Overall Study|Adverse Event|1
7612194|NCT04409509|12020375|FG000|Overall Study|Death|11
7778863|NCT00942188|12226815|FG001|Overall Study|Lack of Efficacy|0
7778864|NCT00942188|12226816|FG002|Overall Study|Lack of Efficacy|0
7778865|NCT00942188|12226817|FG003|Overall Study|Lack of Efficacy|1
7778866|NCT00942188|12226814|FG000|Overall Study|Protocol Violation|1
7612195|NCT04409509|12020376|FG001|Overall Study|Death|10
7612196|NCT04409509|12020375|FG000|Overall Study|Non-compliance with study drug|0
7612197|NCT04409509|12020376|FG001|Overall Study|Non-compliance with study drug|1
7612198|NCT04409509|12020375|FG000|Overall Study|Lost to Follow-up|0
7612199|NCT04409509|12020376|FG001|Overall Study|Lost to Follow-up|3
7612200|NCT04409509|12020375|FG000|Overall Study|Withdrawal by Subject|0
7612201|NCT04409509|12020376|FG001|Overall Study|Withdrawal by Subject|3
7612202|NCT04409509|12020375|FG000|Overall Study|Randomized by mistake|0
7612203|NCT04409509|12020376|FG001|Overall Study|Randomized by mistake|1
7612204|NCT04409509|12020375|FG000|Overall Study|Other|1
7612205|NCT04409509|12020376|FG001|Overall Study|Other|1
7612206|NCT04380519|12020386|FG000|Overall Study|Withdrawal by Subject|4
7612207|NCT04380519|12020387|FG001|Overall Study|Withdrawal by Subject|0
7612208|NCT04380519|12020388|FG002|Overall Study|Withdrawal by Subject|1
7612209|NCT04380519|12020386|FG000|Overall Study|Death|14
7612210|NCT04380519|12020387|FG001|Overall Study|Death|9
7612211|NCT04380519|12020388|FG002|Overall Study|Death|6
7612212|NCT04380519|12020386|FG000|Overall Study|Adverse Event|0
7612213|NCT04380519|12020387|FG001|Overall Study|Adverse Event|1
7612214|NCT04380519|12020388|FG002|Overall Study|Adverse Event|0
7612215|NCT04380519|12020386|FG000|Overall Study|relatives' decision|0
7612216|NCT04380519|12020387|FG001|Overall Study|relatives' decision|1
7612217|NCT04380519|12020388|FG002|Overall Study|relatives' decision|0
7612218|NCT04362813|12020398|FG000|Overall Study|Death|12
7612219|NCT04362813|12020399|FG001|Overall Study|Death|16
7612220|NCT04362813|12020398|FG000|Overall Study|Withdrawal by Subject|3
7612221|NCT04362813|12020399|FG001|Overall Study|Withdrawal by Subject|1
7612222|NCT04362813|12020398|FG000|Overall Study|Protocol Violation|0
7612223|NCT04362813|12020399|FG001|Overall Study|Protocol Violation|3
7612224|NCT04362813|12020398|FG000|Overall Study|Lost to Follow-up|1
7612225|NCT04362813|12020399|FG001|Overall Study|Lost to Follow-up|1
7612226|NCT04362813|12020398|FG000|Overall Study|Enrolled but did not receive treatment|2
7612227|NCT04362813|12020399|FG001|Overall Study|Enrolled but did not receive treatment|4
7612228|NCT03922321|12020457|FG000|Overall Study|Participant Moved|1
7612229|NCT03922321|12020457|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1
7612230|NCT03911713|12020466|FG000|Overall Study|Lost to Follow-up|0
7612231|NCT03911713|12020467|FG001|Overall Study|Lost to Follow-up|2
7612232|NCT03911713|12020468|FG002|Overall Study|Lost to Follow-up|0
7612233|NCT03911713|12020469|FG003|Overall Study|Lost to Follow-up|0
7612234|NCT03911713|12020470|FG004|Overall Study|Lost to Follow-up|0
7612235|NCT03911713|12020466|FG000|Overall Study|Other|0
7612236|NCT03911713|12020467|FG001|Overall Study|Other|0
7612237|NCT03911713|12020468|FG002|Overall Study|Other|0
7612238|NCT03911713|12020469|FG003|Overall Study|Other|1
7612239|NCT03911713|12020470|FG004|Overall Study|Other|0
7612240|NCT03911713|12020466|FG000|Overall Study|Randomized, Never Dosed|1
7612241|NCT03911713|12020467|FG001|Overall Study|Randomized, Never Dosed|0
7612242|NCT03911713|12020468|FG002|Overall Study|Randomized, Never Dosed|0
7612243|NCT03911713|12020469|FG003|Overall Study|Randomized, Never Dosed|1
7612244|NCT03911713|12020470|FG004|Overall Study|Randomized, Never Dosed|0
7612245|NCT03852459|12020495|FG000|Overall Study|Adverse Event|2
7612246|NCT03852459|12020496|FG001|Overall Study|Adverse Event|2
7612247|NCT03852459|12020495|FG000|Overall Study|Withdrawal by Subject|1
7612248|NCT03852459|12020496|FG001|Overall Study|Withdrawal by Subject|1
7612249|NCT03740919|12020505|FG000|Lead-in Period|Lost to Follow-up|1
7612250|NCT03740919|12020506|FG001|Lead-in Period|Lost to Follow-up|0
7612251|NCT03740919|12020507|FG002|Lead-in Period|Lost to Follow-up|0
7612252|NCT03740919|12020508|FG003|Lead-in Period|Lost to Follow-up|0
7612253|NCT03740919|12020505|FG000|Lead-in Period|Physician Decision|2
7612254|NCT03740919|12020506|FG001|Lead-in Period|Physician Decision|0
7612255|NCT03740919|12020507|FG002|Lead-in Period|Physician Decision|0
7612256|NCT03740919|12020508|FG003|Lead-in Period|Physician Decision|0
7612257|NCT03740919|12020505|FG000|Lead-in Period|Protocol Violation|1
7612258|NCT03740919|12020506|FG001|Lead-in Period|Protocol Violation|0
7612259|NCT03740919|12020507|FG002|Lead-in Period|Protocol Violation|0
7612260|NCT03740919|12020508|FG003|Lead-in Period|Protocol Violation|0
7612261|NCT03740919|12020505|FG000|Lead-in Period|Withdrawal by Subject|10
7612262|NCT03740919|12020506|FG001|Lead-in Period|Withdrawal by Subject|0
7612263|NCT03740919|12020507|FG002|Lead-in Period|Withdrawal by Subject|0
7612264|NCT03740919|12020508|FG003|Lead-in Period|Withdrawal by Subject|0
7612265|NCT03740919|12020505|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18
7612266|NCT03740919|12020506|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
7612267|NCT03740919|12020507|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
7612268|NCT03740919|12020508|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
7612269|NCT03740919|12020505|FG000|Lead-in Period|Study Task Too Burdensome|1
7612270|NCT03740919|12020506|FG001|Lead-in Period|Study Task Too Burdensome|0
7612271|NCT03740919|12020507|FG002|Lead-in Period|Study Task Too Burdensome|0
7612272|NCT03740919|12020508|FG003|Lead-in Period|Study Task Too Burdensome|0
7778867|NCT00942188|12226815|FG001|Overall Study|Protocol Violation|1
7778868|NCT00942188|12226816|FG002|Overall Study|Protocol Violation|0
7778869|NCT00942188|12226817|FG003|Overall Study|Protocol Violation|0
7778870|NCT00942188|12226814|FG000|Overall Study|Lost to Follow-up|2
7778871|NCT00942188|12226815|FG001|Overall Study|Lost to Follow-up|1
7778872|NCT00942188|12226816|FG002|Overall Study|Lost to Follow-up|2
7778873|NCT00942188|12226817|FG003|Overall Study|Lost to Follow-up|0
7778874|NCT00942188|12226814|FG000|Overall Study|Withdrawal by Subject|1
7778875|NCT00942188|12226815|FG001|Overall Study|Withdrawal by Subject|3
7778876|NCT00942188|12226816|FG002|Overall Study|Withdrawal by Subject|4
7778877|NCT00942188|12226817|FG003|Overall Study|Withdrawal by Subject|2
7778878|NCT00942188|12226814|FG000|Overall Study|Physician Decision|0
7778879|NCT00942188|12226815|FG001|Overall Study|Physician Decision|0
7612273|NCT03740919|12020505|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1
7612274|NCT03740919|12020506|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
7612275|NCT03740919|12020507|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
7612276|NCT03740919|12020508|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
7612277|NCT03740919|12020505|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1
7612278|NCT03740919|12020506|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0
7612279|NCT03740919|12020507|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0
7612280|NCT03740919|12020508|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0
7612281|NCT03740919|12020505|FG000|Treatment Period|Adverse Event|0
7612282|NCT03740919|12020506|FG001|Treatment Period|Adverse Event|0
7612283|NCT03740919|12020507|FG002|Treatment Period|Adverse Event|2
7612284|NCT03740919|12020508|FG003|Treatment Period|Adverse Event|0
7612285|NCT03740919|12020505|FG000|Treatment Period|Protocol Violation|0
7612286|NCT03740919|12020506|FG001|Treatment Period|Protocol Violation|1
7612287|NCT03740919|12020507|FG002|Treatment Period|Protocol Violation|0
7612288|NCT03740919|12020508|FG003|Treatment Period|Protocol Violation|0
7612289|NCT03740919|12020505|FG000|Treatment Period|Withdrawal by Subject|0
7612290|NCT03740919|12020506|FG001|Treatment Period|Withdrawal by Subject|7
7612291|NCT03740919|12020507|FG002|Treatment Period|Withdrawal by Subject|6
7612292|NCT03740919|12020508|FG003|Treatment Period|Withdrawal by Subject|2
7612293|NCT03740919|12020505|FG000|Treatment Period|Terminated by Sponsor|0
7612294|NCT03740919|12020506|FG001|Treatment Period|Terminated by Sponsor|1
7612295|NCT03740919|12020507|FG002|Treatment Period|Terminated by Sponsor|0
7612296|NCT03740919|12020508|FG003|Treatment Period|Terminated by Sponsor|0
7612297|NCT03740919|12020505|FG000|Treatment Period|Issue with Insulin Pump|0
7612298|NCT03740919|12020506|FG001|Treatment Period|Issue with Insulin Pump|1
7612299|NCT03740919|12020507|FG002|Treatment Period|Issue with Insulin Pump|0
7612300|NCT03740919|12020508|FG003|Treatment Period|Issue with Insulin Pump|0
7612301|NCT03740919|12020505|FG000|Treatment Period|Due to COVID-19 Pandemic|0
7612302|NCT03740919|12020506|FG001|Treatment Period|Due to COVID-19 Pandemic|0
7612303|NCT03740919|12020507|FG002|Treatment Period|Due to COVID-19 Pandemic|3
7778880|NCT00942188|12226816|FG002|Overall Study|Physician Decision|1
7778881|NCT00942188|12226817|FG003|Overall Study|Physician Decision|0
7612304|NCT03740919|12020508|FG003|Treatment Period|Due to COVID-19 Pandemic|1
7612305|NCT03740919|12020505|FG000|Treatment Period|Failure of Inclusion Criteria|0
7612306|NCT03740919|12020506|FG001|Treatment Period|Failure of Inclusion Criteria|0
7612307|NCT03740919|12020507|FG002|Treatment Period|Failure of Inclusion Criteria|1
7612308|NCT03740919|12020508|FG003|Treatment Period|Failure of Inclusion Criteria|0
7612309|NCT03740919|12020505|FG000|Treatment Period|Not Completing Diary|0
7612310|NCT03740919|12020506|FG001|Treatment Period|Not Completing Diary|0
7612311|NCT03740919|12020507|FG002|Treatment Period|Not Completing Diary|1
7612312|NCT03740919|12020508|FG003|Treatment Period|Not Completing Diary|0
7612313|NCT03740919|12020505|FG000|Treatment Period|Insulin Painful to Participant|0
7612314|NCT03740919|12020506|FG001|Treatment Period|Insulin Painful to Participant|0
7612315|NCT03740919|12020507|FG002|Treatment Period|Insulin Painful to Participant|1
7612316|NCT03740919|12020508|FG003|Treatment Period|Insulin Painful to Participant|0
7612317|NCT03647488|12020542|FG000|Overall Study|Progressive disease|10
7612318|NCT03647488|12020543|FG001|Overall Study|Progressive disease|0
7612319|NCT03647488|12020544|FG002|Overall Study|Progressive disease|0
7612320|NCT03647488|12020542|FG000|Overall Study|Adverse Event|5
7612321|NCT03647488|12020543|FG001|Overall Study|Adverse Event|0
7612322|NCT03647488|12020544|FG002|Overall Study|Adverse Event|0
7612323|NCT03647488|12020542|FG000|Overall Study|Clinical progression|2
7612324|NCT03647488|12020543|FG001|Overall Study|Clinical progression|0
7778882|NCT00942188|12226814|FG000|Overall Study|Sponsor Decision|0
7778883|NCT00942188|12226815|FG001|Overall Study|Sponsor Decision|2
7612325|NCT03647488|12020544|FG002|Overall Study|Clinical progression|0
7612326|NCT03647488|12020542|FG000|Overall Study|Participant refused to take investigational product|1
7612327|NCT03647488|12020543|FG001|Overall Study|Participant refused to take investigational product|0
7612328|NCT03647488|12020544|FG002|Overall Study|Participant refused to take investigational product|0
7612329|NCT03614923|12020553|FG000|Overall Study|Withdrawal by Subject|2
7612330|NCT03614923|12020554|FG001|Overall Study|Withdrawal by Subject|1
7612331|NCT03614923|12020555|FG002|Overall Study|Withdrawal by Subject|1
7612332|NCT03614923|12020553|FG000|Overall Study|Adverse Event|0
7612333|NCT03614923|12020554|FG001|Overall Study|Adverse Event|2
7612334|NCT03614923|12020555|FG002|Overall Study|Adverse Event|1
7612335|NCT03614923|12020553|FG000|Overall Study|Lost to Follow-up|1
7612336|NCT03614923|12020554|FG001|Overall Study|Lost to Follow-up|0
7612337|NCT03614923|12020555|FG002|Overall Study|Lost to Follow-up|1
7612338|NCT03614923|12020553|FG000|Overall Study|Lack of Efficacy|2
7612339|NCT03614923|12020554|FG001|Overall Study|Lack of Efficacy|0
7612340|NCT03614923|12020555|FG002|Overall Study|Lack of Efficacy|1
7612341|NCT03614923|12020553|FG000|Overall Study|Non-compliance|0
7612342|NCT03614923|12020554|FG001|Overall Study|Non-compliance|1
7612343|NCT03614923|12020555|FG002|Overall Study|Non-compliance|0
7612344|NCT03614923|12020553|FG000|Overall Study|Other|0
7612345|NCT03614923|12020554|FG001|Overall Study|Other|1
7612346|NCT03614923|12020555|FG002|Overall Study|Other|1
7612347|NCT03502187|12020566|FG000|Overall Study|Withdrawal by Subject|4
7612348|NCT03502187|12020567|FG001|Overall Study|Withdrawal by Subject|3
7612349|NCT03502187|12020568|FG002|Overall Study|Withdrawal by Subject|3
7612350|NCT03502187|12020566|FG000|Overall Study|Lost to Follow-up|5
7612351|NCT03502187|12020567|FG001|Overall Study|Lost to Follow-up|4
7612352|NCT03502187|12020568|FG002|Overall Study|Lost to Follow-up|5
7612353|NCT03447262|12020576|FG000|Overall Study|Adverse Event|7
7612354|NCT03447262|12020576|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2
7612355|NCT03447262|12020576|FG000|Overall Study|Commercial Drug is Available for Participant|9
7612356|NCT03447262|12020576|FG000|Overall Study|Death|2
7612357|NCT03447262|12020576|FG000|Overall Study|Study Termination by Sponsor|455
7612358|NCT03447262|12020576|FG000|Overall Study|Other|4
7612359|NCT03432819|12020585|FG000|Overall Study|Lost to Follow-up|2
7612360|NCT03432819|12020586|FG001|Overall Study|Lost to Follow-up|2
7612361|NCT03432819|12020585|FG000|Overall Study|Withdrawal by Subject|5
7778884|NCT00942188|12226816|FG002|Overall Study|Sponsor Decision|0
7612362|NCT03432819|12020586|FG001|Overall Study|Withdrawal by Subject|3
7612363|NCT03323749|12020594|FG000|Double-blind Period|Lost to Follow-up|4
7612364|NCT03323749|12020595|FG001|Double-blind Period|Lost to Follow-up|5
7612365|NCT03323749|12020594|FG000|Double-blind Period|Adverse Event|3
7612366|NCT03323749|12020595|FG001|Double-blind Period|Adverse Event|1
7612367|NCT03323749|12020594|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83
7612368|NCT03323749|12020595|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88
7612369|NCT03323749|12020594|FG000|Open-Label Period|Adverse Event|3
7612370|NCT03323749|12020595|FG001|Open-Label Period|Adverse Event|10
7612371|NCT03323749|12020594|FG000|Open-Label Period|Withdrawal by Subject|7
7612372|NCT03323749|12020595|FG001|Open-Label Period|Withdrawal by Subject|5
7612373|NCT03322566|12020608|FG000|Overall Study|Death|34
7612374|NCT03322566|12020609|FG001|Overall Study|Death|35
7612375|NCT03322566|12020610|FG002|Overall Study|Death|23
7612376|NCT03322566|12020608|FG000|Overall Study|Physician Decision|6
7612377|NCT03322566|12020609|FG001|Overall Study|Physician Decision|7
7612378|NCT03322566|12020610|FG002|Overall Study|Physician Decision|2
7612379|NCT03322566|12020608|FG000|Overall Study|Withdrawal by Subject|4
7612380|NCT03322566|12020609|FG001|Overall Study|Withdrawal by Subject|3
7778885|NCT00942188|12226817|FG003|Overall Study|Sponsor Decision|1
7778886|NCT00942266|12226829|FG000|Overall Study|Withdrawal by Subject|1
7778887|NCT00942266|12226830|FG001|Overall Study|Withdrawal by Subject|0
7778888|NCT00942266|12226829|FG000|Overall Study|Adverse Event|2
7778889|NCT00942266|12226830|FG001|Overall Study|Adverse Event|1
7778890|NCT00942266|12226829|FG000|Overall Study|Disease Progression|38
7778891|NCT00942266|12226830|FG001|Overall Study|Disease Progression|11
7778892|NCT00942266|12226829|FG000|Overall Study|Failure to thrive and pt withdrawal|0
7778893|NCT00942266|12226830|FG001|Overall Study|Failure to thrive and pt withdrawal|1
7778894|NCT00942266|12226829|FG000|Overall Study|Intercurrent illness|0
7778895|NCT00942266|12226830|FG001|Overall Study|Intercurrent illness|1
7778896|NCT00942266|12226829|FG000|Overall Study|Physician Decision|2
7778897|NCT00942266|12226830|FG001|Overall Study|Physician Decision|0
7778898|NCT00942266|12226829|FG000|Overall Study|medical deterioration (pneumonia)|0
7778899|NCT00942266|12226830|FG001|Overall Study|medical deterioration (pneumonia)|1
7778900|NCT00942357|12226879|FG000|Overall Study|Ineligible|37
7778901|NCT00942357|12226880|FG001|Overall Study|Ineligible|40
7778902|NCT00942422|12226886|FG000|Overall Study|Withdrawal by Subject|1
7778903|NCT00942422|12226886|FG000|Overall Study|Death|1
7778904|NCT00942422|12226886|FG000|Overall Study|Progressive diease|1
7778905|NCT00942604|12226931|FG000|Overall Study|Protocol Violation|1
7778906|NCT00942604|12226932|FG001|Overall Study|Protocol Violation|1
7778907|NCT00942604|12226931|FG000|Overall Study|Adverse Event|0
7778908|NCT00942604|12226932|FG001|Overall Study|Adverse Event|1
7778909|NCT00942604|12226931|FG000|Overall Study|Withdrawal by Subject|0
7778910|NCT00942604|12226932|FG001|Overall Study|Withdrawal by Subject|1
7778911|NCT00942604|12226931|FG000|Overall Study|Patient relocation|1
7778912|NCT00942604|12226932|FG001|Overall Study|Patient relocation|1
7778913|NCT00942708|12226938|FG000|Overall Study|Withdrawal by Subject|1
7778914|NCT00942734|12226943|FG000|Overall Study|Adverse Event|2
7778915|NCT00942734|12226943|FG000|Overall Study|Protocol Violation|3
7778916|NCT00942734|12226943|FG000|Overall Study|Disease Progression|2
7778917|NCT00942734|12226943|FG000|Overall Study|Physician Decision|1
7778918|NCT00942968|12226990|FG000|Overall Study|Adverse Event|60
7778919|NCT00942968|12226990|FG000|Overall Study|Death|76
7778920|NCT00942968|12226990|FG000|Overall Study|Protocol Violation|9
7778921|NCT00942968|12226990|FG000|Overall Study|Lost to Follow-up|4
7778922|NCT00942968|12226990|FG000|Overall Study|Withdrawal by Subject|44
7778923|NCT00942968|12226990|FG000|Overall Study|Sponsor request|5
7778924|NCT00942968|12226990|FG000|Overall Study|Physician Decision|11
7778925|NCT00942968|12226990|FG000|Overall Study|Progression of disease|12
7778926|NCT00942968|12226990|FG000|Overall Study|Inferior vena cava filter placement|4
7778927|NCT00942968|12226990|FG000|Overall Study|Pulmonary embolism (PE)|1
7778928|NCT00942968|12226990|FG000|Overall Study|Participant required pancreatic biopsy|1
7612381|NCT03322566|12020610|FG002|Overall Study|Withdrawal by Subject|6
7612382|NCT03322566|12020608|FG000|Overall Study|Lost to Follow-up|0
7612383|NCT03322566|12020609|FG001|Overall Study|Lost to Follow-up|0
7612384|NCT03322566|12020610|FG002|Overall Study|Lost to Follow-up|1
7612385|NCT03322566|12020608|FG000|Overall Study|Study terminated by sponsor|1
7612386|NCT03322566|12020609|FG001|Overall Study|Study terminated by sponsor|0
7612387|NCT03322566|12020610|FG002|Overall Study|Study terminated by sponsor|1
7612388|NCT03322540|12020620|FG000|Overall Study|Death|21
7612389|NCT03322540|12020621|FG001|Overall Study|Death|28
7612390|NCT03322540|12020620|FG000|Overall Study|Lost to Follow-up|0
7612391|NCT03322540|12020621|FG001|Overall Study|Lost to Follow-up|1
7612392|NCT03322540|12020620|FG000|Overall Study|Physician Decision|7
7612393|NCT03322540|12020621|FG001|Overall Study|Physician Decision|6
7612394|NCT03322540|12020620|FG000|Overall Study|Withdrawal by Subject|3
7612395|NCT03322540|12020621|FG001|Overall Study|Withdrawal by Subject|1
7778929|NCT00942968|12226990|FG000|Overall Study|Deep vein thrombosis (DVT)|2
7778930|NCT00942994|12226996|FG000|Overall Study|Adverse Event|7
7778931|NCT00942994|12226997|FG001|Overall Study|Adverse Event|4
7778932|NCT00942994|12226996|FG000|Overall Study|Abnormal laboratory value(s)|1
7778933|NCT00942994|12226997|FG001|Overall Study|Abnormal laboratory value(s)|0
7778934|NCT00942994|12226996|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7778935|NCT00942994|12226997|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7778936|NCT00942994|12226996|FG000|Overall Study|Patient withdrew consent|5
7778937|NCT00942994|12226997|FG001|Overall Study|Patient withdrew consent|8
7778938|NCT00942994|12226996|FG000|Overall Study|Lost to Follow-up|1
7778939|NCT00942994|12226997|FG001|Overall Study|Lost to Follow-up|4
7778940|NCT00942994|12226996|FG000|Overall Study|Protocol deviation|1
7778941|NCT00942994|12226997|FG001|Overall Study|Protocol deviation|2
7778942|NCT00943072|12227005|FG000|Overall Study|Adverse Event|0
7778943|NCT00943072|12227006|FG001|Overall Study|Adverse Event|3
7778944|NCT00943072|12227005|FG000|Overall Study|Death|0
7778945|NCT00943072|12227006|FG001|Overall Study|Death|2
7778946|NCT00943072|12227005|FG000|Overall Study|Withdrawal by Subject|3
7778947|NCT00943072|12227006|FG001|Overall Study|Withdrawal by Subject|1
7778948|NCT00943072|12227005|FG000|Overall Study|Protocol Violation|0
7778949|NCT00943072|12227006|FG001|Overall Study|Protocol Violation|1
7778950|NCT00943072|12227005|FG000|Overall Study|Lost to Follow-up|1
7778951|NCT00943072|12227006|FG001|Overall Study|Lost to Follow-up|2
7778952|NCT00943072|12227005|FG000|Overall Study|Lack of Efficacy|0
7778953|NCT00943072|12227006|FG001|Overall Study|Lack of Efficacy|4
7778954|NCT00943072|12227005|FG000|Overall Study|Other|1
7778955|NCT00943072|12227006|FG001|Overall Study|Other|1
7778956|NCT00943111|12227025|FG000|52-Weeks Primary Analysis Period|Adverse Event|2
7778957|NCT00943111|12227026|FG001|52-Weeks Primary Analysis Period|Adverse Event|1
7778958|NCT00943111|12227027|FG002|52-Weeks Primary Analysis Period|Adverse Event|0
7778959|NCT00943111|12227025|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
7778960|NCT00943111|12227026|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
7778961|NCT00943111|12227027|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
7778962|NCT00943111|12227025|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
7778963|NCT00943111|12227026|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
7778964|NCT00943111|12227027|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
7778965|NCT00943111|12227025|FG000|5 Years Long-term Treatment Period|Adverse Event|0
7778966|NCT00943111|12227026|FG001|5 Years Long-term Treatment Period|Adverse Event|0
7778967|NCT00943111|12227027|FG002|5 Years Long-term Treatment Period|Adverse Event|9
7778968|NCT00943111|12227025|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0
7778969|NCT00943111|12227026|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0
7612396|NCT03322540|12020620|FG000|Overall Study|Study terminated by sponsor|0
7612397|NCT03322540|12020621|FG001|Overall Study|Study terminated by sponsor|1
7612398|NCT03189719|12020640|FG000|Overall Study|Death|260
7612399|NCT03189719|12020641|FG001|Overall Study|Death|308
7612400|NCT03189719|12020640|FG000|Overall Study|Withdrawal by Subject|5
7612401|NCT03189719|12020641|FG001|Overall Study|Withdrawal by Subject|3
7612402|NCT03189719|12020640|FG000|Overall Study|Ongoing in Study|108
7778970|NCT00943111|12227027|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8
7778971|NCT00943111|12227025|FG000|5 Years Long-term Treatment Period|Pregnancy|0
7778972|NCT00943111|12227026|FG001|5 Years Long-term Treatment Period|Pregnancy|0
7778973|NCT00943111|12227027|FG002|5 Years Long-term Treatment Period|Pregnancy|4
7778974|NCT00943111|12227025|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0
7778975|NCT00943111|12227026|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0
7778976|NCT00943111|12227027|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1
7778977|NCT00943111|12227025|FG000|5 Years Long-term Treatment Period|Other than specified above|0
7778978|NCT00943111|12227026|FG001|5 Years Long-term Treatment Period|Other than specified above|0
7778979|NCT00943111|12227027|FG002|5 Years Long-term Treatment Period|Other than specified above|2
7778980|NCT00943124|12227034|FG000|Period 1|Withdrawal by Subject|1
7778981|NCT00943124|12227035|FG001|Period 1|Withdrawal by Subject|1
7778982|NCT00943124|12227034|FG000|Period 1|Did Not Follow Study Procedures|1
7778983|NCT00943124|12227035|FG001|Period 1|Did Not Follow Study Procedures|0
7778984|NCT00943124|12227034|FG000|Period 1|Personal Reasons|0
7778985|NCT00943124|12227035|FG001|Period 1|Personal Reasons|1
7778986|NCT00943306|12227072|FG000|Overall Study|Physician Decision|1
7778987|NCT00943306|12227072|FG000|Overall Study|Death|1
7778988|NCT00943306|12227072|FG000|Overall Study|Sponsor decision due to non-compliance|1
7778989|NCT00943319|12227076|FG000|Overall Study|Death|1
7778990|NCT00943384|12227080|FG000|Overall Study|Dispositioned prior to treatment|23
7778991|NCT00943384|12227080|FG000|Overall Study|Treated off protocol-protocol violation|5
7778992|NCT00943384|12227080|FG000|Overall Study|Lost to Follow-up|16
7778993|NCT00943384|12227080|FG000|Overall Study|Withdrawal by Subject|5
7778994|NCT00943579|12227104|FG000|Overall Study|Adverse Event|4
7778995|NCT00943579|12227105|FG001|Overall Study|Adverse Event|3
7778996|NCT00943579|12227104|FG000|Overall Study|Lack of Efficacy|2
7778997|NCT00943579|12227105|FG001|Overall Study|Lack of Efficacy|2
7778998|NCT00943592|12227114|FG000|Overall Study|Death|3
7778999|NCT00943670|12227127|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2
7779000|NCT00943670|12227127|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
7779001|NCT00943670|12227127|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15
7779002|NCT00943670|12227127|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2
7779003|NCT00943670|12227127|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20
7779004|NCT00943670|12227127|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
7779005|NCT00943670|12227127|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
7612403|NCT03189719|12020641|FG001|Overall Study|Ongoing in Study|65
7612404|NCT03155997|12020649|FG000|Overall Study|Withdrawal by Subject|119
7612405|NCT03155997|12020650|FG001|Overall Study|Withdrawal by Subject|134
7612406|NCT03155997|12020649|FG000|Overall Study|Lost to Follow-up|12
7612407|NCT03155997|12020650|FG001|Overall Study|Lost to Follow-up|13
7612408|NCT03155997|12020649|FG000|Overall Study|Missing disposition data|0
7612409|NCT03155997|12020650|FG001|Overall Study|Missing disposition data|1
7612410|NCT03155997|12020649|FG000|Overall Study|On study treatment|2027
7612411|NCT03155997|12020650|FG001|Overall Study|On study treatment|2074
7612412|NCT03104400|12020660|FG000|Overall Study|Adverse Event|5
7612413|NCT03104400|12020661|FG001|Overall Study|Adverse Event|7
7612414|NCT03104400|12020662|FG002|Overall Study|Adverse Event|11
7612415|NCT03104400|12020663|FG003|Overall Study|Adverse Event|9
7612416|NCT03104400|12020664|FG004|Overall Study|Adverse Event|21
7612417|NCT03104400|12020660|FG000|Overall Study|Withdrawal by Subject|17
7612418|NCT03104400|12020661|FG001|Overall Study|Withdrawal by Subject|19
7612419|NCT03104400|12020662|FG002|Overall Study|Withdrawal by Subject|29
7612420|NCT03104400|12020663|FG003|Overall Study|Withdrawal by Subject|25
7612421|NCT03104400|12020664|FG004|Overall Study|Withdrawal by Subject|24
7612422|NCT03104400|12020660|FG000|Overall Study|Lost to Follow-up|4
7612423|NCT03104400|12020661|FG001|Overall Study|Lost to Follow-up|1
7612424|NCT03104400|12020662|FG002|Overall Study|Lost to Follow-up|4
7612425|NCT03104400|12020663|FG003|Overall Study|Lost to Follow-up|8
7612426|NCT03104400|12020664|FG004|Overall Study|Lost to Follow-up|7
7612427|NCT03104400|12020660|FG000|Overall Study|Lack of Efficacy|6
7612428|NCT03104400|12020661|FG001|Overall Study|Lack of Efficacy|3
7612429|NCT03104400|12020662|FG002|Overall Study|Lack of Efficacy|8
7612430|NCT03104400|12020663|FG003|Overall Study|Lack of Efficacy|2
7612431|NCT03104400|12020664|FG004|Overall Study|Lack of Efficacy|1
7612432|NCT03104400|12020660|FG000|Overall Study|COVID Logistical Restrictions|0
7612433|NCT03104400|12020661|FG001|Overall Study|COVID Logistical Restrictions|0
7612434|NCT03104400|12020662|FG002|Overall Study|COVID Logistical Restrictions|0
7612435|NCT03104400|12020663|FG003|Overall Study|COVID Logistical Restrictions|1
7612436|NCT03104400|12020664|FG004|Overall Study|COVID Logistical Restrictions|0
7612437|NCT03104400|12020660|FG000|Overall Study|Other|2
7612438|NCT03104400|12020661|FG001|Overall Study|Other|3
7612439|NCT03104400|12020662|FG002|Overall Study|Other|7
7612440|NCT03104400|12020663|FG003|Overall Study|Other|6
7612441|NCT03104400|12020664|FG004|Overall Study|Other|4
7612442|NCT03104400|12020660|FG000|Overall Study|Other|0
7612443|NCT03104400|12020661|FG001|Overall Study|Other|1
7612444|NCT03104400|12020662|FG002|Overall Study|Other|0
7779006|NCT00943670|12227127|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
7779007|NCT00943670|12227127|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
7779008|NCT00943670|12227127|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
7779009|NCT00943735|12227142|FG000|Overall Study|Adverse Event|12
7779010|NCT00943735|12227142|FG000|Overall Study|Withdrawal by Subject|8
7612445|NCT03104400|12020663|FG003|Overall Study|Other|0
7612446|NCT03104400|12020664|FG004|Overall Study|Other|0
7612447|NCT03104374|12020681|FG000|Overall Study|Adverse Event|7
7612448|NCT03104374|12020682|FG001|Overall Study|Adverse Event|6
7612449|NCT03104374|12020683|FG002|Overall Study|Adverse Event|12
7612450|NCT03104374|12020684|FG003|Overall Study|Adverse Event|15
7612451|NCT03104374|12020681|FG000|Overall Study|Withdrawal by Subject|18
7612452|NCT03104374|12020682|FG001|Overall Study|Withdrawal by Subject|10
7612453|NCT03104374|12020683|FG002|Overall Study|Withdrawal by Subject|10
7612454|NCT03104374|12020684|FG003|Overall Study|Withdrawal by Subject|17
7612455|NCT03104374|12020681|FG000|Overall Study|Lost to Follow-up|4
7612456|NCT03104374|12020682|FG001|Overall Study|Lost to Follow-up|4
7612457|NCT03104374|12020683|FG002|Overall Study|Lost to Follow-up|6
7612458|NCT03104374|12020684|FG003|Overall Study|Lost to Follow-up|8
7612459|NCT03104374|12020681|FG000|Overall Study|Lack of Efficacy|6
7612460|NCT03104374|12020682|FG001|Overall Study|Lack of Efficacy|7
7612461|NCT03104374|12020683|FG002|Overall Study|Lack of Efficacy|12
7612462|NCT03104374|12020684|FG003|Overall Study|Lack of Efficacy|6
7612463|NCT03104374|12020681|FG000|Overall Study|Other|2
7612464|NCT03104374|12020682|FG001|Overall Study|Other|2
7612465|NCT03104374|12020683|FG002|Overall Study|Other|4
7612466|NCT03104374|12020684|FG003|Overall Study|Other|7
7612467|NCT03072043|12020697|FG000|Overall Study|Death|0
7612468|NCT03072043|12020698|FG001|Overall Study|Death|0
7612469|NCT03072043|12020699|FG002|Overall Study|Death|3
7612470|NCT03072043|12020697|FG000|Overall Study|Adverse Event|0
7612471|NCT03072043|12020698|FG001|Overall Study|Adverse Event|0
7612472|NCT03072043|12020699|FG002|Overall Study|Adverse Event|2
7612473|NCT03072043|12020697|FG000|Overall Study|Withdrawal by Subject|0
7612474|NCT03072043|12020698|FG001|Overall Study|Withdrawal by Subject|0
7612475|NCT03072043|12020699|FG002|Overall Study|Withdrawal by Subject|4
7612476|NCT02905032|12020727|FG000|Overall Study|Withdrawal by Subject|2
7612477|NCT02905032|12020728|FG001|Overall Study|Withdrawal by Subject|0
7612478|NCT02905032|12020729|FG002|Overall Study|Withdrawal by Subject|0
7612479|NCT02905032|12020727|FG000|Overall Study|Protocol Violation|6
7612480|NCT02905032|12020728|FG001|Overall Study|Protocol Violation|12
7612481|NCT02905032|12020729|FG002|Overall Study|Protocol Violation|0
7612482|NCT02837029|12020739|FG000|Screening|Failed to meet screening requirements.|7
7612483|NCT02837029|12020740|FG001|Screening|Failed to meet screening requirements.|3
7612484|NCT02837029|12020741|FG002|Screening|Failed to meet screening requirements.|0
7612485|NCT02837029|12020739|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2
7612486|NCT02837029|12020740|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
7612487|NCT02837029|12020741|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
7612488|NCT02837029|12020739|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
7612489|NCT02837029|12020740|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2
7612490|NCT02837029|12020741|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
7612491|NCT02837029|12020739|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
7612492|NCT02837029|12020740|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1
7612493|NCT02837029|12020741|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
7612494|NCT02837029|12020739|FG000|Cycle 2 and Beyond|Adverse Event|1
7612495|NCT02837029|12020740|FG001|Cycle 2 and Beyond|Adverse Event|0
7612496|NCT02837029|12020741|FG002|Cycle 2 and Beyond|Adverse Event|0
7612497|NCT02837029|12020739|FG000|2 Year Follow-up|Death|6
7612498|NCT02837029|12020740|FG001|2 Year Follow-up|Death|7
7612499|NCT02837029|12020741|FG002|2 Year Follow-up|Death|0
7612500|NCT02737475|12020796|FG000|Overall Study|Other reasons|0
7612501|NCT02737475|12020797|FG001|Overall Study|Other reasons|0
7612502|NCT02737475|12020798|FG002|Overall Study|Other reasons|0
7612503|NCT02737475|12020799|FG003|Overall Study|Other reasons|0
7612504|NCT02737475|12020800|FG004|Overall Study|Other reasons|1
7612505|NCT02737475|12020801|FG005|Overall Study|Other reasons|1
7612506|NCT02737475|12020802|FG006|Overall Study|Other reasons|0
7612507|NCT02737475|12020803|FG007|Overall Study|Other reasons|0
7612508|NCT02737475|12020804|FG008|Overall Study|Other reasons|1
7612509|NCT02737475|12020805|FG009|Overall Study|Other reasons|0
7612510|NCT02737475|12020806|FG010|Overall Study|Other reasons|1
7612511|NCT02737475|12020807|FG011|Overall Study|Other reasons|0
7612512|NCT02737475|12020808|FG012|Overall Study|Other reasons|0
7612513|NCT02737475|12020809|FG013|Overall Study|Other reasons|0
7612514|NCT02737475|12020810|FG014|Overall Study|Other reasons|0
7612515|NCT02737475|12020811|FG015|Overall Study|Other reasons|0
7612516|NCT02737475|12020812|FG016|Overall Study|Other reasons|0
7612517|NCT02737475|12020813|FG017|Overall Study|Other reasons|0
7612518|NCT02737475|12020814|FG018|Overall Study|Other reasons|0
7612519|NCT02737475|12020815|FG019|Overall Study|Other reasons|0
7612520|NCT02737475|12020816|FG020|Overall Study|Other reasons|0
7612521|NCT02737475|12020817|FG021|Overall Study|Other reasons|1
7612522|NCT02737475|12020818|FG022|Overall Study|Other reasons|0
7612523|NCT02737475|12020819|FG023|Overall Study|Other reasons|1
7612524|NCT02737475|12020820|FG024|Overall Study|Other reasons|1
7612525|NCT02737475|12020821|FG025|Overall Study|Other reasons|1
7612526|NCT02737475|12020822|FG026|Overall Study|Other reasons|0
7612527|NCT02737475|12020796|FG000|Overall Study|Death|1
7612528|NCT02737475|12020797|FG001|Overall Study|Death|0
7612529|NCT02737475|12020798|FG002|Overall Study|Death|0
7612530|NCT02737475|12020799|FG003|Overall Study|Death|1
7612531|NCT02737475|12020800|FG004|Overall Study|Death|0
7612532|NCT02737475|12020801|FG005|Overall Study|Death|0
7612533|NCT02737475|12020802|FG006|Overall Study|Death|0
7612534|NCT02737475|12020803|FG007|Overall Study|Death|2
7612535|NCT02737475|12020804|FG008|Overall Study|Death|0
7612536|NCT02737475|12020805|FG009|Overall Study|Death|0
7612537|NCT02737475|12020806|FG010|Overall Study|Death|0
7612538|NCT02737475|12020807|FG011|Overall Study|Death|4
7612539|NCT02737475|12020808|FG012|Overall Study|Death|2
7612540|NCT02737475|12020809|FG013|Overall Study|Death|2
7612541|NCT02737475|12020810|FG014|Overall Study|Death|0
7612542|NCT02737475|12020811|FG015|Overall Study|Death|2
7612543|NCT02737475|12020812|FG016|Overall Study|Death|2
7612544|NCT02737475|12020813|FG017|Overall Study|Death|2
7612545|NCT02737475|12020814|FG018|Overall Study|Death|1
7612546|NCT02737475|12020815|FG019|Overall Study|Death|0
7612547|NCT02737475|12020816|FG020|Overall Study|Death|0
7612548|NCT02737475|12020817|FG021|Overall Study|Death|0
7612549|NCT02737475|12020818|FG022|Overall Study|Death|0
7612550|NCT02737475|12020819|FG023|Overall Study|Death|0
7612551|NCT02737475|12020820|FG024|Overall Study|Death|0
7612552|NCT02737475|12020821|FG025|Overall Study|Death|0
7612553|NCT02737475|12020822|FG026|Overall Study|Death|0
7612554|NCT02737475|12020796|FG000|Overall Study|Participant withdrew consent|0
7612555|NCT02737475|12020797|FG001|Overall Study|Participant withdrew consent|0
7612556|NCT02737475|12020798|FG002|Overall Study|Participant withdrew consent|0
7612557|NCT02737475|12020799|FG003|Overall Study|Participant withdrew consent|0
7612558|NCT02737475|12020800|FG004|Overall Study|Participant withdrew consent|0
7612559|NCT02737475|12020801|FG005|Overall Study|Participant withdrew consent|2
7612560|NCT02737475|12020802|FG006|Overall Study|Participant withdrew consent|0
7612561|NCT02737475|12020803|FG007|Overall Study|Participant withdrew consent|0
7612562|NCT02737475|12020804|FG008|Overall Study|Participant withdrew consent|0
7612563|NCT02737475|12020805|FG009|Overall Study|Participant withdrew consent|0
7612564|NCT02737475|12020806|FG010|Overall Study|Participant withdrew consent|0
7612565|NCT02737475|12020807|FG011|Overall Study|Participant withdrew consent|0
7612566|NCT02737475|12020808|FG012|Overall Study|Participant withdrew consent|0
7612567|NCT02737475|12020809|FG013|Overall Study|Participant withdrew consent|0
7612568|NCT02737475|12020810|FG014|Overall Study|Participant withdrew consent|1
7612569|NCT02737475|12020811|FG015|Overall Study|Participant withdrew consent|0
7612570|NCT02737475|12020812|FG016|Overall Study|Participant withdrew consent|0
7612571|NCT02737475|12020813|FG017|Overall Study|Participant withdrew consent|2
7612572|NCT02737475|12020814|FG018|Overall Study|Participant withdrew consent|1
7612573|NCT02737475|12020815|FG019|Overall Study|Participant withdrew consent|0
7612574|NCT02737475|12020816|FG020|Overall Study|Participant withdrew consent|2
7612575|NCT02737475|12020817|FG021|Overall Study|Participant withdrew consent|0
7612576|NCT02737475|12020818|FG022|Overall Study|Participant withdrew consent|0
7612577|NCT02737475|12020819|FG023|Overall Study|Participant withdrew consent|0
7612578|NCT02737475|12020820|FG024|Overall Study|Participant withdrew consent|0
7612579|NCT02737475|12020821|FG025|Overall Study|Participant withdrew consent|0
7612580|NCT02737475|12020822|FG026|Overall Study|Participant withdrew consent|0
7612581|NCT02737475|12020796|FG000|Overall Study|Lost to Follow-up|0
7612582|NCT02737475|12020797|FG001|Overall Study|Lost to Follow-up|0
7612583|NCT02737475|12020798|FG002|Overall Study|Lost to Follow-up|0
7612584|NCT02737475|12020799|FG003|Overall Study|Lost to Follow-up|0
7612585|NCT02737475|12020800|FG004|Overall Study|Lost to Follow-up|0
7612586|NCT02737475|12020801|FG005|Overall Study|Lost to Follow-up|0
7612587|NCT02737475|12020802|FG006|Overall Study|Lost to Follow-up|0
7612588|NCT02737475|12020803|FG007|Overall Study|Lost to Follow-up|0
7612589|NCT02737475|12020804|FG008|Overall Study|Lost to Follow-up|0
7612590|NCT02737475|12020805|FG009|Overall Study|Lost to Follow-up|0
7612591|NCT02737475|12020806|FG010|Overall Study|Lost to Follow-up|0
7612592|NCT02737475|12020807|FG011|Overall Study|Lost to Follow-up|0
7612593|NCT02737475|12020808|FG012|Overall Study|Lost to Follow-up|0
7612594|NCT02737475|12020809|FG013|Overall Study|Lost to Follow-up|0
7612595|NCT02737475|12020810|FG014|Overall Study|Lost to Follow-up|0
7612596|NCT02737475|12020811|FG015|Overall Study|Lost to Follow-up|1
7612597|NCT02737475|12020812|FG016|Overall Study|Lost to Follow-up|0
7612598|NCT02737475|12020813|FG017|Overall Study|Lost to Follow-up|0
7612599|NCT02737475|12020814|FG018|Overall Study|Lost to Follow-up|0
7612600|NCT02737475|12020815|FG019|Overall Study|Lost to Follow-up|0
7612601|NCT02737475|12020816|FG020|Overall Study|Lost to Follow-up|0
7612602|NCT02737475|12020817|FG021|Overall Study|Lost to Follow-up|0
7612603|NCT02737475|12020818|FG022|Overall Study|Lost to Follow-up|0
7612604|NCT02737475|12020819|FG023|Overall Study|Lost to Follow-up|0
7612605|NCT02737475|12020820|FG024|Overall Study|Lost to Follow-up|0
7612606|NCT02737475|12020821|FG025|Overall Study|Lost to Follow-up|0
7612607|NCT02737475|12020822|FG026|Overall Study|Lost to Follow-up|0
7612608|NCT02737475|12020796|FG000|Overall Study|Disease Progression|0
7612609|NCT02737475|12020797|FG001|Overall Study|Disease Progression|0
7612610|NCT02737475|12020798|FG002|Overall Study|Disease Progression|0
7612611|NCT02737475|12020799|FG003|Overall Study|Disease Progression|0
7612612|NCT02737475|12020800|FG004|Overall Study|Disease Progression|0
7612613|NCT02737475|12020801|FG005|Overall Study|Disease Progression|0
7612614|NCT02737475|12020802|FG006|Overall Study|Disease Progression|0
7612615|NCT02737475|12020803|FG007|Overall Study|Disease Progression|0
7612616|NCT02737475|12020804|FG008|Overall Study|Disease Progression|0
7612617|NCT02737475|12020805|FG009|Overall Study|Disease Progression|0
7612618|NCT02737475|12020806|FG010|Overall Study|Disease Progression|0
7612619|NCT02737475|12020807|FG011|Overall Study|Disease Progression|0
7612620|NCT02737475|12020808|FG012|Overall Study|Disease Progression|0
7612621|NCT02737475|12020809|FG013|Overall Study|Disease Progression|0
7612622|NCT02737475|12020810|FG014|Overall Study|Disease Progression|0
7612623|NCT02737475|12020811|FG015|Overall Study|Disease Progression|0
7612624|NCT02737475|12020812|FG016|Overall Study|Disease Progression|0
7612625|NCT02737475|12020813|FG017|Overall Study|Disease Progression|0
7612626|NCT02737475|12020814|FG018|Overall Study|Disease Progression|0
7612627|NCT02737475|12020815|FG019|Overall Study|Disease Progression|0
7612628|NCT02737475|12020816|FG020|Overall Study|Disease Progression|0
7612629|NCT02737475|12020817|FG021|Overall Study|Disease Progression|0
7612630|NCT02737475|12020818|FG022|Overall Study|Disease Progression|0
7779011|NCT00943735|12227142|FG000|Overall Study|Death|1
7779012|NCT00943735|12227142|FG000|Overall Study|Other|8
7779013|NCT00943735|12227142|FG000|Overall Study|Other|3
7779014|NCT00943761|12227148|FG000|Overall Study|Lost to Follow-up|2
7612631|NCT02737475|12020819|FG023|Overall Study|Disease Progression|0
7612632|NCT02737475|12020820|FG024|Overall Study|Disease Progression|0
7612633|NCT02737475|12020821|FG025|Overall Study|Disease Progression|0
7612634|NCT02737475|12020822|FG026|Overall Study|Disease Progression|1
7612635|NCT02642965|12020914|FG000|Overall Study|Lack of Efficacy|4
7612636|NCT02642965|12020914|FG000|Overall Study|Physician Decision|9
7612637|NCT02604433|12020920|FG000|Overall Study|Withdrawal by Subject|37
7612638|NCT02604433|12020921|FG001|Overall Study|Withdrawal by Subject|16
7612639|NCT02604433|12020920|FG000|Overall Study|Adverse Event|4
7612640|NCT02604433|12020921|FG001|Overall Study|Adverse Event|0
7612641|NCT02604433|12020920|FG000|Overall Study|Other reasons|3
7612642|NCT02604433|12020921|FG001|Overall Study|Other reasons|5
7612643|NCT02604433|12020920|FG000|Overall Study|Death|4
7612644|NCT02604433|12020921|FG001|Overall Study|Death|1
7612645|NCT02604433|12020920|FG000|Overall Study|Transition to Rollover Protocol|169
7612646|NCT02604433|12020921|FG001|Overall Study|Transition to Rollover Protocol|82
7612647|NCT02604433|12020920|FG000|Overall Study|Physician Decision|1
7612648|NCT02604433|12020921|FG001|Overall Study|Physician Decision|1
7612649|NCT02604433|12020920|FG000|Overall Study|Lack of Efficacy|0
7612650|NCT02604433|12020921|FG001|Overall Study|Lack of Efficacy|1
7612651|NCT02420821|12020946|FG000|Overall Study|Lost to Follow-up|2
7612652|NCT02420821|12020947|FG001|Overall Study|Lost to Follow-up|0
7612653|NCT02420821|12020946|FG000|Overall Study|Non-compliance|1
7612654|NCT02420821|12020947|FG001|Overall Study|Non-compliance|2
7612655|NCT02420821|12020946|FG000|Overall Study|Physician Decision|5
7612656|NCT02420821|12020947|FG001|Overall Study|Physician Decision|2
7612657|NCT02420821|12020946|FG000|Overall Study|Withdrawal by Subject|31
7612658|NCT02420821|12020947|FG001|Overall Study|Withdrawal by Subject|17
7612659|NCT02420821|12020946|FG000|Overall Study|Death|129
7612660|NCT02420821|12020947|FG001|Overall Study|Death|116
7779015|NCT00943761|12227149|FG001|Overall Study|Lost to Follow-up|0
7779016|NCT00943761|12227148|FG000|Overall Study|Withdrawal by Subject|2
7779017|NCT00943761|12227149|FG001|Overall Study|Withdrawal by Subject|1
7779018|NCT00943787|12227155|FG000|Overall Study|Physician Decision|4
7779019|NCT00943787|12227155|FG000|Overall Study|Withdrawal by Subject|3
7779020|NCT00943826|12227165|FG000|Concurrent Phase|Adverse Event|50
7779021|NCT00943826|12227166|FG001|Concurrent Phase|Adverse Event|27
7779022|NCT00943826|12227165|FG000|Concurrent Phase|Withdrew consent|3
7612669|NCT02410343|12020965|FG000|Core Period (24 Weeks)|Adverse Event|1
7612670|NCT02410343|12020966|FG001|Core Period (24 Weeks)|Adverse Event|0
7612671|NCT02410343|12020965|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4
7612672|NCT02410343|12020966|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7
7612673|NCT02410343|12020965|FG000|Extension Period (12 Months)|Adverse Event|1
7612674|NCT02410343|12020966|FG001|Extension Period (12 Months)|Adverse Event|0
7612675|NCT02410343|12020965|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0
7612676|NCT02410343|12020966|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1
7779023|NCT00943826|12227166|FG001|Concurrent Phase|Withdrew consent|7
7779024|NCT00943826|12227165|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5
7779025|NCT00943826|12227166|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7
7779026|NCT00943826|12227165|FG000|Concurrent Phase|Administrative reasons|2
7779027|NCT00943826|12227166|FG001|Concurrent Phase|Administrative reasons|1
7779028|NCT00943826|12227165|FG000|Concurrent Phase|Protocol Violation|1
7779029|NCT00943826|12227166|FG001|Concurrent Phase|Protocol Violation|0
7779030|NCT00943826|12227165|FG000|Maintenance Phase|Adverse Event|31
7779031|NCT00943826|12227166|FG001|Maintenance Phase|Adverse Event|30
7779032|NCT00943826|12227165|FG000|Maintenance Phase|Withdrew consent|2
7779033|NCT00943826|12227166|FG001|Maintenance Phase|Withdrew consent|4
7612677|NCT02339740|12020979|FG000|Overall Study|Death|1
7612678|NCT02339740|12020980|FG001|Overall Study|Death|0
7612679|NCT02339740|12020979|FG000|Overall Study|Physician Decision|0
7612680|NCT02339740|12020980|FG001|Overall Study|Physician Decision|2
7612681|NCT02339740|12020979|FG000|Overall Study|Withdrawal by Subject|5
7612682|NCT02339740|12020980|FG001|Overall Study|Withdrawal by Subject|1
7612683|NCT02339740|12020979|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3
7779034|NCT00943826|12227165|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6
7779035|NCT00943826|12227166|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3
7612684|NCT02339740|12020980|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1
7612685|NCT02045303|12021003|FG000|Overall Study|Protocol Violation|2
7612686|NCT02045303|12021004|FG001|Overall Study|Protocol Violation|1
7612687|NCT02045303|12021005|FG002|Overall Study|Protocol Violation|0
7612688|NCT02045303|12021003|FG000|Overall Study|Withdrawal by Subject|0
7612689|NCT02045303|12021004|FG001|Overall Study|Withdrawal by Subject|2
7612690|NCT02045303|12021005|FG002|Overall Study|Withdrawal by Subject|0
7612691|NCT02025556|12021017|FG000|Overall Study|Adverse Event|0
7612692|NCT02025556|12021018|FG001|Overall Study|Adverse Event|4
7612693|NCT02025556|12021019|FG002|Overall Study|Adverse Event|2
7779036|NCT00943826|12227165|FG000|Maintenance Phase|Administrative reasons|4
7779037|NCT00943826|12227166|FG001|Maintenance Phase|Administrative reasons|1
7612694|NCT02025556|12021017|FG000|Overall Study|Lack of Efficacy|2
7612695|NCT02025556|12021018|FG001|Overall Study|Lack of Efficacy|1
7612696|NCT02025556|12021019|FG002|Overall Study|Lack of Efficacy|0
7612697|NCT02025556|12021017|FG000|Overall Study|Protocol Violation|2
7612698|NCT02025556|12021018|FG001|Overall Study|Protocol Violation|1
7612699|NCT02025556|12021019|FG002|Overall Study|Protocol Violation|0
7612700|NCT02025556|12021017|FG000|Overall Study|Withdrawal by Subject|0
7612701|NCT02025556|12021018|FG001|Overall Study|Withdrawal by Subject|3
7612702|NCT02025556|12021019|FG002|Overall Study|Withdrawal by Subject|6
7612703|NCT02025556|12021017|FG000|Overall Study|Lost to Follow-up|2
7612704|NCT02025556|12021018|FG001|Overall Study|Lost to Follow-up|4
7612705|NCT02025556|12021019|FG002|Overall Study|Lost to Follow-up|0
7612706|NCT02025556|12021017|FG000|Overall Study|Reason not reported|0
7612707|NCT02025556|12021018|FG001|Overall Study|Reason not reported|0
7612708|NCT02025556|12021019|FG002|Overall Study|Reason not reported|1
7612709|NCT01986933|12021032|FG000|Placebo-controlled (Part A)|Adverse Event|1
7612710|NCT01986933|12021033|FG001|Placebo-controlled (Part A)|Adverse Event|5
7612711|NCT01986933|12021034|FG002|Placebo-controlled (Part A)|Adverse Event|2
7612712|NCT01986933|12021035|FG003|Placebo-controlled (Part A)|Adverse Event|2
7612713|NCT01986933|12021036|FG004|Placebo-controlled (Part A)|Adverse Event|4
7612714|NCT01986933|12021032|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3
7612715|NCT01986933|12021033|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1
7612716|NCT01986933|12021034|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1
7612717|NCT01986933|12021035|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2
7612718|NCT01986933|12021036|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1
7612719|NCT01986933|12021032|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5
7612720|NCT01986933|12021033|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2
7612721|NCT01986933|12021034|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6
7612722|NCT01986933|12021035|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2
7612723|NCT01986933|12021036|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7
7612724|NCT01986933|12021032|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0
7612725|NCT01986933|12021033|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1
7612726|NCT01986933|12021034|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0
7612727|NCT01986933|12021035|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1
7612728|NCT01986933|12021036|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0
7612729|NCT01986933|12021032|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0
7612730|NCT01986933|12021033|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0
7612731|NCT01986933|12021034|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0
7612732|NCT01986933|12021035|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0
7612733|NCT01986933|12021036|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2
7612734|NCT01986933|12021032|FG000|Active-to-active (Part B)|Adverse Event|0
7612735|NCT01986933|12021033|FG001|Active-to-active (Part B)|Adverse Event|2
7612736|NCT01986933|12021034|FG002|Active-to-active (Part B)|Adverse Event|0
7612737|NCT01986933|12021035|FG003|Active-to-active (Part B)|Adverse Event|1
7612738|NCT01986933|12021036|FG004|Active-to-active (Part B)|Adverse Event|3
7612739|NCT01986933|12021032|FG000|Active-to-active (Part B)|Lack of Efficacy|0
7612740|NCT01986933|12021033|FG001|Active-to-active (Part B)|Lack of Efficacy|3
7779038|NCT00943826|12227165|FG000|Maintenance Phase|Failure to return|0
7779039|NCT00943826|12227166|FG001|Maintenance Phase|Failure to return|1
7779040|NCT00943826|12227165|FG000|Monotherapy Phase|Adverse Event|42
7779041|NCT00943826|12227166|FG001|Monotherapy Phase|Adverse Event|5
7779042|NCT00943826|12227165|FG000|Monotherapy Phase|Administrative reasons|11
7779043|NCT00943826|12227166|FG001|Monotherapy Phase|Administrative reasons|5
7779044|NCT00943826|12227165|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8
7779045|NCT00943826|12227166|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2
7779046|NCT00943826|12227165|FG000|Monotherapy Phase|Withdrew Consent|2
7779047|NCT00943826|12227166|FG001|Monotherapy Phase|Withdrew Consent|3
7779048|NCT00943826|12227165|FG000|Monotherapy Phase|Failure to return|2
7779049|NCT00943826|12227166|FG001|Monotherapy Phase|Failure to return|1
7779050|NCT00943826|12227165|FG000|After Primary Overall Survival Analysis|Adverse Event|11
7779051|NCT00943826|12227166|FG001|After Primary Overall Survival Analysis|Adverse Event|0
7779052|NCT00943826|12227165|FG000|After Primary Overall Survival Analysis|Administrative reasons|10
7779053|NCT00943826|12227166|FG001|After Primary Overall Survival Analysis|Administrative reasons|16
7779054|NCT00943826|12227165|FG000|After Primary Overall Survival Analysis|Progression of Disease|2
7779055|NCT00943826|12227166|FG001|After Primary Overall Survival Analysis|Progression of Disease|4
7779056|NCT00943826|12227165|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4
7779057|NCT00943826|12227166|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0
7779058|NCT00943917|12227209|FG000|Stage I|Adverse Event|1
7779059|NCT00943917|12227210|FG001|Stage I|Adverse Event|2
7779060|NCT00943917|12227211|FG002|Stage I|Adverse Event|2
7779061|NCT00943917|12227212|FG003|Stage I|Adverse Event|0
7779062|NCT00943917|12227213|FG004|Stage I|Adverse Event|0
7779063|NCT00943917|12227214|FG005|Stage I|Adverse Event|0
7779064|NCT00943917|12227215|FG006|Stage I|Adverse Event|0
7779065|NCT00943917|12227216|FG007|Stage I|Adverse Event|0
7779066|NCT00943917|12227217|FG008|Stage I|Adverse Event|0
7779067|NCT00943917|12227218|FG009|Stage I|Adverse Event|0
7779068|NCT00943917|12227219|FG010|Stage I|Adverse Event|0
7779069|NCT00943917|12227220|FG011|Stage I|Adverse Event|0
7779070|NCT00943917|12227221|FG012|Stage I|Adverse Event|0
7779071|NCT00943917|12227222|FG013|Stage I|Adverse Event|0
7612741|NCT01986933|12021034|FG002|Active-to-active (Part B)|Lack of Efficacy|2
7612742|NCT01986933|12021035|FG003|Active-to-active (Part B)|Lack of Efficacy|0
7779072|NCT00943917|12227223|FG014|Stage I|Adverse Event|0
7779073|NCT00943917|12227209|FG000|Stage I|Lost to Follow-up|0
7779074|NCT00943917|12227210|FG001|Stage I|Lost to Follow-up|0
7779075|NCT00943917|12227211|FG002|Stage I|Lost to Follow-up|1
7779076|NCT00943917|12227212|FG003|Stage I|Lost to Follow-up|0
7779077|NCT00943917|12227213|FG004|Stage I|Lost to Follow-up|0
7779078|NCT00943917|12227214|FG005|Stage I|Lost to Follow-up|0
7779079|NCT00943917|12227215|FG006|Stage I|Lost to Follow-up|0
7779080|NCT00943917|12227216|FG007|Stage I|Lost to Follow-up|0
7779081|NCT00943917|12227217|FG008|Stage I|Lost to Follow-up|0
7779082|NCT00943917|12227218|FG009|Stage I|Lost to Follow-up|0
7779083|NCT00943917|12227219|FG010|Stage I|Lost to Follow-up|0
7779084|NCT00943917|12227220|FG011|Stage I|Lost to Follow-up|0
7779085|NCT00943917|12227221|FG012|Stage I|Lost to Follow-up|0
7779086|NCT00943917|12227222|FG013|Stage I|Lost to Follow-up|0
7779087|NCT00943917|12227223|FG014|Stage I|Lost to Follow-up|0
7779088|NCT00943917|12227209|FG000|Stage I|hyperglycemia|0
7779089|NCT00943917|12227210|FG001|Stage I|hyperglycemia|0
7779090|NCT00943917|12227211|FG002|Stage I|hyperglycemia|1
7779091|NCT00943917|12227212|FG003|Stage I|hyperglycemia|0
7779092|NCT00943917|12227213|FG004|Stage I|hyperglycemia|0
7779093|NCT00943917|12227214|FG005|Stage I|hyperglycemia|0
7779094|NCT00943917|12227215|FG006|Stage I|hyperglycemia|0
7779095|NCT00943917|12227216|FG007|Stage I|hyperglycemia|0
7779096|NCT00943917|12227217|FG008|Stage I|hyperglycemia|0
7779097|NCT00943917|12227218|FG009|Stage I|hyperglycemia|0
7779098|NCT00943917|12227219|FG010|Stage I|hyperglycemia|0
7779099|NCT00943917|12227220|FG011|Stage I|hyperglycemia|0
7779100|NCT00943917|12227221|FG012|Stage I|hyperglycemia|0
7779101|NCT00943917|12227222|FG013|Stage I|hyperglycemia|0
7779102|NCT00943917|12227223|FG014|Stage I|hyperglycemia|0
7779103|NCT00943917|12227209|FG000|Stage I|A1C elevation|1
7779104|NCT00943917|12227210|FG001|Stage I|A1C elevation|0
7779105|NCT00943917|12227211|FG002|Stage I|A1C elevation|0
7779106|NCT00943917|12227212|FG003|Stage I|A1C elevation|0
7779107|NCT00943917|12227213|FG004|Stage I|A1C elevation|0
7612743|NCT01986933|12021036|FG004|Active-to-active (Part B)|Lack of Efficacy|4
7612744|NCT01986933|12021032|FG000|Active-to-active (Part B)|Pregnancy|0
7612745|NCT01986933|12021033|FG001|Active-to-active (Part B)|Pregnancy|0
7612746|NCT01986933|12021034|FG002|Active-to-active (Part B)|Pregnancy|0
7612747|NCT01986933|12021035|FG003|Active-to-active (Part B)|Pregnancy|0
7612748|NCT01986933|12021036|FG004|Active-to-active (Part B)|Pregnancy|1
7612749|NCT01986933|12021032|FG000|Active-to-active (Part B)|Physician Decision|0
7612750|NCT01986933|12021033|FG001|Active-to-active (Part B)|Physician Decision|0
7612751|NCT01986933|12021034|FG002|Active-to-active (Part B)|Physician Decision|1
7612752|NCT01986933|12021035|FG003|Active-to-active (Part B)|Physician Decision|1
7612753|NCT01986933|12021036|FG004|Active-to-active (Part B)|Physician Decision|0
7612754|NCT01986933|12021032|FG000|Active-to-active (Part B)|Withdrawal by Subject|0
7612755|NCT01986933|12021033|FG001|Active-to-active (Part B)|Withdrawal by Subject|4
7612756|NCT01986933|12021034|FG002|Active-to-active (Part B)|Withdrawal by Subject|7
7612757|NCT01986933|12021035|FG003|Active-to-active (Part B)|Withdrawal by Subject|6
7612758|NCT01986933|12021036|FG004|Active-to-active (Part B)|Withdrawal by Subject|6
7612759|NCT01986933|12021032|FG000|Active-to-active (Part B)|Lost to Follow-up|0
7612760|NCT01986933|12021033|FG001|Active-to-active (Part B)|Lost to Follow-up|0
7612761|NCT01986933|12021034|FG002|Active-to-active (Part B)|Lost to Follow-up|0
7612762|NCT01986933|12021035|FG003|Active-to-active (Part B)|Lost to Follow-up|0
7612763|NCT01986933|12021036|FG004|Active-to-active (Part B)|Lost to Follow-up|1
7779108|NCT00943917|12227214|FG005|Stage I|A1C elevation|0
7779109|NCT00943917|12227215|FG006|Stage I|A1C elevation|0
7779110|NCT00943917|12227216|FG007|Stage I|A1C elevation|0
7779111|NCT00943917|12227217|FG008|Stage I|A1C elevation|0
7779112|NCT00943917|12227218|FG009|Stage I|A1C elevation|0
7779113|NCT00943917|12227219|FG010|Stage I|A1C elevation|0
7779114|NCT00943917|12227220|FG011|Stage I|A1C elevation|0
7779115|NCT00943917|12227221|FG012|Stage I|A1C elevation|0
7779116|NCT00943917|12227222|FG013|Stage I|A1C elevation|0
7779117|NCT00943917|12227223|FG014|Stage I|A1C elevation|0
7779118|NCT00943917|12227209|FG000|Stage I|Withdrawal by Subject|2
7779119|NCT00943917|12227210|FG001|Stage I|Withdrawal by Subject|1
7779120|NCT00943917|12227211|FG002|Stage I|Withdrawal by Subject|2
7779121|NCT00943917|12227212|FG003|Stage I|Withdrawal by Subject|0
7779122|NCT00943917|12227213|FG004|Stage I|Withdrawal by Subject|0
7612764|NCT01986933|12021032|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0
7612765|NCT01986933|12021033|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1
7612766|NCT01986933|12021034|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0
7612767|NCT01986933|12021035|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1
7612768|NCT01986933|12021036|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1
7612769|NCT01986933|12021032|FG000|Placebo-to-active (Part B)|Adverse Event|0
7612770|NCT01986933|12021033|FG001|Placebo-to-active (Part B)|Adverse Event|1
7612771|NCT01986933|12021034|FG002|Placebo-to-active (Part B)|Adverse Event|0
7612772|NCT01986933|12021035|FG003|Placebo-to-active (Part B)|Adverse Event|1
7612773|NCT01986933|12021036|FG004|Placebo-to-active (Part B)|Adverse Event|0
7612774|NCT01986933|12021032|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0
7612775|NCT01986933|12021033|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0
7612776|NCT01986933|12021034|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0
7612777|NCT01986933|12021035|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1
7612778|NCT01986933|12021036|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0
7612779|NCT01986933|12021032|FG000|Placebo-to-active (Part B)|Protocol Violation|0
7779123|NCT00943917|12227214|FG005|Stage I|Withdrawal by Subject|0
7779124|NCT00943917|12227215|FG006|Stage I|Withdrawal by Subject|0
7779125|NCT00943917|12227216|FG007|Stage I|Withdrawal by Subject|0
7779126|NCT00943917|12227217|FG008|Stage I|Withdrawal by Subject|0
7779127|NCT00943917|12227218|FG009|Stage I|Withdrawal by Subject|0
7779128|NCT00943917|12227219|FG010|Stage I|Withdrawal by Subject|0
7612780|NCT01986933|12021033|FG001|Placebo-to-active (Part B)|Protocol Violation|0
7612781|NCT01986933|12021034|FG002|Placebo-to-active (Part B)|Protocol Violation|1
7612782|NCT01986933|12021035|FG003|Placebo-to-active (Part B)|Protocol Violation|0
7779129|NCT00943917|12227220|FG011|Stage I|Withdrawal by Subject|0
7612783|NCT01986933|12021036|FG004|Placebo-to-active (Part B)|Protocol Violation|0
7612784|NCT01986933|12021032|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0
7612785|NCT01986933|12021033|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3
7612786|NCT01986933|12021034|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4
7612787|NCT01986933|12021035|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3
7612788|NCT01986933|12021036|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0
7612789|NCT01986933|12021032|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0
7612790|NCT01986933|12021033|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1
7612791|NCT01986933|12021034|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0
7612792|NCT01986933|12021035|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0
7612793|NCT01986933|12021036|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0
7612794|NCT01563107|12021082|FG000|Overall Study|Physician Decision|0
7612795|NCT01563107|12021083|FG001|Overall Study|Physician Decision|1
7612796|NCT01563107|12021084|FG002|Overall Study|Physician Decision|1
7612797|NCT01563107|12021085|FG003|Overall Study|Physician Decision|3
7612798|NCT01563107|12021082|FG000|Overall Study|Withdrawal by Subject|1
7612799|NCT01563107|12021083|FG001|Overall Study|Withdrawal by Subject|2
7612800|NCT01563107|12021084|FG002|Overall Study|Withdrawal by Subject|1
7612801|NCT01563107|12021085|FG003|Overall Study|Withdrawal by Subject|2
7779130|NCT00943917|12227221|FG012|Stage I|Withdrawal by Subject|0
7779131|NCT00943917|12227222|FG013|Stage I|Withdrawal by Subject|0
7779132|NCT00943917|12227223|FG014|Stage I|Withdrawal by Subject|0
7779133|NCT00943917|12227209|FG000|Stage II|Adverse Event|0
7779134|NCT00943917|12227210|FG001|Stage II|Adverse Event|0
7779135|NCT00943917|12227211|FG002|Stage II|Adverse Event|0
7779136|NCT00943917|12227212|FG003|Stage II|Adverse Event|0
7779137|NCT00943917|12227213|FG004|Stage II|Adverse Event|0
7779138|NCT00943917|12227214|FG005|Stage II|Adverse Event|1
7779139|NCT00943917|12227215|FG006|Stage II|Adverse Event|3
7779140|NCT00943917|12227216|FG007|Stage II|Adverse Event|0
7779141|NCT00943917|12227217|FG008|Stage II|Adverse Event|1
7779142|NCT00943917|12227218|FG009|Stage II|Adverse Event|0
7779143|NCT00943917|12227219|FG010|Stage II|Adverse Event|0
7779144|NCT00943917|12227220|FG011|Stage II|Adverse Event|0
7779145|NCT00943917|12227221|FG012|Stage II|Adverse Event|0
7779146|NCT00943917|12227222|FG013|Stage II|Adverse Event|0
7779147|NCT00943917|12227223|FG014|Stage II|Adverse Event|0
7779148|NCT00943917|12227209|FG000|Stage II|Withdrawal by Subject|0
7779149|NCT00943917|12227210|FG001|Stage II|Withdrawal by Subject|0
7779150|NCT00943917|12227211|FG002|Stage II|Withdrawal by Subject|0
7779151|NCT00943917|12227212|FG003|Stage II|Withdrawal by Subject|0
7779152|NCT00943917|12227213|FG004|Stage II|Withdrawal by Subject|0
7779153|NCT00943917|12227214|FG005|Stage II|Withdrawal by Subject|1
7779154|NCT00943917|12227215|FG006|Stage II|Withdrawal by Subject|0
7779155|NCT00943917|12227216|FG007|Stage II|Withdrawal by Subject|0
7779156|NCT00943917|12227217|FG008|Stage II|Withdrawal by Subject|0
7779157|NCT00943917|12227218|FG009|Stage II|Withdrawal by Subject|0
7779158|NCT00943917|12227219|FG010|Stage II|Withdrawal by Subject|0
7779159|NCT00943917|12227220|FG011|Stage II|Withdrawal by Subject|0
7779160|NCT00943917|12227221|FG012|Stage II|Withdrawal by Subject|0
7779161|NCT00943917|12227222|FG013|Stage II|Withdrawal by Subject|0
7779162|NCT00943917|12227223|FG014|Stage II|Withdrawal by Subject|0
7779163|NCT00943917|12227209|FG000|Stage II|Pregnancy|0
7779164|NCT00943917|12227210|FG001|Stage II|Pregnancy|0
7779165|NCT00943917|12227211|FG002|Stage II|Pregnancy|0
7779166|NCT00943917|12227212|FG003|Stage II|Pregnancy|0
7779167|NCT00943917|12227213|FG004|Stage II|Pregnancy|0
7779168|NCT00943917|12227214|FG005|Stage II|Pregnancy|1
7779169|NCT00943917|12227215|FG006|Stage II|Pregnancy|0
7779170|NCT00943917|12227216|FG007|Stage II|Pregnancy|0
7779171|NCT00943917|12227217|FG008|Stage II|Pregnancy|0
7779172|NCT00943917|12227218|FG009|Stage II|Pregnancy|0
7779173|NCT00943917|12227219|FG010|Stage II|Pregnancy|0
7779174|NCT00943917|12227220|FG011|Stage II|Pregnancy|0
7779175|NCT00943917|12227221|FG012|Stage II|Pregnancy|0
7779176|NCT00943917|12227222|FG013|Stage II|Pregnancy|0
7779177|NCT00943917|12227223|FG014|Stage II|Pregnancy|0
7779178|NCT00943917|12227209|FG000|Stage II Continuation|Adverse Event|0
7779179|NCT00943917|12227210|FG001|Stage II Continuation|Adverse Event|0
7779180|NCT00943917|12227211|FG002|Stage II Continuation|Adverse Event|0
7779181|NCT00943917|12227212|FG003|Stage II Continuation|Adverse Event|0
7779182|NCT00943917|12227213|FG004|Stage II Continuation|Adverse Event|0
7779183|NCT00943917|12227214|FG005|Stage II Continuation|Adverse Event|0
7779184|NCT00943917|12227215|FG006|Stage II Continuation|Adverse Event|0
7779185|NCT00943917|12227216|FG007|Stage II Continuation|Adverse Event|0
7779186|NCT00943917|12227217|FG008|Stage II Continuation|Adverse Event|0
7612812|NCT01042522|12021166|FG000|Overall Study|Adverse Event|1
7612813|NCT01042522|12021167|FG001|Overall Study|Adverse Event|2
7612814|NCT01042522|12021166|FG000|Overall Study|Disease Progression|5
7612815|NCT01042522|12021167|FG001|Overall Study|Disease Progression|0
7612816|NCT01042522|12021166|FG000|Overall Study|Death|1
7612817|NCT01042522|12021167|FG001|Overall Study|Death|0
7612818|NCT01042522|12021166|FG000|Overall Study|Patient Refused|0
7612819|NCT01042522|12021167|FG001|Overall Study|Patient Refused|3
7612820|NCT01042522|12021166|FG000|Overall Study|Withdrawal by Subject|1
7612821|NCT01042522|12021167|FG001|Overall Study|Withdrawal by Subject|1
7612822|NCT00710970|12021206|FG000|Overall Study|Never took drug|3
7612823|NCT00685919|12021214|FG000|Overall Study|Withdrawal by Subject|0
7612824|NCT00685919|12021215|FG001|Overall Study|Withdrawal by Subject|0
7612825|NCT00685919|12021216|FG002|Overall Study|Withdrawal by Subject|1
7612826|NCT00685919|12021217|FG003|Overall Study|Withdrawal by Subject|0
7612827|NCT00685919|12021214|FG000|Overall Study|Physician Decision|1
7612828|NCT00685919|12021215|FG001|Overall Study|Physician Decision|0
7612829|NCT00685919|12021216|FG002|Overall Study|Physician Decision|0
7612830|NCT00685919|12021217|FG003|Overall Study|Physician Decision|0
7612831|NCT00344487|12021227|FG000|Overall Study|immunologic failure|1
7612832|NCT00281658|12021235|FG000|Double-blind, Randomized Phase|Death|120
7612833|NCT00281658|12021236|FG001|Double-blind, Randomized Phase|Death|46
7612834|NCT00281658|12021237|FG002|Double-blind, Randomized Phase|Death|0
7612835|NCT00281658|12021235|FG000|Double-blind, Randomized Phase|Lost to Follow-up|12
7612836|NCT00281658|12021236|FG001|Double-blind, Randomized Phase|Lost to Follow-up|5
7612837|NCT00281658|12021237|FG002|Double-blind, Randomized Phase|Lost to Follow-up|0
7612838|NCT00281658|12021235|FG000|Double-blind, Randomized Phase|Withdrawal by Subject|4
7612839|NCT00281658|12021236|FG001|Double-blind, Randomized Phase|Withdrawal by Subject|1
7612840|NCT00281658|12021237|FG002|Double-blind, Randomized Phase|Withdrawal by Subject|0
7612841|NCT00281658|12021235|FG000|Double-blind, Randomized Phase|Participant Entered New Protocol|1
7612842|NCT00281658|12021236|FG001|Double-blind, Randomized Phase|Participant Entered New Protocol|1
7612843|NCT00281658|12021237|FG002|Double-blind, Randomized Phase|Participant Entered New Protocol|0
7612844|NCT00281658|12021235|FG000|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
7612845|NCT00281658|12021236|FG001|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
7612846|NCT00281658|12021237|FG002|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
7612847|NCT00281658|12021235|FG000|Open-label Monotherapy Extension Phase|Death|0
7612848|NCT00281658|12021236|FG001|Open-label Monotherapy Extension Phase|Death|0
7779187|NCT00943917|12227218|FG009|Stage II Continuation|Adverse Event|0
7612849|NCT00281658|12021237|FG002|Open-label Monotherapy Extension Phase|Death|97
7612850|NCT00281658|12021235|FG000|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
7612851|NCT00281658|12021236|FG001|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
7612852|NCT00281658|12021237|FG002|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
7612853|NCT00281658|12021235|FG000|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
7612854|NCT00281658|12021236|FG001|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
7612855|NCT00281658|12021237|FG002|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
7612856|NCT04034355|12021268|FG000|Overall Study|Study terminated by Sponsor|10
7612857|NCT04034355|12021269|FG001|Overall Study|Study terminated by Sponsor|17
7612858|NCT04034355|12021268|FG000|Overall Study|Withdrawal by Subject|12
7612859|NCT04034355|12021269|FG001|Overall Study|Withdrawal by Subject|11
7612860|NCT04034355|12021268|FG000|Overall Study|Site terminated by Sponsor|4
7612861|NCT04034355|12021269|FG001|Overall Study|Site terminated by Sponsor|5
7612862|NCT04034355|12021268|FG000|Overall Study|Adverse Event|2
7612863|NCT04034355|12021269|FG001|Overall Study|Adverse Event|0
7612864|NCT04034355|12021268|FG000|Overall Study|Death|1
7612865|NCT04034355|12021269|FG001|Overall Study|Death|1
7612866|NCT04034355|12021268|FG000|Overall Study|Not reported|2
7612867|NCT04034355|12021269|FG001|Overall Study|Not reported|0
7612868|NCT04034355|12021268|FG000|Overall Study|Lost to Follow-up|1
7612869|NCT04034355|12021269|FG001|Overall Study|Lost to Follow-up|0
7612870|NCT04034355|12021268|FG000|Overall Study|Physician Decision|1
7612871|NCT04034355|12021269|FG001|Overall Study|Physician Decision|0
7612872|NCT04034355|12021268|FG000|Overall Study|Protocol Violation|0
7612873|NCT04034355|12021269|FG001|Overall Study|Protocol Violation|1
7612874|NCT04034355|12021268|FG000|Overall Study|Progressive disease|1
7612875|NCT04034355|12021269|FG001|Overall Study|Progressive disease|0
7612876|NCT03721276|12021281|FG000|Overall Study|Lost to Follow-up|5
7612877|NCT03721276|12021282|FG001|Overall Study|Lost to Follow-up|3
7612878|NCT03721276|12021281|FG000|Overall Study|Adverse Event|0
7612879|NCT03721276|12021282|FG001|Overall Study|Adverse Event|1
7612880|NCT03637491|12021305|FG000|Overall Study|Death|9
7612881|NCT03637491|12021306|FG001|Overall Study|Death|9
7612882|NCT03637491|12021307|FG002|Overall Study|Death|5
7612883|NCT03637491|12021308|FG003|Overall Study|Death|3
7612884|NCT03637491|12021305|FG000|Overall Study|Lost to Follow-up|0
7612885|NCT03637491|12021306|FG001|Overall Study|Lost to Follow-up|1
7612886|NCT03637491|12021307|FG002|Overall Study|Lost to Follow-up|0
7612887|NCT03637491|12021308|FG003|Overall Study|Lost to Follow-up|1
7612888|NCT03637491|12021305|FG000|Overall Study|Study Terminated By Sponsor|0
7612889|NCT03637491|12021306|FG001|Overall Study|Study Terminated By Sponsor|2
7612890|NCT03637491|12021307|FG002|Overall Study|Study Terminated By Sponsor|1
7612891|NCT03637491|12021308|FG003|Overall Study|Study Terminated By Sponsor|0
7612892|NCT03637491|12021305|FG000|Overall Study|Withdrawal by Subject|1
7612893|NCT03637491|12021306|FG001|Overall Study|Withdrawal by Subject|0
7612894|NCT03637491|12021307|FG002|Overall Study|Withdrawal by Subject|1
7612895|NCT03637491|12021308|FG003|Overall Study|Withdrawal by Subject|2
7612896|NCT03334539|12021399|FG000|Overall Study|Adverse Event|3
7612897|NCT03334539|12021400|FG001|Overall Study|Adverse Event|5
7612898|NCT03334539|12021401|FG002|Overall Study|Adverse Event|0
7612899|NCT03334539|12021399|FG000|Overall Study|Withdrawal by Subject|0
7612900|NCT03334539|12021400|FG001|Overall Study|Withdrawal by Subject|1
7612901|NCT03334539|12021401|FG002|Overall Study|Withdrawal by Subject|1
7612902|NCT03334539|12021399|FG000|Overall Study|Administrative Reasons|1
7612903|NCT03334539|12021400|FG001|Overall Study|Administrative Reasons|0
7612904|NCT03334539|12021401|FG002|Overall Study|Administrative Reasons|0
7612905|NCT03334539|12021399|FG000|Overall Study|Hypertension Not Controlled|0
7612906|NCT03334539|12021400|FG001|Overall Study|Hypertension Not Controlled|1
7612907|NCT03334539|12021401|FG002|Overall Study|Hypertension Not Controlled|0
7612908|NCT03269344|12021423|FG000|Overall Study|Protocol Violation|4
7612909|NCT03269344|12021424|FG001|Overall Study|Protocol Violation|3
7612910|NCT03076775|12021438|FG000|Overall Study|Lost to Follow-up|1
7612911|NCT03076775|12021439|FG001|Overall Study|Lost to Follow-up|0
7779188|NCT00943917|12227219|FG010|Stage II Continuation|Adverse Event|0
7779189|NCT00943917|12227220|FG011|Stage II Continuation|Adverse Event|1
7779190|NCT00943917|12227221|FG012|Stage II Continuation|Adverse Event|2
7612912|NCT02660827|12021479|FG000|From Study to End of Continued Access|Withdrawal by Subject|21
7612913|NCT02660827|12021479|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2
7612914|NCT02660827|12021479|FG000|From Study to End of Continued Access|Adverse Event|3
7612915|NCT02660827|12021479|FG000|From Study to End of Continued Access|didn't participate continued access period|5
7612916|NCT02660827|12021479|FG000|Period 1: Study Period|Withdrawal by Subject|1
7612917|NCT02660827|12021479|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20
7612918|NCT02660827|12021479|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2
7612919|NCT02660827|12021479|FG000|Period 2: Continued Access Period|Adverse Event|3
7612920|NCT02425644|12021497|FG000|Overall Study|Lost to Follow-up|2
7612921|NCT02425644|12021498|FG001|Overall Study|Lost to Follow-up|3
7612922|NCT02425644|12021497|FG000|Overall Study|Withdrawal by Subject|41
7612923|NCT02425644|12021498|FG001|Overall Study|Withdrawal by Subject|36
7612924|NCT02425644|12021497|FG000|Overall Study|Lack of Efficacy|3
7612925|NCT02425644|12021498|FG001|Overall Study|Lack of Efficacy|10
7612926|NCT02425644|12021497|FG000|Overall Study|Adverse Event|13
7612927|NCT02425644|12021498|FG001|Overall Study|Adverse Event|3
7612928|NCT02425644|12021497|FG000|Overall Study|Death|0
7612929|NCT02425644|12021498|FG001|Overall Study|Death|2
7612930|NCT02425644|12021497|FG000|Overall Study|Other|18
7612931|NCT02425644|12021498|FG001|Overall Study|Other|17
7612932|NCT02270957|12021511|FG000|Overall Study|Lack of Efficacy|2
7612933|NCT02270957|12021512|FG001|Overall Study|Lack of Efficacy|4
7612934|NCT02270957|12021511|FG000|Overall Study|Adverse Event|2
7612935|NCT02270957|12021512|FG001|Overall Study|Adverse Event|0
7612936|NCT02054104|12021521|FG000|Overall Study|Did not want to continue due to college classes|1
7612937|NCT02054104|12021522|FG001|Overall Study|Did not want to continue due to college classes|0
7612938|NCT02054104|12021521|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1
7612939|NCT02054104|12021522|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0
7612940|NCT02054104|12021521|FG000|Overall Study|No evidence of immunologic response|2
7612941|NCT02054104|12021522|FG001|Overall Study|No evidence of immunologic response|2
7612942|NCT02054104|12021521|FG000|Overall Study|Disease Progression On Study|4
7612943|NCT02054104|12021522|FG001|Overall Study|Disease Progression On Study|5
7612944|NCT02054104|12021521|FG000|Overall Study|Diagnosis of lymphoma|0
7612945|NCT02054104|12021522|FG001|Overall Study|Diagnosis of lymphoma|1
7612946|NCT02054104|12021521|FG000|Overall Study|Inconclusive response|0
7612947|NCT02054104|12021522|FG001|Overall Study|Inconclusive response|1
7612948|NCT01899144|12021528|FG000|Treatment Period 2|Other|1
7779191|NCT00943917|12227222|FG013|Stage II Continuation|Adverse Event|1
7779192|NCT00943917|12227223|FG014|Stage II Continuation|Adverse Event|1
7779193|NCT00943917|12227209|FG000|Stage II Continuation|Withdrawal by Subject|0
7779194|NCT00943917|12227210|FG001|Stage II Continuation|Withdrawal by Subject|0
7779195|NCT00943917|12227211|FG002|Stage II Continuation|Withdrawal by Subject|0
7779196|NCT00943917|12227212|FG003|Stage II Continuation|Withdrawal by Subject|0
7779197|NCT00943917|12227213|FG004|Stage II Continuation|Withdrawal by Subject|0
7779198|NCT00943917|12227214|FG005|Stage II Continuation|Withdrawal by Subject|0
7779199|NCT00943917|12227215|FG006|Stage II Continuation|Withdrawal by Subject|0
7779200|NCT00943917|12227216|FG007|Stage II Continuation|Withdrawal by Subject|0
7779201|NCT00943917|12227217|FG008|Stage II Continuation|Withdrawal by Subject|0
7779202|NCT00943917|12227218|FG009|Stage II Continuation|Withdrawal by Subject|0
7779203|NCT00943917|12227219|FG010|Stage II Continuation|Withdrawal by Subject|0
7779204|NCT00943917|12227220|FG011|Stage II Continuation|Withdrawal by Subject|0
7779205|NCT00943917|12227221|FG012|Stage II Continuation|Withdrawal by Subject|0
7779206|NCT00943917|12227222|FG013|Stage II Continuation|Withdrawal by Subject|1
7779207|NCT00943917|12227223|FG014|Stage II Continuation|Withdrawal by Subject|3
7779208|NCT00943917|12227209|FG000|Stage II Continuation|Protocol Violation|0
7779209|NCT00943917|12227210|FG001|Stage II Continuation|Protocol Violation|0
7779210|NCT00943917|12227211|FG002|Stage II Continuation|Protocol Violation|0
7612949|NCT01899144|12021528|FG000|Treatment Period 3|Other|2
7612950|NCT01899144|12021528|FG000|Treatment Period 5|Other|1
7612951|NCT01757665|12021542|FG000|Overall Study|Still on Study - Visit Completed|240
7612952|NCT01757665|12021543|FG001|Overall Study|Still on Study - Visit Completed|30
7612953|NCT01757665|12021542|FG000|Overall Study|Still on Study - Visit Pending|398
7612954|NCT01757665|12021543|FG001|Overall Study|Still on Study - Visit Pending|40
7612955|NCT01757665|12021542|FG000|Overall Study|Still on Study - Missed Visit|14
7612956|NCT01757665|12021543|FG001|Overall Study|Still on Study - Missed Visit|1
7612957|NCT01757665|12021542|FG000|Overall Study|Death|25
7612958|NCT01757665|12021543|FG001|Overall Study|Death|8
7612959|NCT01757665|12021542|FG000|Overall Study|Explant|1
7612960|NCT01757665|12021543|FG001|Overall Study|Explant|2
7612961|NCT01757665|12021542|FG000|Overall Study|Withdrawal by Subject|10
7612962|NCT01757665|12021543|FG001|Overall Study|Withdrawal by Subject|0
7612963|NCT01757665|12021542|FG000|Overall Study|Lost to Follow-up|1
7612964|NCT01757665|12021543|FG001|Overall Study|Lost to Follow-up|1
7612965|NCT01757665|12021542|FG000|Overall Study|Not Implanted with Device|5
7612966|NCT01757665|12021543|FG001|Overall Study|Not Implanted with Device|1
7779211|NCT00943917|12227212|FG003|Stage II Continuation|Protocol Violation|0
7779212|NCT00943917|12227213|FG004|Stage II Continuation|Protocol Violation|0
7779213|NCT00943917|12227214|FG005|Stage II Continuation|Protocol Violation|0
7779214|NCT00943917|12227215|FG006|Stage II Continuation|Protocol Violation|0
7779215|NCT00943917|12227216|FG007|Stage II Continuation|Protocol Violation|0
7779216|NCT00943917|12227217|FG008|Stage II Continuation|Protocol Violation|0
7779217|NCT00943917|12227218|FG009|Stage II Continuation|Protocol Violation|1
7779218|NCT00943917|12227219|FG010|Stage II Continuation|Protocol Violation|0
7779219|NCT00943917|12227220|FG011|Stage II Continuation|Protocol Violation|1
7779220|NCT00943917|12227221|FG012|Stage II Continuation|Protocol Violation|0
7779221|NCT00943917|12227222|FG013|Stage II Continuation|Protocol Violation|0
7779222|NCT00943917|12227223|FG014|Stage II Continuation|Protocol Violation|0
7779223|NCT00943917|12227209|FG000|Stage II Continuation|hypoglycemia|0
7779224|NCT00943917|12227210|FG001|Stage II Continuation|hypoglycemia|0
7779225|NCT00943917|12227211|FG002|Stage II Continuation|hypoglycemia|0
7779226|NCT00943917|12227212|FG003|Stage II Continuation|hypoglycemia|0
7779227|NCT00943917|12227213|FG004|Stage II Continuation|hypoglycemia|0
7779228|NCT00943917|12227214|FG005|Stage II Continuation|hypoglycemia|0
7779229|NCT00943917|12227215|FG006|Stage II Continuation|hypoglycemia|0
7779230|NCT00943917|12227216|FG007|Stage II Continuation|hypoglycemia|0
7779231|NCT00943917|12227217|FG008|Stage II Continuation|hypoglycemia|0
7779232|NCT00943917|12227218|FG009|Stage II Continuation|hypoglycemia|0
7779233|NCT00943917|12227219|FG010|Stage II Continuation|hypoglycemia|0
7779234|NCT00943917|12227220|FG011|Stage II Continuation|hypoglycemia|0
7779235|NCT00943917|12227221|FG012|Stage II Continuation|hypoglycemia|1
7779236|NCT00943917|12227222|FG013|Stage II Continuation|hypoglycemia|0
7779237|NCT00943917|12227223|FG014|Stage II Continuation|hypoglycemia|0
7779238|NCT00943917|12227209|FG000|Stage II Continuation|A1C elevation|0
7779239|NCT00943917|12227210|FG001|Stage II Continuation|A1C elevation|0
7779240|NCT00943917|12227211|FG002|Stage II Continuation|A1C elevation|0
7779241|NCT00943917|12227212|FG003|Stage II Continuation|A1C elevation|0
7779242|NCT00943917|12227213|FG004|Stage II Continuation|A1C elevation|0
7779243|NCT00943917|12227214|FG005|Stage II Continuation|A1C elevation|0
7779244|NCT00943917|12227215|FG006|Stage II Continuation|A1C elevation|0
7779245|NCT00943917|12227216|FG007|Stage II Continuation|A1C elevation|0
7779246|NCT00943917|12227217|FG008|Stage II Continuation|A1C elevation|0
7779247|NCT00943917|12227218|FG009|Stage II Continuation|A1C elevation|0
7779248|NCT00943917|12227219|FG010|Stage II Continuation|A1C elevation|0
7779249|NCT00943917|12227220|FG011|Stage II Continuation|A1C elevation|0
7779250|NCT00943917|12227221|FG012|Stage II Continuation|A1C elevation|0
7779251|NCT00943917|12227222|FG013|Stage II Continuation|A1C elevation|1
7779252|NCT00943917|12227223|FG014|Stage II Continuation|A1C elevation|0
7800143|NCT01091428|12257329|FG003|Phase 1|Symptomatic Deterioration|0
7800144|NCT01091428|12257326|FG000|Phase 1|Adverse Event|2
7800145|NCT01091428|12257327|FG001|Phase 1|Adverse Event|0
7800146|NCT01091428|12257328|FG002|Phase 1|Adverse Event|0
7800147|NCT01091428|12257329|FG003|Phase 1|Adverse Event|0
7800148|NCT01091428|12257326|FG000|Phase 1|Withdrawal by Subject|7
7779253|NCT00944034|12227289|FG000|Overall Study|Inappropriate enrollment|0
7779254|NCT00944034|12227290|FG001|Overall Study|Inappropriate enrollment|1
7779255|NCT00944034|12227291|FG002|Overall Study|Inappropriate enrollment|0
7779256|NCT00944034|12227292|FG003|Overall Study|Inappropriate enrollment|1
7779257|NCT00944034|12227293|FG004|Overall Study|Inappropriate enrollment|2
7779258|NCT00944034|12227294|FG005|Overall Study|Inappropriate enrollment|1
7779259|NCT00944034|12227295|FG006|Overall Study|Inappropriate enrollment|0
7779260|NCT00944034|12227296|FG007|Overall Study|Inappropriate enrollment|0
7779261|NCT00944034|12227297|FG008|Overall Study|Inappropriate enrollment|1
7779262|NCT00944034|12227298|FG009|Overall Study|Inappropriate enrollment|1
7779263|NCT00944034|12227299|FG010|Overall Study|Inappropriate enrollment|0
7779264|NCT00944034|12227300|FG011|Overall Study|Inappropriate enrollment|0
7779265|NCT00944034|12227289|FG000|Overall Study|Withdrawal by Subject|3
7779266|NCT00944034|12227290|FG001|Overall Study|Withdrawal by Subject|2
7779267|NCT00944034|12227291|FG002|Overall Study|Withdrawal by Subject|6
7779268|NCT00944034|12227292|FG003|Overall Study|Withdrawal by Subject|2
7779269|NCT00944034|12227293|FG004|Overall Study|Withdrawal by Subject|5
7779270|NCT00944034|12227294|FG005|Overall Study|Withdrawal by Subject|8
7779271|NCT00944034|12227295|FG006|Overall Study|Withdrawal by Subject|2
7779272|NCT00944034|12227296|FG007|Overall Study|Withdrawal by Subject|2
7779273|NCT00944034|12227297|FG008|Overall Study|Withdrawal by Subject|3
7779274|NCT00944034|12227298|FG009|Overall Study|Withdrawal by Subject|4
7779275|NCT00944034|12227299|FG010|Overall Study|Withdrawal by Subject|0
7779276|NCT00944034|12227300|FG011|Overall Study|Withdrawal by Subject|4
7779277|NCT00944034|12227289|FG000|Overall Study|Lost to Follow-up|0
7779278|NCT00944034|12227290|FG001|Overall Study|Lost to Follow-up|4
7779279|NCT00944034|12227291|FG002|Overall Study|Lost to Follow-up|2
7779280|NCT00944034|12227292|FG003|Overall Study|Lost to Follow-up|0
7779281|NCT00944034|12227293|FG004|Overall Study|Lost to Follow-up|5
7779282|NCT00944034|12227294|FG005|Overall Study|Lost to Follow-up|7
7779283|NCT00944034|12227295|FG006|Overall Study|Lost to Follow-up|0
7613015|NCT00603954|12021612|FG000|Overall Study|Protocol Violation|1
7613016|NCT00603954|12021613|FG001|Overall Study|Protocol Violation|2
7779284|NCT00944034|12227296|FG007|Overall Study|Lost to Follow-up|1
7613017|NCT04532294|12021627|FG000|Overall Study|Withdrawal by Subject|0
7613018|NCT04532294|12021628|FG001|Overall Study|Withdrawal by Subject|0
7613019|NCT04532294|12021629|FG002|Overall Study|Withdrawal by Subject|1
7613020|NCT04532294|12021627|FG000|Overall Study|Participants Not Dosed|0
7613021|NCT04532294|12021628|FG001|Overall Study|Participants Not Dosed|0
7613022|NCT04532294|12021629|FG002|Overall Study|Participants Not Dosed|2
7613023|NCT04250077|12021642|FG000|Overall Study|Withdrawal by Subject|0
7613024|NCT04250077|12021643|FG001|Overall Study|Withdrawal by Subject|1
7779285|NCT00944034|12227297|FG008|Overall Study|Lost to Follow-up|5
7779286|NCT00944034|12227298|FG009|Overall Study|Lost to Follow-up|1
7779287|NCT00944034|12227299|FG010|Overall Study|Lost to Follow-up|1
7779288|NCT00944034|12227300|FG011|Overall Study|Lost to Follow-up|0
7779289|NCT00944034|12227289|FG000|Overall Study|Death|0
7779290|NCT00944034|12227290|FG001|Overall Study|Death|0
7779291|NCT00944034|12227291|FG002|Overall Study|Death|1
7779292|NCT00944034|12227292|FG003|Overall Study|Death|0
7779293|NCT00944034|12227293|FG004|Overall Study|Death|0
7779294|NCT00944034|12227294|FG005|Overall Study|Death|0
7779295|NCT00944034|12227295|FG006|Overall Study|Death|0
7779296|NCT00944034|12227296|FG007|Overall Study|Death|0
7779297|NCT00944034|12227297|FG008|Overall Study|Death|0
7779298|NCT00944034|12227298|FG009|Overall Study|Death|0
7779299|NCT00944034|12227299|FG010|Overall Study|Death|0
7779300|NCT00944034|12227300|FG011|Overall Study|Death|0
7779301|NCT00944034|12227289|FG000|Overall Study|Protocol Violation|2
7779302|NCT00944034|12227290|FG001|Overall Study|Protocol Violation|0
7613025|NCT04250077|12021644|FG002|Overall Study|Withdrawal by Subject|0
7613026|NCT04250077|12021642|FG000|Overall Study|Lost to Follow-up|2
7613027|NCT04250077|12021643|FG001|Overall Study|Lost to Follow-up|3
7613028|NCT04250077|12021644|FG002|Overall Study|Lost to Follow-up|0
7613029|NCT03505710|12021698|FG000|Overall Study|Progressive Disease|22
7613030|NCT03505710|12021699|FG001|Overall Study|Progressive Disease|9
7613031|NCT03505710|12021700|FG002|Overall Study|Progressive Disease|34
7613032|NCT03505710|12021698|FG000|Overall Study|Clinical Progression|6
7613033|NCT03505710|12021699|FG001|Overall Study|Clinical Progression|6
7613034|NCT03505710|12021700|FG002|Overall Study|Clinical Progression|3
7613035|NCT03505710|12021698|FG000|Overall Study|Adverse Event|12
7779303|NCT00944034|12227291|FG002|Overall Study|Protocol Violation|0
7779304|NCT00944034|12227292|FG003|Overall Study|Protocol Violation|1
7779305|NCT00944034|12227293|FG004|Overall Study|Protocol Violation|2
7779306|NCT00944034|12227294|FG005|Overall Study|Protocol Violation|3
7779307|NCT00944034|12227295|FG006|Overall Study|Protocol Violation|0
7779308|NCT00944034|12227296|FG007|Overall Study|Protocol Violation|1
7779309|NCT00944034|12227297|FG008|Overall Study|Protocol Violation|1
7779310|NCT00944034|12227298|FG009|Overall Study|Protocol Violation|4
7779311|NCT00944034|12227299|FG010|Overall Study|Protocol Violation|0
7779312|NCT00944034|12227300|FG011|Overall Study|Protocol Violation|0
7779313|NCT00944034|12227289|FG000|Overall Study|Unable to classify|0
7779314|NCT00944034|12227290|FG001|Overall Study|Unable to classify|0
7779315|NCT00944034|12227291|FG002|Overall Study|Unable to classify|0
7779316|NCT00944034|12227292|FG003|Overall Study|Unable to classify|0
7779317|NCT00944034|12227293|FG004|Overall Study|Unable to classify|0
7779318|NCT00944034|12227294|FG005|Overall Study|Unable to classify|1
7779319|NCT00944034|12227295|FG006|Overall Study|Unable to classify|1
7779320|NCT00944034|12227296|FG007|Overall Study|Unable to classify|1
7779321|NCT00944034|12227297|FG008|Overall Study|Unable to classify|0
7779322|NCT00944034|12227298|FG009|Overall Study|Unable to classify|0
7779323|NCT00944034|12227299|FG010|Overall Study|Unable to classify|0
7779324|NCT00944034|12227300|FG011|Overall Study|Unable to classify|0
7779325|NCT00944034|12227289|FG000|Overall Study|Administrative reason|0
7779326|NCT00944034|12227290|FG001|Overall Study|Administrative reason|0
7779327|NCT00944034|12227291|FG002|Overall Study|Administrative reason|0
7779328|NCT00944034|12227292|FG003|Overall Study|Administrative reason|0
7779329|NCT00944034|12227293|FG004|Overall Study|Administrative reason|0
7779330|NCT00944034|12227294|FG005|Overall Study|Administrative reason|0
7779331|NCT00944034|12227295|FG006|Overall Study|Administrative reason|1
7779332|NCT00944034|12227296|FG007|Overall Study|Administrative reason|0
7779333|NCT00944034|12227297|FG008|Overall Study|Administrative reason|0
7779334|NCT00944034|12227298|FG009|Overall Study|Administrative reason|0
7613036|NCT03505710|12021699|FG001|Overall Study|Adverse Event|5
7613037|NCT03505710|12021700|FG002|Overall Study|Adverse Event|27
7613038|NCT03505710|12021698|FG000|Overall Study|Withdrawal by Subject|1
7613039|NCT03505710|12021699|FG001|Overall Study|Withdrawal by Subject|3
7613040|NCT03505710|12021700|FG002|Overall Study|Withdrawal by Subject|3
7613041|NCT03505710|12021698|FG000|Overall Study|Physician Decision|1
7613042|NCT03505710|12021699|FG001|Overall Study|Physician Decision|0
7613043|NCT03505710|12021700|FG002|Overall Study|Physician Decision|2
7613044|NCT03505710|12021698|FG000|Overall Study|Death|4
7613045|NCT03505710|12021699|FG001|Overall Study|Death|3
7613046|NCT03505710|12021700|FG002|Overall Study|Death|6
7613047|NCT03505710|12021698|FG000|Overall Study|Other Reasons|1
7779335|NCT00944034|12227299|FG010|Overall Study|Administrative reason|0
7779336|NCT00944034|12227300|FG011|Overall Study|Administrative reason|0
7779337|NCT00944125|12227356|FG000|3 to 6 Months|Withdrawal by Subject|0
7779338|NCT00944125|12227357|FG001|3 to 6 Months|Withdrawal by Subject|2
7779339|NCT00944125|12227356|FG000|6 Months to Study Completion|Withdrawal by Subject|0
7779340|NCT00944125|12227357|FG001|6 Months to Study Completion|Withdrawal by Subject|2
7779341|NCT00944645|12227379|FG000|Period 2|Adverse Event|1
7779342|NCT00944645|12227380|FG001|Period 2|Adverse Event|0
7779343|NCT00944645|12227379|FG000|Period 2|Lost to Follow-up|0
7779344|NCT00944645|12227380|FG001|Period 2|Lost to Follow-up|3
7779345|NCT00944645|12227379|FG000|Period 2|Withdrawal by Subject|7
7779346|NCT00944645|12227380|FG001|Period 2|Withdrawal by Subject|6
7779347|NCT00944658|12227388|FG000|Treatment 12 Weeks|Adverse Event|0
7779348|NCT00944658|12227389|FG001|Treatment 12 Weeks|Adverse Event|2
7779349|NCT00944697|12227416|FG000|Overall Study|Withdrawal by Subject|1
7779350|NCT00944697|12227417|FG001|Overall Study|Withdrawal by Subject|1
7779351|NCT00944697|12227416|FG000|Overall Study|Adverse Event|0
7779352|NCT00944697|12227417|FG001|Overall Study|Adverse Event|3
7779353|NCT00944697|12227416|FG000|Overall Study|Administrative|1
7779354|NCT00944697|12227417|FG001|Overall Study|Administrative|1
7613048|NCT03505710|12021699|FG001|Overall Study|Other Reasons|1
7613049|NCT03505710|12021700|FG002|Overall Study|Other Reasons|1
7613050|NCT03296553|12021710|FG000|Overall Study|Withdrawal by Subject|1
7613051|NCT03296553|12021711|FG001|Overall Study|Withdrawal by Subject|1
7613052|NCT03296553|12021710|FG000|Overall Study|Death|1
7613053|NCT03296553|12021711|FG001|Overall Study|Death|0
7613054|NCT03049449|12021725|FG000|Overall Study|Did not receive treatment.|0
7613055|NCT03049449|12021726|FG001|Overall Study|Did not receive treatment.|0
7613056|NCT03049449|12021727|FG002|Overall Study|Did not receive treatment.|0
7613057|NCT03049449|12021728|FG003|Overall Study|Did not receive treatment.|0
7613058|NCT03049449|12021729|FG004|Overall Study|Did not receive treatment.|0
7613059|NCT03049449|12021730|FG005|Overall Study|Did not receive treatment.|0
7613060|NCT03049449|12021731|FG006|Overall Study|Did not receive treatment.|0
7613061|NCT03049449|12021732|FG007|Overall Study|Did not receive treatment.|0
7613062|NCT03049449|12021733|FG008|Overall Study|Did not receive treatment.|1
7613063|NCT03049449|12021734|FG009|Overall Study|Did not receive treatment.|0
7613064|NCT03049449|12021725|FG000|Overall Study|Enrolled and removed from study with no treatment|0
7613065|NCT03049449|12021726|FG001|Overall Study|Enrolled and removed from study with no treatment|0
7613066|NCT03049449|12021727|FG002|Overall Study|Enrolled and removed from study with no treatment|1
7613067|NCT03049449|12021728|FG003|Overall Study|Enrolled and removed from study with no treatment|1
7613068|NCT03049449|12021729|FG004|Overall Study|Enrolled and removed from study with no treatment|0
7613069|NCT03049449|12021730|FG005|Overall Study|Enrolled and removed from study with no treatment|0
7613070|NCT03049449|12021731|FG006|Overall Study|Enrolled and removed from study with no treatment|0
7613071|NCT03049449|12021732|FG007|Overall Study|Enrolled and removed from study with no treatment|0
7613072|NCT03049449|12021733|FG008|Overall Study|Enrolled and removed from study with no treatment|0
7613073|NCT03049449|12021734|FG009|Overall Study|Enrolled and removed from study with no treatment|0
7613074|NCT03049449|12021725|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613075|NCT03049449|12021726|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613076|NCT03049449|12021727|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613077|NCT03049449|12021728|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613078|NCT03049449|12021729|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613079|NCT03049449|12021730|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613080|NCT03049449|12021731|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613081|NCT03049449|12021732|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1
7613082|NCT03049449|12021733|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613083|NCT03049449|12021734|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1
7613084|NCT03000569|12021754|FG000|Overall Study|Withdrawal by Subject|1
7613085|NCT03000569|12021755|FG001|Overall Study|Withdrawal by Subject|0
7779355|NCT00945191|12227468|FG000|Overall Study|Did not achieve a complete response|18
7779356|NCT00945191|12227468|FG000|Overall Study|Participant relocated to another state|1
7779357|NCT00945191|12227468|FG000|Overall Study|Disease progression|3
7779358|NCT00945191|12227468|FG000|Overall Study|Serious adverse event or adverse event|1
7779359|NCT00945191|12227468|FG000|Overall Study|Investigator's discretion|1
7779360|NCT00945243|12227472|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3
7779361|NCT00945321|12227523|FG000|Period 1|Adverse Event|0
7779362|NCT00945321|12227524|FG001|Period 1|Adverse Event|0
7779363|NCT00945321|12227525|FG002|Period 1|Adverse Event|0
7779364|NCT00945321|12227526|FG003|Period 1|Adverse Event|0
7779365|NCT00945321|12227527|FG004|Period 1|Adverse Event|1
7779366|NCT00945321|12227528|FG005|Period 1|Adverse Event|0
7779367|NCT00945321|12227523|FG000|Period 4|Lost to Follow-up|0
7779368|NCT00945321|12227524|FG001|Period 4|Lost to Follow-up|0
7779369|NCT00945321|12227525|FG002|Period 4|Lost to Follow-up|0
7779370|NCT00945321|12227526|FG003|Period 4|Lost to Follow-up|0
7779371|NCT00945321|12227527|FG004|Period 4|Lost to Follow-up|0
7779372|NCT00945321|12227528|FG005|Period 4|Lost to Follow-up|1
7779373|NCT00945477|12227555|FG000|Overall Study|Adverse Event|3
7779374|NCT00945477|12227555|FG000|Overall Study|Lack of Efficacy|2
7779375|NCT00945477|12227555|FG000|Overall Study|Withdrawal by Subject|1
7779376|NCT00945555|12227560|FG000|Overall Study|Referred to another hospital|5
7779377|NCT00945555|12227560|FG000|Overall Study|Worsening condition, intensive care unit|1
7613086|NCT03000530|12021772|FG000|Overall Study|Adverse Event|0
7613087|NCT03000530|12021773|FG001|Overall Study|Adverse Event|0
7613088|NCT03000530|12021774|FG002|Overall Study|Adverse Event|2
7613089|NCT03000530|12021772|FG000|Overall Study|Lost to Follow-up|0
7613090|NCT03000530|12021773|FG001|Overall Study|Lost to Follow-up|3
7613091|NCT03000530|12021774|FG002|Overall Study|Lost to Follow-up|1
7613092|NCT03000530|12021772|FG000|Overall Study|Withdrawal by Subject|0
7613093|NCT03000530|12021773|FG001|Overall Study|Withdrawal by Subject|2
7613094|NCT03000530|12021774|FG002|Overall Study|Withdrawal by Subject|1
7613095|NCT02978781|12021788|FG000|Part A|Adverse Event|1
7613096|NCT02978781|12021789|FG001|Part A|Adverse Event|1
7613097|NCT02978781|12021790|FG002|Part A|Adverse Event|0
7613098|NCT02978781|12021791|FG003|Part A|Adverse Event|0
7613099|NCT02978781|12021792|FG004|Part A|Adverse Event|0
7613100|NCT02978781|12021788|FG000|Part A|Withdrawal by Subject|0
7613101|NCT02978781|12021789|FG001|Part A|Withdrawal by Subject|1
7613102|NCT02978781|12021790|FG002|Part A|Withdrawal by Subject|0
7613103|NCT02978781|12021791|FG003|Part A|Withdrawal by Subject|0
7613104|NCT02978781|12021792|FG004|Part A|Withdrawal by Subject|0
7613105|NCT02978781|12021788|FG000|Part B|Withdrawal by Subject|0
7613106|NCT02978781|12021789|FG001|Part B|Withdrawal by Subject|0
7613107|NCT02978781|12021790|FG002|Part B|Withdrawal by Subject|0
7613108|NCT02978781|12021791|FG003|Part B|Withdrawal by Subject|1
7613109|NCT02978781|12021792|FG004|Part B|Withdrawal by Subject|0
7613110|NCT02978781|12021788|FG000|Part C|Adverse Event|0
7613111|NCT02978781|12021789|FG001|Part C|Adverse Event|0
7613112|NCT02978781|12021790|FG002|Part C|Adverse Event|0
7613113|NCT02978781|12021791|FG003|Part C|Adverse Event|0
7613114|NCT02978781|12021792|FG004|Part C|Adverse Event|2
7613115|NCT02978781|12021788|FG000|Part C|Withdrawal by Subject|0
7613116|NCT02978781|12021789|FG001|Part C|Withdrawal by Subject|0
7613117|NCT02978781|12021790|FG002|Part C|Withdrawal by Subject|0
7613118|NCT02978781|12021791|FG003|Part C|Withdrawal by Subject|0
7613119|NCT02978781|12021792|FG004|Part C|Withdrawal by Subject|1
7613120|NCT02978781|12021788|FG000|Part C|Tremor not improved due to Topamax discontinuation|0
7613121|NCT02978781|12021789|FG001|Part C|Tremor not improved due to Topamax discontinuation|0
7613122|NCT02978781|12021790|FG002|Part C|Tremor not improved due to Topamax discontinuation|0
7613123|NCT02978781|12021791|FG003|Part C|Tremor not improved due to Topamax discontinuation|0
7613124|NCT02978781|12021792|FG004|Part C|Tremor not improved due to Topamax discontinuation|1
7613125|NCT02964507|12021826|FG000|Overall Study|Protocol specified Withdrawal criteria met|0
7613126|NCT02964507|12021827|FG001|Overall Study|Protocol specified Withdrawal criteria met|1
7613127|NCT02964507|12021828|FG002|Overall Study|Protocol specified Withdrawal criteria met|0
7613128|NCT02964507|12021829|FG003|Overall Study|Protocol specified Withdrawal criteria met|0
7613129|NCT02964507|12021830|FG004|Overall Study|Protocol specified Withdrawal criteria met|1
7613130|NCT02964507|12021831|FG005|Overall Study|Protocol specified Withdrawal criteria met|0
7613131|NCT02964507|12021832|FG006|Overall Study|Protocol specified Withdrawal criteria met|0
7613132|NCT02964507|12021833|FG007|Overall Study|Protocol specified Withdrawal criteria met|0
7613133|NCT02964507|12021826|FG000|Overall Study|Ongoing at the time of analysis|1
7613134|NCT02964507|12021827|FG001|Overall Study|Ongoing at the time of analysis|0
7613135|NCT02964507|12021828|FG002|Overall Study|Ongoing at the time of analysis|2
7613136|NCT02964507|12021829|FG003|Overall Study|Ongoing at the time of analysis|0
7613137|NCT02964507|12021830|FG004|Overall Study|Ongoing at the time of analysis|0
7613138|NCT02964507|12021831|FG005|Overall Study|Ongoing at the time of analysis|0
7613139|NCT02964507|12021832|FG006|Overall Study|Ongoing at the time of analysis|0
7613140|NCT02964507|12021833|FG007|Overall Study|Ongoing at the time of analysis|0
7613141|NCT02964507|12021826|FG000|Overall Study|Study terminated by Sponsor|9
7613142|NCT02964507|12021827|FG001|Overall Study|Study terminated by Sponsor|1
7613143|NCT02964507|12021828|FG002|Overall Study|Study terminated by Sponsor|9
7613144|NCT02964507|12021829|FG003|Overall Study|Study terminated by Sponsor|3
7613145|NCT02964507|12021830|FG004|Overall Study|Study terminated by Sponsor|3
7613146|NCT02964507|12021831|FG005|Overall Study|Study terminated by Sponsor|2
7613147|NCT02964507|12021832|FG006|Overall Study|Study terminated by Sponsor|0
7613148|NCT02964507|12021833|FG007|Overall Study|Study terminated by Sponsor|0
7613149|NCT02964507|12021826|FG000|Overall Study|Other|3
7613150|NCT02964507|12021827|FG001|Overall Study|Other|0
7613151|NCT02964507|12021828|FG002|Overall Study|Other|0
7613152|NCT02964507|12021829|FG003|Overall Study|Other|0
7613153|NCT02964507|12021830|FG004|Overall Study|Other|1
7613154|NCT02964507|12021831|FG005|Overall Study|Other|0
7613155|NCT02964507|12021832|FG006|Overall Study|Other|0
7613156|NCT02964507|12021833|FG007|Overall Study|Other|0
7613157|NCT02964507|12021826|FG000|Overall Study|Death|11
7613158|NCT02964507|12021827|FG001|Overall Study|Death|9
7613159|NCT02964507|12021828|FG002|Overall Study|Death|12
7613160|NCT02964507|12021829|FG003|Overall Study|Death|2
7613161|NCT02964507|12021830|FG004|Overall Study|Death|10
7613162|NCT02964507|12021831|FG005|Overall Study|Death|5
7613163|NCT02964507|12021832|FG006|Overall Study|Death|0
7613164|NCT02964507|12021833|FG007|Overall Study|Death|0
7613165|NCT02964507|12021826|FG000|Overall Study|Withdrawal by Subject|1
7613166|NCT02964507|12021827|FG001|Overall Study|Withdrawal by Subject|0
7613167|NCT02964507|12021828|FG002|Overall Study|Withdrawal by Subject|1
7613168|NCT02964507|12021829|FG003|Overall Study|Withdrawal by Subject|1
7613169|NCT02964507|12021830|FG004|Overall Study|Withdrawal by Subject|0
7613170|NCT02964507|12021831|FG005|Overall Study|Withdrawal by Subject|1
7613171|NCT02964507|12021832|FG006|Overall Study|Withdrawal by Subject|0
7613172|NCT02964507|12021833|FG007|Overall Study|Withdrawal by Subject|0
7613173|NCT02964507|12021826|FG000|Overall Study|Physician Decision|1
7613174|NCT02964507|12021827|FG001|Overall Study|Physician Decision|0
7779378|NCT00945555|12227560|FG000|Overall Study|Withdrawal by Subject|2
7613175|NCT02964507|12021828|FG002|Overall Study|Physician Decision|1
7613176|NCT02964507|12021829|FG003|Overall Study|Physician Decision|0
7613177|NCT02964507|12021830|FG004|Overall Study|Physician Decision|1
7613178|NCT02964507|12021831|FG005|Overall Study|Physician Decision|0
7613179|NCT02964507|12021832|FG006|Overall Study|Physician Decision|0
7613180|NCT02964507|12021833|FG007|Overall Study|Physician Decision|0
7613181|NCT02942277|12021863|FG000|Year 1|Withdrawal by Subject|0
7613182|NCT02942277|12021864|FG001|Year 1|Withdrawal by Subject|0
7613183|NCT02942277|12021865|FG002|Year 1|Withdrawal by Subject|0
7613184|NCT02942277|12021866|FG003|Year 1|Withdrawal by Subject|0
7613185|NCT02942277|12021867|FG004|Year 1|Withdrawal by Subject|1
7613186|NCT02942277|12021868|FG005|Year 1|Withdrawal by Subject|3
7613187|NCT02942277|12021869|FG006|Year 1|Withdrawal by Subject|0
7613188|NCT02942277|12021870|FG007|Year 1|Withdrawal by Subject|1
7613189|NCT02942277|12021871|FG008|Year 1|Withdrawal by Subject|0
7613190|NCT02942277|12021872|FG009|Year 1|Withdrawal by Subject|0
7613191|NCT02942277|12021873|FG010|Year 1|Withdrawal by Subject|3
7613192|NCT02942277|12021863|FG000|Year 1|Travel|0
7613193|NCT02942277|12021864|FG001|Year 1|Travel|1
7613194|NCT02942277|12021865|FG002|Year 1|Travel|0
7613195|NCT02942277|12021866|FG003|Year 1|Travel|0
7613196|NCT02942277|12021867|FG004|Year 1|Travel|4
7613197|NCT02942277|12021868|FG005|Year 1|Travel|5
7613198|NCT02942277|12021869|FG006|Year 1|Travel|0
7613199|NCT02942277|12021870|FG007|Year 1|Travel|0
7613200|NCT02942277|12021871|FG008|Year 1|Travel|0
7613201|NCT02942277|12021872|FG009|Year 1|Travel|0
7613202|NCT02942277|12021873|FG010|Year 1|Travel|8
7779379|NCT00945555|12227560|FG000|Overall Study|Participant continued treatment at home|1
7779380|NCT00945555|12227560|FG000|Overall Study|Death|18
7779381|NCT00945555|12227560|FG000|Overall Study|Other|1
7779382|NCT00945659|12227578|FG000|Overall Study|Lost to Follow-up|7
7779383|NCT00945659|12227579|FG001|Overall Study|Lost to Follow-up|20
7779384|NCT00945659|12227580|FG002|Overall Study|Lost to Follow-up|17
7779385|NCT00945815|12227607|FG000|Overall Study|Death|3
7779386|NCT00945815|12227607|FG000|Overall Study|Not protocol specified|1
7779387|NCT00945815|12227607|FG000|Overall Study|Ineligible|3
7779388|NCT00945815|12227607|FG000|Overall Study|Did not begin protocol therapy|1
7779389|NCT00945893|12227622|FG000|Overall Study|Lost to Follow-up|2
7779390|NCT00945893|12227623|FG001|Overall Study|Lost to Follow-up|8
7779391|NCT00945893|12227622|FG000|Overall Study|Withdrawal of consent|1
7779392|NCT00945893|12227623|FG001|Overall Study|Withdrawal of consent|2
7779393|NCT00945906|12227633|FG000|Overall Study|Withdrawal by Subject|1
7779394|NCT00945906|12227633|FG000|Overall Study|Did not want to return for last visit|2
7779395|NCT00945906|12227633|FG000|Overall Study|Unable to return for last visit|2
7779396|NCT00945906|12227633|FG000|Overall Study|Moved to another country|2
7779397|NCT00945945|12227639|FG000|Overall Study|Adverse Event|15
7779398|NCT00945945|12227640|FG001|Overall Study|Adverse Event|35
7779399|NCT00945945|12227639|FG000|Overall Study|Withdrawal by Subject|7
7779400|NCT00945945|12227640|FG001|Overall Study|Withdrawal by Subject|10
7779401|NCT00945945|12227639|FG000|Overall Study|Lost to Follow-up|4
7779402|NCT00945945|12227640|FG001|Overall Study|Lost to Follow-up|5
7779403|NCT00945945|12227639|FG000|Overall Study|Lack of Efficacy|6
7779404|NCT00945945|12227640|FG001|Overall Study|Lack of Efficacy|2
7779405|NCT00945945|12227639|FG000|Overall Study|Protocol Violation|4
7779406|NCT00945945|12227640|FG001|Overall Study|Protocol Violation|2
7779407|NCT00945945|12227639|FG000|Overall Study|Entry Criteria Not Met|0
7779408|NCT00945945|12227640|FG001|Overall Study|Entry Criteria Not Met|1
7779409|NCT00946088|12227657|FG000|Overall Study|Withdrawal by Subject|0
7779410|NCT00946088|12227658|FG001|Overall Study|Withdrawal by Subject|1
7779411|NCT00946101|12227668|FG000|Overall Study|Lost to Follow-up|2
7779412|NCT00946101|12227669|FG001|Overall Study|Lost to Follow-up|1
7779413|NCT00946101|12227668|FG000|Overall Study|Withdrawal of consent|2
7779414|NCT00946101|12227669|FG001|Overall Study|Withdrawal of consent|0
7779415|NCT00946101|12227668|FG000|Overall Study|Physician Decision|0
7779416|NCT00946101|12227669|FG001|Overall Study|Physician Decision|1
7779417|NCT00946114|12227681|FG000|Overall Study|Death|5
7779418|NCT00946114|12227682|FG001|Overall Study|Death|2
7779419|NCT00946114|12227681|FG000|Overall Study|Other|1
7779420|NCT00946114|12227682|FG001|Overall Study|Other|0
7779421|NCT00946114|12227681|FG000|Overall Study|Withdrawal by Subject|2
7779422|NCT00946114|12227682|FG001|Overall Study|Withdrawal by Subject|0
7779423|NCT00946153|12227693|FG000|Phase 2|Adverse Event|0
7779424|NCT00946153|12227694|FG001|Phase 2|Adverse Event|0
7779425|NCT00946153|12227695|FG002|Phase 2|Adverse Event|0
7779426|NCT00946153|12227696|FG003|Phase 2|Adverse Event|0
7779427|NCT00946153|12227697|FG004|Phase 2|Adverse Event|6
7779428|NCT00946153|12227693|FG000|Phase 2|Need more reduction of dose|0
7779429|NCT00946153|12227694|FG001|Phase 2|Need more reduction of dose|0
7779430|NCT00946153|12227695|FG002|Phase 2|Need more reduction of dose|0
7779431|NCT00946153|12227696|FG003|Phase 2|Need more reduction of dose|0
7779432|NCT00946153|12227697|FG004|Phase 2|Need more reduction of dose|2
7779433|NCT00946153|12227693|FG000|Phase 2|Physician Decision|0
7779434|NCT00946153|12227694|FG001|Phase 2|Physician Decision|0
7779435|NCT00946153|12227695|FG002|Phase 2|Physician Decision|0
7613203|NCT02942277|12021863|FG000|Year 1|Joined Army|0
7613204|NCT02942277|12021864|FG001|Year 1|Joined Army|1
7779436|NCT00946153|12227696|FG003|Phase 2|Physician Decision|0
7779437|NCT00946153|12227697|FG004|Phase 2|Physician Decision|1
7779438|NCT00946153|12227693|FG000|Phase 2|14 days washout for recovery due to AE|0
7779439|NCT00946153|12227694|FG001|Phase 2|14 days washout for recovery due to AE|0
7779440|NCT00946153|12227695|FG002|Phase 2|14 days washout for recovery due to AE|0
7613205|NCT02942277|12021865|FG002|Year 1|Joined Army|0
7779441|NCT00946153|12227696|FG003|Phase 2|14 days washout for recovery due to AE|0
7779442|NCT00946153|12227697|FG004|Phase 2|14 days washout for recovery due to AE|4
7613206|NCT02942277|12021866|FG003|Year 1|Joined Army|0
7613207|NCT02942277|12021867|FG004|Year 1|Joined Army|0
7613208|NCT02942277|12021868|FG005|Year 1|Joined Army|0
7613209|NCT02942277|12021869|FG006|Year 1|Joined Army|0
7613210|NCT02942277|12021870|FG007|Year 1|Joined Army|0
7613211|NCT02942277|12021871|FG008|Year 1|Joined Army|0
7613212|NCT02942277|12021872|FG009|Year 1|Joined Army|0
7613213|NCT02942277|12021873|FG010|Year 1|Joined Army|0
7613214|NCT02942277|12021863|FG000|Year 1|Subject met withdrawal criteria|0
7613215|NCT02942277|12021864|FG001|Year 1|Subject met withdrawal criteria|0
7613216|NCT02942277|12021865|FG002|Year 1|Subject met withdrawal criteria|0
7613217|NCT02942277|12021866|FG003|Year 1|Subject met withdrawal criteria|1
7613218|NCT02942277|12021867|FG004|Year 1|Subject met withdrawal criteria|0
7613219|NCT02942277|12021868|FG005|Year 1|Subject met withdrawal criteria|0
7613220|NCT02942277|12021869|FG006|Year 1|Subject met withdrawal criteria|0
7613221|NCT02942277|12021870|FG007|Year 1|Subject met withdrawal criteria|0
7613222|NCT02942277|12021871|FG008|Year 1|Subject met withdrawal criteria|0
7613223|NCT02942277|12021872|FG009|Year 1|Subject met withdrawal criteria|0
7613224|NCT02942277|12021873|FG010|Year 1|Subject met withdrawal criteria|0
7613225|NCT02942277|12021863|FG000|Year 1|Lost to Follow-up|0
7613226|NCT02942277|12021864|FG001|Year 1|Lost to Follow-up|0
7613227|NCT02942277|12021865|FG002|Year 1|Lost to Follow-up|0
7613228|NCT02942277|12021866|FG003|Year 1|Lost to Follow-up|0
7613229|NCT02942277|12021867|FG004|Year 1|Lost to Follow-up|1
7613230|NCT02942277|12021868|FG005|Year 1|Lost to Follow-up|0
7613231|NCT02942277|12021869|FG006|Year 1|Lost to Follow-up|0
7613232|NCT02942277|12021870|FG007|Year 1|Lost to Follow-up|0
7779443|NCT00946192|12227717|FG000|Overall Study|Lost to Follow-up|6
7613233|NCT02942277|12021871|FG008|Year 1|Lost to Follow-up|0
7613234|NCT02942277|12021872|FG009|Year 1|Lost to Follow-up|0
7613235|NCT02942277|12021873|FG010|Year 1|Lost to Follow-up|2
7613236|NCT02942277|12021863|FG000|Year 1|Protocol Violation|0
7613237|NCT02942277|12021864|FG001|Year 1|Protocol Violation|0
7613238|NCT02942277|12021865|FG002|Year 1|Protocol Violation|0
7613239|NCT02942277|12021866|FG003|Year 1|Protocol Violation|0
7779444|NCT00946192|12227718|FG001|Overall Study|Lost to Follow-up|11
7779445|NCT00946192|12227719|FG002|Overall Study|Lost to Follow-up|9
7779446|NCT00946192|12227717|FG000|Overall Study|Withdrawal by Subject|10
7779447|NCT00946192|12227718|FG001|Overall Study|Withdrawal by Subject|7
7779448|NCT00946192|12227719|FG002|Overall Study|Withdrawal by Subject|3
7779449|NCT00946192|12227717|FG000|Overall Study|Did not start medication|2
7779450|NCT00946192|12227718|FG001|Overall Study|Did not start medication|0
7779451|NCT00946192|12227719|FG002|Overall Study|Did not start medication|0
7613240|NCT02942277|12021867|FG004|Year 1|Protocol Violation|1
7613241|NCT02942277|12021868|FG005|Year 1|Protocol Violation|1
7613242|NCT02942277|12021869|FG006|Year 1|Protocol Violation|0
7613243|NCT02942277|12021870|FG007|Year 1|Protocol Violation|0
7613244|NCT02942277|12021871|FG008|Year 1|Protocol Violation|0
7613245|NCT02942277|12021872|FG009|Year 1|Protocol Violation|0
7613246|NCT02942277|12021873|FG010|Year 1|Protocol Violation|2
7613247|NCT02942277|12021863|FG000|Year 1|Pregnancy|0
7613248|NCT02942277|12021864|FG001|Year 1|Pregnancy|0
7613249|NCT02942277|12021865|FG002|Year 1|Pregnancy|0
7613250|NCT02942277|12021866|FG003|Year 1|Pregnancy|0
7613251|NCT02942277|12021867|FG004|Year 1|Pregnancy|0
7613252|NCT02942277|12021868|FG005|Year 1|Pregnancy|1
7613253|NCT02942277|12021869|FG006|Year 1|Pregnancy|0
7613254|NCT02942277|12021870|FG007|Year 1|Pregnancy|0
7613255|NCT02942277|12021871|FG008|Year 1|Pregnancy|0
7613256|NCT02942277|12021872|FG009|Year 1|Pregnancy|0
7613257|NCT02942277|12021873|FG010|Year 1|Pregnancy|0
7613258|NCT02942277|12021863|FG000|Year 2|Lost to Follow-up|0
7613259|NCT02942277|12021864|FG001|Year 2|Lost to Follow-up|0
7613260|NCT02942277|12021865|FG002|Year 2|Lost to Follow-up|0
7613261|NCT02942277|12021866|FG003|Year 2|Lost to Follow-up|0
7613262|NCT02942277|12021867|FG004|Year 2|Lost to Follow-up|2
7613263|NCT02942277|12021868|FG005|Year 2|Lost to Follow-up|1
7613264|NCT02942277|12021869|FG006|Year 2|Lost to Follow-up|0
7613265|NCT02942277|12021870|FG007|Year 2|Lost to Follow-up|0
7613266|NCT02942277|12021871|FG008|Year 2|Lost to Follow-up|0
7613267|NCT02942277|12021872|FG009|Year 2|Lost to Follow-up|0
7613268|NCT02942277|12021873|FG010|Year 2|Lost to Follow-up|0
7613269|NCT02942277|12021863|FG000|Year 2|Did not rescreen|0
7613270|NCT02942277|12021864|FG001|Year 2|Did not rescreen|0
7613271|NCT02942277|12021865|FG002|Year 2|Did not rescreen|1
7613272|NCT02942277|12021866|FG003|Year 2|Did not rescreen|1
7613273|NCT02942277|12021867|FG004|Year 2|Did not rescreen|9
7613274|NCT02942277|12021868|FG005|Year 2|Did not rescreen|6
7613275|NCT02942277|12021869|FG006|Year 2|Did not rescreen|0
7613276|NCT02942277|12021870|FG007|Year 2|Did not rescreen|1
7613277|NCT02942277|12021871|FG008|Year 2|Did not rescreen|0
7613278|NCT02942277|12021872|FG009|Year 2|Did not rescreen|0
7613279|NCT02942277|12021873|FG010|Year 2|Did not rescreen|21
7613280|NCT02942277|12021863|FG000|Year 2|Met withdrawal criteria|0
7613281|NCT02942277|12021864|FG001|Year 2|Met withdrawal criteria|0
7613282|NCT02942277|12021865|FG002|Year 2|Met withdrawal criteria|0
7613283|NCT02942277|12021866|FG003|Year 2|Met withdrawal criteria|0
7613284|NCT02942277|12021867|FG004|Year 2|Met withdrawal criteria|1
7613285|NCT02942277|12021868|FG005|Year 2|Met withdrawal criteria|2
7613286|NCT02942277|12021869|FG006|Year 2|Met withdrawal criteria|0
7613287|NCT02942277|12021870|FG007|Year 2|Met withdrawal criteria|0
7613288|NCT02942277|12021871|FG008|Year 2|Met withdrawal criteria|0
7613289|NCT02942277|12021872|FG009|Year 2|Met withdrawal criteria|0
7613290|NCT02942277|12021873|FG010|Year 2|Met withdrawal criteria|1
7613291|NCT02942277|12021863|FG000|Year 2|Travel|0
7613292|NCT02942277|12021864|FG001|Year 2|Travel|1
7613293|NCT02942277|12021865|FG002|Year 2|Travel|0
7613294|NCT02942277|12021866|FG003|Year 2|Travel|0
7613295|NCT02942277|12021867|FG004|Year 2|Travel|0
7613296|NCT02942277|12021868|FG005|Year 2|Travel|1
7613297|NCT02942277|12021869|FG006|Year 2|Travel|0
7613298|NCT02942277|12021870|FG007|Year 2|Travel|0
7613299|NCT02942277|12021871|FG008|Year 2|Travel|0
7613300|NCT02942277|12021872|FG009|Year 2|Travel|1
7613301|NCT02942277|12021873|FG010|Year 2|Travel|3
7613302|NCT02942277|12021863|FG000|Year 2|Non-compliant|0
7613303|NCT02942277|12021864|FG001|Year 2|Non-compliant|0
7613304|NCT02942277|12021865|FG002|Year 2|Non-compliant|0
7613305|NCT02942277|12021866|FG003|Year 2|Non-compliant|0
7613306|NCT02942277|12021867|FG004|Year 2|Non-compliant|1
7613307|NCT02942277|12021868|FG005|Year 2|Non-compliant|1
7613308|NCT02942277|12021869|FG006|Year 2|Non-compliant|0
7613309|NCT02942277|12021870|FG007|Year 2|Non-compliant|0
7613310|NCT02942277|12021871|FG008|Year 2|Non-compliant|0
7613311|NCT02942277|12021872|FG009|Year 2|Non-compliant|0
7613312|NCT02942277|12021873|FG010|Year 2|Non-compliant|0
7613313|NCT02942277|12021863|FG000|Year 2|Withdrawal by Subject|0
7613314|NCT02942277|12021864|FG001|Year 2|Withdrawal by Subject|0
7613315|NCT02942277|12021865|FG002|Year 2|Withdrawal by Subject|0
7613316|NCT02942277|12021866|FG003|Year 2|Withdrawal by Subject|0
7613317|NCT02942277|12021867|FG004|Year 2|Withdrawal by Subject|0
7613318|NCT02942277|12021868|FG005|Year 2|Withdrawal by Subject|0
7613319|NCT02942277|12021869|FG006|Year 2|Withdrawal by Subject|1
7613320|NCT02942277|12021870|FG007|Year 2|Withdrawal by Subject|0
7613321|NCT02942277|12021871|FG008|Year 2|Withdrawal by Subject|0
7613322|NCT02942277|12021872|FG009|Year 2|Withdrawal by Subject|0
7613323|NCT02942277|12021873|FG010|Year 2|Withdrawal by Subject|0
7613324|NCT02942017|12021902|FG000|Overall Study|Adverse Event|0
7613325|NCT02942017|12021903|FG001|Overall Study|Adverse Event|1
7613326|NCT02942017|12021902|FG000|Overall Study|Withdrawal by Subject|0
7613327|NCT02942017|12021903|FG001|Overall Study|Withdrawal by Subject|1
7613328|NCT02942017|12021902|FG000|Overall Study|Lost to Follow-up|1
7613329|NCT02942017|12021903|FG001|Overall Study|Lost to Follow-up|1
7613330|NCT02942017|12021902|FG000|Overall Study|Randomized but not dosed|1
7613331|NCT02942017|12021903|FG001|Overall Study|Randomized but not dosed|3
7613332|NCT02942004|12021912|FG000|Overall Study|Withdrawal by Subject|0
7613333|NCT02942004|12021913|FG001|Overall Study|Withdrawal by Subject|2
7613334|NCT02942004|12021914|FG002|Overall Study|Withdrawal by Subject|3
7613335|NCT02942004|12021912|FG000|Overall Study|Lost to Follow-up|1
7613336|NCT02942004|12021913|FG001|Overall Study|Lost to Follow-up|1
7613337|NCT02942004|12021914|FG002|Overall Study|Lost to Follow-up|2
7613338|NCT02942004|12021912|FG000|Overall Study|Randomized but not dosed|3
7613339|NCT02942004|12021913|FG001|Overall Study|Randomized but not dosed|9
7613340|NCT02942004|12021914|FG002|Overall Study|Randomized but not dosed|4
7613341|NCT02861014|12021922|FG000|Primary Analysis|Adverse Event|7
7613342|NCT02861014|12021922|FG000|Primary Analysis|Death|1
7613343|NCT02861014|12021922|FG000|Primary Analysis|Lack of Efficacy|3
7613344|NCT02861014|12021922|FG000|Primary Analysis|Physician Decision|2
7613345|NCT02861014|12021922|FG000|Primary Analysis|Pregnancy|4
7613346|NCT02861014|12021922|FG000|Primary Analysis|Protocol Violation|2
7613347|NCT02861014|12021922|FG000|Primary Analysis|Study Terminated By Sponsor|3
7613348|NCT02861014|12021922|FG000|Primary Analysis|Withdrawal by Subject|14
7613349|NCT02861014|12021922|FG000|Primary Analysis|Commercial ocrelizumab|3
7613350|NCT02861014|12021922|FG000|Safety Follow-up|Adverse Event|1
7613351|NCT02861014|12021922|FG000|Safety Follow-up|Pregnancy|1
7613352|NCT02861014|12021922|FG000|Safety Follow-up|Withdrawal by Subject|9
7613353|NCT02861014|12021922|FG000|Safety Follow-up|Study terminated by sponsor|1
7613354|NCT02861014|12021922|FG000|Safety Follow-up|Physician Decision|1
7613355|NCT02861014|12021922|FG000|Safety Follow-up|Roll-over to a long term extension study|1
7613356|NCT02861014|12021922|FG000|Safety Follow-up|Commercial ocrelizumab|36
7779452|NCT00946296|12227742|FG000|Overall Study|Physician Decision|3
7779453|NCT00946296|12227743|FG001|Overall Study|Physician Decision|0
7779454|NCT00946309|12227751|FG000|Overall Study|Protocol Violation|1
7779455|NCT00946309|12227752|FG001|Overall Study|Protocol Violation|0
7779456|NCT00946309|12227751|FG000|Overall Study|Lost to Follow-up|0
7779457|NCT00946309|12227752|FG001|Overall Study|Lost to Follow-up|1
7779458|NCT00946309|12227751|FG000|Overall Study|Procedure cancelled/discontinued|0
7779459|NCT00946309|12227752|FG001|Overall Study|Procedure cancelled/discontinued|3
7779460|NCT00946322|12227759|FG000|Pre-treatment|participant failure to follow up|1
7779461|NCT00946322|12227759|FG000|Post-treatment|participant failure to follow up|2
7779462|NCT00946530|12227785|FG000|Overall Study|Withdrawal by Subject|0
7779463|NCT00946530|12227786|FG001|Overall Study|Withdrawal by Subject|3
7779464|NCT00946530|12227787|FG002|Overall Study|Withdrawal by Subject|0
7779465|NCT00946530|12227788|FG003|Overall Study|Withdrawal by Subject|3
7779466|NCT00946530|12227785|FG000|Overall Study|Physician Decision|1
7779467|NCT00946530|12227786|FG001|Overall Study|Physician Decision|1
7613373|NCT02726880|12021946|FG000|Overall Study|Withdrawal by Subject|2
7613374|NCT02726880|12021947|FG001|Overall Study|Withdrawal by Subject|0
7613375|NCT02726880|12021946|FG000|Overall Study|Lost to Follow-up|1
7613376|NCT02726880|12021947|FG001|Overall Study|Lost to Follow-up|3
7864091|NCT01609556|12353458|FG014|Dose Expansion: Maximum 124 Weeks|Death|0
7864092|NCT01609556|12353459|FG015|Dose Expansion: Maximum 124 Weeks|Death|3
7613380|NCT02583048|12021983|FG000|Overall Study|Withdrawal by Subject|0
7613381|NCT02583048|12021984|FG001|Overall Study|Withdrawal by Subject|1
7613382|NCT02583048|12021985|FG002|Overall Study|Withdrawal by Subject|0
7613383|NCT02583048|12021983|FG000|Overall Study|Failed to meet eligibility criterion|0
7613384|NCT02583048|12021984|FG001|Overall Study|Failed to meet eligibility criterion|0
7613385|NCT02583048|12021985|FG002|Overall Study|Failed to meet eligibility criterion|1
7779468|NCT00946530|12227787|FG002|Overall Study|Physician Decision|1
7779469|NCT00946530|12227788|FG003|Overall Study|Physician Decision|1
7779470|NCT00946647|12227807|FG000|Phase 1 Part|Adverse Event|2
7779471|NCT00946647|12227808|FG001|Phase 1 Part|Adverse Event|5
7779472|NCT00946647|12227809|FG002|Phase 1 Part|Adverse Event|3
7779473|NCT00946647|12227810|FG003|Phase 1 Part|Adverse Event|0
7779474|NCT00946647|12227811|FG004|Phase 1 Part|Adverse Event|0
7779475|NCT00946647|12227807|FG000|Phase 1 Part|Disease progression|3
7779476|NCT00946647|12227808|FG001|Phase 1 Part|Disease progression|6
7779477|NCT00946647|12227809|FG002|Phase 1 Part|Disease progression|1
7779478|NCT00946647|12227810|FG003|Phase 1 Part|Disease progression|0
7779479|NCT00946647|12227811|FG004|Phase 1 Part|Disease progression|0
7779480|NCT00946647|12227807|FG000|Phase 1 Part|Withdrawal by Subject|1
7779481|NCT00946647|12227808|FG001|Phase 1 Part|Withdrawal by Subject|4
7779482|NCT00946647|12227809|FG002|Phase 1 Part|Withdrawal by Subject|3
7779483|NCT00946647|12227810|FG003|Phase 1 Part|Withdrawal by Subject|0
7779484|NCT00946647|12227811|FG004|Phase 1 Part|Withdrawal by Subject|0
7779485|NCT00946647|12227807|FG000|Phase 1 Part|Abnormal values|0
7779486|NCT00946647|12227808|FG001|Phase 1 Part|Abnormal values|2
7779487|NCT00946647|12227809|FG002|Phase 1 Part|Abnormal values|0
7779488|NCT00946647|12227810|FG003|Phase 1 Part|Abnormal values|0
7779489|NCT00946647|12227811|FG004|Phase 1 Part|Abnormal values|0
7779490|NCT00946647|12227807|FG000|Phase 1 Part|Reason missing|0
7779491|NCT00946647|12227808|FG001|Phase 1 Part|Reason missing|1
7779492|NCT00946647|12227809|FG002|Phase 1 Part|Reason missing|0
7779493|NCT00946647|12227810|FG003|Phase 1 Part|Reason missing|0
7779494|NCT00946647|12227811|FG004|Phase 1 Part|Reason missing|0
7779495|NCT00946647|12227807|FG000|Phase ll Part|Untreated|0
7779496|NCT00946647|12227808|FG001|Phase ll Part|Untreated|0
7779497|NCT00946647|12227809|FG002|Phase ll Part|Untreated|0
7779498|NCT00946647|12227810|FG003|Phase ll Part|Untreated|0
7779499|NCT00946647|12227811|FG004|Phase ll Part|Untreated|2
7779500|NCT00946647|12227807|FG000|Phase ll Part|Adverse Event|0
7779501|NCT00946647|12227808|FG001|Phase ll Part|Adverse Event|0
7613414|NCT02539160|12022007|FG000|Phase 1 Pre-crossover|Adverse Event|3
7613415|NCT02539160|12022008|FG001|Phase 1 Pre-crossover|Adverse Event|3
7613416|NCT02539160|12022009|FG002|Phase 1 Pre-crossover|Adverse Event|2
7613417|NCT02539160|12022010|FG003|Phase 1 Pre-crossover|Adverse Event|1
7613418|NCT02539160|12022007|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2
7613419|NCT02539160|12022008|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1
7613420|NCT02539160|12022009|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1
7613421|NCT02539160|12022010|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0
7613422|NCT02539160|12022007|FG000|Phase 1 Pre-crossover|Protocol Violation|0
7613423|NCT02539160|12022008|FG001|Phase 1 Pre-crossover|Protocol Violation|0
7613424|NCT02539160|12022009|FG002|Phase 1 Pre-crossover|Protocol Violation|0
7613425|NCT02539160|12022010|FG003|Phase 1 Pre-crossover|Protocol Violation|2
7613426|NCT02507973|12022020|FG000|Overall Study|Adverse Event|1
7613427|NCT02477618|12022028|FG000|Overall Study|Completed Visits but Discontinued Drug|2
7613428|NCT02477618|12022029|FG001|Overall Study|Completed Visits but Discontinued Drug|1
7613429|NCT02477618|12022028|FG000|Overall Study|Died in Double-Blind Treatment Period|11
7779502|NCT00946647|12227809|FG002|Phase ll Part|Adverse Event|0
7779503|NCT00946647|12227810|FG003|Phase ll Part|Adverse Event|10
7779504|NCT00946647|12227811|FG004|Phase ll Part|Adverse Event|6
7779505|NCT00946647|12227807|FG000|Phase ll Part|Withdrawal by Subject|0
7779506|NCT00946647|12227808|FG001|Phase ll Part|Withdrawal by Subject|0
7779507|NCT00946647|12227809|FG002|Phase ll Part|Withdrawal by Subject|0
7779508|NCT00946647|12227810|FG003|Phase ll Part|Withdrawal by Subject|8
7779509|NCT00946647|12227811|FG004|Phase ll Part|Withdrawal by Subject|6
7779510|NCT00946647|12227807|FG000|Phase ll Part|Administrative problems|0
7779511|NCT00946647|12227808|FG001|Phase ll Part|Administrative problems|0
7779512|NCT00946647|12227809|FG002|Phase ll Part|Administrative problems|0
7779513|NCT00946647|12227810|FG003|Phase ll Part|Administrative problems|3
7779514|NCT00946647|12227811|FG004|Phase ll Part|Administrative problems|8
7779515|NCT00946647|12227807|FG000|Phase ll Part|Death|0
7779516|NCT00946647|12227808|FG001|Phase ll Part|Death|0
7613430|NCT02477618|12022029|FG001|Overall Study|Died in Double-Blind Treatment Period|11
7613431|NCT02477618|12022028|FG000|Overall Study|Adverse Event|1
7613432|NCT02477618|12022029|FG001|Overall Study|Adverse Event|1
7613433|NCT02477618|12022028|FG000|Overall Study|Transferred Away from Study Site|1
7613434|NCT02477618|12022029|FG001|Overall Study|Transferred Away from Study Site|0
7613435|NCT02477618|12022028|FG000|Overall Study|Left Study Site for Rehabilitation|0
7613436|NCT02477618|12022029|FG001|Overall Study|Left Study Site for Rehabilitation|1
7613437|NCT02003924|12022061|FG000|Double-blind Phase|Lost to Follow-up|2
7613438|NCT02003924|12022062|FG001|Double-blind Phase|Lost to Follow-up|1
7613439|NCT02003924|12022063|FG002|Double-blind Phase|Lost to Follow-up|0
7613440|NCT02003924|12022061|FG000|Double-blind Phase|Protocol Violation|1
7613441|NCT02003924|12022062|FG001|Double-blind Phase|Protocol Violation|2
7613442|NCT02003924|12022063|FG002|Double-blind Phase|Protocol Violation|0
7613443|NCT02003924|12022061|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71
7613444|NCT02003924|12022062|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47
7613445|NCT02003924|12022063|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0
7613446|NCT02003924|12022061|FG000|Double-blind Phase|Disease Progression|229
7613447|NCT02003924|12022062|FG001|Double-blind Phase|Disease Progression|247
7613448|NCT02003924|12022063|FG002|Double-blind Phase|Disease Progression|0
7613449|NCT02003924|12022061|FG000|Double-blind Phase|Adverse Event|120
7613450|NCT02003924|12022062|FG001|Double-blind Phase|Adverse Event|31
7613451|NCT02003924|12022063|FG002|Double-blind Phase|Adverse Event|0
7613452|NCT02003924|12022061|FG000|Double-blind Phase|Randomized But not Treated|3
7613453|NCT02003924|12022062|FG001|Double-blind Phase|Randomized But not Treated|3
7613454|NCT02003924|12022063|FG002|Double-blind Phase|Randomized But not Treated|0
7613455|NCT02003924|12022061|FG000|Double-blind Phase|Other|29
7613456|NCT02003924|12022062|FG001|Double-blind Phase|Other|50
7613457|NCT02003924|12022063|FG002|Double-blind Phase|Other|0
7613458|NCT02003924|12022061|FG000|Open-label Phase|Lost to Follow-up|0
7613459|NCT02003924|12022062|FG001|Open-label Phase|Lost to Follow-up|0
7613460|NCT02003924|12022063|FG002|Open-label Phase|Lost to Follow-up|1
7613461|NCT02003924|12022061|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9
7613462|NCT02003924|12022062|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0
7613463|NCT02003924|12022063|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1
7613464|NCT02003924|12022061|FG000|Open-label Phase|Disease Progression|59
7779517|NCT00946647|12227809|FG002|Phase ll Part|Death|0
7613465|NCT02003924|12022062|FG001|Open-label Phase|Disease Progression|0
7613466|NCT02003924|12022063|FG002|Open-label Phase|Disease Progression|5
7613467|NCT02003924|12022061|FG000|Open-label Phase|Adverse Event|25
7613468|NCT02003924|12022062|FG001|Open-label Phase|Adverse Event|0
7613469|NCT02003924|12022063|FG002|Open-label Phase|Adverse Event|10
7613470|NCT02003924|12022061|FG000|Open-label Phase|Other|7
7613471|NCT02003924|12022062|FG001|Open-label Phase|Other|0
7613472|NCT02003924|12022063|FG002|Open-label Phase|Other|0
7613473|NCT02003924|12022061|FG000|Long-term Follow-up Phase|Death|288
7613474|NCT02003924|12022062|FG001|Long-term Follow-up Phase|Death|174
7613475|NCT02003924|12022063|FG002|Long-term Follow-up Phase|Death|4
7613476|NCT02003924|12022061|FG000|Long-term Follow-up Phase|Lost to Follow-up|8
7613477|NCT02003924|12022062|FG001|Long-term Follow-up Phase|Lost to Follow-up|6
7613478|NCT02003924|12022063|FG002|Long-term Follow-up Phase|Lost to Follow-up|1
7613479|NCT02003924|12022061|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66
7613480|NCT02003924|12022062|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55
7613481|NCT02003924|12022063|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1
7613482|NCT02003924|12022061|FG000|Long-term Follow-up Phase|Other|5
7613483|NCT02003924|12022062|FG001|Long-term Follow-up Phase|Other|2
7613484|NCT02003924|12022063|FG002|Long-term Follow-up Phase|Other|1
7613485|NCT01971970|12022072|FG000|Baseline Until Week 6|Stopped anti-TNF use|1
7613486|NCT01971970|12022073|FG001|Baseline Until Week 6|Stopped anti-TNF use|0
7613487|NCT01971970|12022072|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0
7613488|NCT01971970|12022073|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1
7613489|NCT01971970|12022072|FG000|Week 14 Until Week 22|Lost to Follow-up|0
7613490|NCT01971970|12022073|FG001|Week 14 Until Week 22|Lost to Follow-up|1
7613491|NCT01971970|12022072|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7
7613492|NCT01971970|12022073|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3
7779518|NCT00946647|12227810|FG003|Phase ll Part|Death|7
7779519|NCT00946647|12227811|FG004|Phase ll Part|Death|4
7779520|NCT00946647|12227807|FG000|Phase ll Part|Disease progression|0
7779521|NCT00946647|12227808|FG001|Phase ll Part|Disease progression|0
7779522|NCT00946647|12227809|FG002|Phase ll Part|Disease progression|0
7779523|NCT00946647|12227810|FG003|Phase ll Part|Disease progression|6
7779524|NCT00946647|12227811|FG004|Phase ll Part|Disease progression|14
7779525|NCT00946647|12227807|FG000|Phase ll Part|Protocol Violation|0
7779526|NCT00946647|12227808|FG001|Phase ll Part|Protocol Violation|0
7779527|NCT00946647|12227809|FG002|Phase ll Part|Protocol Violation|0
7779528|NCT00946647|12227810|FG003|Phase ll Part|Protocol Violation|4
7779529|NCT00946647|12227811|FG004|Phase ll Part|Protocol Violation|2
7779530|NCT00946647|12227807|FG000|Phase ll Part|Subj cond no longer required study drug|0
7779531|NCT00946647|12227808|FG001|Phase ll Part|Subj cond no longer required study drug|0
7779532|NCT00946647|12227809|FG002|Phase ll Part|Subj cond no longer required study drug|0
7779533|NCT00946647|12227810|FG003|Phase ll Part|Subj cond no longer required study drug|2
7779534|NCT00946647|12227811|FG004|Phase ll Part|Subj cond no longer required study drug|0
7779535|NCT00946712|12227826|FG000|Overall Study|Adverse Event|118
7779536|NCT00946712|12227827|FG001|Overall Study|Adverse Event|124
7779537|NCT00946712|12227826|FG000|Overall Study|Disease progression|308
7779538|NCT00946712|12227827|FG001|Overall Study|Disease progression|404
7779539|NCT00946712|12227826|FG000|Overall Study|Death|21
7779540|NCT00946712|12227827|FG001|Overall Study|Death|22
7779541|NCT00946712|12227826|FG000|Overall Study|No treatment given|25
7779542|NCT00946712|12227827|FG001|Overall Study|No treatment given|29
7779543|NCT00946712|12227826|FG000|Overall Study|Other reasons|61
7779544|NCT00946712|12227827|FG001|Overall Study|Other reasons|73
7779545|NCT00946712|12227826|FG000|Overall Study|On Treatment|0
7779546|NCT00946712|12227827|FG001|Overall Study|On Treatment|4
7779547|NCT00946712|12227826|FG000|Overall Study|Ineligible|14
7779548|NCT00946712|12227827|FG001|Overall Study|Ineligible|6
7779549|NCT00946881|12227834|FG000|First Treatment|Withdrawal by Subject|1
7779550|NCT00946881|12227834|FG000|First Treatment|Patient relocated to another state|1
7779551|NCT00946881|12227834|FG000|Retreatment|Withdrawal by Subject|1
7779552|NCT00946920|12227861|FG000|Overall Study|Withdrawal by Subject|28
7779553|NCT00946920|12227862|FG001|Overall Study|Withdrawal by Subject|15
7779554|NCT00946920|12227861|FG000|Overall Study|Lost to Follow-up|2
7613493|NCT01971970|12022072|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1
7613494|NCT01971970|12022073|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0
7613495|NCT01971970|12022072|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0
7613496|NCT01971970|12022073|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1
7613497|NCT01971970|12022072|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1
7613498|NCT01971970|12022073|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3
7613499|NCT01969409|12022086|FG000|Overall Study|Death|2
7613500|NCT01969409|12022087|FG001|Overall Study|Death|2
7613501|NCT01969409|12022086|FG000|Overall Study|Transplant|1
7613502|NCT01969409|12022087|FG001|Overall Study|Transplant|1
7613503|NCT01969409|12022086|FG000|Overall Study|Withdrawal by Subject|0
7613504|NCT01969409|12022087|FG001|Overall Study|Withdrawal by Subject|1
7613505|NCT01459497|12022095|FG000|Overall Study|Inability to meet trial constraints.|1
7613506|NCT01459497|12022096|FG001|Overall Study|Inability to meet trial constraints.|0
7779555|NCT00946920|12227862|FG001|Overall Study|Lost to Follow-up|2
7779556|NCT00946920|12227861|FG000|Overall Study|Physician Decision|5
7613507|NCT01459497|12022095|FG000|Overall Study|Physician Decision|1
7613508|NCT01459497|12022096|FG001|Overall Study|Physician Decision|1
7613509|NCT01459497|12022095|FG000|Overall Study|Hospitalization.|0
7613510|NCT01459497|12022096|FG001|Overall Study|Hospitalization.|3
7613511|NCT01459497|12022095|FG000|Overall Study|Disease progression.|0
7613512|NCT01459497|12022096|FG001|Overall Study|Disease progression.|1
7613513|NCT01307787|12022104|FG000|Overall Study|Withdrawal by Subject|2
7613514|NCT01307787|12022105|FG001|Overall Study|Withdrawal by Subject|0
7613515|NCT01250912|12022116|FG000|Overall Study|Lost to Follow-up|1
7613516|NCT01141712|12022132|FG000|Overall Study|Disease progression|3
7613517|NCT00659646|12022149|FG000|Overall Study|Protocol Violation|12
7613518|NCT00659646|12022150|FG001|Overall Study|Protocol Violation|8
7613519|NCT00659646|12022149|FG000|Overall Study|Adverse Event|1
7613520|NCT00659646|12022150|FG001|Overall Study|Adverse Event|0
7613521|NCT00659646|12022149|FG000|Overall Study|Lost to Follow-up|1
7613522|NCT00659646|12022150|FG001|Overall Study|Lost to Follow-up|0
7613523|NCT00659646|12022149|FG000|Overall Study|protocol noncompliance after randomized|1
7613524|NCT00659646|12022150|FG001|Overall Study|protocol noncompliance after randomized|0
7613525|NCT00477412|12022162|FG000|Overall Study|Death|0
7613526|NCT00477412|12022163|FG001|Overall Study|Death|0
7613527|NCT00477412|12022164|FG002|Overall Study|Death|0
7613528|NCT00477412|12022165|FG003|Overall Study|Death|4
7613529|NCT00477412|12022162|FG000|Overall Study|Lost to Follow-up|0
7613530|NCT00477412|12022163|FG001|Overall Study|Lost to Follow-up|0
7613531|NCT00477412|12022164|FG002|Overall Study|Lost to Follow-up|0
7613532|NCT00477412|12022165|FG003|Overall Study|Lost to Follow-up|1
7613533|NCT00477412|12022162|FG000|Overall Study|Withdrawal by Subject|0
7613534|NCT00477412|12022163|FG001|Overall Study|Withdrawal by Subject|0
7613535|NCT00477412|12022164|FG002|Overall Study|Withdrawal by Subject|0
7613536|NCT00477412|12022165|FG003|Overall Study|Withdrawal by Subject|2
7613537|NCT00477412|12022162|FG000|Overall Study|Second Malignancy|0
7613538|NCT00477412|12022163|FG001|Overall Study|Second Malignancy|0
7613539|NCT00477412|12022164|FG002|Overall Study|Second Malignancy|0
7613540|NCT00477412|12022165|FG003|Overall Study|Second Malignancy|1
7613541|NCT00477412|12022162|FG000|Overall Study|Adverse Event|1
7613542|NCT00477412|12022163|FG001|Overall Study|Adverse Event|0
7613543|NCT00477412|12022164|FG002|Overall Study|Adverse Event|1
7613544|NCT00477412|12022165|FG003|Overall Study|Adverse Event|0
7613545|NCT00369317|12022173|FG000|Overall Study|Adverse Event|3
7613546|NCT00369317|12022173|FG000|Overall Study|Death|1
7613547|NCT00369317|12022173|FG000|Overall Study|Lack of Efficacy|5
7613548|NCT00369317|12022173|FG000|Overall Study|Physician Decision|2
7613549|NCT00369317|12022173|FG000|Overall Study|Withdrawal by Subject|8
7613550|NCT00369317|12022173|FG000|Overall Study|Ineligible|1
7613551|NCT00261807|12022178|FG000|Overall Study|Lost to Follow-up|2
7613552|NCT00261807|12022178|FG000|Overall Study|Adverse Event|2
7613553|NCT00261807|12022178|FG000|Overall Study|Death|1
7613554|NCT00261807|12022178|FG000|Overall Study|Protocol Violation|2
7613555|NCT04620798|12022201|FG000|Overall Study|Lost to Follow-up|126
7613556|NCT04620798|12022202|FG001|Overall Study|Lost to Follow-up|138
7613557|NCT04256629|12022227|FG000|Overall Study|Adverse Event|0
7613558|NCT04256629|12022228|FG001|Overall Study|Adverse Event|0
7613559|NCT04256629|12022229|FG002|Overall Study|Adverse Event|0
7613560|NCT04256629|12022230|FG003|Overall Study|Adverse Event|0
7613561|NCT04256629|12022231|FG004|Overall Study|Adverse Event|0
7613562|NCT04256629|12022232|FG005|Overall Study|Adverse Event|1
7613563|NCT04256629|12022227|FG000|Overall Study|Protocol Violation|0
7613564|NCT04256629|12022228|FG001|Overall Study|Protocol Violation|1
7613565|NCT04256629|12022229|FG002|Overall Study|Protocol Violation|0
7613566|NCT04256629|12022230|FG003|Overall Study|Protocol Violation|0
7613567|NCT04256629|12022231|FG004|Overall Study|Protocol Violation|0
7613568|NCT04256629|12022232|FG005|Overall Study|Protocol Violation|0
7779557|NCT00946920|12227862|FG001|Overall Study|Physician Decision|2
7779558|NCT00946920|12227861|FG000|Overall Study|Adverse Event|41
7779559|NCT00946920|12227862|FG001|Overall Study|Adverse Event|14
7779560|NCT00946920|12227861|FG000|Overall Study|Protocol Violation|16
7779561|NCT00946920|12227862|FG001|Overall Study|Protocol Violation|8
7779562|NCT00946920|12227861|FG000|Overall Study|Miscellaneous reasons|18
7779563|NCT00946920|12227862|FG001|Overall Study|Miscellaneous reasons|3
7613576|NCT03284853|12022250|FG000|Overall Study|Adverse Event|40
7613577|NCT03284853|12022251|FG001|Overall Study|Adverse Event|4
7613578|NCT03284853|12022250|FG000|Overall Study|Withdrawal by Subject|5
7613579|NCT03284853|12022251|FG001|Overall Study|Withdrawal by Subject|1
7613580|NCT03284853|12022250|FG000|Overall Study|Lost to Follow-up|1
7613581|NCT03284853|12022251|FG001|Overall Study|Lost to Follow-up|0
7800149|NCT01091428|12257327|FG001|Phase 1|Withdrawal by Subject|0
7613582|NCT03284853|12022250|FG000|Overall Study|Lack of Efficacy|1
7613583|NCT03284853|12022251|FG001|Overall Study|Lack of Efficacy|0
7613584|NCT03284853|12022250|FG000|Overall Study|Disallowed Concurrent Medication|1
7613585|NCT03284853|12022251|FG001|Overall Study|Disallowed Concurrent Medication|1
7613586|NCT03284853|12022250|FG000|Overall Study|Protocol Violation|3
7613587|NCT03284853|12022251|FG001|Overall Study|Protocol Violation|3
7613588|NCT03284853|12022250|FG000|Overall Study|Death|0
7613589|NCT03284853|12022251|FG001|Overall Study|Death|1
7613590|NCT03284853|12022250|FG000|Overall Study|Other - Reason not reported in CSR|4
7613591|NCT03284853|12022251|FG001|Overall Study|Other - Reason not reported in CSR|3
7613592|NCT02774889|12022274|FG000|Overall Study|Lost to Follow-up|2
7613593|NCT02774889|12022275|FG001|Overall Study|Lost to Follow-up|1
7613594|NCT02297438|12022295|FG000|Overall Study|Death|79
7613595|NCT02297438|12022296|FG001|Overall Study|Death|86
7613596|NCT02297438|12022295|FG000|Overall Study|Lost to Follow-up|9
7613597|NCT02297438|12022296|FG001|Overall Study|Lost to Follow-up|7
7613598|NCT02297438|12022295|FG000|Overall Study|Withdrawal by Subject|7
7613599|NCT02297438|12022296|FG001|Overall Study|Withdrawal by Subject|0
7613600|NCT02297438|12022295|FG000|Overall Study|Other|9
7613601|NCT02297438|12022296|FG001|Overall Study|Other|5
7613602|NCT02297438|12022295|FG000|Overall Study|Ongoing|65
7613603|NCT02297438|12022296|FG001|Overall Study|Ongoing|73
7613604|NCT02297412|12022304|FG000|Overall Study|Canceled|1
7613605|NCT02297412|12022305|FG001|Overall Study|Canceled|1
7613606|NCT02250326|12022323|FG000|Treatment Period|Death|1
7613607|NCT02250326|12022324|FG001|Treatment Period|Death|12
7613608|NCT02250326|12022325|FG002|Treatment Period|Death|2
7613609|NCT02250326|12022323|FG000|Treatment Period|Adverse Event|8
7613610|NCT02250326|12022324|FG001|Treatment Period|Adverse Event|4
7613611|NCT02250326|12022325|FG002|Treatment Period|Adverse Event|8
7613612|NCT02250326|12022323|FG000|Treatment Period|Progressive Disease|42
7613613|NCT02250326|12022324|FG001|Treatment Period|Progressive Disease|36
7613614|NCT02250326|12022325|FG002|Treatment Period|Progressive Disease|45
7613615|NCT02250326|12022323|FG000|Treatment Period|Symptomatic Deterioration|9
7613616|NCT02250326|12022324|FG001|Treatment Period|Symptomatic Deterioration|4
7613617|NCT02250326|12022325|FG002|Treatment Period|Symptomatic Deterioration|10
7613618|NCT02250326|12022323|FG000|Treatment Period|Withdrawal by Subject|11
7613619|NCT02250326|12022324|FG001|Treatment Period|Withdrawal by Subject|5
7613620|NCT02250326|12022325|FG002|Treatment Period|Withdrawal by Subject|4
7613621|NCT02250326|12022323|FG000|Treatment Period|Miscellaneous|8
7613622|NCT02250326|12022324|FG001|Treatment Period|Miscellaneous|2
7613623|NCT02250326|12022325|FG002|Treatment Period|Miscellaneous|7
7613624|NCT02250326|12022323|FG000|Treatment Period|Randomized or assigned; not treated|2
7613625|NCT02250326|12022324|FG001|Treatment Period|Randomized or assigned; not treated|1
7613626|NCT02250326|12022325|FG002|Treatment Period|Randomized or assigned; not treated|1
7613627|NCT02250326|12022323|FG000|Follow-Up Period|Death|46
7613628|NCT02250326|12022324|FG001|Follow-Up Period|Death|26
7613629|NCT02250326|12022325|FG002|Follow-Up Period|Death|32
7613630|NCT02250326|12022323|FG000|Follow-Up Period|Unknown or Missing|2
7613631|NCT02250326|12022324|FG001|Follow-Up Period|Unknown or Missing|3
7613632|NCT02250326|12022325|FG002|Follow-Up Period|Unknown or Missing|3
7613633|NCT02250326|12022323|FG000|Follow-Up Period|Lost to Follow-up|1
7779564|NCT00946998|12227870|FG000|Overall Study|Exited prior to first outcome assessment|5
7613634|NCT02250326|12022324|FG001|Follow-Up Period|Lost to Follow-up|1
7613635|NCT02250326|12022325|FG002|Follow-Up Period|Lost to Follow-up|3
7613636|NCT01503515|12022347|FG000|Overall Study|Adverse Event|4
7613637|NCT01503515|12022348|FG001|Overall Study|Adverse Event|5
7613638|NCT01503515|12022347|FG000|Overall Study|Death|0
7613639|NCT01503515|12022348|FG001|Overall Study|Death|1
7613640|NCT01503515|12022347|FG000|Overall Study|Physician Decision|14
7613641|NCT01503515|12022348|FG001|Overall Study|Physician Decision|23
7613642|NCT01503515|12022347|FG000|Overall Study|Withdrawal by Subject|0
7613643|NCT01503515|12022348|FG001|Overall Study|Withdrawal by Subject|1
7613644|NCT01503515|12022347|FG000|Overall Study|Institutional dx of proven/probable IFI|2
7613645|NCT01503515|12022348|FG001|Overall Study|Institutional dx of proven/probable IFI|4
7613646|NCT01503515|12022347|FG000|Overall Study|Ineligible|1
7613647|NCT01503515|12022348|FG001|Overall Study|Ineligible|1
7613648|NCT00245960|12022381|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6
7613649|NCT00245960|12022382|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7
7613650|NCT00245960|12022381|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0
7613651|NCT00245960|12022382|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1
7613652|NCT00245960|12022381|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2
7613653|NCT00245960|12022382|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0
7613654|NCT00245960|12022381|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2
7613655|NCT00245960|12022382|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1
7613656|NCT00245960|12022381|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3
7613657|NCT00245960|12022382|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0
7613658|NCT00245960|12022381|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2
7613659|NCT00245960|12022382|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2
7613660|NCT00245960|12022381|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8
7613661|NCT00245960|12022382|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4
7613662|NCT00245960|12022381|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2
7779565|NCT00946998|12227871|FG001|Overall Study|Exited prior to first outcome assessment|3
7613663|NCT00245960|12022382|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2
7613664|NCT00245960|12022381|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2
7613665|NCT00245960|12022382|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5
7613666|NCT00245960|12022381|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1
7613667|NCT00245960|12022382|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3
7613668|NCT00245960|12022381|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1
7613669|NCT00245960|12022382|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3
7613670|NCT00245960|12022381|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0
7613671|NCT00245960|12022382|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1
7779566|NCT00947115|12227880|FG000|Overall Study|Missed reporting interval|3
7779567|NCT00947115|12227881|FG001|Overall Study|Missed reporting interval|4
7779568|NCT00947115|12227882|FG002|Overall Study|Missed reporting interval|2
7779569|NCT00947115|12227880|FG000|Overall Study|Physician Decision|0
7779570|NCT00947115|12227881|FG001|Overall Study|Physician Decision|2
7779571|NCT00947115|12227882|FG002|Overall Study|Physician Decision|0
7779572|NCT00947115|12227880|FG000|Overall Study|Death|0
7779573|NCT00947115|12227881|FG001|Overall Study|Death|1
7779574|NCT00947115|12227882|FG002|Overall Study|Death|1
7779575|NCT00947115|12227880|FG000|Overall Study|Migrated from study area|2
7779576|NCT00947115|12227881|FG001|Overall Study|Migrated from study area|0
7779577|NCT00947115|12227882|FG002|Overall Study|Migrated from study area|0
7779578|NCT00947115|12227880|FG000|Overall Study|Withdrawal by Subject|1
7779579|NCT00947115|12227881|FG001|Overall Study|Withdrawal by Subject|3
7779580|NCT00947115|12227882|FG002|Overall Study|Withdrawal by Subject|4
7779581|NCT00947115|12227880|FG000|Overall Study|Lost to Follow-up|11
7779582|NCT00947115|12227881|FG001|Overall Study|Lost to Follow-up|12
7613672|NCT04015336|12022469|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1
7779583|NCT00947115|12227882|FG002|Overall Study|Lost to Follow-up|8
7779584|NCT00947154|12227890|FG000|Overall Study|Lost to Follow-up|1
7779585|NCT00947193|12227899|FG000|Overall Study|Lost to Follow-up|1
7779586|NCT00947193|12227900|FG001|Overall Study|Lost to Follow-up|0
7779587|NCT00947193|12227899|FG000|Overall Study|Withdrawal by Subject|1
7779588|NCT00947193|12227900|FG001|Overall Study|Withdrawal by Subject|0
7779589|NCT00947193|12227899|FG000|Overall Study|Factor VIII >1%|1
7779590|NCT00947193|12227900|FG001|Overall Study|Factor VIII >1%|0
7613681|NCT03913091|12022560|FG000|Overall Study|Lost to Follow-up|18
7613682|NCT03913091|12022561|FG001|Overall Study|Lost to Follow-up|11
7613683|NCT03913091|12022560|FG000|Overall Study|Required additional meds/surgery|1
7613684|NCT03913091|12022561|FG001|Overall Study|Required additional meds/surgery|2
7613685|NCT03913091|12022560|FG000|Overall Study|Chronic pain/history of substance abuse|1
7613686|NCT03913091|12022561|FG001|Overall Study|Chronic pain/history of substance abuse|1
7613687|NCT03802565|12022572|FG000|Overall Study|Adverse Event|0
7613688|NCT03802565|12022573|FG001|Overall Study|Adverse Event|1
7613689|NCT03802565|12022574|FG002|Overall Study|Adverse Event|2
7613690|NCT03802565|12022575|FG003|Overall Study|Adverse Event|1
7613691|NCT03802565|12022576|FG004|Overall Study|Adverse Event|1
7613692|NCT03802565|12022572|FG000|Overall Study|Withdrawal by Subject|2
7613693|NCT03802565|12022573|FG001|Overall Study|Withdrawal by Subject|2
7613694|NCT03802565|12022574|FG002|Overall Study|Withdrawal by Subject|2
7613695|NCT03802565|12022575|FG003|Overall Study|Withdrawal by Subject|0
7613696|NCT03802565|12022576|FG004|Overall Study|Withdrawal by Subject|1
7613697|NCT03802565|12022572|FG000|Overall Study|Protocol Violation|2
7613698|NCT03802565|12022573|FG001|Overall Study|Protocol Violation|1
7613699|NCT03802565|12022574|FG002|Overall Study|Protocol Violation|4
7613700|NCT03802565|12022575|FG003|Overall Study|Protocol Violation|5
7613701|NCT03802565|12022576|FG004|Overall Study|Protocol Violation|1
7613702|NCT03802565|12022572|FG000|Overall Study|Lost to Follow-up|0
7613703|NCT03802565|12022573|FG001|Overall Study|Lost to Follow-up|0
7613704|NCT03802565|12022574|FG002|Overall Study|Lost to Follow-up|1
7613705|NCT03802565|12022575|FG003|Overall Study|Lost to Follow-up|0
7613706|NCT03802565|12022576|FG004|Overall Study|Lost to Follow-up|0
7613707|NCT03802565|12022572|FG000|Overall Study|Subjects Related to Each Other|1
7613708|NCT03802565|12022573|FG001|Overall Study|Subjects Related to Each Other|0
7613709|NCT03802565|12022574|FG002|Overall Study|Subjects Related to Each Other|0
7613710|NCT03802565|12022575|FG003|Overall Study|Subjects Related to Each Other|2
7613711|NCT03802565|12022576|FG004|Overall Study|Subjects Related to Each Other|1
7613712|NCT03802565|12022572|FG000|Overall Study|Elevated Enzymes|0
7613713|NCT03802565|12022573|FG001|Overall Study|Elevated Enzymes|0
7613714|NCT03802565|12022574|FG002|Overall Study|Elevated Enzymes|0
7613715|NCT03802565|12022575|FG003|Overall Study|Elevated Enzymes|0
7613716|NCT03802565|12022576|FG004|Overall Study|Elevated Enzymes|2
7613717|NCT03769194|12022592|FG000|Overall Study|Withdrawal by Subject|0
7613718|NCT03769194|12022593|FG001|Overall Study|Withdrawal by Subject|7
7613719|NCT03769194|12022594|FG002|Overall Study|Withdrawal by Subject|4
7613720|NCT03769194|12022595|FG003|Overall Study|Withdrawal by Subject|1
7613721|NCT03769194|12022592|FG000|Overall Study|moved from study area|0
7613722|NCT03769194|12022593|FG001|Overall Study|moved from study area|2
7613723|NCT03769194|12022594|FG002|Overall Study|moved from study area|1
7613724|NCT03769194|12022595|FG003|Overall Study|moved from study area|1
7613725|NCT03769194|12022592|FG000|Overall Study|Lost to Follow-up|3
7613726|NCT03769194|12022593|FG001|Overall Study|Lost to Follow-up|6
7613727|NCT03769194|12022594|FG002|Overall Study|Lost to Follow-up|3
7613728|NCT03769194|12022595|FG003|Overall Study|Lost to Follow-up|6
7613729|NCT03769194|12022592|FG000|Overall Study|other|1
7613730|NCT03769194|12022593|FG001|Overall Study|other|3
7613731|NCT03769194|12022594|FG002|Overall Study|other|0
7613732|NCT03769194|12022595|FG003|Overall Study|other|1
7613733|NCT03738332|12022605|FG000|Overall Study|Withdrawal by Subject|1
7613734|NCT03416179|12022618|FG000|Overall Study|Death|67
7613735|NCT03416179|12022619|FG001|Overall Study|Death|60
7613736|NCT03416179|12022620|FG002|Overall Study|Death|96
7779591|NCT00947349|12227957|FG000|Triple Treatment Combination Period|Adverse Event|0
7613737|NCT03416179|12022621|FG003|Overall Study|Death|88
7779592|NCT00947349|12227958|FG001|Triple Treatment Combination Period|Adverse Event|1
7779593|NCT00947349|12227959|FG002|Triple Treatment Combination Period|Adverse Event|0
7613738|NCT03416179|12022618|FG000|Overall Study|Withdrawal by Subject|13
7613739|NCT03416179|12022619|FG001|Overall Study|Withdrawal by Subject|19
7613740|NCT03416179|12022620|FG002|Overall Study|Withdrawal by Subject|5
7613741|NCT03416179|12022621|FG003|Overall Study|Withdrawal by Subject|6
7613742|NCT03416179|12022618|FG000|Overall Study|Ongoing|121
7613743|NCT03416179|12022619|FG001|Overall Study|Ongoing|123
7613744|NCT03416179|12022620|FG002|Overall Study|Ongoing|62
7779594|NCT00947349|12227960|FG003|Triple Treatment Combination Period|Adverse Event|0
7613745|NCT03416179|12022621|FG003|Overall Study|Ongoing|66
7613746|NCT03416179|12022618|FG000|Overall Study|Lost to Follow-up|0
7613747|NCT03416179|12022619|FG001|Overall Study|Lost to Follow-up|0
7779595|NCT00947349|12227957|FG000|Overall Study Standard of Care|Lack of Efficacy|0
7779596|NCT00947349|12227958|FG001|Overall Study Standard of Care|Lack of Efficacy|0
7779597|NCT00947349|12227959|FG002|Overall Study Standard of Care|Lack of Efficacy|1
7779598|NCT00947349|12227960|FG003|Overall Study Standard of Care|Lack of Efficacy|1
7779599|NCT00947349|12227957|FG000|Overall Study Standard of Care|Withdrawal by Subject|0
7779600|NCT00947349|12227958|FG001|Overall Study Standard of Care|Withdrawal by Subject|0
7779601|NCT00947349|12227959|FG002|Overall Study Standard of Care|Withdrawal by Subject|1
7779602|NCT00947349|12227960|FG003|Overall Study Standard of Care|Withdrawal by Subject|0
7779603|NCT00947349|12227957|FG000|Overall Study Standard of Care|Other|0
7779604|NCT00947349|12227958|FG001|Overall Study Standard of Care|Other|0
7779605|NCT00947349|12227959|FG002|Overall Study Standard of Care|Other|0
7779606|NCT00947349|12227960|FG003|Overall Study Standard of Care|Other|1
7779607|NCT00947427|12227990|FG000|Overall Study|Withdrawal by Subject|1
7779608|NCT00947427|12227991|FG001|Overall Study|Withdrawal by Subject|3
7779609|NCT00947427|12227990|FG000|Overall Study|Protocol Violation|0
7779610|NCT00947427|12227991|FG001|Overall Study|Protocol Violation|1
7779611|NCT00947531|12228008|FG000|Overall Study|Withdrawal by Subject|10
7779612|NCT00947531|12228009|FG001|Overall Study|Withdrawal by Subject|7
7779613|NCT00947531|12228008|FG000|Overall Study|Administrative Reason|0
7779614|NCT00947531|12228009|FG001|Overall Study|Administrative Reason|1
7779615|NCT00947531|12228008|FG000|Overall Study|Adverse Event|2
7779616|NCT00947531|12228009|FG001|Overall Study|Adverse Event|2
7779617|NCT00947531|12228008|FG000|Overall Study|Lack of Efficacy|1
7779618|NCT00947531|12228009|FG001|Overall Study|Lack of Efficacy|0
7613748|NCT03416179|12022620|FG002|Overall Study|Lost to Follow-up|0
7613749|NCT03416179|12022621|FG003|Overall Study|Lost to Follow-up|2
7613750|NCT03416179|12022618|FG000|Overall Study|Other|0
7613751|NCT03416179|12022619|FG001|Overall Study|Other|1
7613752|NCT03416179|12022620|FG002|Overall Study|Other|0
7613753|NCT03416179|12022621|FG003|Overall Study|Other|0
7613754|NCT03353922|12022631|FG000|Overall Study|Withdrawal by Subject|1
7613755|NCT03353922|12022632|FG001|Overall Study|Withdrawal by Subject|0
7613756|NCT03353922|12022633|FG002|Overall Study|Withdrawal by Subject|1
7613757|NCT03353922|12022634|FG003|Overall Study|Withdrawal by Subject|1
7613758|NCT03353922|12022635|FG004|Overall Study|Withdrawal by Subject|0
7613759|NCT03353922|12022636|FG005|Overall Study|Withdrawal by Subject|0
7613760|NCT03353922|12022631|FG000|Overall Study|Adverse Event|0
7613761|NCT03353922|12022632|FG001|Overall Study|Adverse Event|1
7613762|NCT03353922|12022633|FG002|Overall Study|Adverse Event|0
7613763|NCT03353922|12022634|FG003|Overall Study|Adverse Event|0
7613764|NCT03353922|12022635|FG004|Overall Study|Adverse Event|0
7779619|NCT00947531|12228008|FG000|Overall Study|Other|1
7779620|NCT00947531|12228009|FG001|Overall Study|Other|1
7779621|NCT00947544|12228015|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
7613765|NCT03353922|12022636|FG005|Overall Study|Adverse Event|0
7779622|NCT00947544|12228016|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
7779623|NCT00947856|12228055|FG000|Treatment Period|Progressive Disease|33
7779624|NCT00947856|12228056|FG001|Treatment Period|Progressive Disease|12
7779625|NCT00947856|12228055|FG000|Treatment Period|Adverse Event|15
7779626|NCT00947856|12228056|FG001|Treatment Period|Adverse Event|9
7779627|NCT00947856|12228055|FG000|Treatment Period|Physician Decision|14
7779628|NCT00947856|12228056|FG001|Treatment Period|Physician Decision|6
7779629|NCT00947856|12228055|FG000|Treatment Period|Study Stopped by Sponsor|4
7779630|NCT00947856|12228056|FG001|Treatment Period|Study Stopped by Sponsor|4
7779631|NCT00947856|12228055|FG000|Treatment Period|Withdrawal by Subject|12
7779632|NCT00947856|12228056|FG001|Treatment Period|Withdrawal by Subject|1
7779633|NCT00947856|12228055|FG000|Follow-up Period|Study Stopped by Sponsor|40
7779634|NCT00947856|12228056|FG001|Follow-up Period|Study Stopped by Sponsor|20
7779635|NCT00947856|12228055|FG000|Follow-up Period|Re-enrolled for Retreatment|2
7779636|NCT00947856|12228056|FG001|Follow-up Period|Re-enrolled for Retreatment|3
7779637|NCT00947856|12228055|FG000|Follow-up Period|Lost to Follow-up|7
7779638|NCT00947856|12228056|FG001|Follow-up Period|Lost to Follow-up|0
7779639|NCT00947856|12228055|FG000|Follow-up Period|Patient unavailable for site visits|1
7779640|NCT00947856|12228056|FG001|Follow-up Period|Patient unavailable for site visits|0
7779641|NCT00947856|12228055|FG000|Follow-up Period|Withdrawal by Subject|1
7779642|NCT00947856|12228056|FG001|Follow-up Period|Withdrawal by Subject|0
7779643|NCT00947882|12228075|FG000|Overall Study|Adverse Event|0
7779644|NCT00947882|12228076|FG001|Overall Study|Adverse Event|1
7779645|NCT00947882|12228077|FG002|Overall Study|Adverse Event|4
7779646|NCT00947882|12228078|FG003|Overall Study|Adverse Event|4
7779647|NCT00947882|12228075|FG000|Overall Study|Withdrawal by Subject|2
7779648|NCT00947882|12228076|FG001|Overall Study|Withdrawal by Subject|0
7779649|NCT00947882|12228077|FG002|Overall Study|Withdrawal by Subject|8
7779650|NCT00947882|12228078|FG003|Overall Study|Withdrawal by Subject|2
7779651|NCT00947882|12228075|FG000|Overall Study|Protocol Violation|0
7779652|NCT00947882|12228076|FG001|Overall Study|Protocol Violation|0
7613766|NCT03173456|12022671|FG000|Baseline|Medication dispensing system malfunction'|0
7613767|NCT03173456|12022672|FG001|Baseline|Medication dispensing system malfunction'|1
7613768|NCT03173456|12022673|FG002|Baseline|Medication dispensing system malfunction'|0
7613769|NCT03173456|12022674|FG003|Baseline|Medication dispensing system malfunction'|0
7613770|NCT03173456|12022675|FG004|Baseline|Medication dispensing system malfunction'|2
7613771|NCT03173456|12022671|FG000|2 Hour Follow-up|Withdrawal by Subject|0
7613772|NCT03173456|12022672|FG001|2 Hour Follow-up|Withdrawal by Subject|1
7613773|NCT03173456|12022673|FG002|2 Hour Follow-up|Withdrawal by Subject|1
7613774|NCT03173456|12022674|FG003|2 Hour Follow-up|Withdrawal by Subject|1
7613775|NCT03173456|12022675|FG004|2 Hour Follow-up|Withdrawal by Subject|2
7779653|NCT00947882|12228077|FG002|Overall Study|Protocol Violation|1
7779654|NCT00947882|12228078|FG003|Overall Study|Protocol Violation|0
7779655|NCT00947882|12228075|FG000|Overall Study|Lost to Follow-up|0
7779656|NCT00947882|12228076|FG001|Overall Study|Lost to Follow-up|2
7779657|NCT00947882|12228077|FG002|Overall Study|Lost to Follow-up|1
7779658|NCT00947882|12228078|FG003|Overall Study|Lost to Follow-up|0
7779659|NCT00947882|12228075|FG000|Overall Study|Other/Unknown|10
7779660|NCT00947882|12228076|FG001|Overall Study|Other/Unknown|13
7779661|NCT00947882|12228077|FG002|Overall Study|Other/Unknown|3
7779662|NCT00947882|12228078|FG003|Overall Study|Other/Unknown|6
7779663|NCT00947882|12228075|FG000|Overall Study|Trial Terminated by Sponsor|62
7779664|NCT00947882|12228076|FG001|Overall Study|Trial Terminated by Sponsor|61
7779665|NCT00947882|12228077|FG002|Overall Study|Trial Terminated by Sponsor|62
7779666|NCT00947882|12228078|FG003|Overall Study|Trial Terminated by Sponsor|70
7779667|NCT00948025|12228091|FG000|Phase 1 (Pilot Phase)|Adverse Event|1
7779668|NCT00948025|12228092|FG001|Phase 1 (Pilot Phase)|Adverse Event|1
7779669|NCT00948025|12228091|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7
7779670|NCT00948025|12228092|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1
7779671|NCT00948025|12228091|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
7779672|NCT00948025|12228092|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
7779673|NCT00948064|12228102|FG000|Phase I|No treatment received|1
7779674|NCT00948064|12228103|FG001|Phase I|No treatment received|0
7779675|NCT00948064|12228104|FG002|Phase I|No treatment received|0
7779676|NCT00948064|12228102|FG000|Phase II|Physician Decision|0
7779677|NCT00948064|12228103|FG001|Phase II|Physician Decision|0
7779678|NCT00948064|12228104|FG002|Phase II|Physician Decision|1
7779679|NCT00948064|12228102|FG000|Phase II|Withdrawal by Subject|0
7779680|NCT00948064|12228103|FG001|Phase II|Withdrawal by Subject|1
7779681|NCT00948064|12228104|FG002|Phase II|Withdrawal by Subject|0
7779682|NCT00948155|12228128|FG000|First Intervention 21 Days|Lost to Follow-up|2
7779683|NCT00948155|12228129|FG001|First Intervention 21 Days|Lost to Follow-up|2
7779684|NCT00948155|12228128|FG000|Washout 14 Days|Lost to Follow-up|1
7779685|NCT00948155|12228129|FG001|Washout 14 Days|Lost to Follow-up|2
7779686|NCT00948246|12228137|FG000|Overall Study|Lost to Follow-up|11
7779687|NCT00948246|12228137|FG000|Overall Study|Adverse Event|11
7779688|NCT00948246|12228137|FG000|Overall Study|Death|1
7779689|NCT00948246|12228137|FG000|Overall Study|Withdrawal by Subject|1
7779690|NCT00948389|12228155|FG000|Overall Study|Disease Progression/Relapse/Death|3
7779691|NCT00948389|12228156|FG001|Overall Study|Disease Progression/Relapse/Death|3
7779692|NCT00948389|12228157|FG002|Overall Study|Disease Progression/Relapse/Death|7
7779693|NCT00948389|12228158|FG003|Overall Study|Disease Progression/Relapse/Death|8
7779694|NCT00948389|12228159|FG004|Overall Study|Disease Progression/Relapse/Death|1
7779695|NCT00948389|12228155|FG000|Overall Study|Thrombocytopenia, Grade 4|2
7779696|NCT00948389|12228156|FG001|Overall Study|Thrombocytopenia, Grade 4|0
7779697|NCT00948389|12228157|FG002|Overall Study|Thrombocytopenia, Grade 4|0
7613825|NCT02820753|12022752|FG000|2 Month|Withdrawal by Subject|3
7613826|NCT02820753|12022753|FG001|2 Month|Withdrawal by Subject|3
7613827|NCT02820753|12022752|FG000|2 Month|Lost to Follow-up|24
7613828|NCT02820753|12022753|FG001|2 Month|Lost to Follow-up|26
7613829|NCT02820753|12022752|FG000|2 Month|Stopped per NIH Hold|51
7613830|NCT02820753|12022753|FG001|2 Month|Stopped per NIH Hold|13
7613831|NCT02820753|12022752|FG000|6 Month|Withdrawal by Subject|2
7613832|NCT02820753|12022753|FG001|6 Month|Withdrawal by Subject|2
7613833|NCT02820753|12022752|FG000|6 Month|Lost to Follow-up|20
7613834|NCT02820753|12022753|FG001|6 Month|Lost to Follow-up|27
7613835|NCT02820753|12022752|FG000|6 Month|Stopped per NIH Hold|81
7613836|NCT02820753|12022753|FG001|6 Month|Stopped per NIH Hold|81
7613837|NCT02820753|12022752|FG000|6 Month|Death|0
7613838|NCT02820753|12022753|FG001|6 Month|Death|1
7613839|NCT02733042|12022778|FG000|Treatment Period|Adverse Event|1
7613840|NCT02733042|12022779|FG001|Treatment Period|Adverse Event|0
7613841|NCT02733042|12022780|FG002|Treatment Period|Adverse Event|1
7613842|NCT02733042|12022781|FG003|Treatment Period|Adverse Event|1
7613843|NCT02733042|12022782|FG004|Treatment Period|Adverse Event|0
7613844|NCT02733042|12022783|FG005|Treatment Period|Adverse Event|0
7613845|NCT02733042|12022784|FG006|Treatment Period|Adverse Event|0
7613846|NCT02733042|12022785|FG007|Treatment Period|Adverse Event|0
7613847|NCT02733042|12022786|FG008|Treatment Period|Adverse Event|0
7613848|NCT02733042|12022787|FG009|Treatment Period|Adverse Event|0
7613849|NCT02733042|12022788|FG010|Treatment Period|Adverse Event|2
7613850|NCT02733042|12022789|FG011|Treatment Period|Adverse Event|2
7613851|NCT02733042|12022790|FG012|Treatment Period|Adverse Event|0
7779698|NCT00948389|12228158|FG003|Overall Study|Thrombocytopenia, Grade 4|1
7779699|NCT00948389|12228159|FG004|Overall Study|Thrombocytopenia, Grade 4|0
7779700|NCT00948389|12228155|FG000|Overall Study|Both Progression and Toxicity|1
7779701|NCT00948389|12228156|FG001|Overall Study|Both Progression and Toxicity|0
7779702|NCT00948389|12228157|FG002|Overall Study|Both Progression and Toxicity|0
7779703|NCT00948389|12228158|FG003|Overall Study|Both Progression and Toxicity|0
7779704|NCT00948389|12228159|FG004|Overall Study|Both Progression and Toxicity|0
7779705|NCT00948428|12228176|FG000|Overall Study|Withdrawal by Subject|6
7779706|NCT00948428|12228177|FG001|Overall Study|Withdrawal by Subject|12
7779707|NCT00948428|12228178|FG002|Overall Study|Withdrawal by Subject|7
7779708|NCT00948428|12228176|FG000|Overall Study|Adverse Event|6
7613852|NCT02733042|12022791|FG013|Treatment Period|Adverse Event|2
7613853|NCT02733042|12022792|FG014|Treatment Period|Adverse Event|0
7613854|NCT02733042|12022793|FG015|Treatment Period|Adverse Event|0
7613855|NCT02733042|12022794|FG016|Treatment Period|Adverse Event|0
7613856|NCT02733042|12022795|FG017|Treatment Period|Adverse Event|1
7613857|NCT02733042|12022796|FG018|Treatment Period|Adverse Event|0
7613858|NCT02733042|12022778|FG000|Treatment Period|Progressive Disease|2
7613859|NCT02733042|12022779|FG001|Treatment Period|Progressive Disease|1
7613860|NCT02733042|12022780|FG002|Treatment Period|Progressive Disease|3
7613861|NCT02733042|12022781|FG003|Treatment Period|Progressive Disease|1
7613862|NCT02733042|12022782|FG004|Treatment Period|Progressive Disease|1
7613863|NCT02733042|12022783|FG005|Treatment Period|Progressive Disease|3
7613864|NCT02733042|12022784|FG006|Treatment Period|Progressive Disease|0
7613865|NCT02733042|12022785|FG007|Treatment Period|Progressive Disease|3
7613866|NCT02733042|12022786|FG008|Treatment Period|Progressive Disease|3
7613867|NCT02733042|12022787|FG009|Treatment Period|Progressive Disease|0
7613868|NCT02733042|12022788|FG010|Treatment Period|Progressive Disease|2
7613869|NCT02733042|12022789|FG011|Treatment Period|Progressive Disease|2
7613870|NCT02733042|12022790|FG012|Treatment Period|Progressive Disease|8
7613871|NCT02733042|12022791|FG013|Treatment Period|Progressive Disease|1
7613872|NCT02733042|12022792|FG014|Treatment Period|Progressive Disease|4
7613873|NCT02733042|12022793|FG015|Treatment Period|Progressive Disease|7
7613874|NCT02733042|12022794|FG016|Treatment Period|Progressive Disease|2
7613875|NCT02733042|12022795|FG017|Treatment Period|Progressive Disease|3
7613876|NCT02733042|12022796|FG018|Treatment Period|Progressive Disease|4
7613877|NCT02733042|12022778|FG000|Treatment Period|Withdrawal by Subject|0
7613878|NCT02733042|12022779|FG001|Treatment Period|Withdrawal by Subject|1
7613879|NCT02733042|12022780|FG002|Treatment Period|Withdrawal by Subject|2
7613880|NCT02733042|12022781|FG003|Treatment Period|Withdrawal by Subject|1
7613881|NCT02733042|12022782|FG004|Treatment Period|Withdrawal by Subject|0
7779709|NCT00948428|12228177|FG001|Overall Study|Adverse Event|3
7613882|NCT02733042|12022783|FG005|Treatment Period|Withdrawal by Subject|0
7613883|NCT02733042|12022784|FG006|Treatment Period|Withdrawal by Subject|0
7613884|NCT02733042|12022785|FG007|Treatment Period|Withdrawal by Subject|0
7613885|NCT02733042|12022786|FG008|Treatment Period|Withdrawal by Subject|1
7613886|NCT02733042|12022787|FG009|Treatment Period|Withdrawal by Subject|1
7613887|NCT02733042|12022788|FG010|Treatment Period|Withdrawal by Subject|0
7613888|NCT02733042|12022789|FG011|Treatment Period|Withdrawal by Subject|2
7613889|NCT02733042|12022790|FG012|Treatment Period|Withdrawal by Subject|1
7613890|NCT02733042|12022791|FG013|Treatment Period|Withdrawal by Subject|1
7613891|NCT02733042|12022792|FG014|Treatment Period|Withdrawal by Subject|0
7613892|NCT02733042|12022793|FG015|Treatment Period|Withdrawal by Subject|0
7613893|NCT02733042|12022794|FG016|Treatment Period|Withdrawal by Subject|0
7613894|NCT02733042|12022795|FG017|Treatment Period|Withdrawal by Subject|0
7613895|NCT02733042|12022796|FG018|Treatment Period|Withdrawal by Subject|0
7613896|NCT02733042|12022778|FG000|Treatment Period|Other|0
7613897|NCT02733042|12022779|FG001|Treatment Period|Other|0
7613898|NCT02733042|12022780|FG002|Treatment Period|Other|1
7613899|NCT02733042|12022781|FG003|Treatment Period|Other|0
7613900|NCT02733042|12022782|FG004|Treatment Period|Other|0
7613901|NCT02733042|12022783|FG005|Treatment Period|Other|0
7613902|NCT02733042|12022784|FG006|Treatment Period|Other|0
7613903|NCT02733042|12022785|FG007|Treatment Period|Other|0
7613904|NCT02733042|12022786|FG008|Treatment Period|Other|0
7613905|NCT02733042|12022787|FG009|Treatment Period|Other|1
7613906|NCT02733042|12022788|FG010|Treatment Period|Other|1
7613907|NCT02733042|12022789|FG011|Treatment Period|Other|0
7613908|NCT02733042|12022790|FG012|Treatment Period|Other|0
7613909|NCT02733042|12022791|FG013|Treatment Period|Other|0
7613910|NCT02733042|12022792|FG014|Treatment Period|Other|0
7613911|NCT02733042|12022793|FG015|Treatment Period|Other|1
7779710|NCT00948428|12228178|FG002|Overall Study|Adverse Event|0
7779711|NCT00948428|12228176|FG000|Overall Study|Lost to Follow-up|2
7779712|NCT00948428|12228177|FG001|Overall Study|Lost to Follow-up|1
7779713|NCT00948428|12228178|FG002|Overall Study|Lost to Follow-up|1
7779714|NCT00948428|12228176|FG000|Overall Study|Death|2
7779715|NCT00948428|12228177|FG001|Overall Study|Death|0
7779716|NCT00948428|12228178|FG002|Overall Study|Death|0
7779717|NCT00948428|12228176|FG000|Overall Study|Intercurrent Illness|1
7779718|NCT00948428|12228177|FG001|Overall Study|Intercurrent Illness|0
7779719|NCT00948428|12228178|FG002|Overall Study|Intercurrent Illness|0
7779720|NCT00948428|12228176|FG000|Overall Study|Non-compliance|1
7779721|NCT00948428|12228177|FG001|Overall Study|Non-compliance|2
7779722|NCT00948428|12228178|FG002|Overall Study|Non-compliance|0
7779723|NCT00948441|12228188|FG000|Overall Study|no longer meet inclusion criteria|1
7779724|NCT00948441|12228189|FG001|Overall Study|no longer meet inclusion criteria|4
7779725|NCT00948506|12228199|FG000|Overall Study|Withdrawal by Subject|3
7779726|NCT00948506|12228200|FG001|Overall Study|Withdrawal by Subject|1
7779727|NCT00948675|12228220|FG000|Overall Study|Lost to Follow-up|1
7779728|NCT00948675|12228221|FG001|Overall Study|Lost to Follow-up|0
7779729|NCT00948688|12228227|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1
7779730|NCT00948688|12228228|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0
7779731|NCT00948688|12228227|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1
7779732|NCT00948688|12228228|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0
7779733|NCT00948688|12228227|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0
7779734|NCT00948688|12228228|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1
7779735|NCT00948766|12228237|FG000|Core Study|Adverse Event|73
7779736|NCT00948766|12228238|FG001|Core Study|Adverse Event|51
7779737|NCT00948766|12228237|FG000|Core Study|Unsatisfactory Therapeutic Effect|13
7779738|NCT00948766|12228238|FG001|Core Study|Unsatisfactory Therapeutic Effect|14
7779739|NCT00948766|12228237|FG000|Core Study|Patient Withdrew Consent|27
7779740|NCT00948766|12228238|FG001|Core Study|Patient Withdrew Consent|46
7779741|NCT00948766|12228237|FG000|Core Study|Lost to Follow-up|3
7779742|NCT00948766|12228238|FG001|Core Study|Lost to Follow-up|2
7779743|NCT00948766|12228237|FG000|Core Study|Administrative Problems|2
7779744|NCT00948766|12228238|FG001|Core Study|Administrative Problems|2
7779745|NCT00948766|12228237|FG000|Core Study|Death|1
7779746|NCT00948766|12228238|FG001|Core Study|Death|1
7779747|NCT00948766|12228237|FG000|Core Study|Protocol Deviation|8
7779748|NCT00948766|12228238|FG001|Core Study|Protocol Deviation|10
7779749|NCT00948766|12228237|FG000|Extension Study|Adverse Event|43
7779750|NCT00948766|12228238|FG001|Extension Study|Adverse Event|0
7779751|NCT00948766|12228237|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2
7779752|NCT00948766|12228238|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0
7779753|NCT00948766|12228237|FG000|Extension Study|Study Drug No Longer Required|1
7779754|NCT00948766|12228238|FG001|Extension Study|Study Drug No Longer Required|0
7779755|NCT00948766|12228237|FG000|Extension Study|Patient Withdrew Consent|32
7779756|NCT00948766|12228238|FG001|Extension Study|Patient Withdrew Consent|0
7779757|NCT00948766|12228237|FG000|Extension Study|Lost to Follow-up|8
7779758|NCT00948766|12228238|FG001|Extension Study|Lost to Follow-up|0
7779759|NCT00948766|12228237|FG000|Extension Study|Administrative Problems|1
7779760|NCT00948766|12228238|FG001|Extension Study|Administrative Problems|0
7779761|NCT00948766|12228237|FG000|Extension Study|Death|4
7779762|NCT00948766|12228238|FG001|Extension Study|Death|0
7779763|NCT00948818|12228253|FG000|Overall Study|Adverse Event|10
7779764|NCT00948818|12228254|FG001|Overall Study|Adverse Event|32
7779765|NCT00948818|12228253|FG000|Overall Study|Protocol Violation|9
7779766|NCT00948818|12228254|FG001|Overall Study|Protocol Violation|10
7613912|NCT02733042|12022794|FG016|Treatment Period|Other|0
7613913|NCT02733042|12022795|FG017|Treatment Period|Other|1
7613914|NCT02733042|12022796|FG018|Treatment Period|Other|0
7613915|NCT02733042|12022778|FG000|Treatment Period|Ongoing on Assigned Treatment|0
7613916|NCT02733042|12022779|FG001|Treatment Period|Ongoing on Assigned Treatment|0
7613917|NCT02733042|12022780|FG002|Treatment Period|Ongoing on Assigned Treatment|0
7613918|NCT02733042|12022781|FG003|Treatment Period|Ongoing on Assigned Treatment|0
7613919|NCT02733042|12022782|FG004|Treatment Period|Ongoing on Assigned Treatment|3
7613920|NCT02733042|12022783|FG005|Treatment Period|Ongoing on Assigned Treatment|0
7613921|NCT02733042|12022784|FG006|Treatment Period|Ongoing on Assigned Treatment|0
7613922|NCT02733042|12022785|FG007|Treatment Period|Ongoing on Assigned Treatment|0
7613923|NCT02733042|12022786|FG008|Treatment Period|Ongoing on Assigned Treatment|0
7613924|NCT02733042|12022787|FG009|Treatment Period|Ongoing on Assigned Treatment|8
7613925|NCT02733042|12022788|FG010|Treatment Period|Ongoing on Assigned Treatment|4
7613926|NCT02733042|12022789|FG011|Treatment Period|Ongoing on Assigned Treatment|0
7613927|NCT02733042|12022790|FG012|Treatment Period|Ongoing on Assigned Treatment|0
7613928|NCT02733042|12022791|FG013|Treatment Period|Ongoing on Assigned Treatment|0
7613929|NCT02733042|12022792|FG014|Treatment Period|Ongoing on Assigned Treatment|0
7613930|NCT02733042|12022793|FG015|Treatment Period|Ongoing on Assigned Treatment|0
7613931|NCT02733042|12022794|FG016|Treatment Period|Ongoing on Assigned Treatment|0
7613932|NCT02733042|12022795|FG017|Treatment Period|Ongoing on Assigned Treatment|0
7613933|NCT02733042|12022796|FG018|Treatment Period|Ongoing on Assigned Treatment|1
7613934|NCT02733042|12022778|FG000|Treatment Period|Death|0
7613935|NCT02733042|12022779|FG001|Treatment Period|Death|0
7613936|NCT02733042|12022780|FG002|Treatment Period|Death|0
7613937|NCT02733042|12022781|FG003|Treatment Period|Death|0
7613938|NCT02733042|12022782|FG004|Treatment Period|Death|0
7613939|NCT02733042|12022783|FG005|Treatment Period|Death|0
7613940|NCT02733042|12022784|FG006|Treatment Period|Death|1
7613941|NCT02733042|12022785|FG007|Treatment Period|Death|0
7613942|NCT02733042|12022786|FG008|Treatment Period|Death|1
7613943|NCT02733042|12022787|FG009|Treatment Period|Death|0
7613944|NCT02733042|12022788|FG010|Treatment Period|Death|1
7613945|NCT02733042|12022789|FG011|Treatment Period|Death|0
7613946|NCT02733042|12022790|FG012|Treatment Period|Death|0
7613947|NCT02733042|12022791|FG013|Treatment Period|Death|0
7613948|NCT02733042|12022792|FG014|Treatment Period|Death|1
7613949|NCT02733042|12022793|FG015|Treatment Period|Death|2
7613950|NCT02733042|12022794|FG016|Treatment Period|Death|0
7613951|NCT02733042|12022795|FG017|Treatment Period|Death|0
7613952|NCT02733042|12022796|FG018|Treatment Period|Death|0
7613953|NCT02733042|12022778|FG000|Follow-up Period|Ongoing on Follow-up|2
7613954|NCT02733042|12022779|FG001|Follow-up Period|Ongoing on Follow-up|2
7613955|NCT02733042|12022780|FG002|Follow-up Period|Ongoing on Follow-up|4
7613956|NCT02733042|12022781|FG003|Follow-up Period|Ongoing on Follow-up|2
7613957|NCT02733042|12022782|FG004|Follow-up Period|Ongoing on Follow-up|0
7613958|NCT02733042|12022783|FG005|Follow-up Period|Ongoing on Follow-up|0
7613959|NCT02733042|12022784|FG006|Follow-up Period|Ongoing on Follow-up|0
7613960|NCT02733042|12022785|FG007|Follow-up Period|Ongoing on Follow-up|1
7613961|NCT02733042|12022786|FG008|Follow-up Period|Ongoing on Follow-up|0
7613962|NCT02733042|12022787|FG009|Follow-up Period|Ongoing on Follow-up|2
7779767|NCT00948818|12228253|FG000|Overall Study|Withdrawal by Subject|25
7779768|NCT00948818|12228254|FG001|Overall Study|Withdrawal by Subject|25
7779769|NCT00948818|12228253|FG000|Overall Study|Lost to Follow-up|10
7779770|NCT00948818|12228254|FG001|Overall Study|Lost to Follow-up|17
7779771|NCT00948818|12228253|FG000|Overall Study|Lack of Efficacy|4
7779772|NCT00948818|12228254|FG001|Overall Study|Lack of Efficacy|5
7779773|NCT00948818|12228253|FG000|Overall Study|Other Reason|4
7779774|NCT00948818|12228254|FG001|Overall Study|Other Reason|5
7779775|NCT00948857|12228265|FG000|Overall Study|Lost to Follow-up|1
7779776|NCT00948857|12228266|FG001|Overall Study|Lost to Follow-up|0
7779777|NCT00948896|12228280|FG000|Randomization to 24 Months of Age|Death|1
7779778|NCT00948896|12228281|FG001|Randomization to 24 Months of Age|Death|0
7779779|NCT00948896|12228282|FG002|Randomization to 24 Months of Age|Death|0
7779780|NCT00948896|12228283|FG003|Randomization to 24 Months of Age|Death|0
7779781|NCT00948896|12228284|FG004|Randomization to 24 Months of Age|Death|2
7779782|NCT00948896|12228285|FG005|Randomization to 24 Months of Age|Death|1
7779783|NCT00948896|12228286|FG006|Randomization to 24 Months of Age|Death|2
7779784|NCT00948896|12228287|FG007|Randomization to 24 Months of Age|Death|1
7779785|NCT00948896|12228280|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3
7779786|NCT00948896|12228281|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5
7779787|NCT00948896|12228282|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4
7779788|NCT00948896|12228283|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4
7779789|NCT00948896|12228284|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0
7779790|NCT00948896|12228285|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1
7779791|NCT00948896|12228286|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0
7779792|NCT00948896|12228287|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0
7779793|NCT00948896|12228280|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4
7779794|NCT00948896|12228281|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4
7613963|NCT02733042|12022788|FG010|Follow-up Period|Ongoing on Follow-up|4
7613964|NCT02733042|12022789|FG011|Follow-up Period|Ongoing on Follow-up|9
7613965|NCT02733042|12022790|FG012|Follow-up Period|Ongoing on Follow-up|1
7613966|NCT02733042|12022791|FG013|Follow-up Period|Ongoing on Follow-up|3
7613967|NCT02733042|12022792|FG014|Follow-up Period|Ongoing on Follow-up|0
7613968|NCT02733042|12022793|FG015|Follow-up Period|Ongoing on Follow-up|0
7613969|NCT02733042|12022794|FG016|Follow-up Period|Ongoing on Follow-up|0
7613970|NCT02733042|12022795|FG017|Follow-up Period|Ongoing on Follow-up|1
7613971|NCT02733042|12022796|FG018|Follow-up Period|Ongoing on Follow-up|0
7613972|NCT02733042|12022778|FG000|Follow-up Period|Death|1
7613973|NCT02733042|12022779|FG001|Follow-up Period|Death|1
7613974|NCT02733042|12022780|FG002|Follow-up Period|Death|2
7613975|NCT02733042|12022781|FG003|Follow-up Period|Death|0
7613976|NCT02733042|12022782|FG004|Follow-up Period|Death|1
7613977|NCT02733042|12022783|FG005|Follow-up Period|Death|2
7613978|NCT02733042|12022784|FG006|Follow-up Period|Death|0
7613979|NCT02733042|12022785|FG007|Follow-up Period|Death|3
7613980|NCT02733042|12022786|FG008|Follow-up Period|Death|3
7613981|NCT02733042|12022787|FG009|Follow-up Period|Death|0
7613982|NCT02733042|12022788|FG010|Follow-up Period|Death|0
7613983|NCT02733042|12022789|FG011|Follow-up Period|Death|0
7613984|NCT02733042|12022790|FG012|Follow-up Period|Death|8
7613985|NCT02733042|12022791|FG013|Follow-up Period|Death|1
7613986|NCT02733042|12022792|FG014|Follow-up Period|Death|1
7613987|NCT02733042|12022793|FG015|Follow-up Period|Death|4
7613988|NCT02733042|12022794|FG016|Follow-up Period|Death|0
7613989|NCT02733042|12022795|FG017|Follow-up Period|Death|1
7613990|NCT02733042|12022796|FG018|Follow-up Period|Death|2
7613991|NCT02733042|12022778|FG000|Follow-up Period|Other|0
7613992|NCT02733042|12022779|FG001|Follow-up Period|Other|0
7613993|NCT02733042|12022780|FG002|Follow-up Period|Other|0
7613994|NCT02733042|12022781|FG003|Follow-up Period|Other|1
7613995|NCT02733042|12022782|FG004|Follow-up Period|Other|0
7613996|NCT02733042|12022783|FG005|Follow-up Period|Other|0
7613997|NCT02733042|12022784|FG006|Follow-up Period|Other|0
7613998|NCT02733042|12022785|FG007|Follow-up Period|Other|0
7613999|NCT02733042|12022786|FG008|Follow-up Period|Other|0
7614000|NCT02733042|12022787|FG009|Follow-up Period|Other|0
7614001|NCT02733042|12022788|FG010|Follow-up Period|Other|0
7614002|NCT02733042|12022789|FG011|Follow-up Period|Other|0
7614003|NCT02733042|12022790|FG012|Follow-up Period|Other|0
7614004|NCT02733042|12022791|FG013|Follow-up Period|Other|0
7614005|NCT02733042|12022792|FG014|Follow-up Period|Other|0
7614006|NCT02733042|12022793|FG015|Follow-up Period|Other|0
7614007|NCT02733042|12022794|FG016|Follow-up Period|Other|0
7614008|NCT02733042|12022795|FG017|Follow-up Period|Other|0
7614009|NCT02733042|12022796|FG018|Follow-up Period|Other|0
7614010|NCT02733042|12022778|FG000|Follow-up Period|Withdrawal by Subject|0
7614011|NCT02733042|12022779|FG001|Follow-up Period|Withdrawal by Subject|0
7614012|NCT02733042|12022780|FG002|Follow-up Period|Withdrawal by Subject|0
7614013|NCT02733042|12022781|FG003|Follow-up Period|Withdrawal by Subject|0
7614014|NCT02733042|12022782|FG004|Follow-up Period|Withdrawal by Subject|0
7614015|NCT02733042|12022783|FG005|Follow-up Period|Withdrawal by Subject|0
7614016|NCT02733042|12022784|FG006|Follow-up Period|Withdrawal by Subject|0
7614017|NCT02733042|12022785|FG007|Follow-up Period|Withdrawal by Subject|0
7614018|NCT02733042|12022786|FG008|Follow-up Period|Withdrawal by Subject|1
7614019|NCT02733042|12022787|FG009|Follow-up Period|Withdrawal by Subject|0
7614020|NCT02733042|12022788|FG010|Follow-up Period|Withdrawal by Subject|1
7614021|NCT02733042|12022789|FG011|Follow-up Period|Withdrawal by Subject|0
7614022|NCT02733042|12022790|FG012|Follow-up Period|Withdrawal by Subject|0
7614023|NCT02733042|12022791|FG013|Follow-up Period|Withdrawal by Subject|0
7614024|NCT02733042|12022792|FG014|Follow-up Period|Withdrawal by Subject|0
7614025|NCT02733042|12022793|FG015|Follow-up Period|Withdrawal by Subject|1
7614026|NCT02733042|12022794|FG016|Follow-up Period|Withdrawal by Subject|0
7614027|NCT02733042|12022795|FG017|Follow-up Period|Withdrawal by Subject|0
7614028|NCT02733042|12022796|FG018|Follow-up Period|Withdrawal by Subject|0
7614029|NCT02574286|12022857|FG000|Overall Study|Adverse Event|3
7614030|NCT02574286|12022857|FG000|Overall Study|Withdrawal by Subject|2
7614031|NCT02471144|12022865|FG000|Induction Period (Up to Week 12)|Adverse Event|0
7614032|NCT02471144|12022866|FG001|Induction Period (Up to Week 12)|Adverse Event|1
7614033|NCT02471144|12022867|FG002|Induction Period (Up to Week 12)|Adverse Event|1
7614034|NCT02471144|12022868|FG003|Induction Period (Up to Week 12)|Adverse Event|0
7614035|NCT02471144|12022869|FG004|Induction Period (Up to Week 12)|Adverse Event|0
7614036|NCT02471144|12022870|FG005|Induction Period (Up to Week 12)|Adverse Event|0
7614037|NCT02471144|12022871|FG006|Induction Period (Up to Week 12)|Adverse Event|0
7614038|NCT02471144|12022872|FG007|Induction Period (Up to Week 12)|Adverse Event|0
7614039|NCT02471144|12022873|FG008|Induction Period (Up to Week 12)|Adverse Event|0
7614040|NCT02471144|12022874|FG009|Induction Period (Up to Week 12)|Adverse Event|0
7614041|NCT02471144|12022875|FG010|Induction Period (Up to Week 12)|Adverse Event|0
7614042|NCT02471144|12022865|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614043|NCT02471144|12022866|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614044|NCT02471144|12022867|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614045|NCT02471144|12022868|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1
7614046|NCT02471144|12022869|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614047|NCT02471144|12022870|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614048|NCT02471144|12022871|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614049|NCT02471144|12022872|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614050|NCT02471144|12022873|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614051|NCT02471144|12022874|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614052|NCT02471144|12022875|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614053|NCT02471144|12022865|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0
7614054|NCT02471144|12022866|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0
7614055|NCT02471144|12022867|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1
7614056|NCT02471144|12022868|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0
7614057|NCT02471144|12022869|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0
7614058|NCT02471144|12022870|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0
7614059|NCT02471144|12022871|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0
7614060|NCT02471144|12022872|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0
7614061|NCT02471144|12022873|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0
7614062|NCT02471144|12022874|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0
7614063|NCT02471144|12022875|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0
7614064|NCT02471144|12022865|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1
7614065|NCT02471144|12022866|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1
7614066|NCT02471144|12022867|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614067|NCT02471144|12022868|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614068|NCT02471144|12022869|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614069|NCT02471144|12022870|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614070|NCT02471144|12022871|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614071|NCT02471144|12022872|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614072|NCT02471144|12022873|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614073|NCT02471144|12022874|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614074|NCT02471144|12022875|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614075|NCT02471144|12022865|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614076|NCT02471144|12022866|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614077|NCT02471144|12022867|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614078|NCT02471144|12022868|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614079|NCT02471144|12022869|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
7614080|NCT02471144|12022870|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614081|NCT02471144|12022871|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
7614082|NCT02471144|12022872|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614083|NCT02471144|12022873|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
7614084|NCT02471144|12022874|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614085|NCT02471144|12022875|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614086|NCT02471144|12022865|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614087|NCT02471144|12022866|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614088|NCT02471144|12022867|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614089|NCT02471144|12022868|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614090|NCT02471144|12022869|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614091|NCT02471144|12022870|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1
7614092|NCT02471144|12022871|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614093|NCT02471144|12022872|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614094|NCT02471144|12022873|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3
7614095|NCT02471144|12022874|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614096|NCT02471144|12022875|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614097|NCT02471144|12022865|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614098|NCT02471144|12022866|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614099|NCT02471144|12022867|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614100|NCT02471144|12022868|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614101|NCT02471144|12022869|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614102|NCT02471144|12022870|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614103|NCT02471144|12022871|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614104|NCT02471144|12022872|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614105|NCT02471144|12022873|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1
7614106|NCT02471144|12022874|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614107|NCT02471144|12022875|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614108|NCT02471144|12022865|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614109|NCT02471144|12022866|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614110|NCT02471144|12022867|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7779795|NCT00948896|12228282|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2
7779796|NCT00948896|12228283|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5
7779797|NCT00948896|12228284|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0
7614111|NCT02471144|12022868|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614112|NCT02471144|12022869|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614113|NCT02471144|12022870|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614114|NCT02471144|12022871|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614115|NCT02471144|12022872|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2
7614116|NCT02471144|12022873|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1
7614117|NCT02471144|12022874|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614118|NCT02471144|12022875|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614119|NCT02471144|12022865|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614120|NCT02471144|12022866|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614121|NCT02471144|12022867|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614122|NCT02471144|12022868|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614123|NCT02471144|12022869|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614124|NCT02471144|12022870|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614125|NCT02471144|12022871|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614126|NCT02471144|12022872|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614127|NCT02471144|12022873|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614128|NCT02471144|12022874|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|5
7614129|NCT02471144|12022875|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|2
7614130|NCT02471144|12022865|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614131|NCT02471144|12022866|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614132|NCT02471144|12022867|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614133|NCT02471144|12022868|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614134|NCT02471144|12022869|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614135|NCT02471144|12022870|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614136|NCT02471144|12022871|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614137|NCT02471144|12022872|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614138|NCT02471144|12022873|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614139|NCT02471144|12022874|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2
7614140|NCT02471144|12022875|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614141|NCT02471144|12022865|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614142|NCT02471144|12022866|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614143|NCT02471144|12022867|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614144|NCT02471144|12022868|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7779798|NCT00948896|12228285|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0
7779799|NCT00948896|12228286|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1
7779800|NCT00948896|12228287|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0
7779801|NCT00948896|12228280|FG000|Randomization to 24 Months of Age|Protocol Violation|0
7779802|NCT00948896|12228281|FG001|Randomization to 24 Months of Age|Protocol Violation|1
7779803|NCT00948896|12228282|FG002|Randomization to 24 Months of Age|Protocol Violation|0
7779804|NCT00948896|12228283|FG003|Randomization to 24 Months of Age|Protocol Violation|1
7779805|NCT00948896|12228284|FG004|Randomization to 24 Months of Age|Protocol Violation|0
7779806|NCT00948896|12228285|FG005|Randomization to 24 Months of Age|Protocol Violation|0
7779807|NCT00948896|12228286|FG006|Randomization to 24 Months of Age|Protocol Violation|1
7779808|NCT00948896|12228287|FG007|Randomization to 24 Months of Age|Protocol Violation|1
7779809|NCT00948896|12228280|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0
7779810|NCT00948896|12228281|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3
7779811|NCT00948896|12228282|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3
7779812|NCT00948896|12228283|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1
7779813|NCT00948896|12228284|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0
7779814|NCT00948896|12228285|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2
7779815|NCT00948896|12228286|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0
7779816|NCT00948896|12228287|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0
7779817|NCT00948896|12228280|FG000|24 Months of Age to 36 Months of Age|Death|0
7779818|NCT00948896|12228281|FG001|24 Months of Age to 36 Months of Age|Death|2
7779819|NCT00948896|12228282|FG002|24 Months of Age to 36 Months of Age|Death|2
7779820|NCT00948896|12228283|FG003|24 Months of Age to 36 Months of Age|Death|0
7779821|NCT00948896|12228284|FG004|24 Months of Age to 36 Months of Age|Death|0
7779822|NCT00948896|12228285|FG005|24 Months of Age to 36 Months of Age|Death|1
7779823|NCT00948896|12228286|FG006|24 Months of Age to 36 Months of Age|Death|0
7779824|NCT00948896|12228287|FG007|24 Months of Age to 36 Months of Age|Death|0
7779825|NCT00948896|12228280|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
7779826|NCT00948896|12228281|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
7779827|NCT00948896|12228282|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
7779828|NCT00948896|12228283|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
7779829|NCT00948896|12228284|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
7779830|NCT00948896|12228285|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
7779831|NCT00948896|12228286|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
7779832|NCT00948896|12228287|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
7779833|NCT00948896|12228280|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
7779834|NCT00948896|12228281|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
7779835|NCT00948896|12228282|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
7779836|NCT00948896|12228283|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
7779837|NCT00948896|12228284|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
7779838|NCT00948896|12228285|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
7614145|NCT02471144|12022869|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614146|NCT02471144|12022870|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614147|NCT02471144|12022871|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614148|NCT02471144|12022872|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614149|NCT02471144|12022873|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614150|NCT02471144|12022874|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614151|NCT02471144|12022875|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2
7614152|NCT02440464|12022893|FG000|Overall Study|Withdrawal by Subject|3
7614153|NCT02440464|12022894|FG001|Overall Study|Withdrawal by Subject|2
7614154|NCT02366728|12022911|FG000|Overall Study|Death|0
7614155|NCT02366728|12022912|FG001|Overall Study|Death|0
7614156|NCT02366728|12022913|FG002|Overall Study|Death|1
7614157|NCT02366728|12022911|FG000|Overall Study|Adverse Event|1
7614158|NCT02366728|12022912|FG001|Overall Study|Adverse Event|0
7614159|NCT02366728|12022913|FG002|Overall Study|Adverse Event|0
7614160|NCT02366728|12022911|FG000|Overall Study|Screen Failure|2
7614161|NCT02366728|12022912|FG001|Overall Study|Screen Failure|1
7614162|NCT02366728|12022913|FG002|Overall Study|Screen Failure|0
7614163|NCT02366728|12022911|FG000|Overall Study|Only yielded 2 vaccines|1
7614164|NCT02366728|12022912|FG001|Overall Study|Only yielded 2 vaccines|0
7614165|NCT02366728|12022913|FG002|Overall Study|Only yielded 2 vaccines|0
7614166|NCT02236572|12022921|FG000|Overall Study|Withdrawal by Subject|1
7614167|NCT02236572|12022921|FG000|Overall Study|Protocol Violation|1
7614168|NCT02236572|12022921|FG000|Overall Study|Lost to Follow-up|1
7614169|NCT02083354|12022925|FG000|Overall Study|Withdrawal by Subject|9
7614170|NCT02083354|12022925|FG000|Overall Study|Lost to Follow-up|1
7614171|NCT02083354|12022925|FG000|Overall Study|Adverse Event|3
7614172|NCT02083354|12022925|FG000|Overall Study|Disease progression|46
7614173|NCT02083354|12022925|FG000|Overall Study|Study closed/terminated|5
7614174|NCT01446016|12022959|FG000|Overall Study|Lost to Follow-up|3
7614175|NCT01446016|12022959|FG000|Overall Study|Withdrawal by Subject|1
7614176|NCT01446016|12022959|FG000|Overall Study|Toxicity|3
7614177|NCT01411332|12022978|FG000|Overall Study|Lost to Follow-up|1
7614178|NCT01411332|12022979|FG001|Overall Study|Lost to Follow-up|0
7614179|NCT01411332|12022978|FG000|Overall Study|Protocol Violation|1
7614180|NCT01411332|12022979|FG001|Overall Study|Protocol Violation|1
7614181|NCT01411332|12022978|FG000|Overall Study|Withdrawal by Subject|0
7614182|NCT01411332|12022979|FG001|Overall Study|Withdrawal by Subject|1
7614183|NCT01399918|12022985|FG000|Overall Study|Not eligible and not enrolled in the study|2
7614184|NCT01147653|12022995|FG000|Year 2|Withdrawal by Subject|2
7614185|NCT01147653|12022996|FG001|Year 2|Withdrawal by Subject|3
7614186|NCT01078454|12023016|FG000|Overall Study|Adverse Event|1
7614187|NCT01078454|12023017|FG001|Overall Study|Adverse Event|1
7614188|NCT01078454|12023016|FG000|Overall Study|Death|0
7614189|NCT01078454|12023017|FG001|Overall Study|Death|1
7614190|NCT00687596|12023025|FG000|Overall Study|Adverse Event (AE)|10
7614191|NCT00687596|12023026|FG001|Overall Study|Adverse Event (AE)|3
7614192|NCT00687596|12023025|FG000|Overall Study|Radiological Disease Progression|6
7614193|NCT00687596|12023026|FG001|Overall Study|Radiological Disease Progression|2
7614194|NCT00687596|12023025|FG000|Overall Study|Clinical Disease Progression|1
7614195|NCT00687596|12023026|FG001|Overall Study|Clinical Disease Progression|3
7614196|NCT00687596|12023025|FG000|Overall Study|Investigator Discretion|3
7614197|NCT00687596|12023026|FG001|Overall Study|Investigator Discretion|1
7779839|NCT00948896|12228286|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
7779840|NCT00948896|12228287|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
7779841|NCT00948896|12228280|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0
7779842|NCT00948896|12228281|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0
7779843|NCT00948896|12228282|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1
7779844|NCT00948896|12228283|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0
7779845|NCT00948896|12228284|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0
7779846|NCT00948896|12228285|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1
7779847|NCT00948896|12228286|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0
7779848|NCT00948896|12228287|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0
7779849|NCT00948896|12228280|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7779850|NCT00948896|12228281|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7779851|NCT00948896|12228282|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7779852|NCT00948896|12228283|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
7779853|NCT00948896|12228284|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7779854|NCT00948896|12228285|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7614198|NCT00687596|12023025|FG000|Overall Study|Sponsor Terminated Study|6
7614199|NCT00687596|12023026|FG001|Overall Study|Sponsor Terminated Study|17
7614200|NCT00458536|12023032|FG000|Overall Study|Disease progression prior to treatment|7
7614201|NCT00458536|12023032|FG000|Overall Study|Unable to make vaccine|3
7614202|NCT00458536|12023032|FG000|Overall Study|No measurable disease after surgery|2
7614203|NCT00458536|12023032|FG000|Overall Study|Did not have renal cell carcinoma|2
7614204|NCT00458536|12023032|FG000|Overall Study|Patient did not have surgery|1
7614205|NCT00458536|12023032|FG000|Overall Study|Ineligible due to toxicity|1
7614206|NCT00458536|12023032|FG000|Overall Study|Withdrawal by Subject|1
7614207|NCT00458536|12023032|FG000|Overall Study|Progressive disease during treatment|2
7614208|NCT00112840|12023039|FG000|Overall Study|Physician Decision|1
7614209|NCT00112840|12023040|FG001|Overall Study|Physician Decision|0
7614210|NCT00112840|12023041|FG002|Overall Study|Physician Decision|0
7614211|NCT00112840|12023039|FG000|Overall Study|Withdrawal by Subject|1
7614212|NCT00112840|12023040|FG001|Overall Study|Withdrawal by Subject|0
7614213|NCT00112840|12023041|FG002|Overall Study|Withdrawal by Subject|1
7614214|NCT00112840|12023039|FG000|Overall Study|Protocol Violation|0
7614215|NCT00112840|12023040|FG001|Overall Study|Protocol Violation|0
7614216|NCT00112840|12023041|FG002|Overall Study|Protocol Violation|5
7614217|NCT04207749|12023070|FG000|Overall Study|Lost to Follow-up|0
7614218|NCT04207749|12023071|FG001|Overall Study|Lost to Follow-up|2
7614219|NCT04207749|12023070|FG000|Overall Study|Protocol Violation|0
7614220|NCT04207749|12023071|FG001|Overall Study|Protocol Violation|1
7614221|NCT04207749|12023070|FG000|Overall Study|Withdrawal by Subject|3
7614222|NCT04207749|12023071|FG001|Overall Study|Withdrawal by Subject|0
7614223|NCT04207749|12023070|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1
7614224|NCT04207749|12023071|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4
7614225|NCT04167345|12023085|FG000|Overall Study|Other|1
7614226|NCT04167345|12023086|FG001|Overall Study|Other|1
7614227|NCT04167345|12023087|FG002|Overall Study|Other|0
7614228|NCT04167345|12023088|FG003|Overall Study|Other|0
7614229|NCT04167345|12023089|FG004|Overall Study|Other|0
7614230|NCT04042077|12023107|FG000|Overall Study|Adverse Event|0
7614231|NCT04042077|12023108|FG001|Overall Study|Adverse Event|1
7614232|NCT04042077|12023107|FG000|Overall Study|Death|2
7614233|NCT04042077|12023108|FG001|Overall Study|Death|1
7614234|NCT04042077|12023107|FG000|Overall Study|Physician Decision|2
7614235|NCT04042077|12023108|FG001|Overall Study|Physician Decision|0
7614236|NCT04042077|12023107|FG000|Overall Study|Withdrawal by Subject|3
7614237|NCT04042077|12023108|FG001|Overall Study|Withdrawal by Subject|2
7614238|NCT04042077|12023107|FG000|Overall Study|Lack of Efficacy|0
7614239|NCT04042077|12023108|FG001|Overall Study|Lack of Efficacy|1
7614240|NCT04001803|12023120|FG000|Overall Study|Ongoing at the time of analysis|103
7614241|NCT04001803|12023120|FG000|Overall Study|Adverse Event|2
7614242|NCT04001803|12023120|FG000|Overall Study|Protocol Violation|2
7614243|NCT04001803|12023120|FG000|Overall Study|Lost to Follow-up|2
7614244|NCT04001803|12023120|FG000|Overall Study|Physician Decision|1
7614245|NCT04001803|12023120|FG000|Overall Study|Withdrawal by Subject|4
7614246|NCT03925324|12023136|FG000|Overall Study|Death|1
7614247|NCT03925324|12023137|FG001|Overall Study|Death|1
7779855|NCT00948896|12228286|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7779856|NCT00948896|12228287|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7779857|NCT00948922|12228312|FG000|Overall Study|Did not start study treatment|2
7779858|NCT00948922|12228313|FG001|Overall Study|Did not start study treatment|5
7779859|NCT00948922|12228314|FG002|Overall Study|Did not start study treatment|0
7779860|NCT00948922|12228312|FG000|Overall Study|Withdrawal by Subject|0
7614254|NCT03740009|12023156|FG000|Overall Study|Physician Decision|9
7614255|NCT03740009|12023156|FG000|Overall Study|Lost to Follow-up|1
7614256|NCT03738397|12023162|FG000|Overall Study|Adverse Event|3
7614257|NCT03738397|12023163|FG001|Overall Study|Adverse Event|7
7614258|NCT03738397|12023162|FG000|Overall Study|Withdrawal by Subject|8
7614259|NCT03738397|12023163|FG001|Overall Study|Withdrawal by Subject|11
7614260|NCT03738397|12023162|FG000|Overall Study|Lost to Follow-up|8
7614261|NCT03738397|12023163|FG001|Overall Study|Lost to Follow-up|5
7614262|NCT03738397|12023162|FG000|Overall Study|COVID-19 Logistical Restrictions|1
7614263|NCT03738397|12023163|FG001|Overall Study|COVID-19 Logistical Restrictions|1
7614264|NCT03738397|12023162|FG000|Overall Study|Other|4
7614265|NCT03738397|12023163|FG001|Overall Study|Other|6
7614266|NCT03666624|12023171|FG000|Overall Study|participant grieving over recent death of parent|1
7614267|NCT03666624|12023172|FG001|Overall Study|participant grieving over recent death of parent|0
7614268|NCT03649217|12023178|FG000|Overall Study|subject had severe ataxia not initially found|1
7779861|NCT00948922|12228313|FG001|Overall Study|Withdrawal by Subject|2
7779862|NCT00948922|12228314|FG002|Overall Study|Withdrawal by Subject|1
7779863|NCT00948922|12228312|FG000|Overall Study|Death|3
7779864|NCT00948922|12228313|FG001|Overall Study|Death|0
7779865|NCT00948922|12228314|FG002|Overall Study|Death|0
7779866|NCT00948922|12228312|FG000|Overall Study|Disease progression|0
7779867|NCT00948922|12228313|FG001|Overall Study|Disease progression|1
7779868|NCT00948922|12228314|FG002|Overall Study|Disease progression|0
7779869|NCT00948922|12228312|FG000|Overall Study|Insurance issues|1
7779870|NCT00948922|12228313|FG001|Overall Study|Insurance issues|0
7614269|NCT03649217|12023178|FG000|Overall Study|subject had cognitive issues not initially found|1
7779871|NCT00948922|12228314|FG002|Overall Study|Insurance issues|0
7614270|NCT03569293|12023188|FG000|Overall Study|Adverse Event|4
7614271|NCT03569293|12023189|FG001|Overall Study|Adverse Event|1
7614272|NCT03569293|12023190|FG002|Overall Study|Adverse Event|5
7614273|NCT03569293|12023191|FG003|Overall Study|Adverse Event|1
7614274|NCT03569293|12023192|FG004|Overall Study|Adverse Event|0
7614275|NCT03569293|12023193|FG005|Overall Study|Adverse Event|0
7614276|NCT03569293|12023188|FG000|Overall Study|Withdrawal by Subject|16
7614277|NCT03569293|12023189|FG001|Overall Study|Withdrawal by Subject|2
7614278|NCT03569293|12023190|FG002|Overall Study|Withdrawal by Subject|4
7614279|NCT03569293|12023191|FG003|Overall Study|Withdrawal by Subject|1
7614280|NCT03569293|12023192|FG004|Overall Study|Withdrawal by Subject|0
7614281|NCT03569293|12023193|FG005|Overall Study|Withdrawal by Subject|0
7614282|NCT03569293|12023188|FG000|Overall Study|Lost to Follow-up|1
7614283|NCT03569293|12023189|FG001|Overall Study|Lost to Follow-up|3
7614284|NCT03569293|12023190|FG002|Overall Study|Lost to Follow-up|1
7614285|NCT03569293|12023191|FG003|Overall Study|Lost to Follow-up|1
7614286|NCT03569293|12023192|FG004|Overall Study|Lost to Follow-up|0
7614287|NCT03569293|12023193|FG005|Overall Study|Lost to Follow-up|0
7614288|NCT03569293|12023188|FG000|Overall Study|Other|8
7614289|NCT03569293|12023189|FG001|Overall Study|Other|2
7614290|NCT03569293|12023190|FG002|Overall Study|Other|1
7614291|NCT03569293|12023191|FG003|Overall Study|Other|1
7614292|NCT03569293|12023192|FG004|Overall Study|Other|0
7614293|NCT03569293|12023193|FG005|Overall Study|Other|0
7614294|NCT03569293|12023188|FG000|Overall Study|Ongoing at Time of Analysis|8
7614295|NCT03569293|12023189|FG001|Overall Study|Ongoing at Time of Analysis|1
7614296|NCT03569293|12023190|FG002|Overall Study|Ongoing at Time of Analysis|3
7614297|NCT03569293|12023191|FG003|Overall Study|Ongoing at Time of Analysis|0
7614298|NCT03569293|12023192|FG004|Overall Study|Ongoing at Time of Analysis|0
7614299|NCT03569293|12023193|FG005|Overall Study|Ongoing at Time of Analysis|0
7779872|NCT00948922|12228312|FG000|Overall Study|Transplant eligibility issues|2
7779873|NCT00948922|12228313|FG001|Overall Study|Transplant eligibility issues|3
7779874|NCT00948922|12228314|FG002|Overall Study|Transplant eligibility issues|0
7779875|NCT00948922|12228312|FG000|Overall Study|Not evaluable at time of analysis|0
7779876|NCT00948922|12228313|FG001|Overall Study|Not evaluable at time of analysis|3
7779877|NCT00948922|12228314|FG002|Overall Study|Not evaluable at time of analysis|0
7779878|NCT00948974|12228332|FG000|Overall Study|Lost to Follow-up|23
7779879|NCT00948974|12228333|FG001|Overall Study|Lost to Follow-up|20
7779880|NCT00949117|12228350|FG000|Overall Study|Lack of Efficacy|2
7779881|NCT00949117|12228351|FG001|Overall Study|Lack of Efficacy|3
7779882|NCT00949117|12228350|FG000|Overall Study|Protocol Violation|1
7779883|NCT00949117|12228351|FG001|Overall Study|Protocol Violation|1
7779884|NCT00949117|12228350|FG000|Overall Study|Adverse Event|0
7779885|NCT00949117|12228351|FG001|Overall Study|Adverse Event|1
7779886|NCT00949325|12228363|FG000|Overall Study|Adverse Event|0
7779887|NCT00949325|12228364|FG001|Overall Study|Adverse Event|2
7614300|NCT03318003|12023278|FG000|Overall Study|Withdrawal by Subject|1
7779888|NCT00949325|12228365|FG002|Overall Study|Adverse Event|0
7779889|NCT00949533|12228383|FG000|Overall Study|Lost to Follow-up|0
7614301|NCT03318003|12023279|FG001|Overall Study|Withdrawal by Subject|1
7614302|NCT03318003|12023278|FG000|Overall Study|fetal loss|0
7614303|NCT03318003|12023279|FG001|Overall Study|fetal loss|1
7614304|NCT03132753|12023305|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27
7614305|NCT03132753|12023306|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32
7614306|NCT03132753|12023305|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6
7614307|NCT03132753|12023306|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2
7614308|NCT03067077|12023321|FG000|Overall Study|Did not receive surgery|4
7614309|NCT03067077|12023322|FG001|Overall Study|Did not receive surgery|5
7614310|NCT03067077|12023321|FG000|Overall Study|Lost to Follow-up|3
7614311|NCT03067077|12023322|FG001|Overall Study|Lost to Follow-up|2
7614312|NCT03059446|12023328|FG000|Overall Study|Adverse Event|11
7614313|NCT03059446|12023328|FG000|Overall Study|Withdrawal of Consent|16
7614314|NCT03059446|12023328|FG000|Overall Study|Lost to Follow-up|3
7614315|NCT03059446|12023328|FG000|Overall Study|Protocol Violation|1
7614316|NCT03059446|12023328|FG000|Overall Study|Study Terminated by Sponsor|131
7614317|NCT03059446|12023328|FG000|Overall Study|Reason not Specified|5
7614318|NCT03011034|12023338|FG000|Overall Study|Adverse Event|1
7614319|NCT03011034|12023339|FG001|Overall Study|Adverse Event|0
7779890|NCT00949533|12228384|FG001|Overall Study|Lost to Follow-up|1
7779891|NCT00949650|12228392|FG000|Overall Study|Progressive disease|188
7779892|NCT00949650|12228393|FG001|Overall Study|Progressive disease|19
7779893|NCT00949650|12228392|FG000|Overall Study|Completed 6 courses of chemotherapy|0
7779894|NCT00949650|12228393|FG001|Overall Study|Completed 6 courses of chemotherapy|60
7779895|NCT00949650|12228392|FG000|Overall Study|Other Adverse Event (AE)|28
7614326|NCT02601014|12023391|FG000|Overall Study|Adverse Event|3
7614327|NCT02601014|12023392|FG001|Overall Study|Adverse Event|3
7614328|NCT02601014|12023391|FG000|Overall Study|Death|3
7614329|NCT02601014|12023392|FG001|Overall Study|Death|1
7614330|NCT02601014|12023391|FG000|Overall Study|Disease progression|4
7614331|NCT02601014|12023392|FG001|Overall Study|Disease progression|8
7779896|NCT00949650|12228393|FG001|Overall Study|Other Adverse Event (AE)|17
7779897|NCT00949650|12228392|FG000|Overall Study|Protocol Violation|1
7779898|NCT00949650|12228393|FG001|Overall Study|Protocol Violation|4
7779899|NCT00949650|12228392|FG000|Overall Study|Refusal to continue medication|7
7779900|NCT00949650|12228393|FG001|Overall Study|Refusal to continue medication|11
7779901|NCT00949650|12228392|FG000|Overall Study|Not treated|1
7779902|NCT00949650|12228393|FG001|Overall Study|Not treated|4
7779903|NCT00949650|12228392|FG000|Overall Study|Other not specified above|5
7779904|NCT00949650|12228393|FG001|Overall Study|Other not specified above|0
7779905|NCT00949702|12228403|FG000|Overall Study|Death|40
7779906|NCT00949702|12228403|FG000|Overall Study|Disease progression|7
7779907|NCT00949702|12228403|FG000|Overall Study|Withdrawal of consent|1
7779908|NCT00949715|12228409|FG000|Overall Study|Physician Decision|1
7779909|NCT00949715|12228410|FG001|Overall Study|Physician Decision|0
7779910|NCT00949715|12228409|FG000|Overall Study|Lost to Follow-up|1
7779911|NCT00949715|12228410|FG001|Overall Study|Lost to Follow-up|0
7779912|NCT00949715|12228409|FG000|Overall Study|Missing 24 month LVEF measurement|2
7779913|NCT00949715|12228410|FG001|Overall Study|Missing 24 month LVEF measurement|0
7779914|NCT00949884|12228418|FG000|Overall Study|Adverse Event|14
7779915|NCT00949884|12228419|FG001|Overall Study|Adverse Event|3
7779916|NCT00949884|12228420|FG002|Overall Study|Adverse Event|12
7779917|NCT00949884|12228418|FG000|Overall Study|Did not meet inclusion/exclusion|2
7779918|NCT00949884|12228419|FG001|Overall Study|Did not meet inclusion/exclusion|1
7779919|NCT00949884|12228420|FG002|Overall Study|Did not meet inclusion/exclusion|3
7779920|NCT00949884|12228418|FG000|Overall Study|Lost to Follow-up|7
7779921|NCT00949884|12228419|FG001|Overall Study|Lost to Follow-up|5
7779922|NCT00949884|12228420|FG002|Overall Study|Lost to Follow-up|5
7779923|NCT00949884|12228418|FG000|Overall Study|Physician Decision|5
7779924|NCT00949884|12228419|FG001|Overall Study|Physician Decision|0
7779925|NCT00949884|12228420|FG002|Overall Study|Physician Decision|6
7779926|NCT00949884|12228418|FG000|Overall Study|Treatment non-compliance|5
7779927|NCT00949884|12228419|FG001|Overall Study|Treatment non-compliance|0
7779928|NCT00949884|12228420|FG002|Overall Study|Treatment non-compliance|8
7779929|NCT00949884|12228418|FG000|Overall Study|Withdrawal by Subject|13
7779930|NCT00949884|12228419|FG001|Overall Study|Withdrawal by Subject|4
7779931|NCT00949884|12228420|FG002|Overall Study|Withdrawal by Subject|16
7779932|NCT00949884|12228418|FG000|Overall Study|Lack of Efficacy|4
7779933|NCT00949884|12228419|FG001|Overall Study|Lack of Efficacy|2
7779934|NCT00949884|12228420|FG002|Overall Study|Lack of Efficacy|7
7779935|NCT00949884|12228418|FG000|Overall Study|Study terminated by sponsor|0
7779936|NCT00949884|12228419|FG001|Overall Study|Study terminated by sponsor|0
7779937|NCT00949884|12228420|FG002|Overall Study|Study terminated by sponsor|1
7800150|NCT01091428|12257328|FG002|Phase 1|Withdrawal by Subject|0
7800151|NCT01091428|12257329|FG003|Phase 1|Withdrawal by Subject|0
7800152|NCT01091428|12257326|FG000|Phase 1|Reason not specified|0
7800153|NCT01091428|12257327|FG001|Phase 1|Reason not specified|1
7800154|NCT01091428|12257328|FG002|Phase 1|Reason not specified|0
7800155|NCT01091428|12257329|FG003|Phase 1|Reason not specified|0
7800156|NCT01091428|12257326|FG000|Phase 1|Single-Patient IND|2
7800157|NCT01091428|12257327|FG001|Phase 1|Single-Patient IND|0
7800158|NCT01091428|12257328|FG002|Phase 1|Single-Patient IND|0
7800159|NCT01091428|12257329|FG003|Phase 1|Single-Patient IND|0
7800160|NCT01091428|12257326|FG000|Phase 2|Progressive Disease|0
7800161|NCT01091428|12257327|FG001|Phase 2|Progressive Disease|0
7779938|NCT00949910|12228429|FG000|Overall Study|Progressive Disease|3750
7779939|NCT00949910|12228429|FG000|Overall Study|Symptomatic Deterioration|1088
7779940|NCT00949910|12228429|FG000|Overall Study|Lost to Follow-up|100
7779941|NCT00949910|12228429|FG000|Overall Study|Study Drug-Related Adverse Event|315
7779942|NCT00949910|12228429|FG000|Overall Study|Participant Refusal|390
7779943|NCT00949910|12228429|FG000|Overall Study|Death Due to Malignant Disease|456
7779944|NCT00949910|12228429|FG000|Overall Study|Death Due to Progression/Deterioration|4
7779945|NCT00949910|12228429|FG000|Overall Study|Death Due to Adverse Event|115
7779946|NCT00949910|12228429|FG000|Overall Study|Death Due to Toxicity|3
7779947|NCT00949910|12228429|FG000|Overall Study|Death from Unknown Cause|5
7779948|NCT00949910|12228429|FG000|Overall Study|Unspecified Progression/Deterioration|13
7779949|NCT00949910|12228429|FG000|Overall Study|Switched to Compassionate/Other Use|174
7779950|NCT00949910|12228429|FG000|Overall Study|Switched to Commercial Treatment|4
7779951|NCT00949910|12228429|FG000|Overall Study|Violation of Eligibility|23
7779952|NCT00949910|12228429|FG000|Overall Study|Logistical Reasons|13
7779953|NCT00949910|12228429|FG000|Overall Study|Non-Compliance|10
7779954|NCT00949910|12228429|FG000|Overall Study|Prolonged Dosing Interruption|4
7614368|NCT02538666|12023410|FG000|Overall Study|Disease progression|1
7614369|NCT02538666|12023411|FG001|Overall Study|Disease progression|0
7614370|NCT02538666|12023412|FG002|Overall Study|Disease progression|0
7614371|NCT02538666|12023410|FG000|Overall Study|no longer meets study criteria|1
7614372|NCT02538666|12023411|FG001|Overall Study|no longer meets study criteria|0
7614373|NCT02538666|12023412|FG002|Overall Study|no longer meets study criteria|0
7614374|NCT02538666|12023410|FG000|Overall Study|Withdrew Consent|0
7614375|NCT02538666|12023411|FG001|Overall Study|Withdrew Consent|1
7614376|NCT02538666|12023412|FG002|Overall Study|Withdrew Consent|1
7614377|NCT02527200|12023425|FG000|Overall Study|Withdrawal by Subject|3
7614378|NCT02527200|12023426|FG001|Overall Study|Withdrawal by Subject|2
7614379|NCT02527200|12023427|FG002|Overall Study|Withdrawal by Subject|1
7614380|NCT02527200|12023428|FG003|Overall Study|Withdrawal by Subject|0
7614381|NCT02527200|12023425|FG000|Overall Study|Unclassified|0
7614382|NCT02527200|12023426|FG001|Overall Study|Unclassified|1
7614383|NCT02527200|12023427|FG002|Overall Study|Unclassified|0
7614384|NCT02527200|12023428|FG003|Overall Study|Unclassified|0
7614385|NCT02527200|12023425|FG000|Overall Study|Lost to Follow-up|0
7614386|NCT02527200|12023426|FG001|Overall Study|Lost to Follow-up|0
7614387|NCT02527200|12023427|FG002|Overall Study|Lost to Follow-up|1
7614388|NCT02527200|12023428|FG003|Overall Study|Lost to Follow-up|0
7614389|NCT02511106|12023444|FG000|Overall Study|Lost to Follow-up|1
7614390|NCT02511106|12023445|FG001|Overall Study|Lost to Follow-up|2
7614391|NCT02511106|12023444|FG000|Overall Study|Withdrawal by Subject|19
7614392|NCT02511106|12023445|FG001|Overall Study|Withdrawal by Subject|14
7614393|NCT02511106|12023444|FG000|Overall Study|Ongoing study at data cut-off|309
7614394|NCT02511106|12023445|FG001|Overall Study|Ongoing study at data cut-off|307
7614395|NCT02511106|12023444|FG000|Overall Study|Without specified reason|1
7614396|NCT02511106|12023445|FG001|Overall Study|Without specified reason|0
7614397|NCT02511106|12023444|FG000|Overall Study|Missing|1
7614398|NCT02511106|12023445|FG001|Overall Study|Missing|0
7614399|NCT02224573|12023487|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0
7614400|NCT02224573|12023488|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1
7614401|NCT02224573|12023487|FG000|Treatment Phase|Started on Other IMP|1
7614402|NCT02224573|12023488|FG001|Treatment Phase|Started on Other IMP|0
7614403|NCT02224573|12023487|FG000|Treatment Phase|Participant Discontinued IMP|0
7614404|NCT02224573|12023488|FG001|Treatment Phase|Participant Discontinued IMP|1
7614405|NCT02224573|12023487|FG000|Treatment Phase|Lack of Efficacy|15
7614406|NCT02224573|12023488|FG001|Treatment Phase|Lack of Efficacy|8
7614407|NCT02224573|12023487|FG000|Treatment Phase|Began Commercial Product|1
7614408|NCT02224573|12023488|FG001|Treatment Phase|Began Commercial Product|0
7614409|NCT02224573|12023487|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3
7614410|NCT02224573|12023488|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3
7614411|NCT02224573|12023487|FG000|Treatment Phase|Met Withdrawal Criteria|5
7614412|NCT02224573|12023488|FG001|Treatment Phase|Met Withdrawal Criteria|7
7614413|NCT02224573|12023487|FG000|Treatment Phase|Participant Did Not Return for Visits|0
7614414|NCT02224573|12023488|FG001|Treatment Phase|Participant Did Not Return for Visits|1
7614415|NCT02224573|12023487|FG000|Treatment Phase|Continued Compassionate Use|1
7614416|NCT02224573|12023488|FG001|Treatment Phase|Continued Compassionate Use|0
7614417|NCT02224573|12023487|FG000|Treatment Phase|Lack of Efficiency|2
7614418|NCT02224573|12023488|FG001|Treatment Phase|Lack of Efficiency|1
7614419|NCT02224573|12023487|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0
7614420|NCT02224573|12023488|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1
7614421|NCT02224573|12023487|FG000|Treatment Phase|Participant Moved|2
7614422|NCT02224573|12023488|FG001|Treatment Phase|Participant Moved|0
7614423|NCT02224573|12023487|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62
7614424|NCT02224573|12023488|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48
7614425|NCT02224573|12023487|FG000|Treatment Phase|Refused Medication|1
7614426|NCT02224573|12023488|FG001|Treatment Phase|Refused Medication|1
7614427|NCT02224573|12023487|FG000|Treatment Phase|Adverse Event|26
7614428|NCT02224573|12023488|FG001|Treatment Phase|Adverse Event|38
7779955|NCT00949910|12228429|FG000|Overall Study|Adverse Event|83
7779956|NCT00949910|12228429|FG000|Overall Study|Serious Adverse Event|6
7614429|NCT02224573|12023487|FG000|Treatment Phase|Placed in Group Home|0
7779957|NCT00949910|12228429|FG000|Overall Study|Physician/Participant Decision|7
7779958|NCT00949910|12228429|FG000|Overall Study|Other|4
7779959|NCT00949910|12228429|FG000|Overall Study|No Data|9
7779960|NCT00949975|12228437|FG000|Overall Study|Voluntary discontinuation|6
7779961|NCT00949975|12228438|FG001|Overall Study|Voluntary discontinuation|5
7779962|NCT00949975|12228439|FG002|Overall Study|Voluntary discontinuation|3
7779963|NCT00949975|12228440|FG003|Overall Study|Voluntary discontinuation|6
7779964|NCT00949975|12228437|FG000|Overall Study|Adverse Event|11
7779965|NCT00949975|12228438|FG001|Overall Study|Adverse Event|11
7779966|NCT00949975|12228439|FG002|Overall Study|Adverse Event|10
7779967|NCT00949975|12228440|FG003|Overall Study|Adverse Event|10
7779968|NCT00949975|12228437|FG000|Overall Study|Safety reason|0
7779969|NCT00949975|12228438|FG001|Overall Study|Safety reason|1
7779970|NCT00949975|12228439|FG002|Overall Study|Safety reason|0
7779971|NCT00949975|12228440|FG003|Overall Study|Safety reason|0
7779972|NCT00949975|12228437|FG000|Overall Study|Study-specific criteria|0
7779973|NCT00949975|12228438|FG001|Overall Study|Study-specific criteria|1
7779974|NCT00949975|12228439|FG002|Overall Study|Study-specific criteria|1
7779975|NCT00949975|12228440|FG003|Overall Study|Study-specific criteria|0
7779976|NCT00949975|12228437|FG000|Overall Study|Incorrect enrolment|5
7779977|NCT00949975|12228438|FG001|Overall Study|Incorrect enrolment|10
7779978|NCT00949975|12228439|FG002|Overall Study|Incorrect enrolment|4
7779979|NCT00949975|12228440|FG003|Overall Study|Incorrect enrolment|7
7779980|NCT00949975|12228437|FG000|Overall Study|Severe non-compliance|3
7779981|NCT00949975|12228438|FG001|Overall Study|Severe non-compliance|1
7779982|NCT00949975|12228439|FG002|Overall Study|Severe non-compliance|0
7779983|NCT00949975|12228440|FG003|Overall Study|Severe non-compliance|2
7779984|NCT00949975|12228437|FG000|Overall Study|Lost to Follow-up|1
7779985|NCT00949975|12228438|FG001|Overall Study|Lost to Follow-up|0
7779986|NCT00949975|12228439|FG002|Overall Study|Lost to Follow-up|1
7779987|NCT00949975|12228440|FG003|Overall Study|Lost to Follow-up|3
7779988|NCT00949975|12228437|FG000|Overall Study|Other|1
7614430|NCT02224573|12023488|FG001|Treatment Phase|Placed in Group Home|1
7614431|NCT02224573|12023487|FG000|Treatment Phase|Pursued Other Trials|1
7779989|NCT00949975|12228438|FG001|Overall Study|Other|0
7779990|NCT00949975|12228439|FG002|Overall Study|Other|0
7614432|NCT02224573|12023488|FG001|Treatment Phase|Pursued Other Trials|0
7614433|NCT02224573|12023487|FG000|Treatment Phase|Withdrawn by the Investigator|23
7614434|NCT02224573|12023488|FG001|Treatment Phase|Withdrawn by the Investigator|11
7614435|NCT02224573|12023487|FG000|Treatment Phase|Lost to Follow-up|2
7614436|NCT02224573|12023488|FG001|Treatment Phase|Lost to Follow-up|1
7614437|NCT02224573|12023487|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1
7614438|NCT02224573|12023488|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0
7614439|NCT02224573|12023487|FG000|Taper Phase|Hospitalization/Dose Reduction|1
7614440|NCT02224573|12023488|FG001|Taper Phase|Hospitalization/Dose Reduction|0
7614441|NCT02224573|12023487|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0
7614442|NCT02224573|12023488|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3
7614443|NCT02224573|12023487|FG000|Taper Phase|Adverse Event|1
7614444|NCT02224573|12023488|FG001|Taper Phase|Adverse Event|1
7614445|NCT01991067|12023497|FG000|Overall Study|Lost to Follow-up|6
7614446|NCT01991067|12023498|FG001|Overall Study|Lost to Follow-up|5
7614447|NCT01774721|12023519|FG000|Overall Study|Death|76
7614448|NCT01774721|12023520|FG001|Overall Study|Death|91
7614449|NCT01774721|12023519|FG000|Overall Study|Withdrawal by Subject|14
7614450|NCT01774721|12023520|FG001|Overall Study|Withdrawal by Subject|10
7614451|NCT01774721|12023519|FG000|Overall Study|Lost to Follow-up|1
7614452|NCT01774721|12023520|FG001|Overall Study|Lost to Follow-up|1
7614453|NCT01774721|12023519|FG000|Overall Study|Did not meet eligibility criteria|0
7614454|NCT01774721|12023520|FG001|Overall Study|Did not meet eligibility criteria|3
7614455|NCT01774721|12023519|FG000|Overall Study|Ongoing in study|136
7614456|NCT01774721|12023520|FG001|Overall Study|Ongoing in study|120
7614457|NCT01709331|12023537|FG000|Overall Study|Adverse Event|1
7614458|NCT01656434|12023543|FG000|Overall Study|Adverse Event|199
7779991|NCT00949975|12228440|FG003|Overall Study|Other|0
7614459|NCT01656434|12023544|FG001|Overall Study|Adverse Event|63
7614460|NCT01656434|12023543|FG000|Overall Study|Enrollment terminated at trial site|2
7614461|NCT01656434|12023544|FG001|Overall Study|Enrollment terminated at trial site|0
7614462|NCT01656434|12023543|FG000|Overall Study|Lost to Follow-up|309
7614463|NCT01656434|12023544|FG001|Overall Study|Lost to Follow-up|76
7614464|NCT01656434|12023543|FG000|Overall Study|Site discontinued study participation|24
7614465|NCT01656434|12023544|FG001|Overall Study|Site discontinued study participation|9
7614466|NCT01656434|12023543|FG000|Overall Study|Screen failure|2
7614467|NCT01656434|12023544|FG001|Overall Study|Screen failure|0
7614468|NCT01656434|12023543|FG000|Overall Study|Protocol Violation|7
7614469|NCT01656434|12023544|FG001|Overall Study|Protocol Violation|0
7614470|NCT01656434|12023543|FG000|Overall Study|Pregnancy wish|18
7614471|NCT01656434|12023544|FG001|Overall Study|Pregnancy wish|6
7614472|NCT01656434|12023543|FG000|Overall Study|Pregnancy|45
7614473|NCT01656434|12023544|FG001|Overall Study|Pregnancy|10
7614474|NCT01656434|12023543|FG000|Overall Study|Physician Decision|7
7614475|NCT01656434|12023544|FG001|Overall Study|Physician Decision|2
7614476|NCT01656434|12023543|FG000|Overall Study|Non-compliance with study drug|48
7614477|NCT01656434|12023544|FG001|Overall Study|Non-compliance with study drug|9
7614478|NCT01656434|12023543|FG000|Overall Study|Study terminated by sponsor|1501
7614479|NCT01656434|12023544|FG001|Overall Study|Study terminated by sponsor|348
7614480|NCT01656434|12023543|FG000|Overall Study|Participant discontinued; drug related|13
7614481|NCT01656434|12023544|FG001|Overall Study|Participant discontinued; drug related|4
7614482|NCT01656434|12023543|FG000|Overall Study|Part. discontinued; unrelated to drug|55
7614483|NCT01656434|12023544|FG001|Overall Study|Part. discontinued; unrelated to drug|10
7614484|NCT01656434|12023543|FG000|Overall Study|Non-compliance with protocol|39
7614485|NCT01656434|12023544|FG001|Overall Study|Non-compliance with protocol|15
7614486|NCT01656434|12023543|FG000|Overall Study|Participant moved|40
7614487|NCT01656434|12023544|FG001|Overall Study|Participant moved|12
7614488|NCT01656434|12023543|FG000|Overall Study|Participant withdrew consent|28
7614489|NCT01656434|12023544|FG001|Overall Study|Participant withdrew consent|9
7614490|NCT01656434|12023543|FG000|Overall Study|Withdrawal by Subject|64
7614491|NCT01656434|12023544|FG001|Overall Study|Withdrawal by Subject|7
7614492|NCT01496118|12023573|FG000|Overall Study|Disease progression|3
7614493|NCT01496118|12023574|FG001|Overall Study|Disease progression|2
7614494|NCT01496118|12023575|FG002|Overall Study|Disease progression|3
7614495|NCT01496118|12023576|FG003|Overall Study|Disease progression|1
7614496|NCT01496118|12023577|FG004|Overall Study|Disease progression|2
7614497|NCT01496118|12023578|FG005|Overall Study|Disease progression|2
7614498|NCT01496118|12023579|FG006|Overall Study|Disease progression|14
7614499|NCT01496118|12023580|FG007|Overall Study|Disease progression|10
7614500|NCT01496118|12023573|FG000|Overall Study|Physician Decision|0
7614501|NCT01496118|12023574|FG001|Overall Study|Physician Decision|0
7614502|NCT01496118|12023575|FG002|Overall Study|Physician Decision|0
7614503|NCT01496118|12023576|FG003|Overall Study|Physician Decision|0
7614504|NCT01496118|12023577|FG004|Overall Study|Physician Decision|1
7614505|NCT01496118|12023578|FG005|Overall Study|Physician Decision|0
7614506|NCT01496118|12023579|FG006|Overall Study|Physician Decision|3
7614507|NCT01496118|12023580|FG007|Overall Study|Physician Decision|6
7614508|NCT01496118|12023573|FG000|Overall Study|Adverse Event|1
7614509|NCT01496118|12023574|FG001|Overall Study|Adverse Event|1
7614510|NCT01496118|12023575|FG002|Overall Study|Adverse Event|0
7614511|NCT01496118|12023576|FG003|Overall Study|Adverse Event|0
7614512|NCT01496118|12023577|FG004|Overall Study|Adverse Event|0
7614513|NCT01496118|12023578|FG005|Overall Study|Adverse Event|0
7614514|NCT01496118|12023579|FG006|Overall Study|Adverse Event|6
7614515|NCT01496118|12023580|FG007|Overall Study|Adverse Event|10
7614516|NCT01496118|12023573|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0
7614517|NCT01496118|12023574|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0
7614518|NCT01496118|12023575|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0
7614519|NCT01496118|12023576|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0
7614520|NCT01496118|12023577|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0
7614521|NCT01496118|12023578|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0
7614522|NCT01496118|12023579|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1
7614523|NCT01496118|12023580|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0
7614524|NCT01496118|12023573|FG000|Overall Study|Death|0
7614525|NCT01496118|12023574|FG001|Overall Study|Death|0
7614526|NCT01496118|12023575|FG002|Overall Study|Death|0
7614527|NCT01496118|12023576|FG003|Overall Study|Death|0
7614528|NCT01496118|12023577|FG004|Overall Study|Death|0
7614529|NCT01496118|12023578|FG005|Overall Study|Death|0
7614530|NCT01496118|12023579|FG006|Overall Study|Death|1
7614531|NCT01496118|12023580|FG007|Overall Study|Death|1
7614532|NCT01496118|12023573|FG000|Overall Study|Withdrawal by Subject|0
7614533|NCT01496118|12023574|FG001|Overall Study|Withdrawal by Subject|0
7614534|NCT01496118|12023575|FG002|Overall Study|Withdrawal by Subject|0
7614535|NCT01496118|12023576|FG003|Overall Study|Withdrawal by Subject|2
7614536|NCT01496118|12023577|FG004|Overall Study|Withdrawal by Subject|0
7614537|NCT01496118|12023578|FG005|Overall Study|Withdrawal by Subject|1
7614538|NCT01496118|12023579|FG006|Overall Study|Withdrawal by Subject|6
7614539|NCT01496118|12023580|FG007|Overall Study|Withdrawal by Subject|3
7614540|NCT01350934|12023600|FG000|Base Study|Adverse Event|6
7614541|NCT01350934|12023601|FG001|Base Study|Adverse Event|0
7614542|NCT01350934|12023600|FG000|Base Study|Lost to Follow-up|1
7614543|NCT01350934|12023601|FG001|Base Study|Lost to Follow-up|0
7614544|NCT01350934|12023600|FG000|Base Study|Protocol Violation|1
7614545|NCT01350934|12023601|FG001|Base Study|Protocol Violation|1
7614546|NCT01350934|12023600|FG000|Base Study|Withdrawal by Subject|1
7614547|NCT01350934|12023601|FG001|Base Study|Withdrawal by Subject|2
7614548|NCT01350934|12023600|FG000|Base Study|Non-Compliance With Study Drug|2
7614549|NCT01350934|12023601|FG001|Base Study|Non-Compliance With Study Drug|0
7614550|NCT01350934|12023600|FG000|Extension Study|Adverse Event|2
7614551|NCT01350934|12023601|FG001|Extension Study|Adverse Event|1
7614552|NCT01350934|12023600|FG000|Extension Study|Lost to Follow-up|2
7614553|NCT01350934|12023601|FG001|Extension Study|Lost to Follow-up|0
7614554|NCT01350934|12023600|FG000|Extension Study|Protocol Violation|1
7614555|NCT01350934|12023601|FG001|Extension Study|Protocol Violation|1
7779992|NCT00950170|12228450|FG000|Overall Study|Parent/Legal Guardian Request|1
7779993|NCT00950170|12228450|FG000|Overall Study|Adverse Event|2
7779994|NCT00950170|12228450|FG000|Overall Study|Discontinuation of Study by Sponsor|1
7779995|NCT00950248|12228483|FG000|Year 1: Baseline|Withdrawal by Subject|6
7779996|NCT00950248|12228484|FG001|Year 1: Baseline|Withdrawal by Subject|0
7614556|NCT01350934|12023600|FG000|Extension Study|Lack of Efficacy|0
7614557|NCT01350934|12023601|FG001|Extension Study|Lack of Efficacy|1
7614558|NCT01350934|12023600|FG000|Extension Study|Withdrawal by Subject|0
7614559|NCT01350934|12023601|FG001|Extension Study|Withdrawal by Subject|1
7614560|NCT01286207|12023610|FG000|Overall Study|Adverse Event|27
7614561|NCT01286207|12023611|FG001|Overall Study|Adverse Event|41
7614562|NCT01286207|12023612|FG002|Overall Study|Adverse Event|8
7614563|NCT01286207|12023610|FG000|Overall Study|Lost to Follow-up|49
7614564|NCT01286207|12023611|FG001|Overall Study|Lost to Follow-up|43
7614565|NCT01286207|12023612|FG002|Overall Study|Lost to Follow-up|20
7614566|NCT01286207|12023610|FG000|Overall Study|Withdrawal by Subject|93
7614567|NCT01286207|12023611|FG001|Overall Study|Withdrawal by Subject|79
7614568|NCT01286207|12023612|FG002|Overall Study|Withdrawal by Subject|41
7614569|NCT01286207|12023610|FG000|Overall Study|Lack of Response|92
7614570|NCT01286207|12023611|FG001|Overall Study|Lack of Response|38
7614571|NCT01286207|12023612|FG002|Overall Study|Lack of Response|8
7614572|NCT01286207|12023610|FG000|Overall Study|Other|37
7614573|NCT01286207|12023611|FG001|Overall Study|Other|47
7614574|NCT01286207|12023612|FG002|Overall Study|Other|13
7779997|NCT00950248|12228485|FG002|Year 1: Baseline|Withdrawal by Subject|0
7614576|NCT01227187|12023628|FG000|Overall Study|Physician Decision|0
7614577|NCT01227187|12023629|FG001|Overall Study|Physician Decision|0
7614578|NCT01227187|12023630|FG002|Overall Study|Physician Decision|0
7779998|NCT00950248|12228483|FG000|Year 1: Baseline|worsening of symptoms|2
7779999|NCT00950248|12228484|FG001|Year 1: Baseline|worsening of symptoms|0
7780000|NCT00950248|12228485|FG002|Year 1: Baseline|worsening of symptoms|0
7780001|NCT00950248|12228483|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0
7780002|NCT00950248|12228484|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2
7780003|NCT00950248|12228485|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4
7780004|NCT00950248|12228483|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
7780005|NCT00950248|12228484|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3
7780006|NCT00950248|12228485|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
7780007|NCT00950248|12228483|FG000|Year 2&3 Treatment Randomization|Death|0
7780008|NCT00950248|12228484|FG001|Year 2&3 Treatment Randomization|Death|0
7780009|NCT00950248|12228485|FG002|Year 2&3 Treatment Randomization|Death|1
7780010|NCT00950248|12228483|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0
7780011|NCT00950248|12228484|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1
7780012|NCT00950248|12228485|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0
7780013|NCT00950300|12228494|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
7780014|NCT00950300|12228495|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
7780015|NCT00950300|12228494|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1
7780016|NCT00950300|12228495|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3
7614579|NCT01227187|12023631|FG003|Overall Study|Physician Decision|1
7614580|NCT01144416|12023658|FG000|Intervention Period|Adverse Event|5
7614581|NCT01144416|12023659|FG001|Intervention Period|Adverse Event|6
7614582|NCT01144416|12023658|FG000|Intervention Period|Insufficient ovarian response|11
7780017|NCT00950300|12228494|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
7614583|NCT01144416|12023659|FG001|Intervention Period|Insufficient ovarian response|17
7614584|NCT01144416|12023658|FG000|Intervention Period|Risk of OHSS|0
7614585|NCT01144416|12023659|FG001|Intervention Period|Risk of OHSS|1
7614586|NCT01144416|12023658|FG000|Intervention Period|Too high ovarian response|4
7614587|NCT01144416|12023659|FG001|Intervention Period|Too high ovarian response|2
7614588|NCT01144416|12023658|FG000|Intervention Period|No/too few/bad oocytes|7
7614589|NCT01144416|12023659|FG001|Intervention Period|No/too few/bad oocytes|5
7614590|NCT01144416|12023658|FG000|Intervention Period|No or abnormal fertilization|25
7614591|NCT01144416|12023659|FG001|Intervention Period|No or abnormal fertilization|10
7614592|NCT01144416|12023658|FG000|Intervention Period|No/too few/bad quality embryos|3
7614593|NCT01144416|12023659|FG001|Intervention Period|No/too few/bad quality embryos|3
7614594|NCT01144416|12023658|FG000|Intervention Period|Other|7
7614595|NCT01144416|12023659|FG001|Intervention Period|Other|5
7614596|NCT01140048|12023669|FG000|Overall Study|Physician Decision|1
7614597|NCT01140048|12023669|FG000|Overall Study|Withdrawal by Subject|13
7614598|NCT01140048|12023669|FG000|Overall Study|Lost to Follow-up|31
7614599|NCT01065779|12023684|FG000|Overall Study|Duplicate Investigation|1
7614600|NCT01065779|12023684|FG000|Overall Study|Investigation Before Contract Date|37
7614601|NCT01065779|12023684|FG000|Overall Study|Non-enrollment Period Administration|10
7614602|NCT01065779|12023684|FG000|Overall Study|Not Administered With Study Drug|17
7614603|NCT01065779|12023684|FG000|Overall Study|Failed to Follow-up|10
7614604|NCT01065779|12023684|FG000|Overall Study|Inclusion Criteria Violation|7
7614605|NCT00974571|12023691|FG000|Overall Study|Adverse Event|31
7614606|NCT00974571|12023692|FG001|Overall Study|Adverse Event|4
7614607|NCT00974571|12023693|FG002|Overall Study|Adverse Event|27
7614608|NCT00974571|12023691|FG000|Overall Study|Lack of Efficacy|3
7614609|NCT00974571|12023692|FG001|Overall Study|Lack of Efficacy|2
7614610|NCT00974571|12023693|FG002|Overall Study|Lack of Efficacy|9
7614611|NCT00974571|12023691|FG000|Overall Study|Lost to Follow-up|2
7614612|NCT00974571|12023692|FG001|Overall Study|Lost to Follow-up|1
7614613|NCT00974571|12023693|FG002|Overall Study|Lost to Follow-up|2
7614614|NCT00974571|12023691|FG000|Overall Study|Protocol Violation|13
7614615|NCT00974571|12023692|FG001|Overall Study|Protocol Violation|4
7614616|NCT00974571|12023693|FG002|Overall Study|Protocol Violation|18
7780018|NCT00950300|12228495|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
7780019|NCT00950300|12228494|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
7780020|NCT00950300|12228495|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
7780021|NCT00950300|12228494|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
7780022|NCT00950300|12228495|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
7780023|NCT00950300|12228494|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
7780024|NCT00950300|12228495|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
7780025|NCT00950300|12228494|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
7780026|NCT00950300|12228495|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
7780027|NCT00950300|12228494|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
7780028|NCT00950300|12228495|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
7780029|NCT00950300|12228494|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
7780030|NCT00950300|12228495|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
7780031|NCT00950300|12228494|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1
7780032|NCT00950300|12228495|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1
7780033|NCT00950300|12228494|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3
7780034|NCT00950300|12228495|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4
7780035|NCT00950300|12228494|FG000|TFFU Period|Death|4
7780036|NCT00950300|12228495|FG001|TFFU Period|Death|1
7780037|NCT00950300|12228494|FG000|TFFU Period|Refused Treatment|10
7780038|NCT00950300|12228495|FG001|TFFU Period|Refused Treatment|11
7780039|NCT00950300|12228494|FG000|TFFU Period|Failure to Return|16
7780040|NCT00950300|12228495|FG001|TFFU Period|Failure to Return|16
7780041|NCT00950300|12228494|FG000|TFFU Period|Recurrence of Disease|63
7780042|NCT00950300|12228495|FG001|TFFU Period|Recurrence of Disease|72
7780043|NCT00950300|12228494|FG000|TFFU Period|Other|4
7780044|NCT00950300|12228495|FG001|TFFU Period|Other|3
7780045|NCT00950300|12228494|FG000|SFU Period|Death|44
7780046|NCT00950300|12228495|FG001|SFU Period|Death|42
7780047|NCT00950300|12228494|FG000|SFU Period|Lost to Follow-up|30
7780048|NCT00950300|12228495|FG001|SFU Period|Lost to Follow-up|28
7780049|NCT00950300|12228494|FG000|SFU Period|Withdrawal by Subject|4
7780050|NCT00950300|12228495|FG001|SFU Period|Withdrawal by Subject|8
7780051|NCT00950599|12228528|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0
7780052|NCT00950599|12228529|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0
7800162|NCT01091428|12257328|FG002|Phase 2|Progressive Disease|44
7614617|NCT00974571|12023691|FG000|Overall Study|Withdrawal by Subject|14
7614618|NCT00974571|12023692|FG001|Overall Study|Withdrawal by Subject|5
7614619|NCT00974571|12023693|FG002|Overall Study|Withdrawal by Subject|16
7614620|NCT00974571|12023691|FG000|Overall Study|Patient Moved|1
7614621|NCT00974571|12023692|FG001|Overall Study|Patient Moved|0
7614622|NCT00974571|12023693|FG002|Overall Study|Patient Moved|1
7614623|NCT00974571|12023691|FG000|Overall Study|Other|4
7614624|NCT00974571|12023692|FG001|Overall Study|Other|0
7614625|NCT00974571|12023693|FG002|Overall Study|Other|10
7614626|NCT00972738|12023704|FG000|Overall Study|Adverse Event|7
7614627|NCT00972738|12023705|FG001|Overall Study|Adverse Event|1
7614628|NCT00972738|12023706|FG002|Overall Study|Adverse Event|8
7614629|NCT00972738|12023704|FG000|Overall Study|Protocol Violation|2
7614630|NCT00972738|12023705|FG001|Overall Study|Protocol Violation|1
7614631|NCT00972738|12023706|FG002|Overall Study|Protocol Violation|3
7614632|NCT00972738|12023704|FG000|Overall Study|Lost to Follow-up|1
7614633|NCT00972738|12023705|FG001|Overall Study|Lost to Follow-up|0
7614634|NCT00972738|12023706|FG002|Overall Study|Lost to Follow-up|1
7614635|NCT00972738|12023704|FG000|Overall Study|Lack of Efficacy|5
7614636|NCT00972738|12023705|FG001|Overall Study|Lack of Efficacy|1
7614637|NCT00972738|12023706|FG002|Overall Study|Lack of Efficacy|11
7614638|NCT00972738|12023704|FG000|Overall Study|Withdrawal by Subject|5
7614639|NCT00972738|12023705|FG001|Overall Study|Withdrawal by Subject|1
7614640|NCT00972738|12023706|FG002|Overall Study|Withdrawal by Subject|4
7614641|NCT00972738|12023704|FG000|Overall Study|Moved|0
7614642|NCT00972738|12023705|FG001|Overall Study|Moved|0
7614643|NCT00972738|12023706|FG002|Overall Study|Moved|1
7614644|NCT00972738|12023704|FG000|Overall Study|Other|1
7614645|NCT00972738|12023705|FG001|Overall Study|Other|2
7614646|NCT00972738|12023706|FG002|Overall Study|Other|1
7614647|NCT00968201|12023716|FG000|Base Study - (Period II)|Adverse Event|8
7614648|NCT00968201|12023717|FG001|Base Study - (Period II)|Adverse Event|0
7614649|NCT00968201|12023718|FG002|Base Study - (Period II)|Adverse Event|16
7614650|NCT00968201|12023716|FG000|Base Study - (Period II)|Lack of Efficacy|0
7614651|NCT00968201|12023717|FG001|Base Study - (Period II)|Lack of Efficacy|0
7614652|NCT00968201|12023718|FG002|Base Study - (Period II)|Lack of Efficacy|1
7614653|NCT00968201|12023716|FG000|Base Study - (Period II)|Lost to Follow-up|2
7614654|NCT00968201|12023717|FG001|Base Study - (Period II)|Lost to Follow-up|0
7614655|NCT00968201|12023718|FG002|Base Study - (Period II)|Lost to Follow-up|7
7614656|NCT00968201|12023716|FG000|Base Study - (Period II)|Protocol Violation|12
7614657|NCT00968201|12023717|FG001|Base Study - (Period II)|Protocol Violation|0
7614658|NCT00968201|12023718|FG002|Base Study - (Period II)|Protocol Violation|12
7614659|NCT00968201|12023716|FG000|Base Study - (Period II)|Withdrawal by Subject|4
7614660|NCT00968201|12023717|FG001|Base Study - (Period II)|Withdrawal by Subject|0
7614661|NCT00968201|12023718|FG002|Base Study - (Period II)|Withdrawal by Subject|8
7614662|NCT00968201|12023716|FG000|Base Study - (Period II)|Site Error|0
7614663|NCT00968201|12023717|FG001|Base Study - (Period II)|Site Error|0
7614664|NCT00968201|12023718|FG002|Base Study - (Period II)|Site Error|1
7614665|NCT00968201|12023716|FG000|Extension Study - (Period III)|Adverse Event|0
7614666|NCT00968201|12023717|FG001|Extension Study - (Period III)|Adverse Event|5
7614667|NCT00968201|12023718|FG002|Extension Study - (Period III)|Adverse Event|22
7614668|NCT00968201|12023716|FG000|Extension Study - (Period III)|Lost to Follow-up|0
7614669|NCT00968201|12023717|FG001|Extension Study - (Period III)|Lost to Follow-up|7
7614670|NCT00968201|12023718|FG002|Extension Study - (Period III)|Lost to Follow-up|13
7614671|NCT00968201|12023716|FG000|Extension Study - (Period III)|Protocol Violation|0
7614672|NCT00968201|12023717|FG001|Extension Study - (Period III)|Protocol Violation|17
7614673|NCT00968201|12023718|FG002|Extension Study - (Period III)|Protocol Violation|14
7614674|NCT00968201|12023716|FG000|Extension Study - (Period III)|Withdrawal by Subject|0
7614675|NCT00968201|12023717|FG001|Extension Study - (Period III)|Withdrawal by Subject|20
7614676|NCT00968201|12023718|FG002|Extension Study - (Period III)|Withdrawal by Subject|40
7614677|NCT00968201|12023716|FG000|Extension Study - (Period III)|Patient Relocated|0
7614678|NCT00968201|12023717|FG001|Extension Study - (Period III)|Patient Relocated|1
7614679|NCT00968201|12023718|FG002|Extension Study - (Period III)|Patient Relocated|1
7614680|NCT00968201|12023716|FG000|Extension Study - (Period III)|Noncompliance|0
7614681|NCT00968201|12023717|FG001|Extension Study - (Period III)|Noncompliance|0
7614682|NCT00968201|12023718|FG002|Extension Study - (Period III)|Noncompliance|3
7780053|NCT00950599|12228530|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0
7780054|NCT00950599|12228531|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1
7780055|NCT00950599|12228532|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0
7780056|NCT00950599|12228533|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0
7780057|NCT00950599|12228534|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0
7614683|NCT00968201|12023716|FG000|Extension Study - (Period III)|Other|0
7614684|NCT00968201|12023717|FG001|Extension Study - (Period III)|Other|0
7614685|NCT00968201|12023718|FG002|Extension Study - (Period III)|Other|2
7614686|NCT00968201|12023716|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
7614687|NCT00968201|12023717|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
7614688|NCT00968201|12023718|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
7614689|NCT00968149|12023729|FG000|Overall Study|Adverse Event|5
7614690|NCT00968149|12023730|FG001|Overall Study|Adverse Event|1
7614691|NCT00968149|12023729|FG000|Overall Study|Lack of Efficacy|0
7614692|NCT00968149|12023730|FG001|Overall Study|Lack of Efficacy|4
7614693|NCT00968149|12023729|FG000|Overall Study|Lost to Follow-up|0
7614694|NCT00968149|12023730|FG001|Overall Study|Lost to Follow-up|1
7614695|NCT00968149|12023729|FG000|Overall Study|Protocol Violation|4
7614696|NCT00968149|12023730|FG001|Overall Study|Protocol Violation|0
7614697|NCT00968149|12023729|FG000|Overall Study|Withdrawal by Subject|2
7614698|NCT00968149|12023730|FG001|Overall Study|Withdrawal by Subject|0
7614699|NCT00963469|12023739|FG000|Overall Study|Adverse Event|15
7614700|NCT00963469|12023740|FG001|Overall Study|Adverse Event|11
7614701|NCT00963469|12023741|FG002|Overall Study|Adverse Event|1
7614702|NCT00963469|12023739|FG000|Overall Study|Lack of Efficacy|10
7614703|NCT00963469|12023740|FG001|Overall Study|Lack of Efficacy|7
7614704|NCT00963469|12023741|FG002|Overall Study|Lack of Efficacy|2
7614705|NCT00963469|12023739|FG000|Overall Study|Lost to Follow-up|1
7614706|NCT00963469|12023740|FG001|Overall Study|Lost to Follow-up|1
7614707|NCT00963469|12023741|FG002|Overall Study|Lost to Follow-up|0
7614708|NCT00963469|12023739|FG000|Overall Study|Protocol Violation|5
7614709|NCT00963469|12023740|FG001|Overall Study|Protocol Violation|5
7614710|NCT00963469|12023741|FG002|Overall Study|Protocol Violation|3
7614711|NCT00963469|12023739|FG000|Overall Study|Withdrawal by Subject|4
7614712|NCT00963469|12023740|FG001|Overall Study|Withdrawal by Subject|1
7614713|NCT00963469|12023741|FG002|Overall Study|Withdrawal by Subject|1
7614714|NCT00963469|12023739|FG000|Overall Study|Pre-randomization Adverse Event|1
7614715|NCT00963469|12023740|FG001|Overall Study|Pre-randomization Adverse Event|2
7614716|NCT00963469|12023741|FG002|Overall Study|Pre-randomization Adverse Event|0
7614717|NCT00963469|12023739|FG000|Overall Study|Moved|1
7614718|NCT00963469|12023740|FG001|Overall Study|Moved|0
7614719|NCT00963469|12023741|FG002|Overall Study|Moved|0
7614720|NCT00963469|12023739|FG000|Overall Study|Site closed (local pollen Season ended)|4
7614721|NCT00963469|12023740|FG001|Overall Study|Site closed (local pollen Season ended)|1
7614722|NCT00963469|12023741|FG002|Overall Study|Site closed (local pollen Season ended)|3
7614723|NCT00960141|12023752|FG000|Overall Study|Adverse Event|4
7614724|NCT00960141|12023753|FG001|Overall Study|Adverse Event|8
7614725|NCT00960141|12023754|FG002|Overall Study|Adverse Event|2
7614726|NCT00960141|12023752|FG000|Overall Study|Lack of Efficacy|3
7614727|NCT00960141|12023753|FG001|Overall Study|Lack of Efficacy|4
7614728|NCT00960141|12023754|FG002|Overall Study|Lack of Efficacy|2
7614729|NCT00960141|12023752|FG000|Overall Study|Lost to Follow-up|1
7614730|NCT00960141|12023753|FG001|Overall Study|Lost to Follow-up|0
7614731|NCT00960141|12023754|FG002|Overall Study|Lost to Follow-up|0
7614732|NCT00960141|12023752|FG000|Overall Study|Protocol Violation|1
7614733|NCT00960141|12023753|FG001|Overall Study|Protocol Violation|3
7614734|NCT00960141|12023754|FG002|Overall Study|Protocol Violation|2
7614735|NCT00960141|12023752|FG000|Overall Study|Withdrawal by Subject|1
7614736|NCT00960141|12023753|FG001|Overall Study|Withdrawal by Subject|2
7614737|NCT00960141|12023754|FG002|Overall Study|Withdrawal by Subject|1
7614738|NCT00943683|12023764|FG000|Overall Study|Adverse Event|3
7614739|NCT00943683|12023765|FG001|Overall Study|Adverse Event|3
7614740|NCT00943683|12023764|FG000|Overall Study|Lost to Follow-up|1
7614741|NCT00943683|12023765|FG001|Overall Study|Lost to Follow-up|1
7614742|NCT00943683|12023764|FG000|Overall Study|Protocol Violation|1
7614743|NCT00943683|12023765|FG001|Overall Study|Protocol Violation|2
7614744|NCT00943683|12023764|FG000|Overall Study|Withdrawal by Subject|1
7614745|NCT00943683|12023765|FG001|Overall Study|Withdrawal by Subject|0
7614746|NCT00943683|12023764|FG000|Overall Study|Patient Moved|1
7780058|NCT00950599|12228535|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0
7780059|NCT00950599|12228536|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0
7780060|NCT00950599|12228537|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0
7780061|NCT00950599|12228528|FG000|Double-Blind Treatment Period|Adverse Event|0
7780062|NCT00950599|12228529|FG001|Double-Blind Treatment Period|Adverse Event|1
7780063|NCT00950599|12228530|FG002|Double-Blind Treatment Period|Adverse Event|1
7780064|NCT00950599|12228531|FG003|Double-Blind Treatment Period|Adverse Event|1
7780065|NCT00950599|12228532|FG004|Double-Blind Treatment Period|Adverse Event|1
7780066|NCT00950599|12228533|FG005|Double-Blind Treatment Period|Adverse Event|1
7780067|NCT00950599|12228534|FG006|Double-Blind Treatment Period|Adverse Event|0
7780068|NCT00950599|12228535|FG007|Double-Blind Treatment Period|Adverse Event|0
7780069|NCT00950599|12228536|FG008|Double-Blind Treatment Period|Adverse Event|0
7780070|NCT00950599|12228537|FG009|Double-Blind Treatment Period|Adverse Event|0
7780071|NCT00950599|12228528|FG000|Double-Blind Treatment Period|Lack of Efficacy|2
7780072|NCT00950599|12228529|FG001|Double-Blind Treatment Period|Lack of Efficacy|5
7780073|NCT00950599|12228530|FG002|Double-Blind Treatment Period|Lack of Efficacy|5
7780074|NCT00950599|12228531|FG003|Double-Blind Treatment Period|Lack of Efficacy|7
7780075|NCT00950599|12228532|FG004|Double-Blind Treatment Period|Lack of Efficacy|3
7614747|NCT00943683|12023765|FG001|Overall Study|Patient Moved|0
7614748|NCT00943397|12023773|FG000|Overall Study|Adverse Event|0
7614749|NCT00943397|12023774|FG001|Overall Study|Adverse Event|6
7614750|NCT00943397|12023773|FG000|Overall Study|Lost to Follow-up|0
7614751|NCT00943397|12023774|FG001|Overall Study|Lost to Follow-up|4
7614752|NCT00943397|12023773|FG000|Overall Study|Protocol Violation|2
7614753|NCT00943397|12023774|FG001|Overall Study|Protocol Violation|5
7614754|NCT00943397|12023773|FG000|Overall Study|Withdrawal by Subject|1
7614755|NCT00943397|12023774|FG001|Overall Study|Withdrawal by Subject|1
7614756|NCT00943397|12023773|FG000|Overall Study|Site terminated and other|12
7614757|NCT00943397|12023774|FG001|Overall Study|Site terminated and other|56
7614758|NCT00911547|12023784|FG000|Overall Study|Adverse Event|8
7614759|NCT00911547|12023785|FG001|Overall Study|Adverse Event|27
7614760|NCT00911547|12023786|FG002|Overall Study|Adverse Event|11
7614761|NCT00911547|12023787|FG003|Overall Study|Adverse Event|6
7614762|NCT00911547|12023784|FG000|Overall Study|Lost to Follow-up|0
7614763|NCT00911547|12023785|FG001|Overall Study|Lost to Follow-up|0
7614764|NCT00911547|12023786|FG002|Overall Study|Lost to Follow-up|2
7614765|NCT00911547|12023787|FG003|Overall Study|Lost to Follow-up|1
7614766|NCT00911547|12023784|FG000|Overall Study|Protocol Violation|0
7614767|NCT00911547|12023785|FG001|Overall Study|Protocol Violation|5
7614768|NCT00911547|12023786|FG002|Overall Study|Protocol Violation|5
7614769|NCT00911547|12023787|FG003|Overall Study|Protocol Violation|1
7614770|NCT00911547|12023784|FG000|Overall Study|Withdrawal by Subject|3
7614771|NCT00911547|12023785|FG001|Overall Study|Withdrawal by Subject|10
7614772|NCT00911547|12023786|FG002|Overall Study|Withdrawal by Subject|4
7614773|NCT00911547|12023787|FG003|Overall Study|Withdrawal by Subject|8
7614774|NCT00899379|12023802|FG000|Overall Study|Adverse Event|2
7614775|NCT00899379|12023803|FG001|Overall Study|Adverse Event|2
7614776|NCT00899379|12023804|FG002|Overall Study|Adverse Event|1
7614777|NCT00899379|12023805|FG003|Overall Study|Adverse Event|1
7614778|NCT00899379|12023806|FG004|Overall Study|Adverse Event|2
7614779|NCT00899379|12023802|FG000|Overall Study|Lack of Efficacy|0
7614780|NCT00899379|12023803|FG001|Overall Study|Lack of Efficacy|4
7614781|NCT00899379|12023804|FG002|Overall Study|Lack of Efficacy|3
7614782|NCT00899379|12023805|FG003|Overall Study|Lack of Efficacy|0
7614783|NCT00899379|12023806|FG004|Overall Study|Lack of Efficacy|1
7614784|NCT00899379|12023802|FG000|Overall Study|Lost to Follow-up|9
7614785|NCT00899379|12023803|FG001|Overall Study|Lost to Follow-up|3
7614786|NCT00899379|12023804|FG002|Overall Study|Lost to Follow-up|0
7614787|NCT00899379|12023805|FG003|Overall Study|Lost to Follow-up|6
7614788|NCT00899379|12023806|FG004|Overall Study|Lost to Follow-up|2
7614789|NCT00899379|12023802|FG000|Overall Study|Protocol Violation|0
7614790|NCT00899379|12023803|FG001|Overall Study|Protocol Violation|0
7614791|NCT00899379|12023804|FG002|Overall Study|Protocol Violation|1
7614792|NCT00899379|12023805|FG003|Overall Study|Protocol Violation|1
7614793|NCT00899379|12023806|FG004|Overall Study|Protocol Violation|0
7614794|NCT00899379|12023802|FG000|Overall Study|Withdrawal by Subject|2
7614795|NCT00899379|12023803|FG001|Overall Study|Withdrawal by Subject|4
7614796|NCT00899379|12023804|FG002|Overall Study|Withdrawal by Subject|2
7614797|NCT00899379|12023805|FG003|Overall Study|Withdrawal by Subject|3
7614798|NCT00899379|12023806|FG004|Overall Study|Withdrawal by Subject|6
7614799|NCT00899379|12023802|FG000|Overall Study|Pregnancy|0
7614800|NCT00899379|12023803|FG001|Overall Study|Pregnancy|0
7614801|NCT00899379|12023804|FG002|Overall Study|Pregnancy|1
7614802|NCT00899379|12023805|FG003|Overall Study|Pregnancy|0
7614803|NCT00899379|12023806|FG004|Overall Study|Pregnancy|1
7614804|NCT00899379|12023802|FG000|Overall Study|Patient Uncooperative|0
7614805|NCT00899379|12023803|FG001|Overall Study|Patient Uncooperative|1
7614806|NCT00899379|12023804|FG002|Overall Study|Patient Uncooperative|0
7614807|NCT00899379|12023805|FG003|Overall Study|Patient Uncooperative|1
7614808|NCT00899379|12023806|FG004|Overall Study|Patient Uncooperative|2
7614809|NCT00899379|12023802|FG000|Overall Study|Abnormal Baseline ECG|0
7614810|NCT00899379|12023803|FG001|Overall Study|Abnormal Baseline ECG|0
7614811|NCT00899379|12023804|FG002|Overall Study|Abnormal Baseline ECG|0
7614812|NCT00899379|12023805|FG003|Overall Study|Abnormal Baseline ECG|1
7780076|NCT00950599|12228533|FG005|Double-Blind Treatment Period|Lack of Efficacy|6
7614813|NCT00899379|12023806|FG004|Overall Study|Abnormal Baseline ECG|0
7614814|NCT00899379|12023802|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
7614815|NCT00899379|12023803|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1
7614816|NCT00899379|12023804|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1
7614817|NCT00899379|12023805|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0
7614818|NCT00899379|12023806|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0
7614819|NCT00899379|12023802|FG000|Overall Study|Not Completed/Entered Extn|5
7614820|NCT00899379|12023803|FG001|Overall Study|Not Completed/Entered Extn|1
7614821|NCT00899379|12023804|FG002|Overall Study|Not Completed/Entered Extn|6
7614822|NCT00899379|12023805|FG003|Overall Study|Not Completed/Entered Extn|4
7614823|NCT00899379|12023806|FG004|Overall Study|Not Completed/Entered Extn|3
7614824|NCT00899379|12023802|FG000|Overall Study|Study Terminated|3
7614825|NCT00899379|12023803|FG001|Overall Study|Study Terminated|0
7614826|NCT00899379|12023804|FG002|Overall Study|Study Terminated|3
7614827|NCT00899379|12023805|FG003|Overall Study|Study Terminated|3
7614828|NCT00899379|12023806|FG004|Overall Study|Study Terminated|1
7614829|NCT00899379|12023802|FG000|Overall Study|Lost to Follow-up|3
7614830|NCT00899379|12023803|FG001|Overall Study|Lost to Follow-up|1
7614831|NCT00899379|12023804|FG002|Overall Study|Lost to Follow-up|0
7614832|NCT00899379|12023805|FG003|Overall Study|Lost to Follow-up|2
7614833|NCT00899379|12023806|FG004|Overall Study|Lost to Follow-up|5
7614834|NCT00899379|12023802|FG000|Overall Study|Withdrawal by Subject|4
7614835|NCT00899379|12023803|FG001|Overall Study|Withdrawal by Subject|7
7614836|NCT00899379|12023804|FG002|Overall Study|Withdrawal by Subject|4
7614837|NCT00899379|12023805|FG003|Overall Study|Withdrawal by Subject|7
7614838|NCT00899379|12023806|FG004|Overall Study|Withdrawal by Subject|2
7614839|NCT00899379|12023802|FG000|Overall Study|Pregnancy|1
7614840|NCT00899379|12023803|FG001|Overall Study|Pregnancy|0
7614841|NCT00899379|12023804|FG002|Overall Study|Pregnancy|0
7614842|NCT00899379|12023805|FG003|Overall Study|Pregnancy|0
7614843|NCT00899379|12023806|FG004|Overall Study|Pregnancy|0
7614844|NCT00899379|12023802|FG000|Overall Study|Patient Uncooperative|0
7614845|NCT00899379|12023803|FG001|Overall Study|Patient Uncooperative|0
7614846|NCT00899379|12023804|FG002|Overall Study|Patient Uncooperative|0
7614847|NCT00899379|12023805|FG003|Overall Study|Patient Uncooperative|1
7614848|NCT00899379|12023806|FG004|Overall Study|Patient Uncooperative|0
7614849|NCT00899379|12023802|FG000|Overall Study|Abnormal Prestudy Labs|0
7614850|NCT00899379|12023803|FG001|Overall Study|Abnormal Prestudy Labs|0
7614851|NCT00899379|12023804|FG002|Overall Study|Abnormal Prestudy Labs|0
7614852|NCT00899379|12023805|FG003|Overall Study|Abnormal Prestudy Labs|0
7614853|NCT00899379|12023806|FG004|Overall Study|Abnormal Prestudy Labs|2
7614854|NCT00899379|12023802|FG000|Overall Study|Abnormal Baseline ECG|0
7614855|NCT00899379|12023803|FG001|Overall Study|Abnormal Baseline ECG|0
7614856|NCT00899379|12023804|FG002|Overall Study|Abnormal Baseline ECG|1
7614857|NCT00899379|12023805|FG003|Overall Study|Abnormal Baseline ECG|1
7614858|NCT00899379|12023806|FG004|Overall Study|Abnormal Baseline ECG|0
7614859|NCT00899379|12023802|FG000|Overall Study|No Attack Pretreatment|3
7614860|NCT00899379|12023803|FG001|Overall Study|No Attack Pretreatment|5
7614861|NCT00899379|12023804|FG002|Overall Study|No Attack Pretreatment|5
7614862|NCT00899379|12023805|FG003|Overall Study|No Attack Pretreatment|6
7614863|NCT00899379|12023806|FG004|Overall Study|No Attack Pretreatment|4
7614864|NCT00899379|12023802|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
7614865|NCT00899379|12023803|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0
7614866|NCT00899379|12023804|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0
7614867|NCT00899379|12023805|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0
7614868|NCT00899379|12023806|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0
7614869|NCT00899379|12023802|FG000|Overall Study|Inc/Exc Criteria Not Met|0
7614870|NCT00899379|12023803|FG001|Overall Study|Inc/Exc Criteria Not Met|0
7614871|NCT00899379|12023804|FG002|Overall Study|Inc/Exc Criteria Not Met|1
7614872|NCT00899379|12023805|FG003|Overall Study|Inc/Exc Criteria Not Met|0
7614873|NCT00899379|12023806|FG004|Overall Study|Inc/Exc Criteria Not Met|0
7614874|NCT00898677|12023816|FG000|Overall Study|Adverse Event|0
7614875|NCT00898677|12023817|FG001|Overall Study|Adverse Event|0
7614876|NCT00898677|12023818|FG002|Overall Study|Adverse Event|1
7614877|NCT00898677|12023819|FG003|Overall Study|Adverse Event|0
7614878|NCT00898677|12023816|FG000|Overall Study|Lost to Follow-up|0
7614879|NCT00898677|12023817|FG001|Overall Study|Lost to Follow-up|0
7614880|NCT00898677|12023818|FG002|Overall Study|Lost to Follow-up|2
7614881|NCT00898677|12023819|FG003|Overall Study|Lost to Follow-up|0
7614882|NCT00898677|12023816|FG000|Overall Study|Protocol Violation|1
7614883|NCT00898677|12023817|FG001|Overall Study|Protocol Violation|1
7614884|NCT00898677|12023818|FG002|Overall Study|Protocol Violation|2
7614885|NCT00898677|12023819|FG003|Overall Study|Protocol Violation|0
7614886|NCT00898677|12023816|FG000|Overall Study|Withdrawal by Subject|0
7614887|NCT00898677|12023817|FG001|Overall Study|Withdrawal by Subject|0
7614888|NCT00898677|12023818|FG002|Overall Study|Withdrawal by Subject|0
7614889|NCT00898677|12023819|FG003|Overall Study|Withdrawal by Subject|1
7614890|NCT00898677|12023816|FG000|Overall Study|Not Treated: Adverse Event|0
7614891|NCT00898677|12023817|FG001|Overall Study|Not Treated: Adverse Event|2
7614892|NCT00898677|12023818|FG002|Overall Study|Not Treated: Adverse Event|1
7614893|NCT00898677|12023819|FG003|Overall Study|Not Treated: Adverse Event|0
7614894|NCT00898677|12023816|FG000|Overall Study|Not Treated: Lost to Follow-Up|0
7614895|NCT00898677|12023817|FG001|Overall Study|Not Treated: Lost to Follow-Up|5
7614896|NCT00898677|12023818|FG002|Overall Study|Not Treated: Lost to Follow-Up|5
7614897|NCT00898677|12023819|FG003|Overall Study|Not Treated: Lost to Follow-Up|2
7614898|NCT00898677|12023816|FG000|Overall Study|Not Treated: Pregnancy|0
7614899|NCT00898677|12023817|FG001|Overall Study|Not Treated: Pregnancy|0
7614900|NCT00898677|12023818|FG002|Overall Study|Not Treated: Pregnancy|1
7614901|NCT00898677|12023819|FG003|Overall Study|Not Treated: Pregnancy|0
7614902|NCT00898677|12023816|FG000|Overall Study|Not Treated: Protocol Violation|2
7614903|NCT00898677|12023817|FG001|Overall Study|Not Treated: Protocol Violation|0
7614904|NCT00898677|12023818|FG002|Overall Study|Not Treated: Protocol Violation|2
7614905|NCT00898677|12023819|FG003|Overall Study|Not Treated: Protocol Violation|0
7614906|NCT00898677|12023816|FG000|Overall Study|Not Treated: Withdraw by Subject|2
7614907|NCT00898677|12023817|FG001|Overall Study|Not Treated: Withdraw by Subject|16
7614908|NCT00898677|12023818|FG002|Overall Study|Not Treated: Withdraw by Subject|11
7614909|NCT00898677|12023819|FG003|Overall Study|Not Treated: Withdraw by Subject|3
7614910|NCT00898677|12023816|FG000|Overall Study|Not Treated: Patient uncooperative|2
7614911|NCT00898677|12023817|FG001|Overall Study|Not Treated: Patient uncooperative|3
7614912|NCT00898677|12023818|FG002|Overall Study|Not Treated: Patient uncooperative|1
7614913|NCT00898677|12023819|FG003|Overall Study|Not Treated: Patient uncooperative|0
7614914|NCT00898677|12023816|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0
7614915|NCT00898677|12023817|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0
7614916|NCT00898677|12023818|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0
7614917|NCT00898677|12023819|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1
7614918|NCT00898677|12023816|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1
7614919|NCT00898677|12023817|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0
7614920|NCT00898677|12023818|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0
7614921|NCT00898677|12023819|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0
7614922|NCT00898677|12023816|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0
7614923|NCT00898677|12023817|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3
7780077|NCT00950599|12228534|FG006|Double-Blind Treatment Period|Lack of Efficacy|0
7780078|NCT00950599|12228535|FG007|Double-Blind Treatment Period|Lack of Efficacy|1
7780079|NCT00950599|12228536|FG008|Double-Blind Treatment Period|Lack of Efficacy|0
7780080|NCT00950599|12228537|FG009|Double-Blind Treatment Period|Lack of Efficacy|0
7780081|NCT00950599|12228528|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7780082|NCT00950599|12228529|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
7780083|NCT00950599|12228530|FG002|Double-Blind Treatment Period|Lost to Follow-up|0
7614924|NCT00898677|12023818|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1
7614925|NCT00898677|12023819|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0
7614926|NCT00898677|12023816|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9
7614927|NCT00898677|12023817|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39
7614928|NCT00898677|12023818|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43
7614929|NCT00898677|12023819|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12
7614930|NCT00898677|12023816|FG000|Overall Study|Not Treated: Other (Not Specified)|0
7614931|NCT00898677|12023817|FG001|Overall Study|Not Treated: Other (Not Specified)|0
7614932|NCT00898677|12023818|FG002|Overall Study|Not Treated: Other (Not Specified)|2
7614933|NCT00898677|12023819|FG003|Overall Study|Not Treated: Other (Not Specified)|0
7614934|NCT00897949|12023832|FG000|Overall Study|Adverse Event|1
7614935|NCT00897949|12023833|FG001|Overall Study|Adverse Event|1
7614936|NCT00897949|12023834|FG002|Overall Study|Adverse Event|0
7614937|NCT00897949|12023832|FG000|Overall Study|Lost to Follow-up|0
7614938|NCT00897949|12023833|FG001|Overall Study|Lost to Follow-up|2
7614939|NCT00897949|12023834|FG002|Overall Study|Lost to Follow-up|1
7614940|NCT00897949|12023832|FG000|Overall Study|Protocol Violation|6
7614941|NCT00897949|12023833|FG001|Overall Study|Protocol Violation|3
7614942|NCT00897949|12023834|FG002|Overall Study|Protocol Violation|1
7614943|NCT00897949|12023832|FG000|Overall Study|Withdrawal by Subject|1
7614944|NCT00897949|12023833|FG001|Overall Study|Withdrawal by Subject|2
7614945|NCT00897949|12023834|FG002|Overall Study|Withdrawal by Subject|0
7614946|NCT00897949|12023832|FG000|Overall Study|Patient Uncoorperative|0
7614947|NCT00897949|12023833|FG001|Overall Study|Patient Uncoorperative|2
7614948|NCT00897949|12023834|FG002|Overall Study|Patient Uncoorperative|1
7614949|NCT00897949|12023832|FG000|Overall Study|Lost to Follow-up|30
7614950|NCT00897949|12023833|FG001|Overall Study|Lost to Follow-up|23
7614951|NCT00897949|12023834|FG002|Overall Study|Lost to Follow-up|17
7614952|NCT00897949|12023832|FG000|Overall Study|Withdrawal by Subject|24
7614953|NCT00897949|12023833|FG001|Overall Study|Withdrawal by Subject|31
7614954|NCT00897949|12023834|FG002|Overall Study|Withdrawal by Subject|17
7614955|NCT00897949|12023832|FG000|Overall Study|Abnormal Prestudy Labs|2
7614956|NCT00897949|12023833|FG001|Overall Study|Abnormal Prestudy Labs|3
7614957|NCT00897949|12023834|FG002|Overall Study|Abnormal Prestudy Labs|4
7614958|NCT00897949|12023832|FG000|Overall Study|Abnormal Baseline ECG|2
7614959|NCT00897949|12023833|FG001|Overall Study|Abnormal Baseline ECG|2
7614960|NCT00897949|12023834|FG002|Overall Study|Abnormal Baseline ECG|4
7614961|NCT00897949|12023832|FG000|Overall Study|Need for Concom. Med.|0
7614962|NCT00897949|12023833|FG001|Overall Study|Need for Concom. Med.|1
7614963|NCT00897949|12023834|FG002|Overall Study|Need for Concom. Med.|1
7614964|NCT00897949|12023832|FG000|Overall Study|Lack of Migraine Attack|29
7614965|NCT00897949|12023833|FG001|Overall Study|Lack of Migraine Attack|30
7614966|NCT00897949|12023834|FG002|Overall Study|Lack of Migraine Attack|19
7614967|NCT00897949|12023832|FG000|Overall Study|Did not take study drug|9
7614968|NCT00897949|12023833|FG001|Overall Study|Did not take study drug|3
7614969|NCT00897949|12023834|FG002|Overall Study|Did not take study drug|4
7614970|NCT00897104|12023851|FG000|Overall Study|Lost to Follow-up|12
7614971|NCT00897104|12023852|FG001|Overall Study|Lost to Follow-up|17
7614972|NCT00897104|12023853|FG002|Overall Study|Lost to Follow-up|2
7614973|NCT00897104|12023851|FG000|Overall Study|Pregnancy|0
7614974|NCT00897104|12023852|FG001|Overall Study|Pregnancy|1
7614975|NCT00897104|12023853|FG002|Overall Study|Pregnancy|0
7614976|NCT00897104|12023851|FG000|Overall Study|Protocol Violation|0
7614977|NCT00897104|12023852|FG001|Overall Study|Protocol Violation|1
7614978|NCT00897104|12023853|FG002|Overall Study|Protocol Violation|0
7614979|NCT00897104|12023851|FG000|Overall Study|Withdrawal by Subject|23
7614980|NCT00897104|12023852|FG001|Overall Study|Withdrawal by Subject|27
7614981|NCT00897104|12023853|FG002|Overall Study|Withdrawal by Subject|3
7614982|NCT00897104|12023851|FG000|Overall Study|Abnormal Prestudy Labs|2
7614983|NCT00897104|12023852|FG001|Overall Study|Abnormal Prestudy Labs|0
7614984|NCT00897104|12023853|FG002|Overall Study|Abnormal Prestudy Labs|0
7614985|NCT00897104|12023851|FG000|Overall Study|Abnormal Baseline ECG|2
7614986|NCT00897104|12023852|FG001|Overall Study|Abnormal Baseline ECG|2
7614987|NCT00897104|12023853|FG002|Overall Study|Abnormal Baseline ECG|0
7614988|NCT00897104|12023851|FG000|Overall Study|Need for Concom. Med.|0
7614989|NCT00897104|12023852|FG001|Overall Study|Need for Concom. Med.|1
7614990|NCT00897104|12023853|FG002|Overall Study|Need for Concom. Med.|1
7614991|NCT00897104|12023851|FG000|Overall Study|Lack of Migraine Attack|20
7614992|NCT00897104|12023852|FG001|Overall Study|Lack of Migraine Attack|22
7614993|NCT00897104|12023853|FG002|Overall Study|Lack of Migraine Attack|1
7614994|NCT00897104|12023851|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
7614995|NCT00897104|12023852|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0
7614996|NCT00897104|12023853|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0
7614997|NCT00897104|12023851|FG000|Overall Study|Other|3
7614998|NCT00897104|12023852|FG001|Overall Study|Other|0
7614999|NCT00897104|12023853|FG002|Overall Study|Other|0
7615000|NCT00897104|12023851|FG000|Overall Study|Protocol Violation|1
7615001|NCT00897104|12023852|FG001|Overall Study|Protocol Violation|0
7615002|NCT00897104|12023853|FG002|Overall Study|Protocol Violation|0
7615003|NCT00897104|12023851|FG000|Overall Study|Withdrawal by Subject|0
7615004|NCT00897104|12023852|FG001|Overall Study|Withdrawal by Subject|0
7615005|NCT00897104|12023853|FG002|Overall Study|Withdrawal by Subject|1
7615006|NCT00803790|12023863|FG000|Period 1|Adverse Event|0
7615007|NCT00803790|12023864|FG001|Period 1|Adverse Event|1
7615008|NCT00803790|12023865|FG002|Period 1|Adverse Event|0
7615009|NCT00803790|12023866|FG003|Period 1|Adverse Event|0
7615010|NCT00803790|12023863|FG000|Period 1|Lost to Follow-up|1
7615011|NCT00803790|12023864|FG001|Period 1|Lost to Follow-up|2
7615012|NCT00803790|12023865|FG002|Period 1|Lost to Follow-up|0
7615013|NCT00803790|12023866|FG003|Period 1|Lost to Follow-up|0
7615014|NCT00803790|12023863|FG000|Period 1|Withdrawal by Subject|8
7615015|NCT00803790|12023864|FG001|Period 1|Withdrawal by Subject|6
7615016|NCT00803790|12023865|FG002|Period 1|Withdrawal by Subject|0
7615017|NCT00803790|12023866|FG003|Period 1|Withdrawal by Subject|0
7615018|NCT00803790|12023863|FG000|Period 1|positive drug screen or personal reasons|0
7615019|NCT00803790|12023864|FG001|Period 1|positive drug screen or personal reasons|3
7615020|NCT00803790|12023865|FG002|Period 1|positive drug screen or personal reasons|0
7615021|NCT00803790|12023866|FG003|Period 1|positive drug screen or personal reasons|4
7615022|NCT00803790|12023863|FG000|Period 1|Protocol Violation|0
7615023|NCT00803790|12023864|FG001|Period 1|Protocol Violation|0
7615024|NCT00803790|12023865|FG002|Period 1|Protocol Violation|1
7615025|NCT00803790|12023866|FG003|Period 1|Protocol Violation|0
7615026|NCT00803790|12023863|FG000|Period 2|Adverse Event|0
7615027|NCT00803790|12023864|FG001|Period 2|Adverse Event|0
7780084|NCT00950599|12228531|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
7780085|NCT00950599|12228532|FG004|Double-Blind Treatment Period|Lost to Follow-up|1
7780086|NCT00950599|12228533|FG005|Double-Blind Treatment Period|Lost to Follow-up|2
7780087|NCT00950599|12228534|FG006|Double-Blind Treatment Period|Lost to Follow-up|0
7780088|NCT00950599|12228535|FG007|Double-Blind Treatment Period|Lost to Follow-up|1
7780089|NCT00950599|12228536|FG008|Double-Blind Treatment Period|Lost to Follow-up|0
7780090|NCT00950599|12228537|FG009|Double-Blind Treatment Period|Lost to Follow-up|0
7780091|NCT00950599|12228528|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1
7780092|NCT00950599|12228529|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1
7780093|NCT00950599|12228530|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0
7780094|NCT00950599|12228531|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0
7780095|NCT00950599|12228532|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0
7780096|NCT00950599|12228533|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0
7780097|NCT00950599|12228534|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0
7780098|NCT00950599|12228535|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1
7780099|NCT00950599|12228536|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0
7780100|NCT00950599|12228537|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0
7780101|NCT00950599|12228528|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7780102|NCT00950599|12228529|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7780103|NCT00950599|12228530|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7780104|NCT00950599|12228531|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7780105|NCT00950599|12228532|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1
7780106|NCT00950599|12228533|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1
7780107|NCT00950599|12228534|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7615028|NCT00803790|12023865|FG002|Period 2|Adverse Event|1
7615029|NCT00803790|12023866|FG003|Period 2|Adverse Event|1
7615030|NCT00803790|12023863|FG000|Period 2|Withdrawal by Subject|1
7615031|NCT00803790|12023864|FG001|Period 2|Withdrawal by Subject|0
7615032|NCT00803790|12023865|FG002|Period 2|Withdrawal by Subject|0
7615033|NCT00803790|12023866|FG003|Period 2|Withdrawal by Subject|0
7615034|NCT00803790|12023863|FG000|Period 2|Positive Drug Screen or Personal Reasons|1
7615035|NCT00803790|12023864|FG001|Period 2|Positive Drug Screen or Personal Reasons|0
7615036|NCT00803790|12023865|FG002|Period 2|Positive Drug Screen or Personal Reasons|0
7615037|NCT00803790|12023866|FG003|Period 2|Positive Drug Screen or Personal Reasons|0
7615038|NCT00725491|12023879|FG000|Overall Study|Adverse Event|3
7615039|NCT00725491|12023880|FG001|Overall Study|Adverse Event|2
7615040|NCT00725491|12023879|FG000|Overall Study|Pregnancy|0
7615041|NCT00725491|12023880|FG001|Overall Study|Pregnancy|3
7615042|NCT00725491|12023879|FG000|Overall Study|Risk for hyperstimulation|2
7615043|NCT00725491|12023880|FG001|Overall Study|Risk for hyperstimulation|9
7615044|NCT00725491|12023879|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1
7615045|NCT00725491|12023880|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1
7615046|NCT00725491|12023879|FG000|Overall Study|Fertilization failure|0
7615047|NCT00725491|12023880|FG001|Overall Study|Fertilization failure|1
7615048|NCT00725491|12023879|FG000|Overall Study|No/too few embryos/ bad quality embryos|3
7615049|NCT00725491|12023880|FG001|Overall Study|No/too few embryos/ bad quality embryos|2
7615050|NCT00703014|12023888|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
7615051|NCT00703014|12023889|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
7615052|NCT00703014|12023890|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
7615053|NCT00703014|12023891|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
7615054|NCT00703014|12023888|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
7615055|NCT00703014|12023889|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
7615056|NCT00703014|12023890|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
7615057|NCT00703014|12023891|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
7615058|NCT00702845|12023903|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2
7615059|NCT00702845|12023904|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2
7615060|NCT00702845|12023903|FG000|Overall Study|Too high ovarian response|5
7615061|NCT00702845|12023904|FG001|Overall Study|Too high ovarian response|1
7615062|NCT00702845|12023903|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1
7615063|NCT00702845|12023904|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0
7615064|NCT00702845|12023903|FG000|Overall Study|Insufficient ovarian response|1
7615065|NCT00702845|12023904|FG001|Overall Study|Insufficient ovarian response|0
7615066|NCT00702845|12023903|FG000|Overall Study|No/too few/bad quality embryos retrieved|7
7615067|NCT00702845|12023904|FG001|Overall Study|No/too few/bad quality embryos retrieved|1
7615068|NCT00702845|12023903|FG000|Overall Study|No or abnormal fertilization|4
7615069|NCT00702845|12023904|FG001|Overall Study|No or abnormal fertilization|2
7615070|NCT00702845|12023903|FG000|Overall Study|Patient's decision|2
7615071|NCT00702845|12023904|FG001|Overall Study|Patient's decision|1
7615072|NCT00702845|12023903|FG000|Overall Study|Not randomized|0
7615073|NCT00702845|12023904|FG001|Overall Study|Not randomized|1
7615074|NCT00702520|12023939|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
7615075|NCT00702520|12023940|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
7615076|NCT00702520|12023941|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
7615077|NCT00702520|12023942|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
7615078|NCT00702520|12023939|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3
7615079|NCT00702520|12023940|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6
7615080|NCT00702520|12023941|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0
7615081|NCT00702520|12023942|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0
7615082|NCT00702520|12023939|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
7615083|NCT00702520|12023940|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
7615084|NCT00702520|12023941|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
7615085|NCT00702520|12023942|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
7615086|NCT00697255|12023981|FG000|Stage 1a|Insufficient ovarian response|1
7615087|NCT00697255|12023982|FG001|Stage 1a|Insufficient ovarian response|0
7615088|NCT00697255|12023981|FG000|Stage 1a|Multifollicular growth|1
7615089|NCT00697255|12023982|FG001|Stage 1a|Multifollicular growth|0
7615090|NCT00697255|12023981|FG000|Stage 1a|Not growing of dominant follicle|1
7615091|NCT00697255|12023982|FG001|Stage 1a|Not growing of dominant follicle|0
7615092|NCT00697255|12023981|FG000|Stage 1b|Not growing of dominant follicle|0
7615093|NCT00697255|12023982|FG001|Stage 1b|Not growing of dominant follicle|1
7615094|NCT00697255|12023981|FG000|Stage 1b|Insufficient ovarian response|0
7615095|NCT00697255|12023982|FG001|Stage 1b|Insufficient ovarian response|1
7615096|NCT00696878|12023988|FG000|Overall Study|Adverse Event|8
7615097|NCT00696878|12023988|FG000|Overall Study|Withdrawal by Subject|87
7615098|NCT00696878|12023988|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
7615099|NCT00696878|12023988|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304
7615100|NCT00696878|12023988|FG000|Overall Study|Trial stopped|32
7615101|NCT00696878|12023988|FG000|Overall Study|Other reason (not specified)|55
7615102|NCT00696800|12023994|FG000|Overall Study|Adverse Event|16
7615103|NCT00696800|12023995|FG001|Overall Study|Adverse Event|3
7615104|NCT00696800|12023994|FG000|Overall Study|Insufficient compliance with medication|2
7615105|NCT00696800|12023995|FG001|Overall Study|Insufficient compliance with medication|1
7615106|NCT00696800|12023994|FG000|Overall Study|Insufficient ovarian response on Day 8|4
7615107|NCT00696800|12023995|FG001|Overall Study|Insufficient ovarian response on Day 8|1
7615108|NCT00696800|12023994|FG000|Overall Study|Insufficient ovarian response|4
7615109|NCT00696800|12023995|FG001|Overall Study|Insufficient ovarian response|1
7615110|NCT00696800|12023994|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
7615111|NCT00696800|12023995|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
7615112|NCT00696800|12023994|FG000|Overall Study|Too high ovarian response|6
7615113|NCT00696800|12023995|FG001|Overall Study|Too high ovarian response|1
7615114|NCT00696800|12023994|FG000|Overall Study|No/too few/bad quality oocytes|4
7615115|NCT00696800|12023995|FG001|Overall Study|No/too few/bad quality oocytes|3
7615116|NCT00696800|12023994|FG000|Overall Study|No/abnormal fertilization|11
7615117|NCT00696800|12023995|FG001|Overall Study|No/abnormal fertilization|13
7615118|NCT00696800|12023994|FG000|Overall Study|No/too few/bad quality embryos|24
7615119|NCT00696800|12023995|FG001|Overall Study|No/too few/bad quality embryos|18
7615120|NCT00696800|12023994|FG000|Overall Study|Other Reasons|5
7615121|NCT00696800|12023995|FG001|Overall Study|Other Reasons|3
7615122|NCT00696800|12023994|FG000|Overall Study|Not treated|1
7615123|NCT00696800|12023995|FG001|Overall Study|Not treated|2
7615124|NCT00616967|12024003|FG000|Overall Study|Withdrawal by Subject|0
7615125|NCT00616967|12024004|FG001|Overall Study|Withdrawal by Subject|0
7615126|NCT00616967|12024005|FG002|Overall Study|Withdrawal by Subject|1
7615127|NCT00461032|12024025|FG000|Overall Study|Adverse Event|5
7615128|NCT00461032|12024026|FG001|Overall Study|Adverse Event|6
7615129|NCT00461032|12024025|FG000|Overall Study|Lack of Efficacy|5
7615130|NCT00461032|12024026|FG001|Overall Study|Lack of Efficacy|1
7615131|NCT00461032|12024025|FG000|Overall Study|Lost to Follow-up|7
7615132|NCT00461032|12024026|FG001|Overall Study|Lost to Follow-up|12
7615133|NCT00461032|12024025|FG000|Overall Study|Protocol Violation|4
7615134|NCT00461032|12024026|FG001|Overall Study|Protocol Violation|4
7615135|NCT00461032|12024025|FG000|Overall Study|Withdrawal by Subject|7
7615136|NCT00461032|12024026|FG001|Overall Study|Withdrawal by Subject|15
7615137|NCT00461032|12024025|FG000|Overall Study|Patient Moved or Relocated|2
7615138|NCT00461032|12024026|FG001|Overall Study|Patient Moved or Relocated|1
7615139|NCT00461032|12024025|FG000|Overall Study|Other|7
7615140|NCT00461032|12024026|FG001|Overall Study|Other|5
7615141|NCT00289874|12024047|FG000|Overall Study|Adverse Event|1
7615142|NCT00289874|12024048|FG001|Overall Study|Adverse Event|5
7615143|NCT00289874|12024047|FG000|Overall Study|Lost to Follow-up|1
7615144|NCT00289874|12024048|FG001|Overall Study|Lost to Follow-up|1
7615145|NCT00289874|12024047|FG000|Overall Study|Protocol Violation|3
7615146|NCT00289874|12024048|FG001|Overall Study|Protocol Violation|2
7615147|NCT00289874|12024047|FG000|Overall Study|Did not meet eligibility|1
7615148|NCT00289874|12024048|FG001|Overall Study|Did not meet eligibility|0
7615149|NCT00250458|12024056|FG000|Overall Study|Lost to Follow-up|4
7615150|NCT00250458|12024057|FG001|Overall Study|Lost to Follow-up|2
7615151|NCT00250458|12024056|FG000|Overall Study|Protocol Violation|0
7615152|NCT00250458|12024057|FG001|Overall Study|Protocol Violation|1
7615153|NCT00250458|12024056|FG000|Overall Study|Withdrawal by Subject|4
7615154|NCT00250458|12024057|FG001|Overall Study|Withdrawal by Subject|2
7615155|NCT00250458|12024056|FG000|Overall Study|Lack of Migraine Attack|20
7615156|NCT00250458|12024057|FG001|Overall Study|Lack of Migraine Attack|9
7615157|NCT00250458|12024056|FG000|Overall Study|Qualifying migraine but did not treat|3
7615158|NCT00250458|12024057|FG001|Overall Study|Qualifying migraine but did not treat|3
7615159|NCT00250458|12024056|FG000|Overall Study|Other|1
7615160|NCT00250458|12024057|FG001|Overall Study|Other|0
7615161|NCT00245570|12024063|FG000|Washout Between Periods III and IV|Adverse Event|0
7615162|NCT00245570|12024064|FG001|Washout Between Periods III and IV|Adverse Event|1
7615163|NCT00245570|12024065|FG002|Washout Between Periods III and IV|Adverse Event|0
7615164|NCT00245570|12024066|FG003|Washout Between Periods III and IV|Adverse Event|0
7780108|NCT00950599|12228535|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7780109|NCT00950599|12228536|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7615165|NCT00245570|12024067|FG004|Washout Between Periods III and IV|Adverse Event|0
7615166|NCT00245570|12024068|FG005|Washout Between Periods III and IV|Adverse Event|0
7615167|NCT00092131|12024092|FG000|Treatment Period I|Adverse Event|1
7615168|NCT00092131|12024093|FG001|Treatment Period I|Adverse Event|0
7615169|NCT00092131|12024092|FG000|Treatment Period II|Adverse Event|0
7615170|NCT00092131|12024093|FG001|Treatment Period II|Adverse Event|1
7615171|NCT00092118|12024101|FG000|Overall Study|Adverse Event|35
7615172|NCT00092118|12024102|FG001|Overall Study|Adverse Event|32
7615173|NCT00092118|12024101|FG000|Overall Study|Lack of Efficacy|12
7780110|NCT00950599|12228537|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7780111|NCT00950599|12228528|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4
7780112|NCT00950599|12228529|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3
7780113|NCT00950599|12228530|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3
7780114|NCT00950599|12228531|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1
7780115|NCT00950599|12228532|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1
7780116|NCT00950599|12228533|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2
7780117|NCT00950599|12228534|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0
7780118|NCT00950599|12228535|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3
7780119|NCT00950599|12228536|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0
7780120|NCT00950599|12228537|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0
7780121|NCT00950599|12228528|FG000|Follow-Up Period|Adverse Event|0
7780122|NCT00950599|12228529|FG001|Follow-Up Period|Adverse Event|0
7780123|NCT00950599|12228530|FG002|Follow-Up Period|Adverse Event|0
7780124|NCT00950599|12228531|FG003|Follow-Up Period|Adverse Event|0
7780125|NCT00950599|12228532|FG004|Follow-Up Period|Adverse Event|0
7780126|NCT00950599|12228533|FG005|Follow-Up Period|Adverse Event|0
7780127|NCT00950599|12228534|FG006|Follow-Up Period|Adverse Event|0
7780128|NCT00950599|12228535|FG007|Follow-Up Period|Adverse Event|0
7780129|NCT00950599|12228536|FG008|Follow-Up Period|Adverse Event|1
7780130|NCT00950599|12228537|FG009|Follow-Up Period|Adverse Event|0
7780131|NCT00950599|12228528|FG000|Follow-Up Period|Lack of Efficacy|0
7780132|NCT00950599|12228529|FG001|Follow-Up Period|Lack of Efficacy|0
7780133|NCT00950599|12228530|FG002|Follow-Up Period|Lack of Efficacy|0
7780134|NCT00950599|12228531|FG003|Follow-Up Period|Lack of Efficacy|0
7780135|NCT00950599|12228532|FG004|Follow-Up Period|Lack of Efficacy|0
7780136|NCT00950599|12228533|FG005|Follow-Up Period|Lack of Efficacy|0
7780137|NCT00950599|12228534|FG006|Follow-Up Period|Lack of Efficacy|0
7780138|NCT00950599|12228535|FG007|Follow-Up Period|Lack of Efficacy|0
7780139|NCT00950599|12228536|FG008|Follow-Up Period|Lack of Efficacy|3
7780140|NCT00950599|12228537|FG009|Follow-Up Period|Lack of Efficacy|0
7780141|NCT00950599|12228528|FG000|Follow-Up Period|Lost to Follow-up|0
7780142|NCT00950599|12228529|FG001|Follow-Up Period|Lost to Follow-up|0
7780143|NCT00950599|12228530|FG002|Follow-Up Period|Lost to Follow-up|0
7780144|NCT00950599|12228531|FG003|Follow-Up Period|Lost to Follow-up|0
7780145|NCT00950599|12228532|FG004|Follow-Up Period|Lost to Follow-up|0
7780146|NCT00950599|12228533|FG005|Follow-Up Period|Lost to Follow-up|0
7780147|NCT00950599|12228534|FG006|Follow-Up Period|Lost to Follow-up|0
7780148|NCT00950599|12228535|FG007|Follow-Up Period|Lost to Follow-up|0
7780149|NCT00950599|12228536|FG008|Follow-Up Period|Lost to Follow-up|5
7780150|NCT00950599|12228537|FG009|Follow-Up Period|Lost to Follow-up|1
7780151|NCT00950599|12228528|FG000|Follow-Up Period|Physician Decision|0
7780152|NCT00950599|12228529|FG001|Follow-Up Period|Physician Decision|0
7780153|NCT00950599|12228530|FG002|Follow-Up Period|Physician Decision|0
7780154|NCT00950599|12228531|FG003|Follow-Up Period|Physician Decision|0
7780155|NCT00950599|12228532|FG004|Follow-Up Period|Physician Decision|0
7780156|NCT00950599|12228533|FG005|Follow-Up Period|Physician Decision|0
7780157|NCT00950599|12228534|FG006|Follow-Up Period|Physician Decision|0
7780158|NCT00950599|12228535|FG007|Follow-Up Period|Physician Decision|0
7780159|NCT00950599|12228536|FG008|Follow-Up Period|Physician Decision|1
7780160|NCT00950599|12228537|FG009|Follow-Up Period|Physician Decision|0
7780161|NCT00950599|12228528|FG000|Follow-Up Period|Poor/Noncompliance|0
7780162|NCT00950599|12228529|FG001|Follow-Up Period|Poor/Noncompliance|0
7780163|NCT00950599|12228530|FG002|Follow-Up Period|Poor/Noncompliance|0
7780164|NCT00950599|12228531|FG003|Follow-Up Period|Poor/Noncompliance|0
7780165|NCT00950599|12228532|FG004|Follow-Up Period|Poor/Noncompliance|0
7780166|NCT00950599|12228533|FG005|Follow-Up Period|Poor/Noncompliance|0
7780167|NCT00950599|12228534|FG006|Follow-Up Period|Poor/Noncompliance|0
7780168|NCT00950599|12228535|FG007|Follow-Up Period|Poor/Noncompliance|0
7780169|NCT00950599|12228536|FG008|Follow-Up Period|Poor/Noncompliance|1
7780170|NCT00950599|12228537|FG009|Follow-Up Period|Poor/Noncompliance|0
7780171|NCT00950599|12228528|FG000|Follow-Up Period|Subject withdrew Consent|0
7615174|NCT00092118|12024102|FG001|Overall Study|Lack of Efficacy|14
7615175|NCT00092118|12024101|FG000|Overall Study|Lost to Follow-up|4
7615176|NCT00092118|12024102|FG001|Overall Study|Lost to Follow-up|3
7615177|NCT00092118|12024101|FG000|Overall Study|Protocol Violation|23
7615178|NCT00092118|12024102|FG001|Overall Study|Protocol Violation|25
7615179|NCT00092118|12024101|FG000|Overall Study|Withdrawal by Subject|4
7615180|NCT00092118|12024102|FG001|Overall Study|Withdrawal by Subject|10
7615181|NCT00092118|12024101|FG000|Overall Study|Other|6
7615182|NCT00092118|12024102|FG001|Overall Study|Other|5
7615183|NCT00090142|12024108|FG000|Treatment Period I|Lost to Follow-up|1
7615184|NCT00090142|12024109|FG001|Treatment Period I|Lost to Follow-up|2
7615185|NCT00090142|12024108|FG000|Treatment Period I|Protocol Violation|2
7615186|NCT00090142|12024109|FG001|Treatment Period I|Protocol Violation|0
7615187|NCT00090142|12024108|FG000|Treatment Period I|Withdrawal by Subject|2
7615188|NCT00090142|12024109|FG001|Treatment Period I|Withdrawal by Subject|0
7780172|NCT00950599|12228529|FG001|Follow-Up Period|Subject withdrew Consent|0
7780173|NCT00950599|12228530|FG002|Follow-Up Period|Subject withdrew Consent|0
7780174|NCT00950599|12228531|FG003|Follow-Up Period|Subject withdrew Consent|0
7780175|NCT00950599|12228532|FG004|Follow-Up Period|Subject withdrew Consent|0
7615189|NCT00090142|12024108|FG000|Treatment Period I|Other|0
7780176|NCT00950599|12228533|FG005|Follow-Up Period|Subject withdrew Consent|0
7780177|NCT00950599|12228534|FG006|Follow-Up Period|Subject withdrew Consent|0
7780178|NCT00950599|12228535|FG007|Follow-Up Period|Subject withdrew Consent|0
7780179|NCT00950599|12228536|FG008|Follow-Up Period|Subject withdrew Consent|2
7780180|NCT00950599|12228537|FG009|Follow-Up Period|Subject withdrew Consent|1
7780181|NCT00950651|12228571|FG000|Overall Study|Adverse Event|17
7780182|NCT00950651|12228572|FG001|Overall Study|Adverse Event|20
7780183|NCT00950651|12228571|FG000|Overall Study|Death|1
7780184|NCT00950651|12228572|FG001|Overall Study|Death|0
7780185|NCT00950651|12228571|FG000|Overall Study|Lack of Efficacy|2
7780186|NCT00950651|12228572|FG001|Overall Study|Lack of Efficacy|2
7780187|NCT00950651|12228571|FG000|Overall Study|Protocol Violation|3
7780188|NCT00950651|12228572|FG001|Overall Study|Protocol Violation|4
7780189|NCT00950651|12228571|FG000|Overall Study|Withdrawal by Subject|8
7780190|NCT00950651|12228572|FG001|Overall Study|Withdrawal by Subject|9
7780191|NCT00950664|12228580|FG000|First Intervention|Lost to Follow-up|1
7780192|NCT00950664|12228581|FG001|First Intervention|Lost to Follow-up|3
7780193|NCT00950664|12228580|FG000|First Intervention|Withdrawal by Subject|2
7780194|NCT00950664|12228581|FG001|First Intervention|Withdrawal by Subject|2
7780195|NCT00950742|12228593|FG000|Overall Study|Other Adverse Event|1
7780196|NCT00950742|12228594|FG001|Overall Study|Other Adverse Event|0
7780197|NCT00950742|12228593|FG000|Overall Study|Withdrawal by Subject|3
7780198|NCT00950742|12228594|FG001|Overall Study|Withdrawal by Subject|0
7780199|NCT00950742|12228593|FG000|Overall Study|Progressive Disease|6
7780200|NCT00950742|12228594|FG001|Overall Study|Progressive Disease|2
7780201|NCT00950742|12228593|FG000|Overall Study|Dose limiting toxicity|6
7780202|NCT00950742|12228594|FG001|Overall Study|Dose limiting toxicity|0
7780203|NCT00950755|12228604|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
7780204|NCT00950755|12228604|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
7780205|NCT00950755|12228604|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27
7780206|NCT00950755|12228604|FG000|Dosimetric and Therapeutic Treatment|Death|1
7780207|NCT00950755|12228604|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
7780208|NCT00950755|12228604|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
7780209|NCT00950755|12228604|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
7780210|NCT00950755|12228604|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
7780211|NCT00950755|12228604|FG000|Long-Term Follow-Up|Lost to Follow-up|1
7780212|NCT00950755|12228604|FG000|Long-Term Follow-Up|Death|8
7780213|NCT00950807|12228608|FG000|Treatment Period 1|Lack of Efficacy|1
7780214|NCT00950807|12228609|FG001|Treatment Period 1|Lack of Efficacy|0
7780215|NCT00950807|12228610|FG002|Treatment Period 1|Lack of Efficacy|0
7780216|NCT00950807|12228611|FG003|Treatment Period 1|Lack of Efficacy|0
7780217|NCT00950807|12228612|FG004|Treatment Period 1|Lack of Efficacy|0
7780218|NCT00950807|12228613|FG005|Treatment Period 1|Lack of Efficacy|1
7780219|NCT00950807|12228614|FG006|Treatment Period 1|Lack of Efficacy|0
7780220|NCT00950807|12228615|FG007|Treatment Period 1|Lack of Efficacy|0
7615190|NCT00090142|12024109|FG001|Treatment Period I|Other|1
7615191|NCT00090142|12024108|FG000|Treatment Period II|Other|1
7615192|NCT00090142|12024109|FG001|Treatment Period II|Other|0
7780221|NCT00950807|12228616|FG008|Treatment Period 1|Lack of Efficacy|0
7780222|NCT00950807|12228617|FG009|Treatment Period 1|Lack of Efficacy|0
7615193|NCT04771013|12024121|FG000|Overall Study|Withdrawal by Subject|2
7615194|NCT04771013|12024122|FG001|Overall Study|Withdrawal by Subject|0
7615195|NCT04771013|12024121|FG000|Overall Study|Death|0
7615196|NCT04771013|12024122|FG001|Overall Study|Death|5
7615197|NCT04771013|12024121|FG000|Overall Study|Referred to another hospital before day 20|0
7615198|NCT04771013|12024122|FG001|Overall Study|Referred to another hospital before day 20|1
7615199|NCT04497987|12024130|FG000|Overall Study|Adverse Event|1
7615200|NCT04497987|12024131|FG001|Overall Study|Adverse Event|0
7615201|NCT04497987|12024130|FG000|Overall Study|Death|21
7615202|NCT04497987|12024131|FG001|Overall Study|Death|13
7615203|NCT04497987|12024130|FG000|Overall Study|Lost to Follow-up|19
7615204|NCT04497987|12024131|FG001|Overall Study|Lost to Follow-up|17
7615205|NCT04497987|12024130|FG000|Overall Study|Other - as reported by the investigator|22
7615206|NCT04497987|12024131|FG001|Overall Study|Other - as reported by the investigator|16
7615207|NCT04497987|12024130|FG000|Overall Study|Physician Decision|1
7615208|NCT04497987|12024131|FG001|Overall Study|Physician Decision|0
7615209|NCT04497987|12024130|FG000|Overall Study|Withdrawal by Subject|35
7615210|NCT04497987|12024131|FG001|Overall Study|Withdrawal by Subject|21
7615211|NCT03512210|12024187|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3
7615212|NCT03512210|12024187|FG000|Step 1: MINMON Intervention|Protocol Violation|1
7615213|NCT03512210|12024187|FG000|Step 2:Post-MINMON|Death|2
7615214|NCT03512210|12024187|FG000|Step 2:Post-MINMON|Lost to Follow-up|30
7615215|NCT03512210|12024187|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2
7615216|NCT03180307|12024228|FG000|Overall Study|Lost to Follow-up|2
7615217|NCT03180307|12024229|FG001|Overall Study|Lost to Follow-up|0
7615218|NCT03180307|12024228|FG000|Overall Study|Death|1
7615219|NCT03180307|12024229|FG001|Overall Study|Death|0
7615220|NCT03180307|12024228|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3
7615221|NCT03180307|12024229|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0
7615222|NCT02668822|12024248|FG000|Overall Study|Protocol Violation|2
7615223|NCT02668822|12024249|FG001|Overall Study|Protocol Violation|0
7780223|NCT00950807|12228608|FG000|Treatment Period 1|Protocol Violation|1
7615224|NCT02668822|12024248|FG000|Overall Study|Study Terminated by Sponsor|7
7615225|NCT02668822|12024249|FG001|Overall Study|Study Terminated by Sponsor|9
7615226|NCT02668783|12024257|FG000|Overall Study|Pregnancy|0
7615227|NCT02668783|12024258|FG001|Overall Study|Pregnancy|1
7615228|NCT02668783|12024257|FG000|Overall Study|Protocol Violation|2
7615229|NCT02668783|12024258|FG001|Overall Study|Protocol Violation|1
7615230|NCT02668783|12024257|FG000|Overall Study|Study terminated by sponsor|9
7615231|NCT02668783|12024258|FG001|Overall Study|Study terminated by sponsor|10
7615232|NCT02668783|12024257|FG000|Overall Study|Subject moved|1
7615233|NCT02668783|12024258|FG001|Overall Study|Subject moved|0
7615234|NCT02668783|12024257|FG000|Overall Study|Withdrawal by Subject|1
7780224|NCT00950807|12228609|FG001|Treatment Period 1|Protocol Violation|0
7780225|NCT00950807|12228610|FG002|Treatment Period 1|Protocol Violation|0
7780226|NCT00950807|12228611|FG003|Treatment Period 1|Protocol Violation|0
7780227|NCT00950807|12228612|FG004|Treatment Period 1|Protocol Violation|0
7780228|NCT00950807|12228613|FG005|Treatment Period 1|Protocol Violation|0
7780229|NCT00950807|12228614|FG006|Treatment Period 1|Protocol Violation|0
7780230|NCT00950807|12228615|FG007|Treatment Period 1|Protocol Violation|0
7780231|NCT00950807|12228616|FG008|Treatment Period 1|Protocol Violation|0
7780232|NCT00950807|12228617|FG009|Treatment Period 1|Protocol Violation|0
7780233|NCT00950807|12228608|FG000|Treatment Period 1|Lost to Follow-up|0
7780234|NCT00950807|12228609|FG001|Treatment Period 1|Lost to Follow-up|0
7780235|NCT00950807|12228610|FG002|Treatment Period 1|Lost to Follow-up|1
7780236|NCT00950807|12228611|FG003|Treatment Period 1|Lost to Follow-up|0
7780237|NCT00950807|12228612|FG004|Treatment Period 1|Lost to Follow-up|0
7780238|NCT00950807|12228613|FG005|Treatment Period 1|Lost to Follow-up|0
7780239|NCT00950807|12228614|FG006|Treatment Period 1|Lost to Follow-up|0
7780240|NCT00950807|12228615|FG007|Treatment Period 1|Lost to Follow-up|0
7780241|NCT00950807|12228616|FG008|Treatment Period 1|Lost to Follow-up|0
7780242|NCT00950807|12228617|FG009|Treatment Period 1|Lost to Follow-up|0
7780243|NCT00950807|12228608|FG000|Treatment Period 1|Withdrawal by Subject|1
7780244|NCT00950807|12228609|FG001|Treatment Period 1|Withdrawal by Subject|0
7780245|NCT00950807|12228610|FG002|Treatment Period 1|Withdrawal by Subject|0
7780246|NCT00950807|12228611|FG003|Treatment Period 1|Withdrawal by Subject|0
7780247|NCT00950807|12228612|FG004|Treatment Period 1|Withdrawal by Subject|1
7780248|NCT00950807|12228613|FG005|Treatment Period 1|Withdrawal by Subject|0
7780249|NCT00950807|12228614|FG006|Treatment Period 1|Withdrawal by Subject|0
7780250|NCT00950807|12228615|FG007|Treatment Period 1|Withdrawal by Subject|0
7780251|NCT00950807|12228616|FG008|Treatment Period 1|Withdrawal by Subject|1
7780252|NCT00950807|12228617|FG009|Treatment Period 1|Withdrawal by Subject|0
7780253|NCT00950807|12228608|FG000|Treatment Period 1|Adverse Event|0
7780254|NCT00950807|12228609|FG001|Treatment Period 1|Adverse Event|0
7780255|NCT00950807|12228610|FG002|Treatment Period 1|Adverse Event|0
7780256|NCT00950807|12228611|FG003|Treatment Period 1|Adverse Event|0
7780257|NCT00950807|12228612|FG004|Treatment Period 1|Adverse Event|0
7780258|NCT00950807|12228613|FG005|Treatment Period 1|Adverse Event|1
7780259|NCT00950807|12228614|FG006|Treatment Period 1|Adverse Event|0
7780260|NCT00950807|12228615|FG007|Treatment Period 1|Adverse Event|0
7780261|NCT00950807|12228616|FG008|Treatment Period 1|Adverse Event|0
7780262|NCT00950807|12228617|FG009|Treatment Period 1|Adverse Event|0
7780263|NCT00950807|12228608|FG000|Washout Period 1|Lack of Efficacy|0
7615235|NCT02668783|12024258|FG001|Overall Study|Withdrawal by Subject|0
7615236|NCT02616146|12024266|FG000|Overall Study|Adverse Event|64
7615237|NCT02616146|12024267|FG001|Overall Study|Adverse Event|24
7615238|NCT02616146|12024266|FG000|Overall Study|Lost to Follow-up|23
7615239|NCT02616146|12024267|FG001|Overall Study|Lost to Follow-up|13
7615240|NCT02616146|12024266|FG000|Overall Study|Non-compliance with study protocol|2
7615241|NCT02616146|12024267|FG001|Overall Study|Non-compliance with study protocol|0
7615242|NCT02616146|12024266|FG000|Overall Study|Non-compliance with study drug|4
7615243|NCT02616146|12024267|FG001|Overall Study|Non-compliance with study drug|2
7615244|NCT02616146|12024266|FG000|Overall Study|Pregnancy|2
7615245|NCT02616146|12024267|FG001|Overall Study|Pregnancy|2
7615246|NCT02616146|12024266|FG000|Overall Study|Pregnancy wish|3
7615247|NCT02616146|12024267|FG001|Overall Study|Pregnancy wish|0
7615248|NCT02616146|12024266|FG000|Overall Study|Protocol Violation|6
7615249|NCT02616146|12024267|FG001|Overall Study|Protocol Violation|3
7615250|NCT02616146|12024266|FG000|Overall Study|Study terminated by sponsor|1372
7615251|NCT02616146|12024267|FG001|Overall Study|Study terminated by sponsor|432
7615252|NCT02616146|12024266|FG000|Overall Study|Participant moved|4
7615253|NCT02616146|12024267|FG001|Overall Study|Participant moved|3
7615254|NCT02616146|12024266|FG000|Overall Study|Withdrawal by Subject|30
7615255|NCT02616146|12024267|FG001|Overall Study|Withdrawal by Subject|24
7615256|NCT02616146|12024266|FG000|Overall Study|Physician Decision|2
7615257|NCT02616146|12024267|FG001|Overall Study|Physician Decision|1
7615258|NCT02524288|12024286|FG000|Overall Study|Adverse Event|115
7615259|NCT02524288|12024286|FG000|Overall Study|Lost to Follow-up|216
7615260|NCT02524288|12024286|FG000|Overall Study|Non-Compliance With Protocol|32
7615261|NCT02524288|12024286|FG000|Overall Study|Non-Compliance With Study Drug|14
7615262|NCT02524288|12024286|FG000|Overall Study|Pregnancy Wish|6
7615263|NCT02524288|12024286|FG000|Overall Study|Protocol Violation|6
7615264|NCT02524288|12024286|FG000|Overall Study|Screen Failure|2
7615265|NCT02524288|12024286|FG000|Overall Study|Site Discontinued Study Participation|1
7615266|NCT02524288|12024286|FG000|Overall Study|Study Terminated By Sponsor|1417
7615267|NCT02524288|12024286|FG000|Overall Study|Subject Moved|32
7615268|NCT02524288|12024286|FG000|Overall Study|Withdrawal by Subject|76
7615269|NCT02524288|12024286|FG000|Overall Study|Pregnancy|22
7615270|NCT02524288|12024286|FG000|Overall Study|Physician Decision|2
7615271|NCT02489942|12024290|FG000|Overall Study|Request by patient|602
7615272|NCT02489942|12024290|FG000|Overall Study|Improvement/remission|157
7615273|NCT02489942|12024290|FG000|Overall Study|No change/Progressive disease|263
7615274|NCT02489942|12024290|FG000|Overall Study|Adverse Event|522
7615275|NCT02489942|12024290|FG000|Overall Study|Other personal reasons|1218
7615276|NCT02489942|12024290|FG000|Overall Study|Lost to Follow-up|456
7615277|NCT02489942|12024290|FG000|Overall Study|Not continuously investigated|7
7615278|NCT02489942|12024290|FG000|Overall Study|Patient started jardiance treatment out of registration period|1
7615279|NCT02489942|12024290|FG000|Overall Study|Multiple registration|1
7615280|NCT02489942|12024290|FG000|Overall Study|No patient visit after entry|100
7615281|NCT02489942|12024290|FG000|Overall Study|No treatment with Jardiance|2
7615282|NCT02489942|12024290|FG000|Overall Study|Patient received Jardiance before registration|1
7615283|NCT02489942|12024290|FG000|Overall Study|No CRF collected|86
7780264|NCT00950807|12228609|FG001|Washout Period 1|Lack of Efficacy|0
7780265|NCT00950807|12228610|FG002|Washout Period 1|Lack of Efficacy|0
7780266|NCT00950807|12228611|FG003|Washout Period 1|Lack of Efficacy|0
7780267|NCT00950807|12228612|FG004|Washout Period 1|Lack of Efficacy|0
7780268|NCT00950807|12228613|FG005|Washout Period 1|Lack of Efficacy|0
7780269|NCT00950807|12228614|FG006|Washout Period 1|Lack of Efficacy|1
7780270|NCT00950807|12228615|FG007|Washout Period 1|Lack of Efficacy|0
7780271|NCT00950807|12228616|FG008|Washout Period 1|Lack of Efficacy|0
7780272|NCT00950807|12228617|FG009|Washout Period 1|Lack of Efficacy|0
7780273|NCT00950807|12228608|FG000|Washout Period 1|Withdrawal by Subject|0
7780274|NCT00950807|12228609|FG001|Washout Period 1|Withdrawal by Subject|0
7780275|NCT00950807|12228610|FG002|Washout Period 1|Withdrawal by Subject|0
7780276|NCT00950807|12228611|FG003|Washout Period 1|Withdrawal by Subject|0
7780277|NCT00950807|12228612|FG004|Washout Period 1|Withdrawal by Subject|0
7780278|NCT00950807|12228613|FG005|Washout Period 1|Withdrawal by Subject|0
7780279|NCT00950807|12228614|FG006|Washout Period 1|Withdrawal by Subject|0
7780280|NCT00950807|12228615|FG007|Washout Period 1|Withdrawal by Subject|0
7780281|NCT00950807|12228616|FG008|Washout Period 1|Withdrawal by Subject|1
7780282|NCT00950807|12228617|FG009|Washout Period 1|Withdrawal by Subject|0
7780283|NCT00950807|12228608|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3
7780284|NCT00950807|12228609|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0
7780285|NCT00950807|12228610|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0
7780286|NCT00950807|12228611|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0
7615284|NCT02409342|12024296|FG000|Overall Study|Death|181
7615285|NCT02409342|12024297|FG001|Overall Study|Death|174
7615286|NCT02409342|12024296|FG000|Overall Study|Withdrawal by Subject|24
7615287|NCT02409342|12024297|FG001|Overall Study|Withdrawal by Subject|16
7615288|NCT02409342|12024296|FG000|Overall Study|On-going in study|79
7615289|NCT02409342|12024297|FG001|Overall Study|On-going in study|92
7615290|NCT02409342|12024296|FG000|Overall Study|Lost to Follow-up|3
7615291|NCT02409342|12024297|FG001|Overall Study|Lost to Follow-up|3
7615292|NCT02275546|12024314|FG000|Treatment Period 2|Withdrawal by Subject|2
7780287|NCT00950807|12228612|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0
7780288|NCT00950807|12228613|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0
7780289|NCT00950807|12228614|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1
7780290|NCT00950807|12228615|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1
7615293|NCT02275546|12024315|FG001|Treatment Period 2|Withdrawal by Subject|1
7615294|NCT02275546|12024314|FG000|Treatment Period 2|Protocol Violation|0
7615295|NCT02275546|12024315|FG001|Treatment Period 2|Protocol Violation|1
7615296|NCT02077166|12024328|FG000|Overall Study|Death|6
7615297|NCT02077166|12024329|FG001|Overall Study|Death|7
7615298|NCT02077166|12024330|FG002|Overall Study|Death|5
7615299|NCT02077166|12024331|FG003|Overall Study|Death|6
7615300|NCT02077166|12024332|FG004|Overall Study|Death|4
7615301|NCT02077166|12024333|FG005|Overall Study|Death|32
7615302|NCT02077166|12024334|FG006|Overall Study|Death|22
7615303|NCT02077166|12024328|FG000|Overall Study|Study Closure by Sponsor|3
7615304|NCT02077166|12024329|FG001|Overall Study|Study Closure by Sponsor|0
7615305|NCT02077166|12024330|FG002|Overall Study|Study Closure by Sponsor|2
7615306|NCT02077166|12024331|FG003|Overall Study|Study Closure by Sponsor|2
7615307|NCT02077166|12024332|FG004|Overall Study|Study Closure by Sponsor|2
7615308|NCT02077166|12024333|FG005|Overall Study|Study Closure by Sponsor|12
7615309|NCT02077166|12024334|FG006|Overall Study|Study Closure by Sponsor|4
7615310|NCT02077166|12024328|FG000|Overall Study|Lost to Follow-up|0
7615311|NCT02077166|12024329|FG001|Overall Study|Lost to Follow-up|0
7615312|NCT02077166|12024330|FG002|Overall Study|Lost to Follow-up|0
7615313|NCT02077166|12024331|FG003|Overall Study|Lost to Follow-up|0
7615314|NCT02077166|12024332|FG004|Overall Study|Lost to Follow-up|0
7615315|NCT02077166|12024333|FG005|Overall Study|Lost to Follow-up|1
7615316|NCT02077166|12024334|FG006|Overall Study|Lost to Follow-up|0
7615317|NCT02077166|12024328|FG000|Overall Study|Withdrawal by Subject|3
7615318|NCT02077166|12024329|FG001|Overall Study|Withdrawal by Subject|0
7615319|NCT02077166|12024330|FG002|Overall Study|Withdrawal by Subject|1
7615320|NCT02077166|12024331|FG003|Overall Study|Withdrawal by Subject|1
7615321|NCT02077166|12024332|FG004|Overall Study|Withdrawal by Subject|1
7615322|NCT02077166|12024333|FG005|Overall Study|Withdrawal by Subject|3
7615323|NCT02077166|12024334|FG006|Overall Study|Withdrawal by Subject|0
7615324|NCT02077166|12024328|FG000|Overall Study|Other, Not Specified|0
7780291|NCT00950807|12228616|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0
7780292|NCT00950807|12228617|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0
7780293|NCT00950807|12228608|FG000|Washout Period 1|Adverse Event|2
7780294|NCT00950807|12228609|FG001|Washout Period 1|Adverse Event|0
7780295|NCT00950807|12228610|FG002|Washout Period 1|Adverse Event|0
7780296|NCT00950807|12228611|FG003|Washout Period 1|Adverse Event|1
7780297|NCT00950807|12228612|FG004|Washout Period 1|Adverse Event|1
7780298|NCT00950807|12228613|FG005|Washout Period 1|Adverse Event|0
7780299|NCT00950807|12228614|FG006|Washout Period 1|Adverse Event|0
7780300|NCT00950807|12228615|FG007|Washout Period 1|Adverse Event|0
7780301|NCT00950807|12228616|FG008|Washout Period 1|Adverse Event|0
7780302|NCT00950807|12228617|FG009|Washout Period 1|Adverse Event|0
7780303|NCT00950807|12228608|FG000|Treatment Period 2|Lack of Efficacy|1
7780304|NCT00950807|12228609|FG001|Treatment Period 2|Lack of Efficacy|0
7780305|NCT00950807|12228610|FG002|Treatment Period 2|Lack of Efficacy|0
7780306|NCT00950807|12228611|FG003|Treatment Period 2|Lack of Efficacy|0
7780307|NCT00950807|12228612|FG004|Treatment Period 2|Lack of Efficacy|0
7780308|NCT00950807|12228613|FG005|Treatment Period 2|Lack of Efficacy|0
7780309|NCT00950807|12228614|FG006|Treatment Period 2|Lack of Efficacy|0
7780310|NCT00950807|12228615|FG007|Treatment Period 2|Lack of Efficacy|0
7780311|NCT00950807|12228616|FG008|Treatment Period 2|Lack of Efficacy|0
7780312|NCT00950807|12228617|FG009|Treatment Period 2|Lack of Efficacy|0
7615325|NCT02077166|12024329|FG001|Overall Study|Other, Not Specified|0
7615326|NCT02077166|12024330|FG002|Overall Study|Other, Not Specified|1
7615327|NCT02077166|12024331|FG003|Overall Study|Other, Not Specified|0
7615328|NCT02077166|12024332|FG004|Overall Study|Other, Not Specified|1
7780313|NCT00950807|12228608|FG000|Treatment Period 2|Withdrawal by Subject|0
7780314|NCT00950807|12228609|FG001|Treatment Period 2|Withdrawal by Subject|0
7615329|NCT02077166|12024333|FG005|Overall Study|Other, Not Specified|7
7615330|NCT02077166|12024334|FG006|Overall Study|Other, Not Specified|8
7615331|NCT01891344|12024359|FG000|Overall Study|Ongoing|6
7615332|NCT01891344|12024360|FG001|Overall Study|Ongoing|2
7615333|NCT01891344|12024361|FG002|Overall Study|Ongoing|0
7615334|NCT01891344|12024362|FG003|Overall Study|Ongoing|1
7615335|NCT01891344|12024363|FG004|Overall Study|Ongoing|4
7615336|NCT01891344|12024364|FG005|Overall Study|Ongoing|1
7615337|NCT01891344|12024365|FG006|Overall Study|Ongoing|0
7615338|NCT01891344|12024366|FG007|Overall Study|Ongoing|0
7615339|NCT01847274|12024388|FG000|Overall Study|Adverse Event|17
7615340|NCT01847274|12024389|FG001|Overall Study|Adverse Event|1
7615341|NCT01847274|12024390|FG002|Overall Study|Adverse Event|33
7615342|NCT01847274|12024391|FG003|Overall Study|Adverse Event|2
7615343|NCT01847274|12024388|FG000|Overall Study|Withdrawal by Subject|8
7615344|NCT01847274|12024389|FG001|Overall Study|Withdrawal by Subject|8
7615345|NCT01847274|12024390|FG002|Overall Study|Withdrawal by Subject|11
7615346|NCT01847274|12024391|FG003|Overall Study|Withdrawal by Subject|1
7615347|NCT01847274|12024388|FG000|Overall Study|Disease Progression|63
7615348|NCT01847274|12024389|FG001|Overall Study|Disease Progression|49
7615349|NCT01847274|12024390|FG002|Overall Study|Disease Progression|129
7615350|NCT01847274|12024391|FG003|Overall Study|Disease Progression|98
7615351|NCT01847274|12024388|FG000|Overall Study|Treatment Associated Risk|0
7615352|NCT01847274|12024389|FG001|Overall Study|Treatment Associated Risk|2
7615353|NCT01847274|12024390|FG002|Overall Study|Treatment Associated Risk|2
7615354|NCT01847274|12024391|FG003|Overall Study|Treatment Associated Risk|0
7615355|NCT01847274|12024388|FG000|Overall Study|Other Reasons|3
7615356|NCT01847274|12024389|FG001|Overall Study|Other Reasons|1
7615357|NCT01847274|12024390|FG002|Overall Study|Other Reasons|11
7615358|NCT01847274|12024391|FG003|Overall Study|Other Reasons|3
7615359|NCT01847274|12024388|FG000|Overall Study|Non Compliance|0
7615360|NCT01847274|12024389|FG001|Overall Study|Non Compliance|0
7615361|NCT01847274|12024390|FG002|Overall Study|Non Compliance|2
7615362|NCT01847274|12024391|FG003|Overall Study|Non Compliance|0
7615363|NCT01670656|12024406|FG000|Overall Study|Non-compliance with study drug|0
7615364|NCT01670656|12024407|FG001|Overall Study|Non-compliance with study drug|0
7615365|NCT01670656|12024408|FG002|Overall Study|Non-compliance with study drug|3
7615366|NCT01670656|12024409|FG003|Overall Study|Non-compliance with study drug|0
7615367|NCT01670656|12024410|FG004|Overall Study|Non-compliance with study drug|1
7615368|NCT01670656|12024406|FG000|Overall Study|Pregnancy|0
7615369|NCT01670656|12024407|FG001|Overall Study|Pregnancy|0
7615370|NCT01670656|12024408|FG002|Overall Study|Pregnancy|0
7615371|NCT01670656|12024409|FG003|Overall Study|Pregnancy|0
7615372|NCT01670656|12024410|FG004|Overall Study|Pregnancy|1
7615373|NCT01670656|12024406|FG000|Overall Study|Withdrawal by Subject|1
7615374|NCT01670656|12024407|FG001|Overall Study|Withdrawal by Subject|1
7615375|NCT01670656|12024408|FG002|Overall Study|Withdrawal by Subject|0
7615376|NCT01670656|12024409|FG003|Overall Study|Withdrawal by Subject|0
7615377|NCT01670656|12024410|FG004|Overall Study|Withdrawal by Subject|0
7615378|NCT01670656|12024406|FG000|Overall Study|Non-compliance with protocol|0
7615379|NCT01670656|12024407|FG001|Overall Study|Non-compliance with protocol|3
7615380|NCT01670656|12024408|FG002|Overall Study|Non-compliance with protocol|1
7615381|NCT01670656|12024409|FG003|Overall Study|Non-compliance with protocol|1
7615382|NCT01670656|12024410|FG004|Overall Study|Non-compliance with protocol|2
7615383|NCT01670656|12024406|FG000|Overall Study|Adverse Event|2
7615384|NCT01670656|12024407|FG001|Overall Study|Adverse Event|2
7615385|NCT01670656|12024408|FG002|Overall Study|Adverse Event|2
7615386|NCT01670656|12024409|FG003|Overall Study|Adverse Event|3
7615387|NCT01670656|12024410|FG004|Overall Study|Adverse Event|3
7615388|NCT01670656|12024406|FG000|Overall Study|Subject withdrew consent|0
7615389|NCT01670656|12024407|FG001|Overall Study|Subject withdrew consent|1
7615390|NCT01670656|12024408|FG002|Overall Study|Subject withdrew consent|2
7615391|NCT01670656|12024409|FG003|Overall Study|Subject withdrew consent|1
7615392|NCT01670656|12024410|FG004|Overall Study|Subject withdrew consent|1
7615393|NCT01670656|12024406|FG000|Overall Study|Lost to Follow-up|0
7615394|NCT01670656|12024407|FG001|Overall Study|Lost to Follow-up|0
7615395|NCT01670656|12024408|FG002|Overall Study|Lost to Follow-up|0
7615396|NCT01670656|12024409|FG003|Overall Study|Lost to Follow-up|0
7615397|NCT01670656|12024410|FG004|Overall Study|Lost to Follow-up|3
7615398|NCT01670656|12024406|FG000|Overall Study|Subject moved|0
7615399|NCT01670656|12024407|FG001|Overall Study|Subject moved|0
7615400|NCT01670656|12024408|FG002|Overall Study|Subject moved|0
7615401|NCT01670656|12024409|FG003|Overall Study|Subject moved|1
7615402|NCT01670656|12024410|FG004|Overall Study|Subject moved|0
7615403|NCT01501955|12024424|FG000|Overall Study|Withdrawal by Subject|1
7615404|NCT01501955|12024425|FG001|Overall Study|Withdrawal by Subject|0
7615405|NCT01501955|12024424|FG000|Overall Study|Adverse Event|1
7615406|NCT01501955|12024425|FG001|Overall Study|Adverse Event|3
7780315|NCT00950807|12228610|FG002|Treatment Period 2|Withdrawal by Subject|0
7780316|NCT00950807|12228611|FG003|Treatment Period 2|Withdrawal by Subject|0
7780317|NCT00950807|12228612|FG004|Treatment Period 2|Withdrawal by Subject|0
7780318|NCT00950807|12228613|FG005|Treatment Period 2|Withdrawal by Subject|0
7780319|NCT00950807|12228614|FG006|Treatment Period 2|Withdrawal by Subject|1
7780320|NCT00950807|12228615|FG007|Treatment Period 2|Withdrawal by Subject|2
7780321|NCT00950807|12228616|FG008|Treatment Period 2|Withdrawal by Subject|0
7780322|NCT00950807|12228617|FG009|Treatment Period 2|Withdrawal by Subject|0
7615439|NCT01277211|12024442|FG000|Overall Study|Adverse Event|60
7615440|NCT01277211|12024443|FG001|Overall Study|Adverse Event|22
7615441|NCT01277211|12024442|FG000|Overall Study|Pregnancy|9
7615442|NCT01277211|12024443|FG001|Overall Study|Pregnancy|4
7615443|NCT01277211|12024442|FG000|Overall Study|Lost to Follow-up|14
7615444|NCT01277211|12024443|FG001|Overall Study|Lost to Follow-up|9
7615445|NCT01277211|12024442|FG000|Overall Study|Did not wish to continue|17
7615446|NCT01277211|12024443|FG001|Overall Study|Did not wish to continue|0
7615447|NCT01277211|12024442|FG000|Overall Study|Withdrew Consent|9
7615448|NCT01277211|12024443|FG001|Overall Study|Withdrew Consent|9
7615449|NCT01277211|12024442|FG000|Overall Study|Non-compliance with protocol|13
7615450|NCT01277211|12024443|FG001|Overall Study|Non-compliance with protocol|4
7615451|NCT01277211|12024442|FG000|Overall Study|Did not meet protocol eligibility|1
7615452|NCT01277211|12024443|FG001|Overall Study|Did not meet protocol eligibility|0
7615453|NCT01277211|12024442|FG000|Overall Study|Administrative|3
7615454|NCT01277211|12024443|FG001|Overall Study|Administrative|0
7615455|NCT01277211|12024442|FG000|Overall Study|Pregnancy wish|0
7615456|NCT01277211|12024443|FG001|Overall Study|Pregnancy wish|2
7780323|NCT00950807|12228608|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1
7780324|NCT00950807|12228609|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0
7780325|NCT00950807|12228610|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0
7780326|NCT00950807|12228611|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0
7780327|NCT00950807|12228612|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0
7780328|NCT00950807|12228613|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0
7780329|NCT00950807|12228614|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0
7780330|NCT00950807|12228615|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0
7780331|NCT00950807|12228616|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0
7780332|NCT00950807|12228617|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0
7615457|NCT01277211|12024442|FG000|Overall Study|Discontinued prior to treatment|24
7615458|NCT01277211|12024443|FG001|Overall Study|Discontinued prior to treatment|13
7615459|NCT01244828|12024453|FG000|Overall Study|Adverse Event|37
7615460|NCT01244828|12024453|FG000|Overall Study|Withdrawal by Subject|31
7615461|NCT01244828|12024453|FG000|Overall Study|Lack of Efficacy|7
7615462|NCT01244828|12024453|FG000|Overall Study|Lost to Follow-up|2
7615463|NCT01244828|12024453|FG000|Overall Study|Other reason (not specified)|1
7780333|NCT00950807|12228608|FG000|Treatment Period 2|Adverse Event|0
7780334|NCT00950807|12228609|FG001|Treatment Period 2|Adverse Event|1
7780335|NCT00950807|12228610|FG002|Treatment Period 2|Adverse Event|0
7615469|NCT01181778|12024461|FG000|Overall Study|Physician Decision|48
7615470|NCT01047540|12024472|FG000|Overall Study|Protocol Violation|1
7615471|NCT01047540|12024473|FG001|Overall Study|Protocol Violation|0
7615472|NCT01047540|12024474|FG002|Overall Study|Protocol Violation|0
7615473|NCT01047540|12024475|FG003|Overall Study|Protocol Violation|0
7615474|NCT01047540|12024476|FG004|Overall Study|Protocol Violation|0
7615475|NCT01047540|12024472|FG000|Overall Study|Lost to Follow-up|1
7615476|NCT01047540|12024473|FG001|Overall Study|Lost to Follow-up|0
7615477|NCT01047540|12024474|FG002|Overall Study|Lost to Follow-up|0
7615478|NCT01047540|12024475|FG003|Overall Study|Lost to Follow-up|0
7615479|NCT01047540|12024476|FG004|Overall Study|Lost to Follow-up|0
7615480|NCT01047540|12024472|FG000|Overall Study|Withdrawal by Subject|1
7615481|NCT01047540|12024473|FG001|Overall Study|Withdrawal by Subject|0
7615482|NCT01047540|12024474|FG002|Overall Study|Withdrawal by Subject|3
7615483|NCT01047540|12024475|FG003|Overall Study|Withdrawal by Subject|0
7615484|NCT01047540|12024476|FG004|Overall Study|Withdrawal by Subject|1
7615485|NCT01047540|12024472|FG000|Overall Study|Pregnancy|1
7615486|NCT01047540|12024473|FG001|Overall Study|Pregnancy|0
7615487|NCT01047540|12024474|FG002|Overall Study|Pregnancy|0
7615488|NCT01047540|12024475|FG003|Overall Study|Pregnancy|0
7615489|NCT01047540|12024476|FG004|Overall Study|Pregnancy|0
7615490|NCT01047540|12024472|FG000|Overall Study|Adverse Event|1
7615491|NCT01047540|12024473|FG001|Overall Study|Adverse Event|0
7780336|NCT00950807|12228611|FG003|Treatment Period 2|Adverse Event|1
7780337|NCT00950807|12228612|FG004|Treatment Period 2|Adverse Event|0
7780338|NCT00950807|12228613|FG005|Treatment Period 2|Adverse Event|1
7780339|NCT00950807|12228614|FG006|Treatment Period 2|Adverse Event|0
7780340|NCT00950807|12228615|FG007|Treatment Period 2|Adverse Event|1
7615492|NCT01047540|12024474|FG002|Overall Study|Adverse Event|0
7615493|NCT01047540|12024475|FG003|Overall Study|Adverse Event|0
7615494|NCT01047540|12024476|FG004|Overall Study|Adverse Event|0
7615495|NCT00778999|12024521|FG000|Overall Study|Discontinuation: no embryo transfer|14
7615496|NCT00778999|12024522|FG001|Overall Study|Discontinuation: no embryo transfer|14
7615497|NCT00778999|12024521|FG000|Overall Study|Did not receive recFSH|14
7615498|NCT00778999|12024522|FG001|Overall Study|Did not receive recFSH|20
7615499|NCT00620464|12024530|FG000|Overall Study|Adverse Event|15
7615500|NCT00620464|12024531|FG001|Overall Study|Adverse Event|17
7615501|NCT00620464|12024530|FG000|Overall Study|Lost to Follow-up|1
7615502|NCT00620464|12024531|FG001|Overall Study|Lost to Follow-up|1
7615503|NCT00620464|12024530|FG000|Overall Study|Planning Pregnancy|1
7615504|NCT00620464|12024531|FG001|Overall Study|Planning Pregnancy|4
7615505|NCT00620464|12024530|FG000|Overall Study|Personal|2
7615506|NCT00620464|12024531|FG001|Overall Study|Personal|2
7615507|NCT00620464|12024530|FG000|Overall Study|Used prohibited medication|1
7615508|NCT00620464|12024531|FG001|Overall Study|Used prohibited medication|0
7615509|NCT00620035|12024537|FG000|Overall Study|Adverse Event|106
7615510|NCT00620035|12024537|FG000|Overall Study|Withdrawal of Informed Consent|1
7615511|NCT00620035|12024537|FG000|Overall Study|Other Reason|38
7615512|NCT00210249|12024541|FG000|Overall Study|Lost to Follow-up|5
7615513|NCT00210249|12024541|FG000|Overall Study|Protocol Violation|11
7780341|NCT00950807|12228616|FG008|Treatment Period 2|Adverse Event|0
7780342|NCT00950807|12228617|FG009|Treatment Period 2|Adverse Event|0
7780343|NCT00950807|12228608|FG000|Washout Period 2|Lack of Efficacy|1
7780344|NCT00950807|12228609|FG001|Washout Period 2|Lack of Efficacy|0
7780345|NCT00950807|12228610|FG002|Washout Period 2|Lack of Efficacy|0
7780346|NCT00950807|12228611|FG003|Washout Period 2|Lack of Efficacy|0
7780347|NCT00950807|12228612|FG004|Washout Period 2|Lack of Efficacy|0
7780348|NCT00950807|12228613|FG005|Washout Period 2|Lack of Efficacy|0
7780349|NCT00950807|12228614|FG006|Washout Period 2|Lack of Efficacy|0
7780350|NCT00950807|12228615|FG007|Washout Period 2|Lack of Efficacy|0
7780351|NCT00950807|12228616|FG008|Washout Period 2|Lack of Efficacy|0
7780352|NCT00950807|12228617|FG009|Washout Period 2|Lack of Efficacy|0
7780353|NCT00950807|12228608|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0
7780354|NCT00950807|12228609|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1
7780355|NCT00950807|12228610|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0
7780356|NCT00950807|12228611|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0
7780357|NCT00950807|12228612|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1
7780358|NCT00950807|12228613|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0
7780359|NCT00950807|12228614|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1
7615524|NCT03626168|12024573|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1
7615525|NCT03626168|12024574|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0
7615526|NCT03626168|12024573|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0
7615527|NCT03626168|12024574|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1
7615528|NCT03626168|12024573|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0
7615529|NCT03626168|12024574|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2
7780360|NCT00950807|12228615|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1
7780361|NCT00950807|12228616|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0
7780362|NCT00950807|12228617|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0
7780363|NCT00950807|12228608|FG000|Washout Period 2|Adverse Event|3
7780364|NCT00950807|12228609|FG001|Washout Period 2|Adverse Event|0
7615536|NCT04579393|12024604|FG000|Overall Study|Withdrawal by Subject|2
7615537|NCT04579393|12024605|FG001|Overall Study|Withdrawal by Subject|2
7615538|NCT04579393|12024604|FG000|Overall Study|Death|1
7615539|NCT04579393|12024605|FG001|Overall Study|Death|3
7615540|NCT04325906|12024623|FG000|Overall Study|Withdrawal by Subject|2
7615541|NCT04325906|12024624|FG001|Overall Study|Withdrawal by Subject|0
7615542|NCT04203667|12024634|FG000|Overall Study|Withdrawal by Subject|1
7615543|NCT04203667|12024634|FG000|Overall Study|Lost to Follow-up|1
7615544|NCT04203667|12024634|FG000|Overall Study|Death|1
7615545|NCT04203667|12024634|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1
7615546|NCT03679884|12024648|FG000|Overall Study|Other|12
7615547|NCT03679884|12024649|FG001|Overall Study|Other|12
7615548|NCT03679884|12024650|FG002|Overall Study|Other|12
7615549|NCT03679884|12024651|FG003|Overall Study|Other|7
7615550|NCT03679884|12024652|FG004|Overall Study|Other|8
7615551|NCT03679884|12024648|FG000|Overall Study|Lack of Efficacy|15
7780365|NCT00950807|12228610|FG002|Washout Period 2|Adverse Event|0
7780366|NCT00950807|12228611|FG003|Washout Period 2|Adverse Event|1
7780367|NCT00950807|12228612|FG004|Washout Period 2|Adverse Event|0
7780368|NCT00950807|12228613|FG005|Washout Period 2|Adverse Event|0
7780369|NCT00950807|12228614|FG006|Washout Period 2|Adverse Event|0
7780370|NCT00950807|12228615|FG007|Washout Period 2|Adverse Event|0
7780371|NCT00950807|12228616|FG008|Washout Period 2|Adverse Event|0
7780372|NCT00950807|12228617|FG009|Washout Period 2|Adverse Event|0
7780373|NCT00950807|12228608|FG000|Treatment Period 3|Withdrawal by Subject|0
7615552|NCT03679884|12024649|FG001|Overall Study|Lack of Efficacy|29
7615553|NCT03679884|12024650|FG002|Overall Study|Lack of Efficacy|13
7615554|NCT03679884|12024651|FG003|Overall Study|Lack of Efficacy|29
7615555|NCT03679884|12024652|FG004|Overall Study|Lack of Efficacy|10
7615556|NCT03679884|12024648|FG000|Overall Study|Death|1
7615557|NCT03679884|12024649|FG001|Overall Study|Death|0
7615558|NCT03679884|12024650|FG002|Overall Study|Death|0
7615559|NCT03679884|12024651|FG003|Overall Study|Death|0
7615560|NCT03679884|12024652|FG004|Overall Study|Death|0
7615561|NCT03679884|12024648|FG000|Overall Study|Adverse Event|2
7615562|NCT03679884|12024649|FG001|Overall Study|Adverse Event|10
7615563|NCT03679884|12024650|FG002|Overall Study|Adverse Event|9
7615564|NCT03679884|12024651|FG003|Overall Study|Adverse Event|6
7615565|NCT03679884|12024652|FG004|Overall Study|Adverse Event|6
7615566|NCT03679884|12024648|FG000|Overall Study|Withdrawal by Subject|12
7615567|NCT03679884|12024649|FG001|Overall Study|Withdrawal by Subject|23
7615568|NCT03679884|12024650|FG002|Overall Study|Withdrawal by Subject|8
7615569|NCT03679884|12024651|FG003|Overall Study|Withdrawal by Subject|8
7615570|NCT03679884|12024652|FG004|Overall Study|Withdrawal by Subject|9
7615571|NCT03679884|12024648|FG000|Overall Study|Lost to Follow-up|1
7615572|NCT03679884|12024649|FG001|Overall Study|Lost to Follow-up|4
7615573|NCT03679884|12024650|FG002|Overall Study|Lost to Follow-up|2
7615574|NCT03679884|12024651|FG003|Overall Study|Lost to Follow-up|0
7615575|NCT03679884|12024652|FG004|Overall Study|Lost to Follow-up|3
7615576|NCT03653026|12024666|FG000|Part 1: Placebo-controlled Period|Adverse Event|5
7615577|NCT03653026|12024667|FG001|Part 1: Placebo-controlled Period|Adverse Event|6
7615578|NCT03653026|12024668|FG002|Part 1: Placebo-controlled Period|Adverse Event|0
7615579|NCT03653026|12024669|FG003|Part 1: Placebo-controlled Period|Adverse Event|0
7615580|NCT03653026|12024666|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6
7615581|NCT03653026|12024667|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4
7615582|NCT03653026|12024668|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0
7615583|NCT03653026|12024669|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0
7615584|NCT03653026|12024666|FG000|Part 1: Placebo-controlled Period|Other|0
7615585|NCT03653026|12024667|FG001|Part 1: Placebo-controlled Period|Other|3
7615586|NCT03653026|12024668|FG002|Part 1: Placebo-controlled Period|Other|0
7615587|NCT03653026|12024669|FG003|Part 1: Placebo-controlled Period|Other|0
7615588|NCT03653026|12024666|FG000|Part 2: Open-label Extension|Adverse Event|0
7615589|NCT03653026|12024667|FG001|Part 2: Open-label Extension|Adverse Event|0
7615590|NCT03653026|12024668|FG002|Part 2: Open-label Extension|Adverse Event|1
7615591|NCT03653026|12024669|FG003|Part 2: Open-label Extension|Adverse Event|1
7615592|NCT03653026|12024666|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0
7615593|NCT03653026|12024667|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0
7615594|NCT03653026|12024668|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1
7615595|NCT03653026|12024669|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2
7615596|NCT03653026|12024666|FG000|Part 2: Open-label Extension|Other|0
7615597|NCT03653026|12024667|FG001|Part 2: Open-label Extension|Other|0
7615598|NCT03653026|12024668|FG002|Part 2: Open-label Extension|Other|1
7615599|NCT03653026|12024669|FG003|Part 2: Open-label Extension|Other|2
7615600|NCT03553498|12024683|FG000|Overall Study|Missing primary outcome|1
7615601|NCT03553498|12024684|FG001|Overall Study|Missing primary outcome|2
7615602|NCT03530293|12024692|FG000|Pre-randomization|Adverse Event|12
7615603|NCT03530293|12024693|FG001|Pre-randomization|Adverse Event|0
7615604|NCT03530293|12024694|FG002|Pre-randomization|Adverse Event|0
7615605|NCT03530293|12024692|FG000|Pre-randomization|Protocol Violation|2
7615606|NCT03530293|12024693|FG001|Pre-randomization|Protocol Violation|0
7615607|NCT03530293|12024694|FG002|Pre-randomization|Protocol Violation|0
7615608|NCT03530293|12024692|FG000|Pre-randomization|Study Terminated by Sponsor|5
7615609|NCT03530293|12024693|FG001|Pre-randomization|Study Terminated by Sponsor|0
7615610|NCT03530293|12024694|FG002|Pre-randomization|Study Terminated by Sponsor|0
7615611|NCT03530293|12024692|FG000|Pre-randomization|Withdrawal by Subject|5
7615612|NCT03530293|12024693|FG001|Pre-randomization|Withdrawal by Subject|0
7615613|NCT03530293|12024694|FG002|Pre-randomization|Withdrawal by Subject|0
7615614|NCT03530293|12024692|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0
7615615|NCT03530293|12024693|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2
7615616|NCT03530293|12024694|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4
7615617|NCT03530293|12024692|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0
7615618|NCT03530293|12024693|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0
7615619|NCT03530293|12024694|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1
7615620|NCT03530293|12024692|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0
7615621|NCT03530293|12024693|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3
7615622|NCT03530293|12024694|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2
7615623|NCT03530293|12024692|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0
7615624|NCT03530293|12024693|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2
7615625|NCT03530293|12024694|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0
7615626|NCT03530293|12024692|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0
7615627|NCT03530293|12024693|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10
7615628|NCT03530293|12024694|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10
7615629|NCT03505749|12024703|FG000|Overall Study|Lost to Follow-up|7
7615630|NCT03505749|12024704|FG001|Overall Study|Lost to Follow-up|11
7615631|NCT03505749|12024703|FG000|Overall Study|Withdrawal by Subject|6
7615632|NCT03505749|12024704|FG001|Overall Study|Withdrawal by Subject|0
7615633|NCT03505749|12024703|FG000|Overall Study|Discharged from treatment|3
7615634|NCT03505749|12024704|FG001|Overall Study|Discharged from treatment|6
7780374|NCT00950807|12228609|FG001|Treatment Period 3|Withdrawal by Subject|0
7615636|NCT03249376|12024728|FG000|Overall Study|Adverse Event|11
7615637|NCT03249376|12024729|FG001|Overall Study|Adverse Event|5
7615638|NCT03249376|12024728|FG000|Overall Study|Lack of Efficacy|2
7615639|NCT03249376|12024729|FG001|Overall Study|Lack of Efficacy|4
7615640|NCT03249376|12024728|FG000|Overall Study|Protocol Violation|3
7615641|NCT03249376|12024729|FG001|Overall Study|Protocol Violation|2
7615642|NCT03249376|12024728|FG000|Overall Study|Physician Decision|0
7615643|NCT03249376|12024729|FG001|Overall Study|Physician Decision|2
7615644|NCT03249376|12024728|FG000|Overall Study|Withdrawal by Subject|3
7615645|NCT03249376|12024729|FG001|Overall Study|Withdrawal by Subject|9
7615646|NCT03249376|12024728|FG000|Overall Study|LTFU|2
7615647|NCT03249376|12024729|FG001|Overall Study|LTFU|1
7780375|NCT00950807|12228610|FG002|Treatment Period 3|Withdrawal by Subject|0
7780376|NCT00950807|12228611|FG003|Treatment Period 3|Withdrawal by Subject|0
7780377|NCT00950807|12228612|FG004|Treatment Period 3|Withdrawal by Subject|0
7780378|NCT00950807|12228613|FG005|Treatment Period 3|Withdrawal by Subject|0
7780379|NCT00950807|12228614|FG006|Treatment Period 3|Withdrawal by Subject|0
7780380|NCT00950807|12228615|FG007|Treatment Period 3|Withdrawal by Subject|0
7780381|NCT00950807|12228616|FG008|Treatment Period 3|Withdrawal by Subject|0
7780382|NCT00950807|12228617|FG009|Treatment Period 3|Withdrawal by Subject|1
7780383|NCT00950807|12228608|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1
7780384|NCT00950807|12228609|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0
7780385|NCT00950807|12228610|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0
7780386|NCT00950807|12228611|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0
7615648|NCT03137381|12024739|FG000|Overall Study|Adverse Event|3
7615649|NCT03137381|12024740|FG001|Overall Study|Adverse Event|0
7615650|NCT03137381|12024741|FG002|Overall Study|Adverse Event|2
7615651|NCT03137381|12024742|FG003|Overall Study|Adverse Event|0
7615652|NCT03137381|12024739|FG000|Overall Study|Lost to Follow-up|2
7615653|NCT03137381|12024740|FG001|Overall Study|Lost to Follow-up|1
7615654|NCT03137381|12024741|FG002|Overall Study|Lost to Follow-up|1
7780387|NCT00950807|12228612|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0
7780388|NCT00950807|12228613|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0
7780389|NCT00950807|12228614|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0
7780390|NCT00950807|12228615|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1
7780391|NCT00950807|12228616|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0
7780392|NCT00950807|12228617|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0
7780393|NCT00950807|12228608|FG000|Treatment Period 3|Adverse Event|0
7780394|NCT00950807|12228609|FG001|Treatment Period 3|Adverse Event|0
7780395|NCT00950807|12228610|FG002|Treatment Period 3|Adverse Event|0
7780396|NCT00950807|12228611|FG003|Treatment Period 3|Adverse Event|0
7780397|NCT00950807|12228612|FG004|Treatment Period 3|Adverse Event|0
7780398|NCT00950807|12228613|FG005|Treatment Period 3|Adverse Event|0
7780399|NCT00950807|12228614|FG006|Treatment Period 3|Adverse Event|1
7780400|NCT00950807|12228615|FG007|Treatment Period 3|Adverse Event|0
7780401|NCT00950807|12228616|FG008|Treatment Period 3|Adverse Event|0
7780402|NCT00950807|12228617|FG009|Treatment Period 3|Adverse Event|0
7780403|NCT00950859|12228656|FG000|Overall Study|Adverse Event|3
7780404|NCT00950859|12228657|FG001|Overall Study|Adverse Event|3
7780405|NCT00950859|12228656|FG000|Overall Study|Insufficient Viral Load Response|12
7780406|NCT00950859|12228657|FG001|Overall Study|Insufficient Viral Load Response|3
7780407|NCT00950859|12228656|FG000|Overall Study|Protocol Violation|1
7780408|NCT00950859|12228657|FG001|Overall Study|Protocol Violation|1
7780409|NCT00950859|12228656|FG000|Overall Study|Lost to Follow-up|0
7780410|NCT00950859|12228657|FG001|Overall Study|Lost to Follow-up|3
7780411|NCT00950872|12228663|FG000|Overall Study|Withdrawal by Subject|1
7780412|NCT00950872|12228663|FG000|Overall Study|Did not have surgery|2
7780413|NCT00950911|12228669|FG000|Overall Study|Adverse Event|0
7780414|NCT00950911|12228670|FG001|Overall Study|Adverse Event|2
7780415|NCT00950911|12228669|FG000|Overall Study|Death|4
7615655|NCT03137381|12024742|FG003|Overall Study|Lost to Follow-up|0
7615656|NCT03137381|12024739|FG000|Overall Study|Protocol deviation|1
7615657|NCT03137381|12024740|FG001|Overall Study|Protocol deviation|1
7615658|NCT03137381|12024741|FG002|Overall Study|Protocol deviation|0
7615659|NCT03137381|12024742|FG003|Overall Study|Protocol deviation|1
7615660|NCT03137381|12024739|FG000|Overall Study|Withdrawal by Investigator|0
7615661|NCT03137381|12024740|FG001|Overall Study|Withdrawal by Investigator|1
7615662|NCT03137381|12024741|FG002|Overall Study|Withdrawal by Investigator|1
7615663|NCT03137381|12024742|FG003|Overall Study|Withdrawal by Investigator|0
7615664|NCT03137381|12024739|FG000|Overall Study|Withdrawal by Subject|3
7615665|NCT03137381|12024740|FG001|Overall Study|Withdrawal by Subject|4
7615666|NCT03137381|12024741|FG002|Overall Study|Withdrawal by Subject|3
7615667|NCT03137381|12024742|FG003|Overall Study|Withdrawal by Subject|0
7615668|NCT03137381|12024739|FG000|Overall Study|Pregnancy|0
7615669|NCT03137381|12024740|FG001|Overall Study|Pregnancy|0
7615670|NCT03137381|12024741|FG002|Overall Study|Pregnancy|1
7615671|NCT03137381|12024742|FG003|Overall Study|Pregnancy|0
7615672|NCT03118570|12024757|FG000|Overall Study|Adverse Event|2
7615673|NCT03118570|12024758|FG001|Overall Study|Adverse Event|0
7615674|NCT03118570|12024759|FG002|Overall Study|Adverse Event|0
7615675|NCT03118570|12024760|FG003|Overall Study|Adverse Event|0
7615676|NCT03118570|12024761|FG004|Overall Study|Adverse Event|3
7615677|NCT03118570|12024757|FG000|Overall Study|Withdrawal by Subject|0
7615678|NCT03118570|12024758|FG001|Overall Study|Withdrawal by Subject|1
7615679|NCT03118570|12024759|FG002|Overall Study|Withdrawal by Subject|4
7615680|NCT03118570|12024760|FG003|Overall Study|Withdrawal by Subject|0
7615681|NCT03118570|12024761|FG004|Overall Study|Withdrawal by Subject|1
7615682|NCT03118570|12024757|FG000|Overall Study|Lost to Follow-up|2
7615683|NCT03118570|12024758|FG001|Overall Study|Lost to Follow-up|3
7615684|NCT03118570|12024759|FG002|Overall Study|Lost to Follow-up|1
7615685|NCT03118570|12024760|FG003|Overall Study|Lost to Follow-up|0
7615686|NCT03118570|12024761|FG004|Overall Study|Lost to Follow-up|1
7615687|NCT03118570|12024757|FG000|Overall Study|Other, Not Specified|1
7615688|NCT03118570|12024758|FG001|Overall Study|Other, Not Specified|3
7615689|NCT03118570|12024759|FG002|Overall Study|Other, Not Specified|0
7780416|NCT00950911|12228670|FG001|Overall Study|Death|6
7615690|NCT03118570|12024760|FG003|Overall Study|Other, Not Specified|0
7615691|NCT03118570|12024761|FG004|Overall Study|Other, Not Specified|0
7615692|NCT03094416|12024774|FG000|Run-in|Screening failure|8
7615693|NCT03094416|12024774|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8
7615694|NCT03094416|12024774|FG000|Run-in|Withdrawal by Subject|3
7615695|NCT03094416|12024774|FG000|Treatment Period|Withdrawal by Subject|2
7615696|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25
7615697|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19
7615698|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0
7615699|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0
7615700|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Withdrew consent|14
7615701|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Withdrew consent|18
7615702|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Withdrew consent|0
7615703|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Withdrew consent|0
7615704|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6
7615705|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3
7615706|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0
7615707|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0
7615708|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3
7615709|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5
7615710|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0
7615711|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0
7615712|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Protocol Violation|2
7615713|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Protocol Violation|3
7615714|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Protocol Violation|0
7615715|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Protocol Violation|0
7615716|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Adverse Event|0
7615717|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Adverse Event|4
7615718|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Adverse Event|0
7615719|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Adverse Event|0
7615720|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Death|2
7615721|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Death|1
7615722|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Death|0
7615723|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Death|0
7615724|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2
7615725|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0
7615800|NCT00909610|12025017|FG001|Period: First Intervention|Adverse Event|1
7615726|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0
7615727|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0
7615728|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0
7615729|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0
7615730|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15
7615731|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10
7615732|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0
7615733|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0
7615734|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10
7615735|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13
7615736|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0
7615737|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0
7615738|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2
7615739|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5
7615740|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0
7615741|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0
7615742|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4
7615743|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2
7615744|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0
7615745|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0
7615746|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1
7615747|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1
7615748|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0
7615749|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0
7615750|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1
7615751|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1
7615752|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Death|0
7615753|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Death|0
7615754|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Death|0
7615755|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Death|1
7615756|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0
7615757|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0
7615758|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1
7615759|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0
7780417|NCT00950911|12228669|FG000|Overall Study|Disease progression|2
7780418|NCT00950911|12228670|FG001|Overall Study|Disease progression|2
7780419|NCT00950911|12228669|FG000|Overall Study|Consent withdrawn|1
7780420|NCT00950911|12228670|FG001|Overall Study|Consent withdrawn|3
7780421|NCT00950911|12228669|FG000|Overall Study|Administrative decision|3
7780422|NCT00950911|12228670|FG001|Overall Study|Administrative decision|1
7780423|NCT00950911|12228669|FG000|Overall Study|Ineligibility determined|1
7780424|NCT00950911|12228670|FG001|Overall Study|Ineligibility determined|0
7780425|NCT00950911|12228669|FG000|Overall Study|Noncompliance|1
7780426|NCT00950911|12228670|FG001|Overall Study|Noncompliance|0
7780427|NCT00950911|12228669|FG000|Overall Study|Poor performance status|0
7780428|NCT00950911|12228670|FG001|Overall Study|Poor performance status|1
7780429|NCT00950950|12228678|FG000|Overall Study|Adverse Event|1
7780430|NCT00950950|12228679|FG001|Overall Study|Adverse Event|0
7780431|NCT00950950|12228678|FG000|Overall Study|Withdrawal by Subject|0
7780432|NCT00950950|12228679|FG001|Overall Study|Withdrawal by Subject|1
7780433|NCT00950963|12228688|FG000|Overall Study|Lost to Follow-up|29
7780434|NCT00950963|12228689|FG001|Overall Study|Lost to Follow-up|24
7780435|NCT00951015|12228699|FG000|Randomization Phase 96 Week|Adverse Event|1
7780436|NCT00951015|12228700|FG001|Randomization Phase 96 Week|Adverse Event|1
7780437|NCT00951015|12228701|FG002|Randomization Phase 96 Week|Adverse Event|2
7780438|NCT00951015|12228702|FG003|Randomization Phase 96 Week|Adverse Event|5
7780439|NCT00951015|12228703|FG004|Randomization Phase 96 Week|Adverse Event|0
7780440|NCT00951015|12228699|FG000|Randomization Phase 96 Week|Lack of Efficacy|1
7615781|NCT02476201|12024852|FG000|Overall Study|Unable to program MPP|9
7615782|NCT02476201|12024852|FG000|Overall Study|Study echo not performed|5
7615783|NCT02476201|12024852|FG000|Overall Study|Adverse Event|4
7615784|NCT02476201|12024852|FG000|Overall Study|Death|2
7615785|NCT02476201|12024852|FG000|Overall Study|Lost to Follow-up|2
7615786|NCT02476201|12024852|FG000|Overall Study|MPP programmed to OFF|2
7615787|NCT02476201|12024852|FG000|Overall Study|Withdrawal by Subject|1
7615788|NCT02476201|12024852|FG000|Overall Study|Unsuccessful implant|1
7615789|NCT01399658|12024857|FG000|Overall Study|Ineligible|1
7615790|NCT01399658|12024857|FG000|Overall Study|Machine Technical Issue|3
7615791|NCT01399658|12024857|FG000|Overall Study|Standard of Care better than protocol therapy|1
7615792|NCT01399658|12024857|FG000|Overall Study|No reason given|1
7615793|NCT00919893|12024962|FG000|Overall Study|Protocol Violation|19
7615794|NCT00919893|12024963|FG001|Overall Study|Protocol Violation|9
7615795|NCT00909753|12025002|FG000|Period: Washout of 28 Days|Protocol Violation|2
7615796|NCT00909753|12025003|FG001|Period: Washout of 28 Days|Protocol Violation|3
7615797|NCT00909753|12025002|FG000|Period: Second Intervention|Protocol Violation|1
7615798|NCT00909753|12025003|FG001|Period: Second Intervention|Protocol Violation|0
7615799|NCT00909610|12025016|FG000|Period: First Intervention|Adverse Event|0
7615801|NCT00909610|12025016|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3
7615802|NCT00909610|12025017|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6
7615803|NCT00909610|12025016|FG000|Period: Second Intervention|Adverse Event|1
7615804|NCT00909610|12025017|FG001|Period: Second Intervention|Adverse Event|0
7615805|NCT00905606|12025045|FG000|Period 1|Adverse Event|0
7615806|NCT00905606|12025046|FG001|Period 1|Adverse Event|1
7615807|NCT00905606|12025045|FG000|Washout|Withdrawal by Subject|1
7615808|NCT00905606|12025046|FG001|Washout|Withdrawal by Subject|0
7615809|NCT00905567|12025052|FG000|Washout|Withdrawal by Subject|0
7615810|NCT00905567|12025053|FG001|Washout|Withdrawal by Subject|1
7615811|NCT00905346|12025059|FG000|Period 1|Withdrawal by Subject|1
7615812|NCT00905346|12025060|FG001|Period 1|Withdrawal by Subject|0
7615813|NCT00905164|12025066|FG000|Period 1|Protocol Violation|0
7615814|NCT00905164|12025067|FG001|Period 1|Protocol Violation|1
7615815|NCT00890591|12025078|FG000|Overall Study|Lack of Efficacy|20
7615816|NCT00890409|12025086|FG000|Overall Study|Lost to Follow-up|20
7615817|NCT00890409|12025087|FG001|Overall Study|Lost to Follow-up|21
7780441|NCT00951015|12228700|FG001|Randomization Phase 96 Week|Lack of Efficacy|1
7780442|NCT00951015|12228701|FG002|Randomization Phase 96 Week|Lack of Efficacy|0
7780443|NCT00951015|12228702|FG003|Randomization Phase 96 Week|Lack of Efficacy|0
7780444|NCT00951015|12228703|FG004|Randomization Phase 96 Week|Lack of Efficacy|0
7780445|NCT00951015|12228699|FG000|Randomization Phase 96 Week|Protocol Violation|1
7780446|NCT00951015|12228700|FG001|Randomization Phase 96 Week|Protocol Violation|1
7780447|NCT00951015|12228701|FG002|Randomization Phase 96 Week|Protocol Violation|1
7780448|NCT00951015|12228702|FG003|Randomization Phase 96 Week|Protocol Violation|0
7780449|NCT00951015|12228703|FG004|Randomization Phase 96 Week|Protocol Violation|0
7780450|NCT00951015|12228699|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
7780451|NCT00951015|12228700|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
7780452|NCT00951015|12228701|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
7780453|NCT00951015|12228702|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
7780454|NCT00951015|12228703|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
7780455|NCT00951015|12228699|FG000|Randomization Phase 96 Week|Lost to Follow-up|0
7780456|NCT00951015|12228700|FG001|Randomization Phase 96 Week|Lost to Follow-up|3
7780457|NCT00951015|12228701|FG002|Randomization Phase 96 Week|Lost to Follow-up|1
7615818|NCT00888355|12025095|FG000|Overall Study|Adverse Event|10
7615819|NCT00888355|12025096|FG001|Overall Study|Adverse Event|0
7615820|NCT00888355|12025097|FG002|Overall Study|Adverse Event|3
7615821|NCT00888355|12025098|FG003|Overall Study|Adverse Event|3
7615822|NCT00888355|12025095|FG000|Overall Study|Lack of Efficacy|9
7615823|NCT00888355|12025096|FG001|Overall Study|Lack of Efficacy|2
7615824|NCT00888355|12025097|FG002|Overall Study|Lack of Efficacy|5
7615825|NCT00888355|12025098|FG003|Overall Study|Lack of Efficacy|2
7615826|NCT00888355|12025095|FG000|Overall Study|Lost to Follow-up|0
7615827|NCT00888355|12025096|FG001|Overall Study|Lost to Follow-up|2
7615828|NCT00888355|12025097|FG002|Overall Study|Lost to Follow-up|2
7615829|NCT00888355|12025098|FG003|Overall Study|Lost to Follow-up|0
7615830|NCT00888355|12025095|FG000|Overall Study|Protocol Violation|3
7615831|NCT00888355|12025096|FG001|Overall Study|Protocol Violation|2
7615832|NCT00888355|12025097|FG002|Overall Study|Protocol Violation|1
7615833|NCT00888355|12025098|FG003|Overall Study|Protocol Violation|2
7615834|NCT00888355|12025095|FG000|Overall Study|Withdrawal by Subject|0
7615835|NCT00888355|12025096|FG001|Overall Study|Withdrawal by Subject|3
7615836|NCT00888355|12025097|FG002|Overall Study|Withdrawal by Subject|1
7615837|NCT00888355|12025098|FG003|Overall Study|Withdrawal by Subject|3
7615838|NCT00887250|12025107|FG000|Overall Study|Adverse Event|3
7615839|NCT00887250|12025108|FG001|Overall Study|Adverse Event|0
7615840|NCT00887250|12025109|FG002|Overall Study|Adverse Event|7
7615841|NCT00887250|12025107|FG000|Overall Study|Lack of Efficacy|9
7615842|NCT00887250|12025108|FG001|Overall Study|Lack of Efficacy|6
7615843|NCT00887250|12025109|FG002|Overall Study|Lack of Efficacy|1
7615844|NCT00887250|12025107|FG000|Overall Study|Lost to Follow-up|2
7615845|NCT00887250|12025108|FG001|Overall Study|Lost to Follow-up|3
7615846|NCT00887250|12025109|FG002|Overall Study|Lost to Follow-up|1
7615847|NCT00887250|12025107|FG000|Overall Study|Protocol Violation|2
7615848|NCT00887250|12025108|FG001|Overall Study|Protocol Violation|2
7615849|NCT00887250|12025109|FG002|Overall Study|Protocol Violation|1
7615850|NCT00887250|12025107|FG000|Overall Study|Withdrawal by Subject|2
7615851|NCT00887250|12025108|FG001|Overall Study|Withdrawal by Subject|1
7780458|NCT00951015|12228702|FG003|Randomization Phase 96 Week|Lost to Follow-up|2
7780459|NCT00951015|12228703|FG004|Randomization Phase 96 Week|Lost to Follow-up|0
7780460|NCT00951015|12228699|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2
7780461|NCT00951015|12228700|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1
7780462|NCT00951015|12228701|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1
7780463|NCT00951015|12228702|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2
7780464|NCT00951015|12228703|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0
7780465|NCT00951015|12228699|FG000|Open-label Phase|Adverse Event|0
7780466|NCT00951015|12228700|FG001|Open-label Phase|Adverse Event|0
7780467|NCT00951015|12228701|FG002|Open-label Phase|Adverse Event|0
7780468|NCT00951015|12228702|FG003|Open-label Phase|Adverse Event|0
7780469|NCT00951015|12228703|FG004|Open-label Phase|Adverse Event|3
7780470|NCT00951015|12228699|FG000|Open-label Phase|Lack of Efficacy|0
7780471|NCT00951015|12228700|FG001|Open-label Phase|Lack of Efficacy|0
7780472|NCT00951015|12228701|FG002|Open-label Phase|Lack of Efficacy|0
7780473|NCT00951015|12228702|FG003|Open-label Phase|Lack of Efficacy|0
7780474|NCT00951015|12228703|FG004|Open-label Phase|Lack of Efficacy|1
7780475|NCT00951015|12228699|FG000|Open-label Phase|Protocol Violation|0
7780476|NCT00951015|12228700|FG001|Open-label Phase|Protocol Violation|0
7780477|NCT00951015|12228701|FG002|Open-label Phase|Protocol Violation|0
7780478|NCT00951015|12228702|FG003|Open-label Phase|Protocol Violation|0
7780479|NCT00951015|12228703|FG004|Open-label Phase|Protocol Violation|12
7780480|NCT00951015|12228699|FG000|Open-label Phase|Lost to Follow-up|0
7780481|NCT00951015|12228700|FG001|Open-label Phase|Lost to Follow-up|0
7780482|NCT00951015|12228701|FG002|Open-label Phase|Lost to Follow-up|0
7615852|NCT00887250|12025109|FG002|Overall Study|Withdrawal by Subject|2
7615853|NCT00887250|12025107|FG000|Overall Study|Patient uncooperative|0
7615854|NCT00887250|12025108|FG001|Overall Study|Patient uncooperative|0
7615855|NCT00887250|12025109|FG002|Overall Study|Patient uncooperative|1
7615856|NCT00886600|12025118|FG000|Double-blind Monotherapy|Adverse Event|1
7615857|NCT00886600|12025119|FG001|Double-blind Monotherapy|Adverse Event|1
7615858|NCT00886600|12025120|FG002|Double-blind Monotherapy|Adverse Event|1
7615859|NCT00886600|12025121|FG003|Double-blind Monotherapy|Adverse Event|1
7615860|NCT00886600|12025118|FG000|Double-blind Monotherapy|Protocol Violation|0
7615861|NCT00886600|12025119|FG001|Double-blind Monotherapy|Protocol Violation|0
7615862|NCT00886600|12025120|FG002|Double-blind Monotherapy|Protocol Violation|0
7615863|NCT00886600|12025121|FG003|Double-blind Monotherapy|Protocol Violation|1
7615864|NCT00886600|12025118|FG000|Double-blind Monotherapy|Withdrawal by Subject|1
7615865|NCT00886600|12025119|FG001|Double-blind Monotherapy|Withdrawal by Subject|0
7615866|NCT00886600|12025120|FG002|Double-blind Monotherapy|Withdrawal by Subject|0
7615867|NCT00886600|12025121|FG003|Double-blind Monotherapy|Withdrawal by Subject|0
7615868|NCT00886600|12025118|FG000|Combination Therapy Period|Adverse Event|0
7615869|NCT00886600|12025119|FG001|Combination Therapy Period|Adverse Event|0
7615870|NCT00886600|12025120|FG002|Combination Therapy Period|Adverse Event|1
7615871|NCT00886600|12025121|FG003|Combination Therapy Period|Adverse Event|0
7615872|NCT00886600|12025118|FG000|Combination Therapy Period|Protocol Violation|0
7615873|NCT00886600|12025119|FG001|Combination Therapy Period|Protocol Violation|0
7615874|NCT00886600|12025120|FG002|Combination Therapy Period|Protocol Violation|1
7615875|NCT00886600|12025121|FG003|Combination Therapy Period|Protocol Violation|0
7615876|NCT00882440|12025134|FG000|Overall Study|Adverse Event|2
7615877|NCT00882440|12025135|FG001|Overall Study|Adverse Event|2
7615878|NCT00882440|12025136|FG002|Overall Study|Adverse Event|2
7780483|NCT00951015|12228702|FG003|Open-label Phase|Lost to Follow-up|0
7780484|NCT00951015|12228703|FG004|Open-label Phase|Lost to Follow-up|12
7780485|NCT00951015|12228699|FG000|Open-label Phase|Withdrawal by Subject|0
7780486|NCT00951015|12228700|FG001|Open-label Phase|Withdrawal by Subject|0
7780487|NCT00951015|12228701|FG002|Open-label Phase|Withdrawal by Subject|0
7780488|NCT00951015|12228702|FG003|Open-label Phase|Withdrawal by Subject|0
7780489|NCT00951015|12228703|FG004|Open-label Phase|Withdrawal by Subject|14
7780490|NCT00951015|12228699|FG000|Open-label Phase|Physician Decision|0
7780491|NCT00951015|12228700|FG001|Open-label Phase|Physician Decision|0
7780492|NCT00951015|12228701|FG002|Open-label Phase|Physician Decision|0
7780493|NCT00951015|12228702|FG003|Open-label Phase|Physician Decision|0
7780494|NCT00951015|12228703|FG004|Open-label Phase|Physician Decision|8
7780495|NCT00951041|12228728|FG000|Overall Study|Withdrawal by Subject|1
7780496|NCT00951041|12228729|FG001|Overall Study|Withdrawal by Subject|1
7780497|NCT00951041|12228728|FG000|Overall Study|Lost to Follow-up|1
7780498|NCT00951041|12228729|FG001|Overall Study|Lost to Follow-up|0
7780499|NCT00951041|12228728|FG000|Overall Study|Other|3
7780500|NCT00951041|12228729|FG001|Overall Study|Other|0
7780501|NCT00951171|12228744|FG000|Overall Study|Adverse Event|2
7780502|NCT00951171|12228745|FG001|Overall Study|Adverse Event|0
7780503|NCT00951275|12228751|FG000|Overall Study|Administrative Reason|1
7780504|NCT00951275|12228751|FG000|Overall Study|Adverse Event|7
7780505|NCT00951275|12228751|FG000|Overall Study|Withdrawal by Subject|4
7780506|NCT00951275|12228751|FG000|Overall Study|Protocol Violation|1
7780507|NCT00951379|12228757|FG000|Overall Study|Adverse Event|4
7780508|NCT00951379|12228758|FG001|Overall Study|Adverse Event|1
7780509|NCT00951379|12228757|FG000|Overall Study|Withdrawal by Subject|1
7780510|NCT00951379|12228758|FG001|Overall Study|Withdrawal by Subject|0
7780511|NCT00951379|12228757|FG000|Overall Study|Noncompliance|1
7780512|NCT00951379|12228758|FG001|Overall Study|Noncompliance|0
7780513|NCT00951379|12228757|FG000|Overall Study|Disease Progression|0
7780514|NCT00951379|12228758|FG001|Overall Study|Disease Progression|1
7780515|NCT00951483|12228774|FG000|Overall Study|Physician Decision|4
7780516|NCT00951483|12228775|FG001|Overall Study|Physician Decision|0
7780517|NCT00951483|12228774|FG000|Overall Study|Withdrawal by Subject|15
7780518|NCT00951483|12228775|FG001|Overall Study|Withdrawal by Subject|0
7780519|NCT00951496|12228786|FG000|Overall Study|Did not initiate study treatment|10
7780520|NCT00951496|12228787|FG001|Overall Study|Did not initiate study treatment|8
7780521|NCT00951496|12228788|FG002|Overall Study|Did not initiate study treatment|13
7780522|NCT00951509|12228799|FG000|Overall Study|Withdrawal by Subject|2
7780523|NCT00951665|12228821|FG000|Phase 1b|Adverse Event|2
7780524|NCT00951665|12228822|FG001|Phase 1b|Adverse Event|1
7780525|NCT00951665|12228823|FG002|Phase 1b|Adverse Event|0
7780526|NCT00951665|12228824|FG003|Phase 1b|Adverse Event|1
7780527|NCT00951665|12228825|FG004|Phase 1b|Adverse Event|0
7780528|NCT00951665|12228826|FG005|Phase 1b|Adverse Event|0
7615879|NCT00882440|12025137|FG003|Overall Study|Adverse Event|1
7615880|NCT00882440|12025138|FG004|Overall Study|Adverse Event|1
7615881|NCT00882440|12025139|FG005|Overall Study|Adverse Event|4
7615882|NCT00882440|12025140|FG006|Overall Study|Adverse Event|2
7615883|NCT00882440|12025134|FG000|Overall Study|Lack of Efficacy|3
7615884|NCT00882440|12025135|FG001|Overall Study|Lack of Efficacy|5
7615885|NCT00882440|12025136|FG002|Overall Study|Lack of Efficacy|2
7615886|NCT00882440|12025137|FG003|Overall Study|Lack of Efficacy|0
7615887|NCT00882440|12025138|FG004|Overall Study|Lack of Efficacy|0
7615888|NCT00882440|12025139|FG005|Overall Study|Lack of Efficacy|3
7615889|NCT00882440|12025140|FG006|Overall Study|Lack of Efficacy|0
7615890|NCT00882440|12025134|FG000|Overall Study|Lost to Follow-up|2
7615891|NCT00882440|12025135|FG001|Overall Study|Lost to Follow-up|0
7615892|NCT00882440|12025136|FG002|Overall Study|Lost to Follow-up|1
7615893|NCT00882440|12025137|FG003|Overall Study|Lost to Follow-up|1
7615894|NCT00882440|12025138|FG004|Overall Study|Lost to Follow-up|1
7615895|NCT00882440|12025139|FG005|Overall Study|Lost to Follow-up|0
7615896|NCT00882440|12025140|FG006|Overall Study|Lost to Follow-up|1
7615897|NCT00882440|12025134|FG000|Overall Study|Protocol Violation|0
7615898|NCT00882440|12025135|FG001|Overall Study|Protocol Violation|0
7615899|NCT00882440|12025136|FG002|Overall Study|Protocol Violation|1
7615900|NCT00882440|12025137|FG003|Overall Study|Protocol Violation|1
7615901|NCT00882440|12025138|FG004|Overall Study|Protocol Violation|1
7615902|NCT00882440|12025139|FG005|Overall Study|Protocol Violation|0
7615903|NCT00882440|12025140|FG006|Overall Study|Protocol Violation|0
7615904|NCT00882440|12025134|FG000|Overall Study|Withdrawal by Subject|2
7615905|NCT00882440|12025135|FG001|Overall Study|Withdrawal by Subject|1
7615906|NCT00882440|12025136|FG002|Overall Study|Withdrawal by Subject|1
7615907|NCT00882440|12025137|FG003|Overall Study|Withdrawal by Subject|0
7615908|NCT00882440|12025138|FG004|Overall Study|Withdrawal by Subject|6
7615909|NCT00882440|12025139|FG005|Overall Study|Withdrawal by Subject|0
7615910|NCT00882440|12025140|FG006|Overall Study|Withdrawal by Subject|1
7615911|NCT00882440|12025134|FG000|Overall Study|Patient Uncooperative|2
7615912|NCT00882440|12025135|FG001|Overall Study|Patient Uncooperative|0
7615913|NCT00882440|12025136|FG002|Overall Study|Patient Uncooperative|0
7615914|NCT00882440|12025137|FG003|Overall Study|Patient Uncooperative|0
7615915|NCT00882440|12025138|FG004|Overall Study|Patient Uncooperative|1
7615916|NCT00882440|12025139|FG005|Overall Study|Patient Uncooperative|0
7615917|NCT00882440|12025140|FG006|Overall Study|Patient Uncooperative|0
7615918|NCT00870688|12025156|FG000|Overall Study|Lost to Follow-up|2
7615919|NCT00870688|12025156|FG000|Overall Study|Death, Unrelated|1
7615920|NCT00870688|12025156|FG000|Overall Study|Granules in the Stools|1
7615921|NCT00869128|12025159|FG000|Overall Study|lack of Compliance|6
7615922|NCT00869128|12025160|FG001|Overall Study|lack of Compliance|6
7615927|NCT00859521|12025191|FG000|Washout|Withdrawal by Subject|0
7615928|NCT00859521|12025192|FG001|Washout|Withdrawal by Subject|1
7615929|NCT00859430|12025198|FG000|First Intervention|Withdrawal by Subject|0
7615930|NCT00859430|12025199|FG001|First Intervention|Withdrawal by Subject|1
7615931|NCT00858702|12025205|FG000|Overall Study|Lack of Efficacy|1
7615932|NCT00858702|12025206|FG001|Overall Study|Lack of Efficacy|0
7615933|NCT00858702|12025205|FG000|Overall Study|Protocol Violation|1
7615934|NCT00858702|12025206|FG001|Overall Study|Protocol Violation|1
7615935|NCT00858702|12025205|FG000|Overall Study|Other|2
7615936|NCT00858702|12025206|FG001|Overall Study|Other|1
7615937|NCT00858702|12025205|FG000|Overall Study|Withdrawal by Subject|1
7615938|NCT00858702|12025206|FG001|Overall Study|Withdrawal by Subject|0
7615939|NCT00857285|12025214|FG000|Overall Study|Adverse Event|4
7615940|NCT00857285|12025215|FG001|Overall Study|Adverse Event|2
7615941|NCT00857285|12025214|FG000|Overall Study|Lack of Efficacy|0
7615942|NCT00857285|12025215|FG001|Overall Study|Lack of Efficacy|2
7615943|NCT00857285|12025214|FG000|Overall Study|Protocol Violation|3
7615944|NCT00857285|12025215|FG001|Overall Study|Protocol Violation|1
7615945|NCT00857285|12025214|FG000|Overall Study|Withdrawal by Subject|4
7615946|NCT00857285|12025215|FG001|Overall Study|Withdrawal by Subject|0
7615947|NCT00857285|12025214|FG000|Overall Study|Randomization criteria not met|1
7615948|NCT00857285|12025215|FG001|Overall Study|Randomization criteria not met|1
7615949|NCT00850174|12025231|FG000|Washout: One Week|Withdrawal by Subject|0
7615950|NCT00850174|12025232|FG001|Washout: One Week|Withdrawal by Subject|2
7615951|NCT00850174|12025231|FG000|Second Intervention|Withdrawal by Subject|1
7615952|NCT00850174|12025232|FG001|Second Intervention|Withdrawal by Subject|0
7615953|NCT00849797|12025245|FG000|First Intervention|bad veins|1
7615954|NCT00849797|12025246|FG001|First Intervention|bad veins|0
7615955|NCT00849797|12025245|FG000|First Intervention|Adverse Event|0
7615956|NCT00849797|12025246|FG001|First Intervention|Adverse Event|1
7615957|NCT00849797|12025245|FG000|Washout: One Week|Withdrawal by Subject|0
7615958|NCT00849797|12025246|FG001|Washout: One Week|Withdrawal by Subject|2
7615959|NCT00847405|12025260|FG000|First Intervention|Adverse Event|0
7615960|NCT00847405|12025261|FG001|First Intervention|Adverse Event|1
7615961|NCT00847405|12025260|FG000|Washout of 7 Days|Withdrawal by Subject|1
7615962|NCT00847405|12025261|FG001|Washout of 7 Days|Withdrawal by Subject|0
7615963|NCT00841815|12025274|FG000|Washout|Withdrawal by Subject|0
7615964|NCT00841815|12025275|FG001|Washout|Withdrawal by Subject|1
7615965|NCT00841698|12025282|FG000|First Intervention|Withdrawal by Subject|1
7615966|NCT00841698|12025283|FG001|First Intervention|Withdrawal by Subject|0
7780529|NCT00951665|12228821|FG000|Phase 1b|Death|1
7615967|NCT00841659|12025289|FG000|Washout: 2 Weeks|Protocol Violation|1
7615968|NCT00841659|12025290|FG001|Washout: 2 Weeks|Protocol Violation|0
7615969|NCT00841542|12025296|FG000|Period 1|Adverse Event|1
7615970|NCT00841542|12025297|FG001|Period 1|Adverse Event|0
7615971|NCT00840879|12025303|FG000|Second Intervention|Withdrawal by Subject|1
7615972|NCT00840879|12025304|FG001|Second Intervention|Withdrawal by Subject|0
7615973|NCT00840632|12025324|FG000|First Intervention|Withdrawal by Subject|0
7615974|NCT00840632|12025325|FG001|First Intervention|Withdrawal by Subject|1
7615975|NCT00840632|12025324|FG000|Washout|Withdrawal by Subject|1
7615976|NCT00840632|12025325|FG001|Washout|Withdrawal by Subject|1
7615977|NCT00840411|12025338|FG000|First Intervention|Adverse Event|1
7615978|NCT00840411|12025339|FG001|First Intervention|Adverse Event|0
7615979|NCT00840411|12025338|FG000|Washout|Withdrawal by Subject|1
7615980|NCT00840411|12025339|FG001|Washout|Withdrawal by Subject|0
7780530|NCT00951665|12228822|FG001|Phase 1b|Death|0
7615981|NCT00840216|12025352|FG000|Washout: 7 Days|Withdrawal by Subject|1
7615982|NCT00840216|12025353|FG001|Washout: 7 Days|Withdrawal by Subject|0
7615983|NCT00840203|12025359|FG000|First Intervention|Protocol Violation|1
7615984|NCT00840203|12025360|FG001|First Intervention|Protocol Violation|1
7615985|NCT00840203|12025359|FG000|Washout|Protocol Violation|1
7615986|NCT00840203|12025360|FG001|Washout|Protocol Violation|0
7615987|NCT00840073|12025373|FG000|Second Intervention|Missed 72 hour blood draw|1
7615988|NCT00840073|12025374|FG001|Second Intervention|Missed 72 hour blood draw|1
7615989|NCT00838630|12025387|FG000|First Intervention|Adverse Event|1
7615990|NCT00838630|12025388|FG001|First Intervention|Adverse Event|0
7615991|NCT00838630|12025387|FG000|Washout: 7 Days|Protocol Violation|1
7615992|NCT00838630|12025388|FG001|Washout: 7 Days|Protocol Violation|0
7615993|NCT00838279|12025394|FG000|Washout|Protocol Violation|1
7615994|NCT00838279|12025395|FG001|Washout|Protocol Violation|0
7615995|NCT00838279|12025394|FG000|Washout|Withdrawal by Subject|0
7615996|NCT00838279|12025395|FG001|Washout|Withdrawal by Subject|1
7615997|NCT00836901|12025408|FG000|First Intervention|Withdrawal by Subject|1
7615998|NCT00836901|12025409|FG001|First Intervention|Withdrawal by Subject|0
7615999|NCT00836706|12025415|FG000|Washout: 7 Days|Withdrawal by Subject|0
7616000|NCT00836706|12025416|FG001|Washout: 7 Days|Withdrawal by Subject|1
7616001|NCT00836472|12025422|FG000|Washout|Adverse Event|1
7616002|NCT00836472|12025423|FG001|Washout|Adverse Event|2
7616003|NCT00836472|12025422|FG000|Washout|Withdrawal by Subject|1
7616004|NCT00836472|12025423|FG001|Washout|Withdrawal by Subject|1
7616005|NCT00836056|12025429|FG000|First Intervention|Adverse Event|1
7616006|NCT00836056|12025430|FG001|First Intervention|Adverse Event|0
7616007|NCT00835991|12025443|FG000|First Intervention|Adverse Event|0
7616008|NCT00835991|12025444|FG001|First Intervention|Adverse Event|1
7616009|NCT00835991|12025443|FG000|Washout|Protocol Violation|0
7616010|NCT00835991|12025444|FG001|Washout|Protocol Violation|2
7616011|NCT00835991|12025443|FG000|Washout|Withdrawal by Subject|3
7616012|NCT00835991|12025444|FG001|Washout|Withdrawal by Subject|1
7616013|NCT00835796|12025450|FG000|First Intervention|Withdrawal by Subject|0
7616014|NCT00835796|12025451|FG001|First Intervention|Withdrawal by Subject|1
7616015|NCT00835705|12025457|FG000|First Intervention|Difficulty with vein|1
7780531|NCT00951665|12228823|FG002|Phase 1b|Death|2
7780532|NCT00951665|12228824|FG003|Phase 1b|Death|0
7780533|NCT00951665|12228825|FG004|Phase 1b|Death|0
7780534|NCT00951665|12228826|FG005|Phase 1b|Death|0
7780535|NCT00951665|12228821|FG000|Phase 1b|Physician Decision|4
7780536|NCT00951665|12228822|FG001|Phase 1b|Physician Decision|0
7780537|NCT00951665|12228823|FG002|Phase 1b|Physician Decision|1
7780538|NCT00951665|12228824|FG003|Phase 1b|Physician Decision|0
7780539|NCT00951665|12228825|FG004|Phase 1b|Physician Decision|0
7780540|NCT00951665|12228826|FG005|Phase 1b|Physician Decision|0
7780541|NCT00951665|12228821|FG000|Phase 1b|Withdrawal by Subject|0
7780542|NCT00951665|12228822|FG001|Phase 1b|Withdrawal by Subject|1
7780543|NCT00951665|12228823|FG002|Phase 1b|Withdrawal by Subject|0
7780544|NCT00951665|12228824|FG003|Phase 1b|Withdrawal by Subject|0
7780545|NCT00951665|12228825|FG004|Phase 1b|Withdrawal by Subject|0
7780546|NCT00951665|12228826|FG005|Phase 1b|Withdrawal by Subject|0
7780547|NCT00951665|12228821|FG000|Phase 1b|Disease Progression|13
7780548|NCT00951665|12228822|FG001|Phase 1b|Disease Progression|2
7780549|NCT00951665|12228823|FG002|Phase 1b|Disease Progression|14
7780550|NCT00951665|12228824|FG003|Phase 1b|Disease Progression|0
7780551|NCT00951665|12228825|FG004|Phase 1b|Disease Progression|0
7780552|NCT00951665|12228826|FG005|Phase 1b|Disease Progression|0
7780553|NCT00951665|12228821|FG000|Phase 1b|Protocol Violation|2
7780554|NCT00951665|12228822|FG001|Phase 1b|Protocol Violation|0
7780555|NCT00951665|12228823|FG002|Phase 1b|Protocol Violation|0
7780556|NCT00951665|12228824|FG003|Phase 1b|Protocol Violation|0
7780557|NCT00951665|12228825|FG004|Phase 1b|Protocol Violation|0
7780558|NCT00951665|12228826|FG005|Phase 1b|Protocol Violation|0
7780559|NCT00951665|12228821|FG000|Phase 2a|Adverse Event|0
7780560|NCT00951665|12228822|FG001|Phase 2a|Adverse Event|0
7780561|NCT00951665|12228823|FG002|Phase 2a|Adverse Event|0
7780562|NCT00951665|12228824|FG003|Phase 2a|Adverse Event|0
7780563|NCT00951665|12228825|FG004|Phase 2a|Adverse Event|2
7780564|NCT00951665|12228826|FG005|Phase 2a|Adverse Event|0
7780565|NCT00951665|12228821|FG000|Phase 2a|Death|0
7780566|NCT00951665|12228822|FG001|Phase 2a|Death|0
7780567|NCT00951665|12228823|FG002|Phase 2a|Death|0
7780568|NCT00951665|12228824|FG003|Phase 2a|Death|0
7780569|NCT00951665|12228825|FG004|Phase 2a|Death|1
7780570|NCT00951665|12228826|FG005|Phase 2a|Death|1
7780571|NCT00951665|12228821|FG000|Phase 2a|Lost to Follow-up|0
7780572|NCT00951665|12228822|FG001|Phase 2a|Lost to Follow-up|0
7780573|NCT00951665|12228823|FG002|Phase 2a|Lost to Follow-up|0
7780574|NCT00951665|12228824|FG003|Phase 2a|Lost to Follow-up|0
7780575|NCT00951665|12228825|FG004|Phase 2a|Lost to Follow-up|1
7780576|NCT00951665|12228826|FG005|Phase 2a|Lost to Follow-up|0
7780577|NCT00951665|12228821|FG000|Phase 2a|Physician Decision|0
7780578|NCT00951665|12228822|FG001|Phase 2a|Physician Decision|0
7780579|NCT00951665|12228823|FG002|Phase 2a|Physician Decision|0
7780580|NCT00951665|12228824|FG003|Phase 2a|Physician Decision|0
7780581|NCT00951665|12228825|FG004|Phase 2a|Physician Decision|0
7780582|NCT00951665|12228826|FG005|Phase 2a|Physician Decision|1
7780583|NCT00951665|12228821|FG000|Phase 2a|Withdrawal by Subject|0
7780584|NCT00951665|12228822|FG001|Phase 2a|Withdrawal by Subject|0
7780585|NCT00951665|12228823|FG002|Phase 2a|Withdrawal by Subject|0
7780586|NCT00951665|12228824|FG003|Phase 2a|Withdrawal by Subject|0
7780587|NCT00951665|12228825|FG004|Phase 2a|Withdrawal by Subject|2
7780588|NCT00951665|12228826|FG005|Phase 2a|Withdrawal by Subject|0
7780589|NCT00951665|12228821|FG000|Phase 2a|Disease Progression|0
7780590|NCT00951665|12228822|FG001|Phase 2a|Disease Progression|0
7780591|NCT00951665|12228823|FG002|Phase 2a|Disease Progression|0
7780592|NCT00951665|12228824|FG003|Phase 2a|Disease Progression|0
7780593|NCT00951665|12228825|FG004|Phase 2a|Disease Progression|6
7780594|NCT00951665|12228826|FG005|Phase 2a|Disease Progression|5
7780595|NCT00951912|12228889|FG000|Overall Study|Lack of Efficacy|1
7780596|NCT00951912|12228890|FG001|Overall Study|Lack of Efficacy|0
7780597|NCT00951912|12228891|FG002|Overall Study|Lack of Efficacy|0
7780598|NCT00951912|12228889|FG000|Overall Study|Adverse Event|0
7780599|NCT00951912|12228890|FG001|Overall Study|Adverse Event|1
7616016|NCT00835705|12025458|FG001|First Intervention|Difficulty with vein|0
7616017|NCT00835705|12025457|FG000|Second Intervention|Difficulty with vein|1
7616018|NCT00835705|12025458|FG001|Second Intervention|Difficulty with vein|0
7616019|NCT00835692|12025464|FG000|First Intervention|Withdrawal by Subject|1
7616020|NCT00835692|12025465|FG001|First Intervention|Withdrawal by Subject|0
7616021|NCT00835666|12025471|FG000|Washout|Protocol Violation|1
7616022|NCT00835666|12025472|FG001|Washout|Protocol Violation|0
7616023|NCT00835666|12025471|FG000|Washout|Withdrawal by Subject|1
7616024|NCT00835666|12025472|FG001|Washout|Withdrawal by Subject|0
7616025|NCT00835640|12025478|FG000|Second Intervention|Protocol Violation|1
7616026|NCT00835640|12025479|FG001|Second Intervention|Protocol Violation|0
7616027|NCT00835575|12025499|FG000|Washout of 14 Days|Withdrawal by Subject|1
7616028|NCT00835575|12025500|FG001|Washout of 14 Days|Withdrawal by Subject|0
7616029|NCT00835549|12025506|FG000|Washout of 7 Days|Withdrawal by Subject|2
7616030|NCT00835549|12025507|FG001|Washout of 7 Days|Withdrawal by Subject|0
7616031|NCT00835536|12025513|FG000|Washout of 5 Weeks|Withdrawal by Subject|1
7616032|NCT00835536|12025514|FG001|Washout of 5 Weeks|Withdrawal by Subject|0
7616033|NCT00835406|12025534|FG000|Period: First Intervention|Adverse Event|0
7616034|NCT00835406|12025535|FG001|Period: First Intervention|Adverse Event|1
7616035|NCT00835406|12025534|FG000|Period: First Intervention|Withdrawal by Subject|2
7616036|NCT00835406|12025535|FG001|Period: First Intervention|Withdrawal by Subject|0
7616037|NCT00835406|12025534|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0
7616038|NCT00835406|12025535|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2
7616039|NCT00835367|12025541|FG000|Washout|Adverse Event|2
7616040|NCT00835367|12025542|FG001|Washout|Adverse Event|0
7616041|NCT00835367|12025541|FG000|Washout|Withdrawal by Subject|1
7616042|NCT00835367|12025542|FG001|Washout|Withdrawal by Subject|0
7616043|NCT00835367|12025541|FG000|Second Intervention|Adverse Event|1
7616044|NCT00835367|12025542|FG001|Second Intervention|Adverse Event|1
7616045|NCT00835354|12025548|FG000|First Intervention|Adverse Event|0
7616046|NCT00835354|12025549|FG001|First Intervention|Adverse Event|1
7616047|NCT00835263|12025562|FG000|Second Intervention|Adverse Event|1
7616048|NCT00835263|12025563|FG001|Second Intervention|Adverse Event|0
7616049|NCT00835211|12025569|FG000|First Intervention|Withdrawal by Subject|0
7616050|NCT00835211|12025570|FG001|First Intervention|Withdrawal by Subject|1
7616051|NCT00835211|12025569|FG000|Washout: 7 Days|Adverse Event|2
7616052|NCT00835211|12025570|FG001|Washout: 7 Days|Adverse Event|1
7616053|NCT00835211|12025569|FG000|Washout: 7 Days|Withdrawal by Subject|1
7616054|NCT00835211|12025570|FG001|Washout: 7 Days|Withdrawal by Subject|0
7616055|NCT00835172|12025576|FG000|Washout|Protocol Violation|0
7616056|NCT00835172|12025577|FG001|Washout|Protocol Violation|1
7616057|NCT00835081|12025590|FG000|Washout of 7 Days|Withdrawal by Subject|1
7616058|NCT00835081|12025591|FG001|Washout of 7 Days|Withdrawal by Subject|0
7616059|NCT00835042|12025597|FG000|First Intervention|Withdrawal by Subject|3
7616060|NCT00835042|12025598|FG001|First Intervention|Withdrawal by Subject|0
7616061|NCT00835042|12025597|FG000|First Intervention|Adverse Event|1
7616062|NCT00835042|12025598|FG001|First Intervention|Adverse Event|2
7616063|NCT00835042|12025597|FG000|Washout of 21 Days|Withdrawal by Subject|0
7616064|NCT00835042|12025598|FG001|Washout of 21 Days|Withdrawal by Subject|2
7616065|NCT00834873|12025625|FG000|First Intervention|Adverse Event|0
7616066|NCT00834873|12025626|FG001|First Intervention|Adverse Event|1
7616067|NCT00834795|12025632|FG000|Washout: 7 Days|Withdrawal by Subject|0
7780600|NCT00951912|12228891|FG002|Overall Study|Adverse Event|1
7780601|NCT00951912|12228889|FG000|Overall Study|Lost to Follow-up|2
7780602|NCT00951912|12228890|FG001|Overall Study|Lost to Follow-up|2
7780603|NCT00951912|12228891|FG002|Overall Study|Lost to Follow-up|0
7616068|NCT00834795|12025633|FG001|Washout: 7 Days|Withdrawal by Subject|1
7616069|NCT00834795|12025632|FG000|Second Intervention|Adverse Event|1
7616070|NCT00834795|12025633|FG001|Second Intervention|Adverse Event|0
7616071|NCT00834756|12025639|FG000|First Intervention|Adverse Event|1
7616072|NCT00834756|12025640|FG001|First Intervention|Adverse Event|0
7616073|NCT00834756|12025639|FG000|Washout: 21 Days|Withdrawal by Subject|1
7616074|NCT00834756|12025640|FG001|Washout: 21 Days|Withdrawal by Subject|0
7616075|NCT00834743|12025646|FG000|Second Intervention|Withdrawal by Subject|1
7616076|NCT00834743|12025647|FG001|Second Intervention|Withdrawal by Subject|0
7616077|NCT00834717|12025653|FG000|First Intervention|Adverse Event|1
7616078|NCT00834717|12025654|FG001|First Intervention|Adverse Event|0
7616079|NCT00834717|12025653|FG000|First Intervention|Withdrawal by Subject|0
7616080|NCT00834717|12025654|FG001|First Intervention|Withdrawal by Subject|1
7616081|NCT00834639|12025660|FG000|Second Intervention|Physician Decision|0
7616082|NCT00834639|12025661|FG001|Second Intervention|Physician Decision|2
7616083|NCT00834613|12025667|FG000|First Intervention|Protocol Violation|1
7616084|NCT00834613|12025668|FG001|First Intervention|Protocol Violation|0
7616085|NCT00834587|12025674|FG000|Washout: 7 Days|Withdrawal by Subject|1
7616086|NCT00834587|12025675|FG001|Washout: 7 Days|Withdrawal by Subject|0
7616087|NCT00834522|12025702|FG000|Washout|Adverse Event|1
7616088|NCT00834522|12025703|FG001|Washout|Adverse Event|0
7616089|NCT00834522|12025702|FG000|Washout|Withdrawal by Subject|2
7616090|NCT00834522|12025703|FG001|Washout|Withdrawal by Subject|1
7616091|NCT00834444|12025709|FG000|First Intervention|Adverse Event|1
7780604|NCT00951912|12228889|FG000|Overall Study|Physician Decision|1
7780605|NCT00951912|12228890|FG001|Overall Study|Physician Decision|0
7780606|NCT00951912|12228891|FG002|Overall Study|Physician Decision|1
7780607|NCT00951912|12228889|FG000|Overall Study|Withdrawal by Subject|1
7780608|NCT00951912|12228890|FG001|Overall Study|Withdrawal by Subject|1
7780609|NCT00951912|12228891|FG002|Overall Study|Withdrawal by Subject|0
7780610|NCT00951912|12228889|FG000|Overall Study|Other:Depression|1
7780611|NCT00951912|12228890|FG001|Overall Study|Other:Depression|0
7780612|NCT00951912|12228891|FG002|Overall Study|Other:Depression|0
7780613|NCT00951912|12228889|FG000|Overall Study|Other: Colon cancer|1
7780614|NCT00951912|12228890|FG001|Overall Study|Other: Colon cancer|0
7780615|NCT00951912|12228891|FG002|Overall Study|Other: Colon cancer|0
7780616|NCT00951912|12228889|FG000|Overall Study|Other: Stroke|0
7780617|NCT00951912|12228890|FG001|Overall Study|Other: Stroke|1
7780618|NCT00951912|12228891|FG002|Overall Study|Other: Stroke|0
7780619|NCT00952068|12228899|FG000|Overall Study|Adverse Event|3
7780620|NCT00952068|12228899|FG000|Overall Study|Withdrawal by Subject|4
7780621|NCT00952276|12228943|FG000|Overall Study|Withdrawal by Subject|1
7780622|NCT00952276|12228944|FG001|Overall Study|Withdrawal by Subject|0
7780623|NCT00952276|12228945|FG002|Overall Study|Withdrawal by Subject|0
7780624|NCT00952276|12228946|FG003|Overall Study|Withdrawal by Subject|1
7780625|NCT00952276|12228947|FG004|Overall Study|Withdrawal by Subject|0
7780626|NCT00952289|12228961|FG000|All Participants|Death|9
7780627|NCT00952289|12228962|FG001|All Participants|Death|9
7780628|NCT00952289|12228961|FG000|All Participants|Adverse Event|8
7780629|NCT00952289|12228962|FG001|All Participants|Adverse Event|8
7780630|NCT00952289|12228961|FG000|All Participants|Disease progression|3
7780631|NCT00952289|12228962|FG001|All Participants|Disease progression|12
7780632|NCT00952289|12228961|FG000|All Participants|Withdrawal by Subject|1
7780633|NCT00952289|12228962|FG001|All Participants|Withdrawal by Subject|10
7780634|NCT00952289|12228961|FG000|All Participants|Data lost during site relocation|0
7780635|NCT00952289|12228962|FG001|All Participants|Data lost during site relocation|1
7780636|NCT00952289|12228961|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
7780637|NCT00952289|12228962|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
7616092|NCT00834444|12025710|FG001|First Intervention|Adverse Event|0
7616093|NCT00834444|12025709|FG000|First Intervention|Intolerance to Venopuncture|0
7616094|NCT00834444|12025710|FG001|First Intervention|Intolerance to Venopuncture|1
7616095|NCT00834444|12025709|FG000|Washout of 7 Days|Withdrawal by Subject|0
7616096|NCT00834444|12025710|FG001|Washout of 7 Days|Withdrawal by Subject|1
7616097|NCT00834444|12025709|FG000|Second Intervention|Adverse Event|1
7616098|NCT00834444|12025710|FG001|Second Intervention|Adverse Event|0
7616099|NCT00834431|12025716|FG000|First Intervention|Adverse Event|0
7616100|NCT00834431|12025717|FG001|First Intervention|Adverse Event|1
7616101|NCT00834431|12025716|FG000|Washout of 7 Days|Withdrawal by Subject|0
7616102|NCT00834431|12025717|FG001|Washout of 7 Days|Withdrawal by Subject|1
7616103|NCT00834418|12025723|FG000|Overall Study|Adverse Event|0
7616104|NCT00834418|12025724|FG001|Overall Study|Adverse Event|2
7616105|NCT00834340|12025737|FG000|Washout|Adverse Event|1
7616106|NCT00834340|12025738|FG001|Washout|Adverse Event|0
7616107|NCT00834340|12025737|FG000|Washout|Withdrawal by Subject|1
7616108|NCT00834340|12025738|FG001|Washout|Withdrawal by Subject|0
7616109|NCT00834249|12025751|FG000|Washout: 7 Days|Withdrawal by Subject|1
7616110|NCT00834249|12025752|FG001|Washout: 7 Days|Withdrawal by Subject|1
7616111|NCT00834249|12025751|FG000|Second Intervention|Adverse Event|1
7616112|NCT00834249|12025752|FG001|Second Intervention|Adverse Event|0
7616113|NCT00834067|12025772|FG000|Washout of 21 Days|Protocol Violation|0
7616114|NCT00834067|12025773|FG001|Washout of 21 Days|Protocol Violation|1
7616115|NCT00833937|12025779|FG000|Washout|Withdrawal by Subject|1
7616116|NCT00833937|12025780|FG001|Washout|Withdrawal by Subject|0
7616117|NCT00830336|12025807|FG000|Washout: 21 Days|Withdrawal by Subject|1
7616118|NCT00830336|12025808|FG001|Washout: 21 Days|Withdrawal by Subject|0
7616119|NCT00830258|12025814|FG000|First Intervention|Adverse Event|1
7616120|NCT00830258|12025815|FG001|First Intervention|Adverse Event|0
7616121|NCT00830258|12025814|FG000|Washout: 7 Days|Protocol Violation|1
7616122|NCT00830258|12025815|FG001|Washout: 7 Days|Protocol Violation|0
7616123|NCT00830219|12025821|FG000|Washout of 7 Days|Withdrawal by Subject|1
7616124|NCT00830219|12025822|FG001|Washout of 7 Days|Withdrawal by Subject|1
7616125|NCT00830206|12025828|FG000|Washout: 21 Days|Withdrawal by Subject|1
7616126|NCT00830206|12025829|FG001|Washout: 21 Days|Withdrawal by Subject|1
7616127|NCT00830024|12025835|FG000|Washout: 7 Days|Withdrawal by Subject|1
7616128|NCT00830024|12025836|FG001|Washout: 7 Days|Withdrawal by Subject|0
7616129|NCT00829998|12025842|FG000|Washout|Adverse Event|0
7616130|NCT00829998|12025843|FG001|Washout|Adverse Event|1
7616131|NCT00829868|12025849|FG000|Washout|Physician Decision|1
7616132|NCT00829868|12025850|FG001|Washout|Physician Decision|0
7616133|NCT00829790|12025856|FG000|Washout of 14 Days|Withdrawal by Subject|0
7616134|NCT00829790|12025857|FG001|Washout of 14 Days|Withdrawal by Subject|1
7616135|NCT00829764|12025863|FG000|First Intervention|Adverse Event|1
7616136|NCT00829764|12025864|FG001|First Intervention|Adverse Event|0
7616137|NCT00829764|12025863|FG000|First Intervention|Withdrawal by Subject|1
7616138|NCT00829764|12025864|FG001|First Intervention|Withdrawal by Subject|1
7616139|NCT00829712|12025870|FG000|Washout of 7 Days|Withdrawal by Subject|0
7616140|NCT00829712|12025871|FG001|Washout of 7 Days|Withdrawal by Subject|1
7780638|NCT00952289|12228961|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
7780639|NCT00952289|12228962|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
7780640|NCT00952289|12228961|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
7780641|NCT00952289|12228962|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
7780642|NCT00952289|12228961|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
7780643|NCT00952289|12228962|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
7780644|NCT00952289|12228961|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
7780645|NCT00952289|12228962|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
7780646|NCT00952341|12228986|FG000|Cycle 1|Adverse Event|4
7780647|NCT00952341|12228987|FG001|Cycle 1|Adverse Event|1
7780648|NCT00952341|12228986|FG000|Cycle 1|Withdrawal by Subject|3
7780649|NCT00952341|12228987|FG001|Cycle 1|Withdrawal by Subject|8
7780650|NCT00952341|12228986|FG000|Cycle 1|Protocol Violation|2
7780651|NCT00952341|12228987|FG001|Cycle 1|Protocol Violation|1
7780652|NCT00952341|12228986|FG000|Cycle 1|Lost to Follow-up|11
7780653|NCT00952341|12228987|FG001|Cycle 1|Lost to Follow-up|2
7780654|NCT00952341|12228986|FG000|Cycle 1|Physician Decision|0
7780655|NCT00952341|12228987|FG001|Cycle 1|Physician Decision|1
7780656|NCT00952341|12228986|FG000|Cycle 2|Withdrawal by Subject|1
7780657|NCT00952341|12228987|FG001|Cycle 2|Withdrawal by Subject|1
7780658|NCT00952341|12228986|FG000|Cycle 2|Protocol Violation|1
7780659|NCT00952341|12228987|FG001|Cycle 2|Protocol Violation|0
7616141|NCT00829673|12025884|FG000|Washout of 7 Days|Withdrawal by Subject|1
7780660|NCT00952341|12228986|FG000|Cycle 2|Lost to Follow-up|6
7780661|NCT00952341|12228987|FG001|Cycle 2|Lost to Follow-up|9
7780662|NCT00952341|12228986|FG000|Cycle 2|Physician Decision|1
7616142|NCT00829673|12025885|FG001|Washout of 7 Days|Withdrawal by Subject|0
7616143|NCT00829530|12025891|FG000|First Intervention|Adverse Event|0
7616144|NCT00829530|12025892|FG001|First Intervention|Adverse Event|1
7616145|NCT00829530|12025891|FG000|First Intervention|Intolerance to Venopuncture|0
7616146|NCT00829530|12025892|FG001|First Intervention|Intolerance to Venopuncture|1
7616147|NCT00829530|12025891|FG000|Second Intervention|Intolerance to Venopuncture|1
7616148|NCT00829530|12025892|FG001|Second Intervention|Intolerance to Venopuncture|0
7616149|NCT00829504|12025898|FG000|First Intervention|Adverse Event|1
7616150|NCT00829504|12025899|FG001|First Intervention|Adverse Event|0
7616151|NCT00829504|12025898|FG000|Washout of 7 Days|Withdrawal by Subject|1
7616152|NCT00829504|12025899|FG001|Washout of 7 Days|Withdrawal by Subject|0
7616153|NCT00829504|12025898|FG000|Second Intervention|Physician Decision|1
7616154|NCT00829504|12025899|FG001|Second Intervention|Physician Decision|0
7616155|NCT00829452|12025905|FG000|First Intervention|Withdrawal by Subject|0
7616156|NCT00829452|12025906|FG001|First Intervention|Withdrawal by Subject|1
7616157|NCT00829452|12025905|FG000|Washout of 42 Days|Withdrawal by Subject|0
7616158|NCT00829452|12025906|FG001|Washout of 42 Days|Withdrawal by Subject|1
7616159|NCT00829452|12025905|FG000|Second Intervention|Physician Decision|0
7616160|NCT00829452|12025906|FG001|Second Intervention|Physician Decision|1
7616161|NCT00829426|12025912|FG000|Washout: 7 Days|Withdrawal by Subject|1
7616162|NCT00829426|12025913|FG001|Washout: 7 Days|Withdrawal by Subject|0
7616163|NCT00829309|12025919|FG000|Washout: 7 Days|Protocol Violation|1
7616164|NCT00829309|12025920|FG001|Washout: 7 Days|Protocol Violation|0
7616165|NCT00828321|12025926|FG000|Washout of 42 Days|Withdrawal by Subject|2
7616166|NCT00828321|12025927|FG001|Washout of 42 Days|Withdrawal by Subject|0
7616167|NCT00828321|12025926|FG000|Second Intervention|Protocol Violation|0
7616168|NCT00828321|12025927|FG001|Second Intervention|Protocol Violation|1
7616169|NCT00806403|12025933|FG000|Overall Study|Death|4
7616170|NCT00806403|12025934|FG001|Overall Study|Death|3
7616171|NCT00796523|12025974|FG000|Overall Study|Lost to Follow-up|9
7616172|NCT00796523|12025975|FG001|Overall Study|Lost to Follow-up|7
7616173|NCT00794924|12025981|FG000|Overall Study|Lost to Follow-up|6
7616174|NCT00794924|12025982|FG001|Overall Study|Lost to Follow-up|8
7616175|NCT00794924|12025981|FG000|Overall Study|Withdrawal by Subject|48
7616176|NCT00794924|12025982|FG001|Overall Study|Withdrawal by Subject|60
7616177|NCT00794924|12025981|FG000|Overall Study|Adverse Event|6
7616178|NCT00794924|12025982|FG001|Overall Study|Adverse Event|2
7616179|NCT00794677|12025988|FG000|First Intervention|Withdrawal by Subject|2
7616180|NCT00794677|12025989|FG001|First Intervention|Withdrawal by Subject|0
7616181|NCT00792116|12025995|FG000|Overall Study|Lost to Follow-up|0
7616182|NCT00792116|12025996|FG001|Overall Study|Lost to Follow-up|1
7616183|NCT00792116|12025995|FG000|Overall Study|Discontnued intervention|1
7616184|NCT00792116|12025996|FG001|Overall Study|Discontnued intervention|0
7780663|NCT00952341|12228987|FG001|Cycle 2|Physician Decision|1
7616185|NCT00756574|12026016|FG000|Overall Study|Withdrawal by Subject|9
7616186|NCT00756574|12026017|FG001|Overall Study|Withdrawal by Subject|7
7616187|NCT00756574|12026016|FG000|Overall Study|Lost to Follow-up|4
7616188|NCT00756574|12026017|FG001|Overall Study|Lost to Follow-up|4
7616189|NCT00740480|12026024|FG000|Overall Study|Adverse Event|1
7616190|NCT00740480|12026024|FG000|Overall Study|Physician Decision|1
7616191|NCT00724698|12026027|FG000|Overall Study|Adverse Event|9
7616192|NCT00724698|12026027|FG000|Overall Study|Failure of Therapy|4
7616193|NCT00724698|12026027|FG000|Overall Study|Poor Compliance|16
7616194|NCT00724698|12026027|FG000|Overall Study|Lost to Follow-up|36
7616195|NCT00724698|12026027|FG000|Overall Study|No Info|25
7780664|NCT00952341|12228986|FG000|Cycle 2|Progressive Disease|0
7780665|NCT00952341|12228987|FG001|Cycle 2|Progressive Disease|1
7780666|NCT00952367|12228993|FG000|Overall Study|Withdrawal by Subject|2
7780667|NCT00952367|12228993|FG000|Overall Study|Noncoordination|1
7780668|NCT00952367|12228993|FG000|Overall Study|Protocol Violation|3
7780669|NCT00952380|12229002|FG000|Overall Study|Other|0
7780670|NCT00952380|12229003|FG001|Overall Study|Other|0
7780671|NCT00952380|12229004|FG002|Overall Study|Other|0
7780672|NCT00952380|12229005|FG003|Overall Study|Other|0
7780673|NCT00952380|12229006|FG004|Overall Study|Other|1
7780674|NCT00952380|12229002|FG000|Overall Study|Withdrawal by Subject|0
7780675|NCT00952380|12229003|FG001|Overall Study|Withdrawal by Subject|0
7780676|NCT00952380|12229004|FG002|Overall Study|Withdrawal by Subject|1
7780677|NCT00952380|12229005|FG003|Overall Study|Withdrawal by Subject|0
7780678|NCT00952380|12229006|FG004|Overall Study|Withdrawal by Subject|2
7780679|NCT00952380|12229002|FG000|Overall Study|Adverse Event|0
7780680|NCT00952380|12229003|FG001|Overall Study|Adverse Event|1
7780681|NCT00952380|12229004|FG002|Overall Study|Adverse Event|0
7616196|NCT00711555|12026030|FG000|Overall Study|Adverse Event|3
7616197|NCT00676494|12026033|FG000|Overall Study|Missed Visit|8
7616198|NCT00676494|12026033|FG000|Overall Study|Withdrawal by Subject|6
7616199|NCT00659061|12026041|FG000|Overall Study|Migration due to political unrest|21
7616200|NCT00659061|12026042|FG001|Overall Study|Migration due to political unrest|15
7616201|NCT00581477|12026053|FG000|Overall Study|Physician Decision|2
7616208|NCT00495131|12026117|FG000|Overall Study|Adverse Event|6
7616209|NCT00495131|12026118|FG001|Overall Study|Adverse Event|2
7616210|NCT00495131|12026117|FG000|Overall Study|Lack of Efficacy|0
7616211|NCT00495131|12026118|FG001|Overall Study|Lack of Efficacy|2
7616212|NCT00495131|12026117|FG000|Overall Study|Lost to Follow-up|0
7780682|NCT00952380|12229005|FG003|Overall Study|Adverse Event|0
7780683|NCT00952380|12229006|FG004|Overall Study|Adverse Event|3
7780684|NCT00952380|12229002|FG000|Overall Study|Physician Decision|0
7780685|NCT00952380|12229003|FG001|Overall Study|Physician Decision|0
7780686|NCT00952380|12229004|FG002|Overall Study|Physician Decision|1
7780687|NCT00952380|12229005|FG003|Overall Study|Physician Decision|2
7780688|NCT00952380|12229006|FG004|Overall Study|Physician Decision|0
7780689|NCT00952380|12229002|FG000|Overall Study|Non-compliant to protocol|0
7780690|NCT00952380|12229003|FG001|Overall Study|Non-compliant to protocol|0
7780691|NCT00952380|12229004|FG002|Overall Study|Non-compliant to protocol|0
7780692|NCT00952380|12229005|FG003|Overall Study|Non-compliant to protocol|1
7780693|NCT00952380|12229006|FG004|Overall Study|Non-compliant to protocol|0
7780694|NCT00952419|12229030|FG000|Overall Study|Adverse Event|2
7780695|NCT00952419|12229031|FG001|Overall Study|Adverse Event|0
7780696|NCT00952419|12229032|FG002|Overall Study|Adverse Event|0
7780697|NCT00952419|12229030|FG000|Overall Study|Protocol Violation|3
7780698|NCT00952419|12229031|FG001|Overall Study|Protocol Violation|7
7780699|NCT00952419|12229032|FG002|Overall Study|Protocol Violation|0
7780700|NCT00952419|12229030|FG000|Overall Study|Withdrawal by Subject|1
7780701|NCT00952419|12229031|FG001|Overall Study|Withdrawal by Subject|3
7780702|NCT00952419|12229032|FG002|Overall Study|Withdrawal by Subject|0
7780703|NCT00952484|12229043|FG000|Overall Study|Withdrawal by Subject|0
7780704|NCT00952484|12229044|FG001|Overall Study|Withdrawal by Subject|1
7780705|NCT00952484|12229045|FG002|Overall Study|Withdrawal by Subject|0
7780706|NCT00952523|12229054|FG000|Overall Study|Withdrawal by Subject|7
7780707|NCT00952588|12229062|FG000|Overall Study|Death|28
7780708|NCT00952588|12229063|FG001|Overall Study|Death|13
7780709|NCT00952588|12229062|FG000|Overall Study|Withdrawal by Subject|2
7780710|NCT00952588|12229063|FG001|Overall Study|Withdrawal by Subject|5
7780711|NCT00952588|12229062|FG000|Overall Study|Adverse Event|2
7780712|NCT00952588|12229063|FG001|Overall Study|Adverse Event|3
7616281|NCT00430508|12026188|FG003|Overall Study|Adverse Event|3
7780713|NCT00952588|12229062|FG000|Overall Study|Lost to Follow-up|2
7780714|NCT00952588|12229063|FG001|Overall Study|Lost to Follow-up|0
7780715|NCT00952588|12229062|FG000|Overall Study|Physician Decision|0
7780716|NCT00952588|12229063|FG001|Overall Study|Physician Decision|1
7780717|NCT00952588|12229062|FG000|Overall Study|Lack of Efficacy|2
7780718|NCT00952588|12229063|FG001|Overall Study|Lack of Efficacy|2
7780719|NCT00952614|12229069|FG000|Overall Study|Death|3
7780720|NCT00952614|12229069|FG000|Overall Study|Lost to Follow-up|3
7780721|NCT00952614|12229069|FG000|Overall Study|other reason|1
7780722|NCT00952705|12229084|FG000|Overall Study|Lost to Follow-up|24
7780723|NCT00952705|12229085|FG001|Overall Study|Lost to Follow-up|8
7616213|NCT00495131|12026118|FG001|Overall Study|Lost to Follow-up|2
7616202|NCT00554190|12026074|FG000|Overall Study|Termination forms not completed|10
7616203|NCT00529152|12026094|FG000|Overall Study|Adverse Event|2
7616204|NCT00529152|12026094|FG000|Overall Study|Withdrawal by Subject|2
7616205|NCT00529152|12026094|FG000|Overall Study|Lost to Follow-up|1
7616206|NCT00526227|12026097|FG000|Overall Study|Device not implanted|1
7616207|NCT00526227|12026097|FG000|Overall Study|Death|1
7616214|NCT00495131|12026117|FG000|Overall Study|Withdrawal by Subject|1
7616215|NCT00495131|12026118|FG001|Overall Study|Withdrawal by Subject|0
7616216|NCT00484419|12026132|FG000|Overall Study|Adverse Event|3
7616217|NCT00484419|12026133|FG001|Overall Study|Adverse Event|0
7616218|NCT00484419|12026134|FG002|Overall Study|Adverse Event|0
7616219|NCT00484419|12026132|FG000|Overall Study|Lost to Follow-up|1
7616220|NCT00484419|12026133|FG001|Overall Study|Lost to Follow-up|0
7616221|NCT00484419|12026134|FG002|Overall Study|Lost to Follow-up|2
7616222|NCT00484419|12026132|FG000|Overall Study|Withdrawal by Subject|3
7616223|NCT00484419|12026133|FG001|Overall Study|Withdrawal by Subject|1
7616224|NCT00484419|12026134|FG002|Overall Study|Withdrawal by Subject|1
7616225|NCT00484419|12026132|FG000|Overall Study|subject met discontinuation criteria|2
7616226|NCT00484419|12026133|FG001|Overall Study|subject met discontinuation criteria|2
7616227|NCT00484419|12026134|FG002|Overall Study|subject met discontinuation criteria|4
7616228|NCT00484419|12026132|FG000|Overall Study|required restricted medication|1
7616229|NCT00484419|12026133|FG001|Overall Study|required restricted medication|0
7616230|NCT00484419|12026134|FG002|Overall Study|required restricted medication|1
7616231|NCT00484419|12026132|FG000|Overall Study|Physician Decision|1
7616232|NCT00484419|12026133|FG001|Overall Study|Physician Decision|1
7616233|NCT00484419|12026134|FG002|Overall Study|Physician Decision|1
7616234|NCT00484419|12026132|FG000|Overall Study|subject unable to receive medication|1
7616235|NCT00484419|12026133|FG001|Overall Study|subject unable to receive medication|0
7616236|NCT00484419|12026134|FG002|Overall Study|subject unable to receive medication|0
7616237|NCT00484419|12026132|FG000|Overall Study|subject relocated|0
7616238|NCT00484419|12026133|FG001|Overall Study|subject relocated|1
7616239|NCT00484419|12026134|FG002|Overall Study|subject relocated|0
7616240|NCT00484419|12026132|FG000|Overall Study|sponsor decision, randomized in error|0
7616241|NCT00484419|12026133|FG001|Overall Study|sponsor decision, randomized in error|0
7616242|NCT00484419|12026134|FG002|Overall Study|sponsor decision, randomized in error|2
7616243|NCT00474188|12026146|FG000|Overall Study|Withdrawal by Subject|1
7616244|NCT00474188|12026146|FG000|Overall Study|Study discontinued by sponsor|5
7616245|NCT00440531|12026152|FG000|Overall Study|Adverse Event|1
7616246|NCT00440531|12026153|FG001|Overall Study|Adverse Event|0
7616247|NCT00440531|12026154|FG002|Overall Study|Adverse Event|2
7616248|NCT00440531|12026152|FG000|Overall Study|Withdrawal by Subject|2
7616249|NCT00440531|12026153|FG001|Overall Study|Withdrawal by Subject|0
7616250|NCT00440531|12026154|FG002|Overall Study|Withdrawal by Subject|0
7616251|NCT00440531|12026152|FG000|Overall Study|Protocol Violation|1
7616252|NCT00440531|12026153|FG001|Overall Study|Protocol Violation|2
7616253|NCT00440531|12026154|FG002|Overall Study|Protocol Violation|0
7616254|NCT00440531|12026152|FG000|Overall Study|Lost to Follow-up|4
7616255|NCT00440531|12026153|FG001|Overall Study|Lost to Follow-up|3
7616256|NCT00440531|12026154|FG002|Overall Study|Lost to Follow-up|5
7616257|NCT00440531|12026152|FG000|Overall Study|see pre-assignment details|2
7616258|NCT00440531|12026153|FG001|Overall Study|see pre-assignment details|0
7616259|NCT00440531|12026154|FG002|Overall Study|see pre-assignment details|0
7616260|NCT00439738|12026162|FG000|Overall Study|Withdrawal by Subject|16
7616261|NCT00439738|12026163|FG001|Overall Study|Withdrawal by Subject|13
7616262|NCT00439738|12026162|FG000|Overall Study|Adverse Event|6
7616263|NCT00439738|12026163|FG001|Overall Study|Adverse Event|4
7616264|NCT00439738|12026162|FG000|Overall Study|Lost to Follow-up|5
7616265|NCT00439738|12026163|FG001|Overall Study|Lost to Follow-up|6
7616266|NCT00439738|12026162|FG000|Overall Study|Protocol Violation|6
7616267|NCT00439738|12026163|FG001|Overall Study|Protocol Violation|3
7616268|NCT00439738|12026162|FG000|Overall Study|Lack of Efficacy|2
7616269|NCT00439738|12026163|FG001|Overall Study|Lack of Efficacy|2
7616270|NCT00439738|12026162|FG000|Overall Study|Abnormal Lab Values|1
7616271|NCT00439738|12026163|FG001|Overall Study|Abnormal Lab Values|0
7616272|NCT00430950|12026176|FG000|Overall Study|Adverse Event|7
7616273|NCT00430950|12026177|FG001|Overall Study|Adverse Event|6
7616274|NCT00430950|12026176|FG000|Overall Study|Withdrawal by Subject|1
7616275|NCT00430950|12026177|FG001|Overall Study|Withdrawal by Subject|0
7616276|NCT00430950|12026176|FG000|Overall Study|concomitant medication,etc.|5
7616277|NCT00430950|12026177|FG001|Overall Study|concomitant medication,etc.|7
7616278|NCT00430508|12026185|FG000|Overall Study|Adverse Event|2
7616279|NCT00430508|12026186|FG001|Overall Study|Adverse Event|3
7616280|NCT00430508|12026187|FG002|Overall Study|Adverse Event|5
7780724|NCT00952705|12229086|FG002|Overall Study|Lost to Follow-up|9
7616282|NCT00430508|12026185|FG000|Overall Study|Withdrawal by Subject|0
7616283|NCT00430508|12026186|FG001|Overall Study|Withdrawal by Subject|1
7616284|NCT00430508|12026187|FG002|Overall Study|Withdrawal by Subject|1
7616285|NCT00430508|12026188|FG003|Overall Study|Withdrawal by Subject|1
7616286|NCT00430508|12026185|FG000|Overall Study|responder at visit 4|0
7616287|NCT00430508|12026186|FG001|Overall Study|responder at visit 4|0
7616288|NCT00430508|12026187|FG002|Overall Study|responder at visit 4|2
7616289|NCT00430508|12026188|FG003|Overall Study|responder at visit 4|0
7616290|NCT00430508|12026185|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
7616291|NCT00430508|12026186|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
7616292|NCT00430508|12026187|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
7616293|NCT00430508|12026188|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
7616294|NCT00430508|12026185|FG000|Overall Study|Other|1
7616295|NCT00430508|12026186|FG001|Overall Study|Other|1
7616296|NCT00430508|12026187|FG002|Overall Study|Other|3
7616297|NCT00430508|12026188|FG003|Overall Study|Other|0
7616298|NCT00430092|12026197|FG000|Overall Study|Adverse Event|0
7616299|NCT00430092|12026198|FG001|Overall Study|Adverse Event|0
7616300|NCT00430092|12026199|FG002|Overall Study|Adverse Event|1
7616301|NCT00430092|12026197|FG000|Overall Study|Lack of Efficacy|5
7616302|NCT00430092|12026198|FG001|Overall Study|Lack of Efficacy|2
7616303|NCT00430092|12026199|FG002|Overall Study|Lack of Efficacy|54
7616304|NCT00430092|12026197|FG000|Overall Study|Lost to Follow-up|1
7616305|NCT00430092|12026198|FG001|Overall Study|Lost to Follow-up|0
7616306|NCT00430092|12026199|FG002|Overall Study|Lost to Follow-up|0
7616307|NCT00430092|12026197|FG000|Overall Study|Protocol Violation|0
7616308|NCT00430092|12026198|FG001|Overall Study|Protocol Violation|1
7616309|NCT00430092|12026199|FG002|Overall Study|Protocol Violation|1
7616310|NCT00430092|12026197|FG000|Overall Study|Withdrawal by Subject|0
7616311|NCT00430092|12026198|FG001|Overall Study|Withdrawal by Subject|1
7616312|NCT00430092|12026199|FG002|Overall Study|Withdrawal by Subject|1
7616313|NCT00429923|12026207|FG000|Overall Study|Adverse Event|0
7780725|NCT00952705|12229084|FG000|Overall Study|Withdrawal by Subject|2
7780726|NCT00952705|12229085|FG001|Overall Study|Withdrawal by Subject|1
7780727|NCT00952705|12229086|FG002|Overall Study|Withdrawal by Subject|1
7780728|NCT00952705|12229084|FG000|Overall Study|Death|2
7780729|NCT00952705|12229085|FG001|Overall Study|Death|0
7780730|NCT00952705|12229086|FG002|Overall Study|Death|0
7780731|NCT00952705|12229084|FG000|Overall Study|Incarcerated post dose|5
7780732|NCT00952705|12229085|FG001|Overall Study|Incarcerated post dose|0
7780733|NCT00952705|12229086|FG002|Overall Study|Incarcerated post dose|0
7780734|NCT00952705|12229084|FG000|Overall Study|Exclusion criteria not met pre dose|0
7780735|NCT00952705|12229085|FG001|Overall Study|Exclusion criteria not met pre dose|1
7780736|NCT00952705|12229086|FG002|Overall Study|Exclusion criteria not met pre dose|0
7780737|NCT00952731|12229111|FG000|Overall Study|Drug supply expired|1
7780738|NCT00952731|12229112|FG001|Overall Study|Drug supply expired|0
7780739|NCT00952822|12229118|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
7780740|NCT00952822|12229119|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
7780741|NCT00952822|12229120|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
7780742|NCT00952822|12229121|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
7780743|NCT00952822|12229118|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
7780744|NCT00952822|12229119|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
7780745|NCT00952822|12229120|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
7780746|NCT00952822|12229121|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
7780747|NCT00952848|12229132|FG000|Overall Study|Withdrawal by Subject|4
7780748|NCT00953017|12229140|FG000|Overall Study|DId not show up for colonoscopy|4
7780749|NCT00953017|12229141|FG001|Overall Study|DId not show up for colonoscopy|4
7780750|NCT00953017|12229142|FG002|Overall Study|DId not show up for colonoscopy|5
7780751|NCT00953017|12229143|FG003|Overall Study|DId not show up for colonoscopy|4
7780752|NCT00953017|12229140|FG000|Overall Study|Incomplete data|1
7780753|NCT00953017|12229141|FG001|Overall Study|Incomplete data|1
7616314|NCT00429923|12026208|FG001|Overall Study|Adverse Event|2
7616315|NCT00429923|12026209|FG002|Overall Study|Adverse Event|3
7616316|NCT00429923|12026207|FG000|Overall Study|Lack of Efficacy|4
7616317|NCT00429923|12026208|FG001|Overall Study|Lack of Efficacy|1
7616318|NCT00429923|12026209|FG002|Overall Study|Lack of Efficacy|33
7616319|NCT00429923|12026207|FG000|Overall Study|Lost to Follow-up|0
7780754|NCT00953017|12229142|FG002|Overall Study|Incomplete data|0
7780755|NCT00953017|12229143|FG003|Overall Study|Incomplete data|0
7780756|NCT00953017|12229140|FG000|Overall Study|Procedure incomplete due to pain/looping|0
7616320|NCT00429923|12026208|FG001|Overall Study|Lost to Follow-up|0
7616321|NCT00429923|12026209|FG002|Overall Study|Lost to Follow-up|2
7616322|NCT00429923|12026207|FG000|Overall Study|Withdrew Consent|1
7616323|NCT00429923|12026208|FG001|Overall Study|Withdrew Consent|0
7616324|NCT00429923|12026209|FG002|Overall Study|Withdrew Consent|1
7616325|NCT00429923|12026207|FG000|Overall Study|Early Termination|0
7616326|NCT00429923|12026208|FG001|Overall Study|Early Termination|1
7616327|NCT00429923|12026209|FG002|Overall Study|Early Termination|0
7780757|NCT00953017|12229141|FG001|Overall Study|Procedure incomplete due to pain/looping|1
7780758|NCT00953017|12229142|FG002|Overall Study|Procedure incomplete due to pain/looping|0
7780759|NCT00953017|12229143|FG003|Overall Study|Procedure incomplete due to pain/looping|1
7780760|NCT00953017|12229140|FG000|Overall Study|Brown stool prior to procedure|0
7616328|NCT00425100|12026214|FG000|Overall Study|Adverse Event|36
7616329|NCT00425100|12026214|FG000|Overall Study|Lack of Efficacy|4
7616330|NCT00425100|12026214|FG000|Overall Study|Lost to Follow-up|2
7616331|NCT00425100|12026214|FG000|Overall Study|Protocol Violation|4
7616332|NCT00425100|12026214|FG000|Overall Study|Withdrawal by Subject|7
7616333|NCT00415623|12026221|FG000|Overall Study|Adverse Event|3
7616334|NCT00415623|12026222|FG001|Overall Study|Adverse Event|4
7616335|NCT00415623|12026221|FG000|Overall Study|Death|1
7616336|NCT00415623|12026222|FG001|Overall Study|Death|0
7616337|NCT00415623|12026221|FG000|Overall Study|Withdrawal by Subject|1
7616338|NCT00415623|12026222|FG001|Overall Study|Withdrawal by Subject|1
7616339|NCT00412932|12026229|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1
7616340|NCT00412932|12026229|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
7616341|NCT00412932|12026229|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1
7616342|NCT00412932|12026229|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
7616343|NCT00412932|12026229|FG000|Olmesartan (Olm) 20 mg|Other|1
7616344|NCT00412932|12026229|FG000|Olmesartan 40 mg|Adverse Event|4
7616345|NCT00412932|12026229|FG000|Olmesartan 40 mg|Lack of Efficacy|3
7616346|NCT00412932|12026229|FG000|Olmesartan 40 mg|Withdrawal by Subject|1
7616347|NCT00412932|12026229|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
7616348|NCT00412932|12026229|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
7616349|NCT00412932|12026229|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
7616350|NCT00412932|12026229|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
7780761|NCT00953017|12229141|FG001|Overall Study|Brown stool prior to procedure|0
7780762|NCT00953017|12229142|FG002|Overall Study|Brown stool prior to procedure|1
7780763|NCT00953017|12229143|FG003|Overall Study|Brown stool prior to procedure|0
7780764|NCT00953043|12229155|FG000|Overall Study|Withdrawal by Subject|4
7780765|NCT00953043|12229156|FG001|Overall Study|Withdrawal by Subject|0
7780766|NCT00953043|12229155|FG000|Overall Study|Physician Decision|0
7780767|NCT00953043|12229156|FG001|Overall Study|Physician Decision|2
7780768|NCT00953056|12229168|FG000|Overall Study|Withdrew Consent|0
7780769|NCT00953056|12229169|FG001|Overall Study|Withdrew Consent|0
7616351|NCT00397254|12026232|FG000|Overall Study|Lost to Follow-up|2
7616352|NCT00397254|12026233|FG001|Overall Study|Lost to Follow-up|2
7780770|NCT00953056|12229170|FG002|Overall Study|Withdrew Consent|0
7780771|NCT00953056|12229171|FG003|Overall Study|Withdrew Consent|0
7780772|NCT00953056|12229172|FG004|Overall Study|Withdrew Consent|2
7780773|NCT00953056|12229173|FG005|Overall Study|Withdrew Consent|3
7780774|NCT00953056|12229168|FG000|Overall Study|Serious Adverse Event|0
7780775|NCT00953056|12229169|FG001|Overall Study|Serious Adverse Event|0
7780776|NCT00953056|12229170|FG002|Overall Study|Serious Adverse Event|0
7780777|NCT00953056|12229171|FG003|Overall Study|Serious Adverse Event|0
7780778|NCT00953056|12229172|FG004|Overall Study|Serious Adverse Event|0
7780779|NCT00953056|12229173|FG005|Overall Study|Serious Adverse Event|1
7780780|NCT00953147|12229205|FG000|Overall Study|Adverse Event|8
7780781|NCT00953147|12229206|FG001|Overall Study|Adverse Event|16
7780782|NCT00953147|12229207|FG002|Overall Study|Adverse Event|6
7780783|NCT00953147|12229205|FG000|Overall Study|Protocol Violation|2
7780784|NCT00953147|12229206|FG001|Overall Study|Protocol Violation|8
7780785|NCT00953147|12229207|FG002|Overall Study|Protocol Violation|4
7780786|NCT00953147|12229205|FG000|Overall Study|Withdrawal by Subject|13
7780787|NCT00953147|12229206|FG001|Overall Study|Withdrawal by Subject|15
7780788|NCT00953147|12229207|FG002|Overall Study|Withdrawal by Subject|12
7780789|NCT00953147|12229205|FG000|Overall Study|Lost to Follow-up|8
7780790|NCT00953147|12229206|FG001|Overall Study|Lost to Follow-up|9
7780791|NCT00953147|12229207|FG002|Overall Study|Lost to Follow-up|4
7780792|NCT00953147|12229205|FG000|Overall Study|Physician Decision|2
7780793|NCT00953147|12229206|FG001|Overall Study|Physician Decision|7
7780794|NCT00953147|12229207|FG002|Overall Study|Physician Decision|3
7780795|NCT00953147|12229205|FG000|Overall Study|Other|4
7780796|NCT00953147|12229206|FG001|Overall Study|Other|11
7780797|NCT00953147|12229207|FG002|Overall Study|Other|13
7780798|NCT00953160|12229215|FG000|Overall Study|Lost to Follow-up|23
7780799|NCT00953160|12229215|FG000|Overall Study|Withdrawal by Subject|4
7780800|NCT00953225|12229257|FG000|Overall Study|Withdrawal by Subject|2
7780801|NCT00953225|12229258|FG001|Overall Study|Withdrawal by Subject|0
7780802|NCT00953407|12229276|FG000|Overall Study|Failed inclusion criteria|1
7616353|NCT00338104|12026261|FG000|Overall Study|Protocol Violation|2
7616354|NCT00338104|12026262|FG001|Overall Study|Protocol Violation|1
7616355|NCT00338104|12026263|FG002|Overall Study|Protocol Violation|3
7616356|NCT00326183|12026273|FG000|Overall Study|Lost to Follow-up|104
7616357|NCT00326183|12026274|FG001|Overall Study|Lost to Follow-up|56
7616358|NCT00326183|12026273|FG000|Overall Study|Protocol Violation|6
7616359|NCT00326183|12026274|FG001|Overall Study|Protocol Violation|3
7616360|NCT00326183|12026273|FG000|Overall Study|Withdrawal by Subject|35
7616361|NCT00326183|12026274|FG001|Overall Study|Withdrawal by Subject|7
7616362|NCT00326183|12026273|FG000|Overall Study|Subject Moved|7
7616363|NCT00326183|12026274|FG001|Overall Study|Subject Moved|4
7616364|NCT00326183|12026273|FG000|Overall Study|Other|47
7616365|NCT00326183|12026274|FG001|Overall Study|Other|13
7616366|NCT00326183|12026273|FG000|Overall Study|Adverse Event|1
7616367|NCT00326183|12026274|FG001|Overall Study|Adverse Event|0
7616368|NCT00318656|12026287|FG000|Overall Study|Took Avandamet instead of Glim/Met|0
7616369|NCT00318656|12026288|FG001|Overall Study|Took Avandamet instead of Glim/Met|1
7616370|NCT00318656|12026287|FG000|Overall Study|Did not receive any treatment|0
7616371|NCT00318656|12026288|FG001|Overall Study|Did not receive any treatment|1
7616372|NCT00301262|12026294|FG000|Double Blind Phase (DB)|Adverse Event|1
7616373|NCT00301262|12026295|FG001|Double Blind Phase (DB)|Adverse Event|0
7616374|NCT00301262|12026294|FG000|Double Blind Phase (DB)|Lack of Efficacy|0
7616375|NCT00301262|12026295|FG001|Double Blind Phase (DB)|Lack of Efficacy|1
7616376|NCT00301262|12026294|FG000|Double Blind Phase (DB)|Lost to Follow-up|3
7616377|NCT00301262|12026295|FG001|Double Blind Phase (DB)|Lost to Follow-up|3
7616378|NCT00301262|12026294|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5
7616379|NCT00301262|12026295|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5
7616380|NCT00301262|12026294|FG000|Double Blind Phase (DB)|Other|1
7616381|NCT00301262|12026295|FG001|Double Blind Phase (DB)|Other|4
7616382|NCT00301262|12026294|FG000|Open Label Phase (OL)|Adverse Event|1
7616383|NCT00301262|12026295|FG001|Open Label Phase (OL)|Adverse Event|0
7616384|NCT00301262|12026294|FG000|Open Label Phase (OL)|Lost to Follow-up|1
7616385|NCT00301262|12026295|FG001|Open Label Phase (OL)|Lost to Follow-up|2
7616386|NCT00301262|12026294|FG000|Open Label Phase (OL)|Other|2
7616387|NCT00301262|12026295|FG001|Open Label Phase (OL)|Other|0
7616388|NCT00283868|12026322|FG000|Overall Study|Lost to Follow-up|7
7616389|NCT00283868|12026323|FG001|Overall Study|Lost to Follow-up|8
7616390|NCT00282867|12026330|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
7616391|NCT00282867|12026331|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
7616392|NCT00282867|12026332|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
7616393|NCT00275340|12026339|FG000|Overall Study|Lost to Follow-up|2
7616394|NCT00275340|12026340|FG001|Overall Study|Lost to Follow-up|4
7616395|NCT00271544|12026344|FG000|Overall Study|Subjects did not receive a 4196 lead|7
7616396|NCT00271544|12026344|FG000|Overall Study|Model 4196 lead not attempted|9
7616397|NCT00271544|12026344|FG000|Overall Study|Implant not attempted|4
7616398|NCT00235326|12026381|FG000|Overall Study|Lost to Follow-up|746
7616399|NCT00235326|12026382|FG001|Overall Study|Lost to Follow-up|1400
7616400|NCT00232141|12026388|FG000|Overall Study|Adverse Event|9
7616401|NCT00232141|12026389|FG001|Overall Study|Adverse Event|4
7616402|NCT00232141|12026388|FG000|Overall Study|Lack of Efficacy|0
7616403|NCT00232141|12026389|FG001|Overall Study|Lack of Efficacy|3
7616404|NCT00232141|12026388|FG000|Overall Study|Lost to Follow-up|9
7616405|NCT00232141|12026389|FG001|Overall Study|Lost to Follow-up|6
7616406|NCT00232141|12026388|FG000|Overall Study|Other|8
7616407|NCT00232141|12026389|FG001|Overall Study|Other|10
7616408|NCT00232141|12026388|FG000|Overall Study|Withdrawal by Subject|5
7616409|NCT00232141|12026389|FG001|Overall Study|Withdrawal by Subject|3
7616410|NCT00224003|12026400|FG000|Overall Study|Adverse Event|1
7616411|NCT00224003|12026400|FG000|Overall Study|Protocol Violation|2
7616412|NCT00224003|12026400|FG000|Overall Study|Withdrawal by Subject|1
7616413|NCT00224003|12026400|FG000|Overall Study|unk|3
7616414|NCT00162942|12026405|FG000|Overall Study|Adverse Event|10
7616415|NCT00162942|12026406|FG001|Overall Study|Adverse Event|6
7616416|NCT00162942|12026405|FG000|Overall Study|Death|1
7616417|NCT00162942|12026406|FG001|Overall Study|Death|0
7616418|NCT00162942|12026405|FG000|Overall Study|Withdrawal by Subject|3
7616419|NCT00162942|12026406|FG001|Overall Study|Withdrawal by Subject|6
7616420|NCT00162942|12026405|FG000|Overall Study|Physician Decision|1
7616421|NCT00162942|12026406|FG001|Overall Study|Physician Decision|0
7616422|NCT00162942|12026405|FG000|Overall Study|Enter Open-Label Study|76
7616423|NCT00162942|12026406|FG001|Overall Study|Enter Open-Label Study|35
7616424|NCT00162942|12026405|FG000|Overall Study|Alternate Therapy|6
7616425|NCT00162942|12026406|FG001|Overall Study|Alternate Therapy|2
7616426|NCT00162942|12026405|FG000|Overall Study|Lack of Efficacy|1
7616427|NCT00162942|12026406|FG001|Overall Study|Lack of Efficacy|0
7616428|NCT00162942|12026405|FG000|Overall Study|Flare During Active Treatment|7
7616429|NCT00162942|12026406|FG001|Overall Study|Flare During Active Treatment|3
7616430|NCT00162942|12026405|FG000|Overall Study|2 or more consecutive treatments missed|1
7616431|NCT00162942|12026406|FG001|Overall Study|2 or more consecutive treatments missed|0
7616432|NCT00126776|12026426|FG000|Overall Study|follow up complete on all patients|0
7616433|NCT00126776|12026427|FG001|Overall Study|follow up complete on all patients|0
7616434|NCT00120042|12026434|FG000|Overall Study|all completed protocl|0
7616435|NCT00120042|12026435|FG001|Overall Study|all completed protocl|0
7616436|NCT00120042|12026436|FG002|Overall Study|all completed protocl|0
7616437|NCT00106626|12026445|FG000|Overall Study|Adverse Event|5
7616438|NCT00106626|12026446|FG001|Overall Study|Adverse Event|4
7616439|NCT00106626|12026447|FG002|Overall Study|Adverse Event|3
7616440|NCT00106626|12026448|FG003|Overall Study|Adverse Event|3
7616441|NCT00106626|12026445|FG000|Overall Study|Progressive Disease|4
7616442|NCT00106626|12026446|FG001|Overall Study|Progressive Disease|1
7616443|NCT00106626|12026447|FG002|Overall Study|Progressive Disease|9
7616444|NCT00106626|12026448|FG003|Overall Study|Progressive Disease|10
7616445|NCT00106626|12026445|FG000|Overall Study|Received radiation on new therapy|1
7616446|NCT00106626|12026446|FG001|Overall Study|Received radiation on new therapy|0
7616447|NCT00106626|12026447|FG002|Overall Study|Received radiation on new therapy|0
7616448|NCT00106626|12026448|FG003|Overall Study|Received radiation on new therapy|0
7616449|NCT00106626|12026445|FG000|Overall Study|> 14 day delay in therapy start|0
7616450|NCT00106626|12026446|FG001|Overall Study|> 14 day delay in therapy start|1
7616451|NCT00106626|12026447|FG002|Overall Study|> 14 day delay in therapy start|0
7616452|NCT00106626|12026448|FG003|Overall Study|> 14 day delay in therapy start|0
7616453|NCT00089141|12026465|FG000|Overall Study|Termination of trial|18
7616454|NCT00089141|12026466|FG001|Overall Study|Termination of trial|24
7780803|NCT00953407|12229277|FG001|Overall Study|Failed inclusion criteria|1
7780804|NCT00953407|12229278|FG002|Overall Study|Failed inclusion criteria|1
7780805|NCT00953407|12229279|FG003|Overall Study|Failed inclusion criteria|1
7616455|NCT00083759|12026472|FG000|Overall Study|Adverse Event|5
7616456|NCT00083759|12026473|FG001|Overall Study|Adverse Event|3
7616457|NCT00083759|12026472|FG000|Overall Study|Lost to Follow-up|1
7616458|NCT00083759|12026473|FG001|Overall Study|Lost to Follow-up|0
7616459|NCT00083759|12026472|FG000|Overall Study|Death|1
7616460|NCT00083759|12026473|FG001|Overall Study|Death|1
7616461|NCT00083759|12026472|FG000|Overall Study|Inadequate Therapeutic Response|32
7616462|NCT00083759|12026473|FG001|Overall Study|Inadequate Therapeutic Response|35
7616463|NCT00083759|12026472|FG000|Overall Study|Subject Withdrew Consent|2
7616464|NCT00083759|12026473|FG001|Overall Study|Subject Withdrew Consent|2
7616465|NCT00083759|12026472|FG000|Overall Study|Non-Compliance|1
7616466|NCT00083759|12026473|FG001|Overall Study|Non-Compliance|0
7616467|NCT00083759|12026472|FG000|Overall Study|Sponsor's Discretion|28
7616468|NCT00083759|12026473|FG001|Overall Study|Sponsor's Discretion|29
7616469|NCT00083759|12026472|FG000|Overall Study|Other|14
7616470|NCT00083759|12026473|FG001|Overall Study|Other|13
7616471|NCT03513068|12026479|FG000|Overall Study|Death|1
7616472|NCT03513068|12026480|FG001|Overall Study|Death|0
7616473|NCT03513068|12026479|FG000|Overall Study|Withdrawal by Subject|4
7616474|NCT03513068|12026480|FG001|Overall Study|Withdrawal by Subject|6
7616475|NCT03507127|12026488|FG000|Overall Study|Withdrawal by Subject|1
7616476|NCT03507127|12026489|FG001|Overall Study|Withdrawal by Subject|0
7616477|NCT03507127|12026488|FG000|Overall Study|Unable to meet smoking abstinence criterion|1
7616478|NCT03507127|12026489|FG001|Overall Study|Unable to meet smoking abstinence criterion|1
7616479|NCT03502811|12026495|FG000|Overall Study|Death|157
7616480|NCT03502811|12026495|FG000|Overall Study|Withdrawal by Subject|105
7616481|NCT03502811|12026495|FG000|Overall Study|Lost to Follow-up|26
7616482|NCT03502811|12026495|FG000|Overall Study|No Visits (Missed)|31
7616491|NCT03530995|12026529|FG000|Part 1 Period 3|Withdrawal by Subject|2
7616492|NCT03530995|12026530|FG001|Part 1 Period 3|Withdrawal by Subject|0
7616493|NCT03530995|12026529|FG000|Part 1 Period 3|Protocol Violation|1
7616494|NCT03530995|12026530|FG001|Part 1 Period 3|Protocol Violation|0
7616495|NCT03530995|12026529|FG000|Part 1 Period 4|Physician Decision|1
7616496|NCT03530995|12026530|FG001|Part 1 Period 4|Physician Decision|0
7616497|NCT03530995|12026529|FG000|Part 1 Period 4|Withdrawal by Subject|1
7616498|NCT03530995|12026530|FG001|Part 1 Period 4|Withdrawal by Subject|0
7780806|NCT00953407|12229280|FG004|Overall Study|Failed inclusion criteria|1
7616499|NCT03204812|12026560|FG000|Overall Study|Adverse Event|3
7780807|NCT00953407|12229276|FG000|Overall Study|Lost to Follow-up|0
7780808|NCT00953407|12229277|FG001|Overall Study|Lost to Follow-up|0
7780809|NCT00953407|12229278|FG002|Overall Study|Lost to Follow-up|0
7780810|NCT00953407|12229279|FG003|Overall Study|Lost to Follow-up|1
7780811|NCT00953407|12229280|FG004|Overall Study|Lost to Follow-up|0
7780812|NCT00953524|12229296|FG000|Overall Study|Adverse Event|2
7780813|NCT00953524|12229297|FG001|Overall Study|Adverse Event|0
7780814|NCT00953524|12229298|FG002|Overall Study|Adverse Event|1
7780815|NCT00953524|12229299|FG003|Overall Study|Adverse Event|2
7780816|NCT00953524|12229296|FG000|Overall Study|Protocol Violation|18
7616510|NCT03072459|12026571|FG000|Overall Study|Device revised/removed|1
7616511|NCT03072459|12026571|FG000|Overall Study|Subject not able to return|1
7616512|NCT03029234|12026575|FG000|Overall Study|Sponsor Decision|1
7616513|NCT03029234|12026575|FG000|Overall Study|Withdrawal by Subject|5
7616514|NCT03029234|12026575|FG000|Overall Study|Death|91
7616515|NCT03029234|12026575|FG000|Overall Study|Lost to Follow-up|2
7616516|NCT03019406|12026583|FG000|ETP: Ongoing From Week 26|Ongoing|6
7616517|NCT03019406|12026584|FG001|ETP: Ongoing From Week 26|Ongoing|5
7616518|NCT03019406|12026585|FG002|ETP: Ongoing From Week 26|Ongoing|5
7616519|NCT03019406|12026586|FG003|ETP: Ongoing From Week 26|Ongoing|3
7616520|NCT02874144|12026601|FG000|Overall Study|Lost to Follow-up|3
7616521|NCT02874144|12026602|FG001|Overall Study|Lost to Follow-up|5
7616522|NCT02611830|12026612|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9
7616523|NCT02611830|12026613|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0
7616524|NCT02611830|12026614|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0
7616525|NCT02611830|12026615|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0
7616526|NCT02611830|12026612|FG000|OL Induction Phase|Significant Protocol Deviation|4
7616527|NCT02611830|12026613|FG001|OL Induction Phase|Significant Protocol Deviation|0
7616528|NCT02611830|12026614|FG002|OL Induction Phase|Significant Protocol Deviation|0
7616529|NCT02611830|12026615|FG003|OL Induction Phase|Significant Protocol Deviation|0
7616530|NCT02611830|12026612|FG000|OL Induction Phase|Voluntary Withdrawal|5
7616531|NCT02611830|12026613|FG001|OL Induction Phase|Voluntary Withdrawal|0
7616532|NCT02611830|12026614|FG002|OL Induction Phase|Voluntary Withdrawal|0
7616533|NCT02611830|12026615|FG003|OL Induction Phase|Voluntary Withdrawal|0
7616534|NCT02611830|12026612|FG000|OL Induction Phase|Lack of Efficacy|9
7616535|NCT02611830|12026613|FG001|OL Induction Phase|Lack of Efficacy|0
7616536|NCT02611830|12026614|FG002|OL Induction Phase|Lack of Efficacy|0
7616537|NCT02611830|12026615|FG003|OL Induction Phase|Lack of Efficacy|0
7616538|NCT02611830|12026612|FG000|OL Induction Phase|Reason not specified|3
7616539|NCT02611830|12026613|FG001|OL Induction Phase|Reason not specified|0
7780817|NCT00953524|12229297|FG001|Overall Study|Protocol Violation|10
7616540|NCT02611830|12026614|FG002|OL Induction Phase|Reason not specified|0
7616541|NCT02611830|12026615|FG003|OL Induction Phase|Reason not specified|0
7616542|NCT02611830|12026612|FG000|Maintenance Phase|Lack of Efficacy|0
7616543|NCT02611830|12026613|FG001|Maintenance Phase|Lack of Efficacy|29
7616544|NCT02611830|12026614|FG002|Maintenance Phase|Lack of Efficacy|18
7616545|NCT02611830|12026615|FG003|Maintenance Phase|Lack of Efficacy|6
7616546|NCT02611830|12026612|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0
7616547|NCT02611830|12026613|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5
7616548|NCT02611830|12026614|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5
7616549|NCT02611830|12026615|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2
7616550|NCT02611830|12026612|FG000|Maintenance Phase|Significant Protocol Deviation|0
7616551|NCT02611830|12026613|FG001|Maintenance Phase|Significant Protocol Deviation|0
7616552|NCT02611830|12026614|FG002|Maintenance Phase|Significant Protocol Deviation|1
7616553|NCT02611830|12026615|FG003|Maintenance Phase|Significant Protocol Deviation|1
7616554|NCT02611830|12026612|FG000|Maintenance Phase|Lost to Follow-up|0
7616555|NCT02611830|12026613|FG001|Maintenance Phase|Lost to Follow-up|0
7616556|NCT02611830|12026614|FG002|Maintenance Phase|Lost to Follow-up|0
7616557|NCT02611830|12026615|FG003|Maintenance Phase|Lost to Follow-up|1
7616558|NCT02611830|12026612|FG000|Maintenance Phase|Voluntary Withdrawal|0
7616559|NCT02611830|12026613|FG001|Maintenance Phase|Voluntary Withdrawal|1
7616560|NCT02611830|12026614|FG002|Maintenance Phase|Voluntary Withdrawal|2
7616561|NCT02611830|12026615|FG003|Maintenance Phase|Voluntary Withdrawal|5
7616562|NCT02611830|12026612|FG000|Maintenance Phase|Pregnancy|0
7616563|NCT02611830|12026613|FG001|Maintenance Phase|Pregnancy|0
7616564|NCT02611830|12026614|FG002|Maintenance Phase|Pregnancy|1
7616565|NCT02611830|12026615|FG003|Maintenance Phase|Pregnancy|0
7616566|NCT02611830|12026612|FG000|Maintenance Phase|Reason not specified|0
7616567|NCT02611830|12026613|FG001|Maintenance Phase|Reason not specified|1
7616568|NCT02611830|12026614|FG002|Maintenance Phase|Reason not specified|4
7616569|NCT02611830|12026615|FG003|Maintenance Phase|Reason not specified|0
7616570|NCT02611817|12026627|FG000|Open-label Induction Phase|Reason not Specified|9
7616571|NCT02611817|12026628|FG001|Open-label Induction Phase|Reason not Specified|0
7616572|NCT02611817|12026629|FG002|Open-label Induction Phase|Reason not Specified|0
7616573|NCT02611817|12026627|FG000|Open-label Induction Phase|Lack of Efficacy|8
7616574|NCT02611817|12026628|FG001|Open-label Induction Phase|Lack of Efficacy|0
7616575|NCT02611817|12026629|FG002|Open-label Induction Phase|Lack of Efficacy|0
7616576|NCT02611817|12026627|FG000|Open-label Induction Phase|Pregnancy|1
7616577|NCT02611817|12026628|FG001|Open-label Induction Phase|Pregnancy|0
7616578|NCT02611817|12026629|FG002|Open-label Induction Phase|Pregnancy|0
7616579|NCT02611817|12026627|FG000|Open-label Induction Phase|Withdrawal by Subject|9
7616580|NCT02611817|12026628|FG001|Open-label Induction Phase|Withdrawal by Subject|0
7616581|NCT02611817|12026629|FG002|Open-label Induction Phase|Withdrawal by Subject|0
7616582|NCT02611817|12026627|FG000|Open-label Induction Phase|Lost to Follow-up|2
7616583|NCT02611817|12026628|FG001|Open-label Induction Phase|Lost to Follow-up|0
7616584|NCT02611817|12026629|FG002|Open-label Induction Phase|Lost to Follow-up|0
7616585|NCT02611817|12026627|FG000|Open-label Induction Phase|Protocol Violation|5
7616586|NCT02611817|12026628|FG001|Open-label Induction Phase|Protocol Violation|0
7616587|NCT02611817|12026629|FG002|Open-label Induction Phase|Protocol Violation|0
7616588|NCT02611817|12026627|FG000|Open-label Induction Phase|Adverse Event|16
7616589|NCT02611817|12026628|FG001|Open-label Induction Phase|Adverse Event|0
7616590|NCT02611817|12026629|FG002|Open-label Induction Phase|Adverse Event|0
7616591|NCT02611817|12026627|FG000|Double-blind Maintenance Phase|Adverse Event|0
7616592|NCT02611817|12026628|FG001|Double-blind Maintenance Phase|Adverse Event|12
7616593|NCT02611817|12026629|FG002|Double-blind Maintenance Phase|Adverse Event|11
7616594|NCT02611817|12026627|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0
7616595|NCT02611817|12026628|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1
7616596|NCT02611817|12026629|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0
7616597|NCT02611817|12026627|FG000|Double-blind Maintenance Phase|Reason not Specified|0
7616598|NCT02611817|12026628|FG001|Double-blind Maintenance Phase|Reason not Specified|1
7616599|NCT02611817|12026629|FG002|Double-blind Maintenance Phase|Reason not Specified|2
7616600|NCT02611817|12026627|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0
7616601|NCT02611817|12026628|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43
7616602|NCT02611817|12026629|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78
7616603|NCT02611817|12026627|FG000|Double-blind Maintenance Phase|Pregnancy|0
7616604|NCT02611817|12026628|FG001|Double-blind Maintenance Phase|Pregnancy|0
7616605|NCT02611817|12026629|FG002|Double-blind Maintenance Phase|Pregnancy|1
7616606|NCT02611817|12026627|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0
7616607|NCT02611817|12026628|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5
7616608|NCT02611817|12026629|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14
7616609|NCT02611817|12026627|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0
7616610|NCT02611817|12026628|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0
7616611|NCT02611817|12026629|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1
7616612|NCT02557139|12026639|FG000|Overall Study|Significant liver elevation|1
7616613|NCT02557139|12026640|FG001|Overall Study|Significant liver elevation|0
7616614|NCT02557139|12026641|FG002|Overall Study|Significant liver elevation|1
7616615|NCT02557139|12026639|FG000|Overall Study|Withdrawal by Subject|1
7616616|NCT02557139|12026640|FG001|Overall Study|Withdrawal by Subject|0
7616617|NCT02557139|12026641|FG002|Overall Study|Withdrawal by Subject|0
7616618|NCT02557139|12026639|FG000|Overall Study|Illness of prohibited medication|0
7616619|NCT02557139|12026640|FG001|Overall Study|Illness of prohibited medication|0
7616620|NCT02557139|12026641|FG002|Overall Study|Illness of prohibited medication|1
7616621|NCT02211131|12026660|FG000|Overall Study|Death|20
7616622|NCT02211131|12026661|FG001|Overall Study|Death|11
7616623|NCT02211131|12026660|FG000|Overall Study|Lost to Follow-up|1
7616624|NCT02211131|12026661|FG001|Overall Study|Lost to Follow-up|0
7616625|NCT02211131|12026660|FG000|Overall Study|Decision by Sponsor|1
7616626|NCT02211131|12026661|FG001|Overall Study|Decision by Sponsor|1
7616627|NCT02211131|12026660|FG000|Overall Study|Withdrawal by Subject|3
7616628|NCT02211131|12026661|FG001|Overall Study|Withdrawal by Subject|4
7616629|NCT02211131|12026660|FG000|Overall Study|Continuing on Study|49
7616630|NCT02211131|12026661|FG001|Overall Study|Continuing on Study|60
7616631|NCT02186847|12026676|FG000|Overall Study|Protocol Violation|3
7616632|NCT02186847|12026677|FG001|Overall Study|Protocol Violation|0
7616633|NCT02101034|12026688|FG000|Overall Study|Enrolled but did not start treatment|0
7616634|NCT02101034|12026689|FG001|Overall Study|Enrolled but did not start treatment|0
7616635|NCT02101034|12026690|FG002|Overall Study|Enrolled but did not start treatment|1
7616636|NCT02101034|12026691|FG003|Overall Study|Enrolled but did not start treatment|0
7616637|NCT02101034|12026692|FG004|Overall Study|Enrolled but did not start treatment|0
7780818|NCT00953524|12229298|FG002|Overall Study|Protocol Violation|11
7780819|NCT00953524|12229299|FG003|Overall Study|Protocol Violation|6
7780820|NCT00953524|12229296|FG000|Overall Study|Lost to Follow-up|0
7780821|NCT00953524|12229297|FG001|Overall Study|Lost to Follow-up|1
7780822|NCT00953524|12229298|FG002|Overall Study|Lost to Follow-up|1
7780823|NCT00953524|12229299|FG003|Overall Study|Lost to Follow-up|0
7780824|NCT00953524|12229296|FG000|Overall Study|Withdrawal by Subject|2
7780825|NCT00953524|12229297|FG001|Overall Study|Withdrawal by Subject|4
7780826|NCT00953524|12229298|FG002|Overall Study|Withdrawal by Subject|1
7780827|NCT00953524|12229299|FG003|Overall Study|Withdrawal by Subject|0
7780828|NCT00953576|12229311|FG000|Overall Study|Adverse Event|0
7780829|NCT00953576|12229312|FG001|Overall Study|Adverse Event|1
7780830|NCT00953576|12229311|FG000|Overall Study|Ineligible after Consent|2
7780831|NCT00953576|12229312|FG001|Overall Study|Ineligible after Consent|0
7780832|NCT00953667|12229334|FG000|Overall Study|Lost to Follow-up|11
7780833|NCT00953667|12229334|FG000|Overall Study|Physician Decision|35
7780834|NCT00953667|12229334|FG000|Overall Study|Withdrawal by Subject|63
7780835|NCT00953667|12229334|FG000|Overall Study|Adverse Event|10
7780836|NCT00953667|12229334|FG000|Overall Study|poor venous access,unable to draw blood|4
7780837|NCT00953706|12229340|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
7780838|NCT00953706|12229341|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
7780839|NCT00953706|12229342|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
7780840|NCT00953706|12229343|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
7780841|NCT00953706|12229340|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
7780842|NCT00953706|12229341|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
7780843|NCT00953706|12229342|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
7780844|NCT00953706|12229343|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
7780845|NCT00953706|12229340|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
7780846|NCT00953706|12229341|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
7780847|NCT00953706|12229342|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
7780848|NCT00953706|12229343|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
7780849|NCT00953706|12229340|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
7780850|NCT00953706|12229341|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
7780851|NCT00953706|12229342|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
7780852|NCT00953706|12229343|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
7780853|NCT00953706|12229340|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
7780854|NCT00953706|12229341|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
7780855|NCT00953706|12229342|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
7780856|NCT00953706|12229343|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
7780857|NCT00953706|12229340|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0
7780858|NCT00953706|12229341|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0
7616660|NCT01865617|12026732|FG000|Overall Study|Death|27
7616661|NCT01865617|12026733|FG001|Overall Study|Death|3
7616662|NCT01865617|12026734|FG002|Overall Study|Death|1
7616663|NCT01865617|12026735|FG003|Overall Study|Death|1
7616664|NCT01865617|12026736|FG004|Overall Study|Death|5
7616665|NCT01865617|12026737|FG005|Overall Study|Death|1
7616666|NCT01865617|12026738|FG006|Overall Study|Death|11
7616667|NCT01865617|12026739|FG007|Overall Study|Death|1
7616668|NCT01865617|12026740|FG008|Overall Study|Death|11
7616669|NCT01865617|12026741|FG009|Overall Study|Death|3
7616670|NCT01865617|12026742|FG010|Overall Study|Death|32
7616671|NCT01865617|12026743|FG011|Overall Study|Death|6
7616672|NCT01865617|12026744|FG012|Overall Study|Death|13
7616673|NCT01865617|12026732|FG000|Overall Study|Lost to Follow-up|2
7616674|NCT01865617|12026733|FG001|Overall Study|Lost to Follow-up|0
7616675|NCT01865617|12026734|FG002|Overall Study|Lost to Follow-up|0
7616676|NCT01865617|12026735|FG003|Overall Study|Lost to Follow-up|0
7616677|NCT01865617|12026736|FG004|Overall Study|Lost to Follow-up|0
7616678|NCT01865617|12026737|FG005|Overall Study|Lost to Follow-up|0
7616679|NCT01865617|12026738|FG006|Overall Study|Lost to Follow-up|0
7780859|NCT00953706|12229342|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0
7780860|NCT00953706|12229343|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2
7616680|NCT01865617|12026739|FG007|Overall Study|Lost to Follow-up|0
7616681|NCT01865617|12026740|FG008|Overall Study|Lost to Follow-up|0
7616682|NCT01865617|12026741|FG009|Overall Study|Lost to Follow-up|0
7616683|NCT01865617|12026742|FG010|Overall Study|Lost to Follow-up|0
7616684|NCT01865617|12026743|FG011|Overall Study|Lost to Follow-up|0
7616685|NCT01865617|12026744|FG012|Overall Study|Lost to Follow-up|0
7616686|NCT01865617|12026732|FG000|Overall Study|Withdrawal by Subject|1
7616687|NCT01865617|12026733|FG001|Overall Study|Withdrawal by Subject|0
7616688|NCT01865617|12026734|FG002|Overall Study|Withdrawal by Subject|0
7616689|NCT01865617|12026735|FG003|Overall Study|Withdrawal by Subject|0
7616690|NCT01865617|12026736|FG004|Overall Study|Withdrawal by Subject|0
7616691|NCT01865617|12026737|FG005|Overall Study|Withdrawal by Subject|0
7616692|NCT01865617|12026738|FG006|Overall Study|Withdrawal by Subject|0
7616693|NCT01865617|12026739|FG007|Overall Study|Withdrawal by Subject|0
7616694|NCT01865617|12026740|FG008|Overall Study|Withdrawal by Subject|0
7616695|NCT01865617|12026741|FG009|Overall Study|Withdrawal by Subject|0
7616696|NCT01865617|12026742|FG010|Overall Study|Withdrawal by Subject|0
7616697|NCT01865617|12026743|FG011|Overall Study|Withdrawal by Subject|0
7616698|NCT01865617|12026744|FG012|Overall Study|Withdrawal by Subject|0
7616699|NCT01865617|12026732|FG000|Overall Study|Patient proceeded to new therapy|0
7616700|NCT01865617|12026733|FG001|Overall Study|Patient proceeded to new therapy|0
7616701|NCT01865617|12026734|FG002|Overall Study|Patient proceeded to new therapy|0
7616702|NCT01865617|12026735|FG003|Overall Study|Patient proceeded to new therapy|0
7616703|NCT01865617|12026736|FG004|Overall Study|Patient proceeded to new therapy|2
7616704|NCT01865617|12026737|FG005|Overall Study|Patient proceeded to new therapy|0
7616705|NCT01865617|12026738|FG006|Overall Study|Patient proceeded to new therapy|0
7616706|NCT01865617|12026739|FG007|Overall Study|Patient proceeded to new therapy|0
7616707|NCT01865617|12026740|FG008|Overall Study|Patient proceeded to new therapy|0
7616708|NCT01865617|12026741|FG009|Overall Study|Patient proceeded to new therapy|0
7616709|NCT01865617|12026742|FG010|Overall Study|Patient proceeded to new therapy|0
7616710|NCT01865617|12026743|FG011|Overall Study|Patient proceeded to new therapy|0
7616711|NCT01865617|12026744|FG012|Overall Study|Patient proceeded to new therapy|0
7616712|NCT01865617|12026732|FG000|Overall Study|Other|0
7616713|NCT01865617|12026733|FG001|Overall Study|Other|0
7616714|NCT01865617|12026734|FG002|Overall Study|Other|0
7616715|NCT01865617|12026735|FG003|Overall Study|Other|0
7616716|NCT01865617|12026736|FG004|Overall Study|Other|0
7616717|NCT01865617|12026737|FG005|Overall Study|Other|0
7616718|NCT01865617|12026738|FG006|Overall Study|Other|1
7616719|NCT01865617|12026739|FG007|Overall Study|Other|0
7616720|NCT01865617|12026740|FG008|Overall Study|Other|0
7616721|NCT01865617|12026741|FG009|Overall Study|Other|0
7616722|NCT01865617|12026742|FG010|Overall Study|Other|0
7616723|NCT01865617|12026743|FG011|Overall Study|Other|0
7616724|NCT01865617|12026744|FG012|Overall Study|Other|0
7616725|NCT01828112|12026777|FG000|Overall Study|Adverse Event|6
7616726|NCT01828112|12026778|FG001|Overall Study|Adverse Event|8
7780861|NCT00953706|12229340|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
7616727|NCT01828112|12026777|FG000|Overall Study|Death|9
7616728|NCT01828112|12026778|FG001|Overall Study|Death|5
7616729|NCT01828112|12026777|FG000|Overall Study|Physician Decision|5
7616730|NCT01828112|12026778|FG001|Overall Study|Physician Decision|5
7616731|NCT01828112|12026777|FG000|Overall Study|Progressive disease|56
7616732|NCT01828112|12026778|FG001|Overall Study|Progressive disease|82
7616733|NCT01828112|12026777|FG000|Overall Study|Subject/guardian decision|6
7616734|NCT01828112|12026778|FG001|Overall Study|Subject/guardian decision|8
7616735|NCT01670500|12026812|FG000|Overall Study|Withdrawal by Subject|1
7616736|NCT01670500|12026813|FG001|Overall Study|Withdrawal by Subject|0
7780862|NCT00953706|12229341|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
7780863|NCT00953706|12229342|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
7780864|NCT00953706|12229343|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
7780865|NCT00953706|12229340|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
7780866|NCT00953706|12229341|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
7780867|NCT00953706|12229342|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
7780868|NCT00953706|12229343|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
7780869|NCT00953706|12229340|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
7780870|NCT00953706|12229341|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
7780871|NCT00953706|12229342|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
7780872|NCT00953706|12229343|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
7780873|NCT00953706|12229340|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
7780874|NCT00953706|12229341|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
7780875|NCT00953706|12229342|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
7780876|NCT00953706|12229343|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
7780877|NCT00953706|12229340|FG000|Part B (96-Week Open-Label Extension)|Other|0
7780878|NCT00953706|12229341|FG001|Part B (96-Week Open-Label Extension)|Other|0
7780879|NCT00953706|12229342|FG002|Part B (96-Week Open-Label Extension)|Other|0
7780880|NCT00953706|12229343|FG003|Part B (96-Week Open-Label Extension)|Other|2
7780881|NCT00953745|12229364|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
7780882|NCT00953745|12229365|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
7780883|NCT00953745|12229364|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
7780884|NCT00953745|12229365|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
7780885|NCT00953745|12229364|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
7780886|NCT00953745|12229365|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
7780887|NCT00953745|12229364|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
7780888|NCT00953745|12229365|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
7780889|NCT00953745|12229364|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
7780890|NCT00953745|12229365|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
7780891|NCT00953745|12229364|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
7780892|NCT00953745|12229365|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
7780893|NCT00953927|12229402|FG000|Overall Study|Lost to Follow-up|61
7780894|NCT00953927|12229403|FG001|Overall Study|Lost to Follow-up|65
7780895|NCT00953927|12229402|FG000|Overall Study|Withdrawal by Subject|36
7780896|NCT00953927|12229403|FG001|Overall Study|Withdrawal by Subject|25
7780897|NCT00953927|12229402|FG000|Overall Study|Death|7
7780898|NCT00953927|12229403|FG001|Overall Study|Death|4
7780899|NCT00953927|12229402|FG000|Overall Study|Other study discontinuation|1
7780900|NCT00953927|12229403|FG001|Overall Study|Other study discontinuation|1
7780901|NCT00954122|12229413|FG000|Overall Study|Withdrawal by Subject|5
7780902|NCT00954122|12229413|FG000|Overall Study|Adverse Event|1
7780903|NCT00954122|12229413|FG000|Overall Study|Safety Reason|1
7780904|NCT00954174|12229422|FG000|Overall Study|Adverse Event|28
7780905|NCT00954174|12229423|FG001|Overall Study|Adverse Event|23
7780906|NCT00954174|12229424|FG002|Overall Study|Adverse Event|4
7780907|NCT00954174|12229425|FG003|Overall Study|Adverse Event|9
7780908|NCT00954174|12229422|FG000|Overall Study|Death|4
7780909|NCT00954174|12229423|FG001|Overall Study|Death|2
7780910|NCT00954174|12229424|FG002|Overall Study|Death|0
7780911|NCT00954174|12229425|FG003|Overall Study|Death|0
7780912|NCT00954174|12229422|FG000|Overall Study|Lack of Efficacy|32
7780913|NCT00954174|12229423|FG001|Overall Study|Lack of Efficacy|22
7780914|NCT00954174|12229424|FG002|Overall Study|Lack of Efficacy|8
7780915|NCT00954174|12229425|FG003|Overall Study|Lack of Efficacy|6
7780916|NCT00954174|12229422|FG000|Overall Study|Withdrawal by Subject|14
7780917|NCT00954174|12229423|FG001|Overall Study|Withdrawal by Subject|10
7780918|NCT00954174|12229424|FG002|Overall Study|Withdrawal by Subject|4
7780919|NCT00954174|12229425|FG003|Overall Study|Withdrawal by Subject|3
7780920|NCT00954174|12229422|FG000|Overall Study|Medical Reason|4
7780921|NCT00954174|12229423|FG001|Overall Study|Medical Reason|2
7780922|NCT00954174|12229424|FG002|Overall Study|Medical Reason|1
7780923|NCT00954174|12229425|FG003|Overall Study|Medical Reason|0
7780924|NCT00954174|12229422|FG000|Overall Study|Ineligible|40
7780925|NCT00954174|12229423|FG001|Overall Study|Ineligible|47
7780926|NCT00954174|12229424|FG002|Overall Study|Ineligible|7
7780927|NCT00954174|12229425|FG003|Overall Study|Ineligible|4
7780928|NCT00954174|12229422|FG000|Overall Study|Never Treated|4
7780929|NCT00954174|12229423|FG001|Overall Study|Never Treated|17
7780930|NCT00954174|12229424|FG002|Overall Study|Never Treated|0
7780931|NCT00954174|12229425|FG003|Overall Study|Never Treated|3
7780932|NCT00954421|12229447|FG000|Screening|screen failures|3
7780933|NCT00954421|12229447|FG000|6 Months of DBS|Withdrawal by Subject|1
7780934|NCT00954421|12229447|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
7780935|NCT00954447|12229455|FG000|Overall Study|Adverse Event|33
7780936|NCT00954447|12229456|FG001|Overall Study|Adverse Event|25
7780937|NCT00954447|12229455|FG000|Overall Study|Lack of Efficacy|17
7780938|NCT00954447|12229456|FG001|Overall Study|Lack of Efficacy|3
7780939|NCT00954447|12229455|FG000|Overall Study|Protocol Violation|5
7780940|NCT00954447|12229456|FG001|Overall Study|Protocol Violation|7
7780941|NCT00954447|12229455|FG000|Overall Study|Lost to Follow-up|8
7780942|NCT00954447|12229456|FG001|Overall Study|Lost to Follow-up|14
7780943|NCT00954447|12229455|FG000|Overall Study|Withdrawal by Subject|26
7780944|NCT00954447|12229456|FG001|Overall Study|Withdrawal by Subject|21
7780945|NCT00954447|12229455|FG000|Overall Study|Other|21
7780946|NCT00954447|12229456|FG001|Overall Study|Other|18
7780947|NCT00954512|12229468|FG000|Overall Study|Withdrawal by Subject|0
7780948|NCT00954512|12229469|FG001|Overall Study|Withdrawal by Subject|0
7780949|NCT00954512|12229470|FG002|Overall Study|Withdrawal by Subject|0
7780950|NCT00954512|12229471|FG003|Overall Study|Withdrawal by Subject|0
7780951|NCT00954512|12229472|FG004|Overall Study|Withdrawal by Subject|0
7780952|NCT00954512|12229473|FG005|Overall Study|Withdrawal by Subject|1
7780953|NCT00954512|12229468|FG000|Overall Study|Adverse Event|0
7780954|NCT00954512|12229469|FG001|Overall Study|Adverse Event|0
7780955|NCT00954512|12229470|FG002|Overall Study|Adverse Event|0
7780956|NCT00954512|12229471|FG003|Overall Study|Adverse Event|0
7780957|NCT00954512|12229472|FG004|Overall Study|Adverse Event|1
7780958|NCT00954512|12229473|FG005|Overall Study|Adverse Event|2
7780959|NCT00954512|12229468|FG000|Overall Study|Physician Decision|0
7616787|NCT04604184|12026835|FG000|Overall Study|Adverse Event|5
7616788|NCT04604184|12026836|FG001|Overall Study|Adverse Event|5
7616789|NCT04604184|12026835|FG000|Overall Study|Death|2
7616790|NCT04604184|12026836|FG001|Overall Study|Death|1
7616791|NCT04604184|12026835|FG000|Overall Study|Withdrawal by Subject|1
7616792|NCT04604184|12026836|FG001|Overall Study|Withdrawal by Subject|3
7616793|NCT04604184|12026835|FG000|Overall Study|Not treated|2
7616794|NCT04604184|12026836|FG001|Overall Study|Not treated|2
7616795|NCT04604184|12026835|FG000|Overall Study|Due to sponsor decision|9
7616796|NCT04604184|12026836|FG001|Overall Study|Due to sponsor decision|7
7616797|NCT04604184|12026835|FG000|Overall Study|Physician Decision|0
7616798|NCT04604184|12026836|FG001|Overall Study|Physician Decision|1
7616799|NCT04604184|12026835|FG000|Overall Study|Transfer to healthcare|1
7616800|NCT04604184|12026836|FG001|Overall Study|Transfer to healthcare|0
7616805|NCT03688555|12026865|FG000|Treatment Period|Adverse Event|0
7616806|NCT03688555|12026866|FG001|Treatment Period|Adverse Event|0
7616807|NCT03688555|12026867|FG002|Treatment Period|Adverse Event|1
7616808|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39
7616809|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0
7616810|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0
7616811|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0
7616812|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14
7616813|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0
7616814|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0
7780960|NCT00954512|12229469|FG001|Overall Study|Physician Decision|1
7780961|NCT00954512|12229470|FG002|Overall Study|Physician Decision|0
7780962|NCT00954512|12229471|FG003|Overall Study|Physician Decision|1
7780963|NCT00954512|12229472|FG004|Overall Study|Physician Decision|0
7616801|NCT04368429|12026844|FG000|Overall Study|Adverse Event|1
7616802|NCT04368429|12026845|FG001|Overall Study|Adverse Event|0
7616803|NCT03865316|12026859|FG000|Overall Study|Procedure Cancelled|4
7616804|NCT03865316|12026859|FG000|Overall Study|Equipment failure|4
7616815|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0
7616816|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85
7616817|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0
7616818|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0
7616819|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0
7616820|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51
7616821|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0
7616822|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0
7616823|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0
7616824|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Death|1
7616825|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Death|0
7616826|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Death|0
7616827|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Death|0
7616828|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5
7616829|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0
7616830|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0
7616831|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0
7616832|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23
7616833|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0
7616834|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0
7616835|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0
7616836|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90
7616837|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0
7616838|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0
7616839|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0
7616840|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13
7616841|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0
7780964|NCT00954512|12229473|FG005|Overall Study|Physician Decision|0
7780965|NCT00954512|12229468|FG000|Overall Study|Symptomatic Deterioration|0
7780966|NCT00954512|12229469|FG001|Overall Study|Symptomatic Deterioration|1
7780967|NCT00954512|12229470|FG002|Overall Study|Symptomatic Deterioration|0
7780968|NCT00954512|12229471|FG003|Overall Study|Symptomatic Deterioration|0
7780969|NCT00954512|12229472|FG004|Overall Study|Symptomatic Deterioration|2
7780970|NCT00954512|12229473|FG005|Overall Study|Symptomatic Deterioration|0
7780971|NCT00954512|12229468|FG000|Overall Study|Progression of Disease|2
7780972|NCT00954512|12229469|FG001|Overall Study|Progression of Disease|1
7780973|NCT00954512|12229470|FG002|Overall Study|Progression of Disease|0
7780974|NCT00954512|12229471|FG003|Overall Study|Progression of Disease|1
7780975|NCT00954512|12229472|FG004|Overall Study|Progression of Disease|1
7780976|NCT00954512|12229473|FG005|Overall Study|Progression of Disease|1
7780977|NCT00954538|12229488|FG000|Part III|Withdrawal by Subject|0
7780978|NCT00954538|12229489|FG001|Part III|Withdrawal by Subject|0
7780979|NCT00954538|12229490|FG002|Part III|Withdrawal by Subject|0
7780980|NCT00954538|12229491|FG003|Part III|Withdrawal by Subject|0
7780981|NCT00954538|12229492|FG004|Part III|Withdrawal by Subject|1
7780982|NCT00954538|12229493|FG005|Part III|Withdrawal by Subject|0
7780983|NCT00954707|12229506|FG000|Overall Study|Death|34
7780984|NCT00954707|12229506|FG000|Overall Study|Withdrawal by Subject|100
7780985|NCT00954707|12229506|FG000|Overall Study|Lost to Follow-up|33
7780986|NCT00954733|12229510|FG000|Overall Study|blood gas machine did not work|1
7780987|NCT00954941|12229520|FG000|Overall Study|Received treatment at home|1
7780988|NCT00954941|12229521|FG001|Overall Study|Received treatment at home|0
7780989|NCT00954941|12229520|FG000|Overall Study|Withdrawal by Subject|1
7780990|NCT00954941|12229521|FG001|Overall Study|Withdrawal by Subject|0
7780991|NCT00954941|12229520|FG000|Overall Study|Insurance Denial|2
7780992|NCT00954941|12229521|FG001|Overall Study|Insurance Denial|2
7780993|NCT00954941|12229520|FG000|Overall Study|Physician Decision|2
7780994|NCT00954941|12229521|FG001|Overall Study|Physician Decision|2
7780995|NCT00954941|12229520|FG000|Overall Study|Ineligible|2
7780996|NCT00954941|12229521|FG001|Overall Study|Ineligible|2
7780997|NCT00954941|12229520|FG000|Overall Study|Adverse Event|0
7780998|NCT00954941|12229521|FG001|Overall Study|Adverse Event|1
7616842|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0
7616843|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0
7616844|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104
7616845|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0
7616846|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0
7616847|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0
7616848|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0
7616849|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15
7616850|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9
7616851|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8
7616852|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0
7616853|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2
7616854|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0
7616855|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4
7616856|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0
7616857|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4
7616858|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2
7616859|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3
7616860|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0
7616861|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5
7616862|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4
7616863|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1
7616864|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0
7616865|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0
7616866|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0
7616867|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1
7616868|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0
7616869|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3
7616870|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2
7616871|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5
7616872|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0
7616873|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1
7616874|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2
7616875|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0
7616876|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0
7616877|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9
7616878|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11
7616879|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13
7616880|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0
7616881|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1
7616882|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3
7616883|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0
7616884|NCT03248531|12026929|FG000|Overall Study|Adverse Event|0
7616885|NCT03248531|12026930|FG001|Overall Study|Adverse Event|0
7616886|NCT03248531|12026931|FG002|Overall Study|Adverse Event|1
7616887|NCT03248531|12026929|FG000|Overall Study|Lost to Follow-up|1
7616888|NCT03248531|12026930|FG001|Overall Study|Lost to Follow-up|0
7616889|NCT03248531|12026931|FG002|Overall Study|Lost to Follow-up|5
7616890|NCT03248531|12026929|FG000|Overall Study|Withdrawal by Subject|3
7616891|NCT03248531|12026930|FG001|Overall Study|Withdrawal by Subject|3
7616892|NCT03248531|12026931|FG002|Overall Study|Withdrawal by Subject|2
7616893|NCT03248531|12026929|FG000|Overall Study|Sponsor Request|0
7616894|NCT03248531|12026930|FG001|Overall Study|Sponsor Request|2
7616895|NCT03248531|12026931|FG002|Overall Study|Sponsor Request|0
7616896|NCT03205605|12026946|FG000|Overall Study|Withdrawal by Subject|1
7616897|NCT02484456|12026962|FG000|Washout Period|Withdrawal by Subject|0
7616898|NCT02484456|12026963|FG001|Washout Period|Withdrawal by Subject|1
7616899|NCT02484456|12026962|FG000|Second Treatment Period: Week 1|Adverse Event|1
7616900|NCT02484456|12026963|FG001|Second Treatment Period: Week 1|Adverse Event|0
7616901|NCT02484456|12026962|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0
7616902|NCT02484456|12026963|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1
7616903|NCT02484456|12026962|FG000|Second Treatment Period: Week 2|Adverse Event|0
7616904|NCT02484456|12026963|FG001|Second Treatment Period: Week 2|Adverse Event|1
7864093|NCT01609556|12353444|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7864094|NCT01609556|12353445|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7864095|NCT01609556|12353446|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7864096|NCT01609556|12353447|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7864097|NCT01609556|12353448|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7780999|NCT00955110|12229551|FG000|Qualification Phase|Did not meet eligibility criteria|24
7864098|NCT01609556|12353449|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7864099|NCT01609556|12353450|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7781000|NCT00955110|12229551|FG000|Treatment Phase|Adverse Event|2
7616913|NCT02234323|12026979|FG000|All Enrolled|Not Treated: Completed study in database|2
7616914|NCT02234323|12026979|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2
7616915|NCT02234323|12026979|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1
7781001|NCT00955110|12229551|FG000|Treatment Phase|Administrative reasons|2
7781002|NCT00955110|12229551|FG000|Treatment Phase|Non-compliance with study restrictions|1
7781003|NCT00955110|12229551|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1
7800163|NCT01091428|12257329|FG003|Phase 2|Progressive Disease|46
7800164|NCT01091428|12257326|FG000|Phase 2|Symptomatic Deterioration|0
7800165|NCT01091428|12257327|FG001|Phase 2|Symptomatic Deterioration|0
7800166|NCT01091428|12257328|FG002|Phase 2|Symptomatic Deterioration|1
7800167|NCT01091428|12257329|FG003|Phase 2|Symptomatic Deterioration|6
7800168|NCT01091428|12257326|FG000|Phase 2|Adverse Event|0
7800169|NCT01091428|12257327|FG001|Phase 2|Adverse Event|0
7800170|NCT01091428|12257328|FG002|Phase 2|Adverse Event|12
7800171|NCT01091428|12257329|FG003|Phase 2|Adverse Event|5
7800172|NCT01091428|12257326|FG000|Phase 2|Withdrawal by Subject|0
7616916|NCT02234323|12026979|FG000|All Treated|Death|1
7616917|NCT02234323|12026979|FG000|All Treated|Physician Decision|5
7616918|NCT02234323|12026979|FG000|All Treated|Lack of Efficacy|3
7616919|NCT02234323|12026979|FG000|All Treated|Exceeded lab value limit|2
7616920|NCT02234323|12026979|FG000|All Treated|Other|7
7616921|NCT02220855|12026985|FG000|Overall Study|Adverse Event|8
7616922|NCT02220855|12026985|FG000|Overall Study|Disease Progression|5
7616923|NCT02220855|12026985|FG000|Overall Study|Withdrawal by Subject|1
7616924|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1
7616925|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
7616926|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
7616927|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
7616928|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
7616929|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
7616930|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
7616931|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2
7616932|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
7616933|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
7616934|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
7616935|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
7616936|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
7616937|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
7616938|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
7616939|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5
7616940|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
7616941|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
7616942|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
7616943|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
7616944|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
7616945|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
7616946|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
7616947|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1
7616948|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
7616949|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
7616950|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
7616951|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
7616952|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
7616953|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
7616954|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6
7616955|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
7616956|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
7616957|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
7781004|NCT00955279|12229607|FG000|Overall Study|Other|0
7781005|NCT00955279|12229608|FG001|Overall Study|Other|0
7781006|NCT00955279|12229609|FG002|Overall Study|Other|3
7781007|NCT00955279|12229607|FG000|Overall Study|Death|1
7781008|NCT00955279|12229608|FG001|Overall Study|Death|1
7781009|NCT00955279|12229609|FG002|Overall Study|Death|1
7781010|NCT00955279|12229607|FG000|Overall Study|Lost to Follow-up|0
7781011|NCT00955279|12229608|FG001|Overall Study|Lost to Follow-up|3
7781012|NCT00955279|12229609|FG002|Overall Study|Lost to Follow-up|1
7781013|NCT00955279|12229607|FG000|Overall Study|Withdrawal by Subject|2
7781014|NCT00955279|12229608|FG001|Overall Study|Withdrawal by Subject|0
7781015|NCT00955279|12229609|FG002|Overall Study|Withdrawal by Subject|3
7781016|NCT00955305|12229619|FG000|Overall Study|Disease progression|39
7781017|NCT00955305|12229620|FG001|Overall Study|Disease progression|41
7781018|NCT00955305|12229619|FG000|Overall Study|Adverse Event|22
7781019|NCT00955305|12229620|FG001|Overall Study|Adverse Event|22
7781020|NCT00955305|12229619|FG000|Overall Study|Death|2
7781021|NCT00955305|12229620|FG001|Overall Study|Death|1
7781022|NCT00955305|12229619|FG000|Overall Study|Withdrawal by Subject|5
7781023|NCT00955305|12229620|FG001|Overall Study|Withdrawal by Subject|4
7781024|NCT00955305|12229619|FG000|Overall Study|Alternative therapy|4
7781025|NCT00955305|12229620|FG001|Overall Study|Alternative therapy|0
7781026|NCT00955305|12229619|FG000|Overall Study|Other complicating disease|2
7781027|NCT00955305|12229620|FG001|Overall Study|Other complicating disease|4
7781028|NCT00955305|12229619|FG000|Overall Study|Physician Decision|1
7781029|NCT00955305|12229620|FG001|Overall Study|Physician Decision|0
7781030|NCT00955305|12229619|FG000|Overall Study|Continued presence of residual disease|0
7781031|NCT00955305|12229620|FG001|Overall Study|Continued presence of residual disease|1
7781032|NCT00955305|12229619|FG000|Overall Study|Functional decline|2
7781033|NCT00955305|12229620|FG001|Overall Study|Functional decline|0
7781034|NCT00955305|12229619|FG000|Overall Study|Maximum response achieved|0
7781035|NCT00955305|12229620|FG001|Overall Study|Maximum response achieved|1
7781036|NCT00955305|12229619|FG000|Overall Study|Lost to Follow-up|0
7781037|NCT00955305|12229620|FG001|Overall Study|Lost to Follow-up|1
7781038|NCT00955305|12229619|FG000|Overall Study|No off-treatment reason submitted|1
7781039|NCT00955305|12229620|FG001|Overall Study|No off-treatment reason submitted|0
7781040|NCT00955305|12229619|FG000|Overall Study|Never started protocol treatment|5
7781041|NCT00955305|12229620|FG001|Overall Study|Never started protocol treatment|5
7781042|NCT00955305|12229619|FG000|Overall Study|Ineligible|5
7781043|NCT00955305|12229620|FG001|Overall Study|Ineligible|7
7781044|NCT00955357|12229628|FG000|Titration Phase|Adverse Event|9
7781045|NCT00955357|12229629|FG001|Titration Phase|Adverse Event|46
7781046|NCT00955357|12229628|FG000|Titration Phase|Lack of Efficacy|0
7781047|NCT00955357|12229629|FG001|Titration Phase|Lack of Efficacy|2
7781048|NCT00955357|12229628|FG000|Titration Phase|Protocol Violation|3
7781049|NCT00955357|12229629|FG001|Titration Phase|Protocol Violation|7
7781050|NCT00955357|12229628|FG000|Titration Phase|Lost to Follow-up|1
7781051|NCT00955357|12229629|FG001|Titration Phase|Lost to Follow-up|3
7781052|NCT00955357|12229628|FG000|Titration Phase|Withdrawal by Subject|3
7781053|NCT00955357|12229629|FG001|Titration Phase|Withdrawal by Subject|5
7781054|NCT00955357|12229628|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0
7781055|NCT00955357|12229629|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1
7616958|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
7616959|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
7616960|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
7616961|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1
7616962|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
7616963|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
7616964|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
7616965|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
7616966|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
7616967|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
7616968|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
7616969|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2
7616970|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
7616971|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
7616972|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
7616973|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
7616974|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
7616975|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
7616976|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2
7616977|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
7616978|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
7616979|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
7616980|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
7616981|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
7781056|NCT00955357|12229628|FG000|Titration Phase|Study medication not tolerated|0
7781057|NCT00955357|12229629|FG001|Titration Phase|Study medication not tolerated|1
7781058|NCT00955357|12229628|FG000|Titration Phase|Non compliance to study procedures|0
7616982|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
7616983|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
7616984|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4
7616985|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
7616986|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
7616987|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
7616988|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
7616989|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
7616990|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
7616991|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5
7616992|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
7616993|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
7616994|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
7616995|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
7616996|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
7616997|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
7616998|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1
7616999|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
7617000|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
7781059|NCT00955357|12229629|FG001|Titration Phase|Non compliance to study procedures|1
7781060|NCT00955357|12229628|FG000|Maintenance Phase|Adverse Event|3
7781061|NCT00955357|12229629|FG001|Maintenance Phase|Adverse Event|23
7781062|NCT00955357|12229628|FG000|Maintenance Phase|Lack of Efficacy|0
7781063|NCT00955357|12229629|FG001|Maintenance Phase|Lack of Efficacy|4
7781064|NCT00955357|12229628|FG000|Maintenance Phase|Protocol Violation|2
7781065|NCT00955357|12229629|FG001|Maintenance Phase|Protocol Violation|6
7781066|NCT00955357|12229628|FG000|Maintenance Phase|Lost to Follow-up|2
7781067|NCT00955357|12229629|FG001|Maintenance Phase|Lost to Follow-up|7
7781068|NCT00955357|12229628|FG000|Maintenance Phase|Withdrawal by Subject|4
7781069|NCT00955357|12229629|FG001|Maintenance Phase|Withdrawal by Subject|4
7781070|NCT00955357|12229628|FG000|Maintenance Phase|Patient moving out of area|0
7781071|NCT00955357|12229629|FG001|Maintenance Phase|Patient moving out of area|1
7781072|NCT00955357|12229628|FG000|Maintenance Phase|Non compliance to study procedures|1
7781073|NCT00955357|12229629|FG001|Maintenance Phase|Non compliance to study procedures|0
7781074|NCT00955409|12229645|FG000|Overall Study|Lack of Efficacy|1
7781075|NCT00955409|12229646|FG001|Overall Study|Lack of Efficacy|0
7781076|NCT00955409|12229647|FG002|Overall Study|Lack of Efficacy|0
7781077|NCT00955409|12229648|FG003|Overall Study|Lack of Efficacy|0
7781078|NCT00955409|12229649|FG004|Overall Study|Lack of Efficacy|0
7781079|NCT00955409|12229650|FG005|Overall Study|Lack of Efficacy|0
7781080|NCT00955409|12229651|FG006|Overall Study|Lack of Efficacy|0
7617001|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
7617002|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
7617003|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
7617004|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
7617005|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1
7617006|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
7617007|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
7617008|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
7617009|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
7617010|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
7617011|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
7617012|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
7617013|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5
7617014|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
7617015|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
7617016|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
7617017|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
7617018|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
7617019|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
7617020|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3
7617021|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
7617022|NCT01791595|12026996|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
7617023|NCT01791595|12026997|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
7617024|NCT01791595|12026998|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
7617025|NCT01791595|12026999|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
7617026|NCT01791595|12027000|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
7617027|NCT01791595|12027001|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
7617028|NCT01791595|12027002|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1
7617029|NCT01791595|12026996|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
7617030|NCT01791595|12026997|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
7617031|NCT01791595|12026998|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
7617032|NCT01791595|12026999|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
7617033|NCT01791595|12027000|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
7617034|NCT01791595|12027001|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
7617035|NCT01791595|12027002|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6
7617036|NCT01791595|12026996|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
7617037|NCT01791595|12026997|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
7617038|NCT01791595|12026998|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
7617039|NCT01791595|12026999|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
7617040|NCT01791595|12027000|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
7617041|NCT01791595|12027001|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
7617042|NCT01791595|12027002|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2
7617043|NCT01791595|12026996|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
7617044|NCT01791595|12026997|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
7617045|NCT01791595|12026998|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
7617046|NCT01791595|12026999|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
7617047|NCT01791595|12027000|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
7617048|NCT01791595|12027001|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
7617049|NCT01791595|12027002|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1
7617050|NCT01192776|12027026|FG000|Overall Study|Death|8
7617051|NCT01192776|12027027|FG001|Overall Study|Death|15
7617052|NCT01192776|12027028|FG002|Overall Study|Death|18
7617053|NCT01192776|12027029|FG003|Overall Study|Death|15
7617054|NCT01192776|12027026|FG000|Overall Study|Lost to Follow-up|3
7617055|NCT01192776|12027027|FG001|Overall Study|Lost to Follow-up|6
7617056|NCT01192776|12027028|FG002|Overall Study|Lost to Follow-up|3
7617057|NCT01192776|12027029|FG003|Overall Study|Lost to Follow-up|5
7781081|NCT00955409|12229652|FG007|Overall Study|Lack of Efficacy|0
7781082|NCT00955409|12229653|FG008|Overall Study|Lack of Efficacy|0
7781083|NCT00955409|12229654|FG009|Overall Study|Lack of Efficacy|0
7781084|NCT00955409|12229645|FG000|Overall Study|Withdrawal by Subject|1
7781085|NCT00955409|12229646|FG001|Overall Study|Withdrawal by Subject|0
7781086|NCT00955409|12229647|FG002|Overall Study|Withdrawal by Subject|5
7781087|NCT00955409|12229648|FG003|Overall Study|Withdrawal by Subject|2
7781088|NCT00955409|12229649|FG004|Overall Study|Withdrawal by Subject|0
7781089|NCT00955409|12229650|FG005|Overall Study|Withdrawal by Subject|0
7781090|NCT00955409|12229651|FG006|Overall Study|Withdrawal by Subject|2
7781091|NCT00955409|12229652|FG007|Overall Study|Withdrawal by Subject|0
7781092|NCT00955409|12229653|FG008|Overall Study|Withdrawal by Subject|1
7781093|NCT00955409|12229654|FG009|Overall Study|Withdrawal by Subject|0
7781094|NCT00955409|12229645|FG000|Overall Study|Caregiver Request|2
7781095|NCT00955409|12229646|FG001|Overall Study|Caregiver Request|0
7781096|NCT00955409|12229647|FG002|Overall Study|Caregiver Request|6
7781097|NCT00955409|12229648|FG003|Overall Study|Caregiver Request|5
7781098|NCT00955409|12229649|FG004|Overall Study|Caregiver Request|0
7781099|NCT00955409|12229650|FG005|Overall Study|Caregiver Request|2
7781100|NCT00955409|12229651|FG006|Overall Study|Caregiver Request|3
7781101|NCT00955409|12229652|FG007|Overall Study|Caregiver Request|1
7781102|NCT00955409|12229653|FG008|Overall Study|Caregiver Request|3
7781103|NCT00955409|12229654|FG009|Overall Study|Caregiver Request|0
7781104|NCT00955409|12229645|FG000|Overall Study|Investigator Request|0
7781105|NCT00955409|12229646|FG001|Overall Study|Investigator Request|0
7781106|NCT00955409|12229647|FG002|Overall Study|Investigator Request|1
7781107|NCT00955409|12229648|FG003|Overall Study|Investigator Request|0
7781108|NCT00955409|12229649|FG004|Overall Study|Investigator Request|0
7781109|NCT00955409|12229650|FG005|Overall Study|Investigator Request|0
7781110|NCT00955409|12229651|FG006|Overall Study|Investigator Request|0
7781111|NCT00955409|12229652|FG007|Overall Study|Investigator Request|0
7781112|NCT00955409|12229653|FG008|Overall Study|Investigator Request|0
7781113|NCT00955409|12229654|FG009|Overall Study|Investigator Request|0
7781114|NCT00955409|12229645|FG000|Overall Study|Discontinuation of Study by Sponsor|0
7781115|NCT00955409|12229646|FG001|Overall Study|Discontinuation of Study by Sponsor|0
7781116|NCT00955409|12229647|FG002|Overall Study|Discontinuation of Study by Sponsor|0
7781117|NCT00955409|12229648|FG003|Overall Study|Discontinuation of Study by Sponsor|0
7781118|NCT00955409|12229649|FG004|Overall Study|Discontinuation of Study by Sponsor|0
7781119|NCT00955409|12229650|FG005|Overall Study|Discontinuation of Study by Sponsor|0
7781120|NCT00955409|12229651|FG006|Overall Study|Discontinuation of Study by Sponsor|0
7781121|NCT00955409|12229652|FG007|Overall Study|Discontinuation of Study by Sponsor|1
7781122|NCT00955409|12229653|FG008|Overall Study|Discontinuation of Study by Sponsor|0
7781123|NCT00955409|12229654|FG009|Overall Study|Discontinuation of Study by Sponsor|0
7781124|NCT00955409|12229645|FG000|Overall Study|Lost to Follow-up|0
7781125|NCT00955409|12229646|FG001|Overall Study|Lost to Follow-up|0
7781126|NCT00955409|12229647|FG002|Overall Study|Lost to Follow-up|1
7781127|NCT00955409|12229648|FG003|Overall Study|Lost to Follow-up|0
7781128|NCT00955409|12229649|FG004|Overall Study|Lost to Follow-up|0
7781129|NCT00955409|12229650|FG005|Overall Study|Lost to Follow-up|0
7781130|NCT00955409|12229651|FG006|Overall Study|Lost to Follow-up|1
7781131|NCT00955409|12229652|FG007|Overall Study|Lost to Follow-up|0
7781132|NCT00955409|12229653|FG008|Overall Study|Lost to Follow-up|0
7781133|NCT00955409|12229654|FG009|Overall Study|Lost to Follow-up|0
7781134|NCT00955409|12229645|FG000|Overall Study|Failed to Return|2
7781135|NCT00955409|12229646|FG001|Overall Study|Failed to Return|0
7781136|NCT00955409|12229647|FG002|Overall Study|Failed to Return|0
7781137|NCT00955409|12229648|FG003|Overall Study|Failed to Return|0
7781138|NCT00955409|12229649|FG004|Overall Study|Failed to Return|0
7781139|NCT00955409|12229650|FG005|Overall Study|Failed to Return|0
7781140|NCT00955409|12229651|FG006|Overall Study|Failed to Return|0
7781141|NCT00955409|12229652|FG007|Overall Study|Failed to Return|2
7781142|NCT00955409|12229653|FG008|Overall Study|Failed to Return|0
7781143|NCT00955409|12229654|FG009|Overall Study|Failed to Return|0
7781144|NCT00955409|12229645|FG000|Overall Study|Adverse Event (AE)|2
7781145|NCT00955409|12229646|FG001|Overall Study|Adverse Event (AE)|0
7781146|NCT00955409|12229647|FG002|Overall Study|Adverse Event (AE)|0
7781147|NCT00955409|12229648|FG003|Overall Study|Adverse Event (AE)|0
7617080|NCT03392883|12027075|FG000|Overall Study|Lost to Follow-up|122
7617081|NCT03392883|12027076|FG001|Overall Study|Lost to Follow-up|13
7617082|NCT03392883|12027077|FG002|Overall Study|Lost to Follow-up|9
7617083|NCT03392883|12027075|FG000|Overall Study|Death|4
7617084|NCT03392883|12027076|FG001|Overall Study|Death|0
7617085|NCT03392883|12027077|FG002|Overall Study|Death|0
7617086|NCT03392883|12027075|FG000|Overall Study|Lack of Efficacy|29
7617087|NCT03392883|12027076|FG001|Overall Study|Lack of Efficacy|0
7617088|NCT03392883|12027077|FG002|Overall Study|Lack of Efficacy|0
7617089|NCT03392883|12027075|FG000|Overall Study|Withdrawal by Subject|180
7617090|NCT03392883|12027076|FG001|Overall Study|Withdrawal by Subject|0
7617091|NCT03392883|12027077|FG002|Overall Study|Withdrawal by Subject|0
7617092|NCT03392883|12027075|FG000|Overall Study|Adverse Event|1
7617093|NCT03392883|12027076|FG001|Overall Study|Adverse Event|0
7617094|NCT03392883|12027077|FG002|Overall Study|Adverse Event|0
7617095|NCT03376789|12027085|FG000|Overall Study|Withdrawal by Subject|3
7617096|NCT03376789|12027086|FG001|Overall Study|Withdrawal by Subject|5
7617097|NCT03376789|12027085|FG000|Overall Study|Protocol Violation|0
7617098|NCT03376789|12027086|FG001|Overall Study|Protocol Violation|1
7617099|NCT03376789|12027085|FG000|Overall Study|Adverse Event|0
7617100|NCT03376789|12027086|FG001|Overall Study|Adverse Event|1
7617101|NCT03376789|12027085|FG000|Overall Study|Lost to Follow-up|1
7617102|NCT03376789|12027086|FG001|Overall Study|Lost to Follow-up|1
7617103|NCT03376789|12027085|FG000|Overall Study|Per sponsor due to noncompliance|1
7617104|NCT03376789|12027086|FG001|Overall Study|Per sponsor due to noncompliance|0
7617105|NCT03376789|12027085|FG000|Overall Study|Subject off study medication|0
7617106|NCT03376789|12027086|FG001|Overall Study|Subject off study medication|1
7617107|NCT03307967|12027114|FG000|Overall Study|Lost to Follow-up|4
7617108|NCT03288129|12027124|FG000|Overall Study|Adverse Event|10
7617109|NCT03288129|12027124|FG000|Overall Study|Lost to Follow-up|3
7617110|NCT03288129|12027124|FG000|Overall Study|Withdrawal by Subject|3
7617111|NCT03288129|12027124|FG000|Overall Study|Withdrawal of consent/assent|1
7617112|NCT03288129|12027124|FG000|Overall Study|Other|5
7617113|NCT03241225|12027165|FG000|Overall Study|Lost to Follow-up|2
7617114|NCT03241225|12027166|FG001|Overall Study|Lost to Follow-up|1
7617115|NCT03241225|12027165|FG000|Overall Study|Protocol Violation|4
7617116|NCT03241225|12027166|FG001|Overall Study|Protocol Violation|1
7617117|NCT03241225|12027165|FG000|Overall Study|Withdrawal by Subject|1
7617118|NCT03241225|12027166|FG001|Overall Study|Withdrawal by Subject|0
7617119|NCT03225846|12027179|FG000|Overall Study|Adverse Event|0
7617120|NCT03225846|12027180|FG001|Overall Study|Adverse Event|0
7617121|NCT03225846|12027181|FG002|Overall Study|Adverse Event|0
7617122|NCT03225846|12027182|FG003|Overall Study|Adverse Event|0
7617123|NCT03225846|12027183|FG004|Overall Study|Adverse Event|0
7617124|NCT03225846|12027184|FG005|Overall Study|Adverse Event|0
7617125|NCT03225846|12027185|FG006|Overall Study|Adverse Event|6
7617126|NCT03225846|12027179|FG000|Overall Study|Withdrawal by Subject|0
7617127|NCT03225846|12027180|FG001|Overall Study|Withdrawal by Subject|1
7781148|NCT00955409|12229649|FG004|Overall Study|Adverse Event (AE)|0
7617128|NCT03225846|12027181|FG002|Overall Study|Withdrawal by Subject|0
7617129|NCT03225846|12027182|FG003|Overall Study|Withdrawal by Subject|0
7617130|NCT03225846|12027183|FG004|Overall Study|Withdrawal by Subject|0
7617131|NCT03225846|12027184|FG005|Overall Study|Withdrawal by Subject|0
7617132|NCT03225846|12027185|FG006|Overall Study|Withdrawal by Subject|0
7617133|NCT03225846|12027179|FG000|Overall Study|Death|0
7617134|NCT03225846|12027180|FG001|Overall Study|Death|1
7617135|NCT03225846|12027181|FG002|Overall Study|Death|0
7617136|NCT03225846|12027182|FG003|Overall Study|Death|0
7617137|NCT03225846|12027183|FG004|Overall Study|Death|0
7617138|NCT03225846|12027184|FG005|Overall Study|Death|0
7617139|NCT03225846|12027185|FG006|Overall Study|Death|0
7617140|NCT03225846|12027179|FG000|Overall Study|Patient did not wish to comply with IC/EC|0
7781149|NCT00955409|12229650|FG005|Overall Study|Adverse Event (AE)|1
7781150|NCT00955409|12229651|FG006|Overall Study|Adverse Event (AE)|2
7781151|NCT00955409|12229652|FG007|Overall Study|Adverse Event (AE)|0
7781152|NCT00955409|12229653|FG008|Overall Study|Adverse Event (AE)|2
7781153|NCT00955409|12229654|FG009|Overall Study|Adverse Event (AE)|0
7781154|NCT00955409|12229645|FG000|Overall Study|Reason not Specified|2
7781155|NCT00955409|12229646|FG001|Overall Study|Reason not Specified|1
7617141|NCT03225846|12027180|FG001|Overall Study|Patient did not wish to comply with IC/EC|0
7781156|NCT00955409|12229647|FG002|Overall Study|Reason not Specified|13
7781157|NCT00955409|12229648|FG003|Overall Study|Reason not Specified|1
7781158|NCT00955409|12229649|FG004|Overall Study|Reason not Specified|2
7781159|NCT00955409|12229650|FG005|Overall Study|Reason not Specified|0
7781160|NCT00955409|12229651|FG006|Overall Study|Reason not Specified|16
7617142|NCT03225846|12027181|FG002|Overall Study|Patient did not wish to comply with IC/EC|1
7617143|NCT03225846|12027182|FG003|Overall Study|Patient did not wish to comply with IC/EC|0
7617144|NCT03225846|12027183|FG004|Overall Study|Patient did not wish to comply with IC/EC|0
7617145|NCT03225846|12027184|FG005|Overall Study|Patient did not wish to comply with IC/EC|0
7617146|NCT03225846|12027185|FG006|Overall Study|Patient did not wish to comply with IC/EC|0
7617147|NCT03225846|12027179|FG000|Overall Study|Patient decision|0
7617148|NCT03225846|12027180|FG001|Overall Study|Patient decision|0
7617149|NCT03225846|12027181|FG002|Overall Study|Patient decision|0
7617150|NCT03225846|12027182|FG003|Overall Study|Patient decision|0
7617151|NCT03225846|12027183|FG004|Overall Study|Patient decision|0
7617152|NCT03225846|12027184|FG005|Overall Study|Patient decision|0
7617153|NCT03225846|12027185|FG006|Overall Study|Patient decision|1
7617154|NCT03191903|12027228|FG000|Overall Study|Withdrawal by Subject|6
7617155|NCT03191903|12027229|FG001|Overall Study|Withdrawal by Subject|5
7617156|NCT03191903|12027230|FG002|Overall Study|Withdrawal by Subject|4
7617157|NCT03191903|12027228|FG000|Overall Study|Adverse Event|1
7617158|NCT03191903|12027229|FG001|Overall Study|Adverse Event|0
7617159|NCT03191903|12027230|FG002|Overall Study|Adverse Event|0
7617160|NCT03186794|12027243|FG000|Overall Study|Physician Decision|2
7617161|NCT03186794|12027243|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2
7617162|NCT04289051|12027248|FG000|Overall Study|Lost to Follow-up|0
7617163|NCT04289051|12027249|FG001|Overall Study|Lost to Follow-up|0
7617164|NCT04289051|12027250|FG002|Overall Study|Lost to Follow-up|2
7617165|NCT04210180|12027258|FG000|Overall Study|Withdrawal by Subject|2
7617166|NCT03675308|12027301|FG000|Overall Study|Adverse Event|3
7617167|NCT03675308|12027302|FG001|Overall Study|Adverse Event|2
7617168|NCT03675308|12027301|FG000|Overall Study|Withdrawal by Subject|6
7617169|NCT03675308|12027302|FG001|Overall Study|Withdrawal by Subject|4
7617170|NCT03675308|12027301|FG000|Overall Study|Lost to Follow-up|3
7617171|NCT03675308|12027302|FG001|Overall Study|Lost to Follow-up|0
7617172|NCT03675308|12027301|FG000|Overall Study|Lack of Efficacy|1
7617173|NCT03675308|12027302|FG001|Overall Study|Lack of Efficacy|1
7617174|NCT03675308|12027301|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1
7617175|NCT03675308|12027302|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2
7617176|NCT03675308|12027301|FG000|Overall Study|Other|0
7617177|NCT03675308|12027302|FG001|Overall Study|Other|1
7617178|NCT03573817|12027310|FG000|Overall Study|Adverse Event|0
7617179|NCT03573817|12027311|FG001|Overall Study|Adverse Event|2
7617180|NCT03573817|12027310|FG000|Overall Study|Protocol Violation|0
7617181|NCT03573817|12027311|FG001|Overall Study|Protocol Violation|1
7617182|NCT03573817|12027310|FG000|Overall Study|Withdrawal by Subject|1
7617183|NCT03573817|12027311|FG001|Overall Study|Withdrawal by Subject|1
7781161|NCT00955409|12229652|FG007|Overall Study|Reason not Specified|0
7781162|NCT00955409|12229653|FG008|Overall Study|Reason not Specified|8
7781163|NCT00955409|12229654|FG009|Overall Study|Reason not Specified|1
7781164|NCT00955474|12229682|FG000|Overall Study|Physician Decision|7
7781165|NCT00955474|12229683|FG001|Overall Study|Physician Decision|5
7781166|NCT00955617|12229723|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
7781167|NCT00955617|12229724|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
7781168|NCT00955617|12229723|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
7781169|NCT00955617|12229724|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
7781170|NCT00955617|12229723|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0
7781171|NCT00955617|12229724|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1
7781172|NCT00955617|12229723|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
7781173|NCT00955617|12229724|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
7781174|NCT00955682|12229732|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1
7781175|NCT00955682|12229733|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1
7781176|NCT00955708|12229747|FG000|Overall Study|Death|269
7781177|NCT00955708|12229747|FG000|Overall Study|Lost to Follow-up|72
7617203|NCT02919683|12027388|FG000|Post-Surgery Follow-Up|Death|2
7617204|NCT02919683|12027389|FG001|Post-Surgery Follow-Up|Death|2
7617205|NCT02919683|12027388|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1
7617206|NCT02919683|12027389|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0
7617208|NCT02790138|12027402|FG000|Overall Study|Adverse Event|5
7617209|NCT02790138|12027403|FG001|Overall Study|Adverse Event|2
7617210|NCT02790138|12027402|FG000|Overall Study|Significant Protocol Deviation|0
7617211|NCT02790138|12027403|FG001|Overall Study|Significant Protocol Deviation|1
7617212|NCT02790138|12027402|FG000|Overall Study|Lost to Follow-up|1
7617213|NCT02790138|12027403|FG001|Overall Study|Lost to Follow-up|0
7617214|NCT02790138|12027402|FG000|Overall Study|Voluntary Withdrawal|8
7617215|NCT02790138|12027403|FG001|Overall Study|Voluntary Withdrawal|9
7617216|NCT02790138|12027402|FG000|Overall Study|Lack of Efficacy|6
7617217|NCT02790138|12027403|FG001|Overall Study|Lack of Efficacy|7
7617218|NCT02790138|12027402|FG000|Overall Study|Reason not Specified|1
7617219|NCT02790138|12027403|FG001|Overall Study|Reason not Specified|0
7617220|NCT02514239|12027437|FG000|Overall Study|Refused to continue trial medication|0
7617221|NCT02514239|12027438|FG001|Overall Study|Refused to continue trial medication|0
7617222|NCT02514239|12027439|FG002|Overall Study|Refused to continue trial medication|0
7617223|NCT02514239|12027440|FG003|Overall Study|Refused to continue trial medication|0
7617224|NCT02514239|12027441|FG004|Overall Study|Refused to continue trial medication|0
7617225|NCT02514239|12027442|FG005|Overall Study|Refused to continue trial medication|0
7617226|NCT02514239|12027443|FG006|Overall Study|Refused to continue trial medication|0
7617227|NCT02514239|12027444|FG007|Overall Study|Refused to continue trial medication|0
7617228|NCT02514239|12027445|FG008|Overall Study|Refused to continue trial medication|0
7617229|NCT02514239|12027446|FG009|Overall Study|Refused to continue trial medication|1
7617230|NCT02514239|12027437|FG000|Overall Study|Dose-limiting toxicity (DLT)|0
7617231|NCT02514239|12027438|FG001|Overall Study|Dose-limiting toxicity (DLT)|0
7617232|NCT02514239|12027439|FG002|Overall Study|Dose-limiting toxicity (DLT)|0
7617233|NCT02514239|12027440|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
7617234|NCT02514239|12027441|FG004|Overall Study|Dose-limiting toxicity (DLT)|0
7617235|NCT02514239|12027442|FG005|Overall Study|Dose-limiting toxicity (DLT)|0
7617236|NCT02514239|12027443|FG006|Overall Study|Dose-limiting toxicity (DLT)|0
7617237|NCT02514239|12027444|FG007|Overall Study|Dose-limiting toxicity (DLT)|0
7617238|NCT02514239|12027445|FG008|Overall Study|Dose-limiting toxicity (DLT)|1
7617239|NCT02514239|12027446|FG009|Overall Study|Dose-limiting toxicity (DLT)|2
7617240|NCT02514239|12027437|FG000|Overall Study|Not treated|0
7617241|NCT02514239|12027438|FG001|Overall Study|Not treated|1
7617242|NCT02514239|12027439|FG002|Overall Study|Not treated|0
7617243|NCT02514239|12027440|FG003|Overall Study|Not treated|0
7617244|NCT02514239|12027441|FG004|Overall Study|Not treated|0
7617245|NCT02514239|12027442|FG005|Overall Study|Not treated|0
7617246|NCT02514239|12027443|FG006|Overall Study|Not treated|0
7617247|NCT02514239|12027444|FG007|Overall Study|Not treated|0
7781178|NCT00955708|12229747|FG000|Overall Study|Physician Decision|36
7781179|NCT00955708|12229747|FG000|Overall Study|Protocol Violation|134
7781180|NCT00955708|12229747|FG000|Overall Study|Registry Conclusion|186
7781181|NCT00955708|12229747|FG000|Overall Study|Product removed from service|94
7781182|NCT00955708|12229747|FG000|Overall Study|Patient Refused to participate further|116
7781183|NCT00955708|12229747|FG000|Overall Study|Closure of study location|60
7781184|NCT00955708|12229747|FG000|Overall Study|Patient changed care provider/moved|91
7781185|NCT00955721|12229753|FG000|Overall Study|Physician Decision|1
7781186|NCT00955721|12229754|FG001|Overall Study|Physician Decision|0
7781187|NCT00955721|12229753|FG000|Overall Study|Death|1
7781188|NCT00955721|12229754|FG001|Overall Study|Death|0
7781189|NCT00955721|12229753|FG000|Overall Study|Withdrawal by Subject|1
7781190|NCT00955721|12229754|FG001|Overall Study|Withdrawal by Subject|0
7781191|NCT00955825|12229772|FG000|Overall Study|Adverse Event|15
7781192|NCT00955825|12229773|FG001|Overall Study|Adverse Event|2
7781193|NCT00955825|12229772|FG000|Overall Study|Withdrawal by Subject|4
7781194|NCT00955825|12229773|FG001|Overall Study|Withdrawal by Subject|6
7781195|NCT00955825|12229772|FG000|Overall Study|Any other reason not above-mentioned|7
7781196|NCT00955825|12229773|FG001|Overall Study|Any other reason not above-mentioned|9
7781197|NCT00955955|12229812|FG000|Overall Study|Lost to Follow-up|2
7781198|NCT00955955|12229813|FG001|Overall Study|Lost to Follow-up|0
7781199|NCT00955955|12229814|FG002|Overall Study|Lost to Follow-up|0
7781200|NCT00955968|12229830|FG000|Overall Study|Death|2
7781201|NCT00955968|12229831|FG001|Overall Study|Death|4
7781202|NCT00955968|12229830|FG000|Overall Study|Withdrawal by Subject|35
7781203|NCT00955968|12229831|FG001|Overall Study|Withdrawal by Subject|31
7781204|NCT00955968|12229830|FG000|Overall Study|Lost to Follow-up|45
7781205|NCT00955968|12229831|FG001|Overall Study|Lost to Follow-up|39
7781206|NCT00955968|12229830|FG000|Overall Study|Site closed|55
7781207|NCT00955968|12229831|FG001|Overall Study|Site closed|52
7781208|NCT00956293|12229865|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0
7781209|NCT00956293|12229866|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0
7781210|NCT00956293|12229867|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1
7781211|NCT00956293|12229865|FG000|Main Period (Pre-randomization)|Death|0
7781212|NCT00956293|12229866|FG001|Main Period (Pre-randomization)|Death|0
7781213|NCT00956293|12229867|FG002|Main Period (Pre-randomization)|Death|1
7781214|NCT00956293|12229865|FG000|Main Period (Pre-randomization)|Protocol Violation|0
7781215|NCT00956293|12229866|FG001|Main Period (Pre-randomization)|Protocol Violation|0
7781216|NCT00956293|12229867|FG002|Main Period (Pre-randomization)|Protocol Violation|1
7781217|NCT00956293|12229865|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0
7781218|NCT00956293|12229866|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0
7781219|NCT00956293|12229867|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2
7617248|NCT02514239|12027445|FG008|Overall Study|Not treated|0
7617249|NCT02514239|12027446|FG009|Overall Study|Not treated|0
7617250|NCT02514239|12027437|FG000|Overall Study|Other Adverse Events|2
7781220|NCT00956293|12229865|FG000|Main Period (Pre-randomization)|Administrative problems|0
7781221|NCT00956293|12229866|FG001|Main Period (Pre-randomization)|Administrative problems|0
7781222|NCT00956293|12229867|FG002|Main Period (Pre-randomization)|Administrative problems|6
7781223|NCT00956293|12229865|FG000|Main Period (Pre-randomization)|Graft loss|0
7781224|NCT00956293|12229866|FG001|Main Period (Pre-randomization)|Graft loss|0
7781225|NCT00956293|12229867|FG002|Main Period (Pre-randomization)|Graft loss|7
7781226|NCT00956293|12229865|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0
7781227|NCT00956293|12229866|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0
7781228|NCT00956293|12229867|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12
7781229|NCT00956293|12229865|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0
7781230|NCT00956293|12229866|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0
7781231|NCT00956293|12229867|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20
7617251|NCT02514239|12027438|FG001|Overall Study|Other Adverse Events|0
7617252|NCT02514239|12027439|FG002|Overall Study|Other Adverse Events|0
7617253|NCT02514239|12027440|FG003|Overall Study|Other Adverse Events|1
7781232|NCT00956293|12229865|FG000|Main Period (Pre-randomization)|Adverse Event|0
7781233|NCT00956293|12229866|FG001|Main Period (Pre-randomization)|Adverse Event|0
7617254|NCT02514239|12027441|FG004|Overall Study|Other Adverse Events|0
7617255|NCT02514239|12027442|FG005|Overall Study|Other Adverse Events|1
7617256|NCT02514239|12027443|FG006|Overall Study|Other Adverse Events|0
7617257|NCT02514239|12027444|FG007|Overall Study|Other Adverse Events|1
7617258|NCT02514239|12027445|FG008|Overall Study|Other Adverse Events|2
7617259|NCT02514239|12027446|FG009|Overall Study|Other Adverse Events|0
7617260|NCT02514239|12027437|FG000|Overall Study|Progressive disease|3
7617261|NCT02514239|12027438|FG001|Overall Study|Progressive disease|3
7617262|NCT02514239|12027439|FG002|Overall Study|Progressive disease|2
7617263|NCT02514239|12027440|FG003|Overall Study|Progressive disease|2
7617264|NCT02514239|12027441|FG004|Overall Study|Progressive disease|3
7617265|NCT02514239|12027442|FG005|Overall Study|Progressive disease|3
7617266|NCT02514239|12027443|FG006|Overall Study|Progressive disease|4
7617267|NCT02514239|12027444|FG007|Overall Study|Progressive disease|2
7617268|NCT02514239|12027445|FG008|Overall Study|Progressive disease|5
7617269|NCT02514239|12027446|FG009|Overall Study|Progressive disease|0
7617270|NCT02245672|12027515|FG000|Overall Study|Adverse Event|4
7617271|NCT02245672|12027516|FG001|Overall Study|Adverse Event|4
7617272|NCT02245672|12027517|FG002|Overall Study|Adverse Event|4
7617273|NCT02245672|12027515|FG000|Overall Study|Lost to Follow-up|3
7617274|NCT02245672|12027516|FG001|Overall Study|Lost to Follow-up|5
7617275|NCT02245672|12027517|FG002|Overall Study|Lost to Follow-up|1
7617276|NCT02245672|12027515|FG000|Overall Study|Withdrawal by Subject|6
7617277|NCT02245672|12027516|FG001|Overall Study|Withdrawal by Subject|3
7617278|NCT02245672|12027517|FG002|Overall Study|Withdrawal by Subject|0
7617279|NCT02245672|12027515|FG000|Overall Study|Randomized in error (not treated)|0
7617280|NCT02245672|12027516|FG001|Overall Study|Randomized in error (not treated)|1
7617281|NCT02245672|12027517|FG002|Overall Study|Randomized in error (not treated)|0
7617282|NCT02109172|12027525|FG000|Overall Study|Withdrawal by Subject|1
7617283|NCT02109172|12027526|FG001|Overall Study|Withdrawal by Subject|0
7617284|NCT02109172|12027527|FG002|Overall Study|Withdrawal by Subject|0
7617285|NCT02109172|12027528|FG003|Overall Study|Withdrawal by Subject|1
7617286|NCT02109172|12027529|FG004|Overall Study|Withdrawal by Subject|0
7617287|NCT02109172|12027530|FG005|Overall Study|Withdrawal by Subject|0
7617288|NCT02109172|12027525|FG000|Overall Study|Adverse Event|0
7617289|NCT02109172|12027526|FG001|Overall Study|Adverse Event|0
7617290|NCT02109172|12027527|FG002|Overall Study|Adverse Event|1
7617291|NCT02109172|12027528|FG003|Overall Study|Adverse Event|0
7617292|NCT02109172|12027529|FG004|Overall Study|Adverse Event|0
7617293|NCT02109172|12027530|FG005|Overall Study|Adverse Event|1
7617294|NCT02109172|12027525|FG000|Overall Study|Death|0
7781234|NCT00956293|12229867|FG002|Main Period (Pre-randomization)|Adverse Event|36
7781235|NCT00956293|12229865|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0
7617295|NCT02109172|12027526|FG001|Overall Study|Death|0
7617296|NCT02109172|12027527|FG002|Overall Study|Death|0
7617297|NCT02109172|12027528|FG003|Overall Study|Death|0
7617298|NCT02109172|12027529|FG004|Overall Study|Death|1
7617299|NCT02109172|12027530|FG005|Overall Study|Death|0
7617300|NCT00799396|12027588|FG000|Clopidogrel Treatment|Adverse Event|6
7617301|NCT00799396|12027588|FG000|Clopidogrel Treatment|Physician Decision|5
7617302|NCT00799396|12027588|FG000|Clopidogrel Treatment|Withdrawal by Subject|2
7617303|NCT00799396|12027588|FG000|Clopidogrel Plus Aspirin|Adverse Event|2
7617304|NCT00799396|12027588|FG000|Clopidogrel Plus Aspirin|Physician Decision|4
7617305|NCT00069238|12027592|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
7617306|NCT00069238|12027593|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
7617307|NCT00069238|12027594|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
7617308|NCT00069238|12027592|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
7617309|NCT00069238|12027593|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
7617310|NCT00069238|12027594|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
7617311|NCT00069238|12027592|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
7617312|NCT00069238|12027593|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
7617313|NCT00069238|12027594|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
7617314|NCT03138499|12027601|FG000|Overall Study|Lost to Follow-up|1
7617315|NCT03138499|12027602|FG001|Overall Study|Lost to Follow-up|0
7617316|NCT03138499|12027601|FG000|Overall Study|Participants withdrew consent|1
7617317|NCT03138499|12027602|FG001|Overall Study|Participants withdrew consent|0
7617318|NCT03138499|12027601|FG000|Overall Study|Participant discontinued study before treatment|0
7617319|NCT03138499|12027602|FG001|Overall Study|Participant discontinued study before treatment|1
7617320|NCT03138499|12027601|FG000|Overall Study|Disease Progression|2
7617321|NCT03138499|12027602|FG001|Overall Study|Disease Progression|6
7617322|NCT03138499|12027601|FG000|Overall Study|Study drug toxicity|2
7617323|NCT03138499|12027602|FG001|Overall Study|Study drug toxicity|2
7617324|NCT03138499|12027601|FG000|Overall Study|Participant request to discontinue study treatment|1
7617325|NCT03138499|12027602|FG001|Overall Study|Participant request to discontinue study treatment|1
7617326|NCT03138499|12027601|FG000|Overall Study|Other reasons|2
7617327|NCT03138499|12027602|FG001|Overall Study|Other reasons|0
7617328|NCT04466384|12027637|FG000|First Phase|Protocol Violation|1
7617329|NCT04466384|12027638|FG001|First Phase|Protocol Violation|0
7617330|NCT04466384|12027637|FG000|First Phase|Missing data|1
7617331|NCT04466384|12027638|FG001|First Phase|Missing data|0
7617332|NCT04466384|12027637|FG000|Cross Over Phase|Physician Decision|1
7617333|NCT04466384|12027638|FG001|Cross Over Phase|Physician Decision|0
7617334|NCT04466384|12027637|FG000|Cross Over Phase|Withdrawal by Subject|0
7617335|NCT04466384|12027638|FG001|Cross Over Phase|Withdrawal by Subject|1
7781236|NCT00956293|12229866|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0
7781237|NCT00956293|12229867|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44
7781238|NCT00956293|12229865|FG000|Main Period (Randomization)|Abnormal laboratory value|0
7781239|NCT00956293|12229866|FG001|Main Period (Randomization)|Abnormal laboratory value|2
7781240|NCT00956293|12229867|FG002|Main Period (Randomization)|Abnormal laboratory value|0
7781241|NCT00956293|12229865|FG000|Main Period (Randomization)|Lack of Efficacy|1
7781242|NCT00956293|12229866|FG001|Main Period (Randomization)|Lack of Efficacy|10
7781243|NCT00956293|12229867|FG002|Main Period (Randomization)|Lack of Efficacy|0
7781244|NCT00956293|12229865|FG000|Main Period (Randomization)|Adverse Event|0
7781245|NCT00956293|12229866|FG001|Main Period (Randomization)|Adverse Event|15
7781246|NCT00956293|12229867|FG002|Main Period (Randomization)|Adverse Event|0
7781247|NCT00956293|12229865|FG000|Follow-up Period|Follow-up period was terminated.|20
7781248|NCT00956293|12229866|FG001|Follow-up Period|Follow-up period was terminated.|32
7781249|NCT00956293|12229867|FG002|Follow-up Period|Follow-up period was terminated.|0
7781250|NCT00956592|12229892|FG000|Overall Study|Protocol Violation|1
7781251|NCT00956592|12229893|FG001|Overall Study|Protocol Violation|3
7781252|NCT00956813|12229932|FG000|Flaxseed and Placebo|Withdrawal by Subject|5
7781253|NCT00956813|12229933|FG001|Flaxseed and Placebo|Withdrawal by Subject|4
7781254|NCT00956813|12229932|FG000|Flaxseed and Placebo|Ineligible|3
7781255|NCT00956813|12229933|FG001|Flaxseed and Placebo|Ineligible|1
7781256|NCT00956839|12229943|FG000|Overall Study|Lost to Follow-up|3
7781257|NCT00956839|12229944|FG001|Overall Study|Lost to Follow-up|0
7781258|NCT00956839|12229945|FG002|Overall Study|Lost to Follow-up|3
7781259|NCT00956943|12229966|FG000|Overall Study|Lost to Follow-up|9
7781260|NCT00956943|12229967|FG001|Overall Study|Lost to Follow-up|10
7781261|NCT00957008|12229977|FG000|Overall Study|Withdrawal by Subject|13
7781262|NCT00957008|12229978|FG001|Overall Study|Withdrawal by Subject|10
7781263|NCT00957008|12229979|FG002|Overall Study|Withdrawal by Subject|12
7781264|NCT00957008|12229980|FG003|Overall Study|Withdrawal by Subject|16
7781265|NCT00957008|12229977|FG000|Overall Study|Lost to Follow-up|3
7781266|NCT00957008|12229978|FG001|Overall Study|Lost to Follow-up|1
7781267|NCT00957008|12229979|FG002|Overall Study|Lost to Follow-up|3
7781268|NCT00957008|12229980|FG003|Overall Study|Lost to Follow-up|4
7781269|NCT00957008|12229977|FG000|Overall Study|Physician Decision|1
7781270|NCT00957008|12229978|FG001|Overall Study|Physician Decision|0
7781271|NCT00957008|12229979|FG002|Overall Study|Physician Decision|1
7781272|NCT00957008|12229980|FG003|Overall Study|Physician Decision|1
7781273|NCT00957008|12229977|FG000|Overall Study|Relocated; Family conflict|4
7781274|NCT00957008|12229978|FG001|Overall Study|Relocated; Family conflict|1
7781275|NCT00957008|12229979|FG002|Overall Study|Relocated; Family conflict|1
7781276|NCT00957008|12229980|FG003|Overall Study|Relocated; Family conflict|3
7781277|NCT00957021|12229994|FG000|Overall Study|Death|5
7781278|NCT00957021|12229994|FG000|Overall Study|Lost to Follow-up|8
7781279|NCT00957021|12229994|FG000|Overall Study|Withdrawal by Subject|34
7781280|NCT00957021|12229994|FG000|Overall Study|No 2 yr ROM data|35
7781281|NCT00957021|12229994|FG000|Overall Study|Revised study component by 2 yr visit|8
7781282|NCT00957021|12229994|FG000|Overall Study|Site Termination by the 2 yr visit|16
7781283|NCT00957021|12229994|FG000|Overall Study|Surgery Cancelled|9
7781284|NCT00957021|12229994|FG000|Overall Study|Termination due to language issue|2
7781285|NCT00957229|12230027|FG000|Study Start|Adverse Event|0
7781286|NCT00957229|12230028|FG001|Study Start|Adverse Event|3
7781287|NCT00957229|12230027|FG000|Study Start|Disease Progression|1
7781288|NCT00957229|12230028|FG001|Study Start|Disease Progression|0
7781289|NCT00957229|12230027|FG000|Reallocated to or Continued Vismodegib|Death|1
7781290|NCT00957229|12230028|FG001|Reallocated to or Continued Vismodegib|Death|1
7781291|NCT00957229|12230027|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2
7781292|NCT00957229|12230028|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1
7781293|NCT00957268|12230050|FG000|Overall Study|Voluntary Withdrawal|0
7781294|NCT00957268|12230051|FG001|Overall Study|Voluntary Withdrawal|0
7781295|NCT00957268|12230052|FG002|Overall Study|Voluntary Withdrawal|1
7781296|NCT00957268|12230053|FG003|Overall Study|Voluntary Withdrawal|0
7781297|NCT00957268|12230054|FG004|Overall Study|Voluntary Withdrawal|0
7781298|NCT00957372|12230082|FG000|PART I|Lost to Follow-up|0
7781299|NCT00957372|12230083|FG001|PART I|Lost to Follow-up|0
7781300|NCT00957372|12230084|FG002|PART I|Lost to Follow-up|1
7781301|NCT00957372|12230085|FG003|PART I|Lost to Follow-up|0
7781302|NCT00957372|12230082|FG000|PART II|Withdrawal by Subject|0
7781303|NCT00957372|12230083|FG001|PART II|Withdrawal by Subject|0
7781304|NCT00957372|12230084|FG002|PART II|Withdrawal by Subject|0
7781305|NCT00957372|12230085|FG003|PART II|Withdrawal by Subject|8
7781306|NCT00957372|12230082|FG000|PART II|Physician Decision|0
7781307|NCT00957372|12230083|FG001|PART II|Physician Decision|0
7781308|NCT00957372|12230084|FG002|PART II|Physician Decision|0
7781309|NCT00957372|12230085|FG003|PART II|Physician Decision|1
7781310|NCT00957372|12230082|FG000|PART II|Pregnancy|0
7781311|NCT00957372|12230083|FG001|PART II|Pregnancy|0
7781312|NCT00957372|12230084|FG002|PART II|Pregnancy|0
7781313|NCT00957372|12230085|FG003|PART II|Pregnancy|1
7781314|NCT00957372|12230082|FG000|PART II|Not Know|0
7781315|NCT00957372|12230083|FG001|PART II|Not Know|0
7781316|NCT00957372|12230084|FG002|PART II|Not Know|0
7781317|NCT00957372|12230085|FG003|PART II|Not Know|20
7781318|NCT00957372|12230082|FG000|PART II|Adverse Event|0
7781319|NCT00957372|12230083|FG001|PART II|Adverse Event|0
7781320|NCT00957372|12230084|FG002|PART II|Adverse Event|0
7617364|NCT04428645|12027662|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1
7617365|NCT04157751|12027674|FG000|Overall Study|Withdrawal by Subject|12
7617366|NCT04157751|12027675|FG001|Overall Study|Withdrawal by Subject|17
7617367|NCT04157751|12027674|FG000|Overall Study|Lost to Follow-up|6
7617368|NCT04157751|12027675|FG001|Overall Study|Lost to Follow-up|2
7617369|NCT04157751|12027674|FG000|Overall Study|Adverse Event|34
7617370|NCT04157751|12027675|FG001|Overall Study|Adverse Event|23
7617371|NCT04157751|12027674|FG000|Overall Study|Not treated|1
7617372|NCT04157751|12027675|FG001|Overall Study|Not treated|5
7617373|NCT04157751|12027674|FG000|Overall Study|Other reason not stated above|10
7617374|NCT04157751|12027675|FG001|Overall Study|Other reason not stated above|10
7617375|NCT04086121|12027691|FG000|Overall Study|Other than listed|8
7617376|NCT04086121|12027691|FG000|Overall Study|Withdrawal by Subject|3
7617377|NCT04086121|12027691|FG000|Overall Study|Lost to Follow-up|2
7617378|NCT04086121|12027691|FG000|Overall Study|Adverse Event|1
7617379|NCT03965962|12027711|FG000|Overall Study|Adverse Event|1
7617380|NCT03965962|12027712|FG001|Overall Study|Adverse Event|0
7617381|NCT03965962|12027713|FG002|Overall Study|Adverse Event|0
7617382|NCT03965962|12027714|FG003|Overall Study|Adverse Event|0
7617383|NCT03965962|12027711|FG000|Overall Study|Protocol Violation|21
7617384|NCT03965962|12027712|FG001|Overall Study|Protocol Violation|4
7617385|NCT03965962|12027713|FG002|Overall Study|Protocol Violation|10
7617386|NCT03965962|12027714|FG003|Overall Study|Protocol Violation|5
7617387|NCT03965962|12027711|FG000|Overall Study|Lost to Follow-up|0
7617388|NCT03965962|12027712|FG001|Overall Study|Lost to Follow-up|1
7617389|NCT03965962|12027713|FG002|Overall Study|Lost to Follow-up|0
7617390|NCT03965962|12027714|FG003|Overall Study|Lost to Follow-up|0
7617391|NCT03965962|12027711|FG000|Overall Study|Withdrawal by Subject|3
7617392|NCT03965962|12027712|FG001|Overall Study|Withdrawal by Subject|0
7617393|NCT03965962|12027713|FG002|Overall Study|Withdrawal by Subject|0
7617394|NCT03965962|12027714|FG003|Overall Study|Withdrawal by Subject|1
7781321|NCT00957372|12230085|FG003|PART II|Adverse Event|10
7781322|NCT00957372|12230082|FG000|PART II|Patient non-compliance|0
7781323|NCT00957372|12230083|FG001|PART II|Patient non-compliance|0
7781324|NCT00957372|12230084|FG002|PART II|Patient non-compliance|0
7781325|NCT00957372|12230085|FG003|PART II|Patient non-compliance|4
7781326|NCT00957424|12230101|FG000|Overall Study|Lost to Follow-up|19
7781327|NCT00957424|12230101|FG000|Overall Study|Protocol Violation|3
7781328|NCT00957424|12230101|FG000|Overall Study|Withdrawal by Subject|1
7781329|NCT00957528|12230108|FG000|Overall Study|Protocol Violation|0
7781330|NCT00957528|12230109|FG001|Overall Study|Protocol Violation|1
7617405|NCT03112590|12027755|FG000|Overall Study|Adverse Event|0
7617406|NCT03112590|12027756|FG001|Overall Study|Adverse Event|1
7617407|NCT03112590|12027757|FG002|Overall Study|Adverse Event|0
7617408|NCT03086343|12027767|FG000|Overall Study|Adverse Event|7
7617409|NCT03086343|12027768|FG001|Overall Study|Adverse Event|7
7617410|NCT03086343|12027767|FG000|Overall Study|Withdrawal by Subject|10
7617411|NCT03086343|12027768|FG001|Overall Study|Withdrawal by Subject|6
7617412|NCT03086343|12027767|FG000|Overall Study|Lost to Follow-up|3
7617413|NCT03086343|12027768|FG001|Overall Study|Lost to Follow-up|1
7617414|NCT03086343|12027767|FG000|Overall Study|Lack of Efficacy|4
7617415|NCT03086343|12027768|FG001|Overall Study|Lack of Efficacy|6
7617416|NCT03086343|12027767|FG000|Overall Study|Other, not specified|8
7617417|NCT03086343|12027768|FG001|Overall Study|Other, not specified|4
7617418|NCT03086343|12027767|FG000|Overall Study|Missing|0
7617419|NCT03086343|12027768|FG001|Overall Study|Missing|1
7781331|NCT00957528|12230110|FG002|Overall Study|Protocol Violation|0
7781332|NCT00957528|12230108|FG000|Overall Study|Withdrawal by Subject|0
7781333|NCT00957528|12230109|FG001|Overall Study|Withdrawal by Subject|0
7781334|NCT00957528|12230110|FG002|Overall Study|Withdrawal by Subject|1
7781335|NCT00957580|12230121|FG000|Overall Study|Ongoing at data cut-off|0
7781336|NCT00957580|12230122|FG001|Overall Study|Ongoing at data cut-off|1
7781337|NCT00957580|12230123|FG002|Overall Study|Ongoing at data cut-off|0
7781338|NCT00957580|12230121|FG000|Overall Study|Enrolled but not treated|0
7781339|NCT00957580|12230122|FG001|Overall Study|Enrolled but not treated|1
7781340|NCT00957580|12230123|FG002|Overall Study|Enrolled but not treated|0
7781341|NCT00957658|12230155|FG000|Overall Study|Death|1
7781342|NCT00957658|12230155|FG000|Overall Study|Lost to Follow-up|4
7781343|NCT00957658|12230155|FG000|Overall Study|Withdrawal by Subject|12
7781344|NCT00957658|12230155|FG000|Overall Study|Revision|1
7781345|NCT00957658|12230155|FG000|Overall Study|Incomplete 2 yr data|28
7781346|NCT00957658|12230155|FG000|Overall Study|Site termination|10
7781347|NCT00957658|12230155|FG000|Overall Study|unwilling/unable to return|2
7781348|NCT00957658|12230155|FG000|Overall Study|surgery cancelled|2
7781349|NCT00957658|12230155|FG000|Overall Study|Protocol Violation|5
7781350|NCT00957723|12230184|FG000|Overall Study|Death|3
7781351|NCT00957723|12230184|FG000|Overall Study|Revision/ Removal of Study Implant|3
7781352|NCT00957723|12230184|FG000|Overall Study|Lost to Follow-up|8
7781353|NCT00957723|12230184|FG000|Overall Study|Withdrawal by Subject|24
7781354|NCT00957723|12230184|FG000|Overall Study|Investigative Site Terminated|61
7781355|NCT00957723|12230184|FG000|Overall Study|Intercurrent Illness|2
7781356|NCT00957723|12230184|FG000|Overall Study|2yr ROM Data Not Evaluable|12
7781357|NCT00957801|12230194|FG000|Overall Study|Withdrawal by Subject|0
7781358|NCT00957801|12230195|FG001|Overall Study|Withdrawal by Subject|0
7781359|NCT00957801|12230196|FG002|Overall Study|Withdrawal by Subject|0
7781360|NCT00957801|12230197|FG003|Overall Study|Withdrawal by Subject|1
7781361|NCT00957853|12230210|FG000|Overall Study|Withdrawal by Subject|1
7781362|NCT00957853|12230211|FG001|Overall Study|Withdrawal by Subject|0
7781363|NCT00957853|12230212|FG002|Overall Study|Withdrawal by Subject|0
7617450|NCT02657434|12027785|FG000|Overall Study|On-Going in Study|77
7617451|NCT02657434|12027786|FG001|Overall Study|On-Going in Study|91
7617452|NCT02657434|12027785|FG000|Overall Study|Death|177
7617453|NCT02657434|12027786|FG001|Overall Study|Death|183
7781364|NCT00957905|12230222|FG000|Part B|Not Treated|0
7781365|NCT00957905|12230223|FG001|Part B|Not Treated|1
7617454|NCT02657434|12027785|FG000|Overall Study|Lost to Follow-up|2
7617455|NCT02657434|12027786|FG001|Overall Study|Lost to Follow-up|2
7617456|NCT02657434|12027785|FG000|Overall Study|Randomization by Error|2
7617457|NCT02657434|12027786|FG001|Overall Study|Randomization by Error|0
7617458|NCT02657434|12027785|FG000|Overall Study|Withdrawal by Subject|27
7617459|NCT02657434|12027786|FG001|Overall Study|Withdrawal by Subject|16
7617460|NCT02657434|12027785|FG000|Overall Study|Protocol Violation|1
7617461|NCT02657434|12027786|FG001|Overall Study|Protocol Violation|0
7617462|NCT02583269|12027798|FG000|Overall Study|Patient hospitalized prior to start|1
7617463|NCT02583269|12027799|FG001|Overall Study|Patient hospitalized prior to start|0
7617464|NCT02583269|12027800|FG002|Overall Study|Patient hospitalized prior to start|0
7617465|NCT02583269|12027801|FG003|Overall Study|Patient hospitalized prior to start|0
7617466|NCT02583269|12027802|FG004|Overall Study|Patient hospitalized prior to start|0
7781366|NCT00957905|12230222|FG000|Part B|Physician Decision|0
7781367|NCT00957905|12230223|FG001|Part B|Physician Decision|1
7617469|NCT02576847|12027823|FG000|Overall Study|Adverse Event|27
7617470|NCT02576847|12027823|FG000|Overall Study|Lost to Follow-up|22
7617471|NCT02576847|12027823|FG000|Overall Study|Physician Decision|1
7617472|NCT02576847|12027823|FG000|Overall Study|Pregnancy|1
7617473|NCT02576847|12027823|FG000|Overall Study|Protocol Violation|3
7617474|NCT02576847|12027823|FG000|Overall Study|Withdrawal by Subject|78
7617475|NCT02576847|12027823|FG000|Overall Study|Other|5
7781368|NCT00957905|12230222|FG000|Part B|Death|0
7781369|NCT00957905|12230223|FG001|Part B|Death|1
7781370|NCT00957905|12230222|FG000|Part B|Protocol Violation|0
7617479|NCT02425891|12027856|FG000|Overall Study|Death|333
7617480|NCT02425891|12027857|FG001|Overall Study|Death|314
7781371|NCT00957905|12230223|FG001|Part B|Protocol Violation|1
7781372|NCT00957931|12230229|FG000|Overall Study|Death|4
7781373|NCT00957944|12230235|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0
7781374|NCT00957944|12230236|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1
7781375|NCT00957996|12230244|FG000|Overall Study|Death|4
7781376|NCT00957996|12230245|FG001|Overall Study|Death|10
7781377|NCT00957996|12230244|FG000|Overall Study|Lost to Follow-up|4
7781378|NCT00957996|12230245|FG001|Overall Study|Lost to Follow-up|7
7781379|NCT00957996|12230244|FG000|Overall Study|Withdrawal by Subject|9
7781380|NCT00957996|12230245|FG001|Overall Study|Withdrawal by Subject|2
7781381|NCT00957996|12230244|FG000|Overall Study|Adverse Event|2
7781382|NCT00957996|12230245|FG001|Overall Study|Adverse Event|1
7781383|NCT00957996|12230244|FG000|Overall Study|Physician Decision|1
7781384|NCT00957996|12230245|FG001|Overall Study|Physician Decision|1
7781385|NCT00957996|12230244|FG000|Overall Study|Influenza-related complication|0
7781386|NCT00957996|12230245|FG001|Overall Study|Influenza-related complication|1
7781387|NCT00957996|12230244|FG000|Overall Study|Missing|1
7781388|NCT00957996|12230245|FG001|Overall Study|Missing|0
7781389|NCT00957996|12230244|FG000|Overall Study|Noncompliance; Protocol Deviations|5
7781390|NCT00957996|12230245|FG001|Overall Study|Noncompliance; Protocol Deviations|6
7617481|NCT02425891|12027856|FG000|Overall Study|Lost to Follow-up|4
7617482|NCT02425891|12027857|FG001|Overall Study|Lost to Follow-up|6
7617483|NCT02425891|12027856|FG000|Overall Study|Non-Compliance|1
7617484|NCT02425891|12027857|FG001|Overall Study|Non-Compliance|1
7617485|NCT02425891|12027856|FG000|Overall Study|Accidentally randomized screen failure participant|0
7617486|NCT02425891|12027857|FG001|Overall Study|Accidentally randomized screen failure participant|1
7617487|NCT02425891|12027856|FG000|Overall Study|Physician Decision|0
7617488|NCT02425891|12027857|FG001|Overall Study|Physician Decision|1
7617489|NCT02425891|12027856|FG000|Overall Study|Protocol Violation|1
7617490|NCT02425891|12027857|FG001|Overall Study|Protocol Violation|1
7617491|NCT02425891|12027856|FG000|Overall Study|Study Terminated By Sponsor|85
7617492|NCT02425891|12027857|FG001|Overall Study|Study Terminated By Sponsor|95
7617493|NCT02425891|12027856|FG000|Overall Study|Withdrawal by Subject|27
7617494|NCT02425891|12027857|FG001|Overall Study|Withdrawal by Subject|32
7781391|NCT00958009|12230253|FG000|Overall Study|Adverse Event|1
7781392|NCT00958009|12230253|FG000|Overall Study|Subject found device difficult to use|1
7781393|NCT00958074|12230268|FG000|Overall Study|Withdrawal by Subject|0
7781394|NCT00958074|12230269|FG001|Overall Study|Withdrawal by Subject|1
7781395|NCT00958126|12230283|FG000|Overall Study|Serious Adverse Event|0
7781396|NCT00958126|12230284|FG001|Overall Study|Serious Adverse Event|2
7781397|NCT00958126|12230285|FG002|Overall Study|Serious Adverse Event|0
7781398|NCT00958126|12230286|FG003|Overall Study|Serious Adverse Event|0
7781399|NCT00958126|12230287|FG004|Overall Study|Serious Adverse Event|0
7781400|NCT00958126|12230288|FG005|Overall Study|Serious Adverse Event|0
7781401|NCT00958126|12230289|FG006|Overall Study|Serious Adverse Event|1
7781402|NCT00958126|12230290|FG007|Overall Study|Serious Adverse Event|0
7781403|NCT00958126|12230283|FG000|Overall Study|Withdrawal by Subject|0
7781404|NCT00958126|12230284|FG001|Overall Study|Withdrawal by Subject|2
7781405|NCT00958126|12230285|FG002|Overall Study|Withdrawal by Subject|0
7781406|NCT00958126|12230286|FG003|Overall Study|Withdrawal by Subject|0
7781407|NCT00958126|12230287|FG004|Overall Study|Withdrawal by Subject|0
7781408|NCT00958126|12230288|FG005|Overall Study|Withdrawal by Subject|0
7781409|NCT00958126|12230289|FG006|Overall Study|Withdrawal by Subject|0
7781410|NCT00958126|12230290|FG007|Overall Study|Withdrawal by Subject|0
7781411|NCT00958126|12230283|FG000|Overall Study|Moved away from study area|0
7781412|NCT00958126|12230284|FG001|Overall Study|Moved away from study area|0
7781413|NCT00958126|12230285|FG002|Overall Study|Moved away from study area|1
7781414|NCT00958126|12230286|FG003|Overall Study|Moved away from study area|1
7781415|NCT00958126|12230287|FG004|Overall Study|Moved away from study area|0
7781416|NCT00958126|12230288|FG005|Overall Study|Moved away from study area|0
7781417|NCT00958126|12230289|FG006|Overall Study|Moved away from study area|0
7781418|NCT00958126|12230290|FG007|Overall Study|Moved away from study area|0
7781419|NCT00958126|12230283|FG000|Overall Study|Lost to Follow-up|1
7781420|NCT00958126|12230284|FG001|Overall Study|Lost to Follow-up|5
7781421|NCT00958126|12230285|FG002|Overall Study|Lost to Follow-up|9
7781422|NCT00958126|12230286|FG003|Overall Study|Lost to Follow-up|8
7781423|NCT00958126|12230287|FG004|Overall Study|Lost to Follow-up|0
7781424|NCT00958126|12230288|FG005|Overall Study|Lost to Follow-up|0
7781425|NCT00958126|12230289|FG006|Overall Study|Lost to Follow-up|0
7781426|NCT00958126|12230290|FG007|Overall Study|Lost to Follow-up|0
7617531|NCT02352948|12027889|FG000|Overall Study|Death|47
7617532|NCT02352948|12027890|FG001|Overall Study|Death|48
7617533|NCT02352948|12027891|FG002|Overall Study|Death|114
7617534|NCT02352948|12027892|FG003|Overall Study|Death|74
7617535|NCT02352948|12027893|FG004|Overall Study|Death|77
7617536|NCT02352948|12027894|FG005|Overall Study|Death|44
7617537|NCT02352948|12027889|FG000|Overall Study|Lost to Follow-up|1
7617538|NCT02352948|12027890|FG001|Overall Study|Lost to Follow-up|0
7617539|NCT02352948|12027891|FG002|Overall Study|Lost to Follow-up|2
7617540|NCT02352948|12027892|FG003|Overall Study|Lost to Follow-up|1
7617541|NCT02352948|12027893|FG004|Overall Study|Lost to Follow-up|2
7617542|NCT02352948|12027894|FG005|Overall Study|Lost to Follow-up|1
7617543|NCT02352948|12027889|FG000|Overall Study|Withdrawal by Subject|1
7617544|NCT02352948|12027890|FG001|Overall Study|Withdrawal by Subject|10
7617545|NCT02352948|12027891|FG002|Overall Study|Withdrawal by Subject|11
7617546|NCT02352948|12027892|FG003|Overall Study|Withdrawal by Subject|23
7617547|NCT02352948|12027893|FG004|Overall Study|Withdrawal by Subject|9
7781427|NCT00958126|12230283|FG000|Overall Study|Sponsor/Investigator decision|0
7781428|NCT00958126|12230284|FG001|Overall Study|Sponsor/Investigator decision|0
7781429|NCT00958126|12230285|FG002|Overall Study|Sponsor/Investigator decision|0
7781430|NCT00958126|12230286|FG003|Overall Study|Sponsor/Investigator decision|1
7781431|NCT00958126|12230287|FG004|Overall Study|Sponsor/Investigator decision|0
7781432|NCT00958126|12230288|FG005|Overall Study|Sponsor/Investigator decision|0
7781433|NCT00958126|12230289|FG006|Overall Study|Sponsor/Investigator decision|0
7781434|NCT00958126|12230290|FG007|Overall Study|Sponsor/Investigator decision|0
7781435|NCT00958126|12230283|FG000|Overall Study|Other Reason|0
7781436|NCT00958126|12230284|FG001|Overall Study|Other Reason|0
7781437|NCT00958126|12230285|FG002|Overall Study|Other Reason|0
7617548|NCT02352948|12027894|FG005|Overall Study|Withdrawal by Subject|4
7617549|NCT02352948|12027889|FG000|Overall Study|Eligibility criteria not fulfilled|0
7617550|NCT02352948|12027890|FG001|Overall Study|Eligibility criteria not fulfilled|1
7617551|NCT02352948|12027891|FG002|Overall Study|Eligibility criteria not fulfilled|0
7617552|NCT02352948|12027892|FG003|Overall Study|Eligibility criteria not fulfilled|1
7617553|NCT02352948|12027893|FG004|Overall Study|Eligibility criteria not fulfilled|0
7617554|NCT02352948|12027894|FG005|Overall Study|Eligibility criteria not fulfilled|0
7617555|NCT02352948|12027889|FG000|Overall Study|Other|0
7617556|NCT02352948|12027890|FG001|Overall Study|Other|0
7617557|NCT02352948|12027891|FG002|Overall Study|Other|2
7617558|NCT02352948|12027892|FG003|Overall Study|Other|0
7617559|NCT02352948|12027893|FG004|Overall Study|Other|0
7617560|NCT02352948|12027894|FG005|Overall Study|Other|0
7617561|NCT02315703|12027926|FG000|Overall Study|Adverse Event|0
7617562|NCT02315703|12027927|FG001|Overall Study|Adverse Event|0
7617563|NCT02315703|12027928|FG002|Overall Study|Adverse Event|0
7617564|NCT02315703|12027929|FG003|Overall Study|Adverse Event|1
7617565|NCT02315703|12027930|FG004|Overall Study|Adverse Event|1
7617566|NCT02315703|12027931|FG005|Overall Study|Adverse Event|0
7617567|NCT02315703|12027932|FG006|Overall Study|Adverse Event|1
7617568|NCT02315703|12027933|FG007|Overall Study|Adverse Event|0
7617569|NCT02315703|12027926|FG000|Overall Study|Lost to Follow-up|1
7617570|NCT02315703|12027927|FG001|Overall Study|Lost to Follow-up|5
7617571|NCT02315703|12027928|FG002|Overall Study|Lost to Follow-up|3
7617572|NCT02315703|12027929|FG003|Overall Study|Lost to Follow-up|3
7617573|NCT02315703|12027930|FG004|Overall Study|Lost to Follow-up|2
7617574|NCT02315703|12027931|FG005|Overall Study|Lost to Follow-up|1
7617575|NCT02315703|12027932|FG006|Overall Study|Lost to Follow-up|2
7617576|NCT02315703|12027933|FG007|Overall Study|Lost to Follow-up|2
7617577|NCT02315703|12027926|FG000|Overall Study|Pregnancy|0
7617578|NCT02315703|12027927|FG001|Overall Study|Pregnancy|0
7617579|NCT02315703|12027928|FG002|Overall Study|Pregnancy|0
7617580|NCT02315703|12027929|FG003|Overall Study|Pregnancy|0
7617581|NCT02315703|12027930|FG004|Overall Study|Pregnancy|0
7617582|NCT02315703|12027931|FG005|Overall Study|Pregnancy|0
7617583|NCT02315703|12027932|FG006|Overall Study|Pregnancy|0
7617584|NCT02315703|12027933|FG007|Overall Study|Pregnancy|1
7617585|NCT02315703|12027926|FG000|Overall Study|Withdrawal by Subject|1
7617586|NCT02315703|12027927|FG001|Overall Study|Withdrawal by Subject|3
7617587|NCT02315703|12027928|FG002|Overall Study|Withdrawal by Subject|0
7617588|NCT02315703|12027929|FG003|Overall Study|Withdrawal by Subject|3
7617589|NCT02315703|12027930|FG004|Overall Study|Withdrawal by Subject|4
7617590|NCT02315703|12027931|FG005|Overall Study|Withdrawal by Subject|1
7617591|NCT02315703|12027932|FG006|Overall Study|Withdrawal by Subject|1
7617592|NCT02315703|12027933|FG007|Overall Study|Withdrawal by Subject|2
7617593|NCT02315703|12027926|FG000|Overall Study|Physician Decision|0
7617594|NCT02315703|12027927|FG001|Overall Study|Physician Decision|0
7617595|NCT02315703|12027928|FG002|Overall Study|Physician Decision|0
7617596|NCT02315703|12027929|FG003|Overall Study|Physician Decision|0
7617597|NCT02315703|12027930|FG004|Overall Study|Physician Decision|0
7617598|NCT02315703|12027931|FG005|Overall Study|Physician Decision|2
7617599|NCT02315703|12027932|FG006|Overall Study|Physician Decision|1
7617600|NCT02315703|12027933|FG007|Overall Study|Physician Decision|0
7617601|NCT02315703|12027926|FG000|Overall Study|Other|4
7617602|NCT02315703|12027927|FG001|Overall Study|Other|2
7781438|NCT00958126|12230286|FG003|Overall Study|Other Reason|1
7781439|NCT00958126|12230287|FG004|Overall Study|Other Reason|0
7781440|NCT00958126|12230288|FG005|Overall Study|Other Reason|1
7617603|NCT02315703|12027928|FG002|Overall Study|Other|2
7617604|NCT02315703|12027929|FG003|Overall Study|Other|2
7617605|NCT02315703|12027930|FG004|Overall Study|Other|1
7617606|NCT02315703|12027931|FG005|Overall Study|Other|2
7617607|NCT02315703|12027932|FG006|Overall Study|Other|8
7617608|NCT02315703|12027933|FG007|Overall Study|Other|2
7781441|NCT00958126|12230289|FG006|Overall Study|Other Reason|0
7781442|NCT00958126|12230290|FG007|Overall Study|Other Reason|0
7781443|NCT00958165|12230312|FG000|Overall Study|Lost to Follow-up|5
7781444|NCT00958165|12230312|FG000|Overall Study|Not eligible|9
7781445|NCT00958191|12230316|FG000|Overall Study|Death|4
7781446|NCT00958191|12230316|FG000|Overall Study|Lost to Follow-up|5
7781447|NCT00958191|12230316|FG000|Overall Study|Inadequate 5 yr x-ray quality|10
7781448|NCT00958191|12230316|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21
7781449|NCT00958191|12230316|FG000|Overall Study|Revision of study device|4
7781450|NCT00958191|12230316|FG000|Overall Study|Site termination|11
7781451|NCT00958191|12230316|FG000|Overall Study|No 5 yr x-rays|56
7781452|NCT00958217|12230324|FG000|Overall Study|Death|2
7781453|NCT00958217|12230325|FG001|Overall Study|Death|1
7781454|NCT00958217|12230324|FG000|Overall Study|Withdrawal by Subject|4
7781455|NCT00958217|12230325|FG001|Overall Study|Withdrawal by Subject|3
7781456|NCT00958217|12230324|FG000|Overall Study|Lost to Follow-up|17
7617625|NCT02214160|12027971|FG000|Overall Study|Withdrawal by Subject|1
7617626|NCT02214160|12027972|FG001|Overall Study|Withdrawal by Subject|0
7617627|NCT02214160|12027973|FG002|Overall Study|Withdrawal by Subject|6
7617628|NCT02214160|12027971|FG000|Overall Study|Death|2
7617629|NCT02214160|12027972|FG001|Overall Study|Death|2
7617630|NCT02214160|12027973|FG002|Overall Study|Death|1
7617631|NCT02214160|12027971|FG000|Overall Study|Subject Non-Compliance|0
7617632|NCT02214160|12027972|FG001|Overall Study|Subject Non-Compliance|3
7617633|NCT02214160|12027973|FG002|Overall Study|Subject Non-Compliance|1
7617634|NCT02214160|12027971|FG000|Overall Study|Adverse Event|0
7617635|NCT02214160|12027972|FG001|Overall Study|Adverse Event|1
7617636|NCT02214160|12027973|FG002|Overall Study|Adverse Event|1
7617637|NCT02214160|12027971|FG000|Overall Study|Sponsor Decision|0
7617638|NCT02214160|12027972|FG001|Overall Study|Sponsor Decision|2
7617639|NCT02214160|12027973|FG002|Overall Study|Sponsor Decision|0
7617640|NCT02214160|12027971|FG000|Overall Study|Protocol Violation|1
7617641|NCT02214160|12027972|FG001|Overall Study|Protocol Violation|0
7617642|NCT02214160|12027973|FG002|Overall Study|Protocol Violation|0
7617643|NCT02214160|12027971|FG000|Overall Study|Physician Decision|0
7617644|NCT02214160|12027972|FG001|Overall Study|Physician Decision|0
7617645|NCT02214160|12027973|FG002|Overall Study|Physician Decision|1
7617646|NCT02167945|12027985|FG000|Overall Study|Adverse Event|16
7617647|NCT02167945|12027985|FG000|Overall Study|Withdrew Consent|42
7617648|NCT02167945|12027985|FG000|Overall Study|Lost to Follow-up|122
7617649|NCT02167945|12027985|FG000|Overall Study|COVID-19 logistical restrictions|6
7617650|NCT02167945|12027985|FG000|Overall Study|Other, not specified|63
7617651|NCT02128763|12027999|FG000|Overall Study|Death|1
7617652|NCT02128763|12028000|FG001|Overall Study|Death|0
7617653|NCT02128763|12027999|FG000|Overall Study|Lost to Follow-up|19
7617654|NCT02128763|12028000|FG001|Overall Study|Lost to Follow-up|16
7617655|NCT01991977|12028018|FG000|Overall Study|Withdrew prior to receiving treatment|7
7617656|NCT01991977|12028018|FG000|Overall Study|Withdrew after start of treatment|5
7617657|NCT01903733|12028037|FG000|Overall Study|Death|23
7617658|NCT01903733|12028038|FG001|Overall Study|Death|54
7617659|NCT01903733|12028039|FG002|Overall Study|Death|30
7617660|NCT01903733|12028040|FG003|Overall Study|Death|98
7617661|NCT01903733|12028037|FG000|Overall Study|Participant refused further follow-up|35
7617662|NCT01903733|12028038|FG001|Overall Study|Participant refused further follow-up|38
7617663|NCT01903733|12028039|FG002|Overall Study|Participant refused further follow-up|13
7617664|NCT01903733|12028040|FG003|Overall Study|Participant refused further follow-up|9
7617665|NCT01903733|12028037|FG000|Overall Study|Lost to Follow-up|18
7617666|NCT01903733|12028038|FG001|Overall Study|Lost to Follow-up|19
7617667|NCT01903733|12028039|FG002|Overall Study|Lost to Follow-up|6
7617668|NCT01903733|12028040|FG003|Overall Study|Lost to Follow-up|9
7617669|NCT01903733|12028037|FG000|Overall Study|Other|10
7617670|NCT01903733|12028038|FG001|Overall Study|Other|15
7617671|NCT01903733|12028039|FG002|Overall Study|Other|12
7617672|NCT01903733|12028040|FG003|Overall Study|Other|3
7617673|NCT01903733|12028037|FG000|Overall Study|Missing|2
7617674|NCT01903733|12028038|FG001|Overall Study|Missing|0
7617675|NCT01903733|12028039|FG002|Overall Study|Missing|0
7617676|NCT01903733|12028040|FG003|Overall Study|Missing|0
7617677|NCT01903733|12028037|FG000|Overall Study|Investigator request|18
7617678|NCT01903733|12028038|FG001|Overall Study|Investigator request|0
7617679|NCT01903733|12028039|FG002|Overall Study|Investigator request|0
7617680|NCT01903733|12028040|FG003|Overall Study|Investigator request|0
7781457|NCT00958217|12230325|FG001|Overall Study|Lost to Follow-up|19
7781458|NCT00958217|12230324|FG000|Overall Study|Moved out of area|1
7781459|NCT00958217|12230325|FG001|Overall Study|Moved out of area|1
7781460|NCT00958217|12230324|FG000|Overall Study|Inpatient hospitalization|0
7781461|NCT00958217|12230325|FG001|Overall Study|Inpatient hospitalization|1
7781462|NCT00958243|12230338|FG000|Overall Study|Withdrawal by Subject|0
7781463|NCT00958243|12230339|FG001|Overall Study|Withdrawal by Subject|1
7781464|NCT00958243|12230340|FG002|Overall Study|Withdrawal by Subject|3
7781465|NCT00958243|12230341|FG003|Overall Study|Withdrawal by Subject|1
7781466|NCT00958243|12230342|FG004|Overall Study|Withdrawal by Subject|1
7781467|NCT00958243|12230343|FG005|Overall Study|Withdrawal by Subject|5
7781468|NCT00958243|12230338|FG000|Overall Study|Lost to Follow-up|2
7617693|NCT01575548|12028071|FG000|Overall Study|Adverse Event|15
7617694|NCT01575548|12028072|FG001|Overall Study|Adverse Event|2
7617695|NCT01575548|12028071|FG000|Overall Study|Disease progression|12
7617696|NCT01575548|12028072|FG001|Overall Study|Disease progression|25
7617697|NCT01575548|12028071|FG000|Overall Study|Death|1
7617698|NCT01575548|12028072|FG001|Overall Study|Death|0
7617699|NCT01575548|12028071|FG000|Overall Study|Other complicating disease|1
7617700|NCT01575548|12028072|FG001|Overall Study|Other complicating disease|0
7617701|NCT01575548|12028071|FG000|Overall Study|Withdrawal by Subject|7
7617702|NCT01575548|12028072|FG001|Overall Study|Withdrawal by Subject|3
7617703|NCT01575548|12028071|FG000|Overall Study|Noncompliance|1
7617704|NCT01575548|12028072|FG001|Overall Study|Noncompliance|0
7617705|NCT01575548|12028071|FG000|Overall Study|Anticipated surgery|0
7617706|NCT01575548|12028072|FG001|Overall Study|Anticipated surgery|1
7617707|NCT01575548|12028071|FG000|Overall Study|Never started protocol therapy|3
7617708|NCT01575548|12028072|FG001|Overall Study|Never started protocol therapy|2
7781469|NCT00958243|12230339|FG001|Overall Study|Lost to Follow-up|5
7781470|NCT00958243|12230340|FG002|Overall Study|Lost to Follow-up|11
7781471|NCT00958243|12230341|FG003|Overall Study|Lost to Follow-up|2
7781472|NCT00958243|12230342|FG004|Overall Study|Lost to Follow-up|8
7781473|NCT00958243|12230343|FG005|Overall Study|Lost to Follow-up|5
7781474|NCT00958256|12230363|FG000|Overall Study|Adverse Event|3
7781475|NCT00958360|12230404|FG000|Overall Study|Withdrawal by Subject|3
7781476|NCT00958360|12230405|FG001|Overall Study|Withdrawal by Subject|1
7781477|NCT00958360|12230404|FG000|Overall Study|Death|6
7781478|NCT00958360|12230405|FG001|Overall Study|Death|7
7781479|NCT00958360|12230404|FG000|Overall Study|Physician Decision|2
7781480|NCT00958360|12230405|FG001|Overall Study|Physician Decision|1
7781481|NCT00958360|12230404|FG000|Overall Study|Lost to Follow-up|0
7781482|NCT00958360|12230405|FG001|Overall Study|Lost to Follow-up|1
7781483|NCT00958412|12230411|FG000|Overall Study|Study prematurely terminated|18
7781484|NCT00958438|12230418|FG000|Overall Study|Protocol Violation|3
7781485|NCT00958438|12230419|FG001|Overall Study|Protocol Violation|2
7781486|NCT00958438|12230420|FG002|Overall Study|Protocol Violation|2
7781487|NCT00958438|12230418|FG000|Overall Study|Withdrawal by Subject|4
7781488|NCT00958438|12230419|FG001|Overall Study|Withdrawal by Subject|2
7781489|NCT00958438|12230420|FG002|Overall Study|Withdrawal by Subject|1
7781490|NCT00958438|12230418|FG000|Overall Study|Adverse Event|0
7781491|NCT00958438|12230419|FG001|Overall Study|Adverse Event|3
7781492|NCT00958438|12230420|FG002|Overall Study|Adverse Event|0
7781493|NCT00958438|12230418|FG000|Overall Study|Physician Decision|1
7781494|NCT00958438|12230419|FG001|Overall Study|Physician Decision|0
7781495|NCT00958438|12230420|FG002|Overall Study|Physician Decision|1
7781496|NCT00958438|12230418|FG000|Overall Study|Other than specified above|2
7781497|NCT00958438|12230419|FG001|Overall Study|Other than specified above|3
7781498|NCT00958438|12230420|FG002|Overall Study|Other than specified above|2
7781499|NCT00958568|12230451|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
7781500|NCT00958568|12230452|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
7781501|NCT00958568|12230453|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
7781502|NCT00958568|12230454|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
7781503|NCT00958568|12230451|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
7781504|NCT00958568|12230452|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
7781505|NCT00958568|12230453|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
7781506|NCT00958568|12230454|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
7781507|NCT00958568|12230451|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
7781508|NCT00958568|12230452|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
7781509|NCT00958568|12230453|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
7781510|NCT00958568|12230454|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
7781511|NCT00958568|12230451|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
7781512|NCT00958568|12230452|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
7781513|NCT00958568|12230453|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
7781514|NCT00958568|12230454|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
7781515|NCT00958568|12230451|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
7781516|NCT00958568|12230452|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
7781517|NCT00958568|12230453|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
7781518|NCT00958568|12230454|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
7781519|NCT00958568|12230451|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
7781520|NCT00958568|12230452|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
7781521|NCT00958568|12230453|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
7781522|NCT00958568|12230454|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
7781523|NCT00958568|12230451|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
7781524|NCT00958568|12230452|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
7781525|NCT00958568|12230453|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
7781526|NCT00958568|12230454|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
7781527|NCT00958568|12230451|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
7781528|NCT00958568|12230452|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
7781529|NCT00958568|12230453|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
7781530|NCT00958568|12230454|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
7781531|NCT00958568|12230451|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
7781532|NCT00958568|12230452|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
7781533|NCT00958568|12230453|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
7781534|NCT00958568|12230454|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
7781535|NCT00958568|12230451|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
7781536|NCT00958568|12230452|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
7781537|NCT00958568|12230453|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
7781538|NCT00958568|12230454|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
7781539|NCT00958568|12230451|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
7781540|NCT00958568|12230452|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
7781541|NCT00958568|12230453|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
7781542|NCT00958568|12230454|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
7781543|NCT00958568|12230451|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
7781544|NCT00958568|12230452|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
7781545|NCT00958568|12230453|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
7781546|NCT00958568|12230454|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
7781547|NCT00958568|12230451|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
7781548|NCT00958568|12230452|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
7781549|NCT00958568|12230453|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
7781550|NCT00958568|12230454|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
7781551|NCT00958568|12230451|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
7781552|NCT00958568|12230452|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
7781553|NCT00958568|12230453|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
7781554|NCT00958568|12230454|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
7781555|NCT00958568|12230451|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
7781556|NCT00958568|12230452|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
7781557|NCT00958568|12230453|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
7781558|NCT00958568|12230454|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
7781559|NCT00958568|12230451|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
7781560|NCT00958568|12230452|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
7781561|NCT00958568|12230453|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
7781562|NCT00958568|12230454|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
7781563|NCT00958568|12230451|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
7781564|NCT00958568|12230452|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
7781565|NCT00958568|12230453|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
7781566|NCT00958568|12230454|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
7781567|NCT00958568|12230451|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
7781568|NCT00958568|12230452|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
7781569|NCT00958568|12230453|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
7781570|NCT00958568|12230454|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
7781571|NCT00958568|12230451|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
7781572|NCT00958568|12230452|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
7781573|NCT00958568|12230453|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
7781574|NCT00958568|12230454|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
7781575|NCT00958568|12230451|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
7781576|NCT00958568|12230452|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
7781577|NCT00958568|12230453|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
7781578|NCT00958568|12230454|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
7781579|NCT00958568|12230451|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
7781580|NCT00958568|12230452|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
7781581|NCT00958568|12230453|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
7781582|NCT00958568|12230454|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
7781583|NCT00958568|12230451|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
7781584|NCT00958568|12230452|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
7781585|NCT00958568|12230453|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
7781586|NCT00958568|12230454|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
7781587|NCT00958568|12230451|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
7781588|NCT00958568|12230452|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
7781589|NCT00958568|12230453|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
7781590|NCT00958568|12230454|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
7781591|NCT00958568|12230451|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
7781592|NCT00958568|12230452|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
7781593|NCT00958568|12230453|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
7781594|NCT00958568|12230454|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
7781595|NCT00958568|12230451|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
7781596|NCT00958568|12230452|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
7781597|NCT00958568|12230453|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
7781598|NCT00958568|12230454|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
7781599|NCT00958568|12230451|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
7781600|NCT00958568|12230452|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
7781601|NCT00958568|12230453|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
7781602|NCT00958568|12230454|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
7781603|NCT00958568|12230451|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
7781604|NCT00958568|12230452|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
7781605|NCT00958568|12230453|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
7781606|NCT00958568|12230454|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
7781607|NCT00958568|12230451|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
7781608|NCT00958568|12230452|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
7781609|NCT00958568|12230453|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
7781610|NCT00958568|12230454|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
7781611|NCT00958568|12230451|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
7781612|NCT00958568|12230452|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
7781613|NCT00958568|12230453|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
7781614|NCT00958568|12230454|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
7781615|NCT00958711|12230483|FG000|Overall Study|Withdrawal by Subject|0
7617793|NCT01321073|12028120|FG000|Overall Study|Did not attempt implant|4
7617794|NCT01321073|12028120|FG000|Overall Study|Death|3
7781616|NCT00958711|12230484|FG001|Overall Study|Withdrawal by Subject|4
7781617|NCT00958711|12230483|FG000|Overall Study|Physician Decision|5
7781618|NCT00958711|12230484|FG001|Overall Study|Physician Decision|7
7781619|NCT00958711|12230483|FG000|Overall Study|Lost to Follow-up|4
7781620|NCT00958711|12230484|FG001|Overall Study|Lost to Follow-up|1
7781621|NCT00958711|12230483|FG000|Overall Study|Other|2
7781622|NCT00958711|12230484|FG001|Overall Study|Other|5
7781623|NCT00958711|12230483|FG000|Overall Study|Death|1
7781624|NCT00958711|12230484|FG001|Overall Study|Death|2
7781625|NCT00958711|12230483|FG000|Overall Study|Adverse Event|1
7781626|NCT00958711|12230484|FG001|Overall Study|Adverse Event|2
7781627|NCT00958724|12230490|FG000|Overall Study|Disease Progression|6
7781628|NCT00958776|12230496|FG000|Overall Study|Adverse Event|0
7781629|NCT00958776|12230497|FG001|Overall Study|Adverse Event|1
7781630|NCT00958776|12230496|FG000|Overall Study|Physician Decision|1
7781631|NCT00958776|12230497|FG001|Overall Study|Physician Decision|0
7781632|NCT00958776|12230496|FG000|Overall Study|Lost to Follow-up|2
7781633|NCT00958776|12230497|FG001|Overall Study|Lost to Follow-up|6
7781634|NCT00958776|12230496|FG000|Overall Study|Withdrawal by Subject|7
7781635|NCT00958776|12230497|FG001|Overall Study|Withdrawal by Subject|16
7781636|NCT00958776|12230496|FG000|Overall Study|Protocol Violation|1
7781637|NCT00958776|12230497|FG001|Overall Study|Protocol Violation|1
7781638|NCT00958776|12230496|FG000|Overall Study|Death|2
7781639|NCT00958776|12230497|FG001|Overall Study|Death|1
7781640|NCT00958776|12230496|FG000|Overall Study|Noncompliance; Protocol Deviations|2
7781641|NCT00958776|12230497|FG001|Overall Study|Noncompliance; Protocol Deviations|3
7781642|NCT00958776|12230496|FG000|Overall Study|Missing|1
7781643|NCT00958776|12230497|FG001|Overall Study|Missing|1
7781644|NCT00958789|12230504|FG000|Overall Study|Death|5
7781645|NCT00958789|12230504|FG000|Overall Study|Lost to Follow-up|14
7781646|NCT00958789|12230504|FG000|Overall Study|Withdrawal by Subject|17
7781647|NCT00958789|12230504|FG000|Overall Study|No 2 yr. Knee Society Score data|4
7781648|NCT00958789|12230504|FG000|Overall Study|2 yr. Knee Society Score not calculable|1
7781649|NCT00958789|12230504|FG000|Overall Study|Subject terminated|2
7781650|NCT00958789|12230504|FG000|Overall Study|Revision|7
7781651|NCT00958828|12230513|FG000|Period 1, 1 Week of Wear|Randomization break|0
7781652|NCT00958828|12230514|FG001|Period 1, 1 Week of Wear|Randomization break|1
7781653|NCT00958828|12230513|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0
7781654|NCT00958828|12230514|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1
7781655|NCT00958841|12230520|FG000|Overall Study|Abnormal laboratory value(s)|1
7781656|NCT00958841|12230520|FG000|Overall Study|Abnormal test procedure result(s)|3
7781657|NCT00958841|12230520|FG000|Overall Study|Administrative problems|1
7781658|NCT00958841|12230520|FG000|Overall Study|Adverse Event|8
7781659|NCT00958841|12230520|FG000|Overall Study|New cancer therapy|5
7781660|NCT00958841|12230520|FG000|Overall Study|Withdrawal by Subject|1
7781661|NCT00958841|12230520|FG000|Overall Study|Unsatisfactory therapeutic effect|22
7781662|NCT00958841|12230520|FG000|Overall Study|Completed M6/did not enter extension|27
7781663|NCT00958841|12230520|FG000|Overall Study|Discontinued prior to M*|28
7781664|NCT00958880|12230536|FG000|Overall Study|Lost to Follow-up|2
7617843|NCT01236547|12028172|FG000|Overall Study|Protocol Violation|0
7617844|NCT01236547|12028173|FG001|Overall Study|Protocol Violation|1
7617845|NCT01236547|12028174|FG002|Overall Study|Protocol Violation|1
7617846|NCT01236547|12028175|FG003|Overall Study|Protocol Violation|6
7617847|NCT01236547|12028176|FG004|Overall Study|Protocol Violation|12
7617848|NCT01038778|12028219|FG000|Overall Study|Withdrawal by Subject|0
7617849|NCT01038778|12028220|FG001|Overall Study|Withdrawal by Subject|2
7617850|NCT01038778|12028221|FG002|Overall Study|Withdrawal by Subject|3
7781665|NCT00958880|12230537|FG001|Overall Study|Lost to Follow-up|2
7781666|NCT00959049|12230563|FG000|Overall Study|Adverse Event|1
7781667|NCT00959049|12230564|FG001|Overall Study|Adverse Event|0
7781668|NCT00959049|12230565|FG002|Overall Study|Adverse Event|0
7781669|NCT00959049|12230566|FG003|Overall Study|Adverse Event|0
7781670|NCT00959049|12230567|FG004|Overall Study|Adverse Event|0
7781671|NCT00959049|12230568|FG005|Overall Study|Adverse Event|0
7781672|NCT00959049|12230563|FG000|Overall Study|Lost to Follow-up|17
7781673|NCT00959049|12230564|FG001|Overall Study|Lost to Follow-up|5
7781674|NCT00959049|12230565|FG002|Overall Study|Lost to Follow-up|1
7781675|NCT00959049|12230566|FG003|Overall Study|Lost to Follow-up|10
7781676|NCT00959049|12230567|FG004|Overall Study|Lost to Follow-up|9
7781677|NCT00959049|12230568|FG005|Overall Study|Lost to Follow-up|1
7781678|NCT00959049|12230563|FG000|Overall Study|Contraindicated medication|0
7781679|NCT00959049|12230564|FG001|Overall Study|Contraindicated medication|0
7781680|NCT00959049|12230565|FG002|Overall Study|Contraindicated medication|0
7781681|NCT00959049|12230566|FG003|Overall Study|Contraindicated medication|1
7781682|NCT00959049|12230567|FG004|Overall Study|Contraindicated medication|0
7781683|NCT00959049|12230568|FG005|Overall Study|Contraindicated medication|0
7781684|NCT00959049|12230563|FG000|Overall Study|Withdrawal by Subject|0
7781685|NCT00959049|12230564|FG001|Overall Study|Withdrawal by Subject|2
7781686|NCT00959049|12230565|FG002|Overall Study|Withdrawal by Subject|0
7781687|NCT00959049|12230566|FG003|Overall Study|Withdrawal by Subject|0
7781688|NCT00959049|12230567|FG004|Overall Study|Withdrawal by Subject|0
7781689|NCT00959049|12230568|FG005|Overall Study|Withdrawal by Subject|0
7781690|NCT00959192|12230606|FG000|Overall Study|Adverse Event|1
7781691|NCT00959192|12230607|FG001|Overall Study|Adverse Event|1
7781692|NCT00959192|12230608|FG002|Overall Study|Adverse Event|1
7781693|NCT00959192|12230609|FG003|Overall Study|Adverse Event|0
7781694|NCT00959192|12230606|FG000|Overall Study|Investigator Request|1
7781695|NCT00959192|12230607|FG001|Overall Study|Investigator Request|0
7781696|NCT00959192|12230608|FG002|Overall Study|Investigator Request|0
7781697|NCT00959192|12230609|FG003|Overall Study|Investigator Request|0
7781698|NCT00959192|12230606|FG000|Overall Study|Caregiver Request|0
7781699|NCT00959192|12230607|FG001|Overall Study|Caregiver Request|0
7781700|NCT00959192|12230608|FG002|Overall Study|Caregiver Request|2
7781701|NCT00959192|12230609|FG003|Overall Study|Caregiver Request|1
7781702|NCT00959374|12230620|FG000|Overall Study|Withdrawal by Subject|2
7781703|NCT00959374|12230620|FG000|Overall Study|Lost to Follow-up|14
7781704|NCT00959374|12230620|FG000|Overall Study|Death|1
7781705|NCT00959374|12230620|FG000|Overall Study|Protocol Violation|1
7781706|NCT00959374|12230620|FG000|Overall Study|Implant Removed/Not Replaced|4
7781707|NCT00959374|12230620|FG000|Overall Study|Physician Decision|1
7781708|NCT00959647|12230628|FG000|Overall Study|Adverse Event|2
7781709|NCT00959647|12230628|FG000|Overall Study|Progressive disease|6
7781710|NCT00959647|12230628|FG000|Overall Study|Study terminated by sponsor|4
7781711|NCT00959647|12230628|FG000|Overall Study|Withdrawal by Subject|7
7781712|NCT00959699|12230651|FG000|Treatment Period|Adverse Event|3
7781713|NCT00959699|12230652|FG001|Treatment Period|Adverse Event|13
7781714|NCT00959699|12230651|FG000|Treatment Period|Lack of Efficacy|15
7781715|NCT00959699|12230652|FG001|Treatment Period|Lack of Efficacy|6
7781716|NCT00959699|12230651|FG000|Treatment Period|Lost to Follow-up|0
7781717|NCT00959699|12230652|FG001|Treatment Period|Lost to Follow-up|1
7781718|NCT00959699|12230651|FG000|Treatment Period|Withdrawal by Subject|1
7781719|NCT00959699|12230652|FG001|Treatment Period|Withdrawal by Subject|3
7781720|NCT00959699|12230651|FG000|Treatment Period|Non-Compliance with Protocol|0
7781721|NCT00959699|12230652|FG001|Treatment Period|Non-Compliance with Protocol|1
7781722|NCT00959699|12230651|FG000|Treatment Period|Did not receive treatment|0
7781723|NCT00959699|12230652|FG001|Treatment Period|Did not receive treatment|1
7781724|NCT00959699|12230651|FG000|Treatment Period|Futility/crossover to boceprevir|4
7781725|NCT00959699|12230652|FG001|Treatment Period|Futility/crossover to boceprevir|0
7781726|NCT00959699|12230651|FG000|Follow-up Period|Lost to Follow-up|3
7781727|NCT00959699|12230652|FG001|Follow-up Period|Lost to Follow-up|2
7781728|NCT00959699|12230651|FG000|Follow-up Period|Withdrawal by Subject|3
7781729|NCT00959699|12230652|FG001|Follow-up Period|Withdrawal by Subject|4
7781730|NCT00959751|12230661|FG000|Overall Study|Lost to Follow-up|2
7781731|NCT00959751|12230662|FG001|Overall Study|Lost to Follow-up|3
7781732|NCT00959751|12230661|FG000|Overall Study|Consent Withdrawn|0
7781733|NCT00959751|12230662|FG001|Overall Study|Consent Withdrawn|1
7781734|NCT00959751|12230661|FG000|Overall Study|Non-compliance to Study Procedures|0
7781735|NCT00959751|12230662|FG001|Overall Study|Non-compliance to Study Procedures|1
7781736|NCT00959751|12230661|FG000|Overall Study|No migraine headache without aura|7
7781737|NCT00959751|12230662|FG001|Overall Study|No migraine headache without aura|7
7781738|NCT00959894|12230688|FG000|Overall Study|Lost to Follow-up|10
7781739|NCT00959894|12230688|FG000|Overall Study|Adverse Event|3
7781740|NCT00959894|12230688|FG000|Overall Study|Withdrawal by Subject|1
7781741|NCT00959894|12230688|FG000|Overall Study|Need for contraindicated medication|1
7781742|NCT00959894|12230688|FG000|Overall Study|Subject moved out of town|1
7781743|NCT00959907|12230695|FG000|Overall Study|Protocol Violation|0
7781744|NCT00959907|12230696|FG001|Overall Study|Protocol Violation|1
7781745|NCT00959907|12230695|FG000|Overall Study|Adverse Event|1
7781746|NCT00959907|12230696|FG001|Overall Study|Adverse Event|0
7781747|NCT00959907|12230695|FG000|Overall Study|Withdrawal by Subject|2
7781748|NCT00959907|12230696|FG001|Overall Study|Withdrawal by Subject|0
7617915|NCT00919763|12028290|FG000|Overall Study|Adverse Event|7
7617916|NCT00919763|12028291|FG001|Overall Study|Adverse Event|1
7617917|NCT00919763|12028290|FG000|Overall Study|Lost to Follow-up|1
7617918|NCT00919763|12028291|FG001|Overall Study|Lost to Follow-up|0
7617919|NCT00919763|12028290|FG000|Overall Study|Protocol Violation|1
7617920|NCT00919763|12028291|FG001|Overall Study|Protocol Violation|1
7781749|NCT00959946|12230721|FG000|Overall Study|Adverse Event|0
7781750|NCT00959946|12230722|FG001|Overall Study|Adverse Event|0
7781751|NCT00959946|12230723|FG002|Overall Study|Adverse Event|2
7781752|NCT00959946|12230724|FG003|Overall Study|Adverse Event|1
7781753|NCT00959946|12230725|FG004|Overall Study|Adverse Event|0
7781754|NCT00959946|12230726|FG005|Overall Study|Adverse Event|1
7781755|NCT00959946|12230727|FG006|Overall Study|Adverse Event|0
7781756|NCT00959946|12230728|FG007|Overall Study|Adverse Event|0
7781757|NCT00959946|12230721|FG000|Overall Study|Death|0
7781758|NCT00959946|12230722|FG001|Overall Study|Death|0
7617921|NCT00919763|12028290|FG000|Overall Study|Withdrawal by Subject|3
7617922|NCT00919763|12028291|FG001|Overall Study|Withdrawal by Subject|1
7617923|NCT00919763|12028290|FG000|Overall Study|Non-compliance|0
7617924|NCT00919763|12028291|FG001|Overall Study|Non-compliance|1
7781759|NCT00959946|12230723|FG002|Overall Study|Death|0
7781760|NCT00959946|12230724|FG003|Overall Study|Death|0
7781761|NCT00959946|12230725|FG004|Overall Study|Death|0
7781762|NCT00959946|12230726|FG005|Overall Study|Death|1
7781763|NCT00959946|12230727|FG006|Overall Study|Death|0
7781764|NCT00959946|12230728|FG007|Overall Study|Death|0
7781765|NCT00959946|12230721|FG000|Overall Study|Disease Progression|2
7781766|NCT00959946|12230722|FG001|Overall Study|Disease Progression|4
7781767|NCT00959946|12230723|FG002|Overall Study|Disease Progression|2
7781768|NCT00959946|12230724|FG003|Overall Study|Disease Progression|4
7781769|NCT00959946|12230725|FG004|Overall Study|Disease Progression|4
7781770|NCT00959946|12230726|FG005|Overall Study|Disease Progression|6
7781771|NCT00959946|12230727|FG006|Overall Study|Disease Progression|2
7781772|NCT00959946|12230728|FG007|Overall Study|Disease Progression|2
7781773|NCT00959946|12230721|FG000|Overall Study|Withdrawal by Subject|0
7781774|NCT00959946|12230722|FG001|Overall Study|Withdrawal by Subject|0
7781775|NCT00959946|12230723|FG002|Overall Study|Withdrawal by Subject|0
7781776|NCT00959946|12230724|FG003|Overall Study|Withdrawal by Subject|0
7781777|NCT00959946|12230725|FG004|Overall Study|Withdrawal by Subject|0
7781778|NCT00959946|12230726|FG005|Overall Study|Withdrawal by Subject|1
7781779|NCT00959946|12230727|FG006|Overall Study|Withdrawal by Subject|0
7781780|NCT00959946|12230728|FG007|Overall Study|Withdrawal by Subject|0
7781781|NCT00960011|12230770|FG000|Overall Study|Death|5
7781782|NCT00960011|12230771|FG001|Overall Study|Death|0
7781783|NCT00960011|12230770|FG000|Overall Study|Lost to Follow-up|6
7781784|NCT00960011|12230771|FG001|Overall Study|Lost to Follow-up|2
7781785|NCT00960063|12230814|FG000|Overall Study|Adverse Event|1
7781786|NCT00960063|12230815|FG001|Overall Study|Adverse Event|0
7781787|NCT00960063|12230816|FG002|Overall Study|Adverse Event|0
7781788|NCT00960063|12230814|FG000|Overall Study|Progression of Disease|0
7781789|NCT00960063|12230815|FG001|Overall Study|Progression of Disease|0
7781790|NCT00960063|12230816|FG002|Overall Study|Progression of Disease|3
7781791|NCT00960076|12230826|FG000|Overall Study|Adverse Event|1
7781792|NCT00960076|12230827|FG001|Overall Study|Adverse Event|7
7781793|NCT00960076|12230826|FG000|Overall Study|No longer met study criteria|1
7781794|NCT00960076|12230827|FG001|Overall Study|No longer met study criteria|5
7781795|NCT00960076|12230826|FG000|Overall Study|Withdrawal by Subject|1
7781796|NCT00960076|12230827|FG001|Overall Study|Withdrawal by Subject|2
7781797|NCT00960076|12230826|FG000|Overall Study|Lost to Follow-up|3
7781798|NCT00960076|12230827|FG001|Overall Study|Lost to Follow-up|3
7781799|NCT00960076|12230826|FG000|Overall Study|Severe non-compliance to protocol|1
7781800|NCT00960076|12230827|FG001|Overall Study|Severe non-compliance to protocol|2
7781801|NCT00960076|12230826|FG000|Overall Study|Hyperglycemia|1
7781802|NCT00960076|12230827|FG001|Overall Study|Hyperglycemia|5
7781803|NCT00960076|12230826|FG000|Overall Study|Did not attend the termination visit|0
7781804|NCT00960076|12230827|FG001|Overall Study|Did not attend the termination visit|1
7800173|NCT01091428|12257327|FG001|Phase 2|Withdrawal by Subject|0
7800174|NCT01091428|12257328|FG002|Phase 2|Withdrawal by Subject|9
7800175|NCT01091428|12257329|FG003|Phase 2|Withdrawal by Subject|8
7800176|NCT01091428|12257326|FG000|Phase 2|Unsatisfactory Therapeutic Response|0
7800177|NCT01091428|12257327|FG001|Phase 2|Unsatisfactory Therapeutic Response|0
7800178|NCT01091428|12257328|FG002|Phase 2|Unsatisfactory Therapeutic Response|1
7800179|NCT01091428|12257329|FG003|Phase 2|Unsatisfactory Therapeutic Response|1
7800180|NCT01091428|12257326|FG000|Phase 2|Reason not specified|0
7800181|NCT01091428|12257327|FG001|Phase 2|Reason not specified|0
7800182|NCT01091428|12257328|FG002|Phase 2|Reason not specified|4
7800183|NCT01091428|12257329|FG003|Phase 2|Reason not specified|3
7800184|NCT01091428|12257326|FG000|Phase 2|Physician Decision|0
7800185|NCT01091428|12257327|FG001|Phase 2|Physician Decision|0
7800186|NCT01091428|12257328|FG002|Phase 2|Physician Decision|2
7800187|NCT01091428|12257329|FG003|Phase 2|Physician Decision|0
7800188|NCT01091454|12257348|FG000|Overall Study|Ineligible|1
7800189|NCT01091519|12257354|FG000|Overall Study|Adverse Event|12
7800190|NCT01091519|12257355|FG001|Overall Study|Adverse Event|16
7800191|NCT01091519|12257354|FG000|Overall Study|Death|1
7800192|NCT01091519|12257355|FG001|Overall Study|Death|0
7800193|NCT01091519|12257354|FG000|Overall Study|Lack of Efficacy|16
7800194|NCT01091519|12257355|FG001|Overall Study|Lack of Efficacy|19
7800195|NCT01091519|12257354|FG000|Overall Study|Lost to Follow-up|14
7800196|NCT01091519|12257355|FG001|Overall Study|Lost to Follow-up|24
7800197|NCT01091519|12257354|FG000|Overall Study|Withdrawal by Subject|2
7800198|NCT01091519|12257355|FG001|Overall Study|Withdrawal by Subject|2
7800199|NCT01091519|12257354|FG000|Overall Study|Other|6
7800200|NCT01091519|12257355|FG001|Overall Study|Other|8
7800201|NCT01091519|12257354|FG000|Overall Study|Randomized not treated|4
7800202|NCT01091519|12257355|FG001|Overall Study|Randomized not treated|4
7800203|NCT01091662|12257363|FG000|Overall Study|Adverse Event|1
7800204|NCT01091662|12257364|FG001|Overall Study|Adverse Event|9
7800205|NCT01091662|12257363|FG000|Overall Study|Physician Decision|1
7800206|NCT01091662|12257364|FG001|Overall Study|Physician Decision|1
7800207|NCT01091662|12257363|FG000|Overall Study|Withdrawal by Subject|7
7800208|NCT01091662|12257364|FG001|Overall Study|Withdrawal by Subject|6
7800209|NCT01091662|12257363|FG000|Overall Study|met exit criteria|7
7800210|NCT01091662|12257364|FG001|Overall Study|met exit criteria|13
7800211|NCT01091662|12257363|FG000|Overall Study|met exclusion criteria|1
7800212|NCT01091662|12257364|FG001|Overall Study|met exclusion criteria|0
7800213|NCT01091662|12257363|FG000|Overall Study|Lost to Follow-up|0
7800214|NCT01091662|12257364|FG001|Overall Study|Lost to Follow-up|1
7800215|NCT01091662|12257363|FG000|Overall Study|Pregnancy|0
7800216|NCT01091662|12257364|FG001|Overall Study|Pregnancy|1
7800217|NCT01091662|12257363|FG000|Overall Study|Protocol Violation|0
7800218|NCT01091662|12257364|FG001|Overall Study|Protocol Violation|2
7800219|NCT01091662|12257363|FG000|Overall Study|unable to swallow capsule|0
7800220|NCT01091662|12257364|FG001|Overall Study|unable to swallow capsule|1
7781805|NCT00960115|12230835|FG000|Overall Study|Ongoing treatment at data cut-off date|19
7781806|NCT00960115|12230836|FG001|Overall Study|Ongoing treatment at data cut-off date|15
7781807|NCT00960193|12230842|FG000|14 Day Washout Period|Withdrawal by Subject|1
7781808|NCT00960206|12230852|FG000|Overall Study|Death|7
7781809|NCT00960206|12230853|FG001|Overall Study|Death|4
7781810|NCT00960206|12230854|FG002|Overall Study|Death|1
7781811|NCT00960206|12230852|FG000|Overall Study|Unwilling/Unable to return|1
7781812|NCT00960206|12230853|FG001|Overall Study|Unwilling/Unable to return|2
7781813|NCT00960206|12230854|FG002|Overall Study|Unwilling/Unable to return|0
7781814|NCT00960206|12230852|FG000|Overall Study|Lost to Follow-up|8
7781815|NCT00960206|12230853|FG001|Overall Study|Lost to Follow-up|14
7781816|NCT00960206|12230854|FG002|Overall Study|Lost to Follow-up|8
7781817|NCT00960206|12230852|FG000|Overall Study|Withdrawal by Subject|2
7781818|NCT00960206|12230853|FG001|Overall Study|Withdrawal by Subject|4
7781819|NCT00960206|12230854|FG002|Overall Study|Withdrawal by Subject|0
7781820|NCT00960206|12230852|FG000|Overall Study|Revision of study component|2
7781821|NCT00960206|12230853|FG001|Overall Study|Revision of study component|2
7781822|NCT00960206|12230854|FG002|Overall Study|Revision of study component|2
7781823|NCT00960206|12230852|FG000|Overall Study|Missing 10 year data|20
7781824|NCT00960206|12230853|FG001|Overall Study|Missing 10 year data|1
7781825|NCT00960206|12230854|FG002|Overall Study|Missing 10 year data|1
7781826|NCT00960323|12230863|FG000|Atorvastatin Alone|Withdrawal by Subject|1
7781827|NCT00960375|12230873|FG000|Overall Study|Lost to Follow-up|20
7781828|NCT00960375|12230874|FG001|Overall Study|Lost to Follow-up|22
7781829|NCT00960440|12230884|FG000|Overall Study|Death|0
7781830|NCT00960440|12230885|FG001|Overall Study|Death|0
7781831|NCT00960440|12230886|FG002|Overall Study|Death|0
7781832|NCT00960440|12230887|FG003|Overall Study|Death|1
7781833|NCT00960440|12230884|FG000|Overall Study|Adverse Event|12
7781834|NCT00960440|12230885|FG001|Overall Study|Adverse Event|12
7781835|NCT00960440|12230886|FG002|Overall Study|Adverse Event|4
7781836|NCT00960440|12230887|FG003|Overall Study|Adverse Event|4
7781837|NCT00960440|12230884|FG000|Overall Study|Lack of Efficacy|2
7781838|NCT00960440|12230885|FG001|Overall Study|Lack of Efficacy|5
7781839|NCT00960440|12230886|FG002|Overall Study|Lack of Efficacy|3
7781840|NCT00960440|12230887|FG003|Overall Study|Lack of Efficacy|8
7781841|NCT00960440|12230884|FG000|Overall Study|Protocol Violation|2
7781842|NCT00960440|12230885|FG001|Overall Study|Protocol Violation|8
7781843|NCT00960440|12230886|FG002|Overall Study|Protocol Violation|3
7781844|NCT00960440|12230887|FG003|Overall Study|Protocol Violation|4
7781845|NCT00960440|12230884|FG000|Overall Study|Withdrawal by Subject|9
7781846|NCT00960440|12230885|FG001|Overall Study|Withdrawal by Subject|5
7781847|NCT00960440|12230886|FG002|Overall Study|Withdrawal by Subject|2
7781848|NCT00960440|12230887|FG003|Overall Study|Withdrawal by Subject|1
7781849|NCT00960440|12230884|FG000|Overall Study|Other|1
7781850|NCT00960440|12230885|FG001|Overall Study|Other|1
7781851|NCT00960440|12230886|FG002|Overall Study|Other|1
7781852|NCT00960440|12230887|FG003|Overall Study|Other|0
7781853|NCT00960531|12230922|FG000|Overall Study|Lack of Efficacy|1
7781854|NCT00960531|12230923|FG001|Overall Study|Lack of Efficacy|0
7781855|NCT00960531|12230924|FG002|Overall Study|Lack of Efficacy|0
7781856|NCT00960531|12230925|FG003|Overall Study|Lack of Efficacy|0
7781857|NCT00960531|12230926|FG004|Overall Study|Lack of Efficacy|0
7781858|NCT00960531|12230927|FG005|Overall Study|Lack of Efficacy|0
7781859|NCT00960531|12230928|FG006|Overall Study|Lack of Efficacy|0
7781860|NCT00960531|12230929|FG007|Overall Study|Lack of Efficacy|0
7781861|NCT00960531|12230930|FG008|Overall Study|Lack of Efficacy|0
7781862|NCT00960531|12230931|FG009|Overall Study|Lack of Efficacy|0
7781863|NCT00960531|12230922|FG000|Overall Study|Withdrawal by Subject|1
7781864|NCT00960531|12230923|FG001|Overall Study|Withdrawal by Subject|0
7781865|NCT00960531|12230924|FG002|Overall Study|Withdrawal by Subject|5
7781866|NCT00960531|12230925|FG003|Overall Study|Withdrawal by Subject|2
7781867|NCT00960531|12230926|FG004|Overall Study|Withdrawal by Subject|0
7781868|NCT00960531|12230927|FG005|Overall Study|Withdrawal by Subject|0
7781869|NCT00960531|12230928|FG006|Overall Study|Withdrawal by Subject|2
7781870|NCT00960531|12230929|FG007|Overall Study|Withdrawal by Subject|0
7781871|NCT00960531|12230930|FG008|Overall Study|Withdrawal by Subject|1
7781872|NCT00960531|12230931|FG009|Overall Study|Withdrawal by Subject|0
7781873|NCT00960531|12230922|FG000|Overall Study|Caregiver Request|2
7781874|NCT00960531|12230923|FG001|Overall Study|Caregiver Request|0
7781875|NCT00960531|12230924|FG002|Overall Study|Caregiver Request|6
7781876|NCT00960531|12230925|FG003|Overall Study|Caregiver Request|5
7781877|NCT00960531|12230926|FG004|Overall Study|Caregiver Request|0
7781878|NCT00960531|12230927|FG005|Overall Study|Caregiver Request|2
7781879|NCT00960531|12230928|FG006|Overall Study|Caregiver Request|3
7781880|NCT00960531|12230929|FG007|Overall Study|Caregiver Request|1
7781881|NCT00960531|12230930|FG008|Overall Study|Caregiver Request|3
7781882|NCT00960531|12230931|FG009|Overall Study|Caregiver Request|0
7781883|NCT00960531|12230922|FG000|Overall Study|Investigator Request|0
7781884|NCT00960531|12230923|FG001|Overall Study|Investigator Request|0
7781885|NCT00960531|12230924|FG002|Overall Study|Investigator Request|1
7781886|NCT00960531|12230925|FG003|Overall Study|Investigator Request|0
7781887|NCT00960531|12230926|FG004|Overall Study|Investigator Request|0
7781888|NCT00960531|12230927|FG005|Overall Study|Investigator Request|0
7781889|NCT00960531|12230928|FG006|Overall Study|Investigator Request|0
7781890|NCT00960531|12230929|FG007|Overall Study|Investigator Request|0
7781891|NCT00960531|12230930|FG008|Overall Study|Investigator Request|0
7781892|NCT00960531|12230931|FG009|Overall Study|Investigator Request|0
7781893|NCT00960531|12230922|FG000|Overall Study|Discontinuation of Study by Sponsor|0
7781894|NCT00960531|12230923|FG001|Overall Study|Discontinuation of Study by Sponsor|0
7781895|NCT00960531|12230924|FG002|Overall Study|Discontinuation of Study by Sponsor|0
7781896|NCT00960531|12230925|FG003|Overall Study|Discontinuation of Study by Sponsor|0
7781897|NCT00960531|12230926|FG004|Overall Study|Discontinuation of Study by Sponsor|0
7781898|NCT00960531|12230927|FG005|Overall Study|Discontinuation of Study by Sponsor|0
7781899|NCT00960531|12230928|FG006|Overall Study|Discontinuation of Study by Sponsor|0
7781900|NCT00960531|12230929|FG007|Overall Study|Discontinuation of Study by Sponsor|1
7781901|NCT00960531|12230930|FG008|Overall Study|Discontinuation of Study by Sponsor|0
7781902|NCT00960531|12230931|FG009|Overall Study|Discontinuation of Study by Sponsor|0
7781903|NCT00960531|12230922|FG000|Overall Study|Lost to Follow-up|0
7781904|NCT00960531|12230923|FG001|Overall Study|Lost to Follow-up|0
7781905|NCT00960531|12230924|FG002|Overall Study|Lost to Follow-up|1
7781906|NCT00960531|12230925|FG003|Overall Study|Lost to Follow-up|0
7781907|NCT00960531|12230926|FG004|Overall Study|Lost to Follow-up|0
7781908|NCT00960531|12230927|FG005|Overall Study|Lost to Follow-up|0
7781909|NCT00960531|12230928|FG006|Overall Study|Lost to Follow-up|1
7781910|NCT00960531|12230929|FG007|Overall Study|Lost to Follow-up|0
7781911|NCT00960531|12230930|FG008|Overall Study|Lost to Follow-up|0
7781912|NCT00960531|12230931|FG009|Overall Study|Lost to Follow-up|0
7781913|NCT00960531|12230922|FG000|Overall Study|Failed to Return|2
7781914|NCT00960531|12230923|FG001|Overall Study|Failed to Return|0
7781915|NCT00960531|12230924|FG002|Overall Study|Failed to Return|0
7781916|NCT00960531|12230925|FG003|Overall Study|Failed to Return|0
7781917|NCT00960531|12230926|FG004|Overall Study|Failed to Return|0
7781918|NCT00960531|12230927|FG005|Overall Study|Failed to Return|0
7781919|NCT00960531|12230928|FG006|Overall Study|Failed to Return|0
7781920|NCT00960531|12230929|FG007|Overall Study|Failed to Return|2
7781921|NCT00960531|12230930|FG008|Overall Study|Failed to Return|0
7781922|NCT00960531|12230931|FG009|Overall Study|Failed to Return|0
7781923|NCT00960531|12230922|FG000|Overall Study|Adverse Event (AE)|2
7781924|NCT00960531|12230923|FG001|Overall Study|Adverse Event (AE)|0
7781925|NCT00960531|12230924|FG002|Overall Study|Adverse Event (AE)|0
7781926|NCT00960531|12230925|FG003|Overall Study|Adverse Event (AE)|0
7781927|NCT00960531|12230926|FG004|Overall Study|Adverse Event (AE)|0
7781928|NCT00960531|12230927|FG005|Overall Study|Adverse Event (AE)|1
7781929|NCT00960531|12230928|FG006|Overall Study|Adverse Event (AE)|2
7781930|NCT00960531|12230929|FG007|Overall Study|Adverse Event (AE)|0
7781931|NCT00960531|12230930|FG008|Overall Study|Adverse Event (AE)|2
7781932|NCT00960531|12230931|FG009|Overall Study|Adverse Event (AE)|0
7781933|NCT00960531|12230922|FG000|Overall Study|Reason not Specified|2
7781934|NCT00960531|12230923|FG001|Overall Study|Reason not Specified|1
7781935|NCT00960531|12230924|FG002|Overall Study|Reason not Specified|13
7781936|NCT00960531|12230925|FG003|Overall Study|Reason not Specified|1
7781937|NCT00960531|12230926|FG004|Overall Study|Reason not Specified|2
7781938|NCT00960531|12230927|FG005|Overall Study|Reason not Specified|0
7781939|NCT00960531|12230928|FG006|Overall Study|Reason not Specified|16
7781940|NCT00960531|12230929|FG007|Overall Study|Reason not Specified|0
7781941|NCT00960531|12230930|FG008|Overall Study|Reason not Specified|8
7781942|NCT00960531|12230931|FG009|Overall Study|Reason not Specified|1
7781943|NCT00960570|12230957|FG000|21 Day Washout Period|Adverse Event|1
7781944|NCT00960570|12230957|FG000|21 Day Washout Period|Withdrawal by Subject|1
7781945|NCT00960570|12230957|FG000|1 Day Period Between Dosing|Adverse Event|2
7781946|NCT00960570|12230957|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1
7781947|NCT00960661|12230975|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
7781948|NCT00960661|12230976|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
7781949|NCT00960661|12230977|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
7781950|NCT00960661|12230975|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
7781951|NCT00960661|12230976|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
7781952|NCT00960661|12230977|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
7781953|NCT00960661|12230975|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
7781954|NCT00960661|12230976|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
7781955|NCT00960661|12230977|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
7781956|NCT00960661|12230975|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
7781957|NCT00960661|12230976|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
7781958|NCT00960661|12230977|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
7781959|NCT00960661|12230975|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
7781960|NCT00960661|12230976|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
7781961|NCT00960661|12230977|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
7781962|NCT00960661|12230975|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
7781963|NCT00960661|12230976|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
7781964|NCT00960661|12230977|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
7781965|NCT00960661|12230975|FG000|Interventional Phase|Adverse Event|0
7781966|NCT00960661|12230976|FG001|Interventional Phase|Adverse Event|17
7781967|NCT00960661|12230977|FG002|Interventional Phase|Adverse Event|8
7781968|NCT00960661|12230975|FG000|Interventional Phase|Death|0
7781969|NCT00960661|12230976|FG001|Interventional Phase|Death|1
7781970|NCT00960661|12230977|FG002|Interventional Phase|Death|0
7781971|NCT00960661|12230975|FG000|Interventional Phase|Lost to Follow-up|0
7781972|NCT00960661|12230976|FG001|Interventional Phase|Lost to Follow-up|0
7781973|NCT00960661|12230977|FG002|Interventional Phase|Lost to Follow-up|2
7781974|NCT00960661|12230975|FG000|Interventional Phase|entry criteria not met|0
7781975|NCT00960661|12230976|FG001|Interventional Phase|entry criteria not met|3
7781976|NCT00960661|12230977|FG002|Interventional Phase|entry criteria not met|0
7781977|NCT00960661|12230975|FG000|Interventional Phase|Protocol Violation|0
7781978|NCT00960661|12230976|FG001|Interventional Phase|Protocol Violation|7
7781979|NCT00960661|12230977|FG002|Interventional Phase|Protocol Violation|2
7781980|NCT00960661|12230975|FG000|Interventional Phase|Withdrawal by Subject|0
7781981|NCT00960661|12230976|FG001|Interventional Phase|Withdrawal by Subject|18
7781982|NCT00960661|12230977|FG002|Interventional Phase|Withdrawal by Subject|29
7781983|NCT00960661|12230975|FG000|Interventional Phase|Physician Decision|0
7781984|NCT00960661|12230976|FG001|Interventional Phase|Physician Decision|3
7781985|NCT00960661|12230977|FG002|Interventional Phase|Physician Decision|5
7781986|NCT00960661|12230975|FG000|Interventional Phase|sponsor decision|0
7781987|NCT00960661|12230976|FG001|Interventional Phase|sponsor decision|1
7781988|NCT00960661|12230977|FG002|Interventional Phase|sponsor decision|0
7781989|NCT00960661|12230975|FG000|Interventional Phase|Lack of Efficacy|0
7781990|NCT00960661|12230976|FG001|Interventional Phase|Lack of Efficacy|2
7781991|NCT00960661|12230977|FG002|Interventional Phase|Lack of Efficacy|0
7781992|NCT00960687|12230983|FG000|Washout Period of 7 Days|Adverse Event|3
7781993|NCT00960687|12230984|FG001|Washout Period of 7 Days|Adverse Event|2
7781994|NCT00960687|12230983|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
7781995|NCT00960687|12230984|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7781996|NCT00960804|12231002|FG000|Overall Study|Adverse Event|1
7781997|NCT00960804|12231003|FG001|Overall Study|Adverse Event|0
7781998|NCT00960804|12231004|FG002|Overall Study|Adverse Event|0
7781999|NCT00960804|12231002|FG000|Overall Study|Withdrawal by Subject|1
7782000|NCT00960804|12231003|FG001|Overall Study|Withdrawal by Subject|0
7782001|NCT00960804|12231004|FG002|Overall Study|Withdrawal by Subject|0
7782002|NCT00960804|12231002|FG000|Overall Study|Study terminated by the sponsor|5
7782003|NCT00960804|12231003|FG001|Overall Study|Study terminated by the sponsor|4
7782004|NCT00960804|12231004|FG002|Overall Study|Study terminated by the sponsor|10
7782005|NCT00960843|12231014|FG000|Overall Study|Lost to Follow-up|2
7782006|NCT00960843|12231015|FG001|Overall Study|Lost to Follow-up|0
7782007|NCT00960843|12231014|FG000|Overall Study|Protocol Violation|0
7782008|NCT00960843|12231015|FG001|Overall Study|Protocol Violation|4
7782009|NCT00960843|12231014|FG000|Overall Study|Repeated needle dislodgment|0
7782010|NCT00960843|12231015|FG001|Overall Study|Repeated needle dislodgment|1
7782011|NCT00960856|12231021|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
7782012|NCT00960856|12231022|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
7782013|NCT00960856|12231023|FG002|Washout Period of 7 Days|Withdrawal by Subject|0
7782014|NCT00960856|12231024|FG003|Washout Period of 7 Days|Withdrawal by Subject|0
7782015|NCT00960856|12231021|FG000|Washout Period of 7 Days|Adverse Event|0
7782016|NCT00960856|12231022|FG001|Washout Period of 7 Days|Adverse Event|0
7782017|NCT00960856|12231023|FG002|Washout Period of 7 Days|Adverse Event|1
7782018|NCT00960856|12231024|FG003|Washout Period of 7 Days|Adverse Event|0
7782019|NCT00960869|12231036|FG000|Overall Study|Adverse Event|17
7782020|NCT00960869|12231037|FG001|Overall Study|Adverse Event|26
7782021|NCT00960869|12231036|FG000|Overall Study|Withdrawal by Subject|16
7782022|NCT00960869|12231037|FG001|Overall Study|Withdrawal by Subject|14
7782023|NCT00960869|12231036|FG000|Overall Study|Lost to Follow-up|1
7782024|NCT00960869|12231037|FG001|Overall Study|Lost to Follow-up|4
7782025|NCT00960869|12231036|FG000|Overall Study|Misc|19
7782026|NCT00960869|12231037|FG001|Overall Study|Misc|18
7782027|NCT00960934|12231049|FG000|Overall Study|Adverse Event|2
7782028|NCT00960934|12231050|FG001|Overall Study|Adverse Event|3
7782029|NCT00960934|12231051|FG002|Overall Study|Adverse Event|3
7782030|NCT00960934|12231052|FG003|Overall Study|Adverse Event|2
7782031|NCT00960934|12231053|FG004|Overall Study|Adverse Event|4
7782032|NCT00960934|12231054|FG005|Overall Study|Adverse Event|3
7782033|NCT00960934|12231049|FG000|Overall Study|Lack of Efficacy|1
7782034|NCT00960934|12231050|FG001|Overall Study|Lack of Efficacy|0
7782035|NCT00960934|12231051|FG002|Overall Study|Lack of Efficacy|0
7782036|NCT00960934|12231052|FG003|Overall Study|Lack of Efficacy|0
7782037|NCT00960934|12231053|FG004|Overall Study|Lack of Efficacy|0
7782038|NCT00960934|12231054|FG005|Overall Study|Lack of Efficacy|0
7782039|NCT00960934|12231049|FG000|Overall Study|Lost to Follow-up|0
7782040|NCT00960934|12231050|FG001|Overall Study|Lost to Follow-up|1
7782041|NCT00960934|12231051|FG002|Overall Study|Lost to Follow-up|0
7782042|NCT00960934|12231052|FG003|Overall Study|Lost to Follow-up|0
7782043|NCT00960934|12231053|FG004|Overall Study|Lost to Follow-up|0
7782044|NCT00960934|12231054|FG005|Overall Study|Lost to Follow-up|0
7782045|NCT00960934|12231049|FG000|Overall Study|Other|2
7782046|NCT00960934|12231050|FG001|Overall Study|Other|1
7782047|NCT00960934|12231051|FG002|Overall Study|Other|5
7782048|NCT00960934|12231052|FG003|Overall Study|Other|4
7782049|NCT00960934|12231053|FG004|Overall Study|Other|2
7782050|NCT00960934|12231054|FG005|Overall Study|Other|2
7782051|NCT00960934|12231049|FG000|Overall Study|Physician Decision|0
7782052|NCT00960934|12231050|FG001|Overall Study|Physician Decision|1
7782053|NCT00960934|12231051|FG002|Overall Study|Physician Decision|0
7782054|NCT00960934|12231052|FG003|Overall Study|Physician Decision|0
7782055|NCT00960934|12231053|FG004|Overall Study|Physician Decision|0
7782056|NCT00960934|12231054|FG005|Overall Study|Physician Decision|0
7782057|NCT00960934|12231049|FG000|Overall Study|Progressive Disease|1
7618087|NCT00238420|12028427|FG000|Overall Study|Protocol Violation|1
7618088|NCT00238420|12028428|FG001|Overall Study|Protocol Violation|1
7782058|NCT00960934|12231050|FG001|Overall Study|Progressive Disease|1
7782059|NCT00960934|12231051|FG002|Overall Study|Progressive Disease|0
7782060|NCT00960934|12231052|FG003|Overall Study|Progressive Disease|0
7782061|NCT00960934|12231053|FG004|Overall Study|Progressive Disease|1
7782062|NCT00960934|12231054|FG005|Overall Study|Progressive Disease|1
7782063|NCT00960934|12231049|FG000|Overall Study|Protocol Violation|3
7782064|NCT00960934|12231050|FG001|Overall Study|Protocol Violation|4
7782065|NCT00960934|12231051|FG002|Overall Study|Protocol Violation|0
7782066|NCT00960934|12231052|FG003|Overall Study|Protocol Violation|3
7782067|NCT00960934|12231053|FG004|Overall Study|Protocol Violation|3
7782068|NCT00960934|12231054|FG005|Overall Study|Protocol Violation|2
7782069|NCT00960934|12231049|FG000|Overall Study|Withdrawal by Subject|5
7782070|NCT00960934|12231050|FG001|Overall Study|Withdrawal by Subject|6
7782071|NCT00960934|12231051|FG002|Overall Study|Withdrawal by Subject|4
7782072|NCT00960934|12231052|FG003|Overall Study|Withdrawal by Subject|5
7782073|NCT00960934|12231053|FG004|Overall Study|Withdrawal by Subject|5
7782074|NCT00960934|12231054|FG005|Overall Study|Withdrawal by Subject|7
7782075|NCT00960934|12231049|FG000|Overall Study|Study Terminated by Sponsor|50
7782076|NCT00960934|12231050|FG001|Overall Study|Study Terminated by Sponsor|46
7782077|NCT00960934|12231051|FG002|Overall Study|Study Terminated by Sponsor|52
7782078|NCT00960934|12231052|FG003|Overall Study|Study Terminated by Sponsor|50
7618109|NCT04189588|12028504|FG000|Overall Study|Death|0
7618110|NCT04189588|12028505|FG001|Overall Study|Death|1
7618111|NCT04189588|12028504|FG000|Overall Study|Lost to Follow-up|0
7618112|NCT04189588|12028505|FG001|Overall Study|Lost to Follow-up|1
7618113|NCT04115748|12028520|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15
7782079|NCT00960934|12231053|FG004|Overall Study|Study Terminated by Sponsor|49
7782080|NCT00960934|12231054|FG005|Overall Study|Study Terminated by Sponsor|49
7782081|NCT00960986|12231072|FG000|Period 1 (Screening and Washout)|Adverse Event|1
7782082|NCT00960986|12231073|FG001|Period 1 (Screening and Washout)|Adverse Event|2
7782083|NCT00960986|12231074|FG002|Period 1 (Screening and Washout)|Adverse Event|1
7782084|NCT00960986|12231075|FG003|Period 1 (Screening and Washout)|Adverse Event|1
7782085|NCT00960986|12231072|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0
7782086|NCT00960986|12231073|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0
7782087|NCT00960986|12231074|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2
7782088|NCT00960986|12231075|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1
7782089|NCT00960986|12231072|FG000|Period 1 (Screening and Washout)|Protocol Violation|1
7782090|NCT00960986|12231073|FG001|Period 1 (Screening and Washout)|Protocol Violation|0
7782091|NCT00960986|12231074|FG002|Period 1 (Screening and Washout)|Protocol Violation|0
7782092|NCT00960986|12231075|FG003|Period 1 (Screening and Washout)|Protocol Violation|0
7782093|NCT00960986|12231072|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1
7782094|NCT00960986|12231073|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2
7782095|NCT00960986|12231074|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1
7782096|NCT00960986|12231075|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1
7782097|NCT00960986|12231072|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17
7782098|NCT00960986|12231073|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15
7782099|NCT00960986|12231074|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10
7782100|NCT00960986|12231075|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12
7782101|NCT00960986|12231072|FG000|Period 3 (7-week Therapy Period)|Death|0
7782102|NCT00960986|12231073|FG001|Period 3 (7-week Therapy Period)|Death|0
7782103|NCT00960986|12231074|FG002|Period 3 (7-week Therapy Period)|Death|1
7782104|NCT00960986|12231075|FG003|Period 3 (7-week Therapy Period)|Death|0
7782105|NCT00960986|12231072|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
7782106|NCT00960986|12231073|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
7782107|NCT00960986|12231074|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
7782108|NCT00960986|12231075|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
7782109|NCT00960986|12231072|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10
7782110|NCT00960986|12231073|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4
7782111|NCT00960986|12231074|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3
7782112|NCT00960986|12231075|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11
7782113|NCT00960986|12231072|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
7782114|NCT00960986|12231073|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
7782115|NCT00960986|12231074|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
7782116|NCT00960986|12231075|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
7782117|NCT00960986|12231072|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
7782118|NCT00960986|12231073|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
7618114|NCT04115748|12028521|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16
7618115|NCT04115748|12028522|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7
7618116|NCT04115748|12028523|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15
7618117|NCT04115748|12028524|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
7618118|NCT04115748|12028525|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
7618119|NCT04115748|12028526|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
7618120|NCT04115748|12028527|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
7618121|NCT04115748|12028528|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
7618122|NCT04115748|12028529|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
7782119|NCT00960986|12231074|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
7782120|NCT00960986|12231075|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
7618123|NCT04115748|12028520|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618124|NCT04115748|12028521|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618125|NCT04115748|12028522|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618126|NCT04115748|12028523|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1
7782121|NCT00960999|12231087|FG000|Overall Study|Withdrawal by Subject|1
7618127|NCT04115748|12028524|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618128|NCT04115748|12028525|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618129|NCT04115748|12028526|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618130|NCT04115748|12028527|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618131|NCT04115748|12028528|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618132|NCT04115748|12028529|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618133|NCT04115748|12028520|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0
7618134|NCT04115748|12028521|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0
7618135|NCT04115748|12028522|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0
7618136|NCT04115748|12028523|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0
7618137|NCT04115748|12028524|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4
7618138|NCT04115748|12028525|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3
7618139|NCT04115748|12028526|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1
7618140|NCT04115748|12028527|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1
7618141|NCT04115748|12028528|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1
7618142|NCT04115748|12028529|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2
7618143|NCT04115748|12028520|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618144|NCT04115748|12028521|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618145|NCT04115748|12028522|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618146|NCT04115748|12028523|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618147|NCT04115748|12028524|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618148|NCT04115748|12028525|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618149|NCT04115748|12028526|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618150|NCT04115748|12028527|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618151|NCT04115748|12028528|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1
7618152|NCT04115748|12028529|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7782122|NCT00960999|12231088|FG001|Overall Study|Withdrawal by Subject|0
7782123|NCT00960999|12231087|FG000|Overall Study|Protocol Violation|5
7782124|NCT00960999|12231088|FG001|Overall Study|Protocol Violation|2
7618153|NCT04044664|12028554|FG000|Stage 1|Adverse Event|3
7618154|NCT04044664|12028555|FG001|Stage 1|Adverse Event|3
7618155|NCT04044664|12028556|FG002|Stage 1|Adverse Event|1
7618156|NCT04044664|12028554|FG000|Stage 1|Lost to Follow-up|3
7618157|NCT04044664|12028555|FG001|Stage 1|Lost to Follow-up|2
7618158|NCT04044664|12028556|FG002|Stage 1|Lost to Follow-up|2
7618159|NCT04044664|12028554|FG000|Stage 1|Withdrawal by Subject|9
7618160|NCT04044664|12028555|FG001|Stage 1|Withdrawal by Subject|1
7618161|NCT04044664|12028556|FG002|Stage 1|Withdrawal by Subject|0
7618162|NCT04044664|12028554|FG000|Stage 1|noncompliance, personal reason|2
7618163|NCT04044664|12028555|FG001|Stage 1|noncompliance, personal reason|0
7618164|NCT04044664|12028556|FG002|Stage 1|noncompliance, personal reason|0
7618165|NCT04044664|12028554|FG000|Stage 1|randomization error|0
7618166|NCT04044664|12028555|FG001|Stage 1|randomization error|1
7618167|NCT04044664|12028556|FG002|Stage 1|randomization error|0
7618168|NCT04044664|12028554|FG000|Stage 2|Adverse Event|2
7618169|NCT04044664|12028555|FG001|Stage 2|Adverse Event|0
7618170|NCT04044664|12028556|FG002|Stage 2|Adverse Event|0
7618171|NCT04044664|12028554|FG000|Stage 2|Lost to Follow-up|3
7618172|NCT04044664|12028555|FG001|Stage 2|Lost to Follow-up|2
7618173|NCT04044664|12028556|FG002|Stage 2|Lost to Follow-up|1
7618174|NCT04044664|12028554|FG000|Stage 2|Withdrawal by Subject|3
7618175|NCT04044664|12028555|FG001|Stage 2|Withdrawal by Subject|0
7618176|NCT04044664|12028556|FG002|Stage 2|Withdrawal by Subject|0
7618177|NCT04044664|12028554|FG000|Stage 2|protocol deviation|1
7618178|NCT04044664|12028555|FG001|Stage 2|protocol deviation|0
7618179|NCT04044664|12028556|FG002|Stage 2|protocol deviation|0
7618180|NCT03994731|12028575|FG000|Pegloticase + IMM Period|Death|2
7618181|NCT03994731|12028576|FG001|Pegloticase + IMM Period|Death|0
7618182|NCT03994731|12028575|FG000|Pegloticase + IMM Period|Lost to Follow-up|3
7618183|NCT03994731|12028576|FG001|Pegloticase + IMM Period|Lost to Follow-up|6
7618184|NCT03994731|12028575|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15
7618185|NCT03994731|12028576|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9
7618186|NCT03924622|12028604|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2
7618187|NCT03924622|12028605|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3
7618188|NCT03924622|12028606|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3
7618223|NCT03367819|12028696|FG001|Overall Study|Progressive Disease|13
7618189|NCT03924622|12028607|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4
7618190|NCT03924622|12028608|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3
7618191|NCT03924622|12028609|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3
7782125|NCT00960999|12231087|FG000|Overall Study|RT dose constraints not met|2
7782126|NCT00960999|12231088|FG001|Overall Study|RT dose constraints not met|0
7618194|NCT03802513|12028657|FG000|Overall Study|Lost to Follow-up|1
7782127|NCT00961116|12231103|FG000|Washout Period of 7 Days|Adverse Event|1
7782128|NCT00961116|12231104|FG001|Washout Period of 7 Days|Adverse Event|1
7782129|NCT00961116|12231103|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
7782130|NCT00961116|12231104|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7782131|NCT00961116|12231103|FG000|Washout Period of 7 Days|Protocol Violation|0
7782132|NCT00961116|12231104|FG001|Washout Period of 7 Days|Protocol Violation|1
7782133|NCT00961181|12231111|FG000|Overall Study|Death|2
7782134|NCT00961181|12231111|FG000|Overall Study|Withdrawal by Subject|2
7782135|NCT00961181|12231111|FG000|Overall Study|Lost to Follow-up|1
7782136|NCT00961220|12231115|FG000|Overall Study|Adverse Event|3
7782137|NCT00961220|12231115|FG000|Overall Study|Lack of Efficacy|1
7782138|NCT00961220|12231115|FG000|Overall Study|No IV access for O6BG|1
7782139|NCT00961220|12231115|FG000|Overall Study|O6BG no longer supplied|1
7782140|NCT00961220|12231115|FG000|Overall Study|Complete Response prior to 12 courses|1
7782141|NCT00961259|12231132|FG000|Washout Period of 7 Days|due to concomitant medication used|0
7782142|NCT00961259|12231133|FG001|Washout Period of 7 Days|due to concomitant medication used|1
7782143|NCT00961259|12231134|FG002|Washout Period of 7 Days|due to concomitant medication used|0
7782144|NCT00961298|12231143|FG000|Two Week Placebo Run in|Withdrawal by Subject|1
7782145|NCT00961298|12231143|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
7782146|NCT00961298|12231143|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
7782147|NCT00961350|12231153|FG000|Overall Study|Adverse Event|18
7782148|NCT00961350|12231154|FG001|Overall Study|Adverse Event|33
7782149|NCT00961350|12231153|FG000|Overall Study|Withdrawal by Subject|10
7782150|NCT00961350|12231154|FG001|Overall Study|Withdrawal by Subject|10
7782151|NCT00961350|12231153|FG000|Overall Study|Lost to Follow-up|3
7782152|NCT00961350|12231154|FG001|Overall Study|Lost to Follow-up|3
7782153|NCT00961350|12231153|FG000|Overall Study|Misc|16
7782154|NCT00961350|12231154|FG001|Overall Study|Misc|21
7782155|NCT00961415|12231171|FG000|Induction Treatment Phase|Withdrawal by Subject|11
7782156|NCT00961415|12231172|FG001|Induction Treatment Phase|Withdrawal by Subject|0
7782157|NCT00961415|12231173|FG002|Induction Treatment Phase|Withdrawal by Subject|0
7782158|NCT00961415|12231171|FG000|Induction Treatment Phase|Death|77
7782159|NCT00961415|12231172|FG001|Induction Treatment Phase|Death|0
7782160|NCT00961415|12231173|FG002|Induction Treatment Phase|Death|0
7782161|NCT00961415|12231171|FG000|Induction Treatment Phase|Protocol Violation|1
7782162|NCT00961415|12231172|FG001|Induction Treatment Phase|Protocol Violation|0
7782163|NCT00961415|12231173|FG002|Induction Treatment Phase|Protocol Violation|0
7782164|NCT00961415|12231171|FG000|Induction Treatment Phase|Physician Decision|2
7782165|NCT00961415|12231172|FG001|Induction Treatment Phase|Physician Decision|0
7782166|NCT00961415|12231173|FG002|Induction Treatment Phase|Physician Decision|0
7782167|NCT00961415|12231171|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27
7782168|NCT00961415|12231172|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
7782169|NCT00961415|12231173|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
7782170|NCT00961415|12231171|FG000|Induction Treatment Phase|Other Reason|5
7782171|NCT00961415|12231172|FG001|Induction Treatment Phase|Other Reason|0
7782172|NCT00961415|12231173|FG002|Induction Treatment Phase|Other Reason|0
7782173|NCT00961415|12231171|FG000|Maintenance Treatment Phase|Death|0
7782174|NCT00961415|12231172|FG001|Maintenance Treatment Phase|Death|42
7782175|NCT00961415|12231173|FG002|Maintenance Treatment Phase|Death|34
7782176|NCT00961415|12231171|FG000|Maintenance Treatment Phase|Investigators decision|0
7782177|NCT00961415|12231172|FG001|Maintenance Treatment Phase|Investigators decision|2
7782178|NCT00961415|12231173|FG002|Maintenance Treatment Phase|Investigators decision|0
7782179|NCT00961415|12231171|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
7782180|NCT00961415|12231172|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3
7782181|NCT00961415|12231173|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8
7782182|NCT00961415|12231171|FG000|Maintenance Treatment Phase|Other reason|0
7782183|NCT00961415|12231172|FG001|Maintenance Treatment Phase|Other reason|1
7782184|NCT00961415|12231173|FG002|Maintenance Treatment Phase|Other reason|3
7782185|NCT00961571|12231200|FG000|Overall Study|Physician Decision|39
7782186|NCT00961636|12231207|FG000|Overall Study|Adverse Event|35
7782187|NCT00961636|12231208|FG001|Overall Study|Adverse Event|54
7782188|NCT00961636|12231209|FG002|Overall Study|Adverse Event|13
7782189|NCT00961636|12231207|FG000|Overall Study|Flushing Symptoms|29
7782190|NCT00961636|12231208|FG001|Overall Study|Flushing Symptoms|46
7782191|NCT00961636|12231209|FG002|Overall Study|Flushing Symptoms|3
7782192|NCT00961636|12231207|FG000|Overall Study|Lost to Follow-up|2
7782193|NCT00961636|12231208|FG001|Overall Study|Lost to Follow-up|3
7782194|NCT00961636|12231209|FG002|Overall Study|Lost to Follow-up|1
7618215|NCT03576716|12028682|FG000|Overall Study|Withdrawal by Subject|0
7618216|NCT03576716|12028683|FG001|Overall Study|Withdrawal by Subject|1
7618220|NCT03367819|12028695|FG000|Overall Study|Adverse Event|4
7618221|NCT03367819|12028696|FG001|Overall Study|Adverse Event|4
7618222|NCT03367819|12028695|FG000|Overall Study|Progressive Disease|15
7618224|NCT03367819|12028695|FG000|Overall Study|Withdrawal by Subject|1
7618225|NCT03367819|12028696|FG001|Overall Study|Withdrawal by Subject|0
7618226|NCT03367819|12028695|FG000|Overall Study|Other|4
7618227|NCT03367819|12028696|FG001|Overall Study|Other|2
7618228|NCT03182868|12028712|FG000|Overall Study|Protocol Violation|3
7782195|NCT00961636|12231207|FG000|Overall Study|Physician Decision|3
7618229|NCT03182868|12028713|FG001|Overall Study|Protocol Violation|0
7618230|NCT03182868|12028714|FG002|Overall Study|Protocol Violation|4
7618231|NCT03182868|12028715|FG003|Overall Study|Protocol Violation|1
7618232|NCT03182868|12028716|FG004|Overall Study|Protocol Violation|8
7782196|NCT00961636|12231208|FG001|Overall Study|Physician Decision|1
7782197|NCT00961636|12231209|FG002|Overall Study|Physician Decision|1
7782198|NCT00961636|12231207|FG000|Overall Study|Protocol Violation|9
7782199|NCT00961636|12231208|FG001|Overall Study|Protocol Violation|5
7782200|NCT00961636|12231209|FG002|Overall Study|Protocol Violation|1
7782201|NCT00961636|12231207|FG000|Overall Study|Withdrawal by Subject|29
7782202|NCT00961636|12231208|FG001|Overall Study|Withdrawal by Subject|22
7782203|NCT00961636|12231209|FG002|Overall Study|Withdrawal by Subject|13
7782204|NCT00961649|12231221|FG000|Overall Study|Adverse Event|4
7782205|NCT00961649|12231222|FG001|Overall Study|Adverse Event|0
7782206|NCT00961649|12231223|FG002|Overall Study|Adverse Event|0
7782207|NCT00961649|12231224|FG003|Overall Study|Adverse Event|2
7782208|NCT00961649|12231221|FG000|Overall Study|Inadequate control of IOP|0
7618245|NCT03077620|12028741|FG000|Overall Study|Unable to place lumbar catheter|1
7618246|NCT03077620|12028742|FG001|Overall Study|Unable to place lumbar catheter|0
7618247|NCT03077620|12028743|FG002|Overall Study|Unable to place lumbar catheter|1
7618248|NCT03077620|12028744|FG003|Overall Study|Unable to place lumbar catheter|0
7782209|NCT00961649|12231222|FG001|Overall Study|Inadequate control of IOP|0
7782210|NCT00961649|12231223|FG002|Overall Study|Inadequate control of IOP|0
7782211|NCT00961649|12231224|FG003|Overall Study|Inadequate control of IOP|1
7782212|NCT00961649|12231221|FG000|Overall Study|Patient has travel plans during holidays|0
7782213|NCT00961649|12231222|FG001|Overall Study|Patient has travel plans during holidays|0
7782214|NCT00961649|12231223|FG002|Overall Study|Patient has travel plans during holidays|1
7782215|NCT00961649|12231224|FG003|Overall Study|Patient has travel plans during holidays|0
7782216|NCT00961649|12231221|FG000|Overall Study|Patient left to Mexico-family emergency|1
7782217|NCT00961649|12231222|FG001|Overall Study|Patient left to Mexico-family emergency|0
7782218|NCT00961649|12231223|FG002|Overall Study|Patient left to Mexico-family emergency|0
7782219|NCT00961649|12231224|FG003|Overall Study|Patient left to Mexico-family emergency|0
7782220|NCT00961649|12231221|FG000|Overall Study|Study terminated by sponsor|4
7782221|NCT00961649|12231222|FG001|Overall Study|Study terminated by sponsor|4
7782222|NCT00961649|12231223|FG002|Overall Study|Study terminated by sponsor|4
7782223|NCT00961649|12231224|FG003|Overall Study|Study terminated by sponsor|1
7782224|NCT00961896|12231250|FG000|Overall Study|Abnormal laboratory value|0
7782225|NCT00961896|12231251|FG001|Overall Study|Abnormal laboratory value|0
7782226|NCT00961896|12231252|FG002|Overall Study|Abnormal laboratory value|1
7782227|NCT00961961|12231267|FG000|Phase I|Withdrawal by Subject|7
7782228|NCT00961961|12231268|FG001|Phase I|Withdrawal by Subject|0
7782229|NCT00961961|12231269|FG002|Phase I|Withdrawal by Subject|0
7782230|NCT00961961|12231270|FG003|Phase I|Withdrawal by Subject|0
7782231|NCT00961961|12231267|FG000|Phase I|Lost to Follow-up|10
7782232|NCT00961961|12231268|FG001|Phase I|Lost to Follow-up|0
7782233|NCT00961961|12231269|FG002|Phase I|Lost to Follow-up|0
7782234|NCT00961961|12231270|FG003|Phase I|Lost to Follow-up|0
7782235|NCT00961961|12231267|FG000|Phase I|Lack of Efficacy|94
7782236|NCT00961961|12231268|FG001|Phase I|Lack of Efficacy|0
7782237|NCT00961961|12231269|FG002|Phase I|Lack of Efficacy|0
7782238|NCT00961961|12231270|FG003|Phase I|Lack of Efficacy|0
7782239|NCT00961961|12231267|FG000|Phase I|Adverse Event|7
7782240|NCT00961961|12231268|FG001|Phase I|Adverse Event|0
7782241|NCT00961961|12231269|FG002|Phase I|Adverse Event|0
7782242|NCT00961961|12231270|FG003|Phase I|Adverse Event|0
7782243|NCT00961961|12231267|FG000|Phase I|Physician Decision|8
7782244|NCT00961961|12231268|FG001|Phase I|Physician Decision|0
7782245|NCT00961961|12231269|FG002|Phase I|Physician Decision|0
7782246|NCT00961961|12231270|FG003|Phase I|Physician Decision|0
7782247|NCT00961961|12231267|FG000|Phase II|Lost to Follow-up|0
7782248|NCT00961961|12231268|FG001|Phase II|Lost to Follow-up|0
7782249|NCT00961961|12231269|FG002|Phase II|Lost to Follow-up|10
7782250|NCT00961961|12231270|FG003|Phase II|Lost to Follow-up|7
7782251|NCT00961961|12231267|FG000|Phase II|Adverse Event|0
7782252|NCT00961961|12231268|FG001|Phase II|Adverse Event|0
7782253|NCT00961961|12231269|FG002|Phase II|Adverse Event|0
7782254|NCT00961961|12231270|FG003|Phase II|Adverse Event|1
7782255|NCT00961961|12231267|FG000|Phase II|Physician Decision|0
7782256|NCT00961961|12231268|FG001|Phase II|Physician Decision|0
7782257|NCT00961961|12231269|FG002|Phase II|Physician Decision|1
7782258|NCT00961961|12231270|FG003|Phase II|Physician Decision|0
7782259|NCT00961961|12231267|FG000|Phase II|Withdrawal by Subject|0
7782260|NCT00961961|12231268|FG001|Phase II|Withdrawal by Subject|0
7782261|NCT00961961|12231269|FG002|Phase II|Withdrawal by Subject|1
7782262|NCT00961961|12231270|FG003|Phase II|Withdrawal by Subject|0
7782263|NCT00962013|12231297|FG000|Overall Study|Did not have surgery|1
7782264|NCT00962013|12231297|FG000|Overall Study|Death|8
7782265|NCT00962013|12231297|FG000|Overall Study|Lost to Follow-up|12
7782266|NCT00962013|12231297|FG000|Overall Study|Unable/Unwilling to return|6
7782267|NCT00962013|12231297|FG000|Overall Study|Withdrawal by Subject|8
7782268|NCT00962013|12231297|FG000|Overall Study|Removal of study device|3
7782269|NCT00962013|12231297|FG000|Overall Study|Site Termination|24
7782270|NCT00962013|12231297|FG000|Overall Study|No 5 year evaluation|6
7782271|NCT00962091|12231339|FG000|Overall Study|Withdrawal by Subject|1
7782272|NCT00962091|12231340|FG001|Overall Study|Withdrawal by Subject|2
7782273|NCT00962091|12231341|FG002|Overall Study|Withdrawal by Subject|1
7782274|NCT00962091|12231342|FG003|Overall Study|Withdrawal by Subject|1
7782275|NCT00962091|12231343|FG004|Overall Study|Withdrawal by Subject|0
7618249|NCT03077620|12028741|FG000|Overall Study|Withdrawal by Subject|0
7618250|NCT03077620|12028742|FG001|Overall Study|Withdrawal by Subject|1
7618251|NCT03077620|12028743|FG002|Overall Study|Withdrawal by Subject|0
7618252|NCT03077620|12028744|FG003|Overall Study|Withdrawal by Subject|0
7618253|NCT03077620|12028741|FG000|Overall Study|Physician Decision|0
7618254|NCT03077620|12028742|FG001|Overall Study|Physician Decision|0
7618255|NCT03077620|12028743|FG002|Overall Study|Physician Decision|1
7618256|NCT03077620|12028744|FG003|Overall Study|Physician Decision|0
7618257|NCT02951052|12028769|FG000|Overall Study|Adverse Event|13
7618258|NCT02951052|12028770|FG001|Overall Study|Adverse Event|5
7618259|NCT02951052|12028769|FG000|Overall Study|Withdrawal by Subject|1
7782276|NCT00962091|12231344|FG005|Overall Study|Withdrawal by Subject|1
7782277|NCT00962091|12231345|FG006|Overall Study|Withdrawal by Subject|0
7618260|NCT02951052|12028770|FG001|Overall Study|Withdrawal by Subject|5
7618261|NCT02951052|12028769|FG000|Overall Study|Physician Decision|2
7618262|NCT02951052|12028770|FG001|Overall Study|Physician Decision|0
7618263|NCT02951052|12028769|FG000|Overall Study|Lost to Follow-up|1
7618264|NCT02951052|12028770|FG001|Overall Study|Lost to Follow-up|1
7618265|NCT02951052|12028769|FG000|Overall Study|Protocol-specified withdrawal criterion|1
7618266|NCT02951052|12028770|FG001|Overall Study|Protocol-specified withdrawal criterion|0
7618267|NCT02951052|12028769|FG000|Overall Study|Protocol Violation|5
7618268|NCT02951052|12028770|FG001|Overall Study|Protocol Violation|3
7618269|NCT02951052|12028769|FG000|Overall Study|Lack of Efficacy|3
7618270|NCT02951052|12028770|FG001|Overall Study|Lack of Efficacy|4
7618271|NCT02951052|12028769|FG000|Overall Study|Ongoing|1
7618272|NCT02951052|12028770|FG001|Overall Study|Ongoing|0
7782278|NCT00962091|12231339|FG000|Overall Study|Adverse Event|0
7782279|NCT00962091|12231340|FG001|Overall Study|Adverse Event|0
7782280|NCT00962091|12231341|FG002|Overall Study|Adverse Event|0
7782281|NCT00962091|12231342|FG003|Overall Study|Adverse Event|0
7782282|NCT00962091|12231343|FG004|Overall Study|Adverse Event|0
7782283|NCT00962091|12231344|FG005|Overall Study|Adverse Event|0
7782284|NCT00962091|12231345|FG006|Overall Study|Adverse Event|1
7782285|NCT00962104|12231371|FG000|Overall Study|Adverse Event|10
7782286|NCT00962104|12231372|FG001|Overall Study|Adverse Event|3
7782287|NCT00962104|12231371|FG000|Overall Study|Entry Criteria Not Met|1
7782288|NCT00962104|12231372|FG001|Overall Study|Entry Criteria Not Met|2
7782289|NCT00962104|12231371|FG000|Overall Study|Lack of Efficacy|0
7782290|NCT00962104|12231372|FG001|Overall Study|Lack of Efficacy|1
7782291|NCT00962104|12231371|FG000|Overall Study|Lost to Follow-up|10
7782292|NCT00962104|12231372|FG001|Overall Study|Lost to Follow-up|4
7782293|NCT00962104|12231371|FG000|Overall Study|Physician Decision|1
7782294|NCT00962104|12231372|FG001|Overall Study|Physician Decision|0
7782295|NCT00962104|12231371|FG000|Overall Study|Protocol Violation|6
7782296|NCT00962104|12231372|FG001|Overall Study|Protocol Violation|8
7782297|NCT00962104|12231371|FG000|Overall Study|Sponsor Decision|0
7782298|NCT00962104|12231372|FG001|Overall Study|Sponsor Decision|1
7782299|NCT00962104|12231371|FG000|Overall Study|Withdrawal by Subject|10
7782300|NCT00962104|12231372|FG001|Overall Study|Withdrawal by Subject|6
7782301|NCT00962104|12231371|FG000|Overall Study|Other|2
7782302|NCT00962104|12231372|FG001|Overall Study|Other|0
7782303|NCT00962208|12231380|FG000|Overall Study|Could not achieve good vision|9
7782304|NCT00962208|12231381|FG001|Overall Study|Could not achieve good vision|0
7782305|NCT00962208|12231380|FG000|Overall Study|Contraindicated to continue study|5
7782306|NCT00962208|12231381|FG001|Overall Study|Contraindicated to continue study|1
7618273|NCT02598583|12028791|FG000|Extension Period|Withdrawal by Subject|1
7618274|NCT02598583|12028792|FG001|Extension Period|Withdrawal by Subject|0
7618275|NCT02536794|12028807|FG000|Reached 1st Response Assessment|Adverse Event|2
7618276|NCT02536794|12028807|FG000|Reached 1st Response Assessment|Progressive Disease|2
7618277|NCT02536794|12028807|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1
7618278|NCT02536794|12028807|FG000|Reached 1st Response Assessment|Protocol Violation|1
7618279|NCT02536794|12028807|FG000|Continued Treatment After 1st Response|Progressive disease|7
7618280|NCT02536794|12028807|FG000|Continued Treatment After 1st Response|Adverse Event|1
7618281|NCT02285114|12028827|FG000|Overall Study|Investigator's Discretion|0
7618282|NCT02285114|12028828|FG001|Overall Study|Investigator's Discretion|2
7618283|NCT02285114|12028829|FG002|Overall Study|Investigator's Discretion|0
7618284|NCT02285114|12028827|FG000|Overall Study|Withdrew Consent|0
7618285|NCT02285114|12028828|FG001|Overall Study|Withdrew Consent|0
7618286|NCT02285114|12028829|FG002|Overall Study|Withdrew Consent|1
7618287|NCT02285114|12028827|FG000|Overall Study|Enrolled but not treated|1
7618288|NCT02285114|12028828|FG001|Overall Study|Enrolled but not treated|0
7618289|NCT02285114|12028829|FG002|Overall Study|Enrolled but not treated|0
7618290|NCT02285114|12028827|FG000|Overall Study|Still on study|21
7618291|NCT02285114|12028828|FG001|Overall Study|Still on study|5
7618292|NCT02285114|12028829|FG002|Overall Study|Still on study|2
7618293|NCT02263508|12028846|FG000|Overall Study|Withdrawal by Subject|1
7618294|NCT02263508|12028847|FG001|Overall Study|Withdrawal by Subject|23
7618295|NCT02263508|12028848|FG002|Overall Study|Withdrawal by Subject|17
7618296|NCT02263508|12028846|FG000|Overall Study|Sponsor Decision|12
7618297|NCT02263508|12028847|FG001|Overall Study|Sponsor Decision|165
7618298|NCT02263508|12028848|FG002|Overall Study|Sponsor Decision|182
7618299|NCT02263508|12028846|FG000|Overall Study|Lost to Follow-up|2
7782307|NCT00962208|12231380|FG000|Overall Study|Lost to Follow-up|0
7782308|NCT00962208|12231381|FG001|Overall Study|Lost to Follow-up|9
7782309|NCT00962247|12231387|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4
7782310|NCT00962247|12231387|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
7782311|NCT00962390|12231397|FG000|Overall Study|Adverse Event|0
7782312|NCT00962390|12231398|FG001|Overall Study|Adverse Event|0
7782313|NCT00962390|12231399|FG002|Overall Study|Adverse Event|3
7782314|NCT00962390|12231400|FG003|Overall Study|Adverse Event|1
7618300|NCT02263508|12028847|FG001|Overall Study|Lost to Follow-up|7
7618301|NCT02263508|12028848|FG002|Overall Study|Lost to Follow-up|7
7618302|NCT02263508|12028846|FG000|Overall Study|Death|6
7618303|NCT02263508|12028847|FG001|Overall Study|Death|151
7618304|NCT02263508|12028848|FG002|Overall Study|Death|140
7782315|NCT00962390|12231397|FG000|Overall Study|Lost to Follow-up|2
7782316|NCT00962390|12231398|FG001|Overall Study|Lost to Follow-up|2
7618305|NCT02246530|12028861|FG000|Overall Study|Lost to Follow-up|4
7618306|NCT02246530|12028862|FG001|Overall Study|Lost to Follow-up|0
7618307|NCT01936857|12028895|FG000|Overall Study|Sent to prison or 06 center|11
7618308|NCT01936857|12028896|FG001|Overall Study|Sent to prison or 06 center|12
7618309|NCT01936857|12028895|FG000|Overall Study|Lost to Follow-up|10
7618310|NCT01936857|12028896|FG001|Overall Study|Lost to Follow-up|7
7618311|NCT01936857|12028895|FG000|Overall Study|Death|7
7618312|NCT01936857|12028896|FG001|Overall Study|Death|3
7618313|NCT01936857|12028895|FG000|Overall Study|Moved|2
7618314|NCT01936857|12028896|FG001|Overall Study|Moved|1
7618315|NCT01936857|12028895|FG000|Overall Study|Withdrawal by Subject|1
7618316|NCT01936857|12028896|FG001|Overall Study|Withdrawal by Subject|0
7618317|NCT01936857|12028895|FG000|Overall Study|Side effect of medication|1
7618318|NCT01936857|12028896|FG001|Overall Study|Side effect of medication|0
7618319|NCT01936857|12028895|FG000|Overall Study|Other|2
7618320|NCT01936857|12028896|FG001|Overall Study|Other|2
7618321|NCT01715285|12028913|FG000|Treatment Period|Adverse Event|60
7618322|NCT01715285|12028914|FG001|Treatment Period|Adverse Event|33
7618323|NCT01715285|12028915|FG002|Treatment Period|Adverse Event|0
7618324|NCT01715285|12028913|FG000|Treatment Period|Lost to Follow-up|3
7618325|NCT01715285|12028914|FG001|Treatment Period|Lost to Follow-up|2
7618326|NCT01715285|12028915|FG002|Treatment Period|Lost to Follow-up|0
7618327|NCT01715285|12028913|FG000|Treatment Period|Death|36
7618328|NCT01715285|12028914|FG001|Treatment Period|Death|23
7618329|NCT01715285|12028915|FG002|Treatment Period|Death|0
7618330|NCT01715285|12028913|FG000|Treatment Period|Noncompliance With Study Drug|4
7618331|NCT01715285|12028914|FG001|Treatment Period|Noncompliance With Study Drug|2
7618332|NCT01715285|12028915|FG002|Treatment Period|Noncompliance With Study Drug|0
7618333|NCT01715285|12028913|FG000|Treatment Period|Progressive Disease|254
7618334|NCT01715285|12028914|FG001|Treatment Period|Progressive Disease|388
7618335|NCT01715285|12028915|FG002|Treatment Period|Progressive Disease|0
7618336|NCT01715285|12028913|FG000|Treatment Period|Withdrawal Of Consent|52
7618337|NCT01715285|12028914|FG001|Treatment Period|Withdrawal Of Consent|47
7618338|NCT01715285|12028915|FG002|Treatment Period|Withdrawal Of Consent|0
7782317|NCT00962390|12231399|FG002|Overall Study|Lost to Follow-up|0
7618339|NCT01715285|12028913|FG000|Treatment Period|Physician Decision|21
7618340|NCT01715285|12028914|FG001|Treatment Period|Physician Decision|23
7618341|NCT01715285|12028915|FG002|Treatment Period|Physician Decision|0
7618342|NCT01715285|12028913|FG000|Treatment Period|Ongoing|157
7618343|NCT01715285|12028914|FG001|Treatment Period|Ongoing|0
7618344|NCT01715285|12028915|FG002|Treatment Period|Ongoing|0
7618345|NCT01715285|12028913|FG000|Treatment Period|Other|10
7618346|NCT01715285|12028914|FG001|Treatment Period|Other|12
7618347|NCT01715285|12028915|FG002|Treatment Period|Other|0
7618348|NCT01715285|12028913|FG000|Treatment Period|Placebo Cross-over|0
7618349|NCT01715285|12028914|FG001|Treatment Period|Placebo Cross-over|72
7618350|NCT01715285|12028915|FG002|Treatment Period|Placebo Cross-over|0
7618351|NCT01715285|12028913|FG000|Open-label (OL) Extension Phase|Ongoing|157
7618352|NCT01715285|12028914|FG001|Open-label (OL) Extension Phase|Ongoing|0
7618353|NCT01715285|12028915|FG002|Open-label (OL) Extension Phase|Ongoing|72
7782318|NCT00962390|12231400|FG003|Overall Study|Lost to Follow-up|0
7782319|NCT00962390|12231397|FG000|Overall Study|Protocol Violation|1
7782320|NCT00962390|12231398|FG001|Overall Study|Protocol Violation|0
7782321|NCT00962390|12231399|FG002|Overall Study|Protocol Violation|0
7782322|NCT00962390|12231400|FG003|Overall Study|Protocol Violation|0
7782323|NCT00962390|12231397|FG000|Overall Study|Withdrawal by Subject|1
7782324|NCT00962390|12231398|FG001|Overall Study|Withdrawal by Subject|1
7782325|NCT00962390|12231399|FG002|Overall Study|Withdrawal by Subject|1
7782326|NCT00962390|12231400|FG003|Overall Study|Withdrawal by Subject|0
7782327|NCT00962585|12231414|FG000|Overall Study|Adverse Event|0
7782328|NCT00962585|12231415|FG001|Overall Study|Adverse Event|2
7782329|NCT00962585|12231416|FG002|Overall Study|Adverse Event|1
7782330|NCT00962585|12231417|FG003|Overall Study|Adverse Event|0
7782331|NCT00962585|12231414|FG000|Overall Study|Lost to Follow-up|3
7782332|NCT00962585|12231415|FG001|Overall Study|Lost to Follow-up|0
7782333|NCT00962585|12231416|FG002|Overall Study|Lost to Follow-up|1
7782334|NCT00962585|12231417|FG003|Overall Study|Lost to Follow-up|0
7782335|NCT00962585|12231414|FG000|Overall Study|Protocol Violation|0
7782336|NCT00962585|12231415|FG001|Overall Study|Protocol Violation|0
7782337|NCT00962585|12231416|FG002|Overall Study|Protocol Violation|1
7782338|NCT00962585|12231417|FG003|Overall Study|Protocol Violation|0
7782339|NCT00962585|12231414|FG000|Overall Study|Withdrawal by Subject|1
7782340|NCT00962585|12231415|FG001|Overall Study|Withdrawal by Subject|0
7782341|NCT00962585|12231416|FG002|Overall Study|Withdrawal by Subject|0
7782342|NCT00962585|12231417|FG003|Overall Study|Withdrawal by Subject|0
7782343|NCT00962585|12231414|FG000|Overall Study|Withdrew Consent|2
7782344|NCT00962585|12231415|FG001|Overall Study|Withdrew Consent|0
7782345|NCT00962585|12231416|FG002|Overall Study|Withdrew Consent|0
7782346|NCT00962585|12231417|FG003|Overall Study|Withdrew Consent|0
7782347|NCT00962650|12231438|FG000|Overall Study|Transgastric DP was not completed|2
7618354|NCT04209725|12028944|FG000|Overall Study|Adverse Event|1
7618355|NCT04185909|12028948|FG000|Overall Study|Lost to Follow-up|1
7618356|NCT04076943|12028952|FG000|Overall Study|Withdrawal by Subject|12
7618357|NCT04076943|12028952|FG000|Overall Study|Adverse Event|1
7618358|NCT04076943|12028952|FG000|Overall Study|Progressive Disease|2
7618359|NCT04076943|12028952|FG000|Overall Study|Death|13
7618360|NCT04076943|12028952|FG000|Overall Study|Other than specified|6
7618361|NCT03332498|12028969|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0
7782348|NCT00962741|12231442|FG000|Overall Study|Failed to return|3
7782349|NCT00962741|12231442|FG000|Overall Study|Lost to Follow-up|2
7782350|NCT00962741|12231442|FG000|Overall Study|Withdrawal by Subject|1
7782351|NCT00962741|12231442|FG000|Overall Study|Lack of Efficacy|1
7782352|NCT00962741|12231442|FG000|Overall Study|drug ineffective+prohibited drug taken|1
7782353|NCT00962780|12231461|FG000|Overall Study|Death|0
7782354|NCT00962780|12231462|FG001|Overall Study|Death|1
7618362|NCT03332498|12028970|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0
7618363|NCT03332498|12028971|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2
7618364|NCT02900976|12028989|FG000|Overall Study|Adverse Event|0
7618365|NCT02900976|12028990|FG001|Overall Study|Adverse Event|1
7618366|NCT02900976|12028989|FG000|Overall Study|Physician Decision|0
7618367|NCT02900976|12028990|FG001|Overall Study|Physician Decision|2
7618368|NCT02900976|12028989|FG000|Overall Study|Progressive disease|0
7618369|NCT02900976|12028990|FG001|Overall Study|Progressive disease|6
7618370|NCT02720185|12029006|FG000|Overall Study|Lost to Follow-up|1
7618371|NCT02710669|12029013|FG000|Overall Study|Physician Decision|2
7618372|NCT02710669|12029014|FG001|Overall Study|Physician Decision|1
7618373|NCT02710669|12029015|FG002|Overall Study|Physician Decision|0
7618374|NCT02710669|12029013|FG000|Overall Study|Institutional delays (including COVID)|2
7618375|NCT02710669|12029014|FG001|Overall Study|Institutional delays (including COVID)|2
7618376|NCT02710669|12029015|FG002|Overall Study|Institutional delays (including COVID)|0
7618377|NCT02710669|12029013|FG000|Overall Study|arrived in afib/aflutter|10
7618378|NCT02710669|12029014|FG001|Overall Study|arrived in afib/aflutter|8
7618379|NCT02710669|12029015|FG002|Overall Study|arrived in afib/aflutter|2
7618380|NCT02684461|12029026|FG000|Overall Study|Adverse Event|1
7782355|NCT00962780|12231461|FG000|Overall Study|Protocol Violation|9
7782356|NCT00962780|12231462|FG001|Overall Study|Protocol Violation|4
7782357|NCT00962780|12231461|FG000|Overall Study|Withdrawal by Subject|1
7782358|NCT00962780|12231462|FG001|Overall Study|Withdrawal by Subject|8
7782359|NCT00962780|12231461|FG000|Overall Study|Other|0
7782360|NCT00962780|12231462|FG001|Overall Study|Other|1
7782361|NCT00963235|12231534|FG000|Overall Study|Withdrawal by Subject|22
7782362|NCT00963235|12231534|FG000|Overall Study|Lost to Follow-up|14
7782363|NCT00963235|12231534|FG000|Overall Study|Failed to return|9
7782364|NCT00963235|12231534|FG000|Overall Study|Protocol Violation|7
7618381|NCT02684461|12029027|FG001|Overall Study|Adverse Event|0
7618382|NCT02684461|12029028|FG002|Overall Study|Adverse Event|0
7618383|NCT02684461|12029026|FG000|Overall Study|Lack of Efficacy|1
7618384|NCT02684461|12029027|FG001|Overall Study|Lack of Efficacy|2
7618385|NCT02684461|12029028|FG002|Overall Study|Lack of Efficacy|0
7782365|NCT00963235|12231534|FG000|Overall Study|Adverse Event|5
7782366|NCT00963235|12231534|FG000|Overall Study|Physician Decision|2
7782367|NCT00963235|12231534|FG000|Overall Study|Other|1
7782368|NCT00963547|12231572|FG000|Overall Study|Adverse Event|0
7782369|NCT00963547|12231573|FG001|Overall Study|Adverse Event|1
7782370|NCT00963547|12231574|FG002|Overall Study|Adverse Event|0
7782371|NCT00963547|12231575|FG003|Overall Study|Adverse Event|1
7782372|NCT00963547|12231576|FG004|Overall Study|Adverse Event|0
7782373|NCT00963547|12231577|FG005|Overall Study|Adverse Event|0
7782374|NCT00963547|12231578|FG006|Overall Study|Adverse Event|0
7782375|NCT00963547|12231572|FG000|Overall Study|Physician Decision|1
7782376|NCT00963547|12231573|FG001|Overall Study|Physician Decision|1
7782377|NCT00963547|12231574|FG002|Overall Study|Physician Decision|0
7782378|NCT00963547|12231575|FG003|Overall Study|Physician Decision|0
7782379|NCT00963547|12231576|FG004|Overall Study|Physician Decision|0
7782380|NCT00963547|12231577|FG005|Overall Study|Physician Decision|0
7782381|NCT00963547|12231578|FG006|Overall Study|Physician Decision|0
7782382|NCT00963547|12231572|FG000|Overall Study|Progressive Disease|3
7782383|NCT00963547|12231573|FG001|Overall Study|Progressive Disease|8
7782384|NCT00963547|12231574|FG002|Overall Study|Progressive Disease|9
7782385|NCT00963547|12231575|FG003|Overall Study|Progressive Disease|5
7782386|NCT00963547|12231576|FG004|Overall Study|Progressive Disease|0
7782387|NCT00963547|12231577|FG005|Overall Study|Progressive Disease|0
7782388|NCT00963547|12231578|FG006|Overall Study|Progressive Disease|0
7782389|NCT00963547|12231572|FG000|Overall Study|Withdrawal by Subject|0
7782390|NCT00963547|12231573|FG001|Overall Study|Withdrawal by Subject|0
7782391|NCT00963547|12231574|FG002|Overall Study|Withdrawal by Subject|3
7782392|NCT00963547|12231575|FG003|Overall Study|Withdrawal by Subject|0
7782393|NCT00963547|12231576|FG004|Overall Study|Withdrawal by Subject|0
7782394|NCT00963547|12231577|FG005|Overall Study|Withdrawal by Subject|0
7782395|NCT00963547|12231578|FG006|Overall Study|Withdrawal by Subject|0
7782396|NCT00963547|12231572|FG000|Overall Study|Reason Unknown|0
7782397|NCT00963547|12231573|FG001|Overall Study|Reason Unknown|1
7782398|NCT00963547|12231574|FG002|Overall Study|Reason Unknown|0
7782399|NCT00963547|12231575|FG003|Overall Study|Reason Unknown|0
7782400|NCT00963547|12231576|FG004|Overall Study|Reason Unknown|0
7782401|NCT00963547|12231577|FG005|Overall Study|Reason Unknown|0
7782402|NCT00963547|12231578|FG006|Overall Study|Reason Unknown|0
7782403|NCT00963807|12231622|FG000|Overall Study|Physician Decision|2
7782404|NCT00963807|12231622|FG000|Overall Study|Reaction to study chemotherapy regimen|1
7782405|NCT00963807|12231622|FG000|Overall Study|Disease progression|15
7782406|NCT00963820|12231628|FG000|Dose Escalation Phase|Progressive Disease|3
7782407|NCT00963820|12231629|FG001|Dose Escalation Phase|Progressive Disease|3
7782408|NCT00963820|12231630|FG002|Dose Escalation Phase|Progressive Disease|3
7782409|NCT00963820|12231631|FG003|Dose Escalation Phase|Progressive Disease|3
7782410|NCT00963820|12231632|FG004|Dose Escalation Phase|Progressive Disease|4
7782411|NCT00963820|12231633|FG005|Dose Escalation Phase|Progressive Disease|3
7782412|NCT00963820|12231634|FG006|Dose Escalation Phase|Progressive Disease|3
7782413|NCT00963820|12231635|FG007|Dose Escalation Phase|Progressive Disease|2
7782414|NCT00963820|12231636|FG008|Dose Escalation Phase|Progressive Disease|0
7782415|NCT00963820|12231637|FG009|Dose Escalation Phase|Progressive Disease|0
7782416|NCT00963820|12231638|FG010|Dose Escalation Phase|Progressive Disease|0
7782417|NCT00963820|12231639|FG011|Dose Escalation Phase|Progressive Disease|0
7782418|NCT00963820|12231628|FG000|Dose Escalation Phase|Adverse Event|0
7782419|NCT00963820|12231629|FG001|Dose Escalation Phase|Adverse Event|0
7782420|NCT00963820|12231630|FG002|Dose Escalation Phase|Adverse Event|0
7782421|NCT00963820|12231631|FG003|Dose Escalation Phase|Adverse Event|0
7782422|NCT00963820|12231632|FG004|Dose Escalation Phase|Adverse Event|0
7782423|NCT00963820|12231633|FG005|Dose Escalation Phase|Adverse Event|0
7782424|NCT00963820|12231634|FG006|Dose Escalation Phase|Adverse Event|3
7782425|NCT00963820|12231635|FG007|Dose Escalation Phase|Adverse Event|1
7782426|NCT00963820|12231636|FG008|Dose Escalation Phase|Adverse Event|0
7782427|NCT00963820|12231637|FG009|Dose Escalation Phase|Adverse Event|0
7782428|NCT00963820|12231638|FG010|Dose Escalation Phase|Adverse Event|0
7782429|NCT00963820|12231639|FG011|Dose Escalation Phase|Adverse Event|0
7782430|NCT00963820|12231628|FG000|Dose Escalation Phase|Withdrawal by Subject|0
7782431|NCT00963820|12231629|FG001|Dose Escalation Phase|Withdrawal by Subject|0
7782432|NCT00963820|12231630|FG002|Dose Escalation Phase|Withdrawal by Subject|0
7782433|NCT00963820|12231631|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7782434|NCT00963820|12231632|FG004|Dose Escalation Phase|Withdrawal by Subject|0
7782435|NCT00963820|12231633|FG005|Dose Escalation Phase|Withdrawal by Subject|0
7782436|NCT00963820|12231634|FG006|Dose Escalation Phase|Withdrawal by Subject|1
7782437|NCT00963820|12231635|FG007|Dose Escalation Phase|Withdrawal by Subject|2
7782438|NCT00963820|12231636|FG008|Dose Escalation Phase|Withdrawal by Subject|0
7782439|NCT00963820|12231637|FG009|Dose Escalation Phase|Withdrawal by Subject|0
7782440|NCT00963820|12231638|FG010|Dose Escalation Phase|Withdrawal by Subject|0
7782441|NCT00963820|12231639|FG011|Dose Escalation Phase|Withdrawal by Subject|0
7782442|NCT00963820|12231628|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7782443|NCT00963820|12231629|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7782444|NCT00963820|12231630|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7782445|NCT00963820|12231631|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7782446|NCT00963820|12231632|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7782447|NCT00963820|12231633|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7782448|NCT00963820|12231634|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
7618405|NCT01295944|12029122|FG000|Overall Study|Switched to alternative treatment|1
7618406|NCT01295944|12029122|FG000|Overall Study|Ineligible|9
7618407|NCT01295944|12029122|FG000|Overall Study|Withdrawal by Subject|4
7618408|NCT01295944|12029122|FG000|Overall Study|Participant chose to be treated in Peru|1
7618409|NCT01295944|12029122|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1
7618410|NCT01295944|12029122|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1
7618411|NCT01295944|12029122|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1
7618412|NCT01285557|12029128|FG000|Overall Study|Death|173
7618413|NCT01285557|12029129|FG001|Overall Study|Death|90
7618414|NCT01285557|12029128|FG000|Overall Study|Lost to Follow-up|6
7618415|NCT01285557|12029129|FG001|Overall Study|Lost to Follow-up|2
7618416|NCT01285557|12029128|FG000|Overall Study|Withdrew Consent|6
7618417|NCT01285557|12029129|FG001|Overall Study|Withdrew Consent|1
7618418|NCT01285557|12029128|FG000|Overall Study|Sponsor Study Termination|23
7618419|NCT01285557|12029129|FG001|Overall Study|Sponsor Study Termination|13
7618420|NCT01285557|12029128|FG000|Overall Study|Randomized but not treated|1
7618421|NCT01285557|12029129|FG001|Overall Study|Randomized but not treated|1
7618422|NCT01285557|12029128|FG000|Overall Study|Study follow-up ongoing|28
7618423|NCT01285557|12029129|FG001|Overall Study|Study follow-up ongoing|14
7618424|NCT01285557|12029128|FG000|Overall Study|Sponsor Decision|2
7618425|NCT01285557|12029129|FG001|Overall Study|Sponsor Decision|1
7618426|NCT00964002|12029159|FG000|Overall Study|Protocol Violation|8
7618427|NCT00790218|12029172|FG000|Overall Study|Death|1
7618428|NCT00790218|12029173|FG001|Overall Study|Death|0
7618429|NCT00790218|12029174|FG002|Overall Study|Death|0
7618430|NCT00145600|12029227|FG000|Overall Study|Death|1
7618431|NCT00145600|12029228|FG001|Overall Study|Death|2
7618432|NCT00145600|12029229|FG002|Overall Study|Death|2
7618433|NCT00145600|12029230|FG003|Overall Study|Death|6
7782449|NCT00963820|12231635|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7782450|NCT00963820|12231636|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7782451|NCT00963820|12231637|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7782452|NCT00963820|12231638|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7782453|NCT00963820|12231639|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7782454|NCT00963820|12231628|FG000|Expansion Phase|Progressive Disease|0
7782455|NCT00963820|12231629|FG001|Expansion Phase|Progressive Disease|0
7782456|NCT00963820|12231630|FG002|Expansion Phase|Progressive Disease|0
7782457|NCT00963820|12231631|FG003|Expansion Phase|Progressive Disease|0
7782458|NCT00963820|12231632|FG004|Expansion Phase|Progressive Disease|0
7782459|NCT00963820|12231633|FG005|Expansion Phase|Progressive Disease|0
7782460|NCT00963820|12231634|FG006|Expansion Phase|Progressive Disease|0
7782461|NCT00963820|12231635|FG007|Expansion Phase|Progressive Disease|0
7782462|NCT00963820|12231636|FG008|Expansion Phase|Progressive Disease|8
7782463|NCT00963820|12231637|FG009|Expansion Phase|Progressive Disease|6
7782464|NCT00963820|12231638|FG010|Expansion Phase|Progressive Disease|4
7782465|NCT00963820|12231639|FG011|Expansion Phase|Progressive Disease|2
7782466|NCT00963820|12231628|FG000|Expansion Phase|Adverse Event|0
7782467|NCT00963820|12231629|FG001|Expansion Phase|Adverse Event|0
7782468|NCT00963820|12231630|FG002|Expansion Phase|Adverse Event|0
7782469|NCT00963820|12231631|FG003|Expansion Phase|Adverse Event|0
7782470|NCT00963820|12231632|FG004|Expansion Phase|Adverse Event|0
7782471|NCT00963820|12231633|FG005|Expansion Phase|Adverse Event|0
7782472|NCT00963820|12231634|FG006|Expansion Phase|Adverse Event|0
7782473|NCT00963820|12231635|FG007|Expansion Phase|Adverse Event|0
7782474|NCT00963820|12231636|FG008|Expansion Phase|Adverse Event|1
7618434|NCT00145600|12029227|FG000|Overall Study|Ineligible|3
7618435|NCT00145600|12029228|FG001|Overall Study|Ineligible|0
7618436|NCT00145600|12029229|FG002|Overall Study|Ineligible|1
7618437|NCT00145600|12029230|FG003|Overall Study|Ineligible|5
7618438|NCT00145600|12029227|FG000|Overall Study|Lost to Follow-up|2
7618439|NCT00145600|12029228|FG001|Overall Study|Lost to Follow-up|6
7618440|NCT00145600|12029229|FG002|Overall Study|Lost to Follow-up|2
7618441|NCT00145600|12029230|FG003|Overall Study|Lost to Follow-up|4
7618442|NCT00145600|12029227|FG000|Overall Study|Noncompliance|1
7618443|NCT00145600|12029228|FG001|Overall Study|Noncompliance|0
7618444|NCT00145600|12029229|FG002|Overall Study|Noncompliance|0
7618445|NCT00145600|12029230|FG003|Overall Study|Noncompliance|0
7618446|NCT00145600|12029227|FG000|Overall Study|Withdrawal by Subject|1
7782475|NCT00963820|12231637|FG009|Expansion Phase|Adverse Event|3
7782476|NCT00963820|12231638|FG010|Expansion Phase|Adverse Event|0
7782477|NCT00963820|12231639|FG011|Expansion Phase|Adverse Event|0
7782478|NCT00963820|12231628|FG000|Expansion Phase|Withdrawal by Subject|0
7782479|NCT00963820|12231629|FG001|Expansion Phase|Withdrawal by Subject|0
7782480|NCT00963820|12231630|FG002|Expansion Phase|Withdrawal by Subject|0
7782481|NCT00963820|12231631|FG003|Expansion Phase|Withdrawal by Subject|0
7782482|NCT00963820|12231632|FG004|Expansion Phase|Withdrawal by Subject|0
7782483|NCT00963820|12231633|FG005|Expansion Phase|Withdrawal by Subject|0
7618447|NCT00145600|12029228|FG001|Overall Study|Withdrawal by Subject|2
7618448|NCT00145600|12029229|FG002|Overall Study|Withdrawal by Subject|0
7618449|NCT00145600|12029230|FG003|Overall Study|Withdrawal by Subject|1
7618450|NCT03084367|12029276|FG000|Overall Study|Lost to Follow-up|32
7618451|NCT03084367|12029276|FG000|Overall Study|Withdrawal by Subject|4
7618452|NCT03084367|12029276|FG000|Overall Study|Other|1
7618453|NCT04980040|12029365|FG000|Overall Study|Violated the Inclusion Criteria|260
7618454|NCT04980040|12029365|FG000|Overall Study|Violated the Administration & Dosage|225
7618455|NCT04980040|12029365|FG000|Overall Study|Lost to Safety-Follow-up|4
7618456|NCT04980040|12029365|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3
7618457|NCT04167670|12029381|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1
7618458|NCT04167670|12029382|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7
7618459|NCT04167670|12029383|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4
7618460|NCT04167670|12029381|FG000|Overall Study|Significant protocol deviation|3
7618461|NCT04167670|12029382|FG001|Overall Study|Significant protocol deviation|1
7782484|NCT00963820|12231634|FG006|Expansion Phase|Withdrawal by Subject|0
7782485|NCT00963820|12231635|FG007|Expansion Phase|Withdrawal by Subject|0
7782486|NCT00963820|12231636|FG008|Expansion Phase|Withdrawal by Subject|1
7782487|NCT00963820|12231637|FG009|Expansion Phase|Withdrawal by Subject|0
7782488|NCT00963820|12231638|FG010|Expansion Phase|Withdrawal by Subject|1
7618462|NCT04167670|12029383|FG002|Overall Study|Significant protocol deviation|0
7618463|NCT04167670|12029381|FG000|Overall Study|Lost to Follow-up|0
7618464|NCT04167670|12029382|FG001|Overall Study|Lost to Follow-up|3
7618465|NCT04167670|12029383|FG002|Overall Study|Lost to Follow-up|3
7618466|NCT04167670|12029381|FG000|Overall Study|Voluntary Withdrawal|0
7618467|NCT04167670|12029382|FG001|Overall Study|Voluntary Withdrawal|1
7618468|NCT04167670|12029383|FG002|Overall Study|Voluntary Withdrawal|1
7618469|NCT04167670|12029381|FG000|Overall Study|Withdrawal of Consent|4
7618470|NCT04167670|12029382|FG001|Overall Study|Withdrawal of Consent|1
7782489|NCT00963820|12231639|FG011|Expansion Phase|Withdrawal by Subject|1
7782490|NCT00963820|12231628|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0
7782491|NCT00963820|12231629|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0
7782492|NCT00963820|12231630|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0
7782493|NCT00963820|12231631|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0
7782494|NCT00963820|12231632|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0
7782495|NCT00963820|12231633|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0
7782496|NCT00963820|12231634|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0
7782497|NCT00963820|12231635|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0
7782498|NCT00963820|12231636|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0
7782499|NCT00963820|12231637|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0
7782500|NCT00963820|12231638|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0
7782501|NCT00963820|12231639|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1
7782502|NCT00963924|12231675|FG000|Overall Study|Adverse Event|1
7782503|NCT00963924|12231676|FG001|Overall Study|Adverse Event|0
7782504|NCT00963924|12231675|FG000|Overall Study|Withdrawal by Subject|0
7782505|NCT00963924|12231676|FG001|Overall Study|Withdrawal by Subject|1
7782506|NCT00963924|12231675|FG000|Overall Study|Changed antipsychotic|0
7782507|NCT00963924|12231676|FG001|Overall Study|Changed antipsychotic|1
7782508|NCT00963924|12231675|FG000|Overall Study|Lost to Follow-up|0
7782509|NCT00963924|12231676|FG001|Overall Study|Lost to Follow-up|1
7782510|NCT00963937|12231687|FG000|Overall Study|Protocol Violation|1
7782511|NCT00963937|12231688|FG001|Overall Study|Protocol Violation|1
7782512|NCT00963937|12231689|FG002|Overall Study|Protocol Violation|0
7782513|NCT00963937|12231687|FG000|Overall Study|Physician Decision|18
7782514|NCT00963937|12231688|FG001|Overall Study|Physician Decision|10
7782515|NCT00963937|12231689|FG002|Overall Study|Physician Decision|4
7782516|NCT00964028|12231706|FG000|Overall Study|Withdrawal by Subject|0
7782517|NCT00964028|12231707|FG001|Overall Study|Withdrawal by Subject|1
7782518|NCT00964158|12231720|FG000|Overall Study|Lost to Follow-up|0
7782519|NCT00964158|12231721|FG001|Overall Study|Lost to Follow-up|1
7782520|NCT00964158|12231722|FG002|Overall Study|Lost to Follow-up|2
7782521|NCT00964158|12231720|FG000|Overall Study|Withdrawal by Subject|0
7782522|NCT00964158|12231721|FG001|Overall Study|Withdrawal by Subject|0
7782523|NCT00964158|12231722|FG002|Overall Study|Withdrawal by Subject|6
7782524|NCT00964223|12231733|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
7782525|NCT00964366|12231749|FG000|Overall Study|Did not qualify at Day 1|1
7782526|NCT00964366|12231750|FG001|Overall Study|Did not qualify at Day 1|0
7782527|NCT00964366|12231749|FG000|Overall Study|Withdrawal by Subject|0
7782528|NCT00964366|12231750|FG001|Overall Study|Withdrawal by Subject|1
7782529|NCT00964392|12231758|FG000|Overall Study|Withdrawal by Subject|4
7782530|NCT00964392|12231759|FG001|Overall Study|Withdrawal by Subject|6
7782531|NCT00964392|12231758|FG000|Overall Study|Lost to Follow-up|4
7782532|NCT00964392|12231759|FG001|Overall Study|Lost to Follow-up|10
7782533|NCT00964392|12231758|FG000|Overall Study|Early Termination, non-study arrhythmia|1
7782534|NCT00964392|12231759|FG001|Overall Study|Early Termination, non-study arrhythmia|6
7782535|NCT00964392|12231758|FG000|Overall Study|Not completed|44
7782536|NCT00964392|12231759|FG001|Overall Study|Not completed|168
7782537|NCT00964678|12231804|FG000|Overall Study|Physician Decision|4
7782538|NCT00964743|12231809|FG000|Overall Study|Neither patient completed 8 weeks of tre|2
7782539|NCT00964782|12231815|FG000|Overall Study|Lost to Follow-up|1
7782540|NCT00964782|12231816|FG001|Overall Study|Lost to Follow-up|0
7618471|NCT04167670|12029383|FG002|Overall Study|Withdrawal of Consent|3
7618472|NCT04167670|12029381|FG000|Overall Study|Miscellaneous|7
7618473|NCT04167670|12029382|FG001|Overall Study|Miscellaneous|5
7618474|NCT04167670|12029383|FG002|Overall Study|Miscellaneous|3
7618475|NCT04076917|12029391|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49
7618476|NCT04076917|12029391|FG000|Overall Study|Study closure|13
7618477|NCT04076917|12029391|FG000|Overall Study|Physician Decision|3
7618478|NCT04076917|12029391|FG000|Overall Study|Death|1
7618479|NCT04076917|12029391|FG000|Overall Study|Lost to Follow-up|1
7618480|NCT04076917|12029391|FG000|Overall Study|Withdrawal by Subject|1
7618481|NCT04076917|12029391|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1
7782541|NCT00964795|12231824|FG000|Overall Study|Withdrawal by Subject|79
7782542|NCT00964795|12231824|FG000|Overall Study|Adverse Event|12
7782543|NCT00964795|12231824|FG000|Overall Study|Death|14
7782544|NCT00964795|12231824|FG000|Overall Study|Lost to Follow-up|7
7782545|NCT00964795|12231824|FG000|Overall Study|Termination of Study by Sponsor|169
7782546|NCT00964795|12231824|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3
7782547|NCT00964795|12231824|FG000|Overall Study|Other|23
7782548|NCT00964860|12231831|FG000|Overall Study|Withdrawal by Subject|0
7782549|NCT00964860|12231832|FG001|Overall Study|Withdrawal by Subject|1
7782550|NCT00964886|12231842|FG000|Overall Study|Lost to Follow-up|2
7782551|NCT00964886|12231843|FG001|Overall Study|Lost to Follow-up|2
7782552|NCT00964886|12231844|FG002|Overall Study|Lost to Follow-up|6
7782553|NCT00964886|12231845|FG003|Overall Study|Lost to Follow-up|4
7782554|NCT00964886|12231842|FG000|Overall Study|Withdrawal by Subject|6
7782555|NCT00964886|12231843|FG001|Overall Study|Withdrawal by Subject|2
7782556|NCT00964886|12231844|FG002|Overall Study|Withdrawal by Subject|5
7782557|NCT00964886|12231845|FG003|Overall Study|Withdrawal by Subject|3
7782558|NCT00964886|12231842|FG000|Overall Study|Adverse Event|3
7782559|NCT00964886|12231843|FG001|Overall Study|Adverse Event|1
7782560|NCT00964886|12231844|FG002|Overall Study|Adverse Event|5
7782561|NCT00964886|12231845|FG003|Overall Study|Adverse Event|2
7782562|NCT00964886|12231842|FG000|Overall Study|Protocol Violation|0
7782563|NCT00964886|12231843|FG001|Overall Study|Protocol Violation|2
7782564|NCT00964886|12231844|FG002|Overall Study|Protocol Violation|0
7782565|NCT00964886|12231845|FG003|Overall Study|Protocol Violation|0
7782566|NCT00965081|12231861|FG000|Overall Study|Adverse Event|14
7782567|NCT00965081|12231862|FG001|Overall Study|Adverse Event|9
7782568|NCT00965081|12231861|FG000|Overall Study|Lack of Efficacy|2
7782569|NCT00965081|12231862|FG001|Overall Study|Lack of Efficacy|5
7782570|NCT00965081|12231861|FG000|Overall Study|Lost to Follow-up|4
7782571|NCT00965081|12231862|FG001|Overall Study|Lost to Follow-up|5
7782572|NCT00965081|12231861|FG000|Overall Study|Physician Decision|2
7782573|NCT00965081|12231862|FG001|Overall Study|Physician Decision|0
7782574|NCT00965081|12231861|FG000|Overall Study|Protocol Violation|2
7782575|NCT00965081|12231862|FG001|Overall Study|Protocol Violation|5
7782576|NCT00965081|12231861|FG000|Overall Study|Sponsor Decision|1
7782577|NCT00965081|12231862|FG001|Overall Study|Sponsor Decision|0
7782578|NCT00965081|12231861|FG000|Overall Study|Withdrawal by Subject|4
7782579|NCT00965081|12231862|FG001|Overall Study|Withdrawal by Subject|7
7782580|NCT00965081|12231861|FG000|Overall Study|Switched to Rescue Arm|5
7782581|NCT00965081|12231862|FG001|Overall Study|Switched to Rescue Arm|12
7782582|NCT00965094|12231871|FG000|Overall Study|Adverse Event|5
7782583|NCT00965094|12231872|FG001|Overall Study|Adverse Event|0
7782584|NCT00965094|12231871|FG000|Overall Study|Lost to Follow-up|0
7782585|NCT00965094|12231872|FG001|Overall Study|Lost to Follow-up|1
7782586|NCT00965185|12231881|FG000|Overall Study|Lost to Follow-up|2
7782587|NCT00965185|12231882|FG001|Overall Study|Lost to Follow-up|0
7782588|NCT00965185|12231881|FG000|Overall Study|Withdrawal by Subject|0
7782589|NCT00965185|12231882|FG001|Overall Study|Withdrawal by Subject|1
7782590|NCT00965263|12231908|FG000|Overall Study|Physician Decision|2
7782591|NCT00965263|12231909|FG001|Overall Study|Physician Decision|0
7782592|NCT00965263|12231908|FG000|Overall Study|Family emergency|0
7782593|NCT00965263|12231909|FG001|Overall Study|Family emergency|1
7782594|NCT00965263|12231908|FG000|Overall Study|Protocol Violation|0
7782595|NCT00965263|12231909|FG001|Overall Study|Protocol Violation|2
7782596|NCT00965341|12231935|FG000|Overall Study|Withdrew consent|1
7782597|NCT00965341|12231936|FG001|Overall Study|Withdrew consent|5
7782598|NCT00965341|12231935|FG000|Overall Study|Lost to Follow-up|1
7782599|NCT00965341|12231936|FG001|Overall Study|Lost to Follow-up|0
7782600|NCT00965341|12231935|FG000|Overall Study|Transportation issues|4
7782601|NCT00965341|12231936|FG001|Overall Study|Transportation issues|3
7782602|NCT00965419|12231942|FG000|Open Label Treatment for Responders|Adverse Event|33
7782603|NCT00965419|12231942|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1
7782604|NCT00965419|12231942|FG000|Open Label Treatment for Responders|Protocol Violation|21
7782605|NCT00965419|12231942|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27
7782606|NCT00965419|12231942|FG000|Open Label Treatment for Responders|Physician Decision|6
7618482|NCT04000009|12029395|FG000|Overall Study|Adverse Event|13
7618483|NCT04000009|12029395|FG000|Overall Study|Lack of Efficacy|7
7618484|NCT04000009|12029395|FG000|Overall Study|Lost to Follow-up|8
7618485|NCT04000009|12029395|FG000|Overall Study|Noncompliance with study drug|4
7618486|NCT04000009|12029395|FG000|Overall Study|Physician Decision|1
7618487|NCT04000009|12029395|FG000|Overall Study|Use of prohibited medication|3
7618488|NCT04000009|12029395|FG000|Overall Study|Pregnancy|1
7618489|NCT04000009|12029395|FG000|Overall Study|Withdrawal by Subject|22
7618490|NCT04000009|12029395|FG000|Overall Study|Study terminated by sponsor|98
7618491|NCT04000009|12029395|FG000|Overall Study|Not further specified|8
7782607|NCT00965419|12231942|FG000|Open Label Treatment for Responders|Sponsor Decision|5
7782608|NCT00965419|12231942|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41
7782609|NCT00965419|12231942|FG000|Open Label Treatment for Responders|Lack of Efficacy|67
7782610|NCT00965419|12231942|FG000|Open Label Treatment for Responders|Lost to Follow-up|46
7618496|NCT03205371|12029476|FG000|Overall Study|Withdrawal by Subject|4
7618497|NCT03205371|12029477|FG001|Overall Study|Withdrawal by Subject|1
7618498|NCT03205371|12029478|FG002|Overall Study|Withdrawal by Subject|0
7618499|NCT03205371|12029479|FG003|Overall Study|Withdrawal by Subject|0
7618500|NCT03205371|12029480|FG004|Overall Study|Withdrawal by Subject|0
7618501|NCT03205371|12029481|FG005|Overall Study|Withdrawal by Subject|0
7618502|NCT03205371|12029482|FG006|Overall Study|Withdrawal by Subject|4
7782611|NCT00965419|12231942|FG000|Follow-up Phase|Adverse Event|9
7782612|NCT00965419|12231942|FG000|Follow-up Phase|Protocol Violation|4
7782613|NCT00965419|12231942|FG000|Follow-up Phase|Withdrawal by Subject|8
7782614|NCT00965419|12231942|FG000|Follow-up Phase|Physician Decision|4
7618503|NCT03205371|12029483|FG007|Overall Study|Withdrawal by Subject|0
7618504|NCT03205371|12029484|FG008|Overall Study|Withdrawal by Subject|2
7618505|NCT03205371|12029485|FG009|Overall Study|Withdrawal by Subject|0
7618506|NCT03205371|12029486|FG010|Overall Study|Withdrawal by Subject|0
7618507|NCT03205371|12029487|FG011|Overall Study|Withdrawal by Subject|1
7618508|NCT03205371|12029476|FG000|Overall Study|Lost to Follow-up|0
7782615|NCT00965419|12231942|FG000|Follow-up Phase|Parent/Caregiver Decision|9
7782616|NCT00965419|12231942|FG000|Follow-up Phase|Lack of Efficacy|28
7800221|NCT01091675|12257375|FG000|Overall Study|Adverse Event|7
7800222|NCT01091675|12257375|FG000|Overall Study|Lack of Efficacy|27
7800223|NCT01091974|12257393|FG000|Overall Study|Did not start intervention|3
7800224|NCT01091974|12257394|FG001|Overall Study|Did not start intervention|1
7800225|NCT01091974|12257395|FG002|Overall Study|Did not start intervention|3
7800226|NCT01091974|12257396|FG003|Overall Study|Did not start intervention|1
7800227|NCT01091974|12257393|FG000|Overall Study|resumed sleep medication|0
7800228|NCT01091974|12257394|FG001|Overall Study|resumed sleep medication|0
7800229|NCT01091974|12257395|FG002|Overall Study|resumed sleep medication|1
7800230|NCT01091974|12257396|FG003|Overall Study|resumed sleep medication|2
7800231|NCT01091974|12257393|FG000|Overall Study|Withdrawal by Subject|1
7800232|NCT01091974|12257394|FG001|Overall Study|Withdrawal by Subject|3
7800233|NCT01091974|12257395|FG002|Overall Study|Withdrawal by Subject|2
7800234|NCT01091974|12257396|FG003|Overall Study|Withdrawal by Subject|2
7800235|NCT01091974|12257393|FG000|Overall Study|side-effects|1
7800236|NCT01091974|12257394|FG001|Overall Study|side-effects|1
7800237|NCT01091974|12257395|FG002|Overall Study|side-effects|0
7800238|NCT01091974|12257396|FG003|Overall Study|side-effects|2
7800239|NCT01092182|12257409|FG000|Overall Study|Death|0
7800240|NCT01092182|12257410|FG001|Overall Study|Death|5
7800241|NCT01092182|12257411|FG002|Overall Study|Death|3
7800242|NCT01092182|12257409|FG000|Overall Study|participant safety|1
7800243|NCT01092182|12257410|FG001|Overall Study|participant safety|2
7800244|NCT01092182|12257411|FG002|Overall Study|participant safety|0
7800245|NCT01092182|12257409|FG000|Overall Study|Physician Decision|0
7800246|NCT01092182|12257410|FG001|Overall Study|Physician Decision|6
7800247|NCT01092182|12257411|FG002|Overall Study|Physician Decision|0
7800248|NCT01092182|12257409|FG000|Overall Study|Did not meet criteria|0
7800249|NCT01092182|12257410|FG001|Overall Study|Did not meet criteria|0
7800250|NCT01092182|12257411|FG002|Overall Study|Did not meet criteria|25
7800251|NCT01092182|12257409|FG000|Overall Study|Non-compliance|0
7800252|NCT01092182|12257410|FG001|Overall Study|Non-compliance|3
7800253|NCT01092182|12257411|FG002|Overall Study|Non-compliance|0
7800254|NCT01092182|12257409|FG000|Overall Study|Participant refused follow-up|0
7800255|NCT01092182|12257410|FG001|Overall Study|Participant refused follow-up|2
7800256|NCT01092182|12257411|FG002|Overall Study|Participant refused follow-up|0
7800257|NCT01092416|12257454|FG000|Enrollment|Atherectomy device not inserted|3
7800258|NCT01092416|12257454|FG000|30-Day Follow-up|Death|2
7800259|NCT01092416|12257454|FG000|30-Day Follow-up|Missed 30-day follow-up|3
7800260|NCT01092416|12257454|FG000|30-Day Follow-up|Data collected after close of 30D window|5
7800261|NCT01092416|12257454|FG000|12-Month Follow-up|Death|16
7800262|NCT01092416|12257454|FG000|12-Month Follow-up|Lost to Follow-up|4
7800263|NCT01092416|12257454|FG000|12-Month Follow-up|Withdrawal by Subject|2
7618509|NCT03205371|12029477|FG001|Overall Study|Lost to Follow-up|0
7618510|NCT03205371|12029478|FG002|Overall Study|Lost to Follow-up|0
7618511|NCT03205371|12029479|FG003|Overall Study|Lost to Follow-up|0
7618512|NCT03205371|12029480|FG004|Overall Study|Lost to Follow-up|0
7618513|NCT03205371|12029481|FG005|Overall Study|Lost to Follow-up|0
7618514|NCT03205371|12029482|FG006|Overall Study|Lost to Follow-up|5
7618515|NCT03205371|12029483|FG007|Overall Study|Lost to Follow-up|2
7618516|NCT03205371|12029484|FG008|Overall Study|Lost to Follow-up|3
7618517|NCT03205371|12029485|FG009|Overall Study|Lost to Follow-up|0
7618518|NCT03205371|12029486|FG010|Overall Study|Lost to Follow-up|0
7618519|NCT03205371|12029487|FG011|Overall Study|Lost to Follow-up|0
7618520|NCT03205371|12029476|FG000|Overall Study|Protocol Violation|0
7618521|NCT03205371|12029477|FG001|Overall Study|Protocol Violation|0
7618522|NCT03205371|12029478|FG002|Overall Study|Protocol Violation|0
7618523|NCT03205371|12029479|FG003|Overall Study|Protocol Violation|0
7618524|NCT03205371|12029480|FG004|Overall Study|Protocol Violation|0
7618525|NCT03205371|12029481|FG005|Overall Study|Protocol Violation|0
7800264|NCT01092416|12257454|FG000|12-Month Follow-up|Missed 1-year follow-up|1
7800265|NCT01092416|12257454|FG000|12-Month Follow-up|Data collected after close of 1Y window|2
7800266|NCT01092507|12257477|FG000|Overall Study|Withdrawal by Subject|2
7800267|NCT01092507|12257478|FG001|Overall Study|Withdrawal by Subject|0
7800268|NCT01092546|12257484|FG000|Overall Study|Subjects withdrawn prior to dosing|4
7618526|NCT03205371|12029482|FG006|Overall Study|Protocol Violation|1
7618527|NCT03205371|12029483|FG007|Overall Study|Protocol Violation|0
7618528|NCT03205371|12029484|FG008|Overall Study|Protocol Violation|0
7618529|NCT03205371|12029485|FG009|Overall Study|Protocol Violation|0
7618530|NCT03205371|12029486|FG010|Overall Study|Protocol Violation|0
7800269|NCT01092637|12257494|FG000|Overall Study|Death|47
7800270|NCT01092637|12257495|FG001|Overall Study|Death|49
7800271|NCT01092663|12257504|FG000|Overall Study|Withdrawal by Subject|3
7800272|NCT01092663|12257505|FG001|Overall Study|Withdrawal by Subject|2
7800273|NCT01092663|12257504|FG000|Overall Study|Glucose >300mg/dL|1
7618531|NCT03205371|12029487|FG011|Overall Study|Protocol Violation|0
7618532|NCT03205371|12029476|FG000|Overall Study|Adverse Event|0
7618533|NCT03205371|12029477|FG001|Overall Study|Adverse Event|0
7618534|NCT03205371|12029478|FG002|Overall Study|Adverse Event|0
7618535|NCT03205371|12029479|FG003|Overall Study|Adverse Event|0
7618536|NCT03205371|12029480|FG004|Overall Study|Adverse Event|0
7618537|NCT03205371|12029481|FG005|Overall Study|Adverse Event|0
7618538|NCT03205371|12029482|FG006|Overall Study|Adverse Event|0
7782617|NCT00965458|12231949|FG000|Overall Study|Adverse Event|1
7782618|NCT00965458|12231950|FG001|Overall Study|Adverse Event|0
7782619|NCT00965458|12231949|FG000|Overall Study|Lost to Follow-up|1
7782620|NCT00965458|12231950|FG001|Overall Study|Lost to Follow-up|3
7782621|NCT00965458|12231949|FG000|Overall Study|Withdrawal by Subject|0
7782622|NCT00965458|12231950|FG001|Overall Study|Withdrawal by Subject|1
7782623|NCT00965484|12231958|FG000|Overall Study|Protocol Violation|1
7782624|NCT00965484|12231958|FG000|Overall Study|Withdrawal by Subject|1
7782625|NCT00965497|12231962|FG000|Overall Study|Physician Decision|1
7782626|NCT00965523|12231966|FG000|Study 221|Progressive Disease|4
7782627|NCT00965523|12231966|FG000|Study 221|Physician Decision|3
7782628|NCT00965523|12231966|FG000|Study 224|Progressive Disease|5
7782629|NCT00965523|12231966|FG000|Study 224|Physician Decision|1
7782630|NCT00965562|12231973|FG000|Overall Study|Lost to Follow-up|1
7782631|NCT00965562|12231974|FG001|Overall Study|Lost to Follow-up|2
7782632|NCT00965562|12231975|FG002|Overall Study|Lost to Follow-up|3
7782633|NCT00965562|12231973|FG000|Overall Study|Withdrawal by Subject|2
7782634|NCT00965562|12231974|FG001|Overall Study|Withdrawal by Subject|2
7782635|NCT00965562|12231975|FG002|Overall Study|Withdrawal by Subject|0
7782636|NCT00965575|12231986|FG000|Overall Study|subject unwillingness to swallow study c|1
7782637|NCT00965575|12231987|FG001|Overall Study|subject unwillingness to swallow study c|0
7618539|NCT03205371|12029483|FG007|Overall Study|Adverse Event|1
7618540|NCT03205371|12029484|FG008|Overall Study|Adverse Event|0
7618541|NCT03205371|12029485|FG009|Overall Study|Adverse Event|0
7618542|NCT03205371|12029486|FG010|Overall Study|Adverse Event|0
7618543|NCT03205371|12029487|FG011|Overall Study|Adverse Event|0
7618544|NCT03165721|12029536|FG000|Overall Study|Refused further treatment|3
7618545|NCT03165721|12029537|FG001|Overall Study|Refused further treatment|0
7618546|NCT03165721|12029538|FG002|Overall Study|Refused further treatment|0
7618547|NCT03165721|12029536|FG000|Overall Study|Physician Decision|1
7618548|NCT03165721|12029537|FG001|Overall Study|Physician Decision|0
7618549|NCT03165721|12029538|FG002|Overall Study|Physician Decision|0
7782638|NCT00965718|12231995|FG000|Overall Study|Withdrawal by Subject|4
7782639|NCT00965731|12232001|FG000|Overall Study|Death|0
7782640|NCT00965731|12232002|FG001|Overall Study|Death|4
7782641|NCT00965731|12232001|FG000|Overall Study|Withdrawal by Subject|0
7782642|NCT00965731|12232002|FG001|Overall Study|Withdrawal by Subject|1
7782643|NCT00965731|12232001|FG000|Overall Study|Other|7
7782644|NCT00965731|12232002|FG001|Overall Study|Other|15
7782645|NCT00965848|12232013|FG000|Overall Study|Protocol Violation|3
7782646|NCT00965848|12232014|FG001|Overall Study|Protocol Violation|0
7782647|NCT00965848|12232015|FG002|Overall Study|Protocol Violation|1
7782648|NCT00965848|12232013|FG000|Overall Study|Death|11
7782649|NCT00965848|12232014|FG001|Overall Study|Death|1
7782650|NCT00965848|12232015|FG002|Overall Study|Death|5
7782651|NCT00965848|12232013|FG000|Overall Study|Lost to Follow-up|0
7782652|NCT00965848|12232014|FG001|Overall Study|Lost to Follow-up|0
7782653|NCT00965848|12232015|FG002|Overall Study|Lost to Follow-up|1
7782654|NCT00965848|12232013|FG000|Overall Study|Withdrawal by Subject|1
7782655|NCT00965848|12232014|FG001|Overall Study|Withdrawal by Subject|0
7782656|NCT00965848|12232015|FG002|Overall Study|Withdrawal by Subject|0
7782657|NCT00965848|12232013|FG000|Overall Study|Indeterminate Clinical Outcome|2
7782658|NCT00965848|12232014|FG001|Overall Study|Indeterminate Clinical Outcome|0
7782659|NCT00965848|12232015|FG002|Overall Study|Indeterminate Clinical Outcome|1
7782660|NCT00965848|12232013|FG000|Overall Study|Not Clinically Evaluable|7
7782661|NCT00965848|12232014|FG001|Overall Study|Not Clinically Evaluable|1
7782662|NCT00965848|12232015|FG002|Overall Study|Not Clinically Evaluable|1
7782663|NCT00965848|12232013|FG000|Overall Study|Other|5
7782664|NCT00965848|12232014|FG001|Overall Study|Other|0
7782665|NCT00965848|12232015|FG002|Overall Study|Other|1
7782666|NCT00966264|12232059|FG000|Overall Study|Lost to Follow-up|4
7782667|NCT00966264|12232060|FG001|Overall Study|Lost to Follow-up|3
7782668|NCT00966277|12232068|FG000|Overall Study|Withdrawal by Subject|3
7782669|NCT00966277|12232069|FG001|Overall Study|Withdrawal by Subject|0
7782670|NCT00966277|12232068|FG000|Overall Study|Ineligible|1
7782671|NCT00966277|12232069|FG001|Overall Study|Ineligible|3
7782672|NCT00966277|12232068|FG000|Overall Study|Treatment Plan Changed|0
7782673|NCT00966277|12232069|FG001|Overall Study|Treatment Plan Changed|1
7782674|NCT00966355|12232078|FG000|Overall Study|non-variceal bleeding on endoscopy|68
7782675|NCT00966355|12232079|FG001|Overall Study|non-variceal bleeding on endoscopy|70
7782676|NCT00966355|12232080|FG002|Overall Study|non-variceal bleeding on endoscopy|71
7782677|NCT00966355|12232078|FG000|Overall Study|newly diagnosed advanced HCC|11
7782678|NCT00966355|12232079|FG001|Overall Study|newly diagnosed advanced HCC|12
7782679|NCT00966355|12232080|FG002|Overall Study|newly diagnosed advanced HCC|10
7782680|NCT00966355|12232078|FG000|Overall Study|Lost to Follow-up|5
7782681|NCT00966355|12232079|FG001|Overall Study|Lost to Follow-up|4
7782682|NCT00966355|12232080|FG002|Overall Study|Lost to Follow-up|3
7782683|NCT00966693|12232136|FG000|Overall Study|Adverse Event|0
7782684|NCT00966693|12232137|FG001|Overall Study|Adverse Event|0
7782685|NCT00966693|12232138|FG002|Overall Study|Adverse Event|1
7782686|NCT00966693|12232139|FG003|Overall Study|Adverse Event|2
7782687|NCT00966693|12232136|FG000|Overall Study|Death|0
7782688|NCT00966693|12232137|FG001|Overall Study|Death|0
7782689|NCT00966693|12232138|FG002|Overall Study|Death|1
7782690|NCT00966693|12232139|FG003|Overall Study|Death|0
7782691|NCT00966693|12232136|FG000|Overall Study|Withdrawal by Subject|1
7782692|NCT00966693|12232137|FG001|Overall Study|Withdrawal by Subject|0
7782693|NCT00966693|12232138|FG002|Overall Study|Withdrawal by Subject|0
7782694|NCT00966693|12232139|FG003|Overall Study|Withdrawal by Subject|5
7782695|NCT00966693|12232136|FG000|Overall Study|Disease Progression|0
7782696|NCT00966693|12232137|FG001|Overall Study|Disease Progression|0
7782697|NCT00966693|12232138|FG002|Overall Study|Disease Progression|1
7782698|NCT00966693|12232139|FG003|Overall Study|Disease Progression|16
7782699|NCT00966719|12232151|FG000|Overall Study|Lost to Follow-up|6
7782700|NCT00966719|12232152|FG001|Overall Study|Lost to Follow-up|11
7782701|NCT00966875|12232184|FG000|Part A|Adverse Event|2
7782702|NCT00966875|12232185|FG001|Part A|Adverse Event|1
7782703|NCT00966875|12232186|FG002|Part A|Adverse Event|0
7782704|NCT00966875|12232187|FG003|Part A|Adverse Event|1
7782705|NCT00966875|12232188|FG004|Part A|Adverse Event|0
7782706|NCT00966875|12232189|FG005|Part A|Adverse Event|1
7782707|NCT00966875|12232190|FG006|Part A|Adverse Event|0
7782708|NCT00966875|12232191|FG007|Part A|Adverse Event|3
7782709|NCT00966875|12232192|FG008|Part A|Adverse Event|3
7782710|NCT00966875|12232184|FG000|Part A|Entry Criteria|0
7782711|NCT00966875|12232185|FG001|Part A|Entry Criteria|0
7782712|NCT00966875|12232186|FG002|Part A|Entry Criteria|0
7782713|NCT00966875|12232187|FG003|Part A|Entry Criteria|0
7782714|NCT00966875|12232188|FG004|Part A|Entry Criteria|0
7782715|NCT00966875|12232189|FG005|Part A|Entry Criteria|2
7782716|NCT00966875|12232190|FG006|Part A|Entry Criteria|0
7782717|NCT00966875|12232191|FG007|Part A|Entry Criteria|0
7782718|NCT00966875|12232192|FG008|Part A|Entry Criteria|0
7782719|NCT00966875|12232184|FG000|Part A|Lack of Efficacy|0
7782720|NCT00966875|12232185|FG001|Part A|Lack of Efficacy|1
7782721|NCT00966875|12232186|FG002|Part A|Lack of Efficacy|0
7782722|NCT00966875|12232187|FG003|Part A|Lack of Efficacy|0
7782723|NCT00966875|12232188|FG004|Part A|Lack of Efficacy|0
7782724|NCT00966875|12232189|FG005|Part A|Lack of Efficacy|0
7782725|NCT00966875|12232190|FG006|Part A|Lack of Efficacy|4
7782726|NCT00966875|12232191|FG007|Part A|Lack of Efficacy|0
7782727|NCT00966875|12232192|FG008|Part A|Lack of Efficacy|0
7782728|NCT00966875|12232184|FG000|Part A|Lost to Follow-up|2
7782729|NCT00966875|12232185|FG001|Part A|Lost to Follow-up|0
7782730|NCT00966875|12232186|FG002|Part A|Lost to Follow-up|0
7782731|NCT00966875|12232187|FG003|Part A|Lost to Follow-up|0
7782732|NCT00966875|12232188|FG004|Part A|Lost to Follow-up|0
7782733|NCT00966875|12232189|FG005|Part A|Lost to Follow-up|1
7782734|NCT00966875|12232190|FG006|Part A|Lost to Follow-up|0
7782735|NCT00966875|12232191|FG007|Part A|Lost to Follow-up|0
7782736|NCT00966875|12232192|FG008|Part A|Lost to Follow-up|0
7782737|NCT00966875|12232184|FG000|Part A|Parent/Caregiver Decision|0
7782738|NCT00966875|12232185|FG001|Part A|Parent/Caregiver Decision|0
7782739|NCT00966875|12232186|FG002|Part A|Parent/Caregiver Decision|0
7782740|NCT00966875|12232187|FG003|Part A|Parent/Caregiver Decision|1
7782741|NCT00966875|12232188|FG004|Part A|Parent/Caregiver Decision|0
7782742|NCT00966875|12232189|FG005|Part A|Parent/Caregiver Decision|0
7782743|NCT00966875|12232190|FG006|Part A|Parent/Caregiver Decision|0
7782744|NCT00966875|12232191|FG007|Part A|Parent/Caregiver Decision|0
7782745|NCT00966875|12232192|FG008|Part A|Parent/Caregiver Decision|0
7782746|NCT00966875|12232184|FG000|Part A|Physician Decision|0
7782747|NCT00966875|12232185|FG001|Part A|Physician Decision|0
7782748|NCT00966875|12232186|FG002|Part A|Physician Decision|0
7782749|NCT00966875|12232187|FG003|Part A|Physician Decision|0
7782750|NCT00966875|12232188|FG004|Part A|Physician Decision|1
7782751|NCT00966875|12232189|FG005|Part A|Physician Decision|0
7782752|NCT00966875|12232190|FG006|Part A|Physician Decision|1
7782753|NCT00966875|12232191|FG007|Part A|Physician Decision|0
7782754|NCT00966875|12232192|FG008|Part A|Physician Decision|2
7782755|NCT00966875|12232184|FG000|Part A|Sponsor Decision|0
7782756|NCT00966875|12232185|FG001|Part A|Sponsor Decision|0
7782757|NCT00966875|12232186|FG002|Part A|Sponsor Decision|1
7782758|NCT00966875|12232187|FG003|Part A|Sponsor Decision|0
7782759|NCT00966875|12232188|FG004|Part A|Sponsor Decision|1
7782760|NCT00966875|12232189|FG005|Part A|Sponsor Decision|0
7782761|NCT00966875|12232190|FG006|Part A|Sponsor Decision|0
7782762|NCT00966875|12232191|FG007|Part A|Sponsor Decision|2
7782763|NCT00966875|12232192|FG008|Part A|Sponsor Decision|1
7782764|NCT00966875|12232184|FG000|Part A|Withdrawal by Subject|2
7782765|NCT00966875|12232185|FG001|Part A|Withdrawal by Subject|2
7782766|NCT00966875|12232186|FG002|Part A|Withdrawal by Subject|1
7782767|NCT00966875|12232187|FG003|Part A|Withdrawal by Subject|1
7782768|NCT00966875|12232188|FG004|Part A|Withdrawal by Subject|3
7782769|NCT00966875|12232189|FG005|Part A|Withdrawal by Subject|0
7782770|NCT00966875|12232190|FG006|Part A|Withdrawal by Subject|5
7782771|NCT00966875|12232191|FG007|Part A|Withdrawal by Subject|1
7782772|NCT00966875|12232192|FG008|Part A|Withdrawal by Subject|1
7782773|NCT00966875|12232184|FG000|Part A|Protocol Violation|0
7782774|NCT00966875|12232185|FG001|Part A|Protocol Violation|0
7782775|NCT00966875|12232186|FG002|Part A|Protocol Violation|0
7782776|NCT00966875|12232187|FG003|Part A|Protocol Violation|0
7782777|NCT00966875|12232188|FG004|Part A|Protocol Violation|0
7782778|NCT00966875|12232189|FG005|Part A|Protocol Violation|0
7782779|NCT00966875|12232190|FG006|Part A|Protocol Violation|2
7782780|NCT00966875|12232191|FG007|Part A|Protocol Violation|1
7782781|NCT00966875|12232192|FG008|Part A|Protocol Violation|1
7782782|NCT00966875|12232184|FG000|Part B|Adverse Event|0
7782783|NCT00966875|12232185|FG001|Part B|Adverse Event|1
7782784|NCT00966875|12232186|FG002|Part B|Adverse Event|1
7782785|NCT00966875|12232187|FG003|Part B|Adverse Event|0
7782786|NCT00966875|12232188|FG004|Part B|Adverse Event|1
7782787|NCT00966875|12232189|FG005|Part B|Adverse Event|0
7782788|NCT00966875|12232190|FG006|Part B|Adverse Event|5
7782789|NCT00966875|12232191|FG007|Part B|Adverse Event|2
7782790|NCT00966875|12232192|FG008|Part B|Adverse Event|2
7782791|NCT00966875|12232184|FG000|Part B|Death|0
7782792|NCT00966875|12232185|FG001|Part B|Death|0
7782793|NCT00966875|12232186|FG002|Part B|Death|1
7782794|NCT00966875|12232187|FG003|Part B|Death|0
7782795|NCT00966875|12232188|FG004|Part B|Death|0
7782796|NCT00966875|12232189|FG005|Part B|Death|0
7782797|NCT00966875|12232190|FG006|Part B|Death|0
7782798|NCT00966875|12232191|FG007|Part B|Death|1
7782799|NCT00966875|12232192|FG008|Part B|Death|0
7782800|NCT00966875|12232184|FG000|Part B|Lack of Efficacy|2
7782801|NCT00966875|12232185|FG001|Part B|Lack of Efficacy|1
7782802|NCT00966875|12232186|FG002|Part B|Lack of Efficacy|1
7782803|NCT00966875|12232187|FG003|Part B|Lack of Efficacy|1
7782804|NCT00966875|12232188|FG004|Part B|Lack of Efficacy|2
7782805|NCT00966875|12232189|FG005|Part B|Lack of Efficacy|3
7782806|NCT00966875|12232190|FG006|Part B|Lack of Efficacy|12
7782807|NCT00966875|12232191|FG007|Part B|Lack of Efficacy|9
7782808|NCT00966875|12232192|FG008|Part B|Lack of Efficacy|6
7782809|NCT00966875|12232184|FG000|Part B|Lost to Follow-up|0
7782810|NCT00966875|12232185|FG001|Part B|Lost to Follow-up|0
7782811|NCT00966875|12232186|FG002|Part B|Lost to Follow-up|0
7782812|NCT00966875|12232187|FG003|Part B|Lost to Follow-up|1
7782813|NCT00966875|12232188|FG004|Part B|Lost to Follow-up|0
7782814|NCT00966875|12232189|FG005|Part B|Lost to Follow-up|0
7782815|NCT00966875|12232190|FG006|Part B|Lost to Follow-up|0
7782816|NCT00966875|12232191|FG007|Part B|Lost to Follow-up|0
7782817|NCT00966875|12232192|FG008|Part B|Lost to Follow-up|1
7782818|NCT00966875|12232184|FG000|Part B|Physician Decision|0
7782819|NCT00966875|12232185|FG001|Part B|Physician Decision|0
7782820|NCT00966875|12232186|FG002|Part B|Physician Decision|1
7782821|NCT00966875|12232187|FG003|Part B|Physician Decision|0
7782822|NCT00966875|12232188|FG004|Part B|Physician Decision|2
7782823|NCT00966875|12232189|FG005|Part B|Physician Decision|1
7782824|NCT00966875|12232190|FG006|Part B|Physician Decision|0
7782825|NCT00966875|12232191|FG007|Part B|Physician Decision|0
7782826|NCT00966875|12232192|FG008|Part B|Physician Decision|2
7782827|NCT00966875|12232184|FG000|Part B|Sponsor Decision|1
7782828|NCT00966875|12232185|FG001|Part B|Sponsor Decision|0
7782829|NCT00966875|12232186|FG002|Part B|Sponsor Decision|0
7782830|NCT00966875|12232187|FG003|Part B|Sponsor Decision|0
7782831|NCT00966875|12232188|FG004|Part B|Sponsor Decision|0
7782832|NCT00966875|12232189|FG005|Part B|Sponsor Decision|1
7782833|NCT00966875|12232190|FG006|Part B|Sponsor Decision|0
7782834|NCT00966875|12232191|FG007|Part B|Sponsor Decision|2
7782835|NCT00966875|12232192|FG008|Part B|Sponsor Decision|1
7782836|NCT00966875|12232184|FG000|Part B|Withdrawal by Subject|2
7782837|NCT00966875|12232185|FG001|Part B|Withdrawal by Subject|1
7782838|NCT00966875|12232186|FG002|Part B|Withdrawal by Subject|2
7782839|NCT00966875|12232187|FG003|Part B|Withdrawal by Subject|1
7782840|NCT00966875|12232188|FG004|Part B|Withdrawal by Subject|2
7782841|NCT00966875|12232189|FG005|Part B|Withdrawal by Subject|1
7782842|NCT00966875|12232190|FG006|Part B|Withdrawal by Subject|4
7782843|NCT00966875|12232191|FG007|Part B|Withdrawal by Subject|5
7782844|NCT00966875|12232192|FG008|Part B|Withdrawal by Subject|5
7782845|NCT00966875|12232184|FG000|Part B|Entry Criteria|0
7782846|NCT00966875|12232185|FG001|Part B|Entry Criteria|0
7782847|NCT00966875|12232186|FG002|Part B|Entry Criteria|0
7782848|NCT00966875|12232187|FG003|Part B|Entry Criteria|0
7782849|NCT00966875|12232188|FG004|Part B|Entry Criteria|0
7782850|NCT00966875|12232189|FG005|Part B|Entry Criteria|0
7782851|NCT00966875|12232190|FG006|Part B|Entry Criteria|1
7782852|NCT00966875|12232191|FG007|Part B|Entry Criteria|0
7782853|NCT00966875|12232192|FG008|Part B|Entry Criteria|1
7782854|NCT00966940|12232267|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2
7782855|NCT00966940|12232268|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0
7782856|NCT00966940|12232267|FG000|Period 1, First 6 Weeks|Protocol Violation|1
7782857|NCT00966940|12232268|FG001|Period 1, First 6 Weeks|Protocol Violation|0
7782858|NCT00967005|12232276|FG000|Overall Study|Lost to Follow-up|7
7782859|NCT00967005|12232277|FG001|Overall Study|Lost to Follow-up|10
7782860|NCT00967018|12232283|FG000|Overall Study|Adverse Event|2
7782861|NCT00967018|12232283|FG000|Overall Study|Physician Decision|7
7782862|NCT00967018|12232283|FG000|Overall Study|Lost to Follow-up|2
7782863|NCT00967018|12232283|FG000|Overall Study|Withdrawal by Subject|1
7782864|NCT00967018|12232283|FG000|Overall Study|Miscellaneous Reasons|9
7782865|NCT00967226|12232293|FG000|Overall Study|Adverse Event|0
7782866|NCT00967226|12232294|FG001|Overall Study|Adverse Event|5
7782867|NCT00967226|12232293|FG000|Overall Study|Protocol Violation|2
7782868|NCT00967226|12232294|FG001|Overall Study|Protocol Violation|0
7782869|NCT00967226|12232293|FG000|Overall Study|Physician Decision|0
7782870|NCT00967226|12232294|FG001|Overall Study|Physician Decision|1
7782871|NCT00967330|12232326|FG000|Overall Study|Protocol Violation|3
7782872|NCT00967330|12232327|FG001|Overall Study|Protocol Violation|4
7782873|NCT00967330|12232326|FG000|Overall Study|Regular|10
7782874|NCT00967330|12232327|FG001|Overall Study|Regular|3
7782875|NCT00967330|12232326|FG000|Overall Study|Withdrawal by Subject|6
7782876|NCT00967330|12232327|FG001|Overall Study|Withdrawal by Subject|0
7782877|NCT00967330|12232326|FG000|Overall Study|Lost to Follow-up|1
7782878|NCT00967330|12232327|FG001|Overall Study|Lost to Follow-up|1
7782879|NCT00967330|12232326|FG000|Overall Study|Death|102
7782880|NCT00967330|12232327|FG001|Overall Study|Death|51
7782881|NCT00967330|12232326|FG000|Overall Study|Severe protocol deviation|0
7782882|NCT00967330|12232327|FG001|Overall Study|Severe protocol deviation|1
7782883|NCT00967343|12232333|FG000|Overall Study|Study termination by sponsor|12
7782884|NCT00967343|12232333|FG000|Overall Study|Death|24
7782885|NCT00967343|12232333|FG000|Overall Study|Relapse|1
7782886|NCT00967343|12232333|FG000|Overall Study|Lost to Follow-up|1
7782887|NCT00967499|12232361|FG000|Overall Study|Adverse Event|0
7782888|NCT00967499|12232362|FG001|Overall Study|Adverse Event|1
7782889|NCT00967499|12232361|FG000|Overall Study|Protocol Violation|1
7618660|NCT02955797|12029606|FG000|Overall Study|Protocol Violation|1
7618661|NCT02955797|12029607|FG001|Overall Study|Protocol Violation|0
7618662|NCT02955797|12029608|FG002|Overall Study|Protocol Violation|0
7618663|NCT02955797|12029609|FG003|Overall Study|Protocol Violation|1
7618664|NCT02955797|12029606|FG000|Overall Study|Withdrawal by Subject|2
7618665|NCT02955797|12029607|FG001|Overall Study|Withdrawal by Subject|2
7618666|NCT02955797|12029608|FG002|Overall Study|Withdrawal by Subject|0
7618667|NCT02955797|12029609|FG003|Overall Study|Withdrawal by Subject|1
7618668|NCT02955797|12029606|FG000|Overall Study|Lost to Follow-up|0
7618669|NCT02955797|12029607|FG001|Overall Study|Lost to Follow-up|1
7618670|NCT02955797|12029608|FG002|Overall Study|Lost to Follow-up|0
7782890|NCT00967499|12232362|FG001|Overall Study|Protocol Violation|0
7782891|NCT00967499|12232361|FG000|Overall Study|Sponsor Decision|1
7782892|NCT00967499|12232362|FG001|Overall Study|Sponsor Decision|0
7782893|NCT00967499|12232361|FG000|Overall Study|Randomized but not treated|63
7782894|NCT00967499|12232362|FG001|Overall Study|Randomized but not treated|59
7782895|NCT00967616|12232379|FG000|Overall Study|Adverse Event or Serious Adverse Event|2
7782896|NCT00967616|12232380|FG001|Overall Study|Adverse Event or Serious Adverse Event|17
7618671|NCT02955797|12029609|FG003|Overall Study|Lost to Follow-up|0
7782897|NCT00967616|12232379|FG000|Overall Study|Death|0
7782898|NCT00967616|12232380|FG001|Overall Study|Death|3
7782899|NCT00967616|12232379|FG000|Overall Study|Withdrawal by Subject|8
7618672|NCT02859415|12029624|FG000|Overall Study|Physician Decision|1
7618673|NCT02859415|12029625|FG001|Overall Study|Physician Decision|0
7618674|NCT02859415|12029624|FG000|Overall Study|Off treatment due to cardiac event|0
7618675|NCT02859415|12029625|FG001|Overall Study|Off treatment due to cardiac event|1
7618676|NCT02842866|12029634|FG000|Overall Study|Serious Adverse Event|0
7618677|NCT02842866|12029635|FG001|Overall Study|Serious Adverse Event|1
7618678|NCT02842866|12029634|FG000|Overall Study|Protocol Violation|4
7618679|NCT02842866|12029635|FG001|Overall Study|Protocol Violation|2
7618680|NCT02842866|12029634|FG000|Overall Study|Lost to Follow-up|2
7618681|NCT02842866|12029635|FG001|Overall Study|Lost to Follow-up|0
7618682|NCT02842866|12029634|FG000|Overall Study|Withdrawal by Subject|1
7618683|NCT02842866|12029635|FG001|Overall Study|Withdrawal by Subject|0
7618684|NCT02842853|12029645|FG000|Overall Study|Non-compliance with the protocol|3
7618685|NCT02842853|12029646|FG001|Overall Study|Non-compliance with the protocol|7
7618686|NCT02842853|12029647|FG002|Overall Study|Non-compliance with the protocol|2
7618687|NCT02842853|12029648|FG003|Overall Study|Non-compliance with the protocol|5
7618688|NCT02842853|12029645|FG000|Overall Study|Subject met exclusion criteria|0
7618689|NCT02842853|12029646|FG001|Overall Study|Subject met exclusion criteria|1
7618690|NCT02842853|12029647|FG002|Overall Study|Subject met exclusion criteria|0
7618691|NCT02842853|12029648|FG003|Overall Study|Subject met exclusion criteria|0
7618692|NCT02842853|12029645|FG000|Overall Study|Withdrawal by Subject|11
7618693|NCT02842853|12029646|FG001|Overall Study|Withdrawal by Subject|13
7618694|NCT02842853|12029647|FG002|Overall Study|Withdrawal by Subject|9
7618695|NCT02842853|12029648|FG003|Overall Study|Withdrawal by Subject|8
7618696|NCT02842853|12029645|FG000|Overall Study|Lost to Follow-up|9
7618697|NCT02842853|12029646|FG001|Overall Study|Lost to Follow-up|13
7618698|NCT02842853|12029647|FG002|Overall Study|Lost to Follow-up|10
7618699|NCT02842853|12029648|FG003|Overall Study|Lost to Follow-up|11
7618700|NCT02752906|12029662|FG000|Overall Study|Protocol Violation|2
7618701|NCT02752906|12029663|FG001|Overall Study|Protocol Violation|1
7618702|NCT02752906|12029662|FG000|Overall Study|Withdrawal by Subject|2
7618703|NCT02752906|12029663|FG001|Overall Study|Withdrawal by Subject|2
7618704|NCT02752906|12029662|FG000|Overall Study|Lost to Follow-up|3
7618705|NCT02752906|12029663|FG001|Overall Study|Lost to Follow-up|2
7618706|NCT02693691|12029669|FG000|Primary Endpoint Analysis (First 12M)|Death|30
7618707|NCT02693691|12029669|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12
7618708|NCT02693691|12029669|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7
7618709|NCT02693691|12029669|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1
7618710|NCT02693691|12029669|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12
7618711|NCT02693691|12029669|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11
7618712|NCT02693691|12029669|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1
7782900|NCT00967616|12232380|FG001|Overall Study|Withdrawal by Subject|4
7782901|NCT00967616|12232379|FG000|Overall Study|Progressive Disease|31
7618713|NCT04889625|12029673|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2
7618714|NCT04889625|12029674|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1
7618715|NCT04889625|12029673|FG000|Period 1|Subject out of window|0
7618716|NCT04889625|12029674|FG001|Period 1|Subject out of window|1
7618717|NCT04889625|12029673|FG000|Period 1|Wrong add power dispensed|0
7618718|NCT04889625|12029674|FG001|Period 1|Wrong add power dispensed|1
7618719|NCT04889625|12029673|FG000|Period 1|Discontinued due to fitting guide error|1
7618720|NCT04889625|12029674|FG001|Period 1|Discontinued due to fitting guide error|1
7618721|NCT04889625|12029673|FG000|Period 2|Test article no longer available|1
7618722|NCT04889625|12029674|FG001|Period 2|Test article no longer available|0
7618723|NCT04889625|12029673|FG000|Period 2|Incorrect lens dispensed|1
7618724|NCT04889625|12029674|FG001|Period 2|Incorrect lens dispensed|0
7618725|NCT04889625|12029673|FG000|Period 2|Wrong add power dispensed|0
7618726|NCT04889625|12029674|FG001|Period 2|Wrong add power dispensed|1
7618727|NCT04602000|12029715|FG000|Overall Study|Withdrawal by Subject|3
7618728|NCT04602000|12029716|FG001|Overall Study|Withdrawal by Subject|6
7618729|NCT04602000|12029717|FG002|Overall Study|Withdrawal by Subject|3
7618730|NCT04602000|12029718|FG003|Overall Study|Withdrawal by Subject|27
7618731|NCT04602000|12029719|FG004|Overall Study|Withdrawal by Subject|39
7618732|NCT04602000|12029715|FG000|Overall Study|Physician Decision|1
7618733|NCT04602000|12029716|FG001|Overall Study|Physician Decision|0
7618734|NCT04602000|12029717|FG002|Overall Study|Physician Decision|0
7618735|NCT04602000|12029718|FG003|Overall Study|Physician Decision|2
7618736|NCT04602000|12029719|FG004|Overall Study|Physician Decision|2
7618737|NCT04602000|12029715|FG000|Overall Study|Death|0
7618738|NCT04602000|12029716|FG001|Overall Study|Death|1
7618739|NCT04602000|12029717|FG002|Overall Study|Death|0
7618740|NCT04602000|12029718|FG003|Overall Study|Death|1
7618741|NCT04602000|12029719|FG004|Overall Study|Death|2
7782902|NCT00967616|12232380|FG001|Overall Study|Progressive Disease|18
7782903|NCT00967616|12232379|FG000|Overall Study|Other|8
7782904|NCT00967616|12232380|FG001|Overall Study|Other|8
7782905|NCT00967616|12232379|FG000|Overall Study|Protocol Violation|1
7782906|NCT00967616|12232380|FG001|Overall Study|Protocol Violation|0
7782907|NCT00967668|12232389|FG000|Overall Study|Withdrawal by Subject|13
7782908|NCT00967668|12232390|FG001|Overall Study|Withdrawal by Subject|8
7782909|NCT00967668|12232391|FG002|Overall Study|Withdrawal by Subject|8
7782910|NCT00967668|12232389|FG000|Overall Study|Death|0
7782911|NCT00967668|12232390|FG001|Overall Study|Death|2
7782912|NCT00967668|12232391|FG002|Overall Study|Death|4
7782913|NCT00967668|12232389|FG000|Overall Study|Removed due to behavior|1
7782914|NCT00967668|12232390|FG001|Overall Study|Removed due to behavior|1
7782915|NCT00967668|12232391|FG002|Overall Study|Removed due to behavior|2
7782916|NCT00967668|12232389|FG000|Overall Study|Refused Year 2|11
7782917|NCT00967668|12232390|FG001|Overall Study|Refused Year 2|6
7782918|NCT00967668|12232391|FG002|Overall Study|Refused Year 2|4
7782919|NCT00967668|12232389|FG000|Overall Study|Lost to follow-up at 12-mo|27
7782920|NCT00967668|12232390|FG001|Overall Study|Lost to follow-up at 12-mo|29
7782921|NCT00967668|12232391|FG002|Overall Study|Lost to follow-up at 12-mo|26
7782922|NCT00967668|12232389|FG000|Overall Study|Lost to Follow-up|15
7782923|NCT00967668|12232390|FG001|Overall Study|Lost to Follow-up|9
7782924|NCT00967668|12232391|FG002|Overall Study|Lost to Follow-up|16
7782925|NCT00967668|12232389|FG000|Overall Study|Refused 12-mo assessment|3
7782926|NCT00967668|12232390|FG001|Overall Study|Refused 12-mo assessment|1
7782927|NCT00967668|12232391|FG002|Overall Study|Refused 12-mo assessment|9
7782928|NCT00967668|12232389|FG000|Overall Study|Pregnancy|1
7782929|NCT00967668|12232390|FG001|Overall Study|Pregnancy|0
7782930|NCT00967668|12232391|FG002|Overall Study|Pregnancy|0
7782931|NCT00967694|12232402|FG000|Overall Study|Withdrawal by Subject|6
7782932|NCT00967798|12232408|FG000|Overall Study|Withdrawal by Subject|5
7782933|NCT00967798|12232409|FG001|Overall Study|Withdrawal by Subject|2
7782934|NCT00967798|12232408|FG000|Overall Study|Lost to Follow-up|4
7782935|NCT00967798|12232409|FG001|Overall Study|Lost to Follow-up|1
7782936|NCT00968253|12232451|FG000|Overall Study|Death|0
7782937|NCT00968253|12232452|FG001|Overall Study|Death|0
7782938|NCT00968253|12232453|FG002|Overall Study|Death|2
7782939|NCT00968253|12232451|FG000|Overall Study|Withdrawal by Subject|0
7782940|NCT00968253|12232452|FG001|Overall Study|Withdrawal by Subject|0
7782941|NCT00968253|12232453|FG002|Overall Study|Withdrawal by Subject|1
7782942|NCT00968253|12232451|FG000|Overall Study|Disease Progression|0
7782943|NCT00968253|12232452|FG001|Overall Study|Disease Progression|3
7618742|NCT04602000|12029715|FG000|Overall Study|Lost to Follow-up|0
7618743|NCT04602000|12029716|FG001|Overall Study|Lost to Follow-up|0
7618744|NCT04602000|12029717|FG002|Overall Study|Lost to Follow-up|0
7618745|NCT04602000|12029718|FG003|Overall Study|Lost to Follow-up|3
7618746|NCT04602000|12029719|FG004|Overall Study|Lost to Follow-up|4
7782944|NCT00968253|12232453|FG002|Overall Study|Disease Progression|3
7782945|NCT00968253|12232451|FG000|Overall Study|Adverse Event|0
7782946|NCT00968253|12232452|FG001|Overall Study|Adverse Event|0
7782947|NCT00968253|12232453|FG002|Overall Study|Adverse Event|1
7782948|NCT00968526|12232473|FG000|Overall Study|Adverse Event|2
7782949|NCT00968526|12232474|FG001|Overall Study|Adverse Event|0
7782950|NCT00968526|12232473|FG000|Overall Study|Migrated/moved from study area|1
7782951|NCT00968526|12232474|FG001|Overall Study|Migrated/moved from study area|0
7782952|NCT00968539|12232491|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1
7618747|NCT04602000|12029715|FG000|Overall Study|Other|4
7618748|NCT04602000|12029716|FG001|Overall Study|Other|1
7618749|NCT04602000|12029717|FG002|Overall Study|Other|2
7618750|NCT04602000|12029718|FG003|Overall Study|Other|5
7618751|NCT04602000|12029719|FG004|Overall Study|Other|4
7618752|NCT04602000|12029715|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0
7618753|NCT04602000|12029716|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0
7618754|NCT04602000|12029717|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1
7618755|NCT04602000|12029718|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0
7618756|NCT04602000|12029719|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0
7618757|NCT04540887|12029733|FG000|Overall Study|Withdrawal by Subject|2
7618758|NCT04428333|12029740|FG000|Overall Study|Physician Decision|2
7618759|NCT04428333|12029741|FG001|Overall Study|Physician Decision|0
7618760|NCT04428333|12029740|FG000|Overall Study|Withdrawal by Subject|0
7618761|NCT04428333|12029741|FG001|Overall Study|Withdrawal by Subject|1
7618762|NCT04428333|12029740|FG000|Overall Study|In Follow-Up|5
7618763|NCT04428333|12029741|FG001|Overall Study|In Follow-Up|10
7618764|NCT04428333|12029740|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47
7618765|NCT04428333|12029741|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47
7618766|NCT04167085|12029749|FG000|Baseline|Withdrawal by Subject|2
7618767|NCT04167085|12029750|FG001|Baseline|Withdrawal by Subject|1
7618768|NCT04167085|12029749|FG000|Washout (1 Month)|Withdrawal by Subject|1
7618769|NCT04167085|12029750|FG001|Washout (1 Month)|Withdrawal by Subject|0
7618770|NCT04146467|12029758|FG000|Overall Study|Adverse Event|0
7618771|NCT04146467|12029759|FG001|Overall Study|Adverse Event|1
7618772|NCT04146467|12029758|FG000|Overall Study|Lost to Follow-up|0
7618773|NCT04146467|12029759|FG001|Overall Study|Lost to Follow-up|2
7618774|NCT03912337|12029774|FG000|Overall Study|Withdrawal of Consent From Study|1
7618775|NCT03912337|12029775|FG001|Overall Study|Withdrawal of Consent From Study|0
7618776|NCT03912337|12029774|FG000|Overall Study|Lost to Follow-up|1
7618777|NCT03912337|12029775|FG001|Overall Study|Lost to Follow-up|1
7618778|NCT03292588|12029789|FG000|Overall Study|Death|1
7618779|NCT03292588|12029790|FG001|Overall Study|Death|0
7618780|NCT03292588|12029789|FG000|Overall Study|Lost to Follow-up|12
7618781|NCT03292588|12029790|FG001|Overall Study|Lost to Follow-up|16
7618782|NCT03292588|12029789|FG000|Overall Study|Physician Decision|0
7618783|NCT03292588|12029790|FG001|Overall Study|Physician Decision|1
7618784|NCT03292588|12029789|FG000|Overall Study|Withdrawal by Subject|4
7618785|NCT03292588|12029790|FG001|Overall Study|Withdrawal by Subject|4
7618786|NCT03292588|12029789|FG000|Overall Study|Move out of town|1
7618787|NCT03292588|12029790|FG001|Overall Study|Move out of town|0
7618788|NCT03292588|12029789|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2
7618789|NCT03292588|12029790|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1
7618790|NCT03131960|12029804|FG000|Overall Study|Adverse Event|0
7618791|NCT03131960|12029805|FG001|Overall Study|Adverse Event|1
7782953|NCT00968539|12232492|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0
7782954|NCT00968617|12232499|FG000|Overall Study|Study terminated by sponsor|6
7782955|NCT00968669|12232507|FG000|Overall Study|Lost to Follow-up|5
7782956|NCT00968669|12232508|FG001|Overall Study|Lost to Follow-up|2
7782957|NCT00968669|12232509|FG002|Overall Study|Lost to Follow-up|1
7782958|NCT00968669|12232510|FG003|Overall Study|Lost to Follow-up|4
7782959|NCT00968669|12232507|FG000|Overall Study|Withdrawal by Subject|9
7782960|NCT00968669|12232508|FG001|Overall Study|Withdrawal by Subject|7
7782961|NCT00968669|12232509|FG002|Overall Study|Withdrawal by Subject|5
7782962|NCT00968669|12232510|FG003|Overall Study|Withdrawal by Subject|3
7618802|NCT03090737|12029820|FG000|Overall Study|Participant withdrew consent|4
7618803|NCT03090737|12029820|FG000|Overall Study|Death|27
7618804|NCT02906930|12029828|FG000|Overall Study|Withdrawal by Subject|0
7618805|NCT02906930|12029829|FG001|Overall Study|Withdrawal by Subject|5
7618806|NCT02906930|12029830|FG002|Overall Study|Withdrawal by Subject|5
7618807|NCT02906930|12029831|FG003|Overall Study|Withdrawal by Subject|4
7618808|NCT02906930|12029828|FG000|Overall Study|Lost to Follow-up|5
7618809|NCT02906930|12029829|FG001|Overall Study|Lost to Follow-up|7
7618810|NCT02906930|12029830|FG002|Overall Study|Lost to Follow-up|5
7618811|NCT02906930|12029831|FG003|Overall Study|Lost to Follow-up|2
7618812|NCT02906930|12029828|FG000|Overall Study|Death|0
7618813|NCT02906930|12029829|FG001|Overall Study|Death|0
7618814|NCT02906930|12029830|FG002|Overall Study|Death|1
7618815|NCT02906930|12029831|FG003|Overall Study|Death|0
7618816|NCT02906930|12029828|FG000|Overall Study|Other|1
7618817|NCT02906930|12029829|FG001|Overall Study|Other|2
7618818|NCT02906930|12029830|FG002|Overall Study|Other|1
7618819|NCT02906930|12029831|FG003|Overall Study|Other|2
7782963|NCT00968669|12232507|FG000|Overall Study|Pregnancy|0
7782964|NCT00968669|12232508|FG001|Overall Study|Pregnancy|0
7782965|NCT00968669|12232509|FG002|Overall Study|Pregnancy|2
7782966|NCT00968669|12232510|FG003|Overall Study|Pregnancy|0
7782967|NCT00968669|12232507|FG000|Overall Study|AE|1
7782968|NCT00968669|12232508|FG001|Overall Study|AE|0
7782969|NCT00968669|12232509|FG002|Overall Study|AE|0
7782970|NCT00968669|12232510|FG003|Overall Study|AE|0
7782971|NCT00968669|12232507|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
7782972|NCT00968669|12232508|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
7782973|NCT00968669|12232509|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
7782974|NCT00968669|12232510|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
7782975|NCT00968669|12232507|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
7782976|NCT00968669|12232508|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
7782977|NCT00968669|12232509|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
7782978|NCT00968669|12232510|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
7782979|NCT00968669|12232507|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
7782980|NCT00968669|12232508|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
7782981|NCT00968669|12232509|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
7782982|NCT00968669|12232510|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
7782983|NCT00968669|12232507|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
7782984|NCT00968669|12232508|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
7782985|NCT00968669|12232509|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
7782986|NCT00968669|12232510|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
7782987|NCT00968669|12232507|FG000|Overall Study|EARLY WITHDRAWAL|0
7782988|NCT00968669|12232508|FG001|Overall Study|EARLY WITHDRAWAL|1
7782989|NCT00968669|12232509|FG002|Overall Study|EARLY WITHDRAWAL|0
7782990|NCT00968669|12232510|FG003|Overall Study|EARLY WITHDRAWAL|0
7782991|NCT00968669|12232507|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0
7782992|NCT00968669|12232508|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0
7782993|NCT00968669|12232509|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1
7782994|NCT00968669|12232510|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0
7782995|NCT00968669|12232507|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1
7782996|NCT00968669|12232508|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0
7782997|NCT00968669|12232509|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0
7782998|NCT00968669|12232510|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0
7782999|NCT00968669|12232507|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
7783000|NCT00968669|12232508|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
7783001|NCT00968669|12232509|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
7783002|NCT00968669|12232510|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
7783003|NCT00968669|12232507|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
7783004|NCT00968669|12232508|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
7783005|NCT00968669|12232509|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
7783006|NCT00968669|12232510|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
7783007|NCT00968669|12232507|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
7783008|NCT00968669|12232508|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
7783009|NCT00968669|12232509|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
7783010|NCT00968669|12232510|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
7783011|NCT00968669|12232507|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0
7783012|NCT00968669|12232508|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1
7783013|NCT00968669|12232509|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0
7783014|NCT00968669|12232510|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0
7783015|NCT00968669|12232507|FG000|Overall Study|SPONSOR DECISION|0
7783016|NCT00968669|12232508|FG001|Overall Study|SPONSOR DECISION|1
7783017|NCT00968669|12232509|FG002|Overall Study|SPONSOR DECISION|0
7783018|NCT00968669|12232510|FG003|Overall Study|SPONSOR DECISION|0
7783019|NCT00968669|12232507|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
7783020|NCT00968669|12232508|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
7783021|NCT00968669|12232509|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
7783022|NCT00968669|12232510|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
7783023|NCT00968669|12232507|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
7783024|NCT00968669|12232508|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
7783025|NCT00968669|12232509|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
7783026|NCT00968669|12232510|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
7783027|NCT00968669|12232507|FG000|Overall Study|SUBJECT INCARCERATED|0
7783028|NCT00968669|12232508|FG001|Overall Study|SUBJECT INCARCERATED|1
7783029|NCT00968669|12232509|FG002|Overall Study|SUBJECT INCARCERATED|0
7783030|NCT00968669|12232510|FG003|Overall Study|SUBJECT INCARCERATED|0
7783031|NCT00968669|12232507|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
7783032|NCT00968669|12232508|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
7783033|NCT00968669|12232509|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
7783034|NCT00968669|12232510|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
7783035|NCT00968669|12232507|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
7783036|NCT00968669|12232508|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
7783037|NCT00968669|12232509|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
7783038|NCT00968669|12232510|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
7783039|NCT00968708|12232522|FG000|Overall Study|Adverse Event|169
7783040|NCT00968708|12232523|FG001|Overall Study|Adverse Event|150
7783041|NCT00968708|12232522|FG000|Overall Study|Major Protocol Deviation|0
7783042|NCT00968708|12232523|FG001|Overall Study|Major Protocol Deviation|1
7783043|NCT00968708|12232522|FG000|Overall Study|Lost to Follow-up|19
7783044|NCT00968708|12232523|FG001|Overall Study|Lost to Follow-up|11
7783045|NCT00968708|12232522|FG000|Overall Study|Voluntary Withdrawal|104
7783046|NCT00968708|12232523|FG001|Overall Study|Voluntary Withdrawal|101
7783047|NCT00968708|12232522|FG000|Overall Study|Investigator Discretion|0
7783048|NCT00968708|12232523|FG001|Overall Study|Investigator Discretion|1
7783049|NCT00968708|12232522|FG000|Overall Study|Other|26
7783050|NCT00968708|12232523|FG001|Overall Study|Other|34
7783051|NCT00968799|12232529|FG000|Overall Study|Advanced disease, HIPEC not applicable|2
7783052|NCT00968812|12232536|FG000|Overall Study|Adverse Event|30
7783053|NCT00968812|12232537|FG001|Overall Study|Adverse Event|46
7783054|NCT00968812|12232538|FG002|Overall Study|Adverse Event|33
7783055|NCT00968812|12232536|FG000|Overall Study|Death|2
7783056|NCT00968812|12232537|FG001|Overall Study|Death|2
7783057|NCT00968812|12232538|FG002|Overall Study|Death|1
7783058|NCT00968812|12232536|FG000|Overall Study|Lack of Efficacy|9
7783059|NCT00968812|12232537|FG001|Overall Study|Lack of Efficacy|7
7783060|NCT00968812|12232538|FG002|Overall Study|Lack of Efficacy|16
7783061|NCT00968812|12232536|FG000|Overall Study|Lost to Follow-up|17
7783062|NCT00968812|12232537|FG001|Overall Study|Lost to Follow-up|12
7783063|NCT00968812|12232538|FG002|Overall Study|Lost to Follow-up|11
7783064|NCT00968812|12232536|FG000|Overall Study|Physician Decision|8
7783065|NCT00968812|12232537|FG001|Overall Study|Physician Decision|5
7783066|NCT00968812|12232538|FG002|Overall Study|Physician Decision|9
7783067|NCT00968812|12232536|FG000|Overall Study|Protocol Violation|7
7783068|NCT00968812|12232537|FG001|Overall Study|Protocol Violation|4
7783069|NCT00968812|12232538|FG002|Overall Study|Protocol Violation|3
7783070|NCT00968812|12232536|FG000|Overall Study|Withdrawal by Subject|17
7783071|NCT00968812|12232537|FG001|Overall Study|Withdrawal by Subject|23
7783072|NCT00968812|12232538|FG002|Overall Study|Withdrawal by Subject|25
7783073|NCT00968812|12232536|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9
7783074|NCT00968812|12232537|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13
7783075|NCT00968812|12232538|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7
7783076|NCT00968812|12232536|FG000|Overall Study|Noncompliance with study drug|4
7783077|NCT00968812|12232537|FG001|Overall Study|Noncompliance with study drug|1
7783078|NCT00968812|12232538|FG002|Overall Study|Noncompliance with study drug|6
7783079|NCT00968812|12232536|FG000|Overall Study|Unable to take rescue therapy|12
7783080|NCT00968812|12232537|FG001|Overall Study|Unable to take rescue therapy|12
7783081|NCT00968812|12232538|FG002|Overall Study|Unable to take rescue therapy|17
7783082|NCT00968812|12232536|FG000|Overall Study|Other|25
7783083|NCT00968812|12232537|FG001|Overall Study|Other|37
7783084|NCT00968812|12232538|FG002|Overall Study|Other|40
7783085|NCT00968968|12232569|FG000|Overall Study|Study closed/terminated|10
7783086|NCT00968968|12232570|FG001|Overall Study|Study closed/terminated|10
7783087|NCT00968968|12232569|FG000|Overall Study|Protocol defined stopping criteria|3
7783088|NCT00968968|12232570|FG001|Overall Study|Protocol defined stopping criteria|1
7783089|NCT00968968|12232569|FG000|Overall Study|Withdrawal by Subject|2
7783090|NCT00968968|12232570|FG001|Overall Study|Withdrawal by Subject|0
7783091|NCT00968968|12232569|FG000|Overall Study|Physician Decision|1
7783092|NCT00968968|12232570|FG001|Overall Study|Physician Decision|2
7783093|NCT00968968|12232569|FG000|Overall Study|Lost to Follow-up|0
7783094|NCT00968968|12232570|FG001|Overall Study|Lost to Follow-up|1
7783095|NCT00968981|12232580|FG000|Overall Study|Adverse Event|2
7783096|NCT00968981|12232581|FG001|Overall Study|Adverse Event|0
7783097|NCT00968981|12232582|FG002|Overall Study|Adverse Event|0
7783098|NCT00968981|12232580|FG000|Overall Study|Disease Progression|14
7783099|NCT00968981|12232581|FG001|Overall Study|Disease Progression|16
7783100|NCT00968981|12232582|FG002|Overall Study|Disease Progression|13
7783101|NCT00968981|12232580|FG000|Overall Study|Lost to Follow-up|0
7783102|NCT00968981|12232581|FG001|Overall Study|Lost to Follow-up|0
7783103|NCT00968981|12232582|FG002|Overall Study|Lost to Follow-up|1
7783104|NCT00968981|12232580|FG000|Overall Study|Physician Decision|5
7783105|NCT00968981|12232581|FG001|Overall Study|Physician Decision|3
7783106|NCT00968981|12232582|FG002|Overall Study|Physician Decision|5
7783107|NCT00968981|12232580|FG000|Overall Study|Withdrawal by Subject|1
7783108|NCT00968981|12232581|FG001|Overall Study|Withdrawal by Subject|3
7783109|NCT00968981|12232582|FG002|Overall Study|Withdrawal by Subject|3
7783110|NCT00969124|12232591|FG000|Overall Study|Protocol Violation|2
7783111|NCT00969124|12232591|FG000|Overall Study|Inadequate bowel preparation|15
7783112|NCT00969124|12232591|FG000|Overall Study|Inability to reach cecum|9
7783113|NCT00969124|12232591|FG000|Overall Study|Previously unrecognized disease|3
7783114|NCT00969124|12232591|FG000|Overall Study|Technical error|1
7783115|NCT00969150|12232598|FG000|Overall Study|Adverse Event|4
7783116|NCT00969150|12232599|FG001|Overall Study|Adverse Event|14
7783117|NCT00969150|12232598|FG000|Overall Study|Lack of Efficacy|1
7783118|NCT00969150|12232599|FG001|Overall Study|Lack of Efficacy|1
7783119|NCT00969150|12232598|FG000|Overall Study|Protocol Violation|9
7783120|NCT00969150|12232599|FG001|Overall Study|Protocol Violation|12
7783121|NCT00969150|12232598|FG000|Overall Study|Withdrawal by Subject|13
7783122|NCT00969150|12232599|FG001|Overall Study|Withdrawal by Subject|9
7783123|NCT00969150|12232598|FG000|Overall Study|Lost to Follow-up|5
7783124|NCT00969150|12232599|FG001|Overall Study|Lost to Follow-up|4
7783125|NCT00969150|12232598|FG000|Overall Study|Other reasons|1
7783126|NCT00969150|12232599|FG001|Overall Study|Other reasons|0
7783127|NCT00969228|12232607|FG000|Overall Study|Adverse Event|1
7783128|NCT00969228|12232608|FG001|Overall Study|Adverse Event|0
7783129|NCT00969228|12232607|FG000|Overall Study|Withdrawal by Subject|4
7783130|NCT00969228|12232608|FG001|Overall Study|Withdrawal by Subject|0
7800274|NCT01092663|12257505|FG001|Overall Study|Glucose >300mg/dL|0
7783131|NCT00969228|12232607|FG000|Overall Study|Porcine circovirus detection in vaccine|38
7783132|NCT00969228|12232608|FG001|Overall Study|Porcine circovirus detection in vaccine|14
7783133|NCT00969280|12232616|FG000|Overall Study|Protocol Violation|2
7783134|NCT00969280|12232617|FG001|Overall Study|Protocol Violation|1
7783135|NCT00969280|12232616|FG000|Overall Study|Withdrawal by Subject|0
7783136|NCT00969280|12232617|FG001|Overall Study|Withdrawal by Subject|1
7783137|NCT00969280|12232616|FG000|Overall Study|infection of influenza A(H1N1)|0
7783138|NCT00969280|12232617|FG001|Overall Study|infection of influenza A(H1N1)|1
7783139|NCT00969332|12232623|FG000|Overall Study|Physician Decision|8
7783140|NCT00969332|12232623|FG000|Overall Study|Withdrawal by Subject|3
7783141|NCT00969436|12232631|FG000|Overall Study|Protocol Violation|1
7783142|NCT00969436|12232632|FG001|Overall Study|Protocol Violation|3
7783143|NCT00969436|12232633|FG002|Overall Study|Protocol Violation|0
7783144|NCT00969436|12232631|FG000|Overall Study|Migrated/moved from study area|12
7783145|NCT00969436|12232632|FG001|Overall Study|Migrated/moved from study area|10
7783146|NCT00969436|12232633|FG002|Overall Study|Migrated/moved from study area|2
7783147|NCT00969436|12232631|FG000|Overall Study|Father - serious health problem|0
7783148|NCT00969436|12232632|FG001|Overall Study|Father - serious health problem|0
7783149|NCT00969436|12232633|FG002|Overall Study|Father - serious health problem|1
7783150|NCT00969436|12232631|FG000|Overall Study|Parents personal problem|0
7783151|NCT00969436|12232632|FG001|Overall Study|Parents personal problem|0
7783152|NCT00969436|12232633|FG002|Overall Study|Parents personal problem|1
7783153|NCT00969436|12232631|FG000|Overall Study|Subject eliminated (other vaccine)|1
7783154|NCT00969436|12232632|FG001|Overall Study|Subject eliminated (other vaccine)|0
7783155|NCT00969436|12232633|FG002|Overall Study|Subject eliminated (other vaccine)|0
7783156|NCT00969436|12232631|FG000|Overall Study|Withdrawal by Subject|3
7783157|NCT00969436|12232632|FG001|Overall Study|Withdrawal by Subject|0
7783158|NCT00969436|12232633|FG002|Overall Study|Withdrawal by Subject|2
7783159|NCT00969436|12232631|FG000|Overall Study|Lost to Follow-up|8
7783160|NCT00969436|12232632|FG001|Overall Study|Lost to Follow-up|8
7783161|NCT00969436|12232633|FG002|Overall Study|Lost to Follow-up|5
7783162|NCT00969540|12232647|FG000|Overall Study|Lost to Follow-up|1
7783163|NCT00969540|12232648|FG001|Overall Study|Lost to Follow-up|1
7783164|NCT00969553|12232675|FG000|Overall Study|Progressive disease (PD)|2
7783165|NCT00969553|12232676|FG001|Overall Study|Progressive disease (PD)|2
7783166|NCT00969553|12232677|FG002|Overall Study|Progressive disease (PD)|6
7783167|NCT00969553|12232678|FG003|Overall Study|Progressive disease (PD)|9
7783168|NCT00969553|12232679|FG004|Overall Study|Progressive disease (PD)|2
7783169|NCT00969553|12232680|FG005|Overall Study|Progressive disease (PD)|4
7783170|NCT00969553|12232681|FG006|Overall Study|Progressive disease (PD)|2
7783171|NCT00969553|12232682|FG007|Overall Study|Progressive disease (PD)|12
7783172|NCT00969553|12232683|FG008|Overall Study|Progressive disease (PD)|3
7783173|NCT00969553|12232675|FG000|Overall Study|Dose limiting Toxicity (DLT)|0
7783174|NCT00969553|12232676|FG001|Overall Study|Dose limiting Toxicity (DLT)|0
7783175|NCT00969553|12232677|FG002|Overall Study|Dose limiting Toxicity (DLT)|0
7783176|NCT00969553|12232678|FG003|Overall Study|Dose limiting Toxicity (DLT)|0
7783177|NCT00969553|12232679|FG004|Overall Study|Dose limiting Toxicity (DLT)|1
7783178|NCT00969553|12232680|FG005|Overall Study|Dose limiting Toxicity (DLT)|0
7783179|NCT00969553|12232681|FG006|Overall Study|Dose limiting Toxicity (DLT)|0
7783180|NCT00969553|12232682|FG007|Overall Study|Dose limiting Toxicity (DLT)|0
7783181|NCT00969553|12232683|FG008|Overall Study|Dose limiting Toxicity (DLT)|0
7783182|NCT00969553|12232675|FG000|Overall Study|Other Adverse Event|0
7783183|NCT00969553|12232676|FG001|Overall Study|Other Adverse Event|0
7783184|NCT00969553|12232677|FG002|Overall Study|Other Adverse Event|0
7783185|NCT00969553|12232678|FG003|Overall Study|Other Adverse Event|1
7783186|NCT00969553|12232679|FG004|Overall Study|Other Adverse Event|0
7783187|NCT00969553|12232680|FG005|Overall Study|Other Adverse Event|0
7783188|NCT00969553|12232681|FG006|Overall Study|Other Adverse Event|1
7783189|NCT00969553|12232682|FG007|Overall Study|Other Adverse Event|0
7783190|NCT00969553|12232683|FG008|Overall Study|Other Adverse Event|0
7783191|NCT00969553|12232675|FG000|Overall Study|Refused cont. medication|1
7783192|NCT00969553|12232676|FG001|Overall Study|Refused cont. medication|1
7783193|NCT00969553|12232677|FG002|Overall Study|Refused cont. medication|0
7783194|NCT00969553|12232678|FG003|Overall Study|Refused cont. medication|2
7783195|NCT00969553|12232679|FG004|Overall Study|Refused cont. medication|0
7783196|NCT00969553|12232680|FG005|Overall Study|Refused cont. medication|0
7783197|NCT00969553|12232681|FG006|Overall Study|Refused cont. medication|0
7783198|NCT00969553|12232682|FG007|Overall Study|Refused cont. medication|1
7783199|NCT00969553|12232683|FG008|Overall Study|Refused cont. medication|0
7783200|NCT00969553|12232675|FG000|Overall Study|Not specified above|0
7783201|NCT00969553|12232676|FG001|Overall Study|Not specified above|0
7783202|NCT00969553|12232677|FG002|Overall Study|Not specified above|0
7783203|NCT00969553|12232678|FG003|Overall Study|Not specified above|4
7783204|NCT00969553|12232679|FG004|Overall Study|Not specified above|0
7783205|NCT00969553|12232680|FG005|Overall Study|Not specified above|0
7783206|NCT00969553|12232681|FG006|Overall Study|Not specified above|1
7783207|NCT00969553|12232682|FG007|Overall Study|Not specified above|1
7783208|NCT00969553|12232683|FG008|Overall Study|Not specified above|0
7783209|NCT00969618|12232711|FG000|Overall Study|Adverse Event|29
7783210|NCT00969618|12232711|FG000|Overall Study|Entry Criteria Not Met|3
7783211|NCT00969618|12232711|FG000|Overall Study|Lack of Efficacy|2
7783212|NCT00969618|12232711|FG000|Overall Study|Lost to Follow-up|7
7783213|NCT00969618|12232711|FG000|Overall Study|Physician Decision|1
7783214|NCT00969618|12232711|FG000|Overall Study|Protocol Violation|9
7783215|NCT00969618|12232711|FG000|Overall Study|Withdrawal by Subject|27
7783216|NCT00969709|12232719|FG000|Overall Study|Adverse Event|3
7783217|NCT00969709|12232720|FG001|Overall Study|Adverse Event|13
7783218|NCT00969709|12232721|FG002|Overall Study|Adverse Event|26
7783219|NCT00969709|12232722|FG003|Overall Study|Adverse Event|12
7783220|NCT00969709|12232719|FG000|Overall Study|Lack of Efficacy|7
7783221|NCT00969709|12232720|FG001|Overall Study|Lack of Efficacy|4
7783222|NCT00969709|12232721|FG002|Overall Study|Lack of Efficacy|1
7783223|NCT00969709|12232722|FG003|Overall Study|Lack of Efficacy|3
7783224|NCT00969709|12232719|FG000|Overall Study|Protocol Violation|9
7783225|NCT00969709|12232720|FG001|Overall Study|Protocol Violation|5
7783226|NCT00969709|12232721|FG002|Overall Study|Protocol Violation|9
7783227|NCT00969709|12232722|FG003|Overall Study|Protocol Violation|10
7783228|NCT00969709|12232719|FG000|Overall Study|Withdrawal by Subject|9
7783229|NCT00969709|12232720|FG001|Overall Study|Withdrawal by Subject|12
7783230|NCT00969709|12232721|FG002|Overall Study|Withdrawal by Subject|11
7783231|NCT00969709|12232722|FG003|Overall Study|Withdrawal by Subject|23
7783232|NCT00969709|12232719|FG000|Overall Study|Lost to Follow-up|10
7783233|NCT00969709|12232720|FG001|Overall Study|Lost to Follow-up|14
7783234|NCT00969709|12232721|FG002|Overall Study|Lost to Follow-up|8
7783235|NCT00969709|12232722|FG003|Overall Study|Lost to Follow-up|15
7783236|NCT00969709|12232719|FG000|Overall Study|Other reasons|0
7783237|NCT00969709|12232720|FG001|Overall Study|Other reasons|0
7783238|NCT00969709|12232721|FG002|Overall Study|Other reasons|3
7783239|NCT00969709|12232722|FG003|Overall Study|Other reasons|0
7783240|NCT00969761|12232748|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
7783241|NCT00969761|12232749|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7783242|NCT00969761|12232750|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7783243|NCT00969761|12232751|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
7783244|NCT00969761|12232752|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7783245|NCT00969761|12232753|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7783246|NCT00969761|12232754|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7783247|NCT00969761|12232755|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7783248|NCT00969761|12232756|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
7783249|NCT00969761|12232757|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
7783250|NCT00969761|12232758|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7783251|NCT00969761|12232759|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7783252|NCT00969761|12232748|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7783253|NCT00969761|12232749|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7783254|NCT00969761|12232750|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1
7783255|NCT00969761|12232751|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7783256|NCT00969761|12232752|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7783257|NCT00969761|12232753|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7783258|NCT00969761|12232754|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7783259|NCT00969761|12232755|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7783260|NCT00969761|12232756|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7783261|NCT00969761|12232757|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7783262|NCT00969761|12232758|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7783263|NCT00969761|12232759|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7783264|NCT00969761|12232748|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7783265|NCT00969761|12232749|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7783266|NCT00969761|12232750|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1
7783267|NCT00969761|12232751|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7783268|NCT00969761|12232752|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7783269|NCT00969761|12232753|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7783270|NCT00969761|12232754|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7783271|NCT00969761|12232755|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7783272|NCT00969761|12232756|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7783273|NCT00969761|12232757|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7783274|NCT00969761|12232758|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7783275|NCT00969761|12232759|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7783276|NCT00969761|12232748|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7783277|NCT00969761|12232749|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7783278|NCT00969761|12232750|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7783279|NCT00969761|12232751|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7783280|NCT00969761|12232752|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7783281|NCT00969761|12232753|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7783282|NCT00969761|12232754|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7783283|NCT00969761|12232755|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7783284|NCT00969761|12232756|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1
7783285|NCT00969761|12232757|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7783286|NCT00969761|12232758|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7783287|NCT00969761|12232759|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7783288|NCT00969761|12232748|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
7783289|NCT00969761|12232749|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7783290|NCT00969761|12232750|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10
7783291|NCT00969761|12232751|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7783292|NCT00969761|12232752|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
7783293|NCT00969761|12232753|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7783294|NCT00969761|12232754|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7783295|NCT00969761|12232755|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6
7783296|NCT00969761|12232756|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9
7783297|NCT00969761|12232757|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
7783298|NCT00969761|12232758|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7783299|NCT00969761|12232759|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7783300|NCT00969761|12232748|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7783301|NCT00969761|12232749|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7783302|NCT00969761|12232750|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7783303|NCT00969761|12232751|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
7783304|NCT00969761|12232752|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1
7783305|NCT00969761|12232753|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7783306|NCT00969761|12232754|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7783307|NCT00969761|12232755|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7783308|NCT00969761|12232756|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
7783309|NCT00969761|12232757|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7783310|NCT00969761|12232758|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7783311|NCT00969761|12232759|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7783312|NCT00970268|12232824|FG000|Overall Study|Withdrawal by Subject|12
7783313|NCT00970268|12232825|FG001|Overall Study|Withdrawal by Subject|19
7783314|NCT00970268|12232824|FG000|Overall Study|Adverse Event|15
7783315|NCT00970268|12232825|FG001|Overall Study|Adverse Event|12
7783316|NCT00970268|12232824|FG000|Overall Study|Lack of Efficacy|3
7783317|NCT00970268|12232825|FG001|Overall Study|Lack of Efficacy|6
7783318|NCT00970268|12232824|FG000|Overall Study|Protocol Violation|4
7783319|NCT00970268|12232825|FG001|Overall Study|Protocol Violation|7
7783320|NCT00970268|12232824|FG000|Overall Study|Other Reason|3
7783321|NCT00970268|12232825|FG001|Overall Study|Other Reason|1
7783322|NCT00970268|12232824|FG000|Overall Study|COPD Exacerbation|4
7783323|NCT00970268|12232825|FG001|Overall Study|COPD Exacerbation|2
7783324|NCT00970268|12232824|FG000|Overall Study|Lost to Follow-up|1
7783325|NCT00970268|12232825|FG001|Overall Study|Lost to Follow-up|2
7783326|NCT00970268|12232824|FG000|Overall Study|Inclusion/Exclusion Criteria|1
7783327|NCT00970268|12232825|FG001|Overall Study|Inclusion/Exclusion Criteria|0
7783328|NCT00970281|12232839|FG000|Overall Study|Lack of Efficacy|1
7783329|NCT00970281|12232840|FG001|Overall Study|Lack of Efficacy|14
7783330|NCT00970281|12232839|FG000|Overall Study|Withdrawal by Subject|0
7783331|NCT00970281|12232840|FG001|Overall Study|Withdrawal by Subject|1
7783332|NCT00970281|12232839|FG000|Overall Study|Physician Decision|1
7783333|NCT00970281|12232840|FG001|Overall Study|Physician Decision|1
7783334|NCT00970294|12232846|FG000|Overall Study|Physician Decision|4
7783335|NCT00970294|12232846|FG000|Overall Study|Withdrawal by Subject|1
7783336|NCT00970307|12232853|FG000|Overall Study|Serious Adverse Event|1
7783337|NCT00970307|12232854|FG001|Overall Study|Serious Adverse Event|0
7783338|NCT00970307|12232855|FG002|Overall Study|Serious Adverse Event|0
7783339|NCT00970307|12232853|FG000|Overall Study|Withdrawal by Subject|2
7783340|NCT00970307|12232854|FG001|Overall Study|Withdrawal by Subject|3
7783341|NCT00970307|12232855|FG002|Overall Study|Withdrawal by Subject|2
7783342|NCT00970359|12232884|FG000|Overall Study|Not Treated|4
7783343|NCT00970489|12232890|FG000|Overall Study|Death/Withdrew/Criteria Violation|54
7783344|NCT00970489|12232891|FG001|Overall Study|Death/Withdrew/Criteria Violation|41
7783345|NCT00970502|12232897|FG000|Overall Study|Withdrawal by Subject|1
7783346|NCT00970593|12232912|FG000|Overall Study|Adverse Event|1
7783347|NCT00970593|12232913|FG001|Overall Study|Adverse Event|1
7783348|NCT00970593|12232914|FG002|Overall Study|Adverse Event|0
7783349|NCT00970593|12232915|FG003|Overall Study|Adverse Event|0
7783350|NCT00970593|12232916|FG004|Overall Study|Adverse Event|0
7783351|NCT00970593|12232917|FG005|Overall Study|Adverse Event|0
7783352|NCT00970593|12232918|FG006|Overall Study|Adverse Event|0
7783353|NCT00970593|12232912|FG000|Overall Study|Discontinuation of study by sponsor|0
7783354|NCT00970593|12232913|FG001|Overall Study|Discontinuation of study by sponsor|0
7783355|NCT00970593|12232914|FG002|Overall Study|Discontinuation of study by sponsor|5
7783356|NCT00970593|12232915|FG003|Overall Study|Discontinuation of study by sponsor|0
7783357|NCT00970593|12232916|FG004|Overall Study|Discontinuation of study by sponsor|0
7783358|NCT00970593|12232917|FG005|Overall Study|Discontinuation of study by sponsor|0
7783359|NCT00970593|12232918|FG006|Overall Study|Discontinuation of study by sponsor|2
7783360|NCT00970593|12232912|FG000|Overall Study|Withdrawal by Subject|0
7619228|NCT02863419|12029889|FG002|Overall Study|Died|1
7783361|NCT00970593|12232913|FG001|Overall Study|Withdrawal by Subject|0
7783362|NCT00970593|12232914|FG002|Overall Study|Withdrawal by Subject|1
7783363|NCT00970593|12232915|FG003|Overall Study|Withdrawal by Subject|0
7783364|NCT00970593|12232916|FG004|Overall Study|Withdrawal by Subject|0
7783365|NCT00970593|12232917|FG005|Overall Study|Withdrawal by Subject|0
7783366|NCT00970593|12232918|FG006|Overall Study|Withdrawal by Subject|0
7783367|NCT00970632|12232941|FG000|Overall Study|Adverse Event|2
7783368|NCT00970632|12232942|FG001|Overall Study|Adverse Event|2
7783369|NCT00970632|12232943|FG002|Overall Study|Adverse Event|1
7783370|NCT00970632|12232941|FG000|Overall Study|Lack of Efficacy|3
7783371|NCT00970632|12232942|FG001|Overall Study|Lack of Efficacy|0
7783372|NCT00970632|12232943|FG002|Overall Study|Lack of Efficacy|0
7783373|NCT00970632|12232941|FG000|Overall Study|Lost to Follow-up|3
7783374|NCT00970632|12232942|FG001|Overall Study|Lost to Follow-up|0
7783375|NCT00970632|12232943|FG002|Overall Study|Lost to Follow-up|2
7783376|NCT00970632|12232941|FG000|Overall Study|Protocol Violation|8
7783377|NCT00970632|12232942|FG001|Overall Study|Protocol Violation|5
7783378|NCT00970632|12232943|FG002|Overall Study|Protocol Violation|8
7783379|NCT00970632|12232941|FG000|Overall Study|Withdrawal by Subject|7
7783380|NCT00970632|12232942|FG001|Overall Study|Withdrawal by Subject|6
7783381|NCT00970632|12232943|FG002|Overall Study|Withdrawal by Subject|4
7783382|NCT00970632|12232941|FG000|Overall Study|Entry criteria not met|0
7783383|NCT00970632|12232942|FG001|Overall Study|Entry criteria not met|2
7783384|NCT00970632|12232943|FG002|Overall Study|Entry criteria not met|2
7783385|NCT00970632|12232941|FG000|Overall Study|Sponsor decision|1
7783386|NCT00970632|12232942|FG001|Overall Study|Sponsor decision|0
7783387|NCT00970632|12232943|FG002|Overall Study|Sponsor decision|1
7783388|NCT00970944|12232971|FG000|Overall Study|Death|1
7783389|NCT00970944|12232972|FG001|Overall Study|Death|0
7783390|NCT00970944|12232971|FG000|Overall Study|Physician Decision|0
7783391|NCT00970944|12232972|FG001|Overall Study|Physician Decision|2
7783392|NCT00971048|12232983|FG000|Overall Study|Protocol Violation|1
7783393|NCT00971048|12232984|FG001|Overall Study|Protocol Violation|2
7783394|NCT00971048|12232985|FG002|Overall Study|Protocol Violation|0
7783395|NCT00971048|12232986|FG003|Overall Study|Protocol Violation|1
7783396|NCT00971048|12232983|FG000|Overall Study|Adverse Event|0
7783397|NCT00971048|12232984|FG001|Overall Study|Adverse Event|0
7783398|NCT00971048|12232985|FG002|Overall Study|Adverse Event|1
7783399|NCT00971048|12232986|FG003|Overall Study|Adverse Event|0
7783400|NCT00971048|12232983|FG000|Overall Study|Physician Decision|0
7783401|NCT00971048|12232984|FG001|Overall Study|Physician Decision|0
7783402|NCT00971048|12232985|FG002|Overall Study|Physician Decision|0
7783403|NCT00971048|12232986|FG003|Overall Study|Physician Decision|1
7783404|NCT00971178|12233001|FG000|Overall Study|Lost to Follow-up|2
7783405|NCT00971178|12233002|FG001|Overall Study|Lost to Follow-up|2
7783406|NCT00971178|12233003|FG002|Overall Study|Lost to Follow-up|2
7783407|NCT00971204|12233011|FG000|Overall Study|Did not meet all criteria-not treated|14
7783408|NCT00971204|12233011|FG000|Overall Study|Lost to Follow-up|10
7783409|NCT00971243|12233020|FG000|Double Blind Period|Adverse Event|2
7783410|NCT00971243|12233021|FG001|Double Blind Period|Adverse Event|3
7783411|NCT00971243|12233022|FG002|Double Blind Period|Adverse Event|2
7783412|NCT00971243|12233023|FG003|Double Blind Period|Adverse Event|2
7783413|NCT00971243|12233024|FG004|Double Blind Period|Adverse Event|3
7783414|NCT00971243|12233020|FG000|Double Blind Period|Lost to Follow-up|0
7783415|NCT00971243|12233021|FG001|Double Blind Period|Lost to Follow-up|1
7783416|NCT00971243|12233022|FG002|Double Blind Period|Lost to Follow-up|1
7783417|NCT00971243|12233023|FG003|Double Blind Period|Lost to Follow-up|0
7783418|NCT00971243|12233024|FG004|Double Blind Period|Lost to Follow-up|1
7783419|NCT00971243|12233020|FG000|Double Blind Period|Physician Decision|10
7783420|NCT00971243|12233021|FG001|Double Blind Period|Physician Decision|6
7783421|NCT00971243|12233022|FG002|Double Blind Period|Physician Decision|7
7783422|NCT00971243|12233023|FG003|Double Blind Period|Physician Decision|6
7783423|NCT00971243|12233024|FG004|Double Blind Period|Physician Decision|7
7783424|NCT00971243|12233020|FG000|Double Blind Period|Protocol Violation|2
7783425|NCT00971243|12233021|FG001|Double Blind Period|Protocol Violation|0
7783426|NCT00971243|12233022|FG002|Double Blind Period|Protocol Violation|3
7783427|NCT00971243|12233023|FG003|Double Blind Period|Protocol Violation|2
7783428|NCT00971243|12233024|FG004|Double Blind Period|Protocol Violation|2
7783429|NCT00971243|12233020|FG000|Double Blind Period|Withdrawal by Subject|4
7783430|NCT00971243|12233021|FG001|Double Blind Period|Withdrawal by Subject|1
7783431|NCT00971243|12233022|FG002|Double Blind Period|Withdrawal by Subject|4
7783432|NCT00971243|12233023|FG003|Double Blind Period|Withdrawal by Subject|4
7783433|NCT00971243|12233024|FG004|Double Blind Period|Withdrawal by Subject|4
7783434|NCT00971243|12233020|FG000|Double Blind Period|Other reasons|1
7783435|NCT00971243|12233021|FG001|Double Blind Period|Other reasons|0
7783436|NCT00971243|12233022|FG002|Double Blind Period|Other reasons|2
7783437|NCT00971243|12233023|FG003|Double Blind Period|Other reasons|0
7783438|NCT00971243|12233024|FG004|Double Blind Period|Other reasons|1
7783439|NCT00971243|12233020|FG000|Open-label Period|Adverse Event|1
7783440|NCT00971243|12233021|FG001|Open-label Period|Adverse Event|0
7783441|NCT00971243|12233022|FG002|Open-label Period|Adverse Event|1
7783442|NCT00971243|12233023|FG003|Open-label Period|Adverse Event|1
7783443|NCT00971243|12233024|FG004|Open-label Period|Adverse Event|0
7783444|NCT00971243|12233020|FG000|Open-label Period|Physician Decision|5
7783445|NCT00971243|12233021|FG001|Open-label Period|Physician Decision|9
7783446|NCT00971243|12233022|FG002|Open-label Period|Physician Decision|3
7783447|NCT00971243|12233023|FG003|Open-label Period|Physician Decision|7
7783448|NCT00971243|12233024|FG004|Open-label Period|Physician Decision|2
7783449|NCT00971243|12233020|FG000|Open-label Period|Protocol Violation|1
7783450|NCT00971243|12233021|FG001|Open-label Period|Protocol Violation|1
7783451|NCT00971243|12233022|FG002|Open-label Period|Protocol Violation|1
7783452|NCT00971243|12233023|FG003|Open-label Period|Protocol Violation|0
7783453|NCT00971243|12233024|FG004|Open-label Period|Protocol Violation|1
7783454|NCT00971243|12233020|FG000|Open-label Period|Withdrawal by Subject|1
7783455|NCT00971243|12233021|FG001|Open-label Period|Withdrawal by Subject|0
7783456|NCT00971243|12233022|FG002|Open-label Period|Withdrawal by Subject|0
7783457|NCT00971243|12233023|FG003|Open-label Period|Withdrawal by Subject|2
7783458|NCT00971243|12233024|FG004|Open-label Period|Withdrawal by Subject|1
7783459|NCT00971243|12233020|FG000|Open-label Period|Other reason|0
7783460|NCT00971243|12233021|FG001|Open-label Period|Other reason|0
7783461|NCT00971243|12233022|FG002|Open-label Period|Other reason|0
7783462|NCT00971243|12233023|FG003|Open-label Period|Other reason|0
7783463|NCT00971243|12233024|FG004|Open-label Period|Other reason|2
7783464|NCT00971321|12233051|FG000|Up to Month 7|Withdrawal by Subject|1
7783465|NCT00971321|12233052|FG001|Up to Month 7|Withdrawal by Subject|0
7783466|NCT00971321|12233051|FG000|Up to Month 7|Migrated/moved from study area|3
7783467|NCT00971321|12233052|FG001|Up to Month 7|Migrated/moved from study area|2
7783468|NCT00971321|12233051|FG000|Up to Month 11-12|Withdrawal by Subject|2
7783469|NCT00971321|12233052|FG001|Up to Month 11-12|Withdrawal by Subject|1
7783470|NCT00971321|12233051|FG000|Up to Month 11-12|Migrated/moved from study area|2
7783471|NCT00971321|12233052|FG001|Up to Month 11-12|Migrated/moved from study area|2
7783472|NCT00971321|12233051|FG000|Up to Month 11-12|Lost to Follow-up|1
7783473|NCT00971321|12233052|FG001|Up to Month 11-12|Lost to Follow-up|0
7783474|NCT00971425|12233060|FG000|Overall Study|Adverse Event|1
7783475|NCT00971425|12233061|FG001|Overall Study|Adverse Event|1
7783476|NCT00971425|12233060|FG000|Overall Study|Withdrawal by Subject|0
7783477|NCT00971425|12233061|FG001|Overall Study|Withdrawal by Subject|1
7800275|NCT01092663|12257504|FG000|Overall Study|High fasting triglyceride|2
7800276|NCT01092663|12257505|FG001|Overall Study|High fasting triglyceride|0
7800277|NCT01092663|12257504|FG000|Overall Study|Adverse Event|1
7800278|NCT01092663|12257505|FG001|Overall Study|Adverse Event|1
7800279|NCT01092663|12257504|FG000|Overall Study|Protocol Violation|0
7800280|NCT01092663|12257505|FG001|Overall Study|Protocol Violation|1
7800281|NCT01092702|12257525|FG000|Overall Study|Withdrawal by Subject|7
7800282|NCT01092702|12257525|FG000|Overall Study|Lost to Follow-up|2
7800283|NCT01092728|12257531|FG000|Overall Study|Withdrawal by Subject|2
7800284|NCT01092728|12257532|FG001|Overall Study|Withdrawal by Subject|0
7800285|NCT01092728|12257531|FG000|Overall Study|Adverse Event|0
7800286|NCT01092728|12257532|FG001|Overall Study|Adverse Event|1
7800287|NCT01092728|12257531|FG000|Overall Study|Disease Progression|1
7800288|NCT01092728|12257532|FG001|Overall Study|Disease Progression|13
7800289|NCT01092728|12257531|FG000|Overall Study|Prohibited Concomitant Medications|1
7800290|NCT01092728|12257532|FG001|Overall Study|Prohibited Concomitant Medications|0
7800291|NCT01092780|12257542|FG000|Washout Period 1|Adverse Event|0
7800292|NCT01092780|12257543|FG001|Washout Period 1|Adverse Event|1
7800293|NCT01092780|12257544|FG002|Washout Period 1|Adverse Event|0
7800294|NCT01092780|12257545|FG003|Washout Period 1|Adverse Event|0
7800295|NCT01092780|12257542|FG000|Washout Period 1|Noncompliance with nCPAP|1
7800296|NCT01092780|12257543|FG001|Washout Period 1|Noncompliance with nCPAP|0
7800297|NCT01092780|12257544|FG002|Washout Period 1|Noncompliance with nCPAP|0
7800298|NCT01092780|12257545|FG003|Washout Period 1|Noncompliance with nCPAP|0
7800299|NCT01092780|12257542|FG000|Washout Period 2|Adverse Event|0
7800300|NCT01092780|12257543|FG001|Washout Period 2|Adverse Event|1
7800301|NCT01092780|12257544|FG002|Washout Period 2|Adverse Event|1
7800302|NCT01092780|12257545|FG003|Washout Period 2|Adverse Event|0
7800303|NCT01092832|12257557|FG000|Overall Study|Other|1
7800304|NCT01092832|12257558|FG001|Overall Study|Other|0
7800305|NCT01093222|12257609|FG000|Overall Study|Ineligible|6
7800306|NCT01093222|12257609|FG000|Overall Study|Adverse Event|7
7800307|NCT01093222|12257609|FG000|Overall Study|Progression/relapse|24
7800308|NCT01093222|12257609|FG000|Overall Study|Death|2
7800309|NCT01093222|12257609|FG000|Overall Study|Not protocol specified|1
7800310|NCT01093534|12257648|FG000|Overall Study|Adverse Event|2
7800311|NCT01093534|12257649|FG001|Overall Study|Adverse Event|5
7800312|NCT01093534|12257650|FG002|Overall Study|Adverse Event|2
7800313|NCT01093534|12257648|FG000|Overall Study|Lack of Efficacy|2
7800314|NCT01093534|12257649|FG001|Overall Study|Lack of Efficacy|1
7800315|NCT01093534|12257650|FG002|Overall Study|Lack of Efficacy|1
7800316|NCT01093534|12257648|FG000|Overall Study|Withdrawal by Subject|5
7800317|NCT01093534|12257649|FG001|Overall Study|Withdrawal by Subject|7
7800318|NCT01093534|12257650|FG002|Overall Study|Withdrawal by Subject|2
7800319|NCT01093534|12257648|FG000|Overall Study|Other|1
7800320|NCT01093534|12257649|FG001|Overall Study|Other|3
7800321|NCT01093534|12257650|FG002|Overall Study|Other|4
7800322|NCT01093586|12257659|FG000|Overall Study|Failed to engraft|3
7800323|NCT01093599|12257665|FG000|Overall Study|Lost to Follow-up|32
7800324|NCT01093599|12257666|FG001|Overall Study|Lost to Follow-up|46
7800325|NCT01093625|12257674|FG000|Baseline and Dispensed|Withdrawal by Subject|2
7800326|NCT01093625|12257675|FG001|Baseline and Dispensed|Withdrawal by Subject|0
7783478|NCT00971932|12233112|FG000|Overall Study|Withdrawal by Subject|1
7783479|NCT00971932|12233112|FG000|Overall Study|Investigator's decision|2
7783480|NCT00971932|12233112|FG000|Overall Study|Ongoing|4
7783481|NCT00971945|12233116|FG000|Overall Study|Progressive Disease|3
7783482|NCT00971945|12233116|FG000|Overall Study|Change in treatment policy|1
7783483|NCT00971945|12233116|FG000|Overall Study|Other reasons|2
7783484|NCT00971997|12233120|FG000|Overall Study|Adverse Event|2
7783485|NCT00971997|12233120|FG000|Overall Study|Death|1
7783486|NCT00971997|12233120|FG000|Overall Study|Protocol Violation|4
7783487|NCT00971997|12233120|FG000|Overall Study|Withdrawal by Subject|5
7783488|NCT00971997|12233120|FG000|Overall Study|Physician Decision|7
7783489|NCT00972153|12233134|FG000|Overall Study|Equipment malfunction during case|0
7783490|NCT00972153|12233135|FG001|Overall Study|Equipment malfunction during case|1
7783491|NCT00972153|12233136|FG002|Overall Study|Equipment malfunction during case|0
7783492|NCT00972244|12233153|FG000|Overall Study|Incorrect Enrolment|1
7783493|NCT00972244|12233154|FG001|Overall Study|Incorrect Enrolment|0
7783494|NCT00972244|12233155|FG002|Overall Study|Incorrect Enrolment|0
7783495|NCT00972244|12233156|FG003|Overall Study|Incorrect Enrolment|0
7783496|NCT00972244|12233157|FG004|Overall Study|Incorrect Enrolment|0
7783497|NCT00972244|12233153|FG000|Overall Study|Adverse Event|0
7783498|NCT00972244|12233154|FG001|Overall Study|Adverse Event|1
7783499|NCT00972244|12233155|FG002|Overall Study|Adverse Event|1
7783500|NCT00972244|12233156|FG003|Overall Study|Adverse Event|0
7783501|NCT00972244|12233157|FG004|Overall Study|Adverse Event|0
7783502|NCT00972244|12233153|FG000|Overall Study|Subject No Longer Meets Study Criteria|2
7783503|NCT00972244|12233154|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
7783504|NCT00972244|12233155|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
7783505|NCT00972244|12233156|FG003|Overall Study|Subject No Longer Meets Study Criteria|0
7783506|NCT00972244|12233157|FG004|Overall Study|Subject No Longer Meets Study Criteria|5
7783507|NCT00972244|12233153|FG000|Overall Study|Withdrawal by Subject|1
7783508|NCT00972244|12233154|FG001|Overall Study|Withdrawal by Subject|2
7783509|NCT00972244|12233155|FG002|Overall Study|Withdrawal by Subject|1
7783510|NCT00972244|12233156|FG003|Overall Study|Withdrawal by Subject|0
7783511|NCT00972244|12233157|FG004|Overall Study|Withdrawal by Subject|1
7783512|NCT00972244|12233153|FG000|Overall Study|Safety|0
7783513|NCT00972244|12233154|FG001|Overall Study|Safety|0
7783514|NCT00972244|12233155|FG002|Overall Study|Safety|0
7783515|NCT00972244|12233156|FG003|Overall Study|Safety|0
7783516|NCT00972244|12233157|FG004|Overall Study|Safety|1
7783517|NCT00972244|12233153|FG000|Overall Study|Death|1
7783518|NCT00972244|12233154|FG001|Overall Study|Death|0
7783519|NCT00972244|12233155|FG002|Overall Study|Death|0
7783520|NCT00972244|12233156|FG003|Overall Study|Death|0
7783521|NCT00972244|12233157|FG004|Overall Study|Death|0
7783522|NCT00972244|12233153|FG000|Overall Study|Various|0
7783523|NCT00972244|12233154|FG001|Overall Study|Various|0
7783524|NCT00972244|12233155|FG002|Overall Study|Various|0
7783525|NCT00972244|12233156|FG003|Overall Study|Various|0
7783526|NCT00972244|12233157|FG004|Overall Study|Various|2
7783527|NCT00972283|12233171|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
7783528|NCT00972283|12233172|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
7783529|NCT00972283|12233171|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
7783530|NCT00972283|12233172|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
7783531|NCT00972283|12233171|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
7783532|NCT00972283|12233172|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
7783533|NCT00972283|12233171|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
7783534|NCT00972283|12233172|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
7783535|NCT00972283|12233171|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
7783536|NCT00972283|12233172|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
7783537|NCT00972283|12233171|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
7783538|NCT00972283|12233172|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
7783539|NCT00972283|12233171|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
7783540|NCT00972283|12233172|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
7783541|NCT00972283|12233171|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
7783542|NCT00972283|12233172|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
7783543|NCT00972283|12233171|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
7783544|NCT00972283|12233172|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
7783545|NCT00972283|12233171|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
7783546|NCT00972283|12233172|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
7783547|NCT00972322|12233180|FG000|Overall Study|Adverse Event|2
7783548|NCT00972322|12233181|FG001|Overall Study|Adverse Event|1
7783549|NCT00972322|12233180|FG000|Overall Study|Positive drug screen|0
7783550|NCT00972322|12233181|FG001|Overall Study|Positive drug screen|1
7783551|NCT00972322|12233180|FG000|Overall Study|Lost to Follow-up|0
7783552|NCT00972322|12233181|FG001|Overall Study|Lost to Follow-up|1
7783553|NCT00972322|12233180|FG000|Overall Study|Consistently high glucose values|1
7783554|NCT00972322|12233181|FG001|Overall Study|Consistently high glucose values|0
7783555|NCT00972504|12233213|FG000|Overall Study|Adverse Event|2
7783556|NCT00972504|12233213|FG000|Overall Study|Investigator discretion|1
7783557|NCT00972517|12233223|FG000|Overall Study|Adverse Event|0
7783558|NCT00972517|12233224|FG001|Overall Study|Adverse Event|0
7783559|NCT00972517|12233225|FG002|Overall Study|Adverse Event|0
7783560|NCT00972517|12233226|FG003|Overall Study|Adverse Event|1
7783561|NCT00972517|12233227|FG004|Overall Study|Adverse Event|0
7783562|NCT00972517|12233228|FG005|Overall Study|Adverse Event|0
7783563|NCT00972517|12233223|FG000|Overall Study|Withdrawal by Subject|0
7783564|NCT00972517|12233224|FG001|Overall Study|Withdrawal by Subject|1
7783565|NCT00972517|12233225|FG002|Overall Study|Withdrawal by Subject|0
7783566|NCT00972517|12233226|FG003|Overall Study|Withdrawal by Subject|2
7783567|NCT00972517|12233227|FG004|Overall Study|Withdrawal by Subject|1
7783568|NCT00972517|12233228|FG005|Overall Study|Withdrawal by Subject|0
7783569|NCT00972543|12233259|FG000|Overall Study|Adverse Event|1
7783570|NCT00972543|12233260|FG001|Overall Study|Adverse Event|0
7783571|NCT00972543|12233259|FG000|Overall Study|Early study termination by sponsor|4
7783572|NCT00972543|12233260|FG001|Overall Study|Early study termination by sponsor|1
7783573|NCT00972595|12233266|FG000|Period 1|Adverse Event|1
7783574|NCT00972595|12233267|FG001|Period 1|Adverse Event|0
7783575|NCT00972777|12233293|FG000|Overall Study|Adverse Event|3
7783576|NCT00972777|12233294|FG001|Overall Study|Adverse Event|2
7783577|NCT00972777|12233293|FG000|Overall Study|Lost to Follow-up|0
7783578|NCT00972777|12233294|FG001|Overall Study|Lost to Follow-up|4
7783579|NCT00972777|12233293|FG000|Overall Study|Withdrawal by Subject|4
7783580|NCT00972777|12233294|FG001|Overall Study|Withdrawal by Subject|5
7783581|NCT00972777|12233293|FG000|Overall Study|Physician Decision|4
7783582|NCT00972777|12233294|FG001|Overall Study|Physician Decision|0
7783583|NCT00972777|12233293|FG000|Overall Study|Protocol Violation|0
7783584|NCT00972777|12233294|FG001|Overall Study|Protocol Violation|2
7783585|NCT00972777|12233293|FG000|Overall Study|Screening Failure|2
7783586|NCT00972777|12233294|FG001|Overall Study|Screening Failure|1
7783587|NCT00972777|12233293|FG000|Overall Study|Missed visit|1
7783588|NCT00972777|12233294|FG001|Overall Study|Missed visit|0
7783589|NCT00972816|12233308|FG000|Overall Study|Adverse Event|0
7783590|NCT00972816|12233309|FG001|Overall Study|Adverse Event|0
7783591|NCT00972816|12233310|FG002|Overall Study|Adverse Event|1
7783592|NCT00972816|12233311|FG003|Overall Study|Adverse Event|0
7783593|NCT00972816|12233312|FG004|Overall Study|Adverse Event|0
7783594|NCT00972816|12233313|FG005|Overall Study|Adverse Event|0
7783595|NCT00972816|12233314|FG006|Overall Study|Adverse Event|0
7783596|NCT00972816|12233315|FG007|Overall Study|Adverse Event|0
7783597|NCT00972816|12233308|FG000|Overall Study|Withdrawal by Subject|4
7783598|NCT00972816|12233309|FG001|Overall Study|Withdrawal by Subject|2
7783599|NCT00972816|12233310|FG002|Overall Study|Withdrawal by Subject|1
7783600|NCT00972816|12233311|FG003|Overall Study|Withdrawal by Subject|3
7783601|NCT00972816|12233312|FG004|Overall Study|Withdrawal by Subject|0
7783602|NCT00972816|12233313|FG005|Overall Study|Withdrawal by Subject|1
7783603|NCT00972816|12233314|FG006|Overall Study|Withdrawal by Subject|1
7783604|NCT00972816|12233315|FG007|Overall Study|Withdrawal by Subject|2
7783605|NCT00972816|12233308|FG000|Overall Study|Lost to Follow-up|11
7783606|NCT00972816|12233309|FG001|Overall Study|Lost to Follow-up|9
7783607|NCT00972816|12233310|FG002|Overall Study|Lost to Follow-up|7
7783608|NCT00972816|12233311|FG003|Overall Study|Lost to Follow-up|5
7783609|NCT00972816|12233312|FG004|Overall Study|Lost to Follow-up|11
7783610|NCT00972816|12233313|FG005|Overall Study|Lost to Follow-up|10
7783611|NCT00972816|12233314|FG006|Overall Study|Lost to Follow-up|7
7783612|NCT00972816|12233315|FG007|Overall Study|Lost to Follow-up|7
7783613|NCT00972816|12233308|FG000|Overall Study|Inappropriate enrolment|0
7783614|NCT00972816|12233309|FG001|Overall Study|Inappropriate enrolment|0
7783615|NCT00972816|12233310|FG002|Overall Study|Inappropriate enrolment|0
7783616|NCT00972816|12233311|FG003|Overall Study|Inappropriate enrolment|0
7783617|NCT00972816|12233312|FG004|Overall Study|Inappropriate enrolment|0
7783618|NCT00972816|12233313|FG005|Overall Study|Inappropriate enrolment|0
7783619|NCT00972816|12233314|FG006|Overall Study|Inappropriate enrolment|2
7783620|NCT00972816|12233315|FG007|Overall Study|Inappropriate enrolment|0
7783621|NCT00972816|12233308|FG000|Overall Study|Unable to classify|2
7783622|NCT00972816|12233309|FG001|Overall Study|Unable to classify|0
7783623|NCT00972816|12233310|FG002|Overall Study|Unable to classify|0
7783624|NCT00972816|12233311|FG003|Overall Study|Unable to classify|0
7783625|NCT00972816|12233312|FG004|Overall Study|Unable to classify|1
7783626|NCT00972816|12233313|FG005|Overall Study|Unable to classify|0
7783627|NCT00972816|12233314|FG006|Overall Study|Unable to classify|0
7619229|NCT02863328|12029899|FG000|Overall Study|Lost to Follow-up|4
7783628|NCT00972816|12233315|FG007|Overall Study|Unable to classify|0
7783629|NCT00973102|12233339|FG000|Overall Study|Protocol Violation|1
7783630|NCT00973102|12233340|FG001|Overall Study|Protocol Violation|0
7783631|NCT00973102|12233339|FG000|Overall Study|Prisoner|0
7783632|NCT00973102|12233340|FG001|Overall Study|Prisoner|1
7783633|NCT00973349|12233362|FG000|Overall Study|Adverse Event|0
7783634|NCT00973349|12233363|FG001|Overall Study|Adverse Event|0
7783635|NCT00973349|12233364|FG002|Overall Study|Adverse Event|0
7783636|NCT00973349|12233365|FG003|Overall Study|Adverse Event|0
7783637|NCT00973349|12233366|FG004|Overall Study|Adverse Event|1
7783638|NCT00973349|12233367|FG005|Overall Study|Adverse Event|0
7783639|NCT00973349|12233368|FG006|Overall Study|Adverse Event|0
7783640|NCT00973349|12233369|FG007|Overall Study|Adverse Event|0
7783641|NCT00973349|12233370|FG008|Overall Study|Adverse Event|1
7783642|NCT00973349|12233371|FG009|Overall Study|Adverse Event|0
7783643|NCT00973349|12233372|FG010|Overall Study|Adverse Event|0
7783644|NCT00973349|12233373|FG011|Overall Study|Adverse Event|0
7783645|NCT00973349|12233374|FG012|Overall Study|Adverse Event|0
7783646|NCT00973349|12233375|FG013|Overall Study|Adverse Event|0
7783647|NCT00973349|12233376|FG014|Overall Study|Adverse Event|1
7783648|NCT00973349|12233377|FG015|Overall Study|Adverse Event|0
7783649|NCT00973349|12233362|FG000|Overall Study|Withdrawal by Subject|1
7783650|NCT00973349|12233363|FG001|Overall Study|Withdrawal by Subject|2
7783651|NCT00973349|12233364|FG002|Overall Study|Withdrawal by Subject|2
7783652|NCT00973349|12233365|FG003|Overall Study|Withdrawal by Subject|3
7783653|NCT00973349|12233366|FG004|Overall Study|Withdrawal by Subject|2
7783654|NCT00973349|12233367|FG005|Overall Study|Withdrawal by Subject|0
7783655|NCT00973349|12233368|FG006|Overall Study|Withdrawal by Subject|2
7783656|NCT00973349|12233369|FG007|Overall Study|Withdrawal by Subject|2
7783657|NCT00973349|12233370|FG008|Overall Study|Withdrawal by Subject|0
7783658|NCT00973349|12233371|FG009|Overall Study|Withdrawal by Subject|2
7783659|NCT00973349|12233372|FG010|Overall Study|Withdrawal by Subject|0
7783660|NCT00973349|12233373|FG011|Overall Study|Withdrawal by Subject|1
7783661|NCT00973349|12233374|FG012|Overall Study|Withdrawal by Subject|0
7783662|NCT00973349|12233375|FG013|Overall Study|Withdrawal by Subject|0
7783663|NCT00973349|12233376|FG014|Overall Study|Withdrawal by Subject|0
7783664|NCT00973349|12233377|FG015|Overall Study|Withdrawal by Subject|0
7783665|NCT00973349|12233362|FG000|Overall Study|Lost to Follow-up|3
7783666|NCT00973349|12233363|FG001|Overall Study|Lost to Follow-up|1
7783667|NCT00973349|12233364|FG002|Overall Study|Lost to Follow-up|2
7783668|NCT00973349|12233365|FG003|Overall Study|Lost to Follow-up|2
7783669|NCT00973349|12233366|FG004|Overall Study|Lost to Follow-up|1
7783670|NCT00973349|12233367|FG005|Overall Study|Lost to Follow-up|3
7783671|NCT00973349|12233368|FG006|Overall Study|Lost to Follow-up|0
7783672|NCT00973349|12233369|FG007|Overall Study|Lost to Follow-up|1
7783673|NCT00973349|12233370|FG008|Overall Study|Lost to Follow-up|2
7783674|NCT00973349|12233371|FG009|Overall Study|Lost to Follow-up|1
7783675|NCT00973349|12233372|FG010|Overall Study|Lost to Follow-up|0
7783676|NCT00973349|12233373|FG011|Overall Study|Lost to Follow-up|1
7783677|NCT00973349|12233374|FG012|Overall Study|Lost to Follow-up|0
7783678|NCT00973349|12233375|FG013|Overall Study|Lost to Follow-up|0
7783679|NCT00973349|12233376|FG014|Overall Study|Lost to Follow-up|0
7783680|NCT00973349|12233377|FG015|Overall Study|Lost to Follow-up|1
7783681|NCT00973349|12233362|FG000|Overall Study|Inappropriate enrolment|0
7783682|NCT00973349|12233363|FG001|Overall Study|Inappropriate enrolment|0
7783683|NCT00973349|12233364|FG002|Overall Study|Inappropriate enrolment|1
7783684|NCT00973349|12233365|FG003|Overall Study|Inappropriate enrolment|0
7783685|NCT00973349|12233366|FG004|Overall Study|Inappropriate enrolment|0
7783686|NCT00973349|12233367|FG005|Overall Study|Inappropriate enrolment|0
7783687|NCT00973349|12233368|FG006|Overall Study|Inappropriate enrolment|0
7783688|NCT00973349|12233369|FG007|Overall Study|Inappropriate enrolment|0
7783689|NCT00973349|12233370|FG008|Overall Study|Inappropriate enrolment|0
7783690|NCT00973349|12233371|FG009|Overall Study|Inappropriate enrolment|2
7783691|NCT00973349|12233372|FG010|Overall Study|Inappropriate enrolment|0
7783692|NCT00973349|12233373|FG011|Overall Study|Inappropriate enrolment|0
7783693|NCT00973349|12233374|FG012|Overall Study|Inappropriate enrolment|1
7783694|NCT00973349|12233375|FG013|Overall Study|Inappropriate enrolment|0
7783695|NCT00973349|12233376|FG014|Overall Study|Inappropriate enrolment|1
7783696|NCT00973349|12233377|FG015|Overall Study|Inappropriate enrolment|1
7783697|NCT00973349|12233362|FG000|Overall Study|Protocol Violation|0
7783698|NCT00973349|12233363|FG001|Overall Study|Protocol Violation|0
7783699|NCT00973349|12233364|FG002|Overall Study|Protocol Violation|0
7783700|NCT00973349|12233365|FG003|Overall Study|Protocol Violation|0
7783701|NCT00973349|12233366|FG004|Overall Study|Protocol Violation|0
7783702|NCT00973349|12233367|FG005|Overall Study|Protocol Violation|0
7783703|NCT00973349|12233368|FG006|Overall Study|Protocol Violation|0
7783704|NCT00973349|12233369|FG007|Overall Study|Protocol Violation|0
7783705|NCT00973349|12233370|FG008|Overall Study|Protocol Violation|1
7783706|NCT00973349|12233371|FG009|Overall Study|Protocol Violation|0
7783707|NCT00973349|12233372|FG010|Overall Study|Protocol Violation|0
7783708|NCT00973349|12233373|FG011|Overall Study|Protocol Violation|0
7783709|NCT00973349|12233374|FG012|Overall Study|Protocol Violation|0
7783710|NCT00973349|12233375|FG013|Overall Study|Protocol Violation|0
7783711|NCT00973349|12233376|FG014|Overall Study|Protocol Violation|0
7783712|NCT00973349|12233377|FG015|Overall Study|Protocol Violation|0
7783713|NCT00973349|12233362|FG000|Overall Study|Unable to classify|0
7783714|NCT00973349|12233363|FG001|Overall Study|Unable to classify|0
7783715|NCT00973349|12233364|FG002|Overall Study|Unable to classify|0
7783716|NCT00973349|12233365|FG003|Overall Study|Unable to classify|0
7783717|NCT00973349|12233366|FG004|Overall Study|Unable to classify|1
7783718|NCT00973349|12233367|FG005|Overall Study|Unable to classify|1
7783719|NCT00973349|12233368|FG006|Overall Study|Unable to classify|0
7783720|NCT00973349|12233369|FG007|Overall Study|Unable to classify|0
7783721|NCT00973349|12233370|FG008|Overall Study|Unable to classify|0
7783722|NCT00973349|12233371|FG009|Overall Study|Unable to classify|1
7783723|NCT00973349|12233372|FG010|Overall Study|Unable to classify|0
7783724|NCT00973349|12233373|FG011|Overall Study|Unable to classify|0
7783725|NCT00973349|12233374|FG012|Overall Study|Unable to classify|0
7783726|NCT00973349|12233375|FG013|Overall Study|Unable to classify|0
7783727|NCT00973349|12233376|FG014|Overall Study|Unable to classify|0
7783728|NCT00973349|12233377|FG015|Overall Study|Unable to classify|0
7783729|NCT00973362|12233405|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25
7783730|NCT00973362|12233406|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0
7783731|NCT00973362|12233405|FG000|Baseline Evaluation|No colposcopy visit|62
7783732|NCT00973362|12233406|FG001|Baseline Evaluation|No colposcopy visit|0
7783733|NCT00973362|12233405|FG000|Baseline Evaluation|Inevaluable|686
7783734|NCT00973362|12233406|FG001|Baseline Evaluation|Inevaluable|223
7783735|NCT00973362|12233405|FG000|3-Year Follow-up|Lost to Follow-up|17
7783736|NCT00973362|12233406|FG001|3-Year Follow-up|Lost to Follow-up|0
7783737|NCT00973479|12233417|FG000|Overall Study|Lost to Follow-up|0
7783738|NCT00973479|12233418|FG001|Overall Study|Lost to Follow-up|3
7783739|NCT00973479|12233417|FG000|Overall Study|Death|2
7783740|NCT00973479|12233418|FG001|Overall Study|Death|2
7783741|NCT00973479|12233417|FG000|Overall Study|Withdrawal by Subject|15
7783742|NCT00973479|12233418|FG001|Overall Study|Withdrawal by Subject|16
7783743|NCT00973479|12233417|FG000|Overall Study|Lack of Efficacy|5
7783744|NCT00973479|12233418|FG001|Overall Study|Lack of Efficacy|7
7783745|NCT00973479|12233417|FG000|Overall Study|Adverse Event|12
7783746|NCT00973479|12233418|FG001|Overall Study|Adverse Event|32
7783747|NCT00973479|12233417|FG000|Overall Study|Protocol Violation|2
7783748|NCT00973479|12233418|FG001|Overall Study|Protocol Violation|2
7783749|NCT00973479|12233417|FG000|Overall Study|Other|1
7783750|NCT00973479|12233418|FG001|Overall Study|Other|7
7783751|NCT00973622|12233428|FG000|Overall Study|did not attend MRI|14
7783752|NCT00973622|12233429|FG001|Overall Study|did not attend MRI|3
7783753|NCT00973622|12233428|FG000|Overall Study|did not pass MRI screen|6
7783754|NCT00973622|12233429|FG001|Overall Study|did not pass MRI screen|0
7783755|NCT00973622|12233428|FG000|Overall Study|did not complete rTMS sessions|11
7783756|NCT00973622|12233429|FG001|Overall Study|did not complete rTMS sessions|2
7783757|NCT00973674|12233437|FG000|Overall Study|Protocol Violation|2
7783758|NCT00973674|12233438|FG001|Overall Study|Protocol Violation|0
7783759|NCT00973700|12233450|FG000|Overall Study|Withdrawal by Subject|2
7783760|NCT00973700|12233451|FG001|Overall Study|Withdrawal by Subject|2
7783761|NCT00973700|12233452|FG002|Overall Study|Withdrawal by Subject|8
7783762|NCT00973700|12233453|FG003|Overall Study|Withdrawal by Subject|4
7783763|NCT00973700|12233454|FG004|Overall Study|Withdrawal by Subject|4
7783764|NCT00973700|12233450|FG000|Overall Study|Lost to Follow-up|5
7783765|NCT00973700|12233451|FG001|Overall Study|Lost to Follow-up|0
7783766|NCT00973700|12233452|FG002|Overall Study|Lost to Follow-up|1
7783767|NCT00973700|12233453|FG003|Overall Study|Lost to Follow-up|8
7783768|NCT00973700|12233454|FG004|Overall Study|Lost to Follow-up|5
7783769|NCT00973700|12233450|FG000|Overall Study|Inappropriate enrolment|0
7783770|NCT00973700|12233451|FG001|Overall Study|Inappropriate enrolment|0
7783771|NCT00973700|12233452|FG002|Overall Study|Inappropriate enrolment|0
7783772|NCT00973700|12233453|FG003|Overall Study|Inappropriate enrolment|4
7783773|NCT00973700|12233454|FG004|Overall Study|Inappropriate enrolment|0
7783774|NCT00973700|12233450|FG000|Overall Study|Unable to Classify|0
7783775|NCT00973700|12233451|FG001|Overall Study|Unable to Classify|0
7783776|NCT00973700|12233452|FG002|Overall Study|Unable to Classify|1
7783777|NCT00973700|12233453|FG003|Overall Study|Unable to Classify|2
7783778|NCT00973700|12233454|FG004|Overall Study|Unable to Classify|1
7783779|NCT00973765|12233491|FG000|Overall Study|Lost to Follow-up|8
7783780|NCT00973765|12233492|FG001|Overall Study|Lost to Follow-up|14
7783781|NCT00973921|12233498|FG000|Overall Study|IVUS results were not available|9
7783782|NCT00973973|12233504|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
7783783|NCT00973973|12233505|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
7783784|NCT00973973|12233504|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
7783785|NCT00973973|12233505|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
7783786|NCT00973973|12233504|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
7783787|NCT00973973|12233505|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
7783788|NCT00973973|12233504|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
7783789|NCT00973973|12233505|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
7783790|NCT00973973|12233504|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
7783791|NCT00973973|12233505|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
7783792|NCT00973973|12233504|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
7783793|NCT00973973|12233505|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
7783794|NCT00973973|12233504|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
7783795|NCT00973973|12233505|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
7783796|NCT00973973|12233504|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
7783797|NCT00973973|12233505|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
7783798|NCT00973973|12233504|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
7783799|NCT00973973|12233505|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
7783800|NCT00973973|12233504|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
7783801|NCT00973973|12233505|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
7783802|NCT00973973|12233504|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
7783803|NCT00973973|12233505|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
7783804|NCT00973973|12233504|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
7783805|NCT00973973|12233505|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
7783806|NCT00974090|12233524|FG000|Period 1: Double Blind Period|Adverse Event|2
7783807|NCT00974090|12233525|FG001|Period 1: Double Blind Period|Adverse Event|1
7783808|NCT00974090|12233524|FG000|Period 1: Double Blind Period|Physician Decision|1
7783809|NCT00974090|12233525|FG001|Period 1: Double Blind Period|Physician Decision|0
7783810|NCT00974090|12233524|FG000|Period 2: Open-label Period|Adverse Event|4
7783811|NCT00974090|12233525|FG001|Period 2: Open-label Period|Adverse Event|6
7783812|NCT00974090|12233524|FG000|Period 2: Open-label Period|Lack of Efficacy|3
7783813|NCT00974090|12233525|FG001|Period 2: Open-label Period|Lack of Efficacy|1
7783814|NCT00974090|12233524|FG000|Period 2: Open-label Period|Physician Decision|0
7783815|NCT00974090|12233525|FG001|Period 2: Open-label Period|Physician Decision|3
7783816|NCT00974090|12233524|FG000|Period 2: Open-label Period|Withdrawal by Subject|1
7783817|NCT00974090|12233525|FG001|Period 2: Open-label Period|Withdrawal by Subject|0
7783818|NCT00974220|12233544|FG000|Treatment Period 1|Adverse Event|2
7783819|NCT00974220|12233545|FG001|Treatment Period 1|Adverse Event|1
7783820|NCT00974220|12233544|FG000|Treatment Period 1|noncompliant subjects|0
7783821|NCT00974220|12233545|FG001|Treatment Period 1|noncompliant subjects|1
7783822|NCT00974233|12233551|FG000|Induction Chemoimmunotherapy|Death|2
7783823|NCT00974233|12233551|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5
7783824|NCT00974233|12233551|FG000|Induction Chemoimmunotherapy|Adverse Event|7
7783825|NCT00974233|12233551|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1
7783826|NCT00974233|12233551|FG000|Maintenance Lenalidomide|Lack of Efficacy|5
7783827|NCT00974233|12233551|FG000|Maintenance Lenalidomide|Adverse Event|8
7783828|NCT00974259|12233570|FG000|Overall Study|Technically inadequate PbtO2 recordings|2
7783829|NCT00974259|12233571|FG001|Overall Study|Technically inadequate PbtO2 recordings|1
7783830|NCT00974311|12233579|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5
7783831|NCT00974311|12233580|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2
7783832|NCT00974311|12233579|FG000|DB Phase (up to 24 Months)|Death|561
7783833|NCT00974311|12233580|FG001|DB Phase (up to 24 Months)|Death|298
7783834|NCT00974311|12233579|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16
7783835|NCT00974311|12233580|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7
7783836|NCT00974311|12233579|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
7783837|NCT00974311|12233580|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
7783838|NCT00974311|12233579|FG000|DB Phase (up to 24 Months)|Other|1
7783839|NCT00974311|12233580|FG001|DB Phase (up to 24 Months)|Other|0
7783840|NCT00974311|12233579|FG000|OLE Phase (up to 77 Months)|Death|14
7783841|NCT00974311|12233580|FG001|OLE Phase (up to 77 Months)|Death|21
7783842|NCT00974311|12233579|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
7783843|NCT00974311|12233580|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
7783844|NCT00974311|12233579|FG000|OLE Phase (up to 77 Months)|Other|15
7783845|NCT00974311|12233580|FG001|OLE Phase (up to 77 Months)|Other|2
7783846|NCT00974311|12233579|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
7783847|NCT00974311|12233580|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
7783848|NCT00974675|12233653|FG000|Overall Study|Adverse Event|2
7783849|NCT00974675|12233654|FG001|Overall Study|Adverse Event|1
7783850|NCT00974675|12233655|FG002|Overall Study|Adverse Event|1
7783851|NCT00974675|12233656|FG003|Overall Study|Adverse Event|1
7783852|NCT00974675|12233653|FG000|Overall Study|Physician Decision|0
7783853|NCT00974675|12233654|FG001|Overall Study|Physician Decision|0
7783854|NCT00974675|12233655|FG002|Overall Study|Physician Decision|1
7783855|NCT00974675|12233656|FG003|Overall Study|Physician Decision|0
7783856|NCT00974675|12233653|FG000|Overall Study|Participant on holiday; unable to attend|0
7783857|NCT00974675|12233654|FG001|Overall Study|Participant on holiday; unable to attend|0
7783858|NCT00974675|12233655|FG002|Overall Study|Participant on holiday; unable to attend|0
7783859|NCT00974675|12233656|FG003|Overall Study|Participant on holiday; unable to attend|1
7783860|NCT00974974|12233677|FG000|IR CD-LD Dose Adjustment|Adverse Event|0
7783861|NCT00974974|12233678|FG001|IR CD-LD Dose Adjustment|Adverse Event|3
7783862|NCT00974974|12233677|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0
7783863|NCT00974974|12233678|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1
7783864|NCT00974974|12233677|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
7783865|NCT00974974|12233678|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
7783866|NCT00974974|12233677|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
7783867|NCT00974974|12233678|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
7783868|NCT00974974|12233677|FG000|IR CD-LD Dose Adjustment|Various|0
7619220|NCT02863419|12029887|FG000|Overall Study|Lost to Follow-up|0
7619221|NCT02863419|12029888|FG001|Overall Study|Lost to Follow-up|1
7619222|NCT02863419|12029889|FG002|Overall Study|Lost to Follow-up|4
7619223|NCT02863419|12029887|FG000|Overall Study|Withdrawal by Subject|5
7619224|NCT02863419|12029888|FG001|Overall Study|Withdrawal by Subject|5
7619225|NCT02863419|12029889|FG002|Overall Study|Withdrawal by Subject|3
7619226|NCT02863419|12029887|FG000|Overall Study|Died|3
7619227|NCT02863419|12029888|FG001|Overall Study|Died|4
7783869|NCT00974974|12233678|FG001|IR CD-LD Dose Adjustment|Various|9
7783870|NCT00974974|12233677|FG000|IPX066 Dose Conversion|Adverse Event|23
7783871|NCT00974974|12233678|FG001|IPX066 Dose Conversion|Adverse Event|0
7783872|NCT00974974|12233677|FG000|IPX066 Dose Conversion|Death|2
7783873|NCT00974974|12233678|FG001|IPX066 Dose Conversion|Death|0
7783874|NCT00974974|12233677|FG000|IPX066 Dose Conversion|Lack of Efficacy|13
7783875|NCT00974974|12233678|FG001|IPX066 Dose Conversion|Lack of Efficacy|0
7783876|NCT00974974|12233677|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12
7783877|NCT00974974|12233678|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0
7783878|NCT00974974|12233677|FG000|IPX066 Dose Conversion|Various|3
7783879|NCT00974974|12233678|FG001|IPX066 Dose Conversion|Various|0
7619230|NCT02863328|12029900|FG001|Overall Study|Lost to Follow-up|10
7619231|NCT02863328|12029899|FG000|Overall Study|Withdrawal by Subject|7
7619232|NCT02863328|12029900|FG001|Overall Study|Withdrawal by Subject|12
7619233|NCT02863328|12029899|FG000|Overall Study|Died|0
7619234|NCT02863328|12029900|FG001|Overall Study|Died|1
7619235|NCT02849080|12029908|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7
7619236|NCT02849080|12029909|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4
7619237|NCT02849080|12029910|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
7619238|NCT02849080|12029911|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
7619239|NCT02849080|12029908|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5
7619240|NCT02849080|12029909|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1
7619241|NCT02849080|12029910|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
7619242|NCT02849080|12029911|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
7619243|NCT02849080|12029908|FG000|Main Phase: 0 - 52 Weeks|Death|0
7619244|NCT02849080|12029909|FG001|Main Phase: 0 - 52 Weeks|Death|2
7619245|NCT02849080|12029910|FG002|Main Phase: 0 - 52 Weeks|Death|0
7619246|NCT02849080|12029911|FG003|Main Phase: 0 - 52 Weeks|Death|0
7619247|NCT02849080|12029908|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2
7619248|NCT02849080|12029909|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
7619249|NCT02849080|12029910|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
7619250|NCT02849080|12029911|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
7619251|NCT02849080|12029908|FG000|Extension Phase: 53 - 104 Weeks|Other|0
7619252|NCT02849080|12029909|FG001|Extension Phase: 53 - 104 Weeks|Other|0
7619253|NCT02849080|12029910|FG002|Extension Phase: 53 - 104 Weeks|Other|1
7619254|NCT02849080|12029911|FG003|Extension Phase: 53 - 104 Weeks|Other|0
7619255|NCT02849080|12029908|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1
7619256|NCT02849080|12029909|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
7619257|NCT02849080|12029910|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
7619258|NCT02849080|12029911|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
7619259|NCT02764762|12029923|FG000|Overall Study|Adverse Event|5
7619260|NCT02764762|12029923|FG000|Overall Study|Voluntary Withdrawal|3
7619261|NCT02764762|12029923|FG000|Overall Study|Significant Deviation|1
7783880|NCT00974974|12233677|FG000|IPX066 Dose Conversion|Protocol Violation|4
7783881|NCT00974974|12233678|FG001|IPX066 Dose Conversion|Protocol Violation|0
7783882|NCT00974974|12233677|FG000|Maintenance - Double Blind Treatment|Adverse Event|3
7783883|NCT00974974|12233678|FG001|Maintenance - Double Blind Treatment|Adverse Event|3
7783884|NCT00974974|12233677|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1
7783885|NCT00974974|12233678|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1
7783886|NCT00974974|12233677|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
7783887|NCT00974974|12233678|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
7783888|NCT00974974|12233677|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2
7619271|NCT02692716|12029942|FG000|Overall Study|Lost to Follow-up|2
7619272|NCT02692716|12029943|FG001|Overall Study|Lost to Follow-up|5
7619273|NCT02692716|12029942|FG000|Overall Study|Withdrawal by Subject|3
7619274|NCT02692716|12029943|FG001|Overall Study|Withdrawal by Subject|1
7619275|NCT02607865|12029953|FG000|Overall Study|Lost to Follow-up|9
7619276|NCT02607865|12029954|FG001|Overall Study|Lost to Follow-up|7
7619277|NCT02607865|12029955|FG002|Overall Study|Lost to Follow-up|7
7783889|NCT00974974|12233678|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2
7783890|NCT00974974|12233677|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0
7783891|NCT00974974|12233678|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1
7783892|NCT00974974|12233677|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
7783893|NCT00974974|12233678|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
7783894|NCT00974974|12233677|FG000|Maintenance - Double Blind Treatment|Various|4
7783895|NCT00974974|12233678|FG001|Maintenance - Double Blind Treatment|Various|0
7783896|NCT00975000|12233686|FG000|Overall Study|Other|1
7783897|NCT00975000|12233687|FG001|Overall Study|Other|0
7783898|NCT00975000|12233686|FG000|Overall Study|Adverse Event|1
7783899|NCT00975000|12233687|FG001|Overall Study|Adverse Event|1
7783900|NCT00975000|12233686|FG000|Overall Study|Withdrawal by Subject|2
7783901|NCT00975000|12233687|FG001|Overall Study|Withdrawal by Subject|2
7783902|NCT00975000|12233686|FG000|Overall Study|Lost to Follow-up|0
7783903|NCT00975000|12233687|FG001|Overall Study|Lost to Follow-up|1
7783904|NCT00975000|12233686|FG000|Overall Study|Protocol-specified Criteria|1
7783905|NCT00975000|12233687|FG001|Overall Study|Protocol-specified Criteria|0
7783906|NCT00975000|12233686|FG000|Overall Study|Non-compliance|0
7619278|NCT02607865|12029956|FG003|Overall Study|Lost to Follow-up|5
7619279|NCT02607865|12029953|FG000|Overall Study|Withdrawal by Subject|18
7619280|NCT02607865|12029954|FG001|Overall Study|Withdrawal by Subject|18
7619281|NCT02607865|12029955|FG002|Overall Study|Withdrawal by Subject|17
7619282|NCT02607865|12029956|FG003|Overall Study|Withdrawal by Subject|8
7619283|NCT02607865|12029953|FG000|Overall Study|Death|5
7619284|NCT02607865|12029954|FG001|Overall Study|Death|4
7619285|NCT02607865|12029955|FG002|Overall Study|Death|1
7619286|NCT02607865|12029956|FG003|Overall Study|Death|3
7619287|NCT02607865|12029953|FG000|Overall Study|Unclassified|1
7619288|NCT02607865|12029954|FG001|Overall Study|Unclassified|1
7619289|NCT02607865|12029955|FG002|Overall Study|Unclassified|2
7619290|NCT02607865|12029956|FG003|Overall Study|Unclassified|0
7783907|NCT00975000|12233687|FG001|Overall Study|Non-compliance|1
7783908|NCT00975130|12233693|FG000|Study Part 1|Adverse Event|150
7783909|NCT00975130|12233694|FG001|Study Part 1|Adverse Event|0
7783910|NCT00975130|12233695|FG002|Study Part 1|Adverse Event|0
7783911|NCT00975130|12233693|FG000|Study Part 1|Lost to Follow-up|19
7783912|NCT00975130|12233694|FG001|Study Part 1|Lost to Follow-up|0
7783913|NCT00975130|12233695|FG002|Study Part 1|Lost to Follow-up|0
7783914|NCT00975130|12233693|FG000|Study Part 1|Withdrawal by Subject|61
7783915|NCT00975130|12233694|FG001|Study Part 1|Withdrawal by Subject|0
7783916|NCT00975130|12233695|FG002|Study Part 1|Withdrawal by Subject|0
7783917|NCT00975130|12233693|FG000|Study Part 1|Protocol Violation|13
7783918|NCT00975130|12233694|FG001|Study Part 1|Protocol Violation|0
7783919|NCT00975130|12233695|FG002|Study Part 1|Protocol Violation|0
7783920|NCT00975130|12233693|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9
7783921|NCT00975130|12233694|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0
7783922|NCT00975130|12233695|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0
7783923|NCT00975130|12233693|FG000|Study Part 1|Administrative|4
7783924|NCT00975130|12233694|FG001|Study Part 1|Administrative|0
7783925|NCT00975130|12233695|FG002|Study Part 1|Administrative|0
7783926|NCT00975130|12233693|FG000|Study Part 1|Withdrew Consent|24
7783927|NCT00975130|12233694|FG001|Study Part 1|Withdrew Consent|0
7783928|NCT00975130|12233695|FG002|Study Part 1|Withdrew Consent|0
7783929|NCT00975130|12233693|FG000|Study Part 2|Adverse Event|0
7783930|NCT00975130|12233694|FG001|Study Part 2|Adverse Event|14
7783931|NCT00975130|12233695|FG002|Study Part 2|Adverse Event|7
7783932|NCT00975130|12233693|FG000|Study Part 2|Lost to Follow-up|0
7783933|NCT00975130|12233694|FG001|Study Part 2|Lost to Follow-up|0
7783934|NCT00975130|12233695|FG002|Study Part 2|Lost to Follow-up|1
7783935|NCT00975130|12233693|FG000|Study Part 2|Withdrawal by Subject|0
7783936|NCT00975130|12233694|FG001|Study Part 2|Withdrawal by Subject|13
7783937|NCT00975130|12233695|FG002|Study Part 2|Withdrawal by Subject|5
7783938|NCT00975130|12233693|FG000|Study Part 2|Withdrew Consent|0
7783939|NCT00975130|12233694|FG001|Study Part 2|Withdrew Consent|6
7783940|NCT00975130|12233695|FG002|Study Part 2|Withdrew Consent|2
7783941|NCT00975130|12233693|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0
7783942|NCT00975130|12233694|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4
7783943|NCT00975130|12233695|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1
7783944|NCT00975130|12233693|FG000|Study Part 2|Administrative|0
7783945|NCT00975130|12233694|FG001|Study Part 2|Administrative|1
7783946|NCT00975130|12233695|FG002|Study Part 2|Administrative|0
7783947|NCT00975130|12233693|FG000|Study Part 2|Protocol Violation|0
7783948|NCT00975130|12233694|FG001|Study Part 2|Protocol Violation|0
7783949|NCT00975130|12233695|FG002|Study Part 2|Protocol Violation|1
7783950|NCT00975143|12233710|FG000|Overall Study|Adverse Event|19
7783951|NCT00975143|12233711|FG001|Overall Study|Adverse Event|15
7783952|NCT00975143|12233710|FG000|Overall Study|Withdrawal by Subject|15
7783953|NCT00975143|12233711|FG001|Overall Study|Withdrawal by Subject|15
7783954|NCT00975143|12233710|FG000|Overall Study|Lost to Follow-up|20
7783955|NCT00975143|12233711|FG001|Overall Study|Lost to Follow-up|16
7783956|NCT00975143|12233710|FG000|Overall Study|Non-compliance|5
7783957|NCT00975143|12233711|FG001|Overall Study|Non-compliance|8
7783958|NCT00975143|12233710|FG000|Overall Study|Physician Decision|1
7783959|NCT00975143|12233711|FG001|Overall Study|Physician Decision|2
7783960|NCT00975143|12233710|FG000|Overall Study|Details not available|10
7783961|NCT00975143|12233711|FG001|Overall Study|Details not available|4
7783962|NCT00975156|12233719|FG000|Overall Study|Protocol Violation|0
7783963|NCT00975156|12233720|FG001|Overall Study|Protocol Violation|1
7783964|NCT00975195|12233732|FG000|Overall Study|Adverse Event|108
7783965|NCT00975195|12233733|FG001|Overall Study|Adverse Event|101
7783966|NCT00975195|12233732|FG000|Overall Study|Lack of Efficacy|6
7783967|NCT00975195|12233733|FG001|Overall Study|Lack of Efficacy|6
7783968|NCT00975195|12233732|FG000|Overall Study|Protocol Violation|27
7783969|NCT00975195|12233733|FG001|Overall Study|Protocol Violation|23
7783970|NCT00975195|12233732|FG000|Overall Study|Lost to Follow-up|9
7783971|NCT00975195|12233733|FG001|Overall Study|Lost to Follow-up|7
7783972|NCT00975195|12233732|FG000|Overall Study|Withdrawal by Subject|48
7783973|NCT00975195|12233733|FG001|Overall Study|Withdrawal by Subject|61
7783974|NCT00975195|12233732|FG000|Overall Study|Other reason not defined above|29
7783975|NCT00975195|12233733|FG001|Overall Study|Other reason not defined above|33
7783976|NCT00975195|12233732|FG000|Overall Study|Not treated|1
7783977|NCT00975195|12233733|FG001|Overall Study|Not treated|2
7783978|NCT00975221|12233741|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
7783979|NCT00975221|12233742|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
7783980|NCT00975221|12233741|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
7783981|NCT00975221|12233742|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
7783982|NCT00975221|12233741|FG000|Titration Phase (Weeks 1-12)|Other|0
7783983|NCT00975221|12233742|FG001|Titration Phase (Weeks 1-12)|Other|1
7783984|NCT00975221|12233741|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
7783985|NCT00975221|12233742|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
7783986|NCT00975221|12233741|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
7783987|NCT00975221|12233742|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
7783988|NCT00975221|12233741|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
7783989|NCT00975221|12233742|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
7783990|NCT00975286|12233752|FG000|Overall Study|Adverse Event|9
7783991|NCT00975286|12233753|FG001|Overall Study|Adverse Event|19
7783992|NCT00975286|12233752|FG000|Overall Study|Protocol Violation|1
7783993|NCT00975286|12233753|FG001|Overall Study|Protocol Violation|2
7783994|NCT00975286|12233752|FG000|Overall Study|Withdrawal by Subject|0
7783995|NCT00975286|12233753|FG001|Overall Study|Withdrawal by Subject|2
7783996|NCT00975286|12233752|FG000|Overall Study|Familial and Personal Reasons|2
7783997|NCT00975286|12233753|FG001|Overall Study|Familial and Personal Reasons|2
7783998|NCT00975286|12233752|FG000|Overall Study|Poor Compliance to Protocol|0
7783999|NCT00975286|12233753|FG001|Overall Study|Poor Compliance to Protocol|2
7784000|NCT00975286|12233752|FG000|Overall Study|Sponsor Decision|0
7784001|NCT00975286|12233753|FG001|Overall Study|Sponsor Decision|2
7784002|NCT00975416|12233761|FG000|Overall Study|early discharge from tx|3
7784003|NCT00975416|12233762|FG001|Overall Study|early discharge from tx|5
7784004|NCT00975481|12233769|FG000|Second Intervention Period|Adverse Event|2
7784005|NCT00975481|12233770|FG001|Second Intervention Period|Adverse Event|1
7784006|NCT00975481|12233771|FG002|Second Intervention Period|Adverse Event|0
7784007|NCT00975481|12233772|FG003|Second Intervention Period|Adverse Event|0
7784008|NCT00975481|12233773|FG004|Second Intervention Period|Adverse Event|0
7784009|NCT00975481|12233774|FG005|Second Intervention Period|Adverse Event|0
7784010|NCT00975481|12233769|FG000|Second Intervention Period|Withdrawal by Subject|0
7784011|NCT00975481|12233770|FG001|Second Intervention Period|Withdrawal by Subject|0
7784012|NCT00975481|12233771|FG002|Second Intervention Period|Withdrawal by Subject|1
7784013|NCT00975481|12233772|FG003|Second Intervention Period|Withdrawal by Subject|0
7784014|NCT00975481|12233773|FG004|Second Intervention Period|Withdrawal by Subject|0
7784015|NCT00975481|12233774|FG005|Second Intervention Period|Withdrawal by Subject|0
7784016|NCT00975481|12233769|FG000|Fourth Intervention Period|Withdrawal by Subject|0
7784017|NCT00975481|12233770|FG001|Fourth Intervention Period|Withdrawal by Subject|0
7784018|NCT00975481|12233771|FG002|Fourth Intervention Period|Withdrawal by Subject|1
7784019|NCT00975481|12233772|FG003|Fourth Intervention Period|Withdrawal by Subject|1
7784020|NCT00975481|12233773|FG004|Fourth Intervention Period|Withdrawal by Subject|0
7784021|NCT00975481|12233774|FG005|Fourth Intervention Period|Withdrawal by Subject|0
7784022|NCT00975481|12233769|FG000|Fifth Intervention Period|Withdrawal by Subject|0
7784023|NCT00975481|12233770|FG001|Fifth Intervention Period|Withdrawal by Subject|0
7784024|NCT00975481|12233771|FG002|Fifth Intervention Period|Withdrawal by Subject|0
7784025|NCT00975481|12233772|FG003|Fifth Intervention Period|Withdrawal by Subject|0
7784026|NCT00975481|12233773|FG004|Fifth Intervention Period|Withdrawal by Subject|1
7784027|NCT00975481|12233774|FG005|Fifth Intervention Period|Withdrawal by Subject|0
7784028|NCT00975507|12233794|FG000|Overall Study|Adverse Event|1
7784029|NCT00975507|12233795|FG001|Overall Study|Adverse Event|0
7784030|NCT00975507|12233794|FG000|Overall Study|Lost to Follow-up|7
7784031|NCT00975507|12233795|FG001|Overall Study|Lost to Follow-up|1
7784032|NCT00975507|12233794|FG000|Overall Study|Protocol Violation|2
7784033|NCT00975507|12233795|FG001|Overall Study|Protocol Violation|0
7784034|NCT00975507|12233794|FG000|Overall Study|Withdrawal by Subject|10
7784035|NCT00975507|12233795|FG001|Overall Study|Withdrawal by Subject|3
7784036|NCT00975585|12233805|FG000|Overall Study|Adverse Event|0
7784037|NCT00975585|12233806|FG001|Overall Study|Adverse Event|4
7784038|NCT00975585|12233805|FG000|Overall Study|Lost to Follow-up|3
7784039|NCT00975585|12233806|FG001|Overall Study|Lost to Follow-up|5
7784040|NCT00975585|12233805|FG000|Overall Study|Withdrawal by Subject|2
7784041|NCT00975585|12233806|FG001|Overall Study|Withdrawal by Subject|1
7784042|NCT00975585|12233805|FG000|Overall Study|Lens issue|2
7784043|NCT00975585|12233806|FG001|Overall Study|Lens issue|2
7784044|NCT00975676|12233850|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6
7784045|NCT00975676|12233851|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8
7784046|NCT00975689|12233864|FG000|Overall Study|Adverse Event|0
7784047|NCT00975689|12233865|FG001|Overall Study|Adverse Event|3
7784048|NCT00975689|12233864|FG000|Overall Study|Withdrawal by Subject|1
7784049|NCT00975689|12233865|FG001|Overall Study|Withdrawal by Subject|0
7784050|NCT00975689|12233864|FG000|Overall Study|Physician Decision|1
7784051|NCT00975689|12233865|FG001|Overall Study|Physician Decision|0
7784052|NCT00975715|12233873|FG000|Titration Period|Adverse Event|6
7784053|NCT00975715|12233874|FG001|Titration Period|Adverse Event|0
7784054|NCT00975715|12233873|FG000|Titration Period|Protocol Violation|1
7784055|NCT00975715|12233874|FG001|Titration Period|Protocol Violation|0
7784056|NCT00975715|12233873|FG000|Maintenance Period|Adverse Event|2
7619307|NCT02430480|12029984|FG000|Overall Study|Death|1
7619308|NCT02430480|12029984|FG000|Overall Study|Anesthesia concerns|1
7619309|NCT02430480|12029984|FG000|Overall Study|Progressed on treatment|1
7784057|NCT00975715|12233874|FG001|Maintenance Period|Adverse Event|1
7784058|NCT00975780|12233882|FG000|Follow Up|Death|88
7784059|NCT00975780|12233883|FG001|Follow Up|Death|122
7784060|NCT00975780|12233882|FG000|Follow Up|Facility Withdrawal|7
7784061|NCT00975780|12233883|FG001|Follow Up|Facility Withdrawal|23
7784062|NCT00975780|12233882|FG000|Follow Up|Discharged from Facility|7
7784063|NCT00975780|12233883|FG001|Follow Up|Discharged from Facility|12
7784064|NCT00975806|12233892|FG000|Overall Study|Adverse Event|2
7784065|NCT00975806|12233893|FG001|Overall Study|Adverse Event|1
7784066|NCT00975806|12233894|FG002|Overall Study|Adverse Event|2
7784067|NCT00975806|12233892|FG000|Overall Study|Disease Progression|1
7784068|NCT00975806|12233893|FG001|Overall Study|Disease Progression|5
7784069|NCT00975806|12233894|FG002|Overall Study|Disease Progression|1
7784070|NCT00975806|12233892|FG000|Overall Study|Withdrawal by Subject|1
7784071|NCT00975806|12233893|FG001|Overall Study|Withdrawal by Subject|0
7784072|NCT00975806|12233894|FG002|Overall Study|Withdrawal by Subject|0
7784073|NCT00975806|12233892|FG000|Overall Study|Death|0
7784074|NCT00975806|12233893|FG001|Overall Study|Death|1
7784075|NCT00975806|12233894|FG002|Overall Study|Death|0
7784076|NCT00975806|12233892|FG000|Overall Study|Physician decision and disease related|1
7784077|NCT00975806|12233893|FG001|Overall Study|Physician decision and disease related|0
7784078|NCT00975806|12233894|FG002|Overall Study|Physician decision and disease related|1
7784079|NCT00975884|12233906|FG000|Overall Study|Adverse Event|1
7784080|NCT00975884|12233907|FG001|Overall Study|Adverse Event|0
7784081|NCT00975884|12233906|FG000|Overall Study|Lost to Follow-up|5
7784082|NCT00975884|12233907|FG001|Overall Study|Lost to Follow-up|3
7784083|NCT00975884|12233906|FG000|Overall Study|Withdrawal by Subject|9
7784084|NCT00975884|12233907|FG001|Overall Study|Withdrawal by Subject|9
7784085|NCT00975884|12233906|FG000|Overall Study|Other|1
7784086|NCT00975884|12233907|FG001|Overall Study|Other|3
7784087|NCT00975923|12233925|FG000|Overall Study|Withdrawal by Subject|0
7784088|NCT00975923|12233926|FG001|Overall Study|Withdrawal by Subject|1
7784089|NCT00975975|12233933|FG000|Overall Study|Death|6
7784090|NCT00976027|12233939|FG000|Overall Study|Serious Adverse Event|36
7784091|NCT00976027|12233940|FG001|Overall Study|Serious Adverse Event|17
7784092|NCT00976027|12233939|FG000|Overall Study|Adverse Event|0
7784093|NCT00976027|12233940|FG001|Overall Study|Adverse Event|2
7784094|NCT00976027|12233939|FG000|Overall Study|Protocol Violation|60
7784095|NCT00976027|12233940|FG001|Overall Study|Protocol Violation|27
7784096|NCT00976027|12233939|FG000|Overall Study|Lost to Follow-up|208
7784097|NCT00976027|12233940|FG001|Overall Study|Lost to Follow-up|103
7784098|NCT00976027|12233939|FG000|Overall Study|Withdrawal by Subject|107
7784099|NCT00976027|12233940|FG001|Overall Study|Withdrawal by Subject|66
7784100|NCT00976209|12233952|FG000|Treatment Period 1|Protocol Violation|1
7784101|NCT00976209|12233953|FG001|Treatment Period 1|Protocol Violation|0
7784102|NCT00976209|12233952|FG000|Treatment Period 1|Lost to Follow-up|2
7784103|NCT00976209|12233953|FG001|Treatment Period 1|Lost to Follow-up|0
7784104|NCT00976209|12233952|FG000|Treatment Period 1|Other|0
7784105|NCT00976209|12233953|FG001|Treatment Period 1|Other|1
7784106|NCT00976209|12233952|FG000|Wash-out Period|Adverse Event|1
7784107|NCT00976209|12233953|FG001|Wash-out Period|Adverse Event|2
7784108|NCT00976209|12233952|FG000|Wash-out Period|Lost to Follow-up|1
7784109|NCT00976209|12233953|FG001|Wash-out Period|Lost to Follow-up|0
7784110|NCT00976209|12233952|FG000|Wash-out Period|Protocol Violation|1
7784111|NCT00976209|12233953|FG001|Wash-out Period|Protocol Violation|0
7784112|NCT00976209|12233952|FG000|Wash-out Period|Other|1
7784113|NCT00976209|12233953|FG001|Wash-out Period|Other|0
7784114|NCT00976209|12233952|FG000|Treatment Period 2|Withdrawal by Subject|0
7784115|NCT00976209|12233953|FG001|Treatment Period 2|Withdrawal by Subject|1
7784116|NCT00976209|12233952|FG000|Treatment Period 2|Lost to Follow-up|0
7784117|NCT00976209|12233953|FG001|Treatment Period 2|Lost to Follow-up|1
7784118|NCT00976274|12233965|FG000|Overall Study|Lost to Follow-up|5
7784119|NCT00976274|12233966|FG001|Overall Study|Lost to Follow-up|5
7784120|NCT00976274|12233965|FG000|Overall Study|Withdrawal by Subject|1
7784121|NCT00976274|12233966|FG001|Overall Study|Withdrawal by Subject|1
7784122|NCT00976274|12233965|FG000|Overall Study|Physician Decision|1
7784123|NCT00976274|12233966|FG001|Overall Study|Physician Decision|2
7784124|NCT00976391|12233987|FG000|Treatment Period (52 Weeks)|Adverse Event|16
7784125|NCT00976391|12233988|FG001|Treatment Period (52 Weeks)|Adverse Event|2
7784126|NCT00976391|12233987|FG000|Treatment Period (52 Weeks)|Protocol Violation|1
7784127|NCT00976391|12233988|FG001|Treatment Period (52 Weeks)|Protocol Violation|1
7784128|NCT00976391|12233987|FG000|Treatment Period (52 Weeks)|Noncompliance|4
7784129|NCT00976391|12233988|FG001|Treatment Period (52 Weeks)|Noncompliance|4
7784130|NCT00976391|12233987|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10
7784131|NCT00976391|12233988|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8
7784132|NCT00976391|12233987|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9
7784133|NCT00976391|12233988|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19
7784134|NCT00976391|12233987|FG000|Treatment Period (52 Weeks)|Physician Decision|1
7784135|NCT00976391|12233988|FG001|Treatment Period (52 Weeks)|Physician Decision|1
7784136|NCT00976391|12233987|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
7784137|NCT00976391|12233988|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
7784138|NCT00976391|12233987|FG000|Treatment Period (52 Weeks)|Pregnancy|1
7784139|NCT00976391|12233988|FG001|Treatment Period (52 Weeks)|Pregnancy|0
7784140|NCT00976391|12233987|FG000|Follow-up Period (8 Weeks)|Adverse Event|3
7784141|NCT00976391|12233988|FG001|Follow-up Period (8 Weeks)|Adverse Event|1
7784142|NCT00976391|12233987|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
7784143|NCT00976391|12233988|FG001|Follow-up Period (8 Weeks)|Noncompliance|2
7784144|NCT00976391|12233987|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14
7784145|NCT00976391|12233988|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12
7784146|NCT00976391|12233987|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
7619329|NCT01964430|12030036|FG000|Overall Study|Adverse Event|71
7619330|NCT01964430|12030037|FG001|Overall Study|Adverse Event|37
7619331|NCT01964430|12030036|FG000|Overall Study|Withdrawal by Subject|36
7619332|NCT01964430|12030037|FG001|Overall Study|Withdrawal by Subject|27
7619333|NCT01964430|12030036|FG000|Overall Study|Death|1
7619334|NCT01964430|12030037|FG001|Overall Study|Death|3
7619335|NCT01964430|12030036|FG000|Overall Study|Protocol Deviation|0
7619336|NCT01964430|12030037|FG001|Overall Study|Protocol Deviation|1
7619337|NCT01964430|12030036|FG000|Overall Study|Physician Decision|5
7619338|NCT01964430|12030037|FG001|Overall Study|Physician Decision|4
7619339|NCT01964430|12030036|FG000|Overall Study|Disease Relapse|28
7619340|NCT01964430|12030037|FG001|Overall Study|Disease Relapse|38
7619341|NCT01964430|12030036|FG000|Overall Study|Miscellaneous|1
7619342|NCT01964430|12030037|FG001|Overall Study|Miscellaneous|3
7619343|NCT01964430|12030036|FG000|Overall Study|Randomized but not Treated|3
7619344|NCT01964430|12030037|FG001|Overall Study|Randomized but not Treated|11
7619345|NCT01880957|12030045|FG000|Overall Study|Diagnosis: Unipolar Depression|12
7619346|NCT01880957|12030046|FG001|Overall Study|Diagnosis: Unipolar Depression|0
7619347|NCT01880957|12030045|FG000|Overall Study|Lost to Follow-up|11
7619348|NCT01880957|12030046|FG001|Overall Study|Lost to Follow-up|0
7619349|NCT01880957|12030045|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5
7619350|NCT01880957|12030046|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0
7619351|NCT01651403|12030063|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
7619352|NCT01651403|12030064|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
7619353|NCT01651403|12030063|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
7619354|NCT01651403|12030064|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
7619355|NCT01651403|12030063|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0
7619356|NCT01651403|12030064|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1
7619357|NCT01651403|12030063|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13
7619358|NCT01651403|12030064|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9
7619359|NCT01651403|12030063|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2
7619360|NCT01651403|12030064|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1
7619361|NCT01651403|12030063|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6
7619362|NCT01651403|12030064|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4
7784147|NCT00976391|12233988|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
7784148|NCT00976391|12233987|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
7784149|NCT00976391|12233988|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
7784150|NCT00976391|12233987|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
7784151|NCT00976391|12233988|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
7784152|NCT00976456|12234007|FG000|Overall Study|Adverse Event|17
7784153|NCT00976456|12234008|FG001|Overall Study|Adverse Event|22
7784154|NCT00976456|12234007|FG000|Overall Study|Death|7
7784155|NCT00976456|12234008|FG001|Overall Study|Death|9
7784156|NCT00976456|12234007|FG000|Overall Study|Lack of Efficacy|5
7784157|NCT00976456|12234008|FG001|Overall Study|Lack of Efficacy|2
7784158|NCT00976456|12234007|FG000|Overall Study|Withdrawal by Subject|3
7784159|NCT00976456|12234008|FG001|Overall Study|Withdrawal by Subject|1
7784160|NCT00976456|12234007|FG000|Overall Study|screening failure, unknown|11
7784161|NCT00976456|12234008|FG001|Overall Study|screening failure, unknown|4
7784162|NCT00976482|12234014|FG000|Overall Study|Death|208
7784163|NCT00976482|12234014|FG000|Overall Study|Withdrawal by Subject|45
7784164|NCT00976482|12234014|FG000|Overall Study|Center terminated|1
7784165|NCT00976482|12234014|FG000|Overall Study|Protocol Violation|5
7784166|NCT00976495|12234021|FG000|Overall Study|Withdrawal by Subject|0
7784167|NCT00976495|12234022|FG001|Overall Study|Withdrawal by Subject|1
7784168|NCT00976495|12234023|FG002|Overall Study|Withdrawal by Subject|0
7784169|NCT00976508|12234033|FG000|Overall Study|Death|7
7784170|NCT00976508|12234034|FG001|Overall Study|Death|1
7784171|NCT00976508|12234033|FG000|Overall Study|Lost to Follow-up|1
7784172|NCT00976508|12234034|FG001|Overall Study|Lost to Follow-up|0
7784173|NCT00976508|12234033|FG000|Overall Study|Withdrawal by Subject|1
7784174|NCT00976508|12234034|FG001|Overall Study|Withdrawal by Subject|0
7784175|NCT00976508|12234033|FG000|Overall Study|Disease Progression|4
7784176|NCT00976508|12234034|FG001|Overall Study|Disease Progression|4
7784177|NCT00976508|12234033|FG000|Overall Study|Subject Enrolled in Hospice|1
7784178|NCT00976508|12234034|FG001|Overall Study|Subject Enrolled in Hospice|0
7784179|NCT00976508|12234033|FG000|Overall Study|Terminated by the Sponsor|0
7784180|NCT00976508|12234034|FG001|Overall Study|Terminated by the Sponsor|1
7784181|NCT00976560|12234063|FG000|Overall Study|Adverse Event|5
7784182|NCT00976560|12234064|FG001|Overall Study|Adverse Event|5
7784183|NCT00976560|12234063|FG000|Overall Study|Lack of Efficacy|3
7784184|NCT00976560|12234064|FG001|Overall Study|Lack of Efficacy|5
7784185|NCT00976560|12234063|FG000|Overall Study|Protocol Violation|1
7784186|NCT00976560|12234064|FG001|Overall Study|Protocol Violation|0
7784187|NCT00976560|12234063|FG000|Overall Study|Lost to Follow-up|1
7784188|NCT00976560|12234064|FG001|Overall Study|Lost to Follow-up|0
7784189|NCT00976560|12234063|FG000|Overall Study|Physician Decision|2
7784190|NCT00976560|12234064|FG001|Overall Study|Physician Decision|0
7784191|NCT00976560|12234063|FG000|Overall Study|Withdrawal by Subject|2
7784192|NCT00976560|12234064|FG001|Overall Study|Withdrawal by Subject|3
7784193|NCT00976573|12234072|FG000|Overall Study|Ineligible|0
7784194|NCT00976573|12234073|FG001|Overall Study|Ineligible|1
7784195|NCT00976573|12234072|FG000|Overall Study|Cancel prior to receiving treatment|4
7784196|NCT00976573|12234073|FG001|Overall Study|Cancel prior to receiving treatment|2
7784197|NCT00976677|12234099|FG000|Overall Study|Adverse Event|1
7784198|NCT00976677|12234100|FG001|Overall Study|Adverse Event|0
7784199|NCT00976677|12234099|FG000|Overall Study|Withdrawal by Subject|0
7784200|NCT00976677|12234100|FG001|Overall Study|Withdrawal by Subject|2
7784201|NCT00976677|12234099|FG000|Overall Study|Disease progression|1
7784202|NCT00976677|12234100|FG001|Overall Study|Disease progression|1
7784203|NCT00976677|12234099|FG000|Overall Study|Trial unblinded|2
7784204|NCT00976677|12234100|FG001|Overall Study|Trial unblinded|2
7784205|NCT00976677|12234099|FG000|Overall Study|Unknown/Missing|1
7784206|NCT00976677|12234100|FG001|Overall Study|Unknown/Missing|0
7784207|NCT00976703|12234108|FG000|Overall Study|Physician Decision|1
7784208|NCT00976703|12234109|FG001|Overall Study|Physician Decision|1
7784209|NCT00976703|12234108|FG000|Overall Study|ineligible for study|2
7784210|NCT00976703|12234109|FG001|Overall Study|ineligible for study|2
7784211|NCT00976716|12234115|FG000|Overall Study|Adverse Event|1
7784212|NCT00976820|12234124|FG000|Overall Study|Lost to Follow-up|5
7784213|NCT00976820|12234125|FG001|Overall Study|Lost to Follow-up|16
7784214|NCT00976820|12234126|FG002|Overall Study|Lost to Follow-up|2
7784215|NCT00976820|12234127|FG003|Overall Study|Lost to Follow-up|3
7784216|NCT00976820|12234124|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1
7784217|NCT00976820|12234125|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0
7784218|NCT00976820|12234126|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1
7784219|NCT00976820|12234127|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0
7784220|NCT00976820|12234124|FG000|Overall Study|Withdrawal by Subject|2
7784221|NCT00976820|12234125|FG001|Overall Study|Withdrawal by Subject|4
7784222|NCT00976820|12234126|FG002|Overall Study|Withdrawal by Subject|1
7784223|NCT00976820|12234127|FG003|Overall Study|Withdrawal by Subject|4
7784224|NCT00976898|12234178|FG000|Overall Study|Protocol Violation|1
7784225|NCT00976898|12234178|FG000|Overall Study|Adverse Event|1
7784226|NCT00976898|12234178|FG000|Overall Study|Physician Decision|1
7784227|NCT00976898|12234178|FG000|Overall Study|Liver Transplant|1
7784228|NCT00976898|12234178|FG000|Overall Study|Progressive Disease|1
7784229|NCT00976937|12234184|FG000|Overall Study|Adverse Event|4
7784230|NCT00976937|12234185|FG001|Overall Study|Adverse Event|5
7784231|NCT00976937|12234184|FG000|Overall Study|Lost to Follow-up|2
7784232|NCT00976937|12234185|FG001|Overall Study|Lost to Follow-up|1
7784233|NCT00976937|12234184|FG000|Overall Study|Withdrawal by Subject|5
7784234|NCT00976937|12234185|FG001|Overall Study|Withdrawal by Subject|3
7784235|NCT00976937|12234184|FG000|Overall Study|Poor compliance to protocol|3
7784236|NCT00976937|12234185|FG001|Overall Study|Poor compliance to protocol|0
7784237|NCT00976937|12234184|FG000|Overall Study|Personal and Familial Reason|2
7784238|NCT00976937|12234185|FG001|Overall Study|Personal and Familial Reason|2
7784239|NCT00976950|12234191|FG000|Overall Study|Adverse Event|3
7784240|NCT00976950|12234191|FG000|Overall Study|Events with no relationship to Aptivus|3
7784241|NCT00976989|12234198|FG000|Overall Study|Violation of Selection Criteria at Entry|1
7784242|NCT00976989|12234199|FG001|Overall Study|Violation of Selection Criteria at Entry|0
7784243|NCT00976989|12234200|FG002|Overall Study|Violation of Selection Criteria at Entry|1
7784244|NCT00976989|12234198|FG000|Overall Study|Death|5
7784245|NCT00976989|12234199|FG001|Overall Study|Death|7
7784246|NCT00976989|12234200|FG002|Overall Study|Death|10
7784247|NCT00976989|12234198|FG000|Overall Study|Refused Treatment|4
7784248|NCT00976989|12234199|FG001|Overall Study|Refused Treatment|3
7784249|NCT00976989|12234200|FG002|Overall Study|Refused Treatment|5
7784250|NCT00976989|12234198|FG000|Overall Study|Failure to Return|2
7784251|NCT00976989|12234199|FG001|Overall Study|Failure to Return|1
7784252|NCT00976989|12234200|FG002|Overall Study|Failure to Return|0
7784253|NCT00976989|12234198|FG000|Overall Study|Recurrence of Disease|0
7784254|NCT00976989|12234199|FG001|Overall Study|Recurrence of Disease|1
7784255|NCT00976989|12234200|FG002|Overall Study|Recurrence of Disease|0
7784256|NCT00976989|12234198|FG000|Overall Study|Other|1
7784257|NCT00976989|12234199|FG001|Overall Study|Other|0
7784258|NCT00976989|12234200|FG002|Overall Study|Other|1
7784259|NCT00977080|12234212|FG000|Overall Study|Adverse Event|2
7784260|NCT00977080|12234213|FG001|Overall Study|Adverse Event|7
7784261|NCT00977080|12234214|FG002|Overall Study|Adverse Event|7
7784262|NCT00977080|12234215|FG003|Overall Study|Adverse Event|7
7784263|NCT00977080|12234212|FG000|Overall Study|Withdrawal by Subject|1
7784264|NCT00977080|12234213|FG001|Overall Study|Withdrawal by Subject|5
7784265|NCT00977080|12234214|FG002|Overall Study|Withdrawal by Subject|1
7784266|NCT00977080|12234215|FG003|Overall Study|Withdrawal by Subject|5
7784267|NCT00977080|12234212|FG000|Overall Study|Protocol Violation|7
7784268|NCT00977080|12234213|FG001|Overall Study|Protocol Violation|3
7784269|NCT00977080|12234214|FG002|Overall Study|Protocol Violation|4
7784270|NCT00977080|12234215|FG003|Overall Study|Protocol Violation|3
7784271|NCT00977080|12234212|FG000|Overall Study|Noncompliance|0
7784272|NCT00977080|12234213|FG001|Overall Study|Noncompliance|2
7784273|NCT00977080|12234214|FG002|Overall Study|Noncompliance|1
7784274|NCT00977080|12234215|FG003|Overall Study|Noncompliance|0
7784275|NCT00977080|12234212|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
7784276|NCT00977080|12234213|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
7784277|NCT00977080|12234214|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
7784278|NCT00977080|12234215|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
7784279|NCT00977080|12234212|FG000|Overall Study|Required kidney transplantation|1
7784280|NCT00977080|12234213|FG001|Overall Study|Required kidney transplantation|3
7784281|NCT00977080|12234214|FG002|Overall Study|Required kidney transplantation|3
7784282|NCT00977080|12234215|FG003|Overall Study|Required kidney transplantation|1
7784283|NCT00977080|12234212|FG000|Overall Study|Travel for family reasons|1
7784284|NCT00977080|12234213|FG001|Overall Study|Travel for family reasons|0
7784285|NCT00977080|12234214|FG002|Overall Study|Travel for family reasons|0
7784286|NCT00977080|12234215|FG003|Overall Study|Travel for family reasons|0
7784287|NCT00977106|12234227|FG000|Overall Study|Adverse Event|5
7784288|NCT00977106|12234228|FG001|Overall Study|Adverse Event|6
7784289|NCT00977106|12234227|FG000|Overall Study|Withdrawal by Subject|2
7784290|NCT00977106|12234228|FG001|Overall Study|Withdrawal by Subject|2
7784291|NCT00977106|12234227|FG000|Overall Study|Lack of Efficacy|2
7784292|NCT00977106|12234228|FG001|Overall Study|Lack of Efficacy|2
7784293|NCT00977106|12234227|FG000|Overall Study|Protocol Violation|0
7784294|NCT00977106|12234228|FG001|Overall Study|Protocol Violation|1
7784295|NCT00977106|12234227|FG000|Overall Study|Other|1
7784296|NCT00977106|12234228|FG001|Overall Study|Other|0
7800327|NCT01093625|12257674|FG000|2-Week Visit|Withdrawal by Subject|1
7800328|NCT01093625|12257675|FG001|2-Week Visit|Withdrawal by Subject|0
7800329|NCT01093625|12257674|FG000|1-Month Visit|Lost to Follow-up|2
7800330|NCT01093625|12257675|FG001|1-Month Visit|Lost to Follow-up|0
7800331|NCT01093625|12257674|FG000|3-Month Visit|Lost to Follow-up|2
7800332|NCT01093625|12257675|FG001|3-Month Visit|Lost to Follow-up|0
7800333|NCT01093625|12257674|FG000|6-Month Visit|Withdrawal by Subject|6
7800334|NCT01093625|12257675|FG001|6-Month Visit|Withdrawal by Subject|7
7800335|NCT01093625|12257674|FG000|6-Month Visit|Lost to Follow-up|2
7800336|NCT01093625|12257675|FG001|6-Month Visit|Lost to Follow-up|2
7800337|NCT01093625|12257674|FG000|1-Year Visit|Lost to Follow-up|5
7800338|NCT01093625|12257675|FG001|1-Year Visit|Lost to Follow-up|3
7800339|NCT01093755|12257701|FG000|Overall Study|Withdrawal by Subject|3
7800340|NCT01093755|12257702|FG001|Overall Study|Withdrawal by Subject|4
7800341|NCT01093885|12257721|FG000|Overall Study|Adverse Event|4
7800342|NCT01093885|12257721|FG000|Overall Study|Lost to Follow-up|1
7800343|NCT01094119|12257741|FG000|Overall Study|Lack of Efficacy|2
7800344|NCT01094119|12257742|FG001|Overall Study|Lack of Efficacy|4
7800345|NCT01094171|12257748|FG000|Overall Study|Lost to Follow-up|2
7800346|NCT01094171|12257748|FG000|Overall Study|Informed consent withdrawal|4
7800347|NCT01094171|12257748|FG000|Overall Study|Migration from the study area|3
7800348|NCT01094171|12257748|FG000|Overall Study|Other|1
7800349|NCT01094184|12257754|FG000|Overall Study|Death|35
7800350|NCT01094184|12257755|FG001|Overall Study|Death|11
7800351|NCT01094288|12257769|FG000|Overall Study|Adverse Event|0
7800352|NCT01094288|12257770|FG001|Overall Study|Adverse Event|3
7800353|NCT01094288|12257771|FG002|Overall Study|Adverse Event|1
7800354|NCT01094288|12257772|FG003|Overall Study|Adverse Event|1
7800355|NCT01094288|12257773|FG004|Overall Study|Adverse Event|0
7800356|NCT01094288|12257774|FG005|Overall Study|Adverse Event|0
7800357|NCT01094288|12257775|FG006|Overall Study|Adverse Event|0
7800358|NCT01094288|12257776|FG007|Overall Study|Adverse Event|0
7800359|NCT01094288|12257769|FG000|Overall Study|Withdrawal by Subject|0
7800360|NCT01094288|12257770|FG001|Overall Study|Withdrawal by Subject|1
7800361|NCT01094288|12257771|FG002|Overall Study|Withdrawal by Subject|2
7800362|NCT01094288|12257772|FG003|Overall Study|Withdrawal by Subject|0
7800363|NCT01094288|12257773|FG004|Overall Study|Withdrawal by Subject|0
7800364|NCT01094288|12257774|FG005|Overall Study|Withdrawal by Subject|0
7800365|NCT01094288|12257775|FG006|Overall Study|Withdrawal by Subject|0
7800366|NCT01094288|12257776|FG007|Overall Study|Withdrawal by Subject|2
7800367|NCT01094288|12257769|FG000|Overall Study|Initiation of Alternative Therapy|0
7800368|NCT01094288|12257770|FG001|Overall Study|Initiation of Alternative Therapy|0
7800369|NCT01094288|12257771|FG002|Overall Study|Initiation of Alternative Therapy|1
7800370|NCT01094288|12257772|FG003|Overall Study|Initiation of Alternative Therapy|0
7800371|NCT01094288|12257773|FG004|Overall Study|Initiation of Alternative Therapy|0
7800372|NCT01094288|12257774|FG005|Overall Study|Initiation of Alternative Therapy|0
7800373|NCT01094288|12257775|FG006|Overall Study|Initiation of Alternative Therapy|0
7800374|NCT01094288|12257776|FG007|Overall Study|Initiation of Alternative Therapy|0
7800375|NCT01094288|12257769|FG000|Overall Study|Reason not Specified|2
7800376|NCT01094288|12257770|FG001|Overall Study|Reason not Specified|3
7800377|NCT01094288|12257771|FG002|Overall Study|Reason not Specified|0
7800378|NCT01094288|12257772|FG003|Overall Study|Reason not Specified|1
7800379|NCT01094288|12257773|FG004|Overall Study|Reason not Specified|0
7800380|NCT01094288|12257774|FG005|Overall Study|Reason not Specified|0
7800381|NCT01094288|12257775|FG006|Overall Study|Reason not Specified|0
7800382|NCT01094288|12257776|FG007|Overall Study|Reason not Specified|0
7800383|NCT01094288|12257769|FG000|Overall Study|Ongoing Participants|0
7800384|NCT01094288|12257770|FG001|Overall Study|Ongoing Participants|3
7784297|NCT00977197|12234258|FG000|Overall Study|Withdrawal by Subject|3
7784298|NCT00977197|12234259|FG001|Overall Study|Withdrawal by Subject|4
7784299|NCT00977197|12234258|FG000|Overall Study|Adverse Event|3
7784300|NCT00977197|12234259|FG001|Overall Study|Adverse Event|1
7784301|NCT00977197|12234258|FG000|Overall Study|Lack of Efficacy|1
7784302|NCT00977197|12234259|FG001|Overall Study|Lack of Efficacy|0
7784303|NCT00977197|12234258|FG000|Overall Study|Lost to Follow-up|1
7784304|NCT00977197|12234259|FG001|Overall Study|Lost to Follow-up|3
7784305|NCT00977197|12234258|FG000|Overall Study|Nonadherence|1
7784306|NCT00977197|12234259|FG001|Overall Study|Nonadherence|1
7784307|NCT00977314|12234267|FG000|Overall Study|Withdrawal by Subject|1
7784308|NCT00977314|12234268|FG001|Overall Study|Withdrawal by Subject|0
7784309|NCT00977314|12234267|FG000|Overall Study|Physician Decision|1
7784310|NCT00977314|12234268|FG001|Overall Study|Physician Decision|0
7784311|NCT00977379|12234276|FG000|Overall Study|Withdrawal by Subject|1
7784312|NCT00977379|12234277|FG001|Overall Study|Withdrawal by Subject|1
7784313|NCT00977379|12234276|FG000|Overall Study|Death|7
7784314|NCT00977379|12234277|FG001|Overall Study|Death|9
7784315|NCT00977379|12234276|FG000|Overall Study|Premature Study Termination|4
7784316|NCT00977379|12234277|FG001|Overall Study|Premature Study Termination|0
7784317|NCT00977379|12234276|FG000|Overall Study|Participant Moving House|0
7784318|NCT00977379|12234277|FG001|Overall Study|Participant Moving House|1
7784319|NCT00977379|12234276|FG000|Overall Study|Randomization Error|0
7784320|NCT00977379|12234277|FG001|Overall Study|Randomization Error|1
7784321|NCT00977431|12234288|FG000|Overall Study|Other than listed|1
7784322|NCT00977431|12234289|FG001|Overall Study|Other than listed|0
7784323|NCT00977431|12234290|FG002|Overall Study|Other than listed|0
7784324|NCT00977431|12234291|FG003|Overall Study|Other than listed|0
7784325|NCT00977431|12234292|FG004|Overall Study|Other than listed|2
7784326|NCT00977431|12234288|FG000|Overall Study|Protocol Violation|0
7784327|NCT00977431|12234289|FG001|Overall Study|Protocol Violation|0
7784328|NCT00977431|12234290|FG002|Overall Study|Protocol Violation|1
7619470|NCT01241786|12030149|FG000|Overall Study|Lack of Efficacy|5
7784329|NCT00977431|12234291|FG003|Overall Study|Protocol Violation|0
7784330|NCT00977431|12234292|FG004|Overall Study|Protocol Violation|0
7784331|NCT00977431|12234288|FG000|Overall Study|Adverse Event|3
7784332|NCT00977431|12234289|FG001|Overall Study|Adverse Event|0
7784333|NCT00977431|12234290|FG002|Overall Study|Adverse Event|4
7784334|NCT00977431|12234291|FG003|Overall Study|Adverse Event|0
7784335|NCT00977431|12234292|FG004|Overall Study|Adverse Event|6
7784336|NCT00977431|12234288|FG000|Overall Study|Dose-limiting toxicity (DLT)|1
7784337|NCT00977431|12234289|FG001|Overall Study|Dose-limiting toxicity (DLT)|0
7784338|NCT00977431|12234290|FG002|Overall Study|Dose-limiting toxicity (DLT)|1
7784339|NCT00977431|12234291|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
7784340|NCT00977431|12234292|FG004|Overall Study|Dose-limiting toxicity (DLT)|0
7784341|NCT00977431|12234288|FG000|Overall Study|Progressive disease|2
7784342|NCT00977431|12234289|FG001|Overall Study|Progressive disease|6
7784343|NCT00977431|12234290|FG002|Overall Study|Progressive disease|1
7784344|NCT00977431|12234291|FG003|Overall Study|Progressive disease|3
7784345|NCT00977431|12234292|FG004|Overall Study|Progressive disease|5
7784346|NCT00977470|12234310|FG000|Overall Study|Lack of Efficacy|32
7784347|NCT00977470|12234311|FG001|Overall Study|Lack of Efficacy|30
7784348|NCT00977470|12234310|FG000|Overall Study|Physician Decision|2
7784349|NCT00977470|12234311|FG001|Overall Study|Physician Decision|0
7784350|NCT00977470|12234310|FG000|Overall Study|Adverse Event|1
7784351|NCT00977470|12234311|FG001|Overall Study|Adverse Event|2
7784352|NCT00977470|12234310|FG000|Overall Study|Protocol Violation|1
7784353|NCT00977470|12234311|FG001|Overall Study|Protocol Violation|0
7784354|NCT00977470|12234310|FG000|Overall Study|Withdrawal by Subject|0
7784355|NCT00977470|12234311|FG001|Overall Study|Withdrawal by Subject|2
7784356|NCT00977470|12234310|FG000|Overall Study|Death|0
7784357|NCT00977470|12234311|FG001|Overall Study|Death|2
7784358|NCT00977470|12234310|FG000|Overall Study|clinical decline|0
7784359|NCT00977470|12234311|FG001|Overall Study|clinical decline|1
7784360|NCT00977470|12234310|FG000|Overall Study|prolonged recovery post-surgery|0
7784361|NCT00977470|12234311|FG001|Overall Study|prolonged recovery post-surgery|1
7784362|NCT00977470|12234310|FG000|Overall Study|Still on-study|2
7784363|NCT00977470|12234311|FG001|Overall Study|Still on-study|0
7784364|NCT00977548|12234317|FG000|Overall Study|Ineligible|4
7784365|NCT00977548|12234317|FG000|Overall Study|Adverse Event|8
7784366|NCT00977548|12234317|FG000|Overall Study|Withdrawal by Subject|1
7784367|NCT00977561|12234323|FG000|Overall Study|Death|3
7784368|NCT00977561|12234324|FG001|Overall Study|Death|2
7784369|NCT00977561|12234323|FG000|Overall Study|Study terminated|0
7784370|NCT00977561|12234324|FG001|Overall Study|Study terminated|2
7784371|NCT00977561|12234323|FG000|Overall Study|Other|2
7784372|NCT00977561|12234324|FG001|Overall Study|Other|0
7784373|NCT00977613|12234332|FG000|Overall Study|Lost to Follow-up|16
7784374|NCT00977665|12234338|FG000|Overall Study|Withdrawal by Subject|1
7784375|NCT00977665|12234339|FG001|Overall Study|Withdrawal by Subject|3
7784376|NCT00977665|12234338|FG000|Overall Study|Physician Decision|2
7784377|NCT00977665|12234339|FG001|Overall Study|Physician Decision|1
7784378|NCT00977665|12234338|FG000|Overall Study|Sponsor requested withdrawal|0
7784379|NCT00977665|12234339|FG001|Overall Study|Sponsor requested withdrawal|1
7784380|NCT00977665|12234338|FG000|Overall Study|Lost to Follow-up|1
7784381|NCT00977665|12234339|FG001|Overall Study|Lost to Follow-up|0
7784382|NCT00977665|12234338|FG000|Overall Study|Death|3
7784383|NCT00977665|12234339|FG001|Overall Study|Death|2
7784384|NCT00977665|12234338|FG000|Overall Study|Adverse Event|14
7784385|NCT00977665|12234339|FG001|Overall Study|Adverse Event|7
7784386|NCT00977665|12234338|FG000|Overall Study|Treatment failure|0
7784387|NCT00977665|12234339|FG001|Overall Study|Treatment failure|1
7784388|NCT00977938|12234371|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
7784389|NCT00977938|12234372|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
7784390|NCT00977938|12234373|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
7784391|NCT00977938|12234374|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
7784392|NCT00977938|12234371|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
7784393|NCT00977938|12234372|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
7784394|NCT00977938|12234373|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
7784395|NCT00977938|12234374|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
7784396|NCT00977938|12234371|FG000|Treatment (12-30 mo. Post Procedure)|Other|17
7784397|NCT00977938|12234372|FG001|Treatment (12-30 mo. Post Procedure)|Other|18
7784398|NCT00977938|12234373|FG002|Treatment (12-30 mo. Post Procedure)|Other|3
7784399|NCT00977938|12234374|FG003|Treatment (12-30 mo. Post Procedure)|Other|4
7784400|NCT00977938|12234371|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
7784401|NCT00977938|12234372|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
7784402|NCT00977938|12234373|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
7784403|NCT00977938|12234374|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
7784404|NCT00977938|12234371|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
7784405|NCT00977938|12234372|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
7784406|NCT00977938|12234373|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
7784407|NCT00977938|12234374|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
7784408|NCT00977938|12234371|FG000|Observation (30-33 mo. Post Procedure)|Other|8
7784409|NCT00977938|12234372|FG001|Observation (30-33 mo. Post Procedure)|Other|4
7784410|NCT00977938|12234373|FG002|Observation (30-33 mo. Post Procedure)|Other|0
7784411|NCT00977938|12234374|FG003|Observation (30-33 mo. Post Procedure)|Other|0
7784412|NCT00978029|12234389|FG000|Overall Study|Adverse Event|1
7784413|NCT00978029|12234390|FG001|Overall Study|Adverse Event|2
7784414|NCT00978029|12234391|FG002|Overall Study|Adverse Event|5
7784415|NCT00978029|12234389|FG000|Overall Study|Withdrawal by Subject|0
7784416|NCT00978029|12234390|FG001|Overall Study|Withdrawal by Subject|0
7784417|NCT00978029|12234391|FG002|Overall Study|Withdrawal by Subject|1
7784418|NCT00978029|12234389|FG000|Overall Study|Protocol Violation|0
7784419|NCT00978029|12234390|FG001|Overall Study|Protocol Violation|1
7784420|NCT00978029|12234391|FG002|Overall Study|Protocol Violation|0
7784421|NCT00978042|12234401|FG000|Initial Treatment Period|Treated in Error|0
7784422|NCT00978042|12234402|FG001|Initial Treatment Period|Treated in Error|3
7784423|NCT00978042|12234401|FG000|Initial Treatment Period|Ineligibility|1
7784424|NCT00978042|12234402|FG001|Initial Treatment Period|Ineligibility|0
7784425|NCT00978042|12234401|FG000|Initial Treatment Period|Lost to Follow-up|21
7784426|NCT00978042|12234402|FG001|Initial Treatment Period|Lost to Follow-up|3
7784427|NCT00978042|12234401|FG000|Initial Treatment Period|Adverse Event|2
7784428|NCT00978042|12234402|FG001|Initial Treatment Period|Adverse Event|0
7784429|NCT00978042|12234401|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
7784430|NCT00978042|12234402|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
7784431|NCT00978042|12234401|FG000|Initial Treatment Period|Consent withdrawn|22
7784432|NCT00978042|12234402|FG001|Initial Treatment Period|Consent withdrawn|9
7784433|NCT00978042|12234401|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13
7784434|NCT00978042|12234402|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0
7784435|NCT00978068|12234410|FG000|Overall Study|Were Awaiting Initiation of ART|2
7784436|NCT00978068|12234411|FG001|Overall Study|Were Awaiting Initiation of ART|2
7784437|NCT00978068|12234410|FG000|Overall Study|Death|1
7784438|NCT00978068|12234411|FG001|Overall Study|Death|2
7784439|NCT00978068|12234410|FG000|Overall Study|Lost to Follow-up|1
7784440|NCT00978068|12234411|FG001|Overall Study|Lost to Follow-up|2
7784441|NCT00978068|12234410|FG000|Overall Study|Physician Decision|0
7784442|NCT00978068|12234411|FG001|Overall Study|Physician Decision|1
7784443|NCT00978068|12234410|FG000|Overall Study|Unable to Comply with Study|0
7784444|NCT00978068|12234411|FG001|Overall Study|Unable to Comply with Study|2
7619572|NCT00606294|12030222|FG000|Overall Study|Withdrawal by Subject|36
7619573|NCT00606294|12030223|FG001|Overall Study|Withdrawal by Subject|0
7784445|NCT00978120|12234425|FG000|Overall Study|Death|0
7784446|NCT00978120|12234426|FG001|Overall Study|Death|0
7784447|NCT00978120|12234427|FG002|Overall Study|Death|0
7784448|NCT00978120|12234428|FG003|Overall Study|Death|1
7784449|NCT00978120|12234425|FG000|Overall Study|Lost to Follow-up|0
7784450|NCT00978120|12234426|FG001|Overall Study|Lost to Follow-up|0
7784451|NCT00978120|12234427|FG002|Overall Study|Lost to Follow-up|3
7784452|NCT00978120|12234428|FG003|Overall Study|Lost to Follow-up|0
7784453|NCT00978120|12234425|FG000|Overall Study|Withdrawal by Subject|2
7784454|NCT00978120|12234426|FG001|Overall Study|Withdrawal by Subject|0
7784455|NCT00978120|12234427|FG002|Overall Study|Withdrawal by Subject|0
7784456|NCT00978120|12234428|FG003|Overall Study|Withdrawal by Subject|0
7784457|NCT00978120|12234425|FG000|Overall Study|Moved out of state|0
7784458|NCT00978120|12234426|FG001|Overall Study|Moved out of state|0
7784459|NCT00978120|12234427|FG002|Overall Study|Moved out of state|0
7784460|NCT00978120|12234428|FG003|Overall Study|Moved out of state|1
7784461|NCT00978250|12234446|FG000|Overall Study|Late determination of ineligibility|0
7784462|NCT00978250|12234447|FG001|Overall Study|Late determination of ineligibility|1
7784463|NCT00978250|12234448|FG002|Overall Study|Late determination of ineligibility|0
7784464|NCT00978250|12234449|FG003|Overall Study|Late determination of ineligibility|1
7784465|NCT00978341|12234461|FG000|Washout Period of 2 Weeks|Adverse Event|1
7784466|NCT00978341|12234462|FG001|Washout Period of 2 Weeks|Adverse Event|0
7784467|NCT00978380|12234469|FG000|Overall Study|Protocol Violation|2
7784468|NCT00978380|12234469|FG000|Overall Study|Withdrawal criteria|9
7784469|NCT00978380|12234469|FG000|Overall Study|Unclassified|8
7784470|NCT00978432|12234477|FG000|Overall Study|Withdrawal by Subject|0
7784471|NCT00978432|12234478|FG001|Overall Study|Withdrawal by Subject|0
7784472|NCT00978432|12234479|FG002|Overall Study|Withdrawal by Subject|1
7784473|NCT00978432|12234477|FG000|Overall Study|Lack of Efficacy|1
7784474|NCT00978432|12234478|FG001|Overall Study|Lack of Efficacy|1
7784475|NCT00978432|12234479|FG002|Overall Study|Lack of Efficacy|3
7784476|NCT00978432|12234477|FG000|Overall Study|Adverse Event|2
7784477|NCT00978432|12234478|FG001|Overall Study|Adverse Event|0
7784478|NCT00978432|12234479|FG002|Overall Study|Adverse Event|1
7784479|NCT00978627|12234497|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
7784480|NCT00978627|12234498|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
7784481|NCT00978627|12234497|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
7784482|NCT00978627|12234498|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
7784483|NCT00978627|12234497|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
7784484|NCT00978627|12234498|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
7784485|NCT00978627|12234497|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
7784486|NCT00978627|12234498|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
7784487|NCT00978627|12234497|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
7784488|NCT00978627|12234498|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
7784489|NCT00978627|12234497|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
7784490|NCT00978627|12234498|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
7784491|NCT00978627|12234497|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
7784492|NCT00978627|12234498|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
7784493|NCT00978627|12234497|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
7784494|NCT00978627|12234498|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
7784495|NCT00978627|12234497|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
7784496|NCT00978627|12234498|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
7784497|NCT00978731|12234508|FG000|Overall Study|Death|4
7784498|NCT00978731|12234509|FG001|Overall Study|Death|1
7784499|NCT00978731|12234510|FG002|Overall Study|Death|1
7784500|NCT00978731|12234511|FG003|Overall Study|Death|0
7784501|NCT00978731|12234508|FG000|Overall Study|Lost to Follow-up|0
7784502|NCT00978731|12234509|FG001|Overall Study|Lost to Follow-up|0
7784503|NCT00978731|12234510|FG002|Overall Study|Lost to Follow-up|0
7784504|NCT00978731|12234511|FG003|Overall Study|Lost to Follow-up|1
7784505|NCT00978731|12234508|FG000|Overall Study|Adverse Event|5
7784506|NCT00978731|12234509|FG001|Overall Study|Adverse Event|2
7784507|NCT00978731|12234510|FG002|Overall Study|Adverse Event|0
7784508|NCT00978731|12234511|FG003|Overall Study|Adverse Event|0
7784509|NCT00978731|12234508|FG000|Overall Study|Participant's request|1
7784510|NCT00978731|12234509|FG001|Overall Study|Participant's request|0
7784511|NCT00978731|12234510|FG002|Overall Study|Participant's request|0
7784512|NCT00978731|12234511|FG003|Overall Study|Participant's request|0
7784513|NCT00978731|12234508|FG000|Overall Study|Administrative reason|3
7784514|NCT00978731|12234509|FG001|Overall Study|Administrative reason|3
7784515|NCT00978731|12234510|FG002|Overall Study|Administrative reason|1
7784516|NCT00978731|12234511|FG003|Overall Study|Administrative reason|0
7784517|NCT00978731|12234508|FG000|Overall Study|Deterioration without progression|0
7619616|NCT00464178|12030247|FG000|Overall Study|Protocol Violation|1
7784518|NCT00978731|12234509|FG001|Overall Study|Deterioration without progression|1
7784519|NCT00978731|12234510|FG002|Overall Study|Deterioration without progression|0
7784520|NCT00978731|12234511|FG003|Overall Study|Deterioration without progression|0
7784521|NCT00978731|12234508|FG000|Overall Study|Disease progression/relapse|5
7784522|NCT00978731|12234509|FG001|Overall Study|Disease progression/relapse|4
7619617|NCT00464178|12030247|FG000|Overall Study|Withdrawal by Subject|1
7784523|NCT00978731|12234510|FG002|Overall Study|Disease progression/relapse|2
7784524|NCT00978731|12234511|FG003|Overall Study|Disease progression/relapse|2
7784525|NCT00978731|12234508|FG000|Overall Study|Study closure|3
7784526|NCT00978731|12234509|FG001|Overall Study|Study closure|4
7784527|NCT00978731|12234510|FG002|Overall Study|Study closure|1
7784528|NCT00978731|12234511|FG003|Overall Study|Study closure|1
7784529|NCT00978731|12234508|FG000|Overall Study|No response|1
7784530|NCT00978731|12234509|FG001|Overall Study|No response|0
7784531|NCT00978731|12234510|FG002|Overall Study|No response|0
7784532|NCT00978731|12234511|FG003|Overall Study|No response|0
7619624|NCT04516746|12030267|FG000|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|21090
7619625|NCT04516746|12030268|FG001|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|10305
7619626|NCT04516746|12030267|FG000|Overall Study|Withdrawal by Subject|362
7619627|NCT04516746|12030268|FG001|Overall Study|Withdrawal by Subject|408
7619628|NCT04516746|12030267|FG000|Overall Study|Lost to Follow-up|157
7619629|NCT04516746|12030268|FG001|Overall Study|Lost to Follow-up|86
7619630|NCT04516746|12030267|FG000|Overall Study|Protocol deviation|18
7619631|NCT04516746|12030268|FG001|Overall Study|Protocol deviation|7
7784533|NCT00978757|12234527|FG000|Overall Study|Physician Decision|1
7784534|NCT00978757|12234528|FG001|Overall Study|Physician Decision|3
7784535|NCT00979134|12234565|FG000|Overall Study|Disease progression|18
7784536|NCT00979134|12234566|FG001|Overall Study|Disease progression|2
7784537|NCT00979134|12234567|FG002|Overall Study|Disease progression|5
7784538|NCT00979134|12234565|FG000|Overall Study|Adverse Event|0
7784539|NCT00979134|12234566|FG001|Overall Study|Adverse Event|0
7784540|NCT00979134|12234567|FG002|Overall Study|Adverse Event|2
7784541|NCT00979134|12234565|FG000|Overall Study|Withdrawal by Subject|1
7784542|NCT00979134|12234566|FG001|Overall Study|Withdrawal by Subject|1
7784543|NCT00979134|12234567|FG002|Overall Study|Withdrawal by Subject|2
7784544|NCT00979134|12234565|FG000|Overall Study|Lost to Follow-up|2
7784545|NCT00979134|12234566|FG001|Overall Study|Lost to Follow-up|2
7784546|NCT00979134|12234567|FG002|Overall Study|Lost to Follow-up|0
7784547|NCT00979134|12234565|FG000|Overall Study|Death|4
7784548|NCT00979134|12234566|FG001|Overall Study|Death|0
7784549|NCT00979134|12234567|FG002|Overall Study|Death|26
7784550|NCT00979134|12234565|FG000|Overall Study|Other|8
7784551|NCT00979134|12234566|FG001|Overall Study|Other|1
7784552|NCT00979134|12234567|FG002|Overall Study|Other|5
7784553|NCT00979407|12234595|FG000|Overall Study|Withdrawal by Subject|3
7784554|NCT00979407|12234596|FG001|Overall Study|Withdrawal by Subject|4
7784555|NCT00979407|12234595|FG000|Overall Study|Lost to Follow-up|3
7784556|NCT00979407|12234596|FG001|Overall Study|Lost to Follow-up|3
7784557|NCT00979420|12234608|FG000|Overall Study|Adverse Event|1
7784558|NCT00979420|12234609|FG001|Overall Study|Adverse Event|0
7784559|NCT00979420|12234610|FG002|Overall Study|Adverse Event|0
7784560|NCT00979420|12234611|FG003|Overall Study|Adverse Event|0
7784561|NCT00979420|12234608|FG000|Overall Study|Lack of Efficacy|3
7784562|NCT00979420|12234609|FG001|Overall Study|Lack of Efficacy|0
7784563|NCT00979420|12234610|FG002|Overall Study|Lack of Efficacy|1
7784564|NCT00979420|12234611|FG003|Overall Study|Lack of Efficacy|1
7784565|NCT00979420|12234608|FG000|Overall Study|Other reasons not related to Viramune|3
7784566|NCT00979420|12234609|FG001|Overall Study|Other reasons not related to Viramune|0
7784567|NCT00979420|12234610|FG002|Overall Study|Other reasons not related to Viramune|0
7784568|NCT00979420|12234611|FG003|Overall Study|Other reasons not related to Viramune|1
7784569|NCT00979576|12234631|FG000|Combination Treatment Phase|Progressive disease|3
7784570|NCT00979576|12234632|FG001|Combination Treatment Phase|Progressive disease|1
7784571|NCT00979576|12234633|FG002|Combination Treatment Phase|Progressive disease|5
7784572|NCT00979576|12234631|FG000|Combination Treatment Phase|Dose limiting toxicity|0
7784573|NCT00979576|12234632|FG001|Combination Treatment Phase|Dose limiting toxicity|3
7784574|NCT00979576|12234633|FG002|Combination Treatment Phase|Dose limiting toxicity|2
7784575|NCT00979576|12234631|FG000|Combination Treatment Phase|Adverse Event|0
7784576|NCT00979576|12234632|FG001|Combination Treatment Phase|Adverse Event|2
7784577|NCT00979576|12234633|FG002|Combination Treatment Phase|Adverse Event|2
7784578|NCT00979576|12234631|FG000|Combination Followed by Monotherapy|Progressive Disease|0
7784579|NCT00979576|12234632|FG001|Combination Followed by Monotherapy|Progressive Disease|2
7784580|NCT00979576|12234633|FG002|Combination Followed by Monotherapy|Progressive Disease|1
7784581|NCT00979602|12234644|FG000|Overall Study|Serious Adverse Event|5
7784582|NCT00979602|12234645|FG001|Overall Study|Serious Adverse Event|3
7784583|NCT00979602|12234644|FG000|Overall Study|Protocol Violation|3
7784584|NCT00979602|12234645|FG001|Overall Study|Protocol Violation|0
7784585|NCT00979602|12234644|FG000|Overall Study|Withdrawal by Subject|31
7784586|NCT00979602|12234645|FG001|Overall Study|Withdrawal by Subject|25
7784587|NCT00979602|12234644|FG000|Overall Study|Lost to Follow-up|100
7784588|NCT00979602|12234645|FG001|Overall Study|Lost to Follow-up|96
7784589|NCT00979602|12234644|FG000|Overall Study|Migrated/moved from study area|3
7784590|NCT00979602|12234645|FG001|Overall Study|Migrated/moved from study area|6
7784591|NCT00979602|12234644|FG000|Overall Study|Others|3
7784592|NCT00979602|12234645|FG001|Overall Study|Others|3
7784593|NCT00979628|12234675|FG000|Overall Study|received regimen < 24 hours|7
7784594|NCT00979628|12234676|FG001|Overall Study|received regimen < 24 hours|6
7784595|NCT00979628|12234677|FG002|Overall Study|received regimen < 24 hours|5
7784596|NCT00979628|12234675|FG000|Overall Study|received steroids|1
7784597|NCT00979628|12234676|FG001|Overall Study|received steroids|1
7784598|NCT00979628|12234677|FG002|Overall Study|received steroids|0
7784599|NCT00979628|12234675|FG000|Overall Study|transferred to ICU|1
7784600|NCT00979628|12234676|FG001|Overall Study|transferred to ICU|2
7619632|NCT04516746|12030267|FG000|Overall Study|Death|8
7619633|NCT04516746|12030268|FG001|Overall Study|Death|7
7619634|NCT04516746|12030267|FG000|Overall Study|Physician Decision|0
7619635|NCT04516746|12030268|FG001|Overall Study|Physician Decision|2
7619636|NCT04516746|12030267|FG000|Overall Study|Other|0
7619637|NCT04516746|12030268|FG001|Overall Study|Other|1
7619638|NCT04447417|12030276|FG000|Overall Study|Withdrawal by Subject|1
7619639|NCT04447417|12030277|FG001|Overall Study|Withdrawal by Subject|0
7619640|NCT04447417|12030276|FG000|Overall Study|Failure to meet inclusion criteria|1
7619641|NCT04447417|12030277|FG001|Overall Study|Failure to meet inclusion criteria|0
7619642|NCT04447417|12030276|FG000|Overall Study|Lost to Follow-up|1
7619643|NCT04447417|12030277|FG001|Overall Study|Lost to Follow-up|0
7619644|NCT04418765|12030296|FG000|Overall Study|Adverse Event|1
7619645|NCT04418765|12030297|FG001|Overall Study|Adverse Event|1
7619646|NCT04418765|12030298|FG002|Overall Study|Adverse Event|6
7619647|NCT04418765|12030296|FG000|Overall Study|Lack of Efficacy|1
7619648|NCT04418765|12030297|FG001|Overall Study|Lack of Efficacy|3
7619649|NCT04418765|12030298|FG002|Overall Study|Lack of Efficacy|0
7619650|NCT04418765|12030296|FG000|Overall Study|Protocol Violation|0
7619651|NCT04418765|12030297|FG001|Overall Study|Protocol Violation|1
7619652|NCT04418765|12030298|FG002|Overall Study|Protocol Violation|1
7619653|NCT04418765|12030296|FG000|Overall Study|Withdrawal by Subject|1
7619654|NCT04418765|12030297|FG001|Overall Study|Withdrawal by Subject|5
7619655|NCT04418765|12030298|FG002|Overall Study|Withdrawal by Subject|2
7619656|NCT04418765|12030296|FG000|Overall Study|Lost to Follow-up|0
7619657|NCT04418765|12030297|FG001|Overall Study|Lost to Follow-up|1
7619658|NCT04418765|12030298|FG002|Overall Study|Lost to Follow-up|0
7619659|NCT04418765|12030296|FG000|Overall Study|Other than specified|2
7619660|NCT04418765|12030297|FG001|Overall Study|Other than specified|0
7619661|NCT04418765|12030298|FG002|Overall Study|Other than specified|1
7784601|NCT00979628|12234677|FG002|Overall Study|transferred to ICU|1
7784602|NCT00979654|12234688|FG000|Overall Study|Lost to Follow-up|1
7784603|NCT00979654|12234688|FG000|Overall Study|Withdrawal by Subject|22
7784604|NCT00979654|12234688|FG000|Overall Study|Death|1
7784605|NCT00979654|12234688|FG000|Overall Study|Lack of Efficacy|6
7784606|NCT00979654|12234688|FG000|Overall Study|Adverse Event|1
7784607|NCT00979654|12234688|FG000|Overall Study|Adverse Event of Diverticulitis|1
7784608|NCT00979654|12234688|FG000|Overall Study|Per Principal Investigator's Discretion|1
7784609|NCT00979654|12234688|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1
7784610|NCT00979654|12234688|FG000|Overall Study|Serious Adverse Event|1
7784611|NCT00979654|12234688|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1
7784612|NCT00979953|12234742|FG000|Overall Study|Adverse Event|5
7784613|NCT00979953|12234743|FG001|Overall Study|Adverse Event|2
7784614|NCT00979953|12234744|FG002|Overall Study|Adverse Event|17
7784615|NCT00979953|12234745|FG003|Overall Study|Adverse Event|4
7784616|NCT00979953|12234742|FG000|Overall Study|Lack of Efficacy|1
7784617|NCT00979953|12234743|FG001|Overall Study|Lack of Efficacy|2
7784618|NCT00979953|12234744|FG002|Overall Study|Lack of Efficacy|0
7784619|NCT00979953|12234745|FG003|Overall Study|Lack of Efficacy|0
7784620|NCT00979953|12234742|FG000|Overall Study|Lost to Follow-up|1
7784621|NCT00979953|12234743|FG001|Overall Study|Lost to Follow-up|1
7784622|NCT00979953|12234744|FG002|Overall Study|Lost to Follow-up|1
7784623|NCT00979953|12234745|FG003|Overall Study|Lost to Follow-up|0
7784624|NCT00979953|12234742|FG000|Overall Study|Withdrawal by Subject|0
7784625|NCT00979953|12234743|FG001|Overall Study|Withdrawal by Subject|0
7784626|NCT00979953|12234744|FG002|Overall Study|Withdrawal by Subject|2
7784627|NCT00979953|12234745|FG003|Overall Study|Withdrawal by Subject|1
7784628|NCT00979953|12234742|FG000|Overall Study|Protocol Violation|1
7784629|NCT00979953|12234743|FG001|Overall Study|Protocol Violation|0
7784630|NCT00979953|12234744|FG002|Overall Study|Protocol Violation|2
7784631|NCT00979953|12234745|FG003|Overall Study|Protocol Violation|2
7784632|NCT00979992|12234755|FG000|Overall Study|Ineligible - inadequate pathology|1
7784633|NCT00979992|12234755|FG000|Overall Study|Ineligible - wrong cell type|2
7784634|NCT00979992|12234755|FG000|Overall Study|Refused - Never Treated|2
7784635|NCT00980005|12234761|FG000|Overall Study|Withdrawal by Subject|6
7784636|NCT00980005|12234762|FG001|Overall Study|Withdrawal by Subject|17
7784637|NCT00980005|12234761|FG000|Overall Study|Lost to Follow-up|37
7784638|NCT00980005|12234762|FG001|Overall Study|Lost to Follow-up|43
7619662|NCT04418765|12030296|FG000|Overall Study|Randomized but not treated|1
7619663|NCT04418765|12030297|FG001|Overall Study|Randomized but not treated|0
7619664|NCT04418765|12030298|FG002|Overall Study|Randomized but not treated|0
7619665|NCT04343976|12030317|FG000|Overall Study|Withdrawal by Subject|0
7619666|NCT04343976|12030318|FG001|Overall Study|Withdrawal by Subject|1
7784639|NCT00980005|12234761|FG000|Overall Study|Other|4
7784640|NCT00980005|12234762|FG001|Overall Study|Other|3
7784641|NCT00980018|12234772|FG000|Overall Study|Adverse Event|8
7784642|NCT00980018|12234772|FG000|Overall Study|Patient withdrew consent|3
7784643|NCT00980018|12234772|FG000|Overall Study|Lost to Follow-up|1
7784644|NCT00980044|12234779|FG000|Overall Study|Withdrawal by Subject|5
7784645|NCT00980044|12234780|FG001|Overall Study|Withdrawal by Subject|7
7784646|NCT00980044|12234781|FG002|Overall Study|Withdrawal by Subject|3
7619675|NCT04000581|12030335|FG000|Overall Study|Withdrawal by Subject|0
7619676|NCT04000581|12030336|FG001|Overall Study|Withdrawal by Subject|1
7619677|NCT03935880|12030344|FG000|Overall Study|Lost to Follow-up|0
7619678|NCT03935880|12030345|FG001|Overall Study|Lost to Follow-up|1
7619679|NCT03834350|12030351|FG000|Overall Study|Withdrawal by Subject|1
7619680|NCT03761056|12030368|FG000|Overall Study|Still on Study|34
7619681|NCT03761056|12030368|FG000|Overall Study|Death|6
7619682|NCT03761056|12030368|FG000|Overall Study|Investigator Decision|1
7619683|NCT03761056|12030368|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1
7619684|NCT03710564|12030380|FG000|Overall Study|Study Terminated by Sponsor|104
7619685|NCT03710564|12030381|FG001|Overall Study|Study Terminated by Sponsor|55
7619686|NCT03710564|12030380|FG000|Overall Study|Withdrawal by Subject|57
7619687|NCT03710564|12030381|FG001|Overall Study|Withdrawal by Subject|25
7619688|NCT03710564|12030380|FG000|Overall Study|Death|10
7619689|NCT03710564|12030381|FG001|Overall Study|Death|4
7619690|NCT03710564|12030380|FG000|Overall Study|Lost to Follow-up|5
7619691|NCT03710564|12030381|FG001|Overall Study|Lost to Follow-up|4
7619692|NCT03710564|12030380|FG000|Overall Study|Protocol Violation|3
7784647|NCT00980044|12234779|FG000|Overall Study|Protocol Violation|0
7784648|NCT00980044|12234780|FG001|Overall Study|Protocol Violation|0
7784649|NCT00980044|12234781|FG002|Overall Study|Protocol Violation|2
7784650|NCT00980057|12234794|FG000|Overall Study|Death|13
7784651|NCT00980057|12234795|FG001|Overall Study|Death|3
7784652|NCT00980057|12234794|FG000|Overall Study|Adverse Event|0
7784653|NCT00980057|12234795|FG001|Overall Study|Adverse Event|1
7784654|NCT00980057|12234794|FG000|Overall Study|Physician Decision|4
7784655|NCT00980057|12234795|FG001|Overall Study|Physician Decision|0
7784656|NCT00980057|12234794|FG000|Overall Study|Lost to Follow-up|1
7784657|NCT00980057|12234795|FG001|Overall Study|Lost to Follow-up|0
7784658|NCT00980057|12234794|FG000|Overall Study|Withdrawal by Subject|1
7784659|NCT00980057|12234795|FG001|Overall Study|Withdrawal by Subject|1
7784660|NCT00980148|12234804|FG000|Overall Study|Discharged from facility|89
7784661|NCT00980148|12234805|FG001|Overall Study|Discharged from facility|96
7784662|NCT00980148|12234804|FG000|Overall Study|Received other antichlamydia treatment|20
7784663|NCT00980148|12234805|FG001|Overall Study|Received other antichlamydia treatment|14
7784664|NCT00980148|12234804|FG000|Overall Study|Negative for chlamydia at enrollment|12
7784665|NCT00980148|12234805|FG001|Overall Study|Negative for chlamydia at enrollment|9
7784666|NCT00980148|12234804|FG000|Overall Study|Various other reasons|8
7784667|NCT00980148|12234805|FG001|Overall Study|Various other reasons|9
7784668|NCT00980174|12234813|FG000|Overall Study|Withdrawal by Subject|1
7784669|NCT00980174|12234814|FG001|Overall Study|Withdrawal by Subject|4
7784670|NCT00980174|12234813|FG000|Overall Study|Adverse Event|0
7784671|NCT00980174|12234814|FG001|Overall Study|Adverse Event|3
7784672|NCT00980174|12234813|FG000|Overall Study|Ineligibility determined|2
7784673|NCT00980174|12234814|FG001|Overall Study|Ineligibility determined|1
7784674|NCT00980174|12234813|FG000|Overall Study|Death|1
7784675|NCT00980174|12234814|FG001|Overall Study|Death|1
7784676|NCT00980174|12234813|FG000|Overall Study|Other|0
7784677|NCT00980174|12234814|FG001|Overall Study|Other|1
7784678|NCT00980200|12234820|FG000|7-day Treatment Period 1|Withdrawal by Subject|0
7784679|NCT00980200|12234821|FG001|7-day Treatment Period 1|Withdrawal by Subject|1
7784680|NCT00980200|12234822|FG002|7-day Treatment Period 1|Withdrawal by Subject|0
7784681|NCT00980200|12234823|FG003|7-day Treatment Period 1|Withdrawal by Subject|0
7784682|NCT00980200|12234824|FG004|7-day Treatment Period 1|Withdrawal by Subject|0
7784683|NCT00980200|12234820|FG000|7-day Treatment Period 3|Lack of Efficacy|0
7784684|NCT00980200|12234821|FG001|7-day Treatment Period 3|Lack of Efficacy|1
7784685|NCT00980200|12234822|FG002|7-day Treatment Period 3|Lack of Efficacy|0
7784686|NCT00980200|12234823|FG003|7-day Treatment Period 3|Lack of Efficacy|0
7784687|NCT00980200|12234824|FG004|7-day Treatment Period 3|Lack of Efficacy|1
7619693|NCT03710564|12030381|FG001|Overall Study|Protocol Violation|2
7619694|NCT03710564|12030380|FG000|Overall Study|Adverse Event|3
7619695|NCT03710564|12030381|FG001|Overall Study|Adverse Event|0
7619696|NCT03710564|12030380|FG000|Overall Study|Physician Decision|2
7619697|NCT03710564|12030381|FG001|Overall Study|Physician Decision|3
7784688|NCT00980330|12234852|FG000|Overall Study|Adverse Event|0
7784689|NCT00980330|12234853|FG001|Overall Study|Adverse Event|0
7784690|NCT00980330|12234854|FG002|Overall Study|Adverse Event|0
7784691|NCT00980330|12234855|FG003|Overall Study|Adverse Event|1
7784692|NCT00980330|12234856|FG004|Overall Study|Adverse Event|0
7784693|NCT00980330|12234857|FG005|Overall Study|Adverse Event|0
7784694|NCT00980330|12234858|FG006|Overall Study|Adverse Event|0
7784695|NCT00980330|12234852|FG000|Overall Study|Lost to Follow-up|1
7784696|NCT00980330|12234853|FG001|Overall Study|Lost to Follow-up|1
7784697|NCT00980330|12234854|FG002|Overall Study|Lost to Follow-up|4
7784698|NCT00980330|12234855|FG003|Overall Study|Lost to Follow-up|2
7784699|NCT00980330|12234856|FG004|Overall Study|Lost to Follow-up|1
7784700|NCT00980330|12234857|FG005|Overall Study|Lost to Follow-up|1
7784701|NCT00980330|12234858|FG006|Overall Study|Lost to Follow-up|2
7784702|NCT00980330|12234852|FG000|Overall Study|Withdrawal by Subject|2
7784703|NCT00980330|12234853|FG001|Overall Study|Withdrawal by Subject|4
7619698|NCT03693404|12030390|FG000|Overall Study|Withdrawal by Subject|1
7619699|NCT03693404|12030391|FG001|Overall Study|Withdrawal by Subject|0
7784704|NCT00980330|12234854|FG002|Overall Study|Withdrawal by Subject|4
7784705|NCT00980330|12234855|FG003|Overall Study|Withdrawal by Subject|1
7784706|NCT00980330|12234856|FG004|Overall Study|Withdrawal by Subject|3
7619700|NCT03693404|12030390|FG000|Overall Study|Lost to Follow-up|0
7619701|NCT03693404|12030391|FG001|Overall Study|Lost to Follow-up|5
7619702|NCT03693404|12030390|FG000|Overall Study|Excluded from Analysis|0
7619703|NCT03693404|12030391|FG001|Overall Study|Excluded from Analysis|1
7619704|NCT03660943|12030399|FG000|Overall Study|Adverse Event|5
7619705|NCT03660943|12030400|FG001|Overall Study|Adverse Event|3
7619706|NCT03660943|12030399|FG000|Overall Study|Death|0
7619707|NCT03660943|12030400|FG001|Overall Study|Death|2
7619708|NCT03660943|12030399|FG000|Overall Study|Lost to Follow-up|7
7619709|NCT03660943|12030400|FG001|Overall Study|Lost to Follow-up|3
7619710|NCT03660943|12030399|FG000|Overall Study|Protocol Violation|3
7619711|NCT03660943|12030400|FG001|Overall Study|Protocol Violation|5
7619712|NCT03660943|12030399|FG000|Overall Study|Withdrawal by Subject|8
7619713|NCT03660943|12030400|FG001|Overall Study|Withdrawal by Subject|15
7619714|NCT03660943|12030399|FG000|Overall Study|Lack of Efficacy|9
7619715|NCT03660943|12030400|FG001|Overall Study|Lack of Efficacy|12
7619716|NCT03660943|12030399|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4
7619717|NCT03660943|12030400|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13
7619718|NCT03658889|12030408|FG000|Overall Study|Protocol Violation|2
7619719|NCT03658889|12030409|FG001|Overall Study|Protocol Violation|0
7619720|NCT03654885|12030416|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5
7619721|NCT03654885|12030417|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3
7619722|NCT03654885|12030416|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0
7619723|NCT03654885|12030417|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3
7619724|NCT03654885|12030416|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7
7619725|NCT03654885|12030417|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1
7619726|NCT03654885|12030416|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7
7619727|NCT03654885|12030417|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1
7619728|NCT03654885|12030416|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1
7784707|NCT00980330|12234857|FG005|Overall Study|Withdrawal by Subject|2
7784708|NCT00980330|12234858|FG006|Overall Study|Withdrawal by Subject|5
7784709|NCT00980330|12234852|FG000|Overall Study|(not specified)|2
7784710|NCT00980330|12234853|FG001|Overall Study|(not specified)|0
7784711|NCT00980330|12234854|FG002|Overall Study|(not specified)|0
7784712|NCT00980330|12234855|FG003|Overall Study|(not specified)|1
7784713|NCT00980330|12234856|FG004|Overall Study|(not specified)|1
7784714|NCT00980330|12234857|FG005|Overall Study|(not specified)|1
7784715|NCT00980330|12234858|FG006|Overall Study|(not specified)|0
7619729|NCT03654885|12030417|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0
7619730|NCT03654885|12030416|FG000|Overall Study|Adverse Event in Study Eye|3
7619731|NCT03654885|12030417|FG001|Overall Study|Adverse Event in Study Eye|0
7619732|NCT03654885|12030416|FG000|Overall Study|Consent Withdrawn|1
7619733|NCT03654885|12030417|FG001|Overall Study|Consent Withdrawn|0
7619734|NCT03654885|12030416|FG000|Overall Study|Death|3
7619735|NCT03654885|12030417|FG001|Overall Study|Death|1
7619736|NCT03654885|12030416|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0
7619737|NCT03654885|12030417|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1
7619738|NCT03654885|12030416|FG000|Overall Study|Lost to Follow-up|3
7619739|NCT03654885|12030417|FG001|Overall Study|Lost to Follow-up|3
7619740|NCT03568461|12030423|FG000|Overall Study|Death|7
7619741|NCT03568461|12030423|FG000|Overall Study|Physician Decision|5
7619742|NCT03568461|12030423|FG000|Overall Study|Subject decision|5
7784716|NCT00980343|12234877|FG000|Overall Study|no tumor at surgery - treatment effect|1
7784717|NCT00980343|12234878|FG001|Overall Study|no tumor at surgery - treatment effect|3
7784718|NCT00980655|12234910|FG000|Overall Study|Adverse Event|13
7784719|NCT00980655|12234911|FG001|Overall Study|Adverse Event|31
7784720|NCT00980655|12234910|FG000|Overall Study|Death|0
7784721|NCT00980655|12234911|FG001|Overall Study|Death|7
7784722|NCT00980655|12234910|FG000|Overall Study|Protocol Violation|2
7784723|NCT00980655|12234911|FG001|Overall Study|Protocol Violation|7
7784724|NCT00980655|12234910|FG000|Overall Study|Withdrawal by Subject|0
7784725|NCT00980655|12234911|FG001|Overall Study|Withdrawal by Subject|4
7784726|NCT00980655|12234910|FG000|Overall Study|Lost to Follow-up|0
7784727|NCT00980655|12234911|FG001|Overall Study|Lost to Follow-up|1
7784728|NCT00980655|12234910|FG000|Overall Study|Parent/legal guardian request|1
7784729|NCT00980655|12234911|FG001|Overall Study|Parent/legal guardian request|0
7784730|NCT00980655|12234910|FG000|Overall Study|Other|0
7784731|NCT00980655|12234911|FG001|Overall Study|Other|1
7784732|NCT00980798|12234964|FG000|Overall Study|Adverse Event|7
7784733|NCT00980798|12234965|FG001|Overall Study|Adverse Event|36
7784734|NCT00980798|12234964|FG000|Overall Study|Lack of Efficacy|16
7784735|NCT00980798|12234965|FG001|Overall Study|Lack of Efficacy|5
7784736|NCT00980798|12234964|FG000|Overall Study|Lost to Follow-up|0
7784737|NCT00980798|12234965|FG001|Overall Study|Lost to Follow-up|1
7784738|NCT00980798|12234964|FG000|Overall Study|Physician Decision|2
7784739|NCT00980798|12234965|FG001|Overall Study|Physician Decision|1
7619743|NCT03568461|12030423|FG000|Overall Study|Lost to Follow-up|1
7619744|NCT03500692|12030436|FG000|Overall Study|Death|76
7619745|NCT03500692|12030436|FG000|Overall Study|Missed visit|30
7784740|NCT00980798|12234964|FG000|Overall Study|Withdrawal by Subject|8
7784741|NCT00980798|12234965|FG001|Overall Study|Withdrawal by Subject|11
7619746|NCT03500692|12030436|FG000|Overall Study|Termination Reasons|3
7784742|NCT00980798|12234964|FG000|Overall Study|Other|0
7784743|NCT00980798|12234965|FG001|Overall Study|Other|1
7784744|NCT00980980|12234974|FG000|Overall Study|Withdrawal by Hospital|0
7784745|NCT00980980|12234975|FG001|Overall Study|Withdrawal by Hospital|1
7784746|NCT00980980|12234976|FG002|Overall Study|Withdrawal by Hospital|0
7784747|NCT00981019|12234987|FG000|Overall Study|Did not respond|65
7784748|NCT00981019|12234987|FG000|Overall Study|Did not match target population|94
7784749|NCT00981019|12234987|FG000|Overall Study|Inadvertent exclusion|239
7784750|NCT00981019|12234987|FG000|Overall Study|Hit the survey after closure|79
7784751|NCT00981084|12235002|FG000|Post Intervention (Data Analysis)|poor effort|1
7784752|NCT00981084|12235003|FG001|Post Intervention (Data Analysis)|poor effort|1
7784753|NCT00981084|12235002|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1
7784754|NCT00981084|12235003|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0
7784755|NCT00981149|12235013|FG000|Overall Study|Lost to Follow-up|1
7784756|NCT00981149|12235014|FG001|Overall Study|Lost to Follow-up|2
7784757|NCT00981149|12235013|FG000|Overall Study|Withdrawal by Subject|1
7784758|NCT00981149|12235014|FG001|Overall Study|Withdrawal by Subject|1
7784759|NCT00981175|12235023|FG000|Primary Dose Vaccination|Adverse Event|1
7784760|NCT00981175|12235024|FG001|Primary Dose Vaccination|Adverse Event|0
7784761|NCT00981175|12235023|FG000|Primary Dose Vaccination|Protocol Violation|0
7784762|NCT00981175|12235024|FG001|Primary Dose Vaccination|Protocol Violation|1
7784763|NCT00981175|12235023|FG000|Primary Dose Vaccination|Lost to Follow-up|2
7784764|NCT00981175|12235024|FG001|Primary Dose Vaccination|Lost to Follow-up|1
7784765|NCT00981175|12235023|FG000|Booster Dose Vaccination|Lost to Follow-up|2
7784766|NCT00981175|12235024|FG001|Booster Dose Vaccination|Lost to Follow-up|3
7784767|NCT00981292|12235086|FG000|Day 1|Protocol Violation|1
7784768|NCT00981292|12235087|FG001|Day 1|Protocol Violation|0
7784769|NCT00981292|12235088|FG002|Day 1|Protocol Violation|0
7784770|NCT00981292|12235089|FG003|Day 1|Protocol Violation|0
7784771|NCT00981292|12235090|FG004|Day 1|Protocol Violation|0
7784772|NCT00981292|12235091|FG005|Day 1|Protocol Violation|2
7784773|NCT00981292|12235086|FG000|Day 2|Protocol Violation|2
7784774|NCT00981292|12235087|FG001|Day 2|Protocol Violation|0
7784775|NCT00981292|12235088|FG002|Day 2|Protocol Violation|0
7784776|NCT00981292|12235089|FG003|Day 2|Protocol Violation|0
7784777|NCT00981292|12235090|FG004|Day 2|Protocol Violation|0
7784778|NCT00981292|12235091|FG005|Day 2|Protocol Violation|0
7784779|NCT00981292|12235086|FG000|Day 3|Protocol Violation|0
7784780|NCT00981292|12235087|FG001|Day 3|Protocol Violation|0
7784781|NCT00981292|12235088|FG002|Day 3|Protocol Violation|0
7784782|NCT00981292|12235089|FG003|Day 3|Protocol Violation|0
7784783|NCT00981292|12235090|FG004|Day 3|Protocol Violation|0
7784784|NCT00981292|12235091|FG005|Day 3|Protocol Violation|1
7784785|NCT00981409|12235114|FG000|Overall Study|Adverse Event|4
7784786|NCT00981409|12235115|FG001|Overall Study|Adverse Event|0
7784787|NCT00981409|12235114|FG000|Overall Study|Protocol Violation|0
7784788|NCT00981409|12235115|FG001|Overall Study|Protocol Violation|1
7784789|NCT00981409|12235114|FG000|Overall Study|Prostate Cancer Treatment before Trial|2
7784790|NCT00981409|12235115|FG001|Overall Study|Prostate Cancer Treatment before Trial|0
7784791|NCT00981461|12235136|FG000|Overall Study|Lost to Follow-up|5
7784792|NCT00981461|12235137|FG001|Overall Study|Lost to Follow-up|2
7784793|NCT00981526|12235156|FG000|Overall Study|Withdrawal by Subject|0
7784794|NCT00981526|12235157|FG001|Overall Study|Withdrawal by Subject|2
7784795|NCT00981526|12235156|FG000|Overall Study|Physician Decision|4
7784796|NCT00981526|12235157|FG001|Overall Study|Physician Decision|4
7784797|NCT00981578|12235165|FG000|Overall Study|Death|1
7784798|NCT00981578|12235165|FG000|Overall Study|Withdrawal by Subject|2
7784799|NCT00981682|12235195|FG000|Overall Study|Adverse Event|48
7784800|NCT00981682|12235195|FG000|Overall Study|Withdrawal by Subject|52
7784801|NCT00981682|12235195|FG000|Overall Study|Lost to Follow-up|14
7784802|NCT00981682|12235195|FG000|Overall Study|Lack of Efficacy|13
7784803|NCT00981682|12235195|FG000|Overall Study|Protocol Violation|6
7784804|NCT00981682|12235195|FG000|Overall Study|administrative|9
7784805|NCT00981747|12235199|FG000|Losartan|Withdrawal by Subject|1
7784806|NCT00981747|12235199|FG000|Losartan|Death|1
7784807|NCT00981747|12235199|FG000|Placebo Oral Tablet|Withdrawal by Subject|1
7784808|NCT00981799|12235213|FG000|Overall Study|Adverse Event|1
7784809|NCT00981799|12235214|FG001|Overall Study|Adverse Event|1
7784810|NCT00981799|12235215|FG002|Overall Study|Adverse Event|0
7784811|NCT00981799|12235216|FG003|Overall Study|Adverse Event|0
7784812|NCT00982020|12235259|FG000|Overall Study|Adverse Event|19
7784813|NCT00982020|12235260|FG001|Overall Study|Adverse Event|15
7784814|NCT00982020|12235259|FG000|Overall Study|Withdrawal by Subject|11
7784815|NCT00982020|12235260|FG001|Overall Study|Withdrawal by Subject|14
7784816|NCT00982020|12235259|FG000|Overall Study|Lost to Follow-up|5
7784817|NCT00982020|12235260|FG001|Overall Study|Lost to Follow-up|11
7784818|NCT00982020|12235259|FG000|Overall Study|Lack of Efficacy|10
7784819|NCT00982020|12235260|FG001|Overall Study|Lack of Efficacy|4
7784820|NCT00982020|12235259|FG000|Overall Study|Parent/Caregiver Decision|5
7784821|NCT00982020|12235260|FG001|Overall Study|Parent/Caregiver Decision|5
7784822|NCT00982020|12235259|FG000|Overall Study|Treatment Non-compliance|3
7784823|NCT00982020|12235260|FG001|Overall Study|Treatment Non-compliance|6
7784824|NCT00982020|12235259|FG000|Overall Study|Physician Decision|2
7784825|NCT00982020|12235260|FG001|Overall Study|Physician Decision|5
7784826|NCT00982020|12235259|FG000|Overall Study|Entry Criteria Not Met|2
7784827|NCT00982020|12235260|FG001|Overall Study|Entry Criteria Not Met|1
7619763|NCT03412747|12030452|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2
7619764|NCT03412747|12030453|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2
7619765|NCT03412747|12030454|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3
7619766|NCT03412747|12030452|FG000|Initial Treatment Period: Wk0-Wk16|Death|0
7619767|NCT03412747|12030453|FG001|Initial Treatment Period: Wk0-Wk16|Death|0
7784828|NCT00982020|12235259|FG000|Overall Study|Protocol Violation|0
7784829|NCT00982020|12235260|FG001|Overall Study|Protocol Violation|2
7784830|NCT00982020|12235259|FG000|Overall Study|Clinical Relapse|0
7784831|NCT00982020|12235260|FG001|Overall Study|Clinical Relapse|1
7784832|NCT00982137|12235293|FG000|Overall Study|Lost to Follow-up|0
7784833|NCT00982137|12235294|FG001|Overall Study|Lost to Follow-up|0
7784834|NCT00982137|12235295|FG002|Overall Study|Lost to Follow-up|0
7784835|NCT00982137|12235296|FG003|Overall Study|Lost to Follow-up|1
7784836|NCT00982137|12235293|FG000|Overall Study|Withdrawal by Subject|0
7784837|NCT00982137|12235294|FG001|Overall Study|Withdrawal by Subject|1
7784838|NCT00982137|12235295|FG002|Overall Study|Withdrawal by Subject|0
7784839|NCT00982137|12235296|FG003|Overall Study|Withdrawal by Subject|0
7784840|NCT00982228|12235334|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
7784841|NCT00982228|12235335|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
7619768|NCT03412747|12030454|FG002|Initial Treatment Period: Wk0-Wk16|Death|1
7619769|NCT03412747|12030452|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0
7619770|NCT03412747|12030453|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0
7619771|NCT03412747|12030454|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1
7619772|NCT03412747|12030452|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0
7619773|NCT03412747|12030453|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0
7619774|NCT03412747|12030454|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2
7619775|NCT03412747|12030452|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0
7619776|NCT03412747|12030453|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2
7619777|NCT03412747|12030454|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1
7619778|NCT03412747|12030452|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4
7619779|NCT03412747|12030453|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1
7619780|NCT03412747|12030454|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1
7619781|NCT03412747|12030452|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1
7619782|NCT03412747|12030453|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0
7784842|NCT00982228|12235334|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
7784843|NCT00982228|12235335|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
7784844|NCT00982228|12235334|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
7784845|NCT00982228|12235335|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
7784846|NCT00982228|12235334|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
7784847|NCT00982228|12235335|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
7784848|NCT00982228|12235334|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
7784849|NCT00982228|12235335|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
7784850|NCT00982228|12235334|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
7784851|NCT00982228|12235335|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
7784852|NCT00982228|12235334|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
7784853|NCT00982228|12235335|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
7784854|NCT00982228|12235334|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
7784855|NCT00982228|12235335|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
7784856|NCT00982228|12235334|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
7784857|NCT00982228|12235335|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
7784858|NCT00982228|12235334|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
7784859|NCT00982228|12235335|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
7784860|NCT00982280|12235341|FG000|Observation Period|Not eligible to be dosed|19
7784861|NCT00982280|12235341|FG000|Titration and Optimal Dose Period|Adverse Event|5
7784862|NCT00982280|12235341|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2
7784863|NCT00982280|12235341|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1
7784864|NCT00982280|12235341|FG000|Maintenance Period|Adverse Event|1
7784865|NCT00982319|12235348|FG000|Overall Study|Surgery date change|1
7784866|NCT00982319|12235349|FG001|Overall Study|Surgery date change|0
7784867|NCT00982319|12235348|FG000|Overall Study|Preop values out of acceptable range|1
7784868|NCT00982319|12235349|FG001|Overall Study|Preop values out of acceptable range|1
7784869|NCT00982319|12235348|FG000|Overall Study|Pregnancy|0
7784870|NCT00982319|12235349|FG001|Overall Study|Pregnancy|1
7784871|NCT00982410|12235373|FG000|3-month Follow-up Assessment|Could not reach to schedule|8
7784872|NCT00982410|12235374|FG001|3-month Follow-up Assessment|Could not reach to schedule|9
7784873|NCT00982410|12235373|FG000|3-month Follow-up Assessment|Scheduled, no-show|1
7784874|NCT00982410|12235374|FG001|3-month Follow-up Assessment|Scheduled, no-show|2
7784875|NCT00982410|12235373|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0
7784876|NCT00982410|12235374|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2
7784877|NCT00982410|12235373|FG000|6-month Follow-up Assessment|Could not reach to schedule|5
7784878|NCT00982410|12235374|FG001|6-month Follow-up Assessment|Could not reach to schedule|7
7784879|NCT00982410|12235373|FG000|6-month Follow-up Assessment|participant no transportation|1
7619783|NCT03412747|12030454|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0
7619784|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3
7619785|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1
7619786|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0
7619787|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1
7619788|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0
7619789|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0
7619790|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0
7619791|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0
7619792|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1
7619793|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1
7784880|NCT00982410|12235374|FG001|6-month Follow-up Assessment|participant no transportation|0
7784881|NCT00982410|12235373|FG000|6-month Follow-up Assessment|incarceration|0
7784882|NCT00982410|12235374|FG001|6-month Follow-up Assessment|incarceration|2
7784883|NCT00982410|12235373|FG000|6-month Follow-up Assessment|patent surgery|0
7784884|NCT00982410|12235374|FG001|6-month Follow-up Assessment|patent surgery|1
7784885|NCT00982410|12235373|FG000|6-month Follow-up Assessment|scheduled, no-show|0
7619794|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0
7619795|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0
7619796|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3
7619797|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4
7619798|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6
7619799|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0
7619800|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1
7619801|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1
7619802|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0
7619803|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2
7784886|NCT00982410|12235374|FG001|6-month Follow-up Assessment|scheduled, no-show|1
7784887|NCT00982410|12235373|FG000|12-month Follow-up Assessment|Death|0
7784888|NCT00982410|12235374|FG001|12-month Follow-up Assessment|Death|2
7784889|NCT00982410|12235373|FG000|12-month Follow-up Assessment|could not reach to schedule|6
7784890|NCT00982410|12235374|FG001|12-month Follow-up Assessment|could not reach to schedule|5
7784891|NCT00982410|12235373|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0
7784892|NCT00982410|12235374|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1
7784893|NCT00982410|12235373|FG000|12-month Follow-up Assessment|incarceration|2
7784894|NCT00982410|12235374|FG001|12-month Follow-up Assessment|incarceration|1
7784895|NCT00982410|12235373|FG000|12-month Follow-up Assessment|scheduled, no-show|1
7784896|NCT00982410|12235374|FG001|12-month Follow-up Assessment|scheduled, no-show|0
7800385|NCT01094288|12257771|FG002|Overall Study|Ongoing Participants|0
7800386|NCT01094288|12257772|FG003|Overall Study|Ongoing Participants|0
7800387|NCT01094288|12257773|FG004|Overall Study|Ongoing Participants|0
7800388|NCT01094288|12257774|FG005|Overall Study|Ongoing Participants|0
7800389|NCT01094288|12257775|FG006|Overall Study|Ongoing Participants|0
7800390|NCT01094288|12257776|FG007|Overall Study|Ongoing Participants|0
7800391|NCT01094301|12257798|FG000|Trial Stage|Withdrawal by Subject|1
7800392|NCT01094301|12257798|FG000|Implant Stage|Adverse Event|1
7800393|NCT01094301|12257798|FG000|Implant Stage|Protocol Violation|1
7800394|NCT01094301|12257798|FG000|Implant Stage|Withdrawal by Subject|2
7800395|NCT01094301|12257798|FG000|Implant Stage|No return of pain|4
7864100|NCT01609556|12353451|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7864101|NCT01609556|12353452|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7864102|NCT01609556|12353453|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7864103|NCT01609556|12353454|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7864104|NCT01609556|12353455|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7864105|NCT01609556|12353456|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1
7864106|NCT01609556|12353457|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7864107|NCT01609556|12353458|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7784897|NCT00982488|12235396|FG000|Overall Study|Administrative reason by sponsor|81
7784898|NCT00982488|12235397|FG001|Overall Study|Administrative reason by sponsor|3
7784899|NCT00982488|12235398|FG002|Overall Study|Administrative reason by sponsor|11
7784900|NCT00982488|12235399|FG003|Overall Study|Administrative reason by sponsor|0
7784901|NCT00982488|12235400|FG004|Overall Study|Administrative reason by sponsor|0
7784902|NCT00982488|12235396|FG000|Overall Study|Adverse event unrelated to study drug|5
7784903|NCT00982488|12235397|FG001|Overall Study|Adverse event unrelated to study drug|1
7784904|NCT00982488|12235398|FG002|Overall Study|Adverse event unrelated to study drug|0
7784905|NCT00982488|12235399|FG003|Overall Study|Adverse event unrelated to study drug|0
7784906|NCT00982488|12235400|FG004|Overall Study|Adverse event unrelated to study drug|0
7784907|NCT00982488|12235396|FG000|Overall Study|Death|11
7784908|NCT00982488|12235397|FG001|Overall Study|Death|0
7784909|NCT00982488|12235398|FG002|Overall Study|Death|2
7784910|NCT00982488|12235399|FG003|Overall Study|Death|0
7784911|NCT00982488|12235400|FG004|Overall Study|Death|0
7784912|NCT00982488|12235396|FG000|Overall Study|Disease progression|30
7619804|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5
7619805|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3
7619806|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1
7619807|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4
7619808|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0
7619809|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1
7619810|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0
7619811|NCT03326193|12030472|FG000|Overall Study|Treatment ongoing at the time of analysis|26
7619812|NCT03326193|12030472|FG000|Overall Study|Death|19
7619813|NCT03326193|12030472|FG000|Overall Study|Withdrawal by Subject|8
7619814|NCT03230292|12030493|FG000|Overall Study|Adverse Event|1
7619815|NCT03230292|12030493|FG000|Overall Study|Protocol Violation|1
7619816|NCT03230292|12030493|FG000|Overall Study|Lost to Follow-up|1
7619817|NCT03230292|12030493|FG000|Overall Study|Withdrawal by Subject|3
7784913|NCT00982488|12235397|FG001|Overall Study|Disease progression|5
7784914|NCT00982488|12235398|FG002|Overall Study|Disease progression|10
7784915|NCT00982488|12235399|FG003|Overall Study|Disease progression|1
7784916|NCT00982488|12235400|FG004|Overall Study|Disease progression|1
7784917|NCT00982488|12235396|FG000|Overall Study|Lost to Follow-up|1
7784918|NCT00982488|12235397|FG001|Overall Study|Lost to Follow-up|0
7784919|NCT00982488|12235398|FG002|Overall Study|Lost to Follow-up|0
7784920|NCT00982488|12235399|FG003|Overall Study|Lost to Follow-up|0
7784921|NCT00982488|12235400|FG004|Overall Study|Lost to Follow-up|0
7784922|NCT00982488|12235396|FG000|Overall Study|Maximum clinical benefit|1
7784923|NCT00982488|12235397|FG001|Overall Study|Maximum clinical benefit|1
7784924|NCT00982488|12235398|FG002|Overall Study|Maximum clinical benefit|1
7784925|NCT00982488|12235399|FG003|Overall Study|Maximum clinical benefit|0
7784926|NCT00982488|12235400|FG004|Overall Study|Maximum clinical benefit|0
7784927|NCT00982488|12235396|FG000|Overall Study|Other|15
7784928|NCT00982488|12235397|FG001|Overall Study|Other|1
7784929|NCT00982488|12235398|FG002|Overall Study|Other|3
7784930|NCT00982488|12235399|FG003|Overall Study|Other|1
7784931|NCT00982488|12235400|FG004|Overall Study|Other|0
7784932|NCT00982488|12235396|FG000|Overall Study|Poor compliance/noncompliance|0
7784933|NCT00982488|12235397|FG001|Overall Study|Poor compliance/noncompliance|1
7784934|NCT00982488|12235398|FG002|Overall Study|Poor compliance/noncompliance|0
7784935|NCT00982488|12235399|FG003|Overall Study|Poor compliance/noncompliance|0
7784936|NCT00982488|12235400|FG004|Overall Study|Poor compliance/noncompliance|0
7784937|NCT00982488|12235396|FG000|Overall Study|Stem cell transplant|2
7784938|NCT00982488|12235397|FG001|Overall Study|Stem cell transplant|0
7784939|NCT00982488|12235398|FG002|Overall Study|Stem cell transplant|0
7784940|NCT00982488|12235399|FG003|Overall Study|Stem cell transplant|1
7784941|NCT00982488|12235400|FG004|Overall Study|Stem cell transplant|0
7784942|NCT00982488|12235396|FG000|Overall Study|Study drug toxicity|34
7784943|NCT00982488|12235397|FG001|Overall Study|Study drug toxicity|1
7784944|NCT00982488|12235398|FG002|Overall Study|Study drug toxicity|6
7784945|NCT00982488|12235399|FG003|Overall Study|Study drug toxicity|0
7784946|NCT00982488|12235400|FG004|Overall Study|Study drug toxicity|0
7784947|NCT00982488|12235396|FG000|Overall Study|Withdrawal by Subject|5
7784948|NCT00982488|12235397|FG001|Overall Study|Withdrawal by Subject|1
7784949|NCT00982488|12235398|FG002|Overall Study|Withdrawal by Subject|1
7784950|NCT00982488|12235399|FG003|Overall Study|Withdrawal by Subject|0
7619818|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1
7619819|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
7619820|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2
7619821|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
7619822|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2
7619823|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2
7619824|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0
7784951|NCT00982488|12235400|FG004|Overall Study|Withdrawal by Subject|0
7784952|NCT00982644|12235432|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
7784953|NCT00982644|12235433|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
7784954|NCT00982644|12235432|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
7619825|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0
7619826|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3
7619827|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2
7619828|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3
7619829|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2
7619830|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
7619831|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7619832|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7619833|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7784955|NCT00982644|12235433|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
7784956|NCT00982644|12235432|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
7784957|NCT00982644|12235433|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
7784958|NCT00982644|12235432|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
7784959|NCT00982644|12235433|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
7784960|NCT00982644|12235432|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
7784961|NCT00982644|12235433|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
7784962|NCT00982644|12235432|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
7619834|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0
7619835|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0
7619836|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1
7619837|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0
7619838|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2
7619839|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1
7619840|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1
7619841|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4
7619842|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2
7619843|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1
7619844|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0
7619845|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1
7619846|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Other|4
7619847|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Other|0
7619848|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Other|1
7619849|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Other|0
7619850|NCT03227224|12030503|FG000|Follow-up Phase (2 Weeks)|Other|4
7619851|NCT03227224|12030504|FG001|Follow-up Phase (2 Weeks)|Other|4
7619852|NCT03227224|12030505|FG002|Follow-up Phase (2 Weeks)|Other|6
7619853|NCT03227224|12030506|FG003|Follow-up Phase (2 Weeks)|Other|3
7619854|NCT03069352|12030559|FG000|Overall Study|Ongoing|12
7619855|NCT03069352|12030560|FG001|Overall Study|Ongoing|40
7619856|NCT03056040|12030568|FG000|Primary Evaluation Period|Withdrawal by Subject|1
7619857|NCT03056040|12030569|FG001|Primary Evaluation Period|Withdrawal by Subject|1
7619858|NCT03056040|12030568|FG000|Primary Evaluation Period|Lack of Efficacy|0
7619859|NCT03056040|12030569|FG001|Primary Evaluation Period|Lack of Efficacy|1
7619860|NCT03056040|12030568|FG000|Primary Evaluation Period|Pregnancy|0
7619861|NCT03056040|12030569|FG001|Primary Evaluation Period|Pregnancy|1
7784963|NCT00982644|12235433|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
7784964|NCT00982644|12235432|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
7784965|NCT00982644|12235433|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
7784966|NCT00982644|12235432|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
7784967|NCT00982644|12235433|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
7784968|NCT00982644|12235432|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
7784969|NCT00982644|12235433|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
7784970|NCT00982644|12235432|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
7784971|NCT00982644|12235433|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
7784972|NCT00982657|12235443|FG000|Overall Study|Death|1
7784973|NCT00982657|12235444|FG001|Overall Study|Death|0
7784974|NCT00982657|12235445|FG002|Overall Study|Death|1
7784975|NCT00982657|12235446|FG003|Overall Study|Death|1
7784976|NCT00982657|12235443|FG000|Overall Study|Withdrawal by Subject|0
7784977|NCT00982657|12235444|FG001|Overall Study|Withdrawal by Subject|0
7784978|NCT00982657|12235445|FG002|Overall Study|Withdrawal by Subject|1
7784979|NCT00982657|12235446|FG003|Overall Study|Withdrawal by Subject|3
7784980|NCT00982657|12235443|FG000|Overall Study|Other|0
7784981|NCT00982657|12235444|FG001|Overall Study|Other|0
7784982|NCT00982657|12235445|FG002|Overall Study|Other|0
7784983|NCT00982657|12235446|FG003|Overall Study|Other|4
7784984|NCT00982657|12235443|FG000|Overall Study|On going at date of cut-off|0
7784985|NCT00982657|12235444|FG001|Overall Study|On going at date of cut-off|0
7784986|NCT00982657|12235445|FG002|Overall Study|On going at date of cut-off|0
7784987|NCT00982657|12235446|FG003|Overall Study|On going at date of cut-off|1
7784988|NCT00982735|12235466|FG000|Overall Study|Lost to Follow-up|6
7784989|NCT00982735|12235466|FG000|Overall Study|Patient ineligible for trial|224
7784990|NCT00982878|12235524|FG000|Overall Study|Physician Decision|1
7784991|NCT00982930|12235528|FG000|Overall Study|Adverse Event|1
7784992|NCT00982930|12235528|FG000|Overall Study|Withdrawal by Subject|1
7784993|NCT00982930|12235528|FG000|Overall Study|Administrative Problems|2
7784994|NCT00983073|12235532|FG000|Titration and Optimal Dose Period|Adverse Event|19
7784995|NCT00983073|12235532|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11
7784996|NCT00983073|12235532|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5
7784997|NCT00983073|12235532|FG000|Titration and Optimal Dose Period|Non-Compliance|1
7784998|NCT00983073|12235532|FG000|Titration and Optimal Dose Period|Other reason|4
7784999|NCT00983073|12235532|FG000|Maintenance Period|Adverse Event|5
7785000|NCT00983073|12235532|FG000|Maintenance Period|Withdrawal by Subject|2
7785001|NCT00983073|12235532|FG000|Maintenance Period|Lack of Efficacy|2
7785002|NCT00983073|12235532|FG000|Maintenance Period|Other Reason|7
7785003|NCT00983294|12235560|FG000|14 Day Washout Period|Withdrawal by Subject|2
7785004|NCT00983294|12235560|FG000|Colchicine With Azithromycin|Adverse Event|1
7785005|NCT00983372|12235579|FG000|14 Day Washout Period|Withdrawal by Subject|1
7785006|NCT00983372|12235579|FG000|Diltiazem ER Alone|missed diltiazem dose|2
7785007|NCT00983372|12235579|FG000|Diltiazem ER Alone|Adverse Event|1
7785008|NCT00983385|12235586|FG000|Observation Period|Not eligible to be dosed|20
7785009|NCT00983385|12235586|FG000|Observation Period|Not Evaluable due to Non Compliance|12
7785010|NCT00983476|12235608|FG000|Overall Study|Did not receive intervention|17
7785011|NCT00983476|12235609|FG001|Overall Study|Did not receive intervention|22
7619868|NCT03010527|12030619|FG000|Overall Study|Death|0
7619869|NCT03010527|12030620|FG001|Overall Study|Death|0
7619870|NCT03010527|12030621|FG002|Overall Study|Death|1
7619871|NCT03010527|12030619|FG000|Overall Study|Adverse Event|0
7619872|NCT03010527|12030620|FG001|Overall Study|Adverse Event|4
7619873|NCT03010527|12030621|FG002|Overall Study|Adverse Event|2
7619874|NCT03010527|12030619|FG000|Overall Study|Protocol Violation|0
7619875|NCT03010527|12030620|FG001|Overall Study|Protocol Violation|1
7619876|NCT03010527|12030621|FG002|Overall Study|Protocol Violation|0
7619877|NCT03010527|12030619|FG000|Overall Study|Lost to Follow-up|0
7619878|NCT03010527|12030620|FG001|Overall Study|Lost to Follow-up|2
7785012|NCT00983476|12235610|FG002|Overall Study|Did not receive intervention|0
7785013|NCT00983515|12235637|FG000|Ritonavir Alone|liver panel out of range|6
7785014|NCT00983515|12235637|FG000|Colchicine With Ritonavir|Lost to Follow-up|1
7785015|NCT00983528|12235644|FG000|Overall Study|Death|4
7785016|NCT00983528|12235644|FG000|Overall Study|Lost to Follow-up|1
7785017|NCT00983528|12235644|FG000|Overall Study|Study Terminated|1
7785018|NCT00983580|12235654|FG000|Overall Study|Cancel Prior to treatment|1
7785019|NCT00983580|12235655|FG001|Overall Study|Cancel Prior to treatment|3
7785020|NCT00983580|12235654|FG000|Overall Study|Protocol Violation|1
7785021|NCT00983580|12235655|FG001|Overall Study|Protocol Violation|1
7785022|NCT00983580|12235654|FG000|Overall Study|Ineligible|3
7785023|NCT00983580|12235655|FG001|Overall Study|Ineligible|0
7785024|NCT00983619|12235674|FG000|Overall Study|Lost to Follow-up|0
7785025|NCT00983619|12235675|FG001|Overall Study|Lost to Follow-up|1
7785026|NCT00983619|12235676|FG002|Overall Study|Lost to Follow-up|0
7785027|NCT00983619|12235677|FG003|Overall Study|Lost to Follow-up|0
7785028|NCT00983619|12235678|FG004|Overall Study|Lost to Follow-up|0
7785029|NCT00983619|12235679|FG005|Overall Study|Lost to Follow-up|2
7785030|NCT00983619|12235680|FG006|Overall Study|Lost to Follow-up|0
7785031|NCT00983619|12235681|FG007|Overall Study|Lost to Follow-up|0
7785032|NCT00983619|12235682|FG008|Overall Study|Lost to Follow-up|0
7785033|NCT00983619|12235683|FG009|Overall Study|Lost to Follow-up|0
7785034|NCT00983619|12235684|FG010|Overall Study|Lost to Follow-up|0
7785035|NCT00983619|12235685|FG011|Overall Study|Lost to Follow-up|2
7785036|NCT00983619|12235674|FG000|Overall Study|Withdrawal by Subject|2
7785037|NCT00983619|12235675|FG001|Overall Study|Withdrawal by Subject|1
7785038|NCT00983619|12235676|FG002|Overall Study|Withdrawal by Subject|1
7785039|NCT00983619|12235677|FG003|Overall Study|Withdrawal by Subject|3
7785040|NCT00983619|12235678|FG004|Overall Study|Withdrawal by Subject|1
7785041|NCT00983619|12235679|FG005|Overall Study|Withdrawal by Subject|23
7785042|NCT00983619|12235680|FG006|Overall Study|Withdrawal by Subject|0
7785043|NCT00983619|12235681|FG007|Overall Study|Withdrawal by Subject|0
7785044|NCT00983619|12235682|FG008|Overall Study|Withdrawal by Subject|0
7785045|NCT00983619|12235683|FG009|Overall Study|Withdrawal by Subject|0
7785046|NCT00983619|12235684|FG010|Overall Study|Withdrawal by Subject|1
7785047|NCT00983619|12235685|FG011|Overall Study|Withdrawal by Subject|1
7785048|NCT00983619|12235674|FG000|Overall Study|Death|0
7785049|NCT00983619|12235675|FG001|Overall Study|Death|2
7785050|NCT00983619|12235676|FG002|Overall Study|Death|2
7785051|NCT00983619|12235677|FG003|Overall Study|Death|1
7785052|NCT00983619|12235678|FG004|Overall Study|Death|2
7785053|NCT00983619|12235679|FG005|Overall Study|Death|30
7785054|NCT00983619|12235680|FG006|Overall Study|Death|1
7785055|NCT00983619|12235681|FG007|Overall Study|Death|0
7785056|NCT00983619|12235682|FG008|Overall Study|Death|1
7785057|NCT00983619|12235683|FG009|Overall Study|Death|2
7785058|NCT00983619|12235684|FG010|Overall Study|Death|9
7785059|NCT00983619|12235685|FG011|Overall Study|Death|8
7785060|NCT00983619|12235674|FG000|Overall Study|Other|1
7785061|NCT00983619|12235675|FG001|Overall Study|Other|0
7785062|NCT00983619|12235676|FG002|Overall Study|Other|0
7785063|NCT00983619|12235677|FG003|Overall Study|Other|1
7785064|NCT00983619|12235678|FG004|Overall Study|Other|0
7785065|NCT00983619|12235679|FG005|Overall Study|Other|12
7785066|NCT00983619|12235680|FG006|Overall Study|Other|2
7785067|NCT00983619|12235681|FG007|Overall Study|Other|2
7785068|NCT00983619|12235682|FG008|Overall Study|Other|0
7785069|NCT00983619|12235683|FG009|Overall Study|Other|1
7785070|NCT00983619|12235684|FG010|Overall Study|Other|1
7785071|NCT00983619|12235685|FG011|Overall Study|Other|0
7785072|NCT00983749|12235733|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
7619879|NCT03010527|12030621|FG002|Overall Study|Lost to Follow-up|1
7619880|NCT03010527|12030619|FG000|Overall Study|Withdrawal by Subject|0
7619881|NCT03010527|12030620|FG001|Overall Study|Withdrawal by Subject|3
7785073|NCT00983749|12235734|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
7785074|NCT00983827|12235744|FG000|Overall Study|Withdrawal by Subject|1
7785075|NCT00983853|12235754|FG000|Overall Study|Lost to Follow-up|1
7785076|NCT00983853|12235755|FG001|Overall Study|Lost to Follow-up|1
7785077|NCT00983853|12235756|FG002|Overall Study|Lost to Follow-up|2
7785078|NCT00983853|12235757|FG003|Overall Study|Lost to Follow-up|2
7785079|NCT00983853|12235758|FG004|Overall Study|Lost to Follow-up|2
7785080|NCT00983853|12235759|FG005|Overall Study|Lost to Follow-up|1
7785081|NCT00983853|12235754|FG000|Overall Study|Withdrawal by Subject|0
7785082|NCT00983853|12235755|FG001|Overall Study|Withdrawal by Subject|0
7619882|NCT03010527|12030621|FG002|Overall Study|Withdrawal by Subject|4
7619883|NCT03010527|12030619|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0
7619884|NCT03010527|12030620|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4
7619885|NCT03010527|12030621|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6
7619886|NCT03010527|12030619|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0
7619887|NCT03010527|12030620|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4
7619888|NCT03010527|12030621|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2
7619889|NCT03010527|12030619|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0
7619890|NCT03010527|12030620|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1
7619891|NCT03010527|12030621|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0
7619892|NCT03007979|12030638|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1
7785083|NCT00983853|12235756|FG002|Overall Study|Withdrawal by Subject|1
7619894|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619895|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4
7619896|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619897|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5
7619898|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1
7619899|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2
7619900|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1
7619901|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619902|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619903|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619904|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619905|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619906|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619907|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619908|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619909|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619910|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Death|0
7619911|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Death|1
7619912|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Death|0
7619913|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Death|0
7619914|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Death|0
7619915|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Death|0
7619916|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Death|0
7619917|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Death|0
7619918|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Death|0
7619919|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Death|0
7619920|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Death|0
7619921|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Death|0
7619922|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Death|0
7619923|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Death|0
7619924|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Death|0
7619925|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Death|0
7619926|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1
7619927|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1
7619928|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619929|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619930|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619931|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619932|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619933|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619934|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619935|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619936|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619937|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619938|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619939|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619940|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619941|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619942|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2
7619943|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619944|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3
7619945|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1
7619946|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1
7619947|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1
7785084|NCT00983853|12235757|FG003|Overall Study|Withdrawal by Subject|0
7785085|NCT00983853|12235758|FG004|Overall Study|Withdrawal by Subject|1
7785086|NCT00983853|12235759|FG005|Overall Study|Withdrawal by Subject|0
7785087|NCT00983853|12235754|FG000|Overall Study|Unable to come to study follow-up visits|0
7785088|NCT00983853|12235755|FG001|Overall Study|Unable to come to study follow-up visits|1
7785089|NCT00983853|12235756|FG002|Overall Study|Unable to come to study follow-up visits|0
7785090|NCT00983853|12235757|FG003|Overall Study|Unable to come to study follow-up visits|0
7619948|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1
7619949|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7785091|NCT00983853|12235758|FG004|Overall Study|Unable to come to study follow-up visits|0
7619950|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619951|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619952|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619953|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619954|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619955|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619956|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7785092|NCT00983853|12235759|FG005|Overall Study|Unable to come to study follow-up visits|0
7785093|NCT00983892|12235777|FG000|Overall Study|Withdrawal by Subject|10
7785094|NCT00983892|12235778|FG001|Overall Study|Withdrawal by Subject|12
7785095|NCT00983905|12235784|FG000|Theophylline Alone|Adverse Event|1
7785096|NCT00983905|12235784|FG000|Colchicine Alone|Adverse Event|2
7785097|NCT00983918|12235795|FG000|Overall Study|conversion to open cholecystectomy|0
7785098|NCT00983918|12235796|FG001|Overall Study|conversion to open cholecystectomy|2
7785099|NCT00983918|12235797|FG002|Overall Study|conversion to open cholecystectomy|2
7785100|NCT00983918|12235798|FG003|Overall Study|conversion to open cholecystectomy|2
7785101|NCT00983931|12235808|FG000|14 Day Washout Period|Physician Decision|1
7785102|NCT00983957|12235814|FG000|Overall Study|Adverse Event|1
7785103|NCT00983957|12235814|FG000|Overall Study|Personal Reasons|1
7785104|NCT00984009|12235838|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1
7785105|NCT00984022|12235847|FG000|Overall Study|Lost to Follow-up|10
7785106|NCT00984022|12235848|FG001|Overall Study|Lost to Follow-up|14
7785107|NCT00984061|12235854|FG000|Clarithromycin Alone|Protocol Violation|1
7785108|NCT00984126|12235865|FG000|Overall Study|Protocol Violation|0
7785109|NCT00984126|12235866|FG001|Overall Study|Protocol Violation|0
7785110|NCT00984126|12235867|FG002|Overall Study|Protocol Violation|1
7785111|NCT00984126|12235868|FG003|Overall Study|Protocol Violation|2
7785112|NCT00984126|12235865|FG000|Overall Study|Adverse Event|0
7785113|NCT00984126|12235866|FG001|Overall Study|Adverse Event|0
7785114|NCT00984126|12235867|FG002|Overall Study|Adverse Event|0
7785115|NCT00984126|12235868|FG003|Overall Study|Adverse Event|2
7785116|NCT00984126|12235865|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7
7785117|NCT00984126|12235866|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7
7785118|NCT00984126|12235867|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3
7785119|NCT00984126|12235868|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46
7785120|NCT00984126|12235865|FG000|Overall Study|Withdrawal criteria|0
7785121|NCT00984126|12235866|FG001|Overall Study|Withdrawal criteria|1
7785122|NCT00984126|12235867|FG002|Overall Study|Withdrawal criteria|3
7785123|NCT00984126|12235868|FG003|Overall Study|Withdrawal criteria|9
7785124|NCT00984165|12235895|FG000|Overall Study|Death on study|2
7785125|NCT00984165|12235896|FG001|Overall Study|Death on study|0
7785126|NCT00984165|12235897|FG002|Overall Study|Death on study|0
7785127|NCT00984165|12235898|FG003|Overall Study|Death on study|0
7785128|NCT00984165|12235895|FG000|Overall Study|Disease progression on study|5
7785129|NCT00984165|12235896|FG001|Overall Study|Disease progression on study|1
7785130|NCT00984165|12235897|FG002|Overall Study|Disease progression on study|0
7785131|NCT00984165|12235898|FG003|Overall Study|Disease progression on study|0
7785132|NCT00984165|12235895|FG000|Overall Study|Death of recipient|0
7785133|NCT00984165|12235896|FG001|Overall Study|Death of recipient|0
7785134|NCT00984165|12235897|FG002|Overall Study|Death of recipient|0
7785135|NCT00984165|12235898|FG003|Overall Study|Death of recipient|1
7785136|NCT00984165|12235895|FG000|Overall Study|New protocol|0
7785137|NCT00984165|12235896|FG001|Overall Study|New protocol|0
7785138|NCT00984165|12235897|FG002|Overall Study|New protocol|0
7785139|NCT00984165|12235898|FG003|Overall Study|New protocol|1
7785140|NCT00984165|12235895|FG000|Overall Study|P+/donor pair removed from protocol|0
7785141|NCT00984165|12235896|FG001|Overall Study|P+/donor pair removed from protocol|0
7785142|NCT00984165|12235897|FG002|Overall Study|P+/donor pair removed from protocol|0
7785143|NCT00984165|12235898|FG003|Overall Study|P+/donor pair removed from protocol|1
7785144|NCT00984165|12235895|FG000|Overall Study|removed with a pair recipient|0
7785145|NCT00984165|12235896|FG001|Overall Study|removed with a pair recipient|0
7785146|NCT00984165|12235897|FG002|Overall Study|removed with a pair recipient|0
7785147|NCT00984165|12235898|FG003|Overall Study|removed with a pair recipient|1
7785148|NCT00984204|12235909|FG000|Overall Study|Death|1
7785149|NCT00984204|12235909|FG000|Overall Study|Lost to Follow-up|4
7785150|NCT00984204|12235909|FG000|Overall Study|Lack of Efficacy|10
7785151|NCT00984256|12235915|FG000|Overall Study|Withdrawal by Subject|0
7785152|NCT00984256|12235916|FG001|Overall Study|Withdrawal by Subject|1
7785153|NCT00984282|12235933|FG000|Double Blind Treatment|Adverse Event|40
7785154|NCT00984282|12235934|FG001|Double Blind Treatment|Adverse Event|6
7785155|NCT00984282|12235933|FG000|Double Blind Treatment|Progression, recurrence or relapse|25
7785156|NCT00984282|12235934|FG001|Double Blind Treatment|Progression, recurrence or relapse|3
7785157|NCT00984282|12235933|FG000|Double Blind Treatment|Physician Decision|1
7785158|NCT00984282|12235934|FG001|Double Blind Treatment|Physician Decision|2
7785159|NCT00984282|12235933|FG000|Double Blind Treatment|Noncompliance with study medication|3
7785160|NCT00984282|12235934|FG001|Double Blind Treatment|Noncompliance with study medication|0
7785161|NCT00984282|12235933|FG000|Double Blind Treatment|Progression by clinical judgment|2
7785162|NCT00984282|12235934|FG001|Double Blind Treatment|Progression by clinical judgment|0
7785163|NCT00984282|12235933|FG000|Double Blind Treatment|Withdrawal by Subject|13
7619957|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619958|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7785164|NCT00984282|12235934|FG001|Double Blind Treatment|Withdrawal by Subject|18
7785165|NCT00984282|12235933|FG000|Double Blind Treatment|Lost to Follow-up|3
7785166|NCT00984282|12235934|FG001|Double Blind Treatment|Lost to Follow-up|0
7785167|NCT00984282|12235933|FG000|Double Blind Treatment|Death|8
7619959|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619960|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619961|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1
7619962|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619963|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619964|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1
7619965|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619966|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7785168|NCT00984282|12235934|FG001|Double Blind Treatment|Death|4
7785169|NCT00984282|12235933|FG000|Double Blind Treatment|Not treated|0
7785170|NCT00984282|12235934|FG001|Double Blind Treatment|Not treated|1
7785171|NCT00984282|12235933|FG000|Double Blind Treatment|Switched to commercial drug|6
7785172|NCT00984282|12235934|FG001|Double Blind Treatment|Switched to commercial drug|1
7785173|NCT00984282|12235933|FG000|Double Blind Treatment|protocol driven decision point|1
7785174|NCT00984282|12235934|FG001|Double Blind Treatment|protocol driven decision point|1
7785175|NCT00984282|12235933|FG000|Double Blind Treatment|Radiological and clinical progression|0
7785176|NCT00984282|12235934|FG001|Double Blind Treatment|Radiological and clinical progression|1
7785177|NCT00984282|12235933|FG000|Double Blind Treatment|Transferred to treat. continuation study|2
7785178|NCT00984282|12235934|FG001|Double Blind Treatment|Transferred to treat. continuation study|1
7785179|NCT00984282|12235933|FG000|Open-label Treatment|Adverse Event|20
7785180|NCT00984282|12235934|FG001|Open-label Treatment|Adverse Event|30
7785181|NCT00984282|12235933|FG000|Open-label Treatment|Withdrawal by Subject|6
7785182|NCT00984282|12235934|FG001|Open-label Treatment|Withdrawal by Subject|21
7785183|NCT00984282|12235933|FG000|Open-label Treatment|Death|7
7785184|NCT00984282|12235934|FG001|Open-label Treatment|Death|15
7785185|NCT00984282|12235933|FG000|Open-label Treatment|Progression, recurrence or relapse|40
7785186|NCT00984282|12235934|FG001|Open-label Treatment|Progression, recurrence or relapse|82
7785187|NCT00984282|12235933|FG000|Open-label Treatment|Lost to Follow-up|1
7785188|NCT00984282|12235934|FG001|Open-label Treatment|Lost to Follow-up|1
7785189|NCT00984282|12235933|FG000|Open-label Treatment|Patient convenience|1
7785190|NCT00984282|12235934|FG001|Open-label Treatment|Patient convenience|0
7785191|NCT00984282|12235933|FG000|Open-label Treatment|Non-compliant with study medication|1
7785192|NCT00984282|12235934|FG001|Open-label Treatment|Non-compliant with study medication|0
7785193|NCT00984282|12235933|FG000|Open-label Treatment|Target lesion removed|0
7785194|NCT00984282|12235934|FG001|Open-label Treatment|Target lesion removed|1
7785195|NCT00984282|12235933|FG000|Open-label Treatment|Protocol driven decision point|1
7785196|NCT00984282|12235934|FG001|Open-label Treatment|Protocol driven decision point|1
7785197|NCT00984282|12235933|FG000|Open-label Treatment|Transferred to treat. continuation study|2
7785198|NCT00984282|12235934|FG001|Open-label Treatment|Transferred to treat. continuation study|3
7785199|NCT00984282|12235933|FG000|Open-label Treatment|Switched to commercial drug|6
7785200|NCT00984282|12235934|FG001|Open-label Treatment|Switched to commercial drug|7
7785201|NCT00984282|12235933|FG000|Open-label Treatment|Physician Decision|1
7785202|NCT00984282|12235934|FG001|Open-label Treatment|Physician Decision|0
7785203|NCT00984282|12235933|FG000|Long Term Follow-up|Withdrawal by Subject|8
7785204|NCT00984282|12235934|FG001|Long Term Follow-up|Withdrawal by Subject|14
7785205|NCT00984282|12235933|FG000|Long Term Follow-up|Death|27
7785206|NCT00984282|12235934|FG001|Long Term Follow-up|Death|68
7785207|NCT00984282|12235933|FG000|Long Term Follow-up|Lost to Follow-up|3
7785208|NCT00984282|12235934|FG001|Long Term Follow-up|Lost to Follow-up|6
7785209|NCT00984282|12235933|FG000|Long Term Follow-up|Protocol driven decision point|25
7785210|NCT00984282|12235934|FG001|Long Term Follow-up|Protocol driven decision point|26
7785211|NCT00984282|12235933|FG000|Long Term Follow-up|Transferred to treat. continuation study|2
7785212|NCT00984282|12235934|FG001|Long Term Follow-up|Transferred to treat. continuation study|3
7785213|NCT00984282|12235933|FG000|Long Term Follow-up|Switched to commercial drug|4
7785214|NCT00984282|12235934|FG001|Long Term Follow-up|Switched to commercial drug|2
7785215|NCT00984282|12235933|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0
7785216|NCT00984282|12235934|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1
7785217|NCT00984295|12235945|FG000|Overall Study|Lost to Follow-up|31
7785218|NCT00984295|12235946|FG001|Overall Study|Lost to Follow-up|12
7785219|NCT00984295|12235947|FG002|Overall Study|Lost to Follow-up|13
7785220|NCT00984295|12235945|FG000|Overall Study|Protocol Violation|2
7785221|NCT00984295|12235946|FG001|Overall Study|Protocol Violation|1
7785222|NCT00984295|12235947|FG002|Overall Study|Protocol Violation|4
7785223|NCT00984295|12235945|FG000|Overall Study|Withdrawal by Subject|18
7785224|NCT00984295|12235946|FG001|Overall Study|Withdrawal by Subject|9
7785225|NCT00984295|12235947|FG002|Overall Study|Withdrawal by Subject|12
7785226|NCT00984295|12235945|FG000|Overall Study|CAE - discontinued test vaccine|0
7785227|NCT00984295|12235946|FG001|Overall Study|CAE - discontinued test vaccine|1
7619967|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619968|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619969|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7785228|NCT00984295|12235947|FG002|Overall Study|CAE - discontinued test vaccine|3
7785229|NCT00984295|12235945|FG000|Overall Study|Missed one or more blood samplings|3
7785230|NCT00984295|12235946|FG001|Overall Study|Missed one or more blood samplings|7
7785231|NCT00984295|12235947|FG002|Overall Study|Missed one or more blood samplings|2
7785232|NCT00984295|12235945|FG000|Overall Study|Incomplete safety follow-up|11
7785233|NCT00984295|12235946|FG001|Overall Study|Incomplete safety follow-up|2
7785234|NCT00984295|12235947|FG002|Overall Study|Incomplete safety follow-up|3
7785235|NCT00984542|12235985|FG000|Overall Study|disease progression|19
7785236|NCT00984542|12235985|FG000|Overall Study|toxicity|7
7785237|NCT00984542|12235985|FG000|Overall Study|Death|7
7785238|NCT00984542|12235985|FG000|Overall Study|complicating disease|3
7785239|NCT00984542|12235985|FG000|Overall Study|Withdrawal by Subject|3
7785240|NCT00984542|12235985|FG000|Overall Study|clinical deterioration|2
7785241|NCT00984568|12235992|FG000|Overall Study|Withdrawal by Subject|1
7785242|NCT00984568|12235993|FG001|Overall Study|Withdrawal by Subject|2
7785243|NCT00984568|12235992|FG000|Overall Study|Lack of Efficacy|2
7785244|NCT00984568|12235993|FG001|Overall Study|Lack of Efficacy|0
7785245|NCT00984568|12235992|FG000|Overall Study|Adverse Event|2
7785246|NCT00984568|12235993|FG001|Overall Study|Adverse Event|0
7785247|NCT00984568|12235992|FG000|Overall Study|Did Not Meet Randomization Criteria|1
7785248|NCT00984568|12235993|FG001|Overall Study|Did Not Meet Randomization Criteria|0
7785249|NCT00984568|12235992|FG000|Overall Study|Lost to Follow-up|0
7785250|NCT00984568|12235993|FG001|Overall Study|Lost to Follow-up|1
7785251|NCT00984568|12235992|FG000|Overall Study|Opportunistic Infection|1
7785252|NCT00984568|12235993|FG001|Overall Study|Opportunistic Infection|0
7785253|NCT00984568|12235992|FG000|Overall Study|Unknown Reason|1
7785254|NCT00984568|12235993|FG001|Overall Study|Unknown Reason|3
7785255|NCT00984594|12236001|FG000|Overall Study|Lost to Follow-up|1
7785256|NCT00984594|12236002|FG001|Overall Study|Lost to Follow-up|0
7785257|NCT00984594|12236001|FG000|Overall Study|Withdrawal by Subject|0
7785258|NCT00984594|12236002|FG001|Overall Study|Withdrawal by Subject|1
7785259|NCT00984620|12236012|FG000|Overall Study|Adverse Event|5
7785260|NCT00984620|12236013|FG001|Overall Study|Adverse Event|5
7785261|NCT00984620|12236012|FG000|Overall Study|Lost to Follow-up|1
7785262|NCT00984620|12236013|FG001|Overall Study|Lost to Follow-up|1
7785263|NCT00984620|12236012|FG000|Overall Study|Withdrawal by Subject|0
7785264|NCT00984620|12236013|FG001|Overall Study|Withdrawal by Subject|2
7785265|NCT00984620|12236012|FG000|Overall Study|reason other than listed above|0
7785266|NCT00984620|12236013|FG001|Overall Study|reason other than listed above|4
7785267|NCT00984659|12236025|FG000|2-week Run-in Period|Adverse Event|8
7785268|NCT00984659|12236026|FG001|2-week Run-in Period|Adverse Event|0
7785269|NCT00984659|12236027|FG002|2-week Run-in Period|Adverse Event|0
7785270|NCT00984659|12236028|FG003|2-week Run-in Period|Adverse Event|0
7785271|NCT00984659|12236025|FG000|2-week Run-in Period|Protocol Violation|5
7785272|NCT00984659|12236026|FG001|2-week Run-in Period|Protocol Violation|0
7785273|NCT00984659|12236027|FG002|2-week Run-in Period|Protocol Violation|0
7785274|NCT00984659|12236028|FG003|2-week Run-in Period|Protocol Violation|0
7619970|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619971|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619972|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619973|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619974|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619975|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619976|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1
7619977|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619978|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619979|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619980|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619981|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619982|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619983|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619984|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619985|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619986|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619987|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619988|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619989|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619990|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1
7619991|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1
7785275|NCT00984659|12236025|FG000|2-week Run-in Period|Study Closed/Terminated|2
7785276|NCT00984659|12236026|FG001|2-week Run-in Period|Study Closed/Terminated|0
7785277|NCT00984659|12236027|FG002|2-week Run-in Period|Study Closed/Terminated|0
7619992|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1
7619993|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7619994|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7619995|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7619996|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7619997|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7619998|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7619999|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7620000|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7620001|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7620002|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7620003|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7620004|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7620005|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7620006|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Other|0
7620007|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Other|0
7620008|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Other|1
7620009|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Other|2
7620010|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Other|0
7620011|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Other|1
7620012|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Other|0
7620013|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Other|0
7620014|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Other|0
7620015|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Other|0
7620016|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Other|0
7620017|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Other|0
7620018|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Other|0
7620019|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Other|0
7620020|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Other|0
7620021|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Other|0
7620022|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620023|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620024|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620025|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620026|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1
7620027|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620028|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620029|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620030|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620031|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620032|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620033|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620034|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620035|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620036|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620037|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620038|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7620039|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7620040|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7620041|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7620042|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7620043|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7620044|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7620045|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1
7620046|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1
7620047|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2
7620048|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7785278|NCT00984659|12236028|FG003|2-week Run-in Period|Study Closed/Terminated|0
7785279|NCT00984659|12236025|FG000|2-week Run-in Period|Lost to Follow-up|3
7785280|NCT00984659|12236026|FG001|2-week Run-in Period|Lost to Follow-up|0
7785281|NCT00984659|12236027|FG002|2-week Run-in Period|Lost to Follow-up|0
7785282|NCT00984659|12236028|FG003|2-week Run-in Period|Lost to Follow-up|0
7785283|NCT00984659|12236025|FG000|2-week Run-in Period|Physician Decision|10
7785284|NCT00984659|12236026|FG001|2-week Run-in Period|Physician Decision|0
7785285|NCT00984659|12236027|FG002|2-week Run-in Period|Physician Decision|0
7785286|NCT00984659|12236028|FG003|2-week Run-in Period|Physician Decision|0
7785287|NCT00984659|12236025|FG000|2-week Run-in Period|Withdrawal by Subject|10
7785288|NCT00984659|12236026|FG001|2-week Run-in Period|Withdrawal by Subject|0
7785289|NCT00984659|12236027|FG002|2-week Run-in Period|Withdrawal by Subject|0
7785290|NCT00984659|12236028|FG003|2-week Run-in Period|Withdrawal by Subject|0
7785291|NCT00984659|12236025|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14
7785292|NCT00984659|12236026|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7785293|NCT00984659|12236027|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7785294|NCT00984659|12236028|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7785295|NCT00984659|12236025|FG000|6-week Double-blind Treatment Period|Adverse Event|0
7785296|NCT00984659|12236026|FG001|6-week Double-blind Treatment Period|Adverse Event|3
7620049|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1
7620050|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4
7620051|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1
7620052|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1
7620053|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5
7620054|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620055|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620056|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620057|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620058|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620059|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620060|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620061|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620062|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2
7620063|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1
7620064|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620065|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5
7620066|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620067|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2
7620068|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620069|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8
7620070|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620071|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620072|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620073|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620074|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620075|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620076|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620077|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620078|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620079|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1
7620080|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7785297|NCT00984659|12236027|FG002|6-week Double-blind Treatment Period|Adverse Event|3
7785298|NCT00984659|12236028|FG003|6-week Double-blind Treatment Period|Adverse Event|7
7785299|NCT00984659|12236025|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0
7785300|NCT00984659|12236026|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2
7785301|NCT00984659|12236027|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0
7785302|NCT00984659|12236028|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1
7785303|NCT00984659|12236025|FG000|6-week Double-blind Treatment Period|Protocol Violation|0
7785304|NCT00984659|12236026|FG001|6-week Double-blind Treatment Period|Protocol Violation|0
7785305|NCT00984659|12236027|FG002|6-week Double-blind Treatment Period|Protocol Violation|0
7785306|NCT00984659|12236028|FG003|6-week Double-blind Treatment Period|Protocol Violation|4
7785307|NCT00984659|12236025|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0
7785308|NCT00984659|12236026|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0
7785309|NCT00984659|12236027|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1
7785310|NCT00984659|12236028|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0
7785311|NCT00984659|12236025|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0
7785312|NCT00984659|12236026|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1
7785313|NCT00984659|12236027|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7
7785314|NCT00984659|12236028|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1
7785315|NCT00984867|12236050|FG000|Overall Study|Adverse Event|3
7785316|NCT00984867|12236051|FG001|Overall Study|Adverse Event|7
7620081|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620082|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7785317|NCT00984867|12236050|FG000|Overall Study|Death|1
7785318|NCT00984867|12236051|FG001|Overall Study|Death|0
7785319|NCT00984867|12236050|FG000|Overall Study|Withdrawal by Subject|13
7785320|NCT00984867|12236051|FG001|Overall Study|Withdrawal by Subject|4
7785321|NCT00984867|12236050|FG000|Overall Study|Lost to Follow-up|3
7785322|NCT00984867|12236051|FG001|Overall Study|Lost to Follow-up|4
7785323|NCT00984867|12236050|FG000|Overall Study|Poor/non-compliance|0
7785324|NCT00984867|12236051|FG001|Overall Study|Poor/non-compliance|1
7785325|NCT00984867|12236050|FG000|Overall Study|Subject no longer meets study criteria|1
7785326|NCT00984867|12236051|FG001|Overall Study|Subject no longer meets study criteria|1
7785327|NCT00984867|12236050|FG000|Overall Study|site closing|1
7785328|NCT00984867|12236051|FG001|Overall Study|site closing|0
7785329|NCT00984867|12236050|FG000|Overall Study|lack of efficacy and subject compliance|1
7785330|NCT00984867|12236051|FG001|Overall Study|lack of efficacy and subject compliance|0
7620083|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620084|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620085|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1
7620086|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620087|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620088|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620089|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620090|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620091|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620092|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620093|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620094|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620095|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620096|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620097|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1
7620098|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6
7620099|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3
7620100|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3
7620101|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2
7620102|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|Other|0
7620103|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|Other|0
7620104|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|Other|0
7620105|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|Other|0
7620106|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|Other|0
7620107|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|Other|0
7620108|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|Other|0
7620109|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|Other|1
7620110|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|Other|0
7620111|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|Other|1
7620112|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|Other|0
7620113|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|Other|0
7620114|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|Other|1
7620115|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|Other|0
7620116|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|Other|0
7620117|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|Other|1
7620118|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620119|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620120|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620121|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7785331|NCT00985088|12236076|FG000|Overall Study|Serious Adverse Event|1
7785332|NCT00985088|12236077|FG001|Overall Study|Serious Adverse Event|1
7785333|NCT00985088|12236078|FG002|Overall Study|Serious Adverse Event|0
7785334|NCT00985088|12236079|FG003|Overall Study|Serious Adverse Event|0
7785335|NCT00985088|12236080|FG004|Overall Study|Serious Adverse Event|0
7785336|NCT00985088|12236081|FG005|Overall Study|Serious Adverse Event|0
7785337|NCT00985088|12236082|FG006|Overall Study|Serious Adverse Event|0
7785338|NCT00985088|12236083|FG007|Overall Study|Serious Adverse Event|1
7785339|NCT00985088|12236076|FG000|Overall Study|Adverse Event|0
7785340|NCT00985088|12236077|FG001|Overall Study|Adverse Event|0
7785341|NCT00985088|12236078|FG002|Overall Study|Adverse Event|1
7785342|NCT00985088|12236079|FG003|Overall Study|Adverse Event|0
7785343|NCT00985088|12236080|FG004|Overall Study|Adverse Event|0
7785344|NCT00985088|12236081|FG005|Overall Study|Adverse Event|0
7785345|NCT00985088|12236082|FG006|Overall Study|Adverse Event|0
7785346|NCT00985088|12236083|FG007|Overall Study|Adverse Event|0
7785347|NCT00985088|12236076|FG000|Overall Study|Withdrawal by Subject|4
7785348|NCT00985088|12236077|FG001|Overall Study|Withdrawal by Subject|0
7785349|NCT00985088|12236078|FG002|Overall Study|Withdrawal by Subject|0
7785350|NCT00985088|12236079|FG003|Overall Study|Withdrawal by Subject|1
7785351|NCT00985088|12236080|FG004|Overall Study|Withdrawal by Subject|3
7785352|NCT00985088|12236081|FG005|Overall Study|Withdrawal by Subject|2
7785353|NCT00985088|12236082|FG006|Overall Study|Withdrawal by Subject|1
7785354|NCT00985088|12236083|FG007|Overall Study|Withdrawal by Subject|2
7785355|NCT00985088|12236076|FG000|Overall Study|Migrated/moved from study area|0
7785356|NCT00985088|12236077|FG001|Overall Study|Migrated/moved from study area|0
7785357|NCT00985088|12236078|FG002|Overall Study|Migrated/moved from study area|1
7785358|NCT00985088|12236079|FG003|Overall Study|Migrated/moved from study area|0
7785359|NCT00985088|12236080|FG004|Overall Study|Migrated/moved from study area|0
7785360|NCT00985088|12236081|FG005|Overall Study|Migrated/moved from study area|0
7785361|NCT00985088|12236082|FG006|Overall Study|Migrated/moved from study area|0
7785362|NCT00985088|12236083|FG007|Overall Study|Migrated/moved from study area|1
7785363|NCT00985088|12236076|FG000|Overall Study|Lost to Follow-up|6
7785364|NCT00985088|12236077|FG001|Overall Study|Lost to Follow-up|1
7785365|NCT00985088|12236078|FG002|Overall Study|Lost to Follow-up|2
7785366|NCT00985088|12236079|FG003|Overall Study|Lost to Follow-up|6
7620122|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7785367|NCT00985088|12236080|FG004|Overall Study|Lost to Follow-up|6
7785368|NCT00985088|12236081|FG005|Overall Study|Lost to Follow-up|5
7785369|NCT00985088|12236082|FG006|Overall Study|Lost to Follow-up|3
7620123|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620124|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620125|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620126|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620127|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620128|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620129|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620130|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620131|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1
7620132|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620133|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620134|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620135|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620136|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620137|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620138|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620139|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620140|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620141|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620142|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620143|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620144|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620145|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620146|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620147|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1
7620148|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620149|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620150|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620151|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620152|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620153|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620154|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620155|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620156|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620157|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620158|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620159|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1
7620160|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620161|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620162|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620163|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620164|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620165|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620166|NCT02949700|12030715|FG000|Phase I|Withdrawal by Subject|1
7620167|NCT02949700|12030716|FG001|Phase I|Withdrawal by Subject|1
7620168|NCT02949700|12030717|FG002|Phase I|Withdrawal by Subject|0
7620169|NCT02949700|12030718|FG003|Phase I|Withdrawal by Subject|0
7620170|NCT02949700|12030715|FG000|Phase I|Protocol Violation|1
7620171|NCT02949700|12030716|FG001|Phase I|Protocol Violation|0
7620172|NCT02949700|12030717|FG002|Phase I|Protocol Violation|0
7620173|NCT02949700|12030718|FG003|Phase I|Protocol Violation|0
7620174|NCT02949700|12030715|FG000|Phase II|Withdrawal by Subject|0
7620175|NCT02949700|12030716|FG001|Phase II|Withdrawal by Subject|0
7620176|NCT02949700|12030717|FG002|Phase II|Withdrawal by Subject|0
7620177|NCT02949700|12030718|FG003|Phase II|Withdrawal by Subject|2
7620178|NCT02949700|12030715|FG000|Phase II|Protocol Violation|0
7620179|NCT02949700|12030716|FG001|Phase II|Protocol Violation|0
7620180|NCT02949700|12030717|FG002|Phase II|Protocol Violation|1
7620181|NCT02949700|12030718|FG003|Phase II|Protocol Violation|3
7620182|NCT02905006|12030733|FG000|Overall Study|Adverse Event|1
7620183|NCT02905006|12030734|FG001|Overall Study|Adverse Event|1
7620184|NCT02905006|12030735|FG002|Overall Study|Adverse Event|1
7620185|NCT02905006|12030736|FG003|Overall Study|Adverse Event|1
7620186|NCT02905006|12030737|FG004|Overall Study|Adverse Event|0
7620187|NCT02905006|12030738|FG005|Overall Study|Adverse Event|1
7620188|NCT02905006|12030733|FG000|Overall Study|Lack of Efficacy|1
7620189|NCT02905006|12030734|FG001|Overall Study|Lack of Efficacy|0
7620190|NCT02905006|12030735|FG002|Overall Study|Lack of Efficacy|0
7785370|NCT00985088|12236083|FG007|Overall Study|Lost to Follow-up|2
7785371|NCT00985114|12236113|FG000|Overall Study|Adverse Event|1
7785372|NCT00985114|12236114|FG001|Overall Study|Adverse Event|0
7620191|NCT02905006|12030736|FG003|Overall Study|Lack of Efficacy|0
7785373|NCT00985114|12236113|FG000|Overall Study|Withdrawal by Subject|0
7620192|NCT02905006|12030737|FG004|Overall Study|Lack of Efficacy|0
7620193|NCT02905006|12030738|FG005|Overall Study|Lack of Efficacy|0
7620194|NCT02905006|12030733|FG000|Overall Study|Protocol Violation|2
7620195|NCT02905006|12030734|FG001|Overall Study|Protocol Violation|0
7620196|NCT02905006|12030735|FG002|Overall Study|Protocol Violation|0
7620197|NCT02905006|12030736|FG003|Overall Study|Protocol Violation|0
7620198|NCT02905006|12030737|FG004|Overall Study|Protocol Violation|0
7620199|NCT02905006|12030738|FG005|Overall Study|Protocol Violation|0
7620200|NCT02905006|12030733|FG000|Overall Study|Lost to Follow-up|0
7620201|NCT02905006|12030734|FG001|Overall Study|Lost to Follow-up|0
7620202|NCT02905006|12030735|FG002|Overall Study|Lost to Follow-up|0
7620203|NCT02905006|12030736|FG003|Overall Study|Lost to Follow-up|1
7620204|NCT02905006|12030737|FG004|Overall Study|Lost to Follow-up|1
7620205|NCT02905006|12030738|FG005|Overall Study|Lost to Follow-up|0
7620206|NCT02905006|12030733|FG000|Overall Study|Withdrawal by Subject|0
7620207|NCT02905006|12030734|FG001|Overall Study|Withdrawal by Subject|0
7620208|NCT02905006|12030735|FG002|Overall Study|Withdrawal by Subject|1
7620209|NCT02905006|12030736|FG003|Overall Study|Withdrawal by Subject|1
7620210|NCT02905006|12030737|FG004|Overall Study|Withdrawal by Subject|0
7620211|NCT02905006|12030738|FG005|Overall Study|Withdrawal by Subject|1
7620212|NCT02905006|12030733|FG000|Overall Study|Screening exclusion criteria met|1
7620213|NCT02905006|12030734|FG001|Overall Study|Screening exclusion criteria met|0
7620214|NCT02905006|12030735|FG002|Overall Study|Screening exclusion criteria met|0
7620215|NCT02905006|12030736|FG003|Overall Study|Screening exclusion criteria met|0
7620216|NCT02905006|12030737|FG004|Overall Study|Screening exclusion criteria met|0
7620217|NCT02905006|12030738|FG005|Overall Study|Screening exclusion criteria met|0
7620218|NCT02905006|12030733|FG000|Overall Study|Lab withdrawal criterion met|0
7620219|NCT02905006|12030734|FG001|Overall Study|Lab withdrawal criterion met|1
7620220|NCT02905006|12030735|FG002|Overall Study|Lab withdrawal criterion met|2
7620221|NCT02905006|12030736|FG003|Overall Study|Lab withdrawal criterion met|2
7620222|NCT02905006|12030737|FG004|Overall Study|Lab withdrawal criterion met|2
7620223|NCT02905006|12030738|FG005|Overall Study|Lab withdrawal criterion met|1
7620224|NCT02905006|12030733|FG000|Overall Study|Positive for Tuberculosis|0
7620225|NCT02905006|12030734|FG001|Overall Study|Positive for Tuberculosis|1
7620226|NCT02905006|12030735|FG002|Overall Study|Positive for Tuberculosis|0
7620227|NCT02905006|12030736|FG003|Overall Study|Positive for Tuberculosis|0
7620228|NCT02905006|12030737|FG004|Overall Study|Positive for Tuberculosis|0
7620229|NCT02905006|12030738|FG005|Overall Study|Positive for Tuberculosis|0
7620230|NCT02905006|12030733|FG000|Overall Study|Subject positive for Hep B|0
7620231|NCT02905006|12030734|FG001|Overall Study|Subject positive for Hep B|0
7620232|NCT02905006|12030735|FG002|Overall Study|Subject positive for Hep B|1
7620233|NCT02905006|12030736|FG003|Overall Study|Subject positive for Hep B|0
7620234|NCT02905006|12030737|FG004|Overall Study|Subject positive for Hep B|0
7620235|NCT02905006|12030738|FG005|Overall Study|Subject positive for Hep B|0
7620236|NCT02905006|12030733|FG000|Overall Study|Patient moved abroad|0
7620237|NCT02905006|12030734|FG001|Overall Study|Patient moved abroad|0
7620238|NCT02905006|12030735|FG002|Overall Study|Patient moved abroad|0
7620239|NCT02905006|12030736|FG003|Overall Study|Patient moved abroad|1
7620240|NCT02905006|12030737|FG004|Overall Study|Patient moved abroad|0
7620241|NCT02905006|12030738|FG005|Overall Study|Patient moved abroad|0
7620242|NCT02905006|12030733|FG000|Overall Study|Patient randomized by mistake|0
7620243|NCT02905006|12030734|FG001|Overall Study|Patient randomized by mistake|0
7620244|NCT02905006|12030735|FG002|Overall Study|Patient randomized by mistake|0
7620245|NCT02905006|12030736|FG003|Overall Study|Patient randomized by mistake|0
7620246|NCT02905006|12030737|FG004|Overall Study|Patient randomized by mistake|0
7620247|NCT02905006|12030738|FG005|Overall Study|Patient randomized by mistake|1
7620248|NCT02833844|12030778|FG000|Double-Blind Period|Withdrawal by Subject|2
7620249|NCT02833844|12030779|FG001|Double-Blind Period|Withdrawal by Subject|3
7620250|NCT02833844|12030778|FG000|Double-Blind Period|Protocol Violation|0
7620251|NCT02833844|12030779|FG001|Double-Blind Period|Protocol Violation|4
7620252|NCT02833844|12030778|FG000|Open-Label Period|Death|0
7620253|NCT02833844|12030779|FG001|Open-Label Period|Death|2
7620254|NCT02833844|12030778|FG000|Open-Label Period|Lost to Follow-up|1
7620255|NCT02833844|12030779|FG001|Open-Label Period|Lost to Follow-up|0
7620256|NCT02833844|12030778|FG000|Open-Label Period|Withdrawal by Subject|1
7620257|NCT02833844|12030779|FG001|Open-Label Period|Withdrawal by Subject|0
7620258|NCT02778399|12030793|FG000|Up to Week 12 Treatment Period|Adverse Event|1
7620259|NCT02778399|12030794|FG001|Up to Week 12 Treatment Period|Adverse Event|2
7620260|NCT02778399|12030795|FG002|Up to Week 12 Treatment Period|Adverse Event|3
7620261|NCT02778399|12030796|FG003|Up to Week 12 Treatment Period|Adverse Event|2
7785374|NCT00985114|12236114|FG001|Overall Study|Withdrawal by Subject|2
7785375|NCT00985153|12236128|FG000|Overall Study|Lost to Follow-up|16
7785376|NCT00985153|12236129|FG001|Overall Study|Lost to Follow-up|19
7785377|NCT00985153|12236130|FG002|Overall Study|Lost to Follow-up|17
7785378|NCT00985153|12236131|FG003|Overall Study|Lost to Follow-up|20
7785379|NCT00985153|12236128|FG000|Overall Study|Protocol Violation|3
7785380|NCT00985153|12236129|FG001|Overall Study|Protocol Violation|2
7620262|NCT02778399|12030797|FG004|Up to Week 12 Treatment Period|Adverse Event|3
7785381|NCT00985153|12236130|FG002|Overall Study|Protocol Violation|4
7785382|NCT00985153|12236131|FG003|Overall Study|Protocol Violation|3
7785383|NCT00985153|12236128|FG000|Overall Study|Withdrawal by Subject|6
7620263|NCT02778399|12030798|FG005|Up to Week 12 Treatment Period|Adverse Event|3
7620264|NCT02778399|12030793|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5
7620265|NCT02778399|12030794|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2
7620266|NCT02778399|12030795|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1
7620267|NCT02778399|12030796|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4
7620268|NCT02778399|12030797|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2
7620269|NCT02778399|12030798|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3
7620270|NCT02778399|12030793|FG000|Up to Week 12 Treatment Period|Protocol Violation|0
7620271|NCT02778399|12030794|FG001|Up to Week 12 Treatment Period|Protocol Violation|0
7620272|NCT02778399|12030795|FG002|Up to Week 12 Treatment Period|Protocol Violation|0
7620273|NCT02778399|12030796|FG003|Up to Week 12 Treatment Period|Protocol Violation|0
7620274|NCT02778399|12030797|FG004|Up to Week 12 Treatment Period|Protocol Violation|1
7620275|NCT02778399|12030798|FG005|Up to Week 12 Treatment Period|Protocol Violation|0
7620276|NCT02778399|12030793|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3
7620277|NCT02778399|12030794|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0
7620278|NCT02778399|12030795|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0
7620279|NCT02778399|12030796|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0
7620280|NCT02778399|12030797|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0
7620281|NCT02778399|12030798|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2
7620282|NCT02778399|12030793|FG000|Up to Week 12 Treatment Period|other - reason not stated|0
7620283|NCT02778399|12030794|FG001|Up to Week 12 Treatment Period|other - reason not stated|0
7620284|NCT02778399|12030795|FG002|Up to Week 12 Treatment Period|other - reason not stated|0
7620285|NCT02778399|12030796|FG003|Up to Week 12 Treatment Period|other - reason not stated|1
7620286|NCT02778399|12030797|FG004|Up to Week 12 Treatment Period|other - reason not stated|2
7620287|NCT02778399|12030798|FG005|Up to Week 12 Treatment Period|other - reason not stated|0
7785384|NCT00985153|12236129|FG001|Overall Study|Withdrawal by Subject|11
7785385|NCT00985153|12236130|FG002|Overall Study|Withdrawal by Subject|11
7785386|NCT00985153|12236131|FG003|Overall Study|Withdrawal by Subject|10
7785387|NCT00985153|12236128|FG000|Overall Study|Missed One or More Bleeds|7
7785388|NCT00985153|12236129|FG001|Overall Study|Missed One or More Bleeds|7
7785389|NCT00985153|12236130|FG002|Overall Study|Missed One or More Bleeds|8
7785390|NCT00985153|12236131|FG003|Overall Study|Missed One or More Bleeds|10
7785391|NCT00985153|12236128|FG000|Overall Study|Incomplete Safety Follow-up|3
7785392|NCT00985153|12236129|FG001|Overall Study|Incomplete Safety Follow-up|5
7785393|NCT00985153|12236130|FG002|Overall Study|Incomplete Safety Follow-up|4
7785394|NCT00985153|12236131|FG003|Overall Study|Incomplete Safety Follow-up|4
7785395|NCT00985166|12236144|FG000|Overall Study|Lost to Follow-up|3
7785396|NCT00985166|12236145|FG001|Overall Study|Lost to Follow-up|2
7785397|NCT00985166|12236146|FG002|Overall Study|Lost to Follow-up|2
7785398|NCT00985166|12236144|FG000|Overall Study|Withdrawal by Subject|3
7785399|NCT00985166|12236145|FG001|Overall Study|Withdrawal by Subject|2
7785400|NCT00985166|12236146|FG002|Overall Study|Withdrawal by Subject|0
7785401|NCT00985166|12236144|FG000|Overall Study|Test not done|2
7785402|NCT00985166|12236145|FG001|Overall Study|Test not done|0
7785403|NCT00985166|12236146|FG002|Overall Study|Test not done|4
7785404|NCT00985166|12236144|FG000|Overall Study|Other|1
7785405|NCT00985166|12236145|FG001|Overall Study|Other|0
7785406|NCT00985166|12236146|FG002|Overall Study|Other|1
7785407|NCT00985192|12236156|FG000|Overall Study|Withdrawal by Subject|1
7785408|NCT00985192|12236156|FG000|Overall Study|Disease Progression|1
7785409|NCT00985192|12236156|FG000|Overall Study|Determined to be Ineligible During Trial|2
7785410|NCT00985231|12236162|FG000|Overall Study|ineligible|1
7785411|NCT00985231|12236163|FG001|Overall Study|ineligible|0
7785412|NCT00985231|12236162|FG000|Overall Study|Protocol Violation|1
7785413|NCT00985231|12236163|FG001|Overall Study|Protocol Violation|0
7785414|NCT00985231|12236162|FG000|Overall Study|Withdrawal by Subject|1
7785415|NCT00985231|12236163|FG001|Overall Study|Withdrawal by Subject|0
7785416|NCT00985231|12236162|FG000|Overall Study|Lost to Follow-up|0
7785417|NCT00985231|12236163|FG001|Overall Study|Lost to Follow-up|1
7785418|NCT00985231|12236162|FG000|Overall Study|Study related symptoms & complaints|0
7785419|NCT00985231|12236163|FG001|Overall Study|Study related symptoms & complaints|2
7785420|NCT00985426|12236175|FG000|Overall Study|Adverse Event|0
7785421|NCT00985426|12236176|FG001|Overall Study|Adverse Event|1
7785422|NCT00985426|12236175|FG000|Overall Study|Subject Non-Compliance|3
7785423|NCT00985426|12236176|FG001|Overall Study|Subject Non-Compliance|3
7785424|NCT00985426|12236175|FG000|Overall Study|Withdrawal by Subject|12
7785425|NCT00985426|12236176|FG001|Overall Study|Withdrawal by Subject|16
7620288|NCT02778399|12030793|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2
7620289|NCT02778399|12030794|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0
7620290|NCT02778399|12030795|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2
7785426|NCT00985426|12236175|FG000|Overall Study|Lost to Follow-up|8
7785427|NCT00985426|12236176|FG001|Overall Study|Lost to Follow-up|10
7785428|NCT00985426|12236175|FG000|Overall Study|Death|7
7785429|NCT00985426|12236176|FG001|Overall Study|Death|3
7785430|NCT00985426|12236175|FG000|Overall Study|Protocol Violation|2
7785431|NCT00985426|12236176|FG001|Overall Study|Protocol Violation|0
7785432|NCT00985426|12236175|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
7785433|NCT00985426|12236176|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
7785434|NCT00985439|12236186|FG000|Overall Study|Adverse Event|0
7785435|NCT00985439|12236187|FG001|Overall Study|Adverse Event|0
7620291|NCT02778399|12030796|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1
7620292|NCT02778399|12030797|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3
7620293|NCT02778399|12030798|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2
7620294|NCT02778399|12030793|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3
7620295|NCT02778399|12030794|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2
7785436|NCT00985439|12236188|FG002|Overall Study|Adverse Event|1
7785437|NCT00985439|12236189|FG003|Overall Study|Adverse Event|0
7785438|NCT00985465|12236201|FG000|Overall Study|Withdrawal by Subject|1
7785439|NCT00985465|12236202|FG001|Overall Study|Withdrawal by Subject|2
7785440|NCT00985465|12236201|FG000|Overall Study|Considered to be part of the other group|0
7785441|NCT00985465|12236202|FG001|Overall Study|Considered to be part of the other group|1
7785442|NCT00985491|12236209|FG000|Overall Study|Adverse Event|8
7785443|NCT00985491|12236209|FG000|Overall Study|device migration|7
7785444|NCT00985491|12236209|FG000|Overall Study|Withdrawal by Subject|1
7785445|NCT00985491|12236209|FG000|Overall Study|implant failure|3
7785446|NCT00985504|12236216|FG000|Acute Treatment Period|Adverse Event|3
7785447|NCT00985504|12236217|FG001|Acute Treatment Period|Adverse Event|4
7785448|NCT00985504|12236216|FG000|Acute Treatment Period|Entry Criteria Not Met|1
7785449|NCT00985504|12236217|FG001|Acute Treatment Period|Entry Criteria Not Met|2
7785450|NCT00985504|12236216|FG000|Acute Treatment Period|Protocol Violation|2
7785451|NCT00985504|12236217|FG001|Acute Treatment Period|Protocol Violation|0
7785452|NCT00985504|12236216|FG000|Acute Treatment Period|Sponsor Decision|0
7785453|NCT00985504|12236217|FG001|Acute Treatment Period|Sponsor Decision|1
7785454|NCT00985504|12236216|FG000|Acute Treatment Period|Withdrawal by Subject|9
7785455|NCT00985504|12236217|FG001|Acute Treatment Period|Withdrawal by Subject|5
7785456|NCT00985504|12236216|FG000|Optimization Period|Adverse Event|7
7785457|NCT00985504|12236217|FG001|Optimization Period|Adverse Event|9
7785458|NCT00985504|12236216|FG000|Optimization Period|Death|0
7785459|NCT00985504|12236217|FG001|Optimization Period|Death|1
7785460|NCT00985504|12236216|FG000|Optimization Period|Lack of Efficacy|5
7785461|NCT00985504|12236217|FG001|Optimization Period|Lack of Efficacy|3
7620296|NCT02778399|12030795|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0
7620297|NCT02778399|12030796|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3
7620298|NCT02778399|12030797|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2
7620299|NCT02778399|12030798|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2
7620300|NCT02778399|12030793|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0
7620301|NCT02778399|12030794|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1
7785462|NCT00985504|12236216|FG000|Optimization Period|Lost to Follow-up|0
7785463|NCT00985504|12236217|FG001|Optimization Period|Lost to Follow-up|1
7785464|NCT00985504|12236216|FG000|Optimization Period|Physician Decision|1
7785465|NCT00985504|12236217|FG001|Optimization Period|Physician Decision|0
7785466|NCT00985504|12236216|FG000|Optimization Period|Protocol Violation|3
7785467|NCT00985504|12236217|FG001|Optimization Period|Protocol Violation|1
7785468|NCT00985504|12236216|FG000|Optimization Period|Withdrawal by Subject|10
7785469|NCT00985504|12236217|FG001|Optimization Period|Withdrawal by Subject|8
7785470|NCT00985621|12236251|FG000|Overall Study|Adverse Event|2
7785471|NCT00985621|12236252|FG001|Overall Study|Adverse Event|3
7785472|NCT00985621|12236253|FG002|Overall Study|Adverse Event|4
7620302|NCT02778399|12030795|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0
7620303|NCT02778399|12030796|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0
7620304|NCT02778399|12030797|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0
7620305|NCT02778399|12030798|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0
7620306|NCT02778399|12030793|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2
7620307|NCT02778399|12030794|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1
7620308|NCT02778399|12030795|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0
7620309|NCT02778399|12030796|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1
7620310|NCT02778399|12030797|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0
7620311|NCT02778399|12030798|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2
7620312|NCT02778399|12030793|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1
7785473|NCT00985621|12236254|FG003|Overall Study|Adverse Event|16
7785474|NCT00985621|12236251|FG000|Overall Study|Lack of Efficacy|10
7785475|NCT00985621|12236252|FG001|Overall Study|Lack of Efficacy|6
7785476|NCT00985621|12236253|FG002|Overall Study|Lack of Efficacy|5
7785477|NCT00985621|12236254|FG003|Overall Study|Lack of Efficacy|12
7785478|NCT00985621|12236251|FG000|Overall Study|Lost to Follow-up|2
7785479|NCT00985621|12236252|FG001|Overall Study|Lost to Follow-up|3
7785480|NCT00985621|12236253|FG002|Overall Study|Lost to Follow-up|4
7785481|NCT00985621|12236254|FG003|Overall Study|Lost to Follow-up|4
7785482|NCT00985621|12236251|FG000|Overall Study|Study Terminated by Sponsor|89
7785483|NCT00985621|12236252|FG001|Overall Study|Study Terminated by Sponsor|108
7785484|NCT00985621|12236253|FG002|Overall Study|Study Terminated by Sponsor|99
7785485|NCT00985621|12236254|FG003|Overall Study|Study Terminated by Sponsor|92
7785486|NCT00985621|12236251|FG000|Overall Study|Protocol Violation|1
7785487|NCT00985621|12236252|FG001|Overall Study|Protocol Violation|1
7785488|NCT00985621|12236253|FG002|Overall Study|Protocol Violation|1
7620313|NCT02778399|12030794|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0
7620314|NCT02778399|12030795|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2
7620315|NCT02778399|12030796|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0
7620316|NCT02778399|12030797|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0
7620317|NCT02778399|12030798|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0
7620318|NCT02778399|12030793|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0
7620319|NCT02778399|12030794|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0
7620320|NCT02778399|12030795|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1
7620321|NCT02778399|12030796|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0
7620322|NCT02778399|12030797|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1
7620323|NCT02778399|12030798|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1
7620324|NCT02701777|12030834|FG000|Overall Study|Some subjects did not like the stimulation.|4
7620325|NCT02701777|12030835|FG001|Overall Study|Some subjects did not like the stimulation.|0
7620326|NCT02701777|12030836|FG002|Overall Study|Some subjects did not like the stimulation.|0
7620327|NCT02701777|12030837|FG003|Overall Study|Some subjects did not like the stimulation.|2
7620328|NCT02701777|12030834|FG000|Overall Study|Some subjects were unable to commit to the training study.|0
7620329|NCT02701777|12030835|FG001|Overall Study|Some subjects were unable to commit to the training study.|3
7620330|NCT02701777|12030836|FG002|Overall Study|Some subjects were unable to commit to the training study.|4
7620331|NCT02701777|12030837|FG003|Overall Study|Some subjects were unable to commit to the training study.|0
7620332|NCT02546674|12030857|FG000|Overall Study|Adverse Event|19
7620333|NCT02546674|12030857|FG000|Overall Study|Death|1
7620334|NCT02546674|12030857|FG000|Overall Study|Lost to Follow-up|1
7620335|NCT02546674|12030857|FG000|Overall Study|Physician Decision|13
7620336|NCT02546674|12030857|FG000|Overall Study|Pregnancy|1
7620337|NCT02546674|12030857|FG000|Overall Study|Progressive Disease|2
7620338|NCT02546674|12030857|FG000|Overall Study|Protocol Deviation|2
7620339|NCT02546674|12030857|FG000|Overall Study|Subject/Guardian Decision|6
7620340|NCT02546674|12030857|FG000|Overall Study|Withdrawal of Informed Consent|3
7620341|NCT02520661|12030864|FG000|Overall Study|Lost to Follow-up|7
7620342|NCT02520661|12030865|FG001|Overall Study|Lost to Follow-up|3
7620343|NCT02520661|12030864|FG000|Overall Study|Admitted from ED|49
7620344|NCT02520661|12030865|FG001|Overall Study|Admitted from ED|48
7620345|NCT02520661|12030864|FG000|Overall Study|ED greater than 24 hours|29
7620346|NCT02520661|12030865|FG001|Overall Study|ED greater than 24 hours|38
7620347|NCT02520661|12030864|FG000|Overall Study|other ineligibility|14
7620348|NCT02520661|12030865|FG001|Overall Study|other ineligibility|22
7620349|NCT02520661|12030864|FG000|Overall Study|Withdrawal by Subject|7
7620350|NCT02520661|12030865|FG001|Overall Study|Withdrawal by Subject|16
7620351|NCT02483585|12030891|FG000|Double-blind Treatment Phase|Decision by Sponsor|1
7620352|NCT02483585|12030892|FG001|Double-blind Treatment Phase|Decision by Sponsor|1
7620353|NCT02483585|12030891|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12
7620354|NCT02483585|12030892|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12
7620355|NCT02483585|12030891|FG000|Double-blind Treatment Phase|Lost to Follow-up|3
7620356|NCT02483585|12030892|FG001|Double-blind Treatment Phase|Lost to Follow-up|2
7620357|NCT02483585|12030891|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6
7620358|NCT02483585|12030892|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5
7785489|NCT00985621|12236254|FG003|Overall Study|Protocol Violation|0
7785490|NCT00985621|12236251|FG000|Overall Study|Withdrawal by Subject|8
7785491|NCT00985621|12236252|FG001|Overall Study|Withdrawal by Subject|10
7785492|NCT00985621|12236253|FG002|Overall Study|Withdrawal by Subject|8
7785493|NCT00985621|12236254|FG003|Overall Study|Withdrawal by Subject|12
7785494|NCT00985621|12236251|FG000|Overall Study|Other|1
7785495|NCT00985621|12236252|FG001|Overall Study|Other|0
7785496|NCT00985621|12236253|FG002|Overall Study|Other|0
7785497|NCT00985621|12236254|FG003|Overall Study|Other|0
7785498|NCT00985621|12236251|FG000|Overall Study|Randomized but not Treated|1
7785499|NCT00985621|12236252|FG001|Overall Study|Randomized but not Treated|0
7785500|NCT00985621|12236253|FG002|Overall Study|Randomized but not Treated|2
7785501|NCT00985621|12236254|FG003|Overall Study|Randomized but not Treated|1
7785502|NCT00985673|12236272|FG000|Overall Study|Lost to Follow-up|6
7785503|NCT00985673|12236273|FG001|Overall Study|Lost to Follow-up|7
7785504|NCT00985673|12236274|FG002|Overall Study|Lost to Follow-up|6
7785505|NCT00985673|12236275|FG003|Overall Study|Lost to Follow-up|10
7785506|NCT00985673|12236276|FG004|Overall Study|Lost to Follow-up|5
7785507|NCT00985673|12236277|FG005|Overall Study|Lost to Follow-up|3
7785508|NCT00985673|12236272|FG000|Overall Study|Withdrawal by Subject|0
7785509|NCT00985673|12236273|FG001|Overall Study|Withdrawal by Subject|4
7785510|NCT00985673|12236274|FG002|Overall Study|Withdrawal by Subject|5
7785511|NCT00985673|12236275|FG003|Overall Study|Withdrawal by Subject|2
7785512|NCT00985673|12236276|FG004|Overall Study|Withdrawal by Subject|2
7785513|NCT00985673|12236277|FG005|Overall Study|Withdrawal by Subject|3
7785514|NCT00985673|12236272|FG000|Overall Study|Other|1
7785515|NCT00985673|12236273|FG001|Overall Study|Other|0
7785516|NCT00985673|12236274|FG002|Overall Study|Other|1
7785517|NCT00985673|12236275|FG003|Overall Study|Other|0
7785518|NCT00985673|12236276|FG004|Overall Study|Other|1
7785519|NCT00985673|12236277|FG005|Overall Study|Other|0
7785520|NCT00985686|12236296|FG000|Overall Study|Lost to Follow-up|1
7785521|NCT00985686|12236297|FG001|Overall Study|Lost to Follow-up|1
7620359|NCT02483585|12030891|FG000|Open-label Treatment Phase|Decision by Sponsor|0
7620360|NCT02483585|12030892|FG001|Open-label Treatment Phase|Decision by Sponsor|1
7620361|NCT02483585|12030891|FG000|Open-label Treatment Phase|Withdrawal by Subject|18
7620362|NCT02483585|12030892|FG001|Open-label Treatment Phase|Withdrawal by Subject|14
7620363|NCT02483585|12030891|FG000|Open-label Treatment Phase|Lost to Follow-up|3
7620364|NCT02483585|12030892|FG001|Open-label Treatment Phase|Lost to Follow-up|5
7785522|NCT00985686|12236298|FG002|Overall Study|Lost to Follow-up|0
7785523|NCT00985686|12236299|FG003|Overall Study|Lost to Follow-up|2
7785524|NCT00985712|12236309|FG000|Overall Study|Adverse Event|0
7785525|NCT00985712|12236310|FG001|Overall Study|Adverse Event|1
7785526|NCT00985712|12236309|FG000|Overall Study|Lost to Follow-up|2
7785527|NCT00985712|12236310|FG001|Overall Study|Lost to Follow-up|2
7785528|NCT00985712|12236309|FG000|Overall Study|Protocol Violation|0
7785529|NCT00985712|12236310|FG001|Overall Study|Protocol Violation|1
7785530|NCT00985712|12236309|FG000|Overall Study|Withdrawal by Subject|4
7785531|NCT00985712|12236310|FG001|Overall Study|Withdrawal by Subject|1
7785532|NCT00985712|12236309|FG000|Overall Study|Sponsor decision|0
7785533|NCT00985712|12236310|FG001|Overall Study|Sponsor decision|2
7785534|NCT00985725|12236318|FG000|Overall Study|Adverse Event|4
7785535|NCT00985725|12236319|FG001|Overall Study|Adverse Event|1
7785536|NCT00985725|12236318|FG000|Overall Study|Protocol Violation|1
7785537|NCT00985725|12236319|FG001|Overall Study|Protocol Violation|3
7785538|NCT00985725|12236318|FG000|Overall Study|Withdrawal by Subject|4
7785539|NCT00985725|12236319|FG001|Overall Study|Withdrawal by Subject|4
7785540|NCT00985725|12236318|FG000|Overall Study|Lost to Follow-up|1
7785541|NCT00985725|12236319|FG001|Overall Study|Lost to Follow-up|1
7785542|NCT00985725|12236318|FG000|Overall Study|Lack of Efficacy|0
7785543|NCT00985725|12236319|FG001|Overall Study|Lack of Efficacy|1
7785544|NCT00985725|12236318|FG000|Overall Study|Non-compliance|1
7785545|NCT00985725|12236319|FG001|Overall Study|Non-compliance|2
7785546|NCT00985725|12236318|FG000|Overall Study|Out-of-window visits|0
7785547|NCT00985725|12236319|FG001|Overall Study|Out-of-window visits|1
7785548|NCT00985751|12236330|FG000|Overall Study|Adverse Event|0
7785549|NCT00985751|12236331|FG001|Overall Study|Adverse Event|0
7785550|NCT00985751|12236332|FG002|Overall Study|Adverse Event|0
7785551|NCT00985751|12236333|FG003|Overall Study|Adverse Event|0
7785552|NCT00985751|12236334|FG004|Overall Study|Adverse Event|1
7785553|NCT00985790|12236351|FG000|Overall Study|Withdrawal by Subject|1
7785554|NCT00985790|12236352|FG001|Overall Study|Withdrawal by Subject|1
7785555|NCT00985790|12236351|FG000|Overall Study|Lost to Follow-up|6
7785556|NCT00985790|12236352|FG001|Overall Study|Lost to Follow-up|7
7785557|NCT00985946|12236372|FG000|Overall Study|Lost to Follow-up|6
7785558|NCT00985946|12236372|FG000|Overall Study|Withdrawal by Subject|1
7785559|NCT00985959|12236379|FG000|Overall Study|Adverse Event|0
7785560|NCT00985959|12236380|FG001|Overall Study|Adverse Event|0
7785561|NCT00985959|12236381|FG002|Overall Study|Adverse Event|19
7785562|NCT00985959|12236379|FG000|Overall Study|Withdrawal by Subject|0
7785563|NCT00985959|12236380|FG001|Overall Study|Withdrawal by Subject|0
7785564|NCT00985959|12236381|FG002|Overall Study|Withdrawal by Subject|8
7785565|NCT00985959|12236379|FG000|Overall Study|Progressive disease|1
7785566|NCT00985959|12236380|FG001|Overall Study|Progressive disease|2
7785567|NCT00985959|12236381|FG002|Overall Study|Progressive disease|8
7785568|NCT00985959|12236379|FG000|Overall Study|Unrecovered toxicity|0
7785569|NCT00985959|12236380|FG001|Overall Study|Unrecovered toxicity|0
7785570|NCT00985959|12236381|FG002|Overall Study|Unrecovered toxicity|7
7785571|NCT00985959|12236379|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2
7785572|NCT00985959|12236380|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0
7785573|NCT00985959|12236381|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2
7785574|NCT00985959|12236379|FG000|Overall Study|Complete response observed over 2 cycles|0
7785575|NCT00985959|12236380|FG001|Overall Study|Complete response observed over 2 cycles|1
7785576|NCT00985959|12236381|FG002|Overall Study|Complete response observed over 2 cycles|4
7785577|NCT00985959|12236379|FG000|Overall Study|Other|0
7785578|NCT00985959|12236380|FG001|Overall Study|Other|0
7785579|NCT00985959|12236381|FG002|Overall Study|Other|11
7785580|NCT00985985|12236399|FG000|Overall Study|Adverse Event|4
7785581|NCT00985985|12236400|FG001|Overall Study|Adverse Event|2
7785582|NCT00985985|12236401|FG002|Overall Study|Adverse Event|2
7785583|NCT00985985|12236402|FG003|Overall Study|Adverse Event|2
7785584|NCT00985985|12236399|FG000|Overall Study|Lost to Follow-up|4
7785585|NCT00985985|12236400|FG001|Overall Study|Lost to Follow-up|11
7785586|NCT00985985|12236401|FG002|Overall Study|Lost to Follow-up|2
7785587|NCT00985985|12236402|FG003|Overall Study|Lost to Follow-up|3
7785588|NCT00985985|12236399|FG000|Overall Study|Protocol Violation|1
7785589|NCT00985985|12236400|FG001|Overall Study|Protocol Violation|2
7785590|NCT00985985|12236401|FG002|Overall Study|Protocol Violation|0
7785591|NCT00985985|12236402|FG003|Overall Study|Protocol Violation|1
7785592|NCT00985985|12236399|FG000|Overall Study|Lack of Efficacy|5
7785593|NCT00985985|12236400|FG001|Overall Study|Lack of Efficacy|6
7785594|NCT00985985|12236401|FG002|Overall Study|Lack of Efficacy|1
7785595|NCT00985985|12236402|FG003|Overall Study|Lack of Efficacy|3
7785596|NCT00985985|12236399|FG000|Overall Study|Withdrawal by Subject|4
7785597|NCT00985985|12236400|FG001|Overall Study|Withdrawal by Subject|2
7785598|NCT00985985|12236401|FG002|Overall Study|Withdrawal by Subject|2
7785599|NCT00985985|12236402|FG003|Overall Study|Withdrawal by Subject|2
7785600|NCT00985985|12236399|FG000|Overall Study|Other Reason|6
7785601|NCT00985985|12236400|FG001|Overall Study|Other Reason|1
7785602|NCT00985985|12236401|FG002|Overall Study|Other Reason|4
7785603|NCT00985985|12236402|FG003|Overall Study|Other Reason|2
7785604|NCT00986102|12236421|FG000|Overall Study|Lost to Follow-up|0
7785605|NCT00986102|12236422|FG001|Overall Study|Lost to Follow-up|1
7785606|NCT00986102|12236423|FG002|Overall Study|Lost to Follow-up|0
7785607|NCT00986102|12236424|FG003|Overall Study|Lost to Follow-up|1
7785608|NCT00986102|12236421|FG000|Overall Study|Withdrawal by Subject|1
7785609|NCT00986102|12236422|FG001|Overall Study|Withdrawal by Subject|1
7785610|NCT00986102|12236423|FG002|Overall Study|Withdrawal by Subject|0
7785611|NCT00986102|12236424|FG003|Overall Study|Withdrawal by Subject|0
7785612|NCT00986154|12236436|FG000|Overall Study|Death|136
7785613|NCT00986154|12236437|FG001|Overall Study|Death|127
7785614|NCT00986154|12236436|FG000|Overall Study|Lost to Follow-up|7
7785615|NCT00986154|12236437|FG001|Overall Study|Lost to Follow-up|4
7785616|NCT00986154|12236436|FG000|Overall Study|Withdrawal by Subject|32
7785617|NCT00986154|12236437|FG001|Overall Study|Withdrawal by Subject|33
7785618|NCT00986154|12236436|FG000|Overall Study|investigator/subject decide not continue|6
7785619|NCT00986154|12236437|FG001|Overall Study|investigator/subject decide not continue|3
7785620|NCT00986154|12236436|FG000|Overall Study|never received study drug|25
7785621|NCT00986154|12236437|FG001|Overall Study|never received study drug|27
7785622|NCT00986180|12236445|FG000|Overall Study|Adverse Event|21
7785623|NCT00986180|12236446|FG001|Overall Study|Adverse Event|23
7785624|NCT00986180|12236445|FG000|Overall Study|Lack of Efficacy|4
7785625|NCT00986180|12236446|FG001|Overall Study|Lack of Efficacy|3
7785626|NCT00986180|12236445|FG000|Overall Study|Lost to Follow-up|5
7785627|NCT00986180|12236446|FG001|Overall Study|Lost to Follow-up|7
7785628|NCT00986180|12236445|FG000|Overall Study|Physician Decision|1
7785629|NCT00986180|12236446|FG001|Overall Study|Physician Decision|3
7785630|NCT00986180|12236445|FG000|Overall Study|Protocol Violation|2
7785631|NCT00986180|12236446|FG001|Overall Study|Protocol Violation|0
7785632|NCT00986180|12236445|FG000|Overall Study|Withdrawal by Subject|1
7785633|NCT00986180|12236446|FG001|Overall Study|Withdrawal by Subject|9
7785634|NCT00986180|12236445|FG000|Overall Study|Miscellanies|10
7785635|NCT00986180|12236446|FG001|Overall Study|Miscellanies|11
7785636|NCT00986232|12236456|FG000|Overall Study|Adverse Event|1
7785637|NCT00986232|12236457|FG001|Overall Study|Adverse Event|2
7785638|NCT00986232|12236458|FG002|Overall Study|Adverse Event|3
7785639|NCT00986232|12236459|FG003|Overall Study|Adverse Event|0
7785640|NCT00986232|12236456|FG000|Overall Study|Lost to Follow-up|19
7785641|NCT00986232|12236457|FG001|Overall Study|Lost to Follow-up|12
7785642|NCT00986232|12236458|FG002|Overall Study|Lost to Follow-up|12
7785643|NCT00986232|12236459|FG003|Overall Study|Lost to Follow-up|7
7785644|NCT00986232|12236456|FG000|Overall Study|Protocol Violation|2
7785645|NCT00986232|12236457|FG001|Overall Study|Protocol Violation|3
7785646|NCT00986232|12236458|FG002|Overall Study|Protocol Violation|0
7785647|NCT00986232|12236459|FG003|Overall Study|Protocol Violation|1
7785648|NCT00986232|12236456|FG000|Overall Study|Withdrawal by Subject|13
7785649|NCT00986232|12236457|FG001|Overall Study|Withdrawal by Subject|16
7785650|NCT00986232|12236458|FG002|Overall Study|Withdrawal by Subject|12
7785651|NCT00986232|12236459|FG003|Overall Study|Withdrawal by Subject|3
7785652|NCT00986232|12236456|FG000|Overall Study|Missed one or more bleeds|13
7785653|NCT00986232|12236457|FG001|Overall Study|Missed one or more bleeds|10
7785654|NCT00986232|12236458|FG002|Overall Study|Missed one or more bleeds|6
7785655|NCT00986232|12236459|FG003|Overall Study|Missed one or more bleeds|7
7785656|NCT00986232|12236456|FG000|Overall Study|Incomplete safety follow-up|3
7785657|NCT00986232|12236457|FG001|Overall Study|Incomplete safety follow-up|7
7785658|NCT00986232|12236458|FG002|Overall Study|Incomplete safety follow-up|2
7785659|NCT00986232|12236459|FG003|Overall Study|Incomplete safety follow-up|2
7785660|NCT00986245|12236475|FG000|First Intervention|Poor compliance|8
7785661|NCT00986245|12236476|FG001|First Intervention|Poor compliance|4
7785662|NCT00986245|12236475|FG000|First Intervention|Lack of Efficacy|1
7785663|NCT00986245|12236476|FG001|First Intervention|Lack of Efficacy|2
7785664|NCT00986245|12236475|FG000|First Intervention|Withdrawal by Subject|0
7785665|NCT00986245|12236476|FG001|First Intervention|Withdrawal by Subject|1
7785666|NCT00986245|12236475|FG000|First Intervention|Protocol Violation|0
7785667|NCT00986245|12236476|FG001|First Intervention|Protocol Violation|1
7785668|NCT00986245|12236475|FG000|First Intervention|Out of indication|1
7785669|NCT00986245|12236476|FG001|First Intervention|Out of indication|0
7785670|NCT00986245|12236475|FG000|Second Intervention|Poor compliance|1
7785671|NCT00986245|12236476|FG001|Second Intervention|Poor compliance|0
7785672|NCT00986245|12236475|FG000|Second Intervention|Lost to Follow-up|1
7785673|NCT00986245|12236476|FG001|Second Intervention|Lost to Follow-up|0
7785674|NCT00986245|12236475|FG000|Second Intervention|Protocol Violation|0
7785675|NCT00986245|12236476|FG001|Second Intervention|Protocol Violation|1
7785676|NCT00986258|12236487|FG000|Observation Period|Not eligible to be dosed|11
7785677|NCT00986258|12236487|FG000|Titration and Optimal Dose Period|Adverse Event|15
7785678|NCT00986258|12236487|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3
7785679|NCT00986258|12236487|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3
7785680|NCT00986258|12236487|FG000|Titration and Optimal Dose Period|Non-Compliance|1
7785681|NCT00986258|12236487|FG000|Titration and Optimal Dose Period|Other|1
7785682|NCT00986258|12236487|FG000|Maintenance Period|Adverse Event|5
7785683|NCT00986258|12236487|FG000|Maintenance Period|Lack of Efficacy|2
7785684|NCT00986258|12236487|FG000|Maintenance Period|Withdrawal by Subject|2
7785685|NCT00986349|12236501|FG000|Overall Study|Unsuccessful implant procedure|3
7785686|NCT00986349|12236501|FG000|Overall Study|Adverse Event|2
7785687|NCT00986349|12236501|FG000|Overall Study|Physician Decision|1
7785688|NCT00986349|12236501|FG000|Overall Study|device migration|1
7785689|NCT00986362|12236516|FG000|Overall Study|Death|2
7785690|NCT00986362|12236517|FG001|Overall Study|Death|0
7785691|NCT00986362|12236516|FG000|Overall Study|Lost to Follow-up|0
7785692|NCT00986362|12236517|FG001|Overall Study|Lost to Follow-up|1
7785693|NCT00986427|12236537|FG000|Overall Study|Lost to Follow-up|2
7785694|NCT00986427|12236538|FG001|Overall Study|Lost to Follow-up|0
7785695|NCT00986427|12236537|FG000|Overall Study|Lack of Efficacy|1
7785696|NCT00986427|12236538|FG001|Overall Study|Lack of Efficacy|0
7785697|NCT00986427|12236537|FG000|Overall Study|Withdrawal by Subject|1
7785698|NCT00986427|12236538|FG001|Overall Study|Withdrawal by Subject|0
7785699|NCT00986440|12236550|FG000|Overall Study|Progressive disease|27
7785700|NCT00986440|12236551|FG001|Overall Study|Progressive disease|37
7785701|NCT00986440|12236550|FG000|Overall Study|Serious adverse event or adverse event|9
7785702|NCT00986440|12236551|FG001|Overall Study|Serious adverse event or adverse event|2
7785703|NCT00986440|12236550|FG000|Overall Study|Withdrawal by Subject|1
7785704|NCT00986440|12236551|FG001|Overall Study|Withdrawal by Subject|2
7785705|NCT00986440|12236550|FG000|Overall Study|Screen failure (not dosed)|4
7785706|NCT00986440|12236551|FG001|Overall Study|Screen failure (not dosed)|2
7785707|NCT00986479|12236565|FG000|Period 1|Improved mood|1
7785708|NCT00986479|12236566|FG001|Period 1|Improved mood|0
7785709|NCT00986479|12236565|FG000|Period 1|Administrative reasons|1
7785710|NCT00986479|12236566|FG001|Period 1|Administrative reasons|0
7785711|NCT00986570|12236582|FG000|Overall Study|Lost to Follow-up|6
7785712|NCT00986570|12236582|FG000|Overall Study|Potential bias for objective assessment|1
7800396|NCT01094730|12257875|FG000|Period 1 (14 Days)|Lost to Follow-up|0
7800397|NCT01094730|12257876|FG001|Period 1 (14 Days)|Lost to Follow-up|1
7800398|NCT01094730|12257875|FG000|Period 1 (14 Days)|Withdrawal by Subject|0
7800399|NCT01094730|12257876|FG001|Period 1 (14 Days)|Withdrawal by Subject|1
7800400|NCT01094730|12257875|FG000|Period 1 (14 Days)|No time for the follow-up visit|1
7800401|NCT01094730|12257876|FG001|Period 1 (14 Days)|No time for the follow-up visit|0
7800402|NCT01094730|12257875|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1
7800403|NCT01094730|12257876|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0
7800404|NCT01094730|12257875|FG000|Period 2 (14 Days)|Protocol Violation|2
7800405|NCT01094730|12257876|FG001|Period 2 (14 Days)|Protocol Violation|0
7800406|NCT01094730|12257875|FG000|Period 2 (14 Days)|No time for the follow-up visit|1
7800407|NCT01094730|12257876|FG001|Period 2 (14 Days)|No time for the follow-up visit|0
7800408|NCT01094730|12257875|FG000|Period 2 (14 Days)|Adverse Event|0
7800409|NCT01094730|12257876|FG001|Period 2 (14 Days)|Adverse Event|1
7800410|NCT01094730|12257875|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0
7800411|NCT01094730|12257876|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1
7800412|NCT01094743|12257883|FG000|Period 1|Unsatisfactory comfort at lens fitting|2
7800413|NCT01094808|12257891|FG000|Overall Study|Withdrawal by Subject|1
7800414|NCT01094808|12257892|FG001|Overall Study|Withdrawal by Subject|1
7800415|NCT01094808|12257893|FG002|Overall Study|Withdrawal by Subject|0
7800416|NCT01094886|12257901|FG000|Overall Study|Adverse Event|2
7800417|NCT01094886|12257901|FG000|Overall Study|Withdrawal by Subject|5
7800418|NCT01095094|12257905|FG000|Overall Study|Withdrawal by Subject|1
7800419|NCT01095094|12257905|FG000|Overall Study|Death|1
7800420|NCT01095094|12257905|FG000|Overall Study|Physician Decision|1
7800421|NCT01095653|12257940|FG000|Overall Study|Lack of Efficacy|3
7800422|NCT01095653|12257941|FG001|Overall Study|Lack of Efficacy|0
7800423|NCT01095653|12257942|FG002|Overall Study|Lack of Efficacy|0
7800424|NCT01095653|12257940|FG000|Overall Study|Adverse Event|1
7800425|NCT01095653|12257941|FG001|Overall Study|Adverse Event|4
7800426|NCT01095653|12257942|FG002|Overall Study|Adverse Event|4
7800427|NCT01095653|12257940|FG000|Overall Study|Lost to Follow-up|1
7800428|NCT01095653|12257941|FG001|Overall Study|Lost to Follow-up|0
7800429|NCT01095653|12257942|FG002|Overall Study|Lost to Follow-up|4
7800430|NCT01095653|12257940|FG000|Overall Study|Withdrawal by Subject|4
7800431|NCT01095653|12257941|FG001|Overall Study|Withdrawal by Subject|5
7800432|NCT01095653|12257942|FG002|Overall Study|Withdrawal by Subject|3
7800433|NCT01095653|12257940|FG000|Overall Study|non-compliance, not met criteria, etc.|10
7800434|NCT01095653|12257941|FG001|Overall Study|non-compliance, not met criteria, etc.|6
7800435|NCT01095653|12257942|FG002|Overall Study|non-compliance, not met criteria, etc.|5
7800436|NCT01095666|12257953|FG000|Overall Study|Lack of Efficacy|0
7800437|NCT01095666|12257954|FG001|Overall Study|Lack of Efficacy|0
7785713|NCT00986674|12236599|FG000|Overall Study|Lack of Efficacy|28
7785714|NCT00986674|12236600|FG001|Overall Study|Lack of Efficacy|25
7785715|NCT00986674|12236601|FG002|Overall Study|Lack of Efficacy|23
7785716|NCT00986674|12236599|FG000|Overall Study|Adverse Event|4
7785717|NCT00986674|12236600|FG001|Overall Study|Adverse Event|8
7785718|NCT00986674|12236601|FG002|Overall Study|Adverse Event|9
7785719|NCT00986674|12236599|FG000|Overall Study|Death|5
7785720|NCT00986674|12236600|FG001|Overall Study|Death|0
7785721|NCT00986674|12236601|FG002|Overall Study|Death|4
7785722|NCT00986674|12236599|FG000|Overall Study|Withdrawal by Subject|6
7785723|NCT00986674|12236600|FG001|Overall Study|Withdrawal by Subject|2
7785724|NCT00986674|12236601|FG002|Overall Study|Withdrawal by Subject|1
7785725|NCT00986674|12236599|FG000|Overall Study|alternative therapy|0
7785726|NCT00986674|12236600|FG001|Overall Study|alternative therapy|0
7785727|NCT00986674|12236601|FG002|Overall Study|alternative therapy|1
7785728|NCT00986674|12236599|FG000|Overall Study|not start protocol therapy|4
7785729|NCT00986674|12236600|FG001|Overall Study|not start protocol therapy|3
7620428|NCT02399215|12030923|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1
7620429|NCT02399215|12030923|FG000|Overall Study|Withdrawal by Subject|1
7785730|NCT00986674|12236601|FG002|Overall Study|not start protocol therapy|1
7785731|NCT00986674|12236599|FG000|Overall Study|unknown/not specify|0
7785732|NCT00986674|12236600|FG001|Overall Study|unknown/not specify|7
7785733|NCT00986674|12236601|FG002|Overall Study|unknown/not specify|9
7785734|NCT00986830|12236609|FG000|Overall Study|Death|1
7785735|NCT00986830|12236609|FG000|Overall Study|Lost to Follow-up|1
7785736|NCT00986830|12236609|FG000|Overall Study|Lack of Efficacy|1
7785737|NCT00986830|12236609|FG000|Overall Study|Unable to access sinus with device|5
7620438|NCT02202577|12030939|FG000|Overall Study|Lost to Follow-up|6
7620439|NCT02202577|12030940|FG001|Overall Study|Lost to Follow-up|16
7620440|NCT02202577|12030939|FG000|Overall Study|Protocol Violation|7
7620441|NCT02202577|12030940|FG001|Overall Study|Protocol Violation|3
7620442|NCT02130427|12030946|FG000|Overall Study|Imaging results not interpretable|30
7620443|NCT01959698|12030966|FG000|Overall Study|Adverse Event|0
7620444|NCT01959698|12030967|FG001|Overall Study|Adverse Event|0
7620445|NCT01959698|12030968|FG002|Overall Study|Adverse Event|0
7620446|NCT01959698|12030969|FG003|Overall Study|Adverse Event|0
7620447|NCT01959698|12030970|FG004|Overall Study|Adverse Event|0
7620448|NCT01959698|12030971|FG005|Overall Study|Adverse Event|0
7620449|NCT01959698|12030972|FG006|Overall Study|Adverse Event|1
7785738|NCT00986921|12236624|FG000|Overall Study|Physician Decision|1
7785739|NCT00986921|12236625|FG001|Overall Study|Physician Decision|0
7785740|NCT00986973|12236634|FG000|Overall Study|Withdrawn by study team|1
7785741|NCT00986986|12236641|FG000|Overall Study|Lost to Follow-up|0
7785742|NCT00986986|12236642|FG001|Overall Study|Lost to Follow-up|1
7785743|NCT00987337|12236652|FG000|Overall Study|Adverse Event|10
7785744|NCT00987337|12236653|FG001|Overall Study|Adverse Event|9
7785745|NCT00987337|12236654|FG002|Overall Study|Adverse Event|8
7785746|NCT00987337|12236652|FG000|Overall Study|Insufficient Virologic Response|10
7785747|NCT00987337|12236653|FG001|Overall Study|Insufficient Virologic Response|7
7785748|NCT00987337|12236654|FG002|Overall Study|Insufficient Virologic Response|12
7785749|NCT00987337|12236652|FG000|Overall Study|Virologic Breakthrough|2
7620450|NCT01959698|12030966|FG000|Overall Study|Physician Decision|1
7620451|NCT01959698|12030967|FG001|Overall Study|Physician Decision|0
7620452|NCT01959698|12030968|FG002|Overall Study|Physician Decision|1
7620453|NCT01959698|12030969|FG003|Overall Study|Physician Decision|2
7785750|NCT00987337|12236653|FG001|Overall Study|Virologic Breakthrough|2
7785751|NCT00987337|12236654|FG002|Overall Study|Virologic Breakthrough|8
7785752|NCT00987337|12236652|FG000|Overall Study|Lost to Follow-up|10
7785753|NCT00987337|12236653|FG001|Overall Study|Lost to Follow-up|6
7785754|NCT00987337|12236654|FG002|Overall Study|Lost to Follow-up|2
7785755|NCT00987337|12236652|FG000|Overall Study|Withdrawal by Subject|6
7785756|NCT00987337|12236653|FG001|Overall Study|Withdrawal by Subject|9
7785757|NCT00987337|12236654|FG002|Overall Study|Withdrawal by Subject|9
7785758|NCT00987337|12236652|FG000|Overall Study|Other|0
7785759|NCT00987337|12236653|FG001|Overall Study|Other|2
7785760|NCT00987337|12236654|FG002|Overall Study|Other|5
7785761|NCT00987337|12236652|FG000|Overall Study|Protocol Violation|1
7785762|NCT00987337|12236653|FG001|Overall Study|Protocol Violation|0
7785763|NCT00987337|12236654|FG002|Overall Study|Protocol Violation|2
7785764|NCT00987337|12236652|FG000|Overall Study|Participant Relapsed|18
7785765|NCT00987337|12236653|FG001|Overall Study|Participant Relapsed|20
7785766|NCT00987337|12236654|FG002|Overall Study|Participant Relapsed|5
7785767|NCT00987389|12236666|FG000|Overall Study|Ineligible|0
7785768|NCT00987389|12236667|FG001|Overall Study|Ineligible|3
7785769|NCT00987389|12236668|FG002|Overall Study|Ineligible|0
7785770|NCT00987389|12236669|FG003|Overall Study|Ineligible|0
7785771|NCT00987389|12236666|FG000|Overall Study|Lost to Follow-up|4
7785772|NCT00987389|12236667|FG001|Overall Study|Lost to Follow-up|1
7785773|NCT00987389|12236668|FG002|Overall Study|Lost to Follow-up|3
7785774|NCT00987389|12236669|FG003|Overall Study|Lost to Follow-up|1
7785775|NCT00987389|12236666|FG000|Overall Study|Withdrawal by Subject|4
7785776|NCT00987389|12236667|FG001|Overall Study|Withdrawal by Subject|3
7785777|NCT00987389|12236668|FG002|Overall Study|Withdrawal by Subject|2
7785778|NCT00987389|12236669|FG003|Overall Study|Withdrawal by Subject|1
7785779|NCT00987389|12236666|FG000|Overall Study|Withdrawn from Treatment|0
7785780|NCT00987389|12236667|FG001|Overall Study|Withdrawn from Treatment|1
7785781|NCT00987389|12236668|FG002|Overall Study|Withdrawn from Treatment|0
7785782|NCT00987389|12236669|FG003|Overall Study|Withdrawn from Treatment|0
7785783|NCT00987389|12236666|FG000|Overall Study|Multiple different reasons|1
7785784|NCT00987389|12236667|FG001|Overall Study|Multiple different reasons|0
7785785|NCT00987389|12236668|FG002|Overall Study|Multiple different reasons|3
7785786|NCT00987389|12236669|FG003|Overall Study|Multiple different reasons|1
7785787|NCT00987402|12236679|FG000|Overall Study|Insufficient data entry|86
7785788|NCT00987402|12236680|FG001|Overall Study|Insufficient data entry|98
7785789|NCT00987467|12236695|FG000|Overall Study|Lost to Follow-up|2
7785790|NCT00987623|12236714|FG000|Overall Study|Lost to Follow-up|2
7620454|NCT01959698|12030970|FG004|Overall Study|Physician Decision|0
7620455|NCT01959698|12030971|FG005|Overall Study|Physician Decision|3
7620456|NCT01959698|12030972|FG006|Overall Study|Physician Decision|3
7620457|NCT01942837|12030989|FG000|Overall Study|Death|1
7620458|NCT01942837|12030989|FG000|Overall Study|Symptomatic or radiographic progression|49
7620459|NCT01942837|12030989|FG000|Overall Study|Adverse Event|6
7620460|NCT01942837|12030989|FG000|Overall Study|Physician Decision|3
7620461|NCT01942837|12030989|FG000|Overall Study|Withdrawal by Subject|2
7620462|NCT01942837|12030989|FG000|Overall Study|Intercurrent Illness|1
7620463|NCT01942837|12030989|FG000|Overall Study|On treatment|3
7620464|NCT01942837|12030989|FG000|Overall Study|Never initiate the treatment|2
7620465|NCT01906489|12030996|FG000|Overall Study|Adverse Event|10
7620466|NCT01906489|12030997|FG001|Overall Study|Adverse Event|3
7620467|NCT01906489|12030996|FG000|Overall Study|Worsening of CKD|6
7620468|NCT01906489|12030997|FG001|Overall Study|Worsening of CKD|4
7620469|NCT01906489|12030996|FG000|Overall Study|Withdrawal by Subject|5
7620470|NCT01906489|12030997|FG001|Overall Study|Withdrawal by Subject|0
7620471|NCT01906489|12030996|FG000|Overall Study|Worsening of Anemia|1
7620472|NCT01906489|12030997|FG001|Overall Study|Worsening of Anemia|0
7620473|NCT01906489|12030996|FG000|Overall Study|Protocol Violation|0
7620474|NCT01906489|12030997|FG001|Overall Study|Protocol Violation|1
7620475|NCT01906489|12030996|FG000|Overall Study|Non- Compliance|1
7785791|NCT00987623|12236715|FG001|Overall Study|Lost to Follow-up|1
7785792|NCT00987623|12236714|FG000|Overall Study|Time/job conflict|2
7785793|NCT00987623|12236715|FG001|Overall Study|Time/job conflict|0
7785794|NCT00987623|12236714|FG000|Overall Study|Discomfort|1
7785795|NCT00987623|12236715|FG001|Overall Study|Discomfort|0
7785796|NCT00987623|12236714|FG000|Overall Study|Biomicroscopy|0
7785797|NCT00987623|12236715|FG001|Overall Study|Biomicroscopy|1
7785798|NCT00987623|12236714|FG000|Overall Study|Influenza|0
7785799|NCT00987623|12236715|FG001|Overall Study|Influenza|1
7785800|NCT00987831|12236733|FG000|Overall Study|Never flared in 12 months|1
7785801|NCT00987831|12236734|FG001|Overall Study|Never flared in 12 months|0
7785802|NCT00987831|12236735|FG002|Overall Study|Never flared in 12 months|0
7785803|NCT00987831|12236733|FG000|Overall Study|Lost to Follow-up|0
7785804|NCT00987831|12236734|FG001|Overall Study|Lost to Follow-up|3
7785805|NCT00987831|12236735|FG002|Overall Study|Lost to Follow-up|0
7785806|NCT00987935|12236753|FG000|Overall Study|Progressive disease|3
7785807|NCT00987935|12236754|FG001|Overall Study|Progressive disease|2
7785808|NCT00987935|12236755|FG002|Overall Study|Progressive disease|3
7785809|NCT00987935|12236756|FG003|Overall Study|Progressive disease|2
7785810|NCT00987935|12236757|FG004|Overall Study|Progressive disease|5
7785811|NCT00987935|12236758|FG005|Overall Study|Progressive disease|3
7785812|NCT00987935|12236759|FG006|Overall Study|Progressive disease|9
7785813|NCT00987935|12236760|FG007|Overall Study|Progressive disease|48
7785814|NCT00987935|12236761|FG008|Overall Study|Progressive disease|23
7785815|NCT00987935|12236753|FG000|Overall Study|Adverse Event|0
7785816|NCT00987935|12236754|FG001|Overall Study|Adverse Event|1
7785817|NCT00987935|12236755|FG002|Overall Study|Adverse Event|0
7785818|NCT00987935|12236756|FG003|Overall Study|Adverse Event|1
7785819|NCT00987935|12236757|FG004|Overall Study|Adverse Event|1
7785820|NCT00987935|12236758|FG005|Overall Study|Adverse Event|0
7785821|NCT00987935|12236759|FG006|Overall Study|Adverse Event|2
7785822|NCT00987935|12236760|FG007|Overall Study|Adverse Event|10
7785823|NCT00987935|12236761|FG008|Overall Study|Adverse Event|6
7785824|NCT00987935|12236753|FG000|Overall Study|Refused to continue taking trial med.|1
7785825|NCT00987935|12236754|FG001|Overall Study|Refused to continue taking trial med.|0
7785826|NCT00987935|12236755|FG002|Overall Study|Refused to continue taking trial med.|0
7785827|NCT00987935|12236756|FG003|Overall Study|Refused to continue taking trial med.|0
7785828|NCT00987935|12236757|FG004|Overall Study|Refused to continue taking trial med.|1
7785829|NCT00987935|12236758|FG005|Overall Study|Refused to continue taking trial med.|0
7785830|NCT00987935|12236759|FG006|Overall Study|Refused to continue taking trial med.|4
7620476|NCT01906489|12030997|FG001|Overall Study|Non- Compliance|0
7620477|NCT01906489|12030996|FG000|Overall Study|Sponsor Decision|1
7620478|NCT01906489|12030997|FG001|Overall Study|Sponsor Decision|0
7785831|NCT00987935|12236760|FG007|Overall Study|Refused to continue taking trial med.|4
7785832|NCT00987935|12236761|FG008|Overall Study|Refused to continue taking trial med.|2
7785833|NCT00987935|12236753|FG000|Overall Study|Reason other than those specified above|0
7785834|NCT00987935|12236754|FG001|Overall Study|Reason other than those specified above|0
7785835|NCT00987935|12236755|FG002|Overall Study|Reason other than those specified above|0
7785836|NCT00987935|12236756|FG003|Overall Study|Reason other than those specified above|0
7785837|NCT00987935|12236757|FG004|Overall Study|Reason other than those specified above|0
7785838|NCT00987935|12236758|FG005|Overall Study|Reason other than those specified above|0
7785839|NCT00987935|12236759|FG006|Overall Study|Reason other than those specified above|0
7785840|NCT00987935|12236760|FG007|Overall Study|Reason other than those specified above|0
7785841|NCT00987935|12236761|FG008|Overall Study|Reason other than those specified above|1
7620479|NCT01906489|12030996|FG000|Overall Study|Lost to Follow-up|1
7620480|NCT01906489|12030997|FG001|Overall Study|Lost to Follow-up|1
7620481|NCT01906489|12030996|FG000|Overall Study|Other|1
7620482|NCT01906489|12030997|FG001|Overall Study|Other|0
7620483|NCT01855412|12031006|FG000|Overall Study|Death|77
7620484|NCT01855412|12031007|FG001|Overall Study|Death|123
7620485|NCT01855412|12031008|FG002|Overall Study|Death|30
7620486|NCT01855412|12031006|FG000|Overall Study|Lost to Follow-up|28
7620487|NCT01855412|12031007|FG001|Overall Study|Lost to Follow-up|46
7620488|NCT01855412|12031008|FG002|Overall Study|Lost to Follow-up|15
7620489|NCT01855412|12031006|FG000|Overall Study|Withdrawal by Subject|77
7620490|NCT01855412|12031007|FG001|Overall Study|Withdrawal by Subject|123
7620491|NCT01855412|12031008|FG002|Overall Study|Withdrawal by Subject|24
7620492|NCT01855412|12031006|FG000|Overall Study|Physician Decision|25
7620493|NCT01855412|12031007|FG001|Overall Study|Physician Decision|31
7620494|NCT01855412|12031008|FG002|Overall Study|Physician Decision|3
7620495|NCT01855412|12031006|FG000|Overall Study|Site Closure|4
7620496|NCT01855412|12031007|FG001|Overall Study|Site Closure|18
7620497|NCT01855412|12031008|FG002|Overall Study|Site Closure|1
7620498|NCT01855412|12031006|FG000|Overall Study|Reason not Specified|1
7620499|NCT01855412|12031007|FG001|Overall Study|Reason not Specified|2
7620500|NCT01855412|12031008|FG002|Overall Study|Reason not Specified|3
7620501|NCT01845805|12031024|FG000|Overall Study|Withdrawal by Subject|1
7620502|NCT01845805|12031025|FG001|Overall Study|Withdrawal by Subject|2
7620503|NCT01845805|12031024|FG000|Overall Study|Disease Progression|13
7620504|NCT01845805|12031025|FG001|Overall Study|Disease Progression|14
7785842|NCT00988065|12236828|FG000|Overall Study|Adverse Event|4
7785843|NCT00988065|12236829|FG001|Overall Study|Adverse Event|10
7785844|NCT00988065|12236830|FG002|Overall Study|Adverse Event|2
7785845|NCT00988065|12236828|FG000|Overall Study|Lost to Follow-up|1
7785846|NCT00988065|12236829|FG001|Overall Study|Lost to Follow-up|2
7785847|NCT00988065|12236830|FG002|Overall Study|Lost to Follow-up|2
7785848|NCT00988065|12236828|FG000|Overall Study|Subject withdrew consent|3
7785849|NCT00988065|12236829|FG001|Overall Study|Subject withdrew consent|5
7785850|NCT00988065|12236830|FG002|Overall Study|Subject withdrew consent|2
7785851|NCT00988065|12236828|FG000|Overall Study|Noncompliance with protocol|5
7785852|NCT00988065|12236829|FG001|Overall Study|Noncompliance with protocol|6
7785853|NCT00988065|12236830|FG002|Overall Study|Noncompliance with protocol|9
7785854|NCT00988091|12236840|FG000|Double-blind Period|Withdrawal by Subject|15
7785855|NCT00988091|12236841|FG001|Double-blind Period|Withdrawal by Subject|13
7785856|NCT00988091|12236840|FG000|Double-blind Period|Lost to Follow-up|12
7785857|NCT00988091|12236841|FG001|Double-blind Period|Lost to Follow-up|14
7785858|NCT00988091|12236840|FG000|Double-blind Period|Other|8
7785859|NCT00988091|12236841|FG001|Double-blind Period|Other|8
7785860|NCT00988091|12236840|FG000|Double-blind Period|Adverse Event|6
7785861|NCT00988091|12236841|FG001|Double-blind Period|Adverse Event|9
7785862|NCT00988091|12236840|FG000|Double-blind Period|Use of exclusionary medication|2
7785863|NCT00988091|12236841|FG001|Double-blind Period|Use of exclusionary medication|3
7785864|NCT00988091|12236840|FG000|Open-label Period|Adverse Event|4
7785865|NCT00988091|12236841|FG001|Open-label Period|Adverse Event|7
7785866|NCT00988091|12236840|FG000|Open-label Period|Use of exclusionary medication|1
7785867|NCT00988091|12236841|FG001|Open-label Period|Use of exclusionary medication|1
7785868|NCT00988091|12236840|FG000|Open-label Period|Protocol Violation|1
7785869|NCT00988091|12236841|FG001|Open-label Period|Protocol Violation|1
7785870|NCT00988091|12236840|FG000|Open-label Period|Withdrawal by Subject|10
7785871|NCT00988091|12236841|FG001|Open-label Period|Withdrawal by Subject|16
7785872|NCT00988091|12236840|FG000|Open-label Period|Lost to Follow-up|3
7785873|NCT00988091|12236841|FG001|Open-label Period|Lost to Follow-up|5
7785874|NCT00988091|12236840|FG000|Open-label Period|Other|2
7785875|NCT00988091|12236841|FG001|Open-label Period|Other|3
7785876|NCT00988117|12236848|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
7785877|NCT00988117|12236848|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
7785878|NCT00988169|12236875|FG000|Overall Study|Withdrawal by Subject|1
7785879|NCT00988208|12236881|FG000|Overall Study|Adverse Event|71
7785880|NCT00988208|12236882|FG001|Overall Study|Adverse Event|122
7785881|NCT00988208|12236881|FG000|Overall Study|Disease Progression|103
7785882|NCT00988208|12236882|FG001|Overall Study|Disease Progression|89
7785883|NCT00988208|12236881|FG000|Overall Study|Withdrawal by Subject|50
7785884|NCT00988208|12236882|FG001|Overall Study|Withdrawal by Subject|57
7785885|NCT00988208|12236881|FG000|Overall Study|Death|9
7785886|NCT00988208|12236882|FG001|Overall Study|Death|15
7785887|NCT00988208|12236881|FG000|Overall Study|Lost to Follow-up|2
7785888|NCT00988208|12236882|FG001|Overall Study|Lost to Follow-up|3
7785889|NCT00988208|12236881|FG000|Overall Study|Protocol Violation|9
7785890|NCT00988208|12236882|FG001|Overall Study|Protocol Violation|2
7785891|NCT00988208|12236881|FG000|Overall Study|Sponsor Decision|102
7785892|NCT00988208|12236882|FG001|Overall Study|Sponsor Decision|78
7785893|NCT00988208|12236881|FG000|Overall Study|Clinical Progression|17
7785894|NCT00988208|12236882|FG001|Overall Study|Clinical Progression|16
7785895|NCT00988208|12236881|FG000|Overall Study|Biochemical Progression|21
7785896|NCT00988208|12236882|FG001|Overall Study|Biochemical Progression|7
7785897|NCT00988208|12236881|FG000|Overall Study|Clinical Deterioration|7
7785898|NCT00988208|12236882|FG001|Overall Study|Clinical Deterioration|14
7620505|NCT01845805|12031024|FG000|Overall Study|Drug-related Toxicity|4
7620506|NCT01845805|12031025|FG001|Overall Study|Drug-related Toxicity|0
7620507|NCT01764633|12031061|FG000|Overall Study|Withdrawal by Subject|105
7620508|NCT01764633|12031062|FG001|Overall Study|Withdrawal by Subject|88
7620509|NCT01764633|12031061|FG000|Overall Study|Lost to Follow-up|13
7620510|NCT01764633|12031062|FG001|Overall Study|Lost to Follow-up|5
7620511|NCT01744093|12031070|FG000|Overall Study|Withdrawal by Subject|6
7620512|NCT01744093|12031071|FG001|Overall Study|Withdrawal by Subject|1
7785899|NCT00988208|12236881|FG000|Overall Study|Subject Decision/Investigator Discretion|32
7785900|NCT00988208|12236882|FG001|Overall Study|Subject Decision/Investigator Discretion|32
7785901|NCT00988208|12236881|FG000|Overall Study|Other|8
7785902|NCT00988208|12236882|FG001|Overall Study|Other|3
7785903|NCT00988221|12236891|FG000|Part I|Adverse Event|0
7785904|NCT00988221|12236892|FG001|Part I|Adverse Event|1
7785905|NCT00988221|12236893|FG002|Part I|Adverse Event|2
7785906|NCT00988221|12236894|FG003|Part I|Adverse Event|0
7785907|NCT00988221|12236891|FG000|Part I|Insufficient Therapeutic Response|4
7785908|NCT00988221|12236892|FG001|Part I|Insufficient Therapeutic Response|6
7785909|NCT00988221|12236893|FG002|Part I|Insufficient Therapeutic Response|5
7785910|NCT00988221|12236894|FG003|Part I|Insufficient Therapeutic Response|0
7785911|NCT00988221|12236891|FG000|Part I|Refused Treatment|0
7785912|NCT00988221|12236892|FG001|Part I|Refused Treatment|2
7785913|NCT00988221|12236893|FG002|Part I|Refused Treatment|1
7785914|NCT00988221|12236894|FG003|Part I|Refused Treatment|0
7785915|NCT00988221|12236891|FG000|Part I|Lost to Follow-up|0
7785916|NCT00988221|12236892|FG001|Part I|Lost to Follow-up|1
7785917|NCT00988221|12236893|FG002|Part I|Lost to Follow-up|0
7785918|NCT00988221|12236894|FG003|Part I|Lost to Follow-up|0
7785919|NCT00988221|12236891|FG000|Part II|Adverse Event|1
7785920|NCT00988221|12236892|FG001|Part II|Adverse Event|0
7785921|NCT00988221|12236893|FG002|Part II|Adverse Event|0
7785922|NCT00988221|12236894|FG003|Part II|Adverse Event|1
7785923|NCT00988221|12236891|FG000|Part II|Withdrawal by Subject|0
7785924|NCT00988221|12236892|FG001|Part II|Withdrawal by Subject|0
7785925|NCT00988221|12236893|FG002|Part II|Withdrawal by Subject|2
7785926|NCT00988221|12236894|FG003|Part II|Withdrawal by Subject|2
7785927|NCT00988221|12236891|FG000|Part II|Reason not Specified|0
7785928|NCT00988221|12236892|FG001|Part II|Reason not Specified|0
7785929|NCT00988221|12236893|FG002|Part II|Reason not Specified|1
7785930|NCT00988221|12236894|FG003|Part II|Reason not Specified|0
7785931|NCT00988221|12236891|FG000|Part III|Adverse Event|1
7785932|NCT00988221|12236892|FG001|Part III|Adverse Event|0
7785933|NCT00988221|12236893|FG002|Part III|Adverse Event|1
7785934|NCT00988221|12236894|FG003|Part III|Adverse Event|0
7785935|NCT00988221|12236891|FG000|Part III|Insufficient Therapeutic Response|0
7785936|NCT00988221|12236892|FG001|Part III|Insufficient Therapeutic Response|1
7785937|NCT00988221|12236893|FG002|Part III|Insufficient Therapeutic Response|1
7785938|NCT00988221|12236894|FG003|Part III|Insufficient Therapeutic Response|0
7785939|NCT00988221|12236891|FG000|Part III|Refused Treatment|0
7785940|NCT00988221|12236892|FG001|Part III|Refused Treatment|0
7785941|NCT00988221|12236893|FG002|Part III|Refused Treatment|1
7785942|NCT00988221|12236894|FG003|Part III|Refused Treatment|0
7785943|NCT00988351|12236932|FG000|Overall Study|Withdrawal by Subject|8
7785944|NCT00988351|12236933|FG001|Overall Study|Withdrawal by Subject|0
7785945|NCT00988351|12236932|FG000|Overall Study|Lost to Follow-up|6
7785946|NCT00988351|12236933|FG001|Overall Study|Lost to Follow-up|9
7785947|NCT00988351|12236932|FG000|Overall Study|not using CPAP|5
7785948|NCT00988351|12236933|FG001|Overall Study|not using CPAP|3
7785949|NCT00988429|12236942|FG000|Overall Study|Adverse Event|9
7785950|NCT00988429|12236943|FG001|Overall Study|Adverse Event|21
7785951|NCT00988429|12236944|FG002|Overall Study|Adverse Event|45
7785952|NCT00988429|12236942|FG000|Overall Study|Lack of Efficacy|0
7785953|NCT00988429|12236943|FG001|Overall Study|Lack of Efficacy|0
7785954|NCT00988429|12236944|FG002|Overall Study|Lack of Efficacy|1
7785955|NCT00988429|12236942|FG000|Overall Study|Non-Compliance with Study Drug|5
7785956|NCT00988429|12236943|FG001|Overall Study|Non-Compliance with Study Drug|1
7785957|NCT00988429|12236944|FG002|Overall Study|Non-Compliance with Study Drug|3
7785958|NCT00988429|12236942|FG000|Overall Study|Physician Decision|1
7785959|NCT00988429|12236943|FG001|Overall Study|Physician Decision|0
7785960|NCT00988429|12236944|FG002|Overall Study|Physician Decision|3
7785961|NCT00988429|12236942|FG000|Overall Study|Pregnancy|2
7785962|NCT00988429|12236943|FG001|Overall Study|Pregnancy|1
7785963|NCT00988429|12236944|FG002|Overall Study|Pregnancy|0
7785964|NCT00988429|12236942|FG000|Overall Study|Protocol Violation|4
7785965|NCT00988429|12236943|FG001|Overall Study|Protocol Violation|3
7785966|NCT00988429|12236944|FG002|Overall Study|Protocol Violation|3
7785967|NCT00988429|12236942|FG000|Overall Study|Withdrawal by Subject|7
7785968|NCT00988429|12236943|FG001|Overall Study|Withdrawal by Subject|7
7785969|NCT00988429|12236944|FG002|Overall Study|Withdrawal by Subject|12
7785970|NCT00988429|12236942|FG000|Overall Study|Administrative Reasons|1
7785971|NCT00988429|12236943|FG001|Overall Study|Administrative Reasons|2
7785972|NCT00988429|12236944|FG002|Overall Study|Administrative Reasons|1
7785973|NCT00988429|12236942|FG000|Overall Study|other reasons|8
7785974|NCT00988429|12236943|FG001|Overall Study|other reasons|8
7785975|NCT00988429|12236944|FG002|Overall Study|other reasons|1
7620551|NCT01622868|12031135|FG000|Overall Study|Protocol Violation|7
7620552|NCT01622868|12031136|FG001|Overall Study|Protocol Violation|0
7785976|NCT00988442|12236955|FG000|Overall Study|Death|1
7785977|NCT00988442|12236956|FG001|Overall Study|Death|2
7785978|NCT00988442|12236955|FG000|Overall Study|Lost to Follow-up|0
7785979|NCT00988442|12236956|FG001|Overall Study|Lost to Follow-up|1
7620553|NCT01609790|12031145|FG000|Overall Study|Protocol Violation|1
7620554|NCT01609790|12031146|FG001|Overall Study|Protocol Violation|7
7620555|NCT01609790|12031147|FG002|Overall Study|Protocol Violation|8
7785980|NCT00988442|12236955|FG000|Overall Study|Early Study Closure|29
7785981|NCT00988442|12236956|FG001|Overall Study|Early Study Closure|25
7785982|NCT00988533|12236965|FG000|Overall Study|Lost to Follow-up|3
7785983|NCT00988559|12236973|FG000|Overall Study|Withdrawal by Subject|1
7785984|NCT00988559|12236974|FG001|Overall Study|Withdrawal by Subject|1
7785985|NCT00988559|12236975|FG002|Overall Study|Withdrawal by Subject|0
7620562|NCT01516879|12031175|FG000|Overall Study|Withdrawal by Subject|9
7620563|NCT01516879|12031176|FG001|Overall Study|Withdrawal by Subject|11
7620564|NCT01516879|12031175|FG000|Overall Study|Death|0
7620565|NCT01516879|12031176|FG001|Overall Study|Death|2
7620566|NCT01516879|12031175|FG000|Overall Study|Lost to Follow-up|2
7620567|NCT01516879|12031176|FG001|Overall Study|Lost to Follow-up|11
7620568|NCT01516879|12031175|FG000|Overall Study|Other|5
7620569|NCT01516879|12031176|FG001|Overall Study|Other|10
7785986|NCT00988559|12236976|FG003|Overall Study|Withdrawal by Subject|1
7785987|NCT00988559|12236973|FG000|Overall Study|Pregnancy|0
7785988|NCT00988559|12236974|FG001|Overall Study|Pregnancy|1
7785989|NCT00988559|12236975|FG002|Overall Study|Pregnancy|1
7785990|NCT00988559|12236976|FG003|Overall Study|Pregnancy|0
7785991|NCT00988559|12236973|FG000|Overall Study|Lost to Follow-up|0
7785992|NCT00988559|12236974|FG001|Overall Study|Lost to Follow-up|0
7785993|NCT00988559|12236975|FG002|Overall Study|Lost to Follow-up|1
7785994|NCT00988559|12236976|FG003|Overall Study|Lost to Follow-up|0
7785995|NCT00988598|12236988|FG000|Overall Study|Withdrawal by Subject|2
7785996|NCT00988598|12236989|FG001|Overall Study|Withdrawal by Subject|0
7785997|NCT00988858|12237002|FG000|Overall Study|Adverse Event|7
7785998|NCT00988858|12237002|FG000|Overall Study|Death|1
7785999|NCT00988858|12237002|FG000|Overall Study|Physician Decision|1
7786000|NCT00988858|12237002|FG000|Overall Study|Sponsor Decision|1
7786001|NCT00988884|12237008|FG000|Overall Study|Adverse Event|0
7786002|NCT00988884|12237009|FG001|Overall Study|Adverse Event|1
7786003|NCT00988884|12237008|FG000|Overall Study|Lost to Follow-up|20
7786004|NCT00988884|12237009|FG001|Overall Study|Lost to Follow-up|16
7786005|NCT00988884|12237008|FG000|Overall Study|Protocol Violation|0
7786006|NCT00988884|12237009|FG001|Overall Study|Protocol Violation|1
7786007|NCT00988884|12237008|FG000|Overall Study|Withdrawal by Subject|15
7786008|NCT00988884|12237009|FG001|Overall Study|Withdrawal by Subject|18
7786009|NCT00989092|12237034|FG000|Overall Study|Physician Decision|9
7786010|NCT00989092|12237035|FG001|Overall Study|Physician Decision|6
7786011|NCT00989092|12237034|FG000|Overall Study|Adverse Event|20
7786012|NCT00989092|12237035|FG001|Overall Study|Adverse Event|1
7786013|NCT00989092|12237034|FG000|Overall Study|Chemotherapy initiated|12
7786014|NCT00989092|12237035|FG001|Overall Study|Chemotherapy initiated|4
7786015|NCT00989092|12237034|FG000|Overall Study|Withdrawal by Subject|17
7786016|NCT00989092|12237035|FG001|Overall Study|Withdrawal by Subject|9
7786017|NCT00989092|12237034|FG000|Overall Study|Death|14
7786018|NCT00989092|12237035|FG001|Overall Study|Death|2
7786019|NCT00989092|12237034|FG000|Overall Study|Ineligibility determined|3
7786020|NCT00989092|12237035|FG001|Overall Study|Ineligibility determined|3
7786021|NCT00989092|12237034|FG000|Overall Study|Lost to Follow-up|6
7786022|NCT00989092|12237035|FG001|Overall Study|Lost to Follow-up|2
7786023|NCT00989092|12237034|FG000|Overall Study|Other|3
7786024|NCT00989092|12237035|FG001|Overall Study|Other|1
7786025|NCT00989092|12237034|FG000|Overall Study|Protocol deviation|2
7786026|NCT00989092|12237035|FG001|Overall Study|Protocol deviation|0
7786027|NCT00989092|12237034|FG000|Overall Study|Erythropoietin therapy initiated|2
7786028|NCT00989092|12237035|FG001|Overall Study|Erythropoietin therapy initiated|0
7786029|NCT00989092|12237034|FG000|Overall Study|Did not receive study drug|2
7786030|NCT00989092|12237035|FG001|Overall Study|Did not receive study drug|0
7786031|NCT00989196|12237053|FG000|Treatment Period|Lost to Follow-up|1
7786032|NCT00989196|12237054|FG001|Treatment Period|Lost to Follow-up|0
7786033|NCT00989235|12237062|FG000|Overall Study|Death|0
7786034|NCT00989235|12237063|FG001|Overall Study|Death|1
7786035|NCT00989235|12237062|FG000|Overall Study|Adverse Event|0
7786036|NCT00989235|12237063|FG001|Overall Study|Adverse Event|1
7786037|NCT00989235|12237062|FG000|Overall Study|Lack of Efficacy|1
7786038|NCT00989235|12237063|FG001|Overall Study|Lack of Efficacy|0
7786039|NCT00989235|12237062|FG000|Overall Study|Withdrawal of Consent|1
7786040|NCT00989235|12237063|FG001|Overall Study|Withdrawal of Consent|1
7786041|NCT00989235|12237062|FG000|Overall Study|Desire to Become Pregnant|1
7786042|NCT00989235|12237063|FG001|Overall Study|Desire to Become Pregnant|0
7786043|NCT00989235|12237062|FG000|Overall Study|Randomized by Mistake|0
7786044|NCT00989235|12237063|FG001|Overall Study|Randomized by Mistake|2
7786045|NCT00989235|12237062|FG000|Overall Study|Lost to Follow-up|0
7786046|NCT00989235|12237063|FG001|Overall Study|Lost to Follow-up|1
7786047|NCT00989261|12237074|FG000|Overall Study|Still in follow up|12
7786048|NCT00989261|12237075|FG001|Overall Study|Still in follow up|21
7786049|NCT00989261|12237074|FG000|Overall Study|Withdrawal by Subject|0
7786050|NCT00989261|12237075|FG001|Overall Study|Withdrawal by Subject|1
7786051|NCT00989261|12237074|FG000|Overall Study|Lost to Follow-up|3
7786052|NCT00989261|12237075|FG001|Overall Study|Lost to Follow-up|0
7786053|NCT00989287|12237083|FG000|Overall Study|Adverse Event|1
7786054|NCT00989287|12237084|FG001|Overall Study|Adverse Event|0
7786055|NCT00989287|12237083|FG000|Overall Study|Lost to Follow-up|0
7786056|NCT00989287|12237084|FG001|Overall Study|Lost to Follow-up|1
7786057|NCT00989573|12237106|FG000|Overall Study|Adverse Event|8
7786058|NCT00989573|12237107|FG001|Overall Study|Adverse Event|12
7786059|NCT00989573|12237108|FG002|Overall Study|Adverse Event|4
7786060|NCT00989573|12237106|FG000|Overall Study|Physician Decision|0
7786061|NCT00989573|12237107|FG001|Overall Study|Physician Decision|2
7786062|NCT00989573|12237108|FG002|Overall Study|Physician Decision|0
7620612|NCT01261325|12031215|FG000|Overall Study|Lack of Efficacy|1
7620613|NCT01261325|12031216|FG001|Overall Study|Lack of Efficacy|1
7620614|NCT01261325|12031217|FG002|Overall Study|Lack of Efficacy|0
7620615|NCT01261325|12031215|FG000|Overall Study|Withdrawal by Subject|2
7620616|NCT01261325|12031216|FG001|Overall Study|Withdrawal by Subject|2
7620617|NCT01261325|12031217|FG002|Overall Study|Withdrawal by Subject|4
7620618|NCT01261325|12031215|FG000|Overall Study|SAE, non-fatal|1
7620619|NCT01261325|12031216|FG001|Overall Study|SAE, non-fatal|5
7620620|NCT01261325|12031217|FG002|Overall Study|SAE, non-fatal|1
7620621|NCT01261325|12031215|FG000|Overall Study|AE, non-serious non-fatal|9
7620622|NCT01261325|12031216|FG001|Overall Study|AE, non-serious non-fatal|15
7620623|NCT01261325|12031217|FG002|Overall Study|AE, non-serious non-fatal|13
7620624|NCT01261325|12031215|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7620625|NCT01261325|12031216|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7620626|NCT01261325|12031217|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7620627|NCT01261325|12031215|FG000|Overall Study|Non Compliance|2
7620628|NCT01261325|12031216|FG001|Overall Study|Non Compliance|0
7620629|NCT01261325|12031217|FG002|Overall Study|Non Compliance|0
7620630|NCT01261325|12031215|FG000|Overall Study|Patient Randomized by Mistake|0
7620631|NCT01261325|12031216|FG001|Overall Study|Patient Randomized by Mistake|1
7620632|NCT01261325|12031217|FG002|Overall Study|Patient Randomized by Mistake|0
7620633|NCT01261325|12031215|FG000|Overall Study|Erroneously Randomized|1
7620634|NCT01261325|12031216|FG001|Overall Study|Erroneously Randomized|0
7620635|NCT01261325|12031217|FG002|Overall Study|Erroneously Randomized|0
7620636|NCT01261325|12031215|FG000|Overall Study|Screen Failure|1
7620637|NCT01261325|12031216|FG001|Overall Study|Screen Failure|0
7620638|NCT01261325|12031217|FG002|Overall Study|Screen Failure|0
7620639|NCT01261325|12031215|FG000|Overall Study|Randomized in Error|0
7620640|NCT01261325|12031216|FG001|Overall Study|Randomized in Error|0
7620641|NCT01261325|12031217|FG002|Overall Study|Randomized in Error|1
7620642|NCT01261325|12031215|FG000|Overall Study|Protocol Violation|0
7620643|NCT01261325|12031216|FG001|Overall Study|Protocol Violation|3
7620644|NCT01261325|12031217|FG002|Overall Study|Protocol Violation|1
7620645|NCT01261325|12031215|FG000|Overall Study|Lost to Follow-up|0
7620646|NCT01261325|12031216|FG001|Overall Study|Lost to Follow-up|1
7620647|NCT01261325|12031217|FG002|Overall Study|Lost to Follow-up|3
7620648|NCT01261325|12031215|FG000|Overall Study|AE, serious fatal|0
7620649|NCT01261325|12031216|FG001|Overall Study|AE, serious fatal|0
7620650|NCT01261325|12031217|FG002|Overall Study|AE, serious fatal|2
7786063|NCT00989573|12237106|FG000|Overall Study|Protocol Violation|1
7786064|NCT00989573|12237107|FG001|Overall Study|Protocol Violation|1
7786065|NCT00989573|12237108|FG002|Overall Study|Protocol Violation|1
7786066|NCT00989573|12237106|FG000|Overall Study|Withdrawal by Subject|4
7786067|NCT00989573|12237107|FG001|Overall Study|Withdrawal by Subject|7
7786068|NCT00989573|12237108|FG002|Overall Study|Withdrawal by Subject|3
7786069|NCT00989664|12237132|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
7786070|NCT00989664|12237132|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
7786071|NCT00989664|12237132|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49
7786072|NCT00989664|12237132|FG000|Dosimetric and Therapeutic Treatment|Death|1
7786073|NCT00989664|12237132|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
7786074|NCT00989664|12237132|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
7786075|NCT00989664|12237132|FG000|Long-Term Follow-Up|Death|3
7786076|NCT00989781|12237148|FG000|Ovarian Response to hCG|Lost to Follow-up|3
7786077|NCT00989781|12237149|FG001|Ovarian Response to hCG|Lost to Follow-up|2
7786078|NCT00989833|12237159|FG000|Overall Study|Lost to Follow-up|0
7786079|NCT00989833|12237160|FG001|Overall Study|Lost to Follow-up|1
7786080|NCT00989833|12237161|FG002|Overall Study|Lost to Follow-up|0
7786081|NCT00989833|12237159|FG000|Overall Study|Protocol Violation|1
7786082|NCT00989833|12237160|FG001|Overall Study|Protocol Violation|2
7786083|NCT00989833|12237161|FG002|Overall Study|Protocol Violation|1
7786084|NCT00989833|12237159|FG000|Overall Study|Withdrawal by Subject|0
7786085|NCT00989833|12237160|FG001|Overall Study|Withdrawal by Subject|0
7786086|NCT00989833|12237161|FG002|Overall Study|Withdrawal by Subject|1
7786087|NCT00989833|12237159|FG000|Overall Study|Incorrectly randomized|1
7786088|NCT00989833|12237160|FG001|Overall Study|Incorrectly randomized|0
7786089|NCT00989833|12237161|FG002|Overall Study|Incorrectly randomized|0
7786090|NCT00989950|12237177|FG000|Randomized Phase|Protocol Violation|1
7786091|NCT00989950|12237178|FG001|Randomized Phase|Protocol Violation|0
7786092|NCT00989950|12237179|FG002|Randomized Phase|Protocol Violation|0
7786093|NCT00989950|12237180|FG003|Randomized Phase|Protocol Violation|0
7786094|NCT00989950|12237177|FG000|Randomized Phase|Adverse Event|0
7786095|NCT00989950|12237178|FG001|Randomized Phase|Adverse Event|1
7786096|NCT00989950|12237179|FG002|Randomized Phase|Adverse Event|0
7786097|NCT00989950|12237180|FG003|Randomized Phase|Adverse Event|0
7786098|NCT00989963|12237193|FG000|Overall Study|Adverse Event|1
7786099|NCT00989963|12237194|FG001|Overall Study|Adverse Event|1
7786100|NCT00989963|12237195|FG002|Overall Study|Adverse Event|1
7786101|NCT00990093|12237216|FG000|Test Period 1 (1-14 Days)|Adverse Event|1
7786102|NCT00990093|12237217|FG001|Test Period 1 (1-14 Days)|Adverse Event|0
7786103|NCT00990093|12237216|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
7786104|NCT00990093|12237217|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
7786105|NCT00990093|12237216|FG000|Test Period 1 (1-14 Days)|Other|1
7786106|NCT00990093|12237217|FG001|Test Period 1 (1-14 Days)|Other|0
7786107|NCT00990093|12237216|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0
7786108|NCT00990093|12237217|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2
7786109|NCT00990093|12237216|FG000|Test Period 2 (15-28 Days)|Adverse Event|1
7786110|NCT00990093|12237217|FG001|Test Period 2 (15-28 Days)|Adverse Event|0
7786111|NCT00990093|12237216|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1
7786112|NCT00990093|12237217|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0
7786113|NCT00990093|12237216|FG000|Test Period 2 (15-28 Days)|Other|0
7786114|NCT00990093|12237217|FG001|Test Period 2 (15-28 Days)|Other|1
7786115|NCT00990106|12237225|FG000|Overall Study|"too busy to continue"|1
7786116|NCT00990106|12237226|FG001|Overall Study|"too busy to continue"|2
7786117|NCT00990106|12237225|FG000|Overall Study|Lost to Follow-up|1
7786118|NCT00990106|12237226|FG001|Overall Study|Lost to Follow-up|3
7786119|NCT00990106|12237225|FG000|Overall Study|Withdrawal by Subject|2
7786120|NCT00990106|12237226|FG001|Overall Study|Withdrawal by Subject|1
7786121|NCT00990106|12237225|FG000|Overall Study|opted for open label prazosin|1
7786122|NCT00990106|12237226|FG001|Overall Study|opted for open label prazosin|1
7786123|NCT00990106|12237225|FG000|Overall Study|relocation/deployment|4
7786124|NCT00990106|12237226|FG001|Overall Study|relocation/deployment|1
7786125|NCT00990106|12237225|FG000|Overall Study|started exclusionary medication|0
7786126|NCT00990106|12237226|FG001|Overall Study|started exclusionary medication|1
7786127|NCT00990106|12237225|FG000|Overall Study|planned major surgery|0
7786128|NCT00990106|12237226|FG001|Overall Study|planned major surgery|1
7786129|NCT00990106|12237225|FG000|Overall Study|scheduling conflicts|0
7786130|NCT00990106|12237226|FG001|Overall Study|scheduling conflicts|2
7786131|NCT00990184|12237232|FG000|Overall Study|Physician Decision|1
7786132|NCT00990249|12237247|FG000|Overall Study|Disease Progression|8
7786133|NCT00990249|12237247|FG000|Overall Study|Non-Compliance|1
7786134|NCT00990249|12237247|FG000|Overall Study|Death|2
7786135|NCT00990249|12237247|FG000|Overall Study|Not treated|2
7786136|NCT00990314|12237260|FG000|Overall Study|Death|2
7786137|NCT00990314|12237260|FG000|Overall Study|Adverse Event|2
7786138|NCT00990314|12237260|FG000|Overall Study|Withdrawal by Subject|3
7786139|NCT00990314|12237260|FG000|Overall Study|Non-Compliance|1
7786140|NCT00990314|12237260|FG000|Overall Study|Physician Decision|3
7786141|NCT00990314|12237260|FG000|Overall Study|Lack of Efficacy|1
7786142|NCT00990340|12237266|FG000|First 14-day Treatment|Not Compliant|2
7786143|NCT00990340|12237267|FG001|First 14-day Treatment|Not Compliant|1
7786144|NCT00990340|12237266|FG000|First 14-day Treatment|Lost to Follow-up|2
7786145|NCT00990340|12237267|FG001|First 14-day Treatment|Lost to Follow-up|1
7786146|NCT00990340|12237266|FG000|First 14-day Treatment|Protocol Violation|2
7786147|NCT00990340|12237267|FG001|First 14-day Treatment|Protocol Violation|2
7786148|NCT00990652|12237295|FG000|Pre-surgical Bortezomib|Adverse Event|1
7786149|NCT00990652|12237295|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
7786150|NCT00990665|12237300|FG000|Overall Study|Unsuccessful Implant|8
7786151|NCT00990665|12237300|FG000|Overall Study|Death|29
7786152|NCT00990665|12237300|FG000|Overall Study|Heart Transplant|1
7786153|NCT00990665|12237300|FG000|Overall Study|Withdrawal by Subject|6
7786154|NCT00990665|12237300|FG000|Overall Study|Lost to Follow-up|1
7786155|NCT00990665|12237300|FG000|Overall Study|System Explant|3
7786156|NCT00990704|12237308|FG000|Overall Study|Adverse Event|1
7786157|NCT00990704|12237309|FG001|Overall Study|Adverse Event|1
7786158|NCT00990704|12237308|FG000|Overall Study|Physician Decision|0
7786159|NCT00990704|12237309|FG001|Overall Study|Physician Decision|1
7786160|NCT00990821|12237342|FG000|Overall Study|Withdrawal by Subject|0
7786161|NCT00990821|12237343|FG001|Overall Study|Withdrawal by Subject|2
7786162|NCT00990821|12237344|FG002|Overall Study|Withdrawal by Subject|0
7786163|NCT00990821|12237345|FG003|Overall Study|Withdrawal by Subject|0
7786164|NCT00990821|12237346|FG004|Overall Study|Withdrawal by Subject|3
7786165|NCT00990821|12237347|FG005|Overall Study|Withdrawal by Subject|3
7786166|NCT00990821|12237348|FG006|Overall Study|Withdrawal by Subject|1
7786167|NCT00990821|12237349|FG007|Overall Study|Withdrawal by Subject|0
7786168|NCT00990821|12237350|FG008|Overall Study|Withdrawal by Subject|0
7786169|NCT00990821|12237351|FG009|Overall Study|Withdrawal by Subject|1
7786170|NCT00990821|12237352|FG010|Overall Study|Withdrawal by Subject|3
7786171|NCT00990821|12237353|FG011|Overall Study|Withdrawal by Subject|5
7786172|NCT00990821|12237354|FG012|Overall Study|Withdrawal by Subject|2
7786173|NCT00990821|12237355|FG013|Overall Study|Withdrawal by Subject|1
7786174|NCT00991276|12237431|FG000|First Intervention Period|Adverse Event|0
7786175|NCT00991276|12237432|FG001|First Intervention Period|Adverse Event|1
7786176|NCT00991276|12237433|FG002|First Intervention Period|Adverse Event|0
7786177|NCT00991276|12237434|FG003|First Intervention Period|Adverse Event|1
7786178|NCT00991276|12237435|FG004|First Intervention Period|Adverse Event|0
7786179|NCT00991276|12237436|FG005|First Intervention Period|Adverse Event|0
7620708|NCT00746590|12031277|FG000|Overall Study|Death|1
7786180|NCT00991276|12237431|FG000|First Intervention Period|Protocol Violation|0
7786181|NCT00991276|12237432|FG001|First Intervention Period|Protocol Violation|0
7786182|NCT00991276|12237433|FG002|First Intervention Period|Protocol Violation|0
7786183|NCT00991276|12237434|FG003|First Intervention Period|Protocol Violation|0
7786184|NCT00991276|12237435|FG004|First Intervention Period|Protocol Violation|2
7786185|NCT00991276|12237436|FG005|First Intervention Period|Protocol Violation|0
7786186|NCT00991276|12237431|FG000|First Intervention Period|Insufficient clinical response|0
7786187|NCT00991276|12237432|FG001|First Intervention Period|Insufficient clinical response|0
7786188|NCT00991276|12237433|FG002|First Intervention Period|Insufficient clinical response|0
7786189|NCT00991276|12237434|FG003|First Intervention Period|Insufficient clinical response|0
7786190|NCT00991276|12237435|FG004|First Intervention Period|Insufficient clinical response|1
7786191|NCT00991276|12237436|FG005|First Intervention Period|Insufficient clinical response|0
7786192|NCT00991276|12237431|FG000|First Intervention Period|Other|0
7786193|NCT00991276|12237432|FG001|First Intervention Period|Other|0
7786194|NCT00991276|12237433|FG002|First Intervention Period|Other|0
7786195|NCT00991276|12237434|FG003|First Intervention Period|Other|1
7620725|NCT00490035|12031303|FG000|Overall Study|AE, non-serious non-fatal|3
7620726|NCT00490035|12031304|FG001|Overall Study|AE, non-serious non-fatal|4
7620727|NCT00490035|12031305|FG002|Overall Study|AE, non-serious non-fatal|4
7620728|NCT00490035|12031306|FG003|Overall Study|AE, non-serious non-fatal|5
7620729|NCT00490035|12031303|FG000|Overall Study|Lost to Follow-up|2
7620730|NCT00490035|12031304|FG001|Overall Study|Lost to Follow-up|0
7620731|NCT00490035|12031305|FG002|Overall Study|Lost to Follow-up|1
7620732|NCT00490035|12031306|FG003|Overall Study|Lost to Follow-up|0
7620733|NCT00490035|12031303|FG000|Overall Study|Withdrawal by Subject|2
7620734|NCT00490035|12031304|FG001|Overall Study|Withdrawal by Subject|1
7620735|NCT00490035|12031305|FG002|Overall Study|Withdrawal by Subject|1
7620736|NCT00490035|12031306|FG003|Overall Study|Withdrawal by Subject|0
7620737|NCT00490035|12031303|FG000|Overall Study|Other reason|0
7620738|NCT00490035|12031304|FG001|Overall Study|Other reason|1
7620739|NCT00490035|12031305|FG002|Overall Study|Other reason|3
7620740|NCT00490035|12031306|FG003|Overall Study|Other reason|1
7620741|NCT00490035|12031303|FG000|Overall Study|AE, serious fatal|1
7620742|NCT00490035|12031304|FG001|Overall Study|AE, serious fatal|0
7620743|NCT00490035|12031305|FG002|Overall Study|AE, serious fatal|0
7620744|NCT00490035|12031306|FG003|Overall Study|AE, serious fatal|0
7620745|NCT00490035|12031303|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0
7620746|NCT00490035|12031304|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0
7620747|NCT00490035|12031305|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1
7786196|NCT00991276|12237435|FG004|First Intervention Period|Other|1
7786197|NCT00991276|12237436|FG005|First Intervention Period|Other|0
7786198|NCT00991276|12237431|FG000|First Intervention Period|Withdrawal by Subject|0
7786199|NCT00991276|12237432|FG001|First Intervention Period|Withdrawal by Subject|1
7786200|NCT00991276|12237433|FG002|First Intervention Period|Withdrawal by Subject|0
7786201|NCT00991276|12237434|FG003|First Intervention Period|Withdrawal by Subject|1
7786202|NCT00991276|12237435|FG004|First Intervention Period|Withdrawal by Subject|0
7786203|NCT00991276|12237436|FG005|First Intervention Period|Withdrawal by Subject|1
7786204|NCT00991276|12237431|FG000|First Intervention Period|Lost to Follow-up|0
7786205|NCT00991276|12237432|FG001|First Intervention Period|Lost to Follow-up|1
7786206|NCT00991276|12237433|FG002|First Intervention Period|Lost to Follow-up|0
7786207|NCT00991276|12237434|FG003|First Intervention Period|Lost to Follow-up|1
7786208|NCT00991276|12237435|FG004|First Intervention Period|Lost to Follow-up|0
7786209|NCT00991276|12237436|FG005|First Intervention Period|Lost to Follow-up|0
7786210|NCT00991276|12237431|FG000|Second Intervention Period|Adverse Event|0
7786211|NCT00991276|12237432|FG001|Second Intervention Period|Adverse Event|2
7786212|NCT00991276|12237433|FG002|Second Intervention Period|Adverse Event|0
7786213|NCT00991276|12237434|FG003|Second Intervention Period|Adverse Event|1
7786214|NCT00991276|12237435|FG004|Second Intervention Period|Adverse Event|1
7786215|NCT00991276|12237436|FG005|Second Intervention Period|Adverse Event|0
7786216|NCT00991276|12237431|FG000|Second Intervention Period|Protocol Violation|1
7786217|NCT00991276|12237432|FG001|Second Intervention Period|Protocol Violation|0
7786218|NCT00991276|12237433|FG002|Second Intervention Period|Protocol Violation|0
7786219|NCT00991276|12237434|FG003|Second Intervention Period|Protocol Violation|0
7786220|NCT00991276|12237435|FG004|Second Intervention Period|Protocol Violation|0
7620748|NCT00490035|12031306|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0
7620749|NCT00490035|12031303|FG000|Overall Study|AE of unknown type|0
7620750|NCT00490035|12031304|FG001|Overall Study|AE of unknown type|0
7620751|NCT00490035|12031305|FG002|Overall Study|AE of unknown type|2
7786221|NCT00991276|12237436|FG005|Second Intervention Period|Protocol Violation|0
7786222|NCT00991276|12237431|FG000|Second Intervention Period|Other|0
7786223|NCT00991276|12237432|FG001|Second Intervention Period|Other|0
7786224|NCT00991276|12237433|FG002|Second Intervention Period|Other|0
7620752|NCT00490035|12031306|FG003|Overall Study|AE of unknown type|0
7786225|NCT00991276|12237434|FG003|Second Intervention Period|Other|1
7786226|NCT00991276|12237435|FG004|Second Intervention Period|Other|0
7786227|NCT00991276|12237436|FG005|Second Intervention Period|Other|1
7620753|NCT00464269|12031320|FG000|Overall Study|Lack of Efficacy|1
7620754|NCT00464269|12031321|FG001|Overall Study|Lack of Efficacy|0
7620755|NCT00464269|12031322|FG002|Overall Study|Lack of Efficacy|0
7620756|NCT00464269|12031323|FG003|Overall Study|Lack of Efficacy|0
7620757|NCT00464269|12031320|FG000|Overall Study|Lost to Follow-up|0
7620758|NCT00464269|12031321|FG001|Overall Study|Lost to Follow-up|4
7620759|NCT00464269|12031322|FG002|Overall Study|Lost to Follow-up|0
7620760|NCT00464269|12031323|FG003|Overall Study|Lost to Follow-up|1
7620761|NCT00464269|12031320|FG000|Overall Study|Withdrawal by Subject|0
7620762|NCT00464269|12031321|FG001|Overall Study|Withdrawal by Subject|2
7620763|NCT00464269|12031322|FG002|Overall Study|Withdrawal by Subject|1
7620764|NCT00464269|12031323|FG003|Overall Study|Withdrawal by Subject|1
7620765|NCT00464269|12031320|FG000|Overall Study|Other reason|3
7620766|NCT00464269|12031321|FG001|Overall Study|Other reason|3
7620767|NCT00464269|12031322|FG002|Overall Study|Other reason|1
7620768|NCT00464269|12031323|FG003|Overall Study|Other reason|1
7620769|NCT00464269|12031320|FG000|Overall Study|AE, serious fatal|0
7620770|NCT00464269|12031321|FG001|Overall Study|AE, serious fatal|0
7620771|NCT00464269|12031322|FG002|Overall Study|AE, serious fatal|1
7620772|NCT00464269|12031323|FG003|Overall Study|AE, serious fatal|1
7620773|NCT00464269|12031320|FG000|Overall Study|SAE, non-fatal|0
7620774|NCT00464269|12031321|FG001|Overall Study|SAE, non-fatal|0
7620775|NCT00464269|12031322|FG002|Overall Study|SAE, non-fatal|0
7786228|NCT00991276|12237431|FG000|Third Intervention Period|Protocol Violation|1
7786229|NCT00991276|12237432|FG001|Third Intervention Period|Protocol Violation|0
7786230|NCT00991276|12237433|FG002|Third Intervention Period|Protocol Violation|0
7786231|NCT00991276|12237434|FG003|Third Intervention Period|Protocol Violation|0
7786232|NCT00991276|12237435|FG004|Third Intervention Period|Protocol Violation|0
7620776|NCT00464269|12031323|FG003|Overall Study|SAE, non-fatal|1
7786233|NCT00991276|12237436|FG005|Third Intervention Period|Protocol Violation|0
7786234|NCT00991276|12237431|FG000|Third Intervention Period|Other|0
7786235|NCT00991276|12237432|FG001|Third Intervention Period|Other|0
7786236|NCT00991276|12237433|FG002|Third Intervention Period|Other|0
7786237|NCT00991276|12237434|FG003|Third Intervention Period|Other|0
7786238|NCT00991276|12237435|FG004|Third Intervention Period|Other|0
7786239|NCT00991276|12237436|FG005|Third Intervention Period|Other|1
7786240|NCT00991276|12237431|FG000|Third Intervention Period|Adverse Event|0
7786241|NCT00991276|12237432|FG001|Third Intervention Period|Adverse Event|0
7786242|NCT00991276|12237433|FG002|Third Intervention Period|Adverse Event|1
7786243|NCT00991276|12237434|FG003|Third Intervention Period|Adverse Event|0
7786244|NCT00991276|12237435|FG004|Third Intervention Period|Adverse Event|0
7786245|NCT00991276|12237436|FG005|Third Intervention Period|Adverse Event|0
7786246|NCT00991276|12237431|FG000|Third Intervention Period|Withdrawal by Subject|0
7786247|NCT00991276|12237432|FG001|Third Intervention Period|Withdrawal by Subject|0
7786248|NCT00991276|12237433|FG002|Third Intervention Period|Withdrawal by Subject|0
7786249|NCT00991276|12237434|FG003|Third Intervention Period|Withdrawal by Subject|1
7786250|NCT00991276|12237435|FG004|Third Intervention Period|Withdrawal by Subject|0
7786251|NCT00991276|12237436|FG005|Third Intervention Period|Withdrawal by Subject|0
7786252|NCT00991289|12237445|FG000|Overall Study|Adverse Event|1
7786253|NCT00991289|12237445|FG000|Overall Study|Physician Decision|2
7786254|NCT00991289|12237445|FG000|Overall Study|Withdrawal by Subject|3
7786255|NCT00991289|12237445|FG000|Overall Study|Lost to Follow-up|4
7786256|NCT00991289|12237445|FG000|Overall Study|Protocol Violation|2
7786257|NCT00991302|12237451|FG000|Overall Study|Death|0
7786258|NCT00991302|12237452|FG001|Overall Study|Death|1
7786259|NCT00991302|12237451|FG000|Overall Study|Lost to Follow-up|14
7786260|NCT00991302|12237452|FG001|Overall Study|Lost to Follow-up|12
7786261|NCT00991341|12237460|FG000|Overall Study|no surgery w/in 30 days of randomization|11
7786262|NCT00991341|12237461|FG001|Overall Study|no surgery w/in 30 days of randomization|18
7786263|NCT00991341|12237460|FG000|Overall Study|Death|3
7620777|NCT00464269|12031320|FG000|Overall Study|AE, non-serious non-fatal|2
7620778|NCT00464269|12031321|FG001|Overall Study|AE, non-serious non-fatal|8
7620779|NCT00464269|12031322|FG002|Overall Study|AE, non-serious non-fatal|3
7620780|NCT00464269|12031323|FG003|Overall Study|AE, non-serious non-fatal|4
7620781|NCT00464269|12031320|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7620782|NCT00464269|12031321|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7620783|NCT00464269|12031322|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
7620784|NCT00464269|12031323|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7620785|NCT00334815|12031337|FG000|Overall Study|Adverse Event|3
7620786|NCT00334815|12031338|FG001|Overall Study|Adverse Event|2
7620787|NCT00334815|12031337|FG000|Overall Study|Death|0
7620788|NCT00334815|12031338|FG001|Overall Study|Death|2
7620789|NCT00334815|12031337|FG000|Overall Study|Progression|1
7620790|NCT00334815|12031338|FG001|Overall Study|Progression|0
7620791|NCT00334815|12031337|FG000|Overall Study|ineligible|1
7620792|NCT00334815|12031338|FG001|Overall Study|ineligible|1
7620793|NCT00334815|12031337|FG000|Overall Study|patient refused treatment|0
7620794|NCT00334815|12031338|FG001|Overall Study|patient refused treatment|1
7620795|NCT00334815|12031337|FG000|Overall Study|Physician Decision|2
7620796|NCT00334815|12031338|FG001|Overall Study|Physician Decision|4
7620797|NCT00042289|12031393|FG000|Overall Study|Lost to Follow-up|3
7786264|NCT00991341|12237461|FG001|Overall Study|Death|0
7786265|NCT00991341|12237460|FG000|Overall Study|no RBCs received 96hrs after randomized|186
7786266|NCT00991341|12237461|FG001|Overall Study|no RBCs received 96hrs after randomized|155
7620798|NCT00042289|12031394|FG001|Overall Study|Lost to Follow-up|0
7620799|NCT00042289|12031395|FG002|Overall Study|Lost to Follow-up|0
7620800|NCT00042289|12031396|FG003|Overall Study|Lost to Follow-up|1
7620801|NCT00042289|12031397|FG004|Overall Study|Lost to Follow-up|3
7620802|NCT00042289|12031398|FG005|Overall Study|Lost to Follow-up|3
7786267|NCT00991341|12237460|FG000|Overall Study|Physician Decision|1
7786268|NCT00991341|12237461|FG001|Overall Study|Physician Decision|2
7620803|NCT00042289|12031399|FG006|Overall Study|Lost to Follow-up|6
7620804|NCT00042289|12031400|FG007|Overall Study|Lost to Follow-up|1
7620805|NCT00042289|12031401|FG008|Overall Study|Lost to Follow-up|1
7620806|NCT00042289|12031402|FG009|Overall Study|Lost to Follow-up|0
7620807|NCT00042289|12031403|FG010|Overall Study|Lost to Follow-up|0
7620808|NCT00042289|12031404|FG011|Overall Study|Lost to Follow-up|0
7620809|NCT00042289|12031405|FG012|Overall Study|Lost to Follow-up|0
7620810|NCT00042289|12031406|FG013|Overall Study|Lost to Follow-up|0
7620811|NCT00042289|12031407|FG014|Overall Study|Lost to Follow-up|0
7620812|NCT00042289|12031408|FG015|Overall Study|Lost to Follow-up|1
7620813|NCT00042289|12031409|FG016|Overall Study|Lost to Follow-up|1
7620814|NCT00042289|12031410|FG017|Overall Study|Lost to Follow-up|0
7620815|NCT00042289|12031411|FG018|Overall Study|Lost to Follow-up|3
7620816|NCT00042289|12031412|FG019|Overall Study|Lost to Follow-up|2
7620817|NCT00042289|12031413|FG020|Overall Study|Lost to Follow-up|0
7620818|NCT00042289|12031414|FG021|Overall Study|Lost to Follow-up|0
7620819|NCT00042289|12031415|FG022|Overall Study|Lost to Follow-up|0
7620820|NCT00042289|12031416|FG023|Overall Study|Lost to Follow-up|0
7620821|NCT00042289|12031417|FG024|Overall Study|Lost to Follow-up|0
7620822|NCT00042289|12031418|FG025|Overall Study|Lost to Follow-up|0
7620823|NCT00042289|12031419|FG026|Overall Study|Lost to Follow-up|2
7620824|NCT00042289|12031420|FG027|Overall Study|Lost to Follow-up|2
7620825|NCT00042289|12031421|FG028|Overall Study|Lost to Follow-up|2
7620826|NCT00042289|12031422|FG029|Overall Study|Lost to Follow-up|0
7620827|NCT00042289|12031423|FG030|Overall Study|Lost to Follow-up|0
7620828|NCT00042289|12031424|FG031|Overall Study|Lost to Follow-up|2
7620829|NCT00042289|12031425|FG032|Overall Study|Lost to Follow-up|1
7620830|NCT00042289|12031426|FG033|Overall Study|Lost to Follow-up|1
7620831|NCT00042289|12031427|FG034|Overall Study|Lost to Follow-up|1
7620832|NCT00042289|12031428|FG035|Overall Study|Lost to Follow-up|2
7620833|NCT00042289|12031429|FG036|Overall Study|Lost to Follow-up|1
7620834|NCT00042289|12031430|FG037|Overall Study|Lost to Follow-up|1
7620835|NCT00042289|12031431|FG038|Overall Study|Lost to Follow-up|0
7620836|NCT00042289|12031432|FG039|Overall Study|Lost to Follow-up|5
7620837|NCT00042289|12031433|FG040|Overall Study|Lost to Follow-up|0
7620838|NCT00042289|12031434|FG041|Overall Study|Lost to Follow-up|2
7620839|NCT00042289|12031435|FG042|Overall Study|Lost to Follow-up|2
7620840|NCT00042289|12031436|FG043|Overall Study|Lost to Follow-up|0
7620841|NCT00042289|12031437|FG044|Overall Study|Lost to Follow-up|0
7620842|NCT00042289|12031438|FG045|Overall Study|Lost to Follow-up|1
7620843|NCT00042289|12031439|FG046|Overall Study|Lost to Follow-up|0
7620844|NCT00042289|12031393|FG000|Overall Study|Other reason|0
7620845|NCT00042289|12031394|FG001|Overall Study|Other reason|0
7620846|NCT00042289|12031395|FG002|Overall Study|Other reason|0
7620847|NCT00042289|12031396|FG003|Overall Study|Other reason|2
7620848|NCT00042289|12031397|FG004|Overall Study|Other reason|0
7620849|NCT00042289|12031398|FG005|Overall Study|Other reason|0
7620850|NCT00042289|12031399|FG006|Overall Study|Other reason|0
7620851|NCT00042289|12031400|FG007|Overall Study|Other reason|0
7620852|NCT00042289|12031401|FG008|Overall Study|Other reason|0
7620853|NCT00042289|12031402|FG009|Overall Study|Other reason|0
7620854|NCT00042289|12031403|FG010|Overall Study|Other reason|0
7620855|NCT00042289|12031404|FG011|Overall Study|Other reason|0
7620856|NCT00042289|12031405|FG012|Overall Study|Other reason|0
7620857|NCT00042289|12031406|FG013|Overall Study|Other reason|0
7620858|NCT00042289|12031407|FG014|Overall Study|Other reason|0
7620859|NCT00042289|12031408|FG015|Overall Study|Other reason|0
7620860|NCT00042289|12031409|FG016|Overall Study|Other reason|0
7620861|NCT00042289|12031410|FG017|Overall Study|Other reason|0
7620862|NCT00042289|12031411|FG018|Overall Study|Other reason|1
7620863|NCT00042289|12031412|FG019|Overall Study|Other reason|0
7620864|NCT00042289|12031413|FG020|Overall Study|Other reason|0
7620865|NCT00042289|12031414|FG021|Overall Study|Other reason|0
7620866|NCT00042289|12031415|FG022|Overall Study|Other reason|0
7620867|NCT00042289|12031416|FG023|Overall Study|Other reason|1
7620868|NCT00042289|12031417|FG024|Overall Study|Other reason|0
7620869|NCT00042289|12031418|FG025|Overall Study|Other reason|0
7620870|NCT00042289|12031419|FG026|Overall Study|Other reason|1
7620871|NCT00042289|12031420|FG027|Overall Study|Other reason|0
7620872|NCT00042289|12031421|FG028|Overall Study|Other reason|3
7620873|NCT00042289|12031422|FG029|Overall Study|Other reason|0
7786269|NCT00991341|12237460|FG000|Overall Study|Withdrawal by Subject|3
7786270|NCT00991341|12237461|FG001|Overall Study|Withdrawal by Subject|4
7786271|NCT00991406|12237467|FG000|Overall Study|One participant did not respond to FES.|1
7786272|NCT00991510|12237486|FG000|Period I (Days 1-14)|Adverse Event|1
7786273|NCT00991510|12237487|FG001|Period I (Days 1-14)|Adverse Event|0
7620874|NCT00042289|12031423|FG030|Overall Study|Other reason|0
7786274|NCT00991510|12237486|FG000|Period III (Days 29-112)|Adverse Event|1
7620875|NCT00042289|12031424|FG031|Overall Study|Other reason|1
7786275|NCT00991510|12237487|FG001|Period III (Days 29-112)|Adverse Event|1
7786276|NCT00991939|12237510|FG000|Overall Study|Lost to Follow-up|0
7620876|NCT00042289|12031425|FG032|Overall Study|Other reason|0
7620877|NCT00042289|12031426|FG033|Overall Study|Other reason|1
7620878|NCT00042289|12031427|FG034|Overall Study|Other reason|0
7620879|NCT00042289|12031428|FG035|Overall Study|Other reason|2
7620880|NCT00042289|12031429|FG036|Overall Study|Other reason|0
7620881|NCT00042289|12031430|FG037|Overall Study|Other reason|0
7620882|NCT00042289|12031431|FG038|Overall Study|Other reason|0
7620883|NCT00042289|12031432|FG039|Overall Study|Other reason|0
7620884|NCT00042289|12031433|FG040|Overall Study|Other reason|0
7620885|NCT00042289|12031434|FG041|Overall Study|Other reason|0
7620886|NCT00042289|12031435|FG042|Overall Study|Other reason|0
7620887|NCT00042289|12031436|FG043|Overall Study|Other reason|1
7620888|NCT00042289|12031437|FG044|Overall Study|Other reason|0
7620889|NCT00042289|12031438|FG045|Overall Study|Other reason|0
7786277|NCT00991939|12237511|FG001|Overall Study|Lost to Follow-up|1
7786278|NCT00991939|12237510|FG000|Overall Study|Withdrawal by Subject|1
7786279|NCT00991939|12237511|FG001|Overall Study|Withdrawal by Subject|0
7786280|NCT00991939|12237510|FG000|Overall Study|Entire study terminated|4
7786281|NCT00991939|12237511|FG001|Overall Study|Entire study terminated|1
7786282|NCT00991952|12237521|FG000|Overall Study|Adverse Event|0
7786283|NCT00991952|12237522|FG001|Overall Study|Adverse Event|1
7786284|NCT00992017|12237528|FG000|Overall Study|Lost to Follow-up|2
7786285|NCT00992017|12237528|FG000|Overall Study|Withdrawal by Subject|2
7786286|NCT00992017|12237528|FG000|Overall Study|Unable to get to clinic|5
7786287|NCT00992017|12237528|FG000|Overall Study|Not adhere to study requirements|1
7786288|NCT00992056|12237539|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
7786289|NCT00992056|12237540|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
7786290|NCT00992056|12237539|FG000|Washout Period (2 Weeks)|Physician Decision|1
7786291|NCT00992056|12237540|FG001|Washout Period (2 Weeks)|Physician Decision|0
7786292|NCT00992108|12237548|FG000|Overall Study|Lost to Follow-up|0
7786293|NCT00992108|12237549|FG001|Overall Study|Lost to Follow-up|1
7786294|NCT00992186|12237555|FG000|Overall Study|Withdrawal by Subject|2
7786295|NCT00992186|12237555|FG000|Overall Study|Protocol Violation|1
7786296|NCT00992186|12237555|FG000|Overall Study|Physician Decision|1
7786297|NCT00992186|12237555|FG000|Overall Study|Adverse Event|9
7786298|NCT00992186|12237555|FG000|Overall Study|Progressive Disease|30
7786299|NCT00992186|12237555|FG000|Overall Study|Refusal To Receive Study Agent|3
7786300|NCT00992225|12237560|FG000|Overall Study|Entry Criteria Not Met|8
7786301|NCT00992225|12237560|FG000|Overall Study|Adverse Event|2
7786302|NCT00992394|12237608|FG000|Overall Study|Lack of Efficacy|6
7786303|NCT00992394|12237609|FG001|Overall Study|Lack of Efficacy|3
7786304|NCT00992394|12237608|FG000|Overall Study|Adverse Event|4
7786305|NCT00992394|12237609|FG001|Overall Study|Adverse Event|5
7786306|NCT00992394|12237608|FG000|Overall Study|Withdrawal by Subject|8
7786307|NCT00992394|12237609|FG001|Overall Study|Withdrawal by Subject|2
7786308|NCT00992394|12237608|FG000|Overall Study|Physician Decision|1
7786309|NCT00992394|12237609|FG001|Overall Study|Physician Decision|0
7786310|NCT00992394|12237608|FG000|Overall Study|Protocol Violation|2
7786311|NCT00992394|12237609|FG001|Overall Study|Protocol Violation|4
7786312|NCT00992394|12237608|FG000|Overall Study|Lost to Follow-up|2
7786313|NCT00992394|12237609|FG001|Overall Study|Lost to Follow-up|0
7786314|NCT00992394|12237608|FG000|Overall Study|Other event|1
7786315|NCT00992394|12237609|FG001|Overall Study|Other event|0
7786316|NCT00992407|12237617|FG000|Overall Study|Protocol Violation|2
7786317|NCT00992407|12237618|FG001|Overall Study|Protocol Violation|1
7786318|NCT00992407|12237617|FG000|Overall Study|Lost to Follow-up|3
7786319|NCT00992407|12237618|FG001|Overall Study|Lost to Follow-up|3
7786320|NCT00992407|12237617|FG000|Overall Study|Adverse Event|3
7786321|NCT00992407|12237618|FG001|Overall Study|Adverse Event|2
7786322|NCT00992407|12237617|FG000|Overall Study|protocol Violation & Adverse events|2
7786323|NCT00992407|12237618|FG001|Overall Study|protocol Violation & Adverse events|4
7786324|NCT00992407|12237617|FG000|Overall Study|Other|2
7786325|NCT00992407|12237618|FG001|Overall Study|Other|0
7786326|NCT00992407|12237617|FG000|Overall Study|Loss of follow-up & Adverse events|2
7786327|NCT00992407|12237618|FG001|Overall Study|Loss of follow-up & Adverse events|1
7786328|NCT00992407|12237617|FG000|Overall Study|Study medication not administered|17
7786329|NCT00992407|12237618|FG001|Overall Study|Study medication not administered|13
7786330|NCT00992446|12237636|FG000|Overall Study|Disease Progression|1
7786331|NCT00992446|12237636|FG000|Overall Study|Withdrawal by Subject|2
7786332|NCT00992446|12237636|FG000|Overall Study|Maintenance Therapy Screen Fail|5
7786333|NCT00992459|12237642|FG000|Overall Study|Withdrawal by Subject|0
7786334|NCT00992459|12237643|FG001|Overall Study|Withdrawal by Subject|1
7786335|NCT00992459|12237642|FG000|Overall Study|Adverse Event|1
7786336|NCT00992459|12237643|FG001|Overall Study|Adverse Event|0
7786337|NCT00992511|12237653|FG000|Overall Study|Migrated/moved from study area|1
7786338|NCT00992511|12237654|FG001|Overall Study|Migrated/moved from study area|0
7786339|NCT00992511|12237655|FG002|Overall Study|Migrated/moved from study area|1
7786340|NCT00992511|12237656|FG003|Overall Study|Migrated/moved from study area|2
7786341|NCT00992511|12237653|FG000|Overall Study|Lost to Follow-up|1
7786342|NCT00992511|12237654|FG001|Overall Study|Lost to Follow-up|0
7786343|NCT00992511|12237655|FG002|Overall Study|Lost to Follow-up|0
7786344|NCT00992511|12237656|FG003|Overall Study|Lost to Follow-up|2
7786345|NCT00992511|12237653|FG000|Overall Study|Withdrawal by Subject|0
7786346|NCT00992511|12237654|FG001|Overall Study|Withdrawal by Subject|0
7786347|NCT00992511|12237655|FG002|Overall Study|Withdrawal by Subject|1
7786348|NCT00992511|12237656|FG003|Overall Study|Withdrawal by Subject|1
7800438|NCT01095666|12257955|FG002|Overall Study|Lack of Efficacy|1
7800439|NCT01095666|12257953|FG000|Overall Study|Adverse Event|2
7620890|NCT00042289|12031439|FG046|Overall Study|Other reason|0
7620891|NCT00042289|12031393|FG000|Overall Study|Severe debilitation, unable to continue|0
7620892|NCT00042289|12031394|FG001|Overall Study|Severe debilitation, unable to continue|0
7800440|NCT01095666|12257954|FG001|Overall Study|Adverse Event|1
7800441|NCT01095666|12257955|FG002|Overall Study|Adverse Event|3
7800442|NCT01095666|12257953|FG000|Overall Study|Lost to Follow-up|2
7800443|NCT01095666|12257954|FG001|Overall Study|Lost to Follow-up|2
7800444|NCT01095666|12257955|FG002|Overall Study|Lost to Follow-up|0
7800445|NCT01095666|12257953|FG000|Overall Study|Withdrawal by Subject|6
7800446|NCT01095666|12257954|FG001|Overall Study|Withdrawal by Subject|6
7800447|NCT01095666|12257955|FG002|Overall Study|Withdrawal by Subject|1
7800448|NCT01095666|12257953|FG000|Overall Study|Non-compliance, not met criteria etc.|7
7800449|NCT01095666|12257954|FG001|Overall Study|Non-compliance, not met criteria etc.|2
7800450|NCT01095666|12257955|FG002|Overall Study|Non-compliance, not met criteria etc.|2
7800451|NCT01095796|12257970|FG000|Overall Study|Randomized but Not Treated|5
7800452|NCT01095796|12257971|FG001|Overall Study|Randomized but Not Treated|2
7800453|NCT01095796|12257970|FG000|Overall Study|Adverse Event|9
7800454|NCT01095796|12257971|FG001|Overall Study|Adverse Event|19
7800455|NCT01095796|12257970|FG000|Overall Study|Death|3
7800456|NCT01095796|12257971|FG001|Overall Study|Death|2
7800457|NCT01095796|12257970|FG000|Overall Study|Pregnancy|2
7800458|NCT01095796|12257971|FG001|Overall Study|Pregnancy|0
7800459|NCT01095796|12257970|FG000|Overall Study|Lack of Efficacy|5
7800460|NCT01095796|12257971|FG001|Overall Study|Lack of Efficacy|3
7800461|NCT01095796|12257970|FG000|Overall Study|Investigator's Discretion|7
7800462|NCT01095796|12257971|FG001|Overall Study|Investigator's Discretion|2
7800463|NCT01095796|12257970|FG000|Overall Study|Withdrew Consent|16
7800464|NCT01095796|12257971|FG001|Overall Study|Withdrew Consent|22
7800465|NCT01095796|12257970|FG000|Overall Study|Lost to Follow-up|27
7800466|NCT01095796|12257971|FG001|Overall Study|Lost to Follow-up|29
7800467|NCT01095796|12257970|FG000|Overall Study|Participant Noncompliance|5
7800468|NCT01095796|12257971|FG001|Overall Study|Participant Noncompliance|10
7800469|NCT01095796|12257970|FG000|Overall Study|Protocol Violation|1
7800470|NCT01095796|12257971|FG001|Overall Study|Protocol Violation|0
7800471|NCT01095796|12257970|FG000|Overall Study|Participant Transferred to Another Study|215
7800472|NCT01095796|12257971|FG001|Overall Study|Participant Transferred to Another Study|200
7800473|NCT01095835|12257980|FG000|Overall Study|Adverse Event|8
7800474|NCT01095835|12257981|FG001|Overall Study|Adverse Event|6
7800475|NCT01095835|12257982|FG002|Overall Study|Adverse Event|6
7800476|NCT01095835|12257980|FG000|Overall Study|Lack of Efficacy|0
7800477|NCT01095835|12257981|FG001|Overall Study|Lack of Efficacy|1
7620893|NCT00042289|12031395|FG002|Overall Study|Severe debilitation, unable to continue|0
7620894|NCT00042289|12031396|FG003|Overall Study|Severe debilitation, unable to continue|0
7620895|NCT00042289|12031397|FG004|Overall Study|Severe debilitation, unable to continue|0
7620896|NCT00042289|12031398|FG005|Overall Study|Severe debilitation, unable to continue|0
7620897|NCT00042289|12031399|FG006|Overall Study|Severe debilitation, unable to continue|0
7620898|NCT00042289|12031400|FG007|Overall Study|Severe debilitation, unable to continue|0
7620899|NCT00042289|12031401|FG008|Overall Study|Severe debilitation, unable to continue|0
7620900|NCT00042289|12031402|FG009|Overall Study|Severe debilitation, unable to continue|0
7620901|NCT00042289|12031403|FG010|Overall Study|Severe debilitation, unable to continue|0
7620902|NCT00042289|12031404|FG011|Overall Study|Severe debilitation, unable to continue|0
7620903|NCT00042289|12031405|FG012|Overall Study|Severe debilitation, unable to continue|0
7620904|NCT00042289|12031406|FG013|Overall Study|Severe debilitation, unable to continue|0
7620905|NCT00042289|12031407|FG014|Overall Study|Severe debilitation, unable to continue|0
7620906|NCT00042289|12031408|FG015|Overall Study|Severe debilitation, unable to continue|0
7620907|NCT00042289|12031409|FG016|Overall Study|Severe debilitation, unable to continue|0
7620908|NCT00042289|12031410|FG017|Overall Study|Severe debilitation, unable to continue|0
7620909|NCT00042289|12031411|FG018|Overall Study|Severe debilitation, unable to continue|0
7620910|NCT00042289|12031412|FG019|Overall Study|Severe debilitation, unable to continue|0
7620911|NCT00042289|12031413|FG020|Overall Study|Severe debilitation, unable to continue|0
7620912|NCT00042289|12031414|FG021|Overall Study|Severe debilitation, unable to continue|1
7620913|NCT00042289|12031415|FG022|Overall Study|Severe debilitation, unable to continue|0
7620914|NCT00042289|12031416|FG023|Overall Study|Severe debilitation, unable to continue|1
7620915|NCT00042289|12031417|FG024|Overall Study|Severe debilitation, unable to continue|0
7620916|NCT00042289|12031418|FG025|Overall Study|Severe debilitation, unable to continue|0
7620917|NCT00042289|12031419|FG026|Overall Study|Severe debilitation, unable to continue|0
7620918|NCT00042289|12031420|FG027|Overall Study|Severe debilitation, unable to continue|1
7800478|NCT01095835|12257982|FG002|Overall Study|Lack of Efficacy|0
7800479|NCT01095835|12257980|FG000|Overall Study|Physician Decision|0
7800480|NCT01095835|12257981|FG001|Overall Study|Physician Decision|0
7800481|NCT01095835|12257982|FG002|Overall Study|Physician Decision|1
7800482|NCT01095835|12257980|FG000|Overall Study|Withdrawal by Subject|1
7800483|NCT01095835|12257981|FG001|Overall Study|Withdrawal by Subject|3
7800484|NCT01095835|12257982|FG002|Overall Study|Withdrawal by Subject|0
7800485|NCT01095835|12257980|FG000|Overall Study|Non study compliance|0
7620919|NCT00042289|12031421|FG028|Overall Study|Severe debilitation, unable to continue|0
7620920|NCT00042289|12031422|FG029|Overall Study|Severe debilitation, unable to continue|0
7620921|NCT00042289|12031423|FG030|Overall Study|Severe debilitation, unable to continue|0
7620922|NCT00042289|12031424|FG031|Overall Study|Severe debilitation, unable to continue|1
7620923|NCT00042289|12031425|FG032|Overall Study|Severe debilitation, unable to continue|1
7620924|NCT00042289|12031426|FG033|Overall Study|Severe debilitation, unable to continue|0
7620925|NCT00042289|12031427|FG034|Overall Study|Severe debilitation, unable to continue|0
7620926|NCT00042289|12031428|FG035|Overall Study|Severe debilitation, unable to continue|0
7620927|NCT00042289|12031429|FG036|Overall Study|Severe debilitation, unable to continue|0
7620928|NCT00042289|12031430|FG037|Overall Study|Severe debilitation, unable to continue|0
7620929|NCT00042289|12031431|FG038|Overall Study|Severe debilitation, unable to continue|0
7620930|NCT00042289|12031432|FG039|Overall Study|Severe debilitation, unable to continue|0
7620931|NCT00042289|12031433|FG040|Overall Study|Severe debilitation, unable to continue|0
7620932|NCT00042289|12031434|FG041|Overall Study|Severe debilitation, unable to continue|0
7620933|NCT00042289|12031435|FG042|Overall Study|Severe debilitation, unable to continue|0
7620934|NCT00042289|12031436|FG043|Overall Study|Severe debilitation, unable to continue|0
7620935|NCT00042289|12031437|FG044|Overall Study|Severe debilitation, unable to continue|0
7620936|NCT00042289|12031438|FG045|Overall Study|Severe debilitation, unable to continue|0
7620937|NCT00042289|12031439|FG046|Overall Study|Severe debilitation, unable to continue|0
7620938|NCT00042289|12031393|FG000|Overall Study|Site closed|0
7620939|NCT00042289|12031394|FG001|Overall Study|Site closed|0
7620940|NCT00042289|12031395|FG002|Overall Study|Site closed|0
7620941|NCT00042289|12031396|FG003|Overall Study|Site closed|0
7620942|NCT00042289|12031397|FG004|Overall Study|Site closed|0
7620943|NCT00042289|12031398|FG005|Overall Study|Site closed|0
7620944|NCT00042289|12031399|FG006|Overall Study|Site closed|0
7620945|NCT00042289|12031400|FG007|Overall Study|Site closed|0
7620946|NCT00042289|12031401|FG008|Overall Study|Site closed|0
7620947|NCT00042289|12031402|FG009|Overall Study|Site closed|0
7620948|NCT00042289|12031403|FG010|Overall Study|Site closed|0
7620949|NCT00042289|12031404|FG011|Overall Study|Site closed|0
7620950|NCT00042289|12031405|FG012|Overall Study|Site closed|0
7620951|NCT00042289|12031406|FG013|Overall Study|Site closed|0
7620952|NCT00042289|12031407|FG014|Overall Study|Site closed|0
7620953|NCT00042289|12031408|FG015|Overall Study|Site closed|0
7620954|NCT00042289|12031409|FG016|Overall Study|Site closed|0
7620955|NCT00042289|12031410|FG017|Overall Study|Site closed|0
7620956|NCT00042289|12031411|FG018|Overall Study|Site closed|0
7620957|NCT00042289|12031412|FG019|Overall Study|Site closed|0
7620958|NCT00042289|12031413|FG020|Overall Study|Site closed|0
7620959|NCT00042289|12031414|FG021|Overall Study|Site closed|0
7620960|NCT00042289|12031415|FG022|Overall Study|Site closed|0
7620961|NCT00042289|12031416|FG023|Overall Study|Site closed|0
7620962|NCT00042289|12031417|FG024|Overall Study|Site closed|0
7620963|NCT00042289|12031418|FG025|Overall Study|Site closed|0
7620964|NCT00042289|12031419|FG026|Overall Study|Site closed|0
7620965|NCT00042289|12031420|FG027|Overall Study|Site closed|0
7620966|NCT00042289|12031421|FG028|Overall Study|Site closed|0
7620967|NCT00042289|12031422|FG029|Overall Study|Site closed|0
7620968|NCT00042289|12031423|FG030|Overall Study|Site closed|0
7786349|NCT00992589|12237666|FG000|Open-Label Phase|Adverse Event|4
7786350|NCT00992589|12237667|FG001|Open-Label Phase|Adverse Event|0
7786351|NCT00992589|12237668|FG002|Open-Label Phase|Adverse Event|0
7786352|NCT00992589|12237669|FG003|Open-Label Phase|Adverse Event|0
7786353|NCT00992589|12237666|FG000|Open-Label Phase|Withdrawal by Subject|20
7786354|NCT00992589|12237667|FG001|Open-Label Phase|Withdrawal by Subject|0
7786355|NCT00992589|12237668|FG002|Open-Label Phase|Withdrawal by Subject|0
7786356|NCT00992589|12237669|FG003|Open-Label Phase|Withdrawal by Subject|0
7786357|NCT00992589|12237666|FG000|Open-Label Phase|Lost to Follow-up|1
7786358|NCT00992589|12237667|FG001|Open-Label Phase|Lost to Follow-up|0
7786359|NCT00992589|12237668|FG002|Open-Label Phase|Lost to Follow-up|0
7786360|NCT00992589|12237669|FG003|Open-Label Phase|Lost to Follow-up|0
7786361|NCT00992589|12237666|FG000|Open-Label Phase|Protocol Violation|3
7786362|NCT00992589|12237667|FG001|Open-Label Phase|Protocol Violation|0
7786363|NCT00992589|12237668|FG002|Open-Label Phase|Protocol Violation|0
7786364|NCT00992589|12237669|FG003|Open-Label Phase|Protocol Violation|0
7786365|NCT00992589|12237666|FG000|Open-Label Phase|Physician Decision|4
7786366|NCT00992589|12237667|FG001|Open-Label Phase|Physician Decision|0
7786367|NCT00992589|12237668|FG002|Open-Label Phase|Physician Decision|0
7786368|NCT00992589|12237669|FG003|Open-Label Phase|Physician Decision|0
7786369|NCT00992589|12237666|FG000|Open-Label Phase|Other|45
7786370|NCT00992589|12237667|FG001|Open-Label Phase|Other|0
7786371|NCT00992589|12237668|FG002|Open-Label Phase|Other|0
7620969|NCT00042289|12031424|FG031|Overall Study|Site closed|3
7620970|NCT00042289|12031425|FG032|Overall Study|Site closed|0
7620971|NCT00042289|12031426|FG033|Overall Study|Site closed|0
7620972|NCT00042289|12031427|FG034|Overall Study|Site closed|0
7620973|NCT00042289|12031428|FG035|Overall Study|Site closed|0
7620974|NCT00042289|12031429|FG036|Overall Study|Site closed|1
7620975|NCT00042289|12031430|FG037|Overall Study|Site closed|0
7620976|NCT00042289|12031431|FG038|Overall Study|Site closed|0
7620977|NCT00042289|12031432|FG039|Overall Study|Site closed|0
7620978|NCT00042289|12031433|FG040|Overall Study|Site closed|0
7786372|NCT00992589|12237669|FG003|Open-Label Phase|Other|0
7786373|NCT00992589|12237666|FG000|Double-Blind Phase|Adverse Event|0
7786374|NCT00992589|12237667|FG001|Double-Blind Phase|Adverse Event|6
7620979|NCT00042289|12031434|FG041|Overall Study|Site closed|0
7620980|NCT00042289|12031435|FG042|Overall Study|Site closed|1
7620981|NCT00042289|12031436|FG043|Overall Study|Site closed|0
7620982|NCT00042289|12031437|FG044|Overall Study|Site closed|0
7620983|NCT00042289|12031438|FG045|Overall Study|Site closed|0
7620984|NCT00042289|12031439|FG046|Overall Study|Site closed|0
7620985|NCT00042289|12031393|FG000|Overall Study|Participant not willing to adhere to requirements|0
7620986|NCT00042289|12031394|FG001|Overall Study|Participant not willing to adhere to requirements|0
7620987|NCT00042289|12031395|FG002|Overall Study|Participant not willing to adhere to requirements|0
7620988|NCT00042289|12031396|FG003|Overall Study|Participant not willing to adhere to requirements|3
7620989|NCT00042289|12031397|FG004|Overall Study|Participant not willing to adhere to requirements|0
7620990|NCT00042289|12031398|FG005|Overall Study|Participant not willing to adhere to requirements|0
7620991|NCT00042289|12031399|FG006|Overall Study|Participant not willing to adhere to requirements|0
7620992|NCT00042289|12031400|FG007|Overall Study|Participant not willing to adhere to requirements|0
7620993|NCT00042289|12031401|FG008|Overall Study|Participant not willing to adhere to requirements|0
7620994|NCT00042289|12031402|FG009|Overall Study|Participant not willing to adhere to requirements|0
7620995|NCT00042289|12031403|FG010|Overall Study|Participant not willing to adhere to requirements|0
7620996|NCT00042289|12031404|FG011|Overall Study|Participant not willing to adhere to requirements|0
7620997|NCT00042289|12031405|FG012|Overall Study|Participant not willing to adhere to requirements|0
7620998|NCT00042289|12031406|FG013|Overall Study|Participant not willing to adhere to requirements|0
7620999|NCT00042289|12031407|FG014|Overall Study|Participant not willing to adhere to requirements|0
7621000|NCT00042289|12031408|FG015|Overall Study|Participant not willing to adhere to requirements|0
7621001|NCT00042289|12031409|FG016|Overall Study|Participant not willing to adhere to requirements|0
7621002|NCT00042289|12031410|FG017|Overall Study|Participant not willing to adhere to requirements|0
7621003|NCT00042289|12031411|FG018|Overall Study|Participant not willing to adhere to requirements|4
7621004|NCT00042289|12031412|FG019|Overall Study|Participant not willing to adhere to requirements|2
7786375|NCT00992589|12237668|FG002|Double-Blind Phase|Adverse Event|2
7786376|NCT00992589|12237669|FG003|Double-Blind Phase|Adverse Event|3
7786377|NCT00992589|12237666|FG000|Double-Blind Phase|Withdrawal by Subject|0
7786378|NCT00992589|12237667|FG001|Double-Blind Phase|Withdrawal by Subject|6
7786379|NCT00992589|12237668|FG002|Double-Blind Phase|Withdrawal by Subject|5
7786380|NCT00992589|12237669|FG003|Double-Blind Phase|Withdrawal by Subject|2
7786381|NCT00992589|12237666|FG000|Double-Blind Phase|Lost to Follow-up|0
7786382|NCT00992589|12237667|FG001|Double-Blind Phase|Lost to Follow-up|0
7786383|NCT00992589|12237668|FG002|Double-Blind Phase|Lost to Follow-up|0
7786384|NCT00992589|12237669|FG003|Double-Blind Phase|Lost to Follow-up|2
7786385|NCT00992589|12237666|FG000|Double-Blind Phase|Other|0
7786386|NCT00992589|12237667|FG001|Double-Blind Phase|Other|1
7786387|NCT00992589|12237668|FG002|Double-Blind Phase|Other|6
7786388|NCT00992589|12237669|FG003|Double-Blind Phase|Other|3
7786389|NCT00992784|12237707|FG000|Overall Study|Adverse Event|2
7786390|NCT00992784|12237708|FG001|Overall Study|Adverse Event|1
7786391|NCT00992784|12237709|FG002|Overall Study|Adverse Event|0
7786392|NCT00992784|12237707|FG000|Overall Study|Withdrawal by Subject|1
7786393|NCT00992784|12237708|FG001|Overall Study|Withdrawal by Subject|1
7786394|NCT00992784|12237709|FG002|Overall Study|Withdrawal by Subject|1
7786395|NCT00992836|12237717|FG000|Overall Study|Lost to Follow-up|1
7786396|NCT00992836|12237717|FG000|Overall Study|Withdrawal by Subject|2
7786397|NCT00992836|12237717|FG000|Overall Study|Protocol Violation|2
7786398|NCT00992992|12237736|FG000|Overall Study|Lost to Follow-up|3
7786399|NCT00992992|12237736|FG000|Overall Study|Death|16
7786400|NCT00992992|12237736|FG000|Overall Study|GlaxoSmithKline Closed the Study|2
7786401|NCT00992992|12237736|FG000|Overall Study|Sponsor Closed the Study|4
7786402|NCT00993031|12237742|FG000|Overall Study|Death|0
7786403|NCT00993031|12237743|FG001|Overall Study|Death|1
7786404|NCT00993031|12237742|FG000|Overall Study|Physician Decision|0
7786405|NCT00993031|12237743|FG001|Overall Study|Physician Decision|2
7786406|NCT00993031|12237742|FG000|Overall Study|Withdrawal by Subject|3
7786407|NCT00993031|12237743|FG001|Overall Study|Withdrawal by Subject|3
7786408|NCT00993031|12237742|FG000|Overall Study|Lost to Follow-up|19
7786409|NCT00993031|12237743|FG001|Overall Study|Lost to Follow-up|13
7786410|NCT00993044|12237753|FG000|Irinotecan 50 mg|Physician Decision|1
7786411|NCT00993148|12237758|FG000|Overall Study|Lost to Follow-up|2
7786412|NCT00993148|12237758|FG000|Overall Study|never initiated treatment|1
7786413|NCT00993265|12237797|FG000|Overall Study|Adverse Event|1
7786414|NCT00993265|12237798|FG001|Overall Study|Adverse Event|0
7786415|NCT00993265|12237797|FG000|Overall Study|Changed dose of concomitant drug|2
7786416|NCT00993265|12237798|FG001|Overall Study|Changed dose of concomitant drug|0
7786417|NCT00993265|12237797|FG000|Overall Study|Non-compliant with study medication|1
7786418|NCT00993265|12237798|FG001|Overall Study|Non-compliant with study medication|0
7786419|NCT00993291|12237804|FG000|Overall Study|Withdrawal by Subject|1
7786420|NCT00993317|12237810|FG000|Overall Study|Adverse Event|2
7786421|NCT00993317|12237811|FG001|Overall Study|Adverse Event|4
7786422|NCT00993317|12237810|FG000|Overall Study|Lack of Efficacy|18
7786423|NCT00993317|12237811|FG001|Overall Study|Lack of Efficacy|18
7786424|NCT00993317|12237810|FG000|Overall Study|Withdrawal by Subject|0
7786425|NCT00993317|12237811|FG001|Overall Study|Withdrawal by Subject|2
7786426|NCT00993317|12237810|FG000|Overall Study|Investigator's opinion|0
7786427|NCT00993317|12237811|FG001|Overall Study|Investigator's opinion|1
7786428|NCT00993317|12237810|FG000|Overall Study|Early study termination at the site|1
7786429|NCT00993317|12237811|FG001|Overall Study|Early study termination at the site|0
7786430|NCT00993421|12237824|FG000|Overall Study|Adverse Event|2
7786431|NCT00993421|12237825|FG001|Overall Study|Adverse Event|7
7621005|NCT00042289|12031413|FG020|Overall Study|Participant not willing to adhere to requirements|0
7621006|NCT00042289|12031414|FG021|Overall Study|Participant not willing to adhere to requirements|2
7621007|NCT00042289|12031415|FG022|Overall Study|Participant not willing to adhere to requirements|1
7621008|NCT00042289|12031416|FG023|Overall Study|Participant not willing to adhere to requirements|1
7621009|NCT00042289|12031417|FG024|Overall Study|Participant not willing to adhere to requirements|0
7621010|NCT00042289|12031418|FG025|Overall Study|Participant not willing to adhere to requirements|1
7621011|NCT00042289|12031419|FG026|Overall Study|Participant not willing to adhere to requirements|2
7621012|NCT00042289|12031420|FG027|Overall Study|Participant not willing to adhere to requirements|0
7621013|NCT00042289|12031421|FG028|Overall Study|Participant not willing to adhere to requirements|1
7621014|NCT00042289|12031422|FG029|Overall Study|Participant not willing to adhere to requirements|0
7621015|NCT00042289|12031423|FG030|Overall Study|Participant not willing to adhere to requirements|0
7621016|NCT00042289|12031424|FG031|Overall Study|Participant not willing to adhere to requirements|1
7621017|NCT00042289|12031425|FG032|Overall Study|Participant not willing to adhere to requirements|1
7621018|NCT00042289|12031426|FG033|Overall Study|Participant not willing to adhere to requirements|3
7621019|NCT00042289|12031427|FG034|Overall Study|Participant not willing to adhere to requirements|1
7621020|NCT00042289|12031428|FG035|Overall Study|Participant not willing to adhere to requirements|1
7621021|NCT00042289|12031429|FG036|Overall Study|Participant not willing to adhere to requirements|2
7621022|NCT00042289|12031430|FG037|Overall Study|Participant not willing to adhere to requirements|0
7621023|NCT00042289|12031431|FG038|Overall Study|Participant not willing to adhere to requirements|2
7621024|NCT00042289|12031432|FG039|Overall Study|Participant not willing to adhere to requirements|0
7621025|NCT00042289|12031433|FG040|Overall Study|Participant not willing to adhere to requirements|0
7786432|NCT00993421|12237826|FG002|Overall Study|Adverse Event|6
7786433|NCT00993421|12237827|FG003|Overall Study|Adverse Event|9
7786434|NCT00993421|12237828|FG004|Overall Study|Adverse Event|5
7786435|NCT00993421|12237829|FG005|Overall Study|Adverse Event|7
7786436|NCT00993421|12237830|FG006|Overall Study|Adverse Event|1
7786437|NCT00993421|12237824|FG000|Overall Study|Sponsor Decision|36
7786438|NCT00993421|12237825|FG001|Overall Study|Sponsor Decision|31
7786439|NCT00993421|12237826|FG002|Overall Study|Sponsor Decision|28
7786440|NCT00993421|12237827|FG003|Overall Study|Sponsor Decision|30
7786441|NCT00993421|12237828|FG004|Overall Study|Sponsor Decision|38
7786442|NCT00993421|12237829|FG005|Overall Study|Sponsor Decision|30
7786443|NCT00993421|12237830|FG006|Overall Study|Sponsor Decision|29
7786444|NCT00993421|12237824|FG000|Overall Study|Lost to Follow-up|3
7786445|NCT00993421|12237825|FG001|Overall Study|Lost to Follow-up|5
7786446|NCT00993421|12237826|FG002|Overall Study|Lost to Follow-up|5
7786447|NCT00993421|12237827|FG003|Overall Study|Lost to Follow-up|0
7786448|NCT00993421|12237828|FG004|Overall Study|Lost to Follow-up|0
7786449|NCT00993421|12237829|FG005|Overall Study|Lost to Follow-up|0
7786450|NCT00993421|12237830|FG006|Overall Study|Lost to Follow-up|6
7786451|NCT00993421|12237824|FG000|Overall Study|Withdrawal by Subject|3
7786452|NCT00993421|12237825|FG001|Overall Study|Withdrawal by Subject|2
7786453|NCT00993421|12237826|FG002|Overall Study|Withdrawal by Subject|3
7786454|NCT00993421|12237827|FG003|Overall Study|Withdrawal by Subject|3
7786455|NCT00993421|12237828|FG004|Overall Study|Withdrawal by Subject|3
7786456|NCT00993421|12237829|FG005|Overall Study|Withdrawal by Subject|5
7786457|NCT00993421|12237830|FG006|Overall Study|Withdrawal by Subject|3
7786458|NCT00993421|12237824|FG000|Overall Study|Death|0
7786459|NCT00993421|12237825|FG001|Overall Study|Death|0
7786460|NCT00993421|12237826|FG002|Overall Study|Death|0
7786461|NCT00993421|12237827|FG003|Overall Study|Death|0
7786462|NCT00993421|12237828|FG004|Overall Study|Death|0
7786463|NCT00993421|12237829|FG005|Overall Study|Death|0
7786464|NCT00993421|12237830|FG006|Overall Study|Death|1
7786465|NCT00993421|12237824|FG000|Overall Study|Entry Criteria Exclusion|0
7786466|NCT00993421|12237825|FG001|Overall Study|Entry Criteria Exclusion|0
7786467|NCT00993421|12237826|FG002|Overall Study|Entry Criteria Exclusion|1
7786468|NCT00993421|12237827|FG003|Overall Study|Entry Criteria Exclusion|3
7786469|NCT00993421|12237828|FG004|Overall Study|Entry Criteria Exclusion|0
7786470|NCT00993421|12237829|FG005|Overall Study|Entry Criteria Exclusion|1
7786471|NCT00993421|12237830|FG006|Overall Study|Entry Criteria Exclusion|0
7786472|NCT00993421|12237824|FG000|Overall Study|Physician Decision|0
7786473|NCT00993421|12237825|FG001|Overall Study|Physician Decision|0
7786474|NCT00993421|12237826|FG002|Overall Study|Physician Decision|0
7786475|NCT00993421|12237827|FG003|Overall Study|Physician Decision|0
7786476|NCT00993421|12237828|FG004|Overall Study|Physician Decision|0
7621066|NCT00042289|12031427|FG034|Overall Study|Protocol Violation|0
7786477|NCT00993421|12237829|FG005|Overall Study|Physician Decision|1
7786478|NCT00993421|12237830|FG006|Overall Study|Physician Decision|1
7786479|NCT00993421|12237824|FG000|Overall Study|Protocol Violation|0
7786480|NCT00993421|12237825|FG001|Overall Study|Protocol Violation|0
7786481|NCT00993421|12237826|FG002|Overall Study|Protocol Violation|0
7786482|NCT00993421|12237827|FG003|Overall Study|Protocol Violation|0
7786483|NCT00993421|12237828|FG004|Overall Study|Protocol Violation|0
7786484|NCT00993421|12237829|FG005|Overall Study|Protocol Violation|2
7786485|NCT00993421|12237830|FG006|Overall Study|Protocol Violation|1
7786486|NCT00993473|12237848|FG000|Overall Study|Adverse Event|0
7786487|NCT00993473|12237849|FG001|Overall Study|Adverse Event|2
7786488|NCT00993473|12237848|FG000|Overall Study|Protocol Violation|1
7786489|NCT00993473|12237849|FG001|Overall Study|Protocol Violation|2
7621026|NCT00042289|12031434|FG041|Overall Study|Participant not willing to adhere to requirements|0
7621027|NCT00042289|12031435|FG042|Overall Study|Participant not willing to adhere to requirements|2
7621028|NCT00042289|12031436|FG043|Overall Study|Participant not willing to adhere to requirements|1
7621029|NCT00042289|12031437|FG044|Overall Study|Participant not willing to adhere to requirements|0
7621030|NCT00042289|12031438|FG045|Overall Study|Participant not willing to adhere to requirements|0
7621031|NCT00042289|12031439|FG046|Overall Study|Participant not willing to adhere to requirements|1
7621032|NCT00042289|12031393|FG000|Overall Study|Protocol Violation|0
7786490|NCT00993473|12237848|FG000|Overall Study|Lost to Follow-up|1
7786491|NCT00993473|12237849|FG001|Overall Study|Lost to Follow-up|0
7786492|NCT00993473|12237848|FG000|Overall Study|Withdrawal by Subject|1
7786493|NCT00993473|12237849|FG001|Overall Study|Withdrawal by Subject|5
7786494|NCT00993473|12237848|FG000|Overall Study|Technical problem with CGM device|0
7786495|NCT00993473|12237849|FG001|Overall Study|Technical problem with CGM device|1
7786496|NCT00993473|12237848|FG000|Overall Study|Family event|1
7786497|NCT00993473|12237849|FG001|Overall Study|Family event|0
7786498|NCT00993499|12237861|FG000|Run-in Period (8 Days)|Adverse Event|0
7786499|NCT00993499|12237862|FG001|Run-in Period (8 Days)|Adverse Event|1
7786500|NCT00993499|12237863|FG002|Run-in Period (8 Days)|Adverse Event|0
7786501|NCT00993499|12237864|FG003|Run-in Period (8 Days)|Adverse Event|0
7786502|NCT00993499|12237865|FG004|Run-in Period (8 Days)|Adverse Event|0
7786503|NCT00993499|12237866|FG005|Run-in Period (8 Days)|Adverse Event|0
7786504|NCT00993499|12237861|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
7786505|NCT00993499|12237862|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
7786506|NCT00993499|12237863|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
7786507|NCT00993499|12237864|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
7786508|NCT00993499|12237865|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
7786509|NCT00993499|12237866|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
7786510|NCT00993499|12237861|FG000|Run-in Period (8 Days)|Consent withdrawn|0
7786511|NCT00993499|12237862|FG001|Run-in Period (8 Days)|Consent withdrawn|1
7786512|NCT00993499|12237863|FG002|Run-in Period (8 Days)|Consent withdrawn|0
7786513|NCT00993499|12237864|FG003|Run-in Period (8 Days)|Consent withdrawn|0
7786514|NCT00993499|12237865|FG004|Run-in Period (8 Days)|Consent withdrawn|0
7786515|NCT00993499|12237866|FG005|Run-in Period (8 Days)|Consent withdrawn|0
7786516|NCT00993499|12237861|FG000|Run-in Period (8 Days)|Progressive disease|0
7786517|NCT00993499|12237862|FG001|Run-in Period (8 Days)|Progressive disease|1
7786518|NCT00993499|12237863|FG002|Run-in Period (8 Days)|Progressive disease|1
7786519|NCT00993499|12237864|FG003|Run-in Period (8 Days)|Progressive disease|0
7786520|NCT00993499|12237865|FG004|Run-in Period (8 Days)|Progressive disease|0
7786521|NCT00993499|12237866|FG005|Run-in Period (8 Days)|Progressive disease|0
7786522|NCT00993499|12237861|FG000|Discontinued Before Starting Course 3|Progressive Disease|2
7786523|NCT00993499|12237862|FG001|Discontinued Before Starting Course 3|Progressive Disease|2
7786524|NCT00993499|12237863|FG002|Discontinued Before Starting Course 3|Progressive Disease|0
7621033|NCT00042289|12031394|FG001|Overall Study|Protocol Violation|0
7621034|NCT00042289|12031395|FG002|Overall Study|Protocol Violation|0
7621035|NCT00042289|12031396|FG003|Overall Study|Protocol Violation|0
7621036|NCT00042289|12031397|FG004|Overall Study|Protocol Violation|0
7621037|NCT00042289|12031398|FG005|Overall Study|Protocol Violation|1
7621038|NCT00042289|12031399|FG006|Overall Study|Protocol Violation|0
7621039|NCT00042289|12031400|FG007|Overall Study|Protocol Violation|1
7621040|NCT00042289|12031401|FG008|Overall Study|Protocol Violation|0
7621041|NCT00042289|12031402|FG009|Overall Study|Protocol Violation|0
7621042|NCT00042289|12031403|FG010|Overall Study|Protocol Violation|0
7621043|NCT00042289|12031404|FG011|Overall Study|Protocol Violation|0
7621044|NCT00042289|12031405|FG012|Overall Study|Protocol Violation|0
7621045|NCT00042289|12031406|FG013|Overall Study|Protocol Violation|0
7621046|NCT00042289|12031407|FG014|Overall Study|Protocol Violation|0
7621047|NCT00042289|12031408|FG015|Overall Study|Protocol Violation|0
7621048|NCT00042289|12031409|FG016|Overall Study|Protocol Violation|0
7621049|NCT00042289|12031410|FG017|Overall Study|Protocol Violation|0
7621050|NCT00042289|12031411|FG018|Overall Study|Protocol Violation|0
7621051|NCT00042289|12031412|FG019|Overall Study|Protocol Violation|0
7621052|NCT00042289|12031413|FG020|Overall Study|Protocol Violation|0
7621053|NCT00042289|12031414|FG021|Overall Study|Protocol Violation|0
7621054|NCT00042289|12031415|FG022|Overall Study|Protocol Violation|0
7621055|NCT00042289|12031416|FG023|Overall Study|Protocol Violation|1
7621056|NCT00042289|12031417|FG024|Overall Study|Protocol Violation|1
7621057|NCT00042289|12031418|FG025|Overall Study|Protocol Violation|0
7621058|NCT00042289|12031419|FG026|Overall Study|Protocol Violation|2
7621059|NCT00042289|12031420|FG027|Overall Study|Protocol Violation|0
7621060|NCT00042289|12031421|FG028|Overall Study|Protocol Violation|0
7621061|NCT00042289|12031422|FG029|Overall Study|Protocol Violation|0
7621062|NCT00042289|12031423|FG030|Overall Study|Protocol Violation|1
7621063|NCT00042289|12031424|FG031|Overall Study|Protocol Violation|0
7621064|NCT00042289|12031425|FG032|Overall Study|Protocol Violation|0
7621065|NCT00042289|12031426|FG033|Overall Study|Protocol Violation|0
7786525|NCT00993499|12237864|FG003|Discontinued Before Starting Course 3|Progressive Disease|0
7786526|NCT00993499|12237865|FG004|Discontinued Before Starting Course 3|Progressive Disease|0
7621067|NCT00042289|12031428|FG035|Overall Study|Protocol Violation|0
7621068|NCT00042289|12031429|FG036|Overall Study|Protocol Violation|0
7621069|NCT00042289|12031430|FG037|Overall Study|Protocol Violation|0
7621070|NCT00042289|12031431|FG038|Overall Study|Protocol Violation|0
7621071|NCT00042289|12031432|FG039|Overall Study|Protocol Violation|0
7621072|NCT00042289|12031433|FG040|Overall Study|Protocol Violation|0
7621073|NCT00042289|12031434|FG041|Overall Study|Protocol Violation|1
7621074|NCT00042289|12031435|FG042|Overall Study|Protocol Violation|1
7621075|NCT00042289|12031436|FG043|Overall Study|Protocol Violation|1
7621076|NCT00042289|12031437|FG044|Overall Study|Protocol Violation|0
7621077|NCT00042289|12031438|FG045|Overall Study|Protocol Violation|0
7621078|NCT00042289|12031439|FG046|Overall Study|Protocol Violation|0
7621079|NCT00042289|12031393|FG000|Overall Study|Withdrawal by Subject|4
7621080|NCT00042289|12031394|FG001|Overall Study|Withdrawal by Subject|1
7621081|NCT00042289|12031395|FG002|Overall Study|Withdrawal by Subject|0
7621082|NCT00042289|12031396|FG003|Overall Study|Withdrawal by Subject|2
7621083|NCT00042289|12031397|FG004|Overall Study|Withdrawal by Subject|0
7621084|NCT00042289|12031398|FG005|Overall Study|Withdrawal by Subject|2
7621085|NCT00042289|12031399|FG006|Overall Study|Withdrawal by Subject|0
7621086|NCT00042289|12031400|FG007|Overall Study|Withdrawal by Subject|0
7621087|NCT00042289|12031401|FG008|Overall Study|Withdrawal by Subject|0
7621088|NCT00042289|12031402|FG009|Overall Study|Withdrawal by Subject|1
7621089|NCT00042289|12031403|FG010|Overall Study|Withdrawal by Subject|0
7621090|NCT00042289|12031404|FG011|Overall Study|Withdrawal by Subject|0
7621091|NCT00042289|12031405|FG012|Overall Study|Withdrawal by Subject|2
7621092|NCT00042289|12031406|FG013|Overall Study|Withdrawal by Subject|0
7621093|NCT00042289|12031407|FG014|Overall Study|Withdrawal by Subject|0
7621094|NCT00042289|12031408|FG015|Overall Study|Withdrawal by Subject|0
7621095|NCT00042289|12031409|FG016|Overall Study|Withdrawal by Subject|0
7621096|NCT00042289|12031410|FG017|Overall Study|Withdrawal by Subject|0
7621097|NCT00042289|12031411|FG018|Overall Study|Withdrawal by Subject|0
7786527|NCT00993499|12237866|FG005|Discontinued Before Starting Course 3|Progressive Disease|0
7786528|NCT00993499|12237861|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2
7786529|NCT00993499|12237862|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2
7786530|NCT00993499|12237863|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0
7786531|NCT00993499|12237864|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0
7786532|NCT00993499|12237865|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0
7786533|NCT00993499|12237866|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0
7786534|NCT00993499|12237861|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
7786535|NCT00993499|12237862|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
7786536|NCT00993499|12237863|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
7786537|NCT00993499|12237864|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
7786538|NCT00993499|12237865|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
7786539|NCT00993499|12237866|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
7786540|NCT00993499|12237861|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0
7786541|NCT00993499|12237862|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0
7786542|NCT00993499|12237863|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2
7786543|NCT00993499|12237864|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0
7621098|NCT00042289|12031412|FG019|Overall Study|Withdrawal by Subject|0
7621099|NCT00042289|12031413|FG020|Overall Study|Withdrawal by Subject|0
7621100|NCT00042289|12031414|FG021|Overall Study|Withdrawal by Subject|1
7621101|NCT00042289|12031415|FG022|Overall Study|Withdrawal by Subject|1
7621102|NCT00042289|12031416|FG023|Overall Study|Withdrawal by Subject|1
7621103|NCT00042289|12031417|FG024|Overall Study|Withdrawal by Subject|0
7621104|NCT00042289|12031418|FG025|Overall Study|Withdrawal by Subject|0
7621105|NCT00042289|12031419|FG026|Overall Study|Withdrawal by Subject|1
7621106|NCT00042289|12031420|FG027|Overall Study|Withdrawal by Subject|0
7621107|NCT00042289|12031421|FG028|Overall Study|Withdrawal by Subject|2
7621108|NCT00042289|12031422|FG029|Overall Study|Withdrawal by Subject|0
7621109|NCT00042289|12031423|FG030|Overall Study|Withdrawal by Subject|0
7621110|NCT00042289|12031424|FG031|Overall Study|Withdrawal by Subject|1
7621111|NCT00042289|12031425|FG032|Overall Study|Withdrawal by Subject|2
7621112|NCT00042289|12031426|FG033|Overall Study|Withdrawal by Subject|1
7621113|NCT00042289|12031427|FG034|Overall Study|Withdrawal by Subject|0
7621114|NCT00042289|12031428|FG035|Overall Study|Withdrawal by Subject|0
7621115|NCT00042289|12031429|FG036|Overall Study|Withdrawal by Subject|0
7621116|NCT00042289|12031430|FG037|Overall Study|Withdrawal by Subject|1
7621117|NCT00042289|12031431|FG038|Overall Study|Withdrawal by Subject|0
7621118|NCT00042289|12031432|FG039|Overall Study|Withdrawal by Subject|0
7621119|NCT00042289|12031433|FG040|Overall Study|Withdrawal by Subject|0
7621120|NCT00042289|12031434|FG041|Overall Study|Withdrawal by Subject|0
7621121|NCT00042289|12031435|FG042|Overall Study|Withdrawal by Subject|1
7621122|NCT00042289|12031436|FG043|Overall Study|Withdrawal by Subject|0
7621123|NCT00042289|12031437|FG044|Overall Study|Withdrawal by Subject|0
7621124|NCT00042289|12031438|FG045|Overall Study|Withdrawal by Subject|0
7621125|NCT00042289|12031439|FG046|Overall Study|Withdrawal by Subject|0
7621126|NCT02384993|12031625|FG000|Overall Study|Adverse Event|0
7621127|NCT02384993|12031626|FG001|Overall Study|Adverse Event|1
7621128|NCT02304302|12031635|FG000|Overall Study|Adverse Event|2
7621129|NCT02304302|12031636|FG001|Overall Study|Adverse Event|3
7621130|NCT02304302|12031635|FG000|Overall Study|Lost to Follow-up|1
7621131|NCT02304302|12031636|FG001|Overall Study|Lost to Follow-up|4
7621132|NCT02304302|12031635|FG000|Overall Study|Removed from analysis due to low medication compliance|0
7621133|NCT02304302|12031636|FG001|Overall Study|Removed from analysis due to low medication compliance|1
7621134|NCT02269670|12031646|FG000|Overall Study|All subjects have not completed all research related interventions|3
7621135|NCT01860976|12031656|FG000|Blinded Treatment|Adverse Event|1
7621136|NCT01860976|12031657|FG001|Blinded Treatment|Adverse Event|3
7621137|NCT01860976|12031656|FG000|Blinded Treatment|Lack of Efficacy|5
7621138|NCT01860976|12031657|FG001|Blinded Treatment|Lack of Efficacy|12
7621139|NCT01860976|12031656|FG000|Blinded Treatment|Subject request to discontinue treatment|2
7621140|NCT01860976|12031657|FG001|Blinded Treatment|Subject request to discontinue treatment|3
7621141|NCT01860976|12031656|FG000|Blinded Treatment|Withdrawal by Subject|3
7621142|NCT01860976|12031657|FG001|Blinded Treatment|Withdrawal by Subject|5
7621143|NCT01860976|12031656|FG000|Blinded Treatment|Subject no longer met criteria|1
7621144|NCT01860976|12031657|FG001|Blinded Treatment|Subject no longer met criteria|0
7621145|NCT01860976|12031656|FG000|Blinded Treatment|Entered Open-Label in error|0
7621146|NCT01860976|12031657|FG001|Blinded Treatment|Entered Open-Label in error|1
7621147|NCT01860976|12031656|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76
7621148|NCT01860976|12031657|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89
7621149|NCT01860976|12031656|FG000|Open-Label|Adverse Event|2
7621150|NCT01860976|12031657|FG001|Open-Label|Adverse Event|4
7621151|NCT01860976|12031656|FG000|Open-Label|Lack of Efficacy|16
7621152|NCT01860976|12031657|FG001|Open-Label|Lack of Efficacy|8
7621153|NCT01860976|12031656|FG000|Open-Label|Lost to Follow-up|1
7621154|NCT01860976|12031657|FG001|Open-Label|Lost to Follow-up|2
7621155|NCT01860976|12031656|FG000|Open-Label|Subject request discontinue treatment|4
7621156|NCT01860976|12031657|FG001|Open-Label|Subject request discontinue treatment|3
7621157|NCT01860976|12031656|FG000|Open-Label|Withdrawal by Subject|4
7621158|NCT01860976|12031657|FG001|Open-Label|Withdrawal by Subject|1
7621159|NCT01860976|12031656|FG000|Open-Label|Other Reasons|1
7621160|NCT01860976|12031657|FG001|Open-Label|Other Reasons|1
7621161|NCT01860976|12031656|FG000|Long Term Extension|Adverse Event|4
7621162|NCT01860976|12031657|FG001|Long Term Extension|Adverse Event|0
7621163|NCT01860976|12031656|FG000|Long Term Extension|Lack of Efficacy|2
7621164|NCT01860976|12031657|FG001|Long Term Extension|Lack of Efficacy|0
7621165|NCT01860976|12031656|FG000|Long Term Extension|Subject request to discontinue treatment|10
7621166|NCT01860976|12031657|FG001|Long Term Extension|Subject request to discontinue treatment|0
7621167|NCT01860976|12031656|FG000|Long Term Extension|Lost to Follow-up|2
7621168|NCT01860976|12031657|FG001|Long Term Extension|Lost to Follow-up|0
7621169|NCT01860976|12031656|FG000|Long Term Extension|subject withdrew consent|7
7621170|NCT01860976|12031657|FG001|Long Term Extension|subject withdrew consent|0
7621171|NCT01761266|12031668|FG000|Overall Study|Death|415
7621172|NCT01761266|12031669|FG001|Overall Study|Death|402
7621173|NCT01761266|12031668|FG000|Overall Study|Lost to Follow-up|8
7621174|NCT01761266|12031669|FG001|Overall Study|Lost to Follow-up|12
7621175|NCT01761266|12031668|FG000|Overall Study|Withdrawal by Subject|14
7621176|NCT01761266|12031669|FG001|Overall Study|Withdrawal by Subject|10
7621177|NCT01761266|12031668|FG000|Overall Study|Sponsor Decision|41
7621178|NCT01761266|12031669|FG001|Overall Study|Sponsor Decision|52
7621179|NCT01550289|12031680|FG000|Overall Study|Protocol Violation|1
7621180|NCT01550289|12031681|FG001|Overall Study|Protocol Violation|0
7621181|NCT01550289|12031680|FG000|Overall Study|Lost to Follow-up|1
7621182|NCT01550289|12031681|FG001|Overall Study|Lost to Follow-up|1
7621183|NCT01550289|12031680|FG000|Overall Study|Withdrawal by Subject|11
7621184|NCT01550289|12031681|FG001|Overall Study|Withdrawal by Subject|3
7621185|NCT01346709|12031689|FG000|Overall Study|Protocol Violation|35
7621186|NCT01346709|12031689|FG000|Overall Study|Lost to Follow-up|31
7786544|NCT00993499|12237865|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0
7786545|NCT00993499|12237866|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0
7786546|NCT00993499|12237861|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0
7786547|NCT00993499|12237862|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1
7786548|NCT00993499|12237863|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0
7786549|NCT00993499|12237864|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0
7621187|NCT01346709|12031689|FG000|Overall Study|Missing data in candidate risk factor|285
7621188|NCT01074190|12031696|FG000|Overall Study|Emergency Cesarean Delivery|1
7621189|NCT01074190|12031697|FG001|Overall Study|Emergency Cesarean Delivery|2
7621190|NCT01074190|12031698|FG002|Overall Study|Emergency Cesarean Delivery|1
7621191|NCT01074190|12031696|FG000|Overall Study|Protocol Violation|2
7621192|NCT01074190|12031697|FG001|Overall Study|Protocol Violation|1
7621193|NCT01074190|12031698|FG002|Overall Study|Protocol Violation|0
7621194|NCT01074190|12031696|FG000|Overall Study|Delivered in under 90 minutes|0
7621195|NCT01074190|12031697|FG001|Overall Study|Delivered in under 90 minutes|2
7621196|NCT01074190|12031698|FG002|Overall Study|Delivered in under 90 minutes|1
7621197|NCT01074190|12031696|FG000|Overall Study|Subject withdrew consent|1
7621198|NCT01074190|12031697|FG001|Overall Study|Subject withdrew consent|1
7621199|NCT01074190|12031698|FG002|Overall Study|Subject withdrew consent|1
7621200|NCT00875524|12031711|FG000|Overall Study|Serious adverse event|0
7621201|NCT00875524|12031712|FG001|Overall Study|Serious adverse event|1
7621202|NCT00875524|12031711|FG000|Overall Study|Protocol Violation|4
7621203|NCT00875524|12031712|FG001|Overall Study|Protocol Violation|0
7621204|NCT00875524|12031711|FG000|Overall Study|Lost to Follow-up|1
7621205|NCT00875524|12031712|FG001|Overall Study|Lost to Follow-up|0
7621206|NCT00875524|12031711|FG000|Overall Study|Withdrawal by Subject|3
7621207|NCT00875524|12031712|FG001|Overall Study|Withdrawal by Subject|5
7621208|NCT00842530|12031720|FG000|Overall Study|Serious adverse event|0
7621209|NCT00842530|12031721|FG001|Overall Study|Serious adverse event|6
7621210|NCT00842530|12031720|FG000|Overall Study|Other adverse event|6
7621211|NCT00842530|12031721|FG001|Overall Study|Other adverse event|1
7621212|NCT00842530|12031720|FG000|Overall Study|Protocol Violation|32
7621213|NCT00842530|12031721|FG001|Overall Study|Protocol Violation|14
7621214|NCT00842530|12031720|FG000|Overall Study|Lost to Follow-up|6
7621215|NCT00842530|12031721|FG001|Overall Study|Lost to Follow-up|8
7621216|NCT00842530|12031720|FG000|Overall Study|Withdrawal by Subject|73
7621217|NCT00842530|12031721|FG001|Overall Study|Withdrawal by Subject|28
7621218|NCT00788151|12031730|FG000|Overall Study|Other adverse event|0
7621219|NCT00788151|12031731|FG001|Overall Study|Other adverse event|2
7621220|NCT00788151|12031730|FG000|Overall Study|Protocol Violation|0
7621221|NCT00788151|12031731|FG001|Overall Study|Protocol Violation|1
7621222|NCT00788151|12031730|FG000|Overall Study|Withdrawal by Subject|13
7621223|NCT00788151|12031731|FG001|Overall Study|Withdrawal by Subject|6
7621224|NCT00788151|12031730|FG000|Overall Study|Enrolled but not treated|1
7621225|NCT00788151|12031731|FG001|Overall Study|Enrolled but not treated|1
7621226|NCT00539591|12031740|FG000|Overall Study|Toxicity|3
7621227|NCT00539591|12031741|FG001|Overall Study|Toxicity|0
7621228|NCT00539591|12031742|FG002|Overall Study|Toxicity|0
7621229|NCT00539591|12031740|FG000|Overall Study|Disease progression|2
7621230|NCT00539591|12031741|FG001|Overall Study|Disease progression|2
7621231|NCT00539591|12031742|FG002|Overall Study|Disease progression|3
7786550|NCT00993499|12237865|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0
7786551|NCT00993499|12237866|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0
7786552|NCT00993499|12237861|FG000|Discontinued After Starting Course 3|Progressive Disease|6
7786553|NCT00993499|12237862|FG001|Discontinued After Starting Course 3|Progressive Disease|4
7786554|NCT00993499|12237863|FG002|Discontinued After Starting Course 3|Progressive Disease|3
7786555|NCT00993499|12237864|FG003|Discontinued After Starting Course 3|Progressive Disease|1
7786556|NCT00993499|12237865|FG004|Discontinued After Starting Course 3|Progressive Disease|3
7786557|NCT00993499|12237866|FG005|Discontinued After Starting Course 3|Progressive Disease|3
7786558|NCT00993499|12237861|FG000|Discontinued After Starting Course 3|DLT|1
7786559|NCT00993499|12237862|FG001|Discontinued After Starting Course 3|DLT|0
7786560|NCT00993499|12237863|FG002|Discontinued After Starting Course 3|DLT|2
7786561|NCT00993499|12237864|FG003|Discontinued After Starting Course 3|DLT|1
7786562|NCT00993499|12237865|FG004|Discontinued After Starting Course 3|DLT|0
7786563|NCT00993499|12237866|FG005|Discontinued After Starting Course 3|DLT|0
7786564|NCT00993499|12237861|FG000|Discontinued After Starting Course 3|Other adverse event|1
7786565|NCT00993499|12237862|FG001|Discontinued After Starting Course 3|Other adverse event|0
7621232|NCT04794751|12031778|FG000|Period 1|incorrect fitting guide was used to fit subject|2
7621233|NCT04794751|12031779|FG001|Period 1|incorrect fitting guide was used to fit subject|1
7621234|NCT04794751|12031778|FG000|Period 1|Subject no longer meets eligibility criteria|0
7621235|NCT04794751|12031779|FG001|Period 1|Subject no longer meets eligibility criteria|1
7621236|NCT04794751|12031778|FG000|Period 1|Protocol Violation|0
7621237|NCT04794751|12031779|FG001|Period 1|Protocol Violation|2
7621238|NCT04794751|12031778|FG000|Period 1|Withdrawal by Subject|0
7621239|NCT04794751|12031779|FG001|Period 1|Withdrawal by Subject|1
7621240|NCT04794751|12031778|FG000|Period 2|Withdrawal by Subject|0
7621241|NCT04794751|12031779|FG001|Period 2|Withdrawal by Subject|1
7621242|NCT04794751|12031778|FG000|Period 2|incorrect fitting guide was used to fit subject|0
7621243|NCT04794751|12031779|FG001|Period 2|incorrect fitting guide was used to fit subject|2
7621244|NCT04794751|12031778|FG000|Period 2|Protocol Violation|1
7621245|NCT04794751|12031779|FG001|Period 2|Protocol Violation|0
7621246|NCT04584645|12031787|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995
7621247|NCT04584645|12031788|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906
7621248|NCT04538170|12031814|FG000|Overall Study|Withdrawal by Subject|104
7621249|NCT04538170|12031815|FG001|Overall Study|Withdrawal by Subject|210
7621250|NCT04461015|12031827|FG000|Overall Study|IV access lost during the study|0
7621251|NCT04461015|12031828|FG001|Overall Study|IV access lost during the study|1
7621252|NCT04461015|12031827|FG000|Overall Study|Withdrawal by Subject|0
7621253|NCT04461015|12031828|FG001|Overall Study|Withdrawal by Subject|1
7621254|NCT04380961|12031836|FG000|Overall Study|Lost to Follow-up|17
7621255|NCT04380961|12031837|FG001|Overall Study|Lost to Follow-up|11
7621256|NCT04380961|12031836|FG000|Overall Study|Withdrawal by Subject|3
7621257|NCT04380961|12031837|FG001|Overall Study|Withdrawal by Subject|0
7621258|NCT04380961|12031836|FG000|Overall Study|Death|22
7621259|NCT04380961|12031837|FG001|Overall Study|Death|16
7621260|NCT04380961|12031836|FG000|Overall Study|Other|1
7621261|NCT04380961|12031837|FG001|Overall Study|Other|0
7621262|NCT04380961|12031836|FG000|Overall Study|Randomized but Not Treated|1
7621263|NCT04380961|12031837|FG001|Overall Study|Randomized but Not Treated|2
7621264|NCT04332419|12031862|FG000|Overall Study|Withdrawal by Subject|1
7621265|NCT04239872|12031866|FG000|Overall Study|Lost to Follow-up|0
7621266|NCT04239872|12031867|FG001|Overall Study|Lost to Follow-up|1
7621267|NCT04091581|12031886|FG000|Overall Study|Lost to Follow-up|0
7621268|NCT04091581|12031887|FG001|Overall Study|Lost to Follow-up|1
7621269|NCT03839628|12031923|FG000|Overall Study|Withdrawal by Subject|1
7621270|NCT03791398|12031930|FG000|Overall Study|Progression of Disease Under Study|2
7786566|NCT00993499|12237863|FG002|Discontinued After Starting Course 3|Other adverse event|1
7786567|NCT00993499|12237864|FG003|Discontinued After Starting Course 3|Other adverse event|0
7786568|NCT00993499|12237865|FG004|Discontinued After Starting Course 3|Other adverse event|0
7786569|NCT00993499|12237866|FG005|Discontinued After Starting Course 3|Other adverse event|0
7786570|NCT00993616|12237880|FG000|Overall Study|No tumor at entry|1
7786571|NCT00993616|12237880|FG000|Overall Study|Never treated|1
7786572|NCT00993668|12237908|FG000|Single-Blind Period|Adverse Event|1
7786573|NCT00993668|12237909|FG001|Single-Blind Period|Adverse Event|1
7786574|NCT00993668|12237908|FG000|Single-Blind Period|Lack of Efficacy|0
7786575|NCT00993668|12237909|FG001|Single-Blind Period|Lack of Efficacy|1
7786576|NCT00993668|12237908|FG000|Single-Blind Period|Lost to Follow-up|3
7786577|NCT00993668|12237909|FG001|Single-Blind Period|Lost to Follow-up|1
7786578|NCT00993668|12237908|FG000|Open-Label Period|Adverse Event|9
7786579|NCT00993668|12237909|FG001|Open-Label Period|Adverse Event|8
7786580|NCT00993668|12237908|FG000|Open-Label Period|Lack of Efficacy|4
7786581|NCT00993668|12237909|FG001|Open-Label Period|Lack of Efficacy|3
7786582|NCT00993668|12237908|FG000|Open-Label Period|Withdrawal by Subject|4
7786583|NCT00993668|12237909|FG001|Open-Label Period|Withdrawal by Subject|3
7786584|NCT00993668|12237908|FG000|Open-Label Period|Lost to Follow-up|6
7786585|NCT00993668|12237909|FG001|Open-Label Period|Lost to Follow-up|1
7786586|NCT00993915|12237942|FG000|Overall Study|Insufficient clinical response|3
7786587|NCT00993915|12237942|FG000|Overall Study|Withdrawal by Subject|2
7786588|NCT00993915|12237942|FG000|Overall Study|Other|1
7786589|NCT00993915|12237942|FG000|Overall Study|Ongoing|3
7786590|NCT00993928|12237948|FG000|Overall Study|Withdrawal by Subject|4
7786591|NCT00993928|12237949|FG001|Overall Study|Withdrawal by Subject|7
7786592|NCT00993928|12237948|FG000|Overall Study|ineligible|1
7786593|NCT00993928|12237949|FG001|Overall Study|ineligible|0
7786594|NCT00993954|12237961|FG000|Overall Study|Protocol Violation|21
7786595|NCT00993954|12237962|FG001|Overall Study|Protocol Violation|2
7786596|NCT00993967|12237968|FG000|Overall Study|Adverse Event|8
7786597|NCT00993967|12237968|FG000|Overall Study|Death|1
7786598|NCT00993967|12237968|FG000|Overall Study|Lost to Follow-up|14
7786599|NCT00993967|12237968|FG000|Overall Study|Withdrawal by Subject|36
7786600|NCT00993967|12237968|FG000|Overall Study|Protocol Violation|2
7786601|NCT00994110|12237974|FG000|Overall Study|Withdrawal by Subject|9
7621271|NCT03791398|12031931|FG001|Overall Study|Progression of Disease Under Study|0
7621272|NCT03791398|12031932|FG002|Overall Study|Progression of Disease Under Study|0
7786602|NCT00994110|12237975|FG001|Overall Study|Withdrawal by Subject|9
7786603|NCT00994110|12237974|FG000|Overall Study|Not Treated|4
7786604|NCT00994110|12237975|FG001|Overall Study|Not Treated|8
7786605|NCT00994110|12237974|FG000|Overall Study|Adverse Event|1
7786606|NCT00994110|12237975|FG001|Overall Study|Adverse Event|0
7786607|NCT00994110|12237974|FG000|Overall Study|Patient not resected|41
7786608|NCT00994110|12237975|FG001|Overall Study|Patient not resected|52
7786609|NCT00994110|12237974|FG000|Overall Study|Pt not eligible|10
7786610|NCT00994110|12237975|FG001|Overall Study|Pt not eligible|5
7786611|NCT00994214|12238016|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0
7786612|NCT00994214|12238017|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1
7786613|NCT00994214|12238018|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0
7786614|NCT00994214|12238019|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0
7786615|NCT00994214|12238016|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
7786616|NCT00994214|12238017|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
7786617|NCT00994214|12238018|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
7786618|NCT00994214|12238019|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
7786619|NCT00994214|12238016|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
7786620|NCT00994214|12238017|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
7786621|NCT00994214|12238018|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
7786622|NCT00994214|12238019|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
7786623|NCT00994214|12238016|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
7786624|NCT00994214|12238017|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
7786625|NCT00994214|12238018|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
7786626|NCT00994214|12238019|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
7786627|NCT00994214|12238016|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
7786628|NCT00994214|12238017|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
7786629|NCT00994214|12238018|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
7786630|NCT00994214|12238019|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
7786631|NCT00994214|12238016|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
7786632|NCT00994214|12238017|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
7621306|NCT03703882|12031964|FG000|Overall Study|Adverse Event|1
7621307|NCT03703882|12031965|FG001|Overall Study|Adverse Event|0
7621308|NCT03703882|12031964|FG000|Overall Study|Lost to Follow-up|0
7621309|NCT03703882|12031965|FG001|Overall Study|Lost to Follow-up|2
7621310|NCT03703882|12031964|FG000|Overall Study|Non-compliance with study drug|0
7621311|NCT03703882|12031965|FG001|Overall Study|Non-compliance with study drug|1
7621312|NCT03703882|12031964|FG000|Overall Study|Physician Decision|0
7621313|NCT03703882|12031965|FG001|Overall Study|Physician Decision|1
7621314|NCT03703882|12031964|FG000|Overall Study|Progressive disease|1
7621315|NCT03703882|12031965|FG001|Overall Study|Progressive disease|0
7621316|NCT03703882|12031964|FG000|Overall Study|Withdrawal by parent/guardian|1
7621317|NCT03703882|12031965|FG001|Overall Study|Withdrawal by parent/guardian|0
7621318|NCT03703882|12031964|FG000|Overall Study|Starting another treatment|0
7621319|NCT03703882|12031965|FG001|Overall Study|Starting another treatment|1
7621320|NCT03703882|12031964|FG000|Overall Study|noncompliance with study procedures|0
7621321|NCT03703882|12031965|FG001|Overall Study|noncompliance with study procedures|1
7621322|NCT03615040|12031973|FG000|Overall Study|Withdrawal by Subject|2
7621323|NCT03615040|12031974|FG001|Overall Study|Withdrawal by Subject|1
7621324|NCT03615040|12031973|FG000|Overall Study|Physician Decision|2
7621325|NCT03615040|12031974|FG001|Overall Study|Physician Decision|2
7621326|NCT03615040|12031973|FG000|Overall Study|Clinical diagnosis of lung cancer|1
7621327|NCT03615040|12031974|FG001|Overall Study|Clinical diagnosis of lung cancer|0
7621328|NCT03615040|12031973|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1
7621329|NCT03615040|12031974|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0
7621330|NCT03615040|12031973|FG000|Overall Study|Death|0
7621331|NCT03615040|12031974|FG001|Overall Study|Death|2
7621332|NCT03611075|12031989|FG000|Overall Study|Physician Decision|0
7621333|NCT03611075|12031990|FG001|Overall Study|Physician Decision|1
7621334|NCT03611075|12031991|FG002|Overall Study|Physician Decision|1
7621335|NCT03611075|12031992|FG003|Overall Study|Physician Decision|0
7621336|NCT03611075|12031993|FG004|Overall Study|Physician Decision|0
7621337|NCT03611075|12031994|FG005|Overall Study|Physician Decision|0
7621338|NCT03611075|12031995|FG006|Overall Study|Physician Decision|0
7621339|NCT03611075|12031996|FG007|Overall Study|Physician Decision|0
7621340|NCT03611075|12031997|FG008|Overall Study|Physician Decision|0
7621341|NCT03611075|12031989|FG000|Overall Study|Lost to Follow-up|1
7621342|NCT03611075|12031990|FG001|Overall Study|Lost to Follow-up|0
7621343|NCT03611075|12031991|FG002|Overall Study|Lost to Follow-up|0
7621344|NCT03611075|12031992|FG003|Overall Study|Lost to Follow-up|2
7621345|NCT03611075|12031993|FG004|Overall Study|Lost to Follow-up|0
7621346|NCT03611075|12031994|FG005|Overall Study|Lost to Follow-up|0
7621347|NCT03611075|12031995|FG006|Overall Study|Lost to Follow-up|0
7621348|NCT03611075|12031996|FG007|Overall Study|Lost to Follow-up|0
7621349|NCT03611075|12031997|FG008|Overall Study|Lost to Follow-up|0
7621350|NCT03611075|12031989|FG000|Overall Study|Withdrawal by Subject|0
7621351|NCT03611075|12031990|FG001|Overall Study|Withdrawal by Subject|1
7621352|NCT03611075|12031991|FG002|Overall Study|Withdrawal by Subject|1
7621353|NCT03611075|12031992|FG003|Overall Study|Withdrawal by Subject|1
7621354|NCT03611075|12031993|FG004|Overall Study|Withdrawal by Subject|0
7621355|NCT03611075|12031994|FG005|Overall Study|Withdrawal by Subject|0
7621356|NCT03611075|12031995|FG006|Overall Study|Withdrawal by Subject|1
7621357|NCT03611075|12031996|FG007|Overall Study|Withdrawal by Subject|0
7621358|NCT03611075|12031997|FG008|Overall Study|Withdrawal by Subject|0
7786633|NCT00994214|12238018|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
7786634|NCT00994214|12238019|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
7786635|NCT00994240|12238049|FG000|Overall Study|Lost to Follow-up|3
7786636|NCT00994240|12238050|FG001|Overall Study|Lost to Follow-up|2
7786637|NCT00994240|12238049|FG000|Overall Study|Withdrawal by Subject|1
7786638|NCT00994240|12238050|FG001|Overall Study|Withdrawal by Subject|0
7786639|NCT00994240|12238049|FG000|Overall Study|study termination|2
7786640|NCT00994240|12238050|FG001|Overall Study|study termination|3
7786641|NCT00994279|12238058|FG000|Overall Study|Withdrawal by Subject|2
7786642|NCT00994279|12238059|FG001|Overall Study|Withdrawal by Subject|2
7786643|NCT00994279|12238058|FG000|Overall Study|Toxicity|1
7786644|NCT00994279|12238059|FG001|Overall Study|Toxicity|0
7786645|NCT00994279|12238058|FG000|Overall Study|Multiple reasons|1
7786646|NCT00994279|12238059|FG001|Overall Study|Multiple reasons|3
7786647|NCT00994422|12238080|FG000|Overall Study|Lost to Follow-up|7
7786648|NCT00994422|12238081|FG001|Overall Study|Lost to Follow-up|1
7786649|NCT00994448|12238091|FG000|Overall Study|Adverse Event|1
7786650|NCT00994448|12238092|FG001|Overall Study|Adverse Event|0
7786651|NCT00994448|12238091|FG000|Overall Study|Lost to Follow-up|5
7786652|NCT00994448|12238092|FG001|Overall Study|Lost to Follow-up|1
7786653|NCT00994448|12238091|FG000|Overall Study|Withdrawal by Subject|1
7786654|NCT00994448|12238092|FG001|Overall Study|Withdrawal by Subject|1
7786655|NCT00994448|12238091|FG000|Overall Study|Physician Decision|1
7786656|NCT00994448|12238092|FG001|Overall Study|Physician Decision|0
7786657|NCT00994461|12238101|FG000|Overall Study|Adverse Event|2
7786658|NCT00994461|12238102|FG001|Overall Study|Adverse Event|1
7786659|NCT00994461|12238103|FG002|Overall Study|Adverse Event|0
7786660|NCT00994643|12238118|FG000|Overall Study|Withdrawal by Subject|1
7786661|NCT00994682|12238124|FG000|Double Bilnd|Withdrawal by Subject|5
7786662|NCT00994682|12238125|FG001|Double Bilnd|Withdrawal by Subject|6
7786663|NCT00994682|12238124|FG000|Double Bilnd|Lost to Follow-up|3
7786664|NCT00994682|12238125|FG001|Double Bilnd|Lost to Follow-up|3
7786665|NCT00994682|12238124|FG000|Double Bilnd|Adverse Event|1
7786666|NCT00994682|12238125|FG001|Double Bilnd|Adverse Event|0
7786667|NCT00994682|12238124|FG000|Pioglitazone Open Label|Withdrawal by Subject|4
7786668|NCT00994682|12238125|FG001|Pioglitazone Open Label|Withdrawal by Subject|4
7786669|NCT00994682|12238124|FG000|Pioglitazone Open Label|Lost to Follow-up|3
7786670|NCT00994682|12238125|FG001|Pioglitazone Open Label|Lost to Follow-up|2
7786671|NCT00994682|12238124|FG000|Pioglitazone Open Label|Physician Decision|6
7786672|NCT00994682|12238125|FG001|Pioglitazone Open Label|Physician Decision|1
7786673|NCT00994890|12238156|FG000|Overall Study|Adverse Event|13
7786674|NCT00994890|12238157|FG001|Overall Study|Adverse Event|9
7786675|NCT00994890|12238158|FG002|Overall Study|Adverse Event|11
7786676|NCT00994890|12238156|FG000|Overall Study|Lack of Efficacy|0
7786677|NCT00994890|12238157|FG001|Overall Study|Lack of Efficacy|0
7786678|NCT00994890|12238158|FG002|Overall Study|Lack of Efficacy|1
7786679|NCT00994890|12238156|FG000|Overall Study|Lost to Follow-up|6
7786680|NCT00994890|12238157|FG001|Overall Study|Lost to Follow-up|1
7786681|NCT00994890|12238158|FG002|Overall Study|Lost to Follow-up|3
7786682|NCT00994890|12238156|FG000|Overall Study|No longer willing to participate|8
7786683|NCT00994890|12238157|FG001|Overall Study|No longer willing to participate|5
7786684|NCT00994890|12238158|FG002|Overall Study|No longer willing to participate|13
7786685|NCT00994890|12238156|FG000|Overall Study|Protocol Violation|2
7786686|NCT00994890|12238157|FG001|Overall Study|Protocol Violation|4
7786687|NCT00994890|12238158|FG002|Overall Study|Protocol Violation|0
7786688|NCT00994890|12238156|FG000|Overall Study|Study terminated by sponsor|199
7786689|NCT00994890|12238157|FG001|Overall Study|Study terminated by sponsor|201
7786690|NCT00994890|12238158|FG002|Overall Study|Study terminated by sponsor|197
7786691|NCT00994890|12238156|FG000|Overall Study|Randomized, but not treated|1
7621359|NCT03611075|12031989|FG000|Overall Study|Reason unknown|0
7621360|NCT03611075|12031990|FG001|Overall Study|Reason unknown|0
7621361|NCT03611075|12031991|FG002|Overall Study|Reason unknown|0
7621362|NCT03611075|12031992|FG003|Overall Study|Reason unknown|1
7621363|NCT03611075|12031993|FG004|Overall Study|Reason unknown|0
7786692|NCT00994890|12238157|FG001|Overall Study|Randomized, but not treated|0
7786693|NCT00994890|12238158|FG002|Overall Study|Randomized, but not treated|0
7786694|NCT00994890|12238156|FG000|Overall Study|Other|2
7786695|NCT00994890|12238157|FG001|Overall Study|Other|2
7786696|NCT00994890|12238158|FG002|Overall Study|Other|1
7786697|NCT00995007|12238173|FG000|Overall Study|Withdrew consent|1
7786698|NCT00995007|12238174|FG001|Overall Study|Withdrew consent|0
7786699|NCT00995007|12238173|FG000|Overall Study|Refused further treatment|8
7786700|NCT00995007|12238174|FG001|Overall Study|Refused further treatment|2
7621364|NCT03611075|12031994|FG005|Overall Study|Reason unknown|0
7621365|NCT03611075|12031995|FG006|Overall Study|Reason unknown|1
7621366|NCT03611075|12031996|FG007|Overall Study|Reason unknown|0
7621367|NCT03611075|12031997|FG008|Overall Study|Reason unknown|0
7621368|NCT03595176|12032042|FG000|Overall Study|Death|0
7621369|NCT03595176|12032043|FG001|Overall Study|Death|2
7621370|NCT03595176|12032042|FG000|Overall Study|Lost to Follow-up|0
7621371|NCT03595176|12032043|FG001|Overall Study|Lost to Follow-up|1
7786701|NCT00995007|12238173|FG000|Overall Study|Toxicity|8
7786702|NCT00995007|12238174|FG001|Overall Study|Toxicity|0
7786703|NCT00995020|12238191|FG000|Overall Study|margin analysis not performed|2
7786704|NCT00995020|12238192|FG001|Overall Study|margin analysis not performed|5
7786705|NCT00995020|12238191|FG000|Overall Study|specimen fragmentation, thermal damage|1
7786706|NCT00995020|12238192|FG001|Overall Study|specimen fragmentation, thermal damage|2
7786707|NCT00995085|12238209|FG000|Overall Study|Withdrawal by Subject|5
7786708|NCT00995345|12238223|FG000|Overall Study|Withdrawal by Subject|4
7786709|NCT00995345|12238224|FG001|Overall Study|Withdrawal by Subject|2
7786710|NCT00995345|12238225|FG002|Overall Study|Withdrawal by Subject|1
7786711|NCT00995345|12238226|FG003|Overall Study|Withdrawal by Subject|3
7786712|NCT00995345|12238227|FG004|Overall Study|Withdrawal by Subject|1
7786713|NCT00995345|12238223|FG000|Overall Study|Adverse Event|3
7786714|NCT00995345|12238224|FG001|Overall Study|Adverse Event|1
7786715|NCT00995345|12238225|FG002|Overall Study|Adverse Event|2
7786716|NCT00995345|12238226|FG003|Overall Study|Adverse Event|0
7786717|NCT00995345|12238227|FG004|Overall Study|Adverse Event|1
7786718|NCT00995345|12238223|FG000|Overall Study|Lost to Follow-up|2
7786719|NCT00995345|12238224|FG001|Overall Study|Lost to Follow-up|2
7786720|NCT00995345|12238225|FG002|Overall Study|Lost to Follow-up|2
7786721|NCT00995345|12238226|FG003|Overall Study|Lost to Follow-up|1
7786722|NCT00995345|12238227|FG004|Overall Study|Lost to Follow-up|0
7786723|NCT00995345|12238223|FG000|Overall Study|all other reasons combined|2
7786724|NCT00995345|12238224|FG001|Overall Study|all other reasons combined|2
7786725|NCT00995345|12238225|FG002|Overall Study|all other reasons combined|2
7786726|NCT00995345|12238226|FG003|Overall Study|all other reasons combined|1
7786727|NCT00995345|12238227|FG004|Overall Study|all other reasons combined|3
7786728|NCT00995371|12238241|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
7786729|NCT00995371|12238242|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
7786730|NCT00995410|12238250|FG000|Overall Study|Adverse Event|51
7786731|NCT00995410|12238250|FG000|Overall Study|Withdrawal by Subject|7
7786732|NCT00995410|12238250|FG000|Overall Study|Lost to Follow-up|2
7786733|NCT00995410|12238250|FG000|Overall Study|Misc|28
7786734|NCT00995436|12238257|FG000|Overall Study|Withdrawal by Subject|2
7786735|NCT00995436|12238258|FG001|Overall Study|Withdrawal by Subject|5
7786736|NCT00995436|12238259|FG002|Overall Study|Withdrawal by Subject|0
7786737|NCT00995488|12238289|FG000|Overall Study|Withdrawal by Subject|1
7786738|NCT00995553|12238328|FG000|Overall Study|Withdrawal by Subject|2
7786739|NCT00995553|12238329|FG001|Overall Study|Withdrawal by Subject|6
7786740|NCT00995566|12238335|FG000|Overall Study|Adverse Event|2
7786741|NCT00995566|12238335|FG000|Overall Study|Early study termination|52
7786742|NCT00995670|12238342|FG000|Overall Study|Failed arterial cannulation|1
7786743|NCT00995670|12238343|FG001|Overall Study|Failed arterial cannulation|0
7786744|NCT00995670|12238344|FG002|Overall Study|Failed arterial cannulation|3
7786745|NCT00995709|12238355|FG000|Overall Study|Adverse Event|4
7786746|NCT00995709|12238356|FG001|Overall Study|Adverse Event|2
7786747|NCT00995709|12238357|FG002|Overall Study|Adverse Event|0
7786748|NCT00995709|12238355|FG000|Overall Study|Lack of Efficacy|0
7786749|NCT00995709|12238356|FG001|Overall Study|Lack of Efficacy|1
7786750|NCT00995709|12238357|FG002|Overall Study|Lack of Efficacy|4
7786751|NCT00995709|12238355|FG000|Overall Study|Withdrawal by Subject|0
7786752|NCT00995709|12238356|FG001|Overall Study|Withdrawal by Subject|4
7786753|NCT00995709|12238357|FG002|Overall Study|Withdrawal by Subject|1
7786754|NCT00995709|12238355|FG000|Overall Study|Lost to Follow-up|1
7786755|NCT00995709|12238356|FG001|Overall Study|Lost to Follow-up|0
7786756|NCT00995709|12238357|FG002|Overall Study|Lost to Follow-up|0
7786757|NCT00995709|12238355|FG000|Overall Study|Death|0
7786758|NCT00995709|12238356|FG001|Overall Study|Death|1
7786759|NCT00995709|12238357|FG002|Overall Study|Death|0
7786760|NCT00995709|12238355|FG000|Overall Study|Protocol Violation|2
7786761|NCT00995709|12238356|FG001|Overall Study|Protocol Violation|1
7786762|NCT00995709|12238357|FG002|Overall Study|Protocol Violation|0
7786763|NCT00995774|12238380|FG000|Training Period 2|Withdrawal by Subject|2
7786764|NCT00995774|12238381|FG001|Training Period 2|Withdrawal by Subject|0
7786765|NCT00995865|12238390|FG000|Overall Study|Protocol Violation|2
7786766|NCT00995865|12238391|FG001|Overall Study|Protocol Violation|0
7786767|NCT00995865|12238392|FG002|Overall Study|Protocol Violation|0
7786768|NCT00995865|12238390|FG000|Overall Study|Lost to Follow-up|0
7786769|NCT00995865|12238391|FG001|Overall Study|Lost to Follow-up|0
7786770|NCT00995865|12238392|FG002|Overall Study|Lost to Follow-up|1
7786771|NCT00995930|12238423|FG000|Overall Study|Protocol deviation|2
7786772|NCT00995930|12238424|FG001|Overall Study|Protocol deviation|5
7621372|NCT03541317|12032051|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1
7621373|NCT03541317|12032052|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0
7621374|NCT03541317|12032053|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0
7621375|NCT03541317|12032054|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0
7621376|NCT03541317|12032055|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0
7621377|NCT03541317|12032056|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0
7621378|NCT03400943|12032081|FG000|Treatment Period 1|Adverse Event|0
7621379|NCT03400943|12032082|FG001|Treatment Period 1|Adverse Event|0
7621380|NCT03400943|12032083|FG002|Treatment Period 1|Adverse Event|0
7621381|NCT03400943|12032084|FG003|Treatment Period 1|Adverse Event|1
7621382|NCT03400943|12032081|FG000|Treatment Period 1|Lost to Follow-up|1
7621383|NCT03400943|12032082|FG001|Treatment Period 1|Lost to Follow-up|0
7621384|NCT03400943|12032083|FG002|Treatment Period 1|Lost to Follow-up|0
7621385|NCT03400943|12032084|FG003|Treatment Period 1|Lost to Follow-up|0
7621386|NCT03400943|12032081|FG000|Treatment Period 1|Protocol Violation|0
7621387|NCT03400943|12032082|FG001|Treatment Period 1|Protocol Violation|1
7621388|NCT03400943|12032083|FG002|Treatment Period 1|Protocol Violation|1
7621389|NCT03400943|12032084|FG003|Treatment Period 1|Protocol Violation|0
7621390|NCT03400943|12032081|FG000|Treatment Period 1|Study terminated by sponsor|2
7621391|NCT03400943|12032082|FG001|Treatment Period 1|Study terminated by sponsor|0
7621392|NCT03400943|12032083|FG002|Treatment Period 1|Study terminated by sponsor|0
7621393|NCT03400943|12032084|FG003|Treatment Period 1|Study terminated by sponsor|1
7621394|NCT03400943|12032081|FG000|Treatment Period 1|Withdrawal by Subject|0
7621395|NCT03400943|12032082|FG001|Treatment Period 1|Withdrawal by Subject|0
7621396|NCT03400943|12032083|FG002|Treatment Period 1|Withdrawal by Subject|3
7621397|NCT03400943|12032084|FG003|Treatment Period 1|Withdrawal by Subject|1
7621398|NCT03400943|12032081|FG000|Treatment Period 1|Other|2
7621399|NCT03400943|12032082|FG001|Treatment Period 1|Other|1
7621400|NCT03400943|12032083|FG002|Treatment Period 1|Other|2
7621401|NCT03400943|12032084|FG003|Treatment Period 1|Other|2
7621402|NCT03400943|12032081|FG000|Post-treatment Period 1|Adverse Event|2
7621403|NCT03400943|12032082|FG001|Post-treatment Period 1|Adverse Event|0
7621404|NCT03400943|12032083|FG002|Post-treatment Period 1|Adverse Event|0
7621405|NCT03400943|12032084|FG003|Post-treatment Period 1|Adverse Event|0
7621406|NCT03400943|12032081|FG000|Post-treatment Period 1|Protocol Violation|1
7621407|NCT03400943|12032082|FG001|Post-treatment Period 1|Protocol Violation|0
7621408|NCT03400943|12032083|FG002|Post-treatment Period 1|Protocol Violation|0
7621409|NCT03400943|12032084|FG003|Post-treatment Period 1|Protocol Violation|0
7621410|NCT03400943|12032081|FG000|Post-treatment Period 1|Study terminated by sponsor|5
7621411|NCT03400943|12032082|FG001|Post-treatment Period 1|Study terminated by sponsor|0
7621412|NCT03400943|12032083|FG002|Post-treatment Period 1|Study terminated by sponsor|5
7621413|NCT03400943|12032084|FG003|Post-treatment Period 1|Study terminated by sponsor|6
7621414|NCT03400943|12032081|FG000|Post-treatment Period 1|Withdrawal by Subject|1
7621415|NCT03400943|12032082|FG001|Post-treatment Period 1|Withdrawal by Subject|0
7621416|NCT03400943|12032083|FG002|Post-treatment Period 1|Withdrawal by Subject|2
7621417|NCT03400943|12032084|FG003|Post-treatment Period 1|Withdrawal by Subject|2
7621418|NCT03400943|12032081|FG000|Post-treatment Period 1|Other|2
7786773|NCT00995930|12238423|FG000|Overall Study|Death|0
7786774|NCT00995930|12238424|FG001|Overall Study|Death|1
7786775|NCT00995930|12238423|FG000|Overall Study|Administrative problems|4
7786776|NCT00995930|12238424|FG001|Overall Study|Administrative problems|2
7786777|NCT00995930|12238423|FG000|Overall Study|Lost to Follow-up|1
7786778|NCT00995930|12238424|FG001|Overall Study|Lost to Follow-up|2
7786779|NCT00995930|12238423|FG000|Overall Study|Withdrawal by Subject|3
7786780|NCT00995930|12238424|FG001|Overall Study|Withdrawal by Subject|4
7786781|NCT00995930|12238423|FG000|Overall Study|Adverse Event|11
7786782|NCT00995930|12238424|FG001|Overall Study|Adverse Event|14
7786783|NCT00996034|12238431|FG000|Overall Study|Lost to Follow-up|2
7786784|NCT00996034|12238431|FG000|Overall Study|withdrawn by PI|1
7786785|NCT00996125|12238437|FG000|Overall Study|Adverse Event|0
7786786|NCT00996125|12238438|FG001|Overall Study|Adverse Event|2
7786787|NCT00996125|12238437|FG000|Overall Study|Lost to Follow-up|1
7786788|NCT00996125|12238438|FG001|Overall Study|Lost to Follow-up|6
7786789|NCT00996125|12238437|FG000|Overall Study|Withdrawal by Subject|4
7786790|NCT00996125|12238438|FG001|Overall Study|Withdrawal by Subject|3
7786791|NCT00996203|12238453|FG000|Overall Study|Adverse Event|3
7786792|NCT00996203|12238453|FG000|Overall Study|Lost to Follow-up|1
7786793|NCT00996203|12238453|FG000|Overall Study|Lack of Efficacy|1
7786794|NCT00996203|12238453|FG000|Overall Study|Protocol Violation|2
7786795|NCT00996216|12238458|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
7786796|NCT00996216|12238458|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
7786797|NCT00996216|12238458|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
7786798|NCT00996281|12238465|FG000|Overall Study|Adverse Event|75
7621419|NCT03400943|12032082|FG001|Post-treatment Period 1|Other|0
7621420|NCT03400943|12032083|FG002|Post-treatment Period 1|Other|4
7621421|NCT03400943|12032084|FG003|Post-treatment Period 1|Other|5
7621422|NCT03400943|12032081|FG000|Treatment Period 2|Study terminated by sponsor|0
7621423|NCT03400943|12032082|FG001|Treatment Period 2|Study terminated by sponsor|1
7621424|NCT03400943|12032083|FG002|Treatment Period 2|Study terminated by sponsor|0
7621425|NCT03400943|12032084|FG003|Treatment Period 2|Study terminated by sponsor|0
7621426|NCT03400943|12032081|FG000|Treatment Period 2|Withdrawal by Subject|0
7621427|NCT03400943|12032082|FG001|Treatment Period 2|Withdrawal by Subject|1
7621428|NCT03400943|12032083|FG002|Treatment Period 2|Withdrawal by Subject|0
7621429|NCT03400943|12032084|FG003|Treatment Period 2|Withdrawal by Subject|0
7621430|NCT03400943|12032081|FG000|Treatment Period 2|Other|1
7621431|NCT03400943|12032082|FG001|Treatment Period 2|Other|6
7621432|NCT03400943|12032083|FG002|Treatment Period 2|Other|0
7621433|NCT03400943|12032084|FG003|Treatment Period 2|Other|0
7621434|NCT03400943|12032081|FG000|Follow-up Period|Withdrawal by Subject|1
7621435|NCT03400943|12032082|FG001|Follow-up Period|Withdrawal by Subject|0
7621436|NCT03400943|12032083|FG002|Follow-up Period|Withdrawal by Subject|0
7621437|NCT03400943|12032084|FG003|Follow-up Period|Withdrawal by Subject|0
7621438|NCT03302234|12032102|FG000|Overall Study|Death|137
7621439|NCT03302234|12032103|FG001|Overall Study|Death|135
7621440|NCT03302234|12032102|FG000|Overall Study|Withdrawal by Subject|1
7621441|NCT03302234|12032103|FG001|Overall Study|Withdrawal by Subject|1
7621442|NCT03302234|12032102|FG000|Overall Study|Laryngeal carcinoma|0
7621443|NCT03302234|12032103|FG001|Overall Study|Laryngeal carcinoma|1
7621444|NCT03208244|12032123|FG000|Overall Study|Death|1
7621445|NCT03050060|12032150|FG000|Overall Study|Adverse Event|7
7621446|NCT03050060|12032150|FG000|Overall Study|Withdrawal by Subject|1
7621447|NCT03050060|12032150|FG000|Overall Study|Progression|7
7621448|NCT02847637|12032167|FG000|Overall Study|Withdrew from treatment due to AE|0
7621449|NCT02847637|12032168|FG001|Overall Study|Withdrew from treatment due to AE|0
7621450|NCT02847637|12032169|FG002|Overall Study|Withdrew from treatment due to AE|1
7621451|NCT02847637|12032170|FG003|Overall Study|Withdrew from treatment due to AE|0
7621452|NCT02847637|12032167|FG000|Overall Study|Ongoing treatment with emicizumab|16
7621453|NCT02847637|12032168|FG001|Overall Study|Ongoing treatment with emicizumab|35
7621454|NCT02847637|12032169|FG002|Overall Study|Ongoing treatment with emicizumab|34
7621455|NCT02847637|12032170|FG003|Overall Study|Ongoing treatment with emicizumab|63
7621456|NCT02847637|12032167|FG000|Overall Study|First emicizumab dose delayed|1
7621457|NCT02847637|12032168|FG001|Overall Study|First emicizumab dose delayed|0
7621458|NCT02847637|12032169|FG002|Overall Study|First emicizumab dose delayed|0
7621459|NCT02847637|12032170|FG003|Overall Study|First emicizumab dose delayed|0
7621460|NCT02770391|12032194|FG000|Overall Study|Lost to Follow-up|2
7621461|NCT02770391|12032194|FG000|Overall Study|Withdrawal by Subject|1
7621462|NCT02770391|12032194|FG000|Overall Study|Surgery delayed unevaluable|2
7621463|NCT02770391|12032194|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1
7786799|NCT00996281|12238466|FG001|Overall Study|Adverse Event|37
7786800|NCT00996281|12238465|FG000|Overall Study|Major Protocol Deviation|6
7786801|NCT00996281|12238466|FG001|Overall Study|Major Protocol Deviation|7
7786802|NCT00996281|12238465|FG000|Overall Study|Lost to Follow-up|14
7621464|NCT02648724|12032222|FG000|Overall Study|Withdrawal by Subject|0
7621465|NCT02648724|12032223|FG001|Overall Study|Withdrawal by Subject|1
7621466|NCT02648724|12032224|FG002|Overall Study|Withdrawal by Subject|1
7621467|NCT02648724|12032225|FG003|Overall Study|Withdrawal by Subject|0
7786803|NCT00996281|12238466|FG001|Overall Study|Lost to Follow-up|16
7786804|NCT00996281|12238465|FG000|Overall Study|Withdrawal by Subject|31
7786805|NCT00996281|12238466|FG001|Overall Study|Withdrawal by Subject|20
7621468|NCT02648724|12032226|FG004|Overall Study|Withdrawal by Subject|1
7621469|NCT02648724|12032227|FG005|Overall Study|Withdrawal by Subject|0
7621470|NCT02648724|12032228|FG006|Overall Study|Withdrawal by Subject|0
7621471|NCT02648724|12032222|FG000|Overall Study|Progressive disease|2
7621472|NCT02648724|12032223|FG001|Overall Study|Progressive disease|2
7621473|NCT02648724|12032224|FG002|Overall Study|Progressive disease|2
7621474|NCT02648724|12032225|FG003|Overall Study|Progressive disease|3
7621475|NCT02648724|12032226|FG004|Overall Study|Progressive disease|22
7621476|NCT02648724|12032227|FG005|Overall Study|Progressive disease|7
7621477|NCT02648724|12032228|FG006|Overall Study|Progressive disease|8
7621478|NCT02648724|12032222|FG000|Overall Study|Other reason (unknown)|1
7621479|NCT02648724|12032223|FG001|Overall Study|Other reason (unknown)|0
7621480|NCT02648724|12032224|FG002|Overall Study|Other reason (unknown)|0
7621481|NCT02648724|12032225|FG003|Overall Study|Other reason (unknown)|0
7786806|NCT00996281|12238465|FG000|Overall Study|Lack of Efficacy|0
7786807|NCT00996281|12238466|FG001|Overall Study|Lack of Efficacy|2
7786808|NCT00996281|12238465|FG000|Overall Study|Other|5
7786809|NCT00996281|12238466|FG001|Overall Study|Other|7
7786810|NCT00996307|12238476|FG000|Overall Study|Adverse Event|0
7786811|NCT00996307|12238477|FG001|Overall Study|Adverse Event|1
7786812|NCT00996307|12238478|FG002|Overall Study|Adverse Event|0
7786813|NCT00996307|12238479|FG003|Overall Study|Adverse Event|0
7786814|NCT00996307|12238476|FG000|Overall Study|Withdrawal by Subject|3
7786815|NCT00996307|12238477|FG001|Overall Study|Withdrawal by Subject|2
7786816|NCT00996307|12238478|FG002|Overall Study|Withdrawal by Subject|5
7786817|NCT00996307|12238479|FG003|Overall Study|Withdrawal by Subject|5
7786818|NCT00996307|12238476|FG000|Overall Study|Lost to Follow-up|13
7786819|NCT00996307|12238477|FG001|Overall Study|Lost to Follow-up|13
7786820|NCT00996307|12238478|FG002|Overall Study|Lost to Follow-up|7
7786821|NCT00996307|12238479|FG003|Overall Study|Lost to Follow-up|15
7786822|NCT00996307|12238476|FG000|Overall Study|Administrative reason|0
7786823|NCT00996307|12238477|FG001|Overall Study|Administrative reason|1
7786824|NCT00996307|12238478|FG002|Overall Study|Administrative reason|0
7786825|NCT00996307|12238479|FG003|Overall Study|Administrative reason|0
7786826|NCT00996307|12238476|FG000|Overall Study|Unable to classify|4
7786827|NCT00996307|12238477|FG001|Overall Study|Unable to classify|0
7786828|NCT00996307|12238478|FG002|Overall Study|Unable to classify|2
7786829|NCT00996307|12238479|FG003|Overall Study|Unable to classify|1
7786830|NCT00996437|12238531|FG000|Overall Study|Death|1
7786831|NCT00996437|12238532|FG001|Overall Study|Death|0
7786832|NCT00996437|12238531|FG000|Overall Study|Dropped|2
7786833|NCT00996437|12238532|FG001|Overall Study|Dropped|2
7786834|NCT00996437|12238531|FG000|Overall Study|Missed|2
7786835|NCT00996437|12238532|FG001|Overall Study|Missed|5
7786836|NCT00996476|12238543|FG000|Overall Study|Withdrawal by Subject|1
7786837|NCT00996476|12238544|FG001|Overall Study|Withdrawal by Subject|2
7786838|NCT00996476|12238545|FG002|Overall Study|Withdrawal by Subject|1
7786839|NCT00996476|12238546|FG003|Overall Study|Withdrawal by Subject|0
7786840|NCT00996476|12238547|FG004|Overall Study|Withdrawal by Subject|1
7786841|NCT00996476|12238543|FG000|Overall Study|Adverse Event|0
7786842|NCT00996476|12238544|FG001|Overall Study|Adverse Event|1
7786843|NCT00996476|12238545|FG002|Overall Study|Adverse Event|0
7786844|NCT00996476|12238546|FG003|Overall Study|Adverse Event|0
7786845|NCT00996476|12238547|FG004|Overall Study|Adverse Event|1
7786846|NCT00996489|12238564|FG000|Overall Study|Device failure|45
7786847|NCT00996489|12238564|FG000|Overall Study|Discontinued|116
7786848|NCT00996580|12238568|FG000|Overall Study|Adverse Event|466
7621482|NCT02648724|12032226|FG004|Overall Study|Other reason (unknown)|0
7621483|NCT02648724|12032227|FG005|Overall Study|Other reason (unknown)|0
7621484|NCT02648724|12032228|FG006|Overall Study|Other reason (unknown)|0
7621485|NCT02648724|12032222|FG000|Overall Study|Protocol Violation|0
7621486|NCT02648724|12032223|FG001|Overall Study|Protocol Violation|0
7621487|NCT02648724|12032224|FG002|Overall Study|Protocol Violation|0
7621488|NCT02648724|12032225|FG003|Overall Study|Protocol Violation|0
7621489|NCT02648724|12032226|FG004|Overall Study|Protocol Violation|1
7621490|NCT02648724|12032227|FG005|Overall Study|Protocol Violation|0
7621491|NCT02648724|12032228|FG006|Overall Study|Protocol Violation|0
7621492|NCT02648724|12032222|FG000|Overall Study|Death|0
7621493|NCT02648724|12032223|FG001|Overall Study|Death|0
7621494|NCT02648724|12032224|FG002|Overall Study|Death|0
7621495|NCT02648724|12032225|FG003|Overall Study|Death|0
7621496|NCT02648724|12032226|FG004|Overall Study|Death|0
7621497|NCT02648724|12032227|FG005|Overall Study|Death|0
7621498|NCT02648724|12032228|FG006|Overall Study|Death|3
7621499|NCT02648724|12032222|FG000|Overall Study|Physician Decision|0
7621500|NCT02648724|12032223|FG001|Overall Study|Physician Decision|0
7621501|NCT02648724|12032224|FG002|Overall Study|Physician Decision|0
7621502|NCT02648724|12032225|FG003|Overall Study|Physician Decision|0
7621503|NCT02648724|12032226|FG004|Overall Study|Physician Decision|1
7621504|NCT02648724|12032227|FG005|Overall Study|Physician Decision|0
7621505|NCT02648724|12032228|FG006|Overall Study|Physician Decision|1
7621506|NCT02648724|12032222|FG000|Overall Study|Transferred to named patient program|0
7621507|NCT02648724|12032223|FG001|Overall Study|Transferred to named patient program|0
7621508|NCT02648724|12032224|FG002|Overall Study|Transferred to named patient program|0
7621509|NCT02648724|12032225|FG003|Overall Study|Transferred to named patient program|0
7786849|NCT00996580|12238568|FG000|Overall Study|Lost to Follow-up|480
7621510|NCT02648724|12032226|FG004|Overall Study|Transferred to named patient program|0
7621511|NCT02648724|12032227|FG005|Overall Study|Transferred to named patient program|1
7621512|NCT02648724|12032228|FG006|Overall Study|Transferred to named patient program|0
7786850|NCT00996580|12238568|FG000|Overall Study|Noncompliance with the protocol|137
7786851|NCT00996580|12238568|FG000|Overall Study|Physician Decision|5
7786852|NCT00996580|12238568|FG000|Overall Study|Pregnancy|68
7786853|NCT00996580|12238568|FG000|Overall Study|Protocol Violation|16
7786854|NCT00996580|12238568|FG000|Overall Study|Sponsor requested participant withdrawal|35
7786855|NCT00996580|12238568|FG000|Overall Study|Withdrawal by Subject|217
7786856|NCT00996580|12238568|FG000|Overall Study|Other|29
7786857|NCT00996593|12238575|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
7786858|NCT00996593|12238575|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
7786859|NCT00996593|12238575|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22
7786860|NCT00996593|12238575|FG000|Dosimetric and Therapeutic Treatment|Death|1
7786861|NCT00996593|12238575|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
7621525|NCT02554474|12032271|FG000|Overall Study|Protocol Violation|1
7621526|NCT02554474|12032272|FG001|Overall Study|Protocol Violation|1
7786862|NCT00996593|12238575|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
7786863|NCT00996593|12238575|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1
7786864|NCT00996593|12238575|FG000|Long-Term Follow-Up|Withdrawal by Subject|2
7786865|NCT00996593|12238575|FG000|Long-Term Follow-Up|Site Closed|1
7786866|NCT00996606|12238579|FG000|Overall Study|Adverse Event or Intercurrent Illness|2
7786867|NCT00996606|12238579|FG000|Overall Study|Insufficient Therapeutic Response|2
7786868|NCT00996606|12238579|FG000|Overall Study|Protocol Violation|1
7786869|NCT00996606|12238579|FG000|Overall Study|Withdrawal by Subject|3
7786870|NCT00996632|12238585|FG000|Overall Study|Physician Decision|0
7786871|NCT00996632|12238586|FG001|Overall Study|Physician Decision|0
7786872|NCT00996658|12238594|FG000|Overall Study|Adverse Event|2
7786873|NCT00996658|12238595|FG001|Overall Study|Adverse Event|5
7786874|NCT00996658|12238594|FG000|Overall Study|Protocol Violation|0
7786875|NCT00996658|12238595|FG001|Overall Study|Protocol Violation|1
7786876|NCT00996658|12238594|FG000|Overall Study|Lost to Follow-up|2
7786877|NCT00996658|12238595|FG001|Overall Study|Lost to Follow-up|5
7786878|NCT00996658|12238594|FG000|Overall Study|Non-compliance issues|3
7786879|NCT00996658|12238595|FG001|Overall Study|Non-compliance issues|3
7786880|NCT00996658|12238594|FG000|Overall Study|Other|9
7786881|NCT00996658|12238595|FG001|Overall Study|Other|7
7786882|NCT00996736|12238603|FG000|Overall Study|Death|1
7786883|NCT00996736|12238604|FG001|Overall Study|Death|1
7786884|NCT00996736|12238603|FG000|Overall Study|Lost to Follow-up|15
7786885|NCT00996736|12238604|FG001|Overall Study|Lost to Follow-up|14
7621527|NCT02554474|12032271|FG000|Overall Study|Health issue not related to the study|1
7621528|NCT02554474|12032272|FG001|Overall Study|Health issue not related to the study|0
7621529|NCT02554474|12032271|FG000|Overall Study|Withdrawal by Subject|1
7621530|NCT02554474|12032272|FG001|Overall Study|Withdrawal by Subject|1
7621531|NCT02554318|12032280|FG000|Overall Study|Withdrawal by Subject|10
7621532|NCT02554318|12032281|FG001|Overall Study|Withdrawal by Subject|8
7621533|NCT02508532|12032294|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7621534|NCT02508532|12032295|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7621535|NCT02508532|12032296|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7621536|NCT02508532|12032297|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7621537|NCT02508532|12032298|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7786886|NCT00996736|12238603|FG000|Overall Study|Visit not within 3-month window|5
7621538|NCT02508532|12032299|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7786887|NCT00996736|12238604|FG001|Overall Study|Visit not within 3-month window|3
7621539|NCT02508532|12032300|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1
7786888|NCT00996801|12238625|FG000|Overall Study|Adverse Event|6
7786889|NCT00996801|12238626|FG001|Overall Study|Adverse Event|4
7786890|NCT00996801|12238627|FG002|Overall Study|Adverse Event|12
7786891|NCT00996801|12238628|FG003|Overall Study|Adverse Event|17
7786892|NCT00996801|12238629|FG004|Overall Study|Adverse Event|31
7786893|NCT00996801|12238630|FG005|Overall Study|Adverse Event|3
7786894|NCT00996801|12238625|FG000|Overall Study|Lack of Efficacy|3
7786895|NCT00996801|12238626|FG001|Overall Study|Lack of Efficacy|0
7786896|NCT00996801|12238627|FG002|Overall Study|Lack of Efficacy|1
7786897|NCT00996801|12238628|FG003|Overall Study|Lack of Efficacy|3
7786898|NCT00996801|12238629|FG004|Overall Study|Lack of Efficacy|0
7786899|NCT00996801|12238630|FG005|Overall Study|Lack of Efficacy|1
7786900|NCT00996801|12238625|FG000|Overall Study|Lost to Follow-up|0
7786901|NCT00996801|12238626|FG001|Overall Study|Lost to Follow-up|0
7786902|NCT00996801|12238627|FG002|Overall Study|Lost to Follow-up|0
7786903|NCT00996801|12238628|FG003|Overall Study|Lost to Follow-up|3
7786904|NCT00996801|12238629|FG004|Overall Study|Lost to Follow-up|3
7786905|NCT00996801|12238630|FG005|Overall Study|Lost to Follow-up|2
7786906|NCT00996801|12238625|FG000|Overall Study|Physician Decision|0
7786907|NCT00996801|12238626|FG001|Overall Study|Physician Decision|0
7786908|NCT00996801|12238627|FG002|Overall Study|Physician Decision|0
7786909|NCT00996801|12238628|FG003|Overall Study|Physician Decision|1
7786910|NCT00996801|12238629|FG004|Overall Study|Physician Decision|0
7786911|NCT00996801|12238630|FG005|Overall Study|Physician Decision|0
7786912|NCT00996801|12238625|FG000|Overall Study|Progressive Disease|0
7786913|NCT00996801|12238626|FG001|Overall Study|Progressive Disease|1
7786914|NCT00996801|12238627|FG002|Overall Study|Progressive Disease|0
7786915|NCT00996801|12238628|FG003|Overall Study|Progressive Disease|0
7786916|NCT00996801|12238629|FG004|Overall Study|Progressive Disease|0
7786917|NCT00996801|12238630|FG005|Overall Study|Progressive Disease|0
7786918|NCT00996801|12238625|FG000|Overall Study|Protocol Violation|3
7786919|NCT00996801|12238626|FG001|Overall Study|Protocol Violation|4
7786920|NCT00996801|12238627|FG002|Overall Study|Protocol Violation|1
7786921|NCT00996801|12238628|FG003|Overall Study|Protocol Violation|2
7786922|NCT00996801|12238629|FG004|Overall Study|Protocol Violation|3
7786923|NCT00996801|12238630|FG005|Overall Study|Protocol Violation|4
7786924|NCT00996801|12238625|FG000|Overall Study|Study Terminated by Sponsor|0
7786925|NCT00996801|12238626|FG001|Overall Study|Study Terminated by Sponsor|1
7786926|NCT00996801|12238627|FG002|Overall Study|Study Terminated by Sponsor|0
7786927|NCT00996801|12238628|FG003|Overall Study|Study Terminated by Sponsor|0
7786928|NCT00996801|12238629|FG004|Overall Study|Study Terminated by Sponsor|46
7786929|NCT00996801|12238630|FG005|Overall Study|Study Terminated by Sponsor|0
7786930|NCT00996801|12238625|FG000|Overall Study|Withdrawal by Subject|8
7786931|NCT00996801|12238626|FG001|Overall Study|Withdrawal by Subject|6
7786932|NCT00996801|12238627|FG002|Overall Study|Withdrawal by Subject|9
7786933|NCT00996801|12238628|FG003|Overall Study|Withdrawal by Subject|5
7786934|NCT00996801|12238629|FG004|Overall Study|Withdrawal by Subject|5
7786935|NCT00996801|12238630|FG005|Overall Study|Withdrawal by Subject|9
7786936|NCT00996840|12238651|FG000|Overall Study|Adverse Event|0
7786937|NCT00996840|12238652|FG001|Overall Study|Adverse Event|1
7786938|NCT00996840|12238653|FG002|Overall Study|Adverse Event|0
7786939|NCT00996840|12238654|FG003|Overall Study|Adverse Event|0
7786940|NCT00996840|12238655|FG004|Overall Study|Adverse Event|0
7786941|NCT00996840|12238651|FG000|Overall Study|Physician Decision|0
7786942|NCT00996840|12238652|FG001|Overall Study|Physician Decision|0
7786943|NCT00996840|12238653|FG002|Overall Study|Physician Decision|1
7786944|NCT00996840|12238654|FG003|Overall Study|Physician Decision|1
7786945|NCT00996840|12238655|FG004|Overall Study|Physician Decision|2
7786946|NCT00996840|12238651|FG000|Overall Study|Withdrawal by Subject|1
7786947|NCT00996840|12238652|FG001|Overall Study|Withdrawal by Subject|1
7786948|NCT00996840|12238653|FG002|Overall Study|Withdrawal by Subject|0
7786949|NCT00996840|12238654|FG003|Overall Study|Withdrawal by Subject|0
7786950|NCT00996840|12238655|FG004|Overall Study|Withdrawal by Subject|0
7786951|NCT00996892|12238671|FG000|Dose-Escalation Stage 1|Adverse Event|0
7786952|NCT00996892|12238672|FG001|Dose-Escalation Stage 1|Adverse Event|0
7786953|NCT00996892|12238673|FG002|Dose-Escalation Stage 1|Adverse Event|0
7786954|NCT00996892|12238674|FG003|Dose-Escalation Stage 1|Adverse Event|2
7786955|NCT00996892|12238675|FG004|Dose-Escalation Stage 1|Adverse Event|0
7786956|NCT00996892|12238676|FG005|Dose-Escalation Stage 1|Adverse Event|0
7786957|NCT00996892|12238677|FG006|Dose-Escalation Stage 1|Adverse Event|1
7786958|NCT00996892|12238678|FG007|Dose-Escalation Stage 1|Adverse Event|0
7786959|NCT00996892|12238679|FG008|Dose-Escalation Stage 1|Adverse Event|0
7786960|NCT00996892|12238680|FG009|Dose-Escalation Stage 1|Adverse Event|0
7786961|NCT00996892|12238681|FG010|Dose-Escalation Stage 1|Adverse Event|0
7621540|NCT02508532|12032301|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7786962|NCT00996892|12238682|FG011|Dose-Escalation Stage 1|Adverse Event|0
7786963|NCT00996892|12238683|FG012|Dose-Escalation Stage 1|Adverse Event|0
7786964|NCT00996892|12238684|FG013|Dose-Escalation Stage 1|Adverse Event|0
7786965|NCT00996892|12238685|FG014|Dose-Escalation Stage 1|Adverse Event|0
7786966|NCT00996892|12238686|FG015|Dose-Escalation Stage 1|Adverse Event|0
7786967|NCT00996892|12238687|FG016|Dose-Escalation Stage 1|Adverse Event|0
7786968|NCT00996892|12238688|FG017|Dose-Escalation Stage 1|Adverse Event|0
7621541|NCT02508532|12032302|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7621542|NCT02508532|12032294|FG000|Part 1 - Dose Determining Period|Not Evaluable|0
7621543|NCT02508532|12032295|FG001|Part 1 - Dose Determining Period|Not Evaluable|0
7621544|NCT02508532|12032296|FG002|Part 1 - Dose Determining Period|Not Evaluable|0
7621545|NCT02508532|12032297|FG003|Part 1 - Dose Determining Period|Not Evaluable|0
7621546|NCT02508532|12032298|FG004|Part 1 - Dose Determining Period|Not Evaluable|0
7621547|NCT02508532|12032299|FG005|Part 1 - Dose Determining Period|Not Evaluable|0
7621548|NCT02508532|12032300|FG006|Part 1 - Dose Determining Period|Not Evaluable|0
7621549|NCT02508532|12032301|FG007|Part 1 - Dose Determining Period|Not Evaluable|1
7621550|NCT02508532|12032302|FG008|Part 1 - Dose Determining Period|Not Evaluable|0
7621551|NCT02508532|12032294|FG000|Part 2 - Treatment|Disease Progression|0
7621552|NCT02508532|12032295|FG001|Part 2 - Treatment|Disease Progression|0
7621553|NCT02508532|12032296|FG002|Part 2 - Treatment|Disease Progression|0
7621554|NCT02508532|12032297|FG003|Part 2 - Treatment|Disease Progression|0
7621555|NCT02508532|12032298|FG004|Part 2 - Treatment|Disease Progression|0
7621556|NCT02508532|12032299|FG005|Part 2 - Treatment|Disease Progression|0
7621557|NCT02508532|12032300|FG006|Part 2 - Treatment|Disease Progression|0
7621558|NCT02508532|12032301|FG007|Part 2 - Treatment|Disease Progression|0
7621559|NCT02508532|12032302|FG008|Part 2 - Treatment|Disease Progression|118
7621560|NCT02508532|12032294|FG000|Part 2 - Treatment|Adverse Event|0
7621561|NCT02508532|12032295|FG001|Part 2 - Treatment|Adverse Event|0
7621562|NCT02508532|12032296|FG002|Part 2 - Treatment|Adverse Event|0
7621563|NCT02508532|12032297|FG003|Part 2 - Treatment|Adverse Event|0
7621564|NCT02508532|12032298|FG004|Part 2 - Treatment|Adverse Event|0
7621565|NCT02508532|12032299|FG005|Part 2 - Treatment|Adverse Event|0
7621566|NCT02508532|12032300|FG006|Part 2 - Treatment|Adverse Event|0
7621567|NCT02508532|12032301|FG007|Part 2 - Treatment|Adverse Event|0
7621568|NCT02508532|12032302|FG008|Part 2 - Treatment|Adverse Event|49
7621569|NCT02508532|12032294|FG000|Part 2 - Treatment|Physician Decision|0
7621570|NCT02508532|12032295|FG001|Part 2 - Treatment|Physician Decision|0
7621571|NCT02508532|12032296|FG002|Part 2 - Treatment|Physician Decision|0
7621572|NCT02508532|12032297|FG003|Part 2 - Treatment|Physician Decision|0
7621573|NCT02508532|12032298|FG004|Part 2 - Treatment|Physician Decision|0
7621574|NCT02508532|12032299|FG005|Part 2 - Treatment|Physician Decision|0
7621575|NCT02508532|12032300|FG006|Part 2 - Treatment|Physician Decision|0
7621576|NCT02508532|12032301|FG007|Part 2 - Treatment|Physician Decision|0
7621577|NCT02508532|12032302|FG008|Part 2 - Treatment|Physician Decision|12
7621578|NCT02508532|12032294|FG000|Part 2 - Treatment|Administrative|0
7621579|NCT02508532|12032295|FG001|Part 2 - Treatment|Administrative|0
7621580|NCT02508532|12032296|FG002|Part 2 - Treatment|Administrative|0
7786969|NCT00996892|12238689|FG018|Dose-Escalation Stage 1|Adverse Event|0
7786970|NCT00996892|12238690|FG019|Dose-Escalation Stage 1|Adverse Event|0
7786971|NCT00996892|12238671|FG000|Dose-Escalation Stage 1|Death|1
7786972|NCT00996892|12238672|FG001|Dose-Escalation Stage 1|Death|0
7786973|NCT00996892|12238673|FG002|Dose-Escalation Stage 1|Death|0
7786974|NCT00996892|12238674|FG003|Dose-Escalation Stage 1|Death|0
7786975|NCT00996892|12238675|FG004|Dose-Escalation Stage 1|Death|0
7786976|NCT00996892|12238676|FG005|Dose-Escalation Stage 1|Death|1
7786977|NCT00996892|12238677|FG006|Dose-Escalation Stage 1|Death|0
7786978|NCT00996892|12238678|FG007|Dose-Escalation Stage 1|Death|0
7786979|NCT00996892|12238679|FG008|Dose-Escalation Stage 1|Death|0
7786980|NCT00996892|12238680|FG009|Dose-Escalation Stage 1|Death|0
7786981|NCT00996892|12238681|FG010|Dose-Escalation Stage 1|Death|0
7786982|NCT00996892|12238682|FG011|Dose-Escalation Stage 1|Death|0
7786983|NCT00996892|12238683|FG012|Dose-Escalation Stage 1|Death|0
7786984|NCT00996892|12238684|FG013|Dose-Escalation Stage 1|Death|0
7786985|NCT00996892|12238685|FG014|Dose-Escalation Stage 1|Death|0
7786986|NCT00996892|12238686|FG015|Dose-Escalation Stage 1|Death|0
7786987|NCT00996892|12238687|FG016|Dose-Escalation Stage 1|Death|0
7786988|NCT00996892|12238688|FG017|Dose-Escalation Stage 1|Death|0
7786989|NCT00996892|12238689|FG018|Dose-Escalation Stage 1|Death|0
7786990|NCT00996892|12238690|FG019|Dose-Escalation Stage 1|Death|0
7786991|NCT00996892|12238671|FG000|Dose-Escalation Stage 1|Physician Decision|1
7786992|NCT00996892|12238672|FG001|Dose-Escalation Stage 1|Physician Decision|0
7786993|NCT00996892|12238673|FG002|Dose-Escalation Stage 1|Physician Decision|0
7786994|NCT00996892|12238674|FG003|Dose-Escalation Stage 1|Physician Decision|1
7786995|NCT00996892|12238675|FG004|Dose-Escalation Stage 1|Physician Decision|0
7786996|NCT00996892|12238676|FG005|Dose-Escalation Stage 1|Physician Decision|1
7786997|NCT00996892|12238677|FG006|Dose-Escalation Stage 1|Physician Decision|2
7786998|NCT00996892|12238678|FG007|Dose-Escalation Stage 1|Physician Decision|0
7786999|NCT00996892|12238679|FG008|Dose-Escalation Stage 1|Physician Decision|0
7787000|NCT00996892|12238680|FG009|Dose-Escalation Stage 1|Physician Decision|0
7787001|NCT00996892|12238681|FG010|Dose-Escalation Stage 1|Physician Decision|0
7787002|NCT00996892|12238682|FG011|Dose-Escalation Stage 1|Physician Decision|0
7621581|NCT02508532|12032297|FG003|Part 2 - Treatment|Administrative|0
7621582|NCT02508532|12032298|FG004|Part 2 - Treatment|Administrative|0
7787003|NCT00996892|12238683|FG012|Dose-Escalation Stage 1|Physician Decision|0
7621583|NCT02508532|12032299|FG005|Part 2 - Treatment|Administrative|0
7621584|NCT02508532|12032300|FG006|Part 2 - Treatment|Administrative|0
7621585|NCT02508532|12032301|FG007|Part 2 - Treatment|Administrative|0
7621586|NCT02508532|12032302|FG008|Part 2 - Treatment|Administrative|3
7621587|NCT02508532|12032294|FG000|Part 2 - Treatment|Sponsor Decision|0
7621588|NCT02508532|12032295|FG001|Part 2 - Treatment|Sponsor Decision|0
7621589|NCT02508532|12032296|FG002|Part 2 - Treatment|Sponsor Decision|0
7621590|NCT02508532|12032297|FG003|Part 2 - Treatment|Sponsor Decision|0
7621591|NCT02508532|12032298|FG004|Part 2 - Treatment|Sponsor Decision|0
7621592|NCT02508532|12032299|FG005|Part 2 - Treatment|Sponsor Decision|0
7621593|NCT02508532|12032300|FG006|Part 2 - Treatment|Sponsor Decision|0
7621594|NCT02508532|12032301|FG007|Part 2 - Treatment|Sponsor Decision|0
7621595|NCT02508532|12032302|FG008|Part 2 - Treatment|Sponsor Decision|28
7621596|NCT02508532|12032294|FG000|Part 2 - Treatment|Death|0
7621597|NCT02508532|12032295|FG001|Part 2 - Treatment|Death|0
7621598|NCT02508532|12032296|FG002|Part 2 - Treatment|Death|0
7621599|NCT02508532|12032297|FG003|Part 2 - Treatment|Death|0
7621600|NCT02508532|12032298|FG004|Part 2 - Treatment|Death|0
7621601|NCT02508532|12032299|FG005|Part 2 - Treatment|Death|0
7621602|NCT02508532|12032300|FG006|Part 2 - Treatment|Death|0
7621603|NCT02508532|12032301|FG007|Part 2 - Treatment|Death|0
7621604|NCT02508532|12032302|FG008|Part 2 - Treatment|Death|1
7621605|NCT02508532|12032294|FG000|Part 2 - Treatment|Withdrawal by Subject|0
7621606|NCT02508532|12032295|FG001|Part 2 - Treatment|Withdrawal by Subject|0
7621607|NCT02508532|12032296|FG002|Part 2 - Treatment|Withdrawal by Subject|0
7621608|NCT02508532|12032297|FG003|Part 2 - Treatment|Withdrawal by Subject|0
7621609|NCT02508532|12032298|FG004|Part 2 - Treatment|Withdrawal by Subject|0
7621610|NCT02508532|12032299|FG005|Part 2 - Treatment|Withdrawal by Subject|0
7621611|NCT02508532|12032300|FG006|Part 2 - Treatment|Withdrawal by Subject|0
7621612|NCT02508532|12032301|FG007|Part 2 - Treatment|Withdrawal by Subject|0
7621613|NCT02508532|12032302|FG008|Part 2 - Treatment|Withdrawal by Subject|6
7621614|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Disease Progression|2
7621615|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Disease Progression|0
7621616|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Disease Progression|0
7621617|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Disease Progression|0
7621618|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Disease Progression|0
7621619|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Disease Progression|0
7621620|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Disease Progression|0
7621621|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Disease Progression|1
7621622|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Disease Progression|6
7621623|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Adverse Event|1
7621624|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Adverse Event|0
7621625|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Adverse Event|1
7621626|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Adverse Event|0
7621627|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Adverse Event|0
7621628|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Adverse Event|0
7621629|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Adverse Event|0
7621630|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Adverse Event|0
7621631|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Adverse Event|2
7621632|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Death|0
7621633|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Death|4
7621634|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Death|2
7621635|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Death|4
7621636|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Death|3
7621637|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Death|0
7621638|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Death|0
7621639|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Death|1
7621640|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Death|111
7621641|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1
7621642|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1
7621643|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1
7621644|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0
7621645|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0
7621646|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0
7621647|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0
7621648|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0
7621649|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6
7621650|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621651|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621652|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621653|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621654|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621655|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621656|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621657|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621658|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15
7621659|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Physician Decision|0
7621660|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Physician Decision|0
7621661|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Physician Decision|1
7621662|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Physician Decision|0
7621663|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Physician Decision|1
7621664|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Physician Decision|0
7621665|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Physician Decision|0
7621666|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Physician Decision|0
7621667|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Physician Decision|8
7621668|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621669|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621670|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621671|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621672|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621673|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621674|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621675|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621676|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1
7621677|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2
7621678|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1
7621679|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1
7621680|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2
7621681|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2
7621682|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0
7621683|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0
7621684|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1
7621685|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68
7787004|NCT00996892|12238684|FG013|Dose-Escalation Stage 1|Physician Decision|0
7787005|NCT00996892|12238685|FG014|Dose-Escalation Stage 1|Physician Decision|0
7787006|NCT00996892|12238686|FG015|Dose-Escalation Stage 1|Physician Decision|0
7787007|NCT00996892|12238687|FG016|Dose-Escalation Stage 1|Physician Decision|0
7787008|NCT00996892|12238688|FG017|Dose-Escalation Stage 1|Physician Decision|0
7787009|NCT00996892|12238689|FG018|Dose-Escalation Stage 1|Physician Decision|0
7621692|NCT02426684|12032339|FG000|Overall Study|Physician Decision|1
7787010|NCT00996892|12238690|FG019|Dose-Escalation Stage 1|Physician Decision|0
7787011|NCT00996892|12238671|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0
7787012|NCT00996892|12238672|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1
7787013|NCT00996892|12238673|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0
7787014|NCT00996892|12238674|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2
7787015|NCT00996892|12238675|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1
7787016|NCT00996892|12238676|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1
7787017|NCT00996892|12238677|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1
7787018|NCT00996892|12238678|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0
7787019|NCT00996892|12238679|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0
7787020|NCT00996892|12238680|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0
7787021|NCT00996892|12238681|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0
7787022|NCT00996892|12238682|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0
7787023|NCT00996892|12238683|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0
7787024|NCT00996892|12238684|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0
7787025|NCT00996892|12238685|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0
7787026|NCT00996892|12238686|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0
7787027|NCT00996892|12238687|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0
7787028|NCT00996892|12238688|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0
7787029|NCT00996892|12238689|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0
7787030|NCT00996892|12238690|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0
7787031|NCT00996892|12238671|FG000|Dose-Escalation Stage 1|Disease Progression|2
7787032|NCT00996892|12238672|FG001|Dose-Escalation Stage 1|Disease Progression|2
7787033|NCT00996892|12238673|FG002|Dose-Escalation Stage 1|Disease Progression|3
7787034|NCT00996892|12238674|FG003|Dose-Escalation Stage 1|Disease Progression|4
7787035|NCT00996892|12238675|FG004|Dose-Escalation Stage 1|Disease Progression|10
7787036|NCT00996892|12238676|FG005|Dose-Escalation Stage 1|Disease Progression|7
7787037|NCT00996892|12238677|FG006|Dose-Escalation Stage 1|Disease Progression|0
7787038|NCT00996892|12238678|FG007|Dose-Escalation Stage 1|Disease Progression|0
7787039|NCT00996892|12238679|FG008|Dose-Escalation Stage 1|Disease Progression|0
7787040|NCT00996892|12238680|FG009|Dose-Escalation Stage 1|Disease Progression|0
7787041|NCT00996892|12238681|FG010|Dose-Escalation Stage 1|Disease Progression|0
7787042|NCT00996892|12238682|FG011|Dose-Escalation Stage 1|Disease Progression|0
7621705|NCT02337751|12032358|FG000|Overall Study|Pretreatment Event/Adverse Event|2
7621706|NCT02337751|12032359|FG001|Overall Study|Pretreatment Event/Adverse Event|3
7621707|NCT02337751|12032358|FG000|Overall Study|Voluntary Withdrawal|6
7621708|NCT02337751|12032359|FG001|Overall Study|Voluntary Withdrawal|8
7621709|NCT02337751|12032358|FG000|Overall Study|Lack of Efficacy|2
7621710|NCT02337751|12032359|FG001|Overall Study|Lack of Efficacy|5
7621711|NCT02337751|12032358|FG000|Overall Study|Investigator's Judgement|1
7621712|NCT02337751|12032359|FG001|Overall Study|Investigator's Judgement|0
7621713|NCT02337725|12032368|FG000|Overall Study|Pretreatment Event/AE before Treatment|0
7621714|NCT02337725|12032369|FG001|Overall Study|Pretreatment Event/AE before Treatment|1
7621715|NCT02337725|12032368|FG000|Overall Study|Pretreatment Event/AE in Treatment|8
7621716|NCT02337725|12032369|FG001|Overall Study|Pretreatment Event/AE in Treatment|3
7621717|NCT02337725|12032368|FG000|Overall Study|Major Protocol Deviation|0
7621718|NCT02337725|12032369|FG001|Overall Study|Major Protocol Deviation|1
7621719|NCT02337725|12032368|FG000|Overall Study|Voluntary Withdrawal|14
7621720|NCT02337725|12032369|FG001|Overall Study|Voluntary Withdrawal|3
7621721|NCT02337725|12032368|FG000|Overall Study|Lack of Efficacy|4
7621722|NCT02337725|12032369|FG001|Overall Study|Lack of Efficacy|0
7621723|NCT02332655|12032375|FG000|Overall Study|Lack of Efficacy|1
7621724|NCT02317705|12032379|FG000|Overall Study|Withdrawal by Subject|3
7621725|NCT02317705|12032379|FG000|Overall Study|Physician Decision|1
7621726|NCT02317705|12032379|FG000|Overall Study|Drug not usable|1
7787043|NCT00996892|12238683|FG012|Dose-Escalation Stage 1|Disease Progression|0
7787044|NCT00996892|12238684|FG013|Dose-Escalation Stage 1|Disease Progression|0
7787045|NCT00996892|12238685|FG014|Dose-Escalation Stage 1|Disease Progression|0
7787046|NCT00996892|12238686|FG015|Dose-Escalation Stage 1|Disease Progression|0
7787047|NCT00996892|12238687|FG016|Dose-Escalation Stage 1|Disease Progression|0
7787048|NCT00996892|12238688|FG017|Dose-Escalation Stage 1|Disease Progression|0
7787049|NCT00996892|12238689|FG018|Dose-Escalation Stage 1|Disease Progression|0
7787050|NCT00996892|12238690|FG019|Dose-Escalation Stage 1|Disease Progression|0
7787051|NCT00996892|12238671|FG000|Dose-Escalation Stage 1A|Adverse Event|0
7787052|NCT00996892|12238672|FG001|Dose-Escalation Stage 1A|Adverse Event|0
7787053|NCT00996892|12238673|FG002|Dose-Escalation Stage 1A|Adverse Event|0
7787054|NCT00996892|12238674|FG003|Dose-Escalation Stage 1A|Adverse Event|0
7787055|NCT00996892|12238675|FG004|Dose-Escalation Stage 1A|Adverse Event|0
7787056|NCT00996892|12238676|FG005|Dose-Escalation Stage 1A|Adverse Event|0
7787057|NCT00996892|12238677|FG006|Dose-Escalation Stage 1A|Adverse Event|0
7787058|NCT00996892|12238678|FG007|Dose-Escalation Stage 1A|Adverse Event|0
7787059|NCT00996892|12238679|FG008|Dose-Escalation Stage 1A|Adverse Event|0
7787060|NCT00996892|12238680|FG009|Dose-Escalation Stage 1A|Adverse Event|0
7787061|NCT00996892|12238681|FG010|Dose-Escalation Stage 1A|Adverse Event|1
7621727|NCT02272803|12032385|FG000|Overall Study|Disease progression|16
7621728|NCT02272803|12032386|FG001|Overall Study|Disease progression|8
7621729|NCT02272803|12032385|FG000|Overall Study|Adverse Event unrelated to study drug|3
7621730|NCT02272803|12032386|FG001|Overall Study|Adverse Event unrelated to study drug|5
7621731|NCT02272803|12032385|FG000|Overall Study|Study drug toxicity|4
7787062|NCT00996892|12238682|FG011|Dose-Escalation Stage 1A|Adverse Event|0
7787063|NCT00996892|12238683|FG012|Dose-Escalation Stage 1A|Adverse Event|0
7787064|NCT00996892|12238684|FG013|Dose-Escalation Stage 1A|Adverse Event|1
7787065|NCT00996892|12238685|FG014|Dose-Escalation Stage 1A|Adverse Event|0
7787066|NCT00996892|12238686|FG015|Dose-Escalation Stage 1A|Adverse Event|0
7787067|NCT00996892|12238687|FG016|Dose-Escalation Stage 1A|Adverse Event|0
7787068|NCT00996892|12238688|FG017|Dose-Escalation Stage 1A|Adverse Event|0
7787069|NCT00996892|12238689|FG018|Dose-Escalation Stage 1A|Adverse Event|0
7787070|NCT00996892|12238690|FG019|Dose-Escalation Stage 1A|Adverse Event|0
7787071|NCT00996892|12238671|FG000|Dose-Escalation Stage 1A|Death|0
7787072|NCT00996892|12238672|FG001|Dose-Escalation Stage 1A|Death|0
7787073|NCT00996892|12238673|FG002|Dose-Escalation Stage 1A|Death|0
7787074|NCT00996892|12238674|FG003|Dose-Escalation Stage 1A|Death|0
7787075|NCT00996892|12238675|FG004|Dose-Escalation Stage 1A|Death|0
7787076|NCT00996892|12238676|FG005|Dose-Escalation Stage 1A|Death|0
7787077|NCT00996892|12238677|FG006|Dose-Escalation Stage 1A|Death|0
7787078|NCT00996892|12238678|FG007|Dose-Escalation Stage 1A|Death|0
7787079|NCT00996892|12238679|FG008|Dose-Escalation Stage 1A|Death|0
7787080|NCT00996892|12238680|FG009|Dose-Escalation Stage 1A|Death|2
7787081|NCT00996892|12238681|FG010|Dose-Escalation Stage 1A|Death|0
7787082|NCT00996892|12238682|FG011|Dose-Escalation Stage 1A|Death|1
7787083|NCT00996892|12238683|FG012|Dose-Escalation Stage 1A|Death|1
7787084|NCT00996892|12238684|FG013|Dose-Escalation Stage 1A|Death|0
7787085|NCT00996892|12238685|FG014|Dose-Escalation Stage 1A|Death|0
7787086|NCT00996892|12238686|FG015|Dose-Escalation Stage 1A|Death|0
7787087|NCT00996892|12238687|FG016|Dose-Escalation Stage 1A|Death|0
7787088|NCT00996892|12238688|FG017|Dose-Escalation Stage 1A|Death|0
7787089|NCT00996892|12238689|FG018|Dose-Escalation Stage 1A|Death|0
7787090|NCT00996892|12238690|FG019|Dose-Escalation Stage 1A|Death|0
7787091|NCT00996892|12238671|FG000|Dose-Escalation Stage 1A|Physician Decision|0
7787092|NCT00996892|12238672|FG001|Dose-Escalation Stage 1A|Physician Decision|0
7787093|NCT00996892|12238673|FG002|Dose-Escalation Stage 1A|Physician Decision|0
7787094|NCT00996892|12238674|FG003|Dose-Escalation Stage 1A|Physician Decision|0
7787095|NCT00996892|12238675|FG004|Dose-Escalation Stage 1A|Physician Decision|0
7787096|NCT00996892|12238676|FG005|Dose-Escalation Stage 1A|Physician Decision|0
7787097|NCT00996892|12238677|FG006|Dose-Escalation Stage 1A|Physician Decision|0
7787098|NCT00996892|12238678|FG007|Dose-Escalation Stage 1A|Physician Decision|1
7787099|NCT00996892|12238679|FG008|Dose-Escalation Stage 1A|Physician Decision|0
7787100|NCT00996892|12238680|FG009|Dose-Escalation Stage 1A|Physician Decision|0
7787101|NCT00996892|12238681|FG010|Dose-Escalation Stage 1A|Physician Decision|0
7787102|NCT00996892|12238682|FG011|Dose-Escalation Stage 1A|Physician Decision|0
7787103|NCT00996892|12238683|FG012|Dose-Escalation Stage 1A|Physician Decision|0
7787104|NCT00996892|12238684|FG013|Dose-Escalation Stage 1A|Physician Decision|0
7787105|NCT00996892|12238685|FG014|Dose-Escalation Stage 1A|Physician Decision|0
7787106|NCT00996892|12238686|FG015|Dose-Escalation Stage 1A|Physician Decision|0
7787107|NCT00996892|12238687|FG016|Dose-Escalation Stage 1A|Physician Decision|0
7787108|NCT00996892|12238688|FG017|Dose-Escalation Stage 1A|Physician Decision|0
7787109|NCT00996892|12238689|FG018|Dose-Escalation Stage 1A|Physician Decision|0
7787110|NCT00996892|12238690|FG019|Dose-Escalation Stage 1A|Physician Decision|0
7787111|NCT00996892|12238671|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7787112|NCT00996892|12238672|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7787113|NCT00996892|12238673|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7787114|NCT00996892|12238674|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7787115|NCT00996892|12238675|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7787116|NCT00996892|12238676|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7787117|NCT00996892|12238677|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7787118|NCT00996892|12238678|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7787119|NCT00996892|12238679|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7621732|NCT02272803|12032386|FG001|Overall Study|Study drug toxicity|9
7621733|NCT02272803|12032385|FG000|Overall Study|Participant request to discontinue study treatment|3
7621734|NCT02272803|12032386|FG001|Overall Study|Participant request to discontinue study treatment|7
7621735|NCT02272803|12032385|FG000|Overall Study|Maximum clinical benefit|4
7621736|NCT02272803|12032386|FG001|Overall Study|Maximum clinical benefit|2
7621737|NCT02272803|12032385|FG000|Overall Study|Poor/non-compliance|2
7621738|NCT02272803|12032386|FG001|Overall Study|Poor/non-compliance|2
7621739|NCT02272803|12032385|FG000|Overall Study|Withdrawal by Subject|2
7621740|NCT02272803|12032386|FG001|Overall Study|Withdrawal by Subject|1
7621741|NCT02272803|12032385|FG000|Overall Study|Death|0
7621742|NCT02272803|12032386|FG001|Overall Study|Death|1
7621743|NCT02272803|12032385|FG000|Overall Study|Other reasons|1
7621744|NCT02272803|12032386|FG001|Overall Study|Other reasons|3
7621745|NCT02272803|12032385|FG000|Overall Study|Administrative reason by sponsor|5
7621746|NCT02272803|12032386|FG001|Overall Study|Administrative reason by sponsor|4
7787120|NCT00996892|12238680|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1
7787121|NCT00996892|12238681|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1
7787122|NCT00996892|12238682|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1
7787123|NCT00996892|12238683|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1
7787124|NCT00996892|12238684|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7787125|NCT00996892|12238685|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7787126|NCT00996892|12238686|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7787127|NCT00996892|12238687|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7787128|NCT00996892|12238688|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7787129|NCT00996892|12238689|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7787130|NCT00996892|12238690|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7787131|NCT00996892|12238671|FG000|Dose-Escalation Stage 1A|Disease Progression|0
7787132|NCT00996892|12238672|FG001|Dose-Escalation Stage 1A|Disease Progression|0
7787133|NCT00996892|12238673|FG002|Dose-Escalation Stage 1A|Disease Progression|0
7787134|NCT00996892|12238674|FG003|Dose-Escalation Stage 1A|Disease Progression|0
7787135|NCT00996892|12238675|FG004|Dose-Escalation Stage 1A|Disease Progression|0
7621754|NCT01994382|12032470|FG000|Overall Study|Informed consent withdrawn|0
7621755|NCT01994382|12032471|FG001|Overall Study|Informed consent withdrawn|0
7621756|NCT01994382|12032472|FG002|Overall Study|Informed consent withdrawn|0
7621757|NCT01994382|12032473|FG003|Overall Study|Informed consent withdrawn|0
7621758|NCT01994382|12032474|FG004|Overall Study|Informed consent withdrawn|0
7621759|NCT01994382|12032475|FG005|Overall Study|Informed consent withdrawn|0
7621760|NCT01994382|12032476|FG006|Overall Study|Informed consent withdrawn|1
7621761|NCT01994382|12032477|FG007|Overall Study|Informed consent withdrawn|0
7621762|NCT01994382|12032478|FG008|Overall Study|Informed consent withdrawn|0
7621763|NCT01994382|12032479|FG009|Overall Study|Informed consent withdrawn|0
7621764|NCT01994382|12032480|FG010|Overall Study|Informed consent withdrawn|0
7787136|NCT00996892|12238676|FG005|Dose-Escalation Stage 1A|Disease Progression|0
7787137|NCT00996892|12238677|FG006|Dose-Escalation Stage 1A|Disease Progression|0
7787138|NCT00996892|12238678|FG007|Dose-Escalation Stage 1A|Disease Progression|2
7787139|NCT00996892|12238679|FG008|Dose-Escalation Stage 1A|Disease Progression|3
7787140|NCT00996892|12238680|FG009|Dose-Escalation Stage 1A|Disease Progression|1
7787141|NCT00996892|12238681|FG010|Dose-Escalation Stage 1A|Disease Progression|5
7787142|NCT00996892|12238682|FG011|Dose-Escalation Stage 1A|Disease Progression|7
7621765|NCT01994382|12032481|FG011|Overall Study|Informed consent withdrawn|0
7621766|NCT01994382|12032482|FG012|Overall Study|Informed consent withdrawn|0
7621767|NCT01994382|12032483|FG013|Overall Study|Informed consent withdrawn|0
7621768|NCT01994382|12032484|FG014|Overall Study|Informed consent withdrawn|0
7621769|NCT01994382|12032485|FG015|Overall Study|Informed consent withdrawn|0
7621770|NCT01994382|12032486|FG016|Overall Study|Informed consent withdrawn|0
7621771|NCT01994382|12032470|FG000|Overall Study|Progressive disease|3
7621772|NCT01994382|12032471|FG001|Overall Study|Progressive disease|4
7621773|NCT01994382|12032472|FG002|Overall Study|Progressive disease|4
7621774|NCT01994382|12032473|FG003|Overall Study|Progressive disease|3
7621775|NCT01994382|12032474|FG004|Overall Study|Progressive disease|2
7787143|NCT00996892|12238683|FG012|Dose-Escalation Stage 1A|Disease Progression|6
7787144|NCT00996892|12238684|FG013|Dose-Escalation Stage 1A|Disease Progression|4
7787145|NCT00996892|12238685|FG014|Dose-Escalation Stage 1A|Disease Progression|0
7787146|NCT00996892|12238686|FG015|Dose-Escalation Stage 1A|Disease Progression|0
7787147|NCT00996892|12238687|FG016|Dose-Escalation Stage 1A|Disease Progression|0
7787148|NCT00996892|12238688|FG017|Dose-Escalation Stage 1A|Disease Progression|0
7787149|NCT00996892|12238689|FG018|Dose-Escalation Stage 1A|Disease Progression|0
7787150|NCT00996892|12238690|FG019|Dose-Escalation Stage 1A|Disease Progression|0
7787151|NCT00996892|12238671|FG000|Dose-Escalation Stage 1B|Physician Decision|0
7787152|NCT00996892|12238672|FG001|Dose-Escalation Stage 1B|Physician Decision|0
7787153|NCT00996892|12238673|FG002|Dose-Escalation Stage 1B|Physician Decision|0
7787154|NCT00996892|12238674|FG003|Dose-Escalation Stage 1B|Physician Decision|0
7787155|NCT00996892|12238675|FG004|Dose-Escalation Stage 1B|Physician Decision|0
7787156|NCT00996892|12238676|FG005|Dose-Escalation Stage 1B|Physician Decision|0
7787157|NCT00996892|12238677|FG006|Dose-Escalation Stage 1B|Physician Decision|0
7787158|NCT00996892|12238678|FG007|Dose-Escalation Stage 1B|Physician Decision|0
7787159|NCT00996892|12238679|FG008|Dose-Escalation Stage 1B|Physician Decision|0
7787160|NCT00996892|12238680|FG009|Dose-Escalation Stage 1B|Physician Decision|0
7787161|NCT00996892|12238681|FG010|Dose-Escalation Stage 1B|Physician Decision|0
7787162|NCT00996892|12238682|FG011|Dose-Escalation Stage 1B|Physician Decision|0
7787163|NCT00996892|12238683|FG012|Dose-Escalation Stage 1B|Physician Decision|0
7787164|NCT00996892|12238684|FG013|Dose-Escalation Stage 1B|Physician Decision|0
7787165|NCT00996892|12238685|FG014|Dose-Escalation Stage 1B|Physician Decision|0
7787166|NCT00996892|12238686|FG015|Dose-Escalation Stage 1B|Physician Decision|0
7787167|NCT00996892|12238687|FG016|Dose-Escalation Stage 1B|Physician Decision|0
7787168|NCT00996892|12238688|FG017|Dose-Escalation Stage 1B|Physician Decision|2
7787169|NCT00996892|12238689|FG018|Dose-Escalation Stage 1B|Physician Decision|0
7787170|NCT00996892|12238690|FG019|Dose-Escalation Stage 1B|Physician Decision|0
7787171|NCT00996892|12238671|FG000|Dose-Escalation Stage 1B|Disease Progression|0
7787172|NCT00996892|12238672|FG001|Dose-Escalation Stage 1B|Disease Progression|0
7787173|NCT00996892|12238673|FG002|Dose-Escalation Stage 1B|Disease Progression|0
7787174|NCT00996892|12238674|FG003|Dose-Escalation Stage 1B|Disease Progression|0
7787175|NCT00996892|12238675|FG004|Dose-Escalation Stage 1B|Disease Progression|0
7787176|NCT00996892|12238676|FG005|Dose-Escalation Stage 1B|Disease Progression|0
7787177|NCT00996892|12238677|FG006|Dose-Escalation Stage 1B|Disease Progression|0
7787178|NCT00996892|12238678|FG007|Dose-Escalation Stage 1B|Disease Progression|0
7787179|NCT00996892|12238679|FG008|Dose-Escalation Stage 1B|Disease Progression|0
7787180|NCT00996892|12238680|FG009|Dose-Escalation Stage 1B|Disease Progression|0
7787181|NCT00996892|12238681|FG010|Dose-Escalation Stage 1B|Disease Progression|0
7787182|NCT00996892|12238682|FG011|Dose-Escalation Stage 1B|Disease Progression|0
7787183|NCT00996892|12238683|FG012|Dose-Escalation Stage 1B|Disease Progression|0
7787184|NCT00996892|12238684|FG013|Dose-Escalation Stage 1B|Disease Progression|0
7787185|NCT00996892|12238685|FG014|Dose-Escalation Stage 1B|Disease Progression|4
7787186|NCT00996892|12238686|FG015|Dose-Escalation Stage 1B|Disease Progression|3
7787187|NCT00996892|12238687|FG016|Dose-Escalation Stage 1B|Disease Progression|3
7621776|NCT01994382|12032475|FG005|Overall Study|Progressive disease|3
7621777|NCT01994382|12032476|FG006|Overall Study|Progressive disease|3
7621778|NCT01994382|12032477|FG007|Overall Study|Progressive disease|6
7621779|NCT01994382|12032478|FG008|Overall Study|Progressive disease|2
7621780|NCT01994382|12032479|FG009|Overall Study|Progressive disease|2
7621781|NCT01994382|12032480|FG010|Overall Study|Progressive disease|13
7621782|NCT01994382|12032481|FG011|Overall Study|Progressive disease|8
7621783|NCT01994382|12032482|FG012|Overall Study|Progressive disease|7
7621784|NCT01994382|12032483|FG013|Overall Study|Progressive disease|3
7621785|NCT01994382|12032484|FG014|Overall Study|Progressive disease|6
7621786|NCT01994382|12032485|FG015|Overall Study|Progressive disease|44
7787188|NCT00996892|12238688|FG017|Dose-Escalation Stage 1B|Disease Progression|3
7621787|NCT01994382|12032486|FG016|Overall Study|Progressive disease|28
7621788|NCT01994382|12032470|FG000|Overall Study|Physician Decision|0
7621789|NCT01994382|12032471|FG001|Overall Study|Physician Decision|1
7621790|NCT01994382|12032472|FG002|Overall Study|Physician Decision|0
7621791|NCT01994382|12032473|FG003|Overall Study|Physician Decision|0
7621792|NCT01994382|12032474|FG004|Overall Study|Physician Decision|0
7621793|NCT01994382|12032475|FG005|Overall Study|Physician Decision|0
7621794|NCT01994382|12032476|FG006|Overall Study|Physician Decision|0
7621795|NCT01994382|12032477|FG007|Overall Study|Physician Decision|0
7621796|NCT01994382|12032478|FG008|Overall Study|Physician Decision|0
7621797|NCT01994382|12032479|FG009|Overall Study|Physician Decision|0
7621798|NCT01994382|12032480|FG010|Overall Study|Physician Decision|3
7621799|NCT01994382|12032481|FG011|Overall Study|Physician Decision|1
7787189|NCT00996892|12238689|FG018|Dose-Escalation Stage 1B|Disease Progression|0
7787190|NCT00996892|12238690|FG019|Dose-Escalation Stage 1B|Disease Progression|0
7787191|NCT00996892|12238671|FG000|Expansion Stage 2|Adverse Event|0
7787192|NCT00996892|12238672|FG001|Expansion Stage 2|Adverse Event|0
7787193|NCT00996892|12238673|FG002|Expansion Stage 2|Adverse Event|0
7787194|NCT00996892|12238674|FG003|Expansion Stage 2|Adverse Event|0
7787195|NCT00996892|12238675|FG004|Expansion Stage 2|Adverse Event|0
7787196|NCT00996892|12238676|FG005|Expansion Stage 2|Adverse Event|0
7787197|NCT00996892|12238677|FG006|Expansion Stage 2|Adverse Event|0
7621800|NCT01994382|12032482|FG012|Overall Study|Physician Decision|1
7621801|NCT01994382|12032483|FG013|Overall Study|Physician Decision|0
7621802|NCT01994382|12032484|FG014|Overall Study|Physician Decision|1
7621803|NCT01994382|12032485|FG015|Overall Study|Physician Decision|4
7621804|NCT01994382|12032486|FG016|Overall Study|Physician Decision|2
7621805|NCT01994382|12032470|FG000|Overall Study|Death|0
7621806|NCT01994382|12032471|FG001|Overall Study|Death|0
7621807|NCT01994382|12032472|FG002|Overall Study|Death|0
7787198|NCT00996892|12238678|FG007|Expansion Stage 2|Adverse Event|0
7787199|NCT00996892|12238679|FG008|Expansion Stage 2|Adverse Event|0
7787200|NCT00996892|12238680|FG009|Expansion Stage 2|Adverse Event|0
7787201|NCT00996892|12238681|FG010|Expansion Stage 2|Adverse Event|0
7787202|NCT00996892|12238682|FG011|Expansion Stage 2|Adverse Event|0
7787203|NCT00996892|12238683|FG012|Expansion Stage 2|Adverse Event|0
7787204|NCT00996892|12238684|FG013|Expansion Stage 2|Adverse Event|0
7787205|NCT00996892|12238685|FG014|Expansion Stage 2|Adverse Event|0
7787206|NCT00996892|12238686|FG015|Expansion Stage 2|Adverse Event|0
7787207|NCT00996892|12238687|FG016|Expansion Stage 2|Adverse Event|0
7787208|NCT00996892|12238688|FG017|Expansion Stage 2|Adverse Event|0
7787209|NCT00996892|12238689|FG018|Expansion Stage 2|Adverse Event|3
7787210|NCT00996892|12238690|FG019|Expansion Stage 2|Adverse Event|0
7787211|NCT00996892|12238671|FG000|Expansion Stage 2|Death|0
7787212|NCT00996892|12238672|FG001|Expansion Stage 2|Death|0
7787213|NCT00996892|12238673|FG002|Expansion Stage 2|Death|0
7787214|NCT00996892|12238674|FG003|Expansion Stage 2|Death|0
7787215|NCT00996892|12238675|FG004|Expansion Stage 2|Death|0
7787216|NCT00996892|12238676|FG005|Expansion Stage 2|Death|0
7787217|NCT00996892|12238677|FG006|Expansion Stage 2|Death|0
7787218|NCT00996892|12238678|FG007|Expansion Stage 2|Death|0
7787219|NCT00996892|12238679|FG008|Expansion Stage 2|Death|0
7787220|NCT00996892|12238680|FG009|Expansion Stage 2|Death|0
7787221|NCT00996892|12238681|FG010|Expansion Stage 2|Death|0
7787222|NCT00996892|12238682|FG011|Expansion Stage 2|Death|0
7787223|NCT00996892|12238683|FG012|Expansion Stage 2|Death|0
7787224|NCT00996892|12238684|FG013|Expansion Stage 2|Death|0
7787225|NCT00996892|12238685|FG014|Expansion Stage 2|Death|0
7787226|NCT00996892|12238686|FG015|Expansion Stage 2|Death|0
7787227|NCT00996892|12238687|FG016|Expansion Stage 2|Death|0
7787228|NCT00996892|12238688|FG017|Expansion Stage 2|Death|0
7787229|NCT00996892|12238689|FG018|Expansion Stage 2|Death|2
7787230|NCT00996892|12238690|FG019|Expansion Stage 2|Death|0
7787231|NCT00996892|12238671|FG000|Expansion Stage 2|Physician Decision|0
7787232|NCT00996892|12238672|FG001|Expansion Stage 2|Physician Decision|0
7787233|NCT00996892|12238673|FG002|Expansion Stage 2|Physician Decision|0
7787234|NCT00996892|12238674|FG003|Expansion Stage 2|Physician Decision|0
7787235|NCT00996892|12238675|FG004|Expansion Stage 2|Physician Decision|0
7621808|NCT01994382|12032473|FG003|Overall Study|Death|0
7621809|NCT01994382|12032474|FG004|Overall Study|Death|1
7621810|NCT01994382|12032475|FG005|Overall Study|Death|0
7621811|NCT01994382|12032476|FG006|Overall Study|Death|0
7621812|NCT01994382|12032477|FG007|Overall Study|Death|0
7621813|NCT01994382|12032478|FG008|Overall Study|Death|1
7621814|NCT01994382|12032479|FG009|Overall Study|Death|1
7621815|NCT01994382|12032480|FG010|Overall Study|Death|0
7621816|NCT01994382|12032481|FG011|Overall Study|Death|0
7621817|NCT01994382|12032482|FG012|Overall Study|Death|0
7621818|NCT01994382|12032483|FG013|Overall Study|Death|0
7621819|NCT01994382|12032484|FG014|Overall Study|Death|0
7621820|NCT01994382|12032485|FG015|Overall Study|Death|1
7621821|NCT01994382|12032486|FG016|Overall Study|Death|0
7621822|NCT01994382|12032470|FG000|Overall Study|Adverse Event|0
7621823|NCT01994382|12032471|FG001|Overall Study|Adverse Event|1
7621824|NCT01994382|12032472|FG002|Overall Study|Adverse Event|2
7621825|NCT01994382|12032473|FG003|Overall Study|Adverse Event|0
7787236|NCT00996892|12238676|FG005|Expansion Stage 2|Physician Decision|0
7787237|NCT00996892|12238677|FG006|Expansion Stage 2|Physician Decision|0
7787238|NCT00996892|12238678|FG007|Expansion Stage 2|Physician Decision|0
7787239|NCT00996892|12238679|FG008|Expansion Stage 2|Physician Decision|0
7621826|NCT01994382|12032474|FG004|Overall Study|Adverse Event|0
7621827|NCT01994382|12032475|FG005|Overall Study|Adverse Event|0
7621828|NCT01994382|12032476|FG006|Overall Study|Adverse Event|0
7621829|NCT01994382|12032477|FG007|Overall Study|Adverse Event|0
7621830|NCT01994382|12032478|FG008|Overall Study|Adverse Event|0
7621831|NCT01994382|12032479|FG009|Overall Study|Adverse Event|0
7621832|NCT01994382|12032480|FG010|Overall Study|Adverse Event|15
7621833|NCT01994382|12032481|FG011|Overall Study|Adverse Event|2
7787240|NCT00996892|12238680|FG009|Expansion Stage 2|Physician Decision|0
7787241|NCT00996892|12238681|FG010|Expansion Stage 2|Physician Decision|0
7787242|NCT00996892|12238682|FG011|Expansion Stage 2|Physician Decision|0
7787243|NCT00996892|12238683|FG012|Expansion Stage 2|Physician Decision|0
7787244|NCT00996892|12238684|FG013|Expansion Stage 2|Physician Decision|0
7787245|NCT00996892|12238685|FG014|Expansion Stage 2|Physician Decision|0
7787246|NCT00996892|12238686|FG015|Expansion Stage 2|Physician Decision|0
7787247|NCT00996892|12238687|FG016|Expansion Stage 2|Physician Decision|0
7621834|NCT01994382|12032482|FG012|Overall Study|Adverse Event|7
7621835|NCT01994382|12032483|FG013|Overall Study|Adverse Event|3
7787248|NCT00996892|12238688|FG017|Expansion Stage 2|Physician Decision|0
7787249|NCT00996892|12238689|FG018|Expansion Stage 2|Physician Decision|1
7787250|NCT00996892|12238690|FG019|Expansion Stage 2|Physician Decision|0
7787251|NCT00996892|12238671|FG000|Expansion Stage 2|Withdrawal by Subject|0
7787252|NCT00996892|12238672|FG001|Expansion Stage 2|Withdrawal by Subject|0
7787253|NCT00996892|12238673|FG002|Expansion Stage 2|Withdrawal by Subject|0
7787254|NCT00996892|12238674|FG003|Expansion Stage 2|Withdrawal by Subject|0
7787255|NCT00996892|12238675|FG004|Expansion Stage 2|Withdrawal by Subject|0
7787256|NCT00996892|12238676|FG005|Expansion Stage 2|Withdrawal by Subject|0
7787257|NCT00996892|12238677|FG006|Expansion Stage 2|Withdrawal by Subject|0
7787258|NCT00996892|12238678|FG007|Expansion Stage 2|Withdrawal by Subject|0
7787259|NCT00996892|12238679|FG008|Expansion Stage 2|Withdrawal by Subject|0
7787260|NCT00996892|12238680|FG009|Expansion Stage 2|Withdrawal by Subject|0
7787261|NCT00996892|12238681|FG010|Expansion Stage 2|Withdrawal by Subject|0
7787262|NCT00996892|12238682|FG011|Expansion Stage 2|Withdrawal by Subject|0
7787263|NCT00996892|12238683|FG012|Expansion Stage 2|Withdrawal by Subject|0
7787264|NCT00996892|12238684|FG013|Expansion Stage 2|Withdrawal by Subject|0
7787265|NCT00996892|12238685|FG014|Expansion Stage 2|Withdrawal by Subject|0
7787266|NCT00996892|12238686|FG015|Expansion Stage 2|Withdrawal by Subject|0
7787267|NCT00996892|12238687|FG016|Expansion Stage 2|Withdrawal by Subject|0
7787268|NCT00996892|12238688|FG017|Expansion Stage 2|Withdrawal by Subject|0
7787269|NCT00996892|12238689|FG018|Expansion Stage 2|Withdrawal by Subject|1
7787270|NCT00996892|12238690|FG019|Expansion Stage 2|Withdrawal by Subject|0
7787271|NCT00996892|12238671|FG000|Expansion Stage 2|Disease Progression|0
7787272|NCT00996892|12238672|FG001|Expansion Stage 2|Disease Progression|0
7787273|NCT00996892|12238673|FG002|Expansion Stage 2|Disease Progression|0
7787274|NCT00996892|12238674|FG003|Expansion Stage 2|Disease Progression|0
7787275|NCT00996892|12238675|FG004|Expansion Stage 2|Disease Progression|0
7787276|NCT00996892|12238676|FG005|Expansion Stage 2|Disease Progression|0
7787277|NCT00996892|12238677|FG006|Expansion Stage 2|Disease Progression|0
7787278|NCT00996892|12238678|FG007|Expansion Stage 2|Disease Progression|0
7787279|NCT00996892|12238679|FG008|Expansion Stage 2|Disease Progression|0
7787280|NCT00996892|12238680|FG009|Expansion Stage 2|Disease Progression|0
7787281|NCT00996892|12238681|FG010|Expansion Stage 2|Disease Progression|0
7787282|NCT00996892|12238682|FG011|Expansion Stage 2|Disease Progression|0
7787283|NCT00996892|12238683|FG012|Expansion Stage 2|Disease Progression|0
7787284|NCT00996892|12238684|FG013|Expansion Stage 2|Disease Progression|0
7787285|NCT00996892|12238685|FG014|Expansion Stage 2|Disease Progression|0
7787286|NCT00996892|12238686|FG015|Expansion Stage 2|Disease Progression|0
7787287|NCT00996892|12238687|FG016|Expansion Stage 2|Disease Progression|0
7787288|NCT00996892|12238688|FG017|Expansion Stage 2|Disease Progression|0
7787289|NCT00996892|12238689|FG018|Expansion Stage 2|Disease Progression|28
7787290|NCT00996892|12238690|FG019|Expansion Stage 2|Disease Progression|0
7787291|NCT00996892|12238671|FG000|Expansion Stage 2A|Adverse Event|0
7787292|NCT00996892|12238672|FG001|Expansion Stage 2A|Adverse Event|0
7787293|NCT00996892|12238673|FG002|Expansion Stage 2A|Adverse Event|0
7787294|NCT00996892|12238674|FG003|Expansion Stage 2A|Adverse Event|0
7787295|NCT00996892|12238675|FG004|Expansion Stage 2A|Adverse Event|0
7787296|NCT00996892|12238676|FG005|Expansion Stage 2A|Adverse Event|0
7787297|NCT00996892|12238677|FG006|Expansion Stage 2A|Adverse Event|0
7787298|NCT00996892|12238678|FG007|Expansion Stage 2A|Adverse Event|0
7621836|NCT01994382|12032484|FG014|Overall Study|Adverse Event|17
7621837|NCT01994382|12032485|FG015|Overall Study|Adverse Event|6
7621838|NCT01994382|12032486|FG016|Overall Study|Adverse Event|3
7621839|NCT01994382|12032470|FG000|Overall Study|Other than specified|0
7621840|NCT01994382|12032471|FG001|Overall Study|Other than specified|0
7621841|NCT01994382|12032472|FG002|Overall Study|Other than specified|0
7621842|NCT01994382|12032473|FG003|Overall Study|Other than specified|0
7621843|NCT01994382|12032474|FG004|Overall Study|Other than specified|0
7621844|NCT01994382|12032475|FG005|Overall Study|Other than specified|0
7621845|NCT01994382|12032476|FG006|Overall Study|Other than specified|0
7621846|NCT01994382|12032477|FG007|Overall Study|Other than specified|0
7621847|NCT01994382|12032478|FG008|Overall Study|Other than specified|0
7621848|NCT01994382|12032479|FG009|Overall Study|Other than specified|0
7621849|NCT01994382|12032480|FG010|Overall Study|Other than specified|2
7621850|NCT01994382|12032481|FG011|Overall Study|Other than specified|0
7621851|NCT01994382|12032482|FG012|Overall Study|Other than specified|2
7621852|NCT01994382|12032483|FG013|Overall Study|Other than specified|0
7621853|NCT01994382|12032484|FG014|Overall Study|Other than specified|0
7621854|NCT01994382|12032485|FG015|Overall Study|Other than specified|4
7621855|NCT01994382|12032486|FG016|Overall Study|Other than specified|4
7621856|NCT01994382|12032470|FG000|Overall Study|Withdrawal by Subject|0
7621857|NCT01994382|12032471|FG001|Overall Study|Withdrawal by Subject|0
7621858|NCT01994382|12032472|FG002|Overall Study|Withdrawal by Subject|0
7621859|NCT01994382|12032473|FG003|Overall Study|Withdrawal by Subject|0
7787299|NCT00996892|12238679|FG008|Expansion Stage 2A|Adverse Event|0
7787300|NCT00996892|12238680|FG009|Expansion Stage 2A|Adverse Event|0
7787301|NCT00996892|12238681|FG010|Expansion Stage 2A|Adverse Event|0
7787302|NCT00996892|12238682|FG011|Expansion Stage 2A|Adverse Event|0
7787303|NCT00996892|12238683|FG012|Expansion Stage 2A|Adverse Event|0
7787304|NCT00996892|12238684|FG013|Expansion Stage 2A|Adverse Event|0
7787305|NCT00996892|12238685|FG014|Expansion Stage 2A|Adverse Event|0
7787306|NCT00996892|12238686|FG015|Expansion Stage 2A|Adverse Event|0
7787307|NCT00996892|12238687|FG016|Expansion Stage 2A|Adverse Event|0
7787308|NCT00996892|12238688|FG017|Expansion Stage 2A|Adverse Event|0
7787309|NCT00996892|12238689|FG018|Expansion Stage 2A|Adverse Event|0
7787310|NCT00996892|12238690|FG019|Expansion Stage 2A|Adverse Event|8
7787311|NCT00996892|12238671|FG000|Expansion Stage 2A|Physician Decision|0
7787312|NCT00996892|12238672|FG001|Expansion Stage 2A|Physician Decision|0
7787313|NCT00996892|12238673|FG002|Expansion Stage 2A|Physician Decision|0
7787314|NCT00996892|12238674|FG003|Expansion Stage 2A|Physician Decision|0
7787315|NCT00996892|12238675|FG004|Expansion Stage 2A|Physician Decision|0
7787316|NCT00996892|12238676|FG005|Expansion Stage 2A|Physician Decision|0
7787317|NCT00996892|12238677|FG006|Expansion Stage 2A|Physician Decision|0
7787318|NCT00996892|12238678|FG007|Expansion Stage 2A|Physician Decision|0
7787319|NCT00996892|12238679|FG008|Expansion Stage 2A|Physician Decision|0
7787320|NCT00996892|12238680|FG009|Expansion Stage 2A|Physician Decision|0
7787321|NCT00996892|12238681|FG010|Expansion Stage 2A|Physician Decision|0
7787322|NCT00996892|12238682|FG011|Expansion Stage 2A|Physician Decision|0
7621860|NCT01994382|12032474|FG004|Overall Study|Withdrawal by Subject|0
7621861|NCT01994382|12032475|FG005|Overall Study|Withdrawal by Subject|0
7621862|NCT01994382|12032476|FG006|Overall Study|Withdrawal by Subject|0
7621863|NCT01994382|12032477|FG007|Overall Study|Withdrawal by Subject|0
7621864|NCT01994382|12032478|FG008|Overall Study|Withdrawal by Subject|0
7621865|NCT01994382|12032479|FG009|Overall Study|Withdrawal by Subject|0
7621866|NCT01994382|12032480|FG010|Overall Study|Withdrawal by Subject|6
7621867|NCT01994382|12032481|FG011|Overall Study|Withdrawal by Subject|0
7621868|NCT01994382|12032482|FG012|Overall Study|Withdrawal by Subject|2
7621869|NCT01994382|12032483|FG013|Overall Study|Withdrawal by Subject|0
7621870|NCT01994382|12032484|FG014|Overall Study|Withdrawal by Subject|4
7621871|NCT01994382|12032485|FG015|Overall Study|Withdrawal by Subject|3
7621872|NCT01994382|12032486|FG016|Overall Study|Withdrawal by Subject|0
7621873|NCT01994382|12032470|FG000|Overall Study|Lost to Follow-up|0
7787323|NCT00996892|12238683|FG012|Expansion Stage 2A|Physician Decision|0
7787324|NCT00996892|12238684|FG013|Expansion Stage 2A|Physician Decision|0
7787325|NCT00996892|12238685|FG014|Expansion Stage 2A|Physician Decision|0
7787326|NCT00996892|12238686|FG015|Expansion Stage 2A|Physician Decision|0
7787327|NCT00996892|12238687|FG016|Expansion Stage 2A|Physician Decision|0
7787328|NCT00996892|12238688|FG017|Expansion Stage 2A|Physician Decision|0
7787329|NCT00996892|12238689|FG018|Expansion Stage 2A|Physician Decision|0
7787330|NCT00996892|12238690|FG019|Expansion Stage 2A|Physician Decision|2
7787331|NCT00996892|12238671|FG000|Expansion Stage 2A|Withdrawal by Subject|0
7787332|NCT00996892|12238672|FG001|Expansion Stage 2A|Withdrawal by Subject|0
7787333|NCT00996892|12238673|FG002|Expansion Stage 2A|Withdrawal by Subject|0
7787334|NCT00996892|12238674|FG003|Expansion Stage 2A|Withdrawal by Subject|0
7787335|NCT00996892|12238675|FG004|Expansion Stage 2A|Withdrawal by Subject|0
7787336|NCT00996892|12238676|FG005|Expansion Stage 2A|Withdrawal by Subject|0
7787337|NCT00996892|12238677|FG006|Expansion Stage 2A|Withdrawal by Subject|0
7787338|NCT00996892|12238678|FG007|Expansion Stage 2A|Withdrawal by Subject|0
7787339|NCT00996892|12238679|FG008|Expansion Stage 2A|Withdrawal by Subject|0
7621874|NCT01994382|12032471|FG001|Overall Study|Lost to Follow-up|0
7621875|NCT01994382|12032472|FG002|Overall Study|Lost to Follow-up|0
7621876|NCT01994382|12032473|FG003|Overall Study|Lost to Follow-up|0
7621877|NCT01994382|12032474|FG004|Overall Study|Lost to Follow-up|0
7621878|NCT01994382|12032475|FG005|Overall Study|Lost to Follow-up|0
7621879|NCT01994382|12032476|FG006|Overall Study|Lost to Follow-up|0
7621880|NCT01994382|12032477|FG007|Overall Study|Lost to Follow-up|0
7621881|NCT01994382|12032478|FG008|Overall Study|Lost to Follow-up|0
7621882|NCT01994382|12032479|FG009|Overall Study|Lost to Follow-up|0
7621883|NCT01994382|12032480|FG010|Overall Study|Lost to Follow-up|1
7621884|NCT01994382|12032481|FG011|Overall Study|Lost to Follow-up|0
7621885|NCT01994382|12032482|FG012|Overall Study|Lost to Follow-up|0
7621886|NCT01994382|12032483|FG013|Overall Study|Lost to Follow-up|0
7621887|NCT01994382|12032484|FG014|Overall Study|Lost to Follow-up|0
7621888|NCT01994382|12032485|FG015|Overall Study|Lost to Follow-up|0
7621889|NCT01994382|12032486|FG016|Overall Study|Lost to Follow-up|0
7621890|NCT01994382|12032470|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621891|NCT01994382|12032471|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621892|NCT01994382|12032472|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621893|NCT01994382|12032473|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621894|NCT01994382|12032474|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621895|NCT01994382|12032475|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621896|NCT01994382|12032476|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621897|NCT01994382|12032477|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621898|NCT01994382|12032478|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621899|NCT01994382|12032479|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621900|NCT01994382|12032480|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2
7621901|NCT01994382|12032481|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7787340|NCT00996892|12238680|FG009|Expansion Stage 2A|Withdrawal by Subject|0
7787341|NCT00996892|12238681|FG010|Expansion Stage 2A|Withdrawal by Subject|0
7787342|NCT00996892|12238682|FG011|Expansion Stage 2A|Withdrawal by Subject|0
7787343|NCT00996892|12238683|FG012|Expansion Stage 2A|Withdrawal by Subject|0
7787344|NCT00996892|12238684|FG013|Expansion Stage 2A|Withdrawal by Subject|0
7787345|NCT00996892|12238685|FG014|Expansion Stage 2A|Withdrawal by Subject|0
7787346|NCT00996892|12238686|FG015|Expansion Stage 2A|Withdrawal by Subject|0
7787347|NCT00996892|12238687|FG016|Expansion Stage 2A|Withdrawal by Subject|0
7787348|NCT00996892|12238688|FG017|Expansion Stage 2A|Withdrawal by Subject|0
7787349|NCT00996892|12238689|FG018|Expansion Stage 2A|Withdrawal by Subject|0
7787350|NCT00996892|12238690|FG019|Expansion Stage 2A|Withdrawal by Subject|4
7787351|NCT00996892|12238671|FG000|Expansion Stage 2A|Disease Progression|0
7787352|NCT00996892|12238672|FG001|Expansion Stage 2A|Disease Progression|0
7787353|NCT00996892|12238673|FG002|Expansion Stage 2A|Disease Progression|0
7787354|NCT00996892|12238674|FG003|Expansion Stage 2A|Disease Progression|0
7787355|NCT00996892|12238675|FG004|Expansion Stage 2A|Disease Progression|0
7787356|NCT00996892|12238676|FG005|Expansion Stage 2A|Disease Progression|0
7787357|NCT00996892|12238677|FG006|Expansion Stage 2A|Disease Progression|0
7787358|NCT00996892|12238678|FG007|Expansion Stage 2A|Disease Progression|0
7787359|NCT00996892|12238679|FG008|Expansion Stage 2A|Disease Progression|0
7787360|NCT00996892|12238680|FG009|Expansion Stage 2A|Disease Progression|0
7787361|NCT00996892|12238681|FG010|Expansion Stage 2A|Disease Progression|0
7787362|NCT00996892|12238682|FG011|Expansion Stage 2A|Disease Progression|0
7787363|NCT00996892|12238683|FG012|Expansion Stage 2A|Disease Progression|0
7787364|NCT00996892|12238684|FG013|Expansion Stage 2A|Disease Progression|0
7787365|NCT00996892|12238685|FG014|Expansion Stage 2A|Disease Progression|0
7787366|NCT00996892|12238686|FG015|Expansion Stage 2A|Disease Progression|0
7787367|NCT00996892|12238687|FG016|Expansion Stage 2A|Disease Progression|0
7787368|NCT00996892|12238688|FG017|Expansion Stage 2A|Disease Progression|0
7787369|NCT00996892|12238689|FG018|Expansion Stage 2A|Disease Progression|0
7787370|NCT00996892|12238690|FG019|Expansion Stage 2A|Disease Progression|31
7787371|NCT00996918|12238756|FG000|Overall Study|Lack of Efficacy|1
7787372|NCT00996918|12238757|FG001|Overall Study|Lack of Efficacy|1
7787373|NCT00996918|12238758|FG002|Overall Study|Lack of Efficacy|2
7787374|NCT00996918|12238759|FG003|Overall Study|Lack of Efficacy|2
7787375|NCT00996918|12238760|FG004|Overall Study|Lack of Efficacy|0
7787376|NCT00996918|12238756|FG000|Overall Study|Adverse Event|2
7787377|NCT00996918|12238757|FG001|Overall Study|Adverse Event|5
7787378|NCT00996918|12238758|FG002|Overall Study|Adverse Event|2
7787379|NCT00996918|12238759|FG003|Overall Study|Adverse Event|6
7787380|NCT00996918|12238760|FG004|Overall Study|Adverse Event|0
7787381|NCT00996918|12238756|FG000|Overall Study|Withdrawal by Subject|1
7787382|NCT00996918|12238757|FG001|Overall Study|Withdrawal by Subject|4
7787383|NCT00996918|12238758|FG002|Overall Study|Withdrawal by Subject|3
7787384|NCT00996918|12238759|FG003|Overall Study|Withdrawal by Subject|3
7787385|NCT00996918|12238760|FG004|Overall Study|Withdrawal by Subject|2
7787386|NCT00996918|12238756|FG000|Overall Study|Physician Decision|1
7787387|NCT00996918|12238757|FG001|Overall Study|Physician Decision|0
7787388|NCT00996918|12238758|FG002|Overall Study|Physician Decision|0
7787389|NCT00996918|12238759|FG003|Overall Study|Physician Decision|0
7787390|NCT00996918|12238760|FG004|Overall Study|Physician Decision|0
7787391|NCT00996918|12238756|FG000|Overall Study|Discontinuation of Study by Sponsor|31
7787392|NCT00996918|12238757|FG001|Overall Study|Discontinuation of Study by Sponsor|54
7787393|NCT00996918|12238758|FG002|Overall Study|Discontinuation of Study by Sponsor|30
7787394|NCT00996918|12238759|FG003|Overall Study|Discontinuation of Study by Sponsor|45
7621902|NCT01994382|12032482|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7
7621903|NCT01994382|12032483|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621904|NCT01994382|12032484|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621905|NCT01994382|12032485|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3
7621906|NCT01994382|12032486|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2
7621907|NCT01994382|12032470|FG000|Overall Study|Protocol violation/noncompliance|0
7621908|NCT01994382|12032471|FG001|Overall Study|Protocol violation/noncompliance|0
7621909|NCT01994382|12032472|FG002|Overall Study|Protocol violation/noncompliance|0
7621910|NCT01994382|12032473|FG003|Overall Study|Protocol violation/noncompliance|0
7621911|NCT01994382|12032474|FG004|Overall Study|Protocol violation/noncompliance|0
7621912|NCT01994382|12032475|FG005|Overall Study|Protocol violation/noncompliance|0
7621913|NCT01994382|12032476|FG006|Overall Study|Protocol violation/noncompliance|0
7621914|NCT01994382|12032477|FG007|Overall Study|Protocol violation/noncompliance|0
7621915|NCT01994382|12032478|FG008|Overall Study|Protocol violation/noncompliance|0
7621916|NCT01994382|12032479|FG009|Overall Study|Protocol violation/noncompliance|0
7787395|NCT00996918|12238760|FG004|Overall Study|Discontinuation of Study by Sponsor|2
7787396|NCT00996918|12238756|FG000|Overall Study|Loss of Caregiver|0
7787397|NCT00996918|12238757|FG001|Overall Study|Loss of Caregiver|1
7787398|NCT00996918|12238758|FG002|Overall Study|Loss of Caregiver|0
7787399|NCT00996918|12238759|FG003|Overall Study|Loss of Caregiver|0
7787400|NCT00996918|12238760|FG004|Overall Study|Loss of Caregiver|0
7787401|NCT00996918|12238756|FG000|Overall Study|Other|3
7787402|NCT00996918|12238757|FG001|Overall Study|Other|1
7787403|NCT00996918|12238758|FG002|Overall Study|Other|0
7787404|NCT00996918|12238759|FG003|Overall Study|Other|0
7787405|NCT00996918|12238760|FG004|Overall Study|Other|0
7787406|NCT00996944|12238779|FG000|Double-blind Treatment Period|Adverse Event|2
7787407|NCT00996944|12238780|FG001|Double-blind Treatment Period|Adverse Event|1
7787408|NCT00996944|12238779|FG000|Double-blind Treatment Period|Protocol Violation|1
7787409|NCT00996944|12238780|FG001|Double-blind Treatment Period|Protocol Violation|0
7787410|NCT00996944|12238779|FG000|Double-blind Treatment Period|Study Closed/Terminated|6
7787411|NCT00996944|12238780|FG001|Double-blind Treatment Period|Study Closed/Terminated|5
7787412|NCT00996944|12238779|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
7787413|NCT00996944|12238780|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
7787414|NCT00996944|12238779|FG000|Long-term Treatment Period|Study Closed/Terminated|12
7787415|NCT00996944|12238780|FG001|Long-term Treatment Period|Study Closed/Terminated|5
7787416|NCT00996996|12238788|FG000|Overall Study|Progressive Disease|10
7787417|NCT00996996|12238788|FG000|Overall Study|Non-compliance|8
7787418|NCT00996996|12238788|FG000|Overall Study|Lost to Follow-up|9
7787419|NCT00996996|12238788|FG000|Overall Study|Death|5
7787420|NCT00996996|12238788|FG000|Overall Study|Did Not Receive Study Medications|1
7787421|NCT00997035|12238794|FG000|3-week Followup Visit|Lost to Follow-up|9
7787422|NCT00997035|12238795|FG001|3-week Followup Visit|Lost to Follow-up|6
7787423|NCT00997035|12238794|FG000|3-month Follow-up Visit|Lost to Follow-up|12
7787424|NCT00997035|12238795|FG001|3-month Follow-up Visit|Lost to Follow-up|6
7787425|NCT00997126|12238822|FG000|Overall Study|Physician Decision|7
7787426|NCT00997126|12238823|FG001|Overall Study|Physician Decision|11
7787427|NCT00997243|12238848|FG000|Overall Study|Early termination of study by sponsor|7
7787428|NCT00997321|12238854|FG000|Overall Study|did not undergo sedation after enrollmen|0
7787429|NCT00997321|12238855|FG001|Overall Study|did not undergo sedation after enrollmen|3
7787430|NCT00997334|12238867|FG000|Overall Study|still on therapy|12
7787431|NCT00997334|12238867|FG000|Overall Study|Adverse Event|3
7787432|NCT00997334|12238867|FG000|Overall Study|Patient non-compliance|1
7787433|NCT00997334|12238867|FG000|Overall Study|Withdrawal by Subject|3
7787434|NCT00997334|12238867|FG000|Overall Study|Death|2
7787435|NCT00997334|12238867|FG000|Overall Study|Urgent Palliative Care|2
7787436|NCT00997334|12238867|FG000|Overall Study|No lesion amenable|1
7787437|NCT00997334|12238867|FG000|Overall Study|Ineligible|1
7787438|NCT00997373|12238873|FG000|Overall Study|Withdrawal by Subject|5
7787439|NCT00997373|12238874|FG001|Overall Study|Withdrawal by Subject|0
7787440|NCT00997373|12238873|FG000|Overall Study|wrong tumor type|4
7787441|NCT00997373|12238874|FG001|Overall Study|wrong tumor type|0
7787442|NCT00997373|12238873|FG000|Overall Study|could not have hysterectomy|6
7787443|NCT00997373|12238874|FG001|Overall Study|could not have hysterectomy|0
7787444|NCT00997438|12238888|FG000|Overall Study|Blood draw difficulty|2
7787445|NCT00997438|12238889|FG001|Overall Study|Blood draw difficulty|0
7787446|NCT00997438|12238890|FG002|Overall Study|Blood draw difficulty|1
7787447|NCT00997438|12238888|FG000|Overall Study|Withdrawal by Subject|1
7787448|NCT00997438|12238889|FG001|Overall Study|Withdrawal by Subject|1
7787449|NCT00997438|12238890|FG002|Overall Study|Withdrawal by Subject|0
7787450|NCT00997438|12238888|FG000|Overall Study|Exclusion criteria at visit 1|2
7787451|NCT00997438|12238889|FG001|Overall Study|Exclusion criteria at visit 1|2
7787452|NCT00997438|12238890|FG002|Overall Study|Exclusion criteria at visit 1|3
7787453|NCT00997503|12238899|FG000|Overall Study|Death|53
7787454|NCT00997503|12238899|FG000|Overall Study|Withdrawal by Subject|76
7787455|NCT00997503|12238899|FG000|Overall Study|Lost to Follow-up|33
7787456|NCT00997503|12238899|FG000|Overall Study|Adverse Event|3
7787457|NCT00997503|12238899|FG000|Overall Study|Physician Decision|10
7621917|NCT01994382|12032480|FG010|Overall Study|Protocol violation/noncompliance|0
7621918|NCT01994382|12032481|FG011|Overall Study|Protocol violation/noncompliance|1
7621919|NCT01994382|12032482|FG012|Overall Study|Protocol violation/noncompliance|0
7621920|NCT01994382|12032483|FG013|Overall Study|Protocol violation/noncompliance|0
7621921|NCT01994382|12032484|FG014|Overall Study|Protocol violation/noncompliance|0
7621922|NCT01994382|12032485|FG015|Overall Study|Protocol violation/noncompliance|0
7621923|NCT01994382|12032486|FG016|Overall Study|Protocol violation/noncompliance|2
7621924|NCT01994382|12032470|FG000|Overall Study|Rolled over to Phase 2a|0
7621925|NCT01994382|12032471|FG001|Overall Study|Rolled over to Phase 2a|0
7621926|NCT01994382|12032472|FG002|Overall Study|Rolled over to Phase 2a|1
7621927|NCT01994382|12032473|FG003|Overall Study|Rolled over to Phase 2a|0
7621928|NCT01994382|12032474|FG004|Overall Study|Rolled over to Phase 2a|0
7787458|NCT00997503|12238899|FG000|Overall Study|Missed 12-month follow-up|85
7787459|NCT00997503|12238899|FG000|Overall Study|Other reason|13
7787460|NCT00997893|12238957|FG000|Overall Study|Adverse Event|1
7787461|NCT00997893|12238958|FG001|Overall Study|Adverse Event|0
7787462|NCT00997893|12238959|FG002|Overall Study|Adverse Event|0
7787463|NCT00997893|12238957|FG000|Overall Study|Unable to meet study timelines|1
7787464|NCT00997893|12238958|FG001|Overall Study|Unable to meet study timelines|0
7787465|NCT00997893|12238959|FG002|Overall Study|Unable to meet study timelines|0
7787466|NCT00997893|12238957|FG000|Overall Study|Pain/pain meds during Visit 4|0
7787467|NCT00997893|12238958|FG001|Overall Study|Pain/pain meds during Visit 4|1
7787468|NCT00997893|12238959|FG002|Overall Study|Pain/pain meds during Visit 4|0
7787469|NCT00997984|12238975|FG000|Overall Study|Adverse Event|1
7787470|NCT00997984|12238976|FG001|Overall Study|Adverse Event|8
7787471|NCT00997984|12238977|FG002|Overall Study|Adverse Event|8
7787472|NCT00997984|12238975|FG000|Overall Study|Protocol Violation|1
7787473|NCT00997984|12238976|FG001|Overall Study|Protocol Violation|3
7787474|NCT00997984|12238977|FG002|Overall Study|Protocol Violation|0
7787475|NCT00997984|12238975|FG000|Overall Study|Withdrawal by Subject|6
7787476|NCT00997984|12238976|FG001|Overall Study|Withdrawal by Subject|9
7787477|NCT00997984|12238977|FG002|Overall Study|Withdrawal by Subject|5
7787478|NCT00997984|12238975|FG000|Overall Study|Lost to Follow-up|8
7787479|NCT00997984|12238976|FG001|Overall Study|Lost to Follow-up|5
7787480|NCT00997984|12238977|FG002|Overall Study|Lost to Follow-up|4
7787481|NCT00997984|12238975|FG000|Overall Study|Lack of Efficacy|20
7787482|NCT00997984|12238976|FG001|Overall Study|Lack of Efficacy|6
7787483|NCT00997984|12238977|FG002|Overall Study|Lack of Efficacy|3
7787484|NCT00997984|12238975|FG000|Overall Study|Met exclusion criteria|1
7621929|NCT01994382|12032475|FG005|Overall Study|Rolled over to Phase 2a|0
7621930|NCT01994382|12032476|FG006|Overall Study|Rolled over to Phase 2a|0
7621931|NCT01994382|12032477|FG007|Overall Study|Rolled over to Phase 2a|0
7621932|NCT01994382|12032478|FG008|Overall Study|Rolled over to Phase 2a|0
7621933|NCT01994382|12032479|FG009|Overall Study|Rolled over to Phase 2a|2
7621934|NCT01994382|12032480|FG010|Overall Study|Rolled over to Phase 2a|0
7621935|NCT01994382|12032481|FG011|Overall Study|Rolled over to Phase 2a|0
7621936|NCT01994382|12032482|FG012|Overall Study|Rolled over to Phase 2a|0
7621937|NCT01994382|12032483|FG013|Overall Study|Rolled over to Phase 2a|0
7621938|NCT01994382|12032484|FG014|Overall Study|Rolled over to Phase 2a|0
7621939|NCT01994382|12032485|FG015|Overall Study|Rolled over to Phase 2a|0
7621940|NCT01994382|12032486|FG016|Overall Study|Rolled over to Phase 2a|0
7787485|NCT00997984|12238976|FG001|Overall Study|Met exclusion criteria|0
7787486|NCT00997984|12238977|FG002|Overall Study|Met exclusion criteria|0
7787487|NCT00997984|12238975|FG000|Overall Study|non-compliance|0
7787488|NCT00997984|12238976|FG001|Overall Study|non-compliance|2
7787489|NCT00997984|12238977|FG002|Overall Study|non-compliance|3
7787490|NCT00997984|12238975|FG000|Overall Study|Wrong medication dispensed|0
7787491|NCT00997984|12238976|FG001|Overall Study|Wrong medication dispensed|1
7787492|NCT00997984|12238977|FG002|Overall Study|Wrong medication dispensed|0
7787493|NCT00997984|12238975|FG000|Overall Study|Suicidal ideation|0
7787494|NCT00997984|12238976|FG001|Overall Study|Suicidal ideation|0
7787495|NCT00997984|12238977|FG002|Overall Study|Suicidal ideation|1
7787496|NCT00997984|12238975|FG000|Overall Study|Work schedule|0
7787497|NCT00997984|12238976|FG001|Overall Study|Work schedule|0
7787498|NCT00997984|12238977|FG002|Overall Study|Work schedule|2
7787499|NCT00998296|12239020|FG000|Overall Study|Progressive disease|0
7787500|NCT00998296|12239021|FG001|Overall Study|Progressive disease|1
7787501|NCT00998296|12239022|FG002|Overall Study|Progressive disease|0
7787502|NCT00998296|12239023|FG003|Overall Study|Progressive disease|0
7787503|NCT00998296|12239024|FG004|Overall Study|Progressive disease|0
7787504|NCT00998296|12239025|FG005|Overall Study|Progressive disease|0
7787505|NCT00998296|12239026|FG006|Overall Study|Progressive disease|1
7787506|NCT00998296|12239027|FG007|Overall Study|Progressive disease|0
7787507|NCT00998296|12239028|FG008|Overall Study|Progressive disease|0
7787508|NCT00998296|12239029|FG009|Overall Study|Progressive disease|14
7787509|NCT00998296|12239030|FG010|Overall Study|Progressive disease|5
7787510|NCT00998296|12239020|FG000|Overall Study|Dose limiting or dose reducing toxicity|0
7787511|NCT00998296|12239021|FG001|Overall Study|Dose limiting or dose reducing toxicity|0
7787512|NCT00998296|12239022|FG002|Overall Study|Dose limiting or dose reducing toxicity|0
7621941|NCT01896531|12032531|FG000|Overall Study|Death|57
7621942|NCT01896531|12032532|FG001|Overall Study|Death|59
7621943|NCT01896531|12032531|FG000|Overall Study|Lost to Follow-up|3
7621944|NCT01896531|12032532|FG001|Overall Study|Lost to Follow-up|0
7621945|NCT01896531|12032531|FG000|Overall Study|Non-compliance|0
7621946|NCT01896531|12032532|FG001|Overall Study|Non-compliance|1
7621947|NCT01896531|12032531|FG000|Overall Study|Study Ended by Sponsor|7
7621948|NCT01896531|12032532|FG001|Overall Study|Study Ended by Sponsor|20
7621949|NCT01896531|12032531|FG000|Overall Study|Withdrawal by Subject|3
7621950|NCT01896531|12032532|FG001|Overall Study|Withdrawal by Subject|2
7621951|NCT01896531|12032531|FG000|Overall Study|Death Prior to Treatment|1
7621952|NCT01896531|12032532|FG001|Overall Study|Death Prior to Treatment|0
7787513|NCT00998296|12239023|FG003|Overall Study|Dose limiting or dose reducing toxicity|0
7787514|NCT00998296|12239024|FG004|Overall Study|Dose limiting or dose reducing toxicity|1
7787515|NCT00998296|12239025|FG005|Overall Study|Dose limiting or dose reducing toxicity|0
7787516|NCT00998296|12239026|FG006|Overall Study|Dose limiting or dose reducing toxicity|0
7787517|NCT00998296|12239027|FG007|Overall Study|Dose limiting or dose reducing toxicity|2
7787518|NCT00998296|12239028|FG008|Overall Study|Dose limiting or dose reducing toxicity|2
7787519|NCT00998296|12239029|FG009|Overall Study|Dose limiting or dose reducing toxicity|0
7787520|NCT00998296|12239030|FG010|Overall Study|Dose limiting or dose reducing toxicity|0
7787521|NCT00998296|12239020|FG000|Overall Study|Other adverse event|0
7787522|NCT00998296|12239021|FG001|Overall Study|Other adverse event|0
7787523|NCT00998296|12239022|FG002|Overall Study|Other adverse event|0
7787524|NCT00998296|12239023|FG003|Overall Study|Other adverse event|0
7787525|NCT00998296|12239024|FG004|Overall Study|Other adverse event|1
7787526|NCT00998296|12239025|FG005|Overall Study|Other adverse event|0
7787527|NCT00998296|12239026|FG006|Overall Study|Other adverse event|0
7787528|NCT00998296|12239027|FG007|Overall Study|Other adverse event|0
7787529|NCT00998296|12239028|FG008|Overall Study|Other adverse event|0
7787530|NCT00998296|12239029|FG009|Overall Study|Other adverse event|1
7787531|NCT00998296|12239030|FG010|Overall Study|Other adverse event|2
7787532|NCT00998296|12239020|FG000|Overall Study|Refused to continue taking trial med.|0
7787533|NCT00998296|12239021|FG001|Overall Study|Refused to continue taking trial med.|0
7787534|NCT00998296|12239022|FG002|Overall Study|Refused to continue taking trial med.|0
7787535|NCT00998296|12239023|FG003|Overall Study|Refused to continue taking trial med.|0
7787536|NCT00998296|12239024|FG004|Overall Study|Refused to continue taking trial med.|0
7787537|NCT00998296|12239025|FG005|Overall Study|Refused to continue taking trial med.|0
7787538|NCT00998296|12239026|FG006|Overall Study|Refused to continue taking trial med.|0
7787539|NCT00998296|12239027|FG007|Overall Study|Refused to continue taking trial med.|0
7787540|NCT00998296|12239028|FG008|Overall Study|Refused to continue taking trial med.|0
7787541|NCT00998296|12239029|FG009|Overall Study|Refused to continue taking trial med.|2
7787542|NCT00998296|12239030|FG010|Overall Study|Refused to continue taking trial med.|0
7787543|NCT00998296|12239020|FG000|Overall Study|Reason other than those specified above|0
7787544|NCT00998296|12239021|FG001|Overall Study|Reason other than those specified above|0
7787545|NCT00998296|12239022|FG002|Overall Study|Reason other than those specified above|0
7787546|NCT00998296|12239023|FG003|Overall Study|Reason other than those specified above|0
7787547|NCT00998296|12239024|FG004|Overall Study|Reason other than those specified above|0
7787548|NCT00998296|12239025|FG005|Overall Study|Reason other than those specified above|0
7787549|NCT00998296|12239026|FG006|Overall Study|Reason other than those specified above|0
7787550|NCT00998296|12239027|FG007|Overall Study|Reason other than those specified above|0
7787551|NCT00998296|12239028|FG008|Overall Study|Reason other than those specified above|0
7787552|NCT00998296|12239029|FG009|Overall Study|Reason other than those specified above|1
7621953|NCT01864603|12032540|FG000|Stage 2|DSMB design modification|86056
7621954|NCT01864603|12032541|FG001|Stage 2|DSMB design modification|92558
7787553|NCT00998296|12239030|FG010|Overall Study|Reason other than those specified above|0
7787554|NCT00998309|12239059|FG000|Overall Study|Protocol Violation|4
7787555|NCT00998335|12239113|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
7787556|NCT00998335|12239114|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
7787557|NCT00998400|12239139|FG000|Overall Study|Lack of interest/motivation|1
7787558|NCT00998400|12239140|FG001|Overall Study|Lack of interest/motivation|2
7787559|NCT00998400|12239139|FG000|Overall Study|Logistical problems|1
7787560|NCT00998400|12239140|FG001|Overall Study|Logistical problems|0
7787561|NCT00998764|12239183|FG000|Overall Study|Lack of Efficacy|3
7787562|NCT00998764|12239184|FG001|Overall Study|Lack of Efficacy|6
7787563|NCT00998764|12239183|FG000|Overall Study|Adverse Event|17
7787564|NCT00998764|12239184|FG001|Overall Study|Adverse Event|12
7787565|NCT00998764|12239183|FG000|Overall Study|Withdrawal by Subject|19
7787566|NCT00998764|12239184|FG001|Overall Study|Withdrawal by Subject|25
7787567|NCT00998764|12239183|FG000|Overall Study|Physician Decision|3
7787568|NCT00998764|12239184|FG001|Overall Study|Physician Decision|3
7787569|NCT00998764|12239183|FG000|Overall Study|Death|3
7787570|NCT00998764|12239184|FG001|Overall Study|Death|1
7787571|NCT00998764|12239183|FG000|Overall Study|Discontinuation of Study by Sponsor|164
7787572|NCT00998764|12239184|FG001|Overall Study|Discontinuation of Study by Sponsor|217
7787573|NCT00998764|12239183|FG000|Overall Study|Protocol Violation|0
7787574|NCT00998764|12239184|FG001|Overall Study|Protocol Violation|1
7787575|NCT00998764|12239183|FG000|Overall Study|Failed to Return|1
7787576|NCT00998764|12239184|FG001|Overall Study|Failed to Return|1
7787577|NCT00998764|12239183|FG000|Overall Study|Lost to Follow-up|1
7787578|NCT00998764|12239184|FG001|Overall Study|Lost to Follow-up|1
7787579|NCT00998764|12239183|FG000|Overall Study|Loss of Caregiver|0
7787580|NCT00998764|12239184|FG001|Overall Study|Loss of Caregiver|3
7787581|NCT00998764|12239183|FG000|Overall Study|Other|4
7787582|NCT00998764|12239184|FG001|Overall Study|Other|4
7787583|NCT00998764|12239183|FG000|Overall Study|Recurrent Episode of vasogenic edema|1
7787584|NCT00998764|12239184|FG001|Overall Study|Recurrent Episode of vasogenic edema|0
7787585|NCT00998790|12239192|FG000|Overall Study|Withdrawal by Subject|21
7787586|NCT00998881|12239202|FG000|Overall Study|Adverse Event|2
7787587|NCT00998881|12239203|FG001|Overall Study|Adverse Event|2
7787588|NCT00998881|12239202|FG000|Overall Study|Lack of Efficacy|1
7787589|NCT00998881|12239203|FG001|Overall Study|Lack of Efficacy|0
7787590|NCT00998881|12239202|FG000|Overall Study|Physician Decision|3
7787591|NCT00998881|12239203|FG001|Overall Study|Physician Decision|0
7787592|NCT00998881|12239202|FG000|Overall Study|Withdrawal by Subject|1
7787593|NCT00998881|12239203|FG001|Overall Study|Withdrawal by Subject|0
7787594|NCT00998881|12239202|FG000|Overall Study|Personal matter|1
7787595|NCT00998881|12239203|FG001|Overall Study|Personal matter|0
7787596|NCT00998946|12239209|FG000|Overall Study|Lost to Follow-up|1
7787597|NCT00998946|12239209|FG000|Overall Study|Withdrawal by Subject|1
7787598|NCT00998946|12239209|FG000|Overall Study|Death|2
7787599|NCT00998946|12239209|FG000|Overall Study|Reason Unspecified|3
7787600|NCT00998946|12239209|FG000|Overall Study|Enrolled but not Dosed|2
7787601|NCT00998985|12239227|FG000|Overall Study|Withdrawal by Subject|0
7787602|NCT00998985|12239228|FG001|Overall Study|Withdrawal by Subject|0
7787603|NCT00998985|12239229|FG002|Overall Study|Withdrawal by Subject|0
7787604|NCT00998985|12239230|FG003|Overall Study|Withdrawal by Subject|0
7787605|NCT00998985|12239231|FG004|Overall Study|Withdrawal by Subject|0
7787606|NCT00998985|12239232|FG005|Overall Study|Withdrawal by Subject|0
7787607|NCT00998985|12239233|FG006|Overall Study|Withdrawal by Subject|0
7787608|NCT00998985|12239234|FG007|Overall Study|Withdrawal by Subject|0
7787609|NCT00998985|12239235|FG008|Overall Study|Withdrawal by Subject|1
7787610|NCT00998985|12239236|FG009|Overall Study|Withdrawal by Subject|0
7787611|NCT00998985|12239237|FG010|Overall Study|Withdrawal by Subject|0
7787612|NCT00998985|12239238|FG011|Overall Study|Withdrawal by Subject|0
7787613|NCT00998985|12239239|FG012|Overall Study|Withdrawal by Subject|0
7787614|NCT00998985|12239240|FG013|Overall Study|Withdrawal by Subject|0
7787615|NCT00998985|12239227|FG000|Overall Study|Protocol Violation|0
7787616|NCT00998985|12239228|FG001|Overall Study|Protocol Violation|0
7787617|NCT00998985|12239229|FG002|Overall Study|Protocol Violation|0
7787618|NCT00998985|12239230|FG003|Overall Study|Protocol Violation|0
7787619|NCT00998985|12239231|FG004|Overall Study|Protocol Violation|0
7787620|NCT00998985|12239232|FG005|Overall Study|Protocol Violation|1
7787621|NCT00998985|12239233|FG006|Overall Study|Protocol Violation|0
7787622|NCT00998985|12239234|FG007|Overall Study|Protocol Violation|0
7787623|NCT00998985|12239235|FG008|Overall Study|Protocol Violation|0
7787624|NCT00998985|12239236|FG009|Overall Study|Protocol Violation|0
7787625|NCT00998985|12239237|FG010|Overall Study|Protocol Violation|0
7621971|NCT01684722|12032569|FG000|Overall Study|Lost to Follow-up|78
7787626|NCT00998985|12239238|FG011|Overall Study|Protocol Violation|0
7787627|NCT00998985|12239239|FG012|Overall Study|Protocol Violation|0
7787628|NCT00998985|12239240|FG013|Overall Study|Protocol Violation|0
7787629|NCT00999167|12239365|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
7787630|NCT00999167|12239366|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
7787631|NCT00999167|12239367|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
7787632|NCT00999167|12239365|FG000|Part A: Open Label Safety run-in|Adverse Event|3
7787633|NCT00999167|12239366|FG001|Part A: Open Label Safety run-in|Adverse Event|0
7787634|NCT00999167|12239367|FG002|Part A: Open Label Safety run-in|Adverse Event|0
7787635|NCT00999167|12239365|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
7787636|NCT00999167|12239366|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
7787637|NCT00999167|12239367|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
7787638|NCT00999167|12239365|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
7787639|NCT00999167|12239366|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
7787640|NCT00999167|12239367|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
7787641|NCT00999167|12239365|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0
7787642|NCT00999167|12239366|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6
7787643|NCT00999167|12239367|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1
7787644|NCT00999167|12239365|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0
7787645|NCT00999167|12239366|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1
7787646|NCT00999167|12239367|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0
7787647|NCT00999167|12239365|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0
7787648|NCT00999167|12239366|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1
7787649|NCT00999167|12239367|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0
7787650|NCT00999167|12239365|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
7787651|NCT00999167|12239366|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
7787652|NCT00999167|12239367|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
7787653|NCT00999466|12239380|FG000|Main Part|Withdrawal by Subject|0
7787654|NCT00999466|12239381|FG001|Main Part|Withdrawal by Subject|0
7787655|NCT00999466|12239382|FG002|Main Part|Withdrawal by Subject|2
7787656|NCT00999466|12239380|FG000|Main Part|Adverse Event|0
7787657|NCT00999466|12239381|FG001|Main Part|Adverse Event|4
7787658|NCT00999466|12239382|FG002|Main Part|Adverse Event|2
7787659|NCT00999518|12239395|FG000|Overall Study|Adverse Event|1
7787660|NCT00999518|12239396|FG001|Overall Study|Adverse Event|6
7787661|NCT00999518|12239397|FG002|Overall Study|Adverse Event|3
7787662|NCT00999518|12239398|FG003|Overall Study|Adverse Event|1
7787663|NCT00999518|12239399|FG004|Overall Study|Adverse Event|2
7787664|NCT00999518|12239395|FG000|Overall Study|Lack of Efficacy|2
7787665|NCT00999518|12239396|FG001|Overall Study|Lack of Efficacy|0
7787666|NCT00999518|12239397|FG002|Overall Study|Lack of Efficacy|0
7787667|NCT00999518|12239398|FG003|Overall Study|Lack of Efficacy|2
7787668|NCT00999518|12239399|FG004|Overall Study|Lack of Efficacy|2
7787669|NCT00999518|12239395|FG000|Overall Study|Lost to Follow-up|0
7787670|NCT00999518|12239396|FG001|Overall Study|Lost to Follow-up|0
7787671|NCT00999518|12239397|FG002|Overall Study|Lost to Follow-up|0
7787672|NCT00999518|12239398|FG003|Overall Study|Lost to Follow-up|4
7787673|NCT00999518|12239399|FG004|Overall Study|Lost to Follow-up|1
7787674|NCT00999518|12239395|FG000|Overall Study|Did not meet entrance criteria|0
7787675|NCT00999518|12239396|FG001|Overall Study|Did not meet entrance criteria|0
7787676|NCT00999518|12239397|FG002|Overall Study|Did not meet entrance criteria|0
7787677|NCT00999518|12239398|FG003|Overall Study|Did not meet entrance criteria|0
7787678|NCT00999518|12239399|FG004|Overall Study|Did not meet entrance criteria|1
7787679|NCT00999518|12239395|FG000|Overall Study|Study terminated by sponsor|10
7787680|NCT00999518|12239396|FG001|Overall Study|Study terminated by sponsor|6
7787681|NCT00999518|12239397|FG002|Overall Study|Study terminated by sponsor|5
7787682|NCT00999518|12239398|FG003|Overall Study|Study terminated by sponsor|5
7787683|NCT00999518|12239399|FG004|Overall Study|Study terminated by sponsor|9
7787684|NCT00999518|12239395|FG000|Overall Study|Pregnancy|0
7787685|NCT00999518|12239396|FG001|Overall Study|Pregnancy|0
7787686|NCT00999518|12239397|FG002|Overall Study|Pregnancy|1
7787687|NCT00999518|12239398|FG003|Overall Study|Pregnancy|0
7787688|NCT00999518|12239399|FG004|Overall Study|Pregnancy|0
7787689|NCT00999518|12239395|FG000|Overall Study|Protocol Violation|0
7787690|NCT00999518|12239396|FG001|Overall Study|Protocol Violation|1
7787691|NCT00999518|12239397|FG002|Overall Study|Protocol Violation|0
7787692|NCT00999518|12239398|FG003|Overall Study|Protocol Violation|0
7787693|NCT00999518|12239399|FG004|Overall Study|Protocol Violation|2
7787694|NCT00999518|12239395|FG000|Overall Study|Withdrawal by Subject|5
7787695|NCT00999518|12239396|FG001|Overall Study|Withdrawal by Subject|4
7787696|NCT00999518|12239397|FG002|Overall Study|Withdrawal by Subject|10
7787697|NCT00999518|12239398|FG003|Overall Study|Withdrawal by Subject|6
7787698|NCT00999518|12239399|FG004|Overall Study|Withdrawal by Subject|1
7787699|NCT00999518|12239395|FG000|Overall Study|Other|5
7787700|NCT00999518|12239396|FG001|Overall Study|Other|7
7787701|NCT00999518|12239397|FG002|Overall Study|Other|1
7787702|NCT00999518|12239398|FG003|Overall Study|Other|4
7787703|NCT00999518|12239399|FG004|Overall Study|Other|5
7787704|NCT00999518|12239395|FG000|Overall Study|Randomized but not Treated|1
7787705|NCT00999518|12239396|FG001|Overall Study|Randomized but not Treated|1
7787706|NCT00999518|12239397|FG002|Overall Study|Randomized but not Treated|2
7787707|NCT00999518|12239398|FG003|Overall Study|Randomized but not Treated|0
7787708|NCT00999518|12239399|FG004|Overall Study|Randomized but not Treated|1
7787709|NCT00999544|12239415|FG000|Overall Study|Withdrawal by Subject|1
7621972|NCT01684722|12032570|FG001|Overall Study|Lost to Follow-up|56
7621973|NCT01684722|12032571|FG002|Overall Study|Lost to Follow-up|75
7621974|NCT01684722|12032572|FG003|Overall Study|Lost to Follow-up|89
7621975|NCT01684722|12032569|FG000|Overall Study|Death|19
7621976|NCT01684722|12032570|FG001|Overall Study|Death|21
7621977|NCT01684722|12032571|FG002|Overall Study|Death|19
7621978|NCT01684722|12032572|FG003|Overall Study|Death|21
7787710|NCT00999596|12239448|FG000|Overall Study|Statistical population not required|101
7787711|NCT00999661|12239453|FG000|Overall Study|Lost to Follow-up|59
7787712|NCT00999661|12239453|FG000|Overall Study|Adverse Event|1
7787713|NCT00999661|12239453|FG000|Overall Study|Withdrawal by Subject|1
7787714|NCT00999661|12239453|FG000|Overall Study|Not meeting eligibility criteria|9
7787715|NCT00999687|12239457|FG000|First Intervention|Withdrawal by Subject|1
7787716|NCT00999687|12239457|FG000|Second Intervention|Withdrawal by Subject|2
7787717|NCT00999687|12239457|FG000|Second Intervention|Lack of Efficacy|1
7787718|NCT00999713|12239465|FG000|Overall Study|Physician Decision|2
7787719|NCT00999713|12239466|FG001|Overall Study|Physician Decision|0
7787720|NCT00999908|12239481|FG000|Treatment Period 1|Subject withdrew consent|2
7787721|NCT00999908|12239482|FG001|Treatment Period 1|Subject withdrew consent|0
7787722|NCT00999908|12239483|FG002|Treatment Period 1|Subject withdrew consent|0
7787723|NCT00999908|12239481|FG000|Treatment Period 2|Protocol Violation|1
7787724|NCT00999908|12239482|FG001|Treatment Period 2|Protocol Violation|0
7787725|NCT00999908|12239483|FG002|Treatment Period 2|Protocol Violation|0
7787726|NCT00999921|12239493|FG000|Overall Study|Lost to Follow-up|10
7787727|NCT00999921|12239494|FG001|Overall Study|Lost to Follow-up|19
7787728|NCT01000025|12239505|FG000|Overall Study|Adverse Event|43
7787729|NCT01000025|12239506|FG001|Overall Study|Adverse Event|2
7787730|NCT01000025|12239505|FG000|Overall Study|Withdrawal by Subject|13
7787731|NCT01000025|12239506|FG001|Overall Study|Withdrawal by Subject|8
7787732|NCT01000025|12239505|FG000|Overall Study|Death|23
7787733|NCT01000025|12239506|FG001|Overall Study|Death|13
7787734|NCT01000025|12239505|FG000|Overall Study|Lack of Efficacy|363
7787735|NCT01000025|12239506|FG001|Overall Study|Lack of Efficacy|208
7787736|NCT01000025|12239505|FG000|Overall Study|Intercurrent Illness|26
7787737|NCT01000025|12239506|FG001|Overall Study|Intercurrent Illness|7
7787738|NCT01000051|12239514|FG000|Overall Study|Withdrawal by Subject|1
7787739|NCT01000051|12239515|FG001|Overall Study|Withdrawal by Subject|1
7787740|NCT01000051|12239514|FG000|Overall Study|Disease Progression|1
7787741|NCT01000051|12239515|FG001|Overall Study|Disease Progression|0
7787742|NCT01000051|12239514|FG000|Overall Study|Serious noncompliance|1
7787743|NCT01000051|12239515|FG001|Overall Study|Serious noncompliance|0
7787744|NCT01000064|12239521|FG000|Overall Study|Withdrawal by Subject|1
7787745|NCT01000064|12239522|FG001|Overall Study|Withdrawal by Subject|1
7787746|NCT01000155|12239531|FG000|Overall Study|Withdrawal by Subject|1
7787747|NCT01000155|12239531|FG000|Overall Study|Adverse Event|1
7787748|NCT01000311|12239553|FG000|Overall Study|Adverse Event|2
7787749|NCT01000311|12239554|FG001|Overall Study|Adverse Event|5
7787750|NCT01000311|12239553|FG000|Overall Study|Withdrawal by Subject|16
7787751|NCT01000311|12239554|FG001|Overall Study|Withdrawal by Subject|24
7787752|NCT01000311|12239553|FG000|Overall Study|Lost to Follow-up|15
7787753|NCT01000311|12239554|FG001|Overall Study|Lost to Follow-up|24
7787754|NCT01000311|12239553|FG000|Overall Study|Protocol Violation|1
7787755|NCT01000311|12239554|FG001|Overall Study|Protocol Violation|2
7787756|NCT01000311|12239553|FG000|Overall Study|Inappropriate enrollment|2
7787757|NCT01000311|12239554|FG001|Overall Study|Inappropriate enrollment|0
7787758|NCT01000311|12239553|FG000|Overall Study|Administrative reason|9
7787759|NCT01000311|12239554|FG001|Overall Study|Administrative reason|15
7787760|NCT01000337|12239567|FG000|Overall Study|Lost to Follow-up|4
7787761|NCT01000337|12239568|FG001|Overall Study|Lost to Follow-up|3
7787762|NCT01000376|12239576|FG000|Cycle 1 Day 1|Adverse Event|1
7787763|NCT01000376|12239577|FG001|Cycle 1 Day 1|Adverse Event|0
7787764|NCT01000376|12239576|FG000|Cycle 1 Day 1|Progressive Disease|1
7787765|NCT01000376|12239577|FG001|Cycle 1 Day 1|Progressive Disease|0
7787766|NCT01000480|12239583|FG000|Induction Phase|Adverse Event|2
7787767|NCT01000480|12239583|FG000|Induction Phase|Lost to Follow-up|1
7621979|NCT01399372|12032602|FG000|Overall Study|Protocol Violation|3
7621980|NCT01399372|12032603|FG001|Overall Study|Protocol Violation|1
7787768|NCT01000480|12239583|FG000|Induction Phase|Physician Decision|1
7787769|NCT01000480|12239583|FG000|Induction Phase|Entry Criteria Not Met|3
7621983|NCT01082211|12032638|FG000|Overall Study|Protocol Violation|4
7621984|NCT01082211|12032638|FG000|Overall Study|No protocol treatment received|3
7621985|NCT00976911|12032658|FG000|Overall Study|Withdrawal by Subject|4
7621986|NCT00976911|12032659|FG001|Overall Study|Withdrawal by Subject|6
7621987|NCT00976911|12032658|FG000|Overall Study|Death|138
7621988|NCT00976911|12032659|FG001|Overall Study|Death|126
7621989|NCT00976911|12032658|FG000|Overall Study|Adverse Event|0
7621990|NCT00976911|12032659|FG001|Overall Study|Adverse Event|1
7621991|NCT00976911|12032658|FG000|Overall Study|Protocol Violation|2
7621992|NCT00976911|12032659|FG001|Overall Study|Protocol Violation|0
7621993|NCT00976911|12032658|FG000|Overall Study|Other|8
7621994|NCT00976911|12032659|FG001|Overall Study|Other|9
7621995|NCT00976911|12032658|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30
7621996|NCT00976911|12032659|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37
7787770|NCT01000480|12239583|FG000|Concurrent Therapy Phase|Adverse Event|4
7787771|NCT01000480|12239583|FG000|Concurrent Therapy Phase|Protocol Violation|2
7787772|NCT01000480|12239583|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3
7787773|NCT01000480|12239583|FG000|Concurrent Therapy Phase|Physician Decision|1
7787774|NCT01000493|12239589|FG000|Overall Study|Adverse Event|3
7787775|NCT01000493|12239590|FG001|Overall Study|Adverse Event|6
7787776|NCT01000493|12239589|FG000|Overall Study|Lack of Efficacy|1
7787777|NCT01000493|12239590|FG001|Overall Study|Lack of Efficacy|1
7787778|NCT01000493|12239589|FG000|Overall Study|Protocol Violation|1
7787779|NCT01000493|12239590|FG001|Overall Study|Protocol Violation|8
7787780|NCT01000493|12239589|FG000|Overall Study|Study closed/terminated|25
7787781|NCT01000493|12239590|FG001|Overall Study|Study closed/terminated|23
7787782|NCT01000493|12239589|FG000|Overall Study|Lost to Follow-up|5
7787783|NCT01000493|12239590|FG001|Overall Study|Lost to Follow-up|9
7787784|NCT01000493|12239589|FG000|Overall Study|Physician Decision|1
7787785|NCT01000493|12239590|FG001|Overall Study|Physician Decision|1
7787786|NCT01000493|12239589|FG000|Overall Study|Withdrawal by Subject|3
7787787|NCT01000493|12239590|FG001|Overall Study|Withdrawal by Subject|7
7787788|NCT01000506|12239600|FG000|Overall Study|Adverse Event|6
7787789|NCT01000506|12239601|FG001|Overall Study|Adverse Event|5
7787790|NCT01000506|12239602|FG002|Overall Study|Adverse Event|8
7787791|NCT01000506|12239603|FG003|Overall Study|Adverse Event|9
7787792|NCT01000506|12239600|FG000|Overall Study|Lack of Efficacy|8
7787793|NCT01000506|12239601|FG001|Overall Study|Lack of Efficacy|6
7787794|NCT01000506|12239602|FG002|Overall Study|Lack of Efficacy|4
7787795|NCT01000506|12239603|FG003|Overall Study|Lack of Efficacy|4
7787796|NCT01000506|12239600|FG000|Overall Study|Protocol Violation|1
7787797|NCT01000506|12239601|FG001|Overall Study|Protocol Violation|1
7787798|NCT01000506|12239602|FG002|Overall Study|Protocol Violation|0
7787799|NCT01000506|12239603|FG003|Overall Study|Protocol Violation|0
7787800|NCT01000506|12239600|FG000|Overall Study|Lost to Follow-up|1
7787801|NCT01000506|12239601|FG001|Overall Study|Lost to Follow-up|1
7787802|NCT01000506|12239602|FG002|Overall Study|Lost to Follow-up|4
7787803|NCT01000506|12239603|FG003|Overall Study|Lost to Follow-up|0
7787804|NCT01000506|12239600|FG000|Overall Study|Physician Decision|1
7622032|NCT00573131|12032718|FG000|Overall Study|Withdrawal by Subject|10
7622033|NCT00573131|12032719|FG001|Overall Study|Withdrawal by Subject|8
7622034|NCT00533949|12032729|FG000|Overall Study|Protocol Violation|12
7622035|NCT00533949|12032730|FG001|Overall Study|Protocol Violation|12
7622036|NCT00533949|12032731|FG002|Overall Study|Protocol Violation|9
7622037|NCT00533949|12032732|FG003|Overall Study|Protocol Violation|9
7622038|NCT00533949|12032729|FG000|Overall Study|Withdrawal by Subject|3
7622039|NCT00533949|12032730|FG001|Overall Study|Withdrawal by Subject|2
7622040|NCT00533949|12032731|FG002|Overall Study|Withdrawal by Subject|1
7622041|NCT00533949|12032732|FG003|Overall Study|Withdrawal by Subject|1
7622042|NCT00529763|12032753|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1
7622043|NCT00529763|12032754|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
7622044|NCT00529763|12032755|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1
7622045|NCT00529763|12032753|FG000|Overall Study|Death|0
7622046|NCT00529763|12032754|FG001|Overall Study|Death|1
7622047|NCT00529763|12032755|FG002|Overall Study|Death|1
7622048|NCT00529763|12032753|FG000|Overall Study|Disease Progression|6
7622049|NCT00529763|12032754|FG001|Overall Study|Disease Progression|16
7622050|NCT00529763|12032755|FG002|Overall Study|Disease Progression|1
7622051|NCT00529763|12032753|FG000|Overall Study|Lost to Follow-up|0
7622052|NCT00529763|12032754|FG001|Overall Study|Lost to Follow-up|1
7622053|NCT00529763|12032755|FG002|Overall Study|Lost to Follow-up|1
7787805|NCT01000506|12239601|FG001|Overall Study|Physician Decision|3
7622054|NCT00529763|12032753|FG000|Overall Study|Stem Cell Transplant|0
7622055|NCT00529763|12032754|FG001|Overall Study|Stem Cell Transplant|3
7622056|NCT00529763|12032755|FG002|Overall Study|Stem Cell Transplant|0
7622057|NCT00529763|12032753|FG000|Overall Study|Study Drug Toxicity|1
7622058|NCT00529763|12032754|FG001|Overall Study|Study Drug Toxicity|6
7622059|NCT00529763|12032755|FG002|Overall Study|Study Drug Toxicity|1
7622060|NCT00529763|12032753|FG000|Overall Study|Patient Withdrew Consent|2
7622061|NCT00529763|12032754|FG001|Overall Study|Patient Withdrew Consent|3
7622062|NCT00529763|12032755|FG002|Overall Study|Patient Withdrew Consent|2
7622063|NCT00479765|12032770|FG000|Overall Study|study terminated|4
7622064|NCT00450411|12032774|FG000|Overall Study|Protocol Violation|6
7622065|NCT00450411|12032774|FG000|Overall Study|No protocol treatment|2
7622066|NCT00412880|12032778|FG000|Overall Study|Withdrew, overdose of study treatment|1
7622067|NCT00412880|12032778|FG000|Overall Study|Consent withdrawn|1
7622068|NCT00412880|12032778|FG000|Overall Study|Adverse Event|1
7787806|NCT01000506|12239602|FG002|Overall Study|Physician Decision|3
7787807|NCT01000506|12239603|FG003|Overall Study|Physician Decision|3
7787808|NCT01000506|12239600|FG000|Overall Study|Withdrawal by Subject|11
7787809|NCT01000506|12239601|FG001|Overall Study|Withdrawal by Subject|8
7787810|NCT01000506|12239602|FG002|Overall Study|Withdrawal by Subject|2
7787811|NCT01000506|12239603|FG003|Overall Study|Withdrawal by Subject|7
7787812|NCT01000610|12239613|FG000|Overall Study|Adverse Event|1
7787813|NCT01000610|12239613|FG000|Overall Study|Lost to Follow-up|4
7787814|NCT01000610|12239613|FG000|Overall Study|Treatment failure|1
7787815|NCT01000636|12239617|FG000|Overall Study|Withdrawal by Subject|1
7787816|NCT01000636|12239617|FG000|Overall Study|Adverse Event|1
7787817|NCT01000649|12239625|FG000|Overall Study|Adverse Event|5
7787818|NCT01000649|12239626|FG001|Overall Study|Adverse Event|1
7787819|NCT01000649|12239627|FG002|Overall Study|Adverse Event|2
7787820|NCT01000649|12239628|FG003|Overall Study|Adverse Event|4
7787821|NCT01000649|12239625|FG000|Overall Study|Lost to Follow-up|0
7787822|NCT01000649|12239626|FG001|Overall Study|Lost to Follow-up|2
7787823|NCT01000649|12239627|FG002|Overall Study|Lost to Follow-up|0
7787824|NCT01000649|12239628|FG003|Overall Study|Lost to Follow-up|2
7787825|NCT01000727|12239650|FG000|Overall Study|Lost to Follow-up|41
7787826|NCT01000727|12239651|FG001|Overall Study|Lost to Follow-up|43
7787827|NCT01000727|12239650|FG000|Overall Study|Withdrawal by Subject|111
7787828|NCT01000727|12239651|FG001|Overall Study|Withdrawal by Subject|109
7787829|NCT01000727|12239650|FG000|Overall Study|Study closed/terminated|23
7787830|NCT01000727|12239651|FG001|Overall Study|Study closed/terminated|24
7787831|NCT01000805|12239661|FG000|Overall Study|Adverse Event|21
7787832|NCT01000805|12239662|FG001|Overall Study|Adverse Event|9
7787833|NCT01000805|12239661|FG000|Overall Study|Lack of Efficacy|5
7787834|NCT01000805|12239662|FG001|Overall Study|Lack of Efficacy|16
7787835|NCT01000805|12239661|FG000|Overall Study|Lost to Follow-up|16
7787836|NCT01000805|12239662|FG001|Overall Study|Lost to Follow-up|21
7787837|NCT01000805|12239661|FG000|Overall Study|Physician Decision|0
7787838|NCT01000805|12239662|FG001|Overall Study|Physician Decision|1
7787839|NCT01000805|12239661|FG000|Overall Study|Protocol Violation|12
7787840|NCT01000805|12239662|FG001|Overall Study|Protocol Violation|8
7787841|NCT01000805|12239661|FG000|Overall Study|Withdrawal by Subject|16
7787842|NCT01000805|12239662|FG001|Overall Study|Withdrawal by Subject|6
7787843|NCT01000805|12239661|FG000|Overall Study|Sponsor Decision|0
7787844|NCT01000805|12239662|FG001|Overall Study|Sponsor Decision|1
7787845|NCT01000961|12239678|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0
7787846|NCT01000961|12239679|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
7787847|NCT01000961|12239678|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
7787848|NCT01000961|12239679|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
7787849|NCT01000974|12239690|FG000|Primary Vaccination Phase|Withdrawal by Subject|109
7787850|NCT01000974|12239691|FG001|Primary Vaccination Phase|Withdrawal by Subject|17
7787851|NCT01000974|12239692|FG002|Primary Vaccination Phase|Withdrawal by Subject|21
7787852|NCT01000974|12239690|FG000|Primary Vaccination Phase|Lost to Follow-up|171
7787853|NCT01000974|12239691|FG001|Primary Vaccination Phase|Lost to Follow-up|19
7787854|NCT01000974|12239692|FG002|Primary Vaccination Phase|Lost to Follow-up|26
7787855|NCT01000974|12239690|FG000|Primary Vaccination Phase|Protocol Violation|40
7787856|NCT01000974|12239691|FG001|Primary Vaccination Phase|Protocol Violation|3
7787857|NCT01000974|12239692|FG002|Primary Vaccination Phase|Protocol Violation|2
7787858|NCT01000974|12239690|FG000|Primary Vaccination Phase|Adverse Event|14
7787859|NCT01000974|12239691|FG001|Primary Vaccination Phase|Adverse Event|2
7787860|NCT01000974|12239692|FG002|Primary Vaccination Phase|Adverse Event|2
7787861|NCT01000974|12239690|FG000|Primary Vaccination Phase|Other|4
7787862|NCT01000974|12239691|FG001|Primary Vaccination Phase|Other|9
7787863|NCT01000974|12239692|FG002|Primary Vaccination Phase|Other|12
7787864|NCT01000974|12239690|FG000|Booster Vaccination Phase|Protocol Violation|0
7787865|NCT01000974|12239691|FG001|Booster Vaccination Phase|Protocol Violation|0
7787866|NCT01000974|12239692|FG002|Booster Vaccination Phase|Protocol Violation|2
7787867|NCT01000974|12239690|FG000|Booster Vaccination Phase|Withdrawal by Subject|3
7787868|NCT01000974|12239691|FG001|Booster Vaccination Phase|Withdrawal by Subject|1
7787869|NCT01000974|12239692|FG002|Booster Vaccination Phase|Withdrawal by Subject|1
7787870|NCT01000974|12239690|FG000|Booster Vaccination Phase|Lost to Follow-up|40
7787871|NCT01000974|12239691|FG001|Booster Vaccination Phase|Lost to Follow-up|5
7787872|NCT01000974|12239692|FG002|Booster Vaccination Phase|Lost to Follow-up|7
7787873|NCT01000974|12239690|FG000|Booster Vaccination Phase|Other|24
7787874|NCT01000974|12239691|FG001|Booster Vaccination Phase|Other|6
7787875|NCT01000974|12239692|FG002|Booster Vaccination Phase|Other|4
7787876|NCT01001104|12239738|FG000|Overall Study|Adverse Event|2
7787877|NCT01001104|12239739|FG001|Overall Study|Adverse Event|1
7787878|NCT01001104|12239740|FG002|Overall Study|Adverse Event|0
7622069|NCT00412880|12032778|FG000|Overall Study|Progressive disease|20
7622070|NCT00376623|12032785|FG000|Overall Study|Progressive disease|35
7622071|NCT00376623|12032786|FG001|Overall Study|Progressive disease|22
7622072|NCT00376623|12032787|FG002|Overall Study|Progressive disease|17
7622073|NCT00376623|12032785|FG000|Overall Study|Lost to Follow-up|0
7622074|NCT00376623|12032786|FG001|Overall Study|Lost to Follow-up|1
7622075|NCT00376623|12032787|FG002|Overall Study|Lost to Follow-up|0
7622076|NCT00376623|12032785|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6
7622077|NCT00376623|12032786|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1
7622078|NCT00376623|12032787|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2
7622079|NCT00376623|12032785|FG000|Overall Study|Not treated with BI 2536|1
7622080|NCT00376623|12032786|FG001|Overall Study|Not treated with BI 2536|0
7622081|NCT00376623|12032787|FG002|Overall Study|Not treated with BI 2536|0
7622082|NCT00376623|12032785|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1
7622083|NCT00376623|12032786|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0
7622084|NCT00376623|12032787|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0
7622085|NCT00376623|12032785|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1
7622086|NCT00376623|12032786|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0
7622087|NCT00376623|12032787|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0
7622088|NCT00376623|12032785|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2
7622089|NCT00376623|12032786|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0
7622090|NCT00376623|12032787|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0
7622091|NCT00376623|12032785|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0
7622092|NCT00376623|12032786|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1
7622093|NCT00376623|12032787|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0
7622094|NCT00376623|12032785|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0
7622095|NCT00376623|12032786|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0
7622096|NCT00376623|12032787|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1
7622097|NCT00376623|12032785|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2
7622098|NCT00376623|12032786|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0
7622099|NCT00376623|12032787|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1
7622100|NCT00376623|12032785|FG000|Overall Study|Increase of tumour markers|0
7622101|NCT00376623|12032786|FG001|Overall Study|Increase of tumour markers|1
7622102|NCT00376623|12032787|FG002|Overall Study|Increase of tumour markers|0
7622103|NCT00376623|12032785|FG000|Overall Study|Bone metastasis|1
7622104|NCT00376623|12032786|FG001|Overall Study|Bone metastasis|0
7622105|NCT00376623|12032787|FG002|Overall Study|Bone metastasis|0
7622106|NCT00288080|12032803|FG000|Overall Study|Withdrawal by Subject|1
7622107|NCT00288080|12032804|FG001|Overall Study|Withdrawal by Subject|3
7622108|NCT00288080|12032803|FG000|Overall Study|Protocol Violation|25
7622109|NCT00288080|12032804|FG001|Overall Study|Protocol Violation|20
7787879|NCT01001104|12239741|FG003|Overall Study|Adverse Event|0
7787880|NCT01001104|12239738|FG000|Overall Study|Lost to Follow-up|0
7787881|NCT01001104|12239739|FG001|Overall Study|Lost to Follow-up|0
7787882|NCT01001104|12239740|FG002|Overall Study|Lost to Follow-up|1
7787883|NCT01001104|12239741|FG003|Overall Study|Lost to Follow-up|0
7787884|NCT01001104|12239738|FG000|Overall Study|Entry Criteria Not Met|0
7787885|NCT01001104|12239739|FG001|Overall Study|Entry Criteria Not Met|0
7787886|NCT01001104|12239740|FG002|Overall Study|Entry Criteria Not Met|0
7787887|NCT01001104|12239741|FG003|Overall Study|Entry Criteria Not Met|1
7787888|NCT01001104|12239738|FG000|Overall Study|Withdrawal by Subject|0
7787889|NCT01001104|12239739|FG001|Overall Study|Withdrawal by Subject|0
7787890|NCT01001104|12239740|FG002|Overall Study|Withdrawal by Subject|0
7787891|NCT01001104|12239741|FG003|Overall Study|Withdrawal by Subject|2
7787892|NCT01001169|12239756|FG000|Overall Study|Withdrawal by Subject|2
7787893|NCT01001169|12239757|FG001|Overall Study|Withdrawal by Subject|1
7787894|NCT01001208|12239790|FG000|Overall Study|Adverse Event|10
7787895|NCT01001208|12239791|FG001|Overall Study|Adverse Event|5
7787896|NCT01001208|12239790|FG000|Overall Study|Lost to Follow-up|5
7787897|NCT01001208|12239791|FG001|Overall Study|Lost to Follow-up|9
7622118|NCT04794270|12032853|FG000|Period 1|Non Compliance|1
7622119|NCT04794270|12032854|FG001|Period 1|Non Compliance|0
7622120|NCT04794270|12032853|FG000|Period 1|Adverse Event|1
7622121|NCT04794270|12032854|FG001|Period 1|Adverse Event|0
7622122|NCT04794270|12032853|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1
7622123|NCT04794270|12032854|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0
7622124|NCT04327986|12032893|FG000|Overall Study|Physician Decision|2
7622125|NCT04327986|12032894|FG001|Overall Study|Physician Decision|0
7622126|NCT04327986|12032895|FG002|Overall Study|Physician Decision|0
7622127|NCT04327986|12032893|FG000|Overall Study|Death|1
7622128|NCT04327986|12032894|FG001|Overall Study|Death|0
7622129|NCT04327986|12032895|FG002|Overall Study|Death|0
7622130|NCT03655054|12032926|FG000|Overall Study|Lost to Follow-up|1
7622131|NCT03542266|12032941|FG000|Treatment Phase|Withdrawal by Subject|1
7622132|NCT03542266|12032941|FG000|Treatment Phase|Adverse Event|1
7622133|NCT03542266|12032941|FG000|Treatment Phase|PD|1
7622134|NCT03529409|12032948|FG000|Randomized|Lost to Follow-up|0
7622135|NCT03529409|12032949|FG001|Randomized|Lost to Follow-up|0
7622136|NCT03529409|12032950|FG002|Randomized|Lost to Follow-up|4
7622137|NCT03529409|12032948|FG000|Randomized|Excluded|0
7622138|NCT03529409|12032949|FG001|Randomized|Excluded|0
7622139|NCT03529409|12032950|FG002|Randomized|Excluded|1
7622140|NCT03529409|12032948|FG000|Post-treatment Assessment|Death|1
7622141|NCT03529409|12032949|FG001|Post-treatment Assessment|Death|0
7622142|NCT03529409|12032950|FG002|Post-treatment Assessment|Death|0
7622143|NCT03529409|12032948|FG000|Post-treatment Assessment|Lost to Follow-up|1
7622144|NCT03529409|12032949|FG001|Post-treatment Assessment|Lost to Follow-up|1
7622145|NCT03529409|12032950|FG002|Post-treatment Assessment|Lost to Follow-up|0
7622146|NCT03529409|12032948|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2
7622147|NCT03529409|12032949|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4
7622148|NCT03529409|12032950|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0
7622149|NCT03529409|12032948|FG000|Follow-up Assessment|Death|1
7622150|NCT03529409|12032949|FG001|Follow-up Assessment|Death|0
7622151|NCT03529409|12032950|FG002|Follow-up Assessment|Death|0
7622152|NCT03529409|12032948|FG000|Follow-up Assessment|Withdrawal by Subject|0
7622153|NCT03529409|12032949|FG001|Follow-up Assessment|Withdrawal by Subject|1
7622154|NCT03529409|12032950|FG002|Follow-up Assessment|Withdrawal by Subject|0
7622155|NCT03516812|12032957|FG000|Overall Study|Adverse Event|4
7622156|NCT03516812|12032957|FG000|Overall Study|Lack of Efficacy|2
7622157|NCT03463577|12032971|FG000|Overall Study|Lost to Follow-up|238
7622158|NCT03463577|12032972|FG001|Overall Study|Lost to Follow-up|435
7622159|NCT03463577|12032973|FG002|Overall Study|Lost to Follow-up|0
7622160|NCT03463577|12032974|FG003|Overall Study|Lost to Follow-up|0
7622161|NCT03463577|12032975|FG004|Overall Study|Lost to Follow-up|0
7622162|NCT03463577|12032976|FG005|Overall Study|Lost to Follow-up|0
7622163|NCT03463577|12032971|FG000|Overall Study|With unknown pregnancy outcome|0
7622164|NCT03463577|12032972|FG001|Overall Study|With unknown pregnancy outcome|5
7622165|NCT03463577|12032973|FG002|Overall Study|With unknown pregnancy outcome|0
7622166|NCT03463577|12032974|FG003|Overall Study|With unknown pregnancy outcome|0
7787898|NCT01001208|12239790|FG000|Overall Study|Physician Decision|1
7787899|NCT01001208|12239791|FG001|Overall Study|Physician Decision|0
7787900|NCT01001208|12239790|FG000|Overall Study|Withdrawal by Subject|4
7787901|NCT01001208|12239791|FG001|Overall Study|Withdrawal by Subject|5
7787902|NCT01001208|12239790|FG000|Overall Study|Ineligibility Determined|4
7787903|NCT01001208|12239791|FG001|Overall Study|Ineligibility Determined|2
7787904|NCT01001208|12239790|FG000|Overall Study|Noncompliance|4
7787905|NCT01001208|12239791|FG001|Overall Study|Noncompliance|7
7787906|NCT01001208|12239790|FG000|Overall Study|Disease Progression|0
7787907|NCT01001208|12239791|FG001|Overall Study|Disease Progression|3
7787908|NCT01001208|12239790|FG000|Overall Study|Other|0
7787909|NCT01001208|12239791|FG001|Overall Study|Other|2
7787910|NCT01001221|12239801|FG000|Overall Study|Adverse Event|1
7787911|NCT01001221|12239802|FG001|Overall Study|Adverse Event|2
7787912|NCT01001221|12239803|FG002|Overall Study|Adverse Event|0
7787913|NCT01001221|12239804|FG003|Overall Study|Adverse Event|2
7787914|NCT01001221|12239805|FG004|Overall Study|Adverse Event|0
7787915|NCT01001221|12239801|FG000|Overall Study|Disease progression|3
7787916|NCT01001221|12239802|FG001|Overall Study|Disease progression|2
7787917|NCT01001221|12239803|FG002|Overall Study|Disease progression|2
7787918|NCT01001221|12239804|FG003|Overall Study|Disease progression|4
7787919|NCT01001221|12239805|FG004|Overall Study|Disease progression|0
7787920|NCT01001221|12239801|FG000|Overall Study|Other|1
7787921|NCT01001221|12239802|FG001|Overall Study|Other|1
7787922|NCT01001221|12239803|FG002|Overall Study|Other|0
7787923|NCT01001221|12239804|FG003|Overall Study|Other|0
7787924|NCT01001221|12239805|FG004|Overall Study|Other|0
7622167|NCT03463577|12032975|FG004|Overall Study|With unknown pregnancy outcome|0
7622168|NCT03463577|12032976|FG005|Overall Study|With unknown pregnancy outcome|0
7622169|NCT03463577|12032971|FG000|Overall Study|Maternal death|2
7622170|NCT03463577|12032972|FG001|Overall Study|Maternal death|0
7622171|NCT03463577|12032973|FG002|Overall Study|Maternal death|0
7622172|NCT03463577|12032974|FG003|Overall Study|Maternal death|0
7787925|NCT01001221|12239801|FG000|Overall Study|Not treated; protocol exclusion|0
7622173|NCT03463577|12032975|FG004|Overall Study|Maternal death|0
7622174|NCT03463577|12032976|FG005|Overall Study|Maternal death|0
7622175|NCT03463577|12032971|FG000|Overall Study|Neonatal death|0
7622176|NCT03463577|12032972|FG001|Overall Study|Neonatal death|0
7622177|NCT03463577|12032973|FG002|Overall Study|Neonatal death|0
7622178|NCT03463577|12032974|FG003|Overall Study|Neonatal death|15
7622179|NCT03463577|12032975|FG004|Overall Study|Neonatal death|17
7622180|NCT03463577|12032976|FG005|Overall Study|Neonatal death|0
7622181|NCT03373760|12032992|FG000|Overall Study|Adverse Event|8
7622182|NCT03373760|12032992|FG000|Overall Study|Disease Progression|46
7622183|NCT03373760|12032992|FG000|Overall Study|Death|4
7622184|NCT03253627|12033001|FG000|Overall Study|Lost to Follow-up|1
7622185|NCT03253627|12033002|FG001|Overall Study|Lost to Follow-up|2
7622186|NCT03253627|12033001|FG000|Overall Study|Withdrawal by Subject|0
7622187|NCT03253627|12033002|FG001|Overall Study|Withdrawal by Subject|2
7622188|NCT03253627|12033001|FG000|Overall Study|Inability to complete MRI|1
7622189|NCT03253627|12033002|FG001|Overall Study|Inability to complete MRI|0
7622190|NCT03168555|12033008|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1
7622191|NCT03168555|12033008|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1
7622192|NCT03168555|12033008|FG000|Visit 2 (Post-operative)|Adverse Event|1
7622193|NCT03168555|12033008|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2
7787926|NCT01001221|12239802|FG001|Overall Study|Not treated; protocol exclusion|0
7787927|NCT01001221|12239803|FG002|Overall Study|Not treated; protocol exclusion|1
7787928|NCT01001221|12239804|FG003|Overall Study|Not treated; protocol exclusion|0
7787929|NCT01001221|12239805|FG004|Overall Study|Not treated; protocol exclusion|0
7787930|NCT01001299|12239816|FG000|Overall Study|Insufficient Therapeutic Response|20
7787931|NCT01001299|12239816|FG000|Overall Study|Adverse event or Intercurrent Illness|1
7787932|NCT01001299|12239816|FG000|Overall Study|Death|1
7787933|NCT01001299|12239816|FG000|Overall Study|Began Taking Commercially Available Drug|2
7787934|NCT01001299|12239816|FG000|Overall Study|Withdrew Consent|1
7787935|NCT01001325|12239822|FG000|Overall Study|Lost to Follow-up|16
7787936|NCT01001325|12239823|FG001|Overall Study|Lost to Follow-up|10
7787937|NCT01001325|12239822|FG000|Overall Study|Protocol Violation|2
7787938|NCT01001325|12239823|FG001|Overall Study|Protocol Violation|0
7787939|NCT01001429|12239840|FG000|Overall Study|surgery cancelled|0
7787940|NCT01001429|12239841|FG001|Overall Study|surgery cancelled|1
7787941|NCT01001494|12239911|FG000|Overall Study|Adverse Event|8
7787942|NCT01001494|12239912|FG001|Overall Study|Adverse Event|4
7787943|NCT01001494|12239913|FG002|Overall Study|Adverse Event|6
7787944|NCT01001494|12239911|FG000|Overall Study|Protocol Violation|0
7787945|NCT01001494|12239912|FG001|Overall Study|Protocol Violation|1
7787946|NCT01001494|12239913|FG002|Overall Study|Protocol Violation|1
7787947|NCT01001494|12239911|FG000|Overall Study|Lost to Follow-up|2
7787948|NCT01001494|12239912|FG001|Overall Study|Lost to Follow-up|0
7787949|NCT01001494|12239913|FG002|Overall Study|Lost to Follow-up|1
7787950|NCT01001494|12239911|FG000|Overall Study|Withdrawal by Subject|9
7787951|NCT01001494|12239912|FG001|Overall Study|Withdrawal by Subject|7
7787952|NCT01001494|12239913|FG002|Overall Study|Withdrawal by Subject|17
7787953|NCT01001494|12239911|FG000|Overall Study|COPD exacerbation|3
7787954|NCT01001494|12239912|FG001|Overall Study|COPD exacerbation|4
7787955|NCT01001494|12239913|FG002|Overall Study|COPD exacerbation|5
7787956|NCT01001494|12239911|FG000|Overall Study|Lack of Efficacy|2
7787957|NCT01001494|12239912|FG001|Overall Study|Lack of Efficacy|0
7787958|NCT01001494|12239913|FG002|Overall Study|Lack of Efficacy|8
7787959|NCT01001494|12239911|FG000|Overall Study|Other|0
7787960|NCT01001494|12239912|FG001|Overall Study|Other|1
7787961|NCT01001494|12239913|FG002|Overall Study|Other|3
7787962|NCT01001520|12239921|FG000|Medication Period 1|Withdrawal by Subject|2
7622194|NCT03135119|12033017|FG000|Overall Study|Lost to Follow-up|2
7622195|NCT03135119|12033018|FG001|Overall Study|Lost to Follow-up|0
7622196|NCT03135119|12033017|FG000|Overall Study|Physician Decision|1
7622197|NCT03135119|12033018|FG001|Overall Study|Physician Decision|1
7622198|NCT03135119|12033017|FG000|Overall Study|COVID-19 Shutdown|2
7622199|NCT03135119|12033018|FG001|Overall Study|COVID-19 Shutdown|2
7622200|NCT03128411|12033024|FG000|Treatment Phase|Adverse Event|21
7622201|NCT03128411|12033024|FG000|Treatment Phase|Physician Decision|1
7622202|NCT03128411|12033024|FG000|Treatment Phase|Other|2
7622203|NCT03128411|12033024|FG000|Long Term Follow-up Phase|Death|2
7622204|NCT03097328|12033028|FG000|Overall Study|Still on Therapy|2
7622205|NCT03097328|12033028|FG000|Overall Study|Progressive Disease|29
7622206|NCT03097328|12033028|FG000|Overall Study|Adverse Event|4
7622207|NCT03097328|12033028|FG000|Overall Study|Withdrawal by Subject|1
7622208|NCT03097328|12033028|FG000|Overall Study|Physician Decision|1
7622209|NCT03097328|12033028|FG000|Overall Study|Patient Decision|1
7622210|NCT03097328|12033028|FG000|Overall Study|Ineligible for Study Drug|1
7622211|NCT03068715|12033034|FG000|Overall Study|No longer met inclusion criteria|1
7622212|NCT03068715|12033035|FG001|Overall Study|No longer met inclusion criteria|0
7622213|NCT02981472|12033045|FG000|Pre-Treatment Period|Participant withdrew consent|2
7622214|NCT02981472|12033046|FG001|Pre-Treatment Period|Participant withdrew consent|1
7622215|NCT02981472|12033045|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1
7622216|NCT02981472|12033046|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0
7622217|NCT02981472|12033045|FG000|Treatment Period|Adverse Event|6
7787963|NCT01001520|12239922|FG001|Medication Period 1|Withdrawal by Subject|2
7787964|NCT01001520|12239921|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
7787965|NCT01001520|12239922|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
7787966|NCT01001520|12239921|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0
7787967|NCT01001520|12239922|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2
7787968|NCT01001520|12239921|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
7787969|NCT01001520|12239922|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
7787970|NCT01001520|12239921|FG000|Washout Period|Withdrawal by Subject|2
7787971|NCT01001520|12239922|FG001|Washout Period|Withdrawal by Subject|1
7787972|NCT01001520|12239921|FG000|Medication Period 2|Withdrawal by Subject|0
7787973|NCT01001520|12239922|FG001|Medication Period 2|Withdrawal by Subject|3
7787974|NCT01001572|12239951|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
7787975|NCT01001572|12239952|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
7787976|NCT01001572|12239953|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
7787977|NCT01001572|12239951|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11
7787978|NCT01001572|12239952|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0
7787979|NCT01001572|12239953|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0
7787980|NCT01001572|12239951|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
7787981|NCT01001572|12239952|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
7787982|NCT01001572|12239953|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
7787983|NCT01001572|12239951|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
7787984|NCT01001572|12239952|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
7787985|NCT01001572|12239953|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
7787986|NCT01001572|12239951|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
7787987|NCT01001572|12239952|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
7622218|NCT02981472|12033046|FG001|Treatment Period|Adverse Event|1
7622219|NCT02981472|12033045|FG000|Treatment Period|Participant withdrew consent|1
7622220|NCT02981472|12033046|FG001|Treatment Period|Participant withdrew consent|0
7622221|NCT02981472|12033045|FG000|Treatment Period|Lost to Follow-up|0
7622222|NCT02981472|12033046|FG001|Treatment Period|Lost to Follow-up|1
7622223|NCT02853760|12033058|FG000|Washout (1 Week)|acute illness (not connected with the study)|0
7622224|NCT02853760|12033059|FG001|Washout (1 Week)|acute illness (not connected with the study)|0
7622225|NCT02853760|12033060|FG002|Washout (1 Week)|acute illness (not connected with the study)|1
7622226|NCT02853760|12033061|FG003|Washout (1 Week)|acute illness (not connected with the study)|2
7622227|NCT02853760|12033062|FG004|Washout (1 Week)|acute illness (not connected with the study)|0
7622228|NCT02853760|12033063|FG005|Washout (1 Week)|acute illness (not connected with the study)|2
7622229|NCT02789657|12033075|FG000|Overall Study|Withdrawal by Subject|2
7622230|NCT02789657|12033076|FG001|Overall Study|Withdrawal by Subject|0
7622231|NCT02789657|12033077|FG002|Overall Study|Withdrawal by Subject|0
7622232|NCT02789657|12033078|FG003|Overall Study|Withdrawal by Subject|0
7622233|NCT02743871|12033101|FG000|Overall Study|Lost to Follow-up|0
7622234|NCT02743871|12033102|FG001|Overall Study|Lost to Follow-up|0
7622235|NCT02743871|12033103|FG002|Overall Study|Lost to Follow-up|0
7622236|NCT02743871|12033104|FG003|Overall Study|Lost to Follow-up|1
7622237|NCT02743871|12033105|FG004|Overall Study|Lost to Follow-up|0
7622238|NCT02743871|12033106|FG005|Overall Study|Lost to Follow-up|0
7622239|NCT02743871|12033107|FG006|Overall Study|Lost to Follow-up|1
7622240|NCT02743871|12033108|FG007|Overall Study|Lost to Follow-up|0
7622241|NCT02743871|12033109|FG008|Overall Study|Lost to Follow-up|0
7622242|NCT02743871|12033110|FG009|Overall Study|Lost to Follow-up|0
7622243|NCT02743871|12033111|FG010|Overall Study|Lost to Follow-up|0
7622244|NCT02743871|12033112|FG011|Overall Study|Lost to Follow-up|2
7622245|NCT02743871|12033113|FG012|Overall Study|Lost to Follow-up|0
7787988|NCT01001572|12239953|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
7622246|NCT02743871|12033114|FG013|Overall Study|Lost to Follow-up|0
7622247|NCT02743871|12033101|FG000|Overall Study|Withdrawal by Subject|0
7622248|NCT02743871|12033102|FG001|Overall Study|Withdrawal by Subject|0
7622249|NCT02743871|12033103|FG002|Overall Study|Withdrawal by Subject|0
7622250|NCT02743871|12033104|FG003|Overall Study|Withdrawal by Subject|0
7622251|NCT02743871|12033105|FG004|Overall Study|Withdrawal by Subject|0
7622252|NCT02743871|12033106|FG005|Overall Study|Withdrawal by Subject|0
7622253|NCT02743871|12033107|FG006|Overall Study|Withdrawal by Subject|0
7622254|NCT02743871|12033108|FG007|Overall Study|Withdrawal by Subject|0
7622255|NCT02743871|12033109|FG008|Overall Study|Withdrawal by Subject|0
7622256|NCT02743871|12033110|FG009|Overall Study|Withdrawal by Subject|0
7622257|NCT02743871|12033111|FG010|Overall Study|Withdrawal by Subject|1
7622258|NCT02743871|12033112|FG011|Overall Study|Withdrawal by Subject|0
7622259|NCT02743871|12033113|FG012|Overall Study|Withdrawal by Subject|12
7622260|NCT02743871|12033114|FG013|Overall Study|Withdrawal by Subject|6
7622261|NCT02743871|12033101|FG000|Overall Study|Adverse Event|1
7622262|NCT02743871|12033102|FG001|Overall Study|Adverse Event|0
7622263|NCT02743871|12033103|FG002|Overall Study|Adverse Event|0
7622264|NCT02743871|12033104|FG003|Overall Study|Adverse Event|0
7622265|NCT02743871|12033105|FG004|Overall Study|Adverse Event|0
7622266|NCT02743871|12033106|FG005|Overall Study|Adverse Event|0
7622267|NCT02743871|12033107|FG006|Overall Study|Adverse Event|0
7622268|NCT02743871|12033108|FG007|Overall Study|Adverse Event|0
7622269|NCT02743871|12033109|FG008|Overall Study|Adverse Event|0
7622270|NCT02743871|12033110|FG009|Overall Study|Adverse Event|0
7622271|NCT02743871|12033111|FG010|Overall Study|Adverse Event|0
7622272|NCT02743871|12033112|FG011|Overall Study|Adverse Event|0
7622273|NCT02743871|12033113|FG012|Overall Study|Adverse Event|0
7622274|NCT02743871|12033114|FG013|Overall Study|Adverse Event|0
7622275|NCT02743871|12033101|FG000|Overall Study|Other|0
7622276|NCT02743871|12033102|FG001|Overall Study|Other|0
7622277|NCT02743871|12033103|FG002|Overall Study|Other|0
7622278|NCT02743871|12033104|FG003|Overall Study|Other|0
7622279|NCT02743871|12033105|FG004|Overall Study|Other|0
7622280|NCT02743871|12033106|FG005|Overall Study|Other|0
7622281|NCT02743871|12033107|FG006|Overall Study|Other|0
7622282|NCT02743871|12033108|FG007|Overall Study|Other|0
7622283|NCT02743871|12033109|FG008|Overall Study|Other|0
7622284|NCT02743871|12033110|FG009|Overall Study|Other|0
7622285|NCT02743871|12033111|FG010|Overall Study|Other|0
7622286|NCT02743871|12033112|FG011|Overall Study|Other|1
7622287|NCT02743871|12033113|FG012|Overall Study|Other|1
7622288|NCT02743871|12033114|FG013|Overall Study|Other|1
7622289|NCT02743871|12033101|FG000|Overall Study|Protocol Violation|0
7622290|NCT02743871|12033102|FG001|Overall Study|Protocol Violation|0
7622291|NCT02743871|12033103|FG002|Overall Study|Protocol Violation|0
7622292|NCT02743871|12033104|FG003|Overall Study|Protocol Violation|0
7622293|NCT02743871|12033105|FG004|Overall Study|Protocol Violation|0
7622294|NCT02743871|12033106|FG005|Overall Study|Protocol Violation|0
7622295|NCT02743871|12033107|FG006|Overall Study|Protocol Violation|0
7622296|NCT02743871|12033108|FG007|Overall Study|Protocol Violation|0
7622297|NCT02743871|12033109|FG008|Overall Study|Protocol Violation|0
7622298|NCT02743871|12033110|FG009|Overall Study|Protocol Violation|0
7622299|NCT02743871|12033111|FG010|Overall Study|Protocol Violation|0
7622300|NCT02743871|12033112|FG011|Overall Study|Protocol Violation|0
7622301|NCT02743871|12033113|FG012|Overall Study|Protocol Violation|2
7622302|NCT02743871|12033114|FG013|Overall Study|Protocol Violation|0
7622303|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Adverse Event|7
7622304|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Adverse Event|3
7622305|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Adverse Event|2
7622306|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Adverse Event|0
7622307|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4
7622308|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0
7622309|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0
7622310|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0
7787989|NCT01001572|12239951|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
7787990|NCT01001572|12239952|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
7787991|NCT01001572|12239953|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
7787992|NCT01001572|12239951|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82
7787993|NCT01001572|12239952|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0
7787994|NCT01001572|12239953|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0
7787995|NCT01001572|12239951|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
7787996|NCT01001572|12239952|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
7787997|NCT01001572|12239953|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
7787998|NCT01001572|12239951|FG000|Double-Blind Treatment Phase|Adverse Event|0
7787999|NCT01001572|12239952|FG001|Double-Blind Treatment Phase|Adverse Event|2
7788000|NCT01001572|12239953|FG002|Double-Blind Treatment Phase|Adverse Event|2
7788001|NCT01001572|12239951|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0
7788002|NCT01001572|12239952|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8
7788003|NCT01001572|12239953|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13
7788004|NCT01001572|12239951|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
7788005|NCT01001572|12239952|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
7788006|NCT01001572|12239953|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
7788007|NCT01001572|12239951|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
7788008|NCT01001572|12239952|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
7788009|NCT01001572|12239953|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
7788010|NCT01001572|12239951|FG000|Double-Blind Treatment Phase|Protocol deviation|0
7788011|NCT01001572|12239952|FG001|Double-Blind Treatment Phase|Protocol deviation|0
7788012|NCT01001572|12239953|FG002|Double-Blind Treatment Phase|Protocol deviation|1
7788013|NCT01001572|12239951|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0
7788014|NCT01001572|12239952|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
7788015|NCT01001572|12239953|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
7788016|NCT01001598|12239959|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1
7788017|NCT01001598|12239959|FG000|Overall Study|Adverse Event|1
7788018|NCT01001702|12239963|FG000|Overall Study|Lost to Follow-up|7
7788019|NCT01001702|12239963|FG000|Overall Study|Adverse Event|7
7788020|NCT01001702|12239963|FG000|Overall Study|Sponsor Discontinued Study|4
7788021|NCT01001702|12239963|FG000|Overall Study|Subject met Withdrawal Criteria|22
7788022|NCT01001702|12239963|FG000|Overall Study|Investigator withdrew Subject|10
7788023|NCT01001702|12239963|FG000|Overall Study|Withdrawal by Subject|19
7788024|NCT01001702|12239963|FG000|Overall Study|Lack of Efficacy per Investigator|3
7788025|NCT01001767|12239969|FG000|Overall Study|no baseline study performed|1
7788026|NCT01001767|12239970|FG001|Overall Study|no baseline study performed|0
7788027|NCT01001767|12239969|FG000|Overall Study|Protocol Violation|1
7788028|NCT01001767|12239970|FG001|Overall Study|Protocol Violation|0
7788029|NCT01001767|12239969|FG000|Overall Study|Lost to Follow-up|1
7788030|NCT01001767|12239970|FG001|Overall Study|Lost to Follow-up|0
7788031|NCT01001767|12239969|FG000|Overall Study|Physician Decision|1
7788032|NCT01001767|12239970|FG001|Overall Study|Physician Decision|0
7788033|NCT01001832|12239991|FG000|Short-term Period|Adverse Event|2
7788034|NCT01001832|12239992|FG001|Short-term Period|Adverse Event|3
7788035|NCT01001832|12239991|FG000|Long-term Period|Adverse Event|2
7788036|NCT01001832|12239992|FG001|Long-term Period|Adverse Event|1
7788037|NCT01001832|12239991|FG000|Long-term Period|Withdrawal by Subject|1
7788038|NCT01001832|12239992|FG001|Long-term Period|Withdrawal by Subject|0
7788039|NCT01001832|12239991|FG000|Long-term Period|Lack of Efficacy|0
7788040|NCT01001832|12239992|FG001|Long-term Period|Lack of Efficacy|2
7788041|NCT01001832|12239991|FG000|Long-term Period|Other|1
7788042|NCT01001832|12239992|FG001|Long-term Period|Other|2
7788043|NCT01001832|12239991|FG000|Follow-up Period|Withdrawal by Subject|1
7788044|NCT01001832|12239992|FG001|Follow-up Period|Withdrawal by Subject|0
7788045|NCT01001832|12239991|FG000|Follow-up Period|Follow-up no longer required /protocol|15
7788046|NCT01001832|12239992|FG001|Follow-up Period|Follow-up no longer required /protocol|20
7788047|NCT01001832|12239991|FG000|Follow-up Period|Other|2
7788048|NCT01001832|12239992|FG001|Follow-up Period|Other|1
7788049|NCT01001910|12240001|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6
7788050|NCT01001988|12240014|FG000|Overall Study|Protocol Violation|84
7788051|NCT01001988|12240014|FG000|Overall Study|Withdrawal by Subject|18
7788052|NCT01001988|12240014|FG000|Overall Study|Lost to Follow-up|15
7788053|NCT01002105|12240020|FG000|Overall Study|Lost to Follow-up|10
7788054|NCT01002105|12240021|FG001|Overall Study|Lost to Follow-up|16
7788055|NCT01002105|12240020|FG000|Overall Study|non compliance|5
7788056|NCT01002105|12240021|FG001|Overall Study|non compliance|3
7788057|NCT01002105|12240020|FG000|Overall Study|condition worsened|4
7622311|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9
7622312|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4
7622313|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
7622314|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0
7622315|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Physician Decision|2
7622316|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Physician Decision|1
7622317|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Physician Decision|1
7622318|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Physician Decision|0
7622319|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Pregnancy|2
7622320|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Pregnancy|2
7622321|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Pregnancy|0
7622322|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Pregnancy|0
7622323|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Protocol Violation|6
7622324|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Protocol Violation|1
7622325|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Protocol Violation|0
7622326|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Protocol Violation|0
7622327|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Screen failure|0
7622328|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Screen failure|1
7622329|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Screen failure|2
7622330|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Screen failure|0
7622331|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20
7622332|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5
7622333|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7
7622334|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0
7622335|NCT02614261|12033176|FG000|Open-Label Extension Phase|Adverse Event|23
7622336|NCT02614261|12033177|FG001|Open-Label Extension Phase|Adverse Event|12
7622337|NCT02614261|12033178|FG002|Open-Label Extension Phase|Adverse Event|11
7622338|NCT02614261|12033179|FG003|Open-Label Extension Phase|Adverse Event|0
7622339|NCT02614261|12033176|FG000|Open-Label Extension Phase|Lack of Efficacy|14
7622340|NCT02614261|12033177|FG001|Open-Label Extension Phase|Lack of Efficacy|12
7622341|NCT02614261|12033178|FG002|Open-Label Extension Phase|Lack of Efficacy|14
7622342|NCT02614261|12033179|FG003|Open-Label Extension Phase|Lack of Efficacy|0
7622343|NCT02614261|12033176|FG000|Open-Label Extension Phase|Lost to Follow-up|15
7622344|NCT02614261|12033177|FG001|Open-Label Extension Phase|Lost to Follow-up|7
7788058|NCT01002105|12240021|FG001|Overall Study|condition worsened|2
7788059|NCT01002339|12240046|FG000|Overall Study|Withdrawal by Subject|0
7788060|NCT01002339|12240047|FG001|Overall Study|Withdrawal by Subject|1
7788061|NCT01002339|12240048|FG002|Overall Study|Withdrawal by Subject|0
7788062|NCT01002339|12240046|FG000|Overall Study|Incorrect treatment assignment|0
7788063|NCT01002339|12240047|FG001|Overall Study|Incorrect treatment assignment|0
7788064|NCT01002339|12240048|FG002|Overall Study|Incorrect treatment assignment|1
7788065|NCT01002339|12240046|FG000|Overall Study|Protocol Violation|0
7788066|NCT01002339|12240047|FG001|Overall Study|Protocol Violation|0
7788067|NCT01002339|12240048|FG002|Overall Study|Protocol Violation|2
7788068|NCT01002339|12240046|FG000|Overall Study|Lung cancer detected before transplant|0
7788069|NCT01002339|12240047|FG001|Overall Study|Lung cancer detected before transplant|0
7788070|NCT01002339|12240048|FG002|Overall Study|Lung cancer detected before transplant|1
7788071|NCT01002339|12240046|FG000|Overall Study|Randomized. Not transplanted|0
7788072|NCT01002339|12240047|FG001|Overall Study|Randomized. Not transplanted|0
7788073|NCT01002339|12240048|FG002|Overall Study|Randomized. Not transplanted|1
7788074|NCT01002482|12240069|FG000|Overall Study|Withdrawal by Subject|14
7788075|NCT01002482|12240070|FG001|Overall Study|Withdrawal by Subject|21
7788076|NCT01002482|12240069|FG000|Overall Study|Included twice|1
7788077|NCT01002482|12240070|FG001|Overall Study|Included twice|0
7788078|NCT01002547|12240079|FG000|Overall Study|Withdrawal by Subject|4
7788079|NCT01002547|12240080|FG001|Overall Study|Withdrawal by Subject|0
7788080|NCT01002547|12240081|FG002|Overall Study|Withdrawal by Subject|5
7788081|NCT01002547|12240079|FG000|Overall Study|Lost to Follow-up|2
7788082|NCT01002547|12240080|FG001|Overall Study|Lost to Follow-up|1
7788083|NCT01002547|12240081|FG002|Overall Study|Lost to Follow-up|1
7788084|NCT01002547|12240079|FG000|Overall Study|Physician Decision|1
7788085|NCT01002547|12240080|FG001|Overall Study|Physician Decision|0
7788086|NCT01002547|12240081|FG002|Overall Study|Physician Decision|0
7788087|NCT01002547|12240079|FG000|Overall Study|Death|0
7788088|NCT01002547|12240080|FG001|Overall Study|Death|2
7788089|NCT01002547|12240081|FG002|Overall Study|Death|2
7788090|NCT01002547|12240079|FG000|Overall Study|Adverse Event|1
7788091|NCT01002547|12240080|FG001|Overall Study|Adverse Event|0
7788092|NCT01002547|12240081|FG002|Overall Study|Adverse Event|0
7800486|NCT01095835|12257981|FG001|Overall Study|Non study compliance|0
7800487|NCT01095835|12257982|FG002|Overall Study|Non study compliance|1
7800488|NCT01095835|12257980|FG000|Overall Study|Protocol Violation|1
7800489|NCT01095835|12257981|FG001|Overall Study|Protocol Violation|2
7800490|NCT01095835|12257982|FG002|Overall Study|Protocol Violation|0
7800491|NCT01095978|12257995|FG000|Overall Study|Did not take Klacid SR|2
7800492|NCT01095978|12257995|FG000|Overall Study|Adverse Event|1
7622345|NCT02614261|12033178|FG002|Open-Label Extension Phase|Lost to Follow-up|9
7622346|NCT02614261|12033179|FG003|Open-Label Extension Phase|Lost to Follow-up|0
7622347|NCT02614261|12033176|FG000|Open-Label Extension Phase|Physician Decision|2
7800493|NCT01096017|12258001|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1
7800494|NCT01096017|12258002|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1
7800495|NCT01096056|12258010|FG000|Overall Study|Lost to Follow-up|0
7800496|NCT01096056|12258011|FG001|Overall Study|Lost to Follow-up|1
7800497|NCT01096160|12258027|FG000|Overall Study|Adverse Event|0
7800498|NCT01096160|12258028|FG001|Overall Study|Adverse Event|0
7800499|NCT01096160|12258029|FG002|Overall Study|Adverse Event|1
7800500|NCT01096160|12258030|FG003|Overall Study|Adverse Event|0
7800501|NCT01096160|12258031|FG004|Overall Study|Adverse Event|0
7800502|NCT01096160|12258032|FG005|Overall Study|Adverse Event|0
7800503|NCT01096160|12258033|FG006|Overall Study|Adverse Event|0
7800504|NCT01096160|12258034|FG007|Overall Study|Adverse Event|0
7800505|NCT01096160|12258035|FG008|Overall Study|Adverse Event|0
7800506|NCT01096160|12258036|FG009|Overall Study|Adverse Event|1
7800507|NCT01096160|12258027|FG000|Overall Study|Met stopping criteria per protocol|0
7800508|NCT01096160|12258028|FG001|Overall Study|Met stopping criteria per protocol|0
7800509|NCT01096160|12258029|FG002|Overall Study|Met stopping criteria per protocol|0
7788093|NCT01002573|12240091|FG000|Overall Study|Subject did not receive at least 1 dose|11
7788094|NCT01002573|12240092|FG001|Overall Study|Subject did not receive at least 1 dose|7
7788095|NCT01002742|12240100|FG000|Overall Study|Determined to be ineligible|0
7788096|NCT01002742|12240101|FG001|Overall Study|Determined to be ineligible|1
7788097|NCT01002989|12240111|FG000|Overall Study|exclusion criteria, no consent|5
7788098|NCT01003184|12240160|FG000|Overall Study|Adverse Event|12
7788099|NCT01003184|12240161|FG001|Overall Study|Adverse Event|5
7788100|NCT01003184|12240160|FG000|Overall Study|Lost to Follow-up|1
7788101|NCT01003184|12240161|FG001|Overall Study|Lost to Follow-up|0
7788102|NCT01003184|12240160|FG000|Overall Study|Loss of glucose control|1
7788103|NCT01003184|12240161|FG001|Overall Study|Loss of glucose control|1
7788104|NCT01003184|12240160|FG000|Overall Study|Protocol Violation|3
7788105|NCT01003184|12240161|FG001|Overall Study|Protocol Violation|0
7788106|NCT01003184|12240160|FG000|Overall Study|Withdrawal by Subject|1
7788107|NCT01003184|12240161|FG001|Overall Study|Withdrawal by Subject|6
7788108|NCT01003184|12240160|FG000|Overall Study|Physician Decision|1
7788109|NCT01003184|12240161|FG001|Overall Study|Physician Decision|0
7788110|NCT01003210|12240169|FG000|Overall Study|Lost to Follow-up|1
7788111|NCT01003210|12240170|FG001|Overall Study|Lost to Follow-up|3
7788112|NCT01003249|12240176|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1
7788113|NCT01003249|12240177|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1
7788114|NCT01003249|12240176|FG000|First Intervention (4 Weeks)|Non-Serious Event|1
7788115|NCT01003249|12240177|FG001|First Intervention (4 Weeks)|Non-Serious Event|1
7788116|NCT01003249|12240176|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0
7788117|NCT01003249|12240177|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7788118|NCT01003249|12240176|FG000|Second Intervention (4 Weeks)|Adverse Event|1
7788119|NCT01003249|12240177|FG001|Second Intervention (4 Weeks)|Adverse Event|0
7788120|NCT01003639|12240223|FG000|Overall Study|Lost to Follow-up|6
7788121|NCT01003639|12240224|FG001|Overall Study|Lost to Follow-up|9
7788122|NCT01003639|12240223|FG000|Overall Study|Withdrawal by Subject|9
7788123|NCT01003639|12240224|FG001|Overall Study|Withdrawal by Subject|5
7788124|NCT01003639|12240223|FG000|Overall Study|Lack of Efficacy|1
7788125|NCT01003639|12240224|FG001|Overall Study|Lack of Efficacy|6
7788126|NCT01003639|12240223|FG000|Overall Study|Adverse Event|0
7788127|NCT01003639|12240224|FG001|Overall Study|Adverse Event|1
7788128|NCT01003639|12240223|FG000|Overall Study|Protocol Violation|0
7788129|NCT01003639|12240224|FG001|Overall Study|Protocol Violation|1
7788130|NCT01003639|12240223|FG000|Overall Study|Physician Decision|1
7788131|NCT01003639|12240224|FG001|Overall Study|Physician Decision|0
7788132|NCT01003886|12240234|FG000|Overall Study|Lack of Efficacy|5
7788133|NCT01003886|12240234|FG000|Overall Study|Lost to Follow-up|169
7788134|NCT01003886|12240234|FG000|Overall Study|Withdrawal by Subject|39
7788135|NCT01003886|12240234|FG000|Overall Study|Other|14
7788136|NCT01003886|12240234|FG000|Overall Study|Adverse Event|3
7788137|NCT01003899|12240238|FG000|Overall Study|Other Adverse Event|8
7788138|NCT01003899|12240238|FG000|Overall Study|Not entered|4
7788139|NCT01003899|12240238|FG000|Overall Study|Not treated|1
7788140|NCT01003899|12240238|FG000|Overall Study|Progressive disease|34
7788141|NCT01003990|12240249|FG000|Overall Study|Adverse Event|8
7788142|NCT01003990|12240250|FG001|Overall Study|Adverse Event|5
7788143|NCT01003990|12240251|FG002|Overall Study|Adverse Event|11
7788144|NCT01003990|12240249|FG000|Overall Study|Death|0
7788145|NCT01003990|12240250|FG001|Overall Study|Death|8
7788146|NCT01003990|12240251|FG002|Overall Study|Death|1
7788147|NCT01003990|12240249|FG000|Overall Study|Lack of Efficacy|10
7788148|NCT01003990|12240250|FG001|Overall Study|Lack of Efficacy|2
7788149|NCT01003990|12240251|FG002|Overall Study|Lack of Efficacy|3
7788150|NCT01003990|12240249|FG000|Overall Study|Lost to Follow-up|30
7788151|NCT01003990|12240250|FG001|Overall Study|Lost to Follow-up|12
7788152|NCT01003990|12240251|FG002|Overall Study|Lost to Follow-up|7
7788153|NCT01003990|12240249|FG000|Overall Study|Reasons Not Identified|14
7788154|NCT01003990|12240250|FG001|Overall Study|Reasons Not Identified|13
7788155|NCT01003990|12240251|FG002|Overall Study|Reasons Not Identified|8
7788156|NCT01003990|12240249|FG000|Overall Study|Poor/Non-compliance|4
7788157|NCT01003990|12240250|FG001|Overall Study|Poor/Non-compliance|3
7788158|NCT01003990|12240251|FG002|Overall Study|Poor/Non-compliance|2
7788159|NCT01003990|12240249|FG000|Overall Study|Pregnancy|10
7788160|NCT01003990|12240250|FG001|Overall Study|Pregnancy|2
7788161|NCT01003990|12240251|FG002|Overall Study|Pregnancy|4
7788162|NCT01003990|12240249|FG000|Overall Study|No Longer Met Study Criteria|4
7788163|NCT01003990|12240250|FG001|Overall Study|No Longer Met Study Criteria|1
7788164|NCT01003990|12240251|FG002|Overall Study|No Longer Met Study Criteria|0
7788165|NCT01003990|12240249|FG000|Overall Study|Subject Withdrew Consent|12
7788166|NCT01003990|12240250|FG001|Overall Study|Subject Withdrew Consent|5
7788167|NCT01003990|12240251|FG002|Overall Study|Subject Withdrew Consent|7
7788168|NCT01004003|12240268|FG000|Overall Study|Progressive disease|2
7788169|NCT01004003|12240269|FG001|Overall Study|Progressive disease|1
7788170|NCT01004003|12240270|FG002|Overall Study|Progressive disease|1
7788171|NCT01004003|12240271|FG003|Overall Study|Progressive disease|0
7788172|NCT01004003|12240272|FG004|Overall Study|Progressive disease|2
7788173|NCT01004003|12240273|FG005|Overall Study|Progressive disease|1
7788174|NCT01004003|12240274|FG006|Overall Study|Progressive disease|1
7788175|NCT01004003|12240275|FG007|Overall Study|Progressive disease|39
7788176|NCT01004003|12240276|FG008|Overall Study|Progressive disease|22
7788177|NCT01004003|12240268|FG000|Overall Study|Adverse Event|4
7788178|NCT01004003|12240269|FG001|Overall Study|Adverse Event|2
7788179|NCT01004003|12240270|FG002|Overall Study|Adverse Event|3
7788180|NCT01004003|12240271|FG003|Overall Study|Adverse Event|3
7788181|NCT01004003|12240272|FG004|Overall Study|Adverse Event|2
7788182|NCT01004003|12240273|FG005|Overall Study|Adverse Event|2
7788183|NCT01004003|12240274|FG006|Overall Study|Adverse Event|7
7788184|NCT01004003|12240275|FG007|Overall Study|Adverse Event|21
7788185|NCT01004003|12240276|FG008|Overall Study|Adverse Event|6
7788186|NCT01004003|12240268|FG000|Overall Study|Refused to continue taking trial med.|0
7788187|NCT01004003|12240269|FG001|Overall Study|Refused to continue taking trial med.|0
7788188|NCT01004003|12240270|FG002|Overall Study|Refused to continue taking trial med.|0
7788189|NCT01004003|12240271|FG003|Overall Study|Refused to continue taking trial med.|0
7788190|NCT01004003|12240272|FG004|Overall Study|Refused to continue taking trial med.|0
7788191|NCT01004003|12240273|FG005|Overall Study|Refused to continue taking trial med.|0
7788192|NCT01004003|12240274|FG006|Overall Study|Refused to continue taking trial med.|0
7788193|NCT01004003|12240275|FG007|Overall Study|Refused to continue taking trial med.|0
7788194|NCT01004003|12240276|FG008|Overall Study|Refused to continue taking trial med.|2
7788195|NCT01004003|12240268|FG000|Overall Study|Other|0
7788196|NCT01004003|12240269|FG001|Overall Study|Other|0
7788197|NCT01004003|12240270|FG002|Overall Study|Other|0
7788198|NCT01004003|12240271|FG003|Overall Study|Other|0
7788199|NCT01004003|12240272|FG004|Overall Study|Other|0
7788200|NCT01004003|12240273|FG005|Overall Study|Other|1
7788201|NCT01004003|12240274|FG006|Overall Study|Other|0
7788202|NCT01004003|12240275|FG007|Overall Study|Other|0
7788203|NCT01004003|12240276|FG008|Overall Study|Other|0
7788204|NCT01004146|12240337|FG000|Overall Study|Withdrawal by Subject|4
7788205|NCT01004146|12240338|FG001|Overall Study|Withdrawal by Subject|5
7788206|NCT01004159|12240344|FG000|Overall Study|Adverse Event|2
7788207|NCT01004159|12240344|FG000|Overall Study|Disease Progression|18
7788208|NCT01004172|12240348|FG000|Overall Study|Progressive Disease in CNS Only|16
7788209|NCT01004172|12240348|FG000|Overall Study|Progressive Disease in Non-CNS Only|16
7788210|NCT01004172|12240348|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2
7788211|NCT01004172|12240348|FG000|Overall Study|Adverse Event|1
7788212|NCT01004172|12240348|FG000|Overall Study|Physician Decision|1
7788213|NCT01004172|12240348|FG000|Overall Study|Symptomatic Deterioration|2
7788214|NCT01004185|12240355|FG000|Overall Study|Adverse Event|1
7788215|NCT01004185|12240356|FG001|Overall Study|Adverse Event|1
7788216|NCT01004185|12240355|FG000|Overall Study|Lost to Follow-up|0
7788217|NCT01004185|12240356|FG001|Overall Study|Lost to Follow-up|1
7788218|NCT01004185|12240355|FG000|Overall Study|Lack of Efficacy|2
7788219|NCT01004185|12240356|FG001|Overall Study|Lack of Efficacy|1
7788220|NCT01004185|12240355|FG000|Overall Study|Sponsor Terminated Study|4
7788221|NCT01004185|12240356|FG001|Overall Study|Sponsor Terminated Study|5
7788222|NCT01004185|12240355|FG000|Overall Study|Withdrawal by Subject|2
7788223|NCT01004185|12240356|FG001|Overall Study|Withdrawal by Subject|1
7788224|NCT01004250|12240362|FG000|Induction Therapy Period|Adverse Event|10
7788225|NCT01004250|12240362|FG000|Induction Therapy Period|Entry Criteria Not Met|1
7788226|NCT01004250|12240362|FG000|Induction Therapy Period|Withdrawal by Subject|2
7788227|NCT01004250|12240362|FG000|Induction Therapy Period|Physician Decision|2
7788228|NCT01004250|12240362|FG000|Maintenance Therapy Period|Adverse Event|15
7788229|NCT01004250|12240362|FG000|Maintenance Therapy Period|Lost to Follow-up|1
7788230|NCT01004250|12240362|FG000|Maintenance Therapy Period|Protocol Violation|1
7788231|NCT01004250|12240362|FG000|Maintenance Therapy Period|Withdrawal by Subject|5
7788232|NCT01004250|12240362|FG000|Maintenance Therapy Period|Physician Decision|4
7788233|NCT01004250|12240362|FG000|Follow-Up (FU) Period|Lost to Follow-up|1
7788234|NCT01004406|12240380|FG000|Overall Study|Withdrawal by Subject|2
7788235|NCT01004406|12240381|FG001|Overall Study|Withdrawal by Subject|0
7788236|NCT01004406|12240380|FG000|Overall Study|Lost to Follow-up|1
7788237|NCT01004406|12240381|FG001|Overall Study|Lost to Follow-up|0
7788238|NCT01004432|12240387|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20
7788239|NCT01004432|12240388|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
7788240|NCT01004432|12240389|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
7788241|NCT01004432|12240390|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
7788242|NCT01004432|12240391|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
7788243|NCT01004432|12240387|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29
7788244|NCT01004432|12240388|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
7788245|NCT01004432|12240389|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
7788246|NCT01004432|12240390|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
7788247|NCT01004432|12240391|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
7788248|NCT01004432|12240387|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17
7788249|NCT01004432|12240388|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
7788250|NCT01004432|12240389|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
7788251|NCT01004432|12240390|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
7788252|NCT01004432|12240391|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
7788253|NCT01004432|12240387|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15
7788254|NCT01004432|12240388|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
7788255|NCT01004432|12240389|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
7788256|NCT01004432|12240390|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
7788257|NCT01004432|12240391|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
7788258|NCT01004432|12240387|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2
7788259|NCT01004432|12240388|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
7788260|NCT01004432|12240389|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
7788261|NCT01004432|12240390|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
7788262|NCT01004432|12240391|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
7788263|NCT01004432|12240387|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
7788264|NCT01004432|12240388|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
7788265|NCT01004432|12240389|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
7788266|NCT01004432|12240390|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
7788267|NCT01004432|12240391|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
7788268|NCT01004432|12240387|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
7788269|NCT01004432|12240388|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
7788270|NCT01004432|12240389|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
7788271|NCT01004432|12240390|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
7788272|NCT01004432|12240391|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
7788273|NCT01004432|12240387|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
7788274|NCT01004432|12240388|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
7788275|NCT01004432|12240389|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
7788276|NCT01004432|12240390|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
7788277|NCT01004432|12240391|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
7788278|NCT01004432|12240387|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
7788279|NCT01004432|12240388|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
7788280|NCT01004432|12240389|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
7788281|NCT01004432|12240390|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
7788282|NCT01004432|12240391|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
7788283|NCT01004432|12240387|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
7788284|NCT01004432|12240388|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
7788285|NCT01004432|12240389|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
7788286|NCT01004432|12240390|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
7788287|NCT01004432|12240391|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
7788288|NCT01004432|12240387|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
7788289|NCT01004432|12240388|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
7788290|NCT01004432|12240389|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
7788291|NCT01004432|12240390|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
7788292|NCT01004432|12240391|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
7788293|NCT01004432|12240387|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0
7788294|NCT01004432|12240388|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0
7788295|NCT01004432|12240389|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0
7788296|NCT01004432|12240390|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0
7788297|NCT01004432|12240391|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2
7788298|NCT01004432|12240387|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0
7788299|NCT01004432|12240388|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0
7788300|NCT01004432|12240389|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0
7788301|NCT01004432|12240390|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0
7788302|NCT01004432|12240391|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4
7788303|NCT01004432|12240387|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
7788304|NCT01004432|12240388|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
7788305|NCT01004432|12240389|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
7788306|NCT01004432|12240390|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
7788307|NCT01004432|12240391|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
7788308|NCT01004432|12240387|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
7788309|NCT01004432|12240388|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
7788310|NCT01004432|12240389|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
7622348|NCT02614261|12033177|FG001|Open-Label Extension Phase|Physician Decision|0
7622349|NCT02614261|12033178|FG002|Open-Label Extension Phase|Physician Decision|0
7622350|NCT02614261|12033179|FG003|Open-Label Extension Phase|Physician Decision|0
7622351|NCT02614261|12033176|FG000|Open-Label Extension Phase|Pregnancy|1
7622352|NCT02614261|12033177|FG001|Open-Label Extension Phase|Pregnancy|2
7622353|NCT02614261|12033178|FG002|Open-Label Extension Phase|Pregnancy|1
7622354|NCT02614261|12033179|FG003|Open-Label Extension Phase|Pregnancy|0
7788311|NCT01004432|12240390|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
7788312|NCT01004432|12240391|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
7788313|NCT01004614|12240409|FG000|Washout|Withdrawal by Subject|0
7788314|NCT01004614|12240410|FG001|Washout|Withdrawal by Subject|1
7788315|NCT01004614|12240411|FG002|Washout|Withdrawal by Subject|0
7788316|NCT01004614|12240412|FG003|Washout|Withdrawal by Subject|0
7788317|NCT01004822|12240469|FG000|Overall Study|Objective progression or relapse|3
7788318|NCT01004822|12240470|FG001|Overall Study|Objective progression or relapse|3
7788319|NCT01004822|12240471|FG002|Overall Study|Objective progression or relapse|0
7788320|NCT01004822|12240472|FG003|Overall Study|Objective progression or relapse|1
7788321|NCT01004822|12240473|FG004|Overall Study|Objective progression or relapse|2
7788322|NCT01004822|12240474|FG005|Overall Study|Objective progression or relapse|2
7788323|NCT01004822|12240475|FG006|Overall Study|Objective progression or relapse|1
7788324|NCT01004822|12240476|FG007|Overall Study|Objective progression or relapse|4
7788325|NCT01004822|12240469|FG000|Overall Study|Global deterioration of health status|0
7788326|NCT01004822|12240470|FG001|Overall Study|Global deterioration of health status|0
7788327|NCT01004822|12240471|FG002|Overall Study|Global deterioration of health status|0
7788328|NCT01004822|12240472|FG003|Overall Study|Global deterioration of health status|1
7788329|NCT01004822|12240473|FG004|Overall Study|Global deterioration of health status|0
7788330|NCT01004822|12240474|FG005|Overall Study|Global deterioration of health status|0
7788331|NCT01004822|12240475|FG006|Overall Study|Global deterioration of health status|1
7788332|NCT01004822|12240476|FG007|Overall Study|Global deterioration of health status|0
7788333|NCT01004822|12240469|FG000|Overall Study|No longer willing to continue|0
7788334|NCT01004822|12240470|FG001|Overall Study|No longer willing to continue|0
7788335|NCT01004822|12240471|FG002|Overall Study|No longer willing to continue|0
7788336|NCT01004822|12240472|FG003|Overall Study|No longer willing to continue|1
7788337|NCT01004822|12240473|FG004|Overall Study|No longer willing to continue|2
7788338|NCT01004822|12240474|FG005|Overall Study|No longer willing to continue|1
7788339|NCT01004822|12240475|FG006|Overall Study|No longer willing to continue|1
7788340|NCT01004822|12240476|FG007|Overall Study|No longer willing to continue|0
7788341|NCT01004822|12240469|FG000|Overall Study|Adverse Event|0
7788342|NCT01004822|12240470|FG001|Overall Study|Adverse Event|0
7788343|NCT01004822|12240471|FG002|Overall Study|Adverse Event|0
7788344|NCT01004822|12240472|FG003|Overall Study|Adverse Event|0
7788345|NCT01004822|12240473|FG004|Overall Study|Adverse Event|0
7788346|NCT01004822|12240474|FG005|Overall Study|Adverse Event|0
7788347|NCT01004822|12240475|FG006|Overall Study|Adverse Event|1
7788348|NCT01004822|12240476|FG007|Overall Study|Adverse Event|1
7788349|NCT01004822|12240469|FG000|Overall Study|Other|0
7788350|NCT01004822|12240470|FG001|Overall Study|Other|0
7788351|NCT01004822|12240471|FG002|Overall Study|Other|4
7788352|NCT01004822|12240472|FG003|Overall Study|Other|1
7788353|NCT01004822|12240473|FG004|Overall Study|Other|0
7788354|NCT01004822|12240474|FG005|Overall Study|Other|1
7788355|NCT01004822|12240475|FG006|Overall Study|Other|0
7788356|NCT01004822|12240476|FG007|Overall Study|Other|0
7788357|NCT01004848|12240498|FG000|Overall Study|Lost to Follow-up|55
7788358|NCT01004848|12240499|FG001|Overall Study|Lost to Follow-up|45
7788359|NCT01005251|12240522|FG000|Overall Study|Withdrawal by Subject|2
7788360|NCT01005251|12240523|FG001|Overall Study|Withdrawal by Subject|5
7788361|NCT01005251|12240524|FG002|Overall Study|Withdrawal by Subject|3
7788362|NCT01005251|12240525|FG003|Overall Study|Withdrawal by Subject|4
7788363|NCT01005251|12240526|FG004|Overall Study|Withdrawal by Subject|9
7788364|NCT01005251|12240522|FG000|Overall Study|Eligibility criteria not fulfilled|4
7788365|NCT01005251|12240523|FG001|Overall Study|Eligibility criteria not fulfilled|0
7788366|NCT01005251|12240524|FG002|Overall Study|Eligibility criteria not fulfilled|4
7788367|NCT01005251|12240525|FG003|Overall Study|Eligibility criteria not fulfilled|1
7788368|NCT01005251|12240526|FG004|Overall Study|Eligibility criteria not fulfilled|0
7788369|NCT01005251|12240522|FG000|Overall Study|Adverse Event|2
7788370|NCT01005251|12240523|FG001|Overall Study|Adverse Event|6
7788371|NCT01005251|12240524|FG002|Overall Study|Adverse Event|8
7788372|NCT01005251|12240525|FG003|Overall Study|Adverse Event|5
7788373|NCT01005251|12240526|FG004|Overall Study|Adverse Event|4
7788374|NCT01005251|12240522|FG000|Overall Study|Protocol Violation|1
7788375|NCT01005251|12240523|FG001|Overall Study|Protocol Violation|0
7788376|NCT01005251|12240524|FG002|Overall Study|Protocol Violation|0
7788377|NCT01005251|12240525|FG003|Overall Study|Protocol Violation|0
7788378|NCT01005251|12240526|FG004|Overall Study|Protocol Violation|2
7788379|NCT01005251|12240522|FG000|Overall Study|Developed study-specific withdrawal crit|2
7788380|NCT01005251|12240523|FG001|Overall Study|Developed study-specific withdrawal crit|0
7788381|NCT01005251|12240524|FG002|Overall Study|Developed study-specific withdrawal crit|3
7788382|NCT01005251|12240525|FG003|Overall Study|Developed study-specific withdrawal crit|0
7788383|NCT01005251|12240526|FG004|Overall Study|Developed study-specific withdrawal crit|1
7788384|NCT01005251|12240522|FG000|Overall Study|Lost to Follow-up|1
7788385|NCT01005251|12240523|FG001|Overall Study|Lost to Follow-up|4
7788386|NCT01005251|12240524|FG002|Overall Study|Lost to Follow-up|2
7788387|NCT01005251|12240525|FG003|Overall Study|Lost to Follow-up|0
7788388|NCT01005251|12240526|FG004|Overall Study|Lost to Follow-up|0
7788389|NCT01005251|12240522|FG000|Overall Study|Physician Decision|0
7788390|NCT01005251|12240523|FG001|Overall Study|Physician Decision|0
7788391|NCT01005251|12240524|FG002|Overall Study|Physician Decision|0
7788392|NCT01005251|12240525|FG003|Overall Study|Physician Decision|0
7788393|NCT01005251|12240526|FG004|Overall Study|Physician Decision|2
7788394|NCT01005251|12240522|FG000|Overall Study|Patient moved|1
7788395|NCT01005251|12240523|FG001|Overall Study|Patient moved|0
7788396|NCT01005251|12240524|FG002|Overall Study|Patient moved|0
7788397|NCT01005251|12240525|FG003|Overall Study|Patient moved|0
7788398|NCT01005251|12240526|FG004|Overall Study|Patient moved|0
7788399|NCT01005251|12240522|FG000|Overall Study|Wrong drug dispensed|0
7788400|NCT01005251|12240523|FG001|Overall Study|Wrong drug dispensed|1
7788401|NCT01005251|12240524|FG002|Overall Study|Wrong drug dispensed|0
7788402|NCT01005251|12240525|FG003|Overall Study|Wrong drug dispensed|0
7788403|NCT01005251|12240526|FG004|Overall Study|Wrong drug dispensed|0
7788404|NCT01005251|12240522|FG000|Overall Study|Randomized in error|0
7788405|NCT01005251|12240523|FG001|Overall Study|Randomized in error|0
7788406|NCT01005251|12240524|FG002|Overall Study|Randomized in error|1
7788407|NCT01005251|12240525|FG003|Overall Study|Randomized in error|1
7788408|NCT01005251|12240526|FG004|Overall Study|Randomized in error|0
7788409|NCT01005251|12240522|FG000|Overall Study|Lack of Efficacy|0
7788410|NCT01005251|12240523|FG001|Overall Study|Lack of Efficacy|0
7788411|NCT01005251|12240524|FG002|Overall Study|Lack of Efficacy|1
7788412|NCT01005251|12240525|FG003|Overall Study|Lack of Efficacy|1
7788413|NCT01005251|12240526|FG004|Overall Study|Lack of Efficacy|0
7788414|NCT01005316|12240550|FG000|Overall Study|Adverse Event|0
7788415|NCT01005316|12240551|FG001|Overall Study|Adverse Event|0
7788416|NCT01005316|12240552|FG002|Overall Study|Adverse Event|0
7788417|NCT01005316|12240553|FG003|Overall Study|Adverse Event|1
7788418|NCT01005316|12240550|FG000|Overall Study|Death|20
7788419|NCT01005316|12240551|FG001|Overall Study|Death|5
7788420|NCT01005316|12240552|FG002|Overall Study|Death|1
7788421|NCT01005316|12240553|FG003|Overall Study|Death|15
7788422|NCT01005316|12240550|FG000|Overall Study|Study Termination|5
7788423|NCT01005316|12240551|FG001|Overall Study|Study Termination|63
7788424|NCT01005316|12240552|FG002|Overall Study|Study Termination|9
7788425|NCT01005316|12240553|FG003|Overall Study|Study Termination|85
7788426|NCT01005316|12240550|FG000|Overall Study|Lost to Follow-up|1
7788427|NCT01005316|12240551|FG001|Overall Study|Lost to Follow-up|3
7788428|NCT01005316|12240552|FG002|Overall Study|Lost to Follow-up|0
7788429|NCT01005316|12240553|FG003|Overall Study|Lost to Follow-up|2
7788430|NCT01005316|12240550|FG000|Overall Study|Physician Decision|6
7788431|NCT01005316|12240551|FG001|Overall Study|Physician Decision|0
7788432|NCT01005316|12240552|FG002|Overall Study|Physician Decision|0
7788433|NCT01005316|12240553|FG003|Overall Study|Physician Decision|0
7788434|NCT01005316|12240550|FG000|Overall Study|Sponsor Decision|6
7788435|NCT01005316|12240551|FG001|Overall Study|Sponsor Decision|3
7788436|NCT01005316|12240552|FG002|Overall Study|Sponsor Decision|0
7788437|NCT01005316|12240553|FG003|Overall Study|Sponsor Decision|0
7788438|NCT01005316|12240550|FG000|Overall Study|Withdrawal by Subject|1
7788439|NCT01005316|12240551|FG001|Overall Study|Withdrawal by Subject|1
7788440|NCT01005316|12240552|FG002|Overall Study|Withdrawal by Subject|0
7788441|NCT01005316|12240553|FG003|Overall Study|Withdrawal by Subject|2
7788442|NCT01005316|12240550|FG000|Overall Study|Consented to Another Study|2
7788443|NCT01005316|12240551|FG001|Overall Study|Consented to Another Study|0
7788444|NCT01005316|12240552|FG002|Overall Study|Consented to Another Study|0
7788445|NCT01005316|12240553|FG003|Overall Study|Consented to Another Study|0
7788446|NCT01005316|12240550|FG000|Overall Study|Delisted|8
7788447|NCT01005316|12240551|FG001|Overall Study|Delisted|0
7788448|NCT01005316|12240552|FG002|Overall Study|Delisted|0
7788449|NCT01005316|12240553|FG003|Overall Study|Delisted|0
7788450|NCT01005316|12240550|FG000|Overall Study|Transferred Care|1
7788451|NCT01005316|12240551|FG001|Overall Study|Transferred Care|0
7788452|NCT01005316|12240552|FG002|Overall Study|Transferred Care|1
7788453|NCT01005316|12240553|FG003|Overall Study|Transferred Care|3
7788454|NCT01005316|12240550|FG000|Overall Study|Retransplanted|0
7788455|NCT01005316|12240551|FG001|Overall Study|Retransplanted|1
7788456|NCT01005316|12240552|FG002|Overall Study|Retransplanted|0
7788457|NCT01005316|12240553|FG003|Overall Study|Retransplanted|0
7788458|NCT01005329|12240564|FG000|Overall Study|Ineligible or received no protocol trt.|4
7622355|NCT02614261|12033176|FG000|Open-Label Extension Phase|Protocol Violation|3
7622356|NCT02614261|12033177|FG001|Open-Label Extension Phase|Protocol Violation|4
7622357|NCT02614261|12033178|FG002|Open-Label Extension Phase|Protocol Violation|1
7622358|NCT02614261|12033179|FG003|Open-Label Extension Phase|Protocol Violation|0
7622359|NCT02614261|12033176|FG000|Open-Label Extension Phase|Withdrawal by Subject|30
7622360|NCT02614261|12033177|FG001|Open-Label Extension Phase|Withdrawal by Subject|18
7622361|NCT02614261|12033178|FG002|Open-Label Extension Phase|Withdrawal by Subject|18
7622362|NCT02614261|12033179|FG003|Open-Label Extension Phase|Withdrawal by Subject|0
7622363|NCT02614261|12033176|FG000|Follow-up Phase|Adverse Event|2
7622364|NCT02614261|12033177|FG001|Follow-up Phase|Adverse Event|0
7622365|NCT02614261|12033178|FG002|Follow-up Phase|Adverse Event|1
7622366|NCT02614261|12033179|FG003|Follow-up Phase|Adverse Event|0
7622367|NCT02614261|12033176|FG000|Follow-up Phase|Lost to Follow-up|12
7622368|NCT02614261|12033177|FG001|Follow-up Phase|Lost to Follow-up|5
7622369|NCT02614261|12033178|FG002|Follow-up Phase|Lost to Follow-up|2
7622370|NCT02614261|12033179|FG003|Follow-up Phase|Lost to Follow-up|0
7622371|NCT02614261|12033176|FG000|Follow-up Phase|Physician Decision|5
7622372|NCT02614261|12033177|FG001|Follow-up Phase|Physician Decision|1
7622373|NCT02614261|12033178|FG002|Follow-up Phase|Physician Decision|0
7622374|NCT02614261|12033179|FG003|Follow-up Phase|Physician Decision|0
7622375|NCT02614261|12033176|FG000|Follow-up Phase|Pregnancy|0
7622376|NCT02614261|12033177|FG001|Follow-up Phase|Pregnancy|1
7622377|NCT02614261|12033178|FG002|Follow-up Phase|Pregnancy|0
7622378|NCT02614261|12033179|FG003|Follow-up Phase|Pregnancy|0
7622379|NCT02614261|12033176|FG000|Follow-up Phase|Protocol Violation|1
7622380|NCT02614261|12033177|FG001|Follow-up Phase|Protocol Violation|0
7622381|NCT02614261|12033178|FG002|Follow-up Phase|Protocol Violation|0
7622382|NCT02614261|12033179|FG003|Follow-up Phase|Protocol Violation|0
7622383|NCT02614261|12033176|FG000|Follow-up Phase|Withdrawal by Subject|12
7622384|NCT02614261|12033177|FG001|Follow-up Phase|Withdrawal by Subject|4
7622385|NCT02614261|12033178|FG002|Follow-up Phase|Withdrawal by Subject|11
7622386|NCT02614261|12033179|FG003|Follow-up Phase|Withdrawal by Subject|0
7622387|NCT02614261|12033176|FG000|Israel Addendum|Withdrawal by Subject|0
7622388|NCT02614261|12033177|FG001|Israel Addendum|Withdrawal by Subject|0
7788459|NCT01005602|12240609|FG000|Overall Study|Excluded due to unreliable clinical data|1
7788460|NCT01005602|12240610|FG001|Overall Study|Excluded due to unreliable clinical data|0
7788461|NCT01005680|12240625|FG000|Overall Study|Lost to Follow-up|4
7788462|NCT01005680|12240626|FG001|Overall Study|Lost to Follow-up|6
7788463|NCT01005680|12240625|FG000|Overall Study|Withdrawal by Subject|1
7788464|NCT01005680|12240626|FG001|Overall Study|Withdrawal by Subject|4
7788465|NCT01005680|12240625|FG000|Overall Study|Physician Decision|1
7788466|NCT01005680|12240626|FG001|Overall Study|Physician Decision|1
7788467|NCT01005719|12240642|FG000|Period 1|Adverse Event|0
7788468|NCT01005719|12240643|FG001|Period 1|Adverse Event|0
7788469|NCT01005719|12240644|FG002|Period 1|Adverse Event|0
7622389|NCT02614261|12033178|FG002|Israel Addendum|Withdrawal by Subject|0
7622390|NCT02614261|12033179|FG003|Israel Addendum|Withdrawal by Subject|4
7788470|NCT01005719|12240645|FG003|Period 1|Adverse Event|1
7788471|NCT01005719|12240646|FG004|Period 1|Adverse Event|0
7788472|NCT01005719|12240647|FG005|Period 1|Adverse Event|0
7788473|NCT01005719|12240642|FG000|Period 1|Delay in completing study procedures|0
7788474|NCT01005719|12240643|FG001|Period 1|Delay in completing study procedures|0
7788475|NCT01005719|12240644|FG002|Period 1|Delay in completing study procedures|0
7788476|NCT01005719|12240645|FG003|Period 1|Delay in completing study procedures|0
7788477|NCT01005719|12240646|FG004|Period 1|Delay in completing study procedures|0
7788478|NCT01005719|12240647|FG005|Period 1|Delay in completing study procedures|1
7788479|NCT01005719|12240642|FG000|Period 2|Adverse Event|0
7788480|NCT01005719|12240643|FG001|Period 2|Adverse Event|0
7788481|NCT01005719|12240644|FG002|Period 2|Adverse Event|0
7788482|NCT01005719|12240645|FG003|Period 2|Adverse Event|0
7788483|NCT01005719|12240646|FG004|Period 2|Adverse Event|1
7788484|NCT01005719|12240647|FG005|Period 2|Adverse Event|1
7788485|NCT01005732|12240656|FG000|Overall Study|Lost to Follow-up|10
7788486|NCT01005732|12240656|FG000|Overall Study|Death|1
7788487|NCT01005875|12240673|FG000|Overall Study|Death|3
7788488|NCT01005901|12240690|FG000|Overall Study|Withdrawal by Subject|38
7788489|NCT01005901|12240691|FG001|Overall Study|Withdrawal by Subject|14
7788490|NCT01005901|12240690|FG000|Overall Study|Adverse Event|30
7788491|NCT01005901|12240691|FG001|Overall Study|Adverse Event|16
7788492|NCT01005901|12240690|FG000|Overall Study|Administrative problems|21
7788493|NCT01005901|12240691|FG001|Overall Study|Administrative problems|13
7788494|NCT01005901|12240690|FG000|Overall Study|Unsatisfactory therapeutic effect|5
7788495|NCT01005901|12240691|FG001|Overall Study|Unsatisfactory therapeutic effect|5
7788496|NCT01005901|12240690|FG000|Overall Study|Protocol Violation|4
7788497|NCT01005901|12240691|FG001|Overall Study|Protocol Violation|3
7788498|NCT01005901|12240690|FG000|Overall Study|Death|2
7788499|NCT01005901|12240691|FG001|Overall Study|Death|3
7788500|NCT01005901|12240690|FG000|Overall Study|Lost to Follow-up|1
7788501|NCT01005901|12240691|FG001|Overall Study|Lost to Follow-up|2
7788502|NCT01005901|12240690|FG000|Overall Study|Patient's inability to use the device|1
7788503|NCT01005901|12240691|FG001|Overall Study|Patient's inability to use the device|1
7788504|NCT01005901|12240690|FG000|Overall Study|No longer requires study drug|0
7788505|NCT01005901|12240691|FG001|Overall Study|No longer requires study drug|1
7788506|NCT01005966|12240697|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
7788507|NCT01005966|12240698|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
7788508|NCT01005966|12240699|FG002|Treatment Period 1 (14 Days)|Adverse Event|0
7788509|NCT01005966|12240700|FG003|Treatment Period 1 (14 Days)|Adverse Event|0
7788510|NCT01005966|12240701|FG004|Treatment Period 1 (14 Days)|Adverse Event|0
7788511|NCT01005966|12240697|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1
7788512|NCT01005966|12240698|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0
7788513|NCT01005966|12240699|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1
7788514|NCT01005966|12240700|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0
7788515|NCT01005966|12240701|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0
7788516|NCT01005966|12240697|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0
7788517|NCT01005966|12240698|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0
7788518|NCT01005966|12240699|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0
7788519|NCT01005966|12240700|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1
7788520|NCT01005966|12240701|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0
7788521|NCT01005966|12240697|FG000|Treatment Period 2 (14 Days)|Adverse Event|0
7788522|NCT01005966|12240698|FG001|Treatment Period 2 (14 Days)|Adverse Event|1
7788523|NCT01005966|12240699|FG002|Treatment Period 2 (14 Days)|Adverse Event|1
7788524|NCT01005966|12240700|FG003|Treatment Period 2 (14 Days)|Adverse Event|0
7788525|NCT01005966|12240701|FG004|Treatment Period 2 (14 Days)|Adverse Event|0
7788526|NCT01005966|12240697|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0
7788527|NCT01005966|12240698|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0
7788528|NCT01005966|12240699|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0
7788529|NCT01005966|12240700|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1
7788530|NCT01005966|12240701|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0
7788531|NCT01005966|12240697|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7788532|NCT01005966|12240698|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7788533|NCT01005966|12240699|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
7788534|NCT01005966|12240700|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7788535|NCT01005966|12240701|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7788536|NCT01005966|12240697|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0
7788537|NCT01005966|12240698|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1
7788538|NCT01005966|12240699|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0
7788539|NCT01005966|12240700|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0
7788540|NCT01005966|12240701|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1
7788541|NCT01005966|12240697|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0
7788542|NCT01005966|12240698|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1
7788543|NCT01005966|12240699|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0
7788544|NCT01005966|12240700|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0
7788545|NCT01005966|12240701|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0
7788546|NCT01005966|12240697|FG000|Treatment Period 4 (14 Days)|Other Reason|0
7788547|NCT01005966|12240698|FG001|Treatment Period 4 (14 Days)|Other Reason|0
7788548|NCT01005966|12240699|FG002|Treatment Period 4 (14 Days)|Other Reason|0
7788549|NCT01005966|12240700|FG003|Treatment Period 4 (14 Days)|Other Reason|0
7788550|NCT01005966|12240701|FG004|Treatment Period 4 (14 Days)|Other Reason|1
7788551|NCT01006122|12240718|FG000|First Double-blind Intervention Period|Lost to Follow-up|0
7788552|NCT01006122|12240719|FG001|First Double-blind Intervention Period|Lost to Follow-up|2
7788553|NCT01006122|12240718|FG000|First Double-blind Intervention Period|Protocol Violation|1
7788554|NCT01006122|12240719|FG001|First Double-blind Intervention Period|Protocol Violation|1
7788555|NCT01006122|12240718|FG000|First Double-blind Intervention Period|Pregnancy|0
7788556|NCT01006122|12240719|FG001|First Double-blind Intervention Period|Pregnancy|1
7788557|NCT01006122|12240718|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9
7788558|NCT01006122|12240719|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8
7788559|NCT01006122|12240718|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1
7788560|NCT01006122|12240719|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0
7788561|NCT01006122|12240718|FG000|First Double-blind Intervention Period|Lack of Efficacy|2
7788562|NCT01006122|12240719|FG001|First Double-blind Intervention Period|Lack of Efficacy|1
7788563|NCT01006122|12240718|FG000|First Double-blind Intervention Period|Other|3
7788564|NCT01006122|12240719|FG001|First Double-blind Intervention Period|Other|0
7788565|NCT01006122|12240718|FG000|First Double-blind Intervention Period|Adverse Event|0
7788566|NCT01006122|12240719|FG001|First Double-blind Intervention Period|Adverse Event|4
7788567|NCT01006122|12240718|FG000|Second Double-blind Intervention Period|Adverse Event|1
7788568|NCT01006122|12240719|FG001|Second Double-blind Intervention Period|Adverse Event|1
7788569|NCT01006122|12240718|FG000|Second Double-blind Intervention Period|Protocol Violation|1
7788570|NCT01006122|12240719|FG001|Second Double-blind Intervention Period|Protocol Violation|0
7788571|NCT01006122|12240718|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0
7788572|NCT01006122|12240719|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3
7788573|NCT01006122|12240718|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0
7788574|NCT01006122|12240719|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2
7788575|NCT01006122|12240718|FG000|Second Double-blind Intervention Period|Death|0
7788576|NCT01006122|12240719|FG001|Second Double-blind Intervention Period|Death|1
7788577|NCT01006135|12240725|FG000|Overall Study|Adverse Event|22
7788578|NCT01006135|12240725|FG000|Overall Study|Protocol Violation|14
7788579|NCT01006135|12240725|FG000|Overall Study|Lost to Follow-up|32
7788580|NCT01006135|12240725|FG000|Overall Study|Other|72
7788581|NCT01006291|12240745|FG000|Overall Study|Adverse Event|2
7788582|NCT01006291|12240746|FG001|Overall Study|Adverse Event|1
7788583|NCT01006291|12240747|FG002|Overall Study|Adverse Event|2
7788584|NCT01006291|12240745|FG000|Overall Study|Lack of Efficacy|2
7788585|NCT01006291|12240746|FG001|Overall Study|Lack of Efficacy|2
7788586|NCT01006291|12240747|FG002|Overall Study|Lack of Efficacy|1
7788587|NCT01006291|12240745|FG000|Overall Study|Protocol Violation|3
7788588|NCT01006291|12240746|FG001|Overall Study|Protocol Violation|3
7788589|NCT01006291|12240747|FG002|Overall Study|Protocol Violation|3
7788590|NCT01006291|12240745|FG000|Overall Study|Withdrawal criteria|5
7788591|NCT01006291|12240746|FG001|Overall Study|Withdrawal criteria|4
7788592|NCT01006291|12240747|FG002|Overall Study|Withdrawal criteria|4
7788593|NCT01006291|12240745|FG000|Overall Study|Other|14
7788594|NCT01006291|12240746|FG001|Overall Study|Other|14
7788595|NCT01006291|12240747|FG002|Overall Study|Other|17
7788596|NCT01006356|12240755|FG000|Overall Study|Adverse Event|6
7788597|NCT01006356|12240755|FG000|Overall Study|Physician Decision|1
7788598|NCT01006356|12240755|FG000|Overall Study|Paticipants did not cooperate|6
7788599|NCT01006356|12240755|FG000|Overall Study|Withdrawal by Subject|1
7788600|NCT01006356|12240755|FG000|Overall Study|Choice by participants|2
7788601|NCT01006356|12240755|FG000|Overall Study|Protocol Violation|3
7788602|NCT01006356|12240755|FG000|Overall Study|Other|23
7622406|NCT02513667|12033230|FG000|Overall Study|Withdrawal by Subject|0
7622407|NCT02513667|12033231|FG001|Overall Study|Withdrawal by Subject|1
7622408|NCT02415556|12033241|FG000|Overall Study|Adverse Event|3
7622409|NCT02415556|12033242|FG001|Overall Study|Adverse Event|4
7622410|NCT02415556|12033243|FG002|Overall Study|Adverse Event|2
7622411|NCT02415556|12033244|FG003|Overall Study|Adverse Event|4
7622412|NCT02415556|12033241|FG000|Overall Study|Lost to Follow-up|4
7622413|NCT02415556|12033242|FG001|Overall Study|Lost to Follow-up|5
7622414|NCT02415556|12033243|FG002|Overall Study|Lost to Follow-up|4
7622415|NCT02415556|12033244|FG003|Overall Study|Lost to Follow-up|1
7622416|NCT02415556|12033241|FG000|Overall Study|Withdrawal by Subject|13
7622417|NCT02415556|12033242|FG001|Overall Study|Withdrawal by Subject|4
7622418|NCT02415556|12033243|FG002|Overall Study|Withdrawal by Subject|14
7622419|NCT02415556|12033244|FG003|Overall Study|Withdrawal by Subject|12
7622420|NCT02415556|12033241|FG000|Overall Study|Physician Decision|1
7622421|NCT02415556|12033242|FG001|Overall Study|Physician Decision|3
7622422|NCT02415556|12033243|FG002|Overall Study|Physician Decision|1
7622423|NCT02415556|12033244|FG003|Overall Study|Physician Decision|2
7788603|NCT01006590|12240778|FG000|Overall Study|Adverse Event|2
7788604|NCT01006590|12240779|FG001|Overall Study|Adverse Event|3
7622424|NCT02415556|12033241|FG000|Overall Study|Censored - study completion|4
7622425|NCT02415556|12033242|FG001|Overall Study|Censored - study completion|5
7622426|NCT02415556|12033243|FG002|Overall Study|Censored - study completion|1
7622427|NCT02415556|12033244|FG003|Overall Study|Censored - study completion|0
7622428|NCT02415556|12033241|FG000|Overall Study|Family-related issues|0
7622429|NCT02415556|12033242|FG001|Overall Study|Family-related issues|0
7622430|NCT02415556|12033243|FG002|Overall Study|Family-related issues|0
7622431|NCT02415556|12033244|FG003|Overall Study|Family-related issues|1
7788605|NCT01006590|12240778|FG000|Overall Study|Death|1
7788606|NCT01006590|12240779|FG001|Overall Study|Death|1
7788607|NCT01006590|12240778|FG000|Overall Study|Lost to Follow-up|1
7788608|NCT01006590|12240779|FG001|Overall Study|Lost to Follow-up|1
7788609|NCT01006590|12240778|FG000|Overall Study|Protocol Violation|1
7788610|NCT01006590|12240779|FG001|Overall Study|Protocol Violation|0
7788611|NCT01006590|12240778|FG000|Overall Study|Withdrawal by Subject|4
7788612|NCT01006590|12240779|FG001|Overall Study|Withdrawal by Subject|2
7788613|NCT01006590|12240778|FG000|Overall Study|Study specific discontinuation criteria|16
7788614|NCT01006590|12240779|FG001|Overall Study|Study specific discontinuation criteria|23
7788615|NCT01006590|12240778|FG000|Overall Study|Other|3
7788616|NCT01006590|12240779|FG001|Overall Study|Other|2
7788617|NCT01006603|12240787|FG000|Overall Study|Withdrawal by Subject|17
7788618|NCT01006603|12240788|FG001|Overall Study|Withdrawal by Subject|19
7788619|NCT01006603|12240787|FG000|Overall Study|Lost to Follow-up|0
7788620|NCT01006603|12240788|FG001|Overall Study|Lost to Follow-up|1
7788621|NCT01006603|12240787|FG000|Overall Study|Safety reason|1
7788622|NCT01006603|12240788|FG001|Overall Study|Safety reason|1
7788623|NCT01006603|12240787|FG000|Overall Study|Protocol Violation|1
7788624|NCT01006603|12240788|FG001|Overall Study|Protocol Violation|3
7788625|NCT01006603|12240787|FG000|Overall Study|Incorrect enrolment|0
7788626|NCT01006603|12240788|FG001|Overall Study|Incorrect enrolment|2
7788627|NCT01006603|12240787|FG000|Overall Study|Adverse Event|15
7788628|NCT01006603|12240788|FG001|Overall Study|Adverse Event|7
7788629|NCT01006603|12240787|FG000|Overall Study|Death|1
7788630|NCT01006603|12240788|FG001|Overall Study|Death|1
7788631|NCT01006603|12240787|FG000|Overall Study|Study specific discontinuation criteria|33
7788632|NCT01006603|12240788|FG001|Overall Study|Study specific discontinuation criteria|34
7788633|NCT01006603|12240787|FG000|Overall Study|Other|3
7788634|NCT01006603|12240788|FG001|Overall Study|Other|7
7788635|NCT01006616|12240798|FG000|Period 1 (6 Months)|Adverse Event|10
7788636|NCT01006616|12240799|FG001|Period 1 (6 Months)|Adverse Event|31
7788637|NCT01006616|12240800|FG002|Period 1 (6 Months)|Adverse Event|37
7788638|NCT01006616|12240801|FG003|Period 1 (6 Months)|Adverse Event|9
7788639|NCT01006616|12240798|FG000|Period 1 (6 Months)|Lack of Efficacy|3
7788640|NCT01006616|12240799|FG001|Period 1 (6 Months)|Lack of Efficacy|4
7788641|NCT01006616|12240800|FG002|Period 1 (6 Months)|Lack of Efficacy|0
7788642|NCT01006616|12240801|FG003|Period 1 (6 Months)|Lack of Efficacy|4
7788643|NCT01006616|12240798|FG000|Period 1 (6 Months)|Lost to Follow-up|0
7788644|NCT01006616|12240799|FG001|Period 1 (6 Months)|Lost to Follow-up|0
7622432|NCT02386839|12033270|FG000|Overall Study|Death|1
7622433|NCT02386839|12033271|FG001|Overall Study|Death|0
7622434|NCT02386839|12033270|FG000|Overall Study|Withdrawal by Subject|9
7622435|NCT02386839|12033271|FG001|Overall Study|Withdrawal by Subject|10
7622436|NCT02386839|12033270|FG000|Overall Study|Lost to Follow-up|4
7622437|NCT02386839|12033271|FG001|Overall Study|Lost to Follow-up|4
7622438|NCT02386839|12033270|FG000|Overall Study|Other (Site Terminated by Sponsor)|1
7622439|NCT02386839|12033271|FG001|Overall Study|Other (Site Terminated by Sponsor)|0
7622440|NCT02386839|12033270|FG000|Overall Study|Other (Covid 19 Pandemic)|0
7622441|NCT02386839|12033271|FG001|Overall Study|Other (Covid 19 Pandemic)|1
7622442|NCT02386839|12033270|FG000|Overall Study|Other (unspecified)|1
7622443|NCT02386839|12033271|FG001|Overall Study|Other (unspecified)|0
7788645|NCT01006616|12240800|FG002|Period 1 (6 Months)|Lost to Follow-up|1
7788646|NCT01006616|12240801|FG003|Period 1 (6 Months)|Lost to Follow-up|0
7788647|NCT01006616|12240798|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
7788648|NCT01006616|12240799|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
7788649|NCT01006616|12240800|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
7788650|NCT01006616|12240801|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
7788651|NCT01006616|12240798|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
7788652|NCT01006616|12240799|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
7788653|NCT01006616|12240800|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
7788654|NCT01006616|12240801|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
7788655|NCT01006616|12240798|FG000|Period 1 (6 Months)|Withdrawal by Subject|2
7788656|NCT01006616|12240799|FG001|Period 1 (6 Months)|Withdrawal by Subject|2
7788657|NCT01006616|12240800|FG002|Period 1 (6 Months)|Withdrawal by Subject|2
7788658|NCT01006616|12240801|FG003|Period 1 (6 Months)|Withdrawal by Subject|0
7788659|NCT01006616|12240798|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
7788660|NCT01006616|12240799|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
7788661|NCT01006616|12240800|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
7788662|NCT01006616|12240801|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
7788663|NCT01006616|12240798|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0
7788664|NCT01006616|12240799|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2
7788665|NCT01006616|12240800|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2
7788666|NCT01006616|12240801|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3
7788667|NCT01006616|12240798|FG000|Period 1 (6 Months)|Not Treated|0
7788668|NCT01006616|12240799|FG001|Period 1 (6 Months)|Not Treated|0
7788669|NCT01006616|12240800|FG002|Period 1 (6 Months)|Not Treated|1
7788670|NCT01006616|12240801|FG003|Period 1 (6 Months)|Not Treated|1
7788671|NCT01006616|12240798|FG000|Period 2 (18 Months)|Adverse Event|6
7788672|NCT01006616|12240799|FG001|Period 2 (18 Months)|Adverse Event|6
7788673|NCT01006616|12240800|FG002|Period 2 (18 Months)|Adverse Event|6
7788674|NCT01006616|12240801|FG003|Period 2 (18 Months)|Adverse Event|4
7788675|NCT01006616|12240798|FG000|Period 2 (18 Months)|Lack of Efficacy|0
7788676|NCT01006616|12240799|FG001|Period 2 (18 Months)|Lack of Efficacy|0
7788677|NCT01006616|12240800|FG002|Period 2 (18 Months)|Lack of Efficacy|1
7788678|NCT01006616|12240801|FG003|Period 2 (18 Months)|Lack of Efficacy|2
7788679|NCT01006616|12240798|FG000|Period 2 (18 Months)|Lost to Follow-up|2
7788680|NCT01006616|12240799|FG001|Period 2 (18 Months)|Lost to Follow-up|0
7788681|NCT01006616|12240800|FG002|Period 2 (18 Months)|Lost to Follow-up|0
7788682|NCT01006616|12240801|FG003|Period 2 (18 Months)|Lost to Follow-up|0
7788683|NCT01006616|12240798|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
7788684|NCT01006616|12240799|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
7788685|NCT01006616|12240800|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
7788686|NCT01006616|12240801|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
7788687|NCT01006616|12240798|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
7788688|NCT01006616|12240799|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
7788689|NCT01006616|12240800|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
7788690|NCT01006616|12240801|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
7788691|NCT01006616|12240798|FG000|Period 2 (18 Months)|Withdrawal by Subject|1
7788692|NCT01006616|12240799|FG001|Period 2 (18 Months)|Withdrawal by Subject|4
7788693|NCT01006616|12240800|FG002|Period 2 (18 Months)|Withdrawal by Subject|0
7788694|NCT01006616|12240801|FG003|Period 2 (18 Months)|Withdrawal by Subject|1
7788695|NCT01006616|12240798|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0
7788696|NCT01006616|12240799|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1
7788697|NCT01006616|12240800|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0
7788698|NCT01006616|12240801|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1
7788699|NCT01006616|12240798|FG000|Period 2 (18 Months)|Study Terminated|63
7788700|NCT01006616|12240799|FG001|Period 2 (18 Months)|Study Terminated|46
7788701|NCT01006616|12240800|FG002|Period 2 (18 Months)|Study Terminated|44
7788702|NCT01006616|12240801|FG003|Period 2 (18 Months)|Study Terminated|70
7788703|NCT01006629|12240811|FG000|Overall Study|Adverse Event|1
7788704|NCT01006629|12240811|FG000|Overall Study|Parent refused to continue participation|1
7788705|NCT01006629|12240811|FG000|Overall Study|Parent unable to perform site visit|4
7788706|NCT01006707|12240824|FG000|Study Session 1|Lost to Follow-up|2
7788707|NCT01006707|12240825|FG001|Study Session 1|Lost to Follow-up|0
7788708|NCT01006707|12240826|FG002|Study Session 1|Lost to Follow-up|0
7788709|NCT01006707|12240824|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3
7788710|NCT01006707|12240825|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0
7788711|NCT01006707|12240826|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0
7788712|NCT01006889|12240834|FG000|Overall Study|Withdrawal by Subject|3
7788713|NCT01006980|12240852|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
7788714|NCT01006980|12240853|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
7788715|NCT01006980|12240852|FG000|Vemurafenib and Dacarbazine|Adverse Event|25
7788716|NCT01006980|12240853|FG001|Vemurafenib and Dacarbazine|Adverse Event|5
7788717|NCT01006980|12240852|FG000|Vemurafenib and Dacarbazine|Death|13
7788718|NCT01006980|12240853|FG001|Vemurafenib and Dacarbazine|Death|12
7788719|NCT01006980|12240852|FG000|Vemurafenib and Dacarbazine|Progression|257
7788720|NCT01006980|12240853|FG001|Vemurafenib and Dacarbazine|Progression|218
7788721|NCT01006980|12240852|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
7788722|NCT01006980|12240853|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
7788723|NCT01006980|12240852|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9
7788724|NCT01006980|12240853|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6
7788725|NCT01006980|12240852|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2
7788726|NCT01006980|12240853|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3
7788727|NCT01006980|12240852|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26
7788728|NCT01006980|12240853|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43
7788729|NCT01006980|12240852|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
7788730|NCT01006980|12240853|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
7788731|NCT01006980|12240852|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0
7788732|NCT01006980|12240853|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4
7788733|NCT01006980|12240852|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0
7788734|NCT01006980|12240853|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65
7788735|NCT01006980|12240852|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
7788736|NCT01006980|12240853|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
7788737|NCT01006980|12240852|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
7788738|NCT01006980|12240853|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
7788739|NCT01007032|12240864|FG000|Overall Study|On Study Treatment at Cut-off Date|0
7788740|NCT01007032|12240865|FG001|Overall Study|On Study Treatment at Cut-off Date|1
7788741|NCT01007032|12240866|FG002|Overall Study|On Study Treatment at Cut-off Date|1
7788742|NCT01007032|12240867|FG003|Overall Study|On Study Treatment at Cut-off Date|0
7788743|NCT01007032|12240864|FG000|Overall Study|Withdrawal by Subject|0
7788744|NCT01007032|12240865|FG001|Overall Study|Withdrawal by Subject|0
7788745|NCT01007032|12240866|FG002|Overall Study|Withdrawal by Subject|0
7788746|NCT01007032|12240867|FG003|Overall Study|Withdrawal by Subject|1
7788747|NCT01007123|12240906|FG000|Overall Study|Adverse Event|3
7788748|NCT01007123|12240907|FG001|Overall Study|Adverse Event|4
7788749|NCT01007123|12240908|FG002|Overall Study|Adverse Event|7
7788750|NCT01007123|12240909|FG003|Overall Study|Adverse Event|1
7788751|NCT01007123|12240906|FG000|Overall Study|Lack of Efficacy|1
7788752|NCT01007123|12240907|FG001|Overall Study|Lack of Efficacy|0
7788753|NCT01007123|12240908|FG002|Overall Study|Lack of Efficacy|1
7788754|NCT01007123|12240909|FG003|Overall Study|Lack of Efficacy|4
7788755|NCT01007123|12240906|FG000|Overall Study|Protocol Violation|1
7788756|NCT01007123|12240907|FG001|Overall Study|Protocol Violation|1
7788757|NCT01007123|12240908|FG002|Overall Study|Protocol Violation|2
7788758|NCT01007123|12240909|FG003|Overall Study|Protocol Violation|1
7788759|NCT01007123|12240906|FG000|Overall Study|Withdrawal by Subject|1
7788760|NCT01007123|12240907|FG001|Overall Study|Withdrawal by Subject|0
7788761|NCT01007123|12240908|FG002|Overall Study|Withdrawal by Subject|1
7788762|NCT01007123|12240909|FG003|Overall Study|Withdrawal by Subject|0
7788763|NCT01007123|12240906|FG000|Overall Study|Lost to Follow-up|0
7788764|NCT01007123|12240907|FG001|Overall Study|Lost to Follow-up|1
7788765|NCT01007123|12240908|FG002|Overall Study|Lost to Follow-up|0
7788766|NCT01007123|12240909|FG003|Overall Study|Lost to Follow-up|0
7788767|NCT01007149|12240942|FG000|Overall Study|Administrative problems|0
7788768|NCT01007149|12240943|FG001|Overall Study|Administrative problems|1
7788769|NCT01007253|12240949|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1
7788770|NCT01007253|12240950|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0
7788771|NCT01007253|12240951|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0
7788772|NCT01007253|12240952|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0
7788773|NCT01007396|12240962|FG000|Overall Study|Lost to Follow-up|47
7788774|NCT01007435|12240970|FG000|Overall Study|Adverse Event|16
7788775|NCT01007435|12240971|FG001|Overall Study|Adverse Event|25
7788776|NCT01007435|12240972|FG002|Overall Study|Adverse Event|47
7788777|NCT01007435|12240973|FG003|Overall Study|Adverse Event|31
7788778|NCT01007435|12240970|FG000|Overall Study|Death|2
7788779|NCT01007435|12240971|FG001|Overall Study|Death|4
7788780|NCT01007435|12240972|FG002|Overall Study|Death|2
7788781|NCT01007435|12240973|FG003|Overall Study|Death|1
7788782|NCT01007435|12240970|FG000|Overall Study|Insufficient Therapeutic Response|21
7788783|NCT01007435|12240971|FG001|Overall Study|Insufficient Therapeutic Response|7
7788784|NCT01007435|12240972|FG002|Overall Study|Insufficient Therapeutic Response|2
7788785|NCT01007435|12240973|FG003|Overall Study|Insufficient Therapeutic Response|9
7788786|NCT01007435|12240970|FG000|Overall Study|Violation of Selection Criteria at Entry|3
7788787|NCT01007435|12240971|FG001|Overall Study|Violation of Selection Criteria at Entry|5
7788788|NCT01007435|12240972|FG002|Overall Study|Violation of Selection Criteria at Entry|2
7788789|NCT01007435|12240973|FG003|Overall Study|Violation of Selection Criteria at Entry|0
7788790|NCT01007435|12240970|FG000|Overall Study|Other Protocol Violation|2
7788791|NCT01007435|12240971|FG001|Overall Study|Other Protocol Violation|0
7788792|NCT01007435|12240972|FG002|Overall Study|Other Protocol Violation|1
7788793|NCT01007435|12240973|FG003|Overall Study|Other Protocol Violation|0
7788794|NCT01007435|12240970|FG000|Overall Study|Refused Treatment|13
7788795|NCT01007435|12240971|FG001|Overall Study|Refused Treatment|13
7788796|NCT01007435|12240972|FG002|Overall Study|Refused Treatment|5
7788797|NCT01007435|12240973|FG003|Overall Study|Refused Treatment|8
7788798|NCT01007435|12240970|FG000|Overall Study|Failure to Return|5
7788799|NCT01007435|12240971|FG001|Overall Study|Failure to Return|4
7788800|NCT01007435|12240972|FG002|Overall Study|Failure to Return|3
7788801|NCT01007435|12240973|FG003|Overall Study|Failure to Return|6
7788802|NCT01007435|12240970|FG000|Overall Study|Reason not Specified|1
7788803|NCT01007435|12240971|FG001|Overall Study|Reason not Specified|1
7788804|NCT01007435|12240972|FG002|Overall Study|Reason not Specified|2
7788805|NCT01007435|12240973|FG003|Overall Study|Reason not Specified|1
7788806|NCT01007448|12240985|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1
7788807|NCT01007448|12240986|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0
7788808|NCT01007448|12240985|FG000|Overall Study|Staph Skin Infection Flare|1
7788809|NCT01007448|12240986|FG001|Overall Study|Staph Skin Infection Flare|0
7788810|NCT01007448|12240985|FG000|Overall Study|Participant Leaving the Country|1
7788811|NCT01007448|12240986|FG001|Overall Study|Participant Leaving the Country|0
7788812|NCT01007448|12240985|FG000|Overall Study|Participant Given Prohibited Medication|1
7788813|NCT01007448|12240986|FG001|Overall Study|Participant Given Prohibited Medication|0
7788814|NCT01007448|12240985|FG000|Overall Study|Progressive Disease|1
7788815|NCT01007448|12240986|FG001|Overall Study|Progressive Disease|2
7788816|NCT01007448|12240985|FG000|Overall Study|Lack of Efficacy|2
7788817|NCT01007448|12240986|FG001|Overall Study|Lack of Efficacy|0
7788818|NCT01007448|12240985|FG000|Overall Study|Withdrawal by Subject|2
7788819|NCT01007448|12240986|FG001|Overall Study|Withdrawal by Subject|3
7788820|NCT01007448|12240985|FG000|Overall Study|Adverse Event|1
7788821|NCT01007448|12240986|FG001|Overall Study|Adverse Event|4
7788822|NCT01007552|12240996|FG000|Overall Study|Withdrawal by Subject|1
7788823|NCT01007812|12241022|FG000|Period 1, One Week|Lost to Follow-up|0
7788824|NCT01007812|12241023|FG001|Period 1, One Week|Lost to Follow-up|1
7788825|NCT01007812|12241022|FG000|Period 1, One Week|Discomfort|1
7788826|NCT01007812|12241023|FG001|Period 1, One Week|Discomfort|0
7788827|NCT01007838|12241033|FG000|Overall Study|Withdrawal by Subject|1
7788828|NCT01007838|12241034|FG001|Overall Study|Withdrawal by Subject|0
7788829|NCT01007838|12241035|FG002|Overall Study|Withdrawal by Subject|0
7788830|NCT01007838|12241036|FG003|Overall Study|Withdrawal by Subject|0
7788831|NCT01007838|12241033|FG000|Overall Study|Physician Decision|1
7788832|NCT01007838|12241034|FG001|Overall Study|Physician Decision|0
7788833|NCT01007838|12241035|FG002|Overall Study|Physician Decision|0
7788834|NCT01007838|12241036|FG003|Overall Study|Physician Decision|0
7788835|NCT01007838|12241033|FG000|Overall Study|Started home haemodialysis|1
7788836|NCT01007838|12241034|FG001|Overall Study|Started home haemodialysis|0
7788837|NCT01007838|12241035|FG002|Overall Study|Started home haemodialysis|0
7622486|NCT02312258|12033299|FG000|Overall Study|Adverse Event|15
7622487|NCT02312258|12033300|FG001|Overall Study|Adverse Event|47
7622488|NCT02312258|12033299|FG000|Overall Study|Lost to Follow-up|0
7622489|NCT02312258|12033300|FG001|Overall Study|Lost to Follow-up|1
7622490|NCT02312258|12033299|FG000|Overall Study|Progressive Disease|174
7622491|NCT02312258|12033300|FG001|Overall Study|Progressive Disease|188
7622492|NCT02312258|12033299|FG000|Overall Study|Withdrawal by Subject|8
7622493|NCT02312258|12033300|FG001|Overall Study|Withdrawal by Subject|9
7622494|NCT02312258|12033299|FG000|Overall Study|Reason not Specified|11
7622495|NCT02312258|12033300|FG001|Overall Study|Reason not Specified|31
7622496|NCT02312258|12033299|FG000|Overall Study|Participants Ongoing Treatment|43
7622497|NCT02312258|12033300|FG001|Overall Study|Participants Ongoing Treatment|83
7622498|NCT02213380|12033308|FG000|Underwent Randomization|Withdrawal by Subject|2
7622499|NCT02213380|12033309|FG001|Underwent Randomization|Withdrawal by Subject|0
7788838|NCT01007838|12241036|FG003|Overall Study|Started home haemodialysis|0
7788839|NCT01007916|12241046|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
7788840|NCT01007916|12241047|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
7788841|NCT01007916|12241046|FG000|Period 2, 4 Weeks of Wear|Relocation|1
7622500|NCT02213380|12033308|FG000|Underwent Randomization|Not treated|3
7622501|NCT02213380|12033309|FG001|Underwent Randomization|Not treated|3
7622502|NCT02213380|12033308|FG000|Per-protocol Analysis|Protocol Violation|32
7622503|NCT02213380|12033309|FG001|Per-protocol Analysis|Protocol Violation|36
7788842|NCT01007916|12241047|FG001|Period 2, 4 Weeks of Wear|Relocation|0
7788843|NCT01007942|12241055|FG000|Overall Study|Adverse Event|29
7788844|NCT01007942|12241056|FG001|Overall Study|Adverse Event|14
7788845|NCT01007942|12241055|FG000|Overall Study|Abnormal test procedure|0
7788846|NCT01007942|12241056|FG001|Overall Study|Abnormal test procedure|1
7788847|NCT01007942|12241055|FG000|Overall Study|Disease progression|217
7788848|NCT01007942|12241056|FG001|Overall Study|Disease progression|242
7788849|NCT01007942|12241055|FG000|Overall Study|New cancer therapy|5
7788850|NCT01007942|12241056|FG001|Overall Study|New cancer therapy|1
7788851|NCT01007942|12241055|FG000|Overall Study|Protocol Violation|1
7788852|NCT01007942|12241056|FG001|Overall Study|Protocol Violation|1
7788853|NCT01007942|12241055|FG000|Overall Study|Withdrawal by Subject|19
7788854|NCT01007942|12241056|FG001|Overall Study|Withdrawal by Subject|14
7788855|NCT01007942|12241055|FG000|Overall Study|Lost to Follow-up|1
7788856|NCT01007942|12241056|FG001|Overall Study|Lost to Follow-up|0
7788857|NCT01007942|12241055|FG000|Overall Study|Administrative problems|2
7788858|NCT01007942|12241056|FG001|Overall Study|Administrative problems|0
7788859|NCT01007942|12241055|FG000|Overall Study|Death|3
7788860|NCT01007942|12241056|FG001|Overall Study|Death|2
7788861|NCT01007942|12241055|FG000|Overall Study|Patients untreated|4
7788862|NCT01007942|12241056|FG001|Overall Study|Patients untreated|3
7788863|NCT01008150|12241097|FG000|Overall Study|did not receive study drug|1
7788864|NCT01008150|12241098|FG001|Overall Study|did not receive study drug|1
7788865|NCT01008150|12241099|FG002|Overall Study|did not receive study drug|1
7788866|NCT01008150|12241100|FG003|Overall Study|did not receive study drug|0
7788867|NCT01008410|12241135|FG000|Overall Study|Adverse Event|13
7788868|NCT01008410|12241136|FG001|Overall Study|Adverse Event|7
7788869|NCT01008410|12241135|FG000|Overall Study|Withdrawal by Subject|6
7788870|NCT01008410|12241136|FG001|Overall Study|Withdrawal by Subject|2
7788871|NCT01008410|12241135|FG000|Overall Study|Lost to Follow-up|1
7788872|NCT01008410|12241136|FG001|Overall Study|Lost to Follow-up|0
7788873|NCT01008410|12241135|FG000|Overall Study|Noncompliance|1
7788874|NCT01008410|12241136|FG001|Overall Study|Noncompliance|0
7788875|NCT01008410|12241135|FG000|Overall Study|Low Cortisol|2
7788876|NCT01008410|12241136|FG001|Overall Study|Low Cortisol|0
7788877|NCT01008410|12241135|FG000|Overall Study|Lack of Efficacy|2
7788878|NCT01008410|12241136|FG001|Overall Study|Lack of Efficacy|6
7788879|NCT01008410|12241135|FG000|Overall Study|Met Exclusion Criterion|0
7788880|NCT01008410|12241136|FG001|Overall Study|Met Exclusion Criterion|1
7800510|NCT01096160|12258030|FG003|Overall Study|Met stopping criteria per protocol|0
7800511|NCT01096160|12258031|FG004|Overall Study|Met stopping criteria per protocol|1
7800512|NCT01096160|12258032|FG005|Overall Study|Met stopping criteria per protocol|0
7800513|NCT01096160|12258033|FG006|Overall Study|Met stopping criteria per protocol|2
7800514|NCT01096160|12258034|FG007|Overall Study|Met stopping criteria per protocol|0
7800515|NCT01096160|12258035|FG008|Overall Study|Met stopping criteria per protocol|2
7800516|NCT01096160|12258036|FG009|Overall Study|Met stopping criteria per protocol|0
7800517|NCT01096186|12258071|FG000|Overall Study|Adverse Event|16
7800518|NCT01096186|12258071|FG000|Overall Study|Death|4
7800519|NCT01096186|12258071|FG000|Overall Study|Lack of Efficacy|4
7800520|NCT01096186|12258071|FG000|Overall Study|Lost to Follow-up|2
7800521|NCT01096186|12258071|FG000|Overall Study|Withdrawal by Subject|22
7800522|NCT01096186|12258071|FG000|Overall Study|Physician Decision|1
7800523|NCT01096186|12258071|FG000|Overall Study|Noncompliance with study drug|1
7800524|NCT01096316|12258086|FG000|Overall Study|Lost to Follow-up|15
7800525|NCT01096316|12258087|FG001|Overall Study|Lost to Follow-up|9
7800526|NCT01096342|12258093|FG000|Overall Study|Protocol Violation|1
7800527|NCT01096446|12258099|FG000|Overall Study|Death|1
7800528|NCT01096446|12258100|FG001|Overall Study|Death|0
7800529|NCT01096446|12258099|FG000|Overall Study|Protocol Violation|2
7800530|NCT01096446|12258100|FG001|Overall Study|Protocol Violation|0
7800531|NCT01096550|12258107|FG000|Overall Study|discontinued site|10
7800532|NCT01096550|12258108|FG001|Overall Study|discontinued site|11
7800533|NCT01096550|12258107|FG000|Overall Study|non-regular treatment track at clinic|1
7800534|NCT01096550|12258108|FG001|Overall Study|non-regular treatment track at clinic|1
7800535|NCT01096550|12258107|FG000|Overall Study|clinic readmission|1
7800536|NCT01096550|12258108|FG001|Overall Study|clinic readmission|1
7800537|NCT01096550|12258107|FG000|Overall Study|Withdrawal by Subject|0
7800538|NCT01096550|12258108|FG001|Overall Study|Withdrawal by Subject|1
7800539|NCT01096550|12258107|FG000|Overall Study|non-African American participant|13
7800540|NCT01096550|12258108|FG001|Overall Study|non-African American participant|6
7800541|NCT01096550|12258107|FG000|Overall Study|Lost to Follow-up|12
7800542|NCT01096550|12258108|FG001|Overall Study|Lost to Follow-up|9
7800543|NCT01096589|12258118|FG000|Overall Study|Adverse Event|2
7800544|NCT01096589|12258119|FG001|Overall Study|Adverse Event|1
7800545|NCT01096589|12258120|FG002|Overall Study|Adverse Event|2
7800546|NCT01096589|12258121|FG003|Overall Study|Adverse Event|1
7800547|NCT01096589|12258118|FG000|Overall Study|Withdrawal by Subject|2
7800548|NCT01096589|12258119|FG001|Overall Study|Withdrawal by Subject|1
7800549|NCT01096589|12258120|FG002|Overall Study|Withdrawal by Subject|1
7800550|NCT01096589|12258121|FG003|Overall Study|Withdrawal by Subject|1
7788881|NCT01008423|12241144|FG000|Overall Study|Adverse Event|13
7788882|NCT01008423|12241145|FG001|Overall Study|Adverse Event|6
7788883|NCT01008423|12241144|FG000|Overall Study|Withdrawal by Subject|4
7788884|NCT01008423|12241145|FG001|Overall Study|Withdrawal by Subject|7
7788885|NCT01008423|12241144|FG000|Overall Study|Lost to Follow-up|0
7788886|NCT01008423|12241145|FG001|Overall Study|Lost to Follow-up|2
7788887|NCT01008423|12241144|FG000|Overall Study|Low Cortisol|0
7788888|NCT01008423|12241145|FG001|Overall Study|Low Cortisol|1
7788889|NCT01008423|12241144|FG000|Overall Study|Lack of Efficacy|0
7788890|NCT01008423|12241145|FG001|Overall Study|Lack of Efficacy|5
7788891|NCT01008423|12241144|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1
7788892|NCT01008423|12241145|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0
7788893|NCT01008423|12241144|FG000|Overall Study|Personal Conflict|1
7788894|NCT01008423|12241145|FG001|Overall Study|Personal Conflict|0
7788895|NCT01008423|12241144|FG000|Overall Study|Other|0
7788896|NCT01008423|12241145|FG001|Overall Study|Other|1
7788897|NCT01008449|12241153|FG000|Overall Study|Lost to Follow-up|29
7788898|NCT01008449|12241154|FG001|Overall Study|Lost to Follow-up|19
7788899|NCT01008475|12241171|FG000|Overall Study|Ongoing treatment at data cut-off date|0
7788900|NCT01008475|12241172|FG001|Overall Study|Ongoing treatment at data cut-off date|0
7788901|NCT01008475|12241173|FG002|Overall Study|Ongoing treatment at data cut-off date|0
7788902|NCT01008475|12241174|FG003|Overall Study|Ongoing treatment at data cut-off date|0
7788903|NCT01008475|12241175|FG004|Overall Study|Ongoing treatment at data cut-off date|5
7788904|NCT01008475|12241176|FG005|Overall Study|Ongoing treatment at data cut-off date|6
7788905|NCT01008475|12241177|FG006|Overall Study|Ongoing treatment at data cut-off date|4
7788906|NCT01008553|12241193|FG000|Period 1 (Titration Period)|Physician Decision|2
7788907|NCT01008553|12241194|FG001|Period 1 (Titration Period)|Physician Decision|0
7788908|NCT01008553|12241195|FG002|Period 1 (Titration Period)|Physician Decision|0
7788909|NCT01008553|12241193|FG000|Period 1 (Titration Period)|Adverse Event|33
7788910|NCT01008553|12241194|FG001|Period 1 (Titration Period)|Adverse Event|0
7788911|NCT01008553|12241195|FG002|Period 1 (Titration Period)|Adverse Event|0
7788912|NCT01008553|12241193|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6
7788913|NCT01008553|12241194|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0
7788914|NCT01008553|12241195|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0
7788915|NCT01008553|12241193|FG000|Period 1 (Titration Period)|Determined to increase dosage|3
7788916|NCT01008553|12241194|FG001|Period 1 (Titration Period)|Determined to increase dosage|0
7788917|NCT01008553|12241195|FG002|Period 1 (Titration Period)|Determined to increase dosage|0
7788918|NCT01008553|12241193|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
7788919|NCT01008553|12241194|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
7788920|NCT01008553|12241195|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
7788921|NCT01008553|12241193|FG000|Period 1 (Titration Period)|Not appropriate for this study|1
7788922|NCT01008553|12241194|FG001|Period 1 (Titration Period)|Not appropriate for this study|0
7788923|NCT01008553|12241195|FG002|Period 1 (Titration Period)|Not appropriate for this study|0
7788924|NCT01008553|12241193|FG000|Period 2 (Double-Blind Period)|Physician Decision|0
7788925|NCT01008553|12241194|FG001|Period 2 (Double-Blind Period)|Physician Decision|1
7788926|NCT01008553|12241195|FG002|Period 2 (Double-Blind Period)|Physician Decision|2
7788927|NCT01008553|12241193|FG000|Period 2 (Double-Blind Period)|Adverse Event|0
7788928|NCT01008553|12241194|FG001|Period 2 (Double-Blind Period)|Adverse Event|14
7788929|NCT01008553|12241195|FG002|Period 2 (Double-Blind Period)|Adverse Event|4
7788930|NCT01008553|12241193|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
7788931|NCT01008553|12241194|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
7788932|NCT01008553|12241195|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
7788933|NCT01008553|12241193|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
7788934|NCT01008553|12241194|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
7788935|NCT01008553|12241195|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
7788936|NCT01008553|12241193|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
7788937|NCT01008553|12241194|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
7788938|NCT01008553|12241195|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
7788939|NCT01008553|12241193|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
7788940|NCT01008553|12241194|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
7788941|NCT01008553|12241195|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
7788942|NCT01008553|12241193|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
7788943|NCT01008553|12241194|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
7788944|NCT01008553|12241195|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
7788945|NCT01008553|12241193|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
7788946|NCT01008553|12241194|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
7788947|NCT01008553|12241195|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
7788948|NCT01008618|12241216|FG000|Period 1 (Titration Period)|Physician Decision|2
7788949|NCT01008618|12241217|FG001|Period 1 (Titration Period)|Physician Decision|0
7788950|NCT01008618|12241218|FG002|Period 1 (Titration Period)|Physician Decision|0
7788951|NCT01008618|12241216|FG000|Period 1 (Titration Period)|Adverse Event|33
7788952|NCT01008618|12241217|FG001|Period 1 (Titration Period)|Adverse Event|0
7788953|NCT01008618|12241218|FG002|Period 1 (Titration Period)|Adverse Event|0
7788954|NCT01008618|12241216|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11
7788955|NCT01008618|12241217|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0
7788956|NCT01008618|12241218|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0
7788957|NCT01008618|12241216|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
7788958|NCT01008618|12241217|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
7788959|NCT01008618|12241218|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
7788960|NCT01008618|12241216|FG000|Period 1 (Titration Period)|Aggravated symptom|2
7788961|NCT01008618|12241217|FG001|Period 1 (Titration Period)|Aggravated symptom|0
7788962|NCT01008618|12241218|FG002|Period 1 (Titration Period)|Aggravated symptom|0
7788963|NCT01008618|12241216|FG000|Period 2 (Double-Blind Period)|Adverse Event|0
7788964|NCT01008618|12241217|FG001|Period 2 (Double-Blind Period)|Adverse Event|11
7788965|NCT01008618|12241218|FG002|Period 2 (Double-Blind Period)|Adverse Event|2
7788966|NCT01008618|12241216|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
7788967|NCT01008618|12241217|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
7788968|NCT01008618|12241218|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
7788969|NCT01008618|12241216|FG000|Period 2 (Double-Blind Period)|Physician Decision|0
7788970|NCT01008618|12241217|FG001|Period 2 (Double-Blind Period)|Physician Decision|1
7788971|NCT01008618|12241218|FG002|Period 2 (Double-Blind Period)|Physician Decision|0
7788972|NCT01008618|12241216|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
7788973|NCT01008618|12241217|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
7788974|NCT01008618|12241218|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
7788975|NCT01008618|12241216|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
7788976|NCT01008618|12241217|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
7788977|NCT01008618|12241218|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
7788978|NCT01008618|12241216|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
7788979|NCT01008618|12241217|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
7788980|NCT01008618|12241218|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
7788981|NCT01008618|12241216|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0
7788982|NCT01008618|12241217|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0
7788983|NCT01008618|12241218|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1
7788984|NCT01008696|12241229|FG000|Overall Study|Participant's evasion of hospital visit|5
7788985|NCT01008696|12241230|FG001|Overall Study|Participant's evasion of hospital visit|4
7788986|NCT01008696|12241229|FG000|Overall Study|Withdrawal by Subject|2
7788987|NCT01008696|12241230|FG001|Overall Study|Withdrawal by Subject|4
7788988|NCT01008696|12241229|FG000|Overall Study|Physician Decision|5
7788989|NCT01008696|12241230|FG001|Overall Study|Physician Decision|1
7788990|NCT01008696|12241229|FG000|Overall Study|Adverse Event|1
7788991|NCT01008696|12241230|FG001|Overall Study|Adverse Event|0
7788992|NCT01008696|12241229|FG000|Overall Study|Participants' non-cooperation|2
7788993|NCT01008696|12241230|FG001|Overall Study|Participants' non-cooperation|3
7788994|NCT01008696|12241229|FG000|Overall Study|Other|2
7788995|NCT01008696|12241230|FG001|Overall Study|Other|3
7788996|NCT01008696|12241229|FG000|Overall Study|Other|0
7788997|NCT01008696|12241230|FG001|Overall Study|Other|2
7788998|NCT01008748|12241246|FG000|Overall Study|Lost to Follow-up|80
7788999|NCT01008748|12241246|FG000|Overall Study|Other|1
7789000|NCT01008904|12241250|FG000|Overall Study|Lost to Follow-up|1
7789001|NCT01008904|12241250|FG000|Overall Study|Adverse Event|2
7789002|NCT01008904|12241250|FG000|Overall Study|unexpected unrelated surgery|1
7789003|NCT01008943|12241254|FG000|Overall Study|Withdrawal by Subject|1
7789004|NCT01008995|12241264|FG000|Controlled Period|Adverse Event|1
7789005|NCT01008995|12241265|FG001|Controlled Period|Adverse Event|2
7789006|NCT01008995|12241266|FG002|Controlled Period|Adverse Event|0
7789007|NCT01008995|12241267|FG003|Controlled Period|Adverse Event|0
7789008|NCT01008995|12241264|FG000|Controlled Period|Other|2
7789009|NCT01008995|12241265|FG001|Controlled Period|Other|1
7789010|NCT01008995|12241266|FG002|Controlled Period|Other|0
7789011|NCT01008995|12241267|FG003|Controlled Period|Other|0
7789012|NCT01008995|12241264|FG000|After Controlled Period|Adverse Event|0
7789013|NCT01008995|12241265|FG001|After Controlled Period|Adverse Event|0
7789014|NCT01008995|12241266|FG002|After Controlled Period|Adverse Event|1
7789015|NCT01008995|12241267|FG003|After Controlled Period|Adverse Event|1
7789016|NCT01008995|12241264|FG000|After Controlled Period|Other|0
7789017|NCT01008995|12241265|FG001|After Controlled Period|Other|0
7789018|NCT01008995|12241266|FG002|After Controlled Period|Other|1
7789019|NCT01008995|12241267|FG003|After Controlled Period|Other|0
7789020|NCT01009034|12241275|FG000|Overall Study|Lost to Follow-up|2
7789021|NCT01009034|12241275|FG000|Overall Study|Withdrawal by Subject|2
7789022|NCT01009047|12241281|FG000|Overall Study|Adverse Event|5
7789023|NCT01009047|12241282|FG001|Overall Study|Adverse Event|0
7789024|NCT01009047|12241281|FG000|Overall Study|Lost to Follow-up|0
7789025|NCT01009047|12241282|FG001|Overall Study|Lost to Follow-up|2
7789026|NCT01009047|12241281|FG000|Overall Study|Lack of Efficacy|4
7789027|NCT01009047|12241282|FG001|Overall Study|Lack of Efficacy|11
7789028|NCT01009047|12241281|FG000|Overall Study|Withdrawal by consent|16
7789029|NCT01009047|12241282|FG001|Overall Study|Withdrawal by consent|11
7789030|NCT01009047|12241281|FG000|Overall Study|Other|3
7789031|NCT01009047|12241282|FG001|Overall Study|Other|2
7789032|NCT01009060|12241290|FG000|Overall Study|Adverse Event|1
7789033|NCT01009060|12241291|FG001|Overall Study|Adverse Event|2
7789034|NCT01009060|12241290|FG000|Overall Study|Protocol Violation|0
7789035|NCT01009060|12241291|FG001|Overall Study|Protocol Violation|1
7789036|NCT01009060|12241290|FG000|Overall Study|Lost to Follow-up|1
7789037|NCT01009060|12241291|FG001|Overall Study|Lost to Follow-up|0
7789038|NCT01009060|12241290|FG000|Overall Study|Physician Decision|1
7789039|NCT01009060|12241291|FG001|Overall Study|Physician Decision|1
7789040|NCT01009060|12241290|FG000|Overall Study|Withdrawal by Subject|1
7789041|NCT01009060|12241291|FG001|Overall Study|Withdrawal by Subject|1
7789042|NCT01009086|12241304|FG000|Overall Study|Lack of Efficacy|16
7789043|NCT01009086|12241305|FG001|Overall Study|Lack of Efficacy|15
7789044|NCT01009086|12241306|FG002|Overall Study|Lack of Efficacy|9
7789045|NCT01009086|12241304|FG000|Overall Study|Lost to Follow-up|4
7789046|NCT01009086|12241305|FG001|Overall Study|Lost to Follow-up|5
7789047|NCT01009086|12241306|FG002|Overall Study|Lost to Follow-up|3
7789048|NCT01009086|12241304|FG000|Overall Study|Adverse Event|12
7789049|NCT01009086|12241305|FG001|Overall Study|Adverse Event|11
7789050|NCT01009086|12241306|FG002|Overall Study|Adverse Event|8
7789051|NCT01009086|12241304|FG000|Overall Study|Withdrawal by Subject|9
7789052|NCT01009086|12241305|FG001|Overall Study|Withdrawal by Subject|11
7789053|NCT01009086|12241306|FG002|Overall Study|Withdrawal by Subject|13
7789054|NCT01009086|12241304|FG000|Overall Study|Other|3
7789055|NCT01009086|12241305|FG001|Overall Study|Other|5
7789056|NCT01009086|12241306|FG002|Overall Study|Other|1
7789057|NCT01009099|12241321|FG000|Overall Study|Lost to Follow-up|1
7789058|NCT01009099|12241322|FG001|Overall Study|Lost to Follow-up|0
7789059|NCT01009099|12241321|FG000|Overall Study|Physician Decision|3
7789060|NCT01009099|12241322|FG001|Overall Study|Physician Decision|2
7789061|NCT01009099|12241321|FG000|Overall Study|Withdrawal by Subject|1
7789062|NCT01009099|12241322|FG001|Overall Study|Withdrawal by Subject|1
7789063|NCT01009099|12241321|FG000|Overall Study|Death|0
7789064|NCT01009099|12241322|FG001|Overall Study|Death|1
7789065|NCT01009203|12241337|FG000|Overall Study|Withdrawal by Subject|1
7789066|NCT01009203|12241337|FG000|Overall Study|Adverse Event|5
7789067|NCT01009203|12241337|FG000|Overall Study|Treatment-unrelated death|1
7789068|NCT01009281|12241341|FG000|Overall Study|Administrative problems|7
7789069|NCT01009346|12241358|FG000|Overall Study|Adverse Event|4
7789070|NCT01009463|12241367|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
7789071|NCT01009463|12241368|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7789072|NCT01009463|12241369|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7789073|NCT01009463|12241370|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7789074|NCT01009463|12241371|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7789075|NCT01009463|12241367|FG000|4-week, Open-label Run-In Period|Adverse Event|10
7789076|NCT01009463|12241368|FG001|4-week, Open-label Run-In Period|Adverse Event|0
7789077|NCT01009463|12241369|FG002|4-week, Open-label Run-In Period|Adverse Event|0
7789078|NCT01009463|12241370|FG003|4-week, Open-label Run-In Period|Adverse Event|0
7789079|NCT01009463|12241371|FG004|4-week, Open-label Run-In Period|Adverse Event|0
7789080|NCT01009463|12241367|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6
7789081|NCT01009463|12241368|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0
7789082|NCT01009463|12241369|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0
7789083|NCT01009463|12241370|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0
7789084|NCT01009463|12241371|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0
7789085|NCT01009463|12241367|FG000|4-week, Open-label Run-In Period|Physician Decision|10
7789086|NCT01009463|12241368|FG001|4-week, Open-label Run-In Period|Physician Decision|0
7789087|NCT01009463|12241369|FG002|4-week, Open-label Run-In Period|Physician Decision|0
7789088|NCT01009463|12241370|FG003|4-week, Open-label Run-In Period|Physician Decision|0
7789089|NCT01009463|12241371|FG004|4-week, Open-label Run-In Period|Physician Decision|0
7789090|NCT01009463|12241367|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50
7789091|NCT01009463|12241368|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7789092|NCT01009463|12241369|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7789093|NCT01009463|12241370|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7789094|NCT01009463|12241371|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7789095|NCT01009463|12241367|FG000|52-week, Double-blind Treatment Period|Adverse Event|0
7789096|NCT01009463|12241368|FG001|52-week, Double-blind Treatment Period|Adverse Event|22
7789097|NCT01009463|12241369|FG002|52-week, Double-blind Treatment Period|Adverse Event|25
7789098|NCT01009463|12241370|FG003|52-week, Double-blind Treatment Period|Adverse Event|29
7789099|NCT01009463|12241371|FG004|52-week, Double-blind Treatment Period|Adverse Event|31
7789100|NCT01009463|12241367|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
7789101|NCT01009463|12241368|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
7789102|NCT01009463|12241369|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
7789103|NCT01009463|12241370|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
7789104|NCT01009463|12241371|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
7789105|NCT01009463|12241367|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0
7789106|NCT01009463|12241368|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24
7789107|NCT01009463|12241369|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16
7622580|NCT02075320|12033368|FG000|Overall Study|Withdrawal by Subject|2
7622581|NCT02007512|12033376|FG000|Double Blind Treatment Period|Adverse Event|4
7622582|NCT02007512|12033377|FG001|Double Blind Treatment Period|Adverse Event|2
7622583|NCT02007512|12033378|FG002|Double Blind Treatment Period|Adverse Event|6
7622584|NCT02007512|12033379|FG003|Double Blind Treatment Period|Adverse Event|2
7622585|NCT02007512|12033376|FG000|Double Blind Treatment Period|Death|1
7622586|NCT02007512|12033377|FG001|Double Blind Treatment Period|Death|0
7622587|NCT02007512|12033378|FG002|Double Blind Treatment Period|Death|0
7622588|NCT02007512|12033379|FG003|Double Blind Treatment Period|Death|0
7622589|NCT02007512|12033376|FG000|Double Blind Treatment Period|Disease progression|44
7622590|NCT02007512|12033377|FG001|Double Blind Treatment Period|Disease progression|49
7622591|NCT02007512|12033378|FG002|Double Blind Treatment Period|Disease progression|45
7622592|NCT02007512|12033379|FG003|Double Blind Treatment Period|Disease progression|51
7622593|NCT02007512|12033376|FG000|Double Blind Treatment Period|Withdrawal by Subject|4
7622594|NCT02007512|12033377|FG001|Double Blind Treatment Period|Withdrawal by Subject|2
7622595|NCT02007512|12033378|FG002|Double Blind Treatment Period|Withdrawal by Subject|3
7622596|NCT02007512|12033379|FG003|Double Blind Treatment Period|Withdrawal by Subject|3
7622597|NCT02007512|12033376|FG000|Double Blind Treatment Period|Protocol Violation|0
7622598|NCT02007512|12033377|FG001|Double Blind Treatment Period|Protocol Violation|0
7622599|NCT02007512|12033378|FG002|Double Blind Treatment Period|Protocol Violation|0
7622600|NCT02007512|12033379|FG003|Double Blind Treatment Period|Protocol Violation|1
7622601|NCT02007512|12033376|FG000|Double Blind Treatment Period|Other|0
7622602|NCT02007512|12033377|FG001|Double Blind Treatment Period|Other|0
7622603|NCT02007512|12033378|FG002|Double Blind Treatment Period|Other|1
7622604|NCT02007512|12033379|FG003|Double Blind Treatment Period|Other|2
7622605|NCT02007512|12033376|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
7789108|NCT01009463|12241370|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11
7789109|NCT01009463|12241371|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18
7789110|NCT01009463|12241367|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0
7789111|NCT01009463|12241368|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8
7789112|NCT01009463|12241369|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7
7789113|NCT01009463|12241370|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8
7789114|NCT01009463|12241371|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7
7789115|NCT01009463|12241367|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
7789116|NCT01009463|12241368|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
7789117|NCT01009463|12241369|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
7789118|NCT01009463|12241370|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
7789119|NCT01009463|12241371|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
7789120|NCT01009463|12241367|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7789121|NCT01009463|12241368|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
7789122|NCT01009463|12241369|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7789123|NCT01009463|12241370|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
7789124|NCT01009463|12241371|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7789125|NCT01009463|12241367|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0
7789126|NCT01009463|12241368|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11
7789127|NCT01009463|12241369|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7
7789128|NCT01009463|12241370|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6
7789129|NCT01009463|12241371|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5
7789130|NCT01009463|12241367|FG000|52-week, Double-blind Treatment Period|Physician Decision|0
7789131|NCT01009463|12241368|FG001|52-week, Double-blind Treatment Period|Physician Decision|4
7789132|NCT01009463|12241369|FG002|52-week, Double-blind Treatment Period|Physician Decision|6
7789133|NCT01009463|12241370|FG003|52-week, Double-blind Treatment Period|Physician Decision|6
7789134|NCT01009463|12241371|FG004|52-week, Double-blind Treatment Period|Physician Decision|8
7789135|NCT01009515|12241382|FG000|Overall Study|Withdrawal by Subject|3
7789136|NCT01009554|12241388|FG000|Overall Study|Adverse Event|1
7789137|NCT01009554|12241389|FG001|Overall Study|Adverse Event|1
7789138|NCT01009554|12241388|FG000|Overall Study|Withdrawal by Subject|1
7789139|NCT01009554|12241389|FG001|Overall Study|Withdrawal by Subject|3
7789140|NCT01009554|12241388|FG000|Overall Study|Noncompliant with Study Product|0
7789141|NCT01009554|12241389|FG001|Overall Study|Noncompliant with Study Product|3
7789142|NCT01009580|12241397|FG000|Overall Study|Adverse Event|4
7789143|NCT01009580|12241398|FG001|Overall Study|Adverse Event|4
7789144|NCT01009580|12241397|FG000|Overall Study|Lack of Efficacy|0
7789145|NCT01009580|12241398|FG001|Overall Study|Lack of Efficacy|1
7789146|NCT01009580|12241397|FG000|Overall Study|Protocol Violation|2
7789147|NCT01009580|12241398|FG001|Overall Study|Protocol Violation|3
7789148|NCT01009580|12241397|FG000|Overall Study|Withdrawal Criteria|4
7789149|NCT01009580|12241398|FG001|Overall Study|Withdrawal Criteria|6
7789150|NCT01009580|12241397|FG000|Overall Study|Unclassified|17
7789151|NCT01009580|12241398|FG001|Overall Study|Unclassified|21
7789152|NCT01009645|12241417|FG000|Overall Study|Lost to Follow-up|2
7789153|NCT01009645|12241418|FG001|Overall Study|Lost to Follow-up|8
7789154|NCT01009645|12241419|FG002|Overall Study|Lost to Follow-up|4
7789155|NCT01009645|12241420|FG003|Overall Study|Lost to Follow-up|5
7789156|NCT01009814|12241446|FG000|Overall Study|No longer met study criteria|1
7789157|NCT01009814|12241447|FG001|Overall Study|No longer met study criteria|1
7789158|NCT01009814|12241448|FG002|Overall Study|No longer met study criteria|0
7789159|NCT01009814|12241449|FG003|Overall Study|No longer met study criteria|0
7789160|NCT01009814|12241450|FG004|Overall Study|No longer met study criteria|0
7789161|NCT01009840|12241466|FG000|Overall Study|Lost to Follow-up|1
7789162|NCT01009840|12241466|FG000|Overall Study|Adverse Event|4
7789163|NCT01009840|12241466|FG000|Overall Study|Subject Met Withdrawal Criteria|7
7789164|NCT01009840|12241466|FG000|Overall Study|Subject was Withdrawn by Investigator|1
7789165|NCT01009840|12241466|FG000|Overall Study|Subject Withdrew Consent to Participate|1
7789166|NCT01009983|12241483|FG000|Overall Study|necessary scans not completed|1
7789167|NCT01010061|12241502|FG000|Overall Study|Adverse Events or Intercurrent Illness|33
7789168|NCT01010061|12241503|FG001|Overall Study|Adverse Events or Intercurrent Illness|16
7789169|NCT01010061|12241502|FG000|Overall Study|Disease Progression|2
7789170|NCT01010061|12241503|FG001|Overall Study|Disease Progression|8
7789171|NCT01010061|12241502|FG000|Overall Study|Withdrew Consent|5
7789172|NCT01010061|12241503|FG001|Overall Study|Withdrew Consent|1
7789173|NCT01010061|12241502|FG000|Overall Study|Death|3
7789174|NCT01010061|12241503|FG001|Overall Study|Death|6
7789175|NCT01010061|12241502|FG000|Overall Study|Administrative/Other|0
7789176|NCT01010061|12241503|FG001|Overall Study|Administrative/Other|1
7789177|NCT01010061|12241502|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2
7789178|NCT01010061|12241503|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
7789179|NCT01010061|12241502|FG000|Overall Study|Insufficient Therapeutic Response|1
7789180|NCT01010061|12241503|FG001|Overall Study|Insufficient Therapeutic Response|5
7789181|NCT01010061|12241502|FG000|Overall Study|Violation of Selection Criteria|0
7789182|NCT01010061|12241503|FG001|Overall Study|Violation of Selection Criteria|1
7789183|NCT01010061|12241502|FG000|Overall Study|Did Not Receive Treatment|2
7789184|NCT01010061|12241503|FG001|Overall Study|Did Not Receive Treatment|2
7789185|NCT01010126|12241517|FG000|Overall Study|Withdrawal by Subject|1
7789186|NCT01010126|12241518|FG001|Overall Study|Withdrawal by Subject|0
7789187|NCT01010126|12241519|FG002|Overall Study|Withdrawal by Subject|1
7789188|NCT01010126|12241520|FG003|Overall Study|Withdrawal by Subject|0
7789189|NCT01010126|12241521|FG004|Overall Study|Withdrawal by Subject|3
7789190|NCT01010126|12241522|FG005|Overall Study|Withdrawal by Subject|0
7789191|NCT01010204|12241538|FG000|Overall Study|Lost to Follow-up|2
7789192|NCT01010204|12241539|FG001|Overall Study|Lost to Follow-up|2
7789193|NCT01010204|12241538|FG000|Overall Study|Adverse Event|1
7789194|NCT01010204|12241539|FG001|Overall Study|Adverse Event|3
7789195|NCT01010204|12241538|FG000|Overall Study|Withdrawal by Subject|2
7789196|NCT01010204|12241539|FG001|Overall Study|Withdrawal by Subject|3
7789197|NCT01010204|12241538|FG000|Overall Study|psychiatric hospitalization|2
7789198|NCT01010204|12241539|FG001|Overall Study|psychiatric hospitalization|1
7789199|NCT01010217|12241550|FG000|Overall Study|Lost to Follow-up|4
7789200|NCT01010217|12241551|FG001|Overall Study|Lost to Follow-up|5
7789201|NCT01010217|12241552|FG002|Overall Study|Lost to Follow-up|1
7789202|NCT01010217|12241553|FG003|Overall Study|Lost to Follow-up|0
7789203|NCT01010217|12241554|FG004|Overall Study|Lost to Follow-up|0
7789204|NCT01010217|12241550|FG000|Overall Study|Withdrawal by Subject|1
7789205|NCT01010217|12241551|FG001|Overall Study|Withdrawal by Subject|0
7789206|NCT01010217|12241552|FG002|Overall Study|Withdrawal by Subject|0
7789207|NCT01010217|12241553|FG003|Overall Study|Withdrawal by Subject|0
7789208|NCT01010217|12241554|FG004|Overall Study|Withdrawal by Subject|0
7789209|NCT01010217|12241550|FG000|Overall Study|Physician Decision|0
7789210|NCT01010217|12241551|FG001|Overall Study|Physician Decision|0
7789211|NCT01010217|12241552|FG002|Overall Study|Physician Decision|0
7789212|NCT01010217|12241553|FG003|Overall Study|Physician Decision|6
7789213|NCT01010217|12241554|FG004|Overall Study|Physician Decision|3
7789214|NCT01010230|12241568|FG000|Overall Study|Withdrawal by Subject|6
7789215|NCT01010230|12241569|FG001|Overall Study|Withdrawal by Subject|5
7789216|NCT01010230|12241568|FG000|Overall Study|Lost to Follow-up|4
7789217|NCT01010230|12241569|FG001|Overall Study|Lost to Follow-up|2
7789218|NCT01010503|12241601|FG000|Overall Study|Adverse Event|1
7789219|NCT01010503|12241601|FG000|Overall Study|Death|1
7789220|NCT01010633|12241623|FG000|Overall Study|Adverse Event|1
7789221|NCT01010633|12241624|FG001|Overall Study|Adverse Event|1
7789222|NCT01010633|12241623|FG000|Overall Study|Protocol Violation|1
7789223|NCT01010633|12241624|FG001|Overall Study|Protocol Violation|2
7789224|NCT01010633|12241623|FG000|Overall Study|Withdrawal by Subject|2
7789225|NCT01010633|12241624|FG001|Overall Study|Withdrawal by Subject|1
7789226|NCT01010633|12241623|FG000|Overall Study|Investigator decision|0
7789227|NCT01010633|12241624|FG001|Overall Study|Investigator decision|1
7789228|NCT01010750|12241636|FG000|Second Intervention|Adverse Event|0
7789229|NCT01010750|12241637|FG001|Second Intervention|Adverse Event|1
7789230|NCT01010750|12241638|FG002|Second Intervention|Adverse Event|0
7789231|NCT01010750|12241639|FG003|Second Intervention|Adverse Event|0
7789232|NCT01010750|12241640|FG004|Second Intervention|Adverse Event|0
7789233|NCT01010750|12241641|FG005|Second Intervention|Adverse Event|0
7789234|NCT01010776|12241658|FG000|Main Phase|Withdrawal by Subject|14
7622606|NCT02007512|12033377|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
7622607|NCT02007512|12033378|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
7622608|NCT02007512|12033379|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
7622609|NCT02007512|12033376|FG000|Open Label Treatment Period|Adverse Event|0
7622610|NCT02007512|12033377|FG001|Open Label Treatment Period|Adverse Event|1
7622611|NCT02007512|12033378|FG002|Open Label Treatment Period|Adverse Event|0
7622612|NCT02007512|12033379|FG003|Open Label Treatment Period|Adverse Event|0
7622613|NCT02007512|12033376|FG000|Open Label Treatment Period|Other|0
7622614|NCT02007512|12033377|FG001|Open Label Treatment Period|Other|0
7622615|NCT02007512|12033378|FG002|Open Label Treatment Period|Other|0
7622616|NCT02007512|12033379|FG003|Open Label Treatment Period|Other|1
7622617|NCT02007512|12033376|FG000|Open Label Treatment Period|Disease progression|0
7622618|NCT02007512|12033377|FG001|Open Label Treatment Period|Disease progression|17
7622619|NCT02007512|12033378|FG002|Open Label Treatment Period|Disease progression|0
7622620|NCT02007512|12033379|FG003|Open Label Treatment Period|Disease progression|11
7622621|NCT02007512|12033376|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
7622622|NCT02007512|12033377|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
7622623|NCT02007512|12033378|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
7622624|NCT02007512|12033379|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
7622625|NCT01999179|12033392|FG000|Overall Study|Adverse Event|1
7622626|NCT01999179|12033392|FG000|Overall Study|Lost to Follow-up|1
7622627|NCT01999179|12033392|FG000|Overall Study|Change in Therapy|3
7622628|NCT01999179|12033392|FG000|Overall Study|New catheter|2
7622629|NCT01858688|12033396|FG000|Overall Study|Withdrawal by Subject|8
7622630|NCT01858688|12033396|FG000|Overall Study|Participant began another therapy|3
7622631|NCT01858688|12033396|FG000|Overall Study|Physician Decision|2
7622632|NCT01858688|12033396|FG000|Overall Study|Progressive Disease|2
7789235|NCT01010776|12241658|FG000|Main Phase|Lack of Efficacy|8
7789236|NCT01010776|12241658|FG000|Main Phase|Adverse Event|7
7789237|NCT01010776|12241658|FG000|Main Phase|Lost to Follow-up|6
7789238|NCT01010776|12241658|FG000|Main Phase|Non-compliance to study medication|5
7789239|NCT01010776|12241658|FG000|Main Phase|Selection failure|2
7789240|NCT01010776|12241658|FG000|Main Phase|Inform consent withdrawal|1
7789241|NCT01010776|12241658|FG000|Main Phase|Other|1
7789242|NCT01010776|12241658|FG000|Main Phase|Did not received study medication|5
7789243|NCT01010776|12241658|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15
7789244|NCT01010776|12241658|FG000|Extension Phase|Other|3
7789245|NCT01010867|12241677|FG000|Overall Study|< 50% adherence to probiotic|1
7789246|NCT01010971|12241717|FG000|Overall Study|Adverse Event|2
7789247|NCT01010971|12241718|FG001|Overall Study|Adverse Event|4
7789248|NCT01010971|12241719|FG002|Overall Study|Adverse Event|3
7789249|NCT01010971|12241717|FG000|Overall Study|Withdrawal by Subject|0
7789250|NCT01010971|12241718|FG001|Overall Study|Withdrawal by Subject|2
7789251|NCT01010971|12241719|FG002|Overall Study|Withdrawal by Subject|5
7622633|NCT01858688|12033396|FG000|Overall Study|Reason not reproted|5
7622634|NCT01796197|12033400|FG000|Overall Study|Lost to Follow-up|1
7622635|NCT01796197|12033400|FG000|Overall Study|Lack of Efficacy|1
7789252|NCT01010971|12241717|FG000|Overall Study|Lost to Follow-up|0
7789253|NCT01010971|12241718|FG001|Overall Study|Lost to Follow-up|2
7789254|NCT01010971|12241719|FG002|Overall Study|Lost to Follow-up|3
7789255|NCT01010971|12241717|FG000|Overall Study|Other|1
7789256|NCT01010971|12241718|FG001|Overall Study|Other|0
7789257|NCT01010971|12241719|FG002|Overall Study|Other|2
7789258|NCT01011049|12241736|FG000|Overall Study|Protocol Violation|0
7789259|NCT01011049|12241737|FG001|Overall Study|Protocol Violation|0
7789260|NCT01011049|12241738|FG002|Overall Study|Protocol Violation|2
7789261|NCT01011049|12241739|FG003|Overall Study|Protocol Violation|0
7789262|NCT01011049|12241736|FG000|Overall Study|Lost to Follow-up|1
7789263|NCT01011049|12241737|FG001|Overall Study|Lost to Follow-up|2
7789264|NCT01011049|12241738|FG002|Overall Study|Lost to Follow-up|1
7789265|NCT01011049|12241739|FG003|Overall Study|Lost to Follow-up|0
7789266|NCT01011049|12241736|FG000|Overall Study|Withdrawal by Subject|0
7789267|NCT01011049|12241737|FG001|Overall Study|Withdrawal by Subject|0
7789268|NCT01011049|12241738|FG002|Overall Study|Withdrawal by Subject|1
7789269|NCT01011049|12241739|FG003|Overall Study|Withdrawal by Subject|0
7789270|NCT01011153|12241756|FG000|Overall Study|Less than 78 cases completed|8
7789271|NCT01011153|12241757|FG001|Overall Study|Less than 78 cases completed|11
7789272|NCT01011153|12241758|FG002|Overall Study|Less than 78 cases completed|9
7789273|NCT01011283|12241804|FG000|Overall Study|Adverse Event|4
7789274|NCT01011283|12241805|FG001|Overall Study|Adverse Event|2
7789275|NCT01011283|12241804|FG000|Overall Study|Progressive Disease|0
7789276|NCT01011283|12241805|FG001|Overall Study|Progressive Disease|2
7789277|NCT01011283|12241804|FG000|Overall Study|Terminated by Sponsor|5
7789278|NCT01011283|12241805|FG001|Overall Study|Terminated by Sponsor|5
7789279|NCT01011283|12241804|FG000|Overall Study|Other|2
7789280|NCT01011283|12241805|FG001|Overall Study|Other|2
7789281|NCT01011309|12241814|FG000|Overall Study|Adverse Event|2
7789282|NCT01011309|12241815|FG001|Overall Study|Adverse Event|1
7789283|NCT01011309|12241816|FG002|Overall Study|Adverse Event|2
7789284|NCT01011309|12241814|FG000|Overall Study|Lack of Efficacy|0
7789285|NCT01011309|12241815|FG001|Overall Study|Lack of Efficacy|1
7789286|NCT01011309|12241816|FG002|Overall Study|Lack of Efficacy|0
7789287|NCT01011309|12241814|FG000|Overall Study|Protocol Violation|0
7789288|NCT01011309|12241815|FG001|Overall Study|Protocol Violation|1
7789289|NCT01011309|12241816|FG002|Overall Study|Protocol Violation|3
7789290|NCT01011335|12241828|FG000|Overall Study|Lost to Follow-up|0
7789291|NCT01011335|12241829|FG001|Overall Study|Lost to Follow-up|0
7789292|NCT01011335|12241830|FG002|Overall Study|Lost to Follow-up|1
7789293|NCT01011335|12241831|FG003|Overall Study|Lost to Follow-up|1
7789294|NCT01011335|12241832|FG004|Overall Study|Lost to Follow-up|1
7789295|NCT01011335|12241833|FG005|Overall Study|Lost to Follow-up|1
7789296|NCT01011335|12241834|FG006|Overall Study|Lost to Follow-up|2
7789297|NCT01011335|12241835|FG007|Overall Study|Lost to Follow-up|2
7789298|NCT01011335|12241836|FG008|Overall Study|Lost to Follow-up|1
7789299|NCT01011335|12241837|FG009|Overall Study|Lost to Follow-up|0
7789300|NCT01011335|12241838|FG010|Overall Study|Lost to Follow-up|0
7789301|NCT01011335|12241839|FG011|Overall Study|Lost to Follow-up|1
7789302|NCT01011335|12241840|FG012|Overall Study|Lost to Follow-up|2
7789303|NCT01011335|12241828|FG000|Overall Study|Protocol Violation|0
7789304|NCT01011335|12241829|FG001|Overall Study|Protocol Violation|1
7789305|NCT01011335|12241830|FG002|Overall Study|Protocol Violation|0
7789306|NCT01011335|12241831|FG003|Overall Study|Protocol Violation|0
7789307|NCT01011335|12241832|FG004|Overall Study|Protocol Violation|0
7789308|NCT01011335|12241833|FG005|Overall Study|Protocol Violation|0
7789309|NCT01011335|12241834|FG006|Overall Study|Protocol Violation|0
7789310|NCT01011335|12241835|FG007|Overall Study|Protocol Violation|0
7789311|NCT01011335|12241836|FG008|Overall Study|Protocol Violation|0
7789312|NCT01011335|12241837|FG009|Overall Study|Protocol Violation|0
7789313|NCT01011335|12241838|FG010|Overall Study|Protocol Violation|0
7789314|NCT01011335|12241839|FG011|Overall Study|Protocol Violation|0
7789315|NCT01011335|12241840|FG012|Overall Study|Protocol Violation|0
7789316|NCT01011335|12241828|FG000|Overall Study|Moved/deployed or no booster|1
7789317|NCT01011335|12241829|FG001|Overall Study|Moved/deployed or no booster|0
7789318|NCT01011335|12241830|FG002|Overall Study|Moved/deployed or no booster|0
7789319|NCT01011335|12241831|FG003|Overall Study|Moved/deployed or no booster|1
7789320|NCT01011335|12241832|FG004|Overall Study|Moved/deployed or no booster|0
7789321|NCT01011335|12241833|FG005|Overall Study|Moved/deployed or no booster|0
7789322|NCT01011335|12241834|FG006|Overall Study|Moved/deployed or no booster|1
7789323|NCT01011335|12241835|FG007|Overall Study|Moved/deployed or no booster|0
7789324|NCT01011335|12241836|FG008|Overall Study|Moved/deployed or no booster|1
7789325|NCT01011335|12241837|FG009|Overall Study|Moved/deployed or no booster|0
7789326|NCT01011335|12241838|FG010|Overall Study|Moved/deployed or no booster|2
7622636|NCT01751906|12033406|FG000|Overall Study|Lost to Follow-up|151
7789327|NCT01011335|12241839|FG011|Overall Study|Moved/deployed or no booster|0
7789328|NCT01011335|12241840|FG012|Overall Study|Moved/deployed or no booster|0
7789329|NCT01011335|12241828|FG000|Overall Study|Adverse Event|0
7789330|NCT01011335|12241829|FG001|Overall Study|Adverse Event|0
7789331|NCT01011335|12241830|FG002|Overall Study|Adverse Event|0
7789332|NCT01011335|12241831|FG003|Overall Study|Adverse Event|0
7789333|NCT01011335|12241832|FG004|Overall Study|Adverse Event|0
7789334|NCT01011335|12241833|FG005|Overall Study|Adverse Event|0
7789335|NCT01011335|12241834|FG006|Overall Study|Adverse Event|0
7789336|NCT01011335|12241835|FG007|Overall Study|Adverse Event|0
7789337|NCT01011335|12241836|FG008|Overall Study|Adverse Event|0
7789338|NCT01011335|12241837|FG009|Overall Study|Adverse Event|0
7789339|NCT01011335|12241838|FG010|Overall Study|Adverse Event|4
7789340|NCT01011335|12241839|FG011|Overall Study|Adverse Event|0
7789341|NCT01011335|12241840|FG012|Overall Study|Adverse Event|1
7789342|NCT01011387|12241877|FG000|Overall Study|Withdrawal by Subject|3
7789343|NCT01011387|12241877|FG000|Overall Study|Adverse Event|2
7789344|NCT01011387|12241877|FG000|Overall Study|Protocol Violation|1
7789345|NCT01011439|12241897|FG000|Overall Study|Death|37
7789346|NCT01011439|12241897|FG000|Overall Study|Lost to Follow-up|4
7789347|NCT01011439|12241897|FG000|Overall Study|Withdrawal by Subject|1
7789348|NCT01011439|12241897|FG000|Overall Study|Sponsor's decision|15
7789349|NCT01011465|12241910|FG000|Overall Study|Withdrawal by Subject|2
7789350|NCT01011465|12241911|FG001|Overall Study|Withdrawal by Subject|1
7789351|NCT01011465|12241912|FG002|Overall Study|Withdrawal by Subject|0
7789352|NCT01011465|12241913|FG003|Overall Study|Withdrawal by Subject|0
7789353|NCT01011465|12241914|FG004|Overall Study|Withdrawal by Subject|1
7789354|NCT01011465|12241915|FG005|Overall Study|Withdrawal by Subject|0
7789355|NCT01011465|12241916|FG006|Overall Study|Withdrawal by Subject|1
7789356|NCT01011465|12241917|FG007|Overall Study|Withdrawal by Subject|0
7789357|NCT01011556|12241937|FG000|Overall Study|Adverse Event|1
7789358|NCT01011556|12241938|FG001|Overall Study|Adverse Event|3
7789359|NCT01011556|12241939|FG002|Overall Study|Adverse Event|2
7789360|NCT01011556|12241940|FG003|Overall Study|Adverse Event|1
7789361|NCT01011556|12241937|FG000|Overall Study|Lost to Follow-up|1
7789362|NCT01011556|12241938|FG001|Overall Study|Lost to Follow-up|0
7789363|NCT01011556|12241939|FG002|Overall Study|Lost to Follow-up|0
7789364|NCT01011556|12241940|FG003|Overall Study|Lost to Follow-up|0
7622637|NCT01751906|12033407|FG001|Overall Study|Lost to Follow-up|68
7622638|NCT01751906|12033406|FG000|Overall Study|Withdrawal by Subject|22
7622639|NCT01751906|12033407|FG001|Overall Study|Withdrawal by Subject|18
7622640|NCT01751906|12033406|FG000|Overall Study|Physician Decision|5
7622641|NCT01751906|12033407|FG001|Overall Study|Physician Decision|2
7622642|NCT01751906|12033406|FG000|Overall Study|Death|84
7622643|NCT01751906|12033407|FG001|Overall Study|Death|43
7622644|NCT01751906|12033406|FG000|Overall Study|Denied on premises for follow-up by law|1
7622645|NCT01751906|12033407|FG001|Overall Study|Denied on premises for follow-up by law|0
7622646|NCT00669669|12033448|FG000|Overall Study|To late to start treatment|1
7789365|NCT01011556|12241937|FG000|Overall Study|Physician Decision|1
7789366|NCT01011556|12241938|FG001|Overall Study|Physician Decision|0
7789367|NCT01011556|12241939|FG002|Overall Study|Physician Decision|0
7789368|NCT01011556|12241940|FG003|Overall Study|Physician Decision|1
7789369|NCT01011556|12241937|FG000|Overall Study|Protocol Violation|0
7789370|NCT01011556|12241938|FG001|Overall Study|Protocol Violation|1
7789371|NCT01011556|12241939|FG002|Overall Study|Protocol Violation|0
7789372|NCT01011556|12241940|FG003|Overall Study|Protocol Violation|0
7789373|NCT01011556|12241937|FG000|Overall Study|Withdrawal by Subject|1
7789374|NCT01011556|12241938|FG001|Overall Study|Withdrawal by Subject|2
7789375|NCT01011556|12241939|FG002|Overall Study|Withdrawal by Subject|4
7789376|NCT01011556|12241940|FG003|Overall Study|Withdrawal by Subject|4
7789377|NCT01011556|12241937|FG000|Overall Study|Sponsor decision|0
7789378|NCT01011556|12241938|FG001|Overall Study|Sponsor decision|1
7789379|NCT01011556|12241939|FG002|Overall Study|Sponsor decision|1
7789380|NCT01011556|12241940|FG003|Overall Study|Sponsor decision|2
7789381|NCT01011556|12241937|FG000|Overall Study|Inclusion/exclusion criteria not met|2
7789382|NCT01011556|12241938|FG001|Overall Study|Inclusion/exclusion criteria not met|1
7789383|NCT01011556|12241939|FG002|Overall Study|Inclusion/exclusion criteria not met|3
7789384|NCT01011556|12241940|FG003|Overall Study|Inclusion/exclusion criteria not met|5
7789385|NCT01011673|12241955|FG000|Randomized|Secondary headache|2
7789386|NCT01011673|12241956|FG001|Randomized|Secondary headache|1
7789387|NCT01011673|12241955|FG000|24 Hour Follow-up|Lost to Follow-up|3
7789388|NCT01011673|12241956|FG001|24 Hour Follow-up|Lost to Follow-up|3
7622671|NCT00314366|12033475|FG000|Overall Study|not treated due to patient medical condi|1
7622672|NCT00314366|12033476|FG001|Overall Study|not treated due to patient medical condi|0
7789389|NCT01011738|12241965|FG000|Overall Study|Death|12
7789390|NCT01011738|12241966|FG001|Overall Study|Death|3
7789391|NCT01011738|12241967|FG002|Overall Study|Death|0
7789392|NCT01011738|12241965|FG000|Overall Study|Unknown reasons|312
7789393|NCT01011738|12241966|FG001|Overall Study|Unknown reasons|291
7789394|NCT01011738|12241967|FG002|Overall Study|Unknown reasons|17
7789395|NCT01011868|12241999|FG000|After Week 18 Follow-up|Adverse Event|8
7789396|NCT01011868|12242000|FG001|After Week 18 Follow-up|Adverse Event|6
7789397|NCT01011868|12242001|FG002|After Week 18 Follow-up|Adverse Event|13
7789398|NCT01011868|12241999|FG000|After Week 18 Follow-up|Lack of Efficacy|1
7789399|NCT01011868|12242000|FG001|After Week 18 Follow-up|Lack of Efficacy|0
7789400|NCT01011868|12242001|FG002|After Week 18 Follow-up|Lack of Efficacy|0
7789401|NCT01011868|12241999|FG000|After Week 18 Follow-up|Protocol Violation|1
7789402|NCT01011868|12242000|FG001|After Week 18 Follow-up|Protocol Violation|1
7789403|NCT01011868|12242001|FG002|After Week 18 Follow-up|Protocol Violation|1
7789404|NCT01011868|12241999|FG000|After Week 18 Follow-up|Lost to Follow-up|5
7789405|NCT01011868|12242000|FG001|After Week 18 Follow-up|Lost to Follow-up|3
7789406|NCT01011868|12242001|FG002|After Week 18 Follow-up|Lost to Follow-up|0
7789407|NCT01011868|12241999|FG000|After Week 18 Follow-up|Withdrawal by Subject|6
7789408|NCT01011868|12242000|FG001|After Week 18 Follow-up|Withdrawal by Subject|3
7789409|NCT01011868|12242001|FG002|After Week 18 Follow-up|Withdrawal by Subject|0
7789410|NCT01011868|12241999|FG000|After Week 18 Follow-up|Other reason not defined above|2
7789411|NCT01011868|12242000|FG001|After Week 18 Follow-up|Other reason not defined above|3
7789412|NCT01011868|12242001|FG002|After Week 18 Follow-up|Other reason not defined above|12
7789413|NCT01011868|12241999|FG000|After Week 78 Follow-up|Adverse Event|14
7789414|NCT01011868|12242000|FG001|After Week 78 Follow-up|Adverse Event|18
7789415|NCT01011868|12242001|FG002|After Week 78 Follow-up|Adverse Event|21
7789416|NCT01011868|12241999|FG000|After Week 78 Follow-up|Lack of Efficacy|4
7789417|NCT01011868|12242000|FG001|After Week 78 Follow-up|Lack of Efficacy|0
7789418|NCT01011868|12242001|FG002|After Week 78 Follow-up|Lack of Efficacy|0
7789419|NCT01011868|12241999|FG000|After Week 78 Follow-up|Protocol Violation|9
7789420|NCT01011868|12242000|FG001|After Week 78 Follow-up|Protocol Violation|1
7789421|NCT01011868|12242001|FG002|After Week 78 Follow-up|Protocol Violation|2
7789422|NCT01011868|12241999|FG000|After Week 78 Follow-up|Lost to Follow-up|11
7789423|NCT01011868|12242000|FG001|After Week 78 Follow-up|Lost to Follow-up|6
7789424|NCT01011868|12242001|FG002|After Week 78 Follow-up|Lost to Follow-up|4
7789425|NCT01011868|12241999|FG000|After Week 78 Follow-up|Withdrawal by Subject|9
7789426|NCT01011868|12242000|FG001|After Week 78 Follow-up|Withdrawal by Subject|8
7789427|NCT01011868|12242001|FG002|After Week 78 Follow-up|Withdrawal by Subject|1
7789428|NCT01011868|12241999|FG000|After Week 78 Follow-up|Other reason not defined above|5
7789429|NCT01011868|12242000|FG001|After Week 78 Follow-up|Other reason not defined above|5
7789430|NCT01011868|12242001|FG002|After Week 78 Follow-up|Other reason not defined above|16
7789431|NCT01011907|12242015|FG000|Overall Study|Withdrawal by Subject|13
7789432|NCT01011907|12242016|FG001|Overall Study|Withdrawal by Subject|11
7789433|NCT01011907|12242015|FG000|Overall Study|Adverse Event|1
7789434|NCT01011907|12242016|FG001|Overall Study|Adverse Event|4
7789435|NCT01011933|12242022|FG000|Overall Study|Wrong cell type|1
7789436|NCT01011933|12242022|FG000|Overall Study|Improper pre-protocol Rx|1
7789437|NCT01011933|12242022|FG000|Overall Study|Inadequate pathology|1
7789438|NCT01011933|12242022|FG000|Overall Study|Never treated|1
7789439|NCT01011946|12242032|FG000|Overall Study|Transferred to another hospital|2
7789440|NCT01011946|12242032|FG000|Overall Study|No pathological lab value|1
7789441|NCT01012037|12242039|FG000|Overall Study|Adverse Event|0
7789442|NCT01012037|12242040|FG001|Overall Study|Adverse Event|8
7789443|NCT01012037|12242041|FG002|Overall Study|Adverse Event|3
7789444|NCT01012037|12242039|FG000|Overall Study|Protocol Violation|0
7789445|NCT01012037|12242040|FG001|Overall Study|Protocol Violation|3
7789446|NCT01012037|12242041|FG002|Overall Study|Protocol Violation|5
7789447|NCT01012037|12242039|FG000|Overall Study|Withdrawal by Subject|0
7789448|NCT01012037|12242040|FG001|Overall Study|Withdrawal by Subject|4
7789449|NCT01012037|12242041|FG002|Overall Study|Withdrawal by Subject|1
7789450|NCT01012037|12242039|FG000|Overall Study|Other reason (not specified)|1
7789451|NCT01012037|12242040|FG001|Overall Study|Other reason (not specified)|1
7789452|NCT01012037|12242041|FG002|Overall Study|Other reason (not specified)|1
7789453|NCT01012219|12242057|FG000|Period 1|Withdrawal by Subject|1
7789454|NCT01012219|12242057|FG000|Period 2|Withdrawal by Subject|1
7789455|NCT01012258|12242079|FG000|Overall Study|Death|14
7789456|NCT01012258|12242079|FG000|Overall Study|Lost to Follow-up|1
7789457|NCT01012258|12242079|FG000|Overall Study|Adverse Event|1
7789458|NCT01012258|12242079|FG000|Overall Study|Progressive Disease (PD)|18
7789459|NCT01012258|12242079|FG000|Overall Study|Symptomatic Deterioration|1
7789460|NCT01012258|12242079|FG000|Overall Study|Another Anti-cancer Drug Received|1
7789461|NCT01012258|12242079|FG000|Overall Study|Another Tumor Discovered|1
7789462|NCT01012258|12242079|FG000|Overall Study|Ongoing|29
7789463|NCT01012323|12242093|FG000|Overall Study|Investigator Judgment|1
7789464|NCT01012440|12242130|FG000|Overall Study|Withdrawal by Subject|2
7789465|NCT01012622|12242138|FG000|Overall Study|Withdrawal by Subject|6
7789466|NCT01012622|12242138|FG000|Overall Study|Lost to Follow-up|5
7789467|NCT01012622|12242138|FG000|Overall Study|Adverse Event|7
7789468|NCT01012622|12242138|FG000|Overall Study|non-compliance with the drug|9
7789469|NCT01012622|12242138|FG000|Overall Study|Other|1
7789470|NCT01012622|12242138|FG000|Overall Study|screening failure|1
7789471|NCT01012622|12242138|FG000|Overall Study|withdrawal of consent by a parent|2
7789472|NCT01012713|12242156|FG000|Overall Study|Lack of Efficacy|3
7789473|NCT01012739|12242161|FG000|Treatment Period 1|Adverse Event|0
7789474|NCT01012739|12242162|FG001|Treatment Period 1|Adverse Event|0
7789475|NCT01012739|12242163|FG002|Treatment Period 1|Adverse Event|0
7789476|NCT01012739|12242164|FG003|Treatment Period 1|Adverse Event|1
7789477|NCT01012739|12242161|FG000|Treatment Period 2|Abnormal test procedure results|0
7789478|NCT01012739|12242162|FG001|Treatment Period 2|Abnormal test procedure results|0
7789479|NCT01012739|12242163|FG002|Treatment Period 2|Abnormal test procedure results|0
7789480|NCT01012739|12242164|FG003|Treatment Period 2|Abnormal test procedure results|1
7789481|NCT01012765|12242175|FG000|Treatment Period 1|Adverse Event|1
7789482|NCT01012765|12242176|FG001|Treatment Period 1|Adverse Event|0
7789483|NCT01012765|12242177|FG002|Treatment Period 1|Adverse Event|1
7789484|NCT01012765|12242178|FG003|Treatment Period 1|Adverse Event|0
7789485|NCT01012765|12242179|FG004|Treatment Period 1|Adverse Event|0
7789486|NCT01012765|12242180|FG005|Treatment Period 1|Adverse Event|0
7789487|NCT01012765|12242175|FG000|Treatment Period 1|Withdrawal by Subject|2
7789488|NCT01012765|12242176|FG001|Treatment Period 1|Withdrawal by Subject|0
7789489|NCT01012765|12242177|FG002|Treatment Period 1|Withdrawal by Subject|0
7789490|NCT01012765|12242178|FG003|Treatment Period 1|Withdrawal by Subject|0
7789491|NCT01012765|12242179|FG004|Treatment Period 1|Withdrawal by Subject|0
7789492|NCT01012765|12242180|FG005|Treatment Period 1|Withdrawal by Subject|0
7789493|NCT01012765|12242175|FG000|Treatment Period 1|Administrative problems|0
7789494|NCT01012765|12242176|FG001|Treatment Period 1|Administrative problems|0
7789495|NCT01012765|12242177|FG002|Treatment Period 1|Administrative problems|1
7789496|NCT01012765|12242178|FG003|Treatment Period 1|Administrative problems|1
7789497|NCT01012765|12242179|FG004|Treatment Period 1|Administrative problems|1
7789498|NCT01012765|12242180|FG005|Treatment Period 1|Administrative problems|0
7789499|NCT01012765|12242175|FG000|Treatment Period 1|Protocol Violation|0
7789500|NCT01012765|12242176|FG001|Treatment Period 1|Protocol Violation|0
7789501|NCT01012765|12242177|FG002|Treatment Period 1|Protocol Violation|0
7789502|NCT01012765|12242178|FG003|Treatment Period 1|Protocol Violation|2
7789503|NCT01012765|12242179|FG004|Treatment Period 1|Protocol Violation|1
7789504|NCT01012765|12242180|FG005|Treatment Period 1|Protocol Violation|0
7789505|NCT01012765|12242175|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0
7789506|NCT01012765|12242176|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0
7789507|NCT01012765|12242177|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0
7789508|NCT01012765|12242178|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0
7789509|NCT01012765|12242179|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1
7789510|NCT01012765|12242180|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0
7789511|NCT01012765|12242175|FG000|Treatment Period 2|Withdrawal by Subject|1
7789512|NCT01012765|12242176|FG001|Treatment Period 2|Withdrawal by Subject|0
7789513|NCT01012765|12242177|FG002|Treatment Period 2|Withdrawal by Subject|1
7789514|NCT01012765|12242178|FG003|Treatment Period 2|Withdrawal by Subject|0
7789515|NCT01012765|12242179|FG004|Treatment Period 2|Withdrawal by Subject|1
7789516|NCT01012765|12242180|FG005|Treatment Period 2|Withdrawal by Subject|0
7789517|NCT01012765|12242175|FG000|Treatment Period 2|Abnormal laboratory value(s)|0
7789518|NCT01012765|12242176|FG001|Treatment Period 2|Abnormal laboratory value(s)|0
7789519|NCT01012765|12242177|FG002|Treatment Period 2|Abnormal laboratory value(s)|0
7789520|NCT01012765|12242178|FG003|Treatment Period 2|Abnormal laboratory value(s)|0
7789521|NCT01012765|12242179|FG004|Treatment Period 2|Abnormal laboratory value(s)|0
7789522|NCT01012765|12242180|FG005|Treatment Period 2|Abnormal laboratory value(s)|1
7789523|NCT01012765|12242175|FG000|Treatment Period 2|Adverse Event|0
7789524|NCT01012765|12242176|FG001|Treatment Period 2|Adverse Event|1
7789525|NCT01012765|12242177|FG002|Treatment Period 2|Adverse Event|1
7789526|NCT01012765|12242178|FG003|Treatment Period 2|Adverse Event|0
7789527|NCT01012765|12242179|FG004|Treatment Period 2|Adverse Event|0
7789528|NCT01012765|12242180|FG005|Treatment Period 2|Adverse Event|0
7789529|NCT01012765|12242175|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0
7789530|NCT01012765|12242176|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1
7789531|NCT01012765|12242177|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1
7789532|NCT01012765|12242178|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0
7789533|NCT01012765|12242179|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0
7789534|NCT01012765|12242180|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0
7789535|NCT01012947|12242202|FG000|Overall Study|Lost to Follow-up|131
7789536|NCT01012947|12242203|FG001|Overall Study|Lost to Follow-up|135
7789537|NCT01012947|12242204|FG002|Overall Study|Lost to Follow-up|130
7789538|NCT01012947|12242205|FG003|Overall Study|Lost to Follow-up|118
7789539|NCT01012947|12242206|FG004|Overall Study|Lost to Follow-up|142
7789540|NCT01012973|12242220|FG000|Overall Study|Adverse Event|5
7789541|NCT01012973|12242221|FG001|Overall Study|Adverse Event|5
7789542|NCT01012973|12242220|FG000|Overall Study|Lack of Efficacy|0
7789543|NCT01012973|12242221|FG001|Overall Study|Lack of Efficacy|5
7789544|NCT01012973|12242220|FG000|Overall Study|Lost to Follow-up|1
7789545|NCT01012973|12242221|FG001|Overall Study|Lost to Follow-up|0
7789546|NCT01012973|12242220|FG000|Overall Study|(Overseas travel - indefinite period)|1
7789547|NCT01012973|12242221|FG001|Overall Study|(Overseas travel - indefinite period)|0
7789548|NCT01012973|12242220|FG000|Overall Study|Increase in vis. acuity, never injected|0
7789549|NCT01012973|12242221|FG001|Overall Study|Increase in vis. acuity, never injected|1
7789550|NCT01012973|12242220|FG000|Overall Study|Protocol Violation|5
7789551|NCT01012973|12242221|FG001|Overall Study|Protocol Violation|2
7789552|NCT01012973|12242220|FG000|Overall Study|Withdrawal by Subject|4
7789553|NCT01012973|12242221|FG001|Overall Study|Withdrawal by Subject|6
7800551|NCT01096589|12258118|FG000|Overall Study|Compliance with protocol|0
7800552|NCT01096589|12258119|FG001|Overall Study|Compliance with protocol|0
7800553|NCT01096589|12258120|FG002|Overall Study|Compliance with protocol|1
7800554|NCT01096589|12258121|FG003|Overall Study|Compliance with protocol|0
7800555|NCT01096589|12258118|FG000|Overall Study|found treatment exhausting|0
7800556|NCT01096589|12258119|FG001|Overall Study|found treatment exhausting|0
7800557|NCT01096589|12258120|FG002|Overall Study|found treatment exhausting|0
7800558|NCT01096589|12258121|FG003|Overall Study|found treatment exhausting|1
7800559|NCT01096667|12258140|FG000|Overall Study|Lost to Follow-up|1
7800560|NCT01096667|12258141|FG001|Overall Study|Lost to Follow-up|1
7800561|NCT01096667|12258142|FG002|Overall Study|Lost to Follow-up|1
7800562|NCT01096667|12258143|FG003|Overall Study|Lost to Follow-up|0
7800563|NCT01096667|12258144|FG004|Overall Study|Lost to Follow-up|0
7800564|NCT01096667|12258140|FG000|Overall Study|Withdrawal by Subject|1
7800565|NCT01096667|12258141|FG001|Overall Study|Withdrawal by Subject|0
7800566|NCT01096667|12258142|FG002|Overall Study|Withdrawal by Subject|0
7800567|NCT01096667|12258143|FG003|Overall Study|Withdrawal by Subject|1
7800568|NCT01096667|12258144|FG004|Overall Study|Withdrawal by Subject|0
7800569|NCT01096667|12258140|FG000|Overall Study|Reason not available|0
7800570|NCT01096667|12258141|FG001|Overall Study|Reason not available|1
7800571|NCT01096667|12258142|FG002|Overall Study|Reason not available|1
7800572|NCT01096667|12258143|FG003|Overall Study|Reason not available|1
7789554|NCT01012999|12242231|FG000|Overall Study|Protocol Violation|1
7789555|NCT01013207|12242248|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6
7789556|NCT01013285|12242254|FG000|Overall Study|Death|48
7789557|NCT01013285|12242255|FG001|Overall Study|Death|89
7789558|NCT01013350|12242262|FG000|Overall Study|Lost to Follow-up|15
7789559|NCT01013350|12242263|FG001|Overall Study|Lost to Follow-up|95
7789560|NCT01013350|12242262|FG000|Overall Study|Adverse Event|0
7789561|NCT01013350|12242263|FG001|Overall Study|Adverse Event|1
7789562|NCT01013350|12242262|FG000|Overall Study|Physician Decision|4
7789563|NCT01013350|12242263|FG001|Overall Study|Physician Decision|20
7789564|NCT01013350|12242262|FG000|Overall Study|Withdrawal by Subject|15
7789565|NCT01013350|12242263|FG001|Overall Study|Withdrawal by Subject|38
7789566|NCT01013350|12242262|FG000|Overall Study|Death|3
7789567|NCT01013350|12242263|FG001|Overall Study|Death|5
7789568|NCT01013350|12242262|FG000|Overall Study|Participant entered interventional study|0
7789569|NCT01013350|12242263|FG001|Overall Study|Participant entered interventional study|8
7789570|NCT01013350|12242262|FG000|Overall Study|Other|1
7789571|NCT01013350|12242263|FG001|Overall Study|Other|25
7789572|NCT01013597|12242270|FG000|Overall Study|Withdrawal by Subject|1
7789573|NCT01013740|12242276|FG000|Overall Study|Lost to Follow-up|3
7789574|NCT01013740|12242277|FG001|Overall Study|Lost to Follow-up|5
7789575|NCT01013740|12242276|FG000|Overall Study|Physician Decision|2
7789576|NCT01013740|12242277|FG001|Overall Study|Physician Decision|0
7789577|NCT01013740|12242276|FG000|Overall Study|Withdrawal by Subject|2
7789578|NCT01013740|12242277|FG001|Overall Study|Withdrawal by Subject|10
7789579|NCT01013740|12242276|FG000|Overall Study|study close / terminated : done in error|2
7789580|NCT01013740|12242277|FG001|Overall Study|study close / terminated : done in error|1
7789581|NCT01013740|12242276|FG000|Overall Study|Missing|2
7789582|NCT01013740|12242277|FG001|Overall Study|Missing|1
7789583|NCT01013740|12242276|FG000|Overall Study|Ongoing: Study records not completed|0
7789584|NCT01013740|12242277|FG001|Overall Study|Ongoing: Study records not completed|2
7789585|NCT01013753|12242285|FG000|Overall Study|Adverse Event|8
7789586|NCT01013753|12242285|FG000|Overall Study|Protocol Violation|3
7789587|NCT01013753|12242285|FG000|Overall Study|Lost to Follow-up|1
7789588|NCT01013753|12242285|FG000|Overall Study|Withdrawal by Subject|2
7789589|NCT01013753|12242285|FG000|Overall Study|Other|2
7789590|NCT01013792|12242301|FG000|Overall Study|Study suspended|2
7789591|NCT01013792|12242302|FG001|Overall Study|Study suspended|1
7789592|NCT01013792|12242301|FG000|Overall Study|Adverse Event|0
7789593|NCT01013792|12242302|FG001|Overall Study|Adverse Event|3
7789594|NCT01013792|12242301|FG000|Overall Study|Lost to Follow-up|0
7789595|NCT01013792|12242302|FG001|Overall Study|Lost to Follow-up|1
7789596|NCT01013870|12242323|FG000|Overall Study|Lost to Follow-up|1
7789597|NCT01013870|12242324|FG001|Overall Study|Lost to Follow-up|3
7789598|NCT01013883|12242332|FG000|Overall Study|Lost to Follow-up|2
7789599|NCT01013883|12242333|FG001|Overall Study|Lost to Follow-up|2
7789600|NCT01013961|12242341|FG000|Overall Study|Adverse Event|2
7789601|NCT01013961|12242342|FG001|Overall Study|Adverse Event|2
7789602|NCT01013961|12242341|FG000|Overall Study|Withdrawal by Subject|1
7789603|NCT01013961|12242342|FG001|Overall Study|Withdrawal by Subject|0
7789604|NCT01013961|12242341|FG000|Overall Study|Physician Decision|0
7789605|NCT01013961|12242342|FG001|Overall Study|Physician Decision|1
7789606|NCT01014013|12242350|FG000|Overall Study|Inclusion/Exclusion criteria not met|1
7789607|NCT01014013|12242351|FG001|Overall Study|Inclusion/Exclusion criteria not met|3
7789608|NCT01014013|12242350|FG000|Overall Study|Clinical adverse experience|4
7789609|NCT01014013|12242351|FG001|Overall Study|Clinical adverse experience|2
7789610|NCT01014013|12242350|FG000|Overall Study|Laboratory adverse experience|1
7789611|NCT01014013|12242351|FG001|Overall Study|Laboratory adverse experience|1
7789612|NCT01014013|12242350|FG000|Overall Study|Protocol Violation|1
7789613|NCT01014013|12242351|FG001|Overall Study|Protocol Violation|3
7789614|NCT01014013|12242350|FG000|Overall Study|Withdrawal by Subject|7
7789615|NCT01014013|12242351|FG001|Overall Study|Withdrawal by Subject|4
7789616|NCT01014013|12242350|FG000|Overall Study|Clinical/microbiologic failure|1
7789617|NCT01014013|12242351|FG001|Overall Study|Clinical/microbiologic failure|2
7789618|NCT01014013|12242350|FG000|Overall Study|Pathogen culture = no growth|26
7789619|NCT01014013|12242351|FG001|Overall Study|Pathogen culture = no growth|34
7789620|NCT01014013|12242350|FG000|Overall Study|Negative urine culture|2
7789621|NCT01014013|12242351|FG001|Overall Study|Negative urine culture|0
7789622|NCT01014013|12242350|FG000|Overall Study|Pathogen resistant|7
7789623|NCT01014013|12242351|FG001|Overall Study|Pathogen resistant|4
7789624|NCT01014013|12242350|FG000|Overall Study|Physician Decision|0
7789625|NCT01014013|12242351|FG001|Overall Study|Physician Decision|1
7789626|NCT01014013|12242350|FG000|Overall Study|Another antibiotic therapy required|0
7789627|NCT01014013|12242351|FG001|Overall Study|Another antibiotic therapy required|1
7789628|NCT01014013|12242350|FG000|Overall Study|Appendectomy|1
7789629|NCT01014013|12242351|FG001|Overall Study|Appendectomy|0
7789630|NCT01014013|12242350|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0
7789631|NCT01014013|12242351|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1
7789632|NCT01014143|12242396|FG000|Second Intervention|Lost to Follow-up|2
7789633|NCT01014143|12242397|FG001|Second Intervention|Lost to Follow-up|0
7789634|NCT01014143|12242398|FG002|Second Intervention|Lost to Follow-up|0
7789635|NCT01014208|12242417|FG000|Overall Study|Lost to Follow-up|2
7789636|NCT01014208|12242418|FG001|Overall Study|Lost to Follow-up|5
7789637|NCT01014208|12242417|FG000|Overall Study|Participant Withdrew Consent|12
7789638|NCT01014208|12242418|FG001|Overall Study|Participant Withdrew Consent|12
7789639|NCT01014208|12242417|FG000|Overall Study|Did Not Receive Study Drug|2
7789640|NCT01014208|12242418|FG001|Overall Study|Did Not Receive Study Drug|0
7789641|NCT01014208|12242417|FG000|Overall Study|Study Closed/terminated|78
7789642|NCT01014208|12242418|FG001|Overall Study|Study Closed/terminated|83
7789643|NCT01014442|12242443|FG000|Overall Study|Adverse Event|0
7789644|NCT01014442|12242444|FG001|Overall Study|Adverse Event|8
7789645|NCT01014442|12242443|FG000|Overall Study|Withdrawal by Subject|4
7789646|NCT01014442|12242444|FG001|Overall Study|Withdrawal by Subject|4
7789647|NCT01014442|12242443|FG000|Overall Study|Protocol Violation|2
7789648|NCT01014442|12242444|FG001|Overall Study|Protocol Violation|5
7789649|NCT01014442|12242443|FG000|Overall Study|Lack of Compliance|0
7789650|NCT01014442|12242444|FG001|Overall Study|Lack of Compliance|1
7789651|NCT01014442|12242443|FG000|Overall Study|Unspecified Reason|1
7789652|NCT01014442|12242444|FG001|Overall Study|Unspecified Reason|1
7789653|NCT01014533|12242465|FG000|Overall Study|Protocol Violation|3
7789654|NCT01014533|12242466|FG001|Overall Study|Protocol Violation|2
7789655|NCT01014533|12242465|FG000|Overall Study|Withdrawal by Subject|2
7789656|NCT01014533|12242466|FG001|Overall Study|Withdrawal by Subject|0
7789657|NCT01014533|12242465|FG000|Overall Study|unable to come to appointment|0
7789658|NCT01014533|12242466|FG001|Overall Study|unable to come to appointment|3
7789659|NCT01014585|12242477|FG000|Overall Study|Adverse Event|0
7789660|NCT01014585|12242478|FG001|Overall Study|Adverse Event|2
7789661|NCT01014585|12242479|FG002|Overall Study|Adverse Event|0
7789662|NCT01014585|12242480|FG003|Overall Study|Adverse Event|3
7789663|NCT01014585|12242477|FG000|Overall Study|Withdrawal by Subject|2
7789664|NCT01014585|12242478|FG001|Overall Study|Withdrawal by Subject|0
7789665|NCT01014585|12242479|FG002|Overall Study|Withdrawal by Subject|1
7789666|NCT01014585|12242480|FG003|Overall Study|Withdrawal by Subject|3
7789667|NCT01014585|12242477|FG000|Overall Study|Lost to Follow-up|0
7789668|NCT01014585|12242478|FG001|Overall Study|Lost to Follow-up|0
7789669|NCT01014585|12242479|FG002|Overall Study|Lost to Follow-up|0
7789670|NCT01014585|12242480|FG003|Overall Study|Lost to Follow-up|2
7789671|NCT01014585|12242477|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
7789672|NCT01014585|12242478|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
7789673|NCT01014585|12242479|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
7789674|NCT01014585|12242480|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
7789675|NCT01014624|12242492|FG000|Overall Study|Adverse Event|0
7789676|NCT01014624|12242493|FG001|Overall Study|Adverse Event|1
7789677|NCT01014624|12242492|FG000|Overall Study|Protocol Violation|1
7789678|NCT01014624|12242493|FG001|Overall Study|Protocol Violation|0
7789679|NCT01014624|12242492|FG000|Overall Study|Withdrawal by Subject|1
7789680|NCT01014624|12242493|FG001|Overall Study|Withdrawal by Subject|0
7789681|NCT01014689|12242503|FG000|Overall Study|Lack of Efficacy|0
7789682|NCT01014689|12242504|FG001|Overall Study|Lack of Efficacy|1
7789683|NCT01014689|12242503|FG000|Overall Study|Adverse Event|3
7789684|NCT01014689|12242504|FG001|Overall Study|Adverse Event|0
7789685|NCT01014689|12242503|FG000|Overall Study|Withdrawal by Subject|5
7789686|NCT01014689|12242504|FG001|Overall Study|Withdrawal by Subject|4
7789687|NCT01014689|12242503|FG000|Overall Study|Protocol Violation|1
7789688|NCT01014689|12242504|FG001|Overall Study|Protocol Violation|1
7789689|NCT01014689|12242503|FG000|Overall Study|Lost to Follow-up|3
7789690|NCT01014689|12242504|FG001|Overall Study|Lost to Follow-up|7
7789691|NCT01014689|12242503|FG000|Overall Study|Pregnancy|1
7789692|NCT01014689|12242504|FG001|Overall Study|Pregnancy|0
7789693|NCT01014910|12242536|FG000|Overall Study|Withdrawal by Subject|0
7789694|NCT01014910|12242537|FG001|Overall Study|Withdrawal by Subject|2
7789695|NCT01014975|12242543|FG000|Overall Study|Withdrawal by Subject|1
7622678|NCT04405570|12033549|FG000|Overall Study|Adverse Event|0
7622679|NCT04405570|12033550|FG001|Overall Study|Adverse Event|1
7622680|NCT04405570|12033551|FG002|Overall Study|Adverse Event|1
7622681|NCT04405570|12033552|FG003|Overall Study|Adverse Event|1
7622682|NCT04405570|12033549|FG000|Overall Study|Lost to Follow-up|0
7622683|NCT04405570|12033550|FG001|Overall Study|Lost to Follow-up|1
7622684|NCT04405570|12033551|FG002|Overall Study|Lost to Follow-up|0
7622685|NCT04405570|12033552|FG003|Overall Study|Lost to Follow-up|0
7789696|NCT01014975|12242544|FG001|Overall Study|Withdrawal by Subject|0
7789697|NCT01014975|12242545|FG002|Overall Study|Withdrawal by Subject|1
7789698|NCT01014975|12242543|FG000|Overall Study|Death|3
7789699|NCT01014975|12242544|FG001|Overall Study|Death|3
7789700|NCT01014975|12242545|FG002|Overall Study|Death|4
7789701|NCT01014975|12242543|FG000|Overall Study|Lost to Follow-up|0
7789702|NCT01014975|12242544|FG001|Overall Study|Lost to Follow-up|0
7789703|NCT01014975|12242545|FG002|Overall Study|Lost to Follow-up|1
7789704|NCT01014988|12242559|FG000|Overall Study|Adverse Event|20
7789705|NCT01014988|12242560|FG001|Overall Study|Adverse Event|0
7789706|NCT01014988|12242561|FG002|Overall Study|Adverse Event|1
7789707|NCT01014988|12242562|FG003|Overall Study|Adverse Event|0
7789708|NCT01014988|12242563|FG004|Overall Study|Adverse Event|1
7789709|NCT01014988|12242564|FG005|Overall Study|Adverse Event|3
7789710|NCT01014988|12242559|FG000|Overall Study|Lost to Follow-up|1
7789711|NCT01014988|12242560|FG001|Overall Study|Lost to Follow-up|0
7789712|NCT01014988|12242561|FG002|Overall Study|Lost to Follow-up|1
7789713|NCT01014988|12242562|FG003|Overall Study|Lost to Follow-up|0
7789714|NCT01014988|12242563|FG004|Overall Study|Lost to Follow-up|0
7789715|NCT01014988|12242564|FG005|Overall Study|Lost to Follow-up|0
7789716|NCT01014988|12242559|FG000|Overall Study|Physician Decision|1
7789717|NCT01014988|12242560|FG001|Overall Study|Physician Decision|0
7789718|NCT01014988|12242561|FG002|Overall Study|Physician Decision|0
7789719|NCT01014988|12242562|FG003|Overall Study|Physician Decision|0
7789720|NCT01014988|12242563|FG004|Overall Study|Physician Decision|0
7789721|NCT01014988|12242564|FG005|Overall Study|Physician Decision|0
7789722|NCT01014988|12242559|FG000|Overall Study|Withdrawal by Subject|1
7789723|NCT01014988|12242560|FG001|Overall Study|Withdrawal by Subject|0
7789724|NCT01014988|12242561|FG002|Overall Study|Withdrawal by Subject|0
7789725|NCT01014988|12242562|FG003|Overall Study|Withdrawal by Subject|0
7789726|NCT01014988|12242563|FG004|Overall Study|Withdrawal by Subject|0
7789727|NCT01014988|12242564|FG005|Overall Study|Withdrawal by Subject|0
7789728|NCT01015118|12242588|FG000|Overall Study|Protocol Violation|5
7789729|NCT01015118|12242589|FG001|Overall Study|Protocol Violation|6
7789730|NCT01015118|12242588|FG000|Overall Study|Withdrawal by Subject|103
7789731|NCT01015118|12242589|FG001|Overall Study|Withdrawal by Subject|27
7789732|NCT01015118|12242588|FG000|Overall Study|Other Adverse Event (AE)|141
7789733|NCT01015118|12242589|FG001|Overall Study|Other Adverse Event (AE)|33
7789734|NCT01015118|12242588|FG000|Overall Study|Worsening or AE of underlying disease|5
7789735|NCT01015118|12242589|FG001|Overall Study|Worsening or AE of underlying disease|4
7789736|NCT01015118|12242588|FG000|Overall Study|Progressive disease|364
7789737|NCT01015118|12242589|FG001|Overall Study|Progressive disease|229
7789738|NCT01015118|12242588|FG000|Overall Study|Not treated|9
7789739|NCT01015118|12242589|FG001|Overall Study|Not treated|5
7789740|NCT01015118|12242588|FG000|Overall Study|Other than stated above|42
7789741|NCT01015118|12242589|FG001|Overall Study|Other than stated above|23
7789742|NCT01015131|12242595|FG000|Overall Study|Physician Decision|1
7789743|NCT01015131|12242595|FG000|Overall Study|Protocol Violation|1
7789744|NCT01015131|12242595|FG000|Overall Study|Withdrawal by Subject|2
7789745|NCT01015131|12242595|FG000|Overall Study|Other Protocol Specified Criteria|4
7789746|NCT01015287|12242607|FG000|Overall Study|Death|21
7789747|NCT01015287|12242608|FG001|Overall Study|Death|16
7789748|NCT01015287|12242607|FG000|Overall Study|Adverse Event|1
7789749|NCT01015287|12242608|FG001|Overall Study|Adverse Event|0
7789750|NCT01015287|12242607|FG000|Overall Study|Sponsor Decision|3
7789751|NCT01015287|12242608|FG001|Overall Study|Sponsor Decision|7
7789752|NCT01015287|12242607|FG000|Overall Study|Physician Decision|19
7789753|NCT01015287|12242608|FG001|Overall Study|Physician Decision|21
7789754|NCT01015287|12242607|FG000|Overall Study|Withdrawal by Subject|14
7789755|NCT01015287|12242608|FG001|Overall Study|Withdrawal by Subject|19
7789756|NCT01015287|12242607|FG000|Overall Study|Entry Criteria not Met|11
7789757|NCT01015287|12242608|FG001|Overall Study|Entry Criteria not Met|14
7789758|NCT01015287|12242607|FG000|Overall Study|Lost to Follow-up|2
7789759|NCT01015287|12242608|FG001|Overall Study|Lost to Follow-up|1
7789760|NCT01015287|12242607|FG000|Overall Study|Protocol Violation|1
7789761|NCT01015287|12242608|FG001|Overall Study|Protocol Violation|1
7789762|NCT01015560|12242646|FG000|Overall Study|Adverse Event|1
7789763|NCT01015560|12242646|FG000|Overall Study|Not protocol specified|1
7622686|NCT04405570|12033549|FG000|Overall Study|Physician Decision|0
7622687|NCT04405570|12033550|FG001|Overall Study|Physician Decision|0
7622688|NCT04405570|12033551|FG002|Overall Study|Physician Decision|1
7622689|NCT04405570|12033552|FG003|Overall Study|Physician Decision|0
7622690|NCT04405570|12033549|FG000|Overall Study|Withdrawal by Subject|0
7622691|NCT04405570|12033550|FG001|Overall Study|Withdrawal by Subject|1
7622692|NCT04405570|12033551|FG002|Overall Study|Withdrawal by Subject|1
7622693|NCT04405570|12033552|FG003|Overall Study|Withdrawal by Subject|0
7789764|NCT01015560|12242646|FG000|Overall Study|Withdrawal by Subject|1
7789765|NCT01015612|12242659|FG000|Overall Study|Death|113
7789766|NCT01015612|12242659|FG000|Overall Study|Withdrawal by Subject|40
7789767|NCT01015638|12242665|FG000|Overall Study|Withdrawal by Subject|1
7789768|NCT01015638|12242666|FG001|Overall Study|Withdrawal by Subject|0
7622694|NCT04405570|12033549|FG000|Overall Study|Randomized not dosed|0
7622695|NCT04405570|12033550|FG001|Overall Study|Randomized not dosed|2
7622696|NCT04405570|12033551|FG002|Overall Study|Randomized not dosed|0
7622697|NCT04405570|12033552|FG003|Overall Study|Randomized not dosed|0
7789769|NCT01015677|12242675|FG000|Overall Study|Adverse Event|0
7789770|NCT01015677|12242676|FG001|Overall Study|Adverse Event|1
7789771|NCT01015677|12242677|FG002|Overall Study|Adverse Event|0
7789772|NCT01015677|12242675|FG000|Overall Study|Lack of Efficacy|0
7789773|NCT01015677|12242676|FG001|Overall Study|Lack of Efficacy|1
7789774|NCT01015677|12242677|FG002|Overall Study|Lack of Efficacy|0
7789775|NCT01015677|12242675|FG000|Overall Study|Protocol Violation|0
7789776|NCT01015677|12242676|FG001|Overall Study|Protocol Violation|1
7789777|NCT01015677|12242677|FG002|Overall Study|Protocol Violation|0
7789778|NCT01015677|12242675|FG000|Overall Study|Withdrawal by Subject|1
7789779|NCT01015677|12242676|FG001|Overall Study|Withdrawal by Subject|1
7789780|NCT01015677|12242677|FG002|Overall Study|Withdrawal by Subject|0
7789781|NCT01015703|12242690|FG000|Overall Study|Withdrawal by Subject|0
7789782|NCT01015703|12242691|FG001|Overall Study|Withdrawal by Subject|1
7789783|NCT01015703|12242692|FG002|Overall Study|Withdrawal by Subject|0
7789784|NCT01015703|12242693|FG003|Overall Study|Withdrawal by Subject|0
7789785|NCT01015703|12242694|FG004|Overall Study|Withdrawal by Subject|0
7789786|NCT01015703|12242690|FG000|Overall Study|Adverse Event|1
7789787|NCT01015703|12242691|FG001|Overall Study|Adverse Event|0
7789788|NCT01015703|12242692|FG002|Overall Study|Adverse Event|0
7789789|NCT01015703|12242693|FG003|Overall Study|Adverse Event|0
7789790|NCT01015703|12242694|FG004|Overall Study|Adverse Event|0
7789791|NCT01015703|12242690|FG000|Overall Study|Protocol Violation|1
7789792|NCT01015703|12242691|FG001|Overall Study|Protocol Violation|0
7789793|NCT01015703|12242692|FG002|Overall Study|Protocol Violation|0
7789794|NCT01015703|12242693|FG003|Overall Study|Protocol Violation|0
7789795|NCT01015703|12242694|FG004|Overall Study|Protocol Violation|0
7789796|NCT01015768|12242706|FG000|Overall Study|Some subject data unuseable|4
7789797|NCT01015768|12242707|FG001|Overall Study|Some subject data unuseable|4
7789798|NCT01015820|12242739|FG000|Overall Study|Suboptimal measurements|1
7789799|NCT01015820|12242740|FG001|Overall Study|Suboptimal measurements|0
7789800|NCT01016015|12242751|FG000|Overall Study|Not Treated|3
7789801|NCT01016015|12242751|FG000|Overall Study|Withdrawal by Subject|1
7789802|NCT01016015|12242751|FG000|Overall Study|Adverse Event|15
7789803|NCT01016067|12242757|FG000|Overall Study|Lost to Follow-up|1
7789804|NCT01016067|12242758|FG001|Overall Study|Lost to Follow-up|2
7789805|NCT01016067|12242757|FG000|Overall Study|Physician Decision|1
7789806|NCT01016067|12242758|FG001|Overall Study|Physician Decision|1
7789807|NCT01016067|12242757|FG000|Overall Study|Withdrew due to Relocation|0
7789808|NCT01016067|12242758|FG001|Overall Study|Withdrew due to Relocation|1
7789809|NCT01016132|12242773|FG000|Overall Study|Discomfort|1
7789810|NCT01016262|12242780|FG000|Double-blind Phase|Adverse Event|0
7789811|NCT01016262|12242781|FG001|Double-blind Phase|Adverse Event|0
7789812|NCT01016262|12242782|FG002|Double-blind Phase|Adverse Event|1
7789813|NCT01016262|12242783|FG003|Double-blind Phase|Adverse Event|0
7789814|NCT01016262|12242784|FG004|Double-blind Phase|Adverse Event|0
7789815|NCT01016262|12242785|FG005|Double-blind Phase|Adverse Event|0
7789816|NCT01016262|12242780|FG000|Double-blind Phase|Lack of Efficacy|1
7789817|NCT01016262|12242781|FG001|Double-blind Phase|Lack of Efficacy|0
7789818|NCT01016262|12242782|FG002|Double-blind Phase|Lack of Efficacy|5
7789819|NCT01016262|12242783|FG003|Double-blind Phase|Lack of Efficacy|0
7789820|NCT01016262|12242784|FG004|Double-blind Phase|Lack of Efficacy|0
7789821|NCT01016262|12242785|FG005|Double-blind Phase|Lack of Efficacy|0
7789822|NCT01016262|12242780|FG000|Double-blind Phase|Disease Progression|0
7789823|NCT01016262|12242781|FG001|Double-blind Phase|Disease Progression|1
7789824|NCT01016262|12242782|FG002|Double-blind Phase|Disease Progression|2
7789825|NCT01016262|12242783|FG003|Double-blind Phase|Disease Progression|0
7789826|NCT01016262|12242784|FG004|Double-blind Phase|Disease Progression|0
7789827|NCT01016262|12242785|FG005|Double-blind Phase|Disease Progression|0
7789828|NCT01016262|12242780|FG000|Double-blind Phase|Withdrawal of Informed Consent|0
7789829|NCT01016262|12242781|FG001|Double-blind Phase|Withdrawal of Informed Consent|0
7789830|NCT01016262|12242782|FG002|Double-blind Phase|Withdrawal of Informed Consent|1
7789831|NCT01016262|12242783|FG003|Double-blind Phase|Withdrawal of Informed Consent|0
7789832|NCT01016262|12242784|FG004|Double-blind Phase|Withdrawal of Informed Consent|0
7789833|NCT01016262|12242785|FG005|Double-blind Phase|Withdrawal of Informed Consent|0
7789834|NCT01016262|12242780|FG000|Open-Label Phase|Adverse Event|0
7789835|NCT01016262|12242781|FG001|Open-Label Phase|Adverse Event|0
7622698|NCT04135937|12033565|FG000|Overall Study|Lost to Follow-up|2
7622699|NCT04135937|12033565|FG000|Overall Study|Withdrawal by Subject|1
7789836|NCT01016262|12242782|FG002|Open-Label Phase|Adverse Event|0
7622700|NCT03989232|12033571|FG000|Overall Study|Lost to Follow-up|3
7789837|NCT01016262|12242783|FG003|Open-Label Phase|Adverse Event|1
7789838|NCT01016262|12242784|FG004|Open-Label Phase|Adverse Event|0
7789839|NCT01016262|12242785|FG005|Open-Label Phase|Adverse Event|0
7789840|NCT01016262|12242780|FG000|Open-Label Phase|Lost to Follow-up|0
7789841|NCT01016262|12242781|FG001|Open-Label Phase|Lost to Follow-up|0
7789842|NCT01016262|12242782|FG002|Open-Label Phase|Lost to Follow-up|0
7789843|NCT01016262|12242783|FG003|Open-Label Phase|Lost to Follow-up|0
7789844|NCT01016262|12242784|FG004|Open-Label Phase|Lost to Follow-up|1
7789845|NCT01016262|12242785|FG005|Open-Label Phase|Lost to Follow-up|0
7789846|NCT01016262|12242780|FG000|Open-Label Phase|Lack of Efficacy|0
7789847|NCT01016262|12242781|FG001|Open-Label Phase|Lack of Efficacy|0
7789848|NCT01016262|12242782|FG002|Open-Label Phase|Lack of Efficacy|0
7789849|NCT01016262|12242783|FG003|Open-Label Phase|Lack of Efficacy|1
7789850|NCT01016262|12242784|FG004|Open-Label Phase|Lack of Efficacy|0
7789851|NCT01016262|12242785|FG005|Open-Label Phase|Lack of Efficacy|0
7789852|NCT01016262|12242780|FG000|Open-Label Phase|Withdrawal of Informed Consent|0
7789853|NCT01016262|12242781|FG001|Open-Label Phase|Withdrawal of Informed Consent|0
7789854|NCT01016262|12242782|FG002|Open-Label Phase|Withdrawal of Informed Consent|0
7789855|NCT01016262|12242783|FG003|Open-Label Phase|Withdrawal of Informed Consent|0
7789856|NCT01016262|12242784|FG004|Open-Label Phase|Withdrawal of Informed Consent|1
7789857|NCT01016262|12242785|FG005|Open-Label Phase|Withdrawal of Informed Consent|0
7789858|NCT01016600|12242845|FG000|Overall Study|Did not start treatment|1
7789859|NCT01016600|12242846|FG001|Overall Study|Did not start treatment|0
7789860|NCT01016600|12242847|FG002|Overall Study|Did not start treatment|0
7789861|NCT01016600|12242848|FG003|Overall Study|Did not start treatment|0
7789862|NCT01016912|12242943|FG000|End of Treatment Period|Lack of Efficacy|0
7789863|NCT01016912|12242944|FG001|End of Treatment Period|Lack of Efficacy|1
7789864|NCT01016912|12242945|FG002|End of Treatment Period|Lack of Efficacy|0
7789865|NCT01016912|12242946|FG003|End of Treatment Period|Lack of Efficacy|4
7789866|NCT01016912|12242947|FG004|End of Treatment Period|Lack of Efficacy|4
7789867|NCT01016912|12242943|FG000|End of Treatment Period|Adverse Event|0
7789868|NCT01016912|12242944|FG001|End of Treatment Period|Adverse Event|1
7789869|NCT01016912|12242945|FG002|End of Treatment Period|Adverse Event|1
7789870|NCT01016912|12242946|FG003|End of Treatment Period|Adverse Event|0
7789871|NCT01016912|12242947|FG004|End of Treatment Period|Adverse Event|0
7789872|NCT01016912|12242943|FG000|End of Treatment Period|Completed double-blind period only|0
7789873|NCT01016912|12242944|FG001|End of Treatment Period|Completed double-blind period only|1
7789874|NCT01016912|12242945|FG002|End of Treatment Period|Completed double-blind period only|0
7789875|NCT01016912|12242946|FG003|End of Treatment Period|Completed double-blind period only|0
7789876|NCT01016912|12242947|FG004|End of Treatment Period|Completed double-blind period only|0
7789877|NCT01016912|12242943|FG000|Follow-up Period|Other reason|0
7789878|NCT01016912|12242944|FG001|Follow-up Period|Other reason|0
7789879|NCT01016912|12242945|FG002|Follow-up Period|Other reason|1
7789880|NCT01016912|12242946|FG003|Follow-up Period|Other reason|1
7789881|NCT01016912|12242947|FG004|Follow-up Period|Other reason|0
7789882|NCT01016964|12242986|FG000|Overall Study|Lost to Follow-up|3
7789883|NCT01016964|12242987|FG001|Overall Study|Lost to Follow-up|3
7789884|NCT01016977|12242995|FG000|Overall Study|Lost to Follow-up|1
7789885|NCT01016977|12242996|FG001|Overall Study|Lost to Follow-up|0
7789886|NCT01016977|12242995|FG000|Overall Study|Withdrawal by Subject|2
7789887|NCT01016977|12242996|FG001|Overall Study|Withdrawal by Subject|2
7789888|NCT01017029|12243013|FG000|Overall Study|Lost to Follow-up|1
7789889|NCT01017029|12243014|FG001|Overall Study|Lost to Follow-up|0
7789890|NCT01017029|12243013|FG000|Overall Study|Administrative problem|0
7789891|NCT01017029|12243014|FG001|Overall Study|Administrative problem|1
7789892|NCT01017029|12243013|FG000|Overall Study|Death|3
7789893|NCT01017029|12243014|FG001|Overall Study|Death|1
7789894|NCT01017120|12243031|FG000|Overall Study|Adverse Event|9
7789895|NCT01017120|12243032|FG001|Overall Study|Adverse Event|0
7789896|NCT01017120|12243031|FG000|Overall Study|Lost to Follow-up|13
7789897|NCT01017120|12243032|FG001|Overall Study|Lost to Follow-up|11
7789898|NCT01017120|12243031|FG000|Overall Study|Lack of Efficacy|1
7789899|NCT01017120|12243032|FG001|Overall Study|Lack of Efficacy|0
7789900|NCT01017120|12243031|FG000|Overall Study|Withdrawal by Subject|39
7789901|NCT01017120|12243032|FG001|Overall Study|Withdrawal by Subject|21
7789902|NCT01017120|12243031|FG000|Overall Study|Pregnancy|1
7789903|NCT01017120|12243032|FG001|Overall Study|Pregnancy|1
7789904|NCT01017120|12243031|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
7789905|NCT01017120|12243032|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
7789906|NCT01017120|12243031|FG000|Overall Study|Relocated Out of Town|0
7789907|NCT01017120|12243032|FG001|Overall Study|Relocated Out of Town|2
7789908|NCT01017120|12243031|FG000|Overall Study|Protocol Violation|1
7789909|NCT01017120|12243032|FG001|Overall Study|Protocol Violation|0
7789910|NCT01017120|12243031|FG000|Overall Study|Parent Unable to Provide Transportation|1
7789911|NCT01017120|12243032|FG001|Overall Study|Parent Unable to Provide Transportation|0
7789912|NCT01017146|12243040|FG000|Overall Study|Adverse Event|11
7789913|NCT01017146|12243041|FG001|Overall Study|Adverse Event|1
7789914|NCT01017146|12243040|FG000|Overall Study|Lost to Follow-up|14
7789915|NCT01017146|12243041|FG001|Overall Study|Lost to Follow-up|14
7789916|NCT01017146|12243040|FG000|Overall Study|Noncompliance with Study Product|1
7789917|NCT01017146|12243041|FG001|Overall Study|Noncompliance with Study Product|1
7789918|NCT01017146|12243040|FG000|Overall Study|Withdrawal by Subject|32
7789919|NCT01017146|12243041|FG001|Overall Study|Withdrawal by Subject|16
7789920|NCT01017146|12243040|FG000|Overall Study|Relocation|0
7789921|NCT01017146|12243041|FG001|Overall Study|Relocation|4
7789922|NCT01017146|12243040|FG000|Overall Study|Pregnancy|2
7789923|NCT01017146|12243041|FG001|Overall Study|Pregnancy|1
7789924|NCT01017146|12243040|FG000|Overall Study|Protocol Violation|2
7789925|NCT01017146|12243041|FG001|Overall Study|Protocol Violation|0
7789926|NCT01017146|12243040|FG000|Overall Study|Took Excluded Medication|2
7789927|NCT01017146|12243041|FG001|Overall Study|Took Excluded Medication|0
7789928|NCT01017146|12243040|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
7789929|NCT01017146|12243041|FG001|Overall Study|Did Not Meet Eligibility Criteria|2
7789930|NCT01017146|12243040|FG000|Overall Study|Change in Work Situation|1
7789931|NCT01017146|12243041|FG001|Overall Study|Change in Work Situation|0
7789932|NCT01017549|12243079|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
7789933|NCT01017549|12243079|FG000|One-year Follow-up|Lost to Follow-up|2
7789934|NCT01017549|12243079|FG000|One-year Follow-up|Withdrawal by Subject|5
7789935|NCT01017549|12243079|FG000|5 Year Follow-up|Lost to Follow-up|9
7789936|NCT01017549|12243079|FG000|5 Year Follow-up|Mastectomy|3
7789937|NCT01017575|12243088|FG000|Overall Study|Lack of Efficacy|0
7789938|NCT01017575|12243089|FG001|Overall Study|Lack of Efficacy|1
7789939|NCT01017575|12243090|FG002|Overall Study|Lack of Efficacy|0
7789940|NCT01017575|12243091|FG003|Overall Study|Lack of Efficacy|1
7789941|NCT01017575|12243092|FG004|Overall Study|Lack of Efficacy|1
7789942|NCT01017575|12243088|FG000|Overall Study|Adverse Event|0
7789943|NCT01017575|12243089|FG001|Overall Study|Adverse Event|1
7789944|NCT01017575|12243090|FG002|Overall Study|Adverse Event|0
7789945|NCT01017575|12243091|FG003|Overall Study|Adverse Event|0
7789946|NCT01017575|12243092|FG004|Overall Study|Adverse Event|2
7789947|NCT01017575|12243088|FG000|Overall Study|Withdrawal by Subject|1
7789948|NCT01017575|12243089|FG001|Overall Study|Withdrawal by Subject|0
7789949|NCT01017575|12243090|FG002|Overall Study|Withdrawal by Subject|0
7789950|NCT01017575|12243091|FG003|Overall Study|Withdrawal by Subject|0
7789951|NCT01017575|12243092|FG004|Overall Study|Withdrawal by Subject|0
7789952|NCT01017601|12243106|FG000|Overall Study|Disease Progression|12
7789953|NCT01017601|12243107|FG001|Overall Study|Disease Progression|12
7789954|NCT01017601|12243106|FG000|Overall Study|Withdrawal by Subject|0
7789955|NCT01017601|12243107|FG001|Overall Study|Withdrawal by Subject|1
7789956|NCT01017731|12243117|FG000|Overall Study|Lost to Follow-up|2
7789957|NCT01017731|12243117|FG000|Overall Study|Withdrawal by Subject|3
7789958|NCT01017731|12243117|FG000|Overall Study|Physician Decision|2
7789959|NCT01017731|12243117|FG000|Overall Study|Adverse Event|1
7789960|NCT01017874|12243124|FG000|Overall Study|Withdrawal by Subject|23
7789961|NCT01017874|12243125|FG001|Overall Study|Withdrawal by Subject|20
7789962|NCT01017874|12243124|FG000|Overall Study|Sponsor decision|3
7789963|NCT01017874|12243125|FG001|Overall Study|Sponsor decision|1
7789964|NCT01017874|12243124|FG000|Overall Study|Lost to Follow-up|3
7789965|NCT01017874|12243125|FG001|Overall Study|Lost to Follow-up|2
7789966|NCT01017874|12243124|FG000|Overall Study|Physician Decision|1
7789967|NCT01017874|12243125|FG001|Overall Study|Physician Decision|3
7789968|NCT01017952|12243135|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
7789969|NCT01017952|12243136|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7789970|NCT01017952|12243137|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7789971|NCT01017952|12243138|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7789972|NCT01017952|12243139|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7789973|NCT01017952|12243135|FG000|4-week, Open-label Run-In Period|Adverse Event|23
7789974|NCT01017952|12243136|FG001|4-week, Open-label Run-In Period|Adverse Event|0
7789975|NCT01017952|12243137|FG002|4-week, Open-label Run-In Period|Adverse Event|0
7789976|NCT01017952|12243138|FG003|4-week, Open-label Run-In Period|Adverse Event|0
7789977|NCT01017952|12243139|FG004|4-week, Open-label Run-In Period|Adverse Event|0
7789978|NCT01017952|12243135|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
7789979|NCT01017952|12243136|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
7789980|NCT01017952|12243137|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
7789981|NCT01017952|12243138|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
7789982|NCT01017952|12243139|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
7789983|NCT01017952|12243135|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6
7789984|NCT01017952|12243136|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0
7789985|NCT01017952|12243137|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0
7789986|NCT01017952|12243138|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0
7789987|NCT01017952|12243139|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0
7789988|NCT01017952|12243135|FG000|4-week, Open-label Run-In Period|Physician Decision|10
7789989|NCT01017952|12243136|FG001|4-week, Open-label Run-In Period|Physician Decision|0
7789990|NCT01017952|12243137|FG002|4-week, Open-label Run-In Period|Physician Decision|0
7789991|NCT01017952|12243138|FG003|4-week, Open-label Run-In Period|Physician Decision|0
7789992|NCT01017952|12243139|FG004|4-week, Open-label Run-In Period|Physician Decision|0
7789993|NCT01017952|12243135|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63
7789994|NCT01017952|12243136|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7789995|NCT01017952|12243137|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7789996|NCT01017952|12243138|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7622701|NCT03989232|12033572|FG001|Overall Study|Lost to Follow-up|10
7622702|NCT03989232|12033571|FG000|Overall Study|Withdrawal by Subject|6
7622703|NCT03989232|12033572|FG001|Overall Study|Withdrawal by Subject|6
7622704|NCT03989232|12033571|FG000|Overall Study|Death|1
7622705|NCT03989232|12033572|FG001|Overall Study|Death|2
7622706|NCT03896295|12033580|FG000|Overall Study|Adverse Event|0
7622707|NCT03896295|12033581|FG001|Overall Study|Adverse Event|1
7622708|NCT03896295|12033580|FG000|Overall Study|COVID-19|7
7622709|NCT03896295|12033581|FG001|Overall Study|COVID-19|29
7622710|NCT03213457|12033595|FG000|Overall Study|Not Treated|1
7622711|NCT03213457|12033596|FG001|Overall Study|Not Treated|1
7622712|NCT03213457|12033597|FG002|Overall Study|Not Treated|0
7622713|NCT03213457|12033595|FG000|Overall Study|Adverse Event|16
7622714|NCT03213457|12033596|FG001|Overall Study|Adverse Event|9
7622715|NCT03213457|12033597|FG002|Overall Study|Adverse Event|41
7622716|NCT03213457|12033595|FG000|Overall Study|Non-Compliance With Study Drug|1
7622717|NCT03213457|12033596|FG001|Overall Study|Non-Compliance With Study Drug|2
7789997|NCT01017952|12243139|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7789998|NCT01017952|12243135|FG000|52-week, Double-blind Treatment Period|Adverse Event|0
7789999|NCT01017952|12243136|FG001|52-week, Double-blind Treatment Period|Adverse Event|25
7790000|NCT01017952|12243137|FG002|52-week, Double-blind Treatment Period|Adverse Event|32
7790001|NCT01017952|12243138|FG003|52-week, Double-blind Treatment Period|Adverse Event|35
7790002|NCT01017952|12243139|FG004|52-week, Double-blind Treatment Period|Adverse Event|30
7790003|NCT01017952|12243135|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
7790004|NCT01017952|12243136|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
7790005|NCT01017952|12243137|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
7790006|NCT01017952|12243138|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
7790007|NCT01017952|12243139|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
7790008|NCT01017952|12243135|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0
7790009|NCT01017952|12243136|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35
7790010|NCT01017952|12243137|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14
7790011|NCT01017952|12243138|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16
7790012|NCT01017952|12243139|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14
7790013|NCT01017952|12243135|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0
7790014|NCT01017952|12243136|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7
7790015|NCT01017952|12243137|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11
7790016|NCT01017952|12243138|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9
7790017|NCT01017952|12243139|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8
7790018|NCT01017952|12243135|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
7790019|NCT01017952|12243136|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
7790020|NCT01017952|12243137|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
7790021|NCT01017952|12243138|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
7790022|NCT01017952|12243139|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
7790023|NCT01017952|12243135|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7790024|NCT01017952|12243136|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
7790025|NCT01017952|12243137|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
7790026|NCT01017952|12243138|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7790027|NCT01017952|12243139|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7790028|NCT01017952|12243135|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0
7790029|NCT01017952|12243136|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6
7790030|NCT01017952|12243137|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8
7790031|NCT01017952|12243138|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6
7790032|NCT01017952|12243139|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10
7790033|NCT01017952|12243135|FG000|52-week, Double-blind Treatment Period|Physician Decision|0
7790034|NCT01017952|12243136|FG001|52-week, Double-blind Treatment Period|Physician Decision|10
7790035|NCT01017952|12243137|FG002|52-week, Double-blind Treatment Period|Physician Decision|8
7790036|NCT01017952|12243138|FG003|52-week, Double-blind Treatment Period|Physician Decision|9
7790037|NCT01017952|12243139|FG004|52-week, Double-blind Treatment Period|Physician Decision|7
7790038|NCT01018030|12243152|FG000|Overall Study|Adverse Event|10
7790039|NCT01018030|12243153|FG001|Overall Study|Adverse Event|5
7622746|NCT02982720|12033605|FG000|Overall Study|Adverse Event|3
7790040|NCT01018030|12243154|FG002|Overall Study|Adverse Event|5
7790041|NCT01018030|12243152|FG000|Overall Study|Withdrawal by Subject|2
7790042|NCT01018030|12243153|FG001|Overall Study|Withdrawal by Subject|2
7790043|NCT01018030|12243154|FG002|Overall Study|Withdrawal by Subject|4
7790044|NCT01018030|12243152|FG000|Overall Study|Lost to Follow-up|2
7790045|NCT01018030|12243153|FG001|Overall Study|Lost to Follow-up|0
7790046|NCT01018030|12243154|FG002|Overall Study|Lost to Follow-up|3
7622718|NCT03213457|12033597|FG002|Overall Study|Non-Compliance With Study Drug|7
7622719|NCT03213457|12033595|FG000|Overall Study|Non-Compliance Other, Not Specified|0
7622720|NCT03213457|12033596|FG001|Overall Study|Non-Compliance Other, Not Specified|1
7790047|NCT01018030|12243152|FG000|Overall Study|Protocol Violation|2
7790048|NCT01018030|12243153|FG001|Overall Study|Protocol Violation|1
7790049|NCT01018030|12243154|FG002|Overall Study|Protocol Violation|0
7790050|NCT01018030|12243152|FG000|Overall Study|Physician Decision|1
7790051|NCT01018030|12243153|FG001|Overall Study|Physician Decision|0
7790052|NCT01018030|12243154|FG002|Overall Study|Physician Decision|1
7790053|NCT01018030|12243152|FG000|Overall Study|Lack of Efficacy|1
7790054|NCT01018030|12243153|FG001|Overall Study|Lack of Efficacy|0
7790055|NCT01018030|12243154|FG002|Overall Study|Lack of Efficacy|0
7790056|NCT01018030|12243152|FG000|Overall Study|Did Not Receive Study Drug|1
7790057|NCT01018030|12243153|FG001|Overall Study|Did Not Receive Study Drug|3
7790058|NCT01018030|12243154|FG002|Overall Study|Did Not Receive Study Drug|0
7790059|NCT01018186|12243217|FG000|2-week Run-in Period|Protocol Violation|1
7790060|NCT01018186|12243218|FG001|2-week Run-in Period|Protocol Violation|0
7790061|NCT01018186|12243219|FG002|2-week Run-in Period|Protocol Violation|0
7790062|NCT01018186|12243220|FG003|2-week Run-in Period|Protocol Violation|0
7790063|NCT01018186|12243217|FG000|2-week Run-in Period|Lost to Follow-up|2
7790064|NCT01018186|12243218|FG001|2-week Run-in Period|Lost to Follow-up|0
7790065|NCT01018186|12243219|FG002|2-week Run-in Period|Lost to Follow-up|0
7790066|NCT01018186|12243220|FG003|2-week Run-in Period|Lost to Follow-up|0
7790067|NCT01018186|12243217|FG000|2-week Run-in Period|Physician Decision|3
7790068|NCT01018186|12243218|FG001|2-week Run-in Period|Physician Decision|0
7790069|NCT01018186|12243219|FG002|2-week Run-in Period|Physician Decision|0
7790070|NCT01018186|12243220|FG003|2-week Run-in Period|Physician Decision|0
7790071|NCT01018186|12243217|FG000|2-week Run-in Period|Withdrawal by Subject|11
7790072|NCT01018186|12243218|FG001|2-week Run-in Period|Withdrawal by Subject|0
7790073|NCT01018186|12243219|FG002|2-week Run-in Period|Withdrawal by Subject|0
7790074|NCT01018186|12243220|FG003|2-week Run-in Period|Withdrawal by Subject|0
7790075|NCT01018186|12243217|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97
7790076|NCT01018186|12243218|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7790077|NCT01018186|12243219|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7790078|NCT01018186|12243220|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7790079|NCT01018186|12243217|FG000|52-week Double-blind Treatment Period|Adverse Event|0
7790080|NCT01018186|12243218|FG001|52-week Double-blind Treatment Period|Adverse Event|5
7790081|NCT01018186|12243219|FG002|52-week Double-blind Treatment Period|Adverse Event|3
7790082|NCT01018186|12243220|FG003|52-week Double-blind Treatment Period|Adverse Event|6
7790083|NCT01018186|12243217|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0
7790084|NCT01018186|12243218|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1
7790085|NCT01018186|12243219|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4
7790086|NCT01018186|12243220|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1
7790087|NCT01018186|12243217|FG000|52-week Double-blind Treatment Period|Protocol Violation|0
7790088|NCT01018186|12243218|FG001|52-week Double-blind Treatment Period|Protocol Violation|8
7790089|NCT01018186|12243219|FG002|52-week Double-blind Treatment Period|Protocol Violation|8
7790090|NCT01018186|12243220|FG003|52-week Double-blind Treatment Period|Protocol Violation|2
7622721|NCT03213457|12033597|FG002|Overall Study|Non-Compliance Other, Not Specified|5
7622722|NCT03213457|12033595|FG000|Overall Study|Withdrawal by Subject|18
7622723|NCT03213457|12033596|FG001|Overall Study|Withdrawal by Subject|7
7622724|NCT03213457|12033597|FG002|Overall Study|Withdrawal by Subject|35
7622725|NCT03213457|12033595|FG000|Overall Study|Lost to Follow-up|12
7622726|NCT03213457|12033596|FG001|Overall Study|Lost to Follow-up|12
7622727|NCT03213457|12033597|FG002|Overall Study|Lost to Follow-up|33
7622728|NCT03213457|12033595|FG000|Overall Study|Pregnancy|11
7622729|NCT03213457|12033596|FG001|Overall Study|Pregnancy|0
7622730|NCT03213457|12033597|FG002|Overall Study|Pregnancy|7
7622731|NCT03213457|12033595|FG000|Overall Study|Protocol Violation|1
7622732|NCT03213457|12033596|FG001|Overall Study|Protocol Violation|1
7622733|NCT03213457|12033597|FG002|Overall Study|Protocol Violation|6
7622734|NCT03213457|12033595|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4
7622735|NCT03213457|12033596|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0
7622736|NCT03213457|12033597|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2
7622737|NCT03213457|12033595|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1
7622738|NCT03213457|12033596|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1
7622739|NCT03213457|12033597|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3
7622740|NCT03213457|12033595|FG000|Overall Study|Lack of Efficacy|12
7622741|NCT03213457|12033596|FG001|Overall Study|Lack of Efficacy|2
7622742|NCT03213457|12033597|FG002|Overall Study|Lack of Efficacy|9
7622743|NCT03213457|12033595|FG000|Overall Study|Other, Not Specified|11
7622744|NCT03213457|12033596|FG001|Overall Study|Other, Not Specified|3
7622745|NCT03213457|12033597|FG002|Overall Study|Other, Not Specified|26
7622747|NCT02982720|12033605|FG000|Overall Study|Death|1
7790091|NCT01018186|12243217|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
7790092|NCT01018186|12243218|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
7790093|NCT01018186|12243219|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
7790094|NCT01018186|12243220|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
7790095|NCT01018186|12243217|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0
7790096|NCT01018186|12243218|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1
7790097|NCT01018186|12243219|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3
7790098|NCT01018186|12243220|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4
7790099|NCT01018186|12243217|FG000|52-week Double-blind Treatment Period|Physician Decision|0
7790100|NCT01018186|12243218|FG001|52-week Double-blind Treatment Period|Physician Decision|1
7790101|NCT01018186|12243219|FG002|52-week Double-blind Treatment Period|Physician Decision|0
7790102|NCT01018186|12243220|FG003|52-week Double-blind Treatment Period|Physician Decision|3
7790103|NCT01018186|12243217|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0
7790104|NCT01018186|12243218|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10
7790105|NCT01018186|12243219|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7
7790106|NCT01018186|12243220|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9
7790107|NCT01018264|12243234|FG000|Overall Study|Withdrawal by Subject|1
7790108|NCT01018264|12243235|FG001|Overall Study|Withdrawal by Subject|0
7790109|NCT01018264|12243234|FG000|Overall Study|Lost to Follow-up|0
7790110|NCT01018264|12243235|FG001|Overall Study|Lost to Follow-up|1
7790111|NCT01018394|12243243|FG000|Overall Study|Withdrawal by Subject|5
7790112|NCT01018394|12243244|FG001|Overall Study|Withdrawal by Subject|5
7790113|NCT01018394|12243243|FG000|Overall Study|Lost to Follow-up|4
7790114|NCT01018394|12243244|FG001|Overall Study|Lost to Follow-up|3
7790115|NCT01018511|12243280|FG000|Overall Study|Not fulfilling eligibility criteria|6
7790116|NCT01018511|12243281|FG001|Overall Study|Not fulfilling eligibility criteria|7
7790117|NCT01018511|12243282|FG002|Overall Study|Not fulfilling eligibility criteria|7
7790118|NCT01018511|12243283|FG003|Overall Study|Not fulfilling eligibility criteria|3
7790119|NCT01018511|12243280|FG000|Overall Study|Adverse Event|5
7790120|NCT01018511|12243281|FG001|Overall Study|Adverse Event|9
7790121|NCT01018511|12243282|FG002|Overall Study|Adverse Event|13
7790122|NCT01018511|12243283|FG003|Overall Study|Adverse Event|10
7790123|NCT01018511|12243280|FG000|Overall Study|Lack of Efficacy|4
7790124|NCT01018511|12243281|FG001|Overall Study|Lack of Efficacy|1
7790125|NCT01018511|12243282|FG002|Overall Study|Lack of Efficacy|1
7790126|NCT01018511|12243283|FG003|Overall Study|Lack of Efficacy|2
7790127|NCT01018511|12243280|FG000|Overall Study|Withdrawal by Subject|6
7790128|NCT01018511|12243281|FG001|Overall Study|Withdrawal by Subject|5
7790129|NCT01018511|12243282|FG002|Overall Study|Withdrawal by Subject|11
7790130|NCT01018511|12243283|FG003|Overall Study|Withdrawal by Subject|9
7790131|NCT01018511|12243280|FG000|Overall Study|Lost to Follow-up|0
7790132|NCT01018511|12243281|FG001|Overall Study|Lost to Follow-up|0
7790133|NCT01018511|12243282|FG002|Overall Study|Lost to Follow-up|1
7790134|NCT01018511|12243283|FG003|Overall Study|Lost to Follow-up|0
7790135|NCT01018511|12243280|FG000|Overall Study|Protocol Violation|5
7790136|NCT01018511|12243281|FG001|Overall Study|Protocol Violation|8
7790137|NCT01018511|12243282|FG002|Overall Study|Protocol Violation|7
7790138|NCT01018511|12243283|FG003|Overall Study|Protocol Violation|9
7790139|NCT01018511|12243280|FG000|Overall Study|Miscellaneous|0
7790140|NCT01018511|12243281|FG001|Overall Study|Miscellaneous|2
7790141|NCT01018511|12243282|FG002|Overall Study|Miscellaneous|0
7790142|NCT01018511|12243283|FG003|Overall Study|Miscellaneous|0
7790143|NCT01018680|12243301|FG000|Overall Study|Adverse Event|23
7790144|NCT01018680|12243302|FG001|Overall Study|Adverse Event|40
7790145|NCT01018680|12243301|FG000|Overall Study|Withdrawal by Subject|10
7790146|NCT01018680|12243302|FG001|Overall Study|Withdrawal by Subject|10
7790147|NCT01018680|12243301|FG000|Overall Study|Protocol Violation|5
7790148|NCT01018680|12243302|FG001|Overall Study|Protocol Violation|8
7790149|NCT01018680|12243301|FG000|Overall Study|Sponsor Decision|6
7790150|NCT01018680|12243302|FG001|Overall Study|Sponsor Decision|7
7790151|NCT01018680|12243301|FG000|Overall Study|Lack of Efficacy|8
7790152|NCT01018680|12243302|FG001|Overall Study|Lack of Efficacy|2
7790153|NCT01018680|12243301|FG000|Overall Study|Lost to Follow-up|5
7790154|NCT01018680|12243302|FG001|Overall Study|Lost to Follow-up|3
7790155|NCT01018680|12243301|FG000|Overall Study|Entry Criteria Not Met|1
7790156|NCT01018680|12243302|FG001|Overall Study|Entry Criteria Not Met|4
7790157|NCT01018680|12243301|FG000|Overall Study|Physician Decision|3
7790158|NCT01018680|12243302|FG001|Overall Study|Physician Decision|1
7790159|NCT01018732|12243311|FG000|Overall Study|Lost to Follow-up|0
7790160|NCT01018732|12243312|FG001|Overall Study|Lost to Follow-up|0
7790161|NCT01018732|12243313|FG002|Overall Study|Lost to Follow-up|3
7790162|NCT01018732|12243311|FG000|Overall Study|Protocol Violation|1
7790163|NCT01018732|12243312|FG001|Overall Study|Protocol Violation|1
7790164|NCT01018732|12243313|FG002|Overall Study|Protocol Violation|0
7790165|NCT01018732|12243311|FG000|Overall Study|Inappropriate Enrollment|0
7790166|NCT01018732|12243312|FG001|Overall Study|Inappropriate Enrollment|1
7790167|NCT01018732|12243313|FG002|Overall Study|Inappropriate Enrollment|0
7790168|NCT01018732|12243311|FG000|Overall Study|Unable to Classify|0
7790169|NCT01018732|12243312|FG001|Overall Study|Unable to Classify|0
7790170|NCT01018732|12243313|FG002|Overall Study|Unable to Classify|1
7790171|NCT01018862|12243324|FG000|Overall Study|Adverse Event|2
7790172|NCT01018862|12243325|FG001|Overall Study|Adverse Event|0
7790173|NCT01018862|12243326|FG002|Overall Study|Adverse Event|6
7790174|NCT01018862|12243324|FG000|Overall Study|Lack of Efficacy|1
7790175|NCT01018862|12243325|FG001|Overall Study|Lack of Efficacy|0
7790176|NCT01018862|12243326|FG002|Overall Study|Lack of Efficacy|2
7790177|NCT01018862|12243324|FG000|Overall Study|Lost to Follow-up|3
7790178|NCT01018862|12243325|FG001|Overall Study|Lost to Follow-up|1
7790179|NCT01018862|12243326|FG002|Overall Study|Lost to Follow-up|0
7790180|NCT01018862|12243324|FG000|Overall Study|Protocol Violation|1
7790181|NCT01018862|12243325|FG001|Overall Study|Protocol Violation|3
7790182|NCT01018862|12243326|FG002|Overall Study|Protocol Violation|3
7790183|NCT01018862|12243324|FG000|Overall Study|Withdrawal by Subject|1
7790184|NCT01018862|12243325|FG001|Overall Study|Withdrawal by Subject|2
7790185|NCT01018862|12243326|FG002|Overall Study|Withdrawal by Subject|1
7790186|NCT01018862|12243324|FG000|Overall Study|administrative problems|5
7790187|NCT01018862|12243325|FG001|Overall Study|administrative problems|4
7790188|NCT01018862|12243326|FG002|Overall Study|administrative problems|4
7790189|NCT01018953|12243334|FG000|Overall Study|Adverse Event|2
7790190|NCT01018953|12243334|FG000|Overall Study|Withdrawal by Subject|1
7790191|NCT01018953|12243334|FG000|Overall Study|Study termination by sponsor|5
7790192|NCT01018979|12243341|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
7790193|NCT01018979|12243342|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
7790194|NCT01018979|12243341|FG000|Overall Study|Not received at least one dose|0
7790195|NCT01018979|12243342|FG001|Overall Study|Not received at least one dose|1
7790196|NCT01018992|12243353|FG000|Overall Study|Adverse Event|8
7790197|NCT01018992|12243354|FG001|Overall Study|Adverse Event|3
7790198|NCT01018992|12243353|FG000|Overall Study|Withdrawal by Subject|3
7790199|NCT01018992|12243354|FG001|Overall Study|Withdrawal by Subject|8
7790200|NCT01018992|12243353|FG000|Overall Study|Protocol Violation|0
7790201|NCT01018992|12243354|FG001|Overall Study|Protocol Violation|4
7790202|NCT01018992|12243353|FG000|Overall Study|Lost to Follow-up|5
7790203|NCT01018992|12243354|FG001|Overall Study|Lost to Follow-up|1
7790204|NCT01019135|12243363|FG000|Overall Study|Did not receive allocated intervention|12
7790205|NCT01019135|12243364|FG001|Overall Study|Did not receive allocated intervention|6
7790206|NCT01019135|12243365|FG002|Overall Study|Did not receive allocated intervention|25
7790207|NCT01019135|12243363|FG000|Overall Study|Did not attend CR|8
7790208|NCT01019135|12243364|FG001|Overall Study|Did not attend CR|13
7790209|NCT01019135|12243365|FG002|Overall Study|Did not attend CR|6
7800573|NCT01096667|12258144|FG004|Overall Study|Reason not available|0
7800574|NCT01096667|12258140|FG000|Overall Study|Protocol Violation|0
7800575|NCT01096667|12258141|FG001|Overall Study|Protocol Violation|0
7800576|NCT01096667|12258142|FG002|Overall Study|Protocol Violation|0
7800577|NCT01096667|12258143|FG003|Overall Study|Protocol Violation|1
7800578|NCT01096667|12258144|FG004|Overall Study|Protocol Violation|0
7800579|NCT01096667|12258140|FG000|Overall Study|Not treated|1
7800580|NCT01096667|12258141|FG001|Overall Study|Not treated|0
7800581|NCT01096667|12258142|FG002|Overall Study|Not treated|0
7800582|NCT01096667|12258143|FG003|Overall Study|Not treated|0
7800583|NCT01096667|12258144|FG004|Overall Study|Not treated|0
7800584|NCT01096784|12258189|FG000|Overall Study|Withdrawal by Subject|2
7800585|NCT01096784|12258190|FG001|Overall Study|Withdrawal by Subject|1
7800586|NCT01096784|12258189|FG000|Overall Study|Adverse Event|11
7800587|NCT01096784|12258190|FG001|Overall Study|Adverse Event|9
7800588|NCT01096784|12258189|FG000|Overall Study|Protocol Deviation|2
7800589|NCT01096784|12258190|FG001|Overall Study|Protocol Deviation|2
7800590|NCT01096784|12258189|FG000|Overall Study|Administrative Decision|0
7622748|NCT02375672|12033618|FG000|Overall Study|remain on follow up|20
7622749|NCT02329327|12033624|FG000|Overall Study|Death|78
7622750|NCT02329327|12033625|FG001|Overall Study|Death|0
7622751|NCT02329327|12033624|FG000|Overall Study|Withdrawal by Subject|3
7622752|NCT02329327|12033625|FG001|Overall Study|Withdrawal by Subject|0
7622753|NCT02329327|12033624|FG000|Overall Study|Lost to Follow-up|4
7622754|NCT02329327|12033625|FG001|Overall Study|Lost to Follow-up|0
7622755|NCT01566149|12033683|FG000|Overall Study|Adverse Event|0
7622756|NCT01566149|12033684|FG001|Overall Study|Adverse Event|1
7622757|NCT01566149|12033683|FG000|Overall Study|Non-compliance with study medication|2
7622758|NCT01566149|12033684|FG001|Overall Study|Non-compliance with study medication|0
7622759|NCT01566149|12033683|FG000|Overall Study|Protocol Violation|0
7622760|NCT01566149|12033684|FG001|Overall Study|Protocol Violation|1
7622761|NCT01566149|12033683|FG000|Overall Study|Withdrawal by Subject|1
7622762|NCT01566149|12033684|FG001|Overall Study|Withdrawal by Subject|0
7622763|NCT01386125|12033701|FG000|Overall Study|Lost to Follow-up|3
7800591|NCT01096784|12258190|FG001|Overall Study|Administrative Decision|1
7800592|NCT01096784|12258189|FG000|Overall Study|Other Unspecified|0
7800593|NCT01096784|12258190|FG001|Overall Study|Other Unspecified|1
7622764|NCT01386125|12033702|FG001|Overall Study|Lost to Follow-up|9
7622765|NCT01386125|12033701|FG000|Overall Study|Physician Decision|0
7622766|NCT01386125|12033702|FG001|Overall Study|Physician Decision|1
7800594|NCT01096849|12258214|FG000|Overall Study|Consent Withdrawn|1
7800595|NCT01096849|12258215|FG001|Overall Study|Consent Withdrawn|4
7800596|NCT01096849|12258216|FG002|Overall Study|Consent Withdrawn|2
7800597|NCT01096849|12258214|FG000|Overall Study|Lack of Efficacy|0
7800598|NCT01096849|12258215|FG001|Overall Study|Lack of Efficacy|2
7800599|NCT01096849|12258216|FG002|Overall Study|Lack of Efficacy|0
7790210|NCT01019252|12243375|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2
7790211|NCT01019252|12243376|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0
7790212|NCT01019252|12243375|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
7790213|NCT01019252|12243376|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
7790214|NCT01019252|12243375|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0
7790215|NCT01019252|12243376|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2
7790216|NCT01019252|12243375|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
7790217|NCT01019252|12243376|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
7790218|NCT01019317|12243382|FG000|Overall Study|Not Eligible|4
7790219|NCT01019369|12243388|FG000|Overall Study|Lost to Follow-up|10
7790220|NCT01019369|12243389|FG001|Overall Study|Lost to Follow-up|6
7790221|NCT01019369|12243388|FG000|Overall Study|Withdrawal by Subject|0
7790222|NCT01019369|12243389|FG001|Overall Study|Withdrawal by Subject|1
7790223|NCT01019486|12243399|FG000|Overall Study|Withdrawal by Subject|1
7790224|NCT01019486|12243400|FG001|Overall Study|Withdrawal by Subject|1
7790225|NCT01019486|12243401|FG002|Overall Study|Withdrawal by Subject|1
7790226|NCT01019694|12243413|FG000|Overall Study|Adverse Event|12
7790227|NCT01019694|12243414|FG001|Overall Study|Adverse Event|16
7790228|NCT01019694|12243415|FG002|Overall Study|Adverse Event|19
7790229|NCT01019694|12243413|FG000|Overall Study|Protocol Violation|2
7790230|NCT01019694|12243414|FG001|Overall Study|Protocol Violation|6
7790231|NCT01019694|12243415|FG002|Overall Study|Protocol Violation|4
7790232|NCT01019694|12243413|FG000|Overall Study|Lost to Follow-up|5
7790233|NCT01019694|12243414|FG001|Overall Study|Lost to Follow-up|3
7790234|NCT01019694|12243415|FG002|Overall Study|Lost to Follow-up|3
7790235|NCT01019694|12243413|FG000|Overall Study|Withdrawal by Subject|4
7790236|NCT01019694|12243414|FG001|Overall Study|Withdrawal by Subject|6
7790237|NCT01019694|12243415|FG002|Overall Study|Withdrawal by Subject|12
7790238|NCT01019694|12243413|FG000|Overall Study|Not treated|0
7790239|NCT01019694|12243414|FG001|Overall Study|Not treated|2
7790240|NCT01019694|12243415|FG002|Overall Study|Not treated|3
7790241|NCT01019694|12243413|FG000|Overall Study|Other reason (not specified)|1
7790242|NCT01019694|12243414|FG001|Overall Study|Other reason (not specified)|5
7790243|NCT01019694|12243415|FG002|Overall Study|Other reason (not specified)|6
7790244|NCT01020019|12243454|FG000|Overall Study|Lost to Follow-up|21
7790245|NCT01020019|12243455|FG001|Overall Study|Lost to Follow-up|18
7790246|NCT01020019|12243454|FG000|Overall Study|Adverse Event|1
7790247|NCT01020019|12243455|FG001|Overall Study|Adverse Event|5
7790248|NCT01020019|12243454|FG000|Overall Study|not interested in treatment|4
7790249|NCT01020019|12243455|FG001|Overall Study|not interested in treatment|4
7790250|NCT01020019|12243454|FG000|Overall Study|moving|0
7790251|NCT01020019|12243455|FG001|Overall Study|moving|2
7790252|NCT01020123|12243468|FG000|Main Period|Withdrawal by Subject|6
7790253|NCT01020123|12243469|FG001|Main Period|Withdrawal by Subject|5
7790254|NCT01020123|12243470|FG002|Main Period|Withdrawal by Subject|3
7790255|NCT01020123|12243471|FG003|Main Period|Withdrawal by Subject|1
7790256|NCT01020123|12243472|FG004|Main Period|Withdrawal by Subject|6
7790257|NCT01020123|12243473|FG005|Main Period|Withdrawal by Subject|3
7790258|NCT01020123|12243474|FG006|Main Period|Withdrawal by Subject|2
7790259|NCT01020123|12243468|FG000|Main Period|Eligibility Criteria not fullfilled|0
7790260|NCT01020123|12243469|FG001|Main Period|Eligibility Criteria not fullfilled|1
7790261|NCT01020123|12243470|FG002|Main Period|Eligibility Criteria not fullfilled|0
7790262|NCT01020123|12243471|FG003|Main Period|Eligibility Criteria not fullfilled|0
7790263|NCT01020123|12243472|FG004|Main Period|Eligibility Criteria not fullfilled|1
7790264|NCT01020123|12243473|FG005|Main Period|Eligibility Criteria not fullfilled|0
7790265|NCT01020123|12243474|FG006|Main Period|Eligibility Criteria not fullfilled|0
7790266|NCT01020123|12243468|FG000|Main Period|Adverse Event|5
7790267|NCT01020123|12243469|FG001|Main Period|Adverse Event|2
7790268|NCT01020123|12243470|FG002|Main Period|Adverse Event|2
7790269|NCT01020123|12243471|FG003|Main Period|Adverse Event|1
7790270|NCT01020123|12243472|FG004|Main Period|Adverse Event|1
7790271|NCT01020123|12243473|FG005|Main Period|Adverse Event|2
7790272|NCT01020123|12243474|FG006|Main Period|Adverse Event|1
7790273|NCT01020123|12243468|FG000|Main Period|Protocol Violation|4
7790274|NCT01020123|12243469|FG001|Main Period|Protocol Violation|4
7790275|NCT01020123|12243470|FG002|Main Period|Protocol Violation|2
7790276|NCT01020123|12243471|FG003|Main Period|Protocol Violation|5
7790277|NCT01020123|12243472|FG004|Main Period|Protocol Violation|2
7790278|NCT01020123|12243473|FG005|Main Period|Protocol Violation|3
7790279|NCT01020123|12243474|FG006|Main Period|Protocol Violation|2
7790280|NCT01020123|12243468|FG000|Main Period|Lost to Follow-up|0
7790281|NCT01020123|12243469|FG001|Main Period|Lost to Follow-up|2
7790282|NCT01020123|12243470|FG002|Main Period|Lost to Follow-up|0
7790283|NCT01020123|12243471|FG003|Main Period|Lost to Follow-up|0
7790284|NCT01020123|12243472|FG004|Main Period|Lost to Follow-up|0
7790285|NCT01020123|12243473|FG005|Main Period|Lost to Follow-up|0
7790286|NCT01020123|12243474|FG006|Main Period|Lost to Follow-up|0
7790287|NCT01020123|12243468|FG000|Main Period|Unclasified|2
7790288|NCT01020123|12243469|FG001|Main Period|Unclasified|0
7790289|NCT01020123|12243470|FG002|Main Period|Unclasified|1
7790290|NCT01020123|12243471|FG003|Main Period|Unclasified|0
7790291|NCT01020123|12243472|FG004|Main Period|Unclasified|1
7790292|NCT01020123|12243473|FG005|Main Period|Unclasified|3
7790293|NCT01020123|12243474|FG006|Main Period|Unclasified|6
7790294|NCT01020123|12243468|FG000|Extention Period|Withdrawal by Subject|2
7790295|NCT01020123|12243469|FG001|Extention Period|Withdrawal by Subject|1
7790296|NCT01020123|12243470|FG002|Extention Period|Withdrawal by Subject|1
7790297|NCT01020123|12243471|FG003|Extention Period|Withdrawal by Subject|0
7790298|NCT01020123|12243472|FG004|Extention Period|Withdrawal by Subject|0
7790299|NCT01020123|12243473|FG005|Extention Period|Withdrawal by Subject|0
7790300|NCT01020123|12243474|FG006|Extention Period|Withdrawal by Subject|0
7790301|NCT01020123|12243468|FG000|Extention Period|Adverse Event|0
7790302|NCT01020123|12243469|FG001|Extention Period|Adverse Event|0
7790303|NCT01020123|12243470|FG002|Extention Period|Adverse Event|0
7790304|NCT01020123|12243471|FG003|Extention Period|Adverse Event|1
7790305|NCT01020123|12243472|FG004|Extention Period|Adverse Event|0
7790306|NCT01020123|12243473|FG005|Extention Period|Adverse Event|0
7790307|NCT01020123|12243474|FG006|Extention Period|Adverse Event|0
7790308|NCT01020123|12243468|FG000|Extention Period|Protocol Violation|1
7790309|NCT01020123|12243469|FG001|Extention Period|Protocol Violation|1
7790310|NCT01020123|12243470|FG002|Extention Period|Protocol Violation|1
7790311|NCT01020123|12243471|FG003|Extention Period|Protocol Violation|0
7790312|NCT01020123|12243472|FG004|Extention Period|Protocol Violation|0
7790313|NCT01020123|12243473|FG005|Extention Period|Protocol Violation|0
7790314|NCT01020123|12243474|FG006|Extention Period|Protocol Violation|1
7790315|NCT01020123|12243468|FG000|Extention Period|Lost to Follow-up|0
7790316|NCT01020123|12243469|FG001|Extention Period|Lost to Follow-up|0
7790317|NCT01020123|12243470|FG002|Extention Period|Lost to Follow-up|0
7790318|NCT01020123|12243471|FG003|Extention Period|Lost to Follow-up|0
7790319|NCT01020123|12243472|FG004|Extention Period|Lost to Follow-up|0
7790320|NCT01020123|12243473|FG005|Extention Period|Lost to Follow-up|2
7790321|NCT01020123|12243474|FG006|Extention Period|Lost to Follow-up|0
7790322|NCT01020305|12243491|FG000|Overall Study|Adverse Event|2
7790323|NCT01020435|12243497|FG000|Overall Study|Lost to Follow-up|0
7790324|NCT01020435|12243498|FG001|Overall Study|Lost to Follow-up|1
7790325|NCT01020448|12243505|FG000|Pre-assignment|Adverse Event|6
7790326|NCT01020448|12243505|FG000|Pre-assignment|Withdrawal by Subject|5
7790327|NCT01020448|12243505|FG000|Pre-assignment|Does Not Meet Entry Criteria|2
7790328|NCT01020448|12243505|FG000|Treatment|Adverse Event|11
7790329|NCT01020448|12243505|FG000|Treatment|Consent Withdrawn|3
7790330|NCT01020448|12243505|FG000|Treatment|Disease Progression|2
7622767|NCT01386125|12033701|FG000|Overall Study|Protocol Violation|5
7622768|NCT01386125|12033702|FG001|Overall Study|Protocol Violation|7
7622769|NCT01386125|12033701|FG000|Overall Study|Disease Progress|1
7622770|NCT01386125|12033702|FG001|Overall Study|Disease Progress|2
7622771|NCT01386125|12033701|FG000|Overall Study|Withdrawal by Subject|13
7622772|NCT01386125|12033702|FG001|Overall Study|Withdrawal by Subject|12
7622773|NCT01386125|12033701|FG000|Overall Study|Adverse Event|2
7622774|NCT01386125|12033702|FG001|Overall Study|Adverse Event|5
7622775|NCT01386125|12033701|FG000|Overall Study|Lack of Efficacy|0
7622776|NCT01386125|12033702|FG001|Overall Study|Lack of Efficacy|1
7622777|NCT01386125|12033701|FG000|Overall Study|Participant Leaving Country|1
7622778|NCT01386125|12033702|FG001|Overall Study|Participant Leaving Country|0
7622779|NCT01257568|12033708|FG000|Overall Study|Lost to Follow-up|2
7622780|NCT01257568|12033708|FG000|Overall Study|Withdrawal by Subject|6
7622781|NCT01257568|12033708|FG000|Overall Study|Terminated|1
7622782|NCT01257568|12033708|FG000|Overall Study|Component Revision|24
7622783|NCT01165424|12033714|FG000|Overall Study|Clinical adverse experiences|1
7622784|NCT01165424|12033714|FG000|Overall Study|Laboratory adverse experiences|1
7622785|NCT01165424|12033714|FG000|Overall Study|Did not meet entry criteria|1
7622786|NCT01165424|12033714|FG000|Overall Study|Participant moved (relocated)|1
7622787|NCT01135134|12033720|FG000|Overall Study|Adverse Event|1
7622788|NCT01135134|12033721|FG001|Overall Study|Adverse Event|1
7622789|NCT01135134|12033720|FG000|Overall Study|Did not meet protocol eligibility|1
7622790|NCT01135134|12033721|FG001|Overall Study|Did not meet protocol eligibility|0
7622791|NCT00867165|12033729|FG000|Overall Study|Adverse Event|3
7622792|NCT00867165|12033730|FG001|Overall Study|Adverse Event|0
7622793|NCT00867165|12033729|FG000|Overall Study|Withdrawal by Subject|1
7622794|NCT00867165|12033730|FG001|Overall Study|Withdrawal by Subject|0
7622795|NCT00733005|12033738|FG000|Overall Study|Adverse Event|0
7622796|NCT00733005|12033739|FG001|Overall Study|Adverse Event|1
7622797|NCT00733005|12033738|FG000|Overall Study|Treatment Failure|0
7622798|NCT00733005|12033739|FG001|Overall Study|Treatment Failure|1
7622799|NCT00733005|12033738|FG000|Overall Study|Withdrawal by Subject|0
7622800|NCT00733005|12033739|FG001|Overall Study|Withdrawal by Subject|1
7622801|NCT00733005|12033738|FG000|Overall Study|Protocol Violation|2
7622802|NCT00733005|12033739|FG001|Overall Study|Protocol Violation|0
7622803|NCT00732381|12033747|FG000|Overall Study|Adverse Event|1
7622804|NCT00732381|12033748|FG001|Overall Study|Adverse Event|0
7622805|NCT00732381|12033747|FG000|Overall Study|Treatment Failure|1
7622806|NCT00732381|12033748|FG001|Overall Study|Treatment Failure|1
7790331|NCT01020448|12243505|FG000|Treatment|Lack of Efficacy|8
7790332|NCT01020448|12243505|FG000|Treatment|Lost to Follow-up|2
7790333|NCT01020474|12243512|FG000|Overall Study|Adverse Event|4
7622807|NCT00654095|12033754|FG000|Overall Study|Drop in low density lipoprotein (1)|2
7622808|NCT00654095|12033754|FG000|Overall Study|Elevated triglyceride level (2)|1
7622809|NCT00654095|12033754|FG000|Overall Study|Elevated alanine aminotransferase (3)|1
7622810|NCT00654095|12033754|FG000|Overall Study|Adverse Event|11
7790334|NCT01020474|12243513|FG001|Overall Study|Adverse Event|4
7790335|NCT01020474|12243512|FG000|Overall Study|Protocol Violation|0
7790336|NCT01020474|12243513|FG001|Overall Study|Protocol Violation|2
7790337|NCT01020474|12243512|FG000|Overall Study|Withdrawal by Subject|5
7790338|NCT01020474|12243513|FG001|Overall Study|Withdrawal by Subject|7
7790339|NCT01020474|12243512|FG000|Overall Study|Other Reasons|1
7790340|NCT01020474|12243513|FG001|Overall Study|Other Reasons|1
7790341|NCT01020474|12243512|FG000|Overall Study|Insufficient Clinical Response|0
7790342|NCT01020474|12243513|FG001|Overall Study|Insufficient Clinical Response|3
7790343|NCT01020487|12243522|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0
7790344|NCT01020487|12243523|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2
7790345|NCT01020487|12243524|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1
7790346|NCT01020487|12243522|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
7790347|NCT01020487|12243523|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
7790348|NCT01020487|12243524|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
7790349|NCT01020487|12243522|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
7790350|NCT01020487|12243523|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
7790351|NCT01020487|12243524|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
7790352|NCT01020487|12243522|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0
7790353|NCT01020487|12243523|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0
7790354|NCT01020487|12243524|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1
7790355|NCT01020487|12243522|FG000|Part 2 Open-label Period|Adverse Event|0
7790356|NCT01020487|12243523|FG001|Part 2 Open-label Period|Adverse Event|4
7790357|NCT01020487|12243524|FG002|Part 2 Open-label Period|Adverse Event|1
7790358|NCT01020526|12243534|FG000|Overall Study|Withdrawal by Subject|5
7790359|NCT01020526|12243534|FG000|Overall Study|Other reasons|3
7790360|NCT01020526|12243534|FG000|Overall Study|Insufficient clinical response|3
7790361|NCT01020526|12243534|FG000|Overall Study|Lost to Follow-up|1
7790362|NCT01020526|12243534|FG000|Overall Study|Adverse Event|2
7790363|NCT01020747|12243549|FG000|Overall Study|Withdrawal by Subject|1
7790364|NCT01020773|12243556|FG000|Overall Study|Withdrawal by Subject|4
7790365|NCT01020773|12243557|FG001|Overall Study|Withdrawal by Subject|3
7790366|NCT01020786|12243563|FG000|Induction Period|Entry Criteria Not Met|2
7790367|NCT01020786|12243563|FG000|Induction Period|Adverse Event|10
7790368|NCT01020786|12243563|FG000|Induction Period|Progressive Disease|31
7790369|NCT01020786|12243563|FG000|Induction Period|Investigator Decision|3
7790370|NCT01020786|12243563|FG000|Induction Period|Withdrawal by Subject|3
7790371|NCT01020786|12243563|FG000|Maintenance Period|Adverse Event|8
7790372|NCT01020786|12243563|FG000|Maintenance Period|Progressive Disease|43
7790373|NCT01020786|12243563|FG000|Maintenance Period|Withdrawal by Subject|8
7790374|NCT01020786|12243563|FG000|Maintenance Period|Sponsor Decision|1
7790375|NCT01020799|12243571|FG000|Overall Study|Adverse Event|4
7790376|NCT01020799|12243572|FG001|Overall Study|Adverse Event|3
7790377|NCT01020799|12243573|FG002|Overall Study|Adverse Event|2
7790378|NCT01020799|12243571|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4
7790379|NCT01020799|12243572|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3
7790380|NCT01020799|12243573|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0
7790381|NCT01020799|12243571|FG000|Overall Study|Protocol Violation|3
7622811|NCT00654095|12033754|FG000|Overall Study|Withdrawal by Subject|5
7622812|NCT00654095|12033754|FG000|Overall Study|Elevated alanine aminotransferase (4)|7
7622813|NCT00654095|12033754|FG000|Overall Study|Adverse reaction did not improve (5)|4
7622814|NCT00654095|12033754|FG000|Overall Study|Did not meet inclusion criteria|1
7622815|NCT00653523|12033758|FG000|Overall Study|Drop in low density lipoprotein (1)|2
7622816|NCT00653523|12033758|FG000|Overall Study|Elevated creatine phosphokinase (2)|1
7622817|NCT00653523|12033758|FG000|Overall Study|Adverse Event|7
7622818|NCT00653523|12033758|FG000|Overall Study|Withdrawal by Subject|6
7622819|NCT00653523|12033758|FG000|Overall Study|Elevated alanine aminotransferase (3)|2
7622820|NCT00653523|12033758|FG000|Overall Study|Adverse reaction did not improve (4)|1
7790382|NCT01020799|12243572|FG001|Overall Study|Protocol Violation|2
7790383|NCT01020799|12243573|FG002|Overall Study|Protocol Violation|0
7790384|NCT01020799|12243571|FG000|Overall Study|Withdrawal by Subject|2
7790385|NCT01020799|12243572|FG001|Overall Study|Withdrawal by Subject|2
7790386|NCT01020799|12243573|FG002|Overall Study|Withdrawal by Subject|3
7790387|NCT01020799|12243571|FG000|Overall Study|Lost to Follow-up|6
7790388|NCT01020799|12243572|FG001|Overall Study|Lost to Follow-up|4
7790389|NCT01020799|12243573|FG002|Overall Study|Lost to Follow-up|2
7790390|NCT01020812|12243581|FG000|Overall Study|Physician Decision|1
7790391|NCT01020812|12243581|FG000|Overall Study|Withdrawal by Subject|1
7790392|NCT01020812|12243581|FG000|Overall Study|Protocol Violation|1
7790393|NCT01020838|12243585|FG000|Overall Study|Death|90
7790394|NCT01020838|12243585|FG000|Overall Study|Adverse Event|1
7790395|NCT01020838|12243585|FG000|Overall Study|Withdrawal by Subject|9
7790396|NCT01020838|12243585|FG000|Overall Study|Lost to Follow-up|6
7790397|NCT01020838|12243585|FG000|Overall Study|Most common: Study ended by sponsor|77
7790398|NCT01020877|12243600|FG000|Second Intervention|Withdrawal by Subject|1
7790399|NCT01020877|12243601|FG001|Second Intervention|Withdrawal by Subject|0
7790400|NCT01020981|12243609|FG000|Overall Study|Did not return mailed survey|74
7790401|NCT01020981|12243610|FG001|Overall Study|Did not return mailed survey|58
7790402|NCT01020981|12243609|FG000|Overall Study|Survey returned undeliverable|8
7622821|NCT00599027|12033764|FG000|Overall Study|Withdrawal by Subject|1
7790403|NCT01020981|12243610|FG001|Overall Study|Survey returned undeliverable|32
7790404|NCT01020981|12243609|FG000|Overall Study|Participant declined to complete survey|2
7790405|NCT01020981|12243610|FG001|Overall Study|Participant declined to complete survey|0
7790406|NCT01021007|12243620|FG000|Overall Study|Lost to Follow-up|1
7790407|NCT01021007|12243621|FG001|Overall Study|Lost to Follow-up|1
7790408|NCT01021007|12243620|FG000|Overall Study|Adverse Event|1
7790409|NCT01021007|12243621|FG001|Overall Study|Adverse Event|3
7790410|NCT01021020|12243627|FG000|Period I|Protocol Violation|1
7790411|NCT01021020|12243627|FG000|Period I|Withdrawal by Subject|1
7790412|NCT01021020|12243627|FG000|14 Day Washout Period A|Physician Decision|1
7790413|NCT01021137|12243647|FG000|Overall Study|Lost to Follow-up|9
7790414|NCT01021137|12243648|FG001|Overall Study|Lost to Follow-up|4
7790415|NCT01021137|12243649|FG002|Overall Study|Lost to Follow-up|2
7790416|NCT01021137|12243650|FG003|Overall Study|Lost to Follow-up|6
7790417|NCT01021137|12243647|FG000|Overall Study|Withdrawal by Subject|1
7790418|NCT01021137|12243648|FG001|Overall Study|Withdrawal by Subject|0
7790419|NCT01021137|12243649|FG002|Overall Study|Withdrawal by Subject|0
7790420|NCT01021137|12243650|FG003|Overall Study|Withdrawal by Subject|3
7790421|NCT01021215|12243663|FG000|Overall Study|Lost to Follow-up|3
7790422|NCT01021215|12243664|FG001|Overall Study|Lost to Follow-up|0
7800600|NCT01096849|12258214|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0
7800601|NCT01096849|12258215|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1
7800602|NCT01096849|12258216|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1
7800603|NCT01096849|12258214|FG000|Overall Study|Investigator or Medical Monitor Decision|0
7800604|NCT01096849|12258215|FG001|Overall Study|Investigator or Medical Monitor Decision|1
7800605|NCT01096849|12258216|FG002|Overall Study|Investigator or Medical Monitor Decision|0
7800606|NCT01096849|12258214|FG000|Overall Study|Administrative Reasons|0
7800607|NCT01096849|12258215|FG001|Overall Study|Administrative Reasons|1
7800608|NCT01096849|12258216|FG002|Overall Study|Administrative Reasons|2
7800609|NCT01096849|12258214|FG000|Overall Study|Lost to Follow-up|1
7800610|NCT01096849|12258215|FG001|Overall Study|Lost to Follow-up|3
7800611|NCT01096849|12258216|FG002|Overall Study|Lost to Follow-up|1
7800612|NCT01097044|12258259|FG000|Overall Study|Withdrawal by Subject|4
7800613|NCT01097044|12258260|FG001|Overall Study|Withdrawal by Subject|4
7800614|NCT01097044|12258259|FG000|Overall Study|Lost to Follow-up|1
7800615|NCT01097044|12258260|FG001|Overall Study|Lost to Follow-up|0
7800616|NCT01097044|12258259|FG000|Overall Study|Withdrawal by Sponsor|0
7800617|NCT01097044|12258260|FG001|Overall Study|Withdrawal by Sponsor|1
7800618|NCT01097057|12258268|FG000|Overall Study|Physician Decision|3
7800619|NCT01097330|12258279|FG000|Overall Study|Study terminated early|7
7800620|NCT01097330|12258280|FG001|Overall Study|Study terminated early|5
7800621|NCT01097421|12258302|FG000|Overall Study|Adverse Event|8
7800622|NCT01097421|12258302|FG000|Overall Study|Protocol Violation|2
7800623|NCT01097421|12258302|FG000|Overall Study|Lost to Follow-up|1
7800624|NCT01097421|12258302|FG000|Overall Study|Withdrawal by Subject|3
7800625|NCT01097577|12258312|FG000|Overall Study|Adverse Event|0
7800626|NCT01097577|12258313|FG001|Overall Study|Adverse Event|1
7800627|NCT01097616|12258322|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
7800628|NCT01097616|12258323|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
7800629|NCT01097616|12258324|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
7800630|NCT01097616|12258325|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7800631|NCT01097616|12258326|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7800632|NCT01097616|12258327|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7800633|NCT01097616|12258328|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7800634|NCT01097616|12258329|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7800635|NCT01097616|12258322|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
7800636|NCT01097616|12258323|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
7800637|NCT01097616|12258324|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
7800638|NCT01097616|12258325|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7800639|NCT01097616|12258326|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7800640|NCT01097616|12258327|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7800641|NCT01097616|12258328|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7800642|NCT01097616|12258329|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7800643|NCT01097616|12258322|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
7800644|NCT01097616|12258323|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
7800645|NCT01097616|12258324|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
7800646|NCT01097616|12258325|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7800647|NCT01097616|12258326|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7800648|NCT01097616|12258327|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7800649|NCT01097616|12258328|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7800650|NCT01097616|12258329|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7800651|NCT01097616|12258322|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
7800652|NCT01097616|12258323|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
7800653|NCT01097616|12258324|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7800654|NCT01097616|12258325|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7882369|NCT01769508|12381272|FG000|Overall Study|Death|3
7790423|NCT04102501|12243677|FG000|Overall Study|Withdrawal by Subject|7
7790424|NCT04102501|12243678|FG001|Overall Study|Withdrawal by Subject|9
7790425|NCT04102501|12243677|FG000|Overall Study|Adverse Event|1
7790426|NCT04102501|12243678|FG001|Overall Study|Adverse Event|3
7800655|NCT01097616|12258326|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7800656|NCT01097616|12258327|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7800657|NCT01097616|12258328|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7800658|NCT01097616|12258329|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7800659|NCT01097616|12258322|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
7800660|NCT01097616|12258323|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
7800661|NCT01097616|12258324|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
7800662|NCT01097616|12258325|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7800663|NCT01097616|12258326|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7800664|NCT01097616|12258327|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7800665|NCT01097616|12258328|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7800666|NCT01097616|12258329|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7800667|NCT01097616|12258322|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
7800668|NCT01097616|12258323|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
7800669|NCT01097616|12258324|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7800670|NCT01097616|12258325|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7800671|NCT01097616|12258326|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7800672|NCT01097616|12258327|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7800673|NCT01097616|12258328|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7800674|NCT01097616|12258329|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7800675|NCT01097616|12258322|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
7800676|NCT01097616|12258323|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
7800677|NCT01097616|12258324|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7800678|NCT01097616|12258325|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7800679|NCT01097616|12258326|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7800680|NCT01097616|12258327|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7800681|NCT01097616|12258328|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7800682|NCT01097616|12258329|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7800683|NCT01097616|12258322|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7800684|NCT01097616|12258323|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7800685|NCT01097616|12258324|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
7800686|NCT01097616|12258325|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7800687|NCT01097616|12258326|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7800688|NCT01097616|12258327|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7800689|NCT01097616|12258328|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7800690|NCT01097616|12258329|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7800691|NCT01097616|12258322|FG000|Optional DB EXT Phase|Adverse Event|0
7800692|NCT01097616|12258323|FG001|Optional DB EXT Phase|Adverse Event|7
7800693|NCT01097616|12258324|FG002|Optional DB EXT Phase|Adverse Event|2
7800694|NCT01097616|12258325|FG003|Optional DB EXT Phase|Adverse Event|0
7800695|NCT01097616|12258326|FG004|Optional DB EXT Phase|Adverse Event|0
7800696|NCT01097616|12258327|FG005|Optional DB EXT Phase|Adverse Event|0
7800697|NCT01097616|12258328|FG006|Optional DB EXT Phase|Adverse Event|0
7800698|NCT01097616|12258329|FG007|Optional DB EXT Phase|Adverse Event|0
7800699|NCT01097616|12258322|FG000|Optional DB EXT Phase|Withdrawal by Subject|12
7800700|NCT01097616|12258323|FG001|Optional DB EXT Phase|Withdrawal by Subject|6
7800701|NCT01097616|12258324|FG002|Optional DB EXT Phase|Withdrawal by Subject|3
7800702|NCT01097616|12258325|FG003|Optional DB EXT Phase|Withdrawal by Subject|0
7800703|NCT01097616|12258326|FG004|Optional DB EXT Phase|Withdrawal by Subject|0
7800704|NCT01097616|12258327|FG005|Optional DB EXT Phase|Withdrawal by Subject|0
7800705|NCT01097616|12258328|FG006|Optional DB EXT Phase|Withdrawal by Subject|0
7800706|NCT01097616|12258329|FG007|Optional DB EXT Phase|Withdrawal by Subject|0
7622822|NCT00599027|12033765|FG001|Overall Study|Withdrawal by Subject|1
7622823|NCT00599027|12033764|FG000|Overall Study|Adverse Event|0
7622824|NCT00599027|12033765|FG001|Overall Study|Adverse Event|1
7622825|NCT00599027|12033764|FG000|Overall Study|Treatment Failure|0
7622826|NCT00599027|12033765|FG001|Overall Study|Treatment Failure|1
7622827|NCT00552032|12033773|FG000|Overall Study|Withdrawal by Subject|2
7622828|NCT00552032|12033774|FG001|Overall Study|Withdrawal by Subject|2
7622829|NCT00552032|12033773|FG000|Overall Study|Protocol Violation|7
7622830|NCT00552032|12033774|FG001|Overall Study|Protocol Violation|12
7622831|NCT00552032|12033773|FG000|Overall Study|Lost to Follow-up|8
7622832|NCT00552032|12033774|FG001|Overall Study|Lost to Follow-up|5
7622833|NCT00546052|12033780|FG000|Overall Study|Adverse Event|47
7622834|NCT00546052|12033780|FG000|Overall Study|Lost to Follow-up|144
7622835|NCT00546052|12033780|FG000|Overall Study|Protocol Violation|9
7800707|NCT01097616|12258322|FG000|Optional DB EXT Phase|Protocol Violation|0
7800708|NCT01097616|12258323|FG001|Optional DB EXT Phase|Protocol Violation|2
7800709|NCT01097616|12258324|FG002|Optional DB EXT Phase|Protocol Violation|3
7800710|NCT01097616|12258325|FG003|Optional DB EXT Phase|Protocol Violation|0
7622836|NCT00546052|12033780|FG000|Overall Study|Withdrawal by Subject|20
7622837|NCT00546052|12033780|FG000|Overall Study|Non Compliance|7
7790427|NCT03398356|12243721|FG000|Before Treatment|Lost to Follow-up|1
7790428|NCT03398356|12243722|FG001|Before Treatment|Lost to Follow-up|2
7790429|NCT03398356|12243723|FG002|Before Treatment|Lost to Follow-up|0
7790430|NCT03398356|12243721|FG000|Before Treatment|drug intolerance|2
7790431|NCT03398356|12243722|FG001|Before Treatment|drug intolerance|1
7790432|NCT03398356|12243723|FG002|Before Treatment|drug intolerance|0
7790433|NCT03398356|12243721|FG000|Before Treatment|Withdrawal by Subject|0
7790434|NCT03398356|12243722|FG001|Before Treatment|Withdrawal by Subject|5
7790435|NCT03398356|12243723|FG002|Before Treatment|Withdrawal by Subject|0
7790436|NCT03398356|12243721|FG000|Before Treatment|Physician Decision|0
7790437|NCT03398356|12243722|FG001|Before Treatment|Physician Decision|0
7790438|NCT03398356|12243723|FG002|Before Treatment|Physician Decision|11
7790439|NCT03398356|12243721|FG000|After 6 Weeks of Treatment|Physician Decision|0
7790440|NCT03398356|12243722|FG001|After 6 Weeks of Treatment|Physician Decision|2
7790441|NCT03398356|12243723|FG002|After 6 Weeks of Treatment|Physician Decision|0
7790442|NCT03365791|12243731|FG000|Overall Study|Adverse Event|5
7790443|NCT03365791|12243731|FG000|Overall Study|Death|1
7790444|NCT03365791|12243731|FG000|Overall Study|Lost to Follow-up|1
7790445|NCT03365791|12243731|FG000|Overall Study|Physician Decision|9
7790446|NCT03365791|12243731|FG000|Overall Study|Progressive disease|51
7790447|NCT03365791|12243731|FG000|Overall Study|Subject/guardian decision|5
7800711|NCT01097616|12258326|FG004|Optional DB EXT Phase|Protocol Violation|0
7800712|NCT01097616|12258327|FG005|Optional DB EXT Phase|Protocol Violation|0
7800713|NCT01097616|12258328|FG006|Optional DB EXT Phase|Protocol Violation|0
7800714|NCT01097616|12258329|FG007|Optional DB EXT Phase|Protocol Violation|0
7800715|NCT01097616|12258322|FG000|Optional DB EXT Phase|Lost to Follow-up|1
7800716|NCT01097616|12258323|FG001|Optional DB EXT Phase|Lost to Follow-up|5
7800717|NCT01097616|12258324|FG002|Optional DB EXT Phase|Lost to Follow-up|1
7800718|NCT01097616|12258325|FG003|Optional DB EXT Phase|Lost to Follow-up|0
7800719|NCT01097616|12258326|FG004|Optional DB EXT Phase|Lost to Follow-up|0
7800720|NCT01097616|12258327|FG005|Optional DB EXT Phase|Lost to Follow-up|0
7800721|NCT01097616|12258328|FG006|Optional DB EXT Phase|Lost to Follow-up|0
7800722|NCT01097616|12258329|FG007|Optional DB EXT Phase|Lost to Follow-up|0
7800723|NCT01097616|12258322|FG000|Optional DB EXT Phase|Lack of Efficacy|1
7800724|NCT01097616|12258323|FG001|Optional DB EXT Phase|Lack of Efficacy|1
7800725|NCT01097616|12258324|FG002|Optional DB EXT Phase|Lack of Efficacy|1
7800726|NCT01097616|12258325|FG003|Optional DB EXT Phase|Lack of Efficacy|0
7800727|NCT01097616|12258326|FG004|Optional DB EXT Phase|Lack of Efficacy|0
7800728|NCT01097616|12258327|FG005|Optional DB EXT Phase|Lack of Efficacy|0
7800729|NCT01097616|12258328|FG006|Optional DB EXT Phase|Lack of Efficacy|0
7800730|NCT01097616|12258329|FG007|Optional DB EXT Phase|Lack of Efficacy|0
7800731|NCT01097616|12258322|FG000|Optional DB EXT Phase|Physician Decision|1
7800732|NCT01097616|12258323|FG001|Optional DB EXT Phase|Physician Decision|0
7800733|NCT01097616|12258324|FG002|Optional DB EXT Phase|Physician Decision|0
7800734|NCT01097616|12258325|FG003|Optional DB EXT Phase|Physician Decision|0
7800735|NCT01097616|12258326|FG004|Optional DB EXT Phase|Physician Decision|0
7800736|NCT01097616|12258327|FG005|Optional DB EXT Phase|Physician Decision|0
7800737|NCT01097616|12258328|FG006|Optional DB EXT Phase|Physician Decision|0
7800738|NCT01097616|12258329|FG007|Optional DB EXT Phase|Physician Decision|0
7800739|NCT01097616|12258322|FG000|DB RO Phase|Adverse Event|0
7800740|NCT01097616|12258323|FG001|DB RO Phase|Adverse Event|0
7800741|NCT01097616|12258324|FG002|DB RO Phase|Adverse Event|0
7800742|NCT01097616|12258325|FG003|DB RO Phase|Adverse Event|0
7800743|NCT01097616|12258326|FG004|DB RO Phase|Adverse Event|0
7800744|NCT01097616|12258327|FG005|DB RO Phase|Adverse Event|0
7800745|NCT01097616|12258328|FG006|DB RO Phase|Adverse Event|1
7800746|NCT01097616|12258329|FG007|DB RO Phase|Adverse Event|0
7800747|NCT01097616|12258322|FG000|DB RO Phase|Withdrawal by Subject|0
7800748|NCT01097616|12258323|FG001|DB RO Phase|Withdrawal by Subject|0
7800749|NCT01097616|12258324|FG002|DB RO Phase|Withdrawal by Subject|0
7800750|NCT01097616|12258325|FG003|DB RO Phase|Withdrawal by Subject|0
7800751|NCT01097616|12258326|FG004|DB RO Phase|Withdrawal by Subject|0
7800752|NCT01097616|12258327|FG005|DB RO Phase|Withdrawal by Subject|1
7800753|NCT01097616|12258328|FG006|DB RO Phase|Withdrawal by Subject|0
7800754|NCT01097616|12258329|FG007|DB RO Phase|Withdrawal by Subject|0
7800755|NCT01097616|12258322|FG000|DB RO Phase|Lost to Follow-up|0
7800756|NCT01097616|12258323|FG001|DB RO Phase|Lost to Follow-up|0
7800757|NCT01097616|12258324|FG002|DB RO Phase|Lost to Follow-up|0
7800758|NCT01097616|12258325|FG003|DB RO Phase|Lost to Follow-up|1
7800759|NCT01097616|12258326|FG004|DB RO Phase|Lost to Follow-up|1
7800760|NCT01097616|12258327|FG005|DB RO Phase|Lost to Follow-up|0
7800761|NCT01097616|12258328|FG006|DB RO Phase|Lost to Follow-up|0
7800762|NCT01097616|12258329|FG007|DB RO Phase|Lost to Follow-up|1
7800763|NCT01097616|12258322|FG000|DB RO Phase|Not Treated in RO|0
7800764|NCT01097616|12258323|FG001|DB RO Phase|Not Treated in RO|0
7800765|NCT01097616|12258324|FG002|DB RO Phase|Not Treated in RO|0
7800766|NCT01097616|12258325|FG003|DB RO Phase|Not Treated in RO|0
7800767|NCT01097616|12258326|FG004|DB RO Phase|Not Treated in RO|0
7800768|NCT01097616|12258327|FG005|DB RO Phase|Not Treated in RO|1
7800769|NCT01097616|12258328|FG006|DB RO Phase|Not Treated in RO|0
7800770|NCT01097616|12258329|FG007|DB RO Phase|Not Treated in RO|0
7800771|NCT01097629|12258358|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
7800772|NCT01097629|12258359|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
7800773|NCT01097629|12258360|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
7790448|NCT02819440|12243747|FG000|Overall Study|Adverse Event|3
7790449|NCT02819440|12243748|FG001|Overall Study|Adverse Event|1
7790450|NCT02819440|12243747|FG000|Overall Study|Lost to Follow-up|1
7790451|NCT02819440|12243748|FG001|Overall Study|Lost to Follow-up|3
7790452|NCT02819440|12243747|FG000|Overall Study|Withdrawal by Subject|9
7790453|NCT02819440|12243748|FG001|Overall Study|Withdrawal by Subject|8
7790454|NCT02782741|12243756|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0
7790455|NCT02782741|12243757|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4
7790456|NCT02782741|12243756|FG000|Blinded Treatment Period: up to Week 49|Other|0
7790457|NCT02782741|12243757|FG001|Blinded Treatment Period: up to Week 49|Other|1
7790458|NCT02782741|12243756|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2
7790459|NCT02782741|12243757|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1
7790460|NCT02782741|12243756|FG000|Open-label Long-term: Week 50 to 145|Other|1
7790461|NCT02782741|12243757|FG001|Open-label Long-term: Week 50 to 145|Other|0
7790462|NCT02782741|12243756|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48
7622838|NCT00442117|12033789|FG000|Overall Study|Adverse Event|3
7622839|NCT00442117|12033790|FG001|Overall Study|Adverse Event|2
7622840|NCT00442117|12033789|FG000|Overall Study|Lack of Efficacy|2
7622841|NCT00442117|12033790|FG001|Overall Study|Lack of Efficacy|6
7622842|NCT00442117|12033789|FG000|Overall Study|Lost to Follow-up|1
7622843|NCT00442117|12033790|FG001|Overall Study|Lost to Follow-up|2
7622844|NCT00442117|12033789|FG000|Overall Study|Withdrawal by Subject|2
7622845|NCT00442117|12033790|FG001|Overall Study|Withdrawal by Subject|2
7622846|NCT00442117|12033789|FG000|Overall Study|Major Deviation|25
7622847|NCT00442117|12033790|FG001|Overall Study|Major Deviation|20
7622848|NCT00442117|12033789|FG000|Overall Study|Non compliance with protocol|3
7622849|NCT00442117|12033790|FG001|Overall Study|Non compliance with protocol|5
7622850|NCT00442117|12033789|FG000|Overall Study|Met Withdrawal Criteria|2
7622851|NCT00442117|12033790|FG001|Overall Study|Met Withdrawal Criteria|1
7622852|NCT00424008|12033798|FG000|Overall Study|Adverse Event|8
7622853|NCT00424008|12033799|FG001|Overall Study|Adverse Event|6
7622854|NCT00424008|12033798|FG000|Overall Study|Lack of Efficacy|40
7622855|NCT00424008|12033799|FG001|Overall Study|Lack of Efficacy|34
7622856|NCT00424008|12033798|FG000|Overall Study|Lost to Follow-up|1
7622857|NCT00424008|12033799|FG001|Overall Study|Lost to Follow-up|2
7622858|NCT00424008|12033798|FG000|Overall Study|Withdrawal by Subject|5
7622859|NCT00424008|12033799|FG001|Overall Study|Withdrawal by Subject|8
7622860|NCT00424008|12033798|FG000|Overall Study|Noncompliance with protocol|13
7622861|NCT00424008|12033799|FG001|Overall Study|Noncompliance with protocol|7
7622862|NCT00424008|12033798|FG000|Overall Study|Did not meet protocol eligibility|16
7622863|NCT00424008|12033799|FG001|Overall Study|Did not meet protocol eligibility|21
7622864|NCT00424008|12033798|FG000|Overall Study|Administrative|266
7622865|NCT00424008|12033799|FG001|Overall Study|Administrative|257
7622866|NCT00423176|12033808|FG000|Overall Study|Adverse Event|4
7622867|NCT00423176|12033809|FG001|Overall Study|Adverse Event|6
7622868|NCT00423176|12033808|FG000|Overall Study|Treatment Failure|1
7622869|NCT00423176|12033809|FG001|Overall Study|Treatment Failure|6
7622870|NCT00423176|12033808|FG000|Overall Study|Lost to Follow-up|4
7790463|NCT02782741|12243757|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43
7790464|NCT02647359|12243769|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0
7790465|NCT02647359|12243770|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1
7790466|NCT02647359|12243769|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4
7790467|NCT02647359|12243770|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0
7790468|NCT02647359|12243769|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2
7790469|NCT02647359|12243770|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1
7790470|NCT02647359|12243769|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8
7790471|NCT02647359|12243770|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3
7790472|NCT02647359|12243769|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1
7790473|NCT02647359|12243770|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0
7790474|NCT02647359|12243769|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7
7790475|NCT02647359|12243770|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4
7790476|NCT02485691|12243782|FG000|Overall Study|Adverse Event|25
7790477|NCT02485691|12243783|FG001|Overall Study|Adverse Event|11
7790478|NCT02485691|12243782|FG000|Overall Study|Poor compliance to protocol|0
7790479|NCT02485691|12243783|FG001|Overall Study|Poor compliance to protocol|1
7790480|NCT02485691|12243782|FG000|Overall Study|Disease progression|57
7790481|NCT02485691|12243783|FG001|Overall Study|Disease progression|92
7790482|NCT02485691|12243782|FG000|Overall Study|Investigator's decision|23
7790483|NCT02485691|12243783|FG001|Overall Study|Investigator's decision|5
7790484|NCT02485691|12243782|FG000|Overall Study|Participant's request|13
7790485|NCT02485691|12243783|FG001|Overall Study|Participant's request|6
7622871|NCT00423176|12033809|FG001|Overall Study|Lost to Follow-up|7
7622872|NCT00423176|12033808|FG000|Overall Study|Withdrawal by Subject|4
7622873|NCT00423176|12033809|FG001|Overall Study|Withdrawal by Subject|3
7622874|NCT00423176|12033808|FG000|Overall Study|Protocol Violation|1
7622875|NCT00423176|12033809|FG001|Overall Study|Protocol Violation|3
7622876|NCT00423176|12033808|FG000|Overall Study|Did not meet protocol eligibility|2
7622877|NCT00423176|12033809|FG001|Overall Study|Did not meet protocol eligibility|4
7622878|NCT00383240|12033819|FG000|Overall Study|Adverse Event|4
7622879|NCT00383240|12033820|FG001|Overall Study|Adverse Event|6
7622880|NCT00383240|12033821|FG002|Overall Study|Adverse Event|9
7622881|NCT00383240|12033822|FG003|Overall Study|Adverse Event|7
7622882|NCT00383240|12033819|FG000|Overall Study|Treatment Failure|8
7622883|NCT00383240|12033820|FG001|Overall Study|Treatment Failure|13
7622884|NCT00383240|12033821|FG002|Overall Study|Treatment Failure|47
7622885|NCT00383240|12033822|FG003|Overall Study|Treatment Failure|46
7622886|NCT00383240|12033819|FG000|Overall Study|Lost to Follow-up|3
7622887|NCT00383240|12033820|FG001|Overall Study|Lost to Follow-up|0
7622888|NCT00383240|12033821|FG002|Overall Study|Lost to Follow-up|0
7622889|NCT00383240|12033822|FG003|Overall Study|Lost to Follow-up|2
7622890|NCT00383240|12033819|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6
7622891|NCT00383240|12033820|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3
7622892|NCT00383240|12033821|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8
7622893|NCT00383240|12033822|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8
7622894|NCT00383240|12033819|FG000|Overall Study|Withdrawal by subjects, reasons related|0
7622895|NCT00383240|12033820|FG001|Overall Study|Withdrawal by subjects, reasons related|1
7622896|NCT00383240|12033821|FG002|Overall Study|Withdrawal by subjects, reasons related|3
7622897|NCT00383240|12033822|FG003|Overall Study|Withdrawal by subjects, reasons related|5
7790486|NCT02485691|12243782|FG000|Overall Study|Other reason|8
7790487|NCT02485691|12243783|FG001|Overall Study|Other reason|9
7790488|NCT02485691|12243782|FG000|Overall Study|Randomized and not treated|3
7790489|NCT02485691|12243783|FG001|Overall Study|Randomized and not treated|2
7790490|NCT02201251|12243792|FG000|Overall Study|Adverse Event|1
7790491|NCT02201251|12243793|FG001|Overall Study|Adverse Event|1
7790492|NCT02201251|12243792|FG000|Overall Study|Protocol Violation|1
7790493|NCT02201251|12243793|FG001|Overall Study|Protocol Violation|0
7790494|NCT02201251|12243792|FG000|Overall Study|Noncompliance with Study Drug|0
7790495|NCT02201251|12243793|FG001|Overall Study|Noncompliance with Study Drug|1
7790496|NCT02201251|12243792|FG000|Overall Study|Withdrawal by Subject|2
7790497|NCT02201251|12243793|FG001|Overall Study|Withdrawal by Subject|1
7790498|NCT01021293|12243836|FG000|Overall Study|Serious Adverse Event|2
7790499|NCT01021293|12243837|FG001|Overall Study|Serious Adverse Event|1
7790500|NCT01021293|12243836|FG000|Overall Study|Adverse Event|2
7790501|NCT01021293|12243837|FG001|Overall Study|Adverse Event|1
7790502|NCT01021293|12243836|FG000|Overall Study|Withdrawal by Subject|1
7790503|NCT01021293|12243837|FG001|Overall Study|Withdrawal by Subject|3
7790504|NCT01021293|12243836|FG000|Overall Study|Migrated/moved from study area|6
7790505|NCT01021293|12243837|FG001|Overall Study|Migrated/moved from study area|18
7790506|NCT01021293|12243836|FG000|Overall Study|Lost to Follow-up|1
7790507|NCT01021293|12243837|FG001|Overall Study|Lost to Follow-up|1
7790508|NCT01021332|12243861|FG000|Overall Study|Not fulfilling incl./excl.criteria|5
7790509|NCT01021332|12243861|FG000|Overall Study|Adverse Event|43
7790510|NCT01021332|12243861|FG000|Overall Study|Lack of Efficacy|19
7790511|NCT01021332|12243861|FG000|Overall Study|Withdrawal of Consent|23
7790512|NCT01021332|12243861|FG000|Overall Study|Lost to Follow-up|4
7790513|NCT01021332|12243861|FG000|Overall Study|Protocol Violation|9
7622898|NCT00383240|12033819|FG000|Overall Study|Protocol Violation|4
7622899|NCT00383240|12033820|FG001|Overall Study|Protocol Violation|5
7622900|NCT00383240|12033821|FG002|Overall Study|Protocol Violation|9
7790514|NCT01021332|12243861|FG000|Overall Study|Miscellaneous|3
7790515|NCT01021423|12243869|FG000|Overall Study|Study terminated|4
7790516|NCT01021423|12243870|FG001|Overall Study|Study terminated|5
7790517|NCT01021553|12243879|FG000|Overall Study|Adverse Event|1
7790518|NCT01021553|12243880|FG001|Overall Study|Adverse Event|0
7790519|NCT01021553|12243881|FG002|Overall Study|Adverse Event|0
7790520|NCT01021553|12243879|FG000|Overall Study|Lack of Efficacy|2
7790521|NCT01021553|12243880|FG001|Overall Study|Lack of Efficacy|2
7790522|NCT01021553|12243881|FG002|Overall Study|Lack of Efficacy|0
7790523|NCT01021553|12243879|FG000|Overall Study|Protocol Violation|0
7790524|NCT01021553|12243880|FG001|Overall Study|Protocol Violation|2
7790525|NCT01021553|12243881|FG002|Overall Study|Protocol Violation|2
7790526|NCT01021553|12243879|FG000|Overall Study|Lost to Follow-up|0
7790527|NCT01021553|12243880|FG001|Overall Study|Lost to Follow-up|0
7790528|NCT01021553|12243881|FG002|Overall Study|Lost to Follow-up|1
7790529|NCT01021553|12243879|FG000|Overall Study|Withdrawal by Subject|1
7790530|NCT01021553|12243880|FG001|Overall Study|Withdrawal by Subject|1
7790531|NCT01021553|12243881|FG002|Overall Study|Withdrawal by Subject|0
7790532|NCT01021683|12243903|FG000|Overall Study|Lack of Efficacy|12
7790533|NCT01021683|12243903|FG000|Overall Study|Recovery of neutrophil count|51
7790534|NCT01021683|12243903|FG000|Overall Study|Other|8
7790535|NCT01021748|12243916|FG000|Overall Study|Adverse Event|2
7790536|NCT01021748|12243917|FG001|Overall Study|Adverse Event|1
7790537|NCT01021748|12243918|FG002|Overall Study|Adverse Event|2
7790538|NCT01021748|12243919|FG003|Overall Study|Adverse Event|0
7790539|NCT01021748|12243920|FG004|Overall Study|Adverse Event|2
7790540|NCT01021748|12243921|FG005|Overall Study|Adverse Event|0
7790541|NCT01021748|12243922|FG006|Overall Study|Adverse Event|1
7790542|NCT01021748|12243923|FG007|Overall Study|Adverse Event|0
7790543|NCT01021748|12243924|FG008|Overall Study|Adverse Event|7
7790544|NCT01021748|12243916|FG000|Overall Study|Physician Decision|1
7790545|NCT01021748|12243917|FG001|Overall Study|Physician Decision|0
7790546|NCT01021748|12243918|FG002|Overall Study|Physician Decision|1
7790547|NCT01021748|12243919|FG003|Overall Study|Physician Decision|1
7790548|NCT01021748|12243920|FG004|Overall Study|Physician Decision|0
7790549|NCT01021748|12243921|FG005|Overall Study|Physician Decision|0
7790550|NCT01021748|12243922|FG006|Overall Study|Physician Decision|1
7790551|NCT01021748|12243923|FG007|Overall Study|Physician Decision|1
7790552|NCT01021748|12243924|FG008|Overall Study|Physician Decision|2
7790553|NCT01021748|12243916|FG000|Overall Study|Progressive Disease|3
7790554|NCT01021748|12243917|FG001|Overall Study|Progressive Disease|3
7790555|NCT01021748|12243918|FG002|Overall Study|Progressive Disease|4
7790556|NCT01021748|12243919|FG003|Overall Study|Progressive Disease|6
7790557|NCT01021748|12243920|FG004|Overall Study|Progressive Disease|7
7790558|NCT01021748|12243921|FG005|Overall Study|Progressive Disease|3
7790559|NCT01021748|12243922|FG006|Overall Study|Progressive Disease|0
7790560|NCT01021748|12243923|FG007|Overall Study|Progressive Disease|5
7790561|NCT01021748|12243924|FG008|Overall Study|Progressive Disease|6
7790562|NCT01021748|12243916|FG000|Overall Study|Withdrawal by Subject|0
7790563|NCT01021748|12243917|FG001|Overall Study|Withdrawal by Subject|0
7790564|NCT01021748|12243918|FG002|Overall Study|Withdrawal by Subject|0
7790565|NCT01021748|12243919|FG003|Overall Study|Withdrawal by Subject|0
7790566|NCT01021748|12243920|FG004|Overall Study|Withdrawal by Subject|0
7790567|NCT01021748|12243921|FG005|Overall Study|Withdrawal by Subject|0
7622901|NCT00383240|12033822|FG003|Overall Study|Protocol Violation|6
7622902|NCT00383240|12033819|FG000|Overall Study|Did not meet protocol eligibility|9
7622903|NCT00383240|12033820|FG001|Overall Study|Did not meet protocol eligibility|4
7622904|NCT00383240|12033821|FG002|Overall Study|Did not meet protocol eligibility|9
7622905|NCT00383240|12033822|FG003|Overall Study|Did not meet protocol eligibility|3
7622906|NCT00383240|12033819|FG000|Overall Study|Administrative|1
7622907|NCT00383240|12033820|FG001|Overall Study|Administrative|1
7622908|NCT00383240|12033821|FG002|Overall Study|Administrative|0
7622909|NCT00383240|12033822|FG003|Overall Study|Administrative|0
7790568|NCT01021748|12243922|FG006|Overall Study|Withdrawal by Subject|1
7790569|NCT01021748|12243923|FG007|Overall Study|Withdrawal by Subject|0
7790570|NCT01021748|12243924|FG008|Overall Study|Withdrawal by Subject|1
7790571|NCT01021748|12243916|FG000|Overall Study|Not Treated|0
7790572|NCT01021748|12243917|FG001|Overall Study|Not Treated|1
7790573|NCT01021748|12243918|FG002|Overall Study|Not Treated|0
7790574|NCT01021748|12243919|FG003|Overall Study|Not Treated|0
7790575|NCT01021748|12243920|FG004|Overall Study|Not Treated|0
7790576|NCT01021748|12243921|FG005|Overall Study|Not Treated|0
7790577|NCT01021748|12243922|FG006|Overall Study|Not Treated|0
7790578|NCT01021748|12243923|FG007|Overall Study|Not Treated|0
7790579|NCT01021748|12243924|FG008|Overall Study|Not Treated|0
7790580|NCT01021813|12243959|FG000|DB Treatment Phase|Adverse Event|60
7790581|NCT01021813|12243960|FG001|DB Treatment Phase|Adverse Event|22
7790582|NCT01021813|12243961|FG002|DB Treatment Phase|Adverse Event|0
7790583|NCT01021813|12243962|FG003|DB Treatment Phase|Adverse Event|0
7790584|NCT01021813|12243963|FG004|DB Treatment Phase|Adverse Event|0
7790585|NCT01021813|12243959|FG000|DB Treatment Phase|Lack of Efficacy|44
7790586|NCT01021813|12243960|FG001|DB Treatment Phase|Lack of Efficacy|28
7790587|NCT01021813|12243961|FG002|DB Treatment Phase|Lack of Efficacy|0
7790588|NCT01021813|12243962|FG003|DB Treatment Phase|Lack of Efficacy|0
7790589|NCT01021813|12243963|FG004|DB Treatment Phase|Lack of Efficacy|0
7790590|NCT01021813|12243959|FG000|DB Treatment Phase|Lost to Follow-up|14
7790591|NCT01021813|12243960|FG001|DB Treatment Phase|Lost to Follow-up|12
7790592|NCT01021813|12243961|FG002|DB Treatment Phase|Lost to Follow-up|0
7790593|NCT01021813|12243962|FG003|DB Treatment Phase|Lost to Follow-up|0
7790594|NCT01021813|12243963|FG004|DB Treatment Phase|Lost to Follow-up|0
7790595|NCT01021813|12243959|FG000|DB Treatment Phase|Physician Decision|17
7790596|NCT01021813|12243960|FG001|DB Treatment Phase|Physician Decision|8
7790597|NCT01021813|12243961|FG002|DB Treatment Phase|Physician Decision|0
7790598|NCT01021813|12243962|FG003|DB Treatment Phase|Physician Decision|0
7790599|NCT01021813|12243963|FG004|DB Treatment Phase|Physician Decision|0
7790600|NCT01021813|12243959|FG000|DB Treatment Phase|Pregnancy|1
7790601|NCT01021813|12243960|FG001|DB Treatment Phase|Pregnancy|0
7790602|NCT01021813|12243961|FG002|DB Treatment Phase|Pregnancy|0
7790603|NCT01021813|12243962|FG003|DB Treatment Phase|Pregnancy|0
7790604|NCT01021813|12243963|FG004|DB Treatment Phase|Pregnancy|0
7790605|NCT01021813|12243959|FG000|DB Treatment Phase|Protocol Violation|4
7790606|NCT01021813|12243960|FG001|DB Treatment Phase|Protocol Violation|3
7790607|NCT01021813|12243961|FG002|DB Treatment Phase|Protocol Violation|0
7790608|NCT01021813|12243962|FG003|DB Treatment Phase|Protocol Violation|0
7790609|NCT01021813|12243963|FG004|DB Treatment Phase|Protocol Violation|0
7790610|NCT01021813|12243959|FG000|DB Treatment Phase|Withdrawal by Subject|60
7790611|NCT01021813|12243960|FG001|DB Treatment Phase|Withdrawal by Subject|24
7790612|NCT01021813|12243961|FG002|DB Treatment Phase|Withdrawal by Subject|0
7790613|NCT01021813|12243962|FG003|DB Treatment Phase|Withdrawal by Subject|0
7790614|NCT01021813|12243963|FG004|DB Treatment Phase|Withdrawal by Subject|0
7790615|NCT01021813|12243959|FG000|DB Randomized Discontinuation Phase|Adverse Event|0
7790616|NCT01021813|12243960|FG001|DB Randomized Discontinuation Phase|Adverse Event|0
7790617|NCT01021813|12243961|FG002|DB Randomized Discontinuation Phase|Adverse Event|0
7790618|NCT01021813|12243962|FG003|DB Randomized Discontinuation Phase|Adverse Event|3
7790619|NCT01021813|12243963|FG004|DB Randomized Discontinuation Phase|Adverse Event|1
7790620|NCT01021813|12243959|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0
7790621|NCT01021813|12243960|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0
7790622|NCT01021813|12243961|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0
7790623|NCT01021813|12243962|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1
7790624|NCT01021813|12243963|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0
7790625|NCT01021813|12243959|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0
7790626|NCT01021813|12243960|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0
7790627|NCT01021813|12243961|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0
7790628|NCT01021813|12243962|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0
7790629|NCT01021813|12243963|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1
7790630|NCT01021813|12243959|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0
7790631|NCT01021813|12243960|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0
7790632|NCT01021813|12243961|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1
7790633|NCT01021813|12243962|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0
7790634|NCT01021813|12243963|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0
7790635|NCT01021813|12243959|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
7790636|NCT01021813|12243960|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
7790637|NCT01021813|12243961|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
7790638|NCT01021813|12243962|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
7790639|NCT01021813|12243963|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
7790640|NCT01021852|12243988|FG000|Treatment Period 1|Adverse Event|3
7790641|NCT01021852|12243989|FG001|Treatment Period 1|Adverse Event|1
7790642|NCT01021852|12243990|FG002|Treatment Period 1|Adverse Event|1
7790643|NCT01021852|12243991|FG003|Treatment Period 1|Adverse Event|0
7790644|NCT01021852|12243992|FG004|Treatment Period 1|Adverse Event|2
7790645|NCT01021852|12243993|FG005|Treatment Period 1|Adverse Event|2
7790646|NCT01021852|12243994|FG006|Treatment Period 1|Adverse Event|0
7790647|NCT01021852|12243995|FG007|Treatment Period 1|Adverse Event|0
7790648|NCT01021852|12243988|FG000|Treatment Period 1|Pregnancy|0
7790649|NCT01021852|12243989|FG001|Treatment Period 1|Pregnancy|0
7790650|NCT01021852|12243990|FG002|Treatment Period 1|Pregnancy|1
7790651|NCT01021852|12243991|FG003|Treatment Period 1|Pregnancy|0
7790652|NCT01021852|12243992|FG004|Treatment Period 1|Pregnancy|0
7790653|NCT01021852|12243993|FG005|Treatment Period 1|Pregnancy|0
7790654|NCT01021852|12243994|FG006|Treatment Period 1|Pregnancy|0
7790655|NCT01021852|12243995|FG007|Treatment Period 1|Pregnancy|0
7790656|NCT01021852|12243988|FG000|Treatment Period 1|Withdrawal by Subject|0
7790657|NCT01021852|12243989|FG001|Treatment Period 1|Withdrawal by Subject|0
7790658|NCT01021852|12243990|FG002|Treatment Period 1|Withdrawal by Subject|0
7790659|NCT01021852|12243991|FG003|Treatment Period 1|Withdrawal by Subject|0
7790660|NCT01021852|12243992|FG004|Treatment Period 1|Withdrawal by Subject|1
7790661|NCT01021852|12243993|FG005|Treatment Period 1|Withdrawal by Subject|0
7790662|NCT01021852|12243994|FG006|Treatment Period 1|Withdrawal by Subject|0
7790663|NCT01021852|12243995|FG007|Treatment Period 1|Withdrawal by Subject|1
7790664|NCT01021852|12243988|FG000|Treatment Period 1|Not Treated|0
7790665|NCT01021852|12243989|FG001|Treatment Period 1|Not Treated|0
7790666|NCT01021852|12243990|FG002|Treatment Period 1|Not Treated|0
7790667|NCT01021852|12243991|FG003|Treatment Period 1|Not Treated|2
7790668|NCT01021852|12243992|FG004|Treatment Period 1|Not Treated|0
7790669|NCT01021852|12243993|FG005|Treatment Period 1|Not Treated|0
7790670|NCT01021852|12243994|FG006|Treatment Period 1|Not Treated|0
7790671|NCT01021852|12243995|FG007|Treatment Period 1|Not Treated|0
7790672|NCT01021852|12243988|FG000|Washout Period-Placebo|Adverse Event|0
7790673|NCT01021852|12243989|FG001|Washout Period-Placebo|Adverse Event|0
7790674|NCT01021852|12243990|FG002|Washout Period-Placebo|Adverse Event|0
7790675|NCT01021852|12243991|FG003|Washout Period-Placebo|Adverse Event|1
7790676|NCT01021852|12243992|FG004|Washout Period-Placebo|Adverse Event|0
7790677|NCT01021852|12243993|FG005|Washout Period-Placebo|Adverse Event|1
7790678|NCT01021852|12243994|FG006|Washout Period-Placebo|Adverse Event|0
7790679|NCT01021852|12243995|FG007|Washout Period-Placebo|Adverse Event|0
7790680|NCT01021852|12243988|FG000|Washout Period-Placebo|Lost to Follow-up|0
7790681|NCT01021852|12243989|FG001|Washout Period-Placebo|Lost to Follow-up|0
7790682|NCT01021852|12243990|FG002|Washout Period-Placebo|Lost to Follow-up|0
7790683|NCT01021852|12243991|FG003|Washout Period-Placebo|Lost to Follow-up|0
7790684|NCT01021852|12243992|FG004|Washout Period-Placebo|Lost to Follow-up|1
7790685|NCT01021852|12243993|FG005|Washout Period-Placebo|Lost to Follow-up|0
7790686|NCT01021852|12243994|FG006|Washout Period-Placebo|Lost to Follow-up|0
7790687|NCT01021852|12243995|FG007|Washout Period-Placebo|Lost to Follow-up|0
7790688|NCT01021852|12243988|FG000|Washout Period-Placebo|Protocol Violation|0
7790689|NCT01021852|12243989|FG001|Washout Period-Placebo|Protocol Violation|0
7790690|NCT01021852|12243990|FG002|Washout Period-Placebo|Protocol Violation|0
7790691|NCT01021852|12243991|FG003|Washout Period-Placebo|Protocol Violation|0
7790692|NCT01021852|12243992|FG004|Washout Period-Placebo|Protocol Violation|0
7790693|NCT01021852|12243993|FG005|Washout Period-Placebo|Protocol Violation|0
7790694|NCT01021852|12243994|FG006|Washout Period-Placebo|Protocol Violation|1
7790695|NCT01021852|12243995|FG007|Washout Period-Placebo|Protocol Violation|0
7790696|NCT01021852|12243988|FG000|Washout Period-No Drug|Adverse Event|1
7790697|NCT01021852|12243989|FG001|Washout Period-No Drug|Adverse Event|0
7790698|NCT01021852|12243990|FG002|Washout Period-No Drug|Adverse Event|0
7790699|NCT01021852|12243991|FG003|Washout Period-No Drug|Adverse Event|0
7790700|NCT01021852|12243992|FG004|Washout Period-No Drug|Adverse Event|0
7790701|NCT01021852|12243993|FG005|Washout Period-No Drug|Adverse Event|1
7790702|NCT01021852|12243994|FG006|Washout Period-No Drug|Adverse Event|0
7790703|NCT01021852|12243995|FG007|Washout Period-No Drug|Adverse Event|0
7790704|NCT01021852|12243988|FG000|Treatment Period 2|Adverse Event|0
7790705|NCT01021852|12243989|FG001|Treatment Period 2|Adverse Event|1
7790706|NCT01021852|12243990|FG002|Treatment Period 2|Adverse Event|0
7790707|NCT01021852|12243991|FG003|Treatment Period 2|Adverse Event|0
7790708|NCT01021852|12243992|FG004|Treatment Period 2|Adverse Event|1
7790709|NCT01021852|12243993|FG005|Treatment Period 2|Adverse Event|0
7790710|NCT01021852|12243994|FG006|Treatment Period 2|Adverse Event|1
7790711|NCT01021852|12243995|FG007|Treatment Period 2|Adverse Event|0
7790712|NCT01021852|12243988|FG000|Treatment Period 2|Lack of Efficacy|0
7790713|NCT01021852|12243989|FG001|Treatment Period 2|Lack of Efficacy|0
7790714|NCT01021852|12243990|FG002|Treatment Period 2|Lack of Efficacy|0
7790715|NCT01021852|12243991|FG003|Treatment Period 2|Lack of Efficacy|0
7790716|NCT01021852|12243992|FG004|Treatment Period 2|Lack of Efficacy|0
7790717|NCT01021852|12243993|FG005|Treatment Period 2|Lack of Efficacy|1
7790718|NCT01021852|12243994|FG006|Treatment Period 2|Lack of Efficacy|0
7790719|NCT01021852|12243995|FG007|Treatment Period 2|Lack of Efficacy|0
7790720|NCT01021852|12243988|FG000|Treatment Period 2|Physician Decision|0
7790721|NCT01021852|12243989|FG001|Treatment Period 2|Physician Decision|0
7790722|NCT01021852|12243990|FG002|Treatment Period 2|Physician Decision|1
7790723|NCT01021852|12243991|FG003|Treatment Period 2|Physician Decision|0
7790724|NCT01021852|12243992|FG004|Treatment Period 2|Physician Decision|0
7790725|NCT01021852|12243993|FG005|Treatment Period 2|Physician Decision|0
7790726|NCT01021852|12243994|FG006|Treatment Period 2|Physician Decision|0
7790727|NCT01021852|12243995|FG007|Treatment Period 2|Physician Decision|0
7790728|NCT01021852|12243988|FG000|Treatment Period 2|Protocol Violation|0
7790729|NCT01021852|12243989|FG001|Treatment Period 2|Protocol Violation|0
7790730|NCT01021852|12243990|FG002|Treatment Period 2|Protocol Violation|0
7790731|NCT01021852|12243991|FG003|Treatment Period 2|Protocol Violation|0
7790732|NCT01021852|12243992|FG004|Treatment Period 2|Protocol Violation|1
7790733|NCT01021852|12243993|FG005|Treatment Period 2|Protocol Violation|0
7790734|NCT01021852|12243994|FG006|Treatment Period 2|Protocol Violation|1
7790735|NCT01021852|12243995|FG007|Treatment Period 2|Protocol Violation|0
7790736|NCT01021852|12243988|FG000|Treatment Period 2|Withdrawal by Subject|0
7790737|NCT01021852|12243989|FG001|Treatment Period 2|Withdrawal by Subject|0
7790738|NCT01021852|12243990|FG002|Treatment Period 2|Withdrawal by Subject|0
7790739|NCT01021852|12243991|FG003|Treatment Period 2|Withdrawal by Subject|0
7790740|NCT01021852|12243992|FG004|Treatment Period 2|Withdrawal by Subject|0
7790741|NCT01021852|12243993|FG005|Treatment Period 2|Withdrawal by Subject|0
7790742|NCT01021852|12243994|FG006|Treatment Period 2|Withdrawal by Subject|1
7790743|NCT01021852|12243995|FG007|Treatment Period 2|Withdrawal by Subject|2
7790744|NCT01021878|12244011|FG000|Overall Study|Lost to Follow-up|4
7790745|NCT01021878|12244012|FG001|Overall Study|Lost to Follow-up|3
7790746|NCT01021878|12244011|FG000|Overall Study|Death|0
7790747|NCT01021878|12244012|FG001|Overall Study|Death|1
7790748|NCT01021878|12244011|FG000|Overall Study|Adverse Event|6
7790749|NCT01021878|12244012|FG001|Overall Study|Adverse Event|5
7790750|NCT01021878|12244011|FG000|Overall Study|Transplantation|6
7790751|NCT01021878|12244012|FG001|Overall Study|Transplantation|1
7790752|NCT01022112|12244053|FG000|Overall Study|Adverse Event|1
7790753|NCT01022112|12244054|FG001|Overall Study|Adverse Event|2
7790754|NCT01022112|12244055|FG002|Overall Study|Adverse Event|0
7790755|NCT01022112|12244056|FG003|Overall Study|Adverse Event|1
7790756|NCT01022112|12244057|FG004|Overall Study|Adverse Event|0
7790757|NCT01022112|12244053|FG000|Overall Study|Lack of Efficacy|1
7790758|NCT01022112|12244054|FG001|Overall Study|Lack of Efficacy|0
7790759|NCT01022112|12244055|FG002|Overall Study|Lack of Efficacy|0
7790760|NCT01022112|12244056|FG003|Overall Study|Lack of Efficacy|0
7790761|NCT01022112|12244057|FG004|Overall Study|Lack of Efficacy|1
7790762|NCT01022112|12244053|FG000|Overall Study|Physician Decision|0
7790763|NCT01022112|12244054|FG001|Overall Study|Physician Decision|0
7790764|NCT01022112|12244055|FG002|Overall Study|Physician Decision|1
7790765|NCT01022112|12244056|FG003|Overall Study|Physician Decision|0
7790766|NCT01022112|12244057|FG004|Overall Study|Physician Decision|1
7790767|NCT01022112|12244053|FG000|Overall Study|Withdrawal by Subject|0
7790768|NCT01022112|12244054|FG001|Overall Study|Withdrawal by Subject|1
7790769|NCT01022112|12244055|FG002|Overall Study|Withdrawal by Subject|2
7790770|NCT01022112|12244056|FG003|Overall Study|Withdrawal by Subject|2
7790771|NCT01022112|12244057|FG004|Overall Study|Withdrawal by Subject|1
7790772|NCT01022112|12244053|FG000|Overall Study|Fasting plasma glucose level increased|1
7790773|NCT01022112|12244054|FG001|Overall Study|Fasting plasma glucose level increased|0
7790774|NCT01022112|12244055|FG002|Overall Study|Fasting plasma glucose level increased|0
7790775|NCT01022112|12244056|FG003|Overall Study|Fasting plasma glucose level increased|0
7790776|NCT01022112|12244057|FG004|Overall Study|Fasting plasma glucose level increased|7
7790777|NCT01022203|12244075|FG000|Post Treatment Assessment|Withdrawal by Subject|12
7790778|NCT01022203|12244076|FG001|Post Treatment Assessment|Withdrawal by Subject|12
7790779|NCT01022203|12244075|FG000|Post Treatment Assessment|Physician Decision|2
7790780|NCT01022203|12244076|FG001|Post Treatment Assessment|Physician Decision|0
7790781|NCT01022203|12244075|FG000|Post Treatment Assessment|Adverse Event|0
7790782|NCT01022203|12244076|FG001|Post Treatment Assessment|Adverse Event|2
7790783|NCT01022203|12244075|FG000|Follow-Up Assessment|Lost to Follow-up|2
7790784|NCT01022203|12244076|FG001|Follow-Up Assessment|Lost to Follow-up|2
7790785|NCT01022424|12244112|FG000|Overall Study|Adverse Event|1
7790786|NCT01022424|12244112|FG000|Overall Study|Physician Decision|1
7790787|NCT01022424|12244112|FG000|Overall Study|eGFR under the withdrawal criteria|2
7790788|NCT01022502|12244120|FG000|Overall Study|Adverse Event|1
7790789|NCT01022502|12244120|FG000|Overall Study|employment related reasons|1
7790790|NCT01022502|12244120|FG000|Overall Study|Withdrawal by Subject|1
7790791|NCT01022580|12244137|FG000|Overall Study|Death|18
7790792|NCT01022580|12244138|FG001|Overall Study|Death|22
7790793|NCT01022762|12244152|FG000|Overall Study|Adverse Event|3
7790794|NCT01022762|12244153|FG001|Overall Study|Adverse Event|1
7790795|NCT01022762|12244152|FG000|Overall Study|Lack of Efficacy|0
7790796|NCT01022762|12244153|FG001|Overall Study|Lack of Efficacy|1
7790797|NCT01022762|12244152|FG000|Overall Study|Protocol Violation|7
7790798|NCT01022762|12244153|FG001|Overall Study|Protocol Violation|6
7790799|NCT01022762|12244152|FG000|Overall Study|Unclassified|12
7790800|NCT01022762|12244153|FG001|Overall Study|Unclassified|20
7790801|NCT01022853|12244164|FG000|Overall Study|Progressive disease|2
7790802|NCT01022853|12244165|FG001|Overall Study|Progressive disease|3
7790803|NCT01022853|12244166|FG002|Overall Study|Progressive disease|11
7790804|NCT01022853|12244167|FG003|Overall Study|Progressive disease|7
7790805|NCT01022853|12244168|FG004|Overall Study|Progressive disease|1
7790806|NCT01022853|12244164|FG000|Overall Study|Dose-limiting toxicity|0
7790807|NCT01022853|12244165|FG001|Overall Study|Dose-limiting toxicity|0
7790808|NCT01022853|12244166|FG002|Overall Study|Dose-limiting toxicity|0
7790809|NCT01022853|12244167|FG003|Overall Study|Dose-limiting toxicity|0
7790810|NCT01022853|12244168|FG004|Overall Study|Dose-limiting toxicity|1
7790811|NCT01022853|12244164|FG000|Overall Study|Withdrawal by Subject|0
7790812|NCT01022853|12244165|FG001|Overall Study|Withdrawal by Subject|1
7790813|NCT01022853|12244166|FG002|Overall Study|Withdrawal by Subject|1
7790814|NCT01022853|12244167|FG003|Overall Study|Withdrawal by Subject|1
7790815|NCT01022853|12244168|FG004|Overall Study|Withdrawal by Subject|0
7790816|NCT01022853|12244164|FG000|Overall Study|Other not stated above|1
7790817|NCT01022853|12244165|FG001|Overall Study|Other not stated above|0
7790818|NCT01022853|12244166|FG002|Overall Study|Other not stated above|1
7790819|NCT01022853|12244167|FG003|Overall Study|Other not stated above|0
7790820|NCT01022853|12244168|FG004|Overall Study|Other not stated above|0
7790821|NCT01022996|12244183|FG000|Overall Study|Adverse Event|14
7790822|NCT01022996|12244183|FG000|Overall Study|Withdrawal by Subject|3
7790823|NCT01022996|12244183|FG000|Overall Study|Lost to Follow-up|1
7790824|NCT01022996|12244183|FG000|Overall Study|Administrative problems|6
7790825|NCT01022996|12244183|FG000|Overall Study|Disease Progression|32
7790826|NCT01022996|12244183|FG000|Overall Study|Protocol Violation|1
7790827|NCT01023022|12244187|FG000|Overall Study|Death|5
7790828|NCT01023022|12244187|FG000|Overall Study|Lost to Follow-up|7
7790829|NCT01023022|12244187|FG000|Overall Study|due to technical issues|2
7790830|NCT01023035|12244194|FG000|Treatment Period|Adverse Event|27
7790831|NCT01023035|12244195|FG001|Treatment Period|Adverse Event|32
7790832|NCT01023035|12244196|FG002|Treatment Period|Adverse Event|50
7790833|NCT01023035|12244194|FG000|Treatment Period|Non-Medical Reasons|19
7790834|NCT01023035|12244195|FG001|Treatment Period|Non-Medical Reasons|22
7790835|NCT01023035|12244196|FG002|Treatment Period|Non-Medical Reasons|44
7790836|NCT01023035|12244194|FG000|Treatment Period|Treatment Failure|26
7790837|NCT01023035|12244195|FG001|Treatment Period|Treatment Failure|31
7790838|NCT01023035|12244196|FG002|Treatment Period|Treatment Failure|24
7790839|NCT01023035|12244194|FG000|Follow-up Period (up to Week 72)|Adverse Event|2
7790840|NCT01023035|12244195|FG001|Follow-up Period (up to Week 72)|Adverse Event|0
7790841|NCT01023035|12244196|FG002|Follow-up Period (up to Week 72)|Adverse Event|1
7790842|NCT01023035|12244194|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26
7790843|NCT01023035|12244195|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28
7790844|NCT01023035|12244196|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38
7790845|NCT01023061|12244206|FG000|Overall Study|Withdrawal prior to treatment|2
7790846|NCT01023217|12244242|FG000|Overall Study|Withdrawal by Subject|1
7790847|NCT01023217|12244243|FG001|Overall Study|Withdrawal by Subject|0
7790848|NCT01023256|12244253|FG000|Overall Study|Protocol Violation|2
7790849|NCT01023256|12244254|FG001|Overall Study|Protocol Violation|3
7790850|NCT01023256|12244255|FG002|Overall Study|Protocol Violation|0
7790851|NCT01023256|12244256|FG003|Overall Study|Protocol Violation|0
7790852|NCT01023256|12244253|FG000|Overall Study|Randomized but not treated|1
7790853|NCT01023256|12244254|FG001|Overall Study|Randomized but not treated|0
7790854|NCT01023256|12244255|FG002|Overall Study|Randomized but not treated|1
7790855|NCT01023256|12244256|FG003|Overall Study|Randomized but not treated|0
7790856|NCT01023256|12244253|FG000|Overall Study|Other|1
7790857|NCT01023256|12244254|FG001|Overall Study|Other|0
7790858|NCT01023256|12244255|FG002|Overall Study|Other|0
7790859|NCT01023256|12244256|FG003|Overall Study|Other|2
7790860|NCT01023256|12244253|FG000|Overall Study|Adverse Event|0
7790861|NCT01023256|12244254|FG001|Overall Study|Adverse Event|0
7790862|NCT01023256|12244255|FG002|Overall Study|Adverse Event|0
7790863|NCT01023256|12244256|FG003|Overall Study|Adverse Event|1
7790864|NCT01023256|12244253|FG000|Overall Study|Withdrawal by Subject|0
7790865|NCT01023256|12244254|FG001|Overall Study|Withdrawal by Subject|0
7790866|NCT01023256|12244255|FG002|Overall Study|Withdrawal by Subject|0
7790867|NCT01023256|12244256|FG003|Overall Study|Withdrawal by Subject|2
7790868|NCT01023269|12244269|FG000|Overall Study|early termination of the study|2
7790869|NCT01023269|12244270|FG001|Overall Study|early termination of the study|0
7790870|NCT01023308|12244276|FG000|Overall Study|Abnormal test proceedure results|3
7790871|NCT01023308|12244277|FG001|Overall Study|Abnormal test proceedure results|8
7790872|NCT01023308|12244276|FG000|Overall Study|Administrative problems|2
7790873|NCT01023308|12244277|FG001|Overall Study|Administrative problems|1
7790874|NCT01023308|12244276|FG000|Overall Study|Adverse Event|130
7790875|NCT01023308|12244277|FG001|Overall Study|Adverse Event|66
7790876|NCT01023308|12244276|FG000|Overall Study|Death|21
7790877|NCT01023308|12244277|FG001|Overall Study|Death|17
7790878|NCT01023308|12244276|FG000|Overall Study|Disease progression|82
7790879|NCT01023308|12244277|FG001|Overall Study|Disease progression|153
7790880|NCT01023308|12244276|FG000|Overall Study|New Cancer therapy|4
7790881|NCT01023308|12244277|FG001|Overall Study|New Cancer therapy|7
7790882|NCT01023308|12244276|FG000|Overall Study|Protocol Violation|3
7790883|NCT01023308|12244277|FG001|Overall Study|Protocol Violation|4
7790884|NCT01023308|12244276|FG000|Overall Study|Untreated|5
7790885|NCT01023308|12244277|FG001|Overall Study|Untreated|5
7790886|NCT01023308|12244276|FG000|Overall Study|Lost to Follow-up|1
7790887|NCT01023308|12244277|FG001|Overall Study|Lost to Follow-up|0
7790888|NCT01023308|12244276|FG000|Overall Study|Withdrawal by Subject|34
7790889|NCT01023308|12244277|FG001|Overall Study|Withdrawal by Subject|18
7800774|NCT01097629|12258361|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7800775|NCT01097629|12258362|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7800776|NCT01097629|12258363|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7800777|NCT01097629|12258364|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7800778|NCT01097629|12258365|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7800779|NCT01097629|12258358|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
7800780|NCT01097629|12258359|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
7800781|NCT01097629|12258360|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
7800782|NCT01097629|12258361|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7800783|NCT01097629|12258362|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7800784|NCT01097629|12258363|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7800785|NCT01097629|12258364|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7800786|NCT01097629|12258365|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7800787|NCT01097629|12258358|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
7800788|NCT01097629|12258359|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
7800789|NCT01097629|12258360|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
7800790|NCT01097629|12258361|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7800791|NCT01097629|12258362|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7800792|NCT01097629|12258363|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7800793|NCT01097629|12258364|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7800794|NCT01097629|12258365|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7800795|NCT01097629|12258358|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
7800796|NCT01097629|12258359|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
7800797|NCT01097629|12258360|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
7800798|NCT01097629|12258361|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7790890|NCT01023516|12244294|FG000|Overall Study|Voluntary discontinuation|7
7790891|NCT01023516|12244295|FG001|Overall Study|Voluntary discontinuation|5
7790892|NCT01023516|12244294|FG000|Overall Study|Adverse Event|9
7790893|NCT01023516|12244295|FG001|Overall Study|Adverse Event|6
7790894|NCT01023516|12244294|FG000|Overall Study|Safety reason|0
7790895|NCT01023516|12244295|FG001|Overall Study|Safety reason|3
7790896|NCT01023516|12244294|FG000|Overall Study|Study-specific criteria|4
7790897|NCT01023516|12244295|FG001|Overall Study|Study-specific criteria|2
7790898|NCT01023516|12244294|FG000|Overall Study|Incorrect enrolment|4
7790899|NCT01023516|12244295|FG001|Overall Study|Incorrect enrolment|2
7790900|NCT01023581|12244321|FG000|Overall Study|Adverse Event|4
7790901|NCT01023581|12244322|FG001|Overall Study|Adverse Event|4
7790902|NCT01023581|12244323|FG002|Overall Study|Adverse Event|7
7790903|NCT01023581|12244324|FG003|Overall Study|Adverse Event|3
7790904|NCT01023581|12244325|FG004|Overall Study|Adverse Event|2
7790905|NCT01023581|12244326|FG005|Overall Study|Adverse Event|5
7790906|NCT01023581|12244327|FG006|Overall Study|Adverse Event|11
7790907|NCT01023581|12244321|FG000|Overall Study|Major protocol deviation|2
7790908|NCT01023581|12244322|FG001|Overall Study|Major protocol deviation|0
7790909|NCT01023581|12244323|FG002|Overall Study|Major protocol deviation|3
7790910|NCT01023581|12244324|FG003|Overall Study|Major protocol deviation|0
7790911|NCT01023581|12244325|FG004|Overall Study|Major protocol deviation|0
7790912|NCT01023581|12244326|FG005|Overall Study|Major protocol deviation|0
7790913|NCT01023581|12244327|FG006|Overall Study|Major protocol deviation|0
7790914|NCT01023581|12244321|FG000|Overall Study|Lost to Follow-up|4
7790915|NCT01023581|12244322|FG001|Overall Study|Lost to Follow-up|8
7790916|NCT01023581|12244323|FG002|Overall Study|Lost to Follow-up|7
7790917|NCT01023581|12244324|FG003|Overall Study|Lost to Follow-up|2
7790918|NCT01023581|12244325|FG004|Overall Study|Lost to Follow-up|5
7790919|NCT01023581|12244326|FG005|Overall Study|Lost to Follow-up|2
7790920|NCT01023581|12244327|FG006|Overall Study|Lost to Follow-up|2
7790921|NCT01023581|12244321|FG000|Overall Study|Withdrawal by Subject|13
7790922|NCT01023581|12244322|FG001|Overall Study|Withdrawal by Subject|8
7790923|NCT01023581|12244323|FG002|Overall Study|Withdrawal by Subject|16
7790924|NCT01023581|12244324|FG003|Overall Study|Withdrawal by Subject|10
7790925|NCT01023581|12244325|FG004|Overall Study|Withdrawal by Subject|6
7790926|NCT01023581|12244326|FG005|Overall Study|Withdrawal by Subject|8
7790927|NCT01023581|12244327|FG006|Overall Study|Withdrawal by Subject|5
7790928|NCT01023581|12244321|FG000|Overall Study|Pregnancy|0
7790929|NCT01023581|12244322|FG001|Overall Study|Pregnancy|0
7790930|NCT01023581|12244323|FG002|Overall Study|Pregnancy|0
7790931|NCT01023581|12244324|FG003|Overall Study|Pregnancy|2
7790932|NCT01023581|12244325|FG004|Overall Study|Pregnancy|0
7790933|NCT01023581|12244326|FG005|Overall Study|Pregnancy|1
7790934|NCT01023581|12244327|FG006|Overall Study|Pregnancy|0
7790935|NCT01023581|12244321|FG000|Overall Study|Lack of Efficacy|9
7790936|NCT01023581|12244322|FG001|Overall Study|Lack of Efficacy|3
7790937|NCT01023581|12244323|FG002|Overall Study|Lack of Efficacy|6
7790938|NCT01023581|12244324|FG003|Overall Study|Lack of Efficacy|2
7790939|NCT01023581|12244325|FG004|Overall Study|Lack of Efficacy|1
7790940|NCT01023581|12244326|FG005|Overall Study|Lack of Efficacy|2
7790941|NCT01023581|12244327|FG006|Overall Study|Lack of Efficacy|1
7790942|NCT01023581|12244321|FG000|Overall Study|Physician Decision|2
7790943|NCT01023581|12244322|FG001|Overall Study|Physician Decision|0
7790944|NCT01023581|12244323|FG002|Overall Study|Physician Decision|2
7790945|NCT01023581|12244324|FG003|Overall Study|Physician Decision|1
7790946|NCT01023581|12244325|FG004|Overall Study|Physician Decision|1
7790947|NCT01023581|12244326|FG005|Overall Study|Physician Decision|1
7790948|NCT01023581|12244327|FG006|Overall Study|Physician Decision|1
7790949|NCT01023581|12244321|FG000|Overall Study|Other|1
7790950|NCT01023581|12244322|FG001|Overall Study|Other|0
7790951|NCT01023581|12244323|FG002|Overall Study|Other|1
7790952|NCT01023581|12244324|FG003|Overall Study|Other|0
7790953|NCT01023581|12244325|FG004|Overall Study|Other|1
7790954|NCT01023581|12244326|FG005|Overall Study|Other|0
7790955|NCT01023581|12244327|FG006|Overall Study|Other|0
7790956|NCT01023659|12244346|FG000|Overall Study|Lost to Follow-up|73
7790957|NCT01023659|12244347|FG001|Overall Study|Lost to Follow-up|228
7790958|NCT01023659|12244348|FG002|Overall Study|Lost to Follow-up|99
7790959|NCT01023672|12244357|FG000|Overall Study|Worsening disease|2
7790960|NCT01023672|12244357|FG000|Overall Study|Death|1
7790961|NCT01023789|12244379|FG000|3 - Year Visit|Death|29
7790962|NCT01023789|12244379|FG000|3 - Year Visit|Withdrawal of consent|1
7790963|NCT01023789|12244379|FG000|3 - Year Visit|Lost to Follow-up|13
7790964|NCT01023815|12244387|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
7790965|NCT01023815|12244388|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
7790966|NCT01023815|12244389|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
7790967|NCT01023815|12244390|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
7790968|NCT01023815|12244387|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
7790969|NCT01023815|12244388|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
7790970|NCT01023815|12244389|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
7790971|NCT01023815|12244390|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
7790972|NCT01023815|12244387|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
7790973|NCT01023815|12244388|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
7790974|NCT01023815|12244389|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
7790975|NCT01023815|12244390|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
7790976|NCT01023815|12244387|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
7790977|NCT01023815|12244388|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
7790978|NCT01023815|12244389|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
7790979|NCT01023815|12244390|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
7790980|NCT01023815|12244387|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0
7790981|NCT01023815|12244388|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1
7790982|NCT01023815|12244389|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0
7790983|NCT01023815|12244390|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0
7790984|NCT01023958|12244410|FG000|Overall Study|Progressive disease|48
7790985|NCT01023958|12244410|FG000|Overall Study|Other adverse event|1
7790986|NCT01023958|12244410|FG000|Overall Study|Refused to continue medication|1
7790987|NCT01024036|12244425|FG000|Blinded Treatment|Adverse Event|1
7790988|NCT01024036|12244426|FG001|Blinded Treatment|Adverse Event|1
7790989|NCT01024036|12244425|FG000|Blinded Treatment|Lack of Efficacy|16
7790990|NCT01024036|12244426|FG001|Blinded Treatment|Lack of Efficacy|14
7790991|NCT01024036|12244425|FG000|Blinded Treatment|Physician Decision|1
7790992|NCT01024036|12244426|FG001|Blinded Treatment|Physician Decision|0
7622910|NCT02765399|12033853|FG000|Overall Study|Nausea|1
7622911|NCT02765399|12033854|FG001|Overall Study|Nausea|0
7790993|NCT01024036|12244425|FG000|Blinded Treatment|Death|0
7790994|NCT01024036|12244426|FG001|Blinded Treatment|Death|2
7790995|NCT01024036|12244425|FG000|Blinded Treatment|Withdrawal by Subject|4
7790996|NCT01024036|12244426|FG001|Blinded Treatment|Withdrawal by Subject|3
7790997|NCT01024036|12244425|FG000|Unblinded Treatment|Adverse Event|0
7790998|NCT01024036|12244426|FG001|Unblinded Treatment|Adverse Event|1
7790999|NCT01024036|12244425|FG000|Unblinded Treatment|Lack of Efficacy|0
7791000|NCT01024036|12244426|FG001|Unblinded Treatment|Lack of Efficacy|2
7791001|NCT01024036|12244425|FG000|Follow-Up Period|Lost to Follow-up|1
7791002|NCT01024036|12244426|FG001|Follow-Up Period|Lost to Follow-up|1
7791003|NCT01024036|12244425|FG000|Follow-Up Period|Withdrawal by Subject|0
7791004|NCT01024036|12244426|FG001|Follow-Up Period|Withdrawal by Subject|1
7791005|NCT01024036|12244425|FG000|Follow-Up Period|Adverse Event|4
7791006|NCT01024036|12244426|FG001|Follow-Up Period|Adverse Event|1
7791007|NCT01024231|12244442|FG000|Overall Study|Other Reasons|1
7791008|NCT01024231|12244443|FG001|Overall Study|Other Reasons|2
7791009|NCT01024231|12244444|FG002|Overall Study|Other Reasons|0
7791010|NCT01024231|12244445|FG003|Overall Study|Other Reasons|0
7791011|NCT01024231|12244446|FG004|Overall Study|Other Reasons|2
7791012|NCT01024231|12244447|FG005|Overall Study|Other Reasons|0
7791013|NCT01024231|12244448|FG006|Overall Study|Other Reasons|1
7791014|NCT01024231|12244442|FG000|Overall Study|Maximum Clinical Benefit|1
7791015|NCT01024231|12244443|FG001|Overall Study|Maximum Clinical Benefit|2
7791016|NCT01024231|12244444|FG002|Overall Study|Maximum Clinical Benefit|0
7622936|NCT03894969|12033892|FG000|Overall Study|Adverse Event|0
7622937|NCT03894969|12033893|FG001|Overall Study|Adverse Event|2
7622938|NCT03894969|12033894|FG002|Overall Study|Adverse Event|0
7622939|NCT03894969|12033895|FG003|Overall Study|Adverse Event|1
7622940|NCT03894969|12033896|FG004|Overall Study|Adverse Event|2
7622941|NCT03894969|12033892|FG000|Overall Study|Lost to Follow-up|3
7622942|NCT03894969|12033893|FG001|Overall Study|Lost to Follow-up|1
7622943|NCT03894969|12033894|FG002|Overall Study|Lost to Follow-up|1
7622944|NCT03894969|12033895|FG003|Overall Study|Lost to Follow-up|0
7622945|NCT03894969|12033896|FG004|Overall Study|Lost to Follow-up|0
7622946|NCT03894969|12033892|FG000|Overall Study|Withdrawal by Subject|2
7622947|NCT03894969|12033893|FG001|Overall Study|Withdrawal by Subject|1
7622948|NCT03894969|12033894|FG002|Overall Study|Withdrawal by Subject|3
7622949|NCT03894969|12033895|FG003|Overall Study|Withdrawal by Subject|4
7622950|NCT03894969|12033896|FG004|Overall Study|Withdrawal by Subject|8
7622951|NCT03894969|12033892|FG000|Overall Study|Other|0
7622952|NCT03894969|12033893|FG001|Overall Study|Other|0
7791017|NCT01024231|12244445|FG003|Overall Study|Maximum Clinical Benefit|1
7791018|NCT01024231|12244446|FG004|Overall Study|Maximum Clinical Benefit|1
7791019|NCT01024231|12244447|FG005|Overall Study|Maximum Clinical Benefit|0
7791020|NCT01024231|12244448|FG006|Overall Study|Maximum Clinical Benefit|0
7622953|NCT03894969|12033894|FG002|Overall Study|Other|0
7622954|NCT03894969|12033895|FG003|Overall Study|Other|0
7622955|NCT03894969|12033896|FG004|Overall Study|Other|3
7622956|NCT03894969|12033892|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0
7622957|NCT03894969|12033893|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0
7622958|NCT03894969|12033894|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0
7622959|NCT03894969|12033895|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2
7791021|NCT01024231|12244442|FG000|Overall Study|Disease Progression|3
7791022|NCT01024231|12244443|FG001|Overall Study|Disease Progression|1
7622960|NCT03894969|12033896|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1
7622961|NCT03894969|12033892|FG000|Overall Study|Solicited Adverse Event|0
7622962|NCT03894969|12033893|FG001|Overall Study|Solicited Adverse Event|1
7622963|NCT03894969|12033894|FG002|Overall Study|Solicited Adverse Event|0
7622964|NCT03894969|12033895|FG003|Overall Study|Solicited Adverse Event|0
7622965|NCT03894969|12033896|FG004|Overall Study|Solicited Adverse Event|0
7622966|NCT03464136|12033921|FG000|Overall Study|Lost to Follow-up|5
7791023|NCT01024231|12244444|FG002|Overall Study|Disease Progression|3
7791024|NCT01024231|12244445|FG003|Overall Study|Disease Progression|0
7791025|NCT01024231|12244446|FG004|Overall Study|Disease Progression|4
7791026|NCT01024231|12244447|FG005|Overall Study|Disease Progression|11
7791027|NCT01024231|12244448|FG006|Overall Study|Disease Progression|6
7791028|NCT01024231|12244442|FG000|Overall Study|AE unrelated to Study Drug|0
7791029|NCT01024231|12244443|FG001|Overall Study|AE unrelated to Study Drug|1
7791030|NCT01024231|12244444|FG002|Overall Study|AE unrelated to Study Drug|0
7791031|NCT01024231|12244445|FG003|Overall Study|AE unrelated to Study Drug|0
7791032|NCT01024231|12244446|FG004|Overall Study|AE unrelated to Study Drug|0
7791033|NCT01024231|12244447|FG005|Overall Study|AE unrelated to Study Drug|0
7791034|NCT01024231|12244448|FG006|Overall Study|AE unrelated to Study Drug|0
7791035|NCT01024231|12244442|FG000|Overall Study|No longer meets criteria|0
7791036|NCT01024231|12244443|FG001|Overall Study|No longer meets criteria|0
7791037|NCT01024231|12244444|FG002|Overall Study|No longer meets criteria|0
7791038|NCT01024231|12244445|FG003|Overall Study|No longer meets criteria|0
7791039|NCT01024231|12244446|FG004|Overall Study|No longer meets criteria|1
7791040|NCT01024231|12244447|FG005|Overall Study|No longer meets criteria|0
7791041|NCT01024231|12244448|FG006|Overall Study|No longer meets criteria|1
7791042|NCT01024231|12244442|FG000|Overall Study|Study Drug Toxicity|1
7791043|NCT01024231|12244443|FG001|Overall Study|Study Drug Toxicity|6
7791044|NCT01024231|12244444|FG002|Overall Study|Study Drug Toxicity|6
7791045|NCT01024231|12244445|FG003|Overall Study|Study Drug Toxicity|4
7791046|NCT01024231|12244446|FG004|Overall Study|Study Drug Toxicity|2
7791047|NCT01024231|12244447|FG005|Overall Study|Study Drug Toxicity|0
7791048|NCT01024231|12244448|FG006|Overall Study|Study Drug Toxicity|7
7791049|NCT01024231|12244442|FG000|Overall Study|Death|6
7791050|NCT01024231|12244443|FG001|Overall Study|Death|2
7791051|NCT01024231|12244444|FG002|Overall Study|Death|1
7791052|NCT01024231|12244445|FG003|Overall Study|Death|0
7791053|NCT01024231|12244446|FG004|Overall Study|Death|4
7791054|NCT01024231|12244447|FG005|Overall Study|Death|3
7791055|NCT01024231|12244448|FG006|Overall Study|Death|5
7791056|NCT01024231|12244442|FG000|Overall Study|Lost to Follow-up|0
7791057|NCT01024231|12244443|FG001|Overall Study|Lost to Follow-up|0
7791058|NCT01024231|12244444|FG002|Overall Study|Lost to Follow-up|0
7791059|NCT01024231|12244445|FG003|Overall Study|Lost to Follow-up|0
7791060|NCT01024231|12244446|FG004|Overall Study|Lost to Follow-up|0
7791061|NCT01024231|12244447|FG005|Overall Study|Lost to Follow-up|0
7791062|NCT01024231|12244448|FG006|Overall Study|Lost to Follow-up|1
7791063|NCT01024231|12244442|FG000|Overall Study|Withdrew Consent|0
7791064|NCT01024231|12244443|FG001|Overall Study|Withdrew Consent|1
7791065|NCT01024231|12244444|FG002|Overall Study|Withdrew Consent|0
7791066|NCT01024231|12244445|FG003|Overall Study|Withdrew Consent|0
7791067|NCT01024231|12244446|FG004|Overall Study|Withdrew Consent|0
7791068|NCT01024231|12244447|FG005|Overall Study|Withdrew Consent|0
7791069|NCT01024231|12244448|FG006|Overall Study|Withdrew Consent|0
7791070|NCT01024231|12244442|FG000|Overall Study|Continuing on Treatment|0
7791071|NCT01024231|12244443|FG001|Overall Study|Continuing on Treatment|0
7791072|NCT01024231|12244444|FG002|Overall Study|Continuing on Treatment|0
7791073|NCT01024231|12244445|FG003|Overall Study|Continuing on Treatment|0
7791074|NCT01024231|12244446|FG004|Overall Study|Continuing on Treatment|3
7791075|NCT01024231|12244447|FG005|Overall Study|Continuing on Treatment|2
7791076|NCT01024231|12244448|FG006|Overall Study|Continuing on Treatment|0
7791077|NCT01024244|12244474|FG000|Overall Study|Adverse Event|1
7791078|NCT01024244|12244475|FG001|Overall Study|Adverse Event|2
7791079|NCT01024244|12244476|FG002|Overall Study|Adverse Event|0
7791080|NCT01024244|12244477|FG003|Overall Study|Adverse Event|1
7791081|NCT01024244|12244478|FG004|Overall Study|Adverse Event|2
7791082|NCT01024244|12244474|FG000|Overall Study|Entry Criteria Not Met|0
7791083|NCT01024244|12244475|FG001|Overall Study|Entry Criteria Not Met|1
7791084|NCT01024244|12244476|FG002|Overall Study|Entry Criteria Not Met|0
7791085|NCT01024244|12244477|FG003|Overall Study|Entry Criteria Not Met|0
7791086|NCT01024244|12244478|FG004|Overall Study|Entry Criteria Not Met|0
7791087|NCT01024244|12244474|FG000|Overall Study|Lack of Efficacy|1
7791088|NCT01024244|12244475|FG001|Overall Study|Lack of Efficacy|0
7791089|NCT01024244|12244476|FG002|Overall Study|Lack of Efficacy|0
7791090|NCT01024244|12244477|FG003|Overall Study|Lack of Efficacy|0
7622967|NCT03464136|12033922|FG001|Overall Study|Lost to Follow-up|8
7791091|NCT01024244|12244478|FG004|Overall Study|Lack of Efficacy|0
7791092|NCT01024244|12244474|FG000|Overall Study|Protocol Violation|1
7791093|NCT01024244|12244475|FG001|Overall Study|Protocol Violation|0
7791094|NCT01024244|12244476|FG002|Overall Study|Protocol Violation|0
7791095|NCT01024244|12244477|FG003|Overall Study|Protocol Violation|0
7791096|NCT01024244|12244478|FG004|Overall Study|Protocol Violation|2
7791097|NCT01024244|12244474|FG000|Overall Study|Sponsor Decision|14
7791098|NCT01024244|12244475|FG001|Overall Study|Sponsor Decision|7
7791099|NCT01024244|12244476|FG002|Overall Study|Sponsor Decision|14
7791100|NCT01024244|12244477|FG003|Overall Study|Sponsor Decision|12
7791101|NCT01024244|12244478|FG004|Overall Study|Sponsor Decision|10
7791102|NCT01024244|12244474|FG000|Overall Study|Withdrawal by Subject|0
7791103|NCT01024244|12244475|FG001|Overall Study|Withdrawal by Subject|1
7791104|NCT01024244|12244476|FG002|Overall Study|Withdrawal by Subject|0
7791105|NCT01024244|12244477|FG003|Overall Study|Withdrawal by Subject|0
7791106|NCT01024244|12244478|FG004|Overall Study|Withdrawal by Subject|0
7791107|NCT01024309|12244496|FG000|Overall Study|Physician Decision|4
7791108|NCT01024309|12244497|FG001|Overall Study|Physician Decision|0
7791109|NCT01024309|12244496|FG000|Overall Study|Withdrawal by Subject|4
7791110|NCT01024309|12244497|FG001|Overall Study|Withdrawal by Subject|4
7791111|NCT01024387|12244512|FG000|Overall Study|Radiographic Progression|29
7791112|NCT01024387|12244512|FG000|Overall Study|Symptomatic Progression|10
7791113|NCT01024387|12244512|FG000|Overall Study|Physician Decision|5
7791114|NCT01024387|12244512|FG000|Overall Study|Withdrawal by Subject|5
7791115|NCT01024387|12244512|FG000|Overall Study|Death|2
7791116|NCT01024387|12244512|FG000|Overall Study|Prolonged Treatment Delay|1
7791117|NCT01024387|12244512|FG000|Overall Study|Adverse Event|3
7791118|NCT01024387|12244512|FG000|Overall Study|Other|5
7791119|NCT01024465|12244516|FG000|Overall Study|Adverse Event|2
7791120|NCT01024465|12244516|FG000|Overall Study|Physician Decision|1
7791121|NCT01024751|12244559|FG000|Enrolled Participants|Ineligible at baseline|3
7791122|NCT01024751|12244560|FG001|Enrolled Participants|Ineligible at baseline|4
7791123|NCT01024751|12244559|FG000|Eligible Participants|Withdrawal by Subject|0
7791124|NCT01024751|12244560|FG001|Eligible Participants|Withdrawal by Subject|1
7791125|NCT01024751|12244559|FG000|Eligible Participants|Lost to Follow-up|0
7791126|NCT01024751|12244560|FG001|Eligible Participants|Lost to Follow-up|1
7791127|NCT01024751|12244559|FG000|Eligible Participants|Ineligible|0
7791128|NCT01024751|12244560|FG001|Eligible Participants|Ineligible|1
7791129|NCT01024855|12244566|FG000|Overall Study|Inclusion/exclusion criteria|1
7791130|NCT01024920|12244573|FG000|Overall Study|Progressive disease|47
7791131|NCT01024920|12244574|FG001|Overall Study|Progressive disease|25
7791132|NCT01024920|12244573|FG000|Overall Study|Adverse Event|8
7791133|NCT01024920|12244574|FG001|Overall Study|Adverse Event|4
7791134|NCT01024920|12244573|FG000|Overall Study|Lost to Follow-up|0
7791135|NCT01024920|12244574|FG001|Overall Study|Lost to Follow-up|1
7791136|NCT01024920|12244573|FG000|Overall Study|Patient refusal to continue|4
7791137|NCT01024920|12244574|FG001|Overall Study|Patient refusal to continue|0
7791138|NCT01024920|12244573|FG000|Overall Study|Other than listed|5
7791139|NCT01024920|12244574|FG001|Overall Study|Other than listed|1
7791140|NCT01024920|12244573|FG000|Overall Study|Not treated|3
7791141|NCT01024920|12244574|FG001|Overall Study|Not treated|0
7791142|NCT01024920|12244573|FG000|Overall Study|Protocol Violation|0
7791143|NCT01024920|12244574|FG001|Overall Study|Protocol Violation|1
7791144|NCT01024946|12244580|FG000|Overall Study|Screen Failure|3
7791145|NCT01024946|12244580|FG000|Overall Study|Withdrawal by Subject|1
7791146|NCT01024946|12244580|FG000|Overall Study|Adverse Event|1
7791147|NCT01024959|12244584|FG000|Overall Study|ineligible|12
7791148|NCT01024959|12244584|FG000|Overall Study|results not evaluable|12
7791149|NCT01024959|12244584|FG000|Overall Study|missing results required for analysis|17
7791150|NCT01025037|12244603|FG000|Overall Study|Adverse Event|3
7791151|NCT01025037|12244603|FG000|Overall Study|Lost to Follow-up|7
7791152|NCT01025037|12244603|FG000|Overall Study|Withdrawal by Subject|1
7791153|NCT01025154|12244611|FG000|Overall Study|Lost to Follow-up|1
7791154|NCT01025154|12244611|FG000|Overall Study|Withdrawal by Subject|1
7791155|NCT01025193|12244615|FG000|Overall Study|Protocol Violation|1
7791156|NCT01025193|12244615|FG000|Overall Study|Adverse Event|3
7791157|NCT01025232|12244625|FG000|Overall Study|Study drug no longer available|3
7791158|NCT01025232|12244626|FG001|Overall Study|Study drug no longer available|6
7791159|NCT01025284|12244635|FG000|Overall Study|Investigator Decision|0
7791160|NCT01025284|12244636|FG001|Overall Study|Investigator Decision|1
7791161|NCT01025284|12244637|FG002|Overall Study|Investigator Decision|0
7791162|NCT01025284|12244635|FG000|Overall Study|Withdrawal by Subject|0
7791163|NCT01025284|12244636|FG001|Overall Study|Withdrawal by Subject|1
7791164|NCT01025284|12244637|FG002|Overall Study|Withdrawal by Subject|0
7791165|NCT01025336|12244652|FG000|Overall Study|Protocol Violation|0
7791166|NCT01025336|12244653|FG001|Overall Study|Protocol Violation|0
7791167|NCT01025336|12244654|FG002|Overall Study|Protocol Violation|0
7791168|NCT01025336|12244655|FG003|Overall Study|Protocol Violation|2
7791169|NCT01025336|12244656|FG004|Overall Study|Protocol Violation|0
7791170|NCT01025635|12244690|FG000|Overall Study|Withdrawal by Subject|6
7791171|NCT01025635|12244691|FG001|Overall Study|Withdrawal by Subject|7
7791172|NCT01025635|12244690|FG000|Overall Study|Protocol Violation|4
7791173|NCT01025635|12244691|FG001|Overall Study|Protocol Violation|2
7791174|NCT01025635|12244690|FG000|Overall Study|Lack of Efficacy|0
7791175|NCT01025635|12244691|FG001|Overall Study|Lack of Efficacy|1
7791176|NCT01025635|12244690|FG000|Overall Study|Lost to Follow-up|9
7791177|NCT01025635|12244691|FG001|Overall Study|Lost to Follow-up|13
7791178|NCT01025635|12244690|FG000|Overall Study|Reason not known|4
7791179|NCT01025635|12244691|FG001|Overall Study|Reason not known|2
7791180|NCT01025752|12244699|FG000|Overall Study|Lost to Follow-up|7
7791181|NCT01025752|12244700|FG001|Overall Study|Lost to Follow-up|10
7791182|NCT01025752|12244699|FG000|Overall Study|Physician Decision|1
7791183|NCT01025752|12244700|FG001|Overall Study|Physician Decision|3
7791184|NCT01025817|12244775|FG000|Completed Study Medication|Adverse Event|66
7791185|NCT01025817|12244776|FG001|Completed Study Medication|Adverse Event|39
7791186|NCT01025817|12244775|FG000|Completed Study Medication|Protocol Deviation|9
7791187|NCT01025817|12244776|FG001|Completed Study Medication|Protocol Deviation|8
7791188|NCT01025817|12244775|FG000|Completed Study Medication|Withdrawal by Subject|8
7791189|NCT01025817|12244776|FG001|Completed Study Medication|Withdrawal by Subject|9
7791190|NCT01025817|12244775|FG000|Completed Study Medication|Administrative problems|7
7791191|NCT01025817|12244776|FG001|Completed Study Medication|Administrative problems|5
7791192|NCT01025817|12244775|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7
7791193|NCT01025817|12244776|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0
7791194|NCT01025817|12244775|FG000|Completed Study Medication|Abnormal test procedure|4
7791195|NCT01025817|12244776|FG001|Completed Study Medication|Abnormal test procedure|0
7791196|NCT01025817|12244775|FG000|Completed Study Medication|Graft loss|2
7791197|NCT01025817|12244776|FG001|Completed Study Medication|Graft loss|5
7791198|NCT01025817|12244775|FG000|Completed Study Medication|Death|2
7791199|NCT01025817|12244776|FG001|Completed Study Medication|Death|2
7791200|NCT01025817|12244775|FG000|Completed Study Medication|Abnormal lab values|0
7791201|NCT01025817|12244776|FG001|Completed Study Medication|Abnormal lab values|2
7791202|NCT01025817|12244775|FG000|Completed Study Medication|Subject no longer required study drug|0
7791203|NCT01025817|12244776|FG001|Completed Study Medication|Subject no longer required study drug|1
7791204|NCT01025817|12244775|FG000|Completed Study Medication|Lost to Follow-up|0
7791205|NCT01025817|12244776|FG001|Completed Study Medication|Lost to Follow-up|1
7791206|NCT01025817|12244775|FG000|Completed Study|Withdrawal by Subject|8
7791207|NCT01025817|12244776|FG001|Completed Study|Withdrawal by Subject|16
7791208|NCT01025817|12244775|FG000|Completed Study|Death|6
7791209|NCT01025817|12244776|FG001|Completed Study|Death|5
7791210|NCT01025817|12244775|FG000|Completed Study|Missing|2
7791211|NCT01025817|12244776|FG001|Completed Study|Missing|0
7791212|NCT01025817|12244775|FG000|Completed Study|Lost to Follow-up|0
7791213|NCT01025817|12244776|FG001|Completed Study|Lost to Follow-up|1
7791214|NCT01025843|12244804|FG000|Washout 4|Withdrawal by Subject|0
7791215|NCT01025843|12244805|FG001|Washout 4|Withdrawal by Subject|0
7791216|NCT01025843|12244806|FG002|Washout 4|Withdrawal by Subject|1
7791217|NCT01025843|12244807|FG003|Washout 4|Withdrawal by Subject|1
7791218|NCT01025843|12244808|FG004|Washout 4|Withdrawal by Subject|0
7791219|NCT01025843|12244809|FG005|Washout 4|Withdrawal by Subject|0
7791220|NCT01025843|12244810|FG006|Washout 4|Withdrawal by Subject|0
7791221|NCT01025843|12244811|FG007|Washout 4|Withdrawal by Subject|0
7791222|NCT01025843|12244812|FG008|Washout 4|Withdrawal by Subject|0
7791223|NCT01025843|12244813|FG009|Washout 4|Withdrawal by Subject|0
7791224|NCT01026038|12244844|FG000|Overall Study|Lost to Follow-up|1
7791225|NCT01026038|12244845|FG001|Overall Study|Lost to Follow-up|1
7791226|NCT01026038|12244846|FG002|Overall Study|Lost to Follow-up|0
7791227|NCT01026103|12244854|FG000|Overall Study|Physician Decision|1
7791228|NCT01026103|12244854|FG000|Overall Study|did not receive study device bc of error|1
7791229|NCT01026142|12244860|FG000|Overall Study|Death|136
7791230|NCT01026142|12244861|FG001|Overall Study|Death|134
7791231|NCT01026142|12244860|FG000|Overall Study|Withdrew consent or lost to follow-up|36
7791232|NCT01026142|12244861|FG001|Overall Study|Withdrew consent or lost to follow-up|29
7791233|NCT01026194|12244882|FG000|Period 1：Double Blind Period|Adverse Event|2
7791234|NCT01026194|12244883|FG001|Period 1：Double Blind Period|Adverse Event|1
7791235|NCT01026194|12244882|FG000|Period 1：Double Blind Period|Lack of Efficacy|1
7791236|NCT01026194|12244883|FG001|Period 1：Double Blind Period|Lack of Efficacy|0
7791237|NCT01026194|12244882|FG000|Period 1：Double Blind Period|Physician Decision|0
7791238|NCT01026194|12244883|FG001|Period 1：Double Blind Period|Physician Decision|4
7791239|NCT01026194|12244882|FG000|Period 2：Open-label Period|Adverse Event|4
7791240|NCT01026194|12244883|FG001|Period 2：Open-label Period|Adverse Event|5
7791241|NCT01026194|12244882|FG000|Period 2：Open-label Period|Physician Decision|3
7791242|NCT01026194|12244883|FG001|Period 2：Open-label Period|Physician Decision|1
7791243|NCT01026194|12244882|FG000|Period 2：Open-label Period|Withdrawal by Subject|0
7791244|NCT01026194|12244883|FG001|Period 2：Open-label Period|Withdrawal by Subject|4
7791245|NCT01026324|12244894|FG000|Follow up/Survival|Withdrawal by Subject|1
7791246|NCT01026324|12244895|FG001|Follow up/Survival|Withdrawal by Subject|0
7791247|NCT01026324|12244896|FG002|Follow up/Survival|Withdrawal by Subject|0
7791248|NCT01026389|12244907|FG000|Overall Study|Withdrawal by Subject|1
7791249|NCT01026389|12244908|FG001|Overall Study|Withdrawal by Subject|3
7791250|NCT01026389|12244907|FG000|Overall Study|change of treatment, patient moved|4
7791251|NCT01026389|12244908|FG001|Overall Study|change of treatment, patient moved|2
7791252|NCT01026454|12244988|FG000|Second Intervention|Pregnancy|1
7791253|NCT01026454|12244989|FG001|Second Intervention|Pregnancy|1
7791254|NCT01026493|12245003|FG000|Overall Study|Protocol Violation|0
7791255|NCT01026493|12245004|FG001|Overall Study|Protocol Violation|1
7791256|NCT01026493|12245005|FG002|Overall Study|Protocol Violation|0
7791257|NCT01026493|12245006|FG003|Overall Study|Protocol Violation|0
7791258|NCT01026493|12245007|FG004|Overall Study|Protocol Violation|2
7791259|NCT01026493|12245008|FG005|Overall Study|Protocol Violation|3
7791260|NCT01026493|12245009|FG006|Overall Study|Protocol Violation|4
7791261|NCT01026493|12245010|FG007|Overall Study|Protocol Violation|1
7791262|NCT01026792|12245042|FG000|Overall Study|Protocol Violation|1
7791263|NCT01026818|12245053|FG000|Screening Period|Entry Criteria Not Met|105
7791264|NCT01026818|12245054|FG001|Screening Period|Entry Criteria Not Met|0
7791265|NCT01026818|12245055|FG002|Screening Period|Entry Criteria Not Met|0
7791266|NCT01026818|12245056|FG003|Screening Period|Entry Criteria Not Met|0
7791267|NCT01026818|12245053|FG000|Screening Period|Withdrawal by Subject|49
7791268|NCT01026818|12245054|FG001|Screening Period|Withdrawal by Subject|0
7791269|NCT01026818|12245055|FG002|Screening Period|Withdrawal by Subject|0
7791270|NCT01026818|12245056|FG003|Screening Period|Withdrawal by Subject|0
7791271|NCT01026818|12245053|FG000|Screening Period|Protocol Deviation|3
7791272|NCT01026818|12245054|FG001|Screening Period|Protocol Deviation|0
7791273|NCT01026818|12245055|FG002|Screening Period|Protocol Deviation|0
7791274|NCT01026818|12245056|FG003|Screening Period|Protocol Deviation|0
7791275|NCT01026818|12245053|FG000|Screening Period|Adverse Event|2
7791276|NCT01026818|12245054|FG001|Screening Period|Adverse Event|0
7791277|NCT01026818|12245055|FG002|Screening Period|Adverse Event|0
7791278|NCT01026818|12245056|FG003|Screening Period|Adverse Event|0
7791279|NCT01026818|12245053|FG000|Screening Period|Physician Decision|1
7791280|NCT01026818|12245054|FG001|Screening Period|Physician Decision|0
7791281|NCT01026818|12245055|FG002|Screening Period|Physician Decision|0
7791282|NCT01026818|12245056|FG003|Screening Period|Physician Decision|0
7791283|NCT01026818|12245053|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0
7791284|NCT01026818|12245054|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10
7791285|NCT01026818|12245055|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6
7791286|NCT01026818|12245056|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4
7791287|NCT01026818|12245053|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
7791288|NCT01026818|12245054|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
7791289|NCT01026818|12245055|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
7791290|NCT01026818|12245056|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
7791291|NCT01026818|12245053|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
7791292|NCT01026818|12245054|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
7791293|NCT01026818|12245055|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
7791294|NCT01026818|12245056|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
7791295|NCT01026818|12245053|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
7791296|NCT01026818|12245054|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
7791297|NCT01026818|12245055|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
7791298|NCT01026818|12245056|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
7791299|NCT01026818|12245053|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
7791300|NCT01026818|12245054|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
7791301|NCT01026818|12245055|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
7791302|NCT01026818|12245056|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
7791303|NCT01026818|12245053|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
7791304|NCT01026818|12245054|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
7791305|NCT01026818|12245055|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
7791306|NCT01026818|12245056|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
7791307|NCT01026818|12245053|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
7791308|NCT01026818|12245054|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
7791309|NCT01026818|12245055|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
7791310|NCT01026818|12245056|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
7791311|NCT01026818|12245053|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
7791312|NCT01026818|12245054|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
7791313|NCT01026818|12245055|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
7791314|NCT01026818|12245056|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
7791315|NCT01026818|12245053|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
7791316|NCT01026818|12245054|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
7791317|NCT01026818|12245055|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
7791318|NCT01026818|12245056|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
7791319|NCT01026818|12245053|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
7791320|NCT01026818|12245054|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
7791321|NCT01026818|12245055|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
7791322|NCT01026818|12245056|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
7791323|NCT01026818|12245053|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
7791324|NCT01026818|12245054|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
7791325|NCT01026818|12245055|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
7622968|NCT03464136|12033921|FG000|Overall Study|Withdrawal by Subject|16
7622969|NCT03464136|12033922|FG001|Overall Study|Withdrawal by Subject|13
7622970|NCT03464136|12033921|FG000|Overall Study|Death|1
7622971|NCT03464136|12033922|FG001|Overall Study|Death|0
7622972|NCT03464136|12033921|FG000|Overall Study|Other|8
7622973|NCT03464136|12033922|FG001|Overall Study|Other|4
7622974|NCT03338816|12033930|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0
7622975|NCT03338816|12033931|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0
7622976|NCT03338816|12033932|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2
7622977|NCT03338816|12033933|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0
7622978|NCT03338816|12033930|FG000|6-Month DB + Open-Label Extension Period|Death|0
7622979|NCT03338816|12033931|FG001|6-Month DB + Open-Label Extension Period|Death|0
7622980|NCT03338816|12033932|FG002|6-Month DB + Open-Label Extension Period|Death|0
7791326|NCT01026818|12245056|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
7791327|NCT01026818|12245053|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
7622981|NCT03338816|12033933|FG003|6-Month DB + Open-Label Extension Period|Death|1
7622982|NCT03338816|12033930|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0
7622983|NCT03338816|12033931|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0
7791328|NCT01026818|12245054|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
7882370|NCT01769508|12381272|FG000|Overall Study|Withdrawal by Subject|1
7791329|NCT01026818|12245055|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
7791330|NCT01026818|12245056|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
7791331|NCT01026818|12245053|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
7791332|NCT01026818|12245054|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
7791333|NCT01026818|12245055|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
7791334|NCT01026818|12245056|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
7791335|NCT01026818|12245053|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0
7791336|NCT01026818|12245054|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0
7791337|NCT01026818|12245055|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0
7791338|NCT01026818|12245056|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1
7791339|NCT01026818|12245053|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
7791340|NCT01026818|12245054|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
7791341|NCT01026818|12245055|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
7791342|NCT01026818|12245056|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
7791343|NCT01026818|12245053|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
7791344|NCT01026818|12245054|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
7791345|NCT01026818|12245055|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
7791346|NCT01026818|12245056|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
7791347|NCT01026818|12245053|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
7791348|NCT01026818|12245054|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
7791349|NCT01026818|12245055|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
7791350|NCT01026818|12245056|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
7791351|NCT01026818|12245053|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
7791352|NCT01026818|12245054|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
7791353|NCT01026818|12245055|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
7791354|NCT01026818|12245056|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
7791355|NCT01026818|12245053|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
7791356|NCT01026818|12245054|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
7791357|NCT01026818|12245055|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
7791358|NCT01026818|12245056|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
7791359|NCT01026831|12245070|FG000|Overall Study|Adverse Event|4
7791360|NCT01026831|12245071|FG001|Overall Study|Adverse Event|3
7791361|NCT01026831|12245070|FG000|Overall Study|Lost to Follow-up|2
7791362|NCT01026831|12245071|FG001|Overall Study|Lost to Follow-up|0
7791363|NCT01026831|12245070|FG000|Overall Study|Physician Decision|1
7791364|NCT01026831|12245071|FG001|Overall Study|Physician Decision|1
7791365|NCT01026831|12245070|FG000|Overall Study|Protocol Violation|0
7791366|NCT01026831|12245071|FG001|Overall Study|Protocol Violation|2
7791367|NCT01026831|12245070|FG000|Overall Study|Withdrawal by Subject|7
7791368|NCT01026831|12245071|FG001|Overall Study|Withdrawal by Subject|5
7791369|NCT01026948|12245095|FG000|Overall Study|Physician Decision|8
7791370|NCT01026974|12245104|FG000|Overall Study|Withdrawal by Subject|0
7791371|NCT01026974|12245105|FG001|Overall Study|Withdrawal by Subject|1
7791372|NCT01026974|12245106|FG002|Overall Study|Withdrawal by Subject|7
7791373|NCT01026974|12245107|FG003|Overall Study|Withdrawal by Subject|2
7791374|NCT01026974|12245104|FG000|Overall Study|Lost to Follow-up|1
7791375|NCT01026974|12245105|FG001|Overall Study|Lost to Follow-up|1
7791376|NCT01026974|12245106|FG002|Overall Study|Lost to Follow-up|4
7791377|NCT01026974|12245107|FG003|Overall Study|Lost to Follow-up|0
7791378|NCT01026974|12245104|FG000|Overall Study|Adverse Event|0
7791379|NCT01026974|12245105|FG001|Overall Study|Adverse Event|0
7791380|NCT01026974|12245106|FG002|Overall Study|Adverse Event|0
7791381|NCT01026974|12245107|FG003|Overall Study|Adverse Event|1
7791382|NCT01026974|12245104|FG000|Overall Study|Inappropriate enrollment|0
7622984|NCT03338816|12033932|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1
7622985|NCT03338816|12033933|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0
7791383|NCT01026974|12245105|FG001|Overall Study|Inappropriate enrollment|0
7791384|NCT01026974|12245106|FG002|Overall Study|Inappropriate enrollment|1
7791385|NCT01026974|12245107|FG003|Overall Study|Inappropriate enrollment|0
7791386|NCT01027273|12245137|FG000|Overall Study|Lost to Follow-up|57
7791387|NCT01027273|12245138|FG001|Overall Study|Lost to Follow-up|31
7791388|NCT01027273|12245137|FG000|Overall Study|Death|2
7791389|NCT01027273|12245138|FG001|Overall Study|Death|2
7791390|NCT01027286|12245146|FG000|Overall Study|Unable to Obtain Required Blood Volume|1
7791391|NCT01027286|12245147|FG001|Overall Study|Unable to Obtain Required Blood Volume|0
7791392|NCT01027286|12245146|FG000|Overall Study|Lost to Follow-up|0
7791393|NCT01027286|12245147|FG001|Overall Study|Lost to Follow-up|1
7791394|NCT01027351|12245159|FG000|Overall Study|Withdrawal by Subject|1
7791395|NCT01027351|12245160|FG001|Overall Study|Withdrawal by Subject|0
7791396|NCT01027351|12245161|FG002|Overall Study|Withdrawal by Subject|1
7791397|NCT01027351|12245162|FG003|Overall Study|Withdrawal by Subject|0
7791398|NCT01027351|12245163|FG004|Overall Study|Withdrawal by Subject|3
7791399|NCT01027351|12245164|FG005|Overall Study|Withdrawal by Subject|5
7622986|NCT03338816|12033930|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0
7622987|NCT03338816|12033931|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0
7622988|NCT03338816|12033932|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1
7622989|NCT03338816|12033933|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0
7622990|NCT03338816|12033930|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0
7622991|NCT03338816|12033931|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0
7622992|NCT03338816|12033932|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1
7622993|NCT03338816|12033933|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1
7622994|NCT03338816|12033930|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0
7622995|NCT03338816|12033931|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0
7622996|NCT03338816|12033932|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3
7622997|NCT03338816|12033933|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3
7622998|NCT03338816|12033930|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0
7622999|NCT03338816|12033931|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0
7623000|NCT03338816|12033932|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0
7623001|NCT03338816|12033933|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1
7623002|NCT03317496|12033955|FG000|Phase 1b Lead-in: Treatment|Adverse Event|2
7623003|NCT03317496|12033956|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4
7623004|NCT03317496|12033957|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1
7623005|NCT03317496|12033958|FG003|Phase 1b Lead-in: Treatment|Adverse Event|0
7623006|NCT03317496|12033959|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0
7623007|NCT03317496|12033955|FG000|Phase 1b Lead-in: Treatment|Physician Decision|1
7623008|NCT03317496|12033956|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1
7623009|NCT03317496|12033957|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0
7623010|NCT03317496|12033958|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0
7791400|NCT01027351|12245159|FG000|Overall Study|Lost to Follow-up|1
7791401|NCT01027351|12245160|FG001|Overall Study|Lost to Follow-up|1
7791402|NCT01027351|12245161|FG002|Overall Study|Lost to Follow-up|0
7791403|NCT01027351|12245162|FG003|Overall Study|Lost to Follow-up|1
7791404|NCT01027351|12245163|FG004|Overall Study|Lost to Follow-up|6
7791405|NCT01027351|12245164|FG005|Overall Study|Lost to Follow-up|0
7791406|NCT01027351|12245159|FG000|Overall Study|Inappropriate enrollment|0
7791407|NCT01027351|12245160|FG001|Overall Study|Inappropriate enrollment|0
7791408|NCT01027351|12245161|FG002|Overall Study|Inappropriate enrollment|0
7791409|NCT01027351|12245162|FG003|Overall Study|Inappropriate enrollment|0
7791410|NCT01027351|12245163|FG004|Overall Study|Inappropriate enrollment|1
7791411|NCT01027351|12245164|FG005|Overall Study|Inappropriate enrollment|0
7791412|NCT01027351|12245159|FG000|Overall Study|Protocol Violation|1
7791413|NCT01027351|12245160|FG001|Overall Study|Protocol Violation|0
7791414|NCT01027351|12245161|FG002|Overall Study|Protocol Violation|0
7791415|NCT01027351|12245162|FG003|Overall Study|Protocol Violation|1
7791416|NCT01027351|12245163|FG004|Overall Study|Protocol Violation|1
7791417|NCT01027351|12245164|FG005|Overall Study|Protocol Violation|0
7791418|NCT01027364|12245189|FG000|Overall Study|Adverse Event|1
7791419|NCT01027364|12245190|FG001|Overall Study|Adverse Event|0
7791420|NCT01027364|12245191|FG002|Overall Study|Adverse Event|1
7791421|NCT01027364|12245192|FG003|Overall Study|Adverse Event|0
7791422|NCT01027364|12245189|FG000|Overall Study|Lost to Follow-up|1
7791423|NCT01027364|12245190|FG001|Overall Study|Lost to Follow-up|0
7791424|NCT01027364|12245191|FG002|Overall Study|Lost to Follow-up|0
7791425|NCT01027364|12245192|FG003|Overall Study|Lost to Follow-up|0
7791426|NCT01027364|12245189|FG000|Overall Study|Protocol Violation|1
7791427|NCT01027364|12245190|FG001|Overall Study|Protocol Violation|0
7791428|NCT01027364|12245191|FG002|Overall Study|Protocol Violation|0
7791429|NCT01027364|12245192|FG003|Overall Study|Protocol Violation|1
7791430|NCT01027364|12245189|FG000|Overall Study|Withdrawal by Subject|1
7623011|NCT03317496|12033959|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0
7791431|NCT01027364|12245190|FG001|Overall Study|Withdrawal by Subject|2
7791432|NCT01027364|12245191|FG002|Overall Study|Withdrawal by Subject|0
7791433|NCT01027364|12245192|FG003|Overall Study|Withdrawal by Subject|0
7791434|NCT01027416|12245220|FG000|Overall Study|Withdrawal by Subject|0
7791435|NCT01027416|12245221|FG001|Overall Study|Withdrawal by Subject|1
7791436|NCT01027416|12245220|FG000|Overall Study|Physician Decision|1
7791437|NCT01027416|12245221|FG001|Overall Study|Physician Decision|4
7791438|NCT01027650|12245262|FG000|Overall Study|Personal Reasons|0
7791439|NCT01027650|12245263|FG001|Overall Study|Personal Reasons|0
7791440|NCT01027650|12245264|FG002|Overall Study|Personal Reasons|0
7791441|NCT01027650|12245265|FG003|Overall Study|Personal Reasons|0
7791442|NCT01027650|12245266|FG004|Overall Study|Personal Reasons|2
7791443|NCT01027650|12245267|FG005|Overall Study|Personal Reasons|1
7791444|NCT01027650|12245268|FG006|Overall Study|Personal Reasons|0
7791445|NCT01027650|12245269|FG007|Overall Study|Personal Reasons|0
7791446|NCT01027650|12245262|FG000|Overall Study|Lost to Follow-up|0
7791447|NCT01027650|12245263|FG001|Overall Study|Lost to Follow-up|0
7791448|NCT01027650|12245264|FG002|Overall Study|Lost to Follow-up|0
7791449|NCT01027650|12245265|FG003|Overall Study|Lost to Follow-up|0
7791450|NCT01027650|12245266|FG004|Overall Study|Lost to Follow-up|0
7791451|NCT01027650|12245267|FG005|Overall Study|Lost to Follow-up|0
7791452|NCT01027650|12245268|FG006|Overall Study|Lost to Follow-up|1
7791453|NCT01027650|12245269|FG007|Overall Study|Lost to Follow-up|0
7791454|NCT01027650|12245262|FG000|Overall Study|Lack of Efficacy|0
7791455|NCT01027650|12245263|FG001|Overall Study|Lack of Efficacy|0
7791456|NCT01027650|12245264|FG002|Overall Study|Lack of Efficacy|0
7791457|NCT01027650|12245265|FG003|Overall Study|Lack of Efficacy|0
7791458|NCT01027650|12245266|FG004|Overall Study|Lack of Efficacy|0
7791459|NCT01027650|12245267|FG005|Overall Study|Lack of Efficacy|1
7791460|NCT01027650|12245268|FG006|Overall Study|Lack of Efficacy|0
7791461|NCT01027650|12245269|FG007|Overall Study|Lack of Efficacy|0
7791462|NCT01027754|12245289|FG000|Overall Study|withdrew/lost to follow-up after interve|2
7791463|NCT01027754|12245290|FG001|Overall Study|withdrew/lost to follow-up after interve|3
7791464|NCT01027754|12245289|FG000|Overall Study|Withdrawal by Subject|0
7791465|NCT01027754|12245290|FG001|Overall Study|Withdrawal by Subject|5
7791466|NCT01027845|12245335|FG000|Primary Vaccination Phase|Serious Adverse Event|2
7791467|NCT01027845|12245336|FG001|Primary Vaccination Phase|Serious Adverse Event|0
7791468|NCT01027845|12245337|FG002|Primary Vaccination Phase|Serious Adverse Event|0
7791469|NCT01027845|12245338|FG003|Primary Vaccination Phase|Serious Adverse Event|0
7791470|NCT01027845|12245335|FG000|Primary Vaccination Phase|Adverse Event|1
7791471|NCT01027845|12245336|FG001|Primary Vaccination Phase|Adverse Event|0
7791472|NCT01027845|12245337|FG002|Primary Vaccination Phase|Adverse Event|0
7791473|NCT01027845|12245338|FG003|Primary Vaccination Phase|Adverse Event|0
7791474|NCT01027845|12245335|FG000|Primary Vaccination Phase|Protocol Violation|1
7791475|NCT01027845|12245336|FG001|Primary Vaccination Phase|Protocol Violation|0
7791476|NCT01027845|12245337|FG002|Primary Vaccination Phase|Protocol Violation|0
7791477|NCT01027845|12245338|FG003|Primary Vaccination Phase|Protocol Violation|0
7791478|NCT01027845|12245335|FG000|Primary Vaccination Phase|Migrated/moved from study area|0
7791479|NCT01027845|12245336|FG001|Primary Vaccination Phase|Migrated/moved from study area|1
7791480|NCT01027845|12245337|FG002|Primary Vaccination Phase|Migrated/moved from study area|0
7791481|NCT01027845|12245338|FG003|Primary Vaccination Phase|Migrated/moved from study area|0
7791482|NCT01027845|12245335|FG000|Booster Vaccination Phase|Withdrawal by Subject|1
7791483|NCT01027845|12245336|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
7791484|NCT01027845|12245337|FG002|Booster Vaccination Phase|Withdrawal by Subject|0
7791485|NCT01027845|12245338|FG003|Booster Vaccination Phase|Withdrawal by Subject|0
7791486|NCT01027845|12245335|FG000|Booster Vaccination Phase|Migrated/moved from study area|1
7791487|NCT01027845|12245336|FG001|Booster Vaccination Phase|Migrated/moved from study area|0
7791488|NCT01027845|12245337|FG002|Booster Vaccination Phase|Migrated/moved from study area|0
7791489|NCT01027845|12245338|FG003|Booster Vaccination Phase|Migrated/moved from study area|0
7791490|NCT01027871|12245350|FG000|Overall Study|Physician Decision|1
7791491|NCT01027871|12245351|FG001|Overall Study|Physician Decision|5
7791492|NCT01027871|12245352|FG002|Overall Study|Physician Decision|0
7791493|NCT01027871|12245350|FG000|Overall Study|Protocol Violation|0
7791494|NCT01027871|12245351|FG001|Overall Study|Protocol Violation|2
7791495|NCT01027871|12245352|FG002|Overall Study|Protocol Violation|2
7791496|NCT01027871|12245350|FG000|Overall Study|Withdrawal by Subject|1
7791497|NCT01027871|12245351|FG001|Overall Study|Withdrawal by Subject|2
7791498|NCT01027871|12245352|FG002|Overall Study|Withdrawal by Subject|2
7791499|NCT01027871|12245350|FG000|Overall Study|Adverse Event|0
7791500|NCT01027871|12245351|FG001|Overall Study|Adverse Event|2
7791501|NCT01027871|12245352|FG002|Overall Study|Adverse Event|2
7791502|NCT01027871|12245350|FG000|Overall Study|Sponsor Decision|0
7791503|NCT01027871|12245351|FG001|Overall Study|Sponsor Decision|2
7791504|NCT01027871|12245352|FG002|Overall Study|Sponsor Decision|0
7791505|NCT01027871|12245350|FG000|Overall Study|Discontinued Prior to Treatment|0
7791506|NCT01027871|12245351|FG001|Overall Study|Discontinued Prior to Treatment|0
7791507|NCT01027871|12245352|FG002|Overall Study|Discontinued Prior to Treatment|1
7791508|NCT01027884|12245367|FG000|Overall Study|Adverse Event|2
7791509|NCT01027884|12245368|FG001|Overall Study|Adverse Event|1
7791510|NCT01027884|12245367|FG000|Overall Study|Protocol Violation|1
7791511|NCT01027884|12245368|FG001|Overall Study|Protocol Violation|0
7791512|NCT01027884|12245367|FG000|Overall Study|Non-compliance|1
7791513|NCT01027884|12245368|FG001|Overall Study|Non-compliance|1
7791514|NCT01027884|12245367|FG000|Overall Study|Withdrawal by Subject|0
7791515|NCT01027884|12245368|FG001|Overall Study|Withdrawal by Subject|1
7791516|NCT01027884|12245367|FG000|Overall Study|Lost to Follow-up|0
7791517|NCT01027884|12245368|FG001|Overall Study|Lost to Follow-up|1
7791518|NCT01027884|12245367|FG000|Overall Study|Spinal fixation surgery|0
7791519|NCT01027884|12245368|FG001|Overall Study|Spinal fixation surgery|3
7791520|NCT01027897|12245376|FG000|Overall Study|Protocol Violation|1
7791521|NCT01027897|12245376|FG000|Overall Study|Withdrawal by Subject|1
7791522|NCT01027949|12245391|FG000|Overall Study|Death|174
7791523|NCT01027949|12245391|FG000|Overall Study|Progressive Disease|163
7791524|NCT01027949|12245391|FG000|Overall Study|Adverse Event|172
7791525|NCT01027949|12245391|FG000|Overall Study|Withdrawal by Subject|113
7791526|NCT01027949|12245391|FG000|Overall Study|Lost to Follow-up|17
7791527|NCT01027949|12245391|FG000|Overall Study|Protocol Violation|13
7791528|NCT01027949|12245391|FG000|Overall Study|PI Decision|8
7791529|NCT01027949|12245391|FG000|Overall Study|Limited Study Drug Effectiveness|7
7791530|NCT01027949|12245391|FG000|Overall Study|Non-compliance with Study Procedures|7
7791531|NCT01027949|12245391|FG000|Overall Study|Lung Transplant|5
7791532|NCT01027949|12245391|FG000|Overall Study|Unable to Tolerate Study Drug|2
7791533|NCT01027949|12245391|FG000|Overall Study|Use of Excluded Medication|2
7791534|NCT01027949|12245391|FG000|Overall Study|Patient Self-discontinuation|1
7791535|NCT01027949|12245391|FG000|Overall Study|Pregnancy|1
7791536|NCT01027949|12245391|FG000|Overall Study|Surgery|1
7791537|NCT01028014|12245401|FG000|Overall Study|Lost to Follow-up|1
7791538|NCT01028014|12245402|FG001|Overall Study|Lost to Follow-up|2
7791539|NCT01028014|12245403|FG002|Overall Study|Lost to Follow-up|0
7791540|NCT01028014|12245404|FG003|Overall Study|Lost to Follow-up|1
7791541|NCT01028014|12245405|FG004|Overall Study|Lost to Follow-up|1
7791542|NCT01028014|12245406|FG005|Overall Study|Lost to Follow-up|2
7791543|NCT01028027|12245422|FG000|Overall Study|Lost to Follow-up|4
7791544|NCT01028027|12245423|FG001|Overall Study|Lost to Follow-up|1
7791545|NCT01028027|12245422|FG000|Overall Study|Withdrawal by Subject|5
7791546|NCT01028027|12245423|FG001|Overall Study|Withdrawal by Subject|3
7791547|NCT01028027|12245422|FG000|Overall Study|Adverse Event|4
7791548|NCT01028027|12245423|FG001|Overall Study|Adverse Event|7
7791549|NCT01028027|12245422|FG000|Overall Study|Protocol Violation|3
7791550|NCT01028027|12245423|FG001|Overall Study|Protocol Violation|1
7791551|NCT01028027|12245422|FG000|Overall Study|Lack of Efficacy|0
7791552|NCT01028027|12245423|FG001|Overall Study|Lack of Efficacy|1
7791553|NCT01028053|12245429|FG000|Overall Study|Screen Failure|113
7791554|NCT01028053|12245429|FG000|Overall Study|Patient Request|11
7791555|NCT01028053|12245429|FG000|Overall Study|Protocol Violation|1
7791556|NCT01028053|12245429|FG000|Overall Study|Physician Decision|2
7791557|NCT01028053|12245429|FG000|Overall Study|Technical Problem|1
7791558|NCT01028053|12245429|FG000|Overall Study|Terminated by Sponsor|1
7791559|NCT01028053|12245429|FG000|Overall Study|Various reasons|4
7791560|NCT01028222|12245454|FG000|Overall Study|Protocol deviation|1
7791561|NCT01028222|12245455|FG001|Overall Study|Protocol deviation|0
7791562|NCT01028222|12245454|FG000|Overall Study|Disease progression|33
7791563|NCT01028222|12245455|FG001|Overall Study|Disease progression|9
7791564|NCT01028222|12245454|FG000|Overall Study|Administrative problems|1
7791565|NCT01028222|12245455|FG001|Overall Study|Administrative problems|1
7791566|NCT01028222|12245454|FG000|Overall Study|Lost to Follow-up|0
7791567|NCT01028222|12245455|FG001|Overall Study|Lost to Follow-up|1
7791568|NCT01028222|12245454|FG000|Overall Study|Withdrawal by Subject|1
7791569|NCT01028222|12245455|FG001|Overall Study|Withdrawal by Subject|0
7791570|NCT01028222|12245454|FG000|Overall Study|Crossover to nilotinib w/out progression|0
7791571|NCT01028222|12245455|FG001|Overall Study|Crossover to nilotinib w/out progression|2
7791572|NCT01028222|12245454|FG000|Overall Study|Adverse Event|2
7791573|NCT01028222|12245455|FG001|Overall Study|Adverse Event|0
7791574|NCT01028352|12245462|FG000|Overall Study|Ineligible due to baseline average pain|5
7791575|NCT01028352|12245462|FG000|Overall Study|Withdrawal by Subject|1
7791576|NCT01028378|12245466|FG000|Overall Study|Lost to Follow-up|12
7791577|NCT01028378|12245466|FG000|Overall Study|Withdrawal by Subject|1
7791578|NCT01028378|12245466|FG000|Overall Study|Adminstrative Reasons|4
7791579|NCT01028391|12245472|FG000|Overall Study|Adverse Event|4
7791580|NCT01028391|12245473|FG001|Overall Study|Adverse Event|0
7791581|NCT01028391|12245472|FG000|Overall Study|Lack of Efficacy|0
7791582|NCT01028391|12245473|FG001|Overall Study|Lack of Efficacy|2
7791583|NCT01028391|12245472|FG000|Overall Study|Lost to Follow-up|3
7791584|NCT01028391|12245473|FG001|Overall Study|Lost to Follow-up|4
7791585|NCT01028391|12245472|FG000|Overall Study|Physician Decision|0
7791586|NCT01028391|12245473|FG001|Overall Study|Physician Decision|1
7791587|NCT01028391|12245472|FG000|Overall Study|Withdrawal by Subject|6
7791588|NCT01028391|12245473|FG001|Overall Study|Withdrawal by Subject|3
7791589|NCT01028391|12245472|FG000|Overall Study|Needed excluded medication|1
7791590|NCT01028391|12245473|FG001|Overall Study|Needed excluded medication|1
7791591|NCT01028560|12245481|FG000|Overall Study|Lack of Efficacy|3
7791592|NCT01028560|12245482|FG001|Overall Study|Lack of Efficacy|6
7791593|NCT01028560|12245481|FG000|Overall Study|Withdrawal by Subject|7
7791594|NCT01028560|12245482|FG001|Overall Study|Withdrawal by Subject|12
7791595|NCT01028651|12245489|FG000|Overall Study|Death|2
7791596|NCT01028651|12245489|FG000|Overall Study|Adverse Event|1
7800799|NCT01097629|12258362|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7800800|NCT01097629|12258363|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7800801|NCT01097629|12258364|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7800802|NCT01097629|12258365|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7800803|NCT01097629|12258358|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
7800804|NCT01097629|12258359|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
7800805|NCT01097629|12258360|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
7800806|NCT01097629|12258361|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7800807|NCT01097629|12258362|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7800808|NCT01097629|12258363|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7800809|NCT01097629|12258364|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7800810|NCT01097629|12258365|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7800811|NCT01097629|12258358|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
7800812|NCT01097629|12258359|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
7882371|NCT01769508|12381272|FG000|Overall Study|Adverse Event|1
7791597|NCT01029262|12245530|FG000|Overall Study|Adverse Event|9
7791598|NCT01029262|12245531|FG001|Overall Study|Adverse Event|52
7791599|NCT01029262|12245530|FG000|Overall Study|Lack of therapeutic effect|57
7791600|NCT01029262|12245531|FG001|Overall Study|Lack of therapeutic effect|76
7791601|NCT01029262|12245530|FG000|Overall Study|Withdrawal by Subject|10
7791602|NCT01029262|12245531|FG001|Overall Study|Withdrawal by Subject|17
7791603|NCT01029262|12245530|FG000|Overall Study|Protocol Violation|2
7791604|NCT01029262|12245531|FG001|Overall Study|Protocol Violation|3
7791605|NCT01029262|12245530|FG000|Overall Study|Miscellaneous|1
7791606|NCT01029262|12245531|FG001|Overall Study|Miscellaneous|9
7791607|NCT01029262|12245530|FG000|Overall Study|Death|0
7791608|NCT01029262|12245531|FG001|Overall Study|Death|3
7791609|NCT01029340|12245547|FG000|Part B Treatment Period|Withdrawal by Subject|0
7791610|NCT01029340|12245548|FG001|Part B Treatment Period|Withdrawal by Subject|0
7791611|NCT01029340|12245549|FG002|Part B Treatment Period|Withdrawal by Subject|1
7791612|NCT01029340|12245550|FG003|Part B Treatment Period|Withdrawal by Subject|0
7791613|NCT01029340|12245551|FG004|Part B Treatment Period|Withdrawal by Subject|0
7791614|NCT01029340|12245552|FG005|Part B Treatment Period|Withdrawal by Subject|0
7791615|NCT01029340|12245547|FG000|Part B Treatment Period|Protocol Violation|0
7791616|NCT01029340|12245548|FG001|Part B Treatment Period|Protocol Violation|0
7791617|NCT01029340|12245549|FG002|Part B Treatment Period|Protocol Violation|1
7791618|NCT01029340|12245550|FG003|Part B Treatment Period|Protocol Violation|0
7791619|NCT01029340|12245551|FG004|Part B Treatment Period|Protocol Violation|0
7791620|NCT01029340|12245552|FG005|Part B Treatment Period|Protocol Violation|0
7791621|NCT01029340|12245547|FG000|Extension Period|Adverse Event|0
7791622|NCT01029340|12245548|FG001|Extension Period|Adverse Event|0
7791623|NCT01029340|12245549|FG002|Extension Period|Adverse Event|0
7791624|NCT01029340|12245550|FG003|Extension Period|Adverse Event|0
7791625|NCT01029340|12245551|FG004|Extension Period|Adverse Event|0
7791626|NCT01029340|12245552|FG005|Extension Period|Adverse Event|1
7791627|NCT01029340|12245547|FG000|Extension Period|starting another study|0
7791628|NCT01029340|12245548|FG001|Extension Period|starting another study|0
7623012|NCT03317496|12033955|FG000|Phase 1b Lead-in: Treatment|Death|0
7623013|NCT03317496|12033956|FG001|Phase 1b Lead-in: Treatment|Death|0
7623014|NCT03317496|12033957|FG002|Phase 1b Lead-in: Treatment|Death|1
7623015|NCT03317496|12033958|FG003|Phase 1b Lead-in: Treatment|Death|0
7623016|NCT03317496|12033959|FG004|Phase 1b Lead-in: Treatment|Death|0
7623017|NCT03317496|12033955|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1
7623018|NCT03317496|12033956|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6
7623019|NCT03317496|12033957|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3
7623020|NCT03317496|12033958|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4
7623021|NCT03317496|12033959|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0
7623022|NCT03317496|12033955|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0
7623023|NCT03317496|12033956|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0
7623024|NCT03317496|12033957|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1
7623025|NCT03317496|12033958|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0
7623026|NCT03317496|12033959|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0
7623027|NCT03317496|12033955|FG000|Phase 1b Lead-in: Treatment|Other|0
7623028|NCT03317496|12033956|FG001|Phase 1b Lead-in: Treatment|Other|1
7623029|NCT03317496|12033957|FG002|Phase 1b Lead-in: Treatment|Other|0
7623030|NCT03317496|12033958|FG003|Phase 1b Lead-in: Treatment|Other|0
7623031|NCT03317496|12033959|FG004|Phase 1b Lead-in: Treatment|Other|0
7623032|NCT03317496|12033955|FG000|Phase 1b Lead-in: Treatment|Ongoing|2
7623033|NCT03317496|12033956|FG001|Phase 1b Lead-in: Treatment|Ongoing|1
7623034|NCT03317496|12033957|FG002|Phase 1b Lead-in: Treatment|Ongoing|0
7623035|NCT03317496|12033958|FG003|Phase 1b Lead-in: Treatment|Ongoing|2
7623036|NCT03317496|12033959|FG004|Phase 1b Lead-in: Treatment|Ongoing|0
7623037|NCT03317496|12033955|FG000|Phase 1b Lead-in: Follow-up|Death|2
7623038|NCT03317496|12033956|FG001|Phase 1b Lead-in: Follow-up|Death|7
7623039|NCT03317496|12033957|FG002|Phase 1b Lead-in: Follow-up|Death|4
7623040|NCT03317496|12033958|FG003|Phase 1b Lead-in: Follow-up|Death|3
7623041|NCT03317496|12033959|FG004|Phase 1b Lead-in: Follow-up|Death|0
7623042|NCT03317496|12033955|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1
7623043|NCT03317496|12033956|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0
7623044|NCT03317496|12033957|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0
7623045|NCT03317496|12033958|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0
7623046|NCT03317496|12033959|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0
7791629|NCT01029340|12245549|FG002|Extension Period|starting another study|0
7791630|NCT01029340|12245550|FG003|Extension Period|starting another study|0
7791631|NCT01029340|12245551|FG004|Extension Period|starting another study|0
7791632|NCT01029340|12245552|FG005|Extension Period|starting another study|8
7791633|NCT01029340|12245547|FG000|Extension Period|non-compliance|0
7791634|NCT01029340|12245548|FG001|Extension Period|non-compliance|0
7791635|NCT01029340|12245549|FG002|Extension Period|non-compliance|0
7791636|NCT01029340|12245550|FG003|Extension Period|non-compliance|0
7791637|NCT01029340|12245551|FG004|Extension Period|non-compliance|0
7791638|NCT01029340|12245552|FG005|Extension Period|non-compliance|1
7791639|NCT01029340|12245547|FG000|Extension Period|Withdrawal by Subject|0
7791640|NCT01029340|12245548|FG001|Extension Period|Withdrawal by Subject|0
7791641|NCT01029340|12245549|FG002|Extension Period|Withdrawal by Subject|0
7791642|NCT01029340|12245550|FG003|Extension Period|Withdrawal by Subject|0
7791643|NCT01029340|12245551|FG004|Extension Period|Withdrawal by Subject|0
7791644|NCT01029340|12245552|FG005|Extension Period|Withdrawal by Subject|1
7791645|NCT01029340|12245547|FG000|Extension Period|Physician Decision|0
7791646|NCT01029340|12245548|FG001|Extension Period|Physician Decision|0
7791647|NCT01029340|12245549|FG002|Extension Period|Physician Decision|0
7791648|NCT01029340|12245550|FG003|Extension Period|Physician Decision|0
7791649|NCT01029340|12245551|FG004|Extension Period|Physician Decision|0
7791650|NCT01029340|12245552|FG005|Extension Period|Physician Decision|1
7791651|NCT01029353|12245569|FG000|Overall Study|Lost to Follow-up|4
7791652|NCT01029353|12245570|FG001|Overall Study|Lost to Follow-up|5
7791653|NCT01029353|12245571|FG002|Overall Study|Lost to Follow-up|5
7791654|NCT01029353|12245572|FG003|Overall Study|Lost to Follow-up|4
7791655|NCT01029353|12245569|FG000|Overall Study|Consent Withdrawn|2
7791656|NCT01029353|12245570|FG001|Overall Study|Consent Withdrawn|0
7791657|NCT01029353|12245571|FG002|Overall Study|Consent Withdrawn|0
7791658|NCT01029353|12245572|FG003|Overall Study|Consent Withdrawn|0
7791659|NCT01029353|12245569|FG000|Overall Study|Primary Outcome Indeterminate|1
7791660|NCT01029353|12245570|FG001|Overall Study|Primary Outcome Indeterminate|3
7791661|NCT01029353|12245571|FG002|Overall Study|Primary Outcome Indeterminate|2
7791662|NCT01029353|12245572|FG003|Overall Study|Primary Outcome Indeterminate|0
7791663|NCT01029366|12245584|FG000|Overall Study|Withdrawal by Subject|1
7791664|NCT01029366|12245585|FG001|Overall Study|Withdrawal by Subject|0
7791665|NCT01029366|12245584|FG000|Overall Study|Death|1
7791666|NCT01029366|12245585|FG001|Overall Study|Death|1
7791667|NCT01029366|12245584|FG000|Overall Study|disease progression|2
7791668|NCT01029366|12245585|FG001|Overall Study|disease progression|0
7791669|NCT01029366|12245584|FG000|Overall Study|manufacturing failure|0
7791670|NCT01029366|12245585|FG001|Overall Study|manufacturing failure|1
7791671|NCT01029392|12245594|FG000|Overall Study|Withdrawal by Subject|18
7791672|NCT01029392|12245595|FG001|Overall Study|Withdrawal by Subject|11
7791673|NCT01029392|12245594|FG000|Overall Study|Physician Decision|2
7791674|NCT01029392|12245595|FG001|Overall Study|Physician Decision|0
7791675|NCT01029405|12245607|FG000|Overall Study|Withdrawal by Subject|0
7791676|NCT01029405|12245608|FG001|Overall Study|Withdrawal by Subject|1
7791677|NCT01029405|12245609|FG002|Overall Study|Withdrawal by Subject|2
7791678|NCT01029405|12245610|FG003|Overall Study|Withdrawal by Subject|0
7791679|NCT01029405|12245607|FG000|Overall Study|Protocol Violation|0
7791680|NCT01029405|12245608|FG001|Overall Study|Protocol Violation|0
7791681|NCT01029405|12245609|FG002|Overall Study|Protocol Violation|0
7791682|NCT01029405|12245610|FG003|Overall Study|Protocol Violation|1
7791683|NCT01029405|12245607|FG000|Overall Study|Adverse Event|0
7791684|NCT01029405|12245608|FG001|Overall Study|Adverse Event|0
7791685|NCT01029405|12245609|FG002|Overall Study|Adverse Event|1
7791686|NCT01029405|12245610|FG003|Overall Study|Adverse Event|1
7791687|NCT01029405|12245607|FG000|Overall Study|Lost to Follow-up|2
7791688|NCT01029405|12245608|FG001|Overall Study|Lost to Follow-up|1
7791689|NCT01029405|12245609|FG002|Overall Study|Lost to Follow-up|1
7791690|NCT01029405|12245610|FG003|Overall Study|Lost to Follow-up|2
7791691|NCT01029405|12245607|FG000|Overall Study|Other|0
7791692|NCT01029405|12245608|FG001|Overall Study|Other|1
7791693|NCT01029405|12245609|FG002|Overall Study|Other|0
7791694|NCT01029405|12245610|FG003|Overall Study|Other|1
7791695|NCT01029535|12245620|FG000|Overall Study|Lost to Follow-up|24
7791696|NCT01029535|12245620|FG000|Overall Study|Protocol Violation|2
7791697|NCT01029535|12245620|FG000|Overall Study|Participant Withdrew Consent|2
7791698|NCT01029535|12245620|FG000|Overall Study|Adverse Event|1
7791699|NCT01029535|12245620|FG000|Overall Study|Use of Another Treatment|1
7791700|NCT01029535|12245620|FG000|Overall Study|Death|1
7791701|NCT01029652|12245631|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
7791702|NCT01029652|12245632|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
7791703|NCT01029652|12245631|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
7791704|NCT01029652|12245632|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
7791705|NCT01029652|12245631|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3
7791706|NCT01029652|12245632|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1
7791707|NCT01029652|12245631|FG000|Core Study (0-12 Weeks)|Administrative problems|2
7791708|NCT01029652|12245632|FG001|Core Study (0-12 Weeks)|Administrative problems|1
7791709|NCT01029652|12245631|FG000|Core Study (0-12 Weeks)|Death|0
7791710|NCT01029652|12245632|FG001|Core Study (0-12 Weeks)|Death|1
7791711|NCT01029652|12245631|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
7791712|NCT01029652|12245632|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
7791713|NCT01029652|12245631|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
7791714|NCT01029652|12245632|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
7791715|NCT01029652|12245631|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
7791716|NCT01029652|12245632|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
7791717|NCT01029652|12245631|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
7791718|NCT01029652|12245632|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
7791719|NCT01029652|12245631|FG000|Extension Study 2 (25-72 Weeks)|Death|1
7791720|NCT01029652|12245632|FG001|Extension Study 2 (25-72 Weeks)|Death|1
7791721|NCT01029652|12245631|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
7791722|NCT01029652|12245632|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
7791723|NCT01029652|12245631|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
7882372|NCT01769508|12381272|FG000|Overall Study|Lost to Follow-up|1
7791724|NCT01029652|12245632|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
7791725|NCT01029691|12245659|FG000|Continued APAP to Delivery|Death|0
7791726|NCT01029691|12245660|FG001|Continued APAP to Delivery|Death|0
7791727|NCT01029691|12245661|FG002|Continued APAP to Delivery|Death|1
7791728|NCT01029704|12245679|FG000|Overall Study|Adverse Event|0
7791729|NCT01029704|12245680|FG001|Overall Study|Adverse Event|0
7791730|NCT01029704|12245681|FG002|Overall Study|Adverse Event|0
7791731|NCT01029704|12245682|FG003|Overall Study|Adverse Event|0
7791732|NCT01029704|12245683|FG004|Overall Study|Adverse Event|0
7791733|NCT01029704|12245684|FG005|Overall Study|Adverse Event|0
7791734|NCT01029704|12245685|FG006|Overall Study|Adverse Event|1
7791735|NCT01029704|12245686|FG007|Overall Study|Adverse Event|1
7791736|NCT01029704|12245687|FG008|Overall Study|Adverse Event|0
7791737|NCT01029704|12245679|FG000|Overall Study|Withdrawal by Subject|0
7791738|NCT01029704|12245680|FG001|Overall Study|Withdrawal by Subject|0
7791739|NCT01029704|12245681|FG002|Overall Study|Withdrawal by Subject|0
7791740|NCT01029704|12245682|FG003|Overall Study|Withdrawal by Subject|0
7791741|NCT01029704|12245683|FG004|Overall Study|Withdrawal by Subject|2
7791742|NCT01029704|12245684|FG005|Overall Study|Withdrawal by Subject|1
7791743|NCT01029704|12245685|FG006|Overall Study|Withdrawal by Subject|1
7791744|NCT01029704|12245686|FG007|Overall Study|Withdrawal by Subject|1
7791745|NCT01029704|12245687|FG008|Overall Study|Withdrawal by Subject|0
7791746|NCT01029704|12245679|FG000|Overall Study|Lost to Follow-up|0
7791747|NCT01029704|12245680|FG001|Overall Study|Lost to Follow-up|0
7791748|NCT01029704|12245681|FG002|Overall Study|Lost to Follow-up|0
7791749|NCT01029704|12245682|FG003|Overall Study|Lost to Follow-up|0
7791750|NCT01029704|12245683|FG004|Overall Study|Lost to Follow-up|0
7791751|NCT01029704|12245684|FG005|Overall Study|Lost to Follow-up|0
7791752|NCT01029704|12245685|FG006|Overall Study|Lost to Follow-up|1
7791753|NCT01029704|12245686|FG007|Overall Study|Lost to Follow-up|1
7791754|NCT01029704|12245687|FG008|Overall Study|Lost to Follow-up|1
7791755|NCT01029704|12245679|FG000|Overall Study|Lack of Efficacy|0
7791756|NCT01029704|12245680|FG001|Overall Study|Lack of Efficacy|0
7791757|NCT01029704|12245681|FG002|Overall Study|Lack of Efficacy|0
7791758|NCT01029704|12245682|FG003|Overall Study|Lack of Efficacy|0
7791759|NCT01029704|12245683|FG004|Overall Study|Lack of Efficacy|2
7791760|NCT01029704|12245684|FG005|Overall Study|Lack of Efficacy|3
7791761|NCT01029704|12245685|FG006|Overall Study|Lack of Efficacy|1
7791762|NCT01029704|12245686|FG007|Overall Study|Lack of Efficacy|2
7791763|NCT01029704|12245687|FG008|Overall Study|Lack of Efficacy|0
7791764|NCT01029704|12245679|FG000|Overall Study|Withdrawn due to major protocol violation|0
7791765|NCT01029704|12245680|FG001|Overall Study|Withdrawn due to major protocol violation|0
7791766|NCT01029704|12245681|FG002|Overall Study|Withdrawn due to major protocol violation|0
7791767|NCT01029704|12245682|FG003|Overall Study|Withdrawn due to major protocol violation|0
7791768|NCT01029704|12245683|FG004|Overall Study|Withdrawn due to major protocol violation|1
7791769|NCT01029704|12245684|FG005|Overall Study|Withdrawn due to major protocol violation|0
7791770|NCT01029704|12245685|FG006|Overall Study|Withdrawn due to major protocol violation|0
7791771|NCT01029704|12245686|FG007|Overall Study|Withdrawn due to major protocol violation|1
7791772|NCT01029704|12245687|FG008|Overall Study|Withdrawn due to major protocol violation|0
7791773|NCT01029782|12245713|FG000|Overall Study|Lost to Follow-up|2
7791774|NCT01029782|12245714|FG001|Overall Study|Lost to Follow-up|2
7791775|NCT01029782|12245713|FG000|Overall Study|Diagnosis changed|1
7791776|NCT01029782|12245714|FG001|Overall Study|Diagnosis changed|1
7791777|NCT01029782|12245713|FG000|Overall Study|Adverse Event|0
7791778|NCT01029782|12245714|FG001|Overall Study|Adverse Event|1
7791779|NCT01029782|12245713|FG000|Overall Study|Physician Decision|0
7623047|NCT03317496|12033955|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0
7623048|NCT03317496|12033956|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0
7623049|NCT03317496|12033957|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1
7791780|NCT01029782|12245714|FG001|Overall Study|Physician Decision|1
7791781|NCT01029782|12245713|FG000|Overall Study|Protocol Violation|0
7791782|NCT01029782|12245714|FG001|Overall Study|Protocol Violation|2
7791783|NCT01029782|12245713|FG000|Overall Study|Withdrawal by Subject|0
7791784|NCT01029782|12245714|FG001|Overall Study|Withdrawal by Subject|1
7791785|NCT01029795|12245722|FG000|Overall Study|Entry Criteria Not Met|2
7791786|NCT01029795|12245723|FG001|Overall Study|Entry Criteria Not Met|1
7791787|NCT01029795|12245722|FG000|Overall Study|Physician Decision|2
7791788|NCT01029795|12245723|FG001|Overall Study|Physician Decision|1
7791789|NCT01029795|12245722|FG000|Overall Study|Sponsor Decision|11
7791790|NCT01029795|12245723|FG001|Overall Study|Sponsor Decision|17
7791791|NCT01029795|12245722|FG000|Overall Study|Withdrawal by Subject|1
7791792|NCT01029795|12245723|FG001|Overall Study|Withdrawal by Subject|3
7791793|NCT01029886|12245731|FG000|Overall Study|Adverse Event|12
7791794|NCT01029886|12245732|FG001|Overall Study|Adverse Event|25
7791795|NCT01029886|12245731|FG000|Overall Study|Lost to Follow-up|1
7791796|NCT01029886|12245732|FG001|Overall Study|Lost to Follow-up|0
7791797|NCT01029886|12245731|FG000|Overall Study|Physician Decision|2
7791798|NCT01029886|12245732|FG001|Overall Study|Physician Decision|6
7791799|NCT01029886|12245731|FG000|Overall Study|Protocol Violation|17
7791800|NCT01029886|12245732|FG001|Overall Study|Protocol Violation|5
7791801|NCT01029886|12245731|FG000|Overall Study|Withdrawal by Subject|8
7791802|NCT01029886|12245732|FG001|Overall Study|Withdrawal by Subject|18
7791803|NCT01029886|12245731|FG000|Overall Study|Entry Criteria Not Met|13
7791804|NCT01029886|12245732|FG001|Overall Study|Entry Criteria Not Met|5
7791805|NCT01029886|12245731|FG000|Overall Study|Sponsor Decision|1
7791806|NCT01029886|12245732|FG001|Overall Study|Sponsor Decision|0
7791807|NCT01029886|12245731|FG000|Overall Study|Loss Glucose Control|7
7791808|NCT01029886|12245732|FG001|Overall Study|Loss Glucose Control|1
7791809|NCT01029925|12245751|FG000|Completion of Cycle 1 (28 Days)|Death|2
7791810|NCT01029925|12245751|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
7791811|NCT01029925|12245751|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
7623050|NCT03317496|12033958|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0
7623051|NCT03317496|12033959|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0
7623052|NCT03317496|12033955|FG000|Phase 1b Lead-in: Follow-up|Other|1
7623053|NCT03317496|12033956|FG001|Phase 1b Lead-in: Follow-up|Other|3
7623054|NCT03317496|12033957|FG002|Phase 1b Lead-in: Follow-up|Other|0
7623055|NCT03317496|12033958|FG003|Phase 1b Lead-in: Follow-up|Other|1
7623056|NCT03317496|12033959|FG004|Phase 1b Lead-in: Follow-up|Other|0
7623057|NCT03317496|12033955|FG000|Phase 1b Lead-in: Follow-up|Ongoing|0
7623058|NCT03317496|12033956|FG001|Phase 1b Lead-in: Follow-up|Ongoing|1
7623059|NCT03317496|12033957|FG002|Phase 1b Lead-in: Follow-up|Ongoing|0
7623060|NCT03317496|12033958|FG003|Phase 1b Lead-in: Follow-up|Ongoing|0
7623061|NCT03317496|12033959|FG004|Phase 1b Lead-in: Follow-up|Ongoing|0
7623062|NCT03317496|12033955|FG000|Phase 2: Treatment|Adverse Event|0
7623063|NCT03317496|12033956|FG001|Phase 2: Treatment|Adverse Event|0
7623064|NCT03317496|12033957|FG002|Phase 2: Treatment|Adverse Event|0
7623065|NCT03317496|12033958|FG003|Phase 2: Treatment|Adverse Event|0
7623066|NCT03317496|12033959|FG004|Phase 2: Treatment|Adverse Event|4
7623067|NCT03317496|12033955|FG000|Phase 2: Treatment|Death|0
7623068|NCT03317496|12033956|FG001|Phase 2: Treatment|Death|0
7623069|NCT03317496|12033957|FG002|Phase 2: Treatment|Death|0
7623070|NCT03317496|12033958|FG003|Phase 2: Treatment|Death|0
7623071|NCT03317496|12033959|FG004|Phase 2: Treatment|Death|1
7623072|NCT03317496|12033955|FG000|Phase 2: Treatment|Physician Decision|0
7623073|NCT03317496|12033956|FG001|Phase 2: Treatment|Physician Decision|0
7623074|NCT03317496|12033957|FG002|Phase 2: Treatment|Physician Decision|0
7623075|NCT03317496|12033958|FG003|Phase 2: Treatment|Physician Decision|0
7623076|NCT03317496|12033959|FG004|Phase 2: Treatment|Physician Decision|1
7623077|NCT03317496|12033955|FG000|Phase 2: Treatment|Progressive Disease|0
7623078|NCT03317496|12033956|FG001|Phase 2: Treatment|Progressive Disease|0
7623079|NCT03317496|12033957|FG002|Phase 2: Treatment|Progressive Disease|0
7623080|NCT03317496|12033958|FG003|Phase 2: Treatment|Progressive Disease|0
7623081|NCT03317496|12033959|FG004|Phase 2: Treatment|Progressive Disease|18
7623082|NCT03317496|12033955|FG000|Phase 2: Treatment|Withdrawal by Subject|0
7623083|NCT03317496|12033956|FG001|Phase 2: Treatment|Withdrawal by Subject|0
7623084|NCT03317496|12033957|FG002|Phase 2: Treatment|Withdrawal by Subject|0
7623085|NCT03317496|12033958|FG003|Phase 2: Treatment|Withdrawal by Subject|0
7623086|NCT03317496|12033959|FG004|Phase 2: Treatment|Withdrawal by Subject|1
7623087|NCT03317496|12033955|FG000|Phase 2: Treatment|Other|0
7623088|NCT03317496|12033956|FG001|Phase 2: Treatment|Other|0
7623089|NCT03317496|12033957|FG002|Phase 2: Treatment|Other|0
7623090|NCT03317496|12033958|FG003|Phase 2: Treatment|Other|0
7623091|NCT03317496|12033959|FG004|Phase 2: Treatment|Other|2
7623092|NCT03317496|12033955|FG000|Phase 2: Treatment|Ongoing|0
7623093|NCT03317496|12033956|FG001|Phase 2: Treatment|Ongoing|0
7623094|NCT03317496|12033957|FG002|Phase 2: Treatment|Ongoing|0
7623095|NCT03317496|12033958|FG003|Phase 2: Treatment|Ongoing|0
7623096|NCT03317496|12033959|FG004|Phase 2: Treatment|Ongoing|8
7623097|NCT03317496|12033955|FG000|Phase 2: Follow-up|Death|0
7623098|NCT03317496|12033956|FG001|Phase 2: Follow-up|Death|0
7623099|NCT03317496|12033957|FG002|Phase 2: Follow-up|Death|0
7623100|NCT03317496|12033958|FG003|Phase 2: Follow-up|Death|0
7623101|NCT03317496|12033959|FG004|Phase 2: Follow-up|Death|16
7623102|NCT03317496|12033955|FG000|Phase 2: Follow-up|Withdrawal by Subject|0
7623103|NCT03317496|12033956|FG001|Phase 2: Follow-up|Withdrawal by Subject|0
7623104|NCT03317496|12033957|FG002|Phase 2: Follow-up|Withdrawal by Subject|0
7623105|NCT03317496|12033958|FG003|Phase 2: Follow-up|Withdrawal by Subject|0
7623106|NCT03317496|12033959|FG004|Phase 2: Follow-up|Withdrawal by Subject|1
7623107|NCT03317496|12033955|FG000|Phase 2: Follow-up|Lost to Follow-up|0
7791812|NCT01030133|12245757|FG000|Overall Study|failed to experience pain at level 7/10|2
7791813|NCT01030133|12245758|FG001|Overall Study|failed to experience pain at level 7/10|2
7791814|NCT01030458|12245799|FG000|Overall Study|Lost to Follow-up|9
7791815|NCT01030458|12245800|FG001|Overall Study|Lost to Follow-up|10
7791816|NCT01030458|12245799|FG000|Overall Study|Withdrawal by Subject|2
7623108|NCT03317496|12033956|FG001|Phase 2: Follow-up|Lost to Follow-up|0
7791817|NCT01030458|12245800|FG001|Overall Study|Withdrawal by Subject|3
7791818|NCT01030458|12245799|FG000|Overall Study|Logistical reasons|9
7791819|NCT01030458|12245800|FG001|Overall Study|Logistical reasons|5
7791820|NCT01030458|12245799|FG000|Overall Study|Moved or changed job|6
7791821|NCT01030458|12245800|FG001|Overall Study|Moved or changed job|13
7791822|NCT01030458|12245799|FG000|Overall Study|Side effect of medication|1
7791823|NCT01030458|12245800|FG001|Overall Study|Side effect of medication|1
7791824|NCT01030523|12245808|FG000|Overall Study|Death|1
7791825|NCT01030523|12245809|FG001|Overall Study|Death|0
7791826|NCT01030523|12245808|FG000|Overall Study|Lost to Follow-up|4
7791827|NCT01030523|12245809|FG001|Overall Study|Lost to Follow-up|4
7791828|NCT01030523|12245808|FG000|Overall Study|Implant failure|1
7791829|NCT01030523|12245809|FG001|Overall Study|Implant failure|0
7791830|NCT01030523|12245808|FG000|Overall Study|Withdrawal by Subject|0
7791831|NCT01030523|12245809|FG001|Overall Study|Withdrawal by Subject|1
7791832|NCT01030536|12245820|FG000|Overall Study|Withdrawal by Subject|0
7791833|NCT01030536|12245821|FG001|Overall Study|Withdrawal by Subject|0
7791834|NCT01030536|12245822|FG002|Overall Study|Withdrawal by Subject|1
7791835|NCT01030536|12245823|FG003|Overall Study|Withdrawal by Subject|0
7791836|NCT01030536|12245824|FG004|Overall Study|Withdrawal by Subject|0
7791837|NCT01030536|12245820|FG000|Overall Study|undefined|1
7791838|NCT01030536|12245821|FG001|Overall Study|undefined|0
7791839|NCT01030536|12245822|FG002|Overall Study|undefined|1
7791840|NCT01030536|12245823|FG003|Overall Study|undefined|1
7791841|NCT01030536|12245824|FG004|Overall Study|undefined|0
7791842|NCT01030536|12245820|FG000|Overall Study|Adverse Event|0
7791843|NCT01030536|12245821|FG001|Overall Study|Adverse Event|3
7791844|NCT01030536|12245822|FG002|Overall Study|Adverse Event|1
7791845|NCT01030536|12245823|FG003|Overall Study|Adverse Event|0
7791846|NCT01030536|12245824|FG004|Overall Study|Adverse Event|1
7791847|NCT01030536|12245820|FG000|Overall Study|Progressive disease|6
7791848|NCT01030536|12245821|FG001|Overall Study|Progressive disease|2
7791849|NCT01030536|12245822|FG002|Overall Study|Progressive disease|3
7791850|NCT01030536|12245823|FG003|Overall Study|Progressive disease|2
7791851|NCT01030536|12245824|FG004|Overall Study|Progressive disease|0
7791852|NCT01030536|12245820|FG000|Overall Study|Death|0
7791853|NCT01030536|12245821|FG001|Overall Study|Death|1
7791854|NCT01030536|12245822|FG002|Overall Study|Death|0
7791855|NCT01030536|12245823|FG003|Overall Study|Death|0
7791856|NCT01030536|12245824|FG004|Overall Study|Death|0
7791857|NCT01030666|12245852|FG000|Overall Study|Lost to Follow-up|3
7791858|NCT01030666|12245853|FG001|Overall Study|Lost to Follow-up|2
7791859|NCT01030718|12245863|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1
7791860|NCT01030718|12245864|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1
7791861|NCT01030718|12245865|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11
7791862|NCT01030718|12245863|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3
7791863|NCT01030718|12245864|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5
7791864|NCT01030718|12245865|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1
7791865|NCT01030718|12245863|FG000|Studies CA180-031 and -036 Combined|Death|0
7791866|NCT01030718|12245864|FG001|Studies CA180-031 and -036 Combined|Death|1
7791867|NCT01030718|12245865|FG002|Studies CA180-031 and -036 Combined|Death|0
7791868|NCT01030718|12245863|FG000|Studies CA180-031 and -036 Combined|other reasons|0
7791869|NCT01030718|12245864|FG001|Studies CA180-031 and -036 Combined|other reasons|2
7791870|NCT01030718|12245865|FG002|Studies CA180-031 and -036 Combined|other reasons|0
7791871|NCT01030718|12245863|FG000|Study CA180-036 Only|insufficient effect|1
7791872|NCT01030718|12245864|FG001|Study CA180-036 Only|insufficient effect|1
7791873|NCT01030718|12245865|FG002|Study CA180-036 Only|insufficient effect|5
7791874|NCT01030718|12245863|FG000|Study CA180-036 Only|Adverse Event|2
7791875|NCT01030718|12245864|FG001|Study CA180-036 Only|Adverse Event|3
7791876|NCT01030718|12245865|FG002|Study CA180-036 Only|Adverse Event|0
7791877|NCT01030718|12245863|FG000|Study CA180-036 Only|Death|0
7791878|NCT01030718|12245864|FG001|Study CA180-036 Only|Death|1
7791879|NCT01030718|12245865|FG002|Study CA180-036 Only|Death|0
7791880|NCT01030718|12245863|FG000|Study CA180-036 Only|Other Reasons|0
7791881|NCT01030718|12245864|FG001|Study CA180-036 Only|Other Reasons|2
7791882|NCT01030718|12245865|FG002|Study CA180-036 Only|Other Reasons|0
7791883|NCT01030822|12245895|FG000|Overall Study|Moved/migrated from study area|6
7791884|NCT01030822|12245896|FG001|Overall Study|Moved/migrated from study area|7
7791885|NCT01030822|12245897|FG002|Overall Study|Moved/migrated from study area|3
7791886|NCT01030822|12245895|FG000|Overall Study|Withdrawal by Subject|16
7791887|NCT01030822|12245896|FG001|Overall Study|Withdrawal by Subject|13
7791888|NCT01030822|12245897|FG002|Overall Study|Withdrawal by Subject|16
7791889|NCT01030822|12245895|FG000|Overall Study|Lost to Follow-up|9
7791890|NCT01030822|12245896|FG001|Overall Study|Lost to Follow-up|4
7791891|NCT01030822|12245897|FG002|Overall Study|Lost to Follow-up|7
7791892|NCT01030874|12245917|FG000|Overall Study|Withdrawal by Subject|1
7791893|NCT01030874|12245918|FG001|Overall Study|Withdrawal by Subject|0
7791894|NCT01030874|12245917|FG000|Overall Study|Discharged in first 2 weeks|17
7791895|NCT01030874|12245918|FG001|Overall Study|Discharged in first 2 weeks|16
7791896|NCT01030952|12245926|FG000|Overall Study|Protocol Violation|0
7791897|NCT01030952|12245927|FG001|Overall Study|Protocol Violation|1
7791898|NCT01030952|12245926|FG000|Overall Study|Informed consent withdrawal|1
7791899|NCT01030952|12245927|FG001|Overall Study|Informed consent withdrawal|0
7791900|NCT01030952|12245926|FG000|Overall Study|Lost to Follow-up|0
7791901|NCT01030952|12245927|FG001|Overall Study|Lost to Follow-up|1
7791902|NCT01030952|12245926|FG000|Overall Study|Unexplained|1
7791903|NCT01030952|12245927|FG001|Overall Study|Unexplained|1
7791904|NCT01030965|12245939|FG000|Overall Study|Lack of Efficacy|3
7791905|NCT01030965|12245940|FG001|Overall Study|Lack of Efficacy|2
7791906|NCT01030965|12245941|FG002|Overall Study|Lack of Efficacy|0
7791907|NCT01030965|12245942|FG003|Overall Study|Lack of Efficacy|3
7791908|NCT01030965|12245939|FG000|Overall Study|Protocol Violation|1
7791909|NCT01030965|12245940|FG001|Overall Study|Protocol Violation|1
7791910|NCT01030965|12245941|FG002|Overall Study|Protocol Violation|1
7791911|NCT01030965|12245942|FG003|Overall Study|Protocol Violation|1
7791912|NCT01030965|12245939|FG000|Overall Study|Adverse Event|0
7791913|NCT01030965|12245940|FG001|Overall Study|Adverse Event|1
7791914|NCT01030965|12245941|FG002|Overall Study|Adverse Event|2
7791915|NCT01030965|12245942|FG003|Overall Study|Adverse Event|1
7791916|NCT01030965|12245939|FG000|Overall Study|Protocol-defined Stopping Criteria|0
7791917|NCT01030965|12245940|FG001|Overall Study|Protocol-defined Stopping Criteria|1
7791918|NCT01030965|12245941|FG002|Overall Study|Protocol-defined Stopping Criteria|1
7791919|NCT01030965|12245942|FG003|Overall Study|Protocol-defined Stopping Criteria|0
7791920|NCT01030965|12245939|FG000|Overall Study|Withdrawal by Subject|0
7791921|NCT01030965|12245940|FG001|Overall Study|Withdrawal by Subject|1
7791922|NCT01030965|12245941|FG002|Overall Study|Withdrawal by Subject|0
7791923|NCT01030965|12245942|FG003|Overall Study|Withdrawal by Subject|2
7791924|NCT01031004|12245954|FG000|Overall Study|Protocol Violation|0
7791925|NCT01031004|12245955|FG001|Overall Study|Protocol Violation|1
7791926|NCT01031004|12245954|FG000|Overall Study|Lost to Follow-up|1
7791927|NCT01031004|12245955|FG001|Overall Study|Lost to Follow-up|0
7791928|NCT01031069|12245969|FG000|Overall Study|Serious Adverse Event|0
7791929|NCT01031069|12245970|FG001|Overall Study|Serious Adverse Event|1
7791930|NCT01031069|12245971|FG002|Overall Study|Serious Adverse Event|0
7791931|NCT01031069|12245972|FG003|Overall Study|Serious Adverse Event|0
7791932|NCT01031069|12245969|FG000|Overall Study|Withdrawal by Subject|2
7791933|NCT01031069|12245970|FG001|Overall Study|Withdrawal by Subject|3
7791934|NCT01031069|12245971|FG002|Overall Study|Withdrawal by Subject|18
7791935|NCT01031069|12245972|FG003|Overall Study|Withdrawal by Subject|18
7791936|NCT01031069|12245969|FG000|Overall Study|Migrated/moved from study area|1
7791937|NCT01031069|12245970|FG001|Overall Study|Migrated/moved from study area|2
7791938|NCT01031069|12245971|FG002|Overall Study|Migrated/moved from study area|1
7791939|NCT01031069|12245972|FG003|Overall Study|Migrated/moved from study area|1
7791940|NCT01031069|12245969|FG000|Overall Study|Lost to Follow-up|9
7791941|NCT01031069|12245970|FG001|Overall Study|Lost to Follow-up|5
7791942|NCT01031069|12245971|FG002|Overall Study|Lost to Follow-up|21
7791943|NCT01031069|12245972|FG003|Overall Study|Lost to Follow-up|15
7791944|NCT01031069|12245969|FG000|Overall Study|Other|0
7791945|NCT01031069|12245970|FG001|Overall Study|Other|0
7791946|NCT01031069|12245971|FG002|Overall Study|Other|1
7791947|NCT01031069|12245972|FG003|Overall Study|Other|0
7791948|NCT01031381|12246002|FG000|Overall Study|Physician Decision|3
7791949|NCT01031381|12246002|FG000|Overall Study|Withdrawal by Subject|6
7791950|NCT01031446|12246011|FG000|Overall Study|Disease Progression|38
7791951|NCT01031446|12246011|FG000|Overall Study|Adverse Event|9
7791952|NCT01031446|12246011|FG000|Overall Study|Physician Decision|4
7791953|NCT01031446|12246011|FG000|Overall Study|Withdrawal by Subject|3
7623109|NCT03317496|12033957|FG002|Phase 2: Follow-up|Lost to Follow-up|0
7623110|NCT03317496|12033958|FG003|Phase 2: Follow-up|Lost to Follow-up|0
7623111|NCT03317496|12033959|FG004|Phase 2: Follow-up|Lost to Follow-up|1
7623112|NCT03317496|12033955|FG000|Phase 2: Follow-up|Other|0
7623113|NCT03317496|12033956|FG001|Phase 2: Follow-up|Other|0
7623114|NCT03317496|12033957|FG002|Phase 2: Follow-up|Other|0
7623115|NCT03317496|12033958|FG003|Phase 2: Follow-up|Other|0
7623116|NCT03317496|12033959|FG004|Phase 2: Follow-up|Other|6
7623117|NCT03317496|12033955|FG000|Phase 2: Follow-up|Ongoing|0
7623118|NCT03317496|12033956|FG001|Phase 2: Follow-up|Ongoing|0
7623119|NCT03317496|12033957|FG002|Phase 2: Follow-up|Ongoing|0
7623120|NCT03317496|12033958|FG003|Phase 2: Follow-up|Ongoing|0
7623121|NCT03317496|12033959|FG004|Phase 2: Follow-up|Ongoing|1
7623122|NCT03260894|12033972|FG000|Overall Study|Death|6
7623123|NCT03260894|12033973|FG001|Overall Study|Death|8
7623124|NCT03260894|12033972|FG000|Overall Study|Withdrawal by Subject|4
7791954|NCT01031446|12246011|FG000|Overall Study|Still on treatment|1
7791955|NCT01031537|12246030|FG000|Overall Study|medical reasons not related to study|3
7791956|NCT01031537|12246030|FG000|Overall Study|Lack of Efficacy|1
7791957|NCT01031537|12246030|FG000|Overall Study|retired from NIH, met exclusion criteria|1
7791958|NCT01031537|12246030|FG000|Overall Study|moved, met exclusion criteria|10
7791959|NCT01031537|12246030|FG000|Overall Study|Withdrawal by Subject|5
7791960|NCT01031537|12246030|FG000|Overall Study|PI removal, no longer met eligibility|12
7791961|NCT01031680|12246036|FG000|Overall Study|Adverse Event|8
7791962|NCT01031680|12246037|FG001|Overall Study|Adverse Event|3
7791963|NCT01031680|12246036|FG000|Overall Study|Lost to Follow-up|2
7791964|NCT01031680|12246037|FG001|Overall Study|Lost to Follow-up|10
7791965|NCT01031680|12246036|FG000|Overall Study|Withdrawal by Subject|12
7623125|NCT03260894|12033973|FG001|Overall Study|Withdrawal by Subject|11
7623126|NCT03260894|12033972|FG000|Overall Study|On-going at clinical cut off date|36
7623127|NCT03260894|12033973|FG001|Overall Study|On-going at clinical cut off date|31
7791966|NCT01031680|12246037|FG001|Overall Study|Withdrawal by Subject|16
7791967|NCT01031680|12246036|FG000|Overall Study|Death|2
7791968|NCT01031680|12246037|FG001|Overall Study|Death|1
7791969|NCT01031680|12246036|FG000|Overall Study|Subject No Longer Meets Study Criteria|26
7791970|NCT01031680|12246037|FG001|Overall Study|Subject No Longer Meets Study Criteria|17
7791971|NCT01031680|12246036|FG000|Overall Study|Poor/Non-compliance|5
7791972|NCT01031680|12246037|FG001|Overall Study|Poor/Non-compliance|6
7791973|NCT01031680|12246036|FG000|Overall Study|Safety|1
7791974|NCT01031680|12246037|FG001|Overall Study|Safety|0
7791975|NCT01031680|12246036|FG000|Overall Study|Incorrect Enrolment|1
7791976|NCT01031680|12246037|FG001|Overall Study|Incorrect Enrolment|2
7791977|NCT01031680|12246036|FG000|Overall Study|Administrative Reason by Sponsor|0
7791978|NCT01031680|12246037|FG001|Overall Study|Administrative Reason by Sponsor|1
7791979|NCT01031680|12246036|FG000|Overall Study|Various|0
7791980|NCT01031680|12246037|FG001|Overall Study|Various|2
7791981|NCT01031706|12246045|FG000|Overall Study|Adverse Event|1
7791982|NCT01031706|12246046|FG001|Overall Study|Adverse Event|0
7791983|NCT01031706|12246045|FG000|Overall Study|Withdrawal by Subject|1
7791984|NCT01031706|12246046|FG001|Overall Study|Withdrawal by Subject|1
7791985|NCT01031836|12246064|FG000|Stage I|Adverse Event|1
7791986|NCT01031836|12246065|FG001|Stage I|Adverse Event|1
7791987|NCT01031836|12246066|FG002|Stage I|Adverse Event|0
7791988|NCT01031836|12246067|FG003|Stage I|Adverse Event|0
7791989|NCT01031836|12246068|FG004|Stage I|Adverse Event|0
7791990|NCT01031836|12246069|FG005|Stage I|Adverse Event|0
7791991|NCT01031836|12246064|FG000|Stage I|Other|0
7791992|NCT01031836|12246065|FG001|Stage I|Other|1
7791993|NCT01031836|12246066|FG002|Stage I|Other|0
7791994|NCT01031836|12246067|FG003|Stage I|Other|0
7791995|NCT01031836|12246068|FG004|Stage I|Other|0
7791996|NCT01031836|12246069|FG005|Stage I|Other|1
7791997|NCT01031836|12246064|FG000|Stage II|Adverse Event|0
7791998|NCT01031836|12246065|FG001|Stage II|Adverse Event|0
7791999|NCT01031836|12246066|FG002|Stage II|Adverse Event|2
7792000|NCT01031836|12246067|FG003|Stage II|Adverse Event|2
7792001|NCT01031836|12246068|FG004|Stage II|Adverse Event|1
7792002|NCT01031836|12246069|FG005|Stage II|Adverse Event|1
7792003|NCT01031836|12246064|FG000|Stage II|Other|2
7792004|NCT01031836|12246065|FG001|Stage II|Other|0
7792005|NCT01031836|12246066|FG002|Stage II|Other|0
7792006|NCT01031836|12246067|FG003|Stage II|Other|1
7792007|NCT01031836|12246068|FG004|Stage II|Other|1
7792008|NCT01031836|12246069|FG005|Stage II|Other|0
7792009|NCT01031979|12246099|FG000|Overall Study|Lost to Follow-up|5
7792010|NCT01031979|12246100|FG001|Overall Study|Lost to Follow-up|4
7792011|NCT01032018|12246108|FG000|Overall Study|Lost to Follow-up|6
7792012|NCT01032018|12246109|FG001|Overall Study|Lost to Follow-up|5
7792013|NCT01032018|12246108|FG000|Overall Study|Death|0
7792014|NCT01032018|12246109|FG001|Overall Study|Death|1
7792015|NCT01032044|12246117|FG000|Overall Study|Protocol Violation|14
7792016|NCT01032044|12246118|FG001|Overall Study|Protocol Violation|8
7792017|NCT01032044|12246117|FG000|Overall Study|Adverse Event|0
7792018|NCT01032044|12246118|FG001|Overall Study|Adverse Event|1
7792019|NCT01032044|12246117|FG000|Overall Study|Lost to Follow-up|11
7792020|NCT01032044|12246118|FG001|Overall Study|Lost to Follow-up|11
7792021|NCT01032070|12246126|FG000|Overall Study|Disease progression|13
7792022|NCT01032070|12246127|FG001|Overall Study|Disease progression|8
7792023|NCT01032070|12246126|FG000|Overall Study|Medical or ethical reasons|0
7792024|NCT01032070|12246127|FG001|Overall Study|Medical or ethical reasons|2
7792025|NCT01032070|12246126|FG000|Overall Study|Withdrawal by Subject|0
7792026|NCT01032070|12246127|FG001|Overall Study|Withdrawal by Subject|2
7864108|NCT01609556|12353459|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7864109|NCT01609582|12353502|FG000|Overall Study|Adverse Event|20
7864110|NCT01609582|12353503|FG001|Overall Study|Adverse Event|18
7864111|NCT01609582|12353502|FG000|Overall Study|Lost to Follow-up|10
7864112|NCT01609582|12353503|FG001|Overall Study|Lost to Follow-up|10
7864113|NCT01609582|12353502|FG000|Overall Study|Withdrawal by Subject|21
7864114|NCT01609582|12353503|FG001|Overall Study|Withdrawal by Subject|15
7864115|NCT01609582|12353502|FG000|Overall Study|Study Terminated by Sponsor|1543
7864116|NCT01609582|12353503|FG001|Overall Study|Study Terminated by Sponsor|1548
7864117|NCT01609582|12353502|FG000|Overall Study|Other|9
7864118|NCT01609582|12353503|FG001|Overall Study|Other|10
7864119|NCT01609582|12353502|FG000|Overall Study|Randomized, but not treated|0
7864120|NCT01609582|12353503|FG001|Overall Study|Randomized, but not treated|3
7864121|NCT01609933|12353509|FG000|Overall Study|Adverse Event|1
7864122|NCT01609933|12353509|FG000|Overall Study|Withdrawal by Subject|3
7864123|NCT01610037|12353527|FG000|All Patients|Adverse Event|27
7864124|NCT01610037|12353528|FG001|All Patients|Adverse Event|22
7792027|NCT01032174|12246160|FG000|Overall Study|Adverse Event|0
7792028|NCT01032174|12246161|FG001|Overall Study|Adverse Event|1
7792029|NCT01032200|12246169|FG000|Overall Study|Death|1
7792030|NCT01032200|12246170|FG001|Overall Study|Death|1
7792031|NCT01032200|12246169|FG000|Overall Study|Withdrawal by Subject|1
7792032|NCT01032200|12246170|FG001|Overall Study|Withdrawal by Subject|3
7864125|NCT01610037|12353529|FG002|All Patients|Adverse Event|26
7864126|NCT01610037|12353527|FG000|All Patients|Withdrawal by Subject|12
7864127|NCT01610037|12353528|FG001|All Patients|Withdrawal by Subject|10
7864128|NCT01610037|12353529|FG002|All Patients|Withdrawal by Subject|20
7864129|NCT01610037|12353527|FG000|All Patients|Unsatisfactory therapeutic effect|9
7864130|NCT01610037|12353528|FG001|All Patients|Unsatisfactory therapeutic effect|8
7864131|NCT01610037|12353529|FG002|All Patients|Unsatisfactory therapeutic effect|27
7864132|NCT01610037|12353527|FG000|All Patients|Death|4
7864133|NCT01610037|12353528|FG001|All Patients|Death|2
7864134|NCT01610037|12353529|FG002|All Patients|Death|1
7864135|NCT01610037|12353527|FG000|All Patients|Protocol deviation|4
7864136|NCT01610037|12353528|FG001|All Patients|Protocol deviation|3
7864137|NCT01610037|12353529|FG002|All Patients|Protocol deviation|3
7864138|NCT01610037|12353527|FG000|All Patients|Abnormal laboratory value|1
7864139|NCT01610037|12353528|FG001|All Patients|Abnormal laboratory value|1
7864140|NCT01610037|12353529|FG002|All Patients|Abnormal laboratory value|0
7864141|NCT01610037|12353527|FG000|All Patients|Administrative problems|1
7864142|NCT01610037|12353528|FG001|All Patients|Administrative problems|4
7864143|NCT01610037|12353529|FG002|All Patients|Administrative problems|4
7864144|NCT01610037|12353527|FG000|All Patients|Lost to Follow-up|1
7864145|NCT01610037|12353528|FG001|All Patients|Lost to Follow-up|0
7864146|NCT01610037|12353529|FG002|All Patients|Lost to Follow-up|0
7864147|NCT01610037|12353527|FG000|All Patients|Abnormal test procedure result(s)|0
7864148|NCT01610037|12353528|FG001|All Patients|Abnormal test procedure result(s)|1
7864149|NCT01610037|12353529|FG002|All Patients|Abnormal test procedure result(s)|3
7864150|NCT01610037|12353527|FG000|Treatment and Follow up Period|Subject withdrew consent|13
7864151|NCT01610037|12353528|FG001|Treatment and Follow up Period|Subject withdrew consent|14
7864152|NCT01610037|12353529|FG002|Treatment and Follow up Period|Subject withdrew consent|16
7864153|NCT01610037|12353527|FG000|Treatment and Follow up Period|Death|10
7864154|NCT01610037|12353528|FG001|Treatment and Follow up Period|Death|5
7864155|NCT01610037|12353529|FG002|Treatment and Follow up Period|Death|4
7864156|NCT01610037|12353527|FG000|Treatment and Follow up Period|Administrative problems|1
7864157|NCT01610037|12353528|FG001|Treatment and Follow up Period|Administrative problems|3
7864158|NCT01610037|12353529|FG002|Treatment and Follow up Period|Administrative problems|2
7864159|NCT01610037|12353527|FG000|Treatment and Follow up Period|Lost to Follow-up|1
7864160|NCT01610037|12353528|FG001|Treatment and Follow up Period|Lost to Follow-up|6
7864161|NCT01610037|12353529|FG002|Treatment and Follow up Period|Lost to Follow-up|4
7864162|NCT01610063|12353539|FG000|Overall Study|Lost to Follow-up|42
7864163|NCT01610063|12353540|FG001|Overall Study|Lost to Follow-up|20
7864164|NCT01610076|12353548|FG000|Overall Study|Technical issue with video|0
7864165|NCT01610076|12353549|FG001|Overall Study|Technical issue with video|1
7864166|NCT01610076|12353548|FG000|Overall Study|Lost to Follow-up|3
7864167|NCT01610076|12353549|FG001|Overall Study|Lost to Follow-up|4
7864168|NCT01610167|12353565|FG000|Overall Study|Scheduling conflict.|0
7864169|NCT01610167|12353566|FG001|Overall Study|Scheduling conflict.|0
7864170|NCT01610167|12353567|FG002|Overall Study|Scheduling conflict.|2
7864171|NCT01610206|12353577|FG000|Overall Study|Adverse Event|10
7864172|NCT01610206|12353578|FG001|Overall Study|Adverse Event|30
7864173|NCT01610271|12353586|FG000|Overall Study|Surgery not complete|0
7864174|NCT01610271|12353587|FG001|Overall Study|Surgery not complete|1
7864175|NCT01610271|12353586|FG000|Overall Study|Prosthesis not implanted|2
7864176|NCT01610271|12353587|FG001|Overall Study|Prosthesis not implanted|3
7864177|NCT01610284|12353597|FG000|Randomization Phase|Adverse Event|1
7864178|NCT01610284|12353598|FG001|Randomization Phase|Adverse Event|0
7864179|NCT01610284|12353597|FG000|Randomization Phase|Physician Decision|1
7864180|NCT01610284|12353598|FG001|Randomization Phase|Physician Decision|1
7864181|NCT01610284|12353597|FG000|Randomization Phase|Death|0
7864182|NCT01610284|12353598|FG001|Randomization Phase|Death|1
7864183|NCT01610284|12353597|FG000|Treatment Phase|Adverse Event|80
7864184|NCT01610284|12353598|FG001|Treatment Phase|Adverse Event|12
7864185|NCT01610284|12353597|FG000|Treatment Phase|Lost to Follow-up|1
7864186|NCT01610284|12353598|FG001|Treatment Phase|Lost to Follow-up|0
7864187|NCT01610284|12353597|FG000|Treatment Phase|Non-compliance with Study Treatment|8
7864188|NCT01610284|12353598|FG001|Treatment Phase|Non-compliance with Study Treatment|1
7864189|NCT01610284|12353597|FG000|Treatment Phase|Physician Decision|27
7864190|NCT01610284|12353598|FG001|Treatment Phase|Physician Decision|24
7864191|NCT01610284|12353597|FG000|Treatment Phase|Progressive Disease|377
7864192|NCT01610284|12353598|FG001|Treatment Phase|Progressive Disease|486
7864193|NCT01610284|12353597|FG000|Treatment Phase|Protocol Deviation|2
7864194|NCT01610284|12353598|FG001|Treatment Phase|Protocol Deviation|3
7864195|NCT01610284|12353597|FG000|Treatment Phase|Study terminated by Sponsor|18
7864196|NCT01610284|12353598|FG001|Treatment Phase|Study terminated by Sponsor|15
7864197|NCT01610284|12353597|FG000|Treatment Phase|Subject/Guardian Decision|55
7864198|NCT01610284|12353598|FG001|Treatment Phase|Subject/Guardian Decision|23
7864199|NCT01610284|12353597|FG000|Treatment Phase|Death|6
7864200|NCT01610284|12353598|FG001|Treatment Phase|Death|5
7864201|NCT01610284|12353597|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
7864202|NCT01610284|12353598|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7864203|NCT01610284|12353597|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10
7864204|NCT01610284|12353598|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3
7864205|NCT01610284|12353597|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24
7864206|NCT01610284|12353598|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8
7864207|NCT01610284|12353597|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11
7864208|NCT01610284|12353598|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
7864209|NCT01610284|12353597|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4
7864210|NCT01610284|12353598|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4
7864211|NCT01610284|12353597|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38
7864212|NCT01610284|12353598|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13
7864213|NCT01610297|12353604|FG000|Overall Study|Lost to Follow-up|1
7864214|NCT01610336|12353619|FG000|Overall Study|Progressive Disease|4
7864215|NCT01610336|12353620|FG001|Overall Study|Progressive Disease|6
7864216|NCT01610336|12353621|FG002|Overall Study|Progressive Disease|6
7864217|NCT01610336|12353622|FG003|Overall Study|Progressive Disease|5
7864218|NCT01610336|12353623|FG004|Overall Study|Progressive Disease|3
7864219|NCT01610336|12353624|FG005|Overall Study|Progressive Disease|10
7864220|NCT01610336|12353625|FG006|Overall Study|Progressive Disease|1
7864221|NCT01610336|12353626|FG007|Overall Study|Progressive Disease|6
7864222|NCT01610336|12353627|FG008|Overall Study|Progressive Disease|6
7864223|NCT01610336|12353628|FG009|Overall Study|Progressive Disease|40
7864224|NCT01610336|12353629|FG010|Overall Study|Progressive Disease|36
7864225|NCT01610336|12353619|FG000|Overall Study|Adverse Event|0
7864226|NCT01610336|12353620|FG001|Overall Study|Adverse Event|0
7864227|NCT01610336|12353621|FG002|Overall Study|Adverse Event|0
7864228|NCT01610336|12353622|FG003|Overall Study|Adverse Event|1
7864229|NCT01610336|12353623|FG004|Overall Study|Adverse Event|1
7864230|NCT01610336|12353624|FG005|Overall Study|Adverse Event|1
7864231|NCT01610336|12353625|FG006|Overall Study|Adverse Event|0
7864232|NCT01610336|12353626|FG007|Overall Study|Adverse Event|0
7864233|NCT01610336|12353627|FG008|Overall Study|Adverse Event|2
7864234|NCT01610336|12353628|FG009|Overall Study|Adverse Event|8
7864235|NCT01610336|12353629|FG010|Overall Study|Adverse Event|6
7864236|NCT01610336|12353619|FG000|Overall Study|Subject/Guardian decision|1
7864237|NCT01610336|12353620|FG001|Overall Study|Subject/Guardian decision|1
7864238|NCT01610336|12353621|FG002|Overall Study|Subject/Guardian decision|0
7864239|NCT01610336|12353622|FG003|Overall Study|Subject/Guardian decision|1
7864240|NCT01610336|12353623|FG004|Overall Study|Subject/Guardian decision|0
7864241|NCT01610336|12353624|FG005|Overall Study|Subject/Guardian decision|0
7864242|NCT01610336|12353625|FG006|Overall Study|Subject/Guardian decision|0
7864243|NCT01610336|12353626|FG007|Overall Study|Subject/Guardian decision|1
7864244|NCT01610336|12353627|FG008|Overall Study|Subject/Guardian decision|0
7864245|NCT01610336|12353628|FG009|Overall Study|Subject/Guardian decision|2
7864246|NCT01610336|12353629|FG010|Overall Study|Subject/Guardian decision|2
7864247|NCT01610336|12353619|FG000|Overall Study|Death|0
7864248|NCT01610336|12353620|FG001|Overall Study|Death|0
7864249|NCT01610336|12353621|FG002|Overall Study|Death|0
7864250|NCT01610336|12353622|FG003|Overall Study|Death|0
7864251|NCT01610336|12353623|FG004|Overall Study|Death|0
7864252|NCT01610336|12353624|FG005|Overall Study|Death|1
7864253|NCT01610336|12353625|FG006|Overall Study|Death|3
7864254|NCT01610336|12353626|FG007|Overall Study|Death|0
7864255|NCT01610336|12353627|FG008|Overall Study|Death|0
7864256|NCT01610336|12353628|FG009|Overall Study|Death|1
7864257|NCT01610336|12353629|FG010|Overall Study|Death|2
7864258|NCT01610336|12353619|FG000|Overall Study|Non-Compliance with study treatment|0
7864259|NCT01610336|12353620|FG001|Overall Study|Non-Compliance with study treatment|0
7864260|NCT01610336|12353621|FG002|Overall Study|Non-Compliance with study treatment|0
7864261|NCT01610336|12353622|FG003|Overall Study|Non-Compliance with study treatment|0
7864262|NCT01610336|12353623|FG004|Overall Study|Non-Compliance with study treatment|0
7864263|NCT01610336|12353624|FG005|Overall Study|Non-Compliance with study treatment|0
7864264|NCT01610336|12353625|FG006|Overall Study|Non-Compliance with study treatment|0
7864265|NCT01610336|12353626|FG007|Overall Study|Non-Compliance with study treatment|0
7864266|NCT01610336|12353627|FG008|Overall Study|Non-Compliance with study treatment|0
7864267|NCT01610336|12353628|FG009|Overall Study|Non-Compliance with study treatment|1
7864268|NCT01610336|12353629|FG010|Overall Study|Non-Compliance with study treatment|0
7864269|NCT01610336|12353619|FG000|Overall Study|Physician Decision|0
7864270|NCT01610336|12353620|FG001|Overall Study|Physician Decision|0
7864271|NCT01610336|12353621|FG002|Overall Study|Physician Decision|0
7864272|NCT01610336|12353622|FG003|Overall Study|Physician Decision|0
7864273|NCT01610336|12353623|FG004|Overall Study|Physician Decision|0
7864274|NCT01610336|12353624|FG005|Overall Study|Physician Decision|0
7864275|NCT01610336|12353625|FG006|Overall Study|Physician Decision|1
7864276|NCT01610336|12353626|FG007|Overall Study|Physician Decision|0
7864277|NCT01610336|12353627|FG008|Overall Study|Physician Decision|0
7864278|NCT01610336|12353628|FG009|Overall Study|Physician Decision|0
7864279|NCT01610336|12353629|FG010|Overall Study|Physician Decision|0
7864280|NCT01610336|12353619|FG000|Overall Study|Protocol Deviation|0
7864281|NCT01610336|12353620|FG001|Overall Study|Protocol Deviation|0
7864282|NCT01610336|12353621|FG002|Overall Study|Protocol Deviation|0
7864283|NCT01610336|12353622|FG003|Overall Study|Protocol Deviation|0
7864284|NCT01610336|12353623|FG004|Overall Study|Protocol Deviation|0
7864285|NCT01610336|12353624|FG005|Overall Study|Protocol Deviation|0
7864286|NCT01610336|12353625|FG006|Overall Study|Protocol Deviation|0
7864287|NCT01610336|12353626|FG007|Overall Study|Protocol Deviation|0
7864288|NCT01610336|12353627|FG008|Overall Study|Protocol Deviation|0
7864289|NCT01610336|12353628|FG009|Overall Study|Protocol Deviation|1
7864290|NCT01610336|12353629|FG010|Overall Study|Protocol Deviation|0
7864291|NCT01610336|12353619|FG000|Overall Study|Transfer to another trial|0
7864292|NCT01610336|12353620|FG001|Overall Study|Transfer to another trial|0
7864293|NCT01610336|12353621|FG002|Overall Study|Transfer to another trial|0
7864294|NCT01610336|12353622|FG003|Overall Study|Transfer to another trial|0
7864295|NCT01610336|12353623|FG004|Overall Study|Transfer to another trial|0
7864296|NCT01610336|12353624|FG005|Overall Study|Transfer to another trial|0
7864297|NCT01610336|12353625|FG006|Overall Study|Transfer to another trial|0
7864298|NCT01610336|12353626|FG007|Overall Study|Transfer to another trial|0
7864299|NCT01610336|12353627|FG008|Overall Study|Transfer to another trial|0
7864300|NCT01610336|12353628|FG009|Overall Study|Transfer to another trial|0
7864301|NCT01610336|12353629|FG010|Overall Study|Transfer to another trial|1
7864302|NCT01610414|12353659|FG000|Study Start - Month 13|Serious Adverse Event|65
7864303|NCT01610414|12353660|FG001|Study Start - Month 13|Serious Adverse Event|67
7864304|NCT01610414|12353659|FG000|Study Start - Month 13|Adverse Event|14
7864305|NCT01610414|12353660|FG001|Study Start - Month 13|Adverse Event|14
7864306|NCT01610414|12353659|FG000|Study Start - Month 13|Protocol Violation|3
7864307|NCT01610414|12353660|FG001|Study Start - Month 13|Protocol Violation|1
7864308|NCT01610414|12353659|FG000|Study Start - Month 13|Withdrawal by Subject|23
7864309|NCT01610414|12353660|FG001|Study Start - Month 13|Withdrawal by Subject|30
7623128|NCT03215810|12033979|FG000|Overall Study|Still responding to nivolumab|1
7623129|NCT03215810|12033979|FG000|Overall Study|Insufficient TIL growth|1
7623130|NCT03215810|12033979|FG000|Overall Study|Decline in performance status|1
7623131|NCT03215810|12033979|FG000|Overall Study|Withdrawal by Subject|1
7623140|NCT03053102|12034021|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1
7623141|NCT03053102|12034021|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1
7792033|NCT01032200|12246169|FG000|Overall Study|Toxicity|0
7792034|NCT01032200|12246170|FG001|Overall Study|Toxicity|2
7792035|NCT01032200|12246169|FG000|Overall Study|Progression|1
7792036|NCT01032200|12246170|FG001|Overall Study|Progression|0
7792037|NCT01032200|12246169|FG000|Overall Study|Multiple|1
7792038|NCT01032200|12246170|FG001|Overall Study|Multiple|1
7792039|NCT01032239|12246178|FG000|Overall Study|Lost to Follow-up|3
7792040|NCT01032239|12246179|FG001|Overall Study|Lost to Follow-up|2
7792041|NCT01032239|12246178|FG000|Overall Study|Withdrawal by Subject|2
7792042|NCT01032239|12246179|FG001|Overall Study|Withdrawal by Subject|3
7792043|NCT01032239|12246178|FG000|Overall Study|Death|1
7792044|NCT01032239|12246179|FG001|Overall Study|Death|0
7792045|NCT01032239|12246178|FG000|Overall Study|Protocol Violation|1
7792046|NCT01032239|12246179|FG001|Overall Study|Protocol Violation|0
7792047|NCT01032291|12246188|FG000|Safety Lead-in|Adverse Event|1
7792048|NCT01032291|12246189|FG001|Safety Lead-in|Adverse Event|0
7792049|NCT01032291|12246190|FG002|Safety Lead-in|Adverse Event|0
7792050|NCT01032291|12246188|FG000|Safety Lead-in|Death|1
7792051|NCT01032291|12246189|FG001|Safety Lead-in|Death|0
7792052|NCT01032291|12246190|FG002|Safety Lead-in|Death|0
7792053|NCT01032291|12246188|FG000|Proof of Concept|Adverse Event|0
7792054|NCT01032291|12246189|FG001|Proof of Concept|Adverse Event|5
7792055|NCT01032291|12246190|FG002|Proof of Concept|Adverse Event|1
7792056|NCT01032291|12246188|FG000|Proof of Concept|Death|0
7864310|NCT01610414|12353659|FG000|Study Start - Month 13|Migrated/moved from study area|2
7864311|NCT01610414|12353660|FG001|Study Start - Month 13|Migrated/moved from study area|4
7864312|NCT01610414|12353659|FG000|Study Start - Month 13|Lost to Follow-up|4
7864313|NCT01610414|12353660|FG001|Study Start - Month 13|Lost to Follow-up|6
7864314|NCT01610414|12353659|FG000|Study Start - Month 13|Suspected HZ episode|1
7864315|NCT01610414|12353660|FG001|Study Start - Month 13|Suspected HZ episode|3
7864316|NCT01610414|12353659|FG000|Study Start - Month 13|Other reasons for withdrawal|3
7864317|NCT01610414|12353660|FG001|Study Start - Month 13|Other reasons for withdrawal|4
7864318|NCT01610414|12353659|FG000|Month 13 - Month 25|Serious Adverse Event|35
7864319|NCT01610414|12353660|FG001|Month 13 - Month 25|Serious Adverse Event|38
7864320|NCT01610414|12353659|FG000|Month 13 - Month 25|Adverse Event|8
7864321|NCT01610414|12353660|FG001|Month 13 - Month 25|Adverse Event|4
7864322|NCT01610414|12353659|FG000|Month 13 - Month 25|Withdrawal by Subject|7
7864323|NCT01610414|12353660|FG001|Month 13 - Month 25|Withdrawal by Subject|8
7864324|NCT01610414|12353659|FG000|Month 13 - Month 25|Migrated/moved from study area|4
7864325|NCT01610414|12353660|FG001|Month 13 - Month 25|Migrated/moved from study area|2
7864326|NCT01610414|12353659|FG000|Month 13 - Month 25|Protocol Violation|0
7792057|NCT01032291|12246189|FG001|Proof of Concept|Death|1
7792058|NCT01032291|12246190|FG002|Proof of Concept|Death|2
7792059|NCT01032291|12246188|FG000|Proof of Concept|Lack of Efficacy|0
7792060|NCT01032291|12246189|FG001|Proof of Concept|Lack of Efficacy|1
7792061|NCT01032291|12246190|FG002|Proof of Concept|Lack of Efficacy|0
7864327|NCT01610414|12353660|FG001|Month 13 - Month 25|Protocol Violation|2
7864328|NCT01610414|12353659|FG000|Month 13 - Month 25|Lost to Follow-up|5
7864329|NCT01610414|12353660|FG001|Month 13 - Month 25|Lost to Follow-up|9
7864330|NCT01610414|12353659|FG000|Month 13 - Month 25|Other reasons for withdrawal|6
7864331|NCT01610414|12353660|FG001|Month 13 - Month 25|Other reasons for withdrawal|7
7864332|NCT01610414|12353659|FG000|After Month 25|Study end not reached|48
7864333|NCT01610414|12353660|FG001|After Month 25|Study end not reached|53
7864334|NCT01610492|12353676|FG000|Overall Study|Adverse Event|1
7864335|NCT01610492|12353676|FG000|Overall Study|Lack of Efficacy|3
7864336|NCT01610492|12353676|FG000|Overall Study|Other: Reached stopping criteria|1
7864337|NCT01610492|12353676|FG000|Overall Study|Other:Treatment stopped due to remission|1
7864338|NCT01610557|12353684|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7864339|NCT01610557|12353685|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
7864340|NCT01610557|12353686|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7864341|NCT01610557|12353687|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7864342|NCT01610557|12353688|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7864343|NCT01610557|12353684|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0
7864344|NCT01610557|12353685|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0
7864345|NCT01610557|12353686|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0
7864346|NCT01610557|12353687|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0
7864347|NCT01610557|12353688|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3
7864348|NCT01610596|12353724|FG000|Overall Study|Lost to Follow-up|0
7864349|NCT01610596|12353725|FG001|Overall Study|Lost to Follow-up|1
7864350|NCT01610687|12353731|FG000|Overall Study|Lack of Efficacy|26
7864351|NCT01610687|12353731|FG000|Overall Study|Adverse Event|18
7864352|NCT01610687|12353731|FG000|Overall Study|Moved out of area|6
7864353|NCT01610687|12353731|FG000|Overall Study|Withdrawal by Subject|7
7864354|NCT01610687|12353731|FG000|Overall Study|Lost to Follow-up|4
7864355|NCT01610687|12353731|FG000|Overall Study|Symptom control without study medication|2
7864356|NCT01610687|12353731|FG000|Overall Study|Unable to make journey|1
7864357|NCT01610687|12353731|FG000|Overall Study|Death|1
7864358|NCT01610687|12353731|FG000|Overall Study|Cannabis affecting job|1
7864359|NCT01610687|12353731|FG000|Overall Study|Felt more alter without study medication|1
7864360|NCT01610700|12353737|FG000|Overall Study|Adverse Event|3
7864361|NCT01610700|12353738|FG001|Overall Study|Adverse Event|1
7864362|NCT01610700|12353737|FG000|Overall Study|Withdrawal by Subject|0
7864363|NCT01610700|12353738|FG001|Overall Study|Withdrawal by Subject|1
7864364|NCT01610700|12353737|FG000|Overall Study|subject took one dose of street cannabis|0
7864365|NCT01610700|12353738|FG001|Overall Study|subject took one dose of street cannabis|1
7864366|NCT01610713|12353747|FG000|Overall Study|Adverse Event|3
7864367|NCT01610713|12353748|FG001|Overall Study|Adverse Event|0
7864368|NCT01610713|12353747|FG000|Overall Study|Lack of Efficacy|1
7864369|NCT01610713|12353748|FG001|Overall Study|Lack of Efficacy|0
7864370|NCT01610713|12353747|FG000|Overall Study|low mood and poor motivation|1
7864371|NCT01610713|12353748|FG001|Overall Study|low mood and poor motivation|0
7864372|NCT01610713|12353747|FG000|Overall Study|adv. to use original dose/amitriptyline|1
7864373|NCT01610713|12353748|FG001|Overall Study|adv. to use original dose/amitriptyline|0
7864374|NCT01610713|12353747|FG000|Overall Study|Lost to Follow-up|0
7864375|NCT01610713|12353748|FG001|Overall Study|Lost to Follow-up|1
7864376|NCT01610752|12353757|FG000|Overall Study|Miscarriage/Pregnancy loss|0
7864377|NCT01610752|12353758|FG001|Overall Study|Miscarriage/Pregnancy loss|0
7864378|NCT01610752|12353759|FG002|Overall Study|Miscarriage/Pregnancy loss|4
7864379|NCT01610791|12353767|FG000|Overall Study|Lost to Follow-up|7
7864380|NCT01610791|12353767|FG000|Overall Study|Adverse Event|6
7864381|NCT01610791|12353767|FG000|Overall Study|Physician Decision|1
7864382|NCT01610791|12353767|FG000|Overall Study|Adverse event and Investigator decision|1
7864383|NCT01610791|12353767|FG000|Overall Study|Death|1
7864384|NCT01610791|12353767|FG000|Overall Study|Not determined|5
7864385|NCT01611090|12353773|FG000|Randomized Period|Lost to Follow-up|8
7864386|NCT01611090|12353774|FG001|Randomized Period|Lost to Follow-up|3
7864387|NCT01611090|12353775|FG002|Randomized Period|Lost to Follow-up|0
7864388|NCT01611090|12353773|FG000|Randomized Period|Withdrawal by Subject|22
7864389|NCT01611090|12353774|FG001|Randomized Period|Withdrawal by Subject|26
7864390|NCT01611090|12353775|FG002|Randomized Period|Withdrawal by Subject|0
7864391|NCT01611090|12353773|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
7623166|NCT02875860|12034056|FG000|Overall Study|Withdrawal by Subject|0
7623167|NCT02875860|12034057|FG001|Overall Study|Withdrawal by Subject|1
7623168|NCT02779855|12034066|FG000|Overall Study|Withdrawal by patient prior to treatment|1
7623169|NCT02779855|12034067|FG001|Overall Study|Withdrawal by patient prior to treatment|0
7623170|NCT02779855|12034068|FG002|Overall Study|Withdrawal by patient prior to treatment|0
7623171|NCT02663271|12034077|FG000|Overall Study|Withdrawal by Subject|5
7864392|NCT01611090|12353774|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
7864393|NCT01611090|12353775|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4
7864394|NCT01611090|12353773|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
7864395|NCT01611090|12353774|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
7864396|NCT01611090|12353775|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1
7864397|NCT01611155|12353784|FG000|Overall Study|Adverse Event|1
7864398|NCT01611155|12353785|FG001|Overall Study|Adverse Event|1
7864399|NCT01611155|12353784|FG000|Overall Study|Refused further treatment|6
7864400|NCT01611155|12353785|FG001|Overall Study|Refused further treatment|4
7864401|NCT01611155|12353784|FG000|Overall Study|Disease progression|1
7864402|NCT01611155|12353785|FG001|Overall Study|Disease progression|0
7864403|NCT01611155|12353784|FG000|Overall Study|Withdrawal by Subject|1
7864404|NCT01611155|12353785|FG001|Overall Study|Withdrawal by Subject|0
7864405|NCT01611155|12353784|FG000|Overall Study|Alternative treatment|0
7864406|NCT01611155|12353785|FG001|Overall Study|Alternative treatment|1
7864407|NCT01611155|12353784|FG000|Overall Study|Ineligible patient|0
7864408|NCT01611155|12353785|FG001|Overall Study|Ineligible patient|1
7864409|NCT01611194|12353793|FG000|Overall Study|Lost to Follow-up|0
7864410|NCT01611194|12353794|FG001|Overall Study|Lost to Follow-up|1
7864411|NCT01611194|12353793|FG000|Overall Study|Withdrawal by Subject|0
7864412|NCT01611194|12353794|FG001|Overall Study|Withdrawal by Subject|1
7864413|NCT01611194|12353793|FG000|Overall Study|drug use|0
7864414|NCT01611194|12353794|FG001|Overall Study|drug use|1
7864415|NCT01611259|12353800|FG000|Overall Study|Physician Decision|1
7864416|NCT01611259|12353800|FG000|Overall Study|Lack of Efficacy|2
7864417|NCT01611259|12353800|FG000|Overall Study|Adverse Event|4
7864418|NCT01611259|12353800|FG000|Overall Study|Withdrawal by Subject|7
7864419|NCT01611298|12353804|FG000|Overall Study|Relapsed|2
7864420|NCT01611454|12353810|FG000|Overall Study|Lack of Efficacy|18
7864421|NCT01611454|12353811|FG001|Overall Study|Lack of Efficacy|10
7864422|NCT01611558|12353821|FG000|Induction Phase|Study drug toxicity|15
7864423|NCT01611558|12353821|FG000|Induction Phase|Disease progression|18
7864424|NCT01611558|12353821|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1
7864425|NCT01611558|12353821|FG000|Induction Phase|Adverse event unrelated to study drug|3
7864426|NCT01611558|12353821|FG000|Induction Phase|Death|1
7864427|NCT01611558|12353821|FG000|Maintenance Phase|Withdrawal by Subject|1
7864428|NCT01611558|12353821|FG000|Maintenance Phase|Elevated Uric acid|1
7864429|NCT01611792|12353849|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
7864430|NCT01611792|12353850|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
7864431|NCT01611792|12353849|FG000|Followup: at 6 Months|Lost to Follow-up|6
7864432|NCT01611792|12353850|FG001|Followup: at 6 Months|Lost to Follow-up|13
7864433|NCT01611857|12353859|FG000|Overall Study|Withdrawal by Subject|0
7864434|NCT01611857|12353860|FG001|Overall Study|Withdrawal by Subject|2
7864435|NCT01611935|12353870|FG000|Overall Study|Family Declined Participation|1
7864436|NCT01611935|12353871|FG001|Overall Study|Family Declined Participation|0
7864437|NCT01611974|12353889|FG000|Overall Study|Death|10
7864438|NCT01611974|12353890|FG001|Overall Study|Death|12
7864439|NCT01611974|12353891|FG002|Overall Study|Death|10
7864440|NCT01611974|12353889|FG000|Overall Study|Lost to Follow-up|0
7864441|NCT01611974|12353890|FG001|Overall Study|Lost to Follow-up|1
7864442|NCT01611974|12353891|FG002|Overall Study|Lost to Follow-up|0
7864443|NCT01611974|12353889|FG000|Overall Study|Physician Decision|5
7864444|NCT01611974|12353890|FG001|Overall Study|Physician Decision|1
7864445|NCT01611974|12353891|FG002|Overall Study|Physician Decision|2
7864446|NCT01611974|12353889|FG000|Overall Study|Withdrawal by Subject|0
7864447|NCT01611974|12353890|FG001|Overall Study|Withdrawal by Subject|1
7864448|NCT01611974|12353891|FG002|Overall Study|Withdrawal by Subject|4
7864449|NCT01612000|12353903|FG000|Overall Study|Lost to Follow-up|6
7864450|NCT01612000|12353904|FG001|Overall Study|Lost to Follow-up|4
7864451|NCT01612000|12353905|FG002|Overall Study|Lost to Follow-up|4
7864452|NCT01612000|12353906|FG003|Overall Study|Lost to Follow-up|8
7864453|NCT01612000|12353903|FG000|Overall Study|Physician Decision|0
7864454|NCT01612000|12353904|FG001|Overall Study|Physician Decision|0
7864455|NCT01612000|12353905|FG002|Overall Study|Physician Decision|1
7864456|NCT01612000|12353906|FG003|Overall Study|Physician Decision|0
7864457|NCT01612000|12353903|FG000|Overall Study|Withdrawal by Subject|3
7864458|NCT01612000|12353904|FG001|Overall Study|Withdrawal by Subject|1
7864459|NCT01612000|12353905|FG002|Overall Study|Withdrawal by Subject|2
7864460|NCT01612000|12353906|FG003|Overall Study|Withdrawal by Subject|2
7864461|NCT01612156|12353918|FG000|Overall Study|Protocol Violation|2
7864462|NCT01612156|12353919|FG001|Overall Study|Protocol Violation|0
7864463|NCT01612676|12353951|FG000|Overall Study|Adverse Event|2
7864464|NCT01612676|12353952|FG001|Overall Study|Adverse Event|3
7864465|NCT01612676|12353953|FG002|Overall Study|Adverse Event|1
7864466|NCT01612676|12353954|FG003|Overall Study|Adverse Event|3
7864467|NCT01612676|12353951|FG000|Overall Study|Protocol Violation|0
7864468|NCT01612676|12353952|FG001|Overall Study|Protocol Violation|1
7864469|NCT01612676|12353953|FG002|Overall Study|Protocol Violation|0
7864470|NCT01612676|12353954|FG003|Overall Study|Protocol Violation|0
7864471|NCT01612702|12353968|FG000|Overall Study|Protocol Violation|11
7864472|NCT01612702|12353969|FG001|Overall Study|Protocol Violation|11
7882373|NCT01770145|12381312|FG000|Baseline|Adverse Event|20
7882374|NCT01770145|12381312|FG000|Baseline|Withdrawal by Subject|1
7882375|NCT01770145|12381312|FG000|Baseline|Lost to Follow-up|1
7882376|NCT01770145|12381312|FG000|Baseline|Unable to define optimal dose|4
7882377|NCT01770145|12381312|FG000|Treatment|Adverse Event|3
7882378|NCT01770145|12381312|FG000|Treatment|Withdrawal by Subject|1
7882379|NCT01770353|12381327|FG000|Overall Study|Progressive disease|2
7882380|NCT01770353|12381328|FG001|Overall Study|Progressive disease|1
7882381|NCT01770353|12381327|FG000|Overall Study|Adverse Event|0
7882382|NCT01770353|12381328|FG001|Overall Study|Adverse Event|1
7882383|NCT01770353|12381327|FG000|Overall Study|Protocol Violation|1
7882384|NCT01770353|12381328|FG001|Overall Study|Protocol Violation|0
7882385|NCT01770353|12381327|FG000|Overall Study|Physician Decision|0
7882386|NCT01770353|12381328|FG001|Overall Study|Physician Decision|3
7882387|NCT01770353|12381327|FG000|Overall Study|Clinical deterioration|3
7864473|NCT01612780|12354000|FG000|Overall Study|Treatment not completed|1
7864474|NCT01612780|12354000|FG000|Overall Study|Withdrawal by Subject|5
7864475|NCT01612858|12354015|FG000|Overall Study|Withdrawal by Subject|5
7864476|NCT01612858|12354016|FG001|Overall Study|Withdrawal by Subject|1
7864477|NCT01613027|12354040|FG000|Overall Study|Lost to Follow-up|5
7864478|NCT01613027|12354040|FG000|Overall Study|Switched Physician|1
7864479|NCT01613027|12354040|FG000|Overall Study|Lack of Efficacy|1
7864480|NCT01613027|12354040|FG000|Overall Study|Patient's Decision Due to Adverse Event|1
7864481|NCT01613131|12354046|FG000|Overall Study|Withdrawal by Subject|3
7864482|NCT01613131|12354047|FG001|Overall Study|Withdrawal by Subject|5
7864483|NCT01613222|12354053|FG000|Overall Study|Physician Decision|1
7864484|NCT01613222|12354053|FG000|Overall Study|Unable to place arterial line|1
7864485|NCT01613222|12354053|FG000|Overall Study|Reused disposable sensors|10
7864486|NCT01613248|12354072|FG000|Overall Study|Adverse Event|0
7864487|NCT01613248|12354073|FG001|Overall Study|Adverse Event|0
7864488|NCT01613248|12354074|FG002|Overall Study|Adverse Event|0
7864489|NCT01613248|12354075|FG003|Overall Study|Adverse Event|1
7864490|NCT01613248|12354076|FG004|Overall Study|Adverse Event|0
7864491|NCT01613248|12354077|FG005|Overall Study|Adverse Event|0
7864492|NCT01613248|12354072|FG000|Overall Study|Withdrawal by Subject|3
7864493|NCT01613248|12354073|FG001|Overall Study|Withdrawal by Subject|2
7864494|NCT01613248|12354074|FG002|Overall Study|Withdrawal by Subject|2
7864495|NCT01613248|12354075|FG003|Overall Study|Withdrawal by Subject|5
7864496|NCT01613248|12354076|FG004|Overall Study|Withdrawal by Subject|0
7864497|NCT01613248|12354077|FG005|Overall Study|Withdrawal by Subject|1
7864498|NCT01613248|12354072|FG000|Overall Study|Lost to Follow-up|5
7864499|NCT01613248|12354073|FG001|Overall Study|Lost to Follow-up|7
7864500|NCT01613248|12354074|FG002|Overall Study|Lost to Follow-up|4
7864501|NCT01613248|12354075|FG003|Overall Study|Lost to Follow-up|8
7864502|NCT01613248|12354076|FG004|Overall Study|Lost to Follow-up|4
7864503|NCT01613248|12354077|FG005|Overall Study|Lost to Follow-up|2
7864504|NCT01613248|12354072|FG000|Overall Study|Study Terminated by Sponsor|4
7864505|NCT01613248|12354073|FG001|Overall Study|Study Terminated by Sponsor|6
7864506|NCT01613248|12354074|FG002|Overall Study|Study Terminated by Sponsor|8
7864507|NCT01613248|12354075|FG003|Overall Study|Study Terminated by Sponsor|8
7864508|NCT01613248|12354076|FG004|Overall Study|Study Terminated by Sponsor|9
7864509|NCT01613248|12354077|FG005|Overall Study|Study Terminated by Sponsor|11
7864510|NCT01613248|12354072|FG000|Overall Study|Physician Decision|8
7864511|NCT01613248|12354073|FG001|Overall Study|Physician Decision|8
7864512|NCT01613248|12354074|FG002|Overall Study|Physician Decision|9
7864513|NCT01613248|12354075|FG003|Overall Study|Physician Decision|4
7864514|NCT01613248|12354076|FG004|Overall Study|Physician Decision|7
7864515|NCT01613248|12354077|FG005|Overall Study|Physician Decision|6
7864516|NCT01613248|12354072|FG000|Overall Study|Lack of Qualifying Event|9
7864517|NCT01613248|12354073|FG001|Overall Study|Lack of Qualifying Event|11
7864518|NCT01613248|12354074|FG002|Overall Study|Lack of Qualifying Event|10
7864519|NCT01613248|12354075|FG003|Overall Study|Lack of Qualifying Event|11
7864520|NCT01613248|12354076|FG004|Overall Study|Lack of Qualifying Event|15
7864521|NCT01613248|12354077|FG005|Overall Study|Lack of Qualifying Event|18
7864522|NCT01613248|12354072|FG000|Overall Study|Pregnancy|0
7864523|NCT01613248|12354073|FG001|Overall Study|Pregnancy|0
7864524|NCT01613248|12354074|FG002|Overall Study|Pregnancy|0
7623172|NCT02663271|12034077|FG000|Overall Study|Lack of Efficacy|1
7864525|NCT01613248|12354075|FG003|Overall Study|Pregnancy|1
7864526|NCT01613248|12354076|FG004|Overall Study|Pregnancy|0
7864527|NCT01613248|12354077|FG005|Overall Study|Pregnancy|0
7864528|NCT01613326|12354110|FG000|Overall Study|Adverse Event|7
7864529|NCT01613326|12354111|FG001|Overall Study|Adverse Event|5
7864530|NCT01613326|12354110|FG000|Overall Study|Withdrawal by Subject|3
7864531|NCT01613326|12354111|FG001|Overall Study|Withdrawal by Subject|4
7864532|NCT01613326|12354110|FG000|Overall Study|Abnormal test procedure result(s)|2
7864533|NCT01613326|12354111|FG001|Overall Study|Abnormal test procedure result(s)|0
7864534|NCT01613326|12354110|FG000|Overall Study|inability to use device|1
7864535|NCT01613326|12354111|FG001|Overall Study|inability to use device|0
7864536|NCT01613326|12354110|FG000|Overall Study|Lack of Efficacy|0
7864537|NCT01613326|12354111|FG001|Overall Study|Lack of Efficacy|1
7864538|NCT01613326|12354110|FG000|Overall Study|Lost to Follow-up|0
7864539|NCT01613326|12354111|FG001|Overall Study|Lost to Follow-up|1
7864540|NCT01613326|12354110|FG000|Overall Study|Administrative|0
7864541|NCT01613326|12354111|FG001|Overall Study|Administrative|2
7864542|NCT01613326|12354110|FG000|Overall Study|Protocol Violation|0
7864543|NCT01613326|12354111|FG001|Overall Study|Protocol Violation|1
7864544|NCT01613378|12354125|FG000|Overall Study|Lack of Efficacy|13
7864545|NCT01613378|12354125|FG000|Overall Study|Adverse Event|11
7864546|NCT01613378|12354125|FG000|Overall Study|Withdrawal by Subject|8
7864547|NCT01613378|12354125|FG000|Overall Study|Death|2
7623173|NCT02573493|12034094|FG000|Overall Study|Determined to not be eligible after enrollment|0
7623174|NCT02573493|12034095|FG001|Overall Study|Determined to not be eligible after enrollment|0
7864548|NCT01613378|12354125|FG000|Overall Study|Lost to Follow-up|1
7864549|NCT01613378|12354125|FG000|Overall Study|Other Reason|4
7864550|NCT01613417|12354131|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
7864551|NCT01613417|12354132|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
7864552|NCT01613599|12354148|FG000|Overall Study|Death|9
7864553|NCT01613599|12354148|FG000|Overall Study|Lost to Follow-up|5
7623175|NCT02573493|12034096|FG002|Overall Study|Determined to not be eligible after enrollment|0
7623176|NCT02573493|12034097|FG003|Overall Study|Determined to not be eligible after enrollment|1
7864554|NCT01613599|12354148|FG000|Overall Study|Withdrawal by Subject|8
7864555|NCT01613599|12354148|FG000|Overall Study|Reason not specified|3
7864556|NCT01613716|12354152|FG000|Overall Study|screen failures|3
7864557|NCT01613716|12354152|FG000|Overall Study|Lost to Follow-up|4
7864558|NCT01614093|12354161|FG000|Overall Study|Withdrawal by Subject|1
7864559|NCT01614249|12354172|FG000|Overall Study|Lost to Follow-up|11
7864560|NCT01614249|12354173|FG001|Overall Study|Lost to Follow-up|23
7864561|NCT01614457|12354190|FG000|Overall Study|Non-Compliance|1
7864562|NCT01614457|12354191|FG001|Overall Study|Non-Compliance|0
7864563|NCT01614457|12354190|FG000|Overall Study|Pregnancy (Self or Partner)|1
7864564|NCT01614457|12354191|FG001|Overall Study|Pregnancy (Self or Partner)|0
7864565|NCT01614470|12354199|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
7864566|NCT01614470|12354200|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7864567|NCT01614470|12354201|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7864568|NCT01614470|12354199|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
7864569|NCT01614470|12354200|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
7864570|NCT01614470|12354201|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
7864571|NCT01614600|12354223|FG000|Overall Study|Unacceptable fit|1
7864572|NCT01614600|12354223|FG000|Overall Study|Discomfort|1
7864573|NCT01614600|12354223|FG000|Overall Study|Unable to remove lens at the end of day|1
7864574|NCT01614600|12354223|FG000|Overall Study|Protocol deviation|1
7864575|NCT01614769|12354241|FG000|Period 1|Discontinued due to Hypoglycemia|0
7864576|NCT01614769|12354242|FG001|Period 1|Discontinued due to Hypoglycemia|0
7864577|NCT01614769|12354243|FG002|Period 1|Discontinued due to Hypoglycemia|0
7864578|NCT01614769|12354244|FG003|Period 1|Discontinued due to Hypoglycemia|1
7864579|NCT01614769|12354245|FG004|Period 1|Discontinued due to Hypoglycemia|0
7864580|NCT01614769|12354246|FG005|Period 1|Discontinued due to Hypoglycemia|1
7864581|NCT01614769|12354241|FG000|Period 1|Protocol Violation|0
7864582|NCT01614769|12354242|FG001|Period 1|Protocol Violation|0
7864583|NCT01614769|12354243|FG002|Period 1|Protocol Violation|0
7864584|NCT01614769|12354244|FG003|Period 1|Protocol Violation|1
7864585|NCT01614769|12354245|FG004|Period 1|Protocol Violation|0
7864586|NCT01614769|12354246|FG005|Period 1|Protocol Violation|0
7864587|NCT01614769|12354241|FG000|Period 1|Withdrawal by Subject|1
7864588|NCT01614769|12354242|FG001|Period 1|Withdrawal by Subject|0
7864589|NCT01614769|12354243|FG002|Period 1|Withdrawal by Subject|0
7864590|NCT01614769|12354244|FG003|Period 1|Withdrawal by Subject|0
7864591|NCT01614769|12354245|FG004|Period 1|Withdrawal by Subject|0
7864592|NCT01614769|12354246|FG005|Period 1|Withdrawal by Subject|0
7864593|NCT01614769|12354241|FG000|Period 3|Withdrawal by Subject|0
7864594|NCT01614769|12354242|FG001|Period 3|Withdrawal by Subject|0
7864595|NCT01614769|12354243|FG002|Period 3|Withdrawal by Subject|1
7864596|NCT01614769|12354244|FG003|Period 3|Withdrawal by Subject|0
7864597|NCT01614769|12354245|FG004|Period 3|Withdrawal by Subject|0
7864598|NCT01614769|12354246|FG005|Period 3|Withdrawal by Subject|0
7864599|NCT01614795|12354258|FG000|Overall Study|Adverse Event|0
7864600|NCT01614795|12354259|FG001|Overall Study|Adverse Event|0
7864601|NCT01614795|12354260|FG002|Overall Study|Adverse Event|1
7623177|NCT02279173|12034130|FG000|Overall Study|Protocol-specified Criteria|67
7623178|NCT02279173|12034130|FG000|Overall Study|Withdrawal by Subject|20
7623179|NCT02279173|12034130|FG000|Overall Study|Decision by Sponsor|4
7623180|NCT02279173|12034130|FG000|Overall Study|Lost to Follow-up|3
7792062|NCT01032291|12246188|FG000|Proof of Concept|Never Received Study Drug|0
7792063|NCT01032291|12246189|FG001|Proof of Concept|Never Received Study Drug|1
7792064|NCT01032291|12246190|FG002|Proof of Concept|Never Received Study Drug|0
7792065|NCT01032382|12246228|FG000|Overall Study|Disease dissemination|1
7792066|NCT01032382|12246229|FG001|Overall Study|Disease dissemination|1
7792067|NCT01032382|12246228|FG000|Overall Study|Treatment failure|3
7792068|NCT01032382|12246229|FG001|Overall Study|Treatment failure|1
7792069|NCT01032382|12246228|FG000|Overall Study|Index lesion relapse|1
7792070|NCT01032382|12246229|FG001|Overall Study|Index lesion relapse|3
7864602|NCT01614795|12354261|FG003|Overall Study|Adverse Event|1
7864603|NCT01614795|12354258|FG000|Overall Study|Lack of Efficacy|10
7864604|NCT01614795|12354259|FG001|Overall Study|Lack of Efficacy|10
7864605|NCT01614795|12354260|FG002|Overall Study|Lack of Efficacy|9
7864606|NCT01614795|12354261|FG003|Overall Study|Lack of Efficacy|8
7864607|NCT01614795|12354258|FG000|Overall Study|Physician Decision|1
7864608|NCT01614795|12354259|FG001|Overall Study|Physician Decision|0
7864609|NCT01614795|12354260|FG002|Overall Study|Physician Decision|1
7864610|NCT01614795|12354261|FG003|Overall Study|Physician Decision|1
7864611|NCT01614795|12354258|FG000|Overall Study|Withdrawal by Subject|0
7864612|NCT01614795|12354259|FG001|Overall Study|Withdrawal by Subject|1
7792071|NCT01032629|12246244|FG000|Overall Study|Closed Site|21
7792072|NCT01032629|12246245|FG001|Overall Study|Closed Site|18
7792073|NCT01032629|12246246|FG002|Overall Study|Closed Site|16
7792074|NCT01032629|12246244|FG000|Overall Study|Withdrawal by Subject|50
7792075|NCT01032629|12246245|FG001|Overall Study|Withdrawal by Subject|36
7864613|NCT01614795|12354260|FG002|Overall Study|Withdrawal by Subject|0
7864614|NCT01614795|12354261|FG003|Overall Study|Withdrawal by Subject|2
7864615|NCT01614795|12354258|FG000|Overall Study|Ineligible|0
7864616|NCT01614795|12354259|FG001|Overall Study|Ineligible|1
7864617|NCT01614795|12354260|FG002|Overall Study|Ineligible|0
7864618|NCT01614795|12354261|FG003|Overall Study|Ineligible|0
7864619|NCT01614886|12354292|FG000|Overall Study|Adverse Event|15
7864620|NCT01614886|12354293|FG001|Overall Study|Adverse Event|20
7864621|NCT01614886|12354292|FG000|Overall Study|Withdrawal by Subject|4
7864622|NCT01614886|12354293|FG001|Overall Study|Withdrawal by Subject|4
7864623|NCT01614886|12354292|FG000|Overall Study|Death|1
7864624|NCT01614886|12354293|FG001|Overall Study|Death|0
7864625|NCT01614886|12354292|FG000|Overall Study|Protocol deviation|0
7864626|NCT01614886|12354293|FG001|Overall Study|Protocol deviation|2
7864627|NCT01614925|12354301|FG000|Overall Study|Withdrawal by Subject|1
7864628|NCT01614925|12354302|FG001|Overall Study|Withdrawal by Subject|0
7864629|NCT01614925|12354301|FG000|Overall Study|Protocol Violation|3
7864630|NCT01614925|12354302|FG001|Overall Study|Protocol Violation|2
7864631|NCT01615198|12354319|FG000|Overall Study|Withdrawal by Subject|5
7864632|NCT01615198|12354320|FG001|Overall Study|Withdrawal by Subject|5
7864633|NCT01615198|12354319|FG000|Overall Study|Protocol deviation|1
7864634|NCT01615198|12354320|FG001|Overall Study|Protocol deviation|1
7864635|NCT01615198|12354319|FG000|Overall Study|Physician Decision|5
7864636|NCT01615198|12354320|FG001|Overall Study|Physician Decision|1
7864637|NCT01615198|12354319|FG000|Overall Study|Lost to Follow-up|1
7864638|NCT01615198|12354320|FG001|Overall Study|Lost to Follow-up|1
7864639|NCT01615198|12354319|FG000|Overall Study|Lack of Efficacy|1
7864640|NCT01615198|12354320|FG001|Overall Study|Lack of Efficacy|6
7864641|NCT01615198|12354319|FG000|Overall Study|Adverse Event|11
7864642|NCT01615198|12354320|FG001|Overall Study|Adverse Event|5
7864643|NCT01615263|12354328|FG000|Overall Study|Post-randomization exclusion|0
7864644|NCT01615263|12354329|FG001|Overall Study|Post-randomization exclusion|2
7864645|NCT01615328|12354337|FG000|Overall Study|Lost to Follow-up|3
7864646|NCT01615328|12354338|FG001|Overall Study|Lost to Follow-up|5
7864647|NCT01615822|12354382|FG000|Period 1|Withdrawal by Subject|0
7864648|NCT01615822|12354383|FG001|Period 1|Withdrawal by Subject|1
7864649|NCT01615822|12354384|FG002|Period 1|Withdrawal by Subject|0
7864650|NCT01615822|12354382|FG000|Period 1|Adverse Event|1
7864651|NCT01615822|12354383|FG001|Period 1|Adverse Event|1
7864652|NCT01615822|12354384|FG002|Period 1|Adverse Event|0
7864653|NCT01615822|12354382|FG000|Period 2|Lost to Follow-up|0
7864654|NCT01615822|12354383|FG001|Period 2|Lost to Follow-up|1
7864655|NCT01615822|12354384|FG002|Period 2|Lost to Follow-up|2
7864656|NCT01615939|12354397|FG000|Overall Study|Lost to Follow-up|5
7864657|NCT01615939|12354398|FG001|Overall Study|Lost to Follow-up|0
7864658|NCT01616173|12354425|FG000|Overall Study|Lost to Follow-up|0
7864659|NCT01616173|12354426|FG001|Overall Study|Lost to Follow-up|2
7864660|NCT01616173|12354427|FG002|Overall Study|Lost to Follow-up|0
7864661|NCT01616459|12354439|FG000|Overall Study|Adverse Event|1
7864662|NCT01616459|12354440|FG001|Overall Study|Adverse Event|1
7864663|NCT01616459|12354441|FG002|Overall Study|Adverse Event|2
7792076|NCT01032629|12246246|FG002|Overall Study|Withdrawal by Subject|35
7792077|NCT01032629|12246244|FG000|Overall Study|Lost to Follow-up|74
7792078|NCT01032629|12246245|FG001|Overall Study|Lost to Follow-up|47
7792079|NCT01032629|12246246|FG002|Overall Study|Lost to Follow-up|37
7792080|NCT01032837|12246287|FG000|Overall Study|Adverse event/internal illness|0
7792081|NCT01032837|12246288|FG001|Overall Study|Adverse event/internal illness|1
7792082|NCT01032837|12246289|FG002|Overall Study|Adverse event/internal illness|0
7792083|NCT01032837|12246290|FG003|Overall Study|Adverse event/internal illness|1
7792084|NCT01032837|12246287|FG000|Overall Study|Withdrew consent|0
7792085|NCT01032837|12246288|FG001|Overall Study|Withdrew consent|2
7792086|NCT01032837|12246289|FG002|Overall Study|Withdrew consent|0
7792087|NCT01032837|12246290|FG003|Overall Study|Withdrew consent|1
7792088|NCT01032837|12246287|FG000|Overall Study|Failed to return|0
7792089|NCT01032837|12246288|FG001|Overall Study|Failed to return|0
7792090|NCT01032837|12246289|FG002|Overall Study|Failed to return|1
7792091|NCT01032837|12246290|FG003|Overall Study|Failed to return|0
7864664|NCT01616459|12354442|FG003|Overall Study|Adverse Event|0
7864665|NCT01616459|12354439|FG000|Overall Study|Lost to Follow-up|1
7864666|NCT01616459|12354440|FG001|Overall Study|Lost to Follow-up|11
7864667|NCT01616459|12354441|FG002|Overall Study|Lost to Follow-up|3
7864668|NCT01616459|12354442|FG003|Overall Study|Lost to Follow-up|2
7864669|NCT01616459|12354439|FG000|Overall Study|Protocol Violation|0
7864670|NCT01616459|12354440|FG001|Overall Study|Protocol Violation|0
7864671|NCT01616459|12354441|FG002|Overall Study|Protocol Violation|0
7864672|NCT01616459|12354442|FG003|Overall Study|Protocol Violation|2
7864673|NCT01616459|12354439|FG000|Overall Study|Withdrawal by Subject|2
7864674|NCT01616459|12354440|FG001|Overall Study|Withdrawal by Subject|4
7864675|NCT01616459|12354441|FG002|Overall Study|Withdrawal by Subject|4
7864676|NCT01616459|12354442|FG003|Overall Study|Withdrawal by Subject|4
7864677|NCT01616459|12354439|FG000|Overall Study|Other reason|0
7864678|NCT01616459|12354440|FG001|Overall Study|Other reason|1
7864679|NCT01616459|12354441|FG002|Overall Study|Other reason|1
7864680|NCT01616459|12354442|FG003|Overall Study|Other reason|0
7792092|NCT01032837|12246287|FG000|Overall Study|Refused treatment|0
7792093|NCT01032837|12246288|FG001|Overall Study|Refused treatment|0
7864681|NCT01616563|12354457|FG000|Overall Study|Lost to Follow-up|40
7864682|NCT01616654|12354479|FG000|Overall Study|Lack of Efficacy|1
7864683|NCT01616654|12354480|FG001|Overall Study|Lack of Efficacy|0
7864684|NCT01616654|12354481|FG002|Overall Study|Lack of Efficacy|0
7864685|NCT01616654|12354482|FG003|Overall Study|Lack of Efficacy|0
7864686|NCT01616654|12354483|FG004|Overall Study|Lack of Efficacy|1
7864687|NCT01616654|12354479|FG000|Overall Study|Adverse Event|0
7864688|NCT01616654|12354480|FG001|Overall Study|Adverse Event|1
7864689|NCT01616654|12354481|FG002|Overall Study|Adverse Event|2
7864690|NCT01616654|12354482|FG003|Overall Study|Adverse Event|1
7864691|NCT01616654|12354483|FG004|Overall Study|Adverse Event|0
7864692|NCT01616654|12354479|FG000|Overall Study|Withdrawal by Subject|2
7864693|NCT01616654|12354480|FG001|Overall Study|Withdrawal by Subject|2
7864694|NCT01616654|12354481|FG002|Overall Study|Withdrawal by Subject|3
7864695|NCT01616654|12354482|FG003|Overall Study|Withdrawal by Subject|1
7864696|NCT01616654|12354483|FG004|Overall Study|Withdrawal by Subject|5
7864697|NCT01616654|12354479|FG000|Overall Study|Protocol Violation|0
7864698|NCT01616654|12354480|FG001|Overall Study|Protocol Violation|5
7864699|NCT01616654|12354481|FG002|Overall Study|Protocol Violation|2
7864700|NCT01616654|12354482|FG003|Overall Study|Protocol Violation|4
7864701|NCT01616654|12354483|FG004|Overall Study|Protocol Violation|4
7864702|NCT01616654|12354479|FG000|Overall Study|Lost to Follow-up|1
7864703|NCT01616654|12354480|FG001|Overall Study|Lost to Follow-up|0
7864704|NCT01616654|12354481|FG002|Overall Study|Lost to Follow-up|3
7864705|NCT01616654|12354482|FG003|Overall Study|Lost to Follow-up|2
7864706|NCT01616654|12354483|FG004|Overall Study|Lost to Follow-up|1
7864707|NCT01616654|12354479|FG000|Overall Study|Pregnancy|1
7864708|NCT01616654|12354480|FG001|Overall Study|Pregnancy|0
7864709|NCT01616654|12354481|FG002|Overall Study|Pregnancy|0
7864710|NCT01616654|12354482|FG003|Overall Study|Pregnancy|0
7864711|NCT01616654|12354483|FG004|Overall Study|Pregnancy|1
7864712|NCT01616693|12354500|FG000|Evaluated for Safety|Physician Decision|1
7864713|NCT01616693|12354501|FG001|Evaluated for Safety|Physician Decision|0
7864714|NCT01616693|12354502|FG002|Evaluated for Safety|Physician Decision|1
7864715|NCT01616693|12354503|FG003|Evaluated for Safety|Physician Decision|0
7864716|NCT01616693|12354500|FG000|Received Both Vaccines|Adverse Event|2
7864717|NCT01616693|12354501|FG001|Received Both Vaccines|Adverse Event|0
7864718|NCT01616693|12354502|FG002|Received Both Vaccines|Adverse Event|0
7864719|NCT01616693|12354503|FG003|Received Both Vaccines|Adverse Event|0
7864720|NCT01616693|12354500|FG000|Received Both Vaccines|Withdrawal by Subject|7
7864721|NCT01616693|12354501|FG001|Received Both Vaccines|Withdrawal by Subject|7
7864722|NCT01616693|12354502|FG002|Received Both Vaccines|Withdrawal by Subject|8
7864723|NCT01616693|12354503|FG003|Received Both Vaccines|Withdrawal by Subject|15
7864724|NCT01616693|12354500|FG000|Received Both Vaccines|Lost to Follow-up|4
7864725|NCT01616693|12354501|FG001|Received Both Vaccines|Lost to Follow-up|3
7864726|NCT01616693|12354502|FG002|Received Both Vaccines|Lost to Follow-up|4
7864727|NCT01616693|12354503|FG003|Received Both Vaccines|Lost to Follow-up|4
7864728|NCT01616693|12354500|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4
7864729|NCT01616693|12354501|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2
7864730|NCT01616693|12354502|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6
7864731|NCT01616693|12354503|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1
7864732|NCT01616771|12354517|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4
7864733|NCT01616953|12354528|FG000|Overall Study|Lost to Follow-up|1
7864734|NCT01616953|12354529|FG001|Overall Study|Lost to Follow-up|0
7864735|NCT01616953|12354528|FG000|Overall Study|lack of bone and soft tissue|1
7864736|NCT01616953|12354529|FG001|Overall Study|lack of bone and soft tissue|0
7864737|NCT01617005|12354535|FG000|Overall Study|Pregnancy|1
7864738|NCT01617005|12354535|FG000|Overall Study|Lack of motivation for treatment|1
7864739|NCT01617070|12354539|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
7864740|NCT01617434|12354578|FG000|Overall Study|Adverse Event|12
7864741|NCT01617434|12354579|FG001|Overall Study|Adverse Event|3
7864742|NCT01617434|12354578|FG000|Overall Study|Protocol Violation|8
7864743|NCT01617434|12354579|FG001|Overall Study|Protocol Violation|7
7864744|NCT01617434|12354578|FG000|Overall Study|Withdrawal Criteria|12
7864745|NCT01617434|12354579|FG001|Overall Study|Withdrawal Criteria|37
7864746|NCT01617434|12354578|FG000|Overall Study|Unclassified|3
7864747|NCT01617434|12354579|FG001|Overall Study|Unclassified|4
7864748|NCT01617447|12354587|FG000|Overall Study|Adverse Event|0
7864749|NCT01617447|12354588|FG001|Overall Study|Adverse Event|1
7864750|NCT01617447|12354587|FG000|Overall Study|Physician Decision|0
7864751|NCT01617447|12354588|FG001|Overall Study|Physician Decision|2
7864752|NCT01617460|12354594|FG000|Overall Study|Adverse Event|10
7864753|NCT01617460|12354594|FG000|Overall Study|Physician Decision|16
7864754|NCT01617460|12354594|FG000|Overall Study|Protocol Violation|5
7864755|NCT01617460|12354594|FG000|Overall Study|Withdrawal by Subject|9
7864756|NCT01617629|12354621|FG000|Overall Study|Death|2
7864757|NCT01617629|12354621|FG000|Overall Study|Investigator's Clinical Judgement|1
7864758|NCT01617629|12354621|FG000|Overall Study|Reason Not Specified|1
7864759|NCT01617629|12354621|FG000|Overall Study|Participant Withdrew Consent|2
7864760|NCT01617655|12354627|FG000|Overall Study|Adverse Event|2
7864761|NCT01617655|12354628|FG001|Overall Study|Adverse Event|3
7864762|NCT01617655|12354627|FG000|Overall Study|Poor compliance to protocol|1
7864763|NCT01617655|12354628|FG001|Overall Study|Poor compliance to protocol|4
7864764|NCT01617655|12354627|FG000|Overall Study|Participants moved|0
7864765|NCT01617655|12354628|FG001|Overall Study|Participants moved|4
7864766|NCT01617655|12354627|FG000|Overall Study|Consent withdrawn by participant|1
7864767|NCT01617655|12354628|FG001|Overall Study|Consent withdrawn by participant|1
7864768|NCT01617655|12354627|FG000|Overall Study|Last visit outside protocol visit window|1
7864769|NCT01617655|12354628|FG001|Overall Study|Last visit outside protocol visit window|10
7864770|NCT01617655|12354627|FG000|Overall Study|Site closure|3
7864771|NCT01617655|12354628|FG001|Overall Study|Site closure|5
7864772|NCT01617655|12354627|FG000|Overall Study|Other than specified above|1
7864773|NCT01617655|12354628|FG001|Overall Study|Other than specified above|2
7864774|NCT01617668|12354638|FG000|Overall Study|Adverse Event|7
7864775|NCT01617668|12354639|FG001|Overall Study|Adverse Event|0
7864776|NCT01617668|12354640|FG002|Overall Study|Adverse Event|12
7864777|NCT01617668|12354641|FG003|Overall Study|Adverse Event|5
7864778|NCT01617668|12354638|FG000|Overall Study|Physician Decision|1
7864779|NCT01617668|12354639|FG001|Overall Study|Physician Decision|2
7864780|NCT01617668|12354640|FG002|Overall Study|Physician Decision|3
7864781|NCT01617668|12354641|FG003|Overall Study|Physician Decision|0
7864782|NCT01617668|12354638|FG000|Overall Study|Progressive Disease|4
7864783|NCT01617668|12354639|FG001|Overall Study|Progressive Disease|4
7864784|NCT01617668|12354640|FG002|Overall Study|Progressive Disease|6
7864785|NCT01617668|12354641|FG003|Overall Study|Progressive Disease|9
7864786|NCT01617668|12354638|FG000|Overall Study|Subject/guardian decision|1
7864787|NCT01617668|12354639|FG001|Overall Study|Subject/guardian decision|3
7864788|NCT01617668|12354640|FG002|Overall Study|Subject/guardian decision|2
7864789|NCT01617668|12354641|FG003|Overall Study|Subject/guardian decision|1
7864790|NCT01617681|12354659|FG000|Period 1 Double Blind|Adverse Event|2
7864791|NCT01617681|12354660|FG001|Period 1 Double Blind|Adverse Event|0
7864792|NCT01617681|12354661|FG002|Period 1 Double Blind|Adverse Event|0
7864793|NCT01617681|12354662|FG003|Period 1 Double Blind|Adverse Event|2
7864794|NCT01617681|12354663|FG004|Period 1 Double Blind|Adverse Event|0
7864795|NCT01617681|12354659|FG000|Period 1 Double Blind|Withdrawal by Subject|1
7864796|NCT01617681|12354660|FG001|Period 1 Double Blind|Withdrawal by Subject|1
7864797|NCT01617681|12354661|FG002|Period 1 Double Blind|Withdrawal by Subject|1
7864798|NCT01617681|12354662|FG003|Period 1 Double Blind|Withdrawal by Subject|0
7864799|NCT01617681|12354663|FG004|Period 1 Double Blind|Withdrawal by Subject|0
7864800|NCT01617681|12354659|FG000|Period 2 Open Label|Adverse Event|0
7864801|NCT01617681|12354660|FG001|Period 2 Open Label|Adverse Event|0
7864802|NCT01617681|12354661|FG002|Period 2 Open Label|Adverse Event|0
7864803|NCT01617681|12354662|FG003|Period 2 Open Label|Adverse Event|0
7864804|NCT01617681|12354663|FG004|Period 2 Open Label|Adverse Event|3
7864805|NCT01617681|12354659|FG000|Period 2 Open Label|Withdrawal by Subject|0
7864806|NCT01617681|12354660|FG001|Period 2 Open Label|Withdrawal by Subject|0
7864807|NCT01617681|12354661|FG002|Period 2 Open Label|Withdrawal by Subject|0
7864808|NCT01617681|12354662|FG003|Period 2 Open Label|Withdrawal by Subject|0
7864809|NCT01617681|12354663|FG004|Period 2 Open Label|Withdrawal by Subject|3
7864810|NCT01617967|12354678|FG000|Overall Study|Protocol Violation|0
7864811|NCT01617967|12354679|FG001|Overall Study|Protocol Violation|0
7864812|NCT01617967|12354680|FG002|Overall Study|Protocol Violation|0
7864813|NCT01617967|12354681|FG003|Overall Study|Protocol Violation|1
7864814|NCT01617967|12354682|FG004|Overall Study|Protocol Violation|0
7864815|NCT01617967|12354683|FG005|Overall Study|Protocol Violation|0
7864816|NCT01617967|12354678|FG000|Overall Study|Withdrawal by Subject|0
7864817|NCT01617967|12354679|FG001|Overall Study|Withdrawal by Subject|0
7864818|NCT01617967|12354680|FG002|Overall Study|Withdrawal by Subject|0
7864819|NCT01617967|12354681|FG003|Overall Study|Withdrawal by Subject|0
7864820|NCT01617967|12354682|FG004|Overall Study|Withdrawal by Subject|0
7864821|NCT01617967|12354683|FG005|Overall Study|Withdrawal by Subject|1
7864822|NCT01617967|12354678|FG000|Overall Study|Dosing Suspended by Sponsor|1
7864823|NCT01617967|12354679|FG001|Overall Study|Dosing Suspended by Sponsor|0
7864824|NCT01617967|12354680|FG002|Overall Study|Dosing Suspended by Sponsor|0
7864825|NCT01617967|12354681|FG003|Overall Study|Dosing Suspended by Sponsor|0
7864826|NCT01617967|12354682|FG004|Overall Study|Dosing Suspended by Sponsor|0
7864827|NCT01617967|12354683|FG005|Overall Study|Dosing Suspended by Sponsor|0
7864828|NCT01618019|12354700|FG000|Overall Study|Withdrawal by Subject|14
7864829|NCT01618019|12354701|FG001|Overall Study|Withdrawal by Subject|14
7864830|NCT01618162|12354709|FG000|Overall Study|Protocol Violation|13
7864831|NCT01618162|12354710|FG001|Overall Study|Protocol Violation|10
7864832|NCT01618162|12354709|FG000|Overall Study|Adverse Event|9
7864833|NCT01618162|12354710|FG001|Overall Study|Adverse Event|2
7864834|NCT01618162|12354709|FG000|Overall Study|Withdrawal Criteria|2
7864835|NCT01618162|12354710|FG001|Overall Study|Withdrawal Criteria|10
7864836|NCT01618162|12354709|FG000|Overall Study|Unclassified|14
7864837|NCT01618162|12354710|FG001|Overall Study|Unclassified|13
7864838|NCT01618214|12354718|FG000|Overall Study|Adverse Event|3
7864839|NCT01618214|12354719|FG001|Overall Study|Adverse Event|1
7864840|NCT01618214|12354718|FG000|Overall Study|Lack of Efficacy|1
7864841|NCT01618214|12354719|FG001|Overall Study|Lack of Efficacy|1
7864842|NCT01618214|12354718|FG000|Overall Study|Protocol Violation|1
7864843|NCT01618214|12354719|FG001|Overall Study|Protocol Violation|4
7864844|NCT01618214|12354718|FG000|Overall Study|Withdrawal Criteria|1
7864845|NCT01618214|12354719|FG001|Overall Study|Withdrawal Criteria|2
7864846|NCT01618214|12354718|FG000|Overall Study|Unclassified|4
7864847|NCT01618214|12354719|FG001|Overall Study|Unclassified|5
7864848|NCT01618266|12354738|FG000|Overall Study|Lost to Follow-up|9
7864849|NCT01618266|12354738|FG000|Overall Study|Treatment satisfaction|10
7864850|NCT01618266|12354738|FG000|Overall Study|Other reasons|11
7864851|NCT01618266|12354738|FG000|Overall Study|Lack of Efficacy|23
7864852|NCT01618266|12354738|FG000|Overall Study|Protocol Violation|43
7864853|NCT01618305|12354744|FG000|Overall Study|Death|0
7864854|NCT01618305|12354745|FG001|Overall Study|Death|1
7864855|NCT01618305|12354744|FG000|Overall Study|Lost to Follow-up|11
7864856|NCT01618305|12354745|FG001|Overall Study|Lost to Follow-up|7
7864857|NCT01618305|12354744|FG000|Overall Study|Protocol Violation|1
7864858|NCT01618305|12354745|FG001|Overall Study|Protocol Violation|0
7864859|NCT01618305|12354744|FG000|Overall Study|Withdrawal by Subject|3
7864860|NCT01618305|12354745|FG001|Overall Study|Withdrawal by Subject|2
7864861|NCT01618669|12354770|FG000|Overall Study|Lost to Follow-up|1
7864862|NCT01618669|12354771|FG001|Overall Study|Lost to Follow-up|1
7864863|NCT01618669|12354770|FG000|Overall Study|Randomized but Never Received Study Drug|3
7864864|NCT01618669|12354771|FG001|Overall Study|Randomized but Never Received Study Drug|2
7864865|NCT01618669|12354770|FG000|Overall Study|Adverse Event|16
7864866|NCT01618669|12354771|FG001|Overall Study|Adverse Event|7
7864867|NCT01618669|12354770|FG000|Overall Study|Protocol Violation|5
7864868|NCT01618669|12354771|FG001|Overall Study|Protocol Violation|3
7864869|NCT01618669|12354770|FG000|Overall Study|Withdrawal by Subject|9
7864870|NCT01618669|12354771|FG001|Overall Study|Withdrawal by Subject|9
7864871|NCT01618669|12354770|FG000|Overall Study|Miscellaneous Reason|0
7864872|NCT01618669|12354771|FG001|Overall Study|Miscellaneous Reason|1
7864873|NCT01618695|12354793|FG000|Core Phase|Adverse Event|4
7864874|NCT01618695|12354794|FG001|Core Phase|Adverse Event|5
7864875|NCT01618695|12354795|FG002|Core Phase|Adverse Event|15
7864876|NCT01618695|12354796|FG003|Core Phase|Adverse Event|20
7864877|NCT01618695|12354793|FG000|Core Phase|Lost to Follow-up|0
7864878|NCT01618695|12354794|FG001|Core Phase|Lost to Follow-up|0
7864879|NCT01618695|12354795|FG002|Core Phase|Lost to Follow-up|1
7864880|NCT01618695|12354796|FG003|Core Phase|Lost to Follow-up|0
7864881|NCT01618695|12354793|FG000|Core Phase|Withdrawal by Subject|16
7864882|NCT01618695|12354794|FG001|Core Phase|Withdrawal by Subject|11
7864883|NCT01618695|12354795|FG002|Core Phase|Withdrawal by Subject|9
7864884|NCT01618695|12354796|FG003|Core Phase|Withdrawal by Subject|13
7864885|NCT01618695|12354793|FG000|Core Phase|Pregnancy|2
7864886|NCT01618695|12354794|FG001|Core Phase|Pregnancy|0
7864887|NCT01618695|12354795|FG002|Core Phase|Pregnancy|0
7864888|NCT01618695|12354796|FG003|Core Phase|Pregnancy|0
7864889|NCT01618695|12354793|FG000|Core Phase|Lack of Efficacy|1
7864890|NCT01618695|12354794|FG001|Core Phase|Lack of Efficacy|2
7864891|NCT01618695|12354795|FG002|Core Phase|Lack of Efficacy|1
7864892|NCT01618695|12354796|FG003|Core Phase|Lack of Efficacy|1
7864893|NCT01618695|12354793|FG000|Core Phase|Other than specified|1
7864894|NCT01618695|12354794|FG001|Core Phase|Other than specified|2
7864895|NCT01618695|12354795|FG002|Core Phase|Other than specified|2
7864896|NCT01618695|12354796|FG003|Core Phase|Other than specified|2
7864897|NCT01618695|12354793|FG000|Core Phase|Not treated|1
7864898|NCT01618695|12354794|FG001|Core Phase|Not treated|0
7864899|NCT01618695|12354795|FG002|Core Phase|Not treated|2
7864900|NCT01618695|12354796|FG003|Core Phase|Not treated|0
7864901|NCT01618695|12354793|FG000|Extension Phase|Lack of Efficacy|17
7864902|NCT01618695|12354794|FG001|Extension Phase|Lack of Efficacy|33
7864903|NCT01618695|12354795|FG002|Extension Phase|Lack of Efficacy|26
7864904|NCT01618695|12354796|FG003|Extension Phase|Lack of Efficacy|24
7864905|NCT01618695|12354793|FG000|Extension Phase|Pregnancy|2
7864906|NCT01618695|12354794|FG001|Extension Phase|Pregnancy|0
7864907|NCT01618695|12354795|FG002|Extension Phase|Pregnancy|1
7864908|NCT01618695|12354796|FG003|Extension Phase|Pregnancy|1
7864909|NCT01618695|12354793|FG000|Extension Phase|Withdrawal by Subject|43
7864910|NCT01618695|12354794|FG001|Extension Phase|Withdrawal by Subject|48
7864911|NCT01618695|12354795|FG002|Extension Phase|Withdrawal by Subject|42
7864912|NCT01618695|12354796|FG003|Extension Phase|Withdrawal by Subject|33
7864913|NCT01618695|12354793|FG000|Extension Phase|Adverse Event|18
7864914|NCT01618695|12354794|FG001|Extension Phase|Adverse Event|16
7864915|NCT01618695|12354795|FG002|Extension Phase|Adverse Event|9
7864916|NCT01618695|12354796|FG003|Extension Phase|Adverse Event|20
7864917|NCT01618695|12354793|FG000|Extension Phase|Lost to Follow-up|2
7864918|NCT01618695|12354794|FG001|Extension Phase|Lost to Follow-up|1
7864919|NCT01618695|12354795|FG002|Extension Phase|Lost to Follow-up|1
7864920|NCT01618695|12354796|FG003|Extension Phase|Lost to Follow-up|1
7864921|NCT01618695|12354793|FG000|Extension Phase|Other than specified|13
7864922|NCT01618695|12354794|FG001|Extension Phase|Other than specified|18
7864923|NCT01618695|12354795|FG002|Extension Phase|Other than specified|13
7864924|NCT01618695|12354796|FG003|Extension Phase|Other than specified|18
7864925|NCT01618708|12354809|FG000|Overall Study|Adverse Event|10
7864926|NCT01618708|12354810|FG001|Overall Study|Adverse Event|10
7864927|NCT01618708|12354809|FG000|Overall Study|Lost to Follow-up|3
7864928|NCT01618708|12354810|FG001|Overall Study|Lost to Follow-up|3
7864929|NCT01618708|12354809|FG000|Overall Study|Withdrawal by Subject|17
7864930|NCT01618708|12354810|FG001|Overall Study|Withdrawal by Subject|22
7864931|NCT01618708|12354809|FG000|Overall Study|Lack of Efficacy|8
7864932|NCT01618708|12354810|FG001|Overall Study|Lack of Efficacy|8
7864933|NCT01618708|12354809|FG000|Overall Study|Technical problems|2
7864934|NCT01618708|12354810|FG001|Overall Study|Technical problems|0
7864935|NCT01618708|12354809|FG000|Overall Study|Other than specified above|1
7864936|NCT01618708|12354810|FG001|Overall Study|Other than specified above|1
7864937|NCT01618708|12354809|FG000|Overall Study|Randomized but not treated|3
7864938|NCT01618708|12354810|FG001|Overall Study|Randomized but not treated|2
7864939|NCT01618838|12354817|FG000|Overall Study|slow accrual, trial closed prematurely.|4
7864940|NCT01618864|12354822|FG000|Overall Study|Withdrawal by Subject|2
7864941|NCT01618864|12354822|FG000|Overall Study|Lost to Follow-up|2
7864942|NCT01618916|12354837|FG000|Overall Study|Adverse Event|1
7864943|NCT01618916|12354838|FG001|Overall Study|Adverse Event|0
7864944|NCT01618916|12354839|FG002|Overall Study|Adverse Event|0
7864945|NCT01618916|12354840|FG003|Overall Study|Adverse Event|0
7864946|NCT01618916|12354841|FG004|Overall Study|Adverse Event|0
7864947|NCT01618916|12354842|FG005|Overall Study|Adverse Event|0
7864948|NCT01618916|12354837|FG000|Overall Study|Withdrawal by Subject|0
7864949|NCT01618916|12354838|FG001|Overall Study|Withdrawal by Subject|1
7864950|NCT01618916|12354839|FG002|Overall Study|Withdrawal by Subject|1
7864951|NCT01618916|12354840|FG003|Overall Study|Withdrawal by Subject|0
7864952|NCT01618916|12354841|FG004|Overall Study|Withdrawal by Subject|1
7864953|NCT01618916|12354842|FG005|Overall Study|Withdrawal by Subject|0
7864954|NCT01618916|12354837|FG000|Overall Study|Lost to Follow-up|1
7864955|NCT01618916|12354838|FG001|Overall Study|Lost to Follow-up|0
7864956|NCT01618916|12354839|FG002|Overall Study|Lost to Follow-up|0
7864957|NCT01618916|12354840|FG003|Overall Study|Lost to Follow-up|2
7864958|NCT01618916|12354841|FG004|Overall Study|Lost to Follow-up|0
7864959|NCT01618916|12354842|FG005|Overall Study|Lost to Follow-up|0
7864960|NCT01618968|12354885|FG000|Overall Study|Adverse Event|1
7864961|NCT01618968|12354886|FG001|Overall Study|Adverse Event|0
7864962|NCT01618968|12354887|FG002|Overall Study|Adverse Event|0
7864963|NCT01618968|12354888|FG003|Overall Study|Adverse Event|0
7864964|NCT01618968|12354885|FG000|Overall Study|Death|0
7864965|NCT01618968|12354886|FG001|Overall Study|Death|0
7864966|NCT01618968|12354887|FG002|Overall Study|Death|0
7864967|NCT01618968|12354888|FG003|Overall Study|Death|1
7864968|NCT01619059|12354899|FG000|Short-Term (ST) Treatment Period|Adverse Event|1
7864969|NCT01619059|12354900|FG001|Short-Term (ST) Treatment Period|Adverse Event|0
7864970|NCT01619059|12354899|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
7864971|NCT01619059|12354900|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
7864972|NCT01619059|12354899|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2
7864973|NCT01619059|12354900|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4
7864974|NCT01619059|12354899|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
7864975|NCT01619059|12354900|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
7864976|NCT01619059|12354899|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0
7864977|NCT01619059|12354900|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1
7864978|NCT01619059|12354899|FG000|Long-Term (LT) Treatment Period|Adverse Event|2
7864979|NCT01619059|12354900|FG001|Long-Term (LT) Treatment Period|Adverse Event|3
7864980|NCT01619059|12354899|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
7864981|NCT01619059|12354900|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
7864982|NCT01619059|12354899|FG000|Long-Term (LT) Treatment Period|Death|1
7864983|NCT01619059|12354900|FG001|Long-Term (LT) Treatment Period|Death|0
7864984|NCT01619059|12354899|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2
7864985|NCT01619059|12354900|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2
7864986|NCT01619059|12354899|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
7864987|NCT01619059|12354900|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
7864988|NCT01619410|12354908|FG000|Overall Study|Lost to Follow-up|7
7864989|NCT01619410|12354909|FG001|Overall Study|Lost to Follow-up|4
7864990|NCT01619423|12354919|FG000|Part 1 (Dose Escalation)|High basal Mn|0
7864991|NCT01619423|12354920|FG001|Part 1 (Dose Escalation)|High basal Mn|2
7864992|NCT01619423|12354921|FG002|Part 1 (Dose Escalation)|High basal Mn|0
7864993|NCT01619423|12354922|FG003|Part 1 (Dose Escalation)|High basal Mn|0
7864994|NCT01619579|12354935|FG000|Overall Study|Withdrawal by Subject|0
7864995|NCT01619579|12354936|FG001|Overall Study|Withdrawal by Subject|3
7864996|NCT01619787|12354948|FG000|Overall Study|Lost to Follow-up|5
7864997|NCT01619852|12354974|FG000|24 Hour Assessment|Withdrawal by Subject|1
7864998|NCT01619852|12354975|FG001|24 Hour Assessment|Withdrawal by Subject|1
7864999|NCT01619852|12354974|FG000|3 Month Follow up|Lost to Follow-up|31
7865000|NCT01619852|12354975|FG001|3 Month Follow up|Lost to Follow-up|34
7865001|NCT01619865|12354982|FG000|Overall Study|Adverse Event|1
7865002|NCT01619865|12354982|FG000|Overall Study|Death|2
7865003|NCT01619865|12354982|FG000|Overall Study|subject not able to comply|1
7865004|NCT01619878|12354987|FG000|6 Week Follow-up Phase|Adverse Event|1
7865005|NCT01619878|12354987|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1
7865006|NCT01619878|12354987|FG000|Follow-up at 12 Months of Age|Death|2
7882388|NCT01770353|12381328|FG001|Overall Study|Clinical deterioration|6
7882389|NCT01770353|12381327|FG000|Overall Study|Toxicity related diarrhoea + progression|0
7882390|NCT01770353|12381328|FG001|Overall Study|Toxicity related diarrhoea + progression|1
7882391|NCT01770379|12381354|FG000|Overall Study|Technical issues|1
7882392|NCT01770379|12381355|FG001|Overall Study|Technical issues|0
7882393|NCT01770379|12381356|FG002|Overall Study|Technical issues|0
7882394|NCT01770379|12381354|FG000|Overall Study|Withdrawal by Subject|7
7882395|NCT01770379|12381355|FG001|Overall Study|Withdrawal by Subject|10
7882396|NCT01770379|12381356|FG002|Overall Study|Withdrawal by Subject|7
7882397|NCT01770379|12381354|FG000|Overall Study|study terminated by sponsor|22
7882398|NCT01770379|12381355|FG001|Overall Study|study terminated by sponsor|23
7882399|NCT01770379|12381356|FG002|Overall Study|study terminated by sponsor|22
7882400|NCT01770379|12381354|FG000|Overall Study|Protocol Violation|0
7882401|NCT01770379|12381355|FG001|Overall Study|Protocol Violation|1
7882402|NCT01770379|12381356|FG002|Overall Study|Protocol Violation|1
7865007|NCT01620060|12355017|FG000|Overall Study|Adverse Event|9
7865008|NCT01620060|12355017|FG000|Overall Study|Protocol Violation|1
7865009|NCT01620060|12355017|FG000|Overall Study|Withdrawal by Subject|1
7865010|NCT01620060|12355017|FG000|Overall Study|Did not comply with Study Produre|1
7865011|NCT01620060|12355017|FG000|Overall Study|Family emergency|1
7865012|NCT01620060|12355017|FG000|Overall Study|Per Sponsor Decision|2
7865013|NCT01620086|12355023|FG000|Overall Study|Withdrawal by Subject|3
7865014|NCT01620086|12355024|FG001|Overall Study|Withdrawal by Subject|3
7865015|NCT01620086|12355025|FG002|Overall Study|Withdrawal by Subject|0
7865016|NCT01620086|12355023|FG000|Overall Study|failed study criteria|1
7865017|NCT01620086|12355024|FG001|Overall Study|failed study criteria|4
7865018|NCT01620086|12355025|FG002|Overall Study|failed study criteria|0
7865019|NCT01620086|12355023|FG000|Overall Study|Physician Decision|1
7865020|NCT01620086|12355024|FG001|Overall Study|Physician Decision|0
7865021|NCT01620086|12355025|FG002|Overall Study|Physician Decision|0
7865022|NCT01620138|12355036|FG000|Overall Study|Withdrawal by Subject|3
7865023|NCT01620138|12355037|FG001|Overall Study|Withdrawal by Subject|0
7865024|NCT01620138|12355036|FG000|Overall Study|Lack of Efficacy|1
7865025|NCT01620138|12355037|FG001|Overall Study|Lack of Efficacy|0
7865026|NCT01620138|12355036|FG000|Overall Study|Adverse Event|2
7865027|NCT01620138|12355037|FG001|Overall Study|Adverse Event|0
7865028|NCT01620177|12355043|FG000|Overall Study|Failure at Screening Visit|43
7865029|NCT01620177|12355043|FG000|Overall Study|Withdrawal by Subject|26
7865030|NCT01620177|12355043|FG000|Overall Study|Lost to Follow-up|7
7865031|NCT01620177|12355043|FG000|Overall Study|Physician Decision|2
7865032|NCT01620177|12355043|FG000|Overall Study|Randomized, Not Active due to Scheduling|1
7865033|NCT01620255|12355098|FG000|Overall Study|Withdrawal by Subject|4
7865034|NCT01620255|12355099|FG001|Overall Study|Withdrawal by Subject|1
7865035|NCT01620255|12355100|FG002|Overall Study|Withdrawal by Subject|1
7865036|NCT01620255|12355101|FG003|Overall Study|Withdrawal by Subject|2
7865037|NCT01620255|12355102|FG004|Overall Study|Withdrawal by Subject|4
7865038|NCT01620255|12355098|FG000|Overall Study|Participant underwent fecal transplant|0
7865039|NCT01620255|12355099|FG001|Overall Study|Participant underwent fecal transplant|0
7865040|NCT01620255|12355100|FG002|Overall Study|Participant underwent fecal transplant|1
7865041|NCT01620255|12355101|FG003|Overall Study|Participant underwent fecal transplant|0
7865042|NCT01620255|12355102|FG004|Overall Study|Participant underwent fecal transplant|0
7865043|NCT01620255|12355098|FG000|Overall Study|Non-compliance|0
7865044|NCT01620255|12355099|FG001|Overall Study|Non-compliance|1
7865045|NCT01620255|12355100|FG002|Overall Study|Non-compliance|0
7865046|NCT01620255|12355101|FG003|Overall Study|Non-compliance|0
7865047|NCT01620255|12355102|FG004|Overall Study|Non-compliance|0
7865048|NCT01620255|12355098|FG000|Overall Study|Adverse Event|0
7865049|NCT01620255|12355099|FG001|Overall Study|Adverse Event|4
7865050|NCT01620255|12355100|FG002|Overall Study|Adverse Event|0
7865051|NCT01620255|12355101|FG003|Overall Study|Adverse Event|1
7865052|NCT01620255|12355102|FG004|Overall Study|Adverse Event|1
7865053|NCT01620255|12355098|FG000|Overall Study|Withdrawn at discretion of investigator|0
7865054|NCT01620255|12355099|FG001|Overall Study|Withdrawn at discretion of investigator|0
7865055|NCT01620255|12355100|FG002|Overall Study|Withdrawn at discretion of investigator|0
7865056|NCT01620255|12355101|FG003|Overall Study|Withdrawn at discretion of investigator|0
7865057|NCT01620255|12355102|FG004|Overall Study|Withdrawn at discretion of investigator|1
7865058|NCT01620489|12355116|FG000|Overall Study|Adverse Event|17
7865059|NCT01620489|12355117|FG001|Overall Study|Adverse Event|4
7865060|NCT01620489|12355116|FG000|Overall Study|Protocol Violation|0
7865061|NCT01620489|12355117|FG001|Overall Study|Protocol Violation|3
7865062|NCT01620489|12355116|FG000|Overall Study|Withdrawal Criteria|17
7865063|NCT01620489|12355117|FG001|Overall Study|Withdrawal Criteria|25
7865064|NCT01620489|12355116|FG000|Overall Study|Unclassified|1
7865065|NCT01620489|12355117|FG001|Overall Study|Unclassified|2
7865066|NCT01620528|12355126|FG000|Treatment Period|Did Not Receive Study Drug|0
7865067|NCT01620528|12355127|FG001|Treatment Period|Did Not Receive Study Drug|0
7865068|NCT01620528|12355128|FG002|Treatment Period|Did Not Receive Study Drug|1
7865069|NCT01620528|12355126|FG000|Treatment Period|Withdrawal by Subject|35
7865070|NCT01620528|12355127|FG001|Treatment Period|Withdrawal by Subject|21
7865071|NCT01620528|12355128|FG002|Treatment Period|Withdrawal by Subject|16
7865072|NCT01620528|12355126|FG000|Treatment Period|Adverse Event|17
7865073|NCT01620528|12355127|FG001|Treatment Period|Adverse Event|13
7865074|NCT01620528|12355128|FG002|Treatment Period|Adverse Event|21
7865075|NCT01620528|12355126|FG000|Treatment Period|Lost to Follow-up|16
7865076|NCT01620528|12355127|FG001|Treatment Period|Lost to Follow-up|8
7865077|NCT01620528|12355128|FG002|Treatment Period|Lost to Follow-up|14
7865078|NCT01620528|12355126|FG000|Treatment Period|Other|9
7865079|NCT01620528|12355127|FG001|Treatment Period|Other|5
7865080|NCT01620528|12355128|FG002|Treatment Period|Other|7
7865081|NCT01620528|12355126|FG000|Treatment Period|Subject Noncompliant|11
7865082|NCT01620528|12355127|FG001|Treatment Period|Subject Noncompliant|2
7865083|NCT01620528|12355128|FG002|Treatment Period|Subject Noncompliant|2
7865084|NCT01620528|12355126|FG000|Treatment Period|Pregnancy|7
7865085|NCT01620528|12355127|FG001|Treatment Period|Pregnancy|2
7865086|NCT01620528|12355128|FG002|Treatment Period|Pregnancy|2
7865087|NCT01620528|12355126|FG000|Treatment Period|Surgery/Invasive Intervention|5
7865088|NCT01620528|12355127|FG001|Treatment Period|Surgery/Invasive Intervention|1
7865089|NCT01620528|12355128|FG002|Treatment Period|Surgery/Invasive Intervention|3
7865090|NCT01620528|12355126|FG000|Treatment Period|Exclusionary Medication Received|0
7865091|NCT01620528|12355127|FG001|Treatment Period|Exclusionary Medication Received|1
7865092|NCT01620528|12355128|FG002|Treatment Period|Exclusionary Medication Received|0
7865093|NCT01620528|12355126|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
7865094|NCT01620528|12355127|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
7865095|NCT01620528|12355128|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
7865096|NCT01620528|12355126|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7865097|NCT01620528|12355127|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7865098|NCT01620528|12355128|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4
7865099|NCT01620528|12355126|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
7865100|NCT01620528|12355127|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
7865101|NCT01620528|12355128|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
7865102|NCT01620528|12355126|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
7865103|NCT01620528|12355127|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
7865104|NCT01620528|12355128|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
7865105|NCT01620528|12355126|FG000|Post-Treatment Follow-Up Period|Other|6
7865106|NCT01620528|12355127|FG001|Post-Treatment Follow-Up Period|Other|4
7865107|NCT01620528|12355128|FG002|Post-Treatment Follow-Up Period|Other|2
7865108|NCT01620762|12355160|FG000|Overall Study|Protocol Violation|1
7865109|NCT01620762|12355161|FG001|Overall Study|Protocol Violation|1
7865110|NCT01620762|12355162|FG002|Overall Study|Protocol Violation|1
7865111|NCT01620762|12355160|FG000|Overall Study|Adverse Event|9
7865112|NCT01620762|12355161|FG001|Overall Study|Adverse Event|5
7865113|NCT01620762|12355162|FG002|Overall Study|Adverse Event|2
7865114|NCT01620762|12355160|FG000|Overall Study|Withdrawal by Subject|23
7865115|NCT01620762|12355161|FG001|Overall Study|Withdrawal by Subject|26
7865116|NCT01620762|12355162|FG002|Overall Study|Withdrawal by Subject|27
7865117|NCT01620762|12355160|FG000|Overall Study|Lost to Follow-up|11
7865118|NCT01620762|12355161|FG001|Overall Study|Lost to Follow-up|17
7865119|NCT01620762|12355162|FG002|Overall Study|Lost to Follow-up|10
7865120|NCT01620762|12355160|FG000|Overall Study|Protocol deviation|1
7865121|NCT01620762|12355161|FG001|Overall Study|Protocol deviation|1
7865122|NCT01620762|12355162|FG002|Overall Study|Protocol deviation|6
7865123|NCT01620762|12355160|FG000|Overall Study|Subject deterioration|0
7865124|NCT01620762|12355161|FG001|Overall Study|Subject deterioration|1
7865125|NCT01620762|12355162|FG002|Overall Study|Subject deterioration|1
7865126|NCT01620762|12355160|FG000|Overall Study|Non-specified|3
7865127|NCT01620762|12355161|FG001|Overall Study|Non-specified|6
7865128|NCT01620762|12355162|FG002|Overall Study|Non-specified|5
7865129|NCT01620762|12355160|FG000|Overall Study|Use of prohibted therapies|0
7865130|NCT01620762|12355161|FG001|Overall Study|Use of prohibted therapies|1
7865131|NCT01620762|12355162|FG002|Overall Study|Use of prohibted therapies|1
7865132|NCT01620983|12355173|FG000|Overall Study|Lost to Follow-up|8
7865133|NCT01620983|12355174|FG001|Overall Study|Lost to Follow-up|4
7865134|NCT01620983|12355175|FG002|Overall Study|Lost to Follow-up|9
7865135|NCT01620983|12355173|FG000|Overall Study|Withdrawal by Subject|6
7865136|NCT01620983|12355174|FG001|Overall Study|Withdrawal by Subject|8
7792094|NCT01032837|12246289|FG002|Overall Study|Refused treatment|0
7792095|NCT01032837|12246290|FG003|Overall Study|Refused treatment|1
7792096|NCT01032889|12246307|FG000|Overall Study|Adverse Event|2
7792097|NCT01032889|12246308|FG001|Overall Study|Adverse Event|2
7792098|NCT01032889|12246309|FG002|Overall Study|Adverse Event|0
7792099|NCT01032889|12246307|FG000|Overall Study|Withdrawal of Consent|1
7792100|NCT01032889|12246308|FG001|Overall Study|Withdrawal of Consent|2
7792101|NCT01032889|12246309|FG002|Overall Study|Withdrawal of Consent|1
7792102|NCT01032889|12246307|FG000|Overall Study|Patient Request|0
7792103|NCT01032889|12246308|FG001|Overall Study|Patient Request|1
7792104|NCT01032889|12246309|FG002|Overall Study|Patient Request|0
7792105|NCT01032889|12246307|FG000|Overall Study|Lost to Follow-up|1
7792106|NCT01032889|12246308|FG001|Overall Study|Lost to Follow-up|1
7792107|NCT01032889|12246309|FG002|Overall Study|Lost to Follow-up|0
7792108|NCT01032889|12246307|FG000|Overall Study|Lack of Submental Fat|2
7792109|NCT01032889|12246308|FG001|Overall Study|Lack of Submental Fat|8
7792110|NCT01032889|12246309|FG002|Overall Study|Lack of Submental Fat|1
7792111|NCT01032889|12246307|FG000|Overall Study|Miscellaneous Reasons|2
7792112|NCT01032889|12246308|FG001|Overall Study|Miscellaneous Reasons|1
7792113|NCT01032889|12246309|FG002|Overall Study|Miscellaneous Reasons|1
7792114|NCT01032915|12246321|FG000|Overall Study|Adverse Event|2
7792115|NCT01032915|12246322|FG001|Overall Study|Adverse Event|2
7865137|NCT01620983|12355175|FG002|Overall Study|Withdrawal by Subject|1
7865138|NCT01620983|12355173|FG000|Overall Study|Death|2
7865139|NCT01620983|12355174|FG001|Overall Study|Death|0
7865140|NCT01620983|12355175|FG002|Overall Study|Death|0
7865141|NCT01620983|12355173|FG000|Overall Study|Physician Decision|3
7865142|NCT01620983|12355174|FG001|Overall Study|Physician Decision|10
7865143|NCT01620983|12355175|FG002|Overall Study|Physician Decision|5
7865144|NCT01621126|12355198|FG000|Overall Study|Physician Decision|6
7865145|NCT01621178|12355205|FG000|Overall Study|Adverse Event|5
7865146|NCT01621178|12355206|FG001|Overall Study|Adverse Event|2
7865147|NCT01621178|12355207|FG002|Overall Study|Adverse Event|8
7865148|NCT01621178|12355205|FG000|Overall Study|Death|6
7865149|NCT01621178|12355206|FG001|Overall Study|Death|7
7865150|NCT01621178|12355207|FG002|Overall Study|Death|2
7792116|NCT01032915|12246323|FG002|Overall Study|Adverse Event|1
7792117|NCT01032915|12246324|FG003|Overall Study|Adverse Event|1
7792118|NCT01032915|12246321|FG000|Overall Study|Abnormal test procedure result|0
7792119|NCT01032915|12246322|FG001|Overall Study|Abnormal test procedure result|0
7792120|NCT01032915|12246323|FG002|Overall Study|Abnormal test procedure result|1
7792121|NCT01032915|12246324|FG003|Overall Study|Abnormal test procedure result|0
7792122|NCT01032915|12246321|FG000|Overall Study|Withdrawal by Subject|0
7792123|NCT01032915|12246322|FG001|Overall Study|Withdrawal by Subject|3
7792124|NCT01032915|12246323|FG002|Overall Study|Withdrawal by Subject|1
7792125|NCT01032915|12246324|FG003|Overall Study|Withdrawal by Subject|1
7865151|NCT01621178|12355205|FG000|Overall Study|Lost to Follow-up|1
7792126|NCT01032915|12246321|FG000|Overall Study|Administrative reasons|5
7792127|NCT01032915|12246322|FG001|Overall Study|Administrative reasons|6
7792128|NCT01032915|12246323|FG002|Overall Study|Administrative reasons|4
7792129|NCT01032915|12246324|FG003|Overall Study|Administrative reasons|4
7623221|NCT01844505|12034175|FG000|Overall Study|Disease progression|170
7623222|NCT01844505|12034176|FG001|Overall Study|Disease progression|88
7623223|NCT01844505|12034177|FG002|Overall Study|Disease progression|224
7623224|NCT01844505|12034175|FG000|Overall Study|Study drug toxicity|40
7623225|NCT01844505|12034176|FG001|Overall Study|Study drug toxicity|131
7623226|NCT01844505|12034177|FG002|Overall Study|Study drug toxicity|50
7623227|NCT01844505|12034175|FG000|Overall Study|Death|1
7623228|NCT01844505|12034176|FG001|Overall Study|Death|3
7623229|NCT01844505|12034177|FG002|Overall Study|Death|1
7623230|NCT01844505|12034175|FG000|Overall Study|Adverse event unrelated to study drug|7
7623231|NCT01844505|12034176|FG001|Overall Study|Adverse event unrelated to study drug|15
7623232|NCT01844505|12034177|FG002|Overall Study|Adverse event unrelated to study drug|6
7623233|NCT01844505|12034175|FG000|Overall Study|Subject request discontinue treatment|17
7623234|NCT01844505|12034176|FG001|Overall Study|Subject request discontinue treatment|14
7623235|NCT01844505|12034177|FG002|Overall Study|Subject request discontinue treatment|8
7623236|NCT01844505|12034175|FG000|Overall Study|Withdrawal by Subject|0
7623237|NCT01844505|12034176|FG001|Overall Study|Withdrawal by Subject|3
7865152|NCT01621178|12355206|FG001|Overall Study|Lost to Follow-up|2
7865153|NCT01621178|12355207|FG002|Overall Study|Lost to Follow-up|1
7865154|NCT01621178|12355205|FG000|Overall Study|Withdrawal by Subject|14
7865155|NCT01621178|12355206|FG001|Overall Study|Withdrawal by Subject|17
7865156|NCT01621178|12355207|FG002|Overall Study|Withdrawal by Subject|18
7865157|NCT01621178|12355205|FG000|Overall Study|Physician Decision|5
7865158|NCT01621178|12355206|FG001|Overall Study|Physician Decision|2
7865159|NCT01621178|12355207|FG002|Overall Study|Physician Decision|7
7865160|NCT01621191|12355219|FG000|Overall Study|Adverse Event|9
7865161|NCT01621191|12355219|FG000|Overall Study|Withdrawal by Subject|8
7865162|NCT01621191|12355219|FG000|Overall Study|Lack of Efficacy|6
7865163|NCT01621191|12355219|FG000|Overall Study|Lost to Follow-up|1
7865164|NCT01621191|12355219|FG000|Overall Study|Site Removed From Study|1
7865165|NCT01621490|12355249|FG000|Overall Study|Participant completed treatment|4
7865166|NCT01621490|12355250|FG001|Overall Study|Participant completed treatment|4
7865167|NCT01621490|12355251|FG002|Overall Study|Participant completed treatment|1
7865168|NCT01621490|12355252|FG003|Overall Study|Participant completed treatment|0
7865169|NCT01621490|12355253|FG004|Overall Study|Participant completed treatment|0
7865170|NCT01621490|12355254|FG005|Overall Study|Participant completed treatment|0
7865171|NCT01621490|12355255|FG006|Overall Study|Participant completed treatment|0
7865172|NCT01621490|12355256|FG007|Overall Study|Participant completed treatment|1
7865173|NCT01621490|12355257|FG008|Overall Study|Participant completed treatment|0
7623238|NCT01844505|12034177|FG002|Overall Study|Withdrawal by Subject|0
7623239|NCT01844505|12034175|FG000|Overall Study|Lost to Follow-up|1
7623240|NCT01844505|12034176|FG001|Overall Study|Lost to Follow-up|0
7623241|NCT01844505|12034177|FG002|Overall Study|Lost to Follow-up|0
7623242|NCT01844505|12034175|FG000|Overall Study|Maximum clinical benefit|8
7623243|NCT01844505|12034176|FG001|Overall Study|Maximum clinical benefit|11
7623244|NCT01844505|12034177|FG002|Overall Study|Maximum clinical benefit|2
7623245|NCT01844505|12034175|FG000|Overall Study|Poor/non-compliance|1
7623246|NCT01844505|12034176|FG001|Overall Study|Poor/non-compliance|1
7623247|NCT01844505|12034177|FG002|Overall Study|Poor/non-compliance|1
7623248|NCT01844505|12034175|FG000|Overall Study|Subject no longer meets criteria|0
7792130|NCT01032915|12246321|FG000|Overall Study|Protocol Violation|1
7792131|NCT01032915|12246322|FG001|Overall Study|Protocol Violation|0
7792132|NCT01032915|12246323|FG002|Overall Study|Protocol Violation|0
7792133|NCT01032915|12246324|FG003|Overall Study|Protocol Violation|1
7792134|NCT01033019|12246366|FG000|Overall Study|Withdrawal by Subject|1
7792135|NCT01033019|12246367|FG001|Overall Study|Withdrawal by Subject|0
7792136|NCT01033071|12246377|FG000|Overall Study|Adverse Event|28
7792137|NCT01033071|12246378|FG001|Overall Study|Adverse Event|51
7792138|NCT01033071|12246379|FG002|Overall Study|Adverse Event|26
7792139|NCT01033071|12246377|FG000|Overall Study|Protocol Violation|0
7792140|NCT01033071|12246378|FG001|Overall Study|Protocol Violation|2
7792141|NCT01033071|12246379|FG002|Overall Study|Protocol Violation|1
7792142|NCT01033071|12246377|FG000|Overall Study|Lost to Follow-up|4
7792143|NCT01033071|12246378|FG001|Overall Study|Lost to Follow-up|5
7792144|NCT01033071|12246379|FG002|Overall Study|Lost to Follow-up|5
7792145|NCT01033071|12246377|FG000|Overall Study|Withdrawal by Subject|17
7792146|NCT01033071|12246378|FG001|Overall Study|Withdrawal by Subject|14
7792147|NCT01033071|12246379|FG002|Overall Study|Withdrawal by Subject|11
7792148|NCT01033071|12246377|FG000|Overall Study|Lack of Efficacy|0
7792149|NCT01033071|12246378|FG001|Overall Study|Lack of Efficacy|1
7792150|NCT01033071|12246379|FG002|Overall Study|Lack of Efficacy|1
7792151|NCT01033071|12246377|FG000|Overall Study|Other|6
7792152|NCT01033071|12246378|FG001|Overall Study|Other|4
7792153|NCT01033071|12246379|FG002|Overall Study|Other|3
7792154|NCT01033136|12246389|FG000|Follow-Up (3 Month)|Lost to Follow-up|2
7792155|NCT01033136|12246390|FG001|Follow-Up (3 Month)|Lost to Follow-up|2
7792156|NCT01033240|12246412|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10
7792157|NCT01033240|12246413|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8
7865174|NCT01621490|12355249|FG000|Overall Study|Patient could not travel|1
7865175|NCT01621490|12355250|FG001|Overall Study|Patient could not travel|0
7865176|NCT01621490|12355251|FG002|Overall Study|Patient could not travel|0
7865177|NCT01621490|12355252|FG003|Overall Study|Patient could not travel|0
7865178|NCT01621490|12355253|FG004|Overall Study|Patient could not travel|0
7865179|NCT01621490|12355254|FG005|Overall Study|Patient could not travel|0
7865180|NCT01621490|12355255|FG006|Overall Study|Patient could not travel|0
7865181|NCT01621490|12355256|FG007|Overall Study|Patient could not travel|0
7865182|NCT01621490|12355257|FG008|Overall Study|Patient could not travel|0
7865183|NCT01621490|12355249|FG000|Overall Study|Subject no longer meets study criteria|0
7865184|NCT01621490|12355250|FG001|Overall Study|Subject no longer meets study criteria|0
7865185|NCT01621490|12355251|FG002|Overall Study|Subject no longer meets study criteria|0
7865186|NCT01621490|12355252|FG003|Overall Study|Subject no longer meets study criteria|0
7865187|NCT01621490|12355253|FG004|Overall Study|Subject no longer meets study criteria|1
7865188|NCT01621490|12355254|FG005|Overall Study|Subject no longer meets study criteria|0
7865189|NCT01621490|12355255|FG006|Overall Study|Subject no longer meets study criteria|0
7865190|NCT01621490|12355256|FG007|Overall Study|Subject no longer meets study criteria|0
7865191|NCT01621490|12355257|FG008|Overall Study|Subject no longer meets study criteria|0
7865192|NCT01621490|12355249|FG000|Overall Study|Maximum clinical benefit|3
7865193|NCT01621490|12355250|FG001|Overall Study|Maximum clinical benefit|2
7865194|NCT01621490|12355251|FG002|Overall Study|Maximum clinical benefit|0
7865195|NCT01621490|12355252|FG003|Overall Study|Maximum clinical benefit|0
7865196|NCT01621490|12355253|FG004|Overall Study|Maximum clinical benefit|0
7865197|NCT01621490|12355254|FG005|Overall Study|Maximum clinical benefit|0
7865198|NCT01621490|12355255|FG006|Overall Study|Maximum clinical benefit|1
7865199|NCT01621490|12355256|FG007|Overall Study|Maximum clinical benefit|2
7865200|NCT01621490|12355257|FG008|Overall Study|Maximum clinical benefit|0
7865201|NCT01621490|12355249|FG000|Overall Study|Withdrawal by Subject|1
7865202|NCT01621490|12355250|FG001|Overall Study|Withdrawal by Subject|0
7865203|NCT01621490|12355251|FG002|Overall Study|Withdrawal by Subject|0
7865204|NCT01621490|12355252|FG003|Overall Study|Withdrawal by Subject|0
7865205|NCT01621490|12355253|FG004|Overall Study|Withdrawal by Subject|0
7865206|NCT01621490|12355254|FG005|Overall Study|Withdrawal by Subject|3
7865207|NCT01621490|12355255|FG006|Overall Study|Withdrawal by Subject|0
7623249|NCT01844505|12034176|FG001|Overall Study|Subject no longer meets criteria|1
7865208|NCT01621490|12355256|FG007|Overall Study|Withdrawal by Subject|0
7865209|NCT01621490|12355257|FG008|Overall Study|Withdrawal by Subject|0
7865210|NCT01621490|12355249|FG000|Overall Study|Subject request to discontinue study|1
7623250|NCT01844505|12034177|FG002|Overall Study|Subject no longer meets criteria|0
7865211|NCT01621490|12355250|FG001|Overall Study|Subject request to discontinue study|3
7865212|NCT01621490|12355251|FG002|Overall Study|Subject request to discontinue study|1
7865213|NCT01621490|12355252|FG003|Overall Study|Subject request to discontinue study|1
7865214|NCT01621490|12355253|FG004|Overall Study|Subject request to discontinue study|0
7865215|NCT01621490|12355254|FG005|Overall Study|Subject request to discontinue study|2
7865216|NCT01621490|12355255|FG006|Overall Study|Subject request to discontinue study|1
7865217|NCT01621490|12355256|FG007|Overall Study|Subject request to discontinue study|0
7865218|NCT01621490|12355257|FG008|Overall Study|Subject request to discontinue study|1
7865219|NCT01621490|12355249|FG000|Overall Study|Adverse event unrelated to study drug|2
7865220|NCT01621490|12355250|FG001|Overall Study|Adverse event unrelated to study drug|1
7865221|NCT01621490|12355251|FG002|Overall Study|Adverse event unrelated to study drug|0
7865222|NCT01621490|12355252|FG003|Overall Study|Adverse event unrelated to study drug|0
7865223|NCT01621490|12355253|FG004|Overall Study|Adverse event unrelated to study drug|0
7865224|NCT01621490|12355254|FG005|Overall Study|Adverse event unrelated to study drug|0
7865225|NCT01621490|12355255|FG006|Overall Study|Adverse event unrelated to study drug|0
7865226|NCT01621490|12355256|FG007|Overall Study|Adverse event unrelated to study drug|2
7865227|NCT01621490|12355257|FG008|Overall Study|Adverse event unrelated to study drug|1
7865228|NCT01621490|12355249|FG000|Overall Study|Disease progression|27
7865229|NCT01621490|12355250|FG001|Overall Study|Disease progression|28
7865230|NCT01621490|12355251|FG002|Overall Study|Disease progression|1
7865231|NCT01621490|12355252|FG003|Overall Study|Disease progression|5
7865232|NCT01621490|12355253|FG004|Overall Study|Disease progression|3
7865233|NCT01621490|12355254|FG005|Overall Study|Disease progression|8
7865234|NCT01621490|12355255|FG006|Overall Study|Disease progression|7
7865235|NCT01621490|12355256|FG007|Overall Study|Disease progression|0
7865236|NCT01621490|12355257|FG008|Overall Study|Disease progression|4
7865237|NCT01621490|12355249|FG000|Overall Study|Study drug toxicity|1
7865238|NCT01621490|12355250|FG001|Overall Study|Study drug toxicity|4
7865239|NCT01621490|12355251|FG002|Overall Study|Study drug toxicity|5
7865240|NCT01621490|12355252|FG003|Overall Study|Study drug toxicity|3
7865241|NCT01621490|12355253|FG004|Overall Study|Study drug toxicity|1
7865242|NCT01621490|12355254|FG005|Overall Study|Study drug toxicity|10
7865243|NCT01621490|12355255|FG006|Overall Study|Study drug toxicity|1
7865244|NCT01621490|12355256|FG007|Overall Study|Study drug toxicity|4
7865245|NCT01621490|12355257|FG008|Overall Study|Study drug toxicity|1
7865246|NCT01621490|12355249|FG000|Overall Study|Death|0
7865247|NCT01621490|12355250|FG001|Overall Study|Death|0
7865248|NCT01621490|12355251|FG002|Overall Study|Death|0
7865249|NCT01621490|12355252|FG003|Overall Study|Death|0
7865250|NCT01621490|12355253|FG004|Overall Study|Death|0
7865251|NCT01621490|12355254|FG005|Overall Study|Death|0
7865252|NCT01621490|12355255|FG006|Overall Study|Death|0
7865253|NCT01621490|12355256|FG007|Overall Study|Death|1
7865254|NCT01621490|12355257|FG008|Overall Study|Death|0
7865255|NCT01621490|12355249|FG000|Overall Study|Grade 4 Lipase elevation|1
7865256|NCT01621490|12355250|FG001|Overall Study|Grade 4 Lipase elevation|0
7865257|NCT01621490|12355251|FG002|Overall Study|Grade 4 Lipase elevation|0
7865258|NCT01621490|12355252|FG003|Overall Study|Grade 4 Lipase elevation|0
7865259|NCT01621490|12355253|FG004|Overall Study|Grade 4 Lipase elevation|0
7865260|NCT01621490|12355254|FG005|Overall Study|Grade 4 Lipase elevation|0
7865261|NCT01621490|12355255|FG006|Overall Study|Grade 4 Lipase elevation|0
7865262|NCT01621490|12355256|FG007|Overall Study|Grade 4 Lipase elevation|0
7865263|NCT01621490|12355257|FG008|Overall Study|Grade 4 Lipase elevation|0
7865264|NCT01621490|12355249|FG000|Overall Study|BMS informed of patient status|0
7865265|NCT01621490|12355250|FG001|Overall Study|BMS informed of patient status|0
7865266|NCT01621490|12355251|FG002|Overall Study|BMS informed of patient status|1
7865267|NCT01621490|12355252|FG003|Overall Study|BMS informed of patient status|0
7865268|NCT01621490|12355253|FG004|Overall Study|BMS informed of patient status|0
7865269|NCT01621490|12355254|FG005|Overall Study|BMS informed of patient status|0
7865270|NCT01621490|12355255|FG006|Overall Study|BMS informed of patient status|0
7865271|NCT01621490|12355256|FG007|Overall Study|BMS informed of patient status|0
7865272|NCT01621490|12355257|FG008|Overall Study|BMS informed of patient status|0
7865273|NCT01621490|12355249|FG000|Overall Study|Investigator decision|0
7865274|NCT01621490|12355250|FG001|Overall Study|Investigator decision|0
7865275|NCT01621490|12355251|FG002|Overall Study|Investigator decision|1
7865276|NCT01621490|12355252|FG003|Overall Study|Investigator decision|0
7865277|NCT01621490|12355253|FG004|Overall Study|Investigator decision|1
7865278|NCT01621490|12355254|FG005|Overall Study|Investigator decision|0
7865279|NCT01621490|12355255|FG006|Overall Study|Investigator decision|1
7865280|NCT01621490|12355256|FG007|Overall Study|Investigator decision|0
7865281|NCT01621490|12355257|FG008|Overall Study|Investigator decision|0
7865282|NCT01621490|12355249|FG000|Overall Study|Documented disease progression|0
7865283|NCT01621490|12355250|FG001|Overall Study|Documented disease progression|0
7865284|NCT01621490|12355251|FG002|Overall Study|Documented disease progression|1
7865285|NCT01621490|12355252|FG003|Overall Study|Documented disease progression|0
7865286|NCT01621490|12355253|FG004|Overall Study|Documented disease progression|0
7865287|NCT01621490|12355254|FG005|Overall Study|Documented disease progression|0
7865288|NCT01621490|12355255|FG006|Overall Study|Documented disease progression|0
7865289|NCT01621490|12355256|FG007|Overall Study|Documented disease progression|0
7865290|NCT01621490|12355257|FG008|Overall Study|Documented disease progression|0
7865291|NCT01621490|12355249|FG000|Overall Study|Patient reached treatment 2 yr limit|0
7865292|NCT01621490|12355250|FG001|Overall Study|Patient reached treatment 2 yr limit|1
7865293|NCT01621490|12355251|FG002|Overall Study|Patient reached treatment 2 yr limit|0
7865294|NCT01621490|12355252|FG003|Overall Study|Patient reached treatment 2 yr limit|0
7865295|NCT01621490|12355253|FG004|Overall Study|Patient reached treatment 2 yr limit|0
7865296|NCT01621490|12355254|FG005|Overall Study|Patient reached treatment 2 yr limit|0
7865297|NCT01621490|12355255|FG006|Overall Study|Patient reached treatment 2 yr limit|0
7865298|NCT01621490|12355256|FG007|Overall Study|Patient reached treatment 2 yr limit|0
7865299|NCT01621490|12355257|FG008|Overall Study|Patient reached treatment 2 yr limit|0
7865300|NCT01621490|12355249|FG000|Overall Study|Clinical deterioration|0
7865301|NCT01621490|12355250|FG001|Overall Study|Clinical deterioration|1
7865302|NCT01621490|12355251|FG002|Overall Study|Clinical deterioration|0
7865303|NCT01621490|12355252|FG003|Overall Study|Clinical deterioration|0
7865304|NCT01621490|12355253|FG004|Overall Study|Clinical deterioration|0
7865305|NCT01621490|12355254|FG005|Overall Study|Clinical deterioration|0
7865306|NCT01621490|12355255|FG006|Overall Study|Clinical deterioration|0
7865307|NCT01621490|12355256|FG007|Overall Study|Clinical deterioration|0
7865308|NCT01621490|12355257|FG008|Overall Study|Clinical deterioration|0
7865309|NCT01621490|12355249|FG000|Overall Study|Complete response|0
7865310|NCT01621490|12355250|FG001|Overall Study|Complete response|0
7865311|NCT01621490|12355251|FG002|Overall Study|Complete response|0
7865312|NCT01621490|12355252|FG003|Overall Study|Complete response|0
7865313|NCT01621490|12355253|FG004|Overall Study|Complete response|0
7865314|NCT01621490|12355254|FG005|Overall Study|Complete response|0
7865315|NCT01621490|12355255|FG006|Overall Study|Complete response|0
7865316|NCT01621490|12355256|FG007|Overall Study|Complete response|0
7865317|NCT01621490|12355257|FG008|Overall Study|Complete response|1
7865318|NCT01621490|12355249|FG000|Overall Study|Patient delayed due to toxicity|0
7865319|NCT01621490|12355250|FG001|Overall Study|Patient delayed due to toxicity|0
7865320|NCT01621490|12355251|FG002|Overall Study|Patient delayed due to toxicity|0
7865321|NCT01621490|12355252|FG003|Overall Study|Patient delayed due to toxicity|0
7865322|NCT01621490|12355253|FG004|Overall Study|Patient delayed due to toxicity|0
7865323|NCT01621490|12355254|FG005|Overall Study|Patient delayed due to toxicity|1
7865324|NCT01621490|12355255|FG006|Overall Study|Patient delayed due to toxicity|0
7865325|NCT01621490|12355256|FG007|Overall Study|Patient delayed due to toxicity|0
7865326|NCT01621490|12355257|FG008|Overall Study|Patient delayed due to toxicity|0
7865327|NCT01621542|12355376|FG000|Overall Study|Adverse Event|0
7865328|NCT01621542|12355377|FG001|Overall Study|Adverse Event|0
7865329|NCT01621542|12355378|FG002|Overall Study|Adverse Event|1
7865330|NCT01621542|12355379|FG003|Overall Study|Adverse Event|3
7865331|NCT01621542|12355380|FG004|Overall Study|Adverse Event|0
7865332|NCT01621542|12355381|FG005|Overall Study|Adverse Event|0
7865333|NCT01621542|12355376|FG000|Overall Study|Death|0
7865334|NCT01621542|12355377|FG001|Overall Study|Death|1
7865335|NCT01621542|12355378|FG002|Overall Study|Death|0
7865336|NCT01621542|12355379|FG003|Overall Study|Death|0
7865337|NCT01621542|12355380|FG004|Overall Study|Death|0
7865338|NCT01621542|12355381|FG005|Overall Study|Death|0
7865339|NCT01621542|12355376|FG000|Overall Study|Physician Decision|1
7865340|NCT01621542|12355377|FG001|Overall Study|Physician Decision|0
7865341|NCT01621542|12355378|FG002|Overall Study|Physician Decision|1
7865342|NCT01621542|12355379|FG003|Overall Study|Physician Decision|13
7865343|NCT01621542|12355380|FG004|Overall Study|Physician Decision|3
7865344|NCT01621542|12355381|FG005|Overall Study|Physician Decision|1
7865345|NCT01621542|12355376|FG000|Overall Study|Withdrawal by Subject|2
7865346|NCT01621542|12355377|FG001|Overall Study|Withdrawal by Subject|0
7865347|NCT01621542|12355378|FG002|Overall Study|Withdrawal by Subject|1
7865348|NCT01621542|12355379|FG003|Overall Study|Withdrawal by Subject|3
7865349|NCT01621542|12355380|FG004|Overall Study|Withdrawal by Subject|3
7865350|NCT01621542|12355381|FG005|Overall Study|Withdrawal by Subject|3
7865351|NCT01621542|12355376|FG000|Overall Study|progression/treatment failure|2
7865352|NCT01621542|12355377|FG001|Overall Study|progression/treatment failure|4
7865353|NCT01621542|12355378|FG002|Overall Study|progression/treatment failure|3
7865354|NCT01621542|12355379|FG003|Overall Study|progression/treatment failure|7
7865355|NCT01621542|12355380|FG004|Overall Study|progression/treatment failure|3
7865356|NCT01621542|12355381|FG005|Overall Study|progression/treatment failure|5
7865357|NCT01621542|12355376|FG000|Overall Study|Protocol Violation|0
7865358|NCT01621542|12355377|FG001|Overall Study|Protocol Violation|0
7865359|NCT01621542|12355378|FG002|Overall Study|Protocol Violation|0
7865360|NCT01621542|12355379|FG003|Overall Study|Protocol Violation|1
7865361|NCT01621542|12355380|FG004|Overall Study|Protocol Violation|0
7865362|NCT01621542|12355381|FG005|Overall Study|Protocol Violation|0
7865363|NCT01621542|12355376|FG000|Overall Study|study stopped by sponsor|0
7865364|NCT01621542|12355377|FG001|Overall Study|study stopped by sponsor|0
7865365|NCT01621542|12355378|FG002|Overall Study|study stopped by sponsor|0
7865366|NCT01621542|12355379|FG003|Overall Study|study stopped by sponsor|1
7865367|NCT01621542|12355380|FG004|Overall Study|study stopped by sponsor|0
7865368|NCT01621542|12355381|FG005|Overall Study|study stopped by sponsor|0
7865369|NCT01621802|12355440|FG000|Overall Study|Protocol Violation|0
7865370|NCT01621802|12355441|FG001|Overall Study|Protocol Violation|0
7865371|NCT01621802|12355442|FG002|Overall Study|Protocol Violation|0
7865372|NCT01621802|12355443|FG003|Overall Study|Protocol Violation|0
7865373|NCT01621802|12355444|FG004|Overall Study|Protocol Violation|0
7865374|NCT01621802|12355445|FG005|Overall Study|Protocol Violation|1
7865375|NCT01621802|12355440|FG000|Overall Study|Withdrawal by Subject|8
7865376|NCT01621802|12355441|FG001|Overall Study|Withdrawal by Subject|4
7865377|NCT01621802|12355442|FG002|Overall Study|Withdrawal by Subject|4
7865378|NCT01621802|12355443|FG003|Overall Study|Withdrawal by Subject|2
7865379|NCT01621802|12355444|FG004|Overall Study|Withdrawal by Subject|2
7865380|NCT01621802|12355445|FG005|Overall Study|Withdrawal by Subject|0
7865381|NCT01621802|12355440|FG000|Overall Study|Migrated/moved from study area|0
7865382|NCT01621802|12355441|FG001|Overall Study|Migrated/moved from study area|0
7865383|NCT01621802|12355442|FG002|Overall Study|Migrated/moved from study area|2
7865384|NCT01621802|12355443|FG003|Overall Study|Migrated/moved from study area|0
7865385|NCT01621802|12355444|FG004|Overall Study|Migrated/moved from study area|1
7865386|NCT01621802|12355445|FG005|Overall Study|Migrated/moved from study area|0
7865387|NCT01621802|12355440|FG000|Overall Study|Others|3
7865388|NCT01621802|12355441|FG001|Overall Study|Others|3
7865389|NCT01621802|12355442|FG002|Overall Study|Others|3
7865390|NCT01621802|12355443|FG003|Overall Study|Others|2
7865391|NCT01621802|12355444|FG004|Overall Study|Others|1
7865392|NCT01621802|12355445|FG005|Overall Study|Others|0
7865393|NCT01621802|12355440|FG000|Overall Study|Lost to Follow-up|36
7865394|NCT01621802|12355441|FG001|Overall Study|Lost to Follow-up|16
7865395|NCT01621802|12355442|FG002|Overall Study|Lost to Follow-up|24
7865396|NCT01621802|12355443|FG003|Overall Study|Lost to Follow-up|7
7865397|NCT01621802|12355444|FG004|Overall Study|Lost to Follow-up|31
7865398|NCT01621802|12355445|FG005|Overall Study|Lost to Follow-up|11
7865399|NCT01621880|12355464|FG000|Overall Study|Adverse Event|5
7865400|NCT01621880|12355465|FG001|Overall Study|Adverse Event|1
7865401|NCT01621880|12355464|FG000|Overall Study|Withdrawal by Subject|5
7865402|NCT01621880|12355465|FG001|Overall Study|Withdrawal by Subject|4
7865403|NCT01622231|12355483|FG000|Overall Study|Physician Decision|1
7865404|NCT01622231|12355483|FG000|Overall Study|Withdrawal by Subject|1
7865405|NCT01622348|12355509|FG000|Overall Study|Withdrawal by Subject|1
7865406|NCT01622348|12355510|FG001|Overall Study|Withdrawal by Subject|0
7865407|NCT01622348|12355511|FG002|Overall Study|Withdrawal by Subject|1
7865408|NCT01622569|12355532|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
7865409|NCT01622569|12355533|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
7865410|NCT01622569|12355534|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
7865411|NCT01622569|12355535|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
7865412|NCT01622569|12355532|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
7865413|NCT01622569|12355533|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
7865414|NCT01622569|12355534|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
7865415|NCT01622569|12355535|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
7865416|NCT01622569|12355532|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
7865417|NCT01622569|12355533|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
7865418|NCT01622569|12355534|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
7865419|NCT01622569|12355535|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
7865420|NCT01622569|12355532|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7865421|NCT01622569|12355533|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
7865422|NCT01622569|12355534|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7865423|NCT01622569|12355535|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
7865424|NCT01622569|12355532|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
7865425|NCT01622569|12355533|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
7865426|NCT01622569|12355534|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
7865427|NCT01622569|12355535|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
7865428|NCT01622569|12355532|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
7865429|NCT01622569|12355533|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
7865430|NCT01622569|12355534|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7865431|NCT01622569|12355535|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
7865432|NCT01622569|12355532|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
7865433|NCT01622569|12355533|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7865434|NCT01622569|12355534|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
7865435|NCT01622569|12355535|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
7865436|NCT01622569|12355532|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7865437|NCT01622569|12355533|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7865438|NCT01622569|12355534|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7865439|NCT01622569|12355535|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
7865440|NCT01622660|12355555|FG000|Overall Study|Adverse Event|1
7865441|NCT01622673|12355565|FG000|Treatment Period 1|Withdrawal by Subject|0
7865442|NCT01622673|12355566|FG001|Treatment Period 1|Withdrawal by Subject|0
7865443|NCT01622673|12355567|FG002|Treatment Period 1|Withdrawal by Subject|0
7865444|NCT01622673|12355568|FG003|Treatment Period 1|Withdrawal by Subject|1
7865445|NCT01622673|12355569|FG004|Treatment Period 1|Withdrawal by Subject|0
7865446|NCT01622673|12355570|FG005|Treatment Period 1|Withdrawal by Subject|0
7865447|NCT01622673|12355565|FG000|Treatment Period 1|Protocol Violation|0
7865448|NCT01622673|12355566|FG001|Treatment Period 1|Protocol Violation|1
7865449|NCT01622673|12355567|FG002|Treatment Period 1|Protocol Violation|0
7865450|NCT01622673|12355568|FG003|Treatment Period 1|Protocol Violation|0
7865451|NCT01622673|12355569|FG004|Treatment Period 1|Protocol Violation|0
7865452|NCT01622673|12355570|FG005|Treatment Period 1|Protocol Violation|0
7865453|NCT01622673|12355565|FG000|Treatment Period 2|Withdrawal by Subject|0
7865454|NCT01622673|12355566|FG001|Treatment Period 2|Withdrawal by Subject|0
7865455|NCT01622673|12355567|FG002|Treatment Period 2|Withdrawal by Subject|0
7865456|NCT01622673|12355568|FG003|Treatment Period 2|Withdrawal by Subject|1
7865457|NCT01622673|12355569|FG004|Treatment Period 2|Withdrawal by Subject|0
7865458|NCT01622673|12355570|FG005|Treatment Period 2|Withdrawal by Subject|0
7865459|NCT01622673|12355565|FG000|Treatment Period 3|Protocol Violation|0
7865460|NCT01622673|12355566|FG001|Treatment Period 3|Protocol Violation|1
7865461|NCT01622673|12355567|FG002|Treatment Period 3|Protocol Violation|0
7865462|NCT01622673|12355568|FG003|Treatment Period 3|Protocol Violation|0
7865463|NCT01622673|12355569|FG004|Treatment Period 3|Protocol Violation|0
7865464|NCT01622673|12355570|FG005|Treatment Period 3|Protocol Violation|0
7865465|NCT01623050|12355604|FG000|Overall Study|Lost to Follow-up|9
7865466|NCT01623115|12355610|FG000|Overall Study|Randomized but not treated|0
7865467|NCT01623115|12355611|FG001|Overall Study|Randomized but not treated|1
7865468|NCT01623115|12355610|FG000|Overall Study|Physician Decision|1
7865469|NCT01623115|12355611|FG001|Overall Study|Physician Decision|0
7865470|NCT01623115|12355610|FG000|Overall Study|Participants moved|1
7865471|NCT01623115|12355611|FG001|Overall Study|Participants moved|5
7865472|NCT01623115|12355610|FG000|Overall Study|Adverse Event|10
7865473|NCT01623115|12355611|FG001|Overall Study|Adverse Event|13
7865474|NCT01623115|12355610|FG000|Overall Study|Poor compliance to protocol|4
7865475|NCT01623115|12355611|FG001|Overall Study|Poor compliance to protocol|10
7865476|NCT01623115|12355610|FG000|Overall Study|Consent withdrawn by participant|2
7865477|NCT01623115|12355611|FG001|Overall Study|Consent withdrawn by participant|6
7865478|NCT01623115|12355610|FG000|Overall Study|Related to study drug administration|0
7865479|NCT01623115|12355611|FG001|Overall Study|Related to study drug administration|2
7865480|NCT01623115|12355610|FG000|Overall Study|Last visit outside protocol visit window|14
7865481|NCT01623115|12355611|FG001|Overall Study|Last visit outside protocol visit window|26
7865482|NCT01623115|12355610|FG000|Overall Study|Site closure|1
7865483|NCT01623115|12355611|FG001|Overall Study|Site closure|7
7865484|NCT01623115|12355610|FG000|Overall Study|Death|0
7865485|NCT01623115|12355611|FG001|Overall Study|Death|4
7865486|NCT01623115|12355610|FG000|Overall Study|Other than specified above|0
7865487|NCT01623115|12355611|FG001|Overall Study|Other than specified above|3
7865488|NCT01623154|12355617|FG000|Overall Study|Did not drink Pranactin Citric|4
7865489|NCT01623271|12355623|FG000|Overall Study|Withdrawal by Subject|2
7865490|NCT01623310|12355627|FG000|Overall Study|Adverse Event|21
7865491|NCT01623310|12355627|FG000|Overall Study|Lost to Follow-up|18
7865492|NCT01623310|12355627|FG000|Overall Study|Lack of Efficacy|6
7865493|NCT01623310|12355627|FG000|Overall Study|Protocol Violation|6
7865494|NCT01623310|12355627|FG000|Overall Study|Withdrawal by Subject|25
7865495|NCT01623310|12355627|FG000|Overall Study|Became potentially child-bearing|1
7865496|NCT01623310|12355627|FG000|Overall Study|Diagnoses of bilateral cateracts|1
7865497|NCT01623310|12355627|FG000|Overall Study|Investigators Discretion-Noncompliant|1
7865498|NCT01623531|12355650|FG000|Overall Study|Death|1
7865499|NCT01623531|12355651|FG001|Overall Study|Death|0
7865500|NCT01623531|12355650|FG000|Overall Study|Protocol Violation|2
7865501|NCT01623531|12355651|FG001|Overall Study|Protocol Violation|1
7865502|NCT01623531|12355650|FG000|Overall Study|Missing data at primary outcome time poi|1
7865503|NCT01623531|12355651|FG001|Overall Study|Missing data at primary outcome time poi|1
7865504|NCT01623596|12355662|FG000|Overall Study|Abnormal laboratory values|2
7865505|NCT01623596|12355663|FG001|Overall Study|Abnormal laboratory values|0
7865506|NCT01623596|12355662|FG000|Overall Study|Administrative problems|9
7865507|NCT01623596|12355663|FG001|Overall Study|Administrative problems|13
7865508|NCT01623596|12355662|FG000|Overall Study|Adverse Event|20
7865509|NCT01623596|12355663|FG001|Overall Study|Adverse Event|29
7865510|NCT01623596|12355662|FG000|Overall Study|Death|0
7865511|NCT01623596|12355663|FG001|Overall Study|Death|2
7865512|NCT01623596|12355662|FG000|Overall Study|Lost to Follow-up|12
7865513|NCT01623596|12355663|FG001|Overall Study|Lost to Follow-up|16
7865514|NCT01623596|12355662|FG000|Overall Study|Withdrawal by Subject|13
7865515|NCT01623596|12355663|FG001|Overall Study|Withdrawal by Subject|31
7865516|NCT01623596|12355662|FG000|Overall Study|Patient no longer requires study drug|1
7865517|NCT01623596|12355663|FG001|Overall Study|Patient no longer requires study drug|0
7865518|NCT01623596|12355662|FG000|Overall Study|Protocol Violation|0
7865519|NCT01623596|12355663|FG001|Overall Study|Protocol Violation|6
7865520|NCT01623596|12355662|FG000|Overall Study|Lack of Efficacy|5
7865521|NCT01623596|12355663|FG001|Overall Study|Lack of Efficacy|3
7865522|NCT01623752|12355684|FG000|Phase 1 (78 Weeks)|No Data|249
7865523|NCT01623752|12355685|FG001|Phase 1 (78 Weeks)|No Data|66
7865524|NCT01623752|12355686|FG002|Phase 1 (78 Weeks)|No Data|2
7865525|NCT01623752|12355684|FG000|Phase 1 (78 Weeks)|Other|33
7865526|NCT01623752|12355685|FG001|Phase 1 (78 Weeks)|Other|20
7865527|NCT01623752|12355686|FG002|Phase 1 (78 Weeks)|Other|0
7865528|NCT01623752|12355684|FG000|Phase 1 (78 Weeks)|Adverse Event|122
7865529|NCT01623752|12355685|FG001|Phase 1 (78 Weeks)|Adverse Event|39
7865530|NCT01623752|12355686|FG002|Phase 1 (78 Weeks)|Adverse Event|0
7865531|NCT01623752|12355684|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227
7865532|NCT01623752|12355685|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82
7865533|NCT01623752|12355686|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0
7865534|NCT01623752|12355684|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14
7865535|NCT01623752|12355685|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2
7865536|NCT01623752|12355686|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0
7865537|NCT01623752|12355684|FG000|Phase 2 (78 Weeks)|Other|5
7865538|NCT01623752|12355685|FG001|Phase 2 (78 Weeks)|Other|1
7865539|NCT01623752|12355686|FG002|Phase 2 (78 Weeks)|Other|0
7865540|NCT01623752|12355684|FG000|Phase 2 (78 Weeks)|No Data|43
7865541|NCT01623752|12355685|FG001|Phase 2 (78 Weeks)|No Data|11
7865542|NCT01623752|12355686|FG002|Phase 2 (78 Weeks)|No Data|0
7865543|NCT01623752|12355684|FG000|Phase 2 (78 Weeks)|Adverse Event|4
7865544|NCT01623752|12355685|FG001|Phase 2 (78 Weeks)|Adverse Event|4
7865545|NCT01623752|12355686|FG002|Phase 2 (78 Weeks)|Adverse Event|0
7865546|NCT01623830|12355697|FG000|Overall Study|Withdrawal by Subject|6
7865547|NCT01623830|12355698|FG001|Overall Study|Withdrawal by Subject|7
7865548|NCT01623830|12355697|FG000|Overall Study|Exclusion from Study|1
7865549|NCT01623830|12355698|FG001|Overall Study|Exclusion from Study|2
7865550|NCT01624090|12355712|FG000|Overall Study|DLT, taken off therapy|0
7865551|NCT01624090|12355713|FG001|Overall Study|DLT, taken off therapy|1
7865552|NCT01624090|12355714|FG002|Overall Study|DLT, taken off therapy|0
7865553|NCT01624090|12355715|FG003|Overall Study|DLT, taken off therapy|0
7865554|NCT01624090|12355712|FG000|Overall Study|Withdrew prior to treatment|0
7865555|NCT01624090|12355713|FG001|Overall Study|Withdrew prior to treatment|1
7865556|NCT01624090|12355714|FG002|Overall Study|Withdrew prior to treatment|0
7865557|NCT01624090|12355715|FG003|Overall Study|Withdrew prior to treatment|0
7865558|NCT01624090|12355712|FG000|Overall Study|Died on study|0
7865559|NCT01624090|12355713|FG001|Overall Study|Died on study|0
7865560|NCT01624090|12355714|FG002|Overall Study|Died on study|2
7865561|NCT01624090|12355715|FG003|Overall Study|Died on study|0
7865562|NCT01624090|12355712|FG000|Overall Study|Did not complete 1 crse of therapy|0
7865563|NCT01624090|12355713|FG001|Overall Study|Did not complete 1 crse of therapy|0
7865564|NCT01624090|12355714|FG002|Overall Study|Did not complete 1 crse of therapy|2
7865565|NCT01624090|12355715|FG003|Overall Study|Did not complete 1 crse of therapy|0
7865566|NCT01624090|12355712|FG000|Overall Study|Dose escalated|0
7865567|NCT01624090|12355713|FG001|Overall Study|Dose escalated|0
7865568|NCT01624090|12355714|FG002|Overall Study|Dose escalated|3
7865569|NCT01624090|12355715|FG003|Overall Study|Dose escalated|0
7865570|NCT01624142|12355727|FG000|Overall Study|Withdrawal by Subject|14
7865571|NCT01624142|12355728|FG001|Overall Study|Withdrawal by Subject|4
7865572|NCT01624142|12355727|FG000|Overall Study|Death|3
7865573|NCT01624142|12355728|FG001|Overall Study|Death|6
7865574|NCT01624142|12355727|FG000|Overall Study|Study Closure|12
7865575|NCT01624142|12355728|FG001|Overall Study|Study Closure|6
7865576|NCT01624142|12355727|FG000|Overall Study|Lost to Follow-up|2
7865577|NCT01624142|12355728|FG001|Overall Study|Lost to Follow-up|0
7865578|NCT01624142|12355727|FG000|Overall Study|Other|1
7865579|NCT01624142|12355728|FG001|Overall Study|Other|0
7865580|NCT01624194|12355750|FG000|Overall Study|Lost to Follow-up|1
7865581|NCT01624194|12355751|FG001|Overall Study|Lost to Follow-up|0
7865582|NCT01624194|12355750|FG000|Overall Study|Withdrawal by Subject|1
7865583|NCT01624194|12355751|FG001|Overall Study|Withdrawal by Subject|0
7865584|NCT01624233|12355758|FG000|Period 2 - Induction|Adverse Event|1
7865585|NCT01624233|12355758|FG000|Period 3 - Maintenance|Adverse Event|2
7865586|NCT01624233|12355758|FG000|Period 3 - Maintenance|Lack of Efficacy|1
7865587|NCT01624233|12355758|FG000|Period 3 - Maintenance|Physician Decision|2
7865588|NCT01624233|12355758|FG000|Period 3 - Maintenance|Withdrawal by Subject|2
7865589|NCT01624233|12355758|FG000|Period 4 - Drug Free Period|Relapsed|61
7865590|NCT01624233|12355758|FG000|Period 5 - Retreatment Period|Adverse Event|5
7865591|NCT01624233|12355758|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1
7865592|NCT01624233|12355758|FG000|Period 5 - Retreatment Period|Physician Decision|1
7865593|NCT01624233|12355758|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3
7865594|NCT01624233|12355758|FG000|Period 6: Follow-up|Adverse Event|3
7865595|NCT01624233|12355758|FG000|Period 6: Follow-up|Lack of Efficacy|2
7865596|NCT01624233|12355758|FG000|Period 6: Follow-up|Physician Decision|1
7865597|NCT01624233|12355758|FG000|Period 6: Follow-up|Withdrawal by Subject|3
7865598|NCT01624259|12355768|FG000|Overall Study|Adverse Event|18
7865599|NCT01624259|12355769|FG001|Overall Study|Adverse Event|18
7865600|NCT01624259|12355768|FG000|Overall Study|Protocol Violation|1
7865601|NCT01624259|12355769|FG001|Overall Study|Protocol Violation|2
7865602|NCT01624259|12355768|FG000|Overall Study|Withdrawal by Subject|5
7865603|NCT01624259|12355769|FG001|Overall Study|Withdrawal by Subject|7
7865604|NCT01624259|12355768|FG000|Overall Study|Physician Decision|1
7865605|NCT01624259|12355769|FG001|Overall Study|Physician Decision|1
7865606|NCT01624259|12355768|FG000|Overall Study|Lost to Follow-up|2
7865607|NCT01624259|12355769|FG001|Overall Study|Lost to Follow-up|3
7865608|NCT01624259|12355768|FG000|Overall Study|Abnormal laboratory measure|3
7865609|NCT01624259|12355769|FG001|Overall Study|Abnormal laboratory measure|0
7865610|NCT01624467|12355801|FG000|Overall Study|Withdrawal by Subject|2
7865611|NCT01624467|12355801|FG000|Overall Study|Lost to Follow-up|1
7865612|NCT01624467|12355801|FG000|Overall Study|Adverse Event|7
7865613|NCT01624467|12355801|FG000|Overall Study|Progressive Disease|19
7865614|NCT01624467|12355801|FG000|Overall Study|Per Sponsor Requirement|1
7865615|NCT01624467|12355801|FG000|Overall Study|Subject Withdrew from Treatment|1
7865616|NCT01624506|12355809|FG000|Overall Study|Lost to Follow-up|29
7865617|NCT01624506|12355810|FG001|Overall Study|Lost to Follow-up|15
7865618|NCT01624506|12355809|FG000|Overall Study|Withdrawal by Subject|9
7865619|NCT01624506|12355810|FG001|Overall Study|Withdrawal by Subject|2
7865620|NCT01624506|12355809|FG000|Overall Study|Death|1
7865621|NCT01624506|12355810|FG001|Overall Study|Death|0
7865622|NCT01624506|12355809|FG000|Overall Study|LINX explants|23
7865623|NCT01624506|12355810|FG001|Overall Study|LINX explants|0
7865624|NCT01624506|12355809|FG000|Overall Study|Adverse Event|3
7865625|NCT01624506|12355810|FG001|Overall Study|Adverse Event|0
7865626|NCT01624662|12355820|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
7865627|NCT01624662|12355821|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
7865628|NCT01624662|12355822|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
7865629|NCT01624662|12355823|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
7865630|NCT01624662|12355820|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
7865631|NCT01624662|12355821|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
7865632|NCT01624662|12355822|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
7865633|NCT01624662|12355823|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
7865634|NCT01624662|12355820|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7865635|NCT01624662|12355821|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
7865636|NCT01624662|12355822|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7623251|NCT01844505|12034175|FG000|Overall Study|Other Reasons|4
7623252|NCT01844505|12034176|FG001|Overall Study|Other Reasons|2
7623253|NCT01844505|12034177|FG002|Overall Study|Other Reasons|2
7623254|NCT01844505|12034175|FG000|Overall Study|Not Reported|0
7623255|NCT01844505|12034176|FG001|Overall Study|Not Reported|0
7623256|NCT01844505|12034177|FG002|Overall Study|Not Reported|1
7623257|NCT01781390|12034188|FG000|Overall Study|Withdrawal of Consent|0
7623258|NCT01781390|12034189|FG001|Overall Study|Withdrawal of Consent|3
7623259|NCT01781390|12034190|FG002|Overall Study|Withdrawal of Consent|1
7623260|NCT01781390|12034188|FG000|Overall Study|Lost to Follow-up|1
7623261|NCT01781390|12034189|FG001|Overall Study|Lost to Follow-up|1
7623262|NCT01781390|12034190|FG002|Overall Study|Lost to Follow-up|1
7623263|NCT01781390|12034188|FG000|Overall Study|Adverse Event|1
7623264|NCT01781390|12034189|FG001|Overall Study|Adverse Event|2
7865637|NCT01624662|12355823|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7865638|NCT01624662|12355820|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
7865639|NCT01624662|12355821|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
7623265|NCT01781390|12034190|FG002|Overall Study|Adverse Event|1
7623266|NCT01781390|12034188|FG000|Overall Study|Participants who were Randomized and Not Treated|1
7623267|NCT01781390|12034189|FG001|Overall Study|Participants who were Randomized and Not Treated|1
7623268|NCT01781390|12034190|FG002|Overall Study|Participants who were Randomized and Not Treated|1
7623269|NCT01701674|12034198|FG000|Overall Study|Unable to safely complete treatment|1
7623270|NCT01575860|12034202|FG000|Overall Study|Withdrawal by Subject|1
7623271|NCT01575860|12034202|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1
7623272|NCT01402908|12034209|FG000|Overall Study|Withdrawal by Subject|30
7623273|NCT01402908|12034210|FG001|Overall Study|Withdrawal by Subject|17
7623274|NCT01402908|12034209|FG000|Overall Study|Lost to Follow-up|3
7623275|NCT01402908|12034210|FG001|Overall Study|Lost to Follow-up|1
7623276|NCT01402908|12034209|FG000|Overall Study|Physician Decision|1
7623277|NCT01402908|12034210|FG001|Overall Study|Physician Decision|0
7623278|NCT01397201|12034221|FG000|Overall Study|Not treated|0
7623279|NCT01397201|12034222|FG001|Overall Study|Not treated|0
7623280|NCT01397201|12034223|FG002|Overall Study|Not treated|1
7623281|NCT01397201|12034224|FG003|Overall Study|Not treated|0
7623282|NCT01397201|12034225|FG004|Overall Study|Not treated|0
7623283|NCT01397201|12034221|FG000|Overall Study|Not yet defined|3
7623284|NCT01397201|12034222|FG001|Overall Study|Not yet defined|6
7623285|NCT01397201|12034223|FG002|Overall Study|Not yet defined|5
7623286|NCT01397201|12034224|FG003|Overall Study|Not yet defined|5
7623287|NCT01397201|12034225|FG004|Overall Study|Not yet defined|4
7623288|NCT01397201|12034221|FG000|Overall Study|Adverse Event|2
7623289|NCT01397201|12034222|FG001|Overall Study|Adverse Event|0
7623290|NCT01397201|12034223|FG002|Overall Study|Adverse Event|0
7623291|NCT01397201|12034224|FG003|Overall Study|Adverse Event|0
7623292|NCT01397201|12034225|FG004|Overall Study|Adverse Event|0
7623293|NCT01397162|12034242|FG000|Overall Study|Adverse Event|4
7623294|NCT01397162|12034243|FG001|Overall Study|Adverse Event|0
7623295|NCT01397162|12034244|FG002|Overall Study|Adverse Event|0
7623296|NCT01397162|12034245|FG003|Overall Study|Adverse Event|0
7623297|NCT01397162|12034246|FG004|Overall Study|Adverse Event|0
7623298|NCT01397162|12034242|FG000|Overall Study|Not yet defined|3
7623299|NCT01397162|12034243|FG001|Overall Study|Not yet defined|4
7623300|NCT01397162|12034244|FG002|Overall Study|Not yet defined|3
7623301|NCT01397162|12034245|FG003|Overall Study|Not yet defined|5
7623302|NCT01397162|12034246|FG004|Overall Study|Not yet defined|3
7623303|NCT01396278|12034268|FG000|Overall Study|Adverse Event|0
7865640|NCT01624662|12355822|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
7865641|NCT01624662|12355823|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
7865642|NCT01624662|12355820|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7865643|NCT01624662|12355821|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7865644|NCT01624662|12355822|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
7865645|NCT01624662|12355823|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7865646|NCT01624662|12355820|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7865647|NCT01624662|12355821|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
7865648|NCT01624662|12355822|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7865649|NCT01624662|12355823|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7865650|NCT01624662|12355820|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7865651|NCT01624662|12355821|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7865652|NCT01624662|12355822|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
7865653|NCT01624662|12355823|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7865654|NCT01624870|12355844|FG000|Overall Study|Death|19
7865655|NCT01624870|12355844|FG000|Overall Study|Withdrawal by Subject|1
7865656|NCT01624870|12355844|FG000|Overall Study|CoreValve not implanted|6
7865657|NCT01624870|12355844|FG000|Overall Study|Lost to follow up|1
7865658|NCT01624974|12355875|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
7865659|NCT01624974|12355876|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
7865660|NCT01624974|12355875|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
7865661|NCT01624974|12355876|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
7865662|NCT01624974|12355875|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5
7865663|NCT01624974|12355876|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3
7865664|NCT01624974|12355875|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1
7865665|NCT01624974|12355876|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0
7865666|NCT01624974|12355875|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0
7865667|NCT01624974|12355876|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1
7865668|NCT01624974|12355875|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1
7865669|NCT01624974|12355876|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1
7865670|NCT01624974|12355875|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
7865671|NCT01624974|12355876|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
7865672|NCT01624974|12355875|FG000|Period IV Washout (4 Weeks)|Adverse Event|2
7865673|NCT01624974|12355876|FG001|Period IV Washout (4 Weeks)|Adverse Event|0
7865674|NCT01624974|12355875|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
7865675|NCT01624974|12355876|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
7865676|NCT01624974|12355875|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
7865677|NCT01624974|12355876|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
7865678|NCT01624974|12355875|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3
7865679|NCT01624974|12355876|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0
7865680|NCT01624974|12355875|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1
7865681|NCT01624974|12355876|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0
7865682|NCT01625000|12355888|FG000|Overall Study|Physician Decision|15
7865683|NCT01625000|12355889|FG001|Overall Study|Physician Decision|7
7865684|NCT01625000|12355890|FG002|Overall Study|Physician Decision|7
7865685|NCT01625000|12355891|FG003|Overall Study|Physician Decision|2
7865686|NCT01625000|12355892|FG004|Overall Study|Physician Decision|15
7865687|NCT01625000|12355888|FG000|Overall Study|Protocol Violation|3
7865688|NCT01625000|12355889|FG001|Overall Study|Protocol Violation|10
7865689|NCT01625000|12355890|FG002|Overall Study|Protocol Violation|4
7865690|NCT01625000|12355891|FG003|Overall Study|Protocol Violation|1
7865691|NCT01625000|12355892|FG004|Overall Study|Protocol Violation|2
7865692|NCT01625000|12355888|FG000|Overall Study|Withdrawal by Subject|19
7865693|NCT01625000|12355889|FG001|Overall Study|Withdrawal by Subject|16
7865694|NCT01625000|12355890|FG002|Overall Study|Withdrawal by Subject|11
7865695|NCT01625000|12355891|FG003|Overall Study|Withdrawal by Subject|9
7865696|NCT01625000|12355892|FG004|Overall Study|Withdrawal by Subject|17
7865697|NCT01625000|12355888|FG000|Overall Study|Adverse Event (including Death)|15
7865698|NCT01625000|12355889|FG001|Overall Study|Adverse Event (including Death)|19
7865699|NCT01625000|12355890|FG002|Overall Study|Adverse Event (including Death)|11
7865700|NCT01625000|12355891|FG003|Overall Study|Adverse Event (including Death)|7
7865701|NCT01625000|12355892|FG004|Overall Study|Adverse Event (including Death)|21
7865702|NCT01625091|12355911|FG000|Intervention|Death|1
7865703|NCT01625091|12355912|FG001|Intervention|Death|1
7865704|NCT01625091|12355911|FG000|Intervention|Withdrawal by Subject|4
7865705|NCT01625091|12355912|FG001|Intervention|Withdrawal by Subject|1
7865706|NCT01625091|12355911|FG000|Intervention|Adverse Event|0
7865707|NCT01625091|12355912|FG001|Intervention|Adverse Event|2
7865708|NCT01625091|12355911|FG000|Intervention|Lost to Follow-up|4
7623304|NCT01396278|12034269|FG001|Overall Study|Adverse Event|0
7865709|NCT01625091|12355912|FG001|Intervention|Lost to Follow-up|4
7865710|NCT01625091|12355911|FG000|Intervention|Study termination|2
7865711|NCT01625091|12355912|FG001|Intervention|Study termination|3
7865712|NCT01625091|12355911|FG000|Post-intervention|Death|0
7865713|NCT01625091|12355912|FG001|Post-intervention|Death|1
7865714|NCT01625091|12355911|FG000|Post-intervention|Lost to Follow-up|2
7865715|NCT01625091|12355912|FG001|Post-intervention|Lost to Follow-up|0
7865716|NCT01625091|12355911|FG000|Post-intervention|Study termination|2
7865717|NCT01625091|12355912|FG001|Post-intervention|Study termination|1
7865718|NCT01625182|12355933|FG000|Overall Study|Administrative problems|1
7865719|NCT01625182|12355934|FG001|Overall Study|Administrative problems|0
7865720|NCT01625182|12355933|FG000|Overall Study|Protocol deviation|0
7865721|NCT01625182|12355934|FG001|Overall Study|Protocol deviation|2
7865722|NCT01625182|12355933|FG000|Overall Study|Adverse Event|2
7865723|NCT01625182|12355934|FG001|Overall Study|Adverse Event|0
7865724|NCT01625182|12355933|FG000|Overall Study|Withdrawal by Subject|5
7865725|NCT01625182|12355934|FG001|Overall Study|Withdrawal by Subject|1
7865726|NCT01625182|12355933|FG000|Overall Study|Lack of Efficacy|12
7865727|NCT01625182|12355934|FG001|Overall Study|Lack of Efficacy|8
7865728|NCT01625338|12355948|FG000|Overall Study|Enrolled but not Treated|0
7865729|NCT01625338|12355949|FG001|Overall Study|Enrolled but not Treated|0
7865730|NCT01625338|12355950|FG002|Overall Study|Enrolled but not Treated|1
7865731|NCT01625338|12355948|FG000|Overall Study|Efficacy Failure|27
7865732|NCT01625338|12355949|FG001|Overall Study|Efficacy Failure|39
7865733|NCT01625338|12355950|FG002|Overall Study|Efficacy Failure|31
7865734|NCT01625338|12355948|FG000|Overall Study|Lost to Follow-up|3
7865735|NCT01625338|12355949|FG001|Overall Study|Lost to Follow-up|3
7865736|NCT01625338|12355950|FG002|Overall Study|Lost to Follow-up|2
7865737|NCT01625338|12355948|FG000|Overall Study|Investigator Decision|0
7865738|NCT01625338|12355949|FG001|Overall Study|Investigator Decision|2
7865739|NCT01625338|12355950|FG002|Overall Study|Investigator Decision|1
7865740|NCT01625338|12355948|FG000|Overall Study|Subject Withdrew Consent|1
7865741|NCT01625338|12355949|FG001|Overall Study|Subject Withdrew Consent|0
7865742|NCT01625338|12355950|FG002|Overall Study|Subject Withdrew Consent|2
7865743|NCT01625338|12355948|FG000|Overall Study|Adverse Event|1
7865744|NCT01625338|12355949|FG001|Overall Study|Adverse Event|0
7865745|NCT01625338|12355950|FG002|Overall Study|Adverse Event|1
7865746|NCT01625338|12355948|FG000|Overall Study|Study Discontinued by Sponsor|0
7865747|NCT01625338|12355949|FG001|Overall Study|Study Discontinued by Sponsor|0
7865748|NCT01625338|12355950|FG002|Overall Study|Study Discontinued by Sponsor|1
7865749|NCT01625377|12355960|FG000|Overall Study|Death|1
7865750|NCT01625377|12355961|FG001|Overall Study|Death|1
7865751|NCT01625377|12355960|FG000|Overall Study|Administrative Problem|1
7865752|NCT01625377|12355961|FG001|Overall Study|Administrative Problem|1
7865753|NCT01625377|12355960|FG000|Overall Study|Protocol Violation|0
7865754|NCT01625377|12355961|FG001|Overall Study|Protocol Violation|3
7865755|NCT01625377|12355960|FG000|Overall Study|Adverse Event|3
7865756|NCT01625377|12355961|FG001|Overall Study|Adverse Event|16
7865757|NCT01625377|12355960|FG000|Overall Study|Graft loss|1
7865758|NCT01625377|12355961|FG001|Overall Study|Graft loss|0
7865759|NCT01625377|12355960|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7865760|NCT01625377|12355961|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7865761|NCT01625377|12355960|FG000|Overall Study|Abnormal laboratory values|1
7623305|NCT01396278|12034270|FG002|Overall Study|Adverse Event|0
7623306|NCT01396278|12034271|FG003|Overall Study|Adverse Event|2
7623307|NCT01396278|12034272|FG004|Overall Study|Adverse Event|0
7623308|NCT01396278|12034268|FG000|Overall Study|Withdraw due to trial termination|2
7623309|NCT01396278|12034269|FG001|Overall Study|Withdraw due to trial termination|1
7623310|NCT01396278|12034270|FG002|Overall Study|Withdraw due to trial termination|1
7623311|NCT01396278|12034271|FG003|Overall Study|Withdraw due to trial termination|0
7623312|NCT01396278|12034272|FG004|Overall Study|Withdraw due to trial termination|2
7623313|NCT00130442|12034310|FG000|Overall Study|Withdrawal by Subject|0
7623314|NCT00130442|12034311|FG001|Overall Study|Withdrawal by Subject|1
7623315|NCT00130442|12034310|FG000|Overall Study|did not meet criteria|1
7623316|NCT00130442|12034311|FG001|Overall Study|did not meet criteria|1
7792158|NCT01033240|12246414|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6
7792159|NCT01033240|12246412|FG000|Overall Study|Death|2
7792160|NCT01033240|12246413|FG001|Overall Study|Death|0
7792161|NCT01033240|12246414|FG002|Overall Study|Death|0
7792162|NCT01033240|12246412|FG000|Overall Study|Withdrew Consent|2
7792163|NCT01033240|12246413|FG001|Overall Study|Withdrew Consent|9
7792164|NCT01033240|12246414|FG002|Overall Study|Withdrew Consent|2
7865762|NCT01625377|12355961|FG001|Overall Study|Abnormal laboratory values|0
7865763|NCT01625689|12355993|FG000|Overall Study|Migration|2
7865764|NCT01625689|12355994|FG001|Overall Study|Migration|1
7865765|NCT01625845|12356002|FG000|Overall Study|Adverse Event|1
7865766|NCT01625845|12356003|FG001|Overall Study|Adverse Event|2
7865767|NCT01625845|12356002|FG000|Overall Study|Lost to Follow-up|2
7865768|NCT01625845|12356003|FG001|Overall Study|Lost to Follow-up|1
7865769|NCT01625845|12356002|FG000|Overall Study|Withdrawal by Subject|2
7865770|NCT01625845|12356003|FG001|Overall Study|Withdrawal by Subject|0
7865771|NCT01625897|12356011|FG000|Overall Study|Adverse Event|27
7865772|NCT01625897|12356012|FG001|Overall Study|Adverse Event|10
7865773|NCT01625897|12356011|FG000|Overall Study|Physician Decision|0
7865774|NCT01625897|12356012|FG001|Overall Study|Physician Decision|1
7865775|NCT01625897|12356011|FG000|Overall Study|Withdrawal by Subject|25
7865776|NCT01625897|12356012|FG001|Overall Study|Withdrawal by Subject|3
7865777|NCT01625910|12356020|FG000|Overall Study|Lost to Follow-up|3
7865778|NCT01625910|12356021|FG001|Overall Study|Lost to Follow-up|4
7865779|NCT01625988|12356036|FG000|Overall Study|Lost to Follow-up|5
7865780|NCT01625988|12356037|FG001|Overall Study|Lost to Follow-up|6
7865781|NCT01625988|12356036|FG000|Overall Study|Withdrawal by Subject|8
7865782|NCT01625988|12356037|FG001|Overall Study|Withdrawal by Subject|3
7865783|NCT01625988|12356036|FG000|Overall Study|Adverse Event|0
7865784|NCT01625988|12356037|FG001|Overall Study|Adverse Event|1
7865785|NCT01625988|12356036|FG000|Overall Study|Lack of Efficacy|0
7865786|NCT01625988|12356037|FG001|Overall Study|Lack of Efficacy|1
7865787|NCT01625988|12356036|FG000|Overall Study|Randomized Inappropriately|1
7865788|NCT01625988|12356037|FG001|Overall Study|Randomized Inappropriately|0
7865789|NCT01625988|12356036|FG000|Overall Study|Protocol Violation|0
7865790|NCT01625988|12356037|FG001|Overall Study|Protocol Violation|2
7865791|NCT01626118|12356054|FG000|Overall Study|Lack of Efficacy|1
7865792|NCT01626118|12356055|FG001|Overall Study|Lack of Efficacy|0
7865793|NCT01626118|12356056|FG002|Overall Study|Lack of Efficacy|1
7865794|NCT01626118|12356057|FG003|Overall Study|Lack of Efficacy|3
7865795|NCT01626118|12356054|FG000|Overall Study|Lost to Follow-up|1
7865796|NCT01626118|12356055|FG001|Overall Study|Lost to Follow-up|0
7865797|NCT01626118|12356056|FG002|Overall Study|Lost to Follow-up|0
7865798|NCT01626118|12356057|FG003|Overall Study|Lost to Follow-up|0
7865799|NCT01626118|12356054|FG000|Overall Study|Adverse Event|0
7865800|NCT01626118|12356055|FG001|Overall Study|Adverse Event|1
7865801|NCT01626118|12356056|FG002|Overall Study|Adverse Event|1
7865802|NCT01626118|12356057|FG003|Overall Study|Adverse Event|0
7865803|NCT01626118|12356054|FG000|Overall Study|Investigator Decision|0
7865804|NCT01626118|12356055|FG001|Overall Study|Investigator Decision|1
7865805|NCT01626118|12356056|FG002|Overall Study|Investigator Decision|0
7865806|NCT01626118|12356057|FG003|Overall Study|Investigator Decision|0
7865807|NCT01626352|12356067|FG000|Overall Study|Disease Progression|3
7865808|NCT01626352|12356067|FG000|Overall Study|Intercurrent Illness|2
7865809|NCT01626352|12356067|FG000|Overall Study|Death|2
7865810|NCT01626352|12356067|FG000|Overall Study|Withdrawal by Subject|1
7865811|NCT01626352|12356067|FG000|Overall Study|Non-Compliance|1
7865812|NCT01626352|12356067|FG000|Overall Study|Never Treated|1
7865813|NCT01626391|12356076|FG000|Overall Study|Physician Decision|1
7865814|NCT01626391|12356077|FG001|Overall Study|Physician Decision|0
7865815|NCT01626391|12356076|FG000|Overall Study|Withdrawal by Subject|1
7865816|NCT01626391|12356077|FG001|Overall Study|Withdrawal by Subject|0
7865817|NCT01626456|12356085|FG000|Overall Study|Withdrawal by Subject|21
7865818|NCT01626456|12356086|FG001|Overall Study|Withdrawal by Subject|46
7865819|NCT01626456|12356085|FG000|Overall Study|Adverse Event|2
7865820|NCT01626456|12356086|FG001|Overall Study|Adverse Event|27
7865821|NCT01626456|12356085|FG000|Overall Study|Lost to Follow-up|2
7865822|NCT01626456|12356086|FG001|Overall Study|Lost to Follow-up|27
7865823|NCT01626456|12356085|FG000|Overall Study|Lack of Efficacy|6
7865824|NCT01626456|12356086|FG001|Overall Study|Lack of Efficacy|7
7865825|NCT01626456|12356085|FG000|Overall Study|Physician Decision|1
7865826|NCT01626456|12356086|FG001|Overall Study|Physician Decision|4
7865827|NCT01626456|12356085|FG000|Overall Study|Protocol Violation|1
7865828|NCT01626456|12356086|FG001|Overall Study|Protocol Violation|1
7865829|NCT01626456|12356085|FG000|Overall Study|Site Closure|2
7865830|NCT01626456|12356086|FG001|Overall Study|Site Closure|3
7865831|NCT01626456|12356085|FG000|Overall Study|Incarceration|0
7865832|NCT01626456|12356086|FG001|Overall Study|Incarceration|2
7865833|NCT01626495|12356101|FG000|Overall Study|Adverse Event|3
7865834|NCT01626495|12356101|FG000|Overall Study|Disease progression|27
7865835|NCT01626495|12356101|FG000|Overall Study|Withdrawal by Subject|1
7865836|NCT01626495|12356101|FG000|Overall Study|Administrative problem|1
7865837|NCT01626495|12356101|FG000|Overall Study|Death|2
7865838|NCT01626495|12356101|FG000|Overall Study|Physician Decision|1
7865839|NCT01626495|12356101|FG000|Overall Study|New cancer therapy|16
7865840|NCT01626495|12356101|FG000|Overall Study|Manufacturing failure|1
7865841|NCT01626690|12356118|FG000|Overall Study|Protocol Violation|1
7865842|NCT01626690|12356119|FG001|Overall Study|Protocol Violation|0
7865843|NCT01626690|12356118|FG000|Overall Study|Adverse Event|1
7865844|NCT01626690|12356119|FG001|Overall Study|Adverse Event|0
7865845|NCT01626859|12356140|FG000|Overall Study|Adverse Event|1
7865846|NCT01626859|12356141|FG001|Overall Study|Adverse Event|3
7623317|NCT04539262|12034327|FG000|Overall Study|Adverse Event|0
7865847|NCT01626859|12356142|FG002|Overall Study|Adverse Event|2
7865848|NCT01626859|12356140|FG000|Overall Study|Physician Decision|0
7865849|NCT01626859|12356141|FG001|Overall Study|Physician Decision|1
7865850|NCT01626859|12356142|FG002|Overall Study|Physician Decision|0
7865851|NCT01626859|12356140|FG000|Overall Study|Withdrawal by Subject|1
7865852|NCT01626859|12356141|FG001|Overall Study|Withdrawal by Subject|4
7865853|NCT01626859|12356142|FG002|Overall Study|Withdrawal by Subject|2
7865854|NCT01626872|12356153|FG000|Overall Study|Physician Decision|13
7865855|NCT01626872|12356154|FG001|Overall Study|Physician Decision|9
7865856|NCT01626872|12356155|FG002|Overall Study|Physician Decision|6
7865857|NCT01626872|12356153|FG000|Overall Study|Withdrawal by Subject|19
7865858|NCT01626872|12356154|FG001|Overall Study|Withdrawal by Subject|27
7865859|NCT01626872|12356155|FG002|Overall Study|Withdrawal by Subject|8
7865860|NCT01626872|12356153|FG000|Overall Study|Adverse Event (including Death)|20
7865861|NCT01626872|12356154|FG001|Overall Study|Adverse Event (including Death)|28
7865862|NCT01626872|12356155|FG002|Overall Study|Adverse Event (including Death)|8
7865863|NCT01626872|12356153|FG000|Overall Study|Protocol Violation (including Pregnancy)|0
7865864|NCT01626872|12356154|FG001|Overall Study|Protocol Violation (including Pregnancy)|2
7865865|NCT01626872|12356155|FG002|Overall Study|Protocol Violation (including Pregnancy)|2
7865866|NCT01626885|12356163|FG000|Overall Study|Adverse Event|8
7865867|NCT01626885|12356163|FG000|Overall Study|Withdrawal by Subject|4
7865868|NCT01626989|12356167|FG000|Screening Period|Screen Failure|15
7865869|NCT01626989|12356168|FG001|Screening Period|Screen Failure|0
7865870|NCT01626989|12356169|FG002|Screening Period|Screen Failure|0
7865871|NCT01626989|12356167|FG000|Screening Period|Withdrawal by Subject|2
7865872|NCT01626989|12356168|FG001|Screening Period|Withdrawal by Subject|0
7865873|NCT01626989|12356169|FG002|Screening Period|Withdrawal by Subject|0
7882403|NCT01770379|12381354|FG000|Overall Study|Physician Decision|0
7882404|NCT01770379|12381355|FG001|Overall Study|Physician Decision|1
7882405|NCT01770379|12381356|FG002|Overall Study|Physician Decision|2
7882406|NCT01770379|12381354|FG000|Overall Study|Lost to Follow-up|0
7882407|NCT01770379|12381355|FG001|Overall Study|Lost to Follow-up|0
7882408|NCT01770379|12381356|FG002|Overall Study|Lost to Follow-up|2
7882409|NCT01770379|12381354|FG000|Overall Study|Lack of Efficacy|8
7882410|NCT01770379|12381355|FG001|Overall Study|Lack of Efficacy|6
7882411|NCT01770379|12381356|FG002|Overall Study|Lack of Efficacy|6
7882412|NCT01770379|12381354|FG000|Overall Study|Adverse Event|1
7882413|NCT01770379|12381355|FG001|Overall Study|Adverse Event|3
7882414|NCT01770379|12381356|FG002|Overall Study|Adverse Event|2
7882415|NCT01770392|12381366|FG000|Washout Period of at Least 14 Days|Adverse Event|1
7882416|NCT01770509|12381397|FG000|Overall Study|Injury|0
7882417|NCT01770509|12381398|FG001|Overall Study|Injury|1
7882418|NCT01770509|12381397|FG000|Overall Study|Lost to Follow-up|1
7882419|NCT01770509|12381398|FG001|Overall Study|Lost to Follow-up|2
7882420|NCT01770743|12381437|FG000|Overall Study|Adverse Event|1
7882421|NCT01770743|12381438|FG001|Overall Study|Adverse Event|0
7623318|NCT04539262|12034328|FG001|Overall Study|Adverse Event|0
7623319|NCT04539262|12034329|FG002|Overall Study|Adverse Event|1
7623320|NCT04539262|12034330|FG003|Overall Study|Adverse Event|0
7623321|NCT04539262|12034331|FG004|Overall Study|Adverse Event|0
7623322|NCT04539262|12034332|FG005|Overall Study|Adverse Event|0
7623323|NCT04539262|12034333|FG006|Overall Study|Adverse Event|0
7623324|NCT04539262|12034334|FG007|Overall Study|Adverse Event|0
7623325|NCT04539262|12034327|FG000|Overall Study|Withdrew Consent|0
7623326|NCT04539262|12034328|FG001|Overall Study|Withdrew Consent|0
7623327|NCT04539262|12034329|FG002|Overall Study|Withdrew Consent|0
7623328|NCT04539262|12034330|FG003|Overall Study|Withdrew Consent|1
7623329|NCT04539262|12034331|FG004|Overall Study|Withdrew Consent|0
7882422|NCT01770743|12381439|FG002|Overall Study|Adverse Event|0
7882423|NCT01770743|12381440|FG003|Overall Study|Adverse Event|0
7882424|NCT01770743|12381441|FG004|Overall Study|Adverse Event|0
7882425|NCT01770743|12381437|FG000|Overall Study|Withdrawal by Subject|0
7882426|NCT01770743|12381438|FG001|Overall Study|Withdrawal by Subject|0
7882427|NCT01770743|12381439|FG002|Overall Study|Withdrawal by Subject|1
7882428|NCT01770743|12381440|FG003|Overall Study|Withdrawal by Subject|1
7882429|NCT01770743|12381441|FG004|Overall Study|Withdrawal by Subject|1
7882430|NCT01770743|12381437|FG000|Overall Study|Lost to Follow-up|0
7882431|NCT01770743|12381438|FG001|Overall Study|Lost to Follow-up|2
7882432|NCT01770743|12381439|FG002|Overall Study|Lost to Follow-up|0
7882433|NCT01770743|12381440|FG003|Overall Study|Lost to Follow-up|0
7623330|NCT04539262|12034332|FG005|Overall Study|Withdrew Consent|0
7623331|NCT04539262|12034333|FG006|Overall Study|Withdrew Consent|0
7623332|NCT04539262|12034334|FG007|Overall Study|Withdrew Consent|0
7623333|NCT04539262|12034327|FG000|Overall Study|Randomized, Not treated|0
7623334|NCT04539262|12034328|FG001|Overall Study|Randomized, Not treated|1
7623335|NCT04539262|12034329|FG002|Overall Study|Randomized, Not treated|0
7623336|NCT04539262|12034330|FG003|Overall Study|Randomized, Not treated|0
7623337|NCT04539262|12034331|FG004|Overall Study|Randomized, Not treated|0
7623338|NCT04539262|12034332|FG005|Overall Study|Randomized, Not treated|0
7623339|NCT04539262|12034333|FG006|Overall Study|Randomized, Not treated|1
7623340|NCT04539262|12034334|FG007|Overall Study|Randomized, Not treated|0
7865874|NCT01627067|12356215|FG000|Overall Study|Screen Failure|1
7865875|NCT01627249|12356224|FG000|Overall Study|Death|3
7865876|NCT01627249|12356225|FG001|Overall Study|Death|5
7865877|NCT01627249|12356226|FG002|Overall Study|Death|3
7865878|NCT01627249|12356224|FG000|Overall Study|Withdrawal by Subject|12
7865879|NCT01627249|12356225|FG001|Overall Study|Withdrawal by Subject|6
7865880|NCT01627249|12356226|FG002|Overall Study|Withdrawal by Subject|9
7865881|NCT01627249|12356224|FG000|Overall Study|Missed Visit|1
7865882|NCT01627249|12356225|FG001|Overall Study|Missed Visit|1
7865883|NCT01627249|12356226|FG002|Overall Study|Missed Visit|0
7865884|NCT01627327|12356255|FG000|Overall Study|Adverse Event|6
7865885|NCT01627327|12356256|FG001|Overall Study|Adverse Event|12
7865886|NCT01627327|12356255|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0
7865887|NCT01627327|12356256|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2
7865888|NCT01627327|12356255|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
7865889|NCT01627327|12356256|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
7865890|NCT01627327|12356255|FG000|Overall Study|Protocol Violation|4
7865891|NCT01627327|12356256|FG001|Overall Study|Protocol Violation|10
7865892|NCT01627327|12356255|FG000|Overall Study|Lost to Follow-up|1
7865893|NCT01627327|12356256|FG001|Overall Study|Lost to Follow-up|3
7865894|NCT01627327|12356255|FG000|Overall Study|Physician Decision|1
7865895|NCT01627327|12356256|FG001|Overall Study|Physician Decision|0
7865896|NCT01627327|12356255|FG000|Overall Study|Withdrawal by Subject|3
7865897|NCT01627327|12356256|FG001|Overall Study|Withdrawal by Subject|3
7865898|NCT01627340|12356264|FG000|Overall Study|Adverse Event|1
7865899|NCT01627340|12356265|FG001|Overall Study|Adverse Event|0
7865900|NCT01627340|12356264|FG000|Overall Study|Lost to Follow-up|8
7865901|NCT01627340|12356265|FG001|Overall Study|Lost to Follow-up|4
7865902|NCT01627340|12356264|FG000|Overall Study|Pregnancy|1
7865903|NCT01627340|12356265|FG001|Overall Study|Pregnancy|0
7865904|NCT01627340|12356264|FG000|Overall Study|Withdrawal by Subject|2
7865905|NCT01627340|12356265|FG001|Overall Study|Withdrawal by Subject|0
7865906|NCT01627691|12356273|FG000|Overall Study|Death|11
7865907|NCT01627691|12356273|FG000|Overall Study|Lost to Follow-up|3
7865908|NCT01627691|12356273|FG000|Overall Study|Withdrawal by Subject|1
7865909|NCT01627691|12356273|FG000|Overall Study|Missed the visit|3
7865910|NCT01627782|12356281|FG000|Overall Study|Adverse Event|1
7865911|NCT01627782|12356282|FG001|Overall Study|Adverse Event|2
7865912|NCT01627782|12356283|FG002|Overall Study|Adverse Event|0
7865913|NCT01627782|12356284|FG003|Overall Study|Adverse Event|1
7865914|NCT01627782|12356281|FG000|Overall Study|Lack of Efficacy|11
7865915|NCT01627782|12356282|FG001|Overall Study|Lack of Efficacy|1
7865916|NCT01627782|12356283|FG002|Overall Study|Lack of Efficacy|15
7865917|NCT01627782|12356284|FG003|Overall Study|Lack of Efficacy|2
7865918|NCT01627782|12356281|FG000|Overall Study|Protocol Violation|1
7865919|NCT01627782|12356282|FG001|Overall Study|Protocol Violation|0
7865920|NCT01627782|12356283|FG002|Overall Study|Protocol Violation|0
7865921|NCT01627782|12356284|FG003|Overall Study|Protocol Violation|0
7865922|NCT01627782|12356281|FG000|Overall Study|Withdrawal by Subject|2
7865923|NCT01627782|12356282|FG001|Overall Study|Withdrawal by Subject|1
7865924|NCT01627782|12356283|FG002|Overall Study|Withdrawal by Subject|0
7865925|NCT01627782|12356284|FG003|Overall Study|Withdrawal by Subject|0
7865926|NCT01627782|12356281|FG000|Overall Study|Other|0
7865927|NCT01627782|12356282|FG001|Overall Study|Other|2
7865928|NCT01627782|12356283|FG002|Overall Study|Other|0
7865929|NCT01627782|12356284|FG003|Overall Study|Other|3
7865930|NCT01627782|12356281|FG000|Overall Study|Randomized But Not Treated|1
7865931|NCT01627782|12356282|FG001|Overall Study|Randomized But Not Treated|0
7865932|NCT01627782|12356283|FG002|Overall Study|Randomized But Not Treated|0
7865933|NCT01627782|12356284|FG003|Overall Study|Randomized But Not Treated|0
7865934|NCT01627860|12356298|FG000|Overall Study|Adverse Event|9
7865935|NCT01627860|12356299|FG001|Overall Study|Adverse Event|4
7865936|NCT01627860|12356298|FG000|Overall Study|Withdrawal by Subject|2
7865937|NCT01627860|12356299|FG001|Overall Study|Withdrawal by Subject|1
7865938|NCT01627860|12356298|FG000|Overall Study|Seizure frequency doubled|0
7865939|NCT01627860|12356299|FG001|Overall Study|Seizure frequency doubled|1
7865940|NCT01627860|12356298|FG000|Overall Study|Protocol Violation|1
7865941|NCT01627860|12356299|FG001|Overall Study|Protocol Violation|0
7865942|NCT01628107|12356337|FG000|Overall Study|Withdrawal by Subject|17
7865943|NCT01628107|12356337|FG000|Overall Study|Lost to Follow-up|4
7865944|NCT01628107|12356337|FG000|Overall Study|Adverse Event|33
7865945|NCT01628107|12356337|FG000|Overall Study|Physician Decision|2
7865946|NCT01628107|12356337|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1
7865947|NCT01628107|12356337|FG000|Overall Study|Non-compliant with Study Procedures|10
7865948|NCT01628107|12356337|FG000|Overall Study|Not Treated|8
7865949|NCT01628107|12356337|FG000|Overall Study|Sponsor Decision|11
7865950|NCT01628107|12356337|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7
7865951|NCT01628107|12356337|FG000|Overall Study|Relocated|8
7865952|NCT01628107|12356337|FG000|Overall Study|Kidney Transplant|9
7865953|NCT01628107|12356337|FG000|Overall Study|Use of Standard of Care|9
7865954|NCT01628120|12356341|FG000|Overall Study|Withdrawal by Subject|7
7865955|NCT01628120|12356341|FG000|Overall Study|Adverse Event|12
7865956|NCT01628120|12356341|FG000|Overall Study|Lost to Follow-up|1
7623341|NCT04482439|12034355|FG000|Overall Study|Lost to Follow-up|1
7865957|NCT01628120|12356341|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2
7865958|NCT01628120|12356341|FG000|Overall Study|Non-compliant with Study Procedures|1
7865959|NCT01628120|12356341|FG000|Overall Study|Not Treated|3
7865960|NCT01628120|12356341|FG000|Overall Study|Sponsor Decision|5
7623342|NCT04482439|12034355|FG000|Overall Study|Unrelated illness|1
7623343|NCT04404725|12034364|FG000|First Intervention|Withdrawal by Subject|0
7623344|NCT04404725|12034365|FG001|First Intervention|Withdrawal by Subject|2
7623345|NCT04404725|12034364|FG000|Second Intervention|Adverse Event|1
7865961|NCT01628120|12356341|FG000|Overall Study|Switched Dialysis Method|2
7865962|NCT01628120|12356341|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3
7865963|NCT01628120|12356341|FG000|Overall Study|Moved or Relocated|5
7865964|NCT01628120|12356341|FG000|Overall Study|Kidney Transplant|2
7865965|NCT01628120|12356341|FG000|Overall Study|Use of Standard of Care|1
7865966|NCT01628198|12356349|FG000|Overall Study|Lost to Follow-up|7
7865967|NCT01628198|12356349|FG000|Overall Study|Withdrawal by Subject|10
7865968|NCT01628198|12356349|FG000|Overall Study|Screen failure|1
7865969|NCT01628367|12356364|FG000|Overall Study|Adverse Event|1
7865970|NCT01628367|12356365|FG001|Overall Study|Adverse Event|0
7865971|NCT01628393|12356374|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1
7865972|NCT01628393|12356375|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0
7865973|NCT01628393|12356376|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0
7865974|NCT01628393|12356377|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0
7865975|NCT01628393|12356378|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0
7865976|NCT01628393|12356374|FG000|Placebo-controlled Treatment Period|Protocol Violation|0
7865977|NCT01628393|12356375|FG001|Placebo-controlled Treatment Period|Protocol Violation|1
7865978|NCT01628393|12356376|FG002|Placebo-controlled Treatment Period|Protocol Violation|0
7865979|NCT01628393|12356377|FG003|Placebo-controlled Treatment Period|Protocol Violation|0
7865980|NCT01628393|12356378|FG004|Placebo-controlled Treatment Period|Protocol Violation|0
7865981|NCT01628393|12356374|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2
7865982|NCT01628393|12356375|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1
7865983|NCT01628393|12356376|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1
7865984|NCT01628393|12356377|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0
7865985|NCT01628393|12356378|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0
7865986|NCT01628393|12356374|FG000|Blinded Active Extension Period|Adverse Event|0
7865987|NCT01628393|12356375|FG001|Blinded Active Extension Period|Adverse Event|1
7865988|NCT01628393|12356376|FG002|Blinded Active Extension Period|Adverse Event|0
7865989|NCT01628393|12356377|FG003|Blinded Active Extension Period|Adverse Event|2
7865990|NCT01628393|12356378|FG004|Blinded Active Extension Period|Adverse Event|2
7865991|NCT01628393|12356374|FG000|Blinded Active Extension Period|Lack of Efficacy|0
7865992|NCT01628393|12356375|FG001|Blinded Active Extension Period|Lack of Efficacy|0
7865993|NCT01628393|12356376|FG002|Blinded Active Extension Period|Lack of Efficacy|2
7865994|NCT01628393|12356377|FG003|Blinded Active Extension Period|Lack of Efficacy|0
7865995|NCT01628393|12356378|FG004|Blinded Active Extension Period|Lack of Efficacy|2
7865996|NCT01628393|12356374|FG000|Blinded Active Extension Period|Physician Decision|0
7865997|NCT01628393|12356375|FG001|Blinded Active Extension Period|Physician Decision|3
7865998|NCT01628393|12356376|FG002|Blinded Active Extension Period|Physician Decision|0
7865999|NCT01628393|12356377|FG003|Blinded Active Extension Period|Physician Decision|1
7866000|NCT01628393|12356378|FG004|Blinded Active Extension Period|Physician Decision|0
7866001|NCT01628393|12356374|FG000|Blinded Active Extension Period|Protocol Violation|0
7866002|NCT01628393|12356375|FG001|Blinded Active Extension Period|Protocol Violation|0
7866003|NCT01628393|12356376|FG002|Blinded Active Extension Period|Protocol Violation|2
7866004|NCT01628393|12356377|FG003|Blinded Active Extension Period|Protocol Violation|1
7866005|NCT01628393|12356378|FG004|Blinded Active Extension Period|Protocol Violation|0
7866006|NCT01628393|12356374|FG000|Blinded Active Extension Period|Withdrawal by Subject|0
7866007|NCT01628393|12356375|FG001|Blinded Active Extension Period|Withdrawal by Subject|6
7866008|NCT01628393|12356376|FG002|Blinded Active Extension Period|Withdrawal by Subject|2
7866009|NCT01628393|12356377|FG003|Blinded Active Extension Period|Withdrawal by Subject|0
7866010|NCT01628393|12356378|FG004|Blinded Active Extension Period|Withdrawal by Subject|2
7866011|NCT01628510|12356394|FG000|Overall Study|Withdrawal by Subject|0
7866012|NCT01628510|12356395|FG001|Overall Study|Withdrawal by Subject|4
7866013|NCT01628510|12356394|FG000|Overall Study|Death|3
7866014|NCT01628510|12356395|FG001|Overall Study|Death|1
7866015|NCT01628549|12356412|FG000|Overall Study|Adverse Event|1
7866016|NCT01628549|12356413|FG001|Overall Study|Adverse Event|1
7866017|NCT01628549|12356414|FG002|Overall Study|Adverse Event|0
7866018|NCT01628549|12356415|FG003|Overall Study|Adverse Event|4
7866019|NCT01628549|12356412|FG000|Overall Study|Lost to Follow-up|3
7866020|NCT01628549|12356413|FG001|Overall Study|Lost to Follow-up|4
7866021|NCT01628549|12356414|FG002|Overall Study|Lost to Follow-up|3
7866022|NCT01628549|12356415|FG003|Overall Study|Lost to Follow-up|3
7866023|NCT01628549|12356412|FG000|Overall Study|Withdrawal by Subject|3
7866024|NCT01628549|12356413|FG001|Overall Study|Withdrawal by Subject|4
7866025|NCT01628549|12356414|FG002|Overall Study|Withdrawal by Subject|4
7866026|NCT01628549|12356415|FG003|Overall Study|Withdrawal by Subject|1
7866027|NCT01628549|12356412|FG000|Overall Study|Protocol Violation|2
7866028|NCT01628549|12356413|FG001|Overall Study|Protocol Violation|1
7623346|NCT04404725|12034365|FG001|Second Intervention|Adverse Event|1
7866029|NCT01628549|12356414|FG002|Overall Study|Protocol Violation|1
7866030|NCT01628549|12356415|FG003|Overall Study|Protocol Violation|0
7866031|NCT01628549|12356412|FG000|Overall Study|withdrawn for noncompliance|0
7866032|NCT01628549|12356413|FG001|Overall Study|withdrawn for noncompliance|2
7866033|NCT01628549|12356414|FG002|Overall Study|withdrawn for noncompliance|1
7866034|NCT01628549|12356415|FG003|Overall Study|withdrawn for noncompliance|0
7866035|NCT01628549|12356412|FG000|Overall Study|abnormal laboratory test results|0
7866036|NCT01628549|12356413|FG001|Overall Study|abnormal laboratory test results|0
7866037|NCT01628549|12356414|FG002|Overall Study|abnormal laboratory test results|1
7866038|NCT01628549|12356415|FG003|Overall Study|abnormal laboratory test results|0
7866039|NCT01628549|12356412|FG000|Overall Study|positive pregnancy test|0
7866040|NCT01628549|12356413|FG001|Overall Study|positive pregnancy test|0
7866041|NCT01628549|12356414|FG002|Overall Study|positive pregnancy test|0
7866042|NCT01628549|12356415|FG003|Overall Study|positive pregnancy test|1
7866043|NCT01628692|12356443|FG000|Overall Study|Lack of Efficacy|4
7866044|NCT01628692|12356444|FG001|Overall Study|Lack of Efficacy|4
7866045|NCT01628692|12356445|FG002|Overall Study|Lack of Efficacy|5
7866046|NCT01628692|12356446|FG003|Overall Study|Lack of Efficacy|1
7866047|NCT01628692|12356447|FG004|Overall Study|Lack of Efficacy|4
7866048|NCT01628692|12356448|FG005|Overall Study|Lack of Efficacy|7
7866049|NCT01628692|12356443|FG000|Overall Study|Adverse Event|2
7866050|NCT01628692|12356444|FG001|Overall Study|Adverse Event|0
7866051|NCT01628692|12356445|FG002|Overall Study|Adverse Event|2
7866052|NCT01628692|12356446|FG003|Overall Study|Adverse Event|0
7866053|NCT01628692|12356447|FG004|Overall Study|Adverse Event|0
7866054|NCT01628692|12356448|FG005|Overall Study|Adverse Event|0
7866055|NCT01628692|12356443|FG000|Overall Study|Withdrawal by Subject|0
7866056|NCT01628692|12356444|FG001|Overall Study|Withdrawal by Subject|1
7866057|NCT01628692|12356445|FG002|Overall Study|Withdrawal by Subject|1
7866058|NCT01628692|12356446|FG003|Overall Study|Withdrawal by Subject|0
7866059|NCT01628692|12356447|FG004|Overall Study|Withdrawal by Subject|0
7866060|NCT01628692|12356448|FG005|Overall Study|Withdrawal by Subject|0
7866061|NCT01628692|12356443|FG000|Overall Study|Death|0
7866062|NCT01628692|12356444|FG001|Overall Study|Death|1
7866063|NCT01628692|12356445|FG002|Overall Study|Death|0
7866064|NCT01628692|12356446|FG003|Overall Study|Death|0
7866065|NCT01628692|12356447|FG004|Overall Study|Death|0
7866066|NCT01628692|12356448|FG005|Overall Study|Death|0
7866067|NCT01628692|12356443|FG000|Overall Study|Poor compliance/noncompliance|1
7866068|NCT01628692|12356444|FG001|Overall Study|Poor compliance/noncompliance|0
7866069|NCT01628692|12356445|FG002|Overall Study|Poor compliance/noncompliance|0
7866070|NCT01628692|12356446|FG003|Overall Study|Poor compliance/noncompliance|0
7866071|NCT01628692|12356447|FG004|Overall Study|Poor compliance/noncompliance|0
7866072|NCT01628692|12356448|FG005|Overall Study|Poor compliance/noncompliance|0
7866073|NCT01628692|12356443|FG000|Overall Study|Administrative reason by sponsor|0
7866074|NCT01628692|12356444|FG001|Overall Study|Administrative reason by sponsor|0
7866075|NCT01628692|12356445|FG002|Overall Study|Administrative reason by sponsor|0
7866076|NCT01628692|12356446|FG003|Overall Study|Administrative reason by sponsor|0
7866077|NCT01628692|12356447|FG004|Overall Study|Administrative reason by sponsor|0
7866078|NCT01628692|12356448|FG005|Overall Study|Administrative reason by sponsor|1
7866079|NCT01628692|12356443|FG000|Overall Study|Completed 12 Week only|0
7866080|NCT01628692|12356444|FG001|Overall Study|Completed 12 Week only|0
7866081|NCT01628692|12356445|FG002|Overall Study|Completed 12 Week only|0
7866082|NCT01628692|12356446|FG003|Overall Study|Completed 12 Week only|0
7866083|NCT01628692|12356447|FG004|Overall Study|Completed 12 Week only|0
7866084|NCT01628692|12356448|FG005|Overall Study|Completed 12 Week only|1
7866085|NCT01628848|12356476|FG000|Overall Study|Adverse Event|9
7866086|NCT01628848|12356477|FG001|Overall Study|Adverse Event|7
7866087|NCT01628848|12356476|FG000|Overall Study|Lack of Efficacy|0
7866088|NCT01628848|12356477|FG001|Overall Study|Lack of Efficacy|4
7866089|NCT01628848|12356476|FG000|Overall Study|Withdrawal by Subject|0
7866090|NCT01628848|12356477|FG001|Overall Study|Withdrawal by Subject|2
7866091|NCT01628848|12356476|FG000|Overall Study|Physician Decision|3
7866092|NCT01628848|12356477|FG001|Overall Study|Physician Decision|1
7866093|NCT01628874|12356485|FG000|Overall Study|Physician Decision|1
7866094|NCT01628874|12356486|FG001|Overall Study|Physician Decision|1
7866095|NCT01628874|12356485|FG000|Overall Study|Age >4 months|4
7866096|NCT01628874|12356486|FG001|Overall Study|Age >4 months|2
7866097|NCT01628913|12356494|FG000|Overall Study|Adverse Event|12
7866098|NCT01628913|12356495|FG001|Overall Study|Adverse Event|5
7866099|NCT01628913|12356494|FG000|Overall Study|Disease Progression|11
7866100|NCT01628913|12356495|FG001|Overall Study|Disease Progression|14
7866101|NCT01628913|12356494|FG000|Overall Study|Protocol Violation|1
7866102|NCT01628913|12356495|FG001|Overall Study|Protocol Violation|0
7866103|NCT01628913|12356494|FG000|Overall Study|Death|1
7866104|NCT01628913|12356495|FG001|Overall Study|Death|0
7866105|NCT01628913|12356494|FG000|Overall Study|study terminated by Sponsor|4
7866106|NCT01628913|12356495|FG001|Overall Study|study terminated by Sponsor|9
7866107|NCT01628913|12356494|FG000|Overall Study|Withdrawal by Subject|1
7866108|NCT01628913|12356495|FG001|Overall Study|Withdrawal by Subject|0
7866109|NCT01628913|12356494|FG000|Overall Study|Physician Decision|1
7866110|NCT01628913|12356495|FG001|Overall Study|Physician Decision|3
7866111|NCT01628926|12356504|FG000|Overall Study|Adverse Event|13
7866112|NCT01628926|12356505|FG001|Overall Study|Adverse Event|11
7866113|NCT01628926|12356506|FG002|Overall Study|Adverse Event|9
7866114|NCT01628926|12356504|FG000|Overall Study|Lack of Efficacy|2
7866115|NCT01628926|12356505|FG001|Overall Study|Lack of Efficacy|1
7866116|NCT01628926|12356506|FG002|Overall Study|Lack of Efficacy|5
7866117|NCT01628926|12356504|FG000|Overall Study|Withdrawal by Subject|6
7866118|NCT01628926|12356505|FG001|Overall Study|Withdrawal by Subject|4
7866119|NCT01628926|12356506|FG002|Overall Study|Withdrawal by Subject|2
7866120|NCT01628926|12356504|FG000|Overall Study|Protocol Violation|0
7866121|NCT01628926|12356505|FG001|Overall Study|Protocol Violation|1
7866122|NCT01628926|12356506|FG002|Overall Study|Protocol Violation|0
7866123|NCT01628926|12356504|FG000|Overall Study|Discontinuation criteria|3
7866124|NCT01628926|12356505|FG001|Overall Study|Discontinuation criteria|4
7866125|NCT01628926|12356506|FG002|Overall Study|Discontinuation criteria|0
7866126|NCT01628926|12356504|FG000|Overall Study|Physician Decision|2
7866127|NCT01628926|12356505|FG001|Overall Study|Physician Decision|2
7866128|NCT01628926|12356506|FG002|Overall Study|Physician Decision|1
7866129|NCT01628965|12356515|FG000|Overall Study|Adverse Event|30
7866130|NCT01628965|12356515|FG000|Overall Study|Lack of Efficacy|7
7866131|NCT01628965|12356515|FG000|Overall Study|Withdrawal by Subject|3
7866132|NCT01628965|12356515|FG000|Overall Study|Lost to Follow-up|1
7866133|NCT01628965|12356515|FG000|Overall Study|Discontinuation criteria|8
7866134|NCT01629381|12356535|FG000|Overall Study|Withdrawal by Subject|2
7866135|NCT01629381|12356536|FG001|Overall Study|Withdrawal by Subject|5
7866136|NCT01629563|12356548|FG000|Overall Study|Adverse Event|16
7866137|NCT01629563|12356549|FG001|Overall Study|Adverse Event|16
7866138|NCT01629563|12356548|FG000|Overall Study|Death|2
7866139|NCT01629563|12356549|FG001|Overall Study|Death|0
7866140|NCT01629563|12356548|FG000|Overall Study|Lack of Efficacy|2
7866141|NCT01629563|12356549|FG001|Overall Study|Lack of Efficacy|3
7866142|NCT01629563|12356548|FG000|Overall Study|Lost to Follow-up|1
7866143|NCT01629563|12356549|FG001|Overall Study|Lost to Follow-up|0
7866144|NCT01629563|12356548|FG000|Overall Study|Pregnancy|1
7866145|NCT01629563|12356549|FG001|Overall Study|Pregnancy|2
7866146|NCT01629563|12356548|FG000|Overall Study|Protocol Violation|0
7866147|NCT01629563|12356549|FG001|Overall Study|Protocol Violation|1
7866148|NCT01629563|12356548|FG000|Overall Study|Withdrawal by Subject|27
7866149|NCT01629563|12356549|FG001|Overall Study|Withdrawal by Subject|20
7866150|NCT01629563|12356548|FG000|Overall Study|surgery|0
7866151|NCT01629563|12356549|FG001|Overall Study|surgery|3
7623347|NCT04404725|12034364|FG000|Second Intervention|Withdrawal by Subject|0
7623348|NCT04404725|12034365|FG001|Second Intervention|Withdrawal by Subject|1
7623349|NCT04382586|12034373|FG000|Overall Study|Death|3
7623350|NCT04382586|12034374|FG001|Overall Study|Death|4
7623351|NCT04382586|12034373|FG000|Overall Study|Lost to Follow-up|11
7623352|NCT04382586|12034374|FG001|Overall Study|Lost to Follow-up|8
7623353|NCT04382586|12034373|FG000|Overall Study|Withdrawal by Subject|3
7623354|NCT04382586|12034374|FG001|Overall Study|Withdrawal by Subject|1
7623355|NCT04382586|12034373|FG000|Overall Study|Physician Decision|0
7623356|NCT04382586|12034374|FG001|Overall Study|Physician Decision|3
7623357|NCT04348656|12034382|FG000|Overall Study|Withdrawal by Subject|2
7623358|NCT04348656|12034383|FG001|Overall Study|Withdrawal by Subject|0
7623359|NCT04348656|12034382|FG000|Overall Study|Lost to Follow-up|11
7623360|NCT04348656|12034383|FG001|Overall Study|Lost to Follow-up|6
7866152|NCT01629563|12356548|FG000|Overall Study|Lack of return of menses|12
7866153|NCT01629563|12356549|FG001|Overall Study|Lack of return of menses|7
7866154|NCT01629563|12356548|FG000|Overall Study|Protocol Violation|0
7866155|NCT01629563|12356549|FG001|Overall Study|Protocol Violation|1
7866156|NCT01629589|12356557|FG000|Overall Study|Protocol Violation|4
7866157|NCT01629589|12356558|FG001|Overall Study|Protocol Violation|2
7866158|NCT01629589|12356557|FG000|Overall Study|Lost to Follow-up|2
7866159|NCT01629589|12356558|FG001|Overall Study|Lost to Follow-up|1
7866160|NCT01629589|12356557|FG000|Overall Study|Withdrawal by Subject|2
7866161|NCT01629589|12356558|FG001|Overall Study|Withdrawal by Subject|3
7866162|NCT01629589|12356557|FG000|Overall Study|Did not receive study vaccine|0
7866163|NCT01629589|12356558|FG001|Overall Study|Did not receive study vaccine|1
7866164|NCT01629667|12356571|FG000|Overall Study|Lost to Follow-up|0
7866165|NCT01629667|12356572|FG001|Overall Study|Lost to Follow-up|1
7866166|NCT01629667|12356573|FG002|Overall Study|Lost to Follow-up|1
7866167|NCT01629667|12356571|FG000|Overall Study|Withdrawal by Subject|31
7866168|NCT01629667|12356572|FG001|Overall Study|Withdrawal by Subject|20
7866169|NCT01629667|12356573|FG002|Overall Study|Withdrawal by Subject|28
7866170|NCT01629667|12356571|FG000|Overall Study|Death|1
7866171|NCT01629667|12356572|FG001|Overall Study|Death|5
7866172|NCT01629667|12356573|FG002|Overall Study|Death|3
7866173|NCT01629667|12356571|FG000|Overall Study|Randomized, not treated|2
7866174|NCT01629667|12356572|FG001|Overall Study|Randomized, not treated|1
7866175|NCT01629667|12356573|FG002|Overall Study|Randomized, not treated|0
7866176|NCT01629667|12356571|FG000|Overall Study|Ongoing AE worsening right heart failure|0
7866177|NCT01629667|12356572|FG001|Overall Study|Ongoing AE worsening right heart failure|1
7866178|NCT01629667|12356573|FG002|Overall Study|Ongoing AE worsening right heart failure|0
7866179|NCT01629667|12356571|FG000|Overall Study|Requiring lung transplant|2
7866180|NCT01629667|12356572|FG001|Overall Study|Requiring lung transplant|1
7866181|NCT01629667|12356573|FG002|Overall Study|Requiring lung transplant|3
7866182|NCT01629667|12356571|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
7866183|NCT01629667|12356572|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
7866184|NCT01629667|12356573|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
7866185|NCT01629667|12356571|FG000|Overall Study|Started other medicine|1
7866186|NCT01629667|12356572|FG001|Overall Study|Started other medicine|0
7866187|NCT01629667|12356573|FG002|Overall Study|Started other medicine|1
7866188|NCT01629667|12356571|FG000|Overall Study|Site error in safety follow-up|0
7866189|NCT01629667|12356572|FG001|Overall Study|Site error in safety follow-up|0
7866190|NCT01629667|12356573|FG002|Overall Study|Site error in safety follow-up|1
7866191|NCT01629667|12356571|FG000|Overall Study|Enrolled in another clinical study|0
7866192|NCT01629667|12356572|FG001|Overall Study|Enrolled in another clinical study|1
7866193|NCT01629667|12356573|FG002|Overall Study|Enrolled in another clinical study|0
7866194|NCT01629667|12356571|FG000|Overall Study|Code break|1
7866195|NCT01629667|12356572|FG001|Overall Study|Code break|0
7866196|NCT01629667|12356573|FG002|Overall Study|Code break|0
7866197|NCT01629693|12356585|FG000|Overall Study|Lost to Follow-up|2
7866198|NCT01629693|12356586|FG001|Overall Study|Lost to Follow-up|4
7866199|NCT01629693|12356585|FG000|Overall Study|Withdrawal by Subject|2
7866200|NCT01629693|12356586|FG001|Overall Study|Withdrawal by Subject|2
7866201|NCT01629693|12356585|FG000|Overall Study|Adverse Event|1
7866202|NCT01629693|12356586|FG001|Overall Study|Adverse Event|0
7866203|NCT01629693|12356585|FG000|Overall Study|Investigator decision|0
7866204|NCT01629693|12356586|FG001|Overall Study|Investigator decision|1
7866205|NCT01629693|12356585|FG000|Overall Study|Poor comfort of study lenses|0
7866206|NCT01629693|12356586|FG001|Overall Study|Poor comfort of study lenses|2
7866207|NCT01629693|12356585|FG000|Overall Study|Subject decision unrelated to AE|0
7866208|NCT01629693|12356586|FG001|Overall Study|Subject decision unrelated to AE|1
7866209|NCT01629706|12356592|FG000|Phase 1 PureVision|Screen Failure|4
7866210|NCT01629706|12356592|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
7866211|NCT01629706|12356592|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1
7866212|NCT01629706|12356592|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
7866213|NCT01629706|12356592|FG000|Phase 2 Habitual|Screen Failure|6
7866214|NCT01629706|12356592|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
7866215|NCT01629706|12356592|FG000|Phase 2 Habitual|Relocation prior to Dispense|1
7866216|NCT01629706|12356592|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
7866217|NCT01629706|12356592|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1
7866218|NCT01629823|12356626|FG000|Trial Period|Missed visit|11
7866219|NCT01629823|12356627|FG001|Trial Period|Missed visit|9
7866220|NCT01629823|12356628|FG002|Trial Period|Missed visit|8
7866221|NCT01629823|12356626|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1
7866222|NCT01629823|12356627|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1
7866223|NCT01629823|12356628|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1
7866224|NCT01629823|12356626|FG000|Trial Period|Pregnancy|1
7866225|NCT01629823|12356627|FG001|Trial Period|Pregnancy|0
7866226|NCT01629823|12356628|FG002|Trial Period|Pregnancy|0
7866227|NCT01629823|12356626|FG000|Trial Period|Adverse Event|0
7866228|NCT01629823|12356627|FG001|Trial Period|Adverse Event|1
7866229|NCT01629823|12356628|FG002|Trial Period|Adverse Event|0
7866230|NCT01629823|12356626|FG000|Trial Period|Out-of-window visit|0
7866231|NCT01629823|12356627|FG001|Trial Period|Out-of-window visit|2
7866232|NCT01629823|12356628|FG002|Trial Period|Out-of-window visit|0
7866233|NCT01629823|12356626|FG000|Trial Period|Failed to hold medication|0
7866234|NCT01629823|12356627|FG001|Trial Period|Failed to hold medication|0
7866235|NCT01629823|12356628|FG002|Trial Period|Failed to hold medication|1
7866236|NCT01629823|12356626|FG000|Washout Period|Safety|2
7866237|NCT01629823|12356627|FG001|Washout Period|Safety|5
7866238|NCT01629823|12356628|FG002|Washout Period|Safety|0
7866239|NCT01629823|12356626|FG000|Washout Period|Pregnancy|1
7866240|NCT01629823|12356627|FG001|Washout Period|Pregnancy|0
7866241|NCT01629823|12356628|FG002|Washout Period|Pregnancy|0
7866242|NCT01629823|12356626|FG000|Washout Period|Protocol Violation|0
7866243|NCT01629823|12356627|FG001|Washout Period|Protocol Violation|1
7866244|NCT01629823|12356628|FG002|Washout Period|Protocol Violation|0
7866245|NCT01629953|12356647|FG000|Overall Study|Death|3
7866246|NCT01629953|12356648|FG001|Overall Study|Death|1
7866247|NCT01629953|12356647|FG000|Overall Study|Lost to Follow-up|10
7866248|NCT01629953|12356648|FG001|Overall Study|Lost to Follow-up|14
7866249|NCT01629966|12356657|FG000|Overall Study|Pregnancy|0
7866250|NCT01629966|12356658|FG001|Overall Study|Pregnancy|1
7866251|NCT01629966|12356659|FG002|Overall Study|Pregnancy|0
7866252|NCT01629966|12356657|FG000|Overall Study|Lost to Follow-up|10
7866253|NCT01629966|12356658|FG001|Overall Study|Lost to Follow-up|13
7866254|NCT01629966|12356659|FG002|Overall Study|Lost to Follow-up|9
7866255|NCT01629966|12356657|FG000|Overall Study|Withdrawal by Subject|8
7866256|NCT01629966|12356658|FG001|Overall Study|Withdrawal by Subject|9
7866257|NCT01629966|12356659|FG002|Overall Study|Withdrawal by Subject|16
7866258|NCT01629966|12356657|FG000|Overall Study|Protocol Violation|7
7866259|NCT01629966|12356658|FG001|Overall Study|Protocol Violation|9
7866260|NCT01629966|12356659|FG002|Overall Study|Protocol Violation|7
7866261|NCT01629966|12356657|FG000|Overall Study|Lack of Efficacy|5
7866262|NCT01629966|12356658|FG001|Overall Study|Lack of Efficacy|2
7866263|NCT01629966|12356659|FG002|Overall Study|Lack of Efficacy|4
7866264|NCT01629966|12356657|FG000|Overall Study|Adverse Event|11
7866265|NCT01629966|12356658|FG001|Overall Study|Adverse Event|18
7866266|NCT01629966|12356659|FG002|Overall Study|Adverse Event|30
7866267|NCT01630135|12356688|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0
7866268|NCT01630135|12356689|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2
7866269|NCT01630616|12356710|FG000|Overall Study|Adverse Event|0
7866270|NCT01630616|12356711|FG001|Overall Study|Adverse Event|0
7866271|NCT01630616|12356712|FG002|Overall Study|Adverse Event|0
7866272|NCT01630616|12356713|FG003|Overall Study|Adverse Event|1
7866273|NCT01630616|12356714|FG004|Overall Study|Adverse Event|0
7866274|NCT01630616|12356715|FG005|Overall Study|Adverse Event|0
7866275|NCT01630616|12356710|FG000|Overall Study|Withdrawal by Subject|0
7866276|NCT01630616|12356711|FG001|Overall Study|Withdrawal by Subject|0
7866277|NCT01630616|12356712|FG002|Overall Study|Withdrawal by Subject|0
7792165|NCT01033240|12246412|FG000|Overall Study|Disease Progression|35
7792166|NCT01033240|12246413|FG001|Overall Study|Disease Progression|32
7792167|NCT01033240|12246414|FG002|Overall Study|Disease Progression|41
7792168|NCT01033240|12246412|FG000|Overall Study|Investigator Discretion|0
7623375|NCT03671148|12034456|FG001|Overall Study|Lack of Efficacy|2
7623376|NCT03671148|12034455|FG000|Overall Study|COVID-19 Logistical Restrictions|0
7623377|NCT03671148|12034456|FG001|Overall Study|COVID-19 Logistical Restrictions|1
7623378|NCT03671148|12034455|FG000|Overall Study|Other|1
7623379|NCT03671148|12034456|FG001|Overall Study|Other|0
7623380|NCT03671148|12034455|FG000|Overall Study|Incomplete Randomization Visit|1
7623381|NCT03671148|12034456|FG001|Overall Study|Incomplete Randomization Visit|0
7792169|NCT01033240|12246413|FG001|Overall Study|Investigator Discretion|0
7792170|NCT01033240|12246414|FG002|Overall Study|Investigator Discretion|2
7792171|NCT01033240|12246412|FG000|Overall Study|Other|0
7792172|NCT01033240|12246413|FG001|Overall Study|Other|1
7623386|NCT03529773|12034547|FG000|Overall Study|Adverse Event|0
7623387|NCT03529773|12034548|FG001|Overall Study|Adverse Event|0
7623388|NCT03529773|12034549|FG002|Overall Study|Adverse Event|0
7623389|NCT03529773|12034550|FG003|Overall Study|Adverse Event|0
7623390|NCT03529773|12034551|FG004|Overall Study|Adverse Event|0
7623391|NCT03529773|12034552|FG005|Overall Study|Adverse Event|0
7623392|NCT03529773|12034553|FG006|Overall Study|Adverse Event|0
7623393|NCT03529773|12034554|FG007|Overall Study|Adverse Event|0
7623394|NCT03529773|12034555|FG008|Overall Study|Adverse Event|0
7623395|NCT03529773|12034556|FG009|Overall Study|Adverse Event|0
7866278|NCT01630616|12356713|FG003|Overall Study|Withdrawal by Subject|2
7866279|NCT01630616|12356714|FG004|Overall Study|Withdrawal by Subject|0
7866280|NCT01630616|12356715|FG005|Overall Study|Withdrawal by Subject|0
7866281|NCT01630811|12356741|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1
7866282|NCT01630811|12356742|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0
7866283|NCT01630889|12356750|FG000|Overall Study|Death|2
7866284|NCT01630889|12356750|FG000|Overall Study|Withdrawal by Subject|1
7866285|NCT01630889|12356750|FG000|Overall Study|Other than Specified|2
7866286|NCT01630889|12356750|FG000|Overall Study|Lost to Follow-up|4
7866287|NCT01630889|12356750|FG000|Overall Study|Other|1
7866288|NCT01631188|12356781|FG000|Overall Study|Physician Decision|75
7866289|NCT01631214|12356787|FG000|Overall Study|Withdrawal by Subject|276
7866290|NCT01631214|12356788|FG001|Overall Study|Withdrawal by Subject|290
7866291|NCT01631214|12356787|FG000|Overall Study|Death|113
7866292|NCT01631214|12356788|FG001|Overall Study|Death|106
7866293|NCT01631214|12356787|FG000|Overall Study|Lost to Follow-up|54
7623396|NCT03529773|12034557|FG010|Overall Study|Adverse Event|0
7623397|NCT03529773|12034558|FG011|Overall Study|Adverse Event|0
7623398|NCT03529773|12034559|FG012|Overall Study|Adverse Event|0
7623399|NCT03529773|12034560|FG013|Overall Study|Adverse Event|0
7623400|NCT03529773|12034561|FG014|Overall Study|Adverse Event|0
7623401|NCT03529773|12034562|FG015|Overall Study|Adverse Event|0
7623402|NCT03529773|12034563|FG016|Overall Study|Adverse Event|0
7866294|NCT01631214|12356788|FG001|Overall Study|Lost to Follow-up|40
7866295|NCT01631214|12356787|FG000|Overall Study|Adverse Event|45
7866296|NCT01631214|12356788|FG001|Overall Study|Adverse Event|45
7866297|NCT01631214|12356787|FG000|Overall Study|Other|22
7866298|NCT01631214|12356788|FG001|Overall Study|Other|19
7866299|NCT01631214|12356787|FG000|Overall Study|Noncompliance|16
7866300|NCT01631214|12356788|FG001|Overall Study|Noncompliance|15
7792173|NCT01033240|12246414|FG002|Overall Study|Other|2
7792174|NCT01033448|12246452|FG000|Overall Study|Withdrawal by Subject|4
7792175|NCT01033448|12246452|FG000|Overall Study|Positive HCV-RNA at week 48|1
7792176|NCT01033448|12246452|FG000|Overall Study|Lost to Follow-up|3
7792177|NCT01033448|12246452|FG000|Overall Study|Withdrew due to other reasons|3
7792178|NCT01033448|12246452|FG000|Overall Study|Unknown disposition|1
7792179|NCT01033487|12246458|FG000|Fourth Intervention Period|Adverse Event|0
7792180|NCT01033487|12246459|FG001|Fourth Intervention Period|Adverse Event|0
7792181|NCT01033487|12246460|FG002|Fourth Intervention Period|Adverse Event|0
7792182|NCT01033487|12246461|FG003|Fourth Intervention Period|Adverse Event|0
7866301|NCT01631214|12356787|FG000|Overall Study|Requirement for Alternative Therapy|8
7866302|NCT01631214|12356788|FG001|Overall Study|Requirement for Alternative Therapy|3
7866303|NCT01631214|12356787|FG000|Overall Study|Protocol Deviation|4
7866304|NCT01631214|12356788|FG001|Overall Study|Protocol Deviation|3
7866305|NCT01631214|12356787|FG000|Overall Study|Ineligibility determined|5
7866306|NCT01631214|12356788|FG001|Overall Study|Ineligibility determined|2
7866307|NCT01631214|12356787|FG000|Overall Study|Administrative Decision|1
7866308|NCT01631214|12356788|FG001|Overall Study|Administrative Decision|0
7866309|NCT01631227|12356798|FG000|Overall Study|withdrawn consent|27
7866310|NCT01631227|12356799|FG001|Overall Study|withdrawn consent|21
7866311|NCT01631227|12356798|FG000|Overall Study|Adverse Event|1
7866312|NCT01631227|12356799|FG001|Overall Study|Adverse Event|0
7866313|NCT01631227|12356798|FG000|Overall Study|administrative|2
7866314|NCT01631227|12356799|FG001|Overall Study|administrative|1
7866315|NCT01631435|12356810|FG000|Overall Study|Adverse Event|2
7866316|NCT01631435|12356810|FG000|Overall Study|Withdrawal by Subject|2
7866317|NCT01631435|12356810|FG000|Overall Study|incomplete study procedure|5
7866318|NCT01631474|12356820|FG000|Overall Study|Lost to Follow-up|8
7866319|NCT01631474|12356821|FG001|Overall Study|Lost to Follow-up|5
7866320|NCT01631474|12356822|FG002|Overall Study|Lost to Follow-up|7
7866321|NCT01631474|12356823|FG003|Overall Study|Lost to Follow-up|5
7866322|NCT01631474|12356824|FG004|Overall Study|Lost to Follow-up|5
7866323|NCT01631474|12356820|FG000|Overall Study|Withdrawal by Subject|4
7866324|NCT01631474|12356821|FG001|Overall Study|Withdrawal by Subject|4
7866325|NCT01631474|12356822|FG002|Overall Study|Withdrawal by Subject|2
7866326|NCT01631474|12356823|FG003|Overall Study|Withdrawal by Subject|6
7866327|NCT01631474|12356824|FG004|Overall Study|Withdrawal by Subject|5
7866328|NCT01631474|12356820|FG000|Overall Study|Lack of Efficacy|2
7866329|NCT01631474|12356821|FG001|Overall Study|Lack of Efficacy|2
7866330|NCT01631474|12356822|FG002|Overall Study|Lack of Efficacy|0
7866331|NCT01631474|12356823|FG003|Overall Study|Lack of Efficacy|0
7866332|NCT01631474|12356824|FG004|Overall Study|Lack of Efficacy|2
7866333|NCT01631474|12356820|FG000|Overall Study|Noncompliance with Study Drug|0
7866334|NCT01631474|12356821|FG001|Overall Study|Noncompliance with Study Drug|0
7866335|NCT01631474|12356822|FG002|Overall Study|Noncompliance with Study Drug|0
7866336|NCT01631474|12356823|FG003|Overall Study|Noncompliance with Study Drug|0
7866337|NCT01631474|12356824|FG004|Overall Study|Noncompliance with Study Drug|1
7866338|NCT01631474|12356820|FG000|Overall Study|Adverse Event|0
7866339|NCT01631474|12356821|FG001|Overall Study|Adverse Event|1
7866340|NCT01631474|12356822|FG002|Overall Study|Adverse Event|0
7866341|NCT01631474|12356823|FG003|Overall Study|Adverse Event|0
7866342|NCT01631474|12356824|FG004|Overall Study|Adverse Event|0
7866343|NCT01631747|12356892|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1
7866344|NCT01631747|12356893|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0
7866345|NCT01631747|12356892|FG000|Live Birth|Pregnancy Termination|1
7866346|NCT01631747|12356893|FG001|Live Birth|Pregnancy Termination|0
7866347|NCT01631747|12356892|FG000|Live Birth|MIscarriage|2
7866348|NCT01631747|12356893|FG001|Live Birth|MIscarriage|0
7866349|NCT01631747|12356892|FG000|Live Birth|Stillbirth|1
7866350|NCT01631747|12356893|FG001|Live Birth|Stillbirth|1
7866351|NCT01631747|12356892|FG000|One Year Infant Outcomes|Patient Refused|13
7866352|NCT01631747|12356893|FG001|One Year Infant Outcomes|Patient Refused|9
7866353|NCT01631812|12356900|FG000|Overall Study|Adverse Event|25
7623365|NCT03847974|12034426|FG000|Overall Study|relocated out of region|3
7623366|NCT03847974|12034426|FG000|Overall Study|Withdrawal by Subject|2
7623367|NCT03847974|12034426|FG000|Overall Study|Adverse Event|1
7623368|NCT03671148|12034455|FG000|Overall Study|Adverse Event|3
7623369|NCT03671148|12034456|FG001|Overall Study|Adverse Event|2
7623370|NCT03671148|12034455|FG000|Overall Study|Withdrawal by Subject|8
7623371|NCT03671148|12034456|FG001|Overall Study|Withdrawal by Subject|2
7623372|NCT03671148|12034455|FG000|Overall Study|Lost to Follow-up|1
7623373|NCT03671148|12034456|FG001|Overall Study|Lost to Follow-up|2
7866354|NCT01631812|12356900|FG000|Overall Study|Lack of Efficacy|5
7866355|NCT01631812|12356900|FG000|Overall Study|Withdrawal by Subject|4
7866356|NCT01631812|12356900|FG000|Overall Study|Physician Decision|3
7866357|NCT01631825|12356904|FG000|Overall Study|Adverse Event|42
7866358|NCT01631825|12356904|FG000|Overall Study|Lack of Efficacy|7
7623374|NCT03671148|12034455|FG000|Overall Study|Lack of Efficacy|7
7866359|NCT01631825|12356904|FG000|Overall Study|Withdrawal by Subject|9
7866360|NCT01631825|12356904|FG000|Overall Study|Protocol Violation|4
7866361|NCT01631825|12356904|FG000|Overall Study|Discontinuation criteria|1
7866362|NCT01631825|12356904|FG000|Overall Study|Physician Decision|2
7866363|NCT01631864|12356910|FG000|Overall Study|Withdrawal by Subject|0
7866364|NCT01631864|12356911|FG001|Overall Study|Withdrawal by Subject|1
7866365|NCT01631864|12356910|FG000|Overall Study|Adverse Event|2
7866366|NCT01631864|12356911|FG001|Overall Study|Adverse Event|3
7866367|NCT01632150|12356926|FG000|Overall Study|Disease progression|27
7866368|NCT01632150|12356926|FG000|Overall Study|Study drug toxicity|1
7866369|NCT01632150|12356926|FG000|Overall Study|Unrelated adverse event|7
7866370|NCT01632150|12356926|FG000|Overall Study|Withdrawal by Subject|2
7866371|NCT01632150|12356926|FG000|Overall Study|Patient underwent autologous transplant|1
7866372|NCT01632150|12356926|FG000|Overall Study|Moved to compassionate program|2
7866373|NCT01632241|12356953|FG000|Double-blinded (Up to Week 52)|Site Closed|3
7866374|NCT01632241|12356954|FG001|Double-blinded (Up to Week 52)|Site Closed|5
7866375|NCT01632241|12356953|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2
7866376|NCT01632241|12356954|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6
7866377|NCT01632241|12356953|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1
7866378|NCT01632241|12356954|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8
7866379|NCT01632241|12356953|FG000|Double-blinded (Up to Week 52)|Physician Decision|9
7866380|NCT01632241|12356954|FG001|Double-blinded (Up to Week 52)|Physician Decision|12
7866381|NCT01632241|12356953|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9
7866382|NCT01632241|12356954|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15
7866383|NCT01632241|12356953|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10
7866384|NCT01632241|12356954|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14
7866385|NCT01632241|12356953|FG000|Double-blinded (Up to Week 52)|Adverse Event|10
7866386|NCT01632241|12356954|FG001|Double-blinded (Up to Week 52)|Adverse Event|19
7866387|NCT01632241|12356953|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5
7866388|NCT01632241|12356954|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2
7866389|NCT01632241|12356953|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1
7866390|NCT01632241|12356954|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4
7866391|NCT01632241|12356953|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1
7866392|NCT01632241|12356954|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4
7866393|NCT01632241|12356953|FG000|Open-label (Week 52 to Week 76)|Site Closed|2
7866394|NCT01632241|12356954|FG001|Open-label (Week 52 to Week 76)|Site Closed|8
7866395|NCT01632241|12356953|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0
7866396|NCT01632241|12356954|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2
7866397|NCT01632241|12356953|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0
7866398|NCT01632241|12356954|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2
7866399|NCT01632241|12356953|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1
7866400|NCT01632241|12356954|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0
7866401|NCT01632280|12356972|FG000|Overall Study|Withdrawal by Subject|1
7866402|NCT01632280|12356973|FG001|Overall Study|Withdrawal by Subject|0
7866403|NCT01632306|12356981|FG000|Overall Study|Protocol Violation|1
7866404|NCT01632306|12356982|FG001|Overall Study|Protocol Violation|0
7866405|NCT01632306|12356983|FG002|Overall Study|Protocol Violation|0
7866406|NCT01632345|12356994|FG000|Treatment: Part I|Adverse Event|1
7866407|NCT01632345|12356995|FG001|Treatment: Part I|Adverse Event|4
7866408|NCT01632345|12356996|FG002|Treatment: Part I|Adverse Event|2
7866409|NCT01632345|12356997|FG003|Treatment: Part I|Adverse Event|1
7866410|NCT01632345|12356998|FG004|Treatment: Part I|Adverse Event|3
7866411|NCT01632345|12356999|FG005|Treatment: Part I|Adverse Event|0
7866412|NCT01632345|12357000|FG006|Treatment: Part I|Adverse Event|0
7866413|NCT01632345|12356994|FG000|Treatment: Part I|Lack of Efficacy|0
7866414|NCT01632345|12356995|FG001|Treatment: Part I|Lack of Efficacy|1
7866415|NCT01632345|12356996|FG002|Treatment: Part I|Lack of Efficacy|0
7866416|NCT01632345|12356997|FG003|Treatment: Part I|Lack of Efficacy|1
7866417|NCT01632345|12356998|FG004|Treatment: Part I|Lack of Efficacy|1
7866418|NCT01632345|12356999|FG005|Treatment: Part I|Lack of Efficacy|0
7866419|NCT01632345|12357000|FG006|Treatment: Part I|Lack of Efficacy|0
7866420|NCT01632345|12356994|FG000|Treatment: Part I|Lost to Follow-up|3
7866421|NCT01632345|12356995|FG001|Treatment: Part I|Lost to Follow-up|2
7866422|NCT01632345|12356996|FG002|Treatment: Part I|Lost to Follow-up|1
7866423|NCT01632345|12356997|FG003|Treatment: Part I|Lost to Follow-up|3
7866424|NCT01632345|12356998|FG004|Treatment: Part I|Lost to Follow-up|4
7866425|NCT01632345|12356999|FG005|Treatment: Part I|Lost to Follow-up|0
7866426|NCT01632345|12357000|FG006|Treatment: Part I|Lost to Follow-up|0
7866427|NCT01632345|12356994|FG000|Treatment: Part I|Non-Compliance with Study Drug|3
7866428|NCT01632345|12356995|FG001|Treatment: Part I|Non-Compliance with Study Drug|2
7866429|NCT01632345|12356996|FG002|Treatment: Part I|Non-Compliance with Study Drug|2
7866430|NCT01632345|12356997|FG003|Treatment: Part I|Non-Compliance with Study Drug|1
7866431|NCT01632345|12356998|FG004|Treatment: Part I|Non-Compliance with Study Drug|0
7866432|NCT01632345|12356999|FG005|Treatment: Part I|Non-Compliance with Study Drug|0
7866433|NCT01632345|12357000|FG006|Treatment: Part I|Non-Compliance with Study Drug|0
7866434|NCT01632345|12356994|FG000|Treatment: Part I|Physician Decision|2
7866435|NCT01632345|12356995|FG001|Treatment: Part I|Physician Decision|1
7866436|NCT01632345|12356996|FG002|Treatment: Part I|Physician Decision|0
7866437|NCT01632345|12356997|FG003|Treatment: Part I|Physician Decision|0
7866438|NCT01632345|12356998|FG004|Treatment: Part I|Physician Decision|1
7866439|NCT01632345|12356999|FG005|Treatment: Part I|Physician Decision|0
7866440|NCT01632345|12357000|FG006|Treatment: Part I|Physician Decision|0
7866441|NCT01632345|12356994|FG000|Treatment: Part I|Pregnancy|0
7866442|NCT01632345|12356995|FG001|Treatment: Part I|Pregnancy|1
7866443|NCT01632345|12356996|FG002|Treatment: Part I|Pregnancy|0
7866444|NCT01632345|12356997|FG003|Treatment: Part I|Pregnancy|0
7866445|NCT01632345|12356998|FG004|Treatment: Part I|Pregnancy|0
7866446|NCT01632345|12356999|FG005|Treatment: Part I|Pregnancy|0
7866447|NCT01632345|12357000|FG006|Treatment: Part I|Pregnancy|0
7866448|NCT01632345|12356994|FG000|Treatment: Part I|Protocol Deviation|0
7866449|NCT01632345|12356995|FG001|Treatment: Part I|Protocol Deviation|0
7866450|NCT01632345|12356996|FG002|Treatment: Part I|Protocol Deviation|1
7866451|NCT01632345|12356997|FG003|Treatment: Part I|Protocol Deviation|1
7866452|NCT01632345|12356998|FG004|Treatment: Part I|Protocol Deviation|0
7866453|NCT01632345|12356999|FG005|Treatment: Part I|Protocol Deviation|0
7866454|NCT01632345|12357000|FG006|Treatment: Part I|Protocol Deviation|0
7866455|NCT01632345|12356994|FG000|Treatment: Part I|Withdrawal by Subject|3
7866456|NCT01632345|12356995|FG001|Treatment: Part I|Withdrawal by Subject|4
7866457|NCT01632345|12356996|FG002|Treatment: Part I|Withdrawal by Subject|4
7866458|NCT01632345|12356997|FG003|Treatment: Part I|Withdrawal by Subject|1
7866459|NCT01632345|12356998|FG004|Treatment: Part I|Withdrawal by Subject|4
7866460|NCT01632345|12356999|FG005|Treatment: Part I|Withdrawal by Subject|0
7866461|NCT01632345|12357000|FG006|Treatment: Part I|Withdrawal by Subject|0
7866462|NCT01632345|12356994|FG000|Treatment: Part II|Adverse Event|0
7866463|NCT01632345|12356995|FG001|Treatment: Part II|Adverse Event|0
7866464|NCT01632345|12356996|FG002|Treatment: Part II|Adverse Event|0
7866465|NCT01632345|12356997|FG003|Treatment: Part II|Adverse Event|0
7866466|NCT01632345|12356998|FG004|Treatment: Part II|Adverse Event|0
7866467|NCT01632345|12356999|FG005|Treatment: Part II|Adverse Event|3
7866468|NCT01632345|12357000|FG006|Treatment: Part II|Adverse Event|8
7866469|NCT01632345|12356994|FG000|Treatment: Part II|Lost to Follow-up|0
7866470|NCT01632345|12356995|FG001|Treatment: Part II|Lost to Follow-up|0
7866471|NCT01632345|12356996|FG002|Treatment: Part II|Lost to Follow-up|0
7866472|NCT01632345|12356997|FG003|Treatment: Part II|Lost to Follow-up|0
7866473|NCT01632345|12356998|FG004|Treatment: Part II|Lost to Follow-up|0
7866474|NCT01632345|12356999|FG005|Treatment: Part II|Lost to Follow-up|3
7866475|NCT01632345|12357000|FG006|Treatment: Part II|Lost to Follow-up|1
7866476|NCT01632345|12356994|FG000|Treatment: Part II|Non-Compliance with Study Drug|0
7866477|NCT01632345|12356995|FG001|Treatment: Part II|Non-Compliance with Study Drug|0
7866478|NCT01632345|12356996|FG002|Treatment: Part II|Non-Compliance with Study Drug|0
7866479|NCT01632345|12356997|FG003|Treatment: Part II|Non-Compliance with Study Drug|0
7866480|NCT01632345|12356998|FG004|Treatment: Part II|Non-Compliance with Study Drug|0
7866481|NCT01632345|12356999|FG005|Treatment: Part II|Non-Compliance with Study Drug|3
7866482|NCT01632345|12357000|FG006|Treatment: Part II|Non-Compliance with Study Drug|0
7866483|NCT01632345|12356994|FG000|Treatment: Part II|Withdrawal by Subject|0
7866484|NCT01632345|12356995|FG001|Treatment: Part II|Withdrawal by Subject|0
7866485|NCT01632345|12356996|FG002|Treatment: Part II|Withdrawal by Subject|0
7866486|NCT01632345|12356997|FG003|Treatment: Part II|Withdrawal by Subject|0
7866487|NCT01632345|12356998|FG004|Treatment: Part II|Withdrawal by Subject|0
7866488|NCT01632345|12356999|FG005|Treatment: Part II|Withdrawal by Subject|2
7866489|NCT01632345|12357000|FG006|Treatment: Part II|Withdrawal by Subject|2
7866490|NCT01632566|12357024|FG000|Overall Study|Withdrawal by Subject|0
7866491|NCT01632566|12357025|FG001|Overall Study|Withdrawal by Subject|1
7866492|NCT01632566|12357026|FG002|Overall Study|Withdrawal by Subject|0
7866493|NCT01632566|12357027|FG003|Overall Study|Withdrawal by Subject|0
7866494|NCT01632566|12357028|FG004|Overall Study|Withdrawal by Subject|0
7866495|NCT01632566|12357024|FG000|Overall Study|Sponsor Decision|0
7866496|NCT01632566|12357025|FG001|Overall Study|Sponsor Decision|2
7866497|NCT01632566|12357026|FG002|Overall Study|Sponsor Decision|9
7866498|NCT01632566|12357027|FG003|Overall Study|Sponsor Decision|2
7866499|NCT01632566|12357028|FG004|Overall Study|Sponsor Decision|2
7866500|NCT01632579|12357044|FG000|Washout Period|Adverse Event|1
7866501|NCT01632579|12357045|FG001|Washout Period|Adverse Event|0
7866502|NCT01632579|12357046|FG002|Washout Period|Adverse Event|0
7866503|NCT01632579|12357047|FG003|Washout Period|Adverse Event|0
7866504|NCT01632579|12357048|FG004|Washout Period|Adverse Event|0
7866505|NCT01632579|12357049|FG005|Washout Period|Adverse Event|0
7866506|NCT01632579|12357050|FG006|Washout Period|Adverse Event|0
7866507|NCT01632579|12357051|FG007|Washout Period|Adverse Event|0
7866508|NCT01632579|12357052|FG008|Washout Period|Adverse Event|0
7866509|NCT01632579|12357044|FG000|Period 2 (Second Intervention)|Adverse Event|1
7866510|NCT01632579|12357045|FG001|Period 2 (Second Intervention)|Adverse Event|0
7866511|NCT01632579|12357046|FG002|Period 2 (Second Intervention)|Adverse Event|0
7866512|NCT01632579|12357047|FG003|Period 2 (Second Intervention)|Adverse Event|0
7866513|NCT01632579|12357048|FG004|Period 2 (Second Intervention)|Adverse Event|0
7866514|NCT01632579|12357049|FG005|Period 2 (Second Intervention)|Adverse Event|0
7866515|NCT01632579|12357050|FG006|Period 2 (Second Intervention)|Adverse Event|0
7866516|NCT01632579|12357051|FG007|Period 2 (Second Intervention)|Adverse Event|0
7866517|NCT01632579|12357052|FG008|Period 2 (Second Intervention)|Adverse Event|0
7866518|NCT01632800|12357109|FG000|Overall Study|Subject did not fit in apparatus|1
7866519|NCT01632891|12357115|FG000|Overall Study|Lost to Follow-up|0
7866520|NCT01632891|12357116|FG001|Overall Study|Lost to Follow-up|1
7866521|NCT01632891|12357115|FG000|Overall Study|Withdrawal by Subject|1
7866522|NCT01632891|12357116|FG001|Overall Study|Withdrawal by Subject|0
7866523|NCT01632904|12357128|FG000|Overall Study|Adverse Event|4
7866524|NCT01632904|12357129|FG001|Overall Study|Adverse Event|1
7866525|NCT01632904|12357128|FG000|Overall Study|Physician Decision|0
7866526|NCT01632904|12357129|FG001|Overall Study|Physician Decision|1
7866527|NCT01632904|12357128|FG000|Overall Study|Subject decision|3
7866528|NCT01632904|12357129|FG001|Overall Study|Subject decision|2
7866529|NCT01632904|12357128|FG000|Overall Study|Disease Progression|0
7866530|NCT01632904|12357129|FG001|Overall Study|Disease Progression|1
7866531|NCT01632904|12357128|FG000|Overall Study|Reason for discontinuation not available|0
7866532|NCT01632904|12357129|FG001|Overall Study|Reason for discontinuation not available|1
7623403|NCT03529773|12034564|FG017|Overall Study|Adverse Event|0
7623404|NCT03529773|12034565|FG018|Overall Study|Adverse Event|0
7623405|NCT03529773|12034566|FG019|Overall Study|Adverse Event|0
7623406|NCT03529773|12034567|FG020|Overall Study|Adverse Event|0
7623407|NCT03529773|12034568|FG021|Overall Study|Adverse Event|0
7623408|NCT03529773|12034569|FG022|Overall Study|Adverse Event|0
7623409|NCT03529773|12034570|FG023|Overall Study|Adverse Event|0
7623410|NCT03529773|12034571|FG024|Overall Study|Adverse Event|0
7623411|NCT03529773|12034572|FG025|Overall Study|Adverse Event|0
7623412|NCT03529773|12034573|FG026|Overall Study|Adverse Event|0
7623413|NCT03529773|12034574|FG027|Overall Study|Adverse Event|0
7623414|NCT03529773|12034575|FG028|Overall Study|Adverse Event|0
7623415|NCT03529773|12034576|FG029|Overall Study|Adverse Event|0
7623416|NCT03529773|12034577|FG030|Overall Study|Adverse Event|1
7623417|NCT03529773|12034578|FG031|Overall Study|Adverse Event|0
7623418|NCT03529773|12034579|FG032|Overall Study|Adverse Event|0
7623419|NCT03529773|12034580|FG033|Overall Study|Adverse Event|0
7623420|NCT03529773|12034581|FG034|Overall Study|Adverse Event|0
7623421|NCT03529773|12034582|FG035|Overall Study|Adverse Event|1
7623422|NCT03529773|12034583|FG036|Overall Study|Adverse Event|0
7623423|NCT03529773|12034584|FG037|Overall Study|Adverse Event|0
7623424|NCT03529773|12034585|FG038|Overall Study|Adverse Event|1
7623425|NCT03529773|12034586|FG039|Overall Study|Adverse Event|1
7623426|NCT03529773|12034547|FG000|Overall Study|Death|0
7623427|NCT03529773|12034548|FG001|Overall Study|Death|0
7623428|NCT03529773|12034549|FG002|Overall Study|Death|0
7623429|NCT03529773|12034550|FG003|Overall Study|Death|0
7623430|NCT03529773|12034551|FG004|Overall Study|Death|0
7623431|NCT03529773|12034552|FG005|Overall Study|Death|0
7623432|NCT03529773|12034553|FG006|Overall Study|Death|0
7623433|NCT03529773|12034554|FG007|Overall Study|Death|0
7623434|NCT03529773|12034555|FG008|Overall Study|Death|0
7623435|NCT03529773|12034556|FG009|Overall Study|Death|0
7623436|NCT03529773|12034557|FG010|Overall Study|Death|0
7623437|NCT03529773|12034558|FG011|Overall Study|Death|0
7623438|NCT03529773|12034559|FG012|Overall Study|Death|1
7623439|NCT03529773|12034560|FG013|Overall Study|Death|0
7623440|NCT03529773|12034561|FG014|Overall Study|Death|0
7623441|NCT03529773|12034562|FG015|Overall Study|Death|0
7623442|NCT03529773|12034563|FG016|Overall Study|Death|0
7623443|NCT03529773|12034564|FG017|Overall Study|Death|0
7623444|NCT03529773|12034565|FG018|Overall Study|Death|0
7623445|NCT03529773|12034566|FG019|Overall Study|Death|1
7623446|NCT03529773|12034567|FG020|Overall Study|Death|0
7623447|NCT03529773|12034568|FG021|Overall Study|Death|0
7623448|NCT03529773|12034569|FG022|Overall Study|Death|1
7623449|NCT03529773|12034570|FG023|Overall Study|Death|0
7623450|NCT03529773|12034571|FG024|Overall Study|Death|0
7623451|NCT03529773|12034572|FG025|Overall Study|Death|0
7623452|NCT03529773|12034573|FG026|Overall Study|Death|0
7623453|NCT03529773|12034574|FG027|Overall Study|Death|0
7623454|NCT03529773|12034575|FG028|Overall Study|Death|0
7623455|NCT03529773|12034576|FG029|Overall Study|Death|0
7623456|NCT03529773|12034577|FG030|Overall Study|Death|0
7623457|NCT03529773|12034578|FG031|Overall Study|Death|0
7623458|NCT03529773|12034579|FG032|Overall Study|Death|0
7623459|NCT03529773|12034580|FG033|Overall Study|Death|1
7623460|NCT03529773|12034581|FG034|Overall Study|Death|1
7623461|NCT03529773|12034582|FG035|Overall Study|Death|0
7623462|NCT03529773|12034583|FG036|Overall Study|Death|1
7623463|NCT03529773|12034584|FG037|Overall Study|Death|0
7623464|NCT03529773|12034585|FG038|Overall Study|Death|0
7623465|NCT03529773|12034586|FG039|Overall Study|Death|0
7623466|NCT03529773|12034547|FG000|Overall Study|Lost to Follow-up|0
7623467|NCT03529773|12034548|FG001|Overall Study|Lost to Follow-up|0
7623468|NCT03529773|12034549|FG002|Overall Study|Lost to Follow-up|1
7623469|NCT03529773|12034550|FG003|Overall Study|Lost to Follow-up|0
7623470|NCT03529773|12034551|FG004|Overall Study|Lost to Follow-up|1
7623471|NCT03529773|12034552|FG005|Overall Study|Lost to Follow-up|1
7623472|NCT03529773|12034553|FG006|Overall Study|Lost to Follow-up|0
7623473|NCT03529773|12034554|FG007|Overall Study|Lost to Follow-up|0
7623474|NCT03529773|12034555|FG008|Overall Study|Lost to Follow-up|0
7623475|NCT03529773|12034556|FG009|Overall Study|Lost to Follow-up|0
7623476|NCT03529773|12034557|FG010|Overall Study|Lost to Follow-up|0
7623477|NCT03529773|12034558|FG011|Overall Study|Lost to Follow-up|0
7866533|NCT01633060|12357143|FG000|Randomization Phase|Protocol deviation|1
7866534|NCT01633060|12357144|FG001|Randomization Phase|Protocol deviation|2
7866535|NCT01633060|12357143|FG000|Randomization Phase|Technical problem|0
7866536|NCT01633060|12357144|FG001|Randomization Phase|Technical problem|1
7866537|NCT01633060|12357143|FG000|Treatment Phase|Adverse Event|24
7866538|NCT01633060|12357144|FG001|Treatment Phase|Adverse Event|3
7866539|NCT01633060|12357143|FG000|Treatment Phase|Lost to Follow-up|1
7866540|NCT01633060|12357144|FG001|Treatment Phase|Lost to Follow-up|0
7866541|NCT01633060|12357143|FG000|Treatment Phase|Physician Decision|16
7866542|NCT01633060|12357144|FG001|Treatment Phase|Physician Decision|7
7866543|NCT01633060|12357143|FG000|Treatment Phase|Progressive Disease|210
7866544|NCT01633060|12357144|FG001|Treatment Phase|Progressive Disease|120
7866545|NCT01633060|12357143|FG000|Treatment Phase|Protocol Deviation|1
7866546|NCT01633060|12357144|FG001|Treatment Phase|Protocol Deviation|0
7866547|NCT01633060|12357143|FG000|Treatment Phase|Study Terminated by sponsor|7
7866548|NCT01633060|12357144|FG001|Treatment Phase|Study Terminated by sponsor|3
7866549|NCT01633060|12357143|FG000|Treatment Phase|Subject/guardian decision|25
7866550|NCT01633060|12357144|FG001|Treatment Phase|Subject/guardian decision|4
7866551|NCT01633060|12357143|FG000|Treatment Phase|Death|4
7866552|NCT01633060|12357144|FG001|Treatment Phase|Death|3
7866553|NCT01633060|12357143|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
7866554|NCT01633060|12357144|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7866555|NCT01633060|12357143|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1
7866556|NCT01633060|12357144|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0
7866557|NCT01633060|12357143|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10
7866558|NCT01633060|12357144|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1
7866559|NCT01633060|12357143|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1
7866560|NCT01633060|12357144|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0
7866561|NCT01633060|12357143|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
7866562|NCT01633060|12357144|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
7866563|NCT01633060|12357143|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1
7866564|NCT01633060|12357144|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0
7866565|NCT01633112|12357154|FG000|Overall Study|Lack of Efficacy|1
7866566|NCT01633112|12357155|FG001|Overall Study|Lack of Efficacy|6
7866567|NCT01633112|12357156|FG002|Overall Study|Lack of Efficacy|13
7866568|NCT01633112|12357154|FG000|Overall Study|Abnormal laboratory value(s)|3
7866569|NCT01633112|12357155|FG001|Overall Study|Abnormal laboratory value(s)|1
7866570|NCT01633112|12357156|FG002|Overall Study|Abnormal laboratory value(s)|0
7866571|NCT01633112|12357154|FG000|Overall Study|Abnormal test procedure result(s)|0
7866572|NCT01633112|12357155|FG001|Overall Study|Abnormal test procedure result(s)|1
7866573|NCT01633112|12357156|FG002|Overall Study|Abnormal test procedure result(s)|0
7866574|NCT01633112|12357154|FG000|Overall Study|Administrative problems|1
7866575|NCT01633112|12357155|FG001|Overall Study|Administrative problems|2
7866576|NCT01633112|12357156|FG002|Overall Study|Administrative problems|5
7866577|NCT01633112|12357154|FG000|Overall Study|Adverse Event|16
7866578|NCT01633112|12357155|FG001|Overall Study|Adverse Event|18
7866579|NCT01633112|12357156|FG002|Overall Study|Adverse Event|20
7866580|NCT01633112|12357154|FG000|Overall Study|Lost to Follow-up|7
7866581|NCT01633112|12357155|FG001|Overall Study|Lost to Follow-up|19
7866582|NCT01633112|12357156|FG002|Overall Study|Lost to Follow-up|6
7866583|NCT01633112|12357154|FG000|Overall Study|Protocol Violation|4
7866584|NCT01633112|12357155|FG001|Overall Study|Protocol Violation|0
7866585|NCT01633112|12357156|FG002|Overall Study|Protocol Violation|2
7866586|NCT01633112|12357154|FG000|Overall Study|Subject no longer requires study drug|0
7866587|NCT01633112|12357155|FG001|Overall Study|Subject no longer requires study drug|0
7866588|NCT01633112|12357156|FG002|Overall Study|Subject no longer requires study drug|1
7866589|NCT01633112|12357154|FG000|Overall Study|Withdrawal by Subject|20
7866590|NCT01633112|12357155|FG001|Overall Study|Withdrawal by Subject|12
7866591|NCT01633112|12357156|FG002|Overall Study|Withdrawal by Subject|41
7866592|NCT01633112|12357154|FG000|Overall Study|missing Study Completion CRF|1
7866593|NCT01633112|12357155|FG001|Overall Study|missing Study Completion CRF|1
7866594|NCT01633112|12357156|FG002|Overall Study|missing Study Completion CRF|4
7866595|NCT01633788|12357187|FG000|Overall Study|Adverse Event|1
7866596|NCT01633788|12357188|FG001|Overall Study|Adverse Event|3
7866597|NCT01633788|12357189|FG002|Overall Study|Adverse Event|3
7866598|NCT01633788|12357190|FG003|Overall Study|Adverse Event|3
7866599|NCT01633788|12357187|FG000|Overall Study|Lost to Follow-up|2
7866600|NCT01633788|12357188|FG001|Overall Study|Lost to Follow-up|2
7866601|NCT01633788|12357189|FG002|Overall Study|Lost to Follow-up|2
7866602|NCT01633788|12357190|FG003|Overall Study|Lost to Follow-up|0
7866603|NCT01633788|12357187|FG000|Overall Study|Personal Reasons|3
7866604|NCT01633788|12357188|FG001|Overall Study|Personal Reasons|1
7866605|NCT01633788|12357189|FG002|Overall Study|Personal Reasons|1
7866606|NCT01633788|12357190|FG003|Overall Study|Personal Reasons|3
7866607|NCT01633788|12357187|FG000|Overall Study|Protocol Violation|1
7866608|NCT01633788|12357188|FG001|Overall Study|Protocol Violation|0
7866609|NCT01633788|12357189|FG002|Overall Study|Protocol Violation|1
7866610|NCT01633788|12357190|FG003|Overall Study|Protocol Violation|0
7866611|NCT01633788|12357187|FG000|Overall Study|Other Reasons|0
7866612|NCT01633788|12357188|FG001|Overall Study|Other Reasons|2
7866613|NCT01633788|12357189|FG002|Overall Study|Other Reasons|3
7866614|NCT01633788|12357190|FG003|Overall Study|Other Reasons|7
7866615|NCT01633944|12357230|FG000|Open-label Titration Phase|Adverse Event|109
7866616|NCT01633944|12357231|FG001|Open-label Titration Phase|Adverse Event|0
7866617|NCT01633944|12357232|FG002|Open-label Titration Phase|Adverse Event|0
7866618|NCT01633944|12357230|FG000|Open-label Titration Phase|Lack of Efficacy|33
7866619|NCT01633944|12357231|FG001|Open-label Titration Phase|Lack of Efficacy|0
7866620|NCT01633944|12357232|FG002|Open-label Titration Phase|Lack of Efficacy|0
7866621|NCT01633944|12357230|FG000|Open-label Titration Phase|Withdrawal by Subject|34
7866622|NCT01633944|12357231|FG001|Open-label Titration Phase|Withdrawal by Subject|0
7866623|NCT01633944|12357232|FG002|Open-label Titration Phase|Withdrawal by Subject|0
7866624|NCT01633944|12357230|FG000|Open-label Titration Phase|Protocol Violation|24
7866625|NCT01633944|12357231|FG001|Open-label Titration Phase|Protocol Violation|0
7866626|NCT01633944|12357232|FG002|Open-label Titration Phase|Protocol Violation|0
7866627|NCT01633944|12357230|FG000|Open-label Titration Phase|Lost to Follow-up|22
7866628|NCT01633944|12357231|FG001|Open-label Titration Phase|Lost to Follow-up|0
7866629|NCT01633944|12357232|FG002|Open-label Titration Phase|Lost to Follow-up|0
7866630|NCT01633944|12357230|FG000|Open-label Titration Phase|Other|68
7866631|NCT01633944|12357231|FG001|Open-label Titration Phase|Other|0
7866632|NCT01633944|12357232|FG002|Open-label Titration Phase|Other|0
7866633|NCT01633944|12357230|FG000|Double-blind Treatment Phase|Adverse Event|0
7866634|NCT01633944|12357231|FG001|Double-blind Treatment Phase|Adverse Event|13
7866635|NCT01633944|12357232|FG002|Double-blind Treatment Phase|Adverse Event|7
7866636|NCT01633944|12357230|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
7866637|NCT01633944|12357231|FG001|Double-blind Treatment Phase|Lack of Efficacy|8
7866638|NCT01633944|12357232|FG002|Double-blind Treatment Phase|Lack of Efficacy|23
7866639|NCT01633944|12357230|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
7866640|NCT01633944|12357231|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11
7866641|NCT01633944|12357232|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8
7866642|NCT01633944|12357230|FG000|Double-blind Treatment Phase|Protocol Violation|0
7866643|NCT01633944|12357231|FG001|Double-blind Treatment Phase|Protocol Violation|7
7866644|NCT01633944|12357232|FG002|Double-blind Treatment Phase|Protocol Violation|10
7866645|NCT01633944|12357230|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
7866646|NCT01633944|12357231|FG001|Double-blind Treatment Phase|Lost to Follow-up|4
7866647|NCT01633944|12357232|FG002|Double-blind Treatment Phase|Lost to Follow-up|9
7866648|NCT01633944|12357230|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
7866649|NCT01633944|12357231|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
7866650|NCT01633944|12357232|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
7866651|NCT01633944|12357230|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0
7866652|NCT01633944|12357231|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1
7866653|NCT01633944|12357232|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0
7866654|NCT01633944|12357230|FG000|Double-blind Treatment Phase|Other|0
7866655|NCT01633944|12357231|FG001|Double-blind Treatment Phase|Other|7
7866656|NCT01633944|12357232|FG002|Double-blind Treatment Phase|Other|0
7866657|NCT01634100|12357240|FG000|Overall Study|Withdrawal by Subject|1
7866658|NCT01634100|12357241|FG001|Overall Study|Withdrawal by Subject|0
7866659|NCT01634100|12357242|FG002|Overall Study|Withdrawal by Subject|1
7866660|NCT01634100|12357243|FG003|Overall Study|Withdrawal by Subject|0
7866661|NCT01634100|12357244|FG004|Overall Study|Withdrawal by Subject|0
7866662|NCT01634100|12357245|FG005|Overall Study|Withdrawal by Subject|0
7866663|NCT01634113|12357256|FG000|Overall Study|Not treated|0
7866664|NCT01634113|12357257|FG001|Overall Study|Not treated|0
7866665|NCT01634113|12357258|FG002|Overall Study|Not treated|1
7882434|NCT01770743|12381441|FG004|Overall Study|Lost to Follow-up|1
7882435|NCT01770743|12381437|FG000|Overall Study|Sponsor Terminated Subject|1
7882436|NCT01770743|12381438|FG001|Overall Study|Sponsor Terminated Subject|0
7882437|NCT01770743|12381439|FG002|Overall Study|Sponsor Terminated Subject|0
7882438|NCT01770743|12381440|FG003|Overall Study|Sponsor Terminated Subject|1
7882439|NCT01770743|12381441|FG004|Overall Study|Sponsor Terminated Subject|0
7882440|NCT01770743|12381437|FG000|Overall Study|Moving Out of State|0
7882441|NCT01770743|12381438|FG001|Overall Study|Moving Out of State|1
7882442|NCT01770743|12381439|FG002|Overall Study|Moving Out of State|0
7882443|NCT01770743|12381440|FG003|Overall Study|Moving Out of State|0
7882444|NCT01770743|12381441|FG004|Overall Study|Moving Out of State|0
7882445|NCT01770860|12381453|FG000|Overall Study|Withdrawal by Subject|4
7882446|NCT01770860|12381453|FG000|Overall Study|Lost to Follow-up|1
7882447|NCT01770860|12381453|FG000|Overall Study|Administrative decision made by the PI|1
7882448|NCT01770912|12381463|FG000|Overall Study|Lost to Follow-up|2
7882449|NCT01770912|12381464|FG001|Overall Study|Lost to Follow-up|0
7882450|NCT01771250|12381483|FG000|Period 1|Met exclusion criteria|1
7882451|NCT01771250|12381484|FG001|Period 1|Met exclusion criteria|0
7882452|NCT01771731|12381505|FG000|Overall Study|Physician Decision|1
7882453|NCT01771731|12381506|FG001|Overall Study|Physician Decision|0
7882454|NCT01771731|12381505|FG000|Overall Study|Protocol Violation|0
7882455|NCT01771731|12381506|FG001|Overall Study|Protocol Violation|1
7882456|NCT01771731|12381505|FG000|Overall Study|Adverse event: Pain Crisis|1
7882457|NCT01771731|12381506|FG001|Overall Study|Adverse event: Pain Crisis|1
7882458|NCT01771809|12381514|FG000|Overall Study|Adverse Event|4
7882459|NCT01771809|12381515|FG001|Overall Study|Adverse Event|12
7882460|NCT01771809|12381514|FG000|Overall Study|Protocol Violation|0
7882461|NCT01771809|12381515|FG001|Overall Study|Protocol Violation|1
7882462|NCT01771809|12381514|FG000|Overall Study|Withdrawal by Subject|34
7882463|NCT01771809|12381515|FG001|Overall Study|Withdrawal by Subject|42
7882464|NCT01771809|12381514|FG000|Overall Study|Lost to Follow-up|1
7882465|NCT01771809|12381515|FG001|Overall Study|Lost to Follow-up|3
7882466|NCT01771809|12381514|FG000|Overall Study|Other (Insufficient clinical response)|22
7882467|NCT01771809|12381515|FG001|Overall Study|Other (Insufficient clinical response)|20
7882468|NCT01771809|12381514|FG000|Overall Study|Death|1
7882469|NCT01771809|12381515|FG001|Overall Study|Death|0
7882470|NCT01771809|12381514|FG000|Overall Study|Other (other)|9
7882471|NCT01771809|12381515|FG001|Overall Study|Other (other)|5
7882472|NCT01771913|12381523|FG000|Overall Study|Withdrawal by Subject|1
7882473|NCT01771913|12381524|FG001|Overall Study|Withdrawal by Subject|0
7882474|NCT01772134|12381561|FG000|Overall Study|Adverse Event|6
7882475|NCT01772134|12381562|FG001|Overall Study|Adverse Event|5
7882476|NCT01772134|12381563|FG002|Overall Study|Adverse Event|10
7882477|NCT01772134|12381561|FG000|Overall Study|Withdrew Consent|3
7882478|NCT01772134|12381562|FG001|Overall Study|Withdrew Consent|1
7866666|NCT01634139|12357269|FG000|Overall Study|Non compliant with protocol|1
7866667|NCT01634139|12357270|FG001|Overall Study|Non compliant with protocol|0
7866668|NCT01634139|12357271|FG002|Overall Study|Non compliant with protocol|0
7866669|NCT01634139|12357269|FG000|Overall Study|Consent withdrawn not due to AE|4
7866670|NCT01634139|12357270|FG001|Overall Study|Consent withdrawn not due to AE|3
7866671|NCT01634139|12357271|FG002|Overall Study|Consent withdrawn not due to AE|2
7866672|NCT01634139|12357269|FG000|Overall Study|Other|4
7866673|NCT01634139|12357270|FG001|Overall Study|Other|0
7866674|NCT01634139|12357271|FG002|Overall Study|Other|3
7866675|NCT01634139|12357269|FG000|Overall Study|Lost to Follow-up|0
7866676|NCT01634139|12357270|FG001|Overall Study|Lost to Follow-up|2
7866677|NCT01634139|12357271|FG002|Overall Study|Lost to Follow-up|0
7866678|NCT01634139|12357269|FG000|Overall Study|Not treated|1
7866679|NCT01634139|12357270|FG001|Overall Study|Not treated|1
7866680|NCT01634139|12357271|FG002|Overall Study|Not treated|0
7866681|NCT01634152|12357282|FG000|Overall Study|Adverse Event|2
7866682|NCT01634152|12357283|FG001|Overall Study|Adverse Event|0
7866683|NCT01634152|12357284|FG002|Overall Study|Adverse Event|2
7866684|NCT01634152|12357282|FG000|Overall Study|Consent withdrawn not due to AE|1
7866685|NCT01634152|12357283|FG001|Overall Study|Consent withdrawn not due to AE|0
7866686|NCT01634152|12357284|FG002|Overall Study|Consent withdrawn not due to AE|1
7866687|NCT01634152|12357282|FG000|Overall Study|Not treated|0
7866688|NCT01634152|12357283|FG001|Overall Study|Not treated|1
7866689|NCT01634152|12357284|FG002|Overall Study|Not treated|0
7866690|NCT01634152|12357282|FG000|Overall Study|Other reason not defined above|1
7866691|NCT01634152|12357283|FG001|Overall Study|Other reason not defined above|0
7866692|NCT01634152|12357284|FG002|Overall Study|Other reason not defined above|1
7866693|NCT01634165|12357292|FG000|Period 2|Adverse Event|0
7866694|NCT01634165|12357293|FG001|Period 2|Adverse Event|1
7866695|NCT01634165|12357294|FG002|Period 2|Adverse Event|0
7866696|NCT01634165|12357295|FG003|Period 2|Adverse Event|0
7866697|NCT01634178|12357305|FG000|Treatment Period 1|Adverse Event|0
7866698|NCT01634178|12357306|FG001|Treatment Period 1|Adverse Event|1
7866699|NCT01634178|12357305|FG000|Treatment Period 2|Adverse Event|1
7866700|NCT01634178|12357306|FG001|Treatment Period 2|Adverse Event|0
7866701|NCT01634243|12357337|FG000|Overall Study|Adverse Event|5
7866702|NCT01634243|12357338|FG001|Overall Study|Adverse Event|5
7866703|NCT01634243|12357337|FG000|Overall Study|Lack of Efficacy|1
7866704|NCT01634243|12357338|FG001|Overall Study|Lack of Efficacy|0
7866705|NCT01634360|12357365|FG000|Overall Study|Adverse Event|10
7866706|NCT01634360|12357366|FG001|Overall Study|Adverse Event|34
7866707|NCT01634360|12357365|FG000|Overall Study|subject withdrew consent|13
7866708|NCT01634360|12357366|FG001|Overall Study|subject withdrew consent|23
7866709|NCT01634360|12357365|FG000|Overall Study|Protocol Violation|1
7866710|NCT01634360|12357366|FG001|Overall Study|Protocol Violation|1
7866711|NCT01634360|12357365|FG000|Overall Study|Lack of Efficacy|4
7866712|NCT01634360|12357366|FG001|Overall Study|Lack of Efficacy|14
7866713|NCT01634360|12357365|FG000|Overall Study|Other|3
7866714|NCT01634360|12357366|FG001|Overall Study|Other|20
7866715|NCT01634360|12357365|FG000|Overall Study|Study termination by sponsor|18
7866716|NCT01634360|12357366|FG001|Overall Study|Study termination by sponsor|44
7866717|NCT01634555|12357372|FG000|Overall Study|Adverse Event|3
7866718|NCT01634555|12357372|FG000|Overall Study|Physician Decision|1
7866719|NCT01634659|12357388|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2
7866720|NCT01634659|12357389|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0
7866721|NCT01634659|12357388|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1
7866722|NCT01634659|12357389|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0
7866723|NCT01634854|12357397|FG000|Overall Study|Cesarean delivery|2
7866724|NCT01634854|12357398|FG001|Overall Study|Cesarean delivery|7
7866725|NCT01635153|12357435|FG000|Overall Study|Lost to Follow-up|40
7866726|NCT01635153|12357436|FG001|Overall Study|Lost to Follow-up|43
7866727|NCT01635218|12357445|FG000|Overall Study|Lost to Follow-up|3
7866728|NCT01635218|12357446|FG001|Overall Study|Lost to Follow-up|7
7866729|NCT01635218|12357447|FG002|Overall Study|Lost to Follow-up|6
7866730|NCT01635283|12357468|FG000|Overall Study|Tumor Progression|3
7866731|NCT01635283|12357468|FG000|Overall Study|Lost to Follow-up|1
7866732|NCT01635764|12357493|FG000|Overall Study|Adverse Event|46
7866733|NCT01635764|12357493|FG000|Overall Study|Lack of Efficacy|76
7866734|NCT01635764|12357493|FG000|Overall Study|Exceed Protocol-specified Interventions|2
7866735|NCT01635764|12357493|FG000|Overall Study|Protocol Deviation|1
7866736|NCT01635764|12357493|FG000|Overall Study|Withdrew Consent|67
7866737|NCT01635764|12357493|FG000|Overall Study|Lost to Follow-up|53
7866738|NCT01635764|12357493|FG000|Overall Study|Other|28
7866739|NCT01635855|12357504|FG000|Overall Study|Withdrawal by Subject|4
7866740|NCT01635920|12357514|FG000|Overall Study|Adverse Event|1
7866741|NCT01635920|12357515|FG001|Overall Study|Adverse Event|0
7866742|NCT01635920|12357514|FG000|Overall Study|Lost to Follow-up|0
7866743|NCT01635920|12357515|FG001|Overall Study|Lost to Follow-up|1
7866744|NCT01635920|12357514|FG000|Overall Study|Subject decision|2
7866745|NCT01635920|12357515|FG001|Overall Study|Subject decision|0
7866746|NCT01635933|12357524|FG000|Overall Study|Adverse Event|1
7866747|NCT01635933|12357525|FG001|Overall Study|Adverse Event|0
7866748|NCT01635933|12357524|FG000|Overall Study|Lost to Follow-up|0
7866749|NCT01635933|12357525|FG001|Overall Study|Lost to Follow-up|5
7866750|NCT01635933|12357524|FG000|Overall Study|Subject decision|1
7866751|NCT01635933|12357525|FG001|Overall Study|Subject decision|1
7866752|NCT01635933|12357524|FG000|Overall Study|Noncompliance|0
7866753|NCT01635933|12357525|FG001|Overall Study|Noncompliance|1
7866754|NCT01635933|12357524|FG000|Overall Study|No longer had transportation|0
7866755|NCT01635933|12357525|FG001|Overall Study|No longer had transportation|1
7866756|NCT01635998|12357533|FG000|Overall Study|Death|1
7866757|NCT01635998|12357534|FG001|Overall Study|Death|1
7866758|NCT01635998|12357533|FG000|Overall Study|Lost to Follow-up|2
7866759|NCT01635998|12357534|FG001|Overall Study|Lost to Follow-up|1
7866760|NCT01635998|12357533|FG000|Overall Study|Withdrawal by Subject|1
7866761|NCT01635998|12357534|FG001|Overall Study|Withdrawal by Subject|5
7866762|NCT01636076|12357551|FG000|Overall Study|Terminated by sponsor|1
7866763|NCT01636076|12357552|FG001|Overall Study|Terminated by sponsor|1
7866764|NCT01636076|12357551|FG000|Overall Study|Lack of Efficacy|0
7866765|NCT01636076|12357552|FG001|Overall Study|Lack of Efficacy|1
7866766|NCT01636076|12357551|FG000|Overall Study|Lost to Follow-up|1
7866767|NCT01636076|12357552|FG001|Overall Study|Lost to Follow-up|0
7866768|NCT01636076|12357551|FG000|Overall Study|Physician Decision|1
7866769|NCT01636076|12357552|FG001|Overall Study|Physician Decision|1
7866770|NCT01636076|12357551|FG000|Overall Study|Non-compliance with study treatment|1
7866771|NCT01636076|12357552|FG001|Overall Study|Non-compliance with study treatment|1
7866772|NCT01636076|12357551|FG000|Overall Study|Adverse Event|6
7866773|NCT01636076|12357552|FG001|Overall Study|Adverse Event|11
7866774|NCT01636076|12357551|FG000|Overall Study|Withdrawal by Subject|7
7866775|NCT01636076|12357552|FG001|Overall Study|Withdrawal by Subject|10
7866776|NCT01636362|12357603|FG000|Overall Study|Physician Decision|6
7866777|NCT01636362|12357603|FG000|Overall Study|Subject healed, not returning|1
7866778|NCT01636362|12357603|FG000|Overall Study|Withdrawal by Subject|1
7866779|NCT01636687|12357636|FG000|Induction Period|Withdrawal by Subject|1
7866780|NCT01636687|12357637|FG001|Induction Period|Withdrawal by Subject|0
7866781|NCT01636687|12357638|FG002|Induction Period|Withdrawal by Subject|0
7866782|NCT01636687|12357639|FG003|Induction Period|Withdrawal by Subject|0
7866783|NCT01636687|12357640|FG004|Induction Period|Withdrawal by Subject|0
7866784|NCT01636687|12357636|FG000|Induction Period|Adverse Event|1
7866785|NCT01636687|12357637|FG001|Induction Period|Adverse Event|0
7866786|NCT01636687|12357638|FG002|Induction Period|Adverse Event|0
7866787|NCT01636687|12357639|FG003|Induction Period|Adverse Event|0
7866788|NCT01636687|12357640|FG004|Induction Period|Adverse Event|1
7866789|NCT01636687|12357636|FG000|Induction Period|Lack of Efficacy|0
7866790|NCT01636687|12357637|FG001|Induction Period|Lack of Efficacy|0
7866791|NCT01636687|12357638|FG002|Induction Period|Lack of Efficacy|0
7866792|NCT01636687|12357639|FG003|Induction Period|Lack of Efficacy|0
7866793|NCT01636687|12357640|FG004|Induction Period|Lack of Efficacy|1
7866794|NCT01636687|12357636|FG000|Induction Period|Physician Decision|1
7866795|NCT01636687|12357637|FG001|Induction Period|Physician Decision|0
7866796|NCT01636687|12357638|FG002|Induction Period|Physician Decision|0
7866797|NCT01636687|12357639|FG003|Induction Period|Physician Decision|0
7866798|NCT01636687|12357640|FG004|Induction Period|Physician Decision|0
7866799|NCT01636687|12357636|FG000|Maintenance Period|Withdrawal by Subject|2
7866800|NCT01636687|12357637|FG001|Maintenance Period|Withdrawal by Subject|0
7866801|NCT01636687|12357638|FG002|Maintenance Period|Withdrawal by Subject|2
7866802|NCT01636687|12357639|FG003|Maintenance Period|Withdrawal by Subject|0
7866803|NCT01636687|12357640|FG004|Maintenance Period|Withdrawal by Subject|0
7866804|NCT01636687|12357636|FG000|Maintenance Period|Adverse Event|1
7866805|NCT01636687|12357637|FG001|Maintenance Period|Adverse Event|0
7866806|NCT01636687|12357638|FG002|Maintenance Period|Adverse Event|0
7866807|NCT01636687|12357639|FG003|Maintenance Period|Adverse Event|0
7866808|NCT01636687|12357640|FG004|Maintenance Period|Adverse Event|0
7866809|NCT01636687|12357636|FG000|Maintenance Period|Lack of Efficacy|4
7866810|NCT01636687|12357637|FG001|Maintenance Period|Lack of Efficacy|1
7866811|NCT01636687|12357638|FG002|Maintenance Period|Lack of Efficacy|0
7866812|NCT01636687|12357639|FG003|Maintenance Period|Lack of Efficacy|0
7866813|NCT01636687|12357640|FG004|Maintenance Period|Lack of Efficacy|0
7866814|NCT01636687|12357636|FG000|Maintenance Period|Lost to Follow-up|1
7866815|NCT01636687|12357637|FG001|Maintenance Period|Lost to Follow-up|1
7866816|NCT01636687|12357638|FG002|Maintenance Period|Lost to Follow-up|0
7866817|NCT01636687|12357639|FG003|Maintenance Period|Lost to Follow-up|0
7866818|NCT01636687|12357640|FG004|Maintenance Period|Lost to Follow-up|1
7866819|NCT01636687|12357636|FG000|Maintenance Period|Physician Decision|0
7866820|NCT01636687|12357637|FG001|Maintenance Period|Physician Decision|0
7866821|NCT01636687|12357638|FG002|Maintenance Period|Physician Decision|0
7866822|NCT01636687|12357639|FG003|Maintenance Period|Physician Decision|0
7866823|NCT01636687|12357640|FG004|Maintenance Period|Physician Decision|1
7866824|NCT01636687|12357636|FG000|Extension Period|technical problems|0
7866825|NCT01636687|12357637|FG001|Extension Period|technical problems|1
7866826|NCT01636687|12357638|FG002|Extension Period|technical problems|2
7866827|NCT01636687|12357639|FG003|Extension Period|technical problems|1
7866828|NCT01636687|12357640|FG004|Extension Period|technical problems|0
7866829|NCT01636687|12357636|FG000|Extension Period|Adverse Event|4
7866830|NCT01636687|12357637|FG001|Extension Period|Adverse Event|3
7866831|NCT01636687|12357638|FG002|Extension Period|Adverse Event|2
7866832|NCT01636687|12357639|FG003|Extension Period|Adverse Event|1
7866833|NCT01636687|12357640|FG004|Extension Period|Adverse Event|0
7866834|NCT01636687|12357636|FG000|Extension Period|Lack of Efficacy|7
7866835|NCT01636687|12357637|FG001|Extension Period|Lack of Efficacy|0
7866836|NCT01636687|12357638|FG002|Extension Period|Lack of Efficacy|2
7866837|NCT01636687|12357639|FG003|Extension Period|Lack of Efficacy|1
7866838|NCT01636687|12357640|FG004|Extension Period|Lack of Efficacy|0
7866839|NCT01636687|12357636|FG000|Extension Period|Lost to Follow-up|1
7866840|NCT01636687|12357637|FG001|Extension Period|Lost to Follow-up|0
7866841|NCT01636687|12357638|FG002|Extension Period|Lost to Follow-up|1
7866842|NCT01636687|12357639|FG003|Extension Period|Lost to Follow-up|0
7866843|NCT01636687|12357640|FG004|Extension Period|Lost to Follow-up|0
7866844|NCT01636687|12357636|FG000|Extension Period|Physician Decision|1
7866845|NCT01636687|12357637|FG001|Extension Period|Physician Decision|0
7866846|NCT01636687|12357638|FG002|Extension Period|Physician Decision|0
7866847|NCT01636687|12357639|FG003|Extension Period|Physician Decision|1
7866848|NCT01636687|12357640|FG004|Extension Period|Physician Decision|0
7866849|NCT01636687|12357636|FG000|Extension Period|study terminated by sponsor|33
7866850|NCT01636687|12357637|FG001|Extension Period|study terminated by sponsor|50
7866851|NCT01636687|12357638|FG002|Extension Period|study terminated by sponsor|17
7866852|NCT01636687|12357639|FG003|Extension Period|study terminated by sponsor|23
7866853|NCT01636687|12357640|FG004|Extension Period|study terminated by sponsor|0
7866854|NCT01636687|12357636|FG000|Extension Period|Withdrawal by Subject|1
7866855|NCT01636687|12357637|FG001|Extension Period|Withdrawal by Subject|0
7866856|NCT01636687|12357638|FG002|Extension Period|Withdrawal by Subject|1
7866857|NCT01636687|12357639|FG003|Extension Period|Withdrawal by Subject|1
7866858|NCT01636687|12357640|FG004|Extension Period|Withdrawal by Subject|0
7866859|NCT01636687|12357636|FG000|Follow-up Period|Withdrawal by Subject|1
7866860|NCT01636687|12357637|FG001|Follow-up Period|Withdrawal by Subject|0
7866861|NCT01636687|12357638|FG002|Follow-up Period|Withdrawal by Subject|0
7866862|NCT01636687|12357639|FG003|Follow-up Period|Withdrawal by Subject|0
7866863|NCT01636687|12357640|FG004|Follow-up Period|Withdrawal by Subject|1
7866864|NCT01636713|12357661|FG000|Overall Study|Adverse Event|16
7866865|NCT01636713|12357662|FG001|Overall Study|Adverse Event|16
7866866|NCT01636713|12357663|FG002|Overall Study|Adverse Event|7
7866867|NCT01636713|12357661|FG000|Overall Study|Lack of Efficacy|6
7866868|NCT01636713|12357662|FG001|Overall Study|Lack of Efficacy|6
7866869|NCT01636713|12357663|FG002|Overall Study|Lack of Efficacy|2
7866870|NCT01636713|12357661|FG000|Overall Study|Protocol Violation|3
7866871|NCT01636713|12357662|FG001|Overall Study|Protocol Violation|0
7866872|NCT01636713|12357663|FG002|Overall Study|Protocol Violation|1
7866873|NCT01636713|12357661|FG000|Overall Study|Lost to Follow-up|0
7866874|NCT01636713|12357662|FG001|Overall Study|Lost to Follow-up|0
7866875|NCT01636713|12357663|FG002|Overall Study|Lost to Follow-up|1
7866876|NCT01636713|12357661|FG000|Overall Study|Withdrawal by Subject|5
7866877|NCT01636713|12357662|FG001|Overall Study|Withdrawal by Subject|4
7866878|NCT01636713|12357663|FG002|Overall Study|Withdrawal by Subject|8
7866879|NCT01636713|12357661|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2
7866880|NCT01636713|12357662|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2
7866881|NCT01636713|12357663|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4
7866882|NCT01636778|12357675|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
7866883|NCT01636778|12357676|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
7866884|NCT01636778|12357677|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
7866885|NCT01636778|12357675|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
7866886|NCT01636778|12357676|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
7866887|NCT01636778|12357677|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
7866888|NCT01636778|12357675|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0
7866889|NCT01636778|12357676|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7
7866890|NCT01636778|12357677|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0
7623478|NCT03529773|12034559|FG012|Overall Study|Lost to Follow-up|0
7623479|NCT03529773|12034560|FG013|Overall Study|Lost to Follow-up|1
7623480|NCT03529773|12034561|FG014|Overall Study|Lost to Follow-up|4
7623481|NCT03529773|12034562|FG015|Overall Study|Lost to Follow-up|1
7623482|NCT03529773|12034563|FG016|Overall Study|Lost to Follow-up|1
7623483|NCT03529773|12034564|FG017|Overall Study|Lost to Follow-up|0
7623484|NCT03529773|12034565|FG018|Overall Study|Lost to Follow-up|1
7623485|NCT03529773|12034566|FG019|Overall Study|Lost to Follow-up|1
7623486|NCT03529773|12034567|FG020|Overall Study|Lost to Follow-up|2
7623487|NCT03529773|12034568|FG021|Overall Study|Lost to Follow-up|4
7623488|NCT03529773|12034569|FG022|Overall Study|Lost to Follow-up|3
7623489|NCT03529773|12034570|FG023|Overall Study|Lost to Follow-up|4
7623490|NCT03529773|12034571|FG024|Overall Study|Lost to Follow-up|3
7623491|NCT03529773|12034572|FG025|Overall Study|Lost to Follow-up|5
7623492|NCT03529773|12034573|FG026|Overall Study|Lost to Follow-up|5
7623493|NCT03529773|12034574|FG027|Overall Study|Lost to Follow-up|0
7623494|NCT03529773|12034575|FG028|Overall Study|Lost to Follow-up|0
7623495|NCT03529773|12034576|FG029|Overall Study|Lost to Follow-up|0
7623496|NCT03529773|12034577|FG030|Overall Study|Lost to Follow-up|1
7623497|NCT03529773|12034578|FG031|Overall Study|Lost to Follow-up|0
7623498|NCT03529773|12034579|FG032|Overall Study|Lost to Follow-up|0
7623499|NCT03529773|12034580|FG033|Overall Study|Lost to Follow-up|1
7623500|NCT03529773|12034581|FG034|Overall Study|Lost to Follow-up|1
7623501|NCT03529773|12034582|FG035|Overall Study|Lost to Follow-up|0
7623502|NCT03529773|12034583|FG036|Overall Study|Lost to Follow-up|0
7623503|NCT03529773|12034584|FG037|Overall Study|Lost to Follow-up|3
7623504|NCT03529773|12034585|FG038|Overall Study|Lost to Follow-up|1
7623505|NCT03529773|12034586|FG039|Overall Study|Lost to Follow-up|1
7623506|NCT03529773|12034547|FG000|Overall Study|No longer meets eligibility criteria|0
7623507|NCT03529773|12034548|FG001|Overall Study|No longer meets eligibility criteria|0
7623508|NCT03529773|12034549|FG002|Overall Study|No longer meets eligibility criteria|0
7623509|NCT03529773|12034550|FG003|Overall Study|No longer meets eligibility criteria|0
7623510|NCT03529773|12034551|FG004|Overall Study|No longer meets eligibility criteria|0
7623511|NCT03529773|12034552|FG005|Overall Study|No longer meets eligibility criteria|0
7623512|NCT03529773|12034553|FG006|Overall Study|No longer meets eligibility criteria|0
7623513|NCT03529773|12034554|FG007|Overall Study|No longer meets eligibility criteria|0
7623514|NCT03529773|12034555|FG008|Overall Study|No longer meets eligibility criteria|0
7623515|NCT03529773|12034556|FG009|Overall Study|No longer meets eligibility criteria|0
7623516|NCT03529773|12034557|FG010|Overall Study|No longer meets eligibility criteria|0
7623517|NCT03529773|12034558|FG011|Overall Study|No longer meets eligibility criteria|0
7623518|NCT03529773|12034559|FG012|Overall Study|No longer meets eligibility criteria|0
7623519|NCT03529773|12034560|FG013|Overall Study|No longer meets eligibility criteria|0
7623520|NCT03529773|12034561|FG014|Overall Study|No longer meets eligibility criteria|0
7623521|NCT03529773|12034562|FG015|Overall Study|No longer meets eligibility criteria|0
7623522|NCT03529773|12034563|FG016|Overall Study|No longer meets eligibility criteria|0
7623523|NCT03529773|12034564|FG017|Overall Study|No longer meets eligibility criteria|0
7792183|NCT01033487|12246462|FG004|Fourth Intervention Period|Adverse Event|0
7792184|NCT01033487|12246463|FG005|Fourth Intervention Period|Adverse Event|0
7792185|NCT01033487|12246464|FG006|Fourth Intervention Period|Adverse Event|0
7792186|NCT01033487|12246465|FG007|Fourth Intervention Period|Adverse Event|0
7792187|NCT01033487|12246466|FG008|Fourth Intervention Period|Adverse Event|1
7792188|NCT01033487|12246467|FG009|Fourth Intervention Period|Adverse Event|0
7792189|NCT01033643|12246490|FG000|Overall Study|Withdrew Consent|0
7792190|NCT01033643|12246491|FG001|Overall Study|Withdrew Consent|3
7792191|NCT01033643|12246492|FG002|Overall Study|Withdrew Consent|0
7792192|NCT01033643|12246493|FG003|Overall Study|Withdrew Consent|0
7792193|NCT01033643|12246494|FG004|Overall Study|Withdrew Consent|0
7792194|NCT01033643|12246495|FG005|Overall Study|Withdrew Consent|1
7792195|NCT01033734|12246509|FG000|Overall Study|Withdrawal by Subject|1
7792196|NCT01033747|12246524|FG000|Overall Study|Adverse Event|9
7792197|NCT01033747|12246525|FG001|Overall Study|Adverse Event|4
7792198|NCT01033747|12246524|FG000|Overall Study|Abnormal Laboratory Value|1
7792199|NCT01033747|12246525|FG001|Overall Study|Abnormal Laboratory Value|0
7792200|NCT01033747|12246524|FG000|Overall Study|Abnormal test procedure|0
7792201|NCT01033747|12246525|FG001|Overall Study|Abnormal test procedure|1
7792202|NCT01033747|12246524|FG000|Overall Study|Unsatisfactory therapeutic effect|14
7792203|NCT01033747|12246525|FG001|Overall Study|Unsatisfactory therapeutic effect|4
7792204|NCT01033747|12246524|FG000|Overall Study|Protocol Violation|1
7792205|NCT01033747|12246525|FG001|Overall Study|Protocol Violation|0
7866891|NCT01636778|12357675|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0
7866892|NCT01636778|12357676|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1
7866893|NCT01636778|12357677|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0
7866894|NCT01636778|12357675|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0
7866895|NCT01636778|12357676|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2
7866896|NCT01636778|12357677|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0
7866897|NCT01636778|12357675|FG000|Follow-up Period After Part 2|Other|0
7866898|NCT01636778|12357676|FG001|Follow-up Period After Part 2|Other|0
7866899|NCT01636778|12357677|FG002|Follow-up Period After Part 2|Other|1
7866900|NCT01636778|12357675|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
7866901|NCT01636778|12357676|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
7866902|NCT01636778|12357677|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
7866903|NCT01636778|12357675|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0
7866904|NCT01636778|12357676|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0
7866905|NCT01636778|12357677|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2
7866906|NCT01636934|12357691|FG000|Overall Study|Withdrawal by Subject|3
7866907|NCT01636934|12357692|FG001|Overall Study|Withdrawal by Subject|2
7866908|NCT01636934|12357691|FG000|Overall Study|Chemo cancel|1
7866909|NCT01636934|12357692|FG001|Overall Study|Chemo cancel|0
7866910|NCT01636934|12357691|FG000|Overall Study|Too ill to continue|1
7866911|NCT01636934|12357692|FG001|Overall Study|Too ill to continue|0
7866912|NCT01636934|12357691|FG000|Overall Study|Never started study medication|1
7866913|NCT01636934|12357692|FG001|Overall Study|Never started study medication|1
7866914|NCT01636947|12357700|FG000|Overall Study|Not Treated|2
7866915|NCT01636947|12357701|FG001|Overall Study|Not Treated|2
7866916|NCT01636947|12357700|FG000|Overall Study|Lost to Follow-up|4
7866917|NCT01636947|12357701|FG001|Overall Study|Lost to Follow-up|0
7866918|NCT01636947|12357700|FG000|Overall Study|Protocol Violation|1
7866919|NCT01636947|12357701|FG001|Overall Study|Protocol Violation|1
7866920|NCT01636947|12357700|FG000|Overall Study|Withdrawal by Subject|3
7866921|NCT01636947|12357701|FG001|Overall Study|Withdrawal by Subject|3
7866922|NCT01636947|12357700|FG000|Overall Study|Adverse Event|1
7866923|NCT01636947|12357701|FG001|Overall Study|Adverse Event|1
7866924|NCT01636947|12357700|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
7866925|NCT01636947|12357701|FG001|Overall Study|Did Not Meet Eligibility Criteria|4
7866926|NCT01636960|12357707|FG000|Induction Phase|Adverse Event|2
7866927|NCT01636960|12357707|FG000|Maintenance Phase|Continued drug after regulatory approval|3
7866928|NCT01636960|12357707|FG000|Maintenance Phase|Adverse Event|3
7866929|NCT01636960|12357707|FG000|Maintenance Phase|Progressive disease|1
7866930|NCT01636986|12357713|FG000|Overall Study|Withdrawal by Subject|0
7866931|NCT01636986|12357714|FG001|Overall Study|Withdrawal by Subject|1
7866932|NCT01636986|12357713|FG000|Overall Study|Corneal Staining|0
7866933|NCT01636986|12357714|FG001|Overall Study|Corneal Staining|1
7866934|NCT01637077|12357722|FG000|Overall Study|Cancel|1
7866935|NCT01637077|12357723|FG001|Overall Study|Cancel|1
7866936|NCT01637077|12357722|FG000|Overall Study|Withdrawal by Subject|1
7866937|NCT01637077|12357723|FG001|Overall Study|Withdrawal by Subject|0
7866938|NCT01637077|12357722|FG000|Overall Study|No cycle 1 questionnaire data|2
7866939|NCT01637077|12357723|FG001|Overall Study|No cycle 1 questionnaire data|0
7866940|NCT01637142|12357733|FG000|Washout Period (at Least 3 Days)|Physician Decision|1
7866941|NCT01637272|12357743|FG000|Overall Study|Adverse Event|6
7866942|NCT01637272|12357743|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7866943|NCT01637272|12357743|FG000|Overall Study|Withdrawal by Subject|3
7866944|NCT01637272|12357743|FG000|Overall Study|Lost to Follow-up|2
7866945|NCT01637272|12357743|FG000|Overall Study|completed core, did not enter ext. phase|4
7866946|NCT01637272|12357743|FG000|Overall Study|Administrative problems|1
7866947|NCT01637272|12357743|FG000|Overall Study|Protocol Violation|2
7866948|NCT01637402|12357762|FG000|Standard Dose Regimen|Lack of Efficacy|2
7866949|NCT01637402|12357763|FG001|Standard Dose Regimen|Lack of Efficacy|0
7866950|NCT01637402|12357762|FG000|Standard Dose Regimen|Adverse Event|1
7866951|NCT01637402|12357763|FG001|Standard Dose Regimen|Adverse Event|0
7866952|NCT01637402|12357762|FG000|Week 12 Evaluation|Lack of Efficacy|6
7866953|NCT01637402|12357763|FG001|Week 12 Evaluation|Lack of Efficacy|0
7866954|NCT01637402|12357762|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0
7866955|NCT01637402|12357763|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4
7866956|NCT01637402|12357762|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4
7866957|NCT01637402|12357763|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0
7866958|NCT01637402|12357762|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5
7866959|NCT01637402|12357763|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0
7866960|NCT01637584|12357790|FG000|Overall Study|Withdrawal by Subject|1
7866961|NCT01637584|12357791|FG001|Overall Study|Withdrawal by Subject|3
7866962|NCT01637623|12357801|FG000|Overall Study|Lost to Follow-up|0
7866963|NCT01637623|12357802|FG001|Overall Study|Lost to Follow-up|0
7866964|NCT01637623|12357803|FG002|Overall Study|Lost to Follow-up|2
7866965|NCT01637623|12357801|FG000|Overall Study|Physician Decision|1
7866966|NCT01637623|12357802|FG001|Overall Study|Physician Decision|0
7866967|NCT01637623|12357803|FG002|Overall Study|Physician Decision|1
7866968|NCT01637922|12357817|FG000|Overall Study|Adverse Event|0
7866969|NCT01637922|12357818|FG001|Overall Study|Adverse Event|1
7866970|NCT01637922|12357817|FG000|Overall Study|Protocol Violation|0
7866971|NCT01637922|12357818|FG001|Overall Study|Protocol Violation|1
7866972|NCT01637922|12357817|FG000|Overall Study|Withdrawal by Subject|0
7866973|NCT01637922|12357818|FG001|Overall Study|Withdrawal by Subject|3
7866974|NCT01637922|12357817|FG000|Overall Study|Lost to Follow-up|2
7866975|NCT01637922|12357818|FG001|Overall Study|Lost to Follow-up|0
7866976|NCT01637961|12357834|FG000|Overall Study|Ineligible: wrong primary|1
7866977|NCT01637961|12357834|FG000|Overall Study|Ineligible: inadequate pathology|1
7866978|NCT01638000|12357846|FG000|Overall Study|Randomized but Never Received Drug|7
7866979|NCT01638000|12357847|FG001|Overall Study|Randomized but Never Received Drug|10
7866980|NCT01638000|12357846|FG000|Overall Study|Adverse Event|14
7866981|NCT01638000|12357847|FG001|Overall Study|Adverse Event|16
7866982|NCT01638000|12357846|FG000|Overall Study|Lack of Efficacy|5
7866983|NCT01638000|12357847|FG001|Overall Study|Lack of Efficacy|6
7866984|NCT01638000|12357846|FG000|Overall Study|Protocol Violation|11
7866985|NCT01638000|12357847|FG001|Overall Study|Protocol Violation|13
7866986|NCT01638000|12357846|FG000|Overall Study|Withdrawal by Subject|21
7866987|NCT01638000|12357847|FG001|Overall Study|Withdrawal by Subject|24
7866988|NCT01638000|12357846|FG000|Overall Study|Miscellaneous|2
7866989|NCT01638000|12357847|FG001|Overall Study|Miscellaneous|2
7866990|NCT01638013|12357856|FG000|Overall Study|Adverse Event|36
7866991|NCT01638013|12357857|FG001|Overall Study|Adverse Event|29
7866992|NCT01638013|12357858|FG002|Overall Study|Adverse Event|48
7866993|NCT01638013|12357856|FG000|Overall Study|Lack of Efficacy|39
7866994|NCT01638013|12357857|FG001|Overall Study|Lack of Efficacy|11
7866995|NCT01638013|12357858|FG002|Overall Study|Lack of Efficacy|14
7866996|NCT01638013|12357856|FG000|Overall Study|Protocol Violation|10
7866997|NCT01638013|12357857|FG001|Overall Study|Protocol Violation|7
7866998|NCT01638013|12357858|FG002|Overall Study|Protocol Violation|11
7866999|NCT01638013|12357856|FG000|Overall Study|Met discontinuation criteria|4
7867000|NCT01638013|12357857|FG001|Overall Study|Met discontinuation criteria|0
7867001|NCT01638013|12357858|FG002|Overall Study|Met discontinuation criteria|7
7867002|NCT01638013|12357856|FG000|Overall Study|Subject Lost to Follow up|1
7867003|NCT01638013|12357857|FG001|Overall Study|Subject Lost to Follow up|0
7867004|NCT01638013|12357858|FG002|Overall Study|Subject Lost to Follow up|1
7867005|NCT01638013|12357856|FG000|Overall Study|Miscellaneous|25
7867006|NCT01638013|12357857|FG001|Overall Study|Miscellaneous|19
7867007|NCT01638013|12357858|FG002|Overall Study|Miscellaneous|23
7867008|NCT01638013|12357856|FG000|Overall Study|Withdrawal of Consent|16
7867009|NCT01638013|12357857|FG001|Overall Study|Withdrawal of Consent|12
7867010|NCT01638013|12357858|FG002|Overall Study|Withdrawal of Consent|16
7867011|NCT01638013|12357856|FG000|Overall Study|Not met inclusion or exclusion criteria|0
7867012|NCT01638013|12357857|FG001|Overall Study|Not met inclusion or exclusion criteria|0
7867013|NCT01638013|12357858|FG002|Overall Study|Not met inclusion or exclusion criteria|1
7867014|NCT01638390|12357888|FG000|Overall Study|screening failures|21
7867015|NCT01638429|12357909|FG000|Overall Study|Withdrawal by Subject|1
7867016|NCT01638546|12357929|FG000|Overall Study|Adverse Event|1
7867017|NCT01638546|12357930|FG001|Overall Study|Adverse Event|3
7867018|NCT01638559|12357938|FG000|Overall Study|Lost to Follow-up|1
7867019|NCT01638559|12357938|FG000|Overall Study|Withdrawal by Subject|1
7867020|NCT01638559|12357938|FG000|Overall Study|Subject declined to travel for biopsy|1
7867021|NCT01638819|12357955|FG000|Overall Study|Lost to Follow-up|1
7867022|NCT01638819|12357956|FG001|Overall Study|Lost to Follow-up|0
7867023|NCT01639001|12357963|FG000|Overall Study|Refused further follow-up|9
7867024|NCT01639001|12357964|FG001|Overall Study|Refused further follow-up|12
7867025|NCT01639001|12357963|FG000|Overall Study|Lost to Follow-up|3
7867026|NCT01639001|12357964|FG001|Overall Study|Lost to Follow-up|0
7867027|NCT01639001|12357963|FG000|Overall Study|Death|62
7867028|NCT01639001|12357964|FG001|Overall Study|Death|61
7867029|NCT01639001|12357963|FG000|Overall Study|Randomized but not treated|0
7867030|NCT01639001|12357964|FG001|Overall Study|Randomized but not treated|2
7867031|NCT01639001|12357963|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1
7867032|NCT01639001|12357964|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2
7867033|NCT01639040|12357974|FG000|Overall Study|Adverse Event|1
7867034|NCT01639040|12357975|FG001|Overall Study|Adverse Event|0
7867035|NCT01639144|12357986|FG000|Overall Study|Withdrawal by Subject|4
7867036|NCT01639144|12357987|FG001|Overall Study|Withdrawal by Subject|2
7867037|NCT01639144|12357986|FG000|Overall Study|Physician Decision|2
7867038|NCT01639144|12357987|FG001|Overall Study|Physician Decision|0
7867039|NCT01639144|12357986|FG000|Overall Study|Met postoperative exclusion criteria|4
7867040|NCT01639144|12357987|FG001|Overall Study|Met postoperative exclusion criteria|3
7867041|NCT01639339|12358008|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26
7867042|NCT01639339|12358009|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19
7867043|NCT01639339|12358008|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11
7867044|NCT01639339|12358009|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5
7867045|NCT01639339|12358008|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5
7867046|NCT01639339|12358009|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4
7867047|NCT01639339|12358008|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0
7867048|NCT01639339|12358009|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2
7867049|NCT01639339|12358008|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2
7867050|NCT01639339|12358009|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1
7623524|NCT03529773|12034565|FG018|Overall Study|No longer meets eligibility criteria|0
7623525|NCT03529773|12034566|FG019|Overall Study|No longer meets eligibility criteria|0
7623526|NCT03529773|12034567|FG020|Overall Study|No longer meets eligibility criteria|0
7623527|NCT03529773|12034568|FG021|Overall Study|No longer meets eligibility criteria|0
7623528|NCT03529773|12034569|FG022|Overall Study|No longer meets eligibility criteria|1
7623529|NCT03529773|12034570|FG023|Overall Study|No longer meets eligibility criteria|0
7623530|NCT03529773|12034571|FG024|Overall Study|No longer meets eligibility criteria|0
7623531|NCT03529773|12034572|FG025|Overall Study|No longer meets eligibility criteria|0
7623532|NCT03529773|12034573|FG026|Overall Study|No longer meets eligibility criteria|0
7623533|NCT03529773|12034574|FG027|Overall Study|No longer meets eligibility criteria|0
7623534|NCT03529773|12034575|FG028|Overall Study|No longer meets eligibility criteria|0
7623535|NCT03529773|12034576|FG029|Overall Study|No longer meets eligibility criteria|0
7623536|NCT03529773|12034577|FG030|Overall Study|No longer meets eligibility criteria|0
7623537|NCT03529773|12034578|FG031|Overall Study|No longer meets eligibility criteria|0
7623538|NCT03529773|12034579|FG032|Overall Study|No longer meets eligibility criteria|0
7623539|NCT03529773|12034580|FG033|Overall Study|No longer meets eligibility criteria|0
7792206|NCT01033747|12246524|FG000|Overall Study|Withdrawal by Subject|9
7792207|NCT01033747|12246525|FG001|Overall Study|Withdrawal by Subject|6
7792208|NCT01033747|12246524|FG000|Overall Study|Stopped at end of prolongation visit 1|1
7792209|NCT01033747|12246525|FG001|Overall Study|Stopped at end of prolongation visit 1|0
7792210|NCT01033747|12246524|FG000|Overall Study|Stopped at end of Extension 1|2
7792211|NCT01033747|12246525|FG001|Overall Study|Stopped at end of Extension 1|0
7792212|NCT01033825|12246542|FG000|Overall Study|Withdrawal by Subject|2
7792213|NCT01033825|12246543|FG001|Overall Study|Withdrawal by Subject|3
7792214|NCT01033825|12246544|FG002|Overall Study|Withdrawal by Subject|2
7792215|NCT01033825|12246545|FG003|Overall Study|Withdrawal by Subject|1
7792216|NCT01033825|12246546|FG004|Overall Study|Withdrawal by Subject|1
7792217|NCT01033825|12246547|FG005|Overall Study|Withdrawal by Subject|0
7792218|NCT01033825|12246548|FG006|Overall Study|Withdrawal by Subject|0
7792219|NCT01033825|12246542|FG000|Overall Study|Adverse Event|0
7792220|NCT01033825|12246543|FG001|Overall Study|Adverse Event|0
7792221|NCT01033825|12246544|FG002|Overall Study|Adverse Event|0
7792222|NCT01033825|12246545|FG003|Overall Study|Adverse Event|1
7792223|NCT01033825|12246546|FG004|Overall Study|Adverse Event|0
7792224|NCT01033825|12246547|FG005|Overall Study|Adverse Event|0
7792225|NCT01033825|12246548|FG006|Overall Study|Adverse Event|0
7792226|NCT01033825|12246542|FG000|Overall Study|Protocol Violation|1
7792227|NCT01033825|12246543|FG001|Overall Study|Protocol Violation|0
7792228|NCT01033825|12246544|FG002|Overall Study|Protocol Violation|0
7792229|NCT01033825|12246545|FG003|Overall Study|Protocol Violation|0
7792230|NCT01033825|12246546|FG004|Overall Study|Protocol Violation|0
7792231|NCT01033825|12246547|FG005|Overall Study|Protocol Violation|0
7792232|NCT01033825|12246548|FG006|Overall Study|Protocol Violation|0
7792233|NCT01033825|12246542|FG000|Overall Study|Other|0
7792234|NCT01033825|12246543|FG001|Overall Study|Other|0
7792235|NCT01033825|12246544|FG002|Overall Study|Other|0
7792236|NCT01033825|12246545|FG003|Overall Study|Other|0
7792237|NCT01033825|12246546|FG004|Overall Study|Other|1
7792238|NCT01033825|12246547|FG005|Overall Study|Other|0
7792239|NCT01033825|12246548|FG006|Overall Study|Other|0
7792240|NCT01033851|12246568|FG000|Overall Study|Withdrawal by Subject|3
7792241|NCT01033851|12246569|FG001|Overall Study|Withdrawal by Subject|7
7792242|NCT01033942|12246587|FG000|Overall Study|Withdrawal by Subject|1
7792243|NCT01033942|12246588|FG001|Overall Study|Withdrawal by Subject|1
7792244|NCT01033942|12246589|FG002|Overall Study|Withdrawal by Subject|1
7792245|NCT01033942|12246587|FG000|Overall Study|Lost to Follow-up|1
7792246|NCT01033942|12246588|FG001|Overall Study|Lost to Follow-up|0
7792247|NCT01033942|12246589|FG002|Overall Study|Lost to Follow-up|0
7792248|NCT01033942|12246587|FG000|Overall Study|Enrolled in Extension Study|0
7792249|NCT01033942|12246588|FG001|Overall Study|Enrolled in Extension Study|3
7792250|NCT01033942|12246589|FG002|Overall Study|Enrolled in Extension Study|0
7792251|NCT01034137|12246606|FG000|Overall Study|Adverse Event|9
7792252|NCT01034137|12246607|FG001|Overall Study|Adverse Event|10
7792253|NCT01034137|12246608|FG002|Overall Study|Adverse Event|8
7792254|NCT01034137|12246606|FG000|Overall Study|Withdrawal by Subject|4
7792255|NCT01034137|12246607|FG001|Overall Study|Withdrawal by Subject|3
7792256|NCT01034137|12246608|FG002|Overall Study|Withdrawal by Subject|3
7792257|NCT01034137|12246606|FG000|Overall Study|Lack of Efficacy|9
7792258|NCT01034137|12246607|FG001|Overall Study|Lack of Efficacy|4
7792259|NCT01034137|12246608|FG002|Overall Study|Lack of Efficacy|13
7792260|NCT01034137|12246606|FG000|Overall Study|Protocol Violation|2
7792261|NCT01034137|12246607|FG001|Overall Study|Protocol Violation|2
7792262|NCT01034137|12246608|FG002|Overall Study|Protocol Violation|1
7792263|NCT01034137|12246606|FG000|Overall Study|Refused treatment or did not cooperate|2
7792264|NCT01034137|12246607|FG001|Overall Study|Refused treatment or did not cooperate|0
7867051|NCT01639339|12358008|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10
7867052|NCT01639339|12358009|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7
7867053|NCT01639339|12358008|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0
7867054|NCT01639339|12358009|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2
7867055|NCT01639339|12358008|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0
7867056|NCT01639339|12358009|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1
7867057|NCT01639339|12358008|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0
7867058|NCT01639339|12358009|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1
7867059|NCT01639339|12358008|FG000|Open-label Period (Up to Week 28)|Adverse Event|1
7867060|NCT01639339|12358009|FG001|Open-label Period (Up to Week 28)|Adverse Event|4
7867061|NCT01639469|12358034|FG000|Overall Study|Death|4
7867062|NCT01639469|12358035|FG001|Overall Study|Death|2
7867063|NCT01639469|12358034|FG000|Overall Study|Lost to Follow-up|1
7867064|NCT01639469|12358035|FG001|Overall Study|Lost to Follow-up|1
7867065|NCT01639495|12358041|FG000|Overall Study|Lost to Follow-up|6
7867066|NCT01639495|12358041|FG000|Overall Study|Consented but didn't have study catheter|4
7867067|NCT01639495|12358041|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4
7867068|NCT01639495|12358041|FG000|Overall Study|No radiofrequency energy applied|2
7867069|NCT01639560|12358047|FG000|Overall Study|Withdrawal by Subject|9
7867070|NCT01639560|12358048|FG001|Overall Study|Withdrawal by Subject|14
7792265|NCT01034137|12246608|FG002|Overall Study|Refused treatment or did not cooperate|1
7792266|NCT01034137|12246606|FG000|Overall Study|Administrative or other|2
7867071|NCT01639560|12358047|FG000|Overall Study|Lack of Efficacy|1
7867072|NCT01639560|12358048|FG001|Overall Study|Lack of Efficacy|2
7623540|NCT03529773|12034581|FG034|Overall Study|No longer meets eligibility criteria|0
7623541|NCT03529773|12034582|FG035|Overall Study|No longer meets eligibility criteria|0
7623542|NCT03529773|12034583|FG036|Overall Study|No longer meets eligibility criteria|0
7623543|NCT03529773|12034584|FG037|Overall Study|No longer meets eligibility criteria|0
7623544|NCT03529773|12034585|FG038|Overall Study|No longer meets eligibility criteria|1
7623545|NCT03529773|12034586|FG039|Overall Study|No longer meets eligibility criteria|0
7623546|NCT03529773|12034547|FG000|Overall Study|Other|0
7623547|NCT03529773|12034548|FG001|Overall Study|Other|0
7623548|NCT03529773|12034549|FG002|Overall Study|Other|0
7623549|NCT03529773|12034550|FG003|Overall Study|Other|0
7623550|NCT03529773|12034551|FG004|Overall Study|Other|0
7623551|NCT03529773|12034552|FG005|Overall Study|Other|0
7623552|NCT03529773|12034553|FG006|Overall Study|Other|0
7623553|NCT03529773|12034554|FG007|Overall Study|Other|0
7623554|NCT03529773|12034555|FG008|Overall Study|Other|0
7623555|NCT03529773|12034556|FG009|Overall Study|Other|0
7623556|NCT03529773|12034557|FG010|Overall Study|Other|0
7623557|NCT03529773|12034558|FG011|Overall Study|Other|0
7623558|NCT03529773|12034559|FG012|Overall Study|Other|1
7623559|NCT03529773|12034560|FG013|Overall Study|Other|0
7623560|NCT03529773|12034561|FG014|Overall Study|Other|2
7623561|NCT03529773|12034562|FG015|Overall Study|Other|0
7623562|NCT03529773|12034563|FG016|Overall Study|Other|0
7623563|NCT03529773|12034564|FG017|Overall Study|Other|3
7623564|NCT03529773|12034565|FG018|Overall Study|Other|0
7623565|NCT03529773|12034566|FG019|Overall Study|Other|0
7623566|NCT03529773|12034567|FG020|Overall Study|Other|1
7623567|NCT03529773|12034568|FG021|Overall Study|Other|0
7623568|NCT03529773|12034569|FG022|Overall Study|Other|1
7623569|NCT03529773|12034570|FG023|Overall Study|Other|0
7623570|NCT03529773|12034571|FG024|Overall Study|Other|3
7623571|NCT03529773|12034572|FG025|Overall Study|Other|2
7623572|NCT03529773|12034573|FG026|Overall Study|Other|2
7623573|NCT03529773|12034574|FG027|Overall Study|Other|0
7623574|NCT03529773|12034575|FG028|Overall Study|Other|0
7623575|NCT03529773|12034576|FG029|Overall Study|Other|0
7623576|NCT03529773|12034577|FG030|Overall Study|Other|0
7623577|NCT03529773|12034578|FG031|Overall Study|Other|0
7623578|NCT03529773|12034579|FG032|Overall Study|Other|0
7623579|NCT03529773|12034580|FG033|Overall Study|Other|0
7623580|NCT03529773|12034581|FG034|Overall Study|Other|1
7623581|NCT03529773|12034582|FG035|Overall Study|Other|1
7623582|NCT03529773|12034583|FG036|Overall Study|Other|0
7623583|NCT03529773|12034584|FG037|Overall Study|Other|0
7623584|NCT03529773|12034585|FG038|Overall Study|Other|0
7623585|NCT03529773|12034586|FG039|Overall Study|Other|0
7623586|NCT03529773|12034547|FG000|Overall Study|Physician Decision|0
7623587|NCT03529773|12034548|FG001|Overall Study|Physician Decision|0
7623588|NCT03529773|12034549|FG002|Overall Study|Physician Decision|0
7623589|NCT03529773|12034550|FG003|Overall Study|Physician Decision|0
7623590|NCT03529773|12034551|FG004|Overall Study|Physician Decision|0
7623591|NCT03529773|12034552|FG005|Overall Study|Physician Decision|0
7623592|NCT03529773|12034553|FG006|Overall Study|Physician Decision|0
7623593|NCT03529773|12034554|FG007|Overall Study|Physician Decision|0
7867073|NCT01639560|12358047|FG000|Overall Study|Lost to Follow-up|9
7867074|NCT01639560|12358048|FG001|Overall Study|Lost to Follow-up|11
7867075|NCT01639560|12358047|FG000|Overall Study|Adverse Event|0
7867076|NCT01639560|12358048|FG001|Overall Study|Adverse Event|2
7623594|NCT03529773|12034555|FG008|Overall Study|Physician Decision|0
7623595|NCT03529773|12034556|FG009|Overall Study|Physician Decision|0
7623596|NCT03529773|12034557|FG010|Overall Study|Physician Decision|0
7623597|NCT03529773|12034558|FG011|Overall Study|Physician Decision|0
7623598|NCT03529773|12034559|FG012|Overall Study|Physician Decision|0
7623599|NCT03529773|12034560|FG013|Overall Study|Physician Decision|0
7623600|NCT03529773|12034561|FG014|Overall Study|Physician Decision|0
7867077|NCT01639703|12358077|FG000|Overall Study|Withdrawal by Subject|5
7867078|NCT01639703|12358077|FG000|Overall Study|Other reason|7
7867079|NCT01639729|12358093|FG000|Overall Study|Withdrawal by Subject|1
7867080|NCT01639729|12358094|FG001|Overall Study|Withdrawal by Subject|0
7867081|NCT01639729|12358095|FG002|Overall Study|Withdrawal by Subject|1
7867082|NCT01639729|12358096|FG003|Overall Study|Withdrawal by Subject|1
7867083|NCT01639729|12358097|FG004|Overall Study|Withdrawal by Subject|0
7867084|NCT01639729|12358098|FG005|Overall Study|Withdrawal by Subject|0
7867085|NCT01639742|12358108|FG000|Overall Study|Study Ongoing|17
7867086|NCT01639742|12358108|FG000|Overall Study|Lost to Follow-up|1
7867087|NCT01639755|12358112|FG000|Overall Study|Study Ongoing|15
7867088|NCT01639755|12358112|FG000|Overall Study|Patient had device explantation|4
7867089|NCT01639833|12358118|FG000|Overall Study|Death|4
7867090|NCT01639833|12358119|FG001|Overall Study|Death|2
7867091|NCT01639833|12358118|FG000|Overall Study|Withdrawal by Subject|2
7867092|NCT01639833|12358119|FG001|Overall Study|Withdrawal by Subject|2
7867093|NCT01640054|12358134|FG000|Overall Study|Study-specific disc criteria|1
7867094|NCT01640054|12358134|FG000|Overall Study|Lack of Efficacy|3
7867095|NCT01640054|12358134|FG000|Overall Study|Adverse Event|2
7867096|NCT01640184|12358146|FG000|Overall Study|Death|1
7867097|NCT01640184|12358147|FG001|Overall Study|Death|0
7867098|NCT01640184|12358148|FG002|Overall Study|Death|0
7867099|NCT01640184|12358146|FG000|Overall Study|Lost to Follow-up|4
7867100|NCT01640184|12358147|FG001|Overall Study|Lost to Follow-up|1
7867101|NCT01640184|12358148|FG002|Overall Study|Lost to Follow-up|0
7867102|NCT01640184|12358146|FG000|Overall Study|Physician Decision|3
7867103|NCT01640184|12358147|FG001|Overall Study|Physician Decision|0
7867104|NCT01640184|12358148|FG002|Overall Study|Physician Decision|0
7867105|NCT01640184|12358146|FG000|Overall Study|Withdrawal by Subject|0
7867106|NCT01640184|12358147|FG001|Overall Study|Withdrawal by Subject|1
7867107|NCT01640184|12358148|FG002|Overall Study|Withdrawal by Subject|1
7867108|NCT01640184|12358146|FG000|Overall Study|Protocol Violation|0
7867109|NCT01640184|12358147|FG001|Overall Study|Protocol Violation|0
7867110|NCT01640184|12358148|FG002|Overall Study|Protocol Violation|1
7867111|NCT01640249|12358175|FG000|Period 1|Withdrawal by Subject|1
7867112|NCT01640249|12358176|FG001|Period 1|Withdrawal by Subject|0
7867113|NCT01640249|12358177|FG002|Period 1|Withdrawal by Subject|0
7867114|NCT01640249|12358178|FG003|Period 1|Withdrawal by Subject|0
7867115|NCT01640249|12358179|FG004|Period 1|Withdrawal by Subject|0
7867116|NCT01640249|12358180|FG005|Period 1|Withdrawal by Subject|1
7867117|NCT01640249|12358181|FG006|Period 1|Withdrawal by Subject|0
7867118|NCT01640288|12358202|FG000|Overall Study|Equipment Failure or Poor Image Quality|4
7867119|NCT01640288|12358203|FG001|Overall Study|Equipment Failure or Poor Image Quality|5
7867120|NCT01640288|12358202|FG000|Overall Study|Screen Failure|20
7867121|NCT01640288|12358203|FG001|Overall Study|Screen Failure|18
7867122|NCT01640288|12358202|FG000|Overall Study|Withdrawn by PI|5
7867123|NCT01640288|12358203|FG001|Overall Study|Withdrawn by PI|0
7867124|NCT01640288|12358202|FG000|Overall Study|Withdrawal by Subject|1
7867125|NCT01640288|12358203|FG001|Overall Study|Withdrawal by Subject|0
7867126|NCT01640314|12358212|FG000|Overall Study|Protocol Violation|0
7867127|NCT01640314|12358213|FG001|Overall Study|Protocol Violation|1
7867128|NCT01640353|12358237|FG000|Overall Study|Withdrew prior to treatment|10
7867129|NCT01640353|12358237|FG000|Overall Study|Withdrawn from analysis at term site|12
7867130|NCT01640353|12358237|FG000|Overall Study|Withdrawal by Subject|5
7867131|NCT01640353|12358237|FG000|Overall Study|Death|2
7867132|NCT01640353|12358237|FG000|Overall Study|Early site termination|3
7867133|NCT01640353|12358237|FG000|Overall Study|Lost to Follow-up|12
7867134|NCT01640353|12358237|FG000|Overall Study|Physician Decision|1
7867135|NCT01640366|12358241|FG000|Overall Study|Withdrawal by Subject|1
7867136|NCT01640366|12358241|FG000|Overall Study|Protocol Violation|16
7867137|NCT01640366|12358241|FG000|Overall Study|Lost to Follow-up|5
7882479|NCT01772134|12381563|FG002|Overall Study|Withdrew Consent|5
7882480|NCT01772134|12381561|FG000|Overall Study|Lost to Follow-up|2
7882481|NCT01772134|12381562|FG001|Overall Study|Lost to Follow-up|0
7882482|NCT01772134|12381563|FG002|Overall Study|Lost to Follow-up|0
7882483|NCT01772134|12381561|FG000|Overall Study|Protocol Deviation|4
7882484|NCT01772134|12381562|FG001|Overall Study|Protocol Deviation|3
7882485|NCT01772134|12381563|FG002|Overall Study|Protocol Deviation|3
7882486|NCT01772134|12381561|FG000|Overall Study|Lack of Efficacy|11
7882487|NCT01772134|12381562|FG001|Overall Study|Lack of Efficacy|5
7882488|NCT01772134|12381563|FG002|Overall Study|Lack of Efficacy|3
7882489|NCT01772134|12381561|FG000|Overall Study|Protocol-defined Stopping Criteria|1
7882490|NCT01772134|12381562|FG001|Overall Study|Protocol-defined Stopping Criteria|0
7882491|NCT01772134|12381563|FG002|Overall Study|Protocol-defined Stopping Criteria|0
7882492|NCT01772134|12381561|FG000|Overall Study|Randomized Study Medication Not Received|2
7882493|NCT01772134|12381562|FG001|Overall Study|Randomized Study Medication Not Received|0
7882494|NCT01772134|12381563|FG002|Overall Study|Randomized Study Medication Not Received|1
7882495|NCT01772147|12381574|FG000|Overall Study|Adverse Event|13
7882496|NCT01772147|12381575|FG001|Overall Study|Adverse Event|10
7882497|NCT01772147|12381576|FG002|Overall Study|Adverse Event|6
7882498|NCT01772147|12381574|FG000|Overall Study|Withdrew Consent|7
7882499|NCT01772147|12381575|FG001|Overall Study|Withdrew Consent|8
7882500|NCT01772147|12381576|FG002|Overall Study|Withdrew Consent|4
7882501|NCT01772147|12381574|FG000|Overall Study|Lost to Follow-up|1
7882502|NCT01772147|12381575|FG001|Overall Study|Lost to Follow-up|0
7882503|NCT01772147|12381576|FG002|Overall Study|Lost to Follow-up|1
7882504|NCT01772147|12381574|FG000|Overall Study|Protocol Deviation|2
7882505|NCT01772147|12381575|FG001|Overall Study|Protocol Deviation|1
7882506|NCT01772147|12381576|FG002|Overall Study|Protocol Deviation|1
7882507|NCT01772147|12381574|FG000|Overall Study|Lack of Efficacy|8
7882508|NCT01772147|12381575|FG001|Overall Study|Lack of Efficacy|6
7882509|NCT01772147|12381576|FG002|Overall Study|Lack of Efficacy|6
7882510|NCT01772160|12381584|FG000|Overall Study|Death|3
7882511|NCT01772160|12381584|FG000|Overall Study|Eligibility criteria not fulfilled|3
7882512|NCT01772160|12381584|FG000|Overall Study|Consent withdrawal|3
7882513|NCT01772160|12381584|FG000|Overall Study|Migrated / moved from the study area|4
7882514|NCT01772160|12381584|FG000|Overall Study|Lost to Follow-up|30
7882515|NCT01772160|12381584|FG000|Overall Study|Other|5
7882516|NCT01772316|12381588|FG000|Overall Study|Serious adverse event|1
7882517|NCT01772316|12381588|FG000|Overall Study|Inform consent withdrawn|1
7882518|NCT01772316|12381588|FG000|Overall Study|Withdrawn by sponsor decision|5
7882519|NCT01772368|12381592|FG000|Overall Study|Adverse Event|1
7882520|NCT01772368|12381592|FG000|Overall Study|Withdrawal by Subject|3
7882521|NCT01772368|12381592|FG000|Overall Study|Protocol Violation|2
7882522|NCT01772368|12381592|FG000|Overall Study|Other|1
7882523|NCT01772537|12381611|FG000|Overall Study|unsuccessful lumbar drain placement|1
7882524|NCT01772537|12381612|FG001|Overall Study|unsuccessful lumbar drain placement|0
7867138|NCT01640808|12358263|FG000|Overall Study|Unable to continue dynamic CT|14
7867139|NCT01640808|12358264|FG001|Overall Study|Unable to continue dynamic CT|4
7867140|NCT01640808|12358263|FG000|Overall Study|Withdrawal by Subject|12
7867141|NCT01640808|12358264|FG001|Overall Study|Withdrawal by Subject|4
7867142|NCT01640808|12358263|FG000|Overall Study|Lost to Follow-up|4
7867143|NCT01640808|12358264|FG001|Overall Study|Lost to Follow-up|0
7867144|NCT01640808|12358263|FG000|Overall Study|Start an antiviral therapy using IFN|3
7867145|NCT01640808|12358264|FG001|Overall Study|Start an antiviral therapy using IFN|0
7867146|NCT01640808|12358263|FG000|Overall Study|Administration of anticancer drugs|2
7867147|NCT01640808|12358264|FG001|Overall Study|Administration of anticancer drugs|1
7867148|NCT01640808|12358263|FG000|Overall Study|Physician Decision|19
7867149|NCT01640808|12358264|FG001|Overall Study|Physician Decision|5
7867150|NCT01640808|12358263|FG000|Overall Study|Randomized but not treated|4
7867151|NCT01640808|12358264|FG001|Overall Study|Randomized but not treated|2
7867152|NCT01640873|12358287|FG000|Overall Study|Protocol Violation|2
7867153|NCT01640873|12358288|FG001|Overall Study|Protocol Violation|1
7867154|NCT01640925|12358296|FG000|Overall Study|Withdrawal by Subject|1
7867155|NCT01640925|12358297|FG001|Overall Study|Withdrawal by Subject|0
7867156|NCT01640925|12358296|FG000|Overall Study|Previously enrolled in this trial|13
7867157|NCT01640925|12358297|FG001|Overall Study|Previously enrolled in this trial|11
7867158|NCT01640951|12358311|FG000|Overall Study|Adverse Event|8
7867159|NCT01640951|12358312|FG001|Overall Study|Adverse Event|3
7867160|NCT01640951|12358313|FG002|Overall Study|Adverse Event|10
7867161|NCT01640951|12358314|FG003|Overall Study|Adverse Event|6
7867162|NCT01640951|12358315|FG004|Overall Study|Adverse Event|1
7867163|NCT01640951|12358316|FG005|Overall Study|Adverse Event|11
7867164|NCT01640951|12358317|FG006|Overall Study|Adverse Event|1
7867165|NCT01640951|12358318|FG007|Overall Study|Adverse Event|3
7867166|NCT01640951|12358311|FG000|Overall Study|Lack of Efficacy|20
7867167|NCT01640951|12358312|FG001|Overall Study|Lack of Efficacy|1
7867168|NCT01640951|12358313|FG002|Overall Study|Lack of Efficacy|7
7867169|NCT01640951|12358314|FG003|Overall Study|Lack of Efficacy|14
7867170|NCT01640951|12358315|FG004|Overall Study|Lack of Efficacy|0
7867171|NCT01640951|12358316|FG005|Overall Study|Lack of Efficacy|6
7867172|NCT01640951|12358317|FG006|Overall Study|Lack of Efficacy|5
7867173|NCT01640951|12358318|FG007|Overall Study|Lack of Efficacy|6
7867174|NCT01640951|12358311|FG000|Overall Study|Lost to Follow-up|1
7867175|NCT01640951|12358312|FG001|Overall Study|Lost to Follow-up|0
7867176|NCT01640951|12358313|FG002|Overall Study|Lost to Follow-up|6
7867177|NCT01640951|12358314|FG003|Overall Study|Lost to Follow-up|2
7867178|NCT01640951|12358315|FG004|Overall Study|Lost to Follow-up|2
7867179|NCT01640951|12358316|FG005|Overall Study|Lost to Follow-up|3
7867180|NCT01640951|12358317|FG006|Overall Study|Lost to Follow-up|1
7867181|NCT01640951|12358318|FG007|Overall Study|Lost to Follow-up|1
7867182|NCT01640951|12358311|FG000|Overall Study|Non-compliance with study treatment|0
7867183|NCT01640951|12358312|FG001|Overall Study|Non-compliance with study treatment|0
7867184|NCT01640951|12358313|FG002|Overall Study|Non-compliance with study treatment|1
7867185|NCT01640951|12358314|FG003|Overall Study|Non-compliance with study treatment|1
7867186|NCT01640951|12358315|FG004|Overall Study|Non-compliance with study treatment|1
7867187|NCT01640951|12358316|FG005|Overall Study|Non-compliance with study treatment|4
7867188|NCT01640951|12358317|FG006|Overall Study|Non-compliance with study treatment|1
7867189|NCT01640951|12358318|FG007|Overall Study|Non-compliance with study treatment|0
7867190|NCT01640951|12358311|FG000|Overall Study|Physician Decision|2
7867191|NCT01640951|12358312|FG001|Overall Study|Physician Decision|5
7867192|NCT01640951|12358313|FG002|Overall Study|Physician Decision|2
7867193|NCT01640951|12358314|FG003|Overall Study|Physician Decision|2
7867194|NCT01640951|12358315|FG004|Overall Study|Physician Decision|2
7867195|NCT01640951|12358316|FG005|Overall Study|Physician Decision|3
7867196|NCT01640951|12358317|FG006|Overall Study|Physician Decision|3
7867197|NCT01640951|12358318|FG007|Overall Study|Physician Decision|0
7867198|NCT01640951|12358311|FG000|Overall Study|Pregnancy|3
7867199|NCT01640951|12358312|FG001|Overall Study|Pregnancy|0
7867200|NCT01640951|12358313|FG002|Overall Study|Pregnancy|0
7867201|NCT01640951|12358314|FG003|Overall Study|Pregnancy|4
7867202|NCT01640951|12358315|FG004|Overall Study|Pregnancy|0
7867203|NCT01640951|12358316|FG005|Overall Study|Pregnancy|0
7867204|NCT01640951|12358317|FG006|Overall Study|Pregnancy|2
7867205|NCT01640951|12358318|FG007|Overall Study|Pregnancy|0
7867206|NCT01640951|12358311|FG000|Overall Study|Protocol Deviation|0
7867207|NCT01640951|12358312|FG001|Overall Study|Protocol Deviation|1
7867208|NCT01640951|12358313|FG002|Overall Study|Protocol Deviation|2
7867209|NCT01640951|12358314|FG003|Overall Study|Protocol Deviation|1
7867210|NCT01640951|12358315|FG004|Overall Study|Protocol Deviation|0
7867211|NCT01640951|12358316|FG005|Overall Study|Protocol Deviation|1
7867212|NCT01640951|12358317|FG006|Overall Study|Protocol Deviation|0
7867213|NCT01640951|12358318|FG007|Overall Study|Protocol Deviation|0
7867214|NCT01640951|12358311|FG000|Overall Study|Subject/Guardian decision|12
7867215|NCT01640951|12358312|FG001|Overall Study|Subject/Guardian decision|4
7867216|NCT01640951|12358313|FG002|Overall Study|Subject/Guardian decision|13
7867217|NCT01640951|12358314|FG003|Overall Study|Subject/Guardian decision|15
7867218|NCT01640951|12358315|FG004|Overall Study|Subject/Guardian decision|7
7867219|NCT01640951|12358316|FG005|Overall Study|Subject/Guardian decision|19
7867220|NCT01640951|12358317|FG006|Overall Study|Subject/Guardian decision|5
7867221|NCT01640951|12358318|FG007|Overall Study|Subject/Guardian decision|4
7867222|NCT01640951|12358311|FG000|Overall Study|Death|0
7867223|NCT01640951|12358312|FG001|Overall Study|Death|1
7867224|NCT01640951|12358313|FG002|Overall Study|Death|1
7867225|NCT01640951|12358314|FG003|Overall Study|Death|0
7867226|NCT01640951|12358315|FG004|Overall Study|Death|0
7867227|NCT01640951|12358316|FG005|Overall Study|Death|0
7867228|NCT01640951|12358317|FG006|Overall Study|Death|0
7867229|NCT01640951|12358318|FG007|Overall Study|Death|2
7867230|NCT01640964|12358341|FG000|Overall Study|Lost to Follow-up|0
7867231|NCT01640964|12358342|FG001|Overall Study|Lost to Follow-up|0
7867232|NCT01640964|12358343|FG002|Overall Study|Lost to Follow-up|1
7867233|NCT01640964|12358341|FG000|Overall Study|Protocol Deviation|1
7867234|NCT01640964|12358342|FG001|Overall Study|Protocol Deviation|1
7867235|NCT01640964|12358343|FG002|Overall Study|Protocol Deviation|2
7867236|NCT01641081|12358361|FG000|Period 1|Sponsor request (potential unblinding)|0
7867237|NCT01641081|12358362|FG001|Period 1|Sponsor request (potential unblinding)|0
7867238|NCT01641081|12358363|FG002|Period 1|Sponsor request (potential unblinding)|0
7867239|NCT01641081|12358364|FG003|Period 1|Sponsor request (potential unblinding)|0
7867240|NCT01641081|12358365|FG004|Period 1|Sponsor request (potential unblinding)|0
7867241|NCT01641081|12358366|FG005|Period 1|Sponsor request (potential unblinding)|0
7867242|NCT01641081|12358367|FG006|Period 1|Sponsor request (potential unblinding)|1
7867243|NCT01641081|12358368|FG007|Period 1|Sponsor request (potential unblinding)|0
7867244|NCT01641081|12358369|FG008|Period 1|Sponsor request (potential unblinding)|0
7867245|NCT01641081|12358370|FG009|Period 1|Sponsor request (potential unblinding)|0
7867246|NCT01641081|12358361|FG000|Period 1|Protocol Violation|0
7867247|NCT01641081|12358362|FG001|Period 1|Protocol Violation|0
7867248|NCT01641081|12358363|FG002|Period 1|Protocol Violation|0
7867249|NCT01641081|12358364|FG003|Period 1|Protocol Violation|0
7867250|NCT01641081|12358365|FG004|Period 1|Protocol Violation|1
7867251|NCT01641081|12358366|FG005|Period 1|Protocol Violation|0
7867252|NCT01641081|12358367|FG006|Period 1|Protocol Violation|0
7867253|NCT01641081|12358368|FG007|Period 1|Protocol Violation|1
7867254|NCT01641081|12358369|FG008|Period 1|Protocol Violation|0
7867255|NCT01641081|12358370|FG009|Period 1|Protocol Violation|0
7867256|NCT01641081|12358361|FG000|Period 1|Adverse Event|1
7867257|NCT01641081|12358362|FG001|Period 1|Adverse Event|0
7867258|NCT01641081|12358363|FG002|Period 1|Adverse Event|0
7867259|NCT01641081|12358364|FG003|Period 1|Adverse Event|0
7867260|NCT01641081|12358365|FG004|Period 1|Adverse Event|0
7867261|NCT01641081|12358366|FG005|Period 1|Adverse Event|0
7867262|NCT01641081|12358367|FG006|Period 1|Adverse Event|0
7867263|NCT01641081|12358368|FG007|Period 1|Adverse Event|2
7867264|NCT01641081|12358369|FG008|Period 1|Adverse Event|0
7867265|NCT01641081|12358370|FG009|Period 1|Adverse Event|0
7867266|NCT01641081|12358361|FG000|Period 2|Adverse Event|0
7867267|NCT01641081|12358362|FG001|Period 2|Adverse Event|0
7867268|NCT01641081|12358363|FG002|Period 2|Adverse Event|0
7867269|NCT01641081|12358364|FG003|Period 2|Adverse Event|0
7867270|NCT01641081|12358365|FG004|Period 2|Adverse Event|0
7867271|NCT01641081|12358366|FG005|Period 2|Adverse Event|1
7867272|NCT01641081|12358367|FG006|Period 2|Adverse Event|0
7867273|NCT01641081|12358368|FG007|Period 2|Adverse Event|0
7867274|NCT01641081|12358369|FG008|Period 2|Adverse Event|0
7867275|NCT01641081|12358370|FG009|Period 2|Adverse Event|0
7867276|NCT01641081|12358361|FG000|Period 2|Withdrawal by Subject|0
7867277|NCT01641081|12358362|FG001|Period 2|Withdrawal by Subject|0
7867278|NCT01641081|12358363|FG002|Period 2|Withdrawal by Subject|0
7867279|NCT01641081|12358364|FG003|Period 2|Withdrawal by Subject|1
7867280|NCT01641081|12358365|FG004|Period 2|Withdrawal by Subject|0
7867281|NCT01641081|12358366|FG005|Period 2|Withdrawal by Subject|0
7867282|NCT01641081|12358367|FG006|Period 2|Withdrawal by Subject|2
7867283|NCT01641081|12358368|FG007|Period 2|Withdrawal by Subject|0
7867284|NCT01641081|12358369|FG008|Period 2|Withdrawal by Subject|0
7867285|NCT01641081|12358370|FG009|Period 2|Withdrawal by Subject|0
7867286|NCT01641081|12358361|FG000|Period 2|Protocol Violation|1
7867287|NCT01641081|12358362|FG001|Period 2|Protocol Violation|0
7867288|NCT01641081|12358363|FG002|Period 2|Protocol Violation|0
7867289|NCT01641081|12358364|FG003|Period 2|Protocol Violation|0
7867290|NCT01641081|12358365|FG004|Period 2|Protocol Violation|0
7867291|NCT01641081|12358366|FG005|Period 2|Protocol Violation|0
7867292|NCT01641081|12358367|FG006|Period 2|Protocol Violation|0
7867293|NCT01641081|12358368|FG007|Period 2|Protocol Violation|0
7867294|NCT01641081|12358369|FG008|Period 2|Protocol Violation|0
7867295|NCT01641081|12358370|FG009|Period 2|Protocol Violation|0
7867296|NCT01641081|12358361|FG000|Period 3|Adverse Event|0
7867297|NCT01641081|12358362|FG001|Period 3|Adverse Event|0
7867298|NCT01641081|12358363|FG002|Period 3|Adverse Event|1
7867299|NCT01641081|12358364|FG003|Period 3|Adverse Event|0
7867300|NCT01641081|12358365|FG004|Period 3|Adverse Event|0
7867301|NCT01641081|12358366|FG005|Period 3|Adverse Event|0
7867302|NCT01641081|12358367|FG006|Period 3|Adverse Event|0
7867303|NCT01641081|12358368|FG007|Period 3|Adverse Event|0
7867304|NCT01641081|12358369|FG008|Period 3|Adverse Event|0
7867305|NCT01641081|12358370|FG009|Period 3|Adverse Event|0
7867306|NCT01641081|12358361|FG000|Period 3|Withdrawal by Subject|0
7623601|NCT03529773|12034562|FG015|Overall Study|Physician Decision|0
7867307|NCT01641081|12358362|FG001|Period 3|Withdrawal by Subject|0
7867308|NCT01641081|12358363|FG002|Period 3|Withdrawal by Subject|0
7867309|NCT01641081|12358364|FG003|Period 3|Withdrawal by Subject|0
7867310|NCT01641081|12358365|FG004|Period 3|Withdrawal by Subject|0
7867311|NCT01641081|12358366|FG005|Period 3|Withdrawal by Subject|0
7623602|NCT03529773|12034563|FG016|Overall Study|Physician Decision|0
7623603|NCT03529773|12034564|FG017|Overall Study|Physician Decision|0
7623604|NCT03529773|12034565|FG018|Overall Study|Physician Decision|0
7623605|NCT03529773|12034566|FG019|Overall Study|Physician Decision|1
7623606|NCT03529773|12034567|FG020|Overall Study|Physician Decision|1
7623607|NCT03529773|12034568|FG021|Overall Study|Physician Decision|0
7623608|NCT03529773|12034569|FG022|Overall Study|Physician Decision|0
7623609|NCT03529773|12034570|FG023|Overall Study|Physician Decision|0
7623610|NCT03529773|12034571|FG024|Overall Study|Physician Decision|0
7623611|NCT03529773|12034572|FG025|Overall Study|Physician Decision|0
7623612|NCT03529773|12034573|FG026|Overall Study|Physician Decision|0
7623613|NCT03529773|12034574|FG027|Overall Study|Physician Decision|0
7623614|NCT03529773|12034575|FG028|Overall Study|Physician Decision|0
7623615|NCT03529773|12034576|FG029|Overall Study|Physician Decision|0
7623616|NCT03529773|12034577|FG030|Overall Study|Physician Decision|0
7623617|NCT03529773|12034578|FG031|Overall Study|Physician Decision|0
7623618|NCT03529773|12034579|FG032|Overall Study|Physician Decision|0
7623619|NCT03529773|12034580|FG033|Overall Study|Physician Decision|0
7623620|NCT03529773|12034581|FG034|Overall Study|Physician Decision|0
7623621|NCT03529773|12034582|FG035|Overall Study|Physician Decision|0
7623622|NCT03529773|12034583|FG036|Overall Study|Physician Decision|0
7623623|NCT03529773|12034584|FG037|Overall Study|Physician Decision|0
7623624|NCT03529773|12034585|FG038|Overall Study|Physician Decision|0
7623625|NCT03529773|12034586|FG039|Overall Study|Physician Decision|0
7623626|NCT03529773|12034547|FG000|Overall Study|Protocol Violation|0
7623627|NCT03529773|12034548|FG001|Overall Study|Protocol Violation|0
7623628|NCT03529773|12034549|FG002|Overall Study|Protocol Violation|0
7623629|NCT03529773|12034550|FG003|Overall Study|Protocol Violation|0
7623630|NCT03529773|12034551|FG004|Overall Study|Protocol Violation|0
7623631|NCT03529773|12034552|FG005|Overall Study|Protocol Violation|0
7623632|NCT03529773|12034553|FG006|Overall Study|Protocol Violation|0
7623633|NCT03529773|12034554|FG007|Overall Study|Protocol Violation|0
7623634|NCT03529773|12034555|FG008|Overall Study|Protocol Violation|0
7623635|NCT03529773|12034556|FG009|Overall Study|Protocol Violation|0
7623636|NCT03529773|12034557|FG010|Overall Study|Protocol Violation|0
7623637|NCT03529773|12034558|FG011|Overall Study|Protocol Violation|0
7623638|NCT03529773|12034559|FG012|Overall Study|Protocol Violation|0
7623639|NCT03529773|12034560|FG013|Overall Study|Protocol Violation|0
7623640|NCT03529773|12034561|FG014|Overall Study|Protocol Violation|0
7623641|NCT03529773|12034562|FG015|Overall Study|Protocol Violation|0
7623642|NCT03529773|12034563|FG016|Overall Study|Protocol Violation|0
7623643|NCT03529773|12034564|FG017|Overall Study|Protocol Violation|0
7623644|NCT03529773|12034565|FG018|Overall Study|Protocol Violation|0
7623645|NCT03529773|12034566|FG019|Overall Study|Protocol Violation|0
7623646|NCT03529773|12034567|FG020|Overall Study|Protocol Violation|0
7623647|NCT03529773|12034568|FG021|Overall Study|Protocol Violation|0
7623648|NCT03529773|12034569|FG022|Overall Study|Protocol Violation|0
7623649|NCT03529773|12034570|FG023|Overall Study|Protocol Violation|0
7623650|NCT03529773|12034571|FG024|Overall Study|Protocol Violation|0
7623651|NCT03529773|12034572|FG025|Overall Study|Protocol Violation|0
7623652|NCT03529773|12034573|FG026|Overall Study|Protocol Violation|0
7623653|NCT03529773|12034574|FG027|Overall Study|Protocol Violation|0
7867312|NCT01641081|12358367|FG006|Period 3|Withdrawal by Subject|0
7867313|NCT01641081|12358368|FG007|Period 3|Withdrawal by Subject|0
7867314|NCT01641081|12358369|FG008|Period 3|Withdrawal by Subject|1
7867315|NCT01641081|12358370|FG009|Period 3|Withdrawal by Subject|0
7867316|NCT01641081|12358361|FG000|Period 4|Adverse Event|0
7867317|NCT01641081|12358362|FG001|Period 4|Adverse Event|1
7623654|NCT03529773|12034575|FG028|Overall Study|Protocol Violation|0
7623655|NCT03529773|12034576|FG029|Overall Study|Protocol Violation|0
7623656|NCT03529773|12034577|FG030|Overall Study|Protocol Violation|1
7623657|NCT03529773|12034578|FG031|Overall Study|Protocol Violation|0
7623658|NCT03529773|12034579|FG032|Overall Study|Protocol Violation|0
7623659|NCT03529773|12034580|FG033|Overall Study|Protocol Violation|0
7867318|NCT01641081|12358363|FG002|Period 4|Adverse Event|0
7867319|NCT01641081|12358364|FG003|Period 4|Adverse Event|1
7867320|NCT01641081|12358365|FG004|Period 4|Adverse Event|0
7867321|NCT01641081|12358366|FG005|Period 4|Adverse Event|0
7867322|NCT01641081|12358367|FG006|Period 4|Adverse Event|0
7867323|NCT01641081|12358368|FG007|Period 4|Adverse Event|0
7867324|NCT01641081|12358369|FG008|Period 4|Adverse Event|0
7867325|NCT01641081|12358370|FG009|Period 4|Adverse Event|0
7867326|NCT01641081|12358361|FG000|Period 5|Adverse Event|0
7867327|NCT01641081|12358362|FG001|Period 5|Adverse Event|0
7867328|NCT01641081|12358363|FG002|Period 5|Adverse Event|2
7867329|NCT01641081|12358364|FG003|Period 5|Adverse Event|0
7867330|NCT01641081|12358365|FG004|Period 5|Adverse Event|0
7867331|NCT01641081|12358366|FG005|Period 5|Adverse Event|0
7867332|NCT01641081|12358367|FG006|Period 5|Adverse Event|0
7867333|NCT01641081|12358368|FG007|Period 5|Adverse Event|0
7867334|NCT01641081|12358369|FG008|Period 5|Adverse Event|0
7867335|NCT01641081|12358370|FG009|Period 5|Adverse Event|0
7867336|NCT01641133|12358392|FG000|Overall Study|Protocol Violation|0
7867337|NCT01641133|12358393|FG001|Overall Study|Protocol Violation|1
7867338|NCT01641133|12358394|FG002|Overall Study|Protocol Violation|1
7867339|NCT01641133|12358392|FG000|Overall Study|Migrated/moved from study area|5
7867340|NCT01641133|12358393|FG001|Overall Study|Migrated/moved from study area|3
7867341|NCT01641133|12358394|FG002|Overall Study|Migrated/moved from study area|1
7867342|NCT01641133|12358392|FG000|Overall Study|Adverse Event|0
7867343|NCT01641133|12358393|FG001|Overall Study|Adverse Event|0
7867344|NCT01641133|12358394|FG002|Overall Study|Adverse Event|1
7867345|NCT01641133|12358392|FG000|Overall Study|Withdrawal by Subject|5
7867346|NCT01641133|12358393|FG001|Overall Study|Withdrawal by Subject|3
7867347|NCT01641133|12358394|FG002|Overall Study|Withdrawal by Subject|3
7867348|NCT01641133|12358392|FG000|Overall Study|Lost to Follow-up|0
7867349|NCT01641133|12358393|FG001|Overall Study|Lost to Follow-up|2
7867350|NCT01641133|12358394|FG002|Overall Study|Lost to Follow-up|2
7867351|NCT01641159|12358404|FG000|Overall Study|Lost to Follow-up|2
7867352|NCT01641159|12358405|FG001|Overall Study|Lost to Follow-up|1
7867353|NCT01641159|12358404|FG000|Overall Study|Withdrawal by Subject|0
7867354|NCT01641159|12358405|FG001|Overall Study|Withdrawal by Subject|1
7867355|NCT01641198|12358414|FG000|After 12 Months of Function|Lost to Follow-up|3
7867356|NCT01641198|12358415|FG001|After 12 Months of Function|Lost to Follow-up|2
7867357|NCT01641198|12358416|FG002|After 12 Months of Function|Lost to Follow-up|2
7867358|NCT01641198|12358414|FG000|After 12 Months of Function|Protocol Violation|1
7867359|NCT01641198|12358415|FG001|After 12 Months of Function|Protocol Violation|0
7867360|NCT01641198|12358416|FG002|After 12 Months of Function|Protocol Violation|0
7867361|NCT01641198|12358414|FG000|After 12 Months of Function|Adverse Event|0
7867362|NCT01641198|12358415|FG001|After 12 Months of Function|Adverse Event|1
7867363|NCT01641198|12358416|FG002|After 12 Months of Function|Adverse Event|0
7867364|NCT01641198|12358414|FG000|After 24 Months of Function|Lost to Follow-up|4
7867365|NCT01641198|12358415|FG001|After 24 Months of Function|Lost to Follow-up|9
7867366|NCT01641198|12358416|FG002|After 24 Months of Function|Lost to Follow-up|6
7867367|NCT01641198|12358414|FG000|At 15-20 Years of Function|Lost to Follow-up|5
7867368|NCT01641198|12358415|FG001|At 15-20 Years of Function|Lost to Follow-up|1
7867369|NCT01641198|12358416|FG002|At 15-20 Years of Function|Lost to Follow-up|1
7867370|NCT01641198|12358414|FG000|At 15-20 Years of Function|Death|1
7867371|NCT01641198|12358415|FG001|At 15-20 Years of Function|Death|0
7867372|NCT01641198|12358416|FG002|At 15-20 Years of Function|Death|1
7867373|NCT01641237|12358425|FG000|Period II|Withdrawal by Subject|1
7867374|NCT01641237|12358426|FG001|Period II|Withdrawal by Subject|0
7867375|NCT01641237|12358427|FG002|Period II|Withdrawal by Subject|0
7867376|NCT01641237|12358428|FG003|Period II|Withdrawal by Subject|0
7867377|NCT01641237|12358425|FG000|Period III|Lost to Follow-up|1
7867378|NCT01641237|12358426|FG001|Period III|Lost to Follow-up|0
7867379|NCT01641237|12358427|FG002|Period III|Lost to Follow-up|0
7867380|NCT01641237|12358428|FG003|Period III|Lost to Follow-up|0
7867381|NCT01641367|12358444|FG000|Cohorts|Death|18
7867382|NCT01641367|12358445|FG001|Cohorts|Death|1
7867383|NCT01641367|12358446|FG002|Cohorts|Death|2
7867384|NCT01641367|12358447|FG003|Cohorts|Death|0
7867385|NCT01641367|12358448|FG004|Cohorts|Death|1
7867386|NCT01641367|12358449|FG005|Cohorts|Death|1
7867387|NCT01641367|12358450|FG006|Cohorts|Death|0
7867388|NCT01641367|12358451|FG007|Cohorts|Death|0
7867389|NCT01641367|12358444|FG000|Cohorts|Lost to Follow-up|16
7867390|NCT01641367|12358445|FG001|Cohorts|Lost to Follow-up|0
7867391|NCT01641367|12358446|FG002|Cohorts|Lost to Follow-up|2
7867392|NCT01641367|12358447|FG003|Cohorts|Lost to Follow-up|0
7867393|NCT01641367|12358448|FG004|Cohorts|Lost to Follow-up|2
7867394|NCT01641367|12358449|FG005|Cohorts|Lost to Follow-up|0
7867395|NCT01641367|12358450|FG006|Cohorts|Lost to Follow-up|0
7867396|NCT01641367|12358451|FG007|Cohorts|Lost to Follow-up|0
7867397|NCT01641367|12358444|FG000|Randomized Adherence Intervention|Death|0
7867398|NCT01641367|12358445|FG001|Randomized Adherence Intervention|Death|0
7867399|NCT01641367|12358446|FG002|Randomized Adherence Intervention|Death|0
7867400|NCT01641367|12358447|FG003|Randomized Adherence Intervention|Death|0
7867401|NCT01641367|12358448|FG004|Randomized Adherence Intervention|Death|0
7867402|NCT01641367|12358449|FG005|Randomized Adherence Intervention|Death|0
7867403|NCT01641367|12358450|FG006|Randomized Adherence Intervention|Death|11
7867404|NCT01641367|12358451|FG007|Randomized Adherence Intervention|Death|12
7867405|NCT01641367|12358444|FG000|Randomized Adherence Intervention|Lost to Follow-up|0
7867406|NCT01641367|12358445|FG001|Randomized Adherence Intervention|Lost to Follow-up|0
7867407|NCT01641367|12358446|FG002|Randomized Adherence Intervention|Lost to Follow-up|0
7867408|NCT01641367|12358447|FG003|Randomized Adherence Intervention|Lost to Follow-up|0
7867409|NCT01641367|12358448|FG004|Randomized Adherence Intervention|Lost to Follow-up|0
7867410|NCT01641367|12358449|FG005|Randomized Adherence Intervention|Lost to Follow-up|0
7867411|NCT01641367|12358450|FG006|Randomized Adherence Intervention|Lost to Follow-up|8
7867412|NCT01641367|12358451|FG007|Randomized Adherence Intervention|Lost to Follow-up|12
7867413|NCT01641471|12358495|FG000|Overall Study|Withdrawal by Subject|19
7867414|NCT01641471|12358496|FG001|Overall Study|Withdrawal by Subject|19
7867415|NCT01641471|12358495|FG000|Overall Study|Lost to Follow-up|2
7867416|NCT01641471|12358496|FG001|Overall Study|Lost to Follow-up|4
7867417|NCT01641471|12358495|FG000|Overall Study|Protocol Violation|2
7867418|NCT01641471|12358496|FG001|Overall Study|Protocol Violation|4
7867419|NCT01641640|12358502|FG000|Overall Study|Enrolled but not treated|1
7867420|NCT01641640|12358502|FG000|Overall Study|Efficacy failure|29
7867421|NCT01641640|12358502|FG000|Overall Study|Lost to Follow-up|3
7867422|NCT01641640|12358502|FG000|Overall Study|Withdrawal by Subject|2
7867423|NCT01641640|12358502|FG000|Overall Study|Adverse Event|1
7867424|NCT01641692|12358518|FG000|Treatment Period 1|Adverse Event|1
7867425|NCT01641692|12358519|FG001|Treatment Period 1|Adverse Event|0
7867426|NCT01641692|12358520|FG002|Treatment Period 1|Adverse Event|0
7867427|NCT01641692|12358521|FG003|Treatment Period 1|Adverse Event|0
7867428|NCT01641692|12358522|FG004|Treatment Period 1|Adverse Event|0
7867429|NCT01641692|12358523|FG005|Treatment Period 1|Adverse Event|0
7867430|NCT01641692|12358524|FG006|Treatment Period 1|Adverse Event|0
7867431|NCT01641692|12358525|FG007|Treatment Period 1|Adverse Event|0
7867432|NCT01641692|12358518|FG000|Treatment Period 1|Lack of Efficacy|0
7867433|NCT01641692|12358519|FG001|Treatment Period 1|Lack of Efficacy|0
7867434|NCT01641692|12358520|FG002|Treatment Period 1|Lack of Efficacy|0
7867435|NCT01641692|12358521|FG003|Treatment Period 1|Lack of Efficacy|0
7867436|NCT01641692|12358522|FG004|Treatment Period 1|Lack of Efficacy|0
7867437|NCT01641692|12358523|FG005|Treatment Period 1|Lack of Efficacy|0
7867438|NCT01641692|12358524|FG006|Treatment Period 1|Lack of Efficacy|0
7867439|NCT01641692|12358525|FG007|Treatment Period 1|Lack of Efficacy|1
7867440|NCT01641692|12358518|FG000|Treatment Period 1|Protocol Violation|1
7867441|NCT01641692|12358519|FG001|Treatment Period 1|Protocol Violation|0
7867442|NCT01641692|12358520|FG002|Treatment Period 1|Protocol Violation|0
7867443|NCT01641692|12358521|FG003|Treatment Period 1|Protocol Violation|0
7867444|NCT01641692|12358522|FG004|Treatment Period 1|Protocol Violation|2
7867445|NCT01641692|12358523|FG005|Treatment Period 1|Protocol Violation|0
7867446|NCT01641692|12358524|FG006|Treatment Period 1|Protocol Violation|0
7867447|NCT01641692|12358525|FG007|Treatment Period 1|Protocol Violation|0
7867448|NCT01641692|12358518|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0
7867449|NCT01641692|12358519|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0
7867450|NCT01641692|12358520|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0
7867451|NCT01641692|12358521|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0
7867452|NCT01641692|12358522|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1
7867453|NCT01641692|12358523|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0
7867454|NCT01641692|12358524|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0
7867455|NCT01641692|12358525|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1
7867456|NCT01641692|12358518|FG000|Treatment Period 1|Lost to Follow-up|0
7867457|NCT01641692|12358519|FG001|Treatment Period 1|Lost to Follow-up|0
7867458|NCT01641692|12358520|FG002|Treatment Period 1|Lost to Follow-up|1
7867459|NCT01641692|12358521|FG003|Treatment Period 1|Lost to Follow-up|0
7867460|NCT01641692|12358522|FG004|Treatment Period 1|Lost to Follow-up|0
7867461|NCT01641692|12358523|FG005|Treatment Period 1|Lost to Follow-up|0
7867462|NCT01641692|12358524|FG006|Treatment Period 1|Lost to Follow-up|0
7867463|NCT01641692|12358525|FG007|Treatment Period 1|Lost to Follow-up|0
7867464|NCT01641692|12358518|FG000|Treatment Period 1|Physician Decision|0
7867465|NCT01641692|12358519|FG001|Treatment Period 1|Physician Decision|0
7867466|NCT01641692|12358520|FG002|Treatment Period 1|Physician Decision|0
7867467|NCT01641692|12358521|FG003|Treatment Period 1|Physician Decision|0
7867468|NCT01641692|12358522|FG004|Treatment Period 1|Physician Decision|1
7867469|NCT01641692|12358523|FG005|Treatment Period 1|Physician Decision|0
7867470|NCT01641692|12358524|FG006|Treatment Period 1|Physician Decision|0
7867471|NCT01641692|12358525|FG007|Treatment Period 1|Physician Decision|0
7867472|NCT01641692|12358518|FG000|Treatment Period 1|Withdrawal by Subject|0
7867473|NCT01641692|12358519|FG001|Treatment Period 1|Withdrawal by Subject|0
7867474|NCT01641692|12358520|FG002|Treatment Period 1|Withdrawal by Subject|0
7867475|NCT01641692|12358521|FG003|Treatment Period 1|Withdrawal by Subject|0
7867476|NCT01641692|12358522|FG004|Treatment Period 1|Withdrawal by Subject|0
7867477|NCT01641692|12358523|FG005|Treatment Period 1|Withdrawal by Subject|2
7867478|NCT01641692|12358524|FG006|Treatment Period 1|Withdrawal by Subject|0
7867479|NCT01641692|12358525|FG007|Treatment Period 1|Withdrawal by Subject|1
7867480|NCT01641692|12358518|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2
7867481|NCT01641692|12358519|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0
7867482|NCT01641692|12358520|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0
7867483|NCT01641692|12358521|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0
7867484|NCT01641692|12358522|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0
7867485|NCT01641692|12358523|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0
7867486|NCT01641692|12358524|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0
7867487|NCT01641692|12358525|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0
7867488|NCT01641692|12358518|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0
7867489|NCT01641692|12358519|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0
7867490|NCT01641692|12358520|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0
7867491|NCT01641692|12358521|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0
7867492|NCT01641692|12358522|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0
7867493|NCT01641692|12358523|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0
7867494|NCT01641692|12358524|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1
7867495|NCT01641692|12358525|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0
7867496|NCT01641692|12358518|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
7867497|NCT01641692|12358519|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
7867498|NCT01641692|12358520|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
7867499|NCT01641692|12358521|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
7867500|NCT01641692|12358522|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
7867501|NCT01641692|12358523|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
7867502|NCT01641692|12358524|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
7867503|NCT01641692|12358525|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
7867504|NCT01641692|12358518|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7867505|NCT01641692|12358519|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7867506|NCT01641692|12358520|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7867507|NCT01641692|12358521|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7867508|NCT01641692|12358522|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7867509|NCT01641692|12358523|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7867510|NCT01641692|12358524|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7867511|NCT01641692|12358525|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7867512|NCT01641692|12358518|FG000|Treatment Period 2|Lack of Efficacy|1
7867513|NCT01641692|12358519|FG001|Treatment Period 2|Lack of Efficacy|0
7867514|NCT01641692|12358520|FG002|Treatment Period 2|Lack of Efficacy|0
7867515|NCT01641692|12358521|FG003|Treatment Period 2|Lack of Efficacy|0
7867516|NCT01641692|12358522|FG004|Treatment Period 2|Lack of Efficacy|0
7867517|NCT01641692|12358523|FG005|Treatment Period 2|Lack of Efficacy|0
7867518|NCT01641692|12358524|FG006|Treatment Period 2|Lack of Efficacy|0
7867519|NCT01641692|12358525|FG007|Treatment Period 2|Lack of Efficacy|0
7867520|NCT01641692|12358518|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1
7867521|NCT01641692|12358519|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0
7867522|NCT01641692|12358520|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0
7867523|NCT01641692|12358521|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0
7867524|NCT01641692|12358522|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0
7867525|NCT01641692|12358523|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0
7867526|NCT01641692|12358524|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0
7867527|NCT01641692|12358525|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0
7867528|NCT01641692|12358518|FG000|Treatment Period 2|Lost to Follow-up|0
7867529|NCT01641692|12358519|FG001|Treatment Period 2|Lost to Follow-up|0
7867530|NCT01641692|12358520|FG002|Treatment Period 2|Lost to Follow-up|0
7867531|NCT01641692|12358521|FG003|Treatment Period 2|Lost to Follow-up|0
7867532|NCT01641692|12358522|FG004|Treatment Period 2|Lost to Follow-up|0
7867533|NCT01641692|12358523|FG005|Treatment Period 2|Lost to Follow-up|1
7867534|NCT01641692|12358524|FG006|Treatment Period 2|Lost to Follow-up|0
7867535|NCT01641692|12358525|FG007|Treatment Period 2|Lost to Follow-up|0
7867536|NCT01641692|12358518|FG000|Treatment Period 2|Withdrawal by Subject|1
7867537|NCT01641692|12358519|FG001|Treatment Period 2|Withdrawal by Subject|0
7867538|NCT01641692|12358520|FG002|Treatment Period 2|Withdrawal by Subject|0
7867539|NCT01641692|12358521|FG003|Treatment Period 2|Withdrawal by Subject|0
7867540|NCT01641692|12358522|FG004|Treatment Period 2|Withdrawal by Subject|0
7867541|NCT01641692|12358523|FG005|Treatment Period 2|Withdrawal by Subject|1
7867542|NCT01641692|12358524|FG006|Treatment Period 2|Withdrawal by Subject|0
7867543|NCT01641692|12358525|FG007|Treatment Period 2|Withdrawal by Subject|1
7867544|NCT01641692|12358518|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7867545|NCT01641692|12358519|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7867546|NCT01641692|12358520|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7867547|NCT01641692|12358521|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7867548|NCT01641692|12358522|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
7867549|NCT01641692|12358523|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7867550|NCT01641692|12358524|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
7867551|NCT01641692|12358525|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7867552|NCT01641692|12358518|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7867553|NCT01641692|12358519|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7867554|NCT01641692|12358520|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7867555|NCT01641692|12358521|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7867556|NCT01641692|12358522|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7867557|NCT01641692|12358523|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7867558|NCT01641692|12358524|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7867559|NCT01641692|12358525|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7867560|NCT01641692|12358518|FG000|Treatment Period 3|Adverse Event|0
7867561|NCT01641692|12358519|FG001|Treatment Period 3|Adverse Event|0
7867562|NCT01641692|12358520|FG002|Treatment Period 3|Adverse Event|0
7867563|NCT01641692|12358521|FG003|Treatment Period 3|Adverse Event|0
7867564|NCT01641692|12358522|FG004|Treatment Period 3|Adverse Event|0
7867565|NCT01641692|12358523|FG005|Treatment Period 3|Adverse Event|0
7867566|NCT01641692|12358524|FG006|Treatment Period 3|Adverse Event|1
7867567|NCT01641692|12358525|FG007|Treatment Period 3|Adverse Event|0
7867568|NCT01641692|12358518|FG000|Treatment Period 3|Protocol Violation|0
7867569|NCT01641692|12358519|FG001|Treatment Period 3|Protocol Violation|0
7867570|NCT01641692|12358520|FG002|Treatment Period 3|Protocol Violation|1
7867571|NCT01641692|12358521|FG003|Treatment Period 3|Protocol Violation|0
7867572|NCT01641692|12358522|FG004|Treatment Period 3|Protocol Violation|0
7867573|NCT01641692|12358523|FG005|Treatment Period 3|Protocol Violation|0
7867574|NCT01641692|12358524|FG006|Treatment Period 3|Protocol Violation|0
7867575|NCT01641692|12358525|FG007|Treatment Period 3|Protocol Violation|0
7867576|NCT01641692|12358518|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0
7867577|NCT01641692|12358519|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0
7867578|NCT01641692|12358520|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0
7867579|NCT01641692|12358521|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0
7867580|NCT01641692|12358522|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0
7867581|NCT01641692|12358523|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0
7867582|NCT01641692|12358524|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1
7867583|NCT01641692|12358525|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0
7867584|NCT01641692|12358518|FG000|Treatment Period 3|Lost to Follow-up|0
7867585|NCT01641692|12358519|FG001|Treatment Period 3|Lost to Follow-up|1
7867586|NCT01641692|12358520|FG002|Treatment Period 3|Lost to Follow-up|0
7867587|NCT01641692|12358521|FG003|Treatment Period 3|Lost to Follow-up|0
7867588|NCT01641692|12358522|FG004|Treatment Period 3|Lost to Follow-up|0
7867589|NCT01641692|12358523|FG005|Treatment Period 3|Lost to Follow-up|0
7867590|NCT01641692|12358524|FG006|Treatment Period 3|Lost to Follow-up|0
7867591|NCT01641692|12358525|FG007|Treatment Period 3|Lost to Follow-up|0
7867592|NCT01641692|12358518|FG000|Washout Period 3 or Follow-up|Protocol Violation|0
7867593|NCT01641692|12358519|FG001|Washout Period 3 or Follow-up|Protocol Violation|0
7867594|NCT01641692|12358520|FG002|Washout Period 3 or Follow-up|Protocol Violation|0
7867595|NCT01641692|12358521|FG003|Washout Period 3 or Follow-up|Protocol Violation|0
7867596|NCT01641692|12358522|FG004|Washout Period 3 or Follow-up|Protocol Violation|0
7867597|NCT01641692|12358523|FG005|Washout Period 3 or Follow-up|Protocol Violation|1
7867598|NCT01641692|12358524|FG006|Washout Period 3 or Follow-up|Protocol Violation|0
7867599|NCT01641692|12358525|FG007|Washout Period 3 or Follow-up|Protocol Violation|0
7623660|NCT03529773|12034581|FG034|Overall Study|Protocol Violation|0
7623661|NCT03529773|12034582|FG035|Overall Study|Protocol Violation|0
7623662|NCT03529773|12034583|FG036|Overall Study|Protocol Violation|0
7623663|NCT03529773|12034584|FG037|Overall Study|Protocol Violation|0
7623664|NCT03529773|12034585|FG038|Overall Study|Protocol Violation|0
7623665|NCT03529773|12034586|FG039|Overall Study|Protocol Violation|0
7623666|NCT03529773|12034547|FG000|Overall Study|Withdrawal by Subject|0
7623667|NCT03529773|12034548|FG001|Overall Study|Withdrawal by Subject|0
7623668|NCT03529773|12034549|FG002|Overall Study|Withdrawal by Subject|0
7623669|NCT03529773|12034550|FG003|Overall Study|Withdrawal by Subject|0
7623670|NCT03529773|12034551|FG004|Overall Study|Withdrawal by Subject|0
7623671|NCT03529773|12034552|FG005|Overall Study|Withdrawal by Subject|0
7623672|NCT03529773|12034553|FG006|Overall Study|Withdrawal by Subject|0
7623673|NCT03529773|12034554|FG007|Overall Study|Withdrawal by Subject|1
7623674|NCT03529773|12034555|FG008|Overall Study|Withdrawal by Subject|0
7623675|NCT03529773|12034556|FG009|Overall Study|Withdrawal by Subject|1
7867600|NCT01641692|12358518|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7867601|NCT01641692|12358519|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
7867602|NCT01641692|12358520|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7867603|NCT01641692|12358521|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7867604|NCT01641692|12358522|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
7867605|NCT01641692|12358523|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7867606|NCT01641692|12358524|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7867607|NCT01641692|12358525|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
7867608|NCT01641809|12358548|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
7867609|NCT01641809|12358549|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
7867610|NCT01641809|12358550|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0
7867611|NCT01641809|12358551|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
7867612|NCT01641809|12358548|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0
7867613|NCT01641809|12358549|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1
7867614|NCT01641809|12358550|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0
7867615|NCT01641809|12358551|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1
7867616|NCT01641809|12358548|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1
7867617|NCT01641809|12358549|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2
7867618|NCT01641809|12358550|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0
7867619|NCT01641809|12358551|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3
7867620|NCT01641809|12358548|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2
7867621|NCT01641809|12358549|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
7867622|NCT01641809|12358550|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
7867623|NCT01641809|12358551|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0
7867624|NCT01641809|12358548|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4
7867625|NCT01641809|12358549|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1
7867626|NCT01641809|12358550|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2
7867627|NCT01641809|12358551|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3
7867628|NCT01641809|12358548|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0
7867629|NCT01641809|12358549|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1
7867630|NCT01641809|12358550|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3
7867631|NCT01641809|12358551|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7
7867632|NCT01641809|12358548|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2
7867633|NCT01641809|12358549|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3
7867634|NCT01641809|12358550|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1
7867635|NCT01641809|12358551|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0
7867636|NCT01641809|12358548|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
7867637|NCT01641809|12358549|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1
7867638|NCT01641809|12358550|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
7867639|NCT01641809|12358551|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
7867640|NCT01641809|12358548|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
7867641|NCT01641809|12358549|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0
7867642|NCT01641809|12358550|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1
7867643|NCT01641809|12358551|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
7623676|NCT03529773|12034557|FG010|Overall Study|Withdrawal by Subject|1
7623677|NCT03529773|12034558|FG011|Overall Study|Withdrawal by Subject|0
7623678|NCT03529773|12034559|FG012|Overall Study|Withdrawal by Subject|0
7623679|NCT03529773|12034560|FG013|Overall Study|Withdrawal by Subject|0
7623680|NCT03529773|12034561|FG014|Overall Study|Withdrawal by Subject|0
7623681|NCT03529773|12034562|FG015|Overall Study|Withdrawal by Subject|3
7623682|NCT03529773|12034563|FG016|Overall Study|Withdrawal by Subject|0
7623683|NCT03529773|12034564|FG017|Overall Study|Withdrawal by Subject|2
7623684|NCT03529773|12034565|FG018|Overall Study|Withdrawal by Subject|3
7623685|NCT03529773|12034566|FG019|Overall Study|Withdrawal by Subject|1
7623686|NCT03529773|12034567|FG020|Overall Study|Withdrawal by Subject|3
7623687|NCT03529773|12034568|FG021|Overall Study|Withdrawal by Subject|1
7623688|NCT03529773|12034569|FG022|Overall Study|Withdrawal by Subject|1
7623689|NCT03529773|12034570|FG023|Overall Study|Withdrawal by Subject|2
7623690|NCT03529773|12034571|FG024|Overall Study|Withdrawal by Subject|2
7867644|NCT01641809|12358548|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
7867645|NCT01641809|12358549|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
7867646|NCT01641809|12358550|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0
7867647|NCT01641809|12358551|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2
7867648|NCT01641809|12358548|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
7867649|NCT01641809|12358549|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0
7867650|NCT01641809|12358550|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
7867651|NCT01641809|12358551|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2
7867652|NCT01641809|12358548|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2
7867653|NCT01641809|12358549|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3
7867654|NCT01641809|12358550|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1
7867655|NCT01641809|12358551|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0
7867656|NCT01641809|12358548|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0
7867657|NCT01641809|12358549|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1
7867658|NCT01641809|12358550|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1
7867659|NCT01641809|12358551|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0
7867660|NCT01641809|12358548|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
7867661|NCT01641809|12358549|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4
7867662|NCT01641809|12358550|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
7867663|NCT01641809|12358551|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0
7867664|NCT01641809|12358548|FG000|Open-label (Week 96 to Week 324)|Site closed|1
7867665|NCT01641809|12358549|FG001|Open-label (Week 96 to Week 324)|Site closed|0
7867666|NCT01641809|12358550|FG002|Open-label (Week 96 to Week 324)|Site closed|0
7867667|NCT01641809|12358551|FG003|Open-label (Week 96 to Week 324)|Site closed|0
7867668|NCT01641809|12358548|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1
7867669|NCT01641809|12358549|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1
7867670|NCT01641809|12358550|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0
7867671|NCT01641809|12358551|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0
7867672|NCT01641809|12358548|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4
7623693|NCT03529773|12034574|FG027|Overall Study|Withdrawal by Subject|1
7867673|NCT01641809|12358549|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1
7867674|NCT01641809|12358550|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
7867675|NCT01641809|12358551|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
7867676|NCT01641809|12358548|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3
7867677|NCT01641809|12358549|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2
7867678|NCT01641809|12358550|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1
7867679|NCT01641809|12358551|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0
7867680|NCT01641822|12358571|FG000|Run-in Phase|Noncompliance with study drug|1
7867681|NCT01641822|12358572|FG001|Run-in Phase|Noncompliance with study drug|0
7867682|NCT01641822|12358573|FG002|Run-in Phase|Noncompliance with study drug|0
7867683|NCT01641822|12358571|FG000|Run-in Phase|Adverse Event|3
7867684|NCT01641822|12358572|FG001|Run-in Phase|Adverse Event|0
7867685|NCT01641822|12358573|FG002|Run-in Phase|Adverse Event|0
7867686|NCT01641822|12358571|FG000|Run-in Phase|Withdrew consent|1
7867687|NCT01641822|12358572|FG001|Run-in Phase|Withdrew consent|0
7867688|NCT01641822|12358573|FG002|Run-in Phase|Withdrew consent|0
7867689|NCT01641822|12358571|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9
7867690|NCT01641822|12358572|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0
7867691|NCT01641822|12358573|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0
7867692|NCT01641822|12358571|FG000|Comparative Phase|Noncompliance with study drug|0
7867693|NCT01641822|12358572|FG001|Comparative Phase|Noncompliance with study drug|1
7867694|NCT01641822|12358573|FG002|Comparative Phase|Noncompliance with study drug|0
7867695|NCT01641822|12358571|FG000|Comparative Phase|Investigator's discretion|0
7867696|NCT01641822|12358572|FG001|Comparative Phase|Investigator's discretion|0
7867697|NCT01641822|12358573|FG002|Comparative Phase|Investigator's discretion|1
7867698|NCT01641822|12358571|FG000|Comparative Phase|Pregnancy|0
7867699|NCT01641822|12358572|FG001|Comparative Phase|Pregnancy|0
7867700|NCT01641822|12358573|FG002|Comparative Phase|Pregnancy|1
7867701|NCT01641822|12358571|FG000|Comparative Phase|Adverse event, serious fatal|0
7867702|NCT01641822|12358572|FG001|Comparative Phase|Adverse event, serious fatal|1
7867703|NCT01641822|12358573|FG002|Comparative Phase|Adverse event, serious fatal|0
7867704|NCT01641822|12358571|FG000|Comparative Phase|Withdrew consent|0
7867705|NCT01641822|12358572|FG001|Comparative Phase|Withdrew consent|3
7867706|NCT01641822|12358573|FG002|Comparative Phase|Withdrew consent|7
7867707|NCT01641822|12358571|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0
7867708|NCT01641822|12358572|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1
7867709|NCT01641822|12358573|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1
7867710|NCT01641861|12358586|FG000|Overall Study|Lost to Follow-up|21
7867711|NCT01641861|12358587|FG001|Overall Study|Lost to Follow-up|16
7867712|NCT01641861|12358586|FG000|Overall Study|Lost the tooth due to normal exfoliation|14
7867713|NCT01641861|12358587|FG001|Overall Study|Lost the tooth due to normal exfoliation|8
7867714|NCT01641861|12358586|FG000|Overall Study|Died due to drowning|0
7867715|NCT01641861|12358587|FG001|Overall Study|Died due to drowning|1
7867716|NCT01641900|12358595|FG000|Overall Study|Withdrawal by Subject|2
7867717|NCT01641900|12358596|FG001|Overall Study|Withdrawal by Subject|2
7867718|NCT01641926|12358608|FG000|Overall Study|Adverse Event|5
7867719|NCT01641926|12358609|FG001|Overall Study|Adverse Event|2
7867720|NCT01641926|12358610|FG002|Overall Study|Adverse Event|3
7867721|NCT01641926|12358611|FG003|Overall Study|Adverse Event|1
7867722|NCT01641926|12358608|FG000|Overall Study|Lost to Follow-up|2
7867723|NCT01641926|12358609|FG001|Overall Study|Lost to Follow-up|2
7867724|NCT01641926|12358610|FG002|Overall Study|Lost to Follow-up|1
7867725|NCT01641926|12358611|FG003|Overall Study|Lost to Follow-up|0
7867726|NCT01641926|12358608|FG000|Overall Study|Physician Decision|6
7867727|NCT01641926|12358609|FG001|Overall Study|Physician Decision|5
7867728|NCT01641926|12358610|FG002|Overall Study|Physician Decision|0
7867729|NCT01641926|12358611|FG003|Overall Study|Physician Decision|1
7867730|NCT01641926|12358608|FG000|Overall Study|Protocol Violation|1
7867731|NCT01641926|12358609|FG001|Overall Study|Protocol Violation|0
7867732|NCT01641926|12358610|FG002|Overall Study|Protocol Violation|0
7867733|NCT01641926|12358611|FG003|Overall Study|Protocol Violation|1
7867734|NCT01641926|12358608|FG000|Overall Study|Withdrawal by Subject|13
7867735|NCT01641926|12358609|FG001|Overall Study|Withdrawal by Subject|5
7867736|NCT01641926|12358610|FG002|Overall Study|Withdrawal by Subject|6
7867737|NCT01641926|12358611|FG003|Overall Study|Withdrawal by Subject|1
7867738|NCT01641926|12358608|FG000|Overall Study|Not Treated|1
7867739|NCT01641926|12358609|FG001|Overall Study|Not Treated|1
7867740|NCT01641926|12358610|FG002|Overall Study|Not Treated|1
7867741|NCT01641926|12358611|FG003|Overall Study|Not Treated|0
7867742|NCT01641939|12358624|FG000|Overall Study|Death|90
7867743|NCT01641939|12358625|FG001|Overall Study|Death|187
7867744|NCT01641939|12358626|FG002|Overall Study|Death|61
7867745|NCT01641939|12358624|FG000|Overall Study|Lost to Follow-up|3
7867746|NCT01641939|12358625|FG001|Overall Study|Lost to Follow-up|2
7867747|NCT01641939|12358626|FG002|Overall Study|Lost to Follow-up|1
7867748|NCT01641939|12358624|FG000|Overall Study|Withdrawal by Subject|14
7867749|NCT01641939|12358625|FG001|Overall Study|Withdrawal by Subject|11
7867750|NCT01641939|12358626|FG002|Overall Study|Withdrawal by Subject|5
7867751|NCT01641939|12358624|FG000|Overall Study|Study Terminated by Sponsor|10
7867752|NCT01641939|12358625|FG001|Overall Study|Study Terminated by Sponsor|28
7867753|NCT01641939|12358626|FG002|Overall Study|Study Terminated by Sponsor|3
7867754|NCT01641952|12358636|FG000|Overall Study|Lost to Follow-up|28
7867755|NCT01641952|12358636|FG000|Overall Study|Adverse Event|6
7867756|NCT01641991|12358652|FG000|Overall Study|Physician Decision|0
7867757|NCT01641991|12358653|FG001|Overall Study|Physician Decision|1
7867758|NCT01641991|12358654|FG002|Overall Study|Physician Decision|7
7867759|NCT01641991|12358655|FG003|Overall Study|Physician Decision|5
7867760|NCT01641991|12358652|FG000|Overall Study|Withdrawal by Subject|4
7867761|NCT01641991|12358653|FG001|Overall Study|Withdrawal by Subject|2
7867762|NCT01641991|12358654|FG002|Overall Study|Withdrawal by Subject|1
7867763|NCT01641991|12358655|FG003|Overall Study|Withdrawal by Subject|5
7867764|NCT01641991|12358652|FG000|Overall Study|Adverse Event|2
7867765|NCT01641991|12358653|FG001|Overall Study|Adverse Event|1
7867766|NCT01641991|12358654|FG002|Overall Study|Adverse Event|2
7867767|NCT01641991|12358655|FG003|Overall Study|Adverse Event|1
7867768|NCT01641991|12358652|FG000|Overall Study|Lost to Follow-up|0
7867769|NCT01641991|12358653|FG001|Overall Study|Lost to Follow-up|2
7867770|NCT01641991|12358654|FG002|Overall Study|Lost to Follow-up|3
7867771|NCT01641991|12358655|FG003|Overall Study|Lost to Follow-up|1
7867772|NCT01641991|12358652|FG000|Overall Study|Protocol Violation|1
7867773|NCT01641991|12358653|FG001|Overall Study|Protocol Violation|1
7867774|NCT01641991|12358654|FG002|Overall Study|Protocol Violation|3
7867775|NCT01641991|12358655|FG003|Overall Study|Protocol Violation|0
7867776|NCT01641991|12358652|FG000|Overall Study|Pregnancy|0
7867777|NCT01641991|12358653|FG001|Overall Study|Pregnancy|0
7867778|NCT01641991|12358654|FG002|Overall Study|Pregnancy|1
7867779|NCT01641991|12358655|FG003|Overall Study|Pregnancy|0
7867780|NCT01641991|12358652|FG000|Overall Study|no longer eligible|2
7867781|NCT01641991|12358653|FG001|Overall Study|no longer eligible|1
7867782|NCT01641991|12358654|FG002|Overall Study|no longer eligible|0
7867783|NCT01641991|12358655|FG003|Overall Study|no longer eligible|4
7867784|NCT01642212|12358699|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
7867785|NCT01642212|12358700|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7867786|NCT01642212|12358701|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7867787|NCT01642212|12358702|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7867788|NCT01642212|12358703|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7867789|NCT01642212|12358699|FG000|Double-blind Treatment|Other|0
7867790|NCT01642212|12358700|FG001|Double-blind Treatment|Other|2
7867791|NCT01642212|12358701|FG002|Double-blind Treatment|Other|1
7867792|NCT01642212|12358702|FG003|Double-blind Treatment|Other|0
7867793|NCT01642212|12358703|FG004|Double-blind Treatment|Other|0
7867794|NCT01642212|12358699|FG000|Double-blind Treatment|Non-compliance|0
7867795|NCT01642212|12358700|FG001|Double-blind Treatment|Non-compliance|1
7867796|NCT01642212|12358701|FG002|Double-blind Treatment|Non-compliance|0
7867797|NCT01642212|12358702|FG003|Double-blind Treatment|Non-compliance|0
7867798|NCT01642212|12358703|FG004|Double-blind Treatment|Non-compliance|0
7867799|NCT01642212|12358699|FG000|Double-blind Treatment|Adverse Event|0
7867800|NCT01642212|12358700|FG001|Double-blind Treatment|Adverse Event|0
7867801|NCT01642212|12358701|FG002|Double-blind Treatment|Adverse Event|1
7867802|NCT01642212|12358702|FG003|Double-blind Treatment|Adverse Event|0
7867803|NCT01642212|12358703|FG004|Double-blind Treatment|Adverse Event|0
7867804|NCT01642212|12358699|FG000|Open-label Extension|Adverse Event|0
7867805|NCT01642212|12358700|FG001|Open-label Extension|Adverse Event|0
7867806|NCT01642212|12358701|FG002|Open-label Extension|Adverse Event|0
7867807|NCT01642212|12358702|FG003|Open-label Extension|Adverse Event|3
7867808|NCT01642212|12358703|FG004|Open-label Extension|Adverse Event|0
7867809|NCT01642212|12358699|FG000|Open-label Extension|Sponsor Decision|0
7867810|NCT01642212|12358700|FG001|Open-label Extension|Sponsor Decision|0
7867811|NCT01642212|12358701|FG002|Open-label Extension|Sponsor Decision|0
7867812|NCT01642212|12358702|FG003|Open-label Extension|Sponsor Decision|7
7867813|NCT01642212|12358703|FG004|Open-label Extension|Sponsor Decision|4
7867814|NCT01642212|12358699|FG000|Open-label Extension|Consent Withdrawn|0
7867815|NCT01642212|12358700|FG001|Open-label Extension|Consent Withdrawn|0
7867816|NCT01642212|12358701|FG002|Open-label Extension|Consent Withdrawn|0
7867817|NCT01642212|12358702|FG003|Open-label Extension|Consent Withdrawn|0
7867818|NCT01642212|12358703|FG004|Open-label Extension|Consent Withdrawn|2
7867819|NCT01642212|12358699|FG000|Open-label Extension|Lost to Follow-up|0
7867820|NCT01642212|12358700|FG001|Open-label Extension|Lost to Follow-up|0
7867821|NCT01642212|12358701|FG002|Open-label Extension|Lost to Follow-up|0
7867822|NCT01642212|12358702|FG003|Open-label Extension|Lost to Follow-up|0
7867823|NCT01642212|12358703|FG004|Open-label Extension|Lost to Follow-up|1
7867824|NCT01642212|12358699|FG000|Open-label Extension|Other|0
7623691|NCT03529773|12034572|FG025|Overall Study|Withdrawal by Subject|4
7623692|NCT03529773|12034573|FG026|Overall Study|Withdrawal by Subject|2
7867825|NCT01642212|12358700|FG001|Open-label Extension|Other|0
7867826|NCT01642212|12358701|FG002|Open-label Extension|Other|0
7867827|NCT01642212|12358702|FG003|Open-label Extension|Other|0
7867828|NCT01642212|12358703|FG004|Open-label Extension|Other|1
7867829|NCT01642251|12358721|FG000|Overall Study|Progressive disease|0
7867830|NCT01642251|12358722|FG001|Overall Study|Progressive disease|0
7867831|NCT01642251|12358723|FG002|Overall Study|Progressive disease|3
7867832|NCT01642251|12358724|FG003|Overall Study|Progressive disease|3
7867833|NCT01642251|12358721|FG000|Overall Study|Adverse Event|0
7867834|NCT01642251|12358722|FG001|Overall Study|Adverse Event|0
7867835|NCT01642251|12358723|FG002|Overall Study|Adverse Event|5
7623694|NCT03529773|12034575|FG028|Overall Study|Withdrawal by Subject|1
7623695|NCT03529773|12034576|FG029|Overall Study|Withdrawal by Subject|0
7623696|NCT03529773|12034577|FG030|Overall Study|Withdrawal by Subject|0
7623697|NCT03529773|12034578|FG031|Overall Study|Withdrawal by Subject|0
7623698|NCT03529773|12034579|FG032|Overall Study|Withdrawal by Subject|0
7623699|NCT03529773|12034580|FG033|Overall Study|Withdrawal by Subject|0
7623700|NCT03529773|12034581|FG034|Overall Study|Withdrawal by Subject|1
7623701|NCT03529773|12034582|FG035|Overall Study|Withdrawal by Subject|2
7623702|NCT03529773|12034583|FG036|Overall Study|Withdrawal by Subject|0
7623703|NCT03529773|12034584|FG037|Overall Study|Withdrawal by Subject|2
7623704|NCT03529773|12034585|FG038|Overall Study|Withdrawal by Subject|1
7623705|NCT03529773|12034586|FG039|Overall Study|Withdrawal by Subject|1
7623706|NCT03529773|12034547|FG000|Overall Study|Screen Failure|0
7623707|NCT03529773|12034548|FG001|Overall Study|Screen Failure|0
7623708|NCT03529773|12034549|FG002|Overall Study|Screen Failure|0
7623709|NCT03529773|12034550|FG003|Overall Study|Screen Failure|0
7623710|NCT03529773|12034551|FG004|Overall Study|Screen Failure|0
7623711|NCT03529773|12034552|FG005|Overall Study|Screen Failure|0
7623712|NCT03529773|12034553|FG006|Overall Study|Screen Failure|0
7623713|NCT03529773|12034554|FG007|Overall Study|Screen Failure|0
7623714|NCT03529773|12034555|FG008|Overall Study|Screen Failure|0
7623715|NCT03529773|12034556|FG009|Overall Study|Screen Failure|0
7623716|NCT03529773|12034557|FG010|Overall Study|Screen Failure|0
7623717|NCT03529773|12034558|FG011|Overall Study|Screen Failure|0
7623718|NCT03529773|12034559|FG012|Overall Study|Screen Failure|0
7623719|NCT03529773|12034560|FG013|Overall Study|Screen Failure|0
7623720|NCT03529773|12034561|FG014|Overall Study|Screen Failure|0
7623721|NCT03529773|12034562|FG015|Overall Study|Screen Failure|0
7623722|NCT03529773|12034563|FG016|Overall Study|Screen Failure|0
7623723|NCT03529773|12034564|FG017|Overall Study|Screen Failure|0
7623724|NCT03529773|12034565|FG018|Overall Study|Screen Failure|0
7623725|NCT03529773|12034566|FG019|Overall Study|Screen Failure|0
7623726|NCT03529773|12034567|FG020|Overall Study|Screen Failure|0
7623727|NCT03529773|12034568|FG021|Overall Study|Screen Failure|0
7623728|NCT03529773|12034569|FG022|Overall Study|Screen Failure|0
7623729|NCT03529773|12034570|FG023|Overall Study|Screen Failure|0
7623730|NCT03529773|12034571|FG024|Overall Study|Screen Failure|0
7623731|NCT03529773|12034572|FG025|Overall Study|Screen Failure|0
7623732|NCT03529773|12034573|FG026|Overall Study|Screen Failure|0
7623733|NCT03529773|12034574|FG027|Overall Study|Screen Failure|0
7623734|NCT03529773|12034575|FG028|Overall Study|Screen Failure|0
7623735|NCT03529773|12034576|FG029|Overall Study|Screen Failure|0
7867836|NCT01642251|12358724|FG003|Overall Study|Adverse Event|4
7867837|NCT01642251|12358721|FG000|Overall Study|Death|0
7867838|NCT01642251|12358722|FG001|Overall Study|Death|0
7867839|NCT01642251|12358723|FG002|Overall Study|Death|1
7623736|NCT03529773|12034577|FG030|Overall Study|Screen Failure|0
7623737|NCT03529773|12034578|FG031|Overall Study|Screen Failure|0
7623738|NCT03529773|12034579|FG032|Overall Study|Screen Failure|0
7623739|NCT03529773|12034580|FG033|Overall Study|Screen Failure|0
7623740|NCT03529773|12034581|FG034|Overall Study|Screen Failure|0
7623741|NCT03529773|12034582|FG035|Overall Study|Screen Failure|0
7623742|NCT03529773|12034583|FG036|Overall Study|Screen Failure|1
7623743|NCT03529773|12034584|FG037|Overall Study|Screen Failure|1
7623744|NCT03529773|12034585|FG038|Overall Study|Screen Failure|0
7623745|NCT03529773|12034586|FG039|Overall Study|Screen Failure|1
7623746|NCT03529773|12034547|FG000|Overall Study|Randomized but not vaccinated|0
7623747|NCT03529773|12034548|FG001|Overall Study|Randomized but not vaccinated|0
7623748|NCT03529773|12034549|FG002|Overall Study|Randomized but not vaccinated|0
7623749|NCT03529773|12034550|FG003|Overall Study|Randomized but not vaccinated|0
7867840|NCT01642251|12358724|FG003|Overall Study|Death|3
7867841|NCT01642251|12358721|FG000|Overall Study|Withdrawal by Subject|0
7867842|NCT01642251|12358722|FG001|Overall Study|Withdrawal by Subject|0
7867843|NCT01642251|12358723|FG002|Overall Study|Withdrawal by Subject|1
7867844|NCT01642251|12358724|FG003|Overall Study|Withdrawal by Subject|3
7867845|NCT01642251|12358721|FG000|Overall Study|Alternative therapy|0
7867846|NCT01642251|12358722|FG001|Overall Study|Alternative therapy|0
7867847|NCT01642251|12358723|FG002|Overall Study|Alternative therapy|0
7867848|NCT01642251|12358724|FG003|Overall Study|Alternative therapy|2
7867849|NCT01642251|12358721|FG000|Overall Study|Other complicating disease|0
7867850|NCT01642251|12358722|FG001|Overall Study|Other complicating disease|0
7867851|NCT01642251|12358723|FG002|Overall Study|Other complicating disease|1
7867852|NCT01642251|12358724|FG003|Overall Study|Other complicating disease|0
7867853|NCT01642251|12358721|FG000|Overall Study|Ineligible/never start protocol therapy|0
7867854|NCT01642251|12358722|FG001|Overall Study|Ineligible/never start protocol therapy|0
7867855|NCT01642251|12358723|FG002|Overall Study|Ineligible/never start protocol therapy|11
7867856|NCT01642251|12358724|FG003|Overall Study|Ineligible/never start protocol therapy|8
7867857|NCT01642277|12358735|FG000|Overall Study|Adverse Event|10
7867858|NCT01642277|12358736|FG001|Overall Study|Adverse Event|0
7867859|NCT01642277|12358735|FG000|Overall Study|Physician Decision|2
7867860|NCT01642277|12358736|FG001|Overall Study|Physician Decision|0
7867861|NCT01642277|12358735|FG000|Overall Study|Protocol Violation|1
7867862|NCT01642277|12358736|FG001|Overall Study|Protocol Violation|0
7867863|NCT01642277|12358735|FG000|Overall Study|Withdrawal by Subject|11
7867864|NCT01642277|12358736|FG001|Overall Study|Withdrawal by Subject|0
7867865|NCT01642407|12358743|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
7867866|NCT01642407|12358743|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
7867867|NCT01642407|12358743|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
7867868|NCT01642589|12358774|FG000|Overall Study|Withdrawal by Subject|1
7867869|NCT01642589|12358775|FG001|Overall Study|Withdrawal by Subject|1
7867870|NCT01642602|12358781|FG000|Overall Study|Adverse Event|2
7867871|NCT01642615|12358785|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
7623750|NCT03529773|12034551|FG004|Overall Study|Randomized but not vaccinated|0
7623751|NCT03529773|12034552|FG005|Overall Study|Randomized but not vaccinated|0
7623752|NCT03529773|12034553|FG006|Overall Study|Randomized but not vaccinated|0
7623753|NCT03529773|12034554|FG007|Overall Study|Randomized but not vaccinated|0
7623754|NCT03529773|12034555|FG008|Overall Study|Randomized but not vaccinated|0
7623755|NCT03529773|12034556|FG009|Overall Study|Randomized but not vaccinated|0
7623756|NCT03529773|12034557|FG010|Overall Study|Randomized but not vaccinated|0
7623757|NCT03529773|12034558|FG011|Overall Study|Randomized but not vaccinated|0
7623758|NCT03529773|12034559|FG012|Overall Study|Randomized but not vaccinated|0
7623759|NCT03529773|12034560|FG013|Overall Study|Randomized but not vaccinated|0
7623760|NCT03529773|12034561|FG014|Overall Study|Randomized but not vaccinated|0
7623761|NCT03529773|12034562|FG015|Overall Study|Randomized but not vaccinated|0
7623762|NCT03529773|12034563|FG016|Overall Study|Randomized but not vaccinated|0
7623763|NCT03529773|12034564|FG017|Overall Study|Randomized but not vaccinated|1
7623764|NCT03529773|12034565|FG018|Overall Study|Randomized but not vaccinated|0
7623765|NCT03529773|12034566|FG019|Overall Study|Randomized but not vaccinated|0
7623766|NCT03529773|12034567|FG020|Overall Study|Randomized but not vaccinated|0
7623767|NCT03529773|12034568|FG021|Overall Study|Randomized but not vaccinated|0
7623768|NCT03529773|12034569|FG022|Overall Study|Randomized but not vaccinated|0
7623769|NCT03529773|12034570|FG023|Overall Study|Randomized but not vaccinated|0
7623770|NCT03529773|12034571|FG024|Overall Study|Randomized but not vaccinated|0
7623771|NCT03529773|12034572|FG025|Overall Study|Randomized but not vaccinated|0
7623772|NCT03529773|12034573|FG026|Overall Study|Randomized but not vaccinated|0
7623773|NCT03529773|12034574|FG027|Overall Study|Randomized but not vaccinated|1
7623774|NCT03529773|12034575|FG028|Overall Study|Randomized but not vaccinated|0
7623775|NCT03529773|12034576|FG029|Overall Study|Randomized but not vaccinated|0
7623776|NCT03529773|12034577|FG030|Overall Study|Randomized but not vaccinated|0
7623777|NCT03529773|12034578|FG031|Overall Study|Randomized but not vaccinated|0
7623778|NCT03529773|12034579|FG032|Overall Study|Randomized but not vaccinated|0
7623779|NCT03529773|12034580|FG033|Overall Study|Randomized but not vaccinated|0
7623780|NCT03529773|12034581|FG034|Overall Study|Randomized but not vaccinated|0
7623781|NCT03529773|12034582|FG035|Overall Study|Randomized but not vaccinated|0
7623782|NCT03529773|12034583|FG036|Overall Study|Randomized but not vaccinated|0
7623783|NCT03529773|12034584|FG037|Overall Study|Randomized but not vaccinated|0
7623784|NCT03529773|12034585|FG038|Overall Study|Randomized but not vaccinated|0
7623785|NCT03529773|12034586|FG039|Overall Study|Randomized but not vaccinated|0
7623786|NCT03502070|12034689|FG000|Overall Study|Withdrawal by Subject|1
7623787|NCT03502070|12034689|FG000|Overall Study|Screen Failure|1
7623788|NCT03485911|12034696|FG000|Overall Study|Withdrawal by Subject|0
7623789|NCT03485911|12034697|FG001|Overall Study|Withdrawal by Subject|2
7623790|NCT03485911|12034698|FG002|Overall Study|Withdrawal by Subject|2
7623791|NCT03485911|12034696|FG000|Overall Study|Adverse Event|1
7623792|NCT03485911|12034697|FG001|Overall Study|Adverse Event|0
7623793|NCT03485911|12034698|FG002|Overall Study|Adverse Event|1
7623794|NCT03485911|12034696|FG000|Overall Study|High frequency of HAE attacks|0
7623795|NCT03485911|12034697|FG001|Overall Study|High frequency of HAE attacks|0
7623796|NCT03485911|12034698|FG002|Overall Study|High frequency of HAE attacks|1
7867872|NCT01642615|12358786|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
7867873|NCT01642615|12358787|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
7867874|NCT01642615|12358785|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1
7867875|NCT01642615|12358786|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0
7867876|NCT01642615|12358787|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0
7867877|NCT01642615|12358785|FG000|Open Label Maintenance Phase|Lost to Follow-up|1
7867878|NCT01642615|12358786|FG001|Open Label Maintenance Phase|Lost to Follow-up|0
7867879|NCT01642615|12358787|FG002|Open Label Maintenance Phase|Lost to Follow-up|0
7867880|NCT01642615|12358785|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1
7867881|NCT01642615|12358786|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0
7867882|NCT01642615|12358787|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0
7867883|NCT01642615|12358785|FG000|Open Label Maintenance Phase|Did not receive treatment|1
7867884|NCT01642615|12358786|FG001|Open Label Maintenance Phase|Did not receive treatment|0
7867885|NCT01642615|12358787|FG002|Open Label Maintenance Phase|Did not receive treatment|0
7867886|NCT01642615|12358785|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0
7867887|NCT01642615|12358786|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1
7867888|NCT01642615|12358787|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3
7867889|NCT01642615|12358785|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0
7867890|NCT01642615|12358786|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5
7867891|NCT01642615|12358787|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2
7883373|NCT01781429|12382964|FG015|Overall Study|Enrolled, but not treated|0
7867892|NCT01642615|12358785|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
7867893|NCT01642615|12358786|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
7867894|NCT01642615|12358787|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
7867895|NCT01642615|12358785|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
7867896|NCT01642615|12358786|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
7867897|NCT01642615|12358787|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
7867898|NCT01642914|12358798|FG000|Overall Study|Adverse Event|11
7867899|NCT01642914|12358799|FG001|Overall Study|Adverse Event|7
7867900|NCT01642914|12358800|FG002|Overall Study|Adverse Event|15
7867901|NCT01642914|12358798|FG000|Overall Study|Lack of Efficacy|9
7867902|NCT01642914|12358799|FG001|Overall Study|Lack of Efficacy|4
7867903|NCT01642914|12358800|FG002|Overall Study|Lack of Efficacy|2
7867904|NCT01642914|12358798|FG000|Overall Study|Protocol Violation|15
7867905|NCT01642914|12358799|FG001|Overall Study|Protocol Violation|13
7867906|NCT01642914|12358800|FG002|Overall Study|Protocol Violation|6
7867907|NCT01642914|12358798|FG000|Overall Study|Withdrawal by Subject|5
7867908|NCT01642914|12358799|FG001|Overall Study|Withdrawal by Subject|5
7867909|NCT01642914|12358800|FG002|Overall Study|Withdrawal by Subject|10
7867910|NCT01642914|12358798|FG000|Overall Study|Lost to Follow-up|5
7867911|NCT01642914|12358799|FG001|Overall Study|Lost to Follow-up|3
7867912|NCT01642914|12358800|FG002|Overall Study|Lost to Follow-up|7
7867913|NCT01642914|12358798|FG000|Overall Study|Other Reason|1
7867914|NCT01642914|12358799|FG001|Overall Study|Other Reason|0
7867915|NCT01642914|12358800|FG002|Overall Study|Other Reason|0
7867916|NCT01643044|12358812|FG000|Overall Study|Lost to Follow-up|1
7867917|NCT01643044|12358813|FG001|Overall Study|Lost to Follow-up|1
7867918|NCT01643044|12358812|FG000|Overall Study|Miscarried baby|2
7867919|NCT01643044|12358813|FG001|Overall Study|Miscarried baby|2
7867920|NCT01643044|12358812|FG000|Overall Study|Delivered outside of hospital|1
7867921|NCT01643044|12358813|FG001|Overall Study|Delivered outside of hospital|2
7867922|NCT01643408|12358837|FG000|Overall Study|Adverse Event|12
7867923|NCT01643408|12358837|FG000|Overall Study|Other|2
7867924|NCT01643473|12358843|FG000|Overall Study|Lost to Follow-up|1
7867925|NCT01643473|12358844|FG001|Overall Study|Lost to Follow-up|0
7867926|NCT01643668|12358859|FG000|Overall Study|Death|1
7867927|NCT01643772|12358879|FG000|Overall Study|Protocol Violation|0
7867928|NCT01643772|12358880|FG001|Overall Study|Protocol Violation|0
7867929|NCT01643772|12358881|FG002|Overall Study|Protocol Violation|0
7867930|NCT01643772|12358882|FG003|Overall Study|Protocol Violation|1
7867931|NCT01643772|12358879|FG000|Overall Study|Adverse Event|0
7867932|NCT01643772|12358880|FG001|Overall Study|Adverse Event|0
7867933|NCT01643772|12358881|FG002|Overall Study|Adverse Event|0
7867934|NCT01643772|12358882|FG003|Overall Study|Adverse Event|1
7867935|NCT01643798|12358894|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
7867936|NCT01643798|12358895|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
7867937|NCT01643850|12358915|FG000|Overall Study|Withdrawal by Subject|0
7867938|NCT01643850|12358916|FG001|Overall Study|Withdrawal by Subject|0
7867939|NCT01643850|12358917|FG002|Overall Study|Withdrawal by Subject|0
7867940|NCT01643850|12358918|FG003|Overall Study|Withdrawal by Subject|0
7867941|NCT01643850|12358919|FG004|Overall Study|Withdrawal by Subject|1
7867942|NCT01643850|12358920|FG005|Overall Study|Withdrawal by Subject|0
7867943|NCT01643850|12358921|FG006|Overall Study|Withdrawal by Subject|0
7867944|NCT01643850|12358922|FG007|Overall Study|Withdrawal by Subject|0
7867945|NCT01643850|12358923|FG008|Overall Study|Withdrawal by Subject|0
7867946|NCT01643850|12358915|FG000|Overall Study|Lost to Follow-up|0
7867947|NCT01643850|12358916|FG001|Overall Study|Lost to Follow-up|0
7867948|NCT01643850|12358917|FG002|Overall Study|Lost to Follow-up|0
7867949|NCT01643850|12358918|FG003|Overall Study|Lost to Follow-up|0
7867950|NCT01643850|12358919|FG004|Overall Study|Lost to Follow-up|0
7867951|NCT01643850|12358920|FG005|Overall Study|Lost to Follow-up|0
7867952|NCT01643850|12358921|FG006|Overall Study|Lost to Follow-up|1
7867953|NCT01643850|12358922|FG007|Overall Study|Lost to Follow-up|0
7867954|NCT01643850|12358923|FG008|Overall Study|Lost to Follow-up|1
7867955|NCT01643850|12358915|FG000|Overall Study|Adverse Event|0
7867956|NCT01643850|12358916|FG001|Overall Study|Adverse Event|0
7867957|NCT01643850|12358917|FG002|Overall Study|Adverse Event|0
7867958|NCT01643850|12358918|FG003|Overall Study|Adverse Event|0
7867959|NCT01643850|12358919|FG004|Overall Study|Adverse Event|1
7867960|NCT01643850|12358920|FG005|Overall Study|Adverse Event|0
7867961|NCT01643850|12358921|FG006|Overall Study|Adverse Event|0
7867962|NCT01643850|12358922|FG007|Overall Study|Adverse Event|0
7867963|NCT01643850|12358923|FG008|Overall Study|Adverse Event|0
7867964|NCT01643850|12358915|FG000|Overall Study|Administrative Problems|0
7867965|NCT01643850|12358916|FG001|Overall Study|Administrative Problems|0
7867966|NCT01643850|12358917|FG002|Overall Study|Administrative Problems|1
7867967|NCT01643850|12358918|FG003|Overall Study|Administrative Problems|0
7867968|NCT01643850|12358919|FG004|Overall Study|Administrative Problems|1
7867969|NCT01643850|12358920|FG005|Overall Study|Administrative Problems|0
7867970|NCT01643850|12358921|FG006|Overall Study|Administrative Problems|0
7867971|NCT01643850|12358922|FG007|Overall Study|Administrative Problems|0
7867972|NCT01643850|12358923|FG008|Overall Study|Administrative Problems|0
7867973|NCT01643928|12359003|FG000|Overall Study|Lost to Follow-up|1
7867974|NCT01643928|12359004|FG001|Overall Study|Lost to Follow-up|0
7867975|NCT01643928|12359005|FG002|Overall Study|Lost to Follow-up|2
7867976|NCT01643928|12359006|FG003|Overall Study|Lost to Follow-up|0
7867977|NCT01643928|12359007|FG004|Overall Study|Lost to Follow-up|0
7867978|NCT01643928|12359003|FG000|Overall Study|Withdrawal by Subject|2
7867979|NCT01643928|12359004|FG001|Overall Study|Withdrawal by Subject|0
7867980|NCT01643928|12359005|FG002|Overall Study|Withdrawal by Subject|0
7867981|NCT01643928|12359006|FG003|Overall Study|Withdrawal by Subject|1
7867982|NCT01643928|12359007|FG004|Overall Study|Withdrawal by Subject|0
7867983|NCT01643928|12359003|FG000|Overall Study|Pregnancy|0
7867984|NCT01643928|12359004|FG001|Overall Study|Pregnancy|0
7867985|NCT01643928|12359005|FG002|Overall Study|Pregnancy|0
7867986|NCT01643928|12359006|FG003|Overall Study|Pregnancy|1
7867987|NCT01643928|12359007|FG004|Overall Study|Pregnancy|0
7867988|NCT01643928|12359003|FG000|Overall Study|Other|5
7867989|NCT01643928|12359004|FG001|Overall Study|Other|1
7867990|NCT01643928|12359005|FG002|Overall Study|Other|1
7867991|NCT01643928|12359006|FG003|Overall Study|Other|0
7867992|NCT01643928|12359007|FG004|Overall Study|Other|0
7867993|NCT01643928|12359003|FG000|Overall Study|Adverse Event|2
7867994|NCT01643928|12359004|FG001|Overall Study|Adverse Event|1
7867995|NCT01643928|12359005|FG002|Overall Study|Adverse Event|0
7867996|NCT01643928|12359006|FG003|Overall Study|Adverse Event|1
7867997|NCT01643928|12359007|FG004|Overall Study|Adverse Event|2
7867998|NCT01644149|12359055|FG000|Overall Study|Withdrawal by Subject|1
7867999|NCT01644149|12359056|FG001|Overall Study|Withdrawal by Subject|0
7868000|NCT01644149|12359055|FG000|Overall Study|Lost to Follow-up|3
7868001|NCT01644149|12359056|FG001|Overall Study|Lost to Follow-up|1
7868002|NCT01644175|12359065|FG000|Overall Study|Randomized But Not Treated|0
7868003|NCT01644175|12359066|FG001|Overall Study|Randomized But Not Treated|2
7868004|NCT01644175|12359065|FG000|Overall Study|Adverse Event|8
7868005|NCT01644175|12359066|FG001|Overall Study|Adverse Event|13
7868006|NCT01644175|12359065|FG000|Overall Study|Death|1
7868007|NCT01644175|12359066|FG001|Overall Study|Death|2
7868008|NCT01644175|12359065|FG000|Overall Study|Poor compliance to protocol|9
7868009|NCT01644175|12359066|FG001|Overall Study|Poor compliance to protocol|10
7868010|NCT01644175|12359065|FG000|Overall Study|Physician Decision|1
7868011|NCT01644175|12359066|FG001|Overall Study|Physician Decision|2
7868012|NCT01644175|12359065|FG000|Overall Study|Participant Moved|1
7868013|NCT01644175|12359066|FG001|Overall Study|Participant Moved|2
7868014|NCT01644175|12359065|FG000|Overall Study|Consent withdrawn by participant|3
7868015|NCT01644175|12359066|FG001|Overall Study|Consent withdrawn by participant|4
7868016|NCT01644175|12359065|FG000|Overall Study|Related to Autoinjector Administration|2
7868017|NCT01644175|12359066|FG001|Overall Study|Related to Autoinjector Administration|1
7868018|NCT01644175|12359065|FG000|Overall Study|Last visit outside protocol visit window|4
7868019|NCT01644175|12359066|FG001|Overall Study|Last visit outside protocol visit window|11
7868020|NCT01644175|12359065|FG000|Overall Study|Selection criteria finally not met|0
7868021|NCT01644175|12359066|FG001|Overall Study|Selection criteria finally not met|1
7868022|NCT01644175|12359065|FG000|Overall Study|Site closure|2
7868023|NCT01644175|12359066|FG001|Overall Study|Site closure|2
7868024|NCT01644175|12359065|FG000|Overall Study|Lost to Follow-up|1
7868025|NCT01644175|12359066|FG001|Overall Study|Lost to Follow-up|0
7868026|NCT01644175|12359065|FG000|Overall Study|Other than specified above|0
7868027|NCT01644175|12359066|FG001|Overall Study|Other than specified above|3
7868028|NCT01644188|12359074|FG000|Overall Study|Adverse Event|44
7868029|NCT01644188|12359075|FG001|Overall Study|Adverse Event|20
7868030|NCT01644188|12359074|FG000|Overall Study|Poor compliance to protocol|26
7868031|NCT01644188|12359075|FG001|Overall Study|Poor compliance to protocol|14
7868032|NCT01644188|12359074|FG000|Overall Study|Physician Decision|1
7868033|NCT01644188|12359075|FG001|Overall Study|Physician Decision|3
7868034|NCT01644188|12359074|FG000|Overall Study|Participant moved|7
7868035|NCT01644188|12359075|FG001|Overall Study|Participant moved|2
7868036|NCT01644188|12359074|FG000|Overall Study|Related to auto-injector administration|2
7868037|NCT01644188|12359075|FG001|Overall Study|Related to auto-injector administration|2
7868038|NCT01644188|12359074|FG000|Overall Study|Consent withdrawn by participant|14
7868039|NCT01644188|12359075|FG001|Overall Study|Consent withdrawn by participant|7
7868040|NCT01644188|12359074|FG000|Overall Study|Selection criteria finally not met|2
7868041|NCT01644188|12359075|FG001|Overall Study|Selection criteria finally not met|0
7868042|NCT01644188|12359074|FG000|Overall Study|Lost to Follow-up|1
7868043|NCT01644188|12359075|FG001|Overall Study|Lost to Follow-up|0
7868044|NCT01644188|12359074|FG000|Overall Study|Death|4
7868045|NCT01644188|12359075|FG001|Overall Study|Death|3
7868046|NCT01644188|12359074|FG000|Overall Study|Last visit outside protocol visit window|14
7868047|NCT01644188|12359075|FG001|Overall Study|Last visit outside protocol visit window|16
7868048|NCT01644188|12359074|FG000|Overall Study|Site closure|1
7868049|NCT01644188|12359075|FG001|Overall Study|Site closure|1
7868050|NCT01644188|12359074|FG000|Overall Study|Other than specified above|6
7868051|NCT01644188|12359075|FG001|Overall Study|Other than specified above|7
7868052|NCT01644474|12359114|FG000|Overall Study|Poor compliance to protocol|1
7868053|NCT01644474|12359115|FG001|Overall Study|Poor compliance to protocol|0
7868054|NCT01644474|12359114|FG000|Overall Study|Consent withdrawn by participant|0
7868055|NCT01644474|12359115|FG001|Overall Study|Consent withdrawn by participant|1
7868056|NCT01644474|12359114|FG000|Overall Study|Participant moved|0
7868057|NCT01644474|12359115|FG001|Overall Study|Participant moved|1
7868058|NCT01644474|12359114|FG000|Overall Study|Adverse Event|4
7868059|NCT01644474|12359115|FG001|Overall Study|Adverse Event|5
7868060|NCT01644474|12359114|FG000|Overall Study|Site scheduling error|1
7868061|NCT01644474|12359115|FG001|Overall Study|Site scheduling error|1
7868062|NCT01644474|12359114|FG000|Overall Study|Protocol Violation|1
7868063|NCT01644474|12359115|FG001|Overall Study|Protocol Violation|0
7868064|NCT01644500|12359124|FG000|Overall Study|Adverse Event|6
7868065|NCT01644500|12359125|FG001|Overall Study|Adverse Event|1
7868066|NCT01644500|12359126|FG002|Overall Study|Adverse Event|2
7868067|NCT01644500|12359124|FG000|Overall Study|Death|0
7868068|NCT01644500|12359125|FG001|Overall Study|Death|1
7868069|NCT01644500|12359126|FG002|Overall Study|Death|0
7868070|NCT01644500|12359124|FG000|Overall Study|Lost to Follow-up|3
7868071|NCT01644500|12359125|FG001|Overall Study|Lost to Follow-up|8
7868072|NCT01644500|12359126|FG002|Overall Study|Lost to Follow-up|0
7868073|NCT01644500|12359124|FG000|Overall Study|Protocol Violation|1
7868074|NCT01644500|12359125|FG001|Overall Study|Protocol Violation|1
7868075|NCT01644500|12359126|FG002|Overall Study|Protocol Violation|0
7868076|NCT01644500|12359124|FG000|Overall Study|Withdrawal by Subject|11
7868077|NCT01644500|12359125|FG001|Overall Study|Withdrawal by Subject|12
7868078|NCT01644500|12359126|FG002|Overall Study|Withdrawal by Subject|12
7868079|NCT01644500|12359124|FG000|Overall Study|Physician Decision|1
7868080|NCT01644500|12359125|FG001|Overall Study|Physician Decision|1
7868081|NCT01644500|12359126|FG002|Overall Study|Physician Decision|1
7868082|NCT01644565|12359134|FG000|Overall Study|Undisclosed Medical History|1
7868083|NCT01644565|12359135|FG001|Overall Study|Undisclosed Medical History|0
7868084|NCT01644565|12359136|FG002|Overall Study|Undisclosed Medical History|0
7868085|NCT01644565|12359137|FG003|Overall Study|Undisclosed Medical History|0
7868086|NCT01644565|12359138|FG004|Overall Study|Undisclosed Medical History|0
7868087|NCT01644565|12359139|FG005|Overall Study|Undisclosed Medical History|0
7868088|NCT01644565|12359140|FG006|Overall Study|Undisclosed Medical History|0
7868089|NCT01644565|12359141|FG007|Overall Study|Undisclosed Medical History|0
7868090|NCT01644565|12359142|FG008|Overall Study|Undisclosed Medical History|0
7868091|NCT01644565|12359134|FG000|Overall Study|Lost to Follow-up|0
7868092|NCT01644565|12359135|FG001|Overall Study|Lost to Follow-up|0
7868093|NCT01644565|12359136|FG002|Overall Study|Lost to Follow-up|0
7868094|NCT01644565|12359137|FG003|Overall Study|Lost to Follow-up|1
7868095|NCT01644565|12359138|FG004|Overall Study|Lost to Follow-up|0
7868096|NCT01644565|12359139|FG005|Overall Study|Lost to Follow-up|0
7868097|NCT01644565|12359140|FG006|Overall Study|Lost to Follow-up|0
7868098|NCT01644565|12359141|FG007|Overall Study|Lost to Follow-up|2
7868099|NCT01644565|12359142|FG008|Overall Study|Lost to Follow-up|0
7868100|NCT01644565|12359134|FG000|Overall Study|Family emergency|0
7868101|NCT01644565|12359135|FG001|Overall Study|Family emergency|0
7868102|NCT01644565|12359136|FG002|Overall Study|Family emergency|0
7868103|NCT01644565|12359137|FG003|Overall Study|Family emergency|0
7868104|NCT01644565|12359138|FG004|Overall Study|Family emergency|1
7868105|NCT01644565|12359139|FG005|Overall Study|Family emergency|0
7868106|NCT01644565|12359140|FG006|Overall Study|Family emergency|0
7868107|NCT01644565|12359141|FG007|Overall Study|Family emergency|0
7868108|NCT01644565|12359142|FG008|Overall Study|Family emergency|0
7868109|NCT01644565|12359134|FG000|Overall Study|Relocation|0
7868110|NCT01644565|12359135|FG001|Overall Study|Relocation|0
7868111|NCT01644565|12359136|FG002|Overall Study|Relocation|0
7868112|NCT01644565|12359137|FG003|Overall Study|Relocation|0
7868113|NCT01644565|12359138|FG004|Overall Study|Relocation|0
7868114|NCT01644565|12359139|FG005|Overall Study|Relocation|0
7868115|NCT01644565|12359140|FG006|Overall Study|Relocation|0
7868116|NCT01644565|12359141|FG007|Overall Study|Relocation|0
7868117|NCT01644565|12359142|FG008|Overall Study|Relocation|1
7868118|NCT01644617|12359165|FG000|Overall Study|Withdrawal by Subject|3
7868119|NCT01644617|12359166|FG001|Overall Study|Withdrawal by Subject|4
7868120|NCT01644617|12359167|FG002|Overall Study|Withdrawal by Subject|1
7868121|NCT01644617|12359165|FG000|Overall Study|Lost to Follow-up|0
7868122|NCT01644617|12359166|FG001|Overall Study|Lost to Follow-up|1
7868123|NCT01644617|12359167|FG002|Overall Study|Lost to Follow-up|0
7868124|NCT01644617|12359165|FG000|Overall Study|Adverse Event|3
7868125|NCT01644617|12359166|FG001|Overall Study|Adverse Event|0
7868126|NCT01644617|12359167|FG002|Overall Study|Adverse Event|6
7868127|NCT01644643|12359179|FG000|Overall Study|Death|1
7868128|NCT01644643|12359180|FG001|Overall Study|Death|0
7868129|NCT01644643|12359181|FG002|Overall Study|Death|3
7868130|NCT01644643|12359182|FG003|Overall Study|Death|3
7868131|NCT01644643|12359179|FG000|Overall Study|Lost to Follow-up|0
7868132|NCT01644643|12359180|FG001|Overall Study|Lost to Follow-up|0
7868133|NCT01644643|12359181|FG002|Overall Study|Lost to Follow-up|0
7868134|NCT01644643|12359182|FG003|Overall Study|Lost to Follow-up|4
7868135|NCT01644643|12359179|FG000|Overall Study|Withdrawal by Subject|1
7868136|NCT01644643|12359180|FG001|Overall Study|Withdrawal by Subject|0
7868137|NCT01644643|12359181|FG002|Overall Study|Withdrawal by Subject|2
7868138|NCT01644643|12359182|FG003|Overall Study|Withdrawal by Subject|1
7868139|NCT01644643|12359179|FG000|Overall Study|Other Eligibility criteria|0
7868140|NCT01644643|12359180|FG001|Overall Study|Other Eligibility criteria|0
7868141|NCT01644643|12359181|FG002|Overall Study|Other Eligibility criteria|0
7868142|NCT01644643|12359182|FG003|Overall Study|Other Eligibility criteria|2
7868143|NCT01644734|12359202|FG000|Overall Study|Adverse Event|4
7868144|NCT01644734|12359202|FG000|Overall Study|Lost to Follow-up|17
7868145|NCT01644734|12359202|FG000|Overall Study|Reasons other than stated above|7
7868146|NCT01644734|12359202|FG000|Overall Study|Missing documentation|238
7868147|NCT01644890|12359208|FG000|Overall Study|Adverse Event|7
7868148|NCT01644890|12359209|FG001|Overall Study|Adverse Event|20
7868149|NCT01644890|12359208|FG000|Overall Study|Death|1
7868150|NCT01644890|12359209|FG001|Overall Study|Death|3
7868151|NCT01644890|12359208|FG000|Overall Study|Physician Decision|3
7868152|NCT01644890|12359209|FG001|Overall Study|Physician Decision|9
7868153|NCT01644890|12359208|FG000|Overall Study|Protocol Violation|6
7868154|NCT01644890|12359209|FG001|Overall Study|Protocol Violation|7
7868155|NCT01644890|12359208|FG000|Overall Study|Withdrawal by Subject|19
7868156|NCT01644890|12359209|FG001|Overall Study|Withdrawal by Subject|27
7868157|NCT01644890|12359208|FG000|Overall Study|Progression Disease|160
7868158|NCT01644890|12359209|FG001|Overall Study|Progression Disease|131
7868159|NCT01644890|12359208|FG000|Overall Study|Clinical Progression|6
7868160|NCT01644890|12359209|FG001|Overall Study|Clinical Progression|6
7868161|NCT01644890|12359208|FG000|Overall Study|> 28 days since last dose of study drug|6
7868162|NCT01644890|12359209|FG001|Overall Study|> 28 days since last dose of study drug|3
7868163|NCT01644890|12359208|FG000|Overall Study|Other|8
7868164|NCT01644890|12359209|FG001|Overall Study|Other|9
7868165|NCT01645111|12359233|FG000|Overall Study|Did not require Clevidipine|15
7868166|NCT01645176|12359237|FG000|Overall Study|Lack of Efficacy|4
7868167|NCT01645176|12359237|FG000|Overall Study|did not complete final MRI|1
7868168|NCT01645280|12359246|FG000|Overall Study|Death|0
7868169|NCT01645280|12359247|FG001|Overall Study|Death|1
7868170|NCT01645280|12359248|FG002|Overall Study|Death|0
7868171|NCT01645280|12359249|FG003|Overall Study|Death|0
7868172|NCT01645280|12359250|FG004|Overall Study|Death|0
7868173|NCT01645280|12359246|FG000|Overall Study|Withdrawal by Subject|4
7868174|NCT01645280|12359247|FG001|Overall Study|Withdrawal by Subject|0
7868175|NCT01645280|12359248|FG002|Overall Study|Withdrawal by Subject|2
7868176|NCT01645280|12359249|FG003|Overall Study|Withdrawal by Subject|4
7868177|NCT01645280|12359250|FG004|Overall Study|Withdrawal by Subject|5
7868178|NCT01645280|12359246|FG000|Overall Study|Lost to Follow-up|0
7868179|NCT01645280|12359247|FG001|Overall Study|Lost to Follow-up|0
7868180|NCT01645280|12359248|FG002|Overall Study|Lost to Follow-up|0
7868181|NCT01645280|12359249|FG003|Overall Study|Lost to Follow-up|2
7868182|NCT01645280|12359250|FG004|Overall Study|Lost to Follow-up|1
7868183|NCT01645280|12359246|FG000|Overall Study|Other|1
7868184|NCT01645280|12359247|FG001|Overall Study|Other|1
7868185|NCT01645280|12359248|FG002|Overall Study|Other|2
7868186|NCT01645280|12359249|FG003|Overall Study|Other|0
7868187|NCT01645280|12359250|FG004|Overall Study|Other|0
7868188|NCT01645280|12359246|FG000|Overall Study|Treatment not completed/Completed f/u|1
7868189|NCT01645280|12359247|FG001|Overall Study|Treatment not completed/Completed f/u|1
7868190|NCT01645280|12359248|FG002|Overall Study|Treatment not completed/Completed f/u|2
7623797|NCT03403634|12034706|FG000|Overall Study|Disease progression|3
7623798|NCT03403634|12034706|FG000|Overall Study|Did not meet eligibility criteria|4
7868191|NCT01645280|12359249|FG003|Overall Study|Treatment not completed/Completed f/u|0
7868192|NCT01645280|12359250|FG004|Overall Study|Treatment not completed/Completed f/u|2
7868193|NCT01645735|12359278|FG000|Overall Study|Physician Decision|2
7868194|NCT01645735|12359279|FG001|Overall Study|Physician Decision|0
7868195|NCT01645735|12359278|FG000|Overall Study|Withdrawal by Subject|1
7868196|NCT01645735|12359279|FG001|Overall Study|Withdrawal by Subject|0
7868197|NCT01645735|12359278|FG000|Overall Study|Protocol Violation|1
7868198|NCT01645735|12359279|FG001|Overall Study|Protocol Violation|0
7868199|NCT01645735|12359278|FG000|Overall Study|Adverse Event|0
7868200|NCT01645735|12359279|FG001|Overall Study|Adverse Event|1
7868201|NCT01645930|12359286|FG000|Overall Study|Participants Ongoing on Study Treatment|22
7868202|NCT01645930|12359286|FG000|Overall Study|Progressive Disease|12
7868203|NCT01645930|12359286|FG000|Overall Study|Adverse Event|4
7868204|NCT01645930|12359286|FG000|Overall Study|Unsatisfactory Therapeutic Response|2
7868205|NCT01645930|12359286|FG000|Overall Study|Withdrawal by Participant|2
7868206|NCT01645930|12359286|FG000|Overall Study|Reason not Defined|1
7868207|NCT01646021|12359292|FG000|Overall Study|Death|77
7868208|NCT01646021|12359293|FG001|Overall Study|Death|83
7868209|NCT01646021|12359292|FG000|Overall Study|Study Terminated by Sponsor|50
7868210|NCT01646021|12359293|FG001|Overall Study|Study Terminated by Sponsor|41
7868211|NCT01646021|12359292|FG000|Overall Study|Lost to Follow-up|2
7868212|NCT01646021|12359293|FG001|Overall Study|Lost to Follow-up|2
7868213|NCT01646021|12359292|FG000|Overall Study|Withdrawal by Subject|10
7868214|NCT01646021|12359293|FG001|Overall Study|Withdrawal by Subject|15
7868215|NCT01646073|12359301|FG000|Period A (12 Weeks)|Adverse Event|0
7868216|NCT01646073|12359302|FG001|Period A (12 Weeks)|Adverse Event|2
7868217|NCT01646073|12359301|FG000|Period A (12 Weeks)|Withdrawal by Subject|1
7868218|NCT01646073|12359302|FG001|Period A (12 Weeks)|Withdrawal by Subject|1
7868219|NCT01646073|12359301|FG000|Period A (12 Weeks)|Lack of Efficacy|1
7868220|NCT01646073|12359302|FG001|Period A (12 Weeks)|Lack of Efficacy|0
7868221|NCT01646073|12359301|FG000|Period A (12 Weeks)|Protocol Violation|0
7868222|NCT01646073|12359302|FG001|Period A (12 Weeks)|Protocol Violation|1
7868223|NCT01646073|12359301|FG000|Period A (12 Weeks)|Other|0
7868224|NCT01646073|12359302|FG001|Period A (12 Weeks)|Other|1
7868225|NCT01646073|12359301|FG000|Period B (12 Weeks)|Adverse Event|0
7868226|NCT01646073|12359302|FG001|Period B (12 Weeks)|Adverse Event|7
7868227|NCT01646073|12359301|FG000|Period B (12 Weeks)|Withdrawal by Subject|1
7868228|NCT01646073|12359302|FG001|Period B (12 Weeks)|Withdrawal by Subject|5
7868229|NCT01646073|12359301|FG000|Period B (12 Weeks)|Lost to Follow-up|0
7868230|NCT01646073|12359302|FG001|Period B (12 Weeks)|Lost to Follow-up|1
7868231|NCT01646125|12359313|FG000|Overall Study|Untreated|2
7868232|NCT01646125|12359314|FG001|Overall Study|Untreated|5
7868233|NCT01646125|12359313|FG000|Overall Study|Adverse Event|2
7868234|NCT01646125|12359314|FG001|Overall Study|Adverse Event|1
7868235|NCT01646125|12359313|FG000|Overall Study|Death|1
7868236|NCT01646125|12359314|FG001|Overall Study|Death|1
7868237|NCT01646125|12359313|FG000|Overall Study|Physician Decision|1
7868238|NCT01646125|12359314|FG001|Overall Study|Physician Decision|3
7868239|NCT01646125|12359313|FG000|Overall Study|Progressive disease|22
7868240|NCT01646125|12359314|FG001|Overall Study|Progressive disease|16
7868241|NCT01646125|12359313|FG000|Overall Study|Study terminated by sponsor|2
7868242|NCT01646125|12359314|FG001|Overall Study|Study terminated by sponsor|1
7868243|NCT01646125|12359313|FG000|Overall Study|Subject/Guardian decision|1
7868244|NCT01646125|12359314|FG001|Overall Study|Subject/Guardian decision|1
7868245|NCT01646138|12359326|FG000|Overall Study|Lost to Follow-up|0
7868246|NCT01646138|12359327|FG001|Overall Study|Lost to Follow-up|0
7868247|NCT01646138|12359328|FG002|Overall Study|Lost to Follow-up|0
7868248|NCT01646138|12359329|FG003|Overall Study|Lost to Follow-up|0
7868249|NCT01646138|12359330|FG004|Overall Study|Lost to Follow-up|2
7868250|NCT01646177|12359350|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
7868251|NCT01646177|12359351|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
7868252|NCT01646177|12359352|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
7868253|NCT01646177|12359353|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
7868254|NCT01646177|12359354|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7868255|NCT01646177|12359355|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7868256|NCT01646177|12359356|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7868257|NCT01646177|12359357|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7868258|NCT01646177|12359358|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7868259|NCT01646177|12359359|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7868260|NCT01646177|12359360|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7868261|NCT01646177|12359361|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7868262|NCT01646177|12359350|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
7868263|NCT01646177|12359351|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
7868264|NCT01646177|12359352|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
7868265|NCT01646177|12359353|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
7868266|NCT01646177|12359354|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7868267|NCT01646177|12359355|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7868268|NCT01646177|12359356|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7623799|NCT03382041|12034712|FG000|Overall Study|Consent Form Lost|2
7868269|NCT01646177|12359357|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7868270|NCT01646177|12359358|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7868271|NCT01646177|12359359|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7868272|NCT01646177|12359360|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7868273|NCT01646177|12359361|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7868274|NCT01646177|12359350|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
7868275|NCT01646177|12359351|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
7868276|NCT01646177|12359352|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
7868277|NCT01646177|12359353|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
7868278|NCT01646177|12359354|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7868279|NCT01646177|12359355|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7868280|NCT01646177|12359356|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7868281|NCT01646177|12359357|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7868282|NCT01646177|12359358|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7868283|NCT01646177|12359359|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7868284|NCT01646177|12359360|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7868285|NCT01646177|12359361|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7868286|NCT01646177|12359350|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
7868287|NCT01646177|12359351|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
7868288|NCT01646177|12359352|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
7868289|NCT01646177|12359353|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
7868290|NCT01646177|12359354|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7623800|NCT03382041|12034713|FG001|Overall Study|Consent Form Lost|1
7623801|NCT03382041|12034712|FG000|Overall Study|Withdrawal by Subject|1
7623802|NCT03382041|12034713|FG001|Overall Study|Withdrawal by Subject|4
7623803|NCT03382041|12034712|FG000|Overall Study|Lost to Follow-up|1
7623804|NCT03382041|12034713|FG001|Overall Study|Lost to Follow-up|4
7623805|NCT03201419|12034728|FG000|Overall Study|Adverse Event|3
7623806|NCT03201419|12034729|FG001|Overall Study|Adverse Event|1
7623807|NCT03201419|12034730|FG002|Overall Study|Adverse Event|0
7623808|NCT03201419|12034731|FG003|Overall Study|Adverse Event|0
7623809|NCT03201419|12034732|FG004|Overall Study|Adverse Event|1
7623810|NCT03201419|12034733|FG005|Overall Study|Adverse Event|1
7623811|NCT03201419|12034734|FG006|Overall Study|Adverse Event|5
7623812|NCT03201419|12034735|FG007|Overall Study|Adverse Event|0
7623813|NCT03201419|12034736|FG008|Overall Study|Adverse Event|0
7623814|NCT03201419|12034728|FG000|Overall Study|Lost to Follow-up|1
7623815|NCT03201419|12034729|FG001|Overall Study|Lost to Follow-up|0
7623816|NCT03201419|12034730|FG002|Overall Study|Lost to Follow-up|0
7623817|NCT03201419|12034731|FG003|Overall Study|Lost to Follow-up|0
7623818|NCT03201419|12034732|FG004|Overall Study|Lost to Follow-up|0
7623819|NCT03201419|12034733|FG005|Overall Study|Lost to Follow-up|0
7623820|NCT03201419|12034734|FG006|Overall Study|Lost to Follow-up|0
7623821|NCT03201419|12034735|FG007|Overall Study|Lost to Follow-up|0
7623822|NCT03201419|12034736|FG008|Overall Study|Lost to Follow-up|0
7623823|NCT03201419|12034728|FG000|Overall Study|Protocol Deviation|0
7623824|NCT03201419|12034729|FG001|Overall Study|Protocol Deviation|0
7623825|NCT03201419|12034730|FG002|Overall Study|Protocol Deviation|0
7623826|NCT03201419|12034731|FG003|Overall Study|Protocol Deviation|0
7623827|NCT03201419|12034732|FG004|Overall Study|Protocol Deviation|0
7623828|NCT03201419|12034733|FG005|Overall Study|Protocol Deviation|0
7623829|NCT03201419|12034734|FG006|Overall Study|Protocol Deviation|1
7623830|NCT03201419|12034735|FG007|Overall Study|Protocol Deviation|0
7623831|NCT03201419|12034736|FG008|Overall Study|Protocol Deviation|0
7623832|NCT03201419|12034728|FG000|Overall Study|Withdrawal by Subject|4
7623833|NCT03201419|12034729|FG001|Overall Study|Withdrawal by Subject|2
7623834|NCT03201419|12034730|FG002|Overall Study|Withdrawal by Subject|1
7623835|NCT03201419|12034731|FG003|Overall Study|Withdrawal by Subject|0
7623836|NCT03201419|12034732|FG004|Overall Study|Withdrawal by Subject|0
7623837|NCT03201419|12034733|FG005|Overall Study|Withdrawal by Subject|0
7623838|NCT03201419|12034734|FG006|Overall Study|Withdrawal by Subject|0
7623839|NCT03201419|12034735|FG007|Overall Study|Withdrawal by Subject|1
7623840|NCT03201419|12034736|FG008|Overall Study|Withdrawal by Subject|2
7623841|NCT03201419|12034728|FG000|Overall Study|Other|0
7623842|NCT03201419|12034729|FG001|Overall Study|Other|0
7623843|NCT03201419|12034730|FG002|Overall Study|Other|1
7623844|NCT03201419|12034731|FG003|Overall Study|Other|0
7623845|NCT03201419|12034732|FG004|Overall Study|Other|0
7623846|NCT03201419|12034733|FG005|Overall Study|Other|0
7623847|NCT03201419|12034734|FG006|Overall Study|Other|0
7623848|NCT03201419|12034735|FG007|Overall Study|Other|0
7623849|NCT03201419|12034736|FG008|Overall Study|Other|0
7623850|NCT03197766|12034772|FG000|Overall Study|Withdrawal by Subject|2
7623851|NCT03197766|12034773|FG001|Overall Study|Withdrawal by Subject|0
7792267|NCT01034137|12246607|FG001|Overall Study|Administrative or other|3
7792268|NCT01034137|12246608|FG002|Overall Study|Administrative or other|4
7792269|NCT01034163|12246619|FG000|Overall Study|Treatment completed as per protocol|8
7792270|NCT01034163|12246620|FG001|Overall Study|Treatment completed as per protocol|7
7792271|NCT01034163|12246619|FG000|Overall Study|Withdrawal by Subject|8
7792272|NCT01034163|12246620|FG001|Overall Study|Withdrawal by Subject|2
7792273|NCT01034163|12246619|FG000|Overall Study|Protocol deviation|1
7792274|NCT01034163|12246620|FG001|Overall Study|Protocol deviation|0
7792275|NCT01034163|12246619|FG000|Overall Study|Disease progression|3
7792276|NCT01034163|12246620|FG001|Overall Study|Disease progression|4
7792277|NCT01034163|12246619|FG000|Overall Study|Adverse Event|6
7868291|NCT01646177|12359355|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7868292|NCT01646177|12359356|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7868293|NCT01646177|12359357|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7868294|NCT01646177|12359358|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7868295|NCT01646177|12359359|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7868296|NCT01646177|12359360|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7868297|NCT01646177|12359361|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7868298|NCT01646177|12359350|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7868299|NCT01646177|12359351|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7868300|NCT01646177|12359352|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
7868301|NCT01646177|12359353|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
7868302|NCT01646177|12359354|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7868303|NCT01646177|12359355|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7868304|NCT01646177|12359356|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7868305|NCT01646177|12359357|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7868306|NCT01646177|12359358|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7868307|NCT01646177|12359359|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7868308|NCT01646177|12359360|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7868309|NCT01646177|12359361|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7868310|NCT01646177|12359350|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
7868311|NCT01646177|12359351|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
7868312|NCT01646177|12359352|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
7868313|NCT01646177|12359353|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7868314|NCT01646177|12359354|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7868315|NCT01646177|12359355|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7868316|NCT01646177|12359356|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7868317|NCT01646177|12359357|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7868318|NCT01646177|12359358|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7792278|NCT01034163|12246620|FG001|Overall Study|Adverse Event|0
7792279|NCT01034163|12246619|FG000|Overall Study|Administrative problems|0
7868319|NCT01646177|12359359|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7868320|NCT01646177|12359360|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7868321|NCT01646177|12359361|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7868322|NCT01646177|12359350|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7868323|NCT01646177|12359351|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7868324|NCT01646177|12359352|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7868325|NCT01646177|12359353|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7868326|NCT01646177|12359354|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16
7868327|NCT01646177|12359355|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34
7868328|NCT01646177|12359356|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43
7868329|NCT01646177|12359357|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30
7868330|NCT01646177|12359358|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7868331|NCT01646177|12359359|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7868332|NCT01646177|12359360|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7868333|NCT01646177|12359361|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7868334|NCT01646177|12359350|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7868335|NCT01646177|12359351|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7868336|NCT01646177|12359352|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7868337|NCT01646177|12359353|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7868338|NCT01646177|12359354|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11
7868339|NCT01646177|12359355|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30
7868340|NCT01646177|12359356|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29
7868341|NCT01646177|12359357|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27
7868342|NCT01646177|12359358|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7868343|NCT01646177|12359359|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7868344|NCT01646177|12359360|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7868345|NCT01646177|12359361|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7868346|NCT01646177|12359350|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7868347|NCT01646177|12359351|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7623852|NCT04516759|12034791|FG000|Overall Study|Withdrawal by Subject|1
7868348|NCT01646177|12359352|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7868349|NCT01646177|12359353|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7868350|NCT01646177|12359354|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6
7868351|NCT01646177|12359355|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17
7868352|NCT01646177|12359356|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23
7868353|NCT01646177|12359357|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18
7868354|NCT01646177|12359358|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7868355|NCT01646177|12359359|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7868356|NCT01646177|12359360|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7868357|NCT01646177|12359361|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7868358|NCT01646177|12359350|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7868359|NCT01646177|12359351|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7868360|NCT01646177|12359352|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7868361|NCT01646177|12359353|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7868362|NCT01646177|12359354|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6
7868363|NCT01646177|12359355|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14
7868364|NCT01646177|12359356|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10
7868365|NCT01646177|12359357|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11
7868366|NCT01646177|12359358|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7868367|NCT01646177|12359359|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7868368|NCT01646177|12359360|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7868369|NCT01646177|12359361|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7868370|NCT01646177|12359350|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7868371|NCT01646177|12359351|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7868372|NCT01646177|12359352|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7868373|NCT01646177|12359353|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7868374|NCT01646177|12359354|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3
7868375|NCT01646177|12359355|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5
7868376|NCT01646177|12359356|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5
7868377|NCT01646177|12359357|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5
7868378|NCT01646177|12359358|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7868379|NCT01646177|12359359|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7868380|NCT01646177|12359360|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7868381|NCT01646177|12359361|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7868382|NCT01646177|12359350|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7868383|NCT01646177|12359351|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7868384|NCT01646177|12359352|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7868385|NCT01646177|12359353|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7868386|NCT01646177|12359354|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1
7868387|NCT01646177|12359355|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4
7868388|NCT01646177|12359356|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7868389|NCT01646177|12359357|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5
7868390|NCT01646177|12359358|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7868391|NCT01646177|12359359|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7868392|NCT01646177|12359360|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7868393|NCT01646177|12359361|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7868394|NCT01646177|12359350|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7868395|NCT01646177|12359351|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7868396|NCT01646177|12359352|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7868397|NCT01646177|12359353|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7868398|NCT01646177|12359354|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3
7868399|NCT01646177|12359355|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
7868400|NCT01646177|12359356|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
7868401|NCT01646177|12359357|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
7868402|NCT01646177|12359358|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7868403|NCT01646177|12359359|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7868404|NCT01646177|12359360|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7868405|NCT01646177|12359361|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7868406|NCT01646177|12359350|FG000|Long-Term Extension Period (Week 12-264)|Death|0
7868407|NCT01646177|12359351|FG001|Long-Term Extension Period (Week 12-264)|Death|0
7868408|NCT01646177|12359352|FG002|Long-Term Extension Period (Week 12-264)|Death|0
7868409|NCT01646177|12359353|FG003|Long-Term Extension Period (Week 12-264)|Death|0
7868410|NCT01646177|12359354|FG004|Long-Term Extension Period (Week 12-264)|Death|1
7868411|NCT01646177|12359355|FG005|Long-Term Extension Period (Week 12-264)|Death|3
7868412|NCT01646177|12359356|FG006|Long-Term Extension Period (Week 12-264)|Death|1
7868413|NCT01646177|12359357|FG007|Long-Term Extension Period (Week 12-264)|Death|3
7868414|NCT01646177|12359358|FG008|Long-Term Extension Period (Week 12-264)|Death|0
7868415|NCT01646177|12359359|FG009|Long-Term Extension Period (Week 12-264)|Death|0
7868416|NCT01646177|12359360|FG010|Long-Term Extension Period (Week 12-264)|Death|0
7868417|NCT01646177|12359361|FG011|Long-Term Extension Period (Week 12-264)|Death|0
7868418|NCT01646177|12359350|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7868419|NCT01646177|12359351|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7868420|NCT01646177|12359352|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7868421|NCT01646177|12359353|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7868422|NCT01646177|12359354|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
7868423|NCT01646177|12359355|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
7868424|NCT01646177|12359356|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
7868425|NCT01646177|12359357|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4
7868426|NCT01646177|12359358|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7868427|NCT01646177|12359359|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7868428|NCT01646177|12359360|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7868429|NCT01646177|12359361|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7868430|NCT01646177|12359350|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7868431|NCT01646177|12359351|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7868432|NCT01646177|12359352|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7868433|NCT01646177|12359353|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7868434|NCT01646177|12359354|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7623853|NCT04516759|12034792|FG001|Overall Study|Withdrawal by Subject|1
7623854|NCT04516759|12034791|FG000|Overall Study|Other|0
7623855|NCT04516759|12034792|FG001|Overall Study|Other|1
7868435|NCT01646177|12359355|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7868436|NCT01646177|12359356|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7868437|NCT01646177|12359357|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1
7868438|NCT01646177|12359358|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7868439|NCT01646177|12359359|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7868440|NCT01646177|12359360|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7868441|NCT01646177|12359361|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7868442|NCT01646177|12359350|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7868443|NCT01646177|12359351|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7868444|NCT01646177|12359352|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7868445|NCT01646177|12359353|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7868446|NCT01646177|12359354|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7868447|NCT01646177|12359355|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3
7868448|NCT01646177|12359356|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2
7868449|NCT01646177|12359357|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1
7868450|NCT01646177|12359358|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7868451|NCT01646177|12359359|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7868452|NCT01646177|12359360|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7868453|NCT01646177|12359361|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7868454|NCT01646177|12359350|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7868455|NCT01646177|12359351|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7868456|NCT01646177|12359352|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7868457|NCT01646177|12359353|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7868458|NCT01646177|12359354|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7868459|NCT01646177|12359355|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7868460|NCT01646177|12359356|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7868461|NCT01646177|12359357|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7868462|NCT01646177|12359358|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13
7868463|NCT01646177|12359359|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28
7868464|NCT01646177|12359360|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34
7868465|NCT01646177|12359361|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30
7868466|NCT01646177|12359350|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7868467|NCT01646177|12359351|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7868468|NCT01646177|12359352|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7868469|NCT01646177|12359353|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7868470|NCT01646177|12359354|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7868471|NCT01646177|12359355|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7868472|NCT01646177|12359356|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7868473|NCT01646177|12359357|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7868474|NCT01646177|12359358|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7
7868475|NCT01646177|12359359|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21
7868476|NCT01646177|12359360|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
7623856|NCT03409276|12034817|FG000|Overall Study|Withdrawal by Subject|0
7868477|NCT01646177|12359361|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
7868478|NCT01646177|12359350|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7868479|NCT01646177|12359351|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7868480|NCT01646177|12359352|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7868481|NCT01646177|12359353|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7868482|NCT01646177|12359354|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7868483|NCT01646177|12359355|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7868484|NCT01646177|12359356|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7868485|NCT01646177|12359357|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7868486|NCT01646177|12359358|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4
7868487|NCT01646177|12359359|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8
7868488|NCT01646177|12359360|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
7868489|NCT01646177|12359361|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
7868490|NCT01646177|12359350|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7868491|NCT01646177|12359351|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7868492|NCT01646177|12359352|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7868493|NCT01646177|12359353|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7868494|NCT01646177|12359354|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7868495|NCT01646177|12359355|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7868496|NCT01646177|12359356|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7868497|NCT01646177|12359357|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7868498|NCT01646177|12359358|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4
7868499|NCT01646177|12359359|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
7868500|NCT01646177|12359360|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8
7868501|NCT01646177|12359361|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
7868502|NCT01646177|12359350|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7868503|NCT01646177|12359351|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7868504|NCT01646177|12359352|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7868505|NCT01646177|12359353|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7868506|NCT01646177|12359354|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7868507|NCT01646177|12359355|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7868508|NCT01646177|12359356|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7868509|NCT01646177|12359357|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7868510|NCT01646177|12359358|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1
7868511|NCT01646177|12359359|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6
7868512|NCT01646177|12359360|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4
7868513|NCT01646177|12359361|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7
7868514|NCT01646177|12359350|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7868515|NCT01646177|12359351|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7868516|NCT01646177|12359352|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7883486|NCT01782326|12383167|FG001|Double-blind Treatment|Lack of Efficacy|22
7868517|NCT01646177|12359353|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7868518|NCT01646177|12359354|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7868519|NCT01646177|12359355|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7868520|NCT01646177|12359356|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7868521|NCT01646177|12359357|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7868522|NCT01646177|12359358|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1
7868523|NCT01646177|12359359|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
7868524|NCT01646177|12359360|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
7868525|NCT01646177|12359361|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3
7868526|NCT01646177|12359350|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7868527|NCT01646177|12359351|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7868528|NCT01646177|12359352|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7868529|NCT01646177|12359353|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7868530|NCT01646177|12359354|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7868531|NCT01646177|12359355|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7868532|NCT01646177|12359356|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7868533|NCT01646177|12359357|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7868534|NCT01646177|12359358|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7868535|NCT01646177|12359359|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
7868536|NCT01646177|12359360|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
7868537|NCT01646177|12359361|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3
7868538|NCT01646177|12359350|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7868539|NCT01646177|12359351|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7868540|NCT01646177|12359352|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7868541|NCT01646177|12359353|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7868542|NCT01646177|12359354|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7868543|NCT01646177|12359355|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7868544|NCT01646177|12359356|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7868545|NCT01646177|12359357|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7868546|NCT01646177|12359358|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7868547|NCT01646177|12359359|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
7868548|NCT01646177|12359360|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
7868549|NCT01646177|12359361|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
7868550|NCT01646177|12359350|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7868551|NCT01646177|12359351|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7868552|NCT01646177|12359352|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7868553|NCT01646177|12359353|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7868554|NCT01646177|12359354|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7868555|NCT01646177|12359355|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7868556|NCT01646177|12359356|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7868557|NCT01646177|12359357|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7868558|NCT01646177|12359358|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1
7868559|NCT01646177|12359359|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7868560|NCT01646177|12359360|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1
7868561|NCT01646177|12359361|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1
7792280|NCT01034163|12246620|FG001|Overall Study|Administrative problems|1
7868562|NCT01646177|12359350|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7868563|NCT01646177|12359351|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7868564|NCT01646177|12359352|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7868565|NCT01646177|12359353|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7868566|NCT01646177|12359354|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7868567|NCT01646177|12359355|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7868568|NCT01646177|12359356|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7868569|NCT01646177|12359357|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7868570|NCT01646177|12359358|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7868571|NCT01646177|12359359|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7868572|NCT01646177|12359360|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
7868573|NCT01646177|12359361|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
7868574|NCT01646203|12359384|FG000|Overall Study|Adverse Event|2
7868575|NCT01646203|12359385|FG001|Overall Study|Adverse Event|0
7868576|NCT01646203|12359386|FG002|Overall Study|Adverse Event|1
7868577|NCT01646203|12359384|FG000|Overall Study|Withdrawal by Subject|0
7792281|NCT01034163|12246619|FG000|Overall Study|Abnormal laboratory value|1
7792282|NCT01034163|12246620|FG001|Overall Study|Abnormal laboratory value|0
7792283|NCT01034176|12246628|FG000|Overall Study|Physician Decision|2
7792284|NCT01034176|12246629|FG001|Overall Study|Physician Decision|0
7792285|NCT01034176|12246628|FG000|Overall Study|Withdrawal by Subject|0
7792286|NCT01034176|12246629|FG001|Overall Study|Withdrawal by Subject|1
7792287|NCT01034176|12246628|FG000|Overall Study|Lost to Follow-up|0
7792288|NCT01034176|12246629|FG001|Overall Study|Lost to Follow-up|1
7792289|NCT01034358|12246635|FG000|Overall Study|Withdrawal by Subject|1
7792290|NCT01034358|12246635|FG000|Overall Study|Protocol Violation|1
7868578|NCT01646203|12359385|FG001|Overall Study|Withdrawal by Subject|1
7868579|NCT01646203|12359386|FG002|Overall Study|Withdrawal by Subject|0
7868580|NCT01646203|12359384|FG000|Overall Study|Physician's Decision|0
7868581|NCT01646203|12359385|FG001|Overall Study|Physician's Decision|1
7868582|NCT01646203|12359386|FG002|Overall Study|Physician's Decision|0
7868583|NCT01646216|12359401|FG000|Overall Study|Baseline step length difference (<5cm)|10
7868584|NCT01646216|12359402|FG001|Overall Study|Baseline step length difference (<5cm)|10
7868585|NCT01646216|12359401|FG000|Overall Study|Did not complete training|0
7868586|NCT01646216|12359402|FG001|Overall Study|Did not complete training|2
7868587|NCT01646216|12359401|FG000|Overall Study|Investigator decision|1
7868588|NCT01646216|12359402|FG001|Overall Study|Investigator decision|1
7868589|NCT01646255|12359414|FG000|Overall Study|Adverse Event|7
7868590|NCT01646255|12359415|FG001|Overall Study|Adverse Event|8
7868591|NCT01646255|12359414|FG000|Overall Study|Lack of Efficacy|2
7868592|NCT01646255|12359415|FG001|Overall Study|Lack of Efficacy|0
7868593|NCT01646255|12359414|FG000|Overall Study|Withdrawal by Subject|10
7868594|NCT01646255|12359415|FG001|Overall Study|Withdrawal by Subject|6
7868595|NCT01646255|12359414|FG000|Overall Study|Compliance is not well|1
7868596|NCT01646255|12359415|FG001|Overall Study|Compliance is not well|0
7868597|NCT01646255|12359414|FG000|Overall Study|Inclusion Criteria Deviation|1
7868598|NCT01646255|12359415|FG001|Overall Study|Inclusion Criteria Deviation|0
7868599|NCT01646268|12359424|FG000|Overall Study|Adverse Event|6
7868600|NCT01646268|12359425|FG001|Overall Study|Adverse Event|7
7868601|NCT01646268|12359424|FG000|Overall Study|Lack of Efficacy|1
7868602|NCT01646268|12359425|FG001|Overall Study|Lack of Efficacy|3
7868603|NCT01646268|12359424|FG000|Overall Study|Protocol Violation|0
7868604|NCT01646268|12359425|FG001|Overall Study|Protocol Violation|1
7868605|NCT01646268|12359424|FG000|Overall Study|Withdrawal by Subject|2
7868606|NCT01646268|12359425|FG001|Overall Study|Withdrawal by Subject|5
7868607|NCT01646268|12359424|FG000|Overall Study|Other|2
7868608|NCT01646268|12359425|FG001|Overall Study|Other|0
7868609|NCT01646320|12359433|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3
7868610|NCT01646320|12359434|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0
7868611|NCT01646320|12359433|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
7868612|NCT01646320|12359434|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
7868613|NCT01646320|12359433|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2
7868614|NCT01646320|12359434|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2
7868615|NCT01646320|12359433|FG000|Short-term Period (Day 1 to Week 24)|Other|1
7868616|NCT01646320|12359434|FG001|Short-term Period (Day 1 to Week 24)|Other|0
7868617|NCT01646320|12359433|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
7868618|NCT01646320|12359434|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
7868619|NCT01646320|12359433|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
7868620|NCT01646320|12359434|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
7868621|NCT01646320|12359433|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
7868622|NCT01646320|12359434|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
7868623|NCT01646320|12359433|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
7868624|NCT01646320|12359434|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
7868625|NCT01646320|12359433|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4
7868626|NCT01646320|12359434|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2
7868627|NCT01646320|12359433|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
7868628|NCT01646320|12359434|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
7868629|NCT01646320|12359433|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
7868630|NCT01646320|12359434|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
7868631|NCT01646385|12359446|FG000|Overall Study|Death|202
7868632|NCT01646385|12359447|FG001|Overall Study|Death|222
7868633|NCT01646385|12359446|FG000|Overall Study|Switched to alternate biologic|636
7868634|NCT01646385|12359447|FG001|Overall Study|Switched to alternate biologic|649
7868635|NCT01646398|12359455|FG000|Overall Study|Withdrawal by Subject|1
7868636|NCT01646398|12359456|FG001|Overall Study|Withdrawal by Subject|0
7868637|NCT01646645|12359462|FG000|Overall Study|No Treated|1
7868638|NCT01646645|12359462|FG000|Overall Study|Inevaluable Donor|29
7882525|NCT01772537|12381613|FG002|Overall Study|unsuccessful lumbar drain placement|0
7882526|NCT01772550|12381626|FG000|Overall Study|Unable to insert IV in antecubital vein|1
7882527|NCT01772550|12381627|FG001|Overall Study|Unable to insert IV in antecubital vein|1
7882528|NCT01772550|12381628|FG002|Overall Study|Unable to insert IV in antecubital vein|5
7882529|NCT01772550|12381626|FG000|Overall Study|Adverse Event|0
7882530|NCT01772550|12381627|FG001|Overall Study|Adverse Event|0
7882531|NCT01772550|12381628|FG002|Overall Study|Adverse Event|1
7882532|NCT01772576|12381636|FG000|Overall Study|Death|15
7882533|NCT01772576|12381636|FG000|Overall Study|Protocol Violation|1
7882534|NCT01772576|12381636|FG000|Overall Study|Lost to Follow-up|3
7882535|NCT01772576|12381636|FG000|Overall Study|Study device not used|3
7882536|NCT01772576|12381636|FG000|Overall Study|Adverse Event|6
7882537|NCT01772576|12381636|FG000|Overall Study|Withdrawal by Subject|6
7882538|NCT01772693|12381651|FG000|Overall Study|Health Concerns Unrelated to Study|2
7882539|NCT01772693|12381652|FG001|Overall Study|Health Concerns Unrelated to Study|1
7882540|NCT01772693|12381651|FG000|Overall Study|Withdrawal by Subject|2
7882541|NCT01772693|12381652|FG001|Overall Study|Withdrawal by Subject|0
7868639|NCT01646827|12359487|FG000|Overall Study|Lost to Follow-up|0
7868640|NCT01646827|12359488|FG001|Overall Study|Lost to Follow-up|3
7868641|NCT01646827|12359487|FG000|Overall Study|Physician Decision|1
7868642|NCT01646827|12359488|FG001|Overall Study|Physician Decision|2
7868643|NCT01646827|12359487|FG000|Overall Study|Withdrawal by Subject|1
7868644|NCT01646827|12359488|FG001|Overall Study|Withdrawal by Subject|0
7868645|NCT01647282|12359507|FG000|Overall Study|Physician Decision|7
7868646|NCT01647282|12359508|FG001|Overall Study|Physician Decision|5
7868647|NCT01647516|12359530|FG000|Induction Period (IP)|Physician Decision|2
7868648|NCT01647516|12359531|FG001|Induction Period (IP)|Physician Decision|0
7868649|NCT01647516|12359532|FG002|Induction Period (IP)|Physician Decision|0
7868650|NCT01647516|12359533|FG003|Induction Period (IP)|Physician Decision|0
7868651|NCT01647516|12359534|FG004|Induction Period (IP)|Physician Decision|0
7868652|NCT01647516|12359535|FG005|Induction Period (IP)|Physician Decision|0
7868653|NCT01647516|12359530|FG000|Induction Period (IP)|Adverse Event|1
7868654|NCT01647516|12359531|FG001|Induction Period (IP)|Adverse Event|2
7868655|NCT01647516|12359532|FG002|Induction Period (IP)|Adverse Event|0
7868656|NCT01647516|12359533|FG003|Induction Period (IP)|Adverse Event|0
7868657|NCT01647516|12359534|FG004|Induction Period (IP)|Adverse Event|0
7868658|NCT01647516|12359535|FG005|Induction Period (IP)|Adverse Event|0
7868659|NCT01647516|12359530|FG000|Induction Period (IP)|Withdrawal by Subject|1
7868660|NCT01647516|12359531|FG001|Induction Period (IP)|Withdrawal by Subject|0
7868661|NCT01647516|12359532|FG002|Induction Period (IP)|Withdrawal by Subject|3
7868662|NCT01647516|12359533|FG003|Induction Period (IP)|Withdrawal by Subject|0
7868663|NCT01647516|12359534|FG004|Induction Period (IP)|Withdrawal by Subject|0
7868664|NCT01647516|12359535|FG005|Induction Period (IP)|Withdrawal by Subject|0
7868665|NCT01647516|12359530|FG000|Induction Period (IP)|Participant Choice|0
7868666|NCT01647516|12359531|FG001|Induction Period (IP)|Participant Choice|0
7868667|NCT01647516|12359532|FG002|Induction Period (IP)|Participant Choice|1
7868668|NCT01647516|12359533|FG003|Induction Period (IP)|Participant Choice|0
7868669|NCT01647516|12359534|FG004|Induction Period (IP)|Participant Choice|0
7868670|NCT01647516|12359535|FG005|Induction Period (IP)|Participant Choice|0
7868671|NCT01647516|12359530|FG000|Induction Period (IP)|Lack of Efficacy|1
7868672|NCT01647516|12359531|FG001|Induction Period (IP)|Lack of Efficacy|0
7868673|NCT01647516|12359532|FG002|Induction Period (IP)|Lack of Efficacy|0
7868674|NCT01647516|12359533|FG003|Induction Period (IP)|Lack of Efficacy|0
7868675|NCT01647516|12359534|FG004|Induction Period (IP)|Lack of Efficacy|0
7868676|NCT01647516|12359535|FG005|Induction Period (IP)|Lack of Efficacy|0
7868677|NCT01647516|12359530|FG000|Induction Period (IP)|No study drug received|1
7868678|NCT01647516|12359531|FG001|Induction Period (IP)|No study drug received|1
7868679|NCT01647516|12359532|FG002|Induction Period (IP)|No study drug received|0
7868680|NCT01647516|12359533|FG003|Induction Period (IP)|No study drug received|0
7868681|NCT01647516|12359534|FG004|Induction Period (IP)|No study drug received|0
7868682|NCT01647516|12359535|FG005|Induction Period (IP)|No study drug received|0
7868683|NCT01647516|12359530|FG000|Maintenance Period (MP)|Adverse Event|2
7868684|NCT01647516|12359531|FG001|Maintenance Period (MP)|Adverse Event|1
7868685|NCT01647516|12359532|FG002|Maintenance Period (MP)|Adverse Event|0
7868686|NCT01647516|12359533|FG003|Maintenance Period (MP)|Adverse Event|0
7868687|NCT01647516|12359534|FG004|Maintenance Period (MP)|Adverse Event|0
7868688|NCT01647516|12359535|FG005|Maintenance Period (MP)|Adverse Event|0
7868689|NCT01647516|12359530|FG000|Maintenance Period (MP)|Non-compliance|1
7868690|NCT01647516|12359531|FG001|Maintenance Period (MP)|Non-compliance|0
7868691|NCT01647516|12359532|FG002|Maintenance Period (MP)|Non-compliance|0
7868692|NCT01647516|12359533|FG003|Maintenance Period (MP)|Non-compliance|0
7868693|NCT01647516|12359534|FG004|Maintenance Period (MP)|Non-compliance|0
7868694|NCT01647516|12359535|FG005|Maintenance Period (MP)|Non-compliance|0
7868695|NCT01647516|12359530|FG000|Maintenance Period (MP)|Withdrawal by Subject|0
7868696|NCT01647516|12359531|FG001|Maintenance Period (MP)|Withdrawal by Subject|1
7868697|NCT01647516|12359532|FG002|Maintenance Period (MP)|Withdrawal by Subject|1
7868698|NCT01647516|12359533|FG003|Maintenance Period (MP)|Withdrawal by Subject|0
7868699|NCT01647516|12359534|FG004|Maintenance Period (MP)|Withdrawal by Subject|0
7868700|NCT01647516|12359535|FG005|Maintenance Period (MP)|Withdrawal by Subject|0
7868701|NCT01647516|12359530|FG000|Maintenance Period (MP)|Lack of Efficacy|1
7868702|NCT01647516|12359531|FG001|Maintenance Period (MP)|Lack of Efficacy|4
7868703|NCT01647516|12359532|FG002|Maintenance Period (MP)|Lack of Efficacy|1
7868704|NCT01647516|12359533|FG003|Maintenance Period (MP)|Lack of Efficacy|0
7868705|NCT01647516|12359534|FG004|Maintenance Period (MP)|Lack of Efficacy|0
7868706|NCT01647516|12359535|FG005|Maintenance Period (MP)|Lack of Efficacy|0
7868707|NCT01647516|12359530|FG000|Open-Label Period|Adverse Event|0
7868708|NCT01647516|12359531|FG001|Open-Label Period|Adverse Event|0
7868709|NCT01647516|12359532|FG002|Open-Label Period|Adverse Event|0
7868710|NCT01647516|12359533|FG003|Open-Label Period|Adverse Event|5
7868711|NCT01647516|12359534|FG004|Open-Label Period|Adverse Event|6
7868712|NCT01647516|12359535|FG005|Open-Label Period|Adverse Event|3
7868713|NCT01647516|12359530|FG000|Open-Label Period|Pregnancy|0
7868714|NCT01647516|12359531|FG001|Open-Label Period|Pregnancy|0
7868715|NCT01647516|12359532|FG002|Open-Label Period|Pregnancy|0
7868716|NCT01647516|12359533|FG003|Open-Label Period|Pregnancy|0
7868717|NCT01647516|12359534|FG004|Open-Label Period|Pregnancy|0
7868718|NCT01647516|12359535|FG005|Open-Label Period|Pregnancy|1
7868719|NCT01647516|12359530|FG000|Open-Label Period|Non-compliance|0
7868720|NCT01647516|12359531|FG001|Open-Label Period|Non-compliance|0
7868721|NCT01647516|12359532|FG002|Open-Label Period|Non-compliance|0
7868722|NCT01647516|12359533|FG003|Open-Label Period|Non-compliance|1
7868723|NCT01647516|12359534|FG004|Open-Label Period|Non-compliance|0
7868724|NCT01647516|12359535|FG005|Open-Label Period|Non-compliance|1
7868725|NCT01647516|12359530|FG000|Open-Label Period|Physician Decision|0
7868726|NCT01647516|12359531|FG001|Open-Label Period|Physician Decision|0
7868727|NCT01647516|12359532|FG002|Open-Label Period|Physician Decision|0
7868728|NCT01647516|12359533|FG003|Open-Label Period|Physician Decision|1
7868729|NCT01647516|12359534|FG004|Open-Label Period|Physician Decision|1
7868730|NCT01647516|12359535|FG005|Open-Label Period|Physician Decision|0
7868731|NCT01647516|12359530|FG000|Open-Label Period|Withdrawal by Subject|0
7868732|NCT01647516|12359531|FG001|Open-Label Period|Withdrawal by Subject|0
7868733|NCT01647516|12359532|FG002|Open-Label Period|Withdrawal by Subject|0
7868734|NCT01647516|12359533|FG003|Open-Label Period|Withdrawal by Subject|9
7868735|NCT01647516|12359534|FG004|Open-Label Period|Withdrawal by Subject|11
7868736|NCT01647516|12359535|FG005|Open-Label Period|Withdrawal by Subject|6
7868737|NCT01647516|12359530|FG000|Open-Label Period|Lost to Follow-up|0
7868738|NCT01647516|12359531|FG001|Open-Label Period|Lost to Follow-up|0
7868739|NCT01647516|12359532|FG002|Open-Label Period|Lost to Follow-up|0
7868740|NCT01647516|12359533|FG003|Open-Label Period|Lost to Follow-up|1
7868741|NCT01647516|12359534|FG004|Open-Label Period|Lost to Follow-up|0
7868742|NCT01647516|12359535|FG005|Open-Label Period|Lost to Follow-up|1
7868743|NCT01647516|12359530|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0
7868744|NCT01647516|12359531|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0
7868745|NCT01647516|12359532|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0
7868746|NCT01647516|12359533|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18
7868747|NCT01647516|12359534|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13
7868748|NCT01647516|12359535|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23
7868749|NCT01647516|12359530|FG000|Open-Label Period|Lack of Efficacy|0
7868750|NCT01647516|12359531|FG001|Open-Label Period|Lack of Efficacy|0
7868751|NCT01647516|12359532|FG002|Open-Label Period|Lack of Efficacy|0
7868752|NCT01647516|12359533|FG003|Open-Label Period|Lack of Efficacy|7
7868753|NCT01647516|12359534|FG004|Open-Label Period|Lack of Efficacy|9
7868754|NCT01647516|12359535|FG005|Open-Label Period|Lack of Efficacy|10
7868755|NCT01647516|12359530|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0
7868756|NCT01647516|12359531|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0
7868757|NCT01647516|12359532|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0
7868758|NCT01647516|12359533|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7
7868759|NCT01647516|12359534|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9
7868760|NCT01647516|12359535|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10
7868761|NCT01647516|12359530|FG000|Open-Label Period|No completion / discontinuation visit|0
7868762|NCT01647516|12359531|FG001|Open-Label Period|No completion / discontinuation visit|0
7868763|NCT01647516|12359532|FG002|Open-Label Period|No completion / discontinuation visit|0
7868764|NCT01647516|12359533|FG003|Open-Label Period|No completion / discontinuation visit|0
7868765|NCT01647516|12359534|FG004|Open-Label Period|No completion / discontinuation visit|2
7868766|NCT01647516|12359535|FG005|Open-Label Period|No completion / discontinuation visit|1
7868767|NCT01647542|12359553|FG000|Overall Study|Major Protocol Deviation|1
7868768|NCT01647542|12359554|FG001|Overall Study|Major Protocol Deviation|0
7868769|NCT01647542|12359555|FG002|Overall Study|Major Protocol Deviation|0
7868770|NCT01647542|12359553|FG000|Overall Study|Adverse Event|4
7868771|NCT01647542|12359554|FG001|Overall Study|Adverse Event|5
7868772|NCT01647542|12359555|FG002|Overall Study|Adverse Event|4
7868773|NCT01647542|12359553|FG000|Overall Study|Lost to Follow-up|0
7868774|NCT01647542|12359554|FG001|Overall Study|Lost to Follow-up|2
7868775|NCT01647542|12359555|FG002|Overall Study|Lost to Follow-up|2
7868776|NCT01647542|12359553|FG000|Overall Study|Withdrawal by Subject|6
7868777|NCT01647542|12359554|FG001|Overall Study|Withdrawal by Subject|4
7868778|NCT01647542|12359555|FG002|Overall Study|Withdrawal by Subject|0
7868779|NCT01647542|12359553|FG000|Overall Study|Study Termination|64
7868780|NCT01647542|12359554|FG001|Overall Study|Study Termination|61
7868781|NCT01647542|12359555|FG002|Overall Study|Study Termination|65
7868782|NCT01647542|12359553|FG000|Overall Study|Lack of Efficacy|1
7868783|NCT01647542|12359554|FG001|Overall Study|Lack of Efficacy|1
7868784|NCT01647542|12359555|FG002|Overall Study|Lack of Efficacy|0
7868785|NCT01647542|12359553|FG000|Overall Study|Death|0
7868786|NCT01647542|12359554|FG001|Overall Study|Death|0
7868787|NCT01647542|12359555|FG002|Overall Study|Death|1
7868788|NCT01647711|12359577|FG000|Overall Study|Progressive disease|6
7868789|NCT01647711|12359578|FG001|Overall Study|Progressive disease|2
7868790|NCT01647711|12359579|FG002|Overall Study|Progressive disease|6
7868791|NCT01647711|12359580|FG003|Overall Study|Progressive disease|8
7868792|NCT01647711|12359581|FG004|Overall Study|Progressive disease|2
7868793|NCT01647711|12359577|FG000|Overall Study|Other adverse event|0
7868794|NCT01647711|12359578|FG001|Overall Study|Other adverse event|0
7868795|NCT01647711|12359579|FG002|Overall Study|Other adverse event|2
7868796|NCT01647711|12359580|FG003|Overall Study|Other adverse event|0
7868797|NCT01647711|12359581|FG004|Overall Study|Other adverse event|2
7868798|NCT01647711|12359577|FG000|Overall Study|Protocol Violation|0
7868799|NCT01647711|12359578|FG001|Overall Study|Protocol Violation|0
7868800|NCT01647711|12359579|FG002|Overall Study|Protocol Violation|0
7868801|NCT01647711|12359580|FG003|Overall Study|Protocol Violation|0
7868802|NCT01647711|12359581|FG004|Overall Study|Protocol Violation|1
7868803|NCT01647711|12359577|FG000|Overall Study|Refused to continue taking medication|0
7868804|NCT01647711|12359578|FG001|Overall Study|Refused to continue taking medication|0
7868805|NCT01647711|12359579|FG002|Overall Study|Refused to continue taking medication|0
7868806|NCT01647711|12359580|FG003|Overall Study|Refused to continue taking medication|2
7868807|NCT01647711|12359581|FG004|Overall Study|Refused to continue taking medication|1
7868808|NCT01647711|12359577|FG000|Overall Study|Other reason not defined|0
7868809|NCT01647711|12359578|FG001|Overall Study|Other reason not defined|1
7868810|NCT01647711|12359579|FG002|Overall Study|Other reason not defined|1
7868811|NCT01647711|12359580|FG003|Overall Study|Other reason not defined|1
7868812|NCT01647711|12359581|FG004|Overall Study|Other reason not defined|0
7868813|NCT01647958|12359623|FG000|Initial Study|Lost to Follow-up|2
7868814|NCT01647958|12359624|FG001|Initial Study|Lost to Follow-up|3
7868815|NCT01647958|12359623|FG000|Continuation Phase|treatment received during Overall Study|39
7868816|NCT01647958|12359624|FG001|Continuation Phase|treatment received during Overall Study|0
7868817|NCT01647958|12359623|FG000|Extended Follow-up Phase|Lost to Follow-up|8
7868818|NCT01647958|12359624|FG001|Extended Follow-up Phase|Lost to Follow-up|0
7868819|NCT01648101|12359642|FG000|Titration Phase (4 Weeks)|Protocol Violation|2
7868820|NCT01648101|12359643|FG001|Titration Phase (4 Weeks)|Protocol Violation|1
7868821|NCT01648101|12359644|FG002|Titration Phase (4 Weeks)|Protocol Violation|2
7868822|NCT01648101|12359642|FG000|Titration Phase (4 Weeks)|Adverse Event|0
7868823|NCT01648101|12359643|FG001|Titration Phase (4 Weeks)|Adverse Event|2
7868824|NCT01648101|12359644|FG002|Titration Phase (4 Weeks)|Adverse Event|3
7868825|NCT01648101|12359642|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
7868826|NCT01648101|12359643|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
7868827|NCT01648101|12359644|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
7868828|NCT01648101|12359642|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1
7868829|NCT01648101|12359643|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0
7868830|NCT01648101|12359644|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1
7868831|NCT01648101|12359642|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
7868832|NCT01648101|12359643|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
7868833|NCT01648101|12359644|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
7868834|NCT01648101|12359642|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1
7868835|NCT01648101|12359643|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3
7868836|NCT01648101|12359644|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4
7868837|NCT01648101|12359642|FG000|Transition Phase (4 Weeks)|Adverse Event|4
7868838|NCT01648101|12359643|FG001|Transition Phase (4 Weeks)|Adverse Event|3
7868839|NCT01648101|12359644|FG002|Transition Phase (4 Weeks)|Adverse Event|2
7868840|NCT01648101|12359642|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0
7868841|NCT01648101|12359643|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2
7868842|NCT01648101|12359644|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0
7868843|NCT01648101|12359642|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0
7868844|NCT01648101|12359643|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0
7868845|NCT01648101|12359644|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2
7868846|NCT01648101|12359642|FG000|Transition Phase (4 Weeks)|Study Terminated|1
7868847|NCT01648101|12359643|FG001|Transition Phase (4 Weeks)|Study Terminated|0
7868848|NCT01648101|12359644|FG002|Transition Phase (4 Weeks)|Study Terminated|0
7868849|NCT01648101|12359642|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
7868850|NCT01648101|12359643|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
7868851|NCT01648101|12359644|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
7868852|NCT01648140|12359660|FG000|Overall Study|Physician Decision|1
7868853|NCT01648140|12359661|FG001|Overall Study|Physician Decision|0
7868854|NCT01648140|12359662|FG002|Overall Study|Physician Decision|0
7868855|NCT01648140|12359663|FG003|Overall Study|Physician Decision|0
7868856|NCT01648140|12359660|FG000|Overall Study|Lack of Efficacy|4
7868857|NCT01648140|12359661|FG001|Overall Study|Lack of Efficacy|7
7868858|NCT01648140|12359662|FG002|Overall Study|Lack of Efficacy|1
7868859|NCT01648140|12359663|FG003|Overall Study|Lack of Efficacy|0
7868860|NCT01648140|12359660|FG000|Overall Study|Adverse Event|3
7868861|NCT01648140|12359661|FG001|Overall Study|Adverse Event|1
7868862|NCT01648140|12359662|FG002|Overall Study|Adverse Event|2
7868863|NCT01648140|12359663|FG003|Overall Study|Adverse Event|0
7868864|NCT01648140|12359660|FG000|Overall Study|Withdrawal by Subject|2
7868865|NCT01648140|12359661|FG001|Overall Study|Withdrawal by Subject|3
7868866|NCT01648140|12359662|FG002|Overall Study|Withdrawal by Subject|3
7868867|NCT01648140|12359663|FG003|Overall Study|Withdrawal by Subject|2
7868868|NCT01648140|12359660|FG000|Overall Study|Lost to Follow-up|2
7868869|NCT01648140|12359661|FG001|Overall Study|Lost to Follow-up|1
7868870|NCT01648140|12359662|FG002|Overall Study|Lost to Follow-up|2
7868871|NCT01648140|12359663|FG003|Overall Study|Lost to Follow-up|0
7868872|NCT01648166|12359684|FG000|Overall Study|inadequate toenail samples|53
7868873|NCT01648166|12359685|FG001|Overall Study|inadequate toenail samples|100
7868874|NCT01648283|12359691|FG000|Overall Study|Withdrawal by Subject|14
7868875|NCT01648348|12359733|FG000|Overall Study|Cancel|1
7868876|NCT01648348|12359734|FG001|Overall Study|Cancel|0
7868877|NCT01648348|12359735|FG002|Overall Study|Cancel|0
7868878|NCT01648348|12359736|FG003|Overall Study|Cancel|0
7868879|NCT01648348|12359737|FG004|Overall Study|Cancel|3
7868880|NCT01648348|12359738|FG005|Overall Study|Cancel|6
7868881|NCT01648348|12359733|FG000|Overall Study|Replaced for MTD analysis|1
7868882|NCT01648348|12359734|FG001|Overall Study|Replaced for MTD analysis|0
7868883|NCT01648348|12359735|FG002|Overall Study|Replaced for MTD analysis|1
7868884|NCT01648348|12359736|FG003|Overall Study|Replaced for MTD analysis|0
7868885|NCT01648348|12359737|FG004|Overall Study|Replaced for MTD analysis|0
7868886|NCT01648348|12359738|FG005|Overall Study|Replaced for MTD analysis|0
7868887|NCT01648582|12359771|FG000|Overall Study|Adverse Event|6
7868888|NCT01648582|12359772|FG001|Overall Study|Adverse Event|11
7868889|NCT01648582|12359773|FG002|Overall Study|Adverse Event|2
7868890|NCT01648582|12359771|FG000|Overall Study|Lost to Follow-up|9
7868891|NCT01648582|12359772|FG001|Overall Study|Lost to Follow-up|6
7868892|NCT01648582|12359773|FG002|Overall Study|Lost to Follow-up|8
7868893|NCT01648582|12359771|FG000|Overall Study|Protocol Violation|1
7868894|NCT01648582|12359772|FG001|Overall Study|Protocol Violation|2
7868895|NCT01648582|12359773|FG002|Overall Study|Protocol Violation|1
7868896|NCT01648582|12359771|FG000|Overall Study|Withdrawal by Subject|15
7868897|NCT01648582|12359772|FG001|Overall Study|Withdrawal by Subject|17
7868898|NCT01648582|12359773|FG002|Overall Study|Withdrawal by Subject|17
7868899|NCT01648582|12359771|FG000|Overall Study|Physician Decision|0
7868900|NCT01648582|12359772|FG001|Overall Study|Physician Decision|1
7868901|NCT01648582|12359773|FG002|Overall Study|Physician Decision|3
7868902|NCT01648582|12359771|FG000|Overall Study|Death|1
7868903|NCT01648582|12359772|FG001|Overall Study|Death|0
7868904|NCT01648582|12359773|FG002|Overall Study|Death|0
7868905|NCT01648582|12359771|FG000|Overall Study|Sponsor Decision|0
7868906|NCT01648582|12359772|FG001|Overall Study|Sponsor Decision|1
7868907|NCT01648582|12359773|FG002|Overall Study|Sponsor Decision|1
7868908|NCT01648699|12359784|FG000|Overall Study|Death|1
7868909|NCT01648699|12359784|FG000|Overall Study|Lost to Follow-up|2
7868910|NCT01648699|12359784|FG000|Overall Study|Unspecified/unable to complete 4 visits|2
7868911|NCT01648764|12359811|FG000|Overall Study|Progressive Disease|0
7868912|NCT01648764|12359812|FG001|Overall Study|Progressive Disease|1
7868913|NCT01648764|12359813|FG002|Overall Study|Progressive Disease|0
7868914|NCT01648764|12359814|FG003|Overall Study|Progressive Disease|0
7868915|NCT01648764|12359815|FG004|Overall Study|Progressive Disease|0
7868916|NCT01648764|12359816|FG005|Overall Study|Progressive Disease|1
7868917|NCT01648764|12359817|FG006|Overall Study|Progressive Disease|1
7868918|NCT01648764|12359818|FG007|Overall Study|Progressive Disease|0
7868919|NCT01648764|12359819|FG008|Overall Study|Progressive Disease|0
7868920|NCT01648764|12359820|FG009|Overall Study|Progressive Disease|2
7868921|NCT01648764|12359821|FG010|Overall Study|Progressive Disease|0
7868922|NCT01648764|12359822|FG011|Overall Study|Progressive Disease|1
7868923|NCT01648764|12359823|FG012|Overall Study|Progressive Disease|2
7868924|NCT01648764|12359824|FG013|Overall Study|Progressive Disease|1
7868925|NCT01648764|12359811|FG000|Overall Study|Adverse Event|0
7868926|NCT01648764|12359812|FG001|Overall Study|Adverse Event|0
7868927|NCT01648764|12359813|FG002|Overall Study|Adverse Event|0
7868928|NCT01648764|12359814|FG003|Overall Study|Adverse Event|0
7868929|NCT01648764|12359815|FG004|Overall Study|Adverse Event|0
7868930|NCT01648764|12359816|FG005|Overall Study|Adverse Event|1
7868931|NCT01648764|12359817|FG006|Overall Study|Adverse Event|0
7868932|NCT01648764|12359818|FG007|Overall Study|Adverse Event|0
7868933|NCT01648764|12359819|FG008|Overall Study|Adverse Event|0
7868934|NCT01648764|12359820|FG009|Overall Study|Adverse Event|1
7868935|NCT01648764|12359821|FG010|Overall Study|Adverse Event|0
7868936|NCT01648764|12359822|FG011|Overall Study|Adverse Event|3
7868937|NCT01648764|12359823|FG012|Overall Study|Adverse Event|1
7868938|NCT01648764|12359824|FG013|Overall Study|Adverse Event|1
7868939|NCT01648764|12359811|FG000|Overall Study|Death|0
7868940|NCT01648764|12359812|FG001|Overall Study|Death|0
7868941|NCT01648764|12359813|FG002|Overall Study|Death|0
7868942|NCT01648764|12359814|FG003|Overall Study|Death|0
7868943|NCT01648764|12359815|FG004|Overall Study|Death|0
7868944|NCT01648764|12359816|FG005|Overall Study|Death|0
7868945|NCT01648764|12359817|FG006|Overall Study|Death|1
7868946|NCT01648764|12359818|FG007|Overall Study|Death|0
7868947|NCT01648764|12359819|FG008|Overall Study|Death|0
7868948|NCT01648764|12359820|FG009|Overall Study|Death|0
7868949|NCT01648764|12359821|FG010|Overall Study|Death|0
7868950|NCT01648764|12359822|FG011|Overall Study|Death|0
7868951|NCT01648764|12359823|FG012|Overall Study|Death|0
7868952|NCT01648764|12359824|FG013|Overall Study|Death|1
7868953|NCT01648764|12359811|FG000|Overall Study|Withdrawal by Subject|0
7868954|NCT01648764|12359812|FG001|Overall Study|Withdrawal by Subject|0
7868955|NCT01648764|12359813|FG002|Overall Study|Withdrawal by Subject|0
7868956|NCT01648764|12359814|FG003|Overall Study|Withdrawal by Subject|0
7868957|NCT01648764|12359815|FG004|Overall Study|Withdrawal by Subject|0
7868958|NCT01648764|12359816|FG005|Overall Study|Withdrawal by Subject|0
7868959|NCT01648764|12359817|FG006|Overall Study|Withdrawal by Subject|2
7868960|NCT01648764|12359818|FG007|Overall Study|Withdrawal by Subject|0
7868961|NCT01648764|12359819|FG008|Overall Study|Withdrawal by Subject|0
7868962|NCT01648764|12359820|FG009|Overall Study|Withdrawal by Subject|0
7868963|NCT01648764|12359821|FG010|Overall Study|Withdrawal by Subject|0
7868964|NCT01648764|12359822|FG011|Overall Study|Withdrawal by Subject|0
7868965|NCT01648764|12359823|FG012|Overall Study|Withdrawal by Subject|1
7868966|NCT01648764|12359824|FG013|Overall Study|Withdrawal by Subject|0
7868967|NCT01648764|12359811|FG000|Overall Study|Investigator Decision|0
7868968|NCT01648764|12359812|FG001|Overall Study|Investigator Decision|0
7868969|NCT01648764|12359813|FG002|Overall Study|Investigator Decision|0
7868970|NCT01648764|12359814|FG003|Overall Study|Investigator Decision|0
7868971|NCT01648764|12359815|FG004|Overall Study|Investigator Decision|0
7868972|NCT01648764|12359816|FG005|Overall Study|Investigator Decision|0
7868973|NCT01648764|12359817|FG006|Overall Study|Investigator Decision|1
7868974|NCT01648764|12359818|FG007|Overall Study|Investigator Decision|0
7868975|NCT01648764|12359819|FG008|Overall Study|Investigator Decision|0
7868976|NCT01648764|12359820|FG009|Overall Study|Investigator Decision|0
7868977|NCT01648764|12359821|FG010|Overall Study|Investigator Decision|0
7868978|NCT01648764|12359822|FG011|Overall Study|Investigator Decision|1
7868979|NCT01648764|12359823|FG012|Overall Study|Investigator Decision|0
7868980|NCT01648764|12359824|FG013|Overall Study|Investigator Decision|0
7868981|NCT01648790|12359858|FG000|Treatment 3|Withdrawal by Subject|0
7868982|NCT01648790|12359859|FG001|Treatment 3|Withdrawal by Subject|0
7868983|NCT01648790|12359860|FG002|Treatment 3|Withdrawal by Subject|0
7868984|NCT01648790|12359861|FG003|Treatment 3|Withdrawal by Subject|1
7868985|NCT01648790|12359862|FG004|Treatment 3|Withdrawal by Subject|0
7868986|NCT01649232|12359888|FG000|Overall Study|Physician Decision|2
7868987|NCT01649232|12359889|FG001|Overall Study|Physician Decision|0
7868988|NCT01649271|12359903|FG000|Overall Study|Progressive disease|4
7868989|NCT01649271|12359904|FG001|Overall Study|Progressive disease|5
7868990|NCT01649271|12359903|FG000|Overall Study|Other Adverse Event|0
7868991|NCT01649271|12359904|FG001|Overall Study|Other Adverse Event|2
7868992|NCT01649271|12359903|FG000|Overall Study|Withdrawal by Subject|1
7868993|NCT01649271|12359904|FG001|Overall Study|Withdrawal by Subject|0
7868994|NCT01649271|12359903|FG000|Overall Study|Other than stated above|1
7868995|NCT01649271|12359904|FG001|Overall Study|Other than stated above|0
7868996|NCT01649297|12359916|FG000|Overall Study|Adverse Event|5
7868997|NCT01649297|12359917|FG001|Overall Study|Adverse Event|5
7868998|NCT01649297|12359918|FG002|Overall Study|Adverse Event|4
7868999|NCT01649297|12359919|FG003|Overall Study|Adverse Event|13
7869000|NCT01649297|12359920|FG004|Overall Study|Adverse Event|1
7869001|NCT01649297|12359916|FG000|Overall Study|Lack of Efficacy|0
7869002|NCT01649297|12359917|FG001|Overall Study|Lack of Efficacy|0
7869003|NCT01649297|12359918|FG002|Overall Study|Lack of Efficacy|0
7869004|NCT01649297|12359919|FG003|Overall Study|Lack of Efficacy|0
7869005|NCT01649297|12359920|FG004|Overall Study|Lack of Efficacy|1
7869006|NCT01649297|12359916|FG000|Overall Study|Non compliant with Protocol|1
7869007|NCT01649297|12359917|FG001|Overall Study|Non compliant with Protocol|0
7869008|NCT01649297|12359918|FG002|Overall Study|Non compliant with Protocol|3
7869009|NCT01649297|12359919|FG003|Overall Study|Non compliant with Protocol|2
7869010|NCT01649297|12359920|FG004|Overall Study|Non compliant with Protocol|1
7869011|NCT01649297|12359916|FG000|Overall Study|Lost to Follow-up|1
7869012|NCT01649297|12359917|FG001|Overall Study|Lost to Follow-up|1
7869013|NCT01649297|12359918|FG002|Overall Study|Lost to Follow-up|4
7869014|NCT01649297|12359919|FG003|Overall Study|Lost to Follow-up|3
7869015|NCT01649297|12359920|FG004|Overall Study|Lost to Follow-up|0
7869016|NCT01649297|12359916|FG000|Overall Study|Patient withdrawal (not due to AE)|3
7869017|NCT01649297|12359917|FG001|Overall Study|Patient withdrawal (not due to AE)|6
7869018|NCT01649297|12359918|FG002|Overall Study|Patient withdrawal (not due to AE)|4
7623857|NCT03409276|12034818|FG001|Overall Study|Withdrawal by Subject|0
7623858|NCT03409276|12034819|FG002|Overall Study|Withdrawal by Subject|0
7623859|NCT03409276|12034820|FG003|Overall Study|Withdrawal by Subject|0
7623860|NCT03409276|12034821|FG004|Overall Study|Withdrawal by Subject|1
7623861|NCT03409276|12034817|FG000|Overall Study|Lost to Follow-up|0
7623862|NCT03409276|12034818|FG001|Overall Study|Lost to Follow-up|0
7623863|NCT03409276|12034819|FG002|Overall Study|Lost to Follow-up|0
7623864|NCT03409276|12034820|FG003|Overall Study|Lost to Follow-up|2
7623865|NCT03409276|12034821|FG004|Overall Study|Lost to Follow-up|2
7623866|NCT03312907|12034840|FG000|Overall Study|Adverse Event|1
7623867|NCT03312907|12034841|FG001|Overall Study|Adverse Event|6
7623868|NCT03312907|12034842|FG002|Overall Study|Adverse Event|1
7623869|NCT03312907|12034840|FG000|Overall Study|Protocol Violation|2
7623870|NCT03312907|12034841|FG001|Overall Study|Protocol Violation|3
7623871|NCT03312907|12034842|FG002|Overall Study|Protocol Violation|4
7623872|NCT03312907|12034840|FG000|Overall Study|Lost to Follow-up|2
7623873|NCT03312907|12034841|FG001|Overall Study|Lost to Follow-up|3
7623874|NCT03312907|12034842|FG002|Overall Study|Lost to Follow-up|2
7623875|NCT03312907|12034840|FG000|Overall Study|Physician Decision|3
7623876|NCT03312907|12034841|FG001|Overall Study|Physician Decision|4
7623877|NCT03312907|12034842|FG002|Overall Study|Physician Decision|2
7623878|NCT03312907|12034840|FG000|Overall Study|Withdrawal by Subject|9
7623879|NCT03312907|12034841|FG001|Overall Study|Withdrawal by Subject|14
7623880|NCT03312907|12034842|FG002|Overall Study|Withdrawal by Subject|10
7623881|NCT03148756|12034852|FG000|Overall Study|Study Terminated|0
7623882|NCT03148756|12034853|FG001|Overall Study|Study Terminated|1
7623883|NCT03079102|12034861|FG000|Overall Study|Physician Decision|0
7623884|NCT03079102|12034862|FG001|Overall Study|Physician Decision|1
7623885|NCT02944513|12034870|FG000|Overall Study|Withdrawal by Subject|4
7623886|NCT02944513|12034871|FG001|Overall Study|Withdrawal by Subject|1
7623887|NCT02734433|12034888|FG000|Overall Study|Disease progression|1
7869019|NCT01649297|12359919|FG003|Overall Study|Patient withdrawal (not due to AE)|1
7869020|NCT01649297|12359920|FG004|Overall Study|Patient withdrawal (not due to AE)|1
7869021|NCT01649297|12359916|FG000|Overall Study|For other reason|4
7623888|NCT02734433|12034889|FG001|Overall Study|Disease progression|5
7623889|NCT02734433|12034888|FG000|Overall Study|Clinical progression|0
7623890|NCT02734433|12034889|FG001|Overall Study|Clinical progression|1
7623891|NCT02734433|12034888|FG000|Overall Study|Withdrawal by Subject|1
7623892|NCT02734433|12034889|FG001|Overall Study|Withdrawal by Subject|2
7623893|NCT02048722|12034913|FG000|2 Cycles of Treatment|Adverse Event|2
7623894|NCT02048722|12034913|FG000|2 Cycles of Treatment|Withdrawal by Subject|4
7623895|NCT02048722|12034913|FG000|2 Cycles of Treatment|Progressive Disease|2
7623896|NCT02048722|12034913|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10
7623897|NCT02048722|12034913|FG000|Follow up 5 Years or Cut of Timepoint|Death|24
7623898|NCT02048722|12034913|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3
7623899|NCT01896102|12034917|FG000|Overall Study|Death|1
7623900|NCT01896102|12034917|FG000|Overall Study|Participant to receive allogenic transplant|2
7623901|NCT01885078|12034930|FG000|Treatment Period|Adverse Event|52
7623902|NCT01885078|12034931|FG001|Treatment Period|Adverse Event|136
7623903|NCT01885078|12034932|FG002|Treatment Period|Adverse Event|30
7623904|NCT01885078|12034933|FG003|Treatment Period|Adverse Event|73
7623905|NCT01885078|12034934|FG004|Treatment Period|Adverse Event|17
7623906|NCT01885078|12034935|FG005|Treatment Period|Adverse Event|72
7623907|NCT01885078|12034936|FG006|Treatment Period|Adverse Event|24
7623908|NCT01885078|12034937|FG007|Treatment Period|Adverse Event|5
7623909|NCT01885078|12034938|FG008|Treatment Period|Adverse Event|0
7623910|NCT01885078|12034939|FG009|Treatment Period|Adverse Event|0
7623911|NCT01885078|12034930|FG000|Treatment Period|Death|13
7623912|NCT01885078|12034931|FG001|Treatment Period|Death|33
7623913|NCT01885078|12034932|FG002|Treatment Period|Death|5
7623914|NCT01885078|12034933|FG003|Treatment Period|Death|9
7623915|NCT01885078|12034934|FG004|Treatment Period|Death|2
7623916|NCT01885078|12034935|FG005|Treatment Period|Death|10
7623917|NCT01885078|12034936|FG006|Treatment Period|Death|3
7623918|NCT01885078|12034937|FG007|Treatment Period|Death|2
7623919|NCT01885078|12034938|FG008|Treatment Period|Death|0
7623920|NCT01885078|12034939|FG009|Treatment Period|Death|0
7623921|NCT01885078|12034930|FG000|Treatment Period|Lack of Efficacy|12
7623922|NCT01885078|12034931|FG001|Treatment Period|Lack of Efficacy|33
7792291|NCT01034397|12246641|FG000|Overall Study|Lack of compliance|0
7792292|NCT01034397|12246642|FG001|Overall Study|Lack of compliance|1
7792293|NCT01034397|12246641|FG000|Overall Study|Lack of Efficacy|3
7792294|NCT01034397|12246642|FG001|Overall Study|Lack of Efficacy|0
7792295|NCT01034397|12246641|FG000|Overall Study|Adverse Event|4
7792296|NCT01034397|12246642|FG001|Overall Study|Adverse Event|0
7792297|NCT01034397|12246641|FG000|Overall Study|Other|0
7792298|NCT01034397|12246642|FG001|Overall Study|Other|1
7792299|NCT01034462|12246659|FG000|Overall Study|Adverse Event|7
7792300|NCT01034462|12246660|FG001|Overall Study|Adverse Event|17
7792301|NCT01034462|12246659|FG000|Overall Study|Lack of Efficacy|4
7792302|NCT01034462|12246660|FG001|Overall Study|Lack of Efficacy|4
7792303|NCT01034462|12246659|FG000|Overall Study|Protocol Violation|10
7792304|NCT01034462|12246660|FG001|Overall Study|Protocol Violation|7
7792305|NCT01034462|12246659|FG000|Overall Study|Withdrawal by Subject|9
7792306|NCT01034462|12246660|FG001|Overall Study|Withdrawal by Subject|8
7792307|NCT01034462|12246659|FG000|Overall Study|Lost to Follow-up|14
7792308|NCT01034462|12246660|FG001|Overall Study|Lost to Follow-up|16
7623923|NCT01885078|12034932|FG002|Treatment Period|Lack of Efficacy|10
7623924|NCT01885078|12034933|FG003|Treatment Period|Lack of Efficacy|23
7623925|NCT01885078|12034934|FG004|Treatment Period|Lack of Efficacy|24
7623926|NCT01885078|12034935|FG005|Treatment Period|Lack of Efficacy|58
7623927|NCT01885078|12034936|FG006|Treatment Period|Lack of Efficacy|9
7623928|NCT01885078|12034937|FG007|Treatment Period|Lack of Efficacy|5
7623929|NCT01885078|12034938|FG008|Treatment Period|Lack of Efficacy|0
7623930|NCT01885078|12034939|FG009|Treatment Period|Lack of Efficacy|0
7623931|NCT01885078|12034930|FG000|Treatment Period|Lost to Follow-up|16
7623932|NCT01885078|12034931|FG001|Treatment Period|Lost to Follow-up|19
7623933|NCT01885078|12034932|FG002|Treatment Period|Lost to Follow-up|7
7623934|NCT01885078|12034933|FG003|Treatment Period|Lost to Follow-up|9
7623935|NCT01885078|12034934|FG004|Treatment Period|Lost to Follow-up|2
7623936|NCT01885078|12034935|FG005|Treatment Period|Lost to Follow-up|8
7623937|NCT01885078|12034936|FG006|Treatment Period|Lost to Follow-up|2
7623938|NCT01885078|12034937|FG007|Treatment Period|Lost to Follow-up|0
7623939|NCT01885078|12034938|FG008|Treatment Period|Lost to Follow-up|0
7623940|NCT01885078|12034939|FG009|Treatment Period|Lost to Follow-up|0
7623941|NCT01885078|12034930|FG000|Treatment Period|Physician Decision|19
7623942|NCT01885078|12034931|FG001|Treatment Period|Physician Decision|21
7623943|NCT01885078|12034932|FG002|Treatment Period|Physician Decision|5
7623944|NCT01885078|12034933|FG003|Treatment Period|Physician Decision|12
7623945|NCT01885078|12034934|FG004|Treatment Period|Physician Decision|9
7623946|NCT01885078|12034935|FG005|Treatment Period|Physician Decision|24
7623947|NCT01885078|12034936|FG006|Treatment Period|Physician Decision|4
7623948|NCT01885078|12034937|FG007|Treatment Period|Physician Decision|3
7623949|NCT01885078|12034938|FG008|Treatment Period|Physician Decision|0
7623950|NCT01885078|12034939|FG009|Treatment Period|Physician Decision|0
7623951|NCT01885078|12034930|FG000|Treatment Period|Protocol Violation|3
7623952|NCT01885078|12034931|FG001|Treatment Period|Protocol Violation|5
7623953|NCT01885078|12034932|FG002|Treatment Period|Protocol Violation|0
7623954|NCT01885078|12034933|FG003|Treatment Period|Protocol Violation|3
7623955|NCT01885078|12034934|FG004|Treatment Period|Protocol Violation|1
7623956|NCT01885078|12034935|FG005|Treatment Period|Protocol Violation|6
7623957|NCT01885078|12034936|FG006|Treatment Period|Protocol Violation|0
7623958|NCT01885078|12034937|FG007|Treatment Period|Protocol Violation|0
7623959|NCT01885078|12034938|FG008|Treatment Period|Protocol Violation|0
7623960|NCT01885078|12034939|FG009|Treatment Period|Protocol Violation|0
7623961|NCT01885078|12034930|FG000|Treatment Period|Sponsor Decision|245
7623962|NCT01885078|12034931|FG001|Treatment Period|Sponsor Decision|648
7623963|NCT01885078|12034932|FG002|Treatment Period|Sponsor Decision|49
7623964|NCT01885078|12034933|FG003|Treatment Period|Sponsor Decision|90
7623965|NCT01885078|12034934|FG004|Treatment Period|Sponsor Decision|20
7623966|NCT01885078|12034935|FG005|Treatment Period|Sponsor Decision|38
7623967|NCT01885078|12034936|FG006|Treatment Period|Sponsor Decision|162
7623968|NCT01885078|12034937|FG007|Treatment Period|Sponsor Decision|3
7623969|NCT01885078|12034938|FG008|Treatment Period|Sponsor Decision|0
7623970|NCT01885078|12034939|FG009|Treatment Period|Sponsor Decision|0
7623971|NCT01885078|12034930|FG000|Treatment Period|Withdrawal by Subject|72
7623972|NCT01885078|12034931|FG001|Treatment Period|Withdrawal by Subject|132
7623973|NCT01885078|12034932|FG002|Treatment Period|Withdrawal by Subject|25
7623974|NCT01885078|12034933|FG003|Treatment Period|Withdrawal by Subject|63
7623975|NCT01885078|12034934|FG004|Treatment Period|Withdrawal by Subject|15
7623976|NCT01885078|12034935|FG005|Treatment Period|Withdrawal by Subject|34
7623977|NCT01885078|12034936|FG006|Treatment Period|Withdrawal by Subject|17
7623978|NCT01885078|12034937|FG007|Treatment Period|Withdrawal by Subject|10
7623979|NCT01885078|12034938|FG008|Treatment Period|Withdrawal by Subject|0
7623980|NCT01885078|12034939|FG009|Treatment Period|Withdrawal by Subject|0
7623981|NCT01885078|12034930|FG000|Treatment Period|Other|0
7623982|NCT01885078|12034931|FG001|Treatment Period|Other|0
7623983|NCT01885078|12034932|FG002|Treatment Period|Other|0
7623984|NCT01885078|12034933|FG003|Treatment Period|Other|1
7623985|NCT01885078|12034934|FG004|Treatment Period|Other|0
7623986|NCT01885078|12034935|FG005|Treatment Period|Other|0
7623987|NCT01885078|12034936|FG006|Treatment Period|Other|0
7623988|NCT01885078|12034937|FG007|Treatment Period|Other|0
7623989|NCT01885078|12034938|FG008|Treatment Period|Other|0
7623990|NCT01885078|12034939|FG009|Treatment Period|Other|0
7623991|NCT01885078|12034930|FG000|Step-down Period|Sponsor Decision|0
7623992|NCT01885078|12034931|FG001|Step-down Period|Sponsor Decision|0
7623993|NCT01885078|12034932|FG002|Step-down Period|Sponsor Decision|0
7623994|NCT01885078|12034933|FG003|Step-down Period|Sponsor Decision|0
7623995|NCT01885078|12034934|FG004|Step-down Period|Sponsor Decision|0
7623996|NCT01885078|12034935|FG005|Step-down Period|Sponsor Decision|0
7623997|NCT01885078|12034936|FG006|Step-down Period|Sponsor Decision|0
7623998|NCT01885078|12034937|FG007|Step-down Period|Sponsor Decision|0
7623999|NCT01885078|12034938|FG008|Step-down Period|Sponsor Decision|1
7624000|NCT01885078|12034939|FG009|Step-down Period|Sponsor Decision|1
7624001|NCT01885078|12034930|FG000|Step-down Period|Adverse Event|0
7624002|NCT01885078|12034931|FG001|Step-down Period|Adverse Event|0
7624003|NCT01885078|12034932|FG002|Step-down Period|Adverse Event|0
7624004|NCT01885078|12034933|FG003|Step-down Period|Adverse Event|0
7624005|NCT01885078|12034934|FG004|Step-down Period|Adverse Event|0
7624006|NCT01885078|12034935|FG005|Step-down Period|Adverse Event|0
7624007|NCT01885078|12034936|FG006|Step-down Period|Adverse Event|0
7624008|NCT01885078|12034937|FG007|Step-down Period|Adverse Event|0
7624009|NCT01885078|12034938|FG008|Step-down Period|Adverse Event|29
7624010|NCT01885078|12034939|FG009|Step-down Period|Adverse Event|38
7624011|NCT01885078|12034930|FG000|Step-down Period|Withdrawal by Subject|0
7624012|NCT01885078|12034931|FG001|Step-down Period|Withdrawal by Subject|0
7624013|NCT01885078|12034932|FG002|Step-down Period|Withdrawal by Subject|0
7624014|NCT01885078|12034933|FG003|Step-down Period|Withdrawal by Subject|0
7624015|NCT01885078|12034934|FG004|Step-down Period|Withdrawal by Subject|0
7624016|NCT01885078|12034935|FG005|Step-down Period|Withdrawal by Subject|0
7624017|NCT01885078|12034936|FG006|Step-down Period|Withdrawal by Subject|0
7624018|NCT01885078|12034937|FG007|Step-down Period|Withdrawal by Subject|0
7624019|NCT01885078|12034938|FG008|Step-down Period|Withdrawal by Subject|25
7624020|NCT01885078|12034939|FG009|Step-down Period|Withdrawal by Subject|15
7624021|NCT01885078|12034930|FG000|Step-down Period|Physician Decision|0
7624022|NCT01885078|12034931|FG001|Step-down Period|Physician Decision|0
7624023|NCT01885078|12034932|FG002|Step-down Period|Physician Decision|0
7624024|NCT01885078|12034933|FG003|Step-down Period|Physician Decision|0
7624025|NCT01885078|12034934|FG004|Step-down Period|Physician Decision|0
7624026|NCT01885078|12034935|FG005|Step-down Period|Physician Decision|0
7624027|NCT01885078|12034936|FG006|Step-down Period|Physician Decision|0
7624028|NCT01885078|12034937|FG007|Step-down Period|Physician Decision|0
7624029|NCT01885078|12034938|FG008|Step-down Period|Physician Decision|7
7624030|NCT01885078|12034939|FG009|Step-down Period|Physician Decision|2
7624031|NCT01885078|12034930|FG000|Step-down Period|Death|0
7624032|NCT01885078|12034931|FG001|Step-down Period|Death|0
7624033|NCT01885078|12034932|FG002|Step-down Period|Death|0
7624034|NCT01885078|12034933|FG003|Step-down Period|Death|0
7624035|NCT01885078|12034934|FG004|Step-down Period|Death|0
7624036|NCT01885078|12034935|FG005|Step-down Period|Death|0
7624037|NCT01885078|12034936|FG006|Step-down Period|Death|0
7624038|NCT01885078|12034937|FG007|Step-down Period|Death|0
7624039|NCT01885078|12034938|FG008|Step-down Period|Death|4
7624040|NCT01885078|12034939|FG009|Step-down Period|Death|3
7624041|NCT01885078|12034930|FG000|Step-down Period|Lost to Follow-up|0
7624042|NCT01885078|12034931|FG001|Step-down Period|Lost to Follow-up|0
7624043|NCT01885078|12034932|FG002|Step-down Period|Lost to Follow-up|0
7624044|NCT01885078|12034933|FG003|Step-down Period|Lost to Follow-up|0
7624045|NCT01885078|12034934|FG004|Step-down Period|Lost to Follow-up|0
7624046|NCT01885078|12034935|FG005|Step-down Period|Lost to Follow-up|0
7624047|NCT01885078|12034936|FG006|Step-down Period|Lost to Follow-up|0
7624048|NCT01885078|12034937|FG007|Step-down Period|Lost to Follow-up|0
7624049|NCT01885078|12034938|FG008|Step-down Period|Lost to Follow-up|1
7624050|NCT01885078|12034939|FG009|Step-down Period|Lost to Follow-up|1
7624051|NCT01885078|12034930|FG000|Step-down Period|Lack of Efficacy|0
7624052|NCT01885078|12034931|FG001|Step-down Period|Lack of Efficacy|0
7624053|NCT01885078|12034932|FG002|Step-down Period|Lack of Efficacy|0
7624054|NCT01885078|12034933|FG003|Step-down Period|Lack of Efficacy|0
7624055|NCT01885078|12034934|FG004|Step-down Period|Lack of Efficacy|0
7624056|NCT01885078|12034935|FG005|Step-down Period|Lack of Efficacy|0
7624057|NCT01885078|12034936|FG006|Step-down Period|Lack of Efficacy|0
7624058|NCT01885078|12034937|FG007|Step-down Period|Lack of Efficacy|0
7624059|NCT01885078|12034938|FG008|Step-down Period|Lack of Efficacy|1
7624060|NCT01885078|12034939|FG009|Step-down Period|Lack of Efficacy|0
7624061|NCT01885078|12034930|FG000|Step-down Period|Protocol Violation|0
7624062|NCT01885078|12034931|FG001|Step-down Period|Protocol Violation|0
7624063|NCT01885078|12034932|FG002|Step-down Period|Protocol Violation|0
7624064|NCT01885078|12034933|FG003|Step-down Period|Protocol Violation|0
7624065|NCT01885078|12034934|FG004|Step-down Period|Protocol Violation|0
7624066|NCT01885078|12034935|FG005|Step-down Period|Protocol Violation|0
7624067|NCT01885078|12034936|FG006|Step-down Period|Protocol Violation|0
7624068|NCT01885078|12034937|FG007|Step-down Period|Protocol Violation|0
7624069|NCT01885078|12034938|FG008|Step-down Period|Protocol Violation|1
7624070|NCT01885078|12034939|FG009|Step-down Period|Protocol Violation|1
7624071|NCT01047683|12034963|FG000|Overall Study|Adverse Event|3
7624072|NCT01047683|12034964|FG001|Overall Study|Adverse Event|1
7624073|NCT01047683|12034965|FG002|Overall Study|Adverse Event|0
7624074|NCT01047683|12034963|FG000|Overall Study|Withdrew Consent|1
7624075|NCT01047683|12034964|FG001|Overall Study|Withdrew Consent|4
7624076|NCT01047683|12034965|FG002|Overall Study|Withdrew Consent|2
7624077|NCT01047683|12034963|FG000|Overall Study|Lost to Follow-up|0
7624078|NCT01047683|12034964|FG001|Overall Study|Lost to Follow-up|1
7624079|NCT01047683|12034965|FG002|Overall Study|Lost to Follow-up|0
7624080|NCT01047683|12034963|FG000|Overall Study|Triglycerides >2000 mg/dL|1
7624081|NCT01047683|12034964|FG001|Overall Study|Triglycerides >2000 mg/dL|0
7624082|NCT01047683|12034965|FG002|Overall Study|Triglycerides >2000 mg/dL|1
7624083|NCT01047501|12034976|FG000|Overall Study|Adverse Event|7
7624084|NCT01047501|12034977|FG001|Overall Study|Adverse Event|8
7624085|NCT01047501|12034978|FG002|Overall Study|Adverse Event|5
7624086|NCT01047501|12034976|FG000|Overall Study|Withdrew Consent|6
7624087|NCT01047501|12034977|FG001|Overall Study|Withdrew Consent|2
7624088|NCT01047501|12034978|FG002|Overall Study|Withdrew Consent|4
7624089|NCT01047501|12034976|FG000|Overall Study|Lost to Follow-up|0
7624090|NCT01047501|12034977|FG001|Overall Study|Lost to Follow-up|1
7624091|NCT01047501|12034978|FG002|Overall Study|Lost to Follow-up|1
7624092|NCT01047501|12034976|FG000|Overall Study|Triglycerides >800 mg/dL|1
7624093|NCT01047501|12034977|FG001|Overall Study|Triglycerides >800 mg/dL|0
7624094|NCT01047501|12034978|FG002|Overall Study|Triglycerides >800 mg/dL|0
7624095|NCT01047501|12034976|FG000|Overall Study|Death|1
7624096|NCT01047501|12034977|FG001|Overall Study|Death|0
7624097|NCT01047501|12034978|FG002|Overall Study|Death|0
7624098|NCT01047501|12034976|FG000|Overall Study|Other discontinuation|1
7624099|NCT01047501|12034977|FG001|Overall Study|Other discontinuation|0
7624100|NCT01047501|12034978|FG002|Overall Study|Other discontinuation|1
7624101|NCT01047501|12034976|FG000|Overall Study|Investigator judgement|0
7624102|NCT01047501|12034977|FG001|Overall Study|Investigator judgement|0
7624103|NCT01047501|12034978|FG002|Overall Study|Investigator judgement|1
7624104|NCT00981656|12034986|FG000|Overall Study|Protocol Violation|1
7624105|NCT00981656|12034986|FG000|Overall Study|Did not start protocol treatment|2
7624106|NCT00838526|12034992|FG000|Overall Study|Adverse Event|3
7624107|NCT00838526|12034993|FG001|Overall Study|Adverse Event|12
7624108|NCT00838526|12034992|FG000|Overall Study|Lost to Follow-up|4
7624109|NCT00838526|12034993|FG001|Overall Study|Lost to Follow-up|12
7624110|NCT00838526|12034992|FG000|Overall Study|Withdrawal by Subject|4
7624111|NCT00838526|12034993|FG001|Overall Study|Withdrawal by Subject|5
7624112|NCT00838526|12034992|FG000|Overall Study|Lack of Efficacy|2
7624113|NCT00838526|12034993|FG001|Overall Study|Lack of Efficacy|3
7624114|NCT00838526|12034992|FG000|Overall Study|Other|11
7624115|NCT00838526|12034993|FG001|Overall Study|Other|7
7624116|NCT00126672|12034999|FG000|Overall Study|Adverse Event|4
7624117|NCT00126672|12034999|FG000|Overall Study|Lost to Follow-up|4
7624118|NCT03151304|12035016|FG000|Overall Study|Termination of study by Sponsor|23
7624119|NCT03151304|12035016|FG000|Overall Study|missing|3
7624120|NCT03151304|12035016|FG000|Overall Study|Withdrawal by Subject|8
7624121|NCT03151304|12035016|FG000|Overall Study|multiple reasons|30
7624122|NCT03113409|12035020|FG000|Overall Study|Withdrawal by Subject|5
7624123|NCT03113409|12035021|FG001|Overall Study|Withdrawal by Subject|0
7624124|NCT03113409|12035022|FG002|Overall Study|Withdrawal by Subject|0
7624125|NCT02953340|12035028|FG000|Overall Study|Death|0
7624126|NCT02953340|12035029|FG001|Overall Study|Death|1
7624127|NCT02953340|12035028|FG000|Overall Study|Investigator Decision|3
7624128|NCT02953340|12035029|FG001|Overall Study|Investigator Decision|3
7624129|NCT02953340|12035028|FG000|Overall Study|Initiated Non-Protocol Therapy|5
7624130|NCT02953340|12035029|FG001|Overall Study|Initiated Non-Protocol Therapy|14
7624131|NCT02953340|12035028|FG000|Overall Study|Myeloid Growth Factors Treatment|0
7624132|NCT02953340|12035029|FG001|Overall Study|Myeloid Growth Factors Treatment|1
7624133|NCT02953340|12035028|FG000|Overall Study|Withdrawal by Subject|9
7624134|NCT02953340|12035029|FG001|Overall Study|Withdrawal by Subject|9
7624135|NCT02953340|12035028|FG000|Overall Study|Sponsor decision|0
7624136|NCT02953340|12035029|FG001|Overall Study|Sponsor decision|2
7624137|NCT02953340|12035028|FG000|Overall Study|Lost to Follow-up|3
7624138|NCT02953340|12035029|FG001|Overall Study|Lost to Follow-up|2
7624139|NCT02953340|12035028|FG000|Overall Study|Reason not specified|2
7624140|NCT02953340|12035029|FG001|Overall Study|Reason not specified|2
7624141|NCT02855944|12035043|FG000|Period 1: Treatment|Ongoing|44
7624142|NCT02855944|12035044|FG001|Period 1: Treatment|Ongoing|5
7624143|NCT02855944|12035043|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1
7624144|NCT02855944|12035044|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3
7624145|NCT02855944|12035043|FG000|Period 2: Crossover to Rucaparib|Ongoing|0
7624146|NCT02855944|12035044|FG001|Period 2: Crossover to Rucaparib|Ongoing|27
7624147|NCT02851407|12035053|FG000|Overall Study|Withdrawal by parent/guardian|2
7624148|NCT02851407|12035054|FG001|Overall Study|Withdrawal by parent/guardian|7
7624149|NCT02851407|12035053|FG000|Overall Study|Protocol deviation|0
7624150|NCT02851407|12035054|FG001|Overall Study|Protocol deviation|1
7624151|NCT02851407|12035053|FG000|Overall Study|Transferred to another hospital to continue|1
7624152|NCT02851407|12035054|FG001|Overall Study|Transferred to another hospital to continue|0
7624153|NCT02851407|12035053|FG000|Overall Study|Other Death|30
7624154|NCT02851407|12035054|FG001|Overall Study|Other Death|20
7624155|NCT02851407|12035053|FG000|Overall Study|Adverse event, serious fatal|6
7624156|NCT02851407|12035054|FG001|Overall Study|Adverse event, serious fatal|8
7624157|NCT02851407|12035053|FG000|Overall Study|Consent withdrawn by participant|5
7624158|NCT02851407|12035054|FG001|Overall Study|Consent withdrawn by participant|3
7624159|NCT02851407|12035053|FG000|Overall Study|Screen failure|2
7624160|NCT02851407|12035054|FG001|Overall Study|Screen failure|1
7624161|NCT02851407|12035053|FG000|Overall Study|Disease relapse|9
7624162|NCT02851407|12035054|FG001|Overall Study|Disease relapse|6
7624163|NCT02851407|12035053|FG000|Overall Study|Physician Decision|7
7624164|NCT02851407|12035054|FG001|Overall Study|Physician Decision|6
7624165|NCT02851407|12035053|FG000|Overall Study|Transferred to hospital closer to home|0
7624166|NCT02851407|12035054|FG001|Overall Study|Transferred to hospital closer to home|1
7624167|NCT02851407|12035053|FG000|Overall Study|Enrolled in an investigational study|0
7624168|NCT02851407|12035054|FG001|Overall Study|Enrolled in an investigational study|1
7624169|NCT02851407|12035053|FG000|Overall Study|Early recovery|1
7624170|NCT02851407|12035054|FG001|Overall Study|Early recovery|0
7624171|NCT02851407|12035053|FG000|Overall Study|Adverse event, non-fatal|7
7624172|NCT02851407|12035054|FG001|Overall Study|Adverse event, non-fatal|5
7624173|NCT02851407|12035053|FG000|Overall Study|Lost to Follow-up|0
7624174|NCT02851407|12035054|FG001|Overall Study|Lost to Follow-up|2
7624175|NCT02666430|12035079|FG000|Period 1|Lost to Follow-up|1
7624176|NCT02666430|12035080|FG001|Period 1|Lost to Follow-up|0
7624177|NCT02666430|12035079|FG000|Period 1|Adverse Event|0
7624178|NCT02666430|12035080|FG001|Period 1|Adverse Event|1
7624179|NCT02666430|12035079|FG000|Period 2|Withdrawal by Subject|1
7624180|NCT02666430|12035080|FG001|Period 2|Withdrawal by Subject|4
7624181|NCT02666430|12035079|FG000|Period 3|Lost to Follow-up|1
7624182|NCT02666430|12035080|FG001|Period 3|Lost to Follow-up|0
7624183|NCT02643420|12035088|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6
7624184|NCT02643420|12035089|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12
7624185|NCT02643420|12035088|FG000|Overall Study|Withdrawal by Subject|25
7624186|NCT02643420|12035089|FG001|Overall Study|Withdrawal by Subject|19
7624187|NCT02643420|12035088|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6
7624188|NCT02643420|12035089|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10
7624189|NCT02643420|12035088|FG000|Overall Study|Lost to Follow-up|6
7624190|NCT02643420|12035089|FG001|Overall Study|Lost to Follow-up|10
7624191|NCT02643420|12035088|FG000|Overall Study|Investigator Decision|2
7624192|NCT02643420|12035089|FG001|Overall Study|Investigator Decision|4
7624193|NCT02643420|12035088|FG000|Overall Study|Sponsor decision|1
7624194|NCT02643420|12035089|FG001|Overall Study|Sponsor decision|1
7624195|NCT02643420|12035088|FG000|Overall Study|Death|0
7624196|NCT02643420|12035089|FG001|Overall Study|Death|2
7624197|NCT02643420|12035088|FG000|Overall Study|Reason not Specified|8
7624198|NCT02643420|12035089|FG001|Overall Study|Reason not Specified|7
7624199|NCT02639559|12035103|FG000|Overall Study|Mobilization failure|0
7624200|NCT02639559|12035104|FG001|Overall Study|Mobilization failure|3
7624201|NCT02639559|12035103|FG000|Overall Study|Issues with vascular acess|1
7624202|NCT02639559|12035104|FG001|Overall Study|Issues with vascular acess|0
7624203|NCT02569476|12035110|FG000|Overall Study|Roll over to Long-Term Extension Study|73
7624204|NCT02569476|12035110|FG000|Overall Study|Death|33
7624205|NCT02569476|12035110|FG000|Overall Study|Withdrawal by Subject|9
7624206|NCT02569476|12035110|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1
7624207|NCT02569476|12035110|FG000|Overall Study|Palliative care|1
7624208|NCT02569476|12035110|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1
7624209|NCT02569476|12035110|FG000|Overall Study|Transitioned to Long Term Extension Study|1
7624210|NCT02496676|12035126|FG000|Phase 1 - Period 1|Adverse Event|0
7624211|NCT02496676|12035127|FG001|Phase 1 - Period 1|Adverse Event|1
7624212|NCT02496676|12035126|FG000|Phase 2 - IV MgSO4|Adverse Event|0
7624213|NCT02496676|12035127|FG001|Phase 2 - IV MgSO4|Adverse Event|1
7624214|NCT02412618|12035152|FG000|Overall Study|Withdrawal by Subject|1
7624215|NCT02412618|12035153|FG001|Overall Study|Withdrawal by Subject|1
7624216|NCT02412618|12035152|FG000|Overall Study|Expulsion|1
7624217|NCT02412618|12035153|FG001|Overall Study|Expulsion|1
7624218|NCT02351180|12035170|FG000|Overall Study|Withdrawal by Subject|1
7624219|NCT02351180|12035171|FG001|Overall Study|Withdrawal by Subject|0
7624220|NCT02337764|12035177|FG000|Overall Study|Pretreatment Event/Adverse Event|46
7624221|NCT02337764|12035177|FG000|Overall Study|Voluntary Withdrawal|12
7624222|NCT02337764|12035177|FG000|Overall Study|Lack of Efficacy|2
7624223|NCT02337738|12035184|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
7624224|NCT02337738|12035185|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1
7624225|NCT02337738|12035186|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
7624226|NCT02337738|12035184|FG000|Overall Study|Pretreatment Event/Adverse Event|9
7624227|NCT02337738|12035185|FG001|Overall Study|Pretreatment Event/Adverse Event|18
7624228|NCT02337738|12035186|FG002|Overall Study|Pretreatment Event/Adverse Event|21
7624229|NCT02337738|12035184|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0
7624230|NCT02337738|12035185|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1
7624231|NCT02337738|12035186|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0
7624232|NCT02337738|12035184|FG000|Overall Study|Voluntary Withdrawal|10
7624233|NCT02337738|12035185|FG001|Overall Study|Voluntary Withdrawal|5
7624234|NCT02337738|12035186|FG002|Overall Study|Voluntary Withdrawal|2
7624235|NCT02337738|12035184|FG000|Overall Study|Lack of Efficacy|2
7624236|NCT02337738|12035185|FG001|Overall Study|Lack of Efficacy|4
7624237|NCT02337738|12035186|FG002|Overall Study|Lack of Efficacy|0
7624238|NCT02337738|12035184|FG000|Overall Study|Investigator's Judgment|1
7624239|NCT02337738|12035185|FG001|Overall Study|Investigator's Judgment|1
7624240|NCT02337738|12035186|FG002|Overall Study|Investigator's Judgment|3
7624241|NCT02332187|12035196|FG000|Overall Study|Withdrawal by Subject|2
7624242|NCT02332187|12035197|FG001|Overall Study|Withdrawal by Subject|2
7624243|NCT02332187|12035196|FG000|Overall Study|Adverse Event|0
7624244|NCT02332187|12035197|FG001|Overall Study|Adverse Event|1
7624245|NCT02227875|12035205|FG000|Overall Study|Protocol Violation|10
7624246|NCT02227875|12035206|FG001|Overall Study|Protocol Violation|7
7624247|NCT02227875|12035205|FG000|Overall Study|Other|1
7624248|NCT02227875|12035206|FG001|Overall Study|Other|3
7624249|NCT02227875|12035205|FG000|Overall Study|Physician Decision|1
7624250|NCT02227875|12035206|FG001|Overall Study|Physician Decision|0
7624251|NCT02227875|12035205|FG000|Overall Study|Adverse Event|3
7624252|NCT02227875|12035206|FG001|Overall Study|Adverse Event|0
7624253|NCT02227875|12035205|FG000|Overall Study|Withdrawal by Subject|12
7624254|NCT02227875|12035206|FG001|Overall Study|Withdrawal by Subject|13
7624255|NCT02227875|12035205|FG000|Overall Study|Lost to Follow-up|10
7624256|NCT02227875|12035206|FG001|Overall Study|Lost to Follow-up|10
7624257|NCT02227862|12035214|FG000|Overall Study|Protocol Violation|7
7624258|NCT02227862|12035215|FG001|Overall Study|Protocol Violation|9
7624259|NCT02227862|12035214|FG000|Overall Study|Other|0
7624260|NCT02227862|12035215|FG001|Overall Study|Other|2
7624261|NCT02227862|12035214|FG000|Overall Study|Adverse Event|4
7624262|NCT02227862|12035215|FG001|Overall Study|Adverse Event|3
7624263|NCT02227862|12035214|FG000|Overall Study|Withdrawal by Subject|7
7624264|NCT02227862|12035215|FG001|Overall Study|Withdrawal by Subject|6
7624265|NCT02227862|12035214|FG000|Overall Study|Lost to Follow-up|1
7624266|NCT02227862|12035215|FG001|Overall Study|Lost to Follow-up|2
7624267|NCT02200939|12035223|FG000|Overall Study|Participant withdrew consent|0
7624268|NCT02200939|12035224|FG001|Overall Study|Participant withdrew consent|1
7624269|NCT02200939|12035223|FG000|Overall Study|Lost to Follow-up|2
7624270|NCT02200939|12035224|FG001|Overall Study|Lost to Follow-up|9
7624271|NCT02200939|12035223|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0
7624272|NCT02200939|12035224|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1
7624273|NCT02108964|12035242|FG000|Overall Study|Progressive disease|12
7624274|NCT02108964|12035243|FG001|Overall Study|Progressive disease|25
7624275|NCT02108964|12035244|FG002|Overall Study|Progressive disease|50
7624276|NCT02108964|12035245|FG003|Overall Study|Progressive disease|6
7624277|NCT02108964|12035246|FG004|Overall Study|Progressive disease|18
7624278|NCT02108964|12035247|FG005|Overall Study|Progressive disease|5
7624279|NCT02108964|12035248|FG006|Overall Study|Progressive disease|7
7624280|NCT02108964|12035249|FG007|Overall Study|Progressive disease|9
7624281|NCT02108964|12035242|FG000|Overall Study|Physician Decision|1
7624282|NCT02108964|12035243|FG001|Overall Study|Physician Decision|5
7624283|NCT02108964|12035244|FG002|Overall Study|Physician Decision|6
7624284|NCT02108964|12035245|FG003|Overall Study|Physician Decision|0
7624285|NCT02108964|12035246|FG004|Overall Study|Physician Decision|1
7624286|NCT02108964|12035247|FG005|Overall Study|Physician Decision|0
7624287|NCT02108964|12035248|FG006|Overall Study|Physician Decision|0
7624288|NCT02108964|12035249|FG007|Overall Study|Physician Decision|0
7624289|NCT02108964|12035242|FG000|Overall Study|Adverse Event|0
7624290|NCT02108964|12035243|FG001|Overall Study|Adverse Event|0
7624291|NCT02108964|12035244|FG002|Overall Study|Adverse Event|4
7624292|NCT02108964|12035245|FG003|Overall Study|Adverse Event|0
7624293|NCT02108964|12035246|FG004|Overall Study|Adverse Event|1
7624294|NCT02108964|12035247|FG005|Overall Study|Adverse Event|0
7624295|NCT02108964|12035248|FG006|Overall Study|Adverse Event|3
7624296|NCT02108964|12035249|FG007|Overall Study|Adverse Event|1
7624297|NCT02108964|12035242|FG000|Overall Study|Death|1
7624298|NCT02108964|12035243|FG001|Overall Study|Death|1
7624299|NCT02108964|12035244|FG002|Overall Study|Death|2
7624300|NCT02108964|12035245|FG003|Overall Study|Death|0
7624301|NCT02108964|12035246|FG004|Overall Study|Death|3
7624302|NCT02108964|12035247|FG005|Overall Study|Death|0
7624303|NCT02108964|12035248|FG006|Overall Study|Death|0
7624304|NCT02108964|12035249|FG007|Overall Study|Death|1
7624305|NCT02108964|12035242|FG000|Overall Study|Subject/Guardian decision|0
7624306|NCT02108964|12035243|FG001|Overall Study|Subject/Guardian decision|1
7624307|NCT02108964|12035244|FG002|Overall Study|Subject/Guardian decision|3
7624308|NCT02108964|12035245|FG003|Overall Study|Subject/Guardian decision|0
7624309|NCT02108964|12035246|FG004|Overall Study|Subject/Guardian decision|2
7624310|NCT02108964|12035247|FG005|Overall Study|Subject/Guardian decision|0
7624311|NCT02108964|12035248|FG006|Overall Study|Subject/Guardian decision|1
7624312|NCT02108964|12035249|FG007|Overall Study|Subject/Guardian decision|1
7624313|NCT01922895|12035292|FG000|Overall Study|Death|0
7792309|NCT01034462|12246659|FG000|Overall Study|Other reasons|1
7792310|NCT01034462|12246660|FG001|Overall Study|Other reasons|2
7792311|NCT01034540|12246679|FG000|Overall Study|Adverse Event|0
7792312|NCT01034540|12246680|FG001|Overall Study|Adverse Event|1
7800813|NCT01097629|12258360|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7800814|NCT01097629|12258361|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7800815|NCT01097629|12258362|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7800816|NCT01097629|12258363|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7800817|NCT01097629|12258364|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7800818|NCT01097629|12258365|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7800819|NCT01097629|12258358|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
7800820|NCT01097629|12258359|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
7800821|NCT01097629|12258360|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
7800822|NCT01097629|12258361|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7800823|NCT01097629|12258362|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7800824|NCT01097629|12258363|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7800825|NCT01097629|12258364|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7800826|NCT01097629|12258365|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7800827|NCT01097629|12258358|FG000|DB RO Phase|Withdrawal by Subject|0
7800828|NCT01097629|12258359|FG001|DB RO Phase|Withdrawal by Subject|0
7800829|NCT01097629|12258360|FG002|DB RO Phase|Withdrawal by Subject|0
7800830|NCT01097629|12258361|FG003|DB RO Phase|Withdrawal by Subject|0
7800831|NCT01097629|12258362|FG004|DB RO Phase|Withdrawal by Subject|0
7800832|NCT01097629|12258363|FG005|DB RO Phase|Withdrawal by Subject|0
7800833|NCT01097629|12258364|FG006|DB RO Phase|Withdrawal by Subject|0
7800834|NCT01097629|12258365|FG007|DB RO Phase|Withdrawal by Subject|1
7800835|NCT01097629|12258358|FG000|DB RO Phase|Protocol Violation|0
7800836|NCT01097629|12258359|FG001|DB RO Phase|Protocol Violation|0
7800837|NCT01097629|12258360|FG002|DB RO Phase|Protocol Violation|0
7800838|NCT01097629|12258361|FG003|DB RO Phase|Protocol Violation|1
7800839|NCT01097629|12258362|FG004|DB RO Phase|Protocol Violation|0
7800840|NCT01097629|12258363|FG005|DB RO Phase|Protocol Violation|1
7800841|NCT01097629|12258364|FG006|DB RO Phase|Protocol Violation|1
7800842|NCT01097629|12258365|FG007|DB RO Phase|Protocol Violation|0
7800843|NCT01097629|12258358|FG000|DB RO Phase|Lost to Follow-up|0
7800844|NCT01097629|12258359|FG001|DB RO Phase|Lost to Follow-up|0
7800845|NCT01097629|12258360|FG002|DB RO Phase|Lost to Follow-up|0
7800846|NCT01097629|12258361|FG003|DB RO Phase|Lost to Follow-up|0
7800847|NCT01097629|12258362|FG004|DB RO Phase|Lost to Follow-up|0
7800848|NCT01097629|12258363|FG005|DB RO Phase|Lost to Follow-up|0
7800849|NCT01097629|12258364|FG006|DB RO Phase|Lost to Follow-up|2
7800850|NCT01097629|12258365|FG007|DB RO Phase|Lost to Follow-up|0
7800851|NCT01097655|12258397|FG000|Overall Study|Withdrawal by Subject|1
7800852|NCT01097655|12258397|FG000|Overall Study|Subject Documented Twice|1
7800853|NCT01097655|12258397|FG000|Overall Study|Did Not Meet Inclusion Criteria|8
7800854|NCT01097668|12258403|FG000|Overall Study|Withdrawal by Subject|1
7800855|NCT01097668|12258404|FG001|Overall Study|Withdrawal by Subject|2
7800856|NCT01097668|12258403|FG000|Overall Study|Lost to Follow-up|1
7800857|NCT01097668|12258404|FG001|Overall Study|Lost to Follow-up|0
7800858|NCT01097694|12258416|FG000|Overall Study|Adverse Event|5
7800859|NCT01097694|12258417|FG001|Overall Study|Adverse Event|0
7800860|NCT01097694|12258416|FG000|Overall Study|Lost to Follow-up|0
7800861|NCT01097694|12258417|FG001|Overall Study|Lost to Follow-up|3
7800862|NCT01097694|12258416|FG000|Overall Study|Withdrawal by Subject|3
7624314|NCT01922895|12035293|FG001|Overall Study|Death|1
7624315|NCT01922895|12035292|FG000|Overall Study|Withdrawal by Subject|1
7800863|NCT01097694|12258417|FG001|Overall Study|Withdrawal by Subject|1
7800864|NCT01097707|12258428|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7800865|NCT01097707|12258429|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7869022|NCT01649297|12359917|FG001|Overall Study|For other reason|1
7869023|NCT01649297|12359918|FG002|Overall Study|For other reason|2
7869024|NCT01649297|12359919|FG003|Overall Study|For other reason|0
7869025|NCT01649297|12359920|FG004|Overall Study|For other reason|0
7869026|NCT01649375|12359944|FG000|Up to Week 16|Adverse Event|2
7869027|NCT01649375|12359945|FG001|Up to Week 16|Adverse Event|5
7869028|NCT01649375|12359946|FG002|Up to Week 16|Adverse Event|4
7869029|NCT01649375|12359947|FG003|Up to Week 16|Adverse Event|0
7869030|NCT01649375|12359948|FG004|Up to Week 16|Adverse Event|0
7869031|NCT01649375|12359944|FG000|Up to Week 16|Lack of Efficacy|0
7869032|NCT01649375|12359945|FG001|Up to Week 16|Lack of Efficacy|0
7869033|NCT01649375|12359946|FG002|Up to Week 16|Lack of Efficacy|1
7869034|NCT01649375|12359947|FG003|Up to Week 16|Lack of Efficacy|0
7869035|NCT01649375|12359948|FG004|Up to Week 16|Lack of Efficacy|0
7869036|NCT01649375|12359944|FG000|Up to Week 16|Physician Decision|0
7869037|NCT01649375|12359945|FG001|Up to Week 16|Physician Decision|0
7869038|NCT01649375|12359946|FG002|Up to Week 16|Physician Decision|1
7869039|NCT01649375|12359947|FG003|Up to Week 16|Physician Decision|0
7869040|NCT01649375|12359948|FG004|Up to Week 16|Physician Decision|0
7869041|NCT01649375|12359944|FG000|Up to Week 16|Withdrawal by Subject|2
7869042|NCT01649375|12359945|FG001|Up to Week 16|Withdrawal by Subject|1
7869043|NCT01649375|12359946|FG002|Up to Week 16|Withdrawal by Subject|2
7869044|NCT01649375|12359947|FG003|Up to Week 16|Withdrawal by Subject|0
7869045|NCT01649375|12359948|FG004|Up to Week 16|Withdrawal by Subject|0
7869046|NCT01649375|12359944|FG000|Up to Week 16|Death|1
7869047|NCT01649375|12359945|FG001|Up to Week 16|Death|0
7869048|NCT01649375|12359946|FG002|Up to Week 16|Death|0
7869049|NCT01649375|12359947|FG003|Up to Week 16|Death|0
7869050|NCT01649375|12359948|FG004|Up to Week 16|Death|0
7869051|NCT01649375|12359944|FG000|Week 16 up to Week 260|Lack of Efficacy|7
7869052|NCT01649375|12359945|FG001|Week 16 up to Week 260|Lack of Efficacy|4
7869053|NCT01649375|12359946|FG002|Week 16 up to Week 260|Lack of Efficacy|0
7869054|NCT01649375|12359947|FG003|Week 16 up to Week 260|Lack of Efficacy|4
7869055|NCT01649375|12359948|FG004|Week 16 up to Week 260|Lack of Efficacy|2
7869056|NCT01649375|12359944|FG000|Week 16 up to Week 260|Non-compliance|0
7869057|NCT01649375|12359945|FG001|Week 16 up to Week 260|Non-compliance|1
7869058|NCT01649375|12359946|FG002|Week 16 up to Week 260|Non-compliance|0
7869059|NCT01649375|12359947|FG003|Week 16 up to Week 260|Non-compliance|1
7869060|NCT01649375|12359948|FG004|Week 16 up to Week 260|Non-compliance|0
7869061|NCT01649375|12359944|FG000|Week 16 up to Week 260|Physician Decision|0
7869062|NCT01649375|12359945|FG001|Week 16 up to Week 260|Physician Decision|2
7869063|NCT01649375|12359946|FG002|Week 16 up to Week 260|Physician Decision|0
7869064|NCT01649375|12359947|FG003|Week 16 up to Week 260|Physician Decision|0
7869065|NCT01649375|12359948|FG004|Week 16 up to Week 260|Physician Decision|0
7869066|NCT01649375|12359944|FG000|Week 16 up to Week 260|Technical issues|0
7869067|NCT01649375|12359945|FG001|Week 16 up to Week 260|Technical issues|1
7869068|NCT01649375|12359946|FG002|Week 16 up to Week 260|Technical issues|0
7869069|NCT01649375|12359947|FG003|Week 16 up to Week 260|Technical issues|1
7869070|NCT01649375|12359948|FG004|Week 16 up to Week 260|Technical issues|0
7869071|NCT01649375|12359944|FG000|Week 16 up to Week 260|Withdrawal by Subject|7
7869072|NCT01649375|12359945|FG001|Week 16 up to Week 260|Withdrawal by Subject|2
7869073|NCT01649375|12359946|FG002|Week 16 up to Week 260|Withdrawal by Subject|0
7869074|NCT01649375|12359947|FG003|Week 16 up to Week 260|Withdrawal by Subject|3
7869075|NCT01649375|12359948|FG004|Week 16 up to Week 260|Withdrawal by Subject|1
7869076|NCT01649375|12359944|FG000|Week 16 up to Week 260|Death|1
7869077|NCT01649375|12359945|FG001|Week 16 up to Week 260|Death|1
7869078|NCT01649375|12359946|FG002|Week 16 up to Week 260|Death|0
7869079|NCT01649375|12359947|FG003|Week 16 up to Week 260|Death|0
7869080|NCT01649375|12359948|FG004|Week 16 up to Week 260|Death|0
7869081|NCT01649375|12359944|FG000|Week 16 up to Week 260|Adverse Event|5
7869082|NCT01649375|12359945|FG001|Week 16 up to Week 260|Adverse Event|2
7869083|NCT01649375|12359946|FG002|Week 16 up to Week 260|Adverse Event|0
7869084|NCT01649375|12359947|FG003|Week 16 up to Week 260|Adverse Event|3
7869085|NCT01649375|12359948|FG004|Week 16 up to Week 260|Adverse Event|2
7869086|NCT01649427|12359958|FG000|Overall Study|Adverse Event|1
7869087|NCT01649427|12359959|FG001|Overall Study|Adverse Event|1
7869088|NCT01649427|12359958|FG000|Overall Study|Withdrawal by Subject|8
7869089|NCT01649427|12359959|FG001|Overall Study|Withdrawal by Subject|7
7869090|NCT01649427|12359958|FG000|Overall Study|Lost to Follow-up|0
7869091|NCT01649427|12359959|FG001|Overall Study|Lost to Follow-up|1
7792313|NCT01034657|12246721|FG000|Core Phase|Withdrawal by Subject|1
7792314|NCT01034657|12246722|FG001|Core Phase|Withdrawal by Subject|0
7792315|NCT01034657|12246723|FG002|Core Phase|Withdrawal by Subject|0
7792316|NCT01034657|12246721|FG000|Core Phase|Lack of Efficacy|2
7792317|NCT01034657|12246722|FG001|Core Phase|Lack of Efficacy|0
7792318|NCT01034657|12246723|FG002|Core Phase|Lack of Efficacy|0
7792319|NCT01034657|12246721|FG000|Core Phase|Abnormal laboratory value|1
7792320|NCT01034657|12246722|FG001|Core Phase|Abnormal laboratory value|0
7792321|NCT01034657|12246723|FG002|Core Phase|Abnormal laboratory value|0
7792322|NCT01034657|12246721|FG000|Core Phase|Adverse Event|8
7869092|NCT01649427|12359958|FG000|Overall Study|Graft loss|0
7869093|NCT01649427|12359959|FG001|Overall Study|Graft loss|1
7869094|NCT01649427|12359958|FG000|Overall Study|Surgical problems during nephrectomy|2
7869095|NCT01649427|12359959|FG001|Overall Study|Surgical problems during nephrectomy|2
7869096|NCT01649557|12359968|FG000|Overall Study|Lost to Follow-up|5
7792323|NCT01034657|12246722|FG001|Core Phase|Adverse Event|0
7792324|NCT01034657|12246723|FG002|Core Phase|Adverse Event|0
7792325|NCT01034657|12246721|FG000|Core Phase|Protocol Violation|2
7792326|NCT01034657|12246722|FG001|Core Phase|Protocol Violation|0
7792327|NCT01034657|12246723|FG002|Core Phase|Protocol Violation|0
7792328|NCT01034657|12246721|FG000|Randomized Phase|Withdrawal by Subject|0
7792329|NCT01034657|12246722|FG001|Randomized Phase|Withdrawal by Subject|2
7792330|NCT01034657|12246723|FG002|Randomized Phase|Withdrawal by Subject|0
7792331|NCT01034657|12246721|FG000|Randomized Phase|Lack of Efficacy|5
7792332|NCT01034657|12246722|FG001|Randomized Phase|Lack of Efficacy|1
7792333|NCT01034657|12246723|FG002|Randomized Phase|Lack of Efficacy|0
7792334|NCT01034657|12246721|FG000|Randomized Phase|Abnormal laboratory value|0
7792335|NCT01034657|12246722|FG001|Randomized Phase|Abnormal laboratory value|1
7792336|NCT01034657|12246723|FG002|Randomized Phase|Abnormal laboratory value|0
7792337|NCT01034657|12246721|FG000|Randomized Phase|Adverse Event|0
7792338|NCT01034657|12246722|FG001|Randomized Phase|Adverse Event|2
7792339|NCT01034657|12246723|FG002|Randomized Phase|Adverse Event|1
7792340|NCT01034709|12246735|FG000|Overall Study|Protocol Violation|9
7792341|NCT01034709|12246736|FG001|Overall Study|Protocol Violation|16
7792342|NCT01035060|12246753|FG000|Overall Study|Lost to Follow-up|0
7792343|NCT01035060|12246754|FG001|Overall Study|Lost to Follow-up|7
7792344|NCT01035060|12246753|FG000|Overall Study|Did not quality after 2nd screening|14
7792345|NCT01035060|12246754|FG001|Overall Study|Did not quality after 2nd screening|1
7792346|NCT01035060|12246753|FG000|Overall Study|Withdrawal by Subject|8
7792347|NCT01035060|12246754|FG001|Overall Study|Withdrawal by Subject|6
7869097|NCT01649557|12359969|FG001|Overall Study|Lost to Follow-up|0
7869098|NCT01649557|12359970|FG002|Overall Study|Lost to Follow-up|3
7869099|NCT01649557|12359968|FG000|Overall Study|Adverse Event|7
7869100|NCT01649557|12359969|FG001|Overall Study|Adverse Event|5
7869101|NCT01649557|12359970|FG002|Overall Study|Adverse Event|1
7869102|NCT01649557|12359968|FG000|Overall Study|Met withdrawal criteria|4
7869103|NCT01649557|12359969|FG001|Overall Study|Met withdrawal criteria|0
7869104|NCT01649557|12359970|FG002|Overall Study|Met withdrawal criteria|0
7869105|NCT01649557|12359968|FG000|Overall Study|Physician Decision|8
7869106|NCT01649557|12359969|FG001|Overall Study|Physician Decision|2
7869107|NCT01649557|12359970|FG002|Overall Study|Physician Decision|1
7869108|NCT01649557|12359968|FG000|Overall Study|Withdrawal by Subject|15
7869109|NCT01649557|12359969|FG001|Overall Study|Withdrawal by Subject|5
7869110|NCT01649557|12359970|FG002|Overall Study|Withdrawal by Subject|4
7869111|NCT01649557|12359968|FG000|Overall Study|Protocol deviation|0
7869112|NCT01649557|12359969|FG001|Overall Study|Protocol deviation|2
7869113|NCT01649557|12359970|FG002|Overall Study|Protocol deviation|0
7869114|NCT01649557|12359968|FG000|Overall Study|Lack of Efficacy|5
7869115|NCT01649557|12359969|FG001|Overall Study|Lack of Efficacy|0
7869116|NCT01649557|12359970|FG002|Overall Study|Lack of Efficacy|0
7869117|NCT01649765|12359998|FG000|Overall Study|Adverse Event|5
7869118|NCT01649765|12359999|FG001|Overall Study|Adverse Event|3
7869119|NCT01649765|12359998|FG000|Overall Study|Lack of Efficacy|1
7869120|NCT01649765|12359999|FG001|Overall Study|Lack of Efficacy|1
7869121|NCT01649765|12359998|FG000|Overall Study|Physician Decision|0
7869122|NCT01649765|12359999|FG001|Overall Study|Physician Decision|3
7869123|NCT01649765|12359998|FG000|Overall Study|Protocol Violation|1
7869124|NCT01649765|12359999|FG001|Overall Study|Protocol Violation|0
7869125|NCT01649765|12359998|FG000|Overall Study|Withdrawal by Subject|2
7869126|NCT01649765|12359999|FG001|Overall Study|Withdrawal by Subject|1
7869127|NCT01649791|12360006|FG000|Overall Study|Disease Progression|2
7869128|NCT01649791|12360006|FG000|Overall Study|Adverse Event|1
7869129|NCT01649804|12360010|FG000|Overall Study|Administrative/Other|8
7869130|NCT01649856|12360016|FG000|Overall Study|Withdrawal by Subject|14
7869131|NCT01649856|12360017|FG001|Overall Study|Withdrawal by Subject|14
7869132|NCT01649856|12360016|FG000|Overall Study|Protocol Violation|4
7869133|NCT01649856|12360017|FG001|Overall Study|Protocol Violation|4
7869134|NCT01649856|12360016|FG000|Overall Study|Treatment Failure|1
7869135|NCT01649856|12360017|FG001|Overall Study|Treatment Failure|1
7869136|NCT01649856|12360016|FG000|Overall Study|Death|69
7869137|NCT01649856|12360017|FG001|Overall Study|Death|34
7869138|NCT01649856|12360016|FG000|Overall Study|Stable or Progressed Disease|5
7869139|NCT01649856|12360017|FG001|Overall Study|Stable or Progressed Disease|3
7869140|NCT01649856|12360016|FG000|Overall Study|Lost to Follow-up|20
7869141|NCT01649856|12360017|FG001|Overall Study|Lost to Follow-up|16
7869142|NCT01649856|12360016|FG000|Overall Study|Lack of Compliance|6
7869143|NCT01649856|12360017|FG001|Overall Study|Lack of Compliance|1
7869144|NCT01649856|12360016|FG000|Overall Study|Other|20
7869145|NCT01649856|12360017|FG001|Overall Study|Other|5
7792348|NCT01035060|12246753|FG000|Overall Study|Physician Decision|2
7792349|NCT01035060|12246754|FG001|Overall Study|Physician Decision|0
7792350|NCT01035138|12246773|FG000|Overall Study|Adverse Event|4
7792351|NCT01035138|12246774|FG001|Overall Study|Adverse Event|0
7792352|NCT01035138|12246775|FG002|Overall Study|Adverse Event|2
7792353|NCT01035138|12246773|FG000|Overall Study|Caregiver Decision|2
7792354|NCT01035138|12246774|FG001|Overall Study|Caregiver Decision|0
7792355|NCT01035138|12246775|FG002|Overall Study|Caregiver Decision|1
7792356|NCT01035138|12246773|FG000|Overall Study|Withdrawal by Subject|1
7792357|NCT01035138|12246774|FG001|Overall Study|Withdrawal by Subject|0
7792358|NCT01035138|12246775|FG002|Overall Study|Withdrawal by Subject|0
7792359|NCT01035138|12246773|FG000|Overall Study|Physician Decision|0
7792360|NCT01035138|12246774|FG001|Overall Study|Physician Decision|0
7792361|NCT01035138|12246775|FG002|Overall Study|Physician Decision|1
7792362|NCT01035138|12246773|FG000|Overall Study|Sponsor Decision|66
7792363|NCT01035138|12246774|FG001|Overall Study|Sponsor Decision|60
7792364|NCT01035138|12246775|FG002|Overall Study|Sponsor Decision|42
7792365|NCT01035138|12246773|FG000|Overall Study|Lost to Follow-up|0
7792366|NCT01035138|12246774|FG001|Overall Study|Lost to Follow-up|0
7792367|NCT01035138|12246775|FG002|Overall Study|Lost to Follow-up|1
7792368|NCT01035229|12246796|FG000|Overall Study|Adverse Event|61
7792369|NCT01035229|12246797|FG001|Overall Study|Adverse Event|14
7792370|NCT01035229|12246796|FG000|Overall Study|Withdrawal by Subject|20
7792371|NCT01035229|12246797|FG001|Overall Study|Withdrawal by Subject|7
7792372|NCT01035229|12246796|FG000|Overall Study|Lost to Follow-up|1
7792373|NCT01035229|12246797|FG001|Overall Study|Lost to Follow-up|0
7792374|NCT01035229|12246796|FG000|Overall Study|Administrative problems|1
7792375|NCT01035229|12246797|FG001|Overall Study|Administrative problems|1
7792376|NCT01035229|12246796|FG000|Overall Study|Death|13
7792377|NCT01035229|12246797|FG001|Overall Study|Death|5
7792378|NCT01035229|12246796|FG000|Overall Study|New cancer therapy|2
7792379|NCT01035229|12246797|FG001|Overall Study|New cancer therapy|0
7792380|NCT01035229|12246796|FG000|Overall Study|Protocol Violation|0
7792381|NCT01035229|12246797|FG001|Overall Study|Protocol Violation|2
7792382|NCT01035229|12246796|FG000|Overall Study|Sponsor's decision to end study|3
7792383|NCT01035229|12246797|FG001|Overall Study|Sponsor's decision to end study|3
7792384|NCT01035229|12246796|FG000|Overall Study|Disease Progression|261
7792385|NCT01035229|12246797|FG001|Overall Study|Disease Progression|152
7792386|NCT01035255|12246807|FG000|Overall Study|Death|724
7792387|NCT01035255|12246808|FG001|Overall Study|Death|844
7792388|NCT01035255|12246807|FG000|Overall Study|Lost to Follow-up|2
7792389|NCT01035255|12246808|FG001|Overall Study|Lost to Follow-up|5
7792390|NCT01035255|12246807|FG000|Overall Study|patient's request|15
7792391|NCT01035255|12246808|FG001|Overall Study|patient's request|13
7792392|NCT01035463|12246829|FG000|Overall Study|Adverse Event|0
7792393|NCT01035463|12246830|FG001|Overall Study|Adverse Event|0
7792394|NCT01035463|12246831|FG002|Overall Study|Adverse Event|4
7792395|NCT01035463|12246832|FG003|Overall Study|Adverse Event|1
7792396|NCT01035463|12246833|FG004|Overall Study|Adverse Event|5
7792397|NCT01035463|12246834|FG005|Overall Study|Adverse Event|7
7792398|NCT01035463|12246829|FG000|Overall Study|Withdrawal by Subject|0
7792399|NCT01035463|12246830|FG001|Overall Study|Withdrawal by Subject|2
7792400|NCT01035463|12246831|FG002|Overall Study|Withdrawal by Subject|1
7792401|NCT01035463|12246832|FG003|Overall Study|Withdrawal by Subject|0
7792402|NCT01035463|12246833|FG004|Overall Study|Withdrawal by Subject|1
7792403|NCT01035463|12246834|FG005|Overall Study|Withdrawal by Subject|4
7792404|NCT01035463|12246829|FG000|Overall Study|Disease progression|0
7792405|NCT01035463|12246830|FG001|Overall Study|Disease progression|0
7792406|NCT01035463|12246831|FG002|Overall Study|Disease progression|0
7792407|NCT01035463|12246832|FG003|Overall Study|Disease progression|0
7792408|NCT01035463|12246833|FG004|Overall Study|Disease progression|0
7792409|NCT01035463|12246834|FG005|Overall Study|Disease progression|3
7792410|NCT01035463|12246829|FG000|Overall Study|Other Malignancy|0
7792411|NCT01035463|12246830|FG001|Overall Study|Other Malignancy|0
7792412|NCT01035463|12246831|FG002|Overall Study|Other Malignancy|0
7792413|NCT01035463|12246832|FG003|Overall Study|Other Malignancy|0
7792414|NCT01035463|12246833|FG004|Overall Study|Other Malignancy|0
7792415|NCT01035463|12246834|FG005|Overall Study|Other Malignancy|2
7792416|NCT01035463|12246829|FG000|Overall Study|Other|0
7792417|NCT01035463|12246830|FG001|Overall Study|Other|0
7792418|NCT01035463|12246831|FG002|Overall Study|Other|0
7792419|NCT01035463|12246832|FG003|Overall Study|Other|1
7792420|NCT01035463|12246833|FG004|Overall Study|Other|0
7792421|NCT01035463|12246834|FG005|Overall Study|Other|2
7792422|NCT01035606|12246844|FG000|Overall Study|change in health, job demands,family|3
7792423|NCT01035606|12246845|FG001|Overall Study|change in health, job demands,family|3
7792424|NCT01035606|12246846|FG002|Overall Study|change in health, job demands,family|4
7792425|NCT01035905|12246902|FG000|Overall Study|Lack of Efficacy|1
7792426|NCT01035905|12246903|FG001|Overall Study|Lack of Efficacy|1
7792427|NCT01036022|12246925|FG000|Overall Study|Adverse Event|1
7792428|NCT01036022|12246926|FG001|Overall Study|Adverse Event|3
7792429|NCT01036022|12246927|FG002|Overall Study|Adverse Event|2
7792430|NCT01036022|12246928|FG003|Overall Study|Adverse Event|1
7792431|NCT01036022|12246929|FG004|Overall Study|Adverse Event|0
7792432|NCT01036022|12246930|FG005|Overall Study|Adverse Event|2
7792433|NCT01036022|12246925|FG000|Overall Study|Lack of Efficacy|1
7792434|NCT01036022|12246926|FG001|Overall Study|Lack of Efficacy|1
7792435|NCT01036022|12246927|FG002|Overall Study|Lack of Efficacy|1
7792436|NCT01036022|12246928|FG003|Overall Study|Lack of Efficacy|0
7792437|NCT01036022|12246929|FG004|Overall Study|Lack of Efficacy|1
7792438|NCT01036022|12246930|FG005|Overall Study|Lack of Efficacy|1
7792439|NCT01036022|12246925|FG000|Overall Study|Physician Decision|0
7792440|NCT01036022|12246926|FG001|Overall Study|Physician Decision|0
7792441|NCT01036022|12246927|FG002|Overall Study|Physician Decision|1
7792442|NCT01036022|12246928|FG003|Overall Study|Physician Decision|0
7792443|NCT01036022|12246929|FG004|Overall Study|Physician Decision|0
7792444|NCT01036022|12246930|FG005|Overall Study|Physician Decision|0
7792445|NCT01036022|12246925|FG000|Overall Study|Withdrawal by Subject|0
7792446|NCT01036022|12246926|FG001|Overall Study|Withdrawal by Subject|0
7792447|NCT01036022|12246927|FG002|Overall Study|Withdrawal by Subject|0
7792448|NCT01036022|12246928|FG003|Overall Study|Withdrawal by Subject|1
7792449|NCT01036022|12246929|FG004|Overall Study|Withdrawal by Subject|2
7792450|NCT01036022|12246930|FG005|Overall Study|Withdrawal by Subject|0
7792451|NCT01036165|12246952|FG000|Overall Study|Adverse Event|6
7792452|NCT01036165|12246952|FG000|Overall Study|Lost to Follow-up|2
7792453|NCT01036165|12246952|FG000|Overall Study|Withdrawal by Subject|3
7792454|NCT01036165|12246952|FG000|Overall Study|Device Related Issues|3
7792455|NCT01036165|12246952|FG000|Overall Study|Problems finding proper area to inject|1
7792456|NCT01036321|12246958|FG000|Overall Study|Ineligible after randomization|0
7792457|NCT01036321|12246959|FG001|Overall Study|Ineligible after randomization|1
7792458|NCT01036321|12246958|FG000|Overall Study|Withdrawal by Subject|3
7792459|NCT01036321|12246959|FG001|Overall Study|Withdrawal by Subject|2
7792460|NCT01036321|12246958|FG000|Overall Study|Adverse Event|2
7792461|NCT01036321|12246959|FG001|Overall Study|Adverse Event|1
7792462|NCT01036438|12246967|FG000|Overall Study|Adverse Event|7
7792463|NCT01036438|12246968|FG001|Overall Study|Adverse Event|8
7792464|NCT01036438|12246967|FG000|Overall Study|Death|0
7792465|NCT01036438|12246968|FG001|Overall Study|Death|1
7869146|NCT01649869|12360025|FG000|Overall Study|Family member illness|1
7869147|NCT01649869|12360026|FG001|Overall Study|Family member illness|0
7869148|NCT01649869|12360025|FG000|Overall Study|Required treatment outside protocol|1
7869149|NCT01649869|12360026|FG001|Overall Study|Required treatment outside protocol|0
7869150|NCT01649869|12360025|FG000|Overall Study|Severe hearing loss borderline eligible|0
7869151|NCT01649869|12360026|FG001|Overall Study|Severe hearing loss borderline eligible|1
7869152|NCT01650194|12360044|FG000|Overall Study|Progressive Disease (PD)|35
7869153|NCT01650194|12360044|FG000|Overall Study|Withdrawal by Subject|2
7869154|NCT01650194|12360044|FG000|Overall Study|Miscellaneous|10
7869155|NCT01650246|12360049|FG000|Overall Study|Adverse Event|23
7869156|NCT01650246|12360049|FG000|Overall Study|Protocol Violation|5
7869157|NCT01650246|12360049|FG000|Overall Study|Sponsor terminated study|53
7869158|NCT01650246|12360049|FG000|Overall Study|Lost to Follow-up|5
7869159|NCT01650246|12360049|FG000|Overall Study|Withdrawal by Subject|26
7869160|NCT01650246|12360049|FG000|Overall Study|Death|1
7869161|NCT01650246|12360049|FG000|Overall Study|Lack of Efficacy|30
7869162|NCT01650259|12360055|FG000|Overall Study|Improvement|105
7869163|NCT01650259|12360056|FG001|Overall Study|Improvement|0
7869164|NCT01650259|12360055|FG000|Overall Study|Adverse Event|127
7869165|NCT01650259|12360056|FG001|Overall Study|Adverse Event|0
7869166|NCT01650259|12360055|FG000|Overall Study|Lack of Efficacy|143
7869167|NCT01650259|12360056|FG001|Overall Study|Lack of Efficacy|0
7869168|NCT01650259|12360055|FG000|Overall Study|Lost to Follow-up|435
7869169|NCT01650259|12360056|FG001|Overall Study|Lost to Follow-up|0
7869170|NCT01650259|12360055|FG000|Overall Study|Patients had no visit after entry|70
7869171|NCT01650259|12360056|FG001|Overall Study|Patients had no visit after entry|0
7869172|NCT01650259|12360055|FG000|Overall Study|CRF not collected|98
7869173|NCT01650259|12360056|FG001|Overall Study|CRF not collected|82
7869174|NCT01650259|12360055|FG000|Overall Study|Not treated|1
7869175|NCT01650259|12360056|FG001|Overall Study|Not treated|7
7869176|NCT01650259|12360055|FG000|Overall Study|Other than listed|64
7869177|NCT01650259|12360056|FG001|Overall Study|Other than listed|146
7869178|NCT01650519|12360106|FG000|Overall Study|Withdrawal by Subject|1
7869179|NCT01650519|12360107|FG001|Overall Study|Withdrawal by Subject|0
7869180|NCT01650636|12360133|FG000|Washout up to 5 Months|Withdrawal by Subject|4
7869181|NCT01650636|12360134|FG001|Washout up to 5 Months|Withdrawal by Subject|8
7869182|NCT01650636|12360133|FG000|Washout up to 5 Months|Physician Decision|2
7869183|NCT01650636|12360134|FG001|Washout up to 5 Months|Physician Decision|2
7869184|NCT01650636|12360133|FG000|Washout up to 5 Months|Death|1
7869185|NCT01650636|12360134|FG001|Washout up to 5 Months|Death|0
7869186|NCT01650636|12360133|FG000|Washout up to 5 Months|Lost to Follow-up|2
7869187|NCT01650636|12360134|FG001|Washout up to 5 Months|Lost to Follow-up|8
7869188|NCT01650636|12360133|FG000|Washout up to 9 Months|Withdrawal by Subject|4
7869189|NCT01650636|12360134|FG001|Washout up to 9 Months|Withdrawal by Subject|2
7869190|NCT01650636|12360133|FG000|Washout up to 9 Months|Lost to Follow-up|2
7869191|NCT01650636|12360134|FG001|Washout up to 9 Months|Lost to Follow-up|1
7869192|NCT01650779|12360140|FG000|Overall Study|Withdrawal by Subject|1
7869193|NCT01650805|12360146|FG000|Overall Study|Withdrawal by Subject|1
7869194|NCT01650805|12360147|FG001|Overall Study|Withdrawal by Subject|0
7869195|NCT01650831|12360153|FG000|Overall Study|Screen failure|1
7869196|NCT01651000|12360172|FG000|Overall Study|Adverse Event|2
7869197|NCT01651000|12360173|FG001|Overall Study|Adverse Event|8
7869198|NCT01651000|12360172|FG000|Overall Study|Lost to Follow-up|3
7869199|NCT01651000|12360173|FG001|Overall Study|Lost to Follow-up|2
7869200|NCT01651000|12360172|FG000|Overall Study|Protocol Violation|0
7792466|NCT01036438|12246967|FG000|Overall Study|No effect of study treatment|3
7792467|NCT01036438|12246968|FG001|Overall Study|No effect of study treatment|1
7792468|NCT01036529|12246985|FG000|Overall Study|Adverse Event|0
7792469|NCT01036529|12246986|FG001|Overall Study|Adverse Event|1
7792470|NCT01036529|12246985|FG000|Overall Study|Lost to Follow-up|0
7792471|NCT01036529|12246986|FG001|Overall Study|Lost to Follow-up|1
7792472|NCT01036529|12246985|FG000|Overall Study|Physician Decision|1
7792473|NCT01036529|12246986|FG001|Overall Study|Physician Decision|0
7792474|NCT01036529|12246985|FG000|Overall Study|Withdrawal by Subject|1
7792475|NCT01036529|12246986|FG001|Overall Study|Withdrawal by Subject|1
7792476|NCT01036529|12246985|FG000|Overall Study|Sponsor study termination|11
7792477|NCT01036529|12246986|FG001|Overall Study|Sponsor study termination|12
7792478|NCT01036594|12246992|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1
7792479|NCT01036594|12246993|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0
7792480|NCT01036594|12246992|FG000|First Treatment Regimen|Withdrawal by Subject|1
7792481|NCT01036594|12246993|FG001|First Treatment Regimen|Withdrawal by Subject|0
7792482|NCT01036594|12246992|FG000|Week 12 Evaluation|Adverse Event|5
7792483|NCT01036594|12246993|FG001|Week 12 Evaluation|Adverse Event|0
7792484|NCT01036594|12246992|FG000|Week 12 Evaluation|Physician Decision|1
7792485|NCT01036594|12246993|FG001|Week 12 Evaluation|Physician Decision|0
7792486|NCT01036594|12246992|FG000|Treatment Regiments Post Week 12|Physician Decision|1
7792487|NCT01036594|12246993|FG001|Treatment Regiments Post Week 12|Physician Decision|1
7792488|NCT01036594|12246992|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1
7792489|NCT01036594|12246993|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0
7792490|NCT01036594|12246992|FG000|Treatment Regiments Post Week 12|Adverse Event|0
7792491|NCT01036594|12246993|FG001|Treatment Regiments Post Week 12|Adverse Event|1
7792492|NCT01036594|12246992|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0
7792493|NCT01036594|12246993|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1
7792494|NCT01036594|12246992|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0
7792495|NCT01036594|12246993|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1
7792496|NCT01036724|12247001|FG000|Overall Study|Adverse Event|1
7792497|NCT01036724|12247002|FG001|Overall Study|Adverse Event|2
7792498|NCT01036724|12247001|FG000|Overall Study|Lack of Efficacy|1
7792499|NCT01036724|12247002|FG001|Overall Study|Lack of Efficacy|1
7792500|NCT01036724|12247001|FG000|Overall Study|Protocol Violation|4
7792501|NCT01036724|12247002|FG001|Overall Study|Protocol Violation|5
7792502|NCT01036763|12247008|FG000|Overall Study|Adverse Event|25
7792503|NCT01036763|12247008|FG000|Overall Study|Lost to Follow-up|28
7792504|NCT01036763|12247008|FG000|Overall Study|Other reason (not specified)|40
7792505|NCT01037088|12247022|FG000|Overall Study|Withdrawal by Subject|3
7792506|NCT01037114|12247031|FG000|Year 20|Others|1
7792507|NCT01037127|12247037|FG000|Overall Study|Lost to Follow-up|2
7792508|NCT01037127|12247038|FG001|Overall Study|Lost to Follow-up|4
7792509|NCT01037127|12247037|FG000|Overall Study|Physician Decision|1
7792510|NCT01037127|12247038|FG001|Overall Study|Physician Decision|0
7792511|NCT01037127|12247037|FG000|Overall Study|Study Closed Terminated|2
7792512|NCT01037127|12247038|FG001|Overall Study|Study Closed Terminated|17
7792513|NCT01037218|12247069|FG000|Overall Study|Adverse Event|4
7792514|NCT01037218|12247070|FG001|Overall Study|Adverse Event|2
7792515|NCT01037218|12247071|FG002|Overall Study|Adverse Event|2
7792516|NCT01037218|12247072|FG003|Overall Study|Adverse Event|1
7792517|NCT01037218|12247069|FG000|Overall Study|Lack of Efficacy|0
7792518|NCT01037218|12247070|FG001|Overall Study|Lack of Efficacy|2
7792519|NCT01037218|12247071|FG002|Overall Study|Lack of Efficacy|1
7792520|NCT01037218|12247072|FG003|Overall Study|Lack of Efficacy|5
7792521|NCT01037218|12247069|FG000|Overall Study|Lost to Follow-up|3
7792522|NCT01037218|12247070|FG001|Overall Study|Lost to Follow-up|5
7792523|NCT01037218|12247071|FG002|Overall Study|Lost to Follow-up|4
7792524|NCT01037218|12247072|FG003|Overall Study|Lost to Follow-up|2
7792525|NCT01037218|12247069|FG000|Overall Study|Withdrawal by Subject|6
7792526|NCT01037218|12247070|FG001|Overall Study|Withdrawal by Subject|7
7792527|NCT01037218|12247071|FG002|Overall Study|Withdrawal by Subject|7
7792528|NCT01037218|12247072|FG003|Overall Study|Withdrawal by Subject|4
7792529|NCT01037218|12247069|FG000|Overall Study|Partner Withdrew Consent|0
7792530|NCT01037218|12247070|FG001|Overall Study|Partner Withdrew Consent|3
7792531|NCT01037218|12247071|FG002|Overall Study|Partner Withdrew Consent|2
7792532|NCT01037218|12247072|FG003|Overall Study|Partner Withdrew Consent|1
7792533|NCT01037218|12247069|FG000|Overall Study|Protocol Violation|0
7792534|NCT01037218|12247070|FG001|Overall Study|Protocol Violation|0
7792535|NCT01037218|12247071|FG002|Overall Study|Protocol Violation|2
7792536|NCT01037218|12247072|FG003|Overall Study|Protocol Violation|2
7792537|NCT01037218|12247069|FG000|Overall Study|Various|3
7792538|NCT01037218|12247070|FG001|Overall Study|Various|2
7792539|NCT01037218|12247071|FG002|Overall Study|Various|3
7792540|NCT01037218|12247072|FG003|Overall Study|Various|1
7792541|NCT01037244|12247086|FG000|Overall Study|Adverse Event|3
7792542|NCT01037244|12247087|FG001|Overall Study|Adverse Event|2
7792543|NCT01037244|12247088|FG002|Overall Study|Adverse Event|6
7792544|NCT01037244|12247089|FG003|Overall Study|Adverse Event|3
7792545|NCT01037244|12247086|FG000|Overall Study|Lack of Efficacy|1
7792546|NCT01037244|12247087|FG001|Overall Study|Lack of Efficacy|1
7792547|NCT01037244|12247088|FG002|Overall Study|Lack of Efficacy|0
7792548|NCT01037244|12247089|FG003|Overall Study|Lack of Efficacy|1
7792549|NCT01037244|12247086|FG000|Overall Study|Lost to Follow-up|3
7792550|NCT01037244|12247087|FG001|Overall Study|Lost to Follow-up|3
7792551|NCT01037244|12247088|FG002|Overall Study|Lost to Follow-up|4
7792552|NCT01037244|12247089|FG003|Overall Study|Lost to Follow-up|4
7792553|NCT01037244|12247086|FG000|Overall Study|Withdrawal by Subject|1
7792554|NCT01037244|12247087|FG001|Overall Study|Withdrawal by Subject|5
7792555|NCT01037244|12247088|FG002|Overall Study|Withdrawal by Subject|3
7792556|NCT01037244|12247089|FG003|Overall Study|Withdrawal by Subject|5
7792557|NCT01037244|12247086|FG000|Overall Study|Partner Withdrew Consent|2
7792558|NCT01037244|12247087|FG001|Overall Study|Partner Withdrew Consent|1
7792559|NCT01037244|12247088|FG002|Overall Study|Partner Withdrew Consent|0
7792560|NCT01037244|12247089|FG003|Overall Study|Partner Withdrew Consent|0
7792561|NCT01037244|12247086|FG000|Overall Study|Various|3
7792562|NCT01037244|12247087|FG001|Overall Study|Various|2
7792563|NCT01037244|12247088|FG002|Overall Study|Various|1
7792564|NCT01037244|12247089|FG003|Overall Study|Various|1
7792565|NCT01037413|12247136|FG000|Part A: Skin Testing|Adverse Event|1
7792566|NCT01037413|12247137|FG001|Part A: Skin Testing|Adverse Event|0
7792567|NCT01037413|12247136|FG000|Part A: Skin Testing|Protocol Violation|1
7792568|NCT01037413|12247137|FG001|Part A: Skin Testing|Protocol Violation|0
7792569|NCT01037413|12247136|FG000|Part B: Scar Revision|Withdrawal by Subject|0
7792570|NCT01037413|12247137|FG001|Part B: Scar Revision|Withdrawal by Subject|1
7792571|NCT01037413|12247136|FG000|Part B: Scar Revision|Assigned But Not Treated|0
7792572|NCT01037413|12247137|FG001|Part B: Scar Revision|Assigned But Not Treated|1
7792573|NCT01037985|12247226|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3
7792574|NCT01037985|12247227|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0
7792575|NCT01037985|12247226|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1
7792576|NCT01037985|12247227|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0
7792577|NCT01037985|12247226|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0
7792578|NCT01037985|12247227|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1
7792579|NCT01037985|12247226|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0
7792580|NCT01037985|12247227|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4
7792581|NCT01038128|12247237|FG000|Overall Study|Lack of Efficacy|1
7792582|NCT01038128|12247237|FG000|Overall Study|Lost to Follow-up|1
7792583|NCT01038128|12247237|FG000|Overall Study|Withdrawal by Subject|2
7792584|NCT01038297|12247246|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1
7792585|NCT01038297|12247247|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0
7792586|NCT01038297|12247248|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0
7792587|NCT01038323|12247268|FG000|Overall Study|Withdrawal by Subject|3
7792588|NCT01038323|12247269|FG001|Overall Study|Withdrawal by Subject|2
7792589|NCT01038323|12247270|FG002|Overall Study|Withdrawal by Subject|4
7792590|NCT01038427|12247299|FG000|Overall Study|Lost to follow up|1
7792591|NCT01038427|12247300|FG001|Overall Study|Lost to follow up|1
7792592|NCT01038427|12247301|FG002|Overall Study|Lost to follow up|0
7792593|NCT01038427|12247299|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0
7792594|NCT01038427|12247300|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0
7792595|NCT01038427|12247301|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1
7792596|NCT01038427|12247299|FG000|Overall Study|Withdrew consent|0
7792597|NCT01038427|12247300|FG001|Overall Study|Withdrew consent|0
7792598|NCT01038427|12247301|FG002|Overall Study|Withdrew consent|1
7792599|NCT01038427|12247299|FG000|Overall Study|Adverse Event|2
7792600|NCT01038427|12247300|FG001|Overall Study|Adverse Event|2
7792601|NCT01038427|12247301|FG002|Overall Study|Adverse Event|1
7792602|NCT01038427|12247299|FG000|Overall Study|Enrolled in error|0
7792603|NCT01038427|12247300|FG001|Overall Study|Enrolled in error|1
7792604|NCT01038427|12247301|FG002|Overall Study|Enrolled in error|1
7792605|NCT01038427|12247299|FG000|Overall Study|Other|0
7792606|NCT01038427|12247300|FG001|Overall Study|Other|2
7792607|NCT01038427|12247301|FG002|Overall Study|Other|0
7792608|NCT01038609|12247327|FG000|Overall Study|Adverse Event|0
7792609|NCT01038609|12247328|FG001|Overall Study|Adverse Event|0
7792610|NCT01038609|12247329|FG002|Overall Study|Adverse Event|1
7792611|NCT01038609|12247330|FG003|Overall Study|Adverse Event|0
7792612|NCT01038609|12247331|FG004|Overall Study|Adverse Event|0
7792613|NCT01038609|12247327|FG000|Overall Study|Dosing Error|0
7792614|NCT01038609|12247328|FG001|Overall Study|Dosing Error|0
7792615|NCT01038609|12247329|FG002|Overall Study|Dosing Error|0
7792616|NCT01038609|12247330|FG003|Overall Study|Dosing Error|1
7792617|NCT01038609|12247331|FG004|Overall Study|Dosing Error|1
7792618|NCT01038609|12247327|FG000|Overall Study|Death in the Family|1
7792619|NCT01038609|12247328|FG001|Overall Study|Death in the Family|0
7792620|NCT01038609|12247329|FG002|Overall Study|Death in the Family|0
7792621|NCT01038609|12247330|FG003|Overall Study|Death in the Family|0
7792622|NCT01038609|12247331|FG004|Overall Study|Death in the Family|0
7792623|NCT01038609|12247327|FG000|Overall Study|Refusal of Blood Draws|0
7792624|NCT01038609|12247328|FG001|Overall Study|Refusal of Blood Draws|1
7792625|NCT01038609|12247329|FG002|Overall Study|Refusal of Blood Draws|0
7792626|NCT01038609|12247330|FG003|Overall Study|Refusal of Blood Draws|0
7792627|NCT01038609|12247331|FG004|Overall Study|Refusal of Blood Draws|0
7792628|NCT01038635|12247352|FG000|Overall Study|Disease Progression|2
7792629|NCT01038635|12247353|FG001|Overall Study|Disease Progression|0
7792630|NCT01038635|12247354|FG002|Overall Study|Disease Progression|0
7792631|NCT01038635|12247355|FG003|Overall Study|Disease Progression|0
7792632|NCT01038635|12247356|FG004|Overall Study|Disease Progression|0
7792633|NCT01038635|12247357|FG005|Overall Study|Disease Progression|0
7792634|NCT01038635|12247358|FG006|Overall Study|Disease Progression|1
7792635|NCT01038635|12247359|FG007|Overall Study|Disease Progression|4
7792636|NCT01038635|12247360|FG008|Overall Study|Disease Progression|0
7792637|NCT01038635|12247352|FG000|Overall Study|Death|0
7792638|NCT01038635|12247353|FG001|Overall Study|Death|0
7792639|NCT01038635|12247354|FG002|Overall Study|Death|0
7792640|NCT01038635|12247355|FG003|Overall Study|Death|0
7792641|NCT01038635|12247356|FG004|Overall Study|Death|1
7792642|NCT01038635|12247357|FG005|Overall Study|Death|0
7792643|NCT01038635|12247358|FG006|Overall Study|Death|1
7792644|NCT01038635|12247359|FG007|Overall Study|Death|1
7792645|NCT01038635|12247360|FG008|Overall Study|Death|2
7792646|NCT01038687|12247384|FG000|Overall Study|Adverse Event|0
7792647|NCT01038687|12247385|FG001|Overall Study|Adverse Event|2
7792648|NCT01038687|12247386|FG002|Overall Study|Adverse Event|1
7792649|NCT01038713|12247397|FG000|Overall Study|Patient to hospice|1
7792650|NCT01038713|12247398|FG001|Overall Study|Patient to hospice|1
7792651|NCT01038713|12247399|FG002|Overall Study|Patient to hospice|1
7792652|NCT01038713|12247397|FG000|Overall Study|Lost to Follow-up|3
7792653|NCT01038713|12247398|FG001|Overall Study|Lost to Follow-up|0
7792654|NCT01038713|12247399|FG002|Overall Study|Lost to Follow-up|0
7792655|NCT01038713|12247397|FG000|Overall Study|Neuroendocrine Tumor|0
7792656|NCT01038713|12247398|FG001|Overall Study|Neuroendocrine Tumor|1
7792657|NCT01038713|12247399|FG002|Overall Study|Neuroendocrine Tumor|0
7792658|NCT01038713|12247397|FG000|Overall Study|died from PEP|0
7792659|NCT01038713|12247398|FG001|Overall Study|died from PEP|1
7869201|NCT01651000|12360173|FG001|Overall Study|Protocol Violation|3
7869202|NCT01651000|12360172|FG000|Overall Study|Withdrawal by Subject|2
7869203|NCT01651000|12360173|FG001|Overall Study|Withdrawal by Subject|10
7869204|NCT01651000|12360172|FG000|Overall Study|Subject noncompliance|0
7869205|NCT01651000|12360173|FG001|Overall Study|Subject noncompliance|3
7869206|NCT01651000|12360172|FG000|Overall Study|Lack of Efficacy|1
7869207|NCT01651000|12360173|FG001|Overall Study|Lack of Efficacy|1
7869208|NCT01651000|12360172|FG000|Overall Study|Physician Decision|1
7869209|NCT01651000|12360173|FG001|Overall Study|Physician Decision|0
7869210|NCT01651000|12360172|FG000|Overall Study|Administrative reason|1
7869211|NCT01651000|12360173|FG001|Overall Study|Administrative reason|0
7869212|NCT01651000|12360172|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
7869213|NCT01651000|12360173|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
7869214|NCT01651039|12360179|FG000|Overall Study|Non-evaluables|5
7869215|NCT01651039|12360179|FG000|Overall Study|Physician Decision|2
7869216|NCT01651039|12360179|FG000|Overall Study|Withdrawal by Subject|1
7869217|NCT01651039|12360179|FG000|Overall Study|Progressive Disease|22
7869218|NCT01651052|12360183|FG000|Overall Study|Death|21
7869219|NCT01651052|12360183|FG000|Overall Study|Explant|1
7869220|NCT01651052|12360183|FG000|Overall Study|Withdrawal by Subject|1
7869221|NCT01651052|12360183|FG000|Overall Study|Lost to Follow-up|3
7869222|NCT01651117|12360199|FG000|Overall Study|Death|2
7869223|NCT01651117|12360200|FG001|Overall Study|Death|3
7869224|NCT01651117|12360201|FG002|Overall Study|Death|2
7869225|NCT01651117|12360202|FG003|Overall Study|Death|2
7869226|NCT01651208|12360238|FG000|Overall Study|Lost to Follow-up|14
7869227|NCT01651208|12360239|FG001|Overall Study|Lost to Follow-up|16
7869228|NCT01651260|12360246|FG000|Overall Study|unable to apply product|3
7869229|NCT01651780|12360282|FG000|Overall Study|Physician decision: No 30-day visit|2
7792660|NCT01038713|12247399|FG002|Overall Study|died from PEP|0
7792661|NCT01038713|12247397|FG000|Overall Study|Autoimmune Pancreatitis|1
7792662|NCT01038713|12247398|FG001|Overall Study|Autoimmune Pancreatitis|0
7792663|NCT01038713|12247399|FG002|Overall Study|Autoimmune Pancreatitis|0
7792664|NCT01038856|12247407|FG000|Overall Study|Adverse Event|2
7792665|NCT01038869|12247413|FG000|Overall Study|Withdrawal by Subject|1
7792666|NCT01038869|12247413|FG000|Overall Study|Lost to Follow-up|6
7792667|NCT01038921|12247423|FG000|Overall Study|Withdrawal by Subject|1
7792668|NCT01038921|12247424|FG001|Overall Study|Withdrawal by Subject|0
7792669|NCT01038921|12247423|FG000|Overall Study|Physician Decision|1
7792670|NCT01038921|12247424|FG001|Overall Study|Physician Decision|0
7792671|NCT01039376|12247436|FG000|Overall Study|Lost to Follow-up|5
7792672|NCT01039376|12247437|FG001|Overall Study|Lost to Follow-up|12
7792673|NCT01039376|12247436|FG000|Overall Study|Physician Decision|15
7869230|NCT01651780|12360283|FG001|Overall Study|Physician decision: No 30-day visit|1
7869231|NCT01651780|12360282|FG000|Overall Study|Reason Not Specified: No 30-day visit|2
7869232|NCT01651780|12360283|FG001|Overall Study|Reason Not Specified: No 30-day visit|2
7869233|NCT01651780|12360282|FG000|Overall Study|Withdrawal by Subject|2
7869234|NCT01651780|12360283|FG001|Overall Study|Withdrawal by Subject|0
7869235|NCT01651780|12360282|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3
7869236|NCT01651780|12360283|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7869237|NCT01651780|12360282|FG000|Overall Study|Lost to Follow-up|1
7869238|NCT01651780|12360283|FG001|Overall Study|Lost to Follow-up|2
7869239|NCT01651780|12360282|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1
7869240|NCT01651780|12360283|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5
7869241|NCT01651936|12360334|FG000|Base Study|Adverse Event|3
7869242|NCT01651936|12360335|FG001|Base Study|Adverse Event|0
7869243|NCT01651936|12360336|FG002|Base Study|Adverse Event|0
7869244|NCT01651936|12360334|FG000|Base Study|Withdrawal by Subject|1
7869245|NCT01651936|12360335|FG001|Base Study|Withdrawal by Subject|1
7869246|NCT01651936|12360336|FG002|Base Study|Withdrawal by Subject|0
7869247|NCT01651936|12360334|FG000|Base Study|Early Escape|2
7869248|NCT01651936|12360335|FG001|Base Study|Early Escape|8
7869249|NCT01651936|12360336|FG002|Base Study|Early Escape|0
7869250|NCT01651936|12360334|FG000|Base Study|Study terminated by sponsor|21
7792674|NCT01039376|12247437|FG001|Overall Study|Physician Decision|10
7792675|NCT01039376|12247436|FG000|Overall Study|Withdrawal by Subject|20
7792676|NCT01039376|12247437|FG001|Overall Study|Withdrawal by Subject|32
7869251|NCT01651936|12360335|FG001|Base Study|Study terminated by sponsor|16
7869252|NCT01651936|12360336|FG002|Base Study|Study terminated by sponsor|0
7869253|NCT01651936|12360334|FG000|Extension Study|Lack of Efficacy|0
7869254|NCT01651936|12360335|FG001|Extension Study|Lack of Efficacy|0
7869255|NCT01651936|12360336|FG002|Extension Study|Lack of Efficacy|1
7869256|NCT01651936|12360334|FG000|Extension Study|Study terminated by sponsor|0
7869257|NCT01651936|12360335|FG001|Extension Study|Study terminated by sponsor|0
7869258|NCT01651936|12360336|FG002|Extension Study|Study terminated by sponsor|13
7869259|NCT01651949|12360346|FG000|Overall Study|Unknown status|4
7869260|NCT01651949|12360347|FG001|Overall Study|Unknown status|4
7869261|NCT01651949|12360348|FG002|Overall Study|Unknown status|0
7869262|NCT01651949|12360346|FG000|Overall Study|Lost to Follow-up|30
7869263|NCT01651949|12360347|FG001|Overall Study|Lost to Follow-up|56
7869264|NCT01651949|12360348|FG002|Overall Study|Lost to Follow-up|20
7869265|NCT01651949|12360346|FG000|Overall Study|Protocol Violation|0
7869266|NCT01651949|12360347|FG001|Overall Study|Protocol Violation|2
7869267|NCT01651949|12360348|FG002|Overall Study|Protocol Violation|1
7869268|NCT01651949|12360346|FG000|Overall Study|Physician Decision|0
7869269|NCT01651949|12360347|FG001|Overall Study|Physician Decision|2
7869270|NCT01651949|12360348|FG002|Overall Study|Physician Decision|0
7869271|NCT01651949|12360346|FG000|Overall Study|Adverse Event|0
7869272|NCT01651949|12360347|FG001|Overall Study|Adverse Event|2
7869273|NCT01651949|12360348|FG002|Overall Study|Adverse Event|1
7869274|NCT01651949|12360346|FG000|Overall Study|Screen failure|2
7869275|NCT01651949|12360347|FG001|Overall Study|Screen failure|2
7869276|NCT01651949|12360348|FG002|Overall Study|Screen failure|0
7869277|NCT01651949|12360346|FG000|Overall Study|Withdrawal by Subject|17
7869278|NCT01651949|12360347|FG001|Overall Study|Withdrawal by Subject|18
7869279|NCT01651949|12360348|FG002|Overall Study|Withdrawal by Subject|9
7869280|NCT01652287|12360377|FG000|Overall Study|Withdrawal by Subject|2
7869281|NCT01652287|12360378|FG001|Overall Study|Withdrawal by Subject|0
7869282|NCT01652573|12360397|FG000|Overall Study|Adverse Event|0
7869283|NCT01652573|12360398|FG001|Overall Study|Adverse Event|1
7869284|NCT01652664|12360406|FG000|Overall Study|Treatment Failure|5
7869285|NCT01652664|12360407|FG001|Overall Study|Treatment Failure|1
7869286|NCT01652664|12360406|FG000|Overall Study|Inadequate IOP control|1
7869287|NCT01652664|12360407|FG001|Overall Study|Inadequate IOP control|0
7869288|NCT01652690|12360416|FG000|Overall Study|Withdrawal by Subject|16
7869289|NCT01652690|12360417|FG001|Overall Study|Withdrawal by Subject|4
7869290|NCT01652690|12360416|FG000|Overall Study|Other|8
7869291|NCT01652690|12360417|FG001|Overall Study|Other|9
7869292|NCT01652690|12360416|FG000|Overall Study|Lost to Follow-up|6
7869293|NCT01652690|12360417|FG001|Overall Study|Lost to Follow-up|6
7792677|NCT01039376|12247436|FG000|Overall Study|Study terminated by Sponsor|90
7792678|NCT01039376|12247437|FG001|Overall Study|Study terminated by Sponsor|72
7792679|NCT01039428|12247446|FG000|Overall Study|Protocol Violation|1
7792680|NCT01039428|12247447|FG001|Overall Study|Protocol Violation|0
7792681|NCT01039428|12247446|FG000|Overall Study|Withdrawal by Subject|1
7792682|NCT01039428|12247447|FG001|Overall Study|Withdrawal by Subject|0
7792683|NCT01039519|12247464|FG000|Treatment|Progressive disease|20
7792684|NCT01039519|12247464|FG000|Treatment|Treatment failure|2
7792685|NCT01039519|12247464|FG000|Treatment|Adverse Event|3
7792686|NCT01039519|12247464|FG000|Treatment|Physician Decision|2
7792687|NCT01039519|12247464|FG000|Survival Follow-up|Death|23
7792688|NCT01039519|12247464|FG000|Survival Follow-up|Sponsor decision|4
7792689|NCT01039584|12247471|FG000|Overall Study|Withdrawal by Subject|4
7792690|NCT01039584|12247472|FG001|Overall Study|Withdrawal by Subject|2
7792691|NCT01039584|12247473|FG002|Overall Study|Withdrawal by Subject|1
7792692|NCT01039584|12247471|FG000|Overall Study|Protocol Violation|10
7792693|NCT01039584|12247472|FG001|Overall Study|Protocol Violation|4
7792694|NCT01039584|12247473|FG002|Overall Study|Protocol Violation|6
7792695|NCT01039584|12247471|FG000|Overall Study|Lost to Follow-up|5
7792696|NCT01039584|12247472|FG001|Overall Study|Lost to Follow-up|3
7792697|NCT01039584|12247473|FG002|Overall Study|Lost to Follow-up|4
7792698|NCT01039584|12247471|FG000|Overall Study|Negative Baseline culture for Candida|59
7792699|NCT01039584|12247472|FG001|Overall Study|Negative Baseline culture for Candida|59
7792700|NCT01039584|12247473|FG002|Overall Study|Negative Baseline culture for Candida|24
7792701|NCT01039584|12247471|FG000|Overall Study|Lack of Efficacy|7
7792702|NCT01039584|12247472|FG001|Overall Study|Lack of Efficacy|6
7869294|NCT01652690|12360416|FG000|Overall Study|Death|5
7869295|NCT01652690|12360417|FG001|Overall Study|Death|2
7869296|NCT01652703|12360429|FG000|Overall Study|Withdrawal by Subject|0
7869297|NCT01652703|12360430|FG001|Overall Study|Withdrawal by Subject|1
7869298|NCT01652703|12360431|FG002|Overall Study|Withdrawal by Subject|3
7869299|NCT01652703|12360432|FG003|Overall Study|Withdrawal by Subject|1
7869300|NCT01652703|12360433|FG004|Overall Study|Withdrawal by Subject|0
7869301|NCT01652703|12360434|FG005|Overall Study|Withdrawal by Subject|1
7869302|NCT01652703|12360429|FG000|Overall Study|Other|0
7869303|NCT01652703|12360430|FG001|Overall Study|Other|0
7869304|NCT01652703|12360431|FG002|Overall Study|Other|0
7869305|NCT01652703|12360432|FG003|Overall Study|Other|1
7869306|NCT01652703|12360433|FG004|Overall Study|Other|1
7869307|NCT01652703|12360434|FG005|Overall Study|Other|1
7869308|NCT01652716|12360450|FG000|Overall Study|Loss of glucose control|1
7792703|NCT01039584|12247473|FG002|Overall Study|Lack of Efficacy|10
7792704|NCT01039584|12247471|FG000|Overall Study|other|1
7869309|NCT01652716|12360451|FG001|Overall Study|Loss of glucose control|0
7869310|NCT01652716|12360450|FG000|Overall Study|Administrative|0
7869311|NCT01652716|12360451|FG001|Overall Study|Administrative|2
7869312|NCT01652716|12360450|FG000|Overall Study|Investigator decision|1
7869313|NCT01652716|12360451|FG001|Overall Study|Investigator decision|4
7869314|NCT01652716|12360450|FG000|Overall Study|Lost to Follow-up|12
7869315|NCT01652716|12360451|FG001|Overall Study|Lost to Follow-up|11
7869316|NCT01652716|12360450|FG000|Overall Study|Protocol Violation|2
7869317|NCT01652716|12360451|FG001|Overall Study|Protocol Violation|1
7869318|NCT01652716|12360450|FG000|Overall Study|Adverse Event|7
7869319|NCT01652716|12360451|FG001|Overall Study|Adverse Event|10
7869320|NCT01652716|12360450|FG000|Overall Study|Withdrawal by Subject|33
7869321|NCT01652716|12360451|FG001|Overall Study|Withdrawal by Subject|18
7869322|NCT01652729|12360460|FG000|Overall Study|Withdrawal by Subject|14
7869323|NCT01652729|12360461|FG001|Overall Study|Withdrawal by Subject|7
7869324|NCT01652729|12360462|FG002|Overall Study|Withdrawal by Subject|7
7869325|NCT01652729|12360460|FG000|Overall Study|Adverse Event|4
7869326|NCT01652729|12360461|FG001|Overall Study|Adverse Event|0
7869327|NCT01652729|12360462|FG002|Overall Study|Adverse Event|3
7869328|NCT01652729|12360460|FG000|Overall Study|Physician Decision|1
7869329|NCT01652729|12360461|FG001|Overall Study|Physician Decision|0
7869330|NCT01652729|12360462|FG002|Overall Study|Physician Decision|1
7869331|NCT01652729|12360460|FG000|Overall Study|Protocol Violation|1
7869332|NCT01652729|12360461|FG001|Overall Study|Protocol Violation|0
7869333|NCT01652729|12360462|FG002|Overall Study|Protocol Violation|0
7869334|NCT01652729|12360460|FG000|Overall Study|Lost to Follow-up|6
7869335|NCT01652729|12360461|FG001|Overall Study|Lost to Follow-up|6
7869336|NCT01652729|12360462|FG002|Overall Study|Lost to Follow-up|3
7869337|NCT01652729|12360460|FG000|Overall Study|Administrative|1
7869338|NCT01652729|12360461|FG001|Overall Study|Administrative|0
7869339|NCT01652729|12360462|FG002|Overall Study|Administrative|0
7869340|NCT01652885|12360470|FG000|Overall Study|Adverse Event|1
7869341|NCT01653132|12360499|FG000|First Intervention|Protocol Violation|1
7869342|NCT01653132|12360500|FG001|First Intervention|Protocol Violation|0
7869343|NCT01653158|12360510|FG000|Overall Study|Death|0
7869344|NCT01653158|12360511|FG001|Overall Study|Death|0
7869345|NCT01653158|12360512|FG002|Overall Study|Death|0
7869346|NCT01653158|12360513|FG003|Overall Study|Death|1
7792705|NCT01039584|12247472|FG001|Overall Study|other|3
7792706|NCT01039584|12247473|FG002|Overall Study|other|1
7792707|NCT01039584|12247471|FG000|Overall Study|Pap smear with significant pathology|10
7869347|NCT01653158|12360514|FG004|Overall Study|Death|0
7792708|NCT01039584|12247472|FG001|Overall Study|Pap smear with significant pathology|10
7792709|NCT01039584|12247473|FG002|Overall Study|Pap smear with significant pathology|3
7792710|NCT01039584|12247471|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7
7792711|NCT01039584|12247472|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10
7792712|NCT01039584|12247473|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8
7792713|NCT01039675|12247483|FG000|Overall Study|Adverse Event|0
7792714|NCT01039675|12247484|FG001|Overall Study|Adverse Event|2
7792715|NCT01039675|12247483|FG000|Overall Study|Lack of Efficacy|0
7792716|NCT01039675|12247484|FG001|Overall Study|Lack of Efficacy|2
7792717|NCT01039675|12247483|FG000|Overall Study|Withdrawal by Subject|0
7792718|NCT01039675|12247484|FG001|Overall Study|Withdrawal by Subject|1
7792719|NCT01039675|12247483|FG000|Overall Study|Lost to Follow-up|0
7792720|NCT01039675|12247484|FG001|Overall Study|Lost to Follow-up|1
7792721|NCT01039675|12247483|FG000|Overall Study|Physician Decision|0
7792722|NCT01039675|12247484|FG001|Overall Study|Physician Decision|1
7792723|NCT01039688|12247493|FG000|Overall Study|Adverse Event|38
7792724|NCT01039688|12247494|FG001|Overall Study|Adverse Event|39
7792725|NCT01039688|12247495|FG002|Overall Study|Adverse Event|24
7792726|NCT01039688|12247493|FG000|Overall Study|Lack of Efficacy|20
7792727|NCT01039688|12247494|FG001|Overall Study|Lack of Efficacy|11
7792728|NCT01039688|12247495|FG002|Overall Study|Lack of Efficacy|26
7792729|NCT01039688|12247493|FG000|Overall Study|Lost to Follow-up|11
7792730|NCT01039688|12247494|FG001|Overall Study|Lost to Follow-up|9
7792731|NCT01039688|12247495|FG002|Overall Study|Lost to Follow-up|5
7792732|NCT01039688|12247493|FG000|Overall Study|Other|13
7869348|NCT01653158|12360515|FG005|Overall Study|Death|0
7869349|NCT01653158|12360516|FG006|Overall Study|Death|0
7869350|NCT01653158|12360517|FG007|Overall Study|Death|2
7869351|NCT01653158|12360510|FG000|Overall Study|Adverse Event|0
7869352|NCT01653158|12360511|FG001|Overall Study|Adverse Event|0
7869353|NCT01653158|12360512|FG002|Overall Study|Adverse Event|0
7869354|NCT01653158|12360513|FG003|Overall Study|Adverse Event|1
7869355|NCT01653158|12360514|FG004|Overall Study|Adverse Event|0
7869356|NCT01653158|12360515|FG005|Overall Study|Adverse Event|0
7869357|NCT01653158|12360516|FG006|Overall Study|Adverse Event|0
7869358|NCT01653158|12360517|FG007|Overall Study|Adverse Event|3
7869359|NCT01653158|12360510|FG000|Overall Study|Other|0
7869360|NCT01653158|12360511|FG001|Overall Study|Other|0
7869361|NCT01653158|12360512|FG002|Overall Study|Other|0
7869362|NCT01653158|12360513|FG003|Overall Study|Other|0
7869363|NCT01653158|12360514|FG004|Overall Study|Other|0
7869364|NCT01653158|12360515|FG005|Overall Study|Other|0
7869365|NCT01653158|12360516|FG006|Overall Study|Other|0
7869366|NCT01653158|12360517|FG007|Overall Study|Other|1
7869367|NCT01653158|12360510|FG000|Overall Study|Progressive disease|0
7869368|NCT01653158|12360511|FG001|Overall Study|Progressive disease|0
7869369|NCT01653158|12360512|FG002|Overall Study|Progressive disease|0
7869370|NCT01653158|12360513|FG003|Overall Study|Progressive disease|0
7869371|NCT01653158|12360514|FG004|Overall Study|Progressive disease|1
7869372|NCT01653158|12360515|FG005|Overall Study|Progressive disease|1
7869373|NCT01653158|12360516|FG006|Overall Study|Progressive disease|2
7869374|NCT01653158|12360517|FG007|Overall Study|Progressive disease|9
7869375|NCT01653158|12360510|FG000|Overall Study|Withdrawal by Subject|1
7869376|NCT01653158|12360511|FG001|Overall Study|Withdrawal by Subject|0
7869377|NCT01653158|12360512|FG002|Overall Study|Withdrawal by Subject|0
7869378|NCT01653158|12360513|FG003|Overall Study|Withdrawal by Subject|0
7869379|NCT01653158|12360514|FG004|Overall Study|Withdrawal by Subject|0
7869380|NCT01653158|12360515|FG005|Overall Study|Withdrawal by Subject|0
7869381|NCT01653158|12360516|FG006|Overall Study|Withdrawal by Subject|0
7869382|NCT01653158|12360517|FG007|Overall Study|Withdrawal by Subject|0
7869383|NCT01653262|12360544|FG000|Overall Study|Lack of Efficacy|1
7869384|NCT01653262|12360544|FG000|Overall Study|SAE, non-fatal|1
7869385|NCT01653262|12360544|FG000|Overall Study|AE, non-serious non-fatal|1
7869386|NCT01653327|12360559|FG000|Overall Study|Withdrawal by Subject|1
7869387|NCT01653704|12360600|FG000|Overall Study|Technical failure during recording|1
7869388|NCT01653704|12360601|FG001|Overall Study|Technical failure during recording|1
7869389|NCT01653704|12360600|FG000|Overall Study|Performance not reflective of training|1
7869390|NCT01653704|12360601|FG001|Overall Study|Performance not reflective of training|0
7869391|NCT01653743|12360609|FG000|Overall Study|Withdrawal by Subject|1
7869392|NCT01653743|12360610|FG001|Overall Study|Withdrawal by Subject|0
7869393|NCT01653743|12360609|FG000|Overall Study|Investigator discretion|3
7869394|NCT01653743|12360610|FG001|Overall Study|Investigator discretion|0
7869395|NCT01653782|12360619|FG000|Overall Study|Withdrawal by Subject|9
7869396|NCT01653782|12360620|FG001|Overall Study|Withdrawal by Subject|15
7869397|NCT01653782|12360621|FG002|Overall Study|Withdrawal by Subject|4
7869398|NCT01653782|12360619|FG000|Overall Study|Lost to Follow-up|7
7869399|NCT01653782|12360620|FG001|Overall Study|Lost to Follow-up|3
7869400|NCT01653782|12360621|FG002|Overall Study|Lost to Follow-up|2
7869401|NCT01653847|12360631|FG000|Overall Study|Withdrawal by Subject|1
7869402|NCT01653847|12360632|FG001|Overall Study|Withdrawal by Subject|0
7882542|NCT01772693|12381651|FG000|Overall Study|Alternative Treatment|2
7882543|NCT01772693|12381652|FG001|Overall Study|Alternative Treatment|0
7882544|NCT01772823|12381677|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
7882545|NCT01772823|12381678|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
7882546|NCT01772823|12381677|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
7882547|NCT01772823|12381678|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
7882548|NCT01772823|12381677|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
7882549|NCT01772823|12381678|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
7882550|NCT01772823|12381677|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
7882551|NCT01772823|12381678|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
7882552|NCT01772823|12381677|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
7882553|NCT01772823|12381678|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
7882554|NCT01772823|12381677|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
7882555|NCT01772823|12381678|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
7882556|NCT01772823|12381677|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
7882557|NCT01772823|12381678|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
7882558|NCT01772823|12381677|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
7882559|NCT01772823|12381678|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
7882560|NCT01772823|12381677|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4
7882561|NCT01772823|12381678|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3
7882562|NCT01772823|12381677|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1
7882563|NCT01772823|12381678|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0
7792733|NCT01039688|12247494|FG001|Overall Study|Other|25
7792734|NCT01039688|12247495|FG002|Overall Study|Other|12
7792735|NCT01039688|12247493|FG000|Overall Study|Withdrawal by Subject|23
7792736|NCT01039688|12247494|FG001|Overall Study|Withdrawal by Subject|27
7792737|NCT01039688|12247495|FG002|Overall Study|Withdrawal by Subject|13
7792738|NCT01039688|12247493|FG000|Overall Study|Death|2
7792739|NCT01039688|12247494|FG001|Overall Study|Death|0
7792740|NCT01039688|12247495|FG002|Overall Study|Death|0
7792741|NCT01040130|12247519|FG000|Overall Study|Adverse Event|1
7792742|NCT01040130|12247520|FG001|Overall Study|Adverse Event|1
7882564|NCT01772823|12381677|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
7882565|NCT01772823|12381678|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
7882566|NCT01772823|12381677|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
7882567|NCT01772823|12381678|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
7882568|NCT01772823|12381677|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
7882569|NCT01772823|12381678|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
7882570|NCT01772823|12381677|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
7882571|NCT01772823|12381678|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
7882572|NCT01772823|12381677|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
7869403|NCT01653912|12360640|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7869404|NCT01653912|12360641|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
7869405|NCT01653912|12360642|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7869406|NCT01653912|12360643|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7792743|NCT01040130|12247521|FG002|Overall Study|Adverse Event|0
7792744|NCT01040130|12247522|FG003|Overall Study|Adverse Event|5
7792745|NCT01040130|12247523|FG004|Overall Study|Adverse Event|0
7792746|NCT01040130|12247524|FG005|Overall Study|Adverse Event|3
7792747|NCT01040130|12247519|FG000|Overall Study|Protocol Violation|0
7792748|NCT01040130|12247520|FG001|Overall Study|Protocol Violation|0
7792749|NCT01040130|12247521|FG002|Overall Study|Protocol Violation|2
7792750|NCT01040130|12247522|FG003|Overall Study|Protocol Violation|0
7792751|NCT01040130|12247523|FG004|Overall Study|Protocol Violation|0
7792752|NCT01040130|12247524|FG005|Overall Study|Protocol Violation|0
7792753|NCT01040130|12247519|FG000|Overall Study|Withdrawal by Subject|0
7792754|NCT01040130|12247520|FG001|Overall Study|Withdrawal by Subject|2
7792755|NCT01040130|12247521|FG002|Overall Study|Withdrawal by Subject|0
7792756|NCT01040130|12247522|FG003|Overall Study|Withdrawal by Subject|0
7792757|NCT01040130|12247523|FG004|Overall Study|Withdrawal by Subject|0
7792758|NCT01040130|12247524|FG005|Overall Study|Withdrawal by Subject|1
7792759|NCT01040130|12247519|FG000|Overall Study|Other reasons not listed above|2
7792760|NCT01040130|12247520|FG001|Overall Study|Other reasons not listed above|0
7792761|NCT01040130|12247521|FG002|Overall Study|Other reasons not listed above|0
7792762|NCT01040130|12247522|FG003|Overall Study|Other reasons not listed above|0
7792763|NCT01040130|12247523|FG004|Overall Study|Other reasons not listed above|0
7792764|NCT01040130|12247524|FG005|Overall Study|Other reasons not listed above|0
7792765|NCT01040169|12247536|FG000|Overall Study|Lost to Follow-up|3
7792766|NCT01040169|12247537|FG001|Overall Study|Lost to Follow-up|8
7792767|NCT01040260|12247563|FG000|Overall Study|Withdrawal by Subject|12
7792768|NCT01040260|12247564|FG001|Overall Study|Withdrawal by Subject|6
7792769|NCT01040260|12247563|FG000|Overall Study|Lost to Follow-up|3
7792770|NCT01040260|12247564|FG001|Overall Study|Lost to Follow-up|5
7792771|NCT01040351|12247572|FG000|Overall Study|poor ovarian response|1
7792772|NCT01040351|12247573|FG001|Overall Study|poor ovarian response|2
7792773|NCT01040403|12247579|FG000|Overall Study|Adverse Event|10
7792774|NCT01040403|12247579|FG000|Overall Study|Protocol Violation|2
7792775|NCT01040403|12247579|FG000|Overall Study|Lost to Follow-up|1
7792776|NCT01040403|12247579|FG000|Overall Study|Not treated|1
7792777|NCT01040403|12247579|FG000|Overall Study|Other reason not defined above|6
7792778|NCT01040689|12247598|FG000|Overall Study|Adverse Event|0
7792779|NCT01040689|12247599|FG001|Overall Study|Adverse Event|0
7792780|NCT01040689|12247600|FG002|Overall Study|Adverse Event|2
7792781|NCT01040689|12247601|FG003|Overall Study|Adverse Event|4
7792782|NCT01040689|12247598|FG000|Overall Study|Lack of Efficacy|0
7792783|NCT01040689|12247599|FG001|Overall Study|Lack of Efficacy|0
7624316|NCT01922895|12035293|FG001|Overall Study|Withdrawal by Subject|2
7624317|NCT01922895|12035292|FG000|Overall Study|Lost to Follow-up|5
7624318|NCT01922895|12035293|FG001|Overall Study|Lost to Follow-up|11
7624319|NCT01901289|12035299|FG000|Overall Study|Death|32
7624320|NCT01901289|12035299|FG000|Overall Study|Lost to Follow-up|16
7624321|NCT01901289|12035299|FG000|Overall Study|Withdrawal by Subject|35
7624322|NCT01901289|12035299|FG000|Overall Study|Other type of endpoint met|2
7869407|NCT01653912|12360644|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7869408|NCT01653912|12360645|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7869409|NCT01653912|12360640|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7869410|NCT01653912|12360641|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7869411|NCT01653912|12360642|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
7869412|NCT01653912|12360643|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7869413|NCT01653912|12360644|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7869414|NCT01653912|12360645|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7869415|NCT01653912|12360640|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7869416|NCT01653912|12360641|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7869417|NCT01653912|12360642|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7869418|NCT01653912|12360643|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
7869419|NCT01653912|12360644|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7869420|NCT01653912|12360645|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7869421|NCT01653912|12360640|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7869422|NCT01653912|12360641|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7869423|NCT01653912|12360642|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7869424|NCT01653912|12360643|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
7869425|NCT01653912|12360644|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7869426|NCT01653912|12360645|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7792784|NCT01040689|12247600|FG002|Overall Study|Lack of Efficacy|1
7792785|NCT01040689|12247601|FG003|Overall Study|Lack of Efficacy|0
7792786|NCT01040689|12247598|FG000|Overall Study|Lost to Follow-up|1
7792787|NCT01040689|12247599|FG001|Overall Study|Lost to Follow-up|0
7869427|NCT01653912|12360640|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0
7869428|NCT01653912|12360641|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0
7869429|NCT01653912|12360642|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0
7869430|NCT01653912|12360643|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0
7869431|NCT01653912|12360644|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0
7869432|NCT01653912|12360645|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1
7869433|NCT01653912|12360640|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7869434|NCT01653912|12360641|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7869435|NCT01653912|12360642|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7869436|NCT01653912|12360643|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7869437|NCT01653912|12360644|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7869438|NCT01653912|12360645|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6
7869439|NCT01653912|12360640|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7869440|NCT01653912|12360641|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7869441|NCT01653912|12360642|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7869442|NCT01653912|12360643|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7869443|NCT01653912|12360644|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7869444|NCT01653912|12360645|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
7869445|NCT01654224|12360670|FG000|Overall Study|Lost to Follow-up|2
7869446|NCT01654224|12360671|FG001|Overall Study|Lost to Follow-up|2
7869447|NCT01654224|12360670|FG000|Overall Study|Did not receive allocation|1
7869448|NCT01654224|12360671|FG001|Overall Study|Did not receive allocation|8
7869449|NCT01654224|12360670|FG000|Overall Study|Insufficient blood sample|3
7869450|NCT01654224|12360671|FG001|Overall Study|Insufficient blood sample|2
7869451|NCT01654250|12360679|FG000|Overall Study|Lost to Follow-up|1
7869452|NCT01654250|12360680|FG001|Overall Study|Lost to Follow-up|0
7869453|NCT01654276|12360709|FG000|Overall Study|Lack of Efficacy|1
7869454|NCT01654276|12360709|FG000|Overall Study|Lost to Follow-up|4
7869455|NCT01654276|12360709|FG000|Overall Study|Withdrawal by Subject|1
7869456|NCT01654289|12360716|FG000|Overall Study|Withdrawal by Subject|10
7869457|NCT01654289|12360717|FG001|Overall Study|Withdrawal by Subject|8
7869458|NCT01654289|12360718|FG002|Overall Study|Withdrawal by Subject|5
7869459|NCT01654289|12360716|FG000|Overall Study|Withdrew from intervention only|17
7869460|NCT01654289|12360717|FG001|Overall Study|Withdrew from intervention only|20
7869461|NCT01654289|12360718|FG002|Overall Study|Withdrew from intervention only|0
7869462|NCT01654302|12360728|FG000|Second Intervention (Day 7)|Lost to Follow-up|1
7869463|NCT01654302|12360729|FG001|Second Intervention (Day 7)|Lost to Follow-up|1
7869464|NCT01654380|12360737|FG000|Part B, Period 1|Physician Decision|0
7869465|NCT01654380|12360738|FG001|Part B, Period 1|Physician Decision|0
7869466|NCT01654380|12360739|FG002|Part B, Period 1|Physician Decision|1
7869467|NCT01654380|12360740|FG003|Part B, Period 1|Physician Decision|0
7869468|NCT01654523|12360766|FG000|Overall Study|Withdrawal by Subject|1
7869469|NCT01654536|12360772|FG000|Overall Study|Lost to Follow-up|5
7869470|NCT01654536|12360773|FG001|Overall Study|Lost to Follow-up|5
7869471|NCT01654536|12360772|FG000|Overall Study|Physician Decision|12
7869472|NCT01654536|12360773|FG001|Overall Study|Physician Decision|8
7869473|NCT01654536|12360772|FG000|Overall Study|Withdrawal by Subject|27
7869474|NCT01654536|12360773|FG001|Overall Study|Withdrawal by Subject|25
7869475|NCT01654549|12360782|FG000|Overall Study|H.pylori eradication not successful|0
7869476|NCT01654549|12360783|FG001|Overall Study|H.pylori eradication not successful|1
7869477|NCT01654601|12360795|FG000|1st Administration|Withdrawal by Subject|2
7869478|NCT01654601|12360796|FG001|1st Administration|Withdrawal by Subject|0
7869479|NCT01654601|12360795|FG000|1st Administration|Protocol Violation|0
7869480|NCT01654601|12360796|FG001|1st Administration|Protocol Violation|2
7869481|NCT01654601|12360795|FG000|2nd Administration|Adverse Event|1
7869482|NCT01654601|12360796|FG001|2nd Administration|Adverse Event|0
7869483|NCT01654601|12360795|FG000|2nd Administration|Protocol Violation|0
7869484|NCT01654601|12360796|FG001|2nd Administration|Protocol Violation|1
7869485|NCT01654666|12360805|FG000|Overall Study|Protocol Violation|7
7869486|NCT01654666|12360806|FG001|Overall Study|Protocol Violation|4
7869487|NCT01654666|12360807|FG002|Overall Study|Protocol Violation|8
7869488|NCT01654666|12360805|FG000|Overall Study|Lost to Follow-up|4
7624323|NCT01595581|12035318|FG000|Overall Study|Withdrawal by Subject|1
7624324|NCT01595581|12035319|FG001|Overall Study|Withdrawal by Subject|0
7624325|NCT01514682|12035329|FG000|Overall Study|Withdrawal by Subject|2
7624326|NCT01514682|12035330|FG001|Overall Study|Withdrawal by Subject|3
7624327|NCT01514682|12035329|FG000|Overall Study|Physician Decision|4
7624328|NCT01514682|12035330|FG001|Overall Study|Physician Decision|3
7792788|NCT01040689|12247600|FG002|Overall Study|Lost to Follow-up|0
7792789|NCT01040689|12247601|FG003|Overall Study|Lost to Follow-up|0
7792790|NCT01040689|12247598|FG000|Overall Study|Withdrawal by Subject|2
7792791|NCT01040689|12247599|FG001|Overall Study|Withdrawal by Subject|1
7792792|NCT01040689|12247600|FG002|Overall Study|Withdrawal by Subject|1
7792793|NCT01040689|12247601|FG003|Overall Study|Withdrawal by Subject|0
7792794|NCT01040689|12247598|FG000|Overall Study|Other reasons not listed above|0
7792795|NCT01040689|12247599|FG001|Overall Study|Other reasons not listed above|1
7792796|NCT01040689|12247600|FG002|Overall Study|Other reasons not listed above|0
7869489|NCT01654666|12360806|FG001|Overall Study|Lost to Follow-up|5
7869490|NCT01654666|12360807|FG002|Overall Study|Lost to Follow-up|5
7869491|NCT01654666|12360805|FG000|Overall Study|Withdrawal by Subject|4
7869492|NCT01654666|12360806|FG001|Overall Study|Withdrawal by Subject|4
7792797|NCT01040689|12247601|FG003|Overall Study|Other reasons not listed above|0
7792798|NCT01040728|12247616|FG000|Overall Study|Adverse Event|4
7792799|NCT01040728|12247617|FG001|Overall Study|Adverse Event|8
7792800|NCT01040728|12247618|FG002|Overall Study|Adverse Event|0
7792801|NCT01040728|12247619|FG003|Overall Study|Adverse Event|4
7792802|NCT01040728|12247616|FG000|Overall Study|Withdrawal by Subject|0
7792803|NCT01040728|12247617|FG001|Overall Study|Withdrawal by Subject|1
7792804|NCT01040728|12247618|FG002|Overall Study|Withdrawal by Subject|1
7792805|NCT01040728|12247619|FG003|Overall Study|Withdrawal by Subject|0
7792806|NCT01040728|12247616|FG000|Overall Study|Protocol Violation|0
7792807|NCT01040728|12247617|FG001|Overall Study|Protocol Violation|0
7792808|NCT01040728|12247618|FG002|Overall Study|Protocol Violation|0
7792809|NCT01040728|12247619|FG003|Overall Study|Protocol Violation|1
7792810|NCT01040728|12247616|FG000|Overall Study|Lack of Efficacy|0
7792811|NCT01040728|12247617|FG001|Overall Study|Lack of Efficacy|1
7792812|NCT01040728|12247618|FG002|Overall Study|Lack of Efficacy|0
7792813|NCT01040728|12247619|FG003|Overall Study|Lack of Efficacy|1
7792814|NCT01040728|12247616|FG000|Overall Study|Other reasons not listed above|0
7792815|NCT01040728|12247617|FG001|Overall Study|Other reasons not listed above|1
7792816|NCT01040728|12247618|FG002|Overall Study|Other reasons not listed above|0
7792817|NCT01040728|12247619|FG003|Overall Study|Other reasons not listed above|0
7792818|NCT01040780|12247637|FG000|Overall Study|Protocol Violation|1
7792819|NCT01040780|12247638|FG001|Overall Study|Protocol Violation|3
7792820|NCT01040793|12247647|FG000|Overall Study|Adverse Event|5
7792821|NCT01040793|12247648|FG001|Overall Study|Adverse Event|3
7792822|NCT01040793|12247649|FG002|Overall Study|Adverse Event|0
7792823|NCT01040793|12247650|FG003|Overall Study|Adverse Event|2
7792824|NCT01040793|12247651|FG004|Overall Study|Adverse Event|2
7792825|NCT01040793|12247652|FG005|Overall Study|Adverse Event|1
7792826|NCT01040793|12247647|FG000|Overall Study|Protocol Violation|1
7792827|NCT01040793|12247648|FG001|Overall Study|Protocol Violation|1
7792828|NCT01040793|12247649|FG002|Overall Study|Protocol Violation|1
7792829|NCT01040793|12247650|FG003|Overall Study|Protocol Violation|0
7792830|NCT01040793|12247651|FG004|Overall Study|Protocol Violation|1
7792831|NCT01040793|12247652|FG005|Overall Study|Protocol Violation|0
7792832|NCT01040793|12247647|FG000|Overall Study|Lost to Follow-up|0
7792833|NCT01040793|12247648|FG001|Overall Study|Lost to Follow-up|1
7792834|NCT01040793|12247649|FG002|Overall Study|Lost to Follow-up|1
7792835|NCT01040793|12247650|FG003|Overall Study|Lost to Follow-up|0
7792836|NCT01040793|12247651|FG004|Overall Study|Lost to Follow-up|0
7792837|NCT01040793|12247652|FG005|Overall Study|Lost to Follow-up|0
7792838|NCT01040793|12247647|FG000|Overall Study|Withdrawal by Subject|0
7792839|NCT01040793|12247648|FG001|Overall Study|Withdrawal by Subject|0
7792840|NCT01040793|12247649|FG002|Overall Study|Withdrawal by Subject|0
7792841|NCT01040793|12247650|FG003|Overall Study|Withdrawal by Subject|2
7792842|NCT01040793|12247651|FG004|Overall Study|Withdrawal by Subject|0
7792843|NCT01040793|12247652|FG005|Overall Study|Withdrawal by Subject|0
7792844|NCT01040793|12247647|FG000|Overall Study|Other reasons not listed above|0
7792845|NCT01040793|12247648|FG001|Overall Study|Other reasons not listed above|0
7792846|NCT01040793|12247649|FG002|Overall Study|Other reasons not listed above|1
7792847|NCT01040793|12247650|FG003|Overall Study|Other reasons not listed above|0
7792848|NCT01040793|12247651|FG004|Overall Study|Other reasons not listed above|1
7792849|NCT01040793|12247652|FG005|Overall Study|Other reasons not listed above|0
7792850|NCT01040832|12247673|FG000|Overall Study|Adverse Event|4
7792851|NCT01040832|12247674|FG001|Overall Study|Adverse Event|5
7792852|NCT01040832|12247673|FG000|Overall Study|Death|4
7869493|NCT01654666|12360807|FG002|Overall Study|Withdrawal by Subject|1
7869494|NCT01655069|12360851|FG000|Overall Study|Physician Decision|0
7869495|NCT01655069|12360852|FG001|Overall Study|Physician Decision|0
7869496|NCT01655069|12360853|FG002|Overall Study|Physician Decision|0
7869497|NCT01655069|12360854|FG003|Overall Study|Physician Decision|1
7869498|NCT01655069|12360851|FG000|Overall Study|Adverse Event|6
7869499|NCT01655069|12360852|FG001|Overall Study|Adverse Event|7
7869500|NCT01655069|12360853|FG002|Overall Study|Adverse Event|2
7869501|NCT01655069|12360854|FG003|Overall Study|Adverse Event|3
7869502|NCT01655069|12360851|FG000|Overall Study|Lack of Efficacy|0
7869503|NCT01655069|12360852|FG001|Overall Study|Lack of Efficacy|1
7869504|NCT01655069|12360853|FG002|Overall Study|Lack of Efficacy|0
7869505|NCT01655069|12360854|FG003|Overall Study|Lack of Efficacy|0
7869506|NCT01655069|12360851|FG000|Overall Study|No Treatment Needed|0
7869507|NCT01655069|12360852|FG001|Overall Study|No Treatment Needed|1
7869508|NCT01655069|12360853|FG002|Overall Study|No Treatment Needed|0
7869509|NCT01655069|12360854|FG003|Overall Study|No Treatment Needed|0
7869510|NCT01655069|12360851|FG000|Overall Study|Withdrawal by Subject|2
7869511|NCT01655069|12360852|FG001|Overall Study|Withdrawal by Subject|3
7869512|NCT01655069|12360853|FG002|Overall Study|Withdrawal by Subject|0
7869513|NCT01655069|12360854|FG003|Overall Study|Withdrawal by Subject|0
7869514|NCT01655381|12360876|FG000|Overall Study|Investigator Decision|1
7869515|NCT01655381|12360876|FG000|Overall Study|Moved to Another City|1
7869516|NCT01655381|12360876|FG000|Overall Study|Insufficient Treatment Response|1
7869517|NCT01655498|12360881|FG000|Overall Study|Unrelated health issue|2
7792853|NCT01040832|12247674|FG001|Overall Study|Death|6
7792854|NCT01040832|12247673|FG000|Overall Study|Withdrawal by Subject|2
7869518|NCT01655498|12360881|FG000|Overall Study|Protocol Violation|2
7869519|NCT01655498|12360881|FG000|Overall Study|Withdrawal by Subject|1
7869520|NCT01655693|12360900|FG000|Overall Study|Progression of Disease|92
7869521|NCT01655693|12360901|FG001|Overall Study|Progression of Disease|76
7869522|NCT01655693|12360902|FG002|Overall Study|Progression of Disease|58
7869523|NCT01655693|12360900|FG000|Overall Study|Death|8
7869524|NCT01655693|12360901|FG001|Overall Study|Death|9
7869525|NCT01655693|12360902|FG002|Overall Study|Death|12
7869526|NCT01655693|12360900|FG000|Overall Study|Serious Adverse Event|3
7869527|NCT01655693|12360901|FG001|Overall Study|Serious Adverse Event|15
7869528|NCT01655693|12360902|FG002|Overall Study|Serious Adverse Event|11
7869529|NCT01655693|12360900|FG000|Overall Study|Withdrawal by Subject|3
7869530|NCT01655693|12360901|FG001|Overall Study|Withdrawal by Subject|2
7869531|NCT01655693|12360902|FG002|Overall Study|Withdrawal by Subject|20
7869532|NCT01655693|12360900|FG000|Overall Study|Adverse Event|3
7869533|NCT01655693|12360901|FG001|Overall Study|Adverse Event|11
7869534|NCT01655693|12360902|FG002|Overall Study|Adverse Event|3
7869535|NCT01655693|12360900|FG000|Overall Study|Aggravation of Liver Dysfunction|5
7869536|NCT01655693|12360901|FG001|Overall Study|Aggravation of Liver Dysfunction|4
7869537|NCT01655693|12360902|FG002|Overall Study|Aggravation of Liver Dysfunction|0
7869538|NCT01655693|12360900|FG000|Overall Study|Non-Compliance|0
7869539|NCT01655693|12360901|FG001|Overall Study|Non-Compliance|0
7869540|NCT01655693|12360902|FG002|Overall Study|Non-Compliance|7
7869541|NCT01655693|12360900|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1
7869542|NCT01655693|12360901|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3
7869543|NCT01655693|12360902|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0
7869544|NCT01655693|12360900|FG000|Overall Study|Protocol Violation|1
7869545|NCT01655693|12360901|FG001|Overall Study|Protocol Violation|0
7869546|NCT01655693|12360902|FG002|Overall Study|Protocol Violation|3
7869547|NCT01655693|12360900|FG000|Overall Study|Lost to Follow-up|1
7869548|NCT01655693|12360901|FG001|Overall Study|Lost to Follow-up|0
7869549|NCT01655693|12360902|FG002|Overall Study|Lost to Follow-up|1
7869550|NCT01655693|12360900|FG000|Overall Study|Screening Failure|1
7869551|NCT01655693|12360901|FG001|Overall Study|Screening Failure|0
7869552|NCT01655693|12360902|FG002|Overall Study|Screening Failure|0
7869553|NCT01655693|12360900|FG000|Overall Study|Other|8
7869554|NCT01655693|12360901|FG001|Overall Study|Other|6
7869555|NCT01655693|12360902|FG002|Overall Study|Other|15
7869556|NCT01655823|12360929|FG000|Overall Study|Lost to Follow-up|0
7869557|NCT01655823|12360930|FG001|Overall Study|Lost to Follow-up|1
7869558|NCT01655823|12360931|FG002|Overall Study|Lost to Follow-up|0
7792855|NCT01040832|12247674|FG001|Overall Study|Withdrawal by Subject|3
7792856|NCT01040832|12247673|FG000|Overall Study|Progressive disease|32
7792857|NCT01040832|12247674|FG001|Overall Study|Progressive disease|17
7792858|NCT01040832|12247673|FG000|Overall Study|Symptomatic deterioration|2
7792859|NCT01040832|12247674|FG001|Overall Study|Symptomatic deterioration|5
7792860|NCT01040832|12247673|FG000|Overall Study|Other|2
7792861|NCT01040832|12247674|FG001|Overall Study|Other|1
7792862|NCT01040845|12247682|FG000|Overall Study|Withdrawal by Subject|1
7869559|NCT01655823|12360932|FG003|Overall Study|Lost to Follow-up|0
7869560|NCT01655823|12360933|FG004|Overall Study|Lost to Follow-up|1
7869561|NCT01655823|12360929|FG000|Overall Study|Withdrawal by Subject|0
7869562|NCT01655823|12360930|FG001|Overall Study|Withdrawal by Subject|1
7869563|NCT01655823|12360931|FG002|Overall Study|Withdrawal by Subject|0
7869564|NCT01655823|12360932|FG003|Overall Study|Withdrawal by Subject|1
7869565|NCT01655823|12360933|FG004|Overall Study|Withdrawal by Subject|0
7869566|NCT01655901|12360945|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1
7869567|NCT01655901|12360946|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1
7869568|NCT01655901|12360947|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1
7869569|NCT01655901|12360948|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0
7869570|NCT01655901|12360949|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1
7869571|NCT01655901|12360950|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0
7869572|NCT01656161|12360963|FG000|Overall Study|Death|3
7869573|NCT01656161|12360963|FG000|Overall Study|Adverse Event|2
7869574|NCT01656161|12360963|FG000|Overall Study|Protocol Violation|1
7869575|NCT01656161|12360963|FG000|Overall Study|Withdrawal by Subject|1
7869576|NCT01656200|12360979|FG000|Overall Study|Withdrawal by Subject|1
7869577|NCT01656304|12360989|FG000|Overall Study|Ineligible, uncontrolled hypertension|1
7869578|NCT01656395|12360999|FG000|Overall Study|Adverse Event|1
7869579|NCT01656395|12361000|FG001|Overall Study|Adverse Event|14
7869580|NCT01656395|12361001|FG002|Overall Study|Adverse Event|5
7869581|NCT01656395|12361002|FG003|Overall Study|Adverse Event|4
7869582|NCT01656395|12361003|FG004|Overall Study|Adverse Event|5
7869583|NCT01656395|12361004|FG005|Overall Study|Adverse Event|7
7869584|NCT01656395|12361005|FG006|Overall Study|Adverse Event|0
7869585|NCT01656395|12361006|FG007|Overall Study|Adverse Event|0
7869586|NCT01656395|12360999|FG000|Overall Study|Lack of Efficacy|1
7869587|NCT01656395|12361000|FG001|Overall Study|Lack of Efficacy|8
7869588|NCT01656395|12361001|FG002|Overall Study|Lack of Efficacy|6
7869589|NCT01656395|12361002|FG003|Overall Study|Lack of Efficacy|1
7869590|NCT01656395|12361003|FG004|Overall Study|Lack of Efficacy|1
7869591|NCT01656395|12361004|FG005|Overall Study|Lack of Efficacy|6
7869592|NCT01656395|12361005|FG006|Overall Study|Lack of Efficacy|0
7869593|NCT01656395|12361006|FG007|Overall Study|Lack of Efficacy|0
7869594|NCT01656395|12360999|FG000|Overall Study|Lost to Follow-up|1
7792863|NCT01040845|12247683|FG001|Overall Study|Withdrawal by Subject|1
7869595|NCT01656395|12361000|FG001|Overall Study|Lost to Follow-up|0
7869596|NCT01656395|12361001|FG002|Overall Study|Lost to Follow-up|0
7869597|NCT01656395|12361002|FG003|Overall Study|Lost to Follow-up|0
7869598|NCT01656395|12361003|FG004|Overall Study|Lost to Follow-up|0
7869599|NCT01656395|12361004|FG005|Overall Study|Lost to Follow-up|0
7869600|NCT01656395|12361005|FG006|Overall Study|Lost to Follow-up|0
7869601|NCT01656395|12361006|FG007|Overall Study|Lost to Follow-up|0
7869602|NCT01656395|12360999|FG000|Overall Study|Non-Compliance with Study Drug|1
7869603|NCT01656395|12361000|FG001|Overall Study|Non-Compliance with Study Drug|1
7869604|NCT01656395|12361001|FG002|Overall Study|Non-Compliance with Study Drug|0
7869605|NCT01656395|12361002|FG003|Overall Study|Non-Compliance with Study Drug|0
7869606|NCT01656395|12361003|FG004|Overall Study|Non-Compliance with Study Drug|1
7869607|NCT01656395|12361004|FG005|Overall Study|Non-Compliance with Study Drug|1
7869608|NCT01656395|12361005|FG006|Overall Study|Non-Compliance with Study Drug|0
7869609|NCT01656395|12361006|FG007|Overall Study|Non-Compliance with Study Drug|0
7869610|NCT01656395|12360999|FG000|Overall Study|Other|0
7869611|NCT01656395|12361000|FG001|Overall Study|Other|0
7869612|NCT01656395|12361001|FG002|Overall Study|Other|1
7869613|NCT01656395|12361002|FG003|Overall Study|Other|0
7869614|NCT01656395|12361003|FG004|Overall Study|Other|0
7869615|NCT01656395|12361004|FG005|Overall Study|Other|1
7869616|NCT01656395|12361005|FG006|Overall Study|Other|0
7869617|NCT01656395|12361006|FG007|Overall Study|Other|0
7869618|NCT01656395|12360999|FG000|Overall Study|Physician Decision|2
7869619|NCT01656395|12361000|FG001|Overall Study|Physician Decision|3
7869620|NCT01656395|12361001|FG002|Overall Study|Physician Decision|3
7869621|NCT01656395|12361002|FG003|Overall Study|Physician Decision|2
7869622|NCT01656395|12361003|FG004|Overall Study|Physician Decision|3
7869623|NCT01656395|12361004|FG005|Overall Study|Physician Decision|3
7869624|NCT01656395|12361005|FG006|Overall Study|Physician Decision|0
7869625|NCT01656395|12361006|FG007|Overall Study|Physician Decision|0
7869626|NCT01656395|12360999|FG000|Overall Study|Pregnancy|0
7869627|NCT01656395|12361000|FG001|Overall Study|Pregnancy|0
7869628|NCT01656395|12361001|FG002|Overall Study|Pregnancy|1
7869629|NCT01656395|12361002|FG003|Overall Study|Pregnancy|0
7869630|NCT01656395|12361003|FG004|Overall Study|Pregnancy|0
7869631|NCT01656395|12361004|FG005|Overall Study|Pregnancy|0
7869632|NCT01656395|12361005|FG006|Overall Study|Pregnancy|0
7869633|NCT01656395|12361006|FG007|Overall Study|Pregnancy|0
7869634|NCT01656395|12360999|FG000|Overall Study|Progressive Disease|0
7869635|NCT01656395|12361000|FG001|Overall Study|Progressive Disease|0
7869636|NCT01656395|12361001|FG002|Overall Study|Progressive Disease|0
7869637|NCT01656395|12361002|FG003|Overall Study|Progressive Disease|0
7869638|NCT01656395|12361003|FG004|Overall Study|Progressive Disease|0
7869639|NCT01656395|12361004|FG005|Overall Study|Progressive Disease|1
7869640|NCT01656395|12361005|FG006|Overall Study|Progressive Disease|0
7869641|NCT01656395|12361006|FG007|Overall Study|Progressive Disease|0
7869642|NCT01656395|12360999|FG000|Overall Study|Protocol Violation|6
7869643|NCT01656395|12361000|FG001|Overall Study|Protocol Violation|6
7869644|NCT01656395|12361001|FG002|Overall Study|Protocol Violation|9
7869645|NCT01656395|12361002|FG003|Overall Study|Protocol Violation|2
7869646|NCT01656395|12361003|FG004|Overall Study|Protocol Violation|4
7869647|NCT01656395|12361004|FG005|Overall Study|Protocol Violation|10
7869648|NCT01656395|12361005|FG006|Overall Study|Protocol Violation|0
7869649|NCT01656395|12361006|FG007|Overall Study|Protocol Violation|0
7869650|NCT01656395|12360999|FG000|Overall Study|Screen Failure|2
7869651|NCT01656395|12361000|FG001|Overall Study|Screen Failure|1
7869652|NCT01656395|12361001|FG002|Overall Study|Screen Failure|7
7869653|NCT01656395|12361002|FG003|Overall Study|Screen Failure|1
7869654|NCT01656395|12361003|FG004|Overall Study|Screen Failure|0
7869655|NCT01656395|12361004|FG005|Overall Study|Screen Failure|8
7869656|NCT01656395|12361005|FG006|Overall Study|Screen Failure|0
7869657|NCT01656395|12361006|FG007|Overall Study|Screen Failure|0
7869658|NCT01656395|12360999|FG000|Overall Study|Withdrawal by Subject|3
7869659|NCT01656395|12361000|FG001|Overall Study|Withdrawal by Subject|1
7869660|NCT01656395|12361001|FG002|Overall Study|Withdrawal by Subject|4
7869661|NCT01656395|12361002|FG003|Overall Study|Withdrawal by Subject|2
7869662|NCT01656395|12361003|FG004|Overall Study|Withdrawal by Subject|0
7869663|NCT01656395|12361004|FG005|Overall Study|Withdrawal by Subject|3
7869664|NCT01656395|12361005|FG006|Overall Study|Withdrawal by Subject|0
7869665|NCT01656395|12361006|FG007|Overall Study|Withdrawal by Subject|0
7869666|NCT01656408|12361030|FG000|Overall Study|Adverse Event|0
7869667|NCT01656408|12361031|FG001|Overall Study|Adverse Event|0
7869668|NCT01656408|12361032|FG002|Overall Study|Adverse Event|1
7869669|NCT01656408|12361033|FG003|Overall Study|Adverse Event|0
7869670|NCT01656408|12361034|FG004|Overall Study|Adverse Event|0
7869671|NCT01656408|12361035|FG005|Overall Study|Adverse Event|1
7869672|NCT01656408|12361036|FG006|Overall Study|Adverse Event|1
7869673|NCT01656408|12361037|FG007|Overall Study|Adverse Event|0
7869674|NCT01656408|12361038|FG008|Overall Study|Adverse Event|1
7869675|NCT01656408|12361039|FG009|Overall Study|Adverse Event|0
7869676|NCT01656408|12361030|FG000|Overall Study|Physician Decision|1
7869677|NCT01656408|12361031|FG001|Overall Study|Physician Decision|0
7869678|NCT01656408|12361032|FG002|Overall Study|Physician Decision|1
7869679|NCT01656408|12361033|FG003|Overall Study|Physician Decision|0
7869680|NCT01656408|12361034|FG004|Overall Study|Physician Decision|1
7869681|NCT01656408|12361035|FG005|Overall Study|Physician Decision|1
7869682|NCT01656408|12361036|FG006|Overall Study|Physician Decision|0
7869683|NCT01656408|12361037|FG007|Overall Study|Physician Decision|1
7869684|NCT01656408|12361038|FG008|Overall Study|Physician Decision|1
7869685|NCT01656408|12361039|FG009|Overall Study|Physician Decision|3
7869686|NCT01656733|12361113|FG000|Overall Study|No permission to collect birth outcomes|0
7869687|NCT01656733|12361114|FG001|Overall Study|No permission to collect birth outcomes|1
7869688|NCT01656733|12361113|FG000|Overall Study|Delivery at another hospital|0
7869689|NCT01656733|12361114|FG001|Overall Study|Delivery at another hospital|2
7869690|NCT01656733|12361113|FG000|Overall Study|Spontaneous abortion|0
7869691|NCT01656733|12361114|FG001|Overall Study|Spontaneous abortion|1
7869692|NCT01656759|12361122|FG000|Overall Study|Protocol Violation|2
7869693|NCT01656759|12361123|FG001|Overall Study|Protocol Violation|3
7869694|NCT01656850|12361140|FG000|First Intervention (3 Months)|Withdrawal by Subject|3
7869695|NCT01656850|12361141|FG001|First Intervention (3 Months)|Withdrawal by Subject|4
7869696|NCT01656889|12361153|FG000|Treatment Period, 12 Weeks|Adverse Event|10
7869697|NCT01656889|12361154|FG001|Treatment Period, 12 Weeks|Adverse Event|4
7869698|NCT01656889|12361153|FG000|Treatment Period, 12 Weeks|Death|0
7869699|NCT01656889|12361154|FG001|Treatment Period, 12 Weeks|Death|1
7869700|NCT01656889|12361153|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1
7869701|NCT01656889|12361154|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1
7869702|NCT01656889|12361153|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1
7869703|NCT01656889|12361154|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2
7869704|NCT01656889|12361153|FG000|Treatment Period, 12 Weeks|Protocol Violation|0
7869705|NCT01656889|12361154|FG001|Treatment Period, 12 Weeks|Protocol Violation|1
7869706|NCT01656889|12361153|FG000|Treatment Period, 12 Weeks|Moved out of the area|0
7869707|NCT01656889|12361154|FG001|Treatment Period, 12 Weeks|Moved out of the area|2
7869708|NCT01656889|12361153|FG000|Post Treatment Follow-Up, 3 Months|Death|1
7869709|NCT01656889|12361154|FG001|Post Treatment Follow-Up, 3 Months|Death|5
7869710|NCT01656889|12361153|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
7869711|NCT01656889|12361154|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
7869712|NCT01656889|12361153|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
7869713|NCT01656889|12361154|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
7869714|NCT01656889|12361153|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0
7869715|NCT01656889|12361154|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1
7869716|NCT01656967|12361162|FG000|Overall Study|faulty monitor|1
7869717|NCT01656967|12361163|FG001|Overall Study|faulty monitor|0
7869718|NCT01656967|12361162|FG000|Overall Study|unsuccessful ETT insertion|3
7869719|NCT01656967|12361163|FG001|Overall Study|unsuccessful ETT insertion|2
7869720|NCT01657019|12361173|FG000|Overall Study|Withdrawal by Subject|65
7869721|NCT01657019|12361173|FG000|Overall Study|Adverse Event|55
7869722|NCT01657019|12361173|FG000|Overall Study|Lost to Follow-up|48
7869723|NCT01657019|12361173|FG000|Overall Study|Protocol Violation|6
7869724|NCT01657019|12361173|FG000|Overall Study|Lack of Efficacy|3
7869725|NCT01657019|12361173|FG000|Overall Study|Other|58
7869726|NCT01657032|12361179|FG000|Overall Study|Lost to Follow-up|0
7869727|NCT01657032|12361180|FG001|Overall Study|Lost to Follow-up|7
7869728|NCT01657162|12361188|FG000|Overall Study|Adverse Event|26
7869729|NCT01657162|12361189|FG001|Overall Study|Adverse Event|36
7869730|NCT01657162|12361188|FG000|Overall Study|Withdrawal by Subject|13
7869731|NCT01657162|12361189|FG001|Overall Study|Withdrawal by Subject|13
7869732|NCT01657162|12361188|FG000|Overall Study|Continuing Significant Deterioration|9
7869733|NCT01657162|12361189|FG001|Overall Study|Continuing Significant Deterioration|3
7869734|NCT01657162|12361188|FG000|Overall Study|Refusal of Treatment|4
7869735|NCT01657162|12361189|FG001|Overall Study|Refusal of Treatment|6
7869736|NCT01657162|12361188|FG000|Overall Study|Lost to Follow-up|3
7869737|NCT01657162|12361189|FG001|Overall Study|Lost to Follow-up|4
7869738|NCT01657162|12361188|FG000|Overall Study|Death|2
7869739|NCT01657162|12361189|FG001|Overall Study|Death|3
7869740|NCT01657162|12361188|FG000|Overall Study|Inability to Complete Study Procedures|1
7869741|NCT01657162|12361189|FG001|Overall Study|Inability to Complete Study Procedures|7
7869742|NCT01657162|12361188|FG000|Overall Study|Protocol Violation|1
7869743|NCT01657162|12361189|FG001|Overall Study|Protocol Violation|0
7869744|NCT01657162|12361188|FG000|Overall Study|Hypersensitivity to Alendronate|0
7869745|NCT01657162|12361189|FG001|Overall Study|Hypersensitivity to Alendronate|1
7869746|NCT01657162|12361188|FG000|Overall Study|Other than Specified|0
7869747|NCT01657162|12361189|FG001|Overall Study|Other than Specified|2
7869748|NCT01657253|12361197|FG000|Overall Study|Lost to Follow-up|6
7869749|NCT01657253|12361198|FG001|Overall Study|Lost to Follow-up|5
7869750|NCT01657253|12361197|FG000|Overall Study|Withdrawal by Subject|11
7869751|NCT01657253|12361198|FG001|Overall Study|Withdrawal by Subject|12
7869752|NCT01657253|12361197|FG000|Overall Study|Adverse Event|0
7869753|NCT01657253|12361198|FG001|Overall Study|Adverse Event|1
7869754|NCT01657266|12361206|FG000|Overall Study|Lost to Follow-up|2
7869755|NCT01657266|12361207|FG001|Overall Study|Lost to Follow-up|2
7869756|NCT01657266|12361206|FG000|Overall Study|Adverse Event|2
7869757|NCT01657266|12361207|FG001|Overall Study|Adverse Event|3
7869758|NCT01657292|12361213|FG000|Overall Study|Adverse Event|6
7869759|NCT01657292|12361213|FG000|Overall Study|Withdrawal by Subject|2
7869760|NCT01657292|12361213|FG000|Overall Study|Violation of eligibility criteria|1
7869761|NCT01657292|12361213|FG000|Overall Study|Change of therapy|1
7869762|NCT01657305|12361220|FG000|Overall Study|Lack of Wound Closure at Day 28|15
7869763|NCT01657305|12361220|FG000|Overall Study|Withdrawal by Subject|4
7869764|NCT01657305|12361220|FG000|Overall Study|Adverse Event|1
7869765|NCT01657305|12361220|FG000|Overall Study|Lost to Follow-up|1
7869766|NCT01657305|12361220|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4
7869767|NCT01657370|12361282|FG000|Overall Study|Withdrawal by Subject|0
7869768|NCT01657370|12361283|FG001|Overall Study|Withdrawal by Subject|0
7869769|NCT01657370|12361284|FG002|Overall Study|Withdrawal by Subject|1
7869770|NCT01657370|12361285|FG003|Overall Study|Withdrawal by Subject|0
7869771|NCT01657370|12361286|FG004|Overall Study|Withdrawal by Subject|0
7869772|NCT01657370|12361287|FG005|Overall Study|Withdrawal by Subject|1
7869773|NCT01657370|12361282|FG000|Overall Study|Physician Decision|2
7869774|NCT01657370|12361283|FG001|Overall Study|Physician Decision|3
7869775|NCT01657370|12361284|FG002|Overall Study|Physician Decision|1
7869776|NCT01657370|12361285|FG003|Overall Study|Physician Decision|2
7869777|NCT01657370|12361286|FG004|Overall Study|Physician Decision|5
7869778|NCT01657370|12361287|FG005|Overall Study|Physician Decision|0
7869779|NCT01657370|12361282|FG000|Overall Study|Lack of Qualifying Event|1
7869780|NCT01657370|12361283|FG001|Overall Study|Lack of Qualifying Event|0
7869781|NCT01657370|12361284|FG002|Overall Study|Lack of Qualifying Event|3
7869782|NCT01657370|12361285|FG003|Overall Study|Lack of Qualifying Event|2
7869783|NCT01657370|12361286|FG004|Overall Study|Lack of Qualifying Event|1
7869784|NCT01657370|12361287|FG005|Overall Study|Lack of Qualifying Event|2
7869785|NCT01657370|12361282|FG000|Overall Study|Adverse Event|0
7869786|NCT01657370|12361283|FG001|Overall Study|Adverse Event|0
7869787|NCT01657370|12361284|FG002|Overall Study|Adverse Event|0
7869788|NCT01657370|12361285|FG003|Overall Study|Adverse Event|0
7869789|NCT01657370|12361286|FG004|Overall Study|Adverse Event|1
7869790|NCT01657370|12361287|FG005|Overall Study|Adverse Event|0
7869791|NCT01657370|12361282|FG000|Overall Study|Protocol Violation|1
7869792|NCT01657370|12361283|FG001|Overall Study|Protocol Violation|1
7869793|NCT01657370|12361284|FG002|Overall Study|Protocol Violation|1
7869794|NCT01657370|12361285|FG003|Overall Study|Protocol Violation|1
7869795|NCT01657370|12361286|FG004|Overall Study|Protocol Violation|0
7869796|NCT01657370|12361287|FG005|Overall Study|Protocol Violation|0
7869797|NCT01657370|12361282|FG000|Overall Study|Lost to Follow-up|2
7869798|NCT01657370|12361283|FG001|Overall Study|Lost to Follow-up|0
7869799|NCT01657370|12361284|FG002|Overall Study|Lost to Follow-up|1
7869800|NCT01657370|12361285|FG003|Overall Study|Lost to Follow-up|0
7869801|NCT01657370|12361286|FG004|Overall Study|Lost to Follow-up|0
7869802|NCT01657370|12361287|FG005|Overall Study|Lost to Follow-up|1
7869803|NCT01657461|12361308|FG000|Overall Study|Death|9
7869804|NCT01657461|12361309|FG001|Overall Study|Death|12
7869805|NCT01657461|12361308|FG000|Overall Study|Lost to Follow-up|0
7869806|NCT01657461|12361309|FG001|Overall Study|Lost to Follow-up|3
7869807|NCT01657461|12361308|FG000|Overall Study|Physician Decision|0
7869808|NCT01657461|12361309|FG001|Overall Study|Physician Decision|2
7869809|NCT01657461|12361308|FG000|Overall Study|Withdrawal by Subject|1
7869810|NCT01657461|12361309|FG001|Overall Study|Withdrawal by Subject|3
7869811|NCT01657760|12361321|FG000|Overall Study|Withdrawal by Subject|0
7869812|NCT01657760|12361322|FG001|Overall Study|Withdrawal by Subject|0
7869813|NCT01657760|12361323|FG002|Overall Study|Withdrawal by Subject|0
7869814|NCT01657760|12361324|FG003|Overall Study|Withdrawal by Subject|1
7869815|NCT01657760|12361321|FG000|Overall Study|Physician Decision|1
7869816|NCT01657760|12361322|FG001|Overall Study|Physician Decision|1
7869817|NCT01657760|12361323|FG002|Overall Study|Physician Decision|1
7869818|NCT01657760|12361324|FG003|Overall Study|Physician Decision|2
7869819|NCT01657799|12361339|FG000|Overall Study|Adverse Event Related to progression|6
7869820|NCT01657799|12361340|FG001|Overall Study|Adverse Event Related to progression|8
7869821|NCT01657799|12361341|FG002|Overall Study|Adverse Event Related to progression|12
7869822|NCT01657799|12361339|FG000|Overall Study|Adverse Event Not Related to Progression|5
7869823|NCT01657799|12361340|FG001|Overall Study|Adverse Event Not Related to Progression|4
7869824|NCT01657799|12361341|FG002|Overall Study|Adverse Event Not Related to Progression|4
7869825|NCT01657799|12361339|FG000|Overall Study|Withdrawal by Subject|13
7869826|NCT01657799|12361340|FG001|Overall Study|Withdrawal by Subject|10
7869827|NCT01657799|12361341|FG002|Overall Study|Withdrawal by Subject|10
7869828|NCT01657799|12361339|FG000|Overall Study|Lost to Follow-up|1
7869829|NCT01657799|12361340|FG001|Overall Study|Lost to Follow-up|0
7869830|NCT01657799|12361341|FG002|Overall Study|Lost to Follow-up|1
7869831|NCT01657799|12361339|FG000|Overall Study|Disease Progression|2
7869832|NCT01657799|12361340|FG001|Overall Study|Disease Progression|4
7869833|NCT01657799|12361341|FG002|Overall Study|Disease Progression|4
7869834|NCT01657799|12361339|FG000|Overall Study|Progressive Disease Clinical|7
7869835|NCT01657799|12361340|FG001|Overall Study|Progressive Disease Clinical|4
7869836|NCT01657799|12361341|FG002|Overall Study|Progressive Disease Clinical|7
7869837|NCT01657799|12361339|FG000|Overall Study|Radiographic & Clinical Progression|16
7869838|NCT01657799|12361340|FG001|Overall Study|Radiographic & Clinical Progression|11
7792864|NCT01040845|12247682|FG000|Overall Study|Physician Decision|1
7792865|NCT01040845|12247683|FG001|Overall Study|Physician Decision|0
7792866|NCT01040871|12247705|FG000|Overall Study|Adverse Event|6
7792867|NCT01040871|12247706|FG001|Overall Study|Adverse Event|2
7792868|NCT01040871|12247705|FG000|Overall Study|Withdrawal by Subject|2
7792869|NCT01040871|12247706|FG001|Overall Study|Withdrawal by Subject|0
7792870|NCT01040871|12247705|FG000|Overall Study|Death|1
7792871|NCT01040871|12247706|FG001|Overall Study|Death|3
7792872|NCT01040871|12247705|FG000|Overall Study|Lack of Efficacy|1
7792873|NCT01040871|12247706|FG001|Overall Study|Lack of Efficacy|1
7792874|NCT01040871|12247705|FG000|Overall Study|drug supply issue|1
7792875|NCT01040871|12247706|FG001|Overall Study|drug supply issue|0
7792876|NCT01040871|12247705|FG000|Overall Study|Randomized and Not Treated|2
7792877|NCT01040871|12247706|FG001|Overall Study|Randomized and Not Treated|1
7792878|NCT01041287|12247738|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3
7792879|NCT01041287|12247739|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3
7792880|NCT01041287|12247738|FG000|Treatment Period 2 (3 Months)|Adverse Event|0
7792881|NCT01041287|12247739|FG001|Treatment Period 2 (3 Months)|Adverse Event|2
7792882|NCT01041404|12247747|FG000|Overall Study|Adverse Event|45
7792883|NCT01041404|12247748|FG001|Overall Study|Adverse Event|35
7792884|NCT01041404|12247747|FG000|Overall Study|Lack of Efficacy|200
7792885|NCT01041404|12247748|FG001|Overall Study|Lack of Efficacy|210
7792886|NCT01041404|12247747|FG000|Overall Study|Violation of Selection Criteria|0
7792887|NCT01041404|12247748|FG001|Overall Study|Violation of Selection Criteria|1
7792888|NCT01041404|12247747|FG000|Overall Study|Protocol Violation|4
7792889|NCT01041404|12247748|FG001|Overall Study|Protocol Violation|0
7792890|NCT01041404|12247747|FG000|Overall Study|Withdrawal by Subject|29
7792891|NCT01041404|12247748|FG001|Overall Study|Withdrawal by Subject|23
7792892|NCT01041404|12247747|FG000|Overall Study|Failure to Return|1
7792893|NCT01041404|12247748|FG001|Overall Study|Failure to Return|2
7792894|NCT01041404|12247747|FG000|Overall Study|Other|11
7792895|NCT01041404|12247748|FG001|Overall Study|Other|23
7792896|NCT01041417|12247759|FG000|Overall Study|Adverse Event|5
7792897|NCT01041417|12247760|FG001|Overall Study|Adverse Event|2
7792898|NCT01041417|12247759|FG000|Overall Study|Lost to Follow-up|1
7792899|NCT01041417|12247760|FG001|Overall Study|Lost to Follow-up|1
7792900|NCT01041417|12247759|FG000|Overall Study|Death|1
7792901|NCT01041417|12247760|FG001|Overall Study|Death|0
7792902|NCT01041495|12247770|FG000|Overall Study|Withdrawal by Subject|2
7792903|NCT01041495|12247771|FG001|Overall Study|Withdrawal by Subject|5
7792904|NCT01041495|12247770|FG000|Overall Study|Adverse Event|2
7792905|NCT01041495|12247771|FG001|Overall Study|Adverse Event|1
7792906|NCT01041495|12247770|FG000|Overall Study|Lost to Follow-up|0
7792907|NCT01041495|12247771|FG001|Overall Study|Lost to Follow-up|1
7792908|NCT01041573|12247790|FG000|Overall Study|Withdrawal by Subject|2
7792909|NCT01041573|12247791|FG001|Overall Study|Withdrawal by Subject|5
7792910|NCT01041573|12247792|FG002|Overall Study|Withdrawal by Subject|2
7792911|NCT01041573|12247793|FG003|Overall Study|Withdrawal by Subject|0
7792912|NCT01041573|12247790|FG000|Overall Study|Death|1
7792913|NCT01041573|12247791|FG001|Overall Study|Death|0
7792914|NCT01041573|12247792|FG002|Overall Study|Death|0
7792915|NCT01041573|12247793|FG003|Overall Study|Death|0
7792916|NCT01041573|12247790|FG000|Overall Study|Lost to Follow-up|0
7792917|NCT01041573|12247791|FG001|Overall Study|Lost to Follow-up|1
7792918|NCT01041573|12247792|FG002|Overall Study|Lost to Follow-up|2
7792919|NCT01041573|12247793|FG003|Overall Study|Lost to Follow-up|1
7792920|NCT01041573|12247790|FG000|Overall Study|Adverse Event|0
7792921|NCT01041573|12247791|FG001|Overall Study|Adverse Event|2
7792922|NCT01041573|12247792|FG002|Overall Study|Adverse Event|0
7792923|NCT01041573|12247793|FG003|Overall Study|Adverse Event|0
7792924|NCT01041573|12247790|FG000|Overall Study|relocation|1
7792925|NCT01041573|12247791|FG001|Overall Study|relocation|4
7792926|NCT01041573|12247792|FG002|Overall Study|relocation|3
7869839|NCT01657799|12361341|FG002|Overall Study|Radiographic & Clinical Progression|15
7869840|NCT01657799|12361339|FG000|Overall Study|Other|52
7869841|NCT01657799|12361340|FG001|Overall Study|Other|62
7869842|NCT01657799|12361341|FG002|Overall Study|Other|49
7869843|NCT01657877|12361349|FG000|Overall Study|Withdrawal by Subject|4
7869844|NCT01657877|12361349|FG000|Overall Study|Protocol Violation|6
7869845|NCT01657877|12361349|FG000|Overall Study|Adverse Event|2
7869846|NCT01657877|12361349|FG000|Overall Study|Other Reason|2
7869847|NCT01657903|12361366|FG000|Overall Study|Lost to Follow-up|1
7869848|NCT01657903|12361366|FG000|Overall Study|Withdrawal by Subject|1
7869849|NCT01658020|12361379|FG000|Overall Study|Adverse Event|3
7869850|NCT01658020|12361380|FG001|Overall Study|Adverse Event|3
7869851|NCT01658020|12361379|FG000|Overall Study|Lost to Follow-up|1
7869852|NCT01658020|12361380|FG001|Overall Study|Lost to Follow-up|0
7869853|NCT01658020|12361379|FG000|Overall Study|Withdrawal by Subject|4
7869854|NCT01658020|12361380|FG001|Overall Study|Withdrawal by Subject|5
7869855|NCT01658020|12361379|FG000|Overall Study|Protocol Violation|0
7869856|NCT01658020|12361380|FG001|Overall Study|Protocol Violation|1
7869857|NCT01658072|12361396|FG000|Overall Study|Protocol Violation|4
7869858|NCT01658072|12361397|FG001|Overall Study|Protocol Violation|2
7869859|NCT01658150|12361403|FG000|Overall Study|Withdrawal by Subject|1
7869860|NCT01658436|12361417|FG000|Overall Study|Adverse Event|6
7869861|NCT01658436|12361418|FG001|Overall Study|Adverse Event|5
7869862|NCT01658436|12361417|FG000|Overall Study|Physician Decision|1
7869863|NCT01658436|12361418|FG001|Overall Study|Physician Decision|0
7869864|NCT01658436|12361417|FG000|Overall Study|Progressive disease|12
7869865|NCT01658436|12361418|FG001|Overall Study|Progressive disease|4
7869866|NCT01658436|12361417|FG000|Overall Study|Study terminated by sponsor|0
7792927|NCT01041573|12247793|FG003|Overall Study|relocation|1
7792928|NCT01041573|12247790|FG000|Overall Study|further blood extraction|0
7792929|NCT01041573|12247791|FG001|Overall Study|further blood extraction|1
7869867|NCT01658436|12361418|FG001|Overall Study|Study terminated by sponsor|1
7869868|NCT01658436|12361417|FG000|Overall Study|Subject/guardian decision|0
7869869|NCT01658436|12361418|FG001|Overall Study|Subject/guardian decision|1
7869870|NCT01658436|12361417|FG000|Overall Study|Death|1
7869871|NCT01658436|12361418|FG001|Overall Study|Death|0
7869872|NCT01658514|12361427|FG000|Overall Study|Protocol Violation|1
7869873|NCT01658514|12361428|FG001|Overall Study|Protocol Violation|0
7869874|NCT01658514|12361429|FG002|Overall Study|Protocol Violation|2
7869875|NCT01658579|12361440|FG000|Treatment Period A|Other|0
7869876|NCT01658579|12361441|FG001|Treatment Period A|Other|0
7869877|NCT01658579|12361442|FG002|Treatment Period A|Other|1
7869878|NCT01658579|12361443|FG003|Treatment Period A|Other|1
7869879|NCT01658579|12361440|FG000|Treatment Period A|Adverse Event|1
7869880|NCT01658579|12361441|FG001|Treatment Period A|Adverse Event|0
7869881|NCT01658579|12361442|FG002|Treatment Period A|Adverse Event|0
7869882|NCT01658579|12361443|FG003|Treatment Period A|Adverse Event|0
7869883|NCT01658579|12361440|FG000|Treatment Period B|Other|0
7869884|NCT01658579|12361441|FG001|Treatment Period B|Other|0
7869885|NCT01658579|12361442|FG002|Treatment Period B|Other|0
7869886|NCT01658579|12361443|FG003|Treatment Period B|Other|1
7869887|NCT01658735|12361461|FG000|Overall Study|Lack of Efficacy|1
7869888|NCT01658735|12361462|FG001|Overall Study|Lack of Efficacy|0
7869889|NCT01658735|12361463|FG002|Overall Study|Lack of Efficacy|1
7869890|NCT01658735|12361461|FG000|Overall Study|Lost to Follow-up|1
7869891|NCT01658735|12361462|FG001|Overall Study|Lost to Follow-up|1
7869892|NCT01658735|12361463|FG002|Overall Study|Lost to Follow-up|0
7869893|NCT01658735|12361461|FG000|Overall Study|Protocol Violation|0
7869894|NCT01658735|12361462|FG001|Overall Study|Protocol Violation|1
7869895|NCT01658735|12361463|FG002|Overall Study|Protocol Violation|0
7869896|NCT01658735|12361461|FG000|Overall Study|Withdrawal by Subject|3
7869897|NCT01658735|12361462|FG001|Overall Study|Withdrawal by Subject|5
7869898|NCT01658735|12361463|FG002|Overall Study|Withdrawal by Subject|3
7869899|NCT01658904|12361478|FG000|Overall Study|Principal Investigator discretion|2
7869900|NCT01658904|12361479|FG001|Overall Study|Principal Investigator discretion|0
7869901|NCT01658904|12361480|FG002|Overall Study|Principal Investigator discretion|0
7869902|NCT01658943|12361493|FG000|Overall Study|Adverse Event|6
7869903|NCT01658943|12361494|FG001|Overall Study|Adverse Event|13
7869904|NCT01658943|12361493|FG000|Overall Study|Withdrawal by Subject|9
7869905|NCT01658943|12361494|FG001|Overall Study|Withdrawal by Subject|2
7869906|NCT01658943|12361493|FG000|Overall Study|Progression/Relapse|39
7869907|NCT01658943|12361494|FG001|Overall Study|Progression/Relapse|40
7869908|NCT01658943|12361493|FG000|Overall Study|Death|4
7869909|NCT01658943|12361494|FG001|Overall Study|Death|2
7869910|NCT01658943|12361493|FG000|Overall Study|not protocol specified|4
7869911|NCT01658943|12361494|FG001|Overall Study|not protocol specified|1
7869912|NCT01658943|12361493|FG000|Overall Study|Not eligible|7
7869913|NCT01658943|12361494|FG001|Overall Study|Not eligible|9
7869914|NCT01658943|12361493|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1
7869915|NCT01658943|12361494|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0
7869916|NCT01659021|12361511|FG000|Main Study|Adverse Event|2
7869917|NCT01659021|12361512|FG001|Main Study|Adverse Event|3
7869918|NCT01659021|12361511|FG000|Main Study|Lost to Follow-up|1
7869919|NCT01659021|12361512|FG001|Main Study|Lost to Follow-up|0
7869920|NCT01659021|12361511|FG000|Main Study|Unknown Reasons|2
7869921|NCT01659021|12361512|FG001|Main Study|Unknown Reasons|1
7869922|NCT01659021|12361511|FG000|Main Study|Physician Decision|34
7869923|NCT01659021|12361512|FG001|Main Study|Physician Decision|16
7869924|NCT01659021|12361511|FG000|Main Study|Withdrawal by Subject|19
7869925|NCT01659021|12361512|FG001|Main Study|Withdrawal by Subject|16
7869926|NCT01659021|12361511|FG000|Main Study|Study Terminated by Sponsor|16
7869927|NCT01659021|12361512|FG001|Main Study|Study Terminated by Sponsor|1
7869928|NCT01659021|12361511|FG000|Long-Term Follow Up|Lost to Follow-up|3
7869929|NCT01659021|12361512|FG001|Long-Term Follow Up|Lost to Follow-up|3
7869930|NCT01659021|12361511|FG000|Long-Term Follow Up|Withdrawal by Subject|2
7869931|NCT01659021|12361512|FG001|Long-Term Follow Up|Withdrawal by Subject|1
7869932|NCT01659125|12361522|FG000|Overall Study|Withdrawal by Subject|2
7869933|NCT01659125|12361522|FG000|Overall Study|Lost to Follow-up|7
7869934|NCT01659125|12361522|FG000|Overall Study|Technical Problem|1
7869935|NCT01659125|12361522|FG000|Overall Study|Time Constraints|2
7869936|NCT01659125|12361522|FG000|Overall Study|Failed to Start Treatment|2
7869937|NCT01659255|12361543|FG000|Overall Study|Adverse Event|0
7869938|NCT01659255|12361544|FG001|Overall Study|Adverse Event|0
7869939|NCT01659255|12361545|FG002|Overall Study|Adverse Event|0
7869940|NCT01659255|12361546|FG003|Overall Study|Adverse Event|0
7869941|NCT01659255|12361547|FG004|Overall Study|Adverse Event|0
7869942|NCT01659255|12361548|FG005|Overall Study|Adverse Event|1
7869943|NCT01659255|12361549|FG006|Overall Study|Adverse Event|1
7869944|NCT01659255|12361550|FG007|Overall Study|Adverse Event|0
7869945|NCT01659255|12361551|FG008|Overall Study|Adverse Event|0
7869946|NCT01659255|12361552|FG009|Overall Study|Adverse Event|1
7869947|NCT01659255|12361553|FG010|Overall Study|Adverse Event|0
7869948|NCT01659255|12361554|FG011|Overall Study|Adverse Event|1
7869949|NCT01659255|12361555|FG012|Overall Study|Adverse Event|0
7869950|NCT01659255|12361556|FG013|Overall Study|Adverse Event|2
7869951|NCT01659255|12361557|FG014|Overall Study|Adverse Event|0
7869952|NCT01659255|12361558|FG015|Overall Study|Adverse Event|1
7869953|NCT01659255|12361559|FG016|Overall Study|Adverse Event|0
7869954|NCT01659255|12361543|FG000|Overall Study|Death|0
7869955|NCT01659255|12361544|FG001|Overall Study|Death|1
7869956|NCT01659255|12361545|FG002|Overall Study|Death|0
7869957|NCT01659255|12361546|FG003|Overall Study|Death|0
7869958|NCT01659255|12361547|FG004|Overall Study|Death|0
7869959|NCT01659255|12361548|FG005|Overall Study|Death|0
7869960|NCT01659255|12361549|FG006|Overall Study|Death|0
7869961|NCT01659255|12361550|FG007|Overall Study|Death|1
7869962|NCT01659255|12361551|FG008|Overall Study|Death|1
7869963|NCT01659255|12361552|FG009|Overall Study|Death|0
7869964|NCT01659255|12361553|FG010|Overall Study|Death|0
7869965|NCT01659255|12361554|FG011|Overall Study|Death|0
7869966|NCT01659255|12361555|FG012|Overall Study|Death|1
7869967|NCT01659255|12361556|FG013|Overall Study|Death|1
7869968|NCT01659255|12361557|FG014|Overall Study|Death|2
7869969|NCT01659255|12361558|FG015|Overall Study|Death|1
7869970|NCT01659255|12361559|FG016|Overall Study|Death|0
7869971|NCT01659255|12361543|FG000|Overall Study|Progressive Disease|2
7869972|NCT01659255|12361544|FG001|Overall Study|Progressive Disease|0
7869973|NCT01659255|12361545|FG002|Overall Study|Progressive Disease|0
7869974|NCT01659255|12361546|FG003|Overall Study|Progressive Disease|0
7869975|NCT01659255|12361547|FG004|Overall Study|Progressive Disease|0
7869976|NCT01659255|12361548|FG005|Overall Study|Progressive Disease|0
7869977|NCT01659255|12361549|FG006|Overall Study|Progressive Disease|0
7869978|NCT01659255|12361550|FG007|Overall Study|Progressive Disease|1
7869979|NCT01659255|12361551|FG008|Overall Study|Progressive Disease|0
7869980|NCT01659255|12361552|FG009|Overall Study|Progressive Disease|2
7869981|NCT01659255|12361553|FG010|Overall Study|Progressive Disease|2
7869982|NCT01659255|12361554|FG011|Overall Study|Progressive Disease|3
7869983|NCT01659255|12361555|FG012|Overall Study|Progressive Disease|5
7869984|NCT01659255|12361556|FG013|Overall Study|Progressive Disease|13
7869985|NCT01659255|12361557|FG014|Overall Study|Progressive Disease|6
7869986|NCT01659255|12361558|FG015|Overall Study|Progressive Disease|2
7869987|NCT01659255|12361559|FG016|Overall Study|Progressive Disease|3
7869988|NCT01659255|12361543|FG000|Overall Study|Withdrew Consent|0
7869989|NCT01659255|12361544|FG001|Overall Study|Withdrew Consent|0
7869990|NCT01659255|12361545|FG002|Overall Study|Withdrew Consent|0
7869991|NCT01659255|12361546|FG003|Overall Study|Withdrew Consent|0
7869992|NCT01659255|12361547|FG004|Overall Study|Withdrew Consent|0
7869993|NCT01659255|12361548|FG005|Overall Study|Withdrew Consent|0
7869994|NCT01659255|12361549|FG006|Overall Study|Withdrew Consent|0
7869995|NCT01659255|12361550|FG007|Overall Study|Withdrew Consent|0
7869996|NCT01659255|12361551|FG008|Overall Study|Withdrew Consent|0
7869997|NCT01659255|12361552|FG009|Overall Study|Withdrew Consent|0
7869998|NCT01659255|12361553|FG010|Overall Study|Withdrew Consent|1
7869999|NCT01659255|12361554|FG011|Overall Study|Withdrew Consent|0
7870000|NCT01659255|12361555|FG012|Overall Study|Withdrew Consent|0
7870001|NCT01659255|12361556|FG013|Overall Study|Withdrew Consent|1
7870002|NCT01659255|12361557|FG014|Overall Study|Withdrew Consent|0
7870003|NCT01659255|12361558|FG015|Overall Study|Withdrew Consent|0
7870004|NCT01659255|12361559|FG016|Overall Study|Withdrew Consent|0
7870005|NCT01659255|12361543|FG000|Overall Study|Investigator Decision|0
7870006|NCT01659255|12361544|FG001|Overall Study|Investigator Decision|0
7870007|NCT01659255|12361545|FG002|Overall Study|Investigator Decision|0
7870008|NCT01659255|12361546|FG003|Overall Study|Investigator Decision|0
7870009|NCT01659255|12361547|FG004|Overall Study|Investigator Decision|0
7870010|NCT01659255|12361548|FG005|Overall Study|Investigator Decision|0
7870011|NCT01659255|12361549|FG006|Overall Study|Investigator Decision|0
7870012|NCT01659255|12361550|FG007|Overall Study|Investigator Decision|0
7870013|NCT01659255|12361551|FG008|Overall Study|Investigator Decision|0
7870014|NCT01659255|12361552|FG009|Overall Study|Investigator Decision|0
7870015|NCT01659255|12361553|FG010|Overall Study|Investigator Decision|0
7870016|NCT01659255|12361554|FG011|Overall Study|Investigator Decision|0
7792930|NCT01041573|12247792|FG002|Overall Study|further blood extraction|0
7792931|NCT01041573|12247793|FG003|Overall Study|further blood extraction|0
7792932|NCT01041573|12247790|FG000|Overall Study|positive to anti-HCV|1
7792933|NCT01041573|12247791|FG001|Overall Study|positive to anti-HCV|0
7792934|NCT01041573|12247792|FG002|Overall Study|positive to anti-HCV|0
7792935|NCT01041573|12247793|FG003|Overall Study|positive to anti-HCV|0
7792936|NCT01041638|12247812|FG000|Overall Study|Adverse Event|4
7792937|NCT01041638|12247812|FG000|Overall Study|Death|1
7792938|NCT01041638|12247812|FG000|Overall Study|Lack of Efficacy|7
7792939|NCT01041638|12247812|FG000|Overall Study|Physician Decision|4
7792940|NCT01041638|12247812|FG000|Overall Study|Withdrawal by Subject|11
7792941|NCT01041859|12247835|FG000|Open-Label Titration|Adverse Event|69
7792942|NCT01041859|12247836|FG001|Open-Label Titration|Adverse Event|0
7792943|NCT01041859|12247837|FG002|Open-Label Titration|Adverse Event|0
7792944|NCT01041859|12247835|FG000|Open-Label Titration|Lack of Efficacy|3
7792945|NCT01041859|12247836|FG001|Open-Label Titration|Lack of Efficacy|0
7792946|NCT01041859|12247837|FG002|Open-Label Titration|Lack of Efficacy|0
7792947|NCT01041859|12247835|FG000|Open-Label Titration|Lost to Follow-up|1
7792948|NCT01041859|12247836|FG001|Open-Label Titration|Lost to Follow-up|0
7792949|NCT01041859|12247837|FG002|Open-Label Titration|Lost to Follow-up|0
7792950|NCT01041859|12247835|FG000|Open-Label Titration|Physician Decision|1
7792951|NCT01041859|12247836|FG001|Open-Label Titration|Physician Decision|0
7792952|NCT01041859|12247837|FG002|Open-Label Titration|Physician Decision|0
7870017|NCT01659255|12361555|FG012|Overall Study|Investigator Decision|1
7870018|NCT01659255|12361556|FG013|Overall Study|Investigator Decision|1
7870019|NCT01659255|12361557|FG014|Overall Study|Investigator Decision|0
7792953|NCT01041859|12247835|FG000|Open-Label Titration|Protocol Violation|1
7792954|NCT01041859|12247836|FG001|Open-Label Titration|Protocol Violation|0
7792955|NCT01041859|12247837|FG002|Open-Label Titration|Protocol Violation|0
7792956|NCT01041859|12247835|FG000|Open-Label Titration|Other|7
7870020|NCT01659255|12361558|FG015|Overall Study|Investigator Decision|0
7870021|NCT01659255|12361559|FG016|Overall Study|Investigator Decision|0
7870022|NCT01659255|12361543|FG000|Overall Study|Sponsor's Decision|0
7870023|NCT01659255|12361544|FG001|Overall Study|Sponsor's Decision|0
7870024|NCT01659255|12361545|FG002|Overall Study|Sponsor's Decision|0
7870025|NCT01659255|12361546|FG003|Overall Study|Sponsor's Decision|0
7870026|NCT01659255|12361547|FG004|Overall Study|Sponsor's Decision|0
7870027|NCT01659255|12361548|FG005|Overall Study|Sponsor's Decision|0
7870028|NCT01659255|12361549|FG006|Overall Study|Sponsor's Decision|1
7870029|NCT01659255|12361550|FG007|Overall Study|Sponsor's Decision|0
7870030|NCT01659255|12361551|FG008|Overall Study|Sponsor's Decision|0
7870031|NCT01659255|12361552|FG009|Overall Study|Sponsor's Decision|0
7870032|NCT01659255|12361553|FG010|Overall Study|Sponsor's Decision|0
7870033|NCT01659255|12361554|FG011|Overall Study|Sponsor's Decision|0
7870034|NCT01659255|12361555|FG012|Overall Study|Sponsor's Decision|0
7870035|NCT01659255|12361556|FG013|Overall Study|Sponsor's Decision|0
7870036|NCT01659255|12361557|FG014|Overall Study|Sponsor's Decision|0
7870037|NCT01659255|12361558|FG015|Overall Study|Sponsor's Decision|0
7870038|NCT01659255|12361559|FG016|Overall Study|Sponsor's Decision|0
7870039|NCT01659255|12361543|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0
7870040|NCT01659255|12361544|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0
7870041|NCT01659255|12361545|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0
7870042|NCT01659255|12361546|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0
7870043|NCT01659255|12361547|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0
7870044|NCT01659255|12361548|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0
7870045|NCT01659255|12361549|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0
7870046|NCT01659255|12361550|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0
7870047|NCT01659255|12361551|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0
7870048|NCT01659255|12361552|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0
7870049|NCT01659255|12361553|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0
7870050|NCT01659255|12361554|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0
7870051|NCT01659255|12361555|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0
7870052|NCT01659255|12361556|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0
7870053|NCT01659255|12361557|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0
7870054|NCT01659255|12361558|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1
7870055|NCT01659255|12361559|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0
7870056|NCT01659255|12361543|FG000|Overall Study|Participant Went on to Have an Allograft|0
7870057|NCT01659255|12361544|FG001|Overall Study|Participant Went on to Have an Allograft|0
7870058|NCT01659255|12361545|FG002|Overall Study|Participant Went on to Have an Allograft|0
7870059|NCT01659255|12361546|FG003|Overall Study|Participant Went on to Have an Allograft|0
7870060|NCT01659255|12361547|FG004|Overall Study|Participant Went on to Have an Allograft|0
7870061|NCT01659255|12361548|FG005|Overall Study|Participant Went on to Have an Allograft|0
7870062|NCT01659255|12361549|FG006|Overall Study|Participant Went on to Have an Allograft|0
7870063|NCT01659255|12361550|FG007|Overall Study|Participant Went on to Have an Allograft|0
7870064|NCT01659255|12361551|FG008|Overall Study|Participant Went on to Have an Allograft|0
7870065|NCT01659255|12361552|FG009|Overall Study|Participant Went on to Have an Allograft|0
7870066|NCT01659255|12361553|FG010|Overall Study|Participant Went on to Have an Allograft|0
7870067|NCT01659255|12361554|FG011|Overall Study|Participant Went on to Have an Allograft|0
7870068|NCT01659255|12361555|FG012|Overall Study|Participant Went on to Have an Allograft|1
7870069|NCT01659255|12361556|FG013|Overall Study|Participant Went on to Have an Allograft|0
7792957|NCT01041859|12247836|FG001|Open-Label Titration|Other|0
7792958|NCT01041859|12247837|FG002|Open-Label Titration|Other|0
7792959|NCT01041859|12247835|FG000|Open-Label Titration|Noncompliance With Study Drug|8
7792960|NCT01041859|12247836|FG001|Open-Label Titration|Noncompliance With Study Drug|0
7792961|NCT01041859|12247837|FG002|Open-Label Titration|Noncompliance With Study Drug|0
7792962|NCT01041859|12247835|FG000|Open-Label Titration|Withdrawal by Subject|11
7792963|NCT01041859|12247836|FG001|Open-Label Titration|Withdrawal by Subject|0
7792964|NCT01041859|12247837|FG002|Open-Label Titration|Withdrawal by Subject|0
7792965|NCT01041859|12247835|FG000|Double-Blind Maintenance|Adverse Event|0
7792966|NCT01041859|12247836|FG001|Double-Blind Maintenance|Adverse Event|23
7792967|NCT01041859|12247837|FG002|Double-Blind Maintenance|Adverse Event|13
7792968|NCT01041859|12247835|FG000|Double-Blind Maintenance|Lack of Efficacy|0
7792969|NCT01041859|12247836|FG001|Double-Blind Maintenance|Lack of Efficacy|3
7792970|NCT01041859|12247837|FG002|Double-Blind Maintenance|Lack of Efficacy|11
7792971|NCT01041859|12247835|FG000|Double-Blind Maintenance|Lost to Follow-up|0
7792972|NCT01041859|12247836|FG001|Double-Blind Maintenance|Lost to Follow-up|1
7792973|NCT01041859|12247837|FG002|Double-Blind Maintenance|Lost to Follow-up|0
7792974|NCT01041859|12247835|FG000|Double-Blind Maintenance|Physician Decision|0
7792975|NCT01041859|12247836|FG001|Double-Blind Maintenance|Physician Decision|2
7792976|NCT01041859|12247837|FG002|Double-Blind Maintenance|Physician Decision|1
7870070|NCT01659255|12361557|FG014|Overall Study|Participant Went on to Have an Allograft|0
7870071|NCT01659255|12361558|FG015|Overall Study|Participant Went on to Have an Allograft|0
7870072|NCT01659255|12361559|FG016|Overall Study|Participant Went on to Have an Allograft|0
7870073|NCT01659320|12361606|FG000|Overall Study|Withdrawal by Subject|2
7870074|NCT01659320|12361606|FG000|Overall Study|Physician Decision|1
7870075|NCT01659567|12361610|FG000|Overall Study|Lack of Efficacy|22
7870076|NCT01659567|12361610|FG000|Overall Study|Switched to Pegferon|6
7870077|NCT01659567|12361610|FG000|Overall Study|Adverse Event|12
7870078|NCT01659567|12361610|FG000|Overall Study|Good result at early stage of treatment|5
7870079|NCT01659567|12361610|FG000|Overall Study|Withdrawal by Subject|64
7870080|NCT01659567|12361610|FG000|Overall Study|Progression of the main disease|1
7870081|NCT01659567|12361610|FG000|Overall Study|Other|13
7870082|NCT01659736|12361616|FG000|Treatment Period|Adverse Event|1
7870083|NCT01659736|12361617|FG001|Treatment Period|Adverse Event|1
7870084|NCT01659736|12361616|FG000|Treatment Period|Protocol Violation|3
7870085|NCT01659736|12361617|FG001|Treatment Period|Protocol Violation|1
7870086|NCT01659736|12361616|FG000|Treatment Period|Withdrawal by Subject|1
7870087|NCT01659736|12361617|FG001|Treatment Period|Withdrawal by Subject|0
7870088|NCT01659736|12361616|FG000|3-month Follow-up|Lost to Follow-up|0
7870089|NCT01659736|12361617|FG001|3-month Follow-up|Lost to Follow-up|1
7870090|NCT01659996|12361637|FG000|Overall Study|Protocol Violation|3
7870091|NCT01659996|12361638|FG001|Overall Study|Protocol Violation|3
7870092|NCT01659996|12361639|FG002|Overall Study|Protocol Violation|3
7870093|NCT01659996|12361637|FG000|Overall Study|Lost to Follow-up|1
7870094|NCT01659996|12361638|FG001|Overall Study|Lost to Follow-up|3
7870095|NCT01659996|12361639|FG002|Overall Study|Lost to Follow-up|2
7870096|NCT01659996|12361637|FG000|Overall Study|Adverse Event|0
7870097|NCT01659996|12361638|FG001|Overall Study|Adverse Event|0
7870098|NCT01659996|12361639|FG002|Overall Study|Adverse Event|1
7870099|NCT01659996|12361637|FG000|Overall Study|Withdrawal by Subject|4
7870100|NCT01659996|12361638|FG001|Overall Study|Withdrawal by Subject|1
7870101|NCT01659996|12361639|FG002|Overall Study|Withdrawal by Subject|5
7870102|NCT01660022|12361655|FG000|First Sequence (7 Days)|Withdrawal by Subject|0
7870103|NCT01660022|12361656|FG001|First Sequence (7 Days)|Withdrawal by Subject|1
7870104|NCT01660022|12361657|FG002|First Sequence (7 Days)|Withdrawal by Subject|0
7870105|NCT01660022|12361658|FG003|First Sequence (7 Days)|Withdrawal by Subject|1
7870106|NCT01660022|12361659|FG004|First Sequence (7 Days)|Withdrawal by Subject|0
7870107|NCT01660022|12361660|FG005|First Sequence (7 Days)|Withdrawal by Subject|0
7870108|NCT01660022|12361655|FG000|First Sequence (7 Days)|Adverse Event|0
7870109|NCT01660022|12361656|FG001|First Sequence (7 Days)|Adverse Event|0
7870110|NCT01660022|12361657|FG002|First Sequence (7 Days)|Adverse Event|0
7870111|NCT01660022|12361658|FG003|First Sequence (7 Days)|Adverse Event|0
7870112|NCT01660022|12361659|FG004|First Sequence (7 Days)|Adverse Event|1
7870113|NCT01660022|12361660|FG005|First Sequence (7 Days)|Adverse Event|3
7870114|NCT01660022|12361655|FG000|First Sequence (7 Days)|Protocol Violation|0
7870115|NCT01660022|12361656|FG001|First Sequence (7 Days)|Protocol Violation|0
7870116|NCT01660022|12361657|FG002|First Sequence (7 Days)|Protocol Violation|0
7870117|NCT01660022|12361658|FG003|First Sequence (7 Days)|Protocol Violation|0
7870118|NCT01660022|12361659|FG004|First Sequence (7 Days)|Protocol Violation|0
7870119|NCT01660022|12361660|FG005|First Sequence (7 Days)|Protocol Violation|1
7870120|NCT01660256|12361752|FG000|Overall Study|Adverse Event|4
7870121|NCT01660256|12361753|FG001|Overall Study|Adverse Event|0
7870122|NCT01660256|12361754|FG002|Overall Study|Adverse Event|2
7870123|NCT01660256|12361752|FG000|Overall Study|Withdrawal by Subject|1
7870124|NCT01660256|12361753|FG001|Overall Study|Withdrawal by Subject|0
7870125|NCT01660256|12361754|FG002|Overall Study|Withdrawal by Subject|2
7870126|NCT01660334|12361766|FG000|Overall Study|Lost to Follow-up|1
7870127|NCT01660412|12361770|FG000|Overall Study|Protocol Violation|0
7870128|NCT01660412|12361771|FG001|Overall Study|Protocol Violation|3
7870129|NCT01660711|12361791|FG000|Overall Study|Adverse Event|7
7870130|NCT01660711|12361791|FG000|Overall Study|Withdrawal by Subject|1
7870131|NCT01660763|12361801|FG000|Overall Study|Lack of Efficacy|45
7870132|NCT01660763|12361802|FG001|Overall Study|Lack of Efficacy|50
7870133|NCT01660763|12361801|FG000|Overall Study|Adverse Event|22
7792977|NCT01041859|12247835|FG000|Double-Blind Maintenance|Protocol Violation|0
7792978|NCT01041859|12247836|FG001|Double-Blind Maintenance|Protocol Violation|1
7792979|NCT01041859|12247837|FG002|Double-Blind Maintenance|Protocol Violation|3
7792980|NCT01041859|12247835|FG000|Double-Blind Maintenance|Other|0
7792981|NCT01041859|12247836|FG001|Double-Blind Maintenance|Other|6
7792982|NCT01041859|12247837|FG002|Double-Blind Maintenance|Other|2
7792983|NCT01041859|12247835|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0
7792984|NCT01041859|12247836|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2
7792985|NCT01041859|12247837|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6
7792986|NCT01041859|12247835|FG000|Double-Blind Maintenance|Withdrawal by Subject|0
7792987|NCT01041859|12247836|FG001|Double-Blind Maintenance|Withdrawal by Subject|8
7792988|NCT01041859|12247837|FG002|Double-Blind Maintenance|Withdrawal by Subject|9
7792989|NCT01041976|12247846|FG000|Overall Study|Withdrawal by Subject|3
7792990|NCT01041976|12247847|FG001|Overall Study|Withdrawal by Subject|0
7792991|NCT01041976|12247846|FG000|Overall Study|Incarceration|2
7792992|NCT01041976|12247847|FG001|Overall Study|Incarceration|0
7870134|NCT01660763|12361802|FG001|Overall Study|Adverse Event|7
7792993|NCT01041976|12247846|FG000|Overall Study|Death|0
7792994|NCT01041976|12247847|FG001|Overall Study|Death|4
7792995|NCT01042093|12247857|FG000|Overall Study|Protocol Violation|2
7792996|NCT01042093|12247858|FG001|Overall Study|Protocol Violation|2
7624329|NCT01453140|12035336|FG000|Overall Study|Adverse Event|3
7792997|NCT01042093|12247859|FG002|Overall Study|Protocol Violation|2
7792998|NCT01042093|12247860|FG003|Overall Study|Protocol Violation|3
7792999|NCT01042093|12247857|FG000|Overall Study|Withdrawal by Subject|0
7793000|NCT01042093|12247858|FG001|Overall Study|Withdrawal by Subject|0
7793001|NCT01042093|12247859|FG002|Overall Study|Withdrawal by Subject|0
7793002|NCT01042093|12247860|FG003|Overall Study|Withdrawal by Subject|1
7793003|NCT01042158|12247882|FG000|Overall Study|Physician Decision|1
7793004|NCT01042236|12247886|FG000|Treatment Period 1|Adverse Event|0
7793005|NCT01042236|12247887|FG001|Treatment Period 1|Adverse Event|1
7793006|NCT01042236|12247888|FG002|Treatment Period 1|Adverse Event|0
7793007|NCT01042236|12247889|FG003|Treatment Period 1|Adverse Event|0
7793008|NCT01042236|12247890|FG004|Treatment Period 1|Adverse Event|1
7793009|NCT01042236|12247891|FG005|Treatment Period 1|Adverse Event|0
7793010|NCT01042236|12247886|FG000|Treatment Period 3|Adverse Event|0
7793011|NCT01042236|12247887|FG001|Treatment Period 3|Adverse Event|0
7793012|NCT01042236|12247888|FG002|Treatment Period 3|Adverse Event|0
7793013|NCT01042236|12247889|FG003|Treatment Period 3|Adverse Event|1
7793014|NCT01042236|12247890|FG004|Treatment Period 3|Adverse Event|0
7793015|NCT01042236|12247891|FG005|Treatment Period 3|Adverse Event|0
7793016|NCT01042236|12247886|FG000|Treatment Period 3|Protocol Violation|0
7793017|NCT01042236|12247887|FG001|Treatment Period 3|Protocol Violation|0
7793018|NCT01042236|12247888|FG002|Treatment Period 3|Protocol Violation|0
7793019|NCT01042236|12247889|FG003|Treatment Period 3|Protocol Violation|1
7793020|NCT01042236|12247890|FG004|Treatment Period 3|Protocol Violation|0
7793021|NCT01042236|12247891|FG005|Treatment Period 3|Protocol Violation|0
7800866|NCT01097707|12258430|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7800867|NCT01097707|12258431|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7800868|NCT01097707|12258432|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7800869|NCT01097707|12258428|FG000|Overall Study|Adverse Event|4
7800870|NCT01097707|12258429|FG001|Overall Study|Adverse Event|2
7800871|NCT01097707|12258430|FG002|Overall Study|Adverse Event|3
7800872|NCT01097707|12258431|FG003|Overall Study|Adverse Event|1
7800873|NCT01097707|12258432|FG004|Overall Study|Adverse Event|3
7800874|NCT01097707|12258428|FG000|Overall Study|Entry Criteria Not Met|2
7800875|NCT01097707|12258429|FG001|Overall Study|Entry Criteria Not Met|1
7800876|NCT01097707|12258430|FG002|Overall Study|Entry Criteria Not Met|1
7800877|NCT01097707|12258431|FG003|Overall Study|Entry Criteria Not Met|0
7800878|NCT01097707|12258432|FG004|Overall Study|Entry Criteria Not Met|1
7800879|NCT01097707|12258428|FG000|Overall Study|Lack of Efficacy|1
7800880|NCT01097707|12258429|FG001|Overall Study|Lack of Efficacy|0
7800881|NCT01097707|12258430|FG002|Overall Study|Lack of Efficacy|0
7800882|NCT01097707|12258431|FG003|Overall Study|Lack of Efficacy|1
7800883|NCT01097707|12258432|FG004|Overall Study|Lack of Efficacy|0
7800884|NCT01097707|12258428|FG000|Overall Study|Lost to Follow-up|1
7800885|NCT01097707|12258429|FG001|Overall Study|Lost to Follow-up|1
7800886|NCT01097707|12258430|FG002|Overall Study|Lost to Follow-up|2
7800887|NCT01097707|12258431|FG003|Overall Study|Lost to Follow-up|0
7800888|NCT01097707|12258432|FG004|Overall Study|Lost to Follow-up|3
7800889|NCT01097707|12258428|FG000|Overall Study|Protocol Violation|2
7800890|NCT01097707|12258429|FG001|Overall Study|Protocol Violation|2
7800891|NCT01097707|12258430|FG002|Overall Study|Protocol Violation|3
7800892|NCT01097707|12258431|FG003|Overall Study|Protocol Violation|2
7800893|NCT01097707|12258432|FG004|Overall Study|Protocol Violation|2
7800894|NCT01097707|12258428|FG000|Overall Study|Sponsor Decision|31
7800895|NCT01097707|12258429|FG001|Overall Study|Sponsor Decision|31
7800896|NCT01097707|12258430|FG002|Overall Study|Sponsor Decision|34
7800897|NCT01097707|12258431|FG003|Overall Study|Sponsor Decision|35
7800898|NCT01097707|12258432|FG004|Overall Study|Sponsor Decision|36
7800899|NCT01097707|12258428|FG000|Overall Study|Withdrawal by Subject|3
7800900|NCT01097707|12258429|FG001|Overall Study|Withdrawal by Subject|6
7800901|NCT01097707|12258430|FG002|Overall Study|Withdrawal by Subject|1
7800902|NCT01097707|12258431|FG003|Overall Study|Withdrawal by Subject|4
7800903|NCT01097707|12258432|FG004|Overall Study|Withdrawal by Subject|3
7800904|NCT01097707|12258428|FG000|Overall Study|Reason unknown|0
7800905|NCT01097707|12258429|FG001|Overall Study|Reason unknown|0
7800906|NCT01097707|12258430|FG002|Overall Study|Reason unknown|0
7800907|NCT01097707|12258431|FG003|Overall Study|Reason unknown|0
7800908|NCT01097707|12258432|FG004|Overall Study|Reason unknown|1
7800909|NCT01097863|12258457|FG000|Overall Study|Discomfort|1
7800910|NCT01097863|12258458|FG001|Overall Study|Discomfort|0
7800911|NCT01097863|12258459|FG002|Overall Study|Discomfort|1
7800912|NCT01097863|12258457|FG000|Overall Study|Did not return for final visit|0
7800913|NCT01097863|12258458|FG001|Overall Study|Did not return for final visit|0
7800914|NCT01097863|12258459|FG002|Overall Study|Did not return for final visit|1
7800915|NCT01098097|12258504|FG000|Overall Study|Adverse Event|17
7800916|NCT01098097|12258504|FG000|Overall Study|Lost to Follow-up|18
7800917|NCT01098097|12258504|FG000|Overall Study|Status unknown|16
7800918|NCT01098097|12258504|FG000|Overall Study|No reason reported|31
7800919|NCT01098162|12258508|FG000|Overall Study|Adverse Event|37
7870135|NCT01660763|12361801|FG000|Overall Study|Protocol Violation|1
7870136|NCT01660763|12361802|FG001|Overall Study|Protocol Violation|0
7870137|NCT01660763|12361801|FG000|Overall Study|Withdrawal by Subject|4
7870138|NCT01660763|12361802|FG001|Overall Study|Withdrawal by Subject|0
7870139|NCT01660763|12361801|FG000|Overall Study|Patient ready for early discharge|28
7870140|NCT01660763|12361802|FG001|Overall Study|Patient ready for early discharge|4
7870141|NCT01660906|12361835|FG000|Overall Study|Discontinued due to study drug toxicity|3
7882573|NCT01772823|12381678|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
7882574|NCT01772823|12381677|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
7882575|NCT01772823|12381678|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
7882576|NCT01773070|12381689|FG000|Overall Study|Withdrawal by Subject|24
7882577|NCT01773070|12381689|FG000|Overall Study|Lost to Follow-up|39
7882578|NCT01773070|12381689|FG000|Overall Study|Other|15
7882579|NCT01773070|12381689|FG000|Overall Study|Death (unrelated to study procedures)|3
7882580|NCT01773109|12381693|FG000|Overall Study|Symptomatic Progression|2
7882581|NCT01773109|12381693|FG000|Overall Study|Death|1
7793022|NCT01042392|12247916|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
7793023|NCT01042392|12247917|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
7793024|NCT01042392|12247918|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
7793025|NCT01042392|12247919|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
7793026|NCT01042392|12247916|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
7793027|NCT01042392|12247917|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
7793028|NCT01042392|12247918|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
7793029|NCT01042392|12247919|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
7793030|NCT01042392|12247916|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
7793031|NCT01042392|12247917|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
7793032|NCT01042392|12247918|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
7793033|NCT01042392|12247919|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
7793034|NCT01042392|12247916|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
7793035|NCT01042392|12247917|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
7793036|NCT01042392|12247918|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
7793037|NCT01042392|12247919|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
7793038|NCT01042392|12247916|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
7793039|NCT01042392|12247917|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
7793040|NCT01042392|12247918|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
7793041|NCT01042392|12247919|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
7793042|NCT01042392|12247916|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
7793043|NCT01042392|12247917|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
7793044|NCT01042392|12247918|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
7793045|NCT01042392|12247919|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
7793046|NCT01042392|12247916|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
7793047|NCT01042392|12247917|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
7882582|NCT01773122|12381701|FG000|Overall Study|Due to amended age eligibility criteria|3
7882583|NCT01773122|12381702|FG001|Overall Study|Due to amended age eligibility criteria|1
7882584|NCT01773122|12381703|FG002|Overall Study|Due to amended age eligibility criteria|0
7882585|NCT01773122|12381704|FG003|Overall Study|Due to amended age eligibility criteria|1
7882586|NCT01773226|12381730|FG000|Overall Study|Withdrawal by Subject|1
7882587|NCT01773291|12381737|FG000|Overall Study|Protocol Violation|1
7882588|NCT01773291|12381738|FG001|Overall Study|Protocol Violation|0
7882589|NCT01773291|12381739|FG002|Overall Study|Protocol Violation|0
7882590|NCT01773291|12381737|FG000|Overall Study|Withdrawal by Subject|0
7882591|NCT01773291|12381738|FG001|Overall Study|Withdrawal by Subject|0
7882592|NCT01773291|12381739|FG002|Overall Study|Withdrawal by Subject|1
7882593|NCT01773421|12381752|FG000|Treatment Phase|Other|0
7882594|NCT01773421|12381753|FG001|Treatment Phase|Other|0
7882595|NCT01773421|12381754|FG002|Treatment Phase|Other|2
7882596|NCT01773421|12381755|FG003|Treatment Phase|Other|0
7882597|NCT01773421|12381756|FG004|Treatment Phase|Other|0
7882598|NCT01773421|12381757|FG005|Treatment Phase|Other|0
7882599|NCT01773421|12381758|FG006|Treatment Phase|Other|0
7882600|NCT01773421|12381752|FG000|Treatment Phase|Adverse Event|0
7882601|NCT01773421|12381753|FG001|Treatment Phase|Adverse Event|0
7882602|NCT01773421|12381754|FG002|Treatment Phase|Adverse Event|3
7882603|NCT01773421|12381755|FG003|Treatment Phase|Adverse Event|1
7882604|NCT01773421|12381756|FG004|Treatment Phase|Adverse Event|0
7882605|NCT01773421|12381757|FG005|Treatment Phase|Adverse Event|0
7882606|NCT01773421|12381758|FG006|Treatment Phase|Adverse Event|0
7882607|NCT01773421|12381752|FG000|Treatment Phase|Withdrawal by Subject|0
7882608|NCT01773421|12381753|FG001|Treatment Phase|Withdrawal by Subject|0
7882609|NCT01773421|12381754|FG002|Treatment Phase|Withdrawal by Subject|1
7882610|NCT01773421|12381755|FG003|Treatment Phase|Withdrawal by Subject|1
7882611|NCT01773421|12381756|FG004|Treatment Phase|Withdrawal by Subject|0
7882612|NCT01773421|12381757|FG005|Treatment Phase|Withdrawal by Subject|0
7882613|NCT01773421|12381758|FG006|Treatment Phase|Withdrawal by Subject|0
7882614|NCT01773421|12381752|FG000|Extension Phase|Other|0
7870142|NCT01661062|12361839|FG000|Overall Study|Completed Treatment Off Study|3
7870143|NCT01661062|12361839|FG000|Overall Study|Withdrawal by Subject|2
7870144|NCT01661140|12361851|FG000|Open-Label Period|Adverse Event|44
7870145|NCT01661140|12361852|FG001|Open-Label Period|Adverse Event|0
7870146|NCT01661140|12361853|FG002|Open-Label Period|Adverse Event|0
7870147|NCT01661140|12361851|FG000|Open-Label Period|Protocol Violation|3
7870148|NCT01661140|12361852|FG001|Open-Label Period|Protocol Violation|0
7870149|NCT01661140|12361853|FG002|Open-Label Period|Protocol Violation|0
7870150|NCT01661140|12361851|FG000|Open-Label Period|Withdrawal by Subject|5
7870151|NCT01661140|12361852|FG001|Open-Label Period|Withdrawal by Subject|0
7870152|NCT01661140|12361853|FG002|Open-Label Period|Withdrawal by Subject|0
7870153|NCT01661140|12361851|FG000|Open-Label Period|Investigator Decision|3
7870154|NCT01661140|12361852|FG001|Open-Label Period|Investigator Decision|0
7870155|NCT01661140|12361853|FG002|Open-Label Period|Investigator Decision|0
7870156|NCT01661140|12361851|FG000|Open-Label Period|Death|1
7870157|NCT01661140|12361852|FG001|Open-Label Period|Death|0
7870158|NCT01661140|12361853|FG002|Open-Label Period|Death|0
7870159|NCT01661140|12361851|FG000|Open-Label Period|Administrative/Other|1
7870160|NCT01661140|12361852|FG001|Open-Label Period|Administrative/Other|0
7870161|NCT01661140|12361853|FG002|Open-Label Period|Administrative/Other|0
7870162|NCT01661140|12361851|FG000|Open-Label Period|Sponsor termination|16
7870163|NCT01661140|12361852|FG001|Open-Label Period|Sponsor termination|0
7870164|NCT01661140|12361853|FG002|Open-Label Period|Sponsor termination|0
7793048|NCT01042392|12247918|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
7793049|NCT01042392|12247919|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
7793050|NCT01042392|12247916|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
7793051|NCT01042392|12247917|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
7793052|NCT01042392|12247918|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
7793053|NCT01042392|12247919|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
7793054|NCT01042392|12247916|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
7793055|NCT01042392|12247917|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
7793056|NCT01042392|12247918|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
7793057|NCT01042392|12247919|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
7793058|NCT01042535|12247948|FG000|Overall Study|disease progression prior to treatment|3
7793059|NCT01042535|12247948|FG000|Overall Study|disease progression during treatment|3
7793060|NCT01042535|12247948|FG000|Overall Study|complications from other disease|2
7793061|NCT01042600|12247954|FG000|Overall Study|Ineligible|1
7793062|NCT01042600|12247955|FG001|Overall Study|Ineligible|0
7793063|NCT01042678|12247974|FG000|Overall Study|Physician Decision|1
7793064|NCT01042678|12247975|FG001|Overall Study|Physician Decision|0
7793065|NCT01042678|12247976|FG002|Overall Study|Physician Decision|0
7793066|NCT01042678|12247977|FG003|Overall Study|Physician Decision|0
7793067|NCT01042678|12247978|FG004|Overall Study|Physician Decision|0
7793068|NCT01042678|12247979|FG005|Overall Study|Physician Decision|0
7793069|NCT01042938|12247993|FG000|Overall Study|Withdrawal by Subject|1
7793070|NCT01042938|12247994|FG001|Overall Study|Withdrawal by Subject|1
7870165|NCT01661140|12361851|FG000|Open-Label Period|Did not meet EULAR criteria|1
7870166|NCT01661140|12361852|FG001|Open-Label Period|Did not meet EULAR criteria|0
7870167|NCT01661140|12361853|FG002|Open-Label Period|Did not meet EULAR criteria|0
7870168|NCT01661140|12361851|FG000|Open-Label Period|Lost to Follow-up|2
7870169|NCT01661140|12361852|FG001|Open-Label Period|Lost to Follow-up|0
7870170|NCT01661140|12361853|FG002|Open-Label Period|Lost to Follow-up|0
7870171|NCT01661140|12361851|FG000|Double-Blind Period|Refused Treatment|0
7870172|NCT01661140|12361852|FG001|Double-Blind Period|Refused Treatment|0
7870173|NCT01661140|12361853|FG002|Double-Blind Period|Refused Treatment|1
7870174|NCT01661140|12361851|FG000|Double-Blind Period|Adverse Event|0
7870175|NCT01661140|12361852|FG001|Double-Blind Period|Adverse Event|16
7870176|NCT01661140|12361853|FG002|Double-Blind Period|Adverse Event|18
7870177|NCT01661140|12361851|FG000|Double-Blind Period|Protocol Violation|0
7870178|NCT01661140|12361852|FG001|Double-Blind Period|Protocol Violation|2
7870179|NCT01661140|12361853|FG002|Double-Blind Period|Protocol Violation|3
7870180|NCT01661140|12361851|FG000|Double-Blind Period|Withdrawal by Subject|0
7870181|NCT01661140|12361852|FG001|Double-Blind Period|Withdrawal by Subject|1
7870182|NCT01661140|12361853|FG002|Double-Blind Period|Withdrawal by Subject|3
7870183|NCT01661140|12361851|FG000|Double-Blind Period|Investigator's Decision|0
7870184|NCT01661140|12361852|FG001|Double-Blind Period|Investigator's Decision|1
7870185|NCT01661140|12361853|FG002|Double-Blind Period|Investigator's Decision|2
7870186|NCT01661140|12361851|FG000|Double-Blind Period|Sponsor Termination|0
7870187|NCT01661140|12361852|FG001|Double-Blind Period|Sponsor Termination|14
7870188|NCT01661140|12361853|FG002|Double-Blind Period|Sponsor Termination|17
7870189|NCT01661140|12361851|FG000|Double-Blind Period|Administrative/Other|0
7870190|NCT01661140|12361852|FG001|Double-Blind Period|Administrative/Other|7
7870191|NCT01661140|12361853|FG002|Double-Blind Period|Administrative/Other|6
7870192|NCT01661179|12361861|FG000|Overall Study|Death|1
7870193|NCT01661179|12361861|FG000|Overall Study|Withdrawal by Subject|1
7870194|NCT01661179|12361861|FG000|Overall Study|Other Eligibility criteria|4
7870195|NCT01661205|12361865|FG000|Overall Study|Physician Decision|2
7870196|NCT01661595|12361887|FG000|Phase 1: Week 0-4|Adverse Event|1
7870197|NCT01661595|12361888|FG001|Phase 1: Week 0-4|Adverse Event|0
7870198|NCT01661595|12361889|FG002|Phase 1: Week 0-4|Adverse Event|0
7870199|NCT01661595|12361890|FG003|Phase 1: Week 0-4|Adverse Event|0
7870200|NCT01661595|12361887|FG000|Phase 2: Week 5-8.|Protocol Violation|0
7624330|NCT01408641|12035346|FG000|Overall Study|Physician Decision|1
7624331|NCT01408641|12035347|FG001|Overall Study|Physician Decision|0
7624332|NCT00653068|12035366|FG000|Overall Study|Death|9
7624333|NCT00653068|12035366|FG000|Overall Study|Lack of Efficacy|34
7624334|NCT00653068|12035366|FG000|Overall Study|Physician Decision|4
7624335|NCT00653068|12035366|FG000|Overall Study|Withdrawal by Subject|1
7624336|NCT00653068|12035366|FG000|Overall Study|Ineligible|2
7624337|NCT00193479|12035373|FG000|Induction Chemotherapy|Adverse Event|2
7624338|NCT00193479|12035373|FG000|Induction Chemotherapy|Disease Progression|1
7624339|NCT00193479|12035373|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2
7624340|NCT00193479|12035373|FG000|Maintenance Rituximab|Withdrawal by Subject|2
7624341|NCT00085735|12035392|FG000|Overall Study|Adverse Event|1
7624342|NCT00085735|12035393|FG001|Overall Study|Adverse Event|0
7793071|NCT01042938|12247993|FG000|Overall Study|Protocol Violation|1
7793072|NCT01042938|12247994|FG001|Overall Study|Protocol Violation|1
7793073|NCT01042938|12247993|FG000|Overall Study|Ineligible: RTOG study conflict|1
7793074|NCT01042938|12247994|FG001|Overall Study|Ineligible: RTOG study conflict|0
7793075|NCT01042977|12248004|FG000|Overall Study|Adverse Event|4
7793076|NCT01042977|12248005|FG001|Overall Study|Adverse Event|12
7793077|NCT01042977|12248004|FG000|Overall Study|Death|2
7793078|NCT01042977|12248005|FG001|Overall Study|Death|1
7793079|NCT01042977|12248004|FG000|Overall Study|Withdrawal by Subject|8
7793080|NCT01042977|12248005|FG001|Overall Study|Withdrawal by Subject|16
7793081|NCT01042977|12248004|FG000|Overall Study|Lost to Follow-up|0
7793082|NCT01042977|12248005|FG001|Overall Study|Lost to Follow-up|2
7793083|NCT01042977|12248004|FG000|Overall Study|Poor/non-compliance|3
7793084|NCT01042977|12248005|FG001|Overall Study|Poor/non-compliance|4
7793085|NCT01042977|12248004|FG000|Overall Study|Subject no longer meets study criteria|15
7793086|NCT01042977|12248005|FG001|Overall Study|Subject no longer meets study criteria|13
7793087|NCT01042977|12248004|FG000|Overall Study|Incorrect enrollment|6
7793088|NCT01042977|12248005|FG001|Overall Study|Incorrect enrollment|4
7793089|NCT01042977|12248004|FG000|Overall Study|Safety|0
7793090|NCT01042977|12248005|FG001|Overall Study|Safety|2
7793091|NCT01042977|12248004|FG000|Overall Study|Administrative reason by sponsor|0
7793092|NCT01042977|12248005|FG001|Overall Study|Administrative reason by sponsor|1
7793093|NCT01042977|12248004|FG000|Overall Study|Various|3
7793094|NCT01042977|12248005|FG001|Overall Study|Various|0
7793095|NCT01043185|12248054|FG000|Period 6 - Third Washout Period|Protocol Violation|0
7793096|NCT01043185|12248055|FG001|Period 6 - Third Washout Period|Protocol Violation|0
7793097|NCT01043185|12248056|FG002|Period 6 - Third Washout Period|Protocol Violation|0
7793098|NCT01043185|12248057|FG003|Period 6 - Third Washout Period|Protocol Violation|0
7793099|NCT01043185|12248058|FG004|Period 6 - Third Washout Period|Protocol Violation|0
7793100|NCT01043185|12248059|FG005|Period 6 - Third Washout Period|Protocol Violation|0
7793101|NCT01043185|12248060|FG006|Period 6 - Third Washout Period|Protocol Violation|0
7793102|NCT01043185|12248061|FG007|Period 6 - Third Washout Period|Protocol Violation|0
7870201|NCT01661595|12361888|FG001|Phase 2: Week 5-8.|Protocol Violation|0
7870202|NCT01661595|12361889|FG002|Phase 2: Week 5-8.|Protocol Violation|1
7870203|NCT01661595|12361890|FG003|Phase 2: Week 5-8.|Protocol Violation|0
7870204|NCT01661686|12361918|FG000|Overall Study|Lost to Follow-up|2
7624343|NCT00085735|12035394|FG002|Overall Study|Adverse Event|0
7624344|NCT00085735|12035395|FG003|Overall Study|Adverse Event|0
7624345|NCT00085735|12035396|FG004|Overall Study|Adverse Event|0
7624346|NCT00085735|12035397|FG005|Overall Study|Adverse Event|0
7624347|NCT00085735|12035392|FG000|Overall Study|Lack of Efficacy|2
7624348|NCT00085735|12035393|FG001|Overall Study|Lack of Efficacy|4
7624349|NCT00085735|12035394|FG002|Overall Study|Lack of Efficacy|6
7624350|NCT00085735|12035395|FG003|Overall Study|Lack of Efficacy|3
7624351|NCT00085735|12035396|FG004|Overall Study|Lack of Efficacy|4
7624352|NCT00085735|12035397|FG005|Overall Study|Lack of Efficacy|3
7624353|NCT00085735|12035392|FG000|Overall Study|Lost to Follow-up|0
7624354|NCT00085735|12035393|FG001|Overall Study|Lost to Follow-up|1
7624355|NCT00085735|12035394|FG002|Overall Study|Lost to Follow-up|0
7624356|NCT00085735|12035395|FG003|Overall Study|Lost to Follow-up|0
7624357|NCT00085735|12035396|FG004|Overall Study|Lost to Follow-up|1
7624358|NCT00085735|12035397|FG005|Overall Study|Lost to Follow-up|0
7870205|NCT01661686|12361919|FG001|Overall Study|Lost to Follow-up|1
7870206|NCT01661686|12361918|FG000|Overall Study|did not receive allocated intervention|0
7870207|NCT01661686|12361919|FG001|Overall Study|did not receive allocated intervention|1
7870208|NCT01661790|12361967|FG000|Overall Study|Lost to Follow-up|0
7870209|NCT01661790|12361968|FG001|Overall Study|Lost to Follow-up|2
7870210|NCT01661933|12361974|FG000|Low-dose Gluten Challenge|Physician Decision|2
7870211|NCT01661933|12361974|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2
7870212|NCT01661972|12361991|FG000|Overall Study|Adverse Event|1
7870213|NCT01661972|12361992|FG001|Overall Study|Adverse Event|2
7870214|NCT01661972|12361991|FG000|Overall Study|Death during Treatment period|1
7870215|NCT01661972|12361992|FG001|Overall Study|Death during Treatment period|1
7870216|NCT01661972|12361991|FG000|Overall Study|Withdrawal by Subject|0
7870217|NCT01661972|12361992|FG001|Overall Study|Withdrawal by Subject|1
7870218|NCT01662024|12362000|FG000|Overall Study|Pregnancy|2
7870219|NCT01662024|12362000|FG000|Overall Study|Withdrawal by Subject|3
7870220|NCT01662063|12362009|FG000|Overall Study|Adverse Event or Intercurrent Illness|1
7870221|NCT01662063|12362010|FG001|Overall Study|Adverse Event or Intercurrent Illness|12
7870222|NCT01662063|12362011|FG002|Overall Study|Adverse Event or Intercurrent Illness|0
7870223|NCT01662063|12362009|FG000|Overall Study|Lack of Efficacy|1
7870224|NCT01662063|12362010|FG001|Overall Study|Lack of Efficacy|6
7870225|NCT01662063|12362011|FG002|Overall Study|Lack of Efficacy|0
7870226|NCT01662063|12362009|FG000|Overall Study|Lost to Follow-up|0
7870227|NCT01662063|12362010|FG001|Overall Study|Lost to Follow-up|4
7870228|NCT01662063|12362011|FG002|Overall Study|Lost to Follow-up|0
7870229|NCT01662063|12362009|FG000|Overall Study|Protocol Violation|1
7870230|NCT01662063|12362010|FG001|Overall Study|Protocol Violation|0
7870231|NCT01662063|12362011|FG002|Overall Study|Protocol Violation|0
7870232|NCT01662063|12362009|FG000|Overall Study|Withdrawal by Subject|2
7870233|NCT01662063|12362010|FG001|Overall Study|Withdrawal by Subject|4
7870234|NCT01662063|12362011|FG002|Overall Study|Withdrawal by Subject|1
7870235|NCT01662063|12362009|FG000|Overall Study|Physician Decision|0
7870236|NCT01662063|12362010|FG001|Overall Study|Physician Decision|2
7870237|NCT01662063|12362011|FG002|Overall Study|Physician Decision|0
7870238|NCT01662063|12362009|FG000|Overall Study|Other|0
7870239|NCT01662063|12362010|FG001|Overall Study|Other|1
7870240|NCT01662063|12362011|FG002|Overall Study|Other|0
7870241|NCT01662310|12362041|FG000|Run-In or Stabilization Phase|Adverse Event|11
7870242|NCT01662310|12362042|FG001|Run-In or Stabilization Phase|Adverse Event|0
7870243|NCT01662310|12362043|FG002|Run-In or Stabilization Phase|Adverse Event|0
7870244|NCT01662310|12362044|FG003|Run-In or Stabilization Phase|Adverse Event|0
7870245|NCT01662310|12362045|FG004|Run-In or Stabilization Phase|Adverse Event|0
7870246|NCT01662310|12362041|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9
7870247|NCT01662310|12362042|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0
7870248|NCT01662310|12362043|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0
7870249|NCT01662310|12362044|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0
7870250|NCT01662310|12362045|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0
7870251|NCT01662310|12362041|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4
7870252|NCT01662310|12362042|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0
7870253|NCT01662310|12362043|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0
7870254|NCT01662310|12362044|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0
7870255|NCT01662310|12362045|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0
7870256|NCT01662310|12362041|FG000|Run-In or Stabilization Phase|Protocol Violation|15
7870257|NCT01662310|12362042|FG001|Run-In or Stabilization Phase|Protocol Violation|0
7870258|NCT01662310|12362043|FG002|Run-In or Stabilization Phase|Protocol Violation|0
7870259|NCT01662310|12362044|FG003|Run-In or Stabilization Phase|Protocol Violation|0
7870260|NCT01662310|12362045|FG004|Run-In or Stabilization Phase|Protocol Violation|0
7870261|NCT01662310|12362041|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25
7870262|NCT01662310|12362042|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0
7870263|NCT01662310|12362043|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0
7870264|NCT01662310|12362044|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0
7870265|NCT01662310|12362045|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0
7870266|NCT01662310|12362041|FG000|Run-In or Stabilization Phase|Other|1
7870267|NCT01662310|12362042|FG001|Run-In or Stabilization Phase|Other|0
7870268|NCT01662310|12362043|FG002|Run-In or Stabilization Phase|Other|0
7870269|NCT01662310|12362044|FG003|Run-In or Stabilization Phase|Other|0
7870270|NCT01662310|12362045|FG004|Run-In or Stabilization Phase|Other|0
7870271|NCT01662310|12362041|FG000|Double-Blind Phase|Adverse Event|0
7870272|NCT01662310|12362042|FG001|Double-Blind Phase|Adverse Event|0
7870273|NCT01662310|12362043|FG002|Double-Blind Phase|Adverse Event|1
7870274|NCT01662310|12362044|FG003|Double-Blind Phase|Adverse Event|0
7870275|NCT01662310|12362045|FG004|Double-Blind Phase|Adverse Event|0
7870276|NCT01662310|12362041|FG000|Double-Blind Phase|Lost to Follow-up|0
7870277|NCT01662310|12362042|FG001|Double-Blind Phase|Lost to Follow-up|3
7870278|NCT01662310|12362043|FG002|Double-Blind Phase|Lost to Follow-up|0
7870279|NCT01662310|12362044|FG003|Double-Blind Phase|Lost to Follow-up|0
7870280|NCT01662310|12362045|FG004|Double-Blind Phase|Lost to Follow-up|0
7870281|NCT01662310|12362041|FG000|Double-Blind Phase|Pregnancy|0
7870282|NCT01662310|12362042|FG001|Double-Blind Phase|Pregnancy|2
7870283|NCT01662310|12362043|FG002|Double-Blind Phase|Pregnancy|0
7870284|NCT01662310|12362044|FG003|Double-Blind Phase|Pregnancy|0
7870285|NCT01662310|12362045|FG004|Double-Blind Phase|Pregnancy|0
7870286|NCT01662310|12362041|FG000|Double-Blind Phase|Withdrawal by Subject|0
7870287|NCT01662310|12362042|FG001|Double-Blind Phase|Withdrawal by Subject|9
7870288|NCT01662310|12362043|FG002|Double-Blind Phase|Withdrawal by Subject|3
7870289|NCT01662310|12362044|FG003|Double-Blind Phase|Withdrawal by Subject|0
7870290|NCT01662310|12362045|FG004|Double-Blind Phase|Withdrawal by Subject|0
7870291|NCT01662310|12362041|FG000|Double-Blind Phase|Other|0
7870292|NCT01662310|12362042|FG001|Double-Blind Phase|Other|0
7870293|NCT01662310|12362043|FG002|Double-Blind Phase|Other|1
7870294|NCT01662310|12362044|FG003|Double-Blind Phase|Other|0
7870295|NCT01662310|12362045|FG004|Double-Blind Phase|Other|0
7870296|NCT01662310|12362041|FG000|Double-Blind Phase|Randomized but not treated|0
7870297|NCT01662310|12362042|FG001|Double-Blind Phase|Randomized but not treated|1
7870298|NCT01662310|12362043|FG002|Double-Blind Phase|Randomized but not treated|0
7870299|NCT01662310|12362044|FG003|Double-Blind Phase|Randomized but not treated|0
7870300|NCT01662310|12362045|FG004|Double-Blind Phase|Randomized but not treated|0
7870301|NCT01662310|12362041|FG000|Open-Label Extension Phase|Adverse Event|0
7870302|NCT01662310|12362042|FG001|Open-Label Extension Phase|Adverse Event|0
7870303|NCT01662310|12362043|FG002|Open-Label Extension Phase|Adverse Event|0
7870304|NCT01662310|12362044|FG003|Open-Label Extension Phase|Adverse Event|3
7870305|NCT01662310|12362045|FG004|Open-Label Extension Phase|Adverse Event|0
7870306|NCT01662310|12362041|FG000|Open-Label Extension Phase|Death|0
7870307|NCT01662310|12362042|FG001|Open-Label Extension Phase|Death|0
7870308|NCT01662310|12362043|FG002|Open-Label Extension Phase|Death|0
7870309|NCT01662310|12362044|FG003|Open-Label Extension Phase|Death|1
7870310|NCT01662310|12362045|FG004|Open-Label Extension Phase|Death|0
7870311|NCT01662310|12362041|FG000|Open-Label Extension Phase|Lack of Efficacy|0
7870312|NCT01662310|12362042|FG001|Open-Label Extension Phase|Lack of Efficacy|0
7870313|NCT01662310|12362043|FG002|Open-Label Extension Phase|Lack of Efficacy|0
7870314|NCT01662310|12362044|FG003|Open-Label Extension Phase|Lack of Efficacy|2
7870315|NCT01662310|12362045|FG004|Open-Label Extension Phase|Lack of Efficacy|2
7870316|NCT01662310|12362041|FG000|Open-Label Extension Phase|Lost to Follow-up|0
7870317|NCT01662310|12362042|FG001|Open-Label Extension Phase|Lost to Follow-up|0
7870318|NCT01662310|12362043|FG002|Open-Label Extension Phase|Lost to Follow-up|0
7870319|NCT01662310|12362044|FG003|Open-Label Extension Phase|Lost to Follow-up|2
7870320|NCT01662310|12362045|FG004|Open-Label Extension Phase|Lost to Follow-up|1
7870321|NCT01662310|12362041|FG000|Open-Label Extension Phase|Pregnancy|0
7870322|NCT01662310|12362042|FG001|Open-Label Extension Phase|Pregnancy|0
7870323|NCT01662310|12362043|FG002|Open-Label Extension Phase|Pregnancy|0
7870324|NCT01662310|12362044|FG003|Open-Label Extension Phase|Pregnancy|1
7870325|NCT01662310|12362045|FG004|Open-Label Extension Phase|Pregnancy|0
7870326|NCT01662310|12362041|FG000|Open-Label Extension Phase|Withdrawal by Subject|0
7870327|NCT01662310|12362042|FG001|Open-Label Extension Phase|Withdrawal by Subject|0
7870328|NCT01662310|12362043|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
7870329|NCT01662310|12362044|FG003|Open-Label Extension Phase|Withdrawal by Subject|2
7870330|NCT01662310|12362045|FG004|Open-Label Extension Phase|Withdrawal by Subject|7
7870331|NCT01662336|12362057|FG000|Overall Study|Adverse Event|1
7870332|NCT01662336|12362057|FG000|Overall Study|No longer on LPV/r|30
7870333|NCT01662336|12362057|FG000|Overall Study|Other|29
7870334|NCT01662336|12362057|FG000|Overall Study|Withdrawal by Subject|6
7870335|NCT01662362|12362066|FG000|Overall Study|Lost to Follow-up|38
7870336|NCT01662440|12362075|FG000|Overall Study|Adverse Event|1
7870337|NCT01662440|12362076|FG001|Overall Study|Adverse Event|0
7870338|NCT01662440|12362077|FG002|Overall Study|Adverse Event|0
7870339|NCT01662440|12362078|FG003|Overall Study|Adverse Event|1
7870340|NCT01662440|12362075|FG000|Overall Study|Death|0
7870341|NCT01662440|12362076|FG001|Overall Study|Death|1
7870342|NCT01662440|12362077|FG002|Overall Study|Death|0
7870343|NCT01662440|12362078|FG003|Overall Study|Death|0
7870344|NCT01662440|12362075|FG000|Overall Study|Lost to Follow-up|2
7870345|NCT01662440|12362076|FG001|Overall Study|Lost to Follow-up|2
7870346|NCT01662440|12362077|FG002|Overall Study|Lost to Follow-up|4
7870347|NCT01662440|12362078|FG003|Overall Study|Lost to Follow-up|1
7870348|NCT01662440|12362075|FG000|Overall Study|Subject moved to another country.|0
7870349|NCT01662440|12362076|FG001|Overall Study|Subject moved to another country.|1
7870350|NCT01662440|12362077|FG002|Overall Study|Subject moved to another country.|0
7870351|NCT01662440|12362078|FG003|Overall Study|Subject moved to another country.|0
7870352|NCT01662440|12362075|FG000|Overall Study|Protocol Violation|1
7870353|NCT01662440|12362076|FG001|Overall Study|Protocol Violation|0
7870354|NCT01662440|12362077|FG002|Overall Study|Protocol Violation|0
7870355|NCT01662440|12362078|FG003|Overall Study|Protocol Violation|0
7870356|NCT01662440|12362075|FG000|Overall Study|Withdrawal by Subject|5
7870357|NCT01662440|12362076|FG001|Overall Study|Withdrawal by Subject|2
7870358|NCT01662440|12362077|FG002|Overall Study|Withdrawal by Subject|2
7870359|NCT01662440|12362078|FG003|Overall Study|Withdrawal by Subject|2
7870360|NCT01662492|12362101|FG000|Overall Study|Other miscellaneous reasons.|1
7870361|NCT01662492|12362102|FG001|Overall Study|Other miscellaneous reasons.|0
7870362|NCT01662492|12362103|FG002|Overall Study|Other miscellaneous reasons.|1
7870363|NCT01662492|12362101|FG000|Overall Study|Withdrawal by Subject|0
7870364|NCT01662492|12362102|FG001|Overall Study|Withdrawal by Subject|0
7870365|NCT01662492|12362103|FG002|Overall Study|Withdrawal by Subject|1
7870366|NCT01662492|12362101|FG000|Overall Study|Protocol Violation|1
7870367|NCT01662492|12362102|FG001|Overall Study|Protocol Violation|0
7870368|NCT01662492|12362103|FG002|Overall Study|Protocol Violation|0
7870369|NCT01662492|12362101|FG000|Overall Study|Lost to Follow-up|0
7870370|NCT01662492|12362102|FG001|Overall Study|Lost to Follow-up|0
7870371|NCT01662492|12362103|FG002|Overall Study|Lost to Follow-up|2
7870372|NCT01662492|12362101|FG000|Overall Study|Lack of Efficacy|1
7870373|NCT01662492|12362102|FG001|Overall Study|Lack of Efficacy|1
7870374|NCT01662492|12362103|FG002|Overall Study|Lack of Efficacy|2
7870375|NCT01662505|12362114|FG000|Overall Study|Progressive disease|6
7870376|NCT01662505|12362115|FG001|Overall Study|Progressive disease|1
7870377|NCT01662505|12362116|FG002|Overall Study|Progressive disease|5
7870378|NCT01662505|12362114|FG000|Overall Study|Refused cont. medication|0
7870379|NCT01662505|12362115|FG001|Overall Study|Refused cont. medication|0
7870380|NCT01662505|12362116|FG002|Overall Study|Refused cont. medication|1
7870381|NCT01662505|12362114|FG000|Overall Study|Not specified above|1
7870382|NCT01662505|12362115|FG001|Overall Study|Not specified above|3
7870383|NCT01662505|12362116|FG002|Overall Study|Not specified above|2
7870384|NCT01662635|12362146|FG000|Overall Study|scarce samples for evaluation|30
7870385|NCT01662648|12362154|FG000|Overall Study|Death|1
7870386|NCT01662648|12362155|FG001|Overall Study|Death|3
7870387|NCT01662648|12362154|FG000|Overall Study|Adverse Event|40
7870388|NCT01662648|12362155|FG001|Overall Study|Adverse Event|37
7870389|NCT01662648|12362154|FG000|Overall Study|Lack of Efficacy|17
7870390|NCT01662648|12362155|FG001|Overall Study|Lack of Efficacy|16
7870391|NCT01662648|12362154|FG000|Overall Study|Participant ineligible to continue trial|1
7870392|NCT01662648|12362155|FG001|Overall Study|Participant ineligible to continue trial|1
7870393|NCT01662648|12362154|FG000|Overall Study|Lost to Follow-up|24
7870394|NCT01662648|12362155|FG001|Overall Study|Lost to Follow-up|36
7870395|NCT01662648|12362154|FG000|Overall Study|Withdrawal by Subject|36
7870396|NCT01662648|12362155|FG001|Overall Study|Withdrawal by Subject|53
7870397|NCT01662648|12362154|FG000|Overall Study|Participant non-compliant|16
7870398|NCT01662648|12362155|FG001|Overall Study|Participant non-compliant|20
7870399|NCT01662648|12362154|FG000|Overall Study|Other|8
7870400|NCT01662648|12362155|FG001|Overall Study|Other|11
7870401|NCT01662648|12362154|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3
7870402|NCT01662648|12362155|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0
7870403|NCT01662648|12362154|FG000|Overall Study|LOE and other reason unspecified|1
7870404|NCT01662648|12362155|FG001|Overall Study|LOE and other reason unspecified|0
7870405|NCT01662648|12362154|FG000|Overall Study|LOE and Participant non-compliant|0
7870406|NCT01662648|12362155|FG001|Overall Study|LOE and Participant non-compliant|1
7870407|NCT01662895|12362229|FG000|Overall Study|Lost to Follow-up|0
7870408|NCT01662895|12362230|FG001|Overall Study|Lost to Follow-up|1
7870409|NCT01662986|12362264|FG000|Overall Study|Adverse Event|5
7870410|NCT01662986|12362265|FG001|Overall Study|Adverse Event|4
7793103|NCT01043185|12248062|FG008|Period 6 - Third Washout Period|Protocol Violation|1
7793104|NCT01043185|12248063|FG009|Period 6 - Third Washout Period|Protocol Violation|0
7793105|NCT01043705|12248124|FG000|Overall Study|Death|28
7793106|NCT01043705|12248125|FG001|Overall Study|Death|60
7793107|NCT01043705|12248126|FG002|Overall Study|Death|26
7793108|NCT01043705|12248124|FG000|Overall Study|Lost to Follow-up|27
7870411|NCT01662986|12362264|FG000|Overall Study|Protocol Violation|2
7870412|NCT01662986|12362265|FG001|Overall Study|Protocol Violation|3
7870413|NCT01662986|12362264|FG000|Overall Study|Lost to Follow-up|5
7870414|NCT01662986|12362265|FG001|Overall Study|Lost to Follow-up|4
7870415|NCT01662986|12362264|FG000|Overall Study|Withdrawal by Subject|2
7870416|NCT01662986|12362265|FG001|Overall Study|Withdrawal by Subject|2
7870417|NCT01662986|12362264|FG000|Overall Study|Not Treated|1
7870418|NCT01662986|12362265|FG001|Overall Study|Not Treated|0
7870419|NCT01662986|12362264|FG000|Overall Study|Other than stated above|3
7870420|NCT01662986|12362265|FG001|Overall Study|Other than stated above|0
7870421|NCT01662999|12362277|FG000|Period 3|Withdrawal by Subject|0
7870422|NCT01662999|12362278|FG001|Period 3|Withdrawal by Subject|1
7870423|NCT01662999|12362279|FG002|Period 3|Withdrawal by Subject|0
7870424|NCT01662999|12362280|FG003|Period 3|Withdrawal by Subject|0
7870425|NCT01662999|12362281|FG004|Period 3|Withdrawal by Subject|0
7870426|NCT01662999|12362282|FG005|Period 3|Withdrawal by Subject|0
7870427|NCT01663103|12362318|FG000|Overall Study|Withdrawal by Subject|1
7870428|NCT01663103|12362319|FG001|Overall Study|Withdrawal by Subject|2
7870429|NCT01663103|12362318|FG000|Overall Study|Adverse Event|1
7870430|NCT01663103|12362319|FG001|Overall Study|Adverse Event|0
7870431|NCT01663103|12362318|FG000|Overall Study|dog bite|1
7870432|NCT01663103|12362319|FG001|Overall Study|dog bite|0
7870433|NCT01663233|12362331|FG000|Overall Study|Withdrawal by Subject|3
7870434|NCT01663233|12362332|FG001|Overall Study|Withdrawal by Subject|2
7870435|NCT01663233|12362331|FG000|Overall Study|Protocol Deviation|1
7870436|NCT01663233|12362332|FG001|Overall Study|Protocol Deviation|4
7870437|NCT01663233|12362331|FG000|Overall Study|Lost to Follow-up|0
7870438|NCT01663233|12362332|FG001|Overall Study|Lost to Follow-up|1
7870439|NCT01663402|12362354|FG000|Overall Study|Randomized but not treated|19
7870440|NCT01663402|12362355|FG001|Overall Study|Randomized but not treated|11
7870441|NCT01663402|12362354|FG000|Overall Study|Adverse Event|347
7870442|NCT01663402|12362355|FG001|Overall Study|Adverse Event|362
7870443|NCT01663402|12362354|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0
7870444|NCT01663402|12362355|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730
7870445|NCT01663402|12362354|FG000|Overall Study|Poor compliance to protocol|529
7870446|NCT01663402|12362355|FG001|Overall Study|Poor compliance to protocol|454
7870447|NCT01663402|12362354|FG000|Overall Study|Physician Decision|77
7870448|NCT01663402|12362355|FG001|Overall Study|Physician Decision|62
7870449|NCT01663402|12362354|FG000|Overall Study|Site terminated by sponsor|1
7870450|NCT01663402|12362355|FG001|Overall Study|Site terminated by sponsor|3
7870451|NCT01663402|12362354|FG000|Overall Study|Participant moved|139
7870452|NCT01663402|12362355|FG001|Overall Study|Participant moved|104
7870453|NCT01663402|12362354|FG000|Overall Study|Withdrawal by Subject|118
7870454|NCT01663402|12362355|FG001|Overall Study|Withdrawal by Subject|91
7870455|NCT01663402|12362354|FG000|Overall Study|Related to study drug administration|96
7870456|NCT01663402|12362355|FG001|Overall Study|Related to study drug administration|105
7870457|NCT01663402|12362354|FG000|Overall Study|Lost to Follow-up|17
7870458|NCT01663402|12362355|FG001|Overall Study|Lost to Follow-up|15
7870459|NCT01663402|12362354|FG000|Overall Study|Other than specified above|172
7870460|NCT01663402|12362355|FG001|Overall Study|Other than specified above|147
7870461|NCT01663506|12362361|FG000|Overall Study|Lack of Efficacy|3
7870462|NCT01663506|12362361|FG000|Overall Study|Consent Withdrawal by Subject|1
7870463|NCT01663506|12362361|FG000|Overall Study|Lost to Follow-up|1
7870464|NCT01663506|12362361|FG000|Overall Study|Adverse Event|1
7870465|NCT01663506|12362361|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2
7870466|NCT01663532|12362367|FG000|Overall Study|Lost to Follow-up|9
7870467|NCT01663532|12362368|FG001|Overall Study|Lost to Follow-up|10
7870468|NCT01663532|12362367|FG000|Overall Study|Adverse Event|7
7870469|NCT01663532|12362368|FG001|Overall Study|Adverse Event|13
7870470|NCT01663532|12362367|FG000|Overall Study|Met Withdrawal Criteria|7
7870471|NCT01663532|12362368|FG001|Overall Study|Met Withdrawal Criteria|6
7870472|NCT01663532|12362367|FG000|Overall Study|Physician Decision|1
7870473|NCT01663532|12362368|FG001|Overall Study|Physician Decision|1
7870474|NCT01663532|12362367|FG000|Overall Study|Withdrawal by Subject|35
7870475|NCT01663532|12362368|FG001|Overall Study|Withdrawal by Subject|17
7870476|NCT01663532|12362367|FG000|Overall Study|Lack of Efficacy|15
7870477|NCT01663532|12362368|FG001|Overall Study|Lack of Efficacy|60
7793109|NCT01043705|12248125|FG001|Overall Study|Lost to Follow-up|12
7793110|NCT01043705|12248126|FG002|Overall Study|Lost to Follow-up|0
7793111|NCT01043705|12248124|FG000|Overall Study|Multiple Reasons|4
7793112|NCT01043705|12248125|FG001|Overall Study|Multiple Reasons|7
7793113|NCT01043705|12248126|FG002|Overall Study|Multiple Reasons|0
7793114|NCT01043705|12248124|FG000|Overall Study|Protocol Violation|2
7870478|NCT01663623|12362376|FG000|Overall Study|Adverse Event|3
7870479|NCT01663623|12362377|FG001|Overall Study|Adverse Event|7
7870480|NCT01663623|12362376|FG000|Overall Study|Lack of Efficacy|5
7870481|NCT01663623|12362377|FG001|Overall Study|Lack of Efficacy|6
7870482|NCT01663623|12362376|FG000|Overall Study|Protocol Violation|0
7870483|NCT01663623|12362377|FG001|Overall Study|Protocol Violation|1
7870484|NCT01663623|12362376|FG000|Overall Study|Other-Study closed/terminated|1
7870485|NCT01663623|12362377|FG001|Overall Study|Other-Study closed/terminated|1
7870486|NCT01663623|12362376|FG000|Overall Study|Physician Decision|1
7870487|NCT01663623|12362377|FG001|Overall Study|Physician Decision|4
7870488|NCT01663623|12362376|FG000|Overall Study|Withdrawal by Subject|2
7870489|NCT01663623|12362377|FG001|Overall Study|Withdrawal by Subject|1
7870490|NCT01663636|12362385|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
7870491|NCT01663636|12362386|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
7870492|NCT01663714|12362392|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
7870493|NCT01663714|12362392|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11
7870494|NCT01663714|12362392|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
7870495|NCT01663714|12362392|FG000|Long-Term Follow-Up|Lost to Follow-up|1
7870496|NCT01663714|12362392|FG000|Long-Term Follow-Up|Death|4
7870497|NCT01663714|12362392|FG000|Long-Term Follow-Up|Non-compliance|1
7870498|NCT01663727|12362400|FG000|Overall Study|Death|161
7870499|NCT01663727|12362401|FG001|Overall Study|Death|155
7870500|NCT01663727|12362400|FG000|Overall Study|Lost to Follow-up|10
7870501|NCT01663727|12362401|FG001|Overall Study|Lost to Follow-up|8
7870502|NCT01663727|12362400|FG000|Overall Study|Withdrawal by Subject|18
7870503|NCT01663727|12362401|FG001|Overall Study|Withdrawal by Subject|25
7870504|NCT01663727|12362400|FG000|Overall Study|Study Terminated|51
7870505|NCT01663727|12362401|FG001|Overall Study|Study Terminated|50
7870506|NCT01663727|12362400|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1
7870507|NCT01663727|12362401|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0
7870508|NCT01663727|12362400|FG000|Overall Study|Withdrawal prior to dosing.|1
7870509|NCT01663727|12362401|FG001|Overall Study|Withdrawal prior to dosing.|0
7870510|NCT01663740|12362409|FG000|Overall Study|Lost to Follow-up|1
7870511|NCT01663740|12362410|FG001|Overall Study|Lost to Follow-up|4
7870512|NCT01663740|12362409|FG000|Overall Study|Other|9
7870513|NCT01663740|12362410|FG001|Overall Study|Other|2
7870514|NCT01663740|12362409|FG000|Overall Study|Inclusion/Exclusion not met|1
7870515|NCT01663740|12362410|FG001|Overall Study|Inclusion/Exclusion not met|0
7870516|NCT01663740|12362409|FG000|Overall Study|Death|0
7870517|NCT01663740|12362410|FG001|Overall Study|Death|1
7870518|NCT01663740|12362409|FG000|Overall Study|Withdrawal by Subject|2
7870519|NCT01663740|12362410|FG001|Overall Study|Withdrawal by Subject|1
7870520|NCT01663740|12362409|FG000|Overall Study|No end of study status|3
7870521|NCT01663740|12362410|FG001|Overall Study|No end of study status|0
7870522|NCT01663857|12362429|FG000|Overall Study|Withdrew Consent to Study Participation|0
7870523|NCT01663857|12362430|FG001|Overall Study|Withdrew Consent to Study Participation|1
7870524|NCT01663857|12362431|FG002|Overall Study|Withdrew Consent to Study Participation|7
7870525|NCT01663857|12362432|FG003|Overall Study|Withdrew Consent to Study Participation|3
7870526|NCT01663857|12362429|FG000|Overall Study|Lost to Follow-up|0
7870527|NCT01663857|12362430|FG001|Overall Study|Lost to Follow-up|0
7870528|NCT01663857|12362431|FG002|Overall Study|Lost to Follow-up|3
7793115|NCT01043705|12248125|FG001|Overall Study|Protocol Violation|1
7793116|NCT01043705|12248126|FG002|Overall Study|Protocol Violation|0
7793117|NCT01043705|12248124|FG000|Overall Study|Withdrawal by Subject|8
7793118|NCT01043705|12248125|FG001|Overall Study|Withdrawal by Subject|6
7793119|NCT01043705|12248126|FG002|Overall Study|Withdrawal by Subject|0
7793120|NCT01043705|12248124|FG000|Overall Study|Site Closure|8
7793121|NCT01043705|12248125|FG001|Overall Study|Site Closure|0
7793122|NCT01043705|12248126|FG002|Overall Study|Site Closure|0
7793123|NCT01043705|12248124|FG000|Overall Study|Subsequent Procedure|9
7793124|NCT01043705|12248125|FG001|Overall Study|Subsequent Procedure|24
7793125|NCT01043705|12248126|FG002|Overall Study|Subsequent Procedure|29
7793126|NCT01043705|12248124|FG000|Overall Study|Adverse Event|0
7793127|NCT01043705|12248125|FG001|Overall Study|Adverse Event|2
7793128|NCT01043705|12248126|FG002|Overall Study|Adverse Event|0
7793129|NCT01043705|12248124|FG000|Overall Study|Screen Fail|21
7793130|NCT01043705|12248125|FG001|Overall Study|Screen Fail|0
7793131|NCT01043705|12248126|FG002|Overall Study|Screen Fail|0
7793132|NCT01043705|12248124|FG000|Overall Study|Other|0
7793133|NCT01043705|12248125|FG001|Overall Study|Other|19
7793134|NCT01043705|12248126|FG002|Overall Study|Other|25
7793135|NCT01043874|12248134|FG000|Overall Study|Adverse Event|3
7793136|NCT01043874|12248134|FG000|Overall Study|Withdrawal by Subject|1
7793137|NCT01043874|12248134|FG000|Overall Study|Lack of Efficacy|1
7793138|NCT01043874|12248134|FG000|Overall Study|Administrative Problems|1
7793139|NCT01044290|12248193|FG000|Follow-up 1|Death|3
7793140|NCT01044290|12248194|FG001|Follow-up 1|Death|3
7870529|NCT01663857|12362432|FG003|Overall Study|Lost to Follow-up|1
7870530|NCT01663896|12362448|FG000|Overall Study|Various reasons|43
7870531|NCT01663987|12362465|FG000|Overall Study|Adverse Event|7
7870532|NCT01663987|12362466|FG001|Overall Study|Adverse Event|2
7870533|NCT01663987|12362465|FG000|Overall Study|Lost to Follow-up|1
7870534|NCT01663987|12362466|FG001|Overall Study|Lost to Follow-up|1
7870535|NCT01663987|12362465|FG000|Overall Study|Withdrawal by Subject|2
7793141|NCT01044290|12248195|FG002|Follow-up 1|Death|1
7793142|NCT01044290|12248193|FG000|Follow-up 1|Withdrawal by Subject|2
7793143|NCT01044290|12248194|FG001|Follow-up 1|Withdrawal by Subject|2
7793144|NCT01044290|12248195|FG002|Follow-up 1|Withdrawal by Subject|0
7793145|NCT01044290|12248193|FG000|Follow-Up 2|Death|0
7793146|NCT01044290|12248194|FG001|Follow-Up 2|Death|1
7793147|NCT01044290|12248195|FG002|Follow-Up 2|Death|1
7793148|NCT01044290|12248193|FG000|Follow-Up 2|Withdrawal by Subject|0
7793149|NCT01044290|12248194|FG001|Follow-Up 2|Withdrawal by Subject|1
7793150|NCT01044290|12248195|FG002|Follow-Up 2|Withdrawal by Subject|1
7793151|NCT01044303|12248213|FG000|Overall Study|Lost to Follow-up|2
7793152|NCT01044433|12248220|FG000|Overall Study|Lost to Follow-up|3
7793153|NCT01044433|12248220|FG000|Overall Study|Withdrawal by Subject|3
7793154|NCT01044459|12248227|FG000|Overall Study|Withdrawal by Subject|21
7793155|NCT01044459|12248228|FG001|Overall Study|Withdrawal by Subject|28
7793156|NCT01044459|12248227|FG000|Overall Study|Terminated by Sponsor|22
7793157|NCT01044459|12248228|FG001|Overall Study|Terminated by Sponsor|21
7793158|NCT01044459|12248227|FG000|Overall Study|Adverse Event|22
7793159|NCT01044459|12248228|FG001|Overall Study|Adverse Event|20
7793160|NCT01044459|12248227|FG000|Overall Study|Lack of Efficacy|23
7793161|NCT01044459|12248228|FG001|Overall Study|Lack of Efficacy|12
7793162|NCT01044459|12248227|FG000|Overall Study|Protocol Violation|11
7793163|NCT01044459|12248228|FG001|Overall Study|Protocol Violation|16
7793164|NCT01044459|12248227|FG000|Overall Study|Other Reason|7
7793165|NCT01044459|12248228|FG001|Overall Study|Other Reason|14
7793166|NCT01044459|12248227|FG000|Overall Study|COPD exacerbation|9
7793167|NCT01044459|12248228|FG001|Overall Study|COPD exacerbation|8
7793168|NCT01044459|12248227|FG000|Overall Study|Lost to Follow-up|18
7793169|NCT01044459|12248228|FG001|Overall Study|Lost to Follow-up|12
7793170|NCT01044498|12248236|FG000|Overall Study|Withdrew consent|1
7793171|NCT01044498|12248237|FG001|Overall Study|Withdrew consent|1
7793172|NCT01044498|12248236|FG000|Overall Study|Adverse Event|1
7793173|NCT01044498|12248237|FG001|Overall Study|Adverse Event|1
7793174|NCT01044498|12248236|FG000|Overall Study|Other|1
7793175|NCT01044498|12248237|FG001|Overall Study|Other|0
7793176|NCT01044732|12248321|FG000|Overall Study|Lost to Follow-up|2
7793177|NCT01044732|12248322|FG001|Overall Study|Lost to Follow-up|1
7793178|NCT01044732|12248321|FG000|Overall Study|Physician Decision|5
7793179|NCT01044732|12248322|FG001|Overall Study|Physician Decision|3
7793180|NCT01044732|12248321|FG000|Overall Study|Protocol Violation|11
7793181|NCT01044732|12248322|FG001|Overall Study|Protocol Violation|12
7793182|NCT01044732|12248321|FG000|Overall Study|Withdrawal by Subject|0
7793183|NCT01044732|12248322|FG001|Overall Study|Withdrawal by Subject|1
7793184|NCT01044732|12248321|FG000|Overall Study|Inadequate bowel preparation|11
7793185|NCT01044732|12248322|FG001|Overall Study|Inadequate bowel preparation|17
7870536|NCT01663987|12362466|FG001|Overall Study|Withdrawal by Subject|3
7870537|NCT01663987|12362465|FG000|Overall Study|Other reason not defined above|3
7793186|NCT01044732|12248321|FG000|Overall Study|Inability to reach cecum|5
7793187|NCT01044732|12248322|FG001|Overall Study|Inability to reach cecum|2
7793188|NCT01044732|12248321|FG000|Overall Study|Technical error or malfunction|15
7870538|NCT01663987|12362466|FG001|Overall Study|Other reason not defined above|0
7870539|NCT01664039|12362474|FG000|Overall Study|Adverse Event|3
7870540|NCT01664039|12362475|FG001|Overall Study|Adverse Event|4
7870541|NCT01664039|12362474|FG000|Overall Study|Lost to Follow-up|1
7870542|NCT01664039|12362475|FG001|Overall Study|Lost to Follow-up|1
7870543|NCT01664039|12362474|FG000|Overall Study|Withdrawal by Subject|1
7870544|NCT01664039|12362475|FG001|Overall Study|Withdrawal by Subject|3
7870545|NCT01664039|12362474|FG000|Overall Study|Noncompliance|1
7870546|NCT01664039|12362475|FG001|Overall Study|Noncompliance|1
7870547|NCT01664052|12362483|FG000|Phase 1|No device placement|6
7870548|NCT01664052|12362484|FG001|Phase 1|No device placement|0
7870549|NCT01664052|12362483|FG000|Phase 1|No HSG 1 hr post placement|1
7870550|NCT01664052|12362484|FG001|Phase 1|No HSG 1 hr post placement|0
7870551|NCT01664052|12362483|FG000|Phase 2|No device placement|0
7870552|NCT01664052|12362484|FG001|Phase 2|No device placement|4
7870553|NCT01664078|12362491|FG000|Overall Study|Death|9
7870554|NCT01664078|12362491|FG000|Overall Study|Withdrawal by Subject|4
7870555|NCT01664078|12362491|FG000|Overall Study|Lost to Follow-up|2
7870556|NCT01664078|12362491|FG000|Overall Study|missed 5 year visit|1
7870557|NCT01664078|12362491|FG000|Overall Study|Other|53
7870558|NCT01664091|12362541|FG000|Overall Study|Death|1
7870559|NCT01664091|12362541|FG000|Overall Study|Disease Progression|2
7870560|NCT01664091|12362541|FG000|Overall Study|Lost to Follow-up|2
7870561|NCT01664091|12362541|FG000|Overall Study|Withdrawal by Subject|1
7870562|NCT01664104|12362546|FG000|Overall Study|Adverse Event|6
7870563|NCT01664104|12362546|FG000|Overall Study|Lack of Efficacy|2
7870564|NCT01664104|12362546|FG000|Overall Study|Withdrawal by Subject|1
7870565|NCT01664104|12362546|FG000|Overall Study|Lost to Follow-up|4
7870566|NCT01664104|12362546|FG000|Overall Study|Other|1
7870567|NCT01664104|12362546|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2
7870568|NCT01664130|12362559|FG000|Overall Study|competing secondary disease|2
7870569|NCT01664247|12362568|FG000|Overall Study|Adverse Event|5
7870570|NCT01664247|12362569|FG001|Overall Study|Adverse Event|3
7870571|NCT01664247|12362568|FG000|Overall Study|Protocol Violation|3
7870572|NCT01664247|12362569|FG001|Overall Study|Protocol Violation|5
7870573|NCT01664247|12362568|FG000|Overall Study|Withdrawal Criteria|1
7870574|NCT01664247|12362569|FG001|Overall Study|Withdrawal Criteria|4
7870575|NCT01664247|12362568|FG000|Overall Study|Unclassified|5
7870576|NCT01664247|12362569|FG001|Overall Study|Unclassified|29
7870577|NCT01664494|12362575|FG000|Overall Study|Withdrawal by Subject|27
7870578|NCT01664494|12362575|FG000|Overall Study|Death|18
7870579|NCT01664494|12362575|FG000|Overall Study|Other|49
7870580|NCT01664494|12362575|FG000|Overall Study|Lost to Follow-up|99
7870581|NCT01664533|12362579|FG000|Overall Study|Death|42
7870582|NCT01664533|12362579|FG000|Overall Study|Lost to Follow-up|3
7870583|NCT01664533|12362579|FG000|Overall Study|Study termination|9
7870584|NCT01664533|12362579|FG000|Overall Study|Protocol Violation|3
7870585|NCT01664624|12362597|FG000|Overall Study|Adverse Event|0
7870586|NCT01664624|12362598|FG001|Overall Study|Adverse Event|1
7870587|NCT01664624|12362599|FG002|Overall Study|Adverse Event|0
7870588|NCT01664624|12362600|FG003|Overall Study|Adverse Event|0
7870589|NCT01664923|12362664|FG000|Period1:Double Blind Phase-29 Months|Death|8
7870590|NCT01664923|12362665|FG001|Period1:Double Blind Phase-29 Months|Death|6
7870591|NCT01664923|12362664|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0
7870592|NCT01664923|12362665|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1
7870593|NCT01664923|12362664|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2
7870594|NCT01664923|12362665|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0
7870595|NCT01664923|12362664|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12
7870596|NCT01664923|12362665|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8
7870597|NCT01664923|12362664|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65
7793189|NCT01044732|12248322|FG001|Overall Study|Technical error or malfunction|14
7793190|NCT01044745|12248330|FG000|Overall Study|Ineiligible|2
7793191|NCT01045096|12248412|FG000|Overall Study|Withdrawal by Subject|2
7793192|NCT01045096|12248413|FG001|Overall Study|Withdrawal by Subject|0
7793193|NCT01045096|12248414|FG002|Overall Study|Withdrawal by Subject|0
7793194|NCT01045096|12248412|FG000|Overall Study|Other|1
7793195|NCT01045096|12248413|FG001|Overall Study|Other|0
7793196|NCT01045096|12248414|FG002|Overall Study|Other|0
7793197|NCT01045161|12248438|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
7793198|NCT01045161|12248439|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
7793199|NCT01045161|12248440|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
7793200|NCT01045161|12248438|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
7793201|NCT01045161|12248439|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
7793202|NCT01045161|12248440|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
7793203|NCT01045161|12248438|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
7870598|NCT01664923|12362665|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132
7870599|NCT01664923|12362664|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14
7870600|NCT01664923|12362665|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9
7870601|NCT01664923|12362664|FG000|Period1:Double Blind Phase-29 Months|Other|3
7870602|NCT01664923|12362665|FG001|Period1:Double Blind Phase-29 Months|Other|4
7870603|NCT01664923|12362664|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1
7870604|NCT01664923|12362665|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0
7870605|NCT01664923|12362664|FG000|Period 2: Open-label Phase-36 Months|Death|3
7870606|NCT01664923|12362665|FG001|Period 2: Open-label Phase-36 Months|Death|1
7793204|NCT01045161|12248439|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
7793205|NCT01045161|12248440|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
7870607|NCT01664923|12362664|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1
7870608|NCT01664923|12362665|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1
7870609|NCT01664923|12362664|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28
7870610|NCT01664923|12362665|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9
7870611|NCT01664923|12362664|FG000|Period 2: Open-label Phase-36 Months|Other|3
7870612|NCT01664923|12362665|FG001|Period 2: Open-label Phase-36 Months|Other|1
7870613|NCT01664923|12362664|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4
7870614|NCT01664923|12362665|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7
7870615|NCT01664923|12362664|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2
7870616|NCT01664923|12362665|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4
7870617|NCT01664949|12362677|FG000|Overall Study|Adverse Event|11
7870618|NCT01664949|12362678|FG001|Overall Study|Adverse Event|12
7870619|NCT01664949|12362677|FG000|Overall Study|Lack of Efficacy|1
7870620|NCT01664949|12362678|FG001|Overall Study|Lack of Efficacy|1
7870621|NCT01664949|12362677|FG000|Overall Study|Lost to Follow-up|1
7870622|NCT01664949|12362678|FG001|Overall Study|Lost to Follow-up|2
7870623|NCT01664949|12362677|FG000|Overall Study|Personal Reasons|3
7870624|NCT01664949|12362678|FG001|Overall Study|Personal Reasons|4
7870625|NCT01664949|12362677|FG000|Overall Study|Protocol Violation|5
7870626|NCT01664949|12362678|FG001|Overall Study|Protocol Violation|5
7870627|NCT01664949|12362677|FG000|Overall Study|Other Miscellaneous Reasons|3
7870628|NCT01664949|12362678|FG001|Overall Study|Other Miscellaneous Reasons|1
7870629|NCT01665430|12362752|FG000|Overall Study|Adverse Event|1
7870630|NCT01665430|12362752|FG000|Overall Study|Withdrawal by Subject|6
7870631|NCT01665430|12362752|FG000|Overall Study|Other Unspecified|2
7870632|NCT01665599|12362765|FG000|Overall Study|Adverse Event|1
7870633|NCT01665599|12362765|FG000|Overall Study|Consent Withdrawn|1
7870634|NCT01665599|12362765|FG000|Overall Study|Investigator/Sponsor decision|1
7870635|NCT01665599|12362765|FG000|Overall Study|Death|1
7793206|NCT01045161|12248438|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
7793207|NCT01045161|12248439|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
7793208|NCT01045161|12248440|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
7793209|NCT01045161|12248438|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
7793210|NCT01045161|12248439|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
7793211|NCT01045161|12248440|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
7793212|NCT01045161|12248438|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
7793213|NCT01045161|12248439|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
7793214|NCT01045161|12248440|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
7793215|NCT01045161|12248438|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
7793216|NCT01045161|12248439|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
7793217|NCT01045161|12248440|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
7793218|NCT01045161|12248438|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
7793219|NCT01045161|12248439|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
7793220|NCT01045161|12248440|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
7793221|NCT01045161|12248438|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10
7793222|NCT01045161|12248439|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10
7793223|NCT01045161|12248440|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7
7793224|NCT01045161|12248438|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
7793225|NCT01045161|12248439|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
7793226|NCT01045161|12248440|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
7793227|NCT01045161|12248438|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
7793228|NCT01045161|12248439|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
7793229|NCT01045161|12248440|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
7793230|NCT01045161|12248438|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4
7793231|NCT01045161|12248439|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2
7793232|NCT01045161|12248440|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1
7793233|NCT01045161|12248438|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
7793234|NCT01045161|12248439|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
7793235|NCT01045161|12248440|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
7793236|NCT01045161|12248438|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
7793237|NCT01045161|12248439|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
7793238|NCT01045161|12248440|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
7793239|NCT01045421|12248480|FG000|Phase 1|Progressive Disease|0
7793240|NCT01045421|12248481|FG001|Phase 1|Progressive Disease|0
7793241|NCT01045421|12248482|FG002|Phase 1|Progressive Disease|0
7793242|NCT01045421|12248483|FG003|Phase 1|Progressive Disease|0
7793243|NCT01045421|12248484|FG004|Phase 1|Progressive Disease|1
7793244|NCT01045421|12248485|FG005|Phase 1|Progressive Disease|0
7870636|NCT01665599|12362765|FG000|Overall Study|Lost to Follow-up|2
7870637|NCT01665599|12362765|FG000|Overall Study|Participant Left for More Than 3 Months|1
7870638|NCT01665599|12362765|FG000|Overall Study|Could Not Continue Due to Time Constrain|1
7870639|NCT01665768|12362769|FG000|Overall Study|Adverse Event|3
7870640|NCT01665768|12362769|FG000|Overall Study|Lack of Efficacy|19
7870641|NCT01665768|12362769|FG000|Overall Study|Withdrawal by Subject|1
7870642|NCT01665807|12362776|FG000|Overall Study|Withdrawal by Subject|2
7870643|NCT01665807|12362777|FG001|Overall Study|Withdrawal by Subject|0
7870644|NCT01665807|12362778|FG002|Overall Study|Withdrawal by Subject|1
7870645|NCT01665911|12362795|FG000|Overall Study|Protocol Violation|4
7870646|NCT01665911|12362795|FG000|Overall Study|Withdrawal by Subject|1
7870647|NCT01665911|12362795|FG000|Overall Study|Adverse Event|1
7870648|NCT01666002|12362815|FG000|Overall Study|Lost to Follow-up|5
7870649|NCT01666002|12362816|FG001|Overall Study|Lost to Follow-up|0
7870650|NCT01666119|12362823|FG000|Overall Study|Adverse Event|6
7870651|NCT01666119|12362823|FG000|Overall Study|Withdrawal by Subject|16
7870652|NCT01666119|12362823|FG000|Overall Study|Lost to Follow-up|7
7870653|NCT01666119|12362823|FG000|Overall Study|non compliance with study medication, pa|18
7870654|NCT01666119|12362823|FG000|Overall Study|Subject experiencing withdrawal symptoms|5
7870655|NCT01666314|12362853|FG000|Overall Study|Adverse Event|3
7870656|NCT01666314|12362854|FG001|Overall Study|Adverse Event|13
7870657|NCT01666314|12362855|FG002|Overall Study|Adverse Event|7
7870658|NCT01666314|12362856|FG003|Overall Study|Adverse Event|7
7870659|NCT01666314|12362853|FG000|Overall Study|Progressive Disease|11
7870660|NCT01666314|12362854|FG001|Overall Study|Progressive Disease|9
7870661|NCT01666314|12362855|FG002|Overall Study|Progressive Disease|19
7870662|NCT01666314|12362856|FG003|Overall Study|Progressive Disease|20
7870663|NCT01666314|12362853|FG000|Overall Study|Symptomatic Deterioration|1
7870664|NCT01666314|12362854|FG001|Overall Study|Symptomatic Deterioration|0
7870665|NCT01666314|12362855|FG002|Overall Study|Symptomatic Deterioration|2
7870666|NCT01666314|12362856|FG003|Overall Study|Symptomatic Deterioration|0
7870667|NCT01666314|12362853|FG000|Overall Study|Unsatisfactory Therapeutic Response|7
7870668|NCT01666314|12362854|FG001|Overall Study|Unsatisfactory Therapeutic Response|2
7870669|NCT01666314|12362855|FG002|Overall Study|Unsatisfactory Therapeutic Response|1
7870670|NCT01666314|12362856|FG003|Overall Study|Unsatisfactory Therapeutic Response|1
7870671|NCT01666314|12362853|FG000|Overall Study|Withdrawal by Subject|1
7870672|NCT01666314|12362854|FG001|Overall Study|Withdrawal by Subject|1
7870673|NCT01666314|12362855|FG002|Overall Study|Withdrawal by Subject|2
7870674|NCT01666314|12362856|FG003|Overall Study|Withdrawal by Subject|3
7870675|NCT01666314|12362853|FG000|Overall Study|Reason not Specified|10
7870676|NCT01666314|12362854|FG001|Overall Study|Reason not Specified|7
7870677|NCT01666314|12362855|FG002|Overall Study|Reason not Specified|5
7870678|NCT01666314|12362856|FG003|Overall Study|Reason not Specified|5
7882615|NCT01773421|12381753|FG001|Extension Phase|Other|0
7882616|NCT01773421|12381754|FG002|Extension Phase|Other|0
7882617|NCT01773421|12381755|FG003|Extension Phase|Other|0
7882618|NCT01773421|12381756|FG004|Extension Phase|Other|1
7882619|NCT01773421|12381757|FG005|Extension Phase|Other|2
7882620|NCT01773421|12381758|FG006|Extension Phase|Other|0
7882621|NCT01773421|12381752|FG000|Extension Phase|Adverse Event|0
7882622|NCT01773421|12381753|FG001|Extension Phase|Adverse Event|0
7882623|NCT01773421|12381754|FG002|Extension Phase|Adverse Event|0
7882624|NCT01773421|12381755|FG003|Extension Phase|Adverse Event|0
7882625|NCT01773421|12381756|FG004|Extension Phase|Adverse Event|2
7882626|NCT01773421|12381757|FG005|Extension Phase|Adverse Event|0
7882627|NCT01773421|12381758|FG006|Extension Phase|Adverse Event|0
7882628|NCT01773473|12381776|FG000|Overall Study|Adverse Event|3
7882629|NCT01773473|12381777|FG001|Overall Study|Adverse Event|2
7882630|NCT01773473|12381776|FG000|Overall Study|Protocol Violation|0
7882631|NCT01773473|12381777|FG001|Overall Study|Protocol Violation|4
7882632|NCT01773473|12381776|FG000|Overall Study|Physician Decision|3
7882633|NCT01773473|12381777|FG001|Overall Study|Physician Decision|5
7882634|NCT01773473|12381776|FG000|Overall Study|Sponsor Decision|2
7882635|NCT01773473|12381777|FG001|Overall Study|Sponsor Decision|0
7882636|NCT01773473|12381776|FG000|Overall Study|Lack of Efficacy|0
7882637|NCT01773473|12381777|FG001|Overall Study|Lack of Efficacy|1
7882638|NCT01773473|12381776|FG000|Overall Study|Non-Compliance with study drug|1
7882639|NCT01773473|12381777|FG001|Overall Study|Non-Compliance with study drug|4
7882640|NCT01773473|12381776|FG000|Overall Study|Withdrawal by Subject|5
7882641|NCT01773473|12381777|FG001|Overall Study|Withdrawal by Subject|3
7882642|NCT01773473|12381776|FG000|Overall Study|Lost to Follow-up|2
7882643|NCT01773473|12381777|FG001|Overall Study|Lost to Follow-up|0
7882644|NCT01773889|12381783|FG000|Overall Study|lack of funding|2
7882645|NCT01773967|12381793|FG000|Overall Study|Lost to Follow-up|15
7882646|NCT01773967|12381794|FG001|Overall Study|Lost to Follow-up|13
7882647|NCT01773993|12381800|FG000|Overall Study|No Visit After Treatment|35
7882648|NCT01774084|12381816|FG000|Overall Study|Personal reasons|1
7882649|NCT01774084|12381817|FG001|Overall Study|Personal reasons|0
7882650|NCT01774097|12381825|FG000|Overall Study|Withdrawal by Subject|1
7882651|NCT01774097|12381826|FG001|Overall Study|Withdrawal by Subject|1
7882652|NCT01774097|12381825|FG000|Overall Study|Adverse Event|1
7882653|NCT01774097|12381826|FG001|Overall Study|Adverse Event|1
7882654|NCT01774110|12381834|FG000|Overall Study|Lost to Follow-up|7
7882655|NCT01774305|12381850|FG000|Overall Study|Physician Decision|1
7882656|NCT01774305|12381851|FG001|Overall Study|Physician Decision|0
7882657|NCT01774344|12381859|FG000|Overall Study|Withdrawal by Subject|3
7882658|NCT01774344|12381860|FG001|Overall Study|Withdrawal by Subject|10
7882659|NCT01774344|12381859|FG000|Overall Study|Protocol Violation|0
7882660|NCT01774344|12381860|FG001|Overall Study|Protocol Violation|1
7882661|NCT01774344|12381859|FG000|Overall Study|Lost to Follow-up|4
7882662|NCT01774344|12381860|FG001|Overall Study|Lost to Follow-up|10
7882663|NCT01774344|12381859|FG000|Overall Study|End of survival follow-up not available|2
7882664|NCT01774344|12381860|FG001|Overall Study|End of survival follow-up not available|2
7882665|NCT01774344|12381859|FG000|Overall Study|Data collection finished|4
7882666|NCT01774344|12381860|FG001|Overall Study|Data collection finished|14
7882667|NCT01774344|12381859|FG000|Overall Study|Other|0
7882668|NCT01774344|12381860|FG001|Overall Study|Other|1
7882669|NCT01774344|12381859|FG000|Overall Study|Did not enter Survival Follow up|49
7882670|NCT01774344|12381860|FG001|Overall Study|Did not enter Survival Follow up|83
7882671|NCT01774591|12381868|FG000|Overall Study|Physician Decision|1
7882672|NCT01774591|12381869|FG001|Overall Study|Physician Decision|1
7882673|NCT01774591|12381868|FG000|Overall Study|Withdrawal by Subject|0
7882674|NCT01774591|12381869|FG001|Overall Study|Withdrawal by Subject|1
7882675|NCT01774591|12381868|FG000|Overall Study|Adverse Event|0
7882676|NCT01774591|12381869|FG001|Overall Study|Adverse Event|2
7882677|NCT01774786|12381890|FG000|Overall Study|Death|300
7882678|NCT01774786|12381891|FG001|Overall Study|Death|319
7882679|NCT01774786|12381890|FG000|Overall Study|Lost to Follow-up|6
7882680|NCT01774786|12381891|FG001|Overall Study|Lost to Follow-up|7
7882681|NCT01774786|12381890|FG000|Overall Study|Withdrawal by Subject|18
7882682|NCT01774786|12381891|FG001|Overall Study|Withdrawal by Subject|14
7882683|NCT01774786|12381890|FG000|Overall Study|Physician Decision|2
7882684|NCT01774786|12381891|FG001|Overall Study|Physician Decision|0
7882685|NCT01774786|12381890|FG000|Overall Study|Non-compliance|0
7882686|NCT01774786|12381891|FG001|Overall Study|Non-compliance|1
7882687|NCT01774786|12381890|FG000|Overall Study|Reason Not Specified|2
7882688|NCT01774786|12381891|FG001|Overall Study|Reason Not Specified|5
7882689|NCT01774799|12381901|FG000|Overall Study|Lost to Follow-up|1
7882690|NCT01774799|12381902|FG001|Overall Study|Lost to Follow-up|1
7882691|NCT01774799|12381903|FG002|Overall Study|Lost to Follow-up|0
7882692|NCT01774799|12381904|FG003|Overall Study|Lost to Follow-up|0
7882693|NCT01774903|12381919|FG000|Overall Study|Adverse Event|7
7870679|NCT01666444|12362879|FG000|Overall Study|Did not initiate treatment|2
7870680|NCT01666444|12362880|FG001|Overall Study|Did not initiate treatment|1
7870681|NCT01666652|12362891|FG000|Overall Study|Serious Adverse Event|0
7870682|NCT01666652|12362892|FG001|Overall Study|Serious Adverse Event|0
7870683|NCT01666652|12362893|FG002|Overall Study|Serious Adverse Event|0
7870684|NCT01666652|12362894|FG003|Overall Study|Serious Adverse Event|1
7870685|NCT01666652|12362895|FG004|Overall Study|Serious Adverse Event|0
7870686|NCT01666652|12362891|FG000|Overall Study|Withdrawal by Subject|0
7870687|NCT01666652|12362892|FG001|Overall Study|Withdrawal by Subject|0
7870688|NCT01666652|12362893|FG002|Overall Study|Withdrawal by Subject|0
7870689|NCT01666652|12362894|FG003|Overall Study|Withdrawal by Subject|0
7870690|NCT01666652|12362895|FG004|Overall Study|Withdrawal by Subject|1
7870691|NCT01666652|12362891|FG000|Overall Study|Moved from study area|1
7870692|NCT01666652|12362892|FG001|Overall Study|Moved from study area|0
7870693|NCT01666652|12362893|FG002|Overall Study|Moved from study area|0
7870694|NCT01666652|12362894|FG003|Overall Study|Moved from study area|2
7870695|NCT01666652|12362895|FG004|Overall Study|Moved from study area|0
7870696|NCT01666652|12362891|FG000|Overall Study|Lost to Follow-up|1
7870697|NCT01666652|12362892|FG001|Overall Study|Lost to Follow-up|1
7870698|NCT01666652|12362893|FG002|Overall Study|Lost to Follow-up|1
7870699|NCT01666652|12362894|FG003|Overall Study|Lost to Follow-up|1
7870700|NCT01666652|12362895|FG004|Overall Study|Lost to Follow-up|0
7870701|NCT01666730|12362907|FG000|Overall Study|Adverse Event|16
7870702|NCT01666730|12362907|FG000|Overall Study|Death|2
7870703|NCT01666730|12362907|FG000|Overall Study|Physician Decision|5
7870704|NCT01666730|12362907|FG000|Overall Study|Withdrawal by Subject|9
7870705|NCT01666730|12362907|FG000|Overall Study|Disease progression/relapse|18
7870706|NCT01666782|12362913|FG000|Overall Study|Received 2 doses of vaccine|0
7870707|NCT01666782|12362914|FG001|Overall Study|Received 2 doses of vaccine|1
7870708|NCT01666782|12362913|FG000|Overall Study|Enrolled both years; year 1 data used|4
7870709|NCT01666782|12362914|FG001|Overall Study|Enrolled both years; year 1 data used|0
7870710|NCT01666951|12362931|FG000|Overall Study|Not dosed|1
7870711|NCT01666951|12362932|FG001|Overall Study|Not dosed|1
7870712|NCT01667107|12362947|FG000|Overall Study|Adverse Event|4
7870713|NCT01667107|12362948|FG001|Overall Study|Adverse Event|3
7870714|NCT01667107|12362947|FG000|Overall Study|Tolerability issues|0
7870715|NCT01667107|12362948|FG001|Overall Study|Tolerability issues|2
7870716|NCT01667107|12362947|FG000|Overall Study|Protocol Violation|0
7870717|NCT01667107|12362948|FG001|Overall Study|Protocol Violation|1
7870718|NCT01667107|12362947|FG000|Overall Study|Lack of Efficacy|0
7870719|NCT01667107|12362948|FG001|Overall Study|Lack of Efficacy|1
7870720|NCT01667224|12362956|FG000|Overall Study|Withdrawal by Subject|3
7870721|NCT01667224|12362957|FG001|Overall Study|Withdrawal by Subject|1
7870722|NCT01667224|12362956|FG000|Overall Study|Protocol Violation|1
7870723|NCT01667224|12362957|FG001|Overall Study|Protocol Violation|1
7870724|NCT01667419|12363051|FG000|Overall Study|Reason Not Specified|1
7870725|NCT01667419|12363052|FG001|Overall Study|Reason Not Specified|0
7870726|NCT01667419|12363053|FG002|Overall Study|Reason Not Specified|0
7870727|NCT01667419|12363054|FG003|Overall Study|Reason Not Specified|0
7870728|NCT01667419|12363051|FG000|Overall Study|Withdrawal by Subject|16
7870729|NCT01667419|12363052|FG001|Overall Study|Withdrawal by Subject|8
7870730|NCT01667419|12363053|FG002|Overall Study|Withdrawal by Subject|9
7870731|NCT01667419|12363054|FG003|Overall Study|Withdrawal by Subject|8
7870732|NCT01667419|12363051|FG000|Overall Study|Non-compliance|0
7870733|NCT01667419|12363052|FG001|Overall Study|Non-compliance|0
7870734|NCT01667419|12363053|FG002|Overall Study|Non-compliance|0
7870735|NCT01667419|12363054|FG003|Overall Study|Non-compliance|1
7870736|NCT01667419|12363051|FG000|Overall Study|Protocol Violation|1
7870737|NCT01667419|12363052|FG001|Overall Study|Protocol Violation|0
7870738|NCT01667419|12363053|FG002|Overall Study|Protocol Violation|0
7870739|NCT01667419|12363054|FG003|Overall Study|Protocol Violation|0
7870740|NCT01667419|12363051|FG000|Overall Study|Lost to Follow-up|7
7870741|NCT01667419|12363052|FG001|Overall Study|Lost to Follow-up|6
7870742|NCT01667419|12363053|FG002|Overall Study|Lost to Follow-up|2
7870743|NCT01667419|12363054|FG003|Overall Study|Lost to Follow-up|4
7870744|NCT01667419|12363051|FG000|Overall Study|Death|18
7870745|NCT01667419|12363052|FG001|Overall Study|Death|33
7870746|NCT01667419|12363053|FG002|Overall Study|Death|25
7870747|NCT01667419|12363054|FG003|Overall Study|Death|26
7870748|NCT01667432|12363065|FG000|Overall Study|Premature Study Termination|26
7870749|NCT01667432|12363065|FG000|Overall Study|Failure to Return|10
7870750|NCT01667432|12363065|FG000|Overall Study|Moved to Another Center|3
7870751|NCT01667432|12363065|FG000|Overall Study|Lost to Follow-up|3
7870752|NCT01667432|12363065|FG000|Overall Study|Refused Treatment/Withdrew Consent|1
7870753|NCT01667432|12363065|FG000|Overall Study|Insufficient Therapeutic Response|4
7870754|NCT01667432|12363065|FG000|Overall Study|Adverse Event|1
7870755|NCT01667432|12363065|FG000|Overall Study|Protocol Deviation|2
7870756|NCT01667432|12363065|FG000|Overall Study|Principal Investigator Decision|1
7870757|NCT01667432|12363065|FG000|Overall Study|Reason Not Specified|2
7870758|NCT01667432|12363065|FG000|Overall Study|Missing Information|4
7870759|NCT01667549|12363086|FG000|Overall Study|Withdrawal by Subject|3
7870760|NCT01667549|12363087|FG001|Overall Study|Withdrawal by Subject|5
7870761|NCT01667549|12363088|FG002|Overall Study|Withdrawal by Subject|7
7870762|NCT01667549|12363089|FG003|Overall Study|Withdrawal by Subject|6
7870763|NCT01667549|12363090|FG004|Overall Study|Withdrawal by Subject|1
7870764|NCT01667562|12363107|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30
7870765|NCT01667562|12363108|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0
7870766|NCT01667562|12363107|FG000|Erlotinib Phase|Lost to Follow-up|0
7870767|NCT01667562|12363108|FG001|Erlotinib Phase|Lost to Follow-up|1
7870768|NCT01667562|12363107|FG000|Erlotinib Phase|Adverse Event|0
7870769|NCT01667562|12363108|FG001|Erlotinib Phase|Adverse Event|1
7870770|NCT01667562|12363107|FG000|Erlotinib Phase|Switch to Commercial Drug|0
7870771|NCT01667562|12363108|FG001|Erlotinib Phase|Switch to Commercial Drug|1
7870772|NCT01667679|12363115|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
7870773|NCT01667679|12363116|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
7870774|NCT01667679|12363115|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
7870775|NCT01667679|12363116|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
7870776|NCT01667679|12363115|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
7870777|NCT01667679|12363116|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
7870778|NCT01667679|12363115|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
7870779|NCT01667679|12363116|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
7870780|NCT01667679|12363115|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
7870781|NCT01667679|12363116|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
7870782|NCT01667679|12363115|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
7870783|NCT01667679|12363116|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
7870784|NCT01667679|12363115|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
7870785|NCT01667679|12363116|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
7870786|NCT01667679|12363115|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
7870787|NCT01667679|12363116|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
7870788|NCT01667679|12363115|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
7870789|NCT01667679|12363116|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
7870790|NCT01667679|12363115|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
7870791|NCT01667679|12363116|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
7870792|NCT01667679|12363115|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
7870793|NCT01667679|12363116|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
7870794|NCT01667679|12363115|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
7870795|NCT01667679|12363116|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
7870796|NCT01667679|12363115|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
7870797|NCT01667679|12363116|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
7870798|NCT01667679|12363115|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
7870799|NCT01667679|12363116|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
7870800|NCT01667679|12363115|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
7870801|NCT01667679|12363116|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
7870802|NCT01667679|12363115|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
7870803|NCT01667679|12363116|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
7870804|NCT01667679|12363115|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
7870805|NCT01667679|12363116|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
7870806|NCT01667679|12363115|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
7870807|NCT01667679|12363116|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
7870808|NCT01667679|12363115|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
7870809|NCT01667679|12363116|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
7870810|NCT01667679|12363115|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
7870811|NCT01667679|12363116|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
7870812|NCT01667679|12363115|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
7870813|NCT01667679|12363116|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
7870814|NCT01667731|12363129|FG000|Overall Study|Enrolled but not treated|0
7870815|NCT01667731|12363130|FG001|Overall Study|Enrolled but not treated|0
7870816|NCT01667731|12363131|FG002|Overall Study|Enrolled but not treated|0
7870817|NCT01667731|12363132|FG003|Overall Study|Enrolled but not treated|0
7870818|NCT01667731|12363133|FG004|Overall Study|Enrolled but not treated|1
7870819|NCT01667731|12363129|FG000|Overall Study|Efficacy Failure|1
7870820|NCT01667731|12363130|FG001|Overall Study|Efficacy Failure|12
7870821|NCT01667731|12363131|FG002|Overall Study|Efficacy Failure|0
7793245|NCT01045421|12248486|FG006|Phase 1|Progressive Disease|0
7793246|NCT01045421|12248487|FG007|Phase 1|Progressive Disease|0
7793247|NCT01045421|12248488|FG008|Phase 1|Progressive Disease|0
7793248|NCT01045421|12248489|FG009|Phase 1|Progressive Disease|0
7793249|NCT01045421|12248490|FG010|Phase 1|Progressive Disease|0
7793250|NCT01045421|12248480|FG000|Phase 1|Withdrawal by Subject|0
7793251|NCT01045421|12248481|FG001|Phase 1|Withdrawal by Subject|0
7793252|NCT01045421|12248482|FG002|Phase 1|Withdrawal by Subject|0
7793253|NCT01045421|12248483|FG003|Phase 1|Withdrawal by Subject|1
7793254|NCT01045421|12248484|FG004|Phase 1|Withdrawal by Subject|0
7793255|NCT01045421|12248485|FG005|Phase 1|Withdrawal by Subject|0
7793256|NCT01045421|12248486|FG006|Phase 1|Withdrawal by Subject|0
7793257|NCT01045421|12248487|FG007|Phase 1|Withdrawal by Subject|0
7793258|NCT01045421|12248488|FG008|Phase 1|Withdrawal by Subject|0
7793259|NCT01045421|12248489|FG009|Phase 1|Withdrawal by Subject|0
7793260|NCT01045421|12248490|FG010|Phase 1|Withdrawal by Subject|0
7793261|NCT01045421|12248480|FG000|Phase 2|Progressive Disease|0
7793262|NCT01045421|12248481|FG001|Phase 2|Progressive Disease|0
7793263|NCT01045421|12248482|FG002|Phase 2|Progressive Disease|0
7793264|NCT01045421|12248483|FG003|Phase 2|Progressive Disease|0
7793265|NCT01045421|12248484|FG004|Phase 2|Progressive Disease|0
7793266|NCT01045421|12248485|FG005|Phase 2|Progressive Disease|0
7793267|NCT01045421|12248486|FG006|Phase 2|Progressive Disease|0
7793268|NCT01045421|12248487|FG007|Phase 2|Progressive Disease|1
7793269|NCT01045421|12248488|FG008|Phase 2|Progressive Disease|1
7793270|NCT01045421|12248489|FG009|Phase 2|Progressive Disease|1
7793271|NCT01045421|12248490|FG010|Phase 2|Progressive Disease|1
7793272|NCT01045421|12248480|FG000|Phase 2|Death|0
7793273|NCT01045421|12248481|FG001|Phase 2|Death|0
7793274|NCT01045421|12248482|FG002|Phase 2|Death|0
7793275|NCT01045421|12248483|FG003|Phase 2|Death|0
7793276|NCT01045421|12248484|FG004|Phase 2|Death|0
7793277|NCT01045421|12248485|FG005|Phase 2|Death|0
7793278|NCT01045421|12248486|FG006|Phase 2|Death|0
7793279|NCT01045421|12248487|FG007|Phase 2|Death|1
7793280|NCT01045421|12248488|FG008|Phase 2|Death|1
7793281|NCT01045421|12248489|FG009|Phase 2|Death|2
7793282|NCT01045421|12248490|FG010|Phase 2|Death|0
7793283|NCT01045421|12248480|FG000|Phase 2|Other|0
7793284|NCT01045421|12248481|FG001|Phase 2|Other|0
7793285|NCT01045421|12248482|FG002|Phase 2|Other|0
7793286|NCT01045421|12248483|FG003|Phase 2|Other|0
7793287|NCT01045421|12248484|FG004|Phase 2|Other|0
7793288|NCT01045421|12248485|FG005|Phase 2|Other|0
7793289|NCT01045421|12248486|FG006|Phase 2|Other|0
7793290|NCT01045421|12248487|FG007|Phase 2|Other|3
7793291|NCT01045421|12248488|FG008|Phase 2|Other|0
7793292|NCT01045421|12248489|FG009|Phase 2|Other|0
7793293|NCT01045421|12248490|FG010|Phase 2|Other|1
7793294|NCT01045447|12248513|FG000|Overall Study|Adverse Event|0
7793295|NCT01045447|12248514|FG001|Overall Study|Adverse Event|1
7793296|NCT01045447|12248513|FG000|Overall Study|Lack of Efficacy|3
7793297|NCT01045447|12248514|FG001|Overall Study|Lack of Efficacy|1
7793298|NCT01045447|12248513|FG000|Overall Study|Protocol Violation|6
7793299|NCT01045447|12248514|FG001|Overall Study|Protocol Violation|3
7793300|NCT01045447|12248513|FG000|Overall Study|Withdrawal Criteria|10
7793301|NCT01045447|12248514|FG001|Overall Study|Withdrawal Criteria|10
7793302|NCT01045447|12248513|FG000|Overall Study|Unclassified|17
7793303|NCT01045447|12248514|FG001|Overall Study|Unclassified|13
7793304|NCT01045460|12248522|FG000|Overall Study|Physician Decision|3
7793305|NCT01045460|12248523|FG001|Overall Study|Physician Decision|2
7793306|NCT01045460|12248522|FG000|Overall Study|Lost to Follow-up|0
7793307|NCT01045460|12248523|FG001|Overall Study|Lost to Follow-up|1
7870822|NCT01667731|12363132|FG003|Overall Study|Efficacy Failure|1
7870823|NCT01667731|12363133|FG004|Overall Study|Efficacy Failure|24
7870824|NCT01667731|12363129|FG000|Overall Study|Lost to Follow-up|2
7870825|NCT01667731|12363130|FG001|Overall Study|Lost to Follow-up|3
7870826|NCT01667731|12363131|FG002|Overall Study|Lost to Follow-up|1
7870827|NCT01667731|12363132|FG003|Overall Study|Lost to Follow-up|1
7870828|NCT01667731|12363133|FG004|Overall Study|Lost to Follow-up|2
7870829|NCT01667731|12363129|FG000|Overall Study|Subject Withdrew Consent|2
7870830|NCT01667731|12363130|FG001|Overall Study|Subject Withdrew Consent|0
7870831|NCT01667731|12363131|FG002|Overall Study|Subject Withdrew Consent|1
7870832|NCT01667731|12363132|FG003|Overall Study|Subject Withdrew Consent|0
7870833|NCT01667731|12363133|FG004|Overall Study|Subject Withdrew Consent|1
7870834|NCT01667731|12363129|FG000|Overall Study|Death|0
7870835|NCT01667731|12363130|FG001|Overall Study|Death|1
7870836|NCT01667731|12363131|FG002|Overall Study|Death|0
7870837|NCT01667731|12363132|FG003|Overall Study|Death|0
7870838|NCT01667731|12363133|FG004|Overall Study|Death|0
7870839|NCT01667900|12363173|FG000|Part B|Death|0
7870840|NCT01667900|12363174|FG001|Part B|Death|0
7870841|NCT01667900|12363175|FG002|Part B|Death|0
7870842|NCT01667900|12363176|FG003|Part B|Death|0
7870843|NCT01667900|12363177|FG004|Part B|Death|0
7870844|NCT01667900|12363178|FG005|Part B|Death|0
7870845|NCT01667900|12363179|FG006|Part B|Death|0
7870846|NCT01667900|12363180|FG007|Part B|Death|0
7870847|NCT01667900|12363181|FG008|Part B|Death|0
7870848|NCT01667900|12363182|FG009|Part B|Death|0
7870849|NCT01667900|12363183|FG010|Part B|Death|0
7870850|NCT01667900|12363184|FG011|Part B|Death|0
7870851|NCT01667900|12363185|FG012|Part B|Death|0
7870852|NCT01667900|12363186|FG013|Part B|Death|0
7870853|NCT01667900|12363187|FG014|Part B|Death|0
7870854|NCT01667900|12363188|FG015|Part B|Death|0
7870855|NCT01667900|12363189|FG016|Part B|Death|1
7870856|NCT01667900|12363190|FG017|Part B|Death|0
7870857|NCT01667900|12363191|FG018|Part B|Death|0
7870858|NCT01667900|12363192|FG019|Part B|Death|0
7870859|NCT01667926|12363214|FG000|Overall Study|Withdrawal by Subject|1
7870860|NCT01667926|12363215|FG001|Overall Study|Withdrawal by Subject|2
7870861|NCT01667926|12363216|FG002|Overall Study|Withdrawal by Subject|2
7870862|NCT01667926|12363214|FG000|Overall Study|Physician Decision|0
7870863|NCT01667926|12363215|FG001|Overall Study|Physician Decision|0
7870864|NCT01667926|12363216|FG002|Overall Study|Physician Decision|1
7793308|NCT01045460|12248522|FG000|Overall Study|Lack of Efficacy|3
7793309|NCT01045460|12248523|FG001|Overall Study|Lack of Efficacy|0
7870865|NCT01667926|12363214|FG000|Overall Study|Time committment|0
7870866|NCT01667926|12363215|FG001|Overall Study|Time committment|0
7870867|NCT01667926|12363216|FG002|Overall Study|Time committment|2
7870868|NCT01667926|12363214|FG000|Overall Study|Inclusion/Exclusion Criteria|0
7870869|NCT01667926|12363215|FG001|Overall Study|Inclusion/Exclusion Criteria|0
7870870|NCT01667926|12363216|FG002|Overall Study|Inclusion/Exclusion Criteria|5
7870871|NCT01667926|12363214|FG000|Overall Study|Lost to Follow-up|1
7870872|NCT01667926|12363215|FG001|Overall Study|Lost to Follow-up|2
7870873|NCT01667926|12363216|FG002|Overall Study|Lost to Follow-up|1
7870874|NCT01667926|12363214|FG000|Overall Study|Side effects|3
7870875|NCT01667926|12363215|FG001|Overall Study|Side effects|0
7870876|NCT01667926|12363216|FG002|Overall Study|Side effects|0
7870877|NCT01668004|12363231|FG000|Overall Study|Adverse Event|7
7870878|NCT01668004|12363231|FG000|Overall Study|Withdrawal by Subject|2
7870879|NCT01668004|12363231|FG000|Overall Study|Lost to Follow-up|5
7870880|NCT01668004|12363231|FG000|Overall Study|Lack of Efficacy|9
7870881|NCT01668004|12363231|FG000|Overall Study|Non-compliance with treatment|2
7870882|NCT01668173|12363279|FG000|Overall Study|Adverse Event|3
7870883|NCT01668173|12363279|FG000|Overall Study|Trial suspension|4
7870884|NCT01668355|12363285|FG000|Overall Study|Death|3
7870885|NCT01668355|12363286|FG001|Overall Study|Death|1
7870886|NCT01668355|12363285|FG000|Overall Study|Withdrawal by Subject|6
7870887|NCT01668355|12363286|FG001|Overall Study|Withdrawal by Subject|1
7870888|NCT01668537|12363295|FG000|Overall Study|Request to Discontinue Prematurely|1
7870889|NCT01668537|12363296|FG001|Overall Study|Request to Discontinue Prematurely|1
7870890|NCT01668537|12363295|FG000|Overall Study|Subject unwilling/unable to comply|5
7870891|NCT01668537|12363296|FG001|Overall Study|Subject unwilling/unable to comply|0
7870892|NCT01668537|12363295|FG000|Overall Study|Reason Precludes Participation|1
7870893|NCT01668537|12363296|FG001|Overall Study|Reason Precludes Participation|0
7870894|NCT01668537|12363295|FG000|Overall Study|Lost to Follow-up|13
7870895|NCT01668537|12363296|FG001|Overall Study|Lost to Follow-up|6
7870896|NCT01668537|12363295|FG000|Overall Study|Other|2
7870897|NCT01668537|12363296|FG001|Overall Study|Other|3
7870898|NCT01668589|12363306|FG000|Overall Study|Lost to Follow-up|29
7870899|NCT01668589|12363307|FG001|Overall Study|Lost to Follow-up|37
7870900|NCT01668589|12363308|FG002|Overall Study|Lost to Follow-up|15
7870901|NCT01668589|12363309|FG003|Overall Study|Lost to Follow-up|5
7870902|NCT01668589|12363306|FG000|Overall Study|Full Consent/Agreement Withdrawn|54
7870903|NCT01668589|12363307|FG001|Overall Study|Full Consent/Agreement Withdrawn|8
7870904|NCT01668589|12363308|FG002|Overall Study|Full Consent/Agreement Withdrawn|11
7870905|NCT01668589|12363309|FG003|Overall Study|Full Consent/Agreement Withdrawn|4
7870906|NCT01668589|12363306|FG000|Overall Study|Death|12
7870907|NCT01668589|12363307|FG001|Overall Study|Death|3
7870908|NCT01668589|12363308|FG002|Overall Study|Death|2
7870909|NCT01668589|12363309|FG003|Overall Study|Death|11
7870910|NCT01668589|12363306|FG000|Overall Study|Other|44
7870911|NCT01668589|12363307|FG001|Overall Study|Other|10
7870912|NCT01668589|12363308|FG002|Overall Study|Other|7
7870913|NCT01668589|12363309|FG003|Overall Study|Other|15
7870914|NCT01668654|12363347|FG000|Overall Study|Study Closed/Terminated|3
7870915|NCT01668654|12363347|FG000|Overall Study|Withdrawal by Subject|1
7870916|NCT01668667|12363355|FG000|Overall Study|Adverse Event|3
7870917|NCT01668667|12363356|FG001|Overall Study|Adverse Event|6
7870918|NCT01668667|12363357|FG002|Overall Study|Adverse Event|4
7870919|NCT01668667|12363358|FG003|Overall Study|Adverse Event|4
7870920|NCT01668667|12363355|FG000|Overall Study|Lack of Efficacy|3
7870921|NCT01668667|12363356|FG001|Overall Study|Lack of Efficacy|2
7870922|NCT01668667|12363357|FG002|Overall Study|Lack of Efficacy|2
7870923|NCT01668667|12363358|FG003|Overall Study|Lack of Efficacy|3
7870924|NCT01668667|12363355|FG000|Overall Study|Protocol Violation|6
7870925|NCT01668667|12363356|FG001|Overall Study|Protocol Violation|10
7870926|NCT01668667|12363357|FG002|Overall Study|Protocol Violation|12
7870927|NCT01668667|12363358|FG003|Overall Study|Protocol Violation|5
7870928|NCT01668667|12363355|FG000|Overall Study|Lost to Follow-up|9
7870929|NCT01668667|12363356|FG001|Overall Study|Lost to Follow-up|4
7870930|NCT01668667|12363357|FG002|Overall Study|Lost to Follow-up|7
7870931|NCT01668667|12363358|FG003|Overall Study|Lost to Follow-up|6
7870932|NCT01668667|12363355|FG000|Overall Study|Physician Decision|3
7870933|NCT01668667|12363356|FG001|Overall Study|Physician Decision|0
7870934|NCT01668667|12363357|FG002|Overall Study|Physician Decision|1
7870935|NCT01668667|12363358|FG003|Overall Study|Physician Decision|0
7870936|NCT01668667|12363355|FG000|Overall Study|Withdrawal by Subject|7
7870937|NCT01668667|12363356|FG001|Overall Study|Withdrawal by Subject|4
7793310|NCT01045707|12248542|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
7793311|NCT01045707|12248543|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
7793312|NCT01045707|12248542|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
7793313|NCT01045707|12248543|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
7793314|NCT01045707|12248542|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
7793315|NCT01045707|12248543|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
7793316|NCT01045707|12248542|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
7793317|NCT01045707|12248543|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
7793318|NCT01045707|12248542|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
7793319|NCT01045707|12248543|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
7870938|NCT01668667|12363357|FG002|Overall Study|Withdrawal by Subject|5
7870939|NCT01668667|12363358|FG003|Overall Study|Withdrawal by Subject|5
7870940|NCT01668797|12363370|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3
7870941|NCT01668797|12363371|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0
7793320|NCT01045707|12248542|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
7793321|NCT01045707|12248543|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
7793322|NCT01045707|12248542|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
7793323|NCT01045707|12248543|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
7793324|NCT01045707|12248542|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
7793325|NCT01045707|12248543|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
7793326|NCT01045707|12248542|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
7793327|NCT01045707|12248543|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
7793328|NCT01045798|12248551|FG000|Overall Study|Changed to Open-Label Caspofungin|1
7793329|NCT01045798|12248552|FG001|Overall Study|Changed to Open-Label Caspofungin|0
7793330|NCT01045798|12248551|FG000|Overall Study|Invasive Fungal Infection at Baseline|0
7793331|NCT01045798|12248552|FG001|Overall Study|Invasive Fungal Infection at Baseline|1
7793332|NCT01045798|12248551|FG000|Overall Study|Changed to Other Antifungal Therapy|1
7793333|NCT01045798|12248552|FG001|Overall Study|Changed to Other Antifungal Therapy|2
7793334|NCT01045798|12248551|FG000|Overall Study|Received Systemic Antifungal Prestudy|0
7793335|NCT01045798|12248552|FG001|Overall Study|Received Systemic Antifungal Prestudy|1
7793336|NCT01045967|12248560|FG000|Second Intervention|Protocol Violation|0
7793337|NCT01045967|12248561|FG001|Second Intervention|Protocol Violation|1
7793338|NCT01045993|12248571|FG000|Overall Study|Treated-later found eligibility not met|0
7793339|NCT01045993|12248572|FG001|Overall Study|Treated-later found eligibility not met|1
7793340|NCT01045993|12248573|FG002|Overall Study|Treated-later found eligibility not met|0
7793341|NCT01045993|12248574|FG003|Overall Study|Treated-later found eligibility not met|0
7793342|NCT01046084|12248586|FG000|Third Washout of 7 Days|Withdrawal by Subject|2
7793343|NCT01046084|12248587|FG001|Third Washout of 7 Days|Withdrawal by Subject|0
7793344|NCT01046110|12248595|FG000|Overall Study|Adverse Event|9
7793345|NCT01046110|12248596|FG001|Overall Study|Adverse Event|2
7793346|NCT01046110|12248595|FG000|Overall Study|Lack of Efficacy|0
7793347|NCT01046110|12248596|FG001|Overall Study|Lack of Efficacy|1
7793348|NCT01046110|12248595|FG000|Overall Study|Protocol Violation|7
7793349|NCT01046110|12248596|FG001|Overall Study|Protocol Violation|12
7793350|NCT01046110|12248595|FG000|Overall Study|Withdrawal Criteria|3
7793351|NCT01046110|12248596|FG001|Overall Study|Withdrawal Criteria|5
7793352|NCT01046110|12248595|FG000|Overall Study|Unclassified|36
7793353|NCT01046110|12248596|FG001|Overall Study|Unclassified|35
7793354|NCT01046136|12248604|FG000|Overall Study|Withdrawal by Subject|0
7793355|NCT01046136|12248605|FG001|Overall Study|Withdrawal by Subject|4
7793356|NCT01046136|12248604|FG000|Overall Study|Physician Decision|1
7870942|NCT01668797|12363372|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0
7870943|NCT01668797|12363373|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0
7870944|NCT01668797|12363370|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
7870945|NCT01668797|12363371|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
7870946|NCT01668797|12363372|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
7870947|NCT01668797|12363373|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
7870948|NCT01668797|12363370|FG000|Phase A (Conversion Phase)|Physician Decision|2
7870949|NCT01668797|12363371|FG001|Phase A (Conversion Phase)|Physician Decision|0
7870950|NCT01668797|12363372|FG002|Phase A (Conversion Phase)|Physician Decision|0
7870951|NCT01668797|12363373|FG003|Phase A (Conversion Phase)|Physician Decision|0
7870952|NCT01668797|12363370|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16
7870953|NCT01668797|12363371|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0
7870954|NCT01668797|12363372|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0
7870955|NCT01668797|12363373|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0
7870956|NCT01668797|12363370|FG000|Phase A (Conversion Phase)|Protocol Violation|2
7870957|NCT01668797|12363371|FG001|Phase A (Conversion Phase)|Protocol Violation|0
7870958|NCT01668797|12363372|FG002|Phase A (Conversion Phase)|Protocol Violation|0
7870959|NCT01668797|12363373|FG003|Phase A (Conversion Phase)|Protocol Violation|0
7870960|NCT01668797|12363370|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7
7870961|NCT01668797|12363371|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0
7870962|NCT01668797|12363372|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0
7870963|NCT01668797|12363373|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0
7870964|NCT01668797|12363370|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
7870965|NCT01668797|12363371|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
7870966|NCT01668797|12363372|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
7870967|NCT01668797|12363373|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
7870968|NCT01668797|12363370|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
7870969|NCT01668797|12363371|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
7870970|NCT01668797|12363372|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
7870971|NCT01668797|12363373|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
7870972|NCT01668797|12363370|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0
7870973|NCT01668797|12363371|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16
7870974|NCT01668797|12363372|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0
7870975|NCT01668797|12363373|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0
7870976|NCT01668797|12363370|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
7793357|NCT01046136|12248605|FG001|Overall Study|Physician Decision|1
7870977|NCT01668797|12363371|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
7870978|NCT01668797|12363372|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
7870979|NCT01668797|12363373|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
7870980|NCT01668797|12363370|FG000|Phase B (Stabilization Phase)|Physician Decision|0
7870981|NCT01668797|12363371|FG001|Phase B (Stabilization Phase)|Physician Decision|11
7870982|NCT01668797|12363372|FG002|Phase B (Stabilization Phase)|Physician Decision|0
7870983|NCT01668797|12363373|FG003|Phase B (Stabilization Phase)|Physician Decision|0
7870984|NCT01668797|12363370|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0
7870985|NCT01668797|12363371|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60
7870986|NCT01668797|12363372|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0
7870987|NCT01668797|12363373|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0
7870988|NCT01668797|12363370|FG000|Phase B (Stabilization Phase)|Protocol Violation|0
7870989|NCT01668797|12363371|FG001|Phase B (Stabilization Phase)|Protocol Violation|3
7870990|NCT01668797|12363372|FG002|Phase B (Stabilization Phase)|Protocol Violation|0
7870991|NCT01668797|12363373|FG003|Phase B (Stabilization Phase)|Protocol Violation|0
7870992|NCT01668797|12363370|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0
7870993|NCT01668797|12363371|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21
7870994|NCT01668797|12363372|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0
7870995|NCT01668797|12363373|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0
7870996|NCT01668797|12363370|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
7870997|NCT01668797|12363371|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
7870998|NCT01668797|12363372|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
7870999|NCT01668797|12363373|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
7871000|NCT01668797|12363370|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
7871001|NCT01668797|12363371|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
7871002|NCT01668797|12363372|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
7871003|NCT01668797|12363373|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
7871004|NCT01668797|12363370|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
7871005|NCT01668797|12363371|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
7871006|NCT01668797|12363372|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
7871007|NCT01668797|12363373|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
7871008|NCT01668797|12363370|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
7871009|NCT01668797|12363371|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
7871010|NCT01668797|12363372|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
7871011|NCT01668797|12363373|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
7871012|NCT01668797|12363370|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
7871013|NCT01668797|12363371|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
7871014|NCT01668797|12363372|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
7871015|NCT01668797|12363373|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
7793358|NCT01046136|12248604|FG000|Overall Study|Lost to Follow-up|3
7793359|NCT01046136|12248605|FG001|Overall Study|Lost to Follow-up|3
7793360|NCT01046253|12248615|FG000|Second Intervention|Adverse Event|0
7793361|NCT01046253|12248616|FG001|Second Intervention|Adverse Event|1
7793362|NCT01046253|12248615|FG000|Second Intervention|Protocol Violation|0
7793363|NCT01046253|12248616|FG001|Second Intervention|Protocol Violation|1
7793364|NCT01046643|12248624|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0
7793365|NCT01046643|12248625|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1
7793366|NCT01046643|12248626|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0
7793367|NCT01046643|12248627|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0
7793368|NCT01046682|12248648|FG000|Overall Study|Adverse Event|2
7793369|NCT01046682|12248649|FG001|Overall Study|Adverse Event|0
7793370|NCT01046695|12248657|FG000|Overall Study|Subject had a pacemaker|0
7793371|NCT01046695|12248658|FG001|Overall Study|Subject had a pacemaker|1
7793372|NCT01046695|12248657|FG000|Overall Study|TENS interfered with the cardiac monitor|0
7793373|NCT01046695|12248658|FG001|Overall Study|TENS interfered with the cardiac monitor|1
7793374|NCT01046877|12248664|FG000|Overall Study|Exited voluntarily before tube extrusion|7
7793375|NCT01046877|12248664|FG000|Overall Study|Exited voluntarily after tube extrusion|11
7793376|NCT01046903|12248668|FG000|Overall Study|Lost to Follow-up|16
7793377|NCT01046903|12248668|FG000|Overall Study|Adverse Event|4
7793378|NCT01046903|12248668|FG000|Overall Study|Withdrawal by Subject|3
7793379|NCT01046903|12248668|FG000|Overall Study|Other|5
7793380|NCT01047007|12248676|FG000|Overall Study|Adverse Event|0
7793381|NCT01047007|12248677|FG001|Overall Study|Adverse Event|2
7793382|NCT01047007|12248678|FG002|Overall Study|Adverse Event|1
7793383|NCT01047007|12248679|FG003|Overall Study|Adverse Event|0
7793384|NCT01047007|12248676|FG000|Overall Study|Progressive Disease|2
7793385|NCT01047007|12248677|FG001|Overall Study|Progressive Disease|4
7793386|NCT01047007|12248678|FG002|Overall Study|Progressive Disease|1
7793387|NCT01047007|12248679|FG003|Overall Study|Progressive Disease|0
7793388|NCT01047293|12248705|FG000|Overall Study|DLT criteria not fulfilled|1
7793389|NCT01047293|12248706|FG001|Overall Study|DLT criteria not fulfilled|1
7793390|NCT01047293|12248707|FG002|Overall Study|DLT criteria not fulfilled|0
7871016|NCT01668797|12363370|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
7793391|NCT01047293|12248708|FG003|Overall Study|DLT criteria not fulfilled|0
7793392|NCT01047306|12248717|FG000|Overall Study|Withdrawal by Subject|2
7871017|NCT01668797|12363371|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
7871018|NCT01668797|12363372|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
7871019|NCT01668797|12363373|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
7871020|NCT01668797|12363370|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
7871021|NCT01668797|12363371|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
7871022|NCT01668797|12363372|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
7871023|NCT01668797|12363373|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
7871024|NCT01668797|12363370|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
7871025|NCT01668797|12363371|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
7871026|NCT01668797|12363372|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
7871027|NCT01668797|12363373|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
7871028|NCT01668797|12363370|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
7871029|NCT01668797|12363371|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
7871030|NCT01668797|12363372|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
7871031|NCT01668797|12363373|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
7871032|NCT01668797|12363370|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
7871033|NCT01668797|12363371|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
7871034|NCT01668797|12363372|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
7871035|NCT01668797|12363373|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
7871036|NCT01668797|12363370|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
7871037|NCT01668797|12363371|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
7871038|NCT01668797|12363372|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
7871039|NCT01668797|12363373|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
7871040|NCT01668966|12363403|FG000|Overall Study|Withdrawal by Subject|1
7871041|NCT01668966|12363403|FG000|Overall Study|Death|1
7871042|NCT01668966|12363403|FG000|Overall Study|Not treated|2
7871043|NCT01669122|12363411|FG000|Period I|Lost to Follow-up|1
7871044|NCT01669122|12363411|FG000|Washout Period II|Protocol Violation|2
7871045|NCT01669174|12363424|FG000|Overall Study|Subject withdrew consent|2
7871046|NCT01669174|12363425|FG001|Overall Study|Subject withdrew consent|2
7871047|NCT01669174|12363424|FG000|Overall Study|Lost to Follow-up|1
7871048|NCT01669174|12363425|FG001|Overall Study|Lost to Follow-up|0
7871049|NCT01669174|12363424|FG000|Overall Study|Adverse Event|2
7871050|NCT01669174|12363425|FG001|Overall Study|Adverse Event|2
7871051|NCT01669174|12363424|FG000|Overall Study|Administrative problems|1
7871052|NCT01669174|12363425|FG001|Overall Study|Administrative problems|2
7871053|NCT01669343|12363431|FG000|Part A: All Patients|Withdrawal by Subject|7
7871054|NCT01669343|12363431|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2
7871055|NCT01669343|12363431|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13
7871056|NCT01669343|12363431|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3
7871057|NCT01669343|12363431|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1
7871058|NCT01669421|12363438|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1
7871059|NCT01669421|12363438|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1
7871060|NCT01669577|12363470|FG000|Overall Study|Death|22
7871061|NCT01669577|12363470|FG000|Overall Study|Lost to Follow-up|78
7871062|NCT01669577|12363470|FG000|Overall Study|Physician Decision|34
7871063|NCT01669629|12363483|FG000|Period 1|protocol deviation|1
7871064|NCT01669629|12363484|FG001|Period 1|protocol deviation|2
7871065|NCT01669798|12363540|FG000|Overall Study|Physician Decision|5
7871066|NCT01669811|12363546|FG000|Overall Study|Investigator decision|0
7871067|NCT01669811|12363547|FG001|Overall Study|Investigator decision|1
7871068|NCT01669811|12363546|FG000|Overall Study|Withdrawal by Subject|1
7871069|NCT01669811|12363547|FG001|Overall Study|Withdrawal by Subject|2
7871070|NCT01669811|12363546|FG000|Overall Study|Adverse Event|2
7871071|NCT01669811|12363547|FG001|Overall Study|Adverse Event|6
7871072|NCT01669811|12363546|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
7871073|NCT01669811|12363547|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2
7871074|NCT01669902|12363558|FG000|Overall Study|Adverse Event|11
7871075|NCT01669902|12363558|FG000|Overall Study|Lack of Efficacy|10
7871076|NCT01669902|12363558|FG000|Overall Study|Other|8
7871077|NCT01669928|12363564|FG000|First Intervention|Withdrawal by Subject|3
7871078|NCT01669928|12363565|FG001|First Intervention|Withdrawal by Subject|5
7871079|NCT01670019|12363575|FG000|Overall Study|Adverse Event|3
7871080|NCT01670019|12363576|FG001|Overall Study|Adverse Event|0
7871081|NCT01670019|12363575|FG000|Overall Study|Withdrawal by Subject|6
7871082|NCT01670019|12363576|FG001|Overall Study|Withdrawal by Subject|0
7871083|NCT01670045|12363582|FG000|Overall Study|Withdrawal by Subject|3
7871084|NCT01670045|12363582|FG000|Overall Study|Adverse Event|1
7871085|NCT01670045|12363582|FG000|Overall Study|Death|1
7871086|NCT01670045|12363582|FG000|Overall Study|Lost to Follow-up|11
7871087|NCT01670097|12363588|FG000|Overall Study|Started Phase 1 cancer treatment|1
7871088|NCT01670097|12363589|FG001|Overall Study|Started Phase 1 cancer treatment|0
7871089|NCT01670097|12363588|FG000|Overall Study|Study burden|1
7871090|NCT01670097|12363589|FG001|Overall Study|Study burden|0
7871091|NCT01670097|12363588|FG000|Overall Study|COPD exacerbation|0
7871092|NCT01670097|12363589|FG001|Overall Study|COPD exacerbation|1
7871093|NCT01670097|12363588|FG000|Overall Study|Neutropenia|0
7871094|NCT01670097|12363589|FG001|Overall Study|Neutropenia|1
7871095|NCT01670097|12363588|FG000|Overall Study|Clinical deterioration|0
7871096|NCT01670097|12363589|FG001|Overall Study|Clinical deterioration|1
7871097|NCT01670097|12363588|FG000|Overall Study|Disease progression|0
7871098|NCT01670097|12363589|FG001|Overall Study|Disease progression|1
7871099|NCT01670188|12363606|FG000|Overall Study|Death|0
7871100|NCT01670188|12363607|FG001|Overall Study|Death|1
7871101|NCT01670279|12363620|FG000|Overall Study|Adverse Event|0
7871102|NCT01670279|12363621|FG001|Overall Study|Adverse Event|1
7871103|NCT01670279|12363622|FG002|Overall Study|Adverse Event|0
7871104|NCT01670279|12363623|FG003|Overall Study|Adverse Event|0
7871105|NCT01670279|12363620|FG000|Overall Study|Physician Decision|0
7871106|NCT01670279|12363621|FG001|Overall Study|Physician Decision|1
7871107|NCT01670279|12363622|FG002|Overall Study|Physician Decision|0
7871108|NCT01670279|12363623|FG003|Overall Study|Physician Decision|0
7871109|NCT01670279|12363620|FG000|Overall Study|Participant met withdrawal criteria|0
7871110|NCT01670279|12363621|FG001|Overall Study|Participant met withdrawal criteria|0
7871111|NCT01670279|12363622|FG002|Overall Study|Participant met withdrawal criteria|0
7871112|NCT01670279|12363623|FG003|Overall Study|Participant met withdrawal criteria|1
7871113|NCT01670292|12363631|FG000|Overall Study|Lost to Follow-up|14
7871114|NCT01670526|12363654|FG000|Overall Study|Withdrawal by Subject|3
7871115|NCT01670526|12363655|FG001|Overall Study|Withdrawal by Subject|1
7871116|NCT01670526|12363654|FG000|Overall Study|Lost to Follow-up|9
7871117|NCT01670526|12363655|FG001|Overall Study|Lost to Follow-up|5
7871118|NCT01670721|12363661|FG000|Overall Study|Participant's decision|15
7871119|NCT01670721|12363661|FG000|Overall Study|Other than specified above|38
7871120|NCT01671007|12363689|FG000|Overall Study|Other reasons than listed|166
7871121|NCT01671007|12363690|FG001|Overall Study|Other reasons than listed|373
7871122|NCT01671007|12363691|FG002|Overall Study|Other reasons than listed|197
7871123|NCT01671007|12363692|FG003|Overall Study|Other reasons than listed|228
7871124|NCT01671007|12363693|FG004|Overall Study|Other reasons than listed|14
7871125|NCT01671007|12363694|FG005|Overall Study|Other reasons than listed|71
7871126|NCT01671007|12363695|FG006|Overall Study|Other reasons than listed|17
7871127|NCT01671007|12363696|FG007|Overall Study|Other reasons than listed|66
7871128|NCT01671007|12363697|FG008|Overall Study|Other reasons than listed|0
7871129|NCT01671007|12363689|FG000|Overall Study|Withdrawal by Subject|36
7871130|NCT01671007|12363690|FG001|Overall Study|Withdrawal by Subject|59
7871131|NCT01671007|12363691|FG002|Overall Study|Withdrawal by Subject|53
7871132|NCT01671007|12363692|FG003|Overall Study|Withdrawal by Subject|58
7871133|NCT01671007|12363693|FG004|Overall Study|Withdrawal by Subject|4
7871134|NCT01671007|12363694|FG005|Overall Study|Withdrawal by Subject|15
7871135|NCT01671007|12363695|FG006|Overall Study|Withdrawal by Subject|1
7871136|NCT01671007|12363696|FG007|Overall Study|Withdrawal by Subject|19
7871137|NCT01671007|12363697|FG008|Overall Study|Withdrawal by Subject|0
7871138|NCT01671007|12363689|FG000|Overall Study|Lost to Follow-up|93
7871139|NCT01671007|12363690|FG001|Overall Study|Lost to Follow-up|142
7871140|NCT01671007|12363691|FG002|Overall Study|Lost to Follow-up|91
7871141|NCT01671007|12363692|FG003|Overall Study|Lost to Follow-up|63
7871142|NCT01671007|12363693|FG004|Overall Study|Lost to Follow-up|7
7871143|NCT01671007|12363694|FG005|Overall Study|Lost to Follow-up|20
7871144|NCT01671007|12363695|FG006|Overall Study|Lost to Follow-up|2
7871145|NCT01671007|12363696|FG007|Overall Study|Lost to Follow-up|28
7871146|NCT01671007|12363697|FG008|Overall Study|Lost to Follow-up|0
7871147|NCT01671007|12363689|FG000|Overall Study|No end of study case report form|3
7871148|NCT01671007|12363690|FG001|Overall Study|No end of study case report form|1
7871149|NCT01671007|12363691|FG002|Overall Study|No end of study case report form|0
7871150|NCT01671007|12363692|FG003|Overall Study|No end of study case report form|2
7871151|NCT01671007|12363693|FG004|Overall Study|No end of study case report form|0
7871152|NCT01671007|12363694|FG005|Overall Study|No end of study case report form|0
7871153|NCT01671007|12363695|FG006|Overall Study|No end of study case report form|0
7871154|NCT01671007|12363696|FG007|Overall Study|No end of study case report form|0
7871155|NCT01671007|12363697|FG008|Overall Study|No end of study case report form|0
7871156|NCT01671007|12363689|FG000|Overall Study|Not eligible|23
7871157|NCT01671007|12363690|FG001|Overall Study|Not eligible|76
7871158|NCT01671007|12363691|FG002|Overall Study|Not eligible|25
7871159|NCT01671007|12363692|FG003|Overall Study|Not eligible|17
7871160|NCT01671007|12363693|FG004|Overall Study|Not eligible|0
7871161|NCT01671007|12363694|FG005|Overall Study|Not eligible|6
7871162|NCT01671007|12363695|FG006|Overall Study|Not eligible|1
7871163|NCT01671007|12363696|FG007|Overall Study|Not eligible|19
7871164|NCT01671007|12363697|FG008|Overall Study|Not eligible|0
7871165|NCT01671059|12363708|FG000|Overall Study|Adverse Event|4
7871166|NCT01671059|12363708|FG000|Overall Study|Lack of Efficacy|1
7871167|NCT01671085|12363715|FG000|Overall Study|Withdrawal by Subject|1
7871168|NCT01671085|12363716|FG001|Overall Study|Withdrawal by Subject|0
7871169|NCT01671111|12363723|FG000|Overall Study|Adverse Event|2
7871170|NCT01671111|12363723|FG000|Overall Study|Lack of Efficacy|1
7871171|NCT01671111|12363723|FG000|Overall Study|Withdrawal by Subject|2
7871172|NCT01671111|12363723|FG000|Overall Study|Physician Decision|1
7871173|NCT01671111|12363723|FG000|Overall Study|Other|24
7871174|NCT01671280|12363731|FG000|Overall Study|Withdrawal by Subject|2
7871175|NCT01671319|12363744|FG000|Overall Study|Withdrawal by Subject|1
7871176|NCT01671332|12363750|FG000|Overall Study|Withdrawal by Subject|1
7871177|NCT01671332|12363751|FG001|Overall Study|Withdrawal by Subject|1
7871178|NCT01671345|12363759|FG000|Overall Study|Lost to Follow-up|10
7871179|NCT01671345|12363760|FG001|Overall Study|Lost to Follow-up|6
7871180|NCT01671345|12363759|FG000|Overall Study|visit with non-participating physician|3
7871181|NCT01671345|12363760|FG001|Overall Study|visit with non-participating physician|3
7871182|NCT01671488|12363778|FG000|Overall Study|Withdrawal by Subject|1
7871183|NCT01671748|12363793|FG000|4 Week run-in Phase|Withdrawal by Subject|1
7871184|NCT01671748|12363794|FG001|4 Week run-in Phase|Withdrawal by Subject|0
7871185|NCT01671748|12363793|FG000|4 Week run-in Phase|Adverse Event|1
7871186|NCT01671748|12363794|FG001|4 Week run-in Phase|Adverse Event|0
7871187|NCT01671748|12363793|FG000|4 Week run-in Phase|Not eligible|9
7871188|NCT01671748|12363794|FG001|4 Week run-in Phase|Not eligible|0
7871189|NCT01672294|12363811|FG000|Overall Study|Withdrawal by Subject|4
7871190|NCT01672294|12363812|FG001|Overall Study|Withdrawal by Subject|4
7871191|NCT01672294|12363813|FG002|Overall Study|Withdrawal by Subject|4
7871192|NCT01672294|12363814|FG003|Overall Study|Withdrawal by Subject|4
7871193|NCT01672294|12363811|FG000|Overall Study|Excluded by study|1
7871194|NCT01672294|12363812|FG001|Overall Study|Excluded by study|1
7871195|NCT01672294|12363813|FG002|Overall Study|Excluded by study|0
7871196|NCT01672294|12363814|FG003|Overall Study|Excluded by study|0
7871197|NCT01672294|12363811|FG000|Overall Study|Lost to Follow-up|1
7871198|NCT01672294|12363812|FG001|Overall Study|Lost to Follow-up|16
7871199|NCT01672294|12363813|FG002|Overall Study|Lost to Follow-up|7
7793393|NCT01047306|12248718|FG001|Overall Study|Withdrawal by Subject|0
7793394|NCT01047306|12248717|FG000|Overall Study|Lost to Follow-up|1
7793395|NCT01047306|12248718|FG001|Overall Study|Lost to Follow-up|0
7793396|NCT01047332|12248728|FG000|Overall Study|SEMS Obstruction|11
7793397|NCT01047332|12248729|FG001|Overall Study|SEMS Obstruction|20
7793398|NCT01047332|12248728|FG000|Overall Study|Died Unobstructed|38
7793399|NCT01047332|12248729|FG001|Overall Study|Died Unobstructed|41
7793400|NCT01047332|12248728|FG000|Overall Study|Lost to Follow-up|8
7793401|NCT01047332|12248729|FG001|Overall Study|Lost to Follow-up|3
7793402|NCT01047345|12248737|FG000|Base Study|Adverse Event|3
7793403|NCT01047345|12248738|FG001|Base Study|Adverse Event|0
7793404|NCT01047345|12248739|FG002|Base Study|Adverse Event|0
7793405|NCT01047345|12248737|FG000|Base Study|Lost to Follow-up|4
7793406|NCT01047345|12248738|FG001|Base Study|Lost to Follow-up|1
7793407|NCT01047345|12248739|FG002|Base Study|Lost to Follow-up|0
7871200|NCT01672294|12363814|FG003|Overall Study|Lost to Follow-up|9
7871201|NCT01672710|12363835|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
7871202|NCT01672710|12363836|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
7871203|NCT01672710|12363835|FG000|3 Month Follow up|Lost to Follow-up|2
7871204|NCT01672710|12363836|FG001|3 Month Follow up|Lost to Follow-up|3
7871205|NCT01672710|12363835|FG000|3 Month Follow up|follow up due after termination date|4
7871206|NCT01672710|12363836|FG001|3 Month Follow up|follow up due after termination date|1
7871207|NCT01672723|12363842|FG000|First Intervention|Adverse Event|3
7871208|NCT01672723|12363843|FG001|First Intervention|Adverse Event|0
7871209|NCT01672736|12363849|FG000|Overall Study|Available drug expired on 31 May 16|3
7871210|NCT01672788|12363853|FG000|Washout Period 2 (7 Days)|Adverse Event|0
7871211|NCT01672788|12363854|FG001|Washout Period 2 (7 Days)|Adverse Event|0
7871212|NCT01672788|12363855|FG002|Washout Period 2 (7 Days)|Adverse Event|0
7871213|NCT01672788|12363856|FG003|Washout Period 2 (7 Days)|Adverse Event|1
7871214|NCT01672801|12363868|FG000|Overall Study|Screen Failure|0
7871215|NCT01672801|12363869|FG001|Overall Study|Screen Failure|1
7871216|NCT01672853|12363884|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0
7871217|NCT01672853|12363885|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4
7871218|NCT01672853|12363886|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0
7871219|NCT01672853|12363884|FG000|Overall Study|Pregnancy|0
7871220|NCT01672853|12363885|FG001|Overall Study|Pregnancy|1
7871221|NCT01672853|12363886|FG002|Overall Study|Pregnancy|0
7871222|NCT01672853|12363884|FG000|Overall Study|Investigator's Discretion|1
7871223|NCT01672853|12363885|FG001|Overall Study|Investigator's Discretion|0
7871224|NCT01672853|12363886|FG002|Overall Study|Investigator's Discretion|0
7871225|NCT01672853|12363884|FG000|Overall Study|Withdrew Consent|5
7871226|NCT01672853|12363885|FG001|Overall Study|Withdrew Consent|5
7871227|NCT01672853|12363886|FG002|Overall Study|Withdrew Consent|5
7871228|NCT01672853|12363884|FG000|Overall Study|Adverse Event|4
7871229|NCT01672853|12363885|FG001|Overall Study|Adverse Event|6
7871230|NCT01672853|12363886|FG002|Overall Study|Adverse Event|8
7871231|NCT01672853|12363884|FG000|Overall Study|Lost to Follow-up|0
7871232|NCT01672853|12363885|FG001|Overall Study|Lost to Follow-up|1
7871233|NCT01672853|12363886|FG002|Overall Study|Lost to Follow-up|0
7871234|NCT01672853|12363884|FG000|Overall Study|Randomized but Never Treated|0
7871235|NCT01672853|12363885|FG001|Overall Study|Randomized but Never Treated|0
7871236|NCT01672853|12363886|FG002|Overall Study|Randomized but Never Treated|1
7871237|NCT01672866|12363897|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40
7871238|NCT01672866|12363898|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42
7871239|NCT01672866|12363899|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35
7793408|NCT01047345|12248737|FG000|Base Study|Protocol Violation|3
7871240|NCT01672866|12363897|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9
7871241|NCT01672866|12363898|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8
7871242|NCT01672866|12363899|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12
7871243|NCT01672866|12363897|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
7871244|NCT01672866|12363898|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
7871245|NCT01672866|12363899|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5
7871246|NCT01672866|12363897|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3
7871247|NCT01672866|12363898|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3
7871248|NCT01672866|12363899|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3
7871249|NCT01672866|12363897|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
7871250|NCT01672866|12363898|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
7871251|NCT01672866|12363899|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2
7871252|NCT01672866|12363897|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2
7871253|NCT01672866|12363898|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
7871254|NCT01672866|12363899|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
7871255|NCT01672866|12363897|FG000|Blinded Phase (up to 240 Weeks)|Death|0
7871256|NCT01672866|12363898|FG001|Blinded Phase (up to 240 Weeks)|Death|0
7871257|NCT01672866|12363899|FG002|Blinded Phase (up to 240 Weeks)|Death|1
7871258|NCT01672866|12363897|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3
7871259|NCT01672866|12363898|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
7871260|NCT01672866|12363899|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
7871261|NCT01672866|12363897|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11
7871262|NCT01672866|12363898|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15
7871263|NCT01672866|12363899|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16
7871264|NCT01672866|12363897|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8
7871265|NCT01672866|12363898|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
7871266|NCT01672866|12363899|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
7871267|NCT01672866|12363897|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
7871268|NCT01672866|12363898|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0
7871269|NCT01672866|12363899|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
7871270|NCT01672866|12363897|FG000|Open-Label Phase (up to 240 Weeks)|Death|1
7871271|NCT01672866|12363898|FG001|Open-Label Phase (up to 240 Weeks)|Death|0
7871272|NCT01672866|12363899|FG002|Open-Label Phase (up to 240 Weeks)|Death|0
7871273|NCT01672866|12363897|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1
7871274|NCT01672866|12363898|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
7871275|NCT01672866|12363899|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
7871276|NCT01672879|12363912|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43
7871277|NCT01672879|12363913|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55
7871278|NCT01672879|12363914|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61
7871279|NCT01672879|12363912|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14
7871280|NCT01672879|12363913|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7
7871281|NCT01672879|12363914|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6
7871282|NCT01672879|12363912|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5
7871283|NCT01672879|12363913|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2
7871284|NCT01672879|12363914|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7
7871285|NCT01672879|12363912|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4
7871286|NCT01672879|12363913|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3
7871287|NCT01672879|12363914|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1
7871288|NCT01672879|12363912|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5
7871289|NCT01672879|12363913|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0
7871290|NCT01672879|12363914|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2
7871291|NCT01672879|12363912|FG000|Blinded Phase (Up to 240 Weeks)|Death|0
7871292|NCT01672879|12363913|FG001|Blinded Phase (Up to 240 Weeks)|Death|2
7871293|NCT01672879|12363914|FG002|Blinded Phase (Up to 240 Weeks)|Death|0
7871294|NCT01672879|12363912|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1
7871295|NCT01672879|12363913|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0
7871296|NCT01672879|12363914|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0
7871297|NCT01672879|12363912|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
7871298|NCT01672879|12363913|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
7871299|NCT01672879|12363914|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1
7871300|NCT01672879|12363912|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15
7871301|NCT01672879|12363913|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17
7871302|NCT01672879|12363914|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8
7871303|NCT01672879|12363912|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8
7871304|NCT01672879|12363913|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16
7871305|NCT01672879|12363914|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6
7871306|NCT01672879|12363912|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5
7871307|NCT01672879|12363913|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
7871308|NCT01672879|12363914|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
7871309|NCT01672879|12363912|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
7871310|NCT01672879|12363913|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0
7871311|NCT01672879|12363914|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
7871312|NCT01672879|12363912|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1
7871313|NCT01672879|12363913|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
7871314|NCT01672879|12363914|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
7871315|NCT01672957|12363923|FG000|Overall Study|Protocol Violation|48
7871316|NCT01672957|12363923|FG000|Overall Study|Death|2
7871317|NCT01672957|12363923|FG000|Overall Study|ICF Signed After Transplantation|5
7871318|NCT01672970|12363927|FG000|Overall Study|Lack of Efficacy|12
7871319|NCT01672970|12363927|FG000|Overall Study|Adverse Event|18
7871320|NCT01672970|12363927|FG000|Overall Study|Withdrawal by Subject|2
7871321|NCT01672970|12363927|FG000|Overall Study|Lost to Follow-up|5
7871322|NCT01672970|12363927|FG000|Overall Study|Other|9
7871323|NCT01672970|12363927|FG000|Overall Study|Enrolled but not treated|1
7871324|NCT01673009|12363989|FG000|Overall Study|Physician Decision|5
7871325|NCT01673009|12363989|FG000|Overall Study|Withdrawal by Subject|8
7882694|NCT01774903|12381919|FG000|Overall Study|Withdrawal by Subject|2
7882695|NCT01774903|12381919|FG000|Overall Study|Lack of Efficacy|1
7882696|NCT01774903|12381919|FG000|Overall Study|Ineligible to continue the trial|1
7882697|NCT01774929|12381924|FG000|Overall Study|Adverse Event|3
7882698|NCT01774968|12381930|FG000|Overall Study|Adverse Event|4
7882699|NCT01774968|12381931|FG001|Overall Study|Adverse Event|4
7882700|NCT01774968|12381930|FG000|Overall Study|Death|0
7882701|NCT01774968|12381931|FG001|Overall Study|Death|1
7882702|NCT01774968|12381930|FG000|Overall Study|Lost to Follow-up|1
7882703|NCT01774968|12381931|FG001|Overall Study|Lost to Follow-up|3
7882704|NCT01774968|12381930|FG000|Overall Study|Physician Decision|5
7882705|NCT01774968|12381931|FG001|Overall Study|Physician Decision|1
7882706|NCT01774968|12381930|FG000|Overall Study|Protocol Violation|14
7882707|NCT01774968|12381931|FG001|Overall Study|Protocol Violation|13
7882708|NCT01774968|12381930|FG000|Overall Study|Sponsor Decision|0
7882709|NCT01774968|12381931|FG001|Overall Study|Sponsor Decision|2
7882710|NCT01774968|12381930|FG000|Overall Study|Withdrawal by Subject|6
7882711|NCT01774968|12381931|FG001|Overall Study|Withdrawal by Subject|11
7882712|NCT01774981|12381945|FG000|Overall Study|Adverse Event|0
7882713|NCT01774981|12381946|FG001|Overall Study|Adverse Event|0
7882714|NCT01774981|12381947|FG002|Overall Study|Adverse Event|0
7882715|NCT01774981|12381948|FG003|Overall Study|Adverse Event|0
7882716|NCT01774981|12381949|FG004|Overall Study|Adverse Event|0
7882717|NCT01774981|12381950|FG005|Overall Study|Adverse Event|1
7882718|NCT01774981|12381951|FG006|Overall Study|Adverse Event|0
7882719|NCT01774981|12381952|FG007|Overall Study|Adverse Event|0
7882720|NCT01774981|12381945|FG000|Overall Study|Withdrawal by Subject|0
7882721|NCT01774981|12381946|FG001|Overall Study|Withdrawal by Subject|0
7882722|NCT01774981|12381947|FG002|Overall Study|Withdrawal by Subject|0
7882723|NCT01774981|12381948|FG003|Overall Study|Withdrawal by Subject|0
7882724|NCT01774981|12381949|FG004|Overall Study|Withdrawal by Subject|0
7882725|NCT01774981|12381950|FG005|Overall Study|Withdrawal by Subject|0
7882726|NCT01774981|12381951|FG006|Overall Study|Withdrawal by Subject|0
7882727|NCT01774981|12381952|FG007|Overall Study|Withdrawal by Subject|1
7882728|NCT01774981|12381945|FG000|Overall Study|Death|0
7882729|NCT01774981|12381946|FG001|Overall Study|Death|0
7882730|NCT01774981|12381947|FG002|Overall Study|Death|0
7882731|NCT01774981|12381948|FG003|Overall Study|Death|0
7882732|NCT01774981|12381949|FG004|Overall Study|Death|1
7882733|NCT01774981|12381950|FG005|Overall Study|Death|0
7882734|NCT01774981|12381951|FG006|Overall Study|Death|0
7882735|NCT01774981|12381952|FG007|Overall Study|Death|0
7882736|NCT01775124|12381977|FG000|Core Period|Disease Progression|0
7882737|NCT01775124|12381978|FG001|Core Period|Disease Progression|1
7882738|NCT01775124|12381977|FG000|Core Period|Physician Decision|1
7882739|NCT01775124|12381978|FG001|Core Period|Physician Decision|1
7882740|NCT01775124|12381977|FG000|Core Period|Death|0
7882741|NCT01775124|12381978|FG001|Core Period|Death|1
7882742|NCT01775124|12381977|FG000|Core Period|Administrative problems|1
7882743|NCT01775124|12381978|FG001|Core Period|Administrative problems|0
7882744|NCT01775124|12381977|FG000|Core Period|Withdrawal by Subject|4
7882745|NCT01775124|12381978|FG001|Core Period|Withdrawal by Subject|2
7882746|NCT01775124|12381977|FG000|Core Period|Adverse Event|5
7882747|NCT01775124|12381978|FG001|Core Period|Adverse Event|5
7882748|NCT01775124|12381977|FG000|Extension Period|Adverse Event|3
7882749|NCT01775124|12381978|FG001|Extension Period|Adverse Event|2
7882750|NCT01775124|12381977|FG000|Extension Period|Physician Decision|0
7882751|NCT01775124|12381978|FG001|Extension Period|Physician Decision|2
7882752|NCT01775124|12381977|FG000|Extension Period|Administrative problems|0
7882753|NCT01775124|12381978|FG001|Extension Period|Administrative problems|1
7882754|NCT01775124|12381977|FG000|Extension Period|Lost to Follow-up|0
7882755|NCT01775124|12381978|FG001|Extension Period|Lost to Follow-up|1
7882756|NCT01775124|12381977|FG000|Extension Period|Withdrawal by Subject|9
7882757|NCT01775124|12381978|FG001|Extension Period|Withdrawal by Subject|12
7882758|NCT01775137|12381985|FG000|Overall Study|Death|1
7882759|NCT01775137|12381985|FG000|Overall Study|Protocol deviation|2
7882760|NCT01775137|12381985|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7882761|NCT01775137|12381985|FG000|Overall Study|Adverse Event|1
7882762|NCT01775137|12381985|FG000|Overall Study|Withdrawal by participants|5
7882763|NCT01775189|12381992|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0
7882764|NCT01775189|12381993|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3
7871326|NCT01673126|12364009|FG000|Overall Study|change of diagnosis|4
7871327|NCT01673126|12364010|FG001|Overall Study|change of diagnosis|3
7871328|NCT01673178|12364021|FG000|Overall Study|Lost to Follow-up|0
7871329|NCT01673178|12364022|FG001|Overall Study|Lost to Follow-up|1
7871330|NCT01673178|12364023|FG002|Overall Study|Lost to Follow-up|0
7871331|NCT01673178|12364024|FG003|Overall Study|Lost to Follow-up|0
7871332|NCT01673178|12364025|FG004|Overall Study|Lost to Follow-up|0
7871333|NCT01673178|12364021|FG000|Overall Study|Withdrawal by Subject|0
7871334|NCT01673178|12364022|FG001|Overall Study|Withdrawal by Subject|0
7871335|NCT01673178|12364023|FG002|Overall Study|Withdrawal by Subject|1
7871336|NCT01673178|12364024|FG003|Overall Study|Withdrawal by Subject|4
7871337|NCT01673178|12364025|FG004|Overall Study|Withdrawal by Subject|2
7871338|NCT01673178|12364021|FG000|Overall Study|Protocol Violation|1
7871339|NCT01673178|12364022|FG001|Overall Study|Protocol Violation|1
7871340|NCT01673178|12364023|FG002|Overall Study|Protocol Violation|0
7871341|NCT01673178|12364024|FG003|Overall Study|Protocol Violation|1
7871342|NCT01673178|12364025|FG004|Overall Study|Protocol Violation|0
7871343|NCT01673178|12364021|FG000|Overall Study|Adverse Event|1
7871344|NCT01673178|12364022|FG001|Overall Study|Adverse Event|0
7871345|NCT01673178|12364023|FG002|Overall Study|Adverse Event|0
7871346|NCT01673178|12364024|FG003|Overall Study|Adverse Event|2
7871347|NCT01673178|12364025|FG004|Overall Study|Adverse Event|0
7871348|NCT01673178|12364021|FG000|Overall Study|Other|1
7871349|NCT01673178|12364022|FG001|Overall Study|Other|0
7871350|NCT01673178|12364023|FG002|Overall Study|Other|2
7871351|NCT01673178|12364024|FG003|Overall Study|Other|1
7871352|NCT01673178|12364025|FG004|Overall Study|Other|0
7871353|NCT01673282|12364056|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9
7871354|NCT01673282|12364057|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5
7871355|NCT01673282|12364056|FG000|Overall Study|Lack of Efficacy|9
7871356|NCT01673282|12364057|FG001|Overall Study|Lack of Efficacy|2
7871357|NCT01673282|12364056|FG000|Overall Study|Lost to Follow-up|11
7871358|NCT01673282|12364057|FG001|Overall Study|Lost to Follow-up|10
7871359|NCT01673282|12364056|FG000|Overall Study|Withdrawal by Subject|3
7871360|NCT01673282|12364057|FG001|Overall Study|Withdrawal by Subject|3
7871361|NCT01673282|12364056|FG000|Overall Study|Other|1
7871362|NCT01673282|12364057|FG001|Overall Study|Other|6
7871363|NCT01673347|12364063|FG000|Overall Study|failure of allograft|7
7871364|NCT01673373|12364067|FG000|Overall Study|Death|2
7871365|NCT01673386|12364071|FG000|Overall Study|Study terminated by sponsor|16
7871366|NCT01673386|12364072|FG001|Overall Study|Study terminated by sponsor|22
7871367|NCT01673386|12364071|FG000|Overall Study|Adverse Event|5
7871368|NCT01673386|12364072|FG001|Overall Study|Adverse Event|2
7871369|NCT01673386|12364071|FG000|Overall Study|Progressive disease|4
7871370|NCT01673386|12364072|FG001|Overall Study|Progressive disease|1
7871371|NCT01673386|12364071|FG000|Overall Study|Withdrawal by Subject|0
7793409|NCT01047345|12248738|FG001|Base Study|Protocol Violation|1
7793410|NCT01047345|12248739|FG002|Base Study|Protocol Violation|0
7793411|NCT01047345|12248737|FG000|Base Study|Withdrawal by Subject|12
7793412|NCT01047345|12248738|FG001|Base Study|Withdrawal by Subject|4
7871372|NCT01673386|12364072|FG001|Overall Study|Withdrawal by Subject|2
7871373|NCT01673490|12364078|FG000|Overall Study|Lost to Follow-up|1
7871374|NCT01673490|12364078|FG000|Overall Study|Adverse Event|3
7871375|NCT01673490|12364078|FG000|Overall Study|Withdrawal by Subject|3
7871376|NCT01673594|12364093|FG000|Overall Study|Adverse Event|3
7871377|NCT01673594|12364094|FG001|Overall Study|Adverse Event|1
7871378|NCT01673594|12364093|FG000|Overall Study|Lost to Follow-up|1
7871379|NCT01673594|12364094|FG001|Overall Study|Lost to Follow-up|0
7871380|NCT01673594|12364093|FG000|Overall Study|Physician Decision|2
7871381|NCT01673594|12364094|FG001|Overall Study|Physician Decision|4
7871382|NCT01673594|12364093|FG000|Overall Study|Withdrawal by Subject|0
7871383|NCT01673594|12364094|FG001|Overall Study|Withdrawal by Subject|1
7871384|NCT01673646|12364103|FG000|Overall Study|Adverse Event|2
7871385|NCT01673646|12364104|FG001|Overall Study|Adverse Event|1
7871386|NCT01673646|12364105|FG002|Overall Study|Adverse Event|1
7871387|NCT01673646|12364103|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7871388|NCT01673646|12364104|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7871389|NCT01673646|12364105|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7871390|NCT01673646|12364103|FG000|Overall Study|Condition no longer requires study drug|0
7871391|NCT01673646|12364104|FG001|Overall Study|Condition no longer requires study drug|1
7871392|NCT01673646|12364105|FG002|Overall Study|Condition no longer requires study drug|0
7871393|NCT01673646|12364103|FG000|Overall Study|Withdrawal by Subject|0
7793413|NCT01047345|12248739|FG002|Base Study|Withdrawal by Subject|0
7793414|NCT01047345|12248737|FG000|Extension|Withdrawal by Subject|0
7793415|NCT01047345|12248738|FG001|Extension|Withdrawal by Subject|0
7793416|NCT01047345|12248739|FG002|Extension|Withdrawal by Subject|1
7793417|NCT01047345|12248737|FG000|Extension|Lost to Follow-up|0
7793418|NCT01047345|12248738|FG001|Extension|Lost to Follow-up|0
7793419|NCT01047345|12248739|FG002|Extension|Lost to Follow-up|5
7793420|NCT01047436|12248754|FG000|Overall Study|Protocol Violation|1
7793421|NCT01047436|12248755|FG001|Overall Study|Protocol Violation|0
7793422|NCT01047553|12248786|FG000|Overall Study|Adverse Event|10
7793423|NCT01047553|12248787|FG001|Overall Study|Adverse Event|5
7793424|NCT01047553|12248786|FG000|Overall Study|Withdrawal by Subject|4
7793425|NCT01047553|12248787|FG001|Overall Study|Withdrawal by Subject|2
7871394|NCT01673646|12364104|FG001|Overall Study|Withdrawal by Subject|2
7871395|NCT01673646|12364105|FG002|Overall Study|Withdrawal by Subject|2
7871396|NCT01673646|12364103|FG000|Overall Study|Completed Core/did not enter Ext.|2
7871397|NCT01673646|12364104|FG001|Overall Study|Completed Core/did not enter Ext.|1
7871398|NCT01673646|12364105|FG002|Overall Study|Completed Core/did not enter Ext.|1
7871399|NCT01673698|12364119|FG000|Overall Study|Lost to Follow-up|51
7871400|NCT01673698|12364120|FG001|Overall Study|Lost to Follow-up|13
7871401|NCT01673854|12364140|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
7871402|NCT01673854|12364140|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
7871403|NCT01673854|12364140|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
7871404|NCT01673854|12364140|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
7871405|NCT01673854|12364140|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
7871406|NCT01673854|12364140|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
7871407|NCT01673854|12364140|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
7871408|NCT01673854|12364140|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
7871409|NCT01673854|12364140|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
7871410|NCT01673854|12364140|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
7871411|NCT01673854|12364140|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
7871412|NCT01673854|12364140|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
7871413|NCT01673984|12364158|FG000|Overall Study|Adverse Event|1
7871414|NCT01673984|12364159|FG001|Overall Study|Adverse Event|0
7871415|NCT01673984|12364158|FG000|Overall Study|Study termination|9
7871416|NCT01673984|12364159|FG001|Overall Study|Study termination|6
7871417|NCT01674010|12364165|FG000|Open Treatment Phase 1|Adverse Event|10
7871418|NCT01674010|12364166|FG001|Open Treatment Phase 1|Adverse Event|0
7871419|NCT01674010|12364167|FG002|Open Treatment Phase 1|Adverse Event|0
7871420|NCT01674010|12364165|FG000|Open Treatment Phase 1|Death|1
7871421|NCT01674010|12364166|FG001|Open Treatment Phase 1|Death|0
7871422|NCT01674010|12364167|FG002|Open Treatment Phase 1|Death|0
7871423|NCT01674010|12364165|FG000|Open Treatment Phase 1|Lost to Follow-up|19
7871424|NCT01674010|12364166|FG001|Open Treatment Phase 1|Lost to Follow-up|0
7871425|NCT01674010|12364167|FG002|Open Treatment Phase 1|Lost to Follow-up|0
7871426|NCT01674010|12364165|FG000|Open Treatment Phase 1|Physician Decision|9
7793426|NCT01047553|12248786|FG000|Overall Study|Development of Study-Specific Withdrawal|1
7793427|NCT01047553|12248787|FG001|Overall Study|Development of Study-Specific Withdrawal|1
7793428|NCT01047553|12248786|FG000|Overall Study|Lost to Follow-up|1
7793429|NCT01047553|12248787|FG001|Overall Study|Lost to Follow-up|0
7871427|NCT01674010|12364166|FG001|Open Treatment Phase 1|Physician Decision|0
7871428|NCT01674010|12364167|FG002|Open Treatment Phase 1|Physician Decision|0
7871429|NCT01674010|12364165|FG000|Open Treatment Phase 1|Protocol Violation|7
7871430|NCT01674010|12364166|FG001|Open Treatment Phase 1|Protocol Violation|0
7871431|NCT01674010|12364167|FG002|Open Treatment Phase 1|Protocol Violation|0
7871432|NCT01674010|12364165|FG000|Open Treatment Phase 1|Sponsor Decision|79
7871433|NCT01674010|12364166|FG001|Open Treatment Phase 1|Sponsor Decision|0
7871434|NCT01674010|12364167|FG002|Open Treatment Phase 1|Sponsor Decision|0
7871435|NCT01674010|12364165|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30
7871436|NCT01674010|12364166|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0
7871437|NCT01674010|12364167|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0
7871438|NCT01674010|12364165|FG000|Open Treatment Phase 1|Withdrawal by Subject|25
7871439|NCT01674010|12364166|FG001|Open Treatment Phase 1|Withdrawal by Subject|0
7871440|NCT01674010|12364167|FG002|Open Treatment Phase 1|Withdrawal by Subject|0
7871441|NCT01674010|12364165|FG000|Randomization Phase 2|Adverse Event|0
7871442|NCT01674010|12364166|FG001|Randomization Phase 2|Adverse Event|1
7871443|NCT01674010|12364167|FG002|Randomization Phase 2|Adverse Event|1
7871444|NCT01674010|12364165|FG000|Randomization Phase 2|Lost to Follow-up|0
7871445|NCT01674010|12364166|FG001|Randomization Phase 2|Lost to Follow-up|1
7871446|NCT01674010|12364167|FG002|Randomization Phase 2|Lost to Follow-up|2
7871447|NCT01674010|12364165|FG000|Randomization Phase 2|Mood episode recurrence|0
7871448|NCT01674010|12364166|FG001|Randomization Phase 2|Mood episode recurrence|8
7871449|NCT01674010|12364167|FG002|Randomization Phase 2|Mood episode recurrence|2
7793430|NCT01047553|12248786|FG000|Overall Study|Sever Non-Compliance to Protocol|1
7793431|NCT01047553|12248787|FG001|Overall Study|Sever Non-Compliance to Protocol|0
7793432|NCT01047553|12248786|FG000|Overall Study|PI's decision|0
7793433|NCT01047553|12248787|FG001|Overall Study|PI's decision|1
7793434|NCT01048099|12248820|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
7793435|NCT01048099|12248820|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
7793436|NCT01048242|12248828|FG000|Overall Study|See study flow chart|4
7793437|NCT01048242|12248829|FG001|Overall Study|See study flow chart|2
7793438|NCT01048333|12248835|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
7793439|NCT01048333|12248836|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
7793440|NCT01048333|12248837|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
7793441|NCT01048333|12248838|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
7793442|NCT01048333|12248839|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
7793443|NCT01048333|12248840|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
7793444|NCT01048502|12248862|FG000|Overall Study|Lost to Follow-up|2
7793445|NCT01048502|12248863|FG001|Overall Study|Lost to Follow-up|0
7871450|NCT01674010|12364165|FG000|Randomization Phase 2|Physician Decision|0
7871451|NCT01674010|12364166|FG001|Randomization Phase 2|Physician Decision|0
7871452|NCT01674010|12364167|FG002|Randomization Phase 2|Physician Decision|2
7871453|NCT01674010|12364165|FG000|Randomization Phase 2|Pregnancy|0
7871454|NCT01674010|12364166|FG001|Randomization Phase 2|Pregnancy|1
7871455|NCT01674010|12364167|FG002|Randomization Phase 2|Pregnancy|1
7871456|NCT01674010|12364165|FG000|Randomization Phase 2|Protocol Violation|0
7871457|NCT01674010|12364166|FG001|Randomization Phase 2|Protocol Violation|1
7871458|NCT01674010|12364167|FG002|Randomization Phase 2|Protocol Violation|1
7871459|NCT01674010|12364165|FG000|Randomization Phase 2|Sponsor Decision|0
7871460|NCT01674010|12364166|FG001|Randomization Phase 2|Sponsor Decision|42
7871461|NCT01674010|12364167|FG002|Randomization Phase 2|Sponsor Decision|45
7871462|NCT01674010|12364165|FG000|Randomization Phase 2|Withdrawal by Subject|0
7871463|NCT01674010|12364166|FG001|Randomization Phase 2|Withdrawal by Subject|8
7871464|NCT01674010|12364167|FG002|Randomization Phase 2|Withdrawal by Subject|7
7871465|NCT01674062|12364177|FG000|Overall Study|Insufficient Therapeutic Response|56
7871466|NCT01674062|12364178|FG001|Overall Study|Insufficient Therapeutic Response|26
7871467|NCT01674062|12364177|FG000|Overall Study|Other|8
7871468|NCT01674062|12364178|FG001|Overall Study|Other|1
7871469|NCT01674062|12364177|FG000|Overall Study|Adverse Event|1
7871470|NCT01674062|12364178|FG001|Overall Study|Adverse Event|1
7871471|NCT01674062|12364177|FG000|Overall Study|Death|0
7871472|NCT01674062|12364178|FG001|Overall Study|Death|1
7871473|NCT01674062|12364177|FG000|Overall Study|Programming Error|1
7871474|NCT01674062|12364178|FG001|Overall Study|Programming Error|0
7871475|NCT01674569|12364193|FG000|Overall Study|Adverse Event|0
7871476|NCT01674569|12364194|FG001|Overall Study|Adverse Event|2
7871477|NCT01674569|12364195|FG002|Overall Study|Adverse Event|0
7871478|NCT01674569|12364196|FG003|Overall Study|Adverse Event|1
7871479|NCT01674569|12364197|FG004|Overall Study|Adverse Event|2
7871480|NCT01674569|12364198|FG005|Overall Study|Adverse Event|2
7871481|NCT01674569|12364193|FG000|Overall Study|Protocol Violation|0
7871482|NCT01674569|12364194|FG001|Overall Study|Protocol Violation|1
7871483|NCT01674569|12364195|FG002|Overall Study|Protocol Violation|1
7871484|NCT01674569|12364196|FG003|Overall Study|Protocol Violation|0
7871485|NCT01674569|12364197|FG004|Overall Study|Protocol Violation|0
7871486|NCT01674569|12364198|FG005|Overall Study|Protocol Violation|0
7871487|NCT01674569|12364193|FG000|Overall Study|Withdrawal by Subject|0
7871488|NCT01674569|12364194|FG001|Overall Study|Withdrawal by Subject|0
7871489|NCT01674569|12364195|FG002|Overall Study|Withdrawal by Subject|1
7871490|NCT01674569|12364196|FG003|Overall Study|Withdrawal by Subject|0
7871491|NCT01674569|12364197|FG004|Overall Study|Withdrawal by Subject|0
7871492|NCT01674569|12364198|FG005|Overall Study|Withdrawal by Subject|0
7871493|NCT01674621|12364207|FG000|Overall Study|Adverse Event|3
7871494|NCT01674621|12364208|FG001|Overall Study|Adverse Event|2
7871495|NCT01674621|12364209|FG002|Overall Study|Adverse Event|5
7871496|NCT01674621|12364210|FG003|Overall Study|Adverse Event|5
7871497|NCT01674621|12364211|FG004|Overall Study|Adverse Event|1
7871498|NCT01674621|12364207|FG000|Overall Study|Inability to Complete Study Procedures|0
7871499|NCT01674621|12364208|FG001|Overall Study|Inability to Complete Study Procedures|0
7871500|NCT01674621|12364209|FG002|Overall Study|Inability to Complete Study Procedures|0
7871501|NCT01674621|12364210|FG003|Overall Study|Inability to Complete Study Procedures|0
7871502|NCT01674621|12364211|FG004|Overall Study|Inability to Complete Study Procedures|2
7871503|NCT01674621|12364207|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7871504|NCT01674621|12364208|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7871505|NCT01674621|12364209|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7871506|NCT01674621|12364210|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1
7871507|NCT01674621|12364211|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7871508|NCT01674621|12364207|FG000|Overall Study|Withdrawal by Subject|2
7871509|NCT01674621|12364208|FG001|Overall Study|Withdrawal by Subject|5
7871510|NCT01674621|12364209|FG002|Overall Study|Withdrawal by Subject|2
7871511|NCT01674621|12364210|FG003|Overall Study|Withdrawal by Subject|0
7871512|NCT01674621|12364211|FG004|Overall Study|Withdrawal by Subject|1
7871513|NCT01674621|12364207|FG000|Overall Study|Other than specified|0
7871514|NCT01674621|12364208|FG001|Overall Study|Other than specified|1
7871515|NCT01674621|12364209|FG002|Overall Study|Other than specified|0
7871516|NCT01674621|12364210|FG003|Overall Study|Other than specified|0
7871517|NCT01674621|12364211|FG004|Overall Study|Other than specified|2
7871518|NCT01674634|12364224|FG000|Overall Study|Withdrawal by Subject|3
7871519|NCT01674634|12364224|FG000|Overall Study|Lost to Follow-up|3
7871520|NCT01674647|12364234|FG000|Treatment Period|Death|4
7871521|NCT01674647|12364235|FG001|Treatment Period|Death|1
7871522|NCT01674647|12364234|FG000|Treatment Period|Efficacy outcome reached|0
7793446|NCT01048502|12248864|FG002|Overall Study|Lost to Follow-up|0
7793447|NCT01048502|12248865|FG003|Overall Study|Lost to Follow-up|0
7793448|NCT01048502|12248862|FG000|Overall Study|Adverse Event|1
7793449|NCT01048502|12248863|FG001|Overall Study|Adverse Event|0
7793450|NCT01048502|12248864|FG002|Overall Study|Adverse Event|0
7793451|NCT01048502|12248865|FG003|Overall Study|Adverse Event|0
7793452|NCT01048502|12248862|FG000|Overall Study|Withdrawal by Subject|1
7793453|NCT01048502|12248863|FG001|Overall Study|Withdrawal by Subject|4
7793454|NCT01048502|12248864|FG002|Overall Study|Withdrawal by Subject|5
7871523|NCT01674647|12364235|FG001|Treatment Period|Efficacy outcome reached|1
7793455|NCT01048502|12248865|FG003|Overall Study|Withdrawal by Subject|3
7793456|NCT01048502|12248862|FG000|Overall Study|Physician Decision|0
7793457|NCT01048502|12248863|FG001|Overall Study|Physician Decision|3
7793458|NCT01048502|12248864|FG002|Overall Study|Physician Decision|0
7793459|NCT01048502|12248865|FG003|Overall Study|Physician Decision|1
7793460|NCT01048541|12248876|FG000|Overall Study|Withdrawal by Subject|1
7793461|NCT01048541|12248877|FG001|Overall Study|Withdrawal by Subject|0
7793462|NCT01048671|12248925|FG000|Overall Study|Protocol Violation|0
7793463|NCT01048671|12248926|FG001|Overall Study|Protocol Violation|1
7793464|NCT01048671|12248927|FG002|Overall Study|Protocol Violation|1
7793465|NCT01048788|12248942|FG000|Overall Study|Adverse Event|5
7793466|NCT01048788|12248943|FG001|Overall Study|Adverse Event|1
7793467|NCT01048788|12248944|FG002|Overall Study|Adverse Event|1
7793468|NCT01048788|12248942|FG000|Overall Study|Lack of Efficacy|0
7793469|NCT01048788|12248943|FG001|Overall Study|Lack of Efficacy|0
7793470|NCT01048788|12248944|FG002|Overall Study|Lack of Efficacy|1
7793471|NCT01048788|12248942|FG000|Overall Study|Withdrawal by Subject|0
7793472|NCT01048788|12248943|FG001|Overall Study|Withdrawal by Subject|1
7793473|NCT01048788|12248944|FG002|Overall Study|Withdrawal by Subject|0
7793474|NCT01048866|12248954|FG000|Overall Study|Adverse Event|1
7793475|NCT01048866|12248955|FG001|Overall Study|Adverse Event|0
7793476|NCT01048866|12248954|FG000|Overall Study|Protocol Violation|1
7793477|NCT01048866|12248955|FG001|Overall Study|Protocol Violation|0
7793478|NCT01048866|12248954|FG000|Overall Study|Physician Decision|1
7793479|NCT01048866|12248955|FG001|Overall Study|Physician Decision|0
7793480|NCT01048866|12248954|FG000|Overall Study|Withdrawal by Subject|0
7793481|NCT01048866|12248955|FG001|Overall Study|Withdrawal by Subject|2
7793482|NCT01048866|12248954|FG000|Overall Study|Lost to Follow-up|0
7793483|NCT01048866|12248955|FG001|Overall Study|Lost to Follow-up|2
7793484|NCT01048866|12248954|FG000|Overall Study|Other|1
7793485|NCT01048866|12248955|FG001|Overall Study|Other|1
7800920|NCT01098162|12258508|FG000|Overall Study|Lack of Efficacy|4
7800921|NCT01098162|12258508|FG000|Overall Study|Wish of Patient|7
7800922|NCT01098162|12258508|FG000|Overall Study|Lost to Follow-up|9
7800923|NCT01098162|12258508|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5
7800924|NCT01098162|12258508|FG000|Overall Study|Adverse Event & Lack of Efficacy|6
7800925|NCT01098162|12258508|FG000|Overall Study|Adverse Event & Wish of Patient|13
7800926|NCT01098162|12258508|FG000|Overall Study|Adverse Event & Lost to Follow-up|2
7800927|NCT01098162|12258508|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
7800928|NCT01098162|12258508|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1
7800929|NCT01098162|12258508|FG000|Overall Study|Other Reason|1
7800930|NCT01098162|12258508|FG000|Overall Study|Reason Unknown|26
7800931|NCT01098240|12258512|FG000|Open-Label Phase|Study Terminated by Sponsor|27
7800932|NCT01098240|12258513|FG001|Open-Label Phase|Study Terminated by Sponsor|0
7800933|NCT01098240|12258514|FG002|Open-Label Phase|Study Terminated by Sponsor|0
7800934|NCT01098240|12258512|FG000|Open-Label Phase|Protocol Violation|4
7800935|NCT01098240|12258513|FG001|Open-Label Phase|Protocol Violation|0
7800936|NCT01098240|12258514|FG002|Open-Label Phase|Protocol Violation|0
7800937|NCT01098240|12258512|FG000|Open-Label Phase|Lost to Follow-up|13
7800938|NCT01098240|12258513|FG001|Open-Label Phase|Lost to Follow-up|0
7800939|NCT01098240|12258514|FG002|Open-Label Phase|Lost to Follow-up|0
7800940|NCT01098240|12258512|FG000|Open-Label Phase|Other|19
7800941|NCT01098240|12258513|FG001|Open-Label Phase|Other|0
7800942|NCT01098240|12258514|FG002|Open-Label Phase|Other|0
7800943|NCT01098240|12258512|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50
7800944|NCT01098240|12258513|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0
7800945|NCT01098240|12258514|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0
7800946|NCT01098240|12258512|FG000|Open-Label Phase|Pregnancy|1
7800947|NCT01098240|12258513|FG001|Open-Label Phase|Pregnancy|0
7800948|NCT01098240|12258514|FG002|Open-Label Phase|Pregnancy|0
7800949|NCT01098240|12258512|FG000|Open-Label Phase|Withdrawal by Subject|9
7800950|NCT01098240|12258513|FG001|Open-Label Phase|Withdrawal by Subject|0
7800951|NCT01098240|12258514|FG002|Open-Label Phase|Withdrawal by Subject|0
7800952|NCT01098240|12258512|FG000|Open-Label Phase|Adverse Event|12
7800953|NCT01098240|12258513|FG001|Open-Label Phase|Adverse Event|0
7800954|NCT01098240|12258514|FG002|Open-Label Phase|Adverse Event|0
7800955|NCT01098240|12258512|FG000|Double-Blind Phase|Study Terminated by Sponsor|0
7800956|NCT01098240|12258513|FG001|Double-Blind Phase|Study Terminated by Sponsor|5
7800957|NCT01098240|12258514|FG002|Double-Blind Phase|Study Terminated by Sponsor|8
7800958|NCT01098240|12258512|FG000|Double-Blind Phase|Protocol Violation|0
7800959|NCT01098240|12258513|FG001|Double-Blind Phase|Protocol Violation|2
7800960|NCT01098240|12258514|FG002|Double-Blind Phase|Protocol Violation|4
7800961|NCT01098240|12258512|FG000|Double-Blind Phase|Lost to Follow-up|0
7800962|NCT01098240|12258513|FG001|Double-Blind Phase|Lost to Follow-up|2
7800963|NCT01098240|12258514|FG002|Double-Blind Phase|Lost to Follow-up|0
7800964|NCT01098240|12258512|FG000|Double-Blind Phase|Other|0
7800965|NCT01098240|12258513|FG001|Double-Blind Phase|Other|2
7800966|NCT01098240|12258514|FG002|Double-Blind Phase|Other|2
7800967|NCT01098240|12258512|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0
7800968|NCT01098240|12258513|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1
7871524|NCT01674647|12364234|FG000|Treatment Period|Physician Decision|3
7871525|NCT01674647|12364235|FG001|Treatment Period|Physician Decision|1
7871526|NCT01674647|12364234|FG000|Treatment Period|Adverse Event|60
7871527|NCT01674647|12364235|FG001|Treatment Period|Adverse Event|22
7871528|NCT01674647|12364234|FG000|Treatment Period|Non-compliance with study drug|3
7871529|NCT01674647|12364235|FG001|Treatment Period|Non-compliance with study drug|0
7871530|NCT01674647|12364234|FG000|Treatment Period|Lost to Follow-up|1
7871531|NCT01674647|12364235|FG001|Treatment Period|Lost to Follow-up|1
7871532|NCT01674647|12364234|FG000|Treatment Period|Withdrawal by Subject|19
7871533|NCT01674647|12364235|FG001|Treatment Period|Withdrawal by Subject|16
7871534|NCT01674647|12364234|FG000|Treatment Period|Switching to other therapy|5
7871535|NCT01674647|12364235|FG001|Treatment Period|Switching to other therapy|2
7871536|NCT01674647|12364234|FG000|Treatment Period|Logistical difficulties|5
7871537|NCT01674647|12364235|FG001|Treatment Period|Logistical difficulties|8
7871538|NCT01674647|12364234|FG000|Treatment Period|Treatment failure|0
7871539|NCT01674647|12364235|FG001|Treatment Period|Treatment failure|14
7871540|NCT01674647|12364234|FG000|Treatment Period|Protocol Violation|56
7871541|NCT01674647|12364235|FG001|Treatment Period|Protocol Violation|36
7871542|NCT01674647|12364234|FG000|30-day Safety Follow-up Period|Death|3
7871543|NCT01674647|12364235|FG001|30-day Safety Follow-up Period|Death|2
7871544|NCT01674647|12364234|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0
7871545|NCT01674647|12364235|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1
7871546|NCT01674647|12364234|FG000|30-day Safety Follow-up Period|Protocol Violation|39
7871547|NCT01674647|12364235|FG001|30-day Safety Follow-up Period|Protocol Violation|22
7871548|NCT01674647|12364234|FG000|30-day Safety Follow-up Period|Logistical difficulties|1
7871549|NCT01674647|12364235|FG001|30-day Safety Follow-up Period|Logistical difficulties|3
7871550|NCT01674647|12364234|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7
7871551|NCT01674647|12364235|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8
7871552|NCT01674647|12364234|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8
7871553|NCT01674647|12364235|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5
7871554|NCT01674712|12364246|FG000|Overall Study|Adverse Event|5
7871555|NCT01674712|12364247|FG001|Overall Study|Adverse Event|6
7871556|NCT01674712|12364248|FG002|Overall Study|Adverse Event|3
7871557|NCT01674712|12364249|FG003|Overall Study|Adverse Event|4
7871558|NCT01674712|12364250|FG004|Overall Study|Adverse Event|6
7793486|NCT01048944|12248982|FG000|Overall Study|Protocol Violation|8
7793487|NCT01048944|12248983|FG001|Overall Study|Protocol Violation|10
7793488|NCT01048944|12248984|FG002|Overall Study|Protocol Violation|10
7793489|NCT01048944|12248985|FG003|Overall Study|Protocol Violation|2
7793490|NCT01049009|12248997|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2
7793491|NCT01049009|12248998|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2
7793492|NCT01049009|12248997|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7793493|NCT01049009|12248998|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7793494|NCT01049009|12248997|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
7793495|NCT01049009|12248998|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
7793496|NCT01049009|12248997|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8
7793497|NCT01049009|12248998|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7
7793498|NCT01049217|12249006|FG000|Overall Study|Adverse Event|2
7793499|NCT01049217|12249007|FG001|Overall Study|Adverse Event|1
7793500|NCT01049217|12249006|FG000|Overall Study|Lack of Efficacy|1
7793501|NCT01049217|12249007|FG001|Overall Study|Lack of Efficacy|1
7793502|NCT01049217|12249006|FG000|Overall Study|Lost to Follow-up|3
7793503|NCT01049217|12249007|FG001|Overall Study|Lost to Follow-up|8
7793504|NCT01049217|12249006|FG000|Overall Study|Withdrawal by Subject|4
7793505|NCT01049217|12249007|FG001|Overall Study|Withdrawal by Subject|3
7793506|NCT01049217|12249006|FG000|Overall Study|Protocol Violation|1
7793507|NCT01049217|12249007|FG001|Overall Study|Protocol Violation|3
7793508|NCT01049217|12249006|FG000|Overall Study|Pregnancy|1
7793509|NCT01049217|12249007|FG001|Overall Study|Pregnancy|0
7793510|NCT01049217|12249006|FG000|Overall Study|Study Terminated by Sponsor|43
7793511|NCT01049217|12249007|FG001|Overall Study|Study Terminated by Sponsor|43
7793512|NCT01049217|12249006|FG000|Overall Study|Other|1
7793513|NCT01049217|12249007|FG001|Overall Study|Other|2
7793514|NCT01049217|12249006|FG000|Overall Study|Randomized but not Treated|0
7793515|NCT01049217|12249007|FG001|Overall Study|Randomized but not Treated|2
7793516|NCT01049308|12249018|FG000|Pill Counts|Withdrawal by Subject|83
7793517|NCT01049334|12249027|FG000|Overall Study|Withdrawal by Subject|5
7793518|NCT01049334|12249028|FG001|Overall Study|Withdrawal by Subject|3
7793519|NCT01049334|12249027|FG000|Overall Study|Adverse Event|2
7793520|NCT01049334|12249028|FG001|Overall Study|Adverse Event|3
7793521|NCT01049334|12249027|FG000|Overall Study|Physician Decision|2
7793522|NCT01049334|12249028|FG001|Overall Study|Physician Decision|0
7793523|NCT01049334|12249027|FG000|Overall Study|Protocol Violation|0
7793524|NCT01049334|12249028|FG001|Overall Study|Protocol Violation|1
7793525|NCT01049360|12249034|FG000|Period 1|Adverse Event|0
7793526|NCT01049360|12249035|FG001|Period 1|Adverse Event|1
7793527|NCT01049360|12249036|FG002|Period 1|Adverse Event|0
7793528|NCT01049360|12249037|FG003|Period 1|Adverse Event|1
7793529|NCT01049360|12249038|FG004|Period 1|Adverse Event|0
7793530|NCT01049360|12249039|FG005|Period 1|Adverse Event|0
7793531|NCT01049360|12249040|FG006|Period 1|Adverse Event|0
7871559|NCT01674712|12364246|FG000|Overall Study|Lost to Follow-up|1
7871560|NCT01674712|12364247|FG001|Overall Study|Lost to Follow-up|0
7793532|NCT01049360|12249041|FG007|Period 1|Adverse Event|1
7793533|NCT01049360|12249042|FG008|Period 1|Adverse Event|0
7793534|NCT01049360|12249043|FG009|Period 1|Adverse Event|0
7793535|NCT01049360|12249044|FG010|Period 1|Adverse Event|0
7793536|NCT01049360|12249045|FG011|Period 1|Adverse Event|0
7793537|NCT01049360|12249046|FG012|Period 1|Adverse Event|1
7793538|NCT01049360|12249047|FG013|Period 1|Adverse Event|1
7793539|NCT01049360|12249048|FG014|Period 1|Adverse Event|0
7793540|NCT01049360|12249049|FG015|Period 1|Adverse Event|0
7793541|NCT01049360|12249050|FG016|Period 1|Adverse Event|1
7793542|NCT01049360|12249051|FG017|Period 1|Adverse Event|0
7793543|NCT01049360|12249052|FG018|Period 1|Adverse Event|1
7793544|NCT01049360|12249053|FG019|Period 1|Adverse Event|0
7793545|NCT01049360|12249034|FG000|Period 1|Did not meet inc/exc criteria|0
7793546|NCT01049360|12249035|FG001|Period 1|Did not meet inc/exc criteria|0
7793547|NCT01049360|12249036|FG002|Period 1|Did not meet inc/exc criteria|0
7793548|NCT01049360|12249037|FG003|Period 1|Did not meet inc/exc criteria|0
7793549|NCT01049360|12249038|FG004|Period 1|Did not meet inc/exc criteria|0
7793550|NCT01049360|12249039|FG005|Period 1|Did not meet inc/exc criteria|0
7793551|NCT01049360|12249040|FG006|Period 1|Did not meet inc/exc criteria|0
7793552|NCT01049360|12249041|FG007|Period 1|Did not meet inc/exc criteria|1
7793553|NCT01049360|12249042|FG008|Period 1|Did not meet inc/exc criteria|1
7793554|NCT01049360|12249043|FG009|Period 1|Did not meet inc/exc criteria|0
7793555|NCT01049360|12249044|FG010|Period 1|Did not meet inc/exc criteria|0
7793556|NCT01049360|12249045|FG011|Period 1|Did not meet inc/exc criteria|0
7793557|NCT01049360|12249046|FG012|Period 1|Did not meet inc/exc criteria|0
7793558|NCT01049360|12249047|FG013|Period 1|Did not meet inc/exc criteria|0
7793559|NCT01049360|12249048|FG014|Period 1|Did not meet inc/exc criteria|0
7793560|NCT01049360|12249049|FG015|Period 1|Did not meet inc/exc criteria|0
7793561|NCT01049360|12249050|FG016|Period 1|Did not meet inc/exc criteria|0
7793562|NCT01049360|12249051|FG017|Period 1|Did not meet inc/exc criteria|0
7793563|NCT01049360|12249052|FG018|Period 1|Did not meet inc/exc criteria|0
7793564|NCT01049360|12249053|FG019|Period 1|Did not meet inc/exc criteria|0
7793565|NCT01049360|12249034|FG000|Period 1|Withdrawal by Subject|0
7793566|NCT01049360|12249035|FG001|Period 1|Withdrawal by Subject|0
7793567|NCT01049360|12249036|FG002|Period 1|Withdrawal by Subject|0
7793568|NCT01049360|12249037|FG003|Period 1|Withdrawal by Subject|0
7871561|NCT01674712|12364248|FG002|Overall Study|Lost to Follow-up|0
7871562|NCT01674712|12364249|FG003|Overall Study|Lost to Follow-up|0
7871563|NCT01674712|12364250|FG004|Overall Study|Lost to Follow-up|0
7871564|NCT01674712|12364246|FG000|Overall Study|Protocol Violation|2
7871565|NCT01674712|12364247|FG001|Overall Study|Protocol Violation|0
7793569|NCT01049360|12249038|FG004|Period 1|Withdrawal by Subject|0
7793570|NCT01049360|12249039|FG005|Period 1|Withdrawal by Subject|0
7793571|NCT01049360|12249040|FG006|Period 1|Withdrawal by Subject|0
7793572|NCT01049360|12249041|FG007|Period 1|Withdrawal by Subject|0
7793573|NCT01049360|12249042|FG008|Period 1|Withdrawal by Subject|1
7793574|NCT01049360|12249043|FG009|Period 1|Withdrawal by Subject|0
7793575|NCT01049360|12249044|FG010|Period 1|Withdrawal by Subject|1
7793576|NCT01049360|12249045|FG011|Period 1|Withdrawal by Subject|0
7793577|NCT01049360|12249046|FG012|Period 1|Withdrawal by Subject|1
7793578|NCT01049360|12249047|FG013|Period 1|Withdrawal by Subject|0
7793579|NCT01049360|12249048|FG014|Period 1|Withdrawal by Subject|0
7793580|NCT01049360|12249049|FG015|Period 1|Withdrawal by Subject|0
7793581|NCT01049360|12249050|FG016|Period 1|Withdrawal by Subject|0
7793582|NCT01049360|12249051|FG017|Period 1|Withdrawal by Subject|0
7793583|NCT01049360|12249052|FG018|Period 1|Withdrawal by Subject|0
7793584|NCT01049360|12249053|FG019|Period 1|Withdrawal by Subject|0
7793585|NCT01049360|12249034|FG000|Period 2|Protocol Violation|0
7793586|NCT01049360|12249035|FG001|Period 2|Protocol Violation|0
7793587|NCT01049360|12249036|FG002|Period 2|Protocol Violation|0
7793588|NCT01049360|12249037|FG003|Period 2|Protocol Violation|1
7793589|NCT01049360|12249038|FG004|Period 2|Protocol Violation|0
7793590|NCT01049360|12249039|FG005|Period 2|Protocol Violation|0
7793591|NCT01049360|12249040|FG006|Period 2|Protocol Violation|0
7793592|NCT01049360|12249041|FG007|Period 2|Protocol Violation|0
7793593|NCT01049360|12249042|FG008|Period 2|Protocol Violation|0
7793594|NCT01049360|12249043|FG009|Period 2|Protocol Violation|0
7793595|NCT01049360|12249044|FG010|Period 2|Protocol Violation|0
7793596|NCT01049360|12249045|FG011|Period 2|Protocol Violation|0
7793597|NCT01049360|12249046|FG012|Period 2|Protocol Violation|0
7793598|NCT01049360|12249047|FG013|Period 2|Protocol Violation|0
7793599|NCT01049360|12249048|FG014|Period 2|Protocol Violation|1
7793600|NCT01049360|12249049|FG015|Period 2|Protocol Violation|1
7793601|NCT01049360|12249050|FG016|Period 2|Protocol Violation|0
7793602|NCT01049360|12249051|FG017|Period 2|Protocol Violation|0
7793603|NCT01049360|12249052|FG018|Period 2|Protocol Violation|0
7793604|NCT01049360|12249053|FG019|Period 2|Protocol Violation|0
7793605|NCT01049360|12249034|FG000|Period 2|Adverse Event|0
7793606|NCT01049360|12249035|FG001|Period 2|Adverse Event|1
7793607|NCT01049360|12249036|FG002|Period 2|Adverse Event|0
7793608|NCT01049360|12249037|FG003|Period 2|Adverse Event|0
7793609|NCT01049360|12249038|FG004|Period 2|Adverse Event|0
7793610|NCT01049360|12249039|FG005|Period 2|Adverse Event|0
7793611|NCT01049360|12249040|FG006|Period 2|Adverse Event|0
7793612|NCT01049360|12249041|FG007|Period 2|Adverse Event|0
7793613|NCT01049360|12249042|FG008|Period 2|Adverse Event|1
7793614|NCT01049360|12249043|FG009|Period 2|Adverse Event|0
7871566|NCT01674712|12364248|FG002|Overall Study|Protocol Violation|0
7793615|NCT01049360|12249044|FG010|Period 2|Adverse Event|0
7793616|NCT01049360|12249045|FG011|Period 2|Adverse Event|0
7793617|NCT01049360|12249046|FG012|Period 2|Adverse Event|0
7793618|NCT01049360|12249047|FG013|Period 2|Adverse Event|0
7793619|NCT01049360|12249048|FG014|Period 2|Adverse Event|0
7793620|NCT01049360|12249049|FG015|Period 2|Adverse Event|0
7793621|NCT01049360|12249050|FG016|Period 2|Adverse Event|0
7793622|NCT01049360|12249051|FG017|Period 2|Adverse Event|0
7793623|NCT01049360|12249052|FG018|Period 2|Adverse Event|0
7871567|NCT01674712|12364249|FG003|Overall Study|Protocol Violation|0
7871568|NCT01674712|12364250|FG004|Overall Study|Protocol Violation|0
7871569|NCT01674712|12364246|FG000|Overall Study|Withdrawal by Subject|2
7871570|NCT01674712|12364247|FG001|Overall Study|Withdrawal by Subject|2
7871571|NCT01674712|12364248|FG002|Overall Study|Withdrawal by Subject|5
7871572|NCT01674712|12364249|FG003|Overall Study|Withdrawal by Subject|4
7871573|NCT01674712|12364250|FG004|Overall Study|Withdrawal by Subject|3
7871574|NCT01674712|12364246|FG000|Overall Study|Administrative|0
7871575|NCT01674712|12364247|FG001|Overall Study|Administrative|1
7871576|NCT01674712|12364248|FG002|Overall Study|Administrative|0
7871577|NCT01674712|12364249|FG003|Overall Study|Administrative|0
7871578|NCT01674712|12364250|FG004|Overall Study|Administrative|1
7871579|NCT01674712|12364246|FG000|Overall Study|Lack of Efficacy|0
7871580|NCT01674712|12364247|FG001|Overall Study|Lack of Efficacy|0
7871581|NCT01674712|12364248|FG002|Overall Study|Lack of Efficacy|1
7871582|NCT01674712|12364249|FG003|Overall Study|Lack of Efficacy|0
7871583|NCT01674712|12364250|FG004|Overall Study|Lack of Efficacy|1
7871584|NCT01674725|12364264|FG000|Overall Study|Adverse Event|1
7871585|NCT01674725|12364265|FG001|Overall Study|Adverse Event|0
7871586|NCT01674725|12364264|FG000|Overall Study|Did not receive study drug|1
7871587|NCT01674725|12364265|FG001|Overall Study|Did not receive study drug|0
7871588|NCT01674725|12364264|FG000|Overall Study|Withdrawal by Subject|1
7871589|NCT01674725|12364265|FG001|Overall Study|Withdrawal by Subject|0
7871590|NCT01674725|12364264|FG000|Overall Study|Lost to Follow-up|0
7871591|NCT01674725|12364265|FG001|Overall Study|Lost to Follow-up|1
7871592|NCT01675050|12364273|FG000|Period One Treatment|Withdrawal by Subject|1
7871593|NCT01675050|12364274|FG001|Period One Treatment|Withdrawal by Subject|0
7871594|NCT01675128|12364287|FG000|Overall Study|Disease progression on study|1
7871595|NCT01675128|12364288|FG001|Overall Study|Disease progression on study|1
7871596|NCT01675128|12364289|FG002|Overall Study|Disease progression on study|1
7871597|NCT01675128|12364287|FG000|Overall Study|Refused further treatment|1
7871598|NCT01675128|12364288|FG001|Overall Study|Refused further treatment|0
7871599|NCT01675128|12364289|FG002|Overall Study|Refused further treatment|0
7871600|NCT01675128|12364287|FG000|Overall Study|Pulmonary complication; off study|0
7871601|NCT01675128|12364288|FG001|Overall Study|Pulmonary complication; off study|1
7871602|NCT01675128|12364289|FG002|Overall Study|Pulmonary complication; off study|0
7871603|NCT01675141|12364304|FG000|Overall Study|Lenalidomide outside NIH|3
7871604|NCT01675141|12364304|FG000|Overall Study|Withdrawal by Subject|3
7871605|NCT01675141|12364304|FG000|Overall Study|Physician Decision|4
7871606|NCT01675141|12364304|FG000|Overall Study|No treatment, per protocol|1
7871607|NCT01675154|12364312|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
7871608|NCT01675154|12364313|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1
7871609|NCT01675154|12364314|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
7871610|NCT01675154|12364315|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
7871611|NCT01675167|12364339|FG000|Open-label Titration Phase|Adverse Event|81
7871612|NCT01675167|12364340|FG001|Open-label Titration Phase|Adverse Event|0
7871613|NCT01675167|12364341|FG002|Open-label Titration Phase|Adverse Event|0
7871614|NCT01675167|12364339|FG000|Open-label Titration Phase|Lack of Efficacy|63
7871615|NCT01675167|12364340|FG001|Open-label Titration Phase|Lack of Efficacy|0
7871616|NCT01675167|12364341|FG002|Open-label Titration Phase|Lack of Efficacy|0
7871617|NCT01675167|12364339|FG000|Open-label Titration Phase|Withdrawal by Subject|46
7871618|NCT01675167|12364340|FG001|Open-label Titration Phase|Withdrawal by Subject|0
7871619|NCT01675167|12364341|FG002|Open-label Titration Phase|Withdrawal by Subject|0
7871620|NCT01675167|12364339|FG000|Open-label Titration Phase|Protocol Violation|43
7871621|NCT01675167|12364340|FG001|Open-label Titration Phase|Protocol Violation|0
7871622|NCT01675167|12364341|FG002|Open-label Titration Phase|Protocol Violation|0
7871623|NCT01675167|12364339|FG000|Open-label Titration Phase|Lost to Follow-up|15
7871624|NCT01675167|12364340|FG001|Open-label Titration Phase|Lost to Follow-up|0
7871625|NCT01675167|12364341|FG002|Open-label Titration Phase|Lost to Follow-up|0
7871626|NCT01675167|12364339|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
7871627|NCT01675167|12364340|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
7871628|NCT01675167|12364341|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
7871629|NCT01675167|12364339|FG000|Open-label Titration Phase|Other|55
7871630|NCT01675167|12364340|FG001|Open-label Titration Phase|Other|0
7871631|NCT01675167|12364341|FG002|Open-label Titration Phase|Other|0
7871632|NCT01675167|12364339|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
7871633|NCT01675167|12364340|FG001|Double-blind Treatment Phase|Lack of Efficacy|19
7871634|NCT01675167|12364341|FG002|Double-blind Treatment Phase|Lack of Efficacy|61
7871635|NCT01675167|12364339|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
7871636|NCT01675167|12364340|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11
7871637|NCT01675167|12364341|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6
7793624|NCT01049360|12249053|FG019|Period 2|Adverse Event|1
7871638|NCT01675167|12364339|FG000|Double-blind Treatment Phase|Adverse Event|0
7871639|NCT01675167|12364340|FG001|Double-blind Treatment Phase|Adverse Event|5
7871640|NCT01675167|12364341|FG002|Double-blind Treatment Phase|Adverse Event|13
7871641|NCT01675167|12364339|FG000|Double-blind Treatment Phase|Protocol Violation|0
7871642|NCT01675167|12364340|FG001|Double-blind Treatment Phase|Protocol Violation|4
7871643|NCT01675167|12364341|FG002|Double-blind Treatment Phase|Protocol Violation|11
7871644|NCT01675167|12364339|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
7871645|NCT01675167|12364340|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
7871646|NCT01675167|12364341|FG002|Double-blind Treatment Phase|Lost to Follow-up|5
7871647|NCT01675167|12364339|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
7871648|NCT01675167|12364340|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
7871649|NCT01675167|12364341|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
7871650|NCT01675167|12364339|FG000|Double-blind Treatment Phase|Other|0
7871651|NCT01675167|12364340|FG001|Double-blind Treatment Phase|Other|7
7871652|NCT01675167|12364341|FG002|Double-blind Treatment Phase|Other|5
7871653|NCT01675427|12364358|FG000|Overall Study|Withdrawal by Subject|7
7871654|NCT01675427|12364358|FG000|Overall Study|Participant Refused Sample Collection|18
7871655|NCT01675427|12364358|FG000|Overall Study|Sample not Collected by Mistake|2
7871656|NCT01675427|12364358|FG000|Overall Study|Lost to Follow-up|5
7871657|NCT01675427|12364358|FG000|Overall Study|Other|2
7871658|NCT01675492|12364401|FG000|Overall Study|study completed early - product approval|42
7871659|NCT01675531|12364406|FG000|Overall Study|Adverse Event|9
7871660|NCT01675531|12364406|FG000|Overall Study|Withdrawal by Subject|7
7871661|NCT01675531|12364406|FG000|Overall Study|Lack of Efficacy|1
7871662|NCT01675531|12364406|FG000|Overall Study|Protocol Violation|8
7871663|NCT01675544|12364411|FG000|Overall Study|Withdrawal by Subject|2
7871664|NCT01675596|12364415|FG000|Overall Study|Death|6
7871665|NCT01675596|12364415|FG000|Overall Study|Exit with other reason|1
7871666|NCT01675596|12364415|FG000|Overall Study|Missed Visit|1
7871667|NCT01675622|12364421|FG000|Overall Study|Withdrawal by Subject|2
7871668|NCT01675622|12364422|FG001|Overall Study|Withdrawal by Subject|2
7871669|NCT01675622|12364421|FG000|Overall Study|Adverse Event|12
7871670|NCT01675622|12364422|FG001|Overall Study|Adverse Event|10
7871671|NCT01675622|12364421|FG000|Overall Study|Protocol Violation|4
7871672|NCT01675622|12364422|FG001|Overall Study|Protocol Violation|1
7871673|NCT01675622|12364421|FG000|Overall Study|Lack of Efficacy|2
7871674|NCT01675622|12364422|FG001|Overall Study|Lack of Efficacy|4
7871675|NCT01675622|12364421|FG000|Overall Study|Lost to Follow-up|1
7871676|NCT01675622|12364422|FG001|Overall Study|Lost to Follow-up|3
7871677|NCT01675622|12364421|FG000|Overall Study|Other|5
7871678|NCT01675622|12364422|FG001|Overall Study|Other|4
7871679|NCT01675661|12364444|FG000|Overall Study|Lost to Follow-up|22
7871680|NCT01675661|12364445|FG001|Overall Study|Lost to Follow-up|23
7871681|NCT01675661|12364444|FG000|Overall Study|Practical problems|9
7871682|NCT01675661|12364445|FG001|Overall Study|Practical problems|5
7871683|NCT01675661|12364444|FG000|Overall Study|Moved away|5
7871684|NCT01675661|12364445|FG001|Overall Study|Moved away|6
7871685|NCT01675661|12364444|FG000|Overall Study|Withdrawal by Subject|3
7871686|NCT01675661|12364445|FG001|Overall Study|Withdrawal by Subject|7
7871687|NCT01675661|12364444|FG000|Overall Study|Physician Decision|0
7871688|NCT01675661|12364445|FG001|Overall Study|Physician Decision|2
7871689|NCT01675661|12364444|FG000|Overall Study|Death|0
7871690|NCT01675661|12364445|FG001|Overall Study|Death|1
7871691|NCT01675661|12364444|FG000|Overall Study|Other reason|1
7871692|NCT01675661|12364445|FG001|Overall Study|Other reason|2
7871693|NCT01675765|12364453|FG000|Overall Study|Progressive disease|4
7871694|NCT01675765|12364454|FG001|Overall Study|Progressive disease|4
7871695|NCT01675765|12364453|FG000|Overall Study|Adverse Event|1
7871696|NCT01675765|12364454|FG001|Overall Study|Adverse Event|2
7871697|NCT01675765|12364453|FG000|Overall Study|Withdrawal by Subject|2
7871698|NCT01675765|12364454|FG001|Overall Study|Withdrawal by Subject|0
7871699|NCT01675765|12364453|FG000|Overall Study|Death|1
7871700|NCT01675765|12364454|FG001|Overall Study|Death|0
7871701|NCT01675765|12364453|FG000|Overall Study|Clinical progression|3
7871702|NCT01675765|12364454|FG001|Overall Study|Clinical progression|2
7871703|NCT01675882|12364473|FG000|Overall Study|Adverse Event|0
7871704|NCT01675882|12364474|FG001|Overall Study|Adverse Event|2
7871705|NCT01675882|12364475|FG002|Overall Study|Adverse Event|1
7871706|NCT01675882|12364476|FG003|Overall Study|Adverse Event|0
7871707|NCT01675882|12364473|FG000|Overall Study|Participant unwilling to continue|2
7871708|NCT01675882|12364474|FG001|Overall Study|Participant unwilling to continue|4
7871709|NCT01675882|12364475|FG002|Overall Study|Participant unwilling to continue|2
7871710|NCT01675882|12364476|FG003|Overall Study|Participant unwilling to continue|1
7871711|NCT01675882|12364473|FG000|Overall Study|Lost to Follow-up|0
7871712|NCT01675882|12364474|FG001|Overall Study|Lost to Follow-up|1
7871713|NCT01675882|12364475|FG002|Overall Study|Lost to Follow-up|0
7871714|NCT01675882|12364476|FG003|Overall Study|Lost to Follow-up|0
7871715|NCT01675882|12364473|FG000|Overall Study|Non-compliance|0
7871716|NCT01675882|12364474|FG001|Overall Study|Non-compliance|0
7871717|NCT01675882|12364475|FG002|Overall Study|Non-compliance|0
7871718|NCT01675882|12364476|FG003|Overall Study|Non-compliance|1
7871719|NCT01676012|12364486|FG000|Overall Study|Adverse Event|2
7871720|NCT01676012|12364486|FG000|Overall Study|incomplete set of videos|1
7871721|NCT01676116|12364492|FG000|Overall Study|Withdrawal criteria|2
7871722|NCT01676116|12364493|FG001|Overall Study|Withdrawal criteria|14
7871723|NCT01676116|12364492|FG000|Overall Study|Adverse Event|1
7871724|NCT01676116|12364493|FG001|Overall Study|Adverse Event|2
7871725|NCT01676116|12364492|FG000|Overall Study|Unclassified|4
7871726|NCT01676116|12364493|FG001|Overall Study|Unclassified|10
7871727|NCT01676116|12364492|FG000|Overall Study|Protocol Violation|9
7871728|NCT01676116|12364493|FG001|Overall Study|Protocol Violation|3
7871729|NCT01676220|12364501|FG000|Overall Study|Randomized But Not Treated|4
7871730|NCT01676220|12364502|FG001|Overall Study|Randomized But Not Treated|1
7871731|NCT01676220|12364501|FG000|Overall Study|Adverse Event|10
7871732|NCT01676220|12364502|FG001|Overall Study|Adverse Event|8
7871733|NCT01676220|12364501|FG000|Overall Study|Lack of Efficacy|2
7871734|NCT01676220|12364502|FG001|Overall Study|Lack of Efficacy|5
7871735|NCT01676220|12364501|FG000|Overall Study|Protocol Violation|11
7871736|NCT01676220|12364502|FG001|Overall Study|Protocol Violation|12
7871737|NCT01676220|12364501|FG000|Overall Study|Received Rescue Therapy|14
7871738|NCT01676220|12364502|FG001|Overall Study|Received Rescue Therapy|22
7871739|NCT01676220|12364501|FG000|Overall Study|Personal Reason|34
7871740|NCT01676220|12364502|FG001|Overall Study|Personal Reason|45
7871741|NCT01676220|12364501|FG000|Overall Study|Lost to Follow-up|11
7871742|NCT01676220|12364502|FG001|Overall Study|Lost to Follow-up|18
7871743|NCT01676220|12364501|FG000|Overall Study|Selection Criterion/Protocol Violation|9
7871744|NCT01676220|12364502|FG001|Overall Study|Selection Criterion/Protocol Violation|9
7871745|NCT01676220|12364501|FG000|Overall Study|Site Closure/Site Withdrawal|1
7871746|NCT01676220|12364502|FG001|Overall Study|Site Closure/Site Withdrawal|4
7871747|NCT01676220|12364501|FG000|Overall Study|Perceived Lack of Efficacy|3
7871748|NCT01676220|12364502|FG001|Overall Study|Perceived Lack of Efficacy|1
7871749|NCT01676220|12364501|FG000|Overall Study|Non Serious Hypoglycemia|2
7871750|NCT01676220|12364502|FG001|Overall Study|Non Serious Hypoglycemia|0
7871751|NCT01676220|12364501|FG000|Overall Study|No More Need of Insulin|1
7871752|NCT01676220|12364502|FG001|Overall Study|No More Need of Insulin|0
7871753|NCT01676727|12364575|FG000|Overall Study|Death|18
7871754|NCT01676727|12364575|FG000|Overall Study|Withdrawal by Subject|6
7871755|NCT01676727|12364575|FG000|Overall Study|Screening failure|5
7871756|NCT01676727|12364575|FG000|Overall Study|Not willing to attend 1-year visit|2
7871757|NCT01676727|12364575|FG000|Overall Study|Valve explanted|1
7871758|NCT01676896|12364592|FG000|Overall Study|Withdrawal by Subject|12
7871759|NCT01676896|12364593|FG001|Overall Study|Withdrawal by Subject|7
7871760|NCT01676896|12364594|FG002|Overall Study|Withdrawal by Subject|19
7871761|NCT01676909|12364604|FG000|Overall Study|Withdrawal by Subject|3
7871762|NCT01676909|12364605|FG001|Overall Study|Withdrawal by Subject|5
7871763|NCT01676909|12364604|FG000|Overall Study|Lost to Follow-up|15
7871764|NCT01676909|12364605|FG001|Overall Study|Lost to Follow-up|9
7871765|NCT01677182|12364616|FG000|Overall Study|Adverse Event|2
7871766|NCT01677182|12364617|FG001|Overall Study|Adverse Event|1
7871767|NCT01677182|12364618|FG002|Overall Study|Adverse Event|8
7871768|NCT01677182|12364616|FG000|Overall Study|Protocol Violation|5
7871769|NCT01677182|12364617|FG001|Overall Study|Protocol Violation|1
7871770|NCT01677182|12364618|FG002|Overall Study|Protocol Violation|4
7871771|NCT01677182|12364616|FG000|Overall Study|Lost to Follow-up|4
7871772|NCT01677182|12364617|FG001|Overall Study|Lost to Follow-up|0
7871773|NCT01677182|12364618|FG002|Overall Study|Lost to Follow-up|3
7871774|NCT01677182|12364616|FG000|Overall Study|Withdrawal by Subject|7
7871775|NCT01677182|12364617|FG001|Overall Study|Withdrawal by Subject|12
7871776|NCT01677182|12364618|FG002|Overall Study|Withdrawal by Subject|10
7871777|NCT01677182|12364616|FG000|Overall Study|Study termination|12
7871778|NCT01677182|12364617|FG001|Overall Study|Study termination|9
7871779|NCT01677182|12364618|FG002|Overall Study|Study termination|11
7871780|NCT01677182|12364616|FG000|Overall Study|Lack of Efficacy|3
7871781|NCT01677182|12364617|FG001|Overall Study|Lack of Efficacy|0
7871782|NCT01677182|12364618|FG002|Overall Study|Lack of Efficacy|1
7871783|NCT01677182|12364616|FG000|Overall Study|Other reasons|1
7871784|NCT01677182|12364617|FG001|Overall Study|Other reasons|5
7871785|NCT01677182|12364618|FG002|Overall Study|Other reasons|2
7871786|NCT01677195|12364629|FG000|Overall Study|Lost to Follow-up|14
7871787|NCT01677195|12364630|FG001|Overall Study|Lost to Follow-up|22
7871788|NCT01677195|12364631|FG002|Overall Study|Lost to Follow-up|22
7871789|NCT01677195|12364629|FG000|Overall Study|Withdrawal by Subject|1
7871790|NCT01677195|12364630|FG001|Overall Study|Withdrawal by Subject|0
7871791|NCT01677195|12364631|FG002|Overall Study|Withdrawal by Subject|1
7871792|NCT01677195|12364629|FG000|Overall Study|Adverse Event|6
7871793|NCT01677195|12364630|FG001|Overall Study|Adverse Event|4
7871794|NCT01677195|12364631|FG002|Overall Study|Adverse Event|1
7871795|NCT01677195|12364629|FG000|Overall Study|Physician Decision|1
7871796|NCT01677195|12364630|FG001|Overall Study|Physician Decision|2
7871797|NCT01677195|12364631|FG002|Overall Study|Physician Decision|2
7871798|NCT01677195|12364629|FG000|Overall Study|Pregnancy|0
7871799|NCT01677195|12364630|FG001|Overall Study|Pregnancy|1
7871800|NCT01677195|12364631|FG002|Overall Study|Pregnancy|0
7871801|NCT01677195|12364629|FG000|Overall Study|Protocol Violation|7
7871802|NCT01677195|12364630|FG001|Overall Study|Protocol Violation|3
7871803|NCT01677195|12364631|FG002|Overall Study|Protocol Violation|4
7871804|NCT01677299|12364649|FG000|Overall Study|Adverse Event|0
7871805|NCT01677299|12364650|FG001|Overall Study|Adverse Event|2
7871806|NCT01677299|12364651|FG002|Overall Study|Adverse Event|1
7871807|NCT01677299|12364652|FG003|Overall Study|Adverse Event|0
7871808|NCT01677299|12364649|FG000|Overall Study|Withdrawal by Subject|0
7871809|NCT01677299|12364650|FG001|Overall Study|Withdrawal by Subject|1
7871810|NCT01677299|12364651|FG002|Overall Study|Withdrawal by Subject|0
7871811|NCT01677299|12364652|FG003|Overall Study|Withdrawal by Subject|1
7871812|NCT01677377|12364678|FG000|Overall Study|Protocol Violation|1
7871813|NCT01677377|12364679|FG001|Overall Study|Protocol Violation|0
7871814|NCT01677377|12364680|FG002|Overall Study|Protocol Violation|0
7871815|NCT01677377|12364678|FG000|Overall Study|Lost to Follow-up|0
7871816|NCT01677377|12364679|FG001|Overall Study|Lost to Follow-up|1
7871817|NCT01677377|12364680|FG002|Overall Study|Lost to Follow-up|1
7871818|NCT01677377|12364678|FG000|Overall Study|Withdrawal by Subject|0
7871819|NCT01677377|12364679|FG001|Overall Study|Withdrawal by Subject|0
7871820|NCT01677377|12364680|FG002|Overall Study|Withdrawal by Subject|3
7871821|NCT01677377|12364678|FG000|Overall Study|Lack of Efficacy|0
7871822|NCT01677377|12364679|FG001|Overall Study|Lack of Efficacy|0
7871823|NCT01677377|12364680|FG002|Overall Study|Lack of Efficacy|1
7871824|NCT01677377|12364678|FG000|Overall Study|Pregnancy|0
7871825|NCT01677377|12364679|FG001|Overall Study|Pregnancy|0
7871826|NCT01677377|12364680|FG002|Overall Study|Pregnancy|1
7871827|NCT01677507|12364688|FG000|Initial Assignment|Adverse Event|0
7871828|NCT01677507|12364689|FG001|Initial Assignment|Adverse Event|1
7871829|NCT01677507|12364688|FG000|Initial Assignment|Protocol Violation|0
7871830|NCT01677507|12364689|FG001|Initial Assignment|Protocol Violation|1
7871831|NCT01677507|12364688|FG000|Second Assigment|Withdrawal by Subject|2
7871832|NCT01677507|12364689|FG001|Second Assigment|Withdrawal by Subject|2
7871833|NCT01677507|12364688|FG000|Second Assigment|Adverse Event|1
7871834|NCT01677507|12364689|FG001|Second Assigment|Adverse Event|3
7871835|NCT01677624|12364697|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1
7871836|NCT01677741|12364709|FG000|Overall Study|Death|0
7871837|NCT01677741|12364710|FG001|Overall Study|Death|0
7871838|NCT01677741|12364711|FG002|Overall Study|Death|0
7871839|NCT01677741|12364712|FG003|Overall Study|Death|1
7871840|NCT01677741|12364713|FG004|Overall Study|Death|0
7871841|NCT01677741|12364714|FG005|Overall Study|Death|1
7871842|NCT01677741|12364715|FG006|Overall Study|Death|0
7871843|NCT01677741|12364716|FG007|Overall Study|Death|0
7871844|NCT01677741|12364709|FG000|Overall Study|Withdrawal by Subject|2
7871845|NCT01677741|12364710|FG001|Overall Study|Withdrawal by Subject|7
7871846|NCT01677741|12364711|FG002|Overall Study|Withdrawal by Subject|5
7871847|NCT01677741|12364712|FG003|Overall Study|Withdrawal by Subject|4
7871848|NCT01677741|12364713|FG004|Overall Study|Withdrawal by Subject|11
7871849|NCT01677741|12364714|FG005|Overall Study|Withdrawal by Subject|20
7871850|NCT01677741|12364715|FG006|Overall Study|Withdrawal by Subject|4
7871851|NCT01677741|12364716|FG007|Overall Study|Withdrawal by Subject|2
7871852|NCT01677741|12364709|FG000|Overall Study|Enrolled in a rollover study|0
7871853|NCT01677741|12364710|FG001|Overall Study|Enrolled in a rollover study|3
7871854|NCT01677741|12364711|FG002|Overall Study|Enrolled in a rollover study|2
7871855|NCT01677741|12364712|FG003|Overall Study|Enrolled in a rollover study|1
7871856|NCT01677741|12364713|FG004|Overall Study|Enrolled in a rollover study|6
7871857|NCT01677741|12364714|FG005|Overall Study|Enrolled in a rollover study|6
7871858|NCT01677741|12364715|FG006|Overall Study|Enrolled in a rollover study|7
7871859|NCT01677741|12364716|FG007|Overall Study|Enrolled in a rollover study|0
7871860|NCT01677741|12364709|FG000|Overall Study|Progressive disease|1
7871861|NCT01677741|12364710|FG001|Overall Study|Progressive disease|0
7871862|NCT01677741|12364711|FG002|Overall Study|Progressive disease|1
7871863|NCT01677741|12364712|FG003|Overall Study|Progressive disease|0
7871864|NCT01677741|12364713|FG004|Overall Study|Progressive disease|0
7871865|NCT01677741|12364714|FG005|Overall Study|Progressive disease|1
7871866|NCT01677741|12364715|FG006|Overall Study|Progressive disease|0
7871867|NCT01677741|12364716|FG007|Overall Study|Progressive disease|0
7871868|NCT01677767|12364750|FG000|Overall Study|Adverse Event|1
7871869|NCT01677767|12364750|FG000|Overall Study|Death|4
7871870|NCT01677767|12364750|FG000|Overall Study|Protocol Violation|4
7871871|NCT01677767|12364750|FG000|Overall Study|Withdrawal by Subject|10
7871872|NCT01677767|12364750|FG000|Overall Study|Non-compliance by the participants|3
7871873|NCT01677910|12364759|FG000|Double-Blind Treatment Period|Adverse Event|6
7871874|NCT01677910|12364760|FG001|Double-Blind Treatment Period|Adverse Event|2
7871875|NCT01677910|12364761|FG002|Double-Blind Treatment Period|Adverse Event|3
7871876|NCT01677910|12364762|FG003|Double-Blind Treatment Period|Adverse Event|0
7871877|NCT01677910|12364759|FG000|Double-Blind Treatment Period|Physician Decision|0
7871878|NCT01677910|12364760|FG001|Double-Blind Treatment Period|Physician Decision|0
7871879|NCT01677910|12364761|FG002|Double-Blind Treatment Period|Physician Decision|1
7871880|NCT01677910|12364762|FG003|Double-Blind Treatment Period|Physician Decision|0
7871881|NCT01677910|12364759|FG000|Double-Blind Treatment Period|Withdrawal of consent|1
7871882|NCT01677910|12364760|FG001|Double-Blind Treatment Period|Withdrawal of consent|0
7871883|NCT01677910|12364761|FG002|Double-Blind Treatment Period|Withdrawal of consent|3
7871884|NCT01677910|12364762|FG003|Double-Blind Treatment Period|Withdrawal of consent|0
7871885|NCT01677910|12364759|FG000|Double-Blind Treatment Period|Reason Not Specified|0
7871886|NCT01677910|12364760|FG001|Double-Blind Treatment Period|Reason Not Specified|1
7871887|NCT01677910|12364761|FG002|Double-Blind Treatment Period|Reason Not Specified|0
7871888|NCT01677910|12364762|FG003|Double-Blind Treatment Period|Reason Not Specified|0
7871889|NCT01677910|12364759|FG000|Open-Label Extension Period (OLE)|Physician Decision|0
7871890|NCT01677910|12364760|FG001|Open-Label Extension Period (OLE)|Physician Decision|0
7871891|NCT01677910|12364761|FG002|Open-Label Extension Period (OLE)|Physician Decision|0
7871892|NCT01677910|12364762|FG003|Open-Label Extension Period (OLE)|Physician Decision|4
7871893|NCT01677910|12364759|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0
7871894|NCT01677910|12364760|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0
7871895|NCT01677910|12364761|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0
7871896|NCT01677910|12364762|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2
7871897|NCT01677910|12364759|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7793625|NCT01049360|12249034|FG000|Period 2|Withdrawal by Subject|0
7793626|NCT01049360|12249035|FG001|Period 2|Withdrawal by Subject|0
7793627|NCT01049360|12249036|FG002|Period 2|Withdrawal by Subject|0
7793628|NCT01049360|12249037|FG003|Period 2|Withdrawal by Subject|1
7793629|NCT01049360|12249038|FG004|Period 2|Withdrawal by Subject|0
7793630|NCT01049360|12249039|FG005|Period 2|Withdrawal by Subject|0
7793631|NCT01049360|12249040|FG006|Period 2|Withdrawal by Subject|0
7793632|NCT01049360|12249041|FG007|Period 2|Withdrawal by Subject|0
7793633|NCT01049360|12249042|FG008|Period 2|Withdrawal by Subject|0
7793634|NCT01049360|12249043|FG009|Period 2|Withdrawal by Subject|0
7793635|NCT01049360|12249044|FG010|Period 2|Withdrawal by Subject|0
7793636|NCT01049360|12249045|FG011|Period 2|Withdrawal by Subject|0
7793637|NCT01049360|12249046|FG012|Period 2|Withdrawal by Subject|0
7793638|NCT01049360|12249047|FG013|Period 2|Withdrawal by Subject|0
7793639|NCT01049360|12249048|FG014|Period 2|Withdrawal by Subject|1
7793640|NCT01049360|12249049|FG015|Period 2|Withdrawal by Subject|0
7793641|NCT01049360|12249050|FG016|Period 2|Withdrawal by Subject|0
7793642|NCT01049360|12249051|FG017|Period 2|Withdrawal by Subject|0
7793643|NCT01049360|12249052|FG018|Period 2|Withdrawal by Subject|0
7793644|NCT01049360|12249053|FG019|Period 2|Withdrawal by Subject|1
7793645|NCT01049360|12249034|FG000|Period 2|Lack of Efficacy|0
7793646|NCT01049360|12249035|FG001|Period 2|Lack of Efficacy|0
7793647|NCT01049360|12249036|FG002|Period 2|Lack of Efficacy|0
7793648|NCT01049360|12249037|FG003|Period 2|Lack of Efficacy|0
7793649|NCT01049360|12249038|FG004|Period 2|Lack of Efficacy|0
7793650|NCT01049360|12249039|FG005|Period 2|Lack of Efficacy|1
7793651|NCT01049360|12249040|FG006|Period 2|Lack of Efficacy|0
7793652|NCT01049360|12249041|FG007|Period 2|Lack of Efficacy|0
7793653|NCT01049360|12249042|FG008|Period 2|Lack of Efficacy|0
7793654|NCT01049360|12249043|FG009|Period 2|Lack of Efficacy|0
7793655|NCT01049360|12249044|FG010|Period 2|Lack of Efficacy|0
7793656|NCT01049360|12249045|FG011|Period 2|Lack of Efficacy|0
7793657|NCT01049360|12249046|FG012|Period 2|Lack of Efficacy|0
7793658|NCT01049360|12249047|FG013|Period 2|Lack of Efficacy|0
7624359|NCT00085735|12035392|FG000|Overall Study|Physician Decision|2
7624360|NCT00085735|12035393|FG001|Overall Study|Physician Decision|3
7624361|NCT00085735|12035394|FG002|Overall Study|Physician Decision|2
7624362|NCT00085735|12035395|FG003|Overall Study|Physician Decision|3
7624363|NCT00085735|12035396|FG004|Overall Study|Physician Decision|11
7793659|NCT01049360|12249048|FG014|Period 2|Lack of Efficacy|0
7793660|NCT01049360|12249049|FG015|Period 2|Lack of Efficacy|0
7793661|NCT01049360|12249050|FG016|Period 2|Lack of Efficacy|0
7793662|NCT01049360|12249051|FG017|Period 2|Lack of Efficacy|0
7793663|NCT01049360|12249052|FG018|Period 2|Lack of Efficacy|0
7624364|NCT00085735|12035397|FG005|Overall Study|Physician Decision|8
7624365|NCT00085735|12035392|FG000|Overall Study|Protocol Violation|1
7624366|NCT00085735|12035393|FG001|Overall Study|Protocol Violation|0
7624367|NCT00085735|12035394|FG002|Overall Study|Protocol Violation|0
7624368|NCT00085735|12035395|FG003|Overall Study|Protocol Violation|0
7624369|NCT00085735|12035396|FG004|Overall Study|Protocol Violation|0
7624370|NCT00085735|12035397|FG005|Overall Study|Protocol Violation|0
7624371|NCT00085735|12035392|FG000|Overall Study|Withdrawal by Subject|1
7624372|NCT00085735|12035393|FG001|Overall Study|Withdrawal by Subject|0
7624373|NCT00085735|12035394|FG002|Overall Study|Withdrawal by Subject|4
7624374|NCT00085735|12035395|FG003|Overall Study|Withdrawal by Subject|5
7624375|NCT00085735|12035396|FG004|Overall Study|Withdrawal by Subject|7
7624376|NCT00085735|12035397|FG005|Overall Study|Withdrawal by Subject|8
7624377|NCT00085735|12035392|FG000|Overall Study|Patient ineligible|1
7624378|NCT00085735|12035393|FG001|Overall Study|Patient ineligible|0
7793664|NCT01049360|12249053|FG019|Period 2|Lack of Efficacy|0
7793665|NCT01049360|12249034|FG000|Period 4|Protocol Violation|0
7793666|NCT01049360|12249035|FG001|Period 4|Protocol Violation|0
7793667|NCT01049360|12249036|FG002|Period 4|Protocol Violation|0
7793668|NCT01049360|12249037|FG003|Period 4|Protocol Violation|0
7793669|NCT01049360|12249038|FG004|Period 4|Protocol Violation|0
7793670|NCT01049360|12249039|FG005|Period 4|Protocol Violation|0
7793671|NCT01049360|12249040|FG006|Period 4|Protocol Violation|0
7793672|NCT01049360|12249041|FG007|Period 4|Protocol Violation|0
7871898|NCT01677910|12364760|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7871899|NCT01677910|12364761|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7871900|NCT01677910|12364762|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
7793673|NCT01049360|12249042|FG008|Period 4|Protocol Violation|0
7793674|NCT01049360|12249043|FG009|Period 4|Protocol Violation|0
7793675|NCT01049360|12249044|FG010|Period 4|Protocol Violation|0
7793676|NCT01049360|12249045|FG011|Period 4|Protocol Violation|0
7793677|NCT01049360|12249046|FG012|Period 4|Protocol Violation|0
7793678|NCT01049360|12249047|FG013|Period 4|Protocol Violation|0
7793679|NCT01049360|12249048|FG014|Period 4|Protocol Violation|0
7871901|NCT01677910|12364759|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7624379|NCT00085735|12035394|FG002|Overall Study|Patient ineligible|3
7871902|NCT01677910|12364760|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7871903|NCT01677910|12364761|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7871904|NCT01677910|12364762|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5
7871905|NCT01677910|12364759|FG000|Open-Label Extension Period (OLE)|Adverse Event|0
7871906|NCT01677910|12364760|FG001|Open-Label Extension Period (OLE)|Adverse Event|0
7871907|NCT01677910|12364761|FG002|Open-Label Extension Period (OLE)|Adverse Event|0
7871908|NCT01677910|12364762|FG003|Open-Label Extension Period (OLE)|Adverse Event|15
7871909|NCT01677910|12364759|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0
7871910|NCT01677910|12364760|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0
7871911|NCT01677910|12364761|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0
7871912|NCT01677910|12364762|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1
7871913|NCT01677936|12364774|FG000|Overall Study|Lost to Follow-up|4
7871914|NCT01677936|12364775|FG001|Overall Study|Lost to Follow-up|1
7871915|NCT01677936|12364774|FG000|Overall Study|Protocol Violation|3
7871916|NCT01677936|12364775|FG001|Overall Study|Protocol Violation|0
7871917|NCT01677936|12364774|FG000|Overall Study|Adverse Event|1
7871918|NCT01677936|12364775|FG001|Overall Study|Adverse Event|0
7871919|NCT01677936|12364774|FG000|Overall Study|Lost to Follow-up|1
7871920|NCT01677936|12364775|FG001|Overall Study|Lost to Follow-up|0
7871921|NCT01677936|12364774|FG000|Overall Study|Protocol Violation|0
7871922|NCT01677936|12364775|FG001|Overall Study|Protocol Violation|4
7871923|NCT01677988|12364781|FG000|Overall Study|Lack of Efficacy|2
7871924|NCT01678144|12364786|FG000|Stage 1: MAR Classic|Adverse Event|1
7871925|NCT01678209|12364802|FG000|Overall Study|could not scan twice|1
7871926|NCT01678209|12364803|FG001|Overall Study|could not scan twice|1
7871927|NCT01678209|12364804|FG002|Overall Study|could not scan twice|1
7871928|NCT01678209|12364802|FG000|Overall Study|scheduling conflicts|0
7871929|NCT01678209|12364803|FG001|Overall Study|scheduling conflicts|0
7871930|NCT01678209|12364804|FG002|Overall Study|scheduling conflicts|1
7871931|NCT01678209|12364802|FG000|Overall Study|screen fail|16
7871932|NCT01678209|12364803|FG001|Overall Study|screen fail|17
7871933|NCT01678209|12364804|FG002|Overall Study|screen fail|16
7871934|NCT01678313|12364814|FG000|Completed the 3-month Therapy|Lost to Follow-up|3
7871935|NCT01678313|12364815|FG001|Completed the 3-month Therapy|Lost to Follow-up|8
7871936|NCT01678313|12364814|FG000|Completed the 3-month Therapy|Physician Decision|3
7871937|NCT01678313|12364815|FG001|Completed the 3-month Therapy|Physician Decision|4
7871938|NCT01678313|12364814|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8
7871939|NCT01678313|12364815|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9
7871940|NCT01678313|12364814|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
7871941|NCT01678313|12364815|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
7871942|NCT01678560|12364827|FG000|Overall Study|Physician Decision|4
7871943|NCT01678560|12364828|FG001|Overall Study|Physician Decision|4
7871944|NCT01678560|12364827|FG000|Overall Study|Death|0
7871945|NCT01678560|12364828|FG001|Overall Study|Death|1
7871946|NCT01678560|12364827|FG000|Overall Study|Withdrawal by Subject|0
7871947|NCT01678560|12364828|FG001|Overall Study|Withdrawal by Subject|1
7793680|NCT01049360|12249049|FG015|Period 4|Protocol Violation|0
7871948|NCT01678807|12364850|FG000|Overall Study|Adverse Event|4
7871949|NCT01678807|12364851|FG001|Overall Study|Adverse Event|4
7871950|NCT01678807|12364852|FG002|Overall Study|Adverse Event|0
7871951|NCT01678807|12364850|FG000|Overall Study|Withdrawn by Parent/Guardian|0
7871952|NCT01678807|12364851|FG001|Overall Study|Withdrawn by Parent/Guardian|1
7871953|NCT01678807|12364852|FG002|Overall Study|Withdrawn by Parent/Guardian|0
7871954|NCT01678820|12364863|FG000|Overall Study|Study Terminated by Sponsor|45
7871955|NCT01678820|12364864|FG001|Overall Study|Study Terminated by Sponsor|43
7871956|NCT01678820|12364865|FG002|Overall Study|Study Terminated by Sponsor|43
7871957|NCT01678820|12364863|FG000|Overall Study|Withdrawal by Subject|2
7871958|NCT01678820|12364864|FG001|Overall Study|Withdrawal by Subject|5
7871959|NCT01678820|12364865|FG002|Overall Study|Withdrawal by Subject|2
7871960|NCT01678820|12364863|FG000|Overall Study|Protocol Specified Criteria|2
7871961|NCT01678820|12364864|FG001|Overall Study|Protocol Specified Criteria|3
7871962|NCT01678820|12364865|FG002|Overall Study|Protocol Specified Criteria|1
7871963|NCT01678820|12364863|FG000|Overall Study|Adverse Event|2
7871964|NCT01678820|12364864|FG001|Overall Study|Adverse Event|2
7871965|NCT01678820|12364865|FG002|Overall Study|Adverse Event|2
7871966|NCT01678820|12364863|FG000|Overall Study|Lost to Follow-up|7
7871967|NCT01678820|12364864|FG001|Overall Study|Lost to Follow-up|2
7871968|NCT01678820|12364865|FG002|Overall Study|Lost to Follow-up|2
7871969|NCT01678820|12364863|FG000|Overall Study|Non-compliance with study drug|0
7871970|NCT01678820|12364864|FG001|Overall Study|Non-compliance with study drug|1
7871971|NCT01678820|12364865|FG002|Overall Study|Non-compliance with study drug|0
7871972|NCT01678820|12364863|FG000|Overall Study|Physician Decision|0
7871973|NCT01678820|12364864|FG001|Overall Study|Physician Decision|0
7871974|NCT01678820|12364865|FG002|Overall Study|Physician Decision|1
7871975|NCT01678820|12364863|FG000|Overall Study|Protocol Violation|4
7871976|NCT01678820|12364864|FG001|Overall Study|Protocol Violation|5
7871977|NCT01678820|12364865|FG002|Overall Study|Protocol Violation|4
7871978|NCT01678820|12364863|FG000|Overall Study|Not treated with double-blind study drug|0
7871979|NCT01678820|12364864|FG001|Overall Study|Not treated with double-blind study drug|2
7871980|NCT01678820|12364865|FG002|Overall Study|Not treated with double-blind study drug|2
7871981|NCT01678898|12364900|FG000|PB-102-F01|Adverse Event|0
7871982|NCT01678898|12364901|FG001|PB-102-F01|Adverse Event|1
7871983|NCT01678898|12364902|FG002|PB-102-F01|Adverse Event|0
7871984|NCT01678898|12364900|FG000|PB-102-F01|Physician Decision|0
7871985|NCT01678898|12364901|FG001|PB-102-F01|Physician Decision|1
7871986|NCT01678898|12364902|FG002|PB-102-F01|Physician Decision|0
7871987|NCT01678911|12364919|FG000|Second Intervention|Lost to Follow-up|2
7871988|NCT01678911|12364920|FG001|Second Intervention|Lost to Follow-up|0
7871989|NCT01678924|12364930|FG000|Overall Study|Adverse Event|1
7871990|NCT01678924|12364931|FG001|Overall Study|Adverse Event|1
7871991|NCT01678924|12364932|FG002|Overall Study|Adverse Event|0
7871992|NCT01678924|12364933|FG003|Overall Study|Adverse Event|1
7871993|NCT01678924|12364930|FG000|Overall Study|Lack of Efficacy|7
7871994|NCT01678924|12364931|FG001|Overall Study|Lack of Efficacy|2
7871995|NCT01678924|12364932|FG002|Overall Study|Lack of Efficacy|0
7871996|NCT01678924|12364933|FG003|Overall Study|Lack of Efficacy|5
7871997|NCT01678924|12364930|FG000|Overall Study|Lost to Follow-up|0
7871998|NCT01678924|12364931|FG001|Overall Study|Lost to Follow-up|4
7871999|NCT01678924|12364932|FG002|Overall Study|Lost to Follow-up|0
7872000|NCT01678924|12364933|FG003|Overall Study|Lost to Follow-up|2
7872001|NCT01678924|12364930|FG000|Overall Study|Personal Reasons|2
7872002|NCT01678924|12364931|FG001|Overall Study|Personal Reasons|2
7872003|NCT01678924|12364932|FG002|Overall Study|Personal Reasons|2
7872004|NCT01678924|12364933|FG003|Overall Study|Personal Reasons|7
7872005|NCT01678924|12364930|FG000|Overall Study|Withdrawal by Subject|0
7872006|NCT01678924|12364931|FG001|Overall Study|Withdrawal by Subject|3
7872007|NCT01678924|12364932|FG002|Overall Study|Withdrawal by Subject|0
7872008|NCT01678924|12364933|FG003|Overall Study|Withdrawal by Subject|2
7872009|NCT01678924|12364930|FG000|Overall Study|Unable to attend scheduled visits|0
7872010|NCT01678924|12364931|FG001|Overall Study|Unable to attend scheduled visits|0
7872011|NCT01678924|12364932|FG002|Overall Study|Unable to attend scheduled visits|0
7872012|NCT01678924|12364933|FG003|Overall Study|Unable to attend scheduled visits|1
7872013|NCT01679002|12364959|FG000|Overall Study|Adverse Event|1
7872014|NCT01679002|12364960|FG001|Overall Study|Adverse Event|1
7872015|NCT01679002|12364961|FG002|Overall Study|Adverse Event|0
7872016|NCT01679236|12365006|FG000|Overall Study|Lost to Follow-up|15
7872017|NCT01679236|12365007|FG001|Overall Study|Lost to Follow-up|15
7872018|NCT01679301|12365013|FG000|Screening Period|screen failure|3
7872019|NCT01679301|12365014|FG001|Screening Period|screen failure|0
7872020|NCT01679301|12365015|FG002|Screening Period|screen failure|0
7872021|NCT01679405|12365036|FG000|Overall Study|Death|2
7872022|NCT01679405|12365037|FG001|Overall Study|Death|5
7872023|NCT01679613|12365052|FG000|Overall Study|other than stated above|0
7872024|NCT01679613|12365053|FG001|Overall Study|other than stated above|1
7872025|NCT01679613|12365054|FG002|Overall Study|other than stated above|2
7872026|NCT01679613|12365055|FG003|Overall Study|other than stated above|2
7872027|NCT01680016|12365064|FG000|Overall Study|Adverse Event|0
7872028|NCT01680016|12365065|FG001|Overall Study|Adverse Event|0
7872029|NCT01680016|12365066|FG002|Overall Study|Adverse Event|1
7872030|NCT01680016|12365067|FG003|Overall Study|Adverse Event|4
7872031|NCT01680016|12365064|FG000|Overall Study|The Subject went out of The Trial|1
7872032|NCT01680016|12365065|FG001|Overall Study|The Subject went out of The Trial|0
7872033|NCT01680016|12365066|FG002|Overall Study|The Subject went out of The Trial|3
7872034|NCT01680016|12365067|FG003|Overall Study|The Subject went out of The Trial|0
7872035|NCT01680016|12365064|FG000|Overall Study|Protocol Violation|0
7872036|NCT01680016|12365065|FG001|Overall Study|Protocol Violation|1
7872037|NCT01680016|12365066|FG002|Overall Study|Protocol Violation|0
7872038|NCT01680016|12365067|FG003|Overall Study|Protocol Violation|0
7872039|NCT01680016|12365064|FG000|Overall Study|Withdrawal by Subject|5
7872040|NCT01680016|12365065|FG001|Overall Study|Withdrawal by Subject|7
7872041|NCT01680016|12365066|FG002|Overall Study|Withdrawal by Subject|1
7872042|NCT01680016|12365067|FG003|Overall Study|Withdrawal by Subject|1
7882765|NCT01775189|12381994|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0
7882766|NCT01775189|12381995|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0
7882767|NCT01775189|12381996|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0
7882768|NCT01775189|12381997|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0
7882769|NCT01775189|12381998|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0
7882770|NCT01775189|12381992|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0
7882771|NCT01775189|12381993|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1
7882772|NCT01775189|12381994|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0
7882773|NCT01775189|12381995|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0
7882774|NCT01775189|12381996|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0
7882775|NCT01775189|12381997|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0
7882776|NCT01775189|12381998|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0
7882777|NCT01775189|12381992|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7882778|NCT01775189|12381993|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
7882779|NCT01775189|12381994|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
7882780|NCT01775189|12381995|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7882781|NCT01775189|12381996|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7882782|NCT01775189|12381997|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7882783|NCT01775189|12381998|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7882784|NCT01775189|12381992|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0
7882785|NCT01775189|12381993|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0
7882786|NCT01775189|12381994|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0
7882787|NCT01775189|12381995|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0
7882788|NCT01775189|12381996|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0
7882789|NCT01775189|12381997|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1
7882790|NCT01775189|12381998|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0
7882791|NCT01775189|12381992|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0
7882792|NCT01775189|12381993|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0
7882793|NCT01775189|12381994|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0
7882794|NCT01775189|12381995|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1
7882795|NCT01775189|12381996|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0
7882796|NCT01775189|12381997|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0
7882797|NCT01775189|12381998|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0
7882798|NCT01775189|12381992|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0
7882799|NCT01775189|12381993|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0
7882800|NCT01775189|12381994|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0
7882801|NCT01775189|12381995|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1
7882802|NCT01775189|12381996|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0
7882803|NCT01775189|12381997|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0
7882804|NCT01775189|12381998|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1
7882805|NCT01775501|12382041|FG000|Overall Study|Discontinued prior to treatment|1
7882806|NCT01775553|12382045|FG000|Overall Study|Adverse Event|1
7882807|NCT01775553|12382045|FG000|Overall Study|Disease Progression|12
7882808|NCT01775670|12382051|FG000|Overall Study|Lost to Follow-up|1
7882809|NCT01775670|12382052|FG001|Overall Study|Lost to Follow-up|1
7882810|NCT01775787|12382086|FG000|First 7-10 Days|Adverse Event|0
7882811|NCT01775787|12382087|FG001|First 7-10 Days|Adverse Event|1
7882812|NCT01775787|12382086|FG000|First 7-10 Days|family emergency|0
7882813|NCT01775787|12382087|FG001|First 7-10 Days|family emergency|1
7882814|NCT01775787|12382086|FG000|First 7-10 Days|time commitment|0
7882815|NCT01775787|12382087|FG001|First 7-10 Days|time commitment|2
7882816|NCT01775787|12382086|FG000|First 7-10 Days|concerns with using IV|1
7882817|NCT01775787|12382087|FG001|First 7-10 Days|concerns with using IV|2
7882818|NCT01775787|12382086|FG000|Second 7-10 Days|time commitment|0
7882819|NCT01775787|12382087|FG001|Second 7-10 Days|time commitment|1
7882820|NCT01775787|12382086|FG000|Second 7-10 Days|concerns with using IV|0
7882821|NCT01775787|12382087|FG001|Second 7-10 Days|concerns with using IV|1
7882822|NCT01775904|12382132|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1
7882823|NCT01775904|12382132|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1
7882824|NCT01775930|12382142|FG000|Overall Study|Futility stopping boundary met|1
7882825|NCT01775995|12382148|FG000|Overall Study|Lost to Follow-up|1
7882826|NCT01775995|12382149|FG001|Overall Study|Lost to Follow-up|1
7882827|NCT01776008|12382155|FG000|Overall Study|ineligible|2
7882828|NCT01776424|12382172|FG000|Overall Study|Lost to Follow-up|10
7872043|NCT01680159|12365093|FG000|Screening Period|Not meet criteria for dose-up period|7
7872044|NCT01680159|12365093|FG000|Increased Dose Period|Adverse Event|6
7872045|NCT01680159|12365093|FG000|Increased Dose Period|Withdrawal by Subject|2
7872046|NCT01680341|12365159|FG000|Overall Study|Adverse Event|3
7872047|NCT01680341|12365160|FG001|Overall Study|Adverse Event|2
7872048|NCT01680341|12365159|FG000|Overall Study|Unclassified|18
7872049|NCT01680341|12365160|FG001|Overall Study|Unclassified|15
7872050|NCT01680458|12365166|FG000|Overall Study|Protocol Violation|3
7872051|NCT01680497|12365170|FG000|Overall Study|Lost to Follow-up|2
7872052|NCT01680861|12365237|FG000|Early Post-transplant Period|Protocol Violation|1
7872053|NCT01680861|12365238|FG001|Early Post-transplant Period|Protocol Violation|1
7872054|NCT01680991|12365267|FG000|Overall Study|Adverse Event|1
7872055|NCT01680991|12365268|FG001|Overall Study|Adverse Event|0
7872056|NCT01680991|12365269|FG002|Overall Study|Adverse Event|0
7793681|NCT01049360|12249050|FG016|Period 4|Protocol Violation|0
7793682|NCT01049360|12249051|FG017|Period 4|Protocol Violation|1
7793683|NCT01049360|12249052|FG018|Period 4|Protocol Violation|0
7793684|NCT01049360|12249053|FG019|Period 4|Protocol Violation|0
7793685|NCT01049360|12249034|FG000|Period 4|Withdrawal by Subject|0
7793686|NCT01049360|12249035|FG001|Period 4|Withdrawal by Subject|0
7793687|NCT01049360|12249036|FG002|Period 4|Withdrawal by Subject|0
7793688|NCT01049360|12249037|FG003|Period 4|Withdrawal by Subject|1
7793689|NCT01049360|12249038|FG004|Period 4|Withdrawal by Subject|0
7793690|NCT01049360|12249039|FG005|Period 4|Withdrawal by Subject|0
7793691|NCT01049360|12249040|FG006|Period 4|Withdrawal by Subject|0
7793692|NCT01049360|12249041|FG007|Period 4|Withdrawal by Subject|0
7793693|NCT01049360|12249042|FG008|Period 4|Withdrawal by Subject|0
7793694|NCT01049360|12249043|FG009|Period 4|Withdrawal by Subject|0
7793695|NCT01049360|12249044|FG010|Period 4|Withdrawal by Subject|0
7793696|NCT01049360|12249045|FG011|Period 4|Withdrawal by Subject|0
7793697|NCT01049360|12249046|FG012|Period 4|Withdrawal by Subject|0
7793698|NCT01049360|12249047|FG013|Period 4|Withdrawal by Subject|0
7793699|NCT01049360|12249048|FG014|Period 4|Withdrawal by Subject|0
7793700|NCT01049360|12249049|FG015|Period 4|Withdrawal by Subject|0
7793701|NCT01049360|12249050|FG016|Period 4|Withdrawal by Subject|0
7872057|NCT01680991|12365267|FG000|Overall Study|Death|1
7872058|NCT01680991|12365268|FG001|Overall Study|Death|0
7872059|NCT01680991|12365269|FG002|Overall Study|Death|1
7872060|NCT01680991|12365267|FG000|Overall Study|Protocol Violation|0
7793702|NCT01049360|12249051|FG017|Period 4|Withdrawal by Subject|0
7624380|NCT00085735|12035395|FG003|Overall Study|Patient ineligible|7
7624381|NCT00085735|12035396|FG004|Overall Study|Patient ineligible|17
7624382|NCT00085735|12035397|FG005|Overall Study|Patient ineligible|8
7624383|NCT00085735|12035392|FG000|Overall Study|Excess residual disease|2
7624384|NCT00085735|12035393|FG001|Overall Study|Excess residual disease|2
7624385|NCT00085735|12035394|FG002|Overall Study|Excess residual disease|1
7624386|NCT00085735|12035395|FG003|Overall Study|Excess residual disease|1
7624387|NCT00085735|12035396|FG004|Overall Study|Excess residual disease|1
7624388|NCT00085735|12035397|FG005|Overall Study|Excess residual disease|4
7624389|NCT00085735|12035392|FG000|Overall Study|Reason not documented|1
7624390|NCT00085735|12035393|FG001|Overall Study|Reason not documented|0
7624391|NCT00085735|12035394|FG002|Overall Study|Reason not documented|1
7624392|NCT00085735|12035395|FG003|Overall Study|Reason not documented|0
7624393|NCT00085735|12035396|FG004|Overall Study|Reason not documented|1
7624394|NCT00085735|12035397|FG005|Overall Study|Reason not documented|0
7624395|NCT00085735|12035392|FG000|Overall Study|Pt transferred to inst w/out study open|1
7624396|NCT00085735|12035393|FG001|Overall Study|Pt transferred to inst w/out study open|0
7624397|NCT00085735|12035394|FG002|Overall Study|Pt transferred to inst w/out study open|0
7624398|NCT00085735|12035395|FG003|Overall Study|Pt transferred to inst w/out study open|0
7624399|NCT00085735|12035396|FG004|Overall Study|Pt transferred to inst w/out study open|0
7624400|NCT00085735|12035397|FG005|Overall Study|Pt transferred to inst w/out study open|0
7872061|NCT01680991|12365268|FG001|Overall Study|Protocol Violation|1
7872062|NCT01680991|12365269|FG002|Overall Study|Protocol Violation|0
7872063|NCT01680991|12365267|FG000|Overall Study|Withdrawal by Subject|5
7872064|NCT01680991|12365268|FG001|Overall Study|Withdrawal by Subject|1
7872065|NCT01680991|12365269|FG002|Overall Study|Withdrawal by Subject|0
7872066|NCT01680991|12365267|FG000|Overall Study|Progressive disease (PD)|0
7872067|NCT01680991|12365268|FG001|Overall Study|Progressive disease (PD)|10
7872068|NCT01680991|12365269|FG002|Overall Study|Progressive disease (PD)|0
7793703|NCT01049360|12249052|FG018|Period 4|Withdrawal by Subject|0
7793704|NCT01049360|12249053|FG019|Period 4|Withdrawal by Subject|0
7793705|NCT01049373|12249067|FG000|Overall Study|Protocol Violation|9
7793706|NCT01049373|12249068|FG001|Overall Study|Protocol Violation|9
7793707|NCT01049373|12249067|FG000|Overall Study|Withdrawal by Subject|8
7793708|NCT01049373|12249068|FG001|Overall Study|Withdrawal by Subject|5
7793709|NCT01049373|12249067|FG000|Overall Study|Adverse Event|3
7793710|NCT01049373|12249068|FG001|Overall Study|Adverse Event|3
7793711|NCT01049373|12249067|FG000|Overall Study|Lost to Follow-up|9
7793712|NCT01049373|12249068|FG001|Overall Study|Lost to Follow-up|4
7793713|NCT01049373|12249067|FG000|Overall Study|no evaluable study values|9
7793714|NCT01049373|12249068|FG001|Overall Study|no evaluable study values|21
7793715|NCT01049373|12249067|FG000|Overall Study|Other|1
7793716|NCT01049373|12249068|FG001|Overall Study|Other|1
7793717|NCT01049373|12249067|FG000|Overall Study|Non-cooperation|0
7793718|NCT01049373|12249068|FG001|Overall Study|Non-cooperation|1
7793719|NCT01049412|12249078|FG000|Period I|Withdrawal by Subject|4
7793720|NCT01049412|12249079|FG001|Period I|Withdrawal by Subject|6
7793721|NCT01049412|12249078|FG000|Period I|Lost to Follow-up|2
7793722|NCT01049412|12249079|FG001|Period I|Lost to Follow-up|2
7872069|NCT01680991|12365267|FG000|Overall Study|Physician Decision|0
7872070|NCT01680991|12365268|FG001|Overall Study|Physician Decision|7
7872071|NCT01680991|12365269|FG002|Overall Study|Physician Decision|2
7872072|NCT01680991|12365267|FG000|Overall Study|Bad physical condition|0
7872073|NCT01680991|12365268|FG001|Overall Study|Bad physical condition|0
7872074|NCT01680991|12365269|FG002|Overall Study|Bad physical condition|1
7872075|NCT01680991|12365267|FG000|Overall Study|PD confirmed in other hospital|1
7872076|NCT01680991|12365268|FG001|Overall Study|PD confirmed in other hospital|0
7872077|NCT01680991|12365269|FG002|Overall Study|PD confirmed in other hospital|0
7872078|NCT01681004|12365281|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1
7872079|NCT01681004|12365282|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2
7872080|NCT01681004|12365281|FG000|Study Completion|Lost to Follow-up|8
7872081|NCT01681004|12365282|FG001|Study Completion|Lost to Follow-up|3
7872082|NCT01681004|12365281|FG000|Study Completion|Physician Decision|1
7872083|NCT01681004|12365282|FG001|Study Completion|Physician Decision|3
7872084|NCT01681004|12365281|FG000|Study Completion|Site Termination|2
7872085|NCT01681004|12365282|FG001|Study Completion|Site Termination|1
7872086|NCT01681004|12365281|FG000|Study Completion|Death|1
7872087|NCT01681004|12365282|FG001|Study Completion|Death|1
7872088|NCT01681069|12365307|FG000|Overall Study|Withdrawal by Subject|4
7872089|NCT01681069|12365308|FG001|Overall Study|Withdrawal by Subject|5
7872090|NCT01681069|12365307|FG000|Overall Study|Protocol Violation|1
7793723|NCT01049412|12249078|FG000|Period I|Physician Decision|0
7872091|NCT01681069|12365308|FG001|Overall Study|Protocol Violation|1
7872092|NCT01681069|12365307|FG000|Overall Study|Adverse Event|0
7872093|NCT01681069|12365308|FG001|Overall Study|Adverse Event|1
7872094|NCT01681186|12365342|FG000|Washout Period From Second Intervention|Adverse Event|0
7872095|NCT01681186|12365343|FG001|Washout Period From Second Intervention|Adverse Event|0
7872096|NCT01681186|12365344|FG002|Washout Period From Second Intervention|Adverse Event|0
7872097|NCT01681186|12365345|FG003|Washout Period From Second Intervention|Adverse Event|0
7872098|NCT01681186|12365346|FG004|Washout Period From Second Intervention|Adverse Event|0
7872099|NCT01681186|12365347|FG005|Washout Period From Second Intervention|Adverse Event|0
7872100|NCT01681186|12365348|FG006|Washout Period From Second Intervention|Adverse Event|1
7872101|NCT01681186|12365349|FG007|Washout Period From Second Intervention|Adverse Event|0
7872102|NCT01681186|12365342|FG000|Washout Period From Second Intervention|Protocol Violation|0
7793724|NCT01049412|12249079|FG001|Period I|Physician Decision|3
7793725|NCT01049412|12249078|FG000|Period I|Protocol Violation|1
7793726|NCT01049412|12249079|FG001|Period I|Protocol Violation|2
7793727|NCT01049412|12249078|FG000|Period I|Adverse Event|1
7793728|NCT01049412|12249079|FG001|Period I|Adverse Event|0
7793729|NCT01049412|12249078|FG000|Period II|Withdrawal by Subject|2
7793730|NCT01049412|12249079|FG001|Period II|Withdrawal by Subject|3
7793731|NCT01049412|12249078|FG000|Period II|Adverse Event|1
7793732|NCT01049412|12249079|FG001|Period II|Adverse Event|0
7793733|NCT01049412|12249078|FG000|Period II|Lost to Follow-up|1
7793734|NCT01049412|12249079|FG001|Period II|Lost to Follow-up|0
7793735|NCT01049503|12249093|FG000|Overall Study|Lost to Follow-up|11
7793736|NCT01049503|12249094|FG001|Overall Study|Lost to Follow-up|12
7793737|NCT01049503|12249095|FG002|Overall Study|Lost to Follow-up|24
7793738|NCT01049503|12249096|FG003|Overall Study|Lost to Follow-up|26
7793739|NCT01049503|12249097|FG004|Overall Study|Lost to Follow-up|27
7872103|NCT01681186|12365343|FG001|Washout Period From Second Intervention|Protocol Violation|0
7872104|NCT01681186|12365344|FG002|Washout Period From Second Intervention|Protocol Violation|0
7872105|NCT01681186|12365345|FG003|Washout Period From Second Intervention|Protocol Violation|0
7872106|NCT01681186|12365346|FG004|Washout Period From Second Intervention|Protocol Violation|0
7872107|NCT01681186|12365347|FG005|Washout Period From Second Intervention|Protocol Violation|0
7872108|NCT01681186|12365348|FG006|Washout Period From Second Intervention|Protocol Violation|0
7872109|NCT01681186|12365349|FG007|Washout Period From Second Intervention|Protocol Violation|1
7872110|NCT01681186|12365342|FG000|Washout Period From Third Intervention|Lost to Follow-up|0
7872111|NCT01681186|12365343|FG001|Washout Period From Third Intervention|Lost to Follow-up|0
7872112|NCT01681186|12365344|FG002|Washout Period From Third Intervention|Lost to Follow-up|0
7872113|NCT01681186|12365345|FG003|Washout Period From Third Intervention|Lost to Follow-up|0
7872114|NCT01681186|12365346|FG004|Washout Period From Third Intervention|Lost to Follow-up|0
7872115|NCT01681186|12365347|FG005|Washout Period From Third Intervention|Lost to Follow-up|0
7872116|NCT01681186|12365348|FG006|Washout Period From Third Intervention|Lost to Follow-up|1
7872117|NCT01681186|12365349|FG007|Washout Period From Third Intervention|Lost to Follow-up|0
7872118|NCT01681186|12365342|FG000|Fourth Intervention|Protocol Violation|0
7872119|NCT01681186|12365343|FG001|Fourth Intervention|Protocol Violation|0
7872120|NCT01681186|12365344|FG002|Fourth Intervention|Protocol Violation|0
7872121|NCT01681186|12365345|FG003|Fourth Intervention|Protocol Violation|0
7872122|NCT01681186|12365346|FG004|Fourth Intervention|Protocol Violation|0
7872123|NCT01681186|12365347|FG005|Fourth Intervention|Protocol Violation|0
7872124|NCT01681186|12365348|FG006|Fourth Intervention|Protocol Violation|0
7872125|NCT01681186|12365349|FG007|Fourth Intervention|Protocol Violation|1
7872126|NCT01681212|12365379|FG000|Overall Study|No longer met study criteria|5
7872127|NCT01681212|12365379|FG000|Overall Study|Administrative reason by sponsor|1
7872128|NCT01681277|12365388|FG000|Overall Study|Adverse Event|1
7872129|NCT01681277|12365389|FG001|Overall Study|Adverse Event|0
7872130|NCT01681277|12365390|FG002|Overall Study|Adverse Event|0
7872131|NCT01681277|12365391|FG003|Overall Study|Adverse Event|0
7872132|NCT01681277|12365392|FG004|Overall Study|Adverse Event|0
7872133|NCT01681368|12365408|FG000|Overall Study|Refused further treatment|1
7872134|NCT01681368|12365408|FG000|Overall Study|Refused further follow up|1
7872135|NCT01681472|12365416|FG000|Overall Study|Adverse Event|0
7872136|NCT01681472|12365417|FG001|Overall Study|Adverse Event|1
7872137|NCT01681472|12365418|FG002|Overall Study|Adverse Event|0
7872138|NCT01681472|12365419|FG003|Overall Study|Adverse Event|0
7872139|NCT01681511|12365440|FG000|Overall Study|No Treatment Received|1
7872140|NCT01681511|12365441|FG001|Overall Study|No Treatment Received|3
7872141|NCT01681511|12365440|FG000|Overall Study|Failed Inclusion/Exclusion|3
7872142|NCT01681511|12365441|FG001|Overall Study|Failed Inclusion/Exclusion|0
7872143|NCT01681511|12365440|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3
7872144|NCT01681511|12365441|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6
7872145|NCT01681511|12365440|FG000|Overall Study|No Daily Urine Sample Collected|0
7872146|NCT01681511|12365441|FG001|Overall Study|No Daily Urine Sample Collected|1
7872147|NCT01681511|12365440|FG000|Overall Study|No post-catheter sample collected|11
7872148|NCT01681511|12365441|FG001|Overall Study|No post-catheter sample collected|4
7872149|NCT01681576|12365449|FG000|Period 1|Adverse Event|1
7872150|NCT01681576|12365450|FG001|Period 1|Adverse Event|0
7872151|NCT01681576|12365449|FG000|Period 1|Protocol Deviation|1
7872152|NCT01681576|12365450|FG001|Period 1|Protocol Deviation|0
7872153|NCT01681576|12365449|FG000|Period 2|subject/guardian decision|3
7872154|NCT01681576|12365450|FG001|Period 2|subject/guardian decision|1
7872155|NCT01681576|12365449|FG000|Period 2|Non-compliance with study treatment|1
7872156|NCT01681576|12365450|FG001|Period 2|Non-compliance with study treatment|0
7872157|NCT01681628|12365460|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
7872158|NCT01681628|12365461|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
7872159|NCT01681628|12365460|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
7872160|NCT01681628|12365461|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
7872161|NCT01681628|12365460|FG000|19 Months Follow-up|Death|1
7872162|NCT01681628|12365461|FG001|19 Months Follow-up|Death|0
7872163|NCT01681628|12365460|FG000|19 Months Follow-up|Lost to Follow-up|61
7872164|NCT01681628|12365461|FG001|19 Months Follow-up|Lost to Follow-up|43
7872165|NCT01681771|12365472|FG000|Overall Study|Lost to Follow-up|4
7872166|NCT01681771|12365473|FG001|Overall Study|Lost to Follow-up|2
7872167|NCT01681836|12365483|FG000|Second Intervention|Withdrawal by Subject|0
7872168|NCT01681836|12365484|FG001|Second Intervention|Withdrawal by Subject|1
7872169|NCT01681849|12365493|FG000|Overall Study|Protocol Violation|2
7872170|NCT01681849|12365494|FG001|Overall Study|Protocol Violation|0
7872171|NCT01681849|12365495|FG002|Overall Study|Protocol Violation|0
7872172|NCT01681849|12365493|FG000|Overall Study|Withdrawal by Subject|3
7872173|NCT01681849|12365494|FG001|Overall Study|Withdrawal by Subject|5
7872174|NCT01681849|12365495|FG002|Overall Study|Withdrawal by Subject|33
7872175|NCT01681849|12365493|FG000|Overall Study|Lost to Follow-up|3
7872176|NCT01681849|12365494|FG001|Overall Study|Lost to Follow-up|2
7872177|NCT01681849|12365495|FG002|Overall Study|Lost to Follow-up|6
7872178|NCT01681992|12365505|FG000|Overall Study|Adverse Event|3
7872179|NCT01681992|12365506|FG001|Overall Study|Adverse Event|2
7872180|NCT01681992|12365507|FG002|Overall Study|Adverse Event|3
7872181|NCT01681992|12365505|FG000|Overall Study|Lost to Follow-up|36
7872182|NCT01681992|12365506|FG001|Overall Study|Lost to Follow-up|38
7872183|NCT01681992|12365507|FG002|Overall Study|Lost to Follow-up|53
7872184|NCT01681992|12365505|FG000|Overall Study|As Per Sponsor Decision|0
7872185|NCT01681992|12365506|FG001|Overall Study|As Per Sponsor Decision|0
7872186|NCT01681992|12365507|FG002|Overall Study|As Per Sponsor Decision|1
7872187|NCT01681992|12365505|FG000|Overall Study|Protocol Violation|0
7872188|NCT01681992|12365506|FG001|Overall Study|Protocol Violation|0
7872189|NCT01681992|12365507|FG002|Overall Study|Protocol Violation|1
7872190|NCT01681992|12365505|FG000|Overall Study|Withdrawal by Subject|27
7872191|NCT01681992|12365506|FG001|Overall Study|Withdrawal by Subject|30
7872192|NCT01681992|12365507|FG002|Overall Study|Withdrawal by Subject|25
7872193|NCT01682031|12365517|FG000|Overall Study|Withdrawal by Subject|0
7872194|NCT01682031|12365518|FG001|Overall Study|Withdrawal by Subject|1
7872195|NCT01682031|12365517|FG000|Overall Study|Adverse Event|0
7872196|NCT01682031|12365518|FG001|Overall Study|Adverse Event|2
7872197|NCT01682031|12365517|FG000|Overall Study|MRI results indicate increased nodul|0
7872198|NCT01682031|12365518|FG001|Overall Study|MRI results indicate increased nodul|1
7872199|NCT01682031|12365517|FG000|Overall Study|Patient could not swallow tablets|1
7872200|NCT01682031|12365518|FG001|Overall Study|Patient could not swallow tablets|0
7872201|NCT01682031|12365517|FG000|Overall Study|Patient stopped selenium on his own|0
7872202|NCT01682031|12365518|FG001|Overall Study|Patient stopped selenium on his own|1
7872203|NCT01682044|12365524|FG000|Overall Study|Death|1
7872204|NCT01682044|12365524|FG000|Overall Study|Progression|3
7872205|NCT01682213|12365543|FG000|Overall Study|Withdrawal by Subject|2
7872206|NCT01682460|12365548|FG000|Overall Study|Withdrawal by Subject|2
7872207|NCT01682460|12365548|FG000|Overall Study|Did not meet inclusion criteria|2
7872208|NCT01682512|12365555|FG000|Overall Study|Adverse Event|6
7872209|NCT01682512|12365556|FG001|Overall Study|Adverse Event|5
7872210|NCT01682512|12365557|FG002|Overall Study|Adverse Event|2
7872211|NCT01682512|12365555|FG000|Overall Study|Withdrawal by Subject|2
7872212|NCT01682512|12365556|FG001|Overall Study|Withdrawal by Subject|6
7872213|NCT01682512|12365557|FG002|Overall Study|Withdrawal by Subject|3
7872214|NCT01682512|12365555|FG000|Overall Study|Physician Decision|0
7872215|NCT01682512|12365556|FG001|Overall Study|Physician Decision|2
7872216|NCT01682512|12365557|FG002|Overall Study|Physician Decision|0
7872217|NCT01682512|12365555|FG000|Overall Study|Study terminated by sponsor|46
7872218|NCT01682512|12365556|FG001|Overall Study|Study terminated by sponsor|43
7872219|NCT01682512|12365557|FG002|Overall Study|Study terminated by sponsor|0
7872220|NCT01682512|12365555|FG000|Overall Study|Lost to Follow-up|3
7872221|NCT01682512|12365556|FG001|Overall Study|Lost to Follow-up|0
7872222|NCT01682512|12365557|FG002|Overall Study|Lost to Follow-up|2
7872223|NCT01682512|12365555|FG000|Overall Study|Protocol Violation|2
7872224|NCT01682512|12365556|FG001|Overall Study|Protocol Violation|3
7872225|NCT01682512|12365557|FG002|Overall Study|Protocol Violation|2
7872226|NCT01682512|12365555|FG000|Overall Study|Primary lack of efficacy|10
7872227|NCT01682512|12365556|FG001|Overall Study|Primary lack of efficacy|7
7872228|NCT01682512|12365557|FG002|Overall Study|Primary lack of efficacy|7
7872229|NCT01682512|12365555|FG000|Overall Study|Secondary lack of efficacy|1
7872230|NCT01682512|12365556|FG001|Overall Study|Secondary lack of efficacy|1
7872231|NCT01682512|12365557|FG002|Overall Study|Secondary lack of efficacy|0
7872232|NCT01682512|12365555|FG000|Overall Study|Other than stated above|2
7872233|NCT01682512|12365556|FG001|Overall Study|Other than stated above|4
7872234|NCT01682512|12365557|FG002|Overall Study|Other than stated above|2
7872235|NCT01682603|12365580|FG000|Overall Study|Lost to Follow-up|3
7872236|NCT01682681|12365601|FG000|Overall Study|Lack of Efficacy|62
7872237|NCT01682681|12365601|FG000|Overall Study|Withdrawal by Subject|1
7872238|NCT01682681|12365601|FG000|Overall Study|Moved to other hospital|10
7872239|NCT01682681|12365601|FG000|Overall Study|Lost to Follow-up|174
7872240|NCT01682681|12365601|FG000|Overall Study|Adverse Event|46
7872241|NCT01682681|12365601|FG000|Overall Study|tapering of topiramate|5
7872242|NCT01682681|12365601|FG000|Overall Study|Other|21
7872243|NCT01682681|12365601|FG000|Overall Study|Low compliance|13
7872244|NCT01682720|12365609|FG000|Overall Study|Randomized but Not Treated|0
7872245|NCT01682720|12365610|FG001|Overall Study|Randomized but Not Treated|1
7872246|NCT01682720|12365611|FG002|Overall Study|Randomized but Not Treated|1
7872247|NCT01682720|12365612|FG003|Overall Study|Randomized but Not Treated|0
7872248|NCT01682720|12365609|FG000|Overall Study|Terminated by Sponsor|83
7872249|NCT01682720|12365610|FG001|Overall Study|Terminated by Sponsor|0
7872250|NCT01682720|12365611|FG002|Overall Study|Terminated by Sponsor|0
7872251|NCT01682720|12365612|FG003|Overall Study|Terminated by Sponsor|0
7872252|NCT01682720|12365609|FG000|Overall Study|Efficacy Failure|0
7872253|NCT01682720|12365610|FG001|Overall Study|Efficacy Failure|3
7872254|NCT01682720|12365611|FG002|Overall Study|Efficacy Failure|3
7872255|NCT01682720|12365612|FG003|Overall Study|Efficacy Failure|30
7872256|NCT01682720|12365609|FG000|Overall Study|Lost to Follow-up|1
7872257|NCT01682720|12365610|FG001|Overall Study|Lost to Follow-up|1
7872258|NCT01682720|12365611|FG002|Overall Study|Lost to Follow-up|0
7872259|NCT01682720|12365612|FG003|Overall Study|Lost to Follow-up|6
7872260|NCT01682720|12365609|FG000|Overall Study|Subject Withdrew Consent|0
7872261|NCT01682720|12365610|FG001|Overall Study|Subject Withdrew Consent|0
7872262|NCT01682720|12365611|FG002|Overall Study|Subject Withdrew Consent|2
7872263|NCT01682720|12365612|FG003|Overall Study|Subject Withdrew Consent|2
7872264|NCT01682720|12365609|FG000|Overall Study|Adverse Event|1
7872265|NCT01682720|12365610|FG001|Overall Study|Adverse Event|0
7872266|NCT01682720|12365611|FG002|Overall Study|Adverse Event|1
7872267|NCT01682720|12365612|FG003|Overall Study|Adverse Event|1
7872268|NCT01682759|12365624|FG000|Overall Study|Death|2
7872269|NCT01682759|12365625|FG001|Overall Study|Death|1
7872270|NCT01682759|12365624|FG000|Overall Study|Lost to Follow-up|10
7872271|NCT01682759|12365625|FG001|Overall Study|Lost to Follow-up|13
7872272|NCT01682759|12365624|FG000|Overall Study|Physician Decision|1
7872273|NCT01682759|12365625|FG001|Overall Study|Physician Decision|1
7872274|NCT01682759|12365624|FG000|Overall Study|Withdrawal by Subject|56
7872275|NCT01682759|12365625|FG001|Overall Study|Withdrawal by Subject|55
7872276|NCT01682811|12365638|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0
7872277|NCT01682811|12365639|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0
7872278|NCT01682811|12365640|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0
7872279|NCT01682811|12365641|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0
7872280|NCT01682811|12365642|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1
7872281|NCT01682811|12365643|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0
7872282|NCT01682811|12365644|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0
7872283|NCT01682811|12365638|FG000|Part 2 Dose Level 1|Protocol Violation|0
7872284|NCT01682811|12365639|FG001|Part 2 Dose Level 1|Protocol Violation|0
7872285|NCT01682811|12365640|FG002|Part 2 Dose Level 1|Protocol Violation|0
7872286|NCT01682811|12365641|FG003|Part 2 Dose Level 1|Protocol Violation|0
7872287|NCT01682811|12365642|FG004|Part 2 Dose Level 1|Protocol Violation|4
7872288|NCT01682811|12365643|FG005|Part 2 Dose Level 1|Protocol Violation|0
7872289|NCT01682811|12365644|FG006|Part 2 Dose Level 1|Protocol Violation|0
7872290|NCT01682811|12365638|FG000|Part 2 Dose Level 1|Lost to Follow-up|0
7872291|NCT01682811|12365639|FG001|Part 2 Dose Level 1|Lost to Follow-up|0
7872292|NCT01682811|12365640|FG002|Part 2 Dose Level 1|Lost to Follow-up|0
7872293|NCT01682811|12365641|FG003|Part 2 Dose Level 1|Lost to Follow-up|0
7872294|NCT01682811|12365642|FG004|Part 2 Dose Level 1|Lost to Follow-up|6
7872295|NCT01682811|12365643|FG005|Part 2 Dose Level 1|Lost to Follow-up|0
7872296|NCT01682811|12365644|FG006|Part 2 Dose Level 1|Lost to Follow-up|0
7872297|NCT01682811|12365638|FG000|Part 2 Dose Level 2|Lost to Follow-up|0
7872298|NCT01682811|12365639|FG001|Part 2 Dose Level 2|Lost to Follow-up|0
7872299|NCT01682811|12365640|FG002|Part 2 Dose Level 2|Lost to Follow-up|0
7872300|NCT01682811|12365641|FG003|Part 2 Dose Level 2|Lost to Follow-up|0
7872301|NCT01682811|12365642|FG004|Part 2 Dose Level 2|Lost to Follow-up|0
7872302|NCT01682811|12365643|FG005|Part 2 Dose Level 2|Lost to Follow-up|3
7872303|NCT01682811|12365644|FG006|Part 2 Dose Level 2|Lost to Follow-up|0
7872304|NCT01682837|12365663|FG000|Baseline|Withdrawal by Subject|5
7872305|NCT01682863|12365676|FG000|Overall Study|Subject/guardian decision|19
7872306|NCT01682863|12365677|FG001|Overall Study|Subject/guardian decision|12
7872307|NCT01682863|12365678|FG002|Overall Study|Subject/guardian decision|10
7872308|NCT01682863|12365676|FG000|Overall Study|Lost to Follow-up|5
7872309|NCT01682863|12365677|FG001|Overall Study|Lost to Follow-up|1
7872310|NCT01682863|12365678|FG002|Overall Study|Lost to Follow-up|6
7872311|NCT01682863|12365676|FG000|Overall Study|Death|1
7872312|NCT01682863|12365677|FG001|Overall Study|Death|3
7872313|NCT01682863|12365678|FG002|Overall Study|Death|4
7872314|NCT01682863|12365676|FG000|Overall Study|Protocol deviation|1
7872315|NCT01682863|12365677|FG001|Overall Study|Protocol deviation|0
7872316|NCT01682863|12365678|FG002|Overall Study|Protocol deviation|1
7872317|NCT01682863|12365676|FG000|Overall Study|Technical problems|1
7872318|NCT01682863|12365677|FG001|Overall Study|Technical problems|0
7872319|NCT01682863|12365678|FG002|Overall Study|Technical problems|0
7872320|NCT01682863|12365676|FG000|Overall Study|Adverse Event|0
7872321|NCT01682863|12365677|FG001|Overall Study|Adverse Event|1
7872322|NCT01682863|12365678|FG002|Overall Study|Adverse Event|2
7872323|NCT01682863|12365676|FG000|Overall Study|Physician Decision|0
7872324|NCT01682863|12365677|FG001|Overall Study|Physician Decision|0
7872325|NCT01682863|12365678|FG002|Overall Study|Physician Decision|1
7872326|NCT01682876|12365690|FG000|Overall Study|Administrative reason|4
7872327|NCT01682876|12365691|FG001|Overall Study|Administrative reason|4
7872328|NCT01682876|12365692|FG002|Overall Study|Administrative reason|0
7872329|NCT01682876|12365693|FG003|Overall Study|Administrative reason|3
7872330|NCT01682876|12365690|FG000|Overall Study|Adverse Event|0
7872331|NCT01682876|12365691|FG001|Overall Study|Adverse Event|0
7872332|NCT01682876|12365692|FG002|Overall Study|Adverse Event|0
7872333|NCT01682876|12365693|FG003|Overall Study|Adverse Event|1
7872334|NCT01682876|12365690|FG000|Overall Study|Lost to Follow-up|11
7872335|NCT01682876|12365691|FG001|Overall Study|Lost to Follow-up|15
7872336|NCT01682876|12365692|FG002|Overall Study|Lost to Follow-up|9
7872337|NCT01682876|12365693|FG003|Overall Study|Lost to Follow-up|11
7872338|NCT01682876|12365690|FG000|Overall Study|Protocol Violation|1
7872339|NCT01682876|12365691|FG001|Overall Study|Protocol Violation|1
7872340|NCT01682876|12365692|FG002|Overall Study|Protocol Violation|1
7872341|NCT01682876|12365693|FG003|Overall Study|Protocol Violation|1
7872342|NCT01682876|12365690|FG000|Overall Study|Withdrawal by Subject|4
7872343|NCT01682876|12365691|FG001|Overall Study|Withdrawal by Subject|0
7872344|NCT01682876|12365692|FG002|Overall Study|Withdrawal by Subject|0
7872345|NCT01682876|12365693|FG003|Overall Study|Withdrawal by Subject|2
7872346|NCT01682876|12365690|FG000|Overall Study|Other|1
7872347|NCT01682876|12365691|FG001|Overall Study|Other|0
7872348|NCT01682876|12365692|FG002|Overall Study|Other|1
7872349|NCT01682876|12365693|FG003|Overall Study|Other|1
7872350|NCT01683019|12365718|FG000|Overall Study|Withdrawal by Subject|2
7872351|NCT01683019|12365719|FG001|Overall Study|Withdrawal by Subject|1
7872352|NCT01683019|12365720|FG002|Overall Study|Withdrawal by Subject|4
7872353|NCT01683058|12365728|FG000|Overall Study|Lost to Follow-up|9
7872354|NCT01683058|12365728|FG000|Overall Study|Adverse Event|6
7872355|NCT01683058|12365728|FG000|Overall Study|Subject Met Withdrawal Criteria|5
7872356|NCT01683058|12365728|FG000|Overall Study|Withdrawal by Subject|7
7872357|NCT01683058|12365728|FG000|Overall Study|Lack of Efficacy|2
7872358|NCT01683071|12365739|FG000|Part 1|Lack of Efficacy|1
7872359|NCT01683071|12365740|FG001|Part 1|Lack of Efficacy|0
7872360|NCT01683071|12365741|FG002|Part 1|Lack of Efficacy|0
7872361|NCT01683071|12365742|FG003|Part 1|Lack of Efficacy|3
7872362|NCT01683071|12365743|FG004|Part 1|Lack of Efficacy|0
7872363|NCT01683071|12365744|FG005|Part 1|Lack of Efficacy|0
7872364|NCT01683071|12365739|FG000|Part 1|Withdrawal by Subject|1
7872365|NCT01683071|12365740|FG001|Part 1|Withdrawal by Subject|2
7872366|NCT01683071|12365741|FG002|Part 1|Withdrawal by Subject|2
7872367|NCT01683071|12365742|FG003|Part 1|Withdrawal by Subject|1
7872368|NCT01683071|12365743|FG004|Part 1|Withdrawal by Subject|0
7872369|NCT01683071|12365744|FG005|Part 1|Withdrawal by Subject|0
7872370|NCT01683071|12365739|FG000|Part 1|Surgery Cancelled|1
7872371|NCT01683071|12365740|FG001|Part 1|Surgery Cancelled|0
7872372|NCT01683071|12365741|FG002|Part 1|Surgery Cancelled|0
7793740|NCT01049503|12249098|FG005|Overall Study|Lost to Follow-up|8
7793741|NCT01049581|12249123|FG000|Overall Study|Lost to Follow-up|2
7793742|NCT01049581|12249124|FG001|Overall Study|Lost to Follow-up|1
7793743|NCT01049919|12249148|FG000|Overall Study|Met study endpoint (major amputation, death)|36
7793744|NCT01049919|12249149|FG001|Overall Study|Met study endpoint (major amputation, death)|16
7793745|NCT01049919|12249148|FG000|Overall Study|Withdrawal by Subject|5
7793746|NCT01049919|12249149|FG001|Overall Study|Withdrawal by Subject|0
7793747|NCT01049919|12249148|FG000|Overall Study|Lost to Follow-up|6
7793748|NCT01049919|12249149|FG001|Overall Study|Lost to Follow-up|1
7793749|NCT01049919|12249148|FG000|Overall Study|Physician Decision|2
7872373|NCT01683071|12365742|FG003|Part 1|Surgery Cancelled|0
7872374|NCT01683071|12365743|FG004|Part 1|Surgery Cancelled|0
7872375|NCT01683071|12365744|FG005|Part 1|Surgery Cancelled|0
7872376|NCT01683071|12365739|FG000|Part 1|Did not receive study drug|1
7872377|NCT01683071|12365740|FG001|Part 1|Did not receive study drug|0
7872378|NCT01683071|12365741|FG002|Part 1|Did not receive study drug|0
7872379|NCT01683071|12365742|FG003|Part 1|Did not receive study drug|1
7872380|NCT01683071|12365743|FG004|Part 1|Did not receive study drug|0
7872381|NCT01683071|12365744|FG005|Part 1|Did not receive study drug|0
7872382|NCT01683071|12365739|FG000|Part 1|Early termination; met exclusion criteria|0
7872383|NCT01683071|12365740|FG001|Part 1|Early termination; met exclusion criteria|2
7872384|NCT01683071|12365741|FG002|Part 1|Early termination; met exclusion criteria|1
7872385|NCT01683071|12365742|FG003|Part 1|Early termination; met exclusion criteria|0
7872386|NCT01683071|12365743|FG004|Part 1|Early termination; met exclusion criteria|0
7872387|NCT01683071|12365744|FG005|Part 1|Early termination; met exclusion criteria|0
7872388|NCT01683071|12365739|FG000|Part 2|Lack of Efficacy|0
7872389|NCT01683071|12365740|FG001|Part 2|Lack of Efficacy|0
7872390|NCT01683071|12365741|FG002|Part 2|Lack of Efficacy|0
7872391|NCT01683071|12365742|FG003|Part 2|Lack of Efficacy|0
7872392|NCT01683071|12365743|FG004|Part 2|Lack of Efficacy|3
7872393|NCT01683071|12365744|FG005|Part 2|Lack of Efficacy|4
7872394|NCT01683071|12365739|FG000|Part 2|Lost to Follow-up|0
7872395|NCT01683071|12365740|FG001|Part 2|Lost to Follow-up|0
7872396|NCT01683071|12365741|FG002|Part 2|Lost to Follow-up|0
7872397|NCT01683071|12365742|FG003|Part 2|Lost to Follow-up|0
7872398|NCT01683071|12365743|FG004|Part 2|Lost to Follow-up|2
7872399|NCT01683071|12365744|FG005|Part 2|Lost to Follow-up|0
7872400|NCT01683071|12365739|FG000|Part 2|Withdrawal by Subject|0
7872401|NCT01683071|12365740|FG001|Part 2|Withdrawal by Subject|0
7872402|NCT01683071|12365741|FG002|Part 2|Withdrawal by Subject|0
7872403|NCT01683071|12365742|FG003|Part 2|Withdrawal by Subject|0
7872404|NCT01683071|12365743|FG004|Part 2|Withdrawal by Subject|3
7872405|NCT01683071|12365744|FG005|Part 2|Withdrawal by Subject|3
7872406|NCT01683071|12365739|FG000|Part 2|Surgery cancelled|0
7872407|NCT01683071|12365740|FG001|Part 2|Surgery cancelled|0
7872408|NCT01683071|12365741|FG002|Part 2|Surgery cancelled|0
7872409|NCT01683071|12365742|FG003|Part 2|Surgery cancelled|0
7872410|NCT01683071|12365743|FG004|Part 2|Surgery cancelled|4
7872411|NCT01683071|12365744|FG005|Part 2|Surgery cancelled|2
7872412|NCT01683071|12365739|FG000|Part 2|Did not receive study drug|0
7872413|NCT01683071|12365740|FG001|Part 2|Did not receive study drug|0
7872414|NCT01683071|12365741|FG002|Part 2|Did not receive study drug|0
7872415|NCT01683071|12365742|FG003|Part 2|Did not receive study drug|0
7872416|NCT01683071|12365743|FG004|Part 2|Did not receive study drug|2
7872417|NCT01683071|12365744|FG005|Part 2|Did not receive study drug|1
7872418|NCT01683071|12365739|FG000|Part 2|Met exclusion criterion|0
7872419|NCT01683071|12365740|FG001|Part 2|Met exclusion criterion|0
7872420|NCT01683071|12365741|FG002|Part 2|Met exclusion criterion|0
7872421|NCT01683071|12365742|FG003|Part 2|Met exclusion criterion|0
7872422|NCT01683071|12365743|FG004|Part 2|Met exclusion criterion|1
7872423|NCT01683071|12365744|FG005|Part 2|Met exclusion criterion|1
7872424|NCT01683071|12365739|FG000|Part 2|Protocol deviation|0
7872425|NCT01683071|12365740|FG001|Part 2|Protocol deviation|0
7872426|NCT01683071|12365741|FG002|Part 2|Protocol deviation|0
7872427|NCT01683071|12365742|FG003|Part 2|Protocol deviation|0
7872428|NCT01683071|12365743|FG004|Part 2|Protocol deviation|1
7872429|NCT01683071|12365744|FG005|Part 2|Protocol deviation|2
7872430|NCT01683071|12365739|FG000|Part 2|Withdrawal by investigator decision|0
7872431|NCT01683071|12365740|FG001|Part 2|Withdrawal by investigator decision|0
7872432|NCT01683071|12365741|FG002|Part 2|Withdrawal by investigator decision|0
7872433|NCT01683071|12365742|FG003|Part 2|Withdrawal by investigator decision|0
7872434|NCT01683071|12365743|FG004|Part 2|Withdrawal by investigator decision|1
7872435|NCT01683071|12365744|FG005|Part 2|Withdrawal by investigator decision|2
7872436|NCT01683266|12365766|FG000|Overall Study|Adverse Event|5
7872437|NCT01683266|12365767|FG001|Overall Study|Adverse Event|4
7872438|NCT01683266|12365766|FG000|Overall Study|Lack of Efficacy|5
7872439|NCT01683266|12365767|FG001|Overall Study|Lack of Efficacy|2
7872440|NCT01683266|12365766|FG000|Overall Study|Protocol Violation|13
7872441|NCT01683266|12365767|FG001|Overall Study|Protocol Violation|6
7872442|NCT01683266|12365766|FG000|Overall Study|Personal Reason|17
7872443|NCT01683266|12365767|FG001|Overall Study|Personal Reason|25
7872444|NCT01683266|12365766|FG000|Overall Study|Selection Criterion / Protocol Violation|7
7872445|NCT01683266|12365767|FG001|Overall Study|Selection Criterion / Protocol Violation|5
7872446|NCT01683266|12365766|FG000|Overall Study|Lost to Follow-up|5
7872447|NCT01683266|12365767|FG001|Overall Study|Lost to Follow-up|0
7872448|NCT01683266|12365766|FG000|Overall Study|Site Closure / Site Withdrawal|1
7872449|NCT01683266|12365767|FG001|Overall Study|Site Closure / Site Withdrawal|3
7872450|NCT01683266|12365766|FG000|Overall Study|Nonserious Hypoglycemia|0
7872451|NCT01683266|12365767|FG001|Overall Study|Nonserious Hypoglycemia|3
7872452|NCT01683266|12365766|FG000|Overall Study|Perceived Lack of Efficacy|1
7872453|NCT01683266|12365767|FG001|Overall Study|Perceived Lack of Efficacy|1
7872454|NCT01683266|12365766|FG000|Overall Study|Possibly Hypoglycemia|1
7872455|NCT01683266|12365767|FG001|Overall Study|Possibly Hypoglycemia|0
7872456|NCT01683266|12365766|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0
7872457|NCT01683266|12365767|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1
7872458|NCT01683383|12365784|FG000|Overall Study|Infant was not transported|1
7872459|NCT01683383|12365785|FG001|Overall Study|Infant was not transported|0
7872460|NCT01683409|12365796|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7872461|NCT01683409|12365797|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7872462|NCT01683409|12365798|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
7872463|NCT01683409|12365799|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7872464|NCT01683409|12365800|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7872465|NCT01683409|12365796|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0
7872466|NCT01683409|12365797|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3
7872467|NCT01683409|12365798|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0
7872468|NCT01683409|12365799|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1
7872469|NCT01683409|12365800|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1
7872470|NCT01683409|12365796|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7872471|NCT01683409|12365797|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
7872472|NCT01683409|12365798|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7872473|NCT01683409|12365799|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7872474|NCT01683409|12365800|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7872475|NCT01683409|12365796|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
7872476|NCT01683409|12365797|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
7872477|NCT01683409|12365798|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
7793750|NCT01049919|12249149|FG001|Overall Study|Physician Decision|0
7872478|NCT01683409|12365799|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
7872479|NCT01683409|12365800|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
7872480|NCT01683409|12365796|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7872481|NCT01683409|12365797|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7793751|NCT01049919|12249148|FG000|Overall Study|Received 2nd treatment via compassionate use|1
7793752|NCT01049919|12249149|FG001|Overall Study|Received 2nd treatment via compassionate use|0
7793753|NCT01049919|12249148|FG000|Overall Study|Early study termination by sponsor.|2
7793754|NCT01049919|12249149|FG001|Overall Study|Early study termination by sponsor.|0
7793755|NCT01049984|12249178|FG000|Overall Study|Withdrawal by Subject|1
7872482|NCT01683409|12365798|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
7872483|NCT01683409|12365799|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7872484|NCT01683409|12365800|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7872485|NCT01683409|12365796|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
7872486|NCT01683409|12365797|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
7872487|NCT01683409|12365798|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
7872488|NCT01683409|12365799|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
7872489|NCT01683409|12365800|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
7872490|NCT01683409|12365796|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
7872491|NCT01683409|12365797|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
7872492|NCT01683409|12365798|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
7872493|NCT01683409|12365799|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
7872494|NCT01683409|12365800|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
7872495|NCT01683409|12365796|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1
7872496|NCT01683409|12365797|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7872497|NCT01683409|12365798|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7872498|NCT01683409|12365799|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7872499|NCT01683409|12365800|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7872500|NCT01683409|12365796|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0
7872501|NCT01683409|12365797|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4
7872502|NCT01683409|12365798|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0
7872503|NCT01683409|12365799|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1
7872504|NCT01683409|12365800|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2
7872505|NCT01683409|12365796|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7872506|NCT01683409|12365797|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7872507|NCT01683409|12365798|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7872508|NCT01683409|12365799|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7872509|NCT01683409|12365800|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3
7872510|NCT01683409|12365796|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7872511|NCT01683409|12365797|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7872512|NCT01683409|12365798|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1
7872513|NCT01683409|12365799|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7872514|NCT01683409|12365800|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7872515|NCT01683565|12365841|FG000|Overall Study|Lost to Follow-up|2
7872516|NCT01683565|12365842|FG001|Overall Study|Lost to Follow-up|0
7872517|NCT01683565|12365841|FG000|Overall Study|Discontinued Intervention|1
7872518|NCT01683565|12365842|FG001|Overall Study|Discontinued Intervention|1
7872519|NCT01683604|12365850|FG000|Overall Study|Adverse Event|2
7872520|NCT01683604|12365850|FG000|Overall Study|Lack of Efficacy|1
7872521|NCT01683604|12365850|FG000|Overall Study|Other|2
7872522|NCT01683838|12365874|FG000|Overall Study|Adverse Event|12
7872523|NCT01683838|12365875|FG001|Overall Study|Adverse Event|2
7872524|NCT01683838|12365874|FG000|Overall Study|Protocol Violation|3
7872525|NCT01683838|12365875|FG001|Overall Study|Protocol Violation|1
7872526|NCT01683838|12365874|FG000|Overall Study|Withdrawal by Subject|6
7872527|NCT01683838|12365875|FG001|Overall Study|Withdrawal by Subject|5
7872528|NCT01683838|12365874|FG000|Overall Study|Lost to Follow-up|1
7872529|NCT01683838|12365875|FG001|Overall Study|Lost to Follow-up|1
7872530|NCT01683838|12365874|FG000|Overall Study|Other|4
7872531|NCT01683838|12365875|FG001|Overall Study|Other|3
7872532|NCT01683994|12365886|FG000|Overall Study|Withdrawal by Subject|1
7872533|NCT01683994|12365887|FG001|Overall Study|Withdrawal by Subject|0
7872534|NCT01683994|12365888|FG002|Overall Study|Withdrawal by Subject|0
7872535|NCT01683994|12365889|FG003|Overall Study|Withdrawal by Subject|1
7872536|NCT01683994|12365890|FG004|Overall Study|Withdrawal by Subject|0
7872537|NCT01683994|12365886|FG000|Overall Study|Intercurrent illness|0
7872538|NCT01683994|12365887|FG001|Overall Study|Intercurrent illness|0
7872539|NCT01683994|12365888|FG002|Overall Study|Intercurrent illness|0
7872540|NCT01683994|12365889|FG003|Overall Study|Intercurrent illness|2
7872541|NCT01683994|12365890|FG004|Overall Study|Intercurrent illness|1
7872542|NCT01684033|12365926|FG000|Period 1, First 30 Days|Adverse Event|1
7793756|NCT01049984|12249179|FG001|Overall Study|Withdrawal by Subject|5
7793757|NCT01049984|12249178|FG000|Overall Study|Protocol Violation|3
7872543|NCT01684033|12365927|FG001|Period 1, First 30 Days|Adverse Event|1
7872544|NCT01684033|12365926|FG000|Period 1, First 30 Days|Noncompliance|1
7872545|NCT01684033|12365927|FG001|Period 1, First 30 Days|Noncompliance|0
7872546|NCT01684033|12365926|FG000|Period 1, First 30 Days|Withdrawal by Subject|1
7872547|NCT01684033|12365927|FG001|Period 1, First 30 Days|Withdrawal by Subject|0
7872548|NCT01684033|12365926|FG000|Period 1, First 30 Days|Lost to Follow-up|1
7872549|NCT01684033|12365927|FG001|Period 1, First 30 Days|Lost to Follow-up|0
7872550|NCT01684033|12365926|FG000|Period 2, Second 30 Days|Adverse Event|1
7793758|NCT01049984|12249179|FG001|Overall Study|Protocol Violation|4
7793759|NCT01049984|12249178|FG000|Overall Study|Lost to Follow-up|2
7793760|NCT01049984|12249179|FG001|Overall Study|Lost to Follow-up|1
7793761|NCT01049984|12249178|FG000|Overall Study|Adverse Event|13
7793762|NCT01049984|12249179|FG001|Overall Study|Adverse Event|7
7793763|NCT01049984|12249178|FG000|Overall Study|Treatment failure|0
7793764|NCT01049984|12249179|FG001|Overall Study|Treatment failure|2
7793765|NCT01050062|12249187|FG000|Overall Study|Adverse Event|75
7793766|NCT01050062|12249188|FG001|Overall Study|Adverse Event|22
7793767|NCT01050062|12249187|FG000|Overall Study|Lost to Follow-up|83
7793768|NCT01050062|12249188|FG001|Overall Study|Lost to Follow-up|35
7872551|NCT01684033|12365927|FG001|Period 2, Second 30 Days|Adverse Event|0
7872552|NCT01684046|12365933|FG000|Period 1, First 30 Days|Adverse Event|0
7872553|NCT01684046|12365934|FG001|Period 1, First 30 Days|Adverse Event|2
7872554|NCT01684202|12365944|FG000|Dose-escalation Period|Adverse Event|0
7872555|NCT01684202|12365945|FG001|Dose-escalation Period|Adverse Event|1
7872556|NCT01684202|12365946|FG002|Dose-escalation Period|Adverse Event|0
7872557|NCT01684202|12365947|FG003|Dose-escalation Period|Adverse Event|0
7872558|NCT01684202|12365944|FG000|Dose-escalation Period|Withdrawal by Subject|1
7872559|NCT01684202|12365945|FG001|Dose-escalation Period|Withdrawal by Subject|0
7872560|NCT01684202|12365946|FG002|Dose-escalation Period|Withdrawal by Subject|0
7872561|NCT01684202|12365947|FG003|Dose-escalation Period|Withdrawal by Subject|0
7872562|NCT01684202|12365944|FG000|Maintenance Period|Adverse Event|1
7872563|NCT01684202|12365945|FG001|Maintenance Period|Adverse Event|1
7872564|NCT01684202|12365946|FG002|Maintenance Period|Adverse Event|1
7872565|NCT01684202|12365947|FG003|Maintenance Period|Adverse Event|1
7872566|NCT01684202|12365944|FG000|Maintenance Period|Physician Decision|0
7872567|NCT01684202|12365945|FG001|Maintenance Period|Physician Decision|1
7872568|NCT01684202|12365946|FG002|Maintenance Period|Physician Decision|0
7872569|NCT01684202|12365947|FG003|Maintenance Period|Physician Decision|0
7872570|NCT01684202|12365944|FG000|Maintenance Period|Withdrawal by Subject|0
7872571|NCT01684202|12365945|FG001|Maintenance Period|Withdrawal by Subject|1
7872572|NCT01684202|12365946|FG002|Maintenance Period|Withdrawal by Subject|0
7872573|NCT01684202|12365947|FG003|Maintenance Period|Withdrawal by Subject|0
7872574|NCT01684215|12365961|FG000|Phase 1, Part 1|Adverse Event|1
7872575|NCT01684215|12365962|FG001|Phase 1, Part 1|Adverse Event|0
7872576|NCT01684215|12365963|FG002|Phase 1, Part 1|Adverse Event|0
7872577|NCT01684215|12365964|FG003|Phase 1, Part 1|Adverse Event|0
7872578|NCT01684215|12365961|FG000|Phase 1, Part 1|Objective progression or relapse|5
7872579|NCT01684215|12365962|FG001|Phase 1, Part 1|Objective progression or relapse|6
7872580|NCT01684215|12365963|FG002|Phase 1, Part 1|Objective progression or relapse|0
7872581|NCT01684215|12365964|FG003|Phase 1, Part 1|Objective progression or relapse|0
7872582|NCT01684215|12365961|FG000|Phase 1, Part 2|Adverse Event|0
7872583|NCT01684215|12365962|FG001|Phase 1, Part 2|Adverse Event|0
7872584|NCT01684215|12365963|FG002|Phase 1, Part 2|Adverse Event|1
7872585|NCT01684215|12365964|FG003|Phase 1, Part 2|Adverse Event|0
7872586|NCT01684215|12365961|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
7872587|NCT01684215|12365962|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
7872588|NCT01684215|12365963|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4
7872589|NCT01684215|12365964|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
7872590|NCT01684215|12365961|FG000|Phase 1, Part 2|Withdrawal by Subject|0
7872591|NCT01684215|12365962|FG001|Phase 1, Part 2|Withdrawal by Subject|0
7872592|NCT01684215|12365963|FG002|Phase 1, Part 2|Withdrawal by Subject|1
7872593|NCT01684215|12365964|FG003|Phase 1, Part 2|Withdrawal by Subject|0
7872594|NCT01684215|12365961|FG000|Phase 2|Death|0
7872595|NCT01684215|12365962|FG001|Phase 2|Death|0
7872596|NCT01684215|12365963|FG002|Phase 2|Death|0
7872597|NCT01684215|12365964|FG003|Phase 2|Death|8
7872598|NCT01684215|12365961|FG000|Phase 2|Study terminated by sponsor|0
7872599|NCT01684215|12365962|FG001|Phase 2|Study terminated by sponsor|0
7793769|NCT01050062|12249187|FG000|Overall Study|Lack of Efficacy|22
7793770|NCT01050062|12249188|FG001|Overall Study|Lack of Efficacy|35
7793771|NCT01050062|12249187|FG000|Overall Study|Physician Decision|74
7793772|NCT01050062|12249188|FG001|Overall Study|Physician Decision|9
7793773|NCT01050062|12249187|FG000|Overall Study|Others|17
7793774|NCT01050062|12249188|FG001|Overall Study|Others|11
7793775|NCT01050205|12249207|FG000|Overall Study|Lost to Follow-up|7
7793776|NCT01050205|12249208|FG001|Overall Study|Lost to Follow-up|1
7793777|NCT01050205|12249207|FG000|Overall Study|Withdrawal by Subject|1
7793778|NCT01050205|12249208|FG001|Overall Study|Withdrawal by Subject|1
7793779|NCT01050205|12249207|FG000|Overall Study|Relocated from area|1
7793780|NCT01050205|12249208|FG001|Overall Study|Relocated from area|2
7793781|NCT01050205|12249207|FG000|Overall Study|Discontinued Intervention|2
7793782|NCT01050205|12249208|FG001|Overall Study|Discontinued Intervention|0
7793783|NCT01050257|12249226|FG000|Overall Study|Adverse Event|4
7793784|NCT01050257|12249227|FG001|Overall Study|Adverse Event|4
7793785|NCT01050257|12249228|FG002|Overall Study|Adverse Event|2
7793786|NCT01050257|12249226|FG000|Overall Study|Admin/Other (did not switch to oral)|6
7793787|NCT01050257|12249227|FG001|Overall Study|Admin/Other (did not switch to oral)|2
7793788|NCT01050257|12249228|FG002|Overall Study|Admin/Other (did not switch to oral)|2
7793789|NCT01050257|12249226|FG000|Overall Study|Withdrawal by Subject|0
7793790|NCT01050257|12249227|FG001|Overall Study|Withdrawal by Subject|3
7793791|NCT01050257|12249228|FG002|Overall Study|Withdrawal by Subject|0
7793792|NCT01050257|12249226|FG000|Overall Study|No reason specified|0
7793793|NCT01050257|12249227|FG001|Overall Study|No reason specified|0
7793794|NCT01050257|12249228|FG002|Overall Study|No reason specified|2
7793795|NCT01050257|12249226|FG000|Overall Study|Refused treatment/ Did not Cooperate|1
7793796|NCT01050257|12249227|FG001|Overall Study|Refused treatment/ Did not Cooperate|1
7793797|NCT01050257|12249228|FG002|Overall Study|Refused treatment/ Did not Cooperate|0
7793798|NCT01050257|12249226|FG000|Overall Study|Violation criteria|0
7793799|NCT01050257|12249227|FG001|Overall Study|Violation criteria|1
7872600|NCT01684215|12365963|FG002|Phase 2|Study terminated by sponsor|0
7872601|NCT01684215|12365964|FG003|Phase 2|Study terminated by sponsor|30
7872602|NCT01684215|12365961|FG000|Phase 2|Enrolled but not treated|0
7872603|NCT01684215|12365962|FG001|Phase 2|Enrolled but not treated|0
7872604|NCT01684215|12365963|FG002|Phase 2|Enrolled but not treated|0
7872605|NCT01684215|12365964|FG003|Phase 2|Enrolled but not treated|1
7872606|NCT01684215|12365961|FG000|Phase 2|Lost to Follow-up|0
7872607|NCT01684215|12365962|FG001|Phase 2|Lost to Follow-up|0
7872608|NCT01684215|12365963|FG002|Phase 2|Lost to Follow-up|0
7872609|NCT01684215|12365964|FG003|Phase 2|Lost to Follow-up|4
7872610|NCT01684423|12365995|FG000|Overall Study|Withdrawal by Subject|0
7872611|NCT01684423|12365996|FG001|Overall Study|Withdrawal by Subject|0
7872612|NCT01684423|12365997|FG002|Overall Study|Withdrawal by Subject|1
7872613|NCT01684423|12365998|FG003|Overall Study|Withdrawal by Subject|0
7872614|NCT01684423|12365999|FG004|Overall Study|Withdrawal by Subject|0
7872615|NCT01684878|12366052|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1
7872616|NCT01684878|12366053|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1
7872617|NCT01684878|12366054|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0
7872618|NCT01684878|12366055|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0
7872619|NCT01684878|12366052|FG000|Part 1: Safety Run in Phase|Death|15
7872620|NCT01684878|12366053|FG001|Part 1: Safety Run in Phase|Death|20
7872621|NCT01684878|12366054|FG002|Part 1: Safety Run in Phase|Death|0
7872622|NCT01684878|12366055|FG003|Part 1: Safety Run in Phase|Death|0
7872623|NCT01684878|12366052|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0
7872624|NCT01684878|12366053|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2
7872625|NCT01684878|12366054|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0
7872626|NCT01684878|12366055|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0
7872627|NCT01684878|12366052|FG000|Part 2: Randomized Phase|Participant withdrew consent|0
7872628|NCT01684878|12366053|FG001|Part 2: Randomized Phase|Participant withdrew consent|0
7872629|NCT01684878|12366054|FG002|Part 2: Randomized Phase|Participant withdrew consent|1
7872630|NCT01684878|12366055|FG003|Part 2: Randomized Phase|Participant withdrew consent|2
7872631|NCT01684878|12366052|FG000|Part 2: Randomized Phase|Lost to Follow-up|0
7872632|NCT01684878|12366053|FG001|Part 2: Randomized Phase|Lost to Follow-up|0
7872633|NCT01684878|12366054|FG002|Part 2: Randomized Phase|Lost to Follow-up|2
7872634|NCT01684878|12366055|FG003|Part 2: Randomized Phase|Lost to Follow-up|0
7872635|NCT01684878|12366052|FG000|Part 2: Randomized Phase|Death|0
7872636|NCT01684878|12366053|FG001|Part 2: Randomized Phase|Death|0
7872637|NCT01684878|12366054|FG002|Part 2: Randomized Phase|Death|62
7872638|NCT01684878|12366055|FG003|Part 2: Randomized Phase|Death|68
7872639|NCT01684878|12366052|FG000|Part 2: Randomized Phase|Alive at data-cut|0
7872640|NCT01684878|12366053|FG001|Part 2: Randomized Phase|Alive at data-cut|0
7872641|NCT01684878|12366054|FG002|Part 2: Randomized Phase|Alive at data-cut|13
7872642|NCT01684878|12366055|FG003|Part 2: Randomized Phase|Alive at data-cut|7
7872643|NCT01684878|12366052|FG000|Part 2: Randomized Phase|Participant noncompliance|0
7872644|NCT01684878|12366053|FG001|Part 2: Randomized Phase|Participant noncompliance|0
7872645|NCT01684878|12366054|FG002|Part 2: Randomized Phase|Participant noncompliance|0
7872646|NCT01684878|12366055|FG003|Part 2: Randomized Phase|Participant noncompliance|1
7872647|NCT01684930|12366084|FG000|Overall Study|Withdrawal by Subject|3
7872648|NCT01684930|12366085|FG001|Overall Study|Withdrawal by Subject|1
7872649|NCT01684943|12366094|FG000|Overall Study|Inadequate Venous Access|3
7872650|NCT01684943|12366095|FG001|Overall Study|Inadequate Venous Access|0
7872651|NCT01684943|12366096|FG002|Overall Study|Inadequate Venous Access|0
7872652|NCT01684943|12366094|FG000|Overall Study|Principal Investigator Determination|1
7872653|NCT01684943|12366095|FG001|Overall Study|Principal Investigator Determination|0
7872654|NCT01684943|12366096|FG002|Overall Study|Principal Investigator Determination|0
7872655|NCT01684943|12366094|FG000|Overall Study|Excluded from Analysis|1
7872656|NCT01684943|12366095|FG001|Overall Study|Excluded from Analysis|1
7872657|NCT01684943|12366096|FG002|Overall Study|Excluded from Analysis|1
7872658|NCT01684943|12366094|FG000|Overall Study|Lost to Follow-up|3
7872659|NCT01684943|12366095|FG001|Overall Study|Lost to Follow-up|0
7872660|NCT01684943|12366096|FG002|Overall Study|Lost to Follow-up|0
7872661|NCT01684943|12366094|FG000|Overall Study|Planning Pregnancy|1
7872662|NCT01684943|12366095|FG001|Overall Study|Planning Pregnancy|0
7872663|NCT01684943|12366096|FG002|Overall Study|Planning Pregnancy|0
7872664|NCT01685047|12366113|FG000|Overall Study|Withdrawal by Subject|20
7872665|NCT01685047|12366113|FG000|Overall Study|Death|26
7872666|NCT01685047|12366113|FG000|Overall Study|Lost to Follow-up|8
7793800|NCT01050257|12249228|FG002|Overall Study|Violation criteria|0
7793801|NCT01050257|12249226|FG000|Overall Study|Failure to return|0
7793802|NCT01050257|12249227|FG001|Overall Study|Failure to return|2
7793803|NCT01050257|12249228|FG002|Overall Study|Failure to return|0
7793804|NCT01050257|12249226|FG000|Overall Study|Death|0
7793805|NCT01050257|12249227|FG001|Overall Study|Death|0
7793806|NCT01050257|12249228|FG002|Overall Study|Death|1
7793807|NCT01050530|12249238|FG000|Overall Study|Adverse Event|6
7793808|NCT01050530|12249239|FG001|Overall Study|Adverse Event|3
7793809|NCT01050530|12249238|FG000|Overall Study|Lack of Efficacy|1
7793810|NCT01050530|12249239|FG001|Overall Study|Lack of Efficacy|4
7793811|NCT01050530|12249238|FG000|Overall Study|Withdrawal by Subject|0
7793812|NCT01050530|12249239|FG001|Overall Study|Withdrawal by Subject|3
7793813|NCT01050530|12249238|FG000|Overall Study|Protocol Violation|1
7793814|NCT01050530|12249239|FG001|Overall Study|Protocol Violation|0
7793815|NCT01050543|12249247|FG000|Overall Study|Withdrawal by Subject|0
7872667|NCT01685047|12366113|FG000|Overall Study|Physician Decision|25
7872668|NCT01685047|12366113|FG000|Overall Study|Adverse Event|5
7872669|NCT01685047|12366113|FG000|Overall Study|patient withdrawn by sponsor|1
7872670|NCT01685060|12366117|FG000|Overall Study|Rollover patients|16
7872671|NCT01685060|12366117|FG000|Overall Study|Adverse Event|12
7793816|NCT01050543|12249248|FG001|Overall Study|Withdrawal by Subject|2
7793817|NCT01050543|12249247|FG000|Overall Study|Protocol Violation|0
7793818|NCT01050543|12249248|FG001|Overall Study|Protocol Violation|1
7793819|NCT01050543|12249247|FG000|Overall Study|Administrative|4
7793820|NCT01050543|12249248|FG001|Overall Study|Administrative|1
7793821|NCT01050569|12249257|FG000|Overall Study|Lost to Follow-up|20
7793822|NCT01050569|12249258|FG001|Overall Study|Lost to Follow-up|14
7793823|NCT01050569|12249259|FG002|Overall Study|Lost to Follow-up|16
7793824|NCT01050569|12249257|FG000|Overall Study|Withdrawal by Subject|9
7793825|NCT01050569|12249258|FG001|Overall Study|Withdrawal by Subject|3
7793826|NCT01050569|12249259|FG002|Overall Study|Withdrawal by Subject|11
7793827|NCT01050569|12249257|FG000|Overall Study|Lack of Efficacy|5
7793828|NCT01050569|12249258|FG001|Overall Study|Lack of Efficacy|4
7793829|NCT01050569|12249259|FG002|Overall Study|Lack of Efficacy|3
7793830|NCT01050569|12249257|FG000|Overall Study|Adverse Event|1
7793831|NCT01050569|12249258|FG001|Overall Study|Adverse Event|0
7793832|NCT01050569|12249259|FG002|Overall Study|Adverse Event|0
7793833|NCT01050569|12249257|FG000|Overall Study|Physician Decision|3
7793834|NCT01050569|12249258|FG001|Overall Study|Physician Decision|3
7793835|NCT01050569|12249259|FG002|Overall Study|Physician Decision|3
7793836|NCT01050634|12249280|FG000|Overall Study|Enrolled, but Not Treated|56
7793837|NCT01050634|12249280|FG000|Overall Study|Death|2
7793838|NCT01050634|12249280|FG000|Overall Study|Adverse Event|42
7793839|NCT01050634|12249280|FG000|Overall Study|Lost to Follow-up|2
7793840|NCT01050634|12249280|FG000|Overall Study|Other|21
7793841|NCT01050634|12249280|FG000|Overall Study|Ongoing at Date of Cut-Off|5
7793842|NCT01050673|12249304|FG000|Overall Study|Physician Decision|4
7793843|NCT01050673|12249305|FG001|Overall Study|Physician Decision|5
7793844|NCT01050764|12249311|FG000|Overall Study|Death, before HSCT|1
7793845|NCT01050764|12249311|FG000|Overall Study|Donor mobilization failure, death|1
7793846|NCT01050764|12249311|FG000|Overall Study|Death after HSCT, before T-cell infusion|1
7793847|NCT01050790|12249315|FG000|Overall Study|Adverse Event|1
7793848|NCT01050816|12249320|FG000|Overall Study|Lost to Follow-up|2
7793849|NCT01050816|12249320|FG000|Overall Study|patient's refusal|2
7793850|NCT01050998|12249338|FG000|Overall Study|Adverse Event|1
7793851|NCT01050998|12249339|FG001|Overall Study|Adverse Event|0
7793852|NCT01050998|12249340|FG002|Overall Study|Adverse Event|1
7793853|NCT01050998|12249341|FG003|Overall Study|Adverse Event|0
7793854|NCT01050998|12249342|FG004|Overall Study|Adverse Event|2
7793855|NCT01050998|12249338|FG000|Overall Study|Withdrawal by Subject|0
7793856|NCT01050998|12249339|FG001|Overall Study|Withdrawal by Subject|0
7793857|NCT01050998|12249340|FG002|Overall Study|Withdrawal by Subject|0
7793858|NCT01050998|12249341|FG003|Overall Study|Withdrawal by Subject|1
7793859|NCT01050998|12249342|FG004|Overall Study|Withdrawal by Subject|3
7793860|NCT01050998|12249338|FG000|Overall Study|Other|3
7793861|NCT01050998|12249339|FG001|Overall Study|Other|2
7793862|NCT01050998|12249340|FG002|Overall Study|Other|1
7793863|NCT01050998|12249341|FG003|Overall Study|Other|1
7793864|NCT01050998|12249342|FG004|Overall Study|Other|5
7793865|NCT01050998|12249338|FG000|Overall Study|Data integrity issues|0
7793866|NCT01050998|12249339|FG001|Overall Study|Data integrity issues|0
7793867|NCT01050998|12249340|FG002|Overall Study|Data integrity issues|1
7793868|NCT01050998|12249341|FG003|Overall Study|Data integrity issues|1
7793869|NCT01050998|12249342|FG004|Overall Study|Data integrity issues|4
7793870|NCT01051063|12249360|FG000|Overall Study|Death|2
7793871|NCT01051063|12249361|FG001|Overall Study|Death|2
7793872|NCT01051063|12249360|FG000|Overall Study|Withdrawal by Subject|1
7793873|NCT01051063|12249361|FG001|Overall Study|Withdrawal by Subject|1
7793874|NCT01051063|12249360|FG000|Overall Study|Termination of the study|5
7793875|NCT01051063|12249361|FG001|Overall Study|Termination of the study|0
7793876|NCT01051063|12249360|FG000|Overall Study|Moved from the study site area|1
7793877|NCT01051063|12249361|FG001|Overall Study|Moved from the study site area|0
7793878|NCT01051063|12249360|FG000|Overall Study|Other|1
7793879|NCT01051063|12249361|FG001|Overall Study|Other|0
7793880|NCT01051063|12249360|FG000|Overall Study|Lost to Follow-up|0
7793881|NCT01051063|12249361|FG001|Overall Study|Lost to Follow-up|1
7793882|NCT01051323|12249374|FG000|Overall Study|Discontinuation of treatment|103
7793883|NCT01051323|12249374|FG000|Overall Study|Transplantation|28
7793884|NCT01051323|12249374|FG000|Overall Study|Dialysis dependency|22
7793885|NCT01051323|12249374|FG000|Overall Study|Withdrawal by Subject|13
7793886|NCT01051323|12249374|FG000|Overall Study|Lost to Follow-up|31
7793887|NCT01051323|12249374|FG000|Overall Study|Death|129
7872672|NCT01685060|12366117|FG000|Overall Study|Progressive disease|69
7793888|NCT01051323|12249374|FG000|Overall Study|Hospitalization|28
7793889|NCT01051323|12249374|FG000|Overall Study|Other|148
7793890|NCT01051323|12249374|FG000|Overall Study|Missing|37
7793891|NCT01051349|12249382|FG000|Overall Study|Adverse Event|88
7793892|NCT01051349|12249382|FG000|Overall Study|Consent Withdrawn|54
7793893|NCT01051349|12249382|FG000|Overall Study|Investigator Decision|6
7793894|NCT01051349|12249382|FG000|Overall Study|Lost to Follow-up|6
7793895|NCT01051349|12249382|FG000|Overall Study|Subject non-compliance|7
7793896|NCT01051349|12249382|FG000|Overall Study|Reason not Specified|12
7793897|NCT01051466|12249400|FG000|Overall Study|Adverse Event|1
7872673|NCT01685060|12366117|FG000|Overall Study|Physician Decision|14
7872674|NCT01685060|12366117|FG000|Overall Study|Subject/guardian decision|20
7872675|NCT01685060|12366117|FG000|Overall Study|Lost to Follow-up|1
7872676|NCT01685060|12366117|FG000|Overall Study|Death|8
7872677|NCT01685073|12366123|FG000|Overall Study|Lost to Follow-up|6
7872678|NCT01685073|12366124|FG001|Overall Study|Lost to Follow-up|8
7872679|NCT01685073|12366123|FG000|Overall Study|Withdrawal by Subject|24
7872680|NCT01685073|12366124|FG001|Overall Study|Withdrawal by Subject|24
7872681|NCT01685138|12366130|FG000|Overall Study|Lost to Follow-up|1
7872682|NCT01685138|12366130|FG000|Overall Study|Protocol Violation|1
7872683|NCT01685138|12366130|FG000|Overall Study|No longer requires treatment|1
7872684|NCT01685138|12366130|FG000|Overall Study|Subject/guardian decision|2
7872685|NCT01685138|12366130|FG000|Overall Study|Physician Decision|6
7872686|NCT01685138|12366130|FG000|Overall Study|Death|10
7872687|NCT01685138|12366130|FG000|Overall Study|Adverse Event|18
7872688|NCT01685138|12366130|FG000|Overall Study|Progressive disease|53
7872689|NCT01685203|12366141|FG000|Overall Study|Lost to Follow-up|3
7872690|NCT01685203|12366142|FG001|Overall Study|Lost to Follow-up|3
7872691|NCT01685203|12366143|FG002|Overall Study|Lost to Follow-up|0
7872692|NCT01685203|12366144|FG003|Overall Study|Lost to Follow-up|1
7872693|NCT01685203|12366145|FG004|Overall Study|Lost to Follow-up|0
7872694|NCT01685203|12366146|FG005|Overall Study|Lost to Follow-up|0
7872695|NCT01685203|12366147|FG006|Overall Study|Lost to Follow-up|0
7872696|NCT01685203|12366141|FG000|Overall Study|Adverse Event|0
7872697|NCT01685203|12366142|FG001|Overall Study|Adverse Event|0
7872698|NCT01685203|12366143|FG002|Overall Study|Adverse Event|0
7872699|NCT01685203|12366144|FG003|Overall Study|Adverse Event|0
7872700|NCT01685203|12366145|FG004|Overall Study|Adverse Event|0
7872701|NCT01685203|12366146|FG005|Overall Study|Adverse Event|2
7872702|NCT01685203|12366147|FG006|Overall Study|Adverse Event|0
7872703|NCT01685203|12366141|FG000|Overall Study|Adverse event and withdrew consent|1
7872704|NCT01685203|12366142|FG001|Overall Study|Adverse event and withdrew consent|0
7872705|NCT01685203|12366143|FG002|Overall Study|Adverse event and withdrew consent|0
7872706|NCT01685203|12366144|FG003|Overall Study|Adverse event and withdrew consent|0
7872707|NCT01685203|12366145|FG004|Overall Study|Adverse event and withdrew consent|0
7872708|NCT01685203|12366146|FG005|Overall Study|Adverse event and withdrew consent|0
7872709|NCT01685203|12366147|FG006|Overall Study|Adverse event and withdrew consent|0
7872710|NCT01685203|12366141|FG000|Overall Study|Patient's decision|0
7872711|NCT01685203|12366142|FG001|Overall Study|Patient's decision|0
7872712|NCT01685203|12366143|FG002|Overall Study|Patient's decision|0
7872713|NCT01685203|12366144|FG003|Overall Study|Patient's decision|0
7872714|NCT01685203|12366145|FG004|Overall Study|Patient's decision|0
7872715|NCT01685203|12366146|FG005|Overall Study|Patient's decision|1
7872716|NCT01685203|12366147|FG006|Overall Study|Patient's decision|0
7872717|NCT01685216|12366163|FG000|Overall Study|Did not receive study drug|1
7872718|NCT01685229|12366169|FG000|Overall Study|Subjects missing Study Exit form|3
7872719|NCT01685229|12366170|FG001|Overall Study|Subjects missing Study Exit form|1
7872720|NCT01685229|12366169|FG000|Overall Study|Lost to Follow-up|16
7872721|NCT01685229|12366170|FG001|Overall Study|Lost to Follow-up|10
7872722|NCT01685229|12366169|FG000|Overall Study|Withdrawal by Subject|6
7872723|NCT01685229|12366170|FG001|Overall Study|Withdrawal by Subject|5
7872724|NCT01685229|12366169|FG000|Overall Study|Death|1
7872725|NCT01685229|12366170|FG001|Overall Study|Death|0
7872726|NCT01685372|12366199|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
7872727|NCT01685372|12366200|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
7872728|NCT01685437|12366210|FG000|Overall Study|Withdrawal by Subject|22
7872729|NCT01685437|12366210|FG000|Overall Study|Lost to Follow-up|3
7872730|NCT01685437|12366210|FG000|Overall Study|Adverse Event|1
7872731|NCT01685437|12366210|FG000|Overall Study|Protocol Violation|4
7872732|NCT01685437|12366210|FG000|Overall Study|Unable to make visits due to work|1
7882829|NCT01776424|12382173|FG001|Overall Study|Lost to Follow-up|8
7793898|NCT01051466|12249401|FG001|Overall Study|Adverse Event|0
7882830|NCT01776424|12382174|FG002|Overall Study|Lost to Follow-up|9
7882831|NCT01776424|12382172|FG000|Overall Study|Withdrawal by Subject|10
7872733|NCT01685697|12366241|FG000|Overall Study|Protocol Violation|3
7872734|NCT01685697|12366242|FG001|Overall Study|Protocol Violation|3
7872735|NCT01685801|12366252|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
7872736|NCT01685801|12366253|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
7872737|NCT01685801|12366254|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
7872738|NCT01685801|12366255|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
7872739|NCT01685801|12366252|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
7872740|NCT01685801|12366253|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
7872741|NCT01685801|12366254|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
7872742|NCT01685801|12366255|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
7872743|NCT01685840|12366274|FG000|Overall Study|Death|77
7872744|NCT01685840|12366275|FG001|Overall Study|Death|66
7872745|NCT01685840|12366274|FG000|Overall Study|Lost to Follow-up|27
7872746|NCT01685840|12366275|FG001|Overall Study|Lost to Follow-up|25
7872747|NCT01685840|12366274|FG000|Overall Study|Physician Decision|3
7872748|NCT01685840|12366275|FG001|Overall Study|Physician Decision|7
7872749|NCT01685840|12366274|FG000|Overall Study|Withdrawal by Subject|14
7872750|NCT01685840|12366275|FG001|Overall Study|Withdrawal by Subject|17
7872751|NCT01685840|12366274|FG000|Overall Study|Futility|197
7872752|NCT01685840|12366275|FG001|Overall Study|Futility|200
7872753|NCT01685840|12366274|FG000|Overall Study|Had VAD, Dialysis or Transplant|11
7872754|NCT01685840|12366275|FG001|Overall Study|Had VAD, Dialysis or Transplant|17
7872755|NCT01685983|12366283|FG000|Overall Study|Adverse Event|7
7872756|NCT01685983|12366283|FG000|Overall Study|Death|1
7872757|NCT01685983|12366283|FG000|Overall Study|Withdrawal by Subject|19
7872758|NCT01685983|12366283|FG000|Overall Study|Protocol Violation|2
7872759|NCT01685983|12366283|FG000|Overall Study|Physician Decision|13
7872760|NCT01685983|12366283|FG000|Overall Study|Other|7
7872761|NCT01685983|12366283|FG000|Overall Study|Progressive Disease|32
7872762|NCT01685983|12366283|FG000|Overall Study|Noncompliance with Study Drug|1
7872763|NCT01686152|12366299|FG000|Overall Study|Withdrawal by Subject|11
7872764|NCT01686152|12366300|FG001|Overall Study|Withdrawal by Subject|11
7872765|NCT01686152|12366301|FG002|Overall Study|Withdrawal by Subject|3
7872766|NCT01686152|12366299|FG000|Overall Study|Drug Code Unblinded|0
7872767|NCT01686152|12366300|FG001|Overall Study|Drug Code Unblinded|1
7872768|NCT01686152|12366301|FG002|Overall Study|Drug Code Unblinded|0
7872769|NCT01686152|12366299|FG000|Overall Study|Protocol Violation|6
7872770|NCT01686152|12366300|FG001|Overall Study|Protocol Violation|1
7872771|NCT01686152|12366301|FG002|Overall Study|Protocol Violation|0
7872772|NCT01686152|12366299|FG000|Overall Study|Adverse Event|12
7872773|NCT01686152|12366300|FG001|Overall Study|Adverse Event|11
7872774|NCT01686152|12366301|FG002|Overall Study|Adverse Event|0
7872775|NCT01686152|12366299|FG000|Overall Study|Lack of Efficacy|0
7872776|NCT01686152|12366300|FG001|Overall Study|Lack of Efficacy|0
7872777|NCT01686152|12366301|FG002|Overall Study|Lack of Efficacy|1
7872778|NCT01686152|12366299|FG000|Overall Study|IP Non-compliance|5
7872779|NCT01686152|12366300|FG001|Overall Study|IP Non-compliance|5
7872780|NCT01686152|12366301|FG002|Overall Study|IP Non-compliance|0
7872781|NCT01686152|12366299|FG000|Overall Study|Lost to Follow-up|7
7872782|NCT01686152|12366300|FG001|Overall Study|Lost to Follow-up|6
7872783|NCT01686152|12366301|FG002|Overall Study|Lost to Follow-up|5
7872784|NCT01686373|12366315|FG000|Overall Study|Lost to Follow-up|3
7872785|NCT01686373|12366316|FG001|Overall Study|Lost to Follow-up|0
7872786|NCT01686373|12366315|FG000|Overall Study|Withdrawal by Subject|0
7872787|NCT01686373|12366316|FG001|Overall Study|Withdrawal by Subject|1
7872788|NCT01686373|12366315|FG000|Overall Study|Adverse Event|0
7872789|NCT01686373|12366316|FG001|Overall Study|Adverse Event|1
7872790|NCT01686438|12366325|FG000|Overall Study|Lost to Follow-up|8
7872791|NCT01686438|12366326|FG001|Overall Study|Lost to Follow-up|9
7872792|NCT01686438|12366327|FG002|Overall Study|Lost to Follow-up|10
7872793|NCT01686438|12366325|FG000|Overall Study|Adverse Event|0
7872794|NCT01686438|12366326|FG001|Overall Study|Adverse Event|0
7872795|NCT01686438|12366327|FG002|Overall Study|Adverse Event|1
7872796|NCT01686438|12366325|FG000|Overall Study|Protocol Violation|0
7872797|NCT01686438|12366326|FG001|Overall Study|Protocol Violation|0
7872798|NCT01686438|12366327|FG002|Overall Study|Protocol Violation|1
7872799|NCT01686438|12366325|FG000|Overall Study|Withdrawal by Subject|0
7872800|NCT01686438|12366326|FG001|Overall Study|Withdrawal by Subject|0
7872801|NCT01686438|12366327|FG002|Overall Study|Withdrawal by Subject|1
7872802|NCT01686568|12366367|FG000|Main Study|Withdrawal by Subject|1
7872803|NCT01686568|12366368|FG001|Main Study|Withdrawal by Subject|3
7872804|NCT01686568|12366367|FG000|Main Study|Noncompliance with protocol|0
7872805|NCT01686568|12366368|FG001|Main Study|Noncompliance with protocol|1
7872806|NCT01686568|12366367|FG000|Main Study|Liver enzymes above range of exclusion|1
7872807|NCT01686568|12366368|FG001|Main Study|Liver enzymes above range of exclusion|0
7872808|NCT01686568|12366367|FG000|Sub-Study|Not consented for sub-study|2
7872809|NCT01686568|12366368|FG001|Sub-Study|Not consented for sub-study|2
7872810|NCT01686581|12366374|FG000|Overall Study|Side-effects or Health Problems|15
7872811|NCT01686581|12366374|FG000|Overall Study|Lack of Efficacy|90
7872812|NCT01686581|12366374|FG000|Overall Study|Participant Concerned about Risks|6
7872813|NCT01686581|12366374|FG000|Overall Study|Thinks Injections Too Painful|8
7872814|NCT01686581|12366374|FG000|Overall Study|Thinks Injections Take Too Much Time|2
7872815|NCT01686581|12366374|FG000|Overall Study|Trying to get Pregnant or Nursing|2
7872816|NCT01686581|12366374|FG000|Overall Study|Thinks it is Inconvenient|17
7872817|NCT01686581|12366374|FG000|Overall Study|Other Miscellaneous Reasons|36
7872818|NCT01686581|12366374|FG000|Overall Study|Reason Missing|1
7872819|NCT01686633|12366381|FG000|Overall Study|Lack of Efficacy|33
7872820|NCT01686633|12366382|FG001|Overall Study|Lack of Efficacy|13
7872821|NCT01686633|12366383|FG002|Overall Study|Lack of Efficacy|11
7872822|NCT01686633|12366381|FG000|Overall Study|Withdrawal by Subject|8
7872823|NCT01686633|12366382|FG001|Overall Study|Withdrawal by Subject|8
7793899|NCT01051466|12249400|FG000|Overall Study|Lost to Follow-up|1
7793900|NCT01051466|12249401|FG001|Overall Study|Lost to Follow-up|1
7793901|NCT01051466|12249400|FG000|Overall Study|Withdrawal by Subject|5
7793902|NCT01051466|12249401|FG001|Overall Study|Withdrawal by Subject|1
7793903|NCT01051466|12249400|FG000|Overall Study|Entry Criteria Not Met|0
7793904|NCT01051466|12249401|FG001|Overall Study|Entry Criteria Not Met|3
7793905|NCT01051466|12249400|FG000|Overall Study|Physician Decision|1
7793906|NCT01051466|12249401|FG001|Overall Study|Physician Decision|0
7793907|NCT01051557|12249427|FG000|Overall Study|Physician Decision|1
7793908|NCT01051557|12249428|FG001|Overall Study|Physician Decision|0
7793909|NCT01051557|12249429|FG002|Overall Study|Physician Decision|0
7793910|NCT01051557|12249430|FG003|Overall Study|Physician Decision|0
7793911|NCT01051557|12249431|FG004|Overall Study|Physician Decision|0
7872824|NCT01686633|12366383|FG002|Overall Study|Withdrawal by Subject|5
7872825|NCT01686633|12366381|FG000|Overall Study|Physician Decision|3
7872826|NCT01686633|12366382|FG001|Overall Study|Physician Decision|4
7872827|NCT01686633|12366383|FG002|Overall Study|Physician Decision|4
7872828|NCT01686633|12366381|FG000|Overall Study|Adverse Event|4
7872829|NCT01686633|12366382|FG001|Overall Study|Adverse Event|3
7872830|NCT01686633|12366383|FG002|Overall Study|Adverse Event|3
7872831|NCT01686633|12366381|FG000|Overall Study|Protocol Violation|2
7872832|NCT01686633|12366382|FG001|Overall Study|Protocol Violation|3
7872833|NCT01686633|12366383|FG002|Overall Study|Protocol Violation|0
7872834|NCT01686633|12366381|FG000|Overall Study|Protocol-defined Stopping Criteria|1
7872835|NCT01686633|12366382|FG001|Overall Study|Protocol-defined Stopping Criteria|0
7872836|NCT01686633|12366383|FG002|Overall Study|Protocol-defined Stopping Criteria|1
7872837|NCT01686633|12366381|FG000|Overall Study|Lost to Follow-up|0
7872838|NCT01686633|12366382|FG001|Overall Study|Lost to Follow-up|1
7872839|NCT01686633|12366383|FG002|Overall Study|Lost to Follow-up|1
7872840|NCT01686828|12366423|FG000|Overall Study|Physician Decision|1
7872841|NCT01686828|12366424|FG001|Overall Study|Physician Decision|0
7872842|NCT01686828|12366425|FG002|Overall Study|Physician Decision|0
7872843|NCT01686828|12366426|FG003|Overall Study|Physician Decision|0
7872844|NCT01686828|12366423|FG000|Overall Study|New Job|0
7872845|NCT01686828|12366424|FG001|Overall Study|New Job|1
7872846|NCT01686828|12366425|FG002|Overall Study|New Job|0
7872847|NCT01686828|12366426|FG003|Overall Study|New Job|0
7872848|NCT01686828|12366423|FG000|Overall Study|Weight Loss|0
7872849|NCT01686828|12366424|FG001|Overall Study|Weight Loss|0
7872850|NCT01686828|12366425|FG002|Overall Study|Weight Loss|1
7872851|NCT01686828|12366426|FG003|Overall Study|Weight Loss|0
7872852|NCT01686932|12366442|FG000|Period 1|Adverse Event|1
7872853|NCT01686932|12366443|FG001|Period 1|Adverse Event|1
7872854|NCT01686958|12366449|FG000|Overall Study|Withdrawal by Subject|1
7872855|NCT01687101|12366467|FG000|Overall Study|Lost to Follow-up|7
7872856|NCT01687166|12366479|FG000|Overall Study|Attempt subject|2
7872857|NCT01687166|12366480|FG001|Overall Study|Attempt subject|3
7872858|NCT01687166|12366481|FG002|Overall Study|Attempt subject|2
7872859|NCT01687166|12366482|FG003|Overall Study|Attempt subject|0
7872860|NCT01687166|12366479|FG000|Overall Study|Did not meet eligibility criteria|4
7872861|NCT01687166|12366480|FG001|Overall Study|Did not meet eligibility criteria|6
7872862|NCT01687166|12366481|FG002|Overall Study|Did not meet eligibility criteria|1
7872863|NCT01687166|12366482|FG003|Overall Study|Did not meet eligibility criteria|1
7872864|NCT01687166|12366479|FG000|Overall Study|Adverse Event|2
7872865|NCT01687166|12366480|FG001|Overall Study|Adverse Event|1
7872866|NCT01687166|12366481|FG002|Overall Study|Adverse Event|0
7872867|NCT01687166|12366482|FG003|Overall Study|Adverse Event|0
7872868|NCT01687166|12366479|FG000|Overall Study|Physician Decision|3
7872869|NCT01687166|12366480|FG001|Overall Study|Physician Decision|2
7872870|NCT01687166|12366481|FG002|Overall Study|Physician Decision|1
7872871|NCT01687166|12366482|FG003|Overall Study|Physician Decision|0
7872872|NCT01687166|12366479|FG000|Overall Study|Withdrawal by Subject|11
7872873|NCT01687166|12366480|FG001|Overall Study|Withdrawal by Subject|4
7872874|NCT01687166|12366481|FG002|Overall Study|Withdrawal by Subject|3
7872875|NCT01687166|12366482|FG003|Overall Study|Withdrawal by Subject|0
7872876|NCT01687166|12366479|FG000|Overall Study|Lost to Follow-up|2
7872877|NCT01687166|12366480|FG001|Overall Study|Lost to Follow-up|5
7872878|NCT01687166|12366481|FG002|Overall Study|Lost to Follow-up|1
7872879|NCT01687166|12366482|FG003|Overall Study|Lost to Follow-up|0
7872880|NCT01687166|12366479|FG000|Overall Study|Equipment/Device Availability|0
7872881|NCT01687166|12366480|FG001|Overall Study|Equipment/Device Availability|1
7872882|NCT01687166|12366481|FG002|Overall Study|Equipment/Device Availability|0
7872883|NCT01687166|12366482|FG003|Overall Study|Equipment/Device Availability|0
7872884|NCT01687166|12366479|FG000|Overall Study|Death|1
7872885|NCT01687166|12366480|FG001|Overall Study|Death|1
7793912|NCT01051557|12249432|FG005|Overall Study|Physician Decision|0
7872886|NCT01687166|12366481|FG002|Overall Study|Death|0
7872887|NCT01687166|12366482|FG003|Overall Study|Death|0
7872888|NCT01687166|12366479|FG000|Overall Study|Protocol Violation|1
7872889|NCT01687166|12366480|FG001|Overall Study|Protocol Violation|1
7872890|NCT01687166|12366481|FG002|Overall Study|Protocol Violation|1
7872891|NCT01687166|12366482|FG003|Overall Study|Protocol Violation|0
7872892|NCT01687166|12366479|FG000|Overall Study|Subject moved out of state|0
7872893|NCT01687166|12366480|FG001|Overall Study|Subject moved out of state|1
7872894|NCT01687166|12366481|FG002|Overall Study|Subject moved out of state|0
7872895|NCT01687166|12366482|FG003|Overall Study|Subject moved out of state|0
7872896|NCT01687166|12366479|FG000|Overall Study|Patient unable to be compliant|1
7872897|NCT01687166|12366480|FG001|Overall Study|Patient unable to be compliant|0
7872898|NCT01687166|12366481|FG002|Overall Study|Patient unable to be compliant|0
7872899|NCT01687166|12366482|FG003|Overall Study|Patient unable to be compliant|0
7872900|NCT01687166|12366479|FG000|Overall Study|Physician choice to use different device|1
7872901|NCT01687166|12366480|FG001|Overall Study|Physician choice to use different device|2
7872902|NCT01687166|12366481|FG002|Overall Study|Physician choice to use different device|4
7872903|NCT01687166|12366482|FG003|Overall Study|Physician choice to use different device|0
7872904|NCT01687166|12366479|FG000|Overall Study|Insurance|0
7872905|NCT01687166|12366480|FG001|Overall Study|Insurance|0
7872906|NCT01687166|12366481|FG002|Overall Study|Insurance|1
7872907|NCT01687166|12366482|FG003|Overall Study|Insurance|1
7872908|NCT01687218|12366503|FG000|Overall Study|Withdrawal by Subject|2
7872909|NCT01687218|12366504|FG001|Overall Study|Withdrawal by Subject|3
7872910|NCT01687218|12366505|FG002|Overall Study|Withdrawal by Subject|0
7872911|NCT01687218|12366506|FG003|Overall Study|Withdrawal by Subject|1
7872912|NCT01687218|12366507|FG004|Overall Study|Withdrawal by Subject|1
7872913|NCT01687218|12366508|FG005|Overall Study|Withdrawal by Subject|0
7872914|NCT01687218|12366503|FG000|Overall Study|Relocated, no follow-up planned|1
7872915|NCT01687218|12366504|FG001|Overall Study|Relocated, no follow-up planned|0
7872916|NCT01687218|12366505|FG002|Overall Study|Relocated, no follow-up planned|1
7872917|NCT01687218|12366506|FG003|Overall Study|Relocated, no follow-up planned|1
7872918|NCT01687218|12366507|FG004|Overall Study|Relocated, no follow-up planned|0
7872919|NCT01687218|12366508|FG005|Overall Study|Relocated, no follow-up planned|0
7872920|NCT01687257|12366535|FG000|Overall Study|Efficacy Failure|6
7872921|NCT01687257|12366536|FG001|Overall Study|Efficacy Failure|0
7872922|NCT01687257|12366537|FG002|Overall Study|Efficacy Failure|5
7872923|NCT01687257|12366535|FG000|Overall Study|Subject Withdrew Consent|1
7872924|NCT01687257|12366536|FG001|Overall Study|Subject Withdrew Consent|1
7872925|NCT01687257|12366537|FG002|Overall Study|Subject Withdrew Consent|1
7872926|NCT01687257|12366535|FG000|Overall Study|Adverse Event|1
7872927|NCT01687257|12366536|FG001|Overall Study|Adverse Event|0
7872928|NCT01687257|12366537|FG002|Overall Study|Adverse Event|0
7872929|NCT01687257|12366535|FG000|Overall Study|Investigator's Discretion|0
7872930|NCT01687257|12366536|FG001|Overall Study|Investigator's Discretion|3
7872931|NCT01687257|12366537|FG002|Overall Study|Investigator's Discretion|0
7872932|NCT01687270|12366551|FG000|Overall Study|Lack of Efficacy|11
7872933|NCT01687270|12366551|FG000|Overall Study|Lost to Follow-up|1
7872934|NCT01687283|12366557|FG000|Overall Study|Adverse Event|11
7872935|NCT01687283|12366558|FG001|Overall Study|Adverse Event|4
7872936|NCT01687283|12366557|FG000|Overall Study|Lack of Efficacy|3
7872937|NCT01687283|12366558|FG001|Overall Study|Lack of Efficacy|1
7872938|NCT01687283|12366557|FG000|Overall Study|Protocol Violation|1
7872939|NCT01687283|12366558|FG001|Overall Study|Protocol Violation|3
7872940|NCT01687283|12366557|FG000|Overall Study|protocol defined stopping criteria|8
7872941|NCT01687283|12366558|FG001|Overall Study|protocol defined stopping criteria|10
7872942|NCT01687283|12366557|FG000|Overall Study|Lost to Follow-up|1
7872943|NCT01687283|12366558|FG001|Overall Study|Lost to Follow-up|1
7872944|NCT01687283|12366557|FG000|Overall Study|Investigator discretion|2
7872945|NCT01687283|12366558|FG001|Overall Study|Investigator discretion|0
7872946|NCT01687283|12366557|FG000|Overall Study|Withdrawal by Subject|9
7872947|NCT01687283|12366558|FG001|Overall Study|Withdrawal by Subject|8
7872948|NCT01687296|12366566|FG000|Overall Study|Lack of Efficacy|1
7872949|NCT01687296|12366567|FG001|Overall Study|Lack of Efficacy|1
7872950|NCT01687296|12366566|FG000|Overall Study|Protocol Violation|0
7872951|NCT01687296|12366567|FG001|Overall Study|Protocol Violation|1
7872952|NCT01687296|12366566|FG000|Overall Study|Withdrawal by Subject|6
7872953|NCT01687296|12366567|FG001|Overall Study|Withdrawal by Subject|3
7872954|NCT01687413|12366597|FG000|Overall Study|Withdrawal by Subject|0
7872955|NCT01687413|12366598|FG001|Overall Study|Withdrawal by Subject|2
7872956|NCT01687413|12366597|FG000|Overall Study|Not eligible|0
7872957|NCT01687413|12366598|FG001|Overall Study|Not eligible|2
7872958|NCT01687413|12366597|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1
7872959|NCT01687413|12366598|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0
7872960|NCT01687478|12366624|FG000|Overall Study|Adverse Event|3
7872961|NCT01687478|12366625|FG001|Overall Study|Adverse Event|10
7872962|NCT01687478|12366624|FG000|Overall Study|Lost to Follow-up|1
7872963|NCT01687478|12366625|FG001|Overall Study|Lost to Follow-up|3
7872964|NCT01687478|12366624|FG000|Overall Study|Protocol Violation|0
7872965|NCT01687478|12366625|FG001|Overall Study|Protocol Violation|2
7872966|NCT01687478|12366624|FG000|Overall Study|Withdrawal by Subject|21
7872967|NCT01687478|12366625|FG001|Overall Study|Withdrawal by Subject|19
7872968|NCT01687478|12366624|FG000|Overall Study|Physician Decision|1
7872969|NCT01687478|12366625|FG001|Overall Study|Physician Decision|3
7872970|NCT01687478|12366624|FG000|Overall Study|Entry Criteria Not Met|6
7872971|NCT01687478|12366625|FG001|Overall Study|Entry Criteria Not Met|2
7872972|NCT01687595|12366633|FG000|Overall Study|Withdrawal by Subject|8
7872973|NCT01687595|12366634|FG001|Overall Study|Withdrawal by Subject|0
7872974|NCT01687595|12366633|FG000|Overall Study|Lost to Follow-up|3
7872975|NCT01687595|12366634|FG001|Overall Study|Lost to Follow-up|1
7872976|NCT01687595|12366633|FG000|Overall Study|Investigator's decision|1
7872977|NCT01687595|12366634|FG001|Overall Study|Investigator's decision|0
7872978|NCT01687595|12366633|FG000|Overall Study|Sponsor's decision|1
7872979|NCT01687595|12366634|FG001|Overall Study|Sponsor's decision|0
7872980|NCT01687595|12366633|FG000|Overall Study|Noncompliance|1
7872981|NCT01687595|12366634|FG001|Overall Study|Noncompliance|2
7872982|NCT01687595|12366633|FG000|Overall Study|Other than specified|56
7872983|NCT01687595|12366634|FG001|Overall Study|Other than specified|7
7872984|NCT01687673|12366640|FG000|Overall Study|Physician Decision|1
7872985|NCT01687712|12366646|FG000|Cycle 1|Not Biochemically Pregnant|386
7872986|NCT01687712|12366647|FG001|Cycle 1|Not Biochemically Pregnant|348
7872987|NCT01687712|12366646|FG000|Cycle 1|Early Pregnancy Loss|43
7872988|NCT01687712|12366647|FG001|Cycle 1|Early Pregnancy Loss|60
7872989|NCT01687712|12366646|FG000|Cycle 1|Ectopic Pregnancy|5
7872990|NCT01687712|12366647|FG001|Cycle 1|Ectopic Pregnancy|5
7872991|NCT01687712|12366646|FG000|Cycle 1|Heterotropic Pregnancy|1
7872992|NCT01687712|12366647|FG001|Cycle 1|Heterotropic Pregnancy|0
7872993|NCT01687712|12366646|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9
7872994|NCT01687712|12366647|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14
7872995|NCT01687712|12366646|FG000|Cycle 1|Abortion|3
7872996|NCT01687712|12366647|FG001|Cycle 1|Abortion|0
7872997|NCT01687712|12366646|FG000|Cycle 1|Intrauterine Fetal Death|0
7872998|NCT01687712|12366647|FG001|Cycle 1|Intrauterine Fetal Death|1
7872999|NCT01687712|12366646|FG000|Cycle 1|Lost to Follow-up|1
7873000|NCT01687712|12366647|FG001|Cycle 1|Lost to Follow-up|1
7873001|NCT01687712|12366646|FG000|Cycle 2|Not Biochemically Pregnant|74
7873002|NCT01687712|12366647|FG001|Cycle 2|Not Biochemically Pregnant|77
7873003|NCT01687712|12366646|FG000|Cycle 2|Early Pregnancy Loss|18
7873004|NCT01687712|12366647|FG001|Cycle 2|Early Pregnancy Loss|16
7873005|NCT01687712|12366646|FG000|Cycle 2|Ectopic Pregnancy|0
7873006|NCT01687712|12366647|FG001|Cycle 2|Ectopic Pregnancy|1
7873007|NCT01687712|12366646|FG000|Cycle 2|Still Birth|1
7873008|NCT01687712|12366647|FG001|Cycle 2|Still Birth|0
7873009|NCT01687712|12366646|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0
7873010|NCT01687712|12366647|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1
7873011|NCT01687712|12366646|FG000|Cycle 3|Not Biochemically Pregnant|21
7873012|NCT01687712|12366647|FG001|Cycle 3|Not Biochemically Pregnant|22
7873013|NCT01687712|12366646|FG000|Cycle 3|Early Pregnancy Loss|1
7873014|NCT01687712|12366647|FG001|Cycle 3|Early Pregnancy Loss|2
7873015|NCT01687712|12366646|FG000|Cycle 3|Ectopic Pregnancy|1
7873016|NCT01687712|12366647|FG001|Cycle 3|Ectopic Pregnancy|0
7873017|NCT01687712|12366646|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1
7793913|NCT01051557|12249433|FG006|Overall Study|Physician Decision|0
7793914|NCT01051557|12249427|FG000|Overall Study|disease progression|3
7793915|NCT01051557|12249428|FG001|Overall Study|disease progression|3
7793916|NCT01051557|12249429|FG002|Overall Study|disease progression|5
7793917|NCT01051557|12249430|FG003|Overall Study|disease progression|2
7793918|NCT01051557|12249431|FG004|Overall Study|disease progression|4
7793919|NCT01051557|12249432|FG005|Overall Study|disease progression|3
7793920|NCT01051557|12249433|FG006|Overall Study|disease progression|1
7793921|NCT01051557|12249427|FG000|Overall Study|Withdrawal by Subject|0
7793922|NCT01051557|12249428|FG001|Overall Study|Withdrawal by Subject|0
7793923|NCT01051557|12249429|FG002|Overall Study|Withdrawal by Subject|1
7793924|NCT01051557|12249430|FG003|Overall Study|Withdrawal by Subject|0
7793925|NCT01051557|12249431|FG004|Overall Study|Withdrawal by Subject|2
7793926|NCT01051557|12249432|FG005|Overall Study|Withdrawal by Subject|0
7793927|NCT01051557|12249433|FG006|Overall Study|Withdrawal by Subject|1
7793928|NCT01051557|12249427|FG000|Overall Study|Adverse Event|0
7793929|NCT01051557|12249428|FG001|Overall Study|Adverse Event|0
7793930|NCT01051557|12249429|FG002|Overall Study|Adverse Event|0
7793931|NCT01051557|12249430|FG003|Overall Study|Adverse Event|1
7793932|NCT01051557|12249431|FG004|Overall Study|Adverse Event|1
7793933|NCT01051557|12249432|FG005|Overall Study|Adverse Event|3
7793934|NCT01051557|12249433|FG006|Overall Study|Adverse Event|4
7793935|NCT01051661|12249464|FG000|Overall Study|Adverse Event|1
7793936|NCT01051661|12249465|FG001|Overall Study|Adverse Event|1
7793937|NCT01051661|12249466|FG002|Overall Study|Adverse Event|1
7793938|NCT01051661|12249467|FG003|Overall Study|Adverse Event|1
7793939|NCT01051661|12249468|FG004|Overall Study|Adverse Event|0
7793940|NCT01051661|12249469|FG005|Overall Study|Adverse Event|0
7793941|NCT01051661|12249464|FG000|Overall Study|Lost to Follow-up|13
7793942|NCT01051661|12249465|FG001|Overall Study|Lost to Follow-up|22
7793943|NCT01051661|12249466|FG002|Overall Study|Lost to Follow-up|15
7793944|NCT01051661|12249467|FG003|Overall Study|Lost to Follow-up|17
7793945|NCT01051661|12249468|FG004|Overall Study|Lost to Follow-up|10
7793946|NCT01051661|12249469|FG005|Overall Study|Lost to Follow-up|24
7793947|NCT01051661|12249464|FG000|Overall Study|Migrated/moved from study area|1
7793948|NCT01051661|12249465|FG001|Overall Study|Migrated/moved from study area|6
7793949|NCT01051661|12249466|FG002|Overall Study|Migrated/moved from study area|6
7793950|NCT01051661|12249467|FG003|Overall Study|Migrated/moved from study area|8
7873018|NCT01687712|12366647|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0
7793951|NCT01051661|12249468|FG004|Overall Study|Migrated/moved from study area|7
7793952|NCT01051661|12249469|FG005|Overall Study|Migrated/moved from study area|3
7793953|NCT01051661|12249464|FG000|Overall Study|Refused blood sampling|0
7793954|NCT01051661|12249465|FG001|Overall Study|Refused blood sampling|0
7793955|NCT01051661|12249466|FG002|Overall Study|Refused blood sampling|0
7793956|NCT01051661|12249467|FG003|Overall Study|Refused blood sampling|0
7793957|NCT01051661|12249468|FG004|Overall Study|Refused blood sampling|0
7793958|NCT01051661|12249469|FG005|Overall Study|Refused blood sampling|1
7793959|NCT01051661|12249464|FG000|Overall Study|Data not reliable|1
7793960|NCT01051661|12249465|FG001|Overall Study|Data not reliable|0
7793961|NCT01051661|12249466|FG002|Overall Study|Data not reliable|0
7793962|NCT01051661|12249467|FG003|Overall Study|Data not reliable|0
7793963|NCT01051661|12249468|FG004|Overall Study|Data not reliable|0
7793964|NCT01051661|12249469|FG005|Overall Study|Data not reliable|1
7793965|NCT01051661|12249464|FG000|Overall Study|Unable to attend visit(s)|2
7793966|NCT01051661|12249465|FG001|Overall Study|Unable to attend visit(s)|4
7793967|NCT01051661|12249466|FG002|Overall Study|Unable to attend visit(s)|2
7793968|NCT01051661|12249467|FG003|Overall Study|Unable to attend visit(s)|1
7793969|NCT01051661|12249468|FG004|Overall Study|Unable to attend visit(s)|3
7793970|NCT01051661|12249469|FG005|Overall Study|Unable to attend visit(s)|2
7873019|NCT01687998|12366673|FG000|Overall Study|Withdrawal by Subject|49
7873020|NCT01687998|12366674|FG001|Overall Study|Withdrawal by Subject|51
7873021|NCT01687998|12366673|FG000|Overall Study|Known to be Alive at Study End|54
7873022|NCT01687998|12366674|FG001|Overall Study|Known to be Alive at Study End|62
7873023|NCT01687998|12366673|FG000|Overall Study|Lost to Follow-up|9
7873024|NCT01687998|12366674|FG001|Overall Study|Lost to Follow-up|7
7873025|NCT01688037|12366683|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1
7873026|NCT01688037|12366684|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0
7873027|NCT01688037|12366685|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1
7873028|NCT01688037|12366683|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1
7873029|NCT01688037|12366684|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2
7873030|NCT01688037|12366685|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3
7873031|NCT01688037|12366683|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
7873032|NCT01688037|12366684|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
7873033|NCT01688037|12366685|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
7873034|NCT01688037|12366683|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
7873035|NCT01688037|12366684|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
7873036|NCT01688037|12366685|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
7873037|NCT01688037|12366683|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0
7873038|NCT01688037|12366684|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1
7873039|NCT01688037|12366685|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0
7873040|NCT01688037|12366683|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4
7873041|NCT01688037|12366684|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1
7873042|NCT01688037|12366685|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1
7873043|NCT01688037|12366683|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0
7873044|NCT01688037|12366684|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0
7873045|NCT01688037|12366685|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2
7873046|NCT01688037|12366683|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
7873047|NCT01688037|12366684|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
7873048|NCT01688037|12366685|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
7873049|NCT01688037|12366683|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
7873050|NCT01688037|12366684|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
7873051|NCT01688037|12366685|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
7873052|NCT01688037|12366683|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
7873053|NCT01688037|12366684|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
7873054|NCT01688037|12366685|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
7873055|NCT01688050|12366697|FG000|Overall Study|Death|7
7873056|NCT01688050|12366697|FG000|Overall Study|Conversion to open repair|1
7873057|NCT01688050|12366697|FG000|Overall Study|Lost to Follow-up|13
7873058|NCT01688050|12366697|FG000|Overall Study|Withdrawal by Subject|10
7873059|NCT01688466|12366737|FG000|Overall Study|Withdrawal by Subject|2
7873060|NCT01688466|12366738|FG001|Overall Study|Withdrawal by Subject|1
7873061|NCT01688466|12366737|FG000|Overall Study|Death|0
7873062|NCT01688466|12366738|FG001|Overall Study|Death|1
7873063|NCT01688466|12366737|FG000|Overall Study|Adverse Event|0
7873064|NCT01688466|12366738|FG001|Overall Study|Adverse Event|4
7873065|NCT01688466|12366737|FG000|Overall Study|Not evaluable|0
7873066|NCT01688466|12366738|FG001|Overall Study|Not evaluable|1
7873067|NCT01688635|12366757|FG000|Washout 1|Withdrawal by Subject|1
7873068|NCT01688635|12366758|FG001|Washout 1|Withdrawal by Subject|0
7873069|NCT01688635|12366757|FG000|Washout 1|Adverse Event|0
7873070|NCT01688635|12366758|FG001|Washout 1|Adverse Event|1
7873071|NCT01688635|12366757|FG000|Washout 1|Physician Decision|0
7873072|NCT01688635|12366758|FG001|Washout 1|Physician Decision|1
7873073|NCT01688635|12366757|FG000|Washout 2|Physician Decision|1
7873074|NCT01688635|12366758|FG001|Washout 2|Physician Decision|0
7873075|NCT01688635|12366757|FG000|Washout 2|Withdrawal by Subject|1
7873076|NCT01688635|12366758|FG001|Washout 2|Withdrawal by Subject|0
7873077|NCT01688635|12366757|FG000|Washout 2|Sponsor Decision|1
7873078|NCT01688635|12366758|FG001|Washout 2|Sponsor Decision|2
7873079|NCT01688635|12366757|FG000|Washout 3|Withdrawal by Subject|1
7873080|NCT01688635|12366758|FG001|Washout 3|Withdrawal by Subject|0
7873081|NCT01688726|12366767|FG000|Overall Study|Adverse Event|1
7873082|NCT01688726|12366768|FG001|Overall Study|Adverse Event|0
7873083|NCT01688726|12366767|FG000|Overall Study|Relocated abroad|0
7873084|NCT01688726|12366768|FG001|Overall Study|Relocated abroad|1
7873085|NCT01688739|12366788|FG000|Overall Study|Administrative Decision|1
7873086|NCT01688739|12366789|FG001|Overall Study|Administrative Decision|0
7873087|NCT01688739|12366790|FG002|Overall Study|Administrative Decision|0
7873088|NCT01688739|12366791|FG003|Overall Study|Administrative Decision|0
7873089|NCT01688739|12366792|FG004|Overall Study|Administrative Decision|0
7873090|NCT01688739|12366793|FG005|Overall Study|Administrative Decision|0
7873091|NCT01688739|12366794|FG006|Overall Study|Administrative Decision|0
7873092|NCT01688739|12366795|FG007|Overall Study|Administrative Decision|0
7873093|NCT01688739|12366796|FG008|Overall Study|Administrative Decision|0
7873094|NCT01688739|12366797|FG009|Overall Study|Administrative Decision|0
7873095|NCT01688830|12366848|FG000|Overall Study|Lost to Follow-up|0
7873096|NCT01688830|12366849|FG001|Overall Study|Lost to Follow-up|0
7873097|NCT01688830|12366850|FG002|Overall Study|Lost to Follow-up|0
7873098|NCT01688830|12366851|FG003|Overall Study|Lost to Follow-up|0
7873099|NCT01688830|12366852|FG004|Overall Study|Lost to Follow-up|0
7873100|NCT01688830|12366853|FG005|Overall Study|Lost to Follow-up|0
7873101|NCT01688830|12366854|FG006|Overall Study|Lost to Follow-up|0
7873102|NCT01688830|12366855|FG007|Overall Study|Lost to Follow-up|0
7873103|NCT01688830|12366856|FG008|Overall Study|Lost to Follow-up|0
7873104|NCT01688830|12366857|FG009|Overall Study|Lost to Follow-up|0
7873105|NCT01688830|12366858|FG010|Overall Study|Lost to Follow-up|1
7873106|NCT01688830|12366859|FG011|Overall Study|Lost to Follow-up|0
7873107|NCT01688830|12366860|FG012|Overall Study|Lost to Follow-up|0
7873108|NCT01688830|12366861|FG013|Overall Study|Lost to Follow-up|0
7873109|NCT01688830|12366862|FG014|Overall Study|Lost to Follow-up|0
7873110|NCT01688830|12366863|FG015|Overall Study|Lost to Follow-up|0
7873111|NCT01688830|12366864|FG016|Overall Study|Lost to Follow-up|0
7873112|NCT01688830|12366865|FG017|Overall Study|Lost to Follow-up|0
7873113|NCT01688830|12366866|FG018|Overall Study|Lost to Follow-up|0
7873114|NCT01688830|12366867|FG019|Overall Study|Lost to Follow-up|0
7873115|NCT01688830|12366868|FG020|Overall Study|Lost to Follow-up|0
7873116|NCT01688882|12366973|FG000|Overall Study|Adverse Event|1
7873117|NCT01688882|12366974|FG001|Overall Study|Adverse Event|0
7873118|NCT01688882|12366973|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7873119|NCT01688882|12366974|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7873120|NCT01688882|12366973|FG000|Overall Study|Administrative problems|1
7873121|NCT01688882|12366974|FG001|Overall Study|Administrative problems|0
7873122|NCT01688921|12366990|FG000|Overall Study|Lost to Follow-up|7
7873123|NCT01688921|12366991|FG001|Overall Study|Lost to Follow-up|13
7873124|NCT01688921|12366990|FG000|Overall Study|Physician Decision|6
7873125|NCT01688921|12366991|FG001|Overall Study|Physician Decision|1
7873126|NCT01688921|12366990|FG000|Overall Study|Protocol Violation|0
7793971|NCT01051661|12249464|FG000|Overall Study|Consent not received from both parents|0
7793972|NCT01051661|12249465|FG001|Overall Study|Consent not received from both parents|0
7793973|NCT01051661|12249466|FG002|Overall Study|Consent not received from both parents|0
7793974|NCT01051661|12249467|FG003|Overall Study|Consent not received from both parents|0
7793975|NCT01051661|12249468|FG004|Overall Study|Consent not received from both parents|0
7793976|NCT01051661|12249469|FG005|Overall Study|Consent not received from both parents|1
7793977|NCT01051661|12249464|FG000|Overall Study|Failure to comply with protocol|0
7793978|NCT01051661|12249465|FG001|Overall Study|Failure to comply with protocol|0
7793979|NCT01051661|12249466|FG002|Overall Study|Failure to comply with protocol|2
7793980|NCT01051661|12249467|FG003|Overall Study|Failure to comply with protocol|0
7793981|NCT01051661|12249468|FG004|Overall Study|Failure to comply with protocol|0
7793982|NCT01051661|12249469|FG005|Overall Study|Failure to comply with protocol|0
7793983|NCT01051661|12249464|FG000|Overall Study|Subject lost legal representation|0
7793984|NCT01051661|12249465|FG001|Overall Study|Subject lost legal representation|0
7793985|NCT01051661|12249466|FG002|Overall Study|Subject lost legal representation|0
7793986|NCT01051661|12249467|FG003|Overall Study|Subject lost legal representation|0
7793987|NCT01051661|12249468|FG004|Overall Study|Subject lost legal representation|1
7793988|NCT01051661|12249469|FG005|Overall Study|Subject lost legal representation|0
7793989|NCT01051661|12249464|FG000|Overall Study|Protocol Violation|0
7793990|NCT01051661|12249465|FG001|Overall Study|Protocol Violation|0
7793991|NCT01051661|12249466|FG002|Overall Study|Protocol Violation|0
7793992|NCT01051661|12249467|FG003|Overall Study|Protocol Violation|1
7793993|NCT01051661|12249468|FG004|Overall Study|Protocol Violation|2
7793994|NCT01051661|12249469|FG005|Overall Study|Protocol Violation|1
7793995|NCT01051661|12249464|FG000|Overall Study|Withdrawal by Subject|16
7793996|NCT01051661|12249465|FG001|Overall Study|Withdrawal by Subject|30
7793997|NCT01051661|12249466|FG002|Overall Study|Withdrawal by Subject|13
7793998|NCT01051661|12249467|FG003|Overall Study|Withdrawal by Subject|28
7793999|NCT01051661|12249468|FG004|Overall Study|Withdrawal by Subject|12
7794000|NCT01051661|12249469|FG005|Overall Study|Withdrawal by Subject|34
7794001|NCT01051739|12249506|FG000|Overall Study|Death|3
7794002|NCT01051739|12249507|FG001|Overall Study|Death|3
7794003|NCT01051739|12249506|FG000|Overall Study|Withdrawal by Subject|25
7794004|NCT01051739|12249507|FG001|Overall Study|Withdrawal by Subject|10
7794005|NCT01051791|12249522|FG000|Overall Study|Failed screening|3
7794006|NCT01051791|12249522|FG000|Overall Study|Withdrawal by Subject|1
7794007|NCT01051817|12249529|FG000|Overall Study|Adverse Event|0
7794008|NCT01051817|12249530|FG001|Overall Study|Adverse Event|2
7794009|NCT01051817|12249529|FG000|Overall Study|Abnormal Test Proceedure reults|0
7794010|NCT01051817|12249530|FG001|Overall Study|Abnormal Test Proceedure reults|1
7794011|NCT01051817|12249529|FG000|Overall Study|Withdrawal by Subject|3
7794012|NCT01051817|12249530|FG001|Overall Study|Withdrawal by Subject|5
7794013|NCT01051817|12249529|FG000|Overall Study|Protocol Violation|0
7794014|NCT01051817|12249530|FG001|Overall Study|Protocol Violation|1
7794015|NCT01051856|12249538|FG000|Overall Study|Withdrawal by Subject|1
7794016|NCT01051856|12249539|FG001|Overall Study|Withdrawal by Subject|0
7794017|NCT01051960|12249545|FG000|Overall Study|Adverse Event|1
7873127|NCT01688921|12366991|FG001|Overall Study|Protocol Violation|1
7794018|NCT01051986|12249551|FG000|Overall Study|Death|1
7794019|NCT01051986|12249552|FG001|Overall Study|Death|0
7794020|NCT01051986|12249551|FG000|Overall Study|Withdrawal by Subject|2
7794021|NCT01051986|12249552|FG001|Overall Study|Withdrawal by Subject|1
7794022|NCT01051986|12249551|FG000|Overall Study|Protocol Violation|2
7873128|NCT01688921|12366990|FG000|Overall Study|informed consent|3
7873129|NCT01688921|12366991|FG001|Overall Study|informed consent|0
7873130|NCT01688973|12367000|FG000|Overall Study|Ineligible|2
7873131|NCT01688973|12367001|FG001|Overall Study|Ineligible|3
7873132|NCT01688999|12367011|FG000|Overall Study|Withdrawal by Subject|5
7873133|NCT01688999|12367012|FG001|Overall Study|Withdrawal by Subject|1
7873134|NCT01688999|12367013|FG002|Overall Study|Withdrawal by Subject|1
7873135|NCT01688999|12367011|FG000|Overall Study|Adverse Event|2
7873136|NCT01688999|12367012|FG001|Overall Study|Adverse Event|0
7873137|NCT01688999|12367013|FG002|Overall Study|Adverse Event|2
7873138|NCT01688999|12367011|FG000|Overall Study|Ineligible/Not treated|1
7873139|NCT01688999|12367012|FG001|Overall Study|Ineligible/Not treated|0
7873140|NCT01688999|12367013|FG002|Overall Study|Ineligible/Not treated|0
7873141|NCT01689207|12367036|FG000|Overall Study|Adverse Event|0
7873142|NCT01689207|12367037|FG001|Overall Study|Adverse Event|1
7873143|NCT01689207|12367038|FG002|Overall Study|Adverse Event|0
7794023|NCT01051986|12249552|FG001|Overall Study|Protocol Violation|3
7794024|NCT01052012|12249564|FG000|Overall Study|Not treated|2
7794025|NCT01052012|12249565|FG001|Overall Study|Not treated|5
7794026|NCT01052012|12249566|FG002|Overall Study|Not treated|0
7794027|NCT01052012|12249567|FG003|Overall Study|Not treated|0
7794028|NCT01052012|12249568|FG004|Overall Study|Not treated|11
7794029|NCT01052012|12249569|FG005|Overall Study|Not treated|8
7794030|NCT01052012|12249564|FG000|Overall Study|Adverse Event|1
7794031|NCT01052012|12249565|FG001|Overall Study|Adverse Event|0
7794032|NCT01052012|12249566|FG002|Overall Study|Adverse Event|0
7794033|NCT01052012|12249567|FG003|Overall Study|Adverse Event|1
7794034|NCT01052012|12249568|FG004|Overall Study|Adverse Event|0
7794035|NCT01052012|12249569|FG005|Overall Study|Adverse Event|0
7794036|NCT01052012|12249564|FG000|Overall Study|Lost to Follow-up|0
7794037|NCT01052012|12249565|FG001|Overall Study|Lost to Follow-up|0
7794038|NCT01052012|12249566|FG002|Overall Study|Lost to Follow-up|0
7794039|NCT01052012|12249567|FG003|Overall Study|Lost to Follow-up|0
7794040|NCT01052012|12249568|FG004|Overall Study|Lost to Follow-up|1
7794041|NCT01052012|12249569|FG005|Overall Study|Lost to Follow-up|0
7794042|NCT01052012|12249564|FG000|Overall Study|Withdrawal by Subject|1
7794043|NCT01052012|12249565|FG001|Overall Study|Withdrawal by Subject|1
7794044|NCT01052012|12249566|FG002|Overall Study|Withdrawal by Subject|0
7794045|NCT01052012|12249567|FG003|Overall Study|Withdrawal by Subject|0
7794046|NCT01052012|12249568|FG004|Overall Study|Withdrawal by Subject|3
7794047|NCT01052012|12249569|FG005|Overall Study|Withdrawal by Subject|1
7794048|NCT01052012|12249564|FG000|Overall Study|Physician Decision|0
7794049|NCT01052012|12249565|FG001|Overall Study|Physician Decision|0
7794050|NCT01052012|12249566|FG002|Overall Study|Physician Decision|0
7794051|NCT01052012|12249567|FG003|Overall Study|Physician Decision|0
7794052|NCT01052012|12249568|FG004|Overall Study|Physician Decision|0
7794053|NCT01052012|12249569|FG005|Overall Study|Physician Decision|1
7794054|NCT01052012|12249564|FG000|Overall Study|Other|0
7794055|NCT01052012|12249565|FG001|Overall Study|Other|0
7794056|NCT01052012|12249566|FG002|Overall Study|Other|0
7794057|NCT01052012|12249567|FG003|Overall Study|Other|0
7794058|NCT01052012|12249568|FG004|Overall Study|Other|1
7794059|NCT01052012|12249569|FG005|Overall Study|Other|0
7794060|NCT01052038|12249586|FG000|Overall Study|Lost to Follow-up|2
7794061|NCT01052038|12249587|FG001|Overall Study|Lost to Follow-up|3
7794062|NCT01052038|12249588|FG002|Overall Study|Lost to Follow-up|1
7794063|NCT01052038|12249586|FG000|Overall Study|Protocol Violation|2
7794064|NCT01052038|12249587|FG001|Overall Study|Protocol Violation|3
7794065|NCT01052038|12249588|FG002|Overall Study|Protocol Violation|3
7794066|NCT01052077|12249598|FG000|Phase A|Lost to Follow-up|22
7794067|NCT01052077|12249599|FG001|Phase A|Lost to Follow-up|0
7794068|NCT01052077|12249600|FG002|Phase A|Lost to Follow-up|0
7794069|NCT01052077|12249601|FG003|Phase A|Lost to Follow-up|0
7794070|NCT01052077|12249598|FG000|Phase A|Adverse Event|32
7794071|NCT01052077|12249599|FG001|Phase A|Adverse Event|0
7794072|NCT01052077|12249600|FG002|Phase A|Adverse Event|0
7794073|NCT01052077|12249601|FG003|Phase A|Adverse Event|0
7794074|NCT01052077|12249598|FG000|Phase A|Met Withdrawal Criteria|26
7873144|NCT01689207|12367039|FG003|Overall Study|Adverse Event|0
7794075|NCT01052077|12249599|FG001|Phase A|Met Withdrawal Criteria|0
7794076|NCT01052077|12249600|FG002|Phase A|Met Withdrawal Criteria|0
7794077|NCT01052077|12249601|FG003|Phase A|Met Withdrawal Criteria|0
7873145|NCT01689207|12367040|FG004|Overall Study|Adverse Event|2
7794078|NCT01052077|12249598|FG000|Phase A|Physician Decision|10
7794079|NCT01052077|12249599|FG001|Phase A|Physician Decision|0
7794080|NCT01052077|12249600|FG002|Phase A|Physician Decision|0
7794081|NCT01052077|12249601|FG003|Phase A|Physician Decision|0
7794082|NCT01052077|12249598|FG000|Phase A|Withdrawal by Subject|29
7794083|NCT01052077|12249599|FG001|Phase A|Withdrawal by Subject|0
7794084|NCT01052077|12249600|FG002|Phase A|Withdrawal by Subject|0
7794085|NCT01052077|12249601|FG003|Phase A|Withdrawal by Subject|0
7794086|NCT01052077|12249598|FG000|Phase A|Protocol Deviation|27
7794087|NCT01052077|12249599|FG001|Phase A|Protocol Deviation|0
7794088|NCT01052077|12249600|FG002|Phase A|Protocol Deviation|0
7794089|NCT01052077|12249601|FG003|Phase A|Protocol Deviation|0
7794090|NCT01052077|12249598|FG000|Phase B|Lost to Follow-up|0
7794091|NCT01052077|12249599|FG001|Phase B|Lost to Follow-up|2
7794092|NCT01052077|12249600|FG002|Phase B|Lost to Follow-up|3
7794093|NCT01052077|12249601|FG003|Phase B|Lost to Follow-up|0
7873146|NCT01689207|12367041|FG005|Overall Study|Adverse Event|1
7873147|NCT01689207|12367042|FG006|Overall Study|Adverse Event|0
7873148|NCT01689207|12367043|FG007|Overall Study|Adverse Event|0
7873149|NCT01689207|12367044|FG008|Overall Study|Adverse Event|1
7873150|NCT01689207|12367045|FG009|Overall Study|Adverse Event|0
7873151|NCT01689207|12367046|FG010|Overall Study|Adverse Event|0
7873152|NCT01689337|12367080|FG000|Overall Study|Study Discontinuation|1
7873153|NCT01689363|12367095|FG000|Overall Study|Protocol Violation|0
7873154|NCT01689363|12367096|FG001|Overall Study|Protocol Violation|1
7873155|NCT01689363|12367097|FG002|Overall Study|Protocol Violation|0
7873156|NCT01689363|12367098|FG003|Overall Study|Protocol Violation|0
7873157|NCT01689363|12367099|FG004|Overall Study|Protocol Violation|0
7873158|NCT01689363|12367100|FG005|Overall Study|Protocol Violation|0
7873159|NCT01689363|12367101|FG006|Overall Study|Protocol Violation|0
7873160|NCT01689363|12367102|FG007|Overall Study|Protocol Violation|0
7873161|NCT01689532|12367124|FG000|Overall Study|Adverse Event|9
7873162|NCT01689532|12367125|FG001|Overall Study|Adverse Event|5
7873163|NCT01689532|12367124|FG000|Overall Study|Lack of Efficacy|2
7873164|NCT01689532|12367125|FG001|Overall Study|Lack of Efficacy|2
7873165|NCT01689532|12367124|FG000|Overall Study|Withdrawal by Subject|1
7873166|NCT01689532|12367125|FG001|Overall Study|Withdrawal by Subject|2
7873167|NCT01689532|12367124|FG000|Overall Study|Physician Decision|2
7794094|NCT01052077|12249598|FG000|Phase B|Adverse Event|0
7794095|NCT01052077|12249599|FG001|Phase B|Adverse Event|9
7794096|NCT01052077|12249600|FG002|Phase B|Adverse Event|2
7794097|NCT01052077|12249601|FG003|Phase B|Adverse Event|0
7794098|NCT01052077|12249598|FG000|Phase B|Met Withdrawal Criteria|0
7794099|NCT01052077|12249599|FG001|Phase B|Met Withdrawal Criteria|2
7794100|NCT01052077|12249600|FG002|Phase B|Met Withdrawal Criteria|1
7794101|NCT01052077|12249601|FG003|Phase B|Met Withdrawal Criteria|0
7794102|NCT01052077|12249598|FG000|Phase B|Physician Decision|0
7794103|NCT01052077|12249599|FG001|Phase B|Physician Decision|1
7794104|NCT01052077|12249600|FG002|Phase B|Physician Decision|1
7794105|NCT01052077|12249601|FG003|Phase B|Physician Decision|0
7794106|NCT01052077|12249598|FG000|Phase B|Withdrawal by Subject|0
7794107|NCT01052077|12249599|FG001|Phase B|Withdrawal by Subject|0
7794108|NCT01052077|12249600|FG002|Phase B|Withdrawal by Subject|5
7794109|NCT01052077|12249601|FG003|Phase B|Withdrawal by Subject|0
7794110|NCT01052077|12249598|FG000|Phase B|Protocol Deviation|0
7794111|NCT01052077|12249599|FG001|Phase B|Protocol Deviation|3
7794112|NCT01052077|12249600|FG002|Phase B|Protocol Deviation|4
7794113|NCT01052077|12249601|FG003|Phase B|Protocol Deviation|0
7794114|NCT01052077|12249598|FG000|Phase B|Lack of Efficacy|0
7794115|NCT01052077|12249599|FG001|Phase B|Lack of Efficacy|1
7794116|NCT01052077|12249600|FG002|Phase B|Lack of Efficacy|0
7794117|NCT01052077|12249601|FG003|Phase B|Lack of Efficacy|0
7794118|NCT01052077|12249598|FG000|Phase A+|Lost to Follow-up|0
7794119|NCT01052077|12249599|FG001|Phase A+|Lost to Follow-up|0
7794120|NCT01052077|12249600|FG002|Phase A+|Lost to Follow-up|0
7794121|NCT01052077|12249601|FG003|Phase A+|Lost to Follow-up|8
7794122|NCT01052077|12249598|FG000|Phase A+|Adverse Event|0
7794123|NCT01052077|12249599|FG001|Phase A+|Adverse Event|0
7794124|NCT01052077|12249600|FG002|Phase A+|Adverse Event|0
7794125|NCT01052077|12249601|FG003|Phase A+|Adverse Event|4
7794126|NCT01052077|12249598|FG000|Phase A+|Met Withdrawal Criteria|0
7794127|NCT01052077|12249599|FG001|Phase A+|Met Withdrawal Criteria|0
7794128|NCT01052077|12249600|FG002|Phase A+|Met Withdrawal Criteria|0
7794129|NCT01052077|12249601|FG003|Phase A+|Met Withdrawal Criteria|2
7794130|NCT01052077|12249598|FG000|Phase A+|Withdrawal by Subject|0
7794131|NCT01052077|12249599|FG001|Phase A+|Withdrawal by Subject|0
7794132|NCT01052077|12249600|FG002|Phase A+|Withdrawal by Subject|0
7794133|NCT01052077|12249601|FG003|Phase A+|Withdrawal by Subject|7
7794134|NCT01052116|12249609|FG000|Overall Study|Lost to Follow-up|11
7794135|NCT01052116|12249610|FG001|Overall Study|Lost to Follow-up|17
7794136|NCT01052116|12249609|FG000|Overall Study|Withdrawal by Subject|3
7794137|NCT01052116|12249610|FG001|Overall Study|Withdrawal by Subject|6
7794138|NCT01052116|12249609|FG000|Overall Study|Spirometry not performed|0
7794139|NCT01052116|12249610|FG001|Overall Study|Spirometry not performed|4
7794140|NCT01052272|12249629|FG000|Overall Study|Death|0
7794141|NCT01052272|12249630|FG001|Overall Study|Death|0
7794142|NCT01052272|12249631|FG002|Overall Study|Death|1
7794143|NCT01052272|12249632|FG003|Overall Study|Death|1
7794144|NCT01052272|12249629|FG000|Overall Study|Physician Decision|0
7794145|NCT01052272|12249630|FG001|Overall Study|Physician Decision|1
7794146|NCT01052272|12249631|FG002|Overall Study|Physician Decision|0
7794147|NCT01052272|12249632|FG003|Overall Study|Physician Decision|0
7794148|NCT01052272|12249629|FG000|Overall Study|patient refuses follow-up|5
7794149|NCT01052272|12249630|FG001|Overall Study|patient refuses follow-up|4
7794150|NCT01052272|12249631|FG002|Overall Study|patient refuses follow-up|2
7794151|NCT01052272|12249632|FG003|Overall Study|patient refuses follow-up|4
7794152|NCT01052272|12249629|FG000|Overall Study|Withdrawal by Subject|0
7794153|NCT01052272|12249630|FG001|Overall Study|Withdrawal by Subject|2
7794154|NCT01052272|12249631|FG002|Overall Study|Withdrawal by Subject|3
7794155|NCT01052272|12249632|FG003|Overall Study|Withdrawal by Subject|2
7794156|NCT01052272|12249629|FG000|Overall Study|placed in long-term care|0
7873168|NCT01689532|12367125|FG001|Overall Study|Physician Decision|0
7873169|NCT01689649|12367131|FG000|Overall Study|Lack of Efficacy|3
7873170|NCT01689649|12367131|FG000|Overall Study|Non-compliance|11
7873171|NCT01689649|12367131|FG000|Overall Study|Protocol Violation|3
7873172|NCT01689649|12367131|FG000|Overall Study|Lost to Follow-up|5
7873173|NCT01689857|12367155|FG000|Overall Study|Lost to Follow-up|5
7873174|NCT01689857|12367156|FG001|Overall Study|Lost to Follow-up|2
7873175|NCT01690052|12367171|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
7873176|NCT01690052|12367172|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
7873177|NCT01690130|12367191|FG000|Overall Study|Subject have cancelled visit.|1
7873178|NCT01690130|12367192|FG001|Overall Study|Subject have cancelled visit.|0
7873179|NCT01690143|12367198|FG000|Overall Study|Withdrawal by Subject|1
7873180|NCT01690520|12367222|FG000|Overall Study|Death|25
7873181|NCT01690520|12367223|FG001|Overall Study|Death|21
7873182|NCT01690520|12367222|FG000|Overall Study|Lost to Follow-up|2
7873183|NCT01690520|12367223|FG001|Overall Study|Lost to Follow-up|3
7873184|NCT01690520|12367222|FG000|Overall Study|Withdrawal by Subject|2
7873185|NCT01690520|12367223|FG001|Overall Study|Withdrawal by Subject|0
7873186|NCT01690520|12367222|FG000|Overall Study|Relapse|0
7873187|NCT01690520|12367223|FG001|Overall Study|Relapse|1
7873188|NCT01690520|12367222|FG000|Overall Study|Other|0
7873189|NCT01690520|12367223|FG001|Overall Study|Other|1
7873190|NCT01690520|12367222|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22
7873191|NCT01690520|12367223|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21
7873192|NCT01690988|12367258|FG000|Overall Study|Withdrawal by Subject|2
7873193|NCT01690988|12367259|FG001|Overall Study|Withdrawal by Subject|2
7873194|NCT01690988|12367260|FG002|Overall Study|Withdrawal by Subject|3
7873195|NCT01690988|12367258|FG000|Overall Study|Physician Decision|0
7873196|NCT01690988|12367259|FG001|Overall Study|Physician Decision|0
7873197|NCT01690988|12367260|FG002|Overall Study|Physician Decision|1
7873198|NCT01690988|12367258|FG000|Overall Study|Operation Cancelled|1
7873199|NCT01690988|12367259|FG001|Overall Study|Operation Cancelled|1
7873200|NCT01690988|12367260|FG002|Overall Study|Operation Cancelled|0
7873201|NCT01690988|12367258|FG000|Overall Study|Determined ineligible|1
7873202|NCT01690988|12367259|FG001|Overall Study|Determined ineligible|0
7873203|NCT01690988|12367260|FG002|Overall Study|Determined ineligible|0
7873204|NCT01690988|12367258|FG000|Overall Study|Death|1
7873205|NCT01690988|12367259|FG001|Overall Study|Death|1
7873206|NCT01690988|12367260|FG002|Overall Study|Death|1
7873207|NCT01690988|12367258|FG000|Overall Study|Sedated|1
7873208|NCT01690988|12367259|FG001|Overall Study|Sedated|1
7873209|NCT01690988|12367260|FG002|Overall Study|Sedated|2
7873210|NCT01691014|12367275|FG000|Overall Study|Premature Termination|1
7873211|NCT01691014|12367276|FG001|Overall Study|Premature Termination|6
7873212|NCT01691014|12367277|FG002|Overall Study|Premature Termination|0
7873213|NCT01691014|12367278|FG003|Overall Study|Premature Termination|3
7873214|NCT01691014|12367275|FG000|Overall Study|Other|0
7873215|NCT01691014|12367276|FG001|Overall Study|Other|0
7873216|NCT01691014|12367277|FG002|Overall Study|Other|2
7873217|NCT01691014|12367278|FG003|Overall Study|Other|0
7873218|NCT01691014|12367275|FG000|Overall Study|Withdrawal by Subject|0
7873219|NCT01691014|12367276|FG001|Overall Study|Withdrawal by Subject|1
7873220|NCT01691014|12367277|FG002|Overall Study|Withdrawal by Subject|1
7873221|NCT01691014|12367278|FG003|Overall Study|Withdrawal by Subject|1
7873222|NCT01691014|12367275|FG000|Overall Study|Adverse Event|0
7873223|NCT01691014|12367276|FG001|Overall Study|Adverse Event|5
7873224|NCT01691014|12367277|FG002|Overall Study|Adverse Event|1
7873225|NCT01691014|12367278|FG003|Overall Study|Adverse Event|1
7794157|NCT01052272|12249630|FG001|Overall Study|placed in long-term care|0
7873226|NCT01691014|12367275|FG000|Overall Study|Lack of Efficacy|2
7873227|NCT01691014|12367276|FG001|Overall Study|Lack of Efficacy|3
7873228|NCT01691014|12367277|FG002|Overall Study|Lack of Efficacy|7
7873229|NCT01691014|12367278|FG003|Overall Study|Lack of Efficacy|0
7873230|NCT01691092|12367293|FG000|Overall Study|Lost to Follow-up|10
7873231|NCT01691092|12367293|FG000|Overall Study|Physician Decision|4
7873232|NCT01691092|12367293|FG000|Overall Study|Withdrawal by Subject|3
7873233|NCT01691092|12367293|FG000|Overall Study|non-compliance|3
7873234|NCT01691092|12367293|FG000|Overall Study|used for different study|2
7873235|NCT01691092|12367293|FG000|Overall Study|screen fail|19
7873236|NCT01691105|12367299|FG000|1 Month Follow-up|Lost to Follow-up|41
7873237|NCT01691105|12367300|FG001|1 Month Follow-up|Lost to Follow-up|38
7873238|NCT01691105|12367299|FG000|1 Month Follow-up|Death|2
7873239|NCT01691105|12367300|FG001|1 Month Follow-up|Death|3
7873240|NCT01691105|12367299|FG000|6 Month Follow-up|Lost to Follow-up|39
7873241|NCT01691105|12367300|FG001|6 Month Follow-up|Lost to Follow-up|58
7873242|NCT01691105|12367299|FG000|6 Month Follow-up|Death|13
7873243|NCT01691105|12367300|FG001|6 Month Follow-up|Death|13
7873244|NCT01691105|12367299|FG000|12 Month Follow-up|Lost to Follow-up|50
7873245|NCT01691105|12367300|FG001|12 Month Follow-up|Lost to Follow-up|71
7873246|NCT01691105|12367299|FG000|12 Month Follow-up|Death|22
7873247|NCT01691105|12367300|FG001|12 Month Follow-up|Death|30
7873248|NCT01691105|12367299|FG000|12 Month Biochemical Verification|Death|22
7873249|NCT01691105|12367300|FG001|12 Month Biochemical Verification|Death|30
7873250|NCT01691105|12367299|FG000|12 Month Biochemical Verification|Lost to Follow-up|50
7873251|NCT01691105|12367300|FG001|12 Month Biochemical Verification|Lost to Follow-up|71
7873252|NCT01691105|12367299|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352
7873253|NCT01691105|12367300|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401
7873254|NCT01691248|12367308|FG000|Overall Study|Protocol Violation|43
7873255|NCT01691248|12367309|FG001|Overall Study|Protocol Violation|27
7873256|NCT01691248|12367308|FG000|Overall Study|Adverse Event|24
7873257|NCT01691248|12367309|FG001|Overall Study|Adverse Event|22
7873258|NCT01691248|12367308|FG000|Overall Study|Withdrawal by Subject|20
7873259|NCT01691248|12367309|FG001|Overall Study|Withdrawal by Subject|18
7873260|NCT01691248|12367308|FG000|Overall Study|Confirmed CDAD|14
7873261|NCT01691248|12367309|FG001|Overall Study|Confirmed CDAD|31
7873262|NCT01691248|12367308|FG000|Overall Study|Lost to Follow-up|2
7873263|NCT01691248|12367309|FG001|Overall Study|Lost to Follow-up|5
7873264|NCT01691248|12367308|FG000|Overall Study|Reason not provided|4
7873265|NCT01691248|12367309|FG001|Overall Study|Reason not provided|4
7873266|NCT01691248|12367308|FG000|Overall Study|Not Treated|4
7873267|NCT01691248|12367309|FG001|Overall Study|Not Treated|7
7873268|NCT01691378|12367362|FG000|Overall Study|Withdrawal by Subject|2
7873269|NCT01691378|12367363|FG001|Overall Study|Withdrawal by Subject|0
7873270|NCT01691378|12367362|FG000|Overall Study|Lost to Follow-up|5
7873271|NCT01691378|12367363|FG001|Overall Study|Lost to Follow-up|2
7873272|NCT01691430|12367371|FG000|Overall Study|Death|17
7873273|NCT01691430|12367372|FG001|Overall Study|Death|16
7873274|NCT01691430|12367371|FG000|Overall Study|Withdrawal by Subject|5
7873275|NCT01691430|12367372|FG001|Overall Study|Withdrawal by Subject|1
7873276|NCT01691430|12367371|FG000|Overall Study|Lost to Follow-up|0
7873277|NCT01691430|12367372|FG001|Overall Study|Lost to Follow-up|3
7873278|NCT01691482|12367378|FG000|Treatment Period 2|Adverse Event|0
7873279|NCT01691482|12367379|FG001|Treatment Period 2|Adverse Event|1
7873280|NCT01691482|12367378|FG000|Treatment Period 2|Protocol Violation|1
7873281|NCT01691482|12367379|FG001|Treatment Period 2|Protocol Violation|1
7873282|NCT01691508|12367388|FG000|Overall Study|Adverse Event|3
7873283|NCT01691508|12367389|FG001|Overall Study|Adverse Event|3
7873284|NCT01691508|12367388|FG000|Overall Study|Withdrawal by Subject|1
7873285|NCT01691508|12367389|FG001|Overall Study|Withdrawal by Subject|0
7873286|NCT01691521|12367398|FG000|Overall Study|Adverse Event|4
7873287|NCT01691521|12367399|FG001|Overall Study|Adverse Event|0
7873288|NCT01691521|12367400|FG002|Overall Study|Adverse Event|1
7873289|NCT01691521|12367398|FG000|Overall Study|Lack of Efficacy|1
7873290|NCT01691521|12367399|FG001|Overall Study|Lack of Efficacy|1
7873291|NCT01691521|12367400|FG002|Overall Study|Lack of Efficacy|2
7873292|NCT01691521|12367398|FG000|Overall Study|Protocol Violation|0
7873293|NCT01691521|12367399|FG001|Overall Study|Protocol Violation|3
7873294|NCT01691521|12367400|FG002|Overall Study|Protocol Violation|0
7794158|NCT01052272|12249631|FG002|Overall Study|placed in long-term care|1
7794159|NCT01052272|12249632|FG003|Overall Study|placed in long-term care|0
7794160|NCT01052272|12249629|FG000|Overall Study|decline in health|0
7794161|NCT01052272|12249630|FG001|Overall Study|decline in health|0
7794162|NCT01052272|12249631|FG002|Overall Study|decline in health|1
7794163|NCT01052272|12249632|FG003|Overall Study|decline in health|0
7794164|NCT01052428|12249644|FG000|Overall Study|Death|1
7794165|NCT01052428|12249645|FG001|Overall Study|Death|0
7794166|NCT01052428|12249644|FG000|Overall Study|Withdrawal by Subject|0
7794167|NCT01052428|12249645|FG001|Overall Study|Withdrawal by Subject|1
7794168|NCT01052480|12249653|FG000|Overall Study|Lost to Follow-up|3
7794169|NCT01052480|12249654|FG001|Overall Study|Lost to Follow-up|3
7794170|NCT01052480|12249653|FG000|Overall Study|Protocol Violation|1
7794171|NCT01052480|12249654|FG001|Overall Study|Protocol Violation|0
7794172|NCT01052480|12249653|FG000|Overall Study|Withdrawal by Subject|3
7794173|NCT01052480|12249654|FG001|Overall Study|Withdrawal by Subject|7
7794174|NCT01052480|12249653|FG000|Overall Study|Physician Decision|0
7794175|NCT01052480|12249654|FG001|Overall Study|Physician Decision|2
7794176|NCT01052480|12249653|FG000|Overall Study|Death|1
7794177|NCT01052480|12249654|FG001|Overall Study|Death|5
7794178|NCT01052493|12249660|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1
7873295|NCT01691521|12367398|FG000|Overall Study|Lost to Follow-up|0
7873296|NCT01691521|12367399|FG001|Overall Study|Lost to Follow-up|2
7873297|NCT01691521|12367400|FG002|Overall Study|Lost to Follow-up|2
7873298|NCT01691521|12367398|FG000|Overall Study|Physician Decision|2
7873299|NCT01691521|12367399|FG001|Overall Study|Physician Decision|1
7873300|NCT01691521|12367400|FG002|Overall Study|Physician Decision|0
7794179|NCT01052493|12249661|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
7794180|NCT01052493|12249662|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
7794181|NCT01052662|12249699|FG000|Overall Study|Lost to Follow-up|15
7794182|NCT01052662|12249700|FG001|Overall Study|Lost to Follow-up|13
7794183|NCT01052662|12249701|FG002|Overall Study|Lost to Follow-up|18
7794184|NCT01052662|12249699|FG000|Overall Study|Withdrawal by Subject|3
7794185|NCT01052662|12249700|FG001|Overall Study|Withdrawal by Subject|2
7794186|NCT01052662|12249701|FG002|Overall Study|Withdrawal by Subject|1
7794187|NCT01052662|12249699|FG000|Overall Study|Pharmacy issue|1
7794188|NCT01052662|12249700|FG001|Overall Study|Pharmacy issue|3
7794189|NCT01052662|12249701|FG002|Overall Study|Pharmacy issue|3
7794190|NCT01052662|12249699|FG000|Overall Study|Adverse Event|1
7794191|NCT01052662|12249700|FG001|Overall Study|Adverse Event|1
7794192|NCT01052662|12249701|FG002|Overall Study|Adverse Event|0
7794193|NCT01052662|12249699|FG000|Overall Study|Legal Problem|2
7794194|NCT01052662|12249700|FG001|Overall Study|Legal Problem|0
7794195|NCT01052662|12249701|FG002|Overall Study|Legal Problem|0
7794196|NCT01052662|12249699|FG000|Overall Study|Administrative|0
7873301|NCT01691521|12367398|FG000|Overall Study|Withdrawal by Subject|5
7873302|NCT01691521|12367399|FG001|Overall Study|Withdrawal by Subject|9
7873303|NCT01691521|12367400|FG002|Overall Study|Withdrawal by Subject|4
7873304|NCT01691612|12367456|FG000|Overall Study|deemed ineligible after 1st visit|6
7873305|NCT01691612|12367456|FG000|Overall Study|Adverse Event|1
7882832|NCT01776424|12382173|FG001|Overall Study|Withdrawal by Subject|11
7882833|NCT01776424|12382174|FG002|Overall Study|Withdrawal by Subject|15
7882834|NCT01776541|12382184|FG000|Overall Study|Administrative Reason|6
7882835|NCT01776541|12382185|FG001|Overall Study|Administrative Reason|2
7882836|NCT01776541|12382184|FG000|Overall Study|Death|4
7882837|NCT01776541|12382185|FG001|Overall Study|Death|0
7882838|NCT01776541|12382184|FG000|Overall Study|Lost to Follow-up|27
7882839|NCT01776541|12382185|FG001|Overall Study|Lost to Follow-up|48
7882840|NCT01776541|12382184|FG000|Overall Study|Unclassified|5
7882841|NCT01776541|12382185|FG001|Overall Study|Unclassified|4
7882842|NCT01776541|12382184|FG000|Overall Study|Protocol Violation|2
7882843|NCT01776541|12382185|FG001|Overall Study|Protocol Violation|1
7882844|NCT01776541|12382184|FG000|Overall Study|Withdrawal by Subject|12
7882845|NCT01776541|12382185|FG001|Overall Study|Withdrawal by Subject|20
7882846|NCT01776554|12382194|FG000|Overall Study|Adverse Event|1
7882847|NCT01776554|12382195|FG001|Overall Study|Adverse Event|0
7882848|NCT01776554|12382194|FG000|Overall Study|Withdrawal by Subject|3
7882849|NCT01776554|12382195|FG001|Overall Study|Withdrawal by Subject|8
7882850|NCT01776554|12382194|FG000|Overall Study|Lost to Follow-up|6
7882851|NCT01776554|12382195|FG001|Overall Study|Lost to Follow-up|9
7882852|NCT01776554|12382194|FG000|Overall Study|Administrative Reason|2
7882853|NCT01776554|12382195|FG001|Overall Study|Administrative Reason|5
7882854|NCT01776554|12382194|FG000|Overall Study|Protocol Violation|1
7882855|NCT01776554|12382195|FG001|Overall Study|Protocol Violation|0
7882856|NCT01776554|12382194|FG000|Overall Study|Unclassified|4
7882857|NCT01776554|12382195|FG001|Overall Study|Unclassified|1
7882858|NCT01777139|12382230|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7
7882859|NCT01777139|12382231|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0
7882860|NCT01777139|12382230|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6
7882861|NCT01777139|12382231|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0
7882862|NCT01777139|12382230|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8
7882863|NCT01777139|12382231|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0
7882864|NCT01777139|12382230|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3
7882865|NCT01777139|12382231|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0
7794197|NCT01052662|12249700|FG001|Overall Study|Administrative|3
7794198|NCT01052662|12249701|FG002|Overall Study|Administrative|0
7882866|NCT01777139|12382230|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2
7882867|NCT01777139|12382231|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0
7882868|NCT01777139|12382230|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4
7882869|NCT01777139|12382231|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0
7882870|NCT01777139|12382230|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0
7882871|NCT01777139|12382231|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1
7882872|NCT01777139|12382230|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0
7882873|NCT01777139|12382231|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3
7882874|NCT01777152|12382240|FG000|Overall Study|Withdrawal by Subject|22
7882875|NCT01777152|12382241|FG001|Overall Study|Withdrawal by Subject|16
7882876|NCT01777152|12382240|FG000|Overall Study|Lost to Follow-up|3
7882877|NCT01777152|12382241|FG001|Overall Study|Lost to Follow-up|5
7882878|NCT01777152|12382240|FG000|Overall Study|Death|68
7882879|NCT01777152|12382241|FG001|Overall Study|Death|89
7882880|NCT01777152|12382240|FG000|Overall Study|Not eligible, no study drug received|1
7882881|NCT01777152|12382241|FG001|Overall Study|Not eligible, no study drug received|0
7882882|NCT01777152|12382240|FG000|Overall Study|Change of diagnosis|1
7882883|NCT01777152|12382241|FG001|Overall Study|Change of diagnosis|0
7882884|NCT01777191|12382250|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
7882885|NCT01777191|12382251|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
7882886|NCT01777191|12382250|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
7794199|NCT01052714|12249720|FG000|Overall Study|Adverse Event|6
7794200|NCT01052714|12249721|FG001|Overall Study|Adverse Event|3
7794201|NCT01052714|12249722|FG002|Overall Study|Adverse Event|0
7794202|NCT01052714|12249720|FG000|Overall Study|Death|1
7794203|NCT01052714|12249721|FG001|Overall Study|Death|2
7794204|NCT01052714|12249722|FG002|Overall Study|Death|0
7794205|NCT01052714|12249720|FG000|Overall Study|Lost to Follow-up|2
7794206|NCT01052714|12249721|FG001|Overall Study|Lost to Follow-up|3
7794207|NCT01052714|12249722|FG002|Overall Study|Lost to Follow-up|0
7794208|NCT01052714|12249720|FG000|Overall Study|Physician Decision|9
7794209|NCT01052714|12249721|FG001|Overall Study|Physician Decision|9
7794210|NCT01052714|12249722|FG002|Overall Study|Physician Decision|1
7794211|NCT01052714|12249720|FG000|Overall Study|Withdrawal by Subject|7
7794212|NCT01052714|12249721|FG001|Overall Study|Withdrawal by Subject|12
7794213|NCT01052714|12249722|FG002|Overall Study|Withdrawal by Subject|1
7794214|NCT01052779|12249730|FG000|Overall Study|Adverse Event|1
7794215|NCT01052779|12249731|FG001|Overall Study|Adverse Event|4
7794216|NCT01052779|12249730|FG000|Overall Study|Withdrawal by Subject|1
7873306|NCT01691768|12367474|FG000|Overall Study|Death|0
7873307|NCT01691768|12367475|FG001|Overall Study|Death|2
7873308|NCT01691768|12367474|FG000|Overall Study|Lost to Follow-up|4
7873309|NCT01691768|12367475|FG001|Overall Study|Lost to Follow-up|3
7873310|NCT01691768|12367474|FG000|Overall Study|Withdrawal by Subject|10
7873311|NCT01691768|12367475|FG001|Overall Study|Withdrawal by Subject|9
7873312|NCT01691768|12367474|FG000|Overall Study|Relocated|0
7873313|NCT01691768|12367475|FG001|Overall Study|Relocated|1
7873314|NCT01691768|12367474|FG000|Overall Study|Investigator decision|1
7873315|NCT01691768|12367475|FG001|Overall Study|Investigator decision|1
7873316|NCT01691781|12367484|FG000|Overall Study|Withdrawal by Subject|4
7873317|NCT01691781|12367485|FG001|Overall Study|Withdrawal by Subject|3
7873318|NCT01691781|12367484|FG000|Overall Study|Physician Decision|1
7794217|NCT01052779|12249731|FG001|Overall Study|Withdrawal by Subject|2
7794218|NCT01052779|12249730|FG000|Overall Study|Other-Protocol Violation|1
7794219|NCT01052779|12249731|FG001|Overall Study|Other-Protocol Violation|1
7794220|NCT01052779|12249730|FG000|Overall Study|Other-Surgery|0
7794221|NCT01052779|12249731|FG001|Overall Study|Other-Surgery|2
7794222|NCT01052779|12249730|FG000|Overall Study|Other-Missed Week 5 Visit|2
7794223|NCT01052779|12249731|FG001|Overall Study|Other-Missed Week 5 Visit|0
7794224|NCT01052844|12249748|FG000|Overall Study|Adverse Event|0
7794225|NCT01052844|12249749|FG001|Overall Study|Adverse Event|1
7794226|NCT01053247|12249910|FG000|Overall Study|Withdrawal by Subject|9
7794227|NCT01053247|12249911|FG001|Overall Study|Withdrawal by Subject|4
7794228|NCT01053247|12249912|FG002|Overall Study|Withdrawal by Subject|15
7794229|NCT01053247|12249910|FG000|Overall Study|Lack of Efficacy|1
7794230|NCT01053247|12249911|FG001|Overall Study|Lack of Efficacy|0
7794231|NCT01053247|12249912|FG002|Overall Study|Lack of Efficacy|1
7794232|NCT01053247|12249910|FG000|Overall Study|Protocol Violation|2
7794233|NCT01053247|12249911|FG001|Overall Study|Protocol Violation|1
7794234|NCT01053247|12249912|FG002|Overall Study|Protocol Violation|2
7794235|NCT01053247|12249910|FG000|Overall Study|Lost to Follow-up|8
7794236|NCT01053247|12249911|FG001|Overall Study|Lost to Follow-up|5
7794237|NCT01053247|12249912|FG002|Overall Study|Lost to Follow-up|7
7794238|NCT01053247|12249910|FG000|Overall Study|Adverse Event|0
7794239|NCT01053247|12249911|FG001|Overall Study|Adverse Event|9
7794240|NCT01053247|12249912|FG002|Overall Study|Adverse Event|3
7794241|NCT01053429|12249938|FG000|Overall Study|Adverse Event|64
7794242|NCT01053429|12249938|FG000|Overall Study|Other|309
7794243|NCT01053663|12249954|FG000|Overall Study|Death|2
7794244|NCT01053663|12249954|FG000|Overall Study|Lost to Follow-up|1
7794245|NCT01053663|12249954|FG000|Overall Study|Poor IV Access|1
7794246|NCT01053663|12249954|FG000|Overall Study|Transferred to Another Hospital|1
7794247|NCT01053663|12249954|FG000|Overall Study|Negative Influenza Diagnosis|1
7794248|NCT01053741|12249966|FG000|2nd Study Intervention|Physician Decision|0
7794249|NCT01053741|12249967|FG001|2nd Study Intervention|Physician Decision|1
7794250|NCT01053962|12249993|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0
7794251|NCT01053962|12249994|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0
7794252|NCT01053962|12249995|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0
7794253|NCT01053962|12249996|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1
7794254|NCT01053962|12249997|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2
7794255|NCT01053962|12249993|FG000|Pretreatment Period|Venipuncture Failure|0
7794256|NCT01053962|12249994|FG001|Pretreatment Period|Venipuncture Failure|0
7794257|NCT01053962|12249995|FG002|Pretreatment Period|Venipuncture Failure|1
7794258|NCT01053962|12249996|FG003|Pretreatment Period|Venipuncture Failure|0
7794259|NCT01053962|12249997|FG004|Pretreatment Period|Venipuncture Failure|0
7794260|NCT01053962|12249993|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0
7794261|NCT01053962|12249994|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1
7794262|NCT01053962|12249995|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0
7794263|NCT01053962|12249996|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0
7794264|NCT01053962|12249997|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0
7794265|NCT01053962|12249993|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0
7794266|NCT01053962|12249994|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0
7794267|NCT01053962|12249995|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0
7873319|NCT01691781|12367485|FG001|Overall Study|Physician Decision|1
7873320|NCT01691781|12367484|FG000|Overall Study|Protocol Violation|2
7794268|NCT01053962|12249996|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1
7794269|NCT01053962|12249997|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0
7794270|NCT01053962|12249993|FG000|Treatment Period|Lack of Efficacy|0
7794271|NCT01053962|12249994|FG001|Treatment Period|Lack of Efficacy|0
7794272|NCT01053962|12249995|FG002|Treatment Period|Lack of Efficacy|0
7794273|NCT01053962|12249996|FG003|Treatment Period|Lack of Efficacy|0
7794274|NCT01053962|12249997|FG004|Treatment Period|Lack of Efficacy|1
7794275|NCT01053962|12249993|FG000|Treatment Period|Adverse Event|0
7794276|NCT01053962|12249994|FG001|Treatment Period|Adverse Event|0
7794277|NCT01053962|12249995|FG002|Treatment Period|Adverse Event|0
7794278|NCT01053962|12249996|FG003|Treatment Period|Adverse Event|0
7794279|NCT01053962|12249997|FG004|Treatment Period|Adverse Event|1
7794280|NCT01053962|12249993|FG000|Treatment Period|Withdrawal by Subject|0
7794281|NCT01053962|12249994|FG001|Treatment Period|Withdrawal by Subject|0
7873321|NCT01691781|12367485|FG001|Overall Study|Protocol Violation|2
7794282|NCT01053962|12249995|FG002|Treatment Period|Withdrawal by Subject|0
7794283|NCT01053962|12249996|FG003|Treatment Period|Withdrawal by Subject|0
7794284|NCT01053962|12249997|FG004|Treatment Period|Withdrawal by Subject|1
7794285|NCT01053962|12249993|FG000|Treatment Period|Noncompliance with protocol|1
7794286|NCT01053962|12249994|FG001|Treatment Period|Noncompliance with protocol|0
7794287|NCT01053962|12249995|FG002|Treatment Period|Noncompliance with protocol|0
7794288|NCT01053962|12249996|FG003|Treatment Period|Noncompliance with protocol|0
7794289|NCT01053962|12249997|FG004|Treatment Period|Noncompliance with protocol|0
7794290|NCT01053988|12250019|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
7794291|NCT01053988|12250020|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7794292|NCT01053988|12250021|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7794293|NCT01053988|12250022|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7794294|NCT01053988|12250023|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7794295|NCT01053988|12250024|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7794296|NCT01053988|12250019|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
7794297|NCT01053988|12250020|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7794298|NCT01053988|12250021|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7794299|NCT01053988|12250022|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7794300|NCT01053988|12250023|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7794301|NCT01053988|12250024|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7624401|NCT04399356|12035435|FG000|Overall Study|Lost to Follow-up|1
7624402|NCT04399356|12035436|FG001|Overall Study|Lost to Follow-up|1
7794302|NCT01053988|12250019|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
7794303|NCT01053988|12250020|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7794304|NCT01053988|12250021|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7794305|NCT01053988|12250022|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7794306|NCT01053988|12250023|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7794307|NCT01053988|12250024|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7794308|NCT01053988|12250019|FG000|2-week, Single-blind Run-In Period|Adverse Event|6
7794309|NCT01053988|12250020|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
7794310|NCT01053988|12250021|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
7794311|NCT01053988|12250022|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
7794312|NCT01053988|12250023|FG004|2-week, Single-blind Run-In Period|Adverse Event|0
7794313|NCT01053988|12250024|FG005|2-week, Single-blind Run-In Period|Adverse Event|0
7794314|NCT01053988|12250019|FG000|2-week, Single-blind Run-In Period|Physician Decision|5
7794315|NCT01053988|12250020|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
7794316|NCT01053988|12250021|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
7794317|NCT01053988|12250022|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
7794318|NCT01053988|12250023|FG004|2-week, Single-blind Run-In Period|Physician Decision|0
7794319|NCT01053988|12250024|FG005|2-week, Single-blind Run-In Period|Physician Decision|0
7794320|NCT01053988|12250019|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1
7794321|NCT01053988|12250020|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7794322|NCT01053988|12250021|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7794323|NCT01053988|12250022|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7794324|NCT01053988|12250023|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7794325|NCT01053988|12250024|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7794326|NCT01053988|12250019|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
7794327|NCT01053988|12250020|FG001|24-week, Double-blind Treatment Period|Adverse Event|15
7794328|NCT01053988|12250021|FG002|24-week, Double-blind Treatment Period|Adverse Event|23
7794329|NCT01053988|12250022|FG003|24-week, Double-blind Treatment Period|Adverse Event|24
7794330|NCT01053988|12250023|FG004|24-week, Double-blind Treatment Period|Adverse Event|17
7794331|NCT01053988|12250024|FG005|24-week, Double-blind Treatment Period|Adverse Event|14
7794332|NCT01053988|12250019|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7794333|NCT01053988|12250020|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
7624403|NCT04399356|12035435|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1
7624404|NCT04399356|12035436|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2
7624405|NCT04399356|12035435|FG000|Overall Study|Withdrawal by Subject|1
7624406|NCT04399356|12035436|FG001|Overall Study|Withdrawal by Subject|0
7624407|NCT04156399|12035466|FG000|Overall Study|hospitalization unrelated to acupuncture|1
7624408|NCT04156399|12035466|FG000|Overall Study|study suspension due to COVID pandemic|3
7624409|NCT04052620|12035476|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1
7624410|NCT04052620|12035477|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0
7624411|NCT04052620|12035476|FG000|Overall Study|Withdrawal by Subject|1
7624412|NCT04052620|12035477|FG001|Overall Study|Withdrawal by Subject|0
7624413|NCT04052620|12035476|FG000|Overall Study|Lost to Follow-up|1
7624414|NCT04052620|12035477|FG001|Overall Study|Lost to Follow-up|1
7624415|NCT04052620|12035476|FG000|Overall Study|Adverse Event|1
7624416|NCT04052620|12035477|FG001|Overall Study|Adverse Event|0
7624417|NCT04052620|12035476|FG000|Overall Study|Subject did not meet study Criteria|0
7624418|NCT04052620|12035477|FG001|Overall Study|Subject did not meet study Criteria|1
7624419|NCT04052620|12035476|FG000|Overall Study|Screened failure, randomized by mistake|0
7794334|NCT01053988|12250021|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
7794335|NCT01053988|12250022|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
7794336|NCT01053988|12250023|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
7794337|NCT01053988|12250024|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7794338|NCT01053988|12250019|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
7794339|NCT01053988|12250020|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
7794340|NCT01053988|12250021|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
7794341|NCT01053988|12250022|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
7794342|NCT01053988|12250023|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
7794343|NCT01053988|12250024|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
7794344|NCT01053988|12250019|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
7794345|NCT01053988|12250020|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3
7794346|NCT01053988|12250021|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4
7794347|NCT01053988|12250022|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
7794348|NCT01053988|12250023|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1
7794349|NCT01053988|12250024|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4
7794350|NCT01053988|12250019|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
7794351|NCT01053988|12250020|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
7794352|NCT01053988|12250021|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
7794353|NCT01053988|12250022|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
7794354|NCT01053988|12250023|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
7873322|NCT01691781|12367484|FG000|Overall Study|Adverse Event|0
7873323|NCT01691781|12367485|FG001|Overall Study|Adverse Event|1
7873324|NCT01691794|12367494|FG000|Overall Study|Poor/Non-Compliance|1
7873325|NCT01691794|12367495|FG001|Overall Study|Poor/Non-Compliance|4
7873326|NCT01691794|12367496|FG002|Overall Study|Poor/Non-Compliance|1
7873327|NCT01691794|12367494|FG000|Overall Study|Death|0
7873328|NCT01691794|12367495|FG001|Overall Study|Death|0
7873329|NCT01691794|12367496|FG002|Overall Study|Death|1
7873330|NCT01691794|12367494|FG000|Overall Study|Lack of Efficacy|0
7873331|NCT01691794|12367495|FG001|Overall Study|Lack of Efficacy|7
7873332|NCT01691794|12367496|FG002|Overall Study|Lack of Efficacy|1
7873333|NCT01691794|12367494|FG000|Overall Study|Participant request to discontinue|0
7873334|NCT01691794|12367495|FG001|Overall Study|Participant request to discontinue|1
7873335|NCT01691794|12367496|FG002|Overall Study|Participant request to discontinue|0
7873336|NCT01691794|12367494|FG000|Overall Study|Adverse Event|0
7873337|NCT01691794|12367495|FG001|Overall Study|Adverse Event|1
7873338|NCT01691794|12367496|FG002|Overall Study|Adverse Event|1
7873339|NCT01691794|12367494|FG000|Overall Study|Completed Only first 24 weeks of study|0
7873340|NCT01691794|12367495|FG001|Overall Study|Completed Only first 24 weeks of study|2
7873341|NCT01691794|12367496|FG002|Overall Study|Completed Only first 24 weeks of study|3
7873342|NCT01691794|12367494|FG000|Overall Study|Did not complete first 24 weeks of study|0
7873343|NCT01691794|12367495|FG001|Overall Study|Did not complete first 24 weeks of study|3
7873344|NCT01691794|12367496|FG002|Overall Study|Did not complete first 24 weeks of study|3
7873345|NCT01691820|12367506|FG000|Overall Study|Consent withdrawal (not due to an AE)|9
7873346|NCT01691820|12367507|FG001|Overall Study|Consent withdrawal (not due to an AE)|15
7873347|NCT01691820|12367506|FG000|Overall Study|Migrated/moved from study area|7
7873348|NCT01691820|12367507|FG001|Overall Study|Migrated/moved from study area|4
7873349|NCT01691820|12367506|FG000|Overall Study|Lost to Follow-up|6
7873350|NCT01691820|12367507|FG001|Overall Study|Lost to Follow-up|17
7873351|NCT01691820|12367506|FG000|Overall Study|Other (unspecified)|4
7873352|NCT01691820|12367507|FG001|Overall Study|Other (unspecified)|1
7873353|NCT01691859|12367517|FG000|Overall Study|Adverse Event|19
7873354|NCT01691859|12367517|FG000|Overall Study|Lack of Efficacy|11
7873355|NCT01691859|12367517|FG000|Overall Study|Protocol Violation|4
7873356|NCT01691859|12367517|FG000|Overall Study|Product commercially available|221
7873357|NCT01691859|12367517|FG000|Overall Study|Study closed/terminated|50
7873358|NCT01691859|12367517|FG000|Overall Study|Lost to Follow-up|5
7873359|NCT01691859|12367517|FG000|Overall Study|Physician Decision|6
7873360|NCT01691859|12367517|FG000|Overall Study|Withdrawal by Subject|31
7873361|NCT01691885|12367521|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1
7873362|NCT01691885|12367522|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1
7873363|NCT01691885|12367521|FG000|Washout Period (7-9 Days)|Adverse Event|0
7873364|NCT01691885|12367522|FG001|Washout Period (7-9 Days)|Adverse Event|1
7873365|NCT01691898|12367534|FG000|Overall Study|Death|34
7873366|NCT01691898|12367535|FG001|Overall Study|Death|32
7873367|NCT01691898|12367536|FG002|Overall Study|Death|6
7873368|NCT01691898|12367537|FG003|Overall Study|Death|3
7873369|NCT01691898|12367538|FG004|Overall Study|Death|8
7873370|NCT01691898|12367539|FG005|Overall Study|Death|31
7873371|NCT01691898|12367534|FG000|Overall Study|Adverse Event|0
7794355|NCT01053988|12250024|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
7794356|NCT01053988|12250019|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7794357|NCT01053988|12250020|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4
7794358|NCT01053988|12250021|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7794359|NCT01053988|12250022|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2
7794360|NCT01053988|12250023|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1
7794361|NCT01053988|12250024|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3
7794362|NCT01053988|12250019|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
7794363|NCT01053988|12250020|FG001|24-week, Double-blind Treatment Period|Physician Decision|5
7794364|NCT01053988|12250021|FG002|24-week, Double-blind Treatment Period|Physician Decision|2
7794365|NCT01053988|12250022|FG003|24-week, Double-blind Treatment Period|Physician Decision|5
7794366|NCT01053988|12250023|FG004|24-week, Double-blind Treatment Period|Physician Decision|5
7794367|NCT01053988|12250024|FG005|24-week, Double-blind Treatment Period|Physician Decision|4
7794368|NCT01053988|12250019|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
7794369|NCT01053988|12250020|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
7794370|NCT01053988|12250021|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
7794371|NCT01053988|12250022|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
7794372|NCT01053988|12250023|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
7794373|NCT01053988|12250024|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
7794374|NCT01054144|12250040|FG000|Overall Study|Death|2
7794375|NCT01054170|12250049|FG000|Overall Study|Protocol Violation|1
7794376|NCT01054170|12250050|FG001|Overall Study|Protocol Violation|0
7794377|NCT01054170|12250049|FG000|Overall Study|Withdrawal by Subject|3
7794378|NCT01054170|12250050|FG001|Overall Study|Withdrawal by Subject|2
7794379|NCT01054170|12250049|FG000|Overall Study|Adverse Event|0
7794380|NCT01054170|12250050|FG001|Overall Study|Adverse Event|4
7794381|NCT01054222|12250074|FG000|Overall Study|Lack of Efficacy|1
7794382|NCT01054222|12250074|FG000|Overall Study|Lost to Follow-up|4
7794383|NCT01054222|12250074|FG000|Overall Study|Withdrawal by Subject|6
7794384|NCT01054300|12250080|FG000|Period 1|Adverse Event|1
7794385|NCT01054300|12250081|FG001|Period 1|Adverse Event|0
7794386|NCT01054300|12250082|FG002|Period 1|Adverse Event|0
7794387|NCT01054300|12250083|FG003|Period 1|Adverse Event|0
7794388|NCT01054300|12250080|FG000|Period 2|Withdrawal by Subject|0
7794389|NCT01054300|12250081|FG001|Period 2|Withdrawal by Subject|0
7794390|NCT01054300|12250082|FG002|Period 2|Withdrawal by Subject|1
7794391|NCT01054300|12250083|FG003|Period 2|Withdrawal by Subject|0
7794392|NCT01054443|12250121|FG000|Overall Study|Withdrawal by Subject|0
7794393|NCT01054443|12250122|FG001|Overall Study|Withdrawal by Subject|0
7794394|NCT01054443|12250123|FG002|Overall Study|Withdrawal by Subject|0
7794395|NCT01054443|12250124|FG003|Overall Study|Withdrawal by Subject|1
7794396|NCT01054456|12250137|FG000|Overall Study|Other|1
7794397|NCT01054560|12250143|FG000|Overall Study|Death|10
7794398|NCT01054560|12250144|FG001|Overall Study|Death|21
7794399|NCT01054560|12250143|FG000|Overall Study|Lost to Follow-up|2
7794400|NCT01054560|12250144|FG001|Overall Study|Lost to Follow-up|5
7794401|NCT01054560|12250143|FG000|Overall Study|Withdrawal by Subject|0
7794402|NCT01054560|12250144|FG001|Overall Study|Withdrawal by Subject|2
7794403|NCT01054560|12250143|FG000|Overall Study|Physician Decision|1
7794404|NCT01054560|12250144|FG001|Overall Study|Physician Decision|0
7794405|NCT01054573|12250156|FG000|Overall Study|Adverse Event|1
7794406|NCT01054573|12250157|FG001|Overall Study|Adverse Event|0
7794407|NCT01054573|12250158|FG002|Overall Study|Adverse Event|1
7794408|NCT01054573|12250159|FG003|Overall Study|Adverse Event|1
7794409|NCT01054573|12250156|FG000|Overall Study|Lost to Follow-up|0
7794410|NCT01054573|12250157|FG001|Overall Study|Lost to Follow-up|2
7794411|NCT01054573|12250158|FG002|Overall Study|Lost to Follow-up|0
7794412|NCT01054573|12250159|FG003|Overall Study|Lost to Follow-up|0
7794413|NCT01054573|12250156|FG000|Overall Study|Withdrawal by Subject|0
7794414|NCT01054573|12250157|FG001|Overall Study|Withdrawal by Subject|2
7794415|NCT01054573|12250158|FG002|Overall Study|Withdrawal by Subject|2
7794416|NCT01054573|12250159|FG003|Overall Study|Withdrawal by Subject|1
7794417|NCT01054599|12250207|FG000|Overall Study|Dizziness due to phenytoin toxicity|1
7794418|NCT01054599|12250208|FG001|Overall Study|Dizziness due to phenytoin toxicity|0
7794419|NCT01054599|12250207|FG000|Overall Study|Protocol Violation|1
7794420|NCT01054599|12250208|FG001|Overall Study|Protocol Violation|0
7794421|NCT01054599|12250207|FG000|Overall Study|Spells/seizure-like episodes|1
7873372|NCT01691898|12367535|FG001|Overall Study|Adverse Event|1
7873373|NCT01691898|12367536|FG002|Overall Study|Adverse Event|0
7794422|NCT01054599|12250208|FG001|Overall Study|Spells/seizure-like episodes|1
7794423|NCT01054599|12250207|FG000|Overall Study|Timing/scheduling difficulties|1
7794424|NCT01054599|12250208|FG001|Overall Study|Timing/scheduling difficulties|1
7794425|NCT01054599|12250207|FG000|Overall Study|Visual impairment, WTAR <80|0
7794426|NCT01054599|12250208|FG001|Overall Study|Visual impairment, WTAR <80|1
7794427|NCT01054599|12250207|FG000|Overall Study|Lost to Follow-up|0
7794428|NCT01054599|12250208|FG001|Overall Study|Lost to Follow-up|2
7794429|NCT01054599|12250207|FG000|Overall Study|Adverse Event|0
7794430|NCT01054599|12250208|FG001|Overall Study|Adverse Event|1
7794431|NCT01054599|12250207|FG000|Overall Study|Withdrawal by Subject|0
7794432|NCT01054599|12250208|FG001|Overall Study|Withdrawal by Subject|1
7800969|NCT01098240|12258514|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0
7800970|NCT01098240|12258512|FG000|Double-Blind Phase|Insufficient Clinical Response|0
7800971|NCT01098240|12258513|FG001|Double-Blind Phase|Insufficient Clinical Response|1
7800972|NCT01098240|12258514|FG002|Double-Blind Phase|Insufficient Clinical Response|2
7800973|NCT01098240|12258512|FG000|Double-Blind Phase|Withdrawal by Subject|0
7800974|NCT01098240|12258513|FG001|Double-Blind Phase|Withdrawal by Subject|1
7800975|NCT01098240|12258514|FG002|Double-Blind Phase|Withdrawal by Subject|3
7800976|NCT01098240|12258512|FG000|Double-Blind Phase|Adverse Event|0
7800977|NCT01098240|12258513|FG001|Double-Blind Phase|Adverse Event|3
7800978|NCT01098240|12258514|FG002|Double-Blind Phase|Adverse Event|3
7800979|NCT01098266|12258532|FG000|Overall Study|Physician Decision|1
7800980|NCT01098266|12258533|FG001|Overall Study|Physician Decision|0
7800981|NCT01098266|12258532|FG000|Overall Study|Death|3
7800982|NCT01098266|12258533|FG001|Overall Study|Death|2
7800983|NCT01098266|12258532|FG000|Overall Study|Withdrawal by Subject|3
7800984|NCT01098266|12258533|FG001|Overall Study|Withdrawal by Subject|5
7800985|NCT01098305|12258541|FG000|Overall Study|Lost to Follow-up|31
7800986|NCT01098305|12258542|FG001|Overall Study|Lost to Follow-up|33
7873374|NCT01691898|12367537|FG003|Overall Study|Adverse Event|1
7873375|NCT01691898|12367538|FG004|Overall Study|Adverse Event|1
7873376|NCT01691898|12367539|FG005|Overall Study|Adverse Event|0
7873377|NCT01691898|12367534|FG000|Overall Study|Progression of Disease|1
7873378|NCT01691898|12367535|FG001|Overall Study|Progression of Disease|2
7873379|NCT01691898|12367536|FG002|Overall Study|Progression of Disease|1
7873380|NCT01691898|12367537|FG003|Overall Study|Progression of Disease|0
7873381|NCT01691898|12367538|FG004|Overall Study|Progression of Disease|0
7873382|NCT01691898|12367539|FG005|Overall Study|Progression of Disease|1
7873383|NCT01691898|12367534|FG000|Overall Study|Lost to Follow-up|3
7873384|NCT01691898|12367535|FG001|Overall Study|Lost to Follow-up|1
7873385|NCT01691898|12367536|FG002|Overall Study|Lost to Follow-up|0
7873386|NCT01691898|12367537|FG003|Overall Study|Lost to Follow-up|0
7873387|NCT01691898|12367538|FG004|Overall Study|Lost to Follow-up|1
7873388|NCT01691898|12367539|FG005|Overall Study|Lost to Follow-up|0
7873389|NCT01691898|12367534|FG000|Overall Study|Withdrawal by Subject|9
7873390|NCT01691898|12367535|FG001|Overall Study|Withdrawal by Subject|8
7873391|NCT01691898|12367536|FG002|Overall Study|Withdrawal by Subject|2
7873392|NCT01691898|12367537|FG003|Overall Study|Withdrawal by Subject|1
7873393|NCT01691898|12367538|FG004|Overall Study|Withdrawal by Subject|3
7873394|NCT01691898|12367539|FG005|Overall Study|Withdrawal by Subject|3
7873395|NCT01691898|12367534|FG000|Overall Study|Non-Compliance|0
7873396|NCT01691898|12367535|FG001|Overall Study|Non-Compliance|0
7873397|NCT01691898|12367536|FG002|Overall Study|Non-Compliance|0
7873398|NCT01691898|12367537|FG003|Overall Study|Non-Compliance|0
7873399|NCT01691898|12367538|FG004|Overall Study|Non-Compliance|1
7873400|NCT01691898|12367539|FG005|Overall Study|Non-Compliance|0
7873401|NCT01692119|12367582|FG000|Overall Study|Protocol Violation|3
7873402|NCT01692119|12367583|FG001|Overall Study|Protocol Violation|1
7873403|NCT01692119|12367582|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17
7873404|NCT01692119|12367583|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0
7873405|NCT01692197|12367589|FG000|Overall Study|Failed Screening|3
7873406|NCT01692275|12367600|FG000|Overall Study|Lost to Follow-up|57
7873407|NCT01692275|12367601|FG001|Overall Study|Lost to Follow-up|48
7873408|NCT01692275|12367600|FG000|Overall Study|Withdrawal by Subject|9
7873409|NCT01692275|12367601|FG001|Overall Study|Withdrawal by Subject|11
7873410|NCT01692301|12367621|FG000|Overall Study|Adverse Event|15
7873411|NCT01692301|12367622|FG001|Overall Study|Adverse Event|12
7873412|NCT01692301|12367621|FG000|Overall Study|Death|1
7873413|NCT01692301|12367622|FG001|Overall Study|Death|2
7873414|NCT01692301|12367621|FG000|Overall Study|Lack of Efficacy|0
7873415|NCT01692301|12367622|FG001|Overall Study|Lack of Efficacy|5
7873416|NCT01692301|12367621|FG000|Overall Study|Non-compliance with study treatment|1
7873417|NCT01692301|12367622|FG001|Overall Study|Non-compliance with study treatment|2
7873418|NCT01692301|12367621|FG000|Overall Study|Protocol deviation|9
7873419|NCT01692301|12367622|FG001|Overall Study|Protocol deviation|2
7873420|NCT01692301|12367621|FG000|Overall Study|Patient/guardian decision|16
7873421|NCT01692301|12367622|FG001|Overall Study|Patient/guardian decision|15
7873422|NCT01692301|12367621|FG000|Overall Study|Technical problems|0
7873423|NCT01692301|12367622|FG001|Overall Study|Technical problems|1
7873424|NCT01692301|12367621|FG000|Overall Study|Physician Decision|2
7873425|NCT01692301|12367622|FG001|Overall Study|Physician Decision|2
7873426|NCT01692301|12367621|FG000|Overall Study|Lost to Follow-up|1
7873427|NCT01692301|12367622|FG001|Overall Study|Lost to Follow-up|1
7873428|NCT01692626|12367646|FG000|Overall Study|Death|0
7794433|NCT01054729|12250235|FG000|Overall Study|Randomized but Not Treated|0
7794434|NCT01054729|12250236|FG001|Overall Study|Randomized but Not Treated|1
7794435|NCT01054729|12250237|FG002|Overall Study|Randomized but Not Treated|0
7794436|NCT01054729|12250238|FG003|Overall Study|Randomized but Not Treated|0
7794437|NCT01054729|12250235|FG000|Overall Study|Adverse Event|1
7794438|NCT01054729|12250236|FG001|Overall Study|Adverse Event|1
7794439|NCT01054729|12250237|FG002|Overall Study|Adverse Event|2
7794440|NCT01054729|12250238|FG003|Overall Study|Adverse Event|1
7794441|NCT01054729|12250235|FG000|Overall Study|Withdrawal by Subject|1
7794442|NCT01054729|12250236|FG001|Overall Study|Withdrawal by Subject|0
7873429|NCT01692626|12367647|FG001|Overall Study|Death|1
7794443|NCT01054729|12250237|FG002|Overall Study|Withdrawal by Subject|1
7794444|NCT01054729|12250238|FG003|Overall Study|Withdrawal by Subject|0
7794445|NCT01054729|12250235|FG000|Overall Study|Lost to Follow-up|0
7794446|NCT01054729|12250236|FG001|Overall Study|Lost to Follow-up|1
7794447|NCT01054729|12250237|FG002|Overall Study|Lost to Follow-up|0
7794448|NCT01054729|12250238|FG003|Overall Study|Lost to Follow-up|0
7794449|NCT01054729|12250235|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0
7794450|NCT01054729|12250236|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1
7794451|NCT01054729|12250237|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0
7794452|NCT01054729|12250238|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0
7794453|NCT01054729|12250235|FG000|Overall Study|Non-responder|1
7794454|NCT01054729|12250236|FG001|Overall Study|Non-responder|0
7794455|NCT01054729|12250237|FG002|Overall Study|Non-responder|1
7794456|NCT01054729|12250238|FG003|Overall Study|Non-responder|1
7794457|NCT01054729|12250235|FG000|Overall Study|PEG/RBV Non-responder|1
7794458|NCT01054729|12250236|FG001|Overall Study|PEG/RBV Non-responder|0
7794459|NCT01054729|12250237|FG002|Overall Study|PEG/RBV Non-responder|1
7794460|NCT01054729|12250238|FG003|Overall Study|PEG/RBV Non-responder|0
7794461|NCT01054729|12250235|FG000|Overall Study|Personal/Obligations|0
7794462|NCT01054729|12250236|FG001|Overall Study|Personal/Obligations|1
7794463|NCT01054729|12250237|FG002|Overall Study|Personal/Obligations|0
7794464|NCT01054729|12250238|FG003|Overall Study|Personal/Obligations|0
7794465|NCT01054729|12250235|FG000|Overall Study|Subject moved|0
7794466|NCT01054729|12250236|FG001|Overall Study|Subject moved|0
7794467|NCT01054729|12250237|FG002|Overall Study|Subject moved|1
7794468|NCT01054729|12250238|FG003|Overall Study|Subject moved|0
7794469|NCT01054729|12250235|FG000|Overall Study|Lack of Efficacy|0
7794470|NCT01054729|12250236|FG001|Overall Study|Lack of Efficacy|0
7794471|NCT01054729|12250237|FG002|Overall Study|Lack of Efficacy|0
7794472|NCT01054729|12250238|FG003|Overall Study|Lack of Efficacy|1
7794473|NCT01054820|12250261|FG000|Overall Study|Withdrawal by Subject|2
7794474|NCT01054846|12250267|FG000|Overall Study|Lost to Follow-up|76
7794475|NCT01054846|12250268|FG001|Overall Study|Lost to Follow-up|17
7794476|NCT01054885|12250279|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
7794477|NCT01054885|12250280|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7794478|NCT01054885|12250281|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7794479|NCT01054885|12250282|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7794480|NCT01054885|12250283|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7794481|NCT01054885|12250284|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7794482|NCT01054885|12250285|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7794483|NCT01054885|12250279|FG000|2-week, Single-blind Run-In Period|Physician Decision|6
7794484|NCT01054885|12250280|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
7794485|NCT01054885|12250281|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
7794486|NCT01054885|12250282|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
7794487|NCT01054885|12250283|FG004|2-week, Single-blind Run-In Period|Physician Decision|0
7794488|NCT01054885|12250284|FG005|2-week, Single-blind Run-In Period|Physician Decision|0
7794489|NCT01054885|12250285|FG006|2-week, Single-blind Run-In Period|Physician Decision|0
7794490|NCT01054885|12250279|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
7794491|NCT01054885|12250280|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7794492|NCT01054885|12250281|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7794493|NCT01054885|12250282|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7794494|NCT01054885|12250283|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7794495|NCT01054885|12250284|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7794496|NCT01054885|12250285|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7794497|NCT01054885|12250279|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1
7794498|NCT01054885|12250280|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7794499|NCT01054885|12250281|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7794500|NCT01054885|12250282|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7794501|NCT01054885|12250283|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7794502|NCT01054885|12250284|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7794503|NCT01054885|12250285|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7794504|NCT01054885|12250279|FG000|2-week, Single-blind Run-In Period|Adverse Event|7
7794505|NCT01054885|12250280|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
7794506|NCT01054885|12250281|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
7794507|NCT01054885|12250282|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
7794508|NCT01054885|12250283|FG004|2-week, Single-blind Run-In Period|Adverse Event|0
7794509|NCT01054885|12250284|FG005|2-week, Single-blind Run-In Period|Adverse Event|0
7794510|NCT01054885|12250285|FG006|2-week, Single-blind Run-In Period|Adverse Event|0
7794511|NCT01054885|12250279|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
7794512|NCT01054885|12250280|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7794513|NCT01054885|12250281|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7794514|NCT01054885|12250282|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7794515|NCT01054885|12250283|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7794516|NCT01054885|12250284|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7794517|NCT01054885|12250285|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7794518|NCT01054885|12250279|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
7794519|NCT01054885|12250280|FG001|24-week, Double-blind Treatment Period|Adverse Event|18
7794520|NCT01054885|12250281|FG002|24-week, Double-blind Treatment Period|Adverse Event|12
7794521|NCT01054885|12250282|FG003|24-week, Double-blind Treatment Period|Adverse Event|15
7794522|NCT01054885|12250283|FG004|24-week, Double-blind Treatment Period|Adverse Event|15
7794523|NCT01054885|12250284|FG005|24-week, Double-blind Treatment Period|Adverse Event|17
7794524|NCT01054885|12250285|FG006|24-week, Double-blind Treatment Period|Adverse Event|19
7794525|NCT01054885|12250279|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7794526|NCT01054885|12250280|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7794527|NCT01054885|12250281|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
7794528|NCT01054885|12250282|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
7794529|NCT01054885|12250283|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7794530|NCT01054885|12250284|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
7794531|NCT01054885|12250285|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7794532|NCT01054885|12250279|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
7794533|NCT01054885|12250280|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
7794534|NCT01054885|12250281|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
7794535|NCT01054885|12250282|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
7794536|NCT01054885|12250283|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
7794537|NCT01054885|12250284|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
7794538|NCT01054885|12250285|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
7794539|NCT01054885|12250279|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
7794540|NCT01054885|12250280|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7
7794541|NCT01054885|12250281|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7
7794542|NCT01054885|12250282|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
7794543|NCT01054885|12250283|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3
7794544|NCT01054885|12250284|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8
7794545|NCT01054885|12250285|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4
7794546|NCT01054885|12250279|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
7794547|NCT01054885|12250280|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
7794548|NCT01054885|12250281|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
7794549|NCT01054885|12250282|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
7794550|NCT01054885|12250283|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
7794551|NCT01054885|12250284|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
7794552|NCT01054885|12250285|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
7794553|NCT01054885|12250279|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
7794554|NCT01054885|12250280|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
7794555|NCT01054885|12250281|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
7794556|NCT01054885|12250282|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
7794557|NCT01054885|12250283|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
7794558|NCT01054885|12250284|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
7794559|NCT01054885|12250285|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
7794560|NCT01054885|12250279|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7794561|NCT01054885|12250280|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3
7794562|NCT01054885|12250281|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2
7794563|NCT01054885|12250282|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7794564|NCT01054885|12250283|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7794565|NCT01054885|12250284|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2
7794566|NCT01054885|12250285|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1
7794567|NCT01054885|12250279|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
7794568|NCT01054885|12250280|FG001|24-week, Double-blind Treatment Period|Physician Decision|4
7794569|NCT01054885|12250281|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
7794570|NCT01054885|12250282|FG003|24-week, Double-blind Treatment Period|Physician Decision|6
7794571|NCT01054885|12250283|FG004|24-week, Double-blind Treatment Period|Physician Decision|3
7794572|NCT01054885|12250284|FG005|24-week, Double-blind Treatment Period|Physician Decision|1
7794573|NCT01054885|12250285|FG006|24-week, Double-blind Treatment Period|Physician Decision|1
7794574|NCT01054885|12250279|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
7794575|NCT01054885|12250280|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
7794576|NCT01054885|12250281|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
7794577|NCT01054885|12250282|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
7794578|NCT01054885|12250283|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
7794579|NCT01054885|12250284|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
7794580|NCT01054885|12250285|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
7794581|NCT01054976|12250306|FG000|Overall Study|Adverse Event|16
7794582|NCT01054976|12250306|FG000|Overall Study|Uncooperative participations to study|7
7794583|NCT01054976|12250306|FG000|Overall Study|Withdrawal by Subject|4
7794584|NCT01054976|12250306|FG000|Overall Study|Other|8
7794585|NCT01055028|12250312|FG000|Screening|Screen Failure|1
7794586|NCT01055028|12250313|FG001|Screening|Screen Failure|1
7794587|NCT01055028|12250312|FG000|Treatment Cycles 1 to 3|Adverse Event|0
7794588|NCT01055028|12250313|FG001|Treatment Cycles 1 to 3|Adverse Event|1
7794589|NCT01055028|12250312|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
7794590|NCT01055028|12250313|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
7794591|NCT01055028|12250312|FG000|Inter-treatment Period|Did not start Cycle 4|0
7794592|NCT01055028|12250313|FG001|Inter-treatment Period|Did not start Cycle 4|3
7794593|NCT01055132|12250329|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
7794594|NCT01055132|12250330|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
7794595|NCT01055132|12250329|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
7794596|NCT01055132|12250330|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
7794597|NCT01055197|12250355|FG000|Overall Study|Protocol Violation|7
7794598|NCT01055197|12250356|FG001|Overall Study|Protocol Violation|2
7794599|NCT01055197|12250355|FG000|Overall Study|Withdrawal by Subject|2
7794600|NCT01055197|12250356|FG001|Overall Study|Withdrawal by Subject|0
7794601|NCT01055262|12250375|FG000|Overall Study|Adverse Event|5
7794602|NCT01055262|12250375|FG000|Overall Study|Protocol Violation|3
7794603|NCT01055262|12250375|FG000|Overall Study|Uncooperativeness|1
7794604|NCT01055314|12250381|FG000|Overall Study|Adverse Event|7
7794605|NCT01055314|12250382|FG001|Overall Study|Adverse Event|4
7794606|NCT01055314|12250381|FG000|Overall Study|Death|2
7794607|NCT01055314|12250382|FG001|Overall Study|Death|1
7794608|NCT01055314|12250381|FG000|Overall Study|Lack of Efficacy|11
7794609|NCT01055314|12250382|FG001|Overall Study|Lack of Efficacy|19
7794610|NCT01055314|12250381|FG000|Overall Study|Physician Decision|10
7794611|NCT01055314|12250382|FG001|Overall Study|Physician Decision|5
7794612|NCT01055314|12250381|FG000|Overall Study|Withdrawal by Subject|1
7794613|NCT01055314|12250382|FG001|Overall Study|Withdrawal by Subject|0
7794614|NCT01055314|12250381|FG000|Overall Study|Ineligible|3
7794615|NCT01055314|12250382|FG001|Overall Study|Ineligible|5
7794616|NCT01055314|12250381|FG000|Overall Study|Refusal of further protocol therapy|10
7794617|NCT01055314|12250382|FG001|Overall Study|Refusal of further protocol therapy|4
7794618|NCT01055314|12250381|FG000|Overall Study|No treatment|1
7794619|NCT01055314|12250382|FG001|Overall Study|No treatment|0
7794620|NCT01055457|12250399|FG000|Overall Study|Lost to Follow-up|0
7794621|NCT01055457|12250400|FG001|Overall Study|Lost to Follow-up|1
7794622|NCT01055457|12250401|FG002|Overall Study|Lost to Follow-up|0
7794623|NCT01055457|12250402|FG003|Overall Study|Lost to Follow-up|0
7794624|NCT01055457|12250403|FG004|Overall Study|Lost to Follow-up|0
7794625|NCT01055457|12250404|FG005|Overall Study|Lost to Follow-up|1
7794626|NCT01055457|12250405|FG006|Overall Study|Lost to Follow-up|0
7794627|NCT01055457|12250406|FG007|Overall Study|Lost to Follow-up|0
7794628|NCT01055457|12250407|FG008|Overall Study|Lost to Follow-up|0
7794629|NCT01055457|12250408|FG009|Overall Study|Lost to Follow-up|0
7794630|NCT01055457|12250399|FG000|Overall Study|Protocol Violation|0
7794631|NCT01055457|12250400|FG001|Overall Study|Protocol Violation|0
7794632|NCT01055457|12250401|FG002|Overall Study|Protocol Violation|1
7794633|NCT01055457|12250402|FG003|Overall Study|Protocol Violation|1
7794634|NCT01055457|12250403|FG004|Overall Study|Protocol Violation|1
7794635|NCT01055457|12250404|FG005|Overall Study|Protocol Violation|2
7794636|NCT01055457|12250405|FG006|Overall Study|Protocol Violation|1
7794637|NCT01055457|12250406|FG007|Overall Study|Protocol Violation|0
7794638|NCT01055457|12250407|FG008|Overall Study|Protocol Violation|0
7794639|NCT01055457|12250408|FG009|Overall Study|Protocol Violation|1
7794640|NCT01055457|12250399|FG000|Overall Study|Subject Disinterest|0
7794641|NCT01055457|12250400|FG001|Overall Study|Subject Disinterest|0
7794642|NCT01055457|12250401|FG002|Overall Study|Subject Disinterest|0
7794643|NCT01055457|12250402|FG003|Overall Study|Subject Disinterest|0
7794644|NCT01055457|12250403|FG004|Overall Study|Subject Disinterest|0
7794645|NCT01055457|12250404|FG005|Overall Study|Subject Disinterest|0
7794646|NCT01055457|12250405|FG006|Overall Study|Subject Disinterest|0
7794647|NCT01055457|12250406|FG007|Overall Study|Subject Disinterest|1
7794648|NCT01055457|12250407|FG008|Overall Study|Subject Disinterest|0
7794649|NCT01055457|12250408|FG009|Overall Study|Subject Disinterest|0
7794650|NCT01055457|12250399|FG000|Overall Study|Subject Ineligible|1
7794651|NCT01055457|12250400|FG001|Overall Study|Subject Ineligible|0
7794652|NCT01055457|12250401|FG002|Overall Study|Subject Ineligible|1
7794653|NCT01055457|12250402|FG003|Overall Study|Subject Ineligible|0
7794654|NCT01055457|12250403|FG004|Overall Study|Subject Ineligible|1
7794655|NCT01055457|12250404|FG005|Overall Study|Subject Ineligible|0
7794656|NCT01055457|12250405|FG006|Overall Study|Subject Ineligible|0
7794657|NCT01055457|12250406|FG007|Overall Study|Subject Ineligible|0
7794658|NCT01055457|12250407|FG008|Overall Study|Subject Ineligible|0
7794659|NCT01055457|12250408|FG009|Overall Study|Subject Ineligible|0
7794660|NCT01055457|12250399|FG000|Overall Study|Discomfort|0
7794661|NCT01055457|12250400|FG001|Overall Study|Discomfort|0
7794662|NCT01055457|12250401|FG002|Overall Study|Discomfort|0
7794663|NCT01055457|12250402|FG003|Overall Study|Discomfort|0
7794664|NCT01055457|12250403|FG004|Overall Study|Discomfort|1
7794665|NCT01055457|12250404|FG005|Overall Study|Discomfort|0
7794666|NCT01055457|12250405|FG006|Overall Study|Discomfort|0
7794667|NCT01055457|12250406|FG007|Overall Study|Discomfort|0
7794668|NCT01055457|12250407|FG008|Overall Study|Discomfort|0
7794669|NCT01055457|12250408|FG009|Overall Study|Discomfort|0
7794670|NCT01055457|12250399|FG000|Overall Study|Pregnancy|0
7794671|NCT01055457|12250400|FG001|Overall Study|Pregnancy|0
7794672|NCT01055457|12250401|FG002|Overall Study|Pregnancy|0
7794673|NCT01055457|12250402|FG003|Overall Study|Pregnancy|1
7794674|NCT01055457|12250403|FG004|Overall Study|Pregnancy|0
7794675|NCT01055457|12250404|FG005|Overall Study|Pregnancy|0
7794676|NCT01055457|12250405|FG006|Overall Study|Pregnancy|0
7794677|NCT01055457|12250406|FG007|Overall Study|Pregnancy|0
7794678|NCT01055457|12250407|FG008|Overall Study|Pregnancy|0
7794679|NCT01055457|12250408|FG009|Overall Study|Pregnancy|0
7794680|NCT01055457|12250399|FG000|Overall Study|Adverse Event|0
7794681|NCT01055457|12250400|FG001|Overall Study|Adverse Event|0
7794682|NCT01055457|12250401|FG002|Overall Study|Adverse Event|0
7794683|NCT01055457|12250402|FG003|Overall Study|Adverse Event|1
7794684|NCT01055457|12250403|FG004|Overall Study|Adverse Event|0
7794685|NCT01055457|12250404|FG005|Overall Study|Adverse Event|0
7794686|NCT01055457|12250405|FG006|Overall Study|Adverse Event|0
7794687|NCT01055457|12250406|FG007|Overall Study|Adverse Event|0
7794688|NCT01055457|12250407|FG008|Overall Study|Adverse Event|0
7794689|NCT01055457|12250408|FG009|Overall Study|Adverse Event|0
7794690|NCT01055496|12250432|FG000|Overall Study|Withdrawal by Subject|2
7794691|NCT01055496|12250433|FG001|Overall Study|Withdrawal by Subject|4
7794692|NCT01055496|12250432|FG000|Overall Study|Death|13
7794693|NCT01055496|12250433|FG001|Overall Study|Death|23
7794694|NCT01055496|12250432|FG000|Overall Study|Lost to Follow-up|0
7794695|NCT01055496|12250433|FG001|Overall Study|Lost to Follow-up|2
7794696|NCT01055496|12250432|FG000|Overall Study|Other - Unspecified|0
7794697|NCT01055496|12250433|FG001|Overall Study|Other - Unspecified|1
7794698|NCT01055613|12250462|FG000|Overall Study|No Longer Meets Eligibility Criteria|3
7794699|NCT01055613|12250463|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7794700|NCT01055613|12250462|FG000|Overall Study|Unacceptable lens fit|1
7794701|NCT01055613|12250463|FG001|Overall Study|Unacceptable lens fit|0
7794702|NCT01055613|12250462|FG000|Overall Study|Discomfort|2
7794703|NCT01055613|12250463|FG001|Overall Study|Discomfort|1
7794704|NCT01055613|12250462|FG000|Overall Study|Lost to Follow-up|1
7794705|NCT01055613|12250463|FG001|Overall Study|Lost to Follow-up|1
7794706|NCT01055613|12250462|FG000|Overall Study|Protocol Violation|1
7794707|NCT01055613|12250463|FG001|Overall Study|Protocol Violation|1
7794708|NCT01055613|12250462|FG000|Overall Study|Subject Disinterest|1
7794709|NCT01055613|12250463|FG001|Overall Study|Subject Disinterest|1
7794710|NCT01055639|12250471|FG000|Overall Study|Adverse Event|0
7794711|NCT01055639|12250472|FG001|Overall Study|Adverse Event|1
7794712|NCT01055639|12250471|FG000|Overall Study|Lack of Efficacy|0
7794713|NCT01055639|12250472|FG001|Overall Study|Lack of Efficacy|1
7794714|NCT01055639|12250471|FG000|Overall Study|Lost to Follow-up|8
7794715|NCT01055639|12250472|FG001|Overall Study|Lost to Follow-up|11
7794716|NCT01055639|12250471|FG000|Overall Study|Protocol Violation|5
7794717|NCT01055639|12250472|FG001|Overall Study|Protocol Violation|5
7794718|NCT01055639|12250471|FG000|Overall Study|Withdrawal by Subject|8
7794719|NCT01055639|12250472|FG001|Overall Study|Withdrawal by Subject|11
7794720|NCT01055834|12250516|FG000|Treatment Period I|Adverse Event|1
7794721|NCT01055834|12250517|FG001|Treatment Period I|Adverse Event|0
7794722|NCT01055886|12250528|FG000|Overall Study|Withdrawal by Subject|4
7794723|NCT01055886|12250529|FG001|Overall Study|Withdrawal by Subject|9
7794724|NCT01055886|12250528|FG000|Overall Study|Lost to Follow-up|1
7794725|NCT01055886|12250529|FG001|Overall Study|Lost to Follow-up|1
7794726|NCT01055886|12250528|FG000|Overall Study|Withdrawal by PI|0
7794727|NCT01055886|12250529|FG001|Overall Study|Withdrawal by PI|1
7794728|NCT01056107|12250548|FG000|Overall Study|Withdrawal by Subject|0
7794729|NCT01056107|12250549|FG001|Overall Study|Withdrawal by Subject|1
7794730|NCT01056107|12250550|FG002|Overall Study|Withdrawal by Subject|3
7794731|NCT01056107|12250551|FG003|Overall Study|Withdrawal by Subject|0
7794732|NCT01056263|12250572|FG000|Overall Study|Adverse Event|12
7794733|NCT01056263|12250572|FG000|Overall Study|Death|1
7794734|NCT01056263|12250572|FG000|Overall Study|Withdrawal by Subject|1
7794735|NCT01056263|12250572|FG000|Overall Study|Lack of Efficacy|29
7794736|NCT01056263|12250572|FG000|Overall Study|Progressive disease|2
7794737|NCT01056263|12250572|FG000|Overall Study|Neoplasm progression|1
7794738|NCT01056263|12250572|FG000|Overall Study|Objective progression or relapse|1
7794739|NCT01056263|12250572|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
7794740|NCT01056276|12250578|FG000|Treatment Period-Cycles 1-8|Toxicity|2
7794741|NCT01056276|12250579|FG001|Treatment Period-Cycles 1-8|Toxicity|1
7794742|NCT01056276|12250578|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
7794743|NCT01056276|12250579|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
7794744|NCT01056276|12250578|FG000|Treatment Period-Cycles 1-8|Disease Progression|2
7794745|NCT01056276|12250579|FG001|Treatment Period-Cycles 1-8|Disease Progression|2
7794746|NCT01056276|12250578|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1
7794747|NCT01056276|12250579|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2
7794748|NCT01056276|12250578|FG000|Treatment Period-Cycles 1-8|Physician Decision|3
7794749|NCT01056276|12250579|FG001|Treatment Period-Cycles 1-8|Physician Decision|0
7794750|NCT01056276|12250578|FG000|Treatment Period-Cycles 1-8|Death|3
7794751|NCT01056276|12250579|FG001|Treatment Period-Cycles 1-8|Death|1
7794752|NCT01056276|12250578|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1
7794753|NCT01056276|12250579|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0
7794754|NCT01056276|12250578|FG000|Maintenance Therapy|Toxicity|0
7794755|NCT01056276|12250579|FG001|Maintenance Therapy|Toxicity|2
7794756|NCT01056276|12250578|FG000|Maintenance Therapy|Progressive Disease|0
7794757|NCT01056276|12250579|FG001|Maintenance Therapy|Progressive Disease|9
7794758|NCT01056276|12250578|FG000|Maintenance Therapy|Physician Decision|0
7794759|NCT01056276|12250579|FG001|Maintenance Therapy|Physician Decision|1
7794760|NCT01056276|12250578|FG000|Maintenance Therapy|Withdrawal by Subject|0
7794761|NCT01056276|12250579|FG001|Maintenance Therapy|Withdrawal by Subject|1
7794762|NCT01056276|12250578|FG000|Maintenance Therapy|Intercurrent Illness|0
7794763|NCT01056276|12250579|FG001|Maintenance Therapy|Intercurrent Illness|1
7794764|NCT01056276|12250578|FG000|Maintenance Therapy|Continuing maintenance therapy|0
7794765|NCT01056276|12250579|FG001|Maintenance Therapy|Continuing maintenance therapy|14
7794766|NCT01056289|12250590|FG000|Open-label Phase|Adverse Event|29
7794767|NCT01056289|12250591|FG001|Open-label Phase|Adverse Event|0
7794768|NCT01056289|12250592|FG002|Open-label Phase|Adverse Event|0
7794769|NCT01056289|12250593|FG003|Open-label Phase|Adverse Event|0
7794770|NCT01056289|12250590|FG000|Open-label Phase|Lost to Follow-up|30
7794771|NCT01056289|12250591|FG001|Open-label Phase|Lost to Follow-up|0
7794772|NCT01056289|12250592|FG002|Open-label Phase|Lost to Follow-up|0
7794773|NCT01056289|12250593|FG003|Open-label Phase|Lost to Follow-up|0
7794774|NCT01056289|12250590|FG000|Open-label Phase|Other|9
7794775|NCT01056289|12250591|FG001|Open-label Phase|Other|0
7794776|NCT01056289|12250592|FG002|Open-label Phase|Other|0
7794777|NCT01056289|12250593|FG003|Open-label Phase|Other|0
7794778|NCT01056289|12250590|FG000|Open-label Phase|Protocol Violation|6
7794779|NCT01056289|12250591|FG001|Open-label Phase|Protocol Violation|0
7794780|NCT01056289|12250592|FG002|Open-label Phase|Protocol Violation|0
7794781|NCT01056289|12250593|FG003|Open-label Phase|Protocol Violation|0
7794782|NCT01056289|12250590|FG000|Open-label Phase|Withdrawal by Subject|26
7794783|NCT01056289|12250591|FG001|Open-label Phase|Withdrawal by Subject|0
7794784|NCT01056289|12250592|FG002|Open-label Phase|Withdrawal by Subject|0
7794785|NCT01056289|12250593|FG003|Open-label Phase|Withdrawal by Subject|0
7794786|NCT01056289|12250590|FG000|Open-label Phase|Lack of Efficacy|18
7794787|NCT01056289|12250591|FG001|Open-label Phase|Lack of Efficacy|0
7794788|NCT01056289|12250592|FG002|Open-label Phase|Lack of Efficacy|0
7794789|NCT01056289|12250593|FG003|Open-label Phase|Lack of Efficacy|0
7794790|NCT01056289|12250590|FG000|Open-label Phase|Not randomized to Double-blind phase|1
7794791|NCT01056289|12250591|FG001|Open-label Phase|Not randomized to Double-blind phase|0
7794792|NCT01056289|12250592|FG002|Open-label Phase|Not randomized to Double-blind phase|0
7794793|NCT01056289|12250593|FG003|Open-label Phase|Not randomized to Double-blind phase|0
7794794|NCT01056289|12250590|FG000|Double-blind Phase|Adverse Event|0
7794795|NCT01056289|12250591|FG001|Double-blind Phase|Adverse Event|1
7794796|NCT01056289|12250592|FG002|Double-blind Phase|Adverse Event|2
7794797|NCT01056289|12250593|FG003|Double-blind Phase|Adverse Event|1
7794798|NCT01056289|12250590|FG000|Double-blind Phase|Lost to Follow-up|0
7794799|NCT01056289|12250591|FG001|Double-blind Phase|Lost to Follow-up|2
7794800|NCT01056289|12250592|FG002|Double-blind Phase|Lost to Follow-up|2
7794801|NCT01056289|12250593|FG003|Double-blind Phase|Lost to Follow-up|2
7794802|NCT01056289|12250590|FG000|Double-blind Phase|Other|0
7794803|NCT01056289|12250591|FG001|Double-blind Phase|Other|0
7794804|NCT01056289|12250592|FG002|Double-blind Phase|Other|1
7794805|NCT01056289|12250593|FG003|Double-blind Phase|Other|2
7794806|NCT01056289|12250590|FG000|Double-blind Phase|Protocol Violation|0
7794807|NCT01056289|12250591|FG001|Double-blind Phase|Protocol Violation|0
7794808|NCT01056289|12250592|FG002|Double-blind Phase|Protocol Violation|1
7794809|NCT01056289|12250593|FG003|Double-blind Phase|Protocol Violation|1
7794810|NCT01056289|12250590|FG000|Double-blind Phase|Withdrawal by Subject|0
7794811|NCT01056289|12250591|FG001|Double-blind Phase|Withdrawal by Subject|0
7794812|NCT01056289|12250592|FG002|Double-blind Phase|Withdrawal by Subject|4
7794813|NCT01056289|12250593|FG003|Double-blind Phase|Withdrawal by Subject|2
7794814|NCT01056289|12250590|FG000|Double-blind Phase|Discontinuation symptom|0
7794815|NCT01056289|12250591|FG001|Double-blind Phase|Discontinuation symptom|1
7794816|NCT01056289|12250592|FG002|Double-blind Phase|Discontinuation symptom|2
7794817|NCT01056289|12250593|FG003|Double-blind Phase|Discontinuation symptom|2
7794818|NCT01056289|12250590|FG000|Double-blind Phase|Physician Decision|0
7794819|NCT01056289|12250591|FG001|Double-blind Phase|Physician Decision|0
7794820|NCT01056289|12250592|FG002|Double-blind Phase|Physician Decision|1
7794821|NCT01056289|12250593|FG003|Double-blind Phase|Physician Decision|0
7794822|NCT01056341|12250625|FG000|Overall Study|Treatment Intolerance|0
7794823|NCT01056341|12250626|FG001|Overall Study|Treatment Intolerance|2
7794824|NCT01056341|12250627|FG002|Overall Study|Treatment Intolerance|0
7794825|NCT01056341|12250628|FG003|Overall Study|Treatment Intolerance|2
7794826|NCT01056341|12250629|FG004|Overall Study|Treatment Intolerance|0
7794827|NCT01056341|12250625|FG000|Overall Study|Lack of Efficacy|32
7794828|NCT01056341|12250626|FG001|Overall Study|Lack of Efficacy|30
7794829|NCT01056341|12250627|FG002|Overall Study|Lack of Efficacy|7
7794830|NCT01056341|12250628|FG003|Overall Study|Lack of Efficacy|25
7794831|NCT01056341|12250629|FG004|Overall Study|Lack of Efficacy|9
7794832|NCT01056341|12250625|FG000|Overall Study|Other reasons|4
7794833|NCT01056341|12250626|FG001|Overall Study|Other reasons|4
7794834|NCT01056341|12250627|FG002|Overall Study|Other reasons|8
7794835|NCT01056341|12250628|FG003|Overall Study|Other reasons|9
7794836|NCT01056341|12250629|FG004|Overall Study|Other reasons|5
7794837|NCT01056380|12250649|FG000|Overall Study|Lost to Follow-up|2
7794838|NCT01056380|12250650|FG001|Overall Study|Lost to Follow-up|3
7794839|NCT01056484|12250660|FG000|Randomized Controlled Trial|Withdrawal by Subject|6
7794840|NCT01056484|12250661|FG001|Randomized Controlled Trial|Withdrawal by Subject|1
7794841|NCT01056484|12250660|FG000|Randomized Controlled Trial|Physician Decision|1
7794842|NCT01056484|12250661|FG001|Randomized Controlled Trial|Physician Decision|0
7794843|NCT01056484|12250660|FG000|Follow up - Non-randomized|Withdrawal by Subject|0
7794844|NCT01056484|12250661|FG001|Follow up - Non-randomized|Withdrawal by Subject|2
7794845|NCT01056510|12250670|FG000|Overall Study|Dropout Before Start of Treatment|1
7794846|NCT01056510|12250671|FG001|Overall Study|Dropout Before Start of Treatment|1
7794847|NCT01056510|12250670|FG000|Overall Study|Withdrawal by Subject|4
7794848|NCT01056510|12250671|FG001|Overall Study|Withdrawal by Subject|2
7794849|NCT01056510|12250670|FG000|Overall Study|Death|29
7794850|NCT01056510|12250671|FG001|Overall Study|Death|34
7794851|NCT01056510|12250670|FG000|Overall Study|Noncompliance|1
7794852|NCT01056510|12250671|FG001|Overall Study|Noncompliance|3
7794853|NCT01056510|12250670|FG000|Overall Study|Physician Decision|4
7794854|NCT01056510|12250671|FG001|Overall Study|Physician Decision|5
7794855|NCT01056510|12250670|FG000|Overall Study|Lost to Follow-up|5
7794856|NCT01056510|12250671|FG001|Overall Study|Lost to Follow-up|6
7794857|NCT01056510|12250670|FG000|Overall Study|Other|10
7794858|NCT01056510|12250671|FG001|Overall Study|Other|12
7794859|NCT01056510|12250670|FG000|Overall Study|Missing|0
7794860|NCT01056510|12250671|FG001|Overall Study|Missing|1
7794861|NCT01056523|12250677|FG000|Overall Study|Death|1
7794862|NCT01056523|12250678|FG001|Overall Study|Death|0
7794863|NCT01056523|12250679|FG002|Overall Study|Death|2
7794864|NCT01056523|12250680|FG003|Overall Study|Death|3
7794865|NCT01056523|12250681|FG004|Overall Study|Death|0
7794866|NCT01056523|12250682|FG005|Overall Study|Death|0
7794867|NCT01056523|12250683|FG006|Overall Study|Death|1
7794868|NCT01056536|12250691|FG000|Overall Study|Lost to Follow-up|202
7794869|NCT01056536|12250692|FG001|Overall Study|Lost to Follow-up|116
7794870|NCT01056536|12250693|FG002|Overall Study|Lost to Follow-up|248
7794871|NCT01056640|12250707|FG000|Overall Study|Withdrawal by Subject|11
7794872|NCT01056640|12250708|FG001|Overall Study|Withdrawal by Subject|8
7794873|NCT01056640|12250707|FG000|Overall Study|Death|15
7794874|NCT01056640|12250708|FG001|Overall Study|Death|4
7794875|NCT01056653|12250717|FG000|Overall Study|Lost to Follow-up|0
7794876|NCT01056653|12250718|FG001|Overall Study|Lost to Follow-up|0
7794877|NCT01056653|12250719|FG002|Overall Study|Lost to Follow-up|2
7794878|NCT01056718|12250728|FG000|Overall Study|Withdrawal by Subject|2
7794879|NCT01056718|12250728|FG000|Overall Study|Ischemia on baseline stress test|1
7794880|NCT01056822|12250735|FG000|Overall Study|Adverse Event|0
7794881|NCT01056822|12250736|FG001|Overall Study|Adverse Event|1
7794882|NCT01056822|12250735|FG000|Overall Study|Protocol Violation|6
7794883|NCT01056822|12250736|FG001|Overall Study|Protocol Violation|5
7794884|NCT01056822|12250735|FG000|Overall Study|Withdrawal by Subject|1
7794885|NCT01056822|12250736|FG001|Overall Study|Withdrawal by Subject|1
7794886|NCT01056822|12250735|FG000|Overall Study|Lost to Follow-up|1
7794887|NCT01056822|12250736|FG001|Overall Study|Lost to Follow-up|0
7794888|NCT01057251|12250771|FG000|Overall Study|Did not meet InclusionExclusion criteria|4
7794889|NCT01057251|12250772|FG001|Overall Study|Did not meet InclusionExclusion criteria|2
7794890|NCT01057251|12250771|FG000|Overall Study|Adverse Event|4
7794891|NCT01057251|12250772|FG001|Overall Study|Adverse Event|2
7794892|NCT01057251|12250771|FG000|Overall Study|Lack of Efficacy|2
7794893|NCT01057251|12250772|FG001|Overall Study|Lack of Efficacy|11
7794894|NCT01057251|12250771|FG000|Overall Study|Protocol Violation|6
7794895|NCT01057251|12250772|FG001|Overall Study|Protocol Violation|2
7794896|NCT01057251|12250771|FG000|Overall Study|Withdrawal by Subject|4
7794897|NCT01057251|12250772|FG001|Overall Study|Withdrawal by Subject|5
7794898|NCT01057251|12250771|FG000|Overall Study|Lost to Follow-up|7
7794899|NCT01057251|12250772|FG001|Overall Study|Lost to Follow-up|6
7794900|NCT01057251|12250771|FG000|Overall Study|Other Reason|1
7794901|NCT01057251|12250772|FG001|Overall Study|Other Reason|1
7794902|NCT01057394|12250799|FG000|Overall Study|Not eligible|0
7794903|NCT01057394|12250800|FG001|Overall Study|Not eligible|2
7794904|NCT01057433|12250804|FG000|Overall Study|Adverse Event|1
7794905|NCT01057589|12250808|FG000|Overall Study|Disease Progression|35
7794906|NCT01057589|12250808|FG000|Overall Study|Adverse Event|10
7794907|NCT01057589|12250808|FG000|Overall Study|Physician Decision|8
7794908|NCT01057589|12250808|FG000|Overall Study|Withdrawal by Subject|3
7794909|NCT01057589|12250808|FG000|Overall Study|Sponsor Decision|1
7794910|NCT01057589|12250808|FG000|Overall Study|Death|8
7794911|NCT01057589|12250808|FG000|Overall Study|Lost to Follow-up|1
7794912|NCT01057693|12250812|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45
7794913|NCT01057693|12250813|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0
7794914|NCT01057693|12250814|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0
7794915|NCT01057693|12250812|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
7794916|NCT01057693|12250813|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
7794917|NCT01057693|12250814|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
7794918|NCT01057693|12250812|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
7794919|NCT01057693|12250813|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
7794920|NCT01057693|12250814|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
7794921|NCT01057693|12250812|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
7794922|NCT01057693|12250813|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
7794923|NCT01057693|12250814|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
7794924|NCT01057693|12250812|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
7794925|NCT01057693|12250813|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
7794926|NCT01057693|12250814|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
7794927|NCT01057693|12250812|FG000|Single-Blind Phase (Up to Week 6)|Other|2
7794928|NCT01057693|12250813|FG001|Single-Blind Phase (Up to Week 6)|Other|0
7794929|NCT01057693|12250814|FG002|Single-Blind Phase (Up to Week 6)|Other|0
7794930|NCT01057693|12250812|FG000|Between Single-Blind and Double-Blind|Adverse Event|5
7794931|NCT01057693|12250813|FG001|Between Single-Blind and Double-Blind|Adverse Event|0
7794932|NCT01057693|12250814|FG002|Between Single-Blind and Double-Blind|Adverse Event|0
7794933|NCT01057693|12250812|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247
7794934|NCT01057693|12250813|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0
7794935|NCT01057693|12250814|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0
7794936|NCT01057693|12250812|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1
7794937|NCT01057693|12250813|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0
7794938|NCT01057693|12250814|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0
7794939|NCT01057693|12250812|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7
7794940|NCT01057693|12250813|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0
7794941|NCT01057693|12250814|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0
7794942|NCT01057693|12250812|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
7794943|NCT01057693|12250813|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
7794944|NCT01057693|12250814|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
7794945|NCT01057693|12250812|FG000|Between Single-Blind and Double-Blind|Other|6
7794946|NCT01057693|12250813|FG001|Between Single-Blind and Double-Blind|Other|0
7794947|NCT01057693|12250814|FG002|Between Single-Blind and Double-Blind|Other|0
7794948|NCT01057693|12250812|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
7794949|NCT01057693|12250813|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
7794950|NCT01057693|12250814|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
7794951|NCT01057693|12250812|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
7794952|NCT01057693|12250813|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
7794953|NCT01057693|12250814|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
7794954|NCT01057693|12250812|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
7794955|NCT01057693|12250813|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
7794956|NCT01057693|12250814|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
7794957|NCT01057693|12250812|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
7794958|NCT01057693|12250813|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
7794959|NCT01057693|12250814|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
7794960|NCT01057693|12250812|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
7794961|NCT01057693|12250813|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
7794962|NCT01057693|12250814|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
7794963|NCT01057693|12250812|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0
7794964|NCT01057693|12250813|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1
7794965|NCT01057693|12250814|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0
7794966|NCT01057693|12250812|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
7794967|NCT01057693|12250813|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
7794968|NCT01057693|12250814|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
7794969|NCT01057810|12250824|FG000|Overall Study|Disease progression|156
7794970|NCT01057810|12250825|FG001|Overall Study|Disease progression|197
7794971|NCT01057810|12250824|FG000|Overall Study|Study drug toxicity|5
7794972|NCT01057810|12250825|FG001|Overall Study|Study drug toxicity|114
7794973|NCT01057810|12250824|FG000|Overall Study|Adverse event unrelated to study drug|13
7794974|NCT01057810|12250825|FG001|Overall Study|Adverse event unrelated to study drug|29
7794975|NCT01057810|12250824|FG000|Overall Study|Withdrawal by Subject|10
7794976|NCT01057810|12250825|FG001|Overall Study|Withdrawal by Subject|25
7794977|NCT01057810|12250824|FG000|Overall Study|Death|2
7794978|NCT01057810|12250825|FG001|Overall Study|Death|12
7794979|NCT01057810|12250824|FG000|Overall Study|Maximum clinical benefit|5
7794980|NCT01057810|12250825|FG001|Overall Study|Maximum clinical benefit|5
7794981|NCT01057810|12250824|FG000|Overall Study|Poor/non-compliance|0
7794982|NCT01057810|12250825|FG001|Overall Study|Poor/non-compliance|1
7794983|NCT01057810|12250824|FG000|Overall Study|No longer met study criteria|0
7794984|NCT01057810|12250825|FG001|Overall Study|No longer met study criteria|1
7794985|NCT01057810|12250824|FG000|Overall Study|Other|7
7794986|NCT01057810|12250825|FG001|Overall Study|Other|14
7794987|NCT01057862|12250833|FG000|Overall Study|Withdrawal by Subject|1
7794988|NCT01057862|12250834|FG001|Overall Study|Withdrawal by Subject|2
7794989|NCT01058005|12250863|FG000|Overall Study|Adverse Event|0
7794990|NCT01058005|12250864|FG001|Overall Study|Adverse Event|2
7794991|NCT01058005|12250865|FG002|Overall Study|Adverse Event|1
7794992|NCT01058005|12250863|FG000|Overall Study|Physician Decision|2
7794993|NCT01058005|12250864|FG001|Overall Study|Physician Decision|2
7794994|NCT01058005|12250865|FG002|Overall Study|Physician Decision|0
7794995|NCT01058005|12250863|FG000|Overall Study|Withdrawal by Subject|4
7794996|NCT01058005|12250864|FG001|Overall Study|Withdrawal by Subject|5
7794997|NCT01058005|12250865|FG002|Overall Study|Withdrawal by Subject|11
7794998|NCT01058005|12250863|FG000|Overall Study|Withdrawn Due to Study Termination|27
7794999|NCT01058005|12250864|FG001|Overall Study|Withdrawn Due to Study Termination|13
7795000|NCT01058005|12250865|FG002|Overall Study|Withdrawn Due to Study Termination|7
7795001|NCT01058005|12250863|FG000|Overall Study|Reason Missing|5
7795002|NCT01058005|12250864|FG001|Overall Study|Reason Missing|3
7795003|NCT01058005|12250865|FG002|Overall Study|Reason Missing|1
7795004|NCT01058096|12250880|FG000|Double-blind Treatment Phase|Adverse Event|11
7795005|NCT01058096|12250881|FG001|Double-blind Treatment Phase|Adverse Event|15
7795006|NCT01058096|12250880|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
7795007|NCT01058096|12250881|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
7795008|NCT01058096|12250880|FG000|Double-blind Treatment Phase|Protocol Violation|2
7795009|NCT01058096|12250881|FG001|Double-blind Treatment Phase|Protocol Violation|1
7795010|NCT01058096|12250880|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17
7795011|NCT01058096|12250881|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26
7795012|NCT01058096|12250880|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
7795013|NCT01058096|12250881|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
7795014|NCT01058096|12250880|FG000|Double-blind Treatment Phase|Other Unspecified|2
7795015|NCT01058096|12250881|FG001|Double-blind Treatment Phase|Other Unspecified|0
7795016|NCT01058265|12250893|FG000|Overall Study|Lost to Follow-up|11
7795017|NCT01058265|12250894|FG001|Overall Study|Lost to Follow-up|12
7795018|NCT01058304|12250902|FG000|Overall Study|Withdrawal by Subject|8
7795019|NCT01058304|12250903|FG001|Overall Study|Withdrawal by Subject|5
7795020|NCT01058304|12250902|FG000|Overall Study|Lost to Follow-up|13
7795021|NCT01058304|12250903|FG001|Overall Study|Lost to Follow-up|16
7795022|NCT01058304|12250902|FG000|Overall Study|Developed exclusion criterion|6
7795023|NCT01058304|12250903|FG001|Overall Study|Developed exclusion criterion|12
7795024|NCT01058356|12250909|FG000|Overall Study|Adverse Event|5
7795025|NCT01058356|12250909|FG000|Overall Study|Administration of contraindicated drugs|12
7795026|NCT01058356|12250909|FG000|Overall Study|Withdrawal by Subject|21
7795027|NCT01058356|12250909|FG000|Overall Study|Lost to Follow-up|4
7795028|NCT01058395|12250915|FG000|Overall Study|Death|2
7795029|NCT01058395|12250916|FG001|Overall Study|Death|1
7795030|NCT01058395|12250915|FG000|Overall Study|Lost to Follow-up|1
7795031|NCT01058395|12250916|FG001|Overall Study|Lost to Follow-up|0
7795032|NCT01058421|12250924|FG000|1 Month Outcomes|Death|10
7795033|NCT01058421|12250925|FG001|1 Month Outcomes|Death|6
7795034|NCT01058421|12250924|FG000|1 Month Outcomes|Lost to Follow-up|8
7795035|NCT01058421|12250925|FG001|1 Month Outcomes|Lost to Follow-up|7
7795036|NCT01058421|12250924|FG000|1 Month Outcomes|Remained in Hospital|5
7795037|NCT01058421|12250925|FG001|1 Month Outcomes|Remained in Hospital|12
7795038|NCT01058421|12250924|FG000|1 Month Outcomes|Remained in Other Facility|16
7795039|NCT01058421|12250925|FG001|1 Month Outcomes|Remained in Other Facility|17
7795040|NCT01058421|12250924|FG000|3 Month Outcomes|Death|3
7795041|NCT01058421|12250925|FG001|3 Month Outcomes|Death|5
7795042|NCT01058421|12250924|FG000|3 Month Outcomes|Lost to Follow-up|12
7795043|NCT01058421|12250925|FG001|3 Month Outcomes|Lost to Follow-up|11
7795044|NCT01058421|12250924|FG000|3 Month Outcomes|Remained in Hospital|0
7795045|NCT01058421|12250925|FG001|3 Month Outcomes|Remained in Hospital|2
7795046|NCT01058421|12250924|FG000|3 Month Outcomes|Remained in Other Facility|5
7795047|NCT01058421|12250925|FG001|3 Month Outcomes|Remained in Other Facility|8
7795048|NCT01058421|12250924|FG000|6 Month Outcomes|Death|2
7795049|NCT01058421|12250925|FG001|6 Month Outcomes|Death|2
7795050|NCT01058421|12250924|FG000|6 Month Outcomes|Lost to Follow-up|16
7795051|NCT01058421|12250925|FG001|6 Month Outcomes|Lost to Follow-up|21
7795052|NCT01058421|12250924|FG000|6 Month Outcomes|Remained in Other Facility|1
7795053|NCT01058421|12250925|FG001|6 Month Outcomes|Remained in Other Facility|3
7795054|NCT01058655|12250935|FG000|Overall Study|Withdrawal by Subject|1
7795055|NCT01058655|12250936|FG001|Overall Study|Withdrawal by Subject|0
7795056|NCT01058655|12250937|FG002|Overall Study|Withdrawal by Subject|3
7795057|NCT01058655|12250938|FG003|Overall Study|Withdrawal by Subject|4
7795058|NCT01058655|12250935|FG000|Overall Study|Prolonged Treatment Delay|0
7795059|NCT01058655|12250936|FG001|Overall Study|Prolonged Treatment Delay|0
7795060|NCT01058655|12250937|FG002|Overall Study|Prolonged Treatment Delay|0
7795061|NCT01058655|12250938|FG003|Overall Study|Prolonged Treatment Delay|2
7795062|NCT01058655|12250935|FG000|Overall Study|Symptomatic Deterioration|0
7795063|NCT01058655|12250936|FG001|Overall Study|Symptomatic Deterioration|0
7795064|NCT01058655|12250937|FG002|Overall Study|Symptomatic Deterioration|0
7795065|NCT01058655|12250938|FG003|Overall Study|Symptomatic Deterioration|1
7795066|NCT01058655|12250935|FG000|Overall Study|Clinical Progression (non-RECIST)|1
7795067|NCT01058655|12250936|FG001|Overall Study|Clinical Progression (non-RECIST)|0
7795068|NCT01058655|12250937|FG002|Overall Study|Clinical Progression (non-RECIST)|0
7795069|NCT01058655|12250938|FG003|Overall Study|Clinical Progression (non-RECIST)|7
7795070|NCT01058655|12250935|FG000|Overall Study|Death|0
7795071|NCT01058655|12250936|FG001|Overall Study|Death|1
7795072|NCT01058655|12250937|FG002|Overall Study|Death|1
7795073|NCT01058655|12250938|FG003|Overall Study|Death|0
7795074|NCT01058655|12250935|FG000|Overall Study|Disease Progression|1
7795075|NCT01058655|12250936|FG001|Overall Study|Disease Progression|2
7795076|NCT01058655|12250937|FG002|Overall Study|Disease Progression|4
7795077|NCT01058655|12250938|FG003|Overall Study|Disease Progression|24
7795078|NCT01058655|12250935|FG000|Overall Study|Other|0
7795079|NCT01058655|12250936|FG001|Overall Study|Other|0
7795080|NCT01058655|12250937|FG002|Overall Study|Other|0
7795081|NCT01058655|12250938|FG003|Overall Study|Other|4
7795082|NCT01058668|12250952|FG000|Double-blind Treatment Phase|Adverse Event|8
7795083|NCT01058668|12250953|FG001|Double-blind Treatment Phase|Adverse Event|15
7795084|NCT01058668|12250954|FG002|Double-blind Treatment Phase|Adverse Event|25
7795085|NCT01058668|12250952|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
7795086|NCT01058668|12250953|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
7795087|NCT01058668|12250954|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
7795088|NCT01058668|12250952|FG000|Double-blind Treatment Phase|Protocol Violation|1
7795089|NCT01058668|12250953|FG001|Double-blind Treatment Phase|Protocol Violation|1
7795090|NCT01058668|12250954|FG002|Double-blind Treatment Phase|Protocol Violation|2
7795091|NCT01058668|12250952|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14
7795092|NCT01058668|12250953|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18
7795093|NCT01058668|12250954|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17
7795094|NCT01058668|12250952|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
7795095|NCT01058668|12250953|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
7795096|NCT01058668|12250954|FG002|Double-blind Treatment Phase|Lost to Follow-up|1
7795097|NCT01058668|12250952|FG000|Double-blind Treatment Phase|Other Unspecified|1
7795098|NCT01058668|12250953|FG001|Double-blind Treatment Phase|Other Unspecified|1
7795099|NCT01058668|12250954|FG002|Double-blind Treatment Phase|Other Unspecified|0
7795100|NCT01058707|12250969|FG000|Overall Study|Disease Progression|15
7795101|NCT01058707|12250970|FG001|Overall Study|Disease Progression|20
7795102|NCT01058707|12250971|FG002|Overall Study|Disease Progression|20
7795103|NCT01058707|12250972|FG003|Overall Study|Disease Progression|15
7795104|NCT01058707|12250973|FG004|Overall Study|Disease Progression|23
7795105|NCT01058707|12250974|FG005|Overall Study|Disease Progression|10
7795106|NCT01058707|12250975|FG006|Overall Study|Disease Progression|12
7795107|NCT01058707|12250969|FG000|Overall Study|Adverse Event|11
7795108|NCT01058707|12250970|FG001|Overall Study|Adverse Event|4
7795109|NCT01058707|12250971|FG002|Overall Study|Adverse Event|7
7795110|NCT01058707|12250972|FG003|Overall Study|Adverse Event|6
7795111|NCT01058707|12250973|FG004|Overall Study|Adverse Event|7
7795112|NCT01058707|12250974|FG005|Overall Study|Adverse Event|3
7795113|NCT01058707|12250975|FG006|Overall Study|Adverse Event|1
7873430|NCT01692626|12367646|FG000|Overall Study|Adverse Event|2
7873431|NCT01692626|12367647|FG001|Overall Study|Adverse Event|3
7873432|NCT01692626|12367646|FG000|Overall Study|Protocol Violation|1
7873433|NCT01692626|12367647|FG001|Overall Study|Protocol Violation|2
7873434|NCT01692626|12367646|FG000|Overall Study|Withdrawal by Subject|1
7873435|NCT01692626|12367647|FG001|Overall Study|Withdrawal by Subject|0
7873436|NCT01692730|12367654|FG000|Overall Study|Lost to Follow-up|225
7873437|NCT01692730|12367655|FG001|Overall Study|Lost to Follow-up|227
7873438|NCT01692782|12367694|FG000|Overall Study|Adverse Event|12
7873439|NCT01692782|12367695|FG001|Overall Study|Adverse Event|32
7873440|NCT01692782|12367696|FG002|Overall Study|Adverse Event|2
7873441|NCT01692782|12367694|FG000|Overall Study|Lack of Efficacy|1
7873442|NCT01692782|12367695|FG001|Overall Study|Lack of Efficacy|2
7873443|NCT01692782|12367696|FG002|Overall Study|Lack of Efficacy|0
7873444|NCT01692782|12367694|FG000|Overall Study|Lost to Follow-up|2
7873445|NCT01692782|12367695|FG001|Overall Study|Lost to Follow-up|7
7873446|NCT01692782|12367696|FG002|Overall Study|Lost to Follow-up|1
7873447|NCT01692782|12367694|FG000|Overall Study|Pregnancy|1
7873448|NCT01692782|12367695|FG001|Overall Study|Pregnancy|0
7873449|NCT01692782|12367696|FG002|Overall Study|Pregnancy|0
7873450|NCT01692782|12367694|FG000|Overall Study|Protocol Violation|1
7873451|NCT01692782|12367695|FG001|Overall Study|Protocol Violation|0
7873452|NCT01692782|12367696|FG002|Overall Study|Protocol Violation|2
7873453|NCT01692782|12367694|FG000|Overall Study|Non-complance with study drug|0
7873454|NCT01692782|12367695|FG001|Overall Study|Non-complance with study drug|4
7873455|NCT01692782|12367696|FG002|Overall Study|Non-complance with study drug|1
7873456|NCT01692782|12367694|FG000|Overall Study|Non-compliant with study visits|0
7873457|NCT01692782|12367695|FG001|Overall Study|Non-compliant with study visits|0
7873458|NCT01692782|12367696|FG002|Overall Study|Non-compliant with study visits|1
7873459|NCT01692782|12367694|FG000|Overall Study|SAE not related to study drug|0
7873460|NCT01692782|12367695|FG001|Overall Study|SAE not related to study drug|1
7873461|NCT01692782|12367696|FG002|Overall Study|SAE not related to study drug|0
7873462|NCT01692782|12367694|FG000|Overall Study|Withdrawal by Subject|3
7873463|NCT01692782|12367695|FG001|Overall Study|Withdrawal by Subject|10
7795114|NCT01058707|12250969|FG000|Overall Study|Subject Decision|5
7873464|NCT01692782|12367696|FG002|Overall Study|Withdrawal by Subject|3
7873465|NCT01692938|12367706|FG000|Overall Study|Protocol Deviation|1
7873466|NCT01692938|12367707|FG001|Overall Study|Protocol Deviation|1
7873467|NCT01692938|12367706|FG000|Overall Study|Study completed prior to site completion|3
7873468|NCT01692938|12367707|FG001|Overall Study|Study completed prior to site completion|3
7873469|NCT01693029|12367737|FG000|Overall Study|Withdrawal by Subject|15
7873470|NCT01693029|12367738|FG001|Overall Study|Withdrawal by Subject|22
7795115|NCT01058707|12250970|FG001|Overall Study|Subject Decision|3
7795116|NCT01058707|12250971|FG002|Overall Study|Subject Decision|3
7795117|NCT01058707|12250972|FG003|Overall Study|Subject Decision|1
7795118|NCT01058707|12250973|FG004|Overall Study|Subject Decision|2
7795119|NCT01058707|12250974|FG005|Overall Study|Subject Decision|3
7795120|NCT01058707|12250975|FG006|Overall Study|Subject Decision|6
7795121|NCT01058707|12250969|FG000|Overall Study|Lost to Follow-up|0
7795122|NCT01058707|12250970|FG001|Overall Study|Lost to Follow-up|0
7795123|NCT01058707|12250971|FG002|Overall Study|Lost to Follow-up|1
7795124|NCT01058707|12250972|FG003|Overall Study|Lost to Follow-up|0
7795125|NCT01058707|12250973|FG004|Overall Study|Lost to Follow-up|0
7795126|NCT01058707|12250974|FG005|Overall Study|Lost to Follow-up|0
7795127|NCT01058707|12250975|FG006|Overall Study|Lost to Follow-up|0
7795128|NCT01058707|12250969|FG000|Overall Study|Reason Not Specified|0
7795129|NCT01058707|12250970|FG001|Overall Study|Reason Not Specified|3
7795130|NCT01058707|12250971|FG002|Overall Study|Reason Not Specified|2
7795131|NCT01058707|12250972|FG003|Overall Study|Reason Not Specified|0
7795132|NCT01058707|12250973|FG004|Overall Study|Reason Not Specified|7
7795133|NCT01058707|12250974|FG005|Overall Study|Reason Not Specified|1
7795134|NCT01058707|12250975|FG006|Overall Study|Reason Not Specified|7
7795135|NCT01058863|12251013|FG000|Overall Study|Lost to Follow-up|1
7795136|NCT01058863|12251013|FG000|Overall Study|Withdrawal by Subject|1
7795137|NCT01058863|12251013|FG000|Overall Study|Sponsor requested withdrawal|1
7795138|NCT01058863|12251013|FG000|Overall Study|Randomized in error|1
7795139|NCT01059175|12251041|FG000|Overall Study|Death|17
7795140|NCT01059175|12251042|FG001|Overall Study|Death|17
7795141|NCT01059175|12251041|FG000|Overall Study|Adverse Event|4
7795142|NCT01059175|12251042|FG001|Overall Study|Adverse Event|2
7795143|NCT01059175|12251041|FG000|Overall Study|Lost to Follow-up|0
7795144|NCT01059175|12251042|FG001|Overall Study|Lost to Follow-up|1
7795145|NCT01059318|12251052|FG000|Core Study (26 Week)|Adverse Event|3
7795146|NCT01059318|12251052|FG000|Core Study (26 Week)|Withdrawal by Subject|1
7795147|NCT01059318|12251052|FG000|Extension (36 Week)|Adverse Event|3
7795148|NCT01059344|12251061|FG000|Overall Study|Adverse Event|12
7795149|NCT01059344|12251062|FG001|Overall Study|Adverse Event|30
7795150|NCT01059344|12251061|FG000|Overall Study|Withdrawal by Subject|6
7795151|NCT01059344|12251062|FG001|Overall Study|Withdrawal by Subject|9
7795152|NCT01059344|12251061|FG000|Overall Study|Lost to Follow-up|1
7795153|NCT01059344|12251062|FG001|Overall Study|Lost to Follow-up|1
7795154|NCT01059344|12251061|FG000|Overall Study|Other|3
7795155|NCT01059344|12251062|FG001|Overall Study|Other|6
7795156|NCT01059526|12251127|FG000|Overall Study|Patient enrolled but not treated|20
7795157|NCT01059526|12251128|FG001|Overall Study|Patient enrolled but not treated|17
7795158|NCT01059526|12251127|FG000|Overall Study|Adverse Event|2
7795159|NCT01059526|12251128|FG001|Overall Study|Adverse Event|2
7795160|NCT01059526|12251127|FG000|Overall Study|Protocol Violation|0
7795161|NCT01059526|12251128|FG001|Overall Study|Protocol Violation|1
7795162|NCT01059526|12251127|FG000|Overall Study|Withdrawal by Subject|3
7795163|NCT01059526|12251128|FG001|Overall Study|Withdrawal by Subject|1
7795164|NCT01059526|12251127|FG000|Overall Study|Lost to Follow-up|4
7795165|NCT01059526|12251128|FG001|Overall Study|Lost to Follow-up|1
7795166|NCT01059526|12251127|FG000|Overall Study|Patient found to be dermatographic|1
7795167|NCT01059526|12251128|FG001|Overall Study|Patient found to be dermatographic|0
7795168|NCT01059539|12251134|FG000|Overall Study|Adverse Event|66
7795169|NCT01059539|12251134|FG000|Overall Study|Insufficient Therapeutic Response|26
7795170|NCT01059539|12251134|FG000|Overall Study|Protocol Violation|55
7795171|NCT01059539|12251134|FG000|Overall Study|Withdrawal of Consent|80
7795172|NCT01059539|12251134|FG000|Overall Study|Lost to Follow-up|42
7795173|NCT01059539|12251134|FG000|Overall Study|Reason Not Specified|2
7795174|NCT01059565|12251140|FG000|24-Week Randomized Phase|Randomized but not treated|1
7795175|NCT01059565|12251141|FG001|24-Week Randomized Phase|Randomized but not treated|0
7795176|NCT01059565|12251140|FG000|24-Week Randomized Phase|Adverse Event|5
7795177|NCT01059565|12251141|FG001|24-Week Randomized Phase|Adverse Event|0
7795178|NCT01059565|12251140|FG000|24-Week Randomized Phase|Withdrawal by Subject|3
7795179|NCT01059565|12251141|FG001|24-Week Randomized Phase|Withdrawal by Subject|1
7795180|NCT01059565|12251140|FG000|24-Week Randomized Phase|Lost to Follow-up|0
7795181|NCT01059565|12251141|FG001|24-Week Randomized Phase|Lost to Follow-up|1
7795182|NCT01059565|12251140|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
7795183|NCT01059565|12251141|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
7795184|NCT01059565|12251140|FG000|24-Week Open-Label Phase|Adverse Event|2
7795185|NCT01059565|12251141|FG001|24-Week Open-Label Phase|Adverse Event|0
7795186|NCT01059565|12251140|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1
7795187|NCT01059565|12251141|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1
7795188|NCT01059565|12251140|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1
7795189|NCT01059565|12251141|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0
7795190|NCT01059565|12251140|FG000|24-Week Open-Label Phase|Subject noncompliance|1
7795191|NCT01059565|12251141|FG001|24-Week Open-Label Phase|Subject noncompliance|0
7795192|NCT01059565|12251140|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
7795193|NCT01059565|12251141|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
7795194|NCT01059565|12251140|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0
7795195|NCT01059565|12251141|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1
7795196|NCT01059617|12251153|FG000|Overall Study|Other|7
7795197|NCT01059617|12251154|FG001|Overall Study|Other|1
7795198|NCT01059617|12251155|FG002|Overall Study|Other|8
7795199|NCT01059617|12251156|FG003|Overall Study|Other|6
7795200|NCT01059630|12251176|FG000|Overall Study|Death|100
7795201|NCT01059630|12251177|FG001|Overall Study|Death|84
7795202|NCT01059630|12251176|FG000|Overall Study|Lost to Follow-up|4
7795203|NCT01059630|12251177|FG001|Overall Study|Lost to Follow-up|1
7795204|NCT01059630|12251176|FG000|Overall Study|Physician Decision|2
7795205|NCT01059630|12251177|FG001|Overall Study|Physician Decision|4
7795206|NCT01059630|12251176|FG000|Overall Study|Withdrawal by Subject|21
7795207|NCT01059630|12251177|FG001|Overall Study|Withdrawal by Subject|14
7795208|NCT01059643|12251183|FG000|Overall Study|Adverse Event|3
7795209|NCT01059643|12251183|FG000|Overall Study|Withdrawal by Subject|2
7795210|NCT01059643|12251183|FG000|Overall Study|Physician Decision|1
7795211|NCT01059773|12251211|FG000|Overall Study|Adverse Event|2
7795212|NCT01059773|12251212|FG001|Overall Study|Adverse Event|2
7795213|NCT01059773|12251211|FG000|Overall Study|Withdrawal by Subject|1
7795214|NCT01059773|12251212|FG001|Overall Study|Withdrawal by Subject|5
7795215|NCT01059773|12251211|FG000|Overall Study|Lost to Follow-up|1
7795216|NCT01059773|12251212|FG001|Overall Study|Lost to Follow-up|1
7795217|NCT01059773|12251211|FG000|Overall Study|Pregnancy|1
7795218|NCT01059773|12251212|FG001|Overall Study|Pregnancy|1
7795219|NCT01059773|12251211|FG000|Overall Study|Protocol Violation|6
7795220|NCT01059773|12251212|FG001|Overall Study|Protocol Violation|2
7795221|NCT01059773|12251211|FG000|Overall Study|Physician Decision|5
7795222|NCT01059773|12251212|FG001|Overall Study|Physician Decision|4
7795223|NCT01059773|12251211|FG000|Overall Study|Lack of Efficacy|3
7795224|NCT01059773|12251212|FG001|Overall Study|Lack of Efficacy|3
7795225|NCT01059773|12251211|FG000|Overall Study|Death|0
7795226|NCT01059773|12251212|FG001|Overall Study|Death|1
7795227|NCT01059773|12251211|FG000|Overall Study|Malignancy including squamous cell skin|0
7795228|NCT01059773|12251212|FG001|Overall Study|Malignancy including squamous cell skin|1
7795229|NCT01059773|12251211|FG000|Overall Study|Ineligible follow TB screening criteria|0
7795230|NCT01059773|12251212|FG001|Overall Study|Ineligible follow TB screening criteria|1
7795231|NCT01059773|12251211|FG000|Overall Study|Other|1
7795232|NCT01059773|12251212|FG001|Overall Study|Other|3
7795233|NCT01059799|12251225|FG000|Overall Study|Adverse Event|2
7795234|NCT01059799|12251226|FG001|Overall Study|Adverse Event|3
7795235|NCT01059799|12251225|FG000|Overall Study|Lack of Efficacy|1
7795236|NCT01059799|12251226|FG001|Overall Study|Lack of Efficacy|0
7795237|NCT01059799|12251225|FG000|Overall Study|Protocol Violation|3
7795238|NCT01059799|12251226|FG001|Overall Study|Protocol Violation|2
7795239|NCT01059799|12251225|FG000|Overall Study|Withdrawal criteria|13
7795240|NCT01059799|12251226|FG001|Overall Study|Withdrawal criteria|2
7795241|NCT01059799|12251225|FG000|Overall Study|Other|12
7795242|NCT01059799|12251226|FG001|Overall Study|Other|3
7795243|NCT01059812|12251234|FG000|Overall Study|Adverse Event|9
7795244|NCT01059812|12251235|FG001|Overall Study|Adverse Event|5
7795245|NCT01059812|12251234|FG000|Overall Study|Lack of Efficacy|2
7795246|NCT01059812|12251235|FG001|Overall Study|Lack of Efficacy|2
7795247|NCT01059812|12251234|FG000|Overall Study|Protocol Violation|3
7795248|NCT01059812|12251235|FG001|Overall Study|Protocol Violation|1
7795249|NCT01059812|12251234|FG000|Overall Study|Withdrawal Criteria|9
7795250|NCT01059812|12251235|FG001|Overall Study|Withdrawal Criteria|4
7795251|NCT01059812|12251234|FG000|Overall Study|Unclassified|14
7795252|NCT01059812|12251235|FG001|Overall Study|Unclassified|4
7795253|NCT01059825|12251247|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0
7795254|NCT01059825|12251248|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0
7795255|NCT01059825|12251249|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0
7795256|NCT01059825|12251250|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0
7795257|NCT01059825|12251251|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0
7795258|NCT01059825|12251252|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0
7795259|NCT01059825|12251253|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3
7795260|NCT01059825|12251247|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0
7795261|NCT01059825|12251248|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0
7795262|NCT01059825|12251249|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0
7795263|NCT01059825|12251250|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0
7795264|NCT01059825|12251251|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0
7795265|NCT01059825|12251252|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0
7795266|NCT01059825|12251253|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14
7795267|NCT01059825|12251247|FG000|Enrolled, Run-in Period|Lost to Follow-up|0
7795268|NCT01059825|12251248|FG001|Enrolled, Run-in Period|Lost to Follow-up|0
7795269|NCT01059825|12251249|FG002|Enrolled, Run-in Period|Lost to Follow-up|0
7795270|NCT01059825|12251250|FG003|Enrolled, Run-in Period|Lost to Follow-up|0
7795271|NCT01059825|12251251|FG004|Enrolled, Run-in Period|Lost to Follow-up|0
7795272|NCT01059825|12251252|FG005|Enrolled, Run-in Period|Lost to Follow-up|0
7795273|NCT01059825|12251253|FG006|Enrolled, Run-in Period|Lost to Follow-up|5
7795274|NCT01059825|12251247|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0
7795275|NCT01059825|12251248|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0
7795276|NCT01059825|12251249|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0
7795277|NCT01059825|12251250|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0
7795278|NCT01059825|12251251|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0
7795279|NCT01059825|12251252|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0
7795280|NCT01059825|12251253|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13
7795281|NCT01059825|12251247|FG000|Enrolled, Run-in Period|Other reason not specified|0
7795282|NCT01059825|12251248|FG001|Enrolled, Run-in Period|Other reason not specified|0
7795283|NCT01059825|12251249|FG002|Enrolled, Run-in Period|Other reason not specified|0
7795284|NCT01059825|12251250|FG003|Enrolled, Run-in Period|Other reason not specified|0
7795285|NCT01059825|12251251|FG004|Enrolled, Run-in Period|Other reason not specified|0
7795286|NCT01059825|12251252|FG005|Enrolled, Run-in Period|Other reason not specified|0
7795287|NCT01059825|12251253|FG006|Enrolled, Run-in Period|Other reason not specified|7
7795288|NCT01059825|12251247|FG000|Enrolled, Run-in Period|Protocol Violation|0
7795289|NCT01059825|12251248|FG001|Enrolled, Run-in Period|Protocol Violation|0
7795290|NCT01059825|12251249|FG002|Enrolled, Run-in Period|Protocol Violation|0
7795291|NCT01059825|12251250|FG003|Enrolled, Run-in Period|Protocol Violation|0
7795292|NCT01059825|12251251|FG004|Enrolled, Run-in Period|Protocol Violation|0
7795293|NCT01059825|12251252|FG005|Enrolled, Run-in Period|Protocol Violation|0
7795294|NCT01059825|12251253|FG006|Enrolled, Run-in Period|Protocol Violation|5
7795295|NCT01059825|12251247|FG000|Treatment Period|Lost to Follow-up|2
7795296|NCT01059825|12251248|FG001|Treatment Period|Lost to Follow-up|1
7795297|NCT01059825|12251249|FG002|Treatment Period|Lost to Follow-up|0
7795298|NCT01059825|12251250|FG003|Treatment Period|Lost to Follow-up|1
7795299|NCT01059825|12251251|FG004|Treatment Period|Lost to Follow-up|2
7795300|NCT01059825|12251252|FG005|Treatment Period|Lost to Follow-up|0
7795301|NCT01059825|12251253|FG006|Treatment Period|Lost to Follow-up|0
7795302|NCT01059825|12251247|FG000|Treatment Period|Withdrawal by Subject|3
7795303|NCT01059825|12251248|FG001|Treatment Period|Withdrawal by Subject|0
7795304|NCT01059825|12251249|FG002|Treatment Period|Withdrawal by Subject|1
7795305|NCT01059825|12251250|FG003|Treatment Period|Withdrawal by Subject|5
7795306|NCT01059825|12251251|FG004|Treatment Period|Withdrawal by Subject|4
7795307|NCT01059825|12251252|FG005|Treatment Period|Withdrawal by Subject|1
7795308|NCT01059825|12251253|FG006|Treatment Period|Withdrawal by Subject|0
7795309|NCT01059825|12251247|FG000|Treatment Period|Other reason not specified|1
7795310|NCT01059825|12251248|FG001|Treatment Period|Other reason not specified|2
7795311|NCT01059825|12251249|FG002|Treatment Period|Other reason not specified|1
7795312|NCT01059825|12251250|FG003|Treatment Period|Other reason not specified|2
7795313|NCT01059825|12251251|FG004|Treatment Period|Other reason not specified|0
7795314|NCT01059825|12251252|FG005|Treatment Period|Other reason not specified|0
7795315|NCT01059825|12251253|FG006|Treatment Period|Other reason not specified|0
7795316|NCT01059825|12251247|FG000|Treatment Period|Protocol Violation|0
7795317|NCT01059825|12251248|FG001|Treatment Period|Protocol Violation|0
7795318|NCT01059825|12251249|FG002|Treatment Period|Protocol Violation|1
7795319|NCT01059825|12251250|FG003|Treatment Period|Protocol Violation|1
7795320|NCT01059825|12251251|FG004|Treatment Period|Protocol Violation|1
7795321|NCT01059825|12251252|FG005|Treatment Period|Protocol Violation|1
7795322|NCT01059825|12251253|FG006|Treatment Period|Protocol Violation|0
7795323|NCT01059825|12251247|FG000|Treatment Period|Adverse event related to study drug|1
7795324|NCT01059825|12251248|FG001|Treatment Period|Adverse event related to study drug|0
7795325|NCT01059825|12251249|FG002|Treatment Period|Adverse event related to study drug|1
7795326|NCT01059825|12251250|FG003|Treatment Period|Adverse event related to study drug|1
7795327|NCT01059825|12251251|FG004|Treatment Period|Adverse event related to study drug|0
7795328|NCT01059825|12251252|FG005|Treatment Period|Adverse event related to study drug|0
7795329|NCT01059825|12251253|FG006|Treatment Period|Adverse event related to study drug|0
7795330|NCT01059825|12251247|FG000|Treatment Period|Insufficient clinical response|3
7795331|NCT01059825|12251248|FG001|Treatment Period|Insufficient clinical response|0
7795332|NCT01059825|12251249|FG002|Treatment Period|Insufficient clinical response|0
7795333|NCT01059825|12251250|FG003|Treatment Period|Insufficient clinical response|0
7795334|NCT01059825|12251251|FG004|Treatment Period|Insufficient clinical response|0
7795335|NCT01059825|12251252|FG005|Treatment Period|Insufficient clinical response|0
7795336|NCT01059825|12251253|FG006|Treatment Period|Insufficient clinical response|0
7795337|NCT01059825|12251247|FG000|Treatment Period|Adverse event not related to study drug|0
7795338|NCT01059825|12251248|FG001|Treatment Period|Adverse event not related to study drug|1
7795339|NCT01059825|12251249|FG002|Treatment Period|Adverse event not related to study drug|2
7795340|NCT01059825|12251250|FG003|Treatment Period|Adverse event not related to study drug|1
7795341|NCT01059825|12251251|FG004|Treatment Period|Adverse event not related to study drug|1
7795342|NCT01059825|12251252|FG005|Treatment Period|Adverse event not related to study drug|1
7795343|NCT01059825|12251253|FG006|Treatment Period|Adverse event not related to study drug|0
7795344|NCT01059864|12251286|FG000|Open-Label Run-In Phase|Adverse Event|7
7795345|NCT01059864|12251287|FG001|Open-Label Run-In Phase|Adverse Event|0
7795346|NCT01059864|12251288|FG002|Open-Label Run-In Phase|Adverse Event|0
7795347|NCT01059864|12251286|FG000|Open-Label Run-In Phase|Lack of Efficacy|1
7795348|NCT01059864|12251287|FG001|Open-Label Run-In Phase|Lack of Efficacy|0
7795349|NCT01059864|12251288|FG002|Open-Label Run-In Phase|Lack of Efficacy|0
7795350|NCT01059864|12251286|FG000|Open-Label Run-In Phase|Lost to Follow-up|2
7795351|NCT01059864|12251287|FG001|Open-Label Run-In Phase|Lost to Follow-up|0
7795352|NCT01059864|12251288|FG002|Open-Label Run-In Phase|Lost to Follow-up|0
7795353|NCT01059864|12251286|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1
7795354|NCT01059864|12251287|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0
7795355|NCT01059864|12251288|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0
7795356|NCT01059864|12251286|FG000|Open-Label Run-In Phase|Protocol Violation|2
7795357|NCT01059864|12251287|FG001|Open-Label Run-In Phase|Protocol Violation|0
7795358|NCT01059864|12251288|FG002|Open-Label Run-In Phase|Protocol Violation|0
7795359|NCT01059864|12251286|FG000|Double-Blind Treatment Phase|Adverse Event|0
7795360|NCT01059864|12251287|FG001|Double-Blind Treatment Phase|Adverse Event|3
7795361|NCT01059864|12251288|FG002|Double-Blind Treatment Phase|Adverse Event|3
7795362|NCT01059903|12251306|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1
7795363|NCT01059903|12251307|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1
7795364|NCT01060007|12251339|FG000|Overall Study|Withdrawal by Subject|1
7795365|NCT01060007|12251339|FG000|Overall Study|Inevaluable for response at surgery|3
7873471|NCT01693029|12367737|FG000|Overall Study|Kidney transplantation|7
7873472|NCT01693029|12367738|FG001|Overall Study|Kidney transplantation|7
7873473|NCT01693029|12367737|FG000|Overall Study|Bindinging anti-EPO antibodies|6
7873474|NCT01693029|12367738|FG001|Overall Study|Bindinging anti-EPO antibodies|2
7873475|NCT01693029|12367737|FG000|Overall Study|Protocol Violation|6
7873476|NCT01693029|12367738|FG001|Overall Study|Protocol Violation|7
7873477|NCT01693029|12367737|FG000|Overall Study|Change in dialysis modality|2
7873478|NCT01693029|12367738|FG001|Overall Study|Change in dialysis modality|1
7873479|NCT01693029|12367737|FG000|Overall Study|Physician Decision|0
7873480|NCT01693029|12367738|FG001|Overall Study|Physician Decision|2
7873481|NCT01693029|12367737|FG000|Overall Study|Lost to Follow-up|0
7873482|NCT01693029|12367738|FG001|Overall Study|Lost to Follow-up|1
7873483|NCT01693029|12367737|FG000|Overall Study|Adverse Event|1
7873484|NCT01693029|12367738|FG001|Overall Study|Adverse Event|6
7873485|NCT01693029|12367737|FG000|Overall Study|Death|5
7873486|NCT01693029|12367738|FG001|Overall Study|Death|8
7873487|NCT01693029|12367737|FG000|Overall Study|Non-compliance|2
7873488|NCT01693029|12367738|FG001|Overall Study|Non-compliance|1
7873489|NCT01693068|12367746|FG000|Randomization Period|On-study|2
7873490|NCT01693068|12367747|FG001|Randomization Period|On-study|5
7873491|NCT01693068|12367748|FG002|Randomization Period|On-study|0
7873492|NCT01693068|12367746|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0
7873493|NCT01693068|12367747|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0
7873494|NCT01693068|12367748|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1
7873495|NCT01693120|12367756|FG000|Enrollment|Lost to Follow-up|1
7873496|NCT01693120|12367756|FG000|Enrollment|Withdrawal by Subject|10
7873497|NCT01693120|12367756|FG000|Enrollment|Protocol Violation|46
7873498|NCT01693120|12367756|FG000|Enrollment|Physician Decision|3
7873499|NCT01693120|12367756|FG000|Enrollment|Adverse Event|1
7873500|NCT01693120|12367756|FG000|Enrollment|Study closed|8
7873501|NCT01693120|12367756|FG000|Enrollment|Other|1
7873502|NCT01693120|12367756|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
7873503|NCT01693120|12367756|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
7873504|NCT01693120|12367756|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3
7873505|NCT01693120|12367756|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1
7873506|NCT01693120|12367756|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7
7873507|NCT01693185|12367762|FG000|Overall Study|diagnostic procedure after colonoscopy|0
7873508|NCT01693185|12367763|FG001|Overall Study|diagnostic procedure after colonoscopy|6
7873509|NCT01693250|12367771|FG000|Overall Study|Lost to Follow-up|2
7873510|NCT01693250|12367772|FG001|Overall Study|Lost to Follow-up|2
7873511|NCT01693523|12367783|FG000|Overall Study|Adverse Event|2
7873512|NCT01693523|12367784|FG001|Overall Study|Adverse Event|1
7873513|NCT01693523|12367785|FG002|Overall Study|Adverse Event|0
7873514|NCT01693523|12367783|FG000|Overall Study|Death|0
7873515|NCT01693523|12367784|FG001|Overall Study|Death|1
7873516|NCT01693523|12367785|FG002|Overall Study|Death|1
7873517|NCT01693523|12367783|FG000|Overall Study|Lost to Follow-up|0
7873518|NCT01693523|12367784|FG001|Overall Study|Lost to Follow-up|0
7873519|NCT01693523|12367785|FG002|Overall Study|Lost to Follow-up|4
7873520|NCT01693523|12367783|FG000|Overall Study|Physician Decision|0
7873521|NCT01693523|12367784|FG001|Overall Study|Physician Decision|0
7873522|NCT01693523|12367785|FG002|Overall Study|Physician Decision|1
7873523|NCT01693523|12367783|FG000|Overall Study|Withdrawal by Subject|1
7873524|NCT01693523|12367784|FG001|Overall Study|Withdrawal by Subject|2
7873525|NCT01693523|12367785|FG002|Overall Study|Withdrawal by Subject|2
7873526|NCT01693523|12367783|FG000|Overall Study|Lack of compliance study medication|1
7873527|NCT01693523|12367784|FG001|Overall Study|Lack of compliance study medication|2
7873528|NCT01693523|12367785|FG002|Overall Study|Lack of compliance study medication|0
7873529|NCT01693523|12367783|FG000|Overall Study|Chemotherapy was held|1
7873530|NCT01693523|12367784|FG001|Overall Study|Chemotherapy was held|2
7873531|NCT01693523|12367785|FG002|Overall Study|Chemotherapy was held|0
7873532|NCT01693562|12367815|FG000|Escalation Phase|Withdrawal by Subject|0
7873533|NCT01693562|12367816|FG001|Escalation Phase|Withdrawal by Subject|1
7873534|NCT01693562|12367817|FG002|Escalation Phase|Withdrawal by Subject|0
7873535|NCT01693562|12367818|FG003|Escalation Phase|Withdrawal by Subject|0
7873536|NCT01693562|12367819|FG004|Escalation Phase|Withdrawal by Subject|0
7873537|NCT01693562|12367820|FG005|Escalation Phase|Withdrawal by Subject|2
7873538|NCT01693562|12367821|FG006|Escalation Phase|Withdrawal by Subject|0
7795366|NCT01060059|12251353|FG000|Overall Study|Adverse Event|1
7795367|NCT01060059|12251354|FG001|Overall Study|Adverse Event|1
7795368|NCT01060059|12251353|FG000|Overall Study|Death|2
7795369|NCT01060059|12251354|FG001|Overall Study|Death|3
7795370|NCT01060059|12251353|FG000|Overall Study|Lost to Follow-up|18
7795371|NCT01060059|12251354|FG001|Overall Study|Lost to Follow-up|34
7795372|NCT01060059|12251353|FG000|Overall Study|entry criteria not met|4
7795373|NCT01060059|12251354|FG001|Overall Study|entry criteria not met|3
7795374|NCT01060059|12251353|FG000|Overall Study|Withdrawal by Subject|35
7795375|NCT01060059|12251354|FG001|Overall Study|Withdrawal by Subject|23
7795376|NCT01060059|12251353|FG000|Overall Study|lack of glycemic control|2
7795377|NCT01060059|12251354|FG001|Overall Study|lack of glycemic control|1
7795378|NCT01060059|12251353|FG000|Overall Study|lack of compliance|5
7795379|NCT01060059|12251354|FG001|Overall Study|lack of compliance|2
7795380|NCT01060072|12251364|FG000|Overall Study|Adverse Event|1
7795381|NCT01060072|12251365|FG001|Overall Study|Adverse Event|1
7795382|NCT01060072|12251364|FG000|Overall Study|Physician Decision|0
7795383|NCT01060072|12251365|FG001|Overall Study|Physician Decision|2
7795384|NCT01060072|12251364|FG000|Overall Study|Protocol Violation|0
7795385|NCT01060072|12251365|FG001|Overall Study|Protocol Violation|1
7795386|NCT01060072|12251364|FG000|Overall Study|Acute cholecystitis|1
7795387|NCT01060072|12251365|FG001|Overall Study|Acute cholecystitis|0
7795388|NCT01060072|12251364|FG000|Overall Study|Excluded Medications|0
7795389|NCT01060072|12251365|FG001|Overall Study|Excluded Medications|1
7795390|NCT01060111|12251387|FG000|Overall Study|Adverse Event|9
7795391|NCT01060111|12251388|FG001|Overall Study|Adverse Event|5
7795392|NCT01060111|12251389|FG002|Overall Study|Adverse Event|18
7795393|NCT01060111|12251387|FG000|Overall Study|Lack of Efficacy|2
7795394|NCT01060111|12251388|FG001|Overall Study|Lack of Efficacy|1
7795395|NCT01060111|12251389|FG002|Overall Study|Lack of Efficacy|0
7795396|NCT01060111|12251387|FG000|Overall Study|Inappropriate participant|5
7795397|NCT01060111|12251388|FG001|Overall Study|Inappropriate participant|4
7795398|NCT01060111|12251389|FG002|Overall Study|Inappropriate participant|5
7795399|NCT01060111|12251387|FG000|Overall Study|Participants' evasion for hospital visit|0
7795400|NCT01060111|12251388|FG001|Overall Study|Participants' evasion for hospital visit|3
7795401|NCT01060111|12251389|FG002|Overall Study|Participants' evasion for hospital visit|2
7795402|NCT01060111|12251387|FG000|Overall Study|Participants' non-cooperation|8
7795403|NCT01060111|12251388|FG001|Overall Study|Participants' non-cooperation|6
7795404|NCT01060111|12251389|FG002|Overall Study|Participants' non-cooperation|6
7795405|NCT01060111|12251387|FG000|Overall Study|Adverse event and insufficient effect|0
7795406|NCT01060111|12251388|FG001|Overall Study|Adverse event and insufficient effect|1
7795407|NCT01060111|12251389|FG002|Overall Study|Adverse event and insufficient effect|0
7795408|NCT01060111|12251387|FG000|Overall Study|Participants' non-cooperation|1
7795409|NCT01060111|12251388|FG001|Overall Study|Participants' non-cooperation|0
7795410|NCT01060111|12251389|FG002|Overall Study|Participants' non-cooperation|0
7795411|NCT01060111|12251387|FG000|Overall Study|Other|2
7795412|NCT01060111|12251388|FG001|Overall Study|Other|3
7795413|NCT01060111|12251389|FG002|Overall Study|Other|4
7795414|NCT01060124|12251400|FG000|Overall Study|Other|16
7795415|NCT01060124|12251400|FG000|Overall Study|Adverse Event|14
7795416|NCT01060124|12251400|FG000|Overall Study|Withdrawal by Subject|7
7795417|NCT01060150|12251404|FG000|Overall Study|Adverse Event|6
7795418|NCT01060150|12251404|FG000|Overall Study|Lost to Follow-up|1
7795419|NCT01060150|12251404|FG000|Overall Study|Protocol Violation|6
7795420|NCT01060150|12251404|FG000|Overall Study|Withdrawal by Subject|8
7795421|NCT01060150|12251404|FG000|Overall Study|Enrolled, but not treated|2
7795422|NCT01060384|12251412|FG000|Overall Study|Withdrawal by Subject|0
7795423|NCT01060384|12251413|FG001|Overall Study|Withdrawal by Subject|1
7795424|NCT01060384|12251414|FG002|Overall Study|Withdrawal by Subject|0
7795425|NCT01060384|12251415|FG003|Overall Study|Withdrawal by Subject|0
7795426|NCT01060384|12251416|FG004|Overall Study|Withdrawal by Subject|0
7795427|NCT01060384|12251412|FG000|Overall Study|Death|0
7795428|NCT01060384|12251413|FG001|Overall Study|Death|0
7795429|NCT01060384|12251414|FG002|Overall Study|Death|0
7795430|NCT01060384|12251415|FG003|Overall Study|Death|0
7795431|NCT01060384|12251416|FG004|Overall Study|Death|1
7795432|NCT01060384|12251412|FG000|Overall Study|Intercurrent illness|0
7795433|NCT01060384|12251413|FG001|Overall Study|Intercurrent illness|0
7795434|NCT01060384|12251414|FG002|Overall Study|Intercurrent illness|0
7795435|NCT01060384|12251415|FG003|Overall Study|Intercurrent illness|0
7795436|NCT01060384|12251416|FG004|Overall Study|Intercurrent illness|1
7795437|NCT01060540|12251427|FG000|Overall Study|Withdrawal by Subject|10
7795438|NCT01060540|12251428|FG001|Overall Study|Withdrawal by Subject|20
7795439|NCT01060540|12251427|FG000|Overall Study|Lost to Follow-up|52
7795440|NCT01060540|12251428|FG001|Overall Study|Lost to Follow-up|43
7795441|NCT01060540|12251427|FG000|Overall Study|Death|2
7795442|NCT01060540|12251428|FG001|Overall Study|Death|1
7795443|NCT01060540|12251427|FG000|Overall Study|Physician Decision|0
7795444|NCT01060540|12251428|FG001|Overall Study|Physician Decision|1
7795445|NCT01060553|12251436|FG000|Overall Study|Lost to Follow-up|3
7795446|NCT01060553|12251437|FG001|Overall Study|Lost to Follow-up|5
7795447|NCT01060553|12251436|FG000|Overall Study|Withdrawal by Subject|5
7795448|NCT01060553|12251437|FG001|Overall Study|Withdrawal by Subject|5
7795449|NCT01060553|12251436|FG000|Overall Study|Lack of Efficacy|1
7795450|NCT01060553|12251437|FG001|Overall Study|Lack of Efficacy|0
7795451|NCT01060670|12251453|FG000|Run In|screen failure|0
7795452|NCT01060670|12251454|FG001|Run In|screen failure|238
7795453|NCT01061008|12251464|FG000|Overall Study|Badiocephalic fistula failed|3
7795454|NCT01061008|12251465|FG001|Overall Study|Badiocephalic fistula failed|2
7795455|NCT01061008|12251464|FG000|Overall Study|Death|1
7795456|NCT01061008|12251465|FG001|Overall Study|Death|0
7795457|NCT01061008|12251464|FG000|Overall Study|Withdrawal by Subject|1
7795458|NCT01061008|12251465|FG001|Overall Study|Withdrawal by Subject|3
7795459|NCT01061008|12251464|FG000|Overall Study|Unable to exercise following surgery|1
7795460|NCT01061008|12251465|FG001|Overall Study|Unable to exercise following surgery|0
7795461|NCT01061008|12251464|FG000|Overall Study|Adverse Event|0
7795462|NCT01061008|12251465|FG001|Overall Study|Adverse Event|1
7795463|NCT01061177|12251475|FG000|Overall Study|Adverse Event|117
7795464|NCT01061177|12251475|FG000|Overall Study|Withdrawal by Subject|27
7795465|NCT01061177|12251475|FG000|Overall Study|Disease progression|17
7795466|NCT01061177|12251475|FG000|Overall Study|Protocol Violation|11
7795467|NCT01061177|12251475|FG000|Overall Study|Lost to Follow-up|9
7795468|NCT01061177|12251475|FG000|Overall Study|New cancer therapy|9
7795469|NCT01061177|12251475|FG000|Overall Study|Abnormal laboratory values|6
7795470|NCT01061177|12251475|FG000|Overall Study|Abnormal test procedure results|4
7795471|NCT01061177|12251475|FG000|Overall Study|Administratie problems|4
7795472|NCT01061177|12251475|FG000|Overall Study|Death|4
7795473|NCT01061333|12251479|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0
7795474|NCT01061333|12251480|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1
7795475|NCT01061359|12251491|FG000|Overall Study|Death|32
7795476|NCT01061359|12251491|FG000|Overall Study|Lost to Follow-up|1072
7795477|NCT01061359|12251491|FG000|Overall Study|Relapse|187
7795478|NCT01061359|12251491|FG000|Overall Study|Secondary neoplasm|11
7795479|NCT01061385|12251497|FG000|Overall Study|Lost to Follow-up|1
7795480|NCT01061385|12251498|FG001|Overall Study|Lost to Follow-up|0
7795481|NCT01061385|12251497|FG000|Overall Study|subject decision not related to AE|0
7795482|NCT01061385|12251498|FG001|Overall Study|subject decision not related to AE|1
7795483|NCT01061567|12251518|FG000|Overall Study|Adverse Event|32
7795484|NCT01061567|12251518|FG000|Overall Study|Death|2
7795485|NCT01061567|12251518|FG000|Overall Study|Lack of Efficacy|3
7795486|NCT01061567|12251518|FG000|Overall Study|Lost to Follow-up|24
7795487|NCT01061567|12251518|FG000|Overall Study|Protocol Violation|1
7795488|NCT01061567|12251518|FG000|Overall Study|Withdrawal by Subject|11
7795489|NCT01061567|12251518|FG000|Overall Study|Other reason than stated above|3
7795490|NCT01061606|12251522|FG000|Overall Study|Adverse Event|1
7795491|NCT01061606|12251522|FG000|Overall Study|Death|1
7795492|NCT01061606|12251522|FG000|Overall Study|Disease Progression|4
7795493|NCT01061606|12251522|FG000|Overall Study|alternative therapy|2
7795494|NCT01061671|12251528|FG000|Overall Study|Withdrawal by Subject|16
7795495|NCT01061671|12251529|FG001|Overall Study|Withdrawal by Subject|20
7795496|NCT01061671|12251528|FG000|Overall Study|Lost to Follow-up|3
7795497|NCT01061671|12251529|FG001|Overall Study|Lost to Follow-up|5
7795498|NCT01061671|12251528|FG000|Overall Study|Death|28
7795499|NCT01061671|12251529|FG001|Overall Study|Death|30
7795500|NCT01061710|12251535|FG000|Overall Study|Protocol Violation|14
7795501|NCT01061723|12251545|FG000|Overall Study|Adverse Event|0
7795502|NCT01061723|12251546|FG001|Overall Study|Adverse Event|2
7795503|NCT01061723|12251547|FG002|Overall Study|Adverse Event|5
7795504|NCT01061723|12251548|FG003|Overall Study|Adverse Event|5
7795505|NCT01061723|12251549|FG004|Overall Study|Adverse Event|2
7795506|NCT01061723|12251550|FG005|Overall Study|Adverse Event|6
7795507|NCT01061723|12251545|FG000|Overall Study|Lack of Efficacy|2
7795508|NCT01061723|12251546|FG001|Overall Study|Lack of Efficacy|3
7795509|NCT01061723|12251547|FG002|Overall Study|Lack of Efficacy|4
7795510|NCT01061723|12251548|FG003|Overall Study|Lack of Efficacy|2
7795511|NCT01061723|12251549|FG004|Overall Study|Lack of Efficacy|1
7795512|NCT01061723|12251550|FG005|Overall Study|Lack of Efficacy|1
7795513|NCT01061723|12251545|FG000|Overall Study|Randomized but not treated|0
7795514|NCT01061723|12251546|FG001|Overall Study|Randomized but not treated|0
7795515|NCT01061723|12251547|FG002|Overall Study|Randomized but not treated|0
7795516|NCT01061723|12251548|FG003|Overall Study|Randomized but not treated|0
7795517|NCT01061723|12251549|FG004|Overall Study|Randomized but not treated|0
7795518|NCT01061723|12251550|FG005|Overall Study|Randomized but not treated|1
7795519|NCT01061723|12251545|FG000|Overall Study|Other than specified above|2
7795520|NCT01061723|12251546|FG001|Overall Study|Other than specified above|1
7795521|NCT01061723|12251547|FG002|Overall Study|Other than specified above|1
7795522|NCT01061723|12251548|FG003|Overall Study|Other than specified above|1
7795523|NCT01061723|12251549|FG004|Overall Study|Other than specified above|0
7795524|NCT01061723|12251550|FG005|Overall Study|Other than specified above|1
7795525|NCT01061736|12251579|FG000|Overall Study|Dose regimen not selected|0
7795526|NCT01061736|12251580|FG001|Overall Study|Dose regimen not selected|0
7795527|NCT01061736|12251581|FG002|Overall Study|Dose regimen not selected|0
7795528|NCT01061736|12251582|FG003|Overall Study|Dose regimen not selected|0
7795529|NCT01061736|12251583|FG004|Overall Study|Dose regimen not selected|0
7795530|NCT01061736|12251584|FG005|Overall Study|Dose regimen not selected|0
7795531|NCT01061736|12251585|FG006|Overall Study|Dose regimen not selected|79
7795532|NCT01061736|12251586|FG007|Overall Study|Dose regimen not selected|0
7795533|NCT01061736|12251587|FG008|Overall Study|Dose regimen not selected|0
7795534|NCT01061736|12251588|FG009|Overall Study|Dose regimen not selected|0
7795535|NCT01061736|12251579|FG000|Overall Study|Adverse Event|13
7795536|NCT01061736|12251580|FG001|Overall Study|Adverse Event|1
7795537|NCT01061736|12251581|FG002|Overall Study|Adverse Event|3
7795538|NCT01061736|12251582|FG003|Overall Study|Adverse Event|2
7795539|NCT01061736|12251583|FG004|Overall Study|Adverse Event|4
7795540|NCT01061736|12251584|FG005|Overall Study|Adverse Event|1
7795541|NCT01061736|12251585|FG006|Overall Study|Adverse Event|4
7795542|NCT01061736|12251586|FG007|Overall Study|Adverse Event|63
7795543|NCT01061736|12251587|FG008|Overall Study|Adverse Event|67
7795544|NCT01061736|12251588|FG009|Overall Study|Adverse Event|34
7795545|NCT01061736|12251579|FG000|Overall Study|Lack of Efficacy|0
7795546|NCT01061736|12251580|FG001|Overall Study|Lack of Efficacy|2
7795547|NCT01061736|12251581|FG002|Overall Study|Lack of Efficacy|1
7795548|NCT01061736|12251582|FG003|Overall Study|Lack of Efficacy|1
7795549|NCT01061736|12251583|FG004|Overall Study|Lack of Efficacy|1
7795550|NCT01061736|12251584|FG005|Overall Study|Lack of Efficacy|2
7795551|NCT01061736|12251585|FG006|Overall Study|Lack of Efficacy|1
7795552|NCT01061736|12251586|FG007|Overall Study|Lack of Efficacy|9
7795553|NCT01061736|12251587|FG008|Overall Study|Lack of Efficacy|9
7795554|NCT01061736|12251588|FG009|Overall Study|Lack of Efficacy|10
7795555|NCT01061736|12251579|FG000|Overall Study|Poor compliance to protocol|0
7795556|NCT01061736|12251580|FG001|Overall Study|Poor compliance to protocol|0
7795557|NCT01061736|12251581|FG002|Overall Study|Poor compliance to protocol|0
7795558|NCT01061736|12251582|FG003|Overall Study|Poor compliance to protocol|0
7795559|NCT01061736|12251583|FG004|Overall Study|Poor compliance to protocol|0
7795560|NCT01061736|12251584|FG005|Overall Study|Poor compliance to protocol|0
7795561|NCT01061736|12251585|FG006|Overall Study|Poor compliance to protocol|0
7795562|NCT01061736|12251586|FG007|Overall Study|Poor compliance to protocol|2
7795563|NCT01061736|12251587|FG008|Overall Study|Poor compliance to protocol|5
7795564|NCT01061736|12251588|FG009|Overall Study|Poor compliance to protocol|9
7795565|NCT01061736|12251579|FG000|Overall Study|Not treated|0
7795566|NCT01061736|12251580|FG001|Overall Study|Not treated|0
7795567|NCT01061736|12251581|FG002|Overall Study|Not treated|0
7795568|NCT01061736|12251582|FG003|Overall Study|Not treated|0
7795569|NCT01061736|12251583|FG004|Overall Study|Not treated|1
7795570|NCT01061736|12251584|FG005|Overall Study|Not treated|0
7795571|NCT01061736|12251585|FG006|Overall Study|Not treated|0
7795572|NCT01061736|12251586|FG007|Overall Study|Not treated|2
7795573|NCT01061736|12251587|FG008|Overall Study|Not treated|1
7795574|NCT01061736|12251588|FG009|Overall Study|Not treated|0
7795575|NCT01061736|12251579|FG000|Overall Study|Other than specified above|0
7795576|NCT01061736|12251580|FG001|Overall Study|Other than specified above|1
7795577|NCT01061736|12251581|FG002|Overall Study|Other than specified above|2
7795578|NCT01061736|12251582|FG003|Overall Study|Other than specified above|0
7795579|NCT01061736|12251583|FG004|Overall Study|Other than specified above|1
7795580|NCT01061736|12251584|FG005|Overall Study|Other than specified above|0
7795581|NCT01061736|12251585|FG006|Overall Study|Other than specified above|0
7795582|NCT01061736|12251586|FG007|Overall Study|Other than specified above|18
7795583|NCT01061736|12251587|FG008|Overall Study|Other than specified above|15
7795584|NCT01061736|12251588|FG009|Overall Study|Other than specified above|21
7795585|NCT01061775|12251613|FG000|Overall Study|Physician Decision|2
7795586|NCT01061775|12251613|FG000|Overall Study|Lost to Follow-up|1
7795587|NCT01061866|12251618|FG000|Overall Study|Adverse Event|2
7795588|NCT01062061|12251639|FG000|Overall Study|Enrolled more than once|2
7795589|NCT01062061|12251639|FG000|Overall Study|Investigated before study start|13
7795590|NCT01062061|12251639|FG000|Overall Study|Outside chief indications|10
7795591|NCT01062061|12251639|FG000|Overall Study|Failed to meet inclusion criteria|2
7795592|NCT01062113|12251654|FG000|Overall Study|Adverse Event|1
7795593|NCT01062113|12251655|FG001|Overall Study|Adverse Event|0
7795594|NCT01062113|12251656|FG002|Overall Study|Adverse Event|0
7795595|NCT01062113|12251654|FG000|Overall Study|Lack of Efficacy|38
7795596|NCT01062113|12251655|FG001|Overall Study|Lack of Efficacy|22
7795597|NCT01062113|12251656|FG002|Overall Study|Lack of Efficacy|31
7795598|NCT01062113|12251654|FG000|Overall Study|Withdrawal by Subject|1
7795599|NCT01062113|12251655|FG001|Overall Study|Withdrawal by Subject|0
7795600|NCT01062113|12251656|FG002|Overall Study|Withdrawal by Subject|0
7795601|NCT01062126|12251664|FG000|Overall Study|Death|209
7795602|NCT01062126|12251664|FG000|Overall Study|All Withdrawals|324
7795603|NCT01062256|12251679|FG000|Overall Study|Adverse Event|1
7795604|NCT01062256|12251680|FG001|Overall Study|Adverse Event|0
7795605|NCT01062256|12251681|FG002|Overall Study|Adverse Event|0
7795606|NCT01062256|12251679|FG000|Overall Study|Withdrawal by Subject|1
7795607|NCT01062256|12251680|FG001|Overall Study|Withdrawal by Subject|1
7795608|NCT01062256|12251681|FG002|Overall Study|Withdrawal by Subject|1
7795609|NCT01062256|12251679|FG000|Overall Study|Ineligible|1
7795610|NCT01062256|12251680|FG001|Overall Study|Ineligible|4
7795611|NCT01062256|12251681|FG002|Overall Study|Ineligible|3
7795612|NCT01062256|12251679|FG000|Overall Study|Administrative|0
7795613|NCT01062256|12251680|FG001|Overall Study|Administrative|2
7795614|NCT01062256|12251681|FG002|Overall Study|Administrative|0
7795615|NCT01062555|12251708|FG000|Phase 1|Death|10
7795616|NCT01062555|12251709|FG001|Phase 1|Death|17
7795617|NCT01062555|12251710|FG002|Phase 1|Death|0
7795618|NCT01062555|12251711|FG003|Phase 1|Death|0
7795619|NCT01062555|12251708|FG000|Phase 1|Graft Failure|12
7795620|NCT01062555|12251709|FG001|Phase 1|Graft Failure|8
7795621|NCT01062555|12251710|FG002|Phase 1|Graft Failure|0
7795622|NCT01062555|12251711|FG003|Phase 1|Graft Failure|0
7795623|NCT01062555|12251708|FG000|Phase 1|Withdrawal by Subject|1
7795624|NCT01062555|12251709|FG001|Phase 1|Withdrawal by Subject|1
7795625|NCT01062555|12251710|FG002|Phase 1|Withdrawal by Subject|0
7795626|NCT01062555|12251711|FG003|Phase 1|Withdrawal by Subject|0
7795627|NCT01062555|12251708|FG000|Phase 2|Death|0
7795628|NCT01062555|12251709|FG001|Phase 2|Death|0
7795629|NCT01062555|12251710|FG002|Phase 2|Death|8
7795630|NCT01062555|12251711|FG003|Phase 2|Death|3
7795631|NCT01062555|12251708|FG000|Phase 2|Graft failure|0
7795632|NCT01062555|12251709|FG001|Phase 2|Graft failure|0
7795633|NCT01062555|12251710|FG002|Phase 2|Graft failure|7
7795634|NCT01062555|12251711|FG003|Phase 2|Graft failure|4
7795635|NCT01062555|12251708|FG000|Phase 2|Withdrawal by Subject|0
7795636|NCT01062555|12251709|FG001|Phase 2|Withdrawal by Subject|0
7795637|NCT01062555|12251710|FG002|Phase 2|Withdrawal by Subject|0
7795638|NCT01062555|12251711|FG003|Phase 2|Withdrawal by Subject|7
7795639|NCT01062555|12251708|FG000|Phase 2|Protocol Violation|0
7795640|NCT01062555|12251709|FG001|Phase 2|Protocol Violation|0
7795641|NCT01062555|12251710|FG002|Phase 2|Protocol Violation|0
7795642|NCT01062555|12251711|FG003|Phase 2|Protocol Violation|3
7795643|NCT01062555|12251708|FG000|Phase 2|Physician Decision|0
7795644|NCT01062555|12251709|FG001|Phase 2|Physician Decision|0
7795645|NCT01062555|12251710|FG002|Phase 2|Physician Decision|0
7795646|NCT01062555|12251711|FG003|Phase 2|Physician Decision|17
7795647|NCT01062763|12251737|FG000|Overall Study|Adverse Event|3
7795648|NCT01062763|12251738|FG001|Overall Study|Adverse Event|4
7795649|NCT01062841|12251746|FG000|Overall Study|Indwelling Device Removed|41
7795650|NCT01062841|12251747|FG001|Overall Study|Indwelling Device Removed|48
7795651|NCT01062841|12251746|FG000|Overall Study|Death|3
7795652|NCT01062841|12251747|FG001|Overall Study|Death|5
7795653|NCT01062841|12251746|FG000|Overall Study|Withdrawal by Subject|2
7795654|NCT01062841|12251747|FG001|Overall Study|Withdrawal by Subject|0
7795655|NCT01062841|12251746|FG000|Overall Study|Withdrawal by Study|3
7795656|NCT01062841|12251747|FG001|Overall Study|Withdrawal by Study|0
7795657|NCT01062971|12251764|FG000|Overall Study|Protocol Violation|1
7795658|NCT01062971|12251765|FG001|Overall Study|Protocol Violation|3
7795659|NCT01062971|12251764|FG000|Overall Study|Lost to Follow-up|3
7795660|NCT01062971|12251765|FG001|Overall Study|Lost to Follow-up|4
7795661|NCT01063036|12251771|FG000|Participants Treated With Study Drug|Adverse Event|1
7795662|NCT01063036|12251771|FG000|Participants Treated With Study Drug|Protocol Violation|1
7795663|NCT01063036|12251771|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2
7795664|NCT01063036|12251771|FG000|Participants Treated With Study Drug|Lost to Follow-up|1
7795665|NCT01063036|12251771|FG000|Participants Treated With Study Drug|Pregnancy|1
7795666|NCT01063036|12251771|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
7795667|NCT01063036|12251771|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
7795668|NCT01063036|12251771|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
7795669|NCT01063062|12251790|FG000|Overall Study|Patient withdrew consent|0
7795670|NCT01063062|12251791|FG001|Overall Study|Patient withdrew consent|1
7795671|NCT01063062|12251790|FG000|Overall Study|Adverse Event|2
7795672|NCT01063062|12251791|FG001|Overall Study|Adverse Event|4
7795673|NCT01063062|12251790|FG000|Overall Study|Protocol Violation|5
7795674|NCT01063062|12251791|FG001|Overall Study|Protocol Violation|4
7795675|NCT01063062|12251790|FG000|Overall Study|Investigator's request|1
7795676|NCT01063062|12251791|FG001|Overall Study|Investigator's request|0
7795677|NCT01063062|12251790|FG000|Overall Study|Lost to Follow-up|0
7795678|NCT01063062|12251791|FG001|Overall Study|Lost to Follow-up|2
7795679|NCT01063062|12251790|FG000|Overall Study|Miscellaneous reason|0
7795680|NCT01063062|12251791|FG001|Overall Study|Miscellaneous reason|1
7795681|NCT01063153|12251813|FG000|Overall Study|Found Ineligible During Screening|2
7795682|NCT01063153|12251814|FG001|Overall Study|Found Ineligible During Screening|0
7795683|NCT01063153|12251813|FG000|Overall Study|Lost to Follow-up|0
7795684|NCT01063153|12251814|FG001|Overall Study|Lost to Follow-up|7
7795685|NCT01063153|12251813|FG000|Overall Study|Withdrawal by Subject|0
7795686|NCT01063153|12251814|FG001|Overall Study|Withdrawal by Subject|1
7795687|NCT01063153|12251813|FG000|Overall Study|Physician Decision|0
7795688|NCT01063153|12251814|FG001|Overall Study|Physician Decision|4
7795689|NCT01063283|12251826|FG000|Cycle 1|Adverse Event|2
7795690|NCT01063283|12251827|FG001|Cycle 1|Adverse Event|0
7795691|NCT01063283|12251828|FG002|Cycle 1|Adverse Event|0
7795692|NCT01063283|12251826|FG000|Cycle 1|Technical failure in data collection|1
7795693|NCT01063283|12251827|FG001|Cycle 1|Technical failure in data collection|0
7795694|NCT01063283|12251828|FG002|Cycle 1|Technical failure in data collection|0
7795695|NCT01063348|12251836|FG000|Overall Study|Lost to Follow-up|3
7795696|NCT01063348|12251837|FG001|Overall Study|Lost to Follow-up|10
7795697|NCT01063595|12251843|FG000|Enrolled in Study and Randomized|Reason not Specified|1
7795698|NCT01063595|12251844|FG001|Enrolled in Study and Randomized|Reason not Specified|0
7795699|NCT01063595|12251843|FG000|Enrolled in Study and Randomized|Adverse Event|0
7873539|NCT01693562|12367822|FG007|Escalation Phase|Withdrawal by Subject|0
7873540|NCT01693562|12367823|FG008|Escalation Phase|Withdrawal by Subject|0
7873541|NCT01693562|12367824|FG009|Escalation Phase|Withdrawal by Subject|0
7873542|NCT01693562|12367825|FG010|Escalation Phase|Withdrawal by Subject|0
7873543|NCT01693562|12367826|FG011|Escalation Phase|Withdrawal by Subject|0
7795700|NCT01063595|12251844|FG001|Enrolled in Study and Randomized|Adverse Event|1
7795701|NCT01063595|12251843|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
7795702|NCT01063595|12251844|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
7795703|NCT01063595|12251843|FG000|First Intervention|Adverse Event|1
7795704|NCT01063595|12251844|FG001|First Intervention|Adverse Event|4
7795705|NCT01063595|12251843|FG000|First Intervention|Withdrawal by Subject|1
7795706|NCT01063595|12251844|FG001|First Intervention|Withdrawal by Subject|0
7795707|NCT01063595|12251843|FG000|First Intervention|Reason not Specified|0
7795708|NCT01063595|12251844|FG001|First Intervention|Reason not Specified|1
7795709|NCT01063764|12251855|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4
7795710|NCT01063764|12251855|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
7795711|NCT01063764|12251855|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
7795712|NCT01063764|12251855|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3
7795713|NCT01063764|12251855|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
7795714|NCT01063764|12251855|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
7795715|NCT01063764|12251855|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
7795716|NCT01063855|12251878|FG000|Overall Study|Adverse Event|4
7795717|NCT01063855|12251879|FG001|Overall Study|Adverse Event|4
7795718|NCT01063855|12251878|FG000|Overall Study|Death|0
7795719|NCT01063855|12251879|FG001|Overall Study|Death|1
7795720|NCT01063855|12251878|FG000|Overall Study|Lost to Follow-up|8
7795721|NCT01063855|12251879|FG001|Overall Study|Lost to Follow-up|4
7795722|NCT01063855|12251878|FG000|Overall Study|Pregnancy|1
7795723|NCT01063855|12251879|FG001|Overall Study|Pregnancy|0
7795724|NCT01063855|12251878|FG000|Overall Study|Lack of Efficacy|0
7795725|NCT01063855|12251879|FG001|Overall Study|Lack of Efficacy|1
7795726|NCT01063855|12251878|FG000|Overall Study|Withdrawal by Subject|11
7795727|NCT01063855|12251879|FG001|Overall Study|Withdrawal by Subject|8
7795728|NCT01063855|12251878|FG000|Overall Study|Reason not specified|13
7795729|NCT01063855|12251879|FG001|Overall Study|Reason not specified|11
7795730|NCT01063868|12251891|FG000|Overall Study|Adverse Event|9
7795731|NCT01063868|12251892|FG001|Overall Study|Adverse Event|7
7795732|NCT01063868|12251891|FG000|Overall Study|Withdrawal by Subject|3
7795733|NCT01063868|12251892|FG001|Overall Study|Withdrawal by Subject|1
7795734|NCT01063868|12251891|FG000|Overall Study|Study Terminated By Sponsor|23
7795735|NCT01063868|12251892|FG001|Overall Study|Study Terminated By Sponsor|4
7795736|NCT01063881|12251901|FG000|Overall Study|Adverse Event|12
7795737|NCT01063881|12251902|FG001|Overall Study|Adverse Event|2
7795738|NCT01063881|12251903|FG002|Overall Study|Adverse Event|0
7795739|NCT01063881|12251901|FG000|Overall Study|Lost to Follow-up|13
7795740|NCT01063881|12251902|FG001|Overall Study|Lost to Follow-up|7
7795741|NCT01063881|12251903|FG002|Overall Study|Lost to Follow-up|1
7795742|NCT01063881|12251901|FG000|Overall Study|Withdrawal by Subject|25
7795743|NCT01063881|12251902|FG001|Overall Study|Withdrawal by Subject|1
7795744|NCT01063881|12251903|FG002|Overall Study|Withdrawal by Subject|0
7795745|NCT01063881|12251901|FG000|Overall Study|Reason for not completed not specified|5
7795746|NCT01063881|12251902|FG001|Overall Study|Reason for not completed not specified|1
7795747|NCT01063881|12251903|FG002|Overall Study|Reason for not completed not specified|0
7795748|NCT01063972|12251943|FG000|Overall Study|Death|12
7795749|NCT01063972|12251944|FG001|Overall Study|Death|11
7795750|NCT01063972|12251943|FG000|Overall Study|Incarcerated|2
7795751|NCT01063972|12251944|FG001|Overall Study|Incarcerated|1
7795752|NCT01064167|12251957|FG000|Overall Study|Protocol Violation|14
7795753|NCT01064167|12251958|FG001|Overall Study|Protocol Violation|15
7795754|NCT01064297|12251977|FG000|Overall Study|Lost to Follow-up|791
7795755|NCT01064297|12251978|FG001|Overall Study|Lost to Follow-up|48
7795756|NCT01064297|12251979|FG002|Overall Study|Lost to Follow-up|133
7795757|NCT01064310|12251996|FG000|Period 1|Adverse Event|7
7795758|NCT01064310|12251997|FG001|Period 1|Adverse Event|10
7795759|NCT01064310|12251998|FG002|Period 1|Adverse Event|0
7795760|NCT01064310|12251996|FG000|Period 1|Physician Decision|1
7795761|NCT01064310|12251997|FG001|Period 1|Physician Decision|0
7795762|NCT01064310|12251998|FG002|Period 1|Physician Decision|0
7795763|NCT01064310|12251996|FG000|Period 1|Withdrawal by Subject|2
7795764|NCT01064310|12251997|FG001|Period 1|Withdrawal by Subject|2
7795765|NCT01064310|12251998|FG002|Period 1|Withdrawal by Subject|0
7795766|NCT01064310|12251996|FG000|Period 1|Lack of Efficacy|3
7795767|NCT01064310|12251997|FG001|Period 1|Lack of Efficacy|5
7795768|NCT01064310|12251998|FG002|Period 1|Lack of Efficacy|0
7795769|NCT01064310|12251996|FG000|Period 1|Entered Open-label Period|1
7795770|NCT01064310|12251997|FG001|Period 1|Entered Open-label Period|1
7795771|NCT01064310|12251998|FG002|Period 1|Entered Open-label Period|0
7795772|NCT01064310|12251996|FG000|Period 2|Adverse Event|2
7795773|NCT01064310|12251997|FG001|Period 2|Adverse Event|1
7795774|NCT01064310|12251998|FG002|Period 2|Adverse Event|0
7795775|NCT01064310|12251996|FG000|Period 2|Physician Decision|0
7795776|NCT01064310|12251997|FG001|Period 2|Physician Decision|1
7795777|NCT01064310|12251998|FG002|Period 2|Physician Decision|0
7795778|NCT01064310|12251996|FG000|Period 2|Entered Open-label Period|1
7795779|NCT01064310|12251997|FG001|Period 2|Entered Open-label Period|0
7795780|NCT01064310|12251998|FG002|Period 2|Entered Open-label Period|0
7795781|NCT01064310|12251996|FG000|Period 2|Lack of Efficacy|1
7795782|NCT01064310|12251997|FG001|Period 2|Lack of Efficacy|4
7795783|NCT01064310|12251998|FG002|Period 2|Lack of Efficacy|0
7795784|NCT01064310|12251996|FG000|Open Label Pazopinib|Withdrawal by Subject|0
7795785|NCT01064310|12251997|FG001|Open Label Pazopinib|Withdrawal by Subject|0
7795786|NCT01064310|12251998|FG002|Open Label Pazopinib|Withdrawal by Subject|1
7795787|NCT01064310|12251996|FG000|Open Label Pazopinib|Adverse Event|0
7795788|NCT01064310|12251997|FG001|Open Label Pazopinib|Adverse Event|0
7795789|NCT01064310|12251998|FG002|Open Label Pazopinib|Adverse Event|12
7795790|NCT01064310|12251996|FG000|Open Label Pazopinib|Lack of Efficacy|0
7795791|NCT01064310|12251997|FG001|Open Label Pazopinib|Lack of Efficacy|0
7795792|NCT01064310|12251998|FG002|Open Label Pazopinib|Lack of Efficacy|51
7795793|NCT01064310|12251996|FG000|Open Label Pazopinib|Physician Decision|0
7795794|NCT01064310|12251997|FG001|Open Label Pazopinib|Physician Decision|0
7795795|NCT01064310|12251998|FG002|Open Label Pazopinib|Physician Decision|20
7795796|NCT01064401|12252022|FG000|Overall Study|Adverse Event|47
7795797|NCT01064401|12252023|FG001|Overall Study|Adverse Event|56
7795798|NCT01064401|12252022|FG000|Overall Study|Lack of Efficacy|46
7795799|NCT01064401|12252023|FG001|Overall Study|Lack of Efficacy|23
7795800|NCT01064401|12252022|FG000|Overall Study|Lost to Follow-up|12
7795801|NCT01064401|12252023|FG001|Overall Study|Lost to Follow-up|9
7795802|NCT01064401|12252022|FG000|Overall Study|Consent Withdrawn|98
7795803|NCT01064401|12252023|FG001|Overall Study|Consent Withdrawn|80
7795804|NCT01064401|12252022|FG000|Overall Study|Investigator Decision|4
7795805|NCT01064401|12252023|FG001|Overall Study|Investigator Decision|6
7795806|NCT01064401|12252022|FG000|Overall Study|Death|4
7795807|NCT01064401|12252023|FG001|Overall Study|Death|0
7795808|NCT01064401|12252022|FG000|Overall Study|Pregnancy|4
7795809|NCT01064401|12252023|FG001|Overall Study|Pregnancy|7
7795810|NCT01064401|12252022|FG000|Overall Study|Noncompliance|7
7795811|NCT01064401|12252023|FG001|Overall Study|Noncompliance|8
7795812|NCT01064401|12252022|FG000|Overall Study|Site Closure|4
7795813|NCT01064401|12252023|FG001|Overall Study|Site Closure|5
7795814|NCT01064401|12252022|FG000|Overall Study|Other|2
7795815|NCT01064401|12252023|FG001|Overall Study|Other|1
7795816|NCT01064414|12252033|FG000|Core Period: Baseline to Week 26|Adverse Event|4
7795817|NCT01064414|12252034|FG001|Core Period: Baseline to Week 26|Adverse Event|4
7795818|NCT01064414|12252035|FG002|Core Period: Baseline to Week 26|Adverse Event|2
7795819|NCT01064414|12252033|FG000|Core Period: Baseline to Week 26|Death|0
7795820|NCT01064414|12252034|FG001|Core Period: Baseline to Week 26|Death|1
7795821|NCT01064414|12252035|FG002|Core Period: Baseline to Week 26|Death|0
7795822|NCT01064414|12252033|FG000|Core Period: Baseline to Week 26|Protocol Violation|1
7795823|NCT01064414|12252034|FG001|Core Period: Baseline to Week 26|Protocol Violation|0
7795824|NCT01064414|12252035|FG002|Core Period: Baseline to Week 26|Protocol Violation|1
7795825|NCT01064414|12252033|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4
7795826|NCT01064414|12252034|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2
7795827|NCT01064414|12252035|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2
7795828|NCT01064414|12252033|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7795829|NCT01064414|12252034|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
7795830|NCT01064414|12252035|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7795831|NCT01064414|12252033|FG000|Core Period: Baseline to Week 26|Other|4
7795832|NCT01064414|12252034|FG001|Core Period: Baseline to Week 26|Other|7
7795833|NCT01064414|12252035|FG002|Core Period: Baseline to Week 26|Other|2
7795834|NCT01064414|12252033|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2
7795835|NCT01064414|12252034|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
7795836|NCT01064414|12252035|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2
7795837|NCT01064414|12252033|FG000|Extension Period: Week 26 to Week 52|Death|0
7795838|NCT01064414|12252034|FG001|Extension Period: Week 26 to Week 52|Death|1
7795839|NCT01064414|12252035|FG002|Extension Period: Week 26 to Week 52|Death|0
7795840|NCT01064414|12252033|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
7795841|NCT01064414|12252034|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7795842|NCT01064414|12252035|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7795843|NCT01064414|12252033|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1
7795844|NCT01064414|12252034|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0
7795845|NCT01064414|12252035|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0
7795846|NCT01064414|12252033|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7795847|NCT01064414|12252034|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7795848|NCT01064414|12252035|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7795849|NCT01064414|12252033|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
7795850|NCT01064414|12252034|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
7795851|NCT01064414|12252035|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
7795852|NCT01064414|12252033|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1
7795853|NCT01064414|12252034|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
7795854|NCT01064414|12252035|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1
7795855|NCT01064414|12252033|FG000|Extension Period: Week 26 to Week 52|Other|5
7795856|NCT01064414|12252034|FG001|Extension Period: Week 26 to Week 52|Other|2
7795857|NCT01064414|12252035|FG002|Extension Period: Week 26 to Week 52|Other|1
7795858|NCT01064531|12252048|FG000|Overall Study|Lost to Follow-up|0
7795859|NCT01064531|12252049|FG001|Overall Study|Lost to Follow-up|2
7795860|NCT01064531|12252048|FG000|Overall Study|Physician Decision|0
7795861|NCT01064531|12252049|FG001|Overall Study|Physician Decision|1
7795862|NCT01064531|12252048|FG000|Overall Study|Withdrawal by Subject|2
7795863|NCT01064531|12252049|FG001|Overall Study|Withdrawal by Subject|2
7795864|NCT01064531|12252048|FG000|Overall Study|Revision due to femoral stem loosening|1
7795865|NCT01064531|12252049|FG001|Overall Study|Revision due to femoral stem loosening|0
7795866|NCT01064531|12252048|FG000|Overall Study|Revision due to dislocation|0
7795867|NCT01064531|12252049|FG001|Overall Study|Revision due to dislocation|1
7795868|NCT01064531|12252048|FG000|Overall Study|Death|0
7795869|NCT01064531|12252049|FG001|Overall Study|Death|1
7795870|NCT01064622|12252058|FG000|Randomized Phase II|Withdrawal by Subject|2
7795871|NCT01064622|12252059|FG001|Randomized Phase II|Withdrawal by Subject|2
7795872|NCT01064622|12252058|FG000|Randomized Phase II|Protocol Violation|0
7795873|NCT01064622|12252059|FG001|Randomized Phase II|Protocol Violation|1
7795874|NCT01064687|12252072|FG000|Overall Study|Adverse Event|9
7795875|NCT01064687|12252073|FG001|Overall Study|Adverse Event|4
7795876|NCT01064687|12252074|FG002|Overall Study|Adverse Event|10
7795877|NCT01064687|12252075|FG003|Overall Study|Adverse Event|3
7795878|NCT01064687|12252072|FG000|Overall Study|Death|1
7795879|NCT01064687|12252073|FG001|Overall Study|Death|1
7795880|NCT01064687|12252074|FG002|Overall Study|Death|0
7795881|NCT01064687|12252075|FG003|Overall Study|Death|0
7795882|NCT01064687|12252072|FG000|Overall Study|Entry Criteria Not Met|3
7795883|NCT01064687|12252073|FG001|Overall Study|Entry Criteria Not Met|0
7795884|NCT01064687|12252074|FG002|Overall Study|Entry Criteria Not Met|0
7795885|NCT01064687|12252075|FG003|Overall Study|Entry Criteria Not Met|0
7795886|NCT01064687|12252072|FG000|Overall Study|Lack of Efficacy|1
7795887|NCT01064687|12252073|FG001|Overall Study|Lack of Efficacy|0
7795888|NCT01064687|12252074|FG002|Overall Study|Lack of Efficacy|2
7795889|NCT01064687|12252075|FG003|Overall Study|Lack of Efficacy|3
7795890|NCT01064687|12252072|FG000|Overall Study|Lost to Follow-up|7
7795891|NCT01064687|12252073|FG001|Overall Study|Lost to Follow-up|10
7795892|NCT01064687|12252074|FG002|Overall Study|Lost to Follow-up|13
7795893|NCT01064687|12252075|FG003|Overall Study|Lost to Follow-up|5
7795894|NCT01064687|12252072|FG000|Overall Study|Physician Decision|2
7795895|NCT01064687|12252073|FG001|Overall Study|Physician Decision|2
7795896|NCT01064687|12252074|FG002|Overall Study|Physician Decision|0
7795897|NCT01064687|12252075|FG003|Overall Study|Physician Decision|0
7795898|NCT01064687|12252072|FG000|Overall Study|Protocol Violation|1
7795899|NCT01064687|12252073|FG001|Overall Study|Protocol Violation|1
7795900|NCT01064687|12252074|FG002|Overall Study|Protocol Violation|0
7795901|NCT01064687|12252075|FG003|Overall Study|Protocol Violation|1
7795902|NCT01064687|12252072|FG000|Overall Study|Sponsor Decision|0
7795903|NCT01064687|12252073|FG001|Overall Study|Sponsor Decision|0
7795904|NCT01064687|12252074|FG002|Overall Study|Sponsor Decision|3
7795905|NCT01064687|12252075|FG003|Overall Study|Sponsor Decision|0
7795906|NCT01064687|12252072|FG000|Overall Study|Withdrawal by Subject|9
7795907|NCT01064687|12252073|FG001|Overall Study|Withdrawal by Subject|7
7795908|NCT01064687|12252074|FG002|Overall Study|Withdrawal by Subject|12
7795909|NCT01064687|12252075|FG003|Overall Study|Withdrawal by Subject|5
7795910|NCT01064687|12252072|FG000|Overall Study|Treatment Noncompliance|1
7795911|NCT01064687|12252073|FG001|Overall Study|Treatment Noncompliance|1
7795912|NCT01064687|12252074|FG002|Overall Study|Treatment Noncompliance|1
7795913|NCT01064687|12252075|FG003|Overall Study|Treatment Noncompliance|0
7795914|NCT01064739|12252105|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1
7795915|NCT01064856|12252128|FG000|Double-blind (DB) Period|Adverse Event|1
7795916|NCT01064856|12252129|FG001|Double-blind (DB) Period|Adverse Event|0
7795917|NCT01064856|12252130|FG002|Double-blind (DB) Period|Adverse Event|0
7795918|NCT01064856|12252131|FG003|Double-blind (DB) Period|Adverse Event|0
7795919|NCT01064856|12252128|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1
7795920|NCT01064856|12252129|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0
7795921|NCT01064856|12252130|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0
7795922|NCT01064856|12252131|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0
7795923|NCT01064856|12252128|FG000|Open-label (OL) Period|Adverse Event|0
7795924|NCT01064856|12252129|FG001|Open-label (OL) Period|Adverse Event|0
7795925|NCT01064856|12252130|FG002|Open-label (OL) Period|Adverse Event|12
7795926|NCT01064856|12252131|FG003|Open-label (OL) Period|Adverse Event|6
7795927|NCT01064856|12252128|FG000|Open-label (OL) Period|Consent withdrawn by participant|0
7795928|NCT01064856|12252129|FG001|Open-label (OL) Period|Consent withdrawn by participant|0
7795929|NCT01064856|12252130|FG002|Open-label (OL) Period|Consent withdrawn by participant|5
7795930|NCT01064856|12252131|FG003|Open-label (OL) Period|Consent withdrawn by participant|6
7795931|NCT01064856|12252128|FG000|Open-label (OL) Period|Lost to Follow-up|0
7795932|NCT01064856|12252129|FG001|Open-label (OL) Period|Lost to Follow-up|0
7795933|NCT01064856|12252130|FG002|Open-label (OL) Period|Lost to Follow-up|2
7795934|NCT01064856|12252131|FG003|Open-label (OL) Period|Lost to Follow-up|1
7795935|NCT01064856|12252128|FG000|Open-label (OL) Period|Other|0
7795936|NCT01064856|12252129|FG001|Open-label (OL) Period|Other|0
7795937|NCT01064856|12252130|FG002|Open-label (OL) Period|Other|7
7795938|NCT01064856|12252131|FG003|Open-label (OL) Period|Other|7
7795939|NCT01064947|12252151|FG000|Overall Study|negative culture|41
7795940|NCT01065350|12252161|FG000|Overall Study|Received incorrect drug allocation|0
7795941|NCT01065350|12252162|FG001|Overall Study|Received incorrect drug allocation|1
7795942|NCT01065597|12252210|FG000|Overall Study|Adverse Event|1
7795943|NCT01065766|12252221|FG000|Overall Study|Assessed before the contracted date|1
7795944|NCT01065766|12252221|FG000|Overall Study|Contraindication to administration|6
7795945|NCT01065766|12252221|FG000|Overall Study|Violated dosage/administration|25
7795946|NCT01065844|12252225|FG000|Overall Study|Adverse Event|5
7795947|NCT01066000|12252229|FG000|Overall Study|Protocol Violation|4
7795948|NCT01066000|12252229|FG000|Overall Study|Death|3
7795949|NCT01066000|12252229|FG000|Overall Study|Withdrawal by Subject|1
7795950|NCT01066000|12252229|FG000|Overall Study|Adverse Event|1
7795951|NCT01066039|12252239|FG000|Overall Study|Adverse Event|6
7795952|NCT01066039|12252239|FG000|Overall Study|Withdrawal by Subject|17
7795953|NCT01066039|12252239|FG000|Overall Study|Protocol Violation|2
7795954|NCT01066039|12252239|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9
7795955|NCT01066039|12252239|FG000|Overall Study|Investigator's Request|1
7795956|NCT01066039|12252239|FG000|Overall Study|Dropout due to Insulin Administration|1
7795957|NCT01066039|12252239|FG000|Overall Study|Additional Antihypertensive Required|4
7873544|NCT01693562|12367827|FG012|Escalation Phase|Withdrawal by Subject|0
7873545|NCT01693562|12367828|FG013|Escalation Phase|Withdrawal by Subject|0
7873546|NCT01693562|12367829|FG014|Escalation Phase|Withdrawal by Subject|0
7873547|NCT01693562|12367830|FG015|Escalation Phase|Withdrawal by Subject|0
7873548|NCT01693562|12367831|FG016|Escalation Phase|Withdrawal by Subject|0
7873549|NCT01693562|12367832|FG017|Escalation Phase|Withdrawal by Subject|0
7873550|NCT01693562|12367833|FG018|Escalation Phase|Withdrawal by Subject|0
7873551|NCT01693562|12367834|FG019|Escalation Phase|Withdrawal by Subject|0
7873552|NCT01693562|12367835|FG020|Escalation Phase|Withdrawal by Subject|0
7873553|NCT01693562|12367836|FG021|Escalation Phase|Withdrawal by Subject|0
7873554|NCT01693562|12367837|FG022|Escalation Phase|Withdrawal by Subject|0
7873555|NCT01693562|12367815|FG000|Escalation Phase|Death|4
7873556|NCT01693562|12367816|FG001|Escalation Phase|Death|2
7873557|NCT01693562|12367817|FG002|Escalation Phase|Death|0
7873558|NCT01693562|12367818|FG003|Escalation Phase|Death|3
7873559|NCT01693562|12367819|FG004|Escalation Phase|Death|6
7873560|NCT01693562|12367820|FG005|Escalation Phase|Death|4
7873561|NCT01693562|12367821|FG006|Escalation Phase|Death|0
7873562|NCT01693562|12367822|FG007|Escalation Phase|Death|0
7873563|NCT01693562|12367823|FG008|Escalation Phase|Death|0
7873564|NCT01693562|12367824|FG009|Escalation Phase|Death|0
7873565|NCT01693562|12367825|FG010|Escalation Phase|Death|0
7873566|NCT01693562|12367826|FG011|Escalation Phase|Death|0
7873567|NCT01693562|12367827|FG012|Escalation Phase|Death|0
7873568|NCT01693562|12367828|FG013|Escalation Phase|Death|0
7873569|NCT01693562|12367829|FG014|Escalation Phase|Death|0
7873570|NCT01693562|12367830|FG015|Escalation Phase|Death|0
7873571|NCT01693562|12367831|FG016|Escalation Phase|Death|0
7873572|NCT01693562|12367832|FG017|Escalation Phase|Death|0
7873573|NCT01693562|12367833|FG018|Escalation Phase|Death|0
7873574|NCT01693562|12367834|FG019|Escalation Phase|Death|0
7873575|NCT01693562|12367835|FG020|Escalation Phase|Death|0
7873576|NCT01693562|12367836|FG021|Escalation Phase|Death|0
7873577|NCT01693562|12367837|FG022|Escalation Phase|Death|0
7873578|NCT01693562|12367815|FG000|Escalation Phase|Lost to Follow-up|0
7873579|NCT01693562|12367816|FG001|Escalation Phase|Lost to Follow-up|1
7873580|NCT01693562|12367817|FG002|Escalation Phase|Lost to Follow-up|1
7873581|NCT01693562|12367818|FG003|Escalation Phase|Lost to Follow-up|0
7873582|NCT01693562|12367819|FG004|Escalation Phase|Lost to Follow-up|0
7873583|NCT01693562|12367820|FG005|Escalation Phase|Lost to Follow-up|0
7873584|NCT01693562|12367821|FG006|Escalation Phase|Lost to Follow-up|0
7873585|NCT01693562|12367822|FG007|Escalation Phase|Lost to Follow-up|0
7873586|NCT01693562|12367823|FG008|Escalation Phase|Lost to Follow-up|0
7873587|NCT01693562|12367824|FG009|Escalation Phase|Lost to Follow-up|0
7873588|NCT01693562|12367825|FG010|Escalation Phase|Lost to Follow-up|0
7873589|NCT01693562|12367826|FG011|Escalation Phase|Lost to Follow-up|0
7873590|NCT01693562|12367827|FG012|Escalation Phase|Lost to Follow-up|0
7873591|NCT01693562|12367828|FG013|Escalation Phase|Lost to Follow-up|0
7873592|NCT01693562|12367829|FG014|Escalation Phase|Lost to Follow-up|0
7873593|NCT01693562|12367830|FG015|Escalation Phase|Lost to Follow-up|0
7873594|NCT01693562|12367831|FG016|Escalation Phase|Lost to Follow-up|0
7873595|NCT01693562|12367832|FG017|Escalation Phase|Lost to Follow-up|0
7873596|NCT01693562|12367833|FG018|Escalation Phase|Lost to Follow-up|0
7873597|NCT01693562|12367834|FG019|Escalation Phase|Lost to Follow-up|0
7873598|NCT01693562|12367835|FG020|Escalation Phase|Lost to Follow-up|0
7873599|NCT01693562|12367836|FG021|Escalation Phase|Lost to Follow-up|0
7873600|NCT01693562|12367837|FG022|Escalation Phase|Lost to Follow-up|0
7873601|NCT01693562|12367815|FG000|Escalation Phase|Other|0
7873602|NCT01693562|12367816|FG001|Escalation Phase|Other|0
7873603|NCT01693562|12367817|FG002|Escalation Phase|Other|2
7873604|NCT01693562|12367818|FG003|Escalation Phase|Other|0
7873605|NCT01693562|12367819|FG004|Escalation Phase|Other|0
7873606|NCT01693562|12367820|FG005|Escalation Phase|Other|1
7873607|NCT01693562|12367821|FG006|Escalation Phase|Other|0
7873608|NCT01693562|12367822|FG007|Escalation Phase|Other|0
7873609|NCT01693562|12367823|FG008|Escalation Phase|Other|0
7873610|NCT01693562|12367824|FG009|Escalation Phase|Other|0
7873611|NCT01693562|12367825|FG010|Escalation Phase|Other|0
7873612|NCT01693562|12367826|FG011|Escalation Phase|Other|0
7873613|NCT01693562|12367827|FG012|Escalation Phase|Other|0
7873614|NCT01693562|12367828|FG013|Escalation Phase|Other|0
7795958|NCT01066039|12252239|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2
7795959|NCT01066039|12252239|FG000|Overall Study|Failure to Control Blood Pressure|1
7795960|NCT01066039|12252239|FG000|Overall Study|Drug/Dose Adjustment Required|1
7795961|NCT01066052|12252245|FG000|Overall Study|Enrolled But Not Treated|3
7795962|NCT01066052|12252246|FG001|Overall Study|Enrolled But Not Treated|0
7795963|NCT01066104|12252253|FG000|Overall Study|Adverse Event|1
7795964|NCT01066104|12252254|FG001|Overall Study|Adverse Event|1
7795965|NCT01066104|12252253|FG000|Overall Study|Protocol Violation|1
7795966|NCT01066104|12252254|FG001|Overall Study|Protocol Violation|0
7795967|NCT01066143|12252260|FG000|Overall Study|ineligible for the study|8
7795968|NCT01066156|12252264|FG000|Overall Study|ineligible|2
7795969|NCT01066156|12252264|FG000|Overall Study|Lost to Follow-up|7
7795970|NCT01066156|12252264|FG000|Overall Study|Withdrawal by Subject|1
7795971|NCT01066546|12252290|FG000|Overall Study|Study terminated by sponsor|5
7795972|NCT01066585|12252296|FG000|Overall Study|Protocol Violation|1
7795973|NCT01066585|12252297|FG001|Overall Study|Protocol Violation|0
7795974|NCT01066585|12252296|FG000|Overall Study|Withdrawal by Subject|0
7795975|NCT01066585|12252297|FG001|Overall Study|Withdrawal by Subject|3
7873615|NCT01693562|12367829|FG014|Escalation Phase|Other|0
7873616|NCT01693562|12367830|FG015|Escalation Phase|Other|0
7873617|NCT01693562|12367831|FG016|Escalation Phase|Other|0
7873618|NCT01693562|12367832|FG017|Escalation Phase|Other|0
7873619|NCT01693562|12367833|FG018|Escalation Phase|Other|0
7873620|NCT01693562|12367834|FG019|Escalation Phase|Other|0
7873621|NCT01693562|12367835|FG020|Escalation Phase|Other|0
7873622|NCT01693562|12367836|FG021|Escalation Phase|Other|0
7873623|NCT01693562|12367837|FG022|Escalation Phase|Other|0
7873624|NCT01693562|12367815|FG000|Exploration Phase|Withdrawal by Subject|0
7873625|NCT01693562|12367816|FG001|Exploration Phase|Withdrawal by Subject|0
7873626|NCT01693562|12367817|FG002|Exploration Phase|Withdrawal by Subject|0
7873627|NCT01693562|12367818|FG003|Exploration Phase|Withdrawal by Subject|0
7873628|NCT01693562|12367819|FG004|Exploration Phase|Withdrawal by Subject|0
7873629|NCT01693562|12367820|FG005|Exploration Phase|Withdrawal by Subject|0
7873630|NCT01693562|12367821|FG006|Exploration Phase|Withdrawal by Subject|2
7873631|NCT01693562|12367822|FG007|Exploration Phase|Withdrawal by Subject|0
7873632|NCT01693562|12367823|FG008|Exploration Phase|Withdrawal by Subject|0
7873633|NCT01693562|12367824|FG009|Exploration Phase|Withdrawal by Subject|0
7873634|NCT01693562|12367825|FG010|Exploration Phase|Withdrawal by Subject|0
7873635|NCT01693562|12367826|FG011|Exploration Phase|Withdrawal by Subject|0
7873636|NCT01693562|12367827|FG012|Exploration Phase|Withdrawal by Subject|0
7873637|NCT01693562|12367828|FG013|Exploration Phase|Withdrawal by Subject|0
7873638|NCT01693562|12367829|FG014|Exploration Phase|Withdrawal by Subject|0
7873639|NCT01693562|12367830|FG015|Exploration Phase|Withdrawal by Subject|0
7873640|NCT01693562|12367831|FG016|Exploration Phase|Withdrawal by Subject|0
7873641|NCT01693562|12367832|FG017|Exploration Phase|Withdrawal by Subject|0
7873642|NCT01693562|12367833|FG018|Exploration Phase|Withdrawal by Subject|0
7873643|NCT01693562|12367834|FG019|Exploration Phase|Withdrawal by Subject|0
7873644|NCT01693562|12367835|FG020|Exploration Phase|Withdrawal by Subject|0
7873645|NCT01693562|12367836|FG021|Exploration Phase|Withdrawal by Subject|0
7873646|NCT01693562|12367837|FG022|Exploration Phase|Withdrawal by Subject|0
7873647|NCT01693562|12367815|FG000|Exploration Phase|Death|0
7873648|NCT01693562|12367816|FG001|Exploration Phase|Death|0
7873649|NCT01693562|12367817|FG002|Exploration Phase|Death|0
7873650|NCT01693562|12367818|FG003|Exploration Phase|Death|0
7873651|NCT01693562|12367819|FG004|Exploration Phase|Death|0
7873652|NCT01693562|12367820|FG005|Exploration Phase|Death|0
7873653|NCT01693562|12367821|FG006|Exploration Phase|Death|17
7873654|NCT01693562|12367822|FG007|Exploration Phase|Death|0
7873655|NCT01693562|12367823|FG008|Exploration Phase|Death|0
7873656|NCT01693562|12367824|FG009|Exploration Phase|Death|0
7873657|NCT01693562|12367825|FG010|Exploration Phase|Death|0
7873658|NCT01693562|12367826|FG011|Exploration Phase|Death|0
7873659|NCT01693562|12367827|FG012|Exploration Phase|Death|0
7873660|NCT01693562|12367828|FG013|Exploration Phase|Death|0
7873661|NCT01693562|12367829|FG014|Exploration Phase|Death|0
7873662|NCT01693562|12367830|FG015|Exploration Phase|Death|0
7873663|NCT01693562|12367831|FG016|Exploration Phase|Death|0
7873664|NCT01693562|12367832|FG017|Exploration Phase|Death|0
7873665|NCT01693562|12367833|FG018|Exploration Phase|Death|0
7873666|NCT01693562|12367834|FG019|Exploration Phase|Death|0
7873667|NCT01693562|12367835|FG020|Exploration Phase|Death|0
7873668|NCT01693562|12367836|FG021|Exploration Phase|Death|0
7873669|NCT01693562|12367837|FG022|Exploration Phase|Death|0
7873670|NCT01693562|12367815|FG000|Exploration Phase|Other|0
7873671|NCT01693562|12367816|FG001|Exploration Phase|Other|0
7873672|NCT01693562|12367817|FG002|Exploration Phase|Other|0
7873673|NCT01693562|12367818|FG003|Exploration Phase|Other|0
7873674|NCT01693562|12367819|FG004|Exploration Phase|Other|0
7873675|NCT01693562|12367820|FG005|Exploration Phase|Other|0
7873676|NCT01693562|12367821|FG006|Exploration Phase|Other|2
7873677|NCT01693562|12367822|FG007|Exploration Phase|Other|0
7873678|NCT01693562|12367823|FG008|Exploration Phase|Other|0
7873679|NCT01693562|12367824|FG009|Exploration Phase|Other|0
7873680|NCT01693562|12367825|FG010|Exploration Phase|Other|0
7873681|NCT01693562|12367826|FG011|Exploration Phase|Other|0
7873682|NCT01693562|12367827|FG012|Exploration Phase|Other|0
7873683|NCT01693562|12367828|FG013|Exploration Phase|Other|0
7873684|NCT01693562|12367829|FG014|Exploration Phase|Other|0
7873685|NCT01693562|12367830|FG015|Exploration Phase|Other|0
7795976|NCT01066780|12252316|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1
7795977|NCT01066780|12252317|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1
7795978|NCT01066793|12252327|FG000|Overall Study|Death|4
7795979|NCT01066793|12252328|FG001|Overall Study|Death|1
7795980|NCT01066793|12252329|FG002|Overall Study|Death|1
7795981|NCT01066793|12252330|FG003|Overall Study|Death|0
7795982|NCT01066793|12252331|FG004|Overall Study|Death|0
7795983|NCT01066793|12252332|FG005|Overall Study|Death|0
7795984|NCT01066793|12252327|FG000|Overall Study|Lack of Efficacy|2
7795985|NCT01066793|12252328|FG001|Overall Study|Lack of Efficacy|1
7795986|NCT01066793|12252329|FG002|Overall Study|Lack of Efficacy|0
7795987|NCT01066793|12252330|FG003|Overall Study|Lack of Efficacy|0
7795988|NCT01066793|12252331|FG004|Overall Study|Lack of Efficacy|0
7795989|NCT01066793|12252332|FG005|Overall Study|Lack of Efficacy|0
7795990|NCT01066793|12252327|FG000|Overall Study|Lost to Follow-up|180
7795991|NCT01066793|12252328|FG001|Overall Study|Lost to Follow-up|39
7795992|NCT01066793|12252329|FG002|Overall Study|Lost to Follow-up|82
7795993|NCT01066793|12252330|FG003|Overall Study|Lost to Follow-up|16
7795994|NCT01066793|12252331|FG004|Overall Study|Lost to Follow-up|0
7795995|NCT01066793|12252332|FG005|Overall Study|Lost to Follow-up|1
7795996|NCT01066793|12252327|FG000|Overall Study|Physician Decision|3
7795997|NCT01066793|12252328|FG001|Overall Study|Physician Decision|0
7795998|NCT01066793|12252329|FG002|Overall Study|Physician Decision|0
7795999|NCT01066793|12252330|FG003|Overall Study|Physician Decision|0
7796000|NCT01066793|12252331|FG004|Overall Study|Physician Decision|0
7796001|NCT01066793|12252332|FG005|Overall Study|Physician Decision|0
7796002|NCT01066793|12252327|FG000|Overall Study|Protocol Violation|3
7796003|NCT01066793|12252328|FG001|Overall Study|Protocol Violation|2
7796004|NCT01066793|12252329|FG002|Overall Study|Protocol Violation|2
7796005|NCT01066793|12252330|FG003|Overall Study|Protocol Violation|0
7796006|NCT01066793|12252331|FG004|Overall Study|Protocol Violation|0
7796007|NCT01066793|12252332|FG005|Overall Study|Protocol Violation|0
7796008|NCT01066793|12252327|FG000|Overall Study|Withdrawal by Subject|7
7796009|NCT01066793|12252328|FG001|Overall Study|Withdrawal by Subject|4
7796010|NCT01066793|12252329|FG002|Overall Study|Withdrawal by Subject|1
7796011|NCT01066793|12252330|FG003|Overall Study|Withdrawal by Subject|0
7796012|NCT01066793|12252331|FG004|Overall Study|Withdrawal by Subject|0
7796013|NCT01066793|12252332|FG005|Overall Study|Withdrawal by Subject|0
7796014|NCT01066793|12252327|FG000|Overall Study|Early Termination|3
7796015|NCT01066793|12252328|FG001|Overall Study|Early Termination|0
7796016|NCT01066793|12252329|FG002|Overall Study|Early Termination|0
7796017|NCT01066793|12252330|FG003|Overall Study|Early Termination|0
7796018|NCT01066793|12252331|FG004|Overall Study|Early Termination|0
7796019|NCT01066793|12252332|FG005|Overall Study|Early Termination|0
7796020|NCT01066793|12252327|FG000|Overall Study|Lab test not done|7
7796021|NCT01066793|12252328|FG001|Overall Study|Lab test not done|0
7796022|NCT01066793|12252329|FG002|Overall Study|Lab test not done|0
7796023|NCT01066793|12252330|FG003|Overall Study|Lab test not done|1
7796024|NCT01066793|12252331|FG004|Overall Study|Lab test not done|0
7796025|NCT01066793|12252332|FG005|Overall Study|Lab test not done|0
7796026|NCT01066793|12252327|FG000|Overall Study|Miscellaneous|4
7796027|NCT01066793|12252328|FG001|Overall Study|Miscellaneous|5
7796028|NCT01066793|12252329|FG002|Overall Study|Miscellaneous|6
7796029|NCT01066793|12252330|FG003|Overall Study|Miscellaneous|0
7796030|NCT01066793|12252331|FG004|Overall Study|Miscellaneous|0
7796031|NCT01066793|12252332|FG005|Overall Study|Miscellaneous|0
7796032|NCT01066793|12252327|FG000|Overall Study|Non-responders|104
7796033|NCT01066793|12252328|FG001|Overall Study|Non-responders|5
7796034|NCT01066793|12252329|FG002|Overall Study|Non-responders|11
7796035|NCT01066793|12252330|FG003|Overall Study|Non-responders|25
7796036|NCT01066793|12252331|FG004|Overall Study|Non-responders|0
7796037|NCT01066793|12252332|FG005|Overall Study|Non-responders|0
7796038|NCT01066793|12252327|FG000|Overall Study|Other|15
7796039|NCT01066793|12252328|FG001|Overall Study|Other|5
7796040|NCT01066793|12252329|FG002|Overall Study|Other|6
7873686|NCT01693562|12367831|FG016|Exploration Phase|Other|0
7873687|NCT01693562|12367832|FG017|Exploration Phase|Other|0
7873688|NCT01693562|12367833|FG018|Exploration Phase|Other|0
7873689|NCT01693562|12367834|FG019|Exploration Phase|Other|0
7873690|NCT01693562|12367835|FG020|Exploration Phase|Other|0
7796041|NCT01066793|12252330|FG003|Overall Study|Other|2
7796042|NCT01066793|12252331|FG004|Overall Study|Other|0
7796043|NCT01066793|12252332|FG005|Overall Study|Other|0
7796044|NCT01066793|12252327|FG000|Overall Study|Relapse|20
7796045|NCT01066793|12252328|FG001|Overall Study|Relapse|8
7796046|NCT01066793|12252329|FG002|Overall Study|Relapse|2
7796047|NCT01066793|12252330|FG003|Overall Study|Relapse|3
7796048|NCT01066793|12252331|FG004|Overall Study|Relapse|0
7796049|NCT01066793|12252332|FG005|Overall Study|Relapse|0
7796050|NCT01066793|12252327|FG000|Overall Study|Result Not Available|1
7796051|NCT01066793|12252328|FG001|Overall Study|Result Not Available|0
7796052|NCT01066793|12252329|FG002|Overall Study|Result Not Available|0
7873691|NCT01693562|12367836|FG021|Exploration Phase|Other|0
7873692|NCT01693562|12367837|FG022|Exploration Phase|Other|0
7873693|NCT01693562|12367815|FG000|Expansion Phase|Withdrawal by Subject|0
7873694|NCT01693562|12367816|FG001|Expansion Phase|Withdrawal by Subject|0
7873695|NCT01693562|12367817|FG002|Expansion Phase|Withdrawal by Subject|0
7873696|NCT01693562|12367818|FG003|Expansion Phase|Withdrawal by Subject|0
7873697|NCT01693562|12367819|FG004|Expansion Phase|Withdrawal by Subject|0
7796053|NCT01066793|12252330|FG003|Overall Study|Result Not Available|0
7796054|NCT01066793|12252331|FG004|Overall Study|Result Not Available|0
7796055|NCT01066793|12252332|FG005|Overall Study|Result Not Available|0
7796056|NCT01066793|12252327|FG000|Overall Study|Treatment Interrupted|1
7796057|NCT01066793|12252328|FG001|Overall Study|Treatment Interrupted|1
7796058|NCT01066793|12252329|FG002|Overall Study|Treatment Interrupted|0
7796059|NCT01066793|12252330|FG003|Overall Study|Treatment Interrupted|0
7796060|NCT01066793|12252331|FG004|Overall Study|Treatment Interrupted|0
7796061|NCT01066793|12252332|FG005|Overall Study|Treatment Interrupted|0
7796062|NCT01066793|12252327|FG000|Overall Study|Treatment Never Started|18
7796063|NCT01066793|12252328|FG001|Overall Study|Treatment Never Started|5
7796064|NCT01066793|12252329|FG002|Overall Study|Treatment Never Started|4
7796065|NCT01066793|12252330|FG003|Overall Study|Treatment Never Started|1
7796066|NCT01066793|12252331|FG004|Overall Study|Treatment Never Started|0
7796067|NCT01066793|12252332|FG005|Overall Study|Treatment Never Started|0
7796068|NCT01066793|12252327|FG000|Overall Study|Treatment Stopped|2
7796069|NCT01066793|12252328|FG001|Overall Study|Treatment Stopped|1
7796070|NCT01066793|12252329|FG002|Overall Study|Treatment Stopped|0
7796071|NCT01066793|12252330|FG003|Overall Study|Treatment Stopped|1
7796072|NCT01066793|12252331|FG004|Overall Study|Treatment Stopped|0
7796073|NCT01066793|12252332|FG005|Overall Study|Treatment Stopped|0
7796074|NCT01066819|12252353|FG000|Overall Study|Adverse Event|18
7796075|NCT01066819|12252354|FG001|Overall Study|Adverse Event|1
7796076|NCT01066819|12252355|FG002|Overall Study|Adverse Event|6
7796077|NCT01066819|12252356|FG003|Overall Study|Adverse Event|0
7796078|NCT01066819|12252357|FG004|Overall Study|Adverse Event|0
7796079|NCT01066819|12252358|FG005|Overall Study|Adverse Event|0
7796080|NCT01066819|12252353|FG000|Overall Study|Death|5
7796081|NCT01066819|12252354|FG001|Overall Study|Death|0
7796082|NCT01066819|12252355|FG002|Overall Study|Death|1
7796083|NCT01066819|12252356|FG003|Overall Study|Death|0
7796084|NCT01066819|12252357|FG004|Overall Study|Death|0
7796085|NCT01066819|12252358|FG005|Overall Study|Death|0
7796086|NCT01066819|12252353|FG000|Overall Study|Lack of Efficacy|22
7796087|NCT01066819|12252354|FG001|Overall Study|Lack of Efficacy|1
7796088|NCT01066819|12252355|FG002|Overall Study|Lack of Efficacy|2
7796089|NCT01066819|12252356|FG003|Overall Study|Lack of Efficacy|1
7796090|NCT01066819|12252357|FG004|Overall Study|Lack of Efficacy|0
7796091|NCT01066819|12252358|FG005|Overall Study|Lack of Efficacy|0
7796092|NCT01066819|12252353|FG000|Overall Study|Physician Decision|6
7796093|NCT01066819|12252354|FG001|Overall Study|Physician Decision|2
7796094|NCT01066819|12252355|FG002|Overall Study|Physician Decision|3
7796095|NCT01066819|12252356|FG003|Overall Study|Physician Decision|0
7796096|NCT01066819|12252357|FG004|Overall Study|Physician Decision|0
7796097|NCT01066819|12252358|FG005|Overall Study|Physician Decision|0
7796098|NCT01066819|12252353|FG000|Overall Study|Protocol Violation|12
7796099|NCT01066819|12252354|FG001|Overall Study|Protocol Violation|6
7796100|NCT01066819|12252355|FG002|Overall Study|Protocol Violation|0
7796101|NCT01066819|12252356|FG003|Overall Study|Protocol Violation|0
7796102|NCT01066819|12252357|FG004|Overall Study|Protocol Violation|0
7796103|NCT01066819|12252358|FG005|Overall Study|Protocol Violation|0
7796104|NCT01066819|12252353|FG000|Overall Study|Withdrawal by Subject|29
7796105|NCT01066819|12252354|FG001|Overall Study|Withdrawal by Subject|11
7796106|NCT01066819|12252355|FG002|Overall Study|Withdrawal by Subject|6
7796107|NCT01066819|12252356|FG003|Overall Study|Withdrawal by Subject|0
7796108|NCT01066819|12252357|FG004|Overall Study|Withdrawal by Subject|0
7796109|NCT01066819|12252358|FG005|Overall Study|Withdrawal by Subject|0
7796110|NCT01066819|12252353|FG000|Overall Study|Administrative|6
7796111|NCT01066819|12252354|FG001|Overall Study|Administrative|4
7796112|NCT01066819|12252355|FG002|Overall Study|Administrative|2
7796113|NCT01066819|12252356|FG003|Overall Study|Administrative|0
7796114|NCT01066819|12252357|FG004|Overall Study|Administrative|0
7796115|NCT01066819|12252358|FG005|Overall Study|Administrative|0
7796116|NCT01066819|12252353|FG000|Overall Study|Not met inclusion/exclusion criteria|1
7796117|NCT01066819|12252354|FG001|Overall Study|Not met inclusion/exclusion criteria|0
7796118|NCT01066819|12252355|FG002|Overall Study|Not met inclusion/exclusion criteria|0
7796119|NCT01066819|12252356|FG003|Overall Study|Not met inclusion/exclusion criteria|0
7796120|NCT01066819|12252357|FG004|Overall Study|Not met inclusion/exclusion criteria|0
7796121|NCT01066819|12252358|FG005|Overall Study|Not met inclusion/exclusion criteria|0
7796122|NCT01066819|12252353|FG000|Overall Study|Early termination|2
7796123|NCT01066819|12252354|FG001|Overall Study|Early termination|0
7796124|NCT01066819|12252355|FG002|Overall Study|Early termination|0
7796125|NCT01066819|12252356|FG003|Overall Study|Early termination|0
7796126|NCT01066819|12252357|FG004|Overall Study|Early termination|0
7796127|NCT01066819|12252358|FG005|Overall Study|Early termination|0
7796128|NCT01066819|12252353|FG000|Overall Study|Failed to return|298
7796129|NCT01066819|12252354|FG001|Overall Study|Failed to return|107
7796130|NCT01066819|12252355|FG002|Overall Study|Failed to return|68
7796131|NCT01066819|12252356|FG003|Overall Study|Failed to return|7
7796132|NCT01066819|12252357|FG004|Overall Study|Failed to return|2
7796133|NCT01066819|12252358|FG005|Overall Study|Failed to return|3
7796134|NCT01066819|12252353|FG000|Overall Study|Lab test not done|9
7796135|NCT01066819|12252354|FG001|Overall Study|Lab test not done|0
7796136|NCT01066819|12252355|FG002|Overall Study|Lab test not done|2
7796137|NCT01066819|12252356|FG003|Overall Study|Lab test not done|1
7796138|NCT01066819|12252357|FG004|Overall Study|Lab test not done|0
7796139|NCT01066819|12252358|FG005|Overall Study|Lab test not done|0
7796140|NCT01066819|12252353|FG000|Overall Study|Miscellaneous|28
7796141|NCT01066819|12252354|FG001|Overall Study|Miscellaneous|10
7796142|NCT01066819|12252355|FG002|Overall Study|Miscellaneous|18
7796143|NCT01066819|12252356|FG003|Overall Study|Miscellaneous|1
7796144|NCT01066819|12252357|FG004|Overall Study|Miscellaneous|0
7796145|NCT01066819|12252358|FG005|Overall Study|Miscellaneous|0
7796146|NCT01066819|12252353|FG000|Overall Study|Non responders|123
7796147|NCT01066819|12252354|FG001|Overall Study|Non responders|2
7796148|NCT01066819|12252355|FG002|Overall Study|Non responders|7
7796149|NCT01066819|12252356|FG003|Overall Study|Non responders|2
7796150|NCT01066819|12252357|FG004|Overall Study|Non responders|0
7796151|NCT01066819|12252358|FG005|Overall Study|Non responders|1
7796152|NCT01066819|12252353|FG000|Overall Study|Not categorised|9
7796153|NCT01066819|12252354|FG001|Overall Study|Not categorised|2
7796154|NCT01066819|12252355|FG002|Overall Study|Not categorised|6
7796155|NCT01066819|12252356|FG003|Overall Study|Not categorised|1
7796156|NCT01066819|12252357|FG004|Overall Study|Not categorised|0
7796157|NCT01066819|12252358|FG005|Overall Study|Not categorised|0
7796158|NCT01066819|12252353|FG000|Overall Study|Relapse|16
7796159|NCT01066819|12252354|FG001|Overall Study|Relapse|4
7796160|NCT01066819|12252355|FG002|Overall Study|Relapse|3
7796161|NCT01066819|12252356|FG003|Overall Study|Relapse|0
7796162|NCT01066819|12252357|FG004|Overall Study|Relapse|0
7796163|NCT01066819|12252358|FG005|Overall Study|Relapse|0
7796164|NCT01066819|12252353|FG000|Overall Study|Results not available|1
7796165|NCT01066819|12252354|FG001|Overall Study|Results not available|0
7796166|NCT01066819|12252355|FG002|Overall Study|Results not available|0
7796167|NCT01066819|12252356|FG003|Overall Study|Results not available|0
7796168|NCT01066819|12252357|FG004|Overall Study|Results not available|0
7796169|NCT01066819|12252358|FG005|Overall Study|Results not available|0
7796170|NCT01066819|12252353|FG000|Overall Study|Screen failure|1
7796171|NCT01066819|12252354|FG001|Overall Study|Screen failure|0
7796172|NCT01066819|12252355|FG002|Overall Study|Screen failure|0
7796173|NCT01066819|12252356|FG003|Overall Study|Screen failure|0
7796174|NCT01066819|12252357|FG004|Overall Study|Screen failure|0
7796175|NCT01066819|12252358|FG005|Overall Study|Screen failure|0
7796176|NCT01066819|12252353|FG000|Overall Study|Spontaneous cure|1
7796177|NCT01066819|12252354|FG001|Overall Study|Spontaneous cure|0
7796178|NCT01066819|12252355|FG002|Overall Study|Spontaneous cure|0
7796179|NCT01066819|12252356|FG003|Overall Study|Spontaneous cure|0
7796180|NCT01066819|12252357|FG004|Overall Study|Spontaneous cure|0
7796181|NCT01066819|12252358|FG005|Overall Study|Spontaneous cure|0
7796182|NCT01066819|12252353|FG000|Overall Study|Treatment never started|85
7796183|NCT01066819|12252354|FG001|Overall Study|Treatment never started|19
7796184|NCT01066819|12252355|FG002|Overall Study|Treatment never started|19
7796185|NCT01066819|12252356|FG003|Overall Study|Treatment never started|3
7796186|NCT01066819|12252357|FG004|Overall Study|Treatment never started|2
7796187|NCT01066819|12252358|FG005|Overall Study|Treatment never started|2
7796188|NCT01066819|12252353|FG000|Overall Study|Treatment stopped|12
7796189|NCT01066819|12252354|FG001|Overall Study|Treatment stopped|1
7796190|NCT01066819|12252355|FG002|Overall Study|Treatment stopped|2
7796191|NCT01066819|12252356|FG003|Overall Study|Treatment stopped|1
7796192|NCT01066819|12252357|FG004|Overall Study|Treatment stopped|0
7796193|NCT01066819|12252358|FG005|Overall Study|Treatment stopped|0
7796194|NCT01066819|12252353|FG000|Overall Study|Other|5
7796195|NCT01066819|12252354|FG001|Overall Study|Other|1
7796196|NCT01066819|12252355|FG002|Overall Study|Other|1
7796197|NCT01066819|12252356|FG003|Overall Study|Other|0
7796198|NCT01066819|12252357|FG004|Overall Study|Other|0
7796199|NCT01066819|12252358|FG005|Overall Study|Other|0
7873698|NCT01693562|12367820|FG005|Expansion Phase|Withdrawal by Subject|0
7873699|NCT01693562|12367821|FG006|Expansion Phase|Withdrawal by Subject|0
7873700|NCT01693562|12367822|FG007|Expansion Phase|Withdrawal by Subject|16
7873701|NCT01693562|12367823|FG008|Expansion Phase|Withdrawal by Subject|2
7873702|NCT01693562|12367824|FG009|Expansion Phase|Withdrawal by Subject|54
7873703|NCT01693562|12367825|FG010|Expansion Phase|Withdrawal by Subject|2
7873704|NCT01693562|12367826|FG011|Expansion Phase|Withdrawal by Subject|2
7873705|NCT01693562|12367827|FG012|Expansion Phase|Withdrawal by Subject|3
7873706|NCT01693562|12367828|FG013|Expansion Phase|Withdrawal by Subject|5
7873707|NCT01693562|12367829|FG014|Expansion Phase|Withdrawal by Subject|16
7873708|NCT01693562|12367830|FG015|Expansion Phase|Withdrawal by Subject|7
7873709|NCT01693562|12367831|FG016|Expansion Phase|Withdrawal by Subject|40
7796200|NCT01066871|12252374|FG000|Overall Study|Lost to Follow-up|0
7796201|NCT01066871|12252375|FG001|Overall Study|Lost to Follow-up|2
7796202|NCT01066871|12252376|FG002|Overall Study|Lost to Follow-up|2
7796203|NCT01066871|12252377|FG003|Overall Study|Lost to Follow-up|0
7796204|NCT01066871|12252374|FG000|Overall Study|Protocol Violation|1
7796205|NCT01066871|12252375|FG001|Overall Study|Protocol Violation|0
7796206|NCT01066871|12252376|FG002|Overall Study|Protocol Violation|3
7796207|NCT01066871|12252377|FG003|Overall Study|Protocol Violation|2
7796208|NCT01066871|12252374|FG000|Overall Study|Lack of Efficacy|0
7796209|NCT01066871|12252375|FG001|Overall Study|Lack of Efficacy|0
7796210|NCT01066871|12252376|FG002|Overall Study|Lack of Efficacy|0
7796211|NCT01066871|12252377|FG003|Overall Study|Lack of Efficacy|1
7796212|NCT01066871|12252374|FG000|Overall Study|Withdrawal by Subject|3
7796213|NCT01066871|12252375|FG001|Overall Study|Withdrawal by Subject|1
7796214|NCT01066871|12252376|FG002|Overall Study|Withdrawal by Subject|0
7796215|NCT01066871|12252377|FG003|Overall Study|Withdrawal by Subject|0
7796216|NCT01066871|12252374|FG000|Overall Study|Other|0
7796217|NCT01066871|12252375|FG001|Overall Study|Other|2
7796218|NCT01066871|12252376|FG002|Overall Study|Other|1
7796219|NCT01066871|12252377|FG003|Overall Study|Other|2
7796220|NCT01066897|12252394|FG000|Overall Study|Withdrawal by Subject|1
7796221|NCT01066897|12252395|FG001|Overall Study|Withdrawal by Subject|0
7796222|NCT01066897|12252394|FG000|Overall Study|stopped study after developing the flu.|1
7796223|NCT01066897|12252395|FG001|Overall Study|stopped study after developing the flu.|0
7796224|NCT01066923|12252406|FG000|Overall Study|Withdrawal by Subject|3
7796225|NCT01066923|12252407|FG001|Overall Study|Withdrawal by Subject|3
7796226|NCT01066923|12252408|FG002|Overall Study|Withdrawal by Subject|8
7796227|NCT01066923|12252409|FG003|Overall Study|Withdrawal by Subject|8
7796228|NCT01066936|12252419|FG000|Overall Study|Death|2
7796229|NCT01066936|12252419|FG000|Overall Study|Device revised/removed|1
7796230|NCT01066936|12252419|FG000|Overall Study|Lost to Follow-up|3
7796231|NCT01066936|12252419|FG000|Overall Study|Withdrawal by Subject|4
7796232|NCT01067105|12252425|FG000|Overall Study|Adverse Event|14
7796233|NCT01067105|12252425|FG000|Overall Study|Protocol Violation|48
7796234|NCT01067105|12252425|FG000|Overall Study|Withdrawal by Subject|36
7796235|NCT01067105|12252425|FG000|Overall Study|Lost to Follow-up|6
7796236|NCT01067105|12252425|FG000|Overall Study|Physician Decision|6
7796237|NCT01067105|12252425|FG000|Overall Study|Other|31
7796238|NCT01067326|12252431|FG000|Overall Study|Adverse Event|0
7796239|NCT01067326|12252432|FG001|Overall Study|Adverse Event|2
7796240|NCT01067326|12252431|FG000|Overall Study|Withdrawal by Subject|1
7796241|NCT01067326|12252432|FG001|Overall Study|Withdrawal by Subject|0
7796242|NCT01067326|12252431|FG000|Overall Study|Early Study Termination|1
7796243|NCT01067326|12252432|FG001|Overall Study|Early Study Termination|1
7796244|NCT01067339|12252440|FG000|Overall Study|Withdrawal by Subject|6
7796245|NCT01067339|12252441|FG001|Overall Study|Withdrawal by Subject|5
7796246|NCT01067352|12252450|FG000|Overall Study|Withdrawal by Subject|1
7796247|NCT01067352|12252451|FG001|Overall Study|Withdrawal by Subject|2
7796248|NCT01067352|12252452|FG002|Overall Study|Withdrawal by Subject|1
7796249|NCT01067352|12252450|FG000|Overall Study|Physician Decision|0
7796250|NCT01067352|12252451|FG001|Overall Study|Physician Decision|1
7796251|NCT01067352|12252452|FG002|Overall Study|Physician Decision|0
7796252|NCT01067469|12252473|FG000|Overall Study|Withdrawal by Subject|0
7796253|NCT01067469|12252474|FG001|Overall Study|Withdrawal by Subject|1
7796254|NCT01067469|12252473|FG000|Overall Study|Disease Progression|0
7796255|NCT01067469|12252474|FG001|Overall Study|Disease Progression|1
7796256|NCT01067508|12252482|FG000|Overall Study|Physician Decision|0
7796257|NCT01067508|12252483|FG001|Overall Study|Physician Decision|1
7796258|NCT01067508|12252482|FG000|Overall Study|Withdrawal by Subject|0
7796259|NCT01067508|12252483|FG001|Overall Study|Withdrawal by Subject|1
7796260|NCT01067846|12252532|FG000|Overall Study|Lost to Follow-up|17
7796261|NCT01067846|12252533|FG001|Overall Study|Lost to Follow-up|19
7796262|NCT01067846|12252532|FG000|Overall Study|Withdrawal by Subject|1
7796263|NCT01067846|12252533|FG001|Overall Study|Withdrawal by Subject|0
7796264|NCT01067846|12252532|FG000|Overall Study|participation in other tx study|1
7796265|NCT01067846|12252533|FG001|Overall Study|participation in other tx study|0
7796266|NCT01067976|12252539|FG000|Overall Study|Study drug never administered|20
7796267|NCT01067976|12252539|FG000|Overall Study|Study prematurely discontinued|2
7796268|NCT01068158|12252559|FG000|Overall Study|Withdrawal by Subject|1
7796269|NCT01068158|12252560|FG001|Overall Study|Withdrawal by Subject|2
7796270|NCT01068158|12252559|FG000|Overall Study|Lost to Follow-up|7
7796271|NCT01068158|12252560|FG001|Overall Study|Lost to Follow-up|0
7796272|NCT01068158|12252559|FG000|Overall Study|Protocol Violation|0
7796273|NCT01068158|12252560|FG001|Overall Study|Protocol Violation|2
7796274|NCT01068262|12252570|FG000|Overall Study|Adverse Event|2
7796275|NCT01068262|12252571|FG001|Overall Study|Adverse Event|0
7796276|NCT01068262|12252572|FG002|Overall Study|Adverse Event|1
7796277|NCT01068262|12252573|FG003|Overall Study|Adverse Event|0
7796278|NCT01068262|12252570|FG000|Overall Study|Protocol Violation|1
7796279|NCT01068262|12252571|FG001|Overall Study|Protocol Violation|0
7796280|NCT01068262|12252572|FG002|Overall Study|Protocol Violation|0
7796281|NCT01068262|12252573|FG003|Overall Study|Protocol Violation|0
7796282|NCT01068262|12252570|FG000|Overall Study|Withdrawal by Subject|0
7796283|NCT01068262|12252571|FG001|Overall Study|Withdrawal by Subject|1
7796284|NCT01068262|12252572|FG002|Overall Study|Withdrawal by Subject|0
7796285|NCT01068262|12252573|FG003|Overall Study|Withdrawal by Subject|0
7796286|NCT01068418|12252586|FG000|Overall Study|Physician Decision|12
7796287|NCT01068509|12252593|FG000|Overall Study|Death|0
7796288|NCT01068509|12252594|FG001|Overall Study|Death|0
7796289|NCT01068509|12252595|FG002|Overall Study|Death|1
7796290|NCT01068509|12252593|FG000|Overall Study|Disease Progression|5
7796291|NCT01068509|12252594|FG001|Overall Study|Disease Progression|20
7796292|NCT01068509|12252595|FG002|Overall Study|Disease Progression|18
7796293|NCT01068509|12252593|FG000|Overall Study|Lost to Follow-up|1
7796294|NCT01068509|12252594|FG001|Overall Study|Lost to Follow-up|0
7796295|NCT01068509|12252595|FG002|Overall Study|Lost to Follow-up|0
7796296|NCT01068509|12252593|FG000|Overall Study|Withdrew Consent|0
7796297|NCT01068509|12252594|FG001|Overall Study|Withdrew Consent|1
7796298|NCT01068509|12252595|FG002|Overall Study|Withdrew Consent|2
7796299|NCT01068509|12252593|FG000|Overall Study|Reason Not Specified|0
7796300|NCT01068509|12252594|FG001|Overall Study|Reason Not Specified|1
7796301|NCT01068509|12252595|FG002|Overall Study|Reason Not Specified|0
7796302|NCT01068600|12252614|FG000|Overall Study|Withdrawal by Subject|5
7796303|NCT01068600|12252615|FG001|Overall Study|Withdrawal by Subject|6
7796304|NCT01068600|12252614|FG000|Overall Study|Adverse Event|3
7796305|NCT01068600|12252615|FG001|Overall Study|Adverse Event|3
7796306|NCT01068600|12252614|FG000|Overall Study|Abnormal laboratory value(s)|1
7796307|NCT01068600|12252615|FG001|Overall Study|Abnormal laboratory value(s)|0
7796308|NCT01068600|12252614|FG000|Overall Study|Lost to Follow-up|1
7796309|NCT01068600|12252615|FG001|Overall Study|Lost to Follow-up|2
7796310|NCT01068600|12252614|FG000|Overall Study|Protocol deviation|1
7796311|NCT01068600|12252615|FG001|Overall Study|Protocol deviation|1
7796312|NCT01068600|12252614|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7796313|NCT01068600|12252615|FG001|Overall Study|Unsatisfactory therapeutic effect|4
7796314|NCT01068600|12252614|FG000|Overall Study|Administrative problems|0
7796315|NCT01068600|12252615|FG001|Overall Study|Administrative problems|1
7796316|NCT01068626|12252623|FG000|Overall Study|Adverse Event|3
7796317|NCT01068626|12252624|FG001|Overall Study|Adverse Event|0
7796318|NCT01068626|12252623|FG000|Overall Study|Withdrawal by Subject|0
7796319|NCT01068626|12252624|FG001|Overall Study|Withdrawal by Subject|2
7796320|NCT01068652|12252632|FG000|Overall Study|Adverse Event|4
7796321|NCT01068652|12252633|FG001|Overall Study|Adverse Event|0
7796322|NCT01068652|12252632|FG000|Overall Study|Lack of Efficacy|0
7796323|NCT01068652|12252633|FG001|Overall Study|Lack of Efficacy|2
7796324|NCT01068652|12252632|FG000|Overall Study|Lost to Follow-up|2
7796325|NCT01068652|12252633|FG001|Overall Study|Lost to Follow-up|1
7796326|NCT01068652|12252632|FG000|Overall Study|Protocol Violation|3
7796327|NCT01068652|12252633|FG001|Overall Study|Protocol Violation|6
7796328|NCT01068652|12252632|FG000|Overall Study|Withdrawal criteria|1
7796329|NCT01068652|12252633|FG001|Overall Study|Withdrawal criteria|2
7796330|NCT01068652|12252632|FG000|Overall Study|Patient was not eligible|1
7796331|NCT01068652|12252633|FG001|Overall Study|Patient was not eligible|0
7796332|NCT01068652|12252632|FG000|Overall Study|Unclassified|7
7796333|NCT01068652|12252633|FG001|Overall Study|Unclassified|4
7796334|NCT01068665|12252641|FG000|Overall Study|Adverse Event|5
7796335|NCT01068665|12252642|FG001|Overall Study|Adverse Event|4
7796336|NCT01068665|12252641|FG000|Overall Study|Lack of Efficacy|0
7796337|NCT01068665|12252642|FG001|Overall Study|Lack of Efficacy|2
7796338|NCT01068665|12252641|FG000|Overall Study|Protocol Violation|5
7796339|NCT01068665|12252642|FG001|Overall Study|Protocol Violation|2
7796340|NCT01068665|12252641|FG000|Overall Study|Withdrawal Criteria|3
7796341|NCT01068665|12252642|FG001|Overall Study|Withdrawal Criteria|9
7796342|NCT01068665|12252641|FG000|Overall Study|Other|17
7796343|NCT01068665|12252642|FG001|Overall Study|Other|12
7796344|NCT01068678|12252650|FG000|Overall Study|Lack of Efficacy|3
7796345|NCT01068678|12252651|FG001|Overall Study|Lack of Efficacy|2
7796346|NCT01068678|12252650|FG000|Overall Study|Protocol Violation|5
7796347|NCT01068678|12252651|FG001|Overall Study|Protocol Violation|1
7796348|NCT01068678|12252650|FG000|Overall Study|Withdrawal criteria|12
7796349|NCT01068678|12252651|FG001|Overall Study|Withdrawal criteria|6
7796350|NCT01068678|12252650|FG000|Overall Study|Unclassified|18
7796351|NCT01068678|12252651|FG001|Overall Study|Unclassified|15
7796352|NCT01068717|12252657|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
7796353|NCT01068717|12252658|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
7796354|NCT01068717|12252659|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
7796355|NCT01068717|12252660|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
7796356|NCT01068730|12252674|FG000|Period 3|Personal reason|1
7796357|NCT01068730|12252675|FG001|Period 3|Personal reason|0
7796358|NCT01068730|12252676|FG002|Period 3|Personal reason|0
7796359|NCT01068730|12252677|FG003|Period 3|Personal reason|0
7796360|NCT01068730|12252674|FG000|Period 4|Family emergency|0
7796361|NCT01068730|12252675|FG001|Period 4|Family emergency|1
7796362|NCT01068730|12252676|FG002|Period 4|Family emergency|0
7796363|NCT01068730|12252677|FG003|Period 4|Family emergency|0
7796364|NCT01068743|12252694|FG000|Period 3|Adverse Event|0
7796365|NCT01068743|12252695|FG001|Period 3|Adverse Event|1
7796366|NCT01068743|12252696|FG002|Period 3|Adverse Event|0
7796367|NCT01068743|12252697|FG003|Period 3|Adverse Event|0
7796368|NCT01068769|12252710|FG000|Overall Study|Ineligible|1
7796369|NCT01068860|12252733|FG000|Overall Study|Withdrawal by Subject|0
7873710|NCT01693562|12367832|FG017|Expansion Phase|Withdrawal by Subject|4
7796370|NCT01068860|12252734|FG001|Overall Study|Withdrawal by Subject|0
7796371|NCT01068860|12252735|FG002|Overall Study|Withdrawal by Subject|0
7796372|NCT01068860|12252736|FG003|Overall Study|Withdrawal by Subject|0
7796373|NCT01068860|12252737|FG004|Overall Study|Withdrawal by Subject|0
7796374|NCT01068860|12252738|FG005|Overall Study|Withdrawal by Subject|2
7796375|NCT01068860|12252739|FG006|Overall Study|Withdrawal by Subject|0
7796376|NCT01068860|12252740|FG007|Overall Study|Withdrawal by Subject|0
7796377|NCT01068860|12252741|FG008|Overall Study|Withdrawal by Subject|0
7796378|NCT01068860|12252742|FG009|Overall Study|Withdrawal by Subject|3
7796379|NCT01068860|12252733|FG000|Overall Study|Administrative problems; misrandomized|0
7796380|NCT01068860|12252734|FG001|Overall Study|Administrative problems; misrandomized|0
7796381|NCT01068860|12252735|FG002|Overall Study|Administrative problems; misrandomized|0
7796382|NCT01068860|12252736|FG003|Overall Study|Administrative problems; misrandomized|1
7796383|NCT01068860|12252737|FG004|Overall Study|Administrative problems; misrandomized|0
7796384|NCT01068860|12252738|FG005|Overall Study|Administrative problems; misrandomized|0
7796385|NCT01068860|12252739|FG006|Overall Study|Administrative problems; misrandomized|0
7796386|NCT01068860|12252740|FG007|Overall Study|Administrative problems; misrandomized|0
7796387|NCT01068860|12252741|FG008|Overall Study|Administrative problems; misrandomized|0
7796388|NCT01068860|12252742|FG009|Overall Study|Administrative problems; misrandomized|1
7796389|NCT01068860|12252733|FG000|Overall Study|Lost to Follow-up|0
7796390|NCT01068860|12252734|FG001|Overall Study|Lost to Follow-up|1
7796391|NCT01068860|12252735|FG002|Overall Study|Lost to Follow-up|0
7796392|NCT01068860|12252736|FG003|Overall Study|Lost to Follow-up|0
7796393|NCT01068860|12252737|FG004|Overall Study|Lost to Follow-up|0
7796394|NCT01068860|12252738|FG005|Overall Study|Lost to Follow-up|0
7796395|NCT01068860|12252739|FG006|Overall Study|Lost to Follow-up|0
7796396|NCT01068860|12252740|FG007|Overall Study|Lost to Follow-up|0
7796397|NCT01068860|12252741|FG008|Overall Study|Lost to Follow-up|0
7796398|NCT01068860|12252742|FG009|Overall Study|Lost to Follow-up|0
7796399|NCT01068912|12252771|FG000|Overall Study|Adverse Event|2
7796400|NCT01068912|12252772|FG001|Overall Study|Adverse Event|3
7796401|NCT01068912|12252773|FG002|Overall Study|Adverse Event|2
7796402|NCT01068912|12252771|FG000|Overall Study|Withdrawal by Subject|5
7796403|NCT01068912|12252772|FG001|Overall Study|Withdrawal by Subject|6
7796404|NCT01068912|12252773|FG002|Overall Study|Withdrawal by Subject|6
7796405|NCT01068912|12252771|FG000|Overall Study|Lost to Follow-up|3
7796406|NCT01068912|12252772|FG001|Overall Study|Lost to Follow-up|7
7796407|NCT01068912|12252773|FG002|Overall Study|Lost to Follow-up|3
7796408|NCT01068912|12252771|FG000|Overall Study|Protocol Violation|0
7796409|NCT01068912|12252772|FG001|Overall Study|Protocol Violation|2
7796410|NCT01068912|12252773|FG002|Overall Study|Protocol Violation|0
7796411|NCT01068912|12252771|FG000|Overall Study|aggravation influenza|1
7796412|NCT01068912|12252772|FG001|Overall Study|aggravation influenza|1
7796413|NCT01068912|12252773|FG002|Overall Study|aggravation influenza|1
7796414|NCT01068912|12252771|FG000|Overall Study|other underlying illness|0
7796415|NCT01068912|12252772|FG001|Overall Study|other underlying illness|3
7796416|NCT01068912|12252773|FG002|Overall Study|other underlying illness|3
7796417|NCT01069172|12252805|FG000|Overall Study|Withdrawal by Subject|1
7796418|NCT01069172|12252806|FG001|Overall Study|Withdrawal by Subject|0
7796419|NCT01069289|12252824|FG000|Overall Study|Withdrawal by Subject|15
7796420|NCT01069289|12252825|FG001|Overall Study|Withdrawal by Subject|26
7796421|NCT01069289|12252824|FG000|Overall Study|Adverse Event|21
7796422|NCT01069289|12252825|FG001|Overall Study|Adverse Event|28
7796423|NCT01069289|12252824|FG000|Overall Study|Eligibility criteria not fulfilled|2
7796424|NCT01069289|12252825|FG001|Overall Study|Eligibility criteria not fulfilled|0
7796425|NCT01069289|12252824|FG000|Overall Study|Severe non-compliance to protocol|3
7796426|NCT01069289|12252825|FG001|Overall Study|Severe non-compliance to protocol|2
7796427|NCT01069289|12252824|FG000|Overall Study|Due to deteriorating health condition|1
7796428|NCT01069289|12252825|FG001|Overall Study|Due to deteriorating health condition|0
7796429|NCT01069341|12252852|FG000|Overall Study|Lost to Follow-up|1
7796430|NCT01069419|12252864|FG000|Overall Study|Adverse Event|233
7796431|NCT01069419|12252864|FG000|Overall Study|Lack of Efficacy|332
7796432|NCT01069419|12252864|FG000|Overall Study|Lost to Follow-up|49
7796433|NCT01069419|12252864|FG000|Overall Study|Remission of disease|11
7796434|NCT01069419|12252864|FG000|Overall Study|Withdrawal by Subject|34
7796435|NCT01069419|12252864|FG000|Overall Study|Other Reason|43
7796436|NCT01069419|12252864|FG000|Overall Study|Missing termination information|13
7796437|NCT01069484|12252870|FG000|Overall Study|Death-in-near-family|1
7796438|NCT01069484|12252871|FG001|Overall Study|Death-in-near-family|0
7796439|NCT01069484|12252870|FG000|Overall Study|No specific reason|8
7796440|NCT01069484|12252871|FG001|Overall Study|No specific reason|2
7796441|NCT01069484|12252870|FG000|Overall Study|Illness mother or child|3
7796442|NCT01069484|12252871|FG001|Overall Study|Illness mother or child|1
7796443|NCT01069523|12252889|FG000|Overall Study|Withdrawal by Subject|4
7796444|NCT01069523|12252890|FG001|Overall Study|Withdrawal by Subject|7
7796445|NCT01069627|12252907|FG000|Overall Study|Disease progression|7
7796446|NCT01069627|12252907|FG000|Overall Study|Adverse Event|12
7796447|NCT01069627|12252907|FG000|Overall Study|Protocol Violation|1
7796448|NCT01069705|12252911|FG000|Overall Study|Adverse Event|1
7796449|NCT01069705|12252911|FG000|Overall Study|Withdrawal by Subject|2
7873711|NCT01693562|12367833|FG018|Expansion Phase|Withdrawal by Subject|8
7796450|NCT01069900|12252917|FG000|Overall Study|Technical problems|0
7796451|NCT01069900|12252918|FG001|Overall Study|Technical problems|1
7796452|NCT01069900|12252917|FG000|Overall Study|Lost to Follow-up|7
7796453|NCT01069900|12252918|FG001|Overall Study|Lost to Follow-up|1
7796454|NCT01069900|12252917|FG000|Overall Study|Withdrawal by Subject|6
7796455|NCT01069900|12252918|FG001|Overall Study|Withdrawal by Subject|1
7796456|NCT01069900|12252917|FG000|Overall Study|Protocol Violation|4
7796457|NCT01069900|12252918|FG001|Overall Study|Protocol Violation|1
7796458|NCT01069900|12252917|FG000|Overall Study|Insufficient Therapeutic effect|1
7796459|NCT01069900|12252918|FG001|Overall Study|Insufficient Therapeutic effect|0
7796460|NCT01069939|12252926|FG000|Randomised and Included in the Analyses|Adverse Event|17
7796461|NCT01069939|12252927|FG001|Randomised and Included in the Analyses|Adverse Event|22
7796462|NCT01069939|12252926|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15
7796463|NCT01069939|12252927|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12
7796464|NCT01069939|12252926|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1
7796465|NCT01069939|12252927|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1
7796466|NCT01069939|12252926|FG000|Randomised and Included in the Analyses|Protocol Violation|0
7796467|NCT01069939|12252927|FG001|Randomised and Included in the Analyses|Protocol Violation|1
7796468|NCT01069939|12252926|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0
7796469|NCT01069939|12252927|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1
7796470|NCT01069939|12252926|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
7796471|NCT01069939|12252927|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
7796472|NCT01069939|12252926|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
7796473|NCT01069939|12252927|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
7796474|NCT01069939|12252926|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
7796475|NCT01069939|12252927|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
7796476|NCT01069939|12252926|FG000|Randomised and Included in the Analyses|Physician Decision|0
7796477|NCT01069939|12252927|FG001|Randomised and Included in the Analyses|Physician Decision|2
7796478|NCT01069939|12252926|FG000|Randomised and Included in the Analyses|Removal|1
7796479|NCT01069939|12252927|FG001|Randomised and Included in the Analyses|Removal|0
7796480|NCT01070043|12252935|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18
7796481|NCT01070043|12252936|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0
7796482|NCT01070043|12252937|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0
7796483|NCT01070043|12252935|FG000|Double-Blind Treatment|Adverse Event|0
7796484|NCT01070043|12252936|FG001|Double-Blind Treatment|Adverse Event|0
7796485|NCT01070043|12252937|FG002|Double-Blind Treatment|Adverse Event|2
7796486|NCT01070303|12252966|FG000|Overall Study|Adverse Event|39
7796487|NCT01070303|12252966|FG000|Overall Study|Withdrawal by Subject|20
7796488|NCT01070303|12252966|FG000|Overall Study|Lost to Follow-up|9
7796489|NCT01070303|12252966|FG000|Overall Study|Protocol Violation|0
7796490|NCT01070303|12252966|FG000|Overall Study|Lack of Efficacy|2
7796491|NCT01070303|12252966|FG000|Overall Study|Administrative Reason|1
7796492|NCT01070303|12252966|FG000|Overall Study|Other|18
7796493|NCT01070316|12252976|FG000|Extension Phase|Lack of Efficacy|3
7796494|NCT01070316|12252976|FG000|Extension Phase|Withdrawal by Subject|1
7796495|NCT01070329|12252982|FG000|Overall Study|Adverse Event|13
7796496|NCT01070329|12252983|FG001|Overall Study|Adverse Event|10
7796497|NCT01070329|12252982|FG000|Overall Study|Lost to Follow-up|22
7796498|NCT01070329|12252983|FG001|Overall Study|Lost to Follow-up|12
7796499|NCT01070329|12252982|FG000|Overall Study|Withdrawal by Subject|9
7796500|NCT01070329|12252983|FG001|Overall Study|Withdrawal by Subject|11
7796501|NCT01070329|12252982|FG000|Overall Study|Protocol Violation|3
7796502|NCT01070329|12252983|FG001|Overall Study|Protocol Violation|8
7796503|NCT01070329|12252982|FG000|Overall Study|Lack of Efficacy|2
7796504|NCT01070329|12252983|FG001|Overall Study|Lack of Efficacy|6
7796505|NCT01070329|12252982|FG000|Overall Study|Physician Decision|2
7796506|NCT01070329|12252983|FG001|Overall Study|Physician Decision|1
7796507|NCT01070329|12252982|FG000|Overall Study|Entry Criteria Not Met|1
7796508|NCT01070329|12252983|FG001|Overall Study|Entry Criteria Not Met|0
7796509|NCT01070329|12252982|FG000|Overall Study|Sponsor Decision|0
7796510|NCT01070329|12252983|FG001|Overall Study|Sponsor Decision|1
7796511|NCT01070381|12252989|FG000|Period 2, 1 Week of Wear|Handling|0
7796512|NCT01070381|12252990|FG001|Period 2, 1 Week of Wear|Handling|1
7796513|NCT01070381|12252989|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1
7796514|NCT01070381|12252990|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0
7796515|NCT01070394|12252996|FG000|Overall Study|Adverse Event|6
7796516|NCT01070394|12252996|FG000|Overall Study|Withdrawal by Subject|1
7796517|NCT01070550|12253008|FG000|Overall Study|Adverse Event|43
7796518|NCT01070550|12253009|FG001|Overall Study|Adverse Event|1
7796519|NCT01070550|12253010|FG002|Overall Study|Adverse Event|3
7796520|NCT01070550|12253011|FG003|Overall Study|Adverse Event|0
7796521|NCT01070550|12253012|FG004|Overall Study|Adverse Event|0
7796522|NCT01070550|12253013|FG005|Overall Study|Adverse Event|0
7796523|NCT01070550|12253008|FG000|Overall Study|Death|20
7796524|NCT01070550|12253009|FG001|Overall Study|Death|4
7796525|NCT01070550|12253010|FG002|Overall Study|Death|3
7796526|NCT01070550|12253011|FG003|Overall Study|Death|0
7796527|NCT01070550|12253012|FG004|Overall Study|Death|0
7796528|NCT01070550|12253013|FG005|Overall Study|Death|0
7796529|NCT01070550|12253008|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2
7796530|NCT01070550|12253009|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
7796531|NCT01070550|12253010|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1
7796532|NCT01070550|12253011|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0
7796533|NCT01070550|12253012|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0
7796534|NCT01070550|12253013|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0
7796535|NCT01070550|12253008|FG000|Overall Study|Early termination|3
7796536|NCT01070550|12253009|FG001|Overall Study|Early termination|0
7796537|NCT01070550|12253010|FG002|Overall Study|Early termination|0
7796538|NCT01070550|12253011|FG003|Overall Study|Early termination|0
7796539|NCT01070550|12253012|FG004|Overall Study|Early termination|0
7796540|NCT01070550|12253013|FG005|Overall Study|Early termination|0
7796541|NCT01070550|12253008|FG000|Overall Study|Failed to return|450
7796542|NCT01070550|12253009|FG001|Overall Study|Failed to return|33
7796543|NCT01070550|12253010|FG002|Overall Study|Failed to return|144
7796544|NCT01070550|12253011|FG003|Overall Study|Failed to return|40
7796545|NCT01070550|12253012|FG004|Overall Study|Failed to return|1
7796546|NCT01070550|12253013|FG005|Overall Study|Failed to return|2
7796547|NCT01070550|12253008|FG000|Overall Study|Incomplete treatment|2
7796548|NCT01070550|12253009|FG001|Overall Study|Incomplete treatment|0
7796549|NCT01070550|12253010|FG002|Overall Study|Incomplete treatment|0
7796550|NCT01070550|12253011|FG003|Overall Study|Incomplete treatment|0
7796551|NCT01070550|12253012|FG004|Overall Study|Incomplete treatment|0
7796552|NCT01070550|12253013|FG005|Overall Study|Incomplete treatment|0
7796553|NCT01070550|12253008|FG000|Overall Study|Lab test not done|22
7796554|NCT01070550|12253009|FG001|Overall Study|Lab test not done|3
7796555|NCT01070550|12253010|FG002|Overall Study|Lab test not done|4
7796556|NCT01070550|12253011|FG003|Overall Study|Lab test not done|1
7796557|NCT01070550|12253012|FG004|Overall Study|Lab test not done|0
7796558|NCT01070550|12253013|FG005|Overall Study|Lab test not done|1
7796559|NCT01070550|12253008|FG000|Overall Study|Lack of Efficacy|65
7796560|NCT01070550|12253009|FG001|Overall Study|Lack of Efficacy|1
7796561|NCT01070550|12253010|FG002|Overall Study|Lack of Efficacy|5
7796562|NCT01070550|12253011|FG003|Overall Study|Lack of Efficacy|5
7796563|NCT01070550|12253012|FG004|Overall Study|Lack of Efficacy|0
7796564|NCT01070550|12253013|FG005|Overall Study|Lack of Efficacy|1
7796565|NCT01070550|12253008|FG000|Overall Study|Miscellaneous|12
7796566|NCT01070550|12253009|FG001|Overall Study|Miscellaneous|2
7796567|NCT01070550|12253010|FG002|Overall Study|Miscellaneous|3
7796568|NCT01070550|12253011|FG003|Overall Study|Miscellaneous|1
7796569|NCT01070550|12253012|FG004|Overall Study|Miscellaneous|0
7796570|NCT01070550|12253013|FG005|Overall Study|Miscellaneous|0
7796571|NCT01070550|12253008|FG000|Overall Study|New treatment started|3
7796572|NCT01070550|12253009|FG001|Overall Study|New treatment started|1
7796573|NCT01070550|12253010|FG002|Overall Study|New treatment started|0
7796574|NCT01070550|12253011|FG003|Overall Study|New treatment started|2
7796575|NCT01070550|12253012|FG004|Overall Study|New treatment started|0
7796576|NCT01070550|12253013|FG005|Overall Study|New treatment started|0
7796577|NCT01070550|12253008|FG000|Overall Study|Non-responders|493
7796578|NCT01070550|12253009|FG001|Overall Study|Non-responders|4
7796579|NCT01070550|12253010|FG002|Overall Study|Non-responders|21
7796580|NCT01070550|12253011|FG003|Overall Study|Non-responders|20
7796581|NCT01070550|12253012|FG004|Overall Study|Non-responders|0
7796582|NCT01070550|12253013|FG005|Overall Study|Non-responders|2
7796583|NCT01070550|12253008|FG000|Overall Study|Not categorized|33
7796584|NCT01070550|12253009|FG001|Overall Study|Not categorized|2
7796585|NCT01070550|12253010|FG002|Overall Study|Not categorized|6
7796586|NCT01070550|12253011|FG003|Overall Study|Not categorized|1
7796587|NCT01070550|12253012|FG004|Overall Study|Not categorized|0
7796588|NCT01070550|12253013|FG005|Overall Study|Not categorized|1
7796589|NCT01070550|12253008|FG000|Overall Study|Protocol Violation|15
7796590|NCT01070550|12253009|FG001|Overall Study|Protocol Violation|1
7796591|NCT01070550|12253010|FG002|Overall Study|Protocol Violation|1
7796592|NCT01070550|12253011|FG003|Overall Study|Protocol Violation|1
7796593|NCT01070550|12253012|FG004|Overall Study|Protocol Violation|0
7796594|NCT01070550|12253013|FG005|Overall Study|Protocol Violation|0
7796595|NCT01070550|12253008|FG000|Overall Study|Relapse|44
7796596|NCT01070550|12253009|FG001|Overall Study|Relapse|5
7796597|NCT01070550|12253010|FG002|Overall Study|Relapse|14
7796598|NCT01070550|12253011|FG003|Overall Study|Relapse|4
7796599|NCT01070550|12253012|FG004|Overall Study|Relapse|0
7796600|NCT01070550|12253013|FG005|Overall Study|Relapse|0
7796601|NCT01070550|12253008|FG000|Overall Study|Result not available|3
7796602|NCT01070550|12253009|FG001|Overall Study|Result not available|1
7796603|NCT01070550|12253010|FG002|Overall Study|Result not available|3
7796604|NCT01070550|12253011|FG003|Overall Study|Result not available|0
7796605|NCT01070550|12253012|FG004|Overall Study|Result not available|0
7796606|NCT01070550|12253013|FG005|Overall Study|Result not available|0
7796607|NCT01070550|12253008|FG000|Overall Study|Screen failure|1
7796608|NCT01070550|12253009|FG001|Overall Study|Screen failure|0
7796609|NCT01070550|12253010|FG002|Overall Study|Screen failure|0
7796610|NCT01070550|12253011|FG003|Overall Study|Screen failure|0
7796611|NCT01070550|12253012|FG004|Overall Study|Screen failure|0
7796612|NCT01070550|12253013|FG005|Overall Study|Screen failure|0
7796613|NCT01070550|12253008|FG000|Overall Study|Sponsor decision|1
7796614|NCT01070550|12253009|FG001|Overall Study|Sponsor decision|0
7796615|NCT01070550|12253010|FG002|Overall Study|Sponsor decision|0
7796616|NCT01070550|12253011|FG003|Overall Study|Sponsor decision|0
7796617|NCT01070550|12253012|FG004|Overall Study|Sponsor decision|0
7796618|NCT01070550|12253013|FG005|Overall Study|Sponsor decision|0
7873712|NCT01693562|12367834|FG019|Expansion Phase|Withdrawal by Subject|3
7796619|NCT01070550|12253008|FG000|Overall Study|Treatment duration shortened|1
7796620|NCT01070550|12253009|FG001|Overall Study|Treatment duration shortened|0
7796621|NCT01070550|12253010|FG002|Overall Study|Treatment duration shortened|0
7873713|NCT01693562|12367835|FG020|Expansion Phase|Withdrawal by Subject|1
7873714|NCT01693562|12367836|FG021|Expansion Phase|Withdrawal by Subject|8
7873715|NCT01693562|12367837|FG022|Expansion Phase|Withdrawal by Subject|1
7873716|NCT01693562|12367815|FG000|Expansion Phase|Death|0
7873717|NCT01693562|12367816|FG001|Expansion Phase|Death|0
7873718|NCT01693562|12367817|FG002|Expansion Phase|Death|0
7873719|NCT01693562|12367818|FG003|Expansion Phase|Death|0
7873720|NCT01693562|12367819|FG004|Expansion Phase|Death|0
7873721|NCT01693562|12367820|FG005|Expansion Phase|Death|0
7873722|NCT01693562|12367821|FG006|Expansion Phase|Death|0
7873723|NCT01693562|12367822|FG007|Expansion Phase|Death|42
7873724|NCT01693562|12367823|FG008|Expansion Phase|Death|17
7873725|NCT01693562|12367824|FG009|Expansion Phase|Death|208
7873726|NCT01693562|12367825|FG010|Expansion Phase|Death|30
7873727|NCT01693562|12367826|FG011|Expansion Phase|Death|8
7873728|NCT01693562|12367827|FG012|Expansion Phase|Death|19
7873729|NCT01693562|12367828|FG013|Expansion Phase|Death|42
7873730|NCT01693562|12367829|FG014|Expansion Phase|Death|23
7873731|NCT01693562|12367830|FG015|Expansion Phase|Death|23
7873732|NCT01693562|12367831|FG016|Expansion Phase|Death|128
7873733|NCT01693562|12367832|FG017|Expansion Phase|Death|16
7873734|NCT01693562|12367833|FG018|Expansion Phase|Death|36
7873735|NCT01693562|12367834|FG019|Expansion Phase|Death|16
7873736|NCT01693562|12367835|FG020|Expansion Phase|Death|17
7873737|NCT01693562|12367836|FG021|Expansion Phase|Death|35
7873738|NCT01693562|12367837|FG022|Expansion Phase|Death|7
7873739|NCT01693562|12367815|FG000|Expansion Phase|Lost to Follow-up|0
7873740|NCT01693562|12367816|FG001|Expansion Phase|Lost to Follow-up|0
7873741|NCT01693562|12367817|FG002|Expansion Phase|Lost to Follow-up|0
7873742|NCT01693562|12367818|FG003|Expansion Phase|Lost to Follow-up|0
7873743|NCT01693562|12367819|FG004|Expansion Phase|Lost to Follow-up|0
7873744|NCT01693562|12367820|FG005|Expansion Phase|Lost to Follow-up|0
7873745|NCT01693562|12367821|FG006|Expansion Phase|Lost to Follow-up|0
7873746|NCT01693562|12367822|FG007|Expansion Phase|Lost to Follow-up|1
7873747|NCT01693562|12367823|FG008|Expansion Phase|Lost to Follow-up|2
7873748|NCT01693562|12367824|FG009|Expansion Phase|Lost to Follow-up|10
7873749|NCT01693562|12367825|FG010|Expansion Phase|Lost to Follow-up|4
7873750|NCT01693562|12367826|FG011|Expansion Phase|Lost to Follow-up|4
7873751|NCT01693562|12367827|FG012|Expansion Phase|Lost to Follow-up|1
7873752|NCT01693562|12367828|FG013|Expansion Phase|Lost to Follow-up|3
7873753|NCT01693562|12367829|FG014|Expansion Phase|Lost to Follow-up|0
7873754|NCT01693562|12367830|FG015|Expansion Phase|Lost to Follow-up|1
7873755|NCT01693562|12367831|FG016|Expansion Phase|Lost to Follow-up|1
7873756|NCT01693562|12367832|FG017|Expansion Phase|Lost to Follow-up|0
7873757|NCT01693562|12367833|FG018|Expansion Phase|Lost to Follow-up|2
7873758|NCT01693562|12367834|FG019|Expansion Phase|Lost to Follow-up|1
7873759|NCT01693562|12367835|FG020|Expansion Phase|Lost to Follow-up|2
7873760|NCT01693562|12367836|FG021|Expansion Phase|Lost to Follow-up|2
7873761|NCT01693562|12367837|FG022|Expansion Phase|Lost to Follow-up|1
7873762|NCT01693562|12367815|FG000|Expansion Phase|Other|0
7873763|NCT01693562|12367816|FG001|Expansion Phase|Other|0
7873764|NCT01693562|12367817|FG002|Expansion Phase|Other|0
7873765|NCT01693562|12367818|FG003|Expansion Phase|Other|0
7873766|NCT01693562|12367819|FG004|Expansion Phase|Other|0
7873767|NCT01693562|12367820|FG005|Expansion Phase|Other|0
7873768|NCT01693562|12367821|FG006|Expansion Phase|Other|0
7873769|NCT01693562|12367822|FG007|Expansion Phase|Other|3
7873770|NCT01693562|12367823|FG008|Expansion Phase|Other|1
7873771|NCT01693562|12367824|FG009|Expansion Phase|Other|28
7873772|NCT01693562|12367825|FG010|Expansion Phase|Other|4
7873773|NCT01693562|12367826|FG011|Expansion Phase|Other|7
7873774|NCT01693562|12367827|FG012|Expansion Phase|Other|0
7873775|NCT01693562|12367828|FG013|Expansion Phase|Other|1
7873776|NCT01693562|12367829|FG014|Expansion Phase|Other|1
7873777|NCT01693562|12367830|FG015|Expansion Phase|Other|0
7873778|NCT01693562|12367831|FG016|Expansion Phase|Other|28
7873779|NCT01693562|12367832|FG017|Expansion Phase|Other|0
7873780|NCT01693562|12367833|FG018|Expansion Phase|Other|1
7873781|NCT01693562|12367834|FG019|Expansion Phase|Other|0
7873782|NCT01693562|12367835|FG020|Expansion Phase|Other|1
7873783|NCT01693562|12367836|FG021|Expansion Phase|Other|17
7873784|NCT01693562|12367837|FG022|Expansion Phase|Other|1
7873785|NCT01693614|12367923|FG000|Overall Study|Adverse Event|7
7873786|NCT01693614|12367924|FG001|Overall Study|Adverse Event|11
7796622|NCT01070550|12253011|FG003|Overall Study|Treatment duration shortened|0
7796623|NCT01070550|12253012|FG004|Overall Study|Treatment duration shortened|0
7796624|NCT01070550|12253013|FG005|Overall Study|Treatment duration shortened|0
7796625|NCT01070550|12253008|FG000|Overall Study|Treatment interrupted|7
7796626|NCT01070550|12253009|FG001|Overall Study|Treatment interrupted|0
7796627|NCT01070550|12253010|FG002|Overall Study|Treatment interrupted|1
7796628|NCT01070550|12253011|FG003|Overall Study|Treatment interrupted|1
7796629|NCT01070550|12253012|FG004|Overall Study|Treatment interrupted|0
7796630|NCT01070550|12253013|FG005|Overall Study|Treatment interrupted|0
7796631|NCT01070550|12253008|FG000|Overall Study|Treatment not started|14
7796632|NCT01070550|12253009|FG001|Overall Study|Treatment not started|2
7796633|NCT01070550|12253010|FG002|Overall Study|Treatment not started|4
7796634|NCT01070550|12253011|FG003|Overall Study|Treatment not started|0
7796635|NCT01070550|12253012|FG004|Overall Study|Treatment not started|0
7796636|NCT01070550|12253013|FG005|Overall Study|Treatment not started|0
7796637|NCT01070550|12253008|FG000|Overall Study|Treatment restarted|0
7796638|NCT01070550|12253009|FG001|Overall Study|Treatment restarted|1
7796639|NCT01070550|12253010|FG002|Overall Study|Treatment restarted|0
7796640|NCT01070550|12253011|FG003|Overall Study|Treatment restarted|0
7796641|NCT01070550|12253012|FG004|Overall Study|Treatment restarted|0
7796642|NCT01070550|12253013|FG005|Overall Study|Treatment restarted|0
7796643|NCT01070550|12253008|FG000|Overall Study|Treatment stopped|3
7796644|NCT01070550|12253009|FG001|Overall Study|Treatment stopped|0
7796645|NCT01070550|12253010|FG002|Overall Study|Treatment stopped|0
7796646|NCT01070550|12253011|FG003|Overall Study|Treatment stopped|0
7796647|NCT01070550|12253012|FG004|Overall Study|Treatment stopped|0
7796648|NCT01070550|12253013|FG005|Overall Study|Treatment stopped|0
7796649|NCT01070550|12253008|FG000|Overall Study|Treatment unavailable|1
7796650|NCT01070550|12253009|FG001|Overall Study|Treatment unavailable|0
7796651|NCT01070550|12253010|FG002|Overall Study|Treatment unavailable|0
7796652|NCT01070550|12253011|FG003|Overall Study|Treatment unavailable|0
7796653|NCT01070550|12253012|FG004|Overall Study|Treatment unavailable|0
7796654|NCT01070550|12253013|FG005|Overall Study|Treatment unavailable|0
7796655|NCT01070550|12253008|FG000|Overall Study|Treatment was stopped early|7
7796656|NCT01070550|12253009|FG001|Overall Study|Treatment was stopped early|0
7796657|NCT01070550|12253010|FG002|Overall Study|Treatment was stopped early|0
7796658|NCT01070550|12253011|FG003|Overall Study|Treatment was stopped early|0
7796659|NCT01070550|12253012|FG004|Overall Study|Treatment was stopped early|0
7796660|NCT01070550|12253013|FG005|Overall Study|Treatment was stopped early|0
7796661|NCT01070550|12253008|FG000|Overall Study|Other|5
7796662|NCT01070550|12253009|FG001|Overall Study|Other|0
7796663|NCT01070550|12253010|FG002|Overall Study|Other|0
7796664|NCT01070550|12253011|FG003|Overall Study|Other|1
7796665|NCT01070550|12253012|FG004|Overall Study|Other|0
7796666|NCT01070550|12253013|FG005|Overall Study|Other|0
7796667|NCT01070550|12253008|FG000|Overall Study|Withdrawal by Subject|35
7796668|NCT01070550|12253009|FG001|Overall Study|Withdrawal by Subject|0
7873787|NCT01693614|12367925|FG002|Overall Study|Adverse Event|5
7873788|NCT01693614|12367923|FG000|Overall Study|Disease progression|11
7873789|NCT01693614|12367924|FG001|Overall Study|Disease progression|8
7873790|NCT01693614|12367925|FG002|Overall Study|Disease progression|7
7873791|NCT01693614|12367923|FG000|Overall Study|Protocol Violation|5
7873792|NCT01693614|12367924|FG001|Overall Study|Protocol Violation|2
7873793|NCT01693614|12367925|FG002|Overall Study|Protocol Violation|1
7873794|NCT01693614|12367923|FG000|Overall Study|Death|1
7873795|NCT01693614|12367924|FG001|Overall Study|Death|0
7873796|NCT01693614|12367925|FG002|Overall Study|Death|0
7873797|NCT01693614|12367923|FG000|Overall Study|Physician Decision|1
7873798|NCT01693614|12367924|FG001|Overall Study|Physician Decision|1
7873799|NCT01693614|12367925|FG002|Overall Study|Physician Decision|4
7873800|NCT01693614|12367923|FG000|Overall Study|Withdrawal by subject/guardian|0
7873801|NCT01693614|12367924|FG001|Overall Study|Withdrawal by subject/guardian|0
7873802|NCT01693614|12367925|FG002|Overall Study|Withdrawal by subject/guardian|2
7873803|NCT01693614|12367923|FG000|Overall Study|Withdrawal by Subject|1
7873804|NCT01693614|12367924|FG001|Overall Study|Withdrawal by Subject|0
7873805|NCT01693614|12367925|FG002|Overall Study|Withdrawal by Subject|5
7873806|NCT01694121|12367961|FG000|Overall Study|Participant used false ID, was withdrawn|1
7873807|NCT01694121|12367962|FG001|Overall Study|Participant used false ID, was withdrawn|0
7873808|NCT01694420|12367986|FG000|Overall Study|Lost to Follow-up|3
7873809|NCT01694433|12367992|FG000|Overall Study|Adverse Event|7
7873810|NCT01694433|12367993|FG001|Overall Study|Adverse Event|0
7873811|NCT01694433|12367992|FG000|Overall Study|Physician Decision|1
7873812|NCT01694433|12367993|FG001|Overall Study|Physician Decision|0
7873813|NCT01694433|12367992|FG000|Overall Study|Withdrawal by Subject|3
7873814|NCT01694433|12367993|FG001|Overall Study|Withdrawal by Subject|4
7873815|NCT01694485|12368004|FG000|Overall Study|Withdrawal by Subject|20
7873816|NCT01694485|12368005|FG001|Overall Study|Withdrawal by Subject|6
7873817|NCT01694485|12368006|FG002|Overall Study|Withdrawal by Subject|7
7873818|NCT01694485|12368007|FG003|Overall Study|Withdrawal by Subject|25
7873819|NCT01694485|12368008|FG004|Overall Study|Withdrawal by Subject|18
7873820|NCT01694485|12368004|FG000|Overall Study|Sponsor Decision|3
7873821|NCT01694485|12368005|FG001|Overall Study|Sponsor Decision|0
7873822|NCT01694485|12368006|FG002|Overall Study|Sponsor Decision|0
7873823|NCT01694485|12368007|FG003|Overall Study|Sponsor Decision|2
7873824|NCT01694485|12368008|FG004|Overall Study|Sponsor Decision|0
7873825|NCT01694485|12368004|FG000|Overall Study|Lost to Follow-up|9
7873826|NCT01694485|12368005|FG001|Overall Study|Lost to Follow-up|1
7873827|NCT01694485|12368006|FG002|Overall Study|Lost to Follow-up|6
7873828|NCT01694485|12368007|FG003|Overall Study|Lost to Follow-up|10
7873829|NCT01694485|12368008|FG004|Overall Study|Lost to Follow-up|7
7873830|NCT01694485|12368004|FG000|Overall Study|Death|1
7873831|NCT01694485|12368005|FG001|Overall Study|Death|0
7796669|NCT01070550|12253010|FG002|Overall Study|Withdrawal by Subject|3
7796670|NCT01070550|12253011|FG003|Overall Study|Withdrawal by Subject|0
7796671|NCT01070550|12253012|FG004|Overall Study|Withdrawal by Subject|0
7796672|NCT01070550|12253013|FG005|Overall Study|Withdrawal by Subject|0
7796673|NCT01070771|12253037|FG000|Overall Study|Adverse Event|2
7796674|NCT01070771|12253037|FG000|Overall Study|Protocol Violation|1
7796675|NCT01070784|12253044|FG000|Overall Study|Withdrawal by Subject|6
7796676|NCT01070784|12253045|FG001|Overall Study|Withdrawal by Subject|9
7796677|NCT01070784|12253044|FG000|Overall Study|Adverse Event|14
7796678|NCT01070784|12253045|FG001|Overall Study|Adverse Event|9
7796679|NCT01070888|12253064|FG000|First Intervention (14 Days)|Adverse Event|0
7796680|NCT01070888|12253065|FG001|First Intervention (14 Days)|Adverse Event|1
7796681|NCT01070888|12253064|FG000|First Intervention (14 Days)|Lost to Follow-up|0
7796682|NCT01070888|12253065|FG001|First Intervention (14 Days)|Lost to Follow-up|1
7796683|NCT01070888|12253064|FG000|Washout (14 Days)|Physician Decision|1
7796684|NCT01070888|12253065|FG001|Washout (14 Days)|Physician Decision|0
7796685|NCT01070979|12253074|FG000|Overall Study|Adverse Event|2
7796686|NCT01070979|12253075|FG001|Overall Study|Adverse Event|3
7796687|NCT01070979|12253076|FG002|Overall Study|Adverse Event|3
7796688|NCT01070979|12253074|FG000|Overall Study|Lost to Follow-up|2
7796689|NCT01070979|12253075|FG001|Overall Study|Lost to Follow-up|1
7796690|NCT01070979|12253076|FG002|Overall Study|Lost to Follow-up|1
7796691|NCT01070979|12253074|FG000|Overall Study|Protocol Violation|0
7796692|NCT01070979|12253075|FG001|Overall Study|Protocol Violation|2
7796693|NCT01070979|12253076|FG002|Overall Study|Protocol Violation|6
7796694|NCT01070979|12253074|FG000|Overall Study|Surgery, moving, personal, abn. labs|4
7796695|NCT01070979|12253075|FG001|Overall Study|Surgery, moving, personal, abn. labs|4
7796696|NCT01070979|12253076|FG002|Overall Study|Surgery, moving, personal, abn. labs|2
7796697|NCT01070979|12253074|FG000|Overall Study|Withdrawal by Subject|3
7796698|NCT01070979|12253075|FG001|Overall Study|Withdrawal by Subject|1
7796699|NCT01070979|12253076|FG002|Overall Study|Withdrawal by Subject|1
7796700|NCT01070979|12253074|FG000|Overall Study|No study drug taken|0
7796701|NCT01070979|12253075|FG001|Overall Study|No study drug taken|1
7796702|NCT01070979|12253076|FG002|Overall Study|No study drug taken|0
7796703|NCT01071070|12253098|FG000|Overall Study|Adverse Event|0
7796704|NCT01071070|12253099|FG001|Overall Study|Adverse Event|3
7796705|NCT01071070|12253098|FG000|Overall Study|Withdrawal by Subject|1
7796706|NCT01071070|12253099|FG001|Overall Study|Withdrawal by Subject|0
7796707|NCT01071070|12253098|FG000|Overall Study|Missed 3 consecutive doses of study drug|2
7796708|NCT01071070|12253099|FG001|Overall Study|Missed 3 consecutive doses of study drug|0
7796709|NCT01071070|12253098|FG000|Overall Study|Hypercalcemia|1
7796710|NCT01071070|12253099|FG001|Overall Study|Hypercalcemia|0
7796711|NCT01071083|12253110|FG000|Overall Study|Adverse Event|1
7796712|NCT01071083|12253111|FG001|Overall Study|Adverse Event|0
7796713|NCT01071083|12253112|FG002|Overall Study|Adverse Event|1
7796714|NCT01071083|12253113|FG003|Overall Study|Adverse Event|0
7796715|NCT01071083|12253114|FG004|Overall Study|Adverse Event|1
7796716|NCT01071083|12253110|FG000|Overall Study|Withdrawal by Subject|3
7796717|NCT01071083|12253111|FG001|Overall Study|Withdrawal by Subject|0
7796718|NCT01071083|12253112|FG002|Overall Study|Withdrawal by Subject|2
7796719|NCT01071083|12253113|FG003|Overall Study|Withdrawal by Subject|0
7796720|NCT01071083|12253114|FG004|Overall Study|Withdrawal by Subject|3
7796721|NCT01071083|12253110|FG000|Overall Study|Physician Decision|1
7796722|NCT01071083|12253111|FG001|Overall Study|Physician Decision|0
7796723|NCT01071083|12253112|FG002|Overall Study|Physician Decision|0
7796724|NCT01071083|12253113|FG003|Overall Study|Physician Decision|1
7796725|NCT01071083|12253114|FG004|Overall Study|Physician Decision|1
7796726|NCT01071083|12253110|FG000|Overall Study|Early Rescue|1
7796727|NCT01071083|12253111|FG001|Overall Study|Early Rescue|0
7796728|NCT01071083|12253112|FG002|Overall Study|Early Rescue|0
7796729|NCT01071083|12253113|FG003|Overall Study|Early Rescue|0
7796730|NCT01071083|12253114|FG004|Overall Study|Early Rescue|1
7796731|NCT01071083|12253110|FG000|Overall Study|Subject Moved|0
7796732|NCT01071083|12253111|FG001|Overall Study|Subject Moved|1
7796733|NCT01071083|12253112|FG002|Overall Study|Subject Moved|0
7796734|NCT01071083|12253113|FG003|Overall Study|Subject Moved|0
7796735|NCT01071083|12253114|FG004|Overall Study|Subject Moved|0
7796736|NCT01071083|12253110|FG000|Overall Study|Images Not Usable (Motion)|0
7796737|NCT01071083|12253111|FG001|Overall Study|Images Not Usable (Motion)|1
7796738|NCT01071083|12253112|FG002|Overall Study|Images Not Usable (Motion)|0
7796739|NCT01071083|12253113|FG003|Overall Study|Images Not Usable (Motion)|0
7796740|NCT01071083|12253114|FG004|Overall Study|Images Not Usable (Motion)|0
7796741|NCT01071083|12253110|FG000|Overall Study|Did Not Meet Eligibility Criteria|0
7796742|NCT01071083|12253111|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
7796743|NCT01071083|12253112|FG002|Overall Study|Did Not Meet Eligibility Criteria|1
7796744|NCT01071083|12253113|FG003|Overall Study|Did Not Meet Eligibility Criteria|1
7796745|NCT01071083|12253114|FG004|Overall Study|Did Not Meet Eligibility Criteria|1
7796746|NCT01071083|12253110|FG000|Overall Study|Did Not Want Per Protocol Treatment|0
7796747|NCT01071083|12253111|FG001|Overall Study|Did Not Want Per Protocol Treatment|0
7796748|NCT01071083|12253112|FG002|Overall Study|Did Not Want Per Protocol Treatment|1
7796749|NCT01071083|12253113|FG003|Overall Study|Did Not Want Per Protocol Treatment|0
7796750|NCT01071083|12253114|FG004|Overall Study|Did Not Want Per Protocol Treatment|1
7796751|NCT01071083|12253110|FG000|Overall Study|Subject Refused to Continue|1
7796752|NCT01071083|12253111|FG001|Overall Study|Subject Refused to Continue|0
7796753|NCT01071083|12253112|FG002|Overall Study|Subject Refused to Continue|0
7796754|NCT01071083|12253113|FG003|Overall Study|Subject Refused to Continue|0
7796755|NCT01071083|12253114|FG004|Overall Study|Subject Refused to Continue|0
7796756|NCT01071096|12253126|FG000|First Intervention (90 Days)|Lost to Follow-up|1
7796757|NCT01071096|12253127|FG001|First Intervention (90 Days)|Lost to Follow-up|0
7796758|NCT01071200|12253146|FG000|Overall Study|Lack of ovarian response|1
7796759|NCT01071200|12253147|FG001|Overall Study|Lack of ovarian response|1
7796760|NCT01071200|12253146|FG000|Overall Study|No fertilization|4
7796761|NCT01071200|12253147|FG001|Overall Study|No fertilization|0
7796762|NCT01071200|12253146|FG000|Overall Study|No oocytes retrieved|1
7796763|NCT01071200|12253147|FG001|Overall Study|No oocytes retrieved|1
7796764|NCT01071200|12253146|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1
7796765|NCT01071200|12253147|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0
7796766|NCT01071200|12253146|FG000|Overall Study|No viable embryos|0
7796767|NCT01071200|12253147|FG001|Overall Study|No viable embryos|1
7796768|NCT01071252|12253158|FG000|Overall Study|unsatisfactory therapeutic effect|4
7796769|NCT01071252|12253159|FG001|Overall Study|unsatisfactory therapeutic effect|6
7796770|NCT01071252|12253160|FG002|Overall Study|unsatisfactory therapeutic effect|2
7796771|NCT01071252|12253161|FG003|Overall Study|unsatisfactory therapeutic effect|0
7796772|NCT01071252|12253162|FG004|Overall Study|unsatisfactory therapeutic effect|6
7796773|NCT01071252|12253158|FG000|Overall Study|Withdrawal by Subject|8
7796774|NCT01071252|12253159|FG001|Overall Study|Withdrawal by Subject|2
7796775|NCT01071252|12253160|FG002|Overall Study|Withdrawal by Subject|1
7796776|NCT01071252|12253161|FG003|Overall Study|Withdrawal by Subject|2
7796777|NCT01071252|12253162|FG004|Overall Study|Withdrawal by Subject|3
7796778|NCT01071252|12253158|FG000|Overall Study|administrative problems|1
7796779|NCT01071252|12253159|FG001|Overall Study|administrative problems|1
7796780|NCT01071252|12253160|FG002|Overall Study|administrative problems|0
7796781|NCT01071252|12253161|FG003|Overall Study|administrative problems|2
7796782|NCT01071252|12253162|FG004|Overall Study|administrative problems|1
7796783|NCT01071252|12253158|FG000|Overall Study|Lost to Follow-up|1
7796784|NCT01071252|12253159|FG001|Overall Study|Lost to Follow-up|0
7796785|NCT01071252|12253160|FG002|Overall Study|Lost to Follow-up|1
7796786|NCT01071252|12253161|FG003|Overall Study|Lost to Follow-up|2
7796787|NCT01071252|12253162|FG004|Overall Study|Lost to Follow-up|0
7796788|NCT01071252|12253158|FG000|Overall Study|Adverse Event|1
7796789|NCT01071252|12253159|FG001|Overall Study|Adverse Event|1
7796790|NCT01071252|12253160|FG002|Overall Study|Adverse Event|0
7796791|NCT01071252|12253161|FG003|Overall Study|Adverse Event|1
7796792|NCT01071252|12253162|FG004|Overall Study|Adverse Event|0
7796793|NCT01071252|12253158|FG000|Overall Study|Death|0
7796794|NCT01071252|12253159|FG001|Overall Study|Death|0
7796795|NCT01071252|12253160|FG002|Overall Study|Death|0
7796796|NCT01071252|12253161|FG003|Overall Study|Death|0
7796797|NCT01071252|12253162|FG004|Overall Study|Death|1
7796798|NCT01071278|12253174|FG000|Overall Study|Premature Discontinuation|254
7796799|NCT01071278|12253174|FG000|Overall Study|Completion Status Unknown|459
7796800|NCT01071317|12253182|FG000|Overall Study|Lost to Follow-up|2
7796801|NCT01071317|12253183|FG001|Overall Study|Lost to Follow-up|2
7796802|NCT01071395|12253200|FG000|Overall Study|Withdrawal by Subject|2
7796803|NCT01071395|12253201|FG001|Overall Study|Withdrawal by Subject|1
7796804|NCT01071395|12253200|FG000|Overall Study|Adverse Event|3
7796805|NCT01071395|12253201|FG001|Overall Study|Adverse Event|1
7796806|NCT01071512|12253207|FG000|Overall Study|Adverse Event|1
7796807|NCT01071512|12253207|FG000|Overall Study|Development of antibodies to drug|2
7796808|NCT01071512|12253207|FG000|Overall Study|positive anti-JC virus antibody test|2
7796809|NCT01071798|12253215|FG000|Participants Who Received One Cycle|Lack of Efficacy|18
7796810|NCT01071798|12253215|FG000|Participants Who Received One Cycle|Lack of tolerability|14
7796811|NCT01071798|12253215|FG000|Participants Who Received One Cycle|Patient requirement|20
7796812|NCT01071798|12253215|FG000|Participants Who Received One Cycle|Death|5
7796813|NCT01071798|12253215|FG000|Participants Who Received One Cycle|Change of therapy|6
7796814|NCT01071798|12253215|FG000|Participants Who Received One Cycle|Severe concomitant disease|2
7796815|NCT01071798|12253215|FG000|Subpopulation Who Received Two Cycles|Remission|1
7796816|NCT01071798|12253215|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
7796817|NCT01071798|12253215|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
7796818|NCT01071798|12253215|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7
7796819|NCT01071915|12253229|FG000|Overall Study|Adverse Event|3
7796820|NCT01071915|12253229|FG000|Overall Study|Physician Decision|2
7796821|NCT01071915|12253229|FG000|Overall Study|Withdrawal by Subject|2
7796822|NCT01071915|12253229|FG000|Overall Study|Miscellaneous Reasons|2
7796823|NCT01071954|12253233|FG000|Overall Study|Noncompliance|4
7796824|NCT01071954|12253233|FG000|Overall Study|Adverse Event|1
7873832|NCT01694485|12368006|FG002|Overall Study|Death|0
7873833|NCT01694485|12368007|FG003|Overall Study|Death|1
7873834|NCT01694485|12368008|FG004|Overall Study|Death|0
7873835|NCT01694706|12368051|FG000|Overall Study|Adverse Event|0
7873836|NCT01694706|12368052|FG001|Overall Study|Adverse Event|1
7873837|NCT01694706|12368053|FG002|Overall Study|Adverse Event|0
7873838|NCT01694706|12368051|FG000|Overall Study|other reason not defined above|1
7873839|NCT01694706|12368052|FG001|Overall Study|other reason not defined above|0
7873840|NCT01694706|12368053|FG002|Overall Study|other reason not defined above|0
7873841|NCT01694771|12368064|FG000|Overall Study|Adverse Event|18
7873842|NCT01694771|12368065|FG001|Overall Study|Adverse Event|16
7873843|NCT01694771|12368064|FG000|Overall Study|Lack of Efficacy|1
7873844|NCT01694771|12368065|FG001|Overall Study|Lack of Efficacy|0
7873845|NCT01694771|12368064|FG000|Overall Study|Non compliance protocol|7
7873846|NCT01694771|12368065|FG001|Overall Study|Non compliance protocol|6
7873847|NCT01694771|12368064|FG000|Overall Study|Lost to Follow-up|2
7873848|NCT01694771|12368065|FG001|Overall Study|Lost to Follow-up|3
7873849|NCT01694771|12368064|FG000|Overall Study|Consent withdrawn|7
7873850|NCT01694771|12368065|FG001|Overall Study|Consent withdrawn|9
7873851|NCT01694771|12368064|FG000|Overall Study|Other reasons|5
7873852|NCT01694771|12368065|FG001|Overall Study|Other reasons|6
7873853|NCT01695135|12368096|FG000|Double-blind Treatment Phase|Progressive disease|50
7873854|NCT01695135|12368097|FG001|Double-blind Treatment Phase|Progressive disease|110
7873855|NCT01695135|12368098|FG002|Double-blind Treatment Phase|Progressive disease|0
7873856|NCT01695135|12368099|FG003|Double-blind Treatment Phase|Progressive disease|0
7873857|NCT01695135|12368096|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6
7873858|NCT01695135|12368097|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14
7873859|NCT01695135|12368098|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0
7873860|NCT01695135|12368099|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0
7873861|NCT01695135|12368096|FG000|Double-blind Treatment Phase|Adverse Event|7
7873862|NCT01695135|12368097|FG001|Double-blind Treatment Phase|Adverse Event|7
7873863|NCT01695135|12368098|FG002|Double-blind Treatment Phase|Adverse Event|0
7873864|NCT01695135|12368099|FG003|Double-blind Treatment Phase|Adverse Event|0
7873865|NCT01695135|12368096|FG000|Double-blind Treatment Phase|Other|1
7873866|NCT01695135|12368097|FG001|Double-blind Treatment Phase|Other|3
7873867|NCT01695135|12368098|FG002|Double-blind Treatment Phase|Other|0
7873868|NCT01695135|12368099|FG003|Double-blind Treatment Phase|Other|0
7873869|NCT01695135|12368096|FG000|Double-blind Treatment Phase|Physician Decision|6
7873870|NCT01695135|12368097|FG001|Double-blind Treatment Phase|Physician Decision|3
7873871|NCT01695135|12368098|FG002|Double-blind Treatment Phase|Physician Decision|0
7873872|NCT01695135|12368099|FG003|Double-blind Treatment Phase|Physician Decision|0
7873873|NCT01695135|12368096|FG000|Double-blind Treatment Phase|Death|1
7873874|NCT01695135|12368097|FG001|Double-blind Treatment Phase|Death|1
7873875|NCT01695135|12368098|FG002|Double-blind Treatment Phase|Death|0
7873876|NCT01695135|12368099|FG003|Double-blind Treatment Phase|Death|0
7873877|NCT01695135|12368096|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0
7873878|NCT01695135|12368097|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1
7873879|NCT01695135|12368098|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0
7873880|NCT01695135|12368099|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0
7873881|NCT01695135|12368096|FG000|Open Label Extension Treatment Phase|Progressive disease|0
7873882|NCT01695135|12368097|FG001|Open Label Extension Treatment Phase|Progressive disease|0
7873883|NCT01695135|12368098|FG002|Open Label Extension Treatment Phase|Progressive disease|13
7873884|NCT01695135|12368099|FG003|Open Label Extension Treatment Phase|Progressive disease|22
7873885|NCT01695135|12368096|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0
7873886|NCT01695135|12368097|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0
7873887|NCT01695135|12368098|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6
7873888|NCT01695135|12368099|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16
7873889|NCT01695135|12368096|FG000|Open Label Extension Treatment Phase|Adverse Event|0
7873890|NCT01695135|12368097|FG001|Open Label Extension Treatment Phase|Adverse Event|0
7873891|NCT01695135|12368098|FG002|Open Label Extension Treatment Phase|Adverse Event|11
7873892|NCT01695135|12368099|FG003|Open Label Extension Treatment Phase|Adverse Event|16
7873893|NCT01695135|12368096|FG000|Open Label Extension Treatment Phase|Other|0
7873894|NCT01695135|12368097|FG001|Open Label Extension Treatment Phase|Other|0
7873895|NCT01695135|12368098|FG002|Open Label Extension Treatment Phase|Other|4
7873896|NCT01695135|12368099|FG003|Open Label Extension Treatment Phase|Other|7
7873897|NCT01695135|12368096|FG000|Open Label Extension Treatment Phase|Physician Decision|0
7873898|NCT01695135|12368097|FG001|Open Label Extension Treatment Phase|Physician Decision|0
7873899|NCT01695135|12368098|FG002|Open Label Extension Treatment Phase|Physician Decision|4
7873900|NCT01695135|12368099|FG003|Open Label Extension Treatment Phase|Physician Decision|1
7873901|NCT01695135|12368096|FG000|Open Label Extension Treatment Phase|Death|0
7873902|NCT01695135|12368097|FG001|Open Label Extension Treatment Phase|Death|0
7873903|NCT01695135|12368098|FG002|Open Label Extension Treatment Phase|Death|2
7873904|NCT01695135|12368099|FG003|Open Label Extension Treatment Phase|Death|7
7873905|NCT01695135|12368096|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0
7873906|NCT01695135|12368097|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0
7873907|NCT01695135|12368098|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0
7873908|NCT01695135|12368099|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1
7873909|NCT01695239|12368111|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
7873910|NCT01695239|12368112|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
7873911|NCT01695239|12368113|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3
7873912|NCT01695239|12368114|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4
7873913|NCT01695239|12368115|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7873914|NCT01695239|12368116|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7873915|NCT01695239|12368117|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7873916|NCT01695239|12368118|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7873917|NCT01695239|12368119|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7873918|NCT01695239|12368120|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7873919|NCT01695239|12368121|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7873920|NCT01695239|12368122|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7883487|NCT01782326|12383166|FG000|Double-blind Treatment|Physician Decision|13
7873921|NCT01695239|12368123|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7873922|NCT01695239|12368124|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7873923|NCT01695239|12368111|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2
7873924|NCT01695239|12368112|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2
7873925|NCT01695239|12368113|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2
7873926|NCT01695239|12368114|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3
7873927|NCT01695239|12368115|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0
7873928|NCT01695239|12368116|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0
7873929|NCT01695239|12368117|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0
7873930|NCT01695239|12368118|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0
7873931|NCT01695239|12368119|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0
7873932|NCT01695239|12368120|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0
7873933|NCT01695239|12368121|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0
7873934|NCT01695239|12368122|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0
7873935|NCT01695239|12368123|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0
7873936|NCT01695239|12368124|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0
7873937|NCT01695239|12368111|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4
7873938|NCT01695239|12368112|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7873939|NCT01695239|12368113|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
7873940|NCT01695239|12368114|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7873941|NCT01695239|12368115|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7873942|NCT01695239|12368116|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7873943|NCT01695239|12368117|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7873944|NCT01695239|12368118|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7873945|NCT01695239|12368119|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7873946|NCT01695239|12368120|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7873947|NCT01695239|12368121|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7873948|NCT01695239|12368122|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7873949|NCT01695239|12368123|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7873950|NCT01695239|12368124|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7873951|NCT01695239|12368111|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3
7873952|NCT01695239|12368112|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
7873953|NCT01695239|12368113|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
7873954|NCT01695239|12368114|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7873955|NCT01695239|12368115|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7873956|NCT01695239|12368116|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7873957|NCT01695239|12368117|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7873958|NCT01695239|12368118|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7873959|NCT01695239|12368119|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7873960|NCT01695239|12368120|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7873961|NCT01695239|12368121|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7873962|NCT01695239|12368122|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7873963|NCT01695239|12368123|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7873964|NCT01695239|12368124|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7873965|NCT01695239|12368111|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3
7873966|NCT01695239|12368112|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7873967|NCT01695239|12368113|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1
7873968|NCT01695239|12368114|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7873969|NCT01695239|12368115|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7873970|NCT01695239|12368116|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7873971|NCT01695239|12368117|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7873972|NCT01695239|12368118|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7873973|NCT01695239|12368119|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7873974|NCT01695239|12368120|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7873975|NCT01695239|12368121|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7873976|NCT01695239|12368122|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7873977|NCT01695239|12368123|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7873978|NCT01695239|12368124|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7873979|NCT01695239|12368111|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
7873980|NCT01695239|12368112|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7873981|NCT01695239|12368113|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
7873982|NCT01695239|12368114|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7873983|NCT01695239|12368115|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7873984|NCT01695239|12368116|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7873985|NCT01695239|12368117|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7873986|NCT01695239|12368118|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7873987|NCT01695239|12368119|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7873988|NCT01695239|12368120|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7873989|NCT01695239|12368121|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7873990|NCT01695239|12368122|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7873991|NCT01695239|12368123|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7873992|NCT01695239|12368124|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7873993|NCT01695239|12368111|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1
7873994|NCT01695239|12368112|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0
7873995|NCT01695239|12368113|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0
7873996|NCT01695239|12368114|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0
7873997|NCT01695239|12368115|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0
7873998|NCT01695239|12368116|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0
7873999|NCT01695239|12368117|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0
7874000|NCT01695239|12368118|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0
7874001|NCT01695239|12368119|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0
7874002|NCT01695239|12368120|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0
7874003|NCT01695239|12368121|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0
7874004|NCT01695239|12368122|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0
7874005|NCT01695239|12368123|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0
7874006|NCT01695239|12368124|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0
7874007|NCT01695239|12368111|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7874008|NCT01695239|12368112|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7874009|NCT01695239|12368113|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7874010|NCT01695239|12368114|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7874011|NCT01695239|12368115|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7874012|NCT01695239|12368116|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7874013|NCT01695239|12368117|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7874014|NCT01695239|12368118|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9
7874015|NCT01695239|12368119|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7874016|NCT01695239|12368120|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7874017|NCT01695239|12368121|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7874018|NCT01695239|12368122|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7874019|NCT01695239|12368123|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7874020|NCT01695239|12368124|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7874021|NCT01695239|12368111|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7874022|NCT01695239|12368112|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7874023|NCT01695239|12368113|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7874024|NCT01695239|12368114|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7874025|NCT01695239|12368115|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7874026|NCT01695239|12368116|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7874027|NCT01695239|12368117|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7874028|NCT01695239|12368118|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1
7874029|NCT01695239|12368119|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7874030|NCT01695239|12368120|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7874031|NCT01695239|12368121|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7874032|NCT01695239|12368122|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7874033|NCT01695239|12368123|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7874034|NCT01695239|12368124|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7874035|NCT01695239|12368111|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7874036|NCT01695239|12368112|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7874037|NCT01695239|12368113|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7874038|NCT01695239|12368114|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7874039|NCT01695239|12368115|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7874040|NCT01695239|12368116|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7874041|NCT01695239|12368117|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7874042|NCT01695239|12368118|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1
7874043|NCT01695239|12368119|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7874044|NCT01695239|12368120|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7874045|NCT01695239|12368121|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7874046|NCT01695239|12368122|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7874047|NCT01695239|12368123|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7874048|NCT01695239|12368124|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7874049|NCT01695239|12368111|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0
7874050|NCT01695239|12368112|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0
7874051|NCT01695239|12368113|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0
7874052|NCT01695239|12368114|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0
7874053|NCT01695239|12368115|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0
7874054|NCT01695239|12368116|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0
7874055|NCT01695239|12368117|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0
7874056|NCT01695239|12368118|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0
7874057|NCT01695239|12368119|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37
7874058|NCT01695239|12368120|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31
7874059|NCT01695239|12368121|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0
7874060|NCT01695239|12368122|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0
7874061|NCT01695239|12368123|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0
7874062|NCT01695239|12368124|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0
7874063|NCT01695239|12368111|FG000|Extension Long-Term Extension Periods|Adverse Event|0
7874064|NCT01695239|12368112|FG001|Extension Long-Term Extension Periods|Adverse Event|0
7874065|NCT01695239|12368113|FG002|Extension Long-Term Extension Periods|Adverse Event|0
7874066|NCT01695239|12368114|FG003|Extension Long-Term Extension Periods|Adverse Event|0
7874067|NCT01695239|12368115|FG004|Extension Long-Term Extension Periods|Adverse Event|0
7874068|NCT01695239|12368116|FG005|Extension Long-Term Extension Periods|Adverse Event|0
7874069|NCT01695239|12368117|FG006|Extension Long-Term Extension Periods|Adverse Event|0
7874070|NCT01695239|12368118|FG007|Extension Long-Term Extension Periods|Adverse Event|0
7874071|NCT01695239|12368119|FG008|Extension Long-Term Extension Periods|Adverse Event|15
7874072|NCT01695239|12368120|FG009|Extension Long-Term Extension Periods|Adverse Event|21
7874073|NCT01695239|12368121|FG010|Extension Long-Term Extension Periods|Adverse Event|0
7874074|NCT01695239|12368122|FG011|Extension Long-Term Extension Periods|Adverse Event|0
7874075|NCT01695239|12368123|FG012|Extension Long-Term Extension Periods|Adverse Event|0
7874076|NCT01695239|12368124|FG013|Extension Long-Term Extension Periods|Adverse Event|0
7874077|NCT01695239|12368111|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7874078|NCT01695239|12368112|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7874079|NCT01695239|12368113|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7874080|NCT01695239|12368114|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7874081|NCT01695239|12368115|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7874082|NCT01695239|12368116|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7874083|NCT01695239|12368117|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7874084|NCT01695239|12368118|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7874085|NCT01695239|12368119|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6
7874086|NCT01695239|12368120|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7
7874087|NCT01695239|12368121|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7874088|NCT01695239|12368122|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7874089|NCT01695239|12368123|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7874090|NCT01695239|12368124|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7874091|NCT01695239|12368111|FG000|Extension Long-Term Extension Periods|Physician Decision|0
7874092|NCT01695239|12368112|FG001|Extension Long-Term Extension Periods|Physician Decision|0
7874093|NCT01695239|12368113|FG002|Extension Long-Term Extension Periods|Physician Decision|0
7874094|NCT01695239|12368114|FG003|Extension Long-Term Extension Periods|Physician Decision|0
7874095|NCT01695239|12368115|FG004|Extension Long-Term Extension Periods|Physician Decision|0
7874096|NCT01695239|12368116|FG005|Extension Long-Term Extension Periods|Physician Decision|0
7874097|NCT01695239|12368117|FG006|Extension Long-Term Extension Periods|Physician Decision|0
7874098|NCT01695239|12368118|FG007|Extension Long-Term Extension Periods|Physician Decision|0
7874099|NCT01695239|12368119|FG008|Extension Long-Term Extension Periods|Physician Decision|3
7874100|NCT01695239|12368120|FG009|Extension Long-Term Extension Periods|Physician Decision|0
7874101|NCT01695239|12368121|FG010|Extension Long-Term Extension Periods|Physician Decision|0
7874102|NCT01695239|12368122|FG011|Extension Long-Term Extension Periods|Physician Decision|0
7874103|NCT01695239|12368123|FG012|Extension Long-Term Extension Periods|Physician Decision|0
7874104|NCT01695239|12368124|FG013|Extension Long-Term Extension Periods|Physician Decision|0
7874105|NCT01695239|12368111|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0
7874106|NCT01695239|12368112|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0
7874107|NCT01695239|12368113|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0
7874108|NCT01695239|12368114|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0
7874109|NCT01695239|12368115|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0
7874110|NCT01695239|12368116|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0
7874111|NCT01695239|12368117|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0
7874112|NCT01695239|12368118|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0
7874113|NCT01695239|12368119|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2
7874114|NCT01695239|12368120|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1
7874115|NCT01695239|12368121|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0
7874116|NCT01695239|12368122|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0
7874117|NCT01695239|12368123|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0
7874118|NCT01695239|12368124|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0
7874119|NCT01695239|12368111|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0
7874120|NCT01695239|12368112|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0
7874121|NCT01695239|12368113|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0
7874122|NCT01695239|12368114|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0
7874123|NCT01695239|12368115|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0
7874124|NCT01695239|12368116|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0
7874125|NCT01695239|12368117|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0
7874126|NCT01695239|12368118|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0
7874127|NCT01695239|12368119|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2
7874128|NCT01695239|12368120|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1
7874129|NCT01695239|12368121|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0
7874130|NCT01695239|12368122|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0
7874131|NCT01695239|12368123|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0
7874132|NCT01695239|12368124|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0
7874133|NCT01695239|12368111|FG000|Extension Long-Term Extension Periods|Death|0
7874134|NCT01695239|12368112|FG001|Extension Long-Term Extension Periods|Death|0
7874135|NCT01695239|12368113|FG002|Extension Long-Term Extension Periods|Death|0
7874136|NCT01695239|12368114|FG003|Extension Long-Term Extension Periods|Death|0
7874137|NCT01695239|12368115|FG004|Extension Long-Term Extension Periods|Death|0
7874138|NCT01695239|12368116|FG005|Extension Long-Term Extension Periods|Death|0
7874139|NCT01695239|12368117|FG006|Extension Long-Term Extension Periods|Death|0
7874140|NCT01695239|12368118|FG007|Extension Long-Term Extension Periods|Death|0
7874141|NCT01695239|12368119|FG008|Extension Long-Term Extension Periods|Death|1
7874142|NCT01695239|12368120|FG009|Extension Long-Term Extension Periods|Death|0
7874143|NCT01695239|12368121|FG010|Extension Long-Term Extension Periods|Death|0
7874144|NCT01695239|12368122|FG011|Extension Long-Term Extension Periods|Death|0
7874145|NCT01695239|12368123|FG012|Extension Long-Term Extension Periods|Death|0
7874146|NCT01695239|12368124|FG013|Extension Long-Term Extension Periods|Death|0
7874147|NCT01695239|12368111|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7874148|NCT01695239|12368112|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7874149|NCT01695239|12368113|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7874150|NCT01695239|12368114|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7874151|NCT01695239|12368115|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7874152|NCT01695239|12368116|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7874153|NCT01695239|12368117|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7874154|NCT01695239|12368118|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7874155|NCT01695239|12368119|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7874156|NCT01695239|12368120|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7874157|NCT01695239|12368121|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7874158|NCT01695239|12368122|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
7874159|NCT01695239|12368123|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
7874160|NCT01695239|12368124|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
7874161|NCT01695239|12368111|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7874162|NCT01695239|12368112|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7874163|NCT01695239|12368113|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7874164|NCT01695239|12368114|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7874165|NCT01695239|12368115|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7874166|NCT01695239|12368116|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7874167|NCT01695239|12368117|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7874168|NCT01695239|12368118|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7874169|NCT01695239|12368119|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7874170|NCT01695239|12368120|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7874171|NCT01695239|12368121|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7874172|NCT01695239|12368122|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7874173|NCT01695239|12368123|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1
7874174|NCT01695239|12368124|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1
7874175|NCT01695239|12368111|FG000|Post-Treatment Follow-Up Period|Physician Decision|0
7874176|NCT01695239|12368112|FG001|Post-Treatment Follow-Up Period|Physician Decision|0
7874177|NCT01695239|12368113|FG002|Post-Treatment Follow-Up Period|Physician Decision|0
7874178|NCT01695239|12368114|FG003|Post-Treatment Follow-Up Period|Physician Decision|0
7874179|NCT01695239|12368115|FG004|Post-Treatment Follow-Up Period|Physician Decision|0
7874180|NCT01695239|12368116|FG005|Post-Treatment Follow-Up Period|Physician Decision|0
7874181|NCT01695239|12368117|FG006|Post-Treatment Follow-Up Period|Physician Decision|0
7874182|NCT01695239|12368118|FG007|Post-Treatment Follow-Up Period|Physician Decision|0
7874183|NCT01695239|12368119|FG008|Post-Treatment Follow-Up Period|Physician Decision|0
7874184|NCT01695239|12368120|FG009|Post-Treatment Follow-Up Period|Physician Decision|0
7874185|NCT01695239|12368121|FG010|Post-Treatment Follow-Up Period|Physician Decision|0
7874186|NCT01695239|12368122|FG011|Post-Treatment Follow-Up Period|Physician Decision|0
7874187|NCT01695239|12368123|FG012|Post-Treatment Follow-Up Period|Physician Decision|2
7874188|NCT01695239|12368124|FG013|Post-Treatment Follow-Up Period|Physician Decision|0
7874189|NCT01695239|12368111|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0
7874190|NCT01695239|12368112|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0
7874191|NCT01695239|12368113|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0
7874192|NCT01695239|12368114|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0
7874193|NCT01695239|12368115|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0
7874194|NCT01695239|12368116|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0
7874195|NCT01695239|12368117|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0
7874196|NCT01695239|12368118|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0
7874197|NCT01695239|12368119|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0
7874198|NCT01695239|12368120|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0
7874199|NCT01695239|12368121|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0
7874200|NCT01695239|12368122|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0
7874201|NCT01695239|12368123|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0
7874202|NCT01695239|12368124|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1
7796825|NCT01071954|12253233|FG000|Overall Study|Withdrawal by Subject|11
7796826|NCT01071954|12253233|FG000|Overall Study|Requirement for Alternative Therapy|5
7796827|NCT01071954|12253233|FG000|Overall Study|Administrative Decision|5
7796828|NCT01071954|12253233|FG000|Overall Study|Protocol Specified Criteria|1
7796829|NCT01072149|12253277|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796830|NCT01072149|12253278|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796831|NCT01072149|12253279|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7796832|NCT01072149|12253280|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796833|NCT01072149|12253281|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796834|NCT01072149|12253282|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796835|NCT01072149|12253283|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796836|NCT01072149|12253284|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796837|NCT01072149|12253285|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796838|NCT01072149|12253286|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796839|NCT01072149|12253287|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7874203|NCT01695746|12368191|FG000|Overall Study|Adverse Event|1
7874204|NCT01695746|12368191|FG000|Overall Study|Non-compliance by the participant|3
7874205|NCT01695746|12368191|FG000|Overall Study|Protocol Violation|5
7874206|NCT01695746|12368191|FG000|Overall Study|Participant not willing to participate|3
7874207|NCT01695772|12368196|FG000|Overall Study|Withdrawal by Subject|18
7874208|NCT01695772|12368196|FG000|Overall Study|Progressive Disease|8
7874209|NCT01695772|12368196|FG000|Overall Study|Investigator Decision|5
7874210|NCT01695772|12368196|FG000|Overall Study|Lost to Follow-up|4
7874211|NCT01695772|12368196|FG000|Overall Study|Protocol Violation|2
7874212|NCT01695772|12368196|FG000|Overall Study|Unspecified Reason|1
7874213|NCT01695954|12368202|FG000|Overall Study|Withdrawal by Subject|4
7874214|NCT01695954|12368203|FG001|Overall Study|Withdrawal by Subject|0
7874215|NCT01695954|12368202|FG000|Overall Study|Adverse Event|0
7874216|NCT01695954|12368203|FG001|Overall Study|Adverse Event|2
7874217|NCT01695993|12368214|FG000|Overall Study|Lost to Follow-up|2
7874218|NCT01695993|12368215|FG001|Overall Study|Lost to Follow-up|1
7874219|NCT01695993|12368216|FG002|Overall Study|Lost to Follow-up|3
7874220|NCT01695993|12368214|FG000|Overall Study|Withdrawal by Subject|2
7874221|NCT01695993|12368215|FG001|Overall Study|Withdrawal by Subject|2
7874222|NCT01695993|12368216|FG002|Overall Study|Withdrawal by Subject|2
7874223|NCT01695993|12368214|FG000|Overall Study|To ill to continue|1
7874224|NCT01695993|12368215|FG001|Overall Study|To ill to continue|2
7874225|NCT01695993|12368216|FG002|Overall Study|To ill to continue|0
7874226|NCT01695993|12368214|FG000|Overall Study|Changed Medical Facility|0
7874227|NCT01695993|12368215|FG001|Overall Study|Changed Medical Facility|0
7874228|NCT01695993|12368216|FG002|Overall Study|Changed Medical Facility|1
7874229|NCT01696032|12368228|FG000|Overall Study|Withdrawal by Subject|0
7874230|NCT01696032|12368229|FG001|Overall Study|Withdrawal by Subject|0
7874231|NCT01696032|12368230|FG002|Overall Study|Withdrawal by Subject|1
7874232|NCT01696032|12368231|FG003|Overall Study|Withdrawal by Subject|2
7874233|NCT01696032|12368228|FG000|Overall Study|Death|14
7874234|NCT01696032|12368229|FG001|Overall Study|Death|4
7874235|NCT01696032|12368230|FG002|Overall Study|Death|43
7874236|NCT01696032|12368231|FG003|Overall Study|Death|18
7874237|NCT01696032|12368228|FG000|Overall Study|Lost to Follow-up|0
7874238|NCT01696032|12368229|FG001|Overall Study|Lost to Follow-up|1
7874239|NCT01696032|12368230|FG002|Overall Study|Lost to Follow-up|0
7874240|NCT01696032|12368231|FG003|Overall Study|Lost to Follow-up|0
7874241|NCT01696032|12368228|FG000|Overall Study|Database lock|0
7874242|NCT01696032|12368229|FG001|Overall Study|Database lock|1
7874243|NCT01696032|12368230|FG002|Overall Study|Database lock|7
7874244|NCT01696032|12368231|FG003|Overall Study|Database lock|2
7874245|NCT01696045|12368247|FG000|Overall Study|Study drug toxicity|1
7874246|NCT01696045|12368248|FG001|Overall Study|Study drug toxicity|5
7874247|NCT01696045|12368247|FG000|Overall Study|Disease progression|2
7874248|NCT01696045|12368248|FG001|Overall Study|Disease progression|2
7874249|NCT01696058|12368256|FG000|Overall Study|Adverse Event|21
7874250|NCT01696058|12368257|FG001|Overall Study|Adverse Event|11
7874251|NCT01696058|12368256|FG000|Overall Study|Lack of Efficacy|2
7874252|NCT01696058|12368257|FG001|Overall Study|Lack of Efficacy|3
7874253|NCT01696058|12368256|FG000|Overall Study|Protocol Violation|9
7874254|NCT01696058|12368257|FG001|Overall Study|Protocol Violation|3
7874255|NCT01696058|12368256|FG000|Overall Study|Lost to Follow-up|2
7874256|NCT01696058|12368257|FG001|Overall Study|Lost to Follow-up|5
7874257|NCT01696058|12368256|FG000|Overall Study|Withdrawal by Subject|4
7874258|NCT01696058|12368257|FG001|Overall Study|Withdrawal by Subject|6
7874259|NCT01696058|12368256|FG000|Overall Study|Other reason prematurely discontinued|5
7874260|NCT01696058|12368257|FG001|Overall Study|Other reason prematurely discontinued|3
7874261|NCT01696071|12368263|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1
7874262|NCT01696071|12368264|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0
7874263|NCT01696188|12368282|FG000|Overall Study|Protocol Violation|1
7874264|NCT01696188|12368283|FG001|Overall Study|Protocol Violation|1
7874265|NCT01696214|12368293|FG000|Overall Study|Lost to Follow-up|1
7874266|NCT01696214|12368294|FG001|Overall Study|Lost to Follow-up|0
7874267|NCT01696214|12368295|FG002|Overall Study|Lost to Follow-up|0
7874268|NCT01696214|12368296|FG003|Overall Study|Lost to Follow-up|0
7874269|NCT01696279|12368314|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1
7874270|NCT01696279|12368315|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
7874271|NCT01696279|12368316|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
7874272|NCT01696279|12368317|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
7874273|NCT01696279|12368314|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
7874274|NCT01696279|12368315|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5
7874275|NCT01696279|12368316|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
7874276|NCT01696279|12368317|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
7874277|NCT01696279|12368314|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
7874278|NCT01696279|12368315|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1
7874279|NCT01696279|12368316|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
7874280|NCT01696279|12368317|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
7874281|NCT01696279|12368314|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
7874282|NCT01696279|12368315|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1
7874283|NCT01696279|12368316|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
7874284|NCT01696279|12368317|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
7874285|NCT01696279|12368314|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
7874286|NCT01696279|12368315|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3
7874287|NCT01696279|12368316|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
7874288|NCT01696279|12368317|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
7874289|NCT01696279|12368314|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
7874290|NCT01696279|12368315|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7
7874291|NCT01696279|12368316|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
7874292|NCT01696279|12368317|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
7874293|NCT01696279|12368314|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
7874294|NCT01696279|12368315|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2
7874295|NCT01696279|12368316|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
7874296|NCT01696279|12368317|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
7874297|NCT01696279|12368314|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
7874298|NCT01696279|12368315|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
7874299|NCT01696279|12368316|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1
7874300|NCT01696279|12368317|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
7874301|NCT01696279|12368314|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
7874302|NCT01696279|12368315|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
7874303|NCT01696279|12368316|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
7874304|NCT01696279|12368317|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6
7874305|NCT01696279|12368314|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
7874306|NCT01696279|12368315|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
7874307|NCT01696279|12368316|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
7874308|NCT01696279|12368317|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1
7874309|NCT01696279|12368314|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
7874310|NCT01696279|12368315|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
7874311|NCT01696279|12368316|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
7874312|NCT01696279|12368317|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1
7874313|NCT01696396|12368339|FG000|Overall Study|Withdrawal by Subject|19
7874314|NCT01696396|12368340|FG001|Overall Study|Withdrawal by Subject|5
7874315|NCT01696396|12368341|FG002|Overall Study|Withdrawal by Subject|19
7874316|NCT01696396|12368342|FG003|Overall Study|Withdrawal by Subject|11
7874317|NCT01696396|12368339|FG000|Overall Study|Decision by Sponsor|3
7874318|NCT01696396|12368340|FG001|Overall Study|Decision by Sponsor|1
7874319|NCT01696396|12368341|FG002|Overall Study|Decision by Sponsor|2
7874320|NCT01696396|12368342|FG003|Overall Study|Decision by Sponsor|2
7874321|NCT01696396|12368339|FG000|Overall Study|Lost to Follow-up|9
7874322|NCT01696396|12368340|FG001|Overall Study|Lost to Follow-up|1
7874323|NCT01696396|12368341|FG002|Overall Study|Lost to Follow-up|4
7874324|NCT01696396|12368342|FG003|Overall Study|Lost to Follow-up|1
7874325|NCT01696396|12368339|FG000|Overall Study|Death|0
7874326|NCT01696396|12368340|FG001|Overall Study|Death|0
7874327|NCT01696396|12368341|FG002|Overall Study|Death|1
7874328|NCT01696396|12368342|FG003|Overall Study|Death|0
7874329|NCT01696643|12368358|FG000|Overall Study|Adverse Event|15
7874330|NCT01696643|12368359|FG001|Overall Study|Adverse Event|7
7874331|NCT01696643|12368358|FG000|Overall Study|Death|1
7874332|NCT01696643|12368359|FG001|Overall Study|Death|2
7874333|NCT01696643|12368358|FG000|Overall Study|Lack of Efficacy|3
7874334|NCT01696643|12368359|FG001|Overall Study|Lack of Efficacy|0
7874335|NCT01696643|12368358|FG000|Overall Study|Lost to Follow-up|67
7874336|NCT01696643|12368359|FG001|Overall Study|Lost to Follow-up|67
7874337|NCT01696643|12368358|FG000|Overall Study|Physician Decision|3
7874338|NCT01696643|12368359|FG001|Overall Study|Physician Decision|2
7874339|NCT01696643|12368358|FG000|Overall Study|Pregnancy|0
7874340|NCT01696643|12368359|FG001|Overall Study|Pregnancy|1
7874341|NCT01696643|12368358|FG000|Overall Study|Protocol Violation|7
7874342|NCT01696643|12368359|FG001|Overall Study|Protocol Violation|7
7874343|NCT01696643|12368358|FG000|Overall Study|Study Terminated by Sponsor|286
7874344|NCT01696643|12368359|FG001|Overall Study|Study Terminated by Sponsor|294
7874345|NCT01696643|12368358|FG000|Overall Study|Withdrawal by Subject|142
7874346|NCT01696643|12368359|FG001|Overall Study|Withdrawal by Subject|149
7874347|NCT01696643|12368358|FG000|Overall Study|Participant on Restricted Bed Rest|1
7874348|NCT01696643|12368359|FG001|Overall Study|Participant on Restricted Bed Rest|0
7874349|NCT01696643|12368358|FG000|Overall Study|Site Error|2
7874350|NCT01696643|12368359|FG001|Overall Study|Site Error|1
7874351|NCT01696643|12368358|FG000|Overall Study|Participant Incarcerated|0
7874352|NCT01696643|12368359|FG001|Overall Study|Participant Incarcerated|1
7874353|NCT01696643|12368358|FG000|Overall Study|Medical Monitor Decision|0
7874354|NCT01696643|12368359|FG001|Overall Study|Medical Monitor Decision|2
7874355|NCT01696643|12368358|FG000|Overall Study|Participant Did Not Receive Study Drug|2
7874356|NCT01696643|12368359|FG001|Overall Study|Participant Did Not Receive Study Drug|2
7874357|NCT01696695|12368365|FG000|Overall Study|Disease progression|373
7874358|NCT01696695|12368365|FG000|Overall Study|Death|29
7874359|NCT01696695|12368365|FG000|Overall Study|Adverse Event|74
7874360|NCT01696695|12368365|FG000|Overall Study|Withdrawal by Subject|92
7874361|NCT01696695|12368365|FG000|Overall Study|Lost to Follow-up|48
7874362|NCT01696695|12368365|FG000|Overall Study|Other|74
7874363|NCT01696695|12368365|FG000|Overall Study|Major Protocol Violation|192
7874364|NCT01696877|12368380|FG000|Overall Study|Adverse Event|0
7874365|NCT01696877|12368381|FG001|Overall Study|Adverse Event|1
7874366|NCT01696929|12368389|FG000|Overall Study|Physician Decision|1
7874367|NCT01696942|12368395|FG000|Overall Study|Withdrawal by Subject|1
7874368|NCT01696942|12368396|FG001|Overall Study|Withdrawal by Subject|0
7874369|NCT01696942|12368395|FG000|Overall Study|Protocol Violation|1
7874370|NCT01696942|12368396|FG001|Overall Study|Protocol Violation|2
7874371|NCT01696942|12368395|FG000|Overall Study|screen failure|0
7874372|NCT01696942|12368396|FG001|Overall Study|screen failure|1
7874373|NCT01696955|12368404|FG000|Main Study|Protocol Violation|1
7874374|NCT01696955|12368405|FG001|Main Study|Protocol Violation|0
7874375|NCT01696955|12368404|FG000|Main Study|Withdrawal by Subject|1
7874376|NCT01696955|12368405|FG001|Main Study|Withdrawal by Subject|1
7874377|NCT01697319|12368418|FG000|Primary Phase|Withdrawal by Subject|1
7874378|NCT01697319|12368418|FG000|Extension Phase|Terminated by Sponsor|15
7874379|NCT01697345|12368422|FG000|Overall Study|Withdrawal by Subject|1
7874380|NCT01697358|12368443|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6
7874381|NCT01697358|12368444|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0
7874382|NCT01697358|12368443|FG000|Period I: Randomization to 6 Months|Physician Decision|4
7874383|NCT01697358|12368444|FG001|Period I: Randomization to 6 Months|Physician Decision|0
7874384|NCT01697358|12368443|FG000|Period I: Randomization to 6 Months|Adverse Event|1
7874385|NCT01697358|12368444|FG001|Period I: Randomization to 6 Months|Adverse Event|1
7874386|NCT01697358|12368443|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2
7874387|NCT01697358|12368444|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0
7874388|NCT01697358|12368443|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3
7874389|NCT01697358|12368444|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12
7874390|NCT01697358|12368443|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
7874391|NCT01697358|12368444|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
7874392|NCT01697358|12368443|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
7874393|NCT01697358|12368444|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
7874394|NCT01697358|12368443|FG000|Period II: 6-24M Long-term Follow-up|Death|1
7874395|NCT01697358|12368444|FG001|Period II: 6-24M Long-term Follow-up|Death|1
7874396|NCT01697358|12368443|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0
7874397|NCT01697358|12368444|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3
7874398|NCT01697358|12368443|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
7874399|NCT01697358|12368444|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
7874400|NCT01697449|12368450|FG000|Overall Study|Disease progression|47
7874401|NCT01697449|12368450|FG000|Overall Study|Adverse Event|7
7874402|NCT01697449|12368450|FG000|Overall Study|Lost to Follow-up|5
7874403|NCT01697449|12368450|FG000|Overall Study|Withdrawal by Subject|2
7874404|NCT01697449|12368450|FG000|Overall Study|Physician Decision|1
7874405|NCT01697449|12368450|FG000|Overall Study|Death|2
7874406|NCT01697449|12368450|FG000|Overall Study|Other|1
7874407|NCT01697449|12368450|FG000|Overall Study|Missing|25
7874408|NCT01697462|12368457|FG000|Overall Study|Disease Progression|1
7874409|NCT01697462|12368457|FG000|Overall Study|Adverse Event|6
7874410|NCT01697462|12368457|FG000|Overall Study|Lost to Follow-up|21
7874411|NCT01697462|12368457|FG000|Overall Study|Withdrawal by Subject|12
7874412|NCT01697462|12368457|FG000|Overall Study|Investigator Decision|21
7874413|NCT01697462|12368457|FG000|Overall Study|Death|1
7874414|NCT01697462|12368457|FG000|Overall Study|Other|10
7874415|NCT01697462|12368457|FG000|Overall Study|Missing|5
7874416|NCT01697501|12368461|FG000|Overall Study|Protocol Violation|2
7874417|NCT01697579|12368479|FG000|Base Study-Cycle 1|Adverse Event|1
7874418|NCT01697579|12368480|FG001|Base Study-Cycle 1|Adverse Event|0
7874419|NCT01697579|12368481|FG002|Base Study-Cycle 1|Adverse Event|0
7874420|NCT01697579|12368482|FG003|Base Study-Cycle 1|Adverse Event|0
7874421|NCT01697579|12368483|FG004|Base Study-Cycle 1|Adverse Event|0
7874422|NCT01697579|12368484|FG005|Base Study-Cycle 1|Adverse Event|0
7874423|NCT01697579|12368485|FG006|Base Study-Cycle 1|Adverse Event|0
7874424|NCT01697579|12368479|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
7874425|NCT01697579|12368480|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7874426|NCT01697579|12368481|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7874427|NCT01697579|12368482|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7874428|NCT01697579|12368483|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7874429|NCT01697579|12368484|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7874430|NCT01697579|12368485|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7874431|NCT01697579|12368479|FG000|Base Study-Cycle 1|Protocol Violation|0
7874432|NCT01697579|12368480|FG001|Base Study-Cycle 1|Protocol Violation|0
7874433|NCT01697579|12368481|FG002|Base Study-Cycle 1|Protocol Violation|0
7874434|NCT01697579|12368482|FG003|Base Study-Cycle 1|Protocol Violation|0
7874435|NCT01697579|12368483|FG004|Base Study-Cycle 1|Protocol Violation|3
7874436|NCT01697579|12368484|FG005|Base Study-Cycle 1|Protocol Violation|0
7874437|NCT01697579|12368485|FG006|Base Study-Cycle 1|Protocol Violation|0
7874438|NCT01697579|12368479|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7874439|NCT01697579|12368480|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1
7874440|NCT01697579|12368481|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7874441|NCT01697579|12368482|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7874442|NCT01697579|12368483|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7874443|NCT01697579|12368484|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7874444|NCT01697579|12368485|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7874445|NCT01697579|12368479|FG000|Base Study-Cycle 1|Technical Problems|0
7874446|NCT01697579|12368480|FG001|Base Study-Cycle 1|Technical Problems|0
7874447|NCT01697579|12368481|FG002|Base Study-Cycle 1|Technical Problems|1
7874448|NCT01697579|12368482|FG003|Base Study-Cycle 1|Technical Problems|1
7874449|NCT01697579|12368483|FG004|Base Study-Cycle 1|Technical Problems|0
7874450|NCT01697579|12368484|FG005|Base Study-Cycle 1|Technical Problems|0
7874451|NCT01697579|12368485|FG006|Base Study-Cycle 1|Technical Problems|0
7874452|NCT01697579|12368479|FG000|Optional Extension-Cycles 2-6|Death|0
7874453|NCT01697579|12368480|FG001|Optional Extension-Cycles 2-6|Death|0
7874454|NCT01697579|12368481|FG002|Optional Extension-Cycles 2-6|Death|0
7874455|NCT01697579|12368482|FG003|Optional Extension-Cycles 2-6|Death|0
7874456|NCT01697579|12368483|FG004|Optional Extension-Cycles 2-6|Death|0
7874457|NCT01697579|12368484|FG005|Optional Extension-Cycles 2-6|Death|0
7874458|NCT01697579|12368485|FG006|Optional Extension-Cycles 2-6|Death|2
7874459|NCT01697579|12368479|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7874460|NCT01697579|12368480|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7874461|NCT01697579|12368481|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7874462|NCT01697579|12368482|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7874463|NCT01697579|12368483|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7874464|NCT01697579|12368484|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
7874465|NCT01697579|12368485|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
7874466|NCT01697579|12368479|FG000|Optional Extension-Cycles 2-6|Physician Decision|0
7874467|NCT01697579|12368480|FG001|Optional Extension-Cycles 2-6|Physician Decision|0
7874468|NCT01697579|12368481|FG002|Optional Extension-Cycles 2-6|Physician Decision|0
7874469|NCT01697579|12368482|FG003|Optional Extension-Cycles 2-6|Physician Decision|0
7874470|NCT01697579|12368483|FG004|Optional Extension-Cycles 2-6|Physician Decision|0
7874471|NCT01697579|12368484|FG005|Optional Extension-Cycles 2-6|Physician Decision|7
7874472|NCT01697579|12368485|FG006|Optional Extension-Cycles 2-6|Physician Decision|11
7874473|NCT01697579|12368479|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0
7874474|NCT01697579|12368480|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0
7874475|NCT01697579|12368481|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0
7874476|NCT01697579|12368482|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0
7874477|NCT01697579|12368483|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0
7874478|NCT01697579|12368484|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0
7874479|NCT01697579|12368485|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4
7874480|NCT01697579|12368479|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0
7874481|NCT01697579|12368480|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0
7874482|NCT01697579|12368481|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0
7874483|NCT01697579|12368482|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0
7874484|NCT01697579|12368483|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0
7874485|NCT01697579|12368484|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1
7874486|NCT01697579|12368485|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2
7874487|NCT01697579|12368479|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7883488|NCT01782326|12383167|FG001|Double-blind Treatment|Physician Decision|16
7874488|NCT01697579|12368480|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7874489|NCT01697579|12368481|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7874490|NCT01697579|12368482|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7874491|NCT01697579|12368483|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7874492|NCT01697579|12368484|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
7874493|NCT01697579|12368485|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7874494|NCT01697579|12368479|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7874495|NCT01697579|12368480|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7874496|NCT01697579|12368481|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7874497|NCT01697579|12368482|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7874498|NCT01697579|12368483|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7874499|NCT01697579|12368484|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
7874500|NCT01697579|12368485|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
7874501|NCT01697579|12368479|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7874502|NCT01697579|12368480|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7874503|NCT01697579|12368481|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7874504|NCT01697579|12368482|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7874505|NCT01697579|12368483|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7874506|NCT01697579|12368484|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
7874507|NCT01697579|12368485|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
7874508|NCT01697579|12368479|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7874509|NCT01697579|12368480|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7874510|NCT01697579|12368481|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7874511|NCT01697579|12368482|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7874512|NCT01697579|12368483|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7874513|NCT01697579|12368484|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7874514|NCT01697579|12368485|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
7874515|NCT01697579|12368479|FG000|Optional Extension-Cycles 2-6|Technical Problems|0
7874516|NCT01697579|12368480|FG001|Optional Extension-Cycles 2-6|Technical Problems|0
7874517|NCT01697579|12368481|FG002|Optional Extension-Cycles 2-6|Technical Problems|0
7874518|NCT01697579|12368482|FG003|Optional Extension-Cycles 2-6|Technical Problems|0
7874519|NCT01697579|12368483|FG004|Optional Extension-Cycles 2-6|Technical Problems|0
7874520|NCT01697579|12368484|FG005|Optional Extension-Cycles 2-6|Technical Problems|0
7874521|NCT01697579|12368485|FG006|Optional Extension-Cycles 2-6|Technical Problems|1
7874522|NCT01697579|12368479|FG000|Optional Extension-Cycles 2-6|Participant Moved|0
7874523|NCT01697579|12368480|FG001|Optional Extension-Cycles 2-6|Participant Moved|0
7874524|NCT01697579|12368481|FG002|Optional Extension-Cycles 2-6|Participant Moved|0
7874525|NCT01697579|12368482|FG003|Optional Extension-Cycles 2-6|Participant Moved|0
7874526|NCT01697579|12368483|FG004|Optional Extension-Cycles 2-6|Participant Moved|0
7874527|NCT01697579|12368484|FG005|Optional Extension-Cycles 2-6|Participant Moved|0
7874528|NCT01697579|12368485|FG006|Optional Extension-Cycles 2-6|Participant Moved|2
7874529|NCT01697579|12368479|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7874530|NCT01697579|12368480|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7874531|NCT01697579|12368481|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7874532|NCT01697579|12368482|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7874533|NCT01697579|12368483|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7874534|NCT01697579|12368484|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
7874535|NCT01697579|12368485|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
7874536|NCT01697579|12368479|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7874537|NCT01697579|12368480|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7874538|NCT01697579|12368481|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7874539|NCT01697579|12368482|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7874540|NCT01697579|12368483|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7874541|NCT01697579|12368484|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7874542|NCT01697579|12368485|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1
7874543|NCT01697592|12368523|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
7874544|NCT01697592|12368524|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7874545|NCT01697592|12368525|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7874546|NCT01697592|12368526|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7874547|NCT01697592|12368527|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7874548|NCT01697592|12368528|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7874549|NCT01697592|12368529|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7874550|NCT01697592|12368530|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7874551|NCT01697592|12368531|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7874552|NCT01697592|12368532|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7874553|NCT01697592|12368523|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0
7874554|NCT01697592|12368524|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0
7874555|NCT01697592|12368525|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0
7883489|NCT01782326|12383166|FG000|Double-blind Treatment|Protocol deviation|8
7874556|NCT01697592|12368526|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0
7874557|NCT01697592|12368527|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0
7874558|NCT01697592|12368528|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1
7874559|NCT01697592|12368529|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0
7874560|NCT01697592|12368530|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0
7874561|NCT01697592|12368531|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0
7874562|NCT01697592|12368532|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0
7874563|NCT01697592|12368523|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1
7874564|NCT01697592|12368524|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0
7874565|NCT01697592|12368525|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0
7874566|NCT01697592|12368526|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0
7874567|NCT01697592|12368527|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0
7874568|NCT01697592|12368528|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0
7874569|NCT01697592|12368529|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0
7874570|NCT01697592|12368530|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0
7874571|NCT01697592|12368531|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0
7874572|NCT01697592|12368532|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0
7874573|NCT01697592|12368523|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7874574|NCT01697592|12368524|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7874575|NCT01697592|12368525|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7874576|NCT01697592|12368526|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7874577|NCT01697592|12368527|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7874578|NCT01697592|12368528|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7874579|NCT01697592|12368529|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7874580|NCT01697592|12368530|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7874581|NCT01697592|12368531|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7874582|NCT01697592|12368532|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7874583|NCT01697592|12368523|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0
7874584|NCT01697592|12368524|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2
7874585|NCT01697592|12368525|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1
7874586|NCT01697592|12368526|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2
7874587|NCT01697592|12368527|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0
7874588|NCT01697592|12368528|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0
7874589|NCT01697592|12368529|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1
7874590|NCT01697592|12368530|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0
7796840|NCT01072149|12253288|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796841|NCT01072149|12253289|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796842|NCT01072149|12253290|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796843|NCT01072149|12253291|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796844|NCT01072149|12253292|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796845|NCT01072149|12253293|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796846|NCT01072149|12253294|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7796847|NCT01072149|12253277|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0
7796848|NCT01072149|12253278|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0
7796849|NCT01072149|12253279|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0
7796850|NCT01072149|12253280|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0
7796851|NCT01072149|12253281|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0
7796852|NCT01072149|12253282|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0
7874591|NCT01697592|12368531|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0
7874592|NCT01697592|12368532|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1
7874593|NCT01697592|12368523|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1
7874594|NCT01697592|12368524|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0
7874595|NCT01697592|12368525|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0
7874596|NCT01697592|12368526|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1
7874597|NCT01697592|12368527|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0
7874598|NCT01697592|12368528|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0
7874599|NCT01697592|12368529|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0
7874600|NCT01697592|12368530|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0
7874601|NCT01697592|12368531|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0
7874602|NCT01697592|12368532|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0
7874603|NCT01697592|12368523|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
7874604|NCT01697592|12368524|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7874605|NCT01697592|12368525|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7874606|NCT01697592|12368526|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7874607|NCT01697592|12368527|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7796853|NCT01072149|12253283|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0
7796854|NCT01072149|12253284|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0
7874608|NCT01697592|12368528|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
7874609|NCT01697592|12368529|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7874610|NCT01697592|12368530|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
7874611|NCT01697592|12368531|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7874612|NCT01697592|12368532|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7874613|NCT01697592|12368523|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2
7874614|NCT01697592|12368524|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1
7874615|NCT01697592|12368525|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1
7874616|NCT01697592|12368526|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2
7874617|NCT01697592|12368527|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0
7874618|NCT01697592|12368528|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1
7874619|NCT01697592|12368529|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1
7874620|NCT01697592|12368530|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0
7874621|NCT01697592|12368531|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2
7874622|NCT01697592|12368532|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0
7874623|NCT01697696|12368570|FG000|Overall Study|Study terminated by sponsor|0
7874624|NCT01697696|12368571|FG001|Overall Study|Study terminated by sponsor|3
7874625|NCT01697696|12368570|FG000|Overall Study|Protocol deviation|1
7874626|NCT01697696|12368571|FG001|Overall Study|Protocol deviation|0
7874627|NCT01697696|12368570|FG000|Overall Study|Physician Decision|1
7874628|NCT01697696|12368571|FG001|Overall Study|Physician Decision|0
7874629|NCT01697696|12368570|FG000|Overall Study|Death|4
7874630|NCT01697696|12368571|FG001|Overall Study|Death|2
7874631|NCT01697696|12368570|FG000|Overall Study|Lost to Follow-up|10
7874632|NCT01697696|12368571|FG001|Overall Study|Lost to Follow-up|7
7874633|NCT01697696|12368570|FG000|Overall Study|Subject/guardian decision|31
7874634|NCT01697696|12368571|FG001|Overall Study|Subject/guardian decision|35
7874635|NCT01697748|12368588|FG000|Overall Study|ineligible skin incision|1
7874636|NCT01697748|12368589|FG001|Overall Study|ineligible skin incision|2
7874637|NCT01697748|12368588|FG000|Overall Study|ineligible uterine incision|4
7874638|NCT01697748|12368589|FG001|Overall Study|ineligible uterine incision|1
7874639|NCT01697748|12368588|FG000|Overall Study|Lost to Follow-up|53
7874640|NCT01697748|12368589|FG001|Overall Study|Lost to Follow-up|65
7874641|NCT01697956|12368597|FG000|Overall Study|Protocol Violation|1
7874642|NCT01697956|12368598|FG001|Overall Study|Protocol Violation|1
7874643|NCT01697969|12368610|FG000|Overall Study|Did not meet inc/exc criteria|3
7874644|NCT01698008|12368617|FG000|Overall Study|Withdrawal by Subject|1
7874645|NCT01698008|12368618|FG001|Overall Study|Withdrawal by Subject|2
7874646|NCT01698268|12368626|FG000|Overall Study|Physician Decision|2
7874647|NCT01698268|12368627|FG001|Overall Study|Physician Decision|1
7874648|NCT01698320|12368635|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
7874649|NCT01698320|12368636|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
7874650|NCT01698320|12368637|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
7874651|NCT01698320|12368635|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
7874652|NCT01698320|12368636|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
7874653|NCT01698320|12368637|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
7874654|NCT01698320|12368635|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
7874655|NCT01698320|12368636|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
7874656|NCT01698320|12368637|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
7874657|NCT01698320|12368635|FG000|Run-In Period (Week -1 to Day 0)|Other|1
7874658|NCT01698320|12368636|FG001|Run-In Period (Week -1 to Day 0)|Other|0
7874659|NCT01698320|12368637|FG002|Run-In Period (Week -1 to Day 0)|Other|0
7874660|NCT01698320|12368635|FG000|12-Week Double-Blind Period|Adverse Event|0
7874661|NCT01698320|12368636|FG001|12-Week Double-Blind Period|Adverse Event|1
7874662|NCT01698320|12368637|FG002|12-Week Double-Blind Period|Adverse Event|1
7874663|NCT01698320|12368635|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0
7874664|NCT01698320|12368636|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2
7874665|NCT01698320|12368637|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2
7874666|NCT01698320|12368635|FG000|12-Week Double-Blind Period|Protocol Violation|0
7874667|NCT01698320|12368636|FG001|12-Week Double-Blind Period|Protocol Violation|0
7874668|NCT01698320|12368637|FG002|12-Week Double-Blind Period|Protocol Violation|2
7874669|NCT01698320|12368635|FG000|12-Week Double-Blind Period|Pregnancy|0
7874670|NCT01698320|12368636|FG001|12-Week Double-Blind Period|Pregnancy|1
7874671|NCT01698320|12368637|FG002|12-Week Double-Blind Period|Pregnancy|1
7874672|NCT01698320|12368635|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
7874673|NCT01698320|12368636|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
7874674|NCT01698320|12368637|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
7874675|NCT01698320|12368635|FG000|12-Week Double-Blind Period|Lost to Follow-up|0
7874676|NCT01698320|12368636|FG001|12-Week Double-Blind Period|Lost to Follow-up|0
7874677|NCT01698320|12368637|FG002|12-Week Double-Blind Period|Lost to Follow-up|4
7874678|NCT01698320|12368635|FG000|40-Week Open-Label Period|Adverse Event|0
7874679|NCT01698320|12368636|FG001|40-Week Open-Label Period|Adverse Event|3
7874680|NCT01698320|12368637|FG002|40-Week Open-Label Period|Adverse Event|2
7874681|NCT01698320|12368635|FG000|40-Week Open-Label Period|Withdrawal by Subject|0
7874682|NCT01698320|12368636|FG001|40-Week Open-Label Period|Withdrawal by Subject|11
7874683|NCT01698320|12368637|FG002|40-Week Open-Label Period|Withdrawal by Subject|7
7874684|NCT01698320|12368635|FG000|40-Week Open-Label Period|Pregnancy|0
7874685|NCT01698320|12368636|FG001|40-Week Open-Label Period|Pregnancy|2
7874686|NCT01698320|12368637|FG002|40-Week Open-Label Period|Pregnancy|1
7874687|NCT01698320|12368635|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
7874688|NCT01698320|12368636|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
7874689|NCT01698320|12368637|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
7874690|NCT01698320|12368635|FG000|40-Week Open-Label Period|Lost to Follow-up|0
7874691|NCT01698320|12368636|FG001|40-Week Open-Label Period|Lost to Follow-up|2
7874692|NCT01698320|12368637|FG002|40-Week Open-Label Period|Lost to Follow-up|0
7874693|NCT01698554|12368675|FG000|Overall Study|Adverse Event|2
7874694|NCT01698554|12368676|FG001|Overall Study|Adverse Event|5
7874695|NCT01698554|12368677|FG002|Overall Study|Adverse Event|0
7874696|NCT01698554|12368678|FG003|Overall Study|Adverse Event|1
7874697|NCT01698554|12368675|FG000|Overall Study|Lost to Follow-up|1
7874698|NCT01698554|12368676|FG001|Overall Study|Lost to Follow-up|0
7874699|NCT01698554|12368677|FG002|Overall Study|Lost to Follow-up|0
7874700|NCT01698554|12368678|FG003|Overall Study|Lost to Follow-up|0
7874701|NCT01698554|12368675|FG000|Overall Study|Personal Reasons|0
7874702|NCT01698554|12368676|FG001|Overall Study|Personal Reasons|5
7874703|NCT01698554|12368677|FG002|Overall Study|Personal Reasons|1
7874704|NCT01698554|12368678|FG003|Overall Study|Personal Reasons|1
7874705|NCT01698554|12368675|FG000|Overall Study|Protocol Violation|2
7874706|NCT01698554|12368676|FG001|Overall Study|Protocol Violation|0
7874707|NCT01698554|12368677|FG002|Overall Study|Protocol Violation|1
7874708|NCT01698554|12368678|FG003|Overall Study|Protocol Violation|0
7874709|NCT01698554|12368675|FG000|Overall Study|Other Miscellaneous Reasons|1
7874710|NCT01698554|12368676|FG001|Overall Study|Other Miscellaneous Reasons|0
7874711|NCT01698554|12368677|FG002|Overall Study|Other Miscellaneous Reasons|0
7874712|NCT01698554|12368678|FG003|Overall Study|Other Miscellaneous Reasons|0
7874713|NCT01698775|12368707|FG000|Phase A|Adverse Event|2
7874714|NCT01698775|12368708|FG001|Phase A|Adverse Event|1
7874715|NCT01698775|12368707|FG000|Phase A|Death|1
7874716|NCT01698775|12368708|FG001|Phase A|Death|1
7874717|NCT01698775|12368707|FG000|Phase A|Lack of Efficacy|1
7874718|NCT01698775|12368708|FG001|Phase A|Lack of Efficacy|0
7874719|NCT01698775|12368707|FG000|Phase A|Lost to Follow-up|1
7874720|NCT01698775|12368708|FG001|Phase A|Lost to Follow-up|2
7874721|NCT01698775|12368707|FG000|Phase A|Protocol Violation|1
7874722|NCT01698775|12368708|FG001|Phase A|Protocol Violation|0
7874723|NCT01698775|12368707|FG000|Phase A|Withdrawal by Subject|3
7874724|NCT01698775|12368708|FG001|Phase A|Withdrawal by Subject|4
7874725|NCT01698775|12368707|FG000|Phase A|Kidney [transplant]|0
7874726|NCT01698775|12368708|FG001|Phase A|Kidney [transplant]|1
7874727|NCT01698775|12368707|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0
7874728|NCT01698775|12368708|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1
7874729|NCT01698775|12368707|FG000|Phase B|Adverse Event|6
7874730|NCT01698775|12368708|FG001|Phase B|Adverse Event|3
7874731|NCT01698775|12368707|FG000|Phase B|Death|0
7874732|NCT01698775|12368708|FG001|Phase B|Death|1
7874733|NCT01698775|12368707|FG000|Phase B|Lack of Efficacy|0
7874734|NCT01698775|12368708|FG001|Phase B|Lack of Efficacy|1
7874735|NCT01698775|12368707|FG000|Phase B|Lost to Follow-up|0
7874736|NCT01698775|12368708|FG001|Phase B|Lost to Follow-up|1
7874737|NCT01698775|12368707|FG000|Phase B|Physician Decision|1
7874738|NCT01698775|12368708|FG001|Phase B|Physician Decision|1
7874739|NCT01698775|12368707|FG000|Phase B|Protocol Violation|1
7874740|NCT01698775|12368708|FG001|Phase B|Protocol Violation|1
7796855|NCT01072149|12253285|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0
7796856|NCT01072149|12253286|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0
7796857|NCT01072149|12253287|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0
7796858|NCT01072149|12253288|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0
7796859|NCT01072149|12253289|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0
7796860|NCT01072149|12253290|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0
7796861|NCT01072149|12253291|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0
7796862|NCT01072149|12253292|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0
7796863|NCT01072149|12253293|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0
7796864|NCT01072149|12253294|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1
7796865|NCT01072149|12253277|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796866|NCT01072149|12253278|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796867|NCT01072149|12253279|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796868|NCT01072149|12253280|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796869|NCT01072149|12253281|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796870|NCT01072149|12253282|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796871|NCT01072149|12253283|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796872|NCT01072149|12253284|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796873|NCT01072149|12253285|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796874|NCT01072149|12253286|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796875|NCT01072149|12253287|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1
7796876|NCT01072149|12253288|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796877|NCT01072149|12253289|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796878|NCT01072149|12253290|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796879|NCT01072149|12253291|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796880|NCT01072149|12253292|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796881|NCT01072149|12253293|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796882|NCT01072149|12253294|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7796883|NCT01072149|12253277|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796884|NCT01072149|12253278|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1
7874741|NCT01698775|12368707|FG000|Phase B|Withdrawal by Subject|6
7874742|NCT01698775|12368708|FG001|Phase B|Withdrawal by Subject|2
7874743|NCT01698801|12368718|FG000|Treatment Phase|Adverse Event|4
7874744|NCT01698801|12368718|FG000|Treatment Phase|Protocol Violation|1
7874745|NCT01698801|12368718|FG000|Treatment Phase|Other|4
7874746|NCT01698801|12368718|FG000|Treatment Phase|Withdrawal by Subject|1
7874747|NCT01698801|12368718|FG000|Treatment Phase|Disease progression|1
7874748|NCT01698801|12368718|FG000|Follow Up Phase|Withdrawal by Subject|1
7874749|NCT01698801|12368718|FG000|Follow Up Phase|Death|4
7882887|NCT01777191|12382251|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
7882888|NCT01777191|12382250|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
7882889|NCT01777191|12382251|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
7882890|NCT01777191|12382250|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
7874750|NCT01698814|12368725|FG000|Overall Study|Adverse Event|0
7874751|NCT01698814|12368726|FG001|Overall Study|Adverse Event|2
7874752|NCT01698814|12368725|FG000|Overall Study|Lost to Follow-up|0
7874753|NCT01698814|12368726|FG001|Overall Study|Lost to Follow-up|1
7874754|NCT01698814|12368725|FG000|Overall Study|Pregnancy|1
7874755|NCT01698814|12368726|FG001|Overall Study|Pregnancy|0
7874756|NCT01698814|12368725|FG000|Overall Study|Randomized in error|1
7874757|NCT01698814|12368726|FG001|Overall Study|Randomized in error|0
7874758|NCT01698879|12368735|FG000|Overall Study|Withdrawal by Subject|1
7874759|NCT01698879|12368736|FG001|Overall Study|Withdrawal by Subject|0
7874760|NCT01698879|12368737|FG002|Overall Study|Withdrawal by Subject|0
7874761|NCT01699022|12368751|FG000|Overall Study|Early discontinuation from the study|3
7874762|NCT01699087|12368756|FG000|Overall Study|Lost to Follow-up|7
7874763|NCT01699087|12368756|FG000|Overall Study|Screen failure (prior to treatment)|15
7874764|NCT01699087|12368756|FG000|Overall Study|Unable to make future visits|2
7874765|NCT01699178|12368763|FG000|Overall Study|Adverse Event|1
7874766|NCT01699178|12368764|FG001|Overall Study|Adverse Event|5
7874767|NCT01699178|12368763|FG000|Overall Study|Lost to Follow-up|1
7874768|NCT01699178|12368764|FG001|Overall Study|Lost to Follow-up|6
7874769|NCT01699178|12368763|FG000|Overall Study|Non-compliance with Study Drug|3
7874770|NCT01699178|12368764|FG001|Overall Study|Non-compliance with Study Drug|1
7874771|NCT01699178|12368763|FG000|Overall Study|Physician Decision|1
7874772|NCT01699178|12368764|FG001|Overall Study|Physician Decision|0
7874773|NCT01699178|12368763|FG000|Overall Study|Withdrawal by Subject|4
7874774|NCT01699178|12368764|FG001|Overall Study|Withdrawal by Subject|12
7874775|NCT01699178|12368763|FG000|Overall Study|Hematocrit >54%|1
7874776|NCT01699178|12368764|FG001|Overall Study|Hematocrit >54%|1
7874777|NCT01699178|12368763|FG000|Overall Study|PSA increase of >1.4 ng/mL|4
7874778|NCT01699178|12368764|FG001|Overall Study|PSA increase of >1.4 ng/mL|3
7874779|NCT01699178|12368763|FG000|Overall Study|ineligible/noncompliant/ subject reason|4
7874780|NCT01699178|12368764|FG001|Overall Study|ineligible/noncompliant/ subject reason|4
7874781|NCT01699503|12368781|FG000|Overall Study|Death|31
7874782|NCT01699503|12368782|FG001|Overall Study|Death|40
7874783|NCT01699503|12368781|FG000|Overall Study|Withdrawal by Subject|65
7874784|NCT01699503|12368782|FG001|Overall Study|Withdrawal by Subject|57
7874785|NCT01699503|12368781|FG000|Overall Study|Lost to Follow-up|121
7874786|NCT01699503|12368782|FG001|Overall Study|Lost to Follow-up|117
7874787|NCT01699503|12368781|FG000|Overall Study|Excluded due to quality|783
7874788|NCT01699503|12368782|FG001|Overall Study|Excluded due to quality|791
7874789|NCT01699685|12368807|FG000|Period 1|Adverse Event|1
7874790|NCT01699685|12368808|FG001|Period 1|Adverse Event|1
7874791|NCT01699685|12368807|FG000|Period 1|Medical or ethical, noncompliance|2
7874792|NCT01699685|12368808|FG001|Period 1|Medical or ethical, noncompliance|0
7874793|NCT01699685|12368807|FG000|Period 1|Other|0
7874794|NCT01699685|12368808|FG001|Period 1|Other|1
7874795|NCT01699685|12368807|FG000|Period 1|Patient request|0
7874796|NCT01699685|12368808|FG001|Period 1|Patient request|1
7874797|NCT01699685|12368807|FG000|Period 2|Lost to Follow-up|1
7874798|NCT01699685|12368808|FG001|Period 2|Lost to Follow-up|0
7874799|NCT01699750|12368826|FG000|Overall Study|Withdrew Consent|0
7874800|NCT01699750|12368827|FG001|Overall Study|Withdrew Consent|1
7874801|NCT01699750|12368826|FG000|Overall Study|Other|0
7874802|NCT01699750|12368827|FG001|Overall Study|Other|2
7874803|NCT01699789|12368843|FG000|Overall Study|Withdrawal by Subject|18
7874804|NCT01699789|12368844|FG001|Overall Study|Withdrawal by Subject|23
7874805|NCT01699789|12368843|FG000|Overall Study|Death|1
7874806|NCT01699789|12368844|FG001|Overall Study|Death|2
7874807|NCT01699789|12368843|FG000|Overall Study|Lost to Follow-up|83
7874808|NCT01699789|12368844|FG001|Overall Study|Lost to Follow-up|101
7874809|NCT01699815|12368854|FG000|Overall Study|Protocol Violation|4
7874810|NCT01699815|12368855|FG001|Overall Study|Protocol Violation|7
7874811|NCT01699815|12368854|FG000|Overall Study|record could not be located|1
7874812|NCT01699815|12368855|FG001|Overall Study|record could not be located|0
7874813|NCT01699815|12368854|FG000|Overall Study|Adverse Event|0
7874814|NCT01699815|12368855|FG001|Overall Study|Adverse Event|1
7874815|NCT01699867|12368861|FG000|Overall Study|Screening Failure|3
7874816|NCT01700049|12368869|FG000|Overall Study|Withdrawal by Subject|1
7874817|NCT01700140|12368877|FG000|Overall Study|Use of rescue drugs|3
7874818|NCT01700140|12368878|FG001|Overall Study|Use of rescue drugs|3
7874819|NCT01700140|12368879|FG002|Overall Study|Use of rescue drugs|1
7874820|NCT01700140|12368877|FG000|Overall Study|Discontinuation of radiotherapy|1
7874821|NCT01700140|12368878|FG001|Overall Study|Discontinuation of radiotherapy|0
7874822|NCT01700140|12368879|FG002|Overall Study|Discontinuation of radiotherapy|0
7874823|NCT01700140|12368877|FG000|Overall Study|Use of chemotherapy or surgical therapy|0
7874824|NCT01700140|12368878|FG001|Overall Study|Use of chemotherapy or surgical therapy|1
7874825|NCT01700140|12368879|FG002|Overall Study|Use of chemotherapy or surgical therapy|0
7874826|NCT01700140|12368877|FG000|Overall Study|Aggravation of symptoms|1
7874827|NCT01700140|12368878|FG001|Overall Study|Aggravation of symptoms|0
7874828|NCT01700140|12368879|FG002|Overall Study|Aggravation of symptoms|0
7874829|NCT01700140|12368877|FG000|Overall Study|Adverse Event|0
7874830|NCT01700140|12368878|FG001|Overall Study|Adverse Event|1
7874831|NCT01700140|12368879|FG002|Overall Study|Adverse Event|0
7874832|NCT01700140|12368877|FG000|Overall Study|Inclusion/exclusion criteria deviation|1
7874833|NCT01700140|12368878|FG001|Overall Study|Inclusion/exclusion criteria deviation|4
7874834|NCT01700140|12368879|FG002|Overall Study|Inclusion/exclusion criteria deviation|0
7874835|NCT01700179|12368890|FG000|Overall Study|Physician Decision|2
7874836|NCT01700192|12368896|FG000|Overall Study|Adverse Event|73
7874837|NCT01700192|12368897|FG001|Overall Study|Adverse Event|18
7874838|NCT01700192|12368896|FG000|Overall Study|Lack of Efficacy|1
7874839|NCT01700192|12368897|FG001|Overall Study|Lack of Efficacy|0
7874840|NCT01700192|12368896|FG000|Overall Study|Lost to Follow-up|42
7874841|NCT01700192|12368897|FG001|Overall Study|Lost to Follow-up|29
7874842|NCT01700192|12368896|FG000|Overall Study|Noncompliance with study drug|0
7874843|NCT01700192|12368897|FG001|Overall Study|Noncompliance with study drug|5
7874844|NCT01700192|12368896|FG000|Overall Study|Physician Decision|2
7874845|NCT01700192|12368897|FG001|Overall Study|Physician Decision|3
7874846|NCT01700192|12368896|FG000|Overall Study|Pregnancy|1
7874847|NCT01700192|12368897|FG001|Overall Study|Pregnancy|4
7874848|NCT01700192|12368896|FG000|Overall Study|Progressive disease|1
7874849|NCT01700192|12368897|FG001|Overall Study|Progressive disease|0
7874850|NCT01700192|12368896|FG000|Overall Study|Protocol Violation|3
7874851|NCT01700192|12368897|FG001|Overall Study|Protocol Violation|4
7874852|NCT01700192|12368896|FG000|Overall Study|Technical problems|0
7874853|NCT01700192|12368897|FG001|Overall Study|Technical problems|1
7874854|NCT01700192|12368896|FG000|Overall Study|Withdrawal by Subject|56
7874855|NCT01700192|12368897|FG001|Overall Study|Withdrawal by Subject|64
7874856|NCT01700192|12368896|FG000|Overall Study|Never received study drug|1
7874857|NCT01700192|12368897|FG001|Overall Study|Never received study drug|0
7874858|NCT01700205|12368905|FG000|Overall Study|Withdrawal by Subject|13
7874859|NCT01700205|12368906|FG001|Overall Study|Withdrawal by Subject|13
7874860|NCT01700205|12368905|FG000|Overall Study|Protocol Violation|2
7874861|NCT01700205|12368906|FG001|Overall Study|Protocol Violation|2
7874862|NCT01700387|12368922|FG000|Overall Study|Withdrawal by Subject|1
7874863|NCT01700387|12368923|FG001|Overall Study|Withdrawal by Subject|2
7874864|NCT01700387|12368922|FG000|Overall Study|Adverse Event|1
7874865|NCT01700387|12368923|FG001|Overall Study|Adverse Event|1
7874866|NCT01700387|12368922|FG000|Overall Study|Lost to Follow-up|2
7874867|NCT01700387|12368923|FG001|Overall Study|Lost to Follow-up|1
7874868|NCT01700530|12368949|FG000|Overall Study|Withdrawal by Subject|0
7874869|NCT01700530|12368950|FG001|Overall Study|Withdrawal by Subject|3
7874870|NCT01700530|12368951|FG002|Overall Study|Withdrawal by Subject|1
7874871|NCT01700621|12368961|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7
7874872|NCT01700621|12368962|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4
7874873|NCT01700621|12368961|FG000|Analyzed for Immunogenicity|Protocol Violation|5
7874874|NCT01700621|12368962|FG001|Analyzed for Immunogenicity|Protocol Violation|1
7874875|NCT01700621|12368961|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1
7874876|NCT01700621|12368962|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2
7874877|NCT01700829|12368993|FG000|Overall Study|Withdrawal by Subject|1
7874878|NCT01700829|12368994|FG001|Overall Study|Withdrawal by Subject|1
7874879|NCT01700959|12369015|FG000|Overall Study|Adverse Event|0
7874880|NCT01700959|12369016|FG001|Overall Study|Adverse Event|1
7874881|NCT01700959|12369017|FG002|Overall Study|Adverse Event|1
7874882|NCT01700959|12369018|FG003|Overall Study|Adverse Event|2
7874883|NCT01700959|12369019|FG004|Overall Study|Adverse Event|0
7874884|NCT01700959|12369020|FG005|Overall Study|Adverse Event|2
7874885|NCT01700959|12369015|FG000|Overall Study|Withdrawal by Subject|15
7874886|NCT01700959|12369016|FG001|Overall Study|Withdrawal by Subject|9
7874887|NCT01700959|12369017|FG002|Overall Study|Withdrawal by Subject|12
7874888|NCT01700959|12369018|FG003|Overall Study|Withdrawal by Subject|11
7874889|NCT01700959|12369019|FG004|Overall Study|Withdrawal by Subject|8
7874890|NCT01700959|12369020|FG005|Overall Study|Withdrawal by Subject|12
7874891|NCT01700959|12369015|FG000|Overall Study|Ineligible|2
7874892|NCT01700959|12369016|FG001|Overall Study|Ineligible|1
7874893|NCT01700959|12369017|FG002|Overall Study|Ineligible|2
7874894|NCT01700959|12369018|FG003|Overall Study|Ineligible|0
7874895|NCT01700959|12369019|FG004|Overall Study|Ineligible|0
7874896|NCT01700959|12369020|FG005|Overall Study|Ineligible|1
7874897|NCT01700959|12369015|FG000|Overall Study|Noncompliant|9
7874898|NCT01700959|12369016|FG001|Overall Study|Noncompliant|9
7874899|NCT01700959|12369017|FG002|Overall Study|Noncompliant|17
7874900|NCT01700959|12369018|FG003|Overall Study|Noncompliant|18
7874901|NCT01700959|12369019|FG004|Overall Study|Noncompliant|15
7874902|NCT01700959|12369020|FG005|Overall Study|Noncompliant|9
7874903|NCT01700959|12369015|FG000|Overall Study|Side effects|1
7874904|NCT01700959|12369016|FG001|Overall Study|Side effects|4
7874905|NCT01700959|12369017|FG002|Overall Study|Side effects|8
7874906|NCT01700959|12369018|FG003|Overall Study|Side effects|4
7874907|NCT01700959|12369019|FG004|Overall Study|Side effects|4
7874908|NCT01700959|12369020|FG005|Overall Study|Side effects|1
7874909|NCT01700985|12369038|FG000|Overall Study|Incarcerated|0
7874910|NCT01700985|12369039|FG001|Overall Study|Incarcerated|1
7874911|NCT01701063|12369076|FG000|Overall Study|Lost to Follow-up|0
7874912|NCT01701063|12369077|FG001|Overall Study|Lost to Follow-up|1
7874913|NCT01701063|12369078|FG002|Overall Study|Lost to Follow-up|0
7874914|NCT01701063|12369076|FG000|Overall Study|Withdrawal by Subject|0
7874915|NCT01701063|12369077|FG001|Overall Study|Withdrawal by Subject|0
7874916|NCT01701063|12369078|FG002|Overall Study|Withdrawal by Subject|1
7874917|NCT01701063|12369076|FG000|Overall Study|Other|0
7874918|NCT01701063|12369077|FG001|Overall Study|Other|0
7874919|NCT01701063|12369078|FG002|Overall Study|Other|1
7874920|NCT01701193|12369117|FG000|Overall Study|Withdrawal by Subject|2
7874921|NCT01701193|12369118|FG001|Overall Study|Withdrawal by Subject|2
7874922|NCT01701193|12369119|FG002|Overall Study|Withdrawal by Subject|1
7874923|NCT01701193|12369120|FG003|Overall Study|Withdrawal by Subject|2
7874924|NCT01701193|12369117|FG000|Overall Study|Adverse Event|1
7874925|NCT01701193|12369118|FG001|Overall Study|Adverse Event|0
7874926|NCT01701193|12369119|FG002|Overall Study|Adverse Event|0
7874927|NCT01701193|12369120|FG003|Overall Study|Adverse Event|0
7874928|NCT01701245|12369135|FG000|Overall Study|Protocol Violation|1
7874929|NCT01701245|12369136|FG001|Overall Study|Protocol Violation|3
7874930|NCT01701245|12369135|FG000|Overall Study|Did not complete the open label period|11
7874931|NCT01701245|12369136|FG001|Overall Study|Did not complete the open label period|12
7874932|NCT01701258|12369146|FG000|Assessment and Scheduling|Found to be Ineligible|57
7874933|NCT01701258|12369147|FG001|Assessment and Scheduling|Found to be Ineligible|0
7874934|NCT01701258|12369148|FG002|Assessment and Scheduling|Found to be Ineligible|0
7874935|NCT01701258|12369149|FG003|Assessment and Scheduling|Found to be Ineligible|0
7874936|NCT01701258|12369150|FG004|Assessment and Scheduling|Found to be Ineligible|0
7874937|NCT01701258|12369151|FG005|Assessment and Scheduling|Found to be Ineligible|0
7874938|NCT01701258|12369152|FG006|Assessment and Scheduling|Found to be Ineligible|0
7874939|NCT01701258|12369153|FG007|Assessment and Scheduling|Found to be Ineligible|0
7874940|NCT01701258|12369154|FG008|Assessment and Scheduling|Found to be Ineligible|0
7874941|NCT01701258|12369155|FG009|Assessment and Scheduling|Found to be Ineligible|0
7874942|NCT01701258|12369156|FG010|Assessment and Scheduling|Found to be Ineligible|0
7874943|NCT01701258|12369157|FG011|Assessment and Scheduling|Found to be Ineligible|0
7874944|NCT01701258|12369158|FG012|Assessment and Scheduling|Found to be Ineligible|0
7874945|NCT01701258|12369146|FG000|Assessment and Scheduling|Lost to Follow-up|10
7874946|NCT01701258|12369147|FG001|Assessment and Scheduling|Lost to Follow-up|0
7874947|NCT01701258|12369148|FG002|Assessment and Scheduling|Lost to Follow-up|0
7874948|NCT01701258|12369149|FG003|Assessment and Scheduling|Lost to Follow-up|0
7874949|NCT01701258|12369150|FG004|Assessment and Scheduling|Lost to Follow-up|0
7874950|NCT01701258|12369151|FG005|Assessment and Scheduling|Lost to Follow-up|0
7874951|NCT01701258|12369152|FG006|Assessment and Scheduling|Lost to Follow-up|0
7874952|NCT01701258|12369153|FG007|Assessment and Scheduling|Lost to Follow-up|0
7874953|NCT01701258|12369154|FG008|Assessment and Scheduling|Lost to Follow-up|0
7874954|NCT01701258|12369155|FG009|Assessment and Scheduling|Lost to Follow-up|0
7874955|NCT01701258|12369156|FG010|Assessment and Scheduling|Lost to Follow-up|0
7874956|NCT01701258|12369157|FG011|Assessment and Scheduling|Lost to Follow-up|0
7874957|NCT01701258|12369158|FG012|Assessment and Scheduling|Lost to Follow-up|0
7874958|NCT01701258|12369146|FG000|Assessment and Scheduling|Withdrawal by Subject|14
7874959|NCT01701258|12369147|FG001|Assessment and Scheduling|Withdrawal by Subject|0
7874960|NCT01701258|12369148|FG002|Assessment and Scheduling|Withdrawal by Subject|0
7874961|NCT01701258|12369149|FG003|Assessment and Scheduling|Withdrawal by Subject|0
7874962|NCT01701258|12369150|FG004|Assessment and Scheduling|Withdrawal by Subject|0
7874963|NCT01701258|12369151|FG005|Assessment and Scheduling|Withdrawal by Subject|0
7874964|NCT01701258|12369152|FG006|Assessment and Scheduling|Withdrawal by Subject|0
7874965|NCT01701258|12369153|FG007|Assessment and Scheduling|Withdrawal by Subject|0
7874966|NCT01701258|12369154|FG008|Assessment and Scheduling|Withdrawal by Subject|0
7874967|NCT01701258|12369155|FG009|Assessment and Scheduling|Withdrawal by Subject|0
7874968|NCT01701258|12369156|FG010|Assessment and Scheduling|Withdrawal by Subject|0
7874969|NCT01701258|12369157|FG011|Assessment and Scheduling|Withdrawal by Subject|0
7874970|NCT01701258|12369158|FG012|Assessment and Scheduling|Withdrawal by Subject|0
7874971|NCT01701258|12369146|FG000|Assessment and Scheduling|Investigator Terminated|2
7874972|NCT01701258|12369147|FG001|Assessment and Scheduling|Investigator Terminated|0
7874973|NCT01701258|12369148|FG002|Assessment and Scheduling|Investigator Terminated|0
7874974|NCT01701258|12369149|FG003|Assessment and Scheduling|Investigator Terminated|0
7874975|NCT01701258|12369150|FG004|Assessment and Scheduling|Investigator Terminated|0
7874976|NCT01701258|12369151|FG005|Assessment and Scheduling|Investigator Terminated|0
7874977|NCT01701258|12369152|FG006|Assessment and Scheduling|Investigator Terminated|0
7874978|NCT01701258|12369153|FG007|Assessment and Scheduling|Investigator Terminated|0
7874979|NCT01701258|12369154|FG008|Assessment and Scheduling|Investigator Terminated|0
7874980|NCT01701258|12369155|FG009|Assessment and Scheduling|Investigator Terminated|0
7874981|NCT01701258|12369156|FG010|Assessment and Scheduling|Investigator Terminated|0
7874982|NCT01701258|12369157|FG011|Assessment and Scheduling|Investigator Terminated|0
7874983|NCT01701258|12369158|FG012|Assessment and Scheduling|Investigator Terminated|0
7874984|NCT01701362|12369193|FG000|Overall Study|Adverse events not related to study drug|1
7874985|NCT01701362|12369194|FG001|Overall Study|Adverse events not related to study drug|6
7874986|NCT01701362|12369193|FG000|Overall Study|Adverse events related to study drug|12
7874987|NCT01701362|12369194|FG001|Overall Study|Adverse events related to study drug|10
7874988|NCT01701362|12369193|FG000|Overall Study|Protocol Violation|5
7874989|NCT01701362|12369194|FG001|Overall Study|Protocol Violation|3
7874990|NCT01701362|12369193|FG000|Overall Study|No longer willing to participate|8
7874991|NCT01701362|12369194|FG001|Overall Study|No longer willing to participate|14
7874992|NCT01701362|12369193|FG000|Overall Study|Lost to Follow-up|6
7874993|NCT01701362|12369194|FG001|Overall Study|Lost to Follow-up|9
7874994|NCT01701362|12369193|FG000|Overall Study|Insufficient clinical response|6
7874995|NCT01701362|12369194|FG001|Overall Study|Insufficient clinical response|6
7874996|NCT01701362|12369193|FG000|Overall Study|Death|0
7874997|NCT01701362|12369194|FG001|Overall Study|Death|1
7874998|NCT01701362|12369193|FG000|Overall Study|Randomized but not treated|1
7874999|NCT01701362|12369194|FG001|Overall Study|Randomized but not treated|2
7875000|NCT01701362|12369193|FG000|Overall Study|Reasons other than those mentioned above|3
7875001|NCT01701362|12369194|FG001|Overall Study|Reasons other than those mentioned above|5
7875002|NCT01701401|12369208|FG000|Overall Study|Randomized But Not Treated|3
7875003|NCT01701401|12369209|FG001|Overall Study|Randomized But Not Treated|1
7875004|NCT01701401|12369210|FG002|Overall Study|Randomized But Not Treated|0
7875005|NCT01701401|12369211|FG003|Overall Study|Randomized But Not Treated|1
7875006|NCT01701401|12369208|FG000|Overall Study|Lost to Follow-up|5
7875007|NCT01701401|12369209|FG001|Overall Study|Lost to Follow-up|5
7875008|NCT01701401|12369210|FG002|Overall Study|Lost to Follow-up|1
7875009|NCT01701401|12369211|FG003|Overall Study|Lost to Follow-up|3
7875010|NCT01701401|12369208|FG000|Overall Study|Withdrew Consent|0
7875011|NCT01701401|12369209|FG001|Overall Study|Withdrew Consent|3
7875012|NCT01701401|12369210|FG002|Overall Study|Withdrew Consent|1
7875013|NCT01701401|12369211|FG003|Overall Study|Withdrew Consent|2
7875014|NCT01701401|12369208|FG000|Overall Study|Lack of Efficacy|1
7875015|NCT01701401|12369209|FG001|Overall Study|Lack of Efficacy|0
7875016|NCT01701401|12369210|FG002|Overall Study|Lack of Efficacy|2
7875017|NCT01701401|12369211|FG003|Overall Study|Lack of Efficacy|0
7875018|NCT01701401|12369208|FG000|Overall Study|Adverse Event|1
7875019|NCT01701401|12369209|FG001|Overall Study|Adverse Event|0
7875020|NCT01701401|12369210|FG002|Overall Study|Adverse Event|0
7875021|NCT01701401|12369211|FG003|Overall Study|Adverse Event|0
7875022|NCT01701401|12369208|FG000|Overall Study|Protocol Violation|0
7875023|NCT01701401|12369209|FG001|Overall Study|Protocol Violation|0
7875024|NCT01701401|12369210|FG002|Overall Study|Protocol Violation|1
7875025|NCT01701401|12369211|FG003|Overall Study|Protocol Violation|0
7875026|NCT01701973|12369258|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0
7875027|NCT01701973|12369259|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1
7875028|NCT01701973|12369260|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0
7875029|NCT01701973|12369261|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0
7875030|NCT01701973|12369262|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0
7875031|NCT01701973|12369263|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0
7875032|NCT01701973|12369264|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0
7875033|NCT01701973|12369265|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0
7875034|NCT01702025|12369318|FG000|Overall Study|Equipment failure|1
7875035|NCT01702025|12369319|FG001|Overall Study|Equipment failure|0
7875036|NCT01702025|12369320|FG002|Overall Study|Equipment failure|0
7875037|NCT01702025|12369321|FG003|Overall Study|Equipment failure|0
7875038|NCT01702025|12369318|FG000|Overall Study|Adverse Event|1
7875039|NCT01702025|12369319|FG001|Overall Study|Adverse Event|1
7875040|NCT01702025|12369320|FG002|Overall Study|Adverse Event|1
7875041|NCT01702025|12369321|FG003|Overall Study|Adverse Event|0
7875042|NCT01702246|12369349|FG000|Overall Study|Lost to Follow-up|2
7875043|NCT01702246|12369349|FG000|Overall Study|Withdrawal by Subject|2
7875044|NCT01702246|12369349|FG000|Overall Study|Physician Decision|1
7875045|NCT01702298|12369365|FG000|Overall Study|Withdrawal by Subject|1
7875046|NCT01702311|12369371|FG000|Overall Study|Withdrawal by Subject|3
7875047|NCT01702311|12369372|FG001|Overall Study|Withdrawal by Subject|2
7875048|NCT01702311|12369371|FG000|Overall Study|Discharge less than 24 hours|10
7875049|NCT01702311|12369372|FG001|Overall Study|Discharge less than 24 hours|7
7875050|NCT01702311|12369371|FG000|Overall Study|Physician Decision|3
7875051|NCT01702311|12369372|FG001|Overall Study|Physician Decision|4
7875052|NCT01702363|12369381|FG000|Overall Study|Adverse Event|14
7875053|NCT01702363|12369381|FG000|Overall Study|Lack of Efficacy|4
7875054|NCT01702363|12369381|FG000|Overall Study|Withdrawal by Subject|2
7875055|NCT01702428|12369390|FG000|Overall Study|Adverse Event|2
7875056|NCT01702428|12369391|FG001|Overall Study|Adverse Event|0
7875057|NCT01702428|12369392|FG002|Overall Study|Adverse Event|0
7875058|NCT01702428|12369393|FG003|Overall Study|Adverse Event|0
7875059|NCT01702428|12369390|FG000|Overall Study|Lost to Follow-up|33
7875060|NCT01702428|12369391|FG001|Overall Study|Lost to Follow-up|41
7875061|NCT01702428|12369392|FG002|Overall Study|Lost to Follow-up|37
7875062|NCT01702428|12369393|FG003|Overall Study|Lost to Follow-up|44
7875063|NCT01702428|12369390|FG000|Overall Study|Parents cannot assist to site|1
7875064|NCT01702428|12369391|FG001|Overall Study|Parents cannot assist to site|0
7875065|NCT01702428|12369392|FG002|Overall Study|Parents cannot assist to site|1
7875066|NCT01702428|12369393|FG003|Overall Study|Parents cannot assist to site|0
7875067|NCT01702428|12369390|FG000|Overall Study|Lost Coverage|0
7875068|NCT01702428|12369391|FG001|Overall Study|Lost Coverage|0
7875069|NCT01702428|12369392|FG002|Overall Study|Lost Coverage|0
7875070|NCT01702428|12369393|FG003|Overall Study|Lost Coverage|1
7875071|NCT01702428|12369390|FG000|Overall Study|Lost Health Plan|3
7875072|NCT01702428|12369391|FG001|Overall Study|Lost Health Plan|5
7875073|NCT01702428|12369392|FG002|Overall Study|Lost Health Plan|0
7875074|NCT01702428|12369393|FG003|Overall Study|Lost Health Plan|2
7875075|NCT01702428|12369390|FG000|Overall Study|Mother transferred care|0
7875076|NCT01702428|12369391|FG001|Overall Study|Mother transferred care|1
7875077|NCT01702428|12369392|FG002|Overall Study|Mother transferred care|0
7875078|NCT01702428|12369393|FG003|Overall Study|Mother transferred care|0
7875079|NCT01702428|12369390|FG000|Overall Study|Parents too busy|1
7875080|NCT01702428|12369391|FG001|Overall Study|Parents too busy|0
7875081|NCT01702428|12369392|FG002|Overall Study|Parents too busy|0
7875082|NCT01702428|12369393|FG003|Overall Study|Parents too busy|0
7875083|NCT01702428|12369390|FG000|Overall Study|Protocol Violation|3
7875084|NCT01702428|12369391|FG001|Overall Study|Protocol Violation|0
7875085|NCT01702428|12369392|FG002|Overall Study|Protocol Violation|1
7875086|NCT01702428|12369393|FG003|Overall Study|Protocol Violation|0
7875087|NCT01702428|12369390|FG000|Overall Study|Withdrawal by Subject|21
7875088|NCT01702428|12369391|FG001|Overall Study|Withdrawal by Subject|23
7875089|NCT01702428|12369392|FG002|Overall Study|Withdrawal by Subject|14
7875090|NCT01702428|12369393|FG003|Overall Study|Withdrawal by Subject|10
7875091|NCT01702454|12369412|FG000|Overall Study|Consent withdrawal|0
7875092|NCT01702454|12369413|FG001|Overall Study|Consent withdrawal|1
7875093|NCT01702454|12369412|FG000|Overall Study|Migrated/moved from study area|0
7875094|NCT01702454|12369413|FG001|Overall Study|Migrated/moved from study area|1
7875095|NCT01702454|12369412|FG000|Overall Study|Lost to Follow-up|3
7875096|NCT01702454|12369413|FG001|Overall Study|Lost to Follow-up|6
7875097|NCT01702519|12369424|FG000|Washout Period|Lost to Follow-up|1
7875098|NCT01702519|12369425|FG001|Washout Period|Lost to Follow-up|0
7875099|NCT01702519|12369424|FG000|Washout Period|Withdrawal by Subject|0
7875100|NCT01702519|12369425|FG001|Washout Period|Withdrawal by Subject|2
7875101|NCT01702532|12369437|FG000|Overall Study|Adverse Event|0
7875102|NCT01702532|12369438|FG001|Overall Study|Adverse Event|1
7875103|NCT01702558|12369450|FG000|Overall Study|Withdrawal by Subject|0
7875104|NCT01702558|12369451|FG001|Overall Study|Withdrawal by Subject|0
7875105|NCT01702558|12369452|FG002|Overall Study|Withdrawal by Subject|0
7875106|NCT01702558|12369453|FG003|Overall Study|Withdrawal by Subject|12
7875107|NCT01702558|12369454|FG004|Overall Study|Withdrawal by Subject|4
7875108|NCT01702558|12369450|FG000|Overall Study|Lost to Follow-up|0
7875109|NCT01702558|12369451|FG001|Overall Study|Lost to Follow-up|0
7875110|NCT01702558|12369452|FG002|Overall Study|Lost to Follow-up|0
7875111|NCT01702558|12369453|FG003|Overall Study|Lost to Follow-up|3
7875112|NCT01702558|12369454|FG004|Overall Study|Lost to Follow-up|0
7875113|NCT01702558|12369450|FG000|Overall Study|Death|4
7875114|NCT01702558|12369451|FG001|Overall Study|Death|3
7875115|NCT01702558|12369452|FG002|Overall Study|Death|3
7875116|NCT01702558|12369453|FG003|Overall Study|Death|16
7875117|NCT01702558|12369454|FG004|Overall Study|Death|20
7875118|NCT01702558|12369450|FG000|Overall Study|Safety Follow-Up less than 3 Months|0
7875119|NCT01702558|12369451|FG001|Overall Study|Safety Follow-Up less than 3 Months|0
7875120|NCT01702558|12369452|FG002|Overall Study|Safety Follow-Up less than 3 Months|2
7875121|NCT01702558|12369453|FG003|Overall Study|Safety Follow-Up less than 3 Months|0
7875122|NCT01702558|12369454|FG004|Overall Study|Safety Follow-Up less than 3 Months|0
7875123|NCT01702558|12369450|FG000|Overall Study|Study Terminated by Sponsor|0
7875124|NCT01702558|12369451|FG001|Overall Study|Study Terminated by Sponsor|1
7875125|NCT01702558|12369452|FG002|Overall Study|Study Terminated by Sponsor|0
7875126|NCT01702558|12369453|FG003|Overall Study|Study Terminated by Sponsor|0
7875127|NCT01702558|12369454|FG004|Overall Study|Study Terminated by Sponsor|1
7875128|NCT01702558|12369450|FG000|Overall Study|Other|0
7875129|NCT01702558|12369451|FG001|Overall Study|Other|0
7875130|NCT01702558|12369452|FG002|Overall Study|Other|0
7875131|NCT01702558|12369453|FG003|Overall Study|Other|16
7875132|NCT01702558|12369454|FG004|Overall Study|Other|17
7875133|NCT01702844|12369467|FG000|Overall Study|Adverse Event|9
7875134|NCT01702844|12369467|FG000|Overall Study|Death|1
7875135|NCT01702844|12369467|FG000|Overall Study|Withdrawal by Subject|3
7875136|NCT01702844|12369467|FG000|Overall Study|Physician Decision|6
7875137|NCT01702961|12369471|FG000|Overall Study|Additional treatment|3
7875138|NCT01702961|12369471|FG000|Overall Study|Progressive disease|5
7875139|NCT01702961|12369471|FG000|Overall Study|Relapse|20
7875140|NCT01702961|12369471|FG000|Overall Study|Death|6
7875141|NCT01702961|12369471|FG000|Overall Study|Lost to Follow-up|2
7875142|NCT01702961|12369471|FG000|Overall Study|Ongoing|11
7875143|NCT01702987|12369477|FG000|Overall Study|Withdrawal by Subject|1
7875144|NCT01702987|12369478|FG001|Overall Study|Withdrawal by Subject|0
7875145|NCT01703000|12369484|FG000|Overall Study|Death|1
7875146|NCT01703065|12369501|FG000|Overall Study|Lack of Efficacy|1
7875147|NCT01703065|12369502|FG001|Overall Study|Lack of Efficacy|0
7875148|NCT01703091|12369511|FG000|Overall Study|Adverse Event|5
7875149|NCT01703091|12369512|FG001|Overall Study|Adverse Event|3
7875150|NCT01703091|12369511|FG000|Overall Study|Physician Decision|2
7875151|NCT01703091|12369512|FG001|Overall Study|Physician Decision|1
7875152|NCT01703091|12369511|FG000|Overall Study|Withdrawal by Subject|1
7875153|NCT01703091|12369512|FG001|Overall Study|Withdrawal by Subject|0
7875154|NCT01703091|12369511|FG000|Overall Study|Sponsor Decision|1
7875155|NCT01703091|12369512|FG001|Overall Study|Sponsor Decision|0
7875156|NCT01703117|12369520|FG000|Overall Study|Adverse Event|4
7875157|NCT01703117|12369521|FG001|Overall Study|Adverse Event|3
7875158|NCT01703117|12369520|FG000|Overall Study|Withdrawal by Subject|0
7875159|NCT01703117|12369521|FG001|Overall Study|Withdrawal by Subject|1
7875160|NCT01703208|12369535|FG000|Overall Study|Death|61
7875161|NCT01703208|12369536|FG001|Overall Study|Death|48
7875162|NCT01703208|12369535|FG000|Overall Study|Lack of Efficacy|1
7875163|NCT01703208|12369536|FG001|Overall Study|Lack of Efficacy|2
7875164|NCT01703208|12369535|FG000|Overall Study|Lost to Follow-up|68
7875165|NCT01703208|12369536|FG001|Overall Study|Lost to Follow-up|62
7875166|NCT01703208|12369535|FG000|Overall Study|Non-Compliance with Study Drug|1
7875167|NCT01703208|12369536|FG001|Overall Study|Non-Compliance with Study Drug|0
7875168|NCT01703208|12369535|FG000|Overall Study|Excluded Medication|1
7875169|NCT01703208|12369536|FG001|Overall Study|Excluded Medication|2
7875170|NCT01703208|12369535|FG000|Overall Study|Site Discontinued Study Participation|23
7875171|NCT01703208|12369536|FG001|Overall Study|Site Discontinued Study Participation|27
7875172|NCT01703208|12369535|FG000|Overall Study|Physician Decision|11
7875173|NCT01703208|12369536|FG001|Overall Study|Physician Decision|13
7875174|NCT01703208|12369535|FG000|Overall Study|Progressive disease|2
7875175|NCT01703208|12369536|FG001|Overall Study|Progressive disease|2
7875176|NCT01703208|12369535|FG000|Overall Study|Protocol Violation|1
7875177|NCT01703208|12369536|FG001|Overall Study|Protocol Violation|1
7875178|NCT01703208|12369535|FG000|Overall Study|Study Terminated by Sponsor|1710
7875179|NCT01703208|12369536|FG001|Overall Study|Study Terminated by Sponsor|1716
7875180|NCT01703208|12369535|FG000|Overall Study|Withdrawal by Subject|205
7875181|NCT01703208|12369536|FG001|Overall Study|Withdrawal by Subject|209
7875182|NCT01703208|12369535|FG000|Overall Study|Adverse Event|14
7875183|NCT01703208|12369536|FG001|Overall Study|Adverse Event|19
7875184|NCT01703208|12369535|FG000|Overall Study|Technical Problems|0
7875185|NCT01703208|12369536|FG001|Overall Study|Technical Problems|1
7875186|NCT01703208|12369535|FG000|Overall Study|Protocol Deviation|2
7875187|NCT01703208|12369536|FG001|Overall Study|Protocol Deviation|0
7875188|NCT01703221|12369545|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2
7875189|NCT01703221|12369546|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4
7875190|NCT01703221|12369547|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0
7875191|NCT01703221|12369545|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
7875192|NCT01703221|12369546|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
7875193|NCT01703221|12369547|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
7875194|NCT01703221|12369545|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1
7875195|NCT01703221|12369546|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0
7875196|NCT01703221|12369547|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0
7875197|NCT01703221|12369545|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
7875198|NCT01703221|12369546|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7875199|NCT01703221|12369547|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7875200|NCT01703221|12369545|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0
7875201|NCT01703221|12369546|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0
7875202|NCT01703221|12369547|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1
7875203|NCT01703221|12369545|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
7875204|NCT01703221|12369546|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
7875205|NCT01703221|12369547|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
7875206|NCT01703221|12369545|FG000|Phase B - (Week 25 to 52)|Adverse Event|2
7875207|NCT01703221|12369546|FG001|Phase B - (Week 25 to 52)|Adverse Event|3
7875208|NCT01703221|12369547|FG002|Phase B - (Week 25 to 52)|Adverse Event|2
7875209|NCT01703221|12369545|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12
7875210|NCT01703221|12369546|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10
7875211|NCT01703221|12369547|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3
7875212|NCT01703260|12369564|FG000|Overall Study|Adverse Event|1
7875213|NCT01703260|12369565|FG001|Overall Study|Adverse Event|2
7875214|NCT01703260|12369566|FG002|Overall Study|Adverse Event|2
7875215|NCT01703260|12369564|FG000|Overall Study|Lost to Follow-up|1
7875216|NCT01703260|12369565|FG001|Overall Study|Lost to Follow-up|0
7875217|NCT01703260|12369566|FG002|Overall Study|Lost to Follow-up|0
7875218|NCT01703260|12369564|FG000|Overall Study|Withdrawal by Subject|0
7875219|NCT01703260|12369565|FG001|Overall Study|Withdrawal by Subject|0
7875220|NCT01703260|12369566|FG002|Overall Study|Withdrawal by Subject|1
7875221|NCT01703260|12369564|FG000|Overall Study|Study Termination|1
7875222|NCT01703260|12369565|FG001|Overall Study|Study Termination|2
7875223|NCT01703260|12369566|FG002|Overall Study|Study Termination|0
7875224|NCT01703286|12369574|FG000|Period 1 Including Washout|Withdrawal by Subject|0
7875225|NCT01703286|12369575|FG001|Period 1 Including Washout|Withdrawal by Subject|0
7875226|NCT01703286|12369576|FG002|Period 1 Including Washout|Withdrawal by Subject|0
7875227|NCT01703286|12369577|FG003|Period 1 Including Washout|Withdrawal by Subject|1
7875228|NCT01703286|12369578|FG004|Period 1 Including Washout|Withdrawal by Subject|0
7875229|NCT01703286|12369579|FG005|Period 1 Including Washout|Withdrawal by Subject|1
7875230|NCT01703286|12369574|FG000|Period 2 Including Washout|Adverse Event|0
7875231|NCT01703286|12369575|FG001|Period 2 Including Washout|Adverse Event|0
7875232|NCT01703286|12369576|FG002|Period 2 Including Washout|Adverse Event|0
7875233|NCT01703286|12369577|FG003|Period 2 Including Washout|Adverse Event|1
7875234|NCT01703286|12369578|FG004|Period 2 Including Washout|Adverse Event|0
7875235|NCT01703286|12369579|FG005|Period 2 Including Washout|Adverse Event|0
7875236|NCT01703741|12369624|FG000|Overall Study|Withdrawal by Subject|6
7875237|NCT01703741|12369624|FG000|Overall Study|Adverse Event|2
7875238|NCT01703741|12369624|FG000|Overall Study|Physician Decision|2
7875239|NCT01703741|12369624|FG000|Overall Study|Protocol Violation|1
7875240|NCT01703741|12369624|FG000|Overall Study|Lost to Follow-up|3
7875241|NCT01703741|12369624|FG000|Overall Study|Subject did not want to continue|2
7875242|NCT01703741|12369624|FG000|Overall Study|Subject cannot comply with study visits|1
7875243|NCT01703741|12369624|FG000|Overall Study|Subject started testosterone injections|1
7875244|NCT01703819|12369630|FG000|Overall Study|Adverse Event|0
7875245|NCT01703819|12369631|FG001|Overall Study|Adverse Event|1
7875246|NCT01703819|12369630|FG000|Overall Study|Withdrawal by Subject|0
7875247|NCT01703819|12369631|FG001|Overall Study|Withdrawal by Subject|1
7875248|NCT01703832|12369639|FG000|Overall Study|Withdrawal by Subject|1
7875249|NCT01703832|12369640|FG001|Overall Study|Withdrawal by Subject|0
7875250|NCT01703845|12369648|FG000|Overall Study|Adverse Event|1
7875251|NCT01703845|12369649|FG001|Overall Study|Adverse Event|0
7875252|NCT01703845|12369648|FG000|Overall Study|Protocol Violation|1
7875253|NCT01703845|12369649|FG001|Overall Study|Protocol Violation|0
7875254|NCT01703845|12369648|FG000|Overall Study|other than stated above|1
7875255|NCT01703845|12369649|FG001|Overall Study|other than stated above|0
7875256|NCT01703858|12369660|FG000|Overall Study|Withdrawal by Subject|0
7875257|NCT01703858|12369661|FG001|Overall Study|Withdrawal by Subject|1
7875258|NCT01703858|12369662|FG002|Overall Study|Withdrawal by Subject|0
7875259|NCT01703988|12369679|FG000|Overall Study|Investigator Judgment|0
7875260|NCT01703988|12369680|FG001|Overall Study|Investigator Judgment|0
7875261|NCT01703988|12369681|FG002|Overall Study|Investigator Judgment|0
7875262|NCT01703988|12369682|FG003|Overall Study|Investigator Judgment|1
7875263|NCT01704079|12369695|FG000|Overall Study|Withdrawal by Subject|5
7875264|NCT01704079|12369696|FG001|Overall Study|Withdrawal by Subject|7
7875265|NCT01704079|12369695|FG000|Overall Study|Lost to Follow-up|2
7875266|NCT01704079|12369696|FG001|Overall Study|Lost to Follow-up|5
7875267|NCT01704079|12369695|FG000|Overall Study|Adverse Event|4
7875268|NCT01704079|12369696|FG001|Overall Study|Adverse Event|7
7875269|NCT01704079|12369695|FG000|Overall Study|Protocol Violation|1
7875270|NCT01704079|12369696|FG001|Overall Study|Protocol Violation|0
7875271|NCT01704079|12369695|FG000|Overall Study|Subject noncompliance|2
7875272|NCT01704079|12369696|FG001|Overall Study|Subject noncompliance|3
7875273|NCT01704079|12369695|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
7875274|NCT01704079|12369696|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
7875275|NCT01704261|12369713|FG000|Overall Study|Withdrawal by Subject|12
7875276|NCT01704261|12369714|FG001|Overall Study|Withdrawal by Subject|15
7875277|NCT01704261|12369713|FG000|Overall Study|Lost to Follow-up|1
7875278|NCT01704261|12369714|FG001|Overall Study|Lost to Follow-up|0
7875279|NCT01704287|12369723|FG000|Initial Treatment Period|Death|139
7875280|NCT01704287|12369724|FG001|Initial Treatment Period|Death|129
7875281|NCT01704287|12369725|FG002|Initial Treatment Period|Death|71
7875282|NCT01704287|12369726|FG003|Initial Treatment Period|Death|0
7875283|NCT01704287|12369727|FG004|Initial Treatment Period|Death|0
7875284|NCT01704287|12369723|FG000|Initial Treatment Period|Withdrawal by Subject|3
7875285|NCT01704287|12369724|FG001|Initial Treatment Period|Withdrawal by Subject|2
7875286|NCT01704287|12369725|FG002|Initial Treatment Period|Withdrawal by Subject|4
7875287|NCT01704287|12369726|FG003|Initial Treatment Period|Withdrawal by Subject|0
7875288|NCT01704287|12369727|FG004|Initial Treatment Period|Withdrawal by Subject|0
7875289|NCT01704287|12369723|FG000|Initial Treatment Period|Lost to Follow-up|5
7875290|NCT01704287|12369724|FG001|Initial Treatment Period|Lost to Follow-up|3
7875291|NCT01704287|12369725|FG002|Initial Treatment Period|Lost to Follow-up|0
7875292|NCT01704287|12369726|FG003|Initial Treatment Period|Lost to Follow-up|0
7875293|NCT01704287|12369727|FG004|Initial Treatment Period|Lost to Follow-up|0
7875294|NCT01704287|12369723|FG000|Initial Treatment Period|Switched to Pembrolizumab|0
7875295|NCT01704287|12369724|FG001|Initial Treatment Period|Switched to Pembrolizumab|0
7875296|NCT01704287|12369725|FG002|Initial Treatment Period|Switched to Pembrolizumab|98
7875297|NCT01704287|12369726|FG003|Initial Treatment Period|Switched to Pembrolizumab|0
7875298|NCT01704287|12369727|FG004|Initial Treatment Period|Switched to Pembrolizumab|0
7875299|NCT01704287|12369723|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
7875300|NCT01704287|12369724|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
7875301|NCT01704287|12369725|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
7875302|NCT01704287|12369726|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
7875303|NCT01704287|12369727|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
7875304|NCT01704287|12369723|FG000|Switch to Pembrolizumab Treatment Period|Death|0
7875305|NCT01704287|12369724|FG001|Switch to Pembrolizumab Treatment Period|Death|0
7875306|NCT01704287|12369725|FG002|Switch to Pembrolizumab Treatment Period|Death|0
7875307|NCT01704287|12369726|FG003|Switch to Pembrolizumab Treatment Period|Death|35
7875308|NCT01704287|12369727|FG004|Switch to Pembrolizumab Treatment Period|Death|37
7875309|NCT01704287|12369723|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7875310|NCT01704287|12369724|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7875311|NCT01704287|12369725|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7875312|NCT01704287|12369726|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
7875313|NCT01704287|12369727|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7875314|NCT01704456|12369748|FG000|Overall Study|Lost to Follow-up|8
7875315|NCT01704456|12369749|FG001|Overall Study|Lost to Follow-up|14
7875316|NCT01704495|12369759|FG000|Subjects Randomized|Other Reason|3
7875317|NCT01704495|12369760|FG001|Subjects Randomized|Other Reason|2
7875318|NCT01704495|12369761|FG002|Subjects Randomized|Other Reason|3
7875319|NCT01704495|12369762|FG003|Subjects Randomized|Other Reason|2
7875320|NCT01704495|12369759|FG000|Subjects Randomized|Discontinuation criteria met|4
7875321|NCT01704495|12369760|FG001|Subjects Randomized|Discontinuation criteria met|2
7875322|NCT01704495|12369761|FG002|Subjects Randomized|Discontinuation criteria met|2
7875323|NCT01704495|12369762|FG003|Subjects Randomized|Discontinuation criteria met|0
7875324|NCT01704495|12369759|FG000|Subjects Randomized|Adverse Event|8
7875325|NCT01704495|12369760|FG001|Subjects Randomized|Adverse Event|2
7875326|NCT01704495|12369761|FG002|Subjects Randomized|Adverse Event|0
7875327|NCT01704495|12369762|FG003|Subjects Randomized|Adverse Event|7
7875328|NCT01704495|12369759|FG000|Subjects Randomized|Withdrawal by Subject|5
7875329|NCT01704495|12369760|FG001|Subjects Randomized|Withdrawal by Subject|5
7875330|NCT01704495|12369761|FG002|Subjects Randomized|Withdrawal by Subject|5
7875331|NCT01704495|12369762|FG003|Subjects Randomized|Withdrawal by Subject|5
7875332|NCT01704495|12369759|FG000|Subjects Randomized|Protocol Violation|1
7875333|NCT01704495|12369760|FG001|Subjects Randomized|Protocol Violation|1
7875334|NCT01704495|12369761|FG002|Subjects Randomized|Protocol Violation|2
7875335|NCT01704495|12369762|FG003|Subjects Randomized|Protocol Violation|0
7875336|NCT01704495|12369759|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1
7875337|NCT01704495|12369760|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3
7875338|NCT01704495|12369761|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4
7875339|NCT01704495|12369762|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3
7875340|NCT01704495|12369759|FG000|Optional Safety Extension|Adverse Event|0
7875341|NCT01704495|12369760|FG001|Optional Safety Extension|Adverse Event|4
7875342|NCT01704495|12369761|FG002|Optional Safety Extension|Adverse Event|0
7796885|NCT01072149|12253279|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796886|NCT01072149|12253280|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796887|NCT01072149|12253281|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796888|NCT01072149|12253282|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796889|NCT01072149|12253283|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796890|NCT01072149|12253284|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796891|NCT01072149|12253285|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796892|NCT01072149|12253286|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796893|NCT01072149|12253287|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796894|NCT01072149|12253288|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796895|NCT01072149|12253289|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796896|NCT01072149|12253290|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796897|NCT01072149|12253291|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796898|NCT01072149|12253292|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796899|NCT01072149|12253293|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796900|NCT01072149|12253294|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7796901|NCT01072149|12253277|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7796902|NCT01072149|12253278|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7796903|NCT01072149|12253279|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
7796904|NCT01072149|12253280|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7796905|NCT01072149|12253281|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7796906|NCT01072149|12253282|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7796907|NCT01072149|12253283|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7796908|NCT01072149|12253284|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7796909|NCT01072149|12253285|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7796910|NCT01072149|12253286|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7796911|NCT01072149|12253287|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7875343|NCT01704495|12369762|FG003|Optional Safety Extension|Adverse Event|1
7875344|NCT01704495|12369759|FG000|Optional Safety Extension|Other reason|27
7875345|NCT01704495|12369760|FG001|Optional Safety Extension|Other reason|29
7875346|NCT01704495|12369761|FG002|Optional Safety Extension|Other reason|30
7875347|NCT01704495|12369762|FG003|Optional Safety Extension|Other reason|28
7875348|NCT01704495|12369759|FG000|Optional Safety Extension|Withdrawal by Subject|2
7875349|NCT01704495|12369760|FG001|Optional Safety Extension|Withdrawal by Subject|0
7875350|NCT01704495|12369761|FG002|Optional Safety Extension|Withdrawal by Subject|1
7875351|NCT01704495|12369762|FG003|Optional Safety Extension|Withdrawal by Subject|2
7875352|NCT01704599|12369781|FG000|Overall Study|Adverse Event|1
7875353|NCT01704651|12369810|FG000|Overall Study|Pre-op withdrawal by subject|1
7875354|NCT01704651|12369811|FG001|Overall Study|Pre-op withdrawal by subject|1
7875355|NCT01704651|12369810|FG000|Overall Study|Pre-op change in treatment plan|1
7875356|NCT01704651|12369811|FG001|Overall Study|Pre-op change in treatment plan|4
7875357|NCT01704651|12369810|FG000|Overall Study|Nasogastric tube placement in surgery|1
7875358|NCT01704651|12369811|FG001|Overall Study|Nasogastric tube placement in surgery|1
7875359|NCT01704651|12369810|FG000|Overall Study|Post-op did not have laparotomy|2
7875360|NCT01704651|12369811|FG001|Overall Study|Post-op did not have laparotomy|1
7875361|NCT01704755|12369819|FG000|Overall Study|Adverse Event|4
7875362|NCT01704755|12369820|FG001|Overall Study|Adverse Event|1
7875363|NCT01704755|12369819|FG000|Overall Study|Lost to Follow-up|3
7875364|NCT01704755|12369820|FG001|Overall Study|Lost to Follow-up|4
7875365|NCT01704755|12369819|FG000|Overall Study|Withdrew consent|1
7875366|NCT01704755|12369820|FG001|Overall Study|Withdrew consent|1
7875367|NCT01704755|12369819|FG000|Overall Study|Other (not specified)|3
7875368|NCT01704755|12369820|FG001|Overall Study|Other (not specified)|1
7875369|NCT01704755|12369819|FG000|Overall Study|Withdrew consent and personal issues|1
7875370|NCT01704755|12369820|FG001|Overall Study|Withdrew consent and personal issues|0
7875371|NCT01704846|12369851|FG000|Treatment Period 2|Withdrawal by Subject|0
7875372|NCT01704846|12369852|FG001|Treatment Period 2|Withdrawal by Subject|1
7875373|NCT01705080|12369870|FG000|Overall Study|Missed visit|10
7875374|NCT01705080|12369871|FG001|Overall Study|Missed visit|4
7875375|NCT01705080|12369872|FG002|Overall Study|Missed visit|1
7875376|NCT01705080|12369870|FG000|Overall Study|Death|4
7875377|NCT01705080|12369871|FG001|Overall Study|Death|4
7875378|NCT01705080|12369872|FG002|Overall Study|Death|6
7875379|NCT01705080|12369870|FG000|Overall Study|Withdrawal by Subject|61
7875380|NCT01705080|12369871|FG001|Overall Study|Withdrawal by Subject|44
7875381|NCT01705080|12369872|FG002|Overall Study|Withdrawal by Subject|9
7875382|NCT01705145|12369880|FG000|Part B|Adverse Event|1
7882891|NCT01777191|12382251|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
7882892|NCT01777191|12382250|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
7882893|NCT01777191|12382251|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
7882894|NCT01777191|12382250|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
7882895|NCT01777191|12382251|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
7882896|NCT01777191|12382250|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
7882897|NCT01777191|12382251|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
7882898|NCT01777191|12382250|FG000|Safety Extension Per (Week 12-Week 48)|Death|0
7882899|NCT01777191|12382251|FG001|Safety Extension Per (Week 12-Week 48)|Death|1
7882900|NCT01777191|12382250|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
7882901|NCT01777191|12382251|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
7882902|NCT01777191|12382250|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
7882903|NCT01777191|12382251|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
7882904|NCT01777191|12382250|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
7882905|NCT01777191|12382251|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
7883374|NCT01781572|12383067|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7
7883375|NCT01781572|12383068|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0
7883376|NCT01781572|12383069|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11
7883377|NCT01781572|12383067|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8
7883378|NCT01781572|12383068|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6
7883379|NCT01781572|12383069|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23
7883380|NCT01781572|12383067|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1
7883381|NCT01781572|12383068|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0
7883382|NCT01781572|12383069|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2
7883383|NCT01781572|12383067|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
7883384|NCT01781572|12383068|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
7883385|NCT01781572|12383069|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4
7883386|NCT01781572|12383067|FG000|MEK162 45mg BID+LEE011 200mg|Death|0
7883387|NCT01781572|12383068|FG001|MEK162 45mg BID+LEE011 200mg|Death|0
7883388|NCT01781572|12383069|FG002|MEK162 45mg BID+LEE011 200mg|Death|1
7883389|NCT01781572|12383067|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2
7883390|NCT01781572|12383068|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
7883391|NCT01781572|12383069|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
7883392|NCT01781572|12383067|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1
7883393|NCT01781572|12383068|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
7883394|NCT01781572|12383069|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
7883395|NCT01781572|12383067|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1
7883396|NCT01781572|12383068|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
7883397|NCT01781572|12383069|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
7883398|NCT01781572|12383067|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3
7883399|NCT01781572|12383068|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2
7883400|NCT01781572|12383069|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0
7883401|NCT01781572|12383067|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
7883402|NCT01781572|12383068|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
7883403|NCT01781572|12383069|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0
7883404|NCT01781572|12383067|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4
7883405|NCT01781572|12383068|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3
7875383|NCT01705236|12369896|FG000|Overall Study|Lost to Follow-up|1
7875384|NCT01705236|12369896|FG000|Overall Study|Administrative problems|2
7875385|NCT01705236|12369896|FG000|Overall Study|Unsatisfactory therapeutic effect|3
7875386|NCT01705236|12369896|FG000|Overall Study|Protocol Violation|3
7875387|NCT01705236|12369896|FG000|Overall Study|Abnormal test procedure result(s)|4
7875388|NCT01705236|12369896|FG000|Overall Study|Abnormal laboratory value(s)|4
7875389|NCT01705236|12369896|FG000|Overall Study|Withdrawal by Subject|5
7875390|NCT01705236|12369896|FG000|Overall Study|Adverse Event|5
7875391|NCT01705509|12369913|FG000|Inclusion CPET|Screen Failure|5
7875392|NCT01705509|12369913|FG000|Inclusion CPET|Withdrawal by Subject|2
7875393|NCT01705509|12369913|FG000|CPET w/ Ranexa|Screen Failure|2
7875394|NCT01705574|12369919|FG000|Double-Blind Phase|Lost to Follow-up|12
7875395|NCT01705574|12369920|FG001|Double-Blind Phase|Lost to Follow-up|16
7875396|NCT01705574|12369921|FG002|Double-Blind Phase|Lost to Follow-up|0
7875397|NCT01705574|12369922|FG003|Double-Blind Phase|Lost to Follow-up|0
7875398|NCT01705574|12369919|FG000|Double-Blind Phase|Adverse Event|3
7875399|NCT01705574|12369920|FG001|Double-Blind Phase|Adverse Event|10
7875400|NCT01705574|12369921|FG002|Double-Blind Phase|Adverse Event|0
7875401|NCT01705574|12369922|FG003|Double-Blind Phase|Adverse Event|0
7875402|NCT01705574|12369919|FG000|Double-Blind Phase|Withdrew Consent|8
7875403|NCT01705574|12369920|FG001|Double-Blind Phase|Withdrew Consent|5
7875404|NCT01705574|12369921|FG002|Double-Blind Phase|Withdrew Consent|0
7875405|NCT01705574|12369922|FG003|Double-Blind Phase|Withdrew Consent|0
7875406|NCT01705574|12369919|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4
7875407|NCT01705574|12369920|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5
7875408|NCT01705574|12369921|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0
7875409|NCT01705574|12369922|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0
7875410|NCT01705574|12369919|FG000|Double-Blind Phase|Pregnancy|1
7875411|NCT01705574|12369920|FG001|Double-Blind Phase|Pregnancy|1
7875412|NCT01705574|12369921|FG002|Double-Blind Phase|Pregnancy|0
7875413|NCT01705574|12369922|FG003|Double-Blind Phase|Pregnancy|0
7875414|NCT01705574|12369919|FG000|Double-Blind Phase|Protocol Violation|1
7875415|NCT01705574|12369920|FG001|Double-Blind Phase|Protocol Violation|0
7875416|NCT01705574|12369921|FG002|Double-Blind Phase|Protocol Violation|0
7875417|NCT01705574|12369922|FG003|Double-Blind Phase|Protocol Violation|0
7875418|NCT01705574|12369919|FG000|Double-Blind Phase|Randomized but Not Treated|4
7875419|NCT01705574|12369920|FG001|Double-Blind Phase|Randomized but Not Treated|4
7875420|NCT01705574|12369921|FG002|Double-Blind Phase|Randomized but Not Treated|0
7875421|NCT01705574|12369922|FG003|Double-Blind Phase|Randomized but Not Treated|0
7875422|NCT01705574|12369919|FG000|Open-Label Extension Phase|Lost to Follow-up|6
7875423|NCT01705574|12369920|FG001|Open-Label Extension Phase|Lost to Follow-up|0
7875424|NCT01705574|12369921|FG002|Open-Label Extension Phase|Lost to Follow-up|2
7875425|NCT01705574|12369922|FG003|Open-Label Extension Phase|Lost to Follow-up|2
7875426|NCT01705574|12369919|FG000|Open-Label Extension Phase|Withdrew Consent|4
7875427|NCT01705574|12369920|FG001|Open-Label Extension Phase|Withdrew Consent|0
7875428|NCT01705574|12369921|FG002|Open-Label Extension Phase|Withdrew Consent|4
7875429|NCT01705574|12369922|FG003|Open-Label Extension Phase|Withdrew Consent|1
7875430|NCT01705574|12369919|FG000|Open-Label Extension Phase|Adverse Event|3
7875431|NCT01705574|12369920|FG001|Open-Label Extension Phase|Adverse Event|0
7875432|NCT01705574|12369921|FG002|Open-Label Extension Phase|Adverse Event|0
7875433|NCT01705574|12369922|FG003|Open-Label Extension Phase|Adverse Event|1
7875434|NCT01705574|12369919|FG000|Open-Label Extension Phase|Death|2
7875435|NCT01705574|12369920|FG001|Open-Label Extension Phase|Death|0
7875436|NCT01705574|12369921|FG002|Open-Label Extension Phase|Death|1
7875437|NCT01705574|12369922|FG003|Open-Label Extension Phase|Death|0
7875438|NCT01705574|12369919|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0
7875439|NCT01705574|12369920|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0
7875440|NCT01705574|12369921|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1
7875441|NCT01705574|12369922|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0
7875442|NCT01705574|12369919|FG000|Open-Label Extension Phase|Physician Decision|0
7875443|NCT01705574|12369920|FG001|Open-Label Extension Phase|Physician Decision|0
7875444|NCT01705574|12369921|FG002|Open-Label Extension Phase|Physician Decision|2
7875445|NCT01705574|12369922|FG003|Open-Label Extension Phase|Physician Decision|0
7875446|NCT01705574|12369919|FG000|Open-Label Extension Phase|Pregnancy|0
7875447|NCT01705574|12369920|FG001|Open-Label Extension Phase|Pregnancy|0
7875448|NCT01705574|12369921|FG002|Open-Label Extension Phase|Pregnancy|1
7875449|NCT01705574|12369922|FG003|Open-Label Extension Phase|Pregnancy|1
7875450|NCT01705587|12369940|FG000|Overall Study|Withdrawal by Subject|0
7875451|NCT01705587|12369941|FG001|Overall Study|Withdrawal by Subject|1
7875452|NCT01705652|12369949|FG000|Overall Study|Adverse Event|1
7875453|NCT01705652|12369950|FG001|Overall Study|Adverse Event|0
7875454|NCT01705652|12369949|FG000|Overall Study|Withdrawal by Subject|1
7875455|NCT01705652|12369950|FG001|Overall Study|Withdrawal by Subject|2
7875456|NCT01705652|12369949|FG000|Overall Study|non-compliance|1
7875457|NCT01705652|12369950|FG001|Overall Study|non-compliance|1
7875458|NCT01705691|12369958|FG000|Overall Study|Death|1
7875459|NCT01705691|12369959|FG001|Overall Study|Death|2
7875460|NCT01705691|12369958|FG000|Overall Study|Withdrawal by Subject|1
7875461|NCT01705691|12369959|FG001|Overall Study|Withdrawal by Subject|2
7875462|NCT01705691|12369958|FG000|Overall Study|Lost to Follow-up|1
7875463|NCT01705691|12369959|FG001|Overall Study|Lost to Follow-up|1
7875464|NCT01705691|12369958|FG000|Overall Study|Other|0
7875465|NCT01705691|12369959|FG001|Overall Study|Other|1
7875466|NCT01705717|12369967|FG000|Overall Study|Adverse Event|2
7875467|NCT01705717|12369968|FG001|Overall Study|Adverse Event|2
7875468|NCT01705717|12369967|FG000|Overall Study|Lack of Efficacy|0
7875469|NCT01705717|12369968|FG001|Overall Study|Lack of Efficacy|1
7875470|NCT01705717|12369967|FG000|Overall Study|Other|0
7875471|NCT01705717|12369968|FG001|Overall Study|Other|2
7875472|NCT01705730|12369973|FG000|Overall Study|Lack of Efficacy|1
7875473|NCT01705730|12369973|FG000|Overall Study|Adverse Event|3
7875474|NCT01705730|12369973|FG000|Overall Study|Lost to Follow-up|1
7875475|NCT01705730|12369973|FG000|Overall Study|Reason not Specified|4
7875476|NCT01706003|12369988|FG000|Overall Study|Withdrawal by Subject|2
7875477|NCT01706003|12369989|FG001|Overall Study|Withdrawal by Subject|0
7875478|NCT01706003|12369988|FG000|Overall Study|Not scheduled|3
7875479|NCT01706003|12369989|FG001|Overall Study|Not scheduled|0
7875480|NCT01706003|12369988|FG000|Overall Study|Lost to Follow-up|6
7875481|NCT01706003|12369989|FG001|Overall Study|Lost to Follow-up|4
7875482|NCT01706146|12370004|FG000|Overall Study|Withdrawal by Subject|1
7875483|NCT01706146|12370004|FG000|Overall Study|Adverse Event|3
7875484|NCT01706146|12370004|FG000|Overall Study|Developed AF and need for antiplatelets|2
7875485|NCT01706159|12370010|FG000|Overall Study|Withdrawal Criteria|2
7875486|NCT01706159|12370011|FG001|Overall Study|Withdrawal Criteria|1
7875487|NCT01706159|12370010|FG000|Overall Study|Unclassified|6
7875488|NCT01706159|12370011|FG001|Overall Study|Unclassified|1
7875489|NCT01706198|12370019|FG000|Overall Study|Adverse Event|12
7875490|NCT01706198|12370020|FG001|Overall Study|Adverse Event|15
7875491|NCT01706198|12370019|FG000|Overall Study|Protocol Violation|7
7875492|NCT01706198|12370020|FG001|Overall Study|Protocol Violation|5
7875493|NCT01706198|12370019|FG000|Overall Study|Other: Subject reached stopping criteria|11
7875494|NCT01706198|12370020|FG001|Overall Study|Other: Subject reached stopping criteria|13
7875495|NCT01706198|12370019|FG000|Overall Study|Lost to Follow-up|97
7875496|NCT01706198|12370020|FG001|Overall Study|Lost to Follow-up|93
7875497|NCT01706198|12370019|FG000|Overall Study|Physician Decision|23
7875498|NCT01706198|12370020|FG001|Overall Study|Physician Decision|37
7875499|NCT01706198|12370019|FG000|Overall Study|Withdrawal by Subject|23
7875500|NCT01706198|12370020|FG001|Overall Study|Withdrawal by Subject|31
7875501|NCT01706250|12370026|FG000|Overall Study|Lost to Follow-up|2
7875502|NCT01706328|12370042|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
7875503|NCT01706328|12370043|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
7875504|NCT01706328|12370044|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
7875505|NCT01706328|12370042|FG000|2-week Run-in Period|Withdrawal by Subject|15
7875506|NCT01706328|12370043|FG001|2-week Run-in Period|Withdrawal by Subject|0
7875507|NCT01706328|12370044|FG002|2-week Run-in Period|Withdrawal by Subject|0
7875508|NCT01706328|12370042|FG000|2-week Run-in Period|Physician Decision|4
7875509|NCT01706328|12370043|FG001|2-week Run-in Period|Physician Decision|0
7875510|NCT01706328|12370044|FG002|2-week Run-in Period|Physician Decision|0
7875511|NCT01706328|12370042|FG000|2-week Run-in Period|Adverse Event|4
7875512|NCT01706328|12370043|FG001|2-week Run-in Period|Adverse Event|0
7875513|NCT01706328|12370044|FG002|2-week Run-in Period|Adverse Event|0
7875514|NCT01706328|12370042|FG000|2-week Run-in Period|Lost to Follow-up|2
7875515|NCT01706328|12370043|FG001|2-week Run-in Period|Lost to Follow-up|0
7875516|NCT01706328|12370044|FG002|2-week Run-in Period|Lost to Follow-up|0
7875517|NCT01706328|12370042|FG000|12-week Double-blind Treatment Period|Adverse Event|0
7875518|NCT01706328|12370043|FG001|12-week Double-blind Treatment Period|Adverse Event|14
7875519|NCT01706328|12370044|FG002|12-week Double-blind Treatment Period|Adverse Event|16
7875520|NCT01706328|12370042|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0
7875521|NCT01706328|12370043|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4
7875522|NCT01706328|12370044|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4
7875523|NCT01706328|12370042|FG000|12-week Double-blind Treatment Period|Protocol Violation|0
7875524|NCT01706328|12370043|FG001|12-week Double-blind Treatment Period|Protocol Violation|4
7875525|NCT01706328|12370044|FG002|12-week Double-blind Treatment Period|Protocol Violation|2
7875526|NCT01706328|12370042|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
7875527|NCT01706328|12370043|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
7875528|NCT01706328|12370044|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
7875529|NCT01706328|12370042|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0
7875530|NCT01706328|12370043|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3
7875531|NCT01706328|12370044|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1
7875532|NCT01706328|12370042|FG000|12-week Double-blind Treatment Period|Physician Decision|0
7875533|NCT01706328|12370043|FG001|12-week Double-blind Treatment Period|Physician Decision|2
7875534|NCT01706328|12370044|FG002|12-week Double-blind Treatment Period|Physician Decision|2
7875535|NCT01706328|12370042|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0
7875536|NCT01706328|12370043|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8
7875537|NCT01706328|12370044|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11
7875538|NCT01706458|12370052|FG000|Overall Study|Physician Decision|3
7875539|NCT01706458|12370053|FG001|Overall Study|Physician Decision|4
7875540|NCT01706536|12370068|FG000|Overall Study|Withdrawal by Subject|1
7875541|NCT01706536|12370069|FG001|Overall Study|Withdrawal by Subject|0
7875542|NCT01706536|12370070|FG002|Overall Study|Withdrawal by Subject|1
7875543|NCT01706536|12370071|FG003|Overall Study|Withdrawal by Subject|0
7875544|NCT01706536|12370072|FG004|Overall Study|Withdrawal by Subject|0
7875545|NCT01706536|12370068|FG000|Overall Study|Adverse Event|2
7875546|NCT01706536|12370069|FG001|Overall Study|Adverse Event|3
7875547|NCT01706536|12370070|FG002|Overall Study|Adverse Event|4
7875548|NCT01706536|12370071|FG003|Overall Study|Adverse Event|3
7875549|NCT01706536|12370072|FG004|Overall Study|Adverse Event|2
7875550|NCT01706536|12370068|FG000|Overall Study|Lack of Efficacy|1
7875551|NCT01706536|12370069|FG001|Overall Study|Lack of Efficacy|0
7875552|NCT01706536|12370070|FG002|Overall Study|Lack of Efficacy|0
7875553|NCT01706536|12370071|FG003|Overall Study|Lack of Efficacy|1
7875554|NCT01706536|12370072|FG004|Overall Study|Lack of Efficacy|0
7875555|NCT01706536|12370068|FG000|Overall Study|non compliance|0
7875556|NCT01706536|12370069|FG001|Overall Study|non compliance|1
7875557|NCT01706536|12370070|FG002|Overall Study|non compliance|0
7875558|NCT01706536|12370071|FG003|Overall Study|non compliance|0
7875559|NCT01706536|12370072|FG004|Overall Study|non compliance|0
7875560|NCT01706575|12370089|FG000|Overall Study|Participant Withdrew Consent|4
7875561|NCT01706575|12370089|FG000|Overall Study|Lost to Follow-up|2
7875562|NCT01706575|12370089|FG000|Overall Study|Started but not Treated|6
7875563|NCT01706770|12370129|FG000|Overall Study|Lost to Follow-up|1
7875564|NCT01706770|12370130|FG001|Overall Study|Lost to Follow-up|0
7875565|NCT01706770|12370129|FG000|Overall Study|Physician Decision|1
7875566|NCT01706770|12370130|FG001|Overall Study|Physician Decision|0
7875567|NCT01706926|12370144|FG000|Overall Study|Lost to Follow-up|0
7875568|NCT01706926|12370145|FG001|Overall Study|Lost to Follow-up|0
7875569|NCT01706926|12370146|FG002|Overall Study|Lost to Follow-up|1
7875570|NCT01706926|12370147|FG003|Overall Study|Lost to Follow-up|0
7875571|NCT01706926|12370144|FG000|Overall Study|Withdrawal by Subject|2
7875572|NCT01706926|12370145|FG001|Overall Study|Withdrawal by Subject|0
7875573|NCT01706926|12370146|FG002|Overall Study|Withdrawal by Subject|1
7875574|NCT01706926|12370147|FG003|Overall Study|Withdrawal by Subject|2
7875575|NCT01706926|12370144|FG000|Overall Study|Other|4
7875576|NCT01706926|12370145|FG001|Overall Study|Other|4
7875577|NCT01706926|12370146|FG002|Overall Study|Other|4
7875578|NCT01706926|12370147|FG003|Overall Study|Other|3
7875579|NCT01707004|12370184|FG000|Overall Study|Physician Decision|3
7875580|NCT01707030|12370191|FG000|Overall Study|Death|1
7875581|NCT01707030|12370192|FG001|Overall Study|Death|1
7875582|NCT01707030|12370191|FG000|Overall Study|Withdrawal by Subject|2
7875583|NCT01707030|12370192|FG001|Overall Study|Withdrawal by Subject|3
7875584|NCT01707030|12370191|FG000|Overall Study|Lost to Follow-up|8
7875585|NCT01707030|12370192|FG001|Overall Study|Lost to Follow-up|13
7875586|NCT01707147|12370225|FG000|Overall Study|Administered Trajenta prior to contract|5
7875587|NCT01707147|12370225|FG000|Overall Study|Patients who have not taken Trajenta|1
7875588|NCT01707147|12370225|FG000|Overall Study|Follow-up failure|17
7875589|NCT01707147|12370225|FG000|Overall Study|Violated inclusion/exclusion criteria|77
7875590|NCT01707290|12370245|FG000|Overall Study|Adverse event (AE)|1
7875591|NCT01707290|12370246|FG001|Overall Study|Adverse event (AE)|0
7875592|NCT01707290|12370245|FG000|Overall Study|Physician Decision|1
7796912|NCT01072149|12253288|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7796913|NCT01072149|12253289|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7796914|NCT01072149|12253290|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7796915|NCT01072149|12253291|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7796916|NCT01072149|12253292|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7796917|NCT01072149|12253293|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7796918|NCT01072149|12253294|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7875593|NCT01707290|12370246|FG001|Overall Study|Physician Decision|0
7875594|NCT01707290|12370245|FG000|Overall Study|Lost to Follow-up|3
7875595|NCT01707290|12370246|FG001|Overall Study|Lost to Follow-up|0
7875596|NCT01707290|12370245|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4
7875597|NCT01707290|12370246|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0
7875598|NCT01707290|12370245|FG000|Overall Study|Commercial drug available|60
7875599|NCT01707290|12370246|FG001|Overall Study|Commercial drug available|1
7875600|NCT01707290|12370245|FG000|Overall Study|Other unspecified|17
7875601|NCT01707290|12370246|FG001|Overall Study|Other unspecified|0
7875602|NCT01707667|12370296|FG000|Period 1|expulsion of colonic sensor catheter|1
7875603|NCT01707667|12370297|FG001|Period 1|expulsion of colonic sensor catheter|0
7875604|NCT01707693|12370305|FG000|Overall Study Allocation|Withdrawal by Subject|9
7875605|NCT01707693|12370306|FG001|Overall Study Allocation|Withdrawal by Subject|5
7875606|NCT01707693|12370305|FG000|Overall Study Allocation|Protocol Violation|4
7875607|NCT01707693|12370306|FG001|Overall Study Allocation|Protocol Violation|3
7875608|NCT01707693|12370305|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0
7875609|NCT01707693|12370306|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3
7875610|NCT01707693|12370305|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0
7875611|NCT01707693|12370306|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2
7875612|NCT01707992|12370316|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8
7875613|NCT01707992|12370317|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13
7875614|NCT01707992|12370318|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9
7875615|NCT01707992|12370319|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0
7875616|NCT01707992|12370320|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0
7875617|NCT01707992|12370321|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0
7875618|NCT01707992|12370316|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10
7875619|NCT01707992|12370317|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3
7875620|NCT01707992|12370318|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2
7875621|NCT01707992|12370319|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
7875622|NCT01707992|12370320|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
7875623|NCT01707992|12370321|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
7875624|NCT01707992|12370316|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88
7875625|NCT01707992|12370317|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68
7875626|NCT01707992|12370318|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154
7875627|NCT01707992|12370319|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
7875628|NCT01707992|12370320|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
7875629|NCT01707992|12370321|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
7875630|NCT01707992|12370316|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1
7875631|NCT01707992|12370317|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7875632|NCT01707992|12370318|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7875633|NCT01707992|12370319|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7875634|NCT01707992|12370320|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7875635|NCT01707992|12370321|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7875636|NCT01707992|12370316|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12
7875637|NCT01707992|12370317|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5
7875638|NCT01707992|12370318|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9
7875639|NCT01707992|12370319|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0
7875640|NCT01707992|12370320|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0
7875641|NCT01707992|12370321|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0
7875642|NCT01707992|12370316|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10
7875643|NCT01707992|12370317|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4
7875644|NCT01707992|12370318|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9
7875645|NCT01707992|12370319|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
7875646|NCT01707992|12370320|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
7875647|NCT01707992|12370321|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
7875648|NCT01707992|12370316|FG000|Placebo-Controlled Phase (24 Months)|Death|2
7875649|NCT01707992|12370317|FG001|Placebo-Controlled Phase (24 Months)|Death|1
7875650|NCT01707992|12370318|FG002|Placebo-Controlled Phase (24 Months)|Death|1
7875651|NCT01707992|12370319|FG003|Placebo-Controlled Phase (24 Months)|Death|0
7875652|NCT01707992|12370320|FG004|Placebo-Controlled Phase (24 Months)|Death|0
7875653|NCT01707992|12370321|FG005|Placebo-Controlled Phase (24 Months)|Death|0
7875654|NCT01707992|12370316|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2
7875655|NCT01707992|12370317|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1
7875656|NCT01707992|12370318|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6
7875657|NCT01707992|12370319|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
7875658|NCT01707992|12370320|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
7875659|NCT01707992|12370321|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
7875660|NCT01707992|12370316|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11
7875661|NCT01707992|12370317|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9
7875662|NCT01707992|12370318|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10
7875663|NCT01707992|12370319|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0
7875664|NCT01707992|12370320|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0
7875665|NCT01707992|12370321|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0
7875666|NCT01707992|12370316|FG000|Active Treatment Phase (24 Months)|Adverse Event|0
7875667|NCT01707992|12370317|FG001|Active Treatment Phase (24 Months)|Adverse Event|0
7875668|NCT01707992|12370318|FG002|Active Treatment Phase (24 Months)|Adverse Event|0
7875669|NCT01707992|12370319|FG003|Active Treatment Phase (24 Months)|Adverse Event|4
7875670|NCT01707992|12370320|FG004|Active Treatment Phase (24 Months)|Adverse Event|1
7875671|NCT01707992|12370321|FG005|Active Treatment Phase (24 Months)|Adverse Event|0
7875672|NCT01707992|12370316|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0
7875673|NCT01707992|12370317|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0
7875674|NCT01707992|12370318|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0
7875675|NCT01707992|12370319|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3
7875676|NCT01707992|12370320|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1
7875677|NCT01707992|12370321|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2
7875678|NCT01707992|12370316|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
7875679|NCT01707992|12370317|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
7875680|NCT01707992|12370318|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
7875681|NCT01707992|12370319|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58
7875682|NCT01707992|12370320|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220
7875683|NCT01707992|12370321|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32
7875684|NCT01707992|12370316|FG000|Active Treatment Phase (24 Months)|Pregnancy|0
7875685|NCT01707992|12370317|FG001|Active Treatment Phase (24 Months)|Pregnancy|0
7875686|NCT01707992|12370318|FG002|Active Treatment Phase (24 Months)|Pregnancy|0
7875687|NCT01707992|12370319|FG003|Active Treatment Phase (24 Months)|Pregnancy|2
7875688|NCT01707992|12370320|FG004|Active Treatment Phase (24 Months)|Pregnancy|5
7875689|NCT01707992|12370321|FG005|Active Treatment Phase (24 Months)|Pregnancy|2
7875690|NCT01707992|12370316|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0
7875691|NCT01707992|12370317|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0
7875692|NCT01707992|12370318|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0
7875693|NCT01707992|12370319|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5
7875694|NCT01707992|12370320|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11
7875695|NCT01707992|12370321|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1
7875696|NCT01707992|12370316|FG000|Active Treatment Phase (24 Months)|Death|0
7875697|NCT01707992|12370317|FG001|Active Treatment Phase (24 Months)|Death|0
7875698|NCT01707992|12370318|FG002|Active Treatment Phase (24 Months)|Death|0
7875699|NCT01707992|12370319|FG003|Active Treatment Phase (24 Months)|Death|2
7875700|NCT01707992|12370320|FG004|Active Treatment Phase (24 Months)|Death|0
7875701|NCT01707992|12370321|FG005|Active Treatment Phase (24 Months)|Death|0
7875702|NCT01707992|12370316|FG000|Active Treatment Phase (24 Months)|Other than specified|0
7875703|NCT01707992|12370317|FG001|Active Treatment Phase (24 Months)|Other than specified|0
7875704|NCT01707992|12370318|FG002|Active Treatment Phase (24 Months)|Other than specified|0
7875705|NCT01707992|12370319|FG003|Active Treatment Phase (24 Months)|Other than specified|1
7875706|NCT01707992|12370320|FG004|Active Treatment Phase (24 Months)|Other than specified|5
7875707|NCT01707992|12370321|FG005|Active Treatment Phase (24 Months)|Other than specified|2
7875708|NCT01707992|12370316|FG000|Active Treatment Phase (24 Months)|Noncompliance|0
7875709|NCT01707992|12370317|FG001|Active Treatment Phase (24 Months)|Noncompliance|0
7875710|NCT01707992|12370318|FG002|Active Treatment Phase (24 Months)|Noncompliance|0
7875711|NCT01707992|12370319|FG003|Active Treatment Phase (24 Months)|Noncompliance|0
7875712|NCT01707992|12370320|FG004|Active Treatment Phase (24 Months)|Noncompliance|4
7875713|NCT01707992|12370321|FG005|Active Treatment Phase (24 Months)|Noncompliance|2
7875714|NCT01707992|12370316|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
7875715|NCT01707992|12370317|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
7875716|NCT01707992|12370318|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
7875717|NCT01707992|12370319|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809
7875718|NCT01707992|12370320|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243
7875719|NCT01707992|12370321|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174
7875720|NCT01707992|12370316|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7875721|NCT01707992|12370317|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7875722|NCT01707992|12370318|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7875723|NCT01707992|12370319|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7875724|NCT01707992|12370320|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4
7875725|NCT01707992|12370321|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7875726|NCT01708161|12370351|FG000|Overall Study|Adverse Event|1
7875727|NCT01708161|12370352|FG001|Overall Study|Adverse Event|3
7875728|NCT01708161|12370353|FG002|Overall Study|Adverse Event|4
7875729|NCT01708161|12370354|FG003|Overall Study|Adverse Event|2
7875730|NCT01708161|12370355|FG004|Overall Study|Adverse Event|3
7875731|NCT01708161|12370356|FG005|Overall Study|Adverse Event|0
7875732|NCT01708161|12370351|FG000|Overall Study|Death|0
7875733|NCT01708161|12370352|FG001|Overall Study|Death|0
7875734|NCT01708161|12370353|FG002|Overall Study|Death|0
7875735|NCT01708161|12370354|FG003|Overall Study|Death|1
7875736|NCT01708161|12370355|FG004|Overall Study|Death|0
7875737|NCT01708161|12370356|FG005|Overall Study|Death|1
7875738|NCT01708161|12370351|FG000|Overall Study|Withdrawal by Subject|0
7875739|NCT01708161|12370352|FG001|Overall Study|Withdrawal by Subject|1
7875740|NCT01708161|12370353|FG002|Overall Study|Withdrawal by Subject|1
7875741|NCT01708161|12370354|FG003|Overall Study|Withdrawal by Subject|0
7875742|NCT01708161|12370355|FG004|Overall Study|Withdrawal by Subject|0
7875743|NCT01708161|12370356|FG005|Overall Study|Withdrawal by Subject|0
7875744|NCT01708161|12370351|FG000|Overall Study|Administrative problems|0
7875745|NCT01708161|12370352|FG001|Overall Study|Administrative problems|1
7875746|NCT01708161|12370353|FG002|Overall Study|Administrative problems|0
7875747|NCT01708161|12370354|FG003|Overall Study|Administrative problems|0
7875748|NCT01708161|12370355|FG004|Overall Study|Administrative problems|0
7875749|NCT01708161|12370356|FG005|Overall Study|Administrative problems|0
7875750|NCT01708161|12370351|FG000|Overall Study|Disease progression|3
7875751|NCT01708161|12370352|FG001|Overall Study|Disease progression|5
7875752|NCT01708161|12370353|FG002|Overall Study|Disease progression|5
7875753|NCT01708161|12370354|FG003|Overall Study|Disease progression|13
7875754|NCT01708161|12370355|FG004|Overall Study|Disease progression|3
7875755|NCT01708161|12370356|FG005|Overall Study|Disease progression|0
7875756|NCT01708174|12370373|FG000|Treatment Period|Withdrawal by Subject|1
7875757|NCT01708174|12370374|FG001|Treatment Period|Withdrawal by Subject|0
7875758|NCT01708174|12370375|FG002|Treatment Period|Withdrawal by Subject|0
7875759|NCT01708174|12370373|FG000|Treatment Period|Progressive disease|0
7875760|NCT01708174|12370374|FG001|Treatment Period|Progressive disease|1
7875761|NCT01708174|12370375|FG002|Treatment Period|Progressive disease|0
7875762|NCT01708174|12370373|FG000|Treatment Period|Death|0
7875763|NCT01708174|12370374|FG001|Treatment Period|Death|0
7875764|NCT01708174|12370375|FG002|Treatment Period|Death|1
7875765|NCT01708174|12370373|FG000|Treatment Period|Adverse Event|0
7875766|NCT01708174|12370374|FG001|Treatment Period|Adverse Event|1
7875767|NCT01708174|12370375|FG002|Treatment Period|Adverse Event|0
7875768|NCT01708187|12370386|FG000|Overall Study|Lost to Follow-up|0
7875769|NCT01708187|12370387|FG001|Overall Study|Lost to Follow-up|1
7875770|NCT01708291|12370424|FG000|Overall Study|fighting|2
7875771|NCT01708291|12370425|FG001|Overall Study|fighting|1
7875772|NCT01708902|12370511|FG000|Overall Study|Adverse Event|3
7875773|NCT01708902|12370512|FG001|Overall Study|Adverse Event|4
7875774|NCT01708902|12370513|FG002|Overall Study|Adverse Event|9
7875775|NCT01708902|12370514|FG003|Overall Study|Adverse Event|2
7875776|NCT01708902|12370515|FG004|Overall Study|Adverse Event|7
7875777|NCT01708902|12370516|FG005|Overall Study|Adverse Event|3
7875778|NCT01708902|12370517|FG006|Overall Study|Adverse Event|5
7875779|NCT01708902|12370511|FG000|Overall Study|Lack of Efficacy|3
7875780|NCT01708902|12370512|FG001|Overall Study|Lack of Efficacy|1
7875781|NCT01708902|12370513|FG002|Overall Study|Lack of Efficacy|0
7875782|NCT01708902|12370514|FG003|Overall Study|Lack of Efficacy|0
7875783|NCT01708902|12370515|FG004|Overall Study|Lack of Efficacy|0
7875784|NCT01708902|12370516|FG005|Overall Study|Lack of Efficacy|1
7875785|NCT01708902|12370517|FG006|Overall Study|Lack of Efficacy|0
7875786|NCT01708902|12370511|FG000|Overall Study|Non compliance with protocol|0
7875787|NCT01708902|12370512|FG001|Overall Study|Non compliance with protocol|2
7875788|NCT01708902|12370513|FG002|Overall Study|Non compliance with protocol|1
7875789|NCT01708902|12370514|FG003|Overall Study|Non compliance with protocol|3
7875790|NCT01708902|12370515|FG004|Overall Study|Non compliance with protocol|0
7875791|NCT01708902|12370516|FG005|Overall Study|Non compliance with protocol|0
7875792|NCT01708902|12370517|FG006|Overall Study|Non compliance with protocol|0
7875793|NCT01708902|12370511|FG000|Overall Study|Lost to Follow-up|2
7875794|NCT01708902|12370512|FG001|Overall Study|Lost to Follow-up|1
7875795|NCT01708902|12370513|FG002|Overall Study|Lost to Follow-up|2
7875796|NCT01708902|12370514|FG003|Overall Study|Lost to Follow-up|2
7875797|NCT01708902|12370515|FG004|Overall Study|Lost to Follow-up|0
7875798|NCT01708902|12370516|FG005|Overall Study|Lost to Follow-up|0
7875799|NCT01708902|12370517|FG006|Overall Study|Lost to Follow-up|1
7875800|NCT01708902|12370511|FG000|Overall Study|Refused to continue trial medication|8
7875801|NCT01708902|12370512|FG001|Overall Study|Refused to continue trial medication|0
7875802|NCT01708902|12370513|FG002|Overall Study|Refused to continue trial medication|4
7875803|NCT01708902|12370514|FG003|Overall Study|Refused to continue trial medication|2
7875804|NCT01708902|12370515|FG004|Overall Study|Refused to continue trial medication|8
7875805|NCT01708902|12370516|FG005|Overall Study|Refused to continue trial medication|1
7875806|NCT01708902|12370517|FG006|Overall Study|Refused to continue trial medication|1
7875807|NCT01708902|12370511|FG000|Overall Study|Other Reason|1
7875808|NCT01708902|12370512|FG001|Overall Study|Other Reason|0
7875809|NCT01708902|12370513|FG002|Overall Study|Other Reason|1
7875810|NCT01708902|12370514|FG003|Overall Study|Other Reason|1
7875811|NCT01708902|12370515|FG004|Overall Study|Other Reason|1
7875812|NCT01708902|12370516|FG005|Overall Study|Other Reason|2
7875813|NCT01708902|12370517|FG006|Overall Study|Other Reason|0
7875814|NCT01708915|12370540|FG000|Overall Study|Adverse Event|1
7875815|NCT01708915|12370541|FG001|Overall Study|Adverse Event|0
7875816|NCT01708915|12370542|FG002|Overall Study|Adverse Event|9
7875817|NCT01708915|12370543|FG003|Overall Study|Adverse Event|13
7875818|NCT01708915|12370540|FG000|Overall Study|Lack of Efficacy|84
7875819|NCT01708915|12370541|FG001|Overall Study|Lack of Efficacy|60
7875820|NCT01708915|12370542|FG002|Overall Study|Lack of Efficacy|35
7875821|NCT01708915|12370543|FG003|Overall Study|Lack of Efficacy|15
7875822|NCT01708915|12370540|FG000|Overall Study|Protocol Violation|0
7875823|NCT01708915|12370541|FG001|Overall Study|Protocol Violation|0
7875824|NCT01708915|12370542|FG002|Overall Study|Protocol Violation|0
7875825|NCT01708915|12370543|FG003|Overall Study|Protocol Violation|1
7875826|NCT01708915|12370540|FG000|Overall Study|Withdrawal by Subject|0
7875827|NCT01708915|12370541|FG001|Overall Study|Withdrawal by Subject|1
7875828|NCT01708915|12370542|FG002|Overall Study|Withdrawal by Subject|2
7875829|NCT01708915|12370543|FG003|Overall Study|Withdrawal by Subject|2
7875830|NCT01708915|12370540|FG000|Overall Study|Other reasons than stated above|1
7875831|NCT01708915|12370541|FG001|Overall Study|Other reasons than stated above|1
7875832|NCT01708915|12370542|FG002|Overall Study|Other reasons than stated above|0
7875833|NCT01708915|12370543|FG003|Overall Study|Other reasons than stated above|2
7875834|NCT01709084|12370569|FG000|Overall Study|Lost to Follow-up|4
7875835|NCT01709084|12370570|FG001|Overall Study|Lost to Follow-up|7
7875836|NCT01709084|12370569|FG000|Overall Study|Withdrawal by Subject|2
7875837|NCT01709084|12370570|FG001|Overall Study|Withdrawal by Subject|2
7875838|NCT01709084|12370569|FG000|Overall Study|Adverse Event|5
7875839|NCT01709084|12370570|FG001|Overall Study|Adverse Event|0
7875840|NCT01709084|12370569|FG000|Overall Study|Other|5
7875841|NCT01709084|12370570|FG001|Overall Study|Other|3
7875842|NCT01709084|12370569|FG000|Overall Study|Participant Reached a Virologic Endpoint|0
7875843|NCT01709084|12370570|FG001|Overall Study|Participant Reached a Virologic Endpoint|1
7875844|NCT01709084|12370569|FG000|Overall Study|Not Treated|0
7875845|NCT01709084|12370570|FG001|Overall Study|Not Treated|2
7875846|NCT01709110|12370578|FG000|Overall Study|Adverse Event|56
7875847|NCT01709110|12370579|FG001|Overall Study|Adverse Event|48
7875848|NCT01709110|12370578|FG000|Overall Study|Death|14
7875849|NCT01709110|12370579|FG001|Overall Study|Death|6
7875850|NCT01709110|12370578|FG000|Overall Study|Lost to Follow-up|7
7875851|NCT01709110|12370579|FG001|Overall Study|Lost to Follow-up|5
7875852|NCT01709110|12370578|FG000|Overall Study|Protocol Violation|4
7875853|NCT01709110|12370579|FG001|Overall Study|Protocol Violation|6
7875854|NCT01709110|12370578|FG000|Overall Study|Withdrawal by Subject|96
7875855|NCT01709110|12370579|FG001|Overall Study|Withdrawal by Subject|89
7875856|NCT01709110|12370578|FG000|Overall Study|Physician Decision|4
7875857|NCT01709110|12370579|FG001|Overall Study|Physician Decision|10
7875858|NCT01709110|12370578|FG000|Overall Study|Sponsor Decision|2
7875859|NCT01709110|12370579|FG001|Overall Study|Sponsor Decision|2
7875860|NCT01709110|12370578|FG000|Overall Study|Lack of Efficacy|1
7875861|NCT01709110|12370579|FG001|Overall Study|Lack of Efficacy|1
7875862|NCT01709110|12370578|FG000|Overall Study|Caregiver Decision|1
7875863|NCT01709110|12370579|FG001|Overall Study|Caregiver Decision|1
7875864|NCT01709149|12370588|FG000|Open-label Lead-in Phase|Adverse Event|109
7875865|NCT01709149|12370589|FG001|Open-label Lead-in Phase|Adverse Event|0
7875866|NCT01709149|12370590|FG002|Open-label Lead-in Phase|Adverse Event|0
7875867|NCT01709149|12370588|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2
7875868|NCT01709149|12370589|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0
7875869|NCT01709149|12370590|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0
7796919|NCT01072149|12253277|FG000|Treatment Period 2 (28 Days)|Physician Decision|0
7796920|NCT01072149|12253278|FG001|Treatment Period 2 (28 Days)|Physician Decision|0
7796921|NCT01072149|12253279|FG002|Treatment Period 2 (28 Days)|Physician Decision|0
7796922|NCT01072149|12253280|FG003|Treatment Period 2 (28 Days)|Physician Decision|0
7796923|NCT01072149|12253281|FG004|Treatment Period 2 (28 Days)|Physician Decision|0
7796924|NCT01072149|12253282|FG005|Treatment Period 2 (28 Days)|Physician Decision|0
7796925|NCT01072149|12253283|FG006|Treatment Period 2 (28 Days)|Physician Decision|0
7796926|NCT01072149|12253284|FG007|Treatment Period 2 (28 Days)|Physician Decision|1
7796927|NCT01072149|12253285|FG008|Treatment Period 2 (28 Days)|Physician Decision|0
7796928|NCT01072149|12253286|FG009|Treatment Period 2 (28 Days)|Physician Decision|0
7796929|NCT01072149|12253287|FG010|Treatment Period 2 (28 Days)|Physician Decision|0
7796930|NCT01072149|12253288|FG011|Treatment Period 2 (28 Days)|Physician Decision|0
7796931|NCT01072149|12253289|FG012|Treatment Period 2 (28 Days)|Physician Decision|0
7796932|NCT01072149|12253290|FG013|Treatment Period 2 (28 Days)|Physician Decision|0
7796933|NCT01072149|12253291|FG014|Treatment Period 2 (28 Days)|Physician Decision|0
7796934|NCT01072149|12253292|FG015|Treatment Period 2 (28 Days)|Physician Decision|0
7875870|NCT01709149|12370588|FG000|Open-label Lead-in Phase|Death|1
7875871|NCT01709149|12370589|FG001|Open-label Lead-in Phase|Death|0
7875872|NCT01709149|12370590|FG002|Open-label Lead-in Phase|Death|0
7875873|NCT01709149|12370588|FG000|Open-label Lead-in Phase|Protocol Violation|3
7875874|NCT01709149|12370589|FG001|Open-label Lead-in Phase|Protocol Violation|0
7875875|NCT01709149|12370590|FG002|Open-label Lead-in Phase|Protocol Violation|0
7875876|NCT01709149|12370588|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0
7875877|NCT01709149|12370589|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12
7875878|NCT01709149|12370590|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78
7875879|NCT01709149|12370588|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7875880|NCT01709149|12370589|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7
7875881|NCT01709149|12370590|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12
7875882|NCT01709149|12370588|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0
7875883|NCT01709149|12370589|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2
7875884|NCT01709149|12370590|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5
7875885|NCT01709149|12370588|FG000|Double-blind, Placebo-controlled Phase|Death|0
7875886|NCT01709149|12370589|FG001|Double-blind, Placebo-controlled Phase|Death|2
7875887|NCT01709149|12370590|FG002|Double-blind, Placebo-controlled Phase|Death|0
7875888|NCT01709149|12370588|FG000|Double-blind, Placebo-controlled Phase|not defined|0
7875889|NCT01709149|12370589|FG001|Double-blind, Placebo-controlled Phase|not defined|1
7875890|NCT01709149|12370590|FG002|Double-blind, Placebo-controlled Phase|not defined|2
7875891|NCT01709149|12370588|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7875892|NCT01709149|12370589|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
7875893|NCT01709149|12370590|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7875894|NCT01709162|12370599|FG000|Overall Study|Disease progression|3
7875895|NCT01709162|12370600|FG001|Overall Study|Disease progression|3
7875896|NCT01709162|12370599|FG000|Overall Study|Study drug toxicity|2
7875897|NCT01709162|12370600|FG001|Overall Study|Study drug toxicity|0
7875898|NCT01709162|12370599|FG000|Overall Study|Administrative reason by sponsor|0
7875899|NCT01709162|12370600|FG001|Overall Study|Administrative reason by sponsor|1
7875900|NCT01709162|12370599|FG000|Overall Study|Other|1
7875901|NCT01709162|12370600|FG001|Overall Study|Other|0
7875902|NCT01709162|12370599|FG000|Overall Study|Withdrawal by Subject|0
7875903|NCT01709162|12370600|FG001|Overall Study|Withdrawal by Subject|1
7875904|NCT01709227|12370608|FG000|Overall Study|Physician Decision|1
7875905|NCT01709227|12370609|FG001|Overall Study|Physician Decision|0
7875906|NCT01709227|12370608|FG000|Overall Study|Pleural Peritoneal communication|0
7875907|NCT01709227|12370609|FG001|Overall Study|Pleural Peritoneal communication|9
7875908|NCT01709305|12370616|FG000|Phase 1|Clinical Adverse Event|80
7875909|NCT01709305|12370617|FG001|Phase 1|Clinical Adverse Event|0
7875910|NCT01709305|12370618|FG002|Phase 1|Clinical Adverse Event|0
7875911|NCT01709305|12370619|FG003|Phase 1|Clinical Adverse Event|0
7875912|NCT01709305|12370620|FG004|Phase 1|Clinical Adverse Event|0
7875913|NCT01709305|12370616|FG000|Phase 1|Death|2
7875914|NCT01709305|12370617|FG001|Phase 1|Death|0
7875915|NCT01709305|12370618|FG002|Phase 1|Death|0
7875916|NCT01709305|12370619|FG003|Phase 1|Death|0
7875917|NCT01709305|12370620|FG004|Phase 1|Death|0
7875918|NCT01709305|12370616|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13
7875919|NCT01709305|12370617|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0
7875920|NCT01709305|12370618|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0
7875921|NCT01709305|12370619|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0
7875922|NCT01709305|12370620|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0
7875923|NCT01709305|12370616|FG000|Phase 1|Laboratory Adverse Event|16
7875924|NCT01709305|12370617|FG001|Phase 1|Laboratory Adverse Event|0
7875925|NCT01709305|12370618|FG002|Phase 1|Laboratory Adverse Event|0
7875926|NCT01709305|12370619|FG003|Phase 1|Laboratory Adverse Event|0
7875927|NCT01709305|12370620|FG004|Phase 1|Laboratory Adverse Event|0
7875928|NCT01709305|12370616|FG000|Phase 1|Lost to Follow-up|147
7875929|NCT01709305|12370617|FG001|Phase 1|Lost to Follow-up|0
7875930|NCT01709305|12370618|FG002|Phase 1|Lost to Follow-up|0
7875931|NCT01709305|12370619|FG003|Phase 1|Lost to Follow-up|0
7875932|NCT01709305|12370620|FG004|Phase 1|Lost to Follow-up|0
7875933|NCT01709305|12370616|FG000|Phase 1|Travel, moving, etc.|30
7875934|NCT01709305|12370617|FG001|Phase 1|Travel, moving, etc.|0
7875935|NCT01709305|12370618|FG002|Phase 1|Travel, moving, etc.|0
7875936|NCT01709305|12370619|FG003|Phase 1|Travel, moving, etc.|0
7875937|NCT01709305|12370620|FG004|Phase 1|Travel, moving, etc.|0
7875938|NCT01709305|12370616|FG000|Phase 1|Physician Decision|13
7875939|NCT01709305|12370617|FG001|Phase 1|Physician Decision|0
7875940|NCT01709305|12370618|FG002|Phase 1|Physician Decision|0
7875941|NCT01709305|12370619|FG003|Phase 1|Physician Decision|0
7875942|NCT01709305|12370620|FG004|Phase 1|Physician Decision|0
7875943|NCT01709305|12370616|FG000|Phase 1|Protocol Violation|118
7875944|NCT01709305|12370617|FG001|Phase 1|Protocol Violation|0
7875945|NCT01709305|12370618|FG002|Phase 1|Protocol Violation|0
7875946|NCT01709305|12370619|FG003|Phase 1|Protocol Violation|0
7875947|NCT01709305|12370620|FG004|Phase 1|Protocol Violation|0
7875948|NCT01709305|12370616|FG000|Phase 1|Withdrawal by Subject|218
7875949|NCT01709305|12370617|FG001|Phase 1|Withdrawal by Subject|0
7875950|NCT01709305|12370618|FG002|Phase 1|Withdrawal by Subject|0
7875951|NCT01709305|12370619|FG003|Phase 1|Withdrawal by Subject|0
7875952|NCT01709305|12370620|FG004|Phase 1|Withdrawal by Subject|0
7875953|NCT01709305|12370616|FG000|Phase 2|Clinical Adverse Event|0
7875954|NCT01709305|12370617|FG001|Phase 2|Clinical Adverse Event|10
7875955|NCT01709305|12370618|FG002|Phase 2|Clinical Adverse Event|10
7875956|NCT01709305|12370619|FG003|Phase 2|Clinical Adverse Event|6
7875957|NCT01709305|12370620|FG004|Phase 2|Clinical Adverse Event|11
7875958|NCT01709305|12370616|FG000|Phase 2|Death|0
7875959|NCT01709305|12370617|FG001|Phase 2|Death|0
7875960|NCT01709305|12370618|FG002|Phase 2|Death|1
7875961|NCT01709305|12370619|FG003|Phase 2|Death|0
7875962|NCT01709305|12370620|FG004|Phase 2|Death|0
7875963|NCT01709305|12370616|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0
7875964|NCT01709305|12370617|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0
7875965|NCT01709305|12370618|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0
7875966|NCT01709305|12370619|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0
7875967|NCT01709305|12370620|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2
7875968|NCT01709305|12370616|FG000|Phase 2|Laboratory Adverse Event|0
7875969|NCT01709305|12370617|FG001|Phase 2|Laboratory Adverse Event|1
7875970|NCT01709305|12370618|FG002|Phase 2|Laboratory Adverse Event|0
7875971|NCT01709305|12370619|FG003|Phase 2|Laboratory Adverse Event|1
7875972|NCT01709305|12370620|FG004|Phase 2|Laboratory Adverse Event|1
7875973|NCT01709305|12370616|FG000|Phase 2|Lost to Follow-up|0
7875974|NCT01709305|12370617|FG001|Phase 2|Lost to Follow-up|10
7875975|NCT01709305|12370618|FG002|Phase 2|Lost to Follow-up|6
7875976|NCT01709305|12370619|FG003|Phase 2|Lost to Follow-up|9
7875977|NCT01709305|12370620|FG004|Phase 2|Lost to Follow-up|5
7875978|NCT01709305|12370616|FG000|Phase 2|Travel, moving, etc.|0
7875979|NCT01709305|12370617|FG001|Phase 2|Travel, moving, etc.|2
7875980|NCT01709305|12370618|FG002|Phase 2|Travel, moving, etc.|3
7875981|NCT01709305|12370619|FG003|Phase 2|Travel, moving, etc.|3
7875982|NCT01709305|12370620|FG004|Phase 2|Travel, moving, etc.|5
7875983|NCT01709305|12370616|FG000|Phase 2|Physician Decision|0
7875984|NCT01709305|12370617|FG001|Phase 2|Physician Decision|2
7875985|NCT01709305|12370618|FG002|Phase 2|Physician Decision|0
7875986|NCT01709305|12370619|FG003|Phase 2|Physician Decision|1
7875987|NCT01709305|12370620|FG004|Phase 2|Physician Decision|2
7875988|NCT01709305|12370616|FG000|Phase 2|Protocol Violation|0
7875989|NCT01709305|12370617|FG001|Phase 2|Protocol Violation|19
7875990|NCT01709305|12370618|FG002|Phase 2|Protocol Violation|19
7875991|NCT01709305|12370619|FG003|Phase 2|Protocol Violation|13
7875992|NCT01709305|12370620|FG004|Phase 2|Protocol Violation|9
7875993|NCT01709305|12370616|FG000|Phase 2|Withdrawal by Subject|0
7875994|NCT01709305|12370617|FG001|Phase 2|Withdrawal by Subject|8
7875995|NCT01709305|12370618|FG002|Phase 2|Withdrawal by Subject|6
7875996|NCT01709305|12370619|FG003|Phase 2|Withdrawal by Subject|15
7875997|NCT01709305|12370620|FG004|Phase 2|Withdrawal by Subject|12
7875998|NCT01709383|12370637|FG000|Overall Study|Lost to Follow-up|1
7875999|NCT01709383|12370638|FG001|Overall Study|Lost to Follow-up|0
7876000|NCT01709409|12370648|FG000|Overall Study|Protocol Violation|1
7876001|NCT01709409|12370649|FG001|Overall Study|Protocol Violation|0
7876002|NCT01709500|12370677|FG000|Overall Study|Randomized but not treated|0
7876003|NCT01709500|12370678|FG001|Overall Study|Randomized but not treated|1
7876004|NCT01709500|12370677|FG000|Overall Study|Adverse Event|5
7876005|NCT01709500|12370678|FG001|Overall Study|Adverse Event|1
7876006|NCT01709500|12370677|FG000|Overall Study|Poor compliance to protocol|2
7876007|NCT01709500|12370678|FG001|Overall Study|Poor compliance to protocol|1
7876008|NCT01709500|12370677|FG000|Overall Study|Other|3
7876009|NCT01709500|12370678|FG001|Overall Study|Other|1
7876010|NCT01709500|12370677|FG000|Overall Study|Related to IMP administration|1
7876011|NCT01709500|12370678|FG001|Overall Study|Related to IMP administration|0
7876012|NCT01709500|12370677|FG000|Overall Study|Treatment ongoing|156
7876013|NCT01709500|12370678|FG001|Overall Study|Treatment ongoing|78
7876014|NCT01709513|12370687|FG000|Overall Study|Randomized but not treated|0
7876015|NCT01709513|12370688|FG001|Overall Study|Randomized but not treated|1
7876016|NCT01709513|12370689|FG002|Overall Study|Randomized but not treated|0
7876017|NCT01709513|12370687|FG000|Overall Study|Adverse Event|16
7876018|NCT01709513|12370688|FG001|Overall Study|Adverse Event|31
7876019|NCT01709513|12370689|FG002|Overall Study|Adverse Event|23
7876020|NCT01709513|12370687|FG000|Overall Study|Poor compliance to protocol|2
7876021|NCT01709513|12370688|FG001|Overall Study|Poor compliance to protocol|0
7876022|NCT01709513|12370689|FG002|Overall Study|Poor compliance to protocol|0
7876023|NCT01709513|12370687|FG000|Overall Study|Other|3
7876024|NCT01709513|12370688|FG001|Overall Study|Other|11
7876025|NCT01709513|12370689|FG002|Overall Study|Other|7
7876026|NCT01709578|12370703|FG000|Overall Study|Rescued and entered in long term safety|63
7876027|NCT01709578|12370704|FG001|Overall Study|Rescued and entered in long term safety|25
7876028|NCT01709578|12370705|FG002|Overall Study|Rescued and entered in long term safety|26
7876029|NCT01709578|12370703|FG000|Overall Study|Adverse Event|9
7876030|NCT01709578|12370704|FG001|Overall Study|Adverse Event|18
7876031|NCT01709578|12370705|FG002|Overall Study|Adverse Event|17
7876032|NCT01709578|12370703|FG000|Overall Study|Lack of Efficacy|5
7876033|NCT01709578|12370704|FG001|Overall Study|Lack of Efficacy|4
7876034|NCT01709578|12370705|FG002|Overall Study|Lack of Efficacy|2
7876035|NCT01709578|12370703|FG000|Overall Study|Poor compliance to protocol|1
7876036|NCT01709578|12370704|FG001|Overall Study|Poor compliance to protocol|2
7876037|NCT01709578|12370705|FG002|Overall Study|Poor compliance to protocol|1
7876038|NCT01709578|12370703|FG000|Overall Study|Other, not related to safety or efficacy|2
7876039|NCT01709578|12370704|FG001|Overall Study|Other, not related to safety or efficacy|7
7876040|NCT01709578|12370705|FG002|Overall Study|Other, not related to safety or efficacy|5
7876041|NCT01709695|12370715|FG000|Overall Study|Withdrawal by Subject|1
7876042|NCT01709695|12370716|FG001|Overall Study|Withdrawal by Subject|1
7876043|NCT01709708|12370724|FG000|Overall Study|Protocol Violation|1
7876044|NCT01709708|12370725|FG001|Overall Study|Protocol Violation|2
7876045|NCT01709721|12370735|FG000|Open Label Phase|Withdrawal by Subject|0
7876046|NCT01709721|12370736|FG001|Open Label Phase|Withdrawal by Subject|0
7876047|NCT01709721|12370737|FG002|Open Label Phase|Withdrawal by Subject|5
7876048|NCT01709721|12370735|FG000|Open Label Phase|Adverse Event|0
7876049|NCT01709721|12370736|FG001|Open Label Phase|Adverse Event|0
7876050|NCT01709721|12370737|FG002|Open Label Phase|Adverse Event|8
7876051|NCT01709721|12370735|FG000|Open Label Phase|Non-compliance With Study Drug|0
7876052|NCT01709721|12370736|FG001|Open Label Phase|Non-compliance With Study Drug|0
7876053|NCT01709721|12370737|FG002|Open Label Phase|Non-compliance With Study Drug|3
7876054|NCT01709721|12370735|FG000|Open Label Phase|Investigator Decision|0
7876055|NCT01709721|12370736|FG001|Open Label Phase|Investigator Decision|0
7876056|NCT01709721|12370737|FG002|Open Label Phase|Investigator Decision|1
7876057|NCT01709721|12370735|FG000|Open Label Phase|Sponsor Decision|0
7876058|NCT01709721|12370736|FG001|Open Label Phase|Sponsor Decision|0
7876059|NCT01709721|12370737|FG002|Open Label Phase|Sponsor Decision|2
7876060|NCT01709721|12370735|FG000|Open Label Phase|Protocol Violation|0
7876061|NCT01709721|12370736|FG001|Open Label Phase|Protocol Violation|0
7876062|NCT01709721|12370737|FG002|Open Label Phase|Protocol Violation|1
7876063|NCT01709721|12370735|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0
7876064|NCT01709721|12370736|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0
7876065|NCT01709721|12370737|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1
7876066|NCT01709721|12370735|FG000|Open Label Phase|Inadequate Pain Control|0
7876067|NCT01709721|12370736|FG001|Open Label Phase|Inadequate Pain Control|0
7876068|NCT01709721|12370737|FG002|Open Label Phase|Inadequate Pain Control|37
7876069|NCT01709721|12370735|FG000|Open Label Phase|Other, Specify in text field in database|0
7876070|NCT01709721|12370736|FG001|Open Label Phase|Other, Specify in text field in database|0
7876071|NCT01709721|12370737|FG002|Open Label Phase|Other, Specify in text field in database|14
7876072|NCT01709721|12370735|FG000|Randomized Phase|Adverse Event|0
7876073|NCT01709721|12370736|FG001|Randomized Phase|Adverse Event|1
7876074|NCT01709721|12370737|FG002|Randomized Phase|Adverse Event|0
7876075|NCT01709721|12370735|FG000|Randomized Phase|Lost to Follow-up|1
7876076|NCT01709721|12370736|FG001|Randomized Phase|Lost to Follow-up|0
7876077|NCT01709721|12370737|FG002|Randomized Phase|Lost to Follow-up|0
7876078|NCT01709721|12370735|FG000|Randomized Phase|Inadequate Pain Control|1
7876079|NCT01709721|12370736|FG001|Randomized Phase|Inadequate Pain Control|2
7876080|NCT01709721|12370737|FG002|Randomized Phase|Inadequate Pain Control|0
7876081|NCT01709721|12370735|FG000|Randomized Phase|Other, Specify text field in database|1
7876082|NCT01709721|12370736|FG001|Randomized Phase|Other, Specify text field in database|3
7876083|NCT01709721|12370737|FG002|Randomized Phase|Other, Specify text field in database|0
7876084|NCT01709838|12370769|FG000|Overall Study|Withdrawal by Subject|21
7876085|NCT01709838|12370769|FG000|Overall Study|Lost to Follow-up|16
7876086|NCT01709838|12370769|FG000|Overall Study|Pregnancy|10
7876087|NCT01709838|12370769|FG000|Overall Study|Subject/guardian decision|8
7876088|NCT01709838|12370769|FG000|Overall Study|Adverse Event|4
7876089|NCT01709838|12370769|FG000|Overall Study|Physician Decision|4
7876090|NCT01709838|12370769|FG000|Overall Study|Death|3
7876091|NCT01709838|12370769|FG000|Overall Study|Protocol Violation|1
7876092|NCT01709864|12370777|FG000|Overall Study|Physician Decision|0
7876093|NCT01709864|12370778|FG001|Overall Study|Physician Decision|1
7876094|NCT01709864|12370777|FG000|Overall Study|subject/guardian decision|5
7876095|NCT01709864|12370778|FG001|Overall Study|subject/guardian decision|6
7876096|NCT01709864|12370777|FG000|Overall Study|Lost to Follow-up|1
7876097|NCT01709864|12370778|FG001|Overall Study|Lost to Follow-up|0
7876098|NCT01709864|12370777|FG000|Overall Study|non-compliance with study treatment|1
7876099|NCT01709864|12370778|FG001|Overall Study|non-compliance with study treatment|1
7876100|NCT01709864|12370777|FG000|Overall Study|Adverse Event|0
7876101|NCT01709864|12370778|FG001|Overall Study|Adverse Event|2
7876102|NCT01709864|12370777|FG000|Overall Study|Death|0
7876103|NCT01709864|12370778|FG001|Overall Study|Death|1
7876104|NCT01709903|12370786|FG000|Overall Study|administrative problems|2
7876105|NCT01709903|12370787|FG001|Overall Study|administrative problems|6
7876106|NCT01709903|12370786|FG000|Overall Study|Abnormal test procedure results|1
7876107|NCT01709903|12370787|FG001|Overall Study|Abnormal test procedure results|0
7876108|NCT01709903|12370786|FG000|Overall Study|In ability to use device|1
7876109|NCT01709903|12370787|FG001|Overall Study|In ability to use device|1
7876110|NCT01709903|12370786|FG000|Overall Study|no longer needed study drug|0
7876111|NCT01709903|12370787|FG001|Overall Study|no longer needed study drug|1
7876112|NCT01709903|12370786|FG000|Overall Study|Lost to Follow-up|0
7876113|NCT01709903|12370787|FG001|Overall Study|Lost to Follow-up|2
7876114|NCT01709903|12370786|FG000|Overall Study|Death|2
7876115|NCT01709903|12370787|FG001|Overall Study|Death|0
7876116|NCT01709903|12370786|FG000|Overall Study|Protocol Violation|3
7876117|NCT01709903|12370787|FG001|Overall Study|Protocol Violation|2
7876118|NCT01709903|12370786|FG000|Overall Study|Lack of Efficacy|3
7876119|NCT01709903|12370787|FG001|Overall Study|Lack of Efficacy|3
7876120|NCT01709903|12370786|FG000|Overall Study|Withdrawal by Subject|6
7876121|NCT01709903|12370787|FG001|Overall Study|Withdrawal by Subject|6
7876122|NCT01709903|12370786|FG000|Overall Study|Adverse Event|11
7876123|NCT01709903|12370787|FG001|Overall Study|Adverse Event|18
7876124|NCT01710020|12370793|FG000|Period 1|Protocol Violation|1
7876125|NCT01710033|12370803|FG000|Stage 2|Adverse Event|0
7876126|NCT01710033|12370804|FG001|Stage 2|Adverse Event|0
7876127|NCT01710033|12370805|FG002|Stage 2|Adverse Event|0
7876128|NCT01710033|12370806|FG003|Stage 2|Adverse Event|0
7876129|NCT01710033|12370807|FG004|Stage 2|Adverse Event|1
7876130|NCT01710046|12370822|FG000|Overall Study|Lost to Follow-up|1
7876131|NCT01710046|12370823|FG001|Overall Study|Lost to Follow-up|0
7876132|NCT01710345|12370864|FG000|Overall Study|Adverse Event|0
7876133|NCT01710345|12370865|FG001|Overall Study|Adverse Event|2
7876134|NCT01710345|12370866|FG002|Overall Study|Adverse Event|0
7876135|NCT01710345|12370864|FG000|Overall Study|Lack of Efficacy|2
7876136|NCT01710345|12370865|FG001|Overall Study|Lack of Efficacy|3
7876137|NCT01710345|12370866|FG002|Overall Study|Lack of Efficacy|1
7876138|NCT01710345|12370864|FG000|Overall Study|Drug Dosing Error|1
7876139|NCT01710345|12370865|FG001|Overall Study|Drug Dosing Error|0
7876140|NCT01710345|12370866|FG002|Overall Study|Drug Dosing Error|0
7876141|NCT01710358|12370877|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
7876142|NCT01710358|12370878|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
7876143|NCT01710358|12370879|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
7876144|NCT01710358|12370877|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0
7876145|NCT01710358|12370878|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2
7876146|NCT01710358|12370879|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0
7876147|NCT01710358|12370877|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
7876148|NCT01710358|12370878|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
7876149|NCT01710358|12370879|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
7876150|NCT01710358|12370877|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
7876151|NCT01710358|12370878|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
7876152|NCT01710358|12370879|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
7876153|NCT01710358|12370877|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
7876154|NCT01710358|12370878|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
7876155|NCT01710358|12370879|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
7876156|NCT01710358|12370877|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
7876157|NCT01710358|12370878|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
7876158|NCT01710358|12370879|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
7876159|NCT01710358|12370877|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
7876160|NCT01710358|12370878|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
7876161|NCT01710358|12370879|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
7876162|NCT01710358|12370877|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
7876163|NCT01710358|12370878|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
7876164|NCT01710358|12370879|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
7876165|NCT01710358|12370877|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
7876166|NCT01710358|12370878|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
7876167|NCT01710358|12370879|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
7876168|NCT01710358|12370877|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
7876169|NCT01710358|12370878|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
7876170|NCT01710358|12370879|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
7876171|NCT01710358|12370877|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1
7876172|NCT01710358|12370878|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0
7876173|NCT01710358|12370879|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1
7876174|NCT01710358|12370877|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
7876175|NCT01710358|12370878|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
7876176|NCT01710358|12370879|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
7876177|NCT01710358|12370877|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
7876178|NCT01710358|12370878|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
7876179|NCT01710358|12370879|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
7876180|NCT01710358|12370877|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
7876181|NCT01710358|12370878|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
7876182|NCT01710358|12370879|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
7876183|NCT01710358|12370877|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
7876184|NCT01710358|12370878|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
7876185|NCT01710358|12370879|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
7876186|NCT01710358|12370877|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
7876187|NCT01710358|12370878|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
7876188|NCT01710358|12370879|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
7876189|NCT01710358|12370877|FG000|Rescue Period|Adverse Event|0
7876190|NCT01710358|12370878|FG001|Rescue Period|Adverse Event|15
7876191|NCT01710358|12370879|FG002|Rescue Period|Adverse Event|0
7876192|NCT01710358|12370877|FG000|Rescue Period|Death|0
7876193|NCT01710358|12370878|FG001|Rescue Period|Death|1
7876194|NCT01710358|12370879|FG002|Rescue Period|Death|0
7876195|NCT01710358|12370877|FG000|Rescue Period|Lack of Efficacy|0
7876196|NCT01710358|12370878|FG001|Rescue Period|Lack of Efficacy|7
7876197|NCT01710358|12370879|FG002|Rescue Period|Lack of Efficacy|0
7876198|NCT01710358|12370877|FG000|Rescue Period|Withdrawal by Subject|0
7876199|NCT01710358|12370878|FG001|Rescue Period|Withdrawal by Subject|8
7876200|NCT01710358|12370879|FG002|Rescue Period|Withdrawal by Subject|0
7876201|NCT01710501|12370903|FG000|Overall Study|Lost to Follow-up|2
7876202|NCT01710501|12370904|FG001|Overall Study|Lost to Follow-up|0
7876203|NCT01710501|12370905|FG002|Overall Study|Lost to Follow-up|0
7876204|NCT01710514|12370915|FG000|Overall Study|Adverse Event|6
7876205|NCT01710514|12370916|FG001|Overall Study|Adverse Event|7
7876206|NCT01710514|12370915|FG000|Overall Study|Withdrawal by Subject|1
7876207|NCT01710514|12370916|FG001|Overall Study|Withdrawal by Subject|0
7876208|NCT01710527|12370925|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0
7876209|NCT01710527|12370926|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1
7876210|NCT01710657|12370935|FG000|Overall Study|Lost to Follow-up|2
7876211|NCT01710657|12370936|FG001|Overall Study|Lost to Follow-up|0
7876212|NCT01710657|12370937|FG002|Overall Study|Lost to Follow-up|1
7876213|NCT01710657|12370935|FG000|Overall Study|Protocol Violation|2
7876214|NCT01710657|12370936|FG001|Overall Study|Protocol Violation|2
7876215|NCT01710657|12370937|FG002|Overall Study|Protocol Violation|0
7876216|NCT01710657|12370935|FG000|Overall Study|Adverse Event|14
7876217|NCT01710657|12370936|FG001|Overall Study|Adverse Event|8
7876218|NCT01710657|12370937|FG002|Overall Study|Adverse Event|28
7876219|NCT01710657|12370935|FG000|Overall Study|Withdrawal by Subject|0
7876220|NCT01710657|12370936|FG001|Overall Study|Withdrawal by Subject|1
7876221|NCT01710657|12370937|FG002|Overall Study|Withdrawal by Subject|2
7876222|NCT01710657|12370935|FG000|Overall Study|Lack of Efficacy|0
7876223|NCT01710657|12370936|FG001|Overall Study|Lack of Efficacy|1
7876224|NCT01710657|12370937|FG002|Overall Study|Lack of Efficacy|1
7882906|NCT01777269|12382271|FG000|Overall Study|Adverse Event|24
7882907|NCT01777269|12382272|FG001|Overall Study|Adverse Event|33
7882908|NCT01777269|12382271|FG000|Overall Study|Lack of Efficacy|8
7882909|NCT01777269|12382272|FG001|Overall Study|Lack of Efficacy|10
7882910|NCT01777269|12382271|FG000|Overall Study|Protocol Violation|4
7882911|NCT01777269|12382272|FG001|Overall Study|Protocol Violation|4
7882912|NCT01777269|12382271|FG000|Overall Study|Participants reached stopping criteria|1
7882913|NCT01777269|12382272|FG001|Overall Study|Participants reached stopping criteria|1
7882914|NCT01777269|12382271|FG000|Overall Study|Lost to Follow-up|4
7882915|NCT01777269|12382272|FG001|Overall Study|Lost to Follow-up|0
7882916|NCT01777269|12382271|FG000|Overall Study|Physician Decision|5
7882917|NCT01777269|12382272|FG001|Overall Study|Physician Decision|2
7882918|NCT01777269|12382271|FG000|Overall Study|Withdrawal by Subject|9
7882919|NCT01777269|12382272|FG001|Overall Study|Withdrawal by Subject|9
7882920|NCT01777282|12382283|FG000|Overall Study|Persistent Hyperglycemia|0
7882921|NCT01777282|12382284|FG001|Overall Study|Persistent Hyperglycemia|0
7882922|NCT01777282|12382285|FG002|Overall Study|Persistent Hyperglycemia|1
7882923|NCT01777282|12382286|FG003|Overall Study|Persistent Hyperglycemia|0
7882924|NCT01777282|12382287|FG004|Overall Study|Persistent Hyperglycemia|0
7882925|NCT01777282|12382283|FG000|Overall Study|New Antidiabetic Medication|0
7882926|NCT01777282|12382284|FG001|Overall Study|New Antidiabetic Medication|0
7882927|NCT01777282|12382285|FG002|Overall Study|New Antidiabetic Medication|1
7882928|NCT01777282|12382286|FG003|Overall Study|New Antidiabetic Medication|0
7882929|NCT01777282|12382287|FG004|Overall Study|New Antidiabetic Medication|0
7882930|NCT01777282|12382283|FG000|Overall Study|Adverse Event|4
7882931|NCT01777282|12382284|FG001|Overall Study|Adverse Event|4
7882932|NCT01777282|12382285|FG002|Overall Study|Adverse Event|2
7882933|NCT01777282|12382286|FG003|Overall Study|Adverse Event|1
7882934|NCT01777282|12382287|FG004|Overall Study|Adverse Event|3
7882935|NCT01777282|12382283|FG000|Overall Study|Withdrawal by Subject|4
7882936|NCT01777282|12382284|FG001|Overall Study|Withdrawal by Subject|0
7882937|NCT01777282|12382285|FG002|Overall Study|Withdrawal by Subject|0
7882938|NCT01777282|12382286|FG003|Overall Study|Withdrawal by Subject|1
7882939|NCT01777282|12382287|FG004|Overall Study|Withdrawal by Subject|2
7882940|NCT01777282|12382283|FG000|Overall Study|Protocol Violation|2
7882941|NCT01777282|12382284|FG001|Overall Study|Protocol Violation|0
7882942|NCT01777282|12382285|FG002|Overall Study|Protocol Violation|1
7882943|NCT01777282|12382286|FG003|Overall Study|Protocol Violation|0
7882944|NCT01777282|12382287|FG004|Overall Study|Protocol Violation|2
7882945|NCT01777282|12382283|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1
7882946|NCT01777282|12382284|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0
7882947|NCT01777282|12382285|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1
7882948|NCT01777282|12382286|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0
7882949|NCT01777282|12382287|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0
7882950|NCT01777308|12382301|FG000|Overall Study|Withdrawal by Subject|5
7882951|NCT01777308|12382302|FG001|Overall Study|Withdrawal by Subject|1
7882952|NCT01777308|12382301|FG000|Overall Study|Migrated/moved from study area|1
7882953|NCT01777308|12382302|FG001|Overall Study|Migrated/moved from study area|0
7882954|NCT01777308|12382301|FG000|Overall Study|Lost to Follow-up|7
7882955|NCT01777308|12382302|FG001|Overall Study|Lost to Follow-up|2
7882956|NCT01777308|12382301|FG000|Overall Study|Blood draw refusal at Visit 3|1
7882957|NCT01777308|12382302|FG001|Overall Study|Blood draw refusal at Visit 3|0
7882958|NCT01777321|12382311|FG000|Overall Study|Withdrawal by Subject|0
7882959|NCT01777321|12382312|FG001|Overall Study|Withdrawal by Subject|1
7882960|NCT01777334|12382320|FG000|Overall Study|Adverse Event|18
7882961|NCT01777334|12382321|FG001|Overall Study|Adverse Event|14
7882962|NCT01777334|12382320|FG000|Overall Study|Lack of Efficacy|15
7882963|NCT01777334|12382321|FG001|Overall Study|Lack of Efficacy|29
7882964|NCT01777334|12382320|FG000|Overall Study|Protocol Violation|3
7882965|NCT01777334|12382321|FG001|Overall Study|Protocol Violation|7
7882966|NCT01777334|12382320|FG000|Overall Study|Lost to Follow-up|3
7882967|NCT01777334|12382321|FG001|Overall Study|Lost to Follow-up|2
7882968|NCT01777334|12382320|FG000|Overall Study|Withdrawal by Subject|14
7882969|NCT01777334|12382321|FG001|Overall Study|Withdrawal by Subject|11
7882970|NCT01777490|12382349|FG000|Overall Study|Dyad withdrew with data use prohibition|0
7882971|NCT01777490|12382350|FG001|Overall Study|Dyad withdrew with data use prohibition|0
7882972|NCT01777490|12382351|FG002|Overall Study|Dyad withdrew with data use prohibition|1
7882973|NCT01777490|12382352|FG003|Overall Study|Dyad withdrew with data use prohibition|1
7882974|NCT01777542|12382364|FG000|Second Intervention (20 Weeks)|Adverse Event|0
7876225|NCT01710709|12370945|FG000|Overall Study|Lost to Follow-up|29
7876226|NCT01710709|12370945|FG000|Overall Study|Adverse Event|48
7876227|NCT01710709|12370945|FG000|Overall Study|Participant met withdrawal criteria|33
7876228|NCT01710709|12370945|FG000|Overall Study|Participant withdrawn by investigator|2
7876229|NCT01710709|12370945|FG000|Overall Study|Withdrawal by Subject|53
7876230|NCT01710709|12370945|FG000|Overall Study|Protocol Violation|5
7876231|NCT01710709|12370945|FG000|Overall Study|Lack of Efficacy|3
7876232|NCT01710800|12370963|FG000|Overall Study|Withdrawal by Subject|21
7876233|NCT01710800|12370963|FG000|Overall Study|Protocol Violation|1
7876234|NCT01711216|12371000|FG000|Overall Study|Adverse Event|4
7876235|NCT01711216|12371000|FG000|Overall Study|Pregnancy|56
7876236|NCT01711216|12371000|FG000|Overall Study|Withdrawal by Subject|6
7876237|NCT01711216|12371000|FG000|Overall Study|Lost to Follow-up|46
7876238|NCT01711216|12371000|FG000|Overall Study|variety of other minor reasons|83
7876239|NCT01711216|12371000|FG000|Overall Study|no reason specified|22
7876240|NCT01711359|12371020|FG000|Treatment Period|Withdrawal by Subject|18
7876241|NCT01711359|12371021|FG001|Treatment Period|Withdrawal by Subject|7
7876242|NCT01711359|12371022|FG002|Treatment Period|Withdrawal by Subject|13
7876243|NCT01711359|12371020|FG000|Treatment Period|Lack of Efficacy|13
7876244|NCT01711359|12371021|FG001|Treatment Period|Lack of Efficacy|2
7876245|NCT01711359|12371022|FG002|Treatment Period|Lack of Efficacy|2
7876246|NCT01711359|12371020|FG000|Treatment Period|Adverse Event|8
7876247|NCT01711359|12371021|FG001|Treatment Period|Adverse Event|10
7876248|NCT01711359|12371022|FG002|Treatment Period|Adverse Event|24
7876249|NCT01711359|12371020|FG000|Treatment Period|Physician Decision|4
7876250|NCT01711359|12371021|FG001|Treatment Period|Physician Decision|3
7876251|NCT01711359|12371022|FG002|Treatment Period|Physician Decision|2
7876252|NCT01711359|12371020|FG000|Treatment Period|Death|3
7876253|NCT01711359|12371021|FG001|Treatment Period|Death|0
7876254|NCT01711359|12371022|FG002|Treatment Period|Death|0
7876255|NCT01711359|12371020|FG000|Treatment Period|Entry Criteria Not Met|1
7876256|NCT01711359|12371021|FG001|Treatment Period|Entry Criteria Not Met|0
7876257|NCT01711359|12371022|FG002|Treatment Period|Entry Criteria Not Met|0
7876258|NCT01711359|12371020|FG000|Treatment Period|Sponsor Decision|1
7876259|NCT01711359|12371021|FG001|Treatment Period|Sponsor Decision|0
7876260|NCT01711359|12371022|FG002|Treatment Period|Sponsor Decision|0
7876261|NCT01711359|12371020|FG000|Treatment Period|Lost to Follow-up|1
7876262|NCT01711359|12371021|FG001|Treatment Period|Lost to Follow-up|1
7876263|NCT01711359|12371022|FG002|Treatment Period|Lost to Follow-up|1
7876264|NCT01711359|12371020|FG000|Treatment Period|Randomized, Not Treated|3
7876265|NCT01711359|12371021|FG001|Treatment Period|Randomized, Not Treated|1
7876266|NCT01711359|12371022|FG002|Treatment Period|Randomized, Not Treated|0
7876267|NCT01711619|12371049|FG000|Overall Study|Early study termination|10
7876268|NCT01711619|12371050|FG001|Overall Study|Early study termination|14
7876269|NCT01711619|12371049|FG000|Overall Study|Withdrawal by Subject|3
7876270|NCT01711619|12371050|FG001|Overall Study|Withdrawal by Subject|7
7876271|NCT01711619|12371049|FG000|Overall Study|Protocol Violation|2
7876272|NCT01711619|12371050|FG001|Overall Study|Protocol Violation|3
7876273|NCT01711619|12371049|FG000|Overall Study|Adverse Event|2
7876274|NCT01711619|12371050|FG001|Overall Study|Adverse Event|0
7876275|NCT01711619|12371049|FG000|Overall Study|Lost to Follow-up|1
7876276|NCT01711619|12371050|FG001|Overall Study|Lost to Follow-up|0
7876277|NCT01711645|12371056|FG000|Overall Study|Withdrawal by Subject|8
7876278|NCT01711645|12371056|FG000|Overall Study|Lost to Follow-up|6
7876279|NCT01711645|12371056|FG000|Overall Study|Physician Decision|5
7876280|NCT01711736|12371071|FG000|Overall Study|Lost to Follow-up|4
7876281|NCT01711736|12371072|FG001|Overall Study|Lost to Follow-up|1
7876282|NCT01711736|12371071|FG000|Overall Study|Withdrawal by Subject|6
7876283|NCT01711736|12371072|FG001|Overall Study|Withdrawal by Subject|6
7876284|NCT01711736|12371071|FG000|Overall Study|Migrated/moved from study area|2
7876285|NCT01711736|12371072|FG001|Overall Study|Migrated/moved from study area|1
7876286|NCT01711853|12371079|FG000|Overall Study|Not treated|3
7876287|NCT01711866|12371083|FG000|Overall Study|Noncompliant|3
7876288|NCT01711866|12371083|FG000|Overall Study|Withdrawal by Subject|3
7876289|NCT01711866|12371083|FG000|Overall Study|Adverse Event|2
7876290|NCT01711983|12371091|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32
7876291|NCT01711983|12371091|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26
7876292|NCT01711983|12371091|FG000|36-Month Closure Evaluation|Test Device Removal|2
7876293|NCT01711983|12371091|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62
7876294|NCT01712009|12371098|FG000|Overall Study|Withdrawal by Subject|24
7876295|NCT01712009|12371099|FG001|Overall Study|Withdrawal by Subject|15
7876296|NCT01712009|12371100|FG002|Overall Study|Withdrawal by Subject|8
7876297|NCT01712009|12371098|FG000|Overall Study|Lost to Follow-up|2
7876298|NCT01712009|12371099|FG001|Overall Study|Lost to Follow-up|0
7876299|NCT01712009|12371100|FG002|Overall Study|Lost to Follow-up|1
7876300|NCT01712009|12371098|FG000|Overall Study|Decision by Sponsor|12
7876301|NCT01712009|12371099|FG001|Overall Study|Decision by Sponsor|14
7876302|NCT01712009|12371100|FG002|Overall Study|Decision by Sponsor|12
7876303|NCT01712061|12371110|FG000|Overall Study|Adverse Event|4
7876304|NCT01712061|12371111|FG001|Overall Study|Adverse Event|9
7876305|NCT01712061|12371112|FG002|Overall Study|Adverse Event|5
7876306|NCT01712061|12371110|FG000|Overall Study|Death|0
7876307|NCT01712061|12371111|FG001|Overall Study|Death|0
7876308|NCT01712061|12371112|FG002|Overall Study|Death|1
7876309|NCT01712061|12371110|FG000|Overall Study|Lost to Follow-up|1
7876310|NCT01712061|12371111|FG001|Overall Study|Lost to Follow-up|0
7876311|NCT01712061|12371112|FG002|Overall Study|Lost to Follow-up|1
7876312|NCT01712061|12371110|FG000|Overall Study|Did Not Meet Entrance Criteria|4
7876313|NCT01712061|12371111|FG001|Overall Study|Did Not Meet Entrance Criteria|6
7876314|NCT01712061|12371112|FG002|Overall Study|Did Not Meet Entrance Criteria|3
7876315|NCT01712061|12371110|FG000|Overall Study|Medication Error Without Associated AE|0
7876316|NCT01712061|12371111|FG001|Overall Study|Medication Error Without Associated AE|1
7876317|NCT01712061|12371112|FG002|Overall Study|Medication Error Without Associated AE|0
7876318|NCT01712061|12371110|FG000|Overall Study|Withdrawal by Subject|1
7876319|NCT01712061|12371111|FG001|Overall Study|Withdrawal by Subject|7
7876320|NCT01712061|12371112|FG002|Overall Study|Withdrawal by Subject|1
7876321|NCT01712061|12371110|FG000|Overall Study|Other|0
7876322|NCT01712061|12371111|FG001|Overall Study|Other|3
7876323|NCT01712061|12371112|FG002|Overall Study|Other|0
7876324|NCT01712074|12371124|FG000|Placebo Run-in Period|Adverse Event|2
7876325|NCT01712074|12371125|FG001|Placebo Run-in Period|Adverse Event|0
7876326|NCT01712074|12371126|FG002|Placebo Run-in Period|Adverse Event|0
7876327|NCT01712074|12371124|FG000|Placebo Run-in Period|Lost to Follow-up|1
7876328|NCT01712074|12371125|FG001|Placebo Run-in Period|Lost to Follow-up|0
7876329|NCT01712074|12371126|FG002|Placebo Run-in Period|Lost to Follow-up|0
7876330|NCT01712074|12371124|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5
7876331|NCT01712074|12371125|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0
7876332|NCT01712074|12371126|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0
7876333|NCT01712074|12371124|FG000|Placebo Run-in Period|Other|1
7876334|NCT01712074|12371125|FG001|Placebo Run-in Period|Other|0
7876335|NCT01712074|12371126|FG002|Placebo Run-in Period|Other|0
7876336|NCT01712074|12371124|FG000|Placebo Run-in Period|No longer willing to participate|1
7876337|NCT01712074|12371125|FG001|Placebo Run-in Period|No longer willing to participate|0
7876338|NCT01712074|12371126|FG002|Placebo Run-in Period|No longer willing to participate|0
7876339|NCT01712074|12371124|FG000|Double Blind Period|Adverse Event|0
7876340|NCT01712074|12371125|FG001|Double Blind Period|Adverse Event|2
7876341|NCT01712074|12371126|FG002|Double Blind Period|Adverse Event|1
7876342|NCT01712074|12371124|FG000|Double Blind Period|No longer willing to participate|0
7876343|NCT01712074|12371125|FG001|Double Blind Period|No longer willing to participate|2
7876344|NCT01712074|12371126|FG002|Double Blind Period|No longer willing to participate|4
7876345|NCT01712074|12371124|FG000|Double Blind Period|Death|0
7876346|NCT01712074|12371125|FG001|Double Blind Period|Death|1
7876347|NCT01712074|12371126|FG002|Double Blind Period|Death|0
7876348|NCT01712074|12371124|FG000|Double Blind Period|Lost to Follow-up|0
7876349|NCT01712074|12371125|FG001|Double Blind Period|Lost to Follow-up|2
7876350|NCT01712074|12371126|FG002|Double Blind Period|Lost to Follow-up|1
7876351|NCT01712074|12371124|FG000|Double Blind Period|Other|0
7876352|NCT01712074|12371125|FG001|Double Blind Period|Other|4
7876353|NCT01712074|12371126|FG002|Double Blind Period|Other|1
7876354|NCT01712074|12371124|FG000|Double Blind Period|Protocol Violation|0
7876355|NCT01712074|12371125|FG001|Double Blind Period|Protocol Violation|0
7876356|NCT01712074|12371126|FG002|Double Blind Period|Protocol Violation|1
7876357|NCT01712074|12371124|FG000|Double Blind Period|No longer met eligibility criteria|0
7876358|NCT01712074|12371125|FG001|Double Blind Period|No longer met eligibility criteria|3
7876359|NCT01712074|12371126|FG002|Double Blind Period|No longer met eligibility criteria|0
7876360|NCT01712178|12371143|FG000|Overall Study|Withdrew consent due to an adverse event|1
7876361|NCT01712178|12371144|FG001|Overall Study|Withdrew consent due to an adverse event|1
7876362|NCT01712178|12371143|FG000|Overall Study|Serious adverse event/withdrew consent|0
7876363|NCT01712178|12371144|FG001|Overall Study|Serious adverse event/withdrew consent|1
7876364|NCT01712178|12371143|FG000|Overall Study|Lost to Follow-up|0
7876365|NCT01712178|12371144|FG001|Overall Study|Lost to Follow-up|1
7876366|NCT01712204|12371152|FG000|Overall Study|Adverse Event|3
7876367|NCT01712204|12371153|FG001|Overall Study|Adverse Event|1
7876368|NCT01712204|12371152|FG000|Overall Study|Withdrawal by Subject|3
7876369|NCT01712204|12371153|FG001|Overall Study|Withdrawal by Subject|3
7876370|NCT01712204|12371152|FG000|Overall Study|Lost to Follow-up|1
7876371|NCT01712204|12371153|FG001|Overall Study|Lost to Follow-up|0
7876372|NCT01712204|12371152|FG000|Overall Study|Protocol Violation|1
7876373|NCT01712204|12371153|FG001|Overall Study|Protocol Violation|1
7876374|NCT01712256|12371172|FG000|Overall Study|Lost to Follow-up|1
7876375|NCT01712334|12371176|FG000|Treatment Period 1|Randomized in Error|0
7876376|NCT01712334|12371177|FG001|Treatment Period 1|Randomized in Error|2
7876377|NCT01712399|12371206|FG000|Overall Study|Lost to Follow-up|1
7876378|NCT01712399|12371206|FG000|Overall Study|Withdrawal by Subject|39
7876379|NCT01712399|12371206|FG000|Overall Study|Death|1
7876380|NCT01712399|12371206|FG000|Overall Study|Adverse Event|11
7876381|NCT01712399|12371206|FG000|Overall Study|Study closure|345
7876382|NCT01712438|12371210|FG000|Overall Study|Not treated with Human-cl rhFVIII|2
7876383|NCT01712438|12371210|FG000|Overall Study|Ongoing ITI treatment|6
7876384|NCT01712438|12371210|FG000|Overall Study|Violated inclusion & exclusion criteria|4
7876385|NCT01712438|12371210|FG000|Overall Study|Prematurely Discontinued|25
7876386|NCT01712516|12371223|FG000|Overall Study|Technical problems|0
7876387|NCT01712516|12371224|FG001|Overall Study|Technical problems|0
7876388|NCT01712516|12371225|FG002|Overall Study|Technical problems|0
7876389|NCT01712516|12371226|FG003|Overall Study|Technical problems|2
7876390|NCT01712516|12371223|FG000|Overall Study|Lost to Follow-up|0
7876391|NCT01712516|12371224|FG001|Overall Study|Lost to Follow-up|0
7876392|NCT01712516|12371225|FG002|Overall Study|Lost to Follow-up|2
7876393|NCT01712516|12371226|FG003|Overall Study|Lost to Follow-up|1
7876394|NCT01712516|12371223|FG000|Overall Study|Death|0
7876395|NCT01712516|12371224|FG001|Overall Study|Death|1
7876396|NCT01712516|12371225|FG002|Overall Study|Death|0
7876397|NCT01712516|12371226|FG003|Overall Study|Death|0
7876398|NCT01712516|12371223|FG000|Overall Study|Protocol deviation|1
7876399|NCT01712516|12371224|FG001|Overall Study|Protocol deviation|0
7876400|NCT01712516|12371225|FG002|Overall Study|Protocol deviation|1
7876401|NCT01712516|12371226|FG003|Overall Study|Protocol deviation|0
7876402|NCT01712516|12371223|FG000|Overall Study|Physician Decision|2
7876403|NCT01712516|12371224|FG001|Overall Study|Physician Decision|0
7876404|NCT01712516|12371225|FG002|Overall Study|Physician Decision|0
7876405|NCT01712516|12371226|FG003|Overall Study|Physician Decision|1
7876406|NCT01712516|12371223|FG000|Overall Study|Withdrawal by Subject|3
7876407|NCT01712516|12371224|FG001|Overall Study|Withdrawal by Subject|9
7876408|NCT01712516|12371225|FG002|Overall Study|Withdrawal by Subject|3
7876409|NCT01712516|12371226|FG003|Overall Study|Withdrawal by Subject|9
7876410|NCT01712685|12371236|FG000|Overall Study|pt declined to participate before trmt|1
7876411|NCT01712984|12371261|FG000|Overall Study|Adverse Event|0
7876412|NCT01712984|12371262|FG001|Overall Study|Adverse Event|0
7876413|NCT01712984|12371263|FG002|Overall Study|Adverse Event|1
7876414|NCT01712984|12371261|FG000|Overall Study|Protocol Violation|2
7876415|NCT01712984|12371262|FG001|Overall Study|Protocol Violation|0
7876416|NCT01712984|12371263|FG002|Overall Study|Protocol Violation|1
7876417|NCT01712984|12371261|FG000|Overall Study|Lost to Follow-up|8
7876418|NCT01712984|12371262|FG001|Overall Study|Lost to Follow-up|10
7876419|NCT01712984|12371263|FG002|Overall Study|Lost to Follow-up|1
7876420|NCT01712984|12371261|FG000|Overall Study|Withdrawal by Subject|6
7876421|NCT01712984|12371262|FG001|Overall Study|Withdrawal by Subject|6
7876422|NCT01712984|12371263|FG002|Overall Study|Withdrawal by Subject|7
7876423|NCT01713036|12371271|FG000|Overall Study|Death|1
7876424|NCT01713283|12371285|FG000|Overall Study|Lack of Efficacy|10
7876425|NCT01713283|12371286|FG001|Overall Study|Lack of Efficacy|2
7876426|NCT01713283|12371285|FG000|Overall Study|Lost to Follow-up|1
7876427|NCT01713283|12371286|FG001|Overall Study|Lost to Follow-up|1
7876428|NCT01713348|12371300|FG000|Overall Study|Withdrawal by Subject|3
7876429|NCT01713348|12371301|FG001|Overall Study|Withdrawal by Subject|2
7876430|NCT01713348|12371302|FG002|Overall Study|Withdrawal by Subject|2
7876431|NCT01713348|12371303|FG003|Overall Study|Withdrawal by Subject|0
7876432|NCT01713348|12371300|FG000|Overall Study|Lost to Follow-up|1
7876433|NCT01713348|12371301|FG001|Overall Study|Lost to Follow-up|0
7876434|NCT01713348|12371302|FG002|Overall Study|Lost to Follow-up|0
7876435|NCT01713348|12371303|FG003|Overall Study|Lost to Follow-up|0
7876436|NCT01713530|12371324|FG000|Overall Study|Adverse Event|0
7876437|NCT01713530|12371325|FG001|Overall Study|Adverse Event|5
7876438|NCT01713530|12371324|FG000|Overall Study|Withdrawal criteria|21
7876439|NCT01713530|12371325|FG001|Overall Study|Withdrawal criteria|12
7876440|NCT01713530|12371324|FG000|Overall Study|Unclassified|4
7876441|NCT01713530|12371325|FG001|Overall Study|Unclassified|2
7876442|NCT01713582|12371352|FG000|Overall Study|Disease progression|3
7876443|NCT01713582|12371353|FG001|Overall Study|Disease progression|3
7876444|NCT01713582|12371354|FG002|Overall Study|Disease progression|3
7876445|NCT01713582|12371355|FG003|Overall Study|Disease progression|2
7876446|NCT01713582|12371356|FG004|Overall Study|Disease progression|3
7876447|NCT01713582|12371357|FG005|Overall Study|Disease progression|3
7876448|NCT01713582|12371358|FG006|Overall Study|Disease progression|3
7876449|NCT01713582|12371359|FG007|Overall Study|Disease progression|3
7876450|NCT01713582|12371360|FG008|Overall Study|Disease progression|3
7876451|NCT01713582|12371361|FG009|Overall Study|Disease progression|11
7876452|NCT01713582|12371362|FG010|Overall Study|Disease progression|10
7876453|NCT01713582|12371363|FG011|Overall Study|Disease progression|5
7876454|NCT01713582|12371364|FG012|Overall Study|Disease progression|3
7876455|NCT01713582|12371365|FG013|Overall Study|Disease progression|3
7876456|NCT01713582|12371366|FG014|Overall Study|Disease progression|6
7876457|NCT01713582|12371367|FG015|Overall Study|Disease progression|6
7876458|NCT01713582|12371368|FG016|Overall Study|Disease progression|5
7876459|NCT01713582|12371369|FG017|Overall Study|Disease progression|2
7876460|NCT01713582|12371370|FG018|Overall Study|Disease progression|3
7876461|NCT01713582|12371371|FG019|Overall Study|Disease progression|5
7876462|NCT01713582|12371372|FG020|Overall Study|Disease progression|15
7876463|NCT01713582|12371352|FG000|Overall Study|Death|0
7876464|NCT01713582|12371353|FG001|Overall Study|Death|0
7876465|NCT01713582|12371354|FG002|Overall Study|Death|0
7876466|NCT01713582|12371355|FG003|Overall Study|Death|1
7876467|NCT01713582|12371356|FG004|Overall Study|Death|1
7876468|NCT01713582|12371357|FG005|Overall Study|Death|3
7876469|NCT01713582|12371358|FG006|Overall Study|Death|3
7876470|NCT01713582|12371359|FG007|Overall Study|Death|2
7876471|NCT01713582|12371360|FG008|Overall Study|Death|3
7876472|NCT01713582|12371361|FG009|Overall Study|Death|4
7876473|NCT01713582|12371362|FG010|Overall Study|Death|3
7876474|NCT01713582|12371363|FG011|Overall Study|Death|0
7876475|NCT01713582|12371364|FG012|Overall Study|Death|0
7876476|NCT01713582|12371365|FG013|Overall Study|Death|0
7876477|NCT01713582|12371366|FG014|Overall Study|Death|0
7876478|NCT01713582|12371367|FG015|Overall Study|Death|0
7876479|NCT01713582|12371368|FG016|Overall Study|Death|0
7876480|NCT01713582|12371369|FG017|Overall Study|Death|0
7876481|NCT01713582|12371370|FG018|Overall Study|Death|0
7876482|NCT01713582|12371371|FG019|Overall Study|Death|0
7876483|NCT01713582|12371372|FG020|Overall Study|Death|0
7876484|NCT01713582|12371352|FG000|Overall Study|Adverse event-related|0
7876485|NCT01713582|12371353|FG001|Overall Study|Adverse event-related|0
7876486|NCT01713582|12371354|FG002|Overall Study|Adverse event-related|0
7876487|NCT01713582|12371355|FG003|Overall Study|Adverse event-related|0
7876488|NCT01713582|12371356|FG004|Overall Study|Adverse event-related|0
7876489|NCT01713582|12371357|FG005|Overall Study|Adverse event-related|0
7876490|NCT01713582|12371358|FG006|Overall Study|Adverse event-related|0
7876491|NCT01713582|12371359|FG007|Overall Study|Adverse event-related|0
7876492|NCT01713582|12371360|FG008|Overall Study|Adverse event-related|0
7876493|NCT01713582|12371361|FG009|Overall Study|Adverse event-related|1
7876494|NCT01713582|12371362|FG010|Overall Study|Adverse event-related|1
7876495|NCT01713582|12371363|FG011|Overall Study|Adverse event-related|0
7876496|NCT01713582|12371364|FG012|Overall Study|Adverse event-related|0
7876497|NCT01713582|12371365|FG013|Overall Study|Adverse event-related|0
7876498|NCT01713582|12371366|FG014|Overall Study|Adverse event-related|0
7876499|NCT01713582|12371367|FG015|Overall Study|Adverse event-related|0
7876500|NCT01713582|12371368|FG016|Overall Study|Adverse event-related|0
7876501|NCT01713582|12371369|FG017|Overall Study|Adverse event-related|0
7876502|NCT01713582|12371370|FG018|Overall Study|Adverse event-related|1
7876503|NCT01713582|12371371|FG019|Overall Study|Adverse event-related|0
7876504|NCT01713582|12371372|FG020|Overall Study|Adverse event-related|0
7876505|NCT01713582|12371352|FG000|Overall Study|Adverse event-unrelated|0
7876506|NCT01713582|12371353|FG001|Overall Study|Adverse event-unrelated|0
7876507|NCT01713582|12371354|FG002|Overall Study|Adverse event-unrelated|0
7876508|NCT01713582|12371355|FG003|Overall Study|Adverse event-unrelated|0
7876509|NCT01713582|12371356|FG004|Overall Study|Adverse event-unrelated|0
7876510|NCT01713582|12371357|FG005|Overall Study|Adverse event-unrelated|1
7876511|NCT01713582|12371358|FG006|Overall Study|Adverse event-unrelated|1
7876512|NCT01713582|12371359|FG007|Overall Study|Adverse event-unrelated|1
7876513|NCT01713582|12371360|FG008|Overall Study|Adverse event-unrelated|0
7876514|NCT01713582|12371361|FG009|Overall Study|Adverse event-unrelated|0
7876515|NCT01713582|12371362|FG010|Overall Study|Adverse event-unrelated|0
7876516|NCT01713582|12371363|FG011|Overall Study|Adverse event-unrelated|0
7876517|NCT01713582|12371364|FG012|Overall Study|Adverse event-unrelated|0
7876518|NCT01713582|12371365|FG013|Overall Study|Adverse event-unrelated|1
7876519|NCT01713582|12371366|FG014|Overall Study|Adverse event-unrelated|1
7876520|NCT01713582|12371367|FG015|Overall Study|Adverse event-unrelated|0
7876521|NCT01713582|12371368|FG016|Overall Study|Adverse event-unrelated|0
7876522|NCT01713582|12371369|FG017|Overall Study|Adverse event-unrelated|0
7876523|NCT01713582|12371370|FG018|Overall Study|Adverse event-unrelated|0
7876524|NCT01713582|12371371|FG019|Overall Study|Adverse event-unrelated|0
7876525|NCT01713582|12371372|FG020|Overall Study|Adverse event-unrelated|0
7876526|NCT01713582|12371352|FG000|Overall Study|Withdrawal of consent|0
7876527|NCT01713582|12371353|FG001|Overall Study|Withdrawal of consent|0
7876528|NCT01713582|12371354|FG002|Overall Study|Withdrawal of consent|1
7876529|NCT01713582|12371355|FG003|Overall Study|Withdrawal of consent|0
7876530|NCT01713582|12371356|FG004|Overall Study|Withdrawal of consent|0
7876531|NCT01713582|12371357|FG005|Overall Study|Withdrawal of consent|1
7876532|NCT01713582|12371358|FG006|Overall Study|Withdrawal of consent|0
7796935|NCT01072149|12253293|FG016|Treatment Period 2 (28 Days)|Physician Decision|0
7796936|NCT01072149|12253294|FG017|Treatment Period 2 (28 Days)|Physician Decision|0
7796937|NCT01072149|12253277|FG000|Washout Period 2 (14 Days)|Physician Decision|1
7796938|NCT01072149|12253278|FG001|Washout Period 2 (14 Days)|Physician Decision|0
7796939|NCT01072149|12253279|FG002|Washout Period 2 (14 Days)|Physician Decision|0
7796940|NCT01072149|12253280|FG003|Washout Period 2 (14 Days)|Physician Decision|0
7796941|NCT01072149|12253281|FG004|Washout Period 2 (14 Days)|Physician Decision|0
7796942|NCT01072149|12253282|FG005|Washout Period 2 (14 Days)|Physician Decision|0
7796943|NCT01072149|12253283|FG006|Washout Period 2 (14 Days)|Physician Decision|0
7796944|NCT01072149|12253284|FG007|Washout Period 2 (14 Days)|Physician Decision|0
7796945|NCT01072149|12253285|FG008|Washout Period 2 (14 Days)|Physician Decision|0
7796946|NCT01072149|12253286|FG009|Washout Period 2 (14 Days)|Physician Decision|0
7796947|NCT01072149|12253287|FG010|Washout Period 2 (14 Days)|Physician Decision|0
7876533|NCT01713582|12371359|FG007|Overall Study|Withdrawal of consent|0
7876534|NCT01713582|12371360|FG008|Overall Study|Withdrawal of consent|0
7876535|NCT01713582|12371361|FG009|Overall Study|Withdrawal of consent|1
7876536|NCT01713582|12371362|FG010|Overall Study|Withdrawal of consent|0
7876537|NCT01713582|12371363|FG011|Overall Study|Withdrawal of consent|0
7876538|NCT01713582|12371364|FG012|Overall Study|Withdrawal of consent|0
7876539|NCT01713582|12371365|FG013|Overall Study|Withdrawal of consent|0
7876540|NCT01713582|12371366|FG014|Overall Study|Withdrawal of consent|0
7876541|NCT01713582|12371367|FG015|Overall Study|Withdrawal of consent|0
7876542|NCT01713582|12371368|FG016|Overall Study|Withdrawal of consent|0
7876543|NCT01713582|12371369|FG017|Overall Study|Withdrawal of consent|0
7876544|NCT01713582|12371370|FG018|Overall Study|Withdrawal of consent|1
7876545|NCT01713582|12371371|FG019|Overall Study|Withdrawal of consent|0
7876546|NCT01713582|12371372|FG020|Overall Study|Withdrawal of consent|0
7876547|NCT01713582|12371352|FG000|Overall Study|Lack of Efficacy|0
7876548|NCT01713582|12371353|FG001|Overall Study|Lack of Efficacy|0
7876549|NCT01713582|12371354|FG002|Overall Study|Lack of Efficacy|0
7876550|NCT01713582|12371355|FG003|Overall Study|Lack of Efficacy|0
7876551|NCT01713582|12371356|FG004|Overall Study|Lack of Efficacy|0
7876552|NCT01713582|12371357|FG005|Overall Study|Lack of Efficacy|0
7876553|NCT01713582|12371358|FG006|Overall Study|Lack of Efficacy|0
7876554|NCT01713582|12371359|FG007|Overall Study|Lack of Efficacy|0
7876555|NCT01713582|12371360|FG008|Overall Study|Lack of Efficacy|0
7876556|NCT01713582|12371361|FG009|Overall Study|Lack of Efficacy|1
7876557|NCT01713582|12371362|FG010|Overall Study|Lack of Efficacy|2
7876558|NCT01713582|12371363|FG011|Overall Study|Lack of Efficacy|0
7876559|NCT01713582|12371364|FG012|Overall Study|Lack of Efficacy|0
7876560|NCT01713582|12371365|FG013|Overall Study|Lack of Efficacy|0
7876561|NCT01713582|12371366|FG014|Overall Study|Lack of Efficacy|0
7876562|NCT01713582|12371367|FG015|Overall Study|Lack of Efficacy|0
7876563|NCT01713582|12371368|FG016|Overall Study|Lack of Efficacy|0
7876564|NCT01713582|12371369|FG017|Overall Study|Lack of Efficacy|0
7876565|NCT01713582|12371370|FG018|Overall Study|Lack of Efficacy|0
7876566|NCT01713582|12371371|FG019|Overall Study|Lack of Efficacy|0
7876567|NCT01713582|12371372|FG020|Overall Study|Lack of Efficacy|0
7876568|NCT01713582|12371352|FG000|Overall Study|Withdrawal by Subject|0
7876569|NCT01713582|12371353|FG001|Overall Study|Withdrawal by Subject|0
7876570|NCT01713582|12371354|FG002|Overall Study|Withdrawal by Subject|0
7876571|NCT01713582|12371355|FG003|Overall Study|Withdrawal by Subject|0
7876572|NCT01713582|12371356|FG004|Overall Study|Withdrawal by Subject|0
7876573|NCT01713582|12371357|FG005|Overall Study|Withdrawal by Subject|0
7876574|NCT01713582|12371358|FG006|Overall Study|Withdrawal by Subject|0
7876575|NCT01713582|12371359|FG007|Overall Study|Withdrawal by Subject|0
7876576|NCT01713582|12371360|FG008|Overall Study|Withdrawal by Subject|0
7876577|NCT01713582|12371361|FG009|Overall Study|Withdrawal by Subject|0
7876578|NCT01713582|12371362|FG010|Overall Study|Withdrawal by Subject|0
7876579|NCT01713582|12371363|FG011|Overall Study|Withdrawal by Subject|0
7876580|NCT01713582|12371364|FG012|Overall Study|Withdrawal by Subject|0
7876581|NCT01713582|12371365|FG013|Overall Study|Withdrawal by Subject|0
7876582|NCT01713582|12371366|FG014|Overall Study|Withdrawal by Subject|0
7876583|NCT01713582|12371367|FG015|Overall Study|Withdrawal by Subject|0
7876584|NCT01713582|12371368|FG016|Overall Study|Withdrawal by Subject|0
7876585|NCT01713582|12371369|FG017|Overall Study|Withdrawal by Subject|1
7876586|NCT01713582|12371370|FG018|Overall Study|Withdrawal by Subject|0
7876587|NCT01713582|12371371|FG019|Overall Study|Withdrawal by Subject|0
7876588|NCT01713582|12371372|FG020|Overall Study|Withdrawal by Subject|0
7876589|NCT01713582|12371352|FG000|Overall Study|Stopped to receive bone marrow graft|0
7876590|NCT01713582|12371353|FG001|Overall Study|Stopped to receive bone marrow graft|0
7876591|NCT01713582|12371354|FG002|Overall Study|Stopped to receive bone marrow graft|0
7876592|NCT01713582|12371355|FG003|Overall Study|Stopped to receive bone marrow graft|0
7876593|NCT01713582|12371356|FG004|Overall Study|Stopped to receive bone marrow graft|0
7876594|NCT01713582|12371357|FG005|Overall Study|Stopped to receive bone marrow graft|0
7876595|NCT01713582|12371358|FG006|Overall Study|Stopped to receive bone marrow graft|0
7876596|NCT01713582|12371359|FG007|Overall Study|Stopped to receive bone marrow graft|0
7876597|NCT01713582|12371360|FG008|Overall Study|Stopped to receive bone marrow graft|0
7876598|NCT01713582|12371361|FG009|Overall Study|Stopped to receive bone marrow graft|0
7876599|NCT01713582|12371362|FG010|Overall Study|Stopped to receive bone marrow graft|0
7876600|NCT01713582|12371363|FG011|Overall Study|Stopped to receive bone marrow graft|0
7876601|NCT01713582|12371364|FG012|Overall Study|Stopped to receive bone marrow graft|0
7876602|NCT01713582|12371365|FG013|Overall Study|Stopped to receive bone marrow graft|0
7876603|NCT01713582|12371366|FG014|Overall Study|Stopped to receive bone marrow graft|0
7876604|NCT01713582|12371367|FG015|Overall Study|Stopped to receive bone marrow graft|0
7876605|NCT01713582|12371368|FG016|Overall Study|Stopped to receive bone marrow graft|1
7876606|NCT01713582|12371369|FG017|Overall Study|Stopped to receive bone marrow graft|0
7876607|NCT01713582|12371370|FG018|Overall Study|Stopped to receive bone marrow graft|0
7876608|NCT01713582|12371371|FG019|Overall Study|Stopped to receive bone marrow graft|0
7876609|NCT01713582|12371372|FG020|Overall Study|Stopped to receive bone marrow graft|0
7876610|NCT01713582|12371352|FG000|Overall Study|Disease progression and adverse event|0
7876611|NCT01713582|12371353|FG001|Overall Study|Disease progression and adverse event|0
7876612|NCT01713582|12371354|FG002|Overall Study|Disease progression and adverse event|0
7876613|NCT01713582|12371355|FG003|Overall Study|Disease progression and adverse event|0
7876614|NCT01713582|12371356|FG004|Overall Study|Disease progression and adverse event|0
7876615|NCT01713582|12371357|FG005|Overall Study|Disease progression and adverse event|0
7876616|NCT01713582|12371358|FG006|Overall Study|Disease progression and adverse event|0
7876617|NCT01713582|12371359|FG007|Overall Study|Disease progression and adverse event|0
7876618|NCT01713582|12371360|FG008|Overall Study|Disease progression and adverse event|0
7876619|NCT01713582|12371361|FG009|Overall Study|Disease progression and adverse event|0
7876620|NCT01713582|12371362|FG010|Overall Study|Disease progression and adverse event|0
7876621|NCT01713582|12371363|FG011|Overall Study|Disease progression and adverse event|0
7876622|NCT01713582|12371364|FG012|Overall Study|Disease progression and adverse event|0
7876623|NCT01713582|12371365|FG013|Overall Study|Disease progression and adverse event|0
7876624|NCT01713582|12371366|FG014|Overall Study|Disease progression and adverse event|0
7876625|NCT01713582|12371367|FG015|Overall Study|Disease progression and adverse event|0
7876626|NCT01713582|12371368|FG016|Overall Study|Disease progression and adverse event|1
7876627|NCT01713582|12371369|FG017|Overall Study|Disease progression and adverse event|0
7876628|NCT01713582|12371370|FG018|Overall Study|Disease progression and adverse event|0
7876629|NCT01713582|12371371|FG019|Overall Study|Disease progression and adverse event|0
7876630|NCT01713582|12371372|FG020|Overall Study|Disease progression and adverse event|0
7876631|NCT01713686|12371459|FG000|Overall Study|Lost to Follow-up|9
7876632|NCT01713686|12371459|FG000|Overall Study|Withdrawal by Subject|6
7876633|NCT01713933|12371482|FG000|Overall Study|Lost to Follow-up|2
7876634|NCT01713933|12371482|FG000|Overall Study|Withdrawal by Subject|3
7876635|NCT01713933|12371482|FG000|Overall Study|Excluded from analysis as a BMI outlier|1
7876636|NCT01713946|12371489|FG000|Overall Study|Death|0
7876637|NCT01713946|12371490|FG001|Overall Study|Death|2
7876638|NCT01713946|12371491|FG002|Overall Study|Death|2
7876639|NCT01713946|12371489|FG000|Overall Study|Adverse Event|19
7876640|NCT01713946|12371490|FG001|Overall Study|Adverse Event|14
7876641|NCT01713946|12371491|FG002|Overall Study|Adverse Event|13
7876642|NCT01713946|12371489|FG000|Overall Study|Withdrawal by Subject|12
7876643|NCT01713946|12371490|FG001|Overall Study|Withdrawal by Subject|12
7876644|NCT01713946|12371491|FG002|Overall Study|Withdrawal by Subject|8
7876645|NCT01713946|12371489|FG000|Overall Study|Lack of Efficacy|8
7876646|NCT01713946|12371490|FG001|Overall Study|Lack of Efficacy|8
7876647|NCT01713946|12371491|FG002|Overall Study|Lack of Efficacy|14
7876648|NCT01713946|12371489|FG000|Overall Study|Protocol Violation|2
7876649|NCT01713946|12371490|FG001|Overall Study|Protocol Violation|4
7876650|NCT01713946|12371491|FG002|Overall Study|Protocol Violation|1
7876651|NCT01713946|12371489|FG000|Overall Study|Lost to Follow-up|0
7876652|NCT01713946|12371490|FG001|Overall Study|Lost to Follow-up|0
7876653|NCT01713946|12371491|FG002|Overall Study|Lost to Follow-up|1
7876654|NCT01713946|12371489|FG000|Overall Study|Administrative problems|1
7876655|NCT01713946|12371490|FG001|Overall Study|Administrative problems|0
7876656|NCT01713946|12371491|FG002|Overall Study|Administrative problems|0
7876657|NCT01713946|12371489|FG000|Overall Study|Did not continue in Ext|0
7876658|NCT01713946|12371490|FG001|Overall Study|Did not continue in Ext|3
7876659|NCT01713946|12371491|FG002|Overall Study|Did not continue in Ext|0
7876660|NCT01713946|12371489|FG000|Overall Study|Did not continue in Post-Ext. Phase|1
7876661|NCT01713946|12371490|FG001|Overall Study|Did not continue in Post-Ext. Phase|2
7876662|NCT01713946|12371491|FG002|Overall Study|Did not continue in Post-Ext. Phase|0
7876663|NCT01713946|12371489|FG000|Overall Study|Patients never switched to everolimus|0
7876664|NCT01713946|12371490|FG001|Overall Study|Patients never switched to everolimus|0
7876665|NCT01713946|12371491|FG002|Overall Study|Patients never switched to everolimus|5
7876666|NCT01713998|12371520|FG000|Overall Study|Lost to Follow-up|2
7876667|NCT01713998|12371521|FG001|Overall Study|Lost to Follow-up|0
7876668|NCT01713998|12371522|FG002|Overall Study|Lost to Follow-up|2
7876669|NCT01713998|12371520|FG000|Overall Study|Withdrawal by Subject|1
7876670|NCT01713998|12371521|FG001|Overall Study|Withdrawal by Subject|0
7876671|NCT01713998|12371522|FG002|Overall Study|Withdrawal by Subject|0
7876672|NCT01714063|12371552|FG000|Overall Study|Equipment malfunction|2
7876673|NCT01714310|12371567|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0
7876674|NCT01714310|12371568|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0
7876675|NCT01714310|12371569|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1
7876676|NCT01714310|12371567|FG000|Open Lisdexamfetamine Titration|Adverse Event|0
7876677|NCT01714310|12371568|FG001|Open Lisdexamfetamine Titration|Adverse Event|0
7876678|NCT01714310|12371569|FG002|Open Lisdexamfetamine Titration|Adverse Event|3
7876679|NCT01714310|12371567|FG000|Double Blind Adjunctive Treatment|Adverse Event|1
7876680|NCT01714310|12371568|FG001|Double Blind Adjunctive Treatment|Adverse Event|1
7876681|NCT01714310|12371569|FG002|Double Blind Adjunctive Treatment|Adverse Event|0
7876682|NCT01714310|12371567|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1
7876683|NCT01714310|12371568|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2
7876684|NCT01714310|12371569|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0
7876685|NCT01714544|12371617|FG000|Overall Study|Lost to Follow-up|1
7876686|NCT01714544|12371617|FG000|Overall Study|Physician Decision|1
7876687|NCT01714544|12371617|FG000|Overall Study|Withdrawal by Subject|1
7876688|NCT01714609|12371623|FG000|Overall Study|Protocol Violation|1
7876689|NCT01714609|12371624|FG001|Overall Study|Protocol Violation|0
7876690|NCT01714635|12371633|FG000|Overall Study|Discontinued|1
7876691|NCT01714635|12371634|FG001|Overall Study|Discontinued|0
7876692|NCT01714635|12371635|FG002|Overall Study|Discontinued|2
7876693|NCT01714635|12371633|FG000|Overall Study|Missed 6-month exam|1
7876694|NCT01714635|12371634|FG001|Overall Study|Missed 6-month exam|0
7876695|NCT01714635|12371635|FG002|Overall Study|Missed 6-month exam|0
7876696|NCT01714687|12371645|FG000|Overall Study|Withdrawal by Subject|1
7876697|NCT01714687|12371646|FG001|Overall Study|Withdrawal by Subject|0
7876698|NCT01714687|12371645|FG000|Overall Study|Lost to Follow-up|2
7876699|NCT01714687|12371646|FG001|Overall Study|Lost to Follow-up|4
7876700|NCT01714726|12371656|FG000|Double-Blinded Induction Period|Subject not in open label period|3
7876701|NCT01714726|12371657|FG001|Double-Blinded Induction Period|Subject not in open label period|1
7876702|NCT01714726|12371658|FG002|Double-Blinded Induction Period|Subject not in open label period|0
7876703|NCT01714726|12371659|FG003|Double-Blinded Induction Period|Subject not in open label period|0
7876704|NCT01714726|12371656|FG000|Double-Blinded Induction Period|Adverse Event|0
7876705|NCT01714726|12371657|FG001|Double-Blinded Induction Period|Adverse Event|1
7876706|NCT01714726|12371658|FG002|Double-Blinded Induction Period|Adverse Event|0
7876707|NCT01714726|12371659|FG003|Double-Blinded Induction Period|Adverse Event|0
7876708|NCT01714726|12371656|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5
7876709|NCT01714726|12371657|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3
7876710|NCT01714726|12371658|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0
7876711|NCT01714726|12371659|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0
7876712|NCT01714726|12371656|FG000|Double-Blinded Induction Period|Lost to Follow-up|0
7876713|NCT01714726|12371657|FG001|Double-Blinded Induction Period|Lost to Follow-up|2
7876714|NCT01714726|12371658|FG002|Double-Blinded Induction Period|Lost to Follow-up|0
7876715|NCT01714726|12371659|FG003|Double-Blinded Induction Period|Lost to Follow-up|0
7876716|NCT01714726|12371656|FG000|Open-Label Period|Other|0
7876717|NCT01714726|12371657|FG001|Open-Label Period|Other|0
7876718|NCT01714726|12371658|FG002|Open-Label Period|Other|1
7876719|NCT01714726|12371659|FG003|Open-Label Period|Other|3
7876720|NCT01714726|12371656|FG000|Open-Label Period|Adverse Event|0
7876721|NCT01714726|12371657|FG001|Open-Label Period|Adverse Event|0
7876722|NCT01714726|12371658|FG002|Open-Label Period|Adverse Event|1
7876723|NCT01714726|12371659|FG003|Open-Label Period|Adverse Event|0
7876724|NCT01714726|12371656|FG000|Open-Label Period|Withdrawal by Subject|0
7876725|NCT01714726|12371657|FG001|Open-Label Period|Withdrawal by Subject|0
7876726|NCT01714726|12371658|FG002|Open-Label Period|Withdrawal by Subject|9
7876727|NCT01714726|12371659|FG003|Open-Label Period|Withdrawal by Subject|19
7876728|NCT01714726|12371656|FG000|Open-Label Period|Developed specific withdrawal criteria|0
7876729|NCT01714726|12371657|FG001|Open-Label Period|Developed specific withdrawal criteria|0
7876730|NCT01714726|12371658|FG002|Open-Label Period|Developed specific withdrawal criteria|5
7876731|NCT01714726|12371659|FG003|Open-Label Period|Developed specific withdrawal criteria|2
7876732|NCT01714726|12371656|FG000|Open-Label Period|Lost to Follow-up|0
7876733|NCT01714726|12371657|FG001|Open-Label Period|Lost to Follow-up|0
7876734|NCT01714726|12371658|FG002|Open-Label Period|Lost to Follow-up|3
7876735|NCT01714726|12371659|FG003|Open-Label Period|Lost to Follow-up|4
7876736|NCT01714947|12371685|FG000|Part B|Progressive Disease|3
7876737|NCT01715129|12371698|FG000|Overall Study|Adverse Event, fatal|1
7876738|NCT01715129|12371698|FG000|Overall Study|Lack of Efficacy|3
7876739|NCT01715129|12371698|FG000|Overall Study|Protocol Violation|1
7876740|NCT01715129|12371698|FG000|Overall Study|Consent Withdrawn|2
7876741|NCT01715129|12371698|FG000|Overall Study|Lost to Follow-up|1
7876742|NCT01715129|12371698|FG000|Overall Study|Other|1
7876743|NCT01715298|12371720|FG000|Overall Study|Lost to Follow-up|0
7876744|NCT01715298|12371721|FG001|Overall Study|Lost to Follow-up|2
7876745|NCT01715298|12371720|FG000|Overall Study|Patient/guardian decision|7
7876746|NCT01715298|12371721|FG001|Overall Study|Patient/guardian decision|9
7876747|NCT01715415|12371729|FG000|Double-blind Treatment|Did Not Receive Study Drug|0
7876748|NCT01715415|12371730|FG001|Double-blind Treatment|Did Not Receive Study Drug|1
7876749|NCT01715415|12371729|FG000|Double-blind Treatment|Adverse Event|3
7876750|NCT01715415|12371730|FG001|Double-blind Treatment|Adverse Event|0
7876751|NCT01715415|12371729|FG000|Double-blind Treatment|Withdrawal by Subject|1
7876752|NCT01715415|12371730|FG001|Double-blind Treatment|Withdrawal by Subject|1
7876753|NCT01715415|12371729|FG000|Double-blind Treatment|Other|1
7876754|NCT01715415|12371730|FG001|Double-blind Treatment|Other|0
7876755|NCT01715415|12371729|FG000|Open-label Treatment|Adverse Event|0
7876756|NCT01715415|12371730|FG001|Open-label Treatment|Adverse Event|1
7876757|NCT01715415|12371729|FG000|Open-label Treatment|Subject Noncompliant|0
7876758|NCT01715415|12371730|FG001|Open-label Treatment|Subject Noncompliant|1
7876759|NCT01715571|12371737|FG000|Overall Study|Lost to Follow-up|8
7876760|NCT01715805|12371741|FG000|Placebo + ADT Lead-in Period|Adverse Event|41
7876761|NCT01715805|12371742|FG001|Placebo + ADT Lead-in Period|Adverse Event|0
7876762|NCT01715805|12371743|FG002|Placebo + ADT Lead-in Period|Adverse Event|0
7876763|NCT01715805|12371744|FG003|Placebo + ADT Lead-in Period|Adverse Event|0
7876764|NCT01715805|12371741|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6
7876765|NCT01715805|12371742|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
7876766|NCT01715805|12371743|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
7876767|NCT01715805|12371744|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
7876768|NCT01715805|12371741|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74
7876769|NCT01715805|12371742|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0
7876770|NCT01715805|12371743|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0
7876771|NCT01715805|12371744|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0
7876772|NCT01715805|12371741|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49
7876773|NCT01715805|12371742|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
7876774|NCT01715805|12371743|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
7876775|NCT01715805|12371744|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
7876776|NCT01715805|12371741|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34
7876777|NCT01715805|12371742|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0
7876778|NCT01715805|12371743|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0
7876779|NCT01715805|12371744|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0
7876780|NCT01715805|12371741|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1
7876781|NCT01715805|12371742|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
7876782|NCT01715805|12371743|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
7876783|NCT01715805|12371744|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
7876784|NCT01715805|12371741|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10
7876785|NCT01715805|12371742|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
7876786|NCT01715805|12371743|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
7876787|NCT01715805|12371744|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
7876788|NCT01715805|12371741|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
7876789|NCT01715805|12371742|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
7876790|NCT01715805|12371743|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
7876791|NCT01715805|12371744|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1
7876792|NCT01715805|12371741|FG000|Double-Blind or Continued Treatment|Adverse Event|0
7876793|NCT01715805|12371742|FG001|Double-Blind or Continued Treatment|Adverse Event|3
7876794|NCT01715805|12371743|FG002|Double-Blind or Continued Treatment|Adverse Event|23
7876795|NCT01715805|12371744|FG003|Double-Blind or Continued Treatment|Adverse Event|2
7876796|NCT01715805|12371741|FG000|Double-Blind or Continued Treatment|Protocol Violation|0
7876797|NCT01715805|12371742|FG001|Double-Blind or Continued Treatment|Protocol Violation|14
7876798|NCT01715805|12371743|FG002|Double-Blind or Continued Treatment|Protocol Violation|12
7876799|NCT01715805|12371744|FG003|Double-Blind or Continued Treatment|Protocol Violation|19
7876800|NCT01715805|12371741|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0
7876801|NCT01715805|12371742|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11
7876802|NCT01715805|12371743|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11
7876803|NCT01715805|12371744|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13
7876804|NCT01715805|12371741|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0
7876805|NCT01715805|12371742|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7
7876806|NCT01715805|12371743|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10
7876807|NCT01715805|12371744|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10
7876808|NCT01715805|12371741|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0
7876809|NCT01715805|12371742|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1
7876810|NCT01715805|12371743|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0
7876811|NCT01715805|12371744|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3
7876812|NCT01715805|12371741|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
7876813|NCT01715805|12371742|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3
7876814|NCT01715805|12371743|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
7876815|NCT01715805|12371744|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
7876816|NCT01715831|12371752|FG000|Overall Study|Adverse Event|1
7876817|NCT01715857|12371756|FG000|Overall Study|Did Not Meet Eligibility Criteria|96
7876818|NCT01715896|12371767|FG000|Overall Study|Lost to Follow-up|0
7876819|NCT01715896|12371768|FG001|Overall Study|Lost to Follow-up|2
7876820|NCT01715896|12371767|FG000|Overall Study|Withdrawal by Subject|1
7876821|NCT01715896|12371768|FG001|Overall Study|Withdrawal by Subject|4
7876822|NCT01715896|12371767|FG000|Overall Study|Other|2
7876823|NCT01715896|12371768|FG001|Overall Study|Other|5
7876824|NCT01716104|12371820|FG000|Overall Study|Do not meet inclusion criteria|6
7876825|NCT01716104|12371821|FG001|Overall Study|Do not meet inclusion criteria|7
7876826|NCT01716156|12371830|FG000|Overall Study|Protocol Violation|1
7876827|NCT01716156|12371831|FG001|Overall Study|Protocol Violation|0
7876828|NCT01716156|12371832|FG002|Overall Study|Protocol Violation|0
7876829|NCT01716156|12371830|FG000|Overall Study|Withdrawal by Subject|0
7876830|NCT01716156|12371831|FG001|Overall Study|Withdrawal by Subject|1
7876831|NCT01716156|12371832|FG002|Overall Study|Withdrawal by Subject|2
7876832|NCT01716156|12371830|FG000|Overall Study|Lost to Follow-up|1
7876833|NCT01716156|12371831|FG001|Overall Study|Lost to Follow-up|0
7876834|NCT01716156|12371832|FG002|Overall Study|Lost to Follow-up|0
7876835|NCT01716169|12371844|FG000|Overall Study|Adverse Event|1
7876836|NCT01716169|12371844|FG000|Overall Study|Lost to Follow-up|1
7876837|NCT01716169|12371844|FG000|Overall Study|Withdrawal by Subject|1
7876838|NCT01716169|12371844|FG000|Overall Study|inconsistent dressing application|1
7876839|NCT01716234|12371881|FG000|Overall Study|Protocol Violation|0
7876840|NCT01716234|12371882|FG001|Overall Study|Protocol Violation|0
7796948|NCT01072149|12253288|FG011|Washout Period 2 (14 Days)|Physician Decision|0
7796949|NCT01072149|12253289|FG012|Washout Period 2 (14 Days)|Physician Decision|0
7796950|NCT01072149|12253290|FG013|Washout Period 2 (14 Days)|Physician Decision|0
7796951|NCT01072149|12253291|FG014|Washout Period 2 (14 Days)|Physician Decision|0
7796952|NCT01072149|12253292|FG015|Washout Period 2 (14 Days)|Physician Decision|0
7796953|NCT01072149|12253293|FG016|Washout Period 2 (14 Days)|Physician Decision|0
7796954|NCT01072149|12253294|FG017|Washout Period 2 (14 Days)|Physician Decision|0
7796955|NCT01072149|12253277|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796956|NCT01072149|12253278|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796957|NCT01072149|12253279|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796958|NCT01072149|12253280|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796959|NCT01072149|12253281|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796960|NCT01072149|12253282|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796961|NCT01072149|12253283|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796962|NCT01072149|12253284|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796963|NCT01072149|12253285|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796964|NCT01072149|12253286|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796965|NCT01072149|12253287|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796966|NCT01072149|12253288|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796967|NCT01072149|12253289|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796968|NCT01072149|12253290|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796969|NCT01072149|12253291|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796970|NCT01072149|12253292|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1
7796971|NCT01072149|12253293|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7876841|NCT01716234|12371883|FG002|Overall Study|Protocol Violation|0
7876842|NCT01716234|12371884|FG003|Overall Study|Protocol Violation|1
7876843|NCT01716234|12371885|FG004|Overall Study|Protocol Violation|1
7876844|NCT01716234|12371886|FG005|Overall Study|Protocol Violation|1
7876845|NCT01716234|12371887|FG006|Overall Study|Protocol Violation|0
7876846|NCT01716234|12371881|FG000|Overall Study|Lack of Efficacy|0
7876847|NCT01716234|12371882|FG001|Overall Study|Lack of Efficacy|0
7876848|NCT01716234|12371883|FG002|Overall Study|Lack of Efficacy|0
7876849|NCT01716234|12371884|FG003|Overall Study|Lack of Efficacy|1
7876850|NCT01716234|12371885|FG004|Overall Study|Lack of Efficacy|0
7876851|NCT01716234|12371886|FG005|Overall Study|Lack of Efficacy|0
7876852|NCT01716234|12371887|FG006|Overall Study|Lack of Efficacy|0
7876853|NCT01716234|12371881|FG000|Overall Study|Did not meet protocol eligibility|0
7876854|NCT01716234|12371882|FG001|Overall Study|Did not meet protocol eligibility|0
7876855|NCT01716234|12371883|FG002|Overall Study|Did not meet protocol eligibility|1
7876856|NCT01716234|12371884|FG003|Overall Study|Did not meet protocol eligibility|0
7876857|NCT01716234|12371885|FG004|Overall Study|Did not meet protocol eligibility|0
7876858|NCT01716234|12371886|FG005|Overall Study|Did not meet protocol eligibility|4
7876859|NCT01716234|12371887|FG006|Overall Study|Did not meet protocol eligibility|0
7876860|NCT01716234|12371881|FG000|Overall Study|Adverse Event|7
7876861|NCT01716234|12371882|FG001|Overall Study|Adverse Event|10
7876862|NCT01716234|12371883|FG002|Overall Study|Adverse Event|2
7876863|NCT01716234|12371884|FG003|Overall Study|Adverse Event|8
7876864|NCT01716234|12371885|FG004|Overall Study|Adverse Event|3
7876865|NCT01716234|12371886|FG005|Overall Study|Adverse Event|6
7876866|NCT01716234|12371887|FG006|Overall Study|Adverse Event|0
7876867|NCT01716234|12371881|FG000|Overall Study|Withdrawal by Subject|3
7876868|NCT01716234|12371882|FG001|Overall Study|Withdrawal by Subject|0
7876869|NCT01716234|12371883|FG002|Overall Study|Withdrawal by Subject|2
7876870|NCT01716234|12371884|FG003|Overall Study|Withdrawal by Subject|2
7876871|NCT01716234|12371885|FG004|Overall Study|Withdrawal by Subject|1
7876872|NCT01716234|12371886|FG005|Overall Study|Withdrawal by Subject|3
7876873|NCT01716234|12371887|FG006|Overall Study|Withdrawal by Subject|0
7876874|NCT01716520|12371929|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
7876875|NCT01716520|12371930|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
7876876|NCT01716520|12371931|FG002|Treatment Period 1 (14 Days)|Adverse Event|0
7876877|NCT01716520|12371932|FG003|Treatment Period 1 (14 Days)|Adverse Event|0
7876878|NCT01716520|12371933|FG004|Treatment Period 1 (14 Days)|Adverse Event|0
7876879|NCT01716520|12371934|FG005|Treatment Period 1 (14 Days)|Adverse Event|0
7876880|NCT01716520|12371929|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
7876881|NCT01716520|12371930|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
7876882|NCT01716520|12371931|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
7876883|NCT01716520|12371932|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
7876884|NCT01716520|12371933|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
7876885|NCT01716520|12371934|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
7876886|NCT01716520|12371929|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7876887|NCT01716520|12371930|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7876888|NCT01716520|12371931|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7876889|NCT01716520|12371932|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7876890|NCT01716520|12371933|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7876891|NCT01716520|12371934|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7876892|NCT01716520|12371929|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7876893|NCT01716520|12371930|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1
7876894|NCT01716520|12371931|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7876895|NCT01716520|12371932|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7876896|NCT01716520|12371933|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7876897|NCT01716520|12371934|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7876898|NCT01716520|12371929|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7876899|NCT01716520|12371930|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7876900|NCT01716520|12371931|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7876901|NCT01716520|12371932|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7876902|NCT01716520|12371933|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7876903|NCT01716520|12371934|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
7876904|NCT01716520|12371929|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
7876905|NCT01716520|12371930|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
7876906|NCT01716520|12371931|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
7876907|NCT01716520|12371932|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
7876908|NCT01716520|12371933|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
7876909|NCT01716520|12371934|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
7876910|NCT01716520|12371929|FG000|Treatment Period 2 (14 Days)|Adverse Event|0
7876911|NCT01716520|12371930|FG001|Treatment Period 2 (14 Days)|Adverse Event|0
7876912|NCT01716520|12371931|FG002|Treatment Period 2 (14 Days)|Adverse Event|0
7876913|NCT01716520|12371932|FG003|Treatment Period 2 (14 Days)|Adverse Event|0
7876914|NCT01716520|12371933|FG004|Treatment Period 2 (14 Days)|Adverse Event|1
7876915|NCT01716520|12371934|FG005|Treatment Period 2 (14 Days)|Adverse Event|0
7876916|NCT01716520|12371929|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0
7876917|NCT01716520|12371930|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0
7876918|NCT01716520|12371931|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0
7876919|NCT01716520|12371932|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0
7876920|NCT01716520|12371933|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1
7876921|NCT01716520|12371934|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0
7876922|NCT01716520|12371929|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7876923|NCT01716520|12371930|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7876924|NCT01716520|12371931|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7876925|NCT01716520|12371932|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
7876926|NCT01716520|12371933|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7876927|NCT01716520|12371934|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7876928|NCT01716520|12371929|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1
7876929|NCT01716520|12371930|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0
7876930|NCT01716520|12371931|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1
7876931|NCT01716520|12371932|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0
7876932|NCT01716520|12371933|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0
7876933|NCT01716520|12371934|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1
7876934|NCT01716520|12371929|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
7876935|NCT01716520|12371930|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7876936|NCT01716520|12371931|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7876937|NCT01716520|12371932|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7876938|NCT01716520|12371933|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7876939|NCT01716520|12371934|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7876940|NCT01716520|12371929|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7876941|NCT01716520|12371930|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7876942|NCT01716520|12371931|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7876943|NCT01716520|12371932|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7876944|NCT01716520|12371933|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7876945|NCT01716520|12371934|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
7876946|NCT01716520|12371929|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7876947|NCT01716520|12371930|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
7876948|NCT01716520|12371931|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7876949|NCT01716520|12371932|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7876950|NCT01716520|12371933|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7876951|NCT01716520|12371934|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7876952|NCT01716520|12371929|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7876953|NCT01716520|12371930|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7876954|NCT01716520|12371931|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7876955|NCT01716520|12371932|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7876956|NCT01716520|12371933|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7876957|NCT01716520|12371934|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2
7876958|NCT01716520|12371929|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7876959|NCT01716520|12371930|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7876960|NCT01716520|12371931|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
7876961|NCT01716520|12371932|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7876962|NCT01716520|12371933|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7876963|NCT01716520|12371934|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7876964|NCT01716533|12371946|FG000|Overall Study|Failure of antibiotic treatment to treat|0
7876965|NCT01716533|12371947|FG001|Overall Study|Failure of antibiotic treatment to treat|0
7876966|NCT01716533|12371948|FG002|Overall Study|Failure of antibiotic treatment to treat|5
7876967|NCT01716533|12371949|FG003|Overall Study|Failure of antibiotic treatment to treat|0
7876968|NCT01716533|12371946|FG000|Overall Study|Withdrawal by Subject|0
7876969|NCT01716533|12371947|FG001|Overall Study|Withdrawal by Subject|0
7876970|NCT01716533|12371948|FG002|Overall Study|Withdrawal by Subject|0
7876971|NCT01716533|12371949|FG003|Overall Study|Withdrawal by Subject|5
7876972|NCT01716533|12371946|FG000|Overall Study|Death|0
7876973|NCT01716533|12371947|FG001|Overall Study|Death|0
7876974|NCT01716533|12371948|FG002|Overall Study|Death|0
7876975|NCT01716533|12371949|FG003|Overall Study|Death|2
7876976|NCT01716533|12371946|FG000|Overall Study|Immunosuppressants>14days past 6months|0
7876977|NCT01716533|12371947|FG001|Overall Study|Immunosuppressants>14days past 6months|0
7876978|NCT01716533|12371948|FG002|Overall Study|Immunosuppressants>14days past 6months|0
7876979|NCT01716533|12371949|FG003|Overall Study|Immunosuppressants>14days past 6months|1
7876980|NCT01716559|12371963|FG000|Overall Study|Adverse Event|11
7876981|NCT01716559|12371963|FG000|Overall Study|Death|21
7876982|NCT01716559|12371963|FG000|Overall Study|Withdrawal by Subject|4
7876983|NCT01716559|12371963|FG000|Overall Study|Other withdrawal reason|75
7876984|NCT01716585|12371969|FG000|Double-blind Treatment|Did Not Receive Study Drug|4
7876985|NCT01716585|12371970|FG001|Double-blind Treatment|Did Not Receive Study Drug|1
7876986|NCT01716585|12371969|FG000|Double-blind Treatment|Adverse Event|2
7876987|NCT01716585|12371970|FG001|Double-blind Treatment|Adverse Event|1
7876988|NCT01716585|12371969|FG000|Double-blind Treatment|Withdrawal by Subject|3
7876989|NCT01716585|12371970|FG001|Double-blind Treatment|Withdrawal by Subject|0
7876990|NCT01716585|12371969|FG000|Double-blind Treatment|Lost to Follow-up|2
7876991|NCT01716585|12371970|FG001|Double-blind Treatment|Lost to Follow-up|0
7876992|NCT01716585|12371969|FG000|Double-blind Treatment|Subject Noncompliant|1
7876993|NCT01716585|12371970|FG001|Double-blind Treatment|Subject Noncompliant|0
7876994|NCT01716585|12371969|FG000|Double-blind Treatment|Other|1
7876995|NCT01716585|12371970|FG001|Double-blind Treatment|Other|0
7876996|NCT01716585|12371969|FG000|Open-label Treatment|Adverse Event|0
7876997|NCT01716585|12371970|FG001|Open-label Treatment|Adverse Event|2
7876998|NCT01716585|12371969|FG000|Open-label Treatment|Virologic Failure|0
7876999|NCT01716585|12371970|FG001|Open-label Treatment|Virologic Failure|2
7877000|NCT01716585|12371969|FG000|Open-label Treatment|Withdrawal by Subject|0
7877001|NCT01716585|12371970|FG001|Open-label Treatment|Withdrawal by Subject|3
7877002|NCT01716663|12371977|FG000|Overall Study|Withdrawn prior to procedure|4
7877003|NCT01716663|12371977|FG000|Overall Study|Treated with non-study catheter|2
7877004|NCT01716715|12371983|FG000|Overall Study|Never Treated|2
7877005|NCT01716715|12371984|FG001|Overall Study|Never Treated|4
7877006|NCT01716754|12371996|FG000|Overall Study|Death|0
7877007|NCT01716754|12371997|FG001|Overall Study|Death|0
7877008|NCT01716754|12371998|FG002|Overall Study|Death|0
7877009|NCT01716754|12371999|FG003|Overall Study|Death|1
7877010|NCT01716754|12371996|FG000|Overall Study|Protocol deviation|0
7877011|NCT01716754|12371997|FG001|Overall Study|Protocol deviation|2
7877012|NCT01716754|12371998|FG002|Overall Study|Protocol deviation|7
7877013|NCT01716754|12371999|FG003|Overall Study|Protocol deviation|2
7877014|NCT01716754|12371996|FG000|Overall Study|Non-compliance with study treatment|0
7877015|NCT01716754|12371997|FG001|Overall Study|Non-compliance with study treatment|0
7877016|NCT01716754|12371998|FG002|Overall Study|Non-compliance with study treatment|1
7877017|NCT01716754|12371999|FG003|Overall Study|Non-compliance with study treatment|0
7877018|NCT01716754|12371996|FG000|Overall Study|Physician Decision|1
7877019|NCT01716754|12371997|FG001|Overall Study|Physician Decision|0
7877020|NCT01716754|12371998|FG002|Overall Study|Physician Decision|0
7877021|NCT01716754|12371999|FG003|Overall Study|Physician Decision|0
7877022|NCT01716754|12371996|FG000|Overall Study|Lost to Follow-up|1
7877023|NCT01716754|12371997|FG001|Overall Study|Lost to Follow-up|0
7877024|NCT01716754|12371998|FG002|Overall Study|Lost to Follow-up|0
7877025|NCT01716754|12371999|FG003|Overall Study|Lost to Follow-up|1
7877026|NCT01716754|12371996|FG000|Overall Study|Adverse Event|4
7877027|NCT01716754|12371997|FG001|Overall Study|Adverse Event|2
7877028|NCT01716754|12371998|FG002|Overall Study|Adverse Event|2
7877029|NCT01716754|12371999|FG003|Overall Study|Adverse Event|1
7877030|NCT01716754|12371996|FG000|Overall Study|Withdrawal by Subject|5
7877031|NCT01716754|12371997|FG001|Overall Study|Withdrawal by Subject|0
7877032|NCT01716754|12371998|FG002|Overall Study|Withdrawal by Subject|4
7877033|NCT01716754|12371999|FG003|Overall Study|Withdrawal by Subject|3
7877034|NCT01717040|12372023|FG000|Overall Study|Lost to Follow-up|2
7877035|NCT01717040|12372024|FG001|Overall Study|Lost to Follow-up|3
7877036|NCT01717040|12372023|FG000|Overall Study|Lack of Efficacy|1
7877037|NCT01717040|12372024|FG001|Overall Study|Lack of Efficacy|1
7877038|NCT01717040|12372023|FG000|Overall Study|Adverse Event|1
7877039|NCT01717040|12372024|FG001|Overall Study|Adverse Event|0
7877040|NCT01717040|12372023|FG000|Overall Study|Required Medication Change|0
7877041|NCT01717040|12372024|FG001|Overall Study|Required Medication Change|1
7877042|NCT01717040|12372023|FG000|Overall Study|New Substance Use Disorder|1
7877043|NCT01717040|12372024|FG001|Overall Study|New Substance Use Disorder|0
7882975|NCT01777542|12382365|FG001|Second Intervention (20 Weeks)|Adverse Event|1
7882976|NCT01777581|12382383|FG000|Overall Study|Lost to Follow-up|1
7882977|NCT01777581|12382384|FG001|Overall Study|Lost to Follow-up|1
7882978|NCT01777581|12382383|FG000|Overall Study|Adverse Event|2
7882979|NCT01777581|12382384|FG001|Overall Study|Adverse Event|0
7882980|NCT01777581|12382383|FG000|Overall Study|Lack of Efficacy|0
7882981|NCT01777581|12382384|FG001|Overall Study|Lack of Efficacy|1
7882982|NCT01777620|12382392|FG000|Overall Study|Subject Withdrawal|1
7882983|NCT01777620|12382393|FG001|Overall Study|Subject Withdrawal|0
7882984|NCT01777763|12382401|FG000|Overall Study|Adverse Event|2
7882985|NCT01777763|12382402|FG001|Overall Study|Adverse Event|32
7882986|NCT01777763|12382401|FG000|Overall Study|Protocol Violation|1
7882987|NCT01777763|12382402|FG001|Overall Study|Protocol Violation|7
7882988|NCT01777763|12382401|FG000|Overall Study|Withdrawal by Subject|0
7882989|NCT01777763|12382402|FG001|Overall Study|Withdrawal by Subject|2
7882990|NCT01777763|12382401|FG000|Overall Study|Treatment Failure|1
7882991|NCT01777763|12382402|FG001|Overall Study|Treatment Failure|6
7882992|NCT01777776|12382412|FG000|Overall Study|Adverse Event|2
7882993|NCT01777776|12382413|FG001|Overall Study|Adverse Event|4
7882994|NCT01777776|12382414|FG002|Overall Study|Adverse Event|0
7877044|NCT01717287|12372040|FG000|Overall Study|Lost to Follow-up|0
7877045|NCT01717287|12372041|FG001|Overall Study|Lost to Follow-up|2
7877046|NCT01717287|12372040|FG000|Overall Study|Protocol Violation|0
7877047|NCT01717287|12372041|FG001|Overall Study|Protocol Violation|1
7877048|NCT01717313|12372049|FG000|Phase A (Weeks 0 to 24)|Death|0
7877049|NCT01717313|12372050|FG001|Phase A (Weeks 0 to 24)|Death|1
7877050|NCT01717313|12372049|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
7877051|NCT01717313|12372050|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
7877052|NCT01717313|12372049|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
7877053|NCT01717313|12372050|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
7877054|NCT01717313|12372049|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4
7877055|NCT01717313|12372050|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2
7877056|NCT01717313|12372049|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
7877057|NCT01717313|12372050|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
7877058|NCT01717313|12372049|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1
7877059|NCT01717313|12372050|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0
7877060|NCT01717313|12372049|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
7877061|NCT01717313|12372050|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
7877062|NCT01717313|12372049|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
7877063|NCT01717313|12372050|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
7877064|NCT01717313|12372049|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
7877065|NCT01717313|12372050|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
7877066|NCT01717326|12372076|FG000|Overall Study|Death|0
7877067|NCT01717326|12372077|FG001|Overall Study|Death|0
7877068|NCT01717326|12372078|FG002|Overall Study|Death|0
7877069|NCT01717326|12372079|FG003|Overall Study|Death|0
7877070|NCT01717326|12372080|FG004|Overall Study|Death|0
7877071|NCT01717326|12372081|FG005|Overall Study|Death|0
7877072|NCT01717326|12372082|FG006|Overall Study|Death|0
7877073|NCT01717326|12372083|FG007|Overall Study|Death|0
7877074|NCT01717326|12372084|FG008|Overall Study|Death|0
7877075|NCT01717326|12372085|FG009|Overall Study|Death|0
7877076|NCT01717326|12372086|FG010|Overall Study|Death|1
7877077|NCT01717326|12372087|FG011|Overall Study|Death|0
7877078|NCT01717326|12372088|FG012|Overall Study|Death|0
7877079|NCT01717326|12372089|FG013|Overall Study|Death|0
7877080|NCT01717326|12372090|FG014|Overall Study|Death|0
7877081|NCT01717326|12372091|FG015|Overall Study|Death|0
7877082|NCT01717326|12372092|FG016|Overall Study|Death|0
7877083|NCT01717326|12372093|FG017|Overall Study|Death|0
7877084|NCT01717326|12372094|FG018|Overall Study|Death|0
7877085|NCT01717326|12372095|FG019|Overall Study|Death|0
7877086|NCT01717326|12372076|FG000|Overall Study|Lost to Follow-up|3
7877087|NCT01717326|12372077|FG001|Overall Study|Lost to Follow-up|0
7877088|NCT01717326|12372078|FG002|Overall Study|Lost to Follow-up|0
7877089|NCT01717326|12372079|FG003|Overall Study|Lost to Follow-up|2
7877090|NCT01717326|12372080|FG004|Overall Study|Lost to Follow-up|1
7877091|NCT01717326|12372081|FG005|Overall Study|Lost to Follow-up|0
7877092|NCT01717326|12372082|FG006|Overall Study|Lost to Follow-up|1
7877093|NCT01717326|12372083|FG007|Overall Study|Lost to Follow-up|0
7877094|NCT01717326|12372084|FG008|Overall Study|Lost to Follow-up|0
7877095|NCT01717326|12372085|FG009|Overall Study|Lost to Follow-up|0
7877096|NCT01717326|12372086|FG010|Overall Study|Lost to Follow-up|1
7877097|NCT01717326|12372087|FG011|Overall Study|Lost to Follow-up|0
7877098|NCT01717326|12372088|FG012|Overall Study|Lost to Follow-up|0
7877099|NCT01717326|12372089|FG013|Overall Study|Lost to Follow-up|0
7877100|NCT01717326|12372090|FG014|Overall Study|Lost to Follow-up|0
7877101|NCT01717326|12372091|FG015|Overall Study|Lost to Follow-up|2
7877102|NCT01717326|12372092|FG016|Overall Study|Lost to Follow-up|1
7877103|NCT01717326|12372093|FG017|Overall Study|Lost to Follow-up|0
7877104|NCT01717326|12372094|FG018|Overall Study|Lost to Follow-up|2
7877105|NCT01717326|12372095|FG019|Overall Study|Lost to Follow-up|3
7877106|NCT01717326|12372076|FG000|Overall Study|Physician Decision|0
7877107|NCT01717326|12372077|FG001|Overall Study|Physician Decision|0
7877108|NCT01717326|12372078|FG002|Overall Study|Physician Decision|0
7877109|NCT01717326|12372079|FG003|Overall Study|Physician Decision|0
7877110|NCT01717326|12372080|FG004|Overall Study|Physician Decision|0
7877111|NCT01717326|12372081|FG005|Overall Study|Physician Decision|0
7877112|NCT01717326|12372082|FG006|Overall Study|Physician Decision|0
7877113|NCT01717326|12372083|FG007|Overall Study|Physician Decision|0
7877114|NCT01717326|12372084|FG008|Overall Study|Physician Decision|0
7877115|NCT01717326|12372085|FG009|Overall Study|Physician Decision|1
7877116|NCT01717326|12372086|FG010|Overall Study|Physician Decision|0
7877117|NCT01717326|12372087|FG011|Overall Study|Physician Decision|0
7877118|NCT01717326|12372088|FG012|Overall Study|Physician Decision|0
7877119|NCT01717326|12372089|FG013|Overall Study|Physician Decision|0
7877120|NCT01717326|12372090|FG014|Overall Study|Physician Decision|0
7877121|NCT01717326|12372091|FG015|Overall Study|Physician Decision|0
7877122|NCT01717326|12372092|FG016|Overall Study|Physician Decision|0
7877123|NCT01717326|12372093|FG017|Overall Study|Physician Decision|0
7877124|NCT01717326|12372094|FG018|Overall Study|Physician Decision|0
7877125|NCT01717326|12372095|FG019|Overall Study|Physician Decision|0
7877126|NCT01717326|12372076|FG000|Overall Study|Protocol Violation|0
7877127|NCT01717326|12372077|FG001|Overall Study|Protocol Violation|0
7877128|NCT01717326|12372078|FG002|Overall Study|Protocol Violation|0
7877129|NCT01717326|12372079|FG003|Overall Study|Protocol Violation|0
7877130|NCT01717326|12372080|FG004|Overall Study|Protocol Violation|1
7877131|NCT01717326|12372081|FG005|Overall Study|Protocol Violation|0
7877132|NCT01717326|12372082|FG006|Overall Study|Protocol Violation|0
7877133|NCT01717326|12372083|FG007|Overall Study|Protocol Violation|0
7877134|NCT01717326|12372084|FG008|Overall Study|Protocol Violation|0
7877135|NCT01717326|12372085|FG009|Overall Study|Protocol Violation|0
7877136|NCT01717326|12372086|FG010|Overall Study|Protocol Violation|0
7877137|NCT01717326|12372087|FG011|Overall Study|Protocol Violation|0
7877138|NCT01717326|12372088|FG012|Overall Study|Protocol Violation|0
7877139|NCT01717326|12372089|FG013|Overall Study|Protocol Violation|0
7877140|NCT01717326|12372090|FG014|Overall Study|Protocol Violation|0
7877141|NCT01717326|12372091|FG015|Overall Study|Protocol Violation|0
7877142|NCT01717326|12372092|FG016|Overall Study|Protocol Violation|0
7877143|NCT01717326|12372093|FG017|Overall Study|Protocol Violation|0
7877144|NCT01717326|12372094|FG018|Overall Study|Protocol Violation|0
7877145|NCT01717326|12372095|FG019|Overall Study|Protocol Violation|0
7877146|NCT01717326|12372076|FG000|Overall Study|Withdrawal by Subject|0
7877147|NCT01717326|12372077|FG001|Overall Study|Withdrawal by Subject|1
7877148|NCT01717326|12372078|FG002|Overall Study|Withdrawal by Subject|0
7877149|NCT01717326|12372079|FG003|Overall Study|Withdrawal by Subject|0
7877150|NCT01717326|12372080|FG004|Overall Study|Withdrawal by Subject|0
7877151|NCT01717326|12372081|FG005|Overall Study|Withdrawal by Subject|0
7877152|NCT01717326|12372082|FG006|Overall Study|Withdrawal by Subject|0
7877153|NCT01717326|12372083|FG007|Overall Study|Withdrawal by Subject|0
7877154|NCT01717326|12372084|FG008|Overall Study|Withdrawal by Subject|0
7877155|NCT01717326|12372085|FG009|Overall Study|Withdrawal by Subject|1
7877156|NCT01717326|12372086|FG010|Overall Study|Withdrawal by Subject|0
7877157|NCT01717326|12372087|FG011|Overall Study|Withdrawal by Subject|0
7877158|NCT01717326|12372088|FG012|Overall Study|Withdrawal by Subject|1
7877159|NCT01717326|12372089|FG013|Overall Study|Withdrawal by Subject|0
7877160|NCT01717326|12372090|FG014|Overall Study|Withdrawal by Subject|0
7877161|NCT01717326|12372091|FG015|Overall Study|Withdrawal by Subject|1
7877162|NCT01717326|12372092|FG016|Overall Study|Withdrawal by Subject|0
7877163|NCT01717326|12372093|FG017|Overall Study|Withdrawal by Subject|0
7877164|NCT01717326|12372094|FG018|Overall Study|Withdrawal by Subject|2
7877165|NCT01717326|12372095|FG019|Overall Study|Withdrawal by Subject|3
7877166|NCT01717391|12372137|FG000|Overall Study|Withdrawal by Subject|5
7877167|NCT01717391|12372137|FG000|Overall Study|Physician Decision|1
7877168|NCT01717391|12372137|FG000|Overall Study|FLT technical failure|3
7877169|NCT01717456|12372145|FG000|End of Treatment|Physician Decision|0
7877170|NCT01717456|12372146|FG001|End of Treatment|Physician Decision|1
7877171|NCT01717456|12372145|FG000|End of Treatment|Lost to Follow-up|0
7877172|NCT01717456|12372146|FG001|End of Treatment|Lost to Follow-up|1
7877173|NCT01717456|12372145|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
7877174|NCT01717456|12372146|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
7877175|NCT01717638|12372170|FG000|Overall Study|Lost to Follow-up|0
7877176|NCT01717638|12372171|FG001|Overall Study|Lost to Follow-up|0
7877177|NCT01717638|12372172|FG002|Overall Study|Lost to Follow-up|0
7877178|NCT01717638|12372173|FG003|Overall Study|Lost to Follow-up|0
7877179|NCT01717638|12372174|FG004|Overall Study|Lost to Follow-up|0
7877180|NCT01717638|12372175|FG005|Overall Study|Lost to Follow-up|1
7877181|NCT01717638|12372176|FG006|Overall Study|Lost to Follow-up|0
7877182|NCT01717638|12372177|FG007|Overall Study|Lost to Follow-up|0
7877183|NCT01717638|12372178|FG008|Overall Study|Lost to Follow-up|0
7877184|NCT01717638|12372179|FG009|Overall Study|Lost to Follow-up|0
7877185|NCT01717638|12372180|FG010|Overall Study|Lost to Follow-up|0
7877186|NCT01717638|12372181|FG011|Overall Study|Lost to Follow-up|0
7877187|NCT01717638|12372182|FG012|Overall Study|Lost to Follow-up|0
7877188|NCT01717638|12372170|FG000|Overall Study|Father in hospital|0
7877189|NCT01717638|12372171|FG001|Overall Study|Father in hospital|0
7877190|NCT01717638|12372172|FG002|Overall Study|Father in hospital|0
7877191|NCT01717638|12372173|FG003|Overall Study|Father in hospital|0
7877192|NCT01717638|12372174|FG004|Overall Study|Father in hospital|0
7877193|NCT01717638|12372175|FG005|Overall Study|Father in hospital|0
7877194|NCT01717638|12372176|FG006|Overall Study|Father in hospital|0
7877195|NCT01717638|12372177|FG007|Overall Study|Father in hospital|0
7877196|NCT01717638|12372178|FG008|Overall Study|Father in hospital|0
7877197|NCT01717638|12372179|FG009|Overall Study|Father in hospital|0
7877198|NCT01717638|12372180|FG010|Overall Study|Father in hospital|0
7877199|NCT01717638|12372181|FG011|Overall Study|Father in hospital|0
7877200|NCT01717638|12372182|FG012|Overall Study|Father in hospital|1
7877201|NCT01717638|12372170|FG000|Overall Study|Withdrawal by Subject|0
7877202|NCT01717638|12372171|FG001|Overall Study|Withdrawal by Subject|1
7877203|NCT01717638|12372172|FG002|Overall Study|Withdrawal by Subject|1
7877204|NCT01717638|12372173|FG003|Overall Study|Withdrawal by Subject|0
7877205|NCT01717638|12372174|FG004|Overall Study|Withdrawal by Subject|1
7877206|NCT01717638|12372175|FG005|Overall Study|Withdrawal by Subject|0
7877207|NCT01717638|12372176|FG006|Overall Study|Withdrawal by Subject|2
7877208|NCT01717638|12372177|FG007|Overall Study|Withdrawal by Subject|1
7877209|NCT01717638|12372178|FG008|Overall Study|Withdrawal by Subject|2
7877210|NCT01717638|12372179|FG009|Overall Study|Withdrawal by Subject|1
7877211|NCT01717638|12372180|FG010|Overall Study|Withdrawal by Subject|0
7877212|NCT01717638|12372181|FG011|Overall Study|Withdrawal by Subject|0
7877213|NCT01717638|12372182|FG012|Overall Study|Withdrawal by Subject|18
7877214|NCT01717768|12372235|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7877215|NCT01717768|12372236|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
7877216|NCT01717768|12372237|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7877217|NCT01717768|12372238|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7877218|NCT01717768|12372239|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7877219|NCT01717768|12372240|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7877220|NCT01717768|12372241|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7877221|NCT01717768|12372242|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7877222|NCT01717768|12372243|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7877223|NCT01717768|12372244|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7877224|NCT01717768|12372245|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7877225|NCT01717768|12372246|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7877226|NCT01717768|12372235|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7877227|NCT01717768|12372236|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7877228|NCT01717768|12372237|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7877229|NCT01717768|12372238|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7877230|NCT01717768|12372239|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7877231|NCT01717768|12372240|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7882995|NCT01777776|12382415|FG003|Overall Study|Adverse Event|0
7877232|NCT01717768|12372241|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7877233|NCT01717768|12372242|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7877234|NCT01717768|12372243|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7877235|NCT01717768|12372244|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7877236|NCT01717768|12372245|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7877237|NCT01717768|12372246|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
7877238|NCT01717768|12372235|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7877239|NCT01717768|12372236|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7877240|NCT01717768|12372237|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7877241|NCT01717768|12372238|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7877242|NCT01717768|12372239|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7877243|NCT01717768|12372240|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7877244|NCT01717768|12372241|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7877245|NCT01717768|12372242|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
7877246|NCT01717768|12372243|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7877247|NCT01717768|12372244|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7877248|NCT01717768|12372245|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7877249|NCT01717768|12372246|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7877250|NCT01717768|12372235|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7877251|NCT01717768|12372236|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7877252|NCT01717768|12372237|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7877253|NCT01717768|12372238|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7877254|NCT01717768|12372239|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7877255|NCT01717768|12372240|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7877256|NCT01717768|12372241|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7877257|NCT01717768|12372242|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7877258|NCT01717768|12372243|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7877259|NCT01717768|12372244|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
7877260|NCT01717768|12372245|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7877261|NCT01717768|12372246|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7877262|NCT01717859|12372272|FG000|Overall Study|Adverse Event|5
7877263|NCT01717859|12372272|FG000|Overall Study|Moved out of state|1
7877264|NCT01717859|12372272|FG000|Overall Study|Patient concerned about mental health|1
7877265|NCT01717859|12372272|FG000|Overall Study|Lost to Follow-up|1
7877266|NCT01717859|12372272|FG000|Overall Study|Withdrawal by Subject|2
7877267|NCT01717976|12372311|FG000|Overall Study|Protocol Violation|0
7877268|NCT01717976|12372312|FG001|Overall Study|Protocol Violation|1
7877269|NCT01717989|12372318|FG000|Overall Study|Ineligibility determined|6
7877270|NCT01717989|12372318|FG000|Overall Study|Protocol deviation|6
7877271|NCT01717989|12372318|FG000|Overall Study|Withdrawal by Subject|11
7877272|NCT01717989|12372318|FG000|Overall Study|Physician Decision|2
7877273|NCT01717989|12372318|FG000|Overall Study|Lost to Follow-up|11
7877274|NCT01717989|12372318|FG000|Overall Study|Death|439
7877275|NCT01717989|12372318|FG000|Overall Study|Protocol-specified criteria|551
7877276|NCT01717989|12372318|FG000|Overall Study|Other|40
7877277|NCT01718353|12372348|FG000|Overall Study|Lost to Follow-up|0
7877278|NCT01718353|12372349|FG001|Overall Study|Lost to Follow-up|1
7877279|NCT01718353|12372348|FG000|Overall Study|Principal Investigator's Decision|10
7877280|NCT01718353|12372349|FG001|Overall Study|Principal Investigator's Decision|4
7877281|NCT01718353|12372348|FG000|Overall Study|Randomized but not treated|2
7877282|NCT01718353|12372349|FG001|Overall Study|Randomized but not treated|0
7877283|NCT01718483|12372359|FG000|Overall Study|Withdrawal by Subject|14
7877284|NCT01718483|12372360|FG001|Overall Study|Withdrawal by Subject|12
7877285|NCT01718483|12372359|FG000|Overall Study|Adverse Event|5
7877286|NCT01718483|12372360|FG001|Overall Study|Adverse Event|12
7877287|NCT01718483|12372359|FG000|Overall Study|Lost to Follow-up|8
7877288|NCT01718483|12372360|FG001|Overall Study|Lost to Follow-up|3
7877289|NCT01718483|12372359|FG000|Overall Study|Protocol Violation|4
7877290|NCT01718483|12372360|FG001|Overall Study|Protocol Violation|2
7877291|NCT01718483|12372359|FG000|Overall Study|Other|1
7877292|NCT01718483|12372360|FG001|Overall Study|Other|4
7877293|NCT01718483|12372359|FG000|Overall Study|Pregnancy|1
7877294|NCT01718483|12372360|FG001|Overall Study|Pregnancy|1
7877295|NCT01718483|12372359|FG000|Overall Study|Lack of Efficacy|1
7877296|NCT01718483|12372360|FG001|Overall Study|Lack of Efficacy|0
7877297|NCT01718509|12372368|FG000|Overall Study|Lost to Follow-up|18
7877298|NCT01718509|12372369|FG001|Overall Study|Lost to Follow-up|15
7877299|NCT01718509|12372368|FG000|Overall Study|Withdrawal by Subject|7
7877300|NCT01718509|12372369|FG001|Overall Study|Withdrawal by Subject|13
7877301|NCT01718509|12372368|FG000|Overall Study|Adverse Event|5
7877302|NCT01718509|12372369|FG001|Overall Study|Adverse Event|7
7877303|NCT01718509|12372368|FG000|Overall Study|Other|13
7877304|NCT01718509|12372369|FG001|Overall Study|Other|11
7877305|NCT01718509|12372368|FG000|Overall Study|Protocol Violation|4
7877306|NCT01718509|12372369|FG001|Overall Study|Protocol Violation|2
7877307|NCT01718509|12372368|FG000|Overall Study|Lack of Efficacy|1
7877308|NCT01718509|12372369|FG001|Overall Study|Lack of Efficacy|0
7877309|NCT01718535|12372392|FG000|Overall Study|Bidirectional Sequencing not possible|1
7877310|NCT01718535|12372393|FG001|Overall Study|Bidirectional Sequencing not possible|0
7877311|NCT01718535|12372394|FG002|Overall Study|Bidirectional Sequencing not possible|0
7877312|NCT01718535|12372395|FG003|Overall Study|Bidirectional Sequencing not possible|1
7877313|NCT01718535|12372396|FG004|Overall Study|Bidirectional Sequencing not possible|0
7877314|NCT01718535|12372397|FG005|Overall Study|Bidirectional Sequencing not possible|0
7877315|NCT01718535|12372398|FG006|Overall Study|Bidirectional Sequencing not possible|0
7877316|NCT01718535|12372399|FG007|Overall Study|Bidirectional Sequencing not possible|0
7796972|NCT01072149|12253294|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7796973|NCT01072149|12253277|FG000|Washout Period 2 (14 Days)|Adverse Event|0
7796974|NCT01072149|12253278|FG001|Washout Period 2 (14 Days)|Adverse Event|0
7796975|NCT01072149|12253279|FG002|Washout Period 2 (14 Days)|Adverse Event|0
7796976|NCT01072149|12253280|FG003|Washout Period 2 (14 Days)|Adverse Event|0
7796977|NCT01072149|12253281|FG004|Washout Period 2 (14 Days)|Adverse Event|0
7796978|NCT01072149|12253282|FG005|Washout Period 2 (14 Days)|Adverse Event|0
7796979|NCT01072149|12253283|FG006|Washout Period 2 (14 Days)|Adverse Event|0
7796980|NCT01072149|12253284|FG007|Washout Period 2 (14 Days)|Adverse Event|0
7796981|NCT01072149|12253285|FG008|Washout Period 2 (14 Days)|Adverse Event|0
7796982|NCT01072149|12253286|FG009|Washout Period 2 (14 Days)|Adverse Event|0
7796983|NCT01072149|12253287|FG010|Washout Period 2 (14 Days)|Adverse Event|0
7796984|NCT01072149|12253288|FG011|Washout Period 2 (14 Days)|Adverse Event|0
7796985|NCT01072149|12253289|FG012|Washout Period 2 (14 Days)|Adverse Event|0
7796986|NCT01072149|12253290|FG013|Washout Period 2 (14 Days)|Adverse Event|0
7796987|NCT01072149|12253291|FG014|Washout Period 2 (14 Days)|Adverse Event|0
7796988|NCT01072149|12253292|FG015|Washout Period 2 (14 Days)|Adverse Event|1
7796989|NCT01072149|12253293|FG016|Washout Period 2 (14 Days)|Adverse Event|0
7796990|NCT01072149|12253294|FG017|Washout Period 2 (14 Days)|Adverse Event|0
7796991|NCT01072149|12253277|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0
7796992|NCT01072149|12253278|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0
7796993|NCT01072149|12253279|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0
7796994|NCT01072149|12253280|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0
7796995|NCT01072149|12253281|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0
7796996|NCT01072149|12253282|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0
7796997|NCT01072149|12253283|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0
7796998|NCT01072149|12253284|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0
7796999|NCT01072149|12253285|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0
7797000|NCT01072149|12253286|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0
7797001|NCT01072149|12253287|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0
7797002|NCT01072149|12253288|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0
7797003|NCT01072149|12253289|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1
7797004|NCT01072149|12253290|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0
7797005|NCT01072149|12253291|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0
7797006|NCT01072149|12253292|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0
7797007|NCT01072149|12253293|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0
7797008|NCT01072149|12253294|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0
7797009|NCT01072149|12253277|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7797010|NCT01072149|12253278|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7797011|NCT01072149|12253279|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
7797012|NCT01072149|12253280|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7797013|NCT01072149|12253281|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7797014|NCT01072149|12253282|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7797015|NCT01072149|12253283|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7797016|NCT01072149|12253284|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7797017|NCT01072149|12253285|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7797018|NCT01072149|12253286|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7797019|NCT01072149|12253287|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7797020|NCT01072149|12253288|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7797021|NCT01072149|12253289|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7877317|NCT01718535|12372400|FG008|Overall Study|Bidirectional Sequencing not possible|0
7877318|NCT01718535|12372401|FG009|Overall Study|Bidirectional Sequencing not possible|0
7877319|NCT01719003|12372445|FG000|Overall Study|Non compliant with protocol|1
7877320|NCT01719003|12372446|FG001|Overall Study|Non compliant with protocol|1
7877321|NCT01719003|12372447|FG002|Overall Study|Non compliant with protocol|0
7877322|NCT01719003|12372448|FG003|Overall Study|Non compliant with protocol|1
7877323|NCT01719003|12372449|FG004|Overall Study|Non compliant with protocol|2
7877324|NCT01719003|12372450|FG005|Overall Study|Non compliant with protocol|1
7877325|NCT01719003|12372451|FG006|Overall Study|Non compliant with protocol|2
7877326|NCT01719003|12372452|FG007|Overall Study|Non compliant with protocol|3
7877327|NCT01719003|12372453|FG008|Overall Study|Non compliant with protocol|0
7877328|NCT01719003|12372445|FG000|Overall Study|Adverse Event|6
7877329|NCT01719003|12372446|FG001|Overall Study|Adverse Event|5
7877330|NCT01719003|12372447|FG002|Overall Study|Adverse Event|4
7877331|NCT01719003|12372448|FG003|Overall Study|Adverse Event|3
7877332|NCT01719003|12372449|FG004|Overall Study|Adverse Event|4
7877333|NCT01719003|12372450|FG005|Overall Study|Adverse Event|3
7877334|NCT01719003|12372451|FG006|Overall Study|Adverse Event|6
7877335|NCT01719003|12372452|FG007|Overall Study|Adverse Event|5
7877336|NCT01719003|12372453|FG008|Overall Study|Adverse Event|0
7877337|NCT01719003|12372445|FG000|Overall Study|Lost to Follow-up|0
7877338|NCT01719003|12372446|FG001|Overall Study|Lost to Follow-up|6
7877339|NCT01719003|12372447|FG002|Overall Study|Lost to Follow-up|7
7877340|NCT01719003|12372448|FG003|Overall Study|Lost to Follow-up|2
7877341|NCT01719003|12372449|FG004|Overall Study|Lost to Follow-up|3
7877342|NCT01719003|12372450|FG005|Overall Study|Lost to Follow-up|4
7877343|NCT01719003|12372451|FG006|Overall Study|Lost to Follow-up|3
7877344|NCT01719003|12372452|FG007|Overall Study|Lost to Follow-up|2
7877345|NCT01719003|12372453|FG008|Overall Study|Lost to Follow-up|2
7877346|NCT01719003|12372445|FG000|Overall Study|Refusal to continue, not due to AE|2
7877347|NCT01719003|12372446|FG001|Overall Study|Refusal to continue, not due to AE|5
7877348|NCT01719003|12372447|FG002|Overall Study|Refusal to continue, not due to AE|4
7877349|NCT01719003|12372448|FG003|Overall Study|Refusal to continue, not due to AE|4
7877350|NCT01719003|12372449|FG004|Overall Study|Refusal to continue, not due to AE|4
7877351|NCT01719003|12372450|FG005|Overall Study|Refusal to continue, not due to AE|3
7877352|NCT01719003|12372451|FG006|Overall Study|Refusal to continue, not due to AE|8
7877353|NCT01719003|12372452|FG007|Overall Study|Refusal to continue, not due to AE|7
7877354|NCT01719003|12372453|FG008|Overall Study|Refusal to continue, not due to AE|1
7877355|NCT01719003|12372445|FG000|Overall Study|Reason other than those specified|0
7877356|NCT01719003|12372446|FG001|Overall Study|Reason other than those specified|0
7877357|NCT01719003|12372447|FG002|Overall Study|Reason other than those specified|2
7877358|NCT01719003|12372448|FG003|Overall Study|Reason other than those specified|3
7877359|NCT01719003|12372449|FG004|Overall Study|Reason other than those specified|4
7877360|NCT01719003|12372450|FG005|Overall Study|Reason other than those specified|1
7877361|NCT01719003|12372451|FG006|Overall Study|Reason other than those specified|0
7877362|NCT01719003|12372452|FG007|Overall Study|Reason other than those specified|3
7877363|NCT01719003|12372453|FG008|Overall Study|Reason other than those specified|1
7877364|NCT01719003|12372445|FG000|Overall Study|Lack of Efficacy|0
7877365|NCT01719003|12372446|FG001|Overall Study|Lack of Efficacy|0
7877366|NCT01719003|12372447|FG002|Overall Study|Lack of Efficacy|0
7877367|NCT01719003|12372448|FG003|Overall Study|Lack of Efficacy|0
7877368|NCT01719003|12372449|FG004|Overall Study|Lack of Efficacy|0
7877369|NCT01719003|12372450|FG005|Overall Study|Lack of Efficacy|0
7877370|NCT01719003|12372451|FG006|Overall Study|Lack of Efficacy|1
7877371|NCT01719003|12372452|FG007|Overall Study|Lack of Efficacy|0
7877372|NCT01719003|12372453|FG008|Overall Study|Lack of Efficacy|0
7877373|NCT01719172|12372472|FG000|Overall Study|Lost to Follow-up|1
7877374|NCT01719172|12372472|FG000|Overall Study|Death|1
7877375|NCT01719224|12372476|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
7877376|NCT01719224|12372477|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
7877377|NCT01719380|12372503|FG000|Overall Study|Adverse Event|0
7877378|NCT01719380|12372504|FG001|Overall Study|Adverse Event|0
7877379|NCT01719380|12372505|FG002|Overall Study|Adverse Event|1
7877380|NCT01719380|12372506|FG003|Overall Study|Adverse Event|2
7877381|NCT01719380|12372507|FG004|Overall Study|Adverse Event|0
7877382|NCT01719380|12372508|FG005|Overall Study|Adverse Event|1
7877383|NCT01719380|12372509|FG006|Overall Study|Adverse Event|0
7877384|NCT01719380|12372510|FG007|Overall Study|Adverse Event|1
7877385|NCT01719380|12372511|FG008|Overall Study|Adverse Event|4
7877386|NCT01719380|12372512|FG009|Overall Study|Adverse Event|3
7877387|NCT01719380|12372503|FG000|Overall Study|Death|0
7877388|NCT01719380|12372504|FG001|Overall Study|Death|1
7877389|NCT01719380|12372505|FG002|Overall Study|Death|0
7877390|NCT01719380|12372506|FG003|Overall Study|Death|0
7877391|NCT01719380|12372507|FG004|Overall Study|Death|0
7877392|NCT01719380|12372508|FG005|Overall Study|Death|0
7877393|NCT01719380|12372509|FG006|Overall Study|Death|0
7877394|NCT01719380|12372510|FG007|Overall Study|Death|0
7877395|NCT01719380|12372511|FG008|Overall Study|Death|3
7877396|NCT01719380|12372512|FG009|Overall Study|Death|3
7877397|NCT01719380|12372503|FG000|Overall Study|Participant/Guardian Decision|0
7877398|NCT01719380|12372504|FG001|Overall Study|Participant/Guardian Decision|0
7877399|NCT01719380|12372505|FG002|Overall Study|Participant/Guardian Decision|1
7877400|NCT01719380|12372506|FG003|Overall Study|Participant/Guardian Decision|0
7877401|NCT01719380|12372507|FG004|Overall Study|Participant/Guardian Decision|0
7877402|NCT01719380|12372508|FG005|Overall Study|Participant/Guardian Decision|0
7877403|NCT01719380|12372509|FG006|Overall Study|Participant/Guardian Decision|0
7877404|NCT01719380|12372510|FG007|Overall Study|Participant/Guardian Decision|0
7877405|NCT01719380|12372511|FG008|Overall Study|Participant/Guardian Decision|2
7877406|NCT01719380|12372512|FG009|Overall Study|Participant/Guardian Decision|2
7877407|NCT01719380|12372503|FG000|Overall Study|Physician Decision|0
7877408|NCT01719380|12372504|FG001|Overall Study|Physician Decision|0
7877409|NCT01719380|12372505|FG002|Overall Study|Physician Decision|2
7877410|NCT01719380|12372506|FG003|Overall Study|Physician Decision|0
7877411|NCT01719380|12372507|FG004|Overall Study|Physician Decision|0
7877412|NCT01719380|12372508|FG005|Overall Study|Physician Decision|0
7877413|NCT01719380|12372509|FG006|Overall Study|Physician Decision|0
7877414|NCT01719380|12372510|FG007|Overall Study|Physician Decision|0
7877415|NCT01719380|12372511|FG008|Overall Study|Physician Decision|1
7877416|NCT01719380|12372512|FG009|Overall Study|Physician Decision|1
7877417|NCT01719380|12372503|FG000|Overall Study|Lack of Efficacy|2
7877418|NCT01719380|12372504|FG001|Overall Study|Lack of Efficacy|6
7877419|NCT01719380|12372505|FG002|Overall Study|Lack of Efficacy|5
7877420|NCT01719380|12372506|FG003|Overall Study|Lack of Efficacy|6
7877421|NCT01719380|12372507|FG004|Overall Study|Lack of Efficacy|3
7877422|NCT01719380|12372508|FG005|Overall Study|Lack of Efficacy|7
7877423|NCT01719380|12372509|FG006|Overall Study|Lack of Efficacy|10
7877424|NCT01719380|12372510|FG007|Overall Study|Lack of Efficacy|6
7877425|NCT01719380|12372511|FG008|Overall Study|Lack of Efficacy|39
7877426|NCT01719380|12372512|FG009|Overall Study|Lack of Efficacy|42
7877427|NCT01719380|12372503|FG000|Overall Study|Progressive Disease|0
7877428|NCT01719380|12372504|FG001|Overall Study|Progressive Disease|0
7877429|NCT01719380|12372505|FG002|Overall Study|Progressive Disease|0
7877430|NCT01719380|12372506|FG003|Overall Study|Progressive Disease|0
7877431|NCT01719380|12372507|FG004|Overall Study|Progressive Disease|0
7877432|NCT01719380|12372508|FG005|Overall Study|Progressive Disease|0
7877433|NCT01719380|12372509|FG006|Overall Study|Progressive Disease|0
7877434|NCT01719380|12372510|FG007|Overall Study|Progressive Disease|0
7877435|NCT01719380|12372511|FG008|Overall Study|Progressive Disease|1
7877436|NCT01719380|12372512|FG009|Overall Study|Progressive Disease|0
7877437|NCT01719757|12372562|FG000|Overall Study|Adverse Event|38
7877438|NCT01719757|12372562|FG000|Overall Study|Withdrawal by Subject|15
7877439|NCT01719757|12372562|FG000|Overall Study|Lost to Follow-up|20
7877440|NCT01719757|12372562|FG000|Overall Study|Protocol Violation|1
7877441|NCT01719757|12372562|FG000|Overall Study|well controlled pain|27
7877442|NCT01719783|12372570|FG000|Dose 2|Physician Decision|1
7877443|NCT01719783|12372571|FG001|Dose 2|Physician Decision|0
7877444|NCT01719861|12372597|FG000|Cycle 1|Death|4
7877445|NCT01719861|12372597|FG000|Cycle 2|Death|1
7877446|NCT01720043|12372611|FG000|Overall Study|Withdrawal by Subject|1
7877447|NCT01720069|12372618|FG000|Overall Study|Could not use e-diary correctly|0
7877448|NCT01720069|12372619|FG001|Overall Study|Could not use e-diary correctly|1
7877449|NCT01720069|12372620|FG002|Overall Study|Could not use e-diary correctly|1
7877450|NCT01720069|12372618|FG000|Overall Study|Randomised without baseline values|0
7877451|NCT01720069|12372619|FG001|Overall Study|Randomised without baseline values|0
7877452|NCT01720069|12372620|FG002|Overall Study|Randomised without baseline values|1
7877453|NCT01720069|12372618|FG000|Overall Study|Adverse Event|0
7877454|NCT01720069|12372619|FG001|Overall Study|Adverse Event|0
7877455|NCT01720069|12372620|FG002|Overall Study|Adverse Event|1
7877456|NCT01720069|12372618|FG000|Overall Study|Lack of Efficacy|0
7877457|NCT01720069|12372619|FG001|Overall Study|Lack of Efficacy|4
7877458|NCT01720069|12372620|FG002|Overall Study|Lack of Efficacy|0
7877459|NCT01720069|12372618|FG000|Overall Study|Treatment period withdrawal criteria met|4
7877460|NCT01720069|12372619|FG001|Overall Study|Treatment period withdrawal criteria met|8
7877461|NCT01720069|12372620|FG002|Overall Study|Treatment period withdrawal criteria met|9
7877462|NCT01720069|12372618|FG000|Overall Study|Withdrawal by Subject|0
7877463|NCT01720069|12372619|FG001|Overall Study|Withdrawal by Subject|2
7877464|NCT01720069|12372620|FG002|Overall Study|Withdrawal by Subject|1
7877465|NCT01720069|12372618|FG000|Overall Study|OCS bursts occured, discontinued in line|1
7877466|NCT01720069|12372619|FG001|Overall Study|OCS bursts occured, discontinued in line|0
7877467|NCT01720069|12372620|FG002|Overall Study|OCS bursts occured, discontinued in line|0
7877468|NCT01720069|12372618|FG000|Overall Study|Non-compliance on using e-diary|0
7877469|NCT01720069|12372619|FG001|Overall Study|Non-compliance on using e-diary|0
7877470|NCT01720069|12372620|FG002|Overall Study|Non-compliance on using e-diary|1
7877471|NCT01720069|12372618|FG000|Overall Study|Lost to Follow-up|0
7877472|NCT01720069|12372619|FG001|Overall Study|Lost to Follow-up|0
7877473|NCT01720069|12372620|FG002|Overall Study|Lost to Follow-up|1
7877474|NCT01720225|12372634|FG000|Overall Study|Withdrawal by Subject|0
7877475|NCT01720225|12372635|FG001|Overall Study|Withdrawal by Subject|1
7877476|NCT01720225|12372634|FG000|Overall Study|Did not complete 2 cycles of therapy|3
7877477|NCT01720225|12372635|FG001|Overall Study|Did not complete 2 cycles of therapy|0
7877478|NCT01720264|12372654|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1
7877479|NCT01720264|12372654|FG000|Post-transplant (Day 16) to 1 Year|Death|8
7877480|NCT01720264|12372654|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4
7877481|NCT01720446|12372708|FG000|Overall Study|Lost to Follow-up|12
7877482|NCT01720446|12372709|FG001|Overall Study|Lost to Follow-up|6
7877483|NCT01720446|12372710|FG002|Overall Study|Lost to Follow-up|16
7877484|NCT01720446|12372711|FG003|Overall Study|Lost to Follow-up|16
7877485|NCT01720446|12372708|FG000|Overall Study|Withdrawal by Subject|2
7877486|NCT01720446|12372709|FG001|Overall Study|Withdrawal by Subject|5
7877487|NCT01720446|12372710|FG002|Overall Study|Withdrawal by Subject|4
7877488|NCT01720446|12372711|FG003|Overall Study|Withdrawal by Subject|4
7877489|NCT01720524|12372726|FG000|Part A|Insufficient Clinical Response|2
7877490|NCT01720524|12372727|FG001|Part A|Insufficient Clinical Response|4
7877491|NCT01720524|12372726|FG000|Part A|Adverse Event|2
7877492|NCT01720524|12372727|FG001|Part A|Adverse Event|2
7877493|NCT01720524|12372726|FG000|Part A|Death|2
7877494|NCT01720524|12372727|FG001|Part A|Death|1
7877495|NCT01720524|12372726|FG000|Part A|Lost to Follow-up|0
7877496|NCT01720524|12372727|FG001|Part A|Lost to Follow-up|1
7877497|NCT01720524|12372726|FG000|Part A|Missed 28 day follow-up visit|1
7877498|NCT01720524|12372727|FG001|Part A|Missed 28 day follow-up visit|1
7877499|NCT01720524|12372726|FG000|Part A|Withdrawal by Subject|0
7877500|NCT01720524|12372727|FG001|Part A|Withdrawal by Subject|1
7877501|NCT01720524|12372726|FG000|Part A|Other|0
7877502|NCT01720524|12372727|FG001|Part A|Other|1
7877503|NCT01720524|12372726|FG000|Part A|Lost to Follow-up|0
7877504|NCT01720524|12372727|FG001|Part A|Lost to Follow-up|1
7877505|NCT01720524|12372726|FG000|Part B|No longer willing to participate in study|1
7877506|NCT01720524|12372727|FG001|Part B|No longer willing to participate in study|4
7877507|NCT01720524|12372726|FG000|Part B|Other|2
7877508|NCT01720524|12372727|FG001|Part B|Other|0
7877509|NCT01720524|12372726|FG000|Part B|Lost to Follow-up|2
7877510|NCT01720524|12372727|FG001|Part B|Lost to Follow-up|3
7877511|NCT01720524|12372726|FG000|Part B|Death|0
7877512|NCT01720524|12372727|FG001|Part B|Death|2
7877513|NCT01720602|12372735|FG000|Overall Study|Adverse Event|3
7877514|NCT01720602|12372735|FG000|Overall Study|Progressive disease on therapy|2
7877515|NCT01720667|12372741|FG000|Overall Study|Adverse Event|1
7877516|NCT01720667|12372742|FG001|Overall Study|Adverse Event|1
7877517|NCT01720667|12372741|FG000|Overall Study|Withdrawal by Subject|3
7877518|NCT01720667|12372742|FG001|Overall Study|Withdrawal by Subject|0
7877519|NCT01720797|12372752|FG000|Overall Study|Withdrawal by Subject|3
7877520|NCT01720797|12372753|FG001|Overall Study|Withdrawal by Subject|0
7877521|NCT01721044|12372762|FG000|Treatment Period|Adverse Event|7
7877522|NCT01721044|12372763|FG001|Treatment Period|Adverse Event|7
7877523|NCT01721044|12372764|FG002|Treatment Period|Adverse Event|10
7877524|NCT01721044|12372762|FG000|Treatment Period|Death|0
7877525|NCT01721044|12372763|FG001|Treatment Period|Death|0
7877526|NCT01721044|12372764|FG002|Treatment Period|Death|1
7877527|NCT01721044|12372762|FG000|Treatment Period|Lack of Efficacy|16
7877528|NCT01721044|12372763|FG001|Treatment Period|Lack of Efficacy|4
7877529|NCT01721044|12372764|FG002|Treatment Period|Lack of Efficacy|4
7877530|NCT01721044|12372762|FG000|Treatment Period|Lost to Follow-up|0
7877531|NCT01721044|12372763|FG001|Treatment Period|Lost to Follow-up|0
7877532|NCT01721044|12372764|FG002|Treatment Period|Lost to Follow-up|1
7877533|NCT01721044|12372762|FG000|Treatment Period|Physician Decision|1
7877534|NCT01721044|12372763|FG001|Treatment Period|Physician Decision|0
7877535|NCT01721044|12372764|FG002|Treatment Period|Physician Decision|2
7877536|NCT01721044|12372762|FG000|Treatment Period|Protocol Violation|1
7877537|NCT01721044|12372763|FG001|Treatment Period|Protocol Violation|0
7877538|NCT01721044|12372764|FG002|Treatment Period|Protocol Violation|0
7877539|NCT01721044|12372762|FG000|Treatment Period|Withdrawal by Subject|7
7877540|NCT01721044|12372763|FG001|Treatment Period|Withdrawal by Subject|6
7877541|NCT01721044|12372764|FG002|Treatment Period|Withdrawal by Subject|1
7877542|NCT01721057|12372786|FG000|Treatment Period|Withdrawal by Subject|11
7877543|NCT01721057|12372787|FG001|Treatment Period|Withdrawal by Subject|5
7877544|NCT01721057|12372788|FG002|Treatment Period|Withdrawal by Subject|8
7877545|NCT01721057|12372789|FG003|Treatment Period|Withdrawal by Subject|0
7877546|NCT01721057|12372790|FG004|Treatment Period|Withdrawal by Subject|0
7877547|NCT01721057|12372791|FG005|Treatment Period|Withdrawal by Subject|0
7877548|NCT01721057|12372792|FG006|Treatment Period|Withdrawal by Subject|0
7877549|NCT01721057|12372786|FG000|Treatment Period|Adverse Event|7
7877550|NCT01721057|12372787|FG001|Treatment Period|Adverse Event|10
7877551|NCT01721057|12372788|FG002|Treatment Period|Adverse Event|12
7877552|NCT01721057|12372789|FG003|Treatment Period|Adverse Event|0
7877553|NCT01721057|12372790|FG004|Treatment Period|Adverse Event|0
7877554|NCT01721057|12372791|FG005|Treatment Period|Adverse Event|0
7877555|NCT01721057|12372792|FG006|Treatment Period|Adverse Event|0
7877556|NCT01721057|12372786|FG000|Treatment Period|Lack of Efficacy|7
7877557|NCT01721057|12372787|FG001|Treatment Period|Lack of Efficacy|3
7877558|NCT01721057|12372788|FG002|Treatment Period|Lack of Efficacy|0
7877559|NCT01721057|12372789|FG003|Treatment Period|Lack of Efficacy|0
7877560|NCT01721057|12372790|FG004|Treatment Period|Lack of Efficacy|0
7877561|NCT01721057|12372791|FG005|Treatment Period|Lack of Efficacy|0
7877562|NCT01721057|12372792|FG006|Treatment Period|Lack of Efficacy|0
7877563|NCT01721057|12372786|FG000|Treatment Period|Lost to Follow-up|1
7877564|NCT01721057|12372787|FG001|Treatment Period|Lost to Follow-up|0
7877565|NCT01721057|12372788|FG002|Treatment Period|Lost to Follow-up|0
7877566|NCT01721057|12372789|FG003|Treatment Period|Lost to Follow-up|0
7877567|NCT01721057|12372790|FG004|Treatment Period|Lost to Follow-up|0
7877568|NCT01721057|12372791|FG005|Treatment Period|Lost to Follow-up|0
7877569|NCT01721057|12372792|FG006|Treatment Period|Lost to Follow-up|0
7877570|NCT01721057|12372786|FG000|Treatment Period|Physician Decision|0
7877571|NCT01721057|12372787|FG001|Treatment Period|Physician Decision|1
7877572|NCT01721057|12372788|FG002|Treatment Period|Physician Decision|3
7877573|NCT01721057|12372789|FG003|Treatment Period|Physician Decision|0
7877574|NCT01721057|12372790|FG004|Treatment Period|Physician Decision|0
7877575|NCT01721057|12372791|FG005|Treatment Period|Physician Decision|0
7877576|NCT01721057|12372792|FG006|Treatment Period|Physician Decision|0
7877577|NCT01721057|12372786|FG000|Treatment Period|Death|2
7877578|NCT01721057|12372787|FG001|Treatment Period|Death|0
7877579|NCT01721057|12372788|FG002|Treatment Period|Death|0
7877580|NCT01721057|12372789|FG003|Treatment Period|Death|0
7877581|NCT01721057|12372790|FG004|Treatment Period|Death|0
7877582|NCT01721057|12372791|FG005|Treatment Period|Death|0
7877583|NCT01721057|12372792|FG006|Treatment Period|Death|0
7877584|NCT01721057|12372786|FG000|Rescue Period|Adverse Event|0
7877585|NCT01721057|12372787|FG001|Rescue Period|Adverse Event|0
7877586|NCT01721057|12372788|FG002|Rescue Period|Adverse Event|0
7877587|NCT01721057|12372789|FG003|Rescue Period|Adverse Event|1
7877588|NCT01721057|12372790|FG004|Rescue Period|Adverse Event|0
7877589|NCT01721057|12372791|FG005|Rescue Period|Adverse Event|0
7877590|NCT01721057|12372792|FG006|Rescue Period|Adverse Event|0
7877591|NCT01721057|12372786|FG000|Rescue Period|Lack of Efficacy|0
7877592|NCT01721057|12372787|FG001|Rescue Period|Lack of Efficacy|0
7877593|NCT01721057|12372788|FG002|Rescue Period|Lack of Efficacy|0
7877594|NCT01721057|12372789|FG003|Rescue Period|Lack of Efficacy|2
7877595|NCT01721057|12372790|FG004|Rescue Period|Lack of Efficacy|0
7877596|NCT01721057|12372791|FG005|Rescue Period|Lack of Efficacy|0
7877597|NCT01721057|12372792|FG006|Rescue Period|Lack of Efficacy|0
7877598|NCT01721070|12372819|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
7877599|NCT01721109|12372837|FG000|Overall Study|Lack of Efficacy|1
7877600|NCT01721109|12372837|FG000|Overall Study|Non- Compliance with Study Drug|3
7877601|NCT01721109|12372837|FG000|Overall Study|Withdrew Consent|1
7877602|NCT01721109|12372837|FG000|Overall Study|Lost to Follow-up|2
7877603|NCT01721161|12372843|FG000|Overall Study|Adverse Event|2
7877604|NCT01721161|12372844|FG001|Overall Study|Adverse Event|3
7877605|NCT01721161|12372843|FG000|Overall Study|Lost to Follow-up|1
7877606|NCT01721161|12372844|FG001|Overall Study|Lost to Follow-up|2
7877607|NCT01721161|12372843|FG000|Overall Study|Withdrawal by Subject|1
7877608|NCT01721161|12372844|FG001|Overall Study|Withdrawal by Subject|1
7877609|NCT01721161|12372843|FG000|Overall Study|Other|0
7877610|NCT01721161|12372844|FG001|Overall Study|Other|1
7877611|NCT01721200|12372853|FG000|Overall Study|Lost to Follow-up|3
7877612|NCT01721200|12372854|FG001|Overall Study|Lost to Follow-up|5
7877613|NCT01721317|12372876|FG000|Overall Study|Study Closed / Terminated|2
7877614|NCT01721317|12372877|FG001|Overall Study|Study Closed / Terminated|2
7877615|NCT01721317|12372876|FG000|Overall Study|Physician Decision|0
7877616|NCT01721317|12372877|FG001|Overall Study|Physician Decision|1
7877617|NCT01721317|12372876|FG000|Overall Study|Withdrawal by Subject|0
7877618|NCT01721317|12372877|FG001|Overall Study|Withdrawal by Subject|1
7877619|NCT01721330|12372885|FG000|Overall Study|Withdrawal by Subject|0
7877620|NCT01721330|12372886|FG001|Overall Study|Withdrawal by Subject|1
7877621|NCT01721369|12372892|FG000|Overall Study|Not initial etiological diagnosis|12
7877622|NCT01721408|12372898|FG000|Overall Study|Adverse Event|6
7877623|NCT01721408|12372899|FG001|Overall Study|Adverse Event|1
7877624|NCT01721408|12372898|FG000|Overall Study|Death|1
7877625|NCT01721408|12372899|FG001|Overall Study|Death|0
7877626|NCT01721408|12372898|FG000|Overall Study|Insufficient clinical response|15
7877627|NCT01721408|12372899|FG001|Overall Study|Insufficient clinical response|6
7877628|NCT01721408|12372898|FG000|Overall Study|No longer willing to participate study|9
7877629|NCT01721408|12372899|FG001|Overall Study|No longer willing to participate study|10
7877630|NCT01721408|12372898|FG000|Overall Study|Protocol Violation|0
7877631|NCT01721408|12372899|FG001|Overall Study|Protocol Violation|2
7877632|NCT01721408|12372898|FG000|Overall Study|Other|3
7877633|NCT01721408|12372899|FG001|Overall Study|Other|3
7877634|NCT01721408|12372898|FG000|Overall Study|Lost to Follow-up|1
7877635|NCT01721408|12372899|FG001|Overall Study|Lost to Follow-up|2
7877636|NCT01721408|12372898|FG000|Overall Study|Does not meet entrance criteria|1
7877637|NCT01721408|12372899|FG001|Overall Study|Does not meet entrance criteria|0
7877638|NCT01721486|12372938|FG000|Overall Study|Protocol Violation|1
7877639|NCT01721486|12372939|FG001|Overall Study|Protocol Violation|0
7877640|NCT01721486|12372938|FG000|Overall Study|Physician Decision|0
7877641|NCT01721486|12372939|FG001|Overall Study|Physician Decision|1
7877642|NCT01721876|12372963|FG000|Overall Study|Not treated|1
7877643|NCT01721876|12372964|FG001|Overall Study|Not treated|4
7877644|NCT01721876|12372963|FG000|Overall Study|Disease progression / relapse|123
7877645|NCT01721876|12372964|FG001|Overall Study|Disease progression / relapse|156
7877646|NCT01721876|12372963|FG000|Overall Study|Death|6
7877647|NCT01721876|12372964|FG001|Overall Study|Death|13
7877648|NCT01721876|12372963|FG000|Overall Study|Adverse Event|41
7877649|NCT01721876|12372964|FG001|Overall Study|Adverse Event|165
7877650|NCT01721876|12372963|FG000|Overall Study|Protocol Violation|2
7877651|NCT01721876|12372964|FG001|Overall Study|Protocol Violation|1
7877652|NCT01721876|12372963|FG000|Overall Study|Withdrawal by Subject|15
7877653|NCT01721876|12372964|FG001|Overall Study|Withdrawal by Subject|38
7877654|NCT01721876|12372963|FG000|Overall Study|Reason not listed|34
7877655|NCT01721876|12372964|FG001|Overall Study|Reason not listed|63
7877656|NCT01721876|12372963|FG000|Overall Study|Sponsor terminated trial|0
7877657|NCT01721876|12372964|FG001|Overall Study|Sponsor terminated trial|4
7877658|NCT01721954|12372972|FG000|Overall Study|Death|58
7877659|NCT01721954|12372973|FG001|Overall Study|Death|64
7877660|NCT01721954|12372972|FG000|Overall Study|Withdrawal by Subject|8
7877661|NCT01721954|12372973|FG001|Overall Study|Withdrawal by Subject|4
7877662|NCT01721954|12372972|FG000|Overall Study|Adverse Event|2
7877663|NCT01721954|12372973|FG001|Overall Study|Adverse Event|0
7877664|NCT01721954|12372972|FG000|Overall Study|Lost to Follow-up|2
7877665|NCT01721954|12372973|FG001|Overall Study|Lost to Follow-up|1
7877666|NCT01722045|12372983|FG000|Overall Study|Adverse Event|8
7877667|NCT01722045|12372983|FG000|Overall Study|Death|3
7877668|NCT01722045|12372983|FG000|Overall Study|Withdrawal by Subject|8
7877669|NCT01722045|12372983|FG000|Overall Study|Lost to Follow-up|4
7877670|NCT01722045|12372983|FG000|Overall Study|Protocol Deviation|1
7877671|NCT01722045|12372983|FG000|Overall Study|Physician Decision|3
7877672|NCT01722045|12372983|FG000|Overall Study|Relocation (did not wish to transfer)|1
7877673|NCT01722071|12372987|FG000|Overall Study|Protocol Violation|1
7877674|NCT01722071|12372988|FG001|Overall Study|Protocol Violation|0
7877675|NCT01722097|12372996|FG000|Overall Study|Patient sheets not returned|6
7877676|NCT01722097|12372997|FG001|Overall Study|Patient sheets not returned|5
7877677|NCT01722162|12373005|FG000|Overall Study|Withdrawal by Subject|1
7877678|NCT01722162|12373006|FG001|Overall Study|Withdrawal by Subject|1
7877679|NCT01722162|12373005|FG000|Overall Study|Found ineligible|1
7877680|NCT01722162|12373006|FG001|Overall Study|Found ineligible|0
7877681|NCT01722162|12373005|FG000|Overall Study|Unrelated to study adverse event|2
7877682|NCT01722162|12373006|FG001|Overall Study|Unrelated to study adverse event|2
7877683|NCT01722162|12373005|FG000|Overall Study|Adverse Event|1
7877684|NCT01722162|12373006|FG001|Overall Study|Adverse Event|1
7877685|NCT01722162|12373005|FG000|Overall Study|Insurance denial post enrollment|0
7877686|NCT01722162|12373006|FG001|Overall Study|Insurance denial post enrollment|1
7877687|NCT01722162|12373005|FG000|Overall Study|Noncompliance|0
7877688|NCT01722162|12373006|FG001|Overall Study|Noncompliance|1
7877689|NCT01722266|12373016|FG000|Overall Study|Withdrawal by Subject|1
7877690|NCT01722266|12373017|FG001|Overall Study|Withdrawal by Subject|2
7877691|NCT01722266|12373018|FG002|Overall Study|Withdrawal by Subject|0
7877692|NCT01722266|12373019|FG003|Overall Study|Withdrawal by Subject|0
7877693|NCT01722266|12373016|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0
7877694|NCT01722266|12373017|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1
7877695|NCT01722266|12373018|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3
7877696|NCT01722266|12373019|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0
7877697|NCT01722266|12373016|FG000|Overall Study|Dropped out due to Nausea|0
7877698|NCT01722266|12373017|FG001|Overall Study|Dropped out due to Nausea|0
7877699|NCT01722266|12373018|FG002|Overall Study|Dropped out due to Nausea|2
7877700|NCT01722266|12373019|FG003|Overall Study|Dropped out due to Nausea|0
7877701|NCT01722669|12373128|FG000|Overall Study|Withdrawal by Subject|0
7877702|NCT01722669|12373129|FG001|Overall Study|Withdrawal by Subject|0
7877703|NCT01722669|12373130|FG002|Overall Study|Withdrawal by Subject|0
7877704|NCT01722669|12373131|FG003|Overall Study|Withdrawal by Subject|0
7877705|NCT01722669|12373132|FG004|Overall Study|Withdrawal by Subject|0
7877706|NCT01722669|12373133|FG005|Overall Study|Withdrawal by Subject|2
7877707|NCT01722877|12373166|FG000|Overall Study|Death|1
7877708|NCT01722877|12373166|FG000|Overall Study|Lost to Follow-up|1
7877709|NCT01722994|12373174|FG000|Overall Study|Missing data|25
7877710|NCT01722994|12373175|FG001|Overall Study|Missing data|17
7877711|NCT01723072|12373185|FG000|Overall Study|Withdrawal by Subject|7
7877712|NCT01723072|12373186|FG001|Overall Study|Withdrawal by Subject|13
7877713|NCT01723072|12373185|FG000|Overall Study|Discon for rescue medication after wk 24|0
7877714|NCT01723072|12373186|FG001|Overall Study|Discon for rescue medication after wk 24|5
7877715|NCT01723072|12373185|FG000|Overall Study|Other|4
7877716|NCT01723072|12373186|FG001|Overall Study|Other|3
7877717|NCT01723163|12373194|FG000|Treatment Phase|Withdrawal by Subject|14
7877718|NCT01723163|12373195|FG001|Treatment Phase|Withdrawal by Subject|6
7877719|NCT01723163|12373194|FG000|Treatment Phase|Withdrawal by PI|5
7877720|NCT01723163|12373195|FG001|Treatment Phase|Withdrawal by PI|1
7877721|NCT01723163|12373194|FG000|3-Month Follow-up|Withdrawal by Subject|1
7877722|NCT01723163|12373195|FG001|3-Month Follow-up|Withdrawal by Subject|0
7877723|NCT01723163|12373194|FG000|3-Month Follow-up|Unable to Contact|12
7877724|NCT01723163|12373195|FG001|3-Month Follow-up|Unable to Contact|19
7877725|NCT01723163|12373194|FG000|6-Month Follow-up|Death|1
7877726|NCT01723163|12373195|FG001|6-Month Follow-up|Death|0
7877727|NCT01723163|12373194|FG000|6-Month Follow-up|Unable to Contact|17
7877728|NCT01723163|12373195|FG001|6-Month Follow-up|Unable to Contact|15
7877729|NCT01723163|12373194|FG000|12-Month Follow-up|Death|1
7877730|NCT01723163|12373195|FG001|12-Month Follow-up|Death|0
7877731|NCT01723163|12373194|FG000|12-Month Follow-up|Unable to Contact|23
7877732|NCT01723163|12373195|FG001|12-Month Follow-up|Unable to Contact|28
7877733|NCT01723228|12373203|FG000|Overall Study|Adverse Event|2
7877734|NCT01723228|12373204|FG001|Overall Study|Adverse Event|6
7877735|NCT01723228|12373203|FG000|Overall Study|Withdrawal by Subject|2
7877736|NCT01723228|12373204|FG001|Overall Study|Withdrawal by Subject|1
7877737|NCT01723228|12373203|FG000|Overall Study|Protocol Violation|0
7877738|NCT01723228|12373204|FG001|Overall Study|Protocol Violation|2
7877739|NCT01723228|12373203|FG000|Overall Study|Lost to Follow-up|2
7877740|NCT01723228|12373204|FG001|Overall Study|Lost to Follow-up|1
7877741|NCT01723228|12373203|FG000|Overall Study|Other|2
7877742|NCT01723228|12373204|FG001|Overall Study|Other|1
7877743|NCT01723254|12373218|FG000|Overall Study|Conflict with work schedule|0
7877744|NCT01723254|12373219|FG001|Overall Study|Conflict with work schedule|0
7877745|NCT01723254|12373220|FG002|Overall Study|Conflict with work schedule|0
7877746|NCT01723254|12373221|FG003|Overall Study|Conflict with work schedule|0
7877747|NCT01723254|12373222|FG004|Overall Study|Conflict with work schedule|0
7877748|NCT01723254|12373223|FG005|Overall Study|Conflict with work schedule|0
7877749|NCT01723254|12373224|FG006|Overall Study|Conflict with work schedule|0
7877750|NCT01723254|12373225|FG007|Overall Study|Conflict with work schedule|1
7877751|NCT01723254|12373218|FG000|Overall Study|Personal issues|0
7877752|NCT01723254|12373219|FG001|Overall Study|Personal issues|0
7877753|NCT01723254|12373220|FG002|Overall Study|Personal issues|0
7877754|NCT01723254|12373221|FG003|Overall Study|Personal issues|0
7877755|NCT01723254|12373222|FG004|Overall Study|Personal issues|0
7877756|NCT01723254|12373223|FG005|Overall Study|Personal issues|1
7877757|NCT01723254|12373224|FG006|Overall Study|Personal issues|0
7877758|NCT01723254|12373225|FG007|Overall Study|Personal issues|0
7877759|NCT01723254|12373218|FG000|Overall Study|No longer have time to participate|0
7877760|NCT01723254|12373219|FG001|Overall Study|No longer have time to participate|0
7877761|NCT01723254|12373220|FG002|Overall Study|No longer have time to participate|0
7877762|NCT01723254|12373221|FG003|Overall Study|No longer have time to participate|1
7877763|NCT01723254|12373222|FG004|Overall Study|No longer have time to participate|0
7877764|NCT01723254|12373223|FG005|Overall Study|No longer have time to participate|0
7877765|NCT01723254|12373224|FG006|Overall Study|No longer have time to participate|0
7877766|NCT01723254|12373225|FG007|Overall Study|No longer have time to participate|0
7877767|NCT01723254|12373218|FG000|Overall Study|Move/Left to another country/city|0
7877768|NCT01723254|12373219|FG001|Overall Study|Move/Left to another country/city|0
7877769|NCT01723254|12373220|FG002|Overall Study|Move/Left to another country/city|2
7877770|NCT01723254|12373221|FG003|Overall Study|Move/Left to another country/city|1
7877771|NCT01723254|12373222|FG004|Overall Study|Move/Left to another country/city|1
7877772|NCT01723254|12373223|FG005|Overall Study|Move/Left to another country/city|0
7877773|NCT01723254|12373224|FG006|Overall Study|Move/Left to another country/city|0
7877774|NCT01723254|12373225|FG007|Overall Study|Move/Left to another country/city|0
7877775|NCT01723254|12373218|FG000|Overall Study|Protocol Violation|0
7877776|NCT01723254|12373219|FG001|Overall Study|Protocol Violation|1
7877777|NCT01723254|12373220|FG002|Overall Study|Protocol Violation|0
7877778|NCT01723254|12373221|FG003|Overall Study|Protocol Violation|0
7877779|NCT01723254|12373222|FG004|Overall Study|Protocol Violation|0
7877780|NCT01723254|12373223|FG005|Overall Study|Protocol Violation|0
7877781|NCT01723254|12373224|FG006|Overall Study|Protocol Violation|0
7877782|NCT01723254|12373225|FG007|Overall Study|Protocol Violation|0
7877783|NCT01723254|12373218|FG000|Overall Study|Withdrawal by Subject|1
7877784|NCT01723254|12373219|FG001|Overall Study|Withdrawal by Subject|2
7877785|NCT01723254|12373220|FG002|Overall Study|Withdrawal by Subject|1
7877786|NCT01723254|12373221|FG003|Overall Study|Withdrawal by Subject|0
7877787|NCT01723254|12373222|FG004|Overall Study|Withdrawal by Subject|1
7877788|NCT01723254|12373223|FG005|Overall Study|Withdrawal by Subject|1
7877789|NCT01723254|12373224|FG006|Overall Study|Withdrawal by Subject|1
7877790|NCT01723254|12373225|FG007|Overall Study|Withdrawal by Subject|2
7877791|NCT01723397|12373254|FG000|Study Period 1|Protocol Violation|0
7877792|NCT01723397|12373255|FG001|Study Period 1|Protocol Violation|1
7877793|NCT01723397|12373254|FG000|Study Period 2|Protocol Violation|0
7877794|NCT01723397|12373255|FG001|Study Period 2|Protocol Violation|1
7877795|NCT01723826|12373318|FG000|Overall Study|Adverse Event|4
7877796|NCT01723826|12373319|FG001|Overall Study|Adverse Event|1
7877797|NCT01723826|12373320|FG002|Overall Study|Adverse Event|4
7877798|NCT01723826|12373321|FG003|Overall Study|Adverse Event|5
7877799|NCT01723826|12373318|FG000|Overall Study|Death according to AE eCRF|2
7877800|NCT01723826|12373319|FG001|Overall Study|Death according to AE eCRF|3
7877801|NCT01723826|12373320|FG002|Overall Study|Death according to AE eCRF|3
7877802|NCT01723826|12373321|FG003|Overall Study|Death according to AE eCRF|7
7877803|NCT01723826|12373318|FG000|Overall Study|Lost to Follow-up|1
7877804|NCT01723826|12373319|FG001|Overall Study|Lost to Follow-up|3
7877805|NCT01723826|12373320|FG002|Overall Study|Lost to Follow-up|1
7877806|NCT01723826|12373321|FG003|Overall Study|Lost to Follow-up|1
7877807|NCT01723826|12373318|FG000|Overall Study|Non-compliance|0
7877808|NCT01723826|12373319|FG001|Overall Study|Non-compliance|1
7877809|NCT01723826|12373320|FG002|Overall Study|Non-compliance|3
7877810|NCT01723826|12373321|FG003|Overall Study|Non-compliance|3
7877811|NCT01723826|12373318|FG000|Overall Study|Non-compliance With Study Drug|0
7877812|NCT01723826|12373319|FG001|Overall Study|Non-compliance With Study Drug|1
7877813|NCT01723826|12373320|FG002|Overall Study|Non-compliance With Study Drug|0
7877814|NCT01723826|12373321|FG003|Overall Study|Non-compliance With Study Drug|0
7877815|NCT01723826|12373318|FG000|Overall Study|Other Reason|8
7877816|NCT01723826|12373319|FG001|Overall Study|Other Reason|6
7877817|NCT01723826|12373320|FG002|Overall Study|Other Reason|12
7877818|NCT01723826|12373321|FG003|Overall Study|Other Reason|14
7877819|NCT01723826|12373318|FG000|Overall Study|Physician Decision|1
7877820|NCT01723826|12373319|FG001|Overall Study|Physician Decision|3
7877821|NCT01723826|12373320|FG002|Overall Study|Physician Decision|4
7877822|NCT01723826|12373321|FG003|Overall Study|Physician Decision|11
7877823|NCT01723826|12373318|FG000|Overall Study|Protocol Violation|1
7877824|NCT01723826|12373319|FG001|Overall Study|Protocol Violation|1
7877825|NCT01723826|12373320|FG002|Overall Study|Protocol Violation|3
7877826|NCT01723826|12373321|FG003|Overall Study|Protocol Violation|1
7877827|NCT01723826|12373318|FG000|Overall Study|Withdrawal by Subject|10
7877828|NCT01723826|12373319|FG001|Overall Study|Withdrawal by Subject|17
7877829|NCT01723826|12373320|FG002|Overall Study|Withdrawal by Subject|27
7877830|NCT01723826|12373321|FG003|Overall Study|Withdrawal by Subject|48
7877831|NCT01723904|12373331|FG000|Overall Study|Noncompliant|3
7877832|NCT01723904|12373331|FG000|Overall Study|Adverse Event|5
7877833|NCT01723904|12373331|FG000|Overall Study|Unable to follow protocol/ judged by inv|3
7877834|NCT01724021|12373337|FG000|Overall Study|Adverse Event|11
7877835|NCT01724021|12373338|FG001|Overall Study|Adverse Event|6
7877836|NCT01724021|12373337|FG000|Overall Study|Death|46
7877837|NCT01724021|12373338|FG001|Overall Study|Death|58
7877838|NCT01724021|12373337|FG000|Overall Study|Participant request/ Withdrew consent|18
7877839|NCT01724021|12373338|FG001|Overall Study|Participant request/ Withdrew consent|14
7877840|NCT01724021|12373337|FG000|Overall Study|Lost to Follow-up|15
7877841|NCT01724021|12373338|FG001|Overall Study|Lost to Follow-up|15
7877842|NCT01724021|12373337|FG000|Overall Study|Reason Not Specified|36
7877843|NCT01724021|12373338|FG001|Overall Study|Reason Not Specified|39
7877844|NCT01724021|12373337|FG000|Overall Study|Missing|1
7877845|NCT01724021|12373338|FG001|Overall Study|Missing|1
7877846|NCT01724177|12373379|FG000|Overall Study|Adverse Event|8
7877847|NCT01724177|12373379|FG000|Overall Study|Progressive disease or Relapsed Disease|16
7877848|NCT01724177|12373379|FG000|Overall Study|Nervous participant|1
7877849|NCT01724177|12373379|FG000|Overall Study|Serious Adverse Event Related|1
7877850|NCT01724216|12373384|FG000|Overall Study|Scan was not completed|1
7877851|NCT01724359|12373388|FG000|Overall Study|Adverse Event|10
7877852|NCT01724359|12373388|FG000|Overall Study|Death|1
7877853|NCT01724359|12373388|FG000|Overall Study|Other|20
7882996|NCT01777776|12382412|FG000|Overall Study|Disease Progression|4
7882997|NCT01777776|12382413|FG001|Overall Study|Disease Progression|8
7882998|NCT01777776|12382414|FG002|Overall Study|Disease Progression|6
7882999|NCT01777776|12382415|FG003|Overall Study|Disease Progression|3
7883000|NCT01777776|12382412|FG000|Overall Study|Withdrawal by Subject|0
7883001|NCT01777776|12382413|FG001|Overall Study|Withdrawal by Subject|0
7883002|NCT01777776|12382414|FG002|Overall Study|Withdrawal by Subject|0
7883003|NCT01777776|12382415|FG003|Overall Study|Withdrawal by Subject|1
7883004|NCT01777932|12382434|FG000|Overall Study|Disease progression|136
7883005|NCT01777932|12382434|FG000|Overall Study|Death|3
7883006|NCT01777932|12382434|FG000|Overall Study|Adverse Event|34
7883007|NCT01777932|12382434|FG000|Overall Study|Lost to Follow-up|3
7883008|NCT01777932|12382434|FG000|Overall Study|Investigator decision|10
7883009|NCT01777932|12382434|FG000|Overall Study|Reimbursement limit|9
7883010|NCT01777932|12382434|FG000|Overall Study|Patient refused further treatment|10
7883011|NCT01777997|12382442|FG000|12 Week lead-in of no ART|Severe debilitation|2
7883012|NCT01777997|12382442|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
7883013|NCT01777997|12382442|FG000|Weeks 48 to 72/96 on ART|Death|1
7883014|NCT01777997|12382442|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
7883015|NCT01778010|12382446|FG000|Overall Study|Withdrawal by Subject|2
7883016|NCT01778010|12382446|FG000|Overall Study|abnormal ECG before meds|1
7883017|NCT01778010|12382446|FG000|Overall Study|Arrested|1
7883018|NCT01778010|12382446|FG000|Overall Study|rash while on placebo|1
7883019|NCT01778023|12382465|FG000|Overall Study|Withdrawal by Subject|0
7883020|NCT01778023|12382466|FG001|Overall Study|Withdrawal by Subject|3
7883021|NCT01778049|12382474|FG000|Open Label Treatment Period|Adverse Event|5
7883022|NCT01778049|12382475|FG001|Open Label Treatment Period|Adverse Event|15
7883023|NCT01778049|12382476|FG002|Open Label Treatment Period|Adverse Event|0
7883024|NCT01778049|12382477|FG003|Open Label Treatment Period|Adverse Event|0
7877854|NCT01724489|12373396|FG000|Overall Study|Adverse Event|8
7877855|NCT01724489|12373397|FG001|Overall Study|Adverse Event|3
7877856|NCT01724489|12373396|FG000|Overall Study|Surgery, medication|1
7877857|NCT01724489|12373397|FG001|Overall Study|Surgery, medication|1
7877858|NCT01724489|12373396|FG000|Overall Study|Lost to Follow-up|1
7877859|NCT01724489|12373397|FG001|Overall Study|Lost to Follow-up|2
7877860|NCT01724489|12373396|FG000|Overall Study|Withdrawal by Subject|6
7877861|NCT01724489|12373397|FG001|Overall Study|Withdrawal by Subject|6
7877862|NCT01724528|12373405|FG000|Overall Study|Death|3
7877863|NCT01724528|12373406|FG001|Overall Study|Death|0
7877864|NCT01724528|12373405|FG000|Overall Study|Withdrawal by Subject|0
7877865|NCT01724528|12373406|FG001|Overall Study|Withdrawal by Subject|2
7877866|NCT01724528|12373405|FG000|Overall Study|Protocol Violation|0
7877867|NCT01724528|12373406|FG001|Overall Study|Protocol Violation|1
7877868|NCT01724528|12373405|FG000|Overall Study|Patient refused to attend last visit|1
7877869|NCT01724528|12373406|FG001|Overall Study|Patient refused to attend last visit|0
7877870|NCT01725126|12373418|FG000|Overall Study|Protocol Violation|0
7877871|NCT01725126|12373419|FG001|Overall Study|Protocol Violation|1
7877872|NCT01725126|12373420|FG002|Overall Study|Protocol Violation|0
7877873|NCT01725126|12373421|FG003|Overall Study|Protocol Violation|0
7877874|NCT01725126|12373422|FG004|Overall Study|Protocol Violation|0
7877875|NCT01725126|12373423|FG005|Overall Study|Protocol Violation|0
7877876|NCT01725126|12373418|FG000|Overall Study|Withdrawal by Subject|0
7877877|NCT01725126|12373419|FG001|Overall Study|Withdrawal by Subject|0
7877878|NCT01725126|12373420|FG002|Overall Study|Withdrawal by Subject|0
7877879|NCT01725126|12373421|FG003|Overall Study|Withdrawal by Subject|1
7877880|NCT01725126|12373422|FG004|Overall Study|Withdrawal by Subject|0
7877881|NCT01725126|12373423|FG005|Overall Study|Withdrawal by Subject|0
7877882|NCT01725217|12373449|FG000|Overall Study|Withdrawal by Subject|1
7877883|NCT01725217|12373450|FG001|Overall Study|Withdrawal by Subject|0
7877884|NCT01725217|12373451|FG002|Overall Study|Withdrawal by Subject|0
7877885|NCT01725282|12373472|FG000|Overall Study|Adverse Event|1
7877886|NCT01725282|12373473|FG001|Overall Study|Adverse Event|3
7877887|NCT01725282|12373474|FG002|Overall Study|Adverse Event|6
7877888|NCT01725282|12373475|FG003|Overall Study|Adverse Event|4
7877889|NCT01725282|12373472|FG000|Overall Study|Exacerbation of Target Disease|1
7877890|NCT01725282|12373473|FG001|Overall Study|Exacerbation of Target Disease|0
7877891|NCT01725282|12373474|FG002|Overall Study|Exacerbation of Target Disease|0
7877892|NCT01725282|12373475|FG003|Overall Study|Exacerbation of Target Disease|1
7877893|NCT01725282|12373472|FG000|Overall Study|Met Exclusion Criteria|0
7877894|NCT01725282|12373473|FG001|Overall Study|Met Exclusion Criteria|0
7877895|NCT01725282|12373474|FG002|Overall Study|Met Exclusion Criteria|1
7877896|NCT01725282|12373475|FG003|Overall Study|Met Exclusion Criteria|0
7877897|NCT01725282|12373472|FG000|Overall Study|Study Site Withdrawal|0
7877898|NCT01725282|12373473|FG001|Overall Study|Study Site Withdrawal|1
7877899|NCT01725282|12373474|FG002|Overall Study|Study Site Withdrawal|0
7877900|NCT01725282|12373475|FG003|Overall Study|Study Site Withdrawal|0
7877901|NCT01725282|12373472|FG000|Overall Study|Withdrawal by Subject|0
7877902|NCT01725282|12373473|FG001|Overall Study|Withdrawal by Subject|0
7877903|NCT01725282|12373474|FG002|Overall Study|Withdrawal by Subject|1
7877904|NCT01725282|12373475|FG003|Overall Study|Withdrawal by Subject|1
7877905|NCT01725282|12373472|FG000|Overall Study|Lack of Efficacy|0
7877906|NCT01725282|12373473|FG001|Overall Study|Lack of Efficacy|1
7877907|NCT01725282|12373474|FG002|Overall Study|Lack of Efficacy|0
7877908|NCT01725282|12373475|FG003|Overall Study|Lack of Efficacy|1
7877909|NCT01725308|12373488|FG000|Treatment Period I|Did Not Receive Drug|1
7877910|NCT01725308|12373489|FG001|Treatment Period I|Did Not Receive Drug|0
7877911|NCT01725308|12373490|FG002|Treatment Period I|Did Not Receive Drug|0
7877912|NCT01725308|12373488|FG000|Treatment Period I|Adverse Event|5
7877913|NCT01725308|12373489|FG001|Treatment Period I|Adverse Event|4
7877914|NCT01725308|12373490|FG002|Treatment Period I|Adverse Event|21
7877915|NCT01725308|12373488|FG000|Treatment Period I|Insufficient Response|7
7877916|NCT01725308|12373489|FG001|Treatment Period I|Insufficient Response|0
7877917|NCT01725308|12373490|FG002|Treatment Period I|Insufficient Response|5
7877918|NCT01725308|12373488|FG000|Treatment Period I|Worsening of the Target Disease|8
7877919|NCT01725308|12373489|FG001|Treatment Period I|Worsening of the Target Disease|0
7877920|NCT01725308|12373490|FG002|Treatment Period I|Worsening of the Target Disease|2
7877921|NCT01725308|12373488|FG000|Treatment Period I|Changes in the Episodes|3
7877922|NCT01725308|12373489|FG001|Treatment Period I|Changes in the Episodes|0
7877923|NCT01725308|12373490|FG002|Treatment Period I|Changes in the Episodes|2
7877924|NCT01725308|12373488|FG000|Treatment Period I|Withdrawal of Consent|12
7877925|NCT01725308|12373489|FG001|Treatment Period I|Withdrawal of Consent|7
7877926|NCT01725308|12373490|FG002|Treatment Period I|Withdrawal of Consent|5
7877927|NCT01725308|12373488|FG000|Treatment Period I|Lost to Follow-up|3
7877928|NCT01725308|12373489|FG001|Treatment Period I|Lost to Follow-up|2
7877929|NCT01725308|12373490|FG002|Treatment Period I|Lost to Follow-up|2
7877930|NCT01725308|12373488|FG000|Treatment Period I|Protocol Deviations|3
7877931|NCT01725308|12373489|FG001|Treatment Period I|Protocol Deviations|1
7877932|NCT01725308|12373490|FG002|Treatment Period I|Protocol Deviations|1
7877933|NCT01725308|12373488|FG000|Treatment Period I|Miscellaneous|2
7877934|NCT01725308|12373489|FG001|Treatment Period I|Miscellaneous|0
7877935|NCT01725308|12373490|FG002|Treatment Period I|Miscellaneous|3
7877936|NCT01725308|12373488|FG000|Treatment Period II|Did Not Meet Transition Criteria|0
7877937|NCT01725308|12373489|FG001|Treatment Period II|Did Not Meet Transition Criteria|3
7877938|NCT01725308|12373490|FG002|Treatment Period II|Did Not Meet Transition Criteria|4
7877939|NCT01725308|12373488|FG000|Treatment Period II|Did Not Receive Drug|4
7877940|NCT01725308|12373489|FG001|Treatment Period II|Did Not Receive Drug|0
7877941|NCT01725308|12373490|FG002|Treatment Period II|Did Not Receive Drug|0
7877942|NCT01725308|12373488|FG000|Treatment Period II|Adverse Event|13
7877943|NCT01725308|12373489|FG001|Treatment Period II|Adverse Event|8
7877944|NCT01725308|12373490|FG002|Treatment Period II|Adverse Event|20
7877945|NCT01725308|12373488|FG000|Treatment Period II|Insufficient Response|2
7877946|NCT01725308|12373489|FG001|Treatment Period II|Insufficient Response|4
7877947|NCT01725308|12373490|FG002|Treatment Period II|Insufficient Response|6
7877948|NCT01725308|12373488|FG000|Treatment Period II|Worsening of the Target Disease|1
7877949|NCT01725308|12373489|FG001|Treatment Period II|Worsening of the Target Disease|4
7877950|NCT01725308|12373490|FG002|Treatment Period II|Worsening of the Target Disease|2
7877951|NCT01725308|12373488|FG000|Treatment Period II|Changes in the Episodes|1
7877952|NCT01725308|12373489|FG001|Treatment Period II|Changes in the Episodes|0
7877953|NCT01725308|12373490|FG002|Treatment Period II|Changes in the Episodes|5
7877954|NCT01725308|12373488|FG000|Treatment Period II|Withdrawal of Consent|28
7877955|NCT01725308|12373489|FG001|Treatment Period II|Withdrawal of Consent|2
7877956|NCT01725308|12373490|FG002|Treatment Period II|Withdrawal of Consent|16
7877957|NCT01725308|12373488|FG000|Treatment Period II|Lost to Follow-up|1
7877958|NCT01725308|12373489|FG001|Treatment Period II|Lost to Follow-up|5
7877959|NCT01725308|12373490|FG002|Treatment Period II|Lost to Follow-up|3
7877960|NCT01725308|12373488|FG000|Treatment Period II|Protocol Deviations|0
7877961|NCT01725308|12373489|FG001|Treatment Period II|Protocol Deviations|0
7877962|NCT01725308|12373490|FG002|Treatment Period II|Protocol Deviations|1
7877963|NCT01725308|12373488|FG000|Treatment Period II|Miscellaneous|5
7877964|NCT01725308|12373489|FG001|Treatment Period II|Miscellaneous|3
7877965|NCT01725308|12373490|FG002|Treatment Period II|Miscellaneous|7
7877966|NCT01725386|12373507|FG000|Overall Study|Death|84
7877967|NCT01725386|12373508|FG001|Overall Study|Death|40
7877968|NCT01725386|12373507|FG000|Overall Study|Lost to Follow-up|81
7877969|NCT01725386|12373508|FG001|Overall Study|Lost to Follow-up|6
7877970|NCT01725386|12373507|FG000|Overall Study|Withdrawal by Subject|10
7877971|NCT01725386|12373508|FG001|Overall Study|Withdrawal by Subject|0
7877972|NCT01725451|12373514|FG000|Period 1|Withdrawal by Subject|1
7877973|NCT01725451|12373515|FG001|Period 1|Withdrawal by Subject|0
7877974|NCT01725451|12373516|FG002|Period 1|Withdrawal by Subject|0
7877975|NCT01725451|12373517|FG003|Period 1|Withdrawal by Subject|0
7877976|NCT01725451|12373514|FG000|Washout From Period 3|Protocol Violation|0
7877977|NCT01725451|12373515|FG001|Washout From Period 3|Protocol Violation|0
7877978|NCT01725451|12373516|FG002|Washout From Period 3|Protocol Violation|1
7877979|NCT01725451|12373517|FG003|Washout From Period 3|Protocol Violation|0
7877980|NCT01725451|12373514|FG000|Washout From Period 3|Adverse Event|0
7877981|NCT01725451|12373515|FG001|Washout From Period 3|Adverse Event|1
7877982|NCT01725451|12373516|FG002|Washout From Period 3|Adverse Event|0
7877983|NCT01725451|12373517|FG003|Washout From Period 3|Adverse Event|0
7877984|NCT01725451|12373514|FG000|Period 4|Adverse Event|0
7877985|NCT01725451|12373515|FG001|Period 4|Adverse Event|0
7877986|NCT01725451|12373516|FG002|Period 4|Adverse Event|1
7877987|NCT01725451|12373517|FG003|Period 4|Adverse Event|0
7877988|NCT01725529|12373535|FG000|Overall Study|Adverse Event|1
7877989|NCT01725529|12373536|FG001|Overall Study|Adverse Event|0
7877990|NCT01725529|12373537|FG002|Overall Study|Adverse Event|0
7877991|NCT01725529|12373535|FG000|Overall Study|Lost to Follow-up|2
7877992|NCT01725529|12373536|FG001|Overall Study|Lost to Follow-up|1
7877993|NCT01725529|12373537|FG002|Overall Study|Lost to Follow-up|1
7877994|NCT01725529|12373535|FG000|Overall Study|Protocol Violation|0
7877995|NCT01725529|12373536|FG001|Overall Study|Protocol Violation|1
7877996|NCT01725529|12373537|FG002|Overall Study|Protocol Violation|1
7877997|NCT01725529|12373535|FG000|Overall Study|Withdrawal by Subject|12
7877998|NCT01725529|12373536|FG001|Overall Study|Withdrawal by Subject|14
7877999|NCT01725529|12373537|FG002|Overall Study|Withdrawal by Subject|8
7878000|NCT01725750|12373547|FG000|Overall Study|Adverse Event|1
7878001|NCT01725750|12373548|FG001|Overall Study|Adverse Event|0
7878002|NCT01725750|12373547|FG000|Overall Study|Lost to Follow-up|1
7878003|NCT01725750|12373548|FG001|Overall Study|Lost to Follow-up|1
7878004|NCT01725750|12373547|FG000|Overall Study|Withdrawal by Subject|0
7878005|NCT01725750|12373548|FG001|Overall Study|Withdrawal by Subject|9
7878006|NCT01726023|12373576|FG000|Overall Study|Death|1
7878007|NCT01726023|12373577|FG001|Overall Study|Death|1
7878008|NCT01726023|12373576|FG000|Overall Study|Lost to Follow-up|5
7878009|NCT01726023|12373577|FG001|Overall Study|Lost to Follow-up|10
7878010|NCT01726023|12373576|FG000|Overall Study|Other Eligibility criteria|7
7878011|NCT01726023|12373577|FG001|Overall Study|Other Eligibility criteria|7
7878012|NCT01726023|12373576|FG000|Overall Study|Withdrawal by Subject|16
7878013|NCT01726023|12373577|FG001|Overall Study|Withdrawal by Subject|8
7878014|NCT01726049|12373601|FG000|Overall Study|Death|1
7878015|NCT01726049|12373602|FG001|Overall Study|Death|1
7878016|NCT01726049|12373601|FG000|Overall Study|Adverse Event|4
7878017|NCT01726049|12373602|FG001|Overall Study|Adverse Event|1
7878018|NCT01726049|12373601|FG000|Overall Study|refused second HC|0
7878019|NCT01726049|12373602|FG001|Overall Study|refused second HC|2
7878020|NCT01726270|12373608|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10
7878021|NCT01726270|12373608|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20
7878022|NCT01726270|12373608|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21
7878023|NCT01726270|12373608|FG000|Part 2, Actual-Use Phase|Adverse Event|6
7878024|NCT01726270|12373608|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5
7878025|NCT01726270|12373608|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7
7878026|NCT01726335|12373614|FG000|Overall Study|Lost to Follow-up|2
7878027|NCT01726335|12373614|FG000|Overall Study|Withdrawal by Subject|15
7878028|NCT01726335|12373614|FG000|Overall Study|Adverse Event|4
7878029|NCT01726335|12373614|FG000|Overall Study|Lost to Follow-up|2
7878030|NCT01726335|12373614|FG000|Overall Study|Exacerbation of psychotic symptoms|1
7878031|NCT01726517|12373632|FG000|Overall Study|Withdrawal by Subject|0
7878032|NCT01726517|12373633|FG001|Overall Study|Withdrawal by Subject|0
7878033|NCT01726517|12373634|FG002|Overall Study|Withdrawal by Subject|1
7878034|NCT01726517|12373635|FG003|Overall Study|Withdrawal by Subject|0
7878035|NCT01726517|12373636|FG004|Overall Study|Withdrawal by Subject|0
7878036|NCT01726803|12373667|FG000|Overall Study|Lost to Follow-up|6
7878037|NCT01726803|12373668|FG001|Overall Study|Lost to Follow-up|1
7878038|NCT01726803|12373667|FG000|Overall Study|Withdrawal by Subject|1
7878039|NCT01726803|12373668|FG001|Overall Study|Withdrawal by Subject|0
7878040|NCT01727024|12373674|FG000|Period 1|Lost to Follow-up|1
7878041|NCT01727024|12373675|FG001|Period 1|Lost to Follow-up|1
7878042|NCT01727024|12373674|FG000|Period 1|Withdrawal by Subject|2
7878043|NCT01727024|12373675|FG001|Period 1|Withdrawal by Subject|3
7878044|NCT01727141|12373694|FG000|Overall Study|Physician Decision|0
7878045|NCT01727141|12373695|FG001|Overall Study|Physician Decision|1
7878046|NCT01727141|12373696|FG002|Overall Study|Physician Decision|0
7878047|NCT01727141|12373697|FG003|Overall Study|Physician Decision|2
7878048|NCT01727141|12373694|FG000|Overall Study|Lost to Follow-up|0
7878049|NCT01727141|12373695|FG001|Overall Study|Lost to Follow-up|2
7878050|NCT01727141|12373696|FG002|Overall Study|Lost to Follow-up|0
7878051|NCT01727141|12373697|FG003|Overall Study|Lost to Follow-up|0
7878052|NCT01727141|12373694|FG000|Overall Study|Death|0
7878053|NCT01727141|12373695|FG001|Overall Study|Death|1
7878054|NCT01727141|12373696|FG002|Overall Study|Death|1
7878055|NCT01727141|12373697|FG003|Overall Study|Death|1
7878056|NCT01727141|12373694|FG000|Overall Study|Protocol deviation|1
7878057|NCT01727141|12373695|FG001|Overall Study|Protocol deviation|1
7878058|NCT01727141|12373696|FG002|Overall Study|Protocol deviation|0
7878059|NCT01727141|12373697|FG003|Overall Study|Protocol deviation|1
7878060|NCT01727141|12373694|FG000|Overall Study|Withdrawal by Subject|4
7878061|NCT01727141|12373695|FG001|Overall Study|Withdrawal by Subject|4
7878062|NCT01727141|12373696|FG002|Overall Study|Withdrawal by Subject|2
7878063|NCT01727141|12373697|FG003|Overall Study|Withdrawal by Subject|11
7878064|NCT01727154|12373707|FG000|Overall Study|Death|17
7878065|NCT01727154|12373707|FG000|Overall Study|Withdrawal by Subject|14
7878066|NCT01727154|12373707|FG000|Overall Study|Subject Withdrew Consent|18
7878067|NCT01727154|12373707|FG000|Overall Study|Study Terminated|6
7878068|NCT01727154|12373707|FG000|Overall Study|No Discontinuation Documentation|4
7878069|NCT01727258|12373718|FG000|Overall Study|Adverse Event|0
7878070|NCT01727258|12373719|FG001|Overall Study|Adverse Event|2
7878071|NCT01727258|12373720|FG002|Overall Study|Adverse Event|0
7878072|NCT01727258|12373718|FG000|Overall Study|Noncompliance with Study Drug|0
7878073|NCT01727258|12373719|FG001|Overall Study|Noncompliance with Study Drug|0
7878074|NCT01727258|12373720|FG002|Overall Study|Noncompliance with Study Drug|1
7878075|NCT01727258|12373718|FG000|Overall Study|Withdrawal by Subject|1
7878076|NCT01727258|12373719|FG001|Overall Study|Withdrawal by Subject|1
7878077|NCT01727258|12373720|FG002|Overall Study|Withdrawal by Subject|0
7878078|NCT01727258|12373718|FG000|Overall Study|Lost to Follow-up|1
7878079|NCT01727258|12373719|FG001|Overall Study|Lost to Follow-up|0
7878080|NCT01727258|12373720|FG002|Overall Study|Lost to Follow-up|0
7878081|NCT01727297|12373728|FG000|Overall Study|Death|13
7878082|NCT01727297|12373729|FG001|Overall Study|Death|0
7878083|NCT01727297|12373728|FG000|Overall Study|Protocol Violation|1
7878084|NCT01727297|12373729|FG001|Overall Study|Protocol Violation|10
7878085|NCT01727297|12373728|FG000|Overall Study|Adverse Event|3
7878086|NCT01727297|12373729|FG001|Overall Study|Adverse Event|1
7878087|NCT01727297|12373728|FG000|Overall Study|Lost to Follow-up|11
7878088|NCT01727297|12373729|FG001|Overall Study|Lost to Follow-up|0
7878089|NCT01727297|12373728|FG000|Overall Study|Withdrawal by Subject|26
7878090|NCT01727297|12373729|FG001|Overall Study|Withdrawal by Subject|27
7878091|NCT01727297|12373728|FG000|Overall Study|Physician Decision|19
7878092|NCT01727297|12373729|FG001|Overall Study|Physician Decision|5
7878093|NCT01727297|12373728|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29
7878094|NCT01727297|12373729|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8
7878095|NCT01727336|12373748|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7878096|NCT01727336|12373749|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1
7878097|NCT01727336|12373750|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5
7878098|NCT01727336|12373751|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7878099|NCT01727336|12373752|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7878100|NCT01727336|12373753|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7878101|NCT01727336|12373748|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3
7878102|NCT01727336|12373749|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1
7878103|NCT01727336|12373750|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3
7878104|NCT01727336|12373751|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
7878105|NCT01727336|12373752|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
7878106|NCT01727336|12373753|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
7878107|NCT01727336|12373748|FG000|Part 2 Blinded|Death|0
7878108|NCT01727336|12373749|FG001|Part 2 Blinded|Death|0
7878109|NCT01727336|12373750|FG002|Part 2 Blinded|Death|0
7878110|NCT01727336|12373751|FG003|Part 2 Blinded|Death|0
7878111|NCT01727336|12373752|FG004|Part 2 Blinded|Death|20
7878112|NCT01727336|12373753|FG005|Part 2 Blinded|Death|16
7878113|NCT01727336|12373748|FG000|Part 2 Blinded|Lack of Efficacy|0
7878114|NCT01727336|12373749|FG001|Part 2 Blinded|Lack of Efficacy|0
7878115|NCT01727336|12373750|FG002|Part 2 Blinded|Lack of Efficacy|0
7878116|NCT01727336|12373751|FG003|Part 2 Blinded|Lack of Efficacy|0
7878117|NCT01727336|12373752|FG004|Part 2 Blinded|Lack of Efficacy|42
7878118|NCT01727336|12373753|FG005|Part 2 Blinded|Lack of Efficacy|44
7878119|NCT01727336|12373748|FG000|Part 2 Blinded|Lost to Follow-up|0
7878120|NCT01727336|12373749|FG001|Part 2 Blinded|Lost to Follow-up|0
7878121|NCT01727336|12373750|FG002|Part 2 Blinded|Lost to Follow-up|0
7878122|NCT01727336|12373751|FG003|Part 2 Blinded|Lost to Follow-up|0
7878123|NCT01727336|12373752|FG004|Part 2 Blinded|Lost to Follow-up|0
7878124|NCT01727336|12373753|FG005|Part 2 Blinded|Lost to Follow-up|1
7878125|NCT01727336|12373748|FG000|Part 2 Blinded|Withdrawal by Subject|0
7878126|NCT01727336|12373749|FG001|Part 2 Blinded|Withdrawal by Subject|0
7878127|NCT01727336|12373750|FG002|Part 2 Blinded|Withdrawal by Subject|0
7878128|NCT01727336|12373751|FG003|Part 2 Blinded|Withdrawal by Subject|0
7878129|NCT01727336|12373752|FG004|Part 2 Blinded|Withdrawal by Subject|0
7878130|NCT01727336|12373753|FG005|Part 2 Blinded|Withdrawal by Subject|4
7878131|NCT01727336|12373748|FG000|Part 2 Blinded|use of prohibited medications|0
7878132|NCT01727336|12373749|FG001|Part 2 Blinded|use of prohibited medications|0
7878133|NCT01727336|12373750|FG002|Part 2 Blinded|use of prohibited medications|0
7878134|NCT01727336|12373751|FG003|Part 2 Blinded|use of prohibited medications|0
7878135|NCT01727336|12373752|FG004|Part 2 Blinded|use of prohibited medications|1
7878136|NCT01727336|12373753|FG005|Part 2 Blinded|use of prohibited medications|3
7878137|NCT01727505|12373782|FG000|First 24 Hours|Adverse Event|0
7878138|NCT01727505|12373783|FG001|First 24 Hours|Adverse Event|1
7878139|NCT01727505|12373782|FG000|Second 24 Hours|Missing data|0
7878140|NCT01727505|12373783|FG001|Second 24 Hours|Missing data|1
7878141|NCT01727700|12373792|FG000|Overall Study|Adverse Event|0
7878142|NCT01727700|12373793|FG001|Overall Study|Adverse Event|7
7878143|NCT01727700|12373794|FG002|Overall Study|Adverse Event|1
7878144|NCT01727700|12373792|FG000|Overall Study|Particpant withdrew consent|0
7878145|NCT01727700|12373793|FG001|Overall Study|Particpant withdrew consent|3
7878146|NCT01727700|12373794|FG002|Overall Study|Particpant withdrew consent|1
7878147|NCT01727700|12373792|FG000|Overall Study|Protocol Violation|2
7878148|NCT01727700|12373793|FG001|Overall Study|Protocol Violation|0
7878149|NCT01727700|12373794|FG002|Overall Study|Protocol Violation|0
7878150|NCT01727713|12373802|FG000|Overall Study|Lost to Follow-up|5
7878151|NCT01727713|12373802|FG000|Overall Study|Adverse Event|10
7878152|NCT01727713|12373802|FG000|Overall Study|Participant Met Withdrawal Criteria|5
7878153|NCT01727713|12373802|FG000|Overall Study|Withdrawal by Subject|13
7878154|NCT01727713|12373802|FG000|Overall Study|Protocol Deviation|2
7878155|NCT01728077|12373843|FG000|Overall Study|Lack of Efficacy|3
7878156|NCT01728077|12373844|FG001|Overall Study|Lack of Efficacy|1
7878157|NCT01728077|12373843|FG000|Overall Study|Lost to Follow-up|1
7878158|NCT01728077|12373844|FG001|Overall Study|Lost to Follow-up|0
7878159|NCT01728077|12373843|FG000|Overall Study|Subject choice|2
7878160|NCT01728077|12373844|FG001|Overall Study|Subject choice|3
7878161|NCT01728077|12373843|FG000|Overall Study|Death|0
7878162|NCT01728077|12373844|FG001|Overall Study|Death|1
7878163|NCT01728077|12373843|FG000|Overall Study|Patient moving|1
7878164|NCT01728077|12373844|FG001|Overall Study|Patient moving|0
7878165|NCT01728077|12373843|FG000|Overall Study|Non compliance|1
7878166|NCT01728077|12373844|FG001|Overall Study|Non compliance|0
7878167|NCT01728116|12373853|FG000|Overall Study|Sponsor Terminated Study|106
7878168|NCT01728116|12373854|FG001|Overall Study|Sponsor Terminated Study|35
7878169|NCT01728116|12373853|FG000|Overall Study|Withdrawal by Subject|16
7878170|NCT01728116|12373854|FG001|Overall Study|Withdrawal by Subject|9
7878171|NCT01728116|12373853|FG000|Overall Study|Adverse Event|13
7878172|NCT01728116|12373854|FG001|Overall Study|Adverse Event|0
7878173|NCT01728116|12373853|FG000|Overall Study|Procedure/device failure|7
7878174|NCT01728116|12373854|FG001|Overall Study|Procedure/device failure|0
7878175|NCT01728116|12373853|FG000|Overall Study|Lost to Follow-up|9
7878176|NCT01728116|12373854|FG001|Overall Study|Lost to Follow-up|2
7878177|NCT01728116|12373853|FG000|Overall Study|Physician Decision|2
7878178|NCT01728116|12373854|FG001|Overall Study|Physician Decision|0
7878179|NCT01728116|12373853|FG000|Overall Study|Subject Non-Compliance|2
7878180|NCT01728116|12373854|FG001|Overall Study|Subject Non-Compliance|0
7878181|NCT01728116|12373853|FG000|Overall Study|Inter-current finding at procedure|1
7878182|NCT01728116|12373854|FG001|Overall Study|Inter-current finding at procedure|0
7878183|NCT01728116|12373853|FG000|Overall Study|Incorrectly enrolled in Study|0
7878184|NCT01728116|12373854|FG001|Overall Study|Incorrectly enrolled in Study|1
7878185|NCT01728116|12373853|FG000|Overall Study|various not noted previously|5
7878186|NCT01728116|12373854|FG001|Overall Study|various not noted previously|0
7878187|NCT01728194|12373863|FG000|Overall Study|Lost to Follow-up|4
7878188|NCT01728194|12373864|FG001|Overall Study|Lost to Follow-up|3
7878189|NCT01728194|12373863|FG000|Overall Study|Physician Decision|4
7878190|NCT01728194|12373864|FG001|Overall Study|Physician Decision|0
7878191|NCT01728194|12373863|FG000|Overall Study|Withdrawal by Subject|7
7878192|NCT01728194|12373864|FG001|Overall Study|Withdrawal by Subject|3
7878193|NCT01728194|12373863|FG000|Overall Study|Perceived Medication Side Effects|4
7878194|NCT01728194|12373864|FG001|Overall Study|Perceived Medication Side Effects|0
7878195|NCT01728194|12373863|FG000|Overall Study|Family Member Request|1
7878196|NCT01728194|12373864|FG001|Overall Study|Family Member Request|0
7878197|NCT01728246|12373872|FG000|Overall Study|Participant needed rescue medication|1
7878198|NCT01728246|12373873|FG001|Overall Study|Participant needed rescue medication|5
7878199|NCT01728246|12373872|FG000|Overall Study|Protocol Violation|1
7878200|NCT01728246|12373873|FG001|Overall Study|Protocol Violation|0
7878201|NCT01728246|12373872|FG000|Overall Study|Withdrawal by Subject|2
7878202|NCT01728246|12373873|FG001|Overall Study|Withdrawal by Subject|3
7878203|NCT01728246|12373872|FG000|Overall Study|Lost to Follow-up|23
7878204|NCT01728246|12373873|FG001|Overall Study|Lost to Follow-up|22
7878205|NCT01728246|12373872|FG000|Overall Study|Lack of Efficacy|1
7878206|NCT01728246|12373873|FG001|Overall Study|Lack of Efficacy|1
7878207|NCT01728246|12373872|FG000|Overall Study|Adverse Event|8
7878208|NCT01728246|12373873|FG001|Overall Study|Adverse Event|5
7878209|NCT01728324|12373882|FG000|Termination of DBV|Adverse Event|14
7878210|NCT01728324|12373883|FG001|Termination of DBV|Adverse Event|13
7878211|NCT01728324|12373884|FG002|Termination of DBV|Adverse Event|4
7878212|NCT01728324|12373882|FG000|Termination of DBV|Lack of Efficacy|14
7878213|NCT01728324|12373883|FG001|Termination of DBV|Lack of Efficacy|12
7878214|NCT01728324|12373884|FG002|Termination of DBV|Lack of Efficacy|8
7878215|NCT01728324|12373882|FG000|Termination of DBV|Withdrawal by Subject|9
7878216|NCT01728324|12373883|FG001|Termination of DBV|Withdrawal by Subject|6
7878217|NCT01728324|12373884|FG002|Termination of DBV|Withdrawal by Subject|2
7878218|NCT01728324|12373882|FG000|Termination of DBV|Other than stated|1
7878219|NCT01728324|12373883|FG001|Termination of DBV|Other than stated|3
7878220|NCT01728324|12373884|FG002|Termination of DBV|Other than stated|0
7878221|NCT01728324|12373882|FG000|Termination of DBV|Adverse Event (Placebo Period)|0
7878222|NCT01728324|12373883|FG001|Termination of DBV|Adverse Event (Placebo Period)|1
7878223|NCT01728324|12373884|FG002|Termination of DBV|Adverse Event (Placebo Period)|0
7878224|NCT01728324|12373882|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0
7878225|NCT01728324|12373883|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1
7878226|NCT01728324|12373884|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0
7878227|NCT01728324|12373882|FG000|Termination of FDV|Adverse Event|14
7878228|NCT01728324|12373883|FG001|Termination of FDV|Adverse Event|13
7878229|NCT01728324|12373884|FG002|Termination of FDV|Adverse Event|4
7878230|NCT01728324|12373882|FG000|Termination of FDV|Lack of Efficacy|14
7878231|NCT01728324|12373883|FG001|Termination of FDV|Lack of Efficacy|12
7878232|NCT01728324|12373884|FG002|Termination of FDV|Lack of Efficacy|8
7878233|NCT01728324|12373882|FG000|Termination of FDV|Withdrawal by Subject|9
7878234|NCT01728324|12373883|FG001|Termination of FDV|Withdrawal by Subject|6
7878235|NCT01728324|12373884|FG002|Termination of FDV|Withdrawal by Subject|2
7878236|NCT01728324|12373882|FG000|Termination of FDV|Other than stated|1
7878237|NCT01728324|12373883|FG001|Termination of FDV|Other than stated|3
7878238|NCT01728324|12373884|FG002|Termination of FDV|Other than stated|0
7878239|NCT01728324|12373882|FG000|Termination of FDV|Adverse Event (Placebo Period)|0
7878240|NCT01728324|12373883|FG001|Termination of FDV|Adverse Event (Placebo Period)|1
7878241|NCT01728324|12373884|FG002|Termination of FDV|Adverse Event (Placebo Period)|0
7878242|NCT01728324|12373882|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0
7878243|NCT01728324|12373883|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1
7878244|NCT01728324|12373884|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0
7878245|NCT01728324|12373882|FG000|Termination of RBV|Adverse Event|15
7878246|NCT01728324|12373883|FG001|Termination of RBV|Adverse Event|16
7878247|NCT01728324|12373884|FG002|Termination of RBV|Adverse Event|5
7878248|NCT01728324|12373882|FG000|Termination of RBV|Lack of Efficacy|14
7878249|NCT01728324|12373883|FG001|Termination of RBV|Lack of Efficacy|11
7878250|NCT01728324|12373884|FG002|Termination of RBV|Lack of Efficacy|7
7878251|NCT01728324|12373882|FG000|Termination of RBV|Withdrawal by Subject|9
7878252|NCT01728324|12373883|FG001|Termination of RBV|Withdrawal by Subject|5
7878253|NCT01728324|12373884|FG002|Termination of RBV|Withdrawal by Subject|2
7878254|NCT01728324|12373882|FG000|Termination of RBV|Other than stated|1
7878255|NCT01728324|12373883|FG001|Termination of RBV|Other than stated|3
7878256|NCT01728324|12373884|FG002|Termination of RBV|Other than stated|1
7878257|NCT01728324|12373882|FG000|Termination of RBV|Adverse Event (Placebo Period)|0
7878258|NCT01728324|12373883|FG001|Termination of RBV|Adverse Event (Placebo Period)|1
7878259|NCT01728324|12373884|FG002|Termination of RBV|Adverse Event (Placebo Period)|0
7878260|NCT01728324|12373882|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0
7878261|NCT01728324|12373883|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1
7878262|NCT01728324|12373884|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0
7878263|NCT01728376|12373906|FG000|Overall Study|Adverse Event|1
7878264|NCT01728376|12373907|FG001|Overall Study|Adverse Event|1
7878265|NCT01728376|12373908|FG002|Overall Study|Adverse Event|1
7878266|NCT01728376|12373909|FG003|Overall Study|Adverse Event|1
7878267|NCT01728376|12373910|FG004|Overall Study|Adverse Event|1
7878268|NCT01728376|12373911|FG005|Overall Study|Adverse Event|0
7878269|NCT01728376|12373906|FG000|Overall Study|Persistent Positive Blood Cultures|1
7878270|NCT01728376|12373907|FG001|Overall Study|Persistent Positive Blood Cultures|0
7878271|NCT01728376|12373908|FG002|Overall Study|Persistent Positive Blood Cultures|1
7878272|NCT01728376|12373909|FG003|Overall Study|Persistent Positive Blood Cultures|0
7878273|NCT01728376|12373910|FG004|Overall Study|Persistent Positive Blood Cultures|0
7878274|NCT01728376|12373911|FG005|Overall Study|Persistent Positive Blood Cultures|0
7878275|NCT01728376|12373906|FG000|Overall Study|No relevant bacteria|2
7878276|NCT01728376|12373907|FG001|Overall Study|No relevant bacteria|0
7878277|NCT01728376|12373908|FG002|Overall Study|No relevant bacteria|0
7878278|NCT01728376|12373909|FG003|Overall Study|No relevant bacteria|0
7878279|NCT01728376|12373910|FG004|Overall Study|No relevant bacteria|1
7878280|NCT01728376|12373911|FG005|Overall Study|No relevant bacteria|1
7878281|NCT01728376|12373906|FG000|Overall Study|Did not receive treatment|0
7878282|NCT01728376|12373907|FG001|Overall Study|Did not receive treatment|1
7878283|NCT01728376|12373908|FG002|Overall Study|Did not receive treatment|0
7878284|NCT01728376|12373909|FG003|Overall Study|Did not receive treatment|0
7878285|NCT01728376|12373910|FG004|Overall Study|Did not receive treatment|0
7878286|NCT01728376|12373911|FG005|Overall Study|Did not receive treatment|0
7878287|NCT01728376|12373906|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0
7878288|NCT01728376|12373907|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0
7878289|NCT01728376|12373908|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0
7878290|NCT01728376|12373909|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1
7878291|NCT01728376|12373910|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0
7878292|NCT01728376|12373911|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1
7878293|NCT01728454|12373928|FG000|Stage 1 and 2|Pregnancy|1
7878294|NCT01728454|12373929|FG001|Stage 1 and 2|Pregnancy|0
7878295|NCT01728454|12373930|FG002|Stage 1 and 2|Pregnancy|0
7878296|NCT01728454|12373928|FG000|Stage 1 and 2|Non-compliance with Protocol|0
7878297|NCT01728454|12373929|FG001|Stage 1 and 2|Non-compliance with Protocol|0
7878298|NCT01728454|12373930|FG002|Stage 1 and 2|Non-compliance with Protocol|1
7878299|NCT01728454|12373928|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1
7878300|NCT01728454|12373929|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
7878301|NCT01728454|12373930|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
7878302|NCT01728454|12373928|FG000|Stage 1 and 2|Lost to Follow-up|1
7878303|NCT01728454|12373929|FG001|Stage 1 and 2|Lost to Follow-up|1
7878304|NCT01728454|12373930|FG002|Stage 1 and 2|Lost to Follow-up|0
7878305|NCT01728454|12373928|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2
7878306|NCT01728454|12373929|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
7878307|NCT01728454|12373930|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
7878308|NCT01728454|12373928|FG000|Stage 3|Reason Missing|0
7878309|NCT01728454|12373929|FG001|Stage 3|Reason Missing|0
7878310|NCT01728454|12373930|FG002|Stage 3|Reason Missing|1
7878311|NCT01728454|12373928|FG000|Stage 3|Subject Required Other Treatment|0
7878312|NCT01728454|12373929|FG001|Stage 3|Subject Required Other Treatment|1
7878313|NCT01728454|12373930|FG002|Stage 3|Subject Required Other Treatment|0
7878314|NCT01728454|12373928|FG000|Stage 3|Pregnancy|1
7878315|NCT01728454|12373929|FG001|Stage 3|Pregnancy|0
7878316|NCT01728454|12373930|FG002|Stage 3|Pregnancy|0
7878317|NCT01728454|12373928|FG000|Stage 3|Withdrew Consent|1
7878318|NCT01728454|12373929|FG001|Stage 3|Withdrew Consent|0
7878319|NCT01728454|12373930|FG002|Stage 3|Withdrew Consent|1
7878320|NCT01728454|12373928|FG000|Stage 3|Non-compliance with Protocol|0
7878321|NCT01728454|12373929|FG001|Stage 3|Non-compliance with Protocol|0
7878322|NCT01728454|12373930|FG002|Stage 3|Non-compliance with Protocol|1
7878323|NCT01728454|12373928|FG000|Stage 3|Lost to Follow-up|0
7878324|NCT01728454|12373929|FG001|Stage 3|Lost to Follow-up|3
7878325|NCT01728454|12373930|FG002|Stage 3|Lost to Follow-up|1
7878326|NCT01728454|12373928|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1
7878327|NCT01728454|12373929|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0
7878328|NCT01728454|12373930|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0
7878329|NCT01728584|12373945|FG000|Overall Study|Adverse Event|1
7878330|NCT01728584|12373946|FG001|Overall Study|Adverse Event|0
7878331|NCT01728584|12373947|FG002|Overall Study|Adverse Event|0
7878332|NCT01728584|12373948|FG003|Overall Study|Adverse Event|0
7878333|NCT01728584|12373945|FG000|Overall Study|Physician Decision|4
7878334|NCT01728584|12373946|FG001|Overall Study|Physician Decision|0
7878335|NCT01728584|12373947|FG002|Overall Study|Physician Decision|1
7878336|NCT01728584|12373948|FG003|Overall Study|Physician Decision|0
7878337|NCT01728584|12373945|FG000|Overall Study|Withdrawal by Subject|1
7878338|NCT01728584|12373946|FG001|Overall Study|Withdrawal by Subject|0
7878339|NCT01728584|12373947|FG002|Overall Study|Withdrawal by Subject|0
7878340|NCT01728584|12373948|FG003|Overall Study|Withdrawal by Subject|0
7878341|NCT01728584|12373945|FG000|Overall Study|Screen failure|1
7878342|NCT01728584|12373946|FG001|Overall Study|Screen failure|0
7878343|NCT01728584|12373947|FG002|Overall Study|Screen failure|0
7878344|NCT01728584|12373948|FG003|Overall Study|Screen failure|0
7878345|NCT01728584|12373945|FG000|Overall Study|Other reason (not specified)|1
7878346|NCT01728584|12373946|FG001|Overall Study|Other reason (not specified)|0
7878347|NCT01728584|12373947|FG002|Overall Study|Other reason (not specified)|0
7878348|NCT01728584|12373948|FG003|Overall Study|Other reason (not specified)|1
7878349|NCT01728623|12373965|FG000|Overall Study|Disease progression|26
7878350|NCT01728623|12373965|FG000|Overall Study|Adverse Event|1
7878351|NCT01728623|12373965|FG000|Overall Study|Withdrawal by Subject|1
7878352|NCT01728779|12373981|FG000|Overall Study|Withdrawal by Subject|1
7878353|NCT01728792|12373990|FG000|Overall Study|Withdrawal of Consent|1
7878354|NCT01728792|12373991|FG001|Overall Study|Withdrawal of Consent|1
7878355|NCT01728792|12373992|FG002|Overall Study|Withdrawal of Consent|0
7878356|NCT01728792|12373993|FG003|Overall Study|Withdrawal of Consent|1
7878357|NCT01728792|12373994|FG004|Overall Study|Withdrawal of Consent|0
7878358|NCT01728792|12373990|FG000|Overall Study|Lost to Follow-up|2
7878359|NCT01728792|12373991|FG001|Overall Study|Lost to Follow-up|1
7878360|NCT01728792|12373992|FG002|Overall Study|Lost to Follow-up|4
7878361|NCT01728792|12373993|FG003|Overall Study|Lost to Follow-up|2
7878362|NCT01728792|12373994|FG004|Overall Study|Lost to Follow-up|0
7878363|NCT01729026|12374025|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2
7878364|NCT01729026|12374026|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2
7878365|NCT01729026|12374025|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
7878366|NCT01729026|12374026|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
7878367|NCT01729039|12374037|FG000|Overall Study|disqualified|2
7878368|NCT01729039|12374038|FG001|Overall Study|disqualified|5
7878369|NCT01729039|12374037|FG000|Overall Study|Withdrawal by Subject|8
7878370|NCT01729039|12374038|FG001|Overall Study|Withdrawal by Subject|7
7878371|NCT01729156|12374050|FG000|Overall Study|Withdrawal by Subject|1
7878372|NCT01729156|12374051|FG001|Overall Study|Withdrawal by Subject|0
7878373|NCT01729156|12374052|FG002|Overall Study|Withdrawal by Subject|0
7878374|NCT01729208|12374063|FG000|Baseline|Physician Decision|5
7878375|NCT01729208|12374064|FG001|Baseline|Physician Decision|4
7878376|NCT01729208|12374063|FG000|12 Months Follow-up|Withdrawal by Subject|4
7878377|NCT01729208|12374064|FG001|12 Months Follow-up|Withdrawal by Subject|7
7878378|NCT01729208|12374063|FG000|12 Months Follow-up|Lost to Follow-up|3
7878379|NCT01729208|12374064|FG001|12 Months Follow-up|Lost to Follow-up|3
7878380|NCT01729208|12374063|FG000|24 Months Follow-up|Lost to Follow-up|3
7878381|NCT01729208|12374064|FG001|24 Months Follow-up|Lost to Follow-up|0
7878382|NCT01729208|12374063|FG000|36 Months Follow-up|Physician Decision|1
7878383|NCT01729208|12374064|FG001|36 Months Follow-up|Physician Decision|0
7878384|NCT01729208|12374063|FG000|36 Months Follow-up|Withdrawal by Subject|2
7878385|NCT01729208|12374064|FG001|36 Months Follow-up|Withdrawal by Subject|4
7878386|NCT01729559|12374100|FG000|Overall Study|Protocol Violation|31
7878387|NCT01729559|12374101|FG001|Overall Study|Protocol Violation|28
7878388|NCT01729728|12374119|FG000|Overall Study|Adverse Event|0
7878389|NCT01729728|12374120|FG001|Overall Study|Adverse Event|6
7878390|NCT01729728|12374121|FG002|Overall Study|Adverse Event|0
7878391|NCT01729728|12374119|FG000|Overall Study|Protocol Violation|1
7878392|NCT01729728|12374120|FG001|Overall Study|Protocol Violation|0
7878393|NCT01729728|12374121|FG002|Overall Study|Protocol Violation|1
7878394|NCT01729819|12374254|FG000|Overall Study|Adverse Event|2
7878395|NCT01729819|12374255|FG001|Overall Study|Adverse Event|4
7878396|NCT01729819|12374254|FG000|Overall Study|Lack of Efficacy|1
7878397|NCT01729819|12374255|FG001|Overall Study|Lack of Efficacy|0
7878398|NCT01729819|12374254|FG000|Overall Study|Lost to Follow-up|2
7878399|NCT01729819|12374255|FG001|Overall Study|Lost to Follow-up|0
7878400|NCT01729819|12374254|FG000|Overall Study|Other reason|1
7878401|NCT01729819|12374255|FG001|Overall Study|Other reason|0
7878402|NCT01729819|12374254|FG000|Overall Study|Protocol Violation|0
7878403|NCT01729819|12374255|FG001|Overall Study|Protocol Violation|1
7878404|NCT01729819|12374254|FG000|Overall Study|Withdrawal by Subject|0
7878405|NCT01729819|12374255|FG001|Overall Study|Withdrawal by Subject|2
7878406|NCT01729871|12374281|FG000|Overall Study|Adverse Event|7
7878407|NCT01729871|12374282|FG001|Overall Study|Adverse Event|7
7878408|NCT01729871|12374281|FG000|Overall Study|Death|0
7878409|NCT01729871|12374282|FG001|Overall Study|Death|1
7878410|NCT01729871|12374281|FG000|Overall Study|Lack of Efficacy|0
7878411|NCT01729871|12374282|FG001|Overall Study|Lack of Efficacy|1
7878412|NCT01729871|12374281|FG000|Overall Study|Physician Decision|0
7878413|NCT01729871|12374282|FG001|Overall Study|Physician Decision|2
7878414|NCT01729871|12374281|FG000|Overall Study|Protocol Violation|1
7878415|NCT01729871|12374282|FG001|Overall Study|Protocol Violation|0
7878416|NCT01729871|12374281|FG000|Overall Study|Withdrawal by Subject|0
7878417|NCT01729871|12374282|FG001|Overall Study|Withdrawal by Subject|3
7878418|NCT01729871|12374281|FG000|Overall Study|Other|4
7878419|NCT01729871|12374282|FG001|Overall Study|Other|9
7878420|NCT01730040|12374299|FG000|Overall Study|Randomized but not treated|0
7878421|NCT01730040|12374300|FG001|Overall Study|Randomized but not treated|0
7878422|NCT01730040|12374301|FG002|Overall Study|Randomized but not treated|0
7878423|NCT01730040|12374302|FG003|Overall Study|Randomized but not treated|0
7878424|NCT01730040|12374303|FG004|Overall Study|Randomized but not treated|0
7878425|NCT01730040|12374304|FG005|Overall Study|Randomized but not treated|1
7878426|NCT01730040|12374305|FG006|Overall Study|Randomized but not treated|0
7878427|NCT01730040|12374299|FG000|Overall Study|Subject moved|0
7878428|NCT01730040|12374300|FG001|Overall Study|Subject moved|0
7878429|NCT01730040|12374301|FG002|Overall Study|Subject moved|1
7878430|NCT01730040|12374302|FG003|Overall Study|Subject moved|0
7878431|NCT01730040|12374303|FG004|Overall Study|Subject moved|0
7878432|NCT01730040|12374304|FG005|Overall Study|Subject moved|0
7878433|NCT01730040|12374305|FG006|Overall Study|Subject moved|1
7878434|NCT01730040|12374299|FG000|Overall Study|Physician Decision|0
7878435|NCT01730040|12374300|FG001|Overall Study|Physician Decision|0
7878436|NCT01730040|12374301|FG002|Overall Study|Physician Decision|0
7878437|NCT01730040|12374302|FG003|Overall Study|Physician Decision|0
7878438|NCT01730040|12374303|FG004|Overall Study|Physician Decision|0
7878439|NCT01730040|12374304|FG005|Overall Study|Physician Decision|1
7878440|NCT01730040|12374305|FG006|Overall Study|Physician Decision|1
7878441|NCT01730040|12374299|FG000|Overall Study|Other than specified|7
7878442|NCT01730040|12374300|FG001|Overall Study|Other than specified|8
7878443|NCT01730040|12374301|FG002|Overall Study|Other than specified|5
7878444|NCT01730040|12374302|FG003|Overall Study|Other than specified|5
7878445|NCT01730040|12374303|FG004|Overall Study|Other than specified|5
7878446|NCT01730040|12374304|FG005|Overall Study|Other than specified|4
7878447|NCT01730040|12374305|FG006|Overall Study|Other than specified|4
7878448|NCT01730040|12374299|FG000|Overall Study|Adverse Event|4
7878449|NCT01730040|12374300|FG001|Overall Study|Adverse Event|3
7878450|NCT01730040|12374301|FG002|Overall Study|Adverse Event|5
7878451|NCT01730040|12374302|FG003|Overall Study|Adverse Event|3
7878452|NCT01730040|12374303|FG004|Overall Study|Adverse Event|1
7878453|NCT01730040|12374304|FG005|Overall Study|Adverse Event|1
7878454|NCT01730040|12374305|FG006|Overall Study|Adverse Event|2
7878455|NCT01730040|12374299|FG000|Overall Study|Poor compliance to protocol|2
7878456|NCT01730040|12374300|FG001|Overall Study|Poor compliance to protocol|4
7878457|NCT01730040|12374301|FG002|Overall Study|Poor compliance to protocol|0
7878458|NCT01730040|12374302|FG003|Overall Study|Poor compliance to protocol|0
7878459|NCT01730040|12374303|FG004|Overall Study|Poor compliance to protocol|0
7878460|NCT01730040|12374304|FG005|Overall Study|Poor compliance to protocol|0
7878461|NCT01730040|12374305|FG006|Overall Study|Poor compliance to protocol|1
7878462|NCT01730053|12374327|FG000|Overall Study|Participant moved|0
7878463|NCT01730053|12374328|FG001|Overall Study|Participant moved|0
7878464|NCT01730053|12374329|FG002|Overall Study|Participant moved|1
7878465|NCT01730053|12374330|FG003|Overall Study|Participant moved|0
7878466|NCT01730053|12374331|FG004|Overall Study|Participant moved|0
7878467|NCT01730053|12374332|FG005|Overall Study|Participant moved|0
7878468|NCT01730053|12374327|FG000|Overall Study|Physician Decision|0
7878469|NCT01730053|12374328|FG001|Overall Study|Physician Decision|0
7878470|NCT01730053|12374329|FG002|Overall Study|Physician Decision|0
7878471|NCT01730053|12374330|FG003|Overall Study|Physician Decision|1
7878472|NCT01730053|12374331|FG004|Overall Study|Physician Decision|0
7878473|NCT01730053|12374332|FG005|Overall Study|Physician Decision|0
7878474|NCT01730053|12374327|FG000|Overall Study|Adverse Event|2
7878475|NCT01730053|12374328|FG001|Overall Study|Adverse Event|6
7878476|NCT01730053|12374329|FG002|Overall Study|Adverse Event|3
7878477|NCT01730053|12374330|FG003|Overall Study|Adverse Event|3
7878478|NCT01730053|12374331|FG004|Overall Study|Adverse Event|2
7878479|NCT01730053|12374332|FG005|Overall Study|Adverse Event|2
7878480|NCT01730053|12374327|FG000|Overall Study|Poor compliance to protocol|1
7878481|NCT01730053|12374328|FG001|Overall Study|Poor compliance to protocol|2
7878482|NCT01730053|12374329|FG002|Overall Study|Poor compliance to protocol|2
7878483|NCT01730053|12374330|FG003|Overall Study|Poor compliance to protocol|0
7878484|NCT01730053|12374331|FG004|Overall Study|Poor compliance to protocol|0
7878485|NCT01730053|12374332|FG005|Overall Study|Poor compliance to protocol|2
7878486|NCT01730053|12374327|FG000|Overall Study|Other than specified|2
7878487|NCT01730053|12374328|FG001|Overall Study|Other than specified|6
7878488|NCT01730053|12374329|FG002|Overall Study|Other than specified|5
7878489|NCT01730053|12374330|FG003|Overall Study|Other than specified|4
7878490|NCT01730053|12374331|FG004|Overall Study|Other than specified|7
7878491|NCT01730053|12374332|FG005|Overall Study|Other than specified|9
7878492|NCT01730339|12374349|FG000|Overall Study|Withdrawal by Subject|3
7878493|NCT01730339|12374350|FG001|Overall Study|Withdrawal by Subject|2
7878494|NCT01730339|12374349|FG000|Overall Study|Lost to Follow-up|1
7878495|NCT01730339|12374350|FG001|Overall Study|Lost to Follow-up|1
7878496|NCT01730339|12374349|FG000|Overall Study|Un-specified|1
7878497|NCT01730339|12374350|FG001|Overall Study|Un-specified|0
7878498|NCT01730378|12374368|FG000|Overall Study|Lost to Follow-up|1
7878499|NCT01730378|12374369|FG001|Overall Study|Lost to Follow-up|0
7878500|NCT01730534|12374378|FG000|Overall Study|Withdrawal by Subject|97
7878501|NCT01730534|12374379|FG001|Overall Study|Withdrawal by Subject|127
7878502|NCT01730534|12374378|FG000|Overall Study|Lost to Follow-up|12
7878503|NCT01730534|12374379|FG001|Overall Study|Lost to Follow-up|18
7878504|NCT01730586|12374385|FG000|Overall Study|Progressive Disease|2
7878505|NCT01730586|12374385|FG000|Overall Study|Inadequate Trial|8
7878506|NCT01730586|12374385|FG000|Overall Study|Adverse Event|2
7878507|NCT01730586|12374385|FG000|Overall Study|Hospice|1
7878508|NCT01730729|12374391|FG000|Overall Study|Adverse Event|1
7878509|NCT01730729|12374391|FG000|Overall Study|Death|1
7878510|NCT01730729|12374391|FG000|Overall Study|Progressive Disease|12
7878511|NCT01730950|12374422|FG000|Overall Study|Protocol Violation|6
7878512|NCT01730950|12374423|FG001|Overall Study|Protocol Violation|6
7878513|NCT01731002|12374433|FG000|Overall Study|Adverse Event|0
7878514|NCT01731002|12374434|FG001|Overall Study|Adverse Event|2
7878515|NCT01731002|12374435|FG002|Overall Study|Adverse Event|2
7878516|NCT01731002|12374433|FG000|Overall Study|Non-Compliant|0
7878517|NCT01731002|12374434|FG001|Overall Study|Non-Compliant|1
7878518|NCT01731002|12374435|FG002|Overall Study|Non-Compliant|0
7878519|NCT01731002|12374433|FG000|Overall Study|Lost to Follow-up|1
7878520|NCT01731002|12374434|FG001|Overall Study|Lost to Follow-up|0
7878521|NCT01731002|12374435|FG002|Overall Study|Lost to Follow-up|0
7878522|NCT01731002|12374433|FG000|Overall Study|Test Agent Discontinuation|0
7878523|NCT01731002|12374434|FG001|Overall Study|Test Agent Discontinuation|1
7878524|NCT01731002|12374435|FG002|Overall Study|Test Agent Discontinuation|0
7878525|NCT01731002|12374433|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
7878526|NCT01731002|12374434|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
7878527|NCT01731002|12374435|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
7878528|NCT01731002|12374433|FG000|Overall Study|Elevated IOP|1
7878529|NCT01731002|12374434|FG001|Overall Study|Elevated IOP|0
7878530|NCT01731002|12374435|FG002|Overall Study|Elevated IOP|0
7878531|NCT01731002|12374433|FG000|Overall Study|Inappropriate use of study medications|0
7878532|NCT01731002|12374434|FG001|Overall Study|Inappropriate use of study medications|0
7878533|NCT01731002|12374435|FG002|Overall Study|Inappropriate use of study medications|1
7878534|NCT01731171|12374458|FG000|Overall Study|Withdrawal by Subject|4
7878535|NCT01731171|12374459|FG001|Overall Study|Withdrawal by Subject|1
7878536|NCT01731171|12374458|FG000|Overall Study|Lost to Follow-up|3
7878537|NCT01731171|12374459|FG001|Overall Study|Lost to Follow-up|2
7878538|NCT01731171|12374458|FG000|Overall Study|Moved out of Area|0
7878539|NCT01731171|12374459|FG001|Overall Study|Moved out of Area|2
7878540|NCT01731171|12374458|FG000|Overall Study|Terminated for Lack of Adherence|0
7878541|NCT01731171|12374459|FG001|Overall Study|Terminated for Lack of Adherence|1
7878542|NCT01731171|12374458|FG000|Overall Study|Terminated for Safety Reasons|0
7878543|NCT01731171|12374459|FG001|Overall Study|Terminated for Safety Reasons|1
7878544|NCT01731470|12374465|FG000|Overall Study|Withdrawal by Subject|1
7878545|NCT01731470|12374465|FG000|Overall Study|Did not meet study criteria|1
7878546|NCT01731600|12374471|FG000|Overall Study|Adverse Event|2
7878547|NCT01731600|12374472|FG001|Overall Study|Adverse Event|0
7878548|NCT01731600|12374471|FG000|Overall Study|Withdrawal criteria|1
7878549|NCT01731600|12374472|FG001|Overall Study|Withdrawal criteria|0
7878550|NCT01731600|12374471|FG000|Overall Study|Other reasons|3
7878551|NCT01731600|12374472|FG001|Overall Study|Other reasons|0
7878552|NCT01731678|12374482|FG000|Overall Study|Withdrawal by Subject|3
7878553|NCT01731678|12374482|FG000|Overall Study|Did not meet inclusion criteria|1
7878554|NCT01731678|12374482|FG000|Overall Study|RMT too high, making TMS difficult|3
7878555|NCT01731886|12374504|FG000|Overall Study|Death|1
7878556|NCT01731886|12374505|FG001|Overall Study|Death|0
7878557|NCT01731886|12374504|FG000|Overall Study|Never started treatment|0
7878558|NCT01731886|12374505|FG001|Overall Study|Never started treatment|1
7878559|NCT01731886|12374504|FG000|Overall Study|Non-compliant|1
7878560|NCT01731886|12374505|FG001|Overall Study|Non-compliant|0
7878561|NCT01731912|12374512|FG000|Overall Study|noncompliance|2
7878562|NCT01731938|12374520|FG000|Preliminary Part I|Withdrawal by Subject|2
7878563|NCT01731938|12374521|FG001|Preliminary Part I|Withdrawal by Subject|2
7878564|NCT01731938|12374520|FG000|Preliminary Part I|Physician Decision|1
7878565|NCT01731938|12374521|FG001|Preliminary Part I|Physician Decision|0
7878566|NCT01731938|12374520|FG000|Preliminary Part I|Lost to Follow-up|0
7878567|NCT01731938|12374521|FG001|Preliminary Part I|Lost to Follow-up|3
7878568|NCT01731938|12374520|FG000|Preliminary Part I|Missed Week 6 visit|0
7878569|NCT01731938|12374521|FG001|Preliminary Part I|Missed Week 6 visit|3
7878570|NCT01731938|12374520|FG000|Primary Part II|Withdrawal by Subject|5
7878571|NCT01731938|12374521|FG001|Primary Part II|Withdrawal by Subject|4
7878572|NCT01731938|12374520|FG000|Primary Part II|Lost to Follow-up|4
7878573|NCT01731938|12374521|FG001|Primary Part II|Lost to Follow-up|5
7878574|NCT01731938|12374520|FG000|Primary Part II|Death|2
7878575|NCT01731938|12374521|FG001|Primary Part II|Death|1
7878576|NCT01731938|12374520|FG000|Primary Part II|Missed Week 6 visit|2
7878577|NCT01731938|12374521|FG001|Primary Part II|Missed Week 6 visit|3
7878578|NCT01731951|12374534|FG000|Overall Study|Documented Disease Progression|1
7878579|NCT01731951|12374535|FG001|Overall Study|Documented Disease Progression|0
7878580|NCT01731951|12374536|FG002|Overall Study|Documented Disease Progression|0
7878581|NCT01731951|12374537|FG003|Overall Study|Documented Disease Progression|0
7878582|NCT01731951|12374538|FG004|Overall Study|Documented Disease Progression|0
7878583|NCT01731951|12374539|FG005|Overall Study|Documented Disease Progression|0
7878584|NCT01731951|12374534|FG000|Overall Study|Lost to Follow-up|2
7878585|NCT01731951|12374535|FG001|Overall Study|Lost to Follow-up|0
7878586|NCT01731951|12374536|FG002|Overall Study|Lost to Follow-up|0
7878587|NCT01731951|12374537|FG003|Overall Study|Lost to Follow-up|1
7878588|NCT01731951|12374538|FG004|Overall Study|Lost to Follow-up|3
7878589|NCT01731951|12374539|FG005|Overall Study|Lost to Follow-up|1
7878590|NCT01731951|12374534|FG000|Overall Study|Withdrawal of Consent|1
7878591|NCT01731951|12374535|FG001|Overall Study|Withdrawal of Consent|0
7878592|NCT01731951|12374536|FG002|Overall Study|Withdrawal of Consent|0
7878593|NCT01731951|12374537|FG003|Overall Study|Withdrawal of Consent|0
7878594|NCT01731951|12374538|FG004|Overall Study|Withdrawal of Consent|0
7878595|NCT01731951|12374539|FG005|Overall Study|Withdrawal of Consent|2
7878596|NCT01731951|12374534|FG000|Overall Study|Death|13
7878597|NCT01731951|12374535|FG001|Overall Study|Death|15
7878598|NCT01731951|12374536|FG002|Overall Study|Death|9
7878599|NCT01731951|12374537|FG003|Overall Study|Death|8
7878600|NCT01731951|12374538|FG004|Overall Study|Death|9
7878601|NCT01731951|12374539|FG005|Overall Study|Death|6
7878602|NCT01731990|12374559|FG000|Overall Study|Adverse Event|1
7878603|NCT01731990|12374560|FG001|Overall Study|Adverse Event|5
7878604|NCT01731990|12374559|FG000|Overall Study|Withdrawal by Subject|1
7878605|NCT01731990|12374560|FG001|Overall Study|Withdrawal by Subject|1
7878606|NCT01731990|12374559|FG000|Overall Study|Protocol deviation|1
7878607|NCT01731990|12374560|FG001|Overall Study|Protocol deviation|2
7878608|NCT01731990|12374559|FG000|Overall Study|Death|1
7878609|NCT01731990|12374560|FG001|Overall Study|Death|0
7878610|NCT01732458|12374613|FG000|Overall Study|Lost to Follow-up|0
7878611|NCT01732458|12374614|FG001|Overall Study|Lost to Follow-up|2
7878612|NCT01732458|12374615|FG002|Overall Study|Lost to Follow-up|0
7878613|NCT01732458|12374616|FG003|Overall Study|Lost to Follow-up|0
7878614|NCT01732458|12374613|FG000|Overall Study|Non-Compliance With Study Drug|0
7878615|NCT01732458|12374614|FG001|Overall Study|Non-Compliance With Study Drug|0
7878616|NCT01732458|12374615|FG002|Overall Study|Non-Compliance With Study Drug|1
7878617|NCT01732458|12374616|FG003|Overall Study|Non-Compliance With Study Drug|0
7878618|NCT01732458|12374613|FG000|Overall Study|Physician Decision|1
7878619|NCT01732458|12374614|FG001|Overall Study|Physician Decision|2
7878620|NCT01732458|12374615|FG002|Overall Study|Physician Decision|2
7878621|NCT01732458|12374616|FG003|Overall Study|Physician Decision|0
7878622|NCT01732458|12374613|FG000|Overall Study|Protocol Violation|2
7878623|NCT01732458|12374614|FG001|Overall Study|Protocol Violation|0
7878624|NCT01732458|12374615|FG002|Overall Study|Protocol Violation|0
7878625|NCT01732458|12374616|FG003|Overall Study|Protocol Violation|2
7878626|NCT01732458|12374613|FG000|Overall Study|Screen Failure|0
7878627|NCT01732458|12374614|FG001|Overall Study|Screen Failure|1
7878628|NCT01732458|12374615|FG002|Overall Study|Screen Failure|0
7878629|NCT01732458|12374616|FG003|Overall Study|Screen Failure|0
7878630|NCT01732471|12374638|FG000|Overall Study|Withdrawal by Subject|1
7878631|NCT01732484|12374642|FG000|Overall Study|Death|7
7878632|NCT01732484|12374642|FG000|Overall Study|Lost to Follow-up|14
7878633|NCT01732484|12374642|FG000|Overall Study|chronical illness|5
7878634|NCT01732510|12374655|FG000|Overall Study|Adverse Event|0
7878635|NCT01732510|12374656|FG001|Overall Study|Adverse Event|1
7878636|NCT01732510|12374657|FG002|Overall Study|Adverse Event|1
7878637|NCT01732510|12374658|FG003|Overall Study|Adverse Event|0
7878638|NCT01732510|12374659|FG004|Overall Study|Adverse Event|0
7878639|NCT01732510|12374660|FG005|Overall Study|Adverse Event|0
7878640|NCT01732510|12374661|FG006|Overall Study|Adverse Event|1
7878641|NCT01732510|12374655|FG000|Overall Study|Protocol Violation|0
7878642|NCT01732510|12374656|FG001|Overall Study|Protocol Violation|0
7878643|NCT01732510|12374657|FG002|Overall Study|Protocol Violation|0
7878644|NCT01732510|12374658|FG003|Overall Study|Protocol Violation|1
7878645|NCT01732510|12374659|FG004|Overall Study|Protocol Violation|0
7878646|NCT01732510|12374660|FG005|Overall Study|Protocol Violation|0
7878647|NCT01732510|12374661|FG006|Overall Study|Protocol Violation|0
7878648|NCT01732510|12374655|FG000|Overall Study|Withdrawal by Subject|1
7878649|NCT01732510|12374656|FG001|Overall Study|Withdrawal by Subject|3
7878650|NCT01732510|12374657|FG002|Overall Study|Withdrawal by Subject|2
7878651|NCT01732510|12374658|FG003|Overall Study|Withdrawal by Subject|1
7878652|NCT01732510|12374659|FG004|Overall Study|Withdrawal by Subject|5
7878653|NCT01732510|12374660|FG005|Overall Study|Withdrawal by Subject|0
7878654|NCT01732510|12374661|FG006|Overall Study|Withdrawal by Subject|1
7878655|NCT01732510|12374655|FG000|Overall Study|Lost to Follow-up|0
7878656|NCT01732510|12374656|FG001|Overall Study|Lost to Follow-up|0
7878657|NCT01732510|12374657|FG002|Overall Study|Lost to Follow-up|1
7878658|NCT01732510|12374658|FG003|Overall Study|Lost to Follow-up|1
7878659|NCT01732510|12374659|FG004|Overall Study|Lost to Follow-up|0
7878660|NCT01732510|12374660|FG005|Overall Study|Lost to Follow-up|1
7878661|NCT01732510|12374661|FG006|Overall Study|Lost to Follow-up|0
7878662|NCT01732510|12374655|FG000|Overall Study|Physician Decision|0
7878663|NCT01732510|12374656|FG001|Overall Study|Physician Decision|1
7878664|NCT01732510|12374657|FG002|Overall Study|Physician Decision|0
7878665|NCT01732510|12374658|FG003|Overall Study|Physician Decision|0
7878666|NCT01732510|12374659|FG004|Overall Study|Physician Decision|0
7878667|NCT01732510|12374660|FG005|Overall Study|Physician Decision|0
7878668|NCT01732510|12374661|FG006|Overall Study|Physician Decision|0
7878669|NCT01732510|12374655|FG000|Overall Study|Pregnancy|0
7878670|NCT01732510|12374656|FG001|Overall Study|Pregnancy|0
7878671|NCT01732510|12374657|FG002|Overall Study|Pregnancy|0
7878672|NCT01732510|12374658|FG003|Overall Study|Pregnancy|1
7878673|NCT01732510|12374659|FG004|Overall Study|Pregnancy|0
7878674|NCT01732510|12374660|FG005|Overall Study|Pregnancy|0
7878675|NCT01732510|12374661|FG006|Overall Study|Pregnancy|0
7878676|NCT01732510|12374655|FG000|Overall Study|Study Terminated By Sponsor|0
7878677|NCT01732510|12374656|FG001|Overall Study|Study Terminated By Sponsor|0
7878678|NCT01732510|12374657|FG002|Overall Study|Study Terminated By Sponsor|0
7878679|NCT01732510|12374658|FG003|Overall Study|Study Terminated By Sponsor|1
7878680|NCT01732510|12374659|FG004|Overall Study|Study Terminated By Sponsor|0
7878681|NCT01732510|12374660|FG005|Overall Study|Study Terminated By Sponsor|12
7878682|NCT01732510|12374661|FG006|Overall Study|Study Terminated By Sponsor|6
7878683|NCT01732536|12374682|FG000|Overall Study|Withdrawal by Subject|1
7878684|NCT01732536|12374683|FG001|Overall Study|Withdrawal by Subject|1
7878685|NCT01732549|12374694|FG000|Overall Study|Adverse Event|13
7878686|NCT01732549|12374695|FG001|Overall Study|Adverse Event|3
7878687|NCT01732549|12374694|FG000|Overall Study|Consent withdrawn|13
7878688|NCT01732549|12374695|FG001|Overall Study|Consent withdrawn|6
7878689|NCT01732549|12374694|FG000|Overall Study|Disease progression|37
7878690|NCT01732549|12374695|FG001|Overall Study|Disease progression|50
7878691|NCT01732549|12374694|FG000|Overall Study|Other|8
7878692|NCT01732549|12374695|FG001|Overall Study|Other|14
7883025|NCT01778049|12382478|FG004|Open Label Treatment Period|Adverse Event|0
7883026|NCT01778049|12382479|FG005|Open Label Treatment Period|Adverse Event|0
7883027|NCT01778049|12382474|FG000|Open Label Treatment Period|Lack of Efficacy|1
7883028|NCT01778049|12382475|FG001|Open Label Treatment Period|Lack of Efficacy|1
7883029|NCT01778049|12382476|FG002|Open Label Treatment Period|Lack of Efficacy|0
7883030|NCT01778049|12382477|FG003|Open Label Treatment Period|Lack of Efficacy|0
7883031|NCT01778049|12382478|FG004|Open Label Treatment Period|Lack of Efficacy|0
7883032|NCT01778049|12382479|FG005|Open Label Treatment Period|Lack of Efficacy|0
7883033|NCT01778049|12382474|FG000|Open Label Treatment Period|Protocol Violation|5
7883034|NCT01778049|12382475|FG001|Open Label Treatment Period|Protocol Violation|5
7883035|NCT01778049|12382476|FG002|Open Label Treatment Period|Protocol Violation|0
7883036|NCT01778049|12382477|FG003|Open Label Treatment Period|Protocol Violation|0
7883037|NCT01778049|12382478|FG004|Open Label Treatment Period|Protocol Violation|0
7883038|NCT01778049|12382479|FG005|Open Label Treatment Period|Protocol Violation|0
7883039|NCT01778049|12382474|FG000|Open Label Treatment Period|Lost to Follow-up|4
7883040|NCT01778049|12382475|FG001|Open Label Treatment Period|Lost to Follow-up|3
7883041|NCT01778049|12382476|FG002|Open Label Treatment Period|Lost to Follow-up|0
7883042|NCT01778049|12382477|FG003|Open Label Treatment Period|Lost to Follow-up|0
7883043|NCT01778049|12382478|FG004|Open Label Treatment Period|Lost to Follow-up|0
7883044|NCT01778049|12382479|FG005|Open Label Treatment Period|Lost to Follow-up|0
7883045|NCT01778049|12382474|FG000|Open Label Treatment Period|Withdrawal by Subject|4
7883046|NCT01778049|12382475|FG001|Open Label Treatment Period|Withdrawal by Subject|10
7883047|NCT01778049|12382476|FG002|Open Label Treatment Period|Withdrawal by Subject|0
7883048|NCT01778049|12382477|FG003|Open Label Treatment Period|Withdrawal by Subject|0
7883049|NCT01778049|12382478|FG004|Open Label Treatment Period|Withdrawal by Subject|0
7883050|NCT01778049|12382479|FG005|Open Label Treatment Period|Withdrawal by Subject|0
7883051|NCT01778049|12382474|FG000|Open Label Treatment Period|Not treated|2
7883052|NCT01778049|12382475|FG001|Open Label Treatment Period|Not treated|1
7883053|NCT01778049|12382476|FG002|Open Label Treatment Period|Not treated|0
7883054|NCT01778049|12382477|FG003|Open Label Treatment Period|Not treated|0
7883055|NCT01778049|12382478|FG004|Open Label Treatment Period|Not treated|0
7883056|NCT01778049|12382479|FG005|Open Label Treatment Period|Not treated|0
7883057|NCT01778049|12382474|FG000|Open Label Treatment Period|Other reason not defined above|77
7883058|NCT01778049|12382475|FG001|Open Label Treatment Period|Other reason not defined above|94
7883059|NCT01778049|12382476|FG002|Open Label Treatment Period|Other reason not defined above|0
7883060|NCT01778049|12382477|FG003|Open Label Treatment Period|Other reason not defined above|0
7883061|NCT01778049|12382478|FG004|Open Label Treatment Period|Other reason not defined above|0
7883062|NCT01778049|12382479|FG005|Open Label Treatment Period|Other reason not defined above|0
7878693|NCT01732588|12374705|FG000|First Intervention (7 Days)|Adverse Event|0
7878694|NCT01732588|12374706|FG001|First Intervention (7 Days)|Adverse Event|1
7878695|NCT01732588|12374707|FG002|First Intervention (7 Days)|Adverse Event|0
7878696|NCT01732640|12374715|FG000|Overall Study|Adverse Event|0
7878697|NCT01732640|12374716|FG001|Overall Study|Adverse Event|1
7878698|NCT01732640|12374715|FG000|Overall Study|Death|0
7878699|NCT01732640|12374716|FG001|Overall Study|Death|1
7878700|NCT01732692|12374728|FG000|Overall Study|Adverse Event|0
7878701|NCT01732692|12374729|FG001|Overall Study|Adverse Event|1
7878702|NCT01732757|12374751|FG000|Overall Study|Lost to Follow-up|1
7878703|NCT01732757|12374752|FG001|Overall Study|Lost to Follow-up|0
7878704|NCT01732757|12374753|FG002|Overall Study|Lost to Follow-up|0
7878705|NCT01732770|12374763|FG000|Overall Study|Lost to Follow-up|2
7878706|NCT01732770|12374764|FG001|Overall Study|Lost to Follow-up|3
7878707|NCT01732770|12374763|FG000|Overall Study|Withdrawal by Subject|5
7878708|NCT01732770|12374764|FG001|Overall Study|Withdrawal by Subject|3
7878709|NCT01732770|12374763|FG000|Overall Study|Decision by Sponsor|2
7878710|NCT01732770|12374764|FG001|Overall Study|Decision by Sponsor|2
7878711|NCT01732770|12374763|FG000|Overall Study|Death|1
7878712|NCT01732770|12374764|FG001|Overall Study|Death|0
7878713|NCT01732783|12374773|FG000|Overall Study|Discontinued Panitumumab Treatment|106
7878714|NCT01732783|12374774|FG001|Overall Study|Discontinued Panitumumab Treatment|25
7878715|NCT01732783|12374775|FG002|Overall Study|Discontinued Panitumumab Treatment|7
7878716|NCT01732783|12374773|FG000|Overall Study|Death|13
7878717|NCT01732783|12374774|FG001|Overall Study|Death|4
7878718|NCT01732783|12374775|FG002|Overall Study|Death|1
7878719|NCT01732783|12374773|FG000|Overall Study|Lost to Follow-up|7
7878720|NCT01732783|12374774|FG001|Overall Study|Lost to Follow-up|1
7878721|NCT01732783|12374775|FG002|Overall Study|Lost to Follow-up|1
7878722|NCT01732783|12374773|FG000|Overall Study|Administrative Decision|8
7878723|NCT01732783|12374774|FG001|Overall Study|Administrative Decision|2
7878724|NCT01732783|12374775|FG002|Overall Study|Administrative Decision|1
7878725|NCT01732783|12374773|FG000|Overall Study|Withdrawal by Subject|1
7878726|NCT01732783|12374774|FG001|Overall Study|Withdrawal by Subject|0
7878727|NCT01732783|12374775|FG002|Overall Study|Withdrawal by Subject|0
7878728|NCT01732796|12374786|FG000|Overall Study|Adverse Event|16
7878729|NCT01732796|12374787|FG001|Overall Study|Adverse Event|16
7878730|NCT01732796|12374788|FG002|Overall Study|Adverse Event|4
7878731|NCT01732796|12374786|FG000|Overall Study|Lack of Efficacy|21
7878732|NCT01732796|12374787|FG001|Overall Study|Lack of Efficacy|18
7878733|NCT01732796|12374788|FG002|Overall Study|Lack of Efficacy|5
7878734|NCT01732796|12374786|FG000|Overall Study|Lost to Follow-up|2
7878735|NCT01732796|12374787|FG001|Overall Study|Lost to Follow-up|0
7878736|NCT01732796|12374788|FG002|Overall Study|Lost to Follow-up|0
7878737|NCT01732796|12374786|FG000|Overall Study|Withdrawal by Subject|6
7878738|NCT01732796|12374787|FG001|Overall Study|Withdrawal by Subject|8
7878739|NCT01732796|12374788|FG002|Overall Study|Withdrawal by Subject|2
7878740|NCT01732796|12374786|FG000|Overall Study|Other reason not defined above|1
7878741|NCT01732796|12374787|FG001|Overall Study|Other reason not defined above|0
7878742|NCT01732796|12374788|FG002|Overall Study|Other reason not defined above|2
7883063|NCT01778049|12382474|FG000|Double Blind Treatment Period|Adverse Event|0
7883064|NCT01778049|12382475|FG001|Double Blind Treatment Period|Adverse Event|0
7883065|NCT01778049|12382476|FG002|Double Blind Treatment Period|Adverse Event|4
7883066|NCT01778049|12382477|FG003|Double Blind Treatment Period|Adverse Event|5
7883067|NCT01778049|12382478|FG004|Double Blind Treatment Period|Adverse Event|3
7883068|NCT01778049|12382479|FG005|Double Blind Treatment Period|Adverse Event|2
7883069|NCT01778049|12382474|FG000|Double Blind Treatment Period|Lack of Efficacy|0
7883070|NCT01778049|12382475|FG001|Double Blind Treatment Period|Lack of Efficacy|0
7883071|NCT01778049|12382476|FG002|Double Blind Treatment Period|Lack of Efficacy|0
7883072|NCT01778049|12382477|FG003|Double Blind Treatment Period|Lack of Efficacy|0
7883073|NCT01778049|12382478|FG004|Double Blind Treatment Period|Lack of Efficacy|0
7883074|NCT01778049|12382479|FG005|Double Blind Treatment Period|Lack of Efficacy|1
7883075|NCT01778049|12382474|FG000|Double Blind Treatment Period|Protocol Violation|0
7883076|NCT01778049|12382475|FG001|Double Blind Treatment Period|Protocol Violation|0
7883077|NCT01778049|12382476|FG002|Double Blind Treatment Period|Protocol Violation|2
7883078|NCT01778049|12382477|FG003|Double Blind Treatment Period|Protocol Violation|0
7883079|NCT01778049|12382478|FG004|Double Blind Treatment Period|Protocol Violation|0
7883080|NCT01778049|12382479|FG005|Double Blind Treatment Period|Protocol Violation|0
7883081|NCT01778049|12382474|FG000|Double Blind Treatment Period|Lost to Follow-up|0
7883082|NCT01778049|12382475|FG001|Double Blind Treatment Period|Lost to Follow-up|0
7883083|NCT01778049|12382476|FG002|Double Blind Treatment Period|Lost to Follow-up|4
7883084|NCT01778049|12382477|FG003|Double Blind Treatment Period|Lost to Follow-up|1
7883085|NCT01778049|12382478|FG004|Double Blind Treatment Period|Lost to Follow-up|5
7883086|NCT01778049|12382479|FG005|Double Blind Treatment Period|Lost to Follow-up|2
7883087|NCT01778049|12382474|FG000|Double Blind Treatment Period|Withdrawal by Subject|0
7883088|NCT01778049|12382475|FG001|Double Blind Treatment Period|Withdrawal by Subject|0
7883089|NCT01778049|12382476|FG002|Double Blind Treatment Period|Withdrawal by Subject|1
7883090|NCT01778049|12382477|FG003|Double Blind Treatment Period|Withdrawal by Subject|2
7883091|NCT01778049|12382478|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
7883092|NCT01778049|12382479|FG005|Double Blind Treatment Period|Withdrawal by Subject|1
7883093|NCT01778049|12382474|FG000|Double Blind Treatment Period|Not treated|0
7878743|NCT04537234|12374800|FG000|Overall Study|Withdrawal by Subject|2
7878744|NCT04537234|12374801|FG001|Overall Study|Withdrawal by Subject|0
7883094|NCT01778049|12382475|FG001|Double Blind Treatment Period|Not treated|0
7883095|NCT01778049|12382476|FG002|Double Blind Treatment Period|Not treated|0
7883096|NCT01778049|12382477|FG003|Double Blind Treatment Period|Not treated|2
7883097|NCT01778049|12382478|FG004|Double Blind Treatment Period|Not treated|2
7883098|NCT01778049|12382479|FG005|Double Blind Treatment Period|Not treated|0
7883099|NCT01778049|12382474|FG000|Double Blind Treatment Period|Other reason not defined above|0
7883100|NCT01778049|12382475|FG001|Double Blind Treatment Period|Other reason not defined above|0
7883101|NCT01778049|12382476|FG002|Double Blind Treatment Period|Other reason not defined above|4
7883102|NCT01778049|12382477|FG003|Double Blind Treatment Period|Other reason not defined above|2
7883103|NCT01778049|12382478|FG004|Double Blind Treatment Period|Other reason not defined above|2
7883104|NCT01778049|12382479|FG005|Double Blind Treatment Period|Other reason not defined above|1
7883105|NCT01778062|12382493|FG000|Overall Study|Adverse Event|1
7883106|NCT01778062|12382494|FG001|Overall Study|Adverse Event|3
7883107|NCT01778062|12382493|FG000|Overall Study|Consent Withdrawal|1
7883108|NCT01778062|12382494|FG001|Overall Study|Consent Withdrawal|5
7883109|NCT01778062|12382493|FG000|Overall Study|major protocol deviation|4
7883110|NCT01778062|12382494|FG001|Overall Study|major protocol deviation|3
7883111|NCT01778127|12382503|FG000|Overall Study|Lost to Follow-up|5
7883112|NCT01778127|12382504|FG001|Overall Study|Lost to Follow-up|1
7883113|NCT01778127|12382505|FG002|Overall Study|Lost to Follow-up|2
7883114|NCT01778127|12382503|FG000|Overall Study|Withdrawal by Subject|3
7883115|NCT01778127|12382504|FG001|Overall Study|Withdrawal by Subject|1
7883116|NCT01778127|12382505|FG002|Overall Study|Withdrawal by Subject|4
7883117|NCT01778530|12382548|FG000|Overall Study|Progression on study|1
7883118|NCT01778530|12382548|FG000|Overall Study|Adverse event/side effect|1
7883119|NCT01778556|12382554|FG000|Intervention 1 (5 Days)|Protocol Violation|0
7883120|NCT01778556|12382555|FG001|Intervention 1 (5 Days)|Protocol Violation|1
7883121|NCT01778556|12382554|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0
7883122|NCT01778556|12382555|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1
7883123|NCT01778556|12382554|FG000|Intervention 2 (14 Days)|Protocol Violation|1
7883124|NCT01778556|12382555|FG001|Intervention 2 (14 Days)|Protocol Violation|0
7883125|NCT01778556|12382554|FG000|Long-term Follow-up|noncompliance with metreleptin|1
7883126|NCT01778556|12382555|FG001|Long-term Follow-up|noncompliance with metreleptin|0
7797022|NCT01072149|12253290|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
7797023|NCT01072149|12253291|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7797024|NCT01072149|12253292|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7797025|NCT01072149|12253293|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7797026|NCT01072149|12253294|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7797027|NCT01072201|12253315|FG000|Overall Study|Lost to Follow-up|0
7797028|NCT01072201|12253316|FG001|Overall Study|Lost to Follow-up|1
7797029|NCT01072344|12253337|FG000|Overall Study|Relasped-reached end point|7
7883127|NCT01778751|12382576|FG000|Overall Study|Lost to Follow-up|1
7883128|NCT01778751|12382577|FG001|Overall Study|Lost to Follow-up|0
7883129|NCT01778751|12382576|FG000|Overall Study|Withdrawal by Subject|0
7883130|NCT01778751|12382577|FG001|Overall Study|Withdrawal by Subject|2
7883131|NCT01778751|12382576|FG000|Overall Study|Transfered care|1
7883132|NCT01778751|12382577|FG001|Overall Study|Transfered care|0
7883133|NCT01778855|12382585|FG000|Overall Study|Death|0
7883134|NCT01778855|12382586|FG001|Overall Study|Death|1
7883135|NCT01778985|12382594|FG000|Overall Study|Lost to Follow-up|1
7883136|NCT01778985|12382595|FG001|Overall Study|Lost to Follow-up|0
7883137|NCT01778985|12382594|FG000|Overall Study|Physician Decision|2
7883138|NCT01778985|12382595|FG001|Overall Study|Physician Decision|2
7883139|NCT01778985|12382594|FG000|Overall Study|Protocol Violation|4
7883140|NCT01778985|12382595|FG001|Overall Study|Protocol Violation|1
7883141|NCT01779440|12382638|FG000|Overall Study|Withdrawal by Subject|3
7883142|NCT01779440|12382639|FG001|Overall Study|Withdrawal by Subject|5
7883143|NCT01779648|12382647|FG000|Overall Study|Protocol Violation|1
7883144|NCT01779648|12382648|FG001|Overall Study|Protocol Violation|0
7883145|NCT01779700|12382656|FG000|Overall Study|Adverse Event|4
7883146|NCT01779700|12382657|FG001|Overall Study|Adverse Event|3
7883147|NCT01779700|12382656|FG000|Overall Study|Withdrawal by Subject|0
7883148|NCT01779700|12382657|FG001|Overall Study|Withdrawal by Subject|2
7883149|NCT01779856|12382663|FG000|Overall Study|Withdrawal by Subject|15
7883150|NCT01779856|12382663|FG000|Overall Study|Death|3
7883151|NCT01779856|12382663|FG000|Overall Study|Physician Decision|1
7883152|NCT01779856|12382663|FG000|Overall Study|Inclusion/Exclusion Not Met|2
7883153|NCT01779856|12382663|FG000|Overall Study|Delays in scheduling implant|1
7883154|NCT01779856|12382663|FG000|Overall Study|Subject ineligible for Implant|2
7883155|NCT01779869|12382674|FG000|Overall Study|Physician Decision|2
7883156|NCT01780389|12382700|FG000|Overall Study|Adverse Event|1
7883157|NCT01780506|12382711|FG000|Double-Blind Phase|Randomized but not Treated|3
7883158|NCT01780506|12382712|FG001|Double-Blind Phase|Randomized but not Treated|2
7883159|NCT01780506|12382711|FG000|Double-Blind Phase|Adverse Event|4
7883160|NCT01780506|12382712|FG001|Double-Blind Phase|Adverse Event|14
7883161|NCT01780506|12382711|FG000|Double-Blind Phase|Death|1
7883162|NCT01780506|12382712|FG001|Double-Blind Phase|Death|2
7883163|NCT01780506|12382711|FG000|Double-Blind Phase|Pregnancy|2
7883164|NCT01780506|12382712|FG001|Double-Blind Phase|Pregnancy|1
7878745|NCT03478956|12374831|FG000|Overall Study|Adverse Event|1
7878746|NCT03478956|12374832|FG001|Overall Study|Adverse Event|0
7878747|NCT03478956|12374831|FG000|Overall Study|Withdrawal by Subject|0
7878748|NCT03478956|12374832|FG001|Overall Study|Withdrawal by Subject|1
7878749|NCT03478956|12374831|FG000|Overall Study|Ongoing in the Study|11
7878750|NCT03478956|12374832|FG001|Overall Study|Ongoing in the Study|11
7878751|NCT03348930|12374838|FG000|Washout (1 Week)|Lost to Follow-up|1
7878752|NCT03348930|12374839|FG001|Washout (1 Week)|Lost to Follow-up|1
7878753|NCT03282240|12374848|FG000|Overall Study|Adverse Event|2
7878754|NCT03282240|12374849|FG001|Overall Study|Adverse Event|2
7878755|NCT03282240|12374850|FG002|Overall Study|Adverse Event|0
7878756|NCT03282240|12374848|FG000|Overall Study|Lost to Follow-up|3
7878757|NCT03282240|12374849|FG001|Overall Study|Lost to Follow-up|0
7878758|NCT03282240|12374850|FG002|Overall Study|Lost to Follow-up|0
7878759|NCT03282240|12374848|FG000|Overall Study|Protocol Deviation|4
7878760|NCT03282240|12374849|FG001|Overall Study|Protocol Deviation|1
7878761|NCT03282240|12374850|FG002|Overall Study|Protocol Deviation|2
7878762|NCT03282240|12374848|FG000|Overall Study|Withdrawal by Subject|1
7878763|NCT03282240|12374849|FG001|Overall Study|Withdrawal by Subject|0
7878764|NCT03282240|12374850|FG002|Overall Study|Withdrawal by Subject|1
7878765|NCT03260868|12374863|FG000|Overall Study|Poor Compliance to Protocol|0
7878766|NCT03260868|12374864|FG001|Overall Study|Poor Compliance to Protocol|2
7878767|NCT03260868|12374863|FG000|Overall Study|Study Terminated By Sponsor|2
7878768|NCT03260868|12374864|FG001|Overall Study|Study Terminated By Sponsor|1
7878769|NCT03260868|12374863|FG000|Overall Study|Other than specified above|1
7878770|NCT03260868|12374864|FG001|Overall Study|Other than specified above|0
7878771|NCT03157037|12374879|FG000|Overall Study|Death|1
7878772|NCT03128931|12374903|FG000|Overall Study|Physician Decision|1
7878773|NCT03128931|12374903|FG000|Overall Study|Equipment Issues|3
7883165|NCT01780506|12382711|FG000|Double-Blind Phase|Lack of Efficacy|1
7883166|NCT01780506|12382712|FG001|Double-Blind Phase|Lack of Efficacy|1
7883167|NCT01780506|12382711|FG000|Double-Blind Phase|Investigator's Discretion|5
7883168|NCT01780506|12382712|FG001|Double-Blind Phase|Investigator's Discretion|2
7883169|NCT01780506|12382711|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4
7883170|NCT01780506|12382712|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3
7883171|NCT01780506|12382711|FG000|Double-Blind Phase|Protocol Violation|4
7883172|NCT01780506|12382712|FG001|Double-Blind Phase|Protocol Violation|3
7883173|NCT01780506|12382711|FG000|Double-Blind Phase|Withdrew Consent|23
7883174|NCT01780506|12382712|FG001|Double-Blind Phase|Withdrew Consent|24
7883175|NCT01780506|12382711|FG000|Double-Blind Phase|Lost to Follow-up|23
7883176|NCT01780506|12382712|FG001|Double-Blind Phase|Lost to Follow-up|26
7883177|NCT01780506|12382711|FG000|Open-Label Extension Phase|Enrolled but not Treated|0
7883178|NCT01780506|12382712|FG001|Open-Label Extension Phase|Enrolled but not Treated|1
7883179|NCT01780584|12382723|FG000|Overall Study|Death|1
7883180|NCT01780584|12382724|FG001|Overall Study|Death|0
7883181|NCT01780584|12382725|FG002|Overall Study|Death|1
7883182|NCT01780584|12382723|FG000|Overall Study|Adverse Event|0
7883183|NCT01780584|12382724|FG001|Overall Study|Adverse Event|1
7883184|NCT01780584|12382725|FG002|Overall Study|Adverse Event|0
7883185|NCT01780584|12382723|FG000|Overall Study|Protocol Violation|0
7883186|NCT01780584|12382724|FG001|Overall Study|Protocol Violation|0
7883187|NCT01780584|12382725|FG002|Overall Study|Protocol Violation|1
7883188|NCT01780662|12382736|FG000|Overall Study|Adverse Event|1
7883189|NCT01780662|12382737|FG001|Overall Study|Adverse Event|0
7883190|NCT01780662|12382738|FG002|Overall Study|Adverse Event|2
7883191|NCT01780662|12382736|FG000|Overall Study|Physician Decision|0
7883192|NCT01780662|12382737|FG001|Overall Study|Physician Decision|5
7883193|NCT01780662|12382738|FG002|Overall Study|Physician Decision|7
7883194|NCT01780662|12382736|FG000|Overall Study|Protocol Violation|0
7883195|NCT01780662|12382737|FG001|Overall Study|Protocol Violation|1
7883196|NCT01780662|12382738|FG002|Overall Study|Protocol Violation|0
7883197|NCT01780662|12382736|FG000|Overall Study|Ineligible|0
7883198|NCT01780662|12382737|FG001|Overall Study|Ineligible|0
7883199|NCT01780662|12382738|FG002|Overall Study|Ineligible|1
7883200|NCT01780831|12382751|FG000|Overall Study|Withdrawal by Subject|0
7883201|NCT01780831|12382752|FG001|Overall Study|Withdrawal by Subject|0
7883202|NCT01780831|12382753|FG002|Overall Study|Withdrawal by Subject|4
7883203|NCT01780831|12382754|FG003|Overall Study|Withdrawal by Subject|0
7883204|NCT01780831|12382751|FG000|Overall Study|Lost to Follow-up|0
7883205|NCT01780831|12382752|FG001|Overall Study|Lost to Follow-up|0
7883206|NCT01780831|12382753|FG002|Overall Study|Lost to Follow-up|0
7883207|NCT01780831|12382754|FG003|Overall Study|Lost to Follow-up|1
7883208|NCT01780935|12382835|FG000|Overall Study|Admin problems due to early termination|321
7883209|NCT01780935|12382836|FG001|Overall Study|Admin problems due to early termination|309
7883210|NCT01780935|12382835|FG000|Overall Study|Adverse Event|2
7883211|NCT01780935|12382836|FG001|Overall Study|Adverse Event|4
7883212|NCT01780935|12382835|FG000|Overall Study|Death|1
7883213|NCT01780935|12382836|FG001|Overall Study|Death|6
7883214|NCT01780935|12382835|FG000|Overall Study|Lost to Follow-up|2
7883215|NCT01780935|12382836|FG001|Overall Study|Lost to Follow-up|6
7883216|NCT01780935|12382835|FG000|Overall Study|Physician Decision|1
7883217|NCT01780935|12382836|FG001|Overall Study|Physician Decision|1
7883218|NCT01780935|12382835|FG000|Overall Study|Protocol deviation|0
7883219|NCT01780935|12382836|FG001|Overall Study|Protocol deviation|1
7883220|NCT01780935|12382835|FG000|Overall Study|Patient withdrew consent|8
7878774|NCT02498392|12374909|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7
7878775|NCT02498392|12374910|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0
7878776|NCT02498392|12374909|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3
7878777|NCT02498392|12374910|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0
7878778|NCT02498392|12374909|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0
7878779|NCT02498392|12374910|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2
7878780|NCT02498392|12374909|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0
7878781|NCT02498392|12374910|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2
7878782|NCT02498392|12374909|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2
7878783|NCT02498392|12374910|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3
7878784|NCT02498392|12374909|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1
7878785|NCT02498392|12374910|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3
7878786|NCT01899729|12374935|FG000|Overall Study|Adverse Event|1
7878787|NCT01899729|12374936|FG001|Overall Study|Adverse Event|0
7878788|NCT01899729|12374937|FG002|Overall Study|Adverse Event|0
7878789|NCT01899729|12374938|FG003|Overall Study|Adverse Event|0
7878790|NCT01899729|12374939|FG004|Overall Study|Adverse Event|1
7878791|NCT01899729|12374935|FG000|Overall Study|Withdrawal by Subject|1
7878792|NCT01899729|12374936|FG001|Overall Study|Withdrawal by Subject|2
7878793|NCT01899729|12374937|FG002|Overall Study|Withdrawal by Subject|0
7878794|NCT01899729|12374938|FG003|Overall Study|Withdrawal by Subject|0
7878795|NCT01899729|12374939|FG004|Overall Study|Withdrawal by Subject|0
7878796|NCT01899729|12374935|FG000|Overall Study|Lack of Efficacy|0
7878797|NCT01899729|12374936|FG001|Overall Study|Lack of Efficacy|0
7878798|NCT01899729|12374937|FG002|Overall Study|Lack of Efficacy|2
7878799|NCT01899729|12374938|FG003|Overall Study|Lack of Efficacy|0
7878800|NCT01899729|12374939|FG004|Overall Study|Lack of Efficacy|1
7878801|NCT01648205|12374960|FG000|Placebo|Pregnancy|1
7878802|NCT01648205|12374960|FG000|Placebo|Withdrawal by Subject|1
7878803|NCT01648205|12374960|FG000|Placebo|Protocol Violation|2
7878804|NCT01648205|12374960|FG000|Ranolazine|Death|1
7878805|NCT01648205|12374960|FG000|Ranolazine|Withdrawal by Subject|1
7878806|NCT01648205|12374960|FG000|Ranolazine|Protocol Violation|3
7878807|NCT00915681|12374981|FG000|Overall Study|Screening failures|46
7878808|NCT00145158|12374987|FG000|Overall Study|premature withdrawal|2
7878809|NCT00145158|12374988|FG001|Overall Study|premature withdrawal|3
7878810|NCT01732822|12375006|FG000|Overall Study|Withdrawal by Subject|123
7878811|NCT01732822|12375007|FG001|Overall Study|Withdrawal by Subject|113
7878812|NCT01732835|12375035|FG000|6-month Primary Endpoint|Did not receive device|19
7878813|NCT01732835|12375035|FG000|6-month Primary Endpoint|Withdrawal by Subject|2
7878814|NCT01732835|12375035|FG000|6-month Primary Endpoint|Adverse Event|3
7878815|NCT01732835|12375035|FG000|2-year Extended Follow-up|Withdrawal by Subject|1
7878816|NCT01732835|12375035|FG000|2-year Extended Follow-up|Adverse Event|3
7878817|NCT01732835|12375035|FG000|2-year Extended Follow-up|Death|1
7878818|NCT01732874|12375041|FG000|Overall Study|Withdrawal by Subject|5
7878819|NCT01732874|12375042|FG001|Overall Study|Withdrawal by Subject|1
7878820|NCT01732874|12375041|FG000|Overall Study|Death of Infant|3
7878821|NCT01732874|12375042|FG001|Overall Study|Death of Infant|2
7878822|NCT01733121|12375075|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2
7878823|NCT01733121|12375076|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0
7878824|NCT01733121|12375075|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3
7878825|NCT01733121|12375076|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2
7878826|NCT01733121|12375075|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
7878827|NCT01733121|12375076|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
7878828|NCT01733121|12375075|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
7878829|NCT01733121|12375076|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
7878830|NCT01733316|12375115|FG000|RP103 Phase|Non-compliance|1
7878831|NCT01733316|12375115|FG000|Long Term Extension Phase|Adverse Event|1
7878832|NCT01733316|12375115|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2
7878833|NCT01733316|12375115|FG000|Long Term Extension Phase|Sponsor Decision|2
7878834|NCT01733329|12375128|FG000|Overall Study|Protocol Violation|1
7878835|NCT01733329|12375129|FG001|Overall Study|Protocol Violation|1
7878836|NCT01733329|12375128|FG000|Overall Study|Uterine artery injury|1
7878837|NCT01733329|12375129|FG001|Overall Study|Uterine artery injury|0
7878838|NCT01733680|12375166|FG000|Overall Study|Withdrawal by Subject|0
7878839|NCT01733680|12375167|FG001|Overall Study|Withdrawal by Subject|1
7878840|NCT01733732|12375179|FG000|Overall Study|Adverse Event|1
7878841|NCT01733732|12375180|FG001|Overall Study|Adverse Event|0
7878842|NCT01733732|12375179|FG000|Overall Study|Did not attend all study visits|1
7878843|NCT01733732|12375180|FG001|Overall Study|Did not attend all study visits|0
7878844|NCT01733758|12375209|FG000|Overall Study|Adverse Event|5
7878845|NCT01733758|12375210|FG001|Overall Study|Adverse Event|7
7878846|NCT01733758|12375211|FG002|Overall Study|Adverse Event|8
7878847|NCT01733758|12375212|FG003|Overall Study|Adverse Event|1
7878848|NCT01733758|12375209|FG000|Overall Study|Withdrawal by Subject|1
7878849|NCT01733758|12375210|FG001|Overall Study|Withdrawal by Subject|1
7878850|NCT01733758|12375211|FG002|Overall Study|Withdrawal by Subject|5
7878851|NCT01733758|12375212|FG003|Overall Study|Withdrawal by Subject|3
7878852|NCT01733758|12375209|FG000|Overall Study|Persistent Hyperglycemia|3
7878853|NCT01733758|12375210|FG001|Overall Study|Persistent Hyperglycemia|2
7878854|NCT01733758|12375211|FG002|Overall Study|Persistent Hyperglycemia|0
7878855|NCT01733758|12375212|FG003|Overall Study|Persistent Hyperglycemia|0
7878856|NCT01733758|12375209|FG000|Overall Study|Protocol Violation|0
7878857|NCT01733758|12375210|FG001|Overall Study|Protocol Violation|1
7878858|NCT01733758|12375211|FG002|Overall Study|Protocol Violation|2
7878859|NCT01733758|12375212|FG003|Overall Study|Protocol Violation|2
7878860|NCT01733758|12375209|FG000|Overall Study|Non-compliance|1
7878861|NCT01733758|12375210|FG001|Overall Study|Non-compliance|0
7878862|NCT01733758|12375211|FG002|Overall Study|Non-compliance|0
7878863|NCT01733758|12375212|FG003|Overall Study|Non-compliance|0
7878864|NCT01733758|12375209|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4
7878865|NCT01733758|12375210|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0
7878866|NCT01733758|12375211|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0
7878867|NCT01733758|12375212|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1
7878868|NCT01733758|12375209|FG000|Overall Study|Inv Decision, HbA1c not controlled|1
7878869|NCT01733758|12375210|FG001|Overall Study|Inv Decision, HbA1c not controlled|1
7878870|NCT01733758|12375211|FG002|Overall Study|Inv Decision, HbA1c not controlled|0
7878871|NCT01733758|12375212|FG003|Overall Study|Inv Decision, HbA1c not controlled|1
7878872|NCT01734382|12375258|FG000|Part 1|Adverse Event|2
7878873|NCT01734382|12375259|FG001|Part 1|Adverse Event|0
7878874|NCT01734382|12375260|FG002|Part 1|Adverse Event|0
7878875|NCT01734382|12375258|FG000|Part 2|Adverse Event|0
7878876|NCT01734382|12375259|FG001|Part 2|Adverse Event|0
7878877|NCT01734382|12375260|FG002|Part 2|Adverse Event|1
7878878|NCT01734382|12375258|FG000|Part 2|Lack of Efficacy|0
7878879|NCT01734382|12375259|FG001|Part 2|Lack of Efficacy|1
7878880|NCT01734382|12375260|FG002|Part 2|Lack of Efficacy|1
7878881|NCT01734382|12375258|FG000|Part 2|Other|0
7878882|NCT01734382|12375259|FG001|Part 2|Other|0
7878883|NCT01734382|12375260|FG002|Part 2|Other|1
7878884|NCT01734382|12375258|FG000|Part 2|Physician Decision|0
7878885|NCT01734382|12375259|FG001|Part 2|Physician Decision|0
7878886|NCT01734382|12375260|FG002|Part 2|Physician Decision|3
7878887|NCT01734382|12375258|FG000|Part 2|Protocol Violation|0
7878888|NCT01734382|12375259|FG001|Part 2|Protocol Violation|1
7878889|NCT01734382|12375260|FG002|Part 2|Protocol Violation|0
7878890|NCT01734382|12375258|FG000|Part 2|Withdrawal by Subject|0
7878891|NCT01734382|12375259|FG001|Part 2|Withdrawal by Subject|0
7878892|NCT01734382|12375260|FG002|Part 2|Withdrawal by Subject|1
7878893|NCT01734395|12375272|FG000|Overall Study|Other|65
7878894|NCT01734395|12375272|FG000|Overall Study|Lost to Follow-up|287
7878895|NCT01734395|12375272|FG000|Overall Study|Lack of Efficacy|5
7878896|NCT01734395|12375272|FG000|Overall Study|Adverse Event|40
7878897|NCT01734395|12375272|FG000|Overall Study|Withdrawal by Subject|10
7878898|NCT01734395|12375272|FG000|Overall Study|Missing the reasons for not completed|3
7878899|NCT01734434|12375280|FG000|Overall Study|Death Infant|3
7878900|NCT01734434|12375281|FG001|Overall Study|Death Infant|1
7878901|NCT01734434|12375282|FG002|Overall Study|Death Infant|17
7878902|NCT01734434|12375283|FG003|Overall Study|Death Infant|5
7878903|NCT01734434|12375280|FG000|Overall Study|Lost to Follow-up|2
7878904|NCT01734434|12375281|FG001|Overall Study|Lost to Follow-up|9
7878905|NCT01734434|12375282|FG002|Overall Study|Lost to Follow-up|67
7878906|NCT01734434|12375283|FG003|Overall Study|Lost to Follow-up|11
7878907|NCT01734434|12375280|FG000|Overall Study|No Live Birth|1
7878908|NCT01734434|12375281|FG001|Overall Study|No Live Birth|2
7878909|NCT01734434|12375282|FG002|Overall Study|No Live Birth|32
7878910|NCT01734434|12375283|FG003|Overall Study|No Live Birth|6
7878911|NCT01734434|12375280|FG000|Overall Study|Withdrawal by Subject|4
7878912|NCT01734434|12375281|FG001|Overall Study|Withdrawal by Subject|0
7878913|NCT01734434|12375282|FG002|Overall Study|Withdrawal by Subject|8
7878914|NCT01734434|12375283|FG003|Overall Study|Withdrawal by Subject|1
7878915|NCT01734434|12375280|FG000|Overall Study|Signed Adult Version of Consent Form|0
7878916|NCT01734434|12375281|FG001|Overall Study|Signed Adult Version of Consent Form|0
7878917|NCT01734434|12375282|FG002|Overall Study|Signed Adult Version of Consent Form|1
7878918|NCT01734434|12375283|FG003|Overall Study|Signed Adult Version of Consent Form|0
7878919|NCT01734434|12375280|FG000|Overall Study|Subject Not Reachable|0
7878920|NCT01734434|12375281|FG001|Overall Study|Subject Not Reachable|0
7878921|NCT01734434|12375282|FG002|Overall Study|Subject Not Reachable|1
7878922|NCT01734434|12375283|FG003|Overall Study|Subject Not Reachable|0
7878923|NCT01734434|12375280|FG000|Overall Study|Treatment Defaulter|0
7878924|NCT01734434|12375281|FG001|Overall Study|Treatment Defaulter|0
7878925|NCT01734434|12375282|FG002|Overall Study|Treatment Defaulter|1
7878926|NCT01734434|12375283|FG003|Overall Study|Treatment Defaulter|0
7878927|NCT01734434|12375280|FG000|Overall Study|Wrong Version of Consent Form Signed|0
7878928|NCT01734434|12375281|FG001|Overall Study|Wrong Version of Consent Form Signed|0
7878929|NCT01734434|12375282|FG002|Overall Study|Wrong Version of Consent Form Signed|1
7878930|NCT01734434|12375283|FG003|Overall Study|Wrong Version of Consent Form Signed|0
7878931|NCT01734434|12375280|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0
7878932|NCT01734434|12375281|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0
7878933|NCT01734434|12375282|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1
7878934|NCT01734434|12375283|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0
7878935|NCT01734772|12375328|FG000|Overall Study|Adverse Event|1
7878936|NCT01734772|12375329|FG001|Overall Study|Adverse Event|2
7878937|NCT01734772|12375328|FG000|Overall Study|Withdrawal by Subject|0
7878938|NCT01734772|12375329|FG001|Overall Study|Withdrawal by Subject|1
7878939|NCT01734785|12375344|FG000|Open-Label Period|Adverse Event|0
7878940|NCT01734785|12375345|FG001|Open-Label Period|Adverse Event|0
7878941|NCT01734785|12375346|FG002|Open-Label Period|Adverse Event|0
7878942|NCT01734785|12375347|FG003|Open-Label Period|Adverse Event|9
7878943|NCT01734785|12375344|FG000|Open-Label Period|Lack of Efficacy|0
7878944|NCT01734785|12375345|FG001|Open-Label Period|Lack of Efficacy|0
7878945|NCT01734785|12375346|FG002|Open-Label Period|Lack of Efficacy|0
7878946|NCT01734785|12375347|FG003|Open-Label Period|Lack of Efficacy|1
7878947|NCT01734785|12375344|FG000|Open-Label Period|Protocol Violation|0
7878948|NCT01734785|12375345|FG001|Open-Label Period|Protocol Violation|0
7878949|NCT01734785|12375346|FG002|Open-Label Period|Protocol Violation|0
7878950|NCT01734785|12375347|FG003|Open-Label Period|Protocol Violation|13
7878951|NCT01734785|12375344|FG000|Open-Label Period|Lost to Follow-up|0
7878952|NCT01734785|12375345|FG001|Open-Label Period|Lost to Follow-up|0
7878953|NCT01734785|12375346|FG002|Open-Label Period|Lost to Follow-up|0
7878954|NCT01734785|12375347|FG003|Open-Label Period|Lost to Follow-up|14
7878955|NCT01734785|12375344|FG000|Open-Label Period|Withdrawal by Subject|0
7878956|NCT01734785|12375345|FG001|Open-Label Period|Withdrawal by Subject|0
7878957|NCT01734785|12375346|FG002|Open-Label Period|Withdrawal by Subject|0
7878958|NCT01734785|12375347|FG003|Open-Label Period|Withdrawal by Subject|12
7878959|NCT01734785|12375344|FG000|Open-Label Period|Other Reasons|0
7878960|NCT01734785|12375345|FG001|Open-Label Period|Other Reasons|0
7878961|NCT01734785|12375346|FG002|Open-Label Period|Other Reasons|0
7878962|NCT01734785|12375347|FG003|Open-Label Period|Other Reasons|224
7878963|NCT01734785|12375344|FG000|Double-Blind Period|Adverse Event|0
7878964|NCT01734785|12375345|FG001|Double-Blind Period|Adverse Event|3
7878965|NCT01734785|12375346|FG002|Double-Blind Period|Adverse Event|2
7878966|NCT01734785|12375347|FG003|Double-Blind Period|Adverse Event|0
7878967|NCT01734785|12375344|FG000|Double-Blind Period|Lack of Efficacy|0
7878968|NCT01734785|12375345|FG001|Double-Blind Period|Lack of Efficacy|1
7878969|NCT01734785|12375346|FG002|Double-Blind Period|Lack of Efficacy|0
7878970|NCT01734785|12375347|FG003|Double-Blind Period|Lack of Efficacy|0
7878971|NCT01734785|12375344|FG000|Double-Blind Period|Protocol Violation|0
7878972|NCT01734785|12375345|FG001|Double-Blind Period|Protocol Violation|1
7878973|NCT01734785|12375346|FG002|Double-Blind Period|Protocol Violation|1
7878974|NCT01734785|12375347|FG003|Double-Blind Period|Protocol Violation|0
7878975|NCT01734785|12375344|FG000|Double-Blind Period|Lost to Follow-up|2
7878976|NCT01734785|12375345|FG001|Double-Blind Period|Lost to Follow-up|4
7878977|NCT01734785|12375346|FG002|Double-Blind Period|Lost to Follow-up|2
7878978|NCT01734785|12375347|FG003|Double-Blind Period|Lost to Follow-up|0
7878979|NCT01734785|12375344|FG000|Double-Blind Period|Withdrawal by Subject|2
7878980|NCT01734785|12375345|FG001|Double-Blind Period|Withdrawal by Subject|0
7878981|NCT01734785|12375346|FG002|Double-Blind Period|Withdrawal by Subject|0
7878982|NCT01734785|12375347|FG003|Double-Blind Period|Withdrawal by Subject|0
7878983|NCT01734785|12375344|FG000|Double-Blind Period|Not treated|1
7878984|NCT01734785|12375345|FG001|Double-Blind Period|Not treated|0
7878985|NCT01734785|12375346|FG002|Double-Blind Period|Not treated|0
7878986|NCT01734785|12375347|FG003|Double-Blind Period|Not treated|0
7878987|NCT01734811|12375358|FG000|Overall Study|Lost to Follow-up|2
7878988|NCT01734811|12375359|FG001|Overall Study|Lost to Follow-up|3
7878989|NCT01734811|12375358|FG000|Overall Study|Withdrawal by Subject|2
7878990|NCT01734811|12375359|FG001|Overall Study|Withdrawal by Subject|0
7878991|NCT01734850|12375368|FG000|Overall Study|Continued to Week 48 but recommenced ART|3
7878992|NCT01734850|12375369|FG001|Overall Study|Continued to Week 48 but recommenced ART|2
7878993|NCT01734850|12375370|FG002|Overall Study|Continued to Week 48 but recommenced ART|3
7878994|NCT01734850|12375368|FG000|Overall Study|Not infused due to manufacturing failure|0
7878995|NCT01734850|12375369|FG001|Overall Study|Not infused due to manufacturing failure|0
7878996|NCT01734850|12375370|FG002|Overall Study|Not infused due to manufacturing failure|1
7883221|NCT01780935|12382836|FG001|Overall Study|Patient withdrew consent|9
7883222|NCT01780974|12382844|FG000|Overall Study|Death|1
7883223|NCT01780974|12382845|FG001|Overall Study|Death|0
7883224|NCT01780974|12382844|FG000|Overall Study|Adverse Event|1
7883225|NCT01780974|12382845|FG001|Overall Study|Adverse Event|3
7883226|NCT01780987|12382853|FG000|Overall Study|Adverse Event|0
7883227|NCT01780987|12382854|FG001|Overall Study|Adverse Event|4
7883228|NCT01780987|12382853|FG000|Overall Study|Withdrawal by Subject|2
7883229|NCT01780987|12382854|FG001|Overall Study|Withdrawal by Subject|0
7883230|NCT01780987|12382853|FG000|Overall Study|Request of Changing Hospital|0
7883231|NCT01780987|12382854|FG001|Overall Study|Request of Changing Hospital|1
7883232|NCT01780987|12382853|FG000|Overall Study|Changing Residence|1
7883233|NCT01780987|12382854|FG001|Overall Study|Changing Residence|0
7883234|NCT01780987|12382853|FG000|Overall Study|Not Receiving any Study Medication|0
7883235|NCT01780987|12382854|FG001|Overall Study|Not Receiving any Study Medication|1
7883236|NCT01781234|12382889|FG000|Overall Study|Adverse Event|2
7883237|NCT01781234|12382890|FG001|Overall Study|Adverse Event|0
7883238|NCT01781234|12382889|FG000|Overall Study|Protocol Violation|3
7883239|NCT01781234|12382890|FG001|Overall Study|Protocol Violation|0
7883240|NCT01781234|12382889|FG000|Overall Study|Withdrawal by Subject|4
7883241|NCT01781234|12382890|FG001|Overall Study|Withdrawal by Subject|3
7883242|NCT01781286|12382898|FG000|Overall Study|Lost to Follow-up|0
7883243|NCT01781286|12382899|FG001|Overall Study|Lost to Follow-up|0
7883244|NCT01781286|12382900|FG002|Overall Study|Lost to Follow-up|0
7878997|NCT01734902|12375388|FG000|Overall Study|Other than listed|0
7878998|NCT01734902|12375389|FG001|Overall Study|Other than listed|2
7878999|NCT01734993|12375395|FG000|Overall Study|Adverse Event|1
7879000|NCT01734993|12375395|FG000|Overall Study|Lack of Efficacy|1
7879001|NCT01735175|12375402|FG000|Overall Study|Withdrawal by Subject|9
7879002|NCT01735175|12375403|FG001|Overall Study|Withdrawal by Subject|2
7879003|NCT01735175|12375402|FG000|Overall Study|Lost to Follow-up|4
7879004|NCT01735175|12375403|FG001|Overall Study|Lost to Follow-up|2
7879005|NCT01735175|12375402|FG000|Overall Study|Death|3
7879006|NCT01735175|12375403|FG001|Overall Study|Death|2
7879007|NCT01735175|12375402|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13
7879008|NCT01735175|12375403|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7
7879009|NCT01735201|12375417|FG000|Overall Study|Adverse Event|1
7879010|NCT01735201|12375418|FG001|Overall Study|Adverse Event|1
7879011|NCT01735201|12375419|FG002|Overall Study|Adverse Event|0
7879012|NCT01735201|12375420|FG003|Overall Study|Adverse Event|1
7879013|NCT01735201|12375421|FG004|Overall Study|Adverse Event|1
7879014|NCT01735201|12375422|FG005|Overall Study|Adverse Event|3
7879015|NCT01735201|12375423|FG006|Overall Study|Adverse Event|2
7879016|NCT01735201|12375424|FG007|Overall Study|Adverse Event|1
7879017|NCT01735201|12375417|FG000|Overall Study|Personal Reasons|1
7879018|NCT01735201|12375418|FG001|Overall Study|Personal Reasons|0
7879019|NCT01735201|12375419|FG002|Overall Study|Personal Reasons|0
7879020|NCT01735201|12375420|FG003|Overall Study|Personal Reasons|0
7879021|NCT01735201|12375421|FG004|Overall Study|Personal Reasons|0
7879022|NCT01735201|12375422|FG005|Overall Study|Personal Reasons|0
7879023|NCT01735201|12375423|FG006|Overall Study|Personal Reasons|0
7879024|NCT01735201|12375424|FG007|Overall Study|Personal Reasons|0
7879025|NCT01735201|12375417|FG000|Overall Study|Protocol Violation|1
7879026|NCT01735201|12375418|FG001|Overall Study|Protocol Violation|0
7879027|NCT01735201|12375419|FG002|Overall Study|Protocol Violation|0
7879028|NCT01735201|12375420|FG003|Overall Study|Protocol Violation|0
7879029|NCT01735201|12375421|FG004|Overall Study|Protocol Violation|0
7879030|NCT01735201|12375422|FG005|Overall Study|Protocol Violation|0
7879031|NCT01735201|12375423|FG006|Overall Study|Protocol Violation|0
7879032|NCT01735201|12375424|FG007|Overall Study|Protocol Violation|0
7879033|NCT01735201|12375417|FG000|Overall Study|Other Miscellaneous Reasons|0
7879034|NCT01735201|12375418|FG001|Overall Study|Other Miscellaneous Reasons|0
7879035|NCT01735201|12375419|FG002|Overall Study|Other Miscellaneous Reasons|0
7879036|NCT01735201|12375420|FG003|Overall Study|Other Miscellaneous Reasons|1
7879037|NCT01735201|12375421|FG004|Overall Study|Other Miscellaneous Reasons|0
7879038|NCT01735201|12375422|FG005|Overall Study|Other Miscellaneous Reasons|2
7879039|NCT01735201|12375423|FG006|Overall Study|Other Miscellaneous Reasons|1
7879040|NCT01735201|12375424|FG007|Overall Study|Other Miscellaneous Reasons|1
7879041|NCT01735279|12375448|FG000|Overall Study|Lost to Follow-up|11
7879042|NCT01735279|12375449|FG001|Overall Study|Lost to Follow-up|8
7879043|NCT01735396|12375455|FG000|Overall Study|not evaluable|1
7879044|NCT01735630|12375468|FG000|Overall Study|Adverse Event|8
7879045|NCT01735630|12375469|FG001|Overall Study|Adverse Event|7
7879046|NCT01735630|12375468|FG000|Overall Study|Lost to Follow-up|1
7879047|NCT01735630|12375469|FG001|Overall Study|Lost to Follow-up|0
7879048|NCT01735630|12375468|FG000|Overall Study|Physician Decision|0
7879049|NCT01735630|12375469|FG001|Overall Study|Physician Decision|1
7797030|NCT01072344|12253338|FG001|Overall Study|Relasped-reached end point|12
7797031|NCT01072344|12253337|FG000|Overall Study|Protocol Violation|1
7797032|NCT01072344|12253338|FG001|Overall Study|Protocol Violation|2
7797033|NCT01072344|12253337|FG000|Overall Study|Lost to Follow-up|3
7797034|NCT01072344|12253338|FG001|Overall Study|Lost to Follow-up|4
7797035|NCT01072357|12253346|FG000|Overall Study|Lost to Follow-up|0
7797036|NCT01072357|12253347|FG001|Overall Study|Lost to Follow-up|1
7797037|NCT01072396|12253355|FG000|Period One|Adverse Event|1
7797038|NCT01072396|12253356|FG001|Period One|Adverse Event|1
7797039|NCT01072396|12253355|FG000|Period One|Protocol Violation|2
7797040|NCT01072396|12253356|FG001|Period One|Protocol Violation|1
7797041|NCT01072396|12253355|FG000|Period One|Withdrawal by Subject|2
7797042|NCT01072396|12253356|FG001|Period One|Withdrawal by Subject|0
7797043|NCT01072396|12253355|FG000|Washout Period|Missing termination information|0
7797044|NCT01072396|12253356|FG001|Washout Period|Missing termination information|1
7797045|NCT01072396|12253355|FG000|Period Two|Adverse Event|0
7797046|NCT01072396|12253356|FG001|Period Two|Adverse Event|3
7797047|NCT01072396|12253355|FG000|Period Two|Lost to Follow-up|1
7797048|NCT01072396|12253356|FG001|Period Two|Lost to Follow-up|0
7797049|NCT01072448|12253368|FG000|Overall Study|Adverse Event|9
7797050|NCT01072448|12253369|FG001|Overall Study|Adverse Event|10
7797051|NCT01072448|12253368|FG000|Overall Study|Subject withdrew consent|4
7797052|NCT01072448|12253369|FG001|Overall Study|Subject withdrew consent|9
7797053|NCT01072448|12253368|FG000|Overall Study|Protocol deviation|3
7797054|NCT01072448|12253369|FG001|Overall Study|Protocol deviation|4
7797055|NCT01072448|12253368|FG000|Overall Study|Abnormal test procedure result(s)|1
7797056|NCT01072448|12253369|FG001|Overall Study|Abnormal test procedure result(s)|0
7879050|NCT01735630|12375468|FG000|Overall Study|Sponsor Decision|2
7879051|NCT01735630|12375469|FG001|Overall Study|Sponsor Decision|1
7879052|NCT01735630|12375468|FG000|Overall Study|Withdrawal by Subject|7
7879053|NCT01735630|12375469|FG001|Overall Study|Withdrawal by Subject|9
7879054|NCT01735916|12375487|FG000|Overall Study|Subject not eligible to be randomized|11
7879055|NCT01735916|12375488|FG001|Overall Study|Subject not eligible to be randomized|0
7797057|NCT01072448|12253368|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7797058|NCT01072448|12253369|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7797059|NCT01072448|12253368|FG000|Overall Study|Lost to Follow-up|1
7797060|NCT01072448|12253369|FG001|Overall Study|Lost to Follow-up|1
7797061|NCT01072448|12253368|FG000|Overall Study|Abnormal laboratory value(s)|0
7797062|NCT01072448|12253369|FG001|Overall Study|Abnormal laboratory value(s)|1
7797063|NCT01072448|12253368|FG000|Overall Study|Death|0
7797064|NCT01072448|12253369|FG001|Overall Study|Death|2
7797065|NCT01072500|12253377|FG000|Overall Study|Death|2
7797066|NCT01072500|12253378|FG001|Overall Study|Death|2
7797067|NCT01072500|12253377|FG000|Overall Study|Lost to Follow-up|5
7797068|NCT01072500|12253378|FG001|Overall Study|Lost to Follow-up|2
7797069|NCT01072500|12253377|FG000|Overall Study|Withdrawal by Subject|17
7797070|NCT01072500|12253378|FG001|Overall Study|Withdrawal by Subject|10
7797071|NCT01072539|12253386|FG000|Overall Study|Treated prior to the Site Initiation|1
7797072|NCT01072539|12253386|FG000|Overall Study|Protocol Violation|2
7879056|NCT01735916|12375489|FG002|Overall Study|Subject not eligible to be randomized|0
7879057|NCT01735916|12375487|FG000|Overall Study|Early termination of study by sponsor|4
7879058|NCT01735916|12375488|FG001|Overall Study|Early termination of study by sponsor|19
7879059|NCT01735916|12375489|FG002|Overall Study|Early termination of study by sponsor|7
7879060|NCT01735916|12375487|FG000|Overall Study|Withdrawal by Subject|3
7879061|NCT01735916|12375488|FG001|Overall Study|Withdrawal by Subject|0
7879062|NCT01735916|12375489|FG002|Overall Study|Withdrawal by Subject|0
7879063|NCT01735994|12375509|FG000|Overall Study|Withdrawal by Subject|6
7879064|NCT01735994|12375510|FG001|Overall Study|Withdrawal by Subject|4
7879065|NCT01735994|12375509|FG000|Overall Study|Injury|2
7879066|NCT01735994|12375510|FG001|Overall Study|Injury|0
7879067|NCT01735994|12375509|FG000|Overall Study|Kicked off team|5
7879068|NCT01735994|12375510|FG001|Overall Study|Kicked off team|0
7879069|NCT01735994|12375509|FG000|Overall Study|Lost to Follow-up|50
7879070|NCT01735994|12375510|FG001|Overall Study|Lost to Follow-up|62
7879071|NCT01736124|12375540|FG000|Post-intervention Assessment|Death|2
7879072|NCT01736124|12375541|FG001|Post-intervention Assessment|Death|2
7879073|NCT01736124|12375540|FG000|Post-intervention Assessment|lost computer access|1
7879074|NCT01736124|12375541|FG001|Post-intervention Assessment|lost computer access|1
7879075|NCT01736124|12375540|FG000|Post-intervention Assessment|Moved away|3
7879076|NCT01736124|12375541|FG001|Post-intervention Assessment|Moved away|1
7879077|NCT01736124|12375540|FG000|Post-intervention Assessment|Withdrawal by Subject|11
7879078|NCT01736124|12375541|FG001|Post-intervention Assessment|Withdrawal by Subject|9
7879079|NCT01736124|12375540|FG000|Post-intervention Assessment|Illness|3
7879080|NCT01736124|12375541|FG001|Post-intervention Assessment|Illness|2
7879081|NCT01736124|12375540|FG000|Post-intervention Assessment|Lost to Follow-up|8
7879082|NCT01736124|12375541|FG001|Post-intervention Assessment|Lost to Follow-up|5
7879083|NCT01736124|12375540|FG000|Post-intervention Assessment|Temporarily away|3
7879084|NCT01736124|12375541|FG001|Post-intervention Assessment|Temporarily away|1
7879085|NCT01736124|12375540|FG000|6 Mo. Post-Intervention Assessment|Death|0
7879086|NCT01736124|12375541|FG001|6 Mo. Post-Intervention Assessment|Death|1
7879087|NCT01736124|12375540|FG000|6 Mo. Post-Intervention Assessment|Moved away|0
7879088|NCT01736124|12375541|FG001|6 Mo. Post-Intervention Assessment|Moved away|2
7879089|NCT01736124|12375540|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
7879090|NCT01736124|12375541|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
7879091|NCT01736124|12375540|FG000|6 Mo. Post-Intervention Assessment|Illness|1
7879092|NCT01736124|12375541|FG001|6 Mo. Post-Intervention Assessment|Illness|2
7879093|NCT01736124|12375540|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1
7879094|NCT01736124|12375541|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4
7879095|NCT01736124|12375540|FG000|12 Mo. Post-Intervention Assessment|Death|1
7879096|NCT01736124|12375541|FG001|12 Mo. Post-Intervention Assessment|Death|0
7879097|NCT01736124|12375540|FG000|12 Mo. Post-Intervention Assessment|Moved away|1
7879098|NCT01736124|12375541|FG001|12 Mo. Post-Intervention Assessment|Moved away|0
7879099|NCT01736124|12375540|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0
7879100|NCT01736124|12375541|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2
7879101|NCT01736124|12375540|FG000|12 Mo. Post-Intervention Assessment|End of study|10
7879102|NCT01736124|12375541|FG001|12 Mo. Post-Intervention Assessment|End of study|10
7879103|NCT01736176|12375549|FG000|Overall Study|Adverse Event|3
7879104|NCT01736176|12375549|FG000|Overall Study|Withdrawal by Subject|4
7879105|NCT01736176|12375549|FG000|Overall Study|Lack of Efficacy|3
7879106|NCT01736176|12375549|FG000|Overall Study|Unable to Complete PEG Placement|1
7879107|NCT01736189|12375557|FG000|Overall Study|Violation of registration criteria|41
7879108|NCT01736189|12375557|FG000|Overall Study|Protocol Violation|4
7879109|NCT01736189|12375557|FG000|Overall Study|Criteria and protocol violations|1
7879110|NCT01736215|12375561|FG000|Overall Study|Early termination of erythropoietin use|1
7879111|NCT01736215|12375561|FG000|Overall Study|Adverse Event|4
7879112|NCT01736215|12375561|FG000|Overall Study|Progressive disease stop chemotherapy|1
7879113|NCT01736215|12375561|FG000|Overall Study|Insufficient data to perform analysis|8
7879114|NCT01736254|12375595|FG000|Period 2 (Days 2 to 12)|Adverse Event|3
7879115|NCT01736254|12375595|FG000|Period 3 (Days 13 to 23)|Adverse Event|1
7879116|NCT01736397|12375618|FG000|Overall Study|Lack of Efficacy|1
7879117|NCT01736397|12375619|FG001|Overall Study|Lack of Efficacy|11
7879118|NCT01736397|12375618|FG000|Overall Study|Withdrawal by Subject|6
7879119|NCT01736397|12375619|FG001|Overall Study|Withdrawal by Subject|5
7879120|NCT01736397|12375618|FG000|Overall Study|Lost to Follow-up|0
7879121|NCT01736397|12375619|FG001|Overall Study|Lost to Follow-up|1
7879122|NCT01736397|12375618|FG000|Overall Study|Adverse Event|6
7879123|NCT01736397|12375619|FG001|Overall Study|Adverse Event|3
7879124|NCT01736397|12375618|FG000|Overall Study|Not stated|1
7879125|NCT01736397|12375619|FG001|Overall Study|Not stated|4
7879126|NCT01736475|12375627|FG000|Overall Study|Adverse Event|4
7879127|NCT01736475|12375628|FG001|Overall Study|Adverse Event|0
7879128|NCT01736475|12375627|FG000|Overall Study|Withdrawal by Subject|2
7879129|NCT01736475|12375628|FG001|Overall Study|Withdrawal by Subject|0
7879130|NCT01736475|12375627|FG000|Overall Study|Protocol Violation|4
7879131|NCT01736475|12375628|FG001|Overall Study|Protocol Violation|0
7879132|NCT01736475|12375627|FG000|Overall Study|Other - Screen failure|1
7879133|NCT01736475|12375628|FG001|Overall Study|Other - Screen failure|0
7879134|NCT01736475|12375627|FG000|Overall Study|Other - Surgical procedure|1
7879135|NCT01736475|12375628|FG001|Overall Study|Other - Surgical procedure|0
7879136|NCT01736540|12375649|FG000|Overall Study|Did not complete scan within 45 days|2
7879137|NCT01736540|12375649|FG000|Overall Study|Death|1
7879138|NCT01736540|12375649|FG000|Overall Study|Abnormal test procedure|1
7879139|NCT01736540|12375649|FG000|Overall Study|Withdrawal by Subject|5
7879140|NCT01736540|12375649|FG000|Overall Study|Protocol Violation|1
7879141|NCT01736540|12375649|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1
7879142|NCT01736540|12375649|FG000|Overall Study|No show for MRI appointment|1
7879143|NCT01736540|12375649|FG000|Overall Study|Unable to make MRI appointment|3
7879144|NCT01736553|12375662|FG000|Overall Study|Death|12
7879145|NCT01736553|12375663|FG001|Overall Study|Death|0
7879146|NCT01736553|12375662|FG000|Overall Study|Withdrawal by Subject|5
7879147|NCT01736553|12375663|FG001|Overall Study|Withdrawal by Subject|2
7879148|NCT01736553|12375662|FG000|Overall Study|Lost to Follow-up|2
7879149|NCT01736553|12375663|FG001|Overall Study|Lost to Follow-up|2
7879150|NCT01736566|12375692|FG000|Long Term Follow-up|Still collecting data|42
7879151|NCT01736566|12375693|FG001|Long Term Follow-up|Still collecting data|0
7879152|NCT01736566|12375694|FG002|Long Term Follow-up|Still collecting data|49
7879153|NCT01736566|12375695|FG003|Long Term Follow-up|Still collecting data|0
7879154|NCT01736566|12375696|FG004|Long Term Follow-up|Still collecting data|1
7879155|NCT01736579|12375723|FG000|Overall Study|Termination of Study by Sponsor|2
7879156|NCT01736579|12375724|FG001|Overall Study|Termination of Study by Sponsor|2
7879157|NCT01736657|12375730|FG000|Overall Study|insufficient vascular access|1
7879158|NCT01736683|12375739|FG000|Overall Study|Disease Relapse|0
7879159|NCT01736683|12375740|FG001|Overall Study|Disease Relapse|0
7879160|NCT01736683|12375741|FG002|Overall Study|Disease Relapse|2
7879161|NCT01736683|12375742|FG003|Overall Study|Disease Relapse|1
7879162|NCT01736683|12375743|FG004|Overall Study|Disease Relapse|0
7879163|NCT01736683|12375739|FG000|Overall Study|Adverse Event|0
7879164|NCT01736683|12375740|FG001|Overall Study|Adverse Event|2
7879165|NCT01736683|12375741|FG002|Overall Study|Adverse Event|2
7879166|NCT01736683|12375742|FG003|Overall Study|Adverse Event|3
7879167|NCT01736683|12375743|FG004|Overall Study|Adverse Event|2
7879168|NCT01736683|12375739|FG000|Overall Study|Withdrawal by Subject|0
7879169|NCT01736683|12375740|FG001|Overall Study|Withdrawal by Subject|0
7879170|NCT01736683|12375741|FG002|Overall Study|Withdrawal by Subject|3
7879171|NCT01736683|12375742|FG003|Overall Study|Withdrawal by Subject|1
7879172|NCT01736683|12375743|FG004|Overall Study|Withdrawal by Subject|1
7879173|NCT01736683|12375739|FG000|Overall Study|Lack of Therapeutic Effect|7
7879174|NCT01736683|12375740|FG001|Overall Study|Lack of Therapeutic Effect|4
7879175|NCT01736683|12375741|FG002|Overall Study|Lack of Therapeutic Effect|13
7879176|NCT01736683|12375742|FG003|Overall Study|Lack of Therapeutic Effect|20
7879177|NCT01736683|12375743|FG004|Overall Study|Lack of Therapeutic Effect|1
7879178|NCT01736683|12375739|FG000|Overall Study|Progressive Disease|0
7879179|NCT01736683|12375740|FG001|Overall Study|Progressive Disease|0
7879180|NCT01736683|12375741|FG002|Overall Study|Progressive Disease|0
7879181|NCT01736683|12375742|FG003|Overall Study|Progressive Disease|1
7879182|NCT01736683|12375743|FG004|Overall Study|Progressive Disease|0
7879183|NCT01736683|12375739|FG000|Overall Study|Other|0
7879184|NCT01736683|12375740|FG001|Overall Study|Other|0
7879185|NCT01736683|12375741|FG002|Overall Study|Other|1
7879186|NCT01736683|12375742|FG003|Overall Study|Other|9
7879187|NCT01736683|12375743|FG004|Overall Study|Other|1
7879188|NCT01736696|12375764|FG000|Overall Study|Withdrawal by Subject|0
7879189|NCT01736696|12375765|FG001|Overall Study|Withdrawal by Subject|0
7879190|NCT01736696|12375766|FG002|Overall Study|Withdrawal by Subject|1
7879191|NCT01736696|12375767|FG003|Overall Study|Withdrawal by Subject|0
7879192|NCT01736696|12375768|FG004|Overall Study|Withdrawal by Subject|0
7879193|NCT01736696|12375769|FG005|Overall Study|Withdrawal by Subject|0
7879194|NCT01736696|12375770|FG006|Overall Study|Withdrawal by Subject|0
7879195|NCT01736917|12375812|FG000|Overall Study|Adverse Event|1
7879196|NCT01736917|12375812|FG000|Overall Study|Protocol Violation|10
7879197|NCT01737268|12375828|FG000|Overall Study|Adverse Event|6
7879198|NCT01737268|12375828|FG000|Overall Study|Worsening of Target Disease|2
7879199|NCT01737268|12375828|FG000|Overall Study|In consideration of the patient's safety|1
7879200|NCT01737398|12375844|FG000|Overall Study|Adverse event or SAE|16
7879201|NCT01737398|12375845|FG001|Overall Study|Adverse event or SAE|1
7879202|NCT01737398|12375844|FG000|Overall Study|Stopping rule met|2
7879203|NCT01737398|12375845|FG001|Overall Study|Stopping rule met|1
7879204|NCT01737398|12375844|FG000|Overall Study|Voluntary withdrawal|2
7879205|NCT01737398|12375845|FG001|Overall Study|Voluntary withdrawal|3
7879206|NCT01737398|12375844|FG000|Overall Study|Ineligibility|1
7879207|NCT01737398|12375845|FG001|Overall Study|Ineligibility|0
7879208|NCT01737398|12375844|FG000|Overall Study|Liver transplant|1
7879209|NCT01737398|12375845|FG001|Overall Study|Liver transplant|0
7879210|NCT01737398|12375844|FG000|Overall Study|Disease progression|2
7879211|NCT01737398|12375845|FG001|Overall Study|Disease progression|3
7879212|NCT01737398|12375844|FG000|Overall Study|Sponsor's decision|2
7879213|NCT01737398|12375845|FG001|Overall Study|Sponsor's decision|0
7879214|NCT01737697|12375885|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0
7879215|NCT01737697|12375886|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1
7879216|NCT01737697|12375887|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0
7879217|NCT01737697|12375888|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1
7879218|NCT01737697|12375889|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1
7879219|NCT01737697|12375890|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0
7879220|NCT01737697|12375891|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0
7879221|NCT01737697|12375892|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0
7879222|NCT01737697|12375893|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0
7879223|NCT01737697|12375894|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0
7879224|NCT01737697|12375895|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0
7879225|NCT01737697|12375896|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0
7879226|NCT01737697|12375897|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0
7879227|NCT01737697|12375898|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0
7879228|NCT01737697|12375899|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0
7879229|NCT01737697|12375885|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
7879230|NCT01737697|12375886|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
7879231|NCT01737697|12375887|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
7879232|NCT01737697|12375888|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7879233|NCT01737697|12375889|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7879234|NCT01737697|12375890|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7879235|NCT01737697|12375891|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7879236|NCT01737697|12375892|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7879237|NCT01737697|12375893|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7879238|NCT01737697|12375894|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7879239|NCT01737697|12375895|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7879240|NCT01737697|12375896|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7879241|NCT01737697|12375897|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7879242|NCT01737697|12375898|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7879243|NCT01737697|12375899|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7879244|NCT01737697|12375885|FG000|Acute Phase-Initial 48 Hours|Family emergency|0
7879245|NCT01737697|12375886|FG001|Acute Phase-Initial 48 Hours|Family emergency|0
7879246|NCT01737697|12375887|FG002|Acute Phase-Initial 48 Hours|Family emergency|0
7879247|NCT01737697|12375888|FG003|Acute Phase-Initial 48 Hours|Family emergency|1
7879248|NCT01737697|12375889|FG004|Acute Phase-Initial 48 Hours|Family emergency|0
7879249|NCT01737697|12375890|FG005|Acute Phase-Initial 48 Hours|Family emergency|0
7879250|NCT01737697|12375891|FG006|Acute Phase-Initial 48 Hours|Family emergency|0
7879251|NCT01737697|12375892|FG007|Acute Phase-Initial 48 Hours|Family emergency|0
7879252|NCT01737697|12375893|FG008|Acute Phase-Initial 48 Hours|Family emergency|0
7879253|NCT01737697|12375894|FG009|Acute Phase-Initial 48 Hours|Family emergency|0
7879254|NCT01737697|12375895|FG010|Acute Phase-Initial 48 Hours|Family emergency|0
7879255|NCT01737697|12375896|FG011|Acute Phase-Initial 48 Hours|Family emergency|0
7879256|NCT01737697|12375897|FG012|Acute Phase-Initial 48 Hours|Family emergency|0
7879257|NCT01737697|12375898|FG013|Acute Phase-Initial 48 Hours|Family emergency|0
7879258|NCT01737697|12375899|FG014|Acute Phase-Initial 48 Hours|Family emergency|0
7879259|NCT01737697|12375885|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7879260|NCT01737697|12375886|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1
7879261|NCT01737697|12375887|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7879262|NCT01737697|12375888|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7879263|NCT01737697|12375889|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7879264|NCT01737697|12375890|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7879265|NCT01737697|12375891|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7879266|NCT01737697|12375892|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7879267|NCT01737697|12375893|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7879268|NCT01737697|12375894|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7879269|NCT01737697|12375895|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7879270|NCT01737697|12375896|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7879271|NCT01737697|12375897|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7879272|NCT01737697|12375898|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7879273|NCT01737697|12375899|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7879274|NCT01737697|12375885|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7879275|NCT01737697|12375886|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7879276|NCT01737697|12375887|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7879277|NCT01737697|12375888|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7879278|NCT01737697|12375889|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
7879279|NCT01737697|12375890|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7879280|NCT01737697|12375891|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7879281|NCT01737697|12375892|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7879282|NCT01737697|12375893|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7879283|NCT01737697|12375894|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7879284|NCT01737697|12375895|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7879285|NCT01737697|12375896|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7879286|NCT01737697|12375897|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7879287|NCT01737697|12375898|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7879288|NCT01737697|12375899|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7879289|NCT01737697|12375885|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7879290|NCT01737697|12375886|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
7879291|NCT01737697|12375887|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
7879292|NCT01737697|12375888|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
7879293|NCT01737697|12375889|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
7879294|NCT01737697|12375890|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7879295|NCT01737697|12375891|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7879296|NCT01737697|12375892|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7879297|NCT01737697|12375893|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7879298|NCT01737697|12375894|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7879299|NCT01737697|12375895|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7879300|NCT01737697|12375896|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7879301|NCT01737697|12375897|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7879302|NCT01737697|12375898|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7879303|NCT01737697|12375899|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7879304|NCT01737697|12375885|FG000|Subacute Phase|Adverse Event|0
7879305|NCT01737697|12375886|FG001|Subacute Phase|Adverse Event|0
7879306|NCT01737697|12375887|FG002|Subacute Phase|Adverse Event|0
7879307|NCT01737697|12375888|FG003|Subacute Phase|Adverse Event|0
7879308|NCT01737697|12375889|FG004|Subacute Phase|Adverse Event|0
7879309|NCT01737697|12375890|FG005|Subacute Phase|Adverse Event|1
7879310|NCT01737697|12375891|FG006|Subacute Phase|Adverse Event|1
7879311|NCT01737697|12375892|FG007|Subacute Phase|Adverse Event|1
7879312|NCT01737697|12375893|FG008|Subacute Phase|Adverse Event|1
7879313|NCT01737697|12375894|FG009|Subacute Phase|Adverse Event|1
7879314|NCT01737697|12375895|FG010|Subacute Phase|Adverse Event|4
7879315|NCT01737697|12375896|FG011|Subacute Phase|Adverse Event|1
7879316|NCT01737697|12375897|FG012|Subacute Phase|Adverse Event|1
7879317|NCT01737697|12375898|FG013|Subacute Phase|Adverse Event|0
7879318|NCT01737697|12375899|FG014|Subacute Phase|Adverse Event|0
7879319|NCT01737697|12375885|FG000|Subacute Phase|Withdrawal by Subject|0
7879320|NCT01737697|12375886|FG001|Subacute Phase|Withdrawal by Subject|0
7879321|NCT01737697|12375887|FG002|Subacute Phase|Withdrawal by Subject|0
7879322|NCT01737697|12375888|FG003|Subacute Phase|Withdrawal by Subject|0
7879323|NCT01737697|12375889|FG004|Subacute Phase|Withdrawal by Subject|0
7879324|NCT01737697|12375890|FG005|Subacute Phase|Withdrawal by Subject|1
7879325|NCT01737697|12375891|FG006|Subacute Phase|Withdrawal by Subject|0
7879326|NCT01737697|12375892|FG007|Subacute Phase|Withdrawal by Subject|2
7879327|NCT01737697|12375893|FG008|Subacute Phase|Withdrawal by Subject|0
7879328|NCT01737697|12375894|FG009|Subacute Phase|Withdrawal by Subject|1
7879329|NCT01737697|12375895|FG010|Subacute Phase|Withdrawal by Subject|0
7879330|NCT01737697|12375896|FG011|Subacute Phase|Withdrawal by Subject|1
7879331|NCT01737697|12375897|FG012|Subacute Phase|Withdrawal by Subject|1
7797073|NCT01072630|12253398|FG000|Overall Study|Adverse Event|11
7797074|NCT01072630|12253399|FG001|Overall Study|Adverse Event|19
7797075|NCT01072630|12253400|FG002|Overall Study|Adverse Event|2
7797076|NCT01072630|12253398|FG000|Overall Study|Lack of Efficacy|10
7797077|NCT01072630|12253399|FG001|Overall Study|Lack of Efficacy|10
7797078|NCT01072630|12253400|FG002|Overall Study|Lack of Efficacy|1
7797079|NCT01072630|12253398|FG000|Overall Study|Withdrawal by Subject|8
7797080|NCT01072630|12253399|FG001|Overall Study|Withdrawal by Subject|7
7797081|NCT01072630|12253400|FG002|Overall Study|Withdrawal by Subject|2
7797082|NCT01072630|12253398|FG000|Overall Study|Protocol Violation|10
7797083|NCT01072630|12253399|FG001|Overall Study|Protocol Violation|8
7797084|NCT01072630|12253400|FG002|Overall Study|Protocol Violation|4
7797085|NCT01072630|12253398|FG000|Overall Study|Lost to Follow-up|11
7797086|NCT01072630|12253399|FG001|Overall Study|Lost to Follow-up|11
7797087|NCT01072630|12253400|FG002|Overall Study|Lost to Follow-up|1
7797088|NCT01072630|12253398|FG000|Overall Study|Noncompliance with study medication|1
7879332|NCT01737697|12375898|FG013|Subacute Phase|Withdrawal by Subject|1
7879333|NCT01737697|12375899|FG014|Subacute Phase|Withdrawal by Subject|0
7879334|NCT01737697|12375885|FG000|Subacute Phase|Lost to Follow-up|0
7879335|NCT01737697|12375886|FG001|Subacute Phase|Lost to Follow-up|0
7879336|NCT01737697|12375887|FG002|Subacute Phase|Lost to Follow-up|0
7879337|NCT01737697|12375888|FG003|Subacute Phase|Lost to Follow-up|0
7879338|NCT01737697|12375889|FG004|Subacute Phase|Lost to Follow-up|0
7879339|NCT01737697|12375890|FG005|Subacute Phase|Lost to Follow-up|0
7879340|NCT01737697|12375891|FG006|Subacute Phase|Lost to Follow-up|0
7879341|NCT01737697|12375892|FG007|Subacute Phase|Lost to Follow-up|0
7879342|NCT01737697|12375893|FG008|Subacute Phase|Lost to Follow-up|0
7879343|NCT01737697|12375894|FG009|Subacute Phase|Lost to Follow-up|0
7879344|NCT01737697|12375895|FG010|Subacute Phase|Lost to Follow-up|0
7879345|NCT01737697|12375896|FG011|Subacute Phase|Lost to Follow-up|0
7879346|NCT01737697|12375897|FG012|Subacute Phase|Lost to Follow-up|0
7879347|NCT01737697|12375898|FG013|Subacute Phase|Lost to Follow-up|0
7879348|NCT01737697|12375899|FG014|Subacute Phase|Lost to Follow-up|1
7879349|NCT01737697|12375885|FG000|Subacute Phase|Hypo-or hyperkalemia|0
7879350|NCT01737697|12375886|FG001|Subacute Phase|Hypo-or hyperkalemia|0
7879351|NCT01737697|12375887|FG002|Subacute Phase|Hypo-or hyperkalemia|0
7797089|NCT01072630|12253399|FG001|Overall Study|Noncompliance with study medication|1
7624420|NCT04052620|12035477|FG001|Overall Study|Screened failure, randomized by mistake|1
7624421|NCT04052620|12035476|FG000|Overall Study|Personal reasons|2
7624422|NCT04052620|12035477|FG001|Overall Study|Personal reasons|4
7797090|NCT01072630|12253400|FG002|Overall Study|Noncompliance with study medication|1
7797091|NCT01072630|12253398|FG000|Overall Study|Noncompliance with study procedures|1
7797092|NCT01072630|12253399|FG001|Overall Study|Noncompliance with study procedures|2
7797093|NCT01072630|12253400|FG002|Overall Study|Noncompliance with study procedures|1
7797094|NCT01072630|12253398|FG000|Overall Study|Other|3
7797095|NCT01072630|12253399|FG001|Overall Study|Other|2
7797096|NCT01072630|12253400|FG002|Overall Study|Other|1
7797097|NCT01072877|12253460|FG000|Overall Study|Lost to Follow-up|1
7797098|NCT01072877|12253461|FG001|Overall Study|Lost to Follow-up|1
7797099|NCT01072877|12253462|FG002|Overall Study|Lost to Follow-up|0
7797100|NCT01072877|12253463|FG003|Overall Study|Lost to Follow-up|2
7797101|NCT01072877|12253464|FG004|Overall Study|Lost to Follow-up|0
7797102|NCT01072929|12253481|FG000|Overall Study|Adverse Event|8
7797103|NCT01072929|12253482|FG001|Overall Study|Adverse Event|11
7797104|NCT01072929|12253483|FG002|Overall Study|Adverse Event|2
7797105|NCT01072929|12253481|FG000|Overall Study|Lack of Efficacy|7
7797106|NCT01072929|12253482|FG001|Overall Study|Lack of Efficacy|4
7797107|NCT01072929|12253483|FG002|Overall Study|Lack of Efficacy|0
7797108|NCT01072929|12253481|FG000|Overall Study|Withdrawal by Subject|7
7797109|NCT01072929|12253482|FG001|Overall Study|Withdrawal by Subject|15
7797110|NCT01072929|12253483|FG002|Overall Study|Withdrawal by Subject|3
7797111|NCT01072929|12253481|FG000|Overall Study|Protocol Violation|13
7797112|NCT01072929|12253482|FG001|Overall Study|Protocol Violation|11
7797113|NCT01072929|12253483|FG002|Overall Study|Protocol Violation|2
7797114|NCT01072929|12253481|FG000|Overall Study|Lost to Follow-up|8
7797115|NCT01072929|12253482|FG001|Overall Study|Lost to Follow-up|4
7797116|NCT01072929|12253483|FG002|Overall Study|Lost to Follow-up|1
7797117|NCT01072929|12253481|FG000|Overall Study|Noncompliance with study medication|0
7797118|NCT01072929|12253482|FG001|Overall Study|Noncompliance with study medication|3
7797119|NCT01072929|12253483|FG002|Overall Study|Noncompliance with study medication|0
7797120|NCT01072929|12253481|FG000|Overall Study|Noncompliance with study procedures|1
7797121|NCT01072929|12253482|FG001|Overall Study|Noncompliance with study procedures|0
7797122|NCT01072929|12253483|FG002|Overall Study|Noncompliance with study procedures|1
7797123|NCT01072929|12253481|FG000|Overall Study|Other|0
7797124|NCT01072929|12253482|FG001|Overall Study|Other|3
7797125|NCT01072929|12253483|FG002|Overall Study|Other|0
7797126|NCT01073020|12253496|FG000|Overall Study|Withdrawal by Subject|6
7797127|NCT01073020|12253497|FG001|Overall Study|Withdrawal by Subject|4
7797128|NCT01073020|12253498|FG002|Overall Study|Withdrawal by Subject|1
7797129|NCT01073020|12253499|FG003|Overall Study|Withdrawal by Subject|2
7797130|NCT01073020|12253496|FG000|Overall Study|Physician Decision|1
7797131|NCT01073020|12253497|FG001|Overall Study|Physician Decision|0
7797132|NCT01073020|12253498|FG002|Overall Study|Physician Decision|2
7797133|NCT01073020|12253499|FG003|Overall Study|Physician Decision|0
7797134|NCT01073020|12253496|FG000|Overall Study|Death|0
7797135|NCT01073020|12253497|FG001|Overall Study|Death|1
7797136|NCT01073020|12253498|FG002|Overall Study|Death|0
7797137|NCT01073020|12253499|FG003|Overall Study|Death|0
7797138|NCT01073163|12253509|FG000|Overall Study|Adverse Event|1
7797139|NCT01073163|12253509|FG000|Overall Study|Disease Progression|1
7797140|NCT01073163|12253509|FG000|Overall Study|Early termination|1
7797141|NCT01073267|12253517|FG000|Overall Study|Disease Progression|3
7797142|NCT01073293|12253523|FG000|Overall Study|Lost to Follow-up|0
7797143|NCT01073293|12253524|FG001|Overall Study|Lost to Follow-up|1
7797144|NCT01073293|12253523|FG000|Overall Study|Withdrawal by Subject|5
7797145|NCT01073293|12253524|FG001|Overall Study|Withdrawal by Subject|10
7879352|NCT01737697|12375888|FG003|Subacute Phase|Hypo-or hyperkalemia|0
7879353|NCT01737697|12375889|FG004|Subacute Phase|Hypo-or hyperkalemia|0
7879354|NCT01737697|12375890|FG005|Subacute Phase|Hypo-or hyperkalemia|0
7879355|NCT01737697|12375891|FG006|Subacute Phase|Hypo-or hyperkalemia|0
7879356|NCT01737697|12375892|FG007|Subacute Phase|Hypo-or hyperkalemia|0
7879357|NCT01737697|12375893|FG008|Subacute Phase|Hypo-or hyperkalemia|0
7879358|NCT01737697|12375894|FG009|Subacute Phase|Hypo-or hyperkalemia|0
7879359|NCT01737697|12375895|FG010|Subacute Phase|Hypo-or hyperkalemia|0
7879360|NCT01737697|12375896|FG011|Subacute Phase|Hypo-or hyperkalemia|1
7879361|NCT01737697|12375897|FG012|Subacute Phase|Hypo-or hyperkalemia|0
7879362|NCT01737697|12375898|FG013|Subacute Phase|Hypo-or hyperkalemia|1
7879363|NCT01737697|12375899|FG014|Subacute Phase|Hypo-or hyperkalemia|0
7879364|NCT01737697|12375885|FG000|Subacute Phase|Protocol Violation|0
7797146|NCT01073462|12253534|FG000|Overall Study|Death|14
7797147|NCT01073462|12253534|FG000|Overall Study|Kidney transplant|10
7797148|NCT01073462|12253534|FG000|Overall Study|Low parathyroid hormone levels|8
7797149|NCT01073462|12253534|FG000|Overall Study|Serious adverse event|2
7797150|NCT01073462|12253534|FG000|Overall Study|Lost to Follow-up|7
7797151|NCT01073566|12253540|FG000|Period 2 (6 Weeks)|Adverse Event|1
7797152|NCT01073566|12253541|FG001|Period 2 (6 Weeks)|Adverse Event|0
7797153|NCT01073605|12253550|FG000|Overall Study|Ongoing at Cutoff Date|1
7797154|NCT01073605|12253551|FG001|Overall Study|Ongoing at Cutoff Date|1
7797155|NCT01073605|12253552|FG002|Overall Study|Ongoing at Cutoff Date|0
7797156|NCT01073605|12253550|FG000|Overall Study|Adverse Event|2
7797157|NCT01073605|12253551|FG001|Overall Study|Adverse Event|1
7797158|NCT01073605|12253552|FG002|Overall Study|Adverse Event|0
7797159|NCT01073605|12253550|FG000|Overall Study|Lost to Follow-up|3
7797160|NCT01073605|12253551|FG001|Overall Study|Lost to Follow-up|4
7797161|NCT01073605|12253552|FG002|Overall Study|Lost to Follow-up|9
7797162|NCT01073605|12253550|FG000|Overall Study|Other|25
7797163|NCT01073605|12253551|FG001|Overall Study|Other|21
7797164|NCT01073605|12253552|FG002|Overall Study|Other|29
7797165|NCT01073605|12253550|FG000|Overall Study|Withdrawal by Subject|31
7797166|NCT01073605|12253551|FG001|Overall Study|Withdrawal by Subject|39
7797167|NCT01073605|12253552|FG002|Overall Study|Withdrawal by Subject|22
7797168|NCT01073605|12253550|FG000|Overall Study|Randomized But Not Treated|0
7797169|NCT01073605|12253551|FG001|Overall Study|Randomized But Not Treated|1
7797170|NCT01073605|12253552|FG002|Overall Study|Randomized But Not Treated|1
7797171|NCT01073618|12253560|FG000|Overall Study|Death|208
7797172|NCT01073618|12253560|FG000|Overall Study|Adverse Event|19
7797173|NCT01073618|12253560|FG000|Overall Study|Other|80
7797174|NCT01073631|12253564|FG000|Overall Study|Death|82
7797175|NCT01073631|12253564|FG000|Overall Study|Adverse Event|24
7797176|NCT01073631|12253564|FG000|Overall Study|Other|63
7797177|NCT01073865|12253579|FG000|Overall Study|Reasons other than below|19
7797178|NCT01073865|12253580|FG001|Overall Study|Reasons other than below|31
7797179|NCT01073865|12253579|FG000|Overall Study|Lost to Follow-up|1
7797180|NCT01073865|12253580|FG001|Overall Study|Lost to Follow-up|1
7797181|NCT01073865|12253579|FG000|Overall Study|Death|3
7797182|NCT01073865|12253580|FG001|Overall Study|Death|2
7797183|NCT01073865|12253579|FG000|Overall Study|Withdrawal by Subject|5
7797184|NCT01073865|12253580|FG001|Overall Study|Withdrawal by Subject|5
7797185|NCT01073930|12253588|FG000|Overall Study|Withdrawal by Subject|3
7797186|NCT01073930|12253589|FG001|Overall Study|Withdrawal by Subject|2
7797187|NCT01073930|12253588|FG000|Overall Study|Lost to Follow-up|0
7797188|NCT01073930|12253589|FG001|Overall Study|Lost to Follow-up|1
7797189|NCT01073930|12253588|FG000|Overall Study|Adverse Event|0
7797190|NCT01073930|12253589|FG001|Overall Study|Adverse Event|1
7797191|NCT01073930|12253588|FG000|Overall Study|Noncompliance with study drug|0
7797192|NCT01073930|12253589|FG001|Overall Study|Noncompliance with study drug|1
7797193|NCT01073930|12253588|FG000|Overall Study|Inadequate prep; unable to do procedure|0
7797194|NCT01073930|12253589|FG001|Overall Study|Inadequate prep; unable to do procedure|1
7797195|NCT01073943|12253597|FG000|Overall Study|Withdrawal by Subject|8
7797196|NCT01073943|12253598|FG001|Overall Study|Withdrawal by Subject|2
7797197|NCT01073943|12253597|FG000|Overall Study|Protocol Violation|2
7797198|NCT01073943|12253598|FG001|Overall Study|Protocol Violation|1
7797199|NCT01073943|12253597|FG000|Overall Study|Adverse Event|1
7797200|NCT01073943|12253598|FG001|Overall Study|Adverse Event|1
7797201|NCT01073943|12253597|FG000|Overall Study|Lost to Follow-up|0
7797202|NCT01073943|12253598|FG001|Overall Study|Lost to Follow-up|2
7797203|NCT01073943|12253597|FG000|Overall Study|Power outage; colonoscopy not done|1
7797204|NCT01073943|12253598|FG001|Overall Study|Power outage; colonoscopy not done|0
7797205|NCT01073943|12253597|FG000|Overall Study|Subject forgot|0
7797206|NCT01073943|12253598|FG001|Overall Study|Subject forgot|1
7797207|NCT01073943|12253597|FG000|Overall Study|Unable to return for follow-up|0
7797208|NCT01073943|12253598|FG001|Overall Study|Unable to return for follow-up|1
7797209|NCT01073943|12253597|FG000|Overall Study|Could not tolerate prep|1
7797210|NCT01073943|12253598|FG001|Overall Study|Could not tolerate prep|0
7797211|NCT01074008|12253613|FG000|Overall Study|Adverse Event|0
7797212|NCT01074008|12253614|FG001|Overall Study|Adverse Event|1
7797213|NCT01074008|12253615|FG002|Overall Study|Adverse Event|0
7797214|NCT01074008|12253616|FG003|Overall Study|Adverse Event|0
7797215|NCT01074008|12253617|FG004|Overall Study|Adverse Event|0
7797216|NCT01074008|12253618|FG005|Overall Study|Adverse Event|0
7797217|NCT01074008|12253619|FG006|Overall Study|Adverse Event|0
7797218|NCT01074008|12253620|FG007|Overall Study|Adverse Event|0
7797219|NCT01074008|12253621|FG008|Overall Study|Adverse Event|0
7797220|NCT01074008|12253613|FG000|Overall Study|Withdrawal by Subject|1
7797221|NCT01074008|12253614|FG001|Overall Study|Withdrawal by Subject|1
7797222|NCT01074008|12253615|FG002|Overall Study|Withdrawal by Subject|1
7797223|NCT01074008|12253616|FG003|Overall Study|Withdrawal by Subject|0
7797224|NCT01074008|12253617|FG004|Overall Study|Withdrawal by Subject|1
7797225|NCT01074008|12253618|FG005|Overall Study|Withdrawal by Subject|0
7797226|NCT01074008|12253619|FG006|Overall Study|Withdrawal by Subject|0
7797227|NCT01074008|12253620|FG007|Overall Study|Withdrawal by Subject|0
7797228|NCT01074008|12253621|FG008|Overall Study|Withdrawal by Subject|0
7797229|NCT01074008|12253613|FG000|Overall Study|Lost to Follow-up|0
7797230|NCT01074008|12253614|FG001|Overall Study|Lost to Follow-up|1
7797231|NCT01074008|12253615|FG002|Overall Study|Lost to Follow-up|1
7797232|NCT01074008|12253616|FG003|Overall Study|Lost to Follow-up|1
7797233|NCT01074008|12253617|FG004|Overall Study|Lost to Follow-up|1
7797234|NCT01074008|12253618|FG005|Overall Study|Lost to Follow-up|0
7797235|NCT01074008|12253619|FG006|Overall Study|Lost to Follow-up|1
7797236|NCT01074008|12253620|FG007|Overall Study|Lost to Follow-up|0
7797237|NCT01074008|12253621|FG008|Overall Study|Lost to Follow-up|4
7797238|NCT01074047|12253657|FG000|Treatment Phase|Adverse Event|89
7797239|NCT01074047|12253658|FG001|Treatment Phase|Adverse Event|66
7797240|NCT01074047|12253657|FG000|Treatment Phase|Disease Progression|16
7797241|NCT01074047|12253658|FG001|Treatment Phase|Disease Progression|21
7797242|NCT01074047|12253657|FG000|Treatment Phase|Withdrawal by Subject|27
7797243|NCT01074047|12253658|FG001|Treatment Phase|Withdrawal by Subject|48
7797244|NCT01074047|12253657|FG000|Treatment Phase|Death|53
7797245|NCT01074047|12253658|FG001|Treatment Phase|Death|58
7797246|NCT01074047|12253657|FG000|Treatment Phase|Lost to Follow-up|0
7797247|NCT01074047|12253658|FG001|Treatment Phase|Lost to Follow-up|1
7797248|NCT01074047|12253657|FG000|Treatment Phase|Protocol Violation|0
7797249|NCT01074047|12253658|FG001|Treatment Phase|Protocol Violation|1
7797250|NCT01074047|12253657|FG000|Treatment Phase|Miscellaneous|32
7797251|NCT01074047|12253658|FG001|Treatment Phase|Miscellaneous|39
7797252|NCT01074047|12253657|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5
7797253|NCT01074047|12253658|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8
7797254|NCT01074047|12253657|FG000|Survival Follow-Up Phase|Lost to Follow-up|2
7797255|NCT01074047|12253658|FG001|Survival Follow-Up Phase|Lost to Follow-up|1
7797256|NCT01074047|12253657|FG000|Survival Follow-Up Phase|Death|116
7797257|NCT01074047|12253658|FG001|Survival Follow-Up Phase|Death|124
7797258|NCT01074047|12253657|FG000|Survival Follow-Up Phase|Alive at study closure|1
7797259|NCT01074047|12253658|FG001|Survival Follow-Up Phase|Alive at study closure|3
7797260|NCT01074047|12253657|FG000|Extension Phase|Physician Decision|1
7797261|NCT01074047|12253658|FG001|Extension Phase|Physician Decision|0
7797262|NCT01074047|12253657|FG000|Extension Phase|Adverse Event|5
7797263|NCT01074047|12253658|FG001|Extension Phase|Adverse Event|0
7797264|NCT01074047|12253657|FG000|Extension Phase|Disease Progression|9
7797265|NCT01074047|12253658|FG001|Extension Phase|Disease Progression|0
7797266|NCT01074047|12253657|FG000|Extension Phase|Withdrawal by Subject|2
7797267|NCT01074047|12253658|FG001|Extension Phase|Withdrawal by Subject|0
7797268|NCT01074047|12253657|FG000|Extension Phase|Death|5
7797269|NCT01074047|12253658|FG001|Extension Phase|Death|0
7797270|NCT01074216|12253709|FG000|Overall Study|Physician Decision|1
7797271|NCT01074216|12253709|FG000|Overall Study|Not Treated|12
7797272|NCT01074229|12253716|FG000|Overall Study|Lost to Follow-up|1
7797273|NCT01074229|12253717|FG001|Overall Study|Lost to Follow-up|0
7797274|NCT01074229|12253718|FG002|Overall Study|Lost to Follow-up|0
7797275|NCT01074229|12253716|FG000|Overall Study|Change to open surgical procedure|1
7797276|NCT01074229|12253717|FG001|Overall Study|Change to open surgical procedure|3
7797277|NCT01074229|12253718|FG002|Overall Study|Change to open surgical procedure|4
7797278|NCT01074242|12253728|FG000|Overall Study|Case report before date of contract|40
7797279|NCT01074242|12253728|FG000|Overall Study|Lost to Follow-up|1
7797280|NCT01074242|12253728|FG000|Overall Study|Case report unclear|6
7797281|NCT01074242|12253728|FG000|Overall Study|Violation of vaccine dose or dosage|351
7797282|NCT01074242|12253728|FG000|Overall Study|Duplicate Case Report Form|5
7797283|NCT01074255|12253732|FG000|Overall Study|Did not receive EMEND|2
7797284|NCT01074268|12253738|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
7797285|NCT01074268|12253739|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
7797286|NCT01074268|12253738|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
7797287|NCT01074268|12253739|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
7797288|NCT01074268|12253738|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
7797289|NCT01074268|12253739|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
7797290|NCT01074268|12253738|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
7797291|NCT01074268|12253739|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
7797292|NCT01074268|12253738|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
7797293|NCT01074268|12253739|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
7797294|NCT01074268|12253738|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
7797295|NCT01074268|12253739|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
7797296|NCT01074268|12253738|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
7797297|NCT01074268|12253739|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
7797298|NCT01074268|12253738|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
7797299|NCT01074268|12253739|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
7797300|NCT01074268|12253738|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
7797301|NCT01074268|12253739|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
7797302|NCT01074307|12253747|FG000|Overall Study|No primary endpoint evaluation|14
7797303|NCT01074307|12253748|FG001|Overall Study|No primary endpoint evaluation|6
7797304|NCT01074307|12253747|FG000|Overall Study|Exclusion criterion|0
7797305|NCT01074307|12253748|FG001|Overall Study|Exclusion criterion|1
7797306|NCT01074307|12253747|FG000|Overall Study|Protocol Violation|8
7797307|NCT01074307|12253748|FG001|Overall Study|Protocol Violation|5
7797308|NCT01074450|12253756|FG000|First Intervention|Emesis in Dosing Interval|0
7797309|NCT01074450|12253757|FG001|First Intervention|Emesis in Dosing Interval|2
7797310|NCT01074450|12253756|FG000|Second Intervention|Protocol Violation|1
7797311|NCT01074450|12253757|FG001|Second Intervention|Protocol Violation|0
7797312|NCT01074450|12253756|FG000|Second Intervention|Physician Decision|0
7797313|NCT01074450|12253757|FG001|Second Intervention|Physician Decision|1
7797314|NCT01074554|12253774|FG000|Overall Study|Adverse Event|3
7797315|NCT01074554|12253775|FG001|Overall Study|Adverse Event|3
7797316|NCT01074554|12253774|FG000|Overall Study|Lost to Follow-up|0
7797317|NCT01074554|12253775|FG001|Overall Study|Lost to Follow-up|1
7797318|NCT01074658|12253781|FG000|Overall Study|No implant attempted|19
7797319|NCT01074931|12253785|FG000|Overall Study|Economic reasons|1
7797320|NCT01074931|12253785|FG000|Overall Study|Death|5
7797321|NCT01074944|12253793|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2
7797322|NCT01074944|12253794|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0
7797323|NCT01074944|12253795|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0
7797324|NCT01074944|12253796|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0
7797325|NCT01074944|12253797|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0
7797326|NCT01074944|12253793|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
7797327|NCT01074944|12253794|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
7797328|NCT01074944|12253795|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
7797329|NCT01074944|12253796|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
7797330|NCT01074944|12253797|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
7797331|NCT01074944|12253793|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4
7797332|NCT01074944|12253794|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0
7797333|NCT01074944|12253795|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0
7797334|NCT01074944|12253796|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0
7797335|NCT01074944|12253797|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0
7797336|NCT01074944|12253793|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
7797337|NCT01074944|12253794|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
7797338|NCT01074944|12253795|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
7797339|NCT01074944|12253796|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
7797340|NCT01074944|12253797|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
7797341|NCT01074944|12253793|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
7797342|NCT01074944|12253794|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
7797343|NCT01074944|12253795|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
7797344|NCT01074944|12253796|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
7797345|NCT01074944|12253797|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
7797346|NCT01074944|12253793|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
7797347|NCT01074944|12253794|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
7797348|NCT01074944|12253795|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
7797349|NCT01074944|12253796|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
7797350|NCT01074944|12253797|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
7797351|NCT01074944|12253793|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
7797352|NCT01074944|12253794|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
7797353|NCT01074944|12253795|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
7797354|NCT01074944|12253796|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
7797355|NCT01074944|12253797|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
7797356|NCT01074944|12253793|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
7797357|NCT01074944|12253794|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
7797358|NCT01074944|12253795|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
7797359|NCT01074944|12253796|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
7797360|NCT01074944|12253797|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
7797361|NCT01074944|12253793|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
7797362|NCT01074944|12253794|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
7797363|NCT01074944|12253795|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
7879365|NCT01737697|12375886|FG001|Subacute Phase|Protocol Violation|0
7879366|NCT01737697|12375887|FG002|Subacute Phase|Protocol Violation|0
7879367|NCT01737697|12375888|FG003|Subacute Phase|Protocol Violation|0
7879368|NCT01737697|12375889|FG004|Subacute Phase|Protocol Violation|0
7879369|NCT01737697|12375890|FG005|Subacute Phase|Protocol Violation|1
7879370|NCT01737697|12375891|FG006|Subacute Phase|Protocol Violation|0
7879371|NCT01737697|12375892|FG007|Subacute Phase|Protocol Violation|0
7879372|NCT01737697|12375893|FG008|Subacute Phase|Protocol Violation|0
7879373|NCT01737697|12375894|FG009|Subacute Phase|Protocol Violation|0
7879374|NCT01737697|12375895|FG010|Subacute Phase|Protocol Violation|1
7879375|NCT01737697|12375896|FG011|Subacute Phase|Protocol Violation|0
7879376|NCT01737697|12375897|FG012|Subacute Phase|Protocol Violation|0
7879377|NCT01737697|12375898|FG013|Subacute Phase|Protocol Violation|0
7879378|NCT01737697|12375899|FG014|Subacute Phase|Protocol Violation|0
7879379|NCT01737697|12375885|FG000|Subacute Phase|Physician Decision|0
7879380|NCT01737697|12375886|FG001|Subacute Phase|Physician Decision|0
7879381|NCT01737697|12375887|FG002|Subacute Phase|Physician Decision|0
7879382|NCT01737697|12375888|FG003|Subacute Phase|Physician Decision|0
7879383|NCT01737697|12375889|FG004|Subacute Phase|Physician Decision|0
7879384|NCT01737697|12375890|FG005|Subacute Phase|Physician Decision|0
7879385|NCT01737697|12375891|FG006|Subacute Phase|Physician Decision|0
7879386|NCT01737697|12375892|FG007|Subacute Phase|Physician Decision|0
7879387|NCT01737697|12375893|FG008|Subacute Phase|Physician Decision|1
7879388|NCT01737697|12375894|FG009|Subacute Phase|Physician Decision|0
7879389|NCT01737697|12375895|FG010|Subacute Phase|Physician Decision|0
7797364|NCT01074944|12253796|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
7797365|NCT01074944|12253797|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
7797366|NCT01074944|12253793|FG000|Long Term Treatment|Adverse Event|0
7797367|NCT01074944|12253794|FG001|Long Term Treatment|Adverse Event|0
7797368|NCT01074944|12253795|FG002|Long Term Treatment|Adverse Event|0
7797369|NCT01074944|12253796|FG003|Long Term Treatment|Adverse Event|3
7797370|NCT01074944|12253797|FG004|Long Term Treatment|Adverse Event|0
7797371|NCT01074944|12253793|FG000|Long Term Treatment|Lost to Follow-up|0
7797372|NCT01074944|12253794|FG001|Long Term Treatment|Lost to Follow-up|0
7797373|NCT01074944|12253795|FG002|Long Term Treatment|Lost to Follow-up|0
7797374|NCT01074944|12253796|FG003|Long Term Treatment|Lost to Follow-up|2
7797375|NCT01074944|12253797|FG004|Long Term Treatment|Lost to Follow-up|0
7797376|NCT01074944|12253793|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0
7797377|NCT01074944|12253794|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0
7797378|NCT01074944|12253795|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0
7797379|NCT01074944|12253796|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18
7797380|NCT01074944|12253797|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0
7797381|NCT01074944|12253793|FG000|Long Term Treatment|Entered in Period, But Not Treated|0
7797382|NCT01074944|12253794|FG001|Long Term Treatment|Entered in Period, But Not Treated|0
7797383|NCT01074944|12253795|FG002|Long Term Treatment|Entered in Period, But Not Treated|0
7797384|NCT01074944|12253796|FG003|Long Term Treatment|Entered in Period, But Not Treated|1
7797385|NCT01074944|12253797|FG004|Long Term Treatment|Entered in Period, But Not Treated|0
7797386|NCT01074944|12253793|FG000|Long Term Treatment|Withdrawal by Subject|0
7797387|NCT01074944|12253794|FG001|Long Term Treatment|Withdrawal by Subject|0
7879390|NCT01737697|12375896|FG011|Subacute Phase|Physician Decision|0
7879391|NCT01737697|12375897|FG012|Subacute Phase|Physician Decision|0
7879392|NCT01737697|12375898|FG013|Subacute Phase|Physician Decision|0
7879393|NCT01737697|12375899|FG014|Subacute Phase|Physician Decision|0
7879394|NCT01737697|12375885|FG000|Subacute Phase|Death|0
7879395|NCT01737697|12375886|FG001|Subacute Phase|Death|0
7879396|NCT01737697|12375887|FG002|Subacute Phase|Death|0
7879397|NCT01737697|12375888|FG003|Subacute Phase|Death|0
7879398|NCT01737697|12375889|FG004|Subacute Phase|Death|0
7879399|NCT01737697|12375890|FG005|Subacute Phase|Death|0
7879400|NCT01737697|12375891|FG006|Subacute Phase|Death|0
7879401|NCT01737697|12375892|FG007|Subacute Phase|Death|0
7879402|NCT01737697|12375893|FG008|Subacute Phase|Death|0
7879403|NCT01737697|12375894|FG009|Subacute Phase|Death|0
7879404|NCT01737697|12375895|FG010|Subacute Phase|Death|1
7879405|NCT01737697|12375896|FG011|Subacute Phase|Death|0
7879406|NCT01737697|12375897|FG012|Subacute Phase|Death|0
7879407|NCT01737697|12375898|FG013|Subacute Phase|Death|0
7879408|NCT01737697|12375899|FG014|Subacute Phase|Death|0
7879409|NCT01737710|12375937|FG000|Overall Study|Lost to Follow-up|0
7879410|NCT01737710|12375938|FG001|Overall Study|Lost to Follow-up|2
7879411|NCT01737710|12375939|FG002|Overall Study|Lost to Follow-up|2
7879412|NCT01737710|12375940|FG003|Overall Study|Lost to Follow-up|0
7879413|NCT01737710|12375941|FG004|Overall Study|Lost to Follow-up|0
7879414|NCT01737710|12375937|FG000|Overall Study|Withdrawal by Subject|1
7879415|NCT01737710|12375938|FG001|Overall Study|Withdrawal by Subject|1
7879416|NCT01737710|12375939|FG002|Overall Study|Withdrawal by Subject|1
7879417|NCT01737710|12375940|FG003|Overall Study|Withdrawal by Subject|0
7879418|NCT01737710|12375941|FG004|Overall Study|Withdrawal by Subject|0
7879419|NCT01737710|12375937|FG000|Overall Study|Vaccinated in Error/Ineligible|1
7879420|NCT01737710|12375938|FG001|Overall Study|Vaccinated in Error/Ineligible|1
7879421|NCT01737710|12375939|FG002|Overall Study|Vaccinated in Error/Ineligible|0
7879422|NCT01737710|12375940|FG003|Overall Study|Vaccinated in Error/Ineligible|0
7879423|NCT01737710|12375941|FG004|Overall Study|Vaccinated in Error/Ineligible|0
7879424|NCT01737762|12375954|FG000|Overall Study|Adverse Event|2
7879425|NCT01737762|12375955|FG001|Overall Study|Adverse Event|2
7879426|NCT01737762|12375954|FG000|Overall Study|Lost to Follow-up|1
7879427|NCT01737762|12375955|FG001|Overall Study|Lost to Follow-up|0
7879428|NCT01737762|12375954|FG000|Overall Study|Withdrawal by Subject|2
7879429|NCT01737762|12375955|FG001|Overall Study|Withdrawal by Subject|2
7879430|NCT01737762|12375954|FG000|Overall Study|Progressive disease|1
7879431|NCT01737762|12375955|FG001|Overall Study|Progressive disease|2
7879432|NCT01737762|12375954|FG000|Overall Study|Physician Decision|1
7879433|NCT01737762|12375955|FG001|Overall Study|Physician Decision|1
7879434|NCT01737762|12375954|FG000|Overall Study|Moved from area|2
7879435|NCT01737762|12375955|FG001|Overall Study|Moved from area|1
7879436|NCT01737762|12375954|FG000|Overall Study|Trial termination|11
7879437|NCT01737762|12375955|FG001|Overall Study|Trial termination|9
7879438|NCT01737840|12375963|FG000|Overall Study|Diagnosed with an other pathology|2
7879439|NCT01737840|12375964|FG001|Overall Study|Diagnosed with an other pathology|2
7797388|NCT01074944|12253795|FG002|Long Term Treatment|Withdrawal by Subject|0
7797389|NCT01074944|12253796|FG003|Long Term Treatment|Withdrawal by Subject|2
7797390|NCT01074944|12253797|FG004|Long Term Treatment|Withdrawal by Subject|0
7797391|NCT01074944|12253793|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0
7797392|NCT01074944|12253794|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0
7797393|NCT01074944|12253795|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0
7797394|NCT01074944|12253796|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0
7797395|NCT01074944|12253797|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2
7797396|NCT01074944|12253793|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
7797397|NCT01074944|12253794|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
7797398|NCT01074944|12253795|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
7879440|NCT01737879|12375972|FG000|Overall Study|Death|1
7879441|NCT01737879|12375972|FG000|Overall Study|Sponsor decision|40
7879442|NCT01737931|12375979|FG000|Overall Study|Withdrawal by Subject|0
7879443|NCT01737931|12375980|FG001|Overall Study|Withdrawal by Subject|1
7879444|NCT01737931|12375981|FG002|Overall Study|Withdrawal by Subject|1
7879445|NCT01737931|12375979|FG000|Overall Study|Physician Decision|0
7879446|NCT01737931|12375980|FG001|Overall Study|Physician Decision|1
7879447|NCT01737931|12375981|FG002|Overall Study|Physician Decision|0
7879448|NCT01737996|12376006|FG000|Overall Study|Adverse Event|0
7879449|NCT01737996|12376007|FG001|Overall Study|Adverse Event|1
7879450|NCT01737996|12376008|FG002|Overall Study|Adverse Event|1
7879451|NCT01737996|12376006|FG000|Overall Study|Withdrawal by Subject|0
7879452|NCT01737996|12376007|FG001|Overall Study|Withdrawal by Subject|0
7879453|NCT01737996|12376008|FG002|Overall Study|Withdrawal by Subject|1
7879454|NCT01738191|12376018|FG000|Overall Study|Withdrawal by Subject|4
7879455|NCT01738191|12376019|FG001|Overall Study|Withdrawal by Subject|1
7879456|NCT01738438|12376034|FG000|Overall Study|Disease Progression|32
7879457|NCT01738438|12376034|FG000|Overall Study|Adverse Event|3
7879458|NCT01738477|12376040|FG000|Overall Study|Lost to Follow-up|1
7879459|NCT01738477|12376041|FG001|Overall Study|Lost to Follow-up|4
7879460|NCT01738503|12376055|FG000|Induction/Stabilization (Days -14 to -1)|Other|35
7879461|NCT01738503|12376056|FG001|Induction/Stabilization (Days -14 to -1)|Other|0
7879462|NCT01738503|12376057|FG002|Induction/Stabilization (Days -14 to -1)|Other|0
7879463|NCT01738503|12376058|FG003|Induction/Stabilization (Days -14 to -1)|Other|0
7879464|NCT01738503|12376059|FG004|Induction/Stabilization (Days -14 to -1)|Other|0
7879465|NCT01738503|12376060|FG005|Induction/Stabilization (Days -14 to -1)|Other|0
7879466|NCT01738503|12376061|FG006|Induction/Stabilization (Days -14 to -1)|Other|0
7879467|NCT01738503|12376055|FG000|Treatment Period|Adverse Event|0
7879468|NCT01738503|12376056|FG001|Treatment Period|Adverse Event|1
7879469|NCT01738503|12376057|FG002|Treatment Period|Adverse Event|0
7879470|NCT01738503|12376058|FG003|Treatment Period|Adverse Event|1
7879471|NCT01738503|12376059|FG004|Treatment Period|Adverse Event|2
7879472|NCT01738503|12376060|FG005|Treatment Period|Adverse Event|2
7879473|NCT01738503|12376061|FG006|Treatment Period|Adverse Event|2
7879474|NCT01738503|12376055|FG000|Treatment Period|Lost to Follow-up|0
7879475|NCT01738503|12376056|FG001|Treatment Period|Lost to Follow-up|0
7879476|NCT01738503|12376057|FG002|Treatment Period|Lost to Follow-up|3
7879477|NCT01738503|12376058|FG003|Treatment Period|Lost to Follow-up|4
7879478|NCT01738503|12376059|FG004|Treatment Period|Lost to Follow-up|1
7879479|NCT01738503|12376060|FG005|Treatment Period|Lost to Follow-up|1
7879480|NCT01738503|12376061|FG006|Treatment Period|Lost to Follow-up|5
7879481|NCT01738503|12376055|FG000|Treatment Period|Withdrawal by Subject|0
7879482|NCT01738503|12376056|FG001|Treatment Period|Withdrawal by Subject|1
7879483|NCT01738503|12376057|FG002|Treatment Period|Withdrawal by Subject|0
7879484|NCT01738503|12376058|FG003|Treatment Period|Withdrawal by Subject|1
7879485|NCT01738503|12376059|FG004|Treatment Period|Withdrawal by Subject|1
7879486|NCT01738503|12376060|FG005|Treatment Period|Withdrawal by Subject|1
7879487|NCT01738503|12376061|FG006|Treatment Period|Withdrawal by Subject|1
7879488|NCT01738503|12376055|FG000|Treatment Period|Protocol Violation|0
7879489|NCT01738503|12376056|FG001|Treatment Period|Protocol Violation|3
7879490|NCT01738503|12376057|FG002|Treatment Period|Protocol Violation|1
7879491|NCT01738503|12376058|FG003|Treatment Period|Protocol Violation|0
7879492|NCT01738503|12376059|FG004|Treatment Period|Protocol Violation|4
7879493|NCT01738503|12376060|FG005|Treatment Period|Protocol Violation|2
7879494|NCT01738503|12376061|FG006|Treatment Period|Protocol Violation|0
7879495|NCT01738503|12376055|FG000|Treatment Period|Other|0
7879496|NCT01738503|12376056|FG001|Treatment Period|Other|0
7879497|NCT01738503|12376057|FG002|Treatment Period|Other|1
7879498|NCT01738503|12376058|FG003|Treatment Period|Other|0
7879499|NCT01738503|12376059|FG004|Treatment Period|Other|0
7879500|NCT01738503|12376060|FG005|Treatment Period|Other|0
7879501|NCT01738503|12376061|FG006|Treatment Period|Other|0
7879502|NCT01738503|12376055|FG000|PET Imaging Sub-study|Adverse Event|0
7879503|NCT01738503|12376056|FG001|PET Imaging Sub-study|Adverse Event|0
7879504|NCT01738503|12376057|FG002|PET Imaging Sub-study|Adverse Event|0
7879505|NCT01738503|12376058|FG003|PET Imaging Sub-study|Adverse Event|0
7879506|NCT01738503|12376059|FG004|PET Imaging Sub-study|Adverse Event|0
7879507|NCT01738503|12376060|FG005|PET Imaging Sub-study|Adverse Event|1
7879508|NCT01738503|12376061|FG006|PET Imaging Sub-study|Adverse Event|0
7879509|NCT01738503|12376055|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7879510|NCT01738503|12376056|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7879511|NCT01738503|12376057|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7879512|NCT01738503|12376058|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7879513|NCT01738503|12376059|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7797399|NCT01074944|12253796|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
7797400|NCT01074944|12253797|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
7797401|NCT01075048|12253808|FG000|Overall Study|Death|4
7797402|NCT01075048|12253809|FG001|Overall Study|Death|17
7797403|NCT01075048|12253810|FG002|Overall Study|Death|12
7797404|NCT01075048|12253808|FG000|Overall Study|Start of other or new therapy|4
7797405|NCT01075048|12253809|FG001|Overall Study|Start of other or new therapy|36
7797406|NCT01075048|12253810|FG002|Overall Study|Start of other or new therapy|46
7797407|NCT01075048|12253808|FG000|Overall Study|Withdrawal by Subject|1
7797408|NCT01075048|12253809|FG001|Overall Study|Withdrawal by Subject|6
7797409|NCT01075048|12253810|FG002|Overall Study|Withdrawal by Subject|3
7797410|NCT01075048|12253808|FG000|Overall Study|Lost to Follow-up|0
7797411|NCT01075048|12253809|FG001|Overall Study|Lost to Follow-up|1
7797412|NCT01075048|12253810|FG002|Overall Study|Lost to Follow-up|1
7797413|NCT01075074|12253824|FG000|Overall Study|Surgeon changed to open incisional case|1
7797414|NCT01075074|12253825|FG001|Overall Study|Surgeon changed to open incisional case|2
7797415|NCT01075074|12253826|FG002|Overall Study|Surgeon changed to open incisional case|2
7797416|NCT01075100|12253849|FG000|Overall Study|Adverse Event|15
7797417|NCT01075100|12253850|FG001|Overall Study|Adverse Event|18
7797418|NCT01075100|12253849|FG000|Overall Study|Patient Request|4
7797419|NCT01075100|12253850|FG001|Overall Study|Patient Request|4
7797420|NCT01075100|12253849|FG000|Overall Study|Investigator Request|2
7797421|NCT01075100|12253850|FG001|Overall Study|Investigator Request|1
7797422|NCT01075100|12253849|FG000|Overall Study|Disease Progression|25
7797423|NCT01075100|12253850|FG001|Overall Study|Disease Progression|29
7797424|NCT01075100|12253849|FG000|Overall Study|Other|3
7797425|NCT01075100|12253850|FG001|Overall Study|Other|1
7797426|NCT01075152|12253860|FG000|Overall Study|Withdrawal by Subject|1
7797427|NCT01075152|12253861|FG001|Overall Study|Withdrawal by Subject|0
7797428|NCT01075178|12253871|FG000|Subject Matching|eligible but not matched|130
7797429|NCT01075178|12253872|FG001|Subject Matching|eligible but not matched|403
7797430|NCT01075178|12253871|FG000|Subject Chart Review|died before chart review period|0
7797431|NCT01075178|12253872|FG001|Subject Chart Review|died before chart review period|2
7879514|NCT01738503|12376060|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1
7797432|NCT01075178|12253871|FG000|Subject Chart Review|no data collected due to site closure|3
7797433|NCT01075178|12253872|FG001|Subject Chart Review|no data collected due to site closure|4
7797434|NCT01075178|12253871|FG000|Subject Chart Review|matched partner excluded (reasons above)|6
7797435|NCT01075178|12253872|FG001|Subject Chart Review|matched partner excluded (reasons above)|3
7797436|NCT01075191|12253878|FG000|Overall Study|Death|1
7797437|NCT01075191|12253878|FG000|Overall Study|Intensification|3
7797438|NCT01075191|12253878|FG000|Overall Study|Co-morbidities|1
7797439|NCT01075191|12253878|FG000|Overall Study|Adverse Event|4
7797440|NCT01075191|12253878|FG000|Overall Study|Noncompliance|3
7797441|NCT01075191|12253878|FG000|Overall Study|Therapy Break|3
7797442|NCT01075191|12253878|FG000|Overall Study|Patient's Wish|2
7797443|NCT01075191|12253878|FG000|Overall Study|Unknown Reasons|1
7797444|NCT01075217|12253888|FG000|Overall Study|Adverse Event|1
7797445|NCT01075217|12253889|FG001|Overall Study|Adverse Event|1
7797446|NCT01075217|12253888|FG000|Overall Study|Physician Decision|1
7797447|NCT01075217|12253889|FG001|Overall Study|Physician Decision|0
7797448|NCT01075243|12253906|FG000|Overall Study|Lost to Follow-up|5
7797449|NCT01075243|12253907|FG001|Overall Study|Lost to Follow-up|2
7797450|NCT01075243|12253908|FG002|Overall Study|Lost to Follow-up|0
7797451|NCT01075243|12253906|FG000|Overall Study|Withdrawal by Subject|1
7797452|NCT01075243|12253907|FG001|Overall Study|Withdrawal by Subject|1
7797453|NCT01075243|12253908|FG002|Overall Study|Withdrawal by Subject|0
7797454|NCT01075256|12253921|FG000|Overall Study|Withdrawal by Subject|1
7797455|NCT01075256|12253922|FG001|Overall Study|Withdrawal by Subject|0
7797456|NCT01075256|12253923|FG002|Overall Study|Withdrawal by Subject|0
7797457|NCT01075282|12253939|FG000|Overall Study|Withdrawal by Subject|11
7797458|NCT01075282|12253940|FG001|Overall Study|Withdrawal by Subject|7
7797459|NCT01075282|12253941|FG002|Overall Study|Withdrawal by Subject|11
7797460|NCT01075282|12253939|FG000|Overall Study|Adverse Event|9
7797461|NCT01075282|12253940|FG001|Overall Study|Adverse Event|8
7797462|NCT01075282|12253941|FG002|Overall Study|Adverse Event|5
7797463|NCT01075282|12253939|FG000|Overall Study|Entry Criteria Not Met|3
7797464|NCT01075282|12253940|FG001|Overall Study|Entry Criteria Not Met|2
7797465|NCT01075282|12253941|FG002|Overall Study|Entry Criteria Not Met|0
7797466|NCT01075282|12253939|FG000|Overall Study|Lost to Follow-up|3
7797467|NCT01075282|12253940|FG001|Overall Study|Lost to Follow-up|3
7797468|NCT01075282|12253941|FG002|Overall Study|Lost to Follow-up|3
7797469|NCT01075282|12253939|FG000|Overall Study|Physician Decision|3
7797470|NCT01075282|12253940|FG001|Overall Study|Physician Decision|3
7797471|NCT01075282|12253941|FG002|Overall Study|Physician Decision|3
7797472|NCT01075282|12253939|FG000|Overall Study|Lack of Efficacy|1
7797473|NCT01075282|12253940|FG001|Overall Study|Lack of Efficacy|1
7797474|NCT01075282|12253941|FG002|Overall Study|Lack of Efficacy|0
7797475|NCT01075282|12253939|FG000|Overall Study|Treatment Non-compliance|1
7797476|NCT01075282|12253940|FG001|Overall Study|Treatment Non-compliance|2
7797477|NCT01075282|12253941|FG002|Overall Study|Treatment Non-compliance|2
7797478|NCT01075282|12253939|FG000|Overall Study|Protocol Violation|0
7797479|NCT01075282|12253940|FG001|Overall Study|Protocol Violation|2
7797480|NCT01075282|12253941|FG002|Overall Study|Protocol Violation|1
7797481|NCT01075282|12253939|FG000|Overall Study|Death|0
7797482|NCT01075282|12253940|FG001|Overall Study|Death|1
7797483|NCT01075282|12253941|FG002|Overall Study|Death|2
7797484|NCT01075321|12253950|FG000|Overall Study|Withdrawal by Subject|0
7797485|NCT01075321|12253951|FG001|Overall Study|Withdrawal by Subject|0
7797486|NCT01075321|12253952|FG002|Overall Study|Withdrawal by Subject|1
7797487|NCT01075321|12253953|FG003|Overall Study|Withdrawal by Subject|1
7797488|NCT01075321|12253950|FG000|Overall Study|Protocol Violation|0
7797489|NCT01075321|12253951|FG001|Overall Study|Protocol Violation|0
7797490|NCT01075321|12253952|FG002|Overall Study|Protocol Violation|1
7879515|NCT01738503|12376061|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1
7879516|NCT01738581|12376085|FG000|Overall Study|Lost to Follow-up|1
7879517|NCT01738581|12376086|FG001|Overall Study|Lost to Follow-up|0
7879518|NCT01738594|12376095|FG000|Registration and Treatment Start|Adverse Event|0
7879519|NCT01738594|12376096|FG001|Registration and Treatment Start|Adverse Event|1
7879520|NCT01738594|12376097|FG002|Registration and Treatment Start|Adverse Event|0
7879521|NCT01738594|12376098|FG003|Registration and Treatment Start|Adverse Event|0
7879522|NCT01738594|12376099|FG004|Registration and Treatment Start|Adverse Event|0
7879523|NCT01738594|12376100|FG005|Registration and Treatment Start|Adverse Event|0
7879524|NCT01738594|12376101|FG006|Registration and Treatment Start|Adverse Event|0
7879525|NCT01738594|12376102|FG007|Registration and Treatment Start|Adverse Event|0
7879526|NCT01738594|12376095|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7879527|NCT01738594|12376096|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7879528|NCT01738594|12376097|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7879529|NCT01738594|12376098|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7879530|NCT01738594|12376099|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7879531|NCT01738594|12376100|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1
7879532|NCT01738594|12376101|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7879533|NCT01738594|12376102|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7879534|NCT01738594|12376095|FG000|Completed 4 Cycles of Treatment|Progressive disease|0
7879535|NCT01738594|12376096|FG001|Completed 4 Cycles of Treatment|Progressive disease|2
7879536|NCT01738594|12376097|FG002|Completed 4 Cycles of Treatment|Progressive disease|0
7879537|NCT01738594|12376098|FG003|Completed 4 Cycles of Treatment|Progressive disease|0
7879538|NCT01738594|12376099|FG004|Completed 4 Cycles of Treatment|Progressive disease|0
7879539|NCT01738594|12376100|FG005|Completed 4 Cycles of Treatment|Progressive disease|0
7879540|NCT01738594|12376101|FG006|Completed 4 Cycles of Treatment|Progressive disease|0
7879541|NCT01738594|12376102|FG007|Completed 4 Cycles of Treatment|Progressive disease|0
7879542|NCT01738594|12376095|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0
7879543|NCT01738594|12376096|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0
7879544|NCT01738594|12376097|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0
7879545|NCT01738594|12376098|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0
7879546|NCT01738594|12376099|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0
7879547|NCT01738594|12376100|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1
7879548|NCT01738594|12376101|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0
7879549|NCT01738594|12376102|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0
7879550|NCT01738594|12376095|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7879551|NCT01738594|12376096|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7879552|NCT01738594|12376097|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7879553|NCT01738594|12376098|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7879554|NCT01738594|12376099|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7879555|NCT01738594|12376100|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1
7879556|NCT01738594|12376101|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7879557|NCT01738594|12376102|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7879558|NCT01738594|12376095|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7879559|NCT01738594|12376096|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7879560|NCT01738594|12376097|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7879561|NCT01738594|12376098|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7879562|NCT01738594|12376099|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1
7879563|NCT01738594|12376100|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7879564|NCT01738594|12376101|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7879565|NCT01738594|12376102|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7879566|NCT01738594|12376095|FG000|Follow up for 1 Year|Death|0
7879567|NCT01738594|12376096|FG001|Follow up for 1 Year|Death|0
7879568|NCT01738594|12376097|FG002|Follow up for 1 Year|Death|0
7879569|NCT01738594|12376098|FG003|Follow up for 1 Year|Death|0
7879570|NCT01738594|12376099|FG004|Follow up for 1 Year|Death|0
7879571|NCT01738594|12376100|FG005|Follow up for 1 Year|Death|1
7879572|NCT01738594|12376101|FG006|Follow up for 1 Year|Death|0
7879573|NCT01738594|12376102|FG007|Follow up for 1 Year|Death|0
7879574|NCT01738594|12376095|FG000|Follow up for 1 Year|Other|0
7879575|NCT01738594|12376096|FG001|Follow up for 1 Year|Other|0
7879576|NCT01738594|12376097|FG002|Follow up for 1 Year|Other|0
7879577|NCT01738594|12376098|FG003|Follow up for 1 Year|Other|0
7797491|NCT01075321|12253953|FG003|Overall Study|Protocol Violation|0
7797492|NCT01075321|12253950|FG000|Overall Study|Treatment Incomplete due to progression|1
7797493|NCT01075321|12253951|FG001|Overall Study|Treatment Incomplete due to progression|0
7797494|NCT01075321|12253952|FG002|Overall Study|Treatment Incomplete due to progression|0
7797495|NCT01075321|12253953|FG003|Overall Study|Treatment Incomplete due to progression|0
7797496|NCT01075321|12253950|FG000|Overall Study|Ineligible (miscalculated lab value)|0
7797497|NCT01075321|12253951|FG001|Overall Study|Ineligible (miscalculated lab value)|0
7797498|NCT01075321|12253952|FG002|Overall Study|Ineligible (miscalculated lab value)|0
7797499|NCT01075321|12253953|FG003|Overall Study|Ineligible (miscalculated lab value)|1
7797500|NCT01075412|12253980|FG000|Overall Study|Withdrawal by Subject|0
7797501|NCT01075412|12253981|FG001|Overall Study|Withdrawal by Subject|1
7797502|NCT01075516|12253988|FG000|Overall Study|Death|5
7797503|NCT01075516|12253989|FG001|Overall Study|Death|9
7797504|NCT01075516|12253988|FG000|Overall Study|Lost to Follow-up|10
7797505|NCT01075516|12253989|FG001|Overall Study|Lost to Follow-up|2
7797506|NCT01075516|12253988|FG000|Overall Study|Withdrawal by Subject|3
7797507|NCT01075516|12253989|FG001|Overall Study|Withdrawal by Subject|5
7797508|NCT01075646|12253999|FG000|Overall Study|Lost to Follow-up|4
7797509|NCT01075646|12254000|FG001|Overall Study|Lost to Follow-up|3
7797510|NCT01075646|12254001|FG002|Overall Study|Lost to Follow-up|1
7797511|NCT01075646|12254002|FG003|Overall Study|Lost to Follow-up|2
7797512|NCT01075685|12254014|FG000|Overall Study|Protocol Violation|9
7797513|NCT01075685|12254015|FG001|Overall Study|Protocol Violation|1
7797514|NCT01075685|12254014|FG000|Overall Study|Withdrawal by Subject|20
7797515|NCT01075685|12254015|FG001|Overall Study|Withdrawal by Subject|5
7797516|NCT01075685|12254014|FG000|Overall Study|Lost to Follow-up|563
7797517|NCT01075685|12254015|FG001|Overall Study|Lost to Follow-up|220
7797518|NCT01075763|12254023|FG000|Overall Study|Lost to Follow-up|2
7797519|NCT01075763|12254024|FG001|Overall Study|Lost to Follow-up|1
7797520|NCT01075763|12254023|FG000|Overall Study|Lack of Efficacy|0
7797521|NCT01075763|12254024|FG001|Overall Study|Lack of Efficacy|1
7797522|NCT01075763|12254023|FG000|Overall Study|Withdrawal by Subject|2
7797523|NCT01075763|12254024|FG001|Overall Study|Withdrawal by Subject|2
7797524|NCT01075815|12254032|FG000|Overall Study|Withdrawal before r-hCG administration|6
7797525|NCT01075815|12254033|FG001|Overall Study|Withdrawal before r-hCG administration|1
7797526|NCT01075815|12254032|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
7797527|NCT01075815|12254033|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
7797528|NCT01075815|12254032|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3
7797529|NCT01075815|12254033|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2
7797530|NCT01075958|12254039|FG000|Overall Study|Blood sample could not be obtained|44
7797531|NCT01075984|12254052|FG000|Treatment Phase|Adverse Event|0
7797532|NCT01075984|12254053|FG001|Treatment Phase|Adverse Event|1
7797533|NCT01075984|12254054|FG002|Treatment Phase|Adverse Event|3
7797534|NCT01075984|12254055|FG003|Treatment Phase|Adverse Event|7
7797535|NCT01075984|12254056|FG004|Treatment Phase|Adverse Event|35
7797536|NCT01075984|12254052|FG000|Treatment Phase|Protocol Violation|0
7797537|NCT01075984|12254053|FG001|Treatment Phase|Protocol Violation|0
7797538|NCT01075984|12254054|FG002|Treatment Phase|Protocol Violation|1
7797539|NCT01075984|12254055|FG003|Treatment Phase|Protocol Violation|0
7797540|NCT01075984|12254056|FG004|Treatment Phase|Protocol Violation|3
7797541|NCT01075984|12254052|FG000|Treatment Phase|Withdrawal by Subject|0
7797542|NCT01075984|12254053|FG001|Treatment Phase|Withdrawal by Subject|0
7797543|NCT01075984|12254054|FG002|Treatment Phase|Withdrawal by Subject|2
7797544|NCT01075984|12254055|FG003|Treatment Phase|Withdrawal by Subject|0
7797545|NCT01075984|12254056|FG004|Treatment Phase|Withdrawal by Subject|15
7797546|NCT01075984|12254052|FG000|Treatment Phase|Treatment Failure|0
7797547|NCT01075984|12254053|FG001|Treatment Phase|Treatment Failure|0
7797548|NCT01075984|12254054|FG002|Treatment Phase|Treatment Failure|1
7797549|NCT01075984|12254055|FG003|Treatment Phase|Treatment Failure|0
7797550|NCT01075984|12254056|FG004|Treatment Phase|Treatment Failure|5
7797551|NCT01075984|12254052|FG000|Treatment Phase|Progression of disease|0
7797552|NCT01075984|12254053|FG001|Treatment Phase|Progression of disease|0
7797553|NCT01075984|12254054|FG002|Treatment Phase|Progression of disease|0
7797554|NCT01075984|12254055|FG003|Treatment Phase|Progression of disease|0
7797555|NCT01075984|12254056|FG004|Treatment Phase|Progression of disease|2
7797556|NCT01075984|12254052|FG000|Follow-up Phase|Protocol Violation|0
7797557|NCT01075984|12254053|FG001|Follow-up Phase|Protocol Violation|0
7797558|NCT01075984|12254054|FG002|Follow-up Phase|Protocol Violation|1
7797559|NCT01075984|12254055|FG003|Follow-up Phase|Protocol Violation|0
7797560|NCT01075984|12254056|FG004|Follow-up Phase|Protocol Violation|3
7797561|NCT01075984|12254052|FG000|Follow-up Phase|Adverse Event|0
7797562|NCT01075984|12254053|FG001|Follow-up Phase|Adverse Event|0
7797563|NCT01075984|12254054|FG002|Follow-up Phase|Adverse Event|0
7797564|NCT01075984|12254055|FG003|Follow-up Phase|Adverse Event|2
7797565|NCT01075984|12254056|FG004|Follow-up Phase|Adverse Event|27
7797566|NCT01075984|12254052|FG000|Follow-up Phase|Administrative|0
7797567|NCT01075984|12254053|FG001|Follow-up Phase|Administrative|0
7797568|NCT01075984|12254054|FG002|Follow-up Phase|Administrative|0
7797569|NCT01075984|12254055|FG003|Follow-up Phase|Administrative|0
7797570|NCT01075984|12254056|FG004|Follow-up Phase|Administrative|1
7797571|NCT01075984|12254052|FG000|Follow-up Phase|Withdrawal by Subject|0
7797572|NCT01075984|12254053|FG001|Follow-up Phase|Withdrawal by Subject|0
7797573|NCT01075984|12254054|FG002|Follow-up Phase|Withdrawal by Subject|0
7797574|NCT01075984|12254055|FG003|Follow-up Phase|Withdrawal by Subject|0
7797575|NCT01075984|12254056|FG004|Follow-up Phase|Withdrawal by Subject|10
7797576|NCT01075984|12254052|FG000|Follow-up Phase|Progression of disease|0
7797577|NCT01075984|12254053|FG001|Follow-up Phase|Progression of disease|0
7797578|NCT01075984|12254054|FG002|Follow-up Phase|Progression of disease|0
7797579|NCT01075984|12254055|FG003|Follow-up Phase|Progression of disease|0
7797580|NCT01075984|12254056|FG004|Follow-up Phase|Progression of disease|2
7797581|NCT01075984|12254052|FG000|Follow-up Phase|Treatment failure|0
7797582|NCT01075984|12254053|FG001|Follow-up Phase|Treatment failure|0
7797583|NCT01075984|12254054|FG002|Follow-up Phase|Treatment failure|0
7797584|NCT01075984|12254055|FG003|Follow-up Phase|Treatment failure|0
7797585|NCT01075984|12254056|FG004|Follow-up Phase|Treatment failure|4
7797586|NCT01076010|12254071|FG000|Overall Study|Death|15
7797587|NCT01076010|12254072|FG001|Overall Study|Death|1
7797588|NCT01076010|12254073|FG002|Overall Study|Death|0
7797589|NCT01076010|12254071|FG000|Overall Study|Adverse Event|7
7797590|NCT01076010|12254072|FG001|Overall Study|Adverse Event|2
7797591|NCT01076010|12254073|FG002|Overall Study|Adverse Event|0
7879578|NCT01738594|12376099|FG004|Follow up for 1 Year|Other|0
7879579|NCT01738594|12376100|FG005|Follow up for 1 Year|Other|2
7879580|NCT01738594|12376101|FG006|Follow up for 1 Year|Other|0
7879581|NCT01738594|12376102|FG007|Follow up for 1 Year|Other|0
7879582|NCT01738646|12376112|FG000|Overall Study|Still Receiving Treatment|2
7879583|NCT01738919|12376155|FG000|Overall Study|Lost to Follow-up|1
7879584|NCT01738919|12376156|FG001|Overall Study|Lost to Follow-up|0
7879585|NCT01738919|12376155|FG000|Overall Study|Immigrated|0
7879586|NCT01738919|12376156|FG001|Overall Study|Immigrated|1
7879587|NCT01738919|12376155|FG000|Overall Study|Withdrawal by Subject|0
7879588|NCT01738919|12376156|FG001|Overall Study|Withdrawal by Subject|1
7879589|NCT01738919|12376155|FG000|Overall Study|Not treated in accordance to guidelines|0
7879590|NCT01738919|12376156|FG001|Overall Study|Not treated in accordance to guidelines|1
7879591|NCT01738971|12376167|FG000|Overall Study|Lost to Follow-up|19
7879592|NCT01738971|12376168|FG001|Overall Study|Lost to Follow-up|30
7879593|NCT01738971|12376169|FG002|Overall Study|Lost to Follow-up|17
7879594|NCT01738984|12376179|FG000|Overall Study|Pregnancy|4
7879595|NCT01738984|12376180|FG001|Overall Study|Pregnancy|0
7879596|NCT01738984|12376179|FG000|Overall Study|Withdrawal by Subject|1
7879597|NCT01738984|12376180|FG001|Overall Study|Withdrawal by Subject|0
7879598|NCT01738984|12376179|FG000|Overall Study|Lost to Follow-up|59
7879599|NCT01738984|12376180|FG001|Overall Study|Lost to Follow-up|39
7879600|NCT01739309|12376213|FG000|Overall Study|On study treatment|3
7879601|NCT01739335|12376221|FG000|Overall Study|Lost to Follow-up|7
7879602|NCT01739335|12376222|FG001|Overall Study|Lost to Follow-up|4
7879603|NCT01739335|12376221|FG000|Overall Study|Ineligible patient randomized|0
7879604|NCT01739335|12376222|FG001|Overall Study|Ineligible patient randomized|1
7879605|NCT01739348|12376236|FG000|Part I (Base Study)|Adverse Event|41
7879606|NCT01739348|12376237|FG001|Part I (Base Study)|Adverse Event|52
7879607|NCT01739348|12376238|FG002|Part I (Base Study)|Adverse Event|8
7879608|NCT01739348|12376239|FG003|Part I (Base Study)|Adverse Event|33
7879609|NCT01739348|12376236|FG000|Part I (Base Study)|Death|10
7879610|NCT01739348|12376237|FG001|Part I (Base Study)|Death|7
7879611|NCT01739348|12376238|FG002|Part I (Base Study)|Death|2
7879612|NCT01739348|12376239|FG003|Part I (Base Study)|Death|8
7879613|NCT01739348|12376236|FG000|Part I (Base Study)|Lack of Efficacy|3
7879614|NCT01739348|12376237|FG001|Part I (Base Study)|Lack of Efficacy|8
7879615|NCT01739348|12376238|FG002|Part I (Base Study)|Lack of Efficacy|0
7879616|NCT01739348|12376239|FG003|Part I (Base Study)|Lack of Efficacy|7
7879617|NCT01739348|12376236|FG000|Part I (Base Study)|Lost to Follow-up|4
7879618|NCT01739348|12376237|FG001|Part I (Base Study)|Lost to Follow-up|2
7879619|NCT01739348|12376238|FG002|Part I (Base Study)|Lost to Follow-up|4
7879620|NCT01739348|12376239|FG003|Part I (Base Study)|Lost to Follow-up|4
7879621|NCT01739348|12376236|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3
7879622|NCT01739348|12376237|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2
7879623|NCT01739348|12376238|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0
7879624|NCT01739348|12376239|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0
7879625|NCT01739348|12376236|FG000|Part I (Base Study)|Physician Decision|10
7879626|NCT01739348|12376237|FG001|Part I (Base Study)|Physician Decision|7
7879627|NCT01739348|12376238|FG002|Part I (Base Study)|Physician Decision|1
7879628|NCT01739348|12376239|FG003|Part I (Base Study)|Physician Decision|4
7879629|NCT01739348|12376236|FG000|Part I (Base Study)|Protocol Violation|2
7879630|NCT01739348|12376237|FG001|Part I (Base Study)|Protocol Violation|0
7879631|NCT01739348|12376238|FG002|Part I (Base Study)|Protocol Violation|1
7879632|NCT01739348|12376239|FG003|Part I (Base Study)|Protocol Violation|2
7879633|NCT01739348|12376236|FG000|Part I (Base Study)|Screen Failure|2
7879634|NCT01739348|12376237|FG001|Part I (Base Study)|Screen Failure|0
7879635|NCT01739348|12376238|FG002|Part I (Base Study)|Screen Failure|0
7879636|NCT01739348|12376239|FG003|Part I (Base Study)|Screen Failure|0
7879637|NCT01739348|12376236|FG000|Part I (Base Study)|Site Discontinued Study Participation|1
7879638|NCT01739348|12376237|FG001|Part I (Base Study)|Site Discontinued Study Participation|3
7879639|NCT01739348|12376238|FG002|Part I (Base Study)|Site Discontinued Study Participation|0
7879640|NCT01739348|12376239|FG003|Part I (Base Study)|Site Discontinued Study Participation|0
7797592|NCT01076010|12254071|FG000|Overall Study|Progressive disease|90
7797593|NCT01076010|12254072|FG001|Overall Study|Progressive disease|30
7797594|NCT01076010|12254073|FG002|Overall Study|Progressive disease|1
7797595|NCT01076010|12254071|FG000|Overall Study|Lack of Efficacy|4
7797596|NCT01076010|12254072|FG001|Overall Study|Lack of Efficacy|0
7797597|NCT01076010|12254073|FG002|Overall Study|Lack of Efficacy|0
7797598|NCT01076010|12254071|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0
7797599|NCT01076010|12254072|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1
7797600|NCT01076010|12254073|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0
7797601|NCT01076010|12254071|FG000|Overall Study|Significant Surgical Procedure|0
7797602|NCT01076010|12254072|FG001|Overall Study|Significant Surgical Procedure|1
7797603|NCT01076010|12254073|FG002|Overall Study|Significant Surgical Procedure|0
7797604|NCT01076010|12254071|FG000|Overall Study|Protocol Violation|0
7797605|NCT01076010|12254072|FG001|Overall Study|Protocol Violation|1
7797606|NCT01076010|12254073|FG002|Overall Study|Protocol Violation|0
7797607|NCT01076010|12254071|FG000|Overall Study|Noncompliance|1
7797608|NCT01076010|12254072|FG001|Overall Study|Noncompliance|1
7797609|NCT01076010|12254073|FG002|Overall Study|Noncompliance|0
7797610|NCT01076010|12254071|FG000|Overall Study|Withdrawal by Subject|3
7797611|NCT01076010|12254072|FG001|Overall Study|Withdrawal by Subject|0
7797612|NCT01076010|12254073|FG002|Overall Study|Withdrawal by Subject|1
7797613|NCT01076010|12254071|FG000|Overall Study|Other|5
7797614|NCT01076010|12254072|FG001|Overall Study|Other|2
7797615|NCT01076010|12254073|FG002|Overall Study|Other|0
7797616|NCT01076036|12254081|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2
7797617|NCT01076075|12254102|FG000|Overall Study|Adverse Event|3
7797618|NCT01076075|12254103|FG001|Overall Study|Adverse Event|9
7797619|NCT01076075|12254102|FG000|Overall Study|Lack of Efficacy|5
7797620|NCT01076075|12254103|FG001|Overall Study|Lack of Efficacy|4
7797621|NCT01076075|12254102|FG000|Overall Study|Lost to Follow-up|6
7797622|NCT01076075|12254103|FG001|Overall Study|Lost to Follow-up|5
7797623|NCT01076075|12254102|FG000|Overall Study|other|19
7797624|NCT01076075|12254103|FG001|Overall Study|other|9
7797625|NCT01076075|12254102|FG000|Overall Study|Protocol Violation|0
7797626|NCT01076075|12254103|FG001|Overall Study|Protocol Violation|1
7797627|NCT01076075|12254102|FG000|Overall Study|Withdrawal by Subject|8
7797628|NCT01076075|12254103|FG001|Overall Study|Withdrawal by Subject|19
7797629|NCT01076088|12254118|FG000|Overall Study|Adverse Event|1
7797630|NCT01076088|12254119|FG001|Overall Study|Adverse Event|6
7797631|NCT01076088|12254120|FG002|Overall Study|Adverse Event|3
7797632|NCT01076088|12254121|FG003|Overall Study|Adverse Event|2
7797633|NCT01076088|12254122|FG004|Overall Study|Adverse Event|3
7797634|NCT01076088|12254123|FG005|Overall Study|Adverse Event|3
7797635|NCT01076088|12254118|FG000|Overall Study|Lost to Follow-up|1
7797636|NCT01076088|12254119|FG001|Overall Study|Lost to Follow-up|1
7797637|NCT01076088|12254120|FG002|Overall Study|Lost to Follow-up|0
7797638|NCT01076088|12254121|FG003|Overall Study|Lost to Follow-up|1
7797639|NCT01076088|12254122|FG004|Overall Study|Lost to Follow-up|1
7797640|NCT01076088|12254123|FG005|Overall Study|Lost to Follow-up|2
7797641|NCT01076088|12254118|FG000|Overall Study|Non-compliance with study drug|0
7797642|NCT01076088|12254119|FG001|Overall Study|Non-compliance with study drug|0
7797643|NCT01076088|12254120|FG002|Overall Study|Non-compliance with study drug|0
7797644|NCT01076088|12254121|FG003|Overall Study|Non-compliance with study drug|1
7797645|NCT01076088|12254122|FG004|Overall Study|Non-compliance with study drug|0
7797646|NCT01076088|12254123|FG005|Overall Study|Non-compliance with study drug|0
7797647|NCT01076088|12254118|FG000|Overall Study|Physician Decision|1
7797648|NCT01076088|12254119|FG001|Overall Study|Physician Decision|3
7797649|NCT01076088|12254120|FG002|Overall Study|Physician Decision|0
7797650|NCT01076088|12254121|FG003|Overall Study|Physician Decision|1
7797651|NCT01076088|12254122|FG004|Overall Study|Physician Decision|1
7797652|NCT01076088|12254123|FG005|Overall Study|Physician Decision|0
7797653|NCT01076088|12254118|FG000|Overall Study|Withdrawal by Subject|8
7797654|NCT01076088|12254119|FG001|Overall Study|Withdrawal by Subject|8
7797655|NCT01076088|12254120|FG002|Overall Study|Withdrawal by Subject|14
7797656|NCT01076088|12254121|FG003|Overall Study|Withdrawal by Subject|10
7797657|NCT01076088|12254122|FG004|Overall Study|Withdrawal by Subject|11
7797658|NCT01076088|12254123|FG005|Overall Study|Withdrawal by Subject|17
7797659|NCT01076088|12254118|FG000|Overall Study|Other protocol specified criteria|0
7797660|NCT01076088|12254119|FG001|Overall Study|Other protocol specified criteria|0
7797661|NCT01076088|12254120|FG002|Overall Study|Other protocol specified criteria|0
7797662|NCT01076088|12254121|FG003|Overall Study|Other protocol specified criteria|0
7797663|NCT01076088|12254122|FG004|Overall Study|Other protocol specified criteria|0
7797664|NCT01076088|12254123|FG005|Overall Study|Other protocol specified criteria|1
7797665|NCT01076153|12254138|FG000|Overall Study|Symptoms improved/resolved|10
7797666|NCT01076153|12254138|FG000|Overall Study|Adverse Event|1
7797667|NCT01076166|12254146|FG000|Overall Study|Adverse Event|3
7797668|NCT01076166|12254146|FG000|Overall Study|Symptoms improved/resolved|6
7797669|NCT01076179|12254153|FG000|Overall Study|Withdrawal by Subject|1
7797670|NCT01076192|12254158|FG000|Overall Study|Other|197
7797671|NCT01076205|12254163|FG000|Overall Study|Adverse Drug Reaction|299
7797672|NCT01076205|12254163|FG000|Overall Study|Lack of Effectiveness|1423
7797673|NCT01076205|12254163|FG000|Overall Study|Other Reason|1075
7797674|NCT01076205|12254163|FG000|Overall Study|Unknown Reason|71
7797675|NCT01076205|12254163|FG000|Overall Study|Lost to Follow-up|3151
7797676|NCT01076335|12254229|FG000|Overall Study|Withdrawal by Subject|3
7797677|NCT01076335|12254229|FG000|Overall Study|Withdrawal without treatment|1
7797678|NCT01076361|12254237|FG000|Overall Study|22 leads were excluded from analysis|21
7797679|NCT01076400|12254241|FG000|Overall Study|Adverse Event|2
7797680|NCT01076400|12254242|FG001|Overall Study|Adverse Event|0
7797681|NCT01076400|12254243|FG002|Overall Study|Adverse Event|0
7797682|NCT01076400|12254241|FG000|Overall Study|Progressive Disease|5
7797683|NCT01076400|12254242|FG001|Overall Study|Progressive Disease|0
7797684|NCT01076400|12254243|FG002|Overall Study|Progressive Disease|0
7797685|NCT01076543|12254266|FG000|Overall Study|Withdrawal by Subject|2
7797686|NCT01076543|12254267|FG001|Overall Study|Withdrawal by Subject|0
7797687|NCT01076543|12254268|FG002|Overall Study|Withdrawal by Subject|0
7797688|NCT01076543|12254269|FG003|Overall Study|Withdrawal by Subject|0
7797689|NCT01076543|12254270|FG004|Overall Study|Withdrawal by Subject|0
7797690|NCT01076543|12254271|FG005|Overall Study|Withdrawal by Subject|0
7797691|NCT01076647|12254288|FG000|Overall Study|Adverse Event|4
7797692|NCT01076647|12254289|FG001|Overall Study|Adverse Event|1
7797693|NCT01076647|12254288|FG000|Overall Study|Lack of Efficacy|0
7797694|NCT01076647|12254289|FG001|Overall Study|Lack of Efficacy|1
7797695|NCT01076647|12254288|FG000|Overall Study|Protocol Violation|7
7797696|NCT01076647|12254289|FG001|Overall Study|Protocol Violation|9
7797697|NCT01076647|12254288|FG000|Overall Study|Withdrawal criteria|2
7797698|NCT01076647|12254289|FG001|Overall Study|Withdrawal criteria|2
7797699|NCT01076647|12254288|FG000|Overall Study|Unclassified|12
7797700|NCT01076647|12254289|FG001|Overall Study|Unclassified|12
7797701|NCT01076959|12254312|FG000|Overall Study|Adverse Event|767
7797702|NCT01076959|12254312|FG000|Overall Study|Lack of Efficacy|849
7797703|NCT01076959|12254312|FG000|Overall Study|Non-compliance|274
7879641|NCT01739348|12376236|FG000|Part I (Base Study)|Study Terminated by Sponsor|72
7879642|NCT01739348|12376237|FG001|Part I (Base Study)|Study Terminated by Sponsor|73
7879643|NCT01739348|12376238|FG002|Part I (Base Study)|Study Terminated by Sponsor|0
7879644|NCT01739348|12376239|FG003|Part I (Base Study)|Study Terminated by Sponsor|86
7879645|NCT01739348|12376236|FG000|Part I (Base Study)|Participant Moved|4
7879646|NCT01739348|12376237|FG001|Part I (Base Study)|Participant Moved|3
7879647|NCT01739348|12376238|FG002|Part I (Base Study)|Participant Moved|1
7879648|NCT01739348|12376239|FG003|Part I (Base Study)|Participant Moved|7
7879649|NCT01739348|12376236|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
7879650|NCT01739348|12376237|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
7879651|NCT01739348|12376238|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
7879652|NCT01739348|12376239|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
7879653|NCT01739348|12376236|FG000|Part I (Base Study)|Withdrawal by Subject|23
7879654|NCT01739348|12376237|FG001|Part I (Base Study)|Withdrawal by Subject|21
7879655|NCT01739348|12376238|FG002|Part I (Base Study)|Withdrawal by Subject|7
7879656|NCT01739348|12376239|FG003|Part I (Base Study)|Withdrawal by Subject|20
7879657|NCT01739348|12376236|FG000|Part II (Extension Study)|Adverse Event|10
7879658|NCT01739348|12376237|FG001|Part II (Extension Study)|Adverse Event|11
7879659|NCT01739348|12376238|FG002|Part II (Extension Study)|Adverse Event|7
7879660|NCT01739348|12376239|FG003|Part II (Extension Study)|Adverse Event|26
7879661|NCT01739348|12376236|FG000|Part II (Extension Study)|Death|3
7879662|NCT01739348|12376237|FG001|Part II (Extension Study)|Death|3
7879663|NCT01739348|12376238|FG002|Part II (Extension Study)|Death|2
7879664|NCT01739348|12376239|FG003|Part II (Extension Study)|Death|6
7879665|NCT01739348|12376236|FG000|Part II (Extension Study)|Lack of Efficacy|1
7879666|NCT01739348|12376237|FG001|Part II (Extension Study)|Lack of Efficacy|5
7879667|NCT01739348|12376238|FG002|Part II (Extension Study)|Lack of Efficacy|0
7879668|NCT01739348|12376239|FG003|Part II (Extension Study)|Lack of Efficacy|1
7879669|NCT01739348|12376236|FG000|Part II (Extension Study)|Lost to Follow-up|3
7879670|NCT01739348|12376237|FG001|Part II (Extension Study)|Lost to Follow-up|4
7879671|NCT01739348|12376238|FG002|Part II (Extension Study)|Lost to Follow-up|0
7879672|NCT01739348|12376239|FG003|Part II (Extension Study)|Lost to Follow-up|1
7879673|NCT01739348|12376236|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0
7879674|NCT01739348|12376237|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0
7879675|NCT01739348|12376238|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0
7879676|NCT01739348|12376239|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1
7879677|NCT01739348|12376236|FG000|Part II (Extension Study)|Physician Decision|7
7879678|NCT01739348|12376237|FG001|Part II (Extension Study)|Physician Decision|11
7879679|NCT01739348|12376238|FG002|Part II (Extension Study)|Physician Decision|6
7879680|NCT01739348|12376239|FG003|Part II (Extension Study)|Physician Decision|12
7879681|NCT01739348|12376236|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329
7879682|NCT01739348|12376237|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315
7879683|NCT01739348|12376238|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34
7879684|NCT01739348|12376239|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323
7879685|NCT01739348|12376236|FG000|Part II (Extension Study)|Participant Moved|3
7879686|NCT01739348|12376237|FG001|Part II (Extension Study)|Participant Moved|3
7879687|NCT01739348|12376238|FG002|Part II (Extension Study)|Participant Moved|0
7879688|NCT01739348|12376239|FG003|Part II (Extension Study)|Participant Moved|3
7879689|NCT01739348|12376236|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
7879690|NCT01739348|12376237|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
7797704|NCT01076959|12254312|FG000|Overall Study|Lost to Follow-up|241
7797705|NCT01076959|12254312|FG000|Overall Study|Other|119
7797706|NCT01077024|12254351|FG000|Overall Study|Lost to Follow-up|20
7797707|NCT01077024|12254352|FG001|Overall Study|Lost to Follow-up|14
7797708|NCT01077024|12254351|FG000|Overall Study|Withdrawal by Subject|0
7797709|NCT01077024|12254352|FG001|Overall Study|Withdrawal by Subject|2
7797710|NCT01077024|12254351|FG000|Overall Study|Incarcerated|7
7797711|NCT01077024|12254352|FG001|Overall Study|Incarcerated|8
7797712|NCT01077024|12254351|FG000|Overall Study|Other|4
7797713|NCT01077024|12254352|FG001|Overall Study|Other|4
7797714|NCT01077050|12254358|FG000|Overall Study|Subjects signed ICF could not be located|1
7797715|NCT01077050|12254358|FG000|Overall Study|Screen failure|8
7797716|NCT01077063|12254364|FG000|Overall Study|Adverse Event|3
7797717|NCT01077063|12254365|FG001|Overall Study|Adverse Event|0
7797718|NCT01077063|12254364|FG000|Overall Study|Death|1
7797719|NCT01077063|12254365|FG001|Overall Study|Death|1
7797720|NCT01077063|12254364|FG000|Overall Study|Withdrawal by Subject|0
7797721|NCT01077063|12254365|FG001|Overall Study|Withdrawal by Subject|2
7797722|NCT01077076|12254371|FG000|First Intervention|Withdrawal by Subject|1
7797723|NCT01077076|12254372|FG001|First Intervention|Withdrawal by Subject|0
7797724|NCT01077076|12254373|FG002|First Intervention|Withdrawal by Subject|0
7797725|NCT01077076|12254374|FG003|First Intervention|Withdrawal by Subject|0
7797726|NCT01077076|12254375|FG004|First Intervention|Withdrawal by Subject|0
7797727|NCT01077076|12254376|FG005|First Intervention|Withdrawal by Subject|0
7797728|NCT01077076|12254371|FG000|Third Intervention|Death in the participant's family|0
7797729|NCT01077076|12254372|FG001|Third Intervention|Death in the participant's family|0
7797730|NCT01077076|12254373|FG002|Third Intervention|Death in the participant's family|0
7797731|NCT01077076|12254374|FG003|Third Intervention|Death in the participant's family|0
7797732|NCT01077076|12254375|FG004|Third Intervention|Death in the participant's family|0
7797733|NCT01077076|12254376|FG005|Third Intervention|Death in the participant's family|1
7797734|NCT01077128|12254384|FG000|Overall Study|Adverse Event|8
7797735|NCT01077128|12254384|FG000|Overall Study|Lack of Efficacy|1
7797736|NCT01077128|12254384|FG000|Overall Study|Disease exacerbation|1
7797737|NCT01077128|12254384|FG000|Overall Study|Adverse event and consent withdrawal|1
7797738|NCT01077128|12254384|FG000|Overall Study|Adverse event and disease exacerbation|1
7797739|NCT01077128|12254384|FG000|Overall Study|Lack of efficacy/disease exacerbation|1
7797740|NCT01077128|12254384|FG000|Overall Study|Other|54
7797741|NCT01077154|12254440|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524
7797742|NCT01077154|12254441|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514
7797743|NCT01077154|12254440|FG000|Overall Study|Withdrawal by Subject|369
7797744|NCT01077154|12254441|FG001|Overall Study|Withdrawal by Subject|385
7797745|NCT01077154|12254440|FG000|Overall Study|Death|215
7797746|NCT01077154|12254441|FG001|Overall Study|Death|214
7797747|NCT01077154|12254440|FG000|Overall Study|Lost to Follow-up|43
7797748|NCT01077154|12254441|FG001|Overall Study|Lost to Follow-up|35
7797749|NCT01077154|12254440|FG000|Overall Study|Noncompliance|22
7797750|NCT01077154|12254441|FG001|Overall Study|Noncompliance|20
7797751|NCT01077154|12254440|FG000|Overall Study|Disease Progression|18
7797752|NCT01077154|12254441|FG001|Overall Study|Disease Progression|20
7797753|NCT01077154|12254440|FG000|Overall Study|Ineligibility Determined|10
7797754|NCT01077154|12254441|FG001|Overall Study|Ineligibility Determined|14
7797755|NCT01077154|12254440|FG000|Overall Study|Other|14
7797756|NCT01077154|12254441|FG001|Overall Study|Other|11
7797757|NCT01077154|12254440|FG000|Overall Study|Adverse Event|9
7797758|NCT01077154|12254441|FG001|Overall Study|Adverse Event|9
7797759|NCT01077154|12254440|FG000|Overall Study|Administrative Decision|1
7797760|NCT01077154|12254441|FG001|Overall Study|Administrative Decision|6
7797761|NCT01077154|12254440|FG000|Overall Study|Protocol Deviation|1
7797762|NCT01077154|12254441|FG001|Overall Study|Protocol Deviation|0
7797763|NCT01077193|12254447|FG000|Overall Study|Lost to Follow-up|1
7797764|NCT01077193|12254447|FG000|Overall Study|Withdrawal by Subject|2
7797765|NCT01077193|12254447|FG000|Overall Study|Lack of Efficacy|1
7797766|NCT01077193|12254447|FG000|Overall Study|Study Terminated by Sponsor|40
7797767|NCT01077258|12254451|FG000|Overall Study|Lost to Follow-up|1390
7797768|NCT01077258|12254451|FG000|Overall Study|Adverse drug reaction|218
7797769|NCT01077258|12254451|FG000|Overall Study|Lack of Efficacy|663
7797770|NCT01077258|12254451|FG000|Overall Study|Clinical remission|37
7797771|NCT01077258|12254451|FG000|Overall Study|Other reasons|260
7797772|NCT01077271|12254468|FG000|Overall Study|Parental desire|8
7797773|NCT01077271|12254468|FG000|Overall Study|Screen failure, did not take palivizumab|4
7797774|NCT01077271|12254468|FG000|Overall Study|Noncompliance|2
7797775|NCT01077271|12254468|FG000|Overall Study|Quota used up (insurance reimb issue)|2
7797776|NCT01077271|12254468|FG000|Overall Study|Changed doctors|2
7797777|NCT01077271|12254468|FG000|Overall Study|Parents thought too many injections|2
7797778|NCT01077271|12254468|FG000|Overall Study|End of RSV season nearly reached|1
7797779|NCT01077271|12254468|FG000|Overall Study|Mother unconvinced of the necessity|1
7879691|NCT01739348|12376238|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
7879692|NCT01739348|12376239|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
7879693|NCT01739348|12376236|FG000|Part II (Extension Study)|Withdrawal by Subject|5
7879694|NCT01739348|12376237|FG001|Part II (Extension Study)|Withdrawal by Subject|2
7879695|NCT01739348|12376238|FG002|Part II (Extension Study)|Withdrawal by Subject|4
7879696|NCT01739348|12376239|FG003|Part II (Extension Study)|Withdrawal by Subject|7
7879697|NCT01739400|12376264|FG000|Overall Study|Physician Decision|3
7879698|NCT01739400|12376265|FG001|Overall Study|Physician Decision|0
7879699|NCT01739400|12376264|FG000|Overall Study|Lost to Follow-up|2
7879700|NCT01739400|12376265|FG001|Overall Study|Lost to Follow-up|0
7879701|NCT01739400|12376264|FG000|Overall Study|Death|5
7879702|NCT01739400|12376265|FG001|Overall Study|Death|2
7879703|NCT01739400|12376264|FG000|Overall Study|Withdrawal by Subject|7
7879704|NCT01739400|12376265|FG001|Overall Study|Withdrawal by Subject|7
7879705|NCT01739595|12376273|FG000|Overall Study|Adverse Event|3
7879706|NCT01739595|12376274|FG001|Overall Study|Adverse Event|0
7879707|NCT01739595|12376275|FG002|Overall Study|Adverse Event|0
7879708|NCT01739595|12376273|FG000|Overall Study|Lost to Follow-up|2
7879709|NCT01739595|12376274|FG001|Overall Study|Lost to Follow-up|0
7879710|NCT01739595|12376275|FG002|Overall Study|Lost to Follow-up|0
7879711|NCT01739595|12376273|FG000|Overall Study|Withdrawal by Subject|2
7879712|NCT01739595|12376274|FG001|Overall Study|Withdrawal by Subject|1
7879713|NCT01739595|12376275|FG002|Overall Study|Withdrawal by Subject|2
7879714|NCT01739595|12376273|FG000|Overall Study|Eligibility issue|3
7879715|NCT01739595|12376274|FG001|Overall Study|Eligibility issue|0
7879716|NCT01739595|12376275|FG002|Overall Study|Eligibility issue|0
7879717|NCT01739595|12376273|FG000|Overall Study|Protocol Violation|1
7879718|NCT01739595|12376274|FG001|Overall Study|Protocol Violation|0
7879719|NCT01739595|12376275|FG002|Overall Study|Protocol Violation|0
7879720|NCT01739595|12376273|FG000|Overall Study|Lab assessment|1
7879721|NCT01739595|12376274|FG001|Overall Study|Lab assessment|0
7879722|NCT01739595|12376275|FG002|Overall Study|Lab assessment|0
7879723|NCT01739595|12376273|FG000|Overall Study|Drug discrepancy|1
7879724|NCT01739595|12376274|FG001|Overall Study|Drug discrepancy|0
7879725|NCT01739595|12376275|FG002|Overall Study|Drug discrepancy|0
7879726|NCT01739764|12376294|FG000|Overall Study|Adverse Event|0
7879727|NCT01739764|12376295|FG001|Overall Study|Adverse Event|3
7879728|NCT01739764|12376296|FG002|Overall Study|Adverse Event|4
7879729|NCT01739764|12376294|FG000|Overall Study|Death|4
7879730|NCT01739764|12376295|FG001|Overall Study|Death|6
7879731|NCT01739764|12376296|FG002|Overall Study|Death|38
7879732|NCT01739764|12376294|FG000|Overall Study|Lost to Follow-up|0
7879733|NCT01739764|12376295|FG001|Overall Study|Lost to Follow-up|0
7797780|NCT01077284|12254483|FG000|Overall Study|Adverse Event|2
7797781|NCT01077284|12254484|FG001|Overall Study|Adverse Event|0
7797782|NCT01077284|12254485|FG002|Overall Study|Adverse Event|1
7797783|NCT01077284|12254483|FG000|Overall Study|Lost to Follow-up|1
7797784|NCT01077284|12254484|FG001|Overall Study|Lost to Follow-up|2
7797785|NCT01077284|12254485|FG002|Overall Study|Lost to Follow-up|0
7797786|NCT01077284|12254483|FG000|Overall Study|Withdrawal by Subject|2
7797787|NCT01077284|12254484|FG001|Overall Study|Withdrawal by Subject|3
7797788|NCT01077284|12254485|FG002|Overall Study|Withdrawal by Subject|1
7797789|NCT01077284|12254483|FG000|Overall Study|Other|0
7797790|NCT01077284|12254484|FG001|Overall Study|Other|0
7797791|NCT01077284|12254485|FG002|Overall Study|Other|1
7797792|NCT01077323|12254510|FG000|Overall Study|<9 months enroll before drug dispensed|11226
7797793|NCT01077323|12254511|FG001|Overall Study|<9 months enroll before drug dispensed|263954
7797794|NCT01077323|12254512|FG002|Overall Study|<9 months enroll before drug dispensed|11655523
7797795|NCT01077323|12254510|FG000|Overall Study|Dispensing of drug in baseline period|0
7797796|NCT01077323|12254511|FG001|Overall Study|Dispensing of drug in baseline period|120229
7797797|NCT01077323|12254512|FG002|Overall Study|Dispensing of drug in baseline period|256446
7797798|NCT01077323|12254510|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152
7797799|NCT01077323|12254511|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080
7797800|NCT01077323|12254512|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120
7797801|NCT01077362|12254523|FG000|Overall Study|Lack of Efficacy|13
7797802|NCT01077362|12254524|FG001|Overall Study|Lack of Efficacy|8
7797803|NCT01077362|12254525|FG002|Overall Study|Lack of Efficacy|10
7797804|NCT01077362|12254523|FG000|Overall Study|Lost to Follow-up|1
7797805|NCT01077362|12254524|FG001|Overall Study|Lost to Follow-up|0
7797806|NCT01077362|12254525|FG002|Overall Study|Lost to Follow-up|3
7797807|NCT01077362|12254523|FG000|Overall Study|Adverse Event|12
7797808|NCT01077362|12254524|FG001|Overall Study|Adverse Event|7
7797809|NCT01077362|12254525|FG002|Overall Study|Adverse Event|4
7797810|NCT01077362|12254523|FG000|Overall Study|Withdrawal by Subject|5
7797811|NCT01077362|12254524|FG001|Overall Study|Withdrawal by Subject|3
7797812|NCT01077362|12254525|FG002|Overall Study|Withdrawal by Subject|5
7797813|NCT01077362|12254523|FG000|Overall Study|Other|0
7797814|NCT01077362|12254524|FG001|Overall Study|Other|1
7797815|NCT01077362|12254525|FG002|Overall Study|Other|2
7797816|NCT01077375|12254540|FG000|Overall Study|Adverse Event|2
7797817|NCT01077375|12254541|FG001|Overall Study|Adverse Event|15
7797818|NCT01077375|12254540|FG000|Overall Study|Lack of Efficacy|6
7797819|NCT01077375|12254541|FG001|Overall Study|Lack of Efficacy|8
7797820|NCT01077375|12254540|FG000|Overall Study|Withdrawal by Subject|0
7797821|NCT01077375|12254541|FG001|Overall Study|Withdrawal by Subject|6
7797822|NCT01077375|12254540|FG000|Overall Study|Lost to Follow-up|2
7797823|NCT01077375|12254541|FG001|Overall Study|Lost to Follow-up|5
7797824|NCT01077375|12254540|FG000|Overall Study|Other Reason|0
7797825|NCT01077375|12254541|FG001|Overall Study|Other Reason|1
7797826|NCT01077518|12254560|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8
7797827|NCT01077518|12254561|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4
7797828|NCT01077518|12254562|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0
7797829|NCT01077518|12254560|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10
7797830|NCT01077518|12254561|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11
7797831|NCT01077518|12254562|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0
7797832|NCT01077518|12254560|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28
7797833|NCT01077518|12254561|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22
7797834|NCT01077518|12254562|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0
7797835|NCT01077518|12254560|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32
7797836|NCT01077518|12254561|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28
7797837|NCT01077518|12254562|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0
7797838|NCT01077518|12254560|FG000|Optional Ofa Phase|Physician Decision|0
7797839|NCT01077518|12254561|FG001|Optional Ofa Phase|Physician Decision|0
7797840|NCT01077518|12254562|FG002|Optional Ofa Phase|Physician Decision|1
7797841|NCT01077518|12254560|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0
7797842|NCT01077518|12254561|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0
7797843|NCT01077518|12254562|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12
7797844|NCT01077518|12254560|FG000|Optional Ofa Phase|Withdrawal by Subject|0
7797845|NCT01077518|12254561|FG001|Optional Ofa Phase|Withdrawal by Subject|0
7797846|NCT01077518|12254562|FG002|Optional Ofa Phase|Withdrawal by Subject|3
7797847|NCT01077544|12254573|FG000|Overall Study|New Cancer Therapy|3
7797848|NCT01077544|12254574|FG001|Overall Study|New Cancer Therapy|3
7797849|NCT01077544|12254573|FG000|Overall Study|Adverse Event|0
7797850|NCT01077544|12254574|FG001|Overall Study|Adverse Event|1
7797851|NCT01077544|12254573|FG000|Overall Study|Disease Progression|0
7797852|NCT01077544|12254574|FG001|Overall Study|Disease Progression|1
7797853|NCT01077622|12254624|FG000|Overall Study|Physician Decision|2
7797854|NCT01077622|12254624|FG000|Overall Study|Withdrawal by Subject|1
7797855|NCT01077713|12254630|FG000|Overall Study|Withdrawal by Subject|1
7797856|NCT01077713|12254631|FG001|Overall Study|Withdrawal by Subject|2
7797857|NCT01077713|12254630|FG000|Overall Study|Progressive Disease (PD)|0
7797858|NCT01077713|12254631|FG001|Overall Study|Progressive Disease (PD)|1
7797859|NCT01077713|12254630|FG000|Overall Study|Death|28
7797860|NCT01077713|12254631|FG001|Overall Study|Death|29
7797861|NCT01077713|12254630|FG000|Overall Study|Lost to Follow-up|1
7797862|NCT01077713|12254631|FG001|Overall Study|Lost to Follow-up|1
7797863|NCT01077713|12254630|FG000|Overall Study|Adverse Event|2
7797864|NCT01077713|12254631|FG001|Overall Study|Adverse Event|1
7797865|NCT01077713|12254630|FG000|Overall Study|Other|4
7797866|NCT01077713|12254631|FG001|Overall Study|Other|2
7797867|NCT01077739|12254639|FG000|Overall Study|Premature withdrawal|1
7797868|NCT01077739|12254640|FG001|Overall Study|Premature withdrawal|3
7797869|NCT01077739|12254639|FG000|Overall Study|Withdrawal by Subject|1
7797870|NCT01077739|12254640|FG001|Overall Study|Withdrawal by Subject|0
7797871|NCT01077739|12254639|FG000|Overall Study|Death|0
7797872|NCT01077739|12254640|FG001|Overall Study|Death|3
7797873|NCT01077739|12254639|FG000|Overall Study|Unacceptable toxicity|1
7797874|NCT01077739|12254640|FG001|Overall Study|Unacceptable toxicity|2
7797875|NCT01077739|12254639|FG000|Overall Study|Other|2
7797876|NCT01077739|12254640|FG001|Overall Study|Other|2
7797877|NCT01077804|12254646|FG000|Overall Study|Unreachable|102
7797878|NCT01077804|12254646|FG000|Overall Study|Refused to continue|79
7797879|NCT01077804|12254646|FG000|Overall Study|Other|18
7797880|NCT01077960|12254660|FG000|Overall Study|Adverse Event|6
7797881|NCT01077960|12254660|FG000|Overall Study|Protocol Violation|3
7797882|NCT01077960|12254660|FG000|Overall Study|Lost to Follow-up|5
7797883|NCT01077960|12254660|FG000|Overall Study|Subject decision|1
7797884|NCT01077960|12254660|FG000|Overall Study|Reason unspecified|1
7797885|NCT01078090|12254679|FG000|Overall Study|Lost to Follow-up|2363
7797886|NCT01078090|12254679|FG000|Overall Study|Adverse drug reaction (ADR)|453
7797887|NCT01078090|12254679|FG000|Overall Study|Lack of Efficacy|1193
7797888|NCT01078090|12254679|FG000|Overall Study|ADR and lack of efficacy|61
7797889|NCT01078090|12254679|FG000|Overall Study|Other|523
7797890|NCT01078116|12254697|FG000|Overall Study|Lost to Follow-up|17
7797891|NCT01078116|12254697|FG000|Overall Study|Adverse Event|5
7797892|NCT01078116|12254697|FG000|Overall Study|Withdrawal by Subject|8
7797893|NCT01078116|12254697|FG000|Overall Study|Lack of effectiveness|15
7797894|NCT01078116|12254697|FG000|Overall Study|Case report form not completed|3
7797895|NCT01078155|12254701|FG000|Overall Study|Adverse Event|7
7797896|NCT01078155|12254701|FG000|Overall Study|Lack of Efficacy|16
7797897|NCT01078155|12254701|FG000|Overall Study|Participant's Decision|6
7797898|NCT01078155|12254701|FG000|Overall Study|Lost to Follow-up|15
7797899|NCT01078168|12254707|FG000|Overall Study|Physician Decision|0
7797900|NCT01078168|12254708|FG001|Overall Study|Physician Decision|1
7797901|NCT01078298|12254767|FG000|Overall Study|Lost to Follow-up|12
7797902|NCT01078298|12254768|FG001|Overall Study|Lost to Follow-up|13
7797903|NCT01078298|12254767|FG000|Overall Study|Withdrawal by Subject|31
7797904|NCT01078298|12254768|FG001|Overall Study|Withdrawal by Subject|33
7797905|NCT01078298|12254767|FG000|Overall Study|Protocol Violation|6
7797906|NCT01078298|12254768|FG001|Overall Study|Protocol Violation|6
7797907|NCT01078298|12254767|FG000|Overall Study|Adverse Event|6
7797908|NCT01078298|12254768|FG001|Overall Study|Adverse Event|5
7797909|NCT01078298|12254767|FG000|Overall Study|Death|2
7797910|NCT01078298|12254768|FG001|Overall Study|Death|0
7797911|NCT01078298|12254767|FG000|Overall Study|Did not meet entrance criteria|0
7797912|NCT01078298|12254768|FG001|Overall Study|Did not meet entrance criteria|1
7797913|NCT01078298|12254767|FG000|Overall Study|Other|24
7797914|NCT01078298|12254768|FG001|Overall Study|Other|32
7797915|NCT01078389|12254807|FG000|Overall Study|Adverse Event|10
7797916|NCT01078389|12254808|FG001|Overall Study|Adverse Event|6
7797917|NCT01078389|12254807|FG000|Overall Study|Major Protocol Deviation|2
7797918|NCT01078389|12254808|FG001|Overall Study|Major Protocol Deviation|0
7797919|NCT01078389|12254807|FG000|Overall Study|Lost to Follow-up|23
7797920|NCT01078389|12254808|FG001|Overall Study|Lost to Follow-up|23
7797921|NCT01078389|12254807|FG000|Overall Study|Voluntary Withdrawal|20
7797922|NCT01078389|12254808|FG001|Overall Study|Voluntary Withdrawal|36
7797923|NCT01078389|12254807|FG000|Overall Study|Other|9
7797924|NCT01078389|12254808|FG001|Overall Study|Other|2
7797925|NCT01078441|12254831|FG000|Overall Study|Withdrawal by Subject|1
7879734|NCT01739764|12376296|FG002|Overall Study|Lost to Follow-up|5
7879735|NCT01739764|12376294|FG000|Overall Study|Non-Compliance|0
7879736|NCT01739764|12376295|FG001|Overall Study|Non-Compliance|0
7879737|NCT01739764|12376296|FG002|Overall Study|Non-Compliance|1
7879738|NCT01739764|12376294|FG000|Overall Study|Multiple Reasons|3
7879739|NCT01739764|12376295|FG001|Overall Study|Multiple Reasons|2
7879740|NCT01739764|12376296|FG002|Overall Study|Multiple Reasons|3
7879741|NCT01739764|12376294|FG000|Overall Study|Physician Decision|2
7879742|NCT01739764|12376295|FG001|Overall Study|Physician Decision|2
7879743|NCT01739764|12376296|FG002|Overall Study|Physician Decision|4
7879744|NCT01739764|12376294|FG000|Overall Study|Progressive Disease|3
7879745|NCT01739764|12376295|FG001|Overall Study|Progressive Disease|5
7879746|NCT01739764|12376296|FG002|Overall Study|Progressive Disease|16
7879747|NCT01739764|12376294|FG000|Overall Study|Protocol Violation|0
7879748|NCT01739764|12376295|FG001|Overall Study|Protocol Violation|0
7879749|NCT01739764|12376296|FG002|Overall Study|Protocol Violation|2
7879750|NCT01739764|12376294|FG000|Overall Study|Study Terminated by Sponsor|8
7879751|NCT01739764|12376295|FG001|Overall Study|Study Terminated by Sponsor|13
7879752|NCT01739764|12376296|FG002|Overall Study|Study Terminated by Sponsor|26
7879753|NCT01739764|12376294|FG000|Overall Study|Withdrawal by Subject|6
7797926|NCT01078545|12254835|FG000|Overall Study|Lost to Follow-up|13
7879754|NCT01739764|12376295|FG001|Overall Study|Withdrawal by Subject|5
7879755|NCT01739764|12376296|FG002|Overall Study|Withdrawal by Subject|27
7879756|NCT01739790|12376306|FG000|Overall Study|Early Trial Termination|2
7879757|NCT01739790|12376307|FG001|Overall Study|Early Trial Termination|4
7879758|NCT01739803|12376315|FG000|Overall Study|Lost to Follow-up|9
7879759|NCT01739803|12376316|FG001|Overall Study|Lost to Follow-up|6
7879760|NCT01739933|12376324|FG000|Overall Study|Death|89
7879761|NCT01739933|12376325|FG001|Overall Study|Death|86
7879762|NCT01739933|12376324|FG000|Overall Study|Withdrawal by Subject|10
7879763|NCT01739933|12376325|FG001|Overall Study|Withdrawal by Subject|8
7879764|NCT01739933|12376324|FG000|Overall Study|Lost to Follow-up|3
7879765|NCT01739933|12376325|FG001|Overall Study|Lost to Follow-up|10
7879766|NCT01739933|12376324|FG000|Overall Study|Did not speak English required for neurospychological testing|4
7879767|NCT01739933|12376325|FG001|Overall Study|Did not speak English required for neurospychological testing|3
7879768|NCT01740089|12376334|FG000|First 12 Weeks of Treatment|Adverse Event|0
7879769|NCT01740089|12376335|FG001|First 12 Weeks of Treatment|Adverse Event|1
7879770|NCT01740089|12376336|FG002|First 12 Weeks of Treatment|Adverse Event|2
7879771|NCT01740089|12376334|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0
7879772|NCT01740089|12376335|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1
7879773|NCT01740089|12376336|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0
7879774|NCT01740089|12376334|FG000|After 12 Weeks|Lack of Efficacy|3
7879775|NCT01740089|12376335|FG001|After 12 Weeks|Lack of Efficacy|1
7879776|NCT01740089|12376336|FG002|After 12 Weeks|Lack of Efficacy|4
7879777|NCT01740089|12376334|FG000|After 12 Weeks|Adverse Event|2
7879778|NCT01740089|12376335|FG001|After 12 Weeks|Adverse Event|0
7879779|NCT01740089|12376336|FG002|After 12 Weeks|Adverse Event|5
7879780|NCT01740089|12376334|FG000|After 12 Weeks|Protocol Violation|1
7879781|NCT01740089|12376335|FG001|After 12 Weeks|Protocol Violation|1
7879782|NCT01740089|12376336|FG002|After 12 Weeks|Protocol Violation|1
7879783|NCT01740089|12376334|FG000|After 12 Weeks|Withdrawal by Subject|1
7879784|NCT01740089|12376335|FG001|After 12 Weeks|Withdrawal by Subject|1
7879785|NCT01740089|12376336|FG002|After 12 Weeks|Withdrawal by Subject|1
7879786|NCT01740128|12376347|FG000|Overall Study|Pregnancy|0
7879787|NCT01740128|12376348|FG001|Overall Study|Pregnancy|1
7879788|NCT01740128|12376347|FG000|Overall Study|Protocol Violation|1
7879789|NCT01740128|12376348|FG001|Overall Study|Protocol Violation|2
7879790|NCT01740128|12376347|FG000|Overall Study|Lost to Follow-up|2
7879791|NCT01740128|12376348|FG001|Overall Study|Lost to Follow-up|2
7879792|NCT01740128|12376347|FG000|Overall Study|Withdrawal by Subject|1
7879793|NCT01740128|12376348|FG001|Overall Study|Withdrawal by Subject|0
7879794|NCT01740128|12376347|FG000|Overall Study|Insufficient protocol compliance|2
7797927|NCT01078545|12254835|FG000|Overall Study|Physician Decision|6
7879795|NCT01740128|12376348|FG001|Overall Study|Insufficient protocol compliance|2
7797928|NCT01078545|12254835|FG000|Overall Study|Withdrawal by Subject|3
7797929|NCT01078545|12254835|FG000|Overall Study|Death|3
7797930|NCT01078545|12254835|FG000|Overall Study|Participant moved to another physician|1
7797931|NCT01078571|12254852|FG000|Overall Study|Adverse Event|36
7797932|NCT01078571|12254852|FG000|Overall Study|Lack of effectiveness|36
7797933|NCT01078571|12254852|FG000|Overall Study|Reason not reported|21
7797934|NCT01078571|12254852|FG000|Overall Study|Withdrawal by Subject|12
7797935|NCT01078571|12254852|FG000|Overall Study|Lost to Follow-up|8
7797936|NCT01078571|12254852|FG000|Overall Study|Protocol Violation|2
7797937|NCT01078584|12254861|FG000|Overall Study|Final Status Unknown|1073
7797938|NCT01078584|12254861|FG000|Overall Study|Lost to Follow-up|670
7797939|NCT01078584|12254861|FG000|Overall Study|Non-serious Adverse Event|577
7797940|NCT01078584|12254861|FG000|Overall Study|Withdrawal of Consent|244
7797941|NCT01078584|12254861|FG000|Overall Study|Physician Withdrew from Study|90
7797942|NCT01078584|12254861|FG000|Overall Study|Non-compliance|67
7797943|NCT01078584|12254861|FG000|Overall Study|Blood Pressure Controlled|49
7797944|NCT01078584|12254861|FG000|Overall Study|Physician Switched Medication|26
7797945|NCT01078584|12254861|FG000|Overall Study|Physician Discontinued Patient|12
7797946|NCT01078584|12254861|FG000|Overall Study|Lack of Efficacy|98
7797947|NCT01078584|12254861|FG000|Overall Study|Protocol Violation|75
7797948|NCT01078584|12254861|FG000|Overall Study|Serious Adverse Event|27
7797949|NCT01078584|12254861|FG000|Overall Study|Multiple Reasons|2
7797950|NCT01078623|12254878|FG000|Treatment Period 1|Adverse Event|1
7797951|NCT01078623|12254879|FG001|Treatment Period 1|Adverse Event|1
7797952|NCT01078623|12254880|FG002|Treatment Period 1|Adverse Event|1
7797953|NCT01078623|12254881|FG003|Treatment Period 1|Adverse Event|0
7797954|NCT01078623|12254882|FG004|Treatment Period 1|Adverse Event|0
7797955|NCT01078623|12254883|FG005|Treatment Period 1|Adverse Event|0
7797956|NCT01078623|12254884|FG006|Treatment Period 1|Adverse Event|1
7797957|NCT01078623|12254885|FG007|Treatment Period 1|Adverse Event|0
7797958|NCT01078623|12254886|FG008|Treatment Period 1|Adverse Event|1
7797959|NCT01078623|12254887|FG009|Treatment Period 1|Adverse Event|1
7797960|NCT01078623|12254888|FG010|Treatment Period 1|Adverse Event|0
7797961|NCT01078623|12254889|FG011|Treatment Period 1|Adverse Event|0
7797962|NCT01078623|12254890|FG012|Treatment Period 1|Adverse Event|0
7797963|NCT01078623|12254891|FG013|Treatment Period 1|Adverse Event|0
7797964|NCT01078623|12254892|FG014|Treatment Period 1|Adverse Event|0
7797965|NCT01078623|12254893|FG015|Treatment Period 1|Adverse Event|0
7879796|NCT01740323|12376369|FG000|Overall Study|Adverse Event|1
7879797|NCT01740323|12376370|FG001|Overall Study|Adverse Event|0
7879798|NCT01740323|12376369|FG000|Overall Study|Randomized but did not take study drug|1
7797966|NCT01078623|12254894|FG016|Treatment Period 1|Adverse Event|0
7797967|NCT01078623|12254895|FG017|Treatment Period 1|Adverse Event|0
7797968|NCT01078623|12254896|FG018|Treatment Period 1|Adverse Event|0
7797969|NCT01078623|12254897|FG019|Treatment Period 1|Adverse Event|0
7797970|NCT01078623|12254878|FG000|Treatment Period 1|Withdrawal by Subject|0
7797971|NCT01078623|12254879|FG001|Treatment Period 1|Withdrawal by Subject|0
7797972|NCT01078623|12254880|FG002|Treatment Period 1|Withdrawal by Subject|0
7797973|NCT01078623|12254881|FG003|Treatment Period 1|Withdrawal by Subject|0
7797974|NCT01078623|12254882|FG004|Treatment Period 1|Withdrawal by Subject|0
7797975|NCT01078623|12254883|FG005|Treatment Period 1|Withdrawal by Subject|0
7797976|NCT01078623|12254884|FG006|Treatment Period 1|Withdrawal by Subject|0
7797977|NCT01078623|12254885|FG007|Treatment Period 1|Withdrawal by Subject|1
7797978|NCT01078623|12254886|FG008|Treatment Period 1|Withdrawal by Subject|0
7797979|NCT01078623|12254887|FG009|Treatment Period 1|Withdrawal by Subject|0
7797980|NCT01078623|12254888|FG010|Treatment Period 1|Withdrawal by Subject|1
7797981|NCT01078623|12254889|FG011|Treatment Period 1|Withdrawal by Subject|0
7797982|NCT01078623|12254890|FG012|Treatment Period 1|Withdrawal by Subject|0
7797983|NCT01078623|12254891|FG013|Treatment Period 1|Withdrawal by Subject|0
7797984|NCT01078623|12254892|FG014|Treatment Period 1|Withdrawal by Subject|0
7797985|NCT01078623|12254893|FG015|Treatment Period 1|Withdrawal by Subject|0
7797986|NCT01078623|12254894|FG016|Treatment Period 1|Withdrawal by Subject|0
7797987|NCT01078623|12254895|FG017|Treatment Period 1|Withdrawal by Subject|0
7797988|NCT01078623|12254896|FG018|Treatment Period 1|Withdrawal by Subject|0
7797989|NCT01078623|12254897|FG019|Treatment Period 1|Withdrawal by Subject|0
7797990|NCT01078623|12254878|FG000|Treatment Period 1|Protocol Violation|0
7797991|NCT01078623|12254879|FG001|Treatment Period 1|Protocol Violation|0
7797992|NCT01078623|12254880|FG002|Treatment Period 1|Protocol Violation|0
7797993|NCT01078623|12254881|FG003|Treatment Period 1|Protocol Violation|0
7797994|NCT01078623|12254882|FG004|Treatment Period 1|Protocol Violation|0
7797995|NCT01078623|12254883|FG005|Treatment Period 1|Protocol Violation|1
7797996|NCT01078623|12254884|FG006|Treatment Period 1|Protocol Violation|0
7797997|NCT01078623|12254885|FG007|Treatment Period 1|Protocol Violation|0
7797998|NCT01078623|12254886|FG008|Treatment Period 1|Protocol Violation|0
7797999|NCT01078623|12254887|FG009|Treatment Period 1|Protocol Violation|0
7798000|NCT01078623|12254888|FG010|Treatment Period 1|Protocol Violation|0
7798001|NCT01078623|12254889|FG011|Treatment Period 1|Protocol Violation|0
7798002|NCT01078623|12254890|FG012|Treatment Period 1|Protocol Violation|0
7798003|NCT01078623|12254891|FG013|Treatment Period 1|Protocol Violation|0
7798004|NCT01078623|12254892|FG014|Treatment Period 1|Protocol Violation|0
7798005|NCT01078623|12254893|FG015|Treatment Period 1|Protocol Violation|0
7798006|NCT01078623|12254894|FG016|Treatment Period 1|Protocol Violation|0
7798007|NCT01078623|12254895|FG017|Treatment Period 1|Protocol Violation|0
7798008|NCT01078623|12254896|FG018|Treatment Period 1|Protocol Violation|0
7798009|NCT01078623|12254897|FG019|Treatment Period 1|Protocol Violation|0
7798010|NCT01078623|12254878|FG000|Treatment Period 2|Adverse Event|0
7798011|NCT01078623|12254879|FG001|Treatment Period 2|Adverse Event|0
7798012|NCT01078623|12254880|FG002|Treatment Period 2|Adverse Event|0
7798013|NCT01078623|12254881|FG003|Treatment Period 2|Adverse Event|0
7798014|NCT01078623|12254882|FG004|Treatment Period 2|Adverse Event|0
7798015|NCT01078623|12254883|FG005|Treatment Period 2|Adverse Event|0
7798016|NCT01078623|12254884|FG006|Treatment Period 2|Adverse Event|1
7798017|NCT01078623|12254885|FG007|Treatment Period 2|Adverse Event|0
7798018|NCT01078623|12254886|FG008|Treatment Period 2|Adverse Event|0
7798019|NCT01078623|12254887|FG009|Treatment Period 2|Adverse Event|0
7798020|NCT01078623|12254888|FG010|Treatment Period 2|Adverse Event|0
7798021|NCT01078623|12254889|FG011|Treatment Period 2|Adverse Event|0
7798022|NCT01078623|12254890|FG012|Treatment Period 2|Adverse Event|0
7798023|NCT01078623|12254891|FG013|Treatment Period 2|Adverse Event|0
7798024|NCT01078623|12254892|FG014|Treatment Period 2|Adverse Event|0
7798025|NCT01078623|12254893|FG015|Treatment Period 2|Adverse Event|0
7798026|NCT01078623|12254894|FG016|Treatment Period 2|Adverse Event|0
7798027|NCT01078623|12254895|FG017|Treatment Period 2|Adverse Event|0
7798028|NCT01078623|12254896|FG018|Treatment Period 2|Adverse Event|1
7798029|NCT01078623|12254897|FG019|Treatment Period 2|Adverse Event|0
7798030|NCT01078623|12254878|FG000|Treatment Period 2|Withdrawal by Subject|0
7798031|NCT01078623|12254879|FG001|Treatment Period 2|Withdrawal by Subject|0
7798032|NCT01078623|12254880|FG002|Treatment Period 2|Withdrawal by Subject|0
7798033|NCT01078623|12254881|FG003|Treatment Period 2|Withdrawal by Subject|0
7798034|NCT01078623|12254882|FG004|Treatment Period 2|Withdrawal by Subject|0
7798035|NCT01078623|12254883|FG005|Treatment Period 2|Withdrawal by Subject|1
7798036|NCT01078623|12254884|FG006|Treatment Period 2|Withdrawal by Subject|0
7798037|NCT01078623|12254885|FG007|Treatment Period 2|Withdrawal by Subject|0
7798038|NCT01078623|12254886|FG008|Treatment Period 2|Withdrawal by Subject|0
7798039|NCT01078623|12254887|FG009|Treatment Period 2|Withdrawal by Subject|0
7798040|NCT01078623|12254888|FG010|Treatment Period 2|Withdrawal by Subject|0
7798041|NCT01078623|12254889|FG011|Treatment Period 2|Withdrawal by Subject|0
7798042|NCT01078623|12254890|FG012|Treatment Period 2|Withdrawal by Subject|0
7798043|NCT01078623|12254891|FG013|Treatment Period 2|Withdrawal by Subject|0
7798044|NCT01078623|12254892|FG014|Treatment Period 2|Withdrawal by Subject|0
7798045|NCT01078623|12254893|FG015|Treatment Period 2|Withdrawal by Subject|0
7798046|NCT01078623|12254894|FG016|Treatment Period 2|Withdrawal by Subject|0
7798047|NCT01078623|12254895|FG017|Treatment Period 2|Withdrawal by Subject|0
7798048|NCT01078623|12254896|FG018|Treatment Period 2|Withdrawal by Subject|0
7798049|NCT01078623|12254897|FG019|Treatment Period 2|Withdrawal by Subject|0
7798050|NCT01078623|12254878|FG000|Treatment Period 3|Adverse Event|0
7798051|NCT01078623|12254879|FG001|Treatment Period 3|Adverse Event|0
7798052|NCT01078623|12254880|FG002|Treatment Period 3|Adverse Event|0
7798053|NCT01078623|12254881|FG003|Treatment Period 3|Adverse Event|0
7798054|NCT01078623|12254882|FG004|Treatment Period 3|Adverse Event|1
7798055|NCT01078623|12254883|FG005|Treatment Period 3|Adverse Event|0
7798056|NCT01078623|12254884|FG006|Treatment Period 3|Adverse Event|0
7798057|NCT01078623|12254885|FG007|Treatment Period 3|Adverse Event|0
7798058|NCT01078623|12254886|FG008|Treatment Period 3|Adverse Event|0
7798059|NCT01078623|12254887|FG009|Treatment Period 3|Adverse Event|0
7798060|NCT01078623|12254888|FG010|Treatment Period 3|Adverse Event|0
7798061|NCT01078623|12254889|FG011|Treatment Period 3|Adverse Event|0
7798062|NCT01078623|12254890|FG012|Treatment Period 3|Adverse Event|0
7798063|NCT01078623|12254891|FG013|Treatment Period 3|Adverse Event|1
7798064|NCT01078623|12254892|FG014|Treatment Period 3|Adverse Event|0
7798065|NCT01078623|12254893|FG015|Treatment Period 3|Adverse Event|0
7798066|NCT01078623|12254894|FG016|Treatment Period 3|Adverse Event|0
7798067|NCT01078623|12254895|FG017|Treatment Period 3|Adverse Event|0
7798068|NCT01078623|12254896|FG018|Treatment Period 3|Adverse Event|0
7798069|NCT01078623|12254897|FG019|Treatment Period 3|Adverse Event|0
7798070|NCT01078623|12254878|FG000|Treatment Period 4|Adverse Event|0
7798071|NCT01078623|12254879|FG001|Treatment Period 4|Adverse Event|0
7798072|NCT01078623|12254880|FG002|Treatment Period 4|Adverse Event|1
7798073|NCT01078623|12254881|FG003|Treatment Period 4|Adverse Event|0
7798074|NCT01078623|12254882|FG004|Treatment Period 4|Adverse Event|0
7798075|NCT01078623|12254883|FG005|Treatment Period 4|Adverse Event|0
7798076|NCT01078623|12254884|FG006|Treatment Period 4|Adverse Event|0
7798077|NCT01078623|12254885|FG007|Treatment Period 4|Adverse Event|0
7798078|NCT01078623|12254886|FG008|Treatment Period 4|Adverse Event|0
7798079|NCT01078623|12254887|FG009|Treatment Period 4|Adverse Event|0
7798080|NCT01078623|12254888|FG010|Treatment Period 4|Adverse Event|0
7798081|NCT01078623|12254889|FG011|Treatment Period 4|Adverse Event|0
7798082|NCT01078623|12254890|FG012|Treatment Period 4|Adverse Event|0
7798083|NCT01078623|12254891|FG013|Treatment Period 4|Adverse Event|0
7798084|NCT01078623|12254892|FG014|Treatment Period 4|Adverse Event|0
7798085|NCT01078623|12254893|FG015|Treatment Period 4|Adverse Event|0
7798086|NCT01078623|12254894|FG016|Treatment Period 4|Adverse Event|0
7798087|NCT01078623|12254895|FG017|Treatment Period 4|Adverse Event|0
7798088|NCT01078623|12254896|FG018|Treatment Period 4|Adverse Event|0
7798089|NCT01078623|12254897|FG019|Treatment Period 4|Adverse Event|0
7798090|NCT01078623|12254878|FG000|Treatment Period 4|Withdrawal by Subject|0
7798091|NCT01078623|12254879|FG001|Treatment Period 4|Withdrawal by Subject|0
7879799|NCT01740323|12376370|FG001|Overall Study|Randomized but did not take study drug|0
7879800|NCT01740388|12376395|FG000|Overall Study|Withdrawal by Subject|1
7879801|NCT01740388|12376396|FG001|Overall Study|Withdrawal by Subject|2
7879802|NCT01740388|12376395|FG000|Overall Study|Lost to Follow-up|2
7879803|NCT01740388|12376396|FG001|Overall Study|Lost to Follow-up|0
7879804|NCT01740388|12376395|FG000|Overall Study|Physician Decision|2
7879805|NCT01740388|12376396|FG001|Overall Study|Physician Decision|6
7879806|NCT01740388|12376395|FG000|Overall Study|Subjects missing data, completed|41
7879807|NCT01740388|12376396|FG001|Overall Study|Subjects missing data, completed|36
7879808|NCT01740401|12376402|FG000|Overall Study|Progression of disease|6
7879809|NCT01740401|12376402|FG000|Overall Study|Adverse Event|2
7879810|NCT01740401|12376402|FG000|Overall Study|Did not reach primary endpoint|2
7879811|NCT01740440|12376420|FG000|Overall Study|Lost to Follow-up|3
7879812|NCT01740791|12376455|FG000|Overall Study|Randomized but never treated|5
7879813|NCT01740791|12376456|FG001|Overall Study|Randomized but never treated|3
7879814|NCT01740791|12376457|FG002|Overall Study|Randomized but never treated|2
7879815|NCT01740791|12376458|FG003|Overall Study|Randomized but never treated|2
7879816|NCT01740791|12376459|FG004|Overall Study|Randomized but never treated|1
7879817|NCT01740791|12376460|FG005|Overall Study|Randomized but never treated|3
7879818|NCT01740791|12376455|FG000|Overall Study|Lost to Follow-up|2
7879819|NCT01740791|12376456|FG001|Overall Study|Lost to Follow-up|0
7879820|NCT01740791|12376457|FG002|Overall Study|Lost to Follow-up|2
7879821|NCT01740791|12376458|FG003|Overall Study|Lost to Follow-up|3
7879822|NCT01740791|12376459|FG004|Overall Study|Lost to Follow-up|2
7879823|NCT01740791|12376460|FG005|Overall Study|Lost to Follow-up|3
7879824|NCT01740791|12376455|FG000|Overall Study|Withdrew Consent|4
7879825|NCT01740791|12376456|FG001|Overall Study|Withdrew Consent|0
7879826|NCT01740791|12376457|FG002|Overall Study|Withdrew Consent|1
7879827|NCT01740791|12376458|FG003|Overall Study|Withdrew Consent|2
7879828|NCT01740791|12376459|FG004|Overall Study|Withdrew Consent|0
7879829|NCT01740791|12376460|FG005|Overall Study|Withdrew Consent|3
7798092|NCT01078623|12254880|FG002|Treatment Period 4|Withdrawal by Subject|0
7798093|NCT01078623|12254881|FG003|Treatment Period 4|Withdrawal by Subject|0
7798094|NCT01078623|12254882|FG004|Treatment Period 4|Withdrawal by Subject|0
7798095|NCT01078623|12254883|FG005|Treatment Period 4|Withdrawal by Subject|0
7798096|NCT01078623|12254884|FG006|Treatment Period 4|Withdrawal by Subject|0
7798097|NCT01078623|12254885|FG007|Treatment Period 4|Withdrawal by Subject|0
7798098|NCT01078623|12254886|FG008|Treatment Period 4|Withdrawal by Subject|0
7798099|NCT01078623|12254887|FG009|Treatment Period 4|Withdrawal by Subject|0
7798100|NCT01078623|12254888|FG010|Treatment Period 4|Withdrawal by Subject|0
7798101|NCT01078623|12254889|FG011|Treatment Period 4|Withdrawal by Subject|0
7798102|NCT01078623|12254890|FG012|Treatment Period 4|Withdrawal by Subject|0
7879830|NCT01740791|12376455|FG000|Overall Study|Investigator's discretion|1
7879831|NCT01740791|12376456|FG001|Overall Study|Investigator's discretion|0
7879832|NCT01740791|12376457|FG002|Overall Study|Investigator's discretion|1
7879833|NCT01740791|12376458|FG003|Overall Study|Investigator's discretion|0
7879834|NCT01740791|12376459|FG004|Overall Study|Investigator's discretion|0
7879835|NCT01740791|12376460|FG005|Overall Study|Investigator's discretion|1
7879836|NCT01740791|12376455|FG000|Overall Study|Adverse Event|0
7879837|NCT01740791|12376456|FG001|Overall Study|Adverse Event|0
7879838|NCT01740791|12376457|FG002|Overall Study|Adverse Event|0
7879839|NCT01740791|12376458|FG003|Overall Study|Adverse Event|0
7879840|NCT01740791|12376459|FG004|Overall Study|Adverse Event|0
7879841|NCT01740791|12376460|FG005|Overall Study|Adverse Event|1
7879842|NCT01741012|12376522|FG000|Overall Study|Lost to Follow-up|1
7879843|NCT01741012|12376522|FG000|Overall Study|Withdrawal by Subject|2
7879844|NCT01741259|12376529|FG000|Overall Study|Protocol Violation|6
7879845|NCT01741259|12376530|FG001|Overall Study|Protocol Violation|4
7879846|NCT01741259|12376529|FG000|Overall Study|Withdrawal by Subject|0
7879847|NCT01741259|12376530|FG001|Overall Study|Withdrawal by Subject|2
7879848|NCT01741532|12376577|FG000|Overall Study|Adverse Event|4
7879849|NCT01741532|12376578|FG001|Overall Study|Adverse Event|0
7879850|NCT01741532|12376577|FG000|Overall Study|Withdrawal by Subject|1
7879851|NCT01741532|12376578|FG001|Overall Study|Withdrawal by Subject|1
7879852|NCT01741532|12376577|FG000|Overall Study|Protocol Violation|0
7879853|NCT01741532|12376578|FG001|Overall Study|Protocol Violation|1
7879854|NCT01741532|12376577|FG000|Overall Study|Worsening of the disease|3
7879855|NCT01741532|12376578|FG001|Overall Study|Worsening of the disease|1
7879856|NCT01741532|12376577|FG000|Overall Study|Sponsor decision|1
7879857|NCT01741532|12376578|FG001|Overall Study|Sponsor decision|0
7879858|NCT01741532|12376577|FG000|Overall Study|Medical event|1
7879859|NCT01741532|12376578|FG001|Overall Study|Medical event|0
7879860|NCT01741545|12376590|FG000|Treatment Period|Lack of Efficacy|0
7879861|NCT01741545|12376591|FG001|Treatment Period|Lack of Efficacy|1
7879862|NCT01741545|12376590|FG000|Treatment Period|Adverse event, non-fatal|1
7879863|NCT01741545|12376591|FG001|Treatment Period|Adverse event, non-fatal|3
7879864|NCT01741545|12376590|FG000|Follow-up Period (24 Weeks)|Other than specified|0
7879865|NCT01741545|12376591|FG001|Follow-up Period (24 Weeks)|Other than specified|1
7879866|NCT01741545|12376590|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
7798103|NCT01078623|12254891|FG013|Treatment Period 4|Withdrawal by Subject|0
7798104|NCT01078623|12254892|FG014|Treatment Period 4|Withdrawal by Subject|0
7798105|NCT01078623|12254893|FG015|Treatment Period 4|Withdrawal by Subject|1
7798106|NCT01078623|12254894|FG016|Treatment Period 4|Withdrawal by Subject|0
7798107|NCT01078623|12254895|FG017|Treatment Period 4|Withdrawal by Subject|0
7798108|NCT01078623|12254896|FG018|Treatment Period 4|Withdrawal by Subject|0
7798109|NCT01078623|12254897|FG019|Treatment Period 4|Withdrawal by Subject|0
7798110|NCT01078675|12254911|FG000|Overall Study|Withdrawal by Subject|7
7798111|NCT01078675|12254912|FG001|Overall Study|Withdrawal by Subject|3
7798112|NCT01078675|12254911|FG000|Overall Study|Protocol Violation|56
7798113|NCT01078675|12254912|FG001|Overall Study|Protocol Violation|0
7798114|NCT01078675|12254911|FG000|Overall Study|Provided in CRF for specific reasons|2
7798115|NCT01078675|12254912|FG001|Overall Study|Provided in CRF for specific reasons|3
7798116|NCT01078675|12254911|FG000|Overall Study|Adverse Event|3
7798117|NCT01078675|12254912|FG001|Overall Study|Adverse Event|0
7798118|NCT01078805|12254927|FG000|Overall Study|Clinically significant abnormal lab|5
7798119|NCT01078805|12254927|FG000|Overall Study|Death|134
7798120|NCT01078805|12254927|FG000|Overall Study|Lost to Follow-up|676
7798121|NCT01078805|12254927|FG000|Overall Study|Physician Decision|169
7798122|NCT01078805|12254927|FG000|Overall Study|Serious adverse event|26
7798123|NCT01078805|12254927|FG000|Overall Study|Sponsor decision|46
7798124|NCT01078805|12254927|FG000|Overall Study|Withdrawal by Subject|739
7798125|NCT01078805|12254927|FG000|Overall Study|Other|173
7798126|NCT01078805|12254927|FG000|Overall Study|Didn't take study drug|82
7798127|NCT01078922|12254952|FG000|Overall Study|Adverse Event|1
7798128|NCT01078974|12254957|FG000|Overall Study|Adverse Event|3
7798129|NCT01079130|12254967|FG000|Overall Study|Adverse Event|1
7798130|NCT01079130|12254968|FG001|Overall Study|Adverse Event|1
7798131|NCT01079130|12254969|FG002|Overall Study|Adverse Event|0
7798132|NCT01079130|12254970|FG003|Overall Study|Adverse Event|1
7798133|NCT01079130|12254971|FG004|Overall Study|Adverse Event|5
7798134|NCT01079130|12254972|FG005|Overall Study|Adverse Event|1
7798135|NCT01079130|12254967|FG000|Overall Study|Administrative problems|1
7798136|NCT01079130|12254968|FG001|Overall Study|Administrative problems|3
7798137|NCT01079130|12254969|FG002|Overall Study|Administrative problems|0
7798138|NCT01079130|12254970|FG003|Overall Study|Administrative problems|0
7798139|NCT01079130|12254971|FG004|Overall Study|Administrative problems|0
7798140|NCT01079130|12254972|FG005|Overall Study|Administrative problems|1
7798141|NCT01079130|12254967|FG000|Overall Study|Withdrawal by Subject|0
7798142|NCT01079130|12254968|FG001|Overall Study|Withdrawal by Subject|1
7798143|NCT01079130|12254969|FG002|Overall Study|Withdrawal by Subject|0
7798144|NCT01079130|12254970|FG003|Overall Study|Withdrawal by Subject|0
7798145|NCT01079130|12254971|FG004|Overall Study|Withdrawal by Subject|1
7798146|NCT01079130|12254972|FG005|Overall Study|Withdrawal by Subject|3
7798147|NCT01079130|12254967|FG000|Overall Study|Protocol deviation|0
7798148|NCT01079130|12254968|FG001|Overall Study|Protocol deviation|2
7798149|NCT01079130|12254969|FG002|Overall Study|Protocol deviation|1
7798150|NCT01079130|12254970|FG003|Overall Study|Protocol deviation|2
7798151|NCT01079130|12254971|FG004|Overall Study|Protocol deviation|0
7798152|NCT01079130|12254972|FG005|Overall Study|Protocol deviation|0
7798153|NCT01079130|12254967|FG000|Overall Study|Abnormal test procedure result(s)|0
7798154|NCT01079130|12254968|FG001|Overall Study|Abnormal test procedure result(s)|0
7798155|NCT01079130|12254969|FG002|Overall Study|Abnormal test procedure result(s)|0
7798156|NCT01079130|12254970|FG003|Overall Study|Abnormal test procedure result(s)|0
7798157|NCT01079130|12254971|FG004|Overall Study|Abnormal test procedure result(s)|1
7798158|NCT01079130|12254972|FG005|Overall Study|Abnormal test procedure result(s)|0
7798159|NCT01079130|12254967|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7798160|NCT01079130|12254968|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7798161|NCT01079130|12254969|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7798162|NCT01079130|12254970|FG003|Overall Study|Unsatisfactory therapeutic effect|2
7798163|NCT01079130|12254971|FG004|Overall Study|Unsatisfactory therapeutic effect|0
7798164|NCT01079130|12254972|FG005|Overall Study|Unsatisfactory therapeutic effect|0
7798165|NCT01079130|12254967|FG000|Overall Study|Lost to Follow-up|0
7798166|NCT01079130|12254968|FG001|Overall Study|Lost to Follow-up|0
7798167|NCT01079130|12254969|FG002|Overall Study|Lost to Follow-up|0
7798168|NCT01079130|12254970|FG003|Overall Study|Lost to Follow-up|0
7798169|NCT01079130|12254971|FG004|Overall Study|Lost to Follow-up|1
7798170|NCT01079130|12254972|FG005|Overall Study|Lost to Follow-up|0
7798171|NCT01079182|12255007|FG000|Overall Study|Lost to Follow-up|1634
7798172|NCT01079182|12255007|FG000|Overall Study|Adverse Drug Reaction (ADR)|261
7798173|NCT01079182|12255007|FG000|Overall Study|Lack of Efficacy|514
7798174|NCT01079182|12255007|FG000|Overall Study|ADR and Lack of Effectiveness|39
7798175|NCT01079182|12255007|FG000|Overall Study|Reasons not Evaluated|271
7798176|NCT01079195|12255011|FG000|Overall Study|No Documentation of Tarka Therapy|739
7798177|NCT01079195|12255011|FG000|Overall Study|No Documentation Available|437
7798178|NCT01079195|12255011|FG000|Overall Study|Adverse Event|157
7798179|NCT01079195|12255011|FG000|Overall Study|Reason Unknown|39
7798180|NCT01079195|12255011|FG000|Overall Study|Withdrawal by Subject|18
7798181|NCT01079195|12255011|FG000|Overall Study|Financial Reasons|15
7798182|NCT01079195|12255011|FG000|Overall Study|Lack of Effectiveness|12
7798183|NCT01079195|12255011|FG000|Overall Study|Physician Decision|4
7798184|NCT01079195|12255011|FG000|Overall Study|Improved Status of Participant|4
7798185|NCT01079195|12255011|FG000|Overall Study|No Follow-up Documentation Available|4
7798186|NCT01079195|12255011|FG000|Overall Study|Non-compliance|2
7798187|NCT01079234|12255018|FG000|Main: Week 0 to 26|Adverse Event|5
7798188|NCT01079234|12255019|FG001|Main: Week 0 to 26|Adverse Event|4
7798189|NCT01079234|12255020|FG002|Main: Week 0 to 26|Adverse Event|1
7798190|NCT01079234|12255021|FG003|Main: Week 0 to 26|Adverse Event|0
7798191|NCT01079234|12255018|FG000|Main: Week 0 to 26|Lack of Efficacy|2
7798192|NCT01079234|12255019|FG001|Main: Week 0 to 26|Lack of Efficacy|1
7798193|NCT01079234|12255020|FG002|Main: Week 0 to 26|Lack of Efficacy|1
7798194|NCT01079234|12255021|FG003|Main: Week 0 to 26|Lack of Efficacy|0
7798195|NCT01079234|12255018|FG000|Main: Week 0 to 26|Protocol Violation|6
7798196|NCT01079234|12255019|FG001|Main: Week 0 to 26|Protocol Violation|2
7798197|NCT01079234|12255020|FG002|Main: Week 0 to 26|Protocol Violation|4
7798198|NCT01079234|12255021|FG003|Main: Week 0 to 26|Protocol Violation|0
7798199|NCT01079234|12255018|FG000|Main: Week 0 to 26|Withdrawal criteria|6
7798200|NCT01079234|12255019|FG001|Main: Week 0 to 26|Withdrawal criteria|6
7798201|NCT01079234|12255020|FG002|Main: Week 0 to 26|Withdrawal criteria|2
7798202|NCT01079234|12255021|FG003|Main: Week 0 to 26|Withdrawal criteria|0
7798203|NCT01079234|12255018|FG000|Main: Week 0 to 26|Unclassified|7
7798204|NCT01079234|12255019|FG001|Main: Week 0 to 26|Unclassified|13
7798205|NCT01079234|12255020|FG002|Main: Week 0 to 26|Unclassified|4
7798206|NCT01079234|12255021|FG003|Main: Week 0 to 26|Unclassified|0
7798207|NCT01079234|12255018|FG000|Extension: Week 27 to 52|Adverse Event|0
7798208|NCT01079234|12255019|FG001|Extension: Week 27 to 52|Adverse Event|0
7798209|NCT01079234|12255020|FG002|Extension: Week 27 to 52|Adverse Event|1
7798210|NCT01079234|12255021|FG003|Extension: Week 27 to 52|Adverse Event|0
7798211|NCT01079234|12255018|FG000|Extension: Week 27 to 52|Lack of Efficacy|0
7798212|NCT01079234|12255019|FG001|Extension: Week 27 to 52|Lack of Efficacy|0
7798213|NCT01079234|12255020|FG002|Extension: Week 27 to 52|Lack of Efficacy|0
7798214|NCT01079234|12255021|FG003|Extension: Week 27 to 52|Lack of Efficacy|2
7798215|NCT01079234|12255018|FG000|Extension: Week 27 to 52|Protocol Violation|0
7798216|NCT01079234|12255019|FG001|Extension: Week 27 to 52|Protocol Violation|0
7798217|NCT01079234|12255020|FG002|Extension: Week 27 to 52|Protocol Violation|2
7798218|NCT01079234|12255021|FG003|Extension: Week 27 to 52|Protocol Violation|5
7798219|NCT01079234|12255018|FG000|Extension: Week 27 to 52|Withdrawal criteria|0
7798220|NCT01079234|12255019|FG001|Extension: Week 27 to 52|Withdrawal criteria|0
7798221|NCT01079234|12255020|FG002|Extension: Week 27 to 52|Withdrawal criteria|4
7798222|NCT01079234|12255021|FG003|Extension: Week 27 to 52|Withdrawal criteria|2
7798223|NCT01079234|12255018|FG000|Extension: Week 27 to 52|Unclassified|0
7798224|NCT01079234|12255019|FG001|Extension: Week 27 to 52|Unclassified|0
7798225|NCT01079234|12255020|FG002|Extension: Week 27 to 52|Unclassified|4
7798226|NCT01079234|12255021|FG003|Extension: Week 27 to 52|Unclassified|7
7798227|NCT01079663|12255056|FG000|Overall Study|Adverse Event|0
7798228|NCT01079663|12255057|FG001|Overall Study|Adverse Event|2
7798229|NCT01079663|12255056|FG000|Overall Study|Protocol Violation|0
7798230|NCT01079663|12255057|FG001|Overall Study|Protocol Violation|2
7798231|NCT01079741|12255068|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
7798232|NCT01079741|12255069|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
7798233|NCT01079741|12255070|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
7798234|NCT01079741|12255071|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
7798235|NCT01079741|12255072|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
7798236|NCT01079741|12255068|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
7798237|NCT01079741|12255069|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
7798238|NCT01079741|12255070|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
7798239|NCT01079741|12255071|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
7798240|NCT01079741|12255072|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
7798241|NCT01079806|12255086|FG000|Day 1 to Week 96|Adverse Event|0
7798242|NCT01079806|12255087|FG001|Day 1 to Week 96|Adverse Event|3
7798243|NCT01079806|12255086|FG000|Day 1 to Week 96|Withdrawal by Subject|3
7798244|NCT01079806|12255087|FG001|Day 1 to Week 96|Withdrawal by Subject|2
7798245|NCT01079806|12255086|FG000|Day 1 to Week 96|Pregnancy|0
7798246|NCT01079806|12255087|FG001|Day 1 to Week 96|Pregnancy|1
7798247|NCT01079806|12255086|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2
7798248|NCT01079806|12255087|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0
7798249|NCT01079806|12255086|FG000|Day 1 to Week 96|Lost to Follow-up|1
7798250|NCT01079806|12255087|FG001|Day 1 to Week 96|Lost to Follow-up|0
7798251|NCT01079806|12255086|FG000|Day 1 to Week 96|Subject request to stop study treatment|1
7798252|NCT01079806|12255087|FG001|Day 1 to Week 96|Subject request to stop study treatment|0
7798253|NCT01079806|12255086|FG000|Day 1 to Week 96|Removal by Medical Monitor|0
7798254|NCT01079806|12255087|FG001|Day 1 to Week 96|Removal by Medical Monitor|1
7798255|NCT01079806|12255086|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13
7798256|NCT01079806|12255087|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8
7798257|NCT01079806|12255086|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0
7798258|NCT01079806|12255087|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1
7798259|NCT01079806|12255086|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
7798260|NCT01079806|12255087|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
7798261|NCT01079832|12255095|FG000|Overall Study|Withdrawal by Subject|1
7798262|NCT01079936|12255103|FG000|Phase I: MTD|First Remission Status|2
7879867|NCT01741545|12376591|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
7879868|NCT01741688|12376597|FG000|Overall Study|Lack of insurance coverage|2
7879869|NCT01741688|12376597|FG000|Overall Study|Withdrawal by Subject|1
7879870|NCT01741701|12376604|FG000|Overall Study|Adverse Event|5
7879871|NCT01741701|12376605|FG001|Overall Study|Adverse Event|1
7879872|NCT01741701|12376604|FG000|Overall Study|Withdrawal by Subject|0
7879873|NCT01741701|12376605|FG001|Overall Study|Withdrawal by Subject|1
7883245|NCT01781286|12382901|FG003|Overall Study|Lost to Follow-up|0
7883246|NCT01781286|12382902|FG004|Overall Study|Lost to Follow-up|0
7798263|NCT01079936|12255104|FG001|Phase I: MTD|First Remission Status|0
7798264|NCT01079936|12255105|FG002|Phase I: MTD|First Remission Status|0
7798265|NCT01079936|12255106|FG003|Phase I: MTD|First Remission Status|0
7798266|NCT01079936|12255107|FG004|Phase I: MTD|First Remission Status|0
7798267|NCT01079936|12255103|FG000|Phase I: MTD|No Stem Cell Transplantation|2
7798268|NCT01079936|12255104|FG001|Phase I: MTD|No Stem Cell Transplantation|0
7798269|NCT01079936|12255105|FG002|Phase I: MTD|No Stem Cell Transplantation|0
7798270|NCT01079936|12255106|FG003|Phase I: MTD|No Stem Cell Transplantation|0
7798271|NCT01079936|12255107|FG004|Phase I: MTD|No Stem Cell Transplantation|0
7798272|NCT01079936|12255103|FG000|Phase II|Adverse Event|0
7798273|NCT01079936|12255104|FG001|Phase II|Adverse Event|0
7798274|NCT01079936|12255105|FG002|Phase II|Adverse Event|1
7798275|NCT01079936|12255106|FG003|Phase II|Adverse Event|0
7798276|NCT01079936|12255107|FG004|Phase II|Adverse Event|0
7798277|NCT01079936|12255103|FG000|Phase II|Insurance Issue|0
7798278|NCT01079936|12255104|FG001|Phase II|Insurance Issue|0
7798279|NCT01079936|12255105|FG002|Phase II|Insurance Issue|0
7798280|NCT01079936|12255106|FG003|Phase II|Insurance Issue|0
7798281|NCT01079936|12255107|FG004|Phase II|Insurance Issue|1
7798282|NCT01079949|12255120|FG000|Overall Study|Withdrawal before r-hCG administration|2
7798283|NCT01079949|12255121|FG001|Overall Study|Withdrawal before r-hCG administration|3
7798284|NCT01079949|12255120|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
7798285|NCT01079949|12255121|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
7798286|NCT01079949|12255120|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8
7798287|NCT01079949|12255121|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2
7798288|NCT01079949|12255120|FG000|Overall Study|Randomized but not treated|1
7798289|NCT01079949|12255121|FG001|Overall Study|Randomized but not treated|0
7798290|NCT01079962|12255129|FG000|Overall Study|Adverse Event|2
7798291|NCT01079962|12255130|FG001|Overall Study|Adverse Event|2
7798292|NCT01079962|12255129|FG000|Overall Study|Withdrawal by Subject|5
7798293|NCT01079962|12255130|FG001|Overall Study|Withdrawal by Subject|7
7798294|NCT01079962|12255129|FG000|Overall Study|Protocol Violation|2
7798295|NCT01079962|12255130|FG001|Overall Study|Protocol Violation|2
7798296|NCT01079962|12255129|FG000|Overall Study|No blood pressure (BP) control|3
7798297|NCT01079962|12255130|FG001|Overall Study|No blood pressure (BP) control|0
7798298|NCT01079962|12255129|FG000|Overall Study|Inclusion/exclusion criteria|1
7798299|NCT01079962|12255130|FG001|Overall Study|Inclusion/exclusion criteria|3
7798300|NCT01079962|12255129|FG000|Overall Study|Participant not returning for next visit|1
7798301|NCT01079962|12255130|FG001|Overall Study|Participant not returning for next visit|0
7798302|NCT01079962|12255129|FG000|Overall Study|Due to arrhythmia/bradycardia|1
7798303|NCT01079962|12255130|FG001|Overall Study|Due to arrhythmia/bradycardia|1
7798304|NCT01079988|12255141|FG000|Overall Study|Lost to Follow-up|0
7798305|NCT01079988|12255142|FG001|Overall Study|Lost to Follow-up|0
7798306|NCT01079988|12255143|FG002|Overall Study|Lost to Follow-up|0
7798307|NCT01079988|12255144|FG003|Overall Study|Lost to Follow-up|1
7798308|NCT01079988|12255145|FG004|Overall Study|Lost to Follow-up|0
7798309|NCT01079988|12255141|FG000|Overall Study|Lack of Efficacy|1
7798310|NCT01079988|12255142|FG001|Overall Study|Lack of Efficacy|0
7798311|NCT01079988|12255143|FG002|Overall Study|Lack of Efficacy|0
7798312|NCT01079988|12255144|FG003|Overall Study|Lack of Efficacy|0
7798313|NCT01079988|12255145|FG004|Overall Study|Lack of Efficacy|0
7798314|NCT01079988|12255141|FG000|Overall Study|Other|0
7798315|NCT01079988|12255142|FG001|Overall Study|Other|0
7798316|NCT01079988|12255143|FG002|Overall Study|Other|0
7798317|NCT01079988|12255144|FG003|Overall Study|Other|2
7798318|NCT01079988|12255145|FG004|Overall Study|Other|1
7798319|NCT01080131|12255170|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
7798320|NCT01080131|12255171|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
7798321|NCT01080131|12255170|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6
7798322|NCT01080131|12255171|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4
7798323|NCT01080131|12255170|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5
7798324|NCT01080131|12255171|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3
7798325|NCT01080131|12255170|FG000|Core Study (0- 12 Weeks)|Administrative problems|0
7798326|NCT01080131|12255171|FG001|Core Study (0- 12 Weeks)|Administrative problems|1
7798327|NCT01080131|12255170|FG000|Core Study (0- 12 Weeks)|Death|1
7798328|NCT01080131|12255171|FG001|Core Study (0- 12 Weeks)|Death|0
7798329|NCT01080131|12255170|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0
7798330|NCT01080131|12255171|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2
7798331|NCT01080131|12255170|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
7798332|NCT01080131|12255171|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
7798333|NCT01080131|12255170|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
7798334|NCT01080131|12255171|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
7798335|NCT01080131|12255170|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
7798336|NCT01080131|12255171|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
7798337|NCT01080131|12255170|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
7798338|NCT01080131|12255171|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
7798339|NCT01080131|12255170|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1
7798340|NCT01080131|12255171|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2
7798341|NCT01080131|12255170|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
7798342|NCT01080131|12255171|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
7798343|NCT01080131|12255170|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
7798344|NCT01080131|12255171|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
7798345|NCT01080300|12255234|FG000|Overall Study|Adverse Event|49
7798346|NCT01080300|12255235|FG001|Overall Study|Adverse Event|35
7798347|NCT01080300|12255234|FG000|Overall Study|Lack of Efficacy|12
7798348|NCT01080300|12255235|FG001|Overall Study|Lack of Efficacy|15
7798349|NCT01080300|12255234|FG000|Overall Study|Protocol Violation|7
7798350|NCT01080300|12255235|FG001|Overall Study|Protocol Violation|13
7798351|NCT01080300|12255234|FG000|Overall Study|Lost to Follow-up|10
7798352|NCT01080300|12255235|FG001|Overall Study|Lost to Follow-up|6
7798353|NCT01080300|12255234|FG000|Overall Study|Death|0
7798354|NCT01080300|12255235|FG001|Overall Study|Death|1
7798355|NCT01080300|12255234|FG000|Overall Study|Withdrawal by Subject|12
7798356|NCT01080300|12255235|FG001|Overall Study|Withdrawal by Subject|28
7798357|NCT01080300|12255234|FG000|Overall Study|Reasons not specified|4
7798358|NCT01080300|12255235|FG001|Overall Study|Reasons not specified|6
7798359|NCT01080326|12255243|FG000|Overall Study|Patient deterioration prior to procedure|3
7798360|NCT01080326|12255243|FG000|Overall Study|Surgeon decision|1
7798361|NCT01080625|12255250|FG000|Overall Study|Physician Decision|0
7798362|NCT01080625|12255251|FG001|Overall Study|Physician Decision|2
7798363|NCT01080625|12255252|FG002|Overall Study|Physician Decision|1
7798364|NCT01080716|12255277|FG000|Part 1|Physician Decision|1
7798365|NCT01080716|12255278|FG001|Part 1|Physician Decision|0
7798366|NCT01080716|12255279|FG002|Part 1|Physician Decision|0
7798367|NCT01080716|12255280|FG003|Part 1|Physician Decision|0
7798368|NCT01080807|12255313|FG000|Overall Study|Adverse Event|9
7798369|NCT01080807|12255314|FG001|Overall Study|Adverse Event|1
7798370|NCT01080807|12255313|FG000|Overall Study|Lack of Efficacy|0
7798371|NCT01080807|12255314|FG001|Overall Study|Lack of Efficacy|1
7798372|NCT01080807|12255313|FG000|Overall Study|Withdrawal by Subject|7
7798373|NCT01080807|12255314|FG001|Overall Study|Withdrawal by Subject|2
7798374|NCT01080807|12255313|FG000|Overall Study|Protocol Violation|7
7798375|NCT01080807|12255314|FG001|Overall Study|Protocol Violation|6
7798376|NCT01080807|12255313|FG000|Overall Study|Lost to Follow-up|6
7798377|NCT01080807|12255314|FG001|Overall Study|Lost to Follow-up|4
7798378|NCT01080807|12255313|FG000|Overall Study|Noncompliance with drug administration|1
7798379|NCT01080807|12255314|FG001|Overall Study|Noncompliance with drug administration|1
7798380|NCT01080807|12255313|FG000|Overall Study|Noncompliance to study procedures|1
7798381|NCT01080807|12255314|FG001|Overall Study|Noncompliance to study procedures|1
7798382|NCT01080807|12255313|FG000|Overall Study|Began working day shift|0
7798383|NCT01080807|12255314|FG001|Overall Study|Began working day shift|2
7798384|NCT01080807|12255313|FG000|Overall Study|Laid off or terminated from job|1
7798385|NCT01080807|12255314|FG001|Overall Study|Laid off or terminated from job|2
7798386|NCT01080807|12255313|FG000|Overall Study|Stopped working consistent night shifts|0
7798387|NCT01080807|12255314|FG001|Overall Study|Stopped working consistent night shifts|1
7798388|NCT01080807|12255313|FG000|Overall Study|Work schedule changing|1
7798389|NCT01080807|12255314|FG001|Overall Study|Work schedule changing|1
7798390|NCT01080807|12255313|FG000|Overall Study|Work schedule and travel|0
7798391|NCT01080807|12255314|FG001|Overall Study|Work schedule and travel|1
7798392|NCT01080807|12255313|FG000|Overall Study|Switched to first shift|1
7798393|NCT01080807|12255314|FG001|Overall Study|Switched to first shift|0
7798394|NCT01080807|12255313|FG000|Overall Study|Moved away without notifying center|1
7798395|NCT01080807|12255314|FG001|Overall Study|Moved away without notifying center|0
7798396|NCT01081132|12255349|FG000|Overall Study|Lack of Efficacy|25
7798397|NCT01081132|12255350|FG001|Overall Study|Lack of Efficacy|9
7798398|NCT01081132|12255349|FG000|Overall Study|Withdrawal by Subject|13
7798399|NCT01081132|12255350|FG001|Overall Study|Withdrawal by Subject|16
7798400|NCT01081132|12255349|FG000|Overall Study|Lost to Follow-up|4
7798401|NCT01081132|12255350|FG001|Overall Study|Lost to Follow-up|11
7798402|NCT01081132|12255349|FG000|Overall Study|Adverse Event|3
7798403|NCT01081132|12255350|FG001|Overall Study|Adverse Event|9
7798404|NCT01081132|12255349|FG000|Overall Study|Non Compliance|4
7798405|NCT01081132|12255350|FG001|Overall Study|Non Compliance|2
7798406|NCT01081132|12255349|FG000|Overall Study|Lack Of Compliance|0
7798407|NCT01081132|12255350|FG001|Overall Study|Lack Of Compliance|1
7798408|NCT01081132|12255349|FG000|Overall Study|Missed Visits|1
7798409|NCT01081132|12255350|FG001|Overall Study|Missed Visits|1
7798410|NCT01081132|12255349|FG000|Overall Study|Stopped Taking Meds|2
7798411|NCT01081132|12255350|FG001|Overall Study|Stopped Taking Meds|0
7798412|NCT01081132|12255349|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0
7798413|NCT01081132|12255350|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1
7798414|NCT01081132|12255349|FG000|Overall Study|Declined Taper Phase|0
7798415|NCT01081132|12255350|FG001|Overall Study|Declined Taper Phase|1
7798416|NCT01081132|12255349|FG000|Overall Study|Protocol Violation|3
7798417|NCT01081132|12255350|FG001|Overall Study|Protocol Violation|1
7798418|NCT01081145|12255356|FG000|Open-Label Phase|Lack of Efficacy|56
7798419|NCT01081145|12255357|FG001|Open-Label Phase|Lack of Efficacy|0
7798420|NCT01081145|12255356|FG000|Open-Label Phase|Response criteria not met|46
7798421|NCT01081145|12255357|FG001|Open-Label Phase|Response criteria not met|0
7798422|NCT01081145|12255356|FG000|Open-Label Phase|Adverse Event|42
7798423|NCT01081145|12255357|FG001|Open-Label Phase|Adverse Event|0
7798424|NCT01081145|12255356|FG000|Open-Label Phase|Withdrawal by Subject|41
7798425|NCT01081145|12255357|FG001|Open-Label Phase|Withdrawal by Subject|0
7798426|NCT01081145|12255356|FG000|Open-Label Phase|Other|12
7879874|NCT01741792|12376614|FG000|Overall Study|Death|6
7879875|NCT01741792|12376615|FG001|Overall Study|Death|1
7879876|NCT01741792|12376616|FG002|Overall Study|Death|12
7879877|NCT01742078|12376648|FG000|Overall Study|Withdrawal by Subject|0
7879878|NCT01742078|12376649|FG001|Overall Study|Withdrawal by Subject|0
7879879|NCT01742078|12376650|FG002|Overall Study|Withdrawal by Subject|0
7879880|NCT01742078|12376651|FG003|Overall Study|Withdrawal by Subject|1
7879881|NCT01742078|12376652|FG004|Overall Study|Withdrawal by Subject|0
7879882|NCT01742078|12376653|FG005|Overall Study|Withdrawal by Subject|0
7879883|NCT01742078|12376654|FG006|Overall Study|Withdrawal by Subject|0
7879884|NCT01742078|12376655|FG007|Overall Study|Withdrawal by Subject|0
7879885|NCT01742078|12376656|FG008|Overall Study|Withdrawal by Subject|0
7879886|NCT01742091|12376684|FG000|Overall Study|Adverse Event|0
7879887|NCT01742091|12376685|FG001|Overall Study|Adverse Event|0
7879888|NCT01742091|12376686|FG002|Overall Study|Adverse Event|0
7879889|NCT01742091|12376687|FG003|Overall Study|Adverse Event|0
7879890|NCT01742091|12376688|FG004|Overall Study|Adverse Event|1
7879891|NCT01742091|12376689|FG005|Overall Study|Adverse Event|0
7879892|NCT01742091|12376684|FG000|Overall Study|Physician Decision|0
7879893|NCT01742091|12376685|FG001|Overall Study|Physician Decision|0
7879894|NCT01742091|12376686|FG002|Overall Study|Physician Decision|0
7879895|NCT01742091|12376687|FG003|Overall Study|Physician Decision|0
7879896|NCT01742091|12376688|FG004|Overall Study|Physician Decision|0
7879897|NCT01742091|12376689|FG005|Overall Study|Physician Decision|1
7879898|NCT01742091|12376684|FG000|Overall Study|Withdrawal by Subject|0
7879899|NCT01742091|12376685|FG001|Overall Study|Withdrawal by Subject|0
7879900|NCT01742091|12376686|FG002|Overall Study|Withdrawal by Subject|0
7879901|NCT01742091|12376687|FG003|Overall Study|Withdrawal by Subject|1
7879902|NCT01742091|12376688|FG004|Overall Study|Withdrawal by Subject|0
7879903|NCT01742091|12376689|FG005|Overall Study|Withdrawal by Subject|0
7879904|NCT01742091|12376684|FG000|Overall Study|Lost to Follow-up|0
7879905|NCT01742091|12376685|FG001|Overall Study|Lost to Follow-up|0
7879906|NCT01742091|12376686|FG002|Overall Study|Lost to Follow-up|0
7879907|NCT01742091|12376687|FG003|Overall Study|Lost to Follow-up|0
7879908|NCT01742091|12376688|FG004|Overall Study|Lost to Follow-up|0
7879909|NCT01742091|12376689|FG005|Overall Study|Lost to Follow-up|1
7879910|NCT01742286|12376734|FG000|Escalation Phase|Administrative problems|1
7879911|NCT01742286|12376735|FG001|Escalation Phase|Administrative problems|1
7879912|NCT01742286|12376736|FG002|Escalation Phase|Administrative problems|0
7879913|NCT01742286|12376737|FG003|Escalation Phase|Administrative problems|0
7879914|NCT01742286|12376738|FG004|Escalation Phase|Administrative problems|0
7879915|NCT01742286|12376739|FG005|Escalation Phase|Administrative problems|0
7879916|NCT01742286|12376740|FG006|Escalation Phase|Administrative problems|2
7879917|NCT01742286|12376734|FG000|Escalation Phase|Adverse Event|0
7879918|NCT01742286|12376735|FG001|Escalation Phase|Adverse Event|1
7879919|NCT01742286|12376736|FG002|Escalation Phase|Adverse Event|2
7879920|NCT01742286|12376737|FG003|Escalation Phase|Adverse Event|0
7879921|NCT01742286|12376738|FG004|Escalation Phase|Adverse Event|0
7879922|NCT01742286|12376739|FG005|Escalation Phase|Adverse Event|1
7879923|NCT01742286|12376740|FG006|Escalation Phase|Adverse Event|0
7879924|NCT01742286|12376734|FG000|Escalation Phase|Disease progression|3
7879925|NCT01742286|12376735|FG001|Escalation Phase|Disease progression|7
7879926|NCT01742286|12376736|FG002|Escalation Phase|Disease progression|4
7879927|NCT01742286|12376737|FG003|Escalation Phase|Disease progression|1
7879928|NCT01742286|12376738|FG004|Escalation Phase|Disease progression|4
7879929|NCT01742286|12376739|FG005|Escalation Phase|Disease progression|3
7879930|NCT01742286|12376740|FG006|Escalation Phase|Disease progression|2
7879931|NCT01742286|12376734|FG000|Escalation Phase|Death|0
7879932|NCT01742286|12376735|FG001|Escalation Phase|Death|0
7879933|NCT01742286|12376736|FG002|Escalation Phase|Death|0
7879934|NCT01742286|12376737|FG003|Escalation Phase|Death|0
7879935|NCT01742286|12376738|FG004|Escalation Phase|Death|0
7879936|NCT01742286|12376739|FG005|Escalation Phase|Death|1
7879937|NCT01742286|12376740|FG006|Escalation Phase|Death|0
7879938|NCT01742286|12376734|FG000|Escalation Phase|Physician Decision|0
7879939|NCT01742286|12376735|FG001|Escalation Phase|Physician Decision|3
7879940|NCT01742286|12376736|FG002|Escalation Phase|Physician Decision|0
7879941|NCT01742286|12376737|FG003|Escalation Phase|Physician Decision|1
7879942|NCT01742286|12376738|FG004|Escalation Phase|Physician Decision|0
7879943|NCT01742286|12376739|FG005|Escalation Phase|Physician Decision|0
7879944|NCT01742286|12376740|FG006|Escalation Phase|Physician Decision|2
7879945|NCT01742286|12376734|FG000|Escalation Phase|Subject/guardian decision|1
7879946|NCT01742286|12376735|FG001|Escalation Phase|Subject/guardian decision|0
7879947|NCT01742286|12376736|FG002|Escalation Phase|Subject/guardian decision|0
7879948|NCT01742286|12376737|FG003|Escalation Phase|Subject/guardian decision|0
7879949|NCT01742286|12376738|FG004|Escalation Phase|Subject/guardian decision|0
7879950|NCT01742286|12376739|FG005|Escalation Phase|Subject/guardian decision|0
7879951|NCT01742286|12376740|FG006|Escalation Phase|Subject/guardian decision|0
7798427|NCT01081145|12255357|FG001|Open-Label Phase|Other|0
7798428|NCT01081145|12255356|FG000|Open-Label Phase|Lost to Follow-up|11
7798429|NCT01081145|12255357|FG001|Open-Label Phase|Lost to Follow-up|0
7798430|NCT01081145|12255356|FG000|Open-Label Phase|Protocol Violation|4
7798431|NCT01081145|12255357|FG001|Open-Label Phase|Protocol Violation|0
7798432|NCT01081145|12255356|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
7798433|NCT01081145|12255357|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
7798434|NCT01081145|12255356|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
7798435|NCT01081145|12255357|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
7798436|NCT01081145|12255356|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
7798437|NCT01081145|12255357|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
7798438|NCT01081145|12255356|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
7798439|NCT01081145|12255357|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
7798440|NCT01081145|12255356|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
7798441|NCT01081145|12255357|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
7798442|NCT01081145|12255356|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
7798443|NCT01081145|12255357|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
7798444|NCT01081145|12255356|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4
7798445|NCT01081145|12255357|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3
7798446|NCT01081249|12255365|FG000|Overall Study|Diagnosed with Bipolar Disorder|0
7798447|NCT01081249|12255366|FG001|Overall Study|Diagnosed with Bipolar Disorder|1
7798448|NCT01081301|12255372|FG000|Overall Study|Bereaved|3
7798449|NCT01081301|12255372|FG000|Overall Study|Too busy|5
7798450|NCT01081301|12255372|FG000|Overall Study|Patient too ill|2
7798451|NCT01081301|12255372|FG000|Overall Study|Lost to Follow-up|4
7798452|NCT01081626|12255395|FG000|Overall Study|Dosing error|1
7798453|NCT01081626|12255396|FG001|Overall Study|Dosing error|1
7798454|NCT01081626|12255395|FG000|Overall Study|Missing Estradiol|25
7798455|NCT01081626|12255396|FG001|Overall Study|Missing Estradiol|28
7798456|NCT01081626|12255395|FG000|Overall Study|Low antral follicle count|1
7798457|NCT01081626|12255396|FG001|Overall Study|Low antral follicle count|0
7798458|NCT01081626|12255395|FG000|Overall Study|Overstimulation|0
7798459|NCT01081626|12255396|FG001|Overall Study|Overstimulation|1
7798460|NCT01081626|12255395|FG000|Overall Study|Lost to Follow-up|0
7798461|NCT01081626|12255396|FG001|Overall Study|Lost to Follow-up|1
7798462|NCT01081626|12255395|FG000|Overall Study|Other|33
7798463|NCT01081626|12255396|FG001|Overall Study|Other|30
7798464|NCT01081665|12255402|FG000|Overall Study|Death|41
7879952|NCT01742286|12376734|FG000|Expansion Phase|Administrative problems|0
7879953|NCT01742286|12376735|FG001|Expansion Phase|Administrative problems|0
7879954|NCT01742286|12376736|FG002|Expansion Phase|Administrative problems|0
7879955|NCT01742286|12376737|FG003|Expansion Phase|Administrative problems|0
7879956|NCT01742286|12376738|FG004|Expansion Phase|Administrative problems|0
7798465|NCT01081665|12255402|FG000|Overall Study|Lost to Follow-up|18
7798466|NCT01081665|12255402|FG000|Overall Study|Withdrawal by Subject|17
7798467|NCT01081665|12255402|FG000|Overall Study|Change of dialysis unit|10
7798468|NCT01081665|12255402|FG000|Overall Study|Regulation of iPTH|5
7798469|NCT01081665|12255402|FG000|Overall Study|Change in renal replacement therapy|2
7798470|NCT01081665|12255402|FG000|Overall Study|Adverse Event|1
7798471|NCT01081665|12255402|FG000|Overall Study|Lack of Efficacy|1
7798472|NCT01081769|12255408|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10
7798473|NCT01081769|12255409|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12
7798474|NCT01081769|12255408|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
7798475|NCT01081769|12255409|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
7798476|NCT01081769|12255408|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
7798477|NCT01081769|12255409|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
7798478|NCT01081769|12255408|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
7798479|NCT01081769|12255409|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
7798480|NCT01081769|12255408|FG000|CORE Intent-To-Treat|Adverse Event|14
7798481|NCT01081769|12255409|FG001|CORE Intent-To-Treat|Adverse Event|11
7798482|NCT01081769|12255408|FG000|CORE Intent-To-Treat|Death|1
7798483|NCT01081769|12255409|FG001|CORE Intent-To-Treat|Death|1
7798484|NCT01081769|12255408|FG000|CORE Intent-To-Treat|Lack of Efficacy|2
7798485|NCT01081769|12255409|FG001|CORE Intent-To-Treat|Lack of Efficacy|6
7798486|NCT01081769|12255408|FG000|CORE Intent-To-Treat|Lost to Follow-up|4
7798487|NCT01081769|12255409|FG001|CORE Intent-To-Treat|Lost to Follow-up|5
7798488|NCT01081769|12255408|FG000|CORE Intent-To-Treat|Pregnancy|1
7798489|NCT01081769|12255409|FG001|CORE Intent-To-Treat|Pregnancy|0
7798490|NCT01081769|12255408|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52
7798491|NCT01081769|12255409|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60
7798492|NCT01081769|12255408|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0
7798493|NCT01081769|12255409|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5
7798494|NCT01081769|12255408|FG000|CORE Intent-To-Treat|Other|0
7798495|NCT01081769|12255409|FG001|CORE Intent-To-Treat|Other|1
7798496|NCT01081769|12255408|FG000|CORE Intent-To-Treat|Ineligibility|3
7798497|NCT01081769|12255409|FG001|CORE Intent-To-Treat|Ineligibility|4
7798498|NCT01081769|12255408|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1
7798499|NCT01081769|12255409|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2
7798500|NCT01081769|12255408|FG000|CORE Intent-To-Treat|Patient Moved|2
7798501|NCT01081769|12255409|FG001|CORE Intent-To-Treat|Patient Moved|2
7798502|NCT01081795|12255418|FG000|Overall Study|Adverse Event|18
7798503|NCT01081795|12255419|FG001|Overall Study|Adverse Event|23
7798504|NCT01081795|12255420|FG002|Overall Study|Adverse Event|6
7798505|NCT01081795|12255418|FG000|Overall Study|Lack of Efficacy|7
7798506|NCT01081795|12255419|FG001|Overall Study|Lack of Efficacy|5
7798507|NCT01081795|12255420|FG002|Overall Study|Lack of Efficacy|19
7798508|NCT01081795|12255418|FG000|Overall Study|Subject's schedule|1
7798509|NCT01081795|12255419|FG001|Overall Study|Subject's schedule|1
7798510|NCT01081795|12255420|FG002|Overall Study|Subject's schedule|2
7798511|NCT01081795|12255418|FG000|Overall Study|Revocation of informed consent|2
7798512|NCT01081795|12255419|FG001|Overall Study|Revocation of informed consent|0
7798513|NCT01081795|12255420|FG002|Overall Study|Revocation of informed consent|0
7798514|NCT01081795|12255418|FG000|Overall Study|Ineligible for participation|1
7798515|NCT01081795|12255419|FG001|Overall Study|Ineligible for participation|0
7798516|NCT01081795|12255420|FG002|Overall Study|Ineligible for participation|0
7798517|NCT01081795|12255418|FG000|Overall Study|Use of a prohibited concomitant drug|1
7798518|NCT01081795|12255419|FG001|Overall Study|Use of a prohibited concomitant drug|1
7798519|NCT01081795|12255420|FG002|Overall Study|Use of a prohibited concomitant drug|1
7798520|NCT01081795|12255418|FG000|Overall Study|Using drug with restricted days of use|2
7798521|NCT01081795|12255419|FG001|Overall Study|Using drug with restricted days of use|3
7798522|NCT01081795|12255420|FG002|Overall Study|Using drug with restricted days of use|2
7798523|NCT01081795|12255418|FG000|Overall Study|Other|1
7798524|NCT01081795|12255419|FG001|Overall Study|Other|2
7798525|NCT01081795|12255420|FG002|Overall Study|Other|0
7798526|NCT01081834|12255433|FG000|Core Period: Baseline to Week 26|Pregnancy|1
7798527|NCT01081834|12255434|FG001|Core Period: Baseline to Week 26|Pregnancy|0
7798528|NCT01081834|12255435|FG002|Core Period: Baseline to Week 26|Pregnancy|0
7798529|NCT01081834|12255436|FG003|Core Period: Baseline to Week 26|Pregnancy|0
7798530|NCT01081834|12255437|FG004|Core Period: Baseline to Week 26|Pregnancy|0
7798531|NCT01081834|12255433|FG000|Core Period: Baseline to Week 26|Adverse Event|2
7798532|NCT01081834|12255434|FG001|Core Period: Baseline to Week 26|Adverse Event|5
7798533|NCT01081834|12255435|FG002|Core Period: Baseline to Week 26|Adverse Event|3
7798534|NCT01081834|12255436|FG003|Core Period: Baseline to Week 26|Adverse Event|1
7798535|NCT01081834|12255437|FG004|Core Period: Baseline to Week 26|Adverse Event|1
7798536|NCT01081834|12255433|FG000|Core Period: Baseline to Week 26|Death|1
7798537|NCT01081834|12255434|FG001|Core Period: Baseline to Week 26|Death|0
7798538|NCT01081834|12255435|FG002|Core Period: Baseline to Week 26|Death|0
7798539|NCT01081834|12255436|FG003|Core Period: Baseline to Week 26|Death|0
7798540|NCT01081834|12255437|FG004|Core Period: Baseline to Week 26|Death|0
7798541|NCT01081834|12255433|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2
7798542|NCT01081834|12255434|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2
7798543|NCT01081834|12255435|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5
7798544|NCT01081834|12255436|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0
7798545|NCT01081834|12255437|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0
7798546|NCT01081834|12255433|FG000|Core Period: Baseline to Week 26|Protocol Violation|0
7798547|NCT01081834|12255434|FG001|Core Period: Baseline to Week 26|Protocol Violation|4
7798548|NCT01081834|12255435|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
7798549|NCT01081834|12255436|FG003|Core Period: Baseline to Week 26|Protocol Violation|0
7798550|NCT01081834|12255437|FG004|Core Period: Baseline to Week 26|Protocol Violation|2
7798551|NCT01081834|12255433|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15
7798552|NCT01081834|12255434|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3
7798553|NCT01081834|12255435|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9
7798554|NCT01081834|12255436|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3
7798555|NCT01081834|12255437|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1
7798556|NCT01081834|12255433|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3
7798557|NCT01081834|12255434|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4
7798558|NCT01081834|12255435|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2
7798559|NCT01081834|12255436|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2
7798560|NCT01081834|12255437|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7798561|NCT01081834|12255433|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
7798562|NCT01081834|12255434|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7798563|NCT01081834|12255435|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7798564|NCT01081834|12255436|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7798565|NCT01081834|12255437|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7798566|NCT01081834|12255433|FG000|Core Period: Baseline to Week 26|Other|4
7798567|NCT01081834|12255434|FG001|Core Period: Baseline to Week 26|Other|4
7798568|NCT01081834|12255435|FG002|Core Period: Baseline to Week 26|Other|3
7798569|NCT01081834|12255436|FG003|Core Period: Baseline to Week 26|Other|1
7798570|NCT01081834|12255437|FG004|Core Period: Baseline to Week 26|Other|0
7798571|NCT01081834|12255433|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
7798572|NCT01081834|12255434|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
7798573|NCT01081834|12255435|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
7798574|NCT01081834|12255436|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
7798575|NCT01081834|12255437|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
7798576|NCT01081834|12255433|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
7798577|NCT01081834|12255434|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0
7798578|NCT01081834|12255435|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0
7798579|NCT01081834|12255436|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0
7798580|NCT01081834|12255437|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0
7798581|NCT01081834|12255433|FG000|Extension Period: Week 26 to Week 52|Death|1
7798582|NCT01081834|12255434|FG001|Extension Period: Week 26 to Week 52|Death|0
7798583|NCT01081834|12255435|FG002|Extension Period: Week 26 to Week 52|Death|0
7798584|NCT01081834|12255436|FG003|Extension Period: Week 26 to Week 52|Death|0
7798585|NCT01081834|12255437|FG004|Extension Period: Week 26 to Week 52|Death|0
7798586|NCT01081834|12255433|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
7798587|NCT01081834|12255434|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
7798588|NCT01081834|12255435|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7798589|NCT01081834|12255436|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7798590|NCT01081834|12255437|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7798591|NCT01081834|12255433|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0
7798592|NCT01081834|12255434|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
7798593|NCT01081834|12255435|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
7798594|NCT01081834|12255436|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0
7798595|NCT01081834|12255437|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0
7798596|NCT01081834|12255433|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7798597|NCT01081834|12255434|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
7798598|NCT01081834|12255435|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7798599|NCT01081834|12255436|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7798600|NCT01081834|12255437|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7798601|NCT01081834|12255433|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
7798602|NCT01081834|12255434|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7798603|NCT01081834|12255435|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
7798604|NCT01081834|12255436|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7798605|NCT01081834|12255437|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7798606|NCT01081834|12255433|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
7798607|NCT01081834|12255434|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
7798608|NCT01081834|12255435|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
7798609|NCT01081834|12255436|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
7798610|NCT01081834|12255437|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
7798611|NCT01081834|12255433|FG000|Extension Period: Week 26 to Week 52|Other|4
7798612|NCT01081834|12255434|FG001|Extension Period: Week 26 to Week 52|Other|5
7798613|NCT01081834|12255435|FG002|Extension Period: Week 26 to Week 52|Other|4
7798614|NCT01081834|12255436|FG003|Extension Period: Week 26 to Week 52|Other|0
7798615|NCT01081834|12255437|FG004|Extension Period: Week 26 to Week 52|Other|0
7798616|NCT01081834|12255433|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
7798617|NCT01081834|12255434|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
7798618|NCT01081834|12255435|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
7798619|NCT01081834|12255436|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
7798620|NCT01081834|12255437|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
7798621|NCT01081834|12255433|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0
7798622|NCT01081834|12255434|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1
7798623|NCT01081834|12255435|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0
7798624|NCT01081834|12255436|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0
7798625|NCT01081834|12255437|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0
7798626|NCT01081873|12255456|FG000|Overall Study|Death|86
7798627|NCT01081873|12255456|FG000|Overall Study|Withdrawal by Subject|10
7798628|NCT01081873|12255456|FG000|Overall Study|Lost to Follow-up|142
7798629|NCT01081873|12255456|FG000|Overall Study|Progression of prostate cancer|13
7798630|NCT01081873|12255456|FG000|Overall Study|Other|47
7798631|NCT01081912|12255485|FG000|Conversion/Titration|Adverse Event|47
7798632|NCT01081912|12255486|FG001|Conversion/Titration|Adverse Event|0
7798633|NCT01081912|12255487|FG002|Conversion/Titration|Adverse Event|0
7798634|NCT01081912|12255485|FG000|Conversion/Titration|Lack of Efficacy|17
7798635|NCT01081912|12255486|FG001|Conversion/Titration|Lack of Efficacy|0
7879957|NCT01742286|12376739|FG005|Expansion Phase|Administrative problems|0
7879958|NCT01742286|12376740|FG006|Expansion Phase|Administrative problems|5
7879959|NCT01742286|12376734|FG000|Expansion Phase|Physician Decision|0
7879960|NCT01742286|12376735|FG001|Expansion Phase|Physician Decision|0
7879961|NCT01742286|12376736|FG002|Expansion Phase|Physician Decision|4
7879962|NCT01742286|12376737|FG003|Expansion Phase|Physician Decision|0
7879963|NCT01742286|12376738|FG004|Expansion Phase|Physician Decision|0
7879964|NCT01742286|12376739|FG005|Expansion Phase|Physician Decision|0
7879965|NCT01742286|12376740|FG006|Expansion Phase|Physician Decision|9
7879966|NCT01742286|12376734|FG000|Expansion Phase|Adverse Event|0
7879967|NCT01742286|12376735|FG001|Expansion Phase|Adverse Event|0
7879968|NCT01742286|12376736|FG002|Expansion Phase|Adverse Event|0
7879969|NCT01742286|12376737|FG003|Expansion Phase|Adverse Event|0
7879970|NCT01742286|12376738|FG004|Expansion Phase|Adverse Event|0
7879971|NCT01742286|12376739|FG005|Expansion Phase|Adverse Event|0
7879972|NCT01742286|12376740|FG006|Expansion Phase|Adverse Event|6
7879973|NCT01742286|12376734|FG000|Expansion Phase|Disease progression|0
7879974|NCT01742286|12376735|FG001|Expansion Phase|Disease progression|0
7879975|NCT01742286|12376736|FG002|Expansion Phase|Disease progression|3
7879976|NCT01742286|12376737|FG003|Expansion Phase|Disease progression|0
7879977|NCT01742286|12376738|FG004|Expansion Phase|Disease progression|0
7879978|NCT01742286|12376739|FG005|Expansion Phase|Disease progression|0
7879979|NCT01742286|12376740|FG006|Expansion Phase|Disease progression|15
7879980|NCT01742286|12376734|FG000|Expansion Phase|Withdrawal by Subject|0
7879981|NCT01742286|12376735|FG001|Expansion Phase|Withdrawal by Subject|0
7879982|NCT01742286|12376736|FG002|Expansion Phase|Withdrawal by Subject|0
7879983|NCT01742286|12376737|FG003|Expansion Phase|Withdrawal by Subject|0
7879984|NCT01742286|12376738|FG004|Expansion Phase|Withdrawal by Subject|0
7879985|NCT01742286|12376739|FG005|Expansion Phase|Withdrawal by Subject|0
7879986|NCT01742286|12376740|FG006|Expansion Phase|Withdrawal by Subject|1
7879987|NCT01742897|12376790|FG000|Overall Study|Adverse Event|3
7879988|NCT01742897|12376790|FG000|Overall Study|Withdrawal by Subject|1
7879989|NCT01742897|12376790|FG000|Overall Study|Other|1
7879990|NCT01743001|12376815|FG000|Overall Study|Physician Decision|1
7879991|NCT01743001|12376816|FG001|Overall Study|Physician Decision|0
7879992|NCT01743001|12376815|FG000|Overall Study|Pregnancy|1
7879993|NCT01743001|12376816|FG001|Overall Study|Pregnancy|0
7879994|NCT01743001|12376815|FG000|Overall Study|Death|1
7879995|NCT01743001|12376816|FG001|Overall Study|Death|0
7879996|NCT01743027|12376826|FG000|Overall Study|Adverse Event|2
7879997|NCT01743027|12376827|FG001|Overall Study|Adverse Event|0
7879998|NCT01743027|12376828|FG002|Overall Study|Adverse Event|0
7879999|NCT01743027|12376829|FG003|Overall Study|Adverse Event|0
7880000|NCT01743027|12376826|FG000|Overall Study|Lost to Follow-up|0
7880001|NCT01743027|12376827|FG001|Overall Study|Lost to Follow-up|0
7880002|NCT01743027|12376828|FG002|Overall Study|Lost to Follow-up|2
7880003|NCT01743027|12376829|FG003|Overall Study|Lost to Follow-up|0
7880004|NCT01743027|12376826|FG000|Overall Study|Progressive Disease|1
7880005|NCT01743027|12376827|FG001|Overall Study|Progressive Disease|4
7880006|NCT01743027|12376828|FG002|Overall Study|Progressive Disease|3
7880007|NCT01743027|12376829|FG003|Overall Study|Progressive Disease|0
7880008|NCT01743027|12376826|FG000|Overall Study|Protocol Violation|1
7880009|NCT01743027|12376827|FG001|Overall Study|Protocol Violation|1
7880010|NCT01743027|12376828|FG002|Overall Study|Protocol Violation|1
7880011|NCT01743027|12376829|FG003|Overall Study|Protocol Violation|0
7880012|NCT01743027|12376826|FG000|Overall Study|Withdrawal by Subject|1
7880013|NCT01743027|12376827|FG001|Overall Study|Withdrawal by Subject|0
7880014|NCT01743027|12376828|FG002|Overall Study|Withdrawal by Subject|3
7880015|NCT01743027|12376829|FG003|Overall Study|Withdrawal by Subject|1
7880016|NCT01743040|12376839|FG000|Overall Study|Death|1
7880017|NCT01743040|12376839|FG000|Overall Study|Lost to Follow-up|66
7880018|NCT01743040|12376839|FG000|Overall Study|Physician Decision|40
7880019|NCT01743040|12376839|FG000|Overall Study|Protocol Violation|1
7880020|NCT01743040|12376839|FG000|Overall Study|Withdrawal by Subject|121
7880021|NCT01743092|12376845|FG000|Overall Study|Lost to Follow-up|14
7880022|NCT01743092|12376846|FG001|Overall Study|Lost to Follow-up|15
7880023|NCT01743469|12376873|FG000|Active Treatment Phase|Adverse Event|10
7880024|NCT01743469|12376874|FG001|Active Treatment Phase|Adverse Event|5
7880025|NCT01743469|12376875|FG002|Active Treatment Phase|Adverse Event|8
7880026|NCT01743469|12376876|FG003|Active Treatment Phase|Adverse Event|1
7880027|NCT01743469|12376873|FG000|Active Treatment Phase|Disease Progression|40
7880028|NCT01743469|12376874|FG001|Active Treatment Phase|Disease Progression|47
7880029|NCT01743469|12376875|FG002|Active Treatment Phase|Disease Progression|30
7880030|NCT01743469|12376876|FG003|Active Treatment Phase|Disease Progression|20
7880031|NCT01743469|12376873|FG000|Active Treatment Phase|Withdrawal by Subject|2
7880032|NCT01743469|12376874|FG001|Active Treatment Phase|Withdrawal by Subject|3
7880033|NCT01743469|12376875|FG002|Active Treatment Phase|Withdrawal by Subject|0
7880034|NCT01743469|12376876|FG003|Active Treatment Phase|Withdrawal by Subject|0
7880035|NCT01743469|12376873|FG000|Active Treatment Phase|Missing|1
7880036|NCT01743469|12376874|FG001|Active Treatment Phase|Missing|0
7880037|NCT01743469|12376875|FG002|Active Treatment Phase|Missing|0
7880038|NCT01743469|12376876|FG003|Active Treatment Phase|Missing|0
7880039|NCT01743469|12376873|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
7880040|NCT01743469|12376874|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
7880041|NCT01743469|12376875|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
7880042|NCT01743469|12376876|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
7880043|NCT01743469|12376873|FG000|Follow-up Period - Post-Treatment|Death|43
7880044|NCT01743469|12376874|FG001|Follow-up Period - Post-Treatment|Death|47
7880045|NCT01743469|12376875|FG002|Follow-up Period - Post-Treatment|Death|22
7880046|NCT01743469|12376876|FG003|Follow-up Period - Post-Treatment|Death|16
7880047|NCT01743469|12376873|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1
7880048|NCT01743469|12376874|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1
7880049|NCT01743469|12376875|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0
7880050|NCT01743469|12376876|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0
7880051|NCT01743560|12376901|FG000|Overall Study|Disease progression|26
7880052|NCT01743560|12376901|FG000|Overall Study|Adverse Event|8
7880053|NCT01743560|12376901|FG000|Overall Study|Death|3
7880054|NCT01743560|12376901|FG000|Overall Study|Withdrawal by Subject|2
7880055|NCT01743560|12376901|FG000|Overall Study|Protocol Violation|1
7880056|NCT01743560|12376901|FG000|Overall Study|>1 dose of study drug|3
7880057|NCT01743989|12376963|FG000|Treatment Phase|Unstable MR4.0|0
7880058|NCT01743989|12376964|FG001|Treatment Phase|Unstable MR4.0|6
7880059|NCT01743989|12376965|FG002|Treatment Phase|Unstable MR4.0|263
7880060|NCT01743989|12376963|FG000|Treatment Phase|Adverse Event|0
7880061|NCT01743989|12376964|FG001|Treatment Phase|Adverse Event|4
7880062|NCT01743989|12376965|FG002|Treatment Phase|Adverse Event|67
7880063|NCT01743989|12376963|FG000|Treatment Phase|Withdrawal by Subject|1
7880064|NCT01743989|12376964|FG001|Treatment Phase|Withdrawal by Subject|3
7880065|NCT01743989|12376965|FG002|Treatment Phase|Withdrawal by Subject|28
7880066|NCT01743989|12376963|FG000|Treatment Phase|Death|0
7880067|NCT01743989|12376964|FG001|Treatment Phase|Death|1
7880068|NCT01743989|12376965|FG002|Treatment Phase|Death|3
7880069|NCT01743989|12376963|FG000|Treatment Phase|Abnormal laboratory value(s)|0
7880070|NCT01743989|12376964|FG001|Treatment Phase|Abnormal laboratory value(s)|0
7880071|NCT01743989|12376965|FG002|Treatment Phase|Abnormal laboratory value(s)|3
7880072|NCT01743989|12376963|FG000|Treatment Phase|Protocol deviation|0
7880073|NCT01743989|12376964|FG001|Treatment Phase|Protocol deviation|0
7880074|NCT01743989|12376965|FG002|Treatment Phase|Protocol deviation|3
7880075|NCT01743989|12376963|FG000|Treatment Phase|Pregnancy|0
7880076|NCT01743989|12376964|FG001|Treatment Phase|Pregnancy|0
7880077|NCT01743989|12376965|FG002|Treatment Phase|Pregnancy|2
7880078|NCT01743989|12376963|FG000|Treatment Phase|Lost to Follow-up|0
7880079|NCT01743989|12376964|FG001|Treatment Phase|Lost to Follow-up|0
7880080|NCT01743989|12376965|FG002|Treatment Phase|Lost to Follow-up|2
7880081|NCT01743989|12376963|FG000|Treatment Phase|Abnormal test procedure result(s)|0
7880082|NCT01743989|12376964|FG001|Treatment Phase|Abnormal test procedure result(s)|0
7880083|NCT01743989|12376965|FG002|Treatment Phase|Abnormal test procedure result(s)|1
7880084|NCT01743989|12376963|FG000|Treatment Phase|Administrative problems|0
7880085|NCT01743989|12376964|FG001|Treatment Phase|Administrative problems|0
7880086|NCT01743989|12376965|FG002|Treatment Phase|Administrative problems|1
7880087|NCT01743989|12376963|FG000|Treatment Phase|New cancer (CML) therapy|0
7880088|NCT01743989|12376964|FG001|Treatment Phase|New cancer (CML) therapy|1
7880089|NCT01743989|12376965|FG002|Treatment Phase|New cancer (CML) therapy|0
7880090|NCT01743989|12376963|FG000|Treatment Phase|Physician Decision|0
7880091|NCT01743989|12376964|FG001|Treatment Phase|Physician Decision|0
7880092|NCT01743989|12376965|FG002|Treatment Phase|Physician Decision|3
7880093|NCT01743989|12376963|FG000|Treatment Phase|Patient non-compliance to treatment|0
7880094|NCT01743989|12376964|FG001|Treatment Phase|Patient non-compliance to treatment|0
7880095|NCT01743989|12376965|FG002|Treatment Phase|Patient non-compliance to treatment|3
7880096|NCT01743989|12376963|FG000|Treatment Phase|Not randomized by mistake|0
7880097|NCT01743989|12376964|FG001|Treatment Phase|Not randomized by mistake|0
7880098|NCT01743989|12376965|FG002|Treatment Phase|Not randomized by mistake|1
7880099|NCT01743989|12376963|FG000|Treatment Phase|Included by mistake|0
7880100|NCT01743989|12376964|FG001|Treatment Phase|Included by mistake|0
7880101|NCT01743989|12376965|FG002|Treatment Phase|Included by mistake|1
7880102|NCT01743989|12376963|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82
7880103|NCT01743989|12376964|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59
7880104|NCT01743989|12376965|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0
7880105|NCT01743989|12376963|FG000|TFR Phase|Adverse Event|0
7880106|NCT01743989|12376964|FG001|TFR Phase|Adverse Event|1
7880107|NCT01743989|12376965|FG002|TFR Phase|Adverse Event|0
7880108|NCT01743989|12376963|FG000|TFR Phase|Lost to Follow-up|0
7880109|NCT01743989|12376964|FG001|TFR Phase|Lost to Follow-up|2
7880110|NCT01743989|12376965|FG002|TFR Phase|Lost to Follow-up|0
7880111|NCT01743989|12376963|FG000|TFR Phase|Physician Decision|0
7880112|NCT01743989|12376964|FG001|TFR Phase|Physician Decision|1
7880113|NCT01743989|12376965|FG002|TFR Phase|Physician Decision|0
7880114|NCT01743989|12376963|FG000|TFR Phase|Logistical problems|0
7880115|NCT01743989|12376964|FG001|TFR Phase|Logistical problems|2
7880116|NCT01743989|12376965|FG002|TFR Phase|Logistical problems|0
7880117|NCT01743989|12376963|FG000|TFR Phase|Protocol deviation|0
7880118|NCT01743989|12376964|FG001|TFR Phase|Protocol deviation|1
7880119|NCT01743989|12376965|FG002|TFR Phase|Protocol deviation|0
7880120|NCT01743989|12376963|FG000|TFR Phase|Withdrawal by Subject|0
7880121|NCT01743989|12376964|FG001|TFR Phase|Withdrawal by Subject|2
7880122|NCT01743989|12376965|FG002|TFR Phase|Withdrawal by Subject|0
7880123|NCT01743989|12376963|FG000|Re-treatment Phase|Adverse Event|8
7880124|NCT01743989|12376964|FG001|Re-treatment Phase|Adverse Event|4
7880125|NCT01743989|12376965|FG002|Re-treatment Phase|Adverse Event|0
7880126|NCT01743989|12376963|FG000|Re-treatment Phase|Death|1
7880127|NCT01743989|12376964|FG001|Re-treatment Phase|Death|1
7880128|NCT01743989|12376965|FG002|Re-treatment Phase|Death|0
7880129|NCT01743989|12376963|FG000|Re-treatment Phase|Administrative problems|1
7880130|NCT01743989|12376964|FG001|Re-treatment Phase|Administrative problems|1
7880131|NCT01743989|12376965|FG002|Re-treatment Phase|Administrative problems|0
7880132|NCT01743989|12376963|FG000|Re-treatment Phase|Withdrawal by Subject|5
7880133|NCT01743989|12376964|FG001|Re-treatment Phase|Withdrawal by Subject|1
7880134|NCT01743989|12376965|FG002|Re-treatment Phase|Withdrawal by Subject|0
7880135|NCT01743989|12376963|FG000|Re-treatment Phase|Unstable MR|1
7880136|NCT01743989|12376964|FG001|Re-treatment Phase|Unstable MR|0
7880137|NCT01743989|12376965|FG002|Re-treatment Phase|Unstable MR|0
7880138|NCT01743989|12376963|FG000|Re-treatment Phase|Physician Decision|0
7880139|NCT01743989|12376964|FG001|Re-treatment Phase|Physician Decision|1
7880140|NCT01743989|12376965|FG002|Re-treatment Phase|Physician Decision|0
7880141|NCT01743989|12376963|FG000|Re-treatment Phase|Lost to Follow-up|0
7880142|NCT01743989|12376964|FG001|Re-treatment Phase|Lost to Follow-up|1
7880143|NCT01743989|12376965|FG002|Re-treatment Phase|Lost to Follow-up|0
7880144|NCT01744197|12376978|FG000|Overall Study|Received 1 patch|2
7880145|NCT01744197|12376979|FG001|Overall Study|Received 1 patch|1
7880146|NCT01744197|12376978|FG000|Overall Study|No patch received|2
7880147|NCT01744197|12376979|FG001|Overall Study|No patch received|2
7880148|NCT01744392|12377005|FG000|Overall Study|Physician Decision|1
7880149|NCT01744483|12377013|FG000|Overall Study|Death|9
7880150|NCT01744483|12377014|FG001|Overall Study|Death|4
7880151|NCT01744483|12377015|FG002|Overall Study|Death|11
7880152|NCT01744483|12377013|FG000|Overall Study|Lost to Follow-up|8
7880153|NCT01744483|12377014|FG001|Overall Study|Lost to Follow-up|9
7880154|NCT01744483|12377015|FG002|Overall Study|Lost to Follow-up|11
7880155|NCT01744483|12377013|FG000|Overall Study|Protocol Violation|1
7880156|NCT01744483|12377014|FG001|Overall Study|Protocol Violation|2
7880157|NCT01744483|12377015|FG002|Overall Study|Protocol Violation|1
7880158|NCT01744483|12377013|FG000|Overall Study|Withdrawal by Subject|4
7880159|NCT01744483|12377014|FG001|Overall Study|Withdrawal by Subject|6
7880160|NCT01744483|12377015|FG002|Overall Study|Withdrawal by Subject|2
7880161|NCT01744483|12377013|FG000|Overall Study|No ICU Admit|5
7880162|NCT01744483|12377014|FG001|Overall Study|No ICU Admit|1
7880163|NCT01744483|12377015|FG002|Overall Study|No ICU Admit|2
7880164|NCT01744483|12377013|FG000|Overall Study|Routed to OSH|2
7880165|NCT01744483|12377014|FG001|Overall Study|Routed to OSH|0
7880166|NCT01744483|12377015|FG002|Overall Study|Routed to OSH|1
7880167|NCT01744496|12377025|FG000|Titration Period|Adverse Event|2
7880168|NCT01744496|12377026|FG001|Titration Period|Adverse Event|1
7880169|NCT01744496|12377025|FG000|Titration Period|Personal reasons|0
7880170|NCT01744496|12377026|FG001|Titration Period|Personal reasons|1
7880171|NCT01744496|12377025|FG000|Maintenance Period|Adverse Event|1
7880172|NCT01744496|12377026|FG001|Maintenance Period|Adverse Event|3
7880173|NCT01744496|12377025|FG000|Maintenance Period|Protocol Violation|1
7880174|NCT01744496|12377026|FG001|Maintenance Period|Protocol Violation|0
7880175|NCT01744496|12377025|FG000|Maintenance Period|Withdrawal by Subject|1
7880176|NCT01744496|12377026|FG001|Maintenance Period|Withdrawal by Subject|1
7880177|NCT01744496|12377025|FG000|Maintenance Period|Subject left town|1
7880178|NCT01744496|12377026|FG001|Maintenance Period|Subject left town|0
7880179|NCT01744665|12377049|FG000|Monitoring Phase|Adverse Event|4
7880180|NCT01744665|12377049|FG000|Monitoring Phase|Abnormal laboratory value(s)|1
7880181|NCT01744665|12377049|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7
7880182|NCT01744665|12377049|FG000|Monitoring Phase|Withdrawal by Subject|5
7880183|NCT01744665|12377049|FG000|Monitoring Phase|Did not achieve MR4.5|1
7880184|NCT01744665|12377049|FG000|Consolidation Phase|Adverse Event|2
7880185|NCT01744665|12377049|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4
7880186|NCT01744665|12377049|FG000|Consolidation Phase|Withdrawal by Subject|4
7880187|NCT01744665|12377049|FG000|Consolidation Phase|Administrative problems|9
7880188|NCT01744665|12377049|FG000|Re-initiation Phase|Administrative problems|10
7880189|NCT01744665|12377049|FG000|Re-initiation Phase|Adverse Event|1
7880190|NCT01744665|12377049|FG000|Re-initiation Phase|No longer required treatment|1
7880191|NCT01744665|12377049|FG000|Re-initiation Phase|Withdrawal by Subject|1
7880192|NCT01744691|12377056|FG000|Overall Study|Progressive Disease|18
7880193|NCT01744691|12377056|FG000|Overall Study|Unacceptable toxicity, AE or death|18
7880194|NCT01744691|12377056|FG000|Overall Study|Withdrawal of consent for treatment|3
7880195|NCT01744691|12377056|FG000|Overall Study|Physician Decision|4
7880196|NCT01744782|12377132|FG000|Overall Study|Death|1
7880197|NCT01744977|12377167|FG000|Overall Study|Withdrawal by Subject|1
7880198|NCT01744977|12377168|FG001|Overall Study|Withdrawal by Subject|2
7880199|NCT01744977|12377167|FG000|Overall Study|Death|2
7880200|NCT01744977|12377168|FG001|Overall Study|Death|3
7880201|NCT01744977|12377167|FG000|Overall Study|Lost to Follow-up|2
7880202|NCT01744977|12377168|FG001|Overall Study|Lost to Follow-up|0
7880203|NCT01744977|12377167|FG000|Overall Study|No longer meets inclusion|6
7880204|NCT01744977|12377168|FG001|Overall Study|No longer meets inclusion|0
7880205|NCT01745094|12377187|FG000|Overall Study|Not Meeting the Eligibility Criteria|1
7880206|NCT01745094|12377188|FG001|Overall Study|Not Meeting the Eligibility Criteria|0
7880207|NCT01745094|12377189|FG002|Overall Study|Not Meeting the Eligibility Criteria|3
7880208|NCT01745094|12377190|FG003|Overall Study|Not Meeting the Eligibility Criteria|0
7880209|NCT01745094|12377187|FG000|Overall Study|Adverse Event|0
7880210|NCT01745094|12377188|FG001|Overall Study|Adverse Event|0
7880211|NCT01745094|12377189|FG002|Overall Study|Adverse Event|3
7880212|NCT01745094|12377190|FG003|Overall Study|Adverse Event|0
7880213|NCT01745094|12377187|FG000|Overall Study|Withdrawal by Subject|2
7880214|NCT01745094|12377188|FG001|Overall Study|Withdrawal by Subject|0
7880215|NCT01745094|12377189|FG002|Overall Study|Withdrawal by Subject|1
7880216|NCT01745094|12377190|FG003|Overall Study|Withdrawal by Subject|2
7880217|NCT01745094|12377187|FG000|Overall Study|Protocol Violation|1
7880218|NCT01745094|12377188|FG001|Overall Study|Protocol Violation|0
7880219|NCT01745094|12377189|FG002|Overall Study|Protocol Violation|3
7880220|NCT01745094|12377190|FG003|Overall Study|Protocol Violation|1
7880221|NCT01745094|12377187|FG000|Overall Study|Need Further Examinations Due to Biopsy|0
7880222|NCT01745094|12377188|FG001|Overall Study|Need Further Examinations Due to Biopsy|0
7880223|NCT01745094|12377189|FG002|Overall Study|Need Further Examinations Due to Biopsy|1
7880224|NCT01745094|12377190|FG003|Overall Study|Need Further Examinations Due to Biopsy|0
7880225|NCT01745094|12377187|FG000|Overall Study|Show no Stable Solifenacin Intake|0
7880226|NCT01745094|12377188|FG001|Overall Study|Show no Stable Solifenacin Intake|0
7880227|NCT01745094|12377189|FG002|Overall Study|Show no Stable Solifenacin Intake|1
7880228|NCT01745094|12377190|FG003|Overall Study|Show no Stable Solifenacin Intake|0
7880229|NCT01745094|12377187|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1
7880230|NCT01745094|12377188|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0
7880231|NCT01745094|12377189|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0
7880232|NCT01745094|12377190|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0
7880233|NCT01745120|12377205|FG000|Overall Study|Investigator decision|1
7880234|NCT01745120|12377206|FG001|Overall Study|Investigator decision|0
7880235|NCT01745146|12377230|FG000|Overall Study|Withdrawal by Subject|1
7880236|NCT01745146|12377231|FG001|Overall Study|Withdrawal by Subject|3
7880237|NCT01745146|12377230|FG000|Overall Study|Lost to Follow-up|2
7880238|NCT01745146|12377231|FG001|Overall Study|Lost to Follow-up|0
7880239|NCT01745367|12377244|FG000|Overall Study|Death|1
7880240|NCT01745367|12377245|FG001|Overall Study|Death|0
7880241|NCT01745367|12377244|FG000|Overall Study|Withdrawal by Subject|1
7880242|NCT01745367|12377245|FG001|Overall Study|Withdrawal by Subject|2
7880243|NCT01745367|12377244|FG000|Overall Study|Termination of The Study by The Sponsor|6
7880244|NCT01745367|12377245|FG001|Overall Study|Termination of The Study by The Sponsor|18
7880245|NCT01745367|12377244|FG000|Overall Study|Other Reasons Unspecified|0
7880246|NCT01745367|12377245|FG001|Overall Study|Other Reasons Unspecified|2
7880247|NCT01745380|12377253|FG000|Overall Study|Lost to Follow-up|1
7880248|NCT01745380|12377254|FG001|Overall Study|Lost to Follow-up|0
7880249|NCT01745380|12377253|FG000|Overall Study|Lack of Efficacy|0
7880250|NCT01745380|12377254|FG001|Overall Study|Lack of Efficacy|1
7880251|NCT01745393|12377262|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
7880252|NCT01745393|12377263|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
7880253|NCT01745393|12377262|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
7880254|NCT01745393|12377263|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
7880255|NCT01745393|12377262|FG000|12-month Follow-up|Lost to Follow-up|6
7880256|NCT01745393|12377263|FG001|12-month Follow-up|Lost to Follow-up|5
7880257|NCT01745848|12377282|FG000|Overall Study|Adverse Event|6
7880258|NCT01746017|12377313|FG000|Period 1|Withdrawal by Subject|0
7880259|NCT01746017|12377314|FG001|Period 1|Withdrawal by Subject|0
7880260|NCT01746017|12377315|FG002|Period 1|Withdrawal by Subject|0
7880261|NCT01746017|12377316|FG003|Period 1|Withdrawal by Subject|0
7880262|NCT01746017|12377317|FG004|Period 1|Withdrawal by Subject|0
7880263|NCT01746017|12377318|FG005|Period 1|Withdrawal by Subject|0
7880264|NCT01746017|12377319|FG006|Period 1|Withdrawal by Subject|1
7880265|NCT01746017|12377320|FG007|Period 1|Withdrawal by Subject|0
7880266|NCT01746017|12377321|FG008|Period 1|Withdrawal by Subject|0
7880267|NCT01746017|12377322|FG009|Period 1|Withdrawal by Subject|0
7880268|NCT01746017|12377323|FG010|Period 1|Withdrawal by Subject|0
7880269|NCT01746017|12377313|FG000|Period 3|Withdrawal by Subject|0
7880270|NCT01746017|12377314|FG001|Period 3|Withdrawal by Subject|0
7880271|NCT01746017|12377315|FG002|Period 3|Withdrawal by Subject|0
7880272|NCT01746017|12377316|FG003|Period 3|Withdrawal by Subject|0
7880273|NCT01746017|12377317|FG004|Period 3|Withdrawal by Subject|0
7880274|NCT01746017|12377318|FG005|Period 3|Withdrawal by Subject|1
7880275|NCT01746017|12377319|FG006|Period 3|Withdrawal by Subject|0
7880276|NCT01746017|12377320|FG007|Period 3|Withdrawal by Subject|0
7880277|NCT01746017|12377321|FG008|Period 3|Withdrawal by Subject|0
7880278|NCT01746017|12377322|FG009|Period 3|Withdrawal by Subject|0
7880279|NCT01746017|12377323|FG010|Period 3|Withdrawal by Subject|0
7880280|NCT01746108|12377399|FG000|Overall Study|Migrated /moved from study area|0
7880281|NCT01746108|12377400|FG001|Overall Study|Migrated /moved from study area|1
7880282|NCT01746108|12377401|FG002|Overall Study|Migrated /moved from study area|0
7880283|NCT01746108|12377399|FG000|Overall Study|Adverse event, non-fatal|0
7880284|NCT01746108|12377400|FG001|Overall Study|Adverse event, non-fatal|1
7880285|NCT01746108|12377401|FG002|Overall Study|Adverse event, non-fatal|0
7880286|NCT01746108|12377399|FG000|Overall Study|Withdrawal by Subject|0
7880287|NCT01746108|12377400|FG001|Overall Study|Withdrawal by Subject|1
7880288|NCT01746108|12377401|FG002|Overall Study|Withdrawal by Subject|0
7880289|NCT01746108|12377399|FG000|Overall Study|Lost to Follow-up|0
7880290|NCT01746108|12377400|FG001|Overall Study|Lost to Follow-up|1
7880291|NCT01746108|12377401|FG002|Overall Study|Lost to Follow-up|0
7880292|NCT01746225|12377420|FG000|Overall Study|Death|1
7880293|NCT01746225|12377421|FG001|Overall Study|Death|0
7880294|NCT01746225|12377422|FG002|Overall Study|Death|1
7880295|NCT01746225|12377420|FG000|Overall Study|Withdrawal by Subject|5
7880296|NCT01746225|12377421|FG001|Overall Study|Withdrawal by Subject|15
7880297|NCT01746225|12377422|FG002|Overall Study|Withdrawal by Subject|19
7880298|NCT01746225|12377420|FG000|Overall Study|Physician Decision|14
7880299|NCT01746225|12377421|FG001|Overall Study|Physician Decision|11
7880300|NCT01746225|12377422|FG002|Overall Study|Physician Decision|3
7880301|NCT01746225|12377420|FG000|Overall Study|Adverse Event|15
7880302|NCT01746225|12377421|FG001|Overall Study|Adverse Event|12
7880303|NCT01746225|12377422|FG002|Overall Study|Adverse Event|17
7880304|NCT01746225|12377420|FG000|Overall Study|Continuing Treatment|5
7880305|NCT01746225|12377421|FG001|Overall Study|Continuing Treatment|8
7880306|NCT01746225|12377422|FG002|Overall Study|Continuing Treatment|3
7880307|NCT01746368|12377436|FG000|Overall Study|Lost to Follow-up|2
7880308|NCT01746368|12377437|FG001|Overall Study|Lost to Follow-up|0
7880309|NCT01746368|12377436|FG000|Overall Study|Withdrawal by Subject|0
7880310|NCT01746368|12377437|FG001|Overall Study|Withdrawal by Subject|1
7880311|NCT01746732|12377474|FG000|Lead-In Period|Withdrawal by Subject|1
7880312|NCT01746732|12377475|FG001|Lead-In Period|Withdrawal by Subject|0
7880313|NCT01746732|12377476|FG002|Lead-In Period|Withdrawal by Subject|0
7880314|NCT01746732|12377474|FG000|Period 1|Physician Decision|0
7880315|NCT01746732|12377475|FG001|Period 1|Physician Decision|1
7880316|NCT01746732|12377476|FG002|Period 1|Physician Decision|0
7880317|NCT01746732|12377474|FG000|Period 2|Withdrawal by Subject|0
7880318|NCT01746732|12377475|FG001|Period 2|Withdrawal by Subject|0
7880319|NCT01746732|12377476|FG002|Period 2|Withdrawal by Subject|2
7880320|NCT01746732|12377474|FG000|Period 2|Adverse Event|0
7880321|NCT01746732|12377475|FG001|Period 2|Adverse Event|0
7880322|NCT01746732|12377476|FG002|Period 2|Adverse Event|1
7880323|NCT01746732|12377474|FG000|Period 2|Lost to Follow-up|0
7880324|NCT01746732|12377475|FG001|Period 2|Lost to Follow-up|0
7880325|NCT01746732|12377476|FG002|Period 2|Lost to Follow-up|1
7880326|NCT01746862|12377520|FG000|Overall Study|Withdrawal by Subject|1
7880327|NCT01746862|12377521|FG001|Overall Study|Withdrawal by Subject|1
7880328|NCT01746862|12377520|FG000|Overall Study|Protocol Violation|1
7880329|NCT01746862|12377521|FG001|Overall Study|Protocol Violation|0
7880330|NCT01746862|12377520|FG000|Overall Study|Consent withdrawal by parent's guardian|5
7880331|NCT01746862|12377521|FG001|Overall Study|Consent withdrawal by parent's guardian|2
7880332|NCT01746862|12377520|FG000|Overall Study|Entered puberty during the study|1
7880333|NCT01746862|12377521|FG001|Overall Study|Entered puberty during the study|0
7880334|NCT01746901|12377528|FG000|Naloxone Challenge Phase|Adverse Event|2
7880335|NCT01746901|12377529|FG001|Naloxone Challenge Phase|Adverse Event|0
7880336|NCT01746901|12377530|FG002|Naloxone Challenge Phase|Adverse Event|0
7880337|NCT01746901|12377531|FG003|Naloxone Challenge Phase|Adverse Event|0
7880338|NCT01746901|12377532|FG004|Naloxone Challenge Phase|Adverse Event|0
7880339|NCT01746901|12377533|FG005|Naloxone Challenge Phase|Adverse Event|0
7880340|NCT01746901|12377534|FG006|Naloxone Challenge Phase|Adverse Event|0
7880341|NCT01746901|12377535|FG007|Naloxone Challenge Phase|Adverse Event|0
7880342|NCT01746901|12377536|FG008|Naloxone Challenge Phase|Adverse Event|0
7880343|NCT01746901|12377528|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1
7880344|NCT01746901|12377529|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0
7880345|NCT01746901|12377530|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0
7880346|NCT01746901|12377531|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0
7880347|NCT01746901|12377532|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0
7880348|NCT01746901|12377533|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0
7880349|NCT01746901|12377534|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0
7880350|NCT01746901|12377535|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0
7880351|NCT01746901|12377536|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0
7880352|NCT01746901|12377528|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0
7880353|NCT01746901|12377529|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3
7880354|NCT01746901|12377530|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0
7880355|NCT01746901|12377531|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0
7880356|NCT01746901|12377532|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0
7880357|NCT01746901|12377533|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0
7880358|NCT01746901|12377534|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0
7880359|NCT01746901|12377535|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0
7880360|NCT01746901|12377536|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0
7880361|NCT01746901|12377528|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0
7880362|NCT01746901|12377529|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2
7880363|NCT01746901|12377530|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1
7880364|NCT01746901|12377531|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0
7880365|NCT01746901|12377532|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0
7880366|NCT01746901|12377533|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0
7880367|NCT01746901|12377534|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0
7880368|NCT01746901|12377535|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0
7880369|NCT01746901|12377536|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0
7880370|NCT01746901|12377528|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7880371|NCT01746901|12377529|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
7880372|NCT01746901|12377530|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
7880373|NCT01746901|12377531|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7880374|NCT01746901|12377532|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7880375|NCT01746901|12377533|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7880376|NCT01746901|12377534|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7880377|NCT01746901|12377535|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7880378|NCT01746901|12377536|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7880379|NCT01746901|12377528|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0
7880380|NCT01746901|12377529|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3
7880381|NCT01746901|12377530|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3
7880382|NCT01746901|12377531|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0
7880383|NCT01746901|12377532|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0
7880384|NCT01746901|12377533|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0
7880385|NCT01746901|12377534|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0
7880386|NCT01746901|12377535|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0
7880387|NCT01746901|12377536|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0
7880388|NCT01746901|12377528|FG000|Treatment Phase: First Intervention|Protocol Violation|0
7880389|NCT01746901|12377529|FG001|Treatment Phase: First Intervention|Protocol Violation|0
7880390|NCT01746901|12377530|FG002|Treatment Phase: First Intervention|Protocol Violation|0
7880391|NCT01746901|12377531|FG003|Treatment Phase: First Intervention|Protocol Violation|0
7880392|NCT01746901|12377532|FG004|Treatment Phase: First Intervention|Protocol Violation|0
7880393|NCT01746901|12377533|FG005|Treatment Phase: First Intervention|Protocol Violation|0
7880394|NCT01746901|12377534|FG006|Treatment Phase: First Intervention|Protocol Violation|1
7880395|NCT01746901|12377535|FG007|Treatment Phase: First Intervention|Protocol Violation|0
7880396|NCT01746901|12377536|FG008|Treatment Phase: First Intervention|Protocol Violation|0
7880397|NCT01746901|12377528|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7880398|NCT01746901|12377529|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7880399|NCT01746901|12377530|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7880400|NCT01746901|12377531|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7880401|NCT01746901|12377532|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7880402|NCT01746901|12377533|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7880403|NCT01746901|12377534|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7880404|NCT01746901|12377535|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1
7880405|NCT01746901|12377536|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7880406|NCT01746901|12377528|FG000|Treatment Phase: Third Intervention|Protocol Violation|0
7880407|NCT01746901|12377529|FG001|Treatment Phase: Third Intervention|Protocol Violation|0
7880408|NCT01746901|12377530|FG002|Treatment Phase: Third Intervention|Protocol Violation|0
7880409|NCT01746901|12377531|FG003|Treatment Phase: Third Intervention|Protocol Violation|0
7880410|NCT01746901|12377532|FG004|Treatment Phase: Third Intervention|Protocol Violation|0
7880411|NCT01746901|12377533|FG005|Treatment Phase: Third Intervention|Protocol Violation|1
7880412|NCT01746901|12377534|FG006|Treatment Phase: Third Intervention|Protocol Violation|1
7880413|NCT01746901|12377535|FG007|Treatment Phase: Third Intervention|Protocol Violation|0
7880414|NCT01746901|12377536|FG008|Treatment Phase: Third Intervention|Protocol Violation|0
7880415|NCT01746901|12377528|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7880416|NCT01746901|12377529|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7880417|NCT01746901|12377530|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7880418|NCT01746901|12377531|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
7880419|NCT01746901|12377532|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7880420|NCT01746901|12377533|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7880421|NCT01746901|12377534|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7880422|NCT01746901|12377535|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7880423|NCT01746901|12377536|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7880424|NCT01746901|12377528|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0
7880425|NCT01746901|12377529|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0
7880426|NCT01746901|12377530|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0
7880427|NCT01746901|12377531|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0
7880428|NCT01746901|12377532|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0
7880429|NCT01746901|12377533|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1
7880430|NCT01746901|12377534|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0
7880431|NCT01746901|12377535|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0
7880432|NCT01746901|12377536|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1
7880433|NCT01746901|12377528|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0
7880434|NCT01746901|12377529|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0
7880435|NCT01746901|12377530|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0
7880436|NCT01746901|12377531|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0
7880437|NCT01746901|12377532|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0
7880438|NCT01746901|12377533|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0
7880439|NCT01746901|12377534|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1
7880440|NCT01746901|12377535|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0
7880441|NCT01746901|12377536|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1
7880442|NCT01747486|12377606|FG000|Stage 1|Physician Decision|3
7880443|NCT01747486|12377607|FG001|Stage 1|Physician Decision|0
7880444|NCT01747486|12377606|FG000|Stage 1|Withdrawal by Subject|4
7880445|NCT01747486|12377607|FG001|Stage 1|Withdrawal by Subject|3
7880446|NCT01747486|12377606|FG000|Stage 1|Disease progression|4
7880447|NCT01747486|12377607|FG001|Stage 1|Disease progression|9
7880448|NCT01747486|12377606|FG000|Stage 1|Death|1
7880449|NCT01747486|12377607|FG001|Stage 1|Death|1
7880450|NCT01747486|12377606|FG000|Stage 2|Physician Decision|2
7880451|NCT01747486|12377607|FG001|Stage 2|Physician Decision|0
7880452|NCT01747486|12377606|FG000|Stage 2|Withdrawal by Subject|1
7880453|NCT01747486|12377607|FG001|Stage 2|Withdrawal by Subject|0
7880454|NCT01747486|12377606|FG000|Stage 2|New Cancer Therapy|3
7880455|NCT01747486|12377607|FG001|Stage 2|New Cancer Therapy|0
7880456|NCT01747486|12377606|FG000|Stage 2|Disease Progression|3
7880457|NCT01747486|12377607|FG001|Stage 2|Disease Progression|0
7880458|NCT01747499|12377618|FG000|Overall Study|Steroid refractory aGvHD|1
7880459|NCT01747499|12377619|FG001|Overall Study|Steroid refractory aGvHD|0
7880460|NCT01747499|12377620|FG002|Overall Study|Steroid refractory aGvHD|0
7880461|NCT01747499|12377621|FG003|Overall Study|Steroid refractory aGvHD|1
7880462|NCT01747499|12377622|FG004|Overall Study|Steroid refractory aGvHD|4
7880463|NCT01747499|12377618|FG000|Overall Study|Physician Decision|0
7880464|NCT01747499|12377619|FG001|Overall Study|Physician Decision|1
7880465|NCT01747499|12377620|FG002|Overall Study|Physician Decision|0
7880466|NCT01747499|12377621|FG003|Overall Study|Physician Decision|0
7880467|NCT01747499|12377622|FG004|Overall Study|Physician Decision|2
7880468|NCT01747499|12377618|FG000|Overall Study|Death|0
7880469|NCT01747499|12377619|FG001|Overall Study|Death|0
7880470|NCT01747499|12377620|FG002|Overall Study|Death|0
7880471|NCT01747499|12377621|FG003|Overall Study|Death|1
7880472|NCT01747499|12377622|FG004|Overall Study|Death|1
7880473|NCT01747499|12377618|FG000|Overall Study|Withdrawal by Subject|0
7880474|NCT01747499|12377619|FG001|Overall Study|Withdrawal by Subject|0
7880475|NCT01747499|12377620|FG002|Overall Study|Withdrawal by Subject|0
7880476|NCT01747499|12377621|FG003|Overall Study|Withdrawal by Subject|0
7880477|NCT01747499|12377622|FG004|Overall Study|Withdrawal by Subject|6
7880478|NCT01747499|12377618|FG000|Overall Study|Developed AML and death|0
7880479|NCT01747499|12377619|FG001|Overall Study|Developed AML and death|0
7880480|NCT01747499|12377620|FG002|Overall Study|Developed AML and death|0
7880481|NCT01747499|12377621|FG003|Overall Study|Developed AML and death|0
7880482|NCT01747499|12377622|FG004|Overall Study|Developed AML and death|1
7880483|NCT01747499|12377618|FG000|Overall Study|Determined not to be eligible|0
7880484|NCT01747499|12377619|FG001|Overall Study|Determined not to be eligible|0
7880485|NCT01747499|12377620|FG002|Overall Study|Determined not to be eligible|0
7880486|NCT01747499|12377621|FG003|Overall Study|Determined not to be eligible|0
7880487|NCT01747499|12377622|FG004|Overall Study|Determined not to be eligible|1
7880488|NCT01747551|12377638|FG000|Overall Study|Progressive Disease|24
7880489|NCT01747551|12377639|FG001|Overall Study|Progressive Disease|17
7880490|NCT01747551|12377638|FG000|Overall Study|Death|3
7880491|NCT01747551|12377639|FG001|Overall Study|Death|1
7880492|NCT01747551|12377638|FG000|Overall Study|Adverse Event|7
7880493|NCT01747551|12377639|FG001|Overall Study|Adverse Event|1
7880494|NCT01747551|12377638|FG000|Overall Study|Prolonged Treatment Delay|2
7880495|NCT01747551|12377639|FG001|Overall Study|Prolonged Treatment Delay|0
7880496|NCT01747551|12377638|FG000|Overall Study|Withdrawal by Subject|3
7880497|NCT01747551|12377639|FG001|Overall Study|Withdrawal by Subject|1
7880498|NCT01747551|12377638|FG000|Overall Study|Physician Decision|2
7880499|NCT01747551|12377639|FG001|Overall Study|Physician Decision|1
7880500|NCT01747551|12377638|FG000|Overall Study|Other|2
7880501|NCT01747551|12377639|FG001|Overall Study|Other|0
7880502|NCT01747629|12377647|FG000|Overall Study|Adverse Event|1
7880503|NCT01747629|12377648|FG001|Overall Study|Adverse Event|2
7880504|NCT01747629|12377647|FG000|Overall Study|Withdrawal by Subject|2
7880505|NCT01747629|12377648|FG001|Overall Study|Withdrawal by Subject|2
7880506|NCT01747629|12377647|FG000|Overall Study|Noncompliance|1
7880507|NCT01747629|12377648|FG001|Overall Study|Noncompliance|1
7880508|NCT01747629|12377647|FG000|Overall Study|Inclusion criteria not met|1
7880509|NCT01747629|12377648|FG001|Overall Study|Inclusion criteria not met|0
7880510|NCT01747629|12377647|FG000|Overall Study|Not treated|1
7880511|NCT01747629|12377648|FG001|Overall Study|Not treated|0
7880512|NCT01747629|12377647|FG000|Overall Study|Other|2
7880513|NCT01747629|12377648|FG001|Overall Study|Other|1
7880514|NCT01747655|12377654|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
7880515|NCT01747655|12377655|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
7880516|NCT01747655|12377654|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8
7880517|NCT01747655|12377655|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0
7880518|NCT01747655|12377654|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
7880519|NCT01747655|12377655|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
7880520|NCT01747772|12377661|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
7880521|NCT01747811|12377671|FG000|Overall Study|Lack of Efficacy|2
7880522|NCT01747811|12377672|FG001|Overall Study|Lack of Efficacy|4
7880523|NCT01747837|12377682|FG000|Overall Study|Lost to Follow-up|5
7880524|NCT01747837|12377683|FG001|Overall Study|Lost to Follow-up|2
7880525|NCT01747837|12377682|FG000|Overall Study|Death|4
7880526|NCT01747837|12377683|FG001|Overall Study|Death|4
7880527|NCT01747876|12377717|FG000|Overall Study|Adverse Event|1
7880528|NCT01747876|12377718|FG001|Overall Study|Adverse Event|0
7880529|NCT01747876|12377719|FG002|Overall Study|Adverse Event|2
7880530|NCT01747876|12377717|FG000|Overall Study|Withdrawal by Subject|0
7880531|NCT01747876|12377718|FG001|Overall Study|Withdrawal by Subject|1
7880532|NCT01747876|12377719|FG002|Overall Study|Withdrawal by Subject|1
7880533|NCT01747876|12377717|FG000|Overall Study|Disease progression|4
7880534|NCT01747876|12377718|FG001|Overall Study|Disease progression|13
7880535|NCT01747876|12377719|FG002|Overall Study|Disease progression|8
7880536|NCT01747876|12377717|FG000|Overall Study|Trtment duration compl. as per protocol|0
7880537|NCT01747876|12377718|FG001|Overall Study|Trtment duration compl. as per protocol|1
7880538|NCT01747876|12377719|FG002|Overall Study|Trtment duration compl. as per protocol|1
7880539|NCT01747915|12377733|FG000|Overall Study|Other|1
7880540|NCT01747915|12377734|FG001|Overall Study|Other|1
7880541|NCT01747915|12377735|FG002|Overall Study|Other|1
7880542|NCT01747915|12377733|FG000|Overall Study|Adverse Event|8
7880543|NCT01747915|12377734|FG001|Overall Study|Adverse Event|5
7880544|NCT01747915|12377735|FG002|Overall Study|Adverse Event|2
7880545|NCT01747915|12377733|FG000|Overall Study|Death|0
7880546|NCT01747915|12377734|FG001|Overall Study|Death|0
7880547|NCT01747915|12377735|FG002|Overall Study|Death|1
7880548|NCT01747915|12377733|FG000|Overall Study|Lack of Efficacy|0
7880549|NCT01747915|12377734|FG001|Overall Study|Lack of Efficacy|1
7880550|NCT01747915|12377735|FG002|Overall Study|Lack of Efficacy|0
7880551|NCT01747915|12377733|FG000|Overall Study|Lost to Follow-up|1
7880552|NCT01747915|12377734|FG001|Overall Study|Lost to Follow-up|0
7880553|NCT01747915|12377735|FG002|Overall Study|Lost to Follow-up|0
7880554|NCT01747915|12377733|FG000|Overall Study|Withdrawal by Subject|4
7880555|NCT01747915|12377734|FG001|Overall Study|Withdrawal by Subject|4
7880556|NCT01747915|12377735|FG002|Overall Study|Withdrawal by Subject|1
7880557|NCT01747915|12377733|FG000|Overall Study|Protocol Violation|1
7880558|NCT01747915|12377734|FG001|Overall Study|Protocol Violation|0
7880559|NCT01747915|12377735|FG002|Overall Study|Protocol Violation|0
7880560|NCT01747915|12377733|FG000|Overall Study|Pregnancy|0
7880561|NCT01747915|12377734|FG001|Overall Study|Pregnancy|0
7880562|NCT01747915|12377735|FG002|Overall Study|Pregnancy|1
7880563|NCT01748071|12377795|FG000|Overall Study|Adverse Event|2
7880564|NCT01748071|12377796|FG001|Overall Study|Adverse Event|2
7880565|NCT01748071|12377797|FG002|Overall Study|Adverse Event|0
7880566|NCT01748292|12377816|FG000|Overall Study|Adverse Event|2
7880567|NCT01748292|12377817|FG001|Overall Study|Adverse Event|4
7880568|NCT01748292|12377816|FG000|Overall Study|Lost to Follow-up|0
7880569|NCT01748292|12377817|FG001|Overall Study|Lost to Follow-up|3
7880570|NCT01748292|12377816|FG000|Overall Study|Death|0
7880571|NCT01748292|12377817|FG001|Overall Study|Death|3
7880572|NCT01748292|12377816|FG000|Overall Study|Withdrawal by Subject|0
7880573|NCT01748292|12377817|FG001|Overall Study|Withdrawal by Subject|2
7880574|NCT01748552|12377835|FG000|Intervention Period 2 and Washout|Physician Decision|0
7880575|NCT01748552|12377836|FG001|Intervention Period 2 and Washout|Physician Decision|0
7880576|NCT01748552|12377837|FG002|Intervention Period 2 and Washout|Physician Decision|1
7880577|NCT01748552|12377838|FG003|Intervention Period 2 and Washout|Physician Decision|0
7880578|NCT01748552|12377839|FG004|Intervention Period 2 and Washout|Physician Decision|0
7880579|NCT01748552|12377840|FG005|Intervention Period 2 and Washout|Physician Decision|0
7880580|NCT01748552|12377841|FG006|Intervention Period 2 and Washout|Physician Decision|0
7880581|NCT01748552|12377842|FG007|Intervention Period 2 and Washout|Physician Decision|0
7880582|NCT01748552|12377843|FG008|Intervention Period 2 and Washout|Physician Decision|0
7880583|NCT01748552|12377844|FG009|Intervention Period 2 and Washout|Physician Decision|0
7880584|NCT01748552|12377845|FG010|Intervention Period 2 and Washout|Physician Decision|0
7880585|NCT01748552|12377846|FG011|Intervention Period 2 and Washout|Physician Decision|0
7880586|NCT01748552|12377835|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0
7880587|NCT01748552|12377836|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0
7880588|NCT01748552|12377837|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0
7880589|NCT01748552|12377838|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0
7880590|NCT01748552|12377839|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0
7880591|NCT01748552|12377840|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0
7880592|NCT01748552|12377841|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3
7880593|NCT01748552|12377842|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3
7880594|NCT01748552|12377843|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3
7880595|NCT01748552|12377844|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0
7880596|NCT01748552|12377845|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0
7880597|NCT01748552|12377846|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0
7880598|NCT01748760|12377904|FG000|Overall Study|Withdrawal by Subject|1
7880599|NCT01748760|12377905|FG001|Overall Study|Withdrawal by Subject|1
7880600|NCT01748760|12377904|FG000|Overall Study|Lost to Follow-up|5
7880601|NCT01748760|12377905|FG001|Overall Study|Lost to Follow-up|1
7880602|NCT01748825|12377962|FG000|Dose Escalation|Refused further treatment|2
7880603|NCT01748825|12377963|FG001|Dose Escalation|Refused further treatment|2
7880604|NCT01748825|12377964|FG002|Dose Escalation|Refused further treatment|0
7880605|NCT01748825|12377965|FG003|Dose Escalation|Refused further treatment|0
7880606|NCT01748825|12377966|FG004|Dose Escalation|Refused further treatment|1
7880607|NCT01748825|12377967|FG005|Dose Escalation|Refused further treatment|2
7880608|NCT01748825|12377968|FG006|Dose Escalation|Refused further treatment|0
7880609|NCT01748825|12377969|FG007|Dose Escalation|Refused further treatment|0
7880610|NCT01748825|12377970|FG008|Dose Escalation|Refused further treatment|0
7880611|NCT01748825|12377971|FG009|Dose Escalation|Refused further treatment|0
7880612|NCT01748825|12377962|FG000|Dose Escalation|Switched to alternative treatment|0
7880613|NCT01748825|12377963|FG001|Dose Escalation|Switched to alternative treatment|0
7880614|NCT01748825|12377964|FG002|Dose Escalation|Switched to alternative treatment|0
7880615|NCT01748825|12377965|FG003|Dose Escalation|Switched to alternative treatment|1
7880616|NCT01748825|12377966|FG004|Dose Escalation|Switched to alternative treatment|0
7880617|NCT01748825|12377967|FG005|Dose Escalation|Switched to alternative treatment|0
7880618|NCT01748825|12377968|FG006|Dose Escalation|Switched to alternative treatment|0
7880619|NCT01748825|12377969|FG007|Dose Escalation|Switched to alternative treatment|0
7880620|NCT01748825|12377970|FG008|Dose Escalation|Switched to alternative treatment|0
7880621|NCT01748825|12377971|FG009|Dose Escalation|Switched to alternative treatment|0
7880622|NCT01748825|12377962|FG000|Dose Escalation|Adverse Event|0
7880623|NCT01748825|12377963|FG001|Dose Escalation|Adverse Event|0
7880624|NCT01748825|12377964|FG002|Dose Escalation|Adverse Event|0
7880625|NCT01748825|12377965|FG003|Dose Escalation|Adverse Event|0
7880626|NCT01748825|12377966|FG004|Dose Escalation|Adverse Event|0
7880627|NCT01748825|12377967|FG005|Dose Escalation|Adverse Event|0
7880628|NCT01748825|12377968|FG006|Dose Escalation|Adverse Event|1
7880629|NCT01748825|12377969|FG007|Dose Escalation|Adverse Event|0
7880630|NCT01748825|12377970|FG008|Dose Escalation|Adverse Event|0
7880631|NCT01748825|12377971|FG009|Dose Escalation|Adverse Event|0
7880632|NCT01748825|12377962|FG000|Dose Expansion|Refused further treatment|0
7880633|NCT01748825|12377963|FG001|Dose Expansion|Refused further treatment|0
7880634|NCT01748825|12377964|FG002|Dose Expansion|Refused further treatment|0
7880635|NCT01748825|12377965|FG003|Dose Expansion|Refused further treatment|0
7880636|NCT01748825|12377966|FG004|Dose Expansion|Refused further treatment|0
7880637|NCT01748825|12377967|FG005|Dose Expansion|Refused further treatment|0
7880638|NCT01748825|12377968|FG006|Dose Expansion|Refused further treatment|0
7880639|NCT01748825|12377969|FG007|Dose Expansion|Refused further treatment|0
7880640|NCT01748825|12377970|FG008|Dose Expansion|Refused further treatment|1
7880641|NCT01748825|12377971|FG009|Dose Expansion|Refused further treatment|1
7880642|NCT01748825|12377962|FG000|Dose Expansion|Switched to alternative treatment|0
7880643|NCT01748825|12377963|FG001|Dose Expansion|Switched to alternative treatment|0
7880644|NCT01748825|12377964|FG002|Dose Expansion|Switched to alternative treatment|0
7880645|NCT01748825|12377965|FG003|Dose Expansion|Switched to alternative treatment|0
7880646|NCT01748825|12377966|FG004|Dose Expansion|Switched to alternative treatment|0
7880647|NCT01748825|12377967|FG005|Dose Expansion|Switched to alternative treatment|0
7880648|NCT01748825|12377968|FG006|Dose Expansion|Switched to alternative treatment|0
7880649|NCT01748825|12377969|FG007|Dose Expansion|Switched to alternative treatment|0
7880650|NCT01748825|12377970|FG008|Dose Expansion|Switched to alternative treatment|0
7880651|NCT01748825|12377971|FG009|Dose Expansion|Switched to alternative treatment|1
7880652|NCT01748825|12377962|FG000|Dose Expansion|Adverse Event|0
7880653|NCT01748825|12377963|FG001|Dose Expansion|Adverse Event|0
7880654|NCT01748825|12377964|FG002|Dose Expansion|Adverse Event|0
7880655|NCT01748825|12377965|FG003|Dose Expansion|Adverse Event|0
7880656|NCT01748825|12377966|FG004|Dose Expansion|Adverse Event|0
7880657|NCT01748825|12377967|FG005|Dose Expansion|Adverse Event|0
7880658|NCT01748825|12377968|FG006|Dose Expansion|Adverse Event|0
7880659|NCT01748825|12377969|FG007|Dose Expansion|Adverse Event|0
7880660|NCT01748825|12377970|FG008|Dose Expansion|Adverse Event|0
7880661|NCT01748825|12377971|FG009|Dose Expansion|Adverse Event|3
7880662|NCT01748825|12377962|FG000|Dose Expansion|Physician Decision|0
7880663|NCT01748825|12377963|FG001|Dose Expansion|Physician Decision|0
7880664|NCT01748825|12377964|FG002|Dose Expansion|Physician Decision|0
7880665|NCT01748825|12377965|FG003|Dose Expansion|Physician Decision|0
7880666|NCT01748825|12377966|FG004|Dose Expansion|Physician Decision|0
7880667|NCT01748825|12377967|FG005|Dose Expansion|Physician Decision|0
7880668|NCT01748825|12377968|FG006|Dose Expansion|Physician Decision|0
7880669|NCT01748825|12377969|FG007|Dose Expansion|Physician Decision|0
7880670|NCT01748825|12377970|FG008|Dose Expansion|Physician Decision|1
7880671|NCT01748825|12377971|FG009|Dose Expansion|Physician Decision|0
7880672|NCT01748994|12378033|FG000|Overall Study|Lost to Follow-up|8
7880673|NCT01748994|12378034|FG001|Overall Study|Lost to Follow-up|6
7880674|NCT01749033|12378043|FG000|Overall Study|Did not receive allocated intervention|3
7880675|NCT01749033|12378044|FG001|Overall Study|Did not receive allocated intervention|3
7880676|NCT01749033|12378045|FG002|Overall Study|Did not receive allocated intervention|0
7880677|NCT01749033|12378043|FG000|Overall Study|Lost to Follow-up|0
7880678|NCT01749033|12378044|FG001|Overall Study|Lost to Follow-up|2
7880679|NCT01749033|12378045|FG002|Overall Study|Lost to Follow-up|1
7883247|NCT01781286|12382903|FG005|Overall Study|Lost to Follow-up|1
7883248|NCT01781286|12382898|FG000|Overall Study|Time Constraints|2
7883249|NCT01781286|12382899|FG001|Overall Study|Time Constraints|0
7883250|NCT01781286|12382900|FG002|Overall Study|Time Constraints|2
7883251|NCT01781286|12382901|FG003|Overall Study|Time Constraints|0
7883252|NCT01781286|12382902|FG004|Overall Study|Time Constraints|0
7883253|NCT01781286|12382903|FG005|Overall Study|Time Constraints|0
7883254|NCT01781286|12382898|FG000|Overall Study|Noncompliance|0
7883255|NCT01781286|12382899|FG001|Overall Study|Noncompliance|0
7883256|NCT01781286|12382900|FG002|Overall Study|Noncompliance|0
7883257|NCT01781286|12382901|FG003|Overall Study|Noncompliance|1
7883258|NCT01781286|12382902|FG004|Overall Study|Noncompliance|0
7883259|NCT01781286|12382903|FG005|Overall Study|Noncompliance|0
7883260|NCT01781299|12382915|FG000|Overall Study|Withdrawal by Subject|0
7883261|NCT01781299|12382916|FG001|Overall Study|Withdrawal by Subject|1
7883262|NCT01781429|12382949|FG000|Overall Study|Death|0
7883263|NCT01781429|12382950|FG001|Overall Study|Death|0
7883264|NCT01781429|12382951|FG002|Overall Study|Death|0
7883265|NCT01781429|12382952|FG003|Overall Study|Death|0
7883266|NCT01781429|12382953|FG004|Overall Study|Death|0
7883267|NCT01781429|12382954|FG005|Overall Study|Death|0
7883268|NCT01781429|12382955|FG006|Overall Study|Death|0
7883269|NCT01781429|12382956|FG007|Overall Study|Death|0
7883270|NCT01781429|12382957|FG008|Overall Study|Death|0
7883271|NCT01781429|12382958|FG009|Overall Study|Death|1
7883272|NCT01781429|12382959|FG010|Overall Study|Death|0
7883273|NCT01781429|12382960|FG011|Overall Study|Death|0
7883274|NCT01781429|12382961|FG012|Overall Study|Death|1
7883275|NCT01781429|12382962|FG013|Overall Study|Death|0
7883276|NCT01781429|12382963|FG014|Overall Study|Death|1
7883277|NCT01781429|12382964|FG015|Overall Study|Death|0
7883278|NCT01781429|12382949|FG000|Overall Study|Withdrawal by Subject|0
7883279|NCT01781429|12382950|FG001|Overall Study|Withdrawal by Subject|0
7883280|NCT01781429|12382951|FG002|Overall Study|Withdrawal by Subject|0
7880680|NCT01749735|12378096|FG000|Overall Study|Withdrawal by Subject|1
7880681|NCT01749735|12378097|FG001|Overall Study|Withdrawal by Subject|0
7880682|NCT01749800|12378106|FG000|Overall Study|not meeting inclusion criteria|3
7880683|NCT01749800|12378107|FG001|Overall Study|not meeting inclusion criteria|0
7880684|NCT01749800|12378108|FG002|Overall Study|not meeting inclusion criteria|0
7880685|NCT01749800|12378106|FG000|Overall Study|Withdrawal by Subject|0
7880686|NCT01749800|12378107|FG001|Overall Study|Withdrawal by Subject|1
7880687|NCT01749800|12378108|FG002|Overall Study|Withdrawal by Subject|0
7880688|NCT01749982|12378151|FG000|Overall Study|Physician Decision|0
7880689|NCT01749982|12378152|FG001|Overall Study|Physician Decision|0
7880690|NCT01749982|12378153|FG002|Overall Study|Physician Decision|0
7880691|NCT01749982|12378154|FG003|Overall Study|Physician Decision|1
7880692|NCT01749982|12378151|FG000|Overall Study|Lost to Follow-up|0
7880693|NCT01749982|12378152|FG001|Overall Study|Lost to Follow-up|0
7880694|NCT01749982|12378153|FG002|Overall Study|Lost to Follow-up|0
7880695|NCT01749982|12378154|FG003|Overall Study|Lost to Follow-up|1
7880696|NCT01749982|12378151|FG000|Overall Study|Withdrawal by Subject|0
7880697|NCT01749982|12378152|FG001|Overall Study|Withdrawal by Subject|0
7880698|NCT01749982|12378153|FG002|Overall Study|Withdrawal by Subject|0
7880699|NCT01749982|12378154|FG003|Overall Study|Withdrawal by Subject|1
7880700|NCT01750190|12378179|FG000|Overall Study|Adverse Event|47
7880701|NCT01750190|12378180|FG001|Overall Study|Adverse Event|19
7880702|NCT01750190|12378179|FG000|Overall Study|Death|38
7880703|NCT01750190|12378180|FG001|Overall Study|Death|11
7880704|NCT01750190|12378179|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2
7880705|NCT01750190|12378180|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43
7880706|NCT01750190|12378179|FG000|Overall Study|Lost to Follow-up|28
7880707|NCT01750190|12378180|FG001|Overall Study|Lost to Follow-up|7
7880708|NCT01750190|12378179|FG000|Overall Study|Physician Decision|16
7880709|NCT01750190|12378180|FG001|Overall Study|Physician Decision|17
7880710|NCT01750190|12378179|FG000|Overall Study|Protocol Violation|6
7880711|NCT01750190|12378180|FG001|Overall Study|Protocol Violation|5
7880712|NCT01750190|12378179|FG000|Overall Study|Study/Site Terminated by Sponsor|4
7880713|NCT01750190|12378180|FG001|Overall Study|Study/Site Terminated by Sponsor|1
7880714|NCT01750190|12378179|FG000|Overall Study|Withdrawal by Subject|83
7880715|NCT01750190|12378180|FG001|Overall Study|Withdrawal by Subject|89
7880716|NCT01750190|12378179|FG000|Overall Study|Kidney Transplant|8
7880717|NCT01750190|12378180|FG001|Overall Study|Kidney Transplant|4
7880718|NCT01750190|12378179|FG000|Overall Study|Dialysis|22
7880719|NCT01750190|12378180|FG001|Overall Study|Dialysis|8
7880720|NCT01750190|12378179|FG000|Overall Study|Other than Specified|13
7880721|NCT01750190|12378180|FG001|Overall Study|Other than Specified|4
7880722|NCT01750229|12378186|FG000|Randomized Crossover Phase|Adverse Event|1
7880723|NCT01750229|12378186|FG000|Randomized Crossover Phase|Withdrawal by Subject|1
7880724|NCT01750229|12378186|FG000|Long-term Follow-up Phase|Adverse Event|2
7880725|NCT01750229|12378186|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1
7880726|NCT01750242|12378196|FG000|Overall Study|Unreadable Images|3
7880727|NCT01750268|12378213|FG000|Overall Study|Lost to Follow-up|0
7880728|NCT01750268|12378214|FG001|Overall Study|Lost to Follow-up|2
7880729|NCT01750268|12378213|FG000|Overall Study|Physician Decision|0
7880730|NCT01750268|12378214|FG001|Overall Study|Physician Decision|3
7880731|NCT01750268|12378213|FG000|Overall Study|Withdrawal by Subject|2
7880732|NCT01750268|12378214|FG001|Overall Study|Withdrawal by Subject|0
7880733|NCT01750294|12378220|FG000|Overall Study|Withdrawal by Subject|1
7880734|NCT01750294|12378220|FG000|Overall Study|Safety Endpoint|1
7880735|NCT01750346|12378227|FG000|Overall Study|Adverse Event|1
7880736|NCT01750346|12378228|FG001|Overall Study|Adverse Event|0
7880737|NCT01750346|12378229|FG002|Overall Study|Adverse Event|0
7880738|NCT01750684|12378257|FG000|Overall Study|Death|1
7880739|NCT01750684|12378258|FG001|Overall Study|Death|0
7880740|NCT01750684|12378257|FG000|Overall Study|Non-compliance with Study Drug|0
7880741|NCT01750684|12378258|FG001|Overall Study|Non-compliance with Study Drug|1
7880742|NCT01750684|12378257|FG000|Overall Study|Withdrawn by Sponsor|0
7880743|NCT01750684|12378258|FG001|Overall Study|Withdrawn by Sponsor|1
7880744|NCT01750684|12378257|FG000|Overall Study|Protocol Violation|1
7880745|NCT01750684|12378258|FG001|Overall Study|Protocol Violation|0
7880746|NCT01750697|12378265|FG000|Overall Study|Transferred Back to Local Hospital|1
7880747|NCT01750697|12378265|FG000|Overall Study|Physician and Family Decision|1
7880748|NCT01750697|12378265|FG000|Overall Study|Transferred to Adult Services|5
7880749|NCT01750697|12378265|FG000|Overall Study|Physician Decision|1
7880750|NCT01750697|12378265|FG000|Overall Study|Withdrawal by Subject|1
7880751|NCT01750840|12378272|FG000|Overall Study|Lost to Follow-up|4
7880752|NCT01750879|12378279|FG000|Overall Study|Adverse Event|8
7880753|NCT01750879|12378280|FG001|Overall Study|Adverse Event|0
7880754|NCT01750879|12378279|FG000|Overall Study|Lack of Efficacy|1
7880755|NCT01750879|12378280|FG001|Overall Study|Lack of Efficacy|0
7880756|NCT01750879|12378279|FG000|Overall Study|Withdrawal by Subject|1
7880757|NCT01750879|12378280|FG001|Overall Study|Withdrawal by Subject|0
7880758|NCT01750879|12378279|FG000|Overall Study|Did not complete per protocol|0
7880759|NCT01750879|12378280|FG001|Overall Study|Did not complete per protocol|3
7880760|NCT01750918|12378307|FG000|Overall Study|Last patient transitioned to a rollover protocol|0
7880761|NCT01750918|12378308|FG001|Overall Study|Last patient transitioned to a rollover protocol|0
7880762|NCT01750918|12378309|FG002|Overall Study|Last patient transitioned to a rollover protocol|5
7880763|NCT01750918|12378310|FG003|Overall Study|Last patient transitioned to a rollover protocol|2
7880764|NCT01750918|12378311|FG004|Overall Study|Last patient transitioned to a rollover protocol|0
7880765|NCT01750918|12378312|FG005|Overall Study|Last patient transitioned to a rollover protocol|2
7880766|NCT01750918|12378313|FG006|Overall Study|Last patient transitioned to a rollover protocol|1
7880767|NCT01750918|12378314|FG007|Overall Study|Last patient transitioned to a rollover protocol|1
7880768|NCT01750918|12378307|FG000|Overall Study|Lost to Follow-up|0
7880769|NCT01750918|12378308|FG001|Overall Study|Lost to Follow-up|0
7880770|NCT01750918|12378309|FG002|Overall Study|Lost to Follow-up|2
7880771|NCT01750918|12378310|FG003|Overall Study|Lost to Follow-up|2
7880772|NCT01750918|12378311|FG004|Overall Study|Lost to Follow-up|0
7880773|NCT01750918|12378312|FG005|Overall Study|Lost to Follow-up|0
7880774|NCT01750918|12378313|FG006|Overall Study|Lost to Follow-up|0
7880775|NCT01750918|12378314|FG007|Overall Study|Lost to Follow-up|1
7880776|NCT01750918|12378307|FG000|Overall Study|Withdrawal by Subject|0
7880777|NCT01750918|12378308|FG001|Overall Study|Withdrawal by Subject|0
7880778|NCT01750918|12378309|FG002|Overall Study|Withdrawal by Subject|1
7880779|NCT01750918|12378310|FG003|Overall Study|Withdrawal by Subject|2
7880780|NCT01750918|12378311|FG004|Overall Study|Withdrawal by Subject|1
7880781|NCT01750918|12378312|FG005|Overall Study|Withdrawal by Subject|1
7880782|NCT01750918|12378313|FG006|Overall Study|Withdrawal by Subject|2
7880783|NCT01750918|12378314|FG007|Overall Study|Withdrawal by Subject|2
7880784|NCT01751061|12378385|FG000|Overall Study|Death|1
7880785|NCT01751061|12378386|FG001|Overall Study|Death|0
7880786|NCT01751061|12378385|FG000|Overall Study|patient death|5
7880787|NCT01751061|12378386|FG001|Overall Study|patient death|0
7880788|NCT01751061|12378385|FG000|Overall Study|Lost to Follow-up|40
7880789|NCT01751061|12378386|FG001|Overall Study|Lost to Follow-up|25
7880790|NCT01751061|12378385|FG000|Overall Study|patient regained decisional capacity|4
7880791|NCT01751061|12378386|FG001|Overall Study|patient regained decisional capacity|8
7880792|NCT01751061|12378385|FG000|Overall Study|Withdrawal by Subject|4
7880793|NCT01751061|12378386|FG001|Overall Study|Withdrawal by Subject|1
7880794|NCT01751061|12378385|FG000|Overall Study|Physician Decision|2
7880795|NCT01751061|12378386|FG001|Overall Study|Physician Decision|0
7880796|NCT01751087|12378395|FG000|Overall Study|Withdrawal by Subject|1
7880797|NCT01751087|12378396|FG001|Overall Study|Withdrawal by Subject|0
7880798|NCT01751087|12378397|FG002|Overall Study|Withdrawal by Subject|0
7880799|NCT01751087|12378395|FG000|Overall Study|Physician Decision|0
7880800|NCT01751087|12378396|FG001|Overall Study|Physician Decision|0
7880801|NCT01751087|12378397|FG002|Overall Study|Physician Decision|1
7880802|NCT01751113|12378405|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0
7880803|NCT01751113|12378406|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0
7880804|NCT01751113|12378407|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0
7880805|NCT01751113|12378408|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1
7880806|NCT01751113|12378409|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1
7880807|NCT01751113|12378410|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0
7880808|NCT01751113|12378405|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0
7880809|NCT01751113|12378406|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0
7880810|NCT01751113|12378407|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0
7880811|NCT01751113|12378408|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0
7880812|NCT01751113|12378409|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0
7880813|NCT01751113|12378410|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1
7880814|NCT01751139|12378419|FG000|Overall Study|Other|135
7880815|NCT01751139|12378419|FG000|Overall Study|Sponsor study termination|1609
7880816|NCT01751139|12378419|FG000|Overall Study|Lost to Follow-up|240
7880817|NCT01751139|12378419|FG000|Overall Study|Withdrawal by Subject|251
7880818|NCT01751139|12378419|FG000|Overall Study|Adverse Event|1
7880819|NCT01751139|12378419|FG000|Overall Study|Death|31
7880820|NCT01751165|12378426|FG000|Overall Study|Adverse event, serious fatal|1
7880821|NCT01751165|12378427|FG001|Overall Study|Adverse event, serious fatal|0
7880822|NCT01751165|12378428|FG002|Overall Study|Adverse event, serious fatal|1
7880823|NCT01751165|12378426|FG000|Overall Study|Withdrawal by Subject|0
7880824|NCT01751165|12378427|FG001|Overall Study|Withdrawal by Subject|0
7880825|NCT01751165|12378428|FG002|Overall Study|Withdrawal by Subject|1
7880826|NCT01751165|12378426|FG000|Overall Study|Serious adverse event|0
7880827|NCT01751165|12378427|FG001|Overall Study|Serious adverse event|2
7880828|NCT01751165|12378428|FG002|Overall Study|Serious adverse event|0
7880829|NCT01751165|12378426|FG000|Overall Study|Lost to Follow-up|1
7880830|NCT01751165|12378427|FG001|Overall Study|Lost to Follow-up|1
7880831|NCT01751165|12378428|FG002|Overall Study|Lost to Follow-up|1
7880832|NCT01751178|12378441|FG000|Overall Study|Adverse Event|2
7880833|NCT01751178|12378442|FG001|Overall Study|Adverse Event|0
7880834|NCT01751178|12378443|FG002|Overall Study|Adverse Event|0
7880835|NCT01751178|12378441|FG000|Overall Study|Other Reason (unknown)|1
7880836|NCT01751178|12378442|FG001|Overall Study|Other Reason (unknown)|0
7880837|NCT01751178|12378443|FG002|Overall Study|Other Reason (unknown)|2
7880838|NCT01751412|12378519|FG000|Overall Study|Disease Progression Before Treatment|1
7880839|NCT01751568|12378539|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1
7880840|NCT01751568|12378540|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
7880841|NCT01751568|12378541|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
7880842|NCT01751646|12378551|FG000|Overall Study|Lost to Follow-up|5
7880843|NCT01751646|12378552|FG001|Overall Study|Lost to Follow-up|1
7880844|NCT01751646|12378551|FG000|Overall Study|Withdrawal by Subject|0
7880845|NCT01751646|12378552|FG001|Overall Study|Withdrawal by Subject|4
7880846|NCT01751646|12378551|FG000|Overall Study|Starting hormone therapy|1
7880847|NCT01751646|12378552|FG001|Overall Study|Starting hormone therapy|0
7880848|NCT01751646|12378551|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2
7880849|NCT01751646|12378552|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3
7880850|NCT01751646|12378551|FG000|Overall Study|Inadvertent enrollment|1
7880851|NCT01751646|12378552|FG001|Overall Study|Inadvertent enrollment|1
7880852|NCT01751646|12378551|FG000|Overall Study|Moved out of the area|1
7880853|NCT01751646|12378552|FG001|Overall Study|Moved out of the area|5
7880854|NCT01751646|12378551|FG000|Overall Study|Inability to attend required visits|0
7880855|NCT01751646|12378552|FG001|Overall Study|Inability to attend required visits|1
7880856|NCT01751646|12378551|FG000|Overall Study|Off study due to multiple obligations|0
7880857|NCT01751646|12378552|FG001|Overall Study|Off study due to multiple obligations|1
7880858|NCT01751646|12378551|FG000|Overall Study|Fails to comply with study requirements|0
7880859|NCT01751646|12378552|FG001|Overall Study|Fails to comply with study requirements|1
7880860|NCT01751646|12378551|FG000|Overall Study|Childcare issues|1
7880861|NCT01751646|12378552|FG001|Overall Study|Childcare issues|1
7880862|NCT01751724|12378564|FG000|Overall Study|extubated bef.start assigned treatment|1
7880863|NCT01751724|12378565|FG001|Overall Study|extubated bef.start assigned treatment|0
7880864|NCT01751724|12378564|FG000|Overall Study|withdrawn by parent|0
7880865|NCT01751724|12378565|FG001|Overall Study|withdrawn by parent|2
7880866|NCT01751802|12378573|FG000|Overall Study|Adverse Event|4
7880867|NCT01751802|12378574|FG001|Overall Study|Adverse Event|2
7880868|NCT01751867|12378588|FG000|Overall Study|Completed treatment,dropped in follow-up|4
7880869|NCT01751867|12378589|FG001|Overall Study|Completed treatment,dropped in follow-up|8
7880870|NCT01751867|12378588|FG000|Overall Study|Diease Progression|4
7880871|NCT01751867|12378589|FG001|Overall Study|Diease Progression|18
7880872|NCT01751867|12378588|FG000|Overall Study|Adverse Event|8
7880873|NCT01751867|12378589|FG001|Overall Study|Adverse Event|15
7880874|NCT01751867|12378588|FG000|Overall Study|Poor Compliance|0
7880875|NCT01751867|12378589|FG001|Overall Study|Poor Compliance|5
7880876|NCT01751867|12378588|FG000|Overall Study|Withdrawal by Subject|3
7880877|NCT01751867|12378589|FG001|Overall Study|Withdrawal by Subject|1
7880878|NCT01751867|12378588|FG000|Overall Study|Physician Decision|4
7880879|NCT01751867|12378589|FG001|Overall Study|Physician Decision|7
7880880|NCT01751867|12378588|FG000|Overall Study|Protocol Violation|0
7880881|NCT01751867|12378589|FG001|Overall Study|Protocol Violation|2
7880882|NCT01751867|12378588|FG000|Overall Study|Death|0
7880883|NCT01751867|12378589|FG001|Overall Study|Death|5
7880884|NCT01751867|12378588|FG000|Overall Study|Other|11
7880885|NCT01751867|12378589|FG001|Overall Study|Other|37
7880886|NCT01751867|12378588|FG000|Overall Study|Randomized but not treated.|2
7880887|NCT01751867|12378589|FG001|Overall Study|Randomized but not treated.|1
7880888|NCT01752036|12378610|FG000|Overall Study|Death|2
7880889|NCT01752634|12378638|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
7880890|NCT01752634|12378639|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
7880891|NCT01752634|12378640|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
7880892|NCT01752634|12378641|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
7880893|NCT01752634|12378642|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
7880894|NCT01752634|12378643|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3
7880895|NCT01752634|12378638|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0
7880896|NCT01752634|12378639|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1
7880897|NCT01752634|12378640|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0
7880898|NCT01752634|12378641|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0
7880899|NCT01752634|12378642|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0
7880900|NCT01752634|12378643|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0
7880901|NCT01752634|12378638|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2
7880902|NCT01752634|12378639|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
7880903|NCT01752634|12378640|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
7880904|NCT01752634|12378641|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
7880905|NCT01752634|12378642|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
7880906|NCT01752634|12378643|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
7880907|NCT01752634|12378638|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3
7880908|NCT01752634|12378639|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0
7880909|NCT01752634|12378640|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2
7880910|NCT01752634|12378641|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0
7880911|NCT01752634|12378642|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0
7880912|NCT01752634|12378643|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4
7880913|NCT01752634|12378638|FG000|Week 24 to Week 260|Lack of Efficacy|15
7880914|NCT01752634|12378639|FG001|Week 24 to Week 260|Lack of Efficacy|7
7880915|NCT01752634|12378640|FG002|Week 24 to Week 260|Lack of Efficacy|7
7880916|NCT01752634|12378641|FG003|Week 24 to Week 260|Lack of Efficacy|3
7880917|NCT01752634|12378642|FG004|Week 24 to Week 260|Lack of Efficacy|4
7880918|NCT01752634|12378643|FG005|Week 24 to Week 260|Lack of Efficacy|0
7880919|NCT01752634|12378638|FG000|Week 24 to Week 260|Subject/guardian decision|12
7880920|NCT01752634|12378639|FG001|Week 24 to Week 260|Subject/guardian decision|10
7880921|NCT01752634|12378640|FG002|Week 24 to Week 260|Subject/guardian decision|9
7880922|NCT01752634|12378641|FG003|Week 24 to Week 260|Subject/guardian decision|5
7880923|NCT01752634|12378642|FG004|Week 24 to Week 260|Subject/guardian decision|5
7880924|NCT01752634|12378643|FG005|Week 24 to Week 260|Subject/guardian decision|0
7880925|NCT01752634|12378638|FG000|Week 24 to Week 260|Physician Decision|1
7880926|NCT01752634|12378639|FG001|Week 24 to Week 260|Physician Decision|2
7880927|NCT01752634|12378640|FG002|Week 24 to Week 260|Physician Decision|4
7880928|NCT01752634|12378641|FG003|Week 24 to Week 260|Physician Decision|2
7880929|NCT01752634|12378642|FG004|Week 24 to Week 260|Physician Decision|1
7880930|NCT01752634|12378643|FG005|Week 24 to Week 260|Physician Decision|0
7880931|NCT01752634|12378638|FG000|Week 24 to Week 260|Death|0
7880932|NCT01752634|12378639|FG001|Week 24 to Week 260|Death|1
7880933|NCT01752634|12378640|FG002|Week 24 to Week 260|Death|0
7880934|NCT01752634|12378641|FG003|Week 24 to Week 260|Death|0
7880935|NCT01752634|12378642|FG004|Week 24 to Week 260|Death|0
7880936|NCT01752634|12378643|FG005|Week 24 to Week 260|Death|0
7880937|NCT01752634|12378638|FG000|Week 24 to Week 260|Pregnancy|0
7880938|NCT01752634|12378639|FG001|Week 24 to Week 260|Pregnancy|0
7880939|NCT01752634|12378640|FG002|Week 24 to Week 260|Pregnancy|1
7880940|NCT01752634|12378641|FG003|Week 24 to Week 260|Pregnancy|0
7880941|NCT01752634|12378642|FG004|Week 24 to Week 260|Pregnancy|0
7880942|NCT01752634|12378643|FG005|Week 24 to Week 260|Pregnancy|0
7880943|NCT01752634|12378638|FG000|Week 24 to Week 260|Noncompliance with study treatment|0
7880944|NCT01752634|12378639|FG001|Week 24 to Week 260|Noncompliance with study treatment|0
7880945|NCT01752634|12378640|FG002|Week 24 to Week 260|Noncompliance with study treatment|1
7880946|NCT01752634|12378641|FG003|Week 24 to Week 260|Noncompliance with study treatment|0
7880947|NCT01752634|12378642|FG004|Week 24 to Week 260|Noncompliance with study treatment|0
7880948|NCT01752634|12378643|FG005|Week 24 to Week 260|Noncompliance with study treatment|0
7880949|NCT01752634|12378638|FG000|Week 24 to Week 260|Lost to Follow-up|2
7880950|NCT01752634|12378639|FG001|Week 24 to Week 260|Lost to Follow-up|2
7880951|NCT01752634|12378640|FG002|Week 24 to Week 260|Lost to Follow-up|3
7880952|NCT01752634|12378641|FG003|Week 24 to Week 260|Lost to Follow-up|0
7880953|NCT01752634|12378642|FG004|Week 24 to Week 260|Lost to Follow-up|2
7880954|NCT01752634|12378643|FG005|Week 24 to Week 260|Lost to Follow-up|0
7880955|NCT01752634|12378638|FG000|Week 24 to Week 260|Adverse Event|4
7880956|NCT01752634|12378639|FG001|Week 24 to Week 260|Adverse Event|8
7880957|NCT01752634|12378640|FG002|Week 24 to Week 260|Adverse Event|8
7880958|NCT01752634|12378641|FG003|Week 24 to Week 260|Adverse Event|4
7880959|NCT01752634|12378642|FG004|Week 24 to Week 260|Adverse Event|2
7880960|NCT01752634|12378643|FG005|Week 24 to Week 260|Adverse Event|0
7880961|NCT01752842|12378664|FG000|Overall Study|Adverse Event|3
7880962|NCT01752842|12378665|FG001|Overall Study|Adverse Event|0
7880963|NCT01752842|12378664|FG000|Overall Study|Withdrawal by Subject|0
7880964|NCT01752842|12378665|FG001|Overall Study|Withdrawal by Subject|2
7880965|NCT01752855|12378673|FG000|Overall Study|Adverse Event|1
7880966|NCT01752855|12378674|FG001|Overall Study|Adverse Event|0
7880967|NCT01752855|12378673|FG000|Overall Study|Withdrew Consent|0
7880968|NCT01752855|12378674|FG001|Overall Study|Withdrew Consent|2
7880969|NCT01752855|12378673|FG000|Overall Study|Lack of Efficacy|0
7880970|NCT01752855|12378674|FG001|Overall Study|Lack of Efficacy|2
7880971|NCT01752907|12378682|FG000|Overall Study|Withdrawal by Subject|4
7880972|NCT01752907|12378683|FG001|Overall Study|Withdrawal by Subject|10
7880973|NCT01752907|12378682|FG000|Overall Study|Lost to Follow-up|2
7880974|NCT01752907|12378683|FG001|Overall Study|Lost to Follow-up|1
7880975|NCT01752907|12378682|FG000|Overall Study|Decision by Sponsor|6
7880976|NCT01752907|12378683|FG001|Overall Study|Decision by Sponsor|9
7880977|NCT01752933|12378691|FG000|Treatment|Disease Progression|3
7880978|NCT01752933|12378692|FG001|Treatment|Disease Progression|29
7880979|NCT01752933|12378691|FG000|Treatment|Withdrawal by Subject|0
7880980|NCT01752933|12378692|FG001|Treatment|Withdrawal by Subject|5
7880981|NCT01752933|12378691|FG000|Treatment|Adverse Event|1
7880982|NCT01752933|12378692|FG001|Treatment|Adverse Event|4
7880983|NCT01752933|12378691|FG000|Treatment|Physician Decision|0
7880984|NCT01752933|12378692|FG001|Treatment|Physician Decision|3
7880985|NCT01752933|12378691|FG000|Treatment|Death|0
7880986|NCT01752933|12378692|FG001|Treatment|Death|2
7880987|NCT01752933|12378691|FG000|Treatment|Hepatocellular carcinoma not confirmed|0
7880988|NCT01752933|12378692|FG001|Treatment|Hepatocellular carcinoma not confirmed|1
7880989|NCT01752933|12378691|FG000|Treatment|Patient noncompliant|0
7880990|NCT01752933|12378692|FG001|Treatment|Patient noncompliant|1
7880991|NCT01752933|12378691|FG000|Treatment|Patient unable to travel to appointments|0
7880992|NCT01752933|12378692|FG001|Treatment|Patient unable to travel to appointments|1
7880993|NCT01752933|12378691|FG000|Overall Study and Follow-up|Death|4
7880994|NCT01752933|12378692|FG001|Overall Study and Follow-up|Death|34
7880995|NCT01752933|12378691|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0
7880996|NCT01752933|12378692|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7
7880997|NCT01752933|12378691|FG000|Overall Study and Follow-up|Withdrawal by Subject|0
7880998|NCT01752933|12378692|FG001|Overall Study and Follow-up|Withdrawal by Subject|3
7880999|NCT01752933|12378691|FG000|Overall Study and Follow-up|Lost to Follow-up|0
7881000|NCT01752933|12378692|FG001|Overall Study and Follow-up|Lost to Follow-up|2
7881001|NCT01752985|12378702|FG000|Treatment Period|Subject request to discontinue treatment|1
7881002|NCT01752985|12378703|FG001|Treatment Period|Subject request to discontinue treatment|0
7881003|NCT01752985|12378704|FG002|Treatment Period|Subject request to discontinue treatment|1
7881004|NCT01752985|12378702|FG000|Treatment Period|Subject no longer meets study criteria|0
7881005|NCT01752985|12378703|FG001|Treatment Period|Subject no longer meets study criteria|1
7881006|NCT01752985|12378704|FG002|Treatment Period|Subject no longer meets study criteria|1
7881007|NCT01752985|12378702|FG000|Treatment Period|Adverse Event|2
7881008|NCT01752985|12378703|FG001|Treatment Period|Adverse Event|1
7881009|NCT01752985|12378704|FG002|Treatment Period|Adverse Event|2
7881010|NCT01752985|12378702|FG000|Treatment Period|Withdrawal by Subject|1
7881011|NCT01752985|12378703|FG001|Treatment Period|Withdrawal by Subject|1
7881012|NCT01752985|12378704|FG002|Treatment Period|Withdrawal by Subject|0
7881013|NCT01752985|12378702|FG000|Treatment Period|Lost to Follow-up|0
7881014|NCT01752985|12378703|FG001|Treatment Period|Lost to Follow-up|0
7881015|NCT01752985|12378704|FG002|Treatment Period|Lost to Follow-up|1
7881016|NCT01753076|12378714|FG000|Overall Study|Adverse Event|17
7881017|NCT01753076|12378715|FG001|Overall Study|Adverse Event|18
7881018|NCT01753076|12378714|FG000|Overall Study|Lack of Efficacy|3
7881019|NCT01753076|12378715|FG001|Overall Study|Lack of Efficacy|1
7881020|NCT01753076|12378714|FG000|Overall Study|Lost to Follow-up|2
7881021|NCT01753076|12378715|FG001|Overall Study|Lost to Follow-up|1
7881022|NCT01753076|12378714|FG000|Overall Study|Physician Decision|4
7881023|NCT01753076|12378715|FG001|Overall Study|Physician Decision|2
7881024|NCT01753076|12378714|FG000|Overall Study|Withdrawal by Subject|14
7881025|NCT01753076|12378715|FG001|Overall Study|Withdrawal by Subject|24
7881026|NCT01753076|12378714|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1
7881027|NCT01753076|12378715|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0
7881028|NCT01753115|12378726|FG000|Overall Study|Lost to Follow-up|3
7881029|NCT01753115|12378727|FG001|Overall Study|Lost to Follow-up|6
7881030|NCT01753115|12378728|FG002|Overall Study|Lost to Follow-up|8
7881031|NCT01753115|12378726|FG000|Overall Study|Withdrawal by Subject|6
7881032|NCT01753115|12378727|FG001|Overall Study|Withdrawal by Subject|5
7881033|NCT01753115|12378728|FG002|Overall Study|Withdrawal by Subject|6
7881034|NCT01753115|12378726|FG000|Overall Study|Subject non-compliant|3
7881035|NCT01753115|12378727|FG001|Overall Study|Subject non-compliant|3
7881036|NCT01753115|12378728|FG002|Overall Study|Subject non-compliant|0
7881037|NCT01753115|12378726|FG000|Overall Study|Used excluded drug|0
7881038|NCT01753115|12378727|FG001|Overall Study|Used excluded drug|1
7881039|NCT01753115|12378728|FG002|Overall Study|Used excluded drug|0
7881040|NCT01753193|12378736|FG000|Overall Study|Withdrawal by Subject|23
7881041|NCT01753193|12378736|FG000|Overall Study|Lost to Follow-up|6
7881042|NCT01753193|12378736|FG000|Overall Study|Death|1
7881043|NCT01753193|12378736|FG000|Overall Study|Other|16
7881044|NCT01753297|12378742|FG000|Overall Study|Lost to Follow-up|7
7881045|NCT01753297|12378743|FG001|Overall Study|Lost to Follow-up|2
7881046|NCT01753297|12378742|FG000|Overall Study|Withdrawal by Subject|26
7881047|NCT01753297|12378743|FG001|Overall Study|Withdrawal by Subject|23
7881048|NCT01753297|12378742|FG000|Overall Study|Adverse Event (up to Month 36)|1
7881049|NCT01753297|12378743|FG001|Overall Study|Adverse Event (up to Month 36)|1
7881050|NCT01753297|12378742|FG000|Overall Study|Death|0
7881051|NCT01753297|12378743|FG001|Overall Study|Death|2
7881052|NCT01753297|12378742|FG000|Overall Study|Did not attend end of study visit|7
7881053|NCT01753297|12378743|FG001|Overall Study|Did not attend end of study visit|8
7881054|NCT01753310|12378753|FG000|Overall Study|Entered into open label extension study|25
7881055|NCT01753310|12378754|FG001|Overall Study|Entered into open label extension study|22
7881056|NCT01753310|12378753|FG000|Overall Study|Adverse Event|1
7881057|NCT01753310|12378754|FG001|Overall Study|Adverse Event|0
7881058|NCT01753310|12378753|FG000|Overall Study|Lost to Follow-up|2
7881059|NCT01753310|12378754|FG001|Overall Study|Lost to Follow-up|0
7881060|NCT01753310|12378753|FG000|Overall Study|Subject decision|2
7881061|NCT01753310|12378754|FG001|Overall Study|Subject decision|2
7881062|NCT01753310|12378753|FG000|Overall Study|Sponsor decision|1
7881063|NCT01753310|12378754|FG001|Overall Study|Sponsor decision|0
7881064|NCT01753310|12378753|FG000|Overall Study|Withdrawal by Subject|1
7881065|NCT01753310|12378754|FG001|Overall Study|Withdrawal by Subject|0
7881066|NCT01753323|12378763|FG000|Overall Study|Lack of Efficacy|0
7881067|NCT01753323|12378764|FG001|Overall Study|Lack of Efficacy|0
7881068|NCT01753323|12378765|FG002|Overall Study|Lack of Efficacy|8
7881069|NCT01753323|12378763|FG000|Overall Study|Protocol deviation|1
7881070|NCT01753323|12378764|FG001|Overall Study|Protocol deviation|0
7881071|NCT01753323|12378765|FG002|Overall Study|Protocol deviation|0
7881072|NCT01753323|12378763|FG000|Overall Study|Adverse Event|0
7881073|NCT01753323|12378764|FG001|Overall Study|Adverse Event|0
7881074|NCT01753323|12378765|FG002|Overall Study|Adverse Event|1
7881075|NCT01753336|12378774|FG000|Overall Study|Patient decision|12
7881076|NCT01753336|12378774|FG000|Overall Study|Lost to Follow-up|3
7881077|NCT01753336|12378774|FG000|Overall Study|Physician Decision|2
7881078|NCT01753336|12378774|FG000|Overall Study|Sponsor's decision|2
7881079|NCT01753336|12378774|FG000|Overall Study|Withdrawal by Subject|1
7881080|NCT01753401|12378789|FG000|Double-blind Period (8 Weeks)|Adverse Event|0
7881081|NCT01753401|12378790|FG001|Double-blind Period (8 Weeks)|Adverse Event|2
7881082|NCT01753401|12378791|FG002|Double-blind Period (8 Weeks)|Adverse Event|0
7881083|NCT01753401|12378792|FG003|Double-blind Period (8 Weeks)|Adverse Event|0
7881084|NCT01753401|12378789|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
7881085|NCT01753401|12378790|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
7881086|NCT01753401|12378791|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
7881087|NCT01753401|12378792|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
7881088|NCT01753401|12378789|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0
7881089|NCT01753401|12378790|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1
7881090|NCT01753401|12378791|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0
7881091|NCT01753401|12378792|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0
7881092|NCT01753401|12378789|FG000|Open Label Period (44 Weeks)|Adverse Event|0
7881093|NCT01753401|12378790|FG001|Open Label Period (44 Weeks)|Adverse Event|0
7881094|NCT01753401|12378791|FG002|Open Label Period (44 Weeks)|Adverse Event|3
7881095|NCT01753401|12378792|FG003|Open Label Period (44 Weeks)|Adverse Event|4
7881096|NCT01753401|12378789|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0
7881097|NCT01753401|12378790|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0
7881098|NCT01753401|12378791|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0
7881099|NCT01753401|12378792|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2
7881100|NCT01753401|12378789|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0
7881101|NCT01753401|12378790|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0
7881102|NCT01753401|12378791|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1
7881103|NCT01753401|12378792|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1
7881104|NCT01753401|12378789|FG000|Open Label Period (44 Weeks)|Reason not provided|0
7881105|NCT01753401|12378790|FG001|Open Label Period (44 Weeks)|Reason not provided|0
7881106|NCT01753401|12378791|FG002|Open Label Period (44 Weeks)|Reason not provided|0
7881107|NCT01753401|12378792|FG003|Open Label Period (44 Weeks)|Reason not provided|2
7881108|NCT01753518|12378804|FG000|Intention-to-Treat Analysis|Missing consent form|5
7881109|NCT01753518|12378805|FG001|Intention-to-Treat Analysis|Missing consent form|3
7881110|NCT01753518|12378804|FG000|Intention-to-Treat Analysis|Multifetal gestation|2
7881111|NCT01753518|12378805|FG001|Intention-to-Treat Analysis|Multifetal gestation|3
7881112|NCT01753518|12378804|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0
7881113|NCT01753518|12378805|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1
7881114|NCT01753518|12378804|FG000|Postpartum Follow-up|Lost to Follow-up|22
7881115|NCT01753518|12378805|FG001|Postpartum Follow-up|Lost to Follow-up|15
7881116|NCT01753570|12378824|FG000|Overall Study|Adverse Event|1
7881117|NCT01753570|12378825|FG001|Overall Study|Adverse Event|0
7881118|NCT01753570|12378826|FG002|Overall Study|Adverse Event|1
7881119|NCT01753570|12378824|FG000|Overall Study|Physician Decision|0
7881120|NCT01753570|12378825|FG001|Overall Study|Physician Decision|1
7881121|NCT01753570|12378826|FG002|Overall Study|Physician Decision|0
7881122|NCT01753570|12378824|FG000|Overall Study|Withdrawal by Subject|1
7881123|NCT01753570|12378825|FG001|Overall Study|Withdrawal by Subject|4
7881124|NCT01753570|12378826|FG002|Overall Study|Withdrawal by Subject|0
7881125|NCT01753856|12378867|FG000|Overall Study|Adverse Event|1
7881126|NCT01753856|12378868|FG001|Overall Study|Adverse Event|0
7881127|NCT01753856|12378867|FG000|Overall Study|Withdrawal by Subject|0
7881128|NCT01753856|12378868|FG001|Overall Study|Withdrawal by Subject|2
7881129|NCT01753856|12378867|FG000|Overall Study|Sponsor Decision|2
7881130|NCT01753856|12378868|FG001|Overall Study|Sponsor Decision|0
7881131|NCT01753999|12378877|FG000|Period 1 - Initial Assignment|Physician Decision|2
7881132|NCT01753999|12378878|FG001|Period 1 - Initial Assignment|Physician Decision|3
7881133|NCT01753999|12378877|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19
7881134|NCT01753999|12378878|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20
7881135|NCT01753999|12378877|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18
7881136|NCT01753999|12378878|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27
7881137|NCT01753999|12378877|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13
7881138|NCT01753999|12378878|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17
7881139|NCT01753999|12378877|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3
7881140|NCT01753999|12378878|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5
7881141|NCT01753999|12378877|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1
7881142|NCT01753999|12378878|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1
7881143|NCT01754129|12378889|FG000|Overall Study|Death|13
7881144|NCT01754129|12378889|FG000|Overall Study|Duodopa discontinuation|9
7881145|NCT01754129|12378889|FG000|Overall Study|Lost to Follow-up|7
7881146|NCT01754129|12378889|FG000|Overall Study|Withdrew consent|1
7881147|NCT01754129|12378889|FG000|Overall Study|Inclusion/exclusion criteria violation|3
7881148|NCT01754194|12378902|FG000|Overall Study|Lost to Follow-up|39
7881149|NCT01754194|12378903|FG001|Overall Study|Lost to Follow-up|14
7881150|NCT01754194|12378902|FG000|Overall Study|Withdrawal by Subject|4
7881151|NCT01754194|12378903|FG001|Overall Study|Withdrawal by Subject|5
7881152|NCT01754194|12378902|FG000|Overall Study|Other|9
7881153|NCT01754194|12378903|FG001|Overall Study|Other|8
7881154|NCT01754259|12378917|FG000|Overall Study|Withdrawal by Subject|2
7881155|NCT01754259|12378918|FG001|Overall Study|Withdrawal by Subject|4
7881156|NCT01754259|12378917|FG000|Overall Study|Adverse Event|3
7881157|NCT01754259|12378918|FG001|Overall Study|Adverse Event|1
7881158|NCT01754259|12378917|FG000|Overall Study|Lost to Follow-up|0
7881159|NCT01754259|12378918|FG001|Overall Study|Lost to Follow-up|1
7881160|NCT01754376|12378933|FG000|Overall Study|Adverse Event|1
7881161|NCT01754376|12378933|FG000|Overall Study|Lack of Efficacy|2
7881162|NCT01754402|12378954|FG000|Overall Study|Death|0
7881163|NCT01754402|12378955|FG001|Overall Study|Death|0
7881164|NCT01754402|12378956|FG002|Overall Study|Death|1
7881165|NCT01754402|12378954|FG000|Overall Study|Adverse Event|2
7881166|NCT01754402|12378955|FG001|Overall Study|Adverse Event|2
7881167|NCT01754402|12378956|FG002|Overall Study|Adverse Event|1
7881168|NCT01754402|12378954|FG000|Overall Study|Withdrawal by Subject|0
7881169|NCT01754402|12378955|FG001|Overall Study|Withdrawal by Subject|0
7881170|NCT01754402|12378956|FG002|Overall Study|Withdrawal by Subject|1
7881171|NCT01754402|12378954|FG000|Overall Study|Lack of Efficacy|0
7881172|NCT01754402|12378955|FG001|Overall Study|Lack of Efficacy|0
7881173|NCT01754402|12378956|FG002|Overall Study|Lack of Efficacy|1
7881174|NCT01754467|12378965|FG000|Overall Study|Lost to Follow-up|1
7881175|NCT01754493|12378979|FG000|Overall Study|Adverse Event|1
7881176|NCT01754493|12378979|FG000|Overall Study|Lost to Follow-up|3
7881177|NCT01754493|12378979|FG000|Overall Study|Withdrawal by Subject|1
7881178|NCT01754493|12378979|FG000|Overall Study|Moved out of town|1
7881179|NCT01754493|12378979|FG000|Overall Study|Scheduling conflict|1
7881180|NCT01754727|12379016|FG000|Overall Study|Adalimumab Treatment was not Documented|2
7881181|NCT01754753|12379022|FG000|Overall Study|Study close|43
7881182|NCT01754753|12379023|FG001|Overall Study|Study close|44
7881183|NCT01754753|12379022|FG000|Overall Study|Lost to Follow-up|9
7881184|NCT01754753|12379023|FG001|Overall Study|Lost to Follow-up|5
7881185|NCT01754766|12379032|FG000|Overall Study|Personal reasons|1
7881186|NCT01754766|12379033|FG001|Overall Study|Personal reasons|1
7881187|NCT01754766|12379034|FG002|Overall Study|Personal reasons|0
7881188|NCT01754922|12379053|FG000|Overall Study|Adverse Event|0
7881189|NCT01754922|12379054|FG001|Overall Study|Adverse Event|1
7881190|NCT01755026|12379063|FG000|Overall Study|Adverse Event|1
7881191|NCT01755026|12379064|FG001|Overall Study|Adverse Event|0
7881192|NCT01755026|12379063|FG000|Overall Study|Withdrawal by Subject|1
7881193|NCT01755026|12379064|FG001|Overall Study|Withdrawal by Subject|1
7881194|NCT01755091|12379073|FG000|Overall Study|Withdrawal by Subject|6
7881195|NCT01755091|12379074|FG001|Overall Study|Withdrawal by Subject|1
7881196|NCT01755091|12379075|FG002|Overall Study|Withdrawal by Subject|3
7881197|NCT01755091|12379073|FG000|Overall Study|Adverse Event|1
7881198|NCT01755091|12379074|FG001|Overall Study|Adverse Event|1
7881199|NCT01755091|12379075|FG002|Overall Study|Adverse Event|1
7881200|NCT01755091|12379073|FG000|Overall Study|Lost to Follow-up|1
7881201|NCT01755091|12379074|FG001|Overall Study|Lost to Follow-up|0
7881202|NCT01755091|12379075|FG002|Overall Study|Lost to Follow-up|1
7881203|NCT01755091|12379073|FG000|Overall Study|Physician Decision|1
7881204|NCT01755091|12379074|FG001|Overall Study|Physician Decision|1
7881205|NCT01755091|12379075|FG002|Overall Study|Physician Decision|2
7881206|NCT01755156|12379094|FG000|Phase A (Weeks 0-24)|Adverse Event|2
7881207|NCT01755156|12379095|FG001|Phase A (Weeks 0-24)|Adverse Event|3
7881208|NCT01755156|12379094|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1
7881209|NCT01755156|12379095|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0
7881210|NCT01755156|12379094|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5
7881211|NCT01755156|12379095|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3
7881212|NCT01755156|12379094|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1
7881213|NCT01755156|12379095|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0
7881214|NCT01755156|12379094|FG000|Phase A (Weeks 0-24)|Physician Decision|0
7881215|NCT01755156|12379095|FG001|Phase A (Weeks 0-24)|Physician Decision|1
7881216|NCT01755156|12379094|FG000|Phase A (Weeks 0-24)|Protocol Violation|1
7881217|NCT01755156|12379095|FG001|Phase A (Weeks 0-24)|Protocol Violation|1
7881218|NCT01755156|12379094|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6
7881219|NCT01755156|12379095|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13
7881220|NCT01755156|12379094|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
7881221|NCT01755156|12379095|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
7881222|NCT01755156|12379094|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
7881223|NCT01755156|12379095|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
7881224|NCT01755156|12379094|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12
7881225|NCT01755156|12379095|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5
7881226|NCT01755156|12379094|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27
7881227|NCT01755156|12379095|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31
7883281|NCT01781429|12382952|FG003|Overall Study|Withdrawal by Subject|0
7883282|NCT01781429|12382953|FG004|Overall Study|Withdrawal by Subject|0
7883283|NCT01781429|12382954|FG005|Overall Study|Withdrawal by Subject|0
7883284|NCT01781429|12382955|FG006|Overall Study|Withdrawal by Subject|0
7883285|NCT01781429|12382956|FG007|Overall Study|Withdrawal by Subject|0
7881228|NCT01755195|12379122|FG000|Overall Study|Participant noncompliance|2
7881229|NCT01755195|12379122|FG000|Overall Study|Switched to alternative treatment|4
7881230|NCT01755195|12379122|FG000|Overall Study|Withdrawal by Subject|1
7881231|NCT01755195|12379122|FG000|Overall Study|Participant refused to start treatment|1
7881232|NCT01755195|12379122|FG000|Overall Study|Participant has been consented for another trial|1
7881233|NCT01755195|12379122|FG000|Overall Study|Refused further treatment|3
7881234|NCT01755195|12379122|FG000|Overall Study|Complicating disease/intercurrent illness|1
7881235|NCT01755234|12379128|FG000|Overall Study|Lost to Follow-up|11
7881236|NCT01755234|12379129|FG001|Overall Study|Lost to Follow-up|6
7881237|NCT01755234|12379128|FG000|Overall Study|Change in surgical case|2
7881238|NCT01755234|12379129|FG001|Overall Study|Change in surgical case|1
7881239|NCT01755234|12379128|FG000|Overall Study|case cancelled|1
7881240|NCT01755234|12379129|FG001|Overall Study|case cancelled|0
7881241|NCT01755234|12379128|FG000|Overall Study|Withdrawal by Subject|0
7881242|NCT01755234|12379129|FG001|Overall Study|Withdrawal by Subject|1
7881243|NCT01755234|12379128|FG000|Overall Study|unblinded|1
7881244|NCT01755234|12379129|FG001|Overall Study|unblinded|0
7881245|NCT01755416|12379135|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
7881246|NCT01755416|12379136|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
7881247|NCT01755546|12379149|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
7881248|NCT01755546|12379149|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
7881249|NCT01755546|12379149|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
7881250|NCT01755546|12379149|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
7881251|NCT01755546|12379149|FG000|Titration Phase|Adverse Event|11
7881252|NCT01755546|12379149|FG000|Titration Phase|Lack of Efficacy|18
7881253|NCT01755546|12379149|FG000|Titration Phase|Protocol Violation|9
7881254|NCT01755546|12379149|FG000|Titration Phase|Lost to Follow-up|2
7881255|NCT01755546|12379149|FG000|Titration Phase|Other and Continuing|22
7881256|NCT01755546|12379149|FG000|Titration Phase|Withdrawal by Subject|8
7881257|NCT01755546|12379149|FG000|Long Term Treatment|Adverse Event|12
7881258|NCT01755546|12379149|FG000|Long Term Treatment|Lack of Efficacy|6
7881259|NCT01755546|12379149|FG000|Long Term Treatment|Protocol Violation|10
7881260|NCT01755546|12379149|FG000|Long Term Treatment|Withdrawal by Subject|35
7881261|NCT01755546|12379149|FG000|Long Term Treatment|Lost to Follow-up|17
7881262|NCT01755546|12379149|FG000|Long Term Treatment|other and ongoing|41
7881263|NCT01755598|12379155|FG000|Overall Study|Other|109
7881264|NCT01755598|12379156|FG001|Overall Study|Other|109
7881265|NCT01755598|12379155|FG000|Overall Study|Lost to Follow-up|32
7881266|NCT01755598|12379156|FG001|Overall Study|Lost to Follow-up|43
7881267|NCT01755598|12379155|FG000|Overall Study|Migrated/moved from study area|76
7881268|NCT01755598|12379156|FG001|Overall Study|Migrated/moved from study area|65
7881269|NCT01755598|12379155|FG000|Overall Study|Withdrawal by Subject|22
7881270|NCT01755598|12379156|FG001|Overall Study|Withdrawal by Subject|31
7881271|NCT01755598|12379155|FG000|Overall Study|Protocol Violation|7
7881272|NCT01755598|12379156|FG001|Overall Study|Protocol Violation|7
7881273|NCT01755598|12379155|FG000|Overall Study|Adverse Event|19
7881274|NCT01755598|12379156|FG001|Overall Study|Adverse Event|28
7881275|NCT01755637|12379162|FG000|Period 1|Adverse Event|0
7881276|NCT01755637|12379163|FG001|Period 1|Adverse Event|1
7881277|NCT01755702|12379175|FG000|Wash Out Period I|Other Reason|3
7881278|NCT01755702|12379175|FG000|Washout Period II|Other Reason|5
7881279|NCT01755767|12379189|FG000|Overall Study|Progressive Disease|8
7881280|NCT01755767|12379190|FG001|Overall Study|Progressive Disease|7
7881281|NCT01755767|12379191|FG002|Overall Study|Progressive Disease|91
7881282|NCT01755767|12379192|FG003|Overall Study|Progressive Disease|43
7881283|NCT01755767|12379189|FG000|Overall Study|Clinical Disease Progression|4
7881284|NCT01755767|12379190|FG001|Overall Study|Clinical Disease Progression|2
7881285|NCT01755767|12379191|FG002|Overall Study|Clinical Disease Progression|29
7881286|NCT01755767|12379192|FG003|Overall Study|Clinical Disease Progression|20
7881287|NCT01755767|12379189|FG000|Overall Study|Radiographic Disease Progression|9
7881288|NCT01755767|12379190|FG001|Overall Study|Radiographic Disease Progression|4
7881289|NCT01755767|12379191|FG002|Overall Study|Radiographic Disease Progression|44
7881290|NCT01755767|12379192|FG003|Overall Study|Radiographic Disease Progression|27
7881291|NCT01755767|12379189|FG000|Overall Study|Adverse Event|6
7881292|NCT01755767|12379190|FG001|Overall Study|Adverse Event|0
7881293|NCT01755767|12379191|FG002|Overall Study|Adverse Event|28
7881294|NCT01755767|12379192|FG003|Overall Study|Adverse Event|11
7881295|NCT01755767|12379189|FG000|Overall Study|Death|1
7881296|NCT01755767|12379190|FG001|Overall Study|Death|2
7881297|NCT01755767|12379191|FG002|Overall Study|Death|15
7881298|NCT01755767|12379192|FG003|Overall Study|Death|4
7881299|NCT01755767|12379189|FG000|Overall Study|Subject Decision|0
7881300|NCT01755767|12379190|FG001|Overall Study|Subject Decision|0
7881301|NCT01755767|12379191|FG002|Overall Study|Subject Decision|10
7881302|NCT01755767|12379192|FG003|Overall Study|Subject Decision|3
7881303|NCT01755767|12379189|FG000|Overall Study|Withdrawal by Subject|0
7881304|NCT01755767|12379190|FG001|Overall Study|Withdrawal by Subject|0
7881305|NCT01755767|12379191|FG002|Overall Study|Withdrawal by Subject|2
7881306|NCT01755767|12379192|FG003|Overall Study|Withdrawal by Subject|1
7881307|NCT01755767|12379189|FG000|Overall Study|Other|0
7881308|NCT01755767|12379190|FG001|Overall Study|Other|0
7881309|NCT01755767|12379191|FG002|Overall Study|Other|2
7881310|NCT01755767|12379192|FG003|Overall Study|Other|3
7881311|NCT01755767|12379189|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
7881312|NCT01755767|12379190|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
7881313|NCT01755767|12379191|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5
7881314|NCT01755767|12379192|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2
7881315|NCT01755858|12379204|FG000|Overall Study|Adverse Event|1
7881316|NCT01755858|12379205|FG001|Overall Study|Adverse Event|1
7881317|NCT01756053|12379238|FG000|Period 1 (10 Days)|Protocol Violation|1
7881318|NCT01756053|12379239|FG001|Period 1 (10 Days)|Protocol Violation|1
7881319|NCT01756053|12379238|FG000|Period 2 (10 Days)|Protocol Violation|0
7881320|NCT01756053|12379239|FG001|Period 2 (10 Days)|Protocol Violation|2
7881321|NCT01756079|12379245|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
7881322|NCT01756079|12379245|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
7881323|NCT01756079|12379245|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2
7881324|NCT01756079|12379245|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
7881325|NCT01756079|12379245|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
7881326|NCT01756157|12379250|FG000|First Intervention Period|Withdrawal by Subject|1
7881327|NCT01756157|12379251|FG001|First Intervention Period|Withdrawal by Subject|0
7881328|NCT01756157|12379250|FG000|First Intervention Period|Lost to Follow-up|0
7881329|NCT01756157|12379251|FG001|First Intervention Period|Lost to Follow-up|2
7881330|NCT01756235|12379274|FG000|Overall Study|Adalimumab Treatment was not Documented|2
7881331|NCT01756274|12379278|FG000|Overall Study|Protocol Violation|2
7881332|NCT01756274|12379278|FG000|Overall Study|Laboratory error|1
7881333|NCT01756300|12379283|FG000|Overall Study|Death|1
7881334|NCT01756300|12379283|FG000|Overall Study|Withdrawal by Subject|1
7881335|NCT01756352|12379304|FG000|Overall Study|moved away and lost to followup|1
7881336|NCT01756456|12379318|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0
7881337|NCT01756456|12379319|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0
7881338|NCT01756456|12379320|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0
7881339|NCT01756456|12379321|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1
7881340|NCT01756456|12379322|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1
7881341|NCT01756456|12379323|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1
7881342|NCT01756456|12379318|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0
7881343|NCT01756456|12379319|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0
7881344|NCT01756456|12379320|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0
7881345|NCT01756456|12379321|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2
7881346|NCT01756456|12379322|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1
7881347|NCT01756456|12379323|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0
7881348|NCT01756456|12379318|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0
7881349|NCT01756456|12379319|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1
7881350|NCT01756456|12379320|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0
7881351|NCT01756456|12379321|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0
7881352|NCT01756456|12379322|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0
7881353|NCT01756456|12379323|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0
7881354|NCT01756456|12379318|FG000|Treatment Period: Phase I/II|Adverse Event|1
7881355|NCT01756456|12379319|FG001|Treatment Period: Phase I/II|Adverse Event|0
7881356|NCT01756456|12379320|FG002|Treatment Period: Phase I/II|Adverse Event|2
7881357|NCT01756456|12379321|FG003|Treatment Period: Phase I/II|Adverse Event|3
7881358|NCT01756456|12379322|FG004|Treatment Period: Phase I/II|Adverse Event|9
7881359|NCT01756456|12379323|FG005|Treatment Period: Phase I/II|Adverse Event|1
7881360|NCT01756456|12379318|FG000|Treatment Period: Phase I/II|Other causes|0
7881361|NCT01756456|12379319|FG001|Treatment Period: Phase I/II|Other causes|0
7881362|NCT01756456|12379320|FG002|Treatment Period: Phase I/II|Other causes|0
7881363|NCT01756456|12379321|FG003|Treatment Period: Phase I/II|Other causes|1
7881364|NCT01756456|12379322|FG004|Treatment Period: Phase I/II|Other causes|2
7881365|NCT01756456|12379323|FG005|Treatment Period: Phase I/II|Other causes|2
7881366|NCT01756456|12379318|FG000|Follow Up Period Phase I/II|still in study after week 20|0
7881367|NCT01756456|12379319|FG001|Follow Up Period Phase I/II|still in study after week 20|0
7881368|NCT01756456|12379320|FG002|Follow Up Period Phase I/II|still in study after week 20|0
7881369|NCT01756456|12379321|FG003|Follow Up Period Phase I/II|still in study after week 20|25
7881370|NCT01756456|12379322|FG004|Follow Up Period Phase I/II|still in study after week 20|23
7881371|NCT01756456|12379323|FG005|Follow Up Period Phase I/II|still in study after week 20|25
7881372|NCT01756456|12379318|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7881373|NCT01756456|12379319|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1
7881374|NCT01756456|12379320|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7881375|NCT01756456|12379321|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7881376|NCT01756456|12379322|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7881377|NCT01756456|12379323|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7881378|NCT01756456|12379318|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0
7881379|NCT01756456|12379319|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0
7881380|NCT01756456|12379320|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0
7881381|NCT01756456|12379321|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0
7881382|NCT01756456|12379322|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0
7883286|NCT01781429|12382957|FG008|Overall Study|Withdrawal by Subject|1
7881383|NCT01756456|12379323|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1
7881384|NCT01756456|12379318|FG000|Follow Up Period Phase I/II|Adverse Event|1
7881385|NCT01756456|12379319|FG001|Follow Up Period Phase I/II|Adverse Event|0
7881386|NCT01756456|12379320|FG002|Follow Up Period Phase I/II|Adverse Event|0
7881387|NCT01756456|12379321|FG003|Follow Up Period Phase I/II|Adverse Event|5
7881388|NCT01756456|12379322|FG004|Follow Up Period Phase I/II|Adverse Event|0
7881389|NCT01756456|12379323|FG005|Follow Up Period Phase I/II|Adverse Event|1
7881390|NCT01756456|12379318|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0
7881391|NCT01756456|12379319|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0
7881392|NCT01756456|12379320|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1
7881393|NCT01756456|12379321|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2
7881394|NCT01756456|12379322|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0
7881395|NCT01756456|12379323|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1
7881396|NCT01756456|12379318|FG000|Follow Up Period Phase I/II|Other causes|0
7881397|NCT01756456|12379319|FG001|Follow Up Period Phase I/II|Other causes|0
7881398|NCT01756456|12379320|FG002|Follow Up Period Phase I/II|Other causes|0
7881399|NCT01756456|12379321|FG003|Follow Up Period Phase I/II|Other causes|1
7881400|NCT01756456|12379322|FG004|Follow Up Period Phase I/II|Other causes|3
7881401|NCT01756456|12379323|FG005|Follow Up Period Phase I/II|Other causes|5
7881402|NCT01756833|12379348|FG000|Overall Study|Withdrawal by Subject|4
7881403|NCT01756833|12379349|FG001|Overall Study|Withdrawal by Subject|3
7881404|NCT01756846|12379357|FG000|Overall Study|Lost to Follow-up|5
7881405|NCT01756846|12379358|FG001|Overall Study|Lost to Follow-up|10
7881406|NCT01756846|12379357|FG000|Overall Study|Withdrawal by Subject|1
7881407|NCT01756846|12379358|FG001|Overall Study|Withdrawal by Subject|2
7881408|NCT01756898|12379377|FG000|Overall Study|Adverse Event|7
7881409|NCT01756898|12379378|FG001|Overall Study|Adverse Event|1
7881410|NCT01756898|12379379|FG002|Overall Study|Adverse Event|0
7881411|NCT01756898|12379380|FG003|Overall Study|Adverse Event|0
7881412|NCT01756898|12379377|FG000|Overall Study|Lack of Efficacy|4
7881413|NCT01756898|12379378|FG001|Overall Study|Lack of Efficacy|7
7881414|NCT01756898|12379379|FG002|Overall Study|Lack of Efficacy|6
7881415|NCT01756898|12379380|FG003|Overall Study|Lack of Efficacy|6
7881416|NCT01756898|12379377|FG000|Overall Study|Lost to Follow-up|2
7881417|NCT01756898|12379378|FG001|Overall Study|Lost to Follow-up|4
7881418|NCT01756898|12379379|FG002|Overall Study|Lost to Follow-up|2
7881419|NCT01756898|12379380|FG003|Overall Study|Lost to Follow-up|3
7881420|NCT01756898|12379377|FG000|Overall Study|Protocol Violation|1
7881421|NCT01756898|12379378|FG001|Overall Study|Protocol Violation|2
7881422|NCT01756898|12379379|FG002|Overall Study|Protocol Violation|2
7881423|NCT01756898|12379380|FG003|Overall Study|Protocol Violation|1
7881424|NCT01756898|12379377|FG000|Overall Study|Withdrew Consent|5
7881425|NCT01756898|12379378|FG001|Overall Study|Withdrew Consent|3
7881426|NCT01756898|12379379|FG002|Overall Study|Withdrew Consent|5
7881427|NCT01756898|12379380|FG003|Overall Study|Withdrew Consent|6
7881428|NCT01756898|12379377|FG000|Overall Study|Other|0
7881429|NCT01756898|12379378|FG001|Overall Study|Other|2
7881430|NCT01756898|12379379|FG002|Overall Study|Other|2
7881431|NCT01756898|12379380|FG003|Overall Study|Other|0
7881432|NCT01757171|12379413|FG000|Overall Study|Adverse Event|5
7881433|NCT01757171|12379414|FG001|Overall Study|Adverse Event|1
7881434|NCT01757171|12379413|FG000|Overall Study|Disease Progression|1
7881435|NCT01757171|12379414|FG001|Overall Study|Disease Progression|0
7881436|NCT01757171|12379413|FG000|Overall Study|Hospitalization|1
7881437|NCT01757171|12379414|FG001|Overall Study|Hospitalization|0
7881438|NCT01757171|12379413|FG000|Overall Study|ECOG decline|1
7881439|NCT01757171|12379414|FG001|Overall Study|ECOG decline|0
7881440|NCT01757184|12379422|FG000|Double-blind Period|Adverse Event|1
7881441|NCT01757184|12379423|FG001|Double-blind Period|Adverse Event|0
7881442|NCT01757184|12379424|FG002|Double-blind Period|Adverse Event|0
7881443|NCT01757184|12379425|FG003|Double-blind Period|Adverse Event|0
7881444|NCT01757184|12379422|FG000|Open-label Period|Lost to Follow-up|0
7881445|NCT01757184|12379423|FG001|Open-label Period|Lost to Follow-up|0
7881446|NCT01757184|12379424|FG002|Open-label Period|Lost to Follow-up|2
7881447|NCT01757184|12379425|FG003|Open-label Period|Lost to Follow-up|0
7881448|NCT01757184|12379422|FG000|Open-label Period|Withdrawal by Subject|0
7881449|NCT01757184|12379423|FG001|Open-label Period|Withdrawal by Subject|0
7881450|NCT01757184|12379424|FG002|Open-label Period|Withdrawal by Subject|1
7881451|NCT01757184|12379425|FG003|Open-label Period|Withdrawal by Subject|1
7881452|NCT01757184|12379422|FG000|Open-label Period|Discontinued by Sponsor|0
7881453|NCT01757184|12379423|FG001|Open-label Period|Discontinued by Sponsor|0
7881454|NCT01757184|12379424|FG002|Open-label Period|Discontinued by Sponsor|1
7881455|NCT01757184|12379425|FG003|Open-label Period|Discontinued by Sponsor|2
7881456|NCT01757197|12379439|FG000|Overall Study|Death|2
7881457|NCT01757275|12379445|FG000|Overall Study|Lost to Follow-up|1
7881458|NCT01757275|12379446|FG001|Overall Study|Lost to Follow-up|2
7881459|NCT01757275|12379445|FG000|Overall Study|Adverse Event|3
7881460|NCT01757275|12379446|FG001|Overall Study|Adverse Event|3
7881461|NCT01757275|12379445|FG000|Overall Study|Withdrawal by Subject|2
7881462|NCT01757275|12379446|FG001|Overall Study|Withdrawal by Subject|4
7881463|NCT01757275|12379445|FG000|Overall Study|Not treated|3
7881464|NCT01757275|12379446|FG001|Overall Study|Not treated|4
7881465|NCT01757288|12379455|FG000|Overall Study|Consent withdrawal|0
7881466|NCT01757288|12379456|FG001|Overall Study|Consent withdrawal|4
7881467|NCT01757288|12379457|FG002|Overall Study|Consent withdrawal|4
7881468|NCT01757288|12379455|FG000|Overall Study|Patient off study, IRB hold.|0
7881469|NCT01757288|12379456|FG001|Overall Study|Patient off study, IRB hold.|0
7881470|NCT01757288|12379457|FG002|Overall Study|Patient off study, IRB hold.|1
7881471|NCT01757288|12379455|FG000|Overall Study|Patient death prior to starting treatment|0
7881472|NCT01757288|12379456|FG001|Overall Study|Patient death prior to starting treatment|0
7881473|NCT01757288|12379457|FG002|Overall Study|Patient death prior to starting treatment|1
7881474|NCT01757288|12379455|FG000|Overall Study|Wrong medication administered|0
7881475|NCT01757288|12379456|FG001|Overall Study|Wrong medication administered|1
7881476|NCT01757288|12379457|FG002|Overall Study|Wrong medication administered|0
7881477|NCT01757288|12379455|FG000|Overall Study|Liver metastasis identified at CT simulation|0
7881478|NCT01757288|12379456|FG001|Overall Study|Liver metastasis identified at CT simulation|1
7881479|NCT01757288|12379457|FG002|Overall Study|Liver metastasis identified at CT simulation|0
7881480|NCT01757288|12379455|FG000|Overall Study|Not meeting protocol constraints|0
7881481|NCT01757288|12379456|FG001|Overall Study|Not meeting protocol constraints|1
7881482|NCT01757288|12379457|FG002|Overall Study|Not meeting protocol constraints|1
7881483|NCT01757288|12379455|FG000|Overall Study|Multiple missed appointments|0
7881484|NCT01757288|12379456|FG001|Overall Study|Multiple missed appointments|1
7881485|NCT01757288|12379457|FG002|Overall Study|Multiple missed appointments|0
7881486|NCT01757288|12379455|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0
7881487|NCT01757288|12379456|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0
7881488|NCT01757288|12379457|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1
7881489|NCT01757288|12379455|FG000|Overall Study|>2 weeks treatment break|0
7881490|NCT01757288|12379456|FG001|Overall Study|>2 weeks treatment break|0
7881491|NCT01757288|12379457|FG002|Overall Study|>2 weeks treatment break|1
7881492|NCT01757392|12379477|FG000|Overall Study|Withdrawal by Subject|1
7881493|NCT01757392|12379477|FG000|Overall Study|Screen Fail|3
7881494|NCT01757405|12379483|FG000|Overall Study|Lost to Follow-up|1
7881495|NCT01757405|12379484|FG001|Overall Study|Lost to Follow-up|1
7881496|NCT01757405|12379483|FG000|Overall Study|Withdrawal by Subject|0
7881497|NCT01757405|12379484|FG001|Overall Study|Withdrawal by Subject|1
7881498|NCT01757691|12379515|FG000|Overall Study|Administrative problems|2
7881499|NCT01757691|12379516|FG001|Overall Study|Administrative problems|0
7881500|NCT01757704|12379524|FG000|Overall Study|Protocol Violation|1
7881501|NCT01757704|12379525|FG001|Overall Study|Protocol Violation|3
7881502|NCT01757821|12379535|FG000|Overall Study|Adverse Event|1
7881503|NCT01757847|12379545|FG000|Overall Study|Withdrawal by Subject|3
7881504|NCT01757847|12379546|FG001|Overall Study|Withdrawal by Subject|4
7881505|NCT01758289|12379559|FG000|Overall Study|Premature Study Termination|44
7881506|NCT01758289|12379559|FG000|Overall Study|Adverse Event|9
7881507|NCT01758523|12379598|FG000|Overall Study|Adverse Event|2
7881508|NCT01758523|12379599|FG001|Overall Study|Adverse Event|1
7881509|NCT01758523|12379598|FG000|Overall Study|Lack of Efficacy|4
7881510|NCT01758523|12379599|FG001|Overall Study|Lack of Efficacy|2
7881511|NCT01758523|12379598|FG000|Overall Study|Lost to Follow-up|3
7881512|NCT01758523|12379599|FG001|Overall Study|Lost to Follow-up|4
7881513|NCT01758523|12379598|FG000|Overall Study|Withdrawal by Subject|12
7881514|NCT01758523|12379599|FG001|Overall Study|Withdrawal by Subject|7
7881515|NCT01758731|12379620|FG000|Overall Study|Physician Decision|1
7881516|NCT01758900|12379626|FG000|Overall Study|difficulty for further intubation|7
7881517|NCT01758900|12379627|FG001|Overall Study|difficulty for further intubation|8
7881518|NCT01759264|12379646|FG000|Overall Study|Serious Adverse Events (SAEs)|1
7881519|NCT01759264|12379646|FG000|Overall Study|Adverse Event|1
7881520|NCT01759264|12379646|FG000|Overall Study|Other|2
7881521|NCT01759264|12379646|FG000|Overall Study|Lost to Follow-up|2
7881522|NCT01759264|12379646|FG000|Overall Study|Withdrawal by Subject|3
7881523|NCT01759264|12379646|FG000|Overall Study|Discontinued Humira Due to Business Trip|1
7881524|NCT01759290|12379662|FG000|Overall Study|Subjects withdrawn consent|5
7881525|NCT01759290|12379662|FG000|Overall Study|Physician Decision|2
7881526|NCT01759290|12379662|FG000|Overall Study|Death|17
7881527|NCT01759290|12379662|FG000|Overall Study|Lost to Follow-up|53
7881528|NCT01759290|12379662|FG000|Overall Study|Unknown reason|4
7881529|NCT01759368|12379668|FG000|Overall Study|Lost to Follow-up|1
7881530|NCT01759368|12379669|FG001|Overall Study|Lost to Follow-up|0
7881531|NCT01759381|12379679|FG000|Overall Study|Death|1
7881532|NCT01759381|12379680|FG001|Overall Study|Death|0
7881533|NCT01759407|12379688|FG000|Overall Study|Protocol Violation|0
7881534|NCT01759407|12379689|FG001|Overall Study|Protocol Violation|2
7881535|NCT01759420|12379695|FG000|Overall Study|Screen failure|5
7881536|NCT01759420|12379695|FG000|Overall Study|Inaccurate EKG machine readings|1
7881537|NCT01759446|12379704|FG000|Overall Study|Protocol Violation|1
7881538|NCT01759446|12379705|FG001|Overall Study|Protocol Violation|0
7881539|NCT01759446|12379706|FG002|Overall Study|Protocol Violation|1
7881540|NCT01759446|12379707|FG003|Overall Study|Protocol Violation|0
7881541|NCT01759446|12379708|FG004|Overall Study|Protocol Violation|0
7881542|NCT01759446|12379704|FG000|Overall Study|Withdrawal by Subject|0
7881543|NCT01759446|12379705|FG001|Overall Study|Withdrawal by Subject|1
7881544|NCT01759446|12379706|FG002|Overall Study|Withdrawal by Subject|0
7881545|NCT01759446|12379707|FG003|Overall Study|Withdrawal by Subject|1
7881546|NCT01759446|12379708|FG004|Overall Study|Withdrawal by Subject|0
7881547|NCT01759511|12379720|FG000|Overall Study|Adverse Event|4
7881548|NCT01759511|12379720|FG000|Overall Study|Death|2
7881549|NCT01759511|12379720|FG000|Overall Study|Lack of Efficacy|2
7881550|NCT01759511|12379720|FG000|Overall Study|Physician Decision|1
7881551|NCT01759511|12379720|FG000|Overall Study|Progressive Disease|5
7881552|NCT01759511|12379720|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4
7881553|NCT01759511|12379720|FG000|Overall Study|Study Terminated by Sponsor|13
7881554|NCT01759511|12379720|FG000|Overall Study|Withdrawal by Subject|3
7881555|NCT01759862|12379730|FG000|Overall Study|Physician Decision|3
7881556|NCT01759862|12379731|FG001|Overall Study|Physician Decision|1
7881557|NCT01759862|12379730|FG000|Overall Study|Adverse Event|0
7881558|NCT01759862|12379731|FG001|Overall Study|Adverse Event|1
7881559|NCT01760733|12379806|FG000|Waiting List|Death|18
7881560|NCT01760733|12379806|FG000|Waiting List|Removed from waiting list|41
7881561|NCT01760733|12379806|FG000|Waiting List|Not received a transplant yet|13
7881562|NCT01760733|12379806|FG000|Transplanted|Not reached 10 years post transplant|184
7881563|NCT01760733|12379806|FG000|Transplanted|Death|26
7881564|NCT01760733|12379806|FG000|Transplanted|Graft loss|7
7881565|NCT01760876|12379820|FG000|Overall Study|Non-cardiac death (head injury)|1
7881566|NCT01760876|12379820|FG000|Overall Study|Carcinoma of prostate|1
7881567|NCT01760876|12379820|FG000|Overall Study|Impaired renal function|1
7881568|NCT01760876|12379820|FG000|Overall Study|Major depression|1
7881569|NCT01760876|12379820|FG000|Overall Study|Very poor baseline OCT quality|2
7881570|NCT01760954|12379828|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8
7881571|NCT01760954|12379829|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8
7881572|NCT01760954|12379830|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4
7881573|NCT01760954|12379831|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5
7881574|NCT01760954|12379828|FG000|Treatment Period (6 Months)|Adverse Event|5
7881575|NCT01760954|12379829|FG001|Treatment Period (6 Months)|Adverse Event|3
7881576|NCT01760954|12379830|FG002|Treatment Period (6 Months)|Adverse Event|4
7881577|NCT01760954|12379831|FG003|Treatment Period (6 Months)|Adverse Event|10
7881578|NCT01760954|12379828|FG000|Treatment Period (6 Months)|Lost to Follow-up|9
7881579|NCT01760954|12379829|FG001|Treatment Period (6 Months)|Lost to Follow-up|1
7881580|NCT01760954|12379830|FG002|Treatment Period (6 Months)|Lost to Follow-up|4
7881581|NCT01760954|12379831|FG003|Treatment Period (6 Months)|Lost to Follow-up|3
7881582|NCT01760954|12379828|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
7881583|NCT01760954|12379829|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
7881584|NCT01760954|12379830|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
7881585|NCT01760954|12379831|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
7881586|NCT01760954|12379828|FG000|Treatment Period (6 Months)|Pregnancy|5
7881587|NCT01760954|12379829|FG001|Treatment Period (6 Months)|Pregnancy|0
7881588|NCT01760954|12379830|FG002|Treatment Period (6 Months)|Pregnancy|3
7881589|NCT01760954|12379831|FG003|Treatment Period (6 Months)|Pregnancy|2
7881590|NCT01760954|12379828|FG000|Treatment Period (6 Months)|Non-compliance|1
7881591|NCT01760954|12379829|FG001|Treatment Period (6 Months)|Non-compliance|4
7881592|NCT01760954|12379830|FG002|Treatment Period (6 Months)|Non-compliance|0
7881593|NCT01760954|12379831|FG003|Treatment Period (6 Months)|Non-compliance|3
7881594|NCT01760954|12379828|FG000|Treatment Period (6 Months)|Other|0
7881595|NCT01760954|12379829|FG001|Treatment Period (6 Months)|Other|3
7881596|NCT01760954|12379830|FG002|Treatment Period (6 Months)|Other|3
7881597|NCT01760954|12379831|FG003|Treatment Period (6 Months)|Other|1
7881598|NCT01760954|12379828|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
7881599|NCT01760954|12379829|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
7881600|NCT01760954|12379830|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
7881601|NCT01760954|12379831|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
7881602|NCT01760954|12379828|FG000|Treatment Period (6 Months)|Exclusionary Medication|1
7881603|NCT01760954|12379829|FG001|Treatment Period (6 Months)|Exclusionary Medication|0
7881604|NCT01760954|12379830|FG002|Treatment Period (6 Months)|Exclusionary Medication|0
7881605|NCT01760954|12379831|FG003|Treatment Period (6 Months)|Exclusionary Medication|0
7881606|NCT01760954|12379828|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
7881607|NCT01760954|12379829|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
7881608|NCT01760954|12379830|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
7881609|NCT01760954|12379831|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
7881610|NCT01760954|12379828|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
7881611|NCT01760954|12379829|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
7881612|NCT01760954|12379830|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
7881613|NCT01760954|12379831|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
7881614|NCT01760954|12379828|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
7881615|NCT01760954|12379829|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
7881616|NCT01760954|12379830|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
7881617|NCT01760954|12379831|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
7881618|NCT01760954|12379828|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
7881619|NCT01760954|12379829|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
7881620|NCT01760954|12379830|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
7881621|NCT01760954|12379831|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
7881622|NCT01760954|12379828|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
7881623|NCT01760954|12379829|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
7881624|NCT01760954|12379830|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
7881625|NCT01760954|12379831|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
7881626|NCT01760954|12379828|FG000|Post-treatment Follow-up (12 Months)|Other|13
7881627|NCT01760954|12379829|FG001|Post-treatment Follow-up (12 Months)|Other|8
7881628|NCT01760954|12379830|FG002|Post-treatment Follow-up (12 Months)|Other|9
7881629|NCT01760954|12379831|FG003|Post-treatment Follow-up (12 Months)|Other|6
7881630|NCT01761162|12379855|FG000|Overall Study|Withdrawal by Subject|3
7881631|NCT01761292|12379877|FG000|Part 1|Adverse Event|1
7881632|NCT01761292|12379877|FG000|Part 1|not receiving treatment in Part 1|1
7881633|NCT01761292|12379877|FG000|Extension 1|Withdrawal by Subject|1
7881634|NCT01761565|12379888|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
7881635|NCT01762345|12379918|FG000|Overall Study|Adverse Event|5
7881636|NCT01762345|12379918|FG000|Overall Study|Protocol Violation|2
7881637|NCT01762800|12379952|FG000|Overall Study|Adverse Event|8
7881638|NCT01762800|12379953|FG001|Overall Study|Adverse Event|13
7881639|NCT01762800|12379952|FG000|Overall Study|Lack of Efficacy|3
7881640|NCT01762800|12379953|FG001|Overall Study|Lack of Efficacy|2
7881641|NCT01762800|12379952|FG000|Overall Study|Study Closed/Terminated|0
7881642|NCT01762800|12379953|FG001|Overall Study|Study Closed/Terminated|1
7881643|NCT01762800|12379952|FG000|Overall Study|Physician Decision|1
7881644|NCT01762800|12379953|FG001|Overall Study|Physician Decision|1
7881645|NCT01762800|12379952|FG000|Overall Study|Withdrawal by Subject|7
7881646|NCT01762800|12379953|FG001|Overall Study|Withdrawal by Subject|4
7881647|NCT01762943|12379974|FG000|Overall Study|Physician Decision|1
7881648|NCT01762943|12379975|FG001|Overall Study|Physician Decision|1
7881649|NCT01762943|12379974|FG000|Overall Study|Protocol Violation|1
7881650|NCT01762943|12379975|FG001|Overall Study|Protocol Violation|0
7881651|NCT01762943|12379974|FG000|Overall Study|Withdrawal by Subject|2
7881652|NCT01762943|12379975|FG001|Overall Study|Withdrawal by Subject|1
7881653|NCT01763047|12379991|FG000|Period 1|Test Article Not Available|4
7881654|NCT01763047|12379992|FG001|Period 1|Test Article Not Available|1
7881655|NCT01763047|12379991|FG000|Period 1|Protocol Violation|4
7881656|NCT01763047|12379992|FG001|Period 1|Protocol Violation|4
7881657|NCT01763047|12379991|FG000|Period 1|No Longer Meets Eligibility criteria|1
7881658|NCT01763047|12379992|FG001|Period 1|No Longer Meets Eligibility criteria|0
7881659|NCT01763047|12379991|FG000|Period 1|Adverse Event|0
7881660|NCT01763047|12379992|FG001|Period 1|Adverse Event|1
7881661|NCT01763047|12379991|FG000|Period 1|Unsatisfactory Visual Response|0
7881662|NCT01763047|12379992|FG001|Period 1|Unsatisfactory Visual Response|3
7881663|NCT01763047|12379991|FG000|Period 1|Lens Power Not Available|0
7881664|NCT01763047|12379992|FG001|Period 1|Lens Power Not Available|1
7881665|NCT01763047|12379991|FG000|Period 1|Study Site office Closed|0
7881666|NCT01763047|12379992|FG001|Period 1|Study Site office Closed|1
7881667|NCT01763047|12379991|FG000|Period 2|Lens Discomfort|1
7881668|NCT01763047|12379992|FG001|Period 2|Lens Discomfort|0
7881669|NCT01763047|12379991|FG000|Period 2|No longer meets Eligibility Criteria|1
7881670|NCT01763047|12379992|FG001|Period 2|No longer meets Eligibility Criteria|0
7881671|NCT01763047|12379991|FG000|Period 2|Study Site office Closed|1
7881672|NCT01763047|12379992|FG001|Period 2|Study Site office Closed|1
7881673|NCT01763047|12379991|FG000|Period 2|Unsatisfactory Visual Response|1
7881674|NCT01763047|12379992|FG001|Period 2|Unsatisfactory Visual Response|1
7881675|NCT01763047|12379991|FG000|Period 2|Protocol Violation|0
7881676|NCT01763047|12379992|FG001|Period 2|Protocol Violation|2
7881677|NCT01763047|12379991|FG000|Period 2|Unsatisfactory lens Fitting|0
7881678|NCT01763047|12379992|FG001|Period 2|Unsatisfactory lens Fitting|1
7881679|NCT01763164|12380003|FG000|Treatment Phase|Participant/Guardian decision|26
7881680|NCT01763164|12380004|FG001|Treatment Phase|Participant/Guardian decision|14
7881681|NCT01763164|12380003|FG000|Treatment Phase|Protocol Violation|1
7881682|NCT01763164|12380004|FG001|Treatment Phase|Protocol Violation|1
7881683|NCT01763164|12380003|FG000|Treatment Phase|Progressive Disease|142
7881684|NCT01763164|12380004|FG001|Treatment Phase|Progressive Disease|76
7881685|NCT01763164|12380003|FG000|Treatment Phase|Physician Decision|24
7881686|NCT01763164|12380004|FG001|Treatment Phase|Physician Decision|13
7881687|NCT01763164|12380003|FG000|Treatment Phase|Death|10
7881688|NCT01763164|12380004|FG001|Treatment Phase|Death|1
7881689|NCT01763164|12380003|FG000|Treatment Phase|Adverse Event|66
7881690|NCT01763164|12380004|FG001|Treatment Phase|Adverse Event|8
7881691|NCT01763164|12380003|FG000|Treatment Phase|Randomized but not Treated|0
7881692|NCT01763164|12380004|FG001|Treatment Phase|Randomized but not Treated|19
7881693|NCT01763164|12380003|FG000|Treatment Phase|Other|0
7881694|NCT01763164|12380004|FG001|Treatment Phase|Other|1
7881695|NCT01763164|12380003|FG000|Follow up Phase|New therapy for study indication|12
7881696|NCT01763164|12380004|FG001|Follow up Phase|New therapy for study indication|3
7881697|NCT01763164|12380003|FG000|Follow up Phase|Death|21
7881698|NCT01763164|12380004|FG001|Follow up Phase|Death|4
7881699|NCT01763164|12380003|FG000|Follow up Phase|Subject/guardian decision|9
7881700|NCT01763164|12380004|FG001|Follow up Phase|Subject/guardian decision|2
7881701|NCT01763164|12380003|FG000|Follow up Phase|Progressive disease|127
7881702|NCT01763164|12380004|FG001|Follow up Phase|Progressive disease|62
7881703|NCT01763164|12380003|FG000|Follow up Phase|Physician Decision|10
7881704|NCT01763164|12380004|FG001|Follow up Phase|Physician Decision|3
7881705|NCT01763164|12380003|FG000|Follow up Phase|Lost to Follow-up|1
7881706|NCT01763164|12380004|FG001|Follow up Phase|Lost to Follow-up|0
7881707|NCT01763164|12380003|FG000|Follow up Phase|Adverse Event|17
7881708|NCT01763164|12380004|FG001|Follow up Phase|Adverse Event|1
7881709|NCT01763203|12380012|FG000|Overall Study|Death|4
7881710|NCT01763203|12380013|FG001|Overall Study|Death|7
7881711|NCT01763203|12380012|FG000|Overall Study|Lost to Follow-up|12
7881712|NCT01763203|12380013|FG001|Overall Study|Lost to Follow-up|12
7881713|NCT01763203|12380012|FG000|Overall Study|Withdrawal by Subject|8
7881714|NCT01763203|12380013|FG001|Overall Study|Withdrawal by Subject|12
7881715|NCT01763203|12380012|FG000|Overall Study|Moved out of study region|7
7881716|NCT01763203|12380013|FG001|Overall Study|Moved out of study region|10
7881717|NCT01763203|12380012|FG000|Overall Study|Physician Decision|2
7881718|NCT01763203|12380013|FG001|Overall Study|Physician Decision|1
7881719|NCT01763684|12380115|FG000|Overall Study|Study terminated early due to low enrollment|126
7881720|NCT01763684|12380116|FG001|Overall Study|Study terminated early due to low enrollment|127
7881721|NCT01763684|12380115|FG000|Overall Study|Study surgery not performed|7
7881722|NCT01763684|12380116|FG001|Overall Study|Study surgery not performed|6
7881723|NCT01763827|12380128|FG000|Overall Study|Withdrawal by Subject|1
7881724|NCT01763827|12380129|FG001|Overall Study|Withdrawal by Subject|0
7881725|NCT01763827|12380130|FG002|Overall Study|Withdrawal by Subject|0
7881726|NCT01763827|12380131|FG003|Overall Study|Withdrawal by Subject|0
7881727|NCT01763827|12380132|FG004|Overall Study|Withdrawal by Subject|2
7881728|NCT01763827|12380133|FG005|Overall Study|Withdrawal by Subject|0
7881729|NCT01763827|12380128|FG000|Overall Study|Decision by sponsor|2
7881730|NCT01763827|12380129|FG001|Overall Study|Decision by sponsor|0
7881731|NCT01763827|12380130|FG002|Overall Study|Decision by sponsor|3
7881732|NCT01763827|12380131|FG003|Overall Study|Decision by sponsor|0
7881733|NCT01763827|12380132|FG004|Overall Study|Decision by sponsor|2
7881734|NCT01763827|12380133|FG005|Overall Study|Decision by sponsor|1
7881735|NCT01763827|12380128|FG000|Overall Study|Lost to Follow-up|0
7881736|NCT01763827|12380129|FG001|Overall Study|Lost to Follow-up|1
7881737|NCT01763827|12380130|FG002|Overall Study|Lost to Follow-up|1
7881738|NCT01763827|12380131|FG003|Overall Study|Lost to Follow-up|1
7881739|NCT01763827|12380132|FG004|Overall Study|Lost to Follow-up|2
7881740|NCT01763827|12380133|FG005|Overall Study|Lost to Follow-up|1
7881741|NCT01763866|12380171|FG000|Overall Study|Withdrawal by Subject|2
7881742|NCT01763866|12380172|FG001|Overall Study|Withdrawal by Subject|1
7881743|NCT01763866|12380173|FG002|Overall Study|Withdrawal by Subject|4
7881744|NCT01763866|12380174|FG003|Overall Study|Withdrawal by Subject|0
7881745|NCT01763866|12380175|FG004|Overall Study|Withdrawal by Subject|0
7881746|NCT01763866|12380176|FG005|Overall Study|Withdrawal by Subject|3
7881747|NCT01763866|12380177|FG006|Overall Study|Withdrawal by Subject|4
7881748|NCT01763866|12380178|FG007|Overall Study|Withdrawal by Subject|0
7881749|NCT01763866|12380179|FG008|Overall Study|Withdrawal by Subject|1
7881750|NCT01763866|12380180|FG009|Overall Study|Withdrawal by Subject|1
7881751|NCT01763866|12380181|FG010|Overall Study|Withdrawal by Subject|2
7881752|NCT01763866|12380182|FG011|Overall Study|Withdrawal by Subject|2
7881753|NCT01763866|12380183|FG012|Overall Study|Withdrawal by Subject|2
7881754|NCT01763866|12380184|FG013|Overall Study|Withdrawal by Subject|0
7881755|NCT01763866|12380185|FG014|Overall Study|Withdrawal by Subject|6
7881756|NCT01763866|12380186|FG015|Overall Study|Withdrawal by Subject|3
7881757|NCT01763866|12380187|FG016|Overall Study|Withdrawal by Subject|0
7881758|NCT01763866|12380188|FG017|Overall Study|Withdrawal by Subject|1
7881759|NCT01763866|12380189|FG018|Overall Study|Withdrawal by Subject|1
7881760|NCT01763866|12380190|FG019|Overall Study|Withdrawal by Subject|1
7881761|NCT01763866|12380191|FG020|Overall Study|Withdrawal by Subject|2
7881762|NCT01763866|12380192|FG021|Overall Study|Withdrawal by Subject|1
7881763|NCT01763866|12380193|FG022|Overall Study|Withdrawal by Subject|2
7881764|NCT01763866|12380194|FG023|Overall Study|Withdrawal by Subject|1
7881765|NCT01763866|12380171|FG000|Overall Study|Decision by sponsor|0
7881766|NCT01763866|12380172|FG001|Overall Study|Decision by sponsor|0
7881767|NCT01763866|12380173|FG002|Overall Study|Decision by sponsor|1
7881768|NCT01763866|12380174|FG003|Overall Study|Decision by sponsor|0
7881769|NCT01763866|12380175|FG004|Overall Study|Decision by sponsor|2
7881770|NCT01763866|12380176|FG005|Overall Study|Decision by sponsor|0
7881771|NCT01763866|12380177|FG006|Overall Study|Decision by sponsor|2
7881772|NCT01763866|12380178|FG007|Overall Study|Decision by sponsor|0
7881773|NCT01763866|12380179|FG008|Overall Study|Decision by sponsor|2
7881774|NCT01763866|12380180|FG009|Overall Study|Decision by sponsor|0
7881775|NCT01763866|12380181|FG010|Overall Study|Decision by sponsor|6
7881776|NCT01763866|12380182|FG011|Overall Study|Decision by sponsor|0
7881777|NCT01763866|12380183|FG012|Overall Study|Decision by sponsor|1
7881778|NCT01763866|12380184|FG013|Overall Study|Decision by sponsor|0
7881779|NCT01763866|12380185|FG014|Overall Study|Decision by sponsor|5
7881780|NCT01763866|12380186|FG015|Overall Study|Decision by sponsor|0
7881781|NCT01763866|12380187|FG016|Overall Study|Decision by sponsor|0
7881782|NCT01763866|12380188|FG017|Overall Study|Decision by sponsor|0
7881783|NCT01763866|12380189|FG018|Overall Study|Decision by sponsor|4
7881784|NCT01763866|12380190|FG019|Overall Study|Decision by sponsor|0
7881785|NCT01763866|12380191|FG020|Overall Study|Decision by sponsor|2
7881786|NCT01763866|12380192|FG021|Overall Study|Decision by sponsor|0
7881787|NCT01763866|12380193|FG022|Overall Study|Decision by sponsor|1
7881788|NCT01763866|12380194|FG023|Overall Study|Decision by sponsor|0
7881789|NCT01763866|12380171|FG000|Overall Study|Lost to Follow-up|0
7881790|NCT01763866|12380172|FG001|Overall Study|Lost to Follow-up|0
7881791|NCT01763866|12380173|FG002|Overall Study|Lost to Follow-up|0
7881792|NCT01763866|12380174|FG003|Overall Study|Lost to Follow-up|0
7881793|NCT01763866|12380175|FG004|Overall Study|Lost to Follow-up|0
7881794|NCT01763866|12380176|FG005|Overall Study|Lost to Follow-up|0
7881795|NCT01763866|12380177|FG006|Overall Study|Lost to Follow-up|1
7881796|NCT01763866|12380178|FG007|Overall Study|Lost to Follow-up|0
7881797|NCT01763866|12380179|FG008|Overall Study|Lost to Follow-up|0
7881798|NCT01763866|12380180|FG009|Overall Study|Lost to Follow-up|0
7881799|NCT01763866|12380181|FG010|Overall Study|Lost to Follow-up|0
7881800|NCT01763866|12380182|FG011|Overall Study|Lost to Follow-up|0
7881801|NCT01763866|12380183|FG012|Overall Study|Lost to Follow-up|1
7881802|NCT01763866|12380184|FG013|Overall Study|Lost to Follow-up|0
7881803|NCT01763866|12380185|FG014|Overall Study|Lost to Follow-up|1
7881804|NCT01763866|12380186|FG015|Overall Study|Lost to Follow-up|0
7881805|NCT01763866|12380187|FG016|Overall Study|Lost to Follow-up|0
7881806|NCT01763866|12380188|FG017|Overall Study|Lost to Follow-up|0
7881807|NCT01763866|12380189|FG018|Overall Study|Lost to Follow-up|1
7881808|NCT01763866|12380190|FG019|Overall Study|Lost to Follow-up|1
7881809|NCT01763866|12380191|FG020|Overall Study|Lost to Follow-up|0
7881810|NCT01763866|12380192|FG021|Overall Study|Lost to Follow-up|0
7881811|NCT01763866|12380193|FG022|Overall Study|Lost to Follow-up|0
7881812|NCT01763866|12380194|FG023|Overall Study|Lost to Follow-up|1
7881813|NCT01763866|12380171|FG000|Overall Study|Death|0
7881814|NCT01763866|12380172|FG001|Overall Study|Death|0
7881815|NCT01763866|12380173|FG002|Overall Study|Death|0
7881816|NCT01763866|12380174|FG003|Overall Study|Death|0
7881817|NCT01763866|12380175|FG004|Overall Study|Death|0
7881818|NCT01763866|12380176|FG005|Overall Study|Death|0
7881819|NCT01763866|12380177|FG006|Overall Study|Death|0
7881820|NCT01763866|12380178|FG007|Overall Study|Death|0
7881821|NCT01763866|12380179|FG008|Overall Study|Death|0
7881822|NCT01763866|12380180|FG009|Overall Study|Death|0
7881823|NCT01763866|12380181|FG010|Overall Study|Death|0
7881824|NCT01763866|12380182|FG011|Overall Study|Death|0
7881825|NCT01763866|12380183|FG012|Overall Study|Death|0
7881826|NCT01763866|12380184|FG013|Overall Study|Death|0
7881827|NCT01763866|12380185|FG014|Overall Study|Death|0
7881828|NCT01763866|12380186|FG015|Overall Study|Death|0
7881829|NCT01763866|12380187|FG016|Overall Study|Death|1
7881830|NCT01763866|12380188|FG017|Overall Study|Death|0
7881831|NCT01763866|12380189|FG018|Overall Study|Death|0
7881832|NCT01763866|12380190|FG019|Overall Study|Death|0
7881833|NCT01763866|12380191|FG020|Overall Study|Death|0
7881834|NCT01763866|12380192|FG021|Overall Study|Death|0
7881835|NCT01763866|12380193|FG022|Overall Study|Death|0
7881836|NCT01763866|12380194|FG023|Overall Study|Death|0
7881837|NCT01763905|12380248|FG000|Overall Study|Withdrawal by Subject|1
7881838|NCT01763905|12380249|FG001|Overall Study|Withdrawal by Subject|1
7881839|NCT01763905|12380250|FG002|Overall Study|Withdrawal by Subject|0
7881840|NCT01763905|12380251|FG003|Overall Study|Withdrawal by Subject|1
7881841|NCT01763905|12380248|FG000|Overall Study|Decision by sponsor|5
7881842|NCT01763905|12380249|FG001|Overall Study|Decision by sponsor|0
7881843|NCT01763905|12380250|FG002|Overall Study|Decision by sponsor|8
7881844|NCT01763905|12380251|FG003|Overall Study|Decision by sponsor|0
7881845|NCT01763905|12380248|FG000|Overall Study|Lost to Follow-up|0
7881846|NCT01763905|12380249|FG001|Overall Study|Lost to Follow-up|0
7881847|NCT01763905|12380250|FG002|Overall Study|Lost to Follow-up|1
7881848|NCT01763905|12380251|FG003|Overall Study|Lost to Follow-up|0
7883287|NCT01781429|12382958|FG009|Overall Study|Withdrawal by Subject|3
7883288|NCT01781429|12382959|FG010|Overall Study|Withdrawal by Subject|1
7883289|NCT01781429|12382960|FG011|Overall Study|Withdrawal by Subject|1
7883290|NCT01781429|12382961|FG012|Overall Study|Withdrawal by Subject|5
7883291|NCT01781429|12382962|FG013|Overall Study|Withdrawal by Subject|2
7883292|NCT01781429|12382963|FG014|Overall Study|Withdrawal by Subject|3
7883293|NCT01781429|12382964|FG015|Overall Study|Withdrawal by Subject|0
7883294|NCT01781429|12382949|FG000|Overall Study|Disease Progression|1
7883295|NCT01781429|12382950|FG001|Overall Study|Disease Progression|0
7883296|NCT01781429|12382951|FG002|Overall Study|Disease Progression|1
7883297|NCT01781429|12382952|FG003|Overall Study|Disease Progression|1
7883298|NCT01781429|12382953|FG004|Overall Study|Disease Progression|1
7883299|NCT01781429|12382954|FG005|Overall Study|Disease Progression|4
7883300|NCT01781429|12382955|FG006|Overall Study|Disease Progression|7
7883301|NCT01781429|12382956|FG007|Overall Study|Disease Progression|4
7883302|NCT01781429|12382957|FG008|Overall Study|Disease Progression|6
7883303|NCT01781429|12382958|FG009|Overall Study|Disease Progression|15
7883304|NCT01781429|12382959|FG010|Overall Study|Disease Progression|15
7883305|NCT01781429|12382960|FG011|Overall Study|Disease Progression|15
7883306|NCT01781429|12382961|FG012|Overall Study|Disease Progression|15
7883307|NCT01781429|12382962|FG013|Overall Study|Disease Progression|4
7883308|NCT01781429|12382963|FG014|Overall Study|Disease Progression|11
7883309|NCT01781429|12382964|FG015|Overall Study|Disease Progression|0
7883310|NCT01781429|12382949|FG000|Overall Study|Unacceptable Toxicity|0
7883311|NCT01781429|12382950|FG001|Overall Study|Unacceptable Toxicity|0
7883312|NCT01781429|12382951|FG002|Overall Study|Unacceptable Toxicity|0
7883313|NCT01781429|12382952|FG003|Overall Study|Unacceptable Toxicity|0
7883314|NCT01781429|12382953|FG004|Overall Study|Unacceptable Toxicity|0
7883315|NCT01781429|12382954|FG005|Overall Study|Unacceptable Toxicity|0
7883316|NCT01781429|12382955|FG006|Overall Study|Unacceptable Toxicity|0
7883317|NCT01781429|12382956|FG007|Overall Study|Unacceptable Toxicity|0
7883318|NCT01781429|12382957|FG008|Overall Study|Unacceptable Toxicity|0
7883319|NCT01781429|12382958|FG009|Overall Study|Unacceptable Toxicity|0
7883320|NCT01781429|12382959|FG010|Overall Study|Unacceptable Toxicity|0
7883321|NCT01781429|12382960|FG011|Overall Study|Unacceptable Toxicity|2
7883322|NCT01781429|12382961|FG012|Overall Study|Unacceptable Toxicity|0
7883323|NCT01781429|12382962|FG013|Overall Study|Unacceptable Toxicity|0
7883324|NCT01781429|12382963|FG014|Overall Study|Unacceptable Toxicity|0
7883325|NCT01781429|12382964|FG015|Overall Study|Unacceptable Toxicity|0
7883326|NCT01781429|12382949|FG000|Overall Study|Patient Condition Changed|0
7883327|NCT01781429|12382950|FG001|Overall Study|Patient Condition Changed|0
7883328|NCT01781429|12382951|FG002|Overall Study|Patient Condition Changed|0
7883329|NCT01781429|12382952|FG003|Overall Study|Patient Condition Changed|0
7883330|NCT01781429|12382953|FG004|Overall Study|Patient Condition Changed|0
7883331|NCT01781429|12382954|FG005|Overall Study|Patient Condition Changed|0
7883332|NCT01781429|12382955|FG006|Overall Study|Patient Condition Changed|0
7883333|NCT01781429|12382956|FG007|Overall Study|Patient Condition Changed|0
7883334|NCT01781429|12382957|FG008|Overall Study|Patient Condition Changed|0
7883335|NCT01781429|12382958|FG009|Overall Study|Patient Condition Changed|4
7883336|NCT01781429|12382959|FG010|Overall Study|Patient Condition Changed|0
7883337|NCT01781429|12382960|FG011|Overall Study|Patient Condition Changed|1
7883338|NCT01781429|12382961|FG012|Overall Study|Patient Condition Changed|0
7883339|NCT01781429|12382962|FG013|Overall Study|Patient Condition Changed|1
7883340|NCT01781429|12382963|FG014|Overall Study|Patient Condition Changed|0
7883341|NCT01781429|12382964|FG015|Overall Study|Patient Condition Changed|0
7883342|NCT01781429|12382949|FG000|Overall Study|Other - as entered by PI in eCRF|0
7883343|NCT01781429|12382950|FG001|Overall Study|Other - as entered by PI in eCRF|1
7883344|NCT01781429|12382951|FG002|Overall Study|Other - as entered by PI in eCRF|0
7883345|NCT01781429|12382952|FG003|Overall Study|Other - as entered by PI in eCRF|0
7883346|NCT01781429|12382953|FG004|Overall Study|Other - as entered by PI in eCRF|0
7883347|NCT01781429|12382954|FG005|Overall Study|Other - as entered by PI in eCRF|0
7883348|NCT01781429|12382955|FG006|Overall Study|Other - as entered by PI in eCRF|0
7883349|NCT01781429|12382956|FG007|Overall Study|Other - as entered by PI in eCRF|0
7883350|NCT01781429|12382957|FG008|Overall Study|Other - as entered by PI in eCRF|0
7883351|NCT01781429|12382958|FG009|Overall Study|Other - as entered by PI in eCRF|1
7883352|NCT01781429|12382959|FG010|Overall Study|Other - as entered by PI in eCRF|1
7883353|NCT01781429|12382960|FG011|Overall Study|Other - as entered by PI in eCRF|2
7883354|NCT01781429|12382961|FG012|Overall Study|Other - as entered by PI in eCRF|1
7883355|NCT01781429|12382962|FG013|Overall Study|Other - as entered by PI in eCRF|1
7883356|NCT01781429|12382963|FG014|Overall Study|Other - as entered by PI in eCRF|1
7883357|NCT01781429|12382964|FG015|Overall Study|Other - as entered by PI in eCRF|0
7883358|NCT01781429|12382949|FG000|Overall Study|Enrolled, but not treated|0
7883359|NCT01781429|12382950|FG001|Overall Study|Enrolled, but not treated|0
7883360|NCT01781429|12382951|FG002|Overall Study|Enrolled, but not treated|0
7883361|NCT01781429|12382952|FG003|Overall Study|Enrolled, but not treated|0
7883362|NCT01781429|12382953|FG004|Overall Study|Enrolled, but not treated|0
7883363|NCT01781429|12382954|FG005|Overall Study|Enrolled, but not treated|0
7883364|NCT01781429|12382955|FG006|Overall Study|Enrolled, but not treated|0
7881849|NCT01763918|12380265|FG000|Overall Study|Withdrawal by Subject|2
7881850|NCT01763918|12380266|FG001|Overall Study|Withdrawal by Subject|1
7881851|NCT01763918|12380267|FG002|Overall Study|Withdrawal by Subject|1
7881852|NCT01763918|12380268|FG003|Overall Study|Withdrawal by Subject|2
7881853|NCT01763918|12380265|FG000|Overall Study|Sponsor Decision|4
7881854|NCT01763918|12380266|FG001|Overall Study|Sponsor Decision|0
7881855|NCT01763918|12380267|FG002|Overall Study|Sponsor Decision|9
7881856|NCT01763918|12380268|FG003|Overall Study|Sponsor Decision|0
7881857|NCT01763996|12380294|FG000|Treatment Period 2|Adverse Event|0
7881858|NCT01763996|12380295|FG001|Treatment Period 2|Adverse Event|1
7881859|NCT01764022|12380303|FG000|Overall Study|Death|3
7881860|NCT01764022|12380304|FG001|Overall Study|Death|5
7881861|NCT01764022|12380303|FG000|Overall Study|Withdrawal by Subject|2
7881862|NCT01764022|12380304|FG001|Overall Study|Withdrawal by Subject|6
7881863|NCT01764022|12380303|FG000|Overall Study|Lack of Efficacy|0
7881864|NCT01764022|12380304|FG001|Overall Study|Lack of Efficacy|1
7881865|NCT01764022|12380303|FG000|Overall Study|Physician Decision|0
7881866|NCT01764022|12380304|FG001|Overall Study|Physician Decision|2
7881867|NCT01764022|12380303|FG000|Overall Study|Lost to Follow-up|2
7881868|NCT01764022|12380304|FG001|Overall Study|Lost to Follow-up|0
7881869|NCT01764022|12380303|FG000|Overall Study|Protocol Violation|1
7881870|NCT01764022|12380304|FG001|Overall Study|Protocol Violation|0
7881871|NCT01764256|12380316|FG000|Received All Vaccinations|Adverse Event|1
7881872|NCT01764256|12380317|FG001|Received All Vaccinations|Adverse Event|1
7881873|NCT01764256|12380318|FG002|Received All Vaccinations|Adverse Event|0
7881874|NCT01764256|12380319|FG003|Received All Vaccinations|Adverse Event|0
7881875|NCT01764256|12380316|FG000|Received All Vaccinations|Did not meet inclusion criteria|0
7881876|NCT01764256|12380317|FG001|Received All Vaccinations|Did not meet inclusion criteria|0
7881877|NCT01764256|12380318|FG002|Received All Vaccinations|Did not meet inclusion criteria|1
7881878|NCT01764256|12380319|FG003|Received All Vaccinations|Did not meet inclusion criteria|0
7881879|NCT01764256|12380316|FG000|Received All Vaccinations|Lost to Follow-up|1
7881880|NCT01764256|12380317|FG001|Received All Vaccinations|Lost to Follow-up|0
7881881|NCT01764256|12380318|FG002|Received All Vaccinations|Lost to Follow-up|0
7881882|NCT01764256|12380319|FG003|Received All Vaccinations|Lost to Follow-up|0
7881883|NCT01764256|12380316|FG000|Completed Study|Lost to Follow-up|0
7881884|NCT01764256|12380317|FG001|Completed Study|Lost to Follow-up|0
7881885|NCT01764256|12380318|FG002|Completed Study|Lost to Follow-up|0
7881886|NCT01764256|12380319|FG003|Completed Study|Lost to Follow-up|1
7881887|NCT01764386|12380335|FG000|Controlled Treatment Period (CTP)|Adverse Event|35
7881888|NCT01764386|12380336|FG001|Controlled Treatment Period (CTP)|Adverse Event|0
7881889|NCT01764386|12380335|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
7881890|NCT01764386|12380336|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
7881891|NCT01764386|12380335|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9
7881892|NCT01764386|12380336|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5
7881893|NCT01764386|12380335|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
7881894|NCT01764386|12380336|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
7881895|NCT01764386|12380335|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2
7881896|NCT01764386|12380336|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13
7881897|NCT01764386|12380335|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
7881898|NCT01764386|12380336|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
7881899|NCT01764386|12380335|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
7881900|NCT01764386|12380336|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
7881901|NCT01764386|12380335|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
7881902|NCT01764386|12380336|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
7881903|NCT01764464|12380345|FG000|First Intervention|Withdrawal by Subject|1
7881904|NCT01764464|12380346|FG001|First Intervention|Withdrawal by Subject|0
7881905|NCT01764464|12380345|FG000|First Intervention|Lost to Follow-up|1
7881906|NCT01764464|12380346|FG001|First Intervention|Lost to Follow-up|0
7881907|NCT01764464|12380345|FG000|First Intervention|Adverse Event|0
7881908|NCT01764464|12380346|FG001|First Intervention|Adverse Event|2
7881909|NCT01764464|12380345|FG000|First Intervention|did not receive study drug|0
7881910|NCT01764464|12380346|FG001|First Intervention|did not receive study drug|1
7881911|NCT01764464|12380345|FG000|Second Intervention (Cross-over)|Adverse Event|2
7881912|NCT01764464|12380346|FG001|Second Intervention (Cross-over)|Adverse Event|0
7881913|NCT01764659|12380356|FG000|Overall Study|Death|1
7881914|NCT01764659|12380356|FG000|Overall Study|Physician Decision|1
7881915|NCT01764841|12380375|FG000|Overall Study|Logistical Difficulties|0
7881916|NCT01764841|12380376|FG001|Overall Study|Logistical Difficulties|1
7881917|NCT01764841|12380377|FG002|Overall Study|Logistical Difficulties|0
7881918|NCT01764841|12380378|FG003|Overall Study|Logistical Difficulties|0
7881919|NCT01764841|12380375|FG000|Overall Study|Death|3
7881920|NCT01764841|12380376|FG001|Overall Study|Death|0
7881921|NCT01764841|12380377|FG002|Overall Study|Death|1
7881922|NCT01764841|12380378|FG003|Overall Study|Death|4
7881923|NCT01764841|12380375|FG000|Overall Study|No Follow Up|1
7881924|NCT01764841|12380376|FG001|Overall Study|No Follow Up|0
7881925|NCT01764841|12380377|FG002|Overall Study|No Follow Up|1
7881926|NCT01764841|12380378|FG003|Overall Study|No Follow Up|0
7881927|NCT01764841|12380375|FG000|Overall Study|Protocol Violation|0
7881928|NCT01764841|12380376|FG001|Overall Study|Protocol Violation|1
7881929|NCT01764841|12380377|FG002|Overall Study|Protocol Violation|0
7881930|NCT01764841|12380378|FG003|Overall Study|Protocol Violation|0
7881931|NCT01764841|12380375|FG000|Overall Study|Withdrawal by Subject|16
7881932|NCT01764841|12380376|FG001|Overall Study|Withdrawal by Subject|24
7881933|NCT01764841|12380377|FG002|Overall Study|Withdrawal by Subject|11
7881934|NCT01764841|12380378|FG003|Overall Study|Withdrawal by Subject|15
7881935|NCT01764841|12380375|FG000|Overall Study|Lost to Follow-up|3
7881936|NCT01764841|12380376|FG001|Overall Study|Lost to Follow-up|0
7881937|NCT01764841|12380377|FG002|Overall Study|Lost to Follow-up|1
7881938|NCT01764841|12380378|FG003|Overall Study|Lost to Follow-up|0
7881939|NCT01764854|12380392|FG000|Overall Study|Adverse Event|0
7881940|NCT01764854|12380393|FG001|Overall Study|Adverse Event|0
7881941|NCT01764854|12380394|FG002|Overall Study|Adverse Event|2
7881942|NCT01764854|12380395|FG003|Overall Study|Adverse Event|0
7881943|NCT01764854|12380392|FG000|Overall Study|Withdrawal by Subject|0
7881944|NCT01764854|12380393|FG001|Overall Study|Withdrawal by Subject|0
7881945|NCT01764854|12380394|FG002|Overall Study|Withdrawal by Subject|1
7881946|NCT01764854|12380395|FG003|Overall Study|Withdrawal by Subject|0
7881947|NCT01764854|12380392|FG000|Overall Study|relocation|0
7881948|NCT01764854|12380393|FG001|Overall Study|relocation|0
7881949|NCT01764854|12380394|FG002|Overall Study|relocation|2
7881950|NCT01764854|12380395|FG003|Overall Study|relocation|0
7881951|NCT01764854|12380392|FG000|Overall Study|Protocol Violation|0
7881952|NCT01764854|12380393|FG001|Overall Study|Protocol Violation|0
7881953|NCT01764854|12380394|FG002|Overall Study|Protocol Violation|1
7881954|NCT01764854|12380395|FG003|Overall Study|Protocol Violation|2
7881955|NCT01764945|12380417|FG000|Overall Study|Adverse Event|0
7881956|NCT01764945|12380418|FG001|Overall Study|Adverse Event|1
7881957|NCT01764945|12380419|FG002|Overall Study|Adverse Event|0
7881958|NCT01764945|12380420|FG003|Overall Study|Adverse Event|0
7881959|NCT01764945|12380421|FG004|Overall Study|Adverse Event|0
7881960|NCT01764945|12380422|FG005|Overall Study|Adverse Event|0
7881961|NCT01764945|12380423|FG006|Overall Study|Adverse Event|1
7881962|NCT01764945|12380424|FG007|Overall Study|Adverse Event|0
7881963|NCT01765153|12380444|FG000|Training Phase 1|Format of intervention differed|1
7881964|NCT01765153|12380445|FG001|Training Phase 1|Format of intervention differed|0
7881965|NCT01765153|12380444|FG000|Training Phase 1|Poor participation in intervention|0
7881966|NCT01765153|12380445|FG001|Training Phase 1|Poor participation in intervention|1
7881967|NCT01765153|12380444|FG000|Rest Phase 1|Withdrawal by Subject|0
7881968|NCT01765153|12380445|FG001|Rest Phase 1|Withdrawal by Subject|1
7881969|NCT01765153|12380444|FG000|Training Phase 2|Withdrawal by Subject|0
7881970|NCT01765153|12380445|FG001|Training Phase 2|Withdrawal by Subject|1
7881971|NCT01765153|12380444|FG000|Rest Phase 2|Lost to Follow-up|2
7881972|NCT01765153|12380445|FG001|Rest Phase 2|Lost to Follow-up|1
7881973|NCT01765179|12380455|FG000|Overall Study|Adverse Event|3
7881974|NCT01765179|12380455|FG000|Overall Study|Lost to Follow-up|5
7881975|NCT01765179|12380455|FG000|Overall Study|Non-compliance with study drug|2
7881976|NCT01765179|12380455|FG000|Overall Study|Protocol Violation|1
7881977|NCT01765179|12380455|FG000|Overall Study|Withdrawal by Subject|8
7881978|NCT01765179|12380455|FG000|Overall Study|Hematocrit >54%|3
7881979|NCT01765179|12380455|FG000|Overall Study|prohibited med|1
7881980|NCT01765179|12380455|FG000|Overall Study|Out of country unable to finish study|1
7881981|NCT01765179|12380455|FG000|Overall Study|lack of venous access|1
7881982|NCT01765179|12380455|FG000|Overall Study|work conflict|1
7881983|NCT01765179|12380455|FG000|Overall Study|Ca elevated 10.6|1
7881984|NCT01765192|12380461|FG000|Treatment Period 1|Adverse Event|0
7881985|NCT01765192|12380462|FG001|Treatment Period 1|Adverse Event|1
7881986|NCT01765192|12380461|FG000|Washout Period|Voluntary Withdrawal|1
7881987|NCT01765192|12380462|FG001|Washout Period|Voluntary Withdrawal|1
7881988|NCT01765192|12380461|FG000|Washout Period|Reason not specified|1
7881989|NCT01765192|12380462|FG001|Washout Period|Reason not specified|0
7881990|NCT01765192|12380461|FG000|Treatment Period 2|Reason not specified|0
7881991|NCT01765192|12380462|FG001|Treatment Period 2|Reason not specified|2
7881992|NCT01765192|12380461|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0
7881993|NCT01765192|12380462|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1
7881994|NCT01765270|12380470|FG000|Overall Study|Physician Decision|1
7881995|NCT01765270|12380471|FG001|Overall Study|Physician Decision|0
7881996|NCT01765270|12380470|FG000|Overall Study|Withdrawal by Subject|0
7881997|NCT01765270|12380471|FG001|Overall Study|Withdrawal by Subject|1
7881998|NCT01765426|12380482|FG000|Overall Study|Lost to Follow-up|0
7881999|NCT01765426|12380483|FG001|Overall Study|Lost to Follow-up|1
7882000|NCT01765426|12380484|FG002|Overall Study|Lost to Follow-up|0
7882001|NCT01765426|12380485|FG003|Overall Study|Lost to Follow-up|0
7882002|NCT01765543|12380515|FG000|Overall Study|Death|1
7882003|NCT01765543|12380515|FG000|Overall Study|Withdrawal by Subject|2
7882004|NCT01765569|12380523|FG000|Period B|Withdrawal by Subject|1
7882005|NCT01765569|12380523|FG000|Period C|Death|1
7882006|NCT01765582|12380533|FG000|Overall Study|Other|3
7882007|NCT01765582|12380534|FG001|Overall Study|Other|6
7882008|NCT01765582|12380535|FG002|Overall Study|Other|9
7882009|NCT01765582|12380533|FG000|Overall Study|Lost to Follow-up|2
7882010|NCT01765582|12380534|FG001|Overall Study|Lost to Follow-up|2
7882011|NCT01765582|12380535|FG002|Overall Study|Lost to Follow-up|1
7882012|NCT01765582|12380533|FG000|Overall Study|Death|31
7882013|NCT01765582|12380534|FG001|Overall Study|Death|36
7882014|NCT01765582|12380535|FG002|Overall Study|Death|33
7882015|NCT01765582|12380533|FG000|Overall Study|Sponsor Decision|46
7882016|NCT01765582|12380534|FG001|Overall Study|Sponsor Decision|42
7882017|NCT01765582|12380535|FG002|Overall Study|Sponsor Decision|42
7882018|NCT01765582|12380533|FG000|Overall Study|Withdrawal of Consent|11
7882019|NCT01765582|12380534|FG001|Overall Study|Withdrawal of Consent|6
7882020|NCT01765582|12380535|FG002|Overall Study|Withdrawal of Consent|10
7882021|NCT01765673|12380548|FG000|Overall Study|No transportation for 2nd/3rd visits|1
7882022|NCT01765751|12380567|FG000|Overall Study|Lost to Follow-up|0
7882023|NCT01765751|12380568|FG001|Overall Study|Lost to Follow-up|2
7882024|NCT01765751|12380569|FG002|Overall Study|Lost to Follow-up|1
7882025|NCT01765764|12380583|FG000|Treatment Period|Adverse Event|1
7882026|NCT01765764|12380584|FG001|Treatment Period|Adverse Event|2
7882027|NCT01765764|12380585|FG002|Treatment Period|Adverse Event|1
7882028|NCT01765764|12380583|FG000|Treatment Period|Lost to Follow-up|0
7882029|NCT01765764|12380584|FG001|Treatment Period|Lost to Follow-up|3
7882030|NCT01765764|12380585|FG002|Treatment Period|Lost to Follow-up|2
7882031|NCT01765764|12380583|FG000|Treatment Period|Personal Reasons|1
7882032|NCT01765764|12380584|FG001|Treatment Period|Personal Reasons|2
7882033|NCT01765764|12380585|FG002|Treatment Period|Personal Reasons|1
7882034|NCT01765764|12380583|FG000|Treatment Period|Other Miscellaneous Reasons|1
7882035|NCT01765764|12380584|FG001|Treatment Period|Other Miscellaneous Reasons|2
7882036|NCT01765764|12380585|FG002|Treatment Period|Other Miscellaneous Reasons|2
7882037|NCT01765920|12380599|FG000|Overall Study|Incorrect inclusion ineligible patient|2
7882038|NCT01765920|12380600|FG001|Overall Study|Incorrect inclusion ineligible patient|5
7882039|NCT01765920|12380599|FG000|Overall Study|Patient code disclosure|0
7882040|NCT01765920|12380600|FG001|Overall Study|Patient code disclosure|1
7882041|NCT01766037|12380632|FG000|Overall Study|Adverse Event|1
7882042|NCT01766037|12380633|FG001|Overall Study|Adverse Event|0
7882043|NCT01766037|12380632|FG000|Overall Study|Lack of Efficacy|1
7882044|NCT01766037|12380633|FG001|Overall Study|Lack of Efficacy|0
7882045|NCT01766037|12380632|FG000|Overall Study|Lost to Follow-up|0
7882046|NCT01766037|12380633|FG001|Overall Study|Lost to Follow-up|10
7882047|NCT01766037|12380632|FG000|Overall Study|Physician Decision|0
7882048|NCT01766037|12380633|FG001|Overall Study|Physician Decision|1
7882049|NCT01766037|12380632|FG000|Overall Study|Withdrawal by Subject|18
7882050|NCT01766037|12380633|FG001|Overall Study|Withdrawal by Subject|16
7882051|NCT01766037|12380632|FG000|Overall Study|Moved from area|5
7882052|NCT01766037|12380633|FG001|Overall Study|Moved from area|0
7882053|NCT01766037|12380632|FG000|Overall Study|medical - unrelated|1
7882054|NCT01766037|12380633|FG001|Overall Study|medical - unrelated|2
7882055|NCT01766037|12380632|FG000|Overall Study|nausea / discomfort|3
7882056|NCT01766037|12380633|FG001|Overall Study|nausea / discomfort|0
7882057|NCT01766050|12380639|FG000|Overall Study|Adverse Event|1
7882058|NCT01766050|12380639|FG000|Overall Study|Lost to Follow-up|1
7882059|NCT01766050|12380639|FG000|Overall Study|Withdrawal by Subject|2
7882060|NCT01766206|12380675|FG000|Overall Study|Withdrawal by Subject|22
7882061|NCT01766206|12380675|FG000|Overall Study|Lost to Follow-up|10
7882062|NCT01766206|12380675|FG000|Overall Study|Inappropriate enrollment|18
7882063|NCT01766206|12380675|FG000|Overall Study|Withdrawal and inappropriate enrollment|1
7882064|NCT01766310|12380695|FG000|Overall Study|Lost to Follow-up|1
7882065|NCT01766310|12380696|FG001|Overall Study|Lost to Follow-up|3
7882066|NCT01766336|12380704|FG000|Overall Study|Adverse Event|11
7882067|NCT01766336|12380705|FG001|Overall Study|Adverse Event|8
7882068|NCT01766336|12380704|FG000|Overall Study|Death|4
7882069|NCT01766336|12380705|FG001|Overall Study|Death|3
7882070|NCT01766336|12380704|FG000|Overall Study|Lost to Follow-up|1
7882071|NCT01766336|12380705|FG001|Overall Study|Lost to Follow-up|3
7882072|NCT01766336|12380704|FG000|Overall Study|Physician Decision|4
7882073|NCT01766336|12380705|FG001|Overall Study|Physician Decision|2
7882074|NCT01766336|12380704|FG000|Overall Study|Protocol Violation|0
7882075|NCT01766336|12380705|FG001|Overall Study|Protocol Violation|1
7882076|NCT01766336|12380704|FG000|Overall Study|Sponsor Decision|52
7882077|NCT01766336|12380705|FG001|Overall Study|Sponsor Decision|43
7882078|NCT01766336|12380704|FG000|Overall Study|Withdrawal by Subject|18
7882079|NCT01766336|12380705|FG001|Overall Study|Withdrawal by Subject|15
7882080|NCT01766401|12380713|FG000|Overall Study|Adverse Event|7
7882081|NCT01766401|12380714|FG001|Overall Study|Adverse Event|22
7882082|NCT01766401|12380713|FG000|Overall Study|Lack of Efficacy|1
7882083|NCT01766401|12380714|FG001|Overall Study|Lack of Efficacy|2
7882084|NCT01766401|12380713|FG000|Overall Study|Protocol Violation|3
7882085|NCT01766401|12380714|FG001|Overall Study|Protocol Violation|8
7882086|NCT01766401|12380713|FG000|Overall Study|Withdrawal by Subject|15
7882087|NCT01766401|12380714|FG001|Overall Study|Withdrawal by Subject|12
7882088|NCT01766401|12380713|FG000|Overall Study|Lost to Follow-up|10
7882089|NCT01766401|12380714|FG001|Overall Study|Lost to Follow-up|11
7882090|NCT01766401|12380713|FG000|Overall Study|Pregnancy|1
7882091|NCT01766401|12380714|FG001|Overall Study|Pregnancy|1
7882092|NCT01766778|12380749|FG000|Overall Study|Adverse Event|4
7882093|NCT01766778|12380750|FG001|Overall Study|Adverse Event|4
7882094|NCT01766778|12380749|FG000|Overall Study|Withdrawal by Subject|1
7882095|NCT01766778|12380750|FG001|Overall Study|Withdrawal by Subject|0
7882096|NCT01766817|12380759|FG000|Overall Study|Drug-related adverse event|1
7882097|NCT01766817|12380760|FG001|Overall Study|Drug-related adverse event|2
7882098|NCT01766817|12380761|FG002|Overall Study|Drug-related adverse event|1
7882099|NCT01766817|12380759|FG000|Overall Study|Drug-unrelated adverse event|3
7882100|NCT01766817|12380760|FG001|Overall Study|Drug-unrelated adverse event|3
7882101|NCT01766817|12380761|FG002|Overall Study|Drug-unrelated adverse event|3
7882102|NCT01766817|12380759|FG000|Overall Study|Death|1
7882103|NCT01766817|12380760|FG001|Overall Study|Death|1
7882104|NCT01766817|12380761|FG002|Overall Study|Death|0
7882105|NCT01766817|12380759|FG000|Overall Study|Unable to take study drug|0
7882106|NCT01766817|12380760|FG001|Overall Study|Unable to take study drug|1
7882107|NCT01766817|12380761|FG002|Overall Study|Unable to take study drug|0
7882108|NCT01766817|12380759|FG000|Overall Study|Withdrawal by Subject|2
7882109|NCT01766817|12380760|FG001|Overall Study|Withdrawal by Subject|0
7882110|NCT01766817|12380761|FG002|Overall Study|Withdrawal by Subject|3
7882111|NCT01766817|12380759|FG000|Overall Study|Subject non-compliance|0
7882112|NCT01766817|12380760|FG001|Overall Study|Subject non-compliance|1
7882113|NCT01766817|12380761|FG002|Overall Study|Subject non-compliance|2
7882114|NCT01766817|12380759|FG000|Overall Study|Physician Decision|3
7882115|NCT01766817|12380760|FG001|Overall Study|Physician Decision|3
7882116|NCT01766817|12380761|FG002|Overall Study|Physician Decision|4
7882117|NCT01766817|12380759|FG000|Overall Study|Other|1
7882118|NCT01766817|12380760|FG001|Overall Study|Other|0
7882119|NCT01766817|12380761|FG002|Overall Study|Other|0
7882120|NCT01766921|12380771|FG000|Overall Study|Administrative Reason|5
7882121|NCT01766921|12380772|FG001|Overall Study|Administrative Reason|5
7882122|NCT01766921|12380771|FG000|Overall Study|Death|1
7882123|NCT01766921|12380772|FG001|Overall Study|Death|1
7882124|NCT01766921|12380771|FG000|Overall Study|Lost to Follow-up|1
7882125|NCT01766921|12380772|FG001|Overall Study|Lost to Follow-up|3
7882126|NCT01766921|12380771|FG000|Overall Study|Unclassified|2
7882127|NCT01766921|12380772|FG001|Overall Study|Unclassified|2
7882128|NCT01766921|12380771|FG000|Overall Study|Protocol Violation|1
7882129|NCT01766921|12380772|FG001|Overall Study|Protocol Violation|1
7882130|NCT01766921|12380771|FG000|Overall Study|Withdrawal by Subject|14
7882131|NCT01766921|12380772|FG001|Overall Study|Withdrawal by Subject|5
7882132|NCT01767116|12380817|FG000|Overall Study|Lost to Follow-up|2
7882133|NCT01767116|12380818|FG001|Overall Study|Lost to Follow-up|2
7882134|NCT01767142|12380824|FG000|Overall Study|Lost to Follow-up|3
7882135|NCT01767376|12380849|FG000|Overall Study|Lost to Follow-up|3
7882136|NCT01767376|12380850|FG001|Overall Study|Lost to Follow-up|2
7882137|NCT01767376|12380851|FG002|Overall Study|Lost to Follow-up|0
7882138|NCT01767376|12380849|FG000|Overall Study|Withdrawal by Subject|1
7882139|NCT01767376|12380850|FG001|Overall Study|Withdrawal by Subject|1
7882140|NCT01767376|12380851|FG002|Overall Study|Withdrawal by Subject|0
7882141|NCT01767467|12380867|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8
7882142|NCT01767467|12380868|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8
7882143|NCT01767467|12380867|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1
7882144|NCT01767467|12380868|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0
7882145|NCT01767467|12380867|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
7882146|NCT01767467|12380868|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
7882147|NCT01767467|12380867|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
7882148|NCT01767467|12380868|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
7882149|NCT01767467|12380867|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1
7882150|NCT01767467|12380868|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0
7882151|NCT01767467|12380867|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0
7882152|NCT01767467|12380868|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1
7882153|NCT01767467|12380867|FG000|End of Study Phase (up to Month 13)|Adverse Event|29
7882154|NCT01767467|12380868|FG001|End of Study Phase (up to Month 13)|Adverse Event|39
7882155|NCT01767467|12380867|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2
7882156|NCT01767467|12380868|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0
7882157|NCT01767467|12380867|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
7882158|NCT01767467|12380868|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
7882159|NCT01767467|12380867|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
7882160|NCT01767467|12380868|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
7882161|NCT01767467|12380867|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6
7882162|NCT01767467|12380868|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4
7882163|NCT01767467|12380867|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
7882164|NCT01767467|12380868|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
7882165|NCT01767467|12380867|FG000|End of Study Phase (up to Month 13)|Physician Decision|1
7882166|NCT01767467|12380868|FG001|End of Study Phase (up to Month 13)|Physician Decision|0
7882167|NCT01767467|12380867|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0
7882168|NCT01767467|12380868|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2
7882169|NCT01767493|12380881|FG000|Overall Study|screen failures|3
7882170|NCT01767519|12380897|FG000|Overall Study|Other Reasons|4
7882171|NCT01767519|12380898|FG001|Overall Study|Other Reasons|4
7882172|NCT01767519|12380899|FG002|Overall Study|Other Reasons|2
7882173|NCT01767519|12380897|FG000|Overall Study|Protocol Violation|0
7882174|NCT01767519|12380898|FG001|Overall Study|Protocol Violation|3
7882175|NCT01767519|12380899|FG002|Overall Study|Protocol Violation|0
7882176|NCT01767519|12380897|FG000|Overall Study|Personal Reasons|1
7882177|NCT01767519|12380898|FG001|Overall Study|Personal Reasons|0
7882178|NCT01767519|12380899|FG002|Overall Study|Personal Reasons|0
7882179|NCT01767519|12380897|FG000|Overall Study|Lost to Follow-up|3
7882180|NCT01767519|12380898|FG001|Overall Study|Lost to Follow-up|1
7882181|NCT01767519|12380899|FG002|Overall Study|Lost to Follow-up|2
7882182|NCT01767519|12380897|FG000|Overall Study|Lack of Efficacy|1
7798636|NCT01081912|12255487|FG002|Conversion/Titration|Lack of Efficacy|0
7798637|NCT01081912|12255485|FG000|Conversion/Titration|Lost to Follow-up|5
7798638|NCT01081912|12255486|FG001|Conversion/Titration|Lost to Follow-up|0
7798639|NCT01081912|12255487|FG002|Conversion/Titration|Lost to Follow-up|0
7798640|NCT01081912|12255485|FG000|Conversion/Titration|Physician Decision|2
7798641|NCT01081912|12255486|FG001|Conversion/Titration|Physician Decision|0
7798642|NCT01081912|12255487|FG002|Conversion/Titration|Physician Decision|0
7798643|NCT01081912|12255485|FG000|Conversion/Titration|Protocol Violation|67
7798644|NCT01081912|12255486|FG001|Conversion/Titration|Protocol Violation|0
7798645|NCT01081912|12255487|FG002|Conversion/Titration|Protocol Violation|0
7798646|NCT01081912|12255485|FG000|Conversion/Titration|Withdrawal by Subject|23
7798647|NCT01081912|12255486|FG001|Conversion/Titration|Withdrawal by Subject|0
7798648|NCT01081912|12255487|FG002|Conversion/Titration|Withdrawal by Subject|0
7798649|NCT01081912|12255485|FG000|Conversion/Titration|Non-Compliance|47
7628241|NCT04426695|12041195|FG000|Overall Study|Death|2
7628242|NCT04426695|12041196|FG001|Overall Study|Death|0
7628243|NCT04426695|12041197|FG002|Overall Study|Death|1
7628244|NCT04426695|12041198|FG003|Overall Study|Death|27
7628245|NCT04426695|12041199|FG004|Overall Study|Death|25
7628246|NCT04426695|12041200|FG005|Overall Study|Death|21
7628247|NCT04426695|12041201|FG006|Overall Study|Death|42
7628248|NCT04426695|12041202|FG007|Overall Study|Death|23
7628249|NCT04426695|12041203|FG008|Overall Study|Death|37
7628250|NCT04426695|12041204|FG009|Overall Study|Death|14
7628251|NCT04426695|12041205|FG010|Overall Study|Death|8
7628252|NCT04426695|12041206|FG011|Overall Study|Death|7
7628253|NCT04426695|12041207|FG012|Overall Study|Death|13
7628254|NCT04426695|12041208|FG013|Overall Study|Death|25
7628255|NCT04426695|12041209|FG014|Overall Study|Death|19
7628256|NCT04426695|12041210|FG015|Overall Study|Death|7
7628257|NCT04426695|12041211|FG016|Overall Study|Death|8
7628258|NCT04426695|12041212|FG017|Overall Study|Death|4
7628259|NCT04426695|12041195|FG000|Overall Study|Lost to Follow-up|2
7628260|NCT04426695|12041196|FG001|Overall Study|Lost to Follow-up|4
7628261|NCT04426695|12041197|FG002|Overall Study|Lost to Follow-up|1
7628262|NCT04426695|12041198|FG003|Overall Study|Lost to Follow-up|19
7628263|NCT04426695|12041199|FG004|Overall Study|Lost to Follow-up|10
7628264|NCT04426695|12041200|FG005|Overall Study|Lost to Follow-up|14
7628265|NCT04426695|12041201|FG006|Overall Study|Lost to Follow-up|5
7628266|NCT04426695|12041202|FG007|Overall Study|Lost to Follow-up|14
7628267|NCT04426695|12041203|FG008|Overall Study|Lost to Follow-up|10
7628268|NCT04426695|12041204|FG009|Overall Study|Lost to Follow-up|11
7628269|NCT04426695|12041205|FG010|Overall Study|Lost to Follow-up|12
7628270|NCT04426695|12041206|FG011|Overall Study|Lost to Follow-up|6
7628271|NCT04426695|12041207|FG012|Overall Study|Lost to Follow-up|2
7628272|NCT04426695|12041208|FG013|Overall Study|Lost to Follow-up|2
7628273|NCT04426695|12041209|FG014|Overall Study|Lost to Follow-up|2
7628274|NCT04426695|12041210|FG015|Overall Study|Lost to Follow-up|0
7628275|NCT04426695|12041211|FG016|Overall Study|Lost to Follow-up|0
7628276|NCT04426695|12041212|FG017|Overall Study|Lost to Follow-up|0
7628277|NCT04426695|12041195|FG000|Overall Study|Participant Decision|1
7628278|NCT04426695|12041196|FG001|Overall Study|Participant Decision|2
7628279|NCT04426695|12041197|FG002|Overall Study|Participant Decision|2
7628280|NCT04426695|12041198|FG003|Overall Study|Participant Decision|12
7628281|NCT04426695|12041199|FG004|Overall Study|Participant Decision|18
7798650|NCT01081912|12255486|FG001|Conversion/Titration|Non-Compliance|0
7628282|NCT04426695|12041200|FG005|Overall Study|Participant Decision|22
7628283|NCT04426695|12041201|FG006|Overall Study|Participant Decision|13
7628284|NCT04426695|12041202|FG007|Overall Study|Participant Decision|13
7628285|NCT04426695|12041203|FG008|Overall Study|Participant Decision|10
7628286|NCT04426695|12041204|FG009|Overall Study|Participant Decision|15
7628287|NCT04426695|12041205|FG010|Overall Study|Participant Decision|16
7628288|NCT04426695|12041206|FG011|Overall Study|Participant Decision|17
7628289|NCT04426695|12041207|FG012|Overall Study|Participant Decision|2
7628290|NCT04426695|12041208|FG013|Overall Study|Participant Decision|1
7628291|NCT04426695|12041209|FG014|Overall Study|Participant Decision|2
7628292|NCT04426695|12041210|FG015|Overall Study|Participant Decision|0
7628293|NCT04426695|12041211|FG016|Overall Study|Participant Decision|0
7628294|NCT04426695|12041212|FG017|Overall Study|Participant Decision|0
7628295|NCT04426695|12041195|FG000|Overall Study|Adverse Event|0
7628296|NCT04426695|12041196|FG001|Overall Study|Adverse Event|0
7628297|NCT04426695|12041197|FG002|Overall Study|Adverse Event|0
7628298|NCT04426695|12041198|FG003|Overall Study|Adverse Event|0
7628299|NCT04426695|12041199|FG004|Overall Study|Adverse Event|0
7628300|NCT04426695|12041200|FG005|Overall Study|Adverse Event|0
7628301|NCT04426695|12041201|FG006|Overall Study|Adverse Event|0
7628302|NCT04426695|12041202|FG007|Overall Study|Adverse Event|1
7628303|NCT04426695|12041203|FG008|Overall Study|Adverse Event|0
7628304|NCT04426695|12041204|FG009|Overall Study|Adverse Event|0
7628305|NCT04426695|12041205|FG010|Overall Study|Adverse Event|1
7628306|NCT04426695|12041206|FG011|Overall Study|Adverse Event|1
7628307|NCT04426695|12041207|FG012|Overall Study|Adverse Event|0
7628308|NCT04426695|12041208|FG013|Overall Study|Adverse Event|0
7628309|NCT04426695|12041209|FG014|Overall Study|Adverse Event|0
7628310|NCT04426695|12041210|FG015|Overall Study|Adverse Event|0
7628311|NCT04426695|12041211|FG016|Overall Study|Adverse Event|0
7628312|NCT04426695|12041212|FG017|Overall Study|Adverse Event|0
7628313|NCT04426695|12041195|FG000|Overall Study|Sponsor Request|0
7628314|NCT04426695|12041196|FG001|Overall Study|Sponsor Request|0
7628315|NCT04426695|12041197|FG002|Overall Study|Sponsor Request|0
7628316|NCT04426695|12041198|FG003|Overall Study|Sponsor Request|0
7628317|NCT04426695|12041199|FG004|Overall Study|Sponsor Request|0
7628318|NCT04426695|12041200|FG005|Overall Study|Sponsor Request|0
7628319|NCT04426695|12041201|FG006|Overall Study|Sponsor Request|1
7628320|NCT04426695|12041202|FG007|Overall Study|Sponsor Request|0
7628321|NCT04426695|12041203|FG008|Overall Study|Sponsor Request|0
7628322|NCT04426695|12041204|FG009|Overall Study|Sponsor Request|0
7628323|NCT04426695|12041205|FG010|Overall Study|Sponsor Request|0
7628324|NCT04426695|12041206|FG011|Overall Study|Sponsor Request|0
7628325|NCT04426695|12041207|FG012|Overall Study|Sponsor Request|0
7628326|NCT04426695|12041208|FG013|Overall Study|Sponsor Request|0
7628327|NCT04426695|12041209|FG014|Overall Study|Sponsor Request|0
7628328|NCT04426695|12041210|FG015|Overall Study|Sponsor Request|0
7628329|NCT04426695|12041211|FG016|Overall Study|Sponsor Request|0
7628330|NCT04426695|12041212|FG017|Overall Study|Sponsor Request|0
7628331|NCT04426695|12041195|FG000|Overall Study|Physician Decision|0
7628332|NCT04426695|12041196|FG001|Overall Study|Physician Decision|0
7628333|NCT04426695|12041197|FG002|Overall Study|Physician Decision|0
7628334|NCT04426695|12041198|FG003|Overall Study|Physician Decision|0
7628335|NCT04426695|12041199|FG004|Overall Study|Physician Decision|0
7628336|NCT04426695|12041200|FG005|Overall Study|Physician Decision|0
7628337|NCT04426695|12041201|FG006|Overall Study|Physician Decision|0
7628338|NCT04426695|12041202|FG007|Overall Study|Physician Decision|0
7628339|NCT04426695|12041203|FG008|Overall Study|Physician Decision|0
7628340|NCT04426695|12041204|FG009|Overall Study|Physician Decision|1
7628341|NCT04426695|12041205|FG010|Overall Study|Physician Decision|0
7628342|NCT04426695|12041206|FG011|Overall Study|Physician Decision|0
7628343|NCT04426695|12041207|FG012|Overall Study|Physician Decision|1
7628344|NCT04426695|12041208|FG013|Overall Study|Physician Decision|0
7628345|NCT04426695|12041209|FG014|Overall Study|Physician Decision|0
7628346|NCT04426695|12041210|FG015|Overall Study|Physician Decision|0
7628347|NCT04426695|12041211|FG016|Overall Study|Physician Decision|0
7628348|NCT04426695|12041212|FG017|Overall Study|Physician Decision|0
7628349|NCT04426695|12041195|FG000|Overall Study|Randomized but Never Treated|3
7628350|NCT04426695|12041196|FG001|Overall Study|Randomized but Never Treated|1
7628351|NCT04426695|12041197|FG002|Overall Study|Randomized but Never Treated|0
7628352|NCT04426695|12041198|FG003|Overall Study|Randomized but Never Treated|4
7628353|NCT04426695|12041199|FG004|Overall Study|Randomized but Never Treated|5
7628354|NCT04426695|12041200|FG005|Overall Study|Randomized but Never Treated|5
7628355|NCT04426695|12041201|FG006|Overall Study|Randomized but Never Treated|4
7628356|NCT04426695|12041202|FG007|Overall Study|Randomized but Never Treated|6
7628357|NCT04426695|12041203|FG008|Overall Study|Randomized but Never Treated|6
7628358|NCT04426695|12041204|FG009|Overall Study|Randomized but Never Treated|3
7628359|NCT04426695|12041205|FG010|Overall Study|Randomized but Never Treated|3
7628360|NCT04426695|12041206|FG011|Overall Study|Randomized but Never Treated|6
7628361|NCT04426695|12041207|FG012|Overall Study|Randomized but Never Treated|1
7628362|NCT04426695|12041208|FG013|Overall Study|Randomized but Never Treated|2
7628363|NCT04426695|12041209|FG014|Overall Study|Randomized but Never Treated|0
7628364|NCT04426695|12041210|FG015|Overall Study|Randomized but Never Treated|0
7628365|NCT04426695|12041211|FG016|Overall Study|Randomized but Never Treated|0
7628366|NCT04426695|12041212|FG017|Overall Study|Randomized but Never Treated|0
7628367|NCT04209400|12041289|FG000|Overall Study|Withdrawal by Subject|0
7628368|NCT04209400|12041290|FG001|Overall Study|Withdrawal by Subject|1
7798651|NCT01081912|12255487|FG002|Conversion/Titration|Non-Compliance|0
7798652|NCT01081912|12255485|FG000|Maintenance Treatment|Adverse Event|0
7798653|NCT01081912|12255486|FG001|Maintenance Treatment|Adverse Event|2
7798654|NCT01081912|12255487|FG002|Maintenance Treatment|Adverse Event|12
7798655|NCT01081912|12255485|FG000|Maintenance Treatment|Lack of Efficacy|0
7798656|NCT01081912|12255486|FG001|Maintenance Treatment|Lack of Efficacy|14
7798657|NCT01081912|12255487|FG002|Maintenance Treatment|Lack of Efficacy|64
7798658|NCT01081912|12255485|FG000|Maintenance Treatment|Lost to Follow-up|0
7798659|NCT01081912|12255486|FG001|Maintenance Treatment|Lost to Follow-up|1
7798660|NCT01081912|12255487|FG002|Maintenance Treatment|Lost to Follow-up|0
7798661|NCT01081912|12255485|FG000|Maintenance Treatment|Physician Decision|0
7798662|NCT01081912|12255486|FG001|Maintenance Treatment|Physician Decision|0
7798663|NCT01081912|12255487|FG002|Maintenance Treatment|Physician Decision|1
7798664|NCT01081912|12255485|FG000|Maintenance Treatment|Protocol Violation|0
7798665|NCT01081912|12255486|FG001|Maintenance Treatment|Protocol Violation|1
7798666|NCT01081912|12255487|FG002|Maintenance Treatment|Protocol Violation|2
7798667|NCT01081912|12255485|FG000|Maintenance Treatment|Withdrawal by Subject|0
7798668|NCT01081912|12255486|FG001|Maintenance Treatment|Withdrawal by Subject|5
7798669|NCT01081912|12255487|FG002|Maintenance Treatment|Withdrawal by Subject|5
7798670|NCT01081912|12255485|FG000|Maintenance Treatment|Non-Compliance|0
7798671|NCT01081912|12255486|FG001|Maintenance Treatment|Non-Compliance|4
7798672|NCT01081912|12255487|FG002|Maintenance Treatment|Non-Compliance|7
7798673|NCT01081912|12255485|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0
7798674|NCT01081912|12255486|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0
7798675|NCT01081912|12255487|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1
7798676|NCT01082081|12255497|FG000|Overall Study|Lost to Follow-up|0
7798677|NCT01082081|12255498|FG001|Overall Study|Lost to Follow-up|0
7798678|NCT01082081|12255499|FG002|Overall Study|Lost to Follow-up|1
7798679|NCT01082081|12255497|FG000|Overall Study|Withdrawal by Subject|0
7798680|NCT01082081|12255498|FG001|Overall Study|Withdrawal by Subject|0
7628399|NCT04067492|12041348|FG000|Overall Study|Lost to Follow-up|0
7628400|NCT04067492|12041349|FG001|Overall Study|Lost to Follow-up|0
7628401|NCT04067492|12041350|FG002|Overall Study|Lost to Follow-up|0
7628402|NCT04067492|12041351|FG003|Overall Study|Lost to Follow-up|0
7628403|NCT04067492|12041352|FG004|Overall Study|Lost to Follow-up|0
7628404|NCT04067492|12041353|FG005|Overall Study|Lost to Follow-up|1
7628405|NCT04067492|12041348|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0
7628406|NCT04067492|12041349|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1
7628407|NCT04067492|12041350|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0
7628408|NCT04067492|12041351|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0
7628409|NCT04067492|12041352|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0
7628410|NCT04067492|12041353|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0
7628411|NCT04067492|12041348|FG000|Overall Study|COVID-19 epidemiological situation|0
7628412|NCT04067492|12041349|FG001|Overall Study|COVID-19 epidemiological situation|0
7628413|NCT04067492|12041350|FG002|Overall Study|COVID-19 epidemiological situation|0
7628414|NCT04067492|12041351|FG003|Overall Study|COVID-19 epidemiological situation|1
7628415|NCT04067492|12041352|FG004|Overall Study|COVID-19 epidemiological situation|0
7628416|NCT04067492|12041353|FG005|Overall Study|COVID-19 epidemiological situation|0
7798681|NCT01082081|12255499|FG002|Overall Study|Withdrawal by Subject|1
7798682|NCT01082081|12255497|FG000|Overall Study|Other Reason|0
7798683|NCT01082081|12255498|FG001|Overall Study|Other Reason|1
7798684|NCT01082081|12255499|FG002|Overall Study|Other Reason|0
7798685|NCT01082328|12255512|FG000|Overall Study|Adverse Event|1
7798686|NCT01082367|12255518|FG000|Double-blind Period|Administrative problems|0
7798687|NCT01082367|12255519|FG001|Double-blind Period|Administrative problems|1
7798688|NCT01082367|12255518|FG000|Double-blind Period|Lack of Efficacy|5
7628425|NCT03788967|12041379|FG000|Overall Study|Lost to Follow-up|14
7628426|NCT03788967|12041380|FG001|Overall Study|Lost to Follow-up|10
7628427|NCT03788967|12041379|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3
7628428|NCT03788967|12041380|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6
7628429|NCT03788967|12041379|FG000|Overall Study|Participant Withdrawal of Consent|13
7628430|NCT03788967|12041380|FG001|Overall Study|Participant Withdrawal of Consent|5
7628431|NCT03788967|12041379|FG000|Overall Study|Adverse Event|1
7628432|NCT03788967|12041380|FG001|Overall Study|Adverse Event|1
7628433|NCT03788967|12041379|FG000|Overall Study|COVID-19|1
7628434|NCT03788967|12041380|FG001|Overall Study|COVID-19|2
7628435|NCT03721172|12041390|FG000|Placebo-controlled Phase|Adverse Event|7
7628436|NCT03721172|12041391|FG001|Placebo-controlled Phase|Adverse Event|7
7628437|NCT03721172|12041392|FG002|Placebo-controlled Phase|Adverse Event|0
7798689|NCT01082367|12255519|FG001|Double-blind Period|Lack of Efficacy|11
7798690|NCT01082367|12255518|FG000|Double-blind Period|Adverse Event|0
7798691|NCT01082367|12255519|FG001|Double-blind Period|Adverse Event|1
7798692|NCT01082367|12255518|FG000|Follow-up (F-U) Period|Administrative problems|1
7798693|NCT01082367|12255519|FG001|Follow-up (F-U) Period|Administrative problems|0
7798694|NCT01082367|12255518|FG000|Follow-up (F-U) Period|Abnormal lab values|1
7798695|NCT01082367|12255519|FG001|Follow-up (F-U) Period|Abnormal lab values|0
7628438|NCT03721172|12041390|FG000|Placebo-controlled Phase|Lack of Efficacy|4
7628439|NCT03721172|12041391|FG001|Placebo-controlled Phase|Lack of Efficacy|0
7628440|NCT03721172|12041392|FG002|Placebo-controlled Phase|Lack of Efficacy|0
7628441|NCT03721172|12041390|FG000|Placebo-controlled Phase|Non-compliance with study drug|0
7628442|NCT03721172|12041391|FG001|Placebo-controlled Phase|Non-compliance with study drug|1
7628443|NCT03721172|12041392|FG002|Placebo-controlled Phase|Non-compliance with study drug|0
7628444|NCT03721172|12041390|FG000|Placebo-controlled Phase|Lost to Follow-up|15
7628445|NCT03721172|12041391|FG001|Placebo-controlled Phase|Lost to Follow-up|13
7628446|NCT03721172|12041392|FG002|Placebo-controlled Phase|Lost to Follow-up|0
7628447|NCT03721172|12041390|FG000|Placebo-controlled Phase|Withdrawal by Subject|23
7628448|NCT03721172|12041391|FG001|Placebo-controlled Phase|Withdrawal by Subject|18
7628449|NCT03721172|12041392|FG002|Placebo-controlled Phase|Withdrawal by Subject|0
7628450|NCT03721172|12041390|FG000|Placebo-controlled Phase|Other|3
7628451|NCT03721172|12041391|FG001|Placebo-controlled Phase|Other|0
7628452|NCT03721172|12041392|FG002|Placebo-controlled Phase|Other|0
7628453|NCT03721172|12041390|FG000|Apremilast Extension Phase|Adverse Event|0
7628454|NCT03721172|12041391|FG001|Apremilast Extension Phase|Adverse Event|0
7628455|NCT03721172|12041392|FG002|Apremilast Extension Phase|Adverse Event|10
7628456|NCT03721172|12041390|FG000|Apremilast Extension Phase|Lack of Efficacy|0
7628457|NCT03721172|12041391|FG001|Apremilast Extension Phase|Lack of Efficacy|0
7628458|NCT03721172|12041392|FG002|Apremilast Extension Phase|Lack of Efficacy|2
7628459|NCT03721172|12041390|FG000|Apremilast Extension Phase|Non-compliance with study drug|0
7628460|NCT03721172|12041391|FG001|Apremilast Extension Phase|Non-compliance with study drug|0
7628461|NCT03721172|12041392|FG002|Apremilast Extension Phase|Non-compliance with study drug|1
7628462|NCT03721172|12041390|FG000|Apremilast Extension Phase|Lost to Follow-up|0
7628463|NCT03721172|12041391|FG001|Apremilast Extension Phase|Lost to Follow-up|0
7628464|NCT03721172|12041392|FG002|Apremilast Extension Phase|Lost to Follow-up|20
7628465|NCT03721172|12041390|FG000|Apremilast Extension Phase|Protocol Violation|0
7628466|NCT03721172|12041391|FG001|Apremilast Extension Phase|Protocol Violation|0
7628467|NCT03721172|12041392|FG002|Apremilast Extension Phase|Protocol Violation|1
7628468|NCT03721172|12041390|FG000|Apremilast Extension Phase|Physician Decision|0
7628469|NCT03721172|12041391|FG001|Apremilast Extension Phase|Physician Decision|0
7628470|NCT03721172|12041392|FG002|Apremilast Extension Phase|Physician Decision|1
7628471|NCT03721172|12041390|FG000|Apremilast Extension Phase|Withdrawal by Subject|0
7628472|NCT03721172|12041391|FG001|Apremilast Extension Phase|Withdrawal by Subject|0
7628473|NCT03721172|12041392|FG002|Apremilast Extension Phase|Withdrawal by Subject|21
7628474|NCT03721172|12041390|FG000|Apremilast Extension Phase|Other|0
7628475|NCT03721172|12041391|FG001|Apremilast Extension Phase|Other|0
7628476|NCT03721172|12041392|FG002|Apremilast Extension Phase|Other|3
7628477|NCT03721172|12041390|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0
7628478|NCT03721172|12041391|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0
7628479|NCT03721172|12041392|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7
7628480|NCT03692052|12041400|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1
7628481|NCT03692052|12041400|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1
7628482|NCT03692052|12041400|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1
7628483|NCT03692052|12041400|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17
7798696|NCT01082367|12255518|FG000|Follow-up (F-U) Period|Adverse Event|0
7798697|NCT01082367|12255519|FG001|Follow-up (F-U) Period|Adverse Event|1
7798698|NCT01082614|12255548|FG000|Overall Study|Adverse Event|1
7798699|NCT01082614|12255549|FG001|Overall Study|Adverse Event|4
7798700|NCT01082614|12255548|FG000|Overall Study|Equipment Malfunction|0
7798701|NCT01082614|12255549|FG001|Overall Study|Equipment Malfunction|1
7798702|NCT01082614|12255548|FG000|Overall Study|Physician Decision|2
7798703|NCT01082614|12255549|FG001|Overall Study|Physician Decision|0
7798704|NCT01082640|12255558|FG000|Overall Study|Adverse Event|9
7798705|NCT01082640|12255559|FG001|Overall Study|Adverse Event|5
7798706|NCT01082640|12255560|FG002|Overall Study|Adverse Event|3
7798707|NCT01082640|12255558|FG000|Overall Study|Withdrawal by Subject|3
7798708|NCT01082640|12255559|FG001|Overall Study|Withdrawal by Subject|3
7798709|NCT01082640|12255560|FG002|Overall Study|Withdrawal by Subject|2
7798710|NCT01082640|12255558|FG000|Overall Study|Major protocol deviation|3
7798711|NCT01082640|12255559|FG001|Overall Study|Major protocol deviation|3
7798712|NCT01082640|12255560|FG002|Overall Study|Major protocol deviation|0
7798713|NCT01082640|12255558|FG000|Overall Study|Lost to Follow-up|0
7628502|NCT03410992|12041431|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0
7628503|NCT03410992|12041432|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5
7628504|NCT03410992|12041433|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0
7628505|NCT03410992|12041434|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0
7628506|NCT03410992|12041435|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0
7628507|NCT03410992|12041436|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0
7628508|NCT03410992|12041437|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0
7628509|NCT03410992|12041438|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0
7628510|NCT03410992|12041439|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0
7628511|NCT03410992|12041440|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0
7628512|NCT03410992|12041441|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0
7628513|NCT03410992|12041431|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2
7798714|NCT01082640|12255559|FG001|Overall Study|Lost to Follow-up|3
7628514|NCT03410992|12041432|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1
7628515|NCT03410992|12041433|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628516|NCT03410992|12041434|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628517|NCT03410992|12041435|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628518|NCT03410992|12041436|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628519|NCT03410992|12041437|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628520|NCT03410992|12041438|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628521|NCT03410992|12041439|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628522|NCT03410992|12041440|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628523|NCT03410992|12041441|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628524|NCT03410992|12041431|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1
7628525|NCT03410992|12041432|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3
7628526|NCT03410992|12041433|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628527|NCT03410992|12041434|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628528|NCT03410992|12041435|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628529|NCT03410992|12041436|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628530|NCT03410992|12041437|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628531|NCT03410992|12041438|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628532|NCT03410992|12041439|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628533|NCT03410992|12041440|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628534|NCT03410992|12041441|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628535|NCT03410992|12041431|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1
7628536|NCT03410992|12041432|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628537|NCT03410992|12041433|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628538|NCT03410992|12041434|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628539|NCT03410992|12041435|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628540|NCT03410992|12041436|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628541|NCT03410992|12041437|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628542|NCT03410992|12041438|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628543|NCT03410992|12041439|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628544|NCT03410992|12041440|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628545|NCT03410992|12041441|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628546|NCT03410992|12041431|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81
7628547|NCT03410992|12041432|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23
7628548|NCT03410992|12041433|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628549|NCT03410992|12041434|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628550|NCT03410992|12041435|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628551|NCT03410992|12041436|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628552|NCT03410992|12041437|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628553|NCT03410992|12041438|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628554|NCT03410992|12041439|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628555|NCT03410992|12041440|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628556|NCT03410992|12041441|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628557|NCT03410992|12041431|FG000|Week 16 Assessment|Incorrect escapers|0
7628558|NCT03410992|12041432|FG001|Week 16 Assessment|Incorrect escapers|6
7628559|NCT03410992|12041433|FG002|Week 16 Assessment|Incorrect escapers|0
7628560|NCT03410992|12041434|FG003|Week 16 Assessment|Incorrect escapers|0
7628561|NCT03410992|12041435|FG004|Week 16 Assessment|Incorrect escapers|0
7628562|NCT03410992|12041436|FG005|Week 16 Assessment|Incorrect escapers|0
7628563|NCT03410992|12041437|FG006|Week 16 Assessment|Incorrect escapers|0
7628564|NCT03410992|12041438|FG007|Week 16 Assessment|Incorrect escapers|0
7628565|NCT03410992|12041439|FG008|Week 16 Assessment|Incorrect escapers|0
7628566|NCT03410992|12041440|FG009|Week 16 Assessment|Incorrect escapers|0
7628567|NCT03410992|12041441|FG010|Week 16 Assessment|Incorrect escapers|0
7628568|NCT03410992|12041431|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628569|NCT03410992|12041432|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628570|NCT03410992|12041433|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628571|NCT03410992|12041434|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3
7628572|NCT03410992|12041435|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2
7628573|NCT03410992|12041436|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628574|NCT03410992|12041437|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628575|NCT03410992|12041438|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628576|NCT03410992|12041439|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628577|NCT03410992|12041440|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628578|NCT03410992|12041441|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628579|NCT03410992|12041431|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628580|NCT03410992|12041432|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628581|NCT03410992|12041433|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628582|NCT03410992|12041434|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2
7628583|NCT03410992|12041435|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1
7628584|NCT03410992|12041436|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2
7628585|NCT03410992|12041437|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628586|NCT03410992|12041438|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628587|NCT03410992|12041439|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628588|NCT03410992|12041440|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628589|NCT03410992|12041441|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628590|NCT03410992|12041431|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628591|NCT03410992|12041432|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628592|NCT03410992|12041433|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628593|NCT03410992|12041434|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628594|NCT03410992|12041435|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628595|NCT03410992|12041436|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3
7628596|NCT03410992|12041437|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628597|NCT03410992|12041438|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628598|NCT03410992|12041439|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628599|NCT03410992|12041440|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628600|NCT03410992|12041441|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628601|NCT03410992|12041431|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628602|NCT03410992|12041432|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628603|NCT03410992|12041433|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628604|NCT03410992|12041434|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67
7628605|NCT03410992|12041435|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4
7628606|NCT03410992|12041436|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7
7628607|NCT03410992|12041437|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628608|NCT03410992|12041438|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628609|NCT03410992|12041439|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628610|NCT03410992|12041440|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628611|NCT03410992|12041441|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628612|NCT03410992|12041431|FG000|Escape Treatment: 12 Weeks|Adverse Event|0
7628613|NCT03410992|12041432|FG001|Escape Treatment: 12 Weeks|Adverse Event|0
7628614|NCT03410992|12041433|FG002|Escape Treatment: 12 Weeks|Adverse Event|0
7628615|NCT03410992|12041434|FG003|Escape Treatment: 12 Weeks|Adverse Event|0
7628616|NCT03410992|12041435|FG004|Escape Treatment: 12 Weeks|Adverse Event|0
7628617|NCT03410992|12041436|FG005|Escape Treatment: 12 Weeks|Adverse Event|0
7628618|NCT03410992|12041437|FG006|Escape Treatment: 12 Weeks|Adverse Event|0
7628619|NCT03410992|12041438|FG007|Escape Treatment: 12 Weeks|Adverse Event|1
7628620|NCT03410992|12041439|FG008|Escape Treatment: 12 Weeks|Adverse Event|0
7628621|NCT03410992|12041440|FG009|Escape Treatment: 12 Weeks|Adverse Event|0
7628622|NCT03410992|12041441|FG010|Escape Treatment: 12 Weeks|Adverse Event|0
7628623|NCT03410992|12041431|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628624|NCT03410992|12041432|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628625|NCT03410992|12041433|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628626|NCT03410992|12041434|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628627|NCT03410992|12041435|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628628|NCT03410992|12041436|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628629|NCT03410992|12041437|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628630|NCT03410992|12041438|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628631|NCT03410992|12041439|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1
7628632|NCT03410992|12041440|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628633|NCT03410992|12041441|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628634|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Adverse Event|5
7628635|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Adverse Event|5
7628636|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Adverse Event|2
7628637|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Adverse Event|0
7628638|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Adverse Event|0
7628639|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Adverse Event|0
7628640|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Death|1
7628641|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Death|1
7628642|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Death|1
7628643|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Death|0
7628644|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Death|0
7628645|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Death|0
7628646|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2
7628647|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1
7628648|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0
7628649|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0
7628650|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0
7628651|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0
7628652|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0
7628653|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0
7628654|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2
7628655|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0
7628656|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0
7628657|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0
7628658|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0
7628659|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3
7628660|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0
7628661|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0
7628662|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0
7628663|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0
7628664|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1
7628665|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2
7628666|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1
7628667|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0
7628668|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0
7628669|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0
7628670|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Non-compliance|0
7628671|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Non-compliance|1
7628672|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Non-compliance|0
7628673|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Non-compliance|0
7628674|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Non-compliance|0
7628675|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Non-compliance|0
7628676|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Site closed|0
7628677|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Site closed|2
7628678|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Site closed|0
7628679|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Site closed|0
7628680|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Site closed|0
7628681|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Site closed|0
7628682|NCT03370133|12041474|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0
7628683|NCT03370133|12041475|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0
7628684|NCT03370133|12041476|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0
7628685|NCT03370133|12041477|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3
7628686|NCT03370133|12041478|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12
7628687|NCT03370133|12041479|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4
7628688|NCT03370133|12041474|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
7628689|NCT03370133|12041475|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
7628690|NCT03370133|12041476|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
7628691|NCT03370133|12041477|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
7628692|NCT03370133|12041478|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1
7628693|NCT03370133|12041479|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4
7628694|NCT03370133|12041474|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0
7628695|NCT03370133|12041475|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0
7628696|NCT03370133|12041476|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0
7628697|NCT03370133|12041477|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1
7628698|NCT03370133|12041478|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1
7628699|NCT03370133|12041479|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0
7628700|NCT03370133|12041474|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
7628701|NCT03370133|12041475|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
7628702|NCT03370133|12041476|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
7628703|NCT03370133|12041477|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
7628704|NCT03370133|12041478|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4
7628705|NCT03370133|12041479|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3
7628706|NCT03370133|12041474|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0
7628707|NCT03370133|12041475|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0
7628708|NCT03370133|12041476|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0
7628709|NCT03370133|12041477|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1
7628710|NCT03370133|12041478|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4
7628711|NCT03370133|12041479|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4
7628712|NCT03370133|12041474|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0
7628713|NCT03370133|12041475|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0
7628714|NCT03370133|12041476|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0
7628715|NCT03370133|12041477|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0
7628716|NCT03370133|12041478|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1
7628717|NCT03370133|12041479|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0
7628718|NCT03370133|12041474|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
7628719|NCT03370133|12041475|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
7628720|NCT03370133|12041476|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
7628721|NCT03370133|12041477|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
7628722|NCT03370133|12041478|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
7628723|NCT03370133|12041479|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1
7628724|NCT03291587|12041508|FG000|Overall Study|Lost to Follow-up|62
7628725|NCT03291587|12041509|FG001|Overall Study|Lost to Follow-up|43
7628726|NCT03291587|12041508|FG000|Overall Study|Refused to Answer|5
7628727|NCT03291587|12041509|FG001|Overall Study|Refused to Answer|2
7628728|NCT03291587|12041508|FG000|Overall Study|Death|2
7628729|NCT03291587|12041509|FG001|Overall Study|Death|4
7628730|NCT03291587|12041508|FG000|Overall Study|Not interested in participating|8
7628731|NCT03291587|12041509|FG001|Overall Study|Not interested in participating|6
7628732|NCT03291587|12041508|FG000|Overall Study|Too busy to participate|4
7628733|NCT03291587|12041509|FG001|Overall Study|Too busy to participate|2
7798715|NCT01082640|12255560|FG002|Overall Study|Lost to Follow-up|0
7798716|NCT01082640|12255558|FG000|Overall Study|Other|2
7798717|NCT01082640|12255559|FG001|Overall Study|Other|1
7798718|NCT01082640|12255560|FG002|Overall Study|Other|3
7798719|NCT01082874|12255575|FG000|Overall Study|Lost to Follow-up|10
7798720|NCT01082874|12255576|FG001|Overall Study|Lost to Follow-up|10
7798721|NCT01082874|12255577|FG002|Overall Study|Lost to Follow-up|6
7798722|NCT01082874|12255578|FG003|Overall Study|Lost to Follow-up|10
7798723|NCT01082874|12255575|FG000|Overall Study|Withdrawal by Subject|1
7798724|NCT01082874|12255576|FG001|Overall Study|Withdrawal by Subject|2
7798725|NCT01082874|12255577|FG002|Overall Study|Withdrawal by Subject|5
7798726|NCT01082874|12255578|FG003|Overall Study|Withdrawal by Subject|3
7798727|NCT01082965|12255603|FG000|Overall Study|Protocol Violation|0
7798728|NCT01082965|12255604|FG001|Overall Study|Protocol Violation|1
7798729|NCT01082965|12255603|FG000|Overall Study|Other|1
7798730|NCT01082965|12255604|FG001|Overall Study|Other|1
7798731|NCT01083121|12255610|FG000|Overall Study|Use of Humira outside the approved label|81
7798732|NCT01083160|12255618|FG000|Overall Study|Adverse Event|1
7798733|NCT01083173|12255622|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
7798734|NCT01083173|12255623|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
7628754|NCT02948829|12041543|FG000|Overall Study|Lost to Follow-up|2
7628755|NCT02948829|12041543|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5
7628756|NCT02948829|12041543|FG000|Overall Study|Pregnancy|1
7628757|NCT02948829|12041543|FG000|Overall Study|Other: Reason not Specified|8
7628758|NCT02819518|12041578|FG000|Overall Study|Death|9
7628759|NCT02819518|12041579|FG001|Overall Study|Death|11
7628760|NCT02819518|12041580|FG002|Overall Study|Death|9
7628761|NCT02819518|12041581|FG003|Overall Study|Death|447
7628762|NCT02819518|12041582|FG004|Overall Study|Death|233
7628763|NCT02819518|12041578|FG000|Overall Study|Withdrawal by Subject|0
7628764|NCT02819518|12041579|FG001|Overall Study|Withdrawal by Subject|0
7628765|NCT02819518|12041580|FG002|Overall Study|Withdrawal by Subject|0
7628766|NCT02819518|12041581|FG003|Overall Study|Withdrawal by Subject|21
7628767|NCT02819518|12041582|FG004|Overall Study|Withdrawal by Subject|6
7628768|NCT02819518|12041578|FG000|Overall Study|Ongoing in Study|2
7628769|NCT02819518|12041579|FG001|Overall Study|Ongoing in Study|3
7628770|NCT02819518|12041580|FG002|Overall Study|Ongoing in Study|1
7628771|NCT02819518|12041581|FG003|Overall Study|Ongoing in Study|98
7628772|NCT02819518|12041582|FG004|Overall Study|Ongoing in Study|42
7628773|NCT02767856|12041598|FG000|Overall Study|Lost to Follow-up|9
7628774|NCT02767856|12041599|FG001|Overall Study|Lost to Follow-up|1
7628775|NCT02767856|12041598|FG000|Overall Study|Withdrawal by Subject|2
7628776|NCT02767856|12041599|FG001|Overall Study|Withdrawal by Subject|1
7798735|NCT01083173|12255622|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1
7798736|NCT01083173|12255623|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0
7798737|NCT01083173|12255622|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
7798738|NCT01083173|12255623|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
7798739|NCT01083173|12255622|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
7798740|NCT01083173|12255623|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
7798741|NCT01083173|12255622|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
7798742|NCT01083173|12255623|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
7798743|NCT01083173|12255622|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
7798744|NCT01083173|12255623|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
7798745|NCT01083173|12255622|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0
7798746|NCT01083173|12255623|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1
7798747|NCT01083173|12255622|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
7798748|NCT01083173|12255623|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
7798749|NCT01083173|12255622|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
7798750|NCT01083173|12255623|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
7798751|NCT01083173|12255622|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
7798752|NCT01083173|12255623|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
7798753|NCT01083173|12255622|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
7628801|NCT02719691|12041621|FG000|Overall Study|Physician Decision|0
7628802|NCT02719691|12041622|FG001|Overall Study|Physician Decision|0
7628803|NCT02719691|12041623|FG002|Overall Study|Physician Decision|1
7628804|NCT02719691|12041624|FG003|Overall Study|Physician Decision|0
7628805|NCT02719691|12041625|FG004|Overall Study|Physician Decision|0
7628806|NCT02719691|12041626|FG005|Overall Study|Physician Decision|0
7628807|NCT02719691|12041627|FG006|Overall Study|Physician Decision|0
7628808|NCT02719691|12041621|FG000|Overall Study|Withdrawal by Subject|0
7628809|NCT02719691|12041622|FG001|Overall Study|Withdrawal by Subject|0
7628810|NCT02719691|12041623|FG002|Overall Study|Withdrawal by Subject|0
7628811|NCT02719691|12041624|FG003|Overall Study|Withdrawal by Subject|0
7628812|NCT02719691|12041625|FG004|Overall Study|Withdrawal by Subject|0
7628813|NCT02719691|12041626|FG005|Overall Study|Withdrawal by Subject|1
7628814|NCT02719691|12041627|FG006|Overall Study|Withdrawal by Subject|0
7628815|NCT02613507|12041646|FG000|Overall Study|Disease Progression|237
7628816|NCT02613507|12041647|FG001|Overall Study|Disease Progression|109
7628817|NCT02613507|12041646|FG000|Overall Study|Study Drug Toxicity|15
7628818|NCT02613507|12041647|FG001|Overall Study|Study Drug Toxicity|14
7628819|NCT02613507|12041646|FG000|Overall Study|Death|3
7628820|NCT02613507|12041647|FG001|Overall Study|Death|0
7628821|NCT02613507|12041646|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17
7628822|NCT02613507|12041647|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2
7628823|NCT02613507|12041646|FG000|Overall Study|Request to Discontinue Study Treatment|8
7628824|NCT02613507|12041647|FG001|Overall Study|Request to Discontinue Study Treatment|17
7628825|NCT02613507|12041646|FG000|Overall Study|Participant Withdrew Consent|0
7628826|NCT02613507|12041647|FG001|Overall Study|Participant Withdrew Consent|2
7628827|NCT02613507|12041646|FG000|Overall Study|Lost to Follow-up|1
7628828|NCT02613507|12041647|FG001|Overall Study|Lost to Follow-up|0
7628829|NCT02613507|12041646|FG000|Overall Study|Maximum Clinical Benefit|4
7628830|NCT02613507|12041647|FG001|Overall Study|Maximum Clinical Benefit|10
7628831|NCT02613507|12041646|FG000|Overall Study|Brain Radiotherapy Activity Limited|1
7628832|NCT02613507|12041647|FG001|Overall Study|Brain Radiotherapy Activity Limited|0
7628833|NCT02613507|12041646|FG000|Overall Study|Subject no Longer Meets Study Criteria|1
7628834|NCT02613507|12041647|FG001|Overall Study|Subject no Longer Meets Study Criteria|0
7628835|NCT02613507|12041646|FG000|Overall Study|Randomized but not Treated|1
7628836|NCT02613507|12041647|FG001|Overall Study|Randomized but not Treated|10
7798754|NCT01083173|12255623|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
7798755|NCT01083186|12255632|FG000|Overall Study|Lost to Follow-up|48
7798756|NCT01083186|12255632|FG000|Overall Study|Consent Withdrawal|7
7798757|NCT01083186|12255632|FG000|Overall Study|Death|3
7798758|NCT01083186|12255632|FG000|Overall Study|Adverse Event|3
7798759|NCT01083186|12255632|FG000|Overall Study|Lack of Efficacy|2
7628843|NCT02339506|12041684|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
7628844|NCT02339506|12041685|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
7628845|NCT02339506|12041684|FG000|Washout (Period 2)|Withdrawal by Subject|2
7628846|NCT02339506|12041685|FG001|Washout (Period 2)|Withdrawal by Subject|0
7628847|NCT02206048|12041698|FG000|Overall Study|Change in OR schedule and availability of study staff|1
7628848|NCT02068885|12041720|FG000|Overall Study|Withdrew|3
7628849|NCT02068885|12041721|FG001|Overall Study|Withdrew|5
7628850|NCT02068885|12041722|FG002|Overall Study|Withdrew|8
7628865|NCT01565941|12041745|FG000|Overall Study|Withdrawn by parent/guardian|3
7628866|NCT01565941|12041746|FG001|Overall Study|Withdrawn by parent/guardian|2
7628867|NCT01565941|12041745|FG000|Overall Study|Randomized; did not receive intevention|8
7628868|NCT01565941|12041746|FG001|Overall Study|Randomized; did not receive intevention|2
7628869|NCT00676715|12041784|FG000|Overall Study|Withdrawal by Subject|7
7628870|NCT00676715|12041785|FG001|Overall Study|Withdrawal by Subject|9
7628871|NCT00676715|12041786|FG002|Overall Study|Withdrawal by Subject|10
7628872|NCT00676715|12041787|FG003|Overall Study|Withdrawal by Subject|10
7628873|NCT00676715|12041784|FG000|Overall Study|Other|2
7628874|NCT00676715|12041785|FG001|Overall Study|Other|6
7628875|NCT00676715|12041786|FG002|Overall Study|Other|4
7628876|NCT00676715|12041787|FG003|Overall Study|Other|3
7628877|NCT00676715|12041784|FG000|Overall Study|Lost to Follow-up|1
7628878|NCT00676715|12041785|FG001|Overall Study|Lost to Follow-up|1
7628879|NCT00676715|12041786|FG002|Overall Study|Lost to Follow-up|7
7628880|NCT00676715|12041787|FG003|Overall Study|Lost to Follow-up|3
7628881|NCT00676715|12041784|FG000|Overall Study|Death|1
7628882|NCT00676715|12041785|FG001|Overall Study|Death|1
7628883|NCT00676715|12041786|FG002|Overall Study|Death|1
7628884|NCT00676715|12041787|FG003|Overall Study|Death|0
7628885|NCT00676715|12041784|FG000|Overall Study|Adverse Event|0
7628886|NCT00676715|12041785|FG001|Overall Study|Adverse Event|1
7628887|NCT00676715|12041786|FG002|Overall Study|Adverse Event|2
7628888|NCT00676715|12041787|FG003|Overall Study|Adverse Event|0
7628889|NCT00676715|12041784|FG000|Overall Study|Participants Ongoing|29
7628890|NCT00676715|12041785|FG001|Overall Study|Participants Ongoing|29
7798760|NCT01083186|12255632|FG000|Overall Study|Hemodialysis Initiation|28
7628891|NCT00676715|12041786|FG002|Overall Study|Participants Ongoing|17
7628892|NCT00676715|12041787|FG003|Overall Study|Participants Ongoing|24
7628893|NCT00443599|12041799|FG000|Overall Study|Physician Decision|2
7628894|NCT00443599|12041800|FG001|Overall Study|Physician Decision|1
7628895|NCT00443599|12041799|FG000|Overall Study|Death|1
7628896|NCT00443599|12041800|FG001|Overall Study|Death|1
7628897|NCT00443599|12041799|FG000|Overall Study|Cardiopulmonary bypass canceled|3
7628898|NCT00443599|12041800|FG001|Overall Study|Cardiopulmonary bypass canceled|1
7628899|NCT04531098|12041827|FG000|Stage I|Adverse Event|0
7628900|NCT04531098|12041828|FG001|Stage I|Adverse Event|0
7628901|NCT04531098|12041829|FG002|Stage I|Adverse Event|3
7628902|NCT04531098|12041827|FG000|Stage I|Protocol Violation|0
7628903|NCT04531098|12041828|FG001|Stage I|Protocol Violation|0
7628904|NCT04531098|12041829|FG002|Stage I|Protocol Violation|5
7628905|NCT04531098|12041827|FG000|Stage I|Withdrawal by Subject|0
7628906|NCT04531098|12041828|FG001|Stage I|Withdrawal by Subject|5
7628907|NCT04531098|12041829|FG002|Stage I|Withdrawal by Subject|10
7628908|NCT04531098|12041827|FG000|Stage II|Adverse Event|1
7628909|NCT04531098|12041828|FG001|Stage II|Adverse Event|2
7628910|NCT04531098|12041829|FG002|Stage II|Adverse Event|0
7628911|NCT04531098|12041827|FG000|Stage II|Protocol Violation|1
7628912|NCT04531098|12041828|FG001|Stage II|Protocol Violation|2
7628913|NCT04531098|12041829|FG002|Stage II|Protocol Violation|0
7628914|NCT04531098|12041827|FG000|Stage II|Withdrawal by Subject|3
7628915|NCT04531098|12041828|FG001|Stage II|Withdrawal by Subject|1
7628916|NCT04531098|12041829|FG002|Stage II|Withdrawal by Subject|0
7628917|NCT04531098|12041827|FG000|Stage II|Moved from study area|8
7628918|NCT04531098|12041828|FG001|Stage II|Moved from study area|5
7628919|NCT04531098|12041829|FG002|Stage II|Moved from study area|0
7628920|NCT04484857|12041837|FG000|Overall Study|Adverse Event|2
7628921|NCT04484857|12041837|FG000|Overall Study|Death|10
7628922|NCT04484857|12041837|FG000|Overall Study|Withdrawal by Subject|3
7628923|NCT04484857|12041837|FG000|Overall Study|Transferred/Relocation|5
7628924|NCT04484857|12041837|FG000|Overall Study|Kidney Transplant|7
7628925|NCT04484857|12041837|FG000|Overall Study|Other than specified|4
7628926|NCT04484857|12041837|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216
7628927|NCT04382053|12041852|FG000|Overall Study|Death|6
7628928|NCT04382053|12041853|FG001|Overall Study|Death|8
7628929|NCT04382053|12041852|FG000|Overall Study|Lost to Follow-up|0
7628930|NCT04382053|12041853|FG001|Overall Study|Lost to Follow-up|2
7628931|NCT04382053|12041852|FG000|Overall Study|Protocol Deviation|1
7628932|NCT04382053|12041853|FG001|Overall Study|Protocol Deviation|2
7628933|NCT04382053|12041852|FG000|Overall Study|Withdrawal by Subject|2
7628934|NCT04382053|12041853|FG001|Overall Study|Withdrawal by Subject|1
7628935|NCT04353817|12041862|FG000|Overall Study|Adverse Event|0
7628936|NCT04353817|12041863|FG001|Overall Study|Adverse Event|1
7628937|NCT04087720|12041883|FG000|Overall Study|Withdrawal by Subject|2
7628938|NCT04087720|12041883|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3
7628939|NCT03951766|12041887|FG000|Treatment Phase|Lost to Follow-up|1
7628940|NCT03951766|12041887|FG000|Follow-up Phase|Lost to Follow-up|10
7798761|NCT01083186|12255632|FG000|Overall Study|Administrative Reasons|2
7798762|NCT01083186|12255632|FG000|Overall Study|Non-compliance to Study Treatment|1
7798763|NCT01083316|12255661|FG000|Overall Study|Adverse Event|2
7798764|NCT01083316|12255661|FG000|Overall Study|Withdrawal by Subject|1
7882183|NCT01767519|12380898|FG001|Overall Study|Lack of Efficacy|0
7882184|NCT01767519|12380899|FG002|Overall Study|Lack of Efficacy|0
7882185|NCT01767519|12380897|FG000|Overall Study|Adverse Event|5
7882186|NCT01767519|12380898|FG001|Overall Study|Adverse Event|5
7882187|NCT01767519|12380899|FG002|Overall Study|Adverse Event|1
7628950|NCT03737110|12041919|FG000|Run-in (RI) Period|Lack of Efficacy|3
7628951|NCT03737110|12041920|FG001|Run-in (RI) Period|Lack of Efficacy|0
7628952|NCT03737110|12041921|FG002|Run-in (RI) Period|Lack of Efficacy|0
7628953|NCT03737110|12041919|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3
7628954|NCT03737110|12041920|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0
7628955|NCT03737110|12041921|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0
7628956|NCT03737110|12041919|FG000|Run-in (RI) Period|Adverse Event|4
7628957|NCT03737110|12041920|FG001|Run-in (RI) Period|Adverse Event|0
7628958|NCT03737110|12041921|FG002|Run-in (RI) Period|Adverse Event|0
7628959|NCT03737110|12041919|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0
7628960|NCT03737110|12041920|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1
7628961|NCT03737110|12041921|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0
7628962|NCT03737110|12041919|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
7628963|NCT03737110|12041920|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
7628964|NCT03737110|12041921|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
7628965|NCT03649477|12041961|FG000|Overall Study|Adverse Event|2
7628966|NCT03649477|12041962|FG001|Overall Study|Adverse Event|0
7628967|NCT03649477|12041963|FG002|Overall Study|Adverse Event|0
7628968|NCT03631706|12041973|FG000|Overall Study|Randomized, not treated|1
7628969|NCT03631706|12041974|FG001|Overall Study|Randomized, not treated|0
7628970|NCT03631706|12041973|FG000|Overall Study|Treatment ongoing|26
7628971|NCT03631706|12041974|FG001|Overall Study|Treatment ongoing|57
7628972|NCT03631706|12041973|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65
7882188|NCT01767597|12380909|FG000|Overall Study|Incomplete intervention|3
7628973|NCT03631706|12041974|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41
7628974|NCT03615482|12041982|FG000|Overall Study|Death|1
7628975|NCT03615482|12041983|FG001|Overall Study|Death|0
7628976|NCT03615482|12041982|FG000|Overall Study|Lost to Follow-up|7
7628977|NCT03615482|12041983|FG001|Overall Study|Lost to Follow-up|7
7628978|NCT03615482|12041982|FG000|Overall Study|Physician Decision|2
7628979|NCT03615482|12041983|FG001|Overall Study|Physician Decision|3
7628980|NCT03615482|12041982|FG000|Overall Study|Withdrawal by Subject|7
7628981|NCT03615482|12041983|FG001|Overall Study|Withdrawal by Subject|7
7628982|NCT03572933|12041991|FG000|Overall Study|Adverse Event|4
7628983|NCT03572933|12041992|FG001|Overall Study|Adverse Event|1
7628984|NCT03572933|12041991|FG000|Overall Study|Withdrawal by Subject|0
7628985|NCT03572933|12041992|FG001|Overall Study|Withdrawal by Subject|1
7628986|NCT03526861|12042010|FG000|Initial Treatment Period|Not dosed|1
7628987|NCT03526861|12042011|FG001|Initial Treatment Period|Not dosed|1
7628988|NCT03526861|12042012|FG002|Initial Treatment Period|Not dosed|1
7628989|NCT03526861|12042013|FG003|Initial Treatment Period|Not dosed|0
7628990|NCT03526861|12042014|FG004|Initial Treatment Period|Not dosed|0
7628991|NCT03526861|12042015|FG005|Initial Treatment Period|Not dosed|0
7628992|NCT03526861|12042016|FG006|Initial Treatment Period|Not dosed|0
7628993|NCT03526861|12042017|FG007|Initial Treatment Period|Not dosed|0
7628994|NCT03526861|12042018|FG008|Initial Treatment Period|Not dosed|0
7628995|NCT03526861|12042010|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3
7628996|NCT03526861|12042011|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1
7628997|NCT03526861|12042012|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5
7628998|NCT03526861|12042013|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7628999|NCT03526861|12042014|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629000|NCT03526861|12042015|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629001|NCT03526861|12042016|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629002|NCT03526861|12042017|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629003|NCT03526861|12042018|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629004|NCT03526861|12042010|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3
7629005|NCT03526861|12042011|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5
7629006|NCT03526861|12042012|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8
7629007|NCT03526861|12042013|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7629008|NCT03526861|12042014|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7629009|NCT03526861|12042015|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7629010|NCT03526861|12042016|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7629011|NCT03526861|12042017|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7629012|NCT03526861|12042018|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7629013|NCT03526861|12042010|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629014|NCT03526861|12042011|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629015|NCT03526861|12042012|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629016|NCT03526861|12042013|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
7629017|NCT03526861|12042014|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
7629018|NCT03526861|12042015|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629019|NCT03526861|12042016|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
7629020|NCT03526861|12042017|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629021|NCT03526861|12042018|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629022|NCT03526861|12042010|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7629023|NCT03526861|12042011|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7629024|NCT03526861|12042012|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7629025|NCT03526861|12042013|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6
7629026|NCT03526861|12042014|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5
7629027|NCT03526861|12042015|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4
7629028|NCT03526861|12042016|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5
7629029|NCT03526861|12042017|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2
7629030|NCT03526861|12042018|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7629031|NCT03526861|12042010|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629032|NCT03526861|12042011|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629033|NCT03526861|12042012|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629034|NCT03526861|12042013|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1
7629092|NCT03395639|12042060|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1
7629035|NCT03526861|12042014|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629036|NCT03526861|12042015|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629037|NCT03526861|12042016|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629038|NCT03526861|12042017|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629039|NCT03526861|12042018|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629040|NCT03526861|12042010|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629041|NCT03526861|12042011|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629042|NCT03526861|12042012|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629043|NCT03526861|12042013|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629044|NCT03526861|12042014|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629045|NCT03526861|12042015|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629046|NCT03526861|12042016|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629047|NCT03526861|12042017|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629048|NCT03526861|12042018|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19
7629049|NCT03526861|12042010|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629050|NCT03526861|12042011|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629051|NCT03526861|12042012|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629052|NCT03526861|12042013|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629053|NCT03526861|12042014|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629054|NCT03526861|12042015|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629055|NCT03526861|12042016|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629056|NCT03526861|12042017|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629057|NCT03526861|12042018|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1
7629058|NCT03526861|12042010|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629059|NCT03526861|12042011|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629060|NCT03526861|12042012|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629061|NCT03526861|12042013|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629062|NCT03526861|12042014|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629063|NCT03526861|12042015|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629064|NCT03526861|12042016|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629065|NCT03526861|12042017|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629066|NCT03526861|12042018|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8
7629067|NCT03429049|12042050|FG000|Overall Study|Adverse Event|2
7629068|NCT03429049|12042051|FG001|Overall Study|Adverse Event|3
7629069|NCT03429049|12042050|FG000|Overall Study|Death|0
7629070|NCT03429049|12042051|FG001|Overall Study|Death|1
7629071|NCT03429049|12042050|FG000|Overall Study|Lack of Efficacy|4
7629072|NCT03429049|12042051|FG001|Overall Study|Lack of Efficacy|2
7629073|NCT03429049|12042050|FG000|Overall Study|Lost to Follow-up|9
7629074|NCT03429049|12042051|FG001|Overall Study|Lost to Follow-up|8
7629075|NCT03429049|12042050|FG000|Overall Study|Physician Decision|1
7629076|NCT03429049|12042051|FG001|Overall Study|Physician Decision|0
7629077|NCT03429049|12042050|FG000|Overall Study|Protocol Violation|3
7629078|NCT03429049|12042051|FG001|Overall Study|Protocol Violation|0
7629079|NCT03429049|12042050|FG000|Overall Study|Sponsor Decision|2
7629080|NCT03429049|12042051|FG001|Overall Study|Sponsor Decision|0
7629081|NCT03429049|12042050|FG000|Overall Study|Withdrawal by Subject|4
7629082|NCT03429049|12042051|FG001|Overall Study|Withdrawal by Subject|20
7629083|NCT03429049|12042050|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3
7629084|NCT03429049|12042051|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8
7629085|NCT03395639|12042059|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2
7629086|NCT03395639|12042060|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2
7629087|NCT03395639|12042061|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0
7629088|NCT03395639|12042059|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1
7629089|NCT03395639|12042060|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0
7629090|NCT03395639|12042061|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0
7629091|NCT03395639|12042059|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0
7629093|NCT03395639|12042061|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0
7629094|NCT03395639|12042059|FG000|Extension Period (4-13 Months)|Adverse Event|0
7629095|NCT03395639|12042060|FG001|Extension Period (4-13 Months)|Adverse Event|0
7629096|NCT03395639|12042061|FG002|Extension Period (4-13 Months)|Adverse Event|2
7629097|NCT03395639|12042059|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0
7629098|NCT03395639|12042060|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0
7629099|NCT03395639|12042061|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1
7629100|NCT03381274|12042073|FG000|Overall Study|Death|2
7629101|NCT03381274|12042074|FG001|Overall Study|Death|9
7629102|NCT03381274|12042075|FG002|Overall Study|Death|3
7629103|NCT03381274|12042076|FG003|Overall Study|Death|2
7629104|NCT03381274|12042077|FG004|Overall Study|Death|3
7629105|NCT03381274|12042073|FG000|Overall Study|Lost to Follow-up|0
7629106|NCT03381274|12042074|FG001|Overall Study|Lost to Follow-up|0
7629107|NCT03381274|12042075|FG002|Overall Study|Lost to Follow-up|0
7629108|NCT03381274|12042076|FG003|Overall Study|Lost to Follow-up|1
7629109|NCT03381274|12042077|FG004|Overall Study|Lost to Follow-up|0
7629110|NCT03381274|12042073|FG000|Overall Study|Withdrawal by Subject|2
7629111|NCT03381274|12042074|FG001|Overall Study|Withdrawal by Subject|1
7629112|NCT03381274|12042075|FG002|Overall Study|Withdrawal by Subject|3
7629113|NCT03381274|12042076|FG003|Overall Study|Withdrawal by Subject|1
7629114|NCT03381274|12042077|FG004|Overall Study|Withdrawal by Subject|0
7629115|NCT03381274|12042073|FG000|Overall Study|Other|1
7629116|NCT03381274|12042074|FG001|Overall Study|Other|11
7629117|NCT03381274|12042075|FG002|Overall Study|Other|0
7629118|NCT03381274|12042076|FG003|Overall Study|Other|2
7629119|NCT03381274|12042077|FG004|Overall Study|Other|2
7798765|NCT01083485|12255681|FG000|Overall Study|Adverse Event|0
7798766|NCT01083485|12255682|FG001|Overall Study|Adverse Event|1
7798767|NCT01083485|12255681|FG000|Overall Study|Protocol Violation|1
7629123|NCT03338894|12042097|FG000|Overall Study|not able able to attend 9 or more classes|10
7798768|NCT01083485|12255682|FG001|Overall Study|Protocol Violation|0
7798769|NCT01083485|12255681|FG000|Overall Study|Withdrawal by Subject|5
7798770|NCT01083485|12255682|FG001|Overall Study|Withdrawal by Subject|2
7798771|NCT01083485|12255681|FG000|Overall Study|Other|1
7629128|NCT03199963|12042118|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5
7629129|NCT03199963|12042119|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5
7629130|NCT03199963|12042118|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9
7629131|NCT03199963|12042119|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2
7629132|NCT03199963|12042118|FG000|Blinded Phase - Overall Study|Adverse Event|10
7629133|NCT03199963|12042119|FG001|Blinded Phase - Overall Study|Adverse Event|5
7629134|NCT03199963|12042118|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109
7629135|NCT03199963|12042119|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54
7629136|NCT03199963|12042118|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7
7629137|NCT03199963|12042119|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5
7629138|NCT03199963|12042118|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0
7629139|NCT03199963|12042119|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1
7629140|NCT03132636|12042133|FG000|Overall Study|Adverse Event|1
7629141|NCT03132636|12042134|FG001|Overall Study|Adverse Event|2
7629142|NCT03132636|12042133|FG000|Overall Study|Death|4
7629143|NCT03132636|12042134|FG001|Overall Study|Death|7
7629144|NCT03132636|12042133|FG000|Overall Study|Lost to Follow-up|2
7629145|NCT03132636|12042134|FG001|Overall Study|Lost to Follow-up|2
7629146|NCT03132636|12042133|FG000|Overall Study|Protocol Violation|1
7629147|NCT03132636|12042134|FG001|Overall Study|Protocol Violation|1
7629148|NCT03132636|12042133|FG000|Overall Study|Participant Decision|1
7629149|NCT03132636|12042134|FG001|Overall Study|Participant Decision|9
7629150|NCT03132636|12042133|FG000|Overall Study|Sponsor Decision|0
7629151|NCT03132636|12042134|FG001|Overall Study|Sponsor Decision|1
7629152|NCT03132636|12042133|FG000|Overall Study|Progressive disease|32
7629153|NCT03132636|12042134|FG001|Overall Study|Progressive disease|36
7629154|NCT03132636|12042133|FG000|Overall Study|Withdrawal of consent|2
7629155|NCT03132636|12042134|FG001|Overall Study|Withdrawal of consent|5
7629156|NCT03132636|12042133|FG000|Overall Study|Study ongoing|9
7629157|NCT03132636|12042134|FG001|Overall Study|Study ongoing|10
7629158|NCT03132636|12042133|FG000|Overall Study|Other|1
7629159|NCT03132636|12042134|FG001|Overall Study|Other|2
7629160|NCT03116399|12042142|FG000|Overall Study|Death|8
7629161|NCT03116399|12042143|FG001|Overall Study|Death|3
7629162|NCT03116399|12042142|FG000|Overall Study|Lost to Follow-up|7
7629163|NCT03116399|12042143|FG001|Overall Study|Lost to Follow-up|11
7629164|NCT03116399|12042142|FG000|Overall Study|Investigator Decision|1
7629165|NCT03116399|12042143|FG001|Overall Study|Investigator Decision|1
7629166|NCT03116399|12042142|FG000|Overall Study|Withdrawal by Subject|24
7629167|NCT03116399|12042143|FG001|Overall Study|Withdrawal by Subject|9
7629168|NCT02961374|12042166|FG000|Overall Study|Adverse Event|4
7629169|NCT02904954|12042181|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1
7629170|NCT02904954|12042182|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1
7629171|NCT02904954|12042181|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1
7798772|NCT01083485|12255682|FG001|Overall Study|Other|0
7629172|NCT02904954|12042182|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0
7629173|NCT02904954|12042181|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2
7629174|NCT02904954|12042182|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3
7629175|NCT02904954|12042181|FG000|Adjuvant Durvalumab|Recurrence|2
7629176|NCT02904954|12042182|FG001|Adjuvant Durvalumab|Recurrence|0
7629177|NCT02904954|12042181|FG000|Adjuvant Durvalumab|Adverse Event|2
7629178|NCT02904954|12042182|FG001|Adjuvant Durvalumab|Adverse Event|6
7629179|NCT02904954|12042181|FG000|Adjuvant Durvalumab|Participant wishes|12
7629180|NCT02904954|12042182|FG001|Adjuvant Durvalumab|Participant wishes|7
7629181|NCT02904954|12042181|FG000|Adjuvant Durvalumab|Physician Decision|2
7629182|NCT02904954|12042182|FG001|Adjuvant Durvalumab|Physician Decision|1
7629183|NCT02904954|12042181|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1
7629184|NCT02904954|12042182|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0
7629185|NCT02904954|12042181|FG000|Adjuvant Durvalumab|Death|0
7629186|NCT02904954|12042182|FG001|Adjuvant Durvalumab|Death|1
7629187|NCT02904954|12042181|FG000|Adjuvant Durvalumab|Prostate cancer|1
7629188|NCT02904954|12042182|FG001|Adjuvant Durvalumab|Prostate cancer|0
7798773|NCT01083576|12255692|FG000|Overall Study|Treatment Failure|6
7798774|NCT01083576|12255693|FG001|Overall Study|Treatment Failure|1
7798775|NCT01083602|12255700|FG000|Overall Study|Adverse Event|11
7798776|NCT01083602|12255700|FG000|Overall Study|New Cancer Therapy|2
7798777|NCT01083602|12255700|FG000|Overall Study|Death|1
7798778|NCT01083602|12255700|FG000|Overall Study|Withdrawal by Subject|5
7798779|NCT01083602|12255700|FG000|Overall Study|Lack of Efficacy|36
7798780|NCT01083641|12255713|FG000|Overall Study|Withdrawal by Subject|2
7798781|NCT01083680|12255730|FG000|Overall Study|Lost to Follow-up|2758
7798782|NCT01083680|12255730|FG000|Overall Study|Withdrawal by Subject|1086
7798783|NCT01083693|12255737|FG000|Overall Study|Adverse Event|1
7798784|NCT01083693|12255738|FG001|Overall Study|Adverse Event|1
7798785|NCT01083693|12255739|FG002|Overall Study|Adverse Event|0
7798786|NCT01083693|12255737|FG000|Overall Study|Lost to Follow-up|2
7798787|NCT01083693|12255738|FG001|Overall Study|Lost to Follow-up|0
7798788|NCT01083693|12255739|FG002|Overall Study|Lost to Follow-up|2
7798789|NCT01083693|12255737|FG000|Overall Study|Lack of effectiveness|13
7798790|NCT01083693|12255738|FG001|Overall Study|Lack of effectiveness|2
7798791|NCT01083693|12255739|FG002|Overall Study|Lack of effectiveness|2
7798792|NCT01083693|12255737|FG000|Overall Study|Patient Moved|0
7798793|NCT01083693|12255738|FG001|Overall Study|Patient Moved|1
7798794|NCT01083693|12255739|FG002|Overall Study|Patient Moved|0
7798795|NCT01083693|12255737|FG000|Overall Study|Complete remission|0
7798796|NCT01083693|12255738|FG001|Overall Study|Complete remission|1
7798797|NCT01083693|12255739|FG002|Overall Study|Complete remission|0
7798798|NCT01083693|12255737|FG000|Overall Study|Other medical condition/surgery|1
7798799|NCT01083693|12255738|FG001|Overall Study|Other medical condition/surgery|1
7798800|NCT01083693|12255739|FG002|Overall Study|Other medical condition/surgery|0
7798801|NCT01083693|12255737|FG000|Overall Study|Withdrawal by Subject|3
7798802|NCT01083693|12255738|FG001|Overall Study|Withdrawal by Subject|0
7798803|NCT01083693|12255739|FG002|Overall Study|Withdrawal by Subject|2
7798804|NCT01083693|12255737|FG000|Overall Study|Reason unknown|0
7798805|NCT01083693|12255738|FG001|Overall Study|Reason unknown|0
7798806|NCT01083693|12255739|FG002|Overall Study|Reason unknown|1
7798807|NCT01083810|12255778|FG000|Overall Study|Lost to Follow-up|23
7798808|NCT01083810|12255779|FG001|Overall Study|Lost to Follow-up|11
7798809|NCT01083810|12255780|FG002|Overall Study|Lost to Follow-up|4
7798810|NCT01083810|12255778|FG000|Overall Study|Adverse Event|15
7629227|NCT02784431|12042218|FG000|Overall Study|Unsuccessful Implant Attempt|1
7629228|NCT02784431|12042218|FG000|Overall Study|Early Study Termination|19
7798811|NCT01083810|12255779|FG001|Overall Study|Adverse Event|11
7798812|NCT01083810|12255780|FG002|Overall Study|Adverse Event|4
7798813|NCT01083810|12255778|FG000|Overall Study|Withdrawal by Subject|7
7798814|NCT01083810|12255779|FG001|Overall Study|Withdrawal by Subject|2
7798815|NCT01083810|12255780|FG002|Overall Study|Withdrawal by Subject|4
7629234|NCT02634307|12042229|FG000|Overall Study|Adverse Event|50
7629235|NCT02634307|12042230|FG001|Overall Study|Adverse Event|24
7629236|NCT02634307|12042231|FG002|Overall Study|Adverse Event|14
7629237|NCT02634307|12042229|FG000|Overall Study|Lost to Follow-up|21
7629238|NCT02634307|12042230|FG001|Overall Study|Lost to Follow-up|5
7629239|NCT02634307|12042231|FG002|Overall Study|Lost to Follow-up|6
7629240|NCT02634307|12042229|FG000|Overall Study|Pregnancy|5
7629241|NCT02634307|12042230|FG001|Overall Study|Pregnancy|1
7629242|NCT02634307|12042231|FG002|Overall Study|Pregnancy|3
7629243|NCT02634307|12042229|FG000|Overall Study|Withdrawal by Subject|38
7629244|NCT02634307|12042230|FG001|Overall Study|Withdrawal by Subject|24
7629245|NCT02634307|12042231|FG002|Overall Study|Withdrawal by Subject|18
7629246|NCT02634307|12042229|FG000|Overall Study|Non-Compliance with Study Drug|0
7629247|NCT02634307|12042230|FG001|Overall Study|Non-Compliance with Study Drug|2
7629248|NCT02634307|12042231|FG002|Overall Study|Non-Compliance with Study Drug|2
7629249|NCT02634307|12042229|FG000|Overall Study|Lack of Efficacy|1
7629250|NCT02634307|12042230|FG001|Overall Study|Lack of Efficacy|5
7629251|NCT02634307|12042231|FG002|Overall Study|Lack of Efficacy|3
7629252|NCT02634307|12042229|FG000|Overall Study|Physician Decision|7
7629253|NCT02634307|12042230|FG001|Overall Study|Physician Decision|5
7798816|NCT01083810|12255778|FG000|Overall Study|Reason not reported|6
7798817|NCT01083810|12255779|FG001|Overall Study|Reason not reported|1
7629254|NCT02634307|12042231|FG002|Overall Study|Physician Decision|5
7629255|NCT02634307|12042229|FG000|Overall Study|Reason not Specified|3
7629256|NCT02634307|12042230|FG001|Overall Study|Reason not Specified|5
7629257|NCT02634307|12042231|FG002|Overall Study|Reason not Specified|10
7798818|NCT01083810|12255780|FG002|Overall Study|Reason not reported|1
7798819|NCT01083810|12255778|FG000|Overall Study|Non-compliance|4
7629260|NCT02575339|12042246|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1
7629261|NCT02575339|12042247|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0
7629262|NCT02575339|12042248|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0
7629263|NCT02575339|12042246|FG000|Study Treatment|Disease Progression|5
7629264|NCT02575339|12042247|FG001|Study Treatment|Disease Progression|2
7629265|NCT02575339|12042248|FG002|Study Treatment|Disease Progression|0
7629266|NCT02575339|12042246|FG000|Study Treatment|Adverse Event|1
7629267|NCT02575339|12042247|FG001|Study Treatment|Adverse Event|2
7629268|NCT02575339|12042248|FG002|Study Treatment|Adverse Event|0
7629269|NCT02575339|12042246|FG000|Follow up|Death|6
7629270|NCT02575339|12042247|FG001|Follow up|Death|2
7629271|NCT02575339|12042248|FG002|Follow up|Death|0
7629272|NCT02575339|12042246|FG000|Follow up|Study Terminated|0
7629273|NCT02575339|12042247|FG001|Follow up|Study Terminated|2
7629274|NCT02575339|12042248|FG002|Follow up|Study Terminated|0
7629275|NCT02575339|12042246|FG000|Follow up|Death due to progressive disease after coming off treatment early|1
7629276|NCT02575339|12042247|FG001|Follow up|Death due to progressive disease after coming off treatment early|0
7629277|NCT02575339|12042248|FG002|Follow up|Death due to progressive disease after coming off treatment early|0
7798820|NCT01083810|12255779|FG001|Overall Study|Non-compliance|7
7798821|NCT01083810|12255780|FG002|Overall Study|Non-compliance|2
7798822|NCT01083810|12255778|FG000|Overall Study|Simplification|4
7798823|NCT01083810|12255779|FG001|Overall Study|Simplification|1
7798824|NCT01083810|12255780|FG002|Overall Study|Simplification|0
7798825|NCT01083810|12255778|FG000|Overall Study|Death|2
7798826|NCT01083810|12255779|FG001|Overall Study|Death|2
7798827|NCT01083810|12255780|FG002|Overall Study|Death|3
7798828|NCT01083810|12255778|FG000|Overall Study|Co-morbidities|1
7798829|NCT01083810|12255779|FG001|Overall Study|Co-morbidities|0
7798830|NCT01083810|12255780|FG002|Overall Study|Co-morbidities|0
7798831|NCT01083810|12255778|FG000|Overall Study|Participation in study|1
7798832|NCT01083810|12255779|FG001|Overall Study|Participation in study|0
7798833|NCT01083810|12255780|FG002|Overall Study|Participation in study|0
7798834|NCT01083810|12255778|FG000|Overall Study|Therapy break|1
7798835|NCT01083810|12255779|FG001|Overall Study|Therapy break|2
7798836|NCT01083810|12255780|FG002|Overall Study|Therapy break|2
7798837|NCT01083810|12255778|FG000|Overall Study|Virologic failure|1
7798838|NCT01083810|12255779|FG001|Overall Study|Virologic failure|8
7798839|NCT01083810|12255780|FG002|Overall Study|Virologic failure|0
7798840|NCT01084005|12255817|FG000|Overall Study|Adverse Event|1
7798841|NCT01084005|12255818|FG001|Overall Study|Adverse Event|8
7798842|NCT01084005|12255817|FG000|Overall Study|Protocol Violation|3
7798843|NCT01084005|12255818|FG001|Overall Study|Protocol Violation|7
7798844|NCT01084005|12255817|FG000|Overall Study|Withdrawal by Subject|1
7798845|NCT01084005|12255818|FG001|Overall Study|Withdrawal by Subject|1
7798846|NCT01084083|12255824|FG000|Overall Study|Adverse Event|5
7798847|NCT01084083|12255824|FG000|Overall Study|Death|1
7798848|NCT01084083|12255824|FG000|Overall Study|Withdrawal by Subject|2
7629307|NCT02282020|12042323|FG000|Overall Study|Objective Disease Progression|128
7629308|NCT02282020|12042324|FG001|Overall Study|Objective Disease Progression|30
7629309|NCT02282020|12042323|FG000|Overall Study|Adverse Event|18
7629310|NCT02282020|12042324|FG001|Overall Study|Adverse Event|15
7629311|NCT02282020|12042323|FG000|Overall Study|Withdrawal by Subject|7
7629312|NCT02282020|12042324|FG001|Overall Study|Withdrawal by Subject|10
7629313|NCT02282020|12042323|FG000|Overall Study|Miscellaneous|5
7629314|NCT02282020|12042324|FG001|Overall Study|Miscellaneous|19
7629315|NCT02282020|12042323|FG000|Overall Study|Severe Non-compliance to Protocol|1
7629316|NCT02282020|12042324|FG001|Overall Study|Severe Non-compliance to Protocol|0
7629317|NCT02282020|12042323|FG000|Overall Study|Developed Discontinuation Criteria|0
7629318|NCT02282020|12042324|FG001|Overall Study|Developed Discontinuation Criteria|2
7629319|NCT02282020|12042323|FG000|Overall Study|Withdrew Consent Prior to Dosing|0
7629320|NCT02282020|12042324|FG001|Overall Study|Withdrew Consent Prior to Dosing|12
7798849|NCT01084083|12255824|FG000|Overall Study|Complicating disease|1
7629322|NCT02243631|12042337|FG000|Overall Study|no synovial fluid on second aspirate|0
7629323|NCT02243631|12042338|FG001|Overall Study|no synovial fluid on second aspirate|1
7629324|NCT02213926|12042344|FG000|Overall Study|Death|59
7629325|NCT02213926|12042344|FG000|Overall Study|Withdrawal by Subject|10
7629326|NCT02213926|12042344|FG000|Overall Study|study terminated by sponsor|51
7629327|NCT02213926|12042344|FG000|Overall Study|Lost to Follow-up|3
7629328|NCT02213926|12042344|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1
7798850|NCT01084083|12255824|FG000|Overall Study|Other|2
7798851|NCT01084083|12255824|FG000|Overall Study|Never started assigned therapy|1
7798852|NCT01084135|12255833|FG000|20 Week|Physician Decision|0
7798853|NCT01084135|12255834|FG001|20 Week|Physician Decision|1
7629333|NCT02066181|12042354|FG000|Overall Study|Withdrawal by Subject|1
7629334|NCT02066181|12042355|FG001|Overall Study|Withdrawal by Subject|1
7798854|NCT01084174|12255855|FG000|Overall Study|gastrointestinal symptoms|1
7629336|NCT02041533|12042370|FG000|Overall Study|Disease Progression|168
7629337|NCT02041533|12042371|FG001|Overall Study|Disease Progression|142
7629338|NCT02041533|12042370|FG000|Overall Study|Study drug toxicity|27
7629339|NCT02041533|12042371|FG001|Overall Study|Study drug toxicity|30
7629340|NCT02041533|12042370|FG000|Overall Study|Death|1
7629341|NCT02041533|12042371|FG001|Overall Study|Death|0
7629342|NCT02041533|12042370|FG000|Overall Study|Adverse Event unrelated to study drug|20
7629343|NCT02041533|12042371|FG001|Overall Study|Adverse Event unrelated to study drug|21
7629344|NCT02041533|12042370|FG000|Overall Study|Subject request to discontinue treatment|5
7629345|NCT02041533|12042371|FG001|Overall Study|Subject request to discontinue treatment|9
7629346|NCT02041533|12042370|FG000|Overall Study|Withdrawal by Subject|2
7629347|NCT02041533|12042371|FG001|Overall Study|Withdrawal by Subject|1
7629348|NCT02041533|12042370|FG000|Overall Study|Maximum clinical benefit|0
7629349|NCT02041533|12042371|FG001|Overall Study|Maximum clinical benefit|18
7629350|NCT02041533|12042370|FG000|Overall Study|Poor/non-compliance|1
7629351|NCT02041533|12042371|FG001|Overall Study|Poor/non-compliance|0
7629352|NCT02041533|12042370|FG000|Overall Study|Other reasons|0
7629353|NCT02041533|12042371|FG001|Overall Study|Other reasons|1
7629354|NCT02041533|12042370|FG000|Overall Study|Completed max number of chemo cycles|0
7629355|NCT02041533|12042371|FG001|Overall Study|Completed max number of chemo cycles|29
7629356|NCT02041533|12042370|FG000|Overall Study|Randomized, not treated|4
7629357|NCT02041533|12042371|FG001|Overall Study|Randomized, not treated|7
7629358|NCT01963728|12042379|FG000|Overall Study|Study terminated early|0
7629359|NCT01963728|12042380|FG001|Overall Study|Study terminated early|1
7798855|NCT01084174|12255856|FG001|Overall Study|gastrointestinal symptoms|1
7798856|NCT01084174|12255855|FG000|Overall Study|Eosinophilic esophagitis|0
7798857|NCT01084174|12255856|FG001|Overall Study|Eosinophilic esophagitis|1
7798858|NCT01084174|12255855|FG000|Overall Study|Anaphylaxis|0
7798859|NCT01084174|12255856|FG001|Overall Study|Anaphylaxis|1
7798860|NCT01084174|12255855|FG000|Overall Study|Participant noncompliance|0
7798861|NCT01084174|12255856|FG001|Overall Study|Participant noncompliance|1
7798862|NCT01084239|12255864|FG000|28-Day Follow-up|Lost to Follow-up|4
7798863|NCT01084239|12255865|FG001|28-Day Follow-up|Lost to Follow-up|9
7798864|NCT01084538|12255909|FG000|Overall Study|Drug not available|30
7798865|NCT01084538|12255909|FG000|Overall Study|Adverse Event|9
7798866|NCT01084538|12255909|FG000|Overall Study|Kidney transplant|6
7798867|NCT01084538|12255909|FG000|Overall Study|Serious Adverse Event|3
7798868|NCT01084538|12255909|FG000|Overall Study|Lack of effectiveness|2
7798869|NCT01084538|12255909|FG000|Overall Study|Patient noncompliance|2
7798870|NCT01084538|12255909|FG000|Overall Study|Hyperphosphatemia|2
7798871|NCT01084538|12255909|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2
7798872|NCT01084538|12255909|FG000|Overall Study|Change of residence|2
7798873|NCT01084538|12255909|FG000|Overall Study|Over-suppression of parathyroid gland|2
7798874|NCT01084538|12255909|FG000|Overall Study|Reason unknown|8
7798875|NCT01084551|12255916|FG000|Overall Study|Adverse Event|2
7798876|NCT01084551|12255917|FG001|Overall Study|Adverse Event|9
7798877|NCT01084551|12255918|FG002|Overall Study|Adverse Event|4
7798878|NCT01084551|12255916|FG000|Overall Study|Lack of Efficacy|2
7798879|NCT01084551|12255917|FG001|Overall Study|Lack of Efficacy|0
7798880|NCT01084551|12255918|FG002|Overall Study|Lack of Efficacy|1
7798881|NCT01084551|12255916|FG000|Overall Study|Withdrawal by Subject|2
7798882|NCT01084551|12255917|FG001|Overall Study|Withdrawal by Subject|1
7798883|NCT01084551|12255918|FG002|Overall Study|Withdrawal by Subject|0
7798884|NCT01084551|12255916|FG000|Overall Study|Protocol Violation|2
7798885|NCT01084551|12255917|FG001|Overall Study|Protocol Violation|4
7798886|NCT01084551|12255918|FG002|Overall Study|Protocol Violation|0
7798887|NCT01084551|12255916|FG000|Overall Study|Lost to Follow-up|0
7798888|NCT01084551|12255917|FG001|Overall Study|Lost to Follow-up|0
7798889|NCT01084551|12255918|FG002|Overall Study|Lost to Follow-up|3
7798890|NCT01084551|12255916|FG000|Overall Study|Physician Decision|1
7798891|NCT01084551|12255917|FG001|Overall Study|Physician Decision|0
7798892|NCT01084551|12255918|FG002|Overall Study|Physician Decision|0
7798893|NCT01084603|12255926|FG000|Baseline|Withdrawal by Subject|2
7798894|NCT01084603|12255926|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1
7798895|NCT01084603|12255926|FG000|Nicorette® Gum|Withdrawal by Subject|1
7798896|NCT01084603|12255926|FG000|Oral Nicotine 1|Withdrawal by Subject|1
7798897|NCT01084603|12255926|FG000|Washout Period 4|Adverse Event|1
7798898|NCT01084655|12255942|FG000|Overall Study|Radiographic disease progression|3
7798899|NCT01084655|12255943|FG001|Overall Study|Radiographic disease progression|2
7798900|NCT01084655|12255944|FG002|Overall Study|Radiographic disease progression|8
7798901|NCT01084655|12255942|FG000|Overall Study|Withdrawal by Subject|1
7798902|NCT01084655|12255943|FG001|Overall Study|Withdrawal by Subject|0
7798903|NCT01084655|12255944|FG002|Overall Study|Withdrawal by Subject|4
7798904|NCT01084655|12255942|FG000|Overall Study|Adverse Event|2
7798905|NCT01084655|12255943|FG001|Overall Study|Adverse Event|1
7798906|NCT01084655|12255944|FG002|Overall Study|Adverse Event|2
7798907|NCT01084655|12255942|FG000|Overall Study|Other|0
7798908|NCT01084655|12255943|FG001|Overall Study|Other|3
7798909|NCT01084655|12255944|FG002|Overall Study|Other|2
7798910|NCT01084655|12255942|FG000|Overall Study|Symptomatic deterioration|0
7798911|NCT01084655|12255943|FG001|Overall Study|Symptomatic deterioration|0
7798912|NCT01084655|12255944|FG002|Overall Study|Symptomatic deterioration|2
7798913|NCT01084655|12255942|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0
7798914|NCT01084655|12255943|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0
7798915|NCT01084655|12255944|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1
7798916|NCT01084668|12255956|FG000|Overall Study|Lack of Efficacy|5
7798917|NCT01084668|12255956|FG000|Overall Study|Withdrawal by Subject|2
7798918|NCT01084668|12255956|FG000|Overall Study|Pregnancy|1
7798919|NCT01084668|12255956|FG000|Overall Study|Non-compliance|1
7798920|NCT01084694|12255964|FG000|Overall Study|Withdrawal by Subject|2
7798921|NCT01084694|12255965|FG001|Overall Study|Withdrawal by Subject|1
7798922|NCT01084694|12255964|FG000|Overall Study|Death|2
7798923|NCT01084694|12255965|FG001|Overall Study|Death|12
7798924|NCT01084694|12255964|FG000|Overall Study|eligibility not maintained|2
7798925|NCT01084694|12255965|FG001|Overall Study|eligibility not maintained|7
7798926|NCT01084707|12255979|FG000|Overall Study|Withdrawal by Subject|6
7798927|NCT01084772|12255997|FG000|Baseline|Withdrawal by Subject|7
7798928|NCT01084772|12255998|FG001|Baseline|Withdrawal by Subject|6
7798929|NCT01084772|12255997|FG000|3 Months|Death|1
7798930|NCT01084772|12255998|FG001|3 Months|Death|0
7798931|NCT01084772|12255997|FG000|3 Months|Study Termination|2
7798932|NCT01084772|12255998|FG001|3 Months|Study Termination|2
7798933|NCT01084772|12255997|FG000|1 Year|Withdrawal by Subject|0
7798934|NCT01084772|12255998|FG001|1 Year|Withdrawal by Subject|1
7798935|NCT01084772|12255997|FG000|1 Year|Lost to Follow-up|3
7798936|NCT01084772|12255998|FG001|1 Year|Lost to Follow-up|0
7798937|NCT01084772|12255997|FG000|1 Year|Study Termination|0
7798938|NCT01084772|12255998|FG001|1 Year|Study Termination|7
7798939|NCT01084772|12255997|FG000|2 Years|Withdrawal by Subject|1
7798940|NCT01084772|12255998|FG001|2 Years|Withdrawal by Subject|0
7798941|NCT01084772|12255997|FG000|2 Years|Lost to Follow-up|5
7798942|NCT01084772|12255998|FG001|2 Years|Lost to Follow-up|2
7798943|NCT01084772|12255997|FG000|2 Years|Study Termination|3
7798944|NCT01084772|12255998|FG001|2 Years|Study Termination|2
7798945|NCT01085045|12256013|FG000|Part A|Withdrawal by Subject|4
7798946|NCT01085045|12256013|FG000|Part A|Adverse Event|6
7798947|NCT01085045|12256013|FG000|Part A|Protocol Violation|1
7798948|NCT01085045|12256013|FG000|Part A|Protocol Specified Criteria|7
7798949|NCT01085045|12256013|FG000|Part B|Withdrawal by Subject|2
7798950|NCT01085045|12256013|FG000|Part B|Protocol Specified Criteria|6
7798951|NCT01085045|12256013|FG000|Part B|Lost to Follow-up|1
7798952|NCT01085045|12256013|FG000|Part B|Adverse Event|6
7798953|NCT01085136|12256033|FG000|Part A|Other Adverse event|223
7798954|NCT01085136|12256034|FG001|Part A|Other Adverse event|0
7798955|NCT01085136|12256035|FG002|Part A|Other Adverse event|0
7798956|NCT01085136|12256033|FG000|Part A|Protocol Violation|3
7798957|NCT01085136|12256034|FG001|Part A|Protocol Violation|0
7798958|NCT01085136|12256035|FG002|Part A|Protocol Violation|0
7798959|NCT01085136|12256033|FG000|Part A|Lost to Follow-up|3
7798960|NCT01085136|12256034|FG001|Part A|Lost to Follow-up|0
7798961|NCT01085136|12256035|FG002|Part A|Lost to Follow-up|0
7798962|NCT01085136|12256033|FG000|Part A|Refusal to continue trial medication|64
7798963|NCT01085136|12256034|FG001|Part A|Refusal to continue trial medication|0
7798964|NCT01085136|12256035|FG002|Part A|Refusal to continue trial medication|0
7798965|NCT01085136|12256033|FG000|Part A|Other reason not defined above|30
7798966|NCT01085136|12256034|FG001|Part A|Other reason not defined above|0
7798967|NCT01085136|12256035|FG002|Part A|Other reason not defined above|0
7798968|NCT01085136|12256033|FG000|Part B|Other AE|0
7798969|NCT01085136|12256034|FG001|Part B|Other AE|29
7798970|NCT01085136|12256035|FG002|Part B|Other AE|8
7798971|NCT01085136|12256033|FG000|Part B|Refusal to continue trial medication|0
7798972|NCT01085136|12256034|FG001|Part B|Refusal to continue trial medication|12
7798973|NCT01085136|12256035|FG002|Part B|Refusal to continue trial medication|7
7798974|NCT01085136|12256033|FG000|Part B|Not treated|0
7798975|NCT01085136|12256034|FG001|Part B|Not treated|4
7798976|NCT01085136|12256035|FG002|Part B|Not treated|8
7798977|NCT01085136|12256033|FG000|Part B|Other reason not defined above|0
7798978|NCT01085136|12256034|FG001|Part B|Other reason not defined above|6
7798979|NCT01085136|12256035|FG002|Part B|Other reason not defined above|3
7798980|NCT01085201|12256050|FG000|Overall Study|Scheduling conflict|1
7798981|NCT01085201|12256051|FG001|Overall Study|Scheduling conflict|0
7798982|NCT01085201|12256052|FG002|Overall Study|Scheduling conflict|1
7798983|NCT01085201|12256053|FG003|Overall Study|Scheduling conflict|0
7798984|NCT01085201|12256054|FG004|Overall Study|Scheduling conflict|0
7798985|NCT01085201|12256050|FG000|Overall Study|Unknown- no study drug|2
7798986|NCT01085201|12256051|FG001|Overall Study|Unknown- no study drug|0
7798987|NCT01085201|12256052|FG002|Overall Study|Unknown- no study drug|0
7798988|NCT01085201|12256053|FG003|Overall Study|Unknown- no study drug|0
7798989|NCT01085201|12256054|FG004|Overall Study|Unknown- no study drug|0
7798990|NCT01085201|12256050|FG000|Overall Study|Fond ineligible after consent|0
7798991|NCT01085201|12256051|FG001|Overall Study|Fond ineligible after consent|1
7798992|NCT01085201|12256052|FG002|Overall Study|Fond ineligible after consent|1
7798993|NCT01085201|12256053|FG003|Overall Study|Fond ineligible after consent|0
7798994|NCT01085201|12256054|FG004|Overall Study|Fond ineligible after consent|0
7798995|NCT01085214|12256071|FG000|Overall Study|Alternate treatment required|1
7798996|NCT01085357|12256103|FG000|Overall Study|Adverse Event|1
7798997|NCT01085357|12256104|FG001|Overall Study|Adverse Event|1
7798998|NCT01085357|12256103|FG000|Overall Study|Subject Decision|4
7798999|NCT01085357|12256104|FG001|Overall Study|Subject Decision|3
7799000|NCT01085357|12256103|FG000|Overall Study|Investigator Decision|1
7799001|NCT01085357|12256104|FG001|Overall Study|Investigator Decision|1
7799002|NCT01085357|12256103|FG000|Overall Study|Death|11
7799003|NCT01085357|12256104|FG001|Overall Study|Death|1
7799004|NCT01085357|12256103|FG000|Overall Study|Lost to Follow-up|2
7799005|NCT01085357|12256104|FG001|Overall Study|Lost to Follow-up|0
7799006|NCT01085591|12256135|FG000|Overall Study|Adverse Event|0
7799007|NCT01085591|12256136|FG001|Overall Study|Adverse Event|1
7799008|NCT01085591|12256137|FG002|Overall Study|Adverse Event|3
7799009|NCT01085591|12256135|FG000|Overall Study|Physician Decision|1
7799010|NCT01085591|12256136|FG001|Overall Study|Physician Decision|0
7799011|NCT01085591|12256137|FG002|Overall Study|Physician Decision|1
7799012|NCT01085591|12256135|FG000|Overall Study|Withdrawal by Subject|0
7799013|NCT01085591|12256136|FG001|Overall Study|Withdrawal by Subject|2
7799014|NCT01085591|12256137|FG002|Overall Study|Withdrawal by Subject|1
7799015|NCT01085591|12256135|FG000|Overall Study|Lost to Follow-up|0
7799016|NCT01085591|12256136|FG001|Overall Study|Lost to Follow-up|1
7799017|NCT01085591|12256137|FG002|Overall Study|Lost to Follow-up|1
7799018|NCT01085591|12256135|FG000|Overall Study|Protocol Violation|1
7799019|NCT01085591|12256136|FG001|Overall Study|Protocol Violation|1
7799020|NCT01085591|12256137|FG002|Overall Study|Protocol Violation|1
7799021|NCT01085591|12256135|FG000|Overall Study|Other|0
7799022|NCT01085591|12256136|FG001|Overall Study|Other|1
7799023|NCT01085591|12256137|FG002|Overall Study|Other|0
7799024|NCT01085591|12256135|FG000|Overall Study|Not Properly Consented|1
7799025|NCT01085591|12256136|FG001|Overall Study|Not Properly Consented|0
7799026|NCT01085591|12256137|FG002|Overall Study|Not Properly Consented|0
7799027|NCT01085630|12256148|FG000|Overall Study|Insufficient data|1
7799028|NCT01085630|12256149|FG001|Overall Study|Insufficient data|0
7799029|NCT01085630|12256148|FG000|Overall Study|Ineligible|3
7799030|NCT01085630|12256149|FG001|Overall Study|Ineligible|0
7799031|NCT01085682|12256157|FG000|Overall Study|Withdrawal by Subject|25
7799032|NCT01085682|12256158|FG001|Overall Study|Withdrawal by Subject|25
7799033|NCT01085734|12256166|FG000|Overall Study|Adverse Event|0
7799034|NCT01085734|12256167|FG001|Overall Study|Adverse Event|2
7799035|NCT01085734|12256166|FG000|Overall Study|Death|1
7799036|NCT01085734|12256167|FG001|Overall Study|Death|0
7799037|NCT01085734|12256166|FG000|Overall Study|Lost to Follow-up|0
7799038|NCT01085734|12256167|FG001|Overall Study|Lost to Follow-up|1
7799039|NCT01085734|12256166|FG000|Overall Study|Withdrawal by Subject|0
7799040|NCT01085734|12256167|FG001|Overall Study|Withdrawal by Subject|1
7799041|NCT01085812|12256200|FG000|Open-Label Period|Adverse Event|0
7799042|NCT01085812|12256201|FG001|Open-Label Period|Adverse Event|80
7799043|NCT01085812|12256200|FG000|Open-Label Period|Lack of Efficacy|0
7799044|NCT01085812|12256201|FG001|Open-Label Period|Lack of Efficacy|26
7799045|NCT01085812|12256200|FG000|Open-Label Period|Protocol Violation|0
7799046|NCT01085812|12256201|FG001|Open-Label Period|Protocol Violation|39
7799047|NCT01085812|12256200|FG000|Open-Label Period|Withdrawal by Subject|0
7799048|NCT01085812|12256201|FG001|Open-Label Period|Withdrawal by Subject|53
7799049|NCT01085812|12256200|FG000|Open-Label Period|Lost to Follow-up|0
7799050|NCT01085812|12256201|FG001|Open-Label Period|Lost to Follow-up|42
7799051|NCT01085812|12256200|FG000|Double-Blind Period|Adverse Event|3
7799052|NCT01085812|12256201|FG001|Double-Blind Period|Adverse Event|8
7799053|NCT01085812|12256200|FG000|Double-Blind Period|Protocol Violation|2
7799054|NCT01085812|12256201|FG001|Double-Blind Period|Protocol Violation|7
7799055|NCT01085812|12256200|FG000|Double-Blind Period|Withdrawal by Subject|11
7799056|NCT01085812|12256201|FG001|Double-Blind Period|Withdrawal by Subject|24
7799057|NCT01085812|12256200|FG000|Double-Blind Period|Lost to Follow-up|5
7799058|NCT01085812|12256201|FG001|Double-Blind Period|Lost to Follow-up|17
7799059|NCT01085812|12256200|FG000|Double-Blind Period|Other Reasons|0
7799060|NCT01085812|12256201|FG001|Double-Blind Period|Other Reasons|2
7799061|NCT01085812|12256200|FG000|Double-blind Intent-to-treat Population|Adverse Event|3
7799062|NCT01085812|12256201|FG001|Double-blind Intent-to-treat Population|Adverse Event|8
7799063|NCT01085812|12256200|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2
7799064|NCT01085812|12256201|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7
7799065|NCT01085812|12256200|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11
7799066|NCT01085812|12256201|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22
7799067|NCT01085812|12256200|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4
7799068|NCT01085812|12256201|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17
7799069|NCT01085812|12256200|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0
7799070|NCT01085812|12256201|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2
7799071|NCT01086033|12256249|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86
7799072|NCT01086033|12256249|FG000|Overall Study|Lost to Follow-up|86
7799073|NCT01086033|12256249|FG000|Overall Study|Adverse Event|42
7799074|NCT01086033|12256249|FG000|Overall Study|Withdrawal by Subject|41
7799075|NCT01086033|12256249|FG000|Overall Study|Other|14
7799076|NCT01086033|12256249|FG000|Overall Study|Other|13
7799077|NCT01086033|12256249|FG000|Overall Study|AE and Withdrew Consent|5
7799078|NCT01086033|12256249|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5
7799079|NCT01086033|12256249|FG000|Overall Study|Withdrew consent and Other Reason|4
7799080|NCT01086033|12256249|FG000|Overall Study|AE and Lack of Efficacy|4
7799081|NCT01086033|12256249|FG000|Overall Study|Death|1
7799082|NCT01086033|12256249|FG000|Overall Study|AE and Lost to Follow-up|1
7799083|NCT01086033|12256249|FG000|Overall Study|AE and Other Reason|1
7882189|NCT01767597|12380910|FG001|Overall Study|Incomplete intervention|1
7799084|NCT01086033|12256249|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
7799085|NCT01086150|12256259|FG000|Overall Study|Withdrawal by Subject|0
7799086|NCT01086150|12256260|FG001|Overall Study|Withdrawal by Subject|4
7799087|NCT01086150|12256261|FG002|Overall Study|Withdrawal by Subject|1
7799088|NCT01086150|12256259|FG000|Overall Study|Lost to Follow-up|0
7629585|NCT01696981|12042541|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0
7629586|NCT01696981|12042542|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20
7629587|NCT01696981|12042541|FG000|Overall Study|Died Before Randomization|3
7629588|NCT01696981|12042542|FG001|Overall Study|Died Before Randomization|8
7629589|NCT01696981|12042541|FG000|Overall Study|Died Before ASU (Control)|278
7629590|NCT01696981|12042542|FG001|Overall Study|Died Before ASU (Control)|0
7629591|NCT01696981|12042541|FG000|Overall Study|Refused ASU (Control)|920
7629592|NCT01696981|12042542|FG001|Overall Study|Refused ASU (Control)|0
7629593|NCT01696981|12042541|FG000|Overall Study|Refused Screen (Colorectal Screening)|0
7629594|NCT01696981|12042542|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346
7799089|NCT01086150|12256260|FG001|Overall Study|Lost to Follow-up|1
7799090|NCT01086150|12256261|FG002|Overall Study|Lost to Follow-up|0
7799091|NCT01086150|12256259|FG000|Overall Study|Screen Failure|0
7799092|NCT01086150|12256260|FG001|Overall Study|Screen Failure|1
7799093|NCT01086150|12256261|FG002|Overall Study|Screen Failure|0
7799094|NCT01086215|12256273|FG000|Overall Study|Death|14
7799095|NCT01086215|12256274|FG001|Overall Study|Death|8
7799096|NCT01086215|12256275|FG002|Overall Study|Death|8
7799097|NCT01086215|12256276|FG003|Overall Study|Death|1
7799098|NCT01086215|12256273|FG000|Overall Study|Lost to Follow-up|22
7799099|NCT01086215|12256274|FG001|Overall Study|Lost to Follow-up|39
7799100|NCT01086215|12256275|FG002|Overall Study|Lost to Follow-up|18
7799101|NCT01086215|12256276|FG003|Overall Study|Lost to Follow-up|2
7799102|NCT01086358|12256290|FG000|First Intervention|Lost to Follow-up|9
7799103|NCT01086358|12256291|FG001|First Intervention|Lost to Follow-up|4
7799104|NCT01086358|12256290|FG000|First Intervention|Withdrawal by Subject|0
7799105|NCT01086358|12256291|FG001|First Intervention|Withdrawal by Subject|1
7799106|NCT01086358|12256290|FG000|Second Intervention|Lost to Follow-up|4
7799107|NCT01086358|12256291|FG001|Second Intervention|Lost to Follow-up|4
7799108|NCT01086384|12256299|FG000|2-week Run-in Period|Adverse Event|1
7799109|NCT01086384|12256300|FG001|2-week Run-in Period|Adverse Event|0
7799110|NCT01086384|12256301|FG002|2-week Run-in Period|Adverse Event|0
7799111|NCT01086384|12256299|FG000|2-week Run-in Period|Protocol Violation|1
7799112|NCT01086384|12256300|FG001|2-week Run-in Period|Protocol Violation|0
7799113|NCT01086384|12256301|FG002|2-week Run-in Period|Protocol Violation|0
7799114|NCT01086384|12256299|FG000|2-week Run-in Period|Lost to Follow-up|1
7799115|NCT01086384|12256300|FG001|2-week Run-in Period|Lost to Follow-up|0
7629622|NCT01467466|12042577|FG000|Overall Study|Withdrawal by Subject|15
7629623|NCT01467466|12042578|FG001|Overall Study|Withdrawal by Subject|18
7629624|NCT01467466|12042579|FG002|Overall Study|Withdrawal by Subject|13
7629625|NCT01467466|12042580|FG003|Overall Study|Withdrawal by Subject|11
7629626|NCT01467466|12042577|FG000|Overall Study|Revoked Consent Prior To Procedure|10
7629627|NCT01467466|12042578|FG001|Overall Study|Revoked Consent Prior To Procedure|9
7629628|NCT01467466|12042579|FG002|Overall Study|Revoked Consent Prior To Procedure|15
7629629|NCT01467466|12042580|FG003|Overall Study|Revoked Consent Prior To Procedure|5
7629630|NCT01467466|12042577|FG000|Overall Study|Procedure Cancelled|46
7629631|NCT01467466|12042578|FG001|Overall Study|Procedure Cancelled|45
7629632|NCT01467466|12042579|FG002|Overall Study|Procedure Cancelled|25
7629633|NCT01467466|12042580|FG003|Overall Study|Procedure Cancelled|29
7629634|NCT01467466|12042577|FG000|Overall Study|No Endpoint Blood Draw|38
7629635|NCT01467466|12042578|FG001|Overall Study|No Endpoint Blood Draw|32
7629636|NCT01467466|12042579|FG002|Overall Study|No Endpoint Blood Draw|51
7629637|NCT01467466|12042580|FG003|Overall Study|No Endpoint Blood Draw|43
7799116|NCT01086384|12256301|FG002|2-week Run-in Period|Lost to Follow-up|0
7799117|NCT01086384|12256299|FG000|2-week Run-in Period|Physician Decision|6
7799118|NCT01086384|12256300|FG001|2-week Run-in Period|Physician Decision|0
7799119|NCT01086384|12256301|FG002|2-week Run-in Period|Physician Decision|0
7799120|NCT01086384|12256299|FG000|2-week Run-in Period|Withdrawal by Subject|19
7799121|NCT01086384|12256300|FG001|2-week Run-in Period|Withdrawal by Subject|0
7799122|NCT01086384|12256301|FG002|2-week Run-in Period|Withdrawal by Subject|0
7799123|NCT01086384|12256299|FG000|2-week Run-in Period|Study Closed/Terminated|42
7799124|NCT01086384|12256300|FG001|2-week Run-in Period|Study Closed/Terminated|0
7799125|NCT01086384|12256301|FG002|2-week Run-in Period|Study Closed/Terminated|0
7799126|NCT01086384|12256299|FG000|2-week Run-in Period|Continuation Criteria Not Met|92
7799127|NCT01086384|12256300|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
7799128|NCT01086384|12256301|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
7799129|NCT01086384|12256299|FG000|2-week Run-in Period|Randomized in Error|1
7799130|NCT01086384|12256300|FG001|2-week Run-in Period|Randomized in Error|0
7799131|NCT01086384|12256301|FG002|2-week Run-in Period|Randomized in Error|0
7799132|NCT01086384|12256299|FG000|Treatment Period|Withdrawal by Subject|0
7799133|NCT01086384|12256300|FG001|Treatment Period|Withdrawal by Subject|53
7799134|NCT01086384|12256301|FG002|Treatment Period|Withdrawal by Subject|55
7799135|NCT01086384|12256299|FG000|Treatment Period|Protocol Violation|0
7799136|NCT01086384|12256300|FG001|Treatment Period|Protocol Violation|26
7799137|NCT01086384|12256301|FG002|Treatment Period|Protocol Violation|17
7799138|NCT01086384|12256299|FG000|Treatment Period|Lack of Efficacy|0
7799139|NCT01086384|12256300|FG001|Treatment Period|Lack of Efficacy|22
7799140|NCT01086384|12256301|FG002|Treatment Period|Lack of Efficacy|13
7799141|NCT01086384|12256299|FG000|Treatment Period|Adverse Event|0
7799142|NCT01086384|12256300|FG001|Treatment Period|Adverse Event|19
7799143|NCT01086384|12256301|FG002|Treatment Period|Adverse Event|15
7799144|NCT01086384|12256299|FG000|Treatment Period|Lost to Follow-up|0
7799145|NCT01086384|12256300|FG001|Treatment Period|Lost to Follow-up|11
7799146|NCT01086384|12256301|FG002|Treatment Period|Lost to Follow-up|9
7799147|NCT01086384|12256299|FG000|Treatment Period|Physician Decision|0
7799148|NCT01086384|12256300|FG001|Treatment Period|Physician Decision|9
7799149|NCT01086384|12256301|FG002|Treatment Period|Physician Decision|6
7799150|NCT01086384|12256299|FG000|Treatment Period|Study Closed/Terminated|0
7799151|NCT01086384|12256300|FG001|Treatment Period|Study Closed/Terminated|7
7799152|NCT01086384|12256301|FG002|Treatment Period|Study Closed/Terminated|8
7799153|NCT01086384|12256299|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0
7799154|NCT01086384|12256300|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0
7799155|NCT01086384|12256301|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1
7799156|NCT01086384|12256299|FG000|Treatment Period|Received Treatment in Error|0
7799157|NCT01086384|12256300|FG001|Treatment Period|Received Treatment in Error|1
7799158|NCT01086384|12256301|FG002|Treatment Period|Received Treatment in Error|0
7799159|NCT01086410|12256311|FG000|Overall Study|Adverse Event|1
7799160|NCT01086410|12256312|FG001|Overall Study|Adverse Event|0
7799161|NCT01086410|12256313|FG002|Overall Study|Adverse Event|0
7799162|NCT01086410|12256314|FG003|Overall Study|Adverse Event|2
7799163|NCT01086410|12256311|FG000|Overall Study|Lack of Efficacy|1
7799164|NCT01086410|12256312|FG001|Overall Study|Lack of Efficacy|1
7799165|NCT01086410|12256313|FG002|Overall Study|Lack of Efficacy|0
7799166|NCT01086410|12256314|FG003|Overall Study|Lack of Efficacy|0
7799167|NCT01086410|12256311|FG000|Overall Study|Protocol Violation|1
7799168|NCT01086410|12256312|FG001|Overall Study|Protocol Violation|1
7799169|NCT01086410|12256313|FG002|Overall Study|Protocol Violation|0
7799170|NCT01086410|12256314|FG003|Overall Study|Protocol Violation|0
7799171|NCT01086410|12256311|FG000|Overall Study|Lost to Follow-up|0
7799172|NCT01086410|12256312|FG001|Overall Study|Lost to Follow-up|0
7799173|NCT01086410|12256313|FG002|Overall Study|Lost to Follow-up|1
7799174|NCT01086410|12256314|FG003|Overall Study|Lost to Follow-up|0
7799175|NCT01086423|12256327|FG000|Overall Study|Protocol Violation|0
7799176|NCT01086423|12256328|FG001|Overall Study|Protocol Violation|0
7799177|NCT01086423|12256329|FG002|Overall Study|Protocol Violation|1
7799178|NCT01086423|12256327|FG000|Overall Study|Migrated/moved from study area|2
7799179|NCT01086423|12256328|FG001|Overall Study|Migrated/moved from study area|0
7799180|NCT01086423|12256329|FG002|Overall Study|Migrated/moved from study area|4
7799181|NCT01086423|12256327|FG000|Overall Study|Adverse event, fatal|1
7799182|NCT01086423|12256328|FG001|Overall Study|Adverse event, fatal|1
7799183|NCT01086423|12256329|FG002|Overall Study|Adverse event, fatal|0
7799184|NCT01086423|12256327|FG000|Overall Study|Adverse event, non-fatal|2
7799185|NCT01086423|12256328|FG001|Overall Study|Adverse event, non-fatal|1
7799186|NCT01086423|12256329|FG002|Overall Study|Adverse event, non-fatal|0
7799187|NCT01086423|12256327|FG000|Overall Study|Withdrawal by Subject|5
7799188|NCT01086423|12256328|FG001|Overall Study|Withdrawal by Subject|1
7799189|NCT01086423|12256329|FG002|Overall Study|Withdrawal by Subject|3
7799190|NCT01086423|12256327|FG000|Overall Study|Lost to Follow-up|0
7799191|NCT01086423|12256328|FG001|Overall Study|Lost to Follow-up|0
7799192|NCT01086423|12256329|FG002|Overall Study|Lost to Follow-up|1
7799193|NCT01086540|12256348|FG000|Overall Study|Death|3
7799194|NCT01086540|12256349|FG001|Overall Study|Death|1
7799195|NCT01086540|12256348|FG000|Overall Study|Physician Decision|2
7799196|NCT01086540|12256349|FG001|Overall Study|Physician Decision|1
7799197|NCT01086540|12256348|FG000|Overall Study|Addition of new therapy for PAH|1
7799198|NCT01086540|12256349|FG001|Overall Study|Addition of new therapy for PAH|0
7799199|NCT01086969|12256396|FG000|Overall Study|Withdrawal by Subject|1
7799200|NCT01086969|12256397|FG001|Overall Study|Withdrawal by Subject|2
7799201|NCT01086969|12256398|FG002|Overall Study|Withdrawal by Subject|0
7799202|NCT01087489|12256406|FG000|Overall Study|enrolled in another VA study|0
7799203|NCT01087489|12256407|FG001|Overall Study|enrolled in another VA study|1
7799204|NCT01087489|12256406|FG000|Overall Study|Death|0
7799205|NCT01087489|12256407|FG001|Overall Study|Death|1
7799206|NCT01087489|12256406|FG000|Overall Study|unable to survey by telephone|0
7799207|NCT01087489|12256407|FG001|Overall Study|unable to survey by telephone|1
7799208|NCT01087502|12256415|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5
7799209|NCT01087502|12256416|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4
7799210|NCT01087502|12256415|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1
7799211|NCT01087502|12256416|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1
7799212|NCT01087502|12256415|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
7799213|NCT01087502|12256416|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
7799214|NCT01087502|12256415|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
7799215|NCT01087502|12256416|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
7799216|NCT01087502|12256415|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1
7799217|NCT01087502|12256416|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2
7799218|NCT01087502|12256415|FG000|Up to Final Analysis (Week 52)|Adverse Event|17
7799219|NCT01087502|12256416|FG001|Up to Final Analysis (Week 52)|Adverse Event|10
7799220|NCT01087502|12256415|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1
7799221|NCT01087502|12256416|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2
7799222|NCT01087502|12256415|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4
7799223|NCT01087502|12256416|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0
7799224|NCT01087502|12256415|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2
7799225|NCT01087502|12256416|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0
7799226|NCT01087502|12256415|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
7799227|NCT01087502|12256416|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
7799228|NCT01087502|12256415|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
7799229|NCT01087502|12256416|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
7799230|NCT01087502|12256415|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5
7799231|NCT01087502|12256416|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4
7799232|NCT01087528|12256424|FG000|Overall Study|Withdrawal by Subject|1
7799233|NCT01087528|12256424|FG000|Overall Study|Incomplete CE procedure|6
7799234|NCT01087723|12256441|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0
7799235|NCT01087723|12256442|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1
7799236|NCT01087723|12256441|FG000|Overall Study|Withdrawal by Subject|10
7799237|NCT01087723|12256442|FG001|Overall Study|Withdrawal by Subject|13
7799238|NCT01087723|12256441|FG000|Overall Study|Physician Decision|2
7799239|NCT01087723|12256442|FG001|Overall Study|Physician Decision|0
7799240|NCT01087723|12256441|FG000|Overall Study|Lost to Follow-up|1
7799241|NCT01087723|12256442|FG001|Overall Study|Lost to Follow-up|4
7799242|NCT01087723|12256441|FG000|Overall Study|Reason Not Specified|1
7799243|NCT01087723|12256442|FG001|Overall Study|Reason Not Specified|2
7799244|NCT01087736|12256450|FG000|Overall Study|Lost to Follow-up|1
7799245|NCT01087736|12256451|FG001|Overall Study|Lost to Follow-up|0
7799246|NCT01087736|12256450|FG000|Overall Study|Death|0
7799247|NCT01087736|12256451|FG001|Overall Study|Death|1
7799248|NCT01087736|12256450|FG000|Overall Study|Withdrawal by Subject|0
7799249|NCT01087736|12256451|FG001|Overall Study|Withdrawal by Subject|1
7799250|NCT01087762|12256460|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
7799251|NCT01087762|12256461|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
7799252|NCT01087762|12256462|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
7799253|NCT01087762|12256463|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
7799254|NCT01087762|12256464|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
7799255|NCT01087762|12256460|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6
7799256|NCT01087762|12256461|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0
7799257|NCT01087762|12256462|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1
7799258|NCT01087762|12256463|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0
7799259|NCT01087762|12256464|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0
7799260|NCT01087762|12256460|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
7799261|NCT01087762|12256461|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
7799262|NCT01087762|12256462|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
7799263|NCT01087762|12256463|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
7799264|NCT01087762|12256464|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
7799265|NCT01087762|12256460|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
7799266|NCT01087762|12256461|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
7799267|NCT01087762|12256462|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
7799268|NCT01087762|12256463|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
7799269|NCT01087762|12256464|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
7799270|NCT01087762|12256460|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
7799271|NCT01087762|12256461|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
7799272|NCT01087762|12256462|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
7799273|NCT01087762|12256463|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
7799274|NCT01087762|12256464|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
7799275|NCT01087762|12256460|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
7799276|NCT01087762|12256461|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
7799277|NCT01087762|12256462|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
7799278|NCT01087762|12256463|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
7799279|NCT01087762|12256464|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
7799280|NCT01087762|12256460|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0
7799281|NCT01087762|12256461|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0
7799282|NCT01087762|12256462|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0
7799283|NCT01087762|12256463|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1
7799284|NCT01087762|12256464|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1
7799285|NCT01087762|12256460|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
7799286|NCT01087762|12256461|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
7799287|NCT01087762|12256462|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
7799288|NCT01087762|12256463|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
7799289|NCT01087762|12256464|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
7799290|NCT01087762|12256460|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
7799291|NCT01087762|12256461|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
7799292|NCT01087762|12256462|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
7799293|NCT01087762|12256463|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
7799294|NCT01087762|12256464|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
7799295|NCT01087762|12256460|FG000|Open-Label Period (Weeks 48-204)|Other|0
7799296|NCT01087762|12256461|FG001|Open-Label Period (Weeks 48-204)|Other|0
7799297|NCT01087762|12256462|FG002|Open-Label Period (Weeks 48-204)|Other|0
7799298|NCT01087762|12256463|FG003|Open-Label Period (Weeks 48-204)|Other|2
7799299|NCT01087762|12256464|FG004|Open-Label Period (Weeks 48-204)|Other|4
7799300|NCT01087762|12256460|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
7799301|NCT01087762|12256461|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
7799302|NCT01087762|12256462|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
7799303|NCT01087762|12256463|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
7799304|NCT01087762|12256464|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
7799305|NCT01087762|12256460|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
7799306|NCT01087762|12256461|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
7799307|NCT01087762|12256462|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
7799308|NCT01087762|12256463|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
7799309|NCT01087762|12256464|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
7799310|NCT01087762|12256460|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
7799311|NCT01087762|12256461|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
7799312|NCT01087762|12256462|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
7799313|NCT01087762|12256463|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
7799314|NCT01087762|12256464|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
7799315|NCT01087775|12256474|FG000|Overall Study|failed inclusion criteria|2
7799316|NCT01087788|12256482|FG000|24-weeks Double-blind Period|Lack of Efficacy|2
7799317|NCT01087788|12256483|FG001|24-weeks Double-blind Period|Lack of Efficacy|0
7799318|NCT01087788|12256484|FG002|24-weeks Double-blind Period|Lack of Efficacy|1
7799319|NCT01087788|12256482|FG000|24-weeks Double-blind Period|Protocol Violation|0
7799320|NCT01087788|12256483|FG001|24-weeks Double-blind Period|Protocol Violation|1
7799321|NCT01087788|12256484|FG002|24-weeks Double-blind Period|Protocol Violation|0
7799322|NCT01087788|12256482|FG000|24-weeks Double-blind Period|Lost to Follow-up|4
7799323|NCT01087788|12256483|FG001|24-weeks Double-blind Period|Lost to Follow-up|1
7799324|NCT01087788|12256484|FG002|24-weeks Double-blind Period|Lost to Follow-up|1
7799325|NCT01087788|12256482|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7
7799326|NCT01087788|12256483|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2
7799327|NCT01087788|12256484|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5
7799328|NCT01087788|12256482|FG000|24-weeks Double-blind Period|AE, serious fatal|0
7799329|NCT01087788|12256483|FG001|24-weeks Double-blind Period|AE, serious fatal|1
7799330|NCT01087788|12256484|FG002|24-weeks Double-blind Period|AE, serious fatal|1
7799331|NCT01087788|12256482|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0
7799332|NCT01087788|12256483|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2
7799333|NCT01087788|12256484|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3
7799334|NCT01087788|12256482|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2
7799335|NCT01087788|12256483|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1
7799336|NCT01087788|12256484|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2
7799337|NCT01087788|12256482|FG000|24-weeks Double-blind Period|AE, unknown type|0
7799338|NCT01087788|12256483|FG001|24-weeks Double-blind Period|AE, unknown type|0
7799339|NCT01087788|12256484|FG002|24-weeks Double-blind Period|AE, unknown type|1
7799340|NCT01087788|12256482|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1
7799341|NCT01087788|12256483|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0
7799342|NCT01087788|12256484|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0
7799343|NCT01087788|12256482|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
7799344|NCT01087788|12256483|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
7799345|NCT01087788|12256484|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
7799346|NCT01087788|12256482|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0
7799347|NCT01087788|12256483|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1
7799348|NCT01087788|12256484|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0
7799349|NCT01087788|12256482|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
7799350|NCT01087788|12256483|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
7799351|NCT01087788|12256484|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
7799352|NCT01087788|12256482|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0
7799353|NCT01087788|12256483|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2
7799354|NCT01087788|12256484|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1
7799355|NCT01087788|12256482|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1
7799356|NCT01087788|12256483|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0
7799357|NCT01087788|12256484|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1
7799358|NCT01087788|12256482|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1
7799359|NCT01087788|12256483|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0
7799360|NCT01087788|12256484|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0
7799361|NCT01087788|12256482|FG000|24-weeks Dose-blind Period|AE, serious fatal|0
7799362|NCT01087788|12256483|FG001|24-weeks Dose-blind Period|AE, serious fatal|1
7799363|NCT01087788|12256484|FG002|24-weeks Dose-blind Period|AE, serious fatal|0
7799364|NCT01087788|12256482|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2
7799365|NCT01087788|12256483|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1
7799366|NCT01087788|12256484|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2
7799367|NCT01087788|12256482|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
7799368|NCT01087788|12256483|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
7799369|NCT01087788|12256484|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
7799370|NCT01087788|12256482|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
7799371|NCT01087788|12256483|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
7799372|NCT01087788|12256484|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
7799373|NCT01087788|12256482|FG000|24-weeks Dose-blind Period|Patient moved|0
7799374|NCT01087788|12256483|FG001|24-weeks Dose-blind Period|Patient moved|0
7799375|NCT01087788|12256484|FG002|24-weeks Dose-blind Period|Patient moved|1
7799376|NCT01087788|12256482|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4
7799377|NCT01087788|12256483|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2
7799378|NCT01087788|12256484|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3
7799379|NCT01087788|12256482|FG000|Open-Label Period (OL-P)|Protocol Violation|2
7799380|NCT01087788|12256483|FG001|Open-Label Period (OL-P)|Protocol Violation|1
7799381|NCT01087788|12256484|FG002|Open-Label Period (OL-P)|Protocol Violation|0
7799382|NCT01087788|12256482|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0
7799383|NCT01087788|12256483|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4
7799384|NCT01087788|12256484|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2
7799385|NCT01087788|12256482|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13
7799386|NCT01087788|12256483|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8
7629928|NCT01062425|12042859|FG000|Overall Study|Protocol Violation|3
7629929|NCT01062425|12042860|FG001|Overall Study|Protocol Violation|6
7799387|NCT01087788|12256484|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10
7799388|NCT01087788|12256482|FG000|Open-Label Period (OL-P)|AE, serious fatal|2
7799389|NCT01087788|12256483|FG001|Open-Label Period (OL-P)|AE, serious fatal|0
7799390|NCT01087788|12256484|FG002|Open-Label Period (OL-P)|AE, serious fatal|1
7799391|NCT01087788|12256482|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1
7799392|NCT01087788|12256483|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3
7799393|NCT01087788|12256484|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4
7799394|NCT01087788|12256482|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
7799395|NCT01087788|12256483|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
7799396|NCT01087788|12256484|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
7799397|NCT01087788|12256482|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
7799398|NCT01087788|12256483|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
7799399|NCT01087788|12256484|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
7799400|NCT01087788|12256482|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1
7799401|NCT01087788|12256483|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0
7799402|NCT01087788|12256484|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0
7799403|NCT01087788|12256482|FG000|Open-Label Period (OL-P)|Sponsor request|1
7799404|NCT01087788|12256483|FG001|Open-Label Period (OL-P)|Sponsor request|0
7799405|NCT01087788|12256484|FG002|Open-Label Period (OL-P)|Sponsor request|0
7799406|NCT01087788|12256482|FG000|Open-Label Period (OL-P)|Principal investigator decision|0
7799407|NCT01087788|12256483|FG001|Open-Label Period (OL-P)|Principal investigator decision|1
7799408|NCT01087788|12256484|FG002|Open-Label Period (OL-P)|Principal investigator decision|2
7799409|NCT01087788|12256482|FG000|Open-Label Period (OL-P)|No participation in study extension|0
7799410|NCT01087788|12256483|FG001|Open-Label Period (OL-P)|No participation in study extension|0
7799411|NCT01087788|12256484|FG002|Open-Label Period (OL-P)|No participation in study extension|1
7799412|NCT01087788|12256482|FG000|Open-Label Period (OL-P)|Personal reasons|0
7799413|NCT01087788|12256483|FG001|Open-Label Period (OL-P)|Personal reasons|0
7799414|NCT01087788|12256484|FG002|Open-Label Period (OL-P)|Personal reasons|1
7799415|NCT01087814|12256504|FG000|First Intervention (5 Days)|Withdrawal by Subject|3
7799416|NCT01087814|12256505|FG001|First Intervention (5 Days)|Withdrawal by Subject|1
7799417|NCT01087814|12256504|FG000|Second Intervention (5 Days)|Physician Decision|1
7799418|NCT01087814|12256505|FG001|Second Intervention (5 Days)|Physician Decision|0
7799419|NCT01087905|12256519|FG000|Overall Study|Lost to Follow-up|24
7799420|NCT01087905|12256520|FG001|Overall Study|Lost to Follow-up|28
7799421|NCT01087905|12256521|FG002|Overall Study|Lost to Follow-up|18
7799422|NCT01087905|12256522|FG003|Overall Study|Lost to Follow-up|31
7799423|NCT01087905|12256523|FG004|Overall Study|Lost to Follow-up|27
7799424|NCT01087905|12256524|FG005|Overall Study|Lost to Follow-up|25
7799425|NCT01087905|12256525|FG006|Overall Study|Lost to Follow-up|20
7799426|NCT01087905|12256526|FG007|Overall Study|Lost to Follow-up|24
7799427|NCT01087905|12256519|FG000|Overall Study|Withdrawal by Subject|5
7799428|NCT01087905|12256520|FG001|Overall Study|Withdrawal by Subject|4
7799429|NCT01087905|12256521|FG002|Overall Study|Withdrawal by Subject|4
7799430|NCT01087905|12256522|FG003|Overall Study|Withdrawal by Subject|5
7799431|NCT01087905|12256523|FG004|Overall Study|Withdrawal by Subject|4
7799432|NCT01087905|12256524|FG005|Overall Study|Withdrawal by Subject|3
7799433|NCT01087905|12256525|FG006|Overall Study|Withdrawal by Subject|3
7799434|NCT01087905|12256526|FG007|Overall Study|Withdrawal by Subject|5
7799435|NCT01087944|12256564|FG000|Period 1 (Week 1-3)|Adverse Event|1
7799436|NCT01087944|12256565|FG001|Period 1 (Week 1-3)|Adverse Event|0
7799437|NCT01087944|12256564|FG000|Period 2 (Week 4-6)|Adverse Event|0
7799438|NCT01087944|12256565|FG001|Period 2 (Week 4-6)|Adverse Event|2
7799439|NCT01087957|12256573|FG000|Overall Study|Death|2
7799440|NCT01087957|12256574|FG001|Overall Study|Death|2
7799441|NCT01087957|12256573|FG000|Overall Study|Lost to Follow-up|3
7799442|NCT01087957|12256574|FG001|Overall Study|Lost to Follow-up|4
7799443|NCT01087957|12256573|FG000|Overall Study|Protocol Violation|13
7799444|NCT01087957|12256574|FG001|Overall Study|Protocol Violation|25
7799445|NCT01087957|12256573|FG000|Overall Study|Withdrawal by Subject|18
7799446|NCT01087957|12256574|FG001|Overall Study|Withdrawal by Subject|15
7799447|NCT01087957|12256573|FG000|Overall Study|Physician Decision|5
7799448|NCT01087957|12256574|FG001|Overall Study|Physician Decision|9
7799449|NCT01087970|12256580|FG000|Overall Study|Protocol Violation|2
7799450|NCT01088048|12256604|FG000|Overall Study|Adverse Event|7
7799451|NCT01088048|12256605|FG001|Overall Study|Adverse Event|9
7799452|NCT01088048|12256606|FG002|Overall Study|Adverse Event|7
7799453|NCT01088048|12256607|FG003|Overall Study|Adverse Event|5
7799454|NCT01088048|12256608|FG004|Overall Study|Adverse Event|6
7799455|NCT01088048|12256609|FG005|Overall Study|Adverse Event|3
7799456|NCT01088048|12256610|FG006|Overall Study|Adverse Event|3
7799457|NCT01088048|12256611|FG007|Overall Study|Adverse Event|0
7799458|NCT01088048|12256612|FG008|Overall Study|Adverse Event|2
7799459|NCT01088048|12256613|FG009|Overall Study|Adverse Event|2
7799460|NCT01088048|12256604|FG000|Overall Study|Withdrew Consent|1
7799461|NCT01088048|12256605|FG001|Overall Study|Withdrew Consent|1
7799462|NCT01088048|12256606|FG002|Overall Study|Withdrew Consent|1
7799463|NCT01088048|12256607|FG003|Overall Study|Withdrew Consent|1
7799464|NCT01088048|12256608|FG004|Overall Study|Withdrew Consent|2
7799465|NCT01088048|12256609|FG005|Overall Study|Withdrew Consent|1
7799466|NCT01088048|12256610|FG006|Overall Study|Withdrew Consent|0
7799467|NCT01088048|12256611|FG007|Overall Study|Withdrew Consent|2
7799468|NCT01088048|12256612|FG008|Overall Study|Withdrew Consent|2
7799469|NCT01088048|12256613|FG009|Overall Study|Withdrew Consent|1
7799470|NCT01088048|12256604|FG000|Overall Study|Concomitant Medication Prohibited|1
7799471|NCT01088048|12256605|FG001|Overall Study|Concomitant Medication Prohibited|0
7799472|NCT01088048|12256606|FG002|Overall Study|Concomitant Medication Prohibited|0
7799473|NCT01088048|12256607|FG003|Overall Study|Concomitant Medication Prohibited|0
7799474|NCT01088048|12256608|FG004|Overall Study|Concomitant Medication Prohibited|0
7799475|NCT01088048|12256609|FG005|Overall Study|Concomitant Medication Prohibited|0
7799476|NCT01088048|12256610|FG006|Overall Study|Concomitant Medication Prohibited|0
7799477|NCT01088048|12256611|FG007|Overall Study|Concomitant Medication Prohibited|0
7799478|NCT01088048|12256612|FG008|Overall Study|Concomitant Medication Prohibited|0
7799479|NCT01088048|12256613|FG009|Overall Study|Concomitant Medication Prohibited|0
7799480|NCT01088048|12256604|FG000|Overall Study|Investigator Request|2
7799481|NCT01088048|12256605|FG001|Overall Study|Investigator Request|2
7799482|NCT01088048|12256606|FG002|Overall Study|Investigator Request|0
7799483|NCT01088048|12256607|FG003|Overall Study|Investigator Request|0
7799484|NCT01088048|12256608|FG004|Overall Study|Investigator Request|3
7799485|NCT01088048|12256609|FG005|Overall Study|Investigator Request|1
7799486|NCT01088048|12256610|FG006|Overall Study|Investigator Request|1
7799487|NCT01088048|12256611|FG007|Overall Study|Investigator Request|0
7799488|NCT01088048|12256612|FG008|Overall Study|Investigator Request|0
7799489|NCT01088048|12256613|FG009|Overall Study|Investigator Request|0
7799490|NCT01088048|12256604|FG000|Overall Study|Patient Non-compliance|0
7799491|NCT01088048|12256605|FG001|Overall Study|Patient Non-compliance|1
7799492|NCT01088048|12256606|FG002|Overall Study|Patient Non-compliance|0
7799493|NCT01088048|12256607|FG003|Overall Study|Patient Non-compliance|0
7799494|NCT01088048|12256608|FG004|Overall Study|Patient Non-compliance|0
7799495|NCT01088048|12256609|FG005|Overall Study|Patient Non-compliance|0
7799496|NCT01088048|12256610|FG006|Overall Study|Patient Non-compliance|0
7799497|NCT01088048|12256611|FG007|Overall Study|Patient Non-compliance|0
7799498|NCT01088048|12256612|FG008|Overall Study|Patient Non-compliance|0
7799499|NCT01088048|12256613|FG009|Overall Study|Patient Non-compliance|0
7799500|NCT01088048|12256604|FG000|Overall Study|Disease Progression|7
7799501|NCT01088048|12256605|FG001|Overall Study|Disease Progression|4
7799502|NCT01088048|12256606|FG002|Overall Study|Disease Progression|3
7799503|NCT01088048|12256607|FG003|Overall Study|Disease Progression|5
7799504|NCT01088048|12256608|FG004|Overall Study|Disease Progression|3
7799505|NCT01088048|12256609|FG005|Overall Study|Disease Progression|3
7799506|NCT01088048|12256610|FG006|Overall Study|Disease Progression|2
7799507|NCT01088048|12256611|FG007|Overall Study|Disease Progression|1
7799508|NCT01088048|12256612|FG008|Overall Study|Disease Progression|0
7799509|NCT01088048|12256613|FG009|Overall Study|Disease Progression|0
7799510|NCT01088048|12256604|FG000|Overall Study|Death|1
7799511|NCT01088048|12256605|FG001|Overall Study|Death|5
7799512|NCT01088048|12256606|FG002|Overall Study|Death|3
7799513|NCT01088048|12256607|FG003|Overall Study|Death|3
7799514|NCT01088048|12256608|FG004|Overall Study|Death|1
7799515|NCT01088048|12256609|FG005|Overall Study|Death|3
7799516|NCT01088048|12256610|FG006|Overall Study|Death|0
7799517|NCT01088048|12256611|FG007|Overall Study|Death|0
7799518|NCT01088048|12256612|FG008|Overall Study|Death|3
7799519|NCT01088048|12256613|FG009|Overall Study|Death|1
7799520|NCT01088048|12256604|FG000|Overall Study|Other|3
7799521|NCT01088048|12256605|FG001|Overall Study|Other|5
7799522|NCT01088048|12256606|FG002|Overall Study|Other|0
7799523|NCT01088048|12256607|FG003|Overall Study|Other|0
7799524|NCT01088048|12256608|FG004|Overall Study|Other|2
7799525|NCT01088048|12256609|FG005|Overall Study|Other|0
7799526|NCT01088048|12256610|FG006|Overall Study|Other|0
7799527|NCT01088048|12256611|FG007|Overall Study|Other|2
7799528|NCT01088048|12256612|FG008|Overall Study|Other|0
7799529|NCT01088048|12256613|FG009|Overall Study|Other|0
7799530|NCT01088243|12256648|FG000|Overall Study|Adverse Event|1
7799531|NCT01088243|12256649|FG001|Overall Study|Adverse Event|0
7799532|NCT01088399|12256662|FG000|Overall Study|Adverse Event|211
7799533|NCT01088399|12256663|FG001|Overall Study|Adverse Event|16
7799534|NCT01088399|12256664|FG002|Overall Study|Adverse Event|0
7799535|NCT01088399|12256662|FG000|Overall Study|Death|204
7799536|NCT01088399|12256663|FG001|Overall Study|Death|45
7799537|NCT01088399|12256664|FG002|Overall Study|Death|0
7799538|NCT01088399|12256662|FG000|Overall Study|Lack of Efficacy|298
7799539|NCT01088399|12256663|FG001|Overall Study|Lack of Efficacy|7
7799540|NCT01088399|12256664|FG002|Overall Study|Lack of Efficacy|5
7799541|NCT01088399|12256662|FG000|Overall Study|Lost to Follow-up|1070
7799542|NCT01088399|12256663|FG001|Overall Study|Lost to Follow-up|278
7799543|NCT01088399|12256664|FG002|Overall Study|Lost to Follow-up|58
7799544|NCT01088399|12256662|FG000|Overall Study|Physician Decision|531
7799545|NCT01088399|12256663|FG001|Overall Study|Physician Decision|88
7799546|NCT01088399|12256664|FG002|Overall Study|Physician Decision|16
7799547|NCT01088399|12256662|FG000|Overall Study|Withdrawal by Subject|544
7799548|NCT01088399|12256663|FG001|Overall Study|Withdrawal by Subject|195
7799549|NCT01088399|12256664|FG002|Overall Study|Withdrawal by Subject|33
7799550|NCT01088399|12256662|FG000|Overall Study|Change to or start of somatropin therapy|234
7799551|NCT01088399|12256663|FG001|Overall Study|Change to or start of somatropin therapy|17
7799552|NCT01088399|12256664|FG002|Overall Study|Change to or start of somatropin therapy|12
7799553|NCT01088399|12256662|FG000|Overall Study|Sponsor decision|1573
7799554|NCT01088399|12256663|FG001|Overall Study|Sponsor decision|298
7799555|NCT01088399|12256664|FG002|Overall Study|Sponsor decision|7
7799556|NCT01088399|12256662|FG000|Overall Study|Protocol Violation|10
7799557|NCT01088399|12256663|FG001|Overall Study|Protocol Violation|1
7799558|NCT01088399|12256664|FG002|Overall Study|Protocol Violation|0
7799559|NCT01088399|12256662|FG000|Overall Study|Enrollment criteria not met|48
7799560|NCT01088399|12256663|FG001|Overall Study|Enrollment criteria not met|119
7799561|NCT01088399|12256664|FG002|Overall Study|Enrollment criteria not met|70
7799562|NCT01088399|12256662|FG000|Overall Study|Study summary visit not completed|2398
7799563|NCT01088399|12256663|FG001|Overall Study|Study summary visit not completed|283
7799564|NCT01088399|12256664|FG002|Overall Study|Study summary visit not completed|80
7799565|NCT01088412|12256675|FG000|Overall Study|Adverse Event|38
7799566|NCT01088412|12256676|FG001|Overall Study|Adverse Event|0
7799567|NCT01088412|12256677|FG002|Overall Study|Adverse Event|0
7799568|NCT01088412|12256675|FG000|Overall Study|Death|42
7799569|NCT01088412|12256676|FG001|Overall Study|Death|6
7799570|NCT01088412|12256677|FG002|Overall Study|Death|0
7630122|NCT00593840|12043052|FG000|Overall Study|Withdrawal by Subject|1
7799571|NCT01088412|12256675|FG000|Overall Study|Other Reason per Case Report Form|2089
7799572|NCT01088412|12256676|FG001|Overall Study|Other Reason per Case Report Form|103
7799573|NCT01088412|12256677|FG002|Overall Study|Other Reason per Case Report Form|9
7799574|NCT01088412|12256675|FG000|Overall Study|Withdrawal by Subject|1761
7799575|NCT01088412|12256676|FG001|Overall Study|Withdrawal by Subject|25
7799576|NCT01088412|12256677|FG002|Overall Study|Withdrawal by Subject|1
7799577|NCT01088412|12256675|FG000|Overall Study|Received Another GH Product|79
7799578|NCT01088412|12256676|FG001|Overall Study|Received Another GH Product|0
7799579|NCT01088412|12256677|FG002|Overall Study|Received Another GH Product|0
7799580|NCT01088412|12256675|FG000|Overall Study|Participant Moved|601
7799581|NCT01088412|12256676|FG001|Overall Study|Participant Moved|21
7799582|NCT01088412|12256677|FG002|Overall Study|Participant Moved|2
7799583|NCT01088412|12256675|FG000|Overall Study|Physician Decision|1041
7799584|NCT01088412|12256676|FG001|Overall Study|Physician Decision|8
7799585|NCT01088412|12256677|FG002|Overall Study|Physician Decision|4
7799586|NCT01088412|12256675|FG000|Overall Study|Sponsor Decision|4467
7799587|NCT01088412|12256676|FG001|Overall Study|Sponsor Decision|79
7799588|NCT01088412|12256677|FG002|Overall Study|Sponsor Decision|23
7799589|NCT01088412|12256675|FG000|Overall Study|Third Party Required to Change Brand|487
7799590|NCT01088412|12256676|FG001|Overall Study|Third Party Required to Change Brand|0
7799591|NCT01088412|12256677|FG002|Overall Study|Third Party Required to Change Brand|0
7799592|NCT01088412|12256675|FG000|Overall Study|Lost to Follow-up|3052
7799593|NCT01088412|12256676|FG001|Overall Study|Lost to Follow-up|130
7799594|NCT01088412|12256677|FG002|Overall Study|Lost to Follow-up|11
7799595|NCT01088412|12256675|FG000|Overall Study|Study Summary Not Completed|4360
7799596|NCT01088412|12256676|FG001|Overall Study|Study Summary Not Completed|64
7799597|NCT01088412|12256677|FG002|Overall Study|Study Summary Not Completed|22
7882190|NCT01767597|12380909|FG000|Overall Study|Withdrawal by Subject|1
7882191|NCT01767597|12380910|FG001|Overall Study|Withdrawal by Subject|0
7882192|NCT01767857|12380941|FG000|Overall Study|Adverse Event|27
7882193|NCT01767857|12380942|FG001|Overall Study|Adverse Event|7
7882194|NCT01767857|12380941|FG000|Overall Study|Death|28
7882195|NCT01767857|12380942|FG001|Overall Study|Death|13
7882196|NCT01767857|12380941|FG000|Overall Study|Lack of Efficacy|299
7882197|NCT01767857|12380942|FG001|Overall Study|Lack of Efficacy|151
7882198|NCT01767857|12380941|FG000|Overall Study|Lost to Follow-up|1
7882199|NCT01767857|12380942|FG001|Overall Study|Lost to Follow-up|1
7799598|NCT01088438|12256690|FG000|Overall Study|Withdrawal by Subject|11
7799599|NCT01088438|12256691|FG001|Overall Study|Withdrawal by Subject|6
7799600|NCT01088438|12256690|FG000|Overall Study|Lost to Follow-up|18
7799601|NCT01088438|12256691|FG001|Overall Study|Lost to Follow-up|30
7799602|NCT01088503|12256713|FG000|Overall Study|Withdrawal by Subject|118
7799603|NCT01088503|12256714|FG001|Overall Study|Withdrawal by Subject|327
7799604|NCT01088503|12256715|FG002|Overall Study|Withdrawal by Subject|10
7799605|NCT01088503|12256713|FG000|Overall Study|Death|64
7799606|NCT01088503|12256714|FG001|Overall Study|Death|358
7799607|NCT01088503|12256715|FG002|Overall Study|Death|7
7799608|NCT01088529|12256723|FG000|Overall Study|Did not receive study treatment|0
7799609|NCT01088529|12256724|FG001|Overall Study|Did not receive study treatment|1
7882200|NCT01767857|12380941|FG000|Overall Study|Withdrawal by Subject|38
7882201|NCT01767857|12380942|FG001|Overall Study|Withdrawal by Subject|18
7882202|NCT01767857|12380941|FG000|Overall Study|Physician Decision|17
7882203|NCT01767857|12380942|FG001|Overall Study|Physician Decision|10
7882204|NCT01767857|12380941|FG000|Overall Study|Protocol Terminated|1
7882205|NCT01767857|12380942|FG001|Overall Study|Protocol Terminated|0
7882206|NCT01767857|12380941|FG000|Overall Study|Randomized But Never Treated|19
7882207|NCT01767857|12380942|FG001|Overall Study|Randomized But Never Treated|13
7882208|NCT01767909|12380951|FG000|Overall Study|Withdrawal by Subject|4
7882209|NCT01767909|12380952|FG001|Overall Study|Withdrawal by Subject|7
7882210|NCT01767909|12380951|FG000|Overall Study|Adverse Event|3
7882211|NCT01767909|12380952|FG001|Overall Study|Adverse Event|1
7882212|NCT01767909|12380951|FG000|Overall Study|Withdrawal by Study Partner|3
7882213|NCT01767909|12380952|FG001|Overall Study|Withdrawal by Study Partner|1
7882214|NCT01767909|12380951|FG000|Overall Study|Non-Compliance|2
7882215|NCT01767909|12380952|FG001|Overall Study|Non-Compliance|0
7882216|NCT01767909|12380951|FG000|Overall Study|Perceived Lack of Efficacy|1
7882217|NCT01767909|12380952|FG001|Overall Study|Perceived Lack of Efficacy|0
7882218|NCT01767909|12380951|FG000|Overall Study|Investigator Recommendation|0
7882219|NCT01767909|12380952|FG001|Overall Study|Investigator Recommendation|1
7882220|NCT01767909|12380951|FG000|Overall Study|Lost to Follow-up|0
7882221|NCT01767909|12380952|FG001|Overall Study|Lost to Follow-up|1
7882222|NCT01767909|12380951|FG000|Overall Study|LP uncessessful|0
7882223|NCT01767909|12380952|FG001|Overall Study|LP uncessessful|1
7882224|NCT01767987|12380966|FG000|Overall Study|Physician Decision|4
7882225|NCT01767987|12380967|FG001|Overall Study|Physician Decision|1
7882226|NCT01768117|12380996|FG000|Overall Study|Lost to Follow-up|1
7882227|NCT01768117|12380996|FG000|Overall Study|Withdrawal by Subject|2
7882228|NCT01768117|12380996|FG000|Overall Study|Protocol Violation|3
7882229|NCT01768286|12381004|FG000|Overall Study|Randomized But Not Treated|0
7882230|NCT01768286|12381005|FG001|Overall Study|Randomized But Not Treated|0
7882231|NCT01768286|12381006|FG002|Overall Study|Randomized But Not Treated|1
7882232|NCT01768286|12381007|FG003|Overall Study|Randomized But Not Treated|0
7882233|NCT01768286|12381004|FG000|Overall Study|Lack of Efficacy|7
7882234|NCT01768286|12381005|FG001|Overall Study|Lack of Efficacy|4
7882235|NCT01768286|12381006|FG002|Overall Study|Lack of Efficacy|0
7882236|NCT01768286|12381007|FG003|Overall Study|Lack of Efficacy|1
7882237|NCT01768286|12381004|FG000|Overall Study|Withdrew Consent|0
7882238|NCT01768286|12381005|FG001|Overall Study|Withdrew Consent|0
7882239|NCT01768286|12381006|FG002|Overall Study|Withdrew Consent|1
7882240|NCT01768286|12381007|FG003|Overall Study|Withdrew Consent|0
7882241|NCT01768559|12381044|FG000|Overall Study|Randomized but not treated|0
7882242|NCT01768559|12381045|FG001|Overall Study|Randomized but not treated|0
7882243|NCT01768559|12381046|FG002|Overall Study|Randomized but not treated|1
7882244|NCT01768559|12381044|FG000|Overall Study|Adverse Event|15
7882245|NCT01768559|12381045|FG001|Overall Study|Adverse Event|2
7882246|NCT01768559|12381046|FG002|Overall Study|Adverse Event|5
7882247|NCT01768559|12381044|FG000|Overall Study|Lack of Efficacy|6
7882248|NCT01768559|12381045|FG001|Overall Study|Lack of Efficacy|4
7882249|NCT01768559|12381046|FG002|Overall Study|Lack of Efficacy|0
7882250|NCT01768559|12381044|FG000|Overall Study|Poor compliance to protocol|0
7882251|NCT01768559|12381045|FG001|Overall Study|Poor compliance to protocol|3
7882252|NCT01768559|12381046|FG002|Overall Study|Poor compliance to protocol|2
7882253|NCT01768559|12381044|FG000|Overall Study|Other than specified|9
7882254|NCT01768559|12381045|FG001|Overall Study|Other than specified|8
7882255|NCT01768559|12381046|FG002|Overall Study|Other than specified|5
7882256|NCT01768572|12381061|FG000|Overall Study|Adverse Event|7
7882257|NCT01768572|12381062|FG001|Overall Study|Adverse Event|8
7882258|NCT01768572|12381063|FG002|Overall Study|Adverse Event|4
7882259|NCT01768572|12381061|FG000|Overall Study|Lack of Efficacy|1
7882260|NCT01768572|12381062|FG001|Overall Study|Lack of Efficacy|3
7882261|NCT01768572|12381063|FG002|Overall Study|Lack of Efficacy|1
7882262|NCT01768572|12381061|FG000|Overall Study|Other, Not due to an adverse event|1
7882263|NCT01768572|12381062|FG001|Overall Study|Other, Not due to an adverse event|1
7882264|NCT01768572|12381063|FG002|Overall Study|Other, Not due to an adverse event|1
7882265|NCT01768637|12381073|FG000|Overall Study|Lost to Follow-up|2
7882266|NCT01768637|12381074|FG001|Overall Study|Lost to Follow-up|7
7882267|NCT01768637|12381073|FG000|Overall Study|Difficult blood draw|1
7882268|NCT01768637|12381074|FG001|Overall Study|Difficult blood draw|0
7882269|NCT01768676|12381082|FG000|Overall Study|Adverse Event|3
7882270|NCT01768676|12381083|FG001|Overall Study|Adverse Event|3
7882271|NCT01768676|12381082|FG000|Overall Study|Lost to Follow-up|13
7882272|NCT01768676|12381083|FG001|Overall Study|Lost to Follow-up|16
7799610|NCT01088984|12256760|FG000|Phase 1|Death|2
7799611|NCT01088984|12256761|FG001|Phase 1|Death|1
7799612|NCT01088984|12256760|FG000|Phase 1|Disease Progression|2
7799613|NCT01088984|12256761|FG001|Phase 1|Disease Progression|4
7799614|NCT01088984|12256760|FG000|Phase 1|Other|1
7799615|NCT01088984|12256761|FG001|Phase 1|Other|1
7799616|NCT01088984|12256760|FG000|Phase 2|Death|0
7799617|NCT01088984|12256761|FG001|Phase 2|Death|5
7799618|NCT01088984|12256760|FG000|Phase 2|Withdrawal by Subject|0
7799619|NCT01088984|12256761|FG001|Phase 2|Withdrawal by Subject|1
7799620|NCT01088984|12256760|FG000|Phase 2|DIsease Progression|0
7799621|NCT01088984|12256761|FG001|Phase 2|DIsease Progression|25
7799622|NCT01088984|12256760|FG000|Phase 2|Other|0
7799623|NCT01088984|12256761|FG001|Phase 2|Other|1
7799624|NCT01088997|12256772|FG000|Overall Study|Physician Decision|1
7799625|NCT01088997|12256773|FG001|Overall Study|Physician Decision|1
7799626|NCT01088997|12256772|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1
7799627|NCT01088997|12256773|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1
7799628|NCT01088997|12256772|FG000|Overall Study|Excluded prior to receiving drug|1
7799629|NCT01088997|12256773|FG001|Overall Study|Excluded prior to receiving drug|1
7799630|NCT01089023|12256782|FG000|Overall Study|Lost to Follow-up|3
7799631|NCT01089023|12256782|FG000|Overall Study|Adverse Event|1
7799632|NCT01089023|12256782|FG000|Overall Study|Withdrawal by Subject|1
7799633|NCT01089023|12256782|FG000|Overall Study|Protocol Violation|1
7799634|NCT01089023|12256782|FG000|Overall Study|Lack of Efficacy|1
7799635|NCT01089127|12256812|FG000|Overall Study|Adverse Event|5
7799636|NCT01089127|12256813|FG001|Overall Study|Adverse Event|1
7799637|NCT01089127|12256814|FG002|Overall Study|Adverse Event|1
7799638|NCT01089127|12256815|FG003|Overall Study|Adverse Event|0
7799639|NCT01089127|12256816|FG004|Overall Study|Adverse Event|0
7799640|NCT01089127|12256817|FG005|Overall Study|Adverse Event|1
7799641|NCT01089127|12256812|FG000|Overall Study|Subject withdrew consent|0
7799642|NCT01089127|12256813|FG001|Overall Study|Subject withdrew consent|1
7799643|NCT01089127|12256814|FG002|Overall Study|Subject withdrew consent|1
7799644|NCT01089127|12256815|FG003|Overall Study|Subject withdrew consent|1
7799645|NCT01089127|12256816|FG004|Overall Study|Subject withdrew consent|0
7799646|NCT01089127|12256817|FG005|Overall Study|Subject withdrew consent|2
7799647|NCT01089127|12256812|FG000|Overall Study|Abnormal test procedure result(s)|2
7799648|NCT01089127|12256813|FG001|Overall Study|Abnormal test procedure result(s)|1
7799649|NCT01089127|12256814|FG002|Overall Study|Abnormal test procedure result(s)|0
7799650|NCT01089127|12256815|FG003|Overall Study|Abnormal test procedure result(s)|0
7799651|NCT01089127|12256816|FG004|Overall Study|Abnormal test procedure result(s)|0
7799652|NCT01089127|12256817|FG005|Overall Study|Abnormal test procedure result(s)|0
7799653|NCT01089127|12256812|FG000|Overall Study|Lost to Follow-up|1
7799654|NCT01089127|12256813|FG001|Overall Study|Lost to Follow-up|1
7799655|NCT01089127|12256814|FG002|Overall Study|Lost to Follow-up|0
7799656|NCT01089127|12256815|FG003|Overall Study|Lost to Follow-up|0
7799657|NCT01089127|12256816|FG004|Overall Study|Lost to Follow-up|1
7799658|NCT01089127|12256817|FG005|Overall Study|Lost to Follow-up|0
7799659|NCT01089127|12256812|FG000|Overall Study|Protocol deviation|0
7799660|NCT01089127|12256813|FG001|Overall Study|Protocol deviation|1
7799661|NCT01089127|12256814|FG002|Overall Study|Protocol deviation|0
7799662|NCT01089127|12256815|FG003|Overall Study|Protocol deviation|0
7799663|NCT01089127|12256816|FG004|Overall Study|Protocol deviation|1
7799664|NCT01089127|12256817|FG005|Overall Study|Protocol deviation|0
7799665|NCT01089361|12256850|FG000|Overall Study|Death|1
7799666|NCT01089361|12256851|FG001|Overall Study|Death|0
7799667|NCT01089413|12256862|FG000|Overall Study|Lost to Follow-up|1
7799668|NCT01089413|12256862|FG000|Overall Study|Progressive Disease|93
7799669|NCT01089413|12256862|FG000|Overall Study|Participant Withdrew Consent|1
7799670|NCT01089413|12256862|FG000|Overall Study|Unacceptable Toxicity|12
7799671|NCT01089413|12256862|FG000|Overall Study|Death|10
7799672|NCT01089413|12256862|FG000|Overall Study|Metastasectomy|13
7799673|NCT01089413|12256862|FG000|Overall Study|Other|71
7799674|NCT01089504|12256874|FG000|Overall Study|Lost to Follow-up|1
7799675|NCT01089504|12256875|FG001|Overall Study|Lost to Follow-up|1
7799676|NCT01089504|12256874|FG000|Overall Study|Withdrawal by Subject|2
7799677|NCT01089504|12256875|FG001|Overall Study|Withdrawal by Subject|0
7799678|NCT01089543|12256898|FG000|Overall Study|Withdrawal by Subject|2
7799679|NCT01089543|12256899|FG001|Overall Study|Withdrawal by Subject|3
7799680|NCT01089543|12256900|FG002|Overall Study|Withdrawal by Subject|3
7799681|NCT01089543|12256901|FG003|Overall Study|Withdrawal by Subject|1
7799682|NCT01089543|12256898|FG000|Overall Study|Physician Decision|1
7799683|NCT01089543|12256899|FG001|Overall Study|Physician Decision|0
7799684|NCT01089543|12256900|FG002|Overall Study|Physician Decision|0
7799685|NCT01089543|12256901|FG003|Overall Study|Physician Decision|1
7799686|NCT01089543|12256898|FG000|Overall Study|Adverse Event|0
7799687|NCT01089543|12256899|FG001|Overall Study|Adverse Event|1
7799688|NCT01089543|12256900|FG002|Overall Study|Adverse Event|0
7799689|NCT01089543|12256901|FG003|Overall Study|Adverse Event|0
7799690|NCT01089556|12256913|FG000|Study Period II (Weeks 1-8)|Adverse Event|35
7799691|NCT01089556|12256914|FG001|Study Period II (Weeks 1-8)|Adverse Event|39
7799692|NCT01089556|12256915|FG002|Study Period II (Weeks 1-8)|Adverse Event|0
7799693|NCT01089556|12256916|FG003|Study Period II (Weeks 1-8)|Adverse Event|0
7799694|NCT01089556|12256917|FG004|Study Period II (Weeks 1-8)|Adverse Event|0
7799695|NCT01089556|12256918|FG005|Study Period II (Weeks 1-8)|Adverse Event|0
7799696|NCT01089556|12256913|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
7799697|NCT01089556|12256914|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
7799698|NCT01089556|12256915|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
7799699|NCT01089556|12256916|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
7799700|NCT01089556|12256917|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
7799701|NCT01089556|12256918|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
7799702|NCT01089556|12256913|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1
7799703|NCT01089556|12256914|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2
7799704|NCT01089556|12256915|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0
7799705|NCT01089556|12256916|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0
7799706|NCT01089556|12256917|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0
7799707|NCT01089556|12256918|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0
7799708|NCT01089556|12256913|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0
7799709|NCT01089556|12256914|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3
7799710|NCT01089556|12256915|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0
7799711|NCT01089556|12256916|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0
7799712|NCT01089556|12256917|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0
7799713|NCT01089556|12256918|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0
7799714|NCT01089556|12256913|FG000|Study Period II (Weeks 1-8)|Physician Decision|4
7799715|NCT01089556|12256914|FG001|Study Period II (Weeks 1-8)|Physician Decision|0
7799716|NCT01089556|12256915|FG002|Study Period II (Weeks 1-8)|Physician Decision|0
7799717|NCT01089556|12256916|FG003|Study Period II (Weeks 1-8)|Physician Decision|0
7799718|NCT01089556|12256917|FG004|Study Period II (Weeks 1-8)|Physician Decision|0
7799719|NCT01089556|12256918|FG005|Study Period II (Weeks 1-8)|Physician Decision|0
7799720|NCT01089556|12256913|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4
7799721|NCT01089556|12256914|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4
7799722|NCT01089556|12256915|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0
7799723|NCT01089556|12256916|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0
7799724|NCT01089556|12256917|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0
7799725|NCT01089556|12256918|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0
7799726|NCT01089556|12256913|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
7799727|NCT01089556|12256914|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
7799728|NCT01089556|12256915|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
7799729|NCT01089556|12256916|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
7799730|NCT01089556|12256917|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
7799731|NCT01089556|12256918|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
7799732|NCT01089556|12256913|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3
7799733|NCT01089556|12256914|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4
7799734|NCT01089556|12256915|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0
7799735|NCT01089556|12256916|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0
7799736|NCT01089556|12256917|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0
7799737|NCT01089556|12256918|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0
7799738|NCT01089556|12256913|FG000|Study Period III (Weeks 9-16)|Adverse Event|0
7799739|NCT01089556|12256914|FG001|Study Period III (Weeks 9-16)|Adverse Event|0
7799740|NCT01089556|12256915|FG002|Study Period III (Weeks 9-16)|Adverse Event|4
7799741|NCT01089556|12256916|FG003|Study Period III (Weeks 9-16)|Adverse Event|2
7799742|NCT01089556|12256917|FG004|Study Period III (Weeks 9-16)|Adverse Event|4
7799743|NCT01089556|12256918|FG005|Study Period III (Weeks 9-16)|Adverse Event|3
7799744|NCT01089556|12256913|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
7799745|NCT01089556|12256914|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
7799746|NCT01089556|12256915|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
7799747|NCT01089556|12256916|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
7799748|NCT01089556|12256917|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
7799749|NCT01089556|12256918|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
7799750|NCT01089556|12256913|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0
7799751|NCT01089556|12256914|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0
7799752|NCT01089556|12256915|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0
7799753|NCT01089556|12256916|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2
7799754|NCT01089556|12256917|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1
7799755|NCT01089556|12256918|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0
7799756|NCT01089556|12256913|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0
7799757|NCT01089556|12256914|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0
7799758|NCT01089556|12256915|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1
7799759|NCT01089556|12256916|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0
7799760|NCT01089556|12256917|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0
7799761|NCT01089556|12256918|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0
7799762|NCT01089556|12256913|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0
7799763|NCT01089556|12256914|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0
7799764|NCT01089556|12256915|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1
7799765|NCT01089556|12256916|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1
7799766|NCT01089556|12256917|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1
7799767|NCT01089556|12256918|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0
7799768|NCT01089556|12256913|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0
7799769|NCT01089556|12256914|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0
7799770|NCT01089556|12256915|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4
7799771|NCT01089556|12256916|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3
7799772|NCT01089556|12256917|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4
7799773|NCT01089556|12256918|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1
7799774|NCT01089556|12256913|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
7799775|NCT01089556|12256914|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
7799776|NCT01089556|12256915|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
7799777|NCT01089556|12256916|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
7799778|NCT01089556|12256917|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
7799779|NCT01089556|12256918|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
7799780|NCT01089582|12256943|FG000|Overall Study|Death|2
7799781|NCT01089582|12256943|FG000|Overall Study|Adverse Event|15
7799782|NCT01089582|12256943|FG000|Overall Study|Lost to Follow-up|8
7799783|NCT01089582|12256943|FG000|Overall Study|Other|4
7799784|NCT01089582|12256943|FG000|Overall Study|Withdrawal by Subject|1
7799785|NCT01089608|12256960|FG000|Overall Study|Adverse Event|0
7799786|NCT01089608|12256961|FG001|Overall Study|Adverse Event|4
7799787|NCT01089608|12256960|FG000|Overall Study|Lost to Follow-up|0
7799788|NCT01089608|12256961|FG001|Overall Study|Lost to Follow-up|2
7799789|NCT01089647|12256969|FG000|Overall Study|Lost to Follow-up|2
7799790|NCT01089647|12256970|FG001|Overall Study|Lost to Follow-up|2
7799791|NCT01089647|12256969|FG000|Overall Study|Withdrawal by Subject|2
7799792|NCT01089647|12256970|FG001|Overall Study|Withdrawal by Subject|1
7799793|NCT01089647|12256969|FG000|Overall Study|Adverse Event|0
7799794|NCT01089647|12256970|FG001|Overall Study|Adverse Event|1
7799795|NCT01089725|12256981|FG000|Overall Study|Adverse Event|1
7799796|NCT01089725|12256982|FG001|Overall Study|Adverse Event|1
7799797|NCT01089725|12256983|FG002|Overall Study|Adverse Event|0
7799798|NCT01089725|12256984|FG003|Overall Study|Adverse Event|0
7799799|NCT01089725|12256985|FG004|Overall Study|Adverse Event|2
7799800|NCT01089725|12256981|FG000|Overall Study|Lack of Efficacy|4
7799801|NCT01089725|12256982|FG001|Overall Study|Lack of Efficacy|3
7799802|NCT01089725|12256983|FG002|Overall Study|Lack of Efficacy|1
7799803|NCT01089725|12256984|FG003|Overall Study|Lack of Efficacy|0
7799804|NCT01089725|12256985|FG004|Overall Study|Lack of Efficacy|4
7799805|NCT01089725|12256981|FG000|Overall Study|Lost to Follow-up|2
7799806|NCT01089725|12256982|FG001|Overall Study|Lost to Follow-up|2
7799807|NCT01089725|12256983|FG002|Overall Study|Lost to Follow-up|0
7799808|NCT01089725|12256984|FG003|Overall Study|Lost to Follow-up|3
7799809|NCT01089725|12256985|FG004|Overall Study|Lost to Follow-up|0
7799810|NCT01089725|12256981|FG000|Overall Study|Protocol Violation|0
7799811|NCT01089725|12256982|FG001|Overall Study|Protocol Violation|0
7799812|NCT01089725|12256983|FG002|Overall Study|Protocol Violation|1
7799813|NCT01089725|12256984|FG003|Overall Study|Protocol Violation|1
7799814|NCT01089725|12256985|FG004|Overall Study|Protocol Violation|0
7799815|NCT01089725|12256981|FG000|Overall Study|Withdrawal by Subject|5
7799816|NCT01089725|12256982|FG001|Overall Study|Withdrawal by Subject|5
7799817|NCT01089725|12256983|FG002|Overall Study|Withdrawal by Subject|4
7799818|NCT01089725|12256984|FG003|Overall Study|Withdrawal by Subject|5
7799819|NCT01089725|12256985|FG004|Overall Study|Withdrawal by Subject|4
7799820|NCT01089725|12256981|FG000|Overall Study|Study Terminated by Sponsor|51
7799821|NCT01089725|12256982|FG001|Overall Study|Study Terminated by Sponsor|56
7799822|NCT01089725|12256983|FG002|Overall Study|Study Terminated by Sponsor|53
7799823|NCT01089725|12256984|FG003|Overall Study|Study Terminated by Sponsor|68
7799824|NCT01089725|12256985|FG004|Overall Study|Study Terminated by Sponsor|68
7799825|NCT01089725|12256981|FG000|Overall Study|Randomized, but not treated|0
7799826|NCT01089725|12256982|FG001|Overall Study|Randomized, but not treated|1
7799827|NCT01089725|12256983|FG002|Overall Study|Randomized, but not treated|2
7799828|NCT01089725|12256984|FG003|Overall Study|Randomized, but not treated|1
7799829|NCT01089725|12256985|FG004|Overall Study|Randomized, but not treated|2
7799830|NCT01089725|12256981|FG000|Overall Study|Other|3
7799831|NCT01089725|12256982|FG001|Overall Study|Other|0
7799832|NCT01089725|12256983|FG002|Overall Study|Other|0
7799833|NCT01089725|12256984|FG003|Overall Study|Other|1
7799834|NCT01089725|12256985|FG004|Overall Study|Other|0
7799835|NCT01090011|12257010|FG000|Overall Study|Progressive disease|128
7799836|NCT01090011|12257010|FG000|Overall Study|Adverse Event|32
7799837|NCT01090011|12257010|FG000|Overall Study|Protocol Violation|1
7799838|NCT01090011|12257010|FG000|Overall Study|Refusal to start/continue medication|5
7799839|NCT01090011|12257010|FG000|Overall Study|Other reason not defined above|5
7799840|NCT01090050|12257024|FG000|Overall Study|Lost to Follow-up|0
7799841|NCT01090050|12257025|FG001|Overall Study|Lost to Follow-up|1
7799842|NCT01090050|12257024|FG000|Overall Study|Lack of Efficacy|1
7799843|NCT01090050|12257025|FG001|Overall Study|Lack of Efficacy|5
7799844|NCT01090050|12257024|FG000|Overall Study|Physician Decision|0
7799845|NCT01090050|12257025|FG001|Overall Study|Physician Decision|1
7799846|NCT01090063|12257035|FG000|Screen|Screen Failed|4
7799847|NCT01090063|12257035|FG000|Treatment|Withdrawal by Subject|4
7799848|NCT01090076|12257051|FG000|Overall Study|Death|1
7799849|NCT01090076|12257052|FG001|Overall Study|Death|1
7799850|NCT01090076|12257051|FG000|Overall Study|Withdrawal by Subject|0
7799851|NCT01090076|12257052|FG001|Overall Study|Withdrawal by Subject|1
7799852|NCT01090102|12257062|FG000|First 12 Weeks|Withdrawal by Subject|1
7799853|NCT01090102|12257063|FG001|First 12 Weeks|Withdrawal by Subject|1
7630457|NCT00381641|12043121|FG000|Overall Study|Withdrawal by Subject|0
7630458|NCT00381641|12043122|FG001|Overall Study|Withdrawal by Subject|2
7799854|NCT01090102|12257062|FG000|First 12 Weeks|Adverse Event|2
7799855|NCT01090102|12257063|FG001|First 12 Weeks|Adverse Event|0
7799856|NCT01090102|12257062|FG000|First 12 Weeks|Death|1
7799857|NCT01090102|12257063|FG001|First 12 Weeks|Death|1
7799858|NCT01090102|12257062|FG000|Second 12 Weeks|Withdrawal by Subject|0
7799859|NCT01090102|12257063|FG001|Second 12 Weeks|Withdrawal by Subject|1
7799860|NCT01090310|12257082|FG000|Core Study|Adverse Event|2
7799861|NCT01090310|12257083|FG001|Core Study|Adverse Event|2
7799862|NCT01090310|12257084|FG002|Core Study|Adverse Event|1
7799863|NCT01090310|12257085|FG003|Core Study|Adverse Event|1
7799864|NCT01090310|12257082|FG000|Core Study|Subject withdrew consent|0
7799865|NCT01090310|12257083|FG001|Core Study|Subject withdrew consent|3
7799866|NCT01090310|12257084|FG002|Core Study|Subject withdrew consent|1
7799867|NCT01090310|12257085|FG003|Core Study|Subject withdrew consent|1
7799868|NCT01090310|12257082|FG000|Core Study|Abnormal test procedure result|0
7799869|NCT01090310|12257083|FG001|Core Study|Abnormal test procedure result|0
7799870|NCT01090310|12257084|FG002|Core Study|Abnormal test procedure result|1
7799871|NCT01090310|12257085|FG003|Core Study|Abnormal test procedure result|0
7799872|NCT01090310|12257082|FG000|Core Study|Administrative reasons|5
7799873|NCT01090310|12257083|FG001|Core Study|Administrative reasons|6
7799874|NCT01090310|12257084|FG002|Core Study|Administrative reasons|4
7799875|NCT01090310|12257085|FG003|Core Study|Administrative reasons|4
7799876|NCT01090310|12257082|FG000|Core Study|Protocol deviation|1
7799877|NCT01090310|12257083|FG001|Core Study|Protocol deviation|0
7799878|NCT01090310|12257084|FG002|Core Study|Protocol deviation|0
7799879|NCT01090310|12257085|FG003|Core Study|Protocol deviation|1
7799880|NCT01090310|12257082|FG000|Extension Study|Aministrative problems|13
7799881|NCT01090310|12257083|FG001|Extension Study|Aministrative problems|15
7799882|NCT01090310|12257084|FG002|Extension Study|Aministrative problems|14
7799883|NCT01090310|12257085|FG003|Extension Study|Aministrative problems|18
7799884|NCT01090310|12257082|FG000|Extension Study|Adverse Event|0
7799885|NCT01090310|12257083|FG001|Extension Study|Adverse Event|0
7799886|NCT01090310|12257084|FG002|Extension Study|Adverse Event|0
7799887|NCT01090310|12257085|FG003|Extension Study|Adverse Event|1
7799888|NCT01090310|12257082|FG000|Extension Study|Unsatisfactory therapeutic effect|1
7799889|NCT01090310|12257083|FG001|Extension Study|Unsatisfactory therapeutic effect|0
7799890|NCT01090310|12257084|FG002|Extension Study|Unsatisfactory therapeutic effect|1
7630497|NCT05405244|12043191|FG000|Washout (2 Weeks)|Lost to Follow-up|0
7630498|NCT05405244|12043192|FG001|Washout (2 Weeks)|Lost to Follow-up|1
7630499|NCT05405244|12043191|FG000|Washout (2 Weeks)|Adverse Event|2
7630500|NCT05405244|12043192|FG001|Washout (2 Weeks)|Adverse Event|0
7630501|NCT05405244|12043191|FG000|Washout (2 Weeks)|Withdrawal by Subject|2
7630502|NCT05405244|12043192|FG001|Washout (2 Weeks)|Withdrawal by Subject|0
7630503|NCT05271175|12043205|FG000|One Week Follow up|Lost to Follow-up|10
7630504|NCT05271175|12043206|FG001|One Week Follow up|Lost to Follow-up|7
7630505|NCT05271175|12043207|FG002|One Week Follow up|Lost to Follow-up|5
7630506|NCT05271175|12043205|FG000|One Month Follow up|Lost to Follow-up|12
7630507|NCT05271175|12043206|FG001|One Month Follow up|Lost to Follow-up|7
7630508|NCT05271175|12043207|FG002|One Month Follow up|Lost to Follow-up|9
7630509|NCT05271175|12043205|FG000|Six Months Follow up|Lost to Follow-up|8
7630510|NCT05271175|12043206|FG001|Six Months Follow up|Lost to Follow-up|2
7630511|NCT05271175|12043207|FG002|Six Months Follow up|Lost to Follow-up|2
7630512|NCT05200455|12043215|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4
7630513|NCT05091528|12043228|FG000|Overall Study|Study Termination by Sponsor|0
7630514|NCT05091528|12043229|FG001|Overall Study|Study Termination by Sponsor|1
7630515|NCT05091528|12043230|FG002|Overall Study|Study Termination by Sponsor|0
7630516|NCT05091528|12043231|FG003|Overall Study|Study Termination by Sponsor|1
7630517|NCT05090852|12043239|FG000|Overall Study|Physician Decision|5
7630518|NCT05050318|12043253|FG000|Overall Study|Protocol Deviation|1
7630519|NCT05050318|12043254|FG001|Overall Study|Protocol Deviation|0
7630520|NCT05050318|12043255|FG002|Overall Study|Protocol Deviation|0
7630521|NCT04942925|12043265|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0
7630522|NCT04942925|12043266|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1
7630523|NCT04942925|12043265|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0
7630524|NCT04942925|12043266|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1
7630525|NCT04908488|12043277|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1
7630526|NCT04908488|12043278|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0
7630527|NCT04908488|12043277|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1
7630528|NCT04908488|12043278|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0
7630529|NCT04899232|12043299|FG000|Screening Period|Physician Decision|1
7630530|NCT04899232|12043300|FG001|Screening Period|Physician Decision|0
7630531|NCT04899232|12043301|FG002|Screening Period|Physician Decision|0
7630532|NCT04899232|12043299|FG000|Screening Period|Withdrawal by Subject|1
7630533|NCT04899232|12043300|FG001|Screening Period|Withdrawal by Subject|0
7630534|NCT04899232|12043301|FG002|Screening Period|Withdrawal by Subject|0
7630535|NCT04899232|12043299|FG000|Screening Period|Participant discharged before receiving intervention|3
7630536|NCT04899232|12043300|FG001|Screening Period|Participant discharged before receiving intervention|0
7630537|NCT04899232|12043301|FG002|Screening Period|Participant discharged before receiving intervention|0
7630538|NCT04885296|12043309|FG000|Period 1|Covid-19 Related|1
7630539|NCT04885296|12043310|FG001|Period 1|Covid-19 Related|0
7630540|NCT04885296|12043309|FG000|Period 1|Adverse Event|0
7630541|NCT04885296|12043310|FG001|Period 1|Adverse Event|1
7630542|NCT04885296|12043309|FG000|Period 1|Withdrawal by Subject|1
7630543|NCT04885296|12043310|FG001|Period 1|Withdrawal by Subject|1
7630544|NCT04885296|12043309|FG000|Period 1|Test Article No Longer Available|1
7630545|NCT04885296|12043310|FG001|Period 1|Test Article No Longer Available|0
7630546|NCT04885296|12043309|FG000|Period 1|Dispensed Study lens in Error|1
7630547|NCT04885296|12043310|FG001|Period 1|Dispensed Study lens in Error|0
7630548|NCT04885296|12043309|FG000|Period 1|Lost to Follow-up|1
7630549|NCT04885296|12043310|FG001|Period 1|Lost to Follow-up|0
7630550|NCT04885296|12043309|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0
7630551|NCT04885296|12043310|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1
7630552|NCT04862065|12043319|FG000|Screening|Protocol Violation|54
7630553|NCT04862065|12043320|FG001|Screening|Protocol Violation|0
7630554|NCT04862065|12043321|FG002|Screening|Protocol Violation|0
7630555|NCT04862065|12043319|FG000|Screening|Insufficient Sample|1
7630556|NCT04862065|12043320|FG001|Screening|Insufficient Sample|0
7630557|NCT04862065|12043321|FG002|Screening|Insufficient Sample|0
7630558|NCT04862065|12043319|FG000|Follow-Up|Lost to Follow-up|3
7630559|NCT04862065|12043320|FG001|Follow-Up|Lost to Follow-up|0
7630560|NCT04862065|12043321|FG002|Follow-Up|Lost to Follow-up|0
7630561|NCT04822701|12043338|FG000|Overall Study|Not treated|2
7630562|NCT04822701|12043339|FG001|Overall Study|Not treated|0
7630563|NCT04822701|12043338|FG000|Overall Study|Lost to Follow-up|1
7630564|NCT04822701|12043339|FG001|Overall Study|Lost to Follow-up|0
7630565|NCT04822701|12043338|FG000|Overall Study|Withdrawal by Subject|1
7630566|NCT04822701|12043339|FG001|Overall Study|Withdrawal by Subject|0
7630567|NCT04784897|12043348|FG000|Overall Study|Death|4
7630568|NCT04784897|12043349|FG001|Overall Study|Death|2
7630569|NCT04784897|12043350|FG002|Overall Study|Death|1
7630570|NCT04784897|12043348|FG000|Overall Study|Withdrawal by Subject|0
7630571|NCT04784897|12043349|FG001|Overall Study|Withdrawal by Subject|0
7630572|NCT04784897|12043350|FG002|Overall Study|Withdrawal by Subject|1
7630573|NCT04764669|12043379|FG000|Overall Study|Adverse Event|1
7630574|NCT04764669|12043380|FG001|Overall Study|Adverse Event|0
7630575|NCT04764669|12043381|FG002|Overall Study|Adverse Event|1
7630576|NCT04764669|12043382|FG003|Overall Study|Adverse Event|0
7630577|NCT04764669|12043379|FG000|Overall Study|Subject Choice|0
7630578|NCT04764669|12043380|FG001|Overall Study|Subject Choice|0
7630579|NCT04764669|12043381|FG002|Overall Study|Subject Choice|1
7630580|NCT04764669|12043382|FG003|Overall Study|Subject Choice|0
7630581|NCT04764669|12043379|FG000|Overall Study|Withdrawal by Subject|2
7630582|NCT04764669|12043380|FG001|Overall Study|Withdrawal by Subject|0
7630583|NCT04764669|12043381|FG002|Overall Study|Withdrawal by Subject|0
7630584|NCT04764669|12043382|FG003|Overall Study|Withdrawal by Subject|0
7630585|NCT04741503|12043398|FG000|Initial Enrollment|Failed to meet screening criteria|0
7630586|NCT04741503|12043399|FG001|Initial Enrollment|Failed to meet screening criteria|0
7630587|NCT04741503|12043400|FG002|Initial Enrollment|Failed to meet screening criteria|767
7630588|NCT04741503|12043398|FG000|Initial Enrollment|Overquotas removed|0
7630589|NCT04741503|12043399|FG001|Initial Enrollment|Overquotas removed|0
7630590|NCT04741503|12043400|FG002|Initial Enrollment|Overquotas removed|186
7630591|NCT04741503|12043398|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23
7630592|NCT04741503|12043399|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17
7630593|NCT04741503|12043400|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0
7630594|NCT04734873|12043409|FG000|Overall Study|Lost to Follow-up|1
7630595|NCT04734873|12043410|FG001|Overall Study|Lost to Follow-up|3
7630596|NCT04734873|12043411|FG002|Overall Study|Lost to Follow-up|2
7630597|NCT04734873|12043409|FG000|Overall Study|Randomized but not dosed|1
7630598|NCT04734873|12043410|FG001|Overall Study|Randomized but not dosed|0
7630599|NCT04734873|12043411|FG002|Overall Study|Randomized but not dosed|1
7630600|NCT04724733|12043426|FG000|Overall Study|Lost to Follow-up|1
7630601|NCT04724733|12043427|FG001|Overall Study|Lost to Follow-up|1
7630602|NCT04724733|12043428|FG002|Overall Study|Lost to Follow-up|1
7630603|NCT04713748|12043453|FG000|Overall Study|Not enough kits allocated|35
7630604|NCT04668274|12043487|FG000|Part 1 Study Period 1|Adverse Event|3
7630605|NCT04668274|12043488|FG001|Part 1 Study Period 1|Adverse Event|0
7630606|NCT04668274|12043489|FG002|Part 1 Study Period 1|Adverse Event|0
7630607|NCT04668274|12043490|FG003|Part 1 Study Period 1|Adverse Event|0
7630608|NCT04668274|12043487|FG000|Part 1 Study Period 1|Withdrawal by Subject|2
7630609|NCT04668274|12043488|FG001|Part 1 Study Period 1|Withdrawal by Subject|0
7630610|NCT04668274|12043489|FG002|Part 1 Study Period 1|Withdrawal by Subject|0
7630611|NCT04668274|12043490|FG003|Part 1 Study Period 1|Withdrawal by Subject|0
7630612|NCT04668274|12043487|FG000|Part 1 Study Period 2|Other|0
7630613|NCT04668274|12043488|FG001|Part 1 Study Period 2|Other|1
7630614|NCT04668274|12043489|FG002|Part 1 Study Period 2|Other|0
7630615|NCT04668274|12043490|FG003|Part 1 Study Period 2|Other|0
7630616|NCT04668274|12043487|FG000|Part 1 Study Period 3|Adverse Event|0
7630617|NCT04668274|12043488|FG001|Part 1 Study Period 3|Adverse Event|0
7630618|NCT04668274|12043489|FG002|Part 1 Study Period 3|Adverse Event|1
7630619|NCT04668274|12043490|FG003|Part 1 Study Period 3|Adverse Event|0
7630620|NCT04668274|12043487|FG000|Part 1 Study Period 3|Other|0
7630621|NCT04668274|12043488|FG001|Part 1 Study Period 3|Other|0
7630622|NCT04668274|12043489|FG002|Part 1 Study Period 3|Other|2
7630623|NCT04668274|12043490|FG003|Part 1 Study Period 3|Other|0
7630624|NCT04668274|12043487|FG000|Part 2 Study Period 4|Other|0
7630625|NCT04668274|12043488|FG001|Part 2 Study Period 4|Other|0
7630626|NCT04668274|12043489|FG002|Part 2 Study Period 4|Other|0
7630627|NCT04668274|12043490|FG003|Part 2 Study Period 4|Other|1
7630628|NCT04664153|12043516|FG000|Overall Study|Lack of Efficacy|0
7630629|NCT04664153|12043517|FG001|Overall Study|Lack of Efficacy|0
7630630|NCT04664153|12043518|FG002|Overall Study|Lack of Efficacy|1
7630631|NCT04664153|12043519|FG003|Overall Study|Lack of Efficacy|0
7630632|NCT04664153|12043516|FG000|Overall Study|Physician Decision|0
7630633|NCT04664153|12043517|FG001|Overall Study|Physician Decision|0
7630634|NCT04664153|12043518|FG002|Overall Study|Physician Decision|1
7630635|NCT04664153|12043519|FG003|Overall Study|Physician Decision|0
7630636|NCT04664153|12043516|FG000|Overall Study|Withdrawal by Subject|3
7630637|NCT04664153|12043517|FG001|Overall Study|Withdrawal by Subject|2
7630638|NCT04664153|12043518|FG002|Overall Study|Withdrawal by Subject|1
7630639|NCT04664153|12043519|FG003|Overall Study|Withdrawal by Subject|2
7630640|NCT04664153|12043516|FG000|Overall Study|Other|0
7630641|NCT04664153|12043517|FG001|Overall Study|Other|1
7630642|NCT04664153|12043518|FG002|Overall Study|Other|0
7630643|NCT04664153|12043519|FG003|Overall Study|Other|0
7630644|NCT04664153|12043516|FG000|Overall Study|Adverse Event|4
7630645|NCT04664153|12043517|FG001|Overall Study|Adverse Event|0
7630646|NCT04664153|12043518|FG002|Overall Study|Adverse Event|1
7630647|NCT04664153|12043519|FG003|Overall Study|Adverse Event|0
7630648|NCT04663295|12043531|FG000|Run-in Period|Withdrawal by Subject|3
7630649|NCT04663295|12043531|FG000|Overall Study Period|Pregnancy|1
7630650|NCT04663295|12043531|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1
7630651|NCT04623242|12043662|FG000|Overall Study|Withdrawal by Subject|7
7630652|NCT04623242|12043663|FG001|Overall Study|Withdrawal by Subject|12
7630653|NCT04623242|12043664|FG002|Overall Study|Withdrawal by Subject|5
7630654|NCT04623242|12043665|FG003|Overall Study|Withdrawal by Subject|7
7630655|NCT04623242|12043666|FG004|Overall Study|Withdrawal by Subject|0
7630656|NCT04623242|12043662|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6
7630657|NCT04623242|12043663|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4
7630658|NCT04623242|12043664|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5
7630659|NCT04623242|12043665|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3
7630660|NCT04623242|12043666|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0
7630661|NCT04623242|12043662|FG000|Overall Study|Subject unblinded to mutation status|0
7630662|NCT04623242|12043663|FG001|Overall Study|Subject unblinded to mutation status|0
7630663|NCT04623242|12043664|FG002|Overall Study|Subject unblinded to mutation status|0
7630664|NCT04623242|12043665|FG003|Overall Study|Subject unblinded to mutation status|13
7630665|NCT04623242|12043666|FG004|Overall Study|Subject unblinded to mutation status|0
7630666|NCT04619992|12043683|FG000|Overall Study|Withdrawal by Subject|1
7630667|NCT04619992|12043684|FG001|Overall Study|Withdrawal by Subject|0
7630668|NCT04606199|12043690|FG000|Overall Study|Withdrawal by Subject|2
7630669|NCT04587453|12043711|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0
7630670|NCT04587453|12043712|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1
7630671|NCT04584346|12043731|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0
7630672|NCT04584346|12043732|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1
7630673|NCT04580303|12043746|FG000|Overall Study|Adverse Event|0
7630674|NCT04580303|12043747|FG001|Overall Study|Adverse Event|1
7630675|NCT04580303|12043748|FG002|Overall Study|Adverse Event|0
7630676|NCT04580303|12043749|FG003|Overall Study|Adverse Event|0
7630677|NCT04580303|12043746|FG000|Overall Study|Withdrawal by Subject|0
7630678|NCT04580303|12043747|FG001|Overall Study|Withdrawal by Subject|0
7630679|NCT04580303|12043748|FG002|Overall Study|Withdrawal by Subject|1
7630680|NCT04580303|12043749|FG003|Overall Study|Withdrawal by Subject|0
7630681|NCT04575584|12043765|FG000|Overall Study|Death|6
7630682|NCT04575584|12043766|FG001|Overall Study|Death|4
7630683|NCT04575584|12043767|FG002|Overall Study|Death|6
7630684|NCT04575584|12043768|FG003|Overall Study|Death|2
7630685|NCT04575584|12043769|FG004|Overall Study|Death|0
7630686|NCT04575584|12043770|FG005|Overall Study|Death|0
7630687|NCT04575584|12043765|FG000|Overall Study|Lost to Follow-up|1
7630688|NCT04575584|12043766|FG001|Overall Study|Lost to Follow-up|1
7630689|NCT04575584|12043767|FG002|Overall Study|Lost to Follow-up|1
7630690|NCT04575584|12043768|FG003|Overall Study|Lost to Follow-up|1
7630691|NCT04575584|12043769|FG004|Overall Study|Lost to Follow-up|0
7630692|NCT04575584|12043770|FG005|Overall Study|Lost to Follow-up|0
7630693|NCT04575584|12043765|FG000|Overall Study|Physician Decision|0
7630694|NCT04575584|12043766|FG001|Overall Study|Physician Decision|1
7630695|NCT04575584|12043767|FG002|Overall Study|Physician Decision|1
7630696|NCT04575584|12043768|FG003|Overall Study|Physician Decision|1
7630697|NCT04575584|12043769|FG004|Overall Study|Physician Decision|0
7630698|NCT04575584|12043770|FG005|Overall Study|Physician Decision|0
7630699|NCT04575584|12043765|FG000|Overall Study|Withdrawal by Subject|7
7630700|NCT04575584|12043766|FG001|Overall Study|Withdrawal by Subject|9
7630701|NCT04575584|12043767|FG002|Overall Study|Withdrawal by Subject|5
7630702|NCT04575584|12043768|FG003|Overall Study|Withdrawal by Subject|3
7630703|NCT04575584|12043769|FG004|Overall Study|Withdrawal by Subject|0
7630704|NCT04575584|12043770|FG005|Overall Study|Withdrawal by Subject|0
7630705|NCT04575584|12043765|FG000|Overall Study|Not recorded|0
7630706|NCT04575584|12043766|FG001|Overall Study|Not recorded|0
7630707|NCT04575584|12043767|FG002|Overall Study|Not recorded|0
7630708|NCT04575584|12043768|FG003|Overall Study|Not recorded|1
7630709|NCT04575584|12043769|FG004|Overall Study|Not recorded|0
7630710|NCT04575584|12043770|FG005|Overall Study|Not recorded|0
7630711|NCT04571515|12043789|FG000|Overall Study|Physician Decision|0
7630712|NCT04571515|12043790|FG001|Overall Study|Physician Decision|0
7630713|NCT04571515|12043791|FG002|Overall Study|Physician Decision|0
7630714|NCT04571515|12043792|FG003|Overall Study|Physician Decision|0
7630715|NCT04571515|12043793|FG004|Overall Study|Physician Decision|1
7630716|NCT04571515|12043789|FG000|Overall Study|Withdrawal by Subject|0
7630717|NCT04571515|12043790|FG001|Overall Study|Withdrawal by Subject|0
7630718|NCT04571515|12043791|FG002|Overall Study|Withdrawal by Subject|0
7630719|NCT04571515|12043792|FG003|Overall Study|Withdrawal by Subject|0
7630720|NCT04571515|12043793|FG004|Overall Study|Withdrawal by Subject|1
7630721|NCT04571515|12043789|FG000|Overall Study|insufficient pain|1
7630722|NCT04571515|12043790|FG001|Overall Study|insufficient pain|0
7630723|NCT04571515|12043791|FG002|Overall Study|insufficient pain|0
7630724|NCT04571515|12043792|FG003|Overall Study|insufficient pain|0
7630725|NCT04571515|12043793|FG004|Overall Study|insufficient pain|1
7630726|NCT04562155|12043818|FG000|Overall Study|COVID-19 pandemic|0
7630727|NCT04562155|12043819|FG001|Overall Study|COVID-19 pandemic|0
7630728|NCT04562155|12043820|FG002|Overall Study|COVID-19 pandemic|0
7630729|NCT04562155|12043821|FG003|Overall Study|COVID-19 pandemic|1
7630730|NCT04562155|12043818|FG000|Overall Study|Adverse Event|7
7630731|NCT04562155|12043819|FG001|Overall Study|Adverse Event|3
7630732|NCT04562155|12043820|FG002|Overall Study|Adverse Event|8
7630733|NCT04562155|12043821|FG003|Overall Study|Adverse Event|1
7630734|NCT04562155|12043818|FG000|Overall Study|Withdrawal by Subject|3
7630735|NCT04562155|12043819|FG001|Overall Study|Withdrawal by Subject|6
7630736|NCT04562155|12043820|FG002|Overall Study|Withdrawal by Subject|3
7630737|NCT04562155|12043821|FG003|Overall Study|Withdrawal by Subject|3
7630738|NCT04562155|12043818|FG000|Overall Study|Participant personal reason|1
7630739|NCT04562155|12043819|FG001|Overall Study|Participant personal reason|0
7630740|NCT04562155|12043820|FG002|Overall Study|Participant personal reason|2
7630741|NCT04562155|12043821|FG003|Overall Study|Participant personal reason|1
7630742|NCT04546724|12043851|FG000|Overall Study|Withdrawal by Subject|37
7630743|NCT04546724|12043852|FG001|Overall Study|Withdrawal by Subject|10
7630744|NCT04546724|12043851|FG000|Overall Study|Adverse Event|1
7630745|NCT04546724|12043852|FG001|Overall Study|Adverse Event|1
7630746|NCT04546724|12043851|FG000|Overall Study|Lost to Follow-up|30
7630747|NCT04546724|12043852|FG001|Overall Study|Lost to Follow-up|10
7630748|NCT04546724|12043851|FG000|Overall Study|Physician Decision|4
7630749|NCT04546724|12043852|FG001|Overall Study|Physician Decision|1
7630750|NCT04546724|12043851|FG000|Overall Study|Subject Moved|2
7630751|NCT04546724|12043852|FG001|Overall Study|Subject Moved|0
7630752|NCT04546724|12043851|FG000|Overall Study|Subject Praticipating in another trial|0
7630753|NCT04546724|12043852|FG001|Overall Study|Subject Praticipating in another trial|1
7630754|NCT04546724|12043851|FG000|Overall Study|"subjects did not have a Day29 or later visits . These subjects were considered as Not completed."|49
7630755|NCT04546724|12043852|FG001|Overall Study|"subjects did not have a Day29 or later visits . These subjects were considered as Not completed."|12
7630756|NCT04539275|12043871|FG000|Overall Study|Death|2
7630757|NCT04539275|12043872|FG001|Overall Study|Death|4
7630758|NCT04539275|12043871|FG000|Overall Study|Lost to Follow-up|1
7630759|NCT04539275|12043872|FG001|Overall Study|Lost to Follow-up|1
7630760|NCT04539275|12043871|FG000|Overall Study|Withdrawal by Subject|3
7630761|NCT04539275|12043872|FG001|Overall Study|Withdrawal by Subject|0
7630762|NCT04537806|12043880|FG000|Overall Study|Randomized but not treated|1
7630763|NCT04537806|12043881|FG001|Overall Study|Randomized but not treated|0
7630764|NCT04537806|12043880|FG000|Overall Study|Adverse Event|1
7630765|NCT04537806|12043881|FG001|Overall Study|Adverse Event|1
7630766|NCT04535947|12043889|FG000|Overall Study|Adverse Event|1
7630767|NCT04535947|12043890|FG001|Overall Study|Adverse Event|4
7630768|NCT04535947|12043889|FG000|Overall Study|Other reasons not specified|2
7630769|NCT04535947|12043890|FG001|Overall Study|Other reasons not specified|0
7630770|NCT04535947|12043889|FG000|Overall Study|Withdrawal by Subject|1
7630771|NCT04535947|12043890|FG001|Overall Study|Withdrawal by Subject|1
7630772|NCT04529850|12043896|FG000|Overall Study|Death|2
7630773|NCT04529850|12043896|FG000|Overall Study|Physician Decision|1
7630774|NCT04529850|12043896|FG000|Overall Study|Withdrawal by Subject|2
7630775|NCT04529096|12043902|FG000|Overall Study|Adverse Event|6
7630776|NCT04529096|12043903|FG001|Overall Study|Adverse Event|1
7630777|NCT04529096|12043902|FG000|Overall Study|Lack of Efficacy|1
7630778|NCT04529096|12043903|FG001|Overall Study|Lack of Efficacy|0
7630779|NCT04529096|12043902|FG000|Overall Study|Lost to Follow-up|1
7630780|NCT04529096|12043903|FG001|Overall Study|Lost to Follow-up|1
7630781|NCT04529096|12043902|FG000|Overall Study|Non-Compliance With Study Drug|0
7630782|NCT04529096|12043903|FG001|Overall Study|Non-Compliance With Study Drug|1
7630783|NCT04529096|12043902|FG000|Overall Study|Physician Decision|1
7630784|NCT04529096|12043903|FG001|Overall Study|Physician Decision|3
7630785|NCT04529096|12043902|FG000|Overall Study|Withdrawal by Subject|5
7630786|NCT04529096|12043903|FG001|Overall Study|Withdrawal by Subject|0
7630787|NCT04527471|12043911|FG000|Overall Study|Adverse Event|1
7630788|NCT04527471|12043912|FG001|Overall Study|Adverse Event|0
7630789|NCT04527471|12043911|FG000|Overall Study|Lost to Follow-up|1
7630790|NCT04527471|12043912|FG001|Overall Study|Lost to Follow-up|0
7630791|NCT04505722|12043942|FG000|Overall Study|Adverse Event|1
7630792|NCT04505722|12043943|FG001|Overall Study|Adverse Event|2
7630793|NCT04505722|12043942|FG000|Overall Study|Death|34
7630794|NCT04505722|12043943|FG001|Overall Study|Death|63
7630795|NCT04505722|12043942|FG000|Overall Study|Lost to Follow-up|271
7630796|NCT04505722|12043943|FG001|Overall Study|Lost to Follow-up|333
7630797|NCT04505722|12043942|FG000|Overall Study|Physician Decision|17
7630798|NCT04505722|12043943|FG001|Overall Study|Physician Decision|17
7630799|NCT04505722|12043942|FG000|Overall Study|Protocol Violation|0
7630800|NCT04505722|12043943|FG001|Overall Study|Protocol Violation|1
7630801|NCT04505722|12043942|FG000|Overall Study|Withdrawal by Subject|376
7630802|NCT04505722|12043943|FG001|Overall Study|Withdrawal by Subject|714
7630803|NCT04505722|12043942|FG000|Overall Study|Other|61
7630804|NCT04505722|12043943|FG001|Overall Study|Other|98
7630805|NCT04505722|12043942|FG000|Overall Study|Still ongoing|21138
7630806|NCT04505722|12043943|FG001|Overall Study|Still ongoing|20662
7630807|NCT04505722|12043942|FG000|Overall Study|Randomized not vaccinated|276
7630808|NCT04505722|12043943|FG001|Overall Study|Randomized not vaccinated|260
7630809|NCT04498169|12043951|FG000|Study Completion|Adverse Event|1
7630810|NCT04498169|12043952|FG001|Study Completion|Adverse Event|1
7630811|NCT04490499|12043962|FG000|Overall Study|Withdrawal by Subject|2
7630812|NCT04482647|12043966|FG000|Overall Study|Time constraints|2
7630813|NCT04482647|12043966|FG000|Overall Study|Health issues|1
7630814|NCT04482647|12043966|FG000|Overall Study|Death in the family|1
7630815|NCT04482647|12043966|FG000|Overall Study|Disliked the intervention|1
7630816|NCT04482647|12043966|FG000|Overall Study|No reasons specified|7
7630817|NCT04476108|12043972|FG000|Overall Study|Adverse Event|4
7630818|NCT04476108|12043973|FG001|Overall Study|Adverse Event|1
7630819|NCT04476108|12043972|FG000|Overall Study|Lost to Follow-up|1
7630820|NCT04476108|12043973|FG001|Overall Study|Lost to Follow-up|0
7630821|NCT04476108|12043972|FG000|Overall Study|Inadvertent Enrollment|1
7630822|NCT04476108|12043973|FG001|Overall Study|Inadvertent Enrollment|0
7630823|NCT04476108|12043972|FG000|Overall Study|Protocol Violation|1
7630824|NCT04476108|12043973|FG001|Overall Study|Protocol Violation|1
7630825|NCT04476108|12043972|FG000|Overall Study|Withdrawal by Subject|1
7630826|NCT04476108|12043973|FG001|Overall Study|Withdrawal by Subject|1
7630827|NCT04470622|12043981|FG000|Overall Study|Withdrawal by Subject|0
7630828|NCT04470622|12043982|FG001|Overall Study|Withdrawal by Subject|1
7630829|NCT04470622|12043981|FG000|Overall Study|Screen Failure|0
7630830|NCT04470622|12043982|FG001|Overall Study|Screen Failure|1
7630831|NCT04470622|12043981|FG000|Overall Study|Death|0
7630832|NCT04470622|12043982|FG001|Overall Study|Death|1
7630833|NCT04464421|12043990|FG000|Overall Study|Lost to Follow-up|2
7630834|NCT04464421|12043991|FG001|Overall Study|Lost to Follow-up|2
7630835|NCT04456686|12044012|FG000|Overall Study|Adverse Event|2
7630836|NCT04456686|12044013|FG001|Overall Study|Adverse Event|1
7630837|NCT04456686|12044012|FG000|Overall Study|Lack of Efficacy|3
7630838|NCT04456686|12044013|FG001|Overall Study|Lack of Efficacy|1
7630839|NCT04456686|12044012|FG000|Overall Study|Withdrew consent|3
7630840|NCT04456686|12044013|FG001|Overall Study|Withdrew consent|1
7630841|NCT04456686|12044012|FG000|Overall Study|Physician Decision|2
7630842|NCT04456686|12044013|FG001|Overall Study|Physician Decision|2
7630843|NCT04456686|12044012|FG000|Overall Study|Withdrawal by Subject|5
7630844|NCT04456686|12044013|FG001|Overall Study|Withdrawal by Subject|1
7630845|NCT04456686|12044012|FG000|Overall Study|Protocol Violation|0
7630846|NCT04456686|12044013|FG001|Overall Study|Protocol Violation|1
7630847|NCT04447404|12044021|FG000|Overall Study|Death|2
7630848|NCT04447404|12044022|FG001|Overall Study|Death|0
7630849|NCT04439344|12044028|FG000|Overall Study|Never started threapy|3
7630850|NCT04439344|12044028|FG000|Overall Study|Ineligible|3
7630851|NCT04439344|12044028|FG000|Overall Study|Adverse Event|13
7630852|NCT04439344|12044028|FG000|Overall Study|Death|2
7630853|NCT04439344|12044028|FG000|Overall Study|Disease progression|29
7630854|NCT04439344|12044028|FG000|Overall Study|Withdrawal by Subject|2
7630855|NCT04439344|12044028|FG000|Overall Study|Alternative therapy|1
7630856|NCT04439279|12044032|FG000|Overall Study|Adverse Event|7
7630857|NCT04439279|12044032|FG000|Overall Study|Death|4
7630858|NCT04439279|12044032|FG000|Overall Study|Disease progression|17
7630859|NCT04439279|12044032|FG000|Overall Study|Complicating disease|3
7630860|NCT04439279|12044032|FG000|Overall Study|Withdrawal by Subject|2
7630861|NCT04439279|12044032|FG000|Overall Study|Ineligible|1
7630862|NCT04439279|12044032|FG000|Overall Study|Treatment still ongoing|1
7630863|NCT04439266|12044036|FG000|Overall Study|Ineligible|1
7630864|NCT04439266|12044036|FG000|Overall Study|Adverse Event|1
7630865|NCT04439266|12044036|FG000|Overall Study|Death|1
7630866|NCT04439266|12044036|FG000|Overall Study|Disease progression|1
7630867|NCT04439266|12044036|FG000|Overall Study|Still on treatment|1
7630868|NCT04439253|12044040|FG000|Overall Study|Adverse Event|1
7630869|NCT04439253|12044040|FG000|Overall Study|Disease progression|2
7630870|NCT04439253|12044040|FG000|Overall Study|Complicating disease|1
7630871|NCT04439123|12044044|FG000|Overall Study|Adverse Event|11
7630872|NCT04439123|12044044|FG000|Overall Study|Death|1
7630873|NCT04439123|12044044|FG000|Overall Study|Disease progression|19
7630874|NCT04439123|12044044|FG000|Overall Study|Withdrawal by Subject|2
7630875|NCT04439123|12044044|FG000|Overall Study|Still on treatment|2
7630876|NCT04439110|12044048|FG000|Overall Study|Ineligible|2
7630877|NCT04439110|12044048|FG000|Overall Study|Adverse Event|4
7630878|NCT04439110|12044048|FG000|Overall Study|Death|2
7630879|NCT04439110|12044048|FG000|Overall Study|Disease proression|25
7630880|NCT04439110|12044048|FG000|Overall Study|Withdrawal by Subject|1
7630881|NCT04439110|12044048|FG000|Overall Study|Alternative therapy|1
7630882|NCT04439110|12044048|FG000|Overall Study|Other complicating disease|1
7630883|NCT04439110|12044048|FG000|Overall Study|Personal reasons|1
7630884|NCT04439110|12044048|FG000|Overall Study|Still on treatment|1
7630885|NCT04438499|12044052|FG000|Overall Study|Lack of Efficacy|2
7630886|NCT04435665|12044060|FG000|Overall Study|Lost to Follow-up|0
7630887|NCT04435665|12044061|FG001|Overall Study|Lost to Follow-up|0
7630888|NCT04435665|12044062|FG002|Overall Study|Lost to Follow-up|0
7630889|NCT04435665|12044063|FG003|Overall Study|Lost to Follow-up|1
7630890|NCT04427501|12044083|FG000|Overall Study|Death|0
7630891|NCT04427501|12044084|FG001|Overall Study|Death|0
7630892|NCT04427501|12044085|FG002|Overall Study|Death|0
7630893|NCT04427501|12044086|FG003|Overall Study|Death|0
7630894|NCT04427501|12044087|FG004|Overall Study|Death|0
7630895|NCT04427501|12044088|FG005|Overall Study|Death|15
7630896|NCT04427501|12044089|FG006|Overall Study|Death|0
7630897|NCT04427501|12044090|FG007|Overall Study|Death|0
7630898|NCT04427501|12044091|FG008|Overall Study|Death|0
7630899|NCT04427501|12044092|FG009|Overall Study|Death|0
7630900|NCT04427501|12044083|FG000|Overall Study|Lost to Follow-up|5
7630901|NCT04427501|12044084|FG001|Overall Study|Lost to Follow-up|1
7630902|NCT04427501|12044085|FG002|Overall Study|Lost to Follow-up|2
7630903|NCT04427501|12044086|FG003|Overall Study|Lost to Follow-up|0
7630904|NCT04427501|12044087|FG004|Overall Study|Lost to Follow-up|2
7630905|NCT04427501|12044088|FG005|Overall Study|Lost to Follow-up|11
7630906|NCT04427501|12044089|FG006|Overall Study|Lost to Follow-up|10
7630907|NCT04427501|12044090|FG007|Overall Study|Lost to Follow-up|10
7630908|NCT04427501|12044091|FG008|Overall Study|Lost to Follow-up|2
7630909|NCT04427501|12044092|FG009|Overall Study|Lost to Follow-up|5
7630910|NCT04427501|12044083|FG000|Overall Study|Physician Decision|0
7630911|NCT04427501|12044084|FG001|Overall Study|Physician Decision|3
7630912|NCT04427501|12044085|FG002|Overall Study|Physician Decision|0
7630913|NCT04427501|12044086|FG003|Overall Study|Physician Decision|0
7630914|NCT04427501|12044087|FG004|Overall Study|Physician Decision|0
7630915|NCT04427501|12044088|FG005|Overall Study|Physician Decision|0
7630916|NCT04427501|12044089|FG006|Overall Study|Physician Decision|2
7630917|NCT04427501|12044090|FG007|Overall Study|Physician Decision|0
7630918|NCT04427501|12044091|FG008|Overall Study|Physician Decision|0
7630919|NCT04427501|12044092|FG009|Overall Study|Physician Decision|0
7630920|NCT04427501|12044083|FG000|Overall Study|Withdrawal by Subject|9
7630921|NCT04427501|12044084|FG001|Overall Study|Withdrawal by Subject|2
7630922|NCT04427501|12044085|FG002|Overall Study|Withdrawal by Subject|2
7630923|NCT04427501|12044086|FG003|Overall Study|Withdrawal by Subject|3
7630924|NCT04427501|12044087|FG004|Overall Study|Withdrawal by Subject|7
7630925|NCT04427501|12044088|FG005|Overall Study|Withdrawal by Subject|25
7630926|NCT04427501|12044089|FG006|Overall Study|Withdrawal by Subject|15
7630927|NCT04427501|12044090|FG007|Overall Study|Withdrawal by Subject|7
7630928|NCT04427501|12044091|FG008|Overall Study|Withdrawal by Subject|4
7630929|NCT04427501|12044092|FG009|Overall Study|Withdrawal by Subject|1
7630930|NCT04427501|12044083|FG000|Overall Study|Other - as reported by the investigator|1
7630931|NCT04427501|12044084|FG001|Overall Study|Other - as reported by the investigator|0
7630932|NCT04427501|12044085|FG002|Overall Study|Other - as reported by the investigator|0
7630933|NCT04427501|12044086|FG003|Overall Study|Other - as reported by the investigator|0
7630934|NCT04427501|12044087|FG004|Overall Study|Other - as reported by the investigator|0
7630935|NCT04427501|12044088|FG005|Overall Study|Other - as reported by the investigator|6
7630936|NCT04427501|12044089|FG006|Overall Study|Other - as reported by the investigator|6
7630937|NCT04427501|12044090|FG007|Overall Study|Other - as reported by the investigator|0
7630938|NCT04427501|12044091|FG008|Overall Study|Other - as reported by the investigator|0
7630939|NCT04427501|12044092|FG009|Overall Study|Other - as reported by the investigator|0
7630940|NCT04426630|12044125|FG000|Overall Study|Death|4
7630941|NCT04426630|12044125|FG000|Overall Study|Lost to Follow-up|2
7630942|NCT04421027|12044131|FG000|Treatment Period|Adverse Event|5
7630943|NCT04421027|12044132|FG001|Treatment Period|Adverse Event|3
7630944|NCT04421027|12044133|FG002|Treatment Period|Adverse Event|0
7630945|NCT04421027|12044134|FG003|Treatment Period|Adverse Event|0
7630946|NCT04421027|12044131|FG000|Treatment Period|Death|98
7630947|NCT04421027|12044132|FG001|Treatment Period|Death|61
7630948|NCT04421027|12044133|FG002|Treatment Period|Death|0
7630949|NCT04421027|12044134|FG003|Treatment Period|Death|0
7630950|NCT04421027|12044131|FG000|Treatment Period|Lost to Follow-up|22
7630951|NCT04421027|12044132|FG001|Treatment Period|Lost to Follow-up|20
7630952|NCT04421027|12044133|FG002|Treatment Period|Lost to Follow-up|0
7630953|NCT04421027|12044134|FG003|Treatment Period|Lost to Follow-up|0
7630954|NCT04421027|12044131|FG000|Treatment Period|Other-Unknown|15
7630955|NCT04421027|12044132|FG001|Treatment Period|Other-Unknown|9
7630956|NCT04421027|12044133|FG002|Treatment Period|Other-Unknown|0
7630957|NCT04421027|12044134|FG003|Treatment Period|Other-Unknown|0
7630958|NCT04421027|12044131|FG000|Treatment Period|Physician Decision|1
7630959|NCT04421027|12044132|FG001|Treatment Period|Physician Decision|1
7630960|NCT04421027|12044133|FG002|Treatment Period|Physician Decision|0
7630961|NCT04421027|12044134|FG003|Treatment Period|Physician Decision|0
7630962|NCT04421027|12044131|FG000|Treatment Period|Withdrawal by Subject|7
7630963|NCT04421027|12044132|FG001|Treatment Period|Withdrawal by Subject|12
7630964|NCT04421027|12044133|FG002|Treatment Period|Withdrawal by Subject|0
7630965|NCT04421027|12044134|FG003|Treatment Period|Withdrawal by Subject|0
7630966|NCT04421027|12044131|FG000|Treatment Period|Randomized Not Dosed|9
7630967|NCT04421027|12044132|FG001|Treatment Period|Randomized Not Dosed|14
7630968|NCT04421027|12044133|FG002|Treatment Period|Randomized Not Dosed|0
7630969|NCT04421027|12044134|FG003|Treatment Period|Randomized Not Dosed|0
7630970|NCT04421027|12044131|FG000|Follow-Up Period|Adverse Event|0
7630971|NCT04421027|12044132|FG001|Follow-Up Period|Adverse Event|0
7630972|NCT04421027|12044133|FG002|Follow-Up Period|Adverse Event|0
7630973|NCT04421027|12044134|FG003|Follow-Up Period|Adverse Event|3
7630974|NCT04421027|12044131|FG000|Follow-Up Period|Death|0
7630975|NCT04421027|12044132|FG001|Follow-Up Period|Death|0
7630976|NCT04421027|12044133|FG002|Follow-Up Period|Death|16
7630977|NCT04421027|12044134|FG003|Follow-Up Period|Death|17
7630978|NCT04421027|12044131|FG000|Follow-Up Period|Lost to Follow-up|0
7630979|NCT04421027|12044132|FG001|Follow-Up Period|Lost to Follow-up|0
7630980|NCT04421027|12044133|FG002|Follow-Up Period|Lost to Follow-up|7
7630981|NCT04421027|12044134|FG003|Follow-Up Period|Lost to Follow-up|7
7630982|NCT04421027|12044131|FG000|Follow-Up Period|Protocol Deviation|0
7630983|NCT04421027|12044132|FG001|Follow-Up Period|Protocol Deviation|0
7630984|NCT04421027|12044133|FG002|Follow-Up Period|Protocol Deviation|1
7630985|NCT04421027|12044134|FG003|Follow-Up Period|Protocol Deviation|0
7630986|NCT04421027|12044131|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0
7630987|NCT04421027|12044132|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0
7630988|NCT04421027|12044133|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1
7630989|NCT04421027|12044134|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0
7630990|NCT04421027|12044131|FG000|Follow-Up Period|Left message, participant did not call back|0
7630991|NCT04421027|12044132|FG001|Follow-Up Period|Left message, participant did not call back|0
7630992|NCT04421027|12044133|FG002|Follow-Up Period|Left message, participant did not call back|0
7630993|NCT04421027|12044134|FG003|Follow-Up Period|Left message, participant did not call back|1
7630994|NCT04421027|12044131|FG000|Follow-Up Period|Participant died|0
7630995|NCT04421027|12044132|FG001|Follow-Up Period|Participant died|0
7630996|NCT04421027|12044133|FG002|Follow-Up Period|Participant died|0
7630997|NCT04421027|12044134|FG003|Follow-Up Period|Participant died|1
7630998|NCT04421027|12044131|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0
7630999|NCT04421027|12044132|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0
7631000|NCT04421027|12044133|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0
7631001|NCT04421027|12044134|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1
7631002|NCT04413552|12044152|FG000|Overall Study|Adverse Event|0
7631003|NCT04413552|12044153|FG001|Overall Study|Adverse Event|0
7631004|NCT04413552|12044154|FG002|Overall Study|Adverse Event|0
7631005|NCT04413552|12044155|FG003|Overall Study|Adverse Event|0
7631006|NCT04413552|12044156|FG004|Overall Study|Adverse Event|0
7631007|NCT04413552|12044157|FG005|Overall Study|Adverse Event|0
7631008|NCT04413552|12044158|FG006|Overall Study|Adverse Event|1
7631009|NCT04413552|12044159|FG007|Overall Study|Adverse Event|0
7631010|NCT04413552|12044160|FG008|Overall Study|Adverse Event|0
7631011|NCT04413552|12044161|FG009|Overall Study|Adverse Event|0
7631012|NCT04412707|12044189|FG000|Cycle 1|Death|0
7631013|NCT04412707|12044190|FG001|Cycle 1|Death|3
7631014|NCT04412707|12044189|FG000|Cycle 1|Disease progression|1
7631015|NCT04412707|12044190|FG001|Cycle 1|Disease progression|2
7631016|NCT04412707|12044189|FG000|Cycle 2|Death|0
7631017|NCT04412707|12044190|FG001|Cycle 2|Death|1
7631018|NCT04412707|12044189|FG000|Cycle 2|Disease progression|3
7631019|NCT04412707|12044190|FG001|Cycle 2|Disease progression|0
7631020|NCT04412707|12044189|FG000|Cycle 3 to End of Study (EOS)|Death|1
7631021|NCT04412707|12044190|FG001|Cycle 3 to End of Study (EOS)|Death|3
7631022|NCT04412707|12044189|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4
7631023|NCT04412707|12044190|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2
7631024|NCT04412707|12044189|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4
7631025|NCT04412707|12044190|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2
7631026|NCT04412707|12044189|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1
7631027|NCT04412707|12044190|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0
7631028|NCT04410198|12044196|FG000|Overall Study|Death|10
7631029|NCT04410198|12044196|FG000|Overall Study|Withdrawal by Subject|7
7631030|NCT04410198|12044196|FG000|Overall Study|Transferred/Relocation|4
7631031|NCT04410198|12044196|FG000|Overall Study|Kidney Transplant|9
7631032|NCT04410198|12044196|FG000|Overall Study|Adverse Event|4
7631033|NCT04410198|12044196|FG000|Overall Study|Physician Decision|2
7631034|NCT04410198|12044196|FG000|Overall Study|Other than specified|1
7631035|NCT04404010|12044202|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1
7631036|NCT04404010|12044203|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0
7631037|NCT04401423|12044213|FG000|Overall Study|Withdrawal by Subject|3
7631038|NCT04401423|12044214|FG001|Overall Study|Withdrawal by Subject|1
7631039|NCT04401423|12044213|FG000|Overall Study|Physician Decision|2
7631040|NCT04401423|12044214|FG001|Overall Study|Physician Decision|1
7631041|NCT04398134|12044226|FG000|Overall Study|Adverse Event|0
7631042|NCT04398134|12044227|FG001|Overall Study|Adverse Event|0
7631043|NCT04398134|12044228|FG002|Overall Study|Adverse Event|1
7631044|NCT04398134|12044229|FG003|Overall Study|Adverse Event|0
7631045|NCT04398134|12044226|FG000|Overall Study|Withdrawal by Subject|2
7631046|NCT04398134|12044227|FG001|Overall Study|Withdrawal by Subject|0
7631047|NCT04398134|12044228|FG002|Overall Study|Withdrawal by Subject|0
7631048|NCT04398134|12044229|FG003|Overall Study|Withdrawal by Subject|1
7631049|NCT04398134|12044226|FG000|Overall Study|Study Terminated by Sponsor|30
7631050|NCT04398134|12044227|FG001|Overall Study|Study Terminated by Sponsor|11
7631051|NCT04398134|12044228|FG002|Overall Study|Study Terminated by Sponsor|32
7631052|NCT04398134|12044229|FG003|Overall Study|Study Terminated by Sponsor|11
7631053|NCT04398030|12044239|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0
7631054|NCT04398030|12044240|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1
7631055|NCT04398030|12044239|FG000|Treatment Period 2 (1 Week)|Physician Decision|1
7631056|NCT04398030|12044240|FG001|Treatment Period 2 (1 Week)|Physician Decision|0
7631057|NCT04390191|12044257|FG000|Overall Study|Withdrawal by Subject|1
7631058|NCT04390191|12044258|FG001|Overall Study|Withdrawal by Subject|0
7631059|NCT04389840|12044270|FG000|Overall Study|Adverse Event|0
7631060|NCT04389840|12044271|FG001|Overall Study|Adverse Event|0
7631061|NCT04389840|12044272|FG002|Overall Study|Adverse Event|0
7631062|NCT04389840|12044273|FG003|Overall Study|Adverse Event|1
7631063|NCT04389840|12044274|FG004|Overall Study|Adverse Event|0
7631064|NCT04389840|12044275|FG005|Overall Study|Adverse Event|0
7631065|NCT04389840|12044270|FG000|Overall Study|Subject request and prohibited concomitant medication|2
7631066|NCT04389840|12044271|FG001|Overall Study|Subject request and prohibited concomitant medication|0
7631067|NCT04389840|12044272|FG002|Overall Study|Subject request and prohibited concomitant medication|0
7631068|NCT04389840|12044273|FG003|Overall Study|Subject request and prohibited concomitant medication|0
7631069|NCT04389840|12044274|FG004|Overall Study|Subject request and prohibited concomitant medication|1
7631070|NCT04389840|12044275|FG005|Overall Study|Subject request and prohibited concomitant medication|0
7631071|NCT04389840|12044270|FG000|Overall Study|Death|0
7631072|NCT04389840|12044271|FG001|Overall Study|Death|1
7631073|NCT04389840|12044272|FG002|Overall Study|Death|0
7631074|NCT04389840|12044273|FG003|Overall Study|Death|0
7631075|NCT04389840|12044274|FG004|Overall Study|Death|0
7631076|NCT04389840|12044275|FG005|Overall Study|Death|0
7631077|NCT04388826|12044291|FG000|Overall Study|Lost to Follow-up|3
7631078|NCT04388826|12044292|FG001|Overall Study|Lost to Follow-up|2
7631079|NCT04388826|12044291|FG000|Overall Study|Adverse Event|1
7631080|NCT04388826|12044292|FG001|Overall Study|Adverse Event|0
7631081|NCT04382651|12044300|FG000|Overall Study|Death|26
7631082|NCT04382651|12044301|FG001|Overall Study|Death|23
7631083|NCT04382651|12044300|FG000|Overall Study|Lost to Follow-up|3
7631084|NCT04382651|12044301|FG001|Overall Study|Lost to Follow-up|4
7631085|NCT04382651|12044300|FG000|Overall Study|Withdrawal by Subject|2
7631086|NCT04382651|12044301|FG001|Overall Study|Withdrawal by Subject|0
7631087|NCT04382651|12044300|FG000|Overall Study|Physician Decision|0
7631088|NCT04382651|12044301|FG001|Overall Study|Physician Decision|1
7631089|NCT04382066|12044311|FG000|Overall Study|Adverse Event|1
7631090|NCT04382066|12044312|FG001|Overall Study|Adverse Event|0
7631091|NCT04382066|12044313|FG002|Overall Study|Adverse Event|0
7631092|NCT04382066|12044311|FG000|Overall Study|Death|1
7631093|NCT04382066|12044312|FG001|Overall Study|Death|0
7631094|NCT04382066|12044313|FG002|Overall Study|Death|1
7631095|NCT04375878|12044331|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1
7631096|NCT04375878|12044332|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1
7631097|NCT04375878|12044333|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0
7631098|NCT04375878|12044334|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0
7631099|NCT04375878|12044335|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0
7631100|NCT04375878|12044336|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0
7631101|NCT04375878|12044331|FG000|Crossover First and Second Interventions|Adverse Event|0
7631102|NCT04375878|12044332|FG001|Crossover First and Second Interventions|Adverse Event|0
7631103|NCT04375878|12044333|FG002|Crossover First and Second Interventions|Adverse Event|1
7631104|NCT04375878|12044334|FG003|Crossover First and Second Interventions|Adverse Event|0
7631105|NCT04375878|12044335|FG004|Crossover First and Second Interventions|Adverse Event|0
7631106|NCT04375878|12044336|FG005|Crossover First and Second Interventions|Adverse Event|0
7631107|NCT04375878|12044331|FG000|Extension Phase|Withdrawal by Subject|0
7631108|NCT04375878|12044332|FG001|Extension Phase|Withdrawal by Subject|0
7631109|NCT04375878|12044333|FG002|Extension Phase|Withdrawal by Subject|0
7631110|NCT04375878|12044334|FG003|Extension Phase|Withdrawal by Subject|0
7631111|NCT04375878|12044335|FG004|Extension Phase|Withdrawal by Subject|1
7631112|NCT04375878|12044336|FG005|Extension Phase|Withdrawal by Subject|0
7631113|NCT04363736|12044358|FG000|Overall Study|Withdrawal by Subject|1
7631114|NCT04363736|12044359|FG001|Overall Study|Withdrawal by Subject|0
7631115|NCT04363736|12044358|FG000|Overall Study|Lost to Follow-up|10
7631116|NCT04363736|12044359|FG001|Overall Study|Lost to Follow-up|7
7631117|NCT04363736|12044358|FG000|Overall Study|Death|8
7631118|NCT04363736|12044359|FG001|Overall Study|Death|6
7631119|NCT04353596|12044388|FG000|Overall Study|Protocol Violation|4
7631120|NCT04353596|12044389|FG001|Overall Study|Protocol Violation|4
7631121|NCT04353596|12044388|FG000|Overall Study|no evidence of recent SARS-CoV-2|1
7631122|NCT04353596|12044389|FG001|Overall Study|no evidence of recent SARS-CoV-2|3
7631123|NCT04328077|12044407|FG000|Overall Study|Lost to Follow-up|0
7631124|NCT04328077|12044408|FG001|Overall Study|Lost to Follow-up|1
7631125|NCT04328077|12044409|FG002|Overall Study|Lost to Follow-up|0
7631126|NCT04328077|12044410|FG003|Overall Study|Lost to Follow-up|0
7631127|NCT04328077|12044407|FG000|Overall Study|Withdrawal by Subject|0
7631128|NCT04328077|12044408|FG001|Overall Study|Withdrawal by Subject|1
7631129|NCT04328077|12044409|FG002|Overall Study|Withdrawal by Subject|1
7631130|NCT04328077|12044410|FG003|Overall Study|Withdrawal by Subject|3
7631131|NCT04325828|12044426|FG000|Overall Study|Ongoing|26
7631132|NCT04318093|12044432|FG000|Overall Study|Adverse Event|2
7631133|NCT04318093|12044433|FG001|Overall Study|Adverse Event|2
7631134|NCT04318093|12044432|FG000|Overall Study|Participant withdrew consent|1
7631135|NCT04318093|12044433|FG001|Overall Study|Participant withdrew consent|0
7631136|NCT04318093|12044432|FG000|Overall Study|Other reasons|0
7631137|NCT04318093|12044433|FG001|Overall Study|Other reasons|1
7631138|NCT04314284|12044442|FG000|Overall Study|Withdrawal by Subject|4
7631139|NCT04314284|12044443|FG001|Overall Study|Withdrawal by Subject|7
7631140|NCT04314284|12044442|FG000|Overall Study|Consented but did not complete survey|0
7631141|NCT04314284|12044443|FG001|Overall Study|Consented but did not complete survey|6
7631142|NCT04274686|12044477|FG000|Overall Study|Physician Decision|1
7631143|NCT04274686|12044478|FG001|Overall Study|Physician Decision|0
7631144|NCT04253236|12044486|FG000|Overall Study|Adverse Event|1
7631145|NCT04253236|12044487|FG001|Overall Study|Adverse Event|0
7631146|NCT04253236|12044486|FG000|Overall Study|Safety Concerns|1
7631147|NCT04253236|12044487|FG001|Overall Study|Safety Concerns|0
7631148|NCT04253236|12044486|FG000|Overall Study|Study Terminated by Sponsor|1
7631149|NCT04253236|12044487|FG001|Overall Study|Study Terminated by Sponsor|0
7631150|NCT04252586|12044493|FG000|Overall Study|Withdrawal by parent/guardian|3
7631151|NCT04252586|12044493|FG000|Overall Study|Adverse Event|1
7631152|NCT04252586|12044493|FG000|Overall Study|Death|2
7631153|NCT04252586|12044493|FG000|Overall Study|Study terminated by sponsor|4
7631154|NCT04252586|12044493|FG000|Overall Study|Sponsor request|10
7631155|NCT04252586|12044493|FG000|Overall Study|Did not complete treatment period|1
7631156|NCT04245709|12044502|FG000|Overall Study|Adverse Event|13
7631157|NCT04245709|12044502|FG000|Overall Study|Risk of travel during COVID19 pandemic|1
7631158|NCT04236141|12044512|FG000|Overall Study|Death|11
7631159|NCT04236141|12044513|FG001|Overall Study|Death|9
7631160|NCT04236141|12044512|FG000|Overall Study|Withdrawal by Participant|1
7631161|NCT04236141|12044513|FG001|Overall Study|Withdrawal by Participant|0
7631162|NCT04236141|12044512|FG000|Overall Study|Reason not Specified|1
7631163|NCT04236141|12044513|FG001|Overall Study|Reason not Specified|0
7631164|NCT04233580|12044521|FG000|Overall Study|Adverse Event|3
7631165|NCT04233580|12044522|FG001|Overall Study|Adverse Event|3
7631166|NCT04233580|12044521|FG000|Overall Study|Withdrawal by Subject|2
7631167|NCT04233580|12044522|FG001|Overall Study|Withdrawal by Subject|1
7631168|NCT04232943|12044531|FG000|Overall Study|Enrolled but Treatment not Administered|2
7631169|NCT04232943|12044532|FG001|Overall Study|Enrolled but Treatment not Administered|3
7631170|NCT04232943|12044533|FG002|Overall Study|Enrolled but Treatment not Administered|2
7631171|NCT04232943|12044531|FG000|Overall Study|Withdrawal by Subject|1
7631172|NCT04232943|12044532|FG001|Overall Study|Withdrawal by Subject|1
7631173|NCT04232943|12044533|FG002|Overall Study|Withdrawal by Subject|0
7631174|NCT04230876|12044544|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1
7631175|NCT04230876|12044545|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1
7631176|NCT04230213|12044551|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8
7631177|NCT04230213|12044552|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0
7631178|NCT04230213|12044553|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0
7631179|NCT04230213|12044551|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7
7631180|NCT04230213|12044552|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0
7631181|NCT04230213|12044553|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0
7631182|NCT04230213|12044551|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3
7631183|NCT04230213|12044552|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0
7631184|NCT04230213|12044553|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0
7631185|NCT04230213|12044551|FG000|TP2: Week 10 to Week 16|Other|0
7631186|NCT04230213|12044552|FG001|TP2: Week 10 to Week 16|Other|2
7631187|NCT04230213|12044553|FG002|TP2: Week 10 to Week 16|Other|1
7631188|NCT04230213|12044551|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0
7631189|NCT04230213|12044552|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0
7631190|NCT04230213|12044553|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2
7631191|NCT04230213|12044551|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0
7631192|NCT04230213|12044552|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0
7631193|NCT04230213|12044553|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1
7631194|NCT04230213|12044551|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0
7631195|NCT04230213|12044552|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0
7631196|NCT04230213|12044553|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2
7631197|NCT04230213|12044551|FG000|TP3: Week 16 to Week 22|Physician Decision|0
7631198|NCT04230213|12044552|FG001|TP3: Week 16 to Week 22|Physician Decision|0
7631199|NCT04230213|12044553|FG002|TP3: Week 16 to Week 22|Physician Decision|1
7631200|NCT04230213|12044551|FG000|TP3: Week 16 to Week 22|Other|0
7631201|NCT04230213|12044552|FG001|TP3: Week 16 to Week 22|Other|1
7631202|NCT04230213|12044553|FG002|TP3: Week 16 to Week 22|Other|3
7631203|NCT04230213|12044551|FG000|TP4: Week 22 to Week 32|Other|0
7631204|NCT04230213|12044552|FG001|TP4: Week 22 to Week 32|Other|5
7631205|NCT04230213|12044553|FG002|TP4: Week 22 to Week 32|Other|5
7631206|NCT04230213|12044551|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0
7631207|NCT04230213|12044552|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1
7631208|NCT04230213|12044553|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2
7631209|NCT04230213|12044551|FG000|TP4: Week 22 to Week 32|Physician Decision|0
7631210|NCT04230213|12044552|FG001|TP4: Week 22 to Week 32|Physician Decision|2
7631211|NCT04230213|12044553|FG002|TP4: Week 22 to Week 32|Physician Decision|1
7631212|NCT04230213|12044551|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0
7631213|NCT04230213|12044552|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0
7631214|NCT04230213|12044553|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1
7631215|NCT04230213|12044551|FG000|Follow up: Week 32 to Week 36|Other|0
7631216|NCT04230213|12044552|FG001|Follow up: Week 32 to Week 36|Other|1
7631217|NCT04230213|12044553|FG002|Follow up: Week 32 to Week 36|Other|1
7631218|NCT04223791|12044563|FG000|Overall Study|Lost to Follow-up|0
7631219|NCT04223791|12044564|FG001|Overall Study|Lost to Follow-up|4
7631220|NCT04223791|12044563|FG000|Overall Study|Physician Decision|5
7631221|NCT04223791|12044564|FG001|Overall Study|Physician Decision|1
7631222|NCT04223791|12044563|FG000|Overall Study|Protocol Violation|1
7631223|NCT04223791|12044564|FG001|Overall Study|Protocol Violation|1
7631224|NCT04223791|12044563|FG000|Overall Study|Withdrawal by Subject|10
7631225|NCT04223791|12044564|FG001|Overall Study|Withdrawal by Subject|12
7631226|NCT04223791|12044563|FG000|Overall Study|Pregnancy|1
7631227|NCT04223791|12044564|FG001|Overall Study|Pregnancy|1
7631228|NCT04223791|12044563|FG000|Overall Study|Ongoing in Study|305
7631229|NCT04223791|12044564|FG001|Overall Study|Ongoing in Study|302
7631230|NCT04223778|12044572|FG000|Overall Study|Ongoing|322
7631231|NCT04223778|12044573|FG001|Overall Study|Ongoing|326
7631232|NCT04223778|12044572|FG000|Overall Study|Death|0
7631233|NCT04223778|12044573|FG001|Overall Study|Death|1
7631234|NCT04223778|12044572|FG000|Overall Study|Lost to Follow-up|1
7631235|NCT04223778|12044573|FG001|Overall Study|Lost to Follow-up|5
7631236|NCT04223778|12044572|FG000|Overall Study|Physician Decision|3
7631237|NCT04223778|12044573|FG001|Overall Study|Physician Decision|1
7631238|NCT04223778|12044572|FG000|Overall Study|Withdrawal by Subject|10
7631239|NCT04223778|12044573|FG001|Overall Study|Withdrawal by Subject|1
7631240|NCT04223778|12044572|FG000|Overall Study|Lack of Efficacy|0
7631241|NCT04223778|12044573|FG001|Overall Study|Lack of Efficacy|2
7631242|NCT04218695|12044581|FG000|Overall Study|Adverse Event|1
7631243|NCT04218695|12044582|FG001|Overall Study|Adverse Event|0
7631244|NCT04213989|12044590|FG000|Overall Study|Withdrawal by Subject|3
7631245|NCT04213989|12044591|FG001|Overall Study|Withdrawal by Subject|2
7631246|NCT04213989|12044590|FG000|Overall Study|Physician Decision|1
7631247|NCT04213989|12044591|FG001|Overall Study|Physician Decision|0
7631248|NCT04213989|12044590|FG000|Overall Study|Lost to Follow-up|0
7631249|NCT04213989|12044591|FG001|Overall Study|Lost to Follow-up|4
7631250|NCT04206085|12044611|FG000|Overall Study|Lost to Follow-up|0
7631251|NCT04206085|12044612|FG001|Overall Study|Lost to Follow-up|1
7631252|NCT04206085|12044613|FG002|Overall Study|Lost to Follow-up|0
7631253|NCT04206085|12044611|FG000|Overall Study|Lost to Follow-up|0
7631254|NCT04206085|12044612|FG001|Overall Study|Lost to Follow-up|0
7631255|NCT04206085|12044613|FG002|Overall Study|Lost to Follow-up|1
7631256|NCT04202679|12044623|FG000|Overall Study|Adverse Event|2
7631257|NCT04202679|12044624|FG001|Overall Study|Adverse Event|0
7631258|NCT04202679|12044623|FG000|Overall Study|Lack of Efficacy|11
7631259|NCT04202679|12044624|FG001|Overall Study|Lack of Efficacy|1
7631260|NCT04202679|12044623|FG000|Overall Study|Poor compliance to protocol|2
7631261|NCT04202679|12044624|FG001|Overall Study|Poor compliance to protocol|0
7631262|NCT04202679|12044623|FG000|Overall Study|Withdrawal by Subject|10
7631263|NCT04202679|12044624|FG001|Overall Study|Withdrawal by Subject|1
7631264|NCT04202679|12044623|FG000|Overall Study|Randomized and not exposed|0
7631265|NCT04202679|12044624|FG001|Overall Study|Randomized and not exposed|1
7631266|NCT04189952|12044631|FG000|Follow-up Period|Death|1
7631267|NCT04189952|12044631|FG000|Follow-up Period|Withdrawal by Subject|1
7631268|NCT04182880|12044641|FG000|Overall Study|Pregnancy|1
7631269|NCT04182880|12044642|FG001|Overall Study|Pregnancy|0
7631270|NCT04178967|12044667|FG000|Overall Study|Adverse Event|4
7631271|NCT04178967|12044668|FG001|Overall Study|Adverse Event|6
7631272|NCT04178967|12044667|FG000|Overall Study|Due to Epidemic/Pandemic|0
7631273|NCT04178967|12044668|FG001|Overall Study|Due to Epidemic/Pandemic|1
7631274|NCT04178967|12044667|FG000|Overall Study|Lack of Efficacy|3
7631275|NCT04178967|12044668|FG001|Overall Study|Lack of Efficacy|1
7631276|NCT04178967|12044667|FG000|Overall Study|Protocol Violation|0
7631277|NCT04178967|12044668|FG001|Overall Study|Protocol Violation|7
7631278|NCT04178967|12044667|FG000|Overall Study|Withdrawal by Subject|8
7631279|NCT04178967|12044668|FG001|Overall Study|Withdrawal by Subject|7
7631280|NCT04178967|12044667|FG000|Overall Study|Lost to Follow-up|2
7631281|NCT04178967|12044668|FG001|Overall Study|Lost to Follow-up|0
7631282|NCT04175392|12044680|FG000|Overall Study|Withdrawal by Subject|3
7631283|NCT04175392|12044681|FG001|Overall Study|Withdrawal by Subject|2
7631284|NCT04173572|12044689|FG000|Overall Study|Withdrawal by Subject|1
7631285|NCT04173572|12044690|FG001|Overall Study|Withdrawal by Subject|5
7631286|NCT04173572|12044689|FG000|Overall Study|Lost to Follow-up|3
7631287|NCT04173572|12044690|FG001|Overall Study|Lost to Follow-up|1
7631288|NCT04172831|12044698|FG000|Overall Study|Adverse Event|21
7631289|NCT04172831|12044699|FG001|Overall Study|Adverse Event|9
7631290|NCT04172831|12044698|FG000|Overall Study|Lack of Efficacy|2
7631291|NCT04172831|12044699|FG001|Overall Study|Lack of Efficacy|8
7631292|NCT04172831|12044698|FG000|Overall Study|Physician Decision|0
7631293|NCT04172831|12044699|FG001|Overall Study|Physician Decision|1
7631294|NCT04172831|12044698|FG000|Overall Study|Withdrawal by Subject|12
7631295|NCT04172831|12044699|FG001|Overall Study|Withdrawal by Subject|11
7631296|NCT04172831|12044698|FG000|Overall Study|Lost to Follow-up|4
7631297|NCT04172831|12044699|FG001|Overall Study|Lost to Follow-up|9
7631298|NCT04172831|12044698|FG000|Overall Study|COVID-19 related crisis|3
7631299|NCT04172831|12044699|FG001|Overall Study|COVID-19 related crisis|3
7631300|NCT04172831|12044698|FG000|Overall Study|Subject non-compliance|1
7631301|NCT04172831|12044699|FG001|Overall Study|Subject non-compliance|1
7631302|NCT04172831|12044698|FG000|Overall Study|Family emergency|1
7631303|NCT04172831|12044699|FG001|Overall Study|Family emergency|0
7631304|NCT04169373|12044709|FG000|Overall Study|Adverse Event|1
7631305|NCT04169373|12044710|FG001|Overall Study|Adverse Event|0
7631306|NCT04169373|12044711|FG002|Overall Study|Adverse Event|1
7631307|NCT04169373|12044712|FG003|Overall Study|Adverse Event|2
7631308|NCT04169373|12044709|FG000|Overall Study|Withdrawal by Subject|2
7631309|NCT04169373|12044710|FG001|Overall Study|Withdrawal by Subject|0
7631310|NCT04169373|12044711|FG002|Overall Study|Withdrawal by Subject|5
7631311|NCT04169373|12044712|FG003|Overall Study|Withdrawal by Subject|6
7631312|NCT04169373|12044709|FG000|Overall Study|Lost to Follow-up|1
7631313|NCT04169373|12044710|FG001|Overall Study|Lost to Follow-up|1
7631314|NCT04169373|12044711|FG002|Overall Study|Lost to Follow-up|0
7631315|NCT04169373|12044712|FG003|Overall Study|Lost to Follow-up|1
7631316|NCT04169373|12044709|FG000|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0
7631317|NCT04169373|12044710|FG001|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1
7631318|NCT04169373|12044711|FG002|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0
7631319|NCT04169373|12044712|FG003|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0
7631320|NCT04169373|12044709|FG000|Overall Study|Other|1
7631321|NCT04169373|12044710|FG001|Overall Study|Other|3
7631322|NCT04169373|12044711|FG002|Overall Study|Other|3
7631323|NCT04169373|12044712|FG003|Overall Study|Other|5
7631324|NCT04168190|12044731|FG000|Overall Study|Lost to Follow-up|0
7631325|NCT04168190|12044732|FG001|Overall Study|Lost to Follow-up|1
7631326|NCT04168190|12044733|FG002|Overall Study|Lost to Follow-up|0
7631327|NCT04168190|12044734|FG003|Overall Study|Lost to Follow-up|7
7631328|NCT04168190|12044735|FG004|Overall Study|Lost to Follow-up|5
7631329|NCT04168190|12044731|FG000|Overall Study|Withdrawal by Subject|1
7631330|NCT04168190|12044732|FG001|Overall Study|Withdrawal by Subject|0
7631331|NCT04168190|12044733|FG002|Overall Study|Withdrawal by Subject|0
7631332|NCT04168190|12044734|FG003|Overall Study|Withdrawal by Subject|2
7631333|NCT04168190|12044735|FG004|Overall Study|Withdrawal by Subject|4
7631334|NCT04168190|12044731|FG000|Overall Study|Death|0
7631335|NCT04168190|12044732|FG001|Overall Study|Death|0
7631336|NCT04168190|12044733|FG002|Overall Study|Death|0
7631337|NCT04168190|12044734|FG003|Overall Study|Death|1
7631338|NCT04168190|12044735|FG004|Overall Study|Death|0
7631339|NCT04166630|12044749|FG000|Overall Study|Withdrawal by Subject|0
7631340|NCT04166630|12044750|FG001|Overall Study|Withdrawal by Subject|1
7631341|NCT04165824|12044756|FG000|Overall Study|Adverse Event|23
7631342|NCT04165824|12044756|FG000|Overall Study|Physician Decision|1
7631343|NCT04165824|12044756|FG000|Overall Study|Withdrawal by Subject|17
7631344|NCT04165824|12044756|FG000|Overall Study|Other|5
7631345|NCT04161131|12044760|FG000|Overall Study|Ineligible|2
7631346|NCT04161131|12044760|FG000|Overall Study|Lost to Follow-up|4
7631347|NCT04154293|12044771|FG000|Overall Study|Withdrawal by Subject|2
7631348|NCT04154293|12044772|FG001|Overall Study|Withdrawal by Subject|3
7631349|NCT04154293|12044773|FG002|Overall Study|Withdrawal by Subject|1
7631350|NCT04154293|12044771|FG000|Overall Study|Physician Decision|0
7631351|NCT04154293|12044772|FG001|Overall Study|Physician Decision|0
7631352|NCT04154293|12044773|FG002|Overall Study|Physician Decision|1
7631353|NCT04152200|12044783|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6
7631354|NCT04152200|12044784|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15
7631355|NCT04146363|12044794|FG000|Overall Study|Adverse Event|1
7631356|NCT04146363|12044795|FG001|Overall Study|Adverse Event|2
7631357|NCT04146363|12044794|FG000|Overall Study|Due to Epidemic/Pandemic|1
7631358|NCT04146363|12044795|FG001|Overall Study|Due to Epidemic/Pandemic|1
7631359|NCT04146363|12044794|FG000|Overall Study|Lack of Efficacy|6
7631360|NCT04146363|12044795|FG001|Overall Study|Lack of Efficacy|2
7631361|NCT04146363|12044794|FG000|Overall Study|Lost to Follow-up|1
7631362|NCT04146363|12044795|FG001|Overall Study|Lost to Follow-up|4
7631363|NCT04146363|12044794|FG000|Overall Study|Positive quantiferon test|0
7631364|NCT04146363|12044795|FG001|Overall Study|Positive quantiferon test|1
7631365|NCT04146363|12044794|FG000|Overall Study|Protocol Deviation|5
7631366|NCT04146363|12044795|FG001|Overall Study|Protocol Deviation|6
7631367|NCT04146363|12044794|FG000|Overall Study|Withdrawal by Subject|6
7631368|NCT04146363|12044795|FG001|Overall Study|Withdrawal by Subject|4
7631369|NCT04146363|12044794|FG000|Overall Study|Started systemic dexamethasone|1
7631370|NCT04146363|12044795|FG001|Overall Study|Started systemic dexamethasone|0
7631371|NCT04130919|12044822|FG000|Blinded Treatment Phase|Study terminated by sponsor|1
7631372|NCT04130919|12044823|FG001|Blinded Treatment Phase|Study terminated by sponsor|1
7631373|NCT04130919|12044824|FG002|Blinded Treatment Phase|Study terminated by sponsor|1
7631374|NCT04130919|12044825|FG003|Blinded Treatment Phase|Study terminated by sponsor|0
7631375|NCT04130919|12044826|FG004|Blinded Treatment Phase|Study terminated by sponsor|0
7631376|NCT04130919|12044827|FG005|Blinded Treatment Phase|Study terminated by sponsor|0
7631377|NCT04130919|12044822|FG000|Blinded Treatment Phase|Adverse Event|0
7631378|NCT04130919|12044823|FG001|Blinded Treatment Phase|Adverse Event|0
7631379|NCT04130919|12044824|FG002|Blinded Treatment Phase|Adverse Event|1
7631380|NCT04130919|12044825|FG003|Blinded Treatment Phase|Adverse Event|0
7631381|NCT04130919|12044826|FG004|Blinded Treatment Phase|Adverse Event|0
7631382|NCT04130919|12044827|FG005|Blinded Treatment Phase|Adverse Event|0
7631383|NCT04130919|12044822|FG000|Blinded Treatment Phase|Disease worsening|0
7631384|NCT04130919|12044823|FG001|Blinded Treatment Phase|Disease worsening|0
7631385|NCT04130919|12044824|FG002|Blinded Treatment Phase|Disease worsening|1
7631386|NCT04130919|12044825|FG003|Blinded Treatment Phase|Disease worsening|0
7631387|NCT04130919|12044826|FG004|Blinded Treatment Phase|Disease worsening|0
7631388|NCT04130919|12044827|FG005|Blinded Treatment Phase|Disease worsening|0
7631389|NCT04130919|12044822|FG000|Blinded Treatment Phase|Investigator's decision|0
7631390|NCT04130919|12044823|FG001|Blinded Treatment Phase|Investigator's decision|1
7631391|NCT04130919|12044824|FG002|Blinded Treatment Phase|Investigator's decision|0
7631392|NCT04130919|12044825|FG003|Blinded Treatment Phase|Investigator's decision|0
7631393|NCT04130919|12044826|FG004|Blinded Treatment Phase|Investigator's decision|0
7631394|NCT04130919|12044827|FG005|Blinded Treatment Phase|Investigator's decision|0
7631395|NCT04130919|12044822|FG000|Blinded Treatment Phase|Withdrew consent|1
7631396|NCT04130919|12044823|FG001|Blinded Treatment Phase|Withdrew consent|0
7631397|NCT04130919|12044824|FG002|Blinded Treatment Phase|Withdrew consent|0
7631398|NCT04130919|12044825|FG003|Blinded Treatment Phase|Withdrew consent|0
7631399|NCT04130919|12044826|FG004|Blinded Treatment Phase|Withdrew consent|0
7631400|NCT04130919|12044827|FG005|Blinded Treatment Phase|Withdrew consent|0
7631401|NCT04130919|12044822|FG000|Open-label Treatment Phase|Withdrew consent|0
7631402|NCT04130919|12044823|FG001|Open-label Treatment Phase|Withdrew consent|0
7631403|NCT04130919|12044824|FG002|Open-label Treatment Phase|Withdrew consent|0
7631404|NCT04130919|12044825|FG003|Open-label Treatment Phase|Withdrew consent|1
7631405|NCT04130919|12044826|FG004|Open-label Treatment Phase|Withdrew consent|1
7631406|NCT04130919|12044827|FG005|Open-label Treatment Phase|Withdrew consent|1
7631407|NCT04130919|12044822|FG000|Open-label Treatment Phase|Disease worsening|0
7631408|NCT04130919|12044823|FG001|Open-label Treatment Phase|Disease worsening|0
7631409|NCT04130919|12044824|FG002|Open-label Treatment Phase|Disease worsening|0
7631410|NCT04130919|12044825|FG003|Open-label Treatment Phase|Disease worsening|1
7631411|NCT04130919|12044826|FG004|Open-label Treatment Phase|Disease worsening|0
7631412|NCT04130919|12044827|FG005|Open-label Treatment Phase|Disease worsening|1
7631413|NCT04130919|12044822|FG000|Open-label Treatment Phase|Investigator's decision|0
7631414|NCT04130919|12044823|FG001|Open-label Treatment Phase|Investigator's decision|0
7631415|NCT04130919|12044824|FG002|Open-label Treatment Phase|Investigator's decision|0
7631416|NCT04130919|12044825|FG003|Open-label Treatment Phase|Investigator's decision|1
7631417|NCT04130919|12044826|FG004|Open-label Treatment Phase|Investigator's decision|0
7631418|NCT04130919|12044827|FG005|Open-label Treatment Phase|Investigator's decision|0
7631419|NCT04130919|12044822|FG000|Open-label Treatment Phase|Lost to Follow-up|0
7631420|NCT04130919|12044823|FG001|Open-label Treatment Phase|Lost to Follow-up|0
7631421|NCT04130919|12044824|FG002|Open-label Treatment Phase|Lost to Follow-up|0
7631422|NCT04130919|12044825|FG003|Open-label Treatment Phase|Lost to Follow-up|0
7631423|NCT04130919|12044826|FG004|Open-label Treatment Phase|Lost to Follow-up|0
7631424|NCT04130919|12044827|FG005|Open-label Treatment Phase|Lost to Follow-up|1
7631425|NCT04130919|12044822|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0
7631426|NCT04130919|12044823|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0
7631427|NCT04130919|12044824|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0
7631428|NCT04130919|12044825|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0
7631429|NCT04130919|12044826|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1
7631430|NCT04130919|12044827|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0
7631431|NCT04128696|12044843|FG000|Overall Study|Lost to Follow-up|0
7631432|NCT04128696|12044844|FG001|Overall Study|Lost to Follow-up|1
7631433|NCT04128696|12044843|FG000|Overall Study|Withdrawal by Subject|8
7631434|NCT04128696|12044844|FG001|Overall Study|Withdrawal by Subject|5
7631435|NCT04128696|12044843|FG000|Overall Study|In Follow-up|47
7631436|NCT04128696|12044844|FG001|Overall Study|In Follow-up|51
7631437|NCT04128696|12044843|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|52
7631438|NCT04128696|12044844|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|62
7631439|NCT04128267|12044850|FG000|Overall Study|Withdrawal by Subject|6
7631440|NCT04128267|12044850|FG000|Overall Study|Death|2
7631441|NCT04128267|12044850|FG000|Overall Study|Disease progression|1
7631442|NCT04128267|12044850|FG000|Overall Study|Participant had other medical issues|4
7631443|NCT04128267|12044850|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2
7631444|NCT04124926|12044856|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3
7631445|NCT04124926|12044857|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7
7631446|NCT04124926|12044858|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0
7631447|NCT04124926|12044859|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0
7631448|NCT04124926|12044860|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0
7631449|NCT04124926|12044856|FG000|Healing Phase|Protocol Violation|0
7631450|NCT04124926|12044857|FG001|Healing Phase|Protocol Violation|1
7631451|NCT04124926|12044858|FG002|Healing Phase|Protocol Violation|0
7631452|NCT04124926|12044859|FG003|Healing Phase|Protocol Violation|0
7631453|NCT04124926|12044860|FG004|Healing Phase|Protocol Violation|0
7631454|NCT04124926|12044856|FG000|Healing Phase|Lost to Follow-up|5
7631455|NCT04124926|12044857|FG001|Healing Phase|Lost to Follow-up|4
7631456|NCT04124926|12044858|FG002|Healing Phase|Lost to Follow-up|0
7631457|NCT04124926|12044859|FG003|Healing Phase|Lost to Follow-up|0
7631458|NCT04124926|12044860|FG004|Healing Phase|Lost to Follow-up|0
7631459|NCT04124926|12044856|FG000|Healing Phase|Voluntary Withdrawal|10
7631460|NCT04124926|12044857|FG001|Healing Phase|Voluntary Withdrawal|7
7631461|NCT04124926|12044858|FG002|Healing Phase|Voluntary Withdrawal|0
7631462|NCT04124926|12044859|FG003|Healing Phase|Voluntary Withdrawal|0
7631463|NCT04124926|12044860|FG004|Healing Phase|Voluntary Withdrawal|0
7631464|NCT04124926|12044856|FG000|Healing Phase|Withdrawal of Consent|5
7631465|NCT04124926|12044857|FG001|Healing Phase|Withdrawal of Consent|3
7631466|NCT04124926|12044858|FG002|Healing Phase|Withdrawal of Consent|0
7631467|NCT04124926|12044859|FG003|Healing Phase|Withdrawal of Consent|0
7631468|NCT04124926|12044860|FG004|Healing Phase|Withdrawal of Consent|0
7631469|NCT04124926|12044856|FG000|Healing Phase|Miscellaneous|8
7631470|NCT04124926|12044857|FG001|Healing Phase|Miscellaneous|7
7631471|NCT04124926|12044858|FG002|Healing Phase|Miscellaneous|0
7631472|NCT04124926|12044859|FG003|Healing Phase|Miscellaneous|0
7631473|NCT04124926|12044860|FG004|Healing Phase|Miscellaneous|0
7631474|NCT04124926|12044856|FG000|Healing Phase|Randomized but not Treated|0
7631475|NCT04124926|12044857|FG001|Healing Phase|Randomized but not Treated|3
7631476|NCT04124926|12044858|FG002|Healing Phase|Randomized but not Treated|0
7631477|NCT04124926|12044859|FG003|Healing Phase|Randomized but not Treated|0
7631478|NCT04124926|12044860|FG004|Healing Phase|Randomized but not Treated|0
7631479|NCT04124926|12044856|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0
7631480|NCT04124926|12044857|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0
7631481|NCT04124926|12044858|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3
7631482|NCT04124926|12044859|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5
7631483|NCT04124926|12044860|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4
7631484|NCT04124926|12044856|FG000|Maintenance Phase|Protocol Violation|0
7631485|NCT04124926|12044857|FG001|Maintenance Phase|Protocol Violation|0
7631486|NCT04124926|12044858|FG002|Maintenance Phase|Protocol Violation|3
7631487|NCT04124926|12044859|FG003|Maintenance Phase|Protocol Violation|0
7631488|NCT04124926|12044860|FG004|Maintenance Phase|Protocol Violation|0
7631489|NCT04124926|12044856|FG000|Maintenance Phase|Lost to Follow-up|0
7631490|NCT04124926|12044857|FG001|Maintenance Phase|Lost to Follow-up|0
7631491|NCT04124926|12044858|FG002|Maintenance Phase|Lost to Follow-up|7
7631492|NCT04124926|12044859|FG003|Maintenance Phase|Lost to Follow-up|8
7631493|NCT04124926|12044860|FG004|Maintenance Phase|Lost to Follow-up|9
7631494|NCT04124926|12044856|FG000|Maintenance Phase|Voluntary Withdrawal|0
7631495|NCT04124926|12044857|FG001|Maintenance Phase|Voluntary Withdrawal|0
7631496|NCT04124926|12044858|FG002|Maintenance Phase|Voluntary Withdrawal|3
7631497|NCT04124926|12044859|FG003|Maintenance Phase|Voluntary Withdrawal|6
7631498|NCT04124926|12044860|FG004|Maintenance Phase|Voluntary Withdrawal|5
7631499|NCT04124926|12044856|FG000|Maintenance Phase|Pregnancy|0
7631500|NCT04124926|12044857|FG001|Maintenance Phase|Pregnancy|0
7631501|NCT04124926|12044858|FG002|Maintenance Phase|Pregnancy|0
7631502|NCT04124926|12044859|FG003|Maintenance Phase|Pregnancy|1
7631503|NCT04124926|12044860|FG004|Maintenance Phase|Pregnancy|0
7631504|NCT04124926|12044856|FG000|Maintenance Phase|Lack of Efficacy|0
7631505|NCT04124926|12044857|FG001|Maintenance Phase|Lack of Efficacy|0
7631506|NCT04124926|12044858|FG002|Maintenance Phase|Lack of Efficacy|0
7631507|NCT04124926|12044859|FG003|Maintenance Phase|Lack of Efficacy|0
7631508|NCT04124926|12044860|FG004|Maintenance Phase|Lack of Efficacy|1
7631509|NCT04124926|12044856|FG000|Maintenance Phase|Withdrawal of Consent|0
7631510|NCT04124926|12044857|FG001|Maintenance Phase|Withdrawal of Consent|0
7631511|NCT04124926|12044858|FG002|Maintenance Phase|Withdrawal of Consent|5
7631512|NCT04124926|12044859|FG003|Maintenance Phase|Withdrawal of Consent|5
7631513|NCT04124926|12044860|FG004|Maintenance Phase|Withdrawal of Consent|5
7631514|NCT04124926|12044856|FG000|Maintenance Phase|Miscellaneous|0
7631515|NCT04124926|12044857|FG001|Maintenance Phase|Miscellaneous|0
7631516|NCT04124926|12044858|FG002|Maintenance Phase|Miscellaneous|1
7631517|NCT04124926|12044859|FG003|Maintenance Phase|Miscellaneous|2
7631518|NCT04124926|12044860|FG004|Maintenance Phase|Miscellaneous|4
7631519|NCT04124926|12044856|FG000|Maintenance Phase|Randomized but not Treated|0
7631520|NCT04124926|12044857|FG001|Maintenance Phase|Randomized but not Treated|0
7631521|NCT04124926|12044858|FG002|Maintenance Phase|Randomized but not Treated|2
7631522|NCT04124926|12044859|FG003|Maintenance Phase|Randomized but not Treated|2
7631523|NCT04124926|12044860|FG004|Maintenance Phase|Randomized but not Treated|0
7631524|NCT04123067|12044874|FG000|Overall Study|Lost to Follow-up|0
7631525|NCT04123067|12044875|FG001|Overall Study|Lost to Follow-up|1
7631526|NCT04093414|12044887|FG000|3 Month Follow up|Physician Decision|0
7631527|NCT04093414|12044888|FG001|3 Month Follow up|Physician Decision|1
7631528|NCT04093414|12044887|FG000|6month Follow up|Physician Decision|1
7631529|NCT04093414|12044888|FG001|6month Follow up|Physician Decision|3
7631530|NCT04091360|12044900|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631531|NCT04091360|12044901|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631532|NCT04091360|12044902|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631533|NCT04091360|12044903|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631534|NCT04091360|12044904|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631535|NCT04091360|12044905|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631536|NCT04091360|12044906|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631537|NCT04091360|12044907|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631538|NCT04091360|12044908|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1
7631539|NCT04091360|12044909|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1
7631540|NCT04091360|12044900|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631541|NCT04091360|12044901|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631542|NCT04091360|12044902|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631543|NCT04091360|12044903|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631544|NCT04091360|12044904|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631545|NCT04091360|12044905|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631546|NCT04091360|12044906|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1
7631547|NCT04091360|12044907|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1
7631548|NCT04091360|12044908|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631549|NCT04091360|12044909|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631550|NCT04091360|12044900|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631551|NCT04091360|12044901|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631552|NCT04091360|12044902|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631553|NCT04091360|12044903|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631554|NCT04091360|12044904|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631555|NCT04091360|12044905|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631556|NCT04091360|12044906|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1
7631557|NCT04091360|12044907|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631558|NCT04091360|12044908|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631559|NCT04091360|12044909|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1
7631560|NCT04089553|12044933|FG000|Overall Study|Death|12
7631561|NCT04089553|12044934|FG001|Overall Study|Death|11
7631562|NCT04089553|12044933|FG000|Overall Study|Lost to Follow-up|2
7631563|NCT04089553|12044934|FG001|Overall Study|Lost to Follow-up|2
7631564|NCT04089553|12044933|FG000|Overall Study|Progressive disease|0
7631565|NCT04089553|12044934|FG001|Overall Study|Progressive disease|1
7631566|NCT04089553|12044933|FG000|Overall Study|Withdrawal by Subject|5
7631567|NCT04089553|12044934|FG001|Overall Study|Withdrawal by Subject|2
7631568|NCT04089553|12044933|FG000|Overall Study|Other|6
7631569|NCT04089553|12044934|FG001|Overall Study|Other|2
7631570|NCT04086472|12044946|FG000|Overall Study|Lost to Follow-up|1
7631571|NCT04086472|12044947|FG001|Overall Study|Lost to Follow-up|0
7631572|NCT04086472|12044948|FG002|Overall Study|Lost to Follow-up|0
7631573|NCT04086472|12044949|FG003|Overall Study|Lost to Follow-up|0
7631574|NCT04086472|12044950|FG004|Overall Study|Lost to Follow-up|1
7631575|NCT04086472|12044946|FG000|Overall Study|Physician Decision|0
7631576|NCT04086472|12044947|FG001|Overall Study|Physician Decision|1
7631577|NCT04086472|12044948|FG002|Overall Study|Physician Decision|1
7631578|NCT04086472|12044949|FG003|Overall Study|Physician Decision|0
7631579|NCT04086472|12044950|FG004|Overall Study|Physician Decision|0
7631580|NCT04086472|12044946|FG000|Overall Study|Withdrawal by Subject|1
7631581|NCT04086472|12044947|FG001|Overall Study|Withdrawal by Subject|1
7631582|NCT04086472|12044948|FG002|Overall Study|Withdrawal by Subject|1
7631583|NCT04086472|12044949|FG003|Overall Study|Withdrawal by Subject|0
7631584|NCT04086472|12044950|FG004|Overall Study|Withdrawal by Subject|0
7631585|NCT04086472|12044946|FG000|Overall Study|Various reasons|2
7631586|NCT04086472|12044947|FG001|Overall Study|Various reasons|0
7631587|NCT04086472|12044948|FG002|Overall Study|Various reasons|0
7631588|NCT04086472|12044949|FG003|Overall Study|Various reasons|3
7631589|NCT04086472|12044950|FG004|Overall Study|Various reasons|1
7631590|NCT04075604|12044989|FG000|Overall Study|Adverse Event|0
7631591|NCT04075604|12044990|FG001|Overall Study|Adverse Event|0
7631592|NCT04075604|12044991|FG002|Overall Study|Adverse Event|3
7631593|NCT04075604|12044989|FG000|Overall Study|Participant request to discontinue study treatment|0
7631594|NCT04075604|12044990|FG001|Overall Study|Participant request to discontinue study treatment|0
7631595|NCT04075604|12044991|FG002|Overall Study|Participant request to discontinue study treatment|1
7631596|NCT04075604|12044989|FG000|Overall Study|Participant withdrew consent|0
7631597|NCT04075604|12044990|FG001|Overall Study|Participant withdrew consent|0
7631598|NCT04075604|12044991|FG002|Overall Study|Participant withdrew consent|1
7631599|NCT04075604|12044989|FG000|Overall Study|Other reasons|1
7631600|NCT04075604|12044990|FG001|Overall Study|Other reasons|0
7631601|NCT04075604|12044991|FG002|Overall Study|Other reasons|0
7631602|NCT04075604|12044989|FG000|Overall Study|Disease progression|0
7631603|NCT04075604|12044990|FG001|Overall Study|Disease progression|1
7631604|NCT04075604|12044991|FG002|Overall Study|Disease progression|0
7631605|NCT04075604|12044989|FG000|Overall Study|Study drug toxicity|0
7631606|NCT04075604|12044990|FG001|Overall Study|Study drug toxicity|5
7631607|NCT04075604|12044991|FG002|Overall Study|Study drug toxicity|1
7631608|NCT04073186|12044999|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1
7631609|NCT04073186|12044999|FG000|First Wearing Cycle|Withdrawal by Subject|1
7631610|NCT04073186|12044999|FG000|First Wearing Cycle|Protocol Violation|1
7631611|NCT04073186|12044999|FG000|First Wearing Cycle|Lens Discomfort|2
7631612|NCT04073186|12044999|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1
7631613|NCT04073186|12044999|FG000|Second Wearing Cycle|Adverse Event|1
7631614|NCT04068181|12045034|FG000|Overall Study|Withdrawal by Subject|2
7631615|NCT04068181|12045035|FG001|Overall Study|Withdrawal by Subject|0
7631616|NCT04068181|12045036|FG002|Overall Study|Withdrawal by Subject|0
7631617|NCT04068181|12045037|FG003|Overall Study|Withdrawal by Subject|0
7631618|NCT04068181|12045034|FG000|Overall Study|Lost to Follow-up|1
7631619|NCT04068181|12045035|FG001|Overall Study|Lost to Follow-up|0
7631620|NCT04068181|12045036|FG002|Overall Study|Lost to Follow-up|0
7631621|NCT04068181|12045037|FG003|Overall Study|Lost to Follow-up|0
7631622|NCT04068181|12045034|FG000|Overall Study|Death|8
7631623|NCT04068181|12045035|FG001|Overall Study|Death|8
7631624|NCT04068181|12045036|FG002|Overall Study|Death|4
7631625|NCT04068181|12045037|FG003|Overall Study|Death|2
7631626|NCT04068181|12045034|FG000|Overall Study|Continuing Study|16
7631627|NCT04068181|12045035|FG001|Overall Study|Continuing Study|7
7631628|NCT04068181|12045036|FG002|Overall Study|Continuing Study|11
7631629|NCT04068181|12045037|FG003|Overall Study|Continuing Study|13
7631630|NCT04067518|12045049|FG000|Overall Study|Screen Failures|0
7631631|NCT04067518|12045050|FG001|Overall Study|Screen Failures|1
7631632|NCT04067518|12045049|FG000|Overall Study|Enrolled but not Treated|0
7631633|NCT04067518|12045050|FG001|Overall Study|Enrolled but not Treated|1
7631634|NCT04067518|12045049|FG000|Overall Study|Adverse Events|0
7631635|NCT04067518|12045050|FG001|Overall Study|Adverse Events|2
7631636|NCT04067518|12045049|FG000|Overall Study|Ongoing|3
7631637|NCT04067518|12045050|FG001|Overall Study|Ongoing|21
7631638|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Adverse Event|2
7631639|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Adverse Event|0
7631640|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Adverse Event|0
7631641|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Adverse Event|0
7631642|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Lack of Efficacy|0
7631643|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Lack of Efficacy|1
7631644|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Lack of Efficacy|0
7631645|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Lack of Efficacy|0
7631646|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Lost to Follow-up|11
7631647|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Lost to Follow-up|6
7631648|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Lost to Follow-up|0
7631649|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Lost to Follow-up|0
7631650|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Physician Decision|1
7631651|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Physician Decision|0
7631652|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Physician Decision|0
7631653|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Physician Decision|0
7631654|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Pregnancy|1
7631655|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Pregnancy|0
7631656|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Pregnancy|0
7631657|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Pregnancy|0
7631658|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10
7631659|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8
7631660|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0
7631661|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0
7631662|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3
7631663|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1
7631664|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0
7631665|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0
7631666|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1
7631667|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0
7631668|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0
7631669|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0
7631670|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0
7631671|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1
7631672|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0
7631673|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0
7631674|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Not Treated|1
7631675|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Not Treated|0
7631676|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Not Treated|0
7631677|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Not Treated|0
7631678|NCT04057573|12045079|FG000|28-Week Treatment Extension Period|Adverse Event|0
7631679|NCT04057573|12045080|FG001|28-Week Treatment Extension Period|Adverse Event|0
7631680|NCT04057573|12045081|FG002|28-Week Treatment Extension Period|Adverse Event|1
7631681|NCT04057573|12045082|FG003|28-Week Treatment Extension Period|Adverse Event|0
7631682|NCT04057573|12045079|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0
7631683|NCT04057573|12045080|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0
7631684|NCT04057573|12045081|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1
7631685|NCT04057573|12045082|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0
7631686|NCT04057573|12045079|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0
7631687|NCT04057573|12045080|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0
7631688|NCT04057573|12045081|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9
7631689|NCT04057573|12045082|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10
7631690|NCT04057573|12045079|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0
7631691|NCT04057573|12045080|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0
7631692|NCT04057573|12045081|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9
7631693|NCT04057573|12045082|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9
7631694|NCT04057573|12045079|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0
7631695|NCT04057573|12045080|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0
7631696|NCT04057573|12045081|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1
7631697|NCT04057573|12045082|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0
7631698|NCT04057196|12045093|FG000|Overall Study|Withdrawal by Subject|3
7631699|NCT04057196|12045093|FG000|Overall Study|Death|3
7631700|NCT04052425|12045104|FG000|24-Week Double-blind Period|Adverse Event|0
7631701|NCT04052425|12045105|FG001|24-Week Double-blind Period|Adverse Event|1
7631702|NCT04052425|12045106|FG002|24-Week Double-blind Period|Adverse Event|0
7631703|NCT04052425|12045107|FG003|24-Week Double-blind Period|Adverse Event|0
7631704|NCT04052425|12045104|FG000|24-Week Double-blind Period|Lack of Efficacy|0
7631705|NCT04052425|12045105|FG001|24-Week Double-blind Period|Lack of Efficacy|1
7631706|NCT04052425|12045106|FG002|24-Week Double-blind Period|Lack of Efficacy|0
7631707|NCT04052425|12045107|FG003|24-Week Double-blind Period|Lack of Efficacy|0
7631708|NCT04052425|12045104|FG000|24-Week Double-blind Period|Lost to Follow-up|14
7631709|NCT04052425|12045105|FG001|24-Week Double-blind Period|Lost to Follow-up|7
7631710|NCT04052425|12045106|FG002|24-Week Double-blind Period|Lost to Follow-up|0
7631711|NCT04052425|12045107|FG003|24-Week Double-blind Period|Lost to Follow-up|0
7631712|NCT04052425|12045104|FG000|24-Week Double-blind Period|Physician Decision|1
7631713|NCT04052425|12045105|FG001|24-Week Double-blind Period|Physician Decision|0
7631714|NCT04052425|12045106|FG002|24-Week Double-blind Period|Physician Decision|0
7631715|NCT04052425|12045107|FG003|24-Week Double-blind Period|Physician Decision|0
7631716|NCT04052425|12045104|FG000|24-Week Double-blind Period|Protocol Violation|1
7631717|NCT04052425|12045105|FG001|24-Week Double-blind Period|Protocol Violation|0
7631718|NCT04052425|12045106|FG002|24-Week Double-blind Period|Protocol Violation|0
7631719|NCT04052425|12045107|FG003|24-Week Double-blind Period|Protocol Violation|0
7631720|NCT04052425|12045104|FG000|24-Week Double-blind Period|Withdrawal by Subject|9
7631721|NCT04052425|12045105|FG001|24-Week Double-blind Period|Withdrawal by Subject|10
7631722|NCT04052425|12045106|FG002|24-Week Double-blind Period|Withdrawal by Subject|0
7631723|NCT04052425|12045107|FG003|24-Week Double-blind Period|Withdrawal by Subject|0
7631724|NCT04052425|12045104|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3
7631725|NCT04052425|12045105|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0
7631726|NCT04052425|12045106|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0
7631727|NCT04052425|12045107|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0
7631728|NCT04052425|12045104|FG000|28-Week Treatment-Extension Period|Adverse Event|0
7631729|NCT04052425|12045105|FG001|28-Week Treatment-Extension Period|Adverse Event|0
7631730|NCT04052425|12045106|FG002|28-Week Treatment-Extension Period|Adverse Event|1
7631731|NCT04052425|12045107|FG003|28-Week Treatment-Extension Period|Adverse Event|0
7631732|NCT04052425|12045104|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0
7631733|NCT04052425|12045105|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0
7631734|NCT04052425|12045106|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1
7631735|NCT04052425|12045107|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0
7631736|NCT04052425|12045104|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0
7631737|NCT04052425|12045105|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0
7631738|NCT04052425|12045106|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5
7631739|NCT04052425|12045107|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1
7631740|NCT04052425|12045104|FG000|28-Week Treatment-Extension Period|Physician Decision|0
7631741|NCT04052425|12045105|FG001|28-Week Treatment-Extension Period|Physician Decision|0
7631742|NCT04052425|12045106|FG002|28-Week Treatment-Extension Period|Physician Decision|0
7631743|NCT04052425|12045107|FG003|28-Week Treatment-Extension Period|Physician Decision|1
7631744|NCT04052425|12045104|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0
7631745|NCT04052425|12045105|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0
7631746|NCT04052425|12045106|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10
7631747|NCT04052425|12045107|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7
7631748|NCT04052425|12045104|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0
7631749|NCT04052425|12045105|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0
7631750|NCT04052425|12045106|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1
7631751|NCT04052425|12045107|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0
7631752|NCT04052425|12045104|FG000|28-Week Treatment-Extension Period|Participant Moved|0
7631753|NCT04052425|12045105|FG001|28-Week Treatment-Extension Period|Participant Moved|0
7631754|NCT04052425|12045106|FG002|28-Week Treatment-Extension Period|Participant Moved|1
7631755|NCT04052425|12045107|FG003|28-Week Treatment-Extension Period|Participant Moved|1
7631756|NCT04049617|12045132|FG000|Overall Study|Adverse Event|0
7631757|NCT04049617|12045133|FG001|Overall Study|Adverse Event|0
7631758|NCT04049617|12045134|FG002|Overall Study|Adverse Event|0
7631759|NCT04049617|12045135|FG003|Overall Study|Adverse Event|1
7631760|NCT04049617|12045136|FG004|Overall Study|Adverse Event|0
7631761|NCT04049617|12045137|FG005|Overall Study|Adverse Event|0
7631762|NCT04049617|12045132|FG000|Overall Study|Death|0
7631763|NCT04049617|12045133|FG001|Overall Study|Death|0
7631764|NCT04049617|12045134|FG002|Overall Study|Death|0
7631765|NCT04049617|12045135|FG003|Overall Study|Death|0
7631766|NCT04049617|12045136|FG004|Overall Study|Death|0
7631767|NCT04049617|12045137|FG005|Overall Study|Death|1
7631768|NCT04049617|12045132|FG000|Overall Study|Lost to Follow-up|0
7631769|NCT04049617|12045133|FG001|Overall Study|Lost to Follow-up|0
7631770|NCT04049617|12045134|FG002|Overall Study|Lost to Follow-up|0
7631771|NCT04049617|12045135|FG003|Overall Study|Lost to Follow-up|1
7631772|NCT04049617|12045136|FG004|Overall Study|Lost to Follow-up|0
7631773|NCT04049617|12045137|FG005|Overall Study|Lost to Follow-up|0
7631774|NCT04049617|12045132|FG000|Overall Study|Withdrew consent|0
7631775|NCT04049617|12045133|FG001|Overall Study|Withdrew consent|0
7631776|NCT04049617|12045134|FG002|Overall Study|Withdrew consent|1
7631777|NCT04049617|12045135|FG003|Overall Study|Withdrew consent|0
7631778|NCT04049617|12045136|FG004|Overall Study|Withdrew consent|0
7631779|NCT04049617|12045137|FG005|Overall Study|Withdrew consent|0
7631780|NCT04047446|12045171|FG000|Overall Study|Physician Decision|1
7631781|NCT04047446|12045172|FG001|Overall Study|Physician Decision|0
7631782|NCT04030598|12045194|FG000|Overall Study|Voluntary Withdrawal|0
7631783|NCT04030598|12045195|FG001|Overall Study|Voluntary Withdrawal|1
7631784|NCT04030598|12045196|FG002|Overall Study|Voluntary Withdrawal|0
7631785|NCT04026568|12045251|FG000|Overall Study|study terminated|0
7631786|NCT04026568|12045252|FG001|Overall Study|study terminated|1
7631787|NCT04025632|12045260|FG000|Overall Study|Adverse Event|1
7631788|NCT04025632|12045261|FG001|Overall Study|Adverse Event|1
7631789|NCT04025632|12045260|FG000|Overall Study|Withdrawal by Subject|1
7631790|NCT04025632|12045261|FG001|Overall Study|Withdrawal by Subject|1
7631791|NCT04025632|12045260|FG000|Overall Study|Study Terminated by Sponsor|10
7631792|NCT04025632|12045261|FG001|Overall Study|Study Terminated by Sponsor|9
7631793|NCT04025632|12045260|FG000|Overall Study|Physician Decision|3
7631794|NCT04025632|12045261|FG001|Overall Study|Physician Decision|1
7631795|NCT04024891|12045272|FG000|Overall Study|Pregnancy|0
7631796|NCT04024891|12045273|FG001|Overall Study|Pregnancy|1
7631797|NCT04015518|12045297|FG000|Overall Study|Adverse Event|6
7631798|NCT04015518|12045298|FG001|Overall Study|Adverse Event|1
7631799|NCT04015518|12045299|FG002|Overall Study|Adverse Event|1
7631800|NCT04015518|12045300|FG003|Overall Study|Adverse Event|3
7631801|NCT04015518|12045301|FG004|Overall Study|Adverse Event|3
7631802|NCT04015518|12045297|FG000|Overall Study|Lack of Efficacy|1
7631803|NCT04015518|12045298|FG001|Overall Study|Lack of Efficacy|0
7631804|NCT04015518|12045299|FG002|Overall Study|Lack of Efficacy|1
7631805|NCT04015518|12045300|FG003|Overall Study|Lack of Efficacy|0
7631806|NCT04015518|12045301|FG004|Overall Study|Lack of Efficacy|4
7631807|NCT04015518|12045297|FG000|Overall Study|Lost to Follow-up|0
7631808|NCT04015518|12045298|FG001|Overall Study|Lost to Follow-up|0
7631809|NCT04015518|12045299|FG002|Overall Study|Lost to Follow-up|0
7631810|NCT04015518|12045300|FG003|Overall Study|Lost to Follow-up|0
7631811|NCT04015518|12045301|FG004|Overall Study|Lost to Follow-up|1
7631812|NCT04015518|12045297|FG000|Overall Study|Withdrawal by Subject|0
7631813|NCT04015518|12045298|FG001|Overall Study|Withdrawal by Subject|1
7631814|NCT04015518|12045299|FG002|Overall Study|Withdrawal by Subject|0
7631815|NCT04015518|12045300|FG003|Overall Study|Withdrawal by Subject|1
7631816|NCT04015518|12045301|FG004|Overall Study|Withdrawal by Subject|1
7631817|NCT04015518|12045297|FG000|Overall Study|Patient did not come for consecutive visits|0
7631818|NCT04015518|12045298|FG001|Overall Study|Patient did not come for consecutive visits|1
7631819|NCT04015518|12045299|FG002|Overall Study|Patient did not come for consecutive visits|0
7631820|NCT04015518|12045300|FG003|Overall Study|Patient did not come for consecutive visits|0
7631821|NCT04015518|12045301|FG004|Overall Study|Patient did not come for consecutive visits|0
7631822|NCT04015518|12045297|FG000|Overall Study|not willing to travel due to Covid-19|0
7631823|NCT04015518|12045298|FG001|Overall Study|not willing to travel due to Covid-19|0
7631824|NCT04015518|12045299|FG002|Overall Study|not willing to travel due to Covid-19|1
7631825|NCT04015518|12045300|FG003|Overall Study|not willing to travel due to Covid-19|0
7631826|NCT04015518|12045301|FG004|Overall Study|not willing to travel due to Covid-19|0
7631827|NCT04015518|12045297|FG000|Overall Study|Patient wants to discontinue treatment|0
7631828|NCT04015518|12045298|FG001|Overall Study|Patient wants to discontinue treatment|0
7631829|NCT04015518|12045299|FG002|Overall Study|Patient wants to discontinue treatment|0
7631830|NCT04015518|12045300|FG003|Overall Study|Patient wants to discontinue treatment|1
7631831|NCT04015518|12045301|FG004|Overall Study|Patient wants to discontinue treatment|0
7631832|NCT04015518|12045297|FG000|Overall Study|Difficult for patient to come to the hospital|0
7631833|NCT04015518|12045298|FG001|Overall Study|Difficult for patient to come to the hospital|0
7631834|NCT04015518|12045299|FG002|Overall Study|Difficult for patient to come to the hospital|0
7631835|NCT04015518|12045300|FG003|Overall Study|Difficult for patient to come to the hospital|0
7631836|NCT04015518|12045301|FG004|Overall Study|Difficult for patient to come to the hospital|1
7631837|NCT04015518|12045297|FG000|Overall Study|Pregnancy|0
7631838|NCT04015518|12045298|FG001|Overall Study|Pregnancy|0
7631839|NCT04015518|12045299|FG002|Overall Study|Pregnancy|0
7631840|NCT04015518|12045300|FG003|Overall Study|Pregnancy|0
7631841|NCT04015518|12045301|FG004|Overall Study|Pregnancy|1
7631842|NCT04015518|12045297|FG000|Overall Study|Personal reasons|1
7631843|NCT04015518|12045298|FG001|Overall Study|Personal reasons|0
7631844|NCT04015518|12045299|FG002|Overall Study|Personal reasons|0
7631845|NCT04015518|12045300|FG003|Overall Study|Personal reasons|0
7631846|NCT04015518|12045301|FG004|Overall Study|Personal reasons|1
7631847|NCT04015518|12045297|FG000|Overall Study|Withdrew consent|1
7631848|NCT04015518|12045298|FG001|Overall Study|Withdrew consent|0
7631849|NCT04015518|12045299|FG002|Overall Study|Withdrew consent|0
7631850|NCT04015518|12045300|FG003|Overall Study|Withdrew consent|0
7631851|NCT04015518|12045301|FG004|Overall Study|Withdrew consent|0
7631852|NCT04015518|12045297|FG000|Overall Study|Prostate carcinoma|1
7631853|NCT04015518|12045298|FG001|Overall Study|Prostate carcinoma|0
7631854|NCT04015518|12045299|FG002|Overall Study|Prostate carcinoma|0
7631855|NCT04015518|12045300|FG003|Overall Study|Prostate carcinoma|0
7631856|NCT04015518|12045301|FG004|Overall Study|Prostate carcinoma|0
7631857|NCT04015518|12045297|FG000|Overall Study|Could not keep appointments due to work|1
7631858|NCT04015518|12045298|FG001|Overall Study|Could not keep appointments due to work|0
7631859|NCT04015518|12045299|FG002|Overall Study|Could not keep appointments due to work|0
7631860|NCT04015518|12045300|FG003|Overall Study|Could not keep appointments due to work|0
7631861|NCT04015518|12045301|FG004|Overall Study|Could not keep appointments due to work|0
7631862|NCT04014075|12045316|FG000|Overall Study|Progressive Disease|39
7631863|NCT04014075|12045316|FG000|Overall Study|Adverse Event|9
7631864|NCT04014075|12045316|FG000|Overall Study|Clinical Progression|2
7631865|NCT04014075|12045316|FG000|Overall Study|Death|2
7631866|NCT04014075|12045316|FG000|Overall Study|Withdrawal by Subject|2
7631867|NCT04014075|12045316|FG000|Overall Study|Miscellaneous|1
7631868|NCT04014075|12045316|FG000|Overall Study|Physician Decision|1
7631869|NCT04003155|12045332|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9
7631870|NCT04003155|12045333|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8
7631871|NCT04003155|12045334|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5
7631872|NCT04003155|12045335|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0
7631873|NCT04003155|12045336|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0
7631874|NCT04003155|12045332|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3
7631875|NCT04003155|12045333|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4
7631876|NCT04003155|12045334|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0
7631877|NCT04003155|12045335|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0
7631878|NCT04003155|12045336|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0
7631879|NCT04003155|12045332|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1
7631880|NCT04003155|12045333|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3
7631881|NCT04003155|12045334|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3
7631882|NCT04003155|12045335|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0
7631883|NCT04003155|12045336|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0
7631884|NCT04003155|12045332|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9
7631885|NCT04003155|12045333|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12
7631886|NCT04003155|12045334|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4
7631887|NCT04003155|12045335|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0
7631888|NCT04003155|12045336|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0
7631889|NCT04003155|12045332|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1
7631890|NCT04003155|12045333|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7
7631891|NCT04003155|12045334|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3
7631892|NCT04003155|12045335|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0
7631893|NCT04003155|12045336|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0
7631894|NCT04003155|12045332|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0
7631895|NCT04003155|12045333|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5
7631896|NCT04003155|12045334|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4
7631897|NCT04003155|12045335|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2
7631898|NCT04003155|12045336|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2
7631899|NCT04003155|12045332|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0
7631900|NCT04003155|12045333|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1
7631901|NCT04003155|12045334|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3
7631902|NCT04003155|12045335|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1
7631903|NCT04003155|12045336|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1
7631904|NCT04003155|12045332|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0
7631905|NCT04003155|12045333|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12
7632075|NCT03926169|12045608|FG000|Period A|Other, Not Specified|1
7631906|NCT04003155|12045334|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7
7631907|NCT04003155|12045335|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9
7631908|NCT04003155|12045336|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5
7631909|NCT04003155|12045332|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0
7631910|NCT04003155|12045333|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0
7631911|NCT04003155|12045334|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1
7631912|NCT04003155|12045335|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2
7631913|NCT04003155|12045336|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1
7631914|NCT03999892|12045366|FG000|Overall Study|Lost to Follow-up|1
7631915|NCT03988166|12045370|FG000|Overall Study|Lost to Follow-up|2
7631916|NCT03988166|12045370|FG000|Overall Study|Death|1
7631917|NCT03980808|12045379|FG000|Overall Study|Lost to Follow-up|2
7631918|NCT03980808|12045380|FG001|Overall Study|Lost to Follow-up|2
7631919|NCT03977454|12045388|FG000|Overall Study|immediate postoperative revision|2
7631920|NCT03977454|12045389|FG001|Overall Study|immediate postoperative revision|2
7631921|NCT03976401|12045401|FG000|Overall Study|Adverse Event|2
7631922|NCT03976401|12045402|FG001|Overall Study|Adverse Event|0
7631923|NCT03976401|12045403|FG002|Overall Study|Adverse Event|4
7631924|NCT03976401|12045404|FG003|Overall Study|Adverse Event|1
7631925|NCT03976401|12045405|FG004|Overall Study|Adverse Event|1
7631926|NCT03976401|12045406|FG005|Overall Study|Adverse Event|0
7631927|NCT03976401|12045401|FG000|Overall Study|Withdrawal by Subject|0
7631928|NCT03976401|12045402|FG001|Overall Study|Withdrawal by Subject|1
7631929|NCT03976401|12045403|FG002|Overall Study|Withdrawal by Subject|0
7631930|NCT03976401|12045404|FG003|Overall Study|Withdrawal by Subject|0
7631931|NCT03976401|12045405|FG004|Overall Study|Withdrawal by Subject|0
7631932|NCT03976401|12045406|FG005|Overall Study|Withdrawal by Subject|1
7631933|NCT03976401|12045401|FG000|Overall Study|Physician Decision|0
7631934|NCT03976401|12045402|FG001|Overall Study|Physician Decision|0
7631935|NCT03976401|12045403|FG002|Overall Study|Physician Decision|1
7631936|NCT03976401|12045404|FG003|Overall Study|Physician Decision|0
7631937|NCT03976401|12045405|FG004|Overall Study|Physician Decision|0
7631938|NCT03976401|12045406|FG005|Overall Study|Physician Decision|0
7631939|NCT03976401|12045401|FG000|Overall Study|Lost to Follow-up|1
7631940|NCT03976401|12045402|FG001|Overall Study|Lost to Follow-up|2
7631941|NCT03976401|12045403|FG002|Overall Study|Lost to Follow-up|0
7631942|NCT03976401|12045404|FG003|Overall Study|Lost to Follow-up|0
7631943|NCT03976401|12045405|FG004|Overall Study|Lost to Follow-up|0
7631944|NCT03976401|12045406|FG005|Overall Study|Lost to Follow-up|0
7631945|NCT03976401|12045401|FG000|Overall Study|Protocol Violation|0
7631946|NCT03976401|12045402|FG001|Overall Study|Protocol Violation|1
7631947|NCT03976401|12045403|FG002|Overall Study|Protocol Violation|0
7631948|NCT03976401|12045404|FG003|Overall Study|Protocol Violation|0
7631949|NCT03976401|12045405|FG004|Overall Study|Protocol Violation|0
7631950|NCT03976401|12045406|FG005|Overall Study|Protocol Violation|0
7631951|NCT03976401|12045401|FG000|Overall Study|Withdrew Consent|0
7631952|NCT03976401|12045402|FG001|Overall Study|Withdrew Consent|0
7631953|NCT03976401|12045403|FG002|Overall Study|Withdrew Consent|0
7631954|NCT03976401|12045404|FG003|Overall Study|Withdrew Consent|1
7631955|NCT03976401|12045405|FG004|Overall Study|Withdrew Consent|0
7631956|NCT03976401|12045406|FG005|Overall Study|Withdrew Consent|0
7631957|NCT03967444|12045422|FG000|Overall Study|Lost to Follow-up|1
7631958|NCT03967444|12045423|FG001|Overall Study|Lost to Follow-up|2
7631959|NCT03966885|12045431|FG000|Overall Study|Death|1
7631960|NCT03966885|12045432|FG001|Overall Study|Death|0
7631961|NCT03966885|12045431|FG000|Overall Study|Lost to Follow-up|1
7631962|NCT03966885|12045432|FG001|Overall Study|Lost to Follow-up|2
7631963|NCT03966885|12045431|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20
7631964|NCT03966885|12045432|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16
7631965|NCT03966885|12045431|FG000|Overall Study|Moved from study area.|0
7631966|NCT03966885|12045432|FG001|Overall Study|Moved from study area.|2
7631967|NCT03964974|12045441|FG000|Overall Study|Lost to Follow-up|3
7631968|NCT03964974|12045442|FG001|Overall Study|Lost to Follow-up|2
7631969|NCT03964974|12045441|FG000|Overall Study|Withdrawal by Subject|0
7631970|NCT03964974|12045442|FG001|Overall Study|Withdrawal by Subject|3
7631971|NCT03963232|12045450|FG000|Overall Study|Adverse Event|0
7631972|NCT03963232|12045451|FG001|Overall Study|Adverse Event|6
7631973|NCT03963232|12045450|FG000|Overall Study|Protocol Violation|1
7631974|NCT03963232|12045451|FG001|Overall Study|Protocol Violation|1
7631975|NCT03963232|12045450|FG000|Overall Study|Pregnancy|2
7631976|NCT03963232|12045451|FG001|Overall Study|Pregnancy|1
7631977|NCT03963232|12045450|FG000|Overall Study|Withdrawal by Subject|13
7631978|NCT03963232|12045451|FG001|Overall Study|Withdrawal by Subject|5
7631979|NCT03963232|12045450|FG000|Overall Study|Physician Decision|1
7631980|NCT03963232|12045451|FG001|Overall Study|Physician Decision|3
7631981|NCT03958331|12045470|FG000|Overall Study|Withdrawal by Subject|3
7631982|NCT03958331|12045471|FG001|Overall Study|Withdrawal by Subject|1
7631983|NCT03958331|12045472|FG002|Overall Study|Withdrawal by Subject|5
7631984|NCT03958331|12045470|FG000|Overall Study|Weaned from medicine|2
7631985|NCT03958331|12045471|FG001|Overall Study|Weaned from medicine|0
7631986|NCT03958331|12045472|FG002|Overall Study|Weaned from medicine|0
7631987|NCT03958331|12045470|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2
7631988|NCT03958331|12045471|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1
7631989|NCT03958331|12045472|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12
7631990|NCT03955471|12045478|FG000|Overall Study|Death|22
7631991|NCT03955471|12045478|FG000|Overall Study|Lost to Follow-up|1
7631992|NCT03955471|12045478|FG000|Overall Study|Withdrawal by Subject|6
7631993|NCT03955471|12045478|FG000|Overall Study|Sponsor Decision to Terminate Study|11
7631994|NCT03950674|12045484|FG000|Overall Study|Death|3
7631995|NCT03950674|12045485|FG001|Overall Study|Death|7
7631996|NCT03950674|12045484|FG000|Overall Study|Ongoing in Study|22
7631997|NCT03950674|12045485|FG001|Overall Study|Ongoing in Study|8
7631998|NCT03948581|12045498|FG000|Overall Study|Lost to Follow-up|0
7631999|NCT03948581|12045499|FG001|Overall Study|Lost to Follow-up|1
7632000|NCT03943290|12045514|FG000|Overall Study|Sponsor Terminated Study|6
7632001|NCT03943290|12045515|FG001|Overall Study|Sponsor Terminated Study|1
7632002|NCT03943290|12045516|FG002|Overall Study|Sponsor Terminated Study|11
7632003|NCT03943290|12045517|FG003|Overall Study|Sponsor Terminated Study|6
7632004|NCT03943290|12045518|FG004|Overall Study|Sponsor Terminated Study|7
7632005|NCT03943290|12045519|FG005|Overall Study|Sponsor Terminated Study|6
7632006|NCT03943290|12045520|FG006|Overall Study|Sponsor Terminated Study|6
7632007|NCT03943290|12045521|FG007|Overall Study|Sponsor Terminated Study|7
7632008|NCT03943290|12045522|FG008|Overall Study|Sponsor Terminated Study|8
7632009|NCT03943290|12045514|FG000|Overall Study|Lost to Follow-up|1
7632010|NCT03943290|12045515|FG001|Overall Study|Lost to Follow-up|0
7632011|NCT03943290|12045516|FG002|Overall Study|Lost to Follow-up|1
7632012|NCT03943290|12045517|FG003|Overall Study|Lost to Follow-up|0
7632013|NCT03943290|12045518|FG004|Overall Study|Lost to Follow-up|0
7632014|NCT03943290|12045519|FG005|Overall Study|Lost to Follow-up|0
7632015|NCT03943290|12045520|FG006|Overall Study|Lost to Follow-up|0
7632016|NCT03943290|12045521|FG007|Overall Study|Lost to Follow-up|1
7632017|NCT03943290|12045522|FG008|Overall Study|Lost to Follow-up|0
7632018|NCT03943290|12045514|FG000|Overall Study|Withdrawal by Subject|0
7632019|NCT03943290|12045515|FG001|Overall Study|Withdrawal by Subject|0
7632020|NCT03943290|12045516|FG002|Overall Study|Withdrawal by Subject|1
7632021|NCT03943290|12045517|FG003|Overall Study|Withdrawal by Subject|0
7632022|NCT03943290|12045518|FG004|Overall Study|Withdrawal by Subject|0
7632023|NCT03943290|12045519|FG005|Overall Study|Withdrawal by Subject|0
7632024|NCT03943290|12045520|FG006|Overall Study|Withdrawal by Subject|0
7632025|NCT03943290|12045521|FG007|Overall Study|Withdrawal by Subject|0
7632026|NCT03943290|12045522|FG008|Overall Study|Withdrawal by Subject|0
7632027|NCT03938545|12045559|FG000|Overall Study|Lost to Follow-up|0
7632028|NCT03938545|12045560|FG001|Overall Study|Lost to Follow-up|0
7632029|NCT03938545|12045561|FG002|Overall Study|Lost to Follow-up|0
7632030|NCT03938545|12045562|FG003|Overall Study|Lost to Follow-up|1
7632031|NCT03938545|12045559|FG000|Overall Study|Non-compliance with study drug|0
7632032|NCT03938545|12045560|FG001|Overall Study|Non-compliance with study drug|0
7632033|NCT03938545|12045561|FG002|Overall Study|Non-compliance with study drug|1
7632034|NCT03938545|12045562|FG003|Overall Study|Non-compliance with study drug|0
7632035|NCT03938545|12045559|FG000|Overall Study|Pregnancy|1
7632036|NCT03938545|12045560|FG001|Overall Study|Pregnancy|0
7632037|NCT03938545|12045561|FG002|Overall Study|Pregnancy|0
7632038|NCT03938545|12045562|FG003|Overall Study|Pregnancy|0
7632039|NCT03938545|12045559|FG000|Overall Study|Study terminated by sponsor|6
7632040|NCT03938545|12045560|FG001|Overall Study|Study terminated by sponsor|4
7632041|NCT03938545|12045561|FG002|Overall Study|Study terminated by sponsor|2
7632042|NCT03938545|12045562|FG003|Overall Study|Study terminated by sponsor|4
7632043|NCT03938545|12045559|FG000|Overall Study|Withdrawal by Subject|0
7632044|NCT03938545|12045560|FG001|Overall Study|Withdrawal by Subject|1
7632045|NCT03938545|12045561|FG002|Overall Study|Withdrawal by Subject|0
7632046|NCT03938545|12045562|FG003|Overall Study|Withdrawal by Subject|0
7632047|NCT03938545|12045559|FG000|Overall Study|Adverse Event|1
7632048|NCT03938545|12045560|FG001|Overall Study|Adverse Event|0
7632049|NCT03938545|12045561|FG002|Overall Study|Adverse Event|0
7632050|NCT03938545|12045562|FG003|Overall Study|Adverse Event|0
7632051|NCT03933449|12045574|FG000|Overall Study|Adverse Event|6
7632052|NCT03933449|12045575|FG001|Overall Study|Adverse Event|4
7632053|NCT03933449|12045574|FG000|Overall Study|Death|36
7632054|NCT03933449|12045575|FG001|Overall Study|Death|51
7632055|NCT03933449|12045574|FG000|Overall Study|Ongoing in Study|20
7632056|NCT03933449|12045575|FG001|Overall Study|Ongoing in Study|6
7632057|NCT03926169|12045608|FG000|Period A|Adverse Event|2
7632058|NCT03926169|12045609|FG001|Period A|Adverse Event|2
7632059|NCT03926169|12045610|FG002|Period A|Adverse Event|1
7632060|NCT03926169|12045608|FG000|Period A|Withdrawal by Subject|2
7632061|NCT03926169|12045609|FG001|Period A|Withdrawal by Subject|2
7632062|NCT03926169|12045610|FG002|Period A|Withdrawal by Subject|2
7632063|NCT03926169|12045608|FG000|Period A|Lost to Follow-up|3
7632064|NCT03926169|12045609|FG001|Period A|Lost to Follow-up|1
7632065|NCT03926169|12045610|FG002|Period A|Lost to Follow-up|0
7632066|NCT03926169|12045608|FG000|Period A|Lack of Efficacy|0
7632067|NCT03926169|12045609|FG001|Period A|Lack of Efficacy|2
7632068|NCT03926169|12045610|FG002|Period A|Lack of Efficacy|2
7632069|NCT03926169|12045608|FG000|Period A|COVID-19 Infection|0
7632070|NCT03926169|12045609|FG001|Period A|COVID-19 Infection|1
7632071|NCT03926169|12045610|FG002|Period A|COVID-19 Infection|0
7632072|NCT03926169|12045608|FG000|Period A|COVID-19 Logistical Restrictions|0
7632073|NCT03926169|12045609|FG001|Period A|COVID-19 Logistical Restrictions|2
7632074|NCT03926169|12045610|FG002|Period A|COVID-19 Logistical Restrictions|1
7632076|NCT03926169|12045609|FG001|Period A|Other, Not Specified|0
7632077|NCT03926169|12045610|FG002|Period A|Other, Not Specified|0
7632078|NCT03926169|12045608|FG000|Period B|Adverse Event|3
7632079|NCT03926169|12045609|FG001|Period B|Adverse Event|1
7632080|NCT03926169|12045610|FG002|Period B|Adverse Event|1
7632081|NCT03926169|12045608|FG000|Period B|Withdrawal by Subject|1
7632082|NCT03926169|12045609|FG001|Period B|Withdrawal by Subject|3
7632083|NCT03926169|12045610|FG002|Period B|Withdrawal by Subject|0
7632084|NCT03926169|12045608|FG000|Period B|Lack of Efficacy|3
7632085|NCT03926169|12045609|FG001|Period B|Lack of Efficacy|1
7632086|NCT03926169|12045610|FG002|Period B|Lack of Efficacy|1
7632087|NCT03926169|12045608|FG000|Period B|Lost to Follow-up|1
7632088|NCT03926169|12045609|FG001|Period B|Lost to Follow-up|1
7632089|NCT03926169|12045610|FG002|Period B|Lost to Follow-up|4
7632090|NCT03926169|12045608|FG000|Period B|Other, Not Specified|62
7632091|NCT03926169|12045609|FG001|Period B|Other, Not Specified|57
7632092|NCT03926169|12045610|FG002|Period B|Other, Not Specified|65
7632093|NCT03922945|12045624|FG000|Overall Study|Adverse Event|1
7632094|NCT03922945|12045625|FG001|Overall Study|Adverse Event|1
7632095|NCT03922945|12045626|FG002|Overall Study|Adverse Event|2
7632096|NCT03922945|12045624|FG000|Overall Study|Lost to Follow-up|13
7632097|NCT03922945|12045625|FG001|Overall Study|Lost to Follow-up|9
7632098|NCT03922945|12045626|FG002|Overall Study|Lost to Follow-up|20
7632099|NCT03922945|12045624|FG000|Overall Study|Lack of Efficacy|2
7632100|NCT03922945|12045625|FG001|Overall Study|Lack of Efficacy|0
7632101|NCT03922945|12045626|FG002|Overall Study|Lack of Efficacy|1
7632102|NCT03922945|12045624|FG000|Overall Study|Protocol Non-Compliance|0
7632103|NCT03922945|12045625|FG001|Overall Study|Protocol Non-Compliance|0
7632104|NCT03922945|12045626|FG002|Overall Study|Protocol Non-Compliance|1
7632105|NCT03922945|12045624|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10
7632106|NCT03922945|12045625|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6
7632107|NCT03922945|12045626|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14
7632108|NCT03922945|12045624|FG000|Overall Study|All Other Personal Reasons|1
7632109|NCT03922945|12045625|FG001|Overall Study|All Other Personal Reasons|1
7632110|NCT03922945|12045626|FG002|Overall Study|All Other Personal Reasons|2
7632111|NCT03920280|12045639|FG000|Overall Study|Adverse Event|2
7632112|NCT03920280|12045640|FG001|Overall Study|Adverse Event|3
7632113|NCT03920280|12045639|FG000|Overall Study|Lost to Follow-up|0
7632114|NCT03920280|12045640|FG001|Overall Study|Lost to Follow-up|1
7632115|NCT03920280|12045639|FG000|Overall Study|Withdrawal by Subject|1
7632116|NCT03920280|12045640|FG001|Overall Study|Withdrawal by Subject|1
7632117|NCT03920280|12045639|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0
7632118|NCT03920280|12045640|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1
7632119|NCT03917654|12045661|FG000|Year 1|Withdrawal by Subject|1
7632120|NCT03917654|12045662|FG001|Year 1|Withdrawal by Subject|0
7632121|NCT03917654|12045663|FG002|Year 1|Withdrawal by Subject|0
7632122|NCT03917654|12045664|FG003|Year 1|Withdrawal by Subject|0
7632123|NCT03917654|12045665|FG004|Year 1|Withdrawal by Subject|0
7632124|NCT03917654|12045666|FG005|Year 1|Withdrawal by Subject|1
7632125|NCT03917654|12045667|FG006|Year 1|Withdrawal by Subject|6
7632126|NCT03917654|12045668|FG007|Year 1|Withdrawal by Subject|2
7632127|NCT03917654|12045669|FG008|Year 1|Withdrawal by Subject|5
7632128|NCT03917654|12045670|FG009|Year 1|Withdrawal by Subject|3
7632129|NCT03917654|12045671|FG010|Year 1|Withdrawal by Subject|1
7632130|NCT03917654|12045672|FG011|Year 1|Withdrawal by Subject|0
7632131|NCT03917654|12045661|FG000|Year 1|Travel|0
7632132|NCT03917654|12045662|FG001|Year 1|Travel|1
7632133|NCT03917654|12045663|FG002|Year 1|Travel|1
7632134|NCT03917654|12045664|FG003|Year 1|Travel|0
7632135|NCT03917654|12045665|FG004|Year 1|Travel|4
7632136|NCT03917654|12045666|FG005|Year 1|Travel|4
7632137|NCT03917654|12045667|FG006|Year 1|Travel|10
7632138|NCT03917654|12045668|FG007|Year 1|Travel|8
7632139|NCT03917654|12045669|FG008|Year 1|Travel|2
7632140|NCT03917654|12045670|FG009|Year 1|Travel|5
7632141|NCT03917654|12045671|FG010|Year 1|Travel|3
7632142|NCT03917654|12045672|FG011|Year 1|Travel|3
7632143|NCT03917654|12045661|FG000|Year 1|Subject moved away from site|0
7632144|NCT03917654|12045662|FG001|Year 1|Subject moved away from site|1
7632145|NCT03917654|12045663|FG002|Year 1|Subject moved away from site|0
7632146|NCT03917654|12045664|FG003|Year 1|Subject moved away from site|0
7632147|NCT03917654|12045665|FG004|Year 1|Subject moved away from site|0
7632148|NCT03917654|12045666|FG005|Year 1|Subject moved away from site|0
7632149|NCT03917654|12045667|FG006|Year 1|Subject moved away from site|1
7632150|NCT03917654|12045668|FG007|Year 1|Subject moved away from site|2
7632151|NCT03917654|12045669|FG008|Year 1|Subject moved away from site|1
7632152|NCT03917654|12045670|FG009|Year 1|Subject moved away from site|0
7632153|NCT03917654|12045671|FG010|Year 1|Subject moved away from site|0
7632154|NCT03917654|12045672|FG011|Year 1|Subject moved away from site|3
7632155|NCT03917654|12045661|FG000|Year 1|Spouse/Family member request|0
7632156|NCT03917654|12045662|FG001|Year 1|Spouse/Family member request|0
7632157|NCT03917654|12045663|FG002|Year 1|Spouse/Family member request|1
7632158|NCT03917654|12045664|FG003|Year 1|Spouse/Family member request|0
7632159|NCT03917654|12045665|FG004|Year 1|Spouse/Family member request|1
7632160|NCT03917654|12045666|FG005|Year 1|Spouse/Family member request|0
7632161|NCT03917654|12045667|FG006|Year 1|Spouse/Family member request|0
7632162|NCT03917654|12045668|FG007|Year 1|Spouse/Family member request|2
7632163|NCT03917654|12045669|FG008|Year 1|Spouse/Family member request|0
7632164|NCT03917654|12045670|FG009|Year 1|Spouse/Family member request|0
7632165|NCT03917654|12045671|FG010|Year 1|Spouse/Family member request|0
7632166|NCT03917654|12045672|FG011|Year 1|Spouse/Family member request|1
7632167|NCT03917654|12045661|FG000|Year 1|Death|0
7632168|NCT03917654|12045662|FG001|Year 1|Death|0
7632169|NCT03917654|12045663|FG002|Year 1|Death|0
7632170|NCT03917654|12045664|FG003|Year 1|Death|0
7632171|NCT03917654|12045665|FG004|Year 1|Death|0
7632172|NCT03917654|12045666|FG005|Year 1|Death|0
7632173|NCT03917654|12045667|FG006|Year 1|Death|0
7632174|NCT03917654|12045668|FG007|Year 1|Death|0
7632175|NCT03917654|12045669|FG008|Year 1|Death|1
7632176|NCT03917654|12045670|FG009|Year 1|Death|1
7632177|NCT03917654|12045671|FG010|Year 1|Death|0
7632178|NCT03917654|12045672|FG011|Year 1|Death|0
7632179|NCT03917654|12045661|FG000|Year 1|Lost to Follow-up|0
7632180|NCT03917654|12045662|FG001|Year 1|Lost to Follow-up|0
7632181|NCT03917654|12045663|FG002|Year 1|Lost to Follow-up|0
7632182|NCT03917654|12045664|FG003|Year 1|Lost to Follow-up|0
7632183|NCT03917654|12045665|FG004|Year 1|Lost to Follow-up|0
7632184|NCT03917654|12045666|FG005|Year 1|Lost to Follow-up|0
7632185|NCT03917654|12045667|FG006|Year 1|Lost to Follow-up|2
7632186|NCT03917654|12045668|FG007|Year 1|Lost to Follow-up|0
7632187|NCT03917654|12045669|FG008|Year 1|Lost to Follow-up|0
7632188|NCT03917654|12045670|FG009|Year 1|Lost to Follow-up|0
7632189|NCT03917654|12045671|FG010|Year 1|Lost to Follow-up|0
7632190|NCT03917654|12045672|FG011|Year 1|Lost to Follow-up|0
7632191|NCT03917654|12045661|FG000|Year 1|Missed visits|0
7632192|NCT03917654|12045662|FG001|Year 1|Missed visits|0
7632193|NCT03917654|12045663|FG002|Year 1|Missed visits|0
7632194|NCT03917654|12045664|FG003|Year 1|Missed visits|0
7632195|NCT03917654|12045665|FG004|Year 1|Missed visits|0
7632196|NCT03917654|12045666|FG005|Year 1|Missed visits|0
7632197|NCT03917654|12045667|FG006|Year 1|Missed visits|0
7632198|NCT03917654|12045668|FG007|Year 1|Missed visits|0
7632199|NCT03917654|12045669|FG008|Year 1|Missed visits|0
7632200|NCT03917654|12045670|FG009|Year 1|Missed visits|0
7632201|NCT03917654|12045671|FG010|Year 1|Missed visits|1
7632202|NCT03917654|12045672|FG011|Year 1|Missed visits|1
7632203|NCT03917654|12045661|FG000|Year 1|Pregnancy|0
7632204|NCT03917654|12045662|FG001|Year 1|Pregnancy|0
7632205|NCT03917654|12045663|FG002|Year 1|Pregnancy|0
7632206|NCT03917654|12045664|FG003|Year 1|Pregnancy|0
7632207|NCT03917654|12045665|FG004|Year 1|Pregnancy|0
7632208|NCT03917654|12045666|FG005|Year 1|Pregnancy|0
7632209|NCT03917654|12045667|FG006|Year 1|Pregnancy|0
7632210|NCT03917654|12045668|FG007|Year 1|Pregnancy|1
7632211|NCT03917654|12045669|FG008|Year 1|Pregnancy|0
7632212|NCT03917654|12045670|FG009|Year 1|Pregnancy|1
7632213|NCT03917654|12045671|FG010|Year 1|Pregnancy|0
7632214|NCT03917654|12045672|FG011|Year 1|Pregnancy|0
7632215|NCT03917654|12045661|FG000|Year 2|Travel|1
7632216|NCT03917654|12045662|FG001|Year 2|Travel|0
7632217|NCT03917654|12045663|FG002|Year 2|Travel|0
7632218|NCT03917654|12045664|FG003|Year 2|Travel|0
7632219|NCT03917654|12045665|FG004|Year 2|Travel|1
7632220|NCT03917654|12045666|FG005|Year 2|Travel|1
7632221|NCT03917654|12045667|FG006|Year 2|Travel|2
7632222|NCT03917654|12045668|FG007|Year 2|Travel|1
7632223|NCT03917654|12045669|FG008|Year 2|Travel|0
7632224|NCT03917654|12045670|FG009|Year 2|Travel|1
7632225|NCT03917654|12045671|FG010|Year 2|Travel|0
7632226|NCT03917654|12045672|FG011|Year 2|Travel|1
7632227|NCT03917654|12045661|FG000|Year 2|Married|1
7632228|NCT03917654|12045662|FG001|Year 2|Married|0
7632229|NCT03917654|12045663|FG002|Year 2|Married|0
7632230|NCT03917654|12045664|FG003|Year 2|Married|0
7632231|NCT03917654|12045665|FG004|Year 2|Married|0
7632232|NCT03917654|12045666|FG005|Year 2|Married|0
7632233|NCT03917654|12045667|FG006|Year 2|Married|1
7632234|NCT03917654|12045668|FG007|Year 2|Married|1
7632235|NCT03917654|12045669|FG008|Year 2|Married|0
7632236|NCT03917654|12045670|FG009|Year 2|Married|0
7632237|NCT03917654|12045671|FG010|Year 2|Married|0
7632238|NCT03917654|12045672|FG011|Year 2|Married|0
7632239|NCT03917654|12045661|FG000|Year 2|Subject moved away from site|1
7632240|NCT03917654|12045662|FG001|Year 2|Subject moved away from site|0
7632241|NCT03917654|12045663|FG002|Year 2|Subject moved away from site|0
7632242|NCT03917654|12045664|FG003|Year 2|Subject moved away from site|0
7632243|NCT03917654|12045665|FG004|Year 2|Subject moved away from site|1
7632244|NCT03917654|12045666|FG005|Year 2|Subject moved away from site|0
7632245|NCT03917654|12045667|FG006|Year 2|Subject moved away from site|2
7632246|NCT03917654|12045668|FG007|Year 2|Subject moved away from site|3
7632247|NCT03917654|12045669|FG008|Year 2|Subject moved away from site|0
7632248|NCT03917654|12045670|FG009|Year 2|Subject moved away from site|2
7632249|NCT03917654|12045671|FG010|Year 2|Subject moved away from site|0
7632250|NCT03917654|12045672|FG011|Year 2|Subject moved away from site|1
7632251|NCT03917654|12045661|FG000|Year 2|Year 2 Screening failure|0
7632252|NCT03917654|12045662|FG001|Year 2|Year 2 Screening failure|1
7632253|NCT03917654|12045663|FG002|Year 2|Year 2 Screening failure|0
7632254|NCT03917654|12045664|FG003|Year 2|Year 2 Screening failure|0
7632255|NCT03917654|12045665|FG004|Year 2|Year 2 Screening failure|2
7632256|NCT03917654|12045666|FG005|Year 2|Year 2 Screening failure|0
7632257|NCT03917654|12045667|FG006|Year 2|Year 2 Screening failure|4
7632258|NCT03917654|12045668|FG007|Year 2|Year 2 Screening failure|3
7632259|NCT03917654|12045669|FG008|Year 2|Year 2 Screening failure|10
7632260|NCT03917654|12045670|FG009|Year 2|Year 2 Screening failure|2
7632261|NCT03917654|12045671|FG010|Year 2|Year 2 Screening failure|1
7632262|NCT03917654|12045672|FG011|Year 2|Year 2 Screening failure|1
7632263|NCT03917654|12045661|FG000|Year 2|Death|0
7632264|NCT03917654|12045662|FG001|Year 2|Death|0
7632265|NCT03917654|12045663|FG002|Year 2|Death|0
7632266|NCT03917654|12045664|FG003|Year 2|Death|0
7632267|NCT03917654|12045665|FG004|Year 2|Death|0
7632268|NCT03917654|12045666|FG005|Year 2|Death|1
7632269|NCT03917654|12045667|FG006|Year 2|Death|0
7632270|NCT03917654|12045668|FG007|Year 2|Death|0
7632271|NCT03917654|12045669|FG008|Year 2|Death|1
7632272|NCT03917654|12045670|FG009|Year 2|Death|1
7632273|NCT03917654|12045671|FG010|Year 2|Death|0
7632274|NCT03917654|12045672|FG011|Year 2|Death|0
7632275|NCT03917654|12045661|FG000|Year 2|Withdrawal by Subject|0
7632276|NCT03917654|12045662|FG001|Year 2|Withdrawal by Subject|0
7632277|NCT03917654|12045663|FG002|Year 2|Withdrawal by Subject|0
7632278|NCT03917654|12045664|FG003|Year 2|Withdrawal by Subject|0
7632279|NCT03917654|12045665|FG004|Year 2|Withdrawal by Subject|0
7632280|NCT03917654|12045666|FG005|Year 2|Withdrawal by Subject|0
7632281|NCT03917654|12045667|FG006|Year 2|Withdrawal by Subject|3
7632282|NCT03917654|12045668|FG007|Year 2|Withdrawal by Subject|0
7632283|NCT03917654|12045669|FG008|Year 2|Withdrawal by Subject|2
7632284|NCT03917654|12045670|FG009|Year 2|Withdrawal by Subject|5
7632285|NCT03917654|12045671|FG010|Year 2|Withdrawal by Subject|0
7632286|NCT03917654|12045672|FG011|Year 2|Withdrawal by Subject|0
7632287|NCT03917654|12045661|FG000|Year 2|Spouse/family member request|0
7632288|NCT03917654|12045662|FG001|Year 2|Spouse/family member request|0
7632289|NCT03917654|12045663|FG002|Year 2|Spouse/family member request|0
7632290|NCT03917654|12045664|FG003|Year 2|Spouse/family member request|0
7632291|NCT03917654|12045665|FG004|Year 2|Spouse/family member request|0
7632292|NCT03917654|12045666|FG005|Year 2|Spouse/family member request|0
7632293|NCT03917654|12045667|FG006|Year 2|Spouse/family member request|1
7632294|NCT03917654|12045668|FG007|Year 2|Spouse/family member request|0
7632295|NCT03917654|12045669|FG008|Year 2|Spouse/family member request|0
7632296|NCT03917654|12045670|FG009|Year 2|Spouse/family member request|0
7632297|NCT03917654|12045671|FG010|Year 2|Spouse/family member request|0
7632298|NCT03917654|12045672|FG011|Year 2|Spouse/family member request|0
7632299|NCT03917654|12045661|FG000|Year 2|Lost to Follow-up|0
7632300|NCT03917654|12045662|FG001|Year 2|Lost to Follow-up|0
7632301|NCT03917654|12045663|FG002|Year 2|Lost to Follow-up|0
7632302|NCT03917654|12045664|FG003|Year 2|Lost to Follow-up|0
7632303|NCT03917654|12045665|FG004|Year 2|Lost to Follow-up|0
7632304|NCT03917654|12045666|FG005|Year 2|Lost to Follow-up|0
7632305|NCT03917654|12045667|FG006|Year 2|Lost to Follow-up|1
7632306|NCT03917654|12045668|FG007|Year 2|Lost to Follow-up|0
7632307|NCT03917654|12045669|FG008|Year 2|Lost to Follow-up|1
7632308|NCT03917654|12045670|FG009|Year 2|Lost to Follow-up|0
7632309|NCT03917654|12045671|FG010|Year 2|Lost to Follow-up|0
7632310|NCT03917654|12045672|FG011|Year 2|Lost to Follow-up|1
7632311|NCT03917654|12045661|FG000|Year 2|Adverse Event|0
7632312|NCT03917654|12045662|FG001|Year 2|Adverse Event|0
7632313|NCT03917654|12045663|FG002|Year 2|Adverse Event|0
7632314|NCT03917654|12045664|FG003|Year 2|Adverse Event|0
7632315|NCT03917654|12045665|FG004|Year 2|Adverse Event|0
7632316|NCT03917654|12045666|FG005|Year 2|Adverse Event|0
7632317|NCT03917654|12045667|FG006|Year 2|Adverse Event|0
7632318|NCT03917654|12045668|FG007|Year 2|Adverse Event|0
7632319|NCT03917654|12045669|FG008|Year 2|Adverse Event|0
7632320|NCT03917654|12045670|FG009|Year 2|Adverse Event|1
7632321|NCT03917654|12045671|FG010|Year 2|Adverse Event|0
7632322|NCT03917654|12045672|FG011|Year 2|Adverse Event|0
7632323|NCT03917472|12045700|FG000|Overall Study|Physician Decision|4
7632324|NCT03917472|12045701|FG001|Overall Study|Physician Decision|0
7632325|NCT03917472|12045700|FG000|Overall Study|Adverse Event|3
7632326|NCT03917472|12045701|FG001|Overall Study|Adverse Event|1
7632327|NCT03917472|12045700|FG000|Overall Study|Death|7
7632328|NCT03917472|12045701|FG001|Overall Study|Death|5
7632329|NCT03917472|12045700|FG000|Overall Study|Withdrawal by Subject|11
7632330|NCT03917472|12045701|FG001|Overall Study|Withdrawal by Subject|4
7632331|NCT03917472|12045700|FG000|Overall Study|Lost to Follow-up|10
7632332|NCT03917472|12045701|FG001|Overall Study|Lost to Follow-up|5
7632333|NCT03911154|12045724|FG000|Overall Study|Withdrawal by Subject|1
7632334|NCT03905694|12045731|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18
7632335|NCT03905135|12045737|FG000|Dose Escalation|Adverse Event|1
7632336|NCT03905135|12045738|FG001|Dose Escalation|Adverse Event|1
7632337|NCT03905135|12045737|FG000|Dose Escalation|Progressive disease|3
7632338|NCT03905135|12045738|FG001|Dose Escalation|Progressive disease|1
7632339|NCT03905135|12045737|FG000|Dose Escalation|Intercurrent illness|1
7632340|NCT03905135|12045738|FG001|Dose Escalation|Intercurrent illness|0
7632341|NCT03894540|12045794|FG000|Overall Study|Adverse Event|0
7632342|NCT03894540|12045795|FG001|Overall Study|Adverse Event|0
7632343|NCT03894540|12045796|FG002|Overall Study|Adverse Event|0
7632344|NCT03894540|12045797|FG003|Overall Study|Adverse Event|0
7632345|NCT03894540|12045798|FG004|Overall Study|Adverse Event|1
7632346|NCT03894540|12045799|FG005|Overall Study|Adverse Event|0
7632347|NCT03894540|12045794|FG000|Overall Study|Withdrawal by Subject|0
7632348|NCT03894540|12045795|FG001|Overall Study|Withdrawal by Subject|0
7632349|NCT03894540|12045796|FG002|Overall Study|Withdrawal by Subject|0
7632350|NCT03894540|12045797|FG003|Overall Study|Withdrawal by Subject|0
7632351|NCT03894540|12045798|FG004|Overall Study|Withdrawal by Subject|1
7632352|NCT03894540|12045799|FG005|Overall Study|Withdrawal by Subject|0
7632353|NCT03894540|12045794|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0
7632354|NCT03894540|12045795|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0
7632355|NCT03894540|12045796|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1
7632356|NCT03894540|12045797|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3
7632357|NCT03894540|12045798|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2
7632358|NCT03894540|12045799|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3
7632359|NCT03894540|12045794|FG000|Overall Study|Progressive Disease Clinical|1
7632360|NCT03894540|12045795|FG001|Overall Study|Progressive Disease Clinical|1
7632361|NCT03894540|12045796|FG002|Overall Study|Progressive Disease Clinical|0
7632362|NCT03894540|12045797|FG003|Overall Study|Progressive Disease Clinical|1
7632363|NCT03894540|12045798|FG004|Overall Study|Progressive Disease Clinical|5
7632364|NCT03894540|12045799|FG005|Overall Study|Progressive Disease Clinical|1
7632365|NCT03894540|12045794|FG000|Overall Study|Study termination by sponsor|0
7632366|NCT03894540|12045795|FG001|Overall Study|Study termination by sponsor|0
7632367|NCT03894540|12045796|FG002|Overall Study|Study termination by sponsor|0
7632368|NCT03894540|12045797|FG003|Overall Study|Study termination by sponsor|0
7632369|NCT03894540|12045798|FG004|Overall Study|Study termination by sponsor|2
7632370|NCT03894540|12045799|FG005|Overall Study|Study termination by sponsor|0
7632371|NCT03889886|12045821|FG000|Overall Study|Other|0
7632372|NCT03889886|12045822|FG001|Overall Study|Other|1
7632373|NCT03889886|12045823|FG002|Overall Study|Other|0
7632374|NCT03889886|12045824|FG003|Overall Study|Other|1
7632375|NCT03889886|12045821|FG000|Overall Study|Withdrawal by Subject|0
7632376|NCT03889886|12045822|FG001|Overall Study|Withdrawal by Subject|0
7632377|NCT03889886|12045823|FG002|Overall Study|Withdrawal by Subject|1
7632378|NCT03889886|12045824|FG003|Overall Study|Withdrawal by Subject|0
7632379|NCT03889886|12045821|FG000|Overall Study|Adverse Event|0
7632380|NCT03889886|12045822|FG001|Overall Study|Adverse Event|0
7632381|NCT03889886|12045823|FG002|Overall Study|Adverse Event|0
7632382|NCT03889886|12045824|FG003|Overall Study|Adverse Event|6
7632383|NCT03875092|12045854|FG000|Overall Study|Adverse Event|2
7632384|NCT03875092|12045855|FG001|Overall Study|Adverse Event|5
7632385|NCT03875092|12045854|FG000|Overall Study|Death|28
7632386|NCT03875092|12045855|FG001|Overall Study|Death|41
7632387|NCT03875092|12045854|FG000|Overall Study|Ongoing in Study|35
7632388|NCT03875092|12045855|FG001|Overall Study|Ongoing in Study|14
7632389|NCT03866473|12045905|FG000|Phase 1|Death|1
7632390|NCT03866473|12045906|FG001|Phase 1|Death|0
7632391|NCT03866473|12045905|FG000|Phase 2|Death|0
7632392|NCT03866473|12045906|FG001|Phase 2|Death|2
7632393|NCT03866473|12045905|FG000|Phase 2|Dropped|1
7632394|NCT03866473|12045906|FG001|Phase 2|Dropped|1
7632395|NCT03866473|12045905|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1
7632396|NCT03866473|12045906|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0
7632397|NCT03865732|12045918|FG000|Overall Study|Adverse Event|0
7632398|NCT03865732|12045919|FG001|Overall Study|Adverse Event|1
7632399|NCT03864341|12045930|FG000|Overall Study|Withdrawal by Subject|1
7632400|NCT03863834|12045934|FG000|Overall Study|Lost to Follow-up|3
7632401|NCT03853148|12045951|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5
7632402|NCT03853148|12045952|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8
7632403|NCT03853148|12045953|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8
7632404|NCT03853148|12045954|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5
7632405|NCT03850444|12045970|FG000|Overall Study|Adverse Event|12
7632406|NCT03850444|12045971|FG001|Overall Study|Adverse Event|9
7632407|NCT03850444|12045970|FG000|Overall Study|Death|38
7632408|NCT03850444|12045971|FG001|Overall Study|Death|64
7632409|NCT03850444|12045970|FG000|Overall Study|Lost to Follow-up|0
7632410|NCT03850444|12045971|FG001|Overall Study|Lost to Follow-up|1
7632411|NCT03850444|12045970|FG000|Overall Study|Withdrawal by Subject|0
7632412|NCT03850444|12045971|FG001|Overall Study|Withdrawal by Subject|1
7632413|NCT03850444|12045970|FG000|Overall Study|Ongoing in Study|78
7632414|NCT03850444|12045971|FG001|Overall Study|Ongoing in Study|59
7632415|NCT03848832|12045980|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0
7632416|NCT03848832|12045981|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0
7632417|NCT03848832|12045982|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1
7632418|NCT03848832|12045980|FG000|Overall Study|Withdrawal by Subject|0
7632419|NCT03848832|12045981|FG001|Overall Study|Withdrawal by Subject|0
7632420|NCT03848832|12045982|FG002|Overall Study|Withdrawal by Subject|1
7632421|NCT03848832|12045980|FG000|Overall Study|Withdrawal (Covid-19)|0
7632422|NCT03848832|12045981|FG001|Overall Study|Withdrawal (Covid-19)|2
7632423|NCT03848832|12045982|FG002|Overall Study|Withdrawal (Covid-19)|0
7632424|NCT03848832|12045980|FG000|Overall Study|Physician Decision|2
7632425|NCT03848832|12045981|FG001|Overall Study|Physician Decision|1
7632426|NCT03848832|12045982|FG002|Overall Study|Physician Decision|3
7632427|NCT03848832|12045980|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0
7632428|NCT03848832|12045981|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0
7632429|NCT03848832|12045982|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1
7632430|NCT03848832|12045980|FG000|Overall Study|Adverse Event|1
7632431|NCT03848832|12045981|FG001|Overall Study|Adverse Event|0
7632432|NCT03848832|12045982|FG002|Overall Study|Adverse Event|0
7632433|NCT03839940|12046011|FG000|Overall Study|Withdrawal by Subject|3
7632434|NCT03839940|12046012|FG001|Overall Study|Withdrawal by Subject|0
7632435|NCT03839940|12046011|FG000|Overall Study|Protocol Violation|0
7632436|NCT03839940|12046012|FG001|Overall Study|Protocol Violation|1
7632437|NCT03839940|12046011|FG000|Overall Study|No Post-Baseline Pain Score Data|1
7632438|NCT03839940|12046012|FG001|Overall Study|No Post-Baseline Pain Score Data|1
7632439|NCT03839693|12046023|FG000|Overall Study|Lost to Follow-up|0
7632440|NCT03839693|12046024|FG001|Overall Study|Lost to Follow-up|2
7632441|NCT03839693|12046025|FG002|Overall Study|Lost to Follow-up|2
7632442|NCT03839693|12046023|FG000|Overall Study|Withdrawal by Subject|1
7632443|NCT03839693|12046024|FG001|Overall Study|Withdrawal by Subject|0
7632444|NCT03839693|12046025|FG002|Overall Study|Withdrawal by Subject|2
7632445|NCT03839693|12046023|FG000|Overall Study|subject moved out of the area|1
7632446|NCT03839693|12046024|FG001|Overall Study|subject moved out of the area|0
7632447|NCT03839693|12046025|FG002|Overall Study|subject moved out of the area|0
7632448|NCT03837743|12046035|FG000|Overall Study|Adverse Event|1
7632449|NCT03837743|12046035|FG000|Overall Study|Withdrawal by Subject|2
7632450|NCT03834623|12046049|FG000|Overall Study|Progression|0
7632451|NCT03834623|12046050|FG001|Overall Study|Progression|1
7632452|NCT03833817|12046079|FG000|Overall Study|Withdrawal by Subject|3
7632453|NCT03833817|12046080|FG001|Overall Study|Withdrawal by Subject|3
7632454|NCT03833817|12046079|FG000|Overall Study|Lost to Follow-up|3
7632455|NCT03833817|12046080|FG001|Overall Study|Lost to Follow-up|3
7632456|NCT03823703|12046114|FG000|Overall Study|Sponsor request|0
7632457|NCT03823703|12046115|FG001|Overall Study|Sponsor request|3
7632458|NCT03823703|12046116|FG002|Overall Study|Sponsor request|4
7632459|NCT03823703|12046114|FG000|Overall Study|Adverse Event|3
7632460|NCT03823703|12046115|FG001|Overall Study|Adverse Event|1
7632461|NCT03823703|12046116|FG002|Overall Study|Adverse Event|0
7632462|NCT03823703|12046114|FG000|Overall Study|Withdrawal by Subject|0
7632463|NCT03823703|12046115|FG001|Overall Study|Withdrawal by Subject|1
7632464|NCT03823703|12046116|FG002|Overall Study|Withdrawal by Subject|0
7632465|NCT03823300|12046126|FG000|Overall Study|Withdrawal by Subject|5
7632466|NCT03823300|12046127|FG001|Overall Study|Withdrawal by Subject|8
7632467|NCT03823300|12046126|FG000|Overall Study|Death|2
7632468|NCT03823300|12046127|FG001|Overall Study|Death|5
7632469|NCT03823300|12046126|FG000|Overall Study|Adverse Event|2
7632470|NCT03823300|12046127|FG001|Overall Study|Adverse Event|0
7632471|NCT03823300|12046126|FG000|Overall Study|Physician Decision|0
7632472|NCT03823300|12046127|FG001|Overall Study|Physician Decision|2
7632473|NCT03823300|12046126|FG000|Overall Study|Protocol Violation|1
7632474|NCT03823300|12046127|FG001|Overall Study|Protocol Violation|1
7632475|NCT03823300|12046126|FG000|Overall Study|Lost to Follow-up|0
7632476|NCT03823300|12046127|FG001|Overall Study|Lost to Follow-up|1
7632477|NCT03823300|12046126|FG000|Overall Study|Not Eligible|0
7632478|NCT03823300|12046127|FG001|Overall Study|Not Eligible|1
7632479|NCT03823300|12046126|FG000|Overall Study|Ongoing in the study at Primary Completion Date|321
7632480|NCT03823300|12046127|FG001|Overall Study|Ongoing in the study at Primary Completion Date|309
7632481|NCT03817853|12046133|FG000|Induction Phase|Adverse Event|5
7632482|NCT03817853|12046134|FG001|Induction Phase|Adverse Event|0
7632483|NCT03817853|12046135|FG002|Induction Phase|Adverse Event|0
7632484|NCT03817853|12046133|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3
7632485|NCT03817853|12046134|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0
7632486|NCT03817853|12046135|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0
7632487|NCT03817853|12046133|FG000|Induction Phase|Physician Decision|2
7632488|NCT03817853|12046134|FG001|Induction Phase|Physician Decision|0
7632489|NCT03817853|12046135|FG002|Induction Phase|Physician Decision|0
7632490|NCT03817853|12046133|FG000|Induction Phase|Progressive Disease|4
7632491|NCT03817853|12046134|FG001|Induction Phase|Progressive Disease|0
7632492|NCT03817853|12046135|FG002|Induction Phase|Progressive Disease|0
7632493|NCT03817853|12046133|FG000|Induction Phase|Withdrawal by Subject|3
7632494|NCT03817853|12046134|FG001|Induction Phase|Withdrawal by Subject|0
7632495|NCT03817853|12046135|FG002|Induction Phase|Withdrawal by Subject|0
7632496|NCT03817853|12046133|FG000|Induction Phase|Continuing on Study|34
7632497|NCT03817853|12046134|FG001|Induction Phase|Continuing on Study|0
7632498|NCT03817853|12046135|FG002|Induction Phase|Continuing on Study|0
7632499|NCT03817853|12046133|FG000|Maintenance/ Follow-up Phase|Adverse Event|0
7632500|NCT03817853|12046134|FG001|Maintenance/ Follow-up Phase|Adverse Event|1
7632501|NCT03817853|12046135|FG002|Maintenance/ Follow-up Phase|Adverse Event|0
7632502|NCT03817853|12046133|FG000|Maintenance/ Follow-up Phase|Death|0
7632503|NCT03817853|12046134|FG001|Maintenance/ Follow-up Phase|Death|1
7632504|NCT03817853|12046135|FG002|Maintenance/ Follow-up Phase|Death|1
7632505|NCT03817853|12046133|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0
7632506|NCT03817853|12046134|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1
7632507|NCT03817853|12046135|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3
7632508|NCT03817853|12046133|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0
7632509|NCT03817853|12046134|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1
7632510|NCT03817853|12046135|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0
7632511|NCT03817853|12046133|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0
7632512|NCT03817853|12046134|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52
7632513|NCT03817853|12046135|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2
7632514|NCT03814590|12046157|FG000|Overall Study|Adverse Event|0
7632515|NCT03814590|12046158|FG001|Overall Study|Adverse Event|0
7632516|NCT03814590|12046159|FG002|Overall Study|Adverse Event|0
7632517|NCT03814590|12046160|FG003|Overall Study|Adverse Event|0
7632518|NCT03814590|12046161|FG004|Overall Study|Adverse Event|0
7632519|NCT03814590|12046162|FG005|Overall Study|Adverse Event|1
7632520|NCT03814590|12046163|FG006|Overall Study|Adverse Event|1
7632521|NCT03814590|12046164|FG007|Overall Study|Adverse Event|1
7632522|NCT03814590|12046165|FG008|Overall Study|Adverse Event|0
7632523|NCT03814590|12046166|FG009|Overall Study|Adverse Event|0
7632524|NCT03814590|12046167|FG010|Overall Study|Adverse Event|1
7632525|NCT03814590|12046168|FG011|Overall Study|Adverse Event|0
7632526|NCT03814590|12046169|FG012|Overall Study|Adverse Event|3
7632527|NCT03814590|12046170|FG013|Overall Study|Adverse Event|0
7632528|NCT03814590|12046157|FG000|Overall Study|Lost to Follow-up|0
7632529|NCT03814590|12046158|FG001|Overall Study|Lost to Follow-up|2
7632530|NCT03814590|12046159|FG002|Overall Study|Lost to Follow-up|1
7632531|NCT03814590|12046160|FG003|Overall Study|Lost to Follow-up|0
7632532|NCT03814590|12046161|FG004|Overall Study|Lost to Follow-up|1
7632533|NCT03814590|12046162|FG005|Overall Study|Lost to Follow-up|1
7632534|NCT03814590|12046163|FG006|Overall Study|Lost to Follow-up|1
7632535|NCT03814590|12046164|FG007|Overall Study|Lost to Follow-up|1
7632536|NCT03814590|12046165|FG008|Overall Study|Lost to Follow-up|0
7632537|NCT03814590|12046166|FG009|Overall Study|Lost to Follow-up|0
7632538|NCT03814590|12046167|FG010|Overall Study|Lost to Follow-up|1
7632539|NCT03814590|12046168|FG011|Overall Study|Lost to Follow-up|0
7632540|NCT03814590|12046169|FG012|Overall Study|Lost to Follow-up|0
7632541|NCT03814590|12046170|FG013|Overall Study|Lost to Follow-up|1
7632542|NCT03814590|12046157|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632543|NCT03814590|12046158|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632544|NCT03814590|12046159|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632545|NCT03814590|12046160|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632546|NCT03814590|12046161|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632547|NCT03814590|12046162|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632548|NCT03814590|12046163|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632549|NCT03814590|12046164|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632550|NCT03814590|12046165|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632551|NCT03814590|12046166|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1
7632552|NCT03814590|12046167|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632553|NCT03814590|12046168|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632554|NCT03814590|12046169|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632555|NCT03814590|12046170|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632556|NCT03814590|12046157|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7632557|NCT03814590|12046158|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7632558|NCT03814590|12046159|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7632559|NCT03814590|12046160|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7632560|NCT03814590|12046161|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7632561|NCT03814590|12046162|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3
7632562|NCT03814590|12046163|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1
7632563|NCT03814590|12046164|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2
7632564|NCT03814590|12046165|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7632565|NCT03814590|12046166|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3
7632566|NCT03814590|12046167|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1
7632567|NCT03814590|12046168|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7632568|NCT03814590|12046169|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1
7632569|NCT03814590|12046170|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2
7632570|NCT03814590|12046157|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632571|NCT03814590|12046158|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632572|NCT03814590|12046159|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632573|NCT03814590|12046160|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632574|NCT03814590|12046161|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632575|NCT03814590|12046162|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632576|NCT03814590|12046163|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632577|NCT03814590|12046164|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7632578|NCT03814590|12046165|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632579|NCT03814590|12046166|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7632580|NCT03814590|12046167|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632581|NCT03814590|12046168|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632582|NCT03814590|12046169|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632583|NCT03814590|12046170|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632584|NCT03814590|12046157|FG000|Overall Study|UNKNOWN REASON|0
7632585|NCT03814590|12046158|FG001|Overall Study|UNKNOWN REASON|0
7632586|NCT03814590|12046159|FG002|Overall Study|UNKNOWN REASON|0
7632587|NCT03814590|12046160|FG003|Overall Study|UNKNOWN REASON|0
7632588|NCT03814590|12046161|FG004|Overall Study|UNKNOWN REASON|0
7632589|NCT03814590|12046162|FG005|Overall Study|UNKNOWN REASON|0
7632590|NCT03814590|12046163|FG006|Overall Study|UNKNOWN REASON|0
7632591|NCT03814590|12046164|FG007|Overall Study|UNKNOWN REASON|1
7632592|NCT03814590|12046165|FG008|Overall Study|UNKNOWN REASON|0
7632593|NCT03814590|12046166|FG009|Overall Study|UNKNOWN REASON|0
7632594|NCT03814590|12046167|FG010|Overall Study|UNKNOWN REASON|0
7632595|NCT03814590|12046168|FG011|Overall Study|UNKNOWN REASON|0
7632596|NCT03814590|12046169|FG012|Overall Study|UNKNOWN REASON|0
7632597|NCT03814590|12046170|FG013|Overall Study|UNKNOWN REASON|0
7632598|NCT03812380|12046221|FG000|Overall Study|Protocol Violation|3
7632599|NCT03812380|12046222|FG001|Overall Study|Protocol Violation|3
7632600|NCT03812380|12046221|FG000|Overall Study|Withdrawal by Subject|5
7632601|NCT03812380|12046222|FG001|Overall Study|Withdrawal by Subject|4
7632602|NCT03812380|12046221|FG000|Overall Study|Early termination of study|14
7632603|NCT03812380|12046222|FG001|Overall Study|Early termination of study|14
7632604|NCT03812224|12046230|FG000|Double-blind Treatment Period|Withdrawal by Subject|4
7632605|NCT03812224|12046231|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
7632606|NCT03812224|12046230|FG000|Double-blind Treatment Period|Decision by Sponsor|0
7632607|NCT03812224|12046231|FG001|Double-blind Treatment Period|Decision by Sponsor|1
7632608|NCT03812224|12046230|FG000|Open-label Treatment Period|Withdrawal by Subject|2
7632609|NCT03812224|12046231|FG001|Open-label Treatment Period|Withdrawal by Subject|2
7632610|NCT03812224|12046230|FG000|Open-label Treatment Period|Decision by Sponsor|0
7632611|NCT03812224|12046231|FG001|Open-label Treatment Period|Decision by Sponsor|1
7632612|NCT03811093|12046240|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0
7632613|NCT03811093|12046241|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4
7632614|NCT03811093|12046240|FG000|Overall Study|Unable to measure body fat percentage|2
7632615|NCT03811093|12046241|FG001|Overall Study|Unable to measure body fat percentage|0
7632616|NCT03810495|12046268|FG000|Overall Study|Lost to Follow-up|2
7632617|NCT03810495|12046268|FG000|Overall Study|Withdrawal by Subject|1
7632618|NCT03810313|12046274|FG000|Overall Study|Study terminated by sponsor|164
7632619|NCT03810313|12046275|FG001|Overall Study|Study terminated by sponsor|159
7632620|NCT03810313|12046274|FG000|Overall Study|Subject decision|10
7632621|NCT03810313|12046275|FG001|Overall Study|Subject decision|11
7632622|NCT03810313|12046274|FG000|Overall Study|Lost to Follow-up|3
7632623|NCT03810313|12046275|FG001|Overall Study|Lost to Follow-up|3
7632624|NCT03810313|12046274|FG000|Overall Study|Adverse Event|2
7632625|NCT03810313|12046275|FG001|Overall Study|Adverse Event|1
7632626|NCT03810313|12046274|FG000|Overall Study|Death|2
7632627|NCT03810313|12046275|FG001|Overall Study|Death|1
7632628|NCT03810313|12046274|FG000|Overall Study|Physician Decision|0
7632629|NCT03810313|12046275|FG001|Overall Study|Physician Decision|1
7632630|NCT03807843|12046284|FG000|Overall Study|Lost to Follow-up|1
7632631|NCT03807843|12046285|FG001|Overall Study|Lost to Follow-up|0
7632632|NCT03804879|12046293|FG000|Overall Study|Adverse Event|3
7632633|NCT03804879|12046294|FG001|Overall Study|Adverse Event|0
7632634|NCT03804879|12046293|FG000|Overall Study|Study Terminated By Sponsor|10
7632635|NCT03804879|12046294|FG001|Overall Study|Study Terminated By Sponsor|12
7632636|NCT03804879|12046293|FG000|Overall Study|Withdrawal by Subject|3
7632637|NCT03804879|12046294|FG001|Overall Study|Withdrawal by Subject|1
7632638|NCT03802630|12046303|FG000|Overall Study|Study terminated by sponsor|130
7632639|NCT03802630|12046304|FG001|Overall Study|Study terminated by sponsor|134
7632640|NCT03802630|12046303|FG000|Overall Study|Subject decision|16
7632641|NCT03802630|12046304|FG001|Overall Study|Subject decision|9
7632642|NCT03802630|12046303|FG000|Overall Study|Adverse Event|3
7632643|NCT03802630|12046304|FG001|Overall Study|Adverse Event|1
7632644|NCT03802630|12046303|FG000|Overall Study|Lost to Follow-up|2
7632645|NCT03802630|12046304|FG001|Overall Study|Lost to Follow-up|2
7632646|NCT03802630|12046303|FG000|Overall Study|Physician Decision|2
7632647|NCT03802630|12046304|FG001|Overall Study|Physician Decision|0
7632648|NCT03802630|12046303|FG000|Overall Study|Death|0
7632649|NCT03802630|12046304|FG001|Overall Study|Death|2
7632650|NCT03789110|12046344|FG000|Overall Study|Adverse Event|2
7632651|NCT03789110|12046344|FG000|Overall Study|Physician Decision|1
7632652|NCT03789110|12046344|FG000|Overall Study|Withdrawal by Subject|2
7632653|NCT03789110|12046344|FG000|Overall Study|Lack of Efficacy|22
7632654|NCT03789110|12046344|FG000|Overall Study|still on treatment|3
7632655|NCT03782064|12046352|FG000|Overall Study|Lack of Efficacy|2
7632656|NCT03782064|12046352|FG000|Overall Study|Progression Prior to Starting Treatment|3
7632657|NCT03777917|12046358|FG000|Overall Study|Withdrawal by Subject|1
7632658|NCT03777917|12046359|FG001|Overall Study|Withdrawal by Subject|0
7632659|NCT03777917|12046358|FG000|Overall Study|Physician Decision|1
7632660|NCT03777917|12046359|FG001|Overall Study|Physician Decision|0
7632661|NCT03777917|12046358|FG000|Overall Study|Lost to Follow-up|6
7632662|NCT03777917|12046359|FG001|Overall Study|Lost to Follow-up|2
7632663|NCT03777917|12046358|FG000|Overall Study|Other|1
7632664|NCT03777917|12046359|FG001|Overall Study|Other|0
7632665|NCT03774875|12046368|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8
7632666|NCT03774875|12046369|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16
7632667|NCT03774875|12046368|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2
7632668|NCT03774875|12046369|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4
7632669|NCT03774875|12046368|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12
7632670|NCT03774875|12046369|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10
7632671|NCT03774875|12046368|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0
7632672|NCT03774875|12046369|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2
7632673|NCT03774875|12046368|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0
7632674|NCT03774875|12046369|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1
7632675|NCT03774875|12046368|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1
7632676|NCT03774875|12046369|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0
7632677|NCT03774875|12046368|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6
7632678|NCT03774875|12046369|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9
7632679|NCT03774875|12046368|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2
7632680|NCT03774875|12046369|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11
7632681|NCT03774875|12046368|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7
7632682|NCT03774875|12046369|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20
7632683|NCT03774875|12046368|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0
7632684|NCT03774875|12046369|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2
7632685|NCT03774875|12046368|FG000|Apremilast Extension Period (Week 16-52)|Other|1
7632686|NCT03774875|12046369|FG001|Apremilast Extension Period (Week 16-52)|Other|1
7632687|NCT03774875|12046368|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0
7632688|NCT03774875|12046369|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1
7632689|NCT03774875|12046368|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0
7632690|NCT03774875|12046369|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3
7632691|NCT03773484|12046386|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5
7632692|NCT03773133|12046390|FG000|Overall Study|Screen Failure|8
7632693|NCT03769753|12046395|FG000|Overall Study|Not Treated|6
7632694|NCT03769753|12046395|FG000|Overall Study|Inevaluable - No Evidence of Disease|1
7632695|NCT03769090|12046402|FG000|Overall Study|Randomized and did not receive randomized study treatment|1
7632696|NCT03769090|12046403|FG001|Overall Study|Randomized and did not receive randomized study treatment|2
7632697|NCT03769090|12046404|FG002|Overall Study|Randomized and did not receive randomized study treatment|2
7632698|NCT03769090|12046402|FG000|Overall Study|Withdrawal by Subject|52
7632699|NCT03769090|12046403|FG001|Overall Study|Withdrawal by Subject|62
7632700|NCT03769090|12046404|FG002|Overall Study|Withdrawal by Subject|74
7632701|NCT03769090|12046402|FG000|Overall Study|Death|4
7632702|NCT03769090|12046403|FG001|Overall Study|Death|2
7632703|NCT03769090|12046404|FG002|Overall Study|Death|2
7632704|NCT03769090|12046402|FG000|Overall Study|Adverse Event|7
7632705|NCT03769090|12046403|FG001|Overall Study|Adverse Event|7
7632706|NCT03769090|12046404|FG002|Overall Study|Adverse Event|8
7632707|NCT03769090|12046402|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0
7632708|NCT03769090|12046403|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1
7632709|NCT03769090|12046404|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2
7632710|NCT03769090|12046402|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1
7632711|NCT03769090|12046403|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4
7632712|NCT03769090|12046404|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4
7632713|NCT03769090|12046402|FG000|Overall Study|>= 5 total severe exacerbation events|0
7632714|NCT03769090|12046403|FG001|Overall Study|>= 5 total severe exacerbation events|1
7632715|NCT03769090|12046404|FG002|Overall Study|>= 5 total severe exacerbation events|1
7632716|NCT03769090|12046402|FG000|Overall Study|Protocol Violation|5
7632717|NCT03769090|12046403|FG001|Overall Study|Protocol Violation|6
7632718|NCT03769090|12046404|FG002|Overall Study|Protocol Violation|8
7632719|NCT03769090|12046402|FG000|Overall Study|Pregnancy|1
7632720|NCT03769090|12046403|FG001|Overall Study|Pregnancy|0
7632721|NCT03769090|12046404|FG002|Overall Study|Pregnancy|3
7632722|NCT03769090|12046402|FG000|Overall Study|Lost to Follow-up|19
7632723|NCT03769090|12046403|FG001|Overall Study|Lost to Follow-up|25
7632724|NCT03769090|12046404|FG002|Overall Study|Lost to Follow-up|21
7632725|NCT03769090|12046402|FG000|Overall Study|Condition under investigation worsened|2
7632726|NCT03769090|12046403|FG001|Overall Study|Condition under investigation worsened|0
7632727|NCT03769090|12046404|FG002|Overall Study|Condition under investigation worsened|1
7632728|NCT03769090|12046402|FG000|Overall Study|Lack of Efficacy|1
7632729|NCT03769090|12046403|FG001|Overall Study|Lack of Efficacy|2
7632730|NCT03769090|12046404|FG002|Overall Study|Lack of Efficacy|2
7632731|NCT03769090|12046402|FG000|Overall Study|Other reasons|8
7632732|NCT03769090|12046403|FG001|Overall Study|Other reasons|12
7632733|NCT03769090|12046404|FG002|Overall Study|Other reasons|15
7632734|NCT03764475|12046417|FG000|Overall Study|Adverse Event|11
7632735|NCT03764475|12046418|FG001|Overall Study|Adverse Event|2
7632736|NCT03764475|12046417|FG000|Overall Study|Lost to Follow-up|24
7632737|NCT03764475|12046418|FG001|Overall Study|Lost to Follow-up|10
7632738|NCT03764475|12046417|FG000|Overall Study|Withdrawal by Subject|26
7632739|NCT03764475|12046418|FG001|Overall Study|Withdrawal by Subject|10
7632740|NCT03764475|12046417|FG000|Overall Study|Lack of Efficacy|3
7632741|NCT03764475|12046418|FG001|Overall Study|Lack of Efficacy|0
7632742|NCT03764475|12046417|FG000|Overall Study|COVID-19 Disruption|2
7632743|NCT03764475|12046418|FG001|Overall Study|COVID-19 Disruption|0
7632744|NCT03762265|12046430|FG000|BT Period: Weeks 1 to 37|Adverse Event|7
7632745|NCT03762265|12046431|FG001|BT Period: Weeks 1 to 37|Adverse Event|2
7632746|NCT03762265|12046430|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1
7632747|NCT03762265|12046431|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0
7632748|NCT03762265|12046430|FG000|BT Period: Weeks 1 to 37|Physician Decision|1
7632749|NCT03762265|12046431|FG001|BT Period: Weeks 1 to 37|Physician Decision|0
7632750|NCT03762265|12046430|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2
7632751|NCT03762265|12046431|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0
7632752|NCT03762265|12046430|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4
7632753|NCT03762265|12046431|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0
7632754|NCT03762265|12046430|FG000|BT Period: Weeks 1 to 37|Other|0
7632755|NCT03762265|12046431|FG001|BT Period: Weeks 1 to 37|Other|1
7632756|NCT03762265|12046430|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1
7632757|NCT03762265|12046431|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2
7632758|NCT03762265|12046430|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3
7632759|NCT03762265|12046431|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2
7632760|NCT03762265|12046430|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1
7632761|NCT03762265|12046431|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0
7632762|NCT03762265|12046430|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8
7632763|NCT03762265|12046431|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10
7632764|NCT03762265|12046430|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3
7632765|NCT03762265|12046431|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2
7632766|NCT03762265|12046430|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0
7632767|NCT03762265|12046431|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1
7632768|NCT03762265|12046430|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28
7632769|NCT03762265|12046431|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25
7632770|NCT03762265|12046430|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0
7632771|NCT03762265|12046431|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2
7632772|NCT03762265|12046430|FG000|LTE Period: Weeks 61 to 109|Other|1
7632773|NCT03762265|12046431|FG001|LTE Period: Weeks 61 to 109|Other|0
7632774|NCT03760666|12046456|FG000|Overall Study|Adverse Event|2
7632775|NCT03760666|12046457|FG001|Overall Study|Adverse Event|4
7632776|NCT03760666|12046458|FG002|Overall Study|Adverse Event|1
7632777|NCT03760666|12046456|FG000|Overall Study|AML Disease Progression|3
7632778|NCT03760666|12046457|FG001|Overall Study|AML Disease Progression|3
7632779|NCT03760666|12046458|FG002|Overall Study|AML Disease Progression|0
7632780|NCT03760666|12046456|FG000|Overall Study|Physician Decision|0
7632781|NCT03760666|12046457|FG001|Overall Study|Physician Decision|3
7632782|NCT03760666|12046458|FG002|Overall Study|Physician Decision|0
7632783|NCT03760666|12046456|FG000|Overall Study|Withdrawal by Subject|0
7632784|NCT03760666|12046457|FG001|Overall Study|Withdrawal by Subject|1
7632785|NCT03760666|12046458|FG002|Overall Study|Withdrawal by Subject|0
7632786|NCT03759379|12046472|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119
7632787|NCT03759379|12046473|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38
7632788|NCT03759379|12046472|FG000|Treatment Period|Death|2
7632789|NCT03759379|12046473|FG001|Treatment Period|Death|3
7632790|NCT03759379|12046472|FG000|Treatment Period|Lost to Follow-up|1
7632791|NCT03759379|12046473|FG001|Treatment Period|Lost to Follow-up|0
7632792|NCT03759379|12046472|FG000|Treatment Period|Physician Decision|0
7632793|NCT03759379|12046473|FG001|Treatment Period|Physician Decision|1
7632794|NCT03759366|12046479|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1
7632795|NCT03759366|12046479|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10
7632796|NCT03759041|12046486|FG000|Overall Study|Withdrawal by Subject|4
7632797|NCT03759041|12046487|FG001|Overall Study|Withdrawal by Subject|10
7632798|NCT03759041|12046488|FG002|Overall Study|Withdrawal by Subject|10
7632799|NCT03759041|12046486|FG000|Overall Study|Adverse Event|1
7632800|NCT03759041|12046487|FG001|Overall Study|Adverse Event|3
7632801|NCT03759041|12046488|FG002|Overall Study|Adverse Event|4
7632802|NCT03759041|12046486|FG000|Overall Study|Lack of Efficacy|0
7632803|NCT03759041|12046487|FG001|Overall Study|Lack of Efficacy|0
7632804|NCT03759041|12046488|FG002|Overall Study|Lack of Efficacy|1
7632805|NCT03759041|12046486|FG000|Overall Study|Study Terminated by Sponsor|15
7632806|NCT03759041|12046487|FG001|Overall Study|Study Terminated by Sponsor|16
7632807|NCT03759041|12046488|FG002|Overall Study|Study Terminated by Sponsor|10
7632808|NCT03759041|12046486|FG000|Overall Study|Other reason for discontinuation|0
7632809|NCT03759041|12046487|FG001|Overall Study|Other reason for discontinuation|2
7632810|NCT03759041|12046488|FG002|Overall Study|Other reason for discontinuation|1
7632811|NCT03759041|12046486|FG000|Overall Study|Lost to Follow-up|7
7632812|NCT03759041|12046487|FG001|Overall Study|Lost to Follow-up|2
7632813|NCT03759041|12046488|FG002|Overall Study|Lost to Follow-up|2
7632814|NCT03759041|12046486|FG000|Overall Study|Subjects did not have a discontinuation page completed|0
7632815|NCT03759041|12046487|FG001|Overall Study|Subjects did not have a discontinuation page completed|1
7632816|NCT03759041|12046488|FG002|Overall Study|Subjects did not have a discontinuation page completed|0
7632817|NCT03757715|12046498|FG000|Overall Study|Lost to Follow-up|4
7632818|NCT03757715|12046499|FG001|Overall Study|Lost to Follow-up|9
7632819|NCT03757715|12046498|FG000|Overall Study|Withdrawal by Subject|1
7632820|NCT03757715|12046499|FG001|Overall Study|Withdrawal by Subject|1
7632821|NCT03753542|12046507|FG000|Overall Study|Lost to Follow-up|9
7632822|NCT03753542|12046508|FG001|Overall Study|Lost to Follow-up|14
7632823|NCT03750552|12046516|FG000|Overall Study|Adverse Event|5
7632824|NCT03750552|12046517|FG001|Overall Study|Adverse Event|1
7632825|NCT03750552|12046516|FG000|Overall Study|Withdrawal by Subject|1
7632826|NCT03750552|12046517|FG001|Overall Study|Withdrawal by Subject|1
7632827|NCT03750552|12046516|FG000|Overall Study|Other|2
7632828|NCT03750552|12046517|FG001|Overall Study|Other|0
7632829|NCT03750240|12046524|FG000|Overall Study|Technical Difficulties|2
7632830|NCT03749109|12046530|FG000|Overall Study|Adverse Event|2
7632831|NCT03749109|12046531|FG001|Overall Study|Adverse Event|0
7632832|NCT03747302|12046540|FG000|Overall Study|Withdrawal by Subject|1
7632833|NCT03747302|12046541|FG001|Overall Study|Withdrawal by Subject|2
7632834|NCT03739203|12046556|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6
7632835|NCT03739203|12046557|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9
7632836|NCT03739203|12046558|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13
7632837|NCT03739203|12046556|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
7632838|NCT03739203|12046557|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7632839|NCT03739203|12046558|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
7632840|NCT03739203|12046556|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1
7632841|NCT03739203|12046557|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1
7632842|NCT03739203|12046558|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2
7632843|NCT03739203|12046556|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
7632844|NCT03739203|12046557|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
7632845|NCT03739203|12046558|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6
7632846|NCT03739203|12046556|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1
7632847|NCT03739203|12046557|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0
7632848|NCT03739203|12046558|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1
7632849|NCT03739203|12046556|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1
7632850|NCT03739203|12046557|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3
7632851|NCT03739203|12046558|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1
7632852|NCT03739203|12046556|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1
7632853|NCT03739203|12046557|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0
7632854|NCT03739203|12046558|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1
7632855|NCT03739203|12046556|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1
7632856|NCT03739203|12046557|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2
7632857|NCT03739203|12046558|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0
7632858|NCT03739203|12046556|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0
7632859|NCT03739203|12046557|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0
7632860|NCT03739203|12046558|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2
7632861|NCT03739203|12046556|FG000|Safety Follow-Up Period (4 Weeks)|Death|1
7632862|NCT03739203|12046557|FG001|Safety Follow-Up Period (4 Weeks)|Death|0
7632863|NCT03739203|12046558|FG002|Safety Follow-Up Period (4 Weeks)|Death|0
7632864|NCT03739203|12046556|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0
7632865|NCT03739203|12046557|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0
7632866|NCT03739203|12046558|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2
7632867|NCT03733444|12046590|FG000|Overall Study|Adverse Event|8
7632868|NCT03733444|12046591|FG001|Overall Study|Adverse Event|10
7632869|NCT03733444|12046592|FG002|Overall Study|Adverse Event|5
7632870|NCT03733444|12046590|FG000|Overall Study|Death|20
7632871|NCT03733444|12046591|FG001|Overall Study|Death|19
7632872|NCT03733444|12046592|FG002|Overall Study|Death|11
7632873|NCT03733444|12046590|FG000|Overall Study|Lost to Follow-up|3
7632874|NCT03733444|12046591|FG001|Overall Study|Lost to Follow-up|0
7632875|NCT03733444|12046592|FG002|Overall Study|Lost to Follow-up|1
7632876|NCT03733444|12046590|FG000|Overall Study|Lack of Efficacy|0
7632877|NCT03733444|12046591|FG001|Overall Study|Lack of Efficacy|1
7632878|NCT03733444|12046592|FG002|Overall Study|Lack of Efficacy|1
7632879|NCT03733444|12046590|FG000|Overall Study|Physician Decision|2
7632880|NCT03733444|12046591|FG001|Overall Study|Physician Decision|1
7632881|NCT03733444|12046592|FG002|Overall Study|Physician Decision|0
7632882|NCT03733444|12046590|FG000|Overall Study|Protocol Violation|2
7632883|NCT03733444|12046591|FG001|Overall Study|Protocol Violation|1
7632884|NCT03733444|12046592|FG002|Overall Study|Protocol Violation|0
7632885|NCT03733444|12046590|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1
7632886|NCT03733444|12046591|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1
7632887|NCT03733444|12046592|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2
7632888|NCT03733444|12046590|FG000|Overall Study|Study Terminated by Sponsor|203
7632889|NCT03733444|12046591|FG001|Overall Study|Study Terminated by Sponsor|209
7632890|NCT03733444|12046592|FG002|Overall Study|Study Terminated by Sponsor|221
7632891|NCT03733444|12046590|FG000|Overall Study|Withdrawal by Subject|19
7632892|NCT03733444|12046591|FG001|Overall Study|Withdrawal by Subject|18
7632893|NCT03733444|12046592|FG002|Overall Study|Withdrawal by Subject|16
7632894|NCT03733444|12046590|FG000|Overall Study|Miscellaneous|1
7632895|NCT03733444|12046591|FG001|Overall Study|Miscellaneous|0
7632896|NCT03733444|12046592|FG002|Overall Study|Miscellaneous|1
7632897|NCT03733444|12046590|FG000|Overall Study|Not Treated|1
7632898|NCT03733444|12046591|FG001|Overall Study|Not Treated|2
7632899|NCT03733444|12046592|FG002|Overall Study|Not Treated|1
7632900|NCT03730012|12046612|FG000|Overall Study|Adverse Event|0
7632901|NCT03730012|12046613|FG001|Overall Study|Adverse Event|1
7632902|NCT03730012|12046612|FG000|Overall Study|Lack of Efficacy|1
7632903|NCT03730012|12046613|FG001|Overall Study|Lack of Efficacy|5
7632904|NCT03730012|12046612|FG000|Overall Study|Withdrawal by Subject|0
7632905|NCT03730012|12046613|FG001|Overall Study|Withdrawal by Subject|1
7632906|NCT03730012|12046612|FG000|Overall Study|Miscellaneous|2
7632907|NCT03730012|12046613|FG001|Overall Study|Miscellaneous|1
7632908|NCT03727841|12046624|FG000|Overall Study|Physician Decision|3
7632909|NCT03727841|12046625|FG001|Overall Study|Physician Decision|1
7632910|NCT03726879|12046633|FG000|Overall Study|Death|6
7632911|NCT03726879|12046634|FG001|Overall Study|Death|4
7632912|NCT03726879|12046633|FG000|Overall Study|Physician Decision|0
7632913|NCT03726879|12046634|FG001|Overall Study|Physician Decision|2
7632914|NCT03726879|12046633|FG000|Overall Study|Protocol Violation|0
7632915|NCT03726879|12046634|FG001|Overall Study|Protocol Violation|1
7632916|NCT03726879|12046633|FG000|Overall Study|Withdrawal by Subject|5
7632917|NCT03726879|12046634|FG001|Overall Study|Withdrawal by Subject|5
7632918|NCT03726879|12046633|FG000|Overall Study|TSH result is unstable|0
7632919|NCT03726879|12046634|FG001|Overall Study|TSH result is unstable|1
7632920|NCT03726879|12046633|FG000|Overall Study|Continuing on Study|215
7632921|NCT03726879|12046634|FG001|Overall Study|Continuing on Study|215
7632922|NCT03712787|12046685|FG000|Overall Study|Adverse Event|2
7632923|NCT03712787|12046686|FG001|Overall Study|Adverse Event|3
7632924|NCT03712787|12046687|FG002|Overall Study|Adverse Event|0
7632925|NCT03712787|12046688|FG003|Overall Study|Adverse Event|4
7632926|NCT03712787|12046685|FG000|Overall Study|Withdrawal by Subject|4
7632927|NCT03712787|12046686|FG001|Overall Study|Withdrawal by Subject|14
7632928|NCT03712787|12046687|FG002|Overall Study|Withdrawal by Subject|12
7632929|NCT03712787|12046688|FG003|Overall Study|Withdrawal by Subject|8
7632930|NCT03712787|12046685|FG000|Overall Study|Lost to Follow-up|1
7632931|NCT03712787|12046686|FG001|Overall Study|Lost to Follow-up|1
7632932|NCT03712787|12046687|FG002|Overall Study|Lost to Follow-up|2
7632933|NCT03712787|12046688|FG003|Overall Study|Lost to Follow-up|1
7632934|NCT03712787|12046685|FG000|Overall Study|COVID-19 Logistical Restrictions|1
7632935|NCT03712787|12046686|FG001|Overall Study|COVID-19 Logistical Restrictions|1
7632936|NCT03712787|12046687|FG002|Overall Study|COVID-19 Logistical Restrictions|0
7632937|NCT03712787|12046688|FG003|Overall Study|COVID-19 Logistical Restrictions|0
7632938|NCT03712787|12046685|FG000|Overall Study|COVID-19 Infection|0
7632939|NCT03712787|12046686|FG001|Overall Study|COVID-19 Infection|1
7632940|NCT03712787|12046687|FG002|Overall Study|COVID-19 Infection|0
7632941|NCT03712787|12046688|FG003|Overall Study|COVID-19 Infection|0
7632942|NCT03712787|12046685|FG000|Overall Study|Other, Not Specified|79
7632943|NCT03712787|12046686|FG001|Overall Study|Other, Not Specified|77
7632944|NCT03712787|12046687|FG002|Overall Study|Other, Not Specified|74
7632945|NCT03712787|12046688|FG003|Overall Study|Other, Not Specified|78
7632946|NCT03711162|12046701|FG000|Overall Study|Adverse Event|5
7632947|NCT03711162|12046702|FG001|Overall Study|Adverse Event|2
7632948|NCT03711162|12046703|FG002|Overall Study|Adverse Event|4
7632949|NCT03711162|12046701|FG000|Overall Study|Death|11
7632950|NCT03711162|12046702|FG001|Overall Study|Death|7
7632951|NCT03711162|12046703|FG002|Overall Study|Death|8
7632952|NCT03711162|12046701|FG000|Overall Study|Lost to Follow-up|1
7632953|NCT03711162|12046702|FG001|Overall Study|Lost to Follow-up|0
7632954|NCT03711162|12046703|FG002|Overall Study|Lost to Follow-up|1
7632955|NCT03711162|12046701|FG000|Overall Study|Study Terminated by Sponsor|139
7632956|NCT03711162|12046702|FG001|Overall Study|Study Terminated by Sponsor|152
7632957|NCT03711162|12046703|FG002|Overall Study|Study Terminated by Sponsor|146
7632958|NCT03711162|12046701|FG000|Overall Study|Withdrawal by Subject|17
7632959|NCT03711162|12046702|FG001|Overall Study|Withdrawal by Subject|10
7632960|NCT03711162|12046703|FG002|Overall Study|Withdrawal by Subject|10
7632961|NCT03711162|12046701|FG000|Overall Study|Miscellaneous|1
7632962|NCT03711162|12046702|FG001|Overall Study|Miscellaneous|2
7632963|NCT03711162|12046703|FG002|Overall Study|Miscellaneous|2
7632964|NCT03711162|12046701|FG000|Overall Study|Not Treated|1
7632965|NCT03711162|12046702|FG001|Overall Study|Not Treated|0
7632966|NCT03711162|12046703|FG002|Overall Study|Not Treated|1
7632967|NCT03711162|12046701|FG000|Overall Study|Physician Decision|0
7632968|NCT03711162|12046702|FG001|Overall Study|Physician Decision|2
7632969|NCT03711162|12046703|FG002|Overall Study|Physician Decision|0
7632970|NCT03711162|12046701|FG000|Overall Study|Lack of Efficacy|0
7632971|NCT03711162|12046702|FG001|Overall Study|Lack of Efficacy|0
7632972|NCT03711162|12046703|FG002|Overall Study|Lack of Efficacy|2
7632973|NCT03711162|12046701|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0
7632974|NCT03711162|12046702|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0
7632975|NCT03711162|12046703|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1
7632976|NCT03706456|12046717|FG000|Overall Study|Lack of Efficacy|1
7632977|NCT03706456|12046717|FG000|Overall Study|Ongoing|21
7632978|NCT03705793|12046723|FG000|Overall Study|Lost to Follow-up|3
7632979|NCT03705793|12046724|FG001|Overall Study|Lost to Follow-up|4
7632980|NCT03705793|12046723|FG000|Overall Study|Withdrawal by Subject|2
7632981|NCT03705793|12046724|FG001|Overall Study|Withdrawal by Subject|1
7632982|NCT03703466|12046733|FG000|Overall Study|Death|2
7632983|NCT03703466|12046734|FG001|Overall Study|Death|1
7632984|NCT03703466|12046735|FG002|Overall Study|Death|0
7632985|NCT03703466|12046733|FG000|Overall Study|Protocol Violation|1
7632986|NCT03703466|12046734|FG001|Overall Study|Protocol Violation|0
7632987|NCT03703466|12046735|FG002|Overall Study|Protocol Violation|0
7632988|NCT03703466|12046733|FG000|Overall Study|Withdrawal by Subject|0
7632989|NCT03703466|12046734|FG001|Overall Study|Withdrawal by Subject|3
7632990|NCT03703466|12046735|FG002|Overall Study|Withdrawal by Subject|0
7632991|NCT03703466|12046733|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1
7632992|NCT03703466|12046734|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
7632993|NCT03703466|12046735|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
7632994|NCT03693612|12046764|FG000|Overall Study|Lost to Follow-up|0
7632995|NCT03693612|12046765|FG001|Overall Study|Lost to Follow-up|0
7632996|NCT03693612|12046766|FG002|Overall Study|Lost to Follow-up|0
7632997|NCT03693612|12046767|FG003|Overall Study|Lost to Follow-up|0
7632998|NCT03693612|12046768|FG004|Overall Study|Lost to Follow-up|1
7632999|NCT03693612|12046769|FG005|Overall Study|Lost to Follow-up|0
7633000|NCT03693612|12046770|FG006|Overall Study|Lost to Follow-up|0
7633001|NCT03693612|12046764|FG000|Overall Study|Withdrawal by Subject|0
7633002|NCT03693612|12046765|FG001|Overall Study|Withdrawal by Subject|0
7633003|NCT03693612|12046766|FG002|Overall Study|Withdrawal by Subject|1
7633004|NCT03693612|12046767|FG003|Overall Study|Withdrawal by Subject|0
7633005|NCT03693612|12046768|FG004|Overall Study|Withdrawal by Subject|2
7633006|NCT03693612|12046769|FG005|Overall Study|Withdrawal by Subject|0
7633007|NCT03693612|12046770|FG006|Overall Study|Withdrawal by Subject|0
7633008|NCT03693612|12046764|FG000|Overall Study|Study Terminated by Sponsor|0
7633009|NCT03693612|12046765|FG001|Overall Study|Study Terminated by Sponsor|1
7633010|NCT03693612|12046766|FG002|Overall Study|Study Terminated by Sponsor|0
7633011|NCT03693612|12046767|FG003|Overall Study|Study Terminated by Sponsor|0
7633012|NCT03693612|12046768|FG004|Overall Study|Study Terminated by Sponsor|3
7633013|NCT03693612|12046769|FG005|Overall Study|Study Terminated by Sponsor|0
7633014|NCT03693612|12046770|FG006|Overall Study|Study Terminated by Sponsor|0
7633015|NCT03693170|12046786|FG000|Overall Study|Disease Progression|48
7633016|NCT03693170|12046786|FG000|Overall Study|Adverse Event|16
7633017|NCT03693170|12046786|FG000|Overall Study|Physician Decision|6
7633018|NCT03693170|12046786|FG000|Overall Study|Protocol Violation|2
7633019|NCT03693170|12046786|FG000|Overall Study|Death|1
7633020|NCT03693170|12046786|FG000|Overall Study|Non compliance with study drug|1
7633021|NCT03693170|12046786|FG000|Overall Study|Withdrawal by Subject|1
7633022|NCT03692871|12046793|FG000|Overall Study|Death|1
7633023|NCT03692871|12046794|FG001|Overall Study|Death|1
7633024|NCT03692871|12046793|FG000|Overall Study|Lost to Follow-up|24
7633025|NCT03692871|12046794|FG001|Overall Study|Lost to Follow-up|9
7633026|NCT03692871|12046793|FG000|Overall Study|Physician Decision|22
7633027|NCT03692871|12046794|FG001|Overall Study|Physician Decision|7
7633028|NCT03692871|12046793|FG000|Overall Study|Protocol Deviation|1
7633029|NCT03692871|12046794|FG001|Overall Study|Protocol Deviation|0
7633030|NCT03692871|12046793|FG000|Overall Study|Withdrawal by Parent/Guardian|77
7633031|NCT03692871|12046794|FG001|Overall Study|Withdrawal by Parent/Guardian|20
7633032|NCT03689855|12046800|FG000|Overall Study|Adverse Event|3
7633033|NCT03689855|12046800|FG000|Overall Study|Withdrawal by Subject|1
7633034|NCT03687736|12046804|FG000|Overall Study|Lost to Follow-up|7
7633035|NCT03687736|12046804|FG000|Overall Study|Withdrawal by Subject|3
7633036|NCT03682848|12046823|FG000|Overall Study|Withdrawal by Subject|2
7633037|NCT03682848|12046823|FG000|Overall Study|Site closed|5
7633038|NCT03682848|12046823|FG000|Overall Study|Protocol Deviation|1
7633039|NCT03682848|12046823|FG000|Overall Study|Adverse Event|1
7633040|NCT03681691|12046845|FG000|Overall Study|COVID|1
7633041|NCT03681691|12046846|FG001|Overall Study|COVID|0
7633042|NCT03681691|12046845|FG000|Overall Study|prolonged bleeding|1
7633043|NCT03681691|12046846|FG001|Overall Study|prolonged bleeding|0
7633044|NCT03681691|12046845|FG000|Overall Study|veins would not stay open during the PET scan.|0
7633045|NCT03681691|12046846|FG001|Overall Study|veins would not stay open during the PET scan.|1
7633046|NCT03681470|12046854|FG000|Overall Study|Lack of Efficacy|3
7633047|NCT03681470|12046854|FG000|Overall Study|Lost to Follow-up|1
7633048|NCT03681470|12046854|FG000|Overall Study|Protocol Violation|3
7633049|NCT03681470|12046854|FG000|Overall Study|Withdrawal by Subject|1
7633050|NCT03681184|12046860|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0
7633051|NCT03681184|12046861|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1
7633052|NCT03681184|12046860|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12
7633053|NCT03681184|12046861|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23
7633054|NCT03681184|12046860|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
7633055|NCT03681184|12046861|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
7633056|NCT03679767|12046871|FG000|Overall Study|Death|16
7633057|NCT03679767|12046872|FG001|Overall Study|Death|10
7633058|NCT03679767|12046873|FG002|Overall Study|Death|16
7633059|NCT03679767|12046874|FG003|Overall Study|Death|10
7633060|NCT03679767|12046871|FG000|Overall Study|Lost to Follow-up|1
7633061|NCT03679767|12046872|FG001|Overall Study|Lost to Follow-up|0
7633062|NCT03679767|12046873|FG002|Overall Study|Lost to Follow-up|1
7633063|NCT03679767|12046874|FG003|Overall Study|Lost to Follow-up|1
7633064|NCT03679767|12046871|FG000|Overall Study|Withdrawal by Subject|0
7633065|NCT03679767|12046872|FG001|Overall Study|Withdrawal by Subject|0
7633066|NCT03679767|12046873|FG002|Overall Study|Withdrawal by Subject|0
7633067|NCT03679767|12046874|FG003|Overall Study|Withdrawal by Subject|1
7633068|NCT03679767|12046871|FG000|Overall Study|Follow-up Completed|4
7633069|NCT03679767|12046872|FG001|Overall Study|Follow-up Completed|1
7633070|NCT03679767|12046873|FG002|Overall Study|Follow-up Completed|3
7633071|NCT03679767|12046874|FG003|Overall Study|Follow-up Completed|5
7633072|NCT03679767|12046871|FG000|Overall Study|Ongoing|14
7633073|NCT03679767|12046872|FG001|Overall Study|Ongoing|12
7633074|NCT03679767|12046873|FG002|Overall Study|Ongoing|9
7633075|NCT03679767|12046874|FG003|Overall Study|Ongoing|17
7633076|NCT03677869|12046897|FG000|Overall Study|Withdrawal by Subject|1
7633077|NCT03674112|12046903|FG000|Overall Study|Adverse Event|1
7633078|NCT03674112|12046904|FG001|Overall Study|Adverse Event|0
7633079|NCT03674112|12046903|FG000|Overall Study|Ongoing in the Study|79
7633080|NCT03674112|12046904|FG001|Overall Study|Ongoing in the Study|80
7633081|NCT03673046|12046941|FG000|Overall Study|Adverse Event|1
7633082|NCT03673046|12046942|FG001|Overall Study|Adverse Event|1
7633083|NCT03673046|12046941|FG000|Overall Study|Withdrawal by Subject|8
7633084|NCT03673046|12046942|FG001|Overall Study|Withdrawal by Subject|2
7633085|NCT03670810|12046954|FG000|Main Study|Adverse Event|37
7633086|NCT03670810|12046955|FG001|Main Study|Adverse Event|38
7633087|NCT03670810|12046956|FG002|Main Study|Adverse Event|3
7633088|NCT03670810|12046957|FG003|Main Study|Adverse Event|4
7633089|NCT03670810|12046958|FG004|Main Study|Adverse Event|4
7633090|NCT03670810|12046959|FG005|Main Study|Adverse Event|5
7633091|NCT03670810|12046960|FG006|Main Study|Adverse Event|0
7633092|NCT03670810|12046961|FG007|Main Study|Adverse Event|0
7633093|NCT03670810|12046962|FG008|Main Study|Adverse Event|0
7633094|NCT03670810|12046954|FG000|Main Study|Lack of Efficacy|8
7633095|NCT03670810|12046955|FG001|Main Study|Lack of Efficacy|9
7633096|NCT03670810|12046956|FG002|Main Study|Lack of Efficacy|3
7633097|NCT03670810|12046957|FG003|Main Study|Lack of Efficacy|4
7633098|NCT03670810|12046958|FG004|Main Study|Lack of Efficacy|0
7633099|NCT03670810|12046959|FG005|Main Study|Lack of Efficacy|0
7633100|NCT03670810|12046960|FG006|Main Study|Lack of Efficacy|0
7633101|NCT03670810|12046961|FG007|Main Study|Lack of Efficacy|0
7633102|NCT03670810|12046962|FG008|Main Study|Lack of Efficacy|0
7633103|NCT03670810|12046954|FG000|Main Study|Lost to Follow-up|9
7633104|NCT03670810|12046955|FG001|Main Study|Lost to Follow-up|7
7633105|NCT03670810|12046956|FG002|Main Study|Lost to Follow-up|4
7633106|NCT03670810|12046957|FG003|Main Study|Lost to Follow-up|6
7633107|NCT03670810|12046958|FG004|Main Study|Lost to Follow-up|1
7633108|NCT03670810|12046959|FG005|Main Study|Lost to Follow-up|0
7633109|NCT03670810|12046960|FG006|Main Study|Lost to Follow-up|0
7633110|NCT03670810|12046961|FG007|Main Study|Lost to Follow-up|0
7633111|NCT03670810|12046962|FG008|Main Study|Lost to Follow-up|0
7633112|NCT03670810|12046954|FG000|Main Study|Non-compliance with Study Drug|0
7633113|NCT03670810|12046955|FG001|Main Study|Non-compliance with Study Drug|2
7633114|NCT03670810|12046956|FG002|Main Study|Non-compliance with Study Drug|3
7633115|NCT03670810|12046957|FG003|Main Study|Non-compliance with Study Drug|0
7633116|NCT03670810|12046958|FG004|Main Study|Non-compliance with Study Drug|0
7633117|NCT03670810|12046959|FG005|Main Study|Non-compliance with Study Drug|0
7633118|NCT03670810|12046960|FG006|Main Study|Non-compliance with Study Drug|0
7633119|NCT03670810|12046961|FG007|Main Study|Non-compliance with Study Drug|1
7633120|NCT03670810|12046962|FG008|Main Study|Non-compliance with Study Drug|0
7633121|NCT03670810|12046954|FG000|Main Study|Physician Decision|3
7633122|NCT03670810|12046955|FG001|Main Study|Physician Decision|0
7633123|NCT03670810|12046956|FG002|Main Study|Physician Decision|1
7633124|NCT03670810|12046957|FG003|Main Study|Physician Decision|0
7633125|NCT03670810|12046958|FG004|Main Study|Physician Decision|0
7633126|NCT03670810|12046959|FG005|Main Study|Physician Decision|0
7633127|NCT03670810|12046960|FG006|Main Study|Physician Decision|1
7633128|NCT03670810|12046961|FG007|Main Study|Physician Decision|1
7633129|NCT03670810|12046962|FG008|Main Study|Physician Decision|0
7633130|NCT03670810|12046954|FG000|Main Study|Pregnancy|1
7633131|NCT03670810|12046955|FG001|Main Study|Pregnancy|2
7633132|NCT03670810|12046956|FG002|Main Study|Pregnancy|0
7633133|NCT03670810|12046957|FG003|Main Study|Pregnancy|0
7633134|NCT03670810|12046958|FG004|Main Study|Pregnancy|0
7633135|NCT03670810|12046959|FG005|Main Study|Pregnancy|0
7633136|NCT03670810|12046960|FG006|Main Study|Pregnancy|0
7633137|NCT03670810|12046961|FG007|Main Study|Pregnancy|0
7633138|NCT03670810|12046962|FG008|Main Study|Pregnancy|0
7633139|NCT03670810|12046954|FG000|Main Study|Protocol Deviation|2
7633140|NCT03670810|12046955|FG001|Main Study|Protocol Deviation|12
7633141|NCT03670810|12046956|FG002|Main Study|Protocol Deviation|8
7633142|NCT03670810|12046957|FG003|Main Study|Protocol Deviation|4
7633143|NCT03670810|12046958|FG004|Main Study|Protocol Deviation|0
7633144|NCT03670810|12046959|FG005|Main Study|Protocol Deviation|0
7633145|NCT03670810|12046960|FG006|Main Study|Protocol Deviation|0
7633146|NCT03670810|12046961|FG007|Main Study|Protocol Deviation|0
7633147|NCT03670810|12046962|FG008|Main Study|Protocol Deviation|0
7633148|NCT03670810|12046954|FG000|Main Study|Withdrawal by Subject|21
7633149|NCT03670810|12046955|FG001|Main Study|Withdrawal by Subject|21
7633150|NCT03670810|12046956|FG002|Main Study|Withdrawal by Subject|8
7633151|NCT03670810|12046957|FG003|Main Study|Withdrawal by Subject|9
7633152|NCT03670810|12046958|FG004|Main Study|Withdrawal by Subject|5
7633153|NCT03670810|12046959|FG005|Main Study|Withdrawal by Subject|2
7633154|NCT03670810|12046960|FG006|Main Study|Withdrawal by Subject|1
7633155|NCT03670810|12046961|FG007|Main Study|Withdrawal by Subject|1
7633156|NCT03670810|12046962|FG008|Main Study|Withdrawal by Subject|0
7633157|NCT03670810|12046954|FG000|Main Study|Participant did not want to take the three other treatments|1
7633158|NCT03670810|12046955|FG001|Main Study|Participant did not want to take the three other treatments|0
7633159|NCT03670810|12046956|FG002|Main Study|Participant did not want to take the three other treatments|0
7633160|NCT03670810|12046957|FG003|Main Study|Participant did not want to take the three other treatments|0
7633161|NCT03670810|12046958|FG004|Main Study|Participant did not want to take the three other treatments|0
7633162|NCT03670810|12046959|FG005|Main Study|Participant did not want to take the three other treatments|0
7633163|NCT03670810|12046960|FG006|Main Study|Participant did not want to take the three other treatments|0
7633164|NCT03670810|12046961|FG007|Main Study|Participant did not want to take the three other treatments|0
7633165|NCT03670810|12046962|FG008|Main Study|Participant did not want to take the three other treatments|0
7633166|NCT03670810|12046954|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633167|NCT03670810|12046955|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1
7633168|NCT03670810|12046956|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633169|NCT03670810|12046957|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633170|NCT03670810|12046958|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633171|NCT03670810|12046959|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633172|NCT03670810|12046960|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633173|NCT03670810|12046961|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633174|NCT03670810|12046962|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633175|NCT03670810|12046954|FG000|Main Study|Travel and Coronavirus issues|0
7633176|NCT03670810|12046955|FG001|Main Study|Travel and Coronavirus issues|0
7633177|NCT03670810|12046956|FG002|Main Study|Travel and Coronavirus issues|0
7633178|NCT03670810|12046957|FG003|Main Study|Travel and Coronavirus issues|1
7633179|NCT03670810|12046958|FG004|Main Study|Travel and Coronavirus issues|0
7633180|NCT03670810|12046959|FG005|Main Study|Travel and Coronavirus issues|0
7633181|NCT03670810|12046960|FG006|Main Study|Travel and Coronavirus issues|0
7633182|NCT03670810|12046961|FG007|Main Study|Travel and Coronavirus issues|0
7633183|NCT03670810|12046962|FG008|Main Study|Travel and Coronavirus issues|0
7633184|NCT03670810|12046954|FG000|Open Label Extension|Protocol Deviation|0
7633185|NCT03670810|12046955|FG001|Open Label Extension|Protocol Deviation|0
7633186|NCT03670810|12046956|FG002|Open Label Extension|Protocol Deviation|0
7633187|NCT03670810|12046957|FG003|Open Label Extension|Protocol Deviation|0
7633188|NCT03670810|12046958|FG004|Open Label Extension|Protocol Deviation|0
7633189|NCT03670810|12046959|FG005|Open Label Extension|Protocol Deviation|0
7633190|NCT03670810|12046960|FG006|Open Label Extension|Protocol Deviation|0
7633191|NCT03670810|12046961|FG007|Open Label Extension|Protocol Deviation|0
7633192|NCT03670810|12046962|FG008|Open Label Extension|Protocol Deviation|5
7633193|NCT03670810|12046954|FG000|Open Label Extension|Death|0
7633194|NCT03670810|12046955|FG001|Open Label Extension|Death|0
7633195|NCT03670810|12046956|FG002|Open Label Extension|Death|0
7633196|NCT03670810|12046957|FG003|Open Label Extension|Death|0
7633197|NCT03670810|12046958|FG004|Open Label Extension|Death|0
7633198|NCT03670810|12046959|FG005|Open Label Extension|Death|0
7633199|NCT03670810|12046960|FG006|Open Label Extension|Death|0
7633200|NCT03670810|12046961|FG007|Open Label Extension|Death|0
7633201|NCT03670810|12046962|FG008|Open Label Extension|Death|1
7633202|NCT03670810|12046954|FG000|Open Label Extension|COVID-19|0
7633203|NCT03670810|12046955|FG001|Open Label Extension|COVID-19|0
7633204|NCT03670810|12046956|FG002|Open Label Extension|COVID-19|0
7633205|NCT03670810|12046957|FG003|Open Label Extension|COVID-19|0
7633206|NCT03670810|12046958|FG004|Open Label Extension|COVID-19|0
7633207|NCT03670810|12046959|FG005|Open Label Extension|COVID-19|0
7633208|NCT03670810|12046960|FG006|Open Label Extension|COVID-19|0
7633209|NCT03670810|12046961|FG007|Open Label Extension|COVID-19|0
7633210|NCT03670810|12046962|FG008|Open Label Extension|COVID-19|1
7633211|NCT03670810|12046954|FG000|Open Label Extension|Lack of Efficacy|0
7633212|NCT03670810|12046955|FG001|Open Label Extension|Lack of Efficacy|0
7633213|NCT03670810|12046956|FG002|Open Label Extension|Lack of Efficacy|0
7633214|NCT03670810|12046957|FG003|Open Label Extension|Lack of Efficacy|0
7633215|NCT03670810|12046958|FG004|Open Label Extension|Lack of Efficacy|0
7633216|NCT03670810|12046959|FG005|Open Label Extension|Lack of Efficacy|0
7633217|NCT03670810|12046960|FG006|Open Label Extension|Lack of Efficacy|0
7633218|NCT03670810|12046961|FG007|Open Label Extension|Lack of Efficacy|0
7633219|NCT03670810|12046962|FG008|Open Label Extension|Lack of Efficacy|39
7633220|NCT03670810|12046954|FG000|Open Label Extension|Participant refused to comply with face mask use|0
7633221|NCT03670810|12046955|FG001|Open Label Extension|Participant refused to comply with face mask use|0
7633222|NCT03670810|12046956|FG002|Open Label Extension|Participant refused to comply with face mask use|0
7633223|NCT03670810|12046957|FG003|Open Label Extension|Participant refused to comply with face mask use|0
7633224|NCT03670810|12046958|FG004|Open Label Extension|Participant refused to comply with face mask use|0
7633225|NCT03670810|12046959|FG005|Open Label Extension|Participant refused to comply with face mask use|0
7633226|NCT03670810|12046960|FG006|Open Label Extension|Participant refused to comply with face mask use|0
7633227|NCT03670810|12046961|FG007|Open Label Extension|Participant refused to comply with face mask use|0
7633228|NCT03670810|12046962|FG008|Open Label Extension|Participant refused to comply with face mask use|1
7633229|NCT03670810|12046954|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633230|NCT03670810|12046955|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633231|NCT03670810|12046956|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633232|NCT03670810|12046957|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633233|NCT03670810|12046958|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633234|NCT03670810|12046959|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633235|NCT03670810|12046960|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633236|NCT03670810|12046961|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633237|NCT03670810|12046962|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1
7633238|NCT03670810|12046954|FG000|Open Label Extension|Withdrawal by Subject|0
7633239|NCT03670810|12046955|FG001|Open Label Extension|Withdrawal by Subject|0
7633240|NCT03670810|12046956|FG002|Open Label Extension|Withdrawal by Subject|0
7633241|NCT03670810|12046957|FG003|Open Label Extension|Withdrawal by Subject|0
7633242|NCT03670810|12046958|FG004|Open Label Extension|Withdrawal by Subject|0
7633243|NCT03670810|12046959|FG005|Open Label Extension|Withdrawal by Subject|0
7633244|NCT03670810|12046960|FG006|Open Label Extension|Withdrawal by Subject|0
7633245|NCT03670810|12046961|FG007|Open Label Extension|Withdrawal by Subject|0
7633246|NCT03670810|12046962|FG008|Open Label Extension|Withdrawal by Subject|46
7633247|NCT03670810|12046954|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0
7633248|NCT03670810|12046955|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0
7633249|NCT03670810|12046956|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0
7633250|NCT03670810|12046957|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0
7633251|NCT03670810|12046958|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0
7633252|NCT03670810|12046959|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0
7633253|NCT03670810|12046960|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0
7633254|NCT03670810|12046961|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0
7633255|NCT03670810|12046962|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1
7633256|NCT03670810|12046954|FG000|Open Label Extension|Physician Decision|0
7633257|NCT03670810|12046955|FG001|Open Label Extension|Physician Decision|0
7633258|NCT03670810|12046956|FG002|Open Label Extension|Physician Decision|0
7633259|NCT03670810|12046957|FG003|Open Label Extension|Physician Decision|0
7633260|NCT03670810|12046958|FG004|Open Label Extension|Physician Decision|0
7633261|NCT03670810|12046959|FG005|Open Label Extension|Physician Decision|0
7633262|NCT03670810|12046960|FG006|Open Label Extension|Physician Decision|0
7633263|NCT03670810|12046961|FG007|Open Label Extension|Physician Decision|0
7633264|NCT03670810|12046962|FG008|Open Label Extension|Physician Decision|2
7633265|NCT03670810|12046954|FG000|Open Label Extension|Non-compliance with study drug|0
7633266|NCT03670810|12046955|FG001|Open Label Extension|Non-compliance with study drug|0
7633267|NCT03670810|12046956|FG002|Open Label Extension|Non-compliance with study drug|0
7633268|NCT03670810|12046957|FG003|Open Label Extension|Non-compliance with study drug|0
7633269|NCT03670810|12046958|FG004|Open Label Extension|Non-compliance with study drug|0
7633270|NCT03670810|12046959|FG005|Open Label Extension|Non-compliance with study drug|0
7633271|NCT03670810|12046960|FG006|Open Label Extension|Non-compliance with study drug|0
7633272|NCT03670810|12046961|FG007|Open Label Extension|Non-compliance with study drug|0
7633273|NCT03670810|12046962|FG008|Open Label Extension|Non-compliance with study drug|5
7633274|NCT03670810|12046954|FG000|Open Label Extension|Pregnancy|0
7633275|NCT03670810|12046955|FG001|Open Label Extension|Pregnancy|0
7633276|NCT03670810|12046956|FG002|Open Label Extension|Pregnancy|0
7633277|NCT03670810|12046957|FG003|Open Label Extension|Pregnancy|0
7633278|NCT03670810|12046958|FG004|Open Label Extension|Pregnancy|0
7633279|NCT03670810|12046959|FG005|Open Label Extension|Pregnancy|0
7633280|NCT03670810|12046960|FG006|Open Label Extension|Pregnancy|0
7633281|NCT03670810|12046961|FG007|Open Label Extension|Pregnancy|0
7633282|NCT03670810|12046962|FG008|Open Label Extension|Pregnancy|3
7633283|NCT03670810|12046954|FG000|Open Label Extension|Adverse Event|0
7633284|NCT03670810|12046955|FG001|Open Label Extension|Adverse Event|0
7633285|NCT03670810|12046956|FG002|Open Label Extension|Adverse Event|0
7633286|NCT03670810|12046957|FG003|Open Label Extension|Adverse Event|0
7633287|NCT03670810|12046958|FG004|Open Label Extension|Adverse Event|0
7633288|NCT03670810|12046959|FG005|Open Label Extension|Adverse Event|0
7633289|NCT03670810|12046960|FG006|Open Label Extension|Adverse Event|0
7633290|NCT03670810|12046961|FG007|Open Label Extension|Adverse Event|0
7633291|NCT03670810|12046962|FG008|Open Label Extension|Adverse Event|24
7633292|NCT03670810|12046954|FG000|Open Label Extension|Participant wanted to become pregnant|0
7633293|NCT03670810|12046955|FG001|Open Label Extension|Participant wanted to become pregnant|0
7633375|NCT03655717|12047052|FG001|Overall Study|Physician Decision|3
7633294|NCT03670810|12046956|FG002|Open Label Extension|Participant wanted to become pregnant|0
7633295|NCT03670810|12046957|FG003|Open Label Extension|Participant wanted to become pregnant|0
7633296|NCT03670810|12046958|FG004|Open Label Extension|Participant wanted to become pregnant|0
7633297|NCT03670810|12046959|FG005|Open Label Extension|Participant wanted to become pregnant|0
7633298|NCT03670810|12046960|FG006|Open Label Extension|Participant wanted to become pregnant|0
7633299|NCT03670810|12046961|FG007|Open Label Extension|Participant wanted to become pregnant|0
7633300|NCT03670810|12046962|FG008|Open Label Extension|Participant wanted to become pregnant|1
7633301|NCT03670810|12046954|FG000|Open Label Extension|Lost to Follow-up|0
7633302|NCT03670810|12046955|FG001|Open Label Extension|Lost to Follow-up|0
7633303|NCT03670810|12046956|FG002|Open Label Extension|Lost to Follow-up|0
7633304|NCT03670810|12046957|FG003|Open Label Extension|Lost to Follow-up|0
7633305|NCT03670810|12046958|FG004|Open Label Extension|Lost to Follow-up|0
7633306|NCT03670810|12046959|FG005|Open Label Extension|Lost to Follow-up|0
7633307|NCT03670810|12046960|FG006|Open Label Extension|Lost to Follow-up|0
7633308|NCT03670810|12046961|FG007|Open Label Extension|Lost to Follow-up|0
7633309|NCT03670810|12046962|FG008|Open Label Extension|Lost to Follow-up|23
7633310|NCT03665441|12046978|FG000|Overall Study|survival follow up ongoing|23
7633311|NCT03665441|12046979|FG001|Overall Study|survival follow up ongoing|0
7633312|NCT03665441|12046978|FG000|Overall Study|Patients ongoing on treatment|9
7633313|NCT03665441|12046979|FG001|Overall Study|Patients ongoing on treatment|6
7633314|NCT03665441|12046978|FG000|Overall Study|Randomized but not treated|7
7633315|NCT03665441|12046979|FG001|Overall Study|Randomized but not treated|11
7633316|NCT03665038|12046988|FG000|Overall Study|Lost to Follow-up|0
7633317|NCT03665038|12046989|FG001|Overall Study|Lost to Follow-up|0
7633318|NCT03665038|12046990|FG002|Overall Study|Lost to Follow-up|1
7633319|NCT03663179|12047025|FG000|Overall Study|Withdrawal by Subject|2
7633320|NCT03663179|12047026|FG001|Overall Study|Withdrawal by Subject|0
7633321|NCT03663179|12047025|FG000|Overall Study|Lost to Follow-up|1
7633322|NCT03663179|12047026|FG001|Overall Study|Lost to Follow-up|1
7633323|NCT03663179|12047025|FG000|Overall Study|Revealed exclusionary condition|1
7633324|NCT03663179|12047026|FG001|Overall Study|Revealed exclusionary condition|0
7633325|NCT03662659|12047034|FG000|Pre-treatment|Participant no longer met study criteria|1
7633326|NCT03662659|12047035|FG001|Pre-treatment|Participant no longer met study criteria|1
7633327|NCT03662659|12047034|FG000|Pre-treatment|Other reasons|1
7633328|NCT03662659|12047035|FG001|Pre-treatment|Other reasons|0
7633329|NCT03662659|12047034|FG000|Treatment|Completed Treatment|0
7633330|NCT03662659|12047035|FG001|Treatment|Completed Treatment|3
7633331|NCT03662659|12047034|FG000|Treatment|Disease Progression|69
7633332|NCT03662659|12047035|FG001|Treatment|Disease Progression|78
7633333|NCT03662659|12047034|FG000|Treatment|Study Drug Toxicity|18
7633334|NCT03662659|12047035|FG001|Treatment|Study Drug Toxicity|8
7633335|NCT03662659|12047034|FG000|Treatment|Death|12
7633336|NCT03662659|12047035|FG001|Treatment|Death|7
7633337|NCT03662659|12047034|FG000|Treatment|Adverse Event unrelated to Study Drug|7
7633338|NCT03662659|12047035|FG001|Treatment|Adverse Event unrelated to Study Drug|4
7633339|NCT03662659|12047034|FG000|Treatment|Withdrawal by Subject|1
7633340|NCT03662659|12047035|FG001|Treatment|Withdrawal by Subject|1
7633341|NCT03662659|12047034|FG000|Treatment|Poor/Non-compliance|1
7633342|NCT03662659|12047035|FG001|Treatment|Poor/Non-compliance|0
7633343|NCT03662659|12047034|FG000|Treatment|Participant no longer meets study criteria|1
7633344|NCT03662659|12047035|FG001|Treatment|Participant no longer meets study criteria|0
7633345|NCT03662659|12047034|FG000|Treatment|Other reasons|6
7633346|NCT03662659|12047035|FG001|Treatment|Other reasons|5
7633347|NCT03655756|12047045|FG000|Overall Study|Death|1
7633348|NCT03655717|12047051|FG000|Overall Study|Withdrawal by Subject|4
7633349|NCT03655717|12047052|FG001|Overall Study|Withdrawal by Subject|8
7633350|NCT03655717|12047053|FG002|Overall Study|Withdrawal by Subject|1
7633351|NCT03655717|12047054|FG003|Overall Study|Withdrawal by Subject|0
7633352|NCT03655717|12047055|FG004|Overall Study|Withdrawal by Subject|0
7633353|NCT03655717|12047056|FG005|Overall Study|Withdrawal by Subject|1
7633354|NCT03655717|12047057|FG006|Overall Study|Withdrawal by Subject|3
7633355|NCT03655717|12047058|FG007|Overall Study|Withdrawal by Subject|1
7633356|NCT03655717|12047059|FG008|Overall Study|Withdrawal by Subject|2
7633357|NCT03655717|12047060|FG009|Overall Study|Withdrawal by Subject|0
7633358|NCT03655717|12047061|FG010|Overall Study|Withdrawal by Subject|0
7633359|NCT03655717|12047062|FG011|Overall Study|Withdrawal by Subject|1
7633360|NCT03655717|12047063|FG012|Overall Study|Withdrawal by Subject|0
7633361|NCT03655717|12047064|FG013|Overall Study|Withdrawal by Subject|3
7633362|NCT03655717|12047065|FG014|Overall Study|Withdrawal by Subject|0
7633363|NCT03655717|12047066|FG015|Overall Study|Withdrawal by Subject|1
7633364|NCT03655717|12047067|FG016|Overall Study|Withdrawal by Subject|0
7633365|NCT03655717|12047068|FG017|Overall Study|Withdrawal by Subject|0
7633366|NCT03655717|12047069|FG018|Overall Study|Withdrawal by Subject|1
7633367|NCT03655717|12047070|FG019|Overall Study|Withdrawal by Subject|0
7633368|NCT03655717|12047071|FG020|Overall Study|Withdrawal by Subject|0
7633369|NCT03655717|12047072|FG021|Overall Study|Withdrawal by Subject|1
7633370|NCT03655717|12047073|FG022|Overall Study|Withdrawal by Subject|2
7633371|NCT03655717|12047074|FG023|Overall Study|Withdrawal by Subject|1
7633372|NCT03655717|12047075|FG024|Overall Study|Withdrawal by Subject|1
7633373|NCT03655717|12047076|FG025|Overall Study|Withdrawal by Subject|0
7633374|NCT03655717|12047051|FG000|Overall Study|Physician Decision|3
7633376|NCT03655717|12047053|FG002|Overall Study|Physician Decision|0
7633377|NCT03655717|12047054|FG003|Overall Study|Physician Decision|0
7633378|NCT03655717|12047055|FG004|Overall Study|Physician Decision|0
7633379|NCT03655717|12047056|FG005|Overall Study|Physician Decision|0
7633380|NCT03655717|12047057|FG006|Overall Study|Physician Decision|0
7633381|NCT03655717|12047058|FG007|Overall Study|Physician Decision|0
7633382|NCT03655717|12047059|FG008|Overall Study|Physician Decision|0
7633383|NCT03655717|12047060|FG009|Overall Study|Physician Decision|1
7633384|NCT03655717|12047061|FG010|Overall Study|Physician Decision|0
7633385|NCT03655717|12047062|FG011|Overall Study|Physician Decision|0
7633386|NCT03655717|12047063|FG012|Overall Study|Physician Decision|0
7633387|NCT03655717|12047064|FG013|Overall Study|Physician Decision|0
7633388|NCT03655717|12047065|FG014|Overall Study|Physician Decision|0
7633389|NCT03655717|12047066|FG015|Overall Study|Physician Decision|0
7633390|NCT03655717|12047067|FG016|Overall Study|Physician Decision|0
7633391|NCT03655717|12047068|FG017|Overall Study|Physician Decision|0
7633392|NCT03655717|12047069|FG018|Overall Study|Physician Decision|0
7633393|NCT03655717|12047070|FG019|Overall Study|Physician Decision|1
7633394|NCT03655717|12047071|FG020|Overall Study|Physician Decision|0
7633395|NCT03655717|12047072|FG021|Overall Study|Physician Decision|0
7633396|NCT03655717|12047073|FG022|Overall Study|Physician Decision|0
7633397|NCT03655717|12047074|FG023|Overall Study|Physician Decision|1
7633398|NCT03655717|12047075|FG024|Overall Study|Physician Decision|0
7633399|NCT03655717|12047076|FG025|Overall Study|Physician Decision|0
7633400|NCT03655717|12047051|FG000|Overall Study|Lost to Follow-up|3
7633401|NCT03655717|12047052|FG001|Overall Study|Lost to Follow-up|1
7633402|NCT03655717|12047053|FG002|Overall Study|Lost to Follow-up|0
7633403|NCT03655717|12047054|FG003|Overall Study|Lost to Follow-up|1
7633404|NCT03655717|12047055|FG004|Overall Study|Lost to Follow-up|0
7633405|NCT03655717|12047056|FG005|Overall Study|Lost to Follow-up|1
7633406|NCT03655717|12047057|FG006|Overall Study|Lost to Follow-up|0
7633407|NCT03655717|12047058|FG007|Overall Study|Lost to Follow-up|0
7633408|NCT03655717|12047059|FG008|Overall Study|Lost to Follow-up|0
7633409|NCT03655717|12047060|FG009|Overall Study|Lost to Follow-up|0
7633410|NCT03655717|12047061|FG010|Overall Study|Lost to Follow-up|0
7633411|NCT03655717|12047062|FG011|Overall Study|Lost to Follow-up|1
7633412|NCT03655717|12047063|FG012|Overall Study|Lost to Follow-up|0
7633413|NCT03655717|12047064|FG013|Overall Study|Lost to Follow-up|0
7633414|NCT03655717|12047065|FG014|Overall Study|Lost to Follow-up|0
7633415|NCT03655717|12047066|FG015|Overall Study|Lost to Follow-up|0
7633416|NCT03655717|12047067|FG016|Overall Study|Lost to Follow-up|0
7633417|NCT03655717|12047068|FG017|Overall Study|Lost to Follow-up|0
7633418|NCT03655717|12047069|FG018|Overall Study|Lost to Follow-up|0
7633419|NCT03655717|12047070|FG019|Overall Study|Lost to Follow-up|0
7633420|NCT03655717|12047071|FG020|Overall Study|Lost to Follow-up|0
7633421|NCT03655717|12047072|FG021|Overall Study|Lost to Follow-up|0
7633422|NCT03655717|12047073|FG022|Overall Study|Lost to Follow-up|0
7633423|NCT03655717|12047074|FG023|Overall Study|Lost to Follow-up|0
7633424|NCT03655717|12047075|FG024|Overall Study|Lost to Follow-up|0
7633425|NCT03655717|12047076|FG025|Overall Study|Lost to Follow-up|0
7633426|NCT03647267|12047092|FG000|Overall Study|Lost to Follow-up|1
7633427|NCT03647267|12047093|FG001|Overall Study|Lost to Follow-up|0
7633428|NCT03645395|12047126|FG000|Part 1 (Up to 6 Months)|Adverse Event|1
7633429|NCT03645395|12047127|FG001|Part 1 (Up to 6 Months)|Adverse Event|0
7633430|NCT03645395|12047128|FG002|Part 1 (Up to 6 Months)|Adverse Event|0
7633431|NCT03645395|12047129|FG003|Part 1 (Up to 6 Months)|Adverse Event|0
7633432|NCT03645395|12047126|FG000|Part 1 (Up to 6 Months)|Disease Progression|0
7633433|NCT03645395|12047127|FG001|Part 1 (Up to 6 Months)|Disease Progression|1
7633434|NCT03645395|12047128|FG002|Part 1 (Up to 6 Months)|Disease Progression|0
7633435|NCT03645395|12047129|FG003|Part 1 (Up to 6 Months)|Disease Progression|0
7633436|NCT03645395|12047126|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0
7633437|NCT03645395|12047127|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0
7633438|NCT03645395|12047128|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1
7633439|NCT03645395|12047129|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0
7633440|NCT03645395|12047126|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1
7633441|NCT03645395|12047127|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2
7633442|NCT03645395|12047128|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2
7633443|NCT03645395|12047129|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0
7633444|NCT03641651|12047140|FG000|Overall Study|organizational issues at one study site|1
7633445|NCT03638258|12047147|FG000|Overall Study|Adverse Event|1
7633446|NCT03638258|12047148|FG001|Overall Study|Adverse Event|0
7633447|NCT03638258|12047149|FG002|Overall Study|Adverse Event|2
7633448|NCT03638258|12047147|FG000|Overall Study|Lost to Follow-up|2
7633449|NCT03638258|12047148|FG001|Overall Study|Lost to Follow-up|4
7633450|NCT03638258|12047149|FG002|Overall Study|Lost to Follow-up|5
7633451|NCT03638258|12047147|FG000|Overall Study|Pregnancy|0
7633452|NCT03638258|12047148|FG001|Overall Study|Pregnancy|0
7633453|NCT03638258|12047149|FG002|Overall Study|Pregnancy|1
7633454|NCT03638258|12047147|FG000|Overall Study|Protocol Violation|0
7633455|NCT03638258|12047148|FG001|Overall Study|Protocol Violation|0
7633456|NCT03638258|12047149|FG002|Overall Study|Protocol Violation|1
7633457|NCT03638258|12047147|FG000|Overall Study|Withdrawal by Subject|4
7633458|NCT03638258|12047148|FG001|Overall Study|Withdrawal by Subject|5
7633459|NCT03638258|12047149|FG002|Overall Study|Withdrawal by Subject|12
7633460|NCT03638258|12047147|FG000|Overall Study|Lack of Efficacy|0
7633461|NCT03638258|12047148|FG001|Overall Study|Lack of Efficacy|0
7633462|NCT03638258|12047149|FG002|Overall Study|Lack of Efficacy|2
7633463|NCT03637374|12047160|FG000|Overall Study|Death|2
7633464|NCT03637374|12047161|FG001|Overall Study|Death|0
7633465|NCT03636906|12047170|FG000|Overall Study|Adverse Event|0
7633466|NCT03636906|12047171|FG001|Overall Study|Adverse Event|0
7633467|NCT03636906|12047172|FG002|Overall Study|Adverse Event|1
7633468|NCT03636906|12047170|FG000|Overall Study|Lost to Follow-up|1
7633469|NCT03636906|12047171|FG001|Overall Study|Lost to Follow-up|0
7633470|NCT03636906|12047172|FG002|Overall Study|Lost to Follow-up|0
7633471|NCT03636906|12047170|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2
7633472|NCT03636906|12047171|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0
7633473|NCT03636906|12047172|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1
7633474|NCT03636906|12047170|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
7633475|NCT03636906|12047171|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7633476|NCT03636906|12047172|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2
7633477|NCT03636906|12047170|FG000|Overall Study|Other|0
7633478|NCT03636906|12047171|FG001|Overall Study|Other|0
7633479|NCT03636906|12047172|FG002|Overall Study|Other|1
7633480|NCT03635099|12047194|FG000|Period 1|Adverse Event|1
7633481|NCT03635099|12047195|FG001|Period 1|Adverse Event|0
7633482|NCT03635099|12047196|FG002|Period 1|Adverse Event|0
7633483|NCT03635099|12047197|FG003|Period 1|Adverse Event|1
7633484|NCT03635099|12047198|FG004|Period 1|Adverse Event|0
7633485|NCT03635099|12047199|FG005|Period 1|Adverse Event|0
7633486|NCT03635099|12047200|FG006|Period 1|Adverse Event|0
7633487|NCT03635099|12047201|FG007|Period 1|Adverse Event|0
7633488|NCT03635099|12047194|FG000|Period 1|Protocol Violation|0
7633489|NCT03635099|12047195|FG001|Period 1|Protocol Violation|0
7633490|NCT03635099|12047196|FG002|Period 1|Protocol Violation|1
7633491|NCT03635099|12047197|FG003|Period 1|Protocol Violation|0
7633492|NCT03635099|12047198|FG004|Period 1|Protocol Violation|0
7633493|NCT03635099|12047199|FG005|Period 1|Protocol Violation|0
7633494|NCT03635099|12047200|FG006|Period 1|Protocol Violation|0
7633495|NCT03635099|12047201|FG007|Period 1|Protocol Violation|0
7633496|NCT03635099|12047194|FG000|Period 1|Lost to Follow-up|0
7633497|NCT03635099|12047195|FG001|Period 1|Lost to Follow-up|0
7633498|NCT03635099|12047196|FG002|Period 1|Lost to Follow-up|1
7633499|NCT03635099|12047197|FG003|Period 1|Lost to Follow-up|2
7633500|NCT03635099|12047198|FG004|Period 1|Lost to Follow-up|1
7633501|NCT03635099|12047199|FG005|Period 1|Lost to Follow-up|0
7633502|NCT03635099|12047200|FG006|Period 1|Lost to Follow-up|1
7633503|NCT03635099|12047201|FG007|Period 1|Lost to Follow-up|2
7633504|NCT03635099|12047194|FG000|Period 1|Withdrawal by Subject|3
7633505|NCT03635099|12047195|FG001|Period 1|Withdrawal by Subject|3
7633506|NCT03635099|12047196|FG002|Period 1|Withdrawal by Subject|5
7633507|NCT03635099|12047197|FG003|Period 1|Withdrawal by Subject|2
7633508|NCT03635099|12047198|FG004|Period 1|Withdrawal by Subject|2
7633509|NCT03635099|12047199|FG005|Period 1|Withdrawal by Subject|0
7633510|NCT03635099|12047200|FG006|Period 1|Withdrawal by Subject|3
7633511|NCT03635099|12047201|FG007|Period 1|Withdrawal by Subject|0
7633512|NCT03635099|12047194|FG000|Period 1|History of suicidal ideation|0
7633513|NCT03635099|12047195|FG001|Period 1|History of suicidal ideation|0
7633514|NCT03635099|12047196|FG002|Period 1|History of suicidal ideation|1
7633515|NCT03635099|12047197|FG003|Period 1|History of suicidal ideation|0
7633516|NCT03635099|12047198|FG004|Period 1|History of suicidal ideation|0
7633517|NCT03635099|12047199|FG005|Period 1|History of suicidal ideation|0
7633518|NCT03635099|12047200|FG006|Period 1|History of suicidal ideation|0
7633519|NCT03635099|12047201|FG007|Period 1|History of suicidal ideation|0
7633520|NCT03635099|12047194|FG000|Period 1|pursue other treatment options|0
7633521|NCT03635099|12047195|FG001|Period 1|pursue other treatment options|0
7633522|NCT03635099|12047196|FG002|Period 1|pursue other treatment options|0
7633523|NCT03635099|12047197|FG003|Period 1|pursue other treatment options|0
7633524|NCT03635099|12047198|FG004|Period 1|pursue other treatment options|0
7633525|NCT03635099|12047199|FG005|Period 1|pursue other treatment options|1
7633526|NCT03635099|12047200|FG006|Period 1|pursue other treatment options|0
7633527|NCT03635099|12047201|FG007|Period 1|pursue other treatment options|0
7633528|NCT03635099|12047194|FG000|Not Eligible for Period 2|Pregnancy|0
7633529|NCT03635099|12047195|FG001|Not Eligible for Period 2|Pregnancy|0
7633530|NCT03635099|12047196|FG002|Not Eligible for Period 2|Pregnancy|0
7633531|NCT03635099|12047197|FG003|Not Eligible for Period 2|Pregnancy|1
7633532|NCT03635099|12047198|FG004|Not Eligible for Period 2|Pregnancy|0
7633533|NCT03635099|12047199|FG005|Not Eligible for Period 2|Pregnancy|0
7633534|NCT03635099|12047200|FG006|Not Eligible for Period 2|Pregnancy|0
7633535|NCT03635099|12047201|FG007|Not Eligible for Period 2|Pregnancy|0
7633536|NCT03635099|12047194|FG000|Not Eligible for Period 2|Withdrawal by Subject|1
7633537|NCT03635099|12047195|FG001|Not Eligible for Period 2|Withdrawal by Subject|0
7633538|NCT03635099|12047196|FG002|Not Eligible for Period 2|Withdrawal by Subject|0
7633539|NCT03635099|12047197|FG003|Not Eligible for Period 2|Withdrawal by Subject|0
7633540|NCT03635099|12047198|FG004|Not Eligible for Period 2|Withdrawal by Subject|0
7633541|NCT03635099|12047199|FG005|Not Eligible for Period 2|Withdrawal by Subject|0
7633542|NCT03635099|12047200|FG006|Not Eligible for Period 2|Withdrawal by Subject|0
7633543|NCT03635099|12047201|FG007|Not Eligible for Period 2|Withdrawal by Subject|0
7633544|NCT03635099|12047194|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0
7633545|NCT03635099|12047195|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0
7633546|NCT03635099|12047196|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0
7633547|NCT03635099|12047197|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0
7633548|NCT03635099|12047198|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0
7633549|NCT03635099|12047199|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9
7633550|NCT03635099|12047200|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40
7633551|NCT03635099|12047201|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40
7633552|NCT03635099|12047194|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15
7633553|NCT03635099|12047195|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35
7633554|NCT03635099|12047196|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21
7633555|NCT03635099|12047197|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25
7633556|NCT03635099|12047198|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0
7633557|NCT03635099|12047199|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0
7633558|NCT03635099|12047200|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0
7633559|NCT03635099|12047201|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0
7633560|NCT03635099|12047194|FG000|Period 2|Adverse Event|0
7633561|NCT03635099|12047195|FG001|Period 2|Adverse Event|0
7633562|NCT03635099|12047196|FG002|Period 2|Adverse Event|1
7633563|NCT03635099|12047197|FG003|Period 2|Adverse Event|0
7633564|NCT03635099|12047198|FG004|Period 2|Adverse Event|1
7633565|NCT03635099|12047199|FG005|Period 2|Adverse Event|0
7633566|NCT03635099|12047200|FG006|Period 2|Adverse Event|0
7633567|NCT03635099|12047201|FG007|Period 2|Adverse Event|0
7633568|NCT03635099|12047194|FG000|Period 2|Lost to Follow-up|0
7633569|NCT03635099|12047195|FG001|Period 2|Lost to Follow-up|0
7633570|NCT03635099|12047196|FG002|Period 2|Lost to Follow-up|1
7633571|NCT03635099|12047197|FG003|Period 2|Lost to Follow-up|0
7633572|NCT03635099|12047198|FG004|Period 2|Lost to Follow-up|4
7633573|NCT03635099|12047199|FG005|Period 2|Lost to Follow-up|0
7633574|NCT03635099|12047200|FG006|Period 2|Lost to Follow-up|0
7633575|NCT03635099|12047201|FG007|Period 2|Lost to Follow-up|0
7633576|NCT03635099|12047194|FG000|Period 2|Withdrawal by Subject|0
7633577|NCT03635099|12047195|FG001|Period 2|Withdrawal by Subject|0
7633578|NCT03635099|12047196|FG002|Period 2|Withdrawal by Subject|7
7633579|NCT03635099|12047197|FG003|Period 2|Withdrawal by Subject|4
7633580|NCT03635099|12047198|FG004|Period 2|Withdrawal by Subject|7
7633581|NCT03635099|12047199|FG005|Period 2|Withdrawal by Subject|0
7633582|NCT03635099|12047200|FG006|Period 2|Withdrawal by Subject|0
7633583|NCT03635099|12047201|FG007|Period 2|Withdrawal by Subject|0
7633584|NCT03633227|12047229|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1
7633585|NCT03633227|12047230|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1
7633586|NCT03633227|12047229|FG000|Double Blind (DB), up to Week 48|Death|2
7633587|NCT03633227|12047230|FG001|Double Blind (DB), up to Week 48|Death|1
7633588|NCT03633227|12047229|FG000|Double Blind (DB), up to Week 48|Adverse Event|0
7633589|NCT03633227|12047230|FG001|Double Blind (DB), up to Week 48|Adverse Event|1
7633590|NCT03633227|12047229|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2
7633591|NCT03633227|12047230|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1
7633592|NCT03633227|12047229|FG000|Double Blind (DB), up to Week 48|Physician Decision|1
7633593|NCT03633227|12047230|FG001|Double Blind (DB), up to Week 48|Physician Decision|0
7633594|NCT03633227|12047229|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1
7633595|NCT03633227|12047230|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0
7633596|NCT03633227|12047229|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1
7633597|NCT03633227|12047230|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0
7633598|NCT03633227|12047229|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0
7633599|NCT03633227|12047230|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2
7633600|NCT03633227|12047229|FG000|DB Extension, Week 48 up to 3 Years|Death|0
7633601|NCT03633227|12047230|FG001|DB Extension, Week 48 up to 3 Years|Death|1
7633602|NCT03633227|12047229|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3
7633603|NCT03633227|12047230|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2
7633604|NCT03633227|12047229|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1
7633605|NCT03633227|12047230|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0
7633606|NCT03633227|12047229|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0
7633607|NCT03633227|12047230|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1
7633608|NCT03624881|12047261|FG000|Overall Study|Screen Failure|14
7633609|NCT03624881|12047262|FG001|Overall Study|Screen Failure|0
7633610|NCT03624881|12047261|FG000|Overall Study|No Catheter Inserted|6
7633611|NCT03624881|12047262|FG001|Overall Study|No Catheter Inserted|1
7633612|NCT03624881|12047261|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2
7633613|NCT03624881|12047262|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0
7633614|NCT03624881|12047261|FG000|Overall Study|Death|2
7633615|NCT03624881|12047262|FG001|Overall Study|Death|0
7633616|NCT03624881|12047261|FG000|Overall Study|Lost to Follow-up|10
7633617|NCT03624881|12047262|FG001|Overall Study|Lost to Follow-up|4
7633618|NCT03624881|12047261|FG000|Overall Study|Withdrawal by Subject|12
7633619|NCT03624881|12047262|FG001|Overall Study|Withdrawal by Subject|1
7633620|NCT03622593|12047271|FG000|Overall Study|Withdrawal by Subject|11
7633621|NCT03622593|12047272|FG001|Overall Study|Withdrawal by Subject|9
7633622|NCT03622593|12047273|FG002|Overall Study|Withdrawal by Subject|13
7633623|NCT03622593|12047271|FG000|Overall Study|Death|12
7633624|NCT03622593|12047272|FG001|Overall Study|Death|9
7633625|NCT03622593|12047273|FG002|Overall Study|Death|10
7633626|NCT03622593|12047271|FG000|Overall Study|Lost to Follow-up|11
7633627|NCT03622593|12047272|FG001|Overall Study|Lost to Follow-up|5
7633628|NCT03622593|12047273|FG002|Overall Study|Lost to Follow-up|8
7633629|NCT03622593|12047271|FG000|Overall Study|Adverse Event|4
7633630|NCT03622593|12047272|FG001|Overall Study|Adverse Event|5
7633631|NCT03622593|12047273|FG002|Overall Study|Adverse Event|6
7633632|NCT03622593|12047271|FG000|Overall Study|Physician Decision|2
7633633|NCT03622593|12047272|FG001|Overall Study|Physician Decision|1
7633634|NCT03622593|12047273|FG002|Overall Study|Physician Decision|6
7633635|NCT03622593|12047271|FG000|Overall Study|Other|2
7633636|NCT03622593|12047272|FG001|Overall Study|Other|2
7633637|NCT03622593|12047273|FG002|Overall Study|Other|3
7633638|NCT03622593|12047271|FG000|Overall Study|Protocol Violation|0
7633639|NCT03622593|12047272|FG001|Overall Study|Protocol Violation|0
7633640|NCT03622593|12047273|FG002|Overall Study|Protocol Violation|1
7633641|NCT03622593|12047271|FG000|Overall Study|Pregnancy|0
7633642|NCT03622593|12047272|FG001|Overall Study|Pregnancy|0
7633643|NCT03622593|12047273|FG002|Overall Study|Pregnancy|1
7633644|NCT03622580|12047285|FG000|Overall Study|Death|16
7633645|NCT03622580|12047286|FG001|Overall Study|Death|21
7633646|NCT03622580|12047287|FG002|Overall Study|Death|13
7633647|NCT03622580|12047285|FG000|Overall Study|Adverse Event|6
7633648|NCT03622580|12047286|FG001|Overall Study|Adverse Event|6
7633649|NCT03622580|12047287|FG002|Overall Study|Adverse Event|5
7633650|NCT03622580|12047285|FG000|Overall Study|Withdrawal by Subject|12
7633651|NCT03622580|12047286|FG001|Overall Study|Withdrawal by Subject|7
7633652|NCT03622580|12047287|FG002|Overall Study|Withdrawal by Subject|19
7633653|NCT03622580|12047285|FG000|Overall Study|Lost to Follow-up|12
7633654|NCT03622580|12047286|FG001|Overall Study|Lost to Follow-up|9
7633655|NCT03622580|12047287|FG002|Overall Study|Lost to Follow-up|9
7633656|NCT03622580|12047285|FG000|Overall Study|Protocol Violation|1
7633657|NCT03622580|12047286|FG001|Overall Study|Protocol Violation|0
7633658|NCT03622580|12047287|FG002|Overall Study|Protocol Violation|1
7633659|NCT03622580|12047285|FG000|Overall Study|Physician Decision|3
7633660|NCT03622580|12047286|FG001|Overall Study|Physician Decision|0
7633661|NCT03622580|12047287|FG002|Overall Study|Physician Decision|1
7633662|NCT03622580|12047285|FG000|Overall Study|Pregnancy|0
7633663|NCT03622580|12047286|FG001|Overall Study|Pregnancy|1
7633664|NCT03622580|12047287|FG002|Overall Study|Pregnancy|0
7633665|NCT03622580|12047285|FG000|Overall Study|Lack of Efficacy|0
7633666|NCT03622580|12047286|FG001|Overall Study|Lack of Efficacy|0
7633667|NCT03622580|12047287|FG002|Overall Study|Lack of Efficacy|1
7633668|NCT03622580|12047285|FG000|Overall Study|Other|2
7633669|NCT03622580|12047286|FG001|Overall Study|Other|0
7633670|NCT03622580|12047287|FG002|Overall Study|Other|3
7633671|NCT03619174|12047298|FG000|Overall Study|Lost to Follow-up|3
7633672|NCT03619174|12047299|FG001|Overall Study|Lost to Follow-up|0
7633673|NCT03619174|12047298|FG000|Overall Study|Withdrawal by Subject|4
7633674|NCT03619174|12047299|FG001|Overall Study|Withdrawal by Subject|3
7633675|NCT03619174|12047298|FG000|Overall Study|Pregnancy|1
7633676|NCT03619174|12047299|FG001|Overall Study|Pregnancy|1
7633677|NCT03619174|12047298|FG000|Overall Study|Discomfort during treatment|1
7633678|NCT03619174|12047299|FG001|Overall Study|Discomfort during treatment|0
7633679|NCT03607487|12047358|FG000|Overall Study|Withdrawal by Subject|2
7633680|NCT03607487|12047359|FG001|Overall Study|Withdrawal by Subject|0
7633681|NCT03607487|12047360|FG002|Overall Study|Withdrawal by Subject|0
7633682|NCT03607487|12047361|FG003|Overall Study|Withdrawal by Subject|1
7633683|NCT03606109|12047375|FG000|Overall Study|Lost to Follow-up|2
7633684|NCT03606109|12047376|FG001|Overall Study|Lost to Follow-up|1
7633685|NCT03595384|12047395|FG000|Overall Study|Other time commitments|8
7633686|NCT03595384|12047395|FG000|Overall Study|Changes to session time|7
7633687|NCT03595384|12047395|FG000|Overall Study|Relocation out of country|1
7633688|NCT03592277|12047417|FG000|Overall Study|Withdrawal by Subject|6
7633689|NCT03592277|12047418|FG001|Overall Study|Withdrawal by Subject|8
7633690|NCT03590366|12047450|FG000|Overall Study|Adverse Event|0
7633691|NCT03590366|12047451|FG001|Overall Study|Adverse Event|3
7633692|NCT03590366|12047450|FG000|Overall Study|Lost to Follow-up|3
7633693|NCT03590366|12047451|FG001|Overall Study|Lost to Follow-up|3
7633694|NCT03590366|12047450|FG000|Overall Study|Withdrawal by Subject|0
7633695|NCT03590366|12047451|FG001|Overall Study|Withdrawal by Subject|2
7633696|NCT03589469|12047457|FG000|Overall Study|Ongoing in study|58
7633697|NCT03589469|12047457|FG000|Overall Study|Withdrawal by Subject|6
7633698|NCT03589469|12047457|FG000|Overall Study|Physician Decision|1
7633699|NCT03589469|12047457|FG000|Overall Study|Death|77
7633700|NCT03589469|12047457|FG000|Overall Study|Lost to Follow-up|3
7633701|NCT03587584|12047463|FG000|Overall Study|SOC deviations|4
7633702|NCT03587584|12047464|FG001|Overall Study|SOC deviations|6
7633703|NCT03587584|12047463|FG000|Overall Study|Incomplete data|0
7633704|NCT03587584|12047464|FG001|Overall Study|Incomplete data|3
7633705|NCT03586427|12047475|FG000|Overall Study|Lost to Follow-up|0
7633706|NCT03586427|12047476|FG001|Overall Study|Lost to Follow-up|3
7633707|NCT03586427|12047477|FG002|Overall Study|Lost to Follow-up|1
7633708|NCT03586427|12047478|FG003|Overall Study|Lost to Follow-up|3
7633709|NCT03586427|12047479|FG004|Overall Study|Lost to Follow-up|3
7633710|NCT03586427|12047475|FG000|Overall Study|Withdrawal by Subject|0
7633711|NCT03586427|12047476|FG001|Overall Study|Withdrawal by Subject|1
7633712|NCT03586427|12047477|FG002|Overall Study|Withdrawal by Subject|2
7633713|NCT03586427|12047478|FG003|Overall Study|Withdrawal by Subject|1
7633714|NCT03586427|12047479|FG004|Overall Study|Withdrawal by Subject|1
7633715|NCT03586427|12047475|FG000|Overall Study|Adverse Event|0
7633716|NCT03586427|12047476|FG001|Overall Study|Adverse Event|0
7633717|NCT03586427|12047477|FG002|Overall Study|Adverse Event|1
7633718|NCT03586427|12047478|FG003|Overall Study|Adverse Event|0
7633719|NCT03586427|12047479|FG004|Overall Study|Adverse Event|0
7633720|NCT03586427|12047475|FG000|Overall Study|Protocol Violation|0
7633721|NCT03586427|12047476|FG001|Overall Study|Protocol Violation|0
7633722|NCT03586427|12047477|FG002|Overall Study|Protocol Violation|1
7633723|NCT03586427|12047478|FG003|Overall Study|Protocol Violation|0
7633724|NCT03586427|12047479|FG004|Overall Study|Protocol Violation|1
7633725|NCT03586427|12047475|FG000|Overall Study|Noncompliance with study drug|0
7633726|NCT03586427|12047476|FG001|Overall Study|Noncompliance with study drug|0
7633727|NCT03586427|12047477|FG002|Overall Study|Noncompliance with study drug|1
7633728|NCT03586427|12047478|FG003|Overall Study|Noncompliance with study drug|0
7633729|NCT03586427|12047479|FG004|Overall Study|Noncompliance with study drug|0
7633730|NCT03584789|12047503|FG000|Overall Study|refused EHR permission|19
7633731|NCT03584789|12047504|FG001|Overall Study|refused EHR permission|28
7633732|NCT03584789|12047505|FG002|Overall Study|refused EHR permission|23
7633733|NCT03584789|12047503|FG000|Overall Study|patients tied to a provider who retired|0
7633734|NCT03584789|12047504|FG001|Overall Study|patients tied to a provider who retired|0
7633735|NCT03584789|12047505|FG002|Overall Study|patients tied to a provider who retired|3
7633736|NCT03575468|12047515|FG000|Overall Study|Withdrawal by Subject|3
7633737|NCT03575468|12047516|FG001|Overall Study|Withdrawal by Subject|0
7633738|NCT03575468|12047515|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10
7633739|NCT03575468|12047516|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4
7633740|NCT03575468|12047515|FG000|Overall Study|Lost to Follow-up|13
7633741|NCT03575468|12047516|FG001|Overall Study|Lost to Follow-up|17
7633742|NCT03575325|12047522|FG000|Overall Study|Death|1
7633743|NCT03575065|12047530|FG000|Overall Study|Death|31
7633744|NCT03575065|12047531|FG001|Overall Study|Death|12
7633745|NCT03575065|12047530|FG000|Overall Study|Sponsor's Decision|28
7633746|NCT03575065|12047531|FG001|Overall Study|Sponsor's Decision|13
7633747|NCT03575065|12047530|FG000|Overall Study|Withdrawal by Subject|2
7633748|NCT03575065|12047531|FG001|Overall Study|Withdrawal by Subject|1
7633749|NCT03575065|12047530|FG000|Overall Study|Lost to Follow-up|1
7633750|NCT03575065|12047531|FG001|Overall Study|Lost to Follow-up|0
7633751|NCT03571581|12047538|FG000|Overall Study|Death|2
7633752|NCT03571581|12047538|FG000|Overall Study|Withdrawal by Subject|2
7633753|NCT03569371|12047590|FG000|Overall Study|Lack of Efficacy|1
7633754|NCT03569371|12047590|FG000|Overall Study|Lost to Follow-up|1
7633755|NCT03569371|12047590|FG000|Overall Study|Adverse Event|1
7633756|NCT03568162|12047609|FG000|Overall Study|Adverse Event|0
7633757|NCT03568162|12047610|FG001|Overall Study|Adverse Event|1
7633758|NCT03568162|12047611|FG002|Overall Study|Adverse Event|2
7633759|NCT03568162|12047612|FG003|Overall Study|Adverse Event|0
7633760|NCT03568162|12047613|FG004|Overall Study|Adverse Event|0
7633761|NCT03568162|12047614|FG005|Overall Study|Adverse Event|1
7633762|NCT03568162|12047609|FG000|Overall Study|Death|0
7633763|NCT03568162|12047610|FG001|Overall Study|Death|0
7633764|NCT03568162|12047611|FG002|Overall Study|Death|0
7633765|NCT03568162|12047612|FG003|Overall Study|Death|0
7633766|NCT03568162|12047613|FG004|Overall Study|Death|1
7633767|NCT03568162|12047614|FG005|Overall Study|Death|0
7633768|NCT03568162|12047609|FG000|Overall Study|Lost to Follow-up|3
7633769|NCT03568162|12047610|FG001|Overall Study|Lost to Follow-up|2
7633770|NCT03568162|12047611|FG002|Overall Study|Lost to Follow-up|4
7633771|NCT03568162|12047612|FG003|Overall Study|Lost to Follow-up|2
7633772|NCT03568162|12047613|FG004|Overall Study|Lost to Follow-up|3
7633773|NCT03568162|12047614|FG005|Overall Study|Lost to Follow-up|2
7633774|NCT03568162|12047609|FG000|Overall Study|Physician Decision|0
7633775|NCT03568162|12047610|FG001|Overall Study|Physician Decision|1
7633776|NCT03568162|12047611|FG002|Overall Study|Physician Decision|1
7633777|NCT03568162|12047612|FG003|Overall Study|Physician Decision|0
7633778|NCT03568162|12047613|FG004|Overall Study|Physician Decision|1
7633779|NCT03568162|12047614|FG005|Overall Study|Physician Decision|0
7633780|NCT03568162|12047609|FG000|Overall Study|Pregnancy|0
7633781|NCT03568162|12047610|FG001|Overall Study|Pregnancy|0
7633782|NCT03568162|12047611|FG002|Overall Study|Pregnancy|0
7633783|NCT03568162|12047612|FG003|Overall Study|Pregnancy|1
7633784|NCT03568162|12047613|FG004|Overall Study|Pregnancy|0
7633785|NCT03568162|12047614|FG005|Overall Study|Pregnancy|0
7633786|NCT03568162|12047609|FG000|Overall Study|Protocol Violation|1
7633787|NCT03568162|12047610|FG001|Overall Study|Protocol Violation|0
7633788|NCT03568162|12047611|FG002|Overall Study|Protocol Violation|1
7633789|NCT03568162|12047612|FG003|Overall Study|Protocol Violation|1
7633790|NCT03568162|12047613|FG004|Overall Study|Protocol Violation|1
7633791|NCT03568162|12047614|FG005|Overall Study|Protocol Violation|1
7633792|NCT03568162|12047609|FG000|Overall Study|Withdrawal by Subject|15
7633793|NCT03568162|12047610|FG001|Overall Study|Withdrawal by Subject|15
7633794|NCT03568162|12047611|FG002|Overall Study|Withdrawal by Subject|26
7633795|NCT03568162|12047612|FG003|Overall Study|Withdrawal by Subject|22
7633796|NCT03568162|12047613|FG004|Overall Study|Withdrawal by Subject|6
7633797|NCT03568162|12047614|FG005|Overall Study|Withdrawal by Subject|9
7633798|NCT03568162|12047609|FG000|Overall Study|Others|3
7633799|NCT03568162|12047610|FG001|Overall Study|Others|4
7633800|NCT03568162|12047611|FG002|Overall Study|Others|1
7633801|NCT03568162|12047612|FG003|Overall Study|Others|4
7633802|NCT03568162|12047613|FG004|Overall Study|Others|2
7633803|NCT03568162|12047614|FG005|Overall Study|Others|1
7633804|NCT03565237|12047640|FG000|Overall Study|Non-compliance of Investigational Product|1
7633805|NCT03565237|12047640|FG000|Overall Study|Physician Decision|1
7633806|NCT03563716|12047646|FG000|Overall Study|Death|20
7633807|NCT03563716|12047647|FG001|Overall Study|Death|14
7633808|NCT03563716|12047646|FG000|Overall Study|Withdrawal by Subject|3
7633809|NCT03563716|12047647|FG001|Overall Study|Withdrawal by Subject|3
7633810|NCT03563716|12047646|FG000|Overall Study|Still on Study|45
7633811|NCT03563716|12047647|FG001|Overall Study|Still on Study|50
7633812|NCT03558503|12047653|FG000|Overall Study|Adverse Event|1
7633813|NCT03558503|12047653|FG000|Overall Study|Death|1
7633814|NCT03558503|12047653|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1
7633815|NCT03557151|12047659|FG000|Randomization to 3 Months|Lost to Follow-up|2
7633816|NCT03557151|12047660|FG001|Randomization to 3 Months|Lost to Follow-up|2
7633817|NCT03557151|12047659|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2
7633818|NCT03557151|12047660|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0
7633819|NCT03557151|12047659|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0
7633820|NCT03557151|12047660|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2
7633821|NCT03538951|12047706|FG000|Overall Study|Withdrawal by Subject|1
7633822|NCT03538951|12047707|FG001|Overall Study|Withdrawal by Subject|2
7633823|NCT03538054|12047713|FG000|Baseline Phase (2 Weeks)|Physician Decision|1
7633824|NCT03538054|12047713|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2
7633825|NCT03538054|12047713|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2
7633826|NCT03538041|12047721|FG000|12-Week Treatment Period|Adverse Event|1
7633827|NCT03538041|12047722|FG001|12-Week Treatment Period|Adverse Event|1
7633828|NCT03538041|12047721|FG000|12-Week Treatment Period|Withdrawal by Subject|0
7633829|NCT03538041|12047722|FG001|12-Week Treatment Period|Withdrawal by Subject|1
7633830|NCT03538041|12047721|FG000|Treatment Extension Period|Adverse Event|4
7633831|NCT03538041|12047722|FG001|Treatment Extension Period|Adverse Event|0
7633832|NCT03538041|12047721|FG000|Treatment Extension Period|Physician Decision|1
7633833|NCT03538041|12047722|FG001|Treatment Extension Period|Physician Decision|0
7633834|NCT03538041|12047721|FG000|Treatment Extension Period|Lack of Efficacy|1
7633835|NCT03538041|12047722|FG001|Treatment Extension Period|Lack of Efficacy|3
7633836|NCT03538041|12047721|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1
7633837|NCT03538041|12047722|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7
7633838|NCT03525678|12047734|FG000|Overall Study|Ongoing at the time of interim analysis|60
7633839|NCT03525678|12047735|FG001|Overall Study|Ongoing at the time of interim analysis|65
7633840|NCT03525678|12047736|FG002|Overall Study|Ongoing at the time of interim analysis|21
7633841|NCT03525678|12047734|FG000|Overall Study|Withdrawal by Subject|3
7633842|NCT03525678|12047735|FG001|Overall Study|Withdrawal by Subject|1
7633843|NCT03525678|12047736|FG002|Overall Study|Withdrawal by Subject|0
7633844|NCT03525678|12047734|FG000|Overall Study|Physician Decision|1
7633845|NCT03525678|12047735|FG001|Overall Study|Physician Decision|2
7633846|NCT03525678|12047736|FG002|Overall Study|Physician Decision|0
7633847|NCT03525678|12047734|FG000|Overall Study|Lost to Follow-up|1
7633848|NCT03525678|12047735|FG001|Overall Study|Lost to Follow-up|0
7633849|NCT03525678|12047736|FG002|Overall Study|Lost to Follow-up|0
7633850|NCT03525678|12047734|FG000|Overall Study|Death|32
7633851|NCT03525678|12047735|FG001|Overall Study|Death|31
7633852|NCT03525678|12047736|FG002|Overall Study|Death|4
7633853|NCT03525119|12047747|FG000|Overall Study|Adverse Event|0
7633854|NCT03525119|12047748|FG001|Overall Study|Adverse Event|1
7633855|NCT03525119|12047749|FG002|Overall Study|Adverse Event|0
7633856|NCT03525119|12047747|FG000|Overall Study|Lost to Follow-up|32
7633857|NCT03525119|12047748|FG001|Overall Study|Lost to Follow-up|33
7633858|NCT03525119|12047749|FG002|Overall Study|Lost to Follow-up|37
7633859|NCT03525119|12047747|FG000|Overall Study|Withdrawal by Subject|5
7633860|NCT03525119|12047748|FG001|Overall Study|Withdrawal by Subject|4
7633861|NCT03525119|12047749|FG002|Overall Study|Withdrawal by Subject|2
7633862|NCT03525119|12047747|FG000|Overall Study|Reason not Specified|2
7633863|NCT03525119|12047748|FG001|Overall Study|Reason not Specified|1
7633864|NCT03525119|12047749|FG002|Overall Study|Reason not Specified|2
7633865|NCT03525119|12047747|FG000|Overall Study|Randomized but not Vaccinated|1
7633866|NCT03525119|12047748|FG001|Overall Study|Randomized but not Vaccinated|0
7633867|NCT03525119|12047749|FG002|Overall Study|Randomized but not Vaccinated|2
7633868|NCT03521193|12047759|FG000|Overall Study|Withdrawal by Subject|8
7633869|NCT03521193|12047760|FG001|Overall Study|Withdrawal by Subject|0
7633870|NCT03521193|12047759|FG000|Overall Study|non compliant to ASA treatment|8
7633871|NCT03521193|12047760|FG001|Overall Study|non compliant to ASA treatment|0
7633872|NCT03518086|12047769|FG000|Overall Study|Adverse Event|23
7633873|NCT03518086|12047770|FG001|Overall Study|Adverse Event|15
7633874|NCT03518086|12047771|FG002|Overall Study|Adverse Event|0
7633875|NCT03518086|12047772|FG003|Overall Study|Adverse Event|0
7633876|NCT03518086|12047769|FG000|Overall Study|Withdrawal by Subject|8
7633877|NCT03518086|12047770|FG001|Overall Study|Withdrawal by Subject|5
7633878|NCT03518086|12047771|FG002|Overall Study|Withdrawal by Subject|0
7633879|NCT03518086|12047772|FG003|Overall Study|Withdrawal by Subject|0
7633880|NCT03518086|12047769|FG000|Overall Study|Lack of Efficacy|5
7633881|NCT03518086|12047770|FG001|Overall Study|Lack of Efficacy|5
7633882|NCT03518086|12047771|FG002|Overall Study|Lack of Efficacy|0
7633883|NCT03518086|12047772|FG003|Overall Study|Lack of Efficacy|0
7633884|NCT03518086|12047769|FG000|Overall Study|Protocol Violation|1
7633885|NCT03518086|12047770|FG001|Overall Study|Protocol Violation|5
7633886|NCT03518086|12047771|FG002|Overall Study|Protocol Violation|0
7633887|NCT03518086|12047772|FG003|Overall Study|Protocol Violation|0
7633888|NCT03518086|12047769|FG000|Overall Study|Lost to Follow-up|0
7633889|NCT03518086|12047770|FG001|Overall Study|Lost to Follow-up|3
7633890|NCT03518086|12047771|FG002|Overall Study|Lost to Follow-up|0
7633891|NCT03518086|12047772|FG003|Overall Study|Lost to Follow-up|0
7633892|NCT03518086|12047769|FG000|Overall Study|Insufficient Diary Data|0
7633893|NCT03518086|12047770|FG001|Overall Study|Insufficient Diary Data|2
7633894|NCT03518086|12047771|FG002|Overall Study|Insufficient Diary Data|0
7633895|NCT03518086|12047772|FG003|Overall Study|Insufficient Diary Data|0
7633896|NCT03518086|12047769|FG000|Overall Study|Non- compliance to Protocol|0
7633897|NCT03518086|12047770|FG001|Overall Study|Non- compliance to Protocol|1
7633898|NCT03518086|12047771|FG002|Overall Study|Non- compliance to Protocol|0
7633899|NCT03518086|12047772|FG003|Overall Study|Non- compliance to Protocol|0
7633900|NCT03518086|12047769|FG000|Overall Study|COVID-19 Related Study Disruption|0
7633901|NCT03518086|12047770|FG001|Overall Study|COVID-19 Related Study Disruption|2
7633902|NCT03518086|12047771|FG002|Overall Study|COVID-19 Related Study Disruption|0
7633903|NCT03518086|12047772|FG003|Overall Study|COVID-19 Related Study Disruption|0
7633904|NCT03518086|12047769|FG000|Overall Study|Site Terminated by Sponsor|0
7633905|NCT03518086|12047770|FG001|Overall Study|Site Terminated by Sponsor|1
7633906|NCT03518086|12047771|FG002|Overall Study|Site Terminated by Sponsor|0
7633907|NCT03518086|12047772|FG003|Overall Study|Site Terminated by Sponsor|0
7633908|NCT03518073|12047782|FG000|Overall Study|Adverse Event|2
7633909|NCT03518073|12047783|FG001|Overall Study|Adverse Event|4
7633910|NCT03518073|12047784|FG002|Overall Study|Adverse Event|2
7633911|NCT03518073|12047782|FG000|Overall Study|Death|2
7633912|NCT03518073|12047783|FG001|Overall Study|Death|1
7633913|NCT03518073|12047784|FG002|Overall Study|Death|3
7633914|NCT03518073|12047782|FG000|Overall Study|Lost to Follow-up|1
7633915|NCT03518073|12047783|FG001|Overall Study|Lost to Follow-up|0
7633916|NCT03518073|12047784|FG002|Overall Study|Lost to Follow-up|1
7633917|NCT03518073|12047782|FG000|Overall Study|Physician Decision|5
7633918|NCT03518073|12047783|FG001|Overall Study|Physician Decision|0
7633919|NCT03518073|12047784|FG002|Overall Study|Physician Decision|2
7633920|NCT03518073|12047782|FG000|Overall Study|Progressive disease|1
7633921|NCT03518073|12047783|FG001|Overall Study|Progressive disease|1
7633922|NCT03518073|12047784|FG002|Overall Study|Progressive disease|1
7633923|NCT03518073|12047782|FG000|Overall Study|Protocol Violation|1
7633924|NCT03518073|12047783|FG001|Overall Study|Protocol Violation|0
7633925|NCT03518073|12047784|FG002|Overall Study|Protocol Violation|0
7633926|NCT03518073|12047782|FG000|Overall Study|Withdrawal by Subject|30
7633927|NCT03518073|12047783|FG001|Overall Study|Withdrawal by Subject|34
7633928|NCT03518073|12047784|FG002|Overall Study|Withdrawal by Subject|29
7633929|NCT03518073|12047782|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1
7633930|NCT03518073|12047783|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6
7633931|NCT03518073|12047784|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7
7633932|NCT03518073|12047782|FG000|Overall Study|Covid-19|1
7633933|NCT03518073|12047783|FG001|Overall Study|Covid-19|2
7633934|NCT03518073|12047784|FG002|Overall Study|Covid-19|1
7633935|NCT03514914|12047796|FG000|Overall Study|Death|3
7633936|NCT03514914|12047797|FG001|Overall Study|Death|3
7633937|NCT03514914|12047796|FG000|Overall Study|Lost to Follow-up|117
7633938|NCT03514914|12047797|FG001|Overall Study|Lost to Follow-up|89
7633939|NCT03511664|12047818|FG000|Overall Study|Treatment ongoing|49
7633940|NCT03511664|12047819|FG001|Overall Study|Treatment ongoing|5
7633941|NCT03511664|12047818|FG000|Overall Study|Entered long-term follow-up|140
7633942|NCT03511664|12047819|FG001|Overall Study|Entered long-term follow-up|50
7633943|NCT03511664|12047818|FG000|Overall Study|Withdrawal by Subject|29
7633944|NCT03511664|12047819|FG001|Overall Study|Withdrawal by Subject|53
7633945|NCT03511664|12047818|FG000|Overall Study|Lost to Follow-up|4
7633946|NCT03511664|12047819|FG001|Overall Study|Lost to Follow-up|4
7633947|NCT03511664|12047818|FG000|Overall Study|Physician Decision|0
7633948|NCT03511664|12047819|FG001|Overall Study|Physician Decision|1
7633949|NCT03498313|12047853|FG000|Experimental Period 1|Adverse Event|1
7633950|NCT03498313|12047854|FG001|Experimental Period 1|Adverse Event|0
7633951|NCT03498313|12047855|FG002|Experimental Period 1|Adverse Event|0
7633952|NCT03498313|12047856|FG003|Experimental Period 1|Adverse Event|1
7633953|NCT03498313|12047857|FG004|Experimental Period 1|Adverse Event|0
7633954|NCT03498313|12047858|FG005|Experimental Period 1|Adverse Event|0
7633955|NCT03498313|12047853|FG000|Experimental Period 1|Withdrawal by Subject|0
7633956|NCT03498313|12047854|FG001|Experimental Period 1|Withdrawal by Subject|1
7633957|NCT03498313|12047855|FG002|Experimental Period 1|Withdrawal by Subject|0
7633958|NCT03498313|12047856|FG003|Experimental Period 1|Withdrawal by Subject|0
7633959|NCT03498313|12047857|FG004|Experimental Period 1|Withdrawal by Subject|0
7633960|NCT03498313|12047858|FG005|Experimental Period 1|Withdrawal by Subject|0
7633961|NCT03498313|12047853|FG000|Washout Period 1|Anovulation|1
7633962|NCT03498313|12047854|FG001|Washout Period 1|Anovulation|0
7633963|NCT03498313|12047855|FG002|Washout Period 1|Anovulation|0
7633964|NCT03498313|12047856|FG003|Washout Period 1|Anovulation|0
7633965|NCT03498313|12047857|FG004|Washout Period 1|Anovulation|0
7633966|NCT03498313|12047858|FG005|Washout Period 1|Anovulation|0
7633967|NCT03498313|12047853|FG000|Washout Period 1|Withdrawal by Subject|0
7633968|NCT03498313|12047854|FG001|Washout Period 1|Withdrawal by Subject|3
7633969|NCT03498313|12047855|FG002|Washout Period 1|Withdrawal by Subject|0
7633970|NCT03498313|12047856|FG003|Washout Period 1|Withdrawal by Subject|1
7633971|NCT03498313|12047857|FG004|Washout Period 1|Withdrawal by Subject|0
7633972|NCT03498313|12047858|FG005|Washout Period 1|Withdrawal by Subject|1
7633973|NCT03498313|12047853|FG000|Experimental Period 2|Adverse Event|0
7633974|NCT03498313|12047854|FG001|Experimental Period 2|Adverse Event|0
7633975|NCT03498313|12047855|FG002|Experimental Period 2|Adverse Event|0
7633976|NCT03498313|12047856|FG003|Experimental Period 2|Adverse Event|0
7633977|NCT03498313|12047857|FG004|Experimental Period 2|Adverse Event|1
7633978|NCT03498313|12047858|FG005|Experimental Period 2|Adverse Event|2
7633979|NCT03498313|12047853|FG000|Washout Period 2|Physician Decision|1
7633980|NCT03498313|12047854|FG001|Washout Period 2|Physician Decision|0
7633981|NCT03498313|12047855|FG002|Washout Period 2|Physician Decision|0
7633982|NCT03498313|12047856|FG003|Washout Period 2|Physician Decision|1
7633983|NCT03498313|12047857|FG004|Washout Period 2|Physician Decision|0
7633984|NCT03498313|12047858|FG005|Washout Period 2|Physician Decision|1
7633985|NCT03498313|12047853|FG000|Washout Period 2|Withdrawal by Subject|3
7633986|NCT03498313|12047854|FG001|Washout Period 2|Withdrawal by Subject|2
7633987|NCT03498313|12047855|FG002|Washout Period 2|Withdrawal by Subject|0
7633988|NCT03498313|12047856|FG003|Washout Period 2|Withdrawal by Subject|0
7633989|NCT03498313|12047857|FG004|Washout Period 2|Withdrawal by Subject|2
7633990|NCT03498313|12047858|FG005|Washout Period 2|Withdrawal by Subject|0
7633991|NCT03498313|12047853|FG000|Washout Period 2|Anovulation|0
7633992|NCT03498313|12047854|FG001|Washout Period 2|Anovulation|0
7633993|NCT03498313|12047855|FG002|Washout Period 2|Anovulation|0
7633994|NCT03498313|12047856|FG003|Washout Period 2|Anovulation|0
7633995|NCT03498313|12047857|FG004|Washout Period 2|Anovulation|0
7633996|NCT03498313|12047858|FG005|Washout Period 2|Anovulation|1
7633997|NCT03495453|12047876|FG000|Overall Study|Withdrawal by Subject|0
7633998|NCT03495453|12047877|FG001|Overall Study|Withdrawal by Subject|1
7633999|NCT03488251|12047887|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1
7634000|NCT03488251|12047888|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0
7634001|NCT03488251|12047889|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0
7634002|NCT03488251|12047890|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0
7634003|NCT03488251|12047887|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1
7634004|NCT03488251|12047888|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0
7634005|NCT03488251|12047889|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0
7634006|NCT03488251|12047890|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0
7634007|NCT03488251|12047887|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4
7634008|NCT03488251|12047888|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0
7634009|NCT03488251|12047889|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0
7634010|NCT03488251|12047890|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0
7634011|NCT03488251|12047887|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1
7634012|NCT03488251|12047888|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0
7634013|NCT03488251|12047889|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0
7634014|NCT03488251|12047890|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0
7634015|NCT03488251|12047887|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1
7634016|NCT03488251|12047888|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0
7634017|NCT03488251|12047889|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0
7634018|NCT03488251|12047890|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0
7634019|NCT03486899|12047905|FG000|Overall Study|Lost to Follow-up|4
7634020|NCT03486899|12047906|FG001|Overall Study|Lost to Follow-up|1
7634021|NCT03486899|12047907|FG002|Overall Study|Lost to Follow-up|4
7634022|NCT03486899|12047908|FG003|Overall Study|Lost to Follow-up|3
7634023|NCT03486899|12047905|FG000|Overall Study|Death|1
7634024|NCT03486899|12047906|FG001|Overall Study|Death|0
7634025|NCT03486899|12047907|FG002|Overall Study|Death|0
7634026|NCT03486899|12047908|FG003|Overall Study|Death|1
7634027|NCT03486899|12047905|FG000|Overall Study|Adverse Event|0
7634028|NCT03486899|12047906|FG001|Overall Study|Adverse Event|2
7634029|NCT03486899|12047907|FG002|Overall Study|Adverse Event|0
7634030|NCT03486899|12047908|FG003|Overall Study|Adverse Event|2
7634031|NCT03486899|12047905|FG000|Overall Study|Withdrawal by Subject|3
7634032|NCT03486899|12047906|FG001|Overall Study|Withdrawal by Subject|7
7634033|NCT03486899|12047907|FG002|Overall Study|Withdrawal by Subject|4
7634034|NCT03486899|12047908|FG003|Overall Study|Withdrawal by Subject|3
7634035|NCT03486899|12047905|FG000|Overall Study|Other Reasons|0
7634036|NCT03486899|12047906|FG001|Overall Study|Other Reasons|1
7634037|NCT03486899|12047907|FG002|Overall Study|Other Reasons|0
7634038|NCT03486899|12047908|FG003|Overall Study|Other Reasons|1
7634039|NCT03475056|12047956|FG000|Overall Study|Lost to Follow-up|0
7634040|NCT03475056|12047957|FG001|Overall Study|Lost to Follow-up|1
7634041|NCT03475056|12047956|FG000|Overall Study|Moved from Area|0
7634042|NCT03475056|12047957|FG001|Overall Study|Moved from Area|2
7634043|NCT03474107|12047966|FG000|Overall Study|Adverse Event|42
7634044|NCT03474107|12047967|FG001|Overall Study|Adverse Event|46
7634045|NCT03474107|12047966|FG000|Overall Study|Death|2
7634046|NCT03474107|12047967|FG001|Overall Study|Death|2
7634047|NCT03474107|12047966|FG000|Overall Study|Lost to Follow-up|0
7634048|NCT03474107|12047967|FG001|Overall Study|Lost to Follow-up|1
7634049|NCT03474107|12047966|FG000|Overall Study|Progressive Disease|177
7634050|NCT03474107|12047967|FG001|Overall Study|Progressive Disease|180
7634051|NCT03474107|12047966|FG000|Overall Study|Protocol Violation|1
7634052|NCT03474107|12047967|FG001|Overall Study|Protocol Violation|1
7634053|NCT03474107|12047966|FG000|Overall Study|Withdrawal by Subject|15
7634054|NCT03474107|12047967|FG001|Overall Study|Withdrawal by Subject|27
7634055|NCT03474107|12047966|FG000|Overall Study|Physician Decision|7
7634056|NCT03474107|12047967|FG001|Overall Study|Physician Decision|22
7634057|NCT03474107|12047966|FG000|Overall Study|Miscellaneous|1
7634058|NCT03474107|12047967|FG001|Overall Study|Miscellaneous|6
7634059|NCT03473340|12047975|FG000|Overall Study|Follow up not possible due to COVID restrictions|3
7634060|NCT03473340|12047976|FG001|Overall Study|Follow up not possible due to COVID restrictions|0
7634061|NCT03473340|12047975|FG000|Overall Study|Withdrawal by Subject|1
7634062|NCT03473340|12047976|FG001|Overall Study|Withdrawal by Subject|0
7634063|NCT03473340|12047975|FG000|Overall Study|Lost to Follow-up|1
7634064|NCT03473340|12047976|FG001|Overall Study|Lost to Follow-up|2
7634065|NCT03472885|12047982|FG000|Overall Study|Adverse Event|1
7634066|NCT03467152|12047988|FG000|Overall Study|Adverse Event|4
7634067|NCT03467152|12047989|FG001|Overall Study|Adverse Event|5
7634068|NCT03467152|12047990|FG002|Overall Study|Adverse Event|0
7634069|NCT03467152|12047988|FG000|Overall Study|Subject Choice|1
7634070|NCT03467152|12047989|FG001|Overall Study|Subject Choice|3
7634071|NCT03467152|12047990|FG002|Overall Study|Subject Choice|0
7634072|NCT03467152|12047988|FG000|Overall Study|Lost to Follow-up|1
7634073|NCT03467152|12047989|FG001|Overall Study|Lost to Follow-up|0
7634074|NCT03467152|12047990|FG002|Overall Study|Lost to Follow-up|0
7634075|NCT03467152|12047988|FG000|Overall Study|Withdrawal by Subject|4
7634076|NCT03467152|12047989|FG001|Overall Study|Withdrawal by Subject|2
7634077|NCT03467152|12047990|FG002|Overall Study|Withdrawal by Subject|0
7634078|NCT03467152|12047988|FG000|Overall Study|Others|3
7634079|NCT03467152|12047989|FG001|Overall Study|Others|0
7634080|NCT03467152|12047990|FG002|Overall Study|Others|0
7634081|NCT03467152|12047988|FG000|Overall Study|Not treated|3
7634082|NCT03467152|12047989|FG001|Overall Study|Not treated|1
7634083|NCT03467152|12047990|FG002|Overall Study|Not treated|6
7634084|NCT03462719|12048008|FG000|Overall Study|Withdrawal by Subject|2
7634085|NCT03462719|12048009|FG001|Overall Study|Withdrawal by Subject|3
7634086|NCT03462719|12048008|FG000|Overall Study|Ongoing|93
7634087|NCT03462719|12048009|FG001|Overall Study|Ongoing|91
7634088|NCT03462641|12048017|FG000|Visit 1|Failed to complete dopaminergic PET scan|1
7634089|NCT03462641|12048018|FG001|Visit 1|Failed to complete dopaminergic PET scan|0
7634090|NCT03462641|12048017|FG000|Visit 2|Withdrawal by Subject|0
7634091|NCT03462641|12048018|FG001|Visit 2|Withdrawal by Subject|1
7634092|NCT03462563|12048028|FG000|Overall Study|Death|1
7634093|NCT03462563|12048029|FG001|Overall Study|Death|1
7634094|NCT03462563|12048028|FG000|Overall Study|Termination of study|2
7634095|NCT03462563|12048029|FG001|Overall Study|Termination of study|1
7634096|NCT03462563|12048028|FG000|Overall Study|Adverse Event|1
7634097|NCT03462563|12048029|FG001|Overall Study|Adverse Event|3
7634098|NCT03462563|12048028|FG000|Overall Study|Unspecified reason|10
7634099|NCT03462563|12048029|FG001|Overall Study|Unspecified reason|12
7634100|NCT03462563|12048028|FG000|Overall Study|Physician Decision|1
7634101|NCT03462563|12048029|FG001|Overall Study|Physician Decision|0
7634102|NCT03461289|12048035|FG000|Overall Study|Death|1
7634103|NCT03461003|12048041|FG000|Overall Study|Lost to Follow-up|2
7634104|NCT03461003|12048042|FG001|Overall Study|Lost to Follow-up|2
7634105|NCT03461003|12048041|FG000|Overall Study|Withdrawal by Subject|3
7634106|NCT03461003|12048042|FG001|Overall Study|Withdrawal by Subject|1
7634107|NCT03459443|12048048|FG000|Overall Study|Lack of Efficacy|3
7634108|NCT03459443|12048048|FG000|Overall Study|Adverse Event|1
7634109|NCT03459443|12048048|FG000|Overall Study|Sponsor's decision to close the study|18
7634110|NCT03452540|12048061|FG000|Overall Study|Adverse Event|1
7634111|NCT03452540|12048061|FG000|Overall Study|Withdrawal by Subject|1
7634112|NCT03452540|12048061|FG000|Overall Study|Other SAE and AE|2
7634113|NCT03449199|12048068|FG000|Overall Study|Lost to Follow-up|1
7634114|NCT03449199|12048069|FG001|Overall Study|Lost to Follow-up|1
7634115|NCT03449199|12048070|FG002|Overall Study|Lost to Follow-up|0
7634116|NCT03449199|12048068|FG000|Overall Study|Protocol Deviation|0
7634117|NCT03449199|12048069|FG001|Overall Study|Protocol Deviation|0
7634118|NCT03449199|12048070|FG002|Overall Study|Protocol Deviation|1
7634119|NCT03449199|12048068|FG000|Overall Study|Withdrawal by Subject|0
7634120|NCT03449199|12048069|FG001|Overall Study|Withdrawal by Subject|0
7634121|NCT03449199|12048070|FG002|Overall Study|Withdrawal by Subject|1
7634122|NCT03442985|12048084|FG000|Overall Study|Sponsor Request|55
7634123|NCT03442985|12048085|FG001|Overall Study|Sponsor Request|60
7634124|NCT03442985|12048086|FG002|Overall Study|Sponsor Request|54
7634125|NCT03442985|12048084|FG000|Overall Study|Lost to Follow-up|5
7634126|NCT03442985|12048085|FG001|Overall Study|Lost to Follow-up|2
7634127|NCT03442985|12048086|FG002|Overall Study|Lost to Follow-up|7
7634128|NCT03442985|12048084|FG000|Overall Study|Withdrawal by Subject|2
7634129|NCT03442985|12048085|FG001|Overall Study|Withdrawal by Subject|3
7634130|NCT03442985|12048086|FG002|Overall Study|Withdrawal by Subject|4
7634131|NCT03442985|12048084|FG000|Overall Study|Adverse Event|0
7634132|NCT03442985|12048085|FG001|Overall Study|Adverse Event|1
7634133|NCT03442985|12048086|FG002|Overall Study|Adverse Event|0
7634134|NCT03442764|12048099|FG000|Overall Study|Adverse Event|1
7634135|NCT03442764|12048100|FG001|Overall Study|Adverse Event|0
7634136|NCT03442764|12048101|FG002|Overall Study|Adverse Event|0
7634137|NCT03438396|12048110|FG000|Overall Study|Ongoing on study treatment|4
7634138|NCT03438396|12048110|FG000|Overall Study|Ongoing in survival follow-up|33
7634139|NCT03438396|12048110|FG000|Overall Study|Withdrawal by Subject|4
7634140|NCT03438396|12048110|FG000|Overall Study|Lost to Follow-up|2
7634141|NCT03438396|12048110|FG000|Overall Study|Death|58
7634142|NCT03438396|12048110|FG000|Overall Study|Not treated|1
7634143|NCT03435081|12048124|FG000|Week 0 to Week 16|Lack of Efficacy|6
7634144|NCT03435081|12048125|FG001|Week 0 to Week 16|Lack of Efficacy|5
7634145|NCT03435081|12048126|FG002|Week 0 to Week 16|Lack of Efficacy|0
7634146|NCT03435081|12048124|FG000|Week 0 to Week 16|Adverse Event|2
7634147|NCT03435081|12048125|FG001|Week 0 to Week 16|Adverse Event|2
7634148|NCT03435081|12048126|FG002|Week 0 to Week 16|Adverse Event|2
7634149|NCT03435081|12048124|FG000|Week 0 to Week 16|Withdrawal by Subject|8
7634150|NCT03435081|12048125|FG001|Week 0 to Week 16|Withdrawal by Subject|7
7634151|NCT03435081|12048126|FG002|Week 0 to Week 16|Withdrawal by Subject|10
7634152|NCT03435081|12048124|FG000|Week 0 to Week 16|Lost to Follow-up|3
7634153|NCT03435081|12048125|FG001|Week 0 to Week 16|Lost to Follow-up|1
7634154|NCT03435081|12048126|FG002|Week 0 to Week 16|Lost to Follow-up|4
7634155|NCT03435081|12048124|FG000|Week 0 to Week 16|Pregnancy|1
7634156|NCT03435081|12048125|FG001|Week 0 to Week 16|Pregnancy|0
7634157|NCT03435081|12048126|FG002|Week 0 to Week 16|Pregnancy|0
7634158|NCT03435081|12048124|FG000|Week 0 to Week 16|Non-compliance|1
7634159|NCT03435081|12048125|FG001|Week 0 to Week 16|Non-compliance|0
7634160|NCT03435081|12048126|FG002|Week 0 to Week 16|Non-compliance|2
7634161|NCT03435081|12048124|FG000|Week 0 to Week 16|Inadequate Response|0
7634162|NCT03435081|12048125|FG001|Week 0 to Week 16|Inadequate Response|1
7634163|NCT03435081|12048126|FG002|Week 0 to Week 16|Inadequate Response|0
7634164|NCT03435081|12048124|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0
7634165|NCT03435081|12048125|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0
7634166|NCT03435081|12048126|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1
7634167|NCT03435081|12048124|FG000|Week 16 to Week 104|Lack of Efficacy|2
7634168|NCT03435081|12048125|FG001|Week 16 to Week 104|Lack of Efficacy|11
7634169|NCT03435081|12048126|FG002|Week 16 to Week 104|Lack of Efficacy|10
7634170|NCT03435081|12048124|FG000|Week 16 to Week 104|Adverse Event|1
7634171|NCT03435081|12048125|FG001|Week 16 to Week 104|Adverse Event|0
7634172|NCT03435081|12048126|FG002|Week 16 to Week 104|Adverse Event|2
7634173|NCT03435081|12048124|FG000|Week 16 to Week 104|Withdrawal by Subject|0
7634174|NCT03435081|12048125|FG001|Week 16 to Week 104|Withdrawal by Subject|1
7634175|NCT03435081|12048126|FG002|Week 16 to Week 104|Withdrawal by Subject|2
7634176|NCT03435081|12048124|FG000|Week 16 to Week 104|Lost to Follow-up|0
7634177|NCT03435081|12048125|FG001|Week 16 to Week 104|Lost to Follow-up|1
7634178|NCT03435081|12048126|FG002|Week 16 to Week 104|Lost to Follow-up|4
7634179|NCT03435081|12048124|FG000|Week 16 to Week 104|Non--Compliance|0
7634180|NCT03435081|12048125|FG001|Week 16 to Week 104|Non--Compliance|0
7634181|NCT03435081|12048126|FG002|Week 16 to Week 104|Non--Compliance|1
7634182|NCT03434379|12048140|FG000|Global Period|Lost to Follow-up|3
7634183|NCT03434379|12048141|FG001|Global Period|Lost to Follow-up|1
7634184|NCT03434379|12048142|FG002|Global Period|Lost to Follow-up|0
7634185|NCT03434379|12048143|FG003|Global Period|Lost to Follow-up|0
7634186|NCT03434379|12048140|FG000|Global Period|Death|99
7634187|NCT03434379|12048141|FG001|Global Period|Death|179
7634188|NCT03434379|12048142|FG002|Global Period|Death|0
7634189|NCT03434379|12048143|FG003|Global Period|Death|0
7634190|NCT03434379|12048140|FG000|Global Period|Withdrawal by Subject|20
7634191|NCT03434379|12048141|FG001|Global Period|Withdrawal by Subject|20
7634192|NCT03434379|12048142|FG002|Global Period|Withdrawal by Subject|0
7634193|NCT03434379|12048143|FG003|Global Period|Withdrawal by Subject|0
7634194|NCT03434379|12048140|FG000|Global Period|On Study|43
7634195|NCT03434379|12048141|FG001|Global Period|On Study|136
7634196|NCT03434379|12048142|FG002|Global Period|On Study|0
7634197|NCT03434379|12048143|FG003|Global Period|On Study|0
7634198|NCT03434379|12048140|FG000|China Extension Period|Lost to Follow-up|0
7634199|NCT03434379|12048141|FG001|China Extension Period|Lost to Follow-up|0
7634200|NCT03434379|12048142|FG002|China Extension Period|Lost to Follow-up|1
7634201|NCT03434379|12048143|FG003|China Extension Period|Lost to Follow-up|0
7634202|NCT03434379|12048140|FG000|China Extension Period|Death|0
7634203|NCT03434379|12048141|FG001|China Extension Period|Death|0
7634204|NCT03434379|12048142|FG002|China Extension Period|Death|38
7634205|NCT03434379|12048143|FG003|China Extension Period|Death|61
7634206|NCT03434379|12048140|FG000|China Extension Period|Withdrawal by Subject|0
7634207|NCT03434379|12048141|FG001|China Extension Period|Withdrawal by Subject|0
7634208|NCT03434379|12048142|FG002|China Extension Period|Withdrawal by Subject|7
7634209|NCT03434379|12048143|FG003|China Extension Period|Withdrawal by Subject|6
7634210|NCT03434379|12048140|FG000|China Extension Period|On Study|0
7634211|NCT03434379|12048141|FG001|China Extension Period|On Study|0
7634212|NCT03434379|12048142|FG002|China Extension Period|On Study|15
7634213|NCT03434379|12048143|FG003|China Extension Period|On Study|66
7634214|NCT03419364|12048176|FG000|Overall Study|Delivery due to maternal condition|2
7634215|NCT03419364|12048177|FG001|Overall Study|Delivery due to maternal condition|0
7634216|NCT03419364|12048178|FG002|Overall Study|Delivery due to maternal condition|0
7634217|NCT03416374|12048199|FG000|Between Treatment Period I and II|Other|0
7634218|NCT03416374|12048200|FG001|Between Treatment Period I and II|Other|9
7634219|NCT03416374|12048199|FG000|Treatment Period II|Lack of Efficacy|3
7634220|NCT03416374|12048200|FG001|Treatment Period II|Lack of Efficacy|11
7634221|NCT03416374|12048199|FG000|Treatment Period II|Adverse Event|1
7634222|NCT03416374|12048200|FG001|Treatment Period II|Adverse Event|4
7634223|NCT03416374|12048199|FG000|Treatment Period II|Death|0
7634224|NCT03416374|12048200|FG001|Treatment Period II|Death|1
7634225|NCT03416374|12048199|FG000|Treatment Period II|Other|0
7634226|NCT03416374|12048200|FG001|Treatment Period II|Other|2
7634227|NCT03414047|12048213|FG000|Overall Study|Adverse Event|0
7634228|NCT03414047|12048214|FG001|Overall Study|Adverse Event|0
7634229|NCT03414047|12048215|FG002|Overall Study|Adverse Event|1
7634230|NCT03414047|12048216|FG003|Overall Study|Adverse Event|1
7634231|NCT03414047|12048213|FG000|Overall Study|Physician Decision|1
7634232|NCT03414047|12048214|FG001|Overall Study|Physician Decision|0
7634233|NCT03414047|12048215|FG002|Overall Study|Physician Decision|0
7634234|NCT03414047|12048216|FG003|Overall Study|Physician Decision|1
7634235|NCT03414047|12048213|FG000|Overall Study|Withdrawal by Subject|1
7634236|NCT03414047|12048214|FG001|Overall Study|Withdrawal by Subject|0
7634237|NCT03414047|12048215|FG002|Overall Study|Withdrawal by Subject|2
7634238|NCT03414047|12048216|FG003|Overall Study|Withdrawal by Subject|0
7634239|NCT03412604|12048231|FG000|Overall Study|Withdrawal by Subject|1
7634240|NCT03412565|12048239|FG000|Overall Study|Other|0
7634241|NCT03412565|12048240|FG001|Overall Study|Other|0
7634242|NCT03412565|12048241|FG002|Overall Study|Other|0
7634243|NCT03412565|12048242|FG003|Overall Study|Other|3
7634244|NCT03412565|12048239|FG000|Overall Study|Withdrawal by Subject|0
7634245|NCT03412565|12048240|FG001|Overall Study|Withdrawal by Subject|0
7634246|NCT03412565|12048241|FG002|Overall Study|Withdrawal by Subject|1
7634247|NCT03412565|12048242|FG003|Overall Study|Withdrawal by Subject|5
7634248|NCT03412565|12048239|FG000|Overall Study|Physician Decision|0
7634249|NCT03412565|12048240|FG001|Overall Study|Physician Decision|1
7634250|NCT03412565|12048241|FG002|Overall Study|Physician Decision|0
7634251|NCT03412565|12048242|FG003|Overall Study|Physician Decision|1
7634252|NCT03412565|12048239|FG000|Overall Study|Death|1
7634253|NCT03412565|12048240|FG001|Overall Study|Death|2
7634254|NCT03412565|12048241|FG002|Overall Study|Death|2
7634255|NCT03412565|12048242|FG003|Overall Study|Death|4
7634256|NCT03412565|12048239|FG000|Overall Study|Still ongoing|0
7634257|NCT03412565|12048240|FG001|Overall Study|Still ongoing|62
7634258|NCT03412565|12048241|FG002|Overall Study|Still ongoing|59
7634259|NCT03412565|12048242|FG003|Overall Study|Still ongoing|41
7634260|NCT03410693|12048259|FG000|Overall Study|Disc trt: Withdrawal by participant|6
7634261|NCT03410693|12048260|FG001|Overall Study|Disc trt: Withdrawal by participant|4
7634262|NCT03410693|12048259|FG000|Overall Study|Disc trt: Lost to follow up|0
7634263|NCT03410693|12048260|FG001|Overall Study|Disc trt: Lost to follow up|1
7634264|NCT03410693|12048259|FG000|Overall Study|Disc trt: radiological progression|58
7634265|NCT03410693|12048260|FG001|Overall Study|Disc trt: radiological progression|50
7634266|NCT03410693|12048259|FG000|Overall Study|Disc trt: Other|1
7634267|NCT03410693|12048260|FG001|Overall Study|Disc trt: Other|0
7634268|NCT03410693|12048259|FG000|Overall Study|Study drug never administered|1
7634269|NCT03410693|12048260|FG001|Overall Study|Study drug never administered|6
7634270|NCT03410693|12048259|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6
7634271|NCT03410693|12048260|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4
7634272|NCT03410693|12048259|FG000|Overall Study|Disc trt: Adverse Event (AE)|13
7634273|NCT03410693|12048260|FG001|Overall Study|Disc trt: Adverse Event (AE)|9
7634274|NCT03410693|12048259|FG000|Overall Study|Disc trt: Physician decision|0
7634275|NCT03410693|12048260|FG001|Overall Study|Disc trt: Physician decision|5
7634276|NCT03410693|12048259|FG000|Overall Study|Disc trt: clinical progression|1
7634277|NCT03410693|12048260|FG001|Overall Study|Disc trt: clinical progression|5
7634278|NCT03410693|12048259|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1
7634279|NCT03410693|12048260|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4
7634280|NCT03406702|12048272|FG000|Overall Study|Missed Day 27 Dosing|1
7634281|NCT03406507|12048290|FG000|Extension Period|Lack of Efficacy|0
7634282|NCT03406507|12048291|FG001|Extension Period|Lack of Efficacy|1
7634283|NCT03406507|12048290|FG000|Extension Period|Ongoing in Extension Period|5
7634284|NCT03406507|12048291|FG001|Extension Period|Ongoing in Extension Period|5
7634285|NCT03394027|12048306|FG000|Overall Study|Ineligible|3
7634286|NCT03394027|12048307|FG001|Overall Study|Ineligible|1
7634287|NCT03394027|12048308|FG002|Overall Study|Ineligible|3
7634288|NCT03394027|12048306|FG000|Overall Study|Participant declined to participate before treatment started|0
7634370|NCT03345836|12048569|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1
7634289|NCT03394027|12048307|FG001|Overall Study|Participant declined to participate before treatment started|0
7634290|NCT03394027|12048308|FG002|Overall Study|Participant declined to participate before treatment started|1
7634291|NCT03392168|12048361|FG000|Period 2: Cohort 2|Lost to Follow-up|0
7634292|NCT03392168|12048362|FG001|Period 2: Cohort 2|Lost to Follow-up|1
7634293|NCT03392168|12048363|FG002|Period 2: Cohort 2|Lost to Follow-up|1
7634294|NCT03392168|12048364|FG003|Period 2: Cohort 2|Lost to Follow-up|1
7634295|NCT03392168|12048361|FG000|Period 2: Cohort 2|Other|0
7634296|NCT03392168|12048362|FG001|Period 2: Cohort 2|Other|1
7634297|NCT03392168|12048363|FG002|Period 2: Cohort 2|Other|0
7634298|NCT03392168|12048364|FG003|Period 2: Cohort 2|Other|0
7634299|NCT03387735|12048384|FG000|Overall Study|Lost to Follow-up|4
7634300|NCT03387735|12048385|FG001|Overall Study|Lost to Follow-up|8
7634301|NCT03387735|12048384|FG000|Overall Study|Death|4
7634302|NCT03387735|12048385|FG001|Overall Study|Death|8
7634303|NCT03386773|12048407|FG000|Overall Study|Lost to Follow-up|24
7634304|NCT03386773|12048408|FG001|Overall Study|Lost to Follow-up|33
7634305|NCT03386773|12048407|FG000|Overall Study|Withdrawal by Subject|3
7634306|NCT03386773|12048408|FG001|Overall Study|Withdrawal by Subject|2
7634307|NCT03370510|12048437|FG000|Overall Study|COVID-19|2
7634308|NCT03370510|12048438|FG001|Overall Study|COVID-19|0
7634309|NCT03370341|12048446|FG000|Overall Study|Lost to Follow-up|0
7634310|NCT03370341|12048447|FG001|Overall Study|Lost to Follow-up|1
7634311|NCT03364036|12048482|FG000|Overall Study|Adverse Event|1
7634312|NCT03364036|12048482|FG000|Overall Study|Lost to Follow-up|1
7634313|NCT03364036|12048482|FG000|Overall Study|Withdrew Consent|1
7634314|NCT03364036|12048482|FG000|Overall Study|Protocol Non-Compliance|1
7634315|NCT03364036|12048482|FG000|Overall Study|Other|2
7634316|NCT03361306|12048486|FG000|Overall Study|Death|5
7634317|NCT03361306|12048486|FG000|Overall Study|Still On Study (on study treatment)|3
7634318|NCT03361306|12048486|FG000|Overall Study|Still On Study (in follow up)|7
7634319|NCT03358472|12048515|FG000|Overall Study|Death|6
7634320|NCT03358472|12048516|FG001|Overall Study|Death|3
7634321|NCT03358472|12048517|FG002|Overall Study|Death|10
7634322|NCT03358472|12048515|FG000|Overall Study|Physician Decision|0
7634323|NCT03358472|12048516|FG001|Overall Study|Physician Decision|1
7634324|NCT03358472|12048517|FG002|Overall Study|Physician Decision|0
7634325|NCT03358472|12048515|FG000|Overall Study|Withdrawal by Subject|0
7634326|NCT03358472|12048516|FG001|Overall Study|Withdrawal by Subject|0
7634327|NCT03358472|12048517|FG002|Overall Study|Withdrawal by Subject|1
7634328|NCT03358472|12048515|FG000|Overall Study|On-going at clinical cut off date|9
7634329|NCT03358472|12048516|FG001|Overall Study|On-going at clinical cut off date|6
7634330|NCT03358472|12048517|FG002|Overall Study|On-going at clinical cut off date|5
7634331|NCT03350750|12048527|FG000|Overall Study|Death|1
7634332|NCT03350750|12048528|FG001|Overall Study|Death|1
7634333|NCT03346434|12048542|FG000|Overall Study|Randomized in Error|0
7634334|NCT03346434|12048543|FG001|Overall Study|Randomized in Error|0
7634335|NCT03346434|12048544|FG002|Overall Study|Randomized in Error|0
7634336|NCT03346434|12048545|FG003|Overall Study|Randomized in Error|0
7634337|NCT03346434|12048546|FG004|Overall Study|Randomized in Error|1
7634338|NCT03346434|12048547|FG005|Overall Study|Randomized in Error|0
7634339|NCT03346434|12048542|FG000|Overall Study|Withdrawal by Subject|0
7634340|NCT03346434|12048543|FG001|Overall Study|Withdrawal by Subject|0
7634341|NCT03346434|12048544|FG002|Overall Study|Withdrawal by Subject|1
7634342|NCT03346434|12048545|FG003|Overall Study|Withdrawal by Subject|0
7634343|NCT03346434|12048546|FG004|Overall Study|Withdrawal by Subject|1
7634344|NCT03346434|12048547|FG005|Overall Study|Withdrawal by Subject|0
7634345|NCT03346434|12048542|FG000|Overall Study|Lost to Follow-up|0
7634346|NCT03346434|12048543|FG001|Overall Study|Lost to Follow-up|0
7634347|NCT03346434|12048544|FG002|Overall Study|Lost to Follow-up|0
7634348|NCT03346434|12048545|FG003|Overall Study|Lost to Follow-up|0
7634349|NCT03346434|12048546|FG004|Overall Study|Lost to Follow-up|1
7634350|NCT03346434|12048547|FG005|Overall Study|Lost to Follow-up|1
7634351|NCT03346434|12048542|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0
7634352|NCT03346434|12048543|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0
7634353|NCT03346434|12048544|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0
7634354|NCT03346434|12048545|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0
7634355|NCT03346434|12048546|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75
7634356|NCT03346434|12048547|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81
7634357|NCT03345836|12048568|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5
7634358|NCT03345836|12048569|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17
7634359|NCT03345836|12048570|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2
7634360|NCT03345836|12048571|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0
7634361|NCT03345836|12048572|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0
7634362|NCT03345836|12048573|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0
7634363|NCT03345836|12048568|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8
7634364|NCT03345836|12048569|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8
7634365|NCT03345836|12048570|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3
7634366|NCT03345836|12048571|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0
7634367|NCT03345836|12048572|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0
7634368|NCT03345836|12048573|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0
7634369|NCT03345836|12048568|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0
7634371|NCT03345836|12048570|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0
7634372|NCT03345836|12048571|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0
7634373|NCT03345836|12048572|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0
7634374|NCT03345836|12048573|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0
7634375|NCT03345836|12048568|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8
7634376|NCT03345836|12048569|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4
7634377|NCT03345836|12048570|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0
7634378|NCT03345836|12048571|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0
7634379|NCT03345836|12048572|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0
7634380|NCT03345836|12048573|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0
7634381|NCT03345836|12048568|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1
7634382|NCT03345836|12048569|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3
7634383|NCT03345836|12048570|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1
7634384|NCT03345836|12048571|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0
7634385|NCT03345836|12048572|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0
7634386|NCT03345836|12048573|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0
7634387|NCT03345836|12048568|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0
7634388|NCT03345836|12048569|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0
7634389|NCT03345836|12048570|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0
7634390|NCT03345836|12048571|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8
7634391|NCT03345836|12048572|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5
7634392|NCT03345836|12048573|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0
7634393|NCT03345836|12048568|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0
7634394|NCT03345836|12048569|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0
7634395|NCT03345836|12048570|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0
7634396|NCT03345836|12048571|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0
7634397|NCT03345836|12048572|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5
7634398|NCT03345836|12048573|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1
7634399|NCT03345836|12048568|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0
7634400|NCT03345836|12048569|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0
7634401|NCT03345836|12048570|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0
7634402|NCT03345836|12048571|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0
7634403|NCT03345836|12048572|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0
7634404|NCT03345836|12048573|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1
7634405|NCT03345836|12048568|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0
7634406|NCT03345836|12048569|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0
7634407|NCT03345836|12048570|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0
7634408|NCT03345836|12048571|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2
7634409|NCT03345836|12048572|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6
7634410|NCT03345836|12048573|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3
7634411|NCT03345836|12048568|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0
7634412|NCT03345836|12048569|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0
7634413|NCT03345836|12048570|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0
7634414|NCT03345836|12048571|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0
7634415|NCT03345836|12048572|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1
7634416|NCT03345836|12048573|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0
7634417|NCT03345836|12048568|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0
7634418|NCT03345836|12048569|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0
7634419|NCT03345836|12048570|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0
7634420|NCT03345836|12048571|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1
7634421|NCT03345836|12048572|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1
7634422|NCT03345836|12048573|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1
7634423|NCT03343054|12048592|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2
7634424|NCT03343054|12048593|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6
7634425|NCT03343054|12048594|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0
7634426|NCT03343054|12048592|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1
7634427|NCT03343054|12048593|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0
7634428|NCT03343054|12048594|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0
7634429|NCT03343054|12048592|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0
7634430|NCT03343054|12048593|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0
7634431|NCT03343054|12048594|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11
7634432|NCT03343054|12048592|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0
7634433|NCT03343054|12048593|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0
7634434|NCT03343054|12048594|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8
7634435|NCT03342404|12048605|FG000|Overall Study|Withdrawal by Subject|9
7634436|NCT03342404|12048606|FG001|Overall Study|Withdrawal by Subject|10
7634437|NCT03342404|12048605|FG000|Overall Study|Lack of Efficacy|1
7634438|NCT03342404|12048606|FG001|Overall Study|Lack of Efficacy|17
7634439|NCT03342404|12048605|FG000|Overall Study|Adverse Event|3
7634440|NCT03342404|12048606|FG001|Overall Study|Adverse Event|4
7634441|NCT03342404|12048605|FG000|Overall Study|Noncompliance with study drug|1
7634442|NCT03342404|12048606|FG001|Overall Study|Noncompliance with study drug|0
7634443|NCT03342404|12048605|FG000|Overall Study|Other reasons|1
7634444|NCT03342404|12048606|FG001|Overall Study|Other reasons|0
7634445|NCT03338998|12048614|FG000|Treatment Period|Withdrawal by Subject|1
7634446|NCT03338998|12048615|FG001|Treatment Period|Withdrawal by Subject|1
7634447|NCT03338998|12048614|FG000|Treatment Period|Adverse Event|0
7634448|NCT03338998|12048615|FG001|Treatment Period|Adverse Event|2
7634449|NCT03338998|12048614|FG000|Treatment Period|Protocol deviation|1
7634450|NCT03338998|12048615|FG001|Treatment Period|Protocol deviation|0
7634451|NCT03338998|12048614|FG000|Treatment Period|Physician Decision|2
7634452|NCT03338998|12048615|FG001|Treatment Period|Physician Decision|0
7634453|NCT03338998|12048614|FG000|Treatment Period|Subject failed swallow test|4
7634454|NCT03338998|12048615|FG001|Treatment Period|Subject failed swallow test|0
7634455|NCT03338998|12048614|FG000|Safety Follow-Up Period|Adverse Event|0
7634456|NCT03338998|12048615|FG001|Safety Follow-Up Period|Adverse Event|1
7634457|NCT03338998|12048614|FG000|Safety Follow-Up Period|Protocol deviation|1
7634458|NCT03338998|12048615|FG001|Safety Follow-Up Period|Protocol deviation|0
7634459|NCT03338998|12048614|FG000|Safety Follow-Up Period|Lost to Follow-up|1
7634460|NCT03338998|12048615|FG001|Safety Follow-Up Period|Lost to Follow-up|0
7634461|NCT03338972|12048626|FG000|Overall Study|Death|1
7634462|NCT03338972|12048627|FG001|Overall Study|Death|1
7634463|NCT03338972|12048628|FG002|Overall Study|Death|0
7634464|NCT03338972|12048629|FG003|Overall Study|Death|0
7634465|NCT03338972|12048626|FG000|Overall Study|Withdrawal by Subject|1
7634466|NCT03338972|12048627|FG001|Overall Study|Withdrawal by Subject|0
7634467|NCT03338972|12048628|FG002|Overall Study|Withdrawal by Subject|0
7634468|NCT03338972|12048629|FG003|Overall Study|Withdrawal by Subject|0
7634469|NCT03338790|12048643|FG000|Overall Study|Disease Progression|65
7634470|NCT03338790|12048644|FG001|Overall Study|Disease Progression|43
7634471|NCT03338790|12048645|FG002|Overall Study|Disease Progression|50
7634472|NCT03338790|12048646|FG003|Overall Study|Disease Progression|37
7634473|NCT03338790|12048643|FG000|Overall Study|Study Drug Toxicity|9
7634474|NCT03338790|12048644|FG001|Overall Study|Study Drug Toxicity|8
7634475|NCT03338790|12048645|FG002|Overall Study|Study Drug Toxicity|15
7634476|NCT03338790|12048646|FG003|Overall Study|Study Drug Toxicity|0
7634477|NCT03338790|12048643|FG000|Overall Study|Death|1
7634478|NCT03338790|12048644|FG001|Overall Study|Death|1
7634479|NCT03338790|12048645|FG002|Overall Study|Death|1
7634480|NCT03338790|12048646|FG003|Overall Study|Death|0
7634481|NCT03338790|12048643|FG000|Overall Study|Adverse Event unrelated to Study Drug|4
7634482|NCT03338790|12048644|FG001|Overall Study|Adverse Event unrelated to Study Drug|4
7634483|NCT03338790|12048645|FG002|Overall Study|Adverse Event unrelated to Study Drug|6
7634484|NCT03338790|12048646|FG003|Overall Study|Adverse Event unrelated to Study Drug|4
7634485|NCT03338790|12048643|FG000|Overall Study|Participant request to discontinue study treatment|3
7634486|NCT03338790|12048644|FG001|Overall Study|Participant request to discontinue study treatment|3
7634487|NCT03338790|12048645|FG002|Overall Study|Participant request to discontinue study treatment|2
7634488|NCT03338790|12048646|FG003|Overall Study|Participant request to discontinue study treatment|1
7634489|NCT03338790|12048643|FG000|Overall Study|Poor/non-compliance|0
7634490|NCT03338790|12048644|FG001|Overall Study|Poor/non-compliance|1
7634491|NCT03338790|12048645|FG002|Overall Study|Poor/non-compliance|0
7634492|NCT03338790|12048646|FG003|Overall Study|Poor/non-compliance|0
7634493|NCT03338790|12048643|FG000|Overall Study|Participant withdrew consent|1
7634494|NCT03338790|12048644|FG001|Overall Study|Participant withdrew consent|0
7634495|NCT03338790|12048645|FG002|Overall Study|Participant withdrew consent|1
7634496|NCT03338790|12048646|FG003|Overall Study|Participant withdrew consent|1
7634497|NCT03338790|12048643|FG000|Overall Study|Other reasons|0
7634498|NCT03338790|12048644|FG001|Overall Study|Other reasons|5
7634499|NCT03338790|12048645|FG002|Overall Study|Other reasons|0
7634500|NCT03338790|12048646|FG003|Overall Study|Other reasons|2
7634501|NCT03338790|12048643|FG000|Overall Study|Not reported|0
7634502|NCT03338790|12048644|FG001|Overall Study|Not reported|0
7634503|NCT03338790|12048645|FG002|Overall Study|Not reported|1
7634504|NCT03338790|12048646|FG003|Overall Study|Not reported|0
7634505|NCT03338790|12048643|FG000|Overall Study|Completed treatment period|1
7634506|NCT03338790|12048644|FG001|Overall Study|Completed treatment period|2
7634507|NCT03338790|12048645|FG002|Overall Study|Completed treatment period|0
7634508|NCT03338790|12048646|FG003|Overall Study|Completed treatment period|0
7634509|NCT03333837|12048703|FG000|Overall Study|Adverse Event|2
7634510|NCT03333837|12048704|FG001|Overall Study|Adverse Event|1
7634511|NCT03333837|12048705|FG002|Overall Study|Adverse Event|1
7634512|NCT03333837|12048706|FG003|Overall Study|Adverse Event|1
7634513|NCT03333837|12048707|FG004|Overall Study|Adverse Event|0
7634514|NCT03333837|12048703|FG000|Overall Study|Caregiver withdrew|0
7634515|NCT03333837|12048704|FG001|Overall Study|Caregiver withdrew|2
7634516|NCT03333837|12048705|FG002|Overall Study|Caregiver withdrew|1
7634517|NCT03333837|12048706|FG003|Overall Study|Caregiver withdrew|0
7634518|NCT03333837|12048707|FG004|Overall Study|Caregiver withdrew|0
7634519|NCT03333837|12048703|FG000|Overall Study|Withdrawal by Subject|0
7634520|NCT03333837|12048704|FG001|Overall Study|Withdrawal by Subject|0
7634521|NCT03333837|12048705|FG002|Overall Study|Withdrawal by Subject|1
7634522|NCT03333837|12048706|FG003|Overall Study|Withdrawal by Subject|1
7634523|NCT03333837|12048707|FG004|Overall Study|Withdrawal by Subject|3
7634524|NCT03333837|12048703|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0
7634525|NCT03333837|12048704|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0
7634526|NCT03333837|12048705|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2
7634527|NCT03333837|12048706|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0
7634528|NCT03333837|12048707|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0
7634529|NCT03332095|12048736|FG000|Overall Study|Lost to Follow-up|1
7634530|NCT03332095|12048737|FG001|Overall Study|Lost to Follow-up|0
7634531|NCT03332095|12048736|FG000|Overall Study|Pregnancy|0
7634532|NCT03332095|12048737|FG001|Overall Study|Pregnancy|1
7634533|NCT03330847|12048746|FG000|Overall Study|Patients ongoing study|62
7634534|NCT03330847|12048747|FG001|Overall Study|Patients ongoing study|65
7634535|NCT03330847|12048748|FG002|Overall Study|Patients ongoing study|15
7634536|NCT03325712|12048775|FG000|Overall Study|Protocol Violation|0
7634537|NCT03325712|12048776|FG001|Overall Study|Protocol Violation|0
7634538|NCT03325712|12048777|FG002|Overall Study|Protocol Violation|0
7634539|NCT03325712|12048778|FG003|Overall Study|Protocol Violation|0
7634540|NCT03325712|12048779|FG004|Overall Study|Protocol Violation|1
7634541|NCT03325712|12048780|FG005|Overall Study|Protocol Violation|0
7634542|NCT03325712|12048781|FG006|Overall Study|Protocol Violation|0
7634543|NCT03325712|12048782|FG007|Overall Study|Protocol Violation|0
7634544|NCT03325712|12048775|FG000|Overall Study|Adverse Event|0
7634545|NCT03325712|12048776|FG001|Overall Study|Adverse Event|0
7634546|NCT03325712|12048777|FG002|Overall Study|Adverse Event|0
7634547|NCT03325712|12048778|FG003|Overall Study|Adverse Event|0
7634548|NCT03325712|12048779|FG004|Overall Study|Adverse Event|1
7634549|NCT03325712|12048780|FG005|Overall Study|Adverse Event|0
7634550|NCT03325712|12048781|FG006|Overall Study|Adverse Event|0
7634551|NCT03325712|12048782|FG007|Overall Study|Adverse Event|0
7634552|NCT03325166|12048810|FG000|Overall Study|Adverse Event|1
7634553|NCT03323034|12048819|FG000|Overall Study|Lack of Efficacy|5
7634554|NCT03323034|12048820|FG001|Overall Study|Lack of Efficacy|5
7634555|NCT03323034|12048821|FG002|Overall Study|Lack of Efficacy|6
7634556|NCT03323034|12048822|FG003|Overall Study|Lack of Efficacy|5
7634557|NCT03323034|12048823|FG004|Overall Study|Lack of Efficacy|5
7634558|NCT03323034|12048819|FG000|Overall Study|Physician Decision|0
7634559|NCT03323034|12048820|FG001|Overall Study|Physician Decision|0
7634560|NCT03323034|12048821|FG002|Overall Study|Physician Decision|0
7634561|NCT03323034|12048822|FG003|Overall Study|Physician Decision|0
7634562|NCT03323034|12048823|FG004|Overall Study|Physician Decision|1
7634563|NCT03323034|12048819|FG000|Overall Study|Withdrawal by Subject|1
7634564|NCT03323034|12048820|FG001|Overall Study|Withdrawal by Subject|1
7634565|NCT03323034|12048821|FG002|Overall Study|Withdrawal by Subject|0
7634566|NCT03323034|12048822|FG003|Overall Study|Withdrawal by Subject|1
7634567|NCT03323034|12048823|FG004|Overall Study|Withdrawal by Subject|0
7634568|NCT03321526|12048838|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2
7634569|NCT03321526|12048839|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2
7634570|NCT03321526|12048838|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9
7634571|NCT03321526|12048839|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3
7634572|NCT03321526|12048838|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1
7634573|NCT03321526|12048839|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3
7634574|NCT03321526|12048838|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7
7634575|NCT03321526|12048839|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8
7634576|NCT03321526|12048838|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1
7634577|NCT03321526|12048839|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0
7634578|NCT03321526|12048838|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3
7634579|NCT03321526|12048839|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6
7634580|NCT03321526|12048838|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1
7634581|NCT03321526|12048839|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4
7634582|NCT03321526|12048838|FG000|Follow-up Phase (2 Weeks)|Other|24
7634583|NCT03321526|12048839|FG001|Follow-up Phase (2 Weeks)|Other|24
7634584|NCT03320824|12048853|FG000|Overall Study|Withdrawal by Subject|8
7634585|NCT03320824|12048854|FG001|Overall Study|Withdrawal by Subject|1
7634586|NCT03320824|12048853|FG000|Overall Study|Lost to Follow-up|10
7634587|NCT03320824|12048854|FG001|Overall Study|Lost to Follow-up|1
7634588|NCT03320824|12048853|FG000|Overall Study|moved out of state|0
7634589|NCT03320824|12048854|FG001|Overall Study|moved out of state|1
7634590|NCT03320824|12048853|FG000|Overall Study|could not complete final visit|0
7634591|NCT03320824|12048854|FG001|Overall Study|could not complete final visit|1
7634592|NCT03319732|12048873|FG000|Overall Study|Adverse Event|40
7634593|NCT03319732|12048873|FG000|Overall Study|Withdrawal by Subject|50
7634594|NCT03319732|12048873|FG000|Overall Study|MS relapse|10
7634595|NCT03319732|12048873|FG000|Overall Study|reason not specified|5
7634596|NCT03318861|12048883|FG000|Overall Study|Death|1
7634597|NCT03318861|12048884|FG001|Overall Study|Death|2
7634598|NCT03318861|12048885|FG002|Overall Study|Death|2
7634599|NCT03318861|12048886|FG003|Overall Study|Death|1
7634600|NCT03318861|12048887|FG004|Overall Study|Death|1
7634601|NCT03318861|12048883|FG000|Overall Study|Still on Study|2
7634602|NCT03318861|12048884|FG001|Overall Study|Still on Study|1
7634603|NCT03318861|12048885|FG002|Overall Study|Still on Study|1
7634604|NCT03318861|12048886|FG003|Overall Study|Still on Study|2
7634605|NCT03318861|12048887|FG004|Overall Study|Still on Study|1
7634606|NCT03318861|12048883|FG000|Overall Study|Enrolled But Did Not Initiate KITE-585|0
7634607|NCT03318861|12048884|FG001|Overall Study|Enrolled But Did Not Initiate KITE-585|1
7634608|NCT03318861|12048885|FG002|Overall Study|Enrolled But Did Not Initiate KITE-585|0
7634609|NCT03318861|12048886|FG003|Overall Study|Enrolled But Did Not Initiate KITE-585|1
7634610|NCT03318861|12048887|FG004|Overall Study|Enrolled But Did Not Initiate KITE-585|1
7634611|NCT03315130|12048911|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0
7634612|NCT03315130|12048912|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1
7634613|NCT03315130|12048913|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0
7634614|NCT03315130|12048914|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0
7634615|NCT03315130|12048911|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0
7634616|NCT03315130|12048912|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1
7634617|NCT03315130|12048913|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0
7634618|NCT03315130|12048914|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0
7634619|NCT03315130|12048911|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1
7634620|NCT03315130|12048912|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0
7634621|NCT03315130|12048913|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0
7634622|NCT03315130|12048914|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0
7634623|NCT03315130|12048911|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0
7634624|NCT03315130|12048912|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1
7634625|NCT03315130|12048913|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0
7634626|NCT03315130|12048914|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0
7634627|NCT03315130|12048911|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0
7634628|NCT03315130|12048912|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1
7634629|NCT03315130|12048913|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0
7634630|NCT03315130|12048914|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0
7634631|NCT03315130|12048911|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0
7634632|NCT03315130|12048912|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2
7634633|NCT03315130|12048913|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0
7634634|NCT03315130|12048914|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1
7634635|NCT03314857|12048934|FG000|Overall Study|Death|4
7634636|NCT03314857|12048934|FG000|Overall Study|Physician Decision|1
7634637|NCT03308942|12048943|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3
7634638|NCT03308942|12048944|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3
7634639|NCT03308942|12048945|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2
7634640|NCT03308942|12048946|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0
7634641|NCT03308942|12048947|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0
7634642|NCT03308942|12048943|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11
7634643|NCT03308942|12048944|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16
7634644|NCT03308942|12048945|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1
7634645|NCT03308942|12048946|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0
7634646|NCT03308942|12048947|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0
7634647|NCT03308942|12048943|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0
7634648|NCT03308942|12048944|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1
7634649|NCT03308942|12048945|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0
7634650|NCT03308942|12048946|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0
7634651|NCT03308942|12048947|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0
7634652|NCT03308942|12048943|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3
7634653|NCT03308942|12048944|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1
7634654|NCT03308942|12048945|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0
7634655|NCT03308942|12048946|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0
7634656|NCT03308942|12048947|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0
7634657|NCT03308942|12048943|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0
7634658|NCT03308942|12048944|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0
7634659|NCT03308942|12048945|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0
7634660|NCT03308942|12048946|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3
7634661|NCT03308942|12048947|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0
7634662|NCT03308942|12048943|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0
7634663|NCT03308942|12048944|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0
7634664|NCT03308942|12048945|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0
7634665|NCT03308942|12048946|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6
7634666|NCT03308942|12048947|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0
7634667|NCT03308942|12048943|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0
7634668|NCT03308942|12048944|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0
7634669|NCT03308942|12048945|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0
7634670|NCT03308942|12048946|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3
7634671|NCT03308942|12048947|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0
7634672|NCT03308786|12048960|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9
7634673|NCT03307785|12048976|FG000|Part A: Up to 28.5 Months|Disease progression|2
7634674|NCT03307785|12048977|FG001|Part A: Up to 28.5 Months|Disease progression|0
7634675|NCT03307785|12048978|FG002|Part A: Up to 28.5 Months|Disease progression|0
7634676|NCT03307785|12048979|FG003|Part A: Up to 28.5 Months|Disease progression|0
7634677|NCT03307785|12048980|FG004|Part A: Up to 28.5 Months|Disease progression|0
7634678|NCT03307785|12048981|FG005|Part A: Up to 28.5 Months|Disease progression|0
7634679|NCT03307785|12048982|FG006|Part A: Up to 28.5 Months|Disease progression|0
7634680|NCT03307785|12048983|FG007|Part A: Up to 28.5 Months|Disease progression|0
7634681|NCT03307785|12048984|FG008|Part A: Up to 28.5 Months|Disease progression|0
7634682|NCT03307785|12048985|FG009|Part A: Up to 28.5 Months|Disease progression|0
7634683|NCT03307785|12048986|FG010|Part A: Up to 28.5 Months|Disease progression|0
7634684|NCT03307785|12048976|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7
7634685|NCT03307785|12048977|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1
7634686|NCT03307785|12048978|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634687|NCT03307785|12048979|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634688|NCT03307785|12048980|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634689|NCT03307785|12048981|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634690|NCT03307785|12048982|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634691|NCT03307785|12048983|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634692|NCT03307785|12048984|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634693|NCT03307785|12048985|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634694|NCT03307785|12048986|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634695|NCT03307785|12048976|FG000|Part A: Up to 28.5 Months|Death|4
7634696|NCT03307785|12048977|FG001|Part A: Up to 28.5 Months|Death|4
7634697|NCT03307785|12048978|FG002|Part A: Up to 28.5 Months|Death|0
7634698|NCT03307785|12048979|FG003|Part A: Up to 28.5 Months|Death|0
7634699|NCT03307785|12048980|FG004|Part A: Up to 28.5 Months|Death|0
7634700|NCT03307785|12048981|FG005|Part A: Up to 28.5 Months|Death|0
7634701|NCT03307785|12048982|FG006|Part A: Up to 28.5 Months|Death|0
7634702|NCT03307785|12048983|FG007|Part A: Up to 28.5 Months|Death|0
7634703|NCT03307785|12048984|FG008|Part A: Up to 28.5 Months|Death|0
7634704|NCT03307785|12048985|FG009|Part A: Up to 28.5 Months|Death|0
7634705|NCT03307785|12048986|FG010|Part A: Up to 28.5 Months|Death|0
7634706|NCT03307785|12048976|FG000|Part A: Up to 28.5 Months|Physician Decision|3
7634707|NCT03307785|12048977|FG001|Part A: Up to 28.5 Months|Physician Decision|1
7634708|NCT03307785|12048978|FG002|Part A: Up to 28.5 Months|Physician Decision|0
7634709|NCT03307785|12048979|FG003|Part A: Up to 28.5 Months|Physician Decision|0
7634710|NCT03307785|12048980|FG004|Part A: Up to 28.5 Months|Physician Decision|0
7634711|NCT03307785|12048981|FG005|Part A: Up to 28.5 Months|Physician Decision|0
7634712|NCT03307785|12048982|FG006|Part A: Up to 28.5 Months|Physician Decision|0
7634713|NCT03307785|12048983|FG007|Part A: Up to 28.5 Months|Physician Decision|0
7634714|NCT03307785|12048984|FG008|Part A: Up to 28.5 Months|Physician Decision|0
7634715|NCT03307785|12048985|FG009|Part A: Up to 28.5 Months|Physician Decision|0
7634716|NCT03307785|12048986|FG010|Part A: Up to 28.5 Months|Physician Decision|0
7634717|NCT03307785|12048976|FG000|Part B: Up to 28.5 Months|Disease progression|0
7634718|NCT03307785|12048977|FG001|Part B: Up to 28.5 Months|Disease progression|0
7634719|NCT03307785|12048978|FG002|Part B: Up to 28.5 Months|Disease progression|1
7634720|NCT03307785|12048979|FG003|Part B: Up to 28.5 Months|Disease progression|0
7634721|NCT03307785|12048980|FG004|Part B: Up to 28.5 Months|Disease progression|0
7634722|NCT03307785|12048981|FG005|Part B: Up to 28.5 Months|Disease progression|0
7634723|NCT03307785|12048982|FG006|Part B: Up to 28.5 Months|Disease progression|0
7634724|NCT03307785|12048983|FG007|Part B: Up to 28.5 Months|Disease progression|0
7634725|NCT03307785|12048984|FG008|Part B: Up to 28.5 Months|Disease progression|0
7634726|NCT03307785|12048985|FG009|Part B: Up to 28.5 Months|Disease progression|0
7634727|NCT03307785|12048986|FG010|Part B: Up to 28.5 Months|Disease progression|0
7634728|NCT03307785|12048976|FG000|Part B: Up to 28.5 Months|Physician Decision|0
7634729|NCT03307785|12048977|FG001|Part B: Up to 28.5 Months|Physician Decision|0
7634730|NCT03307785|12048978|FG002|Part B: Up to 28.5 Months|Physician Decision|1
7634731|NCT03307785|12048979|FG003|Part B: Up to 28.5 Months|Physician Decision|0
7634732|NCT03307785|12048980|FG004|Part B: Up to 28.5 Months|Physician Decision|0
7634733|NCT03307785|12048981|FG005|Part B: Up to 28.5 Months|Physician Decision|0
7634734|NCT03307785|12048982|FG006|Part B: Up to 28.5 Months|Physician Decision|0
7634735|NCT03307785|12048983|FG007|Part B: Up to 28.5 Months|Physician Decision|0
7634736|NCT03307785|12048984|FG008|Part B: Up to 28.5 Months|Physician Decision|0
7634737|NCT03307785|12048985|FG009|Part B: Up to 28.5 Months|Physician Decision|0
7634738|NCT03307785|12048986|FG010|Part B: Up to 28.5 Months|Physician Decision|0
7634739|NCT03307785|12048976|FG000|Part B: Up to 28.5 Months|Death|0
7634740|NCT03307785|12048977|FG001|Part B: Up to 28.5 Months|Death|0
7634741|NCT03307785|12048978|FG002|Part B: Up to 28.5 Months|Death|7
7634742|NCT03307785|12048979|FG003|Part B: Up to 28.5 Months|Death|0
7634743|NCT03307785|12048980|FG004|Part B: Up to 28.5 Months|Death|0
7634744|NCT03307785|12048981|FG005|Part B: Up to 28.5 Months|Death|0
7634745|NCT03307785|12048982|FG006|Part B: Up to 28.5 Months|Death|0
7634746|NCT03307785|12048983|FG007|Part B: Up to 28.5 Months|Death|0
7634747|NCT03307785|12048984|FG008|Part B: Up to 28.5 Months|Death|0
7634748|NCT03307785|12048985|FG009|Part B: Up to 28.5 Months|Death|0
7634749|NCT03307785|12048986|FG010|Part B: Up to 28.5 Months|Death|0
7634750|NCT03307785|12048976|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634751|NCT03307785|12048977|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634752|NCT03307785|12048978|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1
7634753|NCT03307785|12048979|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634754|NCT03307785|12048980|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634755|NCT03307785|12048981|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634756|NCT03307785|12048982|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634757|NCT03307785|12048983|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634758|NCT03307785|12048984|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634759|NCT03307785|12048985|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634760|NCT03307785|12048986|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634761|NCT03307785|12048976|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634762|NCT03307785|12048977|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634763|NCT03307785|12048978|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4
7634764|NCT03307785|12048979|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634765|NCT03307785|12048980|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634766|NCT03307785|12048981|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634767|NCT03307785|12048982|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634768|NCT03307785|12048983|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634769|NCT03307785|12048984|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634770|NCT03307785|12048985|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634771|NCT03307785|12048986|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634772|NCT03307785|12048976|FG000|Part C: Up to 22.5 Months|Disease progression|0
7634773|NCT03307785|12048977|FG001|Part C: Up to 22.5 Months|Disease progression|0
7634774|NCT03307785|12048978|FG002|Part C: Up to 22.5 Months|Disease progression|0
7634775|NCT03307785|12048979|FG003|Part C: Up to 22.5 Months|Disease progression|0
7634776|NCT03307785|12048980|FG004|Part C: Up to 22.5 Months|Disease progression|1
7634777|NCT03307785|12048981|FG005|Part C: Up to 22.5 Months|Disease progression|0
7634778|NCT03307785|12048982|FG006|Part C: Up to 22.5 Months|Disease progression|0
7634779|NCT03307785|12048983|FG007|Part C: Up to 22.5 Months|Disease progression|0
7634780|NCT03307785|12048984|FG008|Part C: Up to 22.5 Months|Disease progression|0
7634781|NCT03307785|12048985|FG009|Part C: Up to 22.5 Months|Disease progression|0
7634782|NCT03307785|12048986|FG010|Part C: Up to 22.5 Months|Disease progression|0
7634783|NCT03307785|12048976|FG000|Part C: Up to 22.5 Months|Physician Decision|0
7634784|NCT03307785|12048977|FG001|Part C: Up to 22.5 Months|Physician Decision|0
7634785|NCT03307785|12048978|FG002|Part C: Up to 22.5 Months|Physician Decision|0
7634786|NCT03307785|12048979|FG003|Part C: Up to 22.5 Months|Physician Decision|3
7634787|NCT03307785|12048980|FG004|Part C: Up to 22.5 Months|Physician Decision|1
7634788|NCT03307785|12048981|FG005|Part C: Up to 22.5 Months|Physician Decision|0
7634789|NCT03307785|12048982|FG006|Part C: Up to 22.5 Months|Physician Decision|0
7634790|NCT03307785|12048983|FG007|Part C: Up to 22.5 Months|Physician Decision|0
7634791|NCT03307785|12048984|FG008|Part C: Up to 22.5 Months|Physician Decision|0
7634792|NCT03307785|12048985|FG009|Part C: Up to 22.5 Months|Physician Decision|0
7634793|NCT03307785|12048986|FG010|Part C: Up to 22.5 Months|Physician Decision|0
7634794|NCT03307785|12048976|FG000|Part C: Up to 22.5 Months|Death|0
7634795|NCT03307785|12048977|FG001|Part C: Up to 22.5 Months|Death|0
7634796|NCT03307785|12048978|FG002|Part C: Up to 22.5 Months|Death|0
7634797|NCT03307785|12048979|FG003|Part C: Up to 22.5 Months|Death|1
7634798|NCT03307785|12048980|FG004|Part C: Up to 22.5 Months|Death|4
7634799|NCT03307785|12048981|FG005|Part C: Up to 22.5 Months|Death|0
7634800|NCT03307785|12048982|FG006|Part C: Up to 22.5 Months|Death|0
7634801|NCT03307785|12048983|FG007|Part C: Up to 22.5 Months|Death|0
7634802|NCT03307785|12048984|FG008|Part C: Up to 22.5 Months|Death|0
7634803|NCT03307785|12048985|FG009|Part C: Up to 22.5 Months|Death|0
7634804|NCT03307785|12048986|FG010|Part C: Up to 22.5 Months|Death|0
7634805|NCT03307785|12048976|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634806|NCT03307785|12048977|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634807|NCT03307785|12048978|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634808|NCT03307785|12048979|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1
7634809|NCT03307785|12048980|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634810|NCT03307785|12048981|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634811|NCT03307785|12048982|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634812|NCT03307785|12048983|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634813|NCT03307785|12048984|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634814|NCT03307785|12048985|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634815|NCT03307785|12048986|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634816|NCT03307785|12048976|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634817|NCT03307785|12048977|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634818|NCT03307785|12048978|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634819|NCT03307785|12048979|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1
7634820|NCT03307785|12048980|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1
7634821|NCT03307785|12048981|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634822|NCT03307785|12048982|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634823|NCT03307785|12048983|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634824|NCT03307785|12048984|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634825|NCT03307785|12048985|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634826|NCT03307785|12048986|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634827|NCT03307785|12048976|FG000|Part D: Up to 9.5 Months|Physician Decision|0
7634828|NCT03307785|12048977|FG001|Part D: Up to 9.5 Months|Physician Decision|0
7634829|NCT03307785|12048978|FG002|Part D: Up to 9.5 Months|Physician Decision|0
7634830|NCT03307785|12048979|FG003|Part D: Up to 9.5 Months|Physician Decision|0
7634831|NCT03307785|12048980|FG004|Part D: Up to 9.5 Months|Physician Decision|0
7634832|NCT03307785|12048981|FG005|Part D: Up to 9.5 Months|Physician Decision|1
7634833|NCT03307785|12048982|FG006|Part D: Up to 9.5 Months|Physician Decision|0
7634834|NCT03307785|12048983|FG007|Part D: Up to 9.5 Months|Physician Decision|0
7634835|NCT03307785|12048984|FG008|Part D: Up to 9.5 Months|Physician Decision|0
7634836|NCT03307785|12048985|FG009|Part D: Up to 9.5 Months|Physician Decision|0
7634837|NCT03307785|12048986|FG010|Part D: Up to 9.5 Months|Physician Decision|0
7634838|NCT03307785|12048976|FG000|Part D: Up to 9.5 Months|Death|0
7634839|NCT03307785|12048977|FG001|Part D: Up to 9.5 Months|Death|0
7634840|NCT03307785|12048978|FG002|Part D: Up to 9.5 Months|Death|0
7634841|NCT03307785|12048979|FG003|Part D: Up to 9.5 Months|Death|0
7634842|NCT03307785|12048980|FG004|Part D: Up to 9.5 Months|Death|0
7634843|NCT03307785|12048981|FG005|Part D: Up to 9.5 Months|Death|1
7634844|NCT03307785|12048982|FG006|Part D: Up to 9.5 Months|Death|0
7634845|NCT03307785|12048983|FG007|Part D: Up to 9.5 Months|Death|0
7634846|NCT03307785|12048984|FG008|Part D: Up to 9.5 Months|Death|0
7634847|NCT03307785|12048985|FG009|Part D: Up to 9.5 Months|Death|0
7634848|NCT03307785|12048986|FG010|Part D: Up to 9.5 Months|Death|0
7634849|NCT03307785|12048976|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634850|NCT03307785|12048977|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634851|NCT03307785|12048978|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634852|NCT03307785|12048979|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634853|NCT03307785|12048980|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634854|NCT03307785|12048981|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1
7634855|NCT03307785|12048982|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634856|NCT03307785|12048983|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634857|NCT03307785|12048984|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634858|NCT03307785|12048985|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634859|NCT03307785|12048986|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634860|NCT03307785|12048976|FG000|Part E: Up to 4.4 Months|Death|0
7634861|NCT03307785|12048977|FG001|Part E: Up to 4.4 Months|Death|0
7634862|NCT03307785|12048978|FG002|Part E: Up to 4.4 Months|Death|0
7634863|NCT03307785|12048979|FG003|Part E: Up to 4.4 Months|Death|0
7634864|NCT03307785|12048980|FG004|Part E: Up to 4.4 Months|Death|0
7634865|NCT03307785|12048981|FG005|Part E: Up to 4.4 Months|Death|0
7634866|NCT03307785|12048982|FG006|Part E: Up to 4.4 Months|Death|1
7634867|NCT03307785|12048983|FG007|Part E: Up to 4.4 Months|Death|0
7634868|NCT03307785|12048984|FG008|Part E: Up to 4.4 Months|Death|0
7634869|NCT03307785|12048985|FG009|Part E: Up to 4.4 Months|Death|0
7634870|NCT03307785|12048986|FG010|Part E: Up to 4.4 Months|Death|0
7634871|NCT03307785|12048976|FG000|Part E: Up to 4.4 Months|Physician Decision|0
7634872|NCT03307785|12048977|FG001|Part E: Up to 4.4 Months|Physician Decision|0
7634873|NCT03307785|12048978|FG002|Part E: Up to 4.4 Months|Physician Decision|0
7634874|NCT03307785|12048979|FG003|Part E: Up to 4.4 Months|Physician Decision|0
7634875|NCT03307785|12048980|FG004|Part E: Up to 4.4 Months|Physician Decision|0
7634876|NCT03307785|12048981|FG005|Part E: Up to 4.4 Months|Physician Decision|0
7634877|NCT03307785|12048982|FG006|Part E: Up to 4.4 Months|Physician Decision|1
7634878|NCT03307785|12048983|FG007|Part E: Up to 4.4 Months|Physician Decision|0
7634879|NCT03307785|12048984|FG008|Part E: Up to 4.4 Months|Physician Decision|0
7634880|NCT03307785|12048985|FG009|Part E: Up to 4.4 Months|Physician Decision|0
7634881|NCT03307785|12048986|FG010|Part E: Up to 4.4 Months|Physician Decision|0
7634882|NCT03307785|12048976|FG000|Part F: Up to 3.5 Months|Physician Decision|0
7634883|NCT03307785|12048977|FG001|Part F: Up to 3.5 Months|Physician Decision|0
7634884|NCT03307785|12048978|FG002|Part F: Up to 3.5 Months|Physician Decision|0
7634885|NCT03307785|12048979|FG003|Part F: Up to 3.5 Months|Physician Decision|0
7634886|NCT03307785|12048980|FG004|Part F: Up to 3.5 Months|Physician Decision|0
7634887|NCT03307785|12048981|FG005|Part F: Up to 3.5 Months|Physician Decision|0
7634888|NCT03307785|12048982|FG006|Part F: Up to 3.5 Months|Physician Decision|0
7634889|NCT03307785|12048983|FG007|Part F: Up to 3.5 Months|Physician Decision|1
7634890|NCT03307785|12048984|FG008|Part F: Up to 3.5 Months|Physician Decision|0
7634891|NCT03307785|12048985|FG009|Part F: Up to 3.5 Months|Physician Decision|0
7634892|NCT03307785|12048986|FG010|Part F: Up to 3.5 Months|Physician Decision|0
7634893|NCT03306277|12049007|FG000|Overall Study|Death|1
7634894|NCT03306277|12049007|FG000|Overall Study|Adverse Event|1
7634895|NCT03306277|12049007|FG000|Overall Study|Withdrawal by Subject|1
7634896|NCT03299049|12049044|FG000|Overall Study|On-going|486
7634897|NCT03299049|12049045|FG001|Overall Study|On-going|481
7634898|NCT03299049|12049044|FG000|Overall Study|Withdrawal by Subject|6
7634899|NCT03299049|12049045|FG001|Overall Study|Withdrawal by Subject|21
7634900|NCT03299049|12049044|FG000|Overall Study|Physician Decision|5
7634901|NCT03299049|12049045|FG001|Overall Study|Physician Decision|1
7634902|NCT03299049|12049044|FG000|Overall Study|Lost to Follow-up|2
7634903|NCT03299049|12049045|FG001|Overall Study|Lost to Follow-up|0
7634904|NCT03299049|12049044|FG000|Overall Study|Pregnancy|1
7634905|NCT03299049|12049045|FG001|Overall Study|Pregnancy|3
7634906|NCT03299049|12049044|FG000|Overall Study|Protocol Violation|1
7634907|NCT03299049|12049045|FG001|Overall Study|Protocol Violation|1
7634908|NCT03299049|12049044|FG000|Overall Study|Lack of Efficacy|9
7634909|NCT03299049|12049045|FG001|Overall Study|Lack of Efficacy|3
7634910|NCT03299049|12049044|FG000|Overall Study|Adverse Event|12
7634911|NCT03299049|12049045|FG001|Overall Study|Adverse Event|13
7634912|NCT03292913|12049086|FG000|Overall Study|Death|9
7634913|NCT03292913|12049087|FG001|Overall Study|Death|3
7634914|NCT03292913|12049086|FG000|Overall Study|Lost to Follow-up|49
7634915|NCT03292913|12049087|FG001|Overall Study|Lost to Follow-up|49
7634916|NCT03292913|12049086|FG000|Overall Study|Withdrawal by Subject|2
7634917|NCT03292913|12049087|FG001|Overall Study|Withdrawal by Subject|0
7634918|NCT03292913|12049086|FG000|Overall Study|Clinic closed due to COVID|22
7634919|NCT03292913|12049087|FG001|Overall Study|Clinic closed due to COVID|36
7634920|NCT03291808|12049097|FG000|Overall Study|Lost to Follow-up|6
7634921|NCT03291808|12049097|FG000|Overall Study|Research burden|4
7634922|NCT03290300|12049107|FG000|Overall Study|Lost to Follow-up|3
7634923|NCT03287089|12049137|FG000|Overall Study|Lost to Follow-up|0
7634924|NCT03287089|12049138|FG001|Overall Study|Lost to Follow-up|2
7634925|NCT03287089|12049137|FG000|Overall Study|Physician Decision|0
7634926|NCT03287089|12049138|FG001|Overall Study|Physician Decision|2
7634927|NCT03287089|12049137|FG000|Overall Study|Withdrawal by Subject|0
7634928|NCT03287089|12049138|FG001|Overall Study|Withdrawal by Subject|2
7634929|NCT03281304|12049150|FG000|Overall Study|Adverse Event|5
7634930|NCT03281304|12049151|FG001|Overall Study|Adverse Event|2
7634931|NCT03281304|12049150|FG000|Overall Study|Lack of Efficacy|2
7634932|NCT03281304|12049151|FG001|Overall Study|Lack of Efficacy|0
7634933|NCT03281304|12049150|FG000|Overall Study|Pregnancy|1
7634934|NCT03281304|12049151|FG001|Overall Study|Pregnancy|0
7634935|NCT03281304|12049150|FG000|Overall Study|Withdrawal by Subject|5
7634936|NCT03281304|12049151|FG001|Overall Study|Withdrawal by Subject|10
7634937|NCT03277105|12049168|FG000|Overall Study|Death|77
7634938|NCT03277105|12049169|FG001|Overall Study|Death|73
7634939|NCT03277105|12049168|FG000|Overall Study|Lost to Follow-up|0
7634940|NCT03277105|12049169|FG001|Overall Study|Lost to Follow-up|3
7634941|NCT03277105|12049168|FG000|Overall Study|Withdrawal by Subject|10
7634942|NCT03277105|12049169|FG001|Overall Study|Withdrawal by Subject|9
7634943|NCT03277105|12049168|FG000|Overall Study|Other|1
7634944|NCT03277105|12049169|FG001|Overall Study|Other|3
7634945|NCT03277105|12049168|FG000|Overall Study|Ongoing|171
7634946|NCT03277105|12049169|FG001|Overall Study|Ongoing|175
7634947|NCT03276728|12049183|FG000|Overall Study|Lost to Follow-up|0
7634948|NCT03276728|12049184|FG001|Overall Study|Lost to Follow-up|0
7634949|NCT03276728|12049185|FG002|Overall Study|Lost to Follow-up|2
7634950|NCT03276728|12049186|FG003|Overall Study|Lost to Follow-up|2
7634951|NCT03276728|12049187|FG004|Overall Study|Lost to Follow-up|0
7634952|NCT03276728|12049188|FG005|Overall Study|Lost to Follow-up|0
7634953|NCT03276728|12049189|FG006|Overall Study|Lost to Follow-up|0
7634954|NCT03276728|12049190|FG007|Overall Study|Lost to Follow-up|0
7634955|NCT03276728|12049183|FG000|Overall Study|Withdrawal by Subject|0
7634956|NCT03276728|12049184|FG001|Overall Study|Withdrawal by Subject|0
7634957|NCT03276728|12049185|FG002|Overall Study|Withdrawal by Subject|0
7634958|NCT03276728|12049186|FG003|Overall Study|Withdrawal by Subject|3
7634959|NCT03276728|12049187|FG004|Overall Study|Withdrawal by Subject|0
7634960|NCT03276728|12049188|FG005|Overall Study|Withdrawal by Subject|0
7634961|NCT03276728|12049189|FG006|Overall Study|Withdrawal by Subject|0
7634962|NCT03276728|12049190|FG007|Overall Study|Withdrawal by Subject|0
7634963|NCT03276728|12049183|FG000|Overall Study|Decision by sponsor|0
7634964|NCT03276728|12049184|FG001|Overall Study|Decision by sponsor|0
7634965|NCT03276728|12049185|FG002|Overall Study|Decision by sponsor|0
7634966|NCT03276728|12049186|FG003|Overall Study|Decision by sponsor|0
7634967|NCT03276728|12049187|FG004|Overall Study|Decision by sponsor|1
7634968|NCT03276728|12049188|FG005|Overall Study|Decision by sponsor|0
7634969|NCT03276728|12049189|FG006|Overall Study|Decision by sponsor|2
7634970|NCT03276728|12049190|FG007|Overall Study|Decision by sponsor|1
7634971|NCT03274466|12049212|FG000|Overall Study|Withdrawal by Subject|7
7634972|NCT03274466|12049213|FG001|Overall Study|Withdrawal by Subject|3
7634973|NCT03274466|12049212|FG000|Overall Study|Protocol Specified Withdrawal|5
7634974|NCT03274466|12049213|FG001|Overall Study|Protocol Specified Withdrawal|11
7634975|NCT03274466|12049212|FG000|Overall Study|Lost to Follow-up|5
7634976|NCT03274466|12049213|FG001|Overall Study|Lost to Follow-up|7
7634977|NCT03274466|12049212|FG000|Overall Study|Subject Non-compliance|0
7634978|NCT03274466|12049213|FG001|Overall Study|Subject Non-compliance|1
7634979|NCT03274466|12049212|FG000|Overall Study|Adverse Event|3
7634980|NCT03274466|12049213|FG001|Overall Study|Adverse Event|3
7634981|NCT03274466|12049212|FG000|Overall Study|Physician Decision|0
7634982|NCT03274466|12049213|FG001|Overall Study|Physician Decision|1
7634983|NCT03274466|12049212|FG000|Overall Study|Protocol Violation|3
7634984|NCT03274466|12049213|FG001|Overall Study|Protocol Violation|3
7634985|NCT03273907|12049219|FG000|Overall Study|Death|1
7634986|NCT03273907|12049219|FG000|Overall Study|Lost to Follow-up|4
7634987|NCT03273907|12049219|FG000|Overall Study|Withdrawal by Subject|2
7634988|NCT03273907|12049219|FG000|Overall Study|COVID 19|2
7634989|NCT03273153|12049227|FG000|Overall Study|Adverse Event|1
7634990|NCT03273153|12049228|FG001|Overall Study|Adverse Event|2
7634991|NCT03273153|12049227|FG000|Overall Study|Missing|0
7634992|NCT03273153|12049228|FG001|Overall Study|Missing|2
7634993|NCT03273153|12049227|FG000|Overall Study|Other|3
7634994|NCT03273153|12049228|FG001|Overall Study|Other|2
7634995|NCT03273153|12049227|FG000|Overall Study|Symptomatic Deterioration|0
7634996|NCT03273153|12049228|FG001|Overall Study|Symptomatic Deterioration|1
7634997|NCT03273153|12049227|FG000|Overall Study|Progressive Disease|6
7634998|NCT03273153|12049228|FG001|Overall Study|Progressive Disease|5
7634999|NCT03273153|12049227|FG000|Overall Study|Physician Decision|1
7635000|NCT03273153|12049228|FG001|Overall Study|Physician Decision|3
7635001|NCT03273153|12049227|FG000|Overall Study|Study Terminated by Sponsor|112
7635002|NCT03273153|12049228|FG001|Overall Study|Study Terminated by Sponsor|102
7635003|NCT03273153|12049227|FG000|Overall Study|Withdrawal by Subject|26
7635004|NCT03273153|12049228|FG001|Overall Study|Withdrawal by Subject|25
7635005|NCT03273153|12049227|FG000|Overall Study|Protocol Deviation|3
7635006|NCT03273153|12049228|FG001|Overall Study|Protocol Deviation|0
7635007|NCT03273153|12049227|FG000|Overall Study|Lost to Follow-up|6
7635008|NCT03273153|12049228|FG001|Overall Study|Lost to Follow-up|11
7635009|NCT03273153|12049227|FG000|Overall Study|Death|66
7635010|NCT03273153|12049228|FG001|Overall Study|Death|69
7635011|NCT03268954|12049237|FG000|Overall Study|Ongoing|23
7635012|NCT03268954|12049238|FG001|Overall Study|Ongoing|31
7635013|NCT03268954|12049237|FG000|Overall Study|Adverse Event|53
7635014|NCT03268954|12049238|FG001|Overall Study|Adverse Event|62
7635015|NCT03268954|12049237|FG000|Overall Study|Withdrawal by Subject|25
7635016|NCT03268954|12049238|FG001|Overall Study|Withdrawal by Subject|16
7635017|NCT03268954|12049237|FG000|Overall Study|Progressive Disease|61
7635018|NCT03268954|12049238|FG001|Overall Study|Progressive Disease|48
7635019|NCT03268954|12049237|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25
7635020|NCT03268954|12049238|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30
7635021|NCT03268954|12049237|FG000|Overall Study|Reason not Specified|40
7635022|NCT03268954|12049238|FG001|Overall Study|Reason not Specified|40
7635043|NCT03255629|12049261|FG000|Overall Study|Adverse Event|1
7635044|NCT03255629|12049262|FG001|Overall Study|Adverse Event|0
7635045|NCT03255629|12049261|FG000|Overall Study|did not experience hypoglycemia|2
7635046|NCT03255629|12049262|FG001|Overall Study|did not experience hypoglycemia|1
7635047|NCT03255187|12049271|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1
7635048|NCT03255187|12049272|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3
7635049|NCT03255187|12049271|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0
7635050|NCT03255187|12049272|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1
7635051|NCT03254485|12049282|FG000|Overall Study|Adverse Event|3
7635052|NCT03254485|12049283|FG001|Overall Study|Adverse Event|0
7635053|NCT03254485|12049284|FG002|Overall Study|Adverse Event|0
7635054|NCT03254485|12049285|FG003|Overall Study|Adverse Event|6
7635055|NCT03254485|12049282|FG000|Overall Study|Protocol Violation|6
7635056|NCT03254485|12049283|FG001|Overall Study|Protocol Violation|0
7635057|NCT03254485|12049284|FG002|Overall Study|Protocol Violation|0
7635058|NCT03254485|12049285|FG003|Overall Study|Protocol Violation|2
7635059|NCT03254485|12049282|FG000|Overall Study|Withdrawal by Subject|1
7635060|NCT03254485|12049283|FG001|Overall Study|Withdrawal by Subject|0
7635061|NCT03254485|12049284|FG002|Overall Study|Withdrawal by Subject|0
7635062|NCT03254485|12049285|FG003|Overall Study|Withdrawal by Subject|4
7635063|NCT03254485|12049282|FG000|Overall Study|Death|0
7635064|NCT03254485|12049283|FG001|Overall Study|Death|0
7635065|NCT03254485|12049284|FG002|Overall Study|Death|0
7635066|NCT03254485|12049285|FG003|Overall Study|Death|1
7635067|NCT03254485|12049282|FG000|Overall Study|Lost to Follow-up|1
7635068|NCT03254485|12049283|FG001|Overall Study|Lost to Follow-up|0
7635069|NCT03254485|12049284|FG002|Overall Study|Lost to Follow-up|0
7635070|NCT03254485|12049285|FG003|Overall Study|Lost to Follow-up|0
7635071|NCT03254485|12049282|FG000|Overall Study|Other|1
7635072|NCT03254485|12049283|FG001|Overall Study|Other|0
7635073|NCT03254485|12049284|FG002|Overall Study|Other|0
7635074|NCT03254485|12049285|FG003|Overall Study|Other|2
7635075|NCT03253796|12049301|FG000|Period 1: Run-In|Adverse Event|4
7635076|NCT03253796|12049302|FG001|Period 1: Run-In|Adverse Event|0
7635077|NCT03253796|12049303|FG002|Period 1: Run-In|Adverse Event|0
7635078|NCT03253796|12049304|FG003|Period 1: Run-In|Adverse Event|0
7635079|NCT03253796|12049305|FG004|Period 1: Run-In|Adverse Event|0
7635080|NCT03253796|12049301|FG000|Period 1: Run-In|Lack of Efficacy|1
7635081|NCT03253796|12049302|FG001|Period 1: Run-In|Lack of Efficacy|0
7635082|NCT03253796|12049303|FG002|Period 1: Run-In|Lack of Efficacy|0
7635083|NCT03253796|12049304|FG003|Period 1: Run-In|Lack of Efficacy|0
7635084|NCT03253796|12049305|FG004|Period 1: Run-In|Lack of Efficacy|0
7635085|NCT03253796|12049301|FG000|Period 1: Run-In|Lack of Qualifying Event|98
7635086|NCT03253796|12049302|FG001|Period 1: Run-In|Lack of Qualifying Event|0
7635087|NCT03253796|12049303|FG002|Period 1: Run-In|Lack of Qualifying Event|0
7635088|NCT03253796|12049304|FG003|Period 1: Run-In|Lack of Qualifying Event|0
7635089|NCT03253796|12049305|FG004|Period 1: Run-In|Lack of Qualifying Event|0
7635090|NCT03253796|12049301|FG000|Period 1: Run-In|Protocol Violation|5
7635091|NCT03253796|12049302|FG001|Period 1: Run-In|Protocol Violation|0
7635092|NCT03253796|12049303|FG002|Period 1: Run-In|Protocol Violation|0
7635093|NCT03253796|12049304|FG003|Period 1: Run-In|Protocol Violation|0
7635094|NCT03253796|12049305|FG004|Period 1: Run-In|Protocol Violation|0
7635095|NCT03253796|12049301|FG000|Period 1: Run-In|Withdrawal by Subject|8
7635096|NCT03253796|12049302|FG001|Period 1: Run-In|Withdrawal by Subject|0
7635097|NCT03253796|12049303|FG002|Period 1: Run-In|Withdrawal by Subject|0
7635098|NCT03253796|12049304|FG003|Period 1: Run-In|Withdrawal by Subject|0
7635099|NCT03253796|12049305|FG004|Period 1: Run-In|Withdrawal by Subject|0
7635100|NCT03253796|12049301|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0
7635101|NCT03253796|12049302|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0
7635102|NCT03253796|12049303|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2
7635103|NCT03253796|12049304|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0
7635104|NCT03253796|12049305|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0
7635105|NCT03253796|12049301|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0
7635106|NCT03253796|12049302|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0
7635107|NCT03253796|12049303|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1
7635108|NCT03253796|12049304|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0
7635109|NCT03253796|12049305|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0
7635110|NCT03253796|12049301|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0
7635111|NCT03253796|12049302|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0
7635112|NCT03253796|12049303|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2
7635113|NCT03253796|12049304|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3
7635114|NCT03253796|12049305|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0
7635115|NCT03253796|12049301|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0
7635116|NCT03253796|12049302|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0
7635117|NCT03253796|12049303|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1
7635118|NCT03253796|12049304|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0
7635119|NCT03253796|12049305|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0
7635120|NCT03253796|12049301|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0
7635121|NCT03253796|12049302|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10
7635122|NCT03253796|12049303|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15
7635123|NCT03253796|12049304|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38
7635124|NCT03253796|12049305|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0
7635125|NCT03253796|12049301|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0
7635126|NCT03253796|12049302|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0
7635127|NCT03253796|12049303|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0
7635128|NCT03253796|12049304|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0
7635129|NCT03253796|12049305|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5
7635130|NCT03252587|12049324|FG000|Overall Study|Adverse Event|3
7635131|NCT03252587|12049325|FG001|Overall Study|Adverse Event|8
7635132|NCT03252587|12049326|FG002|Overall Study|Adverse Event|6
7635133|NCT03252587|12049327|FG003|Overall Study|Adverse Event|12
7635134|NCT03252587|12049324|FG000|Overall Study|Lack of Efficacy|7
7635135|NCT03252587|12049325|FG001|Overall Study|Lack of Efficacy|2
7635136|NCT03252587|12049326|FG002|Overall Study|Lack of Efficacy|2
7635137|NCT03252587|12049327|FG003|Overall Study|Lack of Efficacy|4
7635138|NCT03252587|12049324|FG000|Overall Study|Lost to Follow-up|2
7635139|NCT03252587|12049325|FG001|Overall Study|Lost to Follow-up|0
7635140|NCT03252587|12049326|FG002|Overall Study|Lost to Follow-up|0
7635141|NCT03252587|12049327|FG003|Overall Study|Lost to Follow-up|2
7635142|NCT03252587|12049324|FG000|Overall Study|Pregnancy|2
7635143|NCT03252587|12049325|FG001|Overall Study|Pregnancy|1
7635144|NCT03252587|12049326|FG002|Overall Study|Pregnancy|0
7635145|NCT03252587|12049327|FG003|Overall Study|Pregnancy|1
7635146|NCT03252587|12049324|FG000|Overall Study|Withdrawal by Subject|8
7635147|NCT03252587|12049325|FG001|Overall Study|Withdrawal by Subject|4
7635148|NCT03252587|12049326|FG002|Overall Study|Withdrawal by Subject|4
7635149|NCT03252587|12049327|FG003|Overall Study|Withdrawal by Subject|4
7635150|NCT03252587|12049324|FG000|Overall Study|Other Reasons|2
7635151|NCT03252587|12049325|FG001|Overall Study|Other Reasons|5
7635152|NCT03252587|12049326|FG002|Overall Study|Other Reasons|5
7635153|NCT03252587|12049327|FG003|Overall Study|Other Reasons|4
7635154|NCT03250273|12049342|FG000|Overall Study|Disease Progression|2
7635155|NCT03250273|12049343|FG001|Overall Study|Disease Progression|9
7635156|NCT03250273|12049342|FG000|Overall Study|Adverse Event|0
7635157|NCT03250273|12049343|FG001|Overall Study|Adverse Event|1
7635158|NCT03250273|12049342|FG000|Overall Study|Death|0
7635159|NCT03250273|12049343|FG001|Overall Study|Death|1
7635160|NCT03250273|12049342|FG000|Overall Study|Failed to Maintain Eligibility|0
7635161|NCT03250273|12049343|FG001|Overall Study|Failed to Maintain Eligibility|1
7635162|NCT03246061|12049355|FG000|Overall Study|Still in follow-up|15
7635163|NCT03246061|12049356|FG001|Overall Study|Still in follow-up|21
7635164|NCT03241173|12049375|FG000|Overall Study|Death|3
7635165|NCT03241173|12049376|FG001|Overall Study|Death|2
7635166|NCT03241173|12049377|FG002|Overall Study|Death|4
7635167|NCT03241173|12049378|FG003|Overall Study|Death|4
7635168|NCT03241173|12049379|FG004|Overall Study|Death|2
7635169|NCT03241173|12049380|FG005|Overall Study|Death|2
7635170|NCT03241173|12049381|FG006|Overall Study|Death|3
7635171|NCT03241173|12049382|FG007|Overall Study|Death|1
7635172|NCT03241173|12049383|FG008|Overall Study|Death|0
7635173|NCT03241173|12049384|FG009|Overall Study|Death|5
7635174|NCT03241173|12049385|FG010|Overall Study|Death|4
7635175|NCT03241173|12049386|FG011|Overall Study|Death|3
7635176|NCT03241173|12049387|FG012|Overall Study|Death|0
7635177|NCT03241173|12049388|FG013|Overall Study|Death|0
7635178|NCT03241173|12049389|FG014|Overall Study|Death|0
7635179|NCT03241173|12049375|FG000|Overall Study|Withdrawal by Subject|0
7635180|NCT03241173|12049376|FG001|Overall Study|Withdrawal by Subject|0
7635181|NCT03241173|12049377|FG002|Overall Study|Withdrawal by Subject|1
7635182|NCT03241173|12049378|FG003|Overall Study|Withdrawal by Subject|0
7635183|NCT03241173|12049379|FG004|Overall Study|Withdrawal by Subject|0
7635184|NCT03241173|12049380|FG005|Overall Study|Withdrawal by Subject|1
7635185|NCT03241173|12049381|FG006|Overall Study|Withdrawal by Subject|0
7635186|NCT03241173|12049382|FG007|Overall Study|Withdrawal by Subject|0
7635187|NCT03241173|12049383|FG008|Overall Study|Withdrawal by Subject|0
7635188|NCT03241173|12049384|FG009|Overall Study|Withdrawal by Subject|0
7635189|NCT03241173|12049385|FG010|Overall Study|Withdrawal by Subject|0
7635190|NCT03241173|12049386|FG011|Overall Study|Withdrawal by Subject|0
7635191|NCT03241173|12049387|FG012|Overall Study|Withdrawal by Subject|0
7635192|NCT03241173|12049388|FG013|Overall Study|Withdrawal by Subject|0
7635193|NCT03241173|12049389|FG014|Overall Study|Withdrawal by Subject|0
7635194|NCT03241173|12049375|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1
7635195|NCT03241173|12049376|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2
7635196|NCT03241173|12049377|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0
7635197|NCT03241173|12049378|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1
7635198|NCT03241173|12049379|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1
7635199|NCT03241173|12049380|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2
7635200|NCT03241173|12049381|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1
7635201|NCT03241173|12049382|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2
7635202|NCT03241173|12049383|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0
7635203|NCT03241173|12049384|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0
7635204|NCT03241173|12049385|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2
7635205|NCT03241173|12049386|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3
7635206|NCT03241173|12049387|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0
7635207|NCT03241173|12049388|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0
7635208|NCT03241173|12049389|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0
7635209|NCT03241173|12049375|FG000|Overall Study|Lost to Follow-up|0
7635210|NCT03241173|12049376|FG001|Overall Study|Lost to Follow-up|0
7635211|NCT03241173|12049377|FG002|Overall Study|Lost to Follow-up|0
7635212|NCT03241173|12049378|FG003|Overall Study|Lost to Follow-up|0
7635213|NCT03241173|12049379|FG004|Overall Study|Lost to Follow-up|1
7635214|NCT03241173|12049380|FG005|Overall Study|Lost to Follow-up|0
7635215|NCT03241173|12049381|FG006|Overall Study|Lost to Follow-up|0
7635216|NCT03241173|12049382|FG007|Overall Study|Lost to Follow-up|0
7635217|NCT03241173|12049383|FG008|Overall Study|Lost to Follow-up|0
7635218|NCT03241173|12049384|FG009|Overall Study|Lost to Follow-up|1
7635219|NCT03241173|12049385|FG010|Overall Study|Lost to Follow-up|0
7635220|NCT03241173|12049386|FG011|Overall Study|Lost to Follow-up|0
7635221|NCT03241173|12049387|FG012|Overall Study|Lost to Follow-up|0
7635222|NCT03241173|12049388|FG013|Overall Study|Lost to Follow-up|0
7635223|NCT03241173|12049389|FG014|Overall Study|Lost to Follow-up|0
7635224|NCT03237325|12049419|FG000|Overall Study|Lost to Follow-up|3
7635225|NCT03237325|12049420|FG001|Overall Study|Lost to Follow-up|5
7635226|NCT03237325|12049419|FG000|Overall Study|Physician Decision|2
7635227|NCT03237325|12049420|FG001|Overall Study|Physician Decision|4
7635228|NCT03237325|12049419|FG000|Overall Study|Withdrawal by Subject|9
7635229|NCT03237325|12049420|FG001|Overall Study|Withdrawal by Subject|12
7635230|NCT03237325|12049419|FG000|Overall Study|Noncompliance with Study Procedures|1
7635231|NCT03237325|12049420|FG001|Overall Study|Noncompliance with Study Procedures|1
7635232|NCT03237325|12049419|FG000|Overall Study|Termination by Sponsor|0
7635233|NCT03237325|12049420|FG001|Overall Study|Termination by Sponsor|1
7635234|NCT03237325|12049419|FG000|Overall Study|Reason other than described|0
7635235|NCT03237325|12049420|FG001|Overall Study|Reason other than described|2
7635236|NCT03234907|12049428|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1
7635237|NCT03234907|12049429|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1
7635238|NCT03234907|12049430|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0
7635239|NCT03234907|12049431|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0
7635240|NCT03234907|12049432|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0
7635241|NCT03234907|12049433|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0
7635242|NCT03234907|12049428|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6
7635243|NCT03234907|12049429|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4
7635244|NCT03234907|12049430|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0
7635245|NCT03234907|12049431|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0
7635246|NCT03234907|12049432|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0
7635247|NCT03234907|12049433|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0
7635248|NCT03234907|12049428|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2
7635249|NCT03234907|12049429|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0
7635250|NCT03234907|12049430|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0
7635251|NCT03234907|12049431|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0
7635252|NCT03234907|12049432|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0
7635253|NCT03234907|12049433|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0
7635254|NCT03234907|12049428|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1
7635255|NCT03234907|12049429|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1
7635256|NCT03234907|12049430|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0
7635257|NCT03234907|12049431|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0
7635258|NCT03234907|12049432|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0
7635259|NCT03234907|12049433|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0
7635260|NCT03234907|12049428|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0
7635261|NCT03234907|12049429|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0
7635262|NCT03234907|12049430|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0
7635263|NCT03234907|12049431|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4
7635264|NCT03234907|12049432|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3
7635265|NCT03234907|12049433|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7
7635266|NCT03234907|12049428|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0
7635267|NCT03234907|12049429|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0
7635268|NCT03234907|12049430|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1
7635269|NCT03234907|12049431|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3
7635270|NCT03234907|12049432|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3
7635271|NCT03234907|12049433|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4
7635272|NCT03234907|12049428|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0
7635273|NCT03234907|12049429|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0
7635274|NCT03234907|12049430|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0
7635275|NCT03234907|12049431|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4
7635276|NCT03234907|12049432|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4
7635277|NCT03234907|12049433|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10
7635278|NCT03221842|12049453|FG000|Period 1 (Open-label)|Adverse Event|4
7635279|NCT03221842|12049454|FG001|Period 1 (Open-label)|Adverse Event|0
7635280|NCT03221842|12049453|FG000|Period 1 (Open-label)|Physician Decision|2
7635281|NCT03221842|12049454|FG001|Period 1 (Open-label)|Physician Decision|0
7635282|NCT03221842|12049453|FG000|Period 1 (Open-label)|Lost to Follow-up|1
7635283|NCT03221842|12049454|FG001|Period 1 (Open-label)|Lost to Follow-up|0
7635284|NCT03221842|12049453|FG000|Period 1 (Open-label)|Terminated by sponsor|1
7635285|NCT03221842|12049454|FG001|Period 1 (Open-label)|Terminated by sponsor|0
7635286|NCT03221842|12049453|FG000|Period 1 (Open-label)|Other|2
7635287|NCT03221842|12049454|FG001|Period 1 (Open-label)|Other|0
7635288|NCT03221842|12049453|FG000|Period 2 (Randomized, Blinded)|Death|0
7635289|NCT03221842|12049454|FG001|Period 2 (Randomized, Blinded)|Death|1
7635290|NCT03221842|12049453|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1
7635291|NCT03221842|12049454|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0
7635292|NCT03217591|12049467|FG000|Overall Study|Adverse Event|1
7635293|NCT03217591|12049468|FG001|Overall Study|Adverse Event|2
7635294|NCT03217591|12049469|FG002|Overall Study|Adverse Event|6
7635295|NCT03217591|12049467|FG000|Overall Study|Withdrawal by Subject|0
7635296|NCT03217591|12049468|FG001|Overall Study|Withdrawal by Subject|1
7635297|NCT03217591|12049469|FG002|Overall Study|Withdrawal by Subject|3
7635298|NCT03217591|12049467|FG000|Overall Study|Lost to Follow-up|1
7635299|NCT03217591|12049468|FG001|Overall Study|Lost to Follow-up|0
7635300|NCT03217591|12049469|FG002|Overall Study|Lost to Follow-up|0
7635301|NCT03217591|12049467|FG000|Overall Study|Protocol Violation|1
7635302|NCT03217591|12049468|FG001|Overall Study|Protocol Violation|0
7635303|NCT03217591|12049469|FG002|Overall Study|Protocol Violation|1
7635304|NCT03214250|12049485|FG000|Overall Study|Death|5
7635305|NCT03214250|12049486|FG001|Overall Study|Death|5
7635306|NCT03214250|12049487|FG002|Overall Study|Death|7
7635307|NCT03214250|12049488|FG003|Overall Study|Death|4
7635308|NCT03214250|12049489|FG004|Overall Study|Death|23
7635309|NCT03214250|12049490|FG005|Overall Study|Death|23
7635310|NCT03214250|12049491|FG006|Overall Study|Death|24
7635311|NCT03214250|12049485|FG000|Overall Study|Lost to Follow-up|0
7635312|NCT03214250|12049486|FG001|Overall Study|Lost to Follow-up|0
7635313|NCT03214250|12049487|FG002|Overall Study|Lost to Follow-up|0
7635314|NCT03214250|12049488|FG003|Overall Study|Lost to Follow-up|1
7635315|NCT03214250|12049489|FG004|Overall Study|Lost to Follow-up|1
7635316|NCT03214250|12049490|FG005|Overall Study|Lost to Follow-up|2
7635317|NCT03214250|12049491|FG006|Overall Study|Lost to Follow-up|0
7635318|NCT03214250|12049485|FG000|Overall Study|Other|0
7635319|NCT03214250|12049486|FG001|Overall Study|Other|0
7635320|NCT03214250|12049487|FG002|Overall Study|Other|0
7635321|NCT03214250|12049488|FG003|Overall Study|Other|0
7635322|NCT03214250|12049489|FG004|Overall Study|Other|1
7635323|NCT03214250|12049490|FG005|Overall Study|Other|1
7635324|NCT03214250|12049491|FG006|Overall Study|Other|2
7635325|NCT03214250|12049485|FG000|Overall Study|Remains on Study|2
7635326|NCT03214250|12049486|FG001|Overall Study|Remains on Study|2
7635327|NCT03214250|12049487|FG002|Overall Study|Remains on Study|0
7635328|NCT03214250|12049488|FG003|Overall Study|Remains on Study|1
7635329|NCT03214250|12049489|FG004|Overall Study|Remains on Study|7
7635330|NCT03214250|12049490|FG005|Overall Study|Remains on Study|5
7635331|NCT03214250|12049491|FG006|Overall Study|Remains on Study|3
7635332|NCT03214250|12049485|FG000|Overall Study|Withdrawal by Subject|0
7635333|NCT03214250|12049486|FG001|Overall Study|Withdrawal by Subject|0
7635334|NCT03214250|12049487|FG002|Overall Study|Withdrawal by Subject|1
7635335|NCT03214250|12049488|FG003|Overall Study|Withdrawal by Subject|2
7635336|NCT03214250|12049489|FG004|Overall Study|Withdrawal by Subject|5
7635337|NCT03214250|12049490|FG005|Overall Study|Withdrawal by Subject|0
7635338|NCT03214250|12049491|FG006|Overall Study|Withdrawal by Subject|2
7635339|NCT03213938|12049513|FG000|Overall Study|Lost to Follow-up|4
7635340|NCT03213938|12049514|FG001|Overall Study|Lost to Follow-up|3
7635341|NCT03213938|12049513|FG000|Overall Study|Lack of Efficacy|1
7635342|NCT03213938|12049514|FG001|Overall Study|Lack of Efficacy|0
7635343|NCT03213938|12049513|FG000|Overall Study|Decline to participate|5
7635344|NCT03213938|12049514|FG001|Overall Study|Decline to participate|4
7635345|NCT03213938|12049513|FG000|Overall Study|Without reason|4
7635346|NCT03213938|12049514|FG001|Overall Study|Without reason|5
7635347|NCT03208127|12049520|FG000|Overall Study|Death|1
7635348|NCT03207451|12049528|FG000|Overall Study|scheduling conflict|1
7635349|NCT03207451|12049529|FG001|Overall Study|scheduling conflict|0
7635350|NCT03207451|12049530|FG002|Overall Study|scheduling conflict|2
7635351|NCT03207451|12049531|FG003|Overall Study|scheduling conflict|2
7635352|NCT03207451|12049528|FG000|Overall Study|Adverse Event|0
7635353|NCT03207451|12049529|FG001|Overall Study|Adverse Event|0
7635354|NCT03207451|12049530|FG002|Overall Study|Adverse Event|0
7635355|NCT03207451|12049531|FG003|Overall Study|Adverse Event|1
7635356|NCT03201965|12049544|FG000|Overall Study|Death|5
7635357|NCT03201965|12049545|FG001|Overall Study|Death|27
7635358|NCT03201965|12049546|FG002|Overall Study|Death|27
7635359|NCT03201965|12049544|FG000|Overall Study|Lost to Follow-up|0
7635360|NCT03201965|12049545|FG001|Overall Study|Lost to Follow-up|1
7635361|NCT03201965|12049546|FG002|Overall Study|Lost to Follow-up|0
7635362|NCT03201965|12049544|FG000|Overall Study|Withdrawal by Subject|3
7635363|NCT03201965|12049545|FG001|Overall Study|Withdrawal by Subject|13
7635364|NCT03201965|12049546|FG002|Overall Study|Withdrawal by Subject|4
7635365|NCT03201965|12049544|FG000|Overall Study|Ongoing|20
7635366|NCT03201965|12049545|FG001|Overall Study|Ongoing|152
7635367|NCT03201965|12049546|FG002|Overall Study|Ongoing|164
7635368|NCT03201562|12049556|FG000|Overall Study|Physician Decision|0
7635369|NCT03201562|12049557|FG001|Overall Study|Physician Decision|0
7635370|NCT03201562|12049558|FG002|Overall Study|Physician Decision|1
7635371|NCT03201562|12049556|FG000|Overall Study|Adverse Event|0
7635372|NCT03201562|12049557|FG001|Overall Study|Adverse Event|0
7635373|NCT03201562|12049558|FG002|Overall Study|Adverse Event|1
7635374|NCT03201562|12049556|FG000|Overall Study|Lost to Follow-up|0
7635375|NCT03201562|12049557|FG001|Overall Study|Lost to Follow-up|1
7635376|NCT03201562|12049558|FG002|Overall Study|Lost to Follow-up|2
7635377|NCT03197935|12049568|FG000|Overall Study|Death due to any cause|9
7635378|NCT03197935|12049569|FG001|Overall Study|Death due to any cause|7
7635379|NCT03197935|12049568|FG000|Overall Study|Lost to Follow-up|0
7635380|NCT03197935|12049569|FG001|Overall Study|Lost to Follow-up|3
7635381|NCT03197935|12049568|FG000|Overall Study|Physician Decision|0
7635382|NCT03197935|12049569|FG001|Overall Study|Physician Decision|1
7635383|NCT03197935|12049568|FG000|Overall Study|Withdrawal by Subject|11
7635384|NCT03197935|12049569|FG001|Overall Study|Withdrawal by Subject|7
7635385|NCT03197935|12049568|FG000|Overall Study|On-Going in Study|147
7635386|NCT03197935|12049569|FG001|Overall Study|On-Going in Study|146
7635387|NCT03197935|12049568|FG000|Overall Study|Did not receive any study treatment|1
7635388|NCT03197935|12049569|FG001|Overall Study|Did not receive any study treatment|1
7635389|NCT03194646|12049580|FG000|Overall Study|Adverse Event|24
7635390|NCT03194646|12049581|FG001|Overall Study|Adverse Event|25
7635391|NCT03194646|12049582|FG002|Overall Study|Adverse Event|14
7635392|NCT03194646|12049583|FG003|Overall Study|Adverse Event|17
7635393|NCT03194646|12049580|FG000|Overall Study|Lack of Efficacy|4
7635394|NCT03194646|12049581|FG001|Overall Study|Lack of Efficacy|2
7635395|NCT03194646|12049582|FG002|Overall Study|Lack of Efficacy|2
7635396|NCT03194646|12049583|FG003|Overall Study|Lack of Efficacy|12
7635397|NCT03194646|12049580|FG000|Overall Study|Lost to Follow-up|30
7635398|NCT03194646|12049581|FG001|Overall Study|Lost to Follow-up|22
7635399|NCT03194646|12049582|FG002|Overall Study|Lost to Follow-up|12
7635400|NCT03194646|12049583|FG003|Overall Study|Lost to Follow-up|35
7635401|NCT03194646|12049580|FG000|Overall Study|Non-compliance with study drug|4
7635402|NCT03194646|12049581|FG001|Overall Study|Non-compliance with study drug|0
7635403|NCT03194646|12049582|FG002|Overall Study|Non-compliance with study drug|1
7635404|NCT03194646|12049583|FG003|Overall Study|Non-compliance with study drug|1
7635405|NCT03194646|12049580|FG000|Overall Study|Other|87
7635406|NCT03194646|12049581|FG001|Overall Study|Other|67
7635407|NCT03194646|12049582|FG002|Overall Study|Other|34
7635408|NCT03194646|12049583|FG003|Overall Study|Other|31
7635409|NCT03194646|12049580|FG000|Overall Study|Physician Decision|7
7635410|NCT03194646|12049581|FG001|Overall Study|Physician Decision|9
7635411|NCT03194646|12049582|FG002|Overall Study|Physician Decision|5
7635412|NCT03194646|12049583|FG003|Overall Study|Physician Decision|4
7635413|NCT03194646|12049580|FG000|Overall Study|Pregnancy|4
7635414|NCT03194646|12049581|FG001|Overall Study|Pregnancy|5
7635415|NCT03194646|12049582|FG002|Overall Study|Pregnancy|1
7635416|NCT03194646|12049583|FG003|Overall Study|Pregnancy|2
7635417|NCT03194646|12049580|FG000|Overall Study|Protocol Violation|4
7635418|NCT03194646|12049581|FG001|Overall Study|Protocol Violation|2
7635419|NCT03194646|12049582|FG002|Overall Study|Protocol Violation|1
7635420|NCT03194646|12049583|FG003|Overall Study|Protocol Violation|1
7635421|NCT03194646|12049580|FG000|Overall Study|Site terminated by sponsor|0
7635422|NCT03194646|12049581|FG001|Overall Study|Site terminated by sponsor|0
7635423|NCT03194646|12049582|FG002|Overall Study|Site terminated by sponsor|2
7635424|NCT03194646|12049583|FG003|Overall Study|Site terminated by sponsor|0
7635425|NCT03194646|12049580|FG000|Overall Study|Study terminated by sponsor|60
7635426|NCT03194646|12049581|FG001|Overall Study|Study terminated by sponsor|61
7635427|NCT03194646|12049582|FG002|Overall Study|Study terminated by sponsor|30
7635428|NCT03194646|12049583|FG003|Overall Study|Study terminated by sponsor|34
7635429|NCT03194646|12049580|FG000|Overall Study|Withdrawal by Subject|74
7635430|NCT03194646|12049581|FG001|Overall Study|Withdrawal by Subject|75
7635431|NCT03194646|12049582|FG002|Overall Study|Withdrawal by Subject|36
7635432|NCT03194646|12049583|FG003|Overall Study|Withdrawal by Subject|131
7635433|NCT03194646|12049580|FG000|Overall Study|Missing|4
7635434|NCT03194646|12049581|FG001|Overall Study|Missing|0
7635435|NCT03194646|12049582|FG002|Overall Study|Missing|1
7635436|NCT03194646|12049583|FG003|Overall Study|Missing|12
7635437|NCT03185949|12049621|FG000|ITT Analysis|Withdrawal by Subject|4
7635438|NCT03185949|12049622|FG001|ITT Analysis|Withdrawal by Subject|3
7635439|NCT03185949|12049621|FG000|PP Analysis|Protocol Violation|2
7635440|NCT03185949|12049622|FG001|PP Analysis|Protocol Violation|2
7635441|NCT03185949|12049621|FG000|PP Analysis|Failed/Incomplete LGA embolization|0
7635442|NCT03185949|12049622|FG001|PP Analysis|Failed/Incomplete LGA embolization|2
7635443|NCT03182686|12049632|FG000|Overall Study|Lost to Follow-up|2
7635444|NCT03182686|12049633|FG001|Overall Study|Lost to Follow-up|0
7635445|NCT03182686|12049632|FG000|Overall Study|Adverse Event|2
7635446|NCT03182686|12049633|FG001|Overall Study|Adverse Event|0
7635447|NCT03182686|12049632|FG000|Overall Study|Withdrawal by Subject|3
7635448|NCT03182686|12049633|FG001|Overall Study|Withdrawal by Subject|0
7635449|NCT03179202|12049648|FG000|Overall Study|Screen Failure|67
7635450|NCT03179202|12049648|FG000|Overall Study|Subject Lost to Follow Up|12
7635451|NCT03179202|12049648|FG000|Overall Study|Withdrawal by Subject|7
7635452|NCT03179202|12049648|FG000|Overall Study|Adverse Event|3
7635453|NCT03179202|12049648|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1
7635454|NCT03179202|12049648|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1
7635455|NCT03175549|12049656|FG000|Overall Study|Lost to Follow-up|2
7635456|NCT03175549|12049657|FG001|Overall Study|Lost to Follow-up|2
7635457|NCT03175549|12049656|FG000|Overall Study|Medication non-compliance|2
7635458|NCT03175549|12049657|FG001|Overall Study|Medication non-compliance|2
7635459|NCT03170349|12049669|FG000|At 30 Days Follow-up|Death|1
7635460|NCT03170349|12049669|FG000|At 6 Months Follow-up|Death|3
7635461|NCT03170349|12049669|FG000|At 6 Months Follow-up|Withdrawal by Subject|1
7635462|NCT03170349|12049669|FG000|At 6 Months Follow-up|Exited for Other Reasons|5
7635463|NCT03170349|12049669|FG000|At 1 Year Follow-up|Death|6
7635464|NCT03170349|12049669|FG000|At 1 Year Follow-up|Exited for Other Reasons|2
7635465|NCT03167619|12049675|FG000|Overall Study|Death|11
7635466|NCT03167619|12049676|FG001|Overall Study|Death|8
7635467|NCT03167619|12049675|FG000|Overall Study|Withdrawal by Subject|1
7635468|NCT03167619|12049676|FG001|Overall Study|Withdrawal by Subject|2
7635469|NCT03167619|12049675|FG000|Overall Study|Physician Decision|0
7635470|NCT03167619|12049676|FG001|Overall Study|Physician Decision|1
7635471|NCT03164772|12049693|FG000|Overall Study|Death|4
7635472|NCT03164772|12049694|FG001|Overall Study|Death|2
7635473|NCT03164772|12049693|FG000|Overall Study|Adverse Event|1
7635474|NCT03164772|12049694|FG001|Overall Study|Adverse Event|4
7635475|NCT03164772|12049693|FG000|Overall Study|Progressive Disease|11
7635476|NCT03164772|12049694|FG001|Overall Study|Progressive Disease|21
7635477|NCT03164772|12049693|FG000|Overall Study|Physician Decision|2
7635478|NCT03164772|12049694|FG001|Overall Study|Physician Decision|0
7635479|NCT03164772|12049693|FG000|Overall Study|Withdrawal by Subject|0
7635480|NCT03164772|12049694|FG001|Overall Study|Withdrawal by Subject|4
7635490|NCT03163667|12049724|FG000|Overall Study|Death|15
7635491|NCT03163667|12049725|FG001|Overall Study|Death|27
7635492|NCT03163667|12049724|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8
7635493|NCT03163667|12049725|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19
7635494|NCT03162224|12049734|FG000|Overall Study|Death|4
7635495|NCT03162224|12049735|FG001|Overall Study|Death|5
7635496|NCT03162224|12049736|FG002|Overall Study|Death|8
7635497|NCT03162224|12049734|FG000|Overall Study|Withdrawal by Subject|1
7635498|NCT03162224|12049735|FG001|Overall Study|Withdrawal by Subject|0
7635499|NCT03162224|12049736|FG002|Overall Study|Withdrawal by Subject|1
7635500|NCT03162224|12049734|FG000|Overall Study|Lost to Follow-up|0
7635501|NCT03162224|12049735|FG001|Overall Study|Lost to Follow-up|1
7635502|NCT03162224|12049736|FG002|Overall Study|Lost to Follow-up|0
7635503|NCT03162224|12049734|FG000|Overall Study|Other|6
7635504|NCT03162224|12049735|FG001|Overall Study|Other|2
7635505|NCT03162224|12049736|FG002|Overall Study|Other|1
7635506|NCT03160716|12049744|FG000|Overall Study|Lost to Follow-up|1
7635507|NCT03158688|12049750|FG000|Overall Study|Continuing in study|107
7635508|NCT03158688|12049751|FG001|Overall Study|Continuing in study|233
7635509|NCT03158688|12049750|FG000|Overall Study|Death|36
7635510|NCT03158688|12049751|FG001|Overall Study|Death|59
7635511|NCT03158688|12049750|FG000|Overall Study|Withdrawal by Subject|9
7635512|NCT03158688|12049751|FG001|Overall Study|Withdrawal by Subject|14
7635513|NCT03158688|12049750|FG000|Overall Study|Decision by sponsor|2
7635514|NCT03158688|12049751|FG001|Overall Study|Decision by sponsor|3
7635515|NCT03158688|12049750|FG000|Overall Study|Lost to Follow-up|0
7635516|NCT03158688|12049751|FG001|Overall Study|Lost to Follow-up|3
7635517|NCT03153137|12049759|FG000|Overall Study|Lost to Follow-up|1
7635518|NCT03153137|12049760|FG001|Overall Study|Lost to Follow-up|0
7635519|NCT03153137|12049759|FG000|Overall Study|Withdrawal by Subject|2
7635520|NCT03153137|12049760|FG001|Overall Study|Withdrawal by Subject|1
7635521|NCT03153137|12049759|FG000|Overall Study|Physician Decision|0
7635522|NCT03153137|12049760|FG001|Overall Study|Physician Decision|3
7635523|NCT03150056|12049781|FG000|Overall Study|Withdrawal by Subject|0
7635524|NCT03150056|12049782|FG001|Overall Study|Withdrawal by Subject|0
7635525|NCT03150056|12049783|FG002|Overall Study|Withdrawal by Subject|0
7635526|NCT03150056|12049784|FG003|Overall Study|Withdrawal by Subject|0
7635527|NCT03150056|12049785|FG004|Overall Study|Withdrawal by Subject|0
7635528|NCT03150056|12049786|FG005|Overall Study|Withdrawal by Subject|2
7635529|NCT03150056|12049781|FG000|Overall Study|Study terminated by Sponsor|1
7635530|NCT03150056|12049782|FG001|Overall Study|Study terminated by Sponsor|3
7635531|NCT03150056|12049783|FG002|Overall Study|Study terminated by Sponsor|1
7635532|NCT03150056|12049784|FG003|Overall Study|Study terminated by Sponsor|1
7635533|NCT03150056|12049785|FG004|Overall Study|Study terminated by Sponsor|5
7635534|NCT03150056|12049786|FG005|Overall Study|Study terminated by Sponsor|6
7635535|NCT03150056|12049781|FG000|Overall Study|Death|9
7635536|NCT03150056|12049782|FG001|Overall Study|Death|2
7635537|NCT03150056|12049783|FG002|Overall Study|Death|2
7635538|NCT03150056|12049784|FG003|Overall Study|Death|7
7635539|NCT03150056|12049785|FG004|Overall Study|Death|8
7635540|NCT03150056|12049786|FG005|Overall Study|Death|10
7635541|NCT03148795|12049803|FG000|Overall Study|Death|6
7635542|NCT03148795|12049803|FG000|Overall Study|Adverse Event|5
7635543|NCT03148795|12049803|FG000|Overall Study|Other|15
7635544|NCT03148795|12049803|FG000|Overall Study|No Longer Clinically Benefitting|2
7635545|NCT03148795|12049803|FG000|Overall Study|Global Deterioration Of Health Status|6
7635546|NCT03148795|12049803|FG000|Overall Study|Withdrawal by Subject|2
7635547|NCT03148795|12049803|FG000|Overall Study|Progressive Disease|62
7635548|NCT03148795|12049803|FG000|Overall Study|Ongoing|30
7635549|NCT03144674|12049811|FG000|Overall Study|Participants Still Ongoing in the Study|1
7635550|NCT03144674|12049812|FG001|Overall Study|Participants Still Ongoing in the Study|4
7635551|NCT03144674|12049813|FG002|Overall Study|Participants Still Ongoing in the Study|24
7635552|NCT03144674|12049814|FG003|Overall Study|Participants Still Ongoing in the Study|54
7635553|NCT03144674|12049811|FG000|Overall Study|Death|3
7635554|NCT03144674|12049812|FG001|Overall Study|Death|1
7635555|NCT03144674|12049813|FG002|Overall Study|Death|1
7635556|NCT03144674|12049814|FG003|Overall Study|Death|10
7635557|NCT03144674|12049811|FG000|Overall Study|Lost to Follow-up|0
7635558|NCT03144674|12049812|FG001|Overall Study|Lost to Follow-up|1
7635559|NCT03144674|12049813|FG002|Overall Study|Lost to Follow-up|1
7635560|NCT03144674|12049814|FG003|Overall Study|Lost to Follow-up|1
7635561|NCT03144674|12049811|FG000|Overall Study|Withdrawal by Participant|0
7635562|NCT03144674|12049812|FG001|Overall Study|Withdrawal by Participant|0
7635563|NCT03144674|12049813|FG002|Overall Study|Withdrawal by Participant|0
7635564|NCT03144674|12049814|FG003|Overall Study|Withdrawal by Participant|3
7635565|NCT03144674|12049811|FG000|Overall Study|Reason not Specified|0
7635566|NCT03144674|12049812|FG001|Overall Study|Reason not Specified|0
7635567|NCT03144674|12049813|FG002|Overall Study|Reason not Specified|2
7635568|NCT03144674|12049814|FG003|Overall Study|Reason not Specified|4
7635569|NCT03141177|12049832|FG000|Overall Study|Death|62
7635570|NCT03141177|12049833|FG001|Overall Study|Death|13
7635571|NCT03141177|12049834|FG002|Overall Study|Death|84
7635572|NCT03141177|12049832|FG000|Overall Study|Participant withdrew consent|9
7635573|NCT03141177|12049833|FG001|Overall Study|Participant withdrew consent|2
7635574|NCT03141177|12049834|FG002|Overall Study|Participant withdrew consent|13
7635575|NCT03141177|12049832|FG000|Overall Study|Not reported|1
7635576|NCT03141177|12049833|FG001|Overall Study|Not reported|0
7635577|NCT03141177|12049834|FG002|Overall Study|Not reported|1
7635578|NCT03141177|12049832|FG000|Overall Study|Lost to Follow-up|2
7635579|NCT03141177|12049833|FG001|Overall Study|Lost to Follow-up|1
7635580|NCT03141177|12049834|FG002|Overall Study|Lost to Follow-up|1
7635581|NCT03141177|12049832|FG000|Overall Study|Other reasons|4
7635582|NCT03141177|12049833|FG001|Overall Study|Other reasons|0
7635583|NCT03141177|12049834|FG002|Overall Study|Other reasons|11
7635584|NCT03141177|12049832|FG000|Overall Study|Participants did not start treatment period|3
7635585|NCT03141177|12049833|FG001|Overall Study|Participants did not start treatment period|0
7635586|NCT03141177|12049834|FG002|Overall Study|Participants did not start treatment period|8
7635587|NCT03132805|12049846|FG000|Overall Study|Lost to Follow-up|142
7635588|NCT03132805|12049847|FG001|Overall Study|Lost to Follow-up|141
7635589|NCT03132805|12049848|FG002|Overall Study|Lost to Follow-up|113
7635590|NCT03132467|12049856|FG000|Overall Study|Adverse Event|2
7635591|NCT03132467|12049856|FG000|Overall Study|Withdrawal by Subject|2
7635592|NCT03131219|12049863|FG000|Initial Evaluation Period|Adverse Event|1
7635593|NCT03131219|12049864|FG001|Initial Evaluation Period|Adverse Event|0
7635594|NCT03131219|12049863|FG000|Initial Evaluation Period|Protocol Violation|1
7635595|NCT03131219|12049864|FG001|Initial Evaluation Period|Protocol Violation|0
7635596|NCT03131219|12049863|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2
7635597|NCT03131219|12049864|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0
7635598|NCT03130959|12049880|FG000|Overall Study|Disease progression|19
7635599|NCT03130959|12049881|FG001|Overall Study|Disease progression|7
7635600|NCT03130959|12049882|FG002|Overall Study|Disease progression|12
7635601|NCT03130959|12049883|FG003|Overall Study|Disease progression|7
7635602|NCT03130959|12049884|FG004|Overall Study|Disease progression|12
7635603|NCT03130959|12049885|FG005|Overall Study|Disease progression|3
7635604|NCT03130959|12049886|FG006|Overall Study|Disease progression|6
7635605|NCT03130959|12049887|FG007|Overall Study|Disease progression|3
7635606|NCT03130959|12049888|FG008|Overall Study|Disease progression|15
7635607|NCT03130959|12049889|FG009|Overall Study|Disease progression|8
7635608|NCT03130959|12049880|FG000|Overall Study|Study drug toxicity|2
7635609|NCT03130959|12049881|FG001|Overall Study|Study drug toxicity|2
7635610|NCT03130959|12049882|FG002|Overall Study|Study drug toxicity|1
7635611|NCT03130959|12049883|FG003|Overall Study|Study drug toxicity|2
7635612|NCT03130959|12049884|FG004|Overall Study|Study drug toxicity|1
7635613|NCT03130959|12049885|FG005|Overall Study|Study drug toxicity|1
7635614|NCT03130959|12049886|FG006|Overall Study|Study drug toxicity|3
7635615|NCT03130959|12049887|FG007|Overall Study|Study drug toxicity|0
7635616|NCT03130959|12049888|FG008|Overall Study|Study drug toxicity|3
7635617|NCT03130959|12049889|FG009|Overall Study|Study drug toxicity|3
7635618|NCT03130959|12049880|FG000|Overall Study|Other reasons|0
7635619|NCT03130959|12049881|FG001|Overall Study|Other reasons|0
7635620|NCT03130959|12049882|FG002|Overall Study|Other reasons|0
7635621|NCT03130959|12049883|FG003|Overall Study|Other reasons|0
7635622|NCT03130959|12049884|FG004|Overall Study|Other reasons|0
7635623|NCT03130959|12049885|FG005|Overall Study|Other reasons|1
7635624|NCT03130959|12049886|FG006|Overall Study|Other reasons|1
7635625|NCT03130959|12049887|FG007|Overall Study|Other reasons|0
7635626|NCT03130959|12049888|FG008|Overall Study|Other reasons|0
7635627|NCT03130959|12049889|FG009|Overall Study|Other reasons|0
7635628|NCT03130959|12049880|FG000|Overall Study|Subject request to discontinue therapy|0
7635629|NCT03130959|12049881|FG001|Overall Study|Subject request to discontinue therapy|0
7635630|NCT03130959|12049882|FG002|Overall Study|Subject request to discontinue therapy|1
7635631|NCT03130959|12049883|FG003|Overall Study|Subject request to discontinue therapy|1
7635632|NCT03130959|12049884|FG004|Overall Study|Subject request to discontinue therapy|0
7635633|NCT03130959|12049885|FG005|Overall Study|Subject request to discontinue therapy|0
7635634|NCT03130959|12049886|FG006|Overall Study|Subject request to discontinue therapy|1
7635635|NCT03130959|12049887|FG007|Overall Study|Subject request to discontinue therapy|1
7635636|NCT03130959|12049888|FG008|Overall Study|Subject request to discontinue therapy|0
7635637|NCT03130959|12049889|FG009|Overall Study|Subject request to discontinue therapy|0
7635638|NCT03130959|12049880|FG000|Overall Study|Not reported|0
7635639|NCT03130959|12049881|FG001|Overall Study|Not reported|0
7635640|NCT03130959|12049882|FG002|Overall Study|Not reported|0
7635641|NCT03130959|12049883|FG003|Overall Study|Not reported|1
7635642|NCT03130959|12049884|FG004|Overall Study|Not reported|0
7635643|NCT03130959|12049885|FG005|Overall Study|Not reported|1
7635644|NCT03130959|12049886|FG006|Overall Study|Not reported|0
7635645|NCT03130959|12049887|FG007|Overall Study|Not reported|0
7635646|NCT03130959|12049888|FG008|Overall Study|Not reported|0
7635647|NCT03130959|12049889|FG009|Overall Study|Not reported|1
7635648|NCT03130959|12049880|FG000|Overall Study|Adverse Event unrelated to drug|0
7635649|NCT03130959|12049881|FG001|Overall Study|Adverse Event unrelated to drug|0
7635650|NCT03130959|12049882|FG002|Overall Study|Adverse Event unrelated to drug|1
7635651|NCT03130959|12049883|FG003|Overall Study|Adverse Event unrelated to drug|1
7635652|NCT03130959|12049884|FG004|Overall Study|Adverse Event unrelated to drug|1
7635653|NCT03130959|12049885|FG005|Overall Study|Adverse Event unrelated to drug|0
7635654|NCT03130959|12049886|FG006|Overall Study|Adverse Event unrelated to drug|1
7635655|NCT03130959|12049887|FG007|Overall Study|Adverse Event unrelated to drug|0
7635656|NCT03130959|12049888|FG008|Overall Study|Adverse Event unrelated to drug|1
7635657|NCT03130959|12049889|FG009|Overall Study|Adverse Event unrelated to drug|1
7635658|NCT03130959|12049880|FG000|Overall Study|Participant withdrew consent|0
7635659|NCT03130959|12049881|FG001|Overall Study|Participant withdrew consent|1
7635660|NCT03130959|12049882|FG002|Overall Study|Participant withdrew consent|0
7635661|NCT03130959|12049883|FG003|Overall Study|Participant withdrew consent|2
7635662|NCT03130959|12049884|FG004|Overall Study|Participant withdrew consent|1
7635663|NCT03130959|12049885|FG005|Overall Study|Participant withdrew consent|0
7635664|NCT03130959|12049886|FG006|Overall Study|Participant withdrew consent|0
7635665|NCT03130959|12049887|FG007|Overall Study|Participant withdrew consent|0
7635666|NCT03130959|12049888|FG008|Overall Study|Participant withdrew consent|0
7635667|NCT03130959|12049889|FG009|Overall Study|Participant withdrew consent|2
7635668|NCT03130959|12049880|FG000|Overall Study|Administrative reason by sponsor|1
7635669|NCT03130959|12049881|FG001|Overall Study|Administrative reason by sponsor|0
7635670|NCT03130959|12049882|FG002|Overall Study|Administrative reason by sponsor|1
7635671|NCT03130959|12049883|FG003|Overall Study|Administrative reason by sponsor|0
7635672|NCT03130959|12049884|FG004|Overall Study|Administrative reason by sponsor|0
7635673|NCT03130959|12049885|FG005|Overall Study|Administrative reason by sponsor|0
7635674|NCT03130959|12049886|FG006|Overall Study|Administrative reason by sponsor|0
7635675|NCT03130959|12049887|FG007|Overall Study|Administrative reason by sponsor|0
7635676|NCT03130959|12049888|FG008|Overall Study|Administrative reason by sponsor|0
7635677|NCT03130959|12049889|FG009|Overall Study|Administrative reason by sponsor|0
7635678|NCT03130959|12049880|FG000|Overall Study|Lost to Follow-up|1
7635679|NCT03130959|12049881|FG001|Overall Study|Lost to Follow-up|0
7635680|NCT03130959|12049882|FG002|Overall Study|Lost to Follow-up|0
7635681|NCT03130959|12049883|FG003|Overall Study|Lost to Follow-up|0
7635682|NCT03130959|12049884|FG004|Overall Study|Lost to Follow-up|0
7635683|NCT03130959|12049885|FG005|Overall Study|Lost to Follow-up|0
7635684|NCT03130959|12049886|FG006|Overall Study|Lost to Follow-up|0
7635685|NCT03130959|12049887|FG007|Overall Study|Lost to Follow-up|0
7635686|NCT03130959|12049888|FG008|Overall Study|Lost to Follow-up|0
7635687|NCT03130959|12049889|FG009|Overall Study|Lost to Follow-up|0
7635688|NCT03127384|12049932|FG000|Overall Study|Lost to Follow-up|4
7635689|NCT03127384|12049932|FG000|Overall Study|Subject request|2
7635690|NCT03125902|12049940|FG000|Overall Study|Death|52
7635691|NCT03125902|12049941|FG001|Overall Study|Death|123
7635692|NCT03125902|12049940|FG000|Overall Study|Lost to Follow-up|1
7635693|NCT03125902|12049941|FG001|Overall Study|Lost to Follow-up|0
7635694|NCT03125902|12049940|FG000|Overall Study|Mastectomy|0
7635695|NCT03125902|12049941|FG001|Overall Study|Mastectomy|1
7635696|NCT03125902|12049940|FG000|Overall Study|Physician Decision|1
7635697|NCT03125902|12049941|FG001|Overall Study|Physician Decision|0
7635698|NCT03125902|12049940|FG000|Overall Study|Withdrawal by Subject|13
7635699|NCT03125902|12049941|FG001|Overall Study|Withdrawal by Subject|25
7635700|NCT03125902|12049940|FG000|Overall Study|Study is ongoing|153
7635701|NCT03125902|12049941|FG001|Overall Study|Study is ongoing|282
7635702|NCT03124459|12049954|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0
7635703|NCT03124459|12049955|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0
7635704|NCT03124459|12049956|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0
7635705|NCT03124459|12049957|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0
7635706|NCT03124459|12049958|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2
7635707|NCT03124459|12049959|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0
7635708|NCT03124459|12049954|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7635709|NCT03124459|12049955|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7635710|NCT03124459|12049956|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7635711|NCT03124459|12049957|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7635712|NCT03124459|12049958|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1
7635713|NCT03124459|12049959|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7635714|NCT03124459|12049954|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7635715|NCT03124459|12049955|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7635716|NCT03124459|12049956|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7635717|NCT03124459|12049957|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11
7635718|NCT03124459|12049958|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12
7635719|NCT03124459|12049959|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7635720|NCT03124459|12049954|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7635721|NCT03124459|12049955|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7635722|NCT03124459|12049956|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7635723|NCT03124459|12049957|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1
7635724|NCT03124459|12049958|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4
7635725|NCT03124459|12049959|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7635726|NCT03124459|12049954|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7635727|NCT03124459|12049955|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7635728|NCT03124459|12049956|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7635729|NCT03124459|12049957|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7635730|NCT03124459|12049958|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7635731|NCT03124459|12049959|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22
7635732|NCT03124459|12049954|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7635733|NCT03124459|12049955|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7635734|NCT03124459|12049956|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7635735|NCT03124459|12049957|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7635736|NCT03124459|12049958|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7635737|NCT03124459|12049959|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1
7635738|NCT03106779|12050009|FG000|Overall Study|Lack of Efficacy|33
7635739|NCT03106779|12050010|FG001|Overall Study|Lack of Efficacy|24
7635740|NCT03106779|12050009|FG000|Overall Study|Adverse Event|8
7635741|NCT03106779|12050010|FG001|Overall Study|Adverse Event|16
7635742|NCT03106779|12050009|FG000|Overall Study|Physician Decision|10
7635743|NCT03106779|12050010|FG001|Overall Study|Physician Decision|6
7635744|NCT03106779|12050009|FG000|Overall Study|Patient/guardian decision|4
7635745|NCT03106779|12050010|FG001|Overall Study|Patient/guardian decision|3
7635746|NCT03106779|12050009|FG000|Overall Study|Progressive disease|1
7635747|NCT03106779|12050010|FG001|Overall Study|Progressive disease|3
7635748|NCT03106779|12050009|FG000|Overall Study|Lost to Follow-up|1
7635749|NCT03106779|12050010|FG001|Overall Study|Lost to Follow-up|2
7635750|NCT03106779|12050009|FG000|Overall Study|Death|1
7635751|NCT03106779|12050010|FG001|Overall Study|Death|0
7635752|NCT03106779|12050009|FG000|Overall Study|Protocol Violation|1
7635753|NCT03106779|12050010|FG001|Overall Study|Protocol Violation|0
7635754|NCT03106779|12050009|FG000|Overall Study|Not treated|1
7635755|NCT03106779|12050010|FG001|Overall Study|Not treated|0
7635756|NCT03101930|12050023|FG000|Overall Study|Withdrawal by Subject|2
7635757|NCT03101930|12050024|FG001|Overall Study|Withdrawal by Subject|1
7635758|NCT03101930|12050025|FG002|Overall Study|Withdrawal by Subject|2
7635759|NCT03100149|12050036|FG000|Overall Study|Adverse Event|0
7635760|NCT03100149|12050037|FG001|Overall Study|Adverse Event|1
7635761|NCT03100149|12050038|FG002|Overall Study|Adverse Event|0
7635762|NCT03100149|12050036|FG000|Overall Study|Participant Moved out of Country|0
7635763|NCT03100149|12050037|FG001|Overall Study|Participant Moved out of Country|0
7635764|NCT03100149|12050038|FG002|Overall Study|Participant Moved out of Country|1
7635765|NCT03100149|12050036|FG000|Overall Study|Withdrawal by Subject|0
7635766|NCT03100149|12050037|FG001|Overall Study|Withdrawal by Subject|3
7635767|NCT03100149|12050038|FG002|Overall Study|Withdrawal by Subject|1
7635768|NCT03095118|12050055|FG000|Overall Study|Adverse Event|1
7635769|NCT03095118|12050055|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1
7635780|NCT03091192|12050080|FG000|Overall Study|Study terminated by sponsor|21
7635781|NCT03091192|12050081|FG001|Overall Study|Study terminated by sponsor|14
7635782|NCT03091192|12050080|FG000|Overall Study|Death|9
7635783|NCT03091192|12050081|FG001|Overall Study|Death|13
7635784|NCT03091192|12050080|FG000|Overall Study|Withdrawal by Subject|2
7635785|NCT03091192|12050081|FG001|Overall Study|Withdrawal by Subject|0
7635786|NCT03091192|12050080|FG000|Overall Study|Lost to Follow-up|1
7635787|NCT03091192|12050081|FG001|Overall Study|Lost to Follow-up|0
7635788|NCT03090152|12050090|FG000|Overall Study|Withdrawal by Subject|0
7635789|NCT03090152|12050091|FG001|Overall Study|Withdrawal by Subject|2
7635790|NCT03090152|12050092|FG002|Overall Study|Withdrawal by Subject|1
7635791|NCT03090152|12050090|FG000|Overall Study|Surgery Canceled|1
7635792|NCT03090152|12050091|FG001|Overall Study|Surgery Canceled|0
7635793|NCT03090152|12050092|FG002|Overall Study|Surgery Canceled|0
7635794|NCT03090152|12050090|FG000|Overall Study|Epidural catheter could not be placed|0
7635795|NCT03090152|12050091|FG001|Overall Study|Epidural catheter could not be placed|2
7635796|NCT03090152|12050092|FG002|Overall Study|Epidural catheter could not be placed|0
7635797|NCT03087058|12050125|FG000|Overall Study|Withdrawal by Subject|2
7635798|NCT03087058|12050126|FG001|Overall Study|Withdrawal by Subject|0
7635799|NCT03087058|12050127|FG002|Overall Study|Withdrawal by Subject|0
7635800|NCT03085914|12050150|FG000|Overall Study|Death|6
7635801|NCT03085914|12050151|FG001|Overall Study|Death|6
7635802|NCT03085914|12050152|FG002|Overall Study|Death|4
7635803|NCT03085914|12050153|FG003|Overall Study|Death|1
7635804|NCT03085914|12050154|FG004|Overall Study|Death|5
7635805|NCT03085914|12050155|FG005|Overall Study|Death|2
7635806|NCT03085914|12050156|FG006|Overall Study|Death|2
7635807|NCT03085914|12050150|FG000|Overall Study|Withdrawal by Subject|1
7635808|NCT03085914|12050151|FG001|Overall Study|Withdrawal by Subject|1
7635809|NCT03085914|12050152|FG002|Overall Study|Withdrawal by Subject|2
7635810|NCT03085914|12050153|FG003|Overall Study|Withdrawal by Subject|2
7635811|NCT03085914|12050154|FG004|Overall Study|Withdrawal by Subject|2
7635812|NCT03085914|12050155|FG005|Overall Study|Withdrawal by Subject|0
7635813|NCT03085914|12050156|FG006|Overall Study|Withdrawal by Subject|1
7635814|NCT03085914|12050150|FG000|Overall Study|Lost to Follow-up|0
7635815|NCT03085914|12050151|FG001|Overall Study|Lost to Follow-up|0
7635816|NCT03085914|12050152|FG002|Overall Study|Lost to Follow-up|1
7635817|NCT03085914|12050153|FG003|Overall Study|Lost to Follow-up|0
7635818|NCT03085914|12050154|FG004|Overall Study|Lost to Follow-up|0
7635819|NCT03085914|12050155|FG005|Overall Study|Lost to Follow-up|1
7635820|NCT03085914|12050156|FG006|Overall Study|Lost to Follow-up|1
7635821|NCT03085914|12050150|FG000|Overall Study|Reason was not specified,|2
7635822|NCT03085914|12050151|FG001|Overall Study|Reason was not specified,|2
7635823|NCT03085914|12050152|FG002|Overall Study|Reason was not specified,|2
7635824|NCT03085914|12050153|FG003|Overall Study|Reason was not specified,|3
7635825|NCT03085914|12050154|FG004|Overall Study|Reason was not specified,|3
7635826|NCT03085914|12050155|FG005|Overall Study|Reason was not specified,|3
7635827|NCT03085914|12050156|FG006|Overall Study|Reason was not specified,|6
7635828|NCT03085914|12050150|FG000|Overall Study|Progressive Disease|0
7635829|NCT03085914|12050151|FG001|Overall Study|Progressive Disease|0
7635830|NCT03085914|12050152|FG002|Overall Study|Progressive Disease|2
7635831|NCT03085914|12050153|FG003|Overall Study|Progressive Disease|2
7635832|NCT03085914|12050154|FG004|Overall Study|Progressive Disease|1
7635833|NCT03085914|12050155|FG005|Overall Study|Progressive Disease|1
7635834|NCT03085914|12050156|FG006|Overall Study|Progressive Disease|1
7635835|NCT03085914|12050150|FG000|Overall Study|Study Terminated by the Sponsor|0
7635836|NCT03085914|12050151|FG001|Overall Study|Study Terminated by the Sponsor|0
7635837|NCT03085914|12050152|FG002|Overall Study|Study Terminated by the Sponsor|0
7635838|NCT03085914|12050153|FG003|Overall Study|Study Terminated by the Sponsor|1
7635839|NCT03085914|12050154|FG004|Overall Study|Study Terminated by the Sponsor|2
7635840|NCT03085914|12050155|FG005|Overall Study|Study Terminated by the Sponsor|1
7635841|NCT03085914|12050156|FG006|Overall Study|Study Terminated by the Sponsor|0
7635842|NCT03084471|12050173|FG000|Overall Study|Development of study specific discontinuation criteria|2
7635843|NCT03084471|12050173|FG000|Overall Study|Condition under investigation worsened|84
7635844|NCT03084471|12050173|FG000|Overall Study|Lack of therapeutic response|2
7635845|NCT03084471|12050173|FG000|Overall Study|Protocol Violation|1
7635846|NCT03084471|12050173|FG000|Overall Study|Adverse Event|73
7635847|NCT03084471|12050173|FG000|Overall Study|Withdrawal by Subject|12
7635848|NCT03084471|12050173|FG000|Overall Study|Disease relapse|181
7635849|NCT03084471|12050173|FG000|Overall Study|Subjective disease progression|359
7635850|NCT03084471|12050173|FG000|Overall Study|Other (as recorded)|33
7635851|NCT03084471|12050173|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120
7635852|NCT03082677|12050180|FG000|Overall Study|Not Treated|2
7635853|NCT03078582|12050195|FG000|Overall Study|Adverse Event|0
7635854|NCT03078582|12050196|FG001|Overall Study|Adverse Event|8
7635855|NCT03075527|12050202|FG000|Overall Study|Ongoing treatment|2
7635856|NCT03064126|12050226|FG000|Overall Study|Death|6
7635857|NCT03064126|12050227|FG001|Overall Study|Death|2
7635858|NCT03064126|12050228|FG002|Overall Study|Death|2
7635859|NCT03064126|12050229|FG003|Overall Study|Death|1
7635860|NCT03064126|12050226|FG000|Overall Study|Investigator Discretion|1
7635861|NCT03064126|12050227|FG001|Overall Study|Investigator Discretion|0
7635862|NCT03064126|12050228|FG002|Overall Study|Investigator Discretion|0
7635863|NCT03064126|12050229|FG003|Overall Study|Investigator Discretion|0
7635864|NCT03064126|12050226|FG000|Overall Study|Withdrawal by Subject|7
7635865|NCT03064126|12050227|FG001|Overall Study|Withdrawal by Subject|4
7635866|NCT03064126|12050228|FG002|Overall Study|Withdrawal by Subject|0
7635867|NCT03064126|12050229|FG003|Overall Study|Withdrawal by Subject|0
7635868|NCT03064126|12050226|FG000|Overall Study|Subject moved|1
7635869|NCT03064126|12050227|FG001|Overall Study|Subject moved|0
7635870|NCT03064126|12050228|FG002|Overall Study|Subject moved|0
7635871|NCT03064126|12050229|FG003|Overall Study|Subject moved|0
7635872|NCT03064126|12050226|FG000|Overall Study|Protocol Violation|11
7635873|NCT03064126|12050227|FG001|Overall Study|Protocol Violation|1
7635874|NCT03064126|12050228|FG002|Overall Study|Protocol Violation|1
7635875|NCT03064126|12050229|FG003|Overall Study|Protocol Violation|0
7635876|NCT03063632|12050242|FG000|Overall Study|Death|3
7635877|NCT03063632|12050243|FG001|Overall Study|Death|6
7635878|NCT03063632|12050242|FG000|Overall Study|Lost to Follow-up|0
7635879|NCT03063632|12050243|FG001|Overall Study|Lost to Follow-up|1
7635880|NCT03063632|12050242|FG000|Overall Study|Withdrawal by Subject|0
7635881|NCT03063632|12050243|FG001|Overall Study|Withdrawal by Subject|2
7635882|NCT03063632|12050242|FG000|Overall Study|Physician Decision|2
7635883|NCT03063632|12050243|FG001|Overall Study|Physician Decision|0
7635884|NCT03063632|12050242|FG000|Overall Study|Other: Disease progression; starting another treatment|2
7635885|NCT03063632|12050243|FG001|Overall Study|Other: Disease progression; starting another treatment|1
7635886|NCT03057600|12050262|FG000|Overall Study|Adverse Event|0
7635887|NCT03057600|12050263|FG001|Overall Study|Adverse Event|0
7635888|NCT03057600|12050264|FG002|Overall Study|Adverse Event|4
7635889|NCT03057600|12050265|FG003|Overall Study|Adverse Event|0
7635890|NCT03057600|12050262|FG000|Overall Study|Radiologic Disease Progression|8
7635891|NCT03057600|12050263|FG001|Overall Study|Radiologic Disease Progression|7
7635892|NCT03057600|12050264|FG002|Overall Study|Radiologic Disease Progression|13
7635893|NCT03057600|12050265|FG003|Overall Study|Radiologic Disease Progression|10
7635894|NCT03057600|12050262|FG000|Overall Study|Symptomatic Deterioration|0
7635895|NCT03057600|12050263|FG001|Overall Study|Symptomatic Deterioration|1
7635896|NCT03057600|12050264|FG002|Overall Study|Symptomatic Deterioration|1
7635897|NCT03057600|12050265|FG003|Overall Study|Symptomatic Deterioration|0
7635898|NCT03057600|12050262|FG000|Overall Study|Investigator Decision|0
7635899|NCT03057600|12050263|FG001|Overall Study|Investigator Decision|0
7635900|NCT03057600|12050264|FG002|Overall Study|Investigator Decision|1
7635901|NCT03057600|12050265|FG003|Overall Study|Investigator Decision|0
7635902|NCT03057600|12050262|FG000|Overall Study|Study Termination by Sponsor|0
7635903|NCT03057600|12050263|FG001|Overall Study|Study Termination by Sponsor|0
7635904|NCT03057600|12050264|FG002|Overall Study|Study Termination by Sponsor|0
7635905|NCT03057600|12050265|FG003|Overall Study|Study Termination by Sponsor|2
7635906|NCT03057600|12050262|FG000|Overall Study|Withdrawal by Subject|0
7635907|NCT03057600|12050263|FG001|Overall Study|Withdrawal by Subject|1
7635908|NCT03057600|12050264|FG002|Overall Study|Withdrawal by Subject|0
7635909|NCT03057600|12050265|FG003|Overall Study|Withdrawal by Subject|0
7635910|NCT03057600|12050262|FG000|Overall Study|Other, Not Specified|1
7635911|NCT03057600|12050263|FG001|Overall Study|Other, Not Specified|1
7635912|NCT03057600|12050264|FG002|Overall Study|Other, Not Specified|1
7635913|NCT03057600|12050265|FG003|Overall Study|Other, Not Specified|1
7635914|NCT03055858|12050276|FG000|Overall Study|Death|5
7635915|NCT03055858|12050276|FG000|Overall Study|Adverse Event|1
7635916|NCT03043872|12050283|FG000|Overall Study|Withdrawal by Subject|6
7635917|NCT03043872|12050284|FG001|Overall Study|Withdrawal by Subject|6
7635918|NCT03043872|12050285|FG002|Overall Study|Withdrawal by Subject|15
7635919|NCT03043872|12050283|FG000|Overall Study|Lost to Follow-up|2
7635920|NCT03043872|12050284|FG001|Overall Study|Lost to Follow-up|1
7635921|NCT03043872|12050285|FG002|Overall Study|Lost to Follow-up|1
7635922|NCT03043872|12050283|FG000|Overall Study|Death|270
7635923|NCT03043872|12050284|FG001|Overall Study|Death|269
7635924|NCT03043872|12050285|FG002|Overall Study|Death|296
7635925|NCT03043664|12050303|FG000|Overall Study|Lost to Follow-up|1
7635926|NCT03043664|12050303|FG000|Overall Study|In Observation for Overall Survival|6
7635927|NCT03041467|12050313|FG000|Overall Study|Death|36
7635928|NCT03041467|12050314|FG001|Overall Study|Death|32
7635929|NCT03041467|12050313|FG000|Overall Study|Withdrawal by Subject|26
7635930|NCT03041467|12050314|FG001|Overall Study|Withdrawal by Subject|28
7635931|NCT03041467|12050313|FG000|Overall Study|Lost to Follow-up|6
7635932|NCT03041467|12050314|FG001|Overall Study|Lost to Follow-up|7
7635933|NCT03041467|12050313|FG000|Overall Study|Declined consent for study extension|21
7635934|NCT03041467|12050314|FG001|Overall Study|Declined consent for study extension|33
7635935|NCT03041467|12050313|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4
7635936|NCT03041467|12050314|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2
7635937|NCT03041467|12050313|FG000|Overall Study|36 Month visit not completed|2
7635938|NCT03041467|12050314|FG001|Overall Study|36 Month visit not completed|0
7635939|NCT03035227|12050349|FG000|Overall Study|study stopped due to PI leaving institut|1
7635940|NCT03035227|12050350|FG001|Overall Study|study stopped due to PI leaving institut|1
7635941|NCT03032198|12050358|FG000|Overall Study|Screen Fail|1
7635942|NCT03031847|12050366|FG000|Overall Study|Death|1
7635943|NCT03031847|12050367|FG001|Overall Study|Death|1
7635944|NCT03031847|12050368|FG002|Overall Study|Death|2
7635945|NCT03031847|12050369|FG003|Overall Study|Death|3
7635946|NCT03031847|12050366|FG000|Overall Study|Lost to Follow-up|1
7635947|NCT03031847|12050367|FG001|Overall Study|Lost to Follow-up|1
7635948|NCT03031847|12050368|FG002|Overall Study|Lost to Follow-up|2
7635949|NCT03031847|12050369|FG003|Overall Study|Lost to Follow-up|3
7635950|NCT03031782|12050379|FG000|Treatment Period 1|Lack of Efficacy|3
7635951|NCT03031782|12050380|FG001|Treatment Period 1|Lack of Efficacy|0
7635952|NCT03031782|12050381|FG002|Treatment Period 1|Lack of Efficacy|0
7635953|NCT03031782|12050382|FG003|Treatment Period 1|Lack of Efficacy|0
7635954|NCT03031782|12050383|FG004|Treatment Period 1|Lack of Efficacy|0
7635955|NCT03031782|12050379|FG000|Treatment Period 2|Physician Decision|0
7635956|NCT03031782|12050380|FG001|Treatment Period 2|Physician Decision|1
7635957|NCT03031782|12050381|FG002|Treatment Period 2|Physician Decision|0
7635958|NCT03031782|12050382|FG003|Treatment Period 2|Physician Decision|0
7635959|NCT03031782|12050383|FG004|Treatment Period 2|Physician Decision|3
7635960|NCT03031782|12050379|FG000|Treatment Period 2|Lack of Efficacy|0
7635961|NCT03031782|12050380|FG001|Treatment Period 2|Lack of Efficacy|1
7635962|NCT03031782|12050381|FG002|Treatment Period 2|Lack of Efficacy|0
7635963|NCT03031782|12050382|FG003|Treatment Period 2|Lack of Efficacy|0
7635964|NCT03031782|12050383|FG004|Treatment Period 2|Lack of Efficacy|1
7635965|NCT03031782|12050379|FG000|Treatment Period 2|Withdrawal by Subject|0
7635966|NCT03031782|12050380|FG001|Treatment Period 2|Withdrawal by Subject|3
7635967|NCT03031782|12050381|FG002|Treatment Period 2|Withdrawal by Subject|0
7635968|NCT03031782|12050382|FG003|Treatment Period 2|Withdrawal by Subject|0
7635969|NCT03031782|12050383|FG004|Treatment Period 2|Withdrawal by Subject|1
7635970|NCT03031782|12050379|FG000|Treatment Period 2|Adverse Event|0
7635971|NCT03031782|12050380|FG001|Treatment Period 2|Adverse Event|1
7635972|NCT03031782|12050381|FG002|Treatment Period 2|Adverse Event|2
7635973|NCT03031782|12050382|FG003|Treatment Period 2|Adverse Event|0
7635974|NCT03031782|12050383|FG004|Treatment Period 2|Adverse Event|0
7635975|NCT03031782|12050379|FG000|Treatment Period 3|Withdrawal by Subject|0
7635976|NCT03031782|12050380|FG001|Treatment Period 3|Withdrawal by Subject|0
7635977|NCT03031782|12050381|FG002|Treatment Period 3|Withdrawal by Subject|0
7635978|NCT03031782|12050382|FG003|Treatment Period 3|Withdrawal by Subject|1
7635979|NCT03031782|12050383|FG004|Treatment Period 3|Withdrawal by Subject|0
7635980|NCT03025828|12050401|FG000|Overall Study|Lost to Follow-up|1
7635981|NCT03025542|12050407|FG000|Overall Study|Adverse Event|0
7635982|NCT03025542|12050408|FG001|Overall Study|Adverse Event|2
7635983|NCT03025542|12050407|FG000|Overall Study|Lost to Follow-up|1
7635984|NCT03025542|12050408|FG001|Overall Study|Lost to Follow-up|0
7635985|NCT03025542|12050407|FG000|Overall Study|Withdrawal by Subject|1
7635986|NCT03025542|12050408|FG001|Overall Study|Withdrawal by Subject|0
7635987|NCT03022578|12050418|FG000|Overall Study|Adverse Event|1
7635988|NCT03022578|12050418|FG000|Overall Study|Lack of Efficacy|2
7635989|NCT03022578|12050418|FG000|Overall Study|Withdrawal by Subject|1
7635990|NCT03021642|12050422|FG000|Washout Period (21 Days)|Adverse Event|1
7635991|NCT03021642|12050423|FG001|Washout Period (21 Days)|Adverse Event|1
7635992|NCT03021486|12050432|FG000|Overall Study|Withdrawal by Subject|1
7635993|NCT03021486|12050433|FG001|Overall Study|Withdrawal by Subject|1
7635994|NCT03021486|12050434|FG002|Overall Study|Withdrawal by Subject|3
7635995|NCT03021486|12050432|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7
7635996|NCT03021486|12050433|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5
7635997|NCT03021486|12050434|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6
7635998|NCT03020160|12050445|FG000|Overall Study|Continuing to receive emicizumab|7
7635999|NCT03020160|12050446|FG001|Overall Study|Continuing to receive emicizumab|41
7636000|NCT03016312|12050470|FG000|Overall Study|Death|194
7636001|NCT03016312|12050471|FG001|Overall Study|Death|164
7636002|NCT03016312|12050470|FG000|Overall Study|Lost to Follow-up|11
7636003|NCT03016312|12050471|FG001|Overall Study|Lost to Follow-up|12
7636004|NCT03016312|12050470|FG000|Overall Study|Started new therapy, loss of contact|2
7636005|NCT03016312|12050471|FG001|Overall Study|Started new therapy, loss of contact|1
7636006|NCT03016312|12050470|FG000|Overall Study|Physician Decision|0
7636007|NCT03016312|12050471|FG001|Overall Study|Physician Decision|2
7636008|NCT03016312|12050470|FG000|Overall Study|Withdrawal by Subject|34
7636009|NCT03016312|12050471|FG001|Overall Study|Withdrawal by Subject|39
7636010|NCT03008005|12050502|FG000|Overall Study|Physician Decision|1
7636011|NCT03008005|12050503|FG001|Overall Study|Physician Decision|0
7636012|NCT03008005|12050504|FG002|Overall Study|Physician Decision|0
7636013|NCT03008005|12050502|FG000|Overall Study|Withdrawal by Subject|1
7636014|NCT03008005|12050503|FG001|Overall Study|Withdrawal by Subject|0
7636015|NCT03008005|12050504|FG002|Overall Study|Withdrawal by Subject|0
7636016|NCT03008005|12050502|FG000|Overall Study|Ineligible|0
7636017|NCT03008005|12050503|FG001|Overall Study|Ineligible|1
7636018|NCT03008005|12050504|FG002|Overall Study|Ineligible|0
7636019|NCT03006926|12050514|FG000|Overall Study|Death|0
7636020|NCT03006926|12050515|FG001|Overall Study|Death|33
7636021|NCT03006926|12050514|FG000|Overall Study|Ongoing Survival Follow-up|0
7636022|NCT03006926|12050515|FG001|Overall Study|Ongoing Survival Follow-up|26
7636023|NCT03006926|12050514|FG000|Overall Study|Ongoing-on Treatment|0
7636024|NCT03006926|12050515|FG001|Overall Study|Ongoing-on Treatment|36
7636025|NCT03006926|12050514|FG000|Overall Study|Lost to Follow-up|0
7636026|NCT03006926|12050515|FG001|Overall Study|Lost to Follow-up|1
7636027|NCT03006926|12050514|FG000|Overall Study|Withdrawal by Subject|0
7636028|NCT03006926|12050515|FG001|Overall Study|Withdrawal by Subject|2
7636029|NCT03006848|12050523|FG000|Overall Study|Adverse Event|1
7636030|NCT03006848|12050523|FG000|Overall Study|Physician Decision|1
7636031|NCT03006848|12050523|FG000|Overall Study|Lack of Efficacy|16
7636032|NCT03004976|12050542|FG000|Overall Study|Lost to Follow-up|3
7636033|NCT03004976|12050543|FG001|Overall Study|Lost to Follow-up|1
7636034|NCT03004976|12050542|FG000|Overall Study|Physician Decision|1
7636035|NCT03004976|12050543|FG001|Overall Study|Physician Decision|0
7636036|NCT03004976|12050542|FG000|Overall Study|Withdrawal by Subject|1
7636037|NCT03004976|12050543|FG001|Overall Study|Withdrawal by Subject|0
7636038|NCT03003520|12050551|FG000|Induction|Ongoing|1
7636039|NCT03003520|12050552|FG001|Induction|Ongoing|0
7636040|NCT03003520|12050551|FG000|Induction|Adverse Event|4
7636041|NCT03003520|12050552|FG001|Induction|Adverse Event|0
7636042|NCT03003520|12050551|FG000|Induction|Death|1
7636043|NCT03003520|12050552|FG001|Induction|Death|0
7636044|NCT03003520|12050551|FG000|Induction|Palliative care|1
7636045|NCT03003520|12050552|FG001|Induction|Palliative care|0
7636046|NCT03003520|12050551|FG000|Induction|Physician Decision|2
7636047|NCT03003520|12050552|FG001|Induction|Physician Decision|0
7636048|NCT03003520|12050551|FG000|Induction|Withdrawal by Subject|3
7636049|NCT03003520|12050552|FG001|Induction|Withdrawal by Subject|0
7636050|NCT03003520|12050551|FG000|Induction|Progressive disease|1
7636051|NCT03003520|12050552|FG001|Induction|Progressive disease|0
7636052|NCT03003520|12050551|FG000|Consolidation|Ongoing|18
7636053|NCT03003520|12050552|FG001|Consolidation|Ongoing|0
7636054|NCT03003520|12050551|FG000|Consolidation|Adverse Event|2
7636055|NCT03003520|12050552|FG001|Consolidation|Adverse Event|0
7636056|NCT03003520|12050551|FG000|Consolidation|Progressive disease|3
7636057|NCT03003520|12050552|FG001|Consolidation|Progressive disease|1
7636058|NCT03003520|12050551|FG000|Consolidation|Withdrawal by Subject|1
7636059|NCT03003520|12050552|FG001|Consolidation|Withdrawal by Subject|0
7636060|NCT03003520|12050551|FG000|Follow-up|Death|1
7636061|NCT03003520|12050552|FG001|Follow-up|Death|1
7636062|NCT03003520|12050551|FG000|Follow-up|Ongoing|12
7636063|NCT03003520|12050552|FG001|Follow-up|Ongoing|2
7636064|NCT03003520|12050551|FG000|Follow-up|Withdrawal by Subject|1
7636065|NCT03003520|12050552|FG001|Follow-up|Withdrawal by Subject|0
7636066|NCT02999984|12050575|FG000|Overall Study|Treatment Failure|1
7636067|NCT02998840|12050583|FG000|Overall Study|Lost to Follow-up|1
7636068|NCT02998840|12050584|FG001|Overall Study|Lost to Follow-up|1
7636069|NCT02998840|12050585|FG002|Overall Study|Lost to Follow-up|2
7636070|NCT02998840|12050586|FG003|Overall Study|Lost to Follow-up|3
7636071|NCT02998840|12050583|FG000|Overall Study|Withdrawal by Subject|1
7636072|NCT02998840|12050584|FG001|Overall Study|Withdrawal by Subject|1
7636073|NCT02998840|12050585|FG002|Overall Study|Withdrawal by Subject|0
7636074|NCT02998840|12050586|FG003|Overall Study|Withdrawal by Subject|1
7636075|NCT02998840|12050583|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2
7636076|NCT02998840|12050584|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1
7636077|NCT02998840|12050585|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0
7636078|NCT02998840|12050586|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1
7636079|NCT02998528|12050597|FG000|Randomization Period|Adverse event unrelated to study drug|0
7636080|NCT02998528|12050598|FG001|Randomization Period|Adverse event unrelated to study drug|0
7636081|NCT02998528|12050599|FG002|Randomization Period|Adverse event unrelated to study drug|1
7636082|NCT02998528|12050597|FG000|Randomization Period|Participant withdrew consent|0
7636083|NCT02998528|12050598|FG001|Randomization Period|Participant withdrew consent|3
7636084|NCT02998528|12050599|FG002|Randomization Period|Participant withdrew consent|0
7636085|NCT02998528|12050597|FG000|Randomization Period|Participant no longer meets study criteria|1
7636086|NCT02998528|12050598|FG001|Randomization Period|Participant no longer meets study criteria|3
7636087|NCT02998528|12050599|FG002|Randomization Period|Participant no longer meets study criteria|2
7636088|NCT02998528|12050597|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0
7636089|NCT02998528|12050598|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7
7636090|NCT02998528|12050599|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0
7636091|NCT02998528|12050597|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0
7636092|NCT02998528|12050598|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4
7636093|NCT02998528|12050599|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0
7636094|NCT02998528|12050597|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0
7636095|NCT02998528|12050598|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1
7636096|NCT02998528|12050599|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0
7636097|NCT02998528|12050597|FG000|Neoadjuvant Treatment Period|Disease progression|3
7636098|NCT02998528|12050598|FG001|Neoadjuvant Treatment Period|Disease progression|2
7636099|NCT02998528|12050599|FG002|Neoadjuvant Treatment Period|Disease progression|1
7636100|NCT02998528|12050597|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6
7636101|NCT02998528|12050598|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14
7636102|NCT02998528|12050599|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10
7636103|NCT02998528|12050597|FG000|Neoadjuvant Treatment Period|Death|1
7636104|NCT02998528|12050598|FG001|Neoadjuvant Treatment Period|Death|0
7636105|NCT02998528|12050599|FG002|Neoadjuvant Treatment Period|Death|0
7636106|NCT02998528|12050597|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0
7636107|NCT02998528|12050598|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3
7636108|NCT02998528|12050599|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0
7636109|NCT02998528|12050597|FG000|Systemic Adjuvant Treatment Period|Disease progression|1
7636110|NCT02998528|12050598|FG001|Systemic Adjuvant Treatment Period|Disease progression|0
7636111|NCT02998528|12050599|FG002|Systemic Adjuvant Treatment Period|Disease progression|0
7636112|NCT02998528|12050597|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4
7636113|NCT02998528|12050598|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5
7636114|NCT02998528|12050599|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1
7636115|NCT02998528|12050597|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1
7636116|NCT02998528|12050598|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0
7636117|NCT02998528|12050599|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1
7636118|NCT02998528|12050597|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3
7636119|NCT02998528|12050598|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1
7636120|NCT02998528|12050599|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1
7636121|NCT02998528|12050597|FG000|Systemic Adjuvant Treatment Period|Other reasons|0
7636122|NCT02998528|12050598|FG001|Systemic Adjuvant Treatment Period|Other reasons|0
7636123|NCT02998528|12050599|FG002|Systemic Adjuvant Treatment Period|Other reasons|1
7636124|NCT02994927|12050608|FG000|Overall Study|Withdrawal by parent/guardian|0
7636125|NCT02994927|12050609|FG001|Overall Study|Withdrawal by parent/guardian|1
7636126|NCT02994927|12050608|FG000|Overall Study|Did not meet eligibility criteria|0
7636127|NCT02994927|12050609|FG001|Overall Study|Did not meet eligibility criteria|1
7636128|NCT02994927|12050608|FG000|Overall Study|Physician Decision|4
7636129|NCT02994927|12050609|FG001|Overall Study|Physician Decision|3
7636130|NCT02994927|12050608|FG000|Overall Study|Death|4
7636131|NCT02994927|12050609|FG001|Overall Study|Death|2
7636132|NCT02994927|12050608|FG000|Overall Study|Adverse Event|2
7636133|NCT02994927|12050609|FG001|Overall Study|Adverse Event|1
7636134|NCT02994927|12050608|FG000|Overall Study|Withdrawal by Subject|3
7636135|NCT02994927|12050609|FG001|Overall Study|Withdrawal by Subject|6
7636136|NCT02994927|12050608|FG000|Overall Study|Lost to Follow-up|2
7636137|NCT02994927|12050609|FG001|Overall Study|Lost to Follow-up|1
7636138|NCT02991482|12050617|FG000|Overall Study|Disease progression|56
7636139|NCT02991482|12050618|FG001|Overall Study|Disease progression|47
7636140|NCT02991482|12050617|FG000|Overall Study|Death|4
7636141|NCT02991482|12050618|FG001|Overall Study|Death|4
7636142|NCT02991482|12050617|FG000|Overall Study|Adverse Event|1
7636143|NCT02991482|12050618|FG001|Overall Study|Adverse Event|6
7636144|NCT02991482|12050617|FG000|Overall Study|Patient decision|1
7636145|NCT02991482|12050618|FG001|Overall Study|Patient decision|1
7636146|NCT02991482|12050617|FG000|Overall Study|Physician Decision|0
7636147|NCT02991482|12050618|FG001|Overall Study|Physician Decision|6
7636148|NCT02991482|12050617|FG000|Overall Study|Clinical deterioration|1
7636149|NCT02991482|12050618|FG001|Overall Study|Clinical deterioration|0
7636150|NCT02991482|12050617|FG000|Overall Study|Patient feeling too unwell|1
7636151|NCT02991482|12050618|FG001|Overall Study|Patient feeling too unwell|0
7636152|NCT02991482|12050617|FG000|Overall Study|Worsening of performance status|0
7636153|NCT02991482|12050618|FG001|Overall Study|Worsening of performance status|1
7636154|NCT02991482|12050617|FG000|Overall Study|Death prior to study drug initiation|1
7636155|NCT02991482|12050618|FG001|Overall Study|Death prior to study drug initiation|0
7636156|NCT02991482|12050617|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0
7636157|NCT02991482|12050618|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1
7636158|NCT02989194|12050627|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1
7636159|NCT02989194|12050628|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0
7636160|NCT02989194|12050629|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0
7636161|NCT02989194|12050627|FG000|Overall Study|Lost to Follow-up|0
7636162|NCT02989194|12050628|FG001|Overall Study|Lost to Follow-up|1
7636163|NCT02989194|12050629|FG002|Overall Study|Lost to Follow-up|0
7636164|NCT02989194|12050627|FG000|Overall Study|Withdrawal by Subject|0
7636165|NCT02989194|12050628|FG001|Overall Study|Withdrawal by Subject|1
7636166|NCT02989194|12050629|FG002|Overall Study|Withdrawal by Subject|0
7636167|NCT02987543|12050652|FG000|Overall Study|Ongoing study at data cut off|49
7636168|NCT02987543|12050653|FG001|Overall Study|Ongoing study at data cut off|21
7636169|NCT02987543|12050654|FG002|Overall Study|Ongoing study at data cut off|19
7636170|NCT02987543|12050655|FG003|Overall Study|Ongoing study at data cut off|12
7636171|NCT02987543|12050652|FG000|Overall Study|Death|88
7636172|NCT02987543|12050653|FG001|Overall Study|Death|54
7636173|NCT02987543|12050654|FG002|Overall Study|Death|67
7636174|NCT02987543|12050655|FG003|Overall Study|Death|28
7636175|NCT02987543|12050652|FG000|Overall Study|Lost to Follow-up|3
7636176|NCT02987543|12050653|FG001|Overall Study|Lost to Follow-up|0
7636177|NCT02987543|12050654|FG002|Overall Study|Lost to Follow-up|1
7636178|NCT02987543|12050655|FG003|Overall Study|Lost to Follow-up|0
7636179|NCT02987543|12050652|FG000|Overall Study|Screen failure|0
7636180|NCT02987543|12050653|FG001|Overall Study|Screen failure|0
7636181|NCT02987543|12050654|FG002|Overall Study|Screen failure|0
7636182|NCT02987543|12050655|FG003|Overall Study|Screen failure|1
7636183|NCT02987543|12050652|FG000|Overall Study|Withdrawal by Subject|21
7636184|NCT02987543|12050653|FG001|Overall Study|Withdrawal by Subject|7
7636185|NCT02987543|12050654|FG002|Overall Study|Withdrawal by Subject|7
7636186|NCT02987543|12050655|FG003|Overall Study|Withdrawal by Subject|6
7636187|NCT02987543|12050652|FG000|Overall Study|Study terminated by sponsor|1
7636188|NCT02987543|12050653|FG001|Overall Study|Study terminated by sponsor|0
7636189|NCT02987543|12050654|FG002|Overall Study|Study terminated by sponsor|0
7636190|NCT02987543|12050655|FG003|Overall Study|Study terminated by sponsor|0
7636191|NCT02987543|12050652|FG000|Overall Study|Investigator decision|0
7636192|NCT02987543|12050653|FG001|Overall Study|Investigator decision|1
7636193|NCT02987543|12050654|FG002|Overall Study|Investigator decision|0
7636194|NCT02987543|12050655|FG003|Overall Study|Investigator decision|0
7636195|NCT02987543|12050652|FG000|Overall Study|Disease progression|0
7636196|NCT02987543|12050653|FG001|Overall Study|Disease progression|0
7636197|NCT02987543|12050654|FG002|Overall Study|Disease progression|0
7636198|NCT02987543|12050655|FG003|Overall Study|Disease progression|1
7636199|NCT02973425|12050680|FG000|Overall Study|Lost to Follow-up|49
7636200|NCT02973425|12050681|FG001|Overall Study|Lost to Follow-up|53
7636201|NCT02971683|12050700|FG000|Overall Study|Other reasons|0
7636202|NCT02971683|12050701|FG001|Overall Study|Other reasons|1
7636203|NCT02971683|12050700|FG000|Overall Study|Poor/Non-Compliance|0
7636204|NCT02971683|12050701|FG001|Overall Study|Poor/Non-Compliance|1
7636205|NCT02971683|12050700|FG000|Overall Study|Lost to Follow-up|1
7636206|NCT02971683|12050701|FG001|Overall Study|Lost to Follow-up|0
7636207|NCT02971683|12050700|FG000|Overall Study|Participant withdrew consent|1
7636208|NCT02971683|12050701|FG001|Overall Study|Participant withdrew consent|1
7636209|NCT02971683|12050700|FG000|Overall Study|Participant request to discontinue study treatment|1
7636210|NCT02971683|12050701|FG001|Overall Study|Participant request to discontinue study treatment|1
7636211|NCT02971683|12050700|FG000|Overall Study|Adverse Event|1
7636212|NCT02971683|12050701|FG001|Overall Study|Adverse Event|2
7636213|NCT02971683|12050700|FG000|Overall Study|Lack of Efficacy|2
7636214|NCT02971683|12050701|FG001|Overall Study|Lack of Efficacy|2
7636215|NCT02969356|12050711|FG000|Overall Study|Adverse Event|7
7636216|NCT02969356|12050711|FG000|Overall Study|Consent withdrawn|2
7636217|NCT02969356|12050711|FG000|Overall Study|Lost to Follow-up|3
7636218|NCT02969356|12050711|FG000|Overall Study|Did not need to be reinjected|6
7636219|NCT02969356|12050711|FG000|Overall Study|Personal reasons|5
7636220|NCT02968004|12050717|FG000|Overall Study|Adverse Event|1
7636221|NCT02968004|12050718|FG001|Overall Study|Adverse Event|0
7636222|NCT02968004|12050717|FG000|Overall Study|Withdrawal by Subject|0
7636223|NCT02968004|12050718|FG001|Overall Study|Withdrawal by Subject|1
7636224|NCT02964741|12050749|FG000|Overall Study|Protocol Violation|1
7636225|NCT02964741|12050750|FG001|Overall Study|Protocol Violation|0
7636226|NCT02964741|12050751|FG002|Overall Study|Protocol Violation|0
7636227|NCT02964741|12050749|FG000|Overall Study|Withdrawal by Subject|0
7636228|NCT02964741|12050750|FG001|Overall Study|Withdrawal by Subject|1
7636229|NCT02964741|12050751|FG002|Overall Study|Withdrawal by Subject|0
7636230|NCT02964741|12050749|FG000|Overall Study|claustrophobia|1
7636231|NCT02964741|12050750|FG001|Overall Study|claustrophobia|0
7636232|NCT02964741|12050751|FG002|Overall Study|claustrophobia|0
7636233|NCT02963506|12050762|FG000|Double-Blind Period|Adverse Event|0
7636234|NCT02963506|12050763|FG001|Double-Blind Period|Adverse Event|0
7636235|NCT02963506|12050764|FG002|Double-Blind Period|Adverse Event|1
7636236|NCT02963506|12050765|FG003|Double-Blind Period|Adverse Event|0
7636237|NCT02963506|12050766|FG004|Double-Blind Period|Adverse Event|0
7636238|NCT02963506|12050767|FG005|Double-Blind Period|Adverse Event|0
7636239|NCT02963506|12050768|FG006|Double-Blind Period|Adverse Event|0
7636240|NCT02963506|12050769|FG007|Double-Blind Period|Adverse Event|0
7636241|NCT02963506|12050770|FG008|Double-Blind Period|Adverse Event|0
7636242|NCT02963506|12050771|FG009|Double-Blind Period|Adverse Event|0
7636243|NCT02963506|12050772|FG010|Double-Blind Period|Adverse Event|0
7636244|NCT02963506|12050773|FG011|Double-Blind Period|Adverse Event|0
7636245|NCT02963506|12050774|FG012|Double-Blind Period|Adverse Event|0
7636246|NCT02963506|12050762|FG000|Double-Blind Period|Death|0
7636247|NCT02963506|12050763|FG001|Double-Blind Period|Death|0
7636248|NCT02963506|12050764|FG002|Double-Blind Period|Death|0
7636249|NCT02963506|12050765|FG003|Double-Blind Period|Death|1
7636250|NCT02963506|12050766|FG004|Double-Blind Period|Death|0
7636251|NCT02963506|12050767|FG005|Double-Blind Period|Death|0
7636252|NCT02963506|12050768|FG006|Double-Blind Period|Death|0
7636253|NCT02963506|12050769|FG007|Double-Blind Period|Death|0
7636254|NCT02963506|12050770|FG008|Double-Blind Period|Death|0
7636255|NCT02963506|12050771|FG009|Double-Blind Period|Death|0
7636256|NCT02963506|12050772|FG010|Double-Blind Period|Death|0
7636257|NCT02963506|12050773|FG011|Double-Blind Period|Death|0
7636258|NCT02963506|12050774|FG012|Double-Blind Period|Death|0
7636259|NCT02963506|12050762|FG000|Double-Blind Period|Lost to Follow-up|0
7636260|NCT02963506|12050763|FG001|Double-Blind Period|Lost to Follow-up|1
7636261|NCT02963506|12050764|FG002|Double-Blind Period|Lost to Follow-up|0
7636262|NCT02963506|12050765|FG003|Double-Blind Period|Lost to Follow-up|0
7636263|NCT02963506|12050766|FG004|Double-Blind Period|Lost to Follow-up|0
7636264|NCT02963506|12050767|FG005|Double-Blind Period|Lost to Follow-up|0
7636265|NCT02963506|12050768|FG006|Double-Blind Period|Lost to Follow-up|0
7636266|NCT02963506|12050769|FG007|Double-Blind Period|Lost to Follow-up|0
7636267|NCT02963506|12050770|FG008|Double-Blind Period|Lost to Follow-up|0
7636268|NCT02963506|12050771|FG009|Double-Blind Period|Lost to Follow-up|0
7636269|NCT02963506|12050772|FG010|Double-Blind Period|Lost to Follow-up|0
7636270|NCT02963506|12050773|FG011|Double-Blind Period|Lost to Follow-up|0
7636271|NCT02963506|12050774|FG012|Double-Blind Period|Lost to Follow-up|0
7636272|NCT02963506|12050762|FG000|Double-Blind Period|Withdrawal by Subject|0
7636273|NCT02963506|12050763|FG001|Double-Blind Period|Withdrawal by Subject|0
7636274|NCT02963506|12050764|FG002|Double-Blind Period|Withdrawal by Subject|1
7636275|NCT02963506|12050765|FG003|Double-Blind Period|Withdrawal by Subject|1
7636276|NCT02963506|12050766|FG004|Double-Blind Period|Withdrawal by Subject|0
7636277|NCT02963506|12050767|FG005|Double-Blind Period|Withdrawal by Subject|0
7636278|NCT02963506|12050768|FG006|Double-Blind Period|Withdrawal by Subject|0
7636279|NCT02963506|12050769|FG007|Double-Blind Period|Withdrawal by Subject|0
7636280|NCT02963506|12050770|FG008|Double-Blind Period|Withdrawal by Subject|0
7636281|NCT02963506|12050771|FG009|Double-Blind Period|Withdrawal by Subject|0
7636282|NCT02963506|12050772|FG010|Double-Blind Period|Withdrawal by Subject|0
7636283|NCT02963506|12050773|FG011|Double-Blind Period|Withdrawal by Subject|0
7636284|NCT02963506|12050774|FG012|Double-Blind Period|Withdrawal by Subject|0
7636285|NCT02963506|12050762|FG000|Double-Blind Period|No compliance|0
7636286|NCT02963506|12050763|FG001|Double-Blind Period|No compliance|1
7636287|NCT02963506|12050764|FG002|Double-Blind Period|No compliance|0
7636288|NCT02963506|12050765|FG003|Double-Blind Period|No compliance|0
7636289|NCT02963506|12050766|FG004|Double-Blind Period|No compliance|0
7636290|NCT02963506|12050767|FG005|Double-Blind Period|No compliance|0
7636291|NCT02963506|12050768|FG006|Double-Blind Period|No compliance|0
7636292|NCT02963506|12050769|FG007|Double-Blind Period|No compliance|0
7636293|NCT02963506|12050770|FG008|Double-Blind Period|No compliance|0
7636294|NCT02963506|12050771|FG009|Double-Blind Period|No compliance|0
7636295|NCT02963506|12050772|FG010|Double-Blind Period|No compliance|0
7636296|NCT02963506|12050773|FG011|Double-Blind Period|No compliance|0
7636297|NCT02963506|12050774|FG012|Double-Blind Period|No compliance|0
7636298|NCT02963506|12050762|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636299|NCT02963506|12050763|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1
7636300|NCT02963506|12050764|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636301|NCT02963506|12050765|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636302|NCT02963506|12050766|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636303|NCT02963506|12050767|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636304|NCT02963506|12050768|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636305|NCT02963506|12050769|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636306|NCT02963506|12050770|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636307|NCT02963506|12050771|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636308|NCT02963506|12050772|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636309|NCT02963506|12050773|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636310|NCT02963506|12050774|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636311|NCT02963506|12050762|FG000|Dose-Blind Period|Adverse Event|0
7636312|NCT02963506|12050763|FG001|Dose-Blind Period|Adverse Event|0
7636313|NCT02963506|12050764|FG002|Dose-Blind Period|Adverse Event|0
7636314|NCT02963506|12050765|FG003|Dose-Blind Period|Adverse Event|0
7636315|NCT02963506|12050766|FG004|Dose-Blind Period|Adverse Event|0
7636316|NCT02963506|12050767|FG005|Dose-Blind Period|Adverse Event|1
7636317|NCT02963506|12050768|FG006|Dose-Blind Period|Adverse Event|3
7636318|NCT02963506|12050769|FG007|Dose-Blind Period|Adverse Event|2
7636319|NCT02963506|12050770|FG008|Dose-Blind Period|Adverse Event|2
7636320|NCT02963506|12050771|FG009|Dose-Blind Period|Adverse Event|2
7636321|NCT02963506|12050772|FG010|Dose-Blind Period|Adverse Event|1
7636322|NCT02963506|12050773|FG011|Dose-Blind Period|Adverse Event|1
7636323|NCT02963506|12050774|FG012|Dose-Blind Period|Adverse Event|6
7636324|NCT02963506|12050762|FG000|Dose-Blind Period|Lack of Efficacy|0
7636325|NCT02963506|12050763|FG001|Dose-Blind Period|Lack of Efficacy|0
7636326|NCT02963506|12050764|FG002|Dose-Blind Period|Lack of Efficacy|0
7636327|NCT02963506|12050765|FG003|Dose-Blind Period|Lack of Efficacy|0
7636328|NCT02963506|12050766|FG004|Dose-Blind Period|Lack of Efficacy|0
7636329|NCT02963506|12050767|FG005|Dose-Blind Period|Lack of Efficacy|0
7636330|NCT02963506|12050768|FG006|Dose-Blind Period|Lack of Efficacy|0
7636331|NCT02963506|12050769|FG007|Dose-Blind Period|Lack of Efficacy|1
7636332|NCT02963506|12050770|FG008|Dose-Blind Period|Lack of Efficacy|0
7636333|NCT02963506|12050771|FG009|Dose-Blind Period|Lack of Efficacy|1
7636334|NCT02963506|12050772|FG010|Dose-Blind Period|Lack of Efficacy|0
7636335|NCT02963506|12050773|FG011|Dose-Blind Period|Lack of Efficacy|0
7636336|NCT02963506|12050774|FG012|Dose-Blind Period|Lack of Efficacy|0
7636337|NCT02963506|12050762|FG000|Dose-Blind Period|Lost to Follow-up|0
7636338|NCT02963506|12050763|FG001|Dose-Blind Period|Lost to Follow-up|0
7636339|NCT02963506|12050764|FG002|Dose-Blind Period|Lost to Follow-up|0
7636340|NCT02963506|12050765|FG003|Dose-Blind Period|Lost to Follow-up|0
7636341|NCT02963506|12050766|FG004|Dose-Blind Period|Lost to Follow-up|0
7636342|NCT02963506|12050767|FG005|Dose-Blind Period|Lost to Follow-up|1
7636343|NCT02963506|12050768|FG006|Dose-Blind Period|Lost to Follow-up|0
7636344|NCT02963506|12050769|FG007|Dose-Blind Period|Lost to Follow-up|0
7636345|NCT02963506|12050770|FG008|Dose-Blind Period|Lost to Follow-up|1
7636346|NCT02963506|12050771|FG009|Dose-Blind Period|Lost to Follow-up|0
7636347|NCT02963506|12050772|FG010|Dose-Blind Period|Lost to Follow-up|0
7636348|NCT02963506|12050773|FG011|Dose-Blind Period|Lost to Follow-up|1
7636349|NCT02963506|12050774|FG012|Dose-Blind Period|Lost to Follow-up|0
7636350|NCT02963506|12050762|FG000|Dose-Blind Period|Withdrawal by Subject|0
7636351|NCT02963506|12050763|FG001|Dose-Blind Period|Withdrawal by Subject|0
7636352|NCT02963506|12050764|FG002|Dose-Blind Period|Withdrawal by Subject|0
7636353|NCT02963506|12050765|FG003|Dose-Blind Period|Withdrawal by Subject|0
7636354|NCT02963506|12050766|FG004|Dose-Blind Period|Withdrawal by Subject|0
7636355|NCT02963506|12050767|FG005|Dose-Blind Period|Withdrawal by Subject|1
7636356|NCT02963506|12050768|FG006|Dose-Blind Period|Withdrawal by Subject|2
7636357|NCT02963506|12050769|FG007|Dose-Blind Period|Withdrawal by Subject|2
7636358|NCT02963506|12050770|FG008|Dose-Blind Period|Withdrawal by Subject|0
7636359|NCT02963506|12050771|FG009|Dose-Blind Period|Withdrawal by Subject|1
7636360|NCT02963506|12050772|FG010|Dose-Blind Period|Withdrawal by Subject|0
7636361|NCT02963506|12050773|FG011|Dose-Blind Period|Withdrawal by Subject|0
7636362|NCT02963506|12050774|FG012|Dose-Blind Period|Withdrawal by Subject|0
7636363|NCT02963506|12050762|FG000|Dose-Blind Period|Sponsor decision|0
7636364|NCT02963506|12050763|FG001|Dose-Blind Period|Sponsor decision|0
7636365|NCT02963506|12050764|FG002|Dose-Blind Period|Sponsor decision|0
7636366|NCT02963506|12050765|FG003|Dose-Blind Period|Sponsor decision|0
7636367|NCT02963506|12050766|FG004|Dose-Blind Period|Sponsor decision|0
7636368|NCT02963506|12050767|FG005|Dose-Blind Period|Sponsor decision|1
7636369|NCT02963506|12050768|FG006|Dose-Blind Period|Sponsor decision|0
7636370|NCT02963506|12050769|FG007|Dose-Blind Period|Sponsor decision|0
7636371|NCT02963506|12050770|FG008|Dose-Blind Period|Sponsor decision|0
7636372|NCT02963506|12050771|FG009|Dose-Blind Period|Sponsor decision|0
7636373|NCT02963506|12050772|FG010|Dose-Blind Period|Sponsor decision|0
7636374|NCT02963506|12050773|FG011|Dose-Blind Period|Sponsor decision|0
7636375|NCT02963506|12050774|FG012|Dose-Blind Period|Sponsor decision|0
7636376|NCT02963506|12050762|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0
7636377|NCT02963506|12050763|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0
7636378|NCT02963506|12050764|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0
7636379|NCT02963506|12050765|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0
7636380|NCT02963506|12050766|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0
7636381|NCT02963506|12050767|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0
7636382|NCT02963506|12050768|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0
7636383|NCT02963506|12050769|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0
7636384|NCT02963506|12050770|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0
7636385|NCT02963506|12050771|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0
7636386|NCT02963506|12050772|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0
7636387|NCT02963506|12050773|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0
7636388|NCT02963506|12050774|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1
7636389|NCT02954887|12050803|FG000|Overall Study|Withdrawal by Subject|3
7636390|NCT02954887|12050803|FG000|Overall Study|Lack of Efficacy|3
7636391|NCT02954887|12050803|FG000|Overall Study|Other|1
7636392|NCT02951767|12050815|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54
7636393|NCT02951767|12050815|FG000|Overall Study|Withdrawal by Subject|5
7636394|NCT02951767|12050815|FG000|Overall Study|Death|59
7636395|NCT02951767|12050815|FG000|Overall Study|Lost to Follow-up|1
7636396|NCT02949128|12050829|FG000|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2
7636397|NCT02949128|12050829|FG000|Initial Evaluation Period|Adverse Event|3
7636398|NCT02949128|12050829|FG000|Initial Evaluation Period|Death|2
7636399|NCT02949128|12050829|FG000|Initial Evaluation Period|Physician Decision|1
7636400|NCT02949128|12050829|FG000|Initial Evaluation Period|Protocol Violation|1
7636401|NCT02949128|12050829|FG000|Extension Period|Withdrawal by Subject|5
7636402|NCT02949128|12050829|FG000|Extension Period|Protocol Violation|1
7636403|NCT02949128|12050829|FG000|Extension Period|Physician Decision|2
7636404|NCT02949128|12050829|FG000|Extension Period|Ongoing in Extension Period as of 07/02/2019|41
7636405|NCT02946931|12050833|FG000|Overall Study|Did not require collection of CRFs|588
7636406|NCT02946931|12050833|FG000|Overall Study|Other than listed|37
7636407|NCT02946931|12050833|FG000|Overall Study|Discharge from hospital|118
7636408|NCT02946931|12050833|FG000|Overall Study|Adverse Event|81
7636409|NCT02946931|12050833|FG000|Overall Study|CRFs not valid|1
7636410|NCT02946931|12050833|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6
7636411|NCT02946463|12050839|FG000|Primary Evaluation Period|Physician Decision|0
7636412|NCT02946463|12050840|FG001|Primary Evaluation Period|Physician Decision|1
7636413|NCT02946463|12050839|FG000|Primary Evaluation Period|Withdrawal by Subject|0
7636414|NCT02946463|12050840|FG001|Primary Evaluation Period|Withdrawal by Subject|1
7636415|NCT02938520|12050852|FG000|Overall Study|On-going at the time of analysis|258
7636416|NCT02938520|12050853|FG001|Overall Study|On-going at the time of analysis|261
7636417|NCT02938520|12050852|FG000|Overall Study|Physician Decision|2
7636418|NCT02938520|12050853|FG001|Overall Study|Physician Decision|5
7636419|NCT02938520|12050852|FG000|Overall Study|Lost to Follow-up|2
7636420|NCT02938520|12050853|FG001|Overall Study|Lost to Follow-up|2
7636421|NCT02938520|12050852|FG000|Overall Study|Withdrawal by Subject|7
7636422|NCT02938520|12050853|FG001|Overall Study|Withdrawal by Subject|7
7636423|NCT02938520|12050852|FG000|Overall Study|Protocol Violation|0
7636424|NCT02938520|12050853|FG001|Overall Study|Protocol Violation|1
7636425|NCT02938520|12050852|FG000|Overall Study|Lack of Efficacy|5
7636426|NCT02938520|12050853|FG001|Overall Study|Lack of Efficacy|3
7636427|NCT02938520|12050852|FG000|Overall Study|Adverse Event|9
7636428|NCT02938520|12050853|FG001|Overall Study|Adverse Event|4
7636429|NCT02937818|12050866|FG000|Overall Study|Participants decision|1
7636430|NCT02937818|12050867|FG001|Overall Study|Participants decision|0
7636431|NCT02937818|12050868|FG002|Overall Study|Participants decision|1
7636432|NCT02937818|12050869|FG003|Overall Study|Participants decision|1
7636433|NCT02937818|12050866|FG000|Overall Study|Adverse Event|2
7636434|NCT02937818|12050867|FG001|Overall Study|Adverse Event|4
7636435|NCT02937818|12050868|FG002|Overall Study|Adverse Event|1
7636436|NCT02937818|12050869|FG003|Overall Study|Adverse Event|1
7636437|NCT02937818|12050866|FG000|Overall Study|Disease progression|17
7636438|NCT02937818|12050867|FG001|Overall Study|Disease progression|14
7636439|NCT02937818|12050868|FG002|Overall Study|Disease progression|7
7636440|NCT02937818|12050869|FG003|Overall Study|Disease progression|18
7636441|NCT02937818|12050866|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1
7636442|NCT02937818|12050867|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2
7636443|NCT02937818|12050868|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0
7636444|NCT02937818|12050869|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0
7636445|NCT02937818|12050866|FG000|Overall Study|Condition under investigation worsened|0
7636446|NCT02937818|12050867|FG001|Overall Study|Condition under investigation worsened|0
7636447|NCT02937818|12050868|FG002|Overall Study|Condition under investigation worsened|1
7636448|NCT02937818|12050869|FG003|Overall Study|Condition under investigation worsened|0
7636449|NCT02937818|12050866|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
7636450|NCT02937818|12050867|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
7636451|NCT02937818|12050868|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
7636452|NCT02937818|12050869|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1
7636453|NCT02933489|12050884|FG000|Overall Study|Ineligible|3
7636454|NCT02933489|12050885|FG001|Overall Study|Ineligible|3
7636455|NCT02933489|12050884|FG000|Overall Study|Withdrawal by Subject|27
7636456|NCT02933489|12050885|FG001|Overall Study|Withdrawal by Subject|18
7636457|NCT02933489|12050884|FG000|Overall Study|Unable to complete exams (other)|14
7636458|NCT02933489|12050885|FG001|Overall Study|Unable to complete exams (other)|7
7882273|NCT01768676|12381082|FG000|Overall Study|Protocol Violation|1
7882274|NCT01768676|12381083|FG001|Overall Study|Protocol Violation|1
7882275|NCT01768676|12381082|FG000|Overall Study|Physician Decision|4
7882276|NCT01768676|12381083|FG001|Overall Study|Physician Decision|1
7882277|NCT01768676|12381082|FG000|Overall Study|Withdrawal by Subject|3
7882278|NCT01768676|12381083|FG001|Overall Study|Withdrawal by Subject|10
7882279|NCT01768858|12381106|FG000|Overall Study|Lost to Follow-up|9
7882280|NCT01768858|12381106|FG000|Overall Study|Lack of Efficacy|8
7882281|NCT01768858|12381106|FG000|Overall Study|Serious Adverse Event|1
7882282|NCT01768858|12381106|FG000|Overall Study|Participant moved to Germany|1
7882283|NCT01768858|12381106|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1
7882284|NCT01768858|12381106|FG000|Overall Study|Exanthema|1
7882285|NCT01768858|12381106|FG000|Overall Study|Withdrawal by Subject|1
7882286|NCT01769105|12381112|FG000|First Intervention|Protocol Violation|2
7882287|NCT01769105|12381113|FG001|First Intervention|Protocol Violation|2
7882288|NCT01769105|12381112|FG000|Cross-over|Lost to Follow-up|5
7882289|NCT01769105|12381113|FG001|Cross-over|Lost to Follow-up|0
7882290|NCT01769196|12381132|FG000|Overall Study|Adverse Event|24
7882291|NCT01769196|12381133|FG001|Overall Study|Adverse Event|20
7882292|NCT01769196|12381132|FG000|Overall Study|Death|21
7882293|NCT01769196|12381133|FG001|Overall Study|Death|26
7882294|NCT01769196|12381132|FG000|Overall Study|Investigator Discretion|7
7882295|NCT01769196|12381133|FG001|Overall Study|Investigator Discretion|3
7882296|NCT01769196|12381132|FG000|Overall Study|Lack of Efficacy|3
7882297|NCT01769196|12381133|FG001|Overall Study|Lack of Efficacy|2
7882298|NCT01769196|12381132|FG000|Overall Study|Progressive disease|11
7882299|NCT01769196|12381133|FG001|Overall Study|Progressive disease|6
7882300|NCT01769196|12381132|FG000|Overall Study|Protocol defined criteria for withdrawal|9
7882301|NCT01769196|12381133|FG001|Overall Study|Protocol defined criteria for withdrawal|11
7882302|NCT01769196|12381132|FG000|Overall Study|Protocol Violation|0
7882303|NCT01769196|12381133|FG001|Overall Study|Protocol Violation|3
7882304|NCT01769196|12381132|FG000|Overall Study|Study terminated by sponsor|160
7882305|NCT01769196|12381133|FG001|Overall Study|Study terminated by sponsor|161
7882306|NCT01769196|12381132|FG000|Overall Study|Participant never dosed with study drug|1
7882307|NCT01769196|12381133|FG001|Overall Study|Participant never dosed with study drug|0
7882308|NCT01769196|12381132|FG000|Overall Study|Withdrew consent|36
7882309|NCT01769196|12381133|FG001|Overall Study|Withdrew consent|40
7882310|NCT01769326|12381180|FG000|Overall Study|Lost to Follow-up|1
7882311|NCT01769326|12381181|FG001|Overall Study|Lost to Follow-up|2
7882312|NCT01769326|12381182|FG002|Overall Study|Lost to Follow-up|0
7882313|NCT01769326|12381183|FG003|Overall Study|Lost to Follow-up|0
7882314|NCT01769326|12381180|FG000|Overall Study|unrelated injry|1
7882315|NCT01769326|12381181|FG001|Overall Study|unrelated injry|1
7882316|NCT01769326|12381182|FG002|Overall Study|unrelated injry|0
7636518|NCT02927080|12050941|FG000|Overall Study|Withdrawal by Subject|0
7636519|NCT02927080|12050942|FG001|Overall Study|Withdrawal by Subject|0
7636520|NCT02927080|12050943|FG002|Overall Study|Withdrawal by Subject|0
7636521|NCT02927080|12050944|FG003|Overall Study|Withdrawal by Subject|0
7636522|NCT02927080|12050945|FG004|Overall Study|Withdrawal by Subject|1
7636523|NCT02927080|12050946|FG005|Overall Study|Withdrawal by Subject|0
7636524|NCT02927080|12050947|FG006|Overall Study|Withdrawal by Subject|1
7636525|NCT02927080|12050948|FG007|Overall Study|Withdrawal by Subject|1
7636526|NCT02927080|12050949|FG008|Overall Study|Withdrawal by Subject|0
7636527|NCT02927080|12050950|FG009|Overall Study|Withdrawal by Subject|2
7636528|NCT02927080|12050941|FG000|Overall Study|Willingness to comply with protocol|0
7636529|NCT02927080|12050942|FG001|Overall Study|Willingness to comply with protocol|0
7636530|NCT02927080|12050943|FG002|Overall Study|Willingness to comply with protocol|0
7636531|NCT02927080|12050944|FG003|Overall Study|Willingness to comply with protocol|0
7636532|NCT02927080|12050945|FG004|Overall Study|Willingness to comply with protocol|0
7636533|NCT02927080|12050946|FG005|Overall Study|Willingness to comply with protocol|0
7636534|NCT02927080|12050947|FG006|Overall Study|Willingness to comply with protocol|0
7636535|NCT02927080|12050948|FG007|Overall Study|Willingness to comply with protocol|0
7636536|NCT02927080|12050949|FG008|Overall Study|Willingness to comply with protocol|0
7636537|NCT02927080|12050950|FG009|Overall Study|Willingness to comply with protocol|1
7636538|NCT02927080|12050941|FG000|Overall Study|Study terminated by Sponsor|0
7636539|NCT02927080|12050942|FG001|Overall Study|Study terminated by Sponsor|0
7636540|NCT02927080|12050943|FG002|Overall Study|Study terminated by Sponsor|0
7636541|NCT02927080|12050944|FG003|Overall Study|Study terminated by Sponsor|0
7636542|NCT02927080|12050945|FG004|Overall Study|Study terminated by Sponsor|0
7636543|NCT02927080|12050946|FG005|Overall Study|Study terminated by Sponsor|0
7636544|NCT02927080|12050947|FG006|Overall Study|Study terminated by Sponsor|6
7636545|NCT02927080|12050948|FG007|Overall Study|Study terminated by Sponsor|7
7636546|NCT02927080|12050949|FG008|Overall Study|Study terminated by Sponsor|2
7636547|NCT02927080|12050950|FG009|Overall Study|Study terminated by Sponsor|3
7636548|NCT02927080|12050941|FG000|Overall Study|Adverse Event|0
7636549|NCT02927080|12050942|FG001|Overall Study|Adverse Event|1
7636550|NCT02927080|12050943|FG002|Overall Study|Adverse Event|0
7636551|NCT02927080|12050944|FG003|Overall Study|Adverse Event|0
7636552|NCT02927080|12050945|FG004|Overall Study|Adverse Event|0
7636553|NCT02927080|12050946|FG005|Overall Study|Adverse Event|0
7636554|NCT02927080|12050947|FG006|Overall Study|Adverse Event|0
7636555|NCT02927080|12050948|FG007|Overall Study|Adverse Event|1
7636556|NCT02927080|12050949|FG008|Overall Study|Adverse Event|0
7636557|NCT02927080|12050950|FG009|Overall Study|Adverse Event|1
7636558|NCT02927080|12050941|FG000|Overall Study|Other|0
7636559|NCT02927080|12050942|FG001|Overall Study|Other|0
7636560|NCT02927080|12050943|FG002|Overall Study|Other|0
7636561|NCT02927080|12050944|FG003|Overall Study|Other|0
7636562|NCT02927080|12050945|FG004|Overall Study|Other|0
7636563|NCT02927080|12050946|FG005|Overall Study|Other|0
7636564|NCT02927080|12050947|FG006|Overall Study|Other|1
7636565|NCT02927080|12050948|FG007|Overall Study|Other|0
7636566|NCT02927080|12050949|FG008|Overall Study|Other|1
7636567|NCT02927080|12050950|FG009|Overall Study|Other|0
7636568|NCT02923180|12050995|FG000|Overall Study|Off Study Due to Detectable PSA|13
7636569|NCT02923180|12050995|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13
7636570|NCT02921919|12051001|FG000|Overall Study|Other|5
7636571|NCT02921919|12051002|FG001|Overall Study|Other|6
7636572|NCT02921919|12051001|FG000|Overall Study|Lost to Follow-up|0
7636573|NCT02921919|12051002|FG001|Overall Study|Lost to Follow-up|1
7636574|NCT02921919|12051001|FG000|Overall Study|Withdrawal by Subject|5
7636575|NCT02921919|12051002|FG001|Overall Study|Withdrawal by Subject|1
7636576|NCT02921919|12051001|FG000|Overall Study|Disease Progression|47
7636577|NCT02921919|12051002|FG001|Overall Study|Disease Progression|38
7636578|NCT02921919|12051001|FG000|Overall Study|Physician Decision|3
7636579|NCT02921919|12051002|FG001|Overall Study|Physician Decision|2
7636580|NCT02921919|12051001|FG000|Overall Study|Adverse Event|6
7636581|NCT02921919|12051002|FG001|Overall Study|Adverse Event|4
7636582|NCT02918292|12051013|FG000|Study Enrollment Prior to Transplant|Death|1
7636583|NCT02918292|12051013|FG000|Study Follow up After Transplant|Death|6
7636584|NCT02908685|12051029|FG000|Part 1 Exploratory|Withdrawal by Subject|0
7636585|NCT02908685|12051030|FG001|Part 1 Exploratory|Withdrawal by Subject|1
7636586|NCT02908685|12051031|FG002|Part 1 Exploratory|Withdrawal by Subject|0
7636587|NCT02908685|12051032|FG003|Part 1 Exploratory|Withdrawal by Subject|0
7636588|NCT02908685|12051033|FG004|Part 1 Exploratory|Withdrawal by Subject|0
7636589|NCT02908685|12051034|FG005|Part 1 Exploratory|Withdrawal by Subject|0
7636590|NCT02908685|12051035|FG006|Part 1 Exploratory|Withdrawal by Subject|0
7636591|NCT02908685|12051036|FG007|Part 1 Exploratory|Withdrawal by Subject|0
7636592|NCT02908685|12051037|FG008|Part 1 Exploratory|Withdrawal by Subject|0
7636593|NCT02908685|12051038|FG009|Part 1 Exploratory|Withdrawal by Subject|0
7636594|NCT02908685|12051039|FG010|Part 1 Exploratory|Withdrawal by Subject|0
7636595|NCT02908685|12051040|FG011|Part 1 Exploratory|Withdrawal by Subject|0
7636596|NCT02908685|12051029|FG000|Part 2 Confirmatory|Changed to Spinraza|0
7636597|NCT02908685|12051030|FG001|Part 2 Confirmatory|Changed to Spinraza|0
7636598|NCT02908685|12051031|FG002|Part 2 Confirmatory|Changed to Spinraza|0
7636599|NCT02908685|12051032|FG003|Part 2 Confirmatory|Changed to Spinraza|0
7636600|NCT02908685|12051033|FG004|Part 2 Confirmatory|Changed to Spinraza|0
7636601|NCT02908685|12051034|FG005|Part 2 Confirmatory|Changed to Spinraza|0
7636602|NCT02908685|12051035|FG006|Part 2 Confirmatory|Changed to Spinraza|0
7636603|NCT02908685|12051036|FG007|Part 2 Confirmatory|Changed to Spinraza|0
7636604|NCT02908685|12051037|FG008|Part 2 Confirmatory|Changed to Spinraza|0
7636605|NCT02908685|12051038|FG009|Part 2 Confirmatory|Changed to Spinraza|0
7636606|NCT02908685|12051039|FG010|Part 2 Confirmatory|Changed to Spinraza|2
7636607|NCT02908685|12051040|FG011|Part 2 Confirmatory|Changed to Spinraza|1
7636608|NCT02908685|12051029|FG000|Part 2 Confirmatory|Changed to other treatment|0
7636609|NCT02908685|12051030|FG001|Part 2 Confirmatory|Changed to other treatment|0
7636610|NCT02908685|12051031|FG002|Part 2 Confirmatory|Changed to other treatment|0
7636611|NCT02908685|12051032|FG003|Part 2 Confirmatory|Changed to other treatment|0
7636612|NCT02908685|12051033|FG004|Part 2 Confirmatory|Changed to other treatment|0
7636613|NCT02908685|12051034|FG005|Part 2 Confirmatory|Changed to other treatment|0
7636614|NCT02908685|12051035|FG006|Part 2 Confirmatory|Changed to other treatment|0
7636615|NCT02908685|12051036|FG007|Part 2 Confirmatory|Changed to other treatment|0
7636616|NCT02908685|12051037|FG008|Part 2 Confirmatory|Changed to other treatment|0
7636617|NCT02908685|12051038|FG009|Part 2 Confirmatory|Changed to other treatment|0
7636618|NCT02908685|12051039|FG010|Part 2 Confirmatory|Changed to other treatment|1
7636619|NCT02908685|12051040|FG011|Part 2 Confirmatory|Changed to other treatment|0
7636620|NCT02908672|12051059|FG000|Overall Study|Death|112
7636621|NCT02908672|12051060|FG001|Overall Study|Death|93
7636622|NCT02908672|12051059|FG000|Overall Study|Lost to Follow-up|3
7636623|NCT02908672|12051060|FG001|Overall Study|Lost to Follow-up|3
7636624|NCT02908672|12051059|FG000|Overall Study|Other|2
7636625|NCT02908672|12051060|FG001|Overall Study|Other|0
7636626|NCT02908672|12051059|FG000|Overall Study|Protocol Violation|1
7636627|NCT02908672|12051060|FG001|Overall Study|Protocol Violation|1
7636628|NCT02908672|12051059|FG000|Overall Study|Withdrawal by Subject|13
7636629|NCT02908672|12051060|FG001|Overall Study|Withdrawal by Subject|18
7636630|NCT02908672|12051059|FG000|Overall Study|Study is ongoing|124
7636631|NCT02908672|12051060|FG001|Overall Study|Study is ongoing|141
7636632|NCT02908672|12051059|FG000|Overall Study|Discontinued the study during run-in|3
7636633|NCT02908672|12051060|FG001|Overall Study|Discontinued the study during run-in|0
7636634|NCT02903914|12051074|FG000|Overall Study|Adverse Event|0
7636635|NCT02903914|12051075|FG001|Overall Study|Adverse Event|0
7636636|NCT02903914|12051076|FG002|Overall Study|Adverse Event|1
7636637|NCT02903914|12051077|FG003|Overall Study|Adverse Event|0
7636638|NCT02903914|12051078|FG004|Overall Study|Adverse Event|0
7636639|NCT02903914|12051079|FG005|Overall Study|Adverse Event|1
7636640|NCT02903914|12051080|FG006|Overall Study|Adverse Event|2
7636641|NCT02903914|12051081|FG007|Overall Study|Adverse Event|1
7636642|NCT02903914|12051074|FG000|Overall Study|Withdrawal by Subject|3
7636643|NCT02903914|12051075|FG001|Overall Study|Withdrawal by Subject|1
7636644|NCT02903914|12051076|FG002|Overall Study|Withdrawal by Subject|28
7636645|NCT02903914|12051077|FG003|Overall Study|Withdrawal by Subject|0
7636646|NCT02903914|12051078|FG004|Overall Study|Withdrawal by Subject|1
7636647|NCT02903914|12051079|FG005|Overall Study|Withdrawal by Subject|1
7636648|NCT02903914|12051080|FG006|Overall Study|Withdrawal by Subject|12
7636649|NCT02903914|12051081|FG007|Overall Study|Withdrawal by Subject|0
7636650|NCT02903914|12051074|FG000|Overall Study|Progressive Disease|1
7636651|NCT02903914|12051075|FG001|Overall Study|Progressive Disease|0
7636652|NCT02903914|12051076|FG002|Overall Study|Progressive Disease|4
7636653|NCT02903914|12051077|FG003|Overall Study|Progressive Disease|0
7636654|NCT02903914|12051078|FG004|Overall Study|Progressive Disease|0
7636655|NCT02903914|12051079|FG005|Overall Study|Progressive Disease|0
7636656|NCT02903914|12051080|FG006|Overall Study|Progressive Disease|2
7636657|NCT02903914|12051081|FG007|Overall Study|Progressive Disease|4
7636658|NCT02903914|12051074|FG000|Overall Study|Death|0
7636659|NCT02903914|12051075|FG001|Overall Study|Death|0
7636660|NCT02903914|12051076|FG002|Overall Study|Death|9
7636661|NCT02903914|12051077|FG003|Overall Study|Death|0
7636662|NCT02903914|12051078|FG004|Overall Study|Death|1
7636663|NCT02903914|12051079|FG005|Overall Study|Death|3
7636664|NCT02903914|12051080|FG006|Overall Study|Death|24
7636665|NCT02903914|12051081|FG007|Overall Study|Death|0
7636666|NCT02903914|12051074|FG000|Overall Study|Lost to Follow-up|0
7636667|NCT02903914|12051075|FG001|Overall Study|Lost to Follow-up|1
7636668|NCT02903914|12051076|FG002|Overall Study|Lost to Follow-up|0
7636669|NCT02903914|12051077|FG003|Overall Study|Lost to Follow-up|0
7636670|NCT02903914|12051078|FG004|Overall Study|Lost to Follow-up|2
7636671|NCT02903914|12051079|FG005|Overall Study|Lost to Follow-up|0
7636672|NCT02903914|12051080|FG006|Overall Study|Lost to Follow-up|1
7636673|NCT02903914|12051081|FG007|Overall Study|Lost to Follow-up|0
7636674|NCT02903914|12051074|FG000|Overall Study|Physician Decision|0
7636675|NCT02903914|12051075|FG001|Overall Study|Physician Decision|0
7636676|NCT02903914|12051076|FG002|Overall Study|Physician Decision|1
7636677|NCT02903914|12051077|FG003|Overall Study|Physician Decision|0
7636678|NCT02903914|12051078|FG004|Overall Study|Physician Decision|0
7636679|NCT02903914|12051079|FG005|Overall Study|Physician Decision|0
7636680|NCT02903914|12051080|FG006|Overall Study|Physician Decision|1
7636681|NCT02903914|12051081|FG007|Overall Study|Physician Decision|0
7636682|NCT02903914|12051074|FG000|Overall Study|Symptomatic Deterioration|0
7636683|NCT02903914|12051075|FG001|Overall Study|Symptomatic Deterioration|0
7636684|NCT02903914|12051076|FG002|Overall Study|Symptomatic Deterioration|1
7636685|NCT02903914|12051077|FG003|Overall Study|Symptomatic Deterioration|0
7636686|NCT02903914|12051078|FG004|Overall Study|Symptomatic Deterioration|0
7636687|NCT02903914|12051079|FG005|Overall Study|Symptomatic Deterioration|0
7636688|NCT02903914|12051080|FG006|Overall Study|Symptomatic Deterioration|0
7636689|NCT02903914|12051081|FG007|Overall Study|Symptomatic Deterioration|0
7636690|NCT02903914|12051074|FG000|Overall Study|New Cancer Therapy|2
7636691|NCT02903914|12051075|FG001|Overall Study|New Cancer Therapy|2
7636692|NCT02903914|12051076|FG002|Overall Study|New Cancer Therapy|21
7636693|NCT02903914|12051077|FG003|Overall Study|New Cancer Therapy|4
7636694|NCT02903914|12051078|FG004|Overall Study|New Cancer Therapy|3
7636695|NCT02903914|12051079|FG005|Overall Study|New Cancer Therapy|6
7636696|NCT02903914|12051080|FG006|Overall Study|New Cancer Therapy|55
7636697|NCT02903914|12051081|FG007|Overall Study|New Cancer Therapy|0
7636698|NCT02903914|12051074|FG000|Overall Study|Reasoning not specified|2
7636699|NCT02903914|12051075|FG001|Overall Study|Reasoning not specified|3
7636700|NCT02903914|12051076|FG002|Overall Study|Reasoning not specified|20
7636701|NCT02903914|12051077|FG003|Overall Study|Reasoning not specified|3
7636702|NCT02903914|12051078|FG004|Overall Study|Reasoning not specified|3
7636703|NCT02903914|12051079|FG005|Overall Study|Reasoning not specified|3
7636704|NCT02903914|12051080|FG006|Overall Study|Reasoning not specified|20
7636705|NCT02903914|12051081|FG007|Overall Study|Reasoning not specified|0
7636706|NCT02901548|12051101|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4
7636707|NCT02899299|12051107|FG000|Pre-treatment|Participant request to discontinue study treatment|0
7636708|NCT02899299|12051108|FG001|Pre-treatment|Participant request to discontinue study treatment|3
7636709|NCT02899299|12051107|FG000|Pre-treatment|Participant withdrew consent|1
7636710|NCT02899299|12051108|FG001|Pre-treatment|Participant withdrew consent|11
7636711|NCT02899299|12051107|FG000|Pre-treatment|Participant no longer meets study criteria|2
7636712|NCT02899299|12051108|FG001|Pre-treatment|Participant no longer meets study criteria|3
7636713|NCT02899299|12051107|FG000|Pre-treatment|Not reported|0
7636714|NCT02899299|12051108|FG001|Pre-treatment|Not reported|1
7636715|NCT02899299|12051107|FG000|Treatment|Disease Progression|182
7636716|NCT02899299|12051108|FG001|Treatment|Disease Progression|44
7636717|NCT02899299|12051107|FG000|Treatment|Study Drug Toxicity|59
7636718|NCT02899299|12051108|FG001|Treatment|Study Drug Toxicity|24
7636719|NCT02899299|12051107|FG000|Treatment|Adverse Event unrelated to Study Drug|12
7636720|NCT02899299|12051108|FG001|Treatment|Adverse Event unrelated to Study Drug|9
7636721|NCT02899299|12051107|FG000|Treatment|Participant request to discontinue Study treatment|4
7636722|NCT02899299|12051108|FG001|Treatment|Participant request to discontinue Study treatment|10
7636723|NCT02899299|12051107|FG000|Treatment|Participant withdrew consent|6
7636724|NCT02899299|12051108|FG001|Treatment|Participant withdrew consent|3
7636725|NCT02899299|12051107|FG000|Treatment|Lost to Follow-up|0
7636726|NCT02899299|12051108|FG001|Treatment|Lost to Follow-up|1
7636727|NCT02899299|12051107|FG000|Treatment|Maximum Clinical Benefit|10
7636728|NCT02899299|12051108|FG001|Treatment|Maximum Clinical Benefit|2
7636729|NCT02899299|12051107|FG000|Treatment|Poor/Non-compliance|1
7636730|NCT02899299|12051108|FG001|Treatment|Poor/Non-compliance|0
7636731|NCT02899299|12051107|FG000|Treatment|Participant no longer meets Study criteria|4
7636732|NCT02899299|12051108|FG001|Treatment|Participant no longer meets Study criteria|0
7636733|NCT02899299|12051107|FG000|Treatment|Administrative reason by Sponsor|2
7636734|NCT02899299|12051108|FG001|Treatment|Administrative reason by Sponsor|0
7636735|NCT02899299|12051107|FG000|Treatment|Other reasons|11
7636736|NCT02899299|12051108|FG001|Treatment|Other reasons|2
7636737|NCT02899299|12051107|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4
7636738|NCT02899299|12051108|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189
7636739|NCT02898259|12051119|FG000|Overall Study|Adverse Event|0
7636740|NCT02898259|12051120|FG001|Overall Study|Adverse Event|0
7636741|NCT02898259|12051121|FG002|Overall Study|Adverse Event|1
7636742|NCT02898259|12051122|FG003|Overall Study|Adverse Event|0
7636743|NCT02898259|12051123|FG004|Overall Study|Adverse Event|0
7636744|NCT02898259|12051119|FG000|Overall Study|Lack of Efficacy|1
7636745|NCT02898259|12051120|FG001|Overall Study|Lack of Efficacy|1
7636746|NCT02898259|12051121|FG002|Overall Study|Lack of Efficacy|3
7636747|NCT02898259|12051122|FG003|Overall Study|Lack of Efficacy|0
7636748|NCT02898259|12051123|FG004|Overall Study|Lack of Efficacy|0
7636749|NCT02898259|12051119|FG000|Overall Study|Lost to Follow-up|0
7636750|NCT02898259|12051120|FG001|Overall Study|Lost to Follow-up|0
7636751|NCT02898259|12051121|FG002|Overall Study|Lost to Follow-up|1
7636752|NCT02898259|12051122|FG003|Overall Study|Lost to Follow-up|0
7636753|NCT02898259|12051123|FG004|Overall Study|Lost to Follow-up|0
7636754|NCT02898259|12051119|FG000|Overall Study|Transformation before study began|0
7636755|NCT02898259|12051120|FG001|Overall Study|Transformation before study began|0
7636756|NCT02898259|12051121|FG002|Overall Study|Transformation before study began|0
7636757|NCT02898259|12051122|FG003|Overall Study|Transformation before study began|1
7636758|NCT02898259|12051123|FG004|Overall Study|Transformation before study began|0
7636759|NCT02893930|12051136|FG000|Overall Study|Adverse Event|3
7636760|NCT02893930|12051136|FG000|Overall Study|Death|1
7636761|NCT02893930|12051136|FG000|Overall Study|Disease progression|5
7636762|NCT02893930|12051136|FG000|Overall Study|Withdrawal by Subject|2
7636763|NCT02893930|12051136|FG000|Overall Study|Physician Decision|1
7636764|NCT02893930|12051136|FG000|Overall Study|Ineligible|1
7636765|NCT02891226|12051157|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4
7636766|NCT02891226|12051158|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1
7636767|NCT02891226|12051159|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3
7636768|NCT02891226|12051160|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636769|NCT02891226|12051161|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636770|NCT02891226|12051162|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636771|NCT02891226|12051163|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636772|NCT02891226|12051164|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636773|NCT02891226|12051165|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636774|NCT02891226|12051166|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636775|NCT02891226|12051167|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636776|NCT02891226|12051168|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636777|NCT02891226|12051169|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636778|NCT02891226|12051170|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636779|NCT02891226|12051171|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636780|NCT02891226|12051172|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636781|NCT02891226|12051157|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
7636782|NCT02891226|12051158|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
7636783|NCT02891226|12051159|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636784|NCT02891226|12051160|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636785|NCT02891226|12051161|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636786|NCT02891226|12051162|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636787|NCT02891226|12051163|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636788|NCT02891226|12051164|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636789|NCT02891226|12051165|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636790|NCT02891226|12051166|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636791|NCT02891226|12051167|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636792|NCT02891226|12051168|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636793|NCT02891226|12051169|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636794|NCT02891226|12051170|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636795|NCT02891226|12051171|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636796|NCT02891226|12051172|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636797|NCT02891226|12051157|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636798|NCT02891226|12051158|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636799|NCT02891226|12051159|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636800|NCT02891226|12051160|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2
7636801|NCT02891226|12051161|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636802|NCT02891226|12051162|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636803|NCT02891226|12051163|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636804|NCT02891226|12051164|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636805|NCT02891226|12051165|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636806|NCT02891226|12051166|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636807|NCT02891226|12051167|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636808|NCT02891226|12051168|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636809|NCT02891226|12051169|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636810|NCT02891226|12051170|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636811|NCT02891226|12051171|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636812|NCT02891226|12051172|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636813|NCT02891226|12051157|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636814|NCT02891226|12051158|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636815|NCT02891226|12051159|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1
7636816|NCT02891226|12051160|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636817|NCT02891226|12051161|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636818|NCT02891226|12051162|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636819|NCT02891226|12051163|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636820|NCT02891226|12051164|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636821|NCT02891226|12051165|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636822|NCT02891226|12051166|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636823|NCT02891226|12051167|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636824|NCT02891226|12051168|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636825|NCT02891226|12051169|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636826|NCT02891226|12051170|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636827|NCT02891226|12051171|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636828|NCT02891226|12051172|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636829|NCT02891226|12051157|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636830|NCT02891226|12051158|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636831|NCT02891226|12051159|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636832|NCT02891226|12051160|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1
7636833|NCT02891226|12051161|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636834|NCT02891226|12051162|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636835|NCT02891226|12051163|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636836|NCT02891226|12051164|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636837|NCT02891226|12051165|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636838|NCT02891226|12051166|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636839|NCT02891226|12051167|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636840|NCT02891226|12051168|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636841|NCT02891226|12051169|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636842|NCT02891226|12051170|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636843|NCT02891226|12051171|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636844|NCT02891226|12051172|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636845|NCT02891226|12051157|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636846|NCT02891226|12051158|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636847|NCT02891226|12051159|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636848|NCT02891226|12051160|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1
7636849|NCT02891226|12051161|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636850|NCT02891226|12051162|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636851|NCT02891226|12051163|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636852|NCT02891226|12051164|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636853|NCT02891226|12051165|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636854|NCT02891226|12051166|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636855|NCT02891226|12051167|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636856|NCT02891226|12051168|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636857|NCT02891226|12051169|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636858|NCT02891226|12051170|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636859|NCT02891226|12051171|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636860|NCT02891226|12051172|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636861|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636862|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636863|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636864|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636865|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636866|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636867|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1
7636868|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1
7636869|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3
7636870|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7
7636871|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636872|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636873|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636874|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636875|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636876|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636877|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636878|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636879|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636880|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636881|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636882|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1
7636883|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636884|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636885|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636886|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1
7636887|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636888|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636889|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636890|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636891|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636892|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636893|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636894|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636895|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636896|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636897|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636898|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636899|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1
7636900|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2
7636901|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1
7636902|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6
7636903|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636904|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636905|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636906|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636907|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636908|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636909|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636910|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636911|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636912|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636913|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1
7636914|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636915|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636916|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636917|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636918|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636919|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636920|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636921|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636922|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636923|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636924|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636925|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636926|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636927|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636928|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636929|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636930|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636931|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1
7636932|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636933|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636934|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636935|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636936|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636937|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7637225|NCT02876328|12051277|FG008|Overall Study|Withdrawal by Subject|1
7636938|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636939|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636940|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636941|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636942|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636943|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636944|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636945|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636946|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636947|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636948|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1
7636949|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1
7636950|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1
7636951|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636952|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636953|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636954|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636955|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636956|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636957|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636958|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636959|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636960|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636961|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636962|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636963|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636964|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1
7636965|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636966|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636967|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636968|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636969|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636970|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636971|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636972|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636973|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636974|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636975|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636976|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636977|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636978|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636979|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636980|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636981|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1
7636982|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636983|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636984|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636985|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636986|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636987|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636988|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636989|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636990|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636991|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636992|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636993|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636994|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636995|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636996|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636997|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636998|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1
7636999|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7637000|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7637001|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7637002|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7637003|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7637004|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7637005|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637006|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637007|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637008|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637009|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637010|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637011|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637012|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637013|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637014|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1
7637015|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637016|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637017|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637018|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637019|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637020|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637021|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637022|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637023|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637024|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637025|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637026|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637027|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637028|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637029|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637030|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637031|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5
7637032|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637033|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637034|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637035|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637036|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637037|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637038|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637039|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637040|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637041|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637042|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637043|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637044|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637045|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637046|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637047|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1
7637048|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637049|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637050|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637051|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637052|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637053|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637054|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637055|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637056|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637057|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637058|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637059|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637060|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637061|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637062|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637063|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14
7637064|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637065|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637066|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637067|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637068|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637069|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637070|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637071|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637072|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637073|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637074|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637075|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637076|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637077|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637078|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637079|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108
7637080|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637081|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637082|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637083|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637084|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637085|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637086|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637087|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637088|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637089|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637090|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637091|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637092|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637093|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637094|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637095|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2
7637096|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637097|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637098|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637099|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637100|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637101|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637102|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637103|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637104|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637105|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637106|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637107|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637108|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637109|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637110|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637111|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3
7637112|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637113|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637114|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637115|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637116|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637117|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637118|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637119|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637120|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637121|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637122|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637123|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637124|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637125|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637126|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637127|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2
7637128|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637129|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637130|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637131|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637132|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637133|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637134|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637135|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637136|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637137|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637138|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637139|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637140|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637141|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637226|NCT02876328|12051278|FG009|Overall Study|Withdrawal by Subject|2
7637142|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637143|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2
7637144|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637145|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637146|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637147|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637148|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637149|NCT02891226|12051157|FG000|Follow-up Period|Withdrawal by Subject|0
7637150|NCT02891226|12051158|FG001|Follow-up Period|Withdrawal by Subject|0
7637151|NCT02891226|12051159|FG002|Follow-up Period|Withdrawal by Subject|0
7637152|NCT02891226|12051160|FG003|Follow-up Period|Withdrawal by Subject|0
7637153|NCT02891226|12051161|FG004|Follow-up Period|Withdrawal by Subject|0
7637154|NCT02891226|12051162|FG005|Follow-up Period|Withdrawal by Subject|0
7637155|NCT02891226|12051163|FG006|Follow-up Period|Withdrawal by Subject|0
7637156|NCT02891226|12051164|FG007|Follow-up Period|Withdrawal by Subject|0
7637157|NCT02891226|12051165|FG008|Follow-up Period|Withdrawal by Subject|0
7637158|NCT02891226|12051166|FG009|Follow-up Period|Withdrawal by Subject|0
7637159|NCT02891226|12051167|FG010|Follow-up Period|Withdrawal by Subject|0
7637160|NCT02891226|12051168|FG011|Follow-up Period|Withdrawal by Subject|1
7637161|NCT02891226|12051169|FG012|Follow-up Period|Withdrawal by Subject|0
7637162|NCT02891226|12051170|FG013|Follow-up Period|Withdrawal by Subject|0
7637163|NCT02891226|12051171|FG014|Follow-up Period|Withdrawal by Subject|1
7637164|NCT02891226|12051172|FG015|Follow-up Period|Withdrawal by Subject|1
7637165|NCT02890355|12051198|FG000|Overall Study|Adverse Event|5
7637166|NCT02890355|12051199|FG001|Overall Study|Adverse Event|5
7637167|NCT02890355|12051198|FG000|Overall Study|Refusal unrelated to adverse event|5
7637168|NCT02890355|12051199|FG001|Overall Study|Refusal unrelated to adverse event|10
7637169|NCT02890355|12051198|FG000|Overall Study|Progression/relapse|46
7637170|NCT02890355|12051199|FG001|Overall Study|Progression/relapse|39
7637171|NCT02890355|12051198|FG000|Overall Study|Not protocol specified|3
7637172|NCT02890355|12051199|FG001|Overall Study|Not protocol specified|4
7637173|NCT02880956|12051220|FG000|Overall Study|Adverse Event|3
7637174|NCT02880956|12051221|FG001|Overall Study|Adverse Event|6
7637175|NCT02880956|12051222|FG002|Overall Study|Adverse Event|5
7637176|NCT02880956|12051223|FG003|Overall Study|Adverse Event|4
7637177|NCT02880956|12051220|FG000|Overall Study|Withdrawal by Subject|9
7637178|NCT02880956|12051221|FG001|Overall Study|Withdrawal by Subject|4
7637179|NCT02880956|12051222|FG002|Overall Study|Withdrawal by Subject|6
7637180|NCT02880956|12051223|FG003|Overall Study|Withdrawal by Subject|11
7637181|NCT02880956|12051220|FG000|Overall Study|Lost to Follow-up|0
7637182|NCT02880956|12051221|FG001|Overall Study|Lost to Follow-up|1
7637183|NCT02880956|12051222|FG002|Overall Study|Lost to Follow-up|0
7637184|NCT02880956|12051223|FG003|Overall Study|Lost to Follow-up|0
7637185|NCT02880956|12051220|FG000|Overall Study|COVID-19 Logistical Restrictions|1
7637186|NCT02880956|12051221|FG001|Overall Study|COVID-19 Logistical Restrictions|2
7637187|NCT02880956|12051222|FG002|Overall Study|COVID-19 Logistical Restrictions|0
7637188|NCT02880956|12051223|FG003|Overall Study|COVID-19 Logistical Restrictions|0
7637189|NCT02880956|12051220|FG000|Overall Study|Other, Not Specified|4
7637190|NCT02880956|12051221|FG001|Overall Study|Other, Not Specified|2
7637191|NCT02880956|12051222|FG002|Overall Study|Other, Not Specified|0
7637192|NCT02880956|12051223|FG003|Overall Study|Other, Not Specified|3
7637193|NCT02876328|12051269|FG000|Overall Study|Death|2
7637194|NCT02876328|12051270|FG001|Overall Study|Death|1
7637195|NCT02876328|12051271|FG002|Overall Study|Death|3
7637196|NCT02876328|12051272|FG003|Overall Study|Death|0
7637197|NCT02876328|12051273|FG004|Overall Study|Death|0
7637198|NCT02876328|12051274|FG005|Overall Study|Death|0
7637199|NCT02876328|12051275|FG006|Overall Study|Death|1
7637200|NCT02876328|12051276|FG007|Overall Study|Death|3
7637201|NCT02876328|12051277|FG008|Overall Study|Death|0
7637202|NCT02876328|12051278|FG009|Overall Study|Death|1
7637203|NCT02876328|12051279|FG010|Overall Study|Death|1
7637204|NCT02876328|12051280|FG011|Overall Study|Death|0
7637205|NCT02876328|12051281|FG012|Overall Study|Death|0
7637206|NCT02876328|12051282|FG013|Overall Study|Death|0
7637207|NCT02876328|12051283|FG014|Overall Study|Death|0
7637208|NCT02876328|12051284|FG015|Overall Study|Death|0
7637209|NCT02876328|12051285|FG016|Overall Study|Death|1
7637210|NCT02876328|12051286|FG017|Overall Study|Death|1
7637211|NCT02876328|12051287|FG018|Overall Study|Death|0
7637212|NCT02876328|12051288|FG019|Overall Study|Death|0
7637213|NCT02876328|12051289|FG020|Overall Study|Death|0
7637214|NCT02876328|12051290|FG021|Overall Study|Death|1
7637215|NCT02876328|12051291|FG022|Overall Study|Death|0
7637216|NCT02876328|12051292|FG023|Overall Study|Death|0
7637217|NCT02876328|12051269|FG000|Overall Study|Withdrawal by Subject|0
7637218|NCT02876328|12051270|FG001|Overall Study|Withdrawal by Subject|2
7637219|NCT02876328|12051271|FG002|Overall Study|Withdrawal by Subject|3
7637220|NCT02876328|12051272|FG003|Overall Study|Withdrawal by Subject|3
7637221|NCT02876328|12051273|FG004|Overall Study|Withdrawal by Subject|0
7637222|NCT02876328|12051274|FG005|Overall Study|Withdrawal by Subject|1
7637223|NCT02876328|12051275|FG006|Overall Study|Withdrawal by Subject|0
7637224|NCT02876328|12051276|FG007|Overall Study|Withdrawal by Subject|1
7637227|NCT02876328|12051279|FG010|Overall Study|Withdrawal by Subject|0
7637228|NCT02876328|12051280|FG011|Overall Study|Withdrawal by Subject|0
7637229|NCT02876328|12051281|FG012|Overall Study|Withdrawal by Subject|0
7637230|NCT02876328|12051282|FG013|Overall Study|Withdrawal by Subject|0
7637231|NCT02876328|12051283|FG014|Overall Study|Withdrawal by Subject|0
7637232|NCT02876328|12051284|FG015|Overall Study|Withdrawal by Subject|0
7637233|NCT02876328|12051285|FG016|Overall Study|Withdrawal by Subject|1
7637234|NCT02876328|12051286|FG017|Overall Study|Withdrawal by Subject|3
7637235|NCT02876328|12051287|FG018|Overall Study|Withdrawal by Subject|0
7637236|NCT02876328|12051288|FG019|Overall Study|Withdrawal by Subject|0
7637237|NCT02876328|12051289|FG020|Overall Study|Withdrawal by Subject|1
7637238|NCT02876328|12051290|FG021|Overall Study|Withdrawal by Subject|0
7637239|NCT02876328|12051291|FG022|Overall Study|Withdrawal by Subject|0
7637240|NCT02876328|12051292|FG023|Overall Study|Withdrawal by Subject|0
7637241|NCT02876328|12051269|FG000|Overall Study|Missed 12 Month Visit|15
7637242|NCT02876328|12051270|FG001|Overall Study|Missed 12 Month Visit|10
7637243|NCT02876328|12051271|FG002|Overall Study|Missed 12 Month Visit|11
7637244|NCT02876328|12051272|FG003|Overall Study|Missed 12 Month Visit|6
7637245|NCT02876328|12051273|FG004|Overall Study|Missed 12 Month Visit|10
7637246|NCT02876328|12051274|FG005|Overall Study|Missed 12 Month Visit|14
7637247|NCT02876328|12051275|FG006|Overall Study|Missed 12 Month Visit|3
7637248|NCT02876328|12051276|FG007|Overall Study|Missed 12 Month Visit|8
7637249|NCT02876328|12051277|FG008|Overall Study|Missed 12 Month Visit|9
7637250|NCT02876328|12051278|FG009|Overall Study|Missed 12 Month Visit|5
7637251|NCT02876328|12051279|FG010|Overall Study|Missed 12 Month Visit|4
7637252|NCT02876328|12051280|FG011|Overall Study|Missed 12 Month Visit|1
7637253|NCT02876328|12051281|FG012|Overall Study|Missed 12 Month Visit|5
7637254|NCT02876328|12051282|FG013|Overall Study|Missed 12 Month Visit|4
7637255|NCT02876328|12051283|FG014|Overall Study|Missed 12 Month Visit|4
7637256|NCT02876328|12051284|FG015|Overall Study|Missed 12 Month Visit|4
7637257|NCT02876328|12051285|FG016|Overall Study|Missed 12 Month Visit|3
7637258|NCT02876328|12051286|FG017|Overall Study|Missed 12 Month Visit|6
7637259|NCT02876328|12051287|FG018|Overall Study|Missed 12 Month Visit|2
7637260|NCT02876328|12051288|FG019|Overall Study|Missed 12 Month Visit|2
7637261|NCT02876328|12051289|FG020|Overall Study|Missed 12 Month Visit|11
7637262|NCT02876328|12051290|FG021|Overall Study|Missed 12 Month Visit|7
7637263|NCT02876328|12051291|FG022|Overall Study|Missed 12 Month Visit|1
7637264|NCT02876328|12051292|FG023|Overall Study|Missed 12 Month Visit|0
7637265|NCT02872116|12051334|FG000|Pre-Treatment|Disease Progression|0
7637266|NCT02872116|12051335|FG001|Pre-Treatment|Disease Progression|1
7637267|NCT02872116|12051336|FG002|Pre-Treatment|Disease Progression|0
7637268|NCT02872116|12051334|FG000|Pre-Treatment|Adverse event unrelated to study drug|0
7637269|NCT02872116|12051335|FG001|Pre-Treatment|Adverse event unrelated to study drug|2
7637270|NCT02872116|12051336|FG002|Pre-Treatment|Adverse event unrelated to study drug|1
7637271|NCT02872116|12051334|FG000|Pre-Treatment|Participants request to discontinue study treatment|0
7637272|NCT02872116|12051335|FG001|Pre-Treatment|Participants request to discontinue study treatment|2
7637273|NCT02872116|12051336|FG002|Pre-Treatment|Participants request to discontinue study treatment|0
7637274|NCT02872116|12051334|FG000|Pre-Treatment|Participant withdrew consent|2
7637275|NCT02872116|12051335|FG001|Pre-Treatment|Participant withdrew consent|20
7637276|NCT02872116|12051336|FG002|Pre-Treatment|Participant withdrew consent|3
7637277|NCT02872116|12051334|FG000|Pre-Treatment|Participant no longer meets study criteria|4
7637278|NCT02872116|12051335|FG001|Pre-Treatment|Participant no longer meets study criteria|0
7637279|NCT02872116|12051336|FG002|Pre-Treatment|Participant no longer meets study criteria|0
7637280|NCT02872116|12051334|FG000|Pre-Treatment|Other reasons|1
7637281|NCT02872116|12051335|FG001|Pre-Treatment|Other reasons|2
7637282|NCT02872116|12051336|FG002|Pre-Treatment|Other reasons|2
7637283|NCT02872116|12051334|FG000|Treatment|Death|122
7637284|NCT02872116|12051335|FG001|Treatment|Death|94
7637285|NCT02872116|12051336|FG002|Treatment|Death|68
7637286|NCT02872116|12051334|FG000|Treatment|Lost to Follow-up|5
7637287|NCT02872116|12051335|FG001|Treatment|Lost to Follow-up|7
7637288|NCT02872116|12051336|FG002|Treatment|Lost to Follow-up|3
7637289|NCT02872116|12051334|FG000|Treatment|Participant withdrew consent|20
7637290|NCT02872116|12051335|FG001|Treatment|Participant withdrew consent|40
7637291|NCT02872116|12051336|FG002|Treatment|Participant withdrew consent|8
7637292|NCT02872116|12051334|FG000|Treatment|Other reasons|12
7637293|NCT02872116|12051335|FG001|Treatment|Other reasons|12
7637294|NCT02872116|12051336|FG002|Treatment|Other reasons|5
7637295|NCT02871791|12051351|FG000|Phase 1b|Death|0
7637296|NCT02871791|12051352|FG001|Phase 1b|Death|1
7637297|NCT02871791|12051351|FG000|Phase 1b|progressive disease|6
7637298|NCT02871791|12051352|FG001|Phase 1b|progressive disease|2
7637299|NCT02871791|12051351|FG000|Phase 2|Death|1
7637300|NCT02871791|12051352|FG001|Phase 2|Death|0
7637301|NCT02871791|12051351|FG000|Phase 2|Lost to Follow-up|2
7637302|NCT02871791|12051352|FG001|Phase 2|Lost to Follow-up|0
7637303|NCT02867761|12051360|FG000|Overall Study|Participant withdrawn by investigator|0
7637304|NCT02867761|12051361|FG001|Overall Study|Participant withdrawn by investigator|1
7637305|NCT02867761|12051360|FG000|Overall Study|Lost to Follow-up|25
7637306|NCT02867761|12051361|FG001|Overall Study|Lost to Follow-up|18
7637307|NCT02867761|12051360|FG000|Overall Study|Unable to complete protocol|3
7637308|NCT02867761|12051361|FG001|Overall Study|Unable to complete protocol|7
7637309|NCT02864394|12051374|FG000|Overall Study|Death|135
7637310|NCT02864394|12051375|FG001|Overall Study|Death|150
7637311|NCT02864394|12051374|FG000|Overall Study|Withdrawal by Subject|1
7637312|NCT02864394|12051375|FG001|Overall Study|Withdrawal by Subject|9
7637313|NCT02864394|12051374|FG000|Overall Study|Ongoing In Study|77
7637314|NCT02864394|12051375|FG001|Overall Study|Ongoing In Study|53
7637315|NCT02862457|12051388|FG000|Overall Study|Death|1
7637316|NCT02862457|12051389|FG001|Overall Study|Death|3
7637317|NCT02862457|12051390|FG002|Overall Study|Death|2
7637318|NCT02862457|12051391|FG003|Overall Study|Death|3
7637319|NCT02862457|12051392|FG004|Overall Study|Death|0
7637320|NCT02862457|12051393|FG005|Overall Study|Death|2
7637321|NCT02862457|12051394|FG006|Overall Study|Death|1
7637322|NCT02862457|12051388|FG000|Overall Study|Lost to Follow-up|1
7637323|NCT02862457|12051389|FG001|Overall Study|Lost to Follow-up|0
7637324|NCT02862457|12051390|FG002|Overall Study|Lost to Follow-up|0
7637325|NCT02862457|12051391|FG003|Overall Study|Lost to Follow-up|1
7637326|NCT02862457|12051392|FG004|Overall Study|Lost to Follow-up|0
7637327|NCT02862457|12051393|FG005|Overall Study|Lost to Follow-up|0
7637328|NCT02862457|12051394|FG006|Overall Study|Lost to Follow-up|0
7637329|NCT02862457|12051388|FG000|Overall Study|Withdrawal by Subject|0
7637330|NCT02862457|12051389|FG001|Overall Study|Withdrawal by Subject|0
7637331|NCT02862457|12051390|FG002|Overall Study|Withdrawal by Subject|1
7637332|NCT02862457|12051391|FG003|Overall Study|Withdrawal by Subject|0
7637333|NCT02862457|12051392|FG004|Overall Study|Withdrawal by Subject|0
7637334|NCT02862457|12051393|FG005|Overall Study|Withdrawal by Subject|1
7637335|NCT02862457|12051394|FG006|Overall Study|Withdrawal by Subject|0
7637336|NCT02854436|12051429|FG000|Overall Study|Adverse Event|1
7637337|NCT02854436|12051429|FG000|Overall Study|Death|208
7637338|NCT02854436|12051429|FG000|Overall Study|Lost to Follow-up|5
7637339|NCT02854436|12051429|FG000|Overall Study|Withdrawal by Subject|12
7637340|NCT02854436|12051429|FG000|Overall Study|Other|45
7637341|NCT02854436|12051429|FG000|Overall Study|Ongoing|18
7637342|NCT02853344|12051435|FG000|Overall Study|Death|23
7637343|NCT02853344|12051436|FG001|Overall Study|Death|84
7637344|NCT02853344|12051435|FG000|Overall Study|Withdrawal by Subject|1
7637345|NCT02853344|12051436|FG001|Overall Study|Withdrawal by Subject|3
7637346|NCT02853344|12051435|FG000|Overall Study|Ongoing|86
7637347|NCT02853344|12051436|FG001|Overall Study|Ongoing|78
7637348|NCT02853331|12051446|FG000|Overall Study|Death|59
7637349|NCT02853331|12051447|FG001|Overall Study|Death|95
7637350|NCT02853331|12051446|FG000|Overall Study|Withdrawal by Subject|5
7637351|NCT02853331|12051447|FG001|Overall Study|Withdrawal by Subject|9
7637352|NCT02853331|12051446|FG000|Overall Study|Ongoing in study|368
7637353|NCT02853331|12051447|FG001|Overall Study|Ongoing in study|325
7637354|NCT02853305|12051456|FG000|Overall Study|Death|244
7637355|NCT02853305|12051457|FG001|Overall Study|Death|207
7637356|NCT02853305|12051458|FG002|Overall Study|Death|263
7637357|NCT02853305|12051456|FG000|Overall Study|Withdrawal by Subject|2
7637358|NCT02853305|12051457|FG001|Overall Study|Withdrawal by Subject|4
7637359|NCT02853305|12051458|FG002|Overall Study|Withdrawal by Subject|2
7637360|NCT02853305|12051456|FG000|Overall Study|Ongoing in Trial|105
7637361|NCT02853305|12051457|FG001|Overall Study|Ongoing in Trial|96
7637362|NCT02853305|12051458|FG002|Overall Study|Ongoing in Trial|87
7637363|NCT02852005|12051471|FG000|Overall Study|Lost to Follow-up|0
7637364|NCT02852005|12051472|FG001|Overall Study|Lost to Follow-up|0
7637365|NCT02852005|12051473|FG002|Overall Study|Lost to Follow-up|0
7637366|NCT02852005|12051474|FG003|Overall Study|Lost to Follow-up|0
7637367|NCT02852005|12051475|FG004|Overall Study|Lost to Follow-up|1
7637368|NCT02852005|12051471|FG000|Overall Study|Withdrawal by Subject|1
7637369|NCT02852005|12051472|FG001|Overall Study|Withdrawal by Subject|0
7637370|NCT02852005|12051473|FG002|Overall Study|Withdrawal by Subject|0
7637371|NCT02852005|12051474|FG003|Overall Study|Withdrawal by Subject|0
7637372|NCT02852005|12051475|FG004|Overall Study|Withdrawal by Subject|0
7637373|NCT02836249|12051500|FG000|Overall Study|Randomized but Never Treated|0
7637374|NCT02836249|12051501|FG001|Overall Study|Randomized but Never Treated|1
7637375|NCT02836249|12051500|FG000|Overall Study|Pregnancy|2
7637376|NCT02836249|12051501|FG001|Overall Study|Pregnancy|0
7637377|NCT02836249|12051500|FG000|Overall Study|Withdrew Consent|0
7637378|NCT02836249|12051501|FG001|Overall Study|Withdrew Consent|1
7637379|NCT02836249|12051500|FG000|Overall Study|Lost to Follow-up|0
7637380|NCT02836249|12051501|FG001|Overall Study|Lost to Follow-up|1
7637381|NCT02836249|12051500|FG000|Overall Study|Still on Study|121
7637382|NCT02836249|12051501|FG001|Overall Study|Still on Study|55
7637383|NCT02832063|12051509|FG000|Overall Study|Adverse Event|2
7637384|NCT02832063|12051510|FG001|Overall Study|Adverse Event|1
7637385|NCT02832063|12051509|FG000|Overall Study|Physician Decision|5
7637386|NCT02832063|12051510|FG001|Overall Study|Physician Decision|7
7637387|NCT02832063|12051509|FG000|Overall Study|Lost to Follow-up|15
7637388|NCT02832063|12051510|FG001|Overall Study|Lost to Follow-up|8
7637389|NCT02832063|12051509|FG000|Overall Study|Withdrawal by Subject|10
7637390|NCT02832063|12051510|FG001|Overall Study|Withdrawal by Subject|21
7637391|NCT02832063|12051509|FG000|Overall Study|Other|2
7637392|NCT02832063|12051510|FG001|Overall Study|Other|1
7637393|NCT02831764|12051518|FG000|Overall Study|Protocol specific withdrawal criteria|0
7637394|NCT02831764|12051519|FG001|Overall Study|Protocol specific withdrawal criteria|2
7637395|NCT02831764|12051518|FG000|Overall Study|Withdrawal by Subject|7
7637396|NCT02831764|12051519|FG001|Overall Study|Withdrawal by Subject|6
7637397|NCT02831764|12051518|FG000|Overall Study|Physician Decision|2
7637398|NCT02831764|12051519|FG001|Overall Study|Physician Decision|2
7637399|NCT02831764|12051518|FG000|Overall Study|Lost to Follow-up|6
7637400|NCT02831764|12051519|FG001|Overall Study|Lost to Follow-up|5
7637401|NCT02831764|12051518|FG000|Overall Study|Adverse Event|8
7637402|NCT02831764|12051519|FG001|Overall Study|Adverse Event|5
7637403|NCT02831764|12051518|FG000|Overall Study|Lack of Efficacy|2
7637404|NCT02831764|12051519|FG001|Overall Study|Lack of Efficacy|2
7637405|NCT02831764|12051518|FG000|Overall Study|Protocol Violation|5
7637406|NCT02831764|12051519|FG001|Overall Study|Protocol Violation|2
7637407|NCT02831764|12051518|FG000|Overall Study|Ongoing at the time of the analysis|330
7637408|NCT02831764|12051519|FG001|Overall Study|Ongoing at the time of the analysis|335
7637409|NCT02831673|12051527|FG000|Overall Study|Adverse Event|6
7637410|NCT02831673|12051528|FG001|Overall Study|Adverse Event|4
7637411|NCT02831673|12051527|FG000|Overall Study|Lack of Efficacy|3
7637412|NCT02831673|12051528|FG001|Overall Study|Lack of Efficacy|1
7637413|NCT02831673|12051527|FG000|Overall Study|Protocol Violation|5
7637414|NCT02831673|12051528|FG001|Overall Study|Protocol Violation|4
7637415|NCT02831673|12051527|FG000|Overall Study|Protocol Withdrawal Criterion Met|1
7637416|NCT02831673|12051528|FG001|Overall Study|Protocol Withdrawal Criterion Met|6
7637417|NCT02831673|12051527|FG000|Overall Study|Lost to Follow-up|9
7637418|NCT02831673|12051528|FG001|Overall Study|Lost to Follow-up|6
7637419|NCT02831673|12051527|FG000|Overall Study|Physician Decision|6
7637420|NCT02831673|12051528|FG001|Overall Study|Physician Decision|3
7637421|NCT02831673|12051527|FG000|Overall Study|Withdrawal by Subject|6
7637422|NCT02831673|12051528|FG001|Overall Study|Withdrawal by Subject|4
7637423|NCT02831673|12051527|FG000|Overall Study|Ongoing at Week 48 primary analysis.|320
7637424|NCT02831673|12051528|FG001|Overall Study|Ongoing at Week 48 primary analysis.|330
7637425|NCT02829918|12051534|FG000|Overall Study|Death|2
7637426|NCT02829918|12051534|FG000|Overall Study|Withdrawal by Subject|4
7637427|NCT02829918|12051534|FG000|Overall Study|Adverse Event|1
7637428|NCT02829918|12051534|FG000|Overall Study|Progression|1
7637429|NCT02824627|12051549|FG000|Overall Study|Adverse Event|1
7637430|NCT02824627|12051550|FG001|Overall Study|Adverse Event|2
7637431|NCT02824627|12051549|FG000|Overall Study|Lost to Follow-up|2
7637432|NCT02824627|12051550|FG001|Overall Study|Lost to Follow-up|1
7637433|NCT02821000|12051556|FG000|Overall Study|Death|44
7637434|NCT02821000|12051556|FG000|Overall Study|Withdrawal by Subject|1
7637435|NCT02821000|12051556|FG000|Overall Study|Ongoing in Study|58
7637436|NCT02815540|12051580|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2
7637437|NCT02807493|12051597|FG000|Overall Study|Adverse Event|5
7637438|NCT02807493|12051598|FG001|Overall Study|Adverse Event|2
7637439|NCT02807493|12051597|FG000|Overall Study|Lost to Follow-up|6
7637440|NCT02807493|12051598|FG001|Overall Study|Lost to Follow-up|0
7637441|NCT02807493|12051597|FG000|Overall Study|Physician Decision|4
7637442|NCT02807493|12051598|FG001|Overall Study|Physician Decision|1
7637443|NCT02807493|12051597|FG000|Overall Study|Protocol Violation|7
7637444|NCT02807493|12051598|FG001|Overall Study|Protocol Violation|0
7637445|NCT02807493|12051597|FG000|Overall Study|Withdrawal by Subject|17
7637446|NCT02807493|12051598|FG001|Overall Study|Withdrawal by Subject|10
7637447|NCT02807493|12051597|FG000|Overall Study|Other withdrawal|17
7637448|NCT02807493|12051598|FG001|Overall Study|Other withdrawal|0
7637449|NCT02807493|12051597|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31
7637450|NCT02807493|12051598|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39
7637451|NCT02784535|12051636|FG000|Overall Study|Adverse Event|1
7637452|NCT02784535|12051637|FG001|Overall Study|Adverse Event|0
7637453|NCT02784535|12051636|FG000|Overall Study|Withdrawal by Subject|0
7637454|NCT02784535|12051637|FG001|Overall Study|Withdrawal by Subject|1
7637455|NCT02784535|12051636|FG000|Overall Study|Physician Decision|0
7637456|NCT02784535|12051637|FG001|Overall Study|Physician Decision|1
7637457|NCT02781506|12051655|FG000|Overall Study|Adverse Event|5
7637458|NCT02775903|12051663|FG000|Overall Study|Ongoing|14
7637459|NCT02775903|12051664|FG001|Overall Study|Ongoing|15
7637460|NCT02775903|12051665|FG002|Overall Study|Ongoing|15
7637461|NCT02775903|12051666|FG003|Overall Study|Ongoing|19
7637462|NCT02775903|12051663|FG000|Overall Study|Death|19
7637463|NCT02775903|12051664|FG001|Overall Study|Death|18
7637464|NCT02775903|12051665|FG002|Overall Study|Death|38
7637465|NCT02775903|12051666|FG003|Overall Study|Death|35
7637466|NCT02775903|12051663|FG000|Overall Study|Withdrawal by Subject|5
7637467|NCT02775903|12051664|FG001|Overall Study|Withdrawal by Subject|5
7637468|NCT02775903|12051665|FG002|Overall Study|Withdrawal by Subject|5
7637469|NCT02775903|12051666|FG003|Overall Study|Withdrawal by Subject|4
7637470|NCT02775903|12051663|FG000|Overall Study|Adverse Event|0
7637471|NCT02775903|12051664|FG001|Overall Study|Adverse Event|0
7637472|NCT02775903|12051665|FG002|Overall Study|Adverse Event|1
7637473|NCT02775903|12051666|FG003|Overall Study|Adverse Event|1
7637474|NCT02775903|12051663|FG000|Overall Study|Lost to Follow-up|0
7637475|NCT02775903|12051664|FG001|Overall Study|Lost to Follow-up|0
7637476|NCT02775903|12051665|FG002|Overall Study|Lost to Follow-up|1
7637477|NCT02775903|12051666|FG003|Overall Study|Lost to Follow-up|1
7637478|NCT02775903|12051663|FG000|Overall Study|Other-Miscellaneous|4
7637479|NCT02775903|12051664|FG001|Overall Study|Other-Miscellaneous|3
7637480|NCT02775903|12051665|FG002|Overall Study|Other-Miscellaneous|4
7637481|NCT02775903|12051666|FG003|Overall Study|Other-Miscellaneous|5
7637482|NCT02775435|12051682|FG000|Overall Study|Adverse Event|48
7637483|NCT02775435|12051683|FG001|Overall Study|Adverse Event|25
7637484|NCT02775435|12051682|FG000|Overall Study|Lost to Follow-up|0
7637485|NCT02775435|12051683|FG001|Overall Study|Lost to Follow-up|2
7637486|NCT02775435|12051682|FG000|Overall Study|Physician Decision|5
7637487|NCT02775435|12051683|FG001|Overall Study|Physician Decision|6
7637488|NCT02775435|12051682|FG000|Overall Study|Withdrawal by Subject|5
7637489|NCT02775435|12051683|FG001|Overall Study|Withdrawal by Subject|9
7637490|NCT02775435|12051682|FG000|Overall Study|Progressive Disease|86
7637491|NCT02775435|12051683|FG001|Overall Study|Progressive Disease|140
7637492|NCT02775435|12051682|FG000|Overall Study|Clinical Progression|13
7637493|NCT02775435|12051683|FG001|Overall Study|Clinical Progression|26
7637494|NCT02775435|12051682|FG000|Overall Study|Ongoing in Study|121
7637495|NCT02775435|12051683|FG001|Overall Study|Ongoing in Study|72
7637496|NCT02775435|12051682|FG000|Overall Study|Not Treated|0
7637497|NCT02775435|12051683|FG001|Overall Study|Not Treated|1
7637498|NCT02773849|12051700|FG000|Overall Study|Adverse Event|3
7637499|NCT02773849|12051700|FG000|Overall Study|Lack of Efficacy|89
7637500|NCT02773849|12051700|FG000|Overall Study|Withdrawal by Subject|1
7637501|NCT02773849|12051700|FG000|Overall Study|Withdrawal of Consent|1
7637502|NCT02770716|12051724|FG000|Overall Study|Death|101
7637503|NCT02770716|12051725|FG001|Overall Study|Death|45
7637504|NCT02770716|12051724|FG000|Overall Study|Withdrawal by Subject|4
7637505|NCT02770716|12051725|FG001|Overall Study|Withdrawal by Subject|2
7637506|NCT02770716|12051724|FG000|Overall Study|Lost to Follow-up|1
7637507|NCT02770716|12051725|FG001|Overall Study|Lost to Follow-up|0
7637508|NCT02770716|12051724|FG000|Overall Study|Various reasons|6
7637509|NCT02770716|12051725|FG001|Overall Study|Various reasons|2
7637510|NCT02768792|12051731|FG000|Overall Study|Adverse Event|1
7637511|NCT02766478|12051744|FG000|Overall Study|Withdrawal by Subject|1
7637512|NCT02766478|12051745|FG001|Overall Study|Withdrawal by Subject|1
7637513|NCT02763566|12051755|FG000|Overall Study|Lost to Follow-up|1
7637514|NCT02763566|12051756|FG001|Overall Study|Lost to Follow-up|4
7637515|NCT02763566|12051757|FG002|Overall Study|Lost to Follow-up|0
7637516|NCT02763566|12051758|FG003|Overall Study|Lost to Follow-up|1
7637517|NCT02763566|12051755|FG000|Overall Study|On study treatment at study conclusion|114
7637518|NCT02763566|12051756|FG001|Overall Study|On study treatment at study conclusion|34
7637519|NCT02763566|12051757|FG002|Overall Study|On study treatment at study conclusion|54
7637520|NCT02763566|12051758|FG003|Overall Study|On study treatment at study conclusion|13
7637521|NCT02763566|12051755|FG000|Overall Study|Withdrawal by Subject|3
7637522|NCT02763566|12051756|FG001|Overall Study|Withdrawal by Subject|1
7637523|NCT02763566|12051757|FG002|Overall Study|Withdrawal by Subject|0
7637524|NCT02763566|12051758|FG003|Overall Study|Withdrawal by Subject|0
7637525|NCT02761057|12051776|FG000|Overall Study|Currently On Study Treatment|0
7637526|NCT02761057|12051777|FG001|Overall Study|Currently On Study Treatment|3
7637527|NCT02761057|12051778|FG002|Overall Study|Currently On Study Treatment|0
7637528|NCT02761057|12051779|FG003|Overall Study|Currently On Study Treatment|0
7637529|NCT02761057|12051776|FG000|Overall Study|Adverse Event|11
7637530|NCT02761057|12051777|FG001|Overall Study|Adverse Event|9
7637531|NCT02761057|12051778|FG002|Overall Study|Adverse Event|5
7637532|NCT02761057|12051779|FG003|Overall Study|Adverse Event|3
7637533|NCT02761057|12051776|FG000|Overall Study|Refusal Unrelated to Adverse Event|2
7637534|NCT02761057|12051777|FG001|Overall Study|Refusal Unrelated to Adverse Event|2
7637535|NCT02761057|12051778|FG002|Overall Study|Refusal Unrelated to Adverse Event|0
7637536|NCT02761057|12051779|FG003|Overall Study|Refusal Unrelated to Adverse Event|2
7637537|NCT02761057|12051776|FG000|Overall Study|Progression/Relapse|29
7637538|NCT02761057|12051777|FG001|Overall Study|Progression/Relapse|27
7637539|NCT02761057|12051778|FG002|Overall Study|Progression/Relapse|20
7637540|NCT02761057|12051779|FG003|Overall Study|Progression/Relapse|23
7637541|NCT02761057|12051776|FG000|Overall Study|Death|2
7637542|NCT02761057|12051777|FG001|Overall Study|Death|2
7637543|NCT02761057|12051778|FG002|Overall Study|Death|1
7637544|NCT02761057|12051779|FG003|Overall Study|Death|1
7637545|NCT02761057|12051776|FG000|Overall Study|Other - Not Protocol Specified|2
7637546|NCT02761057|12051777|FG001|Overall Study|Other - Not Protocol Specified|1
7637547|NCT02761057|12051778|FG002|Overall Study|Other - Not Protocol Specified|2
7637548|NCT02761057|12051779|FG003|Overall Study|Other - Not Protocol Specified|0
7637549|NCT02747927|12051800|FG000|Overall Study|Adverse Event|5
7637550|NCT02747927|12051801|FG001|Overall Study|Adverse Event|14
7637551|NCT02747927|12051800|FG000|Overall Study|Lost to Follow-up|22
7637552|NCT02747927|12051801|FG001|Overall Study|Lost to Follow-up|43
7637553|NCT02747927|12051800|FG000|Overall Study|Pregnancy|34
7637554|NCT02747927|12051801|FG001|Overall Study|Pregnancy|66
7637555|NCT02747927|12051800|FG000|Overall Study|Protocol Violation|2
7637556|NCT02747927|12051801|FG001|Overall Study|Protocol Violation|4
7637557|NCT02747927|12051800|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147
7637558|NCT02747927|12051801|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304
7637559|NCT02747927|12051800|FG000|Overall Study|Reason not Specified|11
7637560|NCT02747927|12051801|FG001|Overall Study|Reason not Specified|27
7637561|NCT02747043|12051809|FG000|Overall Study|Other|1
7637562|NCT02747043|12051810|FG001|Overall Study|Other|1
7637563|NCT02747043|12051809|FG000|Overall Study|Adverse Event|3
7637564|NCT02747043|12051810|FG001|Overall Study|Adverse Event|1
7637565|NCT02747043|12051809|FG000|Overall Study|Withdrawal by Subject|1
7637566|NCT02747043|12051810|FG001|Overall Study|Withdrawal by Subject|1
7637567|NCT02747043|12051809|FG000|Overall Study|Physician Decision|1
7637568|NCT02747043|12051810|FG001|Overall Study|Physician Decision|1
7637569|NCT02747043|12051809|FG000|Overall Study|Protocol Violation|0
7637570|NCT02747043|12051810|FG001|Overall Study|Protocol Violation|1
7637571|NCT02747043|12051809|FG000|Overall Study|Disease progression|4
7637572|NCT02747043|12051810|FG001|Overall Study|Disease progression|0
7637573|NCT02747004|12051819|FG000|Overall Study|Withdrawal by Subject|8
7637574|NCT02747004|12051820|FG001|Overall Study|Withdrawal by Subject|5
7637575|NCT02747004|12051821|FG002|Overall Study|Withdrawal by Subject|4
7637576|NCT02747004|12051819|FG000|Overall Study|Lost to Follow-up|1
7637577|NCT02747004|12051820|FG001|Overall Study|Lost to Follow-up|2
7637578|NCT02747004|12051821|FG002|Overall Study|Lost to Follow-up|2
7637579|NCT02747004|12051819|FG000|Overall Study|on study treatment/follow-up|48
7637580|NCT02747004|12051820|FG001|Overall Study|on study treatment/follow-up|42
7637581|NCT02747004|12051821|FG002|Overall Study|on study treatment/follow-up|41
7637582|NCT02743494|12051835|FG000|Pre-treatment Period|Participant request to discontinue treatment|0
7637583|NCT02743494|12051836|FG001|Pre-treatment Period|Participant request to discontinue treatment|1
7637584|NCT02743494|12051835|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0
7637585|NCT02743494|12051836|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1
7637586|NCT02743494|12051835|FG000|Treatment Period|Completed treatment|229
7637587|NCT02743494|12051836|FG001|Treatment Period|Completed treatment|99
7637588|NCT02743494|12051835|FG000|Treatment Period|Disease recurrence|149
7637589|NCT02743494|12051836|FG001|Treatment Period|Disease recurrence|113
7637590|NCT02743494|12051835|FG000|Treatment Period|Study drug toxicity|57
7637591|NCT02743494|12051836|FG001|Treatment Period|Study drug toxicity|8
7637592|NCT02743494|12051835|FG000|Treatment Period|Death|1
7637593|NCT02743494|12051836|FG001|Treatment Period|Death|0
7637594|NCT02743494|12051835|FG000|Treatment Period|Adverse event unrelated to study drug|15
7637595|NCT02743494|12051836|FG001|Treatment Period|Adverse event unrelated to study drug|9
7637596|NCT02743494|12051835|FG000|Treatment Period|Participant request to discontinue treatment|30
7637597|NCT02743494|12051836|FG001|Treatment Period|Participant request to discontinue treatment|5
7637598|NCT02743494|12051835|FG000|Treatment Period|Participant withdrew consent|12
7637599|NCT02743494|12051836|FG001|Treatment Period|Participant withdrew consent|4
7637600|NCT02743494|12051835|FG000|Treatment Period|Lost to Follow-up|0
7637601|NCT02743494|12051836|FG001|Treatment Period|Lost to Follow-up|1
7637602|NCT02743494|12051835|FG000|Treatment Period|Poor/Non-compliance|1
7637603|NCT02743494|12051836|FG001|Treatment Period|Poor/Non-compliance|0
7637604|NCT02743494|12051835|FG000|Treatment Period|Other reasons|7
7637605|NCT02743494|12051836|FG001|Treatment Period|Other reasons|2
7637606|NCT02741570|12051844|FG000|Pre-Treatment Period|Other reasons|0
7637607|NCT02741570|12051845|FG001|Pre-Treatment Period|Other reasons|3
7637608|NCT02741570|12051844|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3
7637609|NCT02741570|12051845|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6
7637610|NCT02741570|12051844|FG000|Pre-Treatment Period|Poor/non-compliance|0
7637611|NCT02741570|12051845|FG001|Pre-Treatment Period|Poor/non-compliance|1
7637612|NCT02741570|12051844|FG000|Pre-Treatment Period|Lost to Follow-up|0
7637613|NCT02741570|12051845|FG001|Pre-Treatment Period|Lost to Follow-up|2
7637614|NCT02741570|12051844|FG000|Pre-Treatment Period|Participant withdrew consent|0
7637615|NCT02741570|12051845|FG001|Pre-Treatment Period|Participant withdrew consent|18
7637616|NCT02741570|12051844|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0
7637617|NCT02741570|12051845|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2
7637618|NCT02741570|12051844|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1
7637619|NCT02741570|12051845|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0
7637620|NCT02741570|12051844|FG000|Pre-Treatment Period|Death|0
7637621|NCT02741570|12051845|FG001|Pre-Treatment Period|Death|1
7637622|NCT02741570|12051844|FG000|Pre-Treatment Period|Disease progression|0
7637623|NCT02741570|12051845|FG001|Pre-Treatment Period|Disease progression|1
7637624|NCT02741570|12051844|FG000|Treatment Period|Other reasons|47
7637625|NCT02741570|12051845|FG001|Treatment Period|Other reasons|8
7637626|NCT02741570|12051844|FG000|Treatment Period|Poor/non-compliance|0
7637627|NCT02741570|12051845|FG001|Treatment Period|Poor/non-compliance|1
7637628|NCT02741570|12051844|FG000|Treatment Period|Maximum clinical benefit|3
7637629|NCT02741570|12051845|FG001|Treatment Period|Maximum clinical benefit|5
7637630|NCT02741570|12051844|FG000|Treatment Period|Lost to Follow-up|1
7637631|NCT02741570|12051845|FG001|Treatment Period|Lost to Follow-up|3
7637632|NCT02741570|12051844|FG000|Treatment Period|Participant withdrew consent|9
7637633|NCT02741570|12051845|FG001|Treatment Period|Participant withdrew consent|13
7637634|NCT02741570|12051844|FG000|Treatment Period|Participant request to discontinue treatment|8
7637635|NCT02741570|12051845|FG001|Treatment Period|Participant request to discontinue treatment|23
7637636|NCT02741570|12051844|FG000|Treatment Period|Adverse event unrelated to study drug|41
7637637|NCT02741570|12051845|FG001|Treatment Period|Adverse event unrelated to study drug|25
7637638|NCT02741570|12051844|FG000|Treatment Period|Death|9
7637639|NCT02741570|12051845|FG001|Treatment Period|Death|7
7637640|NCT02741570|12051844|FG000|Treatment Period|Study drug toxicity|55
7637641|NCT02741570|12051845|FG001|Treatment Period|Study drug toxicity|45
7637642|NCT02741570|12051844|FG000|Treatment Period|Disease progression|295
7637643|NCT02741570|12051845|FG001|Treatment Period|Disease progression|304
7637644|NCT02735421|12051851|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2
7637645|NCT02735421|12051851|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6
7637646|NCT02735421|12051851|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3
7637647|NCT02735421|12051851|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1
7637648|NCT02735421|12051851|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1
7637649|NCT02735421|12051851|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1
7637650|NCT02735421|12051851|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3
7637651|NCT02730169|12051871|FG000|Overall Study|Protocol Violation|1
7637652|NCT02730169|12051872|FG001|Overall Study|Protocol Violation|0
7637653|NCT02730169|12051873|FG002|Overall Study|Protocol Violation|0
7637654|NCT02730169|12051874|FG003|Overall Study|Protocol Violation|1
7637655|NCT02730169|12051871|FG000|Overall Study|Adverse Event|2
7637656|NCT02730169|12051872|FG001|Overall Study|Adverse Event|3
7637657|NCT02730169|12051873|FG002|Overall Study|Adverse Event|3
7637658|NCT02730169|12051874|FG003|Overall Study|Adverse Event|0
7637659|NCT02730169|12051871|FG000|Overall Study|Adverse Event of Special Interest|0
7637660|NCT02730169|12051872|FG001|Overall Study|Adverse Event of Special Interest|1
7637661|NCT02730169|12051873|FG002|Overall Study|Adverse Event of Special Interest|2
7637662|NCT02730169|12051874|FG003|Overall Study|Adverse Event of Special Interest|0
7637663|NCT02730169|12051871|FG000|Overall Study|Withdrawal by Subject|6
7637664|NCT02730169|12051872|FG001|Overall Study|Withdrawal by Subject|11
7637665|NCT02730169|12051873|FG002|Overall Study|Withdrawal by Subject|6
7637666|NCT02730169|12051874|FG003|Overall Study|Withdrawal by Subject|8
7637667|NCT02730169|12051871|FG000|Overall Study|Lost to Follow-up|5
7637668|NCT02730169|12051872|FG001|Overall Study|Lost to Follow-up|6
7637669|NCT02730169|12051873|FG002|Overall Study|Lost to Follow-up|5
7637670|NCT02730169|12051874|FG003|Overall Study|Lost to Follow-up|6
7637671|NCT02730169|12051871|FG000|Overall Study|Other|0
7637672|NCT02730169|12051872|FG001|Overall Study|Other|0
7637673|NCT02730169|12051873|FG002|Overall Study|Other|1
7637674|NCT02730169|12051874|FG003|Overall Study|Other|1
7637675|NCT02729025|12051886|FG000|Overall Study|Sponsor Decision|0
7637676|NCT02729025|12051887|FG001|Overall Study|Sponsor Decision|1
7637677|NCT02728102|12051896|FG000|Overall Study|Death|3
7637678|NCT02728102|12051897|FG001|Overall Study|Death|0
7637679|NCT02728102|12051898|FG002|Overall Study|Death|1
7637680|NCT02728102|12051896|FG000|Overall Study|Withdrawal by Subject|0
7637681|NCT02728102|12051897|FG001|Overall Study|Withdrawal by Subject|2
7637682|NCT02728102|12051898|FG002|Overall Study|Withdrawal by Subject|3
7637683|NCT02728102|12051896|FG000|Overall Study|Physician Decision|1
7637684|NCT02728102|12051897|FG001|Overall Study|Physician Decision|1
7637685|NCT02728102|12051898|FG002|Overall Study|Physician Decision|0
7637686|NCT02728102|12051896|FG000|Overall Study|Investigational study drug permanently discontinued|3
7637687|NCT02728102|12051897|FG001|Overall Study|Investigational study drug permanently discontinued|1
7637688|NCT02728102|12051898|FG002|Overall Study|Investigational study drug permanently discontinued|0
7637689|NCT02728102|12051896|FG000|Overall Study|Covid|0
7637690|NCT02728102|12051897|FG001|Overall Study|Covid|0
7637691|NCT02728102|12051898|FG002|Overall Study|Covid|1
7637692|NCT02717611|12051957|FG000|Overall Study|Death|13
7637693|NCT02717611|12051957|FG000|Overall Study|Withdrawal by Subject|6
7637694|NCT02717611|12051957|FG000|Overall Study|Active, not recruiting|40
7637695|NCT02717611|12051957|FG000|Overall Study|Complicating disease|1
7637696|NCT02714062|12051968|FG000|Overall Study|Adverse Event|0
7637697|NCT02714062|12051969|FG001|Overall Study|Adverse Event|0
7637698|NCT02714062|12051970|FG002|Overall Study|Adverse Event|2
7637699|NCT02714062|12051968|FG000|Overall Study|Withdrawal by Subject|1
7637700|NCT02714062|12051969|FG001|Overall Study|Withdrawal by Subject|0
7637701|NCT02714062|12051970|FG002|Overall Study|Withdrawal by Subject|1
7637702|NCT02714062|12051968|FG000|Overall Study|Protocol Violation|0
7637703|NCT02714062|12051969|FG001|Overall Study|Protocol Violation|1
7637704|NCT02714062|12051970|FG002|Overall Study|Protocol Violation|0
7637705|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2
7637706|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0
7637707|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0
7637708|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0
7637709|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0
7637710|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8
7637711|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0
7637712|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0
7637713|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0
7637714|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0
7637715|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3
7637716|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0
7637717|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0
7637718|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0
7637719|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0
7637720|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3
7637721|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0
7637722|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0
7637723|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0
7637724|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0
7637725|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15
7637726|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0
7637727|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0
7637728|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0
7637729|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0
7637730|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1
7637731|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0
7637732|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0
7637733|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0
7637734|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0
7637735|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85
7637736|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0
7637737|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0
7637738|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0
7637739|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0
7637740|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20
7637741|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0
7637742|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0
7637743|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0
7637744|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0
7637745|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6
7637746|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0
7637747|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0
7637748|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0
7637749|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0
7637750|NCT02709655|12051984|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0
7637751|NCT02709655|12051985|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1
7637752|NCT02709655|12051986|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2
7637753|NCT02709655|12051987|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3
7637754|NCT02709655|12051988|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0
7637755|NCT02709655|12051984|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0
7637756|NCT02709655|12051985|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2
7637757|NCT02709655|12051986|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0
7637758|NCT02709655|12051987|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0
7637759|NCT02709655|12051988|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1
7637760|NCT02709655|12051984|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0
7637761|NCT02709655|12051985|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1
7637762|NCT02709655|12051986|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3
7637763|NCT02709655|12051987|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6
7637764|NCT02709655|12051988|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1
7637765|NCT02709655|12051984|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0
7637766|NCT02709655|12051985|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1
7637767|NCT02709655|12051986|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0
7637768|NCT02709655|12051987|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0
7637769|NCT02709655|12051988|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0
7637770|NCT02709655|12051984|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0
7637771|NCT02709655|12051985|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4
7637772|NCT02709655|12051986|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4
7637773|NCT02709655|12051987|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4
7637774|NCT02709655|12051988|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1
7637775|NCT02709655|12051984|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0
7637776|NCT02709655|12051985|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1
7637777|NCT02709655|12051986|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0
7637778|NCT02709655|12051987|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2
7637779|NCT02709655|12051988|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0
7637780|NCT02709655|12051984|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0
7637781|NCT02709655|12051985|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5
7637782|NCT02709655|12051986|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7
7637783|NCT02709655|12051987|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5
7637784|NCT02709655|12051988|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2
7637785|NCT02706951|12052022|FG000|Overall Study|Adverse Event|1
7637786|NCT02706951|12052023|FG001|Overall Study|Adverse Event|5
7637787|NCT02706951|12052024|FG002|Overall Study|Adverse Event|3
7637788|NCT02706951|12052022|FG000|Overall Study|Withdrawal by Subject|11
7637789|NCT02706951|12052023|FG001|Overall Study|Withdrawal by Subject|6
7637790|NCT02706951|12052024|FG002|Overall Study|Withdrawal by Subject|6
7637791|NCT02706951|12052022|FG000|Overall Study|Lost to Follow-up|0
7637792|NCT02706951|12052023|FG001|Overall Study|Lost to Follow-up|4
7637793|NCT02706951|12052024|FG002|Overall Study|Lost to Follow-up|1
7637794|NCT02706951|12052022|FG000|Overall Study|Other|2
7637795|NCT02706951|12052023|FG001|Overall Study|Other|1
7637796|NCT02706951|12052024|FG002|Overall Study|Other|0
7637797|NCT02706405|12052040|FG000|Overall Study|Death|3
7637798|NCT02706405|12052041|FG001|Overall Study|Death|2
7637799|NCT02706405|12052042|FG002|Overall Study|Death|0
7637800|NCT02706405|12052043|FG003|Overall Study|Death|1
7637801|NCT02706405|12052044|FG004|Overall Study|Death|0
7637802|NCT02706405|12052045|FG005|Overall Study|Death|0
7637803|NCT02706405|12052046|FG006|Overall Study|Death|3
7637804|NCT02706405|12052047|FG007|Overall Study|Death|4
7637805|NCT02706405|12052040|FG000|Overall Study|Disease progression|0
7637806|NCT02706405|12052041|FG001|Overall Study|Disease progression|0
7637807|NCT02706405|12052042|FG002|Overall Study|Disease progression|0
7637808|NCT02706405|12052043|FG003|Overall Study|Disease progression|0
7637809|NCT02706405|12052044|FG004|Overall Study|Disease progression|0
7637810|NCT02706405|12052045|FG005|Overall Study|Disease progression|0
7637811|NCT02706405|12052046|FG006|Overall Study|Disease progression|0
7637812|NCT02706405|12052047|FG007|Overall Study|Disease progression|1
7637813|NCT02706405|12052040|FG000|Overall Study|Pt moved to new therapy|0
7637814|NCT02706405|12052041|FG001|Overall Study|Pt moved to new therapy|0
7637815|NCT02706405|12052042|FG002|Overall Study|Pt moved to new therapy|0
7637816|NCT02706405|12052043|FG003|Overall Study|Pt moved to new therapy|0
7637817|NCT02706405|12052044|FG004|Overall Study|Pt moved to new therapy|0
7637818|NCT02706405|12052045|FG005|Overall Study|Pt moved to new therapy|1
7637819|NCT02706405|12052046|FG006|Overall Study|Pt moved to new therapy|0
7637820|NCT02706405|12052047|FG007|Overall Study|Pt moved to new therapy|1
7637821|NCT02706405|12052040|FG000|Overall Study|Physician Decision|1
7637822|NCT02706405|12052041|FG001|Overall Study|Physician Decision|0
7637823|NCT02706405|12052042|FG002|Overall Study|Physician Decision|0
7637824|NCT02706405|12052043|FG003|Overall Study|Physician Decision|0
7637825|NCT02706405|12052044|FG004|Overall Study|Physician Decision|0
7637826|NCT02706405|12052045|FG005|Overall Study|Physician Decision|0
7637827|NCT02706405|12052046|FG006|Overall Study|Physician Decision|0
7637828|NCT02706405|12052047|FG007|Overall Study|Physician Decision|0
7637829|NCT02706392|12052079|FG000|Overall Study|Death|1
7637830|NCT02706392|12052080|FG001|Overall Study|Death|0
7637831|NCT02706392|12052081|FG002|Overall Study|Death|2
7637832|NCT02706392|12052082|FG003|Overall Study|Death|2
7637833|NCT02706392|12052083|FG004|Overall Study|Death|5
7637834|NCT02706392|12052084|FG005|Overall Study|Death|2
7637835|NCT02705755|12052098|FG000|Part A (6 Days)|Adverse Event|1
7637836|NCT02705755|12052099|FG001|Part A (6 Days)|Adverse Event|0
7637837|NCT02705755|12052100|FG002|Part A (6 Days)|Adverse Event|0
7637838|NCT02705755|12052101|FG003|Part A (6 Days)|Adverse Event|0
7637839|NCT02705755|12052098|FG000|Part A (6 Days)|Physician Decision|3
7637840|NCT02705755|12052099|FG001|Part A (6 Days)|Physician Decision|0
7637841|NCT02705755|12052100|FG002|Part A (6 Days)|Physician Decision|0
7637842|NCT02705755|12052101|FG003|Part A (6 Days)|Physician Decision|0
7637843|NCT02705755|12052098|FG000|Part A (6 Days)|Withdrawal by Subject|1
7637844|NCT02705755|12052099|FG001|Part A (6 Days)|Withdrawal by Subject|0
7637845|NCT02705755|12052100|FG002|Part A (6 Days)|Withdrawal by Subject|0
7637846|NCT02705755|12052101|FG003|Part A (6 Days)|Withdrawal by Subject|0
7637847|NCT02705755|12052098|FG000|Part C (20 Weeks)|Physician Decision|0
7637848|NCT02705755|12052099|FG001|Part C (20 Weeks)|Physician Decision|0
7637849|NCT02705755|12052100|FG002|Part C (20 Weeks)|Physician Decision|0
7637850|NCT02705755|12052101|FG003|Part C (20 Weeks)|Physician Decision|2
7637851|NCT02705755|12052098|FG000|Part C (20 Weeks)|Adverse Event|0
7637852|NCT02705755|12052099|FG001|Part C (20 Weeks)|Adverse Event|0
7637853|NCT02705755|12052100|FG002|Part C (20 Weeks)|Adverse Event|0
7637854|NCT02705755|12052101|FG003|Part C (20 Weeks)|Adverse Event|6
7637855|NCT02705755|12052098|FG000|Part C (20 Weeks)|Withdrawal by Subject|0
7637856|NCT02705755|12052099|FG001|Part C (20 Weeks)|Withdrawal by Subject|0
7637857|NCT02705755|12052100|FG002|Part C (20 Weeks)|Withdrawal by Subject|0
7637858|NCT02705755|12052101|FG003|Part C (20 Weeks)|Withdrawal by Subject|2
7637859|NCT02705105|12052136|FG000|Treatment|Objective Disease Progression|1
7637860|NCT02705105|12052137|FG001|Treatment|Objective Disease Progression|50
7637861|NCT02705105|12052136|FG000|Treatment|Withdrawal by Subject|3
7637862|NCT02705105|12052137|FG001|Treatment|Withdrawal by Subject|5
7637863|NCT02705105|12052136|FG000|Treatment|Adverse Event|0
7637864|NCT02705105|12052137|FG001|Treatment|Adverse Event|17
7637865|NCT02705105|12052136|FG000|Treatment|Clinical Disease Progression|0
7637866|NCT02705105|12052137|FG001|Treatment|Clinical Disease Progression|32
7637867|NCT02705105|12052136|FG000|Treatment|Physician Decision|0
7637868|NCT02705105|12052137|FG001|Treatment|Physician Decision|3
7637869|NCT02705105|12052136|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0
7637870|NCT02705105|12052137|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2
7637871|NCT02705105|12052136|FG000|Follow-Up|Death|3
7637872|NCT02705105|12052137|FG001|Follow-Up|Death|68
7637873|NCT02705105|12052136|FG000|Follow-Up|Withdrawal by Subject|1
7637874|NCT02705105|12052137|FG001|Follow-Up|Withdrawal by Subject|14
7637875|NCT02705105|12052136|FG000|Follow-Up|Study Terminated|0
7637876|NCT02705105|12052137|FG001|Follow-Up|Study Terminated|26
7637877|NCT02705105|12052136|FG000|Follow-Up|Discontinued per Amendment 3|0
7637878|NCT02705105|12052137|FG001|Follow-Up|Discontinued per Amendment 3|2
7637879|NCT02698189|12052161|FG000|Overall Study|Physician Decision|3
7637880|NCT02698189|12052162|FG001|Overall Study|Physician Decision|0
7637881|NCT02698189|12052161|FG000|Overall Study|Progressive disease|0
7637882|NCT02698189|12052162|FG001|Overall Study|Progressive disease|5
7637883|NCT02698189|12052161|FG000|Overall Study|Study terminated by sponsor|0
7637884|NCT02698189|12052162|FG001|Overall Study|Study terminated by sponsor|1
7637885|NCT02696096|12052179|FG000|Overall Study|ruled out at screening|1
7637886|NCT02696096|12052179|FG000|Overall Study|did not attend second fMRI|1
7637887|NCT02689284|12052189|FG000|Overall Study|Adverse Event|1
7637888|NCT02689284|12052190|FG001|Overall Study|Adverse Event|8
7637889|NCT02689284|12052189|FG000|Overall Study|Death|0
7637890|NCT02689284|12052190|FG001|Overall Study|Death|1
7637891|NCT02689284|12052189|FG000|Overall Study|Physician Decision|1
7637892|NCT02689284|12052190|FG001|Overall Study|Physician Decision|2
7637893|NCT02689284|12052189|FG000|Overall Study|Withdrawal by Subject|0
7637894|NCT02689284|12052190|FG001|Overall Study|Withdrawal by Subject|1
7637895|NCT02689284|12052189|FG000|Overall Study|progression of cancer|1
7637896|NCT02689284|12052190|FG001|Overall Study|progression of cancer|72
7637897|NCT02689284|12052189|FG000|Overall Study|decreased heart function|0
7637898|NCT02689284|12052190|FG001|Overall Study|decreased heart function|1
7637899|NCT02689284|12052189|FG000|Overall Study|concern for anemia|0
7637900|NCT02689284|12052190|FG001|Overall Study|concern for anemia|1
7637901|NCT02689284|12052189|FG000|Overall Study|no measurable cancer for evaluation|0
7637902|NCT02689284|12052190|FG001|Overall Study|no measurable cancer for evaluation|1
7637903|NCT02688647|12052199|FG000|Initial Treatment Period (24 Weeks)|Death|0
7637904|NCT02688647|12052200|FG001|Initial Treatment Period (24 Weeks)|Death|1
7637905|NCT02688647|12052199|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0
7637906|NCT02688647|12052200|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5
7637907|NCT02688647|12052199|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1
7637908|NCT02688647|12052200|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0
7637909|NCT02688647|12052199|FG000|Post Switch Treatment Period (72 Weeks)|Death|7
7637910|NCT02688647|12052200|FG001|Post Switch Treatment Period (72 Weeks)|Death|2
7637911|NCT02688647|12052199|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1
7637912|NCT02688647|12052200|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0
7637913|NCT02688647|12052199|FG000|Post Switch Treatment Period (72 Weeks)|Other|10
7637914|NCT02688647|12052200|FG001|Post Switch Treatment Period (72 Weeks)|Other|6
7637915|NCT02688647|12052199|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10
7637916|NCT02688647|12052200|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6
7637917|NCT02685826|12052230|FG000|Overall Study|Adverse Event|2
7637918|NCT02685826|12052231|FG001|Overall Study|Adverse Event|0
7637919|NCT02685826|12052232|FG002|Overall Study|Adverse Event|1
7637920|NCT02685826|12052230|FG000|Overall Study|Progressive Disease|2
7637921|NCT02685826|12052231|FG001|Overall Study|Progressive Disease|1
7637922|NCT02685826|12052232|FG002|Overall Study|Progressive Disease|0
7637923|NCT02685826|12052230|FG000|Overall Study|Withdrawal by Subject|2
7637924|NCT02685826|12052231|FG001|Overall Study|Withdrawal by Subject|0
7637925|NCT02685826|12052232|FG002|Overall Study|Withdrawal by Subject|0
7637926|NCT02685826|12052230|FG000|Overall Study|Full Clinical Hold by FDA|19
7637927|NCT02685826|12052231|FG001|Overall Study|Full Clinical Hold by FDA|9
7637928|NCT02685826|12052232|FG002|Overall Study|Full Clinical Hold by FDA|20
7637929|NCT02680587|12052242|FG000|Overall Study|Withdrawal by Subject|1
7637930|NCT02680587|12052243|FG001|Overall Study|Withdrawal by Subject|0
7637931|NCT02679755|12052264|FG000|Overall Study|Death|0
7637932|NCT02679755|12052265|FG001|Overall Study|Death|3
7637933|NCT02679755|12052264|FG000|Overall Study|Global deterioration of health status|1
7637934|NCT02679755|12052265|FG001|Overall Study|Global deterioration of health status|8
7637935|NCT02679755|12052264|FG000|Overall Study|Lost to Follow-up|1
7637936|NCT02679755|12052265|FG001|Overall Study|Lost to Follow-up|0
7637937|NCT02679755|12052264|FG000|Overall Study|Objective progression or relapse|24
7637938|NCT02679755|12052265|FG001|Overall Study|Objective progression or relapse|83
7637939|NCT02679755|12052264|FG000|Overall Study|Not defined|0
7637940|NCT02679755|12052265|FG001|Overall Study|Not defined|2
7637941|NCT02679755|12052264|FG000|Overall Study|Withdrawal by participant|6
7637942|NCT02679755|12052265|FG001|Overall Study|Withdrawal by participant|3
7637943|NCT02679755|12052264|FG000|Overall Study|Adverse Event|1
7637944|NCT02679755|12052265|FG001|Overall Study|Adverse Event|4
7637945|NCT02679755|12052264|FG000|Overall Study|Adverse events not related to study drug|1
7637946|NCT02679755|12052265|FG001|Overall Study|Adverse events not related to study drug|2
7637947|NCT02677896|12052276|FG000|Double Blind Period (up to 35 Months)|Death|113
7637948|NCT02677896|12052277|FG001|Double Blind Period (up to 35 Months)|Death|189
7637949|NCT02677896|12052276|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12
7637950|NCT02677896|12052277|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12
7637951|NCT02677896|12052276|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3
7637952|NCT02677896|12052277|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4
7637953|NCT02677896|12052276|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41
7637954|NCT02677896|12052277|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69
7637955|NCT02677896|12052276|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9
7637956|NCT02677896|12052277|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14
7637957|NCT02677896|12052276|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365
7637958|NCT02677896|12052277|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180
7637959|NCT02677896|12052276|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31
7637960|NCT02677896|12052277|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108
7637961|NCT02677896|12052276|FG000|Open-Label Extension (up to 25 Months)|Death|40
7637962|NCT02677896|12052277|FG001|Open-Label Extension (up to 25 Months)|Death|14
7637963|NCT02677896|12052276|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2
7637964|NCT02677896|12052277|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1
7637965|NCT02677896|12052276|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3
7637966|NCT02677896|12052277|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1
7637967|NCT02677896|12052276|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10
7637968|NCT02677896|12052277|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9
7637969|NCT02677896|12052276|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0
7637970|NCT02677896|12052277|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1
7637971|NCT02677896|12052276|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261
7637972|NCT02677896|12052277|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136
7637973|NCT02677896|12052276|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49
7637974|NCT02677896|12052277|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18
7637975|NCT02675231|12052287|FG000|Overall Study|Withdrawal by Subject|1
7637976|NCT02675231|12052288|FG001|Overall Study|Withdrawal by Subject|3
7637977|NCT02675231|12052289|FG002|Overall Study|Withdrawal by Subject|1
7637978|NCT02675231|12052287|FG000|Overall Study|Lost to Follow-up|2
7637979|NCT02675231|12052288|FG001|Overall Study|Lost to Follow-up|2
7637980|NCT02675231|12052289|FG002|Overall Study|Lost to Follow-up|2
7637981|NCT02675231|12052287|FG000|Overall Study|On study treatment/follow up|23
7637982|NCT02675231|12052288|FG001|Overall Study|On study treatment/follow up|31
7637983|NCT02675231|12052289|FG002|Overall Study|On study treatment/follow up|23
7637984|NCT02673697|12052300|FG000|Overall Study|Adverse Event|2
7637985|NCT02673697|12052301|FG001|Overall Study|Adverse Event|0
7637986|NCT02673697|12052300|FG000|Overall Study|Death|32
7637987|NCT02673697|12052301|FG001|Overall Study|Death|24
7637988|NCT02673697|12052300|FG000|Overall Study|Lost to Follow-up|5
7637989|NCT02673697|12052301|FG001|Overall Study|Lost to Follow-up|2
7637990|NCT02673697|12052300|FG000|Overall Study|Physician Decision|2
7637991|NCT02673697|12052301|FG001|Overall Study|Physician Decision|1
7637992|NCT02673697|12052300|FG000|Overall Study|Withdrawal by Subject|10
7637993|NCT02673697|12052301|FG001|Overall Study|Withdrawal by Subject|7
7637994|NCT02673697|12052300|FG000|Overall Study|Change subj medical status|1
7637995|NCT02673697|12052301|FG001|Overall Study|Change subj medical status|2
7637996|NCT02673697|12052300|FG000|Overall Study|Explant|10
7637997|NCT02673697|12052301|FG001|Overall Study|Explant|5
7637998|NCT02673697|12052300|FG000|Overall Study|Sponsor Decision to stop follow up|391
7637999|NCT02673697|12052301|FG001|Overall Study|Sponsor Decision to stop follow up|416
7638000|NCT02667587|12052313|FG000|Pre-Treatment|Not reported|1
7638001|NCT02667587|12052314|FG001|Pre-Treatment|Not reported|0
7638002|NCT02667587|12052313|FG000|Pre-Treatment|Participant no longer meets study criteria|2
7638003|NCT02667587|12052314|FG001|Pre-Treatment|Participant no longer meets study criteria|2
7638004|NCT02667587|12052313|FG000|Pre-Treatment|Participant withdrew consent|0
7638005|NCT02667587|12052314|FG001|Pre-Treatment|Participant withdrew consent|1
7638006|NCT02667587|12052313|FG000|Pre-Treatment|Adverse event unrelated to study drug|1
7638007|NCT02667587|12052314|FG001|Pre-Treatment|Adverse event unrelated to study drug|0
7638008|NCT02667587|12052313|FG000|End of Treatment|Other reasons|11
7638009|NCT02667587|12052314|FG001|End of Treatment|Other reasons|8
7638010|NCT02667587|12052313|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1
7638011|NCT02667587|12052314|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2
7638012|NCT02667587|12052313|FG000|End of Treatment|Poor/Non-Compliance|0
7638013|NCT02667587|12052314|FG001|End of Treatment|Poor/Non-Compliance|1
7638014|NCT02667587|12052313|FG000|End of Treatment|Maximum Clinical Benefit|3
7638015|NCT02667587|12052314|FG001|End of Treatment|Maximum Clinical Benefit|3
7638016|NCT02667587|12052313|FG000|End of Treatment|Participant Withdrew Consent|5
7638017|NCT02667587|12052314|FG001|End of Treatment|Participant Withdrew Consent|6
7638018|NCT02667587|12052313|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25
7638019|NCT02667587|12052314|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26
7638020|NCT02667587|12052313|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19
7638021|NCT02667587|12052314|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20
7638022|NCT02667587|12052313|FG000|End of Treatment|Death|2
7638023|NCT02667587|12052314|FG001|End of Treatment|Death|1
7638024|NCT02667587|12052313|FG000|End of Treatment|Study Drug Toxicity|74
7638025|NCT02667587|12052314|FG001|End of Treatment|Study Drug Toxicity|18
7638026|NCT02667587|12052313|FG000|End of Treatment|Disease progression|177
7638027|NCT02667587|12052314|FG001|End of Treatment|Disease progression|222
7638028|NCT02667587|12052313|FG000|End of Treatment|Lost to Follow-up|1
7638029|NCT02667587|12052314|FG001|End of Treatment|Lost to Follow-up|3
7638030|NCT02667119|12052322|FG000|Overall Study|Lost to Follow-up|3
7638031|NCT02667119|12052323|FG001|Overall Study|Lost to Follow-up|0
7638032|NCT02665338|12052359|FG000|Overall Study|Withdrawal by Subject|0
7638033|NCT02665338|12052360|FG001|Overall Study|Withdrawal by Subject|1
7638034|NCT02660359|12052378|FG000|Overall Study|Protocol Deviation|0
7638035|NCT02660359|12052379|FG001|Overall Study|Protocol Deviation|0
7638036|NCT02660359|12052380|FG002|Overall Study|Protocol Deviation|1
7638037|NCT02660359|12052378|FG000|Overall Study|Sponsor Decision to Terminate Study|73
7638038|NCT02660359|12052379|FG001|Overall Study|Sponsor Decision to Terminate Study|75
7638039|NCT02660359|12052380|FG002|Overall Study|Sponsor Decision to Terminate Study|71
7638040|NCT02660359|12052378|FG000|Overall Study|Lack of Efficacy|1
7638041|NCT02660359|12052379|FG001|Overall Study|Lack of Efficacy|1
7638042|NCT02660359|12052380|FG002|Overall Study|Lack of Efficacy|1
7638043|NCT02660359|12052378|FG000|Overall Study|Adverse Event|0
7638044|NCT02660359|12052379|FG001|Overall Study|Adverse Event|1
7638045|NCT02660359|12052380|FG002|Overall Study|Adverse Event|0
7638046|NCT02660359|12052378|FG000|Overall Study|Other|2
7638047|NCT02660359|12052379|FG001|Overall Study|Other|1
7638048|NCT02660359|12052380|FG002|Overall Study|Other|3
7638049|NCT02660359|12052378|FG000|Overall Study|Withdrawal by Subject|7
7638050|NCT02660359|12052379|FG001|Overall Study|Withdrawal by Subject|5
7638051|NCT02660359|12052380|FG002|Overall Study|Withdrawal by Subject|8
7638052|NCT02660359|12052378|FG000|Overall Study|Lost to Follow-up|3
7638053|NCT02660359|12052379|FG001|Overall Study|Lost to Follow-up|3
7638054|NCT02660359|12052380|FG002|Overall Study|Lost to Follow-up|0
7638055|NCT02660138|12052391|FG000|Overall Study|Adverse Event|0
7638056|NCT02660138|12052392|FG001|Overall Study|Adverse Event|3
7638057|NCT02660138|12052393|FG002|Overall Study|Adverse Event|2
7638058|NCT02660138|12052391|FG000|Overall Study|Lack of Efficacy|1
7638059|NCT02660138|12052392|FG001|Overall Study|Lack of Efficacy|2
7638060|NCT02660138|12052393|FG002|Overall Study|Lack of Efficacy|1
7638061|NCT02660138|12052391|FG000|Overall Study|Withdrawal by Subject|7
7638062|NCT02660138|12052392|FG001|Overall Study|Withdrawal by Subject|6
7638063|NCT02660138|12052393|FG002|Overall Study|Withdrawal by Subject|6
7638064|NCT02660138|12052391|FG000|Overall Study|Lost to Follow-up|4
7638065|NCT02660138|12052392|FG001|Overall Study|Lost to Follow-up|4
7638066|NCT02660138|12052393|FG002|Overall Study|Lost to Follow-up|1
7638067|NCT02660138|12052391|FG000|Overall Study|Sponsor Decision to Terminate Study|57
7638068|NCT02660138|12052392|FG001|Overall Study|Sponsor Decision to Terminate Study|57
7638069|NCT02660138|12052393|FG002|Overall Study|Sponsor Decision to Terminate Study|62
7638070|NCT02660138|12052391|FG000|Overall Study|Other|1
7638071|NCT02660138|12052392|FG001|Overall Study|Other|1
7638072|NCT02660138|12052393|FG002|Overall Study|Other|0
7638073|NCT02660138|12052391|FG000|Overall Study|Not treated|0
7638074|NCT02660138|12052392|FG001|Overall Study|Not treated|1
7638075|NCT02660138|12052393|FG002|Overall Study|Not treated|0
7638076|NCT02659059|12052406|FG000|Overall Study|Completed|1
7638077|NCT02659059|12052407|FG001|Overall Study|Completed|0
7638078|NCT02659059|12052406|FG000|Overall Study|Other reasons|8
7638079|NCT02659059|12052407|FG001|Overall Study|Other reasons|2
7638080|NCT02659059|12052406|FG000|Overall Study|Disease Progression|120
7638081|NCT02659059|12052407|FG001|Overall Study|Disease Progression|16
7638082|NCT02659059|12052406|FG000|Overall Study|Study Drug toxicity|37
7638083|NCT02659059|12052407|FG001|Overall Study|Study Drug toxicity|9
7638084|NCT02659059|12052406|FG000|Overall Study|Death|2
7638085|NCT02659059|12052407|FG001|Overall Study|Death|1
7638086|NCT02659059|12052406|FG000|Overall Study|Adverse Event unrelated to Study drug|22
7638087|NCT02659059|12052407|FG001|Overall Study|Adverse Event unrelated to Study drug|4
7638088|NCT02659059|12052406|FG000|Overall Study|Participant request to discontinue study treatment|5
7638089|NCT02659059|12052407|FG001|Overall Study|Participant request to discontinue study treatment|0
7638090|NCT02659059|12052406|FG000|Overall Study|Participant withdrew consent|4
7638091|NCT02659059|12052407|FG001|Overall Study|Participant withdrew consent|0
7638092|NCT02659059|12052406|FG000|Overall Study|Lost to Follow-up|1
7638093|NCT02659059|12052407|FG001|Overall Study|Lost to Follow-up|0
7638094|NCT02657343|12052420|FG000|Overall Study|Death|0
7638095|NCT02657343|12052421|FG001|Overall Study|Death|2
7638096|NCT02657343|12052422|FG002|Overall Study|Death|0
7638097|NCT02657343|12052423|FG003|Overall Study|Death|0
7638098|NCT02657343|12052424|FG004|Overall Study|Death|0
7638099|NCT02657343|12052425|FG005|Overall Study|Death|0
7638100|NCT02657343|12052420|FG000|Overall Study|Patient went to hospice|1
7638101|NCT02657343|12052421|FG001|Overall Study|Patient went to hospice|0
7638102|NCT02657343|12052422|FG002|Overall Study|Patient went to hospice|0
7638103|NCT02657343|12052423|FG003|Overall Study|Patient went to hospice|0
7638104|NCT02657343|12052424|FG004|Overall Study|Patient went to hospice|0
7638105|NCT02657343|12052425|FG005|Overall Study|Patient went to hospice|0
7638106|NCT02657343|12052420|FG000|Overall Study|Withdrawal by Subject|0
7638107|NCT02657343|12052421|FG001|Overall Study|Withdrawal by Subject|0
7638108|NCT02657343|12052422|FG002|Overall Study|Withdrawal by Subject|0
7638109|NCT02657343|12052423|FG003|Overall Study|Withdrawal by Subject|0
7638110|NCT02657343|12052424|FG004|Overall Study|Withdrawal by Subject|1
7638111|NCT02657343|12052425|FG005|Overall Study|Withdrawal by Subject|0
7638112|NCT02656017|12052441|FG000|Overall Study|Study burden|3
7638113|NCT02656017|12052442|FG001|Overall Study|Study burden|3
7638114|NCT02656017|12052441|FG000|Overall Study|Adverse Event|2
7638115|NCT02656017|12052442|FG001|Overall Study|Adverse Event|1
7638116|NCT02656017|12052441|FG000|Overall Study|Unable/unwilling to take study medication|2
7638117|NCT02656017|12052442|FG001|Overall Study|Unable/unwilling to take study medication|1
7638118|NCT02656017|12052441|FG000|Overall Study|Began Tolvaptan|1
7638119|NCT02656017|12052442|FG001|Overall Study|Began Tolvaptan|1
7638120|NCT02656017|12052441|FG000|Overall Study|Withdrawal by Subject|1
7638121|NCT02656017|12052442|FG001|Overall Study|Withdrawal by Subject|0
7638122|NCT02652767|12052448|FG000|Overall Study|Death|2
7638123|NCT02652767|12052448|FG000|Overall Study|Lost to Follow-up|1
7638124|NCT02652767|12052448|FG000|Overall Study|Withdrawal by Subject|1
7638125|NCT02652260|12052456|FG000|Overall Study|Pregnancy|0
7638126|NCT02652260|12052457|FG001|Overall Study|Pregnancy|1
7638127|NCT02652260|12052456|FG000|Overall Study|Withdrawal by Subject|0
7638128|NCT02652260|12052457|FG001|Overall Study|Withdrawal by Subject|1
7638129|NCT02650921|12052466|FG000|Overall Study|Withdrawal by Subject|4
7638130|NCT02650921|12052466|FG000|Overall Study|Lost to Follow-up|2
7638131|NCT02650921|12052466|FG000|Overall Study|Adverse Event|1
7638132|NCT02650921|12052466|FG000|Overall Study|Due to Medical Condition|1
7638133|NCT02644967|12052472|FG000|Overall Study|Death|26
7638134|NCT02644967|12052472|FG000|Overall Study|Physician Decision|1
7638135|NCT02644967|12052472|FG000|Overall Study|Withdrawal by Subject|2
7638136|NCT02644967|12052472|FG000|Overall Study|Protocol Violation|1
7638137|NCT02644967|12052472|FG000|Overall Study|Progressive Disease|1
7638138|NCT02644967|12052472|FG000|Overall Study|Study Terminated by Sponsor|4
7638139|NCT02642042|12052476|FG000|Overall Study|Adverse Event|22
7638140|NCT02642042|12052476|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
7638141|NCT02642042|12052476|FG000|Overall Study|Progression/Relapse|28
7638142|NCT02642042|12052476|FG000|Overall Study|Death|1
7638143|NCT02642042|12052476|FG000|Overall Study|Not Protocol Specified|2
7638144|NCT02639546|12052488|FG000|Overall Study|Death|2
7638145|NCT02639546|12052489|FG001|Overall Study|Death|2
7638146|NCT02639546|12052490|FG002|Overall Study|Death|1
7638147|NCT02639546|12052491|FG003|Overall Study|Death|2
7638148|NCT02639546|12052492|FG004|Overall Study|Death|2
7638149|NCT02639546|12052493|FG005|Overall Study|Death|2
7638150|NCT02639546|12052494|FG006|Overall Study|Death|0
7638151|NCT02639546|12052495|FG007|Overall Study|Death|0
7638152|NCT02639546|12052488|FG000|Overall Study|Lost to Follow-up|0
7638153|NCT02639546|12052489|FG001|Overall Study|Lost to Follow-up|0
7638154|NCT02639546|12052490|FG002|Overall Study|Lost to Follow-up|1
7638155|NCT02639546|12052491|FG003|Overall Study|Lost to Follow-up|0
7638156|NCT02639546|12052492|FG004|Overall Study|Lost to Follow-up|1
7638157|NCT02639546|12052493|FG005|Overall Study|Lost to Follow-up|1
7638158|NCT02639546|12052494|FG006|Overall Study|Lost to Follow-up|0
7638159|NCT02639546|12052495|FG007|Overall Study|Lost to Follow-up|1
7638160|NCT02639546|12052488|FG000|Overall Study|PI, physician decision; no response to trt.|2
7638161|NCT02639546|12052489|FG001|Overall Study|PI, physician decision; no response to trt.|0
7638162|NCT02639546|12052490|FG002|Overall Study|PI, physician decision; no response to trt.|0
7638163|NCT02639546|12052491|FG003|Overall Study|PI, physician decision; no response to trt.|0
7638164|NCT02639546|12052492|FG004|Overall Study|PI, physician decision; no response to trt.|0
7638165|NCT02639546|12052493|FG005|Overall Study|PI, physician decision; no response to trt.|1
7638166|NCT02639546|12052494|FG006|Overall Study|PI, physician decision; no response to trt.|0
7638167|NCT02639546|12052495|FG007|Overall Study|PI, physician decision; no response to trt.|1
7638168|NCT02639546|12052488|FG000|Overall Study|Study Terminated By Sponsor|0
7638169|NCT02639546|12052489|FG001|Overall Study|Study Terminated By Sponsor|2
7638170|NCT02639546|12052490|FG002|Overall Study|Study Terminated By Sponsor|3
7638171|NCT02639546|12052491|FG003|Overall Study|Study Terminated By Sponsor|4
7638172|NCT02639546|12052492|FG004|Overall Study|Study Terminated By Sponsor|4
7638173|NCT02639546|12052493|FG005|Overall Study|Study Terminated By Sponsor|3
7638174|NCT02639546|12052494|FG006|Overall Study|Study Terminated By Sponsor|3
7638175|NCT02639546|12052495|FG007|Overall Study|Study Terminated By Sponsor|9
7638176|NCT02639546|12052488|FG000|Overall Study|Withdrawal by Subject|2
7638177|NCT02639546|12052489|FG001|Overall Study|Withdrawal by Subject|2
7638178|NCT02639546|12052490|FG002|Overall Study|Withdrawal by Subject|1
7638179|NCT02639546|12052491|FG003|Overall Study|Withdrawal by Subject|0
7638180|NCT02639546|12052492|FG004|Overall Study|Withdrawal by Subject|0
7638181|NCT02639546|12052493|FG005|Overall Study|Withdrawal by Subject|1
7638182|NCT02639546|12052494|FG006|Overall Study|Withdrawal by Subject|2
7638183|NCT02639546|12052495|FG007|Overall Study|Withdrawal by Subject|1
7638184|NCT02634333|12052533|FG000|Overall Study|Completed out of Window|3
7638185|NCT02634333|12052534|FG001|Overall Study|Completed out of Window|2
7638186|NCT02634333|12052533|FG000|Overall Study|Missed Visit|5
7638187|NCT02634333|12052534|FG001|Overall Study|Missed Visit|2
7638188|NCT02634333|12052533|FG000|Overall Study|Lost to Follow-up|12
7638189|NCT02634333|12052534|FG001|Overall Study|Lost to Follow-up|7
7638190|NCT02634333|12052533|FG000|Overall Study|Withdrawal by Subject|9
7638191|NCT02634333|12052534|FG001|Overall Study|Withdrawal by Subject|13
7638192|NCT02634333|12052533|FG000|Overall Study|Death|11
7638193|NCT02634333|12052534|FG001|Overall Study|Death|8
7638194|NCT02630459|12052554|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7638195|NCT02630459|12052555|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1
7638196|NCT02630459|12052556|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7638197|NCT02630459|12052557|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2
7638198|NCT02630459|12052558|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7638199|NCT02630459|12052559|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7638200|NCT02630459|12052560|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7638201|NCT02630459|12052561|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7638202|NCT02630459|12052554|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7638203|NCT02630459|12052555|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7638204|NCT02630459|12052556|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1
7638205|NCT02630459|12052557|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7638206|NCT02630459|12052558|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7638281|NCT02614066|12052643|FG002|Overall Study|Full Consent Withdrawn|0
7638207|NCT02630459|12052559|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7638208|NCT02630459|12052560|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7638209|NCT02630459|12052561|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7638210|NCT02630459|12052554|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2
7638211|NCT02630459|12052555|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
7638212|NCT02630459|12052556|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4
7638213|NCT02630459|12052557|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
7638214|NCT02630459|12052558|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7638215|NCT02630459|12052559|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7638216|NCT02630459|12052560|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7638217|NCT02630459|12052561|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7638218|NCT02630459|12052554|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1
7638219|NCT02630459|12052555|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7638220|NCT02630459|12052556|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7638221|NCT02630459|12052557|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7638222|NCT02630459|12052558|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7638223|NCT02630459|12052559|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7638224|NCT02630459|12052560|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7638225|NCT02630459|12052561|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7638226|NCT02630459|12052554|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7638227|NCT02630459|12052555|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7638228|NCT02630459|12052556|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7638229|NCT02630459|12052557|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7638230|NCT02630459|12052558|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4
7638231|NCT02630459|12052559|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1
7638232|NCT02630459|12052560|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7638233|NCT02630459|12052561|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7638234|NCT02630459|12052554|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0
7638235|NCT02630459|12052555|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0
7638236|NCT02630459|12052556|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0
7638237|NCT02630459|12052557|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0
7638238|NCT02630459|12052558|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24
7638239|NCT02630459|12052559|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3
7638240|NCT02630459|12052560|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0
7638241|NCT02630459|12052561|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0
7638242|NCT02630459|12052554|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7638243|NCT02630459|12052555|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7638244|NCT02630459|12052556|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7638245|NCT02630459|12052557|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7638246|NCT02630459|12052558|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1
7638247|NCT02630459|12052559|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7638248|NCT02630459|12052560|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7638249|NCT02630459|12052561|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7638250|NCT02622386|12052595|FG000|First Assignment|Withdrawal by Subject|3
7638251|NCT02622386|12052596|FG001|First Assignment|Withdrawal by Subject|2
7638252|NCT02622386|12052595|FG000|Washout|Withdrawal by Subject|4
7638253|NCT02622386|12052596|FG001|Washout|Withdrawal by Subject|4
7638254|NCT02622386|12052595|FG000|Second Assignment|Withdrawal by Subject|0
7638255|NCT02622386|12052596|FG001|Second Assignment|Withdrawal by Subject|2
7638256|NCT02621606|12052605|FG000|Overall Study|Withdrawal by Subject|0
7638257|NCT02621606|12052606|FG001|Overall Study|Withdrawal by Subject|1
7638258|NCT02621606|12052607|FG002|Overall Study|Withdrawal by Subject|0
7638259|NCT02619682|12052624|FG000|Overall Study|Withdrawal by Subject|3
7638260|NCT02619682|12052624|FG000|Overall Study|Lack of Efficacy|8
7638261|NCT02619682|12052624|FG000|Overall Study|new secondary cancer|1
7638262|NCT02619682|12052624|FG000|Overall Study|post surgery complications|2
7638263|NCT02614794|12052630|FG000|Overall Study|On treatment|118
7638264|NCT02614794|12052631|FG001|Overall Study|On treatment|27
7638265|NCT02614794|12052630|FG000|Overall Study|In long term follow up|148
7638266|NCT02614794|12052631|FG001|Overall Study|In long term follow up|85
7638267|NCT02614794|12052630|FG000|Overall Study|Death|126
7638268|NCT02614794|12052631|FG001|Overall Study|Death|84
7638269|NCT02614794|12052630|FG000|Overall Study|Withdrawal by Subject|16
7638270|NCT02614794|12052631|FG001|Overall Study|Withdrawal by Subject|5
7638271|NCT02614794|12052630|FG000|Overall Study|Lost to Follow-up|2
7638272|NCT02614794|12052631|FG001|Overall Study|Lost to Follow-up|0
7638273|NCT02614794|12052630|FG000|Overall Study|Physician Decision|0
7638274|NCT02614794|12052631|FG001|Overall Study|Physician Decision|1
7638275|NCT02614066|12052641|FG000|Overall Study|Initiated KTE-X19 and Died|5
7638276|NCT02614066|12052642|FG001|Overall Study|Initiated KTE-X19 and Died|12
7638277|NCT02614066|12052643|FG002|Overall Study|Initiated KTE-X19 and Died|11
7638278|NCT02614066|12052644|FG003|Overall Study|Initiated KTE-X19 and Died|20
7638279|NCT02614066|12052641|FG000|Overall Study|Full Consent Withdrawn|0
7638280|NCT02614066|12052642|FG001|Overall Study|Full Consent Withdrawn|1
7638282|NCT02614066|12052644|FG003|Overall Study|Full Consent Withdrawn|3
7638283|NCT02614066|12052641|FG000|Overall Study|Lost to Follow-up|0
7638284|NCT02614066|12052642|FG001|Overall Study|Lost to Follow-up|1
7638285|NCT02614066|12052643|FG002|Overall Study|Lost to Follow-up|0
7638286|NCT02614066|12052644|FG003|Overall Study|Lost to Follow-up|0
7638287|NCT02614066|12052641|FG000|Overall Study|Still on-study|1
7638288|NCT02614066|12052642|FG001|Overall Study|Still on-study|9
7638289|NCT02614066|12052643|FG002|Overall Study|Still on-study|5
7638290|NCT02614066|12052644|FG003|Overall Study|Still on-study|32
7638291|NCT02614066|12052641|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0
7638292|NCT02614066|12052642|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5
7638293|NCT02614066|12052643|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4
7638294|NCT02614066|12052644|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16
7638295|NCT02610777|12052654|FG000|Overall Study|Lost to Follow-up|1
7638296|NCT02610777|12052655|FG001|Overall Study|Lost to Follow-up|0
7638297|NCT02610777|12052654|FG000|Overall Study|Site Terminated by Sponsor|9
7638298|NCT02610777|12052655|FG001|Overall Study|Site Terminated by Sponsor|8
7638299|NCT02610777|12052654|FG000|Overall Study|Withdrawal by Subject|2
7638300|NCT02610777|12052655|FG001|Overall Study|Withdrawal by Subject|2
7638301|NCT02610777|12052654|FG000|Overall Study|Reason not Specified|0
7638302|NCT02610777|12052655|FG001|Overall Study|Reason not Specified|1
7638303|NCT02610777|12052654|FG000|Overall Study|Death|50
7638304|NCT02610777|12052655|FG001|Overall Study|Death|47
7638305|NCT02604511|12052663|FG000|Overall Study|Adverse Event|3
7638306|NCT02604511|12052663|FG000|Overall Study|Disease Progression|4
7638307|NCT02604511|12052663|FG000|Overall Study|Withdrawal by Subject|3
7638308|NCT02604511|12052663|FG000|Overall Study|Participant ineligible|1
7638309|NCT02604511|12052663|FG000|Overall Study|Intercurrent illness|1
7638310|NCT02603432|12052670|FG000|Overall Study|Ongoing|184
7638311|NCT02603432|12052671|FG001|Overall Study|Ongoing|144
7638312|NCT02603432|12052670|FG000|Overall Study|Adverse Event|1
7638313|NCT02603432|12052671|FG001|Overall Study|Adverse Event|0
7638314|NCT02603432|12052670|FG000|Overall Study|Death|144
7638315|NCT02603432|12052671|FG001|Overall Study|Death|177
7638316|NCT02603432|12052670|FG000|Overall Study|Lost to Follow-up|4
7638317|NCT02603432|12052671|FG001|Overall Study|Lost to Follow-up|6
7638318|NCT02603432|12052670|FG000|Overall Study|Progressive Disease|5
7638319|NCT02603432|12052671|FG001|Overall Study|Progressive Disease|5
7638320|NCT02603432|12052670|FG000|Overall Study|Withdrawal by Subject|9
7638321|NCT02603432|12052671|FG001|Overall Study|Withdrawal by Subject|17
7638322|NCT02603432|12052670|FG000|Overall Study|No Longer Meets Eligibility Criteria|3
7638323|NCT02603432|12052671|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7638324|NCT02603432|12052670|FG000|Overall Study|Other|0
7638325|NCT02603432|12052671|FG001|Overall Study|Other|1
7638326|NCT02601209|12052684|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
7638327|NCT02601209|12052685|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
7638328|NCT02601209|12052686|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
7638329|NCT02601209|12052687|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7638330|NCT02601209|12052688|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7638331|NCT02601209|12052689|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7638332|NCT02601209|12052690|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7638333|NCT02601209|12052691|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7638334|NCT02601209|12052692|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7638335|NCT02601209|12052684|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7638336|NCT02601209|12052685|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7638337|NCT02601209|12052686|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7638338|NCT02601209|12052687|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7638339|NCT02601209|12052688|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
7638340|NCT02601209|12052689|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2
7638341|NCT02601209|12052690|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
7638342|NCT02601209|12052691|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7638343|NCT02601209|12052692|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7638344|NCT02594735|12052706|FG000|Overall Study|Adverse Event|1
7638345|NCT02584634|12052723|FG000|Overall Study|Adverse Event|3
7638346|NCT02584634|12052724|FG001|Overall Study|Adverse Event|3
7638347|NCT02584634|12052723|FG000|Overall Study|Death|0
7638348|NCT02584634|12052724|FG001|Overall Study|Death|1
7638349|NCT02584634|12052723|FG000|Overall Study|Lost to Follow-up|0
7638350|NCT02584634|12052724|FG001|Overall Study|Lost to Follow-up|1
7638351|NCT02584634|12052723|FG000|Overall Study|Physician Decision|1
7638352|NCT02584634|12052724|FG001|Overall Study|Physician Decision|1
7638353|NCT02584634|12052723|FG000|Overall Study|Progressive disease|7
7638354|NCT02584634|12052724|FG001|Overall Study|Progressive disease|14
7638355|NCT02584634|12052723|FG000|Overall Study|Withdrawal by Subject|1
7638356|NCT02584634|12052724|FG001|Overall Study|Withdrawal by Subject|1
7638357|NCT02584634|12052723|FG000|Overall Study|Other|0
7638358|NCT02584634|12052724|FG001|Overall Study|Other|2
7638359|NCT02584634|12052723|FG000|Overall Study|Ongoing|0
7638360|NCT02584634|12052724|FG001|Overall Study|Ongoing|8
7638361|NCT02581930|12052733|FG000|Overall Study|Withdrawal by Subject|1
7638362|NCT02581930|12052733|FG000|Overall Study|patient declined further treatment|1
7638363|NCT02580058|12052744|FG000|Overall Study|Lost to Follow-up|4
7638364|NCT02580058|12052745|FG001|Overall Study|Lost to Follow-up|5
7638365|NCT02580058|12052746|FG002|Overall Study|Lost to Follow-up|4
7638366|NCT02580058|12052744|FG000|Overall Study|Ongoing|51
7638367|NCT02580058|12052745|FG001|Overall Study|Ongoing|55
7638368|NCT02580058|12052746|FG002|Overall Study|Ongoing|46
7638369|NCT02580058|12052744|FG000|Overall Study|Withdrawal by Subject|24
7638370|NCT02580058|12052745|FG001|Overall Study|Withdrawal by Subject|26
7638371|NCT02580058|12052746|FG002|Overall Study|Withdrawal by Subject|36
7638372|NCT02579096|12052756|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10
7638373|NCT02579096|12052757|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6
7638374|NCT02579096|12052756|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2
7638375|NCT02579096|12052757|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1
7638376|NCT02579096|12052756|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32
7638377|NCT02579096|12052757|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36
7638378|NCT02579096|12052756|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9
7638379|NCT02579096|12052757|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4
7638380|NCT02579096|12052756|FG000|Phase 1, Weeks 0 - 24|Other reasons|4
7638381|NCT02579096|12052757|FG001|Phase 1, Weeks 0 - 24|Other reasons|3
7638382|NCT02579096|12052756|FG000|Phase 2, Weeks 25 - 48|Death|2
7638383|NCT02579096|12052757|FG001|Phase 2, Weeks 25 - 48|Death|4
7638384|NCT02579096|12052756|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3
7638385|NCT02579096|12052757|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1
7638386|NCT02579096|12052756|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4
7638387|NCT02579096|12052757|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0
7638388|NCT02579096|12052756|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9
7638389|NCT02579096|12052757|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12
7638390|NCT02579096|12052756|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4
7638391|NCT02579096|12052757|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9
7638392|NCT02579096|12052756|FG000|Phase 2, Weeks 25 - 48|Other reasons|0
7638393|NCT02579096|12052757|FG001|Phase 2, Weeks 25 - 48|Other reasons|5
7638394|NCT02579096|12052756|FG000|Phase 3, Weeks 49 - 72|Death|3
7638395|NCT02579096|12052757|FG001|Phase 3, Weeks 49 - 72|Death|2
7638396|NCT02579096|12052756|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0
7638397|NCT02579096|12052757|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1
7638398|NCT02579096|12052756|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0
7638399|NCT02579096|12052757|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5
7638400|NCT02579096|12052756|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6
7638401|NCT02579096|12052757|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4
7638402|NCT02579096|12052756|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10
7638403|NCT02579096|12052757|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5
7638404|NCT02579096|12052756|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0
7638405|NCT02579096|12052757|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1
7638406|NCT02579096|12052756|FG000|Phase 3, Weeks 49 - 72|Other reasons|3
7638407|NCT02579096|12052757|FG001|Phase 3, Weeks 49 - 72|Other reasons|0
7638408|NCT02578680|12052765|FG000|Overall Study|Death|124
7638409|NCT02578680|12052766|FG001|Overall Study|Death|104
7638410|NCT02578680|12052765|FG000|Overall Study|Protocol Violation|1
7638411|NCT02578680|12052766|FG001|Overall Study|Protocol Violation|1
7638412|NCT02578680|12052765|FG000|Overall Study|Withdrawal by Parent/Guardian|1
7638413|NCT02578680|12052766|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7638414|NCT02578680|12052765|FG000|Overall Study|Withdrawal by Subject|8
7638415|NCT02578680|12052766|FG001|Overall Study|Withdrawal by Subject|5
7638416|NCT02578680|12052765|FG000|Overall Study|Ongoing in Study|276
7638417|NCT02578680|12052766|FG001|Overall Study|Ongoing in Study|96
7638418|NCT02577406|12052774|FG000|Randomized Period|Death|1
7638419|NCT02577406|12052775|FG001|Randomized Period|Death|0
7638420|NCT02577406|12052774|FG000|Randomized Period|Other reasons|0
7638421|NCT02577406|12052775|FG001|Randomized Period|Other reasons|20
7638422|NCT02577406|12052774|FG000|Treatment Period|Transition to commercially available treatment|1
7638423|NCT02577406|12052775|FG001|Treatment Period|Transition to commercially available treatment|0
7638424|NCT02577406|12052774|FG000|Treatment Period|Progressive disease|47
7638425|NCT02577406|12052775|FG001|Treatment Period|Progressive disease|36
7638426|NCT02577406|12052774|FG000|Treatment Period|Death|36
7638427|NCT02577406|12052775|FG001|Treatment Period|Death|23
7638428|NCT02577406|12052774|FG000|Treatment Period|Other reasons|3
7638429|NCT02577406|12052775|FG001|Treatment Period|Other reasons|37
7638430|NCT02577406|12052774|FG000|Treatment Period|Withdrawal by Subject|10
7638431|NCT02577406|12052775|FG001|Treatment Period|Withdrawal by Subject|24
7638432|NCT02577406|12052774|FG000|Treatment Period|Adverse Event|17
7638433|NCT02577406|12052775|FG001|Treatment Period|Adverse Event|12
7638434|NCT02577406|12052774|FG000|Treatment Period|Disease relapse|27
7638435|NCT02577406|12052775|FG001|Treatment Period|Disease relapse|1
7638436|NCT02577406|12052774|FG000|Treatment Period|HSCT|6
7638437|NCT02577406|12052775|FG001|Treatment Period|HSCT|2
7638438|NCT02577406|12052774|FG000|Treatment Period|Lost to Follow-up|0
7638439|NCT02577406|12052775|FG001|Treatment Period|Lost to Follow-up|1
7638440|NCT02577406|12052774|FG000|Treatment Period|Protocol Violation|0
7638441|NCT02577406|12052775|FG001|Treatment Period|Protocol Violation|1
7638442|NCT02576860|12052787|FG000|Overall Study|Adverse Event|6
7638443|NCT02576860|12052788|FG001|Overall Study|Adverse Event|6
7638444|NCT02576860|12052787|FG000|Overall Study|Lost to Follow-up|5
7638445|NCT02576860|12052788|FG001|Overall Study|Lost to Follow-up|7
7638446|NCT02576860|12052787|FG000|Overall Study|Physician Decision|0
7638447|NCT02576860|12052788|FG001|Overall Study|Physician Decision|1
7638448|NCT02576860|12052787|FG000|Overall Study|Protocol Violation|0
7638449|NCT02576860|12052788|FG001|Overall Study|Protocol Violation|2
7638450|NCT02576860|12052787|FG000|Overall Study|Withdrawal by Subject|13
7638451|NCT02576860|12052788|FG001|Overall Study|Withdrawal by Subject|8
7638452|NCT02576860|12052787|FG000|Overall Study|Disallowed medication|1
7638453|NCT02576860|12052788|FG001|Overall Study|Disallowed medication|0
7638454|NCT02576509|12052797|FG000|Pre-Treatment Period|Participant request to stop therapy|0
7638455|NCT02576509|12052798|FG001|Pre-Treatment Period|Participant request to stop therapy|2
7638456|NCT02576509|12052797|FG000|Pre-Treatment Period|Participant withdrew consent|1
7638457|NCT02576509|12052798|FG001|Pre-Treatment Period|Participant withdrew consent|5
7638458|NCT02576509|12052797|FG000|Pre-Treatment Period|Participant no longer meets criteria|3
7638459|NCT02576509|12052798|FG001|Pre-Treatment Period|Participant no longer meets criteria|2
7638460|NCT02576509|12052797|FG000|Treatment Period|Disease progression|245
7638461|NCT02576509|12052798|FG001|Treatment Period|Disease progression|240
7638462|NCT02576509|12052797|FG000|Treatment Period|Study drug toxicity|32
7638463|NCT02576509|12052798|FG001|Treatment Period|Study drug toxicity|41
7638464|NCT02576509|12052797|FG000|Treatment Period|Death|1
7638465|NCT02576509|12052798|FG001|Treatment Period|Death|1
7638466|NCT02576509|12052797|FG000|Treatment Period|Adverse event unrelated to study drug|37
7638467|NCT02576509|12052798|FG001|Treatment Period|Adverse event unrelated to study drug|40
7638468|NCT02576509|12052797|FG000|Treatment Period|Participant request to stop treatment|8
7638469|NCT02576509|12052798|FG001|Treatment Period|Participant request to stop treatment|17
7638470|NCT02576509|12052797|FG000|Treatment Period|Participant withdrew consent|2
7638471|NCT02576509|12052798|FG001|Treatment Period|Participant withdrew consent|7
7638472|NCT02576509|12052797|FG000|Treatment Period|Lost to Follow-up|0
7638473|NCT02576509|12052798|FG001|Treatment Period|Lost to Follow-up|1
7638474|NCT02576509|12052797|FG000|Treatment Period|Maximum clinical benefit|1
7638475|NCT02576509|12052798|FG001|Treatment Period|Maximum clinical benefit|0
7638476|NCT02576509|12052797|FG000|Treatment Period|Poor/non-compliance|0
7638477|NCT02576509|12052798|FG001|Treatment Period|Poor/non-compliance|1
7638478|NCT02576509|12052797|FG000|Treatment Period|Participant no longer meets criteria|1
7638479|NCT02576509|12052798|FG001|Treatment Period|Participant no longer meets criteria|0
7638480|NCT02576509|12052797|FG000|Treatment Period|Other reason|2
7638481|NCT02576509|12052798|FG001|Treatment Period|Other reason|7
7638482|NCT02576509|12052797|FG000|Follow-up Period|Death|41
7638483|NCT02576509|12052798|FG001|Follow-up Period|Death|35
7638484|NCT02576509|12052797|FG000|Follow-up Period|Participant withdrew consent|7
7638485|NCT02576509|12052798|FG001|Follow-up Period|Participant withdrew consent|14
7638486|NCT02576509|12052797|FG000|Follow-up Period|Lost to Follow-up|0
7638487|NCT02576509|12052798|FG001|Follow-up Period|Lost to Follow-up|1
7638488|NCT02576509|12052797|FG000|Follow-up Period|Other reason|1
7638489|NCT02576509|12052798|FG001|Follow-up Period|Other reason|2
7638510|NCT02565784|12052837|FG000|First Treatment|Adverse Event|1
7638511|NCT02565784|12052837|FG000|First Treatment|Withdrawal by Subject|1
7638512|NCT02565784|12052837|FG000|Second Treatment|Withdrawal by Subject|2
7638513|NCT02565108|12052847|FG000|Overall Study|Adverse Event|1
7638514|NCT02565108|12052848|FG001|Overall Study|Adverse Event|0
7638515|NCT02565108|12052847|FG000|Overall Study|Withdrew Consent|1
7638516|NCT02565108|12052848|FG001|Overall Study|Withdrew Consent|0
7638517|NCT02564952|12052854|FG000|Overall Study|Adverse Event|6
7638518|NCT02564952|12052854|FG000|Overall Study|Lost to Follow-up|1
7638519|NCT02564952|12052854|FG000|Overall Study|Participant Withdrawn by Investigator|1
7638520|NCT02564952|12052854|FG000|Overall Study|Withdrawal by Subject|1
7638521|NCT02564952|12052854|FG000|Overall Study|Low Efficacy|1
7638522|NCT02564952|12052854|FG000|Overall Study|Participant Met Withdrawal Criteria|1
7638523|NCT02563925|12052858|FG000|Overall Study|Withdrawal by Subject|2
7638524|NCT02563002|12052865|FG000|Overall Study|Death|62
7638525|NCT02563002|12052866|FG001|Overall Study|Death|75
7638526|NCT02563002|12052865|FG000|Overall Study|Lost to Follow-up|1
7638527|NCT02563002|12052866|FG001|Overall Study|Lost to Follow-up|0
7638528|NCT02563002|12052865|FG000|Overall Study|Withdrawal by Subject|0
7638529|NCT02563002|12052866|FG001|Overall Study|Withdrawal by Subject|9
7638530|NCT02563002|12052865|FG000|Overall Study|Ongoing|90
7638531|NCT02563002|12052866|FG001|Overall Study|Ongoing|70
7638532|NCT02562235|12052875|FG000|Overall Study|Adverse Event|3
7638533|NCT02560623|12052897|FG000|Overall Study|Unable to swallow sponge|0
7638534|NCT02560623|12052898|FG001|Overall Study|Unable to swallow sponge|1
7638535|NCT02560623|12052899|FG002|Overall Study|Unable to swallow sponge|0
7638536|NCT02560623|12052900|FG003|Overall Study|Unable to swallow sponge|0
7638537|NCT02560623|12052897|FG000|Overall Study|Intervention prior to sponge administration|0
7638538|NCT02560623|12052898|FG001|Overall Study|Intervention prior to sponge administration|1
7638539|NCT02560623|12052899|FG002|Overall Study|Intervention prior to sponge administration|0
7638540|NCT02560623|12052900|FG003|Overall Study|Intervention prior to sponge administration|0
7638541|NCT02559687|12052910|FG000|Overall Study|Death|112
7638542|NCT02559687|12052910|FG000|Overall Study|Sponsor Decision|5
7638543|NCT02559687|12052910|FG000|Overall Study|Withdrawal by Subject|4
7638544|NCT02556710|12052917|FG000|Overall Study|Surgical treatment|3
7638545|NCT02556710|12052918|FG001|Overall Study|Surgical treatment|0
7638546|NCT02556710|12052917|FG000|Overall Study|Required proscribed pain medication|2
7638547|NCT02556710|12052918|FG001|Overall Study|Required proscribed pain medication|1
7638548|NCT02556710|12052917|FG000|Overall Study|Lack of Efficacy|1
7638549|NCT02556710|12052918|FG001|Overall Study|Lack of Efficacy|0
7638550|NCT02556710|12052917|FG000|Overall Study|Worsening osteoarthritis|1
7638551|NCT02556710|12052918|FG001|Overall Study|Worsening osteoarthritis|0
7638552|NCT02556710|12052917|FG000|Overall Study|Moved out of state|1
7638553|NCT02556710|12052918|FG001|Overall Study|Moved out of state|0
7638554|NCT02556710|12052917|FG000|Overall Study|Missing reason|3
7638555|NCT02556710|12052918|FG001|Overall Study|Missing reason|1
7638556|NCT02556710|12052917|FG000|Overall Study|Pain as lack of efficacy|0
7638557|NCT02556710|12052918|FG001|Overall Study|Pain as lack of efficacy|4
7638558|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6
7638559|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3
7638560|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0
7638561|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2
7638562|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2
7638563|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0
7638564|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1
7638565|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1
7638566|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0
7638567|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1
7638568|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0
7638569|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0
7638570|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3
7638571|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7
7638572|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0
7638573|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1
7638574|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1
7638575|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0
7638576|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0
7638577|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1
7638578|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0
7638579|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0
7638580|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1
7638581|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0
7638582|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0
7638583|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1
7638584|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0
7638585|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1
7638586|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0
7638587|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0
7638588|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Adverse Event|0
7638589|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Adverse Event|0
7638590|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Adverse Event|5
7638591|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0
7638592|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0
7638593|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4
7638594|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0
7638595|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0
7638596|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2
7638597|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0
7638598|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0
7638599|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18
7638600|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0
7638849|NCT02499328|12053188|FG005|Overall Study|Disease Progression|0
7638601|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0
7638602|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1
7638603|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0
7638604|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0
7638605|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1
7638606|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Investigator decision|0
7638607|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Investigator decision|0
7638608|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Investigator decision|1
7638609|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0
7638610|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0
7638611|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1
7638612|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Compassionate access|0
7638613|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Compassionate access|0
7638614|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Compassionate access|2
7638615|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0
7638616|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0
7638617|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1
7638618|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0
7638619|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0
7638620|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1
7638621|NCT02550652|12052948|FG000|Overall Study|Death|1
7638622|NCT02550652|12052949|FG001|Overall Study|Death|4
7638623|NCT02550652|12052948|FG000|Overall Study|Lack of Efficacy|1
7638624|NCT02550652|12052949|FG001|Overall Study|Lack of Efficacy|0
7638625|NCT02550652|12052948|FG000|Overall Study|Withdrawal by Subject|3
7638626|NCT02550652|12052949|FG001|Overall Study|Withdrawal by Subject|7
7638627|NCT02550652|12052948|FG000|Overall Study|Post Trial Access|1
7638628|NCT02550652|12052949|FG001|Overall Study|Post Trial Access|0
7638629|NCT02550652|12052948|FG000|Overall Study|Lost to Follow-up|1
7638630|NCT02550652|12052949|FG001|Overall Study|Lost to Follow-up|3
7638631|NCT02550652|12052948|FG000|Overall Study|Physician Decision|0
7638632|NCT02550652|12052949|FG001|Overall Study|Physician Decision|2
7638633|NCT02550652|12052948|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14
7638634|NCT02550652|12052949|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5
7638635|NCT02547441|12052957|FG000|Double-Blind Study Period|Adverse Event|4
7638636|NCT02547441|12052958|FG001|Double-Blind Study Period|Adverse Event|9
7638637|NCT02547441|12052957|FG000|Double-Blind Study Period|Lost to Follow-up|2
7638638|NCT02547441|12052958|FG001|Double-Blind Study Period|Lost to Follow-up|4
7638639|NCT02547441|12052957|FG000|Double-Blind Study Period|Physician Decision|1
7638640|NCT02547441|12052958|FG001|Double-Blind Study Period|Physician Decision|0
7638641|NCT02547441|12052957|FG000|Double-Blind Study Period|Protocol Violation|1
7638642|NCT02547441|12052958|FG001|Double-Blind Study Period|Protocol Violation|2
7638643|NCT02547441|12052957|FG000|Double-Blind Study Period|Withdrawal by Subject|15
7638644|NCT02547441|12052958|FG001|Double-Blind Study Period|Withdrawal by Subject|17
7638645|NCT02547441|12052957|FG000|Double-Blind Study Period|Sponsor Decision|1
7638646|NCT02547441|12052958|FG001|Double-Blind Study Period|Sponsor Decision|0
7638647|NCT02547441|12052957|FG000|Open-Label Study Period|Adverse Event|10
7638648|NCT02547441|12052958|FG001|Open-Label Study Period|Adverse Event|11
7638649|NCT02547441|12052957|FG000|Open-Label Study Period|Lack of Efficacy|3
7638650|NCT02547441|12052958|FG001|Open-Label Study Period|Lack of Efficacy|2
7638651|NCT02547441|12052957|FG000|Open-Label Study Period|Lost to Follow-up|7
7638652|NCT02547441|12052958|FG001|Open-Label Study Period|Lost to Follow-up|8
7638653|NCT02547441|12052957|FG000|Open-Label Study Period|Physician Decision|1
7638654|NCT02547441|12052958|FG001|Open-Label Study Period|Physician Decision|0
7638655|NCT02547441|12052957|FG000|Open-Label Study Period|Protocol Violation|2
7638656|NCT02547441|12052958|FG001|Open-Label Study Period|Protocol Violation|0
7638657|NCT02547441|12052957|FG000|Open-Label Study Period|Withdrawal by Subject|33
7638658|NCT02547441|12052958|FG001|Open-Label Study Period|Withdrawal by Subject|37
7638659|NCT02547441|12052957|FG000|Open-Label Study Period|Terminated by Sponsor|66
7638660|NCT02547441|12052958|FG001|Open-Label Study Period|Terminated by Sponsor|69
7638661|NCT02546986|12052967|FG000|Treatment Period|Progressive Disease|20
7638662|NCT02546986|12052968|FG001|Treatment Period|Progressive Disease|22
7638663|NCT02546986|12052967|FG000|Treatment Period|Adverse Event|14
7638664|NCT02546986|12052968|FG001|Treatment Period|Adverse Event|6
7638665|NCT02546986|12052967|FG000|Treatment Period|Symptomatic Deterioration|4
7638666|NCT02546986|12052968|FG001|Treatment Period|Symptomatic Deterioration|3
7638667|NCT02546986|12052967|FG000|Treatment Period|Death|3
7638668|NCT02546986|12052968|FG001|Treatment Period|Death|4
7638669|NCT02546986|12052967|FG000|Treatment Period|Physician Decision|1
7638670|NCT02546986|12052968|FG001|Treatment Period|Physician Decision|2
7638671|NCT02546986|12052967|FG000|Treatment Period|Protocol Violation|1
7638672|NCT02546986|12052968|FG001|Treatment Period|Protocol Violation|0
7638673|NCT02546986|12052967|FG000|Treatment Period|Withdrawal by Subject|1
7638674|NCT02546986|12052968|FG001|Treatment Period|Withdrawal by Subject|1
7638675|NCT02546986|12052967|FG000|Treatment Period|Non-compliance with Study Drug|0
7638676|NCT02546986|12052968|FG001|Treatment Period|Non-compliance with Study Drug|1
7638677|NCT02546986|12052967|FG000|Treatment Period|Study Terminated by Sponsor|0
7638678|NCT02546986|12052968|FG001|Treatment Period|Study Terminated by Sponsor|1
7638679|NCT02546986|12052967|FG000|Treatment Period|Miscellaneous|7
7638680|NCT02546986|12052968|FG001|Treatment Period|Miscellaneous|9
7638681|NCT02546986|12052967|FG000|Survival Follow-Up Phase|Missing Status|3
7638682|NCT02546986|12052968|FG001|Survival Follow-Up Phase|Missing Status|5
7638683|NCT02546986|12052967|FG000|Survival Follow-Up Phase|Death|18
7638684|NCT02546986|12052968|FG001|Survival Follow-Up Phase|Death|12
7638685|NCT02546986|12052967|FG000|Survival Follow-Up Phase|Alive|13
7638686|NCT02546986|12052968|FG001|Survival Follow-Up Phase|Alive|16
7638687|NCT02546986|12052967|FG000|Survival Follow-Up Phase|Lost to Follow-up|2
7638688|NCT02546986|12052968|FG001|Survival Follow-Up Phase|Lost to Follow-up|2
7638689|NCT02544763|12052987|FG000|Overall Study|Adverse Event|8
7638690|NCT02544763|12052988|FG001|Overall Study|Adverse Event|8
7638691|NCT02544763|12052989|FG002|Overall Study|Adverse Event|0
7638692|NCT02544763|12052987|FG000|Overall Study|Withdrawn by parent/guardian|1
7638693|NCT02544763|12052988|FG001|Overall Study|Withdrawn by parent/guardian|1
7638694|NCT02544763|12052989|FG002|Overall Study|Withdrawn by parent/guardian|1
7638695|NCT02544763|12052987|FG000|Overall Study|Met withdrawal criteria|0
7638696|NCT02544763|12052988|FG001|Overall Study|Met withdrawal criteria|2
7638697|NCT02544763|12052989|FG002|Overall Study|Met withdrawal criteria|0
7638698|NCT02544763|12052987|FG000|Overall Study|Physician Decision|0
7638699|NCT02544763|12052988|FG001|Overall Study|Physician Decision|1
7638700|NCT02544763|12052989|FG002|Overall Study|Physician Decision|0
7638701|NCT02544763|12052987|FG000|Overall Study|Difficulties taking IMP|1
7638702|NCT02544763|12052988|FG001|Overall Study|Difficulties taking IMP|0
7638703|NCT02544763|12052989|FG002|Overall Study|Difficulties taking IMP|0
7638704|NCT02544503|12052999|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24
7638705|NCT02544503|12053000|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3
7638706|NCT02544503|12052999|FG000|Overall Study|Lost to Follow-up|9
7638707|NCT02544503|12053000|FG001|Overall Study|Lost to Follow-up|0
7638708|NCT02544503|12052999|FG000|Overall Study|Withdrawal by Subject|1
7638709|NCT02544503|12053000|FG001|Overall Study|Withdrawal by Subject|0
7638710|NCT02544373|12053008|FG000|Overall Study|Lost to Follow-up|5
7638711|NCT02544373|12053009|FG001|Overall Study|Lost to Follow-up|3
7638712|NCT02544373|12053008|FG000|Overall Study|Withdrawal by Subject|8
7638713|NCT02544373|12053009|FG001|Overall Study|Withdrawal by Subject|2
7638714|NCT02542293|12053027|FG000|Overall Study|Death|367
7638715|NCT02542293|12053028|FG001|Overall Study|Death|377
7638716|NCT02542293|12053027|FG000|Overall Study|Withdrawal by Subject|8
7638717|NCT02542293|12053028|FG001|Overall Study|Withdrawal by Subject|19
7638718|NCT02533180|12053069|FG000|Overall Study|Death|0
7638719|NCT02533180|12053070|FG001|Overall Study|Death|1
7638720|NCT02533180|12053069|FG000|Overall Study|Lost to Follow-up|0
7638721|NCT02533180|12053070|FG001|Overall Study|Lost to Follow-up|1
7638722|NCT02533180|12053069|FG000|Overall Study|Physician Decision|0
7638723|NCT02533180|12053070|FG001|Overall Study|Physician Decision|1
7638724|NCT02533180|12053069|FG000|Overall Study|Withdrawal by Subject|2
7638725|NCT02533180|12053070|FG001|Overall Study|Withdrawal by Subject|4
7638726|NCT02533180|12053069|FG000|Overall Study|Screen Failure|37
7638727|NCT02533180|12053070|FG001|Overall Study|Screen Failure|0
7638728|NCT02533180|12053069|FG000|Overall Study|Protocol Deviation|0
7638729|NCT02533180|12053070|FG001|Overall Study|Protocol Deviation|1
7638730|NCT02533180|12053069|FG000|Overall Study|On Study|0
7638731|NCT02533180|12053070|FG001|Overall Study|On Study|39
7638732|NCT02527434|12053082|FG000|Overall Study|Lost to Follow-up|2
7638733|NCT02527434|12053083|FG001|Overall Study|Lost to Follow-up|2
7638734|NCT02527434|12053084|FG002|Overall Study|Lost to Follow-up|0
7638735|NCT02527434|12053082|FG000|Overall Study|Death|19
7638736|NCT02527434|12053083|FG001|Overall Study|Death|6
7638737|NCT02527434|12053084|FG002|Overall Study|Death|17
7638738|NCT02527434|12053082|FG000|Overall Study|Withdrawal by Subject|5
7638739|NCT02527434|12053083|FG001|Overall Study|Withdrawal by Subject|3
7638740|NCT02527434|12053084|FG002|Overall Study|Withdrawal by Subject|3
7638741|NCT02527434|12053082|FG000|Overall Study|Reason Not Specified|1
7638742|NCT02527434|12053083|FG001|Overall Study|Reason Not Specified|0
7638743|NCT02527434|12053084|FG002|Overall Study|Reason Not Specified|0
7638744|NCT02527434|12053082|FG000|Overall Study|Site closure|1
7638745|NCT02527434|12053083|FG001|Overall Study|Site closure|0
7638746|NCT02527434|12053084|FG002|Overall Study|Site closure|0
7638747|NCT02524275|12053106|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5
7638748|NCT02522494|12053121|FG000|Overall Study|Lost to Follow-up|6
7638749|NCT02522494|12053122|FG001|Overall Study|Lost to Follow-up|2
7638750|NCT02522494|12053121|FG000|Overall Study|Withdrawal by Subject|1
7638751|NCT02522494|12053122|FG001|Overall Study|Withdrawal by Subject|0
7638752|NCT02522494|12053121|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6
7638753|NCT02522494|12053122|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2
7638754|NCT02522494|12053121|FG000|Overall Study|Participant did not watch the video|1
7638755|NCT02522494|12053122|FG001|Overall Study|Participant did not watch the video|0
7638756|NCT02522494|12053121|FG000|Overall Study|Death|0
7638757|NCT02522494|12053122|FG001|Overall Study|Death|1
7638758|NCT02513485|12053148|FG000|Overall Study|Adverse Event|1
7638759|NCT02513485|12053149|FG001|Overall Study|Adverse Event|0
7638760|NCT02504151|12053157|FG000|First Intervention (4 Weeks)|Physician Decision|1
7638761|NCT02504151|12053158|FG001|First Intervention (4 Weeks)|Physician Decision|1
7638762|NCT02504151|12053157|FG000|Washout (2 Weeks)|Lost to Follow-up|1
7638763|NCT02504151|12053158|FG001|Washout (2 Weeks)|Lost to Follow-up|0
7638764|NCT02504151|12053157|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0
7638765|NCT02504151|12053158|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7638766|NCT02504151|12053157|FG000|Second Intervention (4 Weeks)|Physician Decision|2
7638767|NCT02504151|12053158|FG001|Second Intervention (4 Weeks)|Physician Decision|1
7638768|NCT02499328|12053183|FG000|Overall Study|Withdrawal by Subject|1
7638769|NCT02499328|12053184|FG001|Overall Study|Withdrawal by Subject|1
7638770|NCT02499328|12053185|FG002|Overall Study|Withdrawal by Subject|5
7638771|NCT02499328|12053186|FG003|Overall Study|Withdrawal by Subject|3
7638772|NCT02499328|12053187|FG004|Overall Study|Withdrawal by Subject|5
7638773|NCT02499328|12053188|FG005|Overall Study|Withdrawal by Subject|0
7638774|NCT02499328|12053189|FG006|Overall Study|Withdrawal by Subject|0
7638775|NCT02499328|12053190|FG007|Overall Study|Withdrawal by Subject|0
7638776|NCT02499328|12053191|FG008|Overall Study|Withdrawal by Subject|2
7638777|NCT02499328|12053192|FG009|Overall Study|Withdrawal by Subject|2
7638778|NCT02499328|12053193|FG010|Overall Study|Withdrawal by Subject|0
7638779|NCT02499328|12053194|FG011|Overall Study|Withdrawal by Subject|3
7638780|NCT02499328|12053195|FG012|Overall Study|Withdrawal by Subject|7
7638781|NCT02499328|12053196|FG013|Overall Study|Withdrawal by Subject|3
7638782|NCT02499328|12053197|FG014|Overall Study|Withdrawal by Subject|1
7638783|NCT02499328|12053198|FG015|Overall Study|Withdrawal by Subject|0
7638784|NCT02499328|12053199|FG016|Overall Study|Withdrawal by Subject|0
7638785|NCT02499328|12053200|FG017|Overall Study|Withdrawal by Subject|3
7638786|NCT02499328|12053201|FG018|Overall Study|Withdrawal by Subject|0
7638787|NCT02499328|12053183|FG000|Overall Study|Lost to Follow-up|0
7638788|NCT02499328|12053184|FG001|Overall Study|Lost to Follow-up|1
7638789|NCT02499328|12053185|FG002|Overall Study|Lost to Follow-up|1
7638790|NCT02499328|12053186|FG003|Overall Study|Lost to Follow-up|2
7638791|NCT02499328|12053187|FG004|Overall Study|Lost to Follow-up|0
7638792|NCT02499328|12053188|FG005|Overall Study|Lost to Follow-up|0
7638793|NCT02499328|12053189|FG006|Overall Study|Lost to Follow-up|0
7638794|NCT02499328|12053190|FG007|Overall Study|Lost to Follow-up|2
7638795|NCT02499328|12053191|FG008|Overall Study|Lost to Follow-up|3
7638796|NCT02499328|12053192|FG009|Overall Study|Lost to Follow-up|0
7638797|NCT02499328|12053193|FG010|Overall Study|Lost to Follow-up|0
7638798|NCT02499328|12053194|FG011|Overall Study|Lost to Follow-up|0
7638799|NCT02499328|12053195|FG012|Overall Study|Lost to Follow-up|0
7638800|NCT02499328|12053196|FG013|Overall Study|Lost to Follow-up|0
7638801|NCT02499328|12053197|FG014|Overall Study|Lost to Follow-up|0
7638802|NCT02499328|12053198|FG015|Overall Study|Lost to Follow-up|0
7638803|NCT02499328|12053199|FG016|Overall Study|Lost to Follow-up|0
7638804|NCT02499328|12053200|FG017|Overall Study|Lost to Follow-up|0
7638805|NCT02499328|12053201|FG018|Overall Study|Lost to Follow-up|1
7638806|NCT02499328|12053183|FG000|Overall Study|Death|0
7638807|NCT02499328|12053184|FG001|Overall Study|Death|3
7638808|NCT02499328|12053185|FG002|Overall Study|Death|3
7638809|NCT02499328|12053186|FG003|Overall Study|Death|2
7638810|NCT02499328|12053187|FG004|Overall Study|Death|4
7638811|NCT02499328|12053188|FG005|Overall Study|Death|7
7638812|NCT02499328|12053189|FG006|Overall Study|Death|3
7638813|NCT02499328|12053190|FG007|Overall Study|Death|0
7638814|NCT02499328|12053191|FG008|Overall Study|Death|2
7638815|NCT02499328|12053192|FG009|Overall Study|Death|6
7638816|NCT02499328|12053193|FG010|Overall Study|Death|6
7638817|NCT02499328|12053194|FG011|Overall Study|Death|20
7638818|NCT02499328|12053195|FG012|Overall Study|Death|9
7638819|NCT02499328|12053196|FG013|Overall Study|Death|7
7638820|NCT02499328|12053197|FG014|Overall Study|Death|3
7638821|NCT02499328|12053198|FG015|Overall Study|Death|1
7638822|NCT02499328|12053199|FG016|Overall Study|Death|1
7638823|NCT02499328|12053200|FG017|Overall Study|Death|16
7638824|NCT02499328|12053201|FG018|Overall Study|Death|5
7638825|NCT02499328|12053183|FG000|Overall Study|"Other"|2
7638826|NCT02499328|12053184|FG001|Overall Study|"Other"|2
7638827|NCT02499328|12053185|FG002|Overall Study|"Other"|1
7638828|NCT02499328|12053186|FG003|Overall Study|"Other"|3
7638829|NCT02499328|12053187|FG004|Overall Study|"Other"|6
7638830|NCT02499328|12053188|FG005|Overall Study|"Other"|2
7638831|NCT02499328|12053189|FG006|Overall Study|"Other"|3
7638832|NCT02499328|12053190|FG007|Overall Study|"Other"|4
7638833|NCT02499328|12053191|FG008|Overall Study|"Other"|6
7638834|NCT02499328|12053192|FG009|Overall Study|"Other"|16
7638835|NCT02499328|12053193|FG010|Overall Study|"Other"|13
7638836|NCT02499328|12053194|FG011|Overall Study|"Other"|31
7638837|NCT02499328|12053195|FG012|Overall Study|"Other"|8
7638838|NCT02499328|12053196|FG013|Overall Study|"Other"|7
7638839|NCT02499328|12053197|FG014|Overall Study|"Other"|6
7638840|NCT02499328|12053198|FG015|Overall Study|"Other"|0
7638841|NCT02499328|12053199|FG016|Overall Study|"Other"|0
7638842|NCT02499328|12053200|FG017|Overall Study|"Other"|34
7638843|NCT02499328|12053201|FG018|Overall Study|"Other"|43
7638844|NCT02499328|12053183|FG000|Overall Study|Disease Progression|0
7638845|NCT02499328|12053184|FG001|Overall Study|Disease Progression|0
7638846|NCT02499328|12053185|FG002|Overall Study|Disease Progression|0
7638847|NCT02499328|12053186|FG003|Overall Study|Disease Progression|0
7638848|NCT02499328|12053187|FG004|Overall Study|Disease Progression|0
7638850|NCT02499328|12053189|FG006|Overall Study|Disease Progression|1
7638851|NCT02499328|12053190|FG007|Overall Study|Disease Progression|0
7638852|NCT02499328|12053191|FG008|Overall Study|Disease Progression|1
7638853|NCT02499328|12053192|FG009|Overall Study|Disease Progression|0
7638854|NCT02499328|12053193|FG010|Overall Study|Disease Progression|1
7638855|NCT02499328|12053194|FG011|Overall Study|Disease Progression|0
7638856|NCT02499328|12053195|FG012|Overall Study|Disease Progression|0
7638857|NCT02499328|12053196|FG013|Overall Study|Disease Progression|0
7638858|NCT02499328|12053197|FG014|Overall Study|Disease Progression|0
7638859|NCT02499328|12053198|FG015|Overall Study|Disease Progression|0
7638860|NCT02499328|12053199|FG016|Overall Study|Disease Progression|0
7638861|NCT02499328|12053200|FG017|Overall Study|Disease Progression|2
7638862|NCT02499328|12053201|FG018|Overall Study|Disease Progression|0
7638863|NCT02499328|12053183|FG000|Overall Study|Adverse Event|1
7638864|NCT02499328|12053184|FG001|Overall Study|Adverse Event|0
7638865|NCT02499328|12053185|FG002|Overall Study|Adverse Event|0
7638866|NCT02499328|12053186|FG003|Overall Study|Adverse Event|1
7638867|NCT02499328|12053187|FG004|Overall Study|Adverse Event|0
7638868|NCT02499328|12053188|FG005|Overall Study|Adverse Event|0
7638869|NCT02499328|12053189|FG006|Overall Study|Adverse Event|0
7638870|NCT02499328|12053190|FG007|Overall Study|Adverse Event|0
7638871|NCT02499328|12053191|FG008|Overall Study|Adverse Event|0
7638872|NCT02499328|12053192|FG009|Overall Study|Adverse Event|0
7638873|NCT02499328|12053193|FG010|Overall Study|Adverse Event|0
7638874|NCT02499328|12053194|FG011|Overall Study|Adverse Event|0
7638875|NCT02499328|12053195|FG012|Overall Study|Adverse Event|1
7638876|NCT02499328|12053196|FG013|Overall Study|Adverse Event|0
7638877|NCT02499328|12053197|FG014|Overall Study|Adverse Event|0
7638878|NCT02499328|12053198|FG015|Overall Study|Adverse Event|0
7638879|NCT02499328|12053199|FG016|Overall Study|Adverse Event|0
7638880|NCT02499328|12053200|FG017|Overall Study|Adverse Event|0
7638881|NCT02499328|12053201|FG018|Overall Study|Adverse Event|0
7638882|NCT02495077|12053295|FG000|Overall Study|Adverse Event|0
7638883|NCT02495077|12053296|FG001|Overall Study|Adverse Event|1
7638884|NCT02495077|12053297|FG002|Overall Study|Adverse Event|1
7638885|NCT02495077|12053298|FG003|Overall Study|Adverse Event|0
7638886|NCT02495077|12053295|FG000|Overall Study|Death|3
7638887|NCT02495077|12053296|FG001|Overall Study|Death|5
7638888|NCT02495077|12053297|FG002|Overall Study|Death|0
7638889|NCT02495077|12053298|FG003|Overall Study|Death|0
7638890|NCT02495077|12053295|FG000|Overall Study|Lost to Follow-up|6
7638891|NCT02495077|12053296|FG001|Overall Study|Lost to Follow-up|4
7638892|NCT02495077|12053297|FG002|Overall Study|Lost to Follow-up|0
7638893|NCT02495077|12053298|FG003|Overall Study|Lost to Follow-up|0
7638894|NCT02495077|12053295|FG000|Overall Study|Physician Decision|2
7638895|NCT02495077|12053296|FG001|Overall Study|Physician Decision|1
7638896|NCT02495077|12053297|FG002|Overall Study|Physician Decision|4
7638897|NCT02495077|12053298|FG003|Overall Study|Physician Decision|0
7638898|NCT02495077|12053295|FG000|Overall Study|Protocol Violation|0
7638899|NCT02495077|12053296|FG001|Overall Study|Protocol Violation|1
7638900|NCT02495077|12053297|FG002|Overall Study|Protocol Violation|0
7638901|NCT02495077|12053298|FG003|Overall Study|Protocol Violation|0
7638902|NCT02495077|12053295|FG000|Overall Study|Screen Failure|0
7638903|NCT02495077|12053296|FG001|Overall Study|Screen Failure|0
7638904|NCT02495077|12053297|FG002|Overall Study|Screen Failure|0
7638905|NCT02495077|12053298|FG003|Overall Study|Screen Failure|48
7638906|NCT02495077|12053295|FG000|Overall Study|Withdrawal by Subject|7
7638907|NCT02495077|12053296|FG001|Overall Study|Withdrawal by Subject|7
7638908|NCT02495077|12053297|FG002|Overall Study|Withdrawal by Subject|7
7638909|NCT02495077|12053298|FG003|Overall Study|Withdrawal by Subject|0
7638910|NCT02495077|12053295|FG000|Overall Study|Covid-19 research restrictions|1
7638911|NCT02495077|12053296|FG001|Overall Study|Covid-19 research restrictions|0
7638912|NCT02495077|12053297|FG002|Overall Study|Covid-19 research restrictions|0
7638913|NCT02495077|12053298|FG003|Overall Study|Covid-19 research restrictions|0
7638914|NCT02495077|12053295|FG000|Overall Study|Visit 14 scheduling difficulties|1
7638915|NCT02495077|12053296|FG001|Overall Study|Visit 14 scheduling difficulties|0
7638916|NCT02495077|12053297|FG002|Overall Study|Visit 14 scheduling difficulties|0
7638917|NCT02495077|12053298|FG003|Overall Study|Visit 14 scheduling difficulties|0
7638918|NCT02495077|12053295|FG000|Overall Study|Incarcerated|0
7638919|NCT02495077|12053296|FG001|Overall Study|Incarcerated|1
7638920|NCT02495077|12053297|FG002|Overall Study|Incarcerated|0
7638921|NCT02495077|12053298|FG003|Overall Study|Incarcerated|0
7638922|NCT02495077|12053295|FG000|Overall Study|Transplant nephrectomy, patient decision|0
7638923|NCT02495077|12053296|FG001|Overall Study|Transplant nephrectomy, patient decision|1
7638924|NCT02495077|12053297|FG002|Overall Study|Transplant nephrectomy, patient decision|0
7638925|NCT02495077|12053298|FG003|Overall Study|Transplant nephrectomy, patient decision|0
7638926|NCT02495077|12053295|FG000|Overall Study|Timing of transplant and randomization|0
7638927|NCT02495077|12053296|FG001|Overall Study|Timing of transplant and randomization|0
7638928|NCT02495077|12053297|FG002|Overall Study|Timing of transplant and randomization|5
7638929|NCT02495077|12053298|FG003|Overall Study|Timing of transplant and randomization|0
7638930|NCT02494921|12053309|FG000|Phase 1b, Dose Level I|Adverse Event|2
7638931|NCT02494921|12053310|FG001|Phase 1b, Dose Level I|Adverse Event|0
7638932|NCT02494921|12053311|FG002|Phase 1b, Dose Level I|Adverse Event|0
7638933|NCT02494921|12053312|FG003|Phase 1b, Dose Level I|Adverse Event|0
7638934|NCT02494921|12053313|FG004|Phase 1b, Dose Level I|Adverse Event|0
7638935|NCT02494921|12053309|FG000|Phase 1b, Dose Level IA|Adverse Event|0
7638936|NCT02494921|12053310|FG001|Phase 1b, Dose Level IA|Adverse Event|1
7638937|NCT02494921|12053311|FG002|Phase 1b, Dose Level IA|Adverse Event|0
7638938|NCT02494921|12053312|FG003|Phase 1b, Dose Level IA|Adverse Event|0
7638939|NCT02494921|12053313|FG004|Phase 1b, Dose Level IA|Adverse Event|0
7638940|NCT02494921|12053309|FG000|Phase 1b, Dose Level IIC|Physician Decision|0
7638941|NCT02494921|12053310|FG001|Phase 1b, Dose Level IIC|Physician Decision|0
7638942|NCT02494921|12053311|FG002|Phase 1b, Dose Level IIC|Physician Decision|1
7638943|NCT02494921|12053312|FG003|Phase 1b, Dose Level IIC|Physician Decision|0
7638944|NCT02494921|12053313|FG004|Phase 1b, Dose Level IIC|Physician Decision|0
7638945|NCT02494583|12053334|FG000|Overall Study|Death|195
7638946|NCT02494583|12053335|FG001|Overall Study|Death|189
7638947|NCT02494583|12053336|FG002|Overall Study|Death|201
7638948|NCT02494583|12053334|FG000|Overall Study|Lost to Follow-up|1
7638949|NCT02494583|12053335|FG001|Overall Study|Lost to Follow-up|0
7638950|NCT02494583|12053336|FG002|Overall Study|Lost to Follow-up|0
7638951|NCT02494583|12053334|FG000|Overall Study|Protocol Violation|1
7638952|NCT02494583|12053335|FG001|Overall Study|Protocol Violation|2
7638953|NCT02494583|12053336|FG002|Overall Study|Protocol Violation|0
7638954|NCT02494583|12053334|FG000|Overall Study|Withdrawal by Subject|3
7638955|NCT02494583|12053335|FG001|Overall Study|Withdrawal by Subject|15
7638956|NCT02494583|12053336|FG002|Overall Study|Withdrawal by Subject|15
7638957|NCT02494583|12053334|FG000|Overall Study|Ongoing in Study|56
7638958|NCT02494583|12053335|FG001|Overall Study|Ongoing in Study|51
7638959|NCT02494583|12053336|FG002|Overall Study|Ongoing in Study|34
7638960|NCT02493946|12053347|FG000|DB Period|Withdrawal by Subject|8
7638961|NCT02493946|12053348|FG001|DB Period|Withdrawal by Subject|5
7638962|NCT02493946|12053349|FG002|DB Period|Withdrawal by Subject|0
7638963|NCT02493946|12053347|FG000|Open Label Period|Withdrawal by Subject|0
7638964|NCT02493946|12053348|FG001|Open Label Period|Withdrawal by Subject|0
7638965|NCT02493946|12053349|FG002|Open Label Period|Withdrawal by Subject|74
7638966|NCT02493946|12053347|FG000|Open Label Period|Adverse Event|0
7638967|NCT02493946|12053348|FG001|Open Label Period|Adverse Event|0
7638968|NCT02493946|12053349|FG002|Open Label Period|Adverse Event|4
7638969|NCT02493946|12053347|FG000|Open Label Period|Lost to Follow-up|0
7638970|NCT02493946|12053348|FG001|Open Label Period|Lost to Follow-up|0
7638971|NCT02493946|12053349|FG002|Open Label Period|Lost to Follow-up|1
7638972|NCT02493946|12053347|FG000|Open Label Period|Investigator decision, non-compliance|0
7638973|NCT02493946|12053348|FG001|Open Label Period|Investigator decision, non-compliance|0
7638974|NCT02493946|12053349|FG002|Open Label Period|Investigator decision, non-compliance|2
7638975|NCT02493946|12053347|FG000|Open Label Period|Investigator decision, non-availability|0
7638976|NCT02493946|12053348|FG001|Open Label Period|Investigator decision, non-availability|0
7638977|NCT02493946|12053349|FG002|Open Label Period|Investigator decision, non-availability|1
7638978|NCT02493946|12053347|FG000|Open Label Period|Pregnancy|0
7638979|NCT02493946|12053348|FG001|Open Label Period|Pregnancy|0
7638980|NCT02493946|12053349|FG002|Open Label Period|Pregnancy|3
7638981|NCT02493946|12053347|FG000|Open Label Period|Site error|0
7638982|NCT02493946|12053348|FG001|Open Label Period|Site error|0
7638983|NCT02493946|12053349|FG002|Open Label Period|Site error|1
7638984|NCT02489318|12053368|FG000|Randomized|Withdrawal by Subject|0
7638985|NCT02489318|12053369|FG001|Randomized|Withdrawal by Subject|1
7638986|NCT02489318|12053368|FG000|Treated|Adverse Event|19
7638987|NCT02489318|12053369|FG001|Treated|Adverse Event|62
7638988|NCT02489318|12053368|FG000|Treated|Death|13
7638989|NCT02489318|12053369|FG001|Treated|Death|11
7638990|NCT02489318|12053368|FG000|Treated|Physician Decision|4
7638991|NCT02489318|12053369|FG001|Treated|Physician Decision|6
7638992|NCT02489318|12053368|FG000|Treated|Protocol Violation|1
7638993|NCT02489318|12053369|FG001|Treated|Protocol Violation|2
7638994|NCT02489318|12053368|FG000|Treated|Withdrawal by Subject|37
7638995|NCT02489318|12053369|FG001|Treated|Withdrawal by Subject|36
7638996|NCT02489318|12053368|FG000|Treated|Other: Progressive Disease|245
7638997|NCT02489318|12053369|FG001|Treated|Other: Progressive Disease|138
7638998|NCT02489318|12053368|FG000|Treated|Other|0
7638999|NCT02489318|12053369|FG001|Treated|Other|2
7639000|NCT02489318|12053368|FG000|Treated|Ongoing|0
7639001|NCT02489318|12053369|FG001|Treated|Ongoing|267
7639002|NCT02488759|12053391|FG000|Overall Study|Disease progression|74
7639003|NCT02488759|12053392|FG001|Overall Study|Disease progression|110
7639004|NCT02488759|12053393|FG002|Overall Study|Disease progression|62
7639005|NCT02488759|12053394|FG003|Overall Study|Disease progression|7
7639006|NCT02488759|12053395|FG004|Overall Study|Disease progression|4
7639007|NCT02488759|12053396|FG005|Overall Study|Disease progression|2
7639008|NCT02488759|12053391|FG000|Overall Study|Study drug toxicity|11
7639009|NCT02488759|12053392|FG001|Overall Study|Study drug toxicity|33
7639010|NCT02488759|12053393|FG002|Overall Study|Study drug toxicity|31
7639011|NCT02488759|12053394|FG003|Overall Study|Study drug toxicity|0
7639012|NCT02488759|12053395|FG004|Overall Study|Study drug toxicity|0
7639013|NCT02488759|12053396|FG005|Overall Study|Study drug toxicity|2
7639014|NCT02488759|12053391|FG000|Overall Study|Adverse event unrelated to study drug|9
7639015|NCT02488759|12053392|FG001|Overall Study|Adverse event unrelated to study drug|11
7639016|NCT02488759|12053393|FG002|Overall Study|Adverse event unrelated to study drug|7
7639017|NCT02488759|12053394|FG003|Overall Study|Adverse event unrelated to study drug|0
7639018|NCT02488759|12053395|FG004|Overall Study|Adverse event unrelated to study drug|1
7639019|NCT02488759|12053396|FG005|Overall Study|Adverse event unrelated to study drug|0
7639020|NCT02488759|12053391|FG000|Overall Study|Participant request to discontinue study treatment|7
7639021|NCT02488759|12053392|FG001|Overall Study|Participant request to discontinue study treatment|8
7639022|NCT02488759|12053393|FG002|Overall Study|Participant request to discontinue study treatment|4
7639023|NCT02488759|12053394|FG003|Overall Study|Participant request to discontinue study treatment|0
7639024|NCT02488759|12053395|FG004|Overall Study|Participant request to discontinue study treatment|0
7639025|NCT02488759|12053396|FG005|Overall Study|Participant request to discontinue study treatment|0
7639026|NCT02488759|12053391|FG000|Overall Study|Withdrawal by Subject|2
7639027|NCT02488759|12053392|FG001|Overall Study|Withdrawal by Subject|0
7639028|NCT02488759|12053393|FG002|Overall Study|Withdrawal by Subject|3
7639029|NCT02488759|12053394|FG003|Overall Study|Withdrawal by Subject|0
7639030|NCT02488759|12053395|FG004|Overall Study|Withdrawal by Subject|0
7639031|NCT02488759|12053396|FG005|Overall Study|Withdrawal by Subject|2
7639032|NCT02488759|12053391|FG000|Overall Study|Lost to Follow-up|0
7639033|NCT02488759|12053392|FG001|Overall Study|Lost to Follow-up|1
7639034|NCT02488759|12053393|FG002|Overall Study|Lost to Follow-up|2
7639035|NCT02488759|12053394|FG003|Overall Study|Lost to Follow-up|0
7639036|NCT02488759|12053395|FG004|Overall Study|Lost to Follow-up|0
7639037|NCT02488759|12053396|FG005|Overall Study|Lost to Follow-up|0
7639038|NCT02488759|12053391|FG000|Overall Study|Maximum clinical benefit|3
7639039|NCT02488759|12053392|FG001|Overall Study|Maximum clinical benefit|0
7639040|NCT02488759|12053393|FG002|Overall Study|Maximum clinical benefit|1
7639041|NCT02488759|12053394|FG003|Overall Study|Maximum clinical benefit|0
7639042|NCT02488759|12053395|FG004|Overall Study|Maximum clinical benefit|0
7639043|NCT02488759|12053396|FG005|Overall Study|Maximum clinical benefit|0
7639044|NCT02488759|12053391|FG000|Overall Study|Completed treatment|0
7639045|NCT02488759|12053392|FG001|Overall Study|Completed treatment|0
7639046|NCT02488759|12053393|FG002|Overall Study|Completed treatment|0
7639047|NCT02488759|12053394|FG003|Overall Study|Completed treatment|0
7639048|NCT02488759|12053395|FG004|Overall Study|Completed treatment|0
7639049|NCT02488759|12053396|FG005|Overall Study|Completed treatment|116
7639050|NCT02488759|12053391|FG000|Overall Study|Other reasons|5
7639051|NCT02488759|12053392|FG001|Overall Study|Other reasons|32
7639052|NCT02488759|12053393|FG002|Overall Study|Other reasons|21
7639053|NCT02488759|12053394|FG003|Overall Study|Other reasons|1
7639054|NCT02488759|12053395|FG004|Overall Study|Other reasons|1
7639055|NCT02488759|12053396|FG005|Overall Study|Other reasons|1
7639056|NCT02488551|12053414|FG000|Overall Study|Lost to Follow-up|4
7639057|NCT02488551|12053415|FG001|Overall Study|Lost to Follow-up|7
7639058|NCT02488551|12053416|FG002|Overall Study|Lost to Follow-up|0
7639059|NCT02488551|12053417|FG003|Overall Study|Lost to Follow-up|0
7639060|NCT02488551|12053414|FG000|Overall Study|Military Deployment|1
7639061|NCT02488551|12053415|FG001|Overall Study|Military Deployment|1
7639062|NCT02488551|12053416|FG002|Overall Study|Military Deployment|0
7639063|NCT02488551|12053417|FG003|Overall Study|Military Deployment|0
7639064|NCT02485899|12053455|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2
7639065|NCT02485899|12053456|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0
7639066|NCT02485899|12053455|FG000|Overall Study|Withdrawal by Subject|1
7639067|NCT02485899|12053456|FG001|Overall Study|Withdrawal by Subject|0
7639068|NCT02485899|12053455|FG000|Overall Study|Withdrawal by Parent/ Guardian|4
7639069|NCT02485899|12053456|FG001|Overall Study|Withdrawal by Parent/ Guardian|0
7639070|NCT02484443|12053462|FG000|Overall Study|Lack of Efficacy|28
7639071|NCT02484443|12053462|FG000|Overall Study|Physician Decision|2
7639072|NCT02484443|12053462|FG000|Overall Study|Ineligible|2
7639073|NCT02477696|12053477|FG000|Overall Study|Adverse Event|40
7639074|NCT02477696|12053478|FG001|Overall Study|Adverse Event|59
7639075|NCT02477696|12053477|FG000|Overall Study|CLL Disease Progression|82
7639076|NCT02477696|12053478|FG001|Overall Study|CLL Disease Progression|68
7639077|NCT02477696|12053477|FG000|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|2
7639078|NCT02477696|12053478|FG001|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|10
7639079|NCT02477696|12053477|FG000|Overall Study|Death|5
7639080|NCT02477696|12053478|FG001|Overall Study|Death|6
7639081|NCT02477696|12053477|FG000|Overall Study|Withdrawal by Subject|7
7639082|NCT02477696|12053478|FG001|Overall Study|Withdrawal by Subject|7
7639083|NCT02477696|12053477|FG000|Overall Study|Physician Decision|5
7639084|NCT02477696|12053478|FG001|Overall Study|Physician Decision|5
7639085|NCT02476968|12053487|FG000|Overall Study|Other|0
7639086|NCT02476968|12053488|FG001|Overall Study|Other|2
7639087|NCT02476968|12053489|FG002|Overall Study|Other|0
7639088|NCT02476968|12053487|FG000|Overall Study|Lost to Follow-up|10
7639089|NCT02476968|12053488|FG001|Overall Study|Lost to Follow-up|0
7639090|NCT02476968|12053489|FG002|Overall Study|Lost to Follow-up|1
7639091|NCT02476968|12053487|FG000|Overall Study|Death|48
7639092|NCT02476968|12053488|FG001|Overall Study|Death|8
7639093|NCT02476968|12053489|FG002|Overall Study|Death|1
7639094|NCT02476968|12053487|FG000|Overall Study|Eligibility criteria not fulfilled|0
7639095|NCT02476968|12053488|FG001|Overall Study|Eligibility criteria not fulfilled|0
7639096|NCT02476968|12053489|FG002|Overall Study|Eligibility criteria not fulfilled|1
7639097|NCT02476968|12053487|FG000|Overall Study|Patient decision|37
7639098|NCT02476968|12053488|FG001|Overall Study|Patient decision|8
7639099|NCT02476968|12053489|FG002|Overall Study|Patient decision|0
7639100|NCT02476916|12053501|FG000|Core Period|Adverse Event|2
7639101|NCT02476916|12053502|FG001|Core Period|Adverse Event|2
7639102|NCT02476916|12053501|FG000|Core Period|Investigator decision|1
7639103|NCT02476916|12053502|FG001|Core Period|Investigator decision|1
7639104|NCT02476916|12053501|FG000|Core Period|Withdrawal by Subject|3
7639105|NCT02476916|12053502|FG001|Core Period|Withdrawal by Subject|0
7639106|NCT02476916|12053501|FG000|Extension Period|Prematurely Discontinued Treatment|6
7639107|NCT02476916|12053502|FG001|Extension Period|Prematurely Discontinued Treatment|1
7639108|NCT02476916|12053501|FG000|Extension Period|On Treatment|12
7639109|NCT02476916|12053502|FG001|Extension Period|On Treatment|17
7639110|NCT02464410|12053528|FG000|Overall Study|Death|3
7639111|NCT02464410|12053529|FG001|Overall Study|Death|4
7639112|NCT02464410|12053528|FG000|Overall Study|Lost to Follow-up|7
7639113|NCT02464410|12053529|FG001|Overall Study|Lost to Follow-up|9
7639114|NCT02464410|12053528|FG000|Overall Study|Withdrawal by Subject|12
7639115|NCT02464410|12053529|FG001|Overall Study|Withdrawal by Subject|3
7639116|NCT02460198|12053563|FG000|Overall Study|Adverse Event|1
7639117|NCT02460198|12053564|FG001|Overall Study|Adverse Event|3
7639118|NCT02460198|12053563|FG000|Overall Study|Death|36
7639119|NCT02460198|12053564|FG001|Overall Study|Death|28
7639120|NCT02460198|12053563|FG000|Overall Study|Lost to Follow-up|1
7639121|NCT02460198|12053564|FG001|Overall Study|Lost to Follow-up|1
7639122|NCT02460198|12053563|FG000|Overall Study|Transferred to Extension Study|15
7639123|NCT02460198|12053564|FG001|Overall Study|Transferred to Extension Study|15
7639124|NCT02460198|12053563|FG000|Overall Study|Withdrawal by Subject|2
7639125|NCT02460198|12053564|FG001|Overall Study|Withdrawal by Subject|4
7639126|NCT02460198|12053563|FG000|Overall Study|Site Terminated By Sponsor|0
7639127|NCT02460198|12053564|FG001|Overall Study|Site Terminated By Sponsor|1
7639128|NCT02460198|12053563|FG000|Overall Study|Did Not Continue on Extension Study|6
7639129|NCT02460198|12053564|FG001|Overall Study|Did Not Continue on Extension Study|11
7639130|NCT02457910|12053578|FG000|Overall Study|Withdrawal by Subject|0
7639131|NCT02457910|12053579|FG001|Overall Study|Withdrawal by Subject|0
7639132|NCT02457910|12053580|FG002|Overall Study|Withdrawal by Subject|0
7639133|NCT02457910|12053581|FG003|Overall Study|Withdrawal by Subject|0
7639134|NCT02457910|12053582|FG004|Overall Study|Withdrawal by Subject|0
7639135|NCT02457910|12053583|FG005|Overall Study|Withdrawal by Subject|1
7639136|NCT02457910|12053578|FG000|Overall Study|Adverse Event|0
7639137|NCT02457910|12053579|FG001|Overall Study|Adverse Event|2
7639138|NCT02457910|12053580|FG002|Overall Study|Adverse Event|1
7639139|NCT02457910|12053581|FG003|Overall Study|Adverse Event|1
7639140|NCT02457910|12053582|FG004|Overall Study|Adverse Event|1
7639141|NCT02457910|12053583|FG005|Overall Study|Adverse Event|3
7639142|NCT02457910|12053578|FG000|Overall Study|Disease progression|3
7639143|NCT02457910|12053579|FG001|Overall Study|Disease progression|3
7639144|NCT02457910|12053580|FG002|Overall Study|Disease progression|1
7639145|NCT02457910|12053581|FG003|Overall Study|Disease progression|1
7639146|NCT02457910|12053582|FG004|Overall Study|Disease progression|4
7639147|NCT02457910|12053583|FG005|Overall Study|Disease progression|6
7639148|NCT02457910|12053578|FG000|Overall Study|Other complicating illness|0
7639149|NCT02457910|12053579|FG001|Overall Study|Other complicating illness|0
7639150|NCT02457910|12053580|FG002|Overall Study|Other complicating illness|0
7639151|NCT02457910|12053581|FG003|Overall Study|Other complicating illness|0
7639152|NCT02457910|12053582|FG004|Overall Study|Other complicating illness|0
7639153|NCT02457910|12053583|FG005|Overall Study|Other complicating illness|1
7639154|NCT02457910|12053578|FG000|Overall Study|Death|0
7639155|NCT02457910|12053579|FG001|Overall Study|Death|0
7639156|NCT02457910|12053580|FG002|Overall Study|Death|1
7639157|NCT02457910|12053581|FG003|Overall Study|Death|0
7639158|NCT02457910|12053582|FG004|Overall Study|Death|0
7639159|NCT02457910|12053583|FG005|Overall Study|Death|0
7639160|NCT02456740|12053603|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
7639161|NCT02456740|12053604|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
7639162|NCT02456740|12053605|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
7639163|NCT02456740|12053606|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7639164|NCT02456740|12053607|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7639165|NCT02456740|12053608|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7639166|NCT02456740|12053609|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7639167|NCT02456740|12053610|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7639168|NCT02456740|12053611|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7639169|NCT02456740|12053603|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
7639170|NCT02456740|12053604|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
7639171|NCT02456740|12053605|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
7639172|NCT02456740|12053606|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7639173|NCT02456740|12053607|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7639174|NCT02456740|12053608|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7639175|NCT02456740|12053609|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7639176|NCT02456740|12053610|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7639177|NCT02456740|12053611|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7639178|NCT02456740|12053603|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
7639179|NCT02456740|12053604|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
7639254|NCT02446600|12053667|FG003|Overall Study|Withdrawal by Subject|0
7639180|NCT02456740|12053605|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
7639181|NCT02456740|12053606|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7639182|NCT02456740|12053607|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7639183|NCT02456740|12053608|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7639184|NCT02456740|12053609|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7639185|NCT02456740|12053610|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7639186|NCT02456740|12053611|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7639187|NCT02456740|12053603|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7639188|NCT02456740|12053604|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7639189|NCT02456740|12053605|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7639190|NCT02456740|12053606|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
7639191|NCT02456740|12053607|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
7639192|NCT02456740|12053608|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7639193|NCT02456740|12053609|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7639194|NCT02456740|12053610|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7639195|NCT02456740|12053611|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
7639196|NCT02456740|12053603|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7639197|NCT02456740|12053604|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7639198|NCT02456740|12053605|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7639199|NCT02456740|12053606|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
7639200|NCT02456740|12053607|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
7639201|NCT02456740|12053608|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
7639202|NCT02456740|12053609|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
7639203|NCT02456740|12053610|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
7639204|NCT02456740|12053611|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
7639205|NCT02456740|12053603|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639206|NCT02456740|12053604|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639207|NCT02456740|12053605|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639208|NCT02456740|12053606|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639209|NCT02456740|12053607|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639210|NCT02456740|12053608|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639211|NCT02456740|12053609|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639212|NCT02456740|12053610|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1
7639213|NCT02456740|12053611|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639214|NCT02456740|12053603|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7639215|NCT02456740|12053604|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7639216|NCT02456740|12053605|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7639217|NCT02456740|12053606|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
7639218|NCT02456740|12053607|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
7639219|NCT02456740|12053608|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
7639220|NCT02456740|12053609|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
7639221|NCT02456740|12053610|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
7639222|NCT02456740|12053611|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
7639223|NCT02454933|12053623|FG000|Overall Study|Progressive disease|7
7639224|NCT02454933|12053624|FG001|Overall Study|Progressive disease|5
7639225|NCT02454933|12053623|FG000|Overall Study|Adverse Event|1
7639226|NCT02454933|12053624|FG001|Overall Study|Adverse Event|1
7639227|NCT02454933|12053623|FG000|Overall Study|Withdrawal by Subject|0
7639228|NCT02454933|12053624|FG001|Overall Study|Withdrawal by Subject|2
7639229|NCT02453282|12053632|FG000|Overall Study|Death|275
7639230|NCT02453282|12053633|FG001|Overall Study|Death|277
7639231|NCT02453282|12053634|FG002|Overall Study|Death|296
7639232|NCT02453282|12053632|FG000|Overall Study|Lost to Follow-up|1
7639233|NCT02453282|12053633|FG001|Overall Study|Lost to Follow-up|0
7639234|NCT02453282|12053634|FG002|Overall Study|Lost to Follow-up|2
7639235|NCT02453282|12053632|FG000|Overall Study|Withdrawal by Subject|12
7639236|NCT02453282|12053633|FG001|Overall Study|Withdrawal by Subject|10
7639237|NCT02453282|12053634|FG002|Overall Study|Withdrawal by Subject|11
7639238|NCT02453282|12053632|FG000|Overall Study|Participants ongoing at data cut-off|85
7639239|NCT02453282|12053633|FG001|Overall Study|Participants ongoing at data cut-off|84
7639240|NCT02453282|12053634|FG002|Overall Study|Participants ongoing at data cut-off|62
7639241|NCT02453282|12053632|FG000|Overall Study|Other|1
7639242|NCT02453282|12053633|FG001|Overall Study|Other|1
7639243|NCT02453282|12053634|FG002|Overall Study|Other|1
7639244|NCT02448225|12053653|FG000|Overall Study|Withdrawal by Subject|1
7639245|NCT02448225|12053653|FG000|Overall Study|Did not get FSPG scan|18
7639246|NCT02448225|12053653|FG000|Overall Study|Treated between the FDG and FSPG scan|1
7639247|NCT02446600|12053664|FG000|Overall Study|Never treated|20
7639248|NCT02446600|12053665|FG001|Overall Study|Never treated|2
7639249|NCT02446600|12053666|FG002|Overall Study|Never treated|6
7639250|NCT02446600|12053667|FG003|Overall Study|Never treated|0
7639251|NCT02446600|12053664|FG000|Overall Study|Withdrawal by Subject|19
7639252|NCT02446600|12053665|FG001|Overall Study|Withdrawal by Subject|5
7639253|NCT02446600|12053666|FG002|Overall Study|Withdrawal by Subject|17
7639255|NCT02446600|12053664|FG000|Overall Study|Ineligible|1
7639256|NCT02446600|12053665|FG001|Overall Study|Ineligible|4
7639257|NCT02446600|12053666|FG002|Overall Study|Ineligible|4
7639258|NCT02446600|12053667|FG003|Overall Study|Ineligible|1
7639259|NCT02446600|12053664|FG000|Overall Study|Duplicate Enrollment|0
7639260|NCT02446600|12053665|FG001|Overall Study|Duplicate Enrollment|1
7639261|NCT02446600|12053666|FG002|Overall Study|Duplicate Enrollment|0
7639262|NCT02446600|12053667|FG003|Overall Study|Duplicate Enrollment|0
7639263|NCT02442778|12053680|FG000|Overall Study|Adverse Event|2
7639264|NCT02442778|12053681|FG001|Overall Study|Adverse Event|6
7639265|NCT02442778|12053682|FG002|Overall Study|Adverse Event|6
7639266|NCT02442778|12053680|FG000|Overall Study|Death|0
7639267|NCT02442778|12053681|FG001|Overall Study|Death|2
7639268|NCT02442778|12053682|FG002|Overall Study|Death|0
7639269|NCT02442778|12053680|FG000|Overall Study|Lack of Efficacy|1
7639270|NCT02442778|12053681|FG001|Overall Study|Lack of Efficacy|0
7639271|NCT02442778|12053682|FG002|Overall Study|Lack of Efficacy|0
7639272|NCT02442778|12053680|FG000|Overall Study|Lost to Follow-up|1
7639273|NCT02442778|12053681|FG001|Overall Study|Lost to Follow-up|1
7639274|NCT02442778|12053682|FG002|Overall Study|Lost to Follow-up|1
7639275|NCT02442778|12053680|FG000|Overall Study|Non-compliance with study drug|2
7639276|NCT02442778|12053681|FG001|Overall Study|Non-compliance with study drug|0
7639277|NCT02442778|12053682|FG002|Overall Study|Non-compliance with study drug|1
7639278|NCT02442778|12053680|FG000|Overall Study|Physician Decision|1
7639279|NCT02442778|12053681|FG001|Overall Study|Physician Decision|1
7639280|NCT02442778|12053682|FG002|Overall Study|Physician Decision|1
7639281|NCT02442778|12053680|FG000|Overall Study|Protocol Deviation|3
7639282|NCT02442778|12053681|FG001|Overall Study|Protocol Deviation|0
7639283|NCT02442778|12053682|FG002|Overall Study|Protocol Deviation|1
7639284|NCT02442778|12053680|FG000|Overall Study|Study participant withdrawal by parent or guardian|3
7639285|NCT02442778|12053681|FG001|Overall Study|Study participant withdrawal by parent or guardian|12
7639286|NCT02442778|12053682|FG002|Overall Study|Study participant withdrawal by parent or guardian|2
7639287|NCT02442778|12053680|FG000|Overall Study|Withdrawal by Subject|4
7639288|NCT02442778|12053681|FG001|Overall Study|Withdrawal by Subject|4
7639289|NCT02442778|12053682|FG002|Overall Study|Withdrawal by Subject|3
7639290|NCT02442778|12053680|FG000|Overall Study|Reason not specified|1
7639291|NCT02442778|12053681|FG001|Overall Study|Reason not specified|4
7639292|NCT02442778|12053682|FG002|Overall Study|Reason not specified|0
7639293|NCT02439216|12053696|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1
7639294|NCT02439216|12053697|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639295|NCT02439216|12053698|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639296|NCT02439216|12053699|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639297|NCT02439216|12053700|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639298|NCT02439216|12053701|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639299|NCT02439216|12053702|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639300|NCT02439216|12053703|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639301|NCT02439216|12053704|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639302|NCT02439216|12053696|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639303|NCT02439216|12053697|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639304|NCT02439216|12053698|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639305|NCT02439216|12053699|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639306|NCT02439216|12053700|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639307|NCT02439216|12053701|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639308|NCT02439216|12053702|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639309|NCT02439216|12053703|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1
7639310|NCT02439216|12053704|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639311|NCT02439216|12053696|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0
7639312|NCT02439216|12053697|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0
7639313|NCT02439216|12053698|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0
7639314|NCT02439216|12053699|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0
7639315|NCT02439216|12053700|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0
7639316|NCT02439216|12053701|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0
7639317|NCT02439216|12053702|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0
7639318|NCT02439216|12053703|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1
7639319|NCT02439216|12053704|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2
7639320|NCT02439216|12053696|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639321|NCT02439216|12053697|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639322|NCT02439216|12053698|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639323|NCT02439216|12053699|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639324|NCT02439216|12053700|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639325|NCT02439216|12053701|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639326|NCT02439216|12053702|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639327|NCT02439216|12053703|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639328|NCT02439216|12053704|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3
7639329|NCT02439216|12053696|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0
7639330|NCT02439216|12053697|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0
7639331|NCT02439216|12053698|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0
7639332|NCT02439216|12053699|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0
7639333|NCT02439216|12053700|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0
7639334|NCT02439216|12053701|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0
7639335|NCT02439216|12053702|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0
7639336|NCT02439216|12053703|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5
7639337|NCT02439216|12053704|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6
7639338|NCT02437318|12053730|FG000|Overall Study|Progressive disease|173
7639339|NCT02437318|12053731|FG001|Overall Study|Progressive disease|208
7639340|NCT02437318|12053730|FG000|Overall Study|Subject/guardian decision|22
7639341|NCT02437318|12053731|FG001|Overall Study|Subject/guardian decision|10
7639342|NCT02437318|12053730|FG000|Overall Study|Physician Decision|11
7639343|NCT02437318|12053731|FG001|Overall Study|Physician Decision|10
7639344|NCT02437318|12053730|FG000|Overall Study|Adverse Event|14
7639345|NCT02437318|12053731|FG001|Overall Study|Adverse Event|3
7639346|NCT02437318|12053730|FG000|Overall Study|Death|4
7639347|NCT02437318|12053731|FG001|Overall Study|Death|4
7639348|NCT02437318|12053730|FG000|Overall Study|Protocol Violation|5
7639349|NCT02437318|12053731|FG001|Overall Study|Protocol Violation|6
7639350|NCT02437318|12053730|FG000|Overall Study|Untreated|0
7639351|NCT02437318|12053731|FG001|Overall Study|Untreated|1
7639352|NCT02434081|12053756|FG000|Overall Study|Death (never started treatment)|2
7639353|NCT02434081|12053756|FG000|Overall Study|Death|2
7639354|NCT02434081|12053756|FG000|Overall Study|Progression|20
7639355|NCT02434081|12053756|FG000|Overall Study|Adverse Event|20
7639356|NCT02434081|12053756|FG000|Overall Study|Physician Decision|2
7639357|NCT02434081|12053756|FG000|Overall Study|Withdrawal by Subject|1
7639358|NCT02434081|12053756|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1
7639359|NCT02433210|12053763|FG000|Overall Study|Physician Decision|1
7639360|NCT02433210|12053764|FG001|Overall Study|Physician Decision|0
7639361|NCT02433210|12053765|FG002|Overall Study|Physician Decision|0
7639362|NCT02432846|12053857|FG000|Overall Study (4 Arms/Strata)|Death|3
7639363|NCT02432846|12053858|FG001|Overall Study (4 Arms/Strata)|Death|2
7639364|NCT02432846|12053859|FG002|Overall Study (4 Arms/Strata)|Death|4
7639365|NCT02432846|12053860|FG003|Overall Study (4 Arms/Strata)|Death|3
7639366|NCT02432846|12053861|FG004|Overall Study (4 Arms/Strata)|Death|0
7639367|NCT02432846|12053862|FG005|Overall Study (4 Arms/Strata)|Death|0
7639368|NCT02432846|12053857|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0
7639369|NCT02432846|12053858|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1
7639370|NCT02432846|12053859|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1
7639371|NCT02432846|12053860|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0
7639372|NCT02432846|12053861|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0
7639373|NCT02432846|12053862|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0
7639374|NCT02432846|12053857|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2
7639375|NCT02432846|12053858|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0
7639376|NCT02432846|12053859|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0
7639377|NCT02432846|12053860|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0
7639378|NCT02432846|12053861|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0
7639379|NCT02432846|12053862|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0
7639380|NCT02432846|12053857|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2
7639381|NCT02432846|12053858|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0
7639382|NCT02432846|12053859|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1
7639383|NCT02432846|12053860|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1
7639384|NCT02432846|12053861|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0
7639385|NCT02432846|12053862|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0
7639386|NCT02432846|12053857|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0
7639387|NCT02432846|12053858|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0
7639388|NCT02432846|12053859|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2
7639389|NCT02432846|12053860|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1
7639390|NCT02432846|12053861|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0
7639391|NCT02432846|12053862|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0
7639392|NCT02432846|12053857|FG000|Overall Study (4 Arms/Strata)|Disease progression|8
7639393|NCT02432846|12053858|FG001|Overall Study (4 Arms/Strata)|Disease progression|5
7639394|NCT02432846|12053859|FG002|Overall Study (4 Arms/Strata)|Disease progression|15
7639395|NCT02432846|12053860|FG003|Overall Study (4 Arms/Strata)|Disease progression|9
7639396|NCT02432846|12053861|FG004|Overall Study (4 Arms/Strata)|Disease progression|0
7639397|NCT02432846|12053862|FG005|Overall Study (4 Arms/Strata)|Disease progression|0
7639398|NCT02432846|12053857|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0
7639399|NCT02432846|12053858|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0
7639400|NCT02432846|12053859|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1
7639401|NCT02432846|12053860|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0
7639402|NCT02432846|12053861|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0
7639403|NCT02432846|12053862|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0
7639404|NCT02432846|12053857|FG000|Overall Study (2 Total/Combined Groups)|Death|0
7639405|NCT02432846|12053858|FG001|Overall Study (2 Total/Combined Groups)|Death|0
7639406|NCT02432846|12053859|FG002|Overall Study (2 Total/Combined Groups)|Death|0
7639407|NCT02432846|12053860|FG003|Overall Study (2 Total/Combined Groups)|Death|0
7639408|NCT02432846|12053861|FG004|Overall Study (2 Total/Combined Groups)|Death|7
7639409|NCT02432846|12053862|FG005|Overall Study (2 Total/Combined Groups)|Death|5
7639410|NCT02432846|12053857|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0
7639411|NCT02432846|12053858|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0
7639412|NCT02432846|12053859|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0
7639413|NCT02432846|12053860|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0
7639414|NCT02432846|12053861|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1
7639415|NCT02432846|12053862|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1
7639416|NCT02432846|12053857|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0
7639417|NCT02432846|12053858|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0
7639418|NCT02432846|12053859|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0
7639419|NCT02432846|12053860|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0
7639420|NCT02432846|12053861|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2
7639421|NCT02432846|12053862|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0
7639422|NCT02432846|12053857|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0
7639423|NCT02432846|12053858|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0
7639424|NCT02432846|12053859|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0
7639425|NCT02432846|12053860|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0
7639426|NCT02432846|12053861|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3
7639427|NCT02432846|12053862|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1
7639428|NCT02432846|12053857|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0
7639429|NCT02432846|12053858|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0
7639430|NCT02432846|12053859|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0
7639431|NCT02432846|12053860|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0
7639432|NCT02432846|12053861|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2
7639433|NCT02432846|12053862|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1
7639434|NCT02432846|12053857|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0
7639435|NCT02432846|12053858|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0
7639436|NCT02432846|12053859|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0
7639437|NCT02432846|12053860|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0
7639438|NCT02432846|12053861|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23
7639439|NCT02432846|12053862|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14
7639440|NCT02432846|12053857|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0
7639441|NCT02432846|12053858|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0
7639442|NCT02432846|12053859|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0
7639443|NCT02432846|12053860|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0
7639444|NCT02432846|12053861|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1
7639445|NCT02432846|12053862|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0
7639446|NCT02432274|12053892|FG000|Overall Study|Radiological Disease Progression|3
7639447|NCT02432274|12053893|FG001|Overall Study|Radiological Disease Progression|4
7639448|NCT02432274|12053894|FG002|Overall Study|Radiological Disease Progression|7
7639449|NCT02432274|12053895|FG003|Overall Study|Radiological Disease Progression|0
7639450|NCT02432274|12053896|FG004|Overall Study|Radiological Disease Progression|24
7639451|NCT02432274|12053897|FG005|Overall Study|Radiological Disease Progression|6
7639452|NCT02432274|12053898|FG006|Overall Study|Radiological Disease Progression|11
7639453|NCT02432274|12053899|FG007|Overall Study|Radiological Disease Progression|9
7639454|NCT02432274|12053892|FG000|Overall Study|Clinical Disease Progression|0
7639455|NCT02432274|12053893|FG001|Overall Study|Clinical Disease Progression|4
7639456|NCT02432274|12053894|FG002|Overall Study|Clinical Disease Progression|1
7639457|NCT02432274|12053895|FG003|Overall Study|Clinical Disease Progression|0
7639458|NCT02432274|12053896|FG004|Overall Study|Clinical Disease Progression|1
7639459|NCT02432274|12053897|FG005|Overall Study|Clinical Disease Progression|0
7639460|NCT02432274|12053898|FG006|Overall Study|Clinical Disease Progression|0
7639461|NCT02432274|12053899|FG007|Overall Study|Clinical Disease Progression|1
7639462|NCT02432274|12053892|FG000|Overall Study|Adverse Event|0
7639463|NCT02432274|12053893|FG001|Overall Study|Adverse Event|0
7639464|NCT02432274|12053894|FG002|Overall Study|Adverse Event|1
7639465|NCT02432274|12053895|FG003|Overall Study|Adverse Event|0
7639466|NCT02432274|12053896|FG004|Overall Study|Adverse Event|1
7639467|NCT02432274|12053897|FG005|Overall Study|Adverse Event|0
7639468|NCT02432274|12053898|FG006|Overall Study|Adverse Event|2
7639469|NCT02432274|12053899|FG007|Overall Study|Adverse Event|0
7639470|NCT02432274|12053892|FG000|Overall Study|Withdrawal by Subject|0
7639471|NCT02432274|12053893|FG001|Overall Study|Withdrawal by Subject|0
7639472|NCT02432274|12053894|FG002|Overall Study|Withdrawal by Subject|0
7639473|NCT02432274|12053895|FG003|Overall Study|Withdrawal by Subject|0
7639474|NCT02432274|12053896|FG004|Overall Study|Withdrawal by Subject|2
7639475|NCT02432274|12053897|FG005|Overall Study|Withdrawal by Subject|0
7639476|NCT02432274|12053898|FG006|Overall Study|Withdrawal by Subject|1
7639477|NCT02432274|12053899|FG007|Overall Study|Withdrawal by Subject|2
7639478|NCT02432274|12053892|FG000|Overall Study|Participant Choice|0
7639479|NCT02432274|12053893|FG001|Overall Study|Participant Choice|0
7639480|NCT02432274|12053894|FG002|Overall Study|Participant Choice|1
7639481|NCT02432274|12053895|FG003|Overall Study|Participant Choice|0
7639482|NCT02432274|12053896|FG004|Overall Study|Participant Choice|0
7639483|NCT02432274|12053897|FG005|Overall Study|Participant Choice|0
7639484|NCT02432274|12053898|FG006|Overall Study|Participant Choice|1
7639485|NCT02432274|12053899|FG007|Overall Study|Participant Choice|0
7639486|NCT02432274|12053892|FG000|Overall Study|Other than specified|0
7639487|NCT02432274|12053893|FG001|Overall Study|Other than specified|1
7639488|NCT02432274|12053894|FG002|Overall Study|Other than specified|0
7639489|NCT02432274|12053895|FG003|Overall Study|Other than specified|0
7639490|NCT02432274|12053896|FG004|Overall Study|Other than specified|0
7639491|NCT02432274|12053897|FG005|Overall Study|Other than specified|1
7639492|NCT02432274|12053898|FG006|Overall Study|Other than specified|0
7639493|NCT02432274|12053899|FG007|Overall Study|Other than specified|1
7639494|NCT02432274|12053892|FG000|Overall Study|Ongoing|0
7639495|NCT02432274|12053893|FG001|Overall Study|Ongoing|0
7639496|NCT02432274|12053894|FG002|Overall Study|Ongoing|1
7639497|NCT02432274|12053895|FG003|Overall Study|Ongoing|1
7639498|NCT02432274|12053896|FG004|Overall Study|Ongoing|3
7639499|NCT02432274|12053897|FG005|Overall Study|Ongoing|0
7639500|NCT02432274|12053898|FG006|Overall Study|Ongoing|0
7639501|NCT02432274|12053899|FG007|Overall Study|Ongoing|7
7639502|NCT02432196|12053929|FG000|Overall Study|Not Implanted with Device|1
7639503|NCT02432196|12053929|FG000|Overall Study|Death|2
7639504|NCT02432196|12053929|FG000|Overall Study|Reoperation|3
7639505|NCT02432196|12053929|FG000|Overall Study|On Study|20
7639506|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Other|11
7639507|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Other|2
7639508|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Other|0
7639509|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17
7639510|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8
7639511|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0
7639512|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9
7639513|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4
7639514|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0
7639515|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1
7639516|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1
7639517|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0
7639518|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12
7639519|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16
7639520|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0
7639521|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Death|0
7639522|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Death|1
7639523|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Death|0
7639524|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14
7639525|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9
7639526|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0
7639527|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2
7639528|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0
7639529|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0
7639530|NCT02431247|12053935|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0
7639531|NCT02431247|12053936|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0
7639532|NCT02431247|12053937|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4
7639533|NCT02431247|12053935|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
7639534|NCT02431247|12053936|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
7639535|NCT02431247|12053937|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12
7639536|NCT02431247|12053935|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
7639537|NCT02431247|12053936|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
7639538|NCT02431247|12053937|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1
7639539|NCT02431247|12053935|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
7639540|NCT02431247|12053936|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
7639541|NCT02431247|12053937|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5
7639542|NCT02431247|12053935|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0
7639543|NCT02431247|12053936|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0
7639544|NCT02431247|12053937|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1
7639545|NCT02431247|12053935|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
7639546|NCT02431247|12053936|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
7639547|NCT02431247|12053937|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10
7639548|NCT02429830|12053949|FG000|Overall Study|Lost to Follow-up|1
7639549|NCT02429830|12053949|FG000|Overall Study|Device Explant|2
7639550|NCT02427464|12053955|FG000|Overall Study|Adverse Event|6
7639551|NCT02427464|12053956|FG001|Overall Study|Adverse Event|1
7639552|NCT02427464|12053955|FG000|Overall Study|Lost to Follow-up|16
7639553|NCT02427464|12053956|FG001|Overall Study|Lost to Follow-up|5
7639554|NCT02427464|12053955|FG000|Overall Study|Physician Decision|2
7639555|NCT02427464|12053956|FG001|Overall Study|Physician Decision|0
7639556|NCT02427464|12053955|FG000|Overall Study|Withdrawal by Subject|10
7639557|NCT02427464|12053956|FG001|Overall Study|Withdrawal by Subject|8
7639558|NCT02427464|12053955|FG000|Overall Study|Noncompliance|16
7639559|NCT02427464|12053956|FG001|Overall Study|Noncompliance|10
7639560|NCT02426125|12053964|FG000|Overall Study|Lost to Follow-up|12
7639561|NCT02426125|12053965|FG001|Overall Study|Lost to Follow-up|10
7639562|NCT02426125|12053964|FG000|Overall Study|Protocol Violation|1
7639563|NCT02426125|12053965|FG001|Overall Study|Protocol Violation|0
7639564|NCT02426125|12053964|FG000|Overall Study|Withdrawal by Subject|16
7639565|NCT02426125|12053965|FG001|Overall Study|Withdrawal by Subject|16
7639566|NCT02422615|12053975|FG000|Overall Study|Progressive disease|193
7639567|NCT02422615|12053976|FG001|Overall Study|Progressive disease|142
7639568|NCT02422615|12053975|FG000|Overall Study|Adverse Event|41
7639569|NCT02422615|12053976|FG001|Overall Study|Adverse Event|10
7639570|NCT02422615|12053975|FG000|Overall Study|Physician Decision|22
7639571|NCT02422615|12053976|FG001|Overall Study|Physician Decision|7
7639572|NCT02422615|12053975|FG000|Overall Study|Subject/guardian decision|21
7639573|NCT02422615|12053976|FG001|Overall Study|Subject/guardian decision|5
7639574|NCT02422615|12053975|FG000|Overall Study|Death|2
7639575|NCT02422615|12053976|FG001|Overall Study|Death|0
7639576|NCT02422615|12053975|FG000|Overall Study|Protocol Violation|1
7639577|NCT02422615|12053976|FG001|Overall Study|Protocol Violation|1
7639578|NCT02422615|12053975|FG000|Overall Study|Technical problems|0
7639579|NCT02422615|12053976|FG001|Overall Study|Technical problems|1
7639580|NCT02421939|12053984|FG000|Overall Study|Progressive disease|70
7639581|NCT02421939|12053985|FG001|Overall Study|Progressive disease|16
7639582|NCT02421939|12053984|FG000|Overall Study|Lack of Efficacy|21
7639583|NCT02421939|12053985|FG001|Overall Study|Lack of Efficacy|31
7639584|NCT02421939|12053984|FG000|Overall Study|Death|36
7639585|NCT02421939|12053985|FG001|Overall Study|Death|10
7639586|NCT02421939|12053984|FG000|Overall Study|Disease relapse|33
7639587|NCT02421939|12053985|FG001|Overall Study|Disease relapse|2
7639588|NCT02421939|12053984|FG000|Overall Study|Adverse Event|28
7639589|NCT02421939|12053985|FG001|Overall Study|Adverse Event|5
7639590|NCT02421939|12053984|FG000|Overall Study|Withdrawal by Subject|5
7639591|NCT02421939|12053985|FG001|Overall Study|Withdrawal by Subject|24
7639592|NCT02421939|12053984|FG000|Overall Study|Physician Decision|11
7639593|NCT02421939|12053985|FG001|Overall Study|Physician Decision|11
7639594|NCT02421939|12053984|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0
7639595|NCT02421939|12053985|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19
7639596|NCT02421939|12053984|FG000|Overall Study|Miscellaneous|4
7639597|NCT02421939|12053985|FG001|Overall Study|Miscellaneous|5
7639598|NCT02421939|12053984|FG000|Overall Study|Protocol deviation|1
7639599|NCT02421939|12053985|FG001|Overall Study|Protocol deviation|1
7639600|NCT02420119|12053991|FG000|Overall Study|insufficient laboratory data|5
7639601|NCT02412878|12054014|FG000|Overall Study|Withdrawal by Subject|19
7639602|NCT02412878|12054015|FG001|Overall Study|Withdrawal by Subject|10
7639603|NCT02412878|12054014|FG000|Overall Study|Lost to Follow-up|2
7639604|NCT02412878|12054015|FG001|Overall Study|Lost to Follow-up|3
7639605|NCT02412670|12054023|FG000|Overall Study|Adverse Event|4
7639606|NCT02412670|12054024|FG001|Overall Study|Adverse Event|1
7639607|NCT02412670|12054023|FG000|Overall Study|Physician Decision|1
7639608|NCT02412670|12054024|FG001|Overall Study|Physician Decision|0
7639609|NCT02412670|12054023|FG000|Overall Study|Withdrawal by Subject|1
7639610|NCT02412670|12054024|FG001|Overall Study|Withdrawal by Subject|0
7639611|NCT02412670|12054023|FG000|Overall Study|Ineligible|1
7639612|NCT02412670|12054024|FG001|Overall Study|Ineligible|0
7639613|NCT02412306|12054035|FG000|Overall Study|Lost to Follow-up|0
7639614|NCT02412306|12054036|FG001|Overall Study|Lost to Follow-up|1
7639615|NCT02412306|12054037|FG002|Overall Study|Lost to Follow-up|0
7639616|NCT02412306|12054038|FG003|Overall Study|Lost to Follow-up|0
7639617|NCT02412306|12054039|FG004|Overall Study|Lost to Follow-up|0
7639618|NCT02412306|12054035|FG000|Overall Study|Withdrawal by Subject|0
7639619|NCT02412306|12054036|FG001|Overall Study|Withdrawal by Subject|0
7639620|NCT02412306|12054037|FG002|Overall Study|Withdrawal by Subject|1
7639621|NCT02412306|12054038|FG003|Overall Study|Withdrawal by Subject|0
7639622|NCT02412306|12054039|FG004|Overall Study|Withdrawal by Subject|0
7639623|NCT02412306|12054035|FG000|Overall Study|Death|5
7639624|NCT02412306|12054036|FG001|Overall Study|Death|7
7639625|NCT02412306|12054037|FG002|Overall Study|Death|15
7639626|NCT02412306|12054038|FG003|Overall Study|Death|0
7639627|NCT02412306|12054039|FG004|Overall Study|Death|2
7639628|NCT02408887|12054062|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1
7639629|NCT02408887|12054063|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0
7639630|NCT02408887|12054062|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0
7639631|NCT02408887|12054063|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1
7639632|NCT02407236|12054077|FG000|Induction Study (8 Weeks)|Adverse Event|3
7639633|NCT02407236|12054078|FG001|Induction Study (8 Weeks)|Adverse Event|0
7639634|NCT02407236|12054079|FG002|Induction Study (8 Weeks)|Adverse Event|1
7639635|NCT02407236|12054080|FG003|Induction Study (8 Weeks)|Adverse Event|0
7639636|NCT02407236|12054081|FG004|Induction Study (8 Weeks)|Adverse Event|0
7639637|NCT02407236|12054082|FG005|Induction Study (8 Weeks)|Adverse Event|0
7639638|NCT02407236|12054083|FG006|Induction Study (8 Weeks)|Adverse Event|0
7639639|NCT02407236|12054084|FG007|Induction Study (8 Weeks)|Adverse Event|0
7639640|NCT02407236|12054077|FG000|Induction Study (8 Weeks)|Death|0
7639641|NCT02407236|12054078|FG001|Induction Study (8 Weeks)|Death|0
7639642|NCT02407236|12054079|FG002|Induction Study (8 Weeks)|Death|1
7639643|NCT02407236|12054080|FG003|Induction Study (8 Weeks)|Death|0
7639644|NCT02407236|12054081|FG004|Induction Study (8 Weeks)|Death|0
7639645|NCT02407236|12054082|FG005|Induction Study (8 Weeks)|Death|0
7639646|NCT02407236|12054083|FG006|Induction Study (8 Weeks)|Death|0
7639647|NCT02407236|12054084|FG007|Induction Study (8 Weeks)|Death|0
7639648|NCT02407236|12054077|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17
7639649|NCT02407236|12054078|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9
7639650|NCT02407236|12054079|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7
7639651|NCT02407236|12054080|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0
7639652|NCT02407236|12054081|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0
7639653|NCT02407236|12054082|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0
7639654|NCT02407236|12054083|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0
7639655|NCT02407236|12054084|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0
7639656|NCT02407236|12054077|FG000|Induction Study (8 Weeks)|Lost to Follow-up|0
7639657|NCT02407236|12054078|FG001|Induction Study (8 Weeks)|Lost to Follow-up|0
7639658|NCT02407236|12054079|FG002|Induction Study (8 Weeks)|Lost to Follow-up|1
7639659|NCT02407236|12054080|FG003|Induction Study (8 Weeks)|Lost to Follow-up|0
7639660|NCT02407236|12054081|FG004|Induction Study (8 Weeks)|Lost to Follow-up|0
7639661|NCT02407236|12054082|FG005|Induction Study (8 Weeks)|Lost to Follow-up|0
7639662|NCT02407236|12054083|FG006|Induction Study (8 Weeks)|Lost to Follow-up|0
7639663|NCT02407236|12054084|FG007|Induction Study (8 Weeks)|Lost to Follow-up|0
7639664|NCT02407236|12054077|FG000|Induction Study (8 Weeks)|Physician Decision|1
7639665|NCT02407236|12054078|FG001|Induction Study (8 Weeks)|Physician Decision|1
7639666|NCT02407236|12054079|FG002|Induction Study (8 Weeks)|Physician Decision|0
7639667|NCT02407236|12054080|FG003|Induction Study (8 Weeks)|Physician Decision|0
7639668|NCT02407236|12054081|FG004|Induction Study (8 Weeks)|Physician Decision|0
7639669|NCT02407236|12054082|FG005|Induction Study (8 Weeks)|Physician Decision|0
7639670|NCT02407236|12054083|FG006|Induction Study (8 Weeks)|Physician Decision|0
7639671|NCT02407236|12054084|FG007|Induction Study (8 Weeks)|Physician Decision|0
7639672|NCT02407236|12054077|FG000|Induction Study (8 Weeks)|Other|2
7639673|NCT02407236|12054078|FG001|Induction Study (8 Weeks)|Other|1
7639674|NCT02407236|12054079|FG002|Induction Study (8 Weeks)|Other|5
7639675|NCT02407236|12054080|FG003|Induction Study (8 Weeks)|Other|0
7639676|NCT02407236|12054081|FG004|Induction Study (8 Weeks)|Other|0
7639677|NCT02407236|12054082|FG005|Induction Study (8 Weeks)|Other|0
7639678|NCT02407236|12054083|FG006|Induction Study (8 Weeks)|Other|0
7639679|NCT02407236|12054084|FG007|Induction Study (8 Weeks)|Other|0
7639680|NCT02407236|12054077|FG000|Maintenance Study (44 Weeks)|Lost to Follow-up|0
7639681|NCT02407236|12054078|FG001|Maintenance Study (44 Weeks)|Lost to Follow-up|0
7639682|NCT02407236|12054079|FG002|Maintenance Study (44 Weeks)|Lost to Follow-up|0
7639683|NCT02407236|12054080|FG003|Maintenance Study (44 Weeks)|Lost to Follow-up|1
7639684|NCT02407236|12054081|FG004|Maintenance Study (44 Weeks)|Lost to Follow-up|0
7639685|NCT02407236|12054082|FG005|Maintenance Study (44 Weeks)|Lost to Follow-up|1
7639686|NCT02407236|12054083|FG006|Maintenance Study (44 Weeks)|Lost to Follow-up|0
7639687|NCT02407236|12054084|FG007|Maintenance Study (44 Weeks)|Lost to Follow-up|1
7639688|NCT02407236|12054077|FG000|Maintenance Study (44 Weeks)|Death|0
7639689|NCT02407236|12054078|FG001|Maintenance Study (44 Weeks)|Death|0
7639690|NCT02407236|12054079|FG002|Maintenance Study (44 Weeks)|Death|0
7639691|NCT02407236|12054080|FG003|Maintenance Study (44 Weeks)|Death|0
7639692|NCT02407236|12054081|FG004|Maintenance Study (44 Weeks)|Death|0
7639693|NCT02407236|12054082|FG005|Maintenance Study (44 Weeks)|Death|0
7639694|NCT02407236|12054083|FG006|Maintenance Study (44 Weeks)|Death|0
7639695|NCT02407236|12054084|FG007|Maintenance Study (44 Weeks)|Death|1
7639696|NCT02407236|12054077|FG000|Maintenance Study (44 Weeks)|Withdraw of consent|0
7639697|NCT02407236|12054078|FG001|Maintenance Study (44 Weeks)|Withdraw of consent|0
7639698|NCT02407236|12054079|FG002|Maintenance Study (44 Weeks)|Withdraw of consent|0
7639699|NCT02407236|12054080|FG003|Maintenance Study (44 Weeks)|Withdraw of consent|8
7639700|NCT02407236|12054081|FG004|Maintenance Study (44 Weeks)|Withdraw of consent|10
7639701|NCT02407236|12054082|FG005|Maintenance Study (44 Weeks)|Withdraw of consent|5
7639702|NCT02407236|12054083|FG006|Maintenance Study (44 Weeks)|Withdraw of consent|7
7639703|NCT02407236|12054084|FG007|Maintenance Study (44 Weeks)|Withdraw of consent|5
7639704|NCT02407236|12054077|FG000|Maintenance Study (44 Weeks)|Sponsor decision|0
7639705|NCT02407236|12054078|FG001|Maintenance Study (44 Weeks)|Sponsor decision|0
7639706|NCT02407236|12054079|FG002|Maintenance Study (44 Weeks)|Sponsor decision|0
7639707|NCT02407236|12054080|FG003|Maintenance Study (44 Weeks)|Sponsor decision|1
7639708|NCT02407236|12054081|FG004|Maintenance Study (44 Weeks)|Sponsor decision|0
7639709|NCT02407236|12054082|FG005|Maintenance Study (44 Weeks)|Sponsor decision|1
7639710|NCT02407236|12054083|FG006|Maintenance Study (44 Weeks)|Sponsor decision|0
7639711|NCT02407236|12054084|FG007|Maintenance Study (44 Weeks)|Sponsor decision|0
7639712|NCT02407236|12054077|FG000|Maintenance Study (44 Weeks)|Other|0
7639713|NCT02407236|12054078|FG001|Maintenance Study (44 Weeks)|Other|0
7639714|NCT02407236|12054079|FG002|Maintenance Study (44 Weeks)|Other|0
7639715|NCT02407236|12054080|FG003|Maintenance Study (44 Weeks)|Other|0
7639716|NCT02407236|12054081|FG004|Maintenance Study (44 Weeks)|Other|1
7639717|NCT02407236|12054082|FG005|Maintenance Study (44 Weeks)|Other|1
7639718|NCT02407236|12054083|FG006|Maintenance Study (44 Weeks)|Other|2
7639719|NCT02407236|12054084|FG007|Maintenance Study (44 Weeks)|Other|1
7639720|NCT02404441|12054112|FG000|Phase 1 Part|Adverse Event|1
7639721|NCT02404441|12054113|FG001|Phase 1 Part|Adverse Event|0
7639722|NCT02404441|12054114|FG002|Phase 1 Part|Adverse Event|0
7639723|NCT02404441|12054115|FG003|Phase 1 Part|Adverse Event|0
7639724|NCT02404441|12054116|FG004|Phase 1 Part|Adverse Event|0
7639725|NCT02404441|12054117|FG005|Phase 1 Part|Adverse Event|0
7639726|NCT02404441|12054118|FG006|Phase 1 Part|Adverse Event|0
7639727|NCT02404441|12054119|FG007|Phase 1 Part|Adverse Event|0
7639728|NCT02404441|12054120|FG008|Phase 1 Part|Adverse Event|0
7639729|NCT02404441|12054121|FG009|Phase 1 Part|Adverse Event|0
7639730|NCT02404441|12054112|FG000|Phase 1 Part|Physician Decision|0
7639731|NCT02404441|12054113|FG001|Phase 1 Part|Physician Decision|1
7639732|NCT02404441|12054114|FG002|Phase 1 Part|Physician Decision|0
7639733|NCT02404441|12054115|FG003|Phase 1 Part|Physician Decision|0
7639734|NCT02404441|12054116|FG004|Phase 1 Part|Physician Decision|0
7639735|NCT02404441|12054117|FG005|Phase 1 Part|Physician Decision|0
7639736|NCT02404441|12054118|FG006|Phase 1 Part|Physician Decision|0
7639737|NCT02404441|12054119|FG007|Phase 1 Part|Physician Decision|0
7639738|NCT02404441|12054120|FG008|Phase 1 Part|Physician Decision|0
7639739|NCT02404441|12054121|FG009|Phase 1 Part|Physician Decision|0
7639740|NCT02404441|12054112|FG000|Phase 1 Part|Progressive Disease|14
7639741|NCT02404441|12054113|FG001|Phase 1 Part|Progressive Disease|11
7639742|NCT02404441|12054114|FG002|Phase 1 Part|Progressive Disease|7
7639743|NCT02404441|12054115|FG003|Phase 1 Part|Progressive Disease|6
7639744|NCT02404441|12054116|FG004|Phase 1 Part|Progressive Disease|9
7639745|NCT02404441|12054117|FG005|Phase 1 Part|Progressive Disease|0
7639746|NCT02404441|12054118|FG006|Phase 1 Part|Progressive Disease|0
7639747|NCT02404441|12054119|FG007|Phase 1 Part|Progressive Disease|0
7639748|NCT02404441|12054120|FG008|Phase 1 Part|Progressive Disease|0
7639749|NCT02404441|12054121|FG009|Phase 1 Part|Progressive Disease|0
7639750|NCT02404441|12054112|FG000|Phase 1 Part|Subject/Guardian Decision|0
7639751|NCT02404441|12054113|FG001|Phase 1 Part|Subject/Guardian Decision|2
7639752|NCT02404441|12054114|FG002|Phase 1 Part|Subject/Guardian Decision|3
7639753|NCT02404441|12054115|FG003|Phase 1 Part|Subject/Guardian Decision|0
7639754|NCT02404441|12054116|FG004|Phase 1 Part|Subject/Guardian Decision|0
7639755|NCT02404441|12054117|FG005|Phase 1 Part|Subject/Guardian Decision|0
7639756|NCT02404441|12054118|FG006|Phase 1 Part|Subject/Guardian Decision|0
7639757|NCT02404441|12054119|FG007|Phase 1 Part|Subject/Guardian Decision|0
7639758|NCT02404441|12054120|FG008|Phase 1 Part|Subject/Guardian Decision|0
7639759|NCT02404441|12054121|FG009|Phase 1 Part|Subject/Guardian Decision|0
7639760|NCT02404441|12054112|FG000|Phase 1 Part|Death|1
7639761|NCT02404441|12054113|FG001|Phase 1 Part|Death|1
7639762|NCT02404441|12054114|FG002|Phase 1 Part|Death|1
7639763|NCT02404441|12054115|FG003|Phase 1 Part|Death|0
7639764|NCT02404441|12054116|FG004|Phase 1 Part|Death|1
7639765|NCT02404441|12054117|FG005|Phase 1 Part|Death|0
7639766|NCT02404441|12054118|FG006|Phase 1 Part|Death|0
7639767|NCT02404441|12054119|FG007|Phase 1 Part|Death|0
7639768|NCT02404441|12054120|FG008|Phase 1 Part|Death|0
7639769|NCT02404441|12054121|FG009|Phase 1 Part|Death|0
7639770|NCT02404441|12054112|FG000|Phase 2 Part|Adverse Event|0
7639771|NCT02404441|12054113|FG001|Phase 2 Part|Adverse Event|0
7639772|NCT02404441|12054114|FG002|Phase 2 Part|Adverse Event|0
7639773|NCT02404441|12054115|FG003|Phase 2 Part|Adverse Event|0
7639774|NCT02404441|12054116|FG004|Phase 2 Part|Adverse Event|0
7639775|NCT02404441|12054117|FG005|Phase 2 Part|Adverse Event|2
7639776|NCT02404441|12054118|FG006|Phase 2 Part|Adverse Event|3
7639777|NCT02404441|12054119|FG007|Phase 2 Part|Adverse Event|3
7639778|NCT02404441|12054120|FG008|Phase 2 Part|Adverse Event|6
7639779|NCT02404441|12054121|FG009|Phase 2 Part|Adverse Event|1
7639780|NCT02404441|12054112|FG000|Phase 2 Part|Physician Decision|0
7639781|NCT02404441|12054113|FG001|Phase 2 Part|Physician Decision|0
7639782|NCT02404441|12054114|FG002|Phase 2 Part|Physician Decision|0
7639783|NCT02404441|12054115|FG003|Phase 2 Part|Physician Decision|0
7639784|NCT02404441|12054116|FG004|Phase 2 Part|Physician Decision|0
7639785|NCT02404441|12054117|FG005|Phase 2 Part|Physician Decision|7
7639786|NCT02404441|12054118|FG006|Phase 2 Part|Physician Decision|9
7639787|NCT02404441|12054119|FG007|Phase 2 Part|Physician Decision|2
7639788|NCT02404441|12054120|FG008|Phase 2 Part|Physician Decision|1
7639789|NCT02404441|12054121|FG009|Phase 2 Part|Physician Decision|3
7639790|NCT02404441|12054112|FG000|Phase 2 Part|Progressive disease|0
7639791|NCT02404441|12054113|FG001|Phase 2 Part|Progressive disease|0
7639792|NCT02404441|12054114|FG002|Phase 2 Part|Progressive disease|0
7639793|NCT02404441|12054115|FG003|Phase 2 Part|Progressive disease|0
7639794|NCT02404441|12054116|FG004|Phase 2 Part|Progressive disease|0
7639795|NCT02404441|12054117|FG005|Phase 2 Part|Progressive disease|43
7639796|NCT02404441|12054118|FG006|Phase 2 Part|Progressive disease|32
7639797|NCT02404441|12054119|FG007|Phase 2 Part|Progressive disease|31
7639798|NCT02404441|12054120|FG008|Phase 2 Part|Progressive disease|39
7639799|NCT02404441|12054121|FG009|Phase 2 Part|Progressive disease|27
7639800|NCT02404441|12054112|FG000|Phase 2 Part|Subject/guardian decision|0
7639801|NCT02404441|12054113|FG001|Phase 2 Part|Subject/guardian decision|0
7639802|NCT02404441|12054114|FG002|Phase 2 Part|Subject/guardian decision|0
7639803|NCT02404441|12054115|FG003|Phase 2 Part|Subject/guardian decision|0
7639804|NCT02404441|12054116|FG004|Phase 2 Part|Subject/guardian decision|0
7639805|NCT02404441|12054117|FG005|Phase 2 Part|Subject/guardian decision|3
7639806|NCT02404441|12054118|FG006|Phase 2 Part|Subject/guardian decision|9
7639807|NCT02404441|12054119|FG007|Phase 2 Part|Subject/guardian decision|0
7639808|NCT02404441|12054120|FG008|Phase 2 Part|Subject/guardian decision|3
7639809|NCT02404441|12054121|FG009|Phase 2 Part|Subject/guardian decision|2
7639810|NCT02404441|12054112|FG000|Phase 2 Part|Death|0
7639811|NCT02404441|12054113|FG001|Phase 2 Part|Death|0
7639812|NCT02404441|12054114|FG002|Phase 2 Part|Death|0
7639813|NCT02404441|12054115|FG003|Phase 2 Part|Death|0
7639814|NCT02404441|12054116|FG004|Phase 2 Part|Death|0
7639815|NCT02404441|12054117|FG005|Phase 2 Part|Death|4
7639816|NCT02404441|12054118|FG006|Phase 2 Part|Death|8
7639817|NCT02404441|12054119|FG007|Phase 2 Part|Death|4
7639818|NCT02404441|12054120|FG008|Phase 2 Part|Death|10
7639819|NCT02404441|12054121|FG009|Phase 2 Part|Death|9
7639820|NCT02403674|12054185|FG000|Overall Study|Adverse Event|10
7639821|NCT02403674|12054186|FG001|Overall Study|Adverse Event|23
7639822|NCT02403674|12054185|FG000|Overall Study|Death|1
7639823|NCT02403674|12054186|FG001|Overall Study|Death|3
7639824|NCT02403674|12054185|FG000|Overall Study|Lack of Efficacy|18
7639825|NCT02403674|12054186|FG001|Overall Study|Lack of Efficacy|10
7639826|NCT02403674|12054185|FG000|Overall Study|Lost to Follow-up|6
7639827|NCT02403674|12054186|FG001|Overall Study|Lost to Follow-up|7
7639828|NCT02403674|12054185|FG000|Overall Study|Noncompliance with study drug|1
7639829|NCT02403674|12054186|FG001|Overall Study|Noncompliance with study drug|2
7639830|NCT02403674|12054185|FG000|Overall Study|Withdrawal by Subject|8
7639831|NCT02403674|12054186|FG001|Overall Study|Withdrawal by Subject|11
7639832|NCT02403674|12054185|FG000|Overall Study|Physician Decision|2
7639833|NCT02403674|12054186|FG001|Overall Study|Physician Decision|2
7639834|NCT02403674|12054185|FG000|Overall Study|Not treated with study drug|4
7639835|NCT02403674|12054186|FG001|Overall Study|Not treated with study drug|2
7639836|NCT02403674|12054185|FG000|Overall Study|Pregnancy|1
7639837|NCT02403674|12054186|FG001|Overall Study|Pregnancy|1
7639838|NCT02403674|12054185|FG000|Overall Study|Protocol Violation|4
7639839|NCT02403674|12054186|FG001|Overall Study|Protocol Violation|2
7639840|NCT02399449|12054194|FG000|Overall Study|Withdrawal by Subject|3
7639841|NCT02399449|12054195|FG001|Overall Study|Withdrawal by Subject|9
7639842|NCT02399449|12054194|FG000|Overall Study|Physician Decision|0
7639843|NCT02399449|12054195|FG001|Overall Study|Physician Decision|1
7639844|NCT02397096|12054203|FG000|Day 1 to Week 24|Adverse Event|7
7639845|NCT02397096|12054204|FG001|Day 1 to Week 24|Adverse Event|1
7639846|NCT02397096|12054203|FG000|Day 1 to Week 24|Death|1
7639847|NCT02397096|12054204|FG001|Day 1 to Week 24|Death|0
7639848|NCT02397096|12054203|FG000|Day 1 to Week 24|Lack of Efficacy|0
7639849|NCT02397096|12054204|FG001|Day 1 to Week 24|Lack of Efficacy|1
7639850|NCT02397096|12054203|FG000|Day 1 to Week 24|Lost to Follow-up|3
7639851|NCT02397096|12054204|FG001|Day 1 to Week 24|Lost to Follow-up|4
7639852|NCT02397096|12054203|FG000|Day 1 to Week 24|Physician Decision|2
7639853|NCT02397096|12054204|FG001|Day 1 to Week 24|Physician Decision|3
7639854|NCT02397096|12054203|FG000|Day 1 to Week 24|Protocol Violation|1
7639855|NCT02397096|12054204|FG001|Day 1 to Week 24|Protocol Violation|4
7639856|NCT02397096|12054203|FG000|Day 1 to Week 24|Withdrawal by Subject|6
7639857|NCT02397096|12054204|FG001|Day 1 to Week 24|Withdrawal by Subject|1
7639858|NCT02397096|12054203|FG000|Week 24 to Week 48|Adverse Event|6
7639859|NCT02397096|12054204|FG001|Week 24 to Week 48|Adverse Event|2
7639860|NCT02397096|12054203|FG000|Week 24 to Week 48|Lack of Efficacy|5
7639861|NCT02397096|12054204|FG001|Week 24 to Week 48|Lack of Efficacy|1
7639862|NCT02397096|12054203|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0
7639863|NCT02397096|12054204|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1
7639864|NCT02397096|12054203|FG000|Week 24 to Week 48|Physician Decision|2
7639865|NCT02397096|12054204|FG001|Week 24 to Week 48|Physician Decision|1
7639866|NCT02397096|12054203|FG000|Week 24 to Week 48|Withdrawal by Subject|5
7639867|NCT02397096|12054204|FG001|Week 24 to Week 48|Withdrawal by Subject|2
7639868|NCT02397096|12054203|FG000|Week 24 to Week 48|Lost to Follow-up|2
7639869|NCT02397096|12054204|FG001|Week 24 to Week 48|Lost to Follow-up|0
7639870|NCT02397096|12054203|FG000|Study Extensions|Ongoing|399
7639871|NCT02397096|12054204|FG001|Study Extensions|Ongoing|202
7639872|NCT02393859|12054237|FG000|Overall Study|Decision by Sponsor|1
7639873|NCT02393859|12054238|FG001|Overall Study|Decision by Sponsor|1
7639874|NCT02393859|12054237|FG000|Overall Study|Withdrawal by Subject|5
7639875|NCT02393859|12054238|FG001|Overall Study|Withdrawal by Subject|2
7639876|NCT02393859|12054237|FG000|Overall Study|Death|16
7639877|NCT02393859|12054238|FG001|Overall Study|Death|8
7639878|NCT02393859|12054237|FG000|Overall Study|Continuing Study|32
7639879|NCT02393859|12054238|FG001|Overall Study|Continuing Study|43
7639880|NCT02390245|12054259|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0
7639881|NCT02390245|12054260|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103
7639882|NCT02390245|12054261|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104
7639883|NCT02390245|12054259|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0
7639884|NCT02390245|12054260|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95
7639885|NCT02390245|12054261|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106
7639886|NCT02388906|12054281|FG000|Pre-Treatment Period|Participant withdrew consent|1
7639887|NCT02388906|12054282|FG001|Pre-Treatment Period|Participant withdrew consent|0
7639888|NCT02388906|12054281|FG000|Treatment Period|Disease progression|121
7639889|NCT02388906|12054282|FG001|Treatment Period|Disease progression|101
7639890|NCT02388906|12054281|FG000|Treatment Period|Study drug toxicity|41
7639891|NCT02388906|12054282|FG001|Treatment Period|Study drug toxicity|208
7639970|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Other|0
7639892|NCT02388906|12054281|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5
7639893|NCT02388906|12054282|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5
7639894|NCT02388906|12054281|FG000|Treatment Period|Participant request to stop treatment|5
7639895|NCT02388906|12054282|FG001|Treatment Period|Participant request to stop treatment|9
7639896|NCT02388906|12054281|FG000|Treatment Period|Participant withdrew consent|2
7639897|NCT02388906|12054282|FG001|Treatment Period|Participant withdrew consent|3
7639898|NCT02388906|12054281|FG000|Treatment Period|Poor/non-compliance|0
7639899|NCT02388906|12054282|FG001|Treatment Period|Poor/non-compliance|1
7639900|NCT02388906|12054281|FG000|Treatment Period|Participant no longer meets study criteria|0
7639901|NCT02388906|12054282|FG001|Treatment Period|Participant no longer meets study criteria|1
7639902|NCT02388906|12054281|FG000|Treatment Period|Other reasons|3
7639903|NCT02388906|12054282|FG001|Treatment Period|Other reasons|3
7639904|NCT02376790|12054291|FG000|Overall Study|Withdrawal by Subject|43
7639905|NCT02376790|12054292|FG001|Overall Study|Withdrawal by Subject|36
7639906|NCT02376790|12054293|FG002|Overall Study|Withdrawal by Subject|37
7639907|NCT02376790|12054291|FG000|Overall Study|Decision by Sponsor|2
7639908|NCT02376790|12054292|FG001|Overall Study|Decision by Sponsor|1
7639909|NCT02376790|12054293|FG002|Overall Study|Decision by Sponsor|4
7639910|NCT02376790|12054291|FG000|Overall Study|Lost to Follow-up|15
7639911|NCT02376790|12054292|FG001|Overall Study|Lost to Follow-up|10
7639912|NCT02376790|12054293|FG002|Overall Study|Lost to Follow-up|12
7639913|NCT02370914|12054305|FG000|Overall Study|Protocol Violation|2
7639914|NCT02370238|12054311|FG000|Overall Study|Death|42
7639915|NCT02370238|12054312|FG001|Overall Study|Death|35
7639916|NCT02370238|12054311|FG000|Overall Study|Lost to Follow-up|1
7639917|NCT02370238|12054312|FG001|Overall Study|Lost to Follow-up|3
7639918|NCT02370238|12054311|FG000|Overall Study|Withdrawal by Subject|2
7639919|NCT02370238|12054312|FG001|Overall Study|Withdrawal by Subject|6
7639920|NCT02370238|12054311|FG000|Overall Study|Other|2
7639921|NCT02370238|12054312|FG001|Overall Study|Other|1
7882317|NCT01769326|12381183|FG003|Overall Study|unrelated injry|0
7882318|NCT01769326|12381180|FG000|Overall Study|got a job|0
7882319|NCT01769326|12381181|FG001|Overall Study|got a job|1
7882320|NCT01769326|12381182|FG002|Overall Study|got a job|0
7882321|NCT01769326|12381183|FG003|Overall Study|got a job|0
7882322|NCT01769326|12381180|FG000|Overall Study|Got sick and could not complete study|0
7882323|NCT01769326|12381181|FG001|Overall Study|Got sick and could not complete study|0
7882324|NCT01769326|12381182|FG002|Overall Study|Got sick and could not complete study|1
7882325|NCT01769326|12381183|FG003|Overall Study|Got sick and could not complete study|0
7882326|NCT01769339|12381193|FG000|Overall Study|Lost to Follow-up|42
7882327|NCT01769339|12381193|FG000|Overall Study|Adverse Event|1
7882328|NCT01769378|12381230|FG000|Overall Study|Adverse Event|10
7882329|NCT01769378|12381231|FG001|Overall Study|Adverse Event|0
7882330|NCT01769378|12381230|FG000|Overall Study|Entry criteria not met|1
7882331|NCT01769378|12381231|FG001|Overall Study|Entry criteria not met|0
7882332|NCT01769378|12381230|FG000|Overall Study|Protocol Violation|1
7882333|NCT01769378|12381231|FG001|Overall Study|Protocol Violation|1
7882334|NCT01769378|12381230|FG000|Overall Study|Withdrawal by Subject|10
7882335|NCT01769378|12381231|FG001|Overall Study|Withdrawal by Subject|3
7882336|NCT01769378|12381230|FG000|Overall Study|Sponsor Decision|1
7882337|NCT01769378|12381231|FG001|Overall Study|Sponsor Decision|0
7882338|NCT01769378|12381230|FG000|Overall Study|Lost to Follow-up|2
7882339|NCT01769378|12381231|FG001|Overall Study|Lost to Follow-up|0
7882340|NCT01769391|12381239|FG000|Overall Study|Death|10
7882341|NCT01769391|12381240|FG001|Overall Study|Death|1
7882342|NCT01769391|12381239|FG000|Overall Study|Adverse Event|0
7882343|NCT01769391|12381240|FG001|Overall Study|Adverse Event|3
7882344|NCT01769391|12381239|FG000|Overall Study|Progressive Disease|1
7882345|NCT01769391|12381240|FG001|Overall Study|Progressive Disease|2
7882346|NCT01769391|12381239|FG000|Overall Study|Withdrawal by Subject|4
7882347|NCT01769391|12381240|FG001|Overall Study|Withdrawal by Subject|3
7882348|NCT01769391|12381239|FG000|Overall Study|Investigator Decision|2
7882349|NCT01769391|12381240|FG001|Overall Study|Investigator Decision|0
7882350|NCT01769404|12381252|FG000|Treatment Period 1|Did not meet eligibility criteria|1
7882351|NCT01769404|12381253|FG001|Treatment Period 1|Did not meet eligibility criteria|0
7882352|NCT01769404|12381252|FG000|Treatment Period 1|Withdrawal by Subject|3
7639958|NCT02362503|12054347|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0
7639959|NCT02362503|12054348|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2
7639960|NCT02362503|12054349|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0
7639961|NCT02362503|12054347|FG000|Double-blind Period-Up to 8 Days|Death|1
7639962|NCT02362503|12054348|FG001|Double-blind Period-Up to 8 Days|Death|0
7639963|NCT02362503|12054349|FG002|Double-blind Period-Up to 8 Days|Death|0
7639964|NCT02362503|12054347|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
7639965|NCT02362503|12054348|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
7639966|NCT02362503|12054349|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
7639967|NCT02362503|12054347|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
7639968|NCT02362503|12054348|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
7639969|NCT02362503|12054349|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
7882353|NCT01769404|12381253|FG001|Treatment Period 1|Withdrawal by Subject|0
7882354|NCT01769404|12381252|FG000|Treatment Period 1|Sponsor decision|1
7882355|NCT01769404|12381253|FG001|Treatment Period 1|Sponsor decision|0
7639971|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Other|1
7639972|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Other|1
7639973|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0
7639974|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4
7639975|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4
7639976|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0
7639977|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1
7639978|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0
7639979|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3
7639980|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8
7639981|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6
7639982|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4
7639983|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3
7639984|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1
7639985|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Death|1
7639986|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Death|7
7639987|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Death|15
7639988|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0
7639989|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5
7639990|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1
7639991|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3
7639992|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2
7639993|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4
7639994|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3
7639995|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9
7639996|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6
7639997|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54
7639998|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159
7639999|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61
7640000|NCT02362464|12054360|FG000|Overall Study|Switched to alternative therapy|1
7640001|NCT02362464|12054360|FG000|Overall Study|Refused further treatment|1
7640002|NCT02362464|12054360|FG000|Overall Study|Physician Decision|4
7640003|NCT02361346|12054373|FG000|Part 1 and 2 ( Up to Day 112)|Death|0
7640004|NCT02361346|12054374|FG001|Part 1 and 2 ( Up to Day 112)|Death|0
7640005|NCT02361346|12054375|FG002|Part 1 and 2 ( Up to Day 112)|Death|0
7640006|NCT02361346|12054376|FG003|Part 1 and 2 ( Up to Day 112)|Death|1
7640007|NCT02361346|12054377|FG004|Part 1 and 2 ( Up to Day 112)|Death|0
7640008|NCT02361346|12054378|FG005|Part 1 and 2 ( Up to Day 112)|Death|0
7640009|NCT02361346|12054379|FG006|Part 1 and 2 ( Up to Day 112)|Death|0
7640010|NCT02361346|12054380|FG007|Part 1 and 2 ( Up to Day 112)|Death|0
7640011|NCT02361346|12054381|FG008|Part 1 and 2 ( Up to Day 112)|Death|0
7640012|NCT02361346|12054373|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640013|NCT02361346|12054374|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640014|NCT02361346|12054375|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640015|NCT02361346|12054376|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640016|NCT02361346|12054377|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2
7640017|NCT02361346|12054378|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640018|NCT02361346|12054379|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640019|NCT02361346|12054380|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640020|NCT02361346|12054381|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640021|NCT02361346|12054373|FG000|Part 3 (Up to Day 112)|Adverse Event|0
7640022|NCT02361346|12054374|FG001|Part 3 (Up to Day 112)|Adverse Event|0
7640023|NCT02361346|12054375|FG002|Part 3 (Up to Day 112)|Adverse Event|0
7640024|NCT02361346|12054376|FG003|Part 3 (Up to Day 112)|Adverse Event|0
7640025|NCT02361346|12054377|FG004|Part 3 (Up to Day 112)|Adverse Event|0
7640026|NCT02361346|12054378|FG005|Part 3 (Up to Day 112)|Adverse Event|0
7640027|NCT02361346|12054379|FG006|Part 3 (Up to Day 112)|Adverse Event|0
7640028|NCT02361346|12054380|FG007|Part 3 (Up to Day 112)|Adverse Event|1
7640029|NCT02361346|12054381|FG008|Part 3 (Up to Day 112)|Adverse Event|0
7640030|NCT02361346|12054373|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640031|NCT02361346|12054374|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640032|NCT02361346|12054375|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640033|NCT02361346|12054376|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640034|NCT02361346|12054377|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640035|NCT02361346|12054378|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640036|NCT02361346|12054379|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640037|NCT02361346|12054380|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1
7640038|NCT02361346|12054381|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640039|NCT02361346|12054373|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640040|NCT02361346|12054374|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640041|NCT02361346|12054375|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640042|NCT02361346|12054376|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640043|NCT02361346|12054377|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640044|NCT02361346|12054378|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640045|NCT02361346|12054379|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640046|NCT02361346|12054380|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7
7640047|NCT02361346|12054381|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640048|NCT02361346|12054373|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0
7640049|NCT02361346|12054374|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0
7640050|NCT02361346|12054375|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0
7640051|NCT02361346|12054376|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0
7640052|NCT02361346|12054377|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0
7640053|NCT02361346|12054378|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0
7640054|NCT02361346|12054379|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0
7640055|NCT02361346|12054380|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2
7640056|NCT02361346|12054381|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0
7640057|NCT02358538|12054427|FG000|Through Week 26|Adverse Event|0
7640058|NCT02358538|12054428|FG001|Through Week 26|Adverse Event|1
7640059|NCT02358538|12054429|FG002|Through Week 26|Adverse Event|1
7640060|NCT02358538|12054430|FG003|Through Week 26|Adverse Event|2
7640061|NCT02358538|12054427|FG000|Through Week 26|Lack of Efficacy|1
7640062|NCT02358538|12054428|FG001|Through Week 26|Lack of Efficacy|1
7640063|NCT02358538|12054429|FG002|Through Week 26|Lack of Efficacy|3
7640064|NCT02358538|12054430|FG003|Through Week 26|Lack of Efficacy|3
7640065|NCT02358538|12054427|FG000|Through Week 26|Withdrawal by Subject|1
7640066|NCT02358538|12054428|FG001|Through Week 26|Withdrawal by Subject|0
7640067|NCT02358538|12054429|FG002|Through Week 26|Withdrawal by Subject|0
7640068|NCT02358538|12054430|FG003|Through Week 26|Withdrawal by Subject|0
7640069|NCT02358538|12054427|FG000|Through Week 26|Non-Compliance|0
7640070|NCT02358538|12054428|FG001|Through Week 26|Non-Compliance|0
7640071|NCT02358538|12054429|FG002|Through Week 26|Non-Compliance|1
7640072|NCT02358538|12054430|FG003|Through Week 26|Non-Compliance|0
7640073|NCT02358538|12054427|FG000|Through Week 26|Family did not see benefit from IP|1
7640074|NCT02358538|12054428|FG001|Through Week 26|Family did not see benefit from IP|0
7640075|NCT02358538|12054429|FG002|Through Week 26|Family did not see benefit from IP|0
7640076|NCT02358538|12054430|FG003|Through Week 26|Family did not see benefit from IP|0
7640077|NCT02358538|12054427|FG000|52 Week Extension Period|Lack of Efficacy|0
7640078|NCT02358538|12054428|FG001|52 Week Extension Period|Lack of Efficacy|0
7640079|NCT02358538|12054429|FG002|52 Week Extension Period|Lack of Efficacy|2
7640080|NCT02358538|12054430|FG003|52 Week Extension Period|Lack of Efficacy|4
7640081|NCT02358031|12054447|FG000|Overall Study|Death|226
7640082|NCT02358031|12054448|FG001|Overall Study|Death|204
7640083|NCT02358031|12054449|FG002|Overall Study|Death|249
7640084|NCT02358031|12054447|FG000|Overall Study|Lost to Follow-up|0
7640085|NCT02358031|12054448|FG001|Overall Study|Lost to Follow-up|1
7640086|NCT02358031|12054449|FG002|Overall Study|Lost to Follow-up|1
7640087|NCT02358031|12054447|FG000|Overall Study|Withdrawal by Subject|14
7640088|NCT02358031|12054448|FG001|Overall Study|Withdrawal by Subject|12
7640089|NCT02358031|12054449|FG002|Overall Study|Withdrawal by Subject|17
7640090|NCT02358031|12054447|FG000|Overall Study|Ongoing in Study|61
7640091|NCT02358031|12054448|FG001|Overall Study|Ongoing in Study|64
7640092|NCT02358031|12054449|FG002|Overall Study|Ongoing in Study|33
7640093|NCT02354586|12054466|FG000|Overall Study|Death|230
7640094|NCT02354586|12054466|FG000|Overall Study|Withdrawal by Subject|59
7640095|NCT02354586|12054466|FG000|Overall Study|Lost to Follow-up|11
7640096|NCT02354586|12054466|FG000|Overall Study|Sponsor decision|51
7640097|NCT02354586|12054466|FG000|Overall Study|Site closure|2
7640098|NCT02354586|12054466|FG000|Overall Study|Intercurrent illness|1
7640099|NCT02354586|12054466|FG000|Overall Study|Protocol Violation|3
7640100|NCT02354586|12054466|FG000|Overall Study|Physician Decision|13
7640101|NCT02354586|12054466|FG000|Overall Study|Lack of Efficacy|86
7640102|NCT02354586|12054466|FG000|Overall Study|Adverse Event|7
7640103|NCT02353871|12054481|FG000|Overall Study|Protocol deviation|0
7640104|NCT02353871|12054482|FG001|Overall Study|Protocol deviation|1
7640105|NCT02353871|12054481|FG000|Overall Study|Consent withdrawn|1
7640106|NCT02353871|12054482|FG001|Overall Study|Consent withdrawn|8
7640107|NCT02353871|12054481|FG000|Overall Study|Lost to Follow-up|2
7640108|NCT02353871|12054482|FG001|Overall Study|Lost to Follow-up|0
7640109|NCT02352090|12054491|FG000|Overall Study|general malaise|1
7640110|NCT02352090|12054492|FG001|Overall Study|general malaise|0
7640111|NCT02352090|12054493|FG002|Overall Study|general malaise|0
7640112|NCT02352090|12054491|FG000|Overall Study|non-specified mild side-effects|0
7640113|NCT02352090|12054492|FG001|Overall Study|non-specified mild side-effects|0
7640114|NCT02352090|12054493|FG002|Overall Study|non-specified mild side-effects|2
7640115|NCT02348008|12054503|FG000|Overall Study|Adverse Event|2
7640116|NCT02348008|12054504|FG001|Overall Study|Adverse Event|3
7640117|NCT02348008|12054505|FG002|Overall Study|Adverse Event|3
7640118|NCT02348008|12054503|FG000|Overall Study|Disease Progression|1
7640119|NCT02348008|12054504|FG001|Overall Study|Disease Progression|5
7640120|NCT02348008|12054505|FG002|Overall Study|Disease Progression|16
7640121|NCT02348008|12054503|FG000|Overall Study|Withdrawal by Subject|0
7640122|NCT02348008|12054504|FG001|Overall Study|Withdrawal by Subject|1
7640123|NCT02348008|12054505|FG002|Overall Study|Withdrawal by Subject|0
7640124|NCT02348008|12054503|FG000|Overall Study|Symptomatic Deterioration|0
7640125|NCT02348008|12054504|FG001|Overall Study|Symptomatic Deterioration|1
7640126|NCT02348008|12054505|FG002|Overall Study|Symptomatic Deterioration|0
7640127|NCT02347527|12054515|FG000|Overall Study|MRI not completed due to technical difficulties|1
7640128|NCT02347527|12054516|FG001|Overall Study|MRI not completed due to technical difficulties|0
7640129|NCT02347527|12054517|FG002|Overall Study|MRI not completed due to technical difficulties|0
7640130|NCT02347527|12054518|FG003|Overall Study|MRI not completed due to technical difficulties|0
7640131|NCT02347527|12054515|FG000|Overall Study|MRI stopped due to participant anxiety|0
7640132|NCT02347527|12054516|FG001|Overall Study|MRI stopped due to participant anxiety|1
7640133|NCT02347527|12054517|FG002|Overall Study|MRI stopped due to participant anxiety|0
7640134|NCT02347527|12054518|FG003|Overall Study|MRI stopped due to participant anxiety|0
7640135|NCT02347527|12054515|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1
7640136|NCT02347527|12054516|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1
7640137|NCT02347527|12054517|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0
7640138|NCT02347527|12054518|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0
7640139|NCT02347527|12054515|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1
7640140|NCT02347527|12054516|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0
7640141|NCT02347527|12054517|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1
7640142|NCT02347527|12054518|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2
7640143|NCT02347527|12054515|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0
7640144|NCT02347527|12054516|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1
7640145|NCT02347527|12054517|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0
7640146|NCT02347527|12054518|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0
7640147|NCT02341625|12054540|FG000|Overall Study|Disease Progression|2
7640148|NCT02341625|12054541|FG001|Overall Study|Disease Progression|2
7640149|NCT02341625|12054542|FG002|Overall Study|Disease Progression|3
7640150|NCT02341625|12054543|FG003|Overall Study|Disease Progression|6
7640151|NCT02341625|12054544|FG004|Overall Study|Disease Progression|7
7640152|NCT02341625|12054545|FG005|Overall Study|Disease Progression|7
7640153|NCT02341625|12054546|FG006|Overall Study|Disease Progression|28
7640154|NCT02341625|12054547|FG007|Overall Study|Disease Progression|5
7640155|NCT02341625|12054548|FG008|Overall Study|Disease Progression|4
7640156|NCT02341625|12054549|FG009|Overall Study|Disease Progression|19
7640157|NCT02341625|12054540|FG000|Overall Study|Study Drug Toxicity|0
7640158|NCT02341625|12054541|FG001|Overall Study|Study Drug Toxicity|0
7640159|NCT02341625|12054542|FG002|Overall Study|Study Drug Toxicity|0
7640160|NCT02341625|12054543|FG003|Overall Study|Study Drug Toxicity|1
7640161|NCT02341625|12054544|FG004|Overall Study|Study Drug Toxicity|0
7640162|NCT02341625|12054545|FG005|Overall Study|Study Drug Toxicity|3
7640163|NCT02341625|12054546|FG006|Overall Study|Study Drug Toxicity|10
7640164|NCT02341625|12054547|FG007|Overall Study|Study Drug Toxicity|0
7640165|NCT02341625|12054548|FG008|Overall Study|Study Drug Toxicity|0
7640166|NCT02341625|12054549|FG009|Overall Study|Study Drug Toxicity|3
7640167|NCT02341625|12054540|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0
7640168|NCT02341625|12054541|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0
7640169|NCT02341625|12054542|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0
7640170|NCT02341625|12054543|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0
7640171|NCT02341625|12054544|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0
7640172|NCT02341625|12054545|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0
7640173|NCT02341625|12054546|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2
7640174|NCT02341625|12054547|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1
7640175|NCT02341625|12054548|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0
7640176|NCT02341625|12054549|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2
7640177|NCT02341625|12054540|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0
7640178|NCT02341625|12054541|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0
7640179|NCT02341625|12054542|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0
7640180|NCT02341625|12054543|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0
7640181|NCT02341625|12054544|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0
7640182|NCT02341625|12054545|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0
7640183|NCT02341625|12054546|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6
7640184|NCT02341625|12054547|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2
7640185|NCT02341625|12054548|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0
7640186|NCT02341625|12054549|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0
7640187|NCT02341625|12054540|FG000|Overall Study|Participant Withdrew Consent|0
7640188|NCT02341625|12054541|FG001|Overall Study|Participant Withdrew Consent|0
7640189|NCT02341625|12054542|FG002|Overall Study|Participant Withdrew Consent|0
7640190|NCT02341625|12054543|FG003|Overall Study|Participant Withdrew Consent|1
7640191|NCT02341625|12054544|FG004|Overall Study|Participant Withdrew Consent|0
7640192|NCT02341625|12054545|FG005|Overall Study|Participant Withdrew Consent|0
7640193|NCT02341625|12054546|FG006|Overall Study|Participant Withdrew Consent|0
7640194|NCT02341625|12054547|FG007|Overall Study|Participant Withdrew Consent|0
7640195|NCT02341625|12054548|FG008|Overall Study|Participant Withdrew Consent|0
7640196|NCT02341625|12054549|FG009|Overall Study|Participant Withdrew Consent|0
7640197|NCT02341625|12054540|FG000|Overall Study|Completed Treatment as per Protocol|0
7640198|NCT02341625|12054541|FG001|Overall Study|Completed Treatment as per Protocol|0
7640199|NCT02341625|12054542|FG002|Overall Study|Completed Treatment as per Protocol|0
7640200|NCT02341625|12054543|FG003|Overall Study|Completed Treatment as per Protocol|0
7640201|NCT02341625|12054544|FG004|Overall Study|Completed Treatment as per Protocol|0
7640202|NCT02341625|12054545|FG005|Overall Study|Completed Treatment as per Protocol|0
7640203|NCT02341625|12054546|FG006|Overall Study|Completed Treatment as per Protocol|0
7640204|NCT02341625|12054547|FG007|Overall Study|Completed Treatment as per Protocol|0
7640205|NCT02341625|12054548|FG008|Overall Study|Completed Treatment as per Protocol|0
7640206|NCT02341625|12054549|FG009|Overall Study|Completed Treatment as per Protocol|1
7640207|NCT02341625|12054540|FG000|Overall Study|Other Reasons|0
7640208|NCT02341625|12054541|FG001|Overall Study|Other Reasons|0
7640209|NCT02341625|12054542|FG002|Overall Study|Other Reasons|0
7640210|NCT02341625|12054543|FG003|Overall Study|Other Reasons|0
7640211|NCT02341625|12054544|FG004|Overall Study|Other Reasons|1
7640212|NCT02341625|12054545|FG005|Overall Study|Other Reasons|0
7640213|NCT02341625|12054546|FG006|Overall Study|Other Reasons|5
7640214|NCT02341625|12054547|FG007|Overall Study|Other Reasons|0
7640215|NCT02341625|12054548|FG008|Overall Study|Other Reasons|0
7640216|NCT02341625|12054549|FG009|Overall Study|Other Reasons|2
7640217|NCT02341625|12054540|FG000|Overall Study|Not Reported|0
7640218|NCT02341625|12054541|FG001|Overall Study|Not Reported|0
7640219|NCT02341625|12054542|FG002|Overall Study|Not Reported|0
7640220|NCT02341625|12054543|FG003|Overall Study|Not Reported|0
7640221|NCT02341625|12054544|FG004|Overall Study|Not Reported|0
7640222|NCT02341625|12054545|FG005|Overall Study|Not Reported|0
7640223|NCT02341625|12054546|FG006|Overall Study|Not Reported|0
7640224|NCT02341625|12054547|FG007|Overall Study|Not Reported|0
7640225|NCT02341625|12054548|FG008|Overall Study|Not Reported|0
7640226|NCT02341625|12054549|FG009|Overall Study|Not Reported|3
7640227|NCT02335424|12054594|FG000|Overall Study|Withdrawal by Subject|12
7640228|NCT02335424|12054594|FG000|Overall Study|Ongoing In Study|89
7640229|NCT02335424|12054594|FG000|Overall Study|Adverse Event|25
7640230|NCT02335424|12054594|FG000|Overall Study|Death|239
7640231|NCT02335424|12054594|FG000|Overall Study|Lost to Follow-up|2
7640232|NCT02335424|12054594|FG000|Overall Study|Physician Decision|3
7640233|NCT02335424|12054594|FG000|Overall Study|Not treated|4
7640234|NCT02335411|12054601|FG000|Overall Study|Death|223
7640235|NCT02335411|12054602|FG001|Overall Study|Death|22
7640236|NCT02335411|12054603|FG002|Overall Study|Death|26
7640237|NCT02335411|12054601|FG000|Overall Study|Physician Decision|3
7640238|NCT02335411|12054602|FG001|Overall Study|Physician Decision|0
7640239|NCT02335411|12054603|FG002|Overall Study|Physician Decision|0
7640240|NCT02335411|12054601|FG000|Overall Study|Protocol Violation|1
7640241|NCT02335411|12054602|FG001|Overall Study|Protocol Violation|0
7640242|NCT02335411|12054603|FG002|Overall Study|Protocol Violation|0
7640243|NCT02335411|12054601|FG000|Overall Study|Withdrawal by Subject|11
7640244|NCT02335411|12054602|FG001|Overall Study|Withdrawal by Subject|0
7640245|NCT02335411|12054603|FG002|Overall Study|Withdrawal by Subject|3
7640246|NCT02335411|12054601|FG000|Overall Study|Sponsor Decision|12
7640247|NCT02335411|12054602|FG001|Overall Study|Sponsor Decision|3
7640248|NCT02335411|12054603|FG002|Overall Study|Sponsor Decision|2
7640249|NCT02335411|12054601|FG000|Overall Study|Adverse Event|9
7640250|NCT02335411|12054602|FG001|Overall Study|Adverse Event|0
7640251|NCT02335411|12054603|FG002|Overall Study|Adverse Event|0
7640252|NCT02328105|12054614|FG000|Overall Study|Death|6
7640253|NCT02328105|12054614|FG000|Overall Study|Withdrawal by Subject|1
7640254|NCT02328105|12054614|FG000|Overall Study|Still On Study in Follow-Up|4
7640255|NCT02321514|12054631|FG000|Overall Study|Death|15
7640256|NCT02321514|12054631|FG000|Overall Study|Missed Visit|7
7640257|NCT02321514|12054631|FG000|Overall Study|Study Exit|3
7640258|NCT02321436|12054637|FG000|Overall Study|Withdrawal by Subject|1
7640259|NCT02321436|12054638|FG001|Overall Study|Withdrawal by Subject|0
7640260|NCT02321436|12054637|FG000|Overall Study|Lost to Follow-up|0
7640261|NCT02321436|12054638|FG001|Overall Study|Lost to Follow-up|1
7640262|NCT02316171|12054647|FG000|Overall Study|difficulties with urinary catheter|1
7640263|NCT02316171|12054648|FG001|Overall Study|difficulties with urinary catheter|0
7640264|NCT02316171|12054649|FG002|Overall Study|difficulties with urinary catheter|0
7640265|NCT02316171|12054650|FG003|Overall Study|difficulties with urinary catheter|0
7640266|NCT02308488|12054656|FG000|Overall Study|Withdrawal by Subject|2
7640267|NCT02306161|12054671|FG000|Overall Study|Death|1
7640268|NCT02306161|12054672|FG001|Overall Study|Death|3
7640269|NCT02306161|12054671|FG000|Overall Study|Lack of Efficacy|20
7640270|NCT02306161|12054672|FG001|Overall Study|Lack of Efficacy|43
7640271|NCT02306161|12054671|FG000|Overall Study|Physician Decision|30
7640272|NCT02306161|12054672|FG001|Overall Study|Physician Decision|18
7640273|NCT02306161|12054671|FG000|Overall Study|Withdrawal by Subject|4
7640274|NCT02306161|12054672|FG001|Overall Study|Withdrawal by Subject|0
7640275|NCT02306161|12054671|FG000|Overall Study|Ineligible|9
7640276|NCT02306161|12054672|FG001|Overall Study|Ineligible|5
7640277|NCT02302222|12054680|FG000|Overall Study|Physician Decision|0
7640278|NCT02302222|12054681|FG001|Overall Study|Physician Decision|4
7640279|NCT02302222|12054680|FG000|Overall Study|Lost to Follow-up|1
7640280|NCT02302222|12054681|FG001|Overall Study|Lost to Follow-up|0
7640281|NCT02302222|12054680|FG000|Overall Study|Treatment discontinued before day 5|0
7640282|NCT02302222|12054681|FG001|Overall Study|Treatment discontinued before day 5|1
7640283|NCT02302222|12054680|FG000|Overall Study|Withdrawn prior to any treatment|0
7640284|NCT02302222|12054681|FG001|Overall Study|Withdrawn prior to any treatment|1
7640285|NCT02297503|12054689|FG000|Overall Study|Withdrawal by Subject|1
7640286|NCT02297503|12054690|FG001|Overall Study|Withdrawal by Subject|1
7640287|NCT02297503|12054689|FG000|Overall Study|Protocol Violation|1
7640288|NCT02297503|12054690|FG001|Overall Study|Protocol Violation|0
7640289|NCT02297503|12054689|FG000|Overall Study|Pregnancy|0
7640290|NCT02297503|12054690|FG001|Overall Study|Pregnancy|1
7640291|NCT02297503|12054689|FG000|Overall Study|Lost to Follow-up|0
7640292|NCT02297503|12054690|FG001|Overall Study|Lost to Follow-up|1
7640293|NCT02297503|12054689|FG000|Overall Study|Medical reason|0
7640294|NCT02297503|12054690|FG001|Overall Study|Medical reason|1
7640295|NCT02296125|12054707|FG000|Overall Study|Withdrawal by Subject|18
7640296|NCT02296125|12054708|FG001|Overall Study|Withdrawal by Subject|8
7640297|NCT02296125|12054709|FG002|Overall Study|Withdrawal by Subject|6
7640298|NCT02296125|12054710|FG003|Overall Study|Withdrawal by Subject|2
7640299|NCT02296125|12054707|FG000|Overall Study|Adverse Event|41
7640300|NCT02296125|12054708|FG001|Overall Study|Adverse Event|52
7640301|NCT02296125|12054709|FG002|Overall Study|Adverse Event|9
7640302|NCT02296125|12054710|FG003|Overall Study|Adverse Event|4
7640303|NCT02296125|12054707|FG000|Overall Study|Severe non-compliance to protocol|0
7640304|NCT02296125|12054708|FG001|Overall Study|Severe non-compliance to protocol|1
7640305|NCT02296125|12054709|FG002|Overall Study|Severe non-compliance to protocol|0
7640306|NCT02296125|12054710|FG003|Overall Study|Severe non-compliance to protocol|0
7640307|NCT02296125|12054707|FG000|Overall Study|Condition under investigation worsened|153
7640308|NCT02296125|12054708|FG001|Overall Study|Condition under investigation worsened|199
7640309|NCT02296125|12054709|FG002|Overall Study|Condition under investigation worsened|39
7640310|NCT02296125|12054710|FG003|Overall Study|Condition under investigation worsened|56
7640311|NCT02296125|12054707|FG000|Overall Study|Any reason not specifically recorded|6
7640312|NCT02296125|12054708|FG001|Overall Study|Any reason not specifically recorded|4
7640313|NCT02296125|12054709|FG002|Overall Study|Any reason not specifically recorded|2
7640314|NCT02296125|12054710|FG003|Overall Study|Any reason not specifically recorded|0
7640315|NCT02294461|12054723|FG000|Double-blind Period (up to 29.4 Months)|Death|6
7640316|NCT02294461|12054724|FG001|Double-blind Period (up to 29.4 Months)|Death|4
7640317|NCT02294461|12054723|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30
7640318|NCT02294461|12054724|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66
7640319|NCT02294461|12054723|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27
7640320|NCT02294461|12054724|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54
7640321|NCT02294461|12054723|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0
7640322|NCT02294461|12054724|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2
7640323|NCT02294461|12054723|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1
7640324|NCT02294461|12054724|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0
7640325|NCT02294461|12054723|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38
7640326|NCT02294461|12054724|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51
7640327|NCT02294461|12054723|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16
7640328|NCT02294461|12054724|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15
7640329|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19
7640330|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9
7640331|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16
7640332|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12
7640333|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18
7640334|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9
7640335|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2
7640336|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0
7640337|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3
7640338|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1
7640339|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15
7640340|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9
7640341|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Death|6
7640342|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Death|5
7640343|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6
7640344|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6
7640345|NCT02287233|12054745|FG000|Overall Study|Adverse Event Not Related to Progression|1
7640346|NCT02287233|12054746|FG001|Overall Study|Adverse Event Not Related to Progression|2
7640347|NCT02287233|12054747|FG002|Overall Study|Adverse Event Not Related to Progression|10
7640348|NCT02287233|12054745|FG000|Overall Study|Adverse Event Related to Progression|0
7640349|NCT02287233|12054746|FG001|Overall Study|Adverse Event Related to Progression|2
7640350|NCT02287233|12054747|FG002|Overall Study|Adverse Event Related to Progression|8
7640351|NCT02287233|12054745|FG000|Overall Study|Physician Decision|1
7640352|NCT02287233|12054746|FG001|Overall Study|Physician Decision|2
7640353|NCT02287233|12054747|FG002|Overall Study|Physician Decision|4
7640354|NCT02287233|12054745|FG000|Overall Study|Progressive Disease with Death|0
7640355|NCT02287233|12054746|FG001|Overall Study|Progressive Disease with Death|0
7640356|NCT02287233|12054747|FG002|Overall Study|Progressive Disease with Death|10
7640357|NCT02287233|12054745|FG000|Overall Study|Progressive Disease Without Death|2
7640358|NCT02287233|12054746|FG001|Overall Study|Progressive Disease Without Death|3
7640359|NCT02287233|12054747|FG002|Overall Study|Progressive Disease Without Death|20
7640360|NCT02287233|12054745|FG000|Overall Study|Withdrawal by Subject|1
7640361|NCT02287233|12054746|FG001|Overall Study|Withdrawal by Subject|1
7640362|NCT02287233|12054747|FG002|Overall Study|Withdrawal by Subject|7
7640363|NCT02287233|12054745|FG000|Overall Study|Other|3
7640364|NCT02287233|12054746|FG001|Overall Study|Other|0
7640365|NCT02287233|12054747|FG002|Overall Study|Other|15
7640366|NCT02287233|12054745|FG000|Overall Study|Did Not Receive Treatment|0
7640367|NCT02287233|12054746|FG001|Overall Study|Did Not Receive Treatment|0
7640368|NCT02287233|12054747|FG002|Overall Study|Did Not Receive Treatment|2
7640369|NCT02285062|12054760|FG000|Overall Study|Withdrawal by Subject|12
7640370|NCT02285062|12054761|FG001|Overall Study|Withdrawal by Subject|17
7640371|NCT02285062|12054760|FG000|Overall Study|Death|58
7640372|NCT02285062|12054761|FG001|Overall Study|Death|62
7640373|NCT02285062|12054760|FG000|Overall Study|Lost to Follow-up|8
7640374|NCT02285062|12054761|FG001|Overall Study|Lost to Follow-up|5
7640375|NCT02281084|12054771|FG000|Overall Study|Adverse Event|1
7640376|NCT02281084|12054772|FG001|Overall Study|Adverse Event|0
7640377|NCT02281084|12054773|FG002|Overall Study|Adverse Event|0
7640378|NCT02281084|12054774|FG003|Overall Study|Adverse Event|0
7640379|NCT02281084|12054771|FG000|Overall Study|Withdrawal by Subject|1
7640380|NCT02281084|12054772|FG001|Overall Study|Withdrawal by Subject|2
7640381|NCT02281084|12054773|FG002|Overall Study|Withdrawal by Subject|0
7640382|NCT02281084|12054774|FG003|Overall Study|Withdrawal by Subject|0
7640383|NCT02281084|12054771|FG000|Overall Study|Death|20
7640384|NCT02281084|12054772|FG001|Overall Study|Death|16
7640385|NCT02281084|12054773|FG002|Overall Study|Death|3
7640386|NCT02281084|12054774|FG003|Overall Study|Death|5
7640387|NCT02281084|12054771|FG000|Overall Study|Physician Decision|0
7640388|NCT02281084|12054772|FG001|Overall Study|Physician Decision|0
7640389|NCT02281084|12054773|FG002|Overall Study|Physician Decision|1
7640390|NCT02281084|12054774|FG003|Overall Study|Physician Decision|0
7640391|NCT02278120|12054786|FG000|Overall Study|Progressive disease|122
7640392|NCT02278120|12054787|FG001|Overall Study|Progressive disease|174
7640393|NCT02278120|12054786|FG000|Overall Study|Patient/guardian decision|14
7640394|NCT02278120|12054787|FG001|Overall Study|Patient/guardian decision|8
7640395|NCT02278120|12054786|FG000|Overall Study|Adverse Event|12
7640396|NCT02278120|12054787|FG001|Overall Study|Adverse Event|10
7640397|NCT02278120|12054786|FG000|Overall Study|Physician Decision|8
7640398|NCT02278120|12054787|FG001|Overall Study|Physician Decision|19
7640399|NCT02278120|12054786|FG000|Overall Study|Death|3
7640400|NCT02278120|12054787|FG001|Overall Study|Death|3
7640401|NCT02278120|12054786|FG000|Overall Study|Lost to Follow-up|2
7640402|NCT02278120|12054787|FG001|Overall Study|Lost to Follow-up|0
7640403|NCT02278120|12054786|FG000|Overall Study|Protocol Violation|0
7640404|NCT02278120|12054787|FG001|Overall Study|Protocol Violation|2
7640405|NCT02277444|12054793|FG000|Overall Study|Adverse Event|10
7640406|NCT02277444|12054793|FG000|Overall Study|Withdrawal by Subject|3
7640407|NCT02277444|12054793|FG000|Overall Study|Other|1
7640408|NCT02277444|12054793|FG000|Overall Study|Enrolled and not Treated|3
7640409|NCT02277444|12054793|FG000|Overall Study|Ongoing|113
7640410|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Adverse Event|6
7640411|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Adverse Event|14
7640412|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Death|3
7640413|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Death|1
7640414|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Lack of Efficacy|21
7640415|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Lack of Efficacy|32
7640416|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Lost to Follow-up|28
7640417|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Lost to Follow-up|24
7640418|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Protocol Violation|1
7640419|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Protocol Violation|6
7640420|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19
7640421|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22
7640422|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Noncompliance with drug|9
7640423|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Noncompliance with drug|6
7640424|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Physician Decision|2
7640425|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Physician Decision|4
7640426|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Pregnancy|2
7640427|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Pregnancy|1
7640428|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Randomized not treated|2
7640429|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Randomized not treated|1
7640430|NCT02275780|12054799|FG000|Extension Study: up to 192 Weeks|Ongoing|260
7640431|NCT02275780|12054800|FG001|Extension Study: up to 192 Weeks|Ongoing|233
7640432|NCT02272790|12054812|FG000|Overall Study|Physician Decision|0
7640433|NCT02272790|12054813|FG001|Overall Study|Physician Decision|1
7640434|NCT02272790|12054814|FG002|Overall Study|Physician Decision|0
7640435|NCT02272790|12054815|FG003|Overall Study|Physician Decision|0
7640436|NCT02272790|12054816|FG004|Overall Study|Physician Decision|0
7640437|NCT02272790|12054817|FG005|Overall Study|Physician Decision|0
7640438|NCT02268916|12054839|FG000|Overall Study|Lost to Follow-up|1
7640439|NCT02268916|12054840|FG001|Overall Study|Lost to Follow-up|1
7640440|NCT02268916|12054839|FG000|Overall Study|Withdrawal by Subject|6
7640441|NCT02268916|12054840|FG001|Overall Study|Withdrawal by Subject|5
7640442|NCT02268916|12054839|FG000|Overall Study|Participant did not have diabetes|1
7640443|NCT02268916|12054840|FG001|Overall Study|Participant did not have diabetes|0
7640444|NCT02268916|12054839|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9
7640445|NCT02268916|12054840|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4
7640446|NCT02268851|12054853|FG000|Overall Study|Death|0
7640447|NCT02268851|12054854|FG001|Overall Study|Death|0
7640448|NCT02268851|12054855|FG002|Overall Study|Death|0
7640449|NCT02268851|12054856|FG003|Overall Study|Death|1
7640450|NCT02268851|12054857|FG004|Overall Study|Death|2
7640451|NCT02268851|12054858|FG005|Overall Study|Death|1
7640452|NCT02268851|12054853|FG000|Overall Study|Adverse Event|0
7640453|NCT02268851|12054854|FG001|Overall Study|Adverse Event|0
7640454|NCT02268851|12054855|FG002|Overall Study|Adverse Event|0
7640455|NCT02268851|12054856|FG003|Overall Study|Adverse Event|0
7640456|NCT02268851|12054857|FG004|Overall Study|Adverse Event|2
7640457|NCT02268851|12054858|FG005|Overall Study|Adverse Event|2
7640458|NCT02268851|12054853|FG000|Overall Study|Withdrawal by Subject|0
7640459|NCT02268851|12054854|FG001|Overall Study|Withdrawal by Subject|0
7640460|NCT02268851|12054855|FG002|Overall Study|Withdrawal by Subject|0
7640461|NCT02268851|12054856|FG003|Overall Study|Withdrawal by Subject|2
7640462|NCT02268851|12054857|FG004|Overall Study|Withdrawal by Subject|0
7640463|NCT02268851|12054858|FG005|Overall Study|Withdrawal by Subject|1
7640464|NCT02268851|12054853|FG000|Overall Study|Progressive Disease|1
7640465|NCT02268851|12054854|FG001|Overall Study|Progressive Disease|3
7640466|NCT02268851|12054855|FG002|Overall Study|Progressive Disease|0
7640467|NCT02268851|12054856|FG003|Overall Study|Progressive Disease|0
7640468|NCT02268851|12054857|FG004|Overall Study|Progressive Disease|1
7640469|NCT02268851|12054858|FG005|Overall Study|Progressive Disease|4
7640470|NCT02268851|12054853|FG000|Overall Study|Physician Decision|0
7640471|NCT02268851|12054854|FG001|Overall Study|Physician Decision|0
7640472|NCT02268851|12054855|FG002|Overall Study|Physician Decision|1
7640473|NCT02268851|12054856|FG003|Overall Study|Physician Decision|0
7640474|NCT02268851|12054857|FG004|Overall Study|Physician Decision|0
7640475|NCT02268851|12054858|FG005|Overall Study|Physician Decision|1
7640476|NCT02268851|12054853|FG000|Overall Study|Patient Compliance|0
7640477|NCT02268851|12054854|FG001|Overall Study|Patient Compliance|0
7640478|NCT02268851|12054855|FG002|Overall Study|Patient Compliance|0
7640479|NCT02268851|12054856|FG003|Overall Study|Patient Compliance|0
7640480|NCT02268851|12054857|FG004|Overall Study|Patient Compliance|1
7640481|NCT02268851|12054858|FG005|Overall Study|Patient Compliance|1
7640482|NCT02268851|12054853|FG000|Overall Study|Co-Morbid Condition|0
7640483|NCT02268851|12054854|FG001|Overall Study|Co-Morbid Condition|0
7640484|NCT02268851|12054855|FG002|Overall Study|Co-Morbid Condition|0
7640485|NCT02268851|12054856|FG003|Overall Study|Co-Morbid Condition|0
7640486|NCT02268851|12054857|FG004|Overall Study|Co-Morbid Condition|1
7640487|NCT02268851|12054858|FG005|Overall Study|Co-Morbid Condition|1
7640488|NCT02264977|12054881|FG000|Overall Study|Death|3
7640489|NCT02264977|12054881|FG000|Overall Study|Physician Decision|1
7640490|NCT02264977|12054881|FG000|Overall Study|Refuse to return|1
7640513|NCT02257736|12054898|FG000|Overall Study|Progressive disease|365
7640514|NCT02257736|12054899|FG001|Overall Study|Progressive disease|327
7640515|NCT02257736|12054898|FG000|Overall Study|Adverse Event|45
7640516|NCT02257736|12054899|FG001|Overall Study|Adverse Event|56
7640517|NCT02257736|12054898|FG000|Overall Study|Withdrawal by Subject|21
7640518|NCT02257736|12054899|FG001|Overall Study|Withdrawal by Subject|38
7640519|NCT02257736|12054898|FG000|Overall Study|Death|11
7640520|NCT02257736|12054899|FG001|Overall Study|Death|6
7640521|NCT02257736|12054898|FG000|Overall Study|Physician Decision|5
7640522|NCT02257736|12054899|FG001|Overall Study|Physician Decision|9
7640523|NCT02257736|12054898|FG000|Overall Study|Non-Compliance with study drug|1
7640524|NCT02257736|12054899|FG001|Overall Study|Non-Compliance with study drug|2
7640525|NCT02257736|12054898|FG000|Overall Study|Protocol Violation|1
7640526|NCT02257736|12054899|FG001|Overall Study|Protocol Violation|0
7640527|NCT02257736|12054898|FG000|Overall Study|Other|1
7640528|NCT02257736|12054899|FG001|Overall Study|Other|7
7640529|NCT02257736|12054898|FG000|Overall Study|Randomized, not treated|1
7640530|NCT02257736|12054899|FG001|Overall Study|Randomized, not treated|2
7640531|NCT02257528|12054905|FG000|Overall Study|Never received study treatment|1
7640532|NCT02257489|12054918|FG000|Overall Study|Withdrawal by Subject|0
7640533|NCT02257489|12054919|FG001|Overall Study|Withdrawal by Subject|0
7640534|NCT02257489|12054920|FG002|Overall Study|Withdrawal by Subject|0
7640535|NCT02257489|12054921|FG003|Overall Study|Withdrawal by Subject|1
7640536|NCT02257489|12054922|FG004|Overall Study|Withdrawal by Subject|0
7640537|NCT02257489|12054923|FG005|Overall Study|Withdrawal by Subject|0
7640538|NCT02257489|12054924|FG006|Overall Study|Withdrawal by Subject|0
7640539|NCT02257489|12054925|FG007|Overall Study|Withdrawal by Subject|0
7640540|NCT02257489|12054926|FG008|Overall Study|Withdrawal by Subject|0
7640541|NCT02254278|12054966|FG000|Overall Study|Protocol Violation|1
7640542|NCT02254278|12054967|FG001|Overall Study|Protocol Violation|1
7640543|NCT02253316|12054989|FG000|Consolidation|Progression|4
7640544|NCT02253316|12054990|FG001|Consolidation|Progression|0
7640545|NCT02253316|12054991|FG002|Consolidation|Progression|0
7640546|NCT02253316|12054989|FG000|Consolidation|Non-Compliance|1
7640547|NCT02253316|12054990|FG001|Consolidation|Non-Compliance|0
7640548|NCT02253316|12054991|FG002|Consolidation|Non-Compliance|0
7640549|NCT02253316|12054989|FG000|Consolidation|Patient Withdrew Logistical Concerns|2
7640550|NCT02253316|12054990|FG001|Consolidation|Patient Withdrew Logistical Concerns|0
7640551|NCT02253316|12054991|FG002|Consolidation|Patient Withdrew Logistical Concerns|0
7640552|NCT02253316|12054989|FG000|Consolidation|Secondary Malignancy|2
7640553|NCT02253316|12054990|FG001|Consolidation|Secondary Malignancy|0
7640554|NCT02253316|12054991|FG002|Consolidation|Secondary Malignancy|0
7640555|NCT02253316|12054989|FG000|Consolidation|Adverse Event|7
7640556|NCT02253316|12054990|FG001|Consolidation|Adverse Event|0
7640557|NCT02253316|12054991|FG002|Consolidation|Adverse Event|0
7640558|NCT02253316|12054989|FG000|Maintenance|Patient Withdrew Logistical Concerns|0
7640559|NCT02253316|12054990|FG001|Maintenance|Patient Withdrew Logistical Concerns|7
7640560|NCT02253316|12054991|FG002|Maintenance|Patient Withdrew Logistical Concerns|7
7640561|NCT02253316|12054989|FG000|Maintenance|Physician Decision|0
7640562|NCT02253316|12054990|FG001|Maintenance|Physician Decision|5
7640563|NCT02253316|12054991|FG002|Maintenance|Physician Decision|16
7640564|NCT02253316|12054989|FG000|Maintenance|Non-Compliance|0
7640565|NCT02253316|12054990|FG001|Maintenance|Non-Compliance|1
7640566|NCT02253316|12054991|FG002|Maintenance|Non-Compliance|0
7640567|NCT02253316|12054989|FG000|Maintenance|Secondary Malignancy|0
7640568|NCT02253316|12054990|FG001|Maintenance|Secondary Malignancy|1
7640569|NCT02253316|12054991|FG002|Maintenance|Secondary Malignancy|5
7640570|NCT02253316|12054989|FG000|Maintenance|Adverse Event|0
7640571|NCT02253316|12054990|FG001|Maintenance|Adverse Event|8
7640572|NCT02253316|12054991|FG002|Maintenance|Adverse Event|12
7640573|NCT02253316|12054989|FG000|Maintenance|Still receiving active treatment|0
7640574|NCT02253316|12054990|FG001|Maintenance|Still receiving active treatment|23
7640575|NCT02253316|12054991|FG002|Maintenance|Still receiving active treatment|26
7640576|NCT02252172|12055001|FG000|Overall Study|Lost to Follow-up|3
7640577|NCT02252172|12055002|FG001|Overall Study|Lost to Follow-up|1
7640578|NCT02252172|12055001|FG000|Overall Study|Ongoing|276
7640579|NCT02252172|12055002|FG001|Overall Study|Ongoing|298
7640580|NCT02252042|12055010|FG000|Overall Study|Death|170
7640581|NCT02252042|12055011|FG001|Overall Study|Death|192
7640582|NCT02252042|12055010|FG000|Overall Study|Physician Decision|0
7640583|NCT02252042|12055011|FG001|Overall Study|Physician Decision|1
7640584|NCT02252042|12055010|FG000|Overall Study|Withdrawal by Subject|13
7640585|NCT02252042|12055011|FG001|Overall Study|Withdrawal by Subject|20
7640586|NCT02252042|12055010|FG000|Overall Study|Ongoing in study|64
7640587|NCT02252042|12055011|FG001|Overall Study|Ongoing in study|35
7640588|NCT02246621|12055027|FG000|Overall Study|Withdrawal by Subject|28
7640589|NCT02246621|12055028|FG001|Overall Study|Withdrawal by Subject|16
7640590|NCT02246621|12055027|FG000|Overall Study|Lost to Follow-up|1
7640591|NCT02246621|12055028|FG001|Overall Study|Lost to Follow-up|0
7640592|NCT02246621|12055027|FG000|Overall Study|On Study Treatment/ Follow Up|236
7640593|NCT02246621|12055028|FG001|Overall Study|On Study Treatment/ Follow Up|119
7640594|NCT02243605|12055036|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1
7640595|NCT02243605|12055037|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1
7640596|NCT02243605|12055036|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1
7640597|NCT02243605|12055037|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0
7640598|NCT02243605|12055036|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5
7640599|NCT02243605|12055037|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1
7640600|NCT02243605|12055036|FG000|Stage 2 - Final Analysis Population|Adverse Event|1
7640601|NCT02243605|12055037|FG001|Stage 2 - Final Analysis Population|Adverse Event|1
7640602|NCT02243605|12055036|FG000|Stage 2 - Final Analysis Population|Progression|0
7640603|NCT02243605|12055037|FG001|Stage 2 - Final Analysis Population|Progression|1
7640604|NCT02242435|12055054|FG000|Overall Study|Lost to Follow-up|3
7640605|NCT02242435|12055055|FG001|Overall Study|Lost to Follow-up|4
7640606|NCT02242435|12055054|FG000|Overall Study|Adverse Event|3
7640607|NCT02242435|12055055|FG001|Overall Study|Adverse Event|2
7640608|NCT02242435|12055054|FG000|Overall Study|Withdrawal by Subject|13
7640609|NCT02242435|12055055|FG001|Overall Study|Withdrawal by Subject|8
7640610|NCT02242435|12055054|FG000|Overall Study|Death|0
7640611|NCT02242435|12055055|FG001|Overall Study|Death|1
7640612|NCT02242435|12055054|FG000|Overall Study|Protocol Violation|1
7640613|NCT02242435|12055055|FG001|Overall Study|Protocol Violation|0
7640614|NCT02242435|12055054|FG000|Overall Study|Physician Decision|0
7640615|NCT02242435|12055055|FG001|Overall Study|Physician Decision|1
7640616|NCT02230189|12055064|FG000|Overall Study|Withdrawal by Subject|3
7640617|NCT02230189|12055065|FG001|Overall Study|Withdrawal by Subject|0
7640618|NCT02230189|12055066|FG002|Overall Study|Withdrawal by Subject|1
7640619|NCT02230189|12055064|FG000|Overall Study|Lost to Follow-up|1
7640620|NCT02230189|12055065|FG001|Overall Study|Lost to Follow-up|0
7640621|NCT02230189|12055066|FG002|Overall Study|Lost to Follow-up|0
7640622|NCT02230189|12055064|FG000|Overall Study|Physician Decision|1
7640623|NCT02230189|12055065|FG001|Overall Study|Physician Decision|0
7640624|NCT02230189|12055066|FG002|Overall Study|Physician Decision|0
7640625|NCT02224703|12055091|FG000|Overall Study|Adverse Event|0
7640626|NCT02224703|12055092|FG001|Overall Study|Adverse Event|5
7640627|NCT02224703|12055093|FG002|Overall Study|Adverse Event|0
7640628|NCT02224703|12055091|FG000|Overall Study|Withdrawn by investigator|1
7640629|NCT02224703|12055092|FG001|Overall Study|Withdrawn by investigator|0
7640630|NCT02224703|12055093|FG002|Overall Study|Withdrawn by investigator|0
7640631|NCT02224703|12055091|FG000|Overall Study|Advised by medical monitor|1
7640632|NCT02224703|12055092|FG001|Overall Study|Advised by medical monitor|0
7640633|NCT02224703|12055093|FG002|Overall Study|Advised by medical monitor|0
7640634|NCT02224703|12055091|FG000|Overall Study|Withdrawn by parent/guardian|0
7640635|NCT02224703|12055092|FG001|Overall Study|Withdrawn by parent/guardian|1
7640636|NCT02224703|12055093|FG002|Overall Study|Withdrawn by parent/guardian|0
7640637|NCT02224703|12055091|FG000|Overall Study|Lack of Efficacy|1
7640638|NCT02224703|12055092|FG001|Overall Study|Lack of Efficacy|0
7640639|NCT02224703|12055093|FG002|Overall Study|Lack of Efficacy|0
7640640|NCT02224690|12055104|FG000|Overall Study|Adverse Event|8
7640641|NCT02224690|12055105|FG001|Overall Study|Adverse Event|1
7640642|NCT02224690|12055104|FG000|Overall Study|Met Withdrawal Criteria|4
7640643|NCT02224690|12055105|FG001|Overall Study|Met Withdrawal Criteria|0
7640644|NCT02224690|12055104|FG000|Overall Study|Use of G-tube|1
7640645|NCT02224690|12055105|FG001|Overall Study|Use of G-tube|0
7640646|NCT02224690|12055104|FG000|Overall Study|Did not meet eligibility criteria|1
7640647|NCT02224690|12055105|FG001|Overall Study|Did not meet eligibility criteria|0
7640648|NCT02224560|12055114|FG000|Overall Study|Protocol Deviation|1
7640649|NCT02224560|12055115|FG001|Overall Study|Protocol Deviation|0
7640650|NCT02224560|12055116|FG002|Overall Study|Protocol Deviation|0
7640651|NCT02224560|12055114|FG000|Overall Study|Withdrawal by Subject|2
7640652|NCT02224560|12055115|FG001|Overall Study|Withdrawal by Subject|0
7640653|NCT02224560|12055116|FG002|Overall Study|Withdrawal by Subject|1
7640654|NCT02224560|12055114|FG000|Overall Study|Met Withdrawal Criteria|1
7640655|NCT02224560|12055115|FG001|Overall Study|Met Withdrawal Criteria|0
7640656|NCT02224560|12055116|FG002|Overall Study|Met Withdrawal Criteria|0
7640657|NCT02224560|12055114|FG000|Overall Study|Adverse Event|4
7640658|NCT02224560|12055115|FG001|Overall Study|Adverse Event|1
7640659|NCT02224560|12055116|FG002|Overall Study|Adverse Event|1
7640660|NCT02224560|12055114|FG000|Overall Study|Withdrawn by Investigator|1
7640661|NCT02224560|12055115|FG001|Overall Study|Withdrawn by Investigator|1
7640662|NCT02224560|12055116|FG002|Overall Study|Withdrawn by Investigator|0
7640663|NCT02224391|12055126|FG000|Overall Study|Lost to Follow-up|26
7640664|NCT02224391|12055127|FG001|Overall Study|Lost to Follow-up|19
7640665|NCT02224391|12055126|FG000|Overall Study|Withdrawal by Subject|6
7640666|NCT02224391|12055127|FG001|Overall Study|Withdrawal by Subject|5
7640667|NCT02220894|12055135|FG000|Overall Study|Adverse Event|118
7640668|NCT02220894|12055136|FG001|Overall Study|Adverse Event|70
7640669|NCT02220894|12055135|FG000|Overall Study|Death|252
7640670|NCT02220894|12055136|FG001|Overall Study|Death|368
7640671|NCT02220894|12055135|FG000|Overall Study|Lost to Follow-up|0
7640672|NCT02220894|12055136|FG001|Overall Study|Lost to Follow-up|2
7640673|NCT02220894|12055135|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7640674|NCT02220894|12055136|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7640675|NCT02220894|12055135|FG000|Overall Study|Withdrawal by Subject|2
7640676|NCT02220894|12055136|FG001|Overall Study|Withdrawal by Subject|13
7640677|NCT02220894|12055135|FG000|Overall Study|Ongoing in Study|265
7640678|NCT02220894|12055136|FG001|Overall Study|Ongoing in Study|183
7640679|NCT02203513|12055167|FG000|Overall Study|Refused further treatment|2
7640680|NCT02203513|12055168|FG001|Overall Study|Refused further treatment|0
7640681|NCT02203513|12055169|FG002|Overall Study|Refused further treatment|1
7640682|NCT02203513|12055170|FG003|Overall Study|Refused further treatment|0
7640683|NCT02203513|12055171|FG004|Overall Study|Refused further treatment|0
7640684|NCT02203513|12055167|FG000|Overall Study|Switched to alternative treatment|3
7640685|NCT02203513|12055168|FG001|Overall Study|Switched to alternative treatment|4
7640686|NCT02203513|12055169|FG002|Overall Study|Switched to alternative treatment|0
7640687|NCT02203513|12055170|FG003|Overall Study|Switched to alternative treatment|0
7640688|NCT02203513|12055171|FG004|Overall Study|Switched to alternative treatment|4
7640689|NCT02203513|12055167|FG000|Overall Study|Did not receive investigational product (IP)|0
7640690|NCT02203513|12055168|FG001|Overall Study|Did not receive investigational product (IP)|1
7640691|NCT02203513|12055169|FG002|Overall Study|Did not receive investigational product (IP)|0
7640692|NCT02203513|12055170|FG003|Overall Study|Did not receive investigational product (IP)|0
7640693|NCT02203513|12055171|FG004|Overall Study|Did not receive investigational product (IP)|0
7640694|NCT02203513|12055167|FG000|Overall Study|Death (unrelated to study therapy)|1
7640695|NCT02203513|12055168|FG001|Overall Study|Death (unrelated to study therapy)|3
7640696|NCT02203513|12055169|FG002|Overall Study|Death (unrelated to study therapy)|1
7640697|NCT02203513|12055170|FG003|Overall Study|Death (unrelated to study therapy)|0
7640698|NCT02203513|12055171|FG004|Overall Study|Death (unrelated to study therapy)|2
7640699|NCT02203513|12055167|FG000|Overall Study|Lost to Follow-up|0
7640700|NCT02203513|12055168|FG001|Overall Study|Lost to Follow-up|0
7640701|NCT02203513|12055169|FG002|Overall Study|Lost to Follow-up|1
7640702|NCT02203513|12055170|FG003|Overall Study|Lost to Follow-up|1
7640703|NCT02203513|12055171|FG004|Overall Study|Lost to Follow-up|0
7640704|NCT02200445|12055188|FG000|Overall Study|Lack of Efficacy|1
7640705|NCT02200445|12055189|FG001|Overall Study|Lack of Efficacy|2
7640706|NCT02200445|12055190|FG002|Overall Study|Lack of Efficacy|2
7640707|NCT02200445|12055188|FG000|Overall Study|Adverse Event|0
7640708|NCT02200445|12055189|FG001|Overall Study|Adverse Event|2
7640709|NCT02200445|12055190|FG002|Overall Study|Adverse Event|0
7640710|NCT02197234|12055198|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
7640711|NCT02197234|12055198|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
7640712|NCT02197234|12055198|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
7640713|NCT02197234|12055198|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
7640714|NCT02197234|12055198|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
7640715|NCT02197234|12055198|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6
7640716|NCT02197234|12055198|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
7640717|NCT02195479|12055207|FG000|Overall Study|Lost to Follow-up|3
7640718|NCT02195479|12055208|FG001|Overall Study|Lost to Follow-up|0
7640719|NCT02195479|12055207|FG000|Overall Study|Death|48
7640720|NCT02195479|12055208|FG001|Overall Study|Death|45
7640721|NCT02195479|12055207|FG000|Overall Study|Physician Decision|1
7640722|NCT02195479|12055208|FG001|Overall Study|Physician Decision|0
7640723|NCT02195479|12055207|FG000|Overall Study|Withdrawal by Subject|11
7640724|NCT02195479|12055208|FG001|Overall Study|Withdrawal by Subject|6
7640725|NCT02195479|12055207|FG000|Overall Study|Other|2
7640726|NCT02195479|12055208|FG001|Overall Study|Other|2
7640727|NCT02195479|12055207|FG000|Overall Study|Ongoing|291
7640728|NCT02195479|12055208|FG001|Overall Study|Ongoing|297
7640729|NCT02186834|12055214|FG000|Dose Escalation|Death|0
7640730|NCT02186834|12055215|FG001|Dose Escalation|Death|0
7640731|NCT02186834|12055216|FG002|Dose Escalation|Death|0
7640732|NCT02186834|12055217|FG003|Dose Escalation|Death|1
7640733|NCT02186834|12055218|FG004|Dose Escalation|Death|0
7640734|NCT02186834|12055219|FG005|Dose Escalation|Death|0
7640735|NCT02186834|12055214|FG000|Treatment at RP2D|Died prior to treatment|0
7640736|NCT02186834|12055215|FG001|Treatment at RP2D|Died prior to treatment|0
7640737|NCT02186834|12055216|FG002|Treatment at RP2D|Died prior to treatment|0
7640738|NCT02186834|12055217|FG003|Treatment at RP2D|Died prior to treatment|0
7640739|NCT02186834|12055218|FG004|Treatment at RP2D|Died prior to treatment|0
7640740|NCT02186834|12055219|FG005|Treatment at RP2D|Died prior to treatment|1
7640741|NCT02184195|12055230|FG000|Overall Study|Patients ongoing Study Treatment|19
7640742|NCT02184195|12055231|FG001|Overall Study|Patients ongoing Study Treatment|7
7640743|NCT02180867|12055244|FG000|Overall Study|Adverse Event|3
7640744|NCT02180867|12055245|FG001|Overall Study|Adverse Event|4
7640745|NCT02180867|12055246|FG002|Overall Study|Adverse Event|1
7640746|NCT02180867|12055247|FG003|Overall Study|Adverse Event|5
7640747|NCT02180867|12055248|FG004|Overall Study|Adverse Event|0
7640748|NCT02180867|12055249|FG005|Overall Study|Adverse Event|0
7640749|NCT02180867|12055250|FG006|Overall Study|Adverse Event|0
7640750|NCT02180867|12055244|FG000|Overall Study|Death|0
7640751|NCT02180867|12055245|FG001|Overall Study|Death|0
7640752|NCT02180867|12055246|FG002|Overall Study|Death|0
7640753|NCT02180867|12055247|FG003|Overall Study|Death|0
7640754|NCT02180867|12055248|FG004|Overall Study|Death|1
7640755|NCT02180867|12055249|FG005|Overall Study|Death|0
7640756|NCT02180867|12055250|FG006|Overall Study|Death|0
7640757|NCT02180867|12055244|FG000|Overall Study|Lack of Efficacy|0
7640758|NCT02180867|12055245|FG001|Overall Study|Lack of Efficacy|2
7640759|NCT02180867|12055246|FG002|Overall Study|Lack of Efficacy|0
7640760|NCT02180867|12055247|FG003|Overall Study|Lack of Efficacy|1
7640761|NCT02180867|12055248|FG004|Overall Study|Lack of Efficacy|6
7640762|NCT02180867|12055249|FG005|Overall Study|Lack of Efficacy|0
7640763|NCT02180867|12055250|FG006|Overall Study|Lack of Efficacy|1
7640764|NCT02180867|12055244|FG000|Overall Study|Physician Decision|1
7640765|NCT02180867|12055245|FG001|Overall Study|Physician Decision|3
7640766|NCT02180867|12055246|FG002|Overall Study|Physician Decision|1
7640767|NCT02180867|12055247|FG003|Overall Study|Physician Decision|10
7640768|NCT02180867|12055248|FG004|Overall Study|Physician Decision|9
7640769|NCT02180867|12055249|FG005|Overall Study|Physician Decision|3
7640770|NCT02180867|12055250|FG006|Overall Study|Physician Decision|4
7640771|NCT02180867|12055244|FG000|Overall Study|Withdrawal by Subject|0
7640772|NCT02180867|12055245|FG001|Overall Study|Withdrawal by Subject|0
7640773|NCT02180867|12055246|FG002|Overall Study|Withdrawal by Subject|0
7640774|NCT02180867|12055247|FG003|Overall Study|Withdrawal by Subject|1
7640775|NCT02180867|12055248|FG004|Overall Study|Withdrawal by Subject|1
7640776|NCT02180867|12055249|FG005|Overall Study|Withdrawal by Subject|0
7640777|NCT02180867|12055250|FG006|Overall Study|Withdrawal by Subject|0
7640778|NCT02180867|12055244|FG000|Overall Study|Ineligible|1
7640779|NCT02180867|12055245|FG001|Overall Study|Ineligible|2
7640780|NCT02180867|12055246|FG002|Overall Study|Ineligible|0
7640781|NCT02180867|12055247|FG003|Overall Study|Ineligible|3
7640782|NCT02180867|12055248|FG004|Overall Study|Ineligible|5
7640783|NCT02180867|12055249|FG005|Overall Study|Ineligible|0
7640784|NCT02180867|12055250|FG006|Overall Study|Ineligible|0
7640785|NCT02180867|12055244|FG000|Overall Study|Repeat Eligibility Studies|0
7640786|NCT02180867|12055245|FG001|Overall Study|Repeat Eligibility Studies|0
7640787|NCT02180867|12055246|FG002|Overall Study|Repeat Eligibility Studies|0
7640788|NCT02180867|12055247|FG003|Overall Study|Repeat Eligibility Studies|0
7640789|NCT02180867|12055248|FG004|Overall Study|Repeat Eligibility Studies|1
7640790|NCT02180867|12055249|FG005|Overall Study|Repeat Eligibility Studies|0
7640791|NCT02180867|12055250|FG006|Overall Study|Repeat Eligibility Studies|0
7640792|NCT02180867|12055244|FG000|Overall Study|Refusal of further protocol therapy|1
7640793|NCT02180867|12055245|FG001|Overall Study|Refusal of further protocol therapy|0
7640794|NCT02180867|12055246|FG002|Overall Study|Refusal of further protocol therapy|2
7640795|NCT02180867|12055247|FG003|Overall Study|Refusal of further protocol therapy|6
7640796|NCT02180867|12055248|FG004|Overall Study|Refusal of further protocol therapy|4
7640797|NCT02180867|12055249|FG005|Overall Study|Refusal of further protocol therapy|0
7640798|NCT02180867|12055250|FG006|Overall Study|Refusal of further protocol therapy|0
7640799|NCT02173379|12055280|FG000|Overall Study|Lost to Follow-up|48
7640800|NCT02173379|12055281|FG001|Overall Study|Lost to Follow-up|34
7640801|NCT02173379|12055280|FG000|Overall Study|Withdrawal by Subject|14
7640802|NCT02173379|12055281|FG001|Overall Study|Withdrawal by Subject|17
7640803|NCT02173379|12055280|FG000|Overall Study|Physician Decision|7
7640804|NCT02173379|12055281|FG001|Overall Study|Physician Decision|4
7640805|NCT02173379|12055280|FG000|Overall Study|Death|22
7640806|NCT02173379|12055281|FG001|Overall Study|Death|22
7640807|NCT02163733|12055312|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0
7640808|NCT02163733|12055313|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0
7640809|NCT02163733|12055314|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5
7640810|NCT02163733|12055312|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
7640811|NCT02163733|12055313|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
7640812|NCT02163733|12055314|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
7640813|NCT02157883|12055334|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
7640814|NCT02157883|12055334|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
7640815|NCT02157883|12055334|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
7640816|NCT02157883|12055334|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
7640817|NCT02157883|12055334|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3
7640818|NCT02155712|12055362|FG000|Primary Objective|Death|3
7640819|NCT02155712|12055363|FG001|Primary Objective|Death|0
7640820|NCT02155712|12055362|FG000|Primary Objective|Lost to Follow-up|22
7640821|NCT02155712|12055363|FG001|Primary Objective|Lost to Follow-up|0
7640822|NCT02155712|12055362|FG000|Primary Objective|No 2-Year Forms but not Terminated|13
7640823|NCT02155712|12055363|FG001|Primary Objective|No 2-Year Forms but not Terminated|0
7640824|NCT02155712|12055362|FG000|Primary Objective|Revision/Removal of Tibial Baseplate|1
7640825|NCT02155712|12055363|FG001|Primary Objective|Revision/Removal of Tibial Baseplate|0
7640826|NCT02155712|12055362|FG000|Primary Objective|Withdrawal by Subject|21
7640827|NCT02155712|12055363|FG001|Primary Objective|Withdrawal by Subject|0
7640828|NCT02152631|12055371|FG000|Overall Study|Adverse Event|32
7640829|NCT02152631|12055372|FG001|Overall Study|Adverse Event|4
7640830|NCT02152631|12055371|FG000|Overall Study|Withdrawal by Subject|13
7640831|NCT02152631|12055372|FG001|Overall Study|Withdrawal by Subject|16
7640832|NCT02152631|12055371|FG000|Overall Study|Noncompliance with study drug|1
7640833|NCT02152631|12055372|FG001|Overall Study|Noncompliance with study drug|0
7640834|NCT02152631|12055371|FG000|Overall Study|Physician Decision|1
7640835|NCT02152631|12055372|FG001|Overall Study|Physician Decision|2
7640836|NCT02152631|12055371|FG000|Overall Study|Lost to Follow-up|0
7640837|NCT02152631|12055372|FG001|Overall Study|Lost to Follow-up|1
7640838|NCT02152631|12055371|FG000|Overall Study|On Treatment|19
7640839|NCT02152631|12055372|FG001|Overall Study|On Treatment|3
7882356|NCT01769404|12381252|FG000|Treatment Period 2|Sponsor decision|7
7882357|NCT01769404|12381253|FG001|Treatment Period 2|Sponsor decision|0
7640842|NCT02136134|12055389|FG000|Overall Study|Death|35
7640843|NCT02136134|12055390|FG001|Overall Study|Death|29
7640844|NCT02136134|12055389|FG000|Overall Study|Withdrawal by Subject|14
7640845|NCT02136134|12055390|FG001|Overall Study|Withdrawal by Subject|4
7640846|NCT02136134|12055389|FG000|Overall Study|Other|3
7640847|NCT02136134|12055390|FG001|Overall Study|Other|3
7640848|NCT02136134|12055389|FG000|Overall Study|Ongoing|185
7640849|NCT02136134|12055390|FG001|Overall Study|Ongoing|207
7640850|NCT02136134|12055389|FG000|Overall Study|Subjects randomized but not treated|10
7640851|NCT02136134|12055390|FG001|Overall Study|Subjects randomized but not treated|8
7640852|NCT02134925|12055398|FG000|Overall Study|Withdrawal by Subject|1
7640853|NCT02134925|12055399|FG001|Overall Study|Withdrawal by Subject|0
7640854|NCT02134925|12055398|FG000|Overall Study|Cancel|1
7640855|NCT02134925|12055399|FG001|Overall Study|Cancel|6
7640856|NCT02130466|12055419|FG000|Overall Study|Death|4
7640857|NCT02130466|12055420|FG001|Overall Study|Death|1
7640858|NCT02130466|12055421|FG002|Overall Study|Death|1
7640859|NCT02130466|12055422|FG003|Overall Study|Death|3
7640860|NCT02130466|12055423|FG004|Overall Study|Death|2
7640861|NCT02130466|12055424|FG005|Overall Study|Death|30
7640862|NCT02130466|12055425|FG006|Overall Study|Death|45
7640863|NCT02130466|12055426|FG007|Overall Study|Death|2
7640864|NCT02130466|12055427|FG008|Overall Study|Death|3
7640865|NCT02130466|12055428|FG009|Overall Study|Death|4
7640866|NCT02130466|12055429|FG010|Overall Study|Death|5
7640867|NCT02130466|12055430|FG011|Overall Study|Death|3
7640868|NCT02130466|12055431|FG012|Overall Study|Death|11
7640869|NCT02130466|12055432|FG013|Overall Study|Death|7
7640870|NCT02130466|12055419|FG000|Overall Study|Lost to Follow-up|1
7640871|NCT02130466|12055420|FG001|Overall Study|Lost to Follow-up|0
7640872|NCT02130466|12055421|FG002|Overall Study|Lost to Follow-up|0
7640873|NCT02130466|12055422|FG003|Overall Study|Lost to Follow-up|0
7640874|NCT02130466|12055423|FG004|Overall Study|Lost to Follow-up|0
7640875|NCT02130466|12055424|FG005|Overall Study|Lost to Follow-up|1
7640876|NCT02130466|12055425|FG006|Overall Study|Lost to Follow-up|0
7640877|NCT02130466|12055426|FG007|Overall Study|Lost to Follow-up|0
7640878|NCT02130466|12055427|FG008|Overall Study|Lost to Follow-up|0
7640879|NCT02130466|12055428|FG009|Overall Study|Lost to Follow-up|0
7640880|NCT02130466|12055429|FG010|Overall Study|Lost to Follow-up|0
7640881|NCT02130466|12055430|FG011|Overall Study|Lost to Follow-up|0
7640882|NCT02130466|12055431|FG012|Overall Study|Lost to Follow-up|1
7640883|NCT02130466|12055432|FG013|Overall Study|Lost to Follow-up|0
7640884|NCT02130466|12055419|FG000|Overall Study|Physician Decision|0
7640885|NCT02130466|12055420|FG001|Overall Study|Physician Decision|0
7640886|NCT02130466|12055421|FG002|Overall Study|Physician Decision|0
7640887|NCT02130466|12055422|FG003|Overall Study|Physician Decision|0
7640888|NCT02130466|12055423|FG004|Overall Study|Physician Decision|0
7640889|NCT02130466|12055424|FG005|Overall Study|Physician Decision|1
7640890|NCT02130466|12055425|FG006|Overall Study|Physician Decision|1
7640891|NCT02130466|12055426|FG007|Overall Study|Physician Decision|0
7640892|NCT02130466|12055427|FG008|Overall Study|Physician Decision|0
7640893|NCT02130466|12055428|FG009|Overall Study|Physician Decision|0
7640894|NCT02130466|12055429|FG010|Overall Study|Physician Decision|0
7640895|NCT02130466|12055430|FG011|Overall Study|Physician Decision|0
7640896|NCT02130466|12055431|FG012|Overall Study|Physician Decision|0
7640897|NCT02130466|12055432|FG013|Overall Study|Physician Decision|0
7640898|NCT02130466|12055419|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1
7640899|NCT02130466|12055420|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2
7640900|NCT02130466|12055421|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1
7640901|NCT02130466|12055422|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5
7640902|NCT02130466|12055423|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0
7640903|NCT02130466|12055424|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27
7640904|NCT02130466|12055425|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14
7640905|NCT02130466|12055426|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1
7640906|NCT02130466|12055427|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0
7640907|NCT02130466|12055428|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1
7640908|NCT02130466|12055429|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1
7640909|NCT02130466|12055430|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0
7640910|NCT02130466|12055431|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0
7640911|NCT02130466|12055432|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2
7640912|NCT02130466|12055419|FG000|Overall Study|Withdrawal by Subject|1
7640913|NCT02130466|12055420|FG001|Overall Study|Withdrawal by Subject|0
7640914|NCT02130466|12055421|FG002|Overall Study|Withdrawal by Subject|0
7640915|NCT02130466|12055422|FG003|Overall Study|Withdrawal by Subject|0
7640916|NCT02130466|12055423|FG004|Overall Study|Withdrawal by Subject|0
7640917|NCT02130466|12055424|FG005|Overall Study|Withdrawal by Subject|1
7640918|NCT02130466|12055425|FG006|Overall Study|Withdrawal by Subject|0
7640919|NCT02130466|12055426|FG007|Overall Study|Withdrawal by Subject|0
7640920|NCT02130466|12055427|FG008|Overall Study|Withdrawal by Subject|1
7640921|NCT02130466|12055428|FG009|Overall Study|Withdrawal by Subject|0
7640922|NCT02130466|12055429|FG010|Overall Study|Withdrawal by Subject|0
7640923|NCT02130466|12055430|FG011|Overall Study|Withdrawal by Subject|0
7640924|NCT02130466|12055431|FG012|Overall Study|Withdrawal by Subject|0
7640925|NCT02130466|12055432|FG013|Overall Study|Withdrawal by Subject|0
7640926|NCT02126969|12055485|FG000|Overall Study|Withdrawal by Subject|1
7640927|NCT02126969|12055486|FG001|Overall Study|Withdrawal by Subject|2
7640928|NCT02125461|12055494|FG000|Overall Study|Withdrawal by Subject|30
7640929|NCT02125461|12055495|FG001|Overall Study|Withdrawal by Subject|16
7640930|NCT02125461|12055494|FG000|Overall Study|Lost to Follow-up|8
7640931|NCT02125461|12055495|FG001|Overall Study|Lost to Follow-up|3
7640932|NCT02125461|12055494|FG000|Overall Study|Death|260
7640933|NCT02125461|12055495|FG001|Overall Study|Death|149
7640934|NCT02125461|12055494|FG000|Overall Study|Missing Termination Reason|0
7640935|NCT02125461|12055495|FG001|Overall Study|Missing Termination Reason|1
7640936|NCT02120352|12055510|FG000|Induction Period (20 Weeks)|Adverse Event|3
7640937|NCT02120352|12055511|FG001|Induction Period (20 Weeks)|Adverse Event|0
7640938|NCT02120352|12055512|FG002|Induction Period (20 Weeks)|Adverse Event|0
7640939|NCT02120352|12055513|FG003|Induction Period (20 Weeks)|Adverse Event|0
7640940|NCT02120352|12055510|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5
7640941|NCT02120352|12055511|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0
7640942|NCT02120352|12055512|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0
7640943|NCT02120352|12055513|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0
7640944|NCT02120352|12055510|FG000|Induction Period (20 Weeks)|Protocol Violation|2
7640945|NCT02120352|12055511|FG001|Induction Period (20 Weeks)|Protocol Violation|0
7640946|NCT02120352|12055512|FG002|Induction Period (20 Weeks)|Protocol Violation|0
7640947|NCT02120352|12055513|FG003|Induction Period (20 Weeks)|Protocol Violation|0
7640948|NCT02120352|12055510|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3
7640949|NCT02120352|12055511|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
7640950|NCT02120352|12055512|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
7640951|NCT02120352|12055513|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
7640952|NCT02120352|12055510|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2
7640953|NCT02120352|12055511|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0
7640954|NCT02120352|12055512|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0
7640955|NCT02120352|12055513|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0
7640956|NCT02120352|12055510|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5
7640957|NCT02120352|12055511|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0
7640958|NCT02120352|12055512|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0
7640959|NCT02120352|12055513|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0
7640960|NCT02120352|12055510|FG000|Induction Period (20 Weeks)|Physician Decision|1
7640961|NCT02120352|12055511|FG001|Induction Period (20 Weeks)|Physician Decision|0
7640962|NCT02120352|12055512|FG002|Induction Period (20 Weeks)|Physician Decision|0
7640963|NCT02120352|12055513|FG003|Induction Period (20 Weeks)|Physician Decision|0
7640964|NCT02120352|12055510|FG000|Maintenance Period (32 Weeks)|Adverse Event|0
7640965|NCT02120352|12055511|FG001|Maintenance Period (32 Weeks)|Adverse Event|0
7640966|NCT02120352|12055512|FG002|Maintenance Period (32 Weeks)|Adverse Event|6
7640967|NCT02120352|12055513|FG003|Maintenance Period (32 Weeks)|Adverse Event|1
7640968|NCT02120352|12055510|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0
7640969|NCT02120352|12055511|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1
7640970|NCT02120352|12055512|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0
7640971|NCT02120352|12055513|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1
7640972|NCT02120352|12055510|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0
7640973|NCT02120352|12055511|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0
7640974|NCT02120352|12055512|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2
7640975|NCT02120352|12055513|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0
7640976|NCT02120352|12055510|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
7640977|NCT02120352|12055511|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
7640978|NCT02120352|12055512|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
7640979|NCT02120352|12055513|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
7640980|NCT02120352|12055510|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0
7640981|NCT02120352|12055511|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0
7640982|NCT02120352|12055512|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0
7640983|NCT02120352|12055513|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1
7640984|NCT02120352|12055510|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0
7640985|NCT02120352|12055511|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
7640986|NCT02120352|12055512|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1
7640987|NCT02120352|12055513|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
7640988|NCT02120352|12055510|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0
7640989|NCT02120352|12055511|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112
7640990|NCT02120352|12055512|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105
7640991|NCT02120352|12055513|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50
7640992|NCT02119416|12055530|FG000|Overall Study|Protocol Violation|1
7640993|NCT02119416|12055531|FG001|Overall Study|Protocol Violation|1
7640994|NCT02119416|12055532|FG002|Overall Study|Protocol Violation|1
7640995|NCT02119416|12055530|FG000|Overall Study|wrong pubertal stage|1
7640996|NCT02119416|12055531|FG001|Overall Study|wrong pubertal stage|0
7640997|NCT02119416|12055532|FG002|Overall Study|wrong pubertal stage|1
7640998|NCT02108652|12055572|FG000|Overall Study|Death|226
7640999|NCT02108652|12055572|FG000|Overall Study|Lost to Follow-up|2
7641000|NCT02108652|12055572|FG000|Overall Study|Withdrawal by Subject|8
7641001|NCT02108652|12055572|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74
7641002|NCT02106351|12055579|FG000|Treatment Cycle 1|Adverse Event|2
7641003|NCT02106351|12055580|FG001|Treatment Cycle 1|Adverse Event|0
7641004|NCT02106351|12055581|FG002|Treatment Cycle 1|Adverse Event|0
7641005|NCT02106351|12055579|FG000|Treatment Cycle 1|Consent withdrawn|1
7641006|NCT02106351|12055580|FG001|Treatment Cycle 1|Consent withdrawn|0
7641007|NCT02106351|12055581|FG002|Treatment Cycle 1|Consent withdrawn|2
7641008|NCT02106351|12055579|FG000|Treatment Cycle 1|Lost to Follow-up|1
7641009|NCT02106351|12055580|FG001|Treatment Cycle 1|Lost to Follow-up|0
7641010|NCT02106351|12055581|FG002|Treatment Cycle 1|Lost to Follow-up|0
7641011|NCT02106351|12055579|FG000|Treatment Cycle 1|Other|0
7641012|NCT02106351|12055580|FG001|Treatment Cycle 1|Other|3
7641013|NCT02106351|12055581|FG002|Treatment Cycle 1|Other|1
7641014|NCT02106351|12055579|FG000|Treatment Cycle 1|Randomised but not treated|1
7641015|NCT02106351|12055580|FG001|Treatment Cycle 1|Randomised but not treated|0
7641016|NCT02106351|12055581|FG002|Treatment Cycle 1|Randomised but not treated|1
7641017|NCT02106351|12055579|FG000|Treatment Cycle 2|Adverse Event|0
7641018|NCT02106351|12055580|FG001|Treatment Cycle 2|Adverse Event|2
7641019|NCT02106351|12055581|FG002|Treatment Cycle 2|Adverse Event|0
7641020|NCT02106351|12055579|FG000|Treatment Cycle 2|Consent withdrawn|0
7641021|NCT02106351|12055580|FG001|Treatment Cycle 2|Consent withdrawn|1
7641022|NCT02106351|12055581|FG002|Treatment Cycle 2|Consent withdrawn|1
7641023|NCT02106351|12055579|FG000|Treatment Cycle 2|Other|0
7641024|NCT02106351|12055580|FG001|Treatment Cycle 2|Other|2
7641025|NCT02106351|12055581|FG002|Treatment Cycle 2|Other|2
7641026|NCT02106351|12055579|FG000|Treatment Cycle 3|Adverse Event|0
7641027|NCT02106351|12055580|FG001|Treatment Cycle 3|Adverse Event|1
7641028|NCT02106351|12055581|FG002|Treatment Cycle 3|Adverse Event|0
7641029|NCT02106351|12055579|FG000|Treatment Cycle 3|Consent withdrawn|0
7641030|NCT02106351|12055580|FG001|Treatment Cycle 3|Consent withdrawn|0
7641031|NCT02106351|12055581|FG002|Treatment Cycle 3|Consent withdrawn|2
7641032|NCT02106351|12055579|FG000|Treatment Cycle 3|Lost to Follow-up|0
7641033|NCT02106351|12055580|FG001|Treatment Cycle 3|Lost to Follow-up|1
7641034|NCT02106351|12055581|FG002|Treatment Cycle 3|Lost to Follow-up|0
7641035|NCT02106351|12055579|FG000|Treatment Cycle 3|Other|0
7641036|NCT02106351|12055580|FG001|Treatment Cycle 3|Other|2
7641037|NCT02106351|12055581|FG002|Treatment Cycle 3|Other|3
7641038|NCT02106351|12055579|FG000|Treatment Cycle 4|Consent withdrawn|0
7641039|NCT02106351|12055580|FG001|Treatment Cycle 4|Consent withdrawn|0
7641040|NCT02106351|12055581|FG002|Treatment Cycle 4|Consent withdrawn|2
7641041|NCT02106351|12055579|FG000|Treatment Cycle 4|Other|0
7641042|NCT02106351|12055580|FG001|Treatment Cycle 4|Other|1
7641043|NCT02106351|12055581|FG002|Treatment Cycle 4|Other|0
7641044|NCT02098876|12055605|FG000|Overall Study|Withdrawal by Subject|5
7641045|NCT02098876|12055606|FG001|Overall Study|Withdrawal by Subject|5
7641046|NCT02094261|12055634|FG000|Overall Study|Death|24
7641047|NCT02094261|12055634|FG000|Overall Study|Lost to Follow-up|1
7641048|NCT02094261|12055634|FG000|Overall Study|Withdrawal by Subject|4
7641049|NCT02094261|12055634|FG000|Overall Study|Ongoing Study at Data Cut-off|181
7641050|NCT02091960|12055638|FG000|Overall Study|Death|7
7641051|NCT02091960|12055638|FG000|Overall Study|Withdrawal by Subject|1
7641052|NCT02091960|12055638|FG000|Overall Study|Miscellaneous Reasons|31
7641053|NCT02091960|12055638|FG000|Overall Study|On Study at Data Cut-off|12
7641054|NCT02091375|12055644|FG000|Overall Study|Adverse Event|8
7641055|NCT02091375|12055645|FG001|Overall Study|Adverse Event|1
7641056|NCT02091375|12055644|FG000|Overall Study|Lost to Follow-up|0
7641057|NCT02091375|12055645|FG001|Overall Study|Lost to Follow-up|1
7641058|NCT02091375|12055644|FG000|Overall Study|Withdrawal by Subject|0
7641059|NCT02091375|12055645|FG001|Overall Study|Withdrawal by Subject|1
7641060|NCT02091375|12055644|FG000|Overall Study|Withdrawn by the investigator|1
7641061|NCT02091375|12055645|FG001|Overall Study|Withdrawn by the investigator|0
7641062|NCT02091206|12055655|FG000|Treatment Period|Adverse Event|0
7641063|NCT02091206|12055656|FG001|Treatment Period|Adverse Event|1
7641064|NCT02091206|12055657|FG002|Treatment Period|Adverse Event|0
7641065|NCT02091206|12055658|FG003|Treatment Period|Adverse Event|0
7641066|NCT02091206|12055655|FG000|Treatment Period|Met withdrawal criteria|0
7641067|NCT02091206|12055656|FG001|Treatment Period|Met withdrawal criteria|0
7641068|NCT02091206|12055657|FG002|Treatment Period|Met withdrawal criteria|1
7641069|NCT02091206|12055658|FG003|Treatment Period|Met withdrawal criteria|0
7641070|NCT02091206|12055655|FG000|Taper Period|Participant refused study drug|1
7641071|NCT02091206|12055656|FG001|Taper Period|Participant refused study drug|0
7641072|NCT02091206|12055657|FG002|Taper Period|Participant refused study drug|0
7641073|NCT02091206|12055658|FG003|Taper Period|Participant refused study drug|1
7641074|NCT02091206|12055655|FG000|Taper Period|Lost to Follow-up|0
7641075|NCT02091206|12055656|FG001|Taper Period|Lost to Follow-up|0
7641076|NCT02091206|12055657|FG002|Taper Period|Lost to Follow-up|0
7641077|NCT02091206|12055658|FG003|Taper Period|Lost to Follow-up|1
7641078|NCT02089685|12055674|FG000|Overall Study|Adverse Event|1
7641079|NCT02089685|12055675|FG001|Overall Study|Adverse Event|0
7641080|NCT02089685|12055676|FG002|Overall Study|Adverse Event|0
7641081|NCT02089685|12055677|FG003|Overall Study|Adverse Event|0
7641082|NCT02089685|12055678|FG004|Overall Study|Adverse Event|1
7641083|NCT02089685|12055679|FG005|Overall Study|Adverse Event|0
7641084|NCT02089685|12055674|FG000|Overall Study|Clinical Progression|4
7641085|NCT02089685|12055675|FG001|Overall Study|Clinical Progression|0
7641086|NCT02089685|12055676|FG002|Overall Study|Clinical Progression|0
7641087|NCT02089685|12055677|FG003|Overall Study|Clinical Progression|5
7641088|NCT02089685|12055678|FG004|Overall Study|Clinical Progression|1
7641089|NCT02089685|12055679|FG005|Overall Study|Clinical Progression|2
7641090|NCT02089685|12055674|FG000|Overall Study|Excluded Medication|1
7641091|NCT02089685|12055675|FG001|Overall Study|Excluded Medication|0
7641092|NCT02089685|12055676|FG002|Overall Study|Excluded Medication|0
7641093|NCT02089685|12055677|FG003|Overall Study|Excluded Medication|11
7641094|NCT02089685|12055678|FG004|Overall Study|Excluded Medication|2
7641095|NCT02089685|12055679|FG005|Overall Study|Excluded Medication|1
7641096|NCT02089685|12055674|FG000|Overall Study|Progressive disease|13
7641097|NCT02089685|12055675|FG001|Overall Study|Progressive disease|10
7641098|NCT02089685|12055676|FG002|Overall Study|Progressive disease|3
7641099|NCT02089685|12055677|FG003|Overall Study|Progressive disease|51
7641100|NCT02089685|12055678|FG004|Overall Study|Progressive disease|17
7641101|NCT02089685|12055679|FG005|Overall Study|Progressive disease|12
7641102|NCT02089685|12055674|FG000|Overall Study|Follow up ended by sponsor|2
7641103|NCT02089685|12055675|FG001|Overall Study|Follow up ended by sponsor|2
7641104|NCT02089685|12055676|FG002|Overall Study|Follow up ended by sponsor|0
7641105|NCT02089685|12055677|FG003|Overall Study|Follow up ended by sponsor|70
7641106|NCT02089685|12055678|FG004|Overall Study|Follow up ended by sponsor|26
7641107|NCT02089685|12055679|FG005|Overall Study|Follow up ended by sponsor|26
7641108|NCT02089685|12055674|FG000|Overall Study|Withdrawal by Subject|0
7641109|NCT02089685|12055675|FG001|Overall Study|Withdrawal by Subject|2
7641110|NCT02089685|12055676|FG002|Overall Study|Withdrawal by Subject|0
7641111|NCT02089685|12055677|FG003|Overall Study|Withdrawal by Subject|8
7641112|NCT02089685|12055678|FG004|Overall Study|Withdrawal by Subject|1
7641113|NCT02089685|12055679|FG005|Overall Study|Withdrawal by Subject|1
7641114|NCT02089685|12055674|FG000|Overall Study|Status not recorded|1
7641115|NCT02089685|12055675|FG001|Overall Study|Status not recorded|0
7641116|NCT02089685|12055676|FG002|Overall Study|Status not recorded|0
7641117|NCT02089685|12055677|FG003|Overall Study|Status not recorded|0
7641118|NCT02089685|12055678|FG004|Overall Study|Status not recorded|1
7641119|NCT02089685|12055679|FG005|Overall Study|Status not recorded|0
7641120|NCT02089685|12055674|FG000|Overall Study|Death|0
7641121|NCT02089685|12055675|FG001|Overall Study|Death|0
7641122|NCT02089685|12055676|FG002|Overall Study|Death|0
7641123|NCT02089685|12055677|FG003|Overall Study|Death|7
7641124|NCT02089685|12055678|FG004|Overall Study|Death|2
7641125|NCT02089685|12055679|FG005|Overall Study|Death|5
7641126|NCT02089685|12055674|FG000|Overall Study|Lost to Follow-up|0
7641127|NCT02089685|12055675|FG001|Overall Study|Lost to Follow-up|0
7641128|NCT02089685|12055676|FG002|Overall Study|Lost to Follow-up|0
7641129|NCT02089685|12055677|FG003|Overall Study|Lost to Follow-up|1
7641130|NCT02089685|12055678|FG004|Overall Study|Lost to Follow-up|0
7641131|NCT02089685|12055679|FG005|Overall Study|Lost to Follow-up|0
7641132|NCT02089685|12055674|FG000|Overall Study|Physician Decision|0
7641133|NCT02089685|12055675|FG001|Overall Study|Physician Decision|0
7641134|NCT02089685|12055676|FG002|Overall Study|Physician Decision|0
7641135|NCT02089685|12055677|FG003|Overall Study|Physician Decision|0
7641136|NCT02089685|12055678|FG004|Overall Study|Physician Decision|0
7641137|NCT02089685|12055679|FG005|Overall Study|Physician Decision|4
7641138|NCT02089685|12055674|FG000|Overall Study|Screen failure|1
7641139|NCT02089685|12055675|FG001|Overall Study|Screen failure|0
7641140|NCT02089685|12055676|FG002|Overall Study|Screen failure|0
7641141|NCT02089685|12055677|FG003|Overall Study|Screen failure|0
7641142|NCT02089685|12055678|FG004|Overall Study|Screen failure|0
7641143|NCT02089685|12055679|FG005|Overall Study|Screen failure|0
7641144|NCT02085941|12055705|FG000|Overall Study|Lack of Efficacy|1
7641145|NCT02085941|12055706|FG001|Overall Study|Lack of Efficacy|0
7641146|NCT02085941|12055705|FG000|Overall Study|Death|6
7641147|NCT02085941|12055706|FG001|Overall Study|Death|1
7641148|NCT02085941|12055705|FG000|Overall Study|Lost to Follow-up|1
7641149|NCT02085941|12055706|FG001|Overall Study|Lost to Follow-up|0
7641150|NCT02085941|12055705|FG000|Overall Study|Physician Decision|0
7641151|NCT02085941|12055706|FG001|Overall Study|Physician Decision|2
7641152|NCT02080403|12055714|FG000|Overall Study|Adverse Event|5
7641153|NCT02080403|12055715|FG001|Overall Study|Adverse Event|1
7641154|NCT02080403|12055714|FG000|Overall Study|Death|0
7641155|NCT02080403|12055715|FG001|Overall Study|Death|2
7641156|NCT02080403|12055714|FG000|Overall Study|Lost to Follow-up|2
7641157|NCT02080403|12055715|FG001|Overall Study|Lost to Follow-up|0
7641158|NCT02080403|12055714|FG000|Overall Study|Pregnancy|0
7641159|NCT02080403|12055715|FG001|Overall Study|Pregnancy|1
7641160|NCT02080403|12055714|FG000|Overall Study|Protocol Violation|3
7641161|NCT02080403|12055715|FG001|Overall Study|Protocol Violation|7
7641162|NCT02080403|12055714|FG000|Overall Study|Withdrawal by Subject|5
7641163|NCT02080403|12055715|FG001|Overall Study|Withdrawal by Subject|1
7641164|NCT02080221|12055721|FG000|Overall Study|Withdrawal by Subject|1
7641165|NCT02080221|12055721|FG000|Overall Study|Clinical Progression of Disease|1
7641166|NCT02076113|12055727|FG000|Overall Study|Lost to Follow-up|4
7641167|NCT02076113|12055728|FG001|Overall Study|Lost to Follow-up|1
7641168|NCT02076113|12055727|FG000|Overall Study|Withdrawal by Subject|2
7641169|NCT02076113|12055728|FG001|Overall Study|Withdrawal by Subject|3
7641170|NCT02076113|12055727|FG000|Overall Study|Death|1
7641171|NCT02076113|12055728|FG001|Overall Study|Death|3
7641172|NCT02076009|12055739|FG000|Overall Study|Death|44
7641173|NCT02076009|12055740|FG001|Overall Study|Death|30
7641174|NCT02076009|12055739|FG000|Overall Study|Withdrawal by Subject|9
7641175|NCT02076009|12055740|FG001|Overall Study|Withdrawal by Subject|3
7641176|NCT02076009|12055739|FG000|Overall Study|Lost to Follow-up|1
7641177|NCT02076009|12055740|FG001|Overall Study|Lost to Follow-up|1
7641178|NCT02076009|12055739|FG000|Overall Study|Progressive disease|1
7641179|NCT02076009|12055740|FG001|Overall Study|Progressive disease|0
7641180|NCT02076009|12055739|FG000|Overall Study|Ongoing|226
7641181|NCT02076009|12055740|FG001|Overall Study|Ongoing|249
7641182|NCT02076009|12055739|FG000|Overall Study|Subjects randomized but not treated|2
7641183|NCT02076009|12055740|FG001|Overall Study|Subjects randomized but not treated|3
7641184|NCT02075840|12055748|FG000|Overall Study|Withdrawal by Subject|13
7641185|NCT02075840|12055749|FG001|Overall Study|Withdrawal by Subject|22
7641186|NCT02075840|12055748|FG000|Overall Study|Reason not specified|1
7641187|NCT02075840|12055749|FG001|Overall Study|Reason not specified|0
7641188|NCT02075840|12055748|FG000|Overall Study|Adverse Event|0
7641189|NCT02075840|12055749|FG001|Overall Study|Adverse Event|2
7641190|NCT02075840|12055748|FG000|Overall Study|Death|35
7641191|NCT02075840|12055749|FG001|Overall Study|Death|40
7641192|NCT02075840|12055748|FG000|Overall Study|Lost to Follow-up|3
7641193|NCT02075840|12055749|FG001|Overall Study|Lost to Follow-up|2
7641194|NCT02075840|12055748|FG000|Overall Study|Physician Decision|1
7641195|NCT02075840|12055749|FG001|Overall Study|Physician Decision|3
7641196|NCT02075840|12055748|FG000|Overall Study|Ongoing at CCOD|99
7641197|NCT02075840|12055749|FG001|Overall Study|Ongoing at CCOD|82
7641198|NCT02069366|12055761|FG000|Overall Study|Lost to Follow-up|0
7641199|NCT02069366|12055762|FG001|Overall Study|Lost to Follow-up|0
7641200|NCT02069366|12055763|FG002|Overall Study|Lost to Follow-up|1
7641201|NCT02069366|12055764|FG003|Overall Study|Lost to Follow-up|0
7641202|NCT02069366|12055765|FG004|Overall Study|Lost to Follow-up|0
7641203|NCT02069366|12055766|FG005|Overall Study|Lost to Follow-up|2
7641204|NCT02069366|12055761|FG000|Overall Study|Protocol Violation|0
7641205|NCT02069366|12055762|FG001|Overall Study|Protocol Violation|0
7641206|NCT02069366|12055763|FG002|Overall Study|Protocol Violation|1
7641207|NCT02069366|12055764|FG003|Overall Study|Protocol Violation|0
7641208|NCT02069366|12055765|FG004|Overall Study|Protocol Violation|0
7641209|NCT02069366|12055766|FG005|Overall Study|Protocol Violation|0
7641210|NCT02069366|12055761|FG000|Overall Study|Withdrawal by Subject|1
7641211|NCT02069366|12055762|FG001|Overall Study|Withdrawal by Subject|0
7641212|NCT02069366|12055763|FG002|Overall Study|Withdrawal by Subject|1
7641213|NCT02069366|12055764|FG003|Overall Study|Withdrawal by Subject|2
7641214|NCT02069366|12055765|FG004|Overall Study|Withdrawal by Subject|0
7641215|NCT02069366|12055766|FG005|Overall Study|Withdrawal by Subject|0
7641216|NCT02066415|12055784|FG000|Overall Study|Decision by Sponsor|5
7641217|NCT02066415|12055785|FG001|Overall Study|Decision by Sponsor|4
7641218|NCT02066415|12055786|FG002|Overall Study|Decision by Sponsor|2
7641219|NCT02066415|12055784|FG000|Overall Study|Withdrawal by Subject|9
7641220|NCT02066415|12055785|FG001|Overall Study|Withdrawal by Subject|1
7641221|NCT02066415|12055786|FG002|Overall Study|Withdrawal by Subject|4
7641222|NCT02066415|12055784|FG000|Overall Study|Lost to Follow-up|7
7641223|NCT02066415|12055785|FG001|Overall Study|Lost to Follow-up|2
7641224|NCT02066415|12055786|FG002|Overall Study|Lost to Follow-up|2
7641225|NCT02064296|12055797|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1
7641226|NCT02064296|12055798|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0
7641227|NCT02064296|12055799|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0
7641228|NCT02064296|12055797|FG000|Intervention|Withdrawal by Subject|0
7641229|NCT02064296|12055798|FG001|Intervention|Withdrawal by Subject|1
7641230|NCT02064296|12055799|FG002|Intervention|Withdrawal by Subject|2
7641231|NCT02063724|12055809|FG000|Overall Study|Disease progression|1
7641232|NCT02059265|12055850|FG000|Overall Study|Ineligible|4
7641233|NCT02043678|12055865|FG000|Overall Study|Never treated|11
7641234|NCT02043678|12055866|FG001|Overall Study|Never treated|9
7641235|NCT02043678|12055865|FG000|Overall Study|AE with clinical progressive disease(PD)|18
7641236|NCT02043678|12055866|FG001|Overall Study|AE with clinical progressive disease(PD)|18
7641237|NCT02043678|12055865|FG000|Overall Study|AE without clinical PD|51
7641238|NCT02043678|12055866|FG001|Overall Study|AE without clinical PD|34
7641239|NCT02043678|12055865|FG000|Overall Study|Lost to Follow-up|1
7641240|NCT02043678|12055866|FG001|Overall Study|Lost to Follow-up|1
7641241|NCT02043678|12055865|FG000|Overall Study|Other|19
7641242|NCT02043678|12055866|FG001|Overall Study|Other|16
7641243|NCT02043678|12055865|FG000|Overall Study|Clinical PD|108
7641244|NCT02043678|12055866|FG001|Overall Study|Clinical PD|138
7641245|NCT02043678|12055865|FG000|Overall Study|Radiological PD|91
7641246|NCT02043678|12055866|FG001|Overall Study|Radiological PD|80
7641247|NCT02043678|12055865|FG000|Overall Study|Protocol-driven decision point|56
7641248|NCT02043678|12055866|FG001|Overall Study|Protocol-driven decision point|56
7641249|NCT02043678|12055865|FG000|Overall Study|Withdrawal by Subject|12
7641250|NCT02043678|12055866|FG001|Overall Study|Withdrawal by Subject|15
7641251|NCT02043678|12055865|FG000|Overall Study|Ongoing with treatment|34
7641252|NCT02043678|12055866|FG001|Overall Study|Ongoing with treatment|38
7641253|NCT02032823|12055874|FG000|Overall Study|Death|59
7641254|NCT02032823|12055875|FG001|Overall Study|Death|86
7641255|NCT02032823|12055874|FG000|Overall Study|Lost to Follow-up|12
7641256|NCT02032823|12055875|FG001|Overall Study|Lost to Follow-up|15
7641257|NCT02032823|12055874|FG000|Overall Study|Withdrawal by Subject|65
7641258|NCT02032823|12055875|FG001|Overall Study|Withdrawal by Subject|49
7641259|NCT02032823|12055874|FG000|Overall Study|Ongoing study at data cut-off|782
7641260|NCT02032823|12055875|FG001|Overall Study|Ongoing study at data cut-off|760
7641261|NCT02032823|12055874|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3
7641262|NCT02032823|12055875|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5
7641263|NCT02029443|12055886|FG000|Overall Study|Completed 30-Day safety follow-up visit|53
7641264|NCT02029443|12055887|FG001|Overall Study|Completed 30-Day safety follow-up visit|16
7641265|NCT02029443|12055888|FG002|Overall Study|Completed 30-Day safety follow-up visit|12
7641266|NCT02029443|12055889|FG003|Overall Study|Completed 30-Day safety follow-up visit|2
7641267|NCT02029443|12055890|FG004|Overall Study|Completed 30-Day safety follow-up visit|1
7641268|NCT02029443|12055886|FG000|Overall Study|Death|13
7641269|NCT02029443|12055887|FG001|Overall Study|Death|2
7641270|NCT02029443|12055888|FG002|Overall Study|Death|2
7641271|NCT02029443|12055889|FG003|Overall Study|Death|11
7641272|NCT02029443|12055890|FG004|Overall Study|Death|2
7641273|NCT02029443|12055886|FG000|Overall Study|Lost to Follow-up|1
7641274|NCT02029443|12055887|FG001|Overall Study|Lost to Follow-up|0
7641275|NCT02029443|12055888|FG002|Overall Study|Lost to Follow-up|1
7641276|NCT02029443|12055889|FG003|Overall Study|Lost to Follow-up|1
7641277|NCT02029443|12055890|FG004|Overall Study|Lost to Follow-up|0
7641278|NCT02029443|12055886|FG000|Overall Study|Started other anti-cancer therapy|17
7641279|NCT02029443|12055887|FG001|Overall Study|Started other anti-cancer therapy|4
7641280|NCT02029443|12055888|FG002|Overall Study|Started other anti-cancer therapy|7
7641281|NCT02029443|12055889|FG003|Overall Study|Started other anti-cancer therapy|9
7641282|NCT02029443|12055890|FG004|Overall Study|Started other anti-cancer therapy|3
7641283|NCT02029443|12055886|FG000|Overall Study|Withdrawal by Subject|3
7641284|NCT02029443|12055887|FG001|Overall Study|Withdrawal by Subject|1
7641285|NCT02029443|12055888|FG002|Overall Study|Withdrawal by Subject|1
7641286|NCT02029443|12055889|FG003|Overall Study|Withdrawal by Subject|1
7641287|NCT02029443|12055890|FG004|Overall Study|Withdrawal by Subject|0
7641288|NCT02029443|12055886|FG000|Overall Study|Other|6
7641289|NCT02029443|12055887|FG001|Overall Study|Other|6
7641290|NCT02029443|12055888|FG002|Overall Study|Other|4
7641291|NCT02029443|12055889|FG003|Overall Study|Other|2
7641292|NCT02029443|12055890|FG004|Overall Study|Other|0
7641293|NCT02024529|12055926|FG000|Overall Study|Withdrawal by Subject|11
7641294|NCT02024529|12055927|FG001|Overall Study|Withdrawal by Subject|21
7641295|NCT02024529|12055926|FG000|Overall Study|Lost to Follow-up|2
7641296|NCT02024529|12055927|FG001|Overall Study|Lost to Follow-up|4
7641297|NCT02021812|12055945|FG000|Overall Study|Death|8
7641298|NCT02021812|12055945|FG000|Overall Study|Withdrawal by Subject|3
7641299|NCT02021812|12055945|FG000|Overall Study|Lost to Follow-up|2
7641300|NCT02021812|12055945|FG000|Overall Study|Refuse to return, COVD 19|2
7641301|NCT02016781|12055951|FG000|Interim Look for Primary Analysis|Alive and on study|71
7641302|NCT02016781|12055952|FG001|Interim Look for Primary Analysis|Alive and on study|23
7641303|NCT02016781|12055951|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2
7641304|NCT02016781|12055952|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1
7641305|NCT02016781|12055951|FG000|Final Database Lock|Withdrawal by Subject|2
7641306|NCT02016781|12055952|FG001|Final Database Lock|Withdrawal by Subject|1
7641307|NCT02016781|12055951|FG000|Final Database Lock|Lost to Follow-up|11
7641308|NCT02016781|12055952|FG001|Final Database Lock|Lost to Follow-up|4
7641309|NCT02016781|12055951|FG000|Final Database Lock|Missing data|0
7641310|NCT02016781|12055952|FG001|Final Database Lock|Missing data|3
7641311|NCT02006628|12055960|FG000|Overall Study|Adverse Event|1
7641312|NCT02006628|12055961|FG001|Overall Study|Adverse Event|1
7641313|NCT02006628|12055960|FG000|Overall Study|Withdrawal by Subject|2
7641314|NCT02006628|12055961|FG001|Overall Study|Withdrawal by Subject|1
7641315|NCT02003144|12055969|FG000|Open Label Maintenance Phase|Other than specified|2
7641316|NCT02003144|12055970|FG001|Open Label Maintenance Phase|Other than specified|4
7641317|NCT02003144|12055969|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4
7641318|NCT02003144|12055970|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5
7641319|NCT02003144|12055969|FG000|Open Label Maintenance Phase|Pregnancy|0
7641320|NCT02003144|12055970|FG001|Open Label Maintenance Phase|Pregnancy|2
7641321|NCT02003144|12055969|FG000|Open Label Maintenance Phase|Physician Decision|1
7641322|NCT02003144|12055970|FG001|Open Label Maintenance Phase|Physician Decision|1
7641323|NCT02003144|12055969|FG000|Open Label Maintenance Phase|Lost to Follow-up|0
7641324|NCT02003144|12055970|FG001|Open Label Maintenance Phase|Lost to Follow-up|1
7641325|NCT02003144|12055969|FG000|Open Label Maintenance Phase|Adverse Event|2
7641326|NCT02003144|12055970|FG001|Open Label Maintenance Phase|Adverse Event|1
7641327|NCT02002182|12055979|FG000|Overall Study|Withdraw from study|3
7641328|NCT02002182|12055980|FG001|Overall Study|Withdraw from study|1
7641329|NCT02002182|12055979|FG000|Overall Study|Health Reasons|1
7641330|NCT02002182|12055980|FG001|Overall Study|Health Reasons|0
7641331|NCT02002182|12055979|FG000|Overall Study|Death|1
7641332|NCT02002182|12055980|FG001|Overall Study|Death|0
7641333|NCT02000427|12055986|FG000|Overall Study|Death|22
7641334|NCT01988493|12056008|FG000|Overall Study|Randomized but not treated|0
7641335|NCT01988493|12056009|FG001|Overall Study|Randomized but not treated|0
7641336|NCT01988493|12056010|FG002|Overall Study|Randomized but not treated|0
7641337|NCT01988493|12056011|FG003|Overall Study|Randomized but not treated|0
7641338|NCT01988493|12056012|FG004|Overall Study|Randomized but not treated|1
7641339|NCT01988233|12056026|FG000|Overall Study|Lost to Follow-up|64
7641340|NCT01988233|12056027|FG001|Overall Study|Lost to Follow-up|51
7641341|NCT01986881|12056036|FG000|Overall Study|Death|228
7641342|NCT01986881|12056037|FG001|Overall Study|Death|233
7641343|NCT01986881|12056038|FG002|Overall Study|Death|247
7641344|NCT01986881|12056036|FG000|Overall Study|Lost to Follow-up|51
7641345|NCT01986881|12056037|FG001|Overall Study|Lost to Follow-up|44
7641346|NCT01986881|12056038|FG002|Overall Study|Lost to Follow-up|55
7641347|NCT01986881|12056036|FG000|Overall Study|Physician Decision|7
7641348|NCT01986881|12056037|FG001|Overall Study|Physician Decision|4
7641349|NCT01986881|12056038|FG002|Overall Study|Physician Decision|6
7641350|NCT01986881|12056036|FG000|Overall Study|Study Site Terminated by Sponsor|2
7641351|NCT01986881|12056037|FG001|Overall Study|Study Site Terminated by Sponsor|2
7641352|NCT01986881|12056038|FG002|Overall Study|Study Site Terminated by Sponsor|3
7641353|NCT01986881|12056036|FG000|Overall Study|Withdrawal by Subject|41
7641354|NCT01986881|12056037|FG001|Overall Study|Withdrawal by Subject|60
7641355|NCT01986881|12056038|FG002|Overall Study|Withdrawal by Subject|45
7641356|NCT01986881|12056036|FG000|Overall Study|Subject Moved|0
7641357|NCT01986881|12056037|FG001|Overall Study|Subject Moved|1
7641358|NCT01986881|12056038|FG002|Overall Study|Subject Moved|0
7641359|NCT01986881|12056036|FG000|Overall Study|Other|1
7641360|NCT01986881|12056037|FG001|Overall Study|Other|2
7641361|NCT01986881|12056038|FG002|Overall Study|Other|2
7641362|NCT01982955|12056074|FG000|Overall Study|Randomized but not treated|0
7641363|NCT01982955|12056075|FG001|Overall Study|Randomized but not treated|0
7641364|NCT01982955|12056076|FG002|Overall Study|Randomized but not treated|0
7641365|NCT01982955|12056077|FG003|Overall Study|Randomized but not treated|1
7641366|NCT01982955|12056078|FG004|Overall Study|Randomized but not treated|0
7641367|NCT01982955|12056074|FG000|Overall Study|Ongoing|0
7641368|NCT01982955|12056075|FG001|Overall Study|Ongoing|0
7641369|NCT01982955|12056076|FG002|Overall Study|Ongoing|4
7641370|NCT01982955|12056077|FG003|Overall Study|Ongoing|0
7641371|NCT01982955|12056078|FG004|Overall Study|Ongoing|0
7641372|NCT01979536|12056097|FG000|Overall Study|Physician Decision|2
7641373|NCT01979536|12056098|FG001|Overall Study|Physician Decision|3
7641374|NCT01979536|12056097|FG000|Overall Study|Withdrawal by Subject|0
7641375|NCT01979536|12056098|FG001|Overall Study|Withdrawal by Subject|1
7641376|NCT01979536|12056097|FG000|Overall Study|Refusal|0
7641377|NCT01979536|12056098|FG001|Overall Study|Refusal|1
7641378|NCT01979536|12056097|FG000|Overall Study|Relapse|0
7641379|NCT01979536|12056098|FG001|Overall Study|Relapse|1
7641380|NCT01979536|12056097|FG000|Overall Study|Study terminated by Sponsor|0
7641381|NCT01979536|12056098|FG001|Overall Study|Study terminated by Sponsor|1
7641382|NCT01979536|12056097|FG000|Overall Study|Did not start treatment|0
7641383|NCT01979536|12056098|FG001|Overall Study|Did not start treatment|1
7641384|NCT01975272|12056124|FG000|Overall Study|Excluded after protocol amendment|1
7641385|NCT01975272|12056125|FG001|Overall Study|Excluded after protocol amendment|1
7641386|NCT01975272|12056126|FG002|Overall Study|Excluded after protocol amendment|2
7641387|NCT01972308|12056136|FG000|Overall Study|Withdrawal by Subject|0
7641388|NCT01972308|12056137|FG001|Overall Study|Withdrawal by Subject|1
7641389|NCT01972308|12056136|FG000|Overall Study|Lost to Follow-up|4
7641390|NCT01972308|12056137|FG001|Overall Study|Lost to Follow-up|6
7641391|NCT01972308|12056136|FG000|Overall Study|Death|4
7641392|NCT01972308|12056137|FG001|Overall Study|Death|1
7641393|NCT01970501|12056147|FG000|Overall Study|Discontinuation of study by sponsor|16
7641394|NCT01970501|12056148|FG001|Overall Study|Discontinuation of study by sponsor|14
7641395|NCT01970501|12056147|FG000|Overall Study|Withdrawal by Subject|6
7641396|NCT01970501|12056148|FG001|Overall Study|Withdrawal by Subject|7
7641397|NCT01970501|12056147|FG000|Overall Study|Adverse Event|2
7641398|NCT01970501|12056148|FG001|Overall Study|Adverse Event|4
7641399|NCT01970501|12056147|FG000|Overall Study|Death|1
7641400|NCT01970501|12056148|FG001|Overall Study|Death|3
7641401|NCT01970501|12056147|FG000|Overall Study|Physician Decision|2
7641402|NCT01970501|12056148|FG001|Overall Study|Physician Decision|0
7641403|NCT01958021|12056156|FG000|Overall Study|Progressive disease|87
7641404|NCT01958021|12056157|FG001|Overall Study|Progressive disease|146
7641405|NCT01958021|12056156|FG000|Overall Study|Adverse Event|25
7641406|NCT01958021|12056157|FG001|Overall Study|Adverse Event|7
7641407|NCT01958021|12056156|FG000|Overall Study|Subject/guardian decision|12
7641408|NCT01958021|12056157|FG001|Overall Study|Subject/guardian decision|13
7641409|NCT01958021|12056156|FG000|Overall Study|Physician Decision|10
7641410|NCT01958021|12056157|FG001|Overall Study|Physician Decision|13
7641411|NCT01958021|12056156|FG000|Overall Study|Protocol Violation|3
7641412|NCT01958021|12056157|FG001|Overall Study|Protocol Violation|1
7641413|NCT01958021|12056156|FG000|Overall Study|Death|2
7641414|NCT01958021|12056157|FG001|Overall Study|Death|0
7641415|NCT01952574|12056167|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9
7641416|NCT01952574|12056168|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3
7641417|NCT01952574|12056169|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3
7641418|NCT01952574|12056170|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4
7641419|NCT01952574|12056171|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0
7641420|NCT01952574|12056172|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0
7641421|NCT01952574|12056173|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0
7641422|NCT01952574|12056167|FG000|Double-blind Treatment Phase|Sponsor Decision|6
7641423|NCT01952574|12056168|FG001|Double-blind Treatment Phase|Sponsor Decision|0
7641424|NCT01952574|12056169|FG002|Double-blind Treatment Phase|Sponsor Decision|5
7641425|NCT01952574|12056170|FG003|Double-blind Treatment Phase|Sponsor Decision|2
7641426|NCT01952574|12056171|FG004|Double-blind Treatment Phase|Sponsor Decision|0
7641427|NCT01952574|12056172|FG005|Double-blind Treatment Phase|Sponsor Decision|0
7641428|NCT01952574|12056173|FG006|Double-blind Treatment Phase|Sponsor Decision|0
7641429|NCT01952574|12056167|FG000|Double-blind Treatment Phase|Lost to Follow-up|2
7641430|NCT01952574|12056168|FG001|Double-blind Treatment Phase|Lost to Follow-up|0
7641431|NCT01952574|12056169|FG002|Double-blind Treatment Phase|Lost to Follow-up|1
7641432|NCT01952574|12056170|FG003|Double-blind Treatment Phase|Lost to Follow-up|0
7641433|NCT01952574|12056171|FG004|Double-blind Treatment Phase|Lost to Follow-up|0
7641434|NCT01952574|12056172|FG005|Double-blind Treatment Phase|Lost to Follow-up|0
7641435|NCT01952574|12056173|FG006|Double-blind Treatment Phase|Lost to Follow-up|0
7641436|NCT01952574|12056167|FG000|Open-label Treatment Phase|Withdrawal by Subject|0
7641437|NCT01952574|12056168|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
7641438|NCT01952574|12056169|FG002|Open-label Treatment Phase|Withdrawal by Subject|0
7641439|NCT01952574|12056170|FG003|Open-label Treatment Phase|Withdrawal by Subject|0
7641440|NCT01952574|12056171|FG004|Open-label Treatment Phase|Withdrawal by Subject|121
7641441|NCT01952574|12056172|FG005|Open-label Treatment Phase|Withdrawal by Subject|0
7641442|NCT01952574|12056173|FG006|Open-label Treatment Phase|Withdrawal by Subject|0
7641443|NCT01952574|12056167|FG000|Open-label Treatment Phase|Decision by Sponsor|0
7641444|NCT01952574|12056168|FG001|Open-label Treatment Phase|Decision by Sponsor|0
7641445|NCT01952574|12056169|FG002|Open-label Treatment Phase|Decision by Sponsor|0
7641446|NCT01952574|12056170|FG003|Open-label Treatment Phase|Decision by Sponsor|0
7641447|NCT01952574|12056171|FG004|Open-label Treatment Phase|Decision by Sponsor|17
7641448|NCT01952574|12056172|FG005|Open-label Treatment Phase|Decision by Sponsor|0
7641449|NCT01952574|12056173|FG006|Open-label Treatment Phase|Decision by Sponsor|0
7641450|NCT01952574|12056167|FG000|Open-label Treatment Phase|Missing|0
7641451|NCT01952574|12056168|FG001|Open-label Treatment Phase|Missing|0
7641452|NCT01952574|12056169|FG002|Open-label Treatment Phase|Missing|0
7641453|NCT01952574|12056170|FG003|Open-label Treatment Phase|Missing|0
7641454|NCT01952574|12056171|FG004|Open-label Treatment Phase|Missing|4
7641455|NCT01952574|12056172|FG005|Open-label Treatment Phase|Missing|0
7641456|NCT01952574|12056173|FG006|Open-label Treatment Phase|Missing|0
7641457|NCT01952574|12056167|FG000|Open-label Treatment Phase|Lost to Follow-up|0
7641458|NCT01952574|12056168|FG001|Open-label Treatment Phase|Lost to Follow-up|0
7641459|NCT01952574|12056169|FG002|Open-label Treatment Phase|Lost to Follow-up|0
7641460|NCT01952574|12056170|FG003|Open-label Treatment Phase|Lost to Follow-up|0
7641461|NCT01952574|12056171|FG004|Open-label Treatment Phase|Lost to Follow-up|19
7641462|NCT01952574|12056172|FG005|Open-label Treatment Phase|Lost to Follow-up|0
7641463|NCT01952574|12056173|FG006|Open-label Treatment Phase|Lost to Follow-up|0
7641464|NCT01952574|12056167|FG000|Open-label Treatment Phase|Death|0
7641465|NCT01952574|12056168|FG001|Open-label Treatment Phase|Death|0
7641466|NCT01952574|12056169|FG002|Open-label Treatment Phase|Death|0
7641467|NCT01952574|12056170|FG003|Open-label Treatment Phase|Death|0
7641468|NCT01952574|12056171|FG004|Open-label Treatment Phase|Death|1
7641469|NCT01952574|12056172|FG005|Open-label Treatment Phase|Death|0
7641470|NCT01952574|12056173|FG006|Open-label Treatment Phase|Death|0
7641471|NCT01952574|12056167|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0
7641472|NCT01952574|12056168|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0
7641473|NCT01952574|12056169|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0
7641474|NCT01952574|12056170|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0
7641475|NCT01952574|12056171|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0
7641476|NCT01952574|12056172|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1
7641477|NCT01952574|12056173|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0
7641478|NCT01952574|12056167|FG000|Clinical Home Use Substudy|Decision by Sponsor|0
7641479|NCT01952574|12056168|FG001|Clinical Home Use Substudy|Decision by Sponsor|0
7641480|NCT01952574|12056169|FG002|Clinical Home Use Substudy|Decision by Sponsor|0
7641481|NCT01952574|12056170|FG003|Clinical Home Use Substudy|Decision by Sponsor|0
7641482|NCT01952574|12056171|FG004|Clinical Home Use Substudy|Decision by Sponsor|0
7641483|NCT01952574|12056172|FG005|Clinical Home Use Substudy|Decision by Sponsor|2
7641484|NCT01952574|12056173|FG006|Clinical Home Use Substudy|Decision by Sponsor|1
7641485|NCT01951417|12056198|FG000|Overall Study|Withdrawal by Subject|1
7641486|NCT01951417|12056198|FG000|Overall Study|Protocol Violation|2
7641487|NCT01951417|12056198|FG000|Overall Study|Lost to Follow-up|6
7641488|NCT01949662|12056208|FG000|Overall Study|Death|9
7641489|NCT01949662|12056209|FG001|Overall Study|Death|7
7641490|NCT01949662|12056208|FG000|Overall Study|Discharged before an agitation event|8
7641491|NCT01949662|12056209|FG001|Overall Study|Discharged before an agitation event|3
7641492|NCT01949662|12056208|FG000|Overall Study|Dropped out|1
7641493|NCT01949662|12056209|FG001|Overall Study|Dropped out|3
7641494|NCT01949662|12056208|FG000|Overall Study|Ineligible|0
7641495|NCT01949662|12056209|FG001|Overall Study|Ineligible|1
7641496|NCT01946529|12056227|FG000|End of Window Therapy (2 Courses)|Physician Decision|0
7641497|NCT01946529|12056228|FG001|End of Window Therapy (2 Courses)|Physician Decision|1
7641498|NCT01946529|12056229|FG002|End of Window Therapy (2 Courses)|Physician Decision|0
7641499|NCT01946529|12056227|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1
7641500|NCT01946529|12056228|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16
7641501|NCT01946529|12056229|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6
7641502|NCT01946204|12056238|FG000|Overall Study|Death|38
7641503|NCT01946204|12056239|FG001|Overall Study|Death|59
7641504|NCT01946204|12056238|FG000|Overall Study|Withdrawal by Subject|37
7641505|NCT01946204|12056239|FG001|Overall Study|Withdrawal by Subject|50
7641506|NCT01946204|12056238|FG000|Overall Study|Lost to Follow-up|3
7641507|NCT01946204|12056239|FG001|Overall Study|Lost to Follow-up|7
7641508|NCT01946204|12056238|FG000|Overall Study|Ongoing|316
7641509|NCT01946204|12056239|FG001|Overall Study|Ongoing|687
7641510|NCT01946204|12056238|FG000|Overall Study|Other|7
7641511|NCT01946204|12056239|FG001|Overall Study|Other|3
7641512|NCT01942135|12056256|FG000|Overall Study|Adverse Event|9
7641513|NCT01942135|12056257|FG001|Overall Study|Adverse Event|3
7641514|NCT01942135|12056256|FG000|Overall Study|Global deterioration of health status|8
7641515|NCT01942135|12056257|FG001|Overall Study|Global deterioration of health status|3
7641516|NCT01942135|12056256|FG000|Overall Study|Randomized Not Treated|2
7641517|NCT01942135|12056257|FG001|Overall Study|Randomized Not Treated|2
7641518|NCT01942135|12056256|FG000|Overall Study|Death|0
7641519|NCT01942135|12056257|FG001|Overall Study|Death|1
7641520|NCT01942135|12056256|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85
7641521|NCT01942135|12056257|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87
7641522|NCT01942135|12056256|FG000|Overall Study|Participant Refused toContinue Treatment|1
7641523|NCT01942135|12056257|FG001|Overall Study|Participant Refused toContinue Treatment|1
7641524|NCT01942135|12056256|FG000|Overall Study|Withdrawal by Subject|4
7641525|NCT01942135|12056257|FG001|Overall Study|Withdrawal by Subject|2
7641526|NCT01942135|12056256|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
7641527|NCT01942135|12056257|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
7641528|NCT01940471|12056265|FG000|Double-Blind Phase|Randomized but Never Treated|1
7641529|NCT01940471|12056266|FG001|Double-Blind Phase|Randomized but Never Treated|1
7641530|NCT01940471|12056265|FG000|Double-Blind Phase|Withdrew Consent|13
7641531|NCT01940471|12056266|FG001|Double-Blind Phase|Withdrew Consent|7
7641532|NCT01940471|12056265|FG000|Double-Blind Phase|Adverse Event|1
7641533|NCT01940471|12056266|FG001|Double-Blind Phase|Adverse Event|2
7641534|NCT01940471|12056265|FG000|Double-Blind Phase|Lost to Follow-up|3
7641535|NCT01940471|12056266|FG001|Double-Blind Phase|Lost to Follow-up|2
7641536|NCT01940471|12056265|FG000|Double-Blind Phase|Pregnancy|2
7641537|NCT01940471|12056266|FG001|Double-Blind Phase|Pregnancy|1
7641538|NCT01940471|12056265|FG000|Double-Blind Phase|Investigator's Discretion|5
7641539|NCT01940471|12056266|FG001|Double-Blind Phase|Investigator's Discretion|0
7641540|NCT01940471|12056265|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
7641541|NCT01940471|12056266|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
7641542|NCT01940471|12056265|FG000|Double-Blind Phase|Protocol-Specified Criteria|1
7641543|NCT01940471|12056266|FG001|Double-Blind Phase|Protocol-Specified Criteria|0
7641544|NCT01940471|12056265|FG000|Double-Blind Phase|Death|1
7641545|NCT01940471|12056266|FG001|Double-Blind Phase|Death|0
7641546|NCT01940471|12056265|FG000|Double-Blind Phase|Lack of Efficacy|1
7641547|NCT01940471|12056266|FG001|Double-Blind Phase|Lack of Efficacy|0
7641548|NCT01940471|12056265|FG000|Double-Blind Phase|Protocol Violation|0
7641549|NCT01940471|12056266|FG001|Double-Blind Phase|Protocol Violation|1
7641550|NCT01940471|12056265|FG000|Double-Blind Phase|Still in Double-Blind Phase|539
7641551|NCT01940471|12056266|FG001|Double-Blind Phase|Still in Double-Blind Phase|270
7641552|NCT01940471|12056265|FG000|Open-Label Extension|Still in Open-Label Extension Phase|14
7641553|NCT01940471|12056266|FG001|Open-Label Extension|Still in Open-Label Extension Phase|8
7641554|NCT01933932|12056287|FG000|Overall Study|Death|173
7641555|NCT01933932|12056288|FG001|Overall Study|Death|163
7641556|NCT01933932|12056287|FG000|Overall Study|Withdrawal by Subject|11
7641557|NCT01933932|12056288|FG001|Overall Study|Withdrawal by Subject|14
7641558|NCT01933932|12056287|FG000|Overall Study|Eligibility criteria not fulfilled|0
7641559|NCT01933932|12056288|FG001|Overall Study|Eligibility criteria not fulfilled|1
7641560|NCT01930123|12056296|FG000|Overall Study|Adverse Event|1
7641561|NCT01930123|12056297|FG001|Overall Study|Adverse Event|0
7641562|NCT01930123|12056296|FG000|Overall Study|Physician Decision|21
7641563|NCT01930123|12056297|FG001|Overall Study|Physician Decision|8
7641564|NCT01930123|12056296|FG000|Overall Study|Withdrawal by Subject|1
7641565|NCT01930123|12056297|FG001|Overall Study|Withdrawal by Subject|0
7641566|NCT01924533|12056305|FG000|Overall Study|Death|181
7641567|NCT01924533|12056306|FG001|Overall Study|Death|200
7641568|NCT01924533|12056305|FG000|Overall Study|Lost to Follow-up|0
7641569|NCT01924533|12056306|FG001|Overall Study|Lost to Follow-up|1
7641570|NCT01924533|12056305|FG000|Overall Study|Withdrawal by Subject|7
7641571|NCT01924533|12056306|FG001|Overall Study|Withdrawal by Subject|3
7641572|NCT01924533|12056305|FG000|Overall Study|Other Eligibility criteria|1
7641573|NCT01924533|12056306|FG001|Overall Study|Other Eligibility criteria|1
7641574|NCT01920932|12056312|FG000|Overall Study|Death|1
7641575|NCT01920932|12056312|FG000|Overall Study|Withdrawal of consent|1
7641576|NCT01920061|12056353|FG000|Overall Study|Death|1
7641577|NCT01920061|12056354|FG001|Overall Study|Death|1
7641578|NCT01920061|12056355|FG002|Overall Study|Death|0
7641579|NCT01920061|12056356|FG003|Overall Study|Death|1
7641580|NCT01920061|12056357|FG004|Overall Study|Death|1
7641581|NCT01920061|12056358|FG005|Overall Study|Death|0
7641582|NCT01920061|12056359|FG006|Overall Study|Death|0
7641583|NCT01920061|12056360|FG007|Overall Study|Death|1
7641584|NCT01920061|12056361|FG008|Overall Study|Death|0
7641585|NCT01920061|12056362|FG009|Overall Study|Death|1
7641586|NCT01920061|12056363|FG010|Overall Study|Death|0
7641587|NCT01920061|12056364|FG011|Overall Study|Death|1
7641588|NCT01920061|12056365|FG012|Overall Study|Death|0
7641589|NCT01920061|12056366|FG013|Overall Study|Death|2
7641590|NCT01920061|12056367|FG014|Overall Study|Death|0
7641591|NCT01920061|12056368|FG015|Overall Study|Death|0
7641592|NCT01920061|12056369|FG016|Overall Study|Death|0
7641593|NCT01920061|12056370|FG017|Overall Study|Death|0
7641594|NCT01920061|12056371|FG018|Overall Study|Death|1
7641595|NCT01920061|12056372|FG019|Overall Study|Death|0
7641596|NCT01920061|12056353|FG000|Overall Study|Lost to Follow-up|0
7641597|NCT01920061|12056354|FG001|Overall Study|Lost to Follow-up|2
7641598|NCT01920061|12056355|FG002|Overall Study|Lost to Follow-up|0
7641599|NCT01920061|12056356|FG003|Overall Study|Lost to Follow-up|0
7641600|NCT01920061|12056357|FG004|Overall Study|Lost to Follow-up|0
7641601|NCT01920061|12056358|FG005|Overall Study|Lost to Follow-up|0
7641602|NCT01920061|12056359|FG006|Overall Study|Lost to Follow-up|1
7641603|NCT01920061|12056360|FG007|Overall Study|Lost to Follow-up|0
7641604|NCT01920061|12056361|FG008|Overall Study|Lost to Follow-up|0
7641605|NCT01920061|12056362|FG009|Overall Study|Lost to Follow-up|0
7641606|NCT01920061|12056363|FG010|Overall Study|Lost to Follow-up|3
7641607|NCT01920061|12056364|FG011|Overall Study|Lost to Follow-up|0
7641608|NCT01920061|12056365|FG012|Overall Study|Lost to Follow-up|0
7641609|NCT01920061|12056366|FG013|Overall Study|Lost to Follow-up|0
7641610|NCT01920061|12056367|FG014|Overall Study|Lost to Follow-up|0
7641611|NCT01920061|12056368|FG015|Overall Study|Lost to Follow-up|0
7641612|NCT01920061|12056369|FG016|Overall Study|Lost to Follow-up|0
7641613|NCT01920061|12056370|FG017|Overall Study|Lost to Follow-up|1
7641614|NCT01920061|12056371|FG018|Overall Study|Lost to Follow-up|4
7641615|NCT01920061|12056372|FG019|Overall Study|Lost to Follow-up|3
7641616|NCT01920061|12056353|FG000|Overall Study|Other|1
7641617|NCT01920061|12056354|FG001|Overall Study|Other|1
7641618|NCT01920061|12056355|FG002|Overall Study|Other|2
7641619|NCT01920061|12056356|FG003|Overall Study|Other|1
7641620|NCT01920061|12056357|FG004|Overall Study|Other|0
7641621|NCT01920061|12056358|FG005|Overall Study|Other|1
7641622|NCT01920061|12056359|FG006|Overall Study|Other|0
7641623|NCT01920061|12056360|FG007|Overall Study|Other|0
7641624|NCT01920061|12056361|FG008|Overall Study|Other|0
7641625|NCT01920061|12056362|FG009|Overall Study|Other|1
7641626|NCT01920061|12056363|FG010|Overall Study|Other|1
7641627|NCT01920061|12056364|FG011|Overall Study|Other|2
7641628|NCT01920061|12056365|FG012|Overall Study|Other|1
7641629|NCT01920061|12056366|FG013|Overall Study|Other|4
7641630|NCT01920061|12056367|FG014|Overall Study|Other|0
7641631|NCT01920061|12056368|FG015|Overall Study|Other|1
7641632|NCT01920061|12056369|FG016|Overall Study|Other|1
7641633|NCT01920061|12056370|FG017|Overall Study|Other|0
7641634|NCT01920061|12056371|FG018|Overall Study|Other|1
7641635|NCT01920061|12056372|FG019|Overall Study|Other|1
7641636|NCT01920061|12056353|FG000|Overall Study|Participant refused further follow-up|0
7641637|NCT01920061|12056354|FG001|Overall Study|Participant refused further follow-up|0
7641638|NCT01920061|12056355|FG002|Overall Study|Participant refused further follow-up|0
7641639|NCT01920061|12056356|FG003|Overall Study|Participant refused further follow-up|0
7641640|NCT01920061|12056357|FG004|Overall Study|Participant refused further follow-up|1
7641641|NCT01920061|12056358|FG005|Overall Study|Participant refused further follow-up|1
7641642|NCT01920061|12056359|FG006|Overall Study|Participant refused further follow-up|0
7641643|NCT01920061|12056360|FG007|Overall Study|Participant refused further follow-up|0
7641644|NCT01920061|12056361|FG008|Overall Study|Participant refused further follow-up|1
7641645|NCT01920061|12056362|FG009|Overall Study|Participant refused further follow-up|0
7641646|NCT01920061|12056363|FG010|Overall Study|Participant refused further follow-up|1
7641647|NCT01920061|12056364|FG011|Overall Study|Participant refused further follow-up|0
7641648|NCT01920061|12056365|FG012|Overall Study|Participant refused further follow-up|1
7641649|NCT01920061|12056366|FG013|Overall Study|Participant refused further follow-up|0
7641650|NCT01920061|12056367|FG014|Overall Study|Participant refused further follow-up|1
7641651|NCT01920061|12056368|FG015|Overall Study|Participant refused further follow-up|2
7641652|NCT01920061|12056369|FG016|Overall Study|Participant refused further follow-up|1
7641653|NCT01920061|12056370|FG017|Overall Study|Participant refused further follow-up|1
7641654|NCT01920061|12056371|FG018|Overall Study|Participant refused further follow-up|0
7641655|NCT01920061|12056372|FG019|Overall Study|Participant refused further follow-up|0
7882358|NCT01769456|12381261|FG000|Overall Study|Lost to Follow-up|19
7882359|NCT01769456|12381261|FG000|Overall Study|Withdrawal by Subject|3
7882360|NCT01769456|12381261|FG000|Overall Study|Did not receive PCC intervention|6
7882361|NCT01769456|12381261|FG000|Overall Study|Moved out of the area|3
7882362|NCT01769456|12381261|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5
7882363|NCT01769456|12381261|FG000|Overall Study|Parental request to youth to withdraw|1
7882364|NCT01769469|12381266|FG000|Overall Study|Consent Withdrawn|5
7882365|NCT01769469|12381266|FG000|Overall Study|Moved Out Of Area|3
7882366|NCT01769469|12381266|FG000|Overall Study|Lost to Follow-up|17
7882367|NCT01769469|12381266|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7
7882368|NCT01769469|12381266|FG000|Overall Study|Subject Confirmed HIV Positive|3
7883365|NCT01781429|12382956|FG007|Overall Study|Enrolled, but not treated|0
7883366|NCT01781429|12382957|FG008|Overall Study|Enrolled, but not treated|0
7883367|NCT01781429|12382958|FG009|Overall Study|Enrolled, but not treated|0
7883368|NCT01781429|12382959|FG010|Overall Study|Enrolled, but not treated|1
7883369|NCT01781429|12382960|FG011|Overall Study|Enrolled, but not treated|0
7883370|NCT01781429|12382961|FG012|Overall Study|Enrolled, but not treated|0
7883371|NCT01781429|12382962|FG013|Overall Study|Enrolled, but not treated|0
7883372|NCT01781429|12382963|FG014|Overall Study|Enrolled, but not treated|0
7641676|NCT01909479|12056473|FG000|From Baseline to Week 26|Adverse Event|3
7641677|NCT01909479|12056474|FG001|From Baseline to Week 26|Adverse Event|2
7641678|NCT01909479|12056473|FG000|From Baseline to Week 26|Withdrawal by Subject|3
7641679|NCT01909479|12056474|FG001|From Baseline to Week 26|Withdrawal by Subject|6
7641680|NCT01909479|12056473|FG000|From Baseline to Week 26|Site and study closed by PI|0
7641681|NCT01909479|12056474|FG001|From Baseline to Week 26|Site and study closed by PI|1
7641682|NCT01909479|12056473|FG000|26 - 52 Weeks|Adverse Event|0
7641683|NCT01909479|12056474|FG001|26 - 52 Weeks|Adverse Event|1
7641684|NCT01909479|12056473|FG000|26 - 52 Weeks|Withdrawal by Subject|2
7641685|NCT01909479|12056474|FG001|26 - 52 Weeks|Withdrawal by Subject|1
7641686|NCT01909479|12056473|FG000|26 - 52 Weeks|Lost to Follow-up|1
7641687|NCT01909479|12056474|FG001|26 - 52 Weeks|Lost to Follow-up|0
7641688|NCT01909479|12056473|FG000|52 Weeks to End of Study|Withdrawal by Subject|18
7641689|NCT01909479|12056474|FG001|52 Weeks to End of Study|Withdrawal by Subject|8
7641690|NCT01909479|12056473|FG000|52 Weeks to End of Study|Adverse Event|2
7641691|NCT01909479|12056474|FG001|52 Weeks to End of Study|Adverse Event|1
7641692|NCT01909479|12056473|FG000|52 Weeks to End of Study|Death|0
7641693|NCT01909479|12056474|FG001|52 Weeks to End of Study|Death|1
7641694|NCT01909479|12056473|FG000|52 Weeks to End of Study|Lost to Follow-up|1
7641695|NCT01909479|12056474|FG001|52 Weeks to End of Study|Lost to Follow-up|0
7641696|NCT01909479|12056473|FG000|52 Weeks to End of Study|Protocol Violation|1
7641697|NCT01909479|12056474|FG001|52 Weeks to End of Study|Protocol Violation|0
7641698|NCT01909479|12056473|FG000|52 Weeks to End of Study|Progressive disease|1
7641699|NCT01909479|12056474|FG001|52 Weeks to End of Study|Progressive disease|1
7641700|NCT01909479|12056473|FG000|52 Weeks to End of Study|Personal reasons|2
7641701|NCT01909479|12056474|FG001|52 Weeks to End of Study|Personal reasons|1
7641702|NCT01909479|12056473|FG000|52 Weeks to End of Study|Sponsor's decision|1
7641703|NCT01909479|12056474|FG001|52 Weeks to End of Study|Sponsor's decision|1
7641704|NCT01909479|12056473|FG000|52 Weeks to End of Study|Study termination by sponsor|0
7641705|NCT01909479|12056474|FG001|52 Weeks to End of Study|Study termination by sponsor|1
7641706|NCT01909479|12056473|FG000|52 Weeks to End of Study|Lack of contact|1
7641707|NCT01909479|12056474|FG001|52 Weeks to End of Study|Lack of contact|0
7641708|NCT01909479|12056473|FG000|52 Weeks to End of Study|Occurrence of malignancy|1
7641709|NCT01909479|12056474|FG001|52 Weeks to End of Study|Occurrence of malignancy|0
7641710|NCT01909479|12056473|FG000|52 Weeks to End of Study|Diabetes not controlled|0
7641711|NCT01909479|12056474|FG001|52 Weeks to End of Study|Diabetes not controlled|1
7641712|NCT01909453|12056489|FG000|Overall Study|Ongoing|118
7641713|NCT01909453|12056490|FG001|Overall Study|Ongoing|103
7641714|NCT01909453|12056491|FG002|Overall Study|Ongoing|83
7641715|NCT01909453|12056492|FG003|Overall Study|Ongoing|164
7641716|NCT01909453|12056493|FG004|Overall Study|Ongoing|50
7641717|NCT01909453|12056489|FG000|Overall Study|Death|69
7641718|NCT01909453|12056490|FG001|Overall Study|Death|74
7641719|NCT01909453|12056491|FG002|Overall Study|Death|88
7641720|NCT01909453|12056492|FG003|Overall Study|Death|86
7641721|NCT01909453|12056493|FG004|Overall Study|Death|29
7641722|NCT01909453|12056489|FG000|Overall Study|Lost to Follow-up|3
7641723|NCT01909453|12056490|FG001|Overall Study|Lost to Follow-up|4
7641724|NCT01909453|12056491|FG002|Overall Study|Lost to Follow-up|4
7641725|NCT01909453|12056492|FG003|Overall Study|Lost to Follow-up|3
7641726|NCT01909453|12056493|FG004|Overall Study|Lost to Follow-up|3
7641727|NCT01909453|12056489|FG000|Overall Study|Withdrawal by Subject|2
7641728|NCT01909453|12056490|FG001|Overall Study|Withdrawal by Subject|13
7641729|NCT01909453|12056491|FG002|Overall Study|Withdrawal by Subject|16
7641730|NCT01909453|12056492|FG003|Overall Study|Withdrawal by Subject|5
7641731|NCT01909453|12056493|FG004|Overall Study|Withdrawal by Subject|4
7641732|NCT01902290|12056524|FG000|Overall Study|Withdrawal by Subject|19
7641733|NCT01902290|12056525|FG001|Overall Study|Withdrawal by Subject|27
7641734|NCT01902290|12056524|FG000|Overall Study|Lost to Follow-up|2
7641735|NCT01902290|12056525|FG001|Overall Study|Lost to Follow-up|2
7641736|NCT01902290|12056524|FG000|Overall Study|Death|1
7641737|NCT01902290|12056525|FG001|Overall Study|Death|0
7641738|NCT01902290|12056524|FG000|Overall Study|Sponsor Decision|26
7641739|NCT01902290|12056525|FG001|Overall Study|Sponsor Decision|24
7641740|NCT01902173|12056538|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1
7641741|NCT01902173|12056539|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7641742|NCT01902173|12056540|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7641743|NCT01902173|12056541|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7641744|NCT01902173|12056542|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7641745|NCT01902173|12056543|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7641746|NCT01902173|12056538|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2
7641747|NCT01902173|12056539|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7641748|NCT01902173|12056540|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7641749|NCT01902173|12056541|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7641750|NCT01902173|12056542|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7641751|NCT01902173|12056543|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7641752|NCT01902173|12056538|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7641753|NCT01902173|12056539|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5
7641754|NCT01902173|12056540|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7641755|NCT01902173|12056541|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7641756|NCT01902173|12056542|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7641757|NCT01902173|12056543|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7641758|NCT01902173|12056538|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7641759|NCT01902173|12056539|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1
7641760|NCT01902173|12056540|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7641761|NCT01902173|12056541|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7641762|NCT01902173|12056542|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7641763|NCT01902173|12056543|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7641764|NCT01902173|12056538|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0
7641765|NCT01902173|12056539|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3
7641766|NCT01902173|12056540|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0
7641767|NCT01902173|12056541|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0
7641768|NCT01902173|12056542|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0
7641769|NCT01902173|12056543|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0
7641770|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7641771|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7641772|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3
7641773|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7641774|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7641775|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7641776|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7641777|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7641778|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1
7641779|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7641780|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7641781|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7641782|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7641783|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7641784|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7641785|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1
7641786|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7641787|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7641788|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7641789|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7641790|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7641791|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2
7641792|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7641793|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7641794|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7641795|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7641796|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7641797|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7641798|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1
7641799|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7641800|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7641801|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7641802|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7641803|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7641804|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2
7641805|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7641806|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7641807|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7641808|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7641809|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7641810|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7641811|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1
7641812|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7641813|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7641814|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7641815|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7641816|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7641817|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3
7641818|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0
7641819|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0
7641820|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0
7641821|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0
7641822|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0
7641823|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1
7641824|NCT01900691|12056560|FG000|Overall Study|Death|7
7641825|NCT01900691|12056560|FG000|Overall Study|Lost to Follow-up|4
7641826|NCT01900691|12056560|FG000|Overall Study|Study Device Not Placed|3
7641827|NCT01900691|12056560|FG000|Overall Study|Non study stent placed|2
7641828|NCT01900691|12056560|FG000|Overall Study|Six month Follow up completed, stent not removed|2
7641829|NCT01900691|12056560|FG000|Overall Study|Complete stent migration through digestive tract|1
7641830|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0
7641831|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0
7641832|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0
7641833|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0
7641834|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2
7641835|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0
7641836|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0
7641837|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0
7641838|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0
7641839|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1
7641840|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0
7641841|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0
7641842|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0
7641843|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0
7641844|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7
7641845|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0
7641846|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0
7641847|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0
7641848|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0
7641849|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9
7641850|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0
7641851|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0
7641852|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0
7641853|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0
7641854|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2
7641855|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0
7641856|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0
7641857|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0
7641858|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0
7641859|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1
7641860|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0
7641861|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0
7641862|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0
7641863|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0
7641864|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1
7641865|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0
7641866|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0
7641867|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0
7641868|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0
7641869|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1
7641870|NCT01898494|12056569|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0
7641871|NCT01898494|12056570|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0
7641872|NCT01898494|12056571|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2
7641873|NCT01898494|12056572|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3
7641874|NCT01898494|12056573|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0
7641875|NCT01898494|12056569|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0
7641876|NCT01898494|12056570|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0
7641877|NCT01898494|12056571|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6
7641878|NCT01898494|12056572|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3
7641879|NCT01898494|12056573|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0
7641880|NCT01898494|12056569|FG000|Step 2 (Adjuvant Treatment)|Death|0
7641881|NCT01898494|12056570|FG001|Step 2 (Adjuvant Treatment)|Death|0
7641882|NCT01898494|12056571|FG002|Step 2 (Adjuvant Treatment)|Death|0
7641883|NCT01898494|12056572|FG003|Step 2 (Adjuvant Treatment)|Death|1
7641884|NCT01898494|12056573|FG004|Step 2 (Adjuvant Treatment)|Death|0
7641885|NCT01898494|12056569|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0
7641886|NCT01898494|12056570|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1
7641887|NCT01898494|12056571|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0
7641888|NCT01898494|12056572|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0
7641889|NCT01898494|12056573|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0
7641890|NCT01898494|12056569|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0
7641891|NCT01898494|12056570|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0
7641892|NCT01898494|12056571|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1
7641893|NCT01898494|12056572|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0
7641894|NCT01898494|12056573|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0
7641895|NCT01898494|12056569|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0
7641896|NCT01898494|12056570|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6
7641897|NCT01898494|12056571|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5
7641898|NCT01898494|12056572|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4
7641899|NCT01898494|12056573|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0
7641900|NCT01892722|12056591|FG000|Overall Study|Protocol deviation|0
7641901|NCT01892722|12056592|FG001|Overall Study|Protocol deviation|1
7641902|NCT01892722|12056591|FG000|Overall Study|Administrative problems|0
7641903|NCT01892722|12056592|FG001|Overall Study|Administrative problems|1
7641904|NCT01892722|12056591|FG000|Overall Study|Patient/guardian decision|0
7641905|NCT01892722|12056592|FG001|Overall Study|Patient/guardian decision|2
7641906|NCT01892722|12056591|FG000|Overall Study|Physician Decision|1
7641907|NCT01892722|12056592|FG001|Overall Study|Physician Decision|2
7641908|NCT01892722|12056591|FG000|Overall Study|Adverse Event|3
7641909|NCT01892722|12056592|FG001|Overall Study|Adverse Event|2
7641910|NCT01892722|12056591|FG000|Overall Study|Lack of Efficacy|0
7641911|NCT01892722|12056592|FG001|Overall Study|Lack of Efficacy|7
7641912|NCT01892722|12056591|FG000|Overall Study|Withdrawal by Subject|3
7641913|NCT01892722|12056592|FG001|Overall Study|Withdrawal by Subject|5
7641914|NCT01892657|12056598|FG000|Overall Study|Withdrawal by Subject|6
7641915|NCT01892657|12056598|FG000|Overall Study|Protocol Violation|12
7641916|NCT01886872|12056626|FG000|Overall Study|Ineligible|7
7641917|NCT01886872|12056627|FG001|Overall Study|Ineligible|4
7641918|NCT01886872|12056628|FG002|Overall Study|Ineligible|12
7641919|NCT01872715|12056653|FG000|Overall Study|Adverse Event|1
7641920|NCT01872715|12056653|FG000|Overall Study|Protocol Violation|1
7641921|NCT01872715|12056653|FG000|Overall Study|Withdrawal by Subject|2
7641922|NCT01867580|12056669|FG000|Overall Study|Withdrawal by Subject|2
7641923|NCT01867580|12056670|FG001|Overall Study|Withdrawal by Subject|3
7641924|NCT01867580|12056669|FG000|Overall Study|Physician Decision|17
7641925|NCT01867580|12056670|FG001|Overall Study|Physician Decision|12
7641926|NCT01867580|12056669|FG000|Overall Study|Lost to Follow-up|3
7641927|NCT01867580|12056670|FG001|Overall Study|Lost to Follow-up|5
7641928|NCT01867580|12056669|FG000|Overall Study|Sponsor terminated study|1
7641929|NCT01867580|12056670|FG001|Overall Study|Sponsor terminated study|0
7641930|NCT01867580|12056669|FG000|Overall Study|Missed follow-up assessment|2
7641931|NCT01867580|12056670|FG001|Overall Study|Missed follow-up assessment|1
7641932|NCT01867580|12056669|FG000|Overall Study|Interruption to therapy|3
7641933|NCT01867580|12056670|FG001|Overall Study|Interruption to therapy|0
7641934|NCT01867580|12056669|FG000|Overall Study|Osteomyelitis|0
7641935|NCT01867580|12056670|FG001|Overall Study|Osteomyelitis|1
7641936|NCT01867580|12056669|FG000|Overall Study|Continuation of therapy|0
7641937|NCT01867580|12056670|FG001|Overall Study|Continuation of therapy|1
7641938|NCT01867580|12056669|FG000|Overall Study|Wound recurrence|0
7641939|NCT01867580|12056670|FG001|Overall Study|Wound recurrence|1
7641940|NCT01865812|12056676|FG000|Primary Treatment Phase|Adverse Event|2
7641941|NCT01865812|12056677|FG001|Primary Treatment Phase|Adverse Event|0
7641942|NCT01865812|12056676|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0
7641943|NCT01865812|12056677|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1
7641944|NCT01865812|12056676|FG000|Long-term Safety Extension Phase|Pruritus|0
7641945|NCT01865812|12056677|FG001|Long-term Safety Extension Phase|Pruritus|3
7641946|NCT01865812|12056676|FG000|Long-term Safety Extension Phase|Physician Decision|0
7641947|NCT01865812|12056677|FG001|Long-term Safety Extension Phase|Physician Decision|1
7641948|NCT01865812|12056676|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0
7641949|NCT01865812|12056677|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1
7641950|NCT01864018|12056686|FG000|Overall Study|Ineligible|3
7641951|NCT01864018|12056687|FG001|Overall Study|Ineligible|1
7641952|NCT01856192|12056700|FG000|Overall Study|Adverse Event|12
7641953|NCT01856192|12056701|FG001|Overall Study|Adverse Event|4
7641954|NCT01856192|12056700|FG000|Overall Study|Alternative therapy|0
7641955|NCT01856192|12056701|FG001|Overall Study|Alternative therapy|3
7641956|NCT01856192|12056700|FG000|Overall Study|Death|3
7641957|NCT01856192|12056701|FG001|Overall Study|Death|5
7641958|NCT01856192|12056700|FG000|Overall Study|Lack of Efficacy|0
7641959|NCT01856192|12056701|FG001|Overall Study|Lack of Efficacy|5
7641960|NCT01856192|12056700|FG000|Overall Study|Withdrawal by Subject|1
7641961|NCT01856192|12056701|FG001|Overall Study|Withdrawal by Subject|1
7641962|NCT01856192|12056700|FG000|Overall Study|Other diseases|1
7641963|NCT01856192|12056701|FG001|Overall Study|Other diseases|0
7641964|NCT01856192|12056700|FG000|Overall Study|Never started treatment|7
7641965|NCT01856192|12056701|FG001|Overall Study|Never started treatment|5
7641966|NCT01856192|12056700|FG000|Overall Study|Path ineligible|20
7641967|NCT01856192|12056701|FG001|Overall Study|Path ineligible|34
7641968|NCT01856192|12056700|FG000|Overall Study|Non-path ineligible|2
7641969|NCT01856192|12056701|FG001|Overall Study|Non-path ineligible|2
7641970|NCT01856192|12056700|FG000|Overall Study|Physician Decision|1
7641971|NCT01856192|12056701|FG001|Overall Study|Physician Decision|1
7641972|NCT01856192|12056700|FG000|Overall Study|Suspicion of progressive disease|1
7641973|NCT01856192|12056701|FG001|Overall Study|Suspicion of progressive disease|0
7641974|NCT01856192|12056700|FG000|Overall Study|Non-compliance|1
7641975|NCT01856192|12056701|FG001|Overall Study|Non-compliance|0
7641976|NCT01850524|12056743|FG000|Overall Study|Ongoing on Treatment|57
7641977|NCT01850524|12056744|FG001|Overall Study|Ongoing on Treatment|54
7641978|NCT01850524|12056743|FG000|Overall Study|Adverse Event|96
7641979|NCT01850524|12056744|FG001|Overall Study|Adverse Event|122
7641980|NCT01850524|12056743|FG000|Overall Study|Lost to Follow-up|2
7641981|NCT01850524|12056744|FG001|Overall Study|Lost to Follow-up|0
7641982|NCT01850524|12056743|FG000|Overall Study|Progressive Disease|166
7641983|NCT01850524|12056744|FG001|Overall Study|Progressive Disease|123
7641984|NCT01850524|12056743|FG000|Overall Study|Protocol Violation|1
7641985|NCT01850524|12056744|FG001|Overall Study|Protocol Violation|2
7641986|NCT01850524|12056743|FG000|Overall Study|Withdrawal by Subject|8
7641987|NCT01850524|12056744|FG001|Overall Study|Withdrawal by Subject|19
7641988|NCT01850524|12056743|FG000|Overall Study|Participant Wished to Discontinue Treatment|15
7641989|NCT01850524|12056744|FG001|Overall Study|Participant Wished to Discontinue Treatment|22
7641990|NCT01850524|12056743|FG000|Overall Study|Investigator Decision|4
7641991|NCT01850524|12056744|FG001|Overall Study|Investigator Decision|4
7641992|NCT01850524|12056743|FG000|Overall Study|Participants Removed From Study|0
7641993|NCT01850524|12056744|FG001|Overall Study|Participants Removed From Study|1
7641994|NCT01850524|12056743|FG000|Overall Study|Medical Monitor Decision|0
7641995|NCT01850524|12056744|FG001|Overall Study|Medical Monitor Decision|1
7641996|NCT01850524|12056743|FG000|Overall Study|Participants Decision|2
7641997|NCT01850524|12056744|FG001|Overall Study|Participants Decision|2
7641998|NCT01850524|12056743|FG000|Overall Study|Progressive Disease Per Local Lab|1
7641999|NCT01850524|12056744|FG001|Overall Study|Progressive Disease Per Local Lab|0
7642000|NCT01850524|12056743|FG000|Overall Study|Lack of Improvement|0
7642001|NCT01850524|12056744|FG001|Overall Study|Lack of Improvement|1
7642002|NCT01850524|12056743|FG000|Overall Study|Minimal Response|1
7642003|NCT01850524|12056744|FG001|Overall Study|Minimal Response|0
7642004|NCT01850524|12056743|FG000|Overall Study|Comorbidities|1
7642005|NCT01850524|12056744|FG001|Overall Study|Comorbidities|0
7642006|NCT01844986|12056769|FG000|Overall Study|Severe non-compliance to protocol|1
7642007|NCT01844986|12056770|FG001|Overall Study|Severe non-compliance to protocol|0
7642008|NCT01844986|12056769|FG000|Overall Study|Withdrawal by Subject|21
7642009|NCT01844986|12056770|FG001|Overall Study|Withdrawal by Subject|14
7642010|NCT01844986|12056769|FG000|Overall Study|Death|55
7642011|NCT01844986|12056770|FG001|Overall Study|Death|26
7642012|NCT01844518|12056778|FG000|Overall Study|Adverse Event|7
7642013|NCT01844518|12056779|FG001|Overall Study|Adverse Event|1
7642014|NCT01844518|12056778|FG000|Overall Study|Lack of Efficacy|17
7642015|NCT01844518|12056779|FG001|Overall Study|Lack of Efficacy|5
7642016|NCT01844518|12056778|FG000|Overall Study|Participant's request to discontinue|4
7642017|NCT01844518|12056779|FG001|Overall Study|Participant's request to discontinue|1
7642018|NCT01844518|12056778|FG000|Overall Study|Poor/Non-compliance|1
7642019|NCT01844518|12056779|FG001|Overall Study|Poor/Non-compliance|0
7642020|NCT01844518|12056778|FG000|Overall Study|No Longer Met Study Criteria|2
7642021|NCT01844518|12056779|FG001|Overall Study|No Longer Met Study Criteria|0
7642022|NCT01844518|12056778|FG000|Overall Study|Withdrawal by Subject|9
7642023|NCT01844518|12056779|FG001|Overall Study|Withdrawal by Subject|0
7642024|NCT01844518|12056778|FG000|Overall Study|Pregnancy|1
7642025|NCT01844518|12056779|FG001|Overall Study|Pregnancy|0
7642026|NCT01843374|12056790|FG000|Overall Study|Death|155
7642027|NCT01843374|12056791|FG001|Overall Study|Death|313
7642028|NCT01843374|12056790|FG000|Overall Study|Withdrawal by Subject|14
7642029|NCT01843374|12056791|FG001|Overall Study|Withdrawal by Subject|20
7642030|NCT01843374|12056790|FG000|Overall Study|Withdrawing due to Other reason|20
7642031|NCT01843374|12056791|FG001|Overall Study|Withdrawing due to Other reason|46
7642032|NCT01835145|12056830|FG000|Overall Study|Ineligible prior to treatment|1
7642033|NCT01835145|12056831|FG001|Overall Study|Ineligible prior to treatment|0
7642034|NCT01831596|12056839|FG000|Overall Study|Other|8
7642051|NCT01809691|12056863|FG000|Overall Study|Currently on Treatment|192
7642052|NCT01809691|12056864|FG001|Overall Study|Currently on Treatment|100
7642053|NCT01809691|12056863|FG000|Overall Study|No Protocol Treatment|10
7642054|NCT01809691|12056864|FG001|Overall Study|No Protocol Treatment|11
7642055|NCT01809691|12056863|FG000|Overall Study|Adverse Event|80
7642056|NCT01809691|12056864|FG001|Overall Study|Adverse Event|21
7642057|NCT01809691|12056863|FG000|Overall Study|Disease Progression|226
7642058|NCT01809691|12056864|FG001|Overall Study|Disease Progression|372
7642059|NCT01809691|12056863|FG000|Overall Study|Death|26
7642060|NCT01809691|12056864|FG001|Overall Study|Death|13
7642061|NCT01809691|12056863|FG000|Overall Study|Participant Refusal|70
7642062|NCT01809691|12056864|FG001|Overall Study|Participant Refusal|72
7642063|NCT01809691|12056863|FG000|Overall Study|Other, Not Specified|34
7642064|NCT01809691|12056864|FG001|Overall Study|Other, Not Specified|52
7642065|NCT01802632|12056880|FG000|Overall Study|Death|28
7642066|NCT01802632|12056881|FG001|Overall Study|Death|1
7642067|NCT01802632|12056882|FG002|Overall Study|Death|38
7642068|NCT01802632|12056883|FG003|Overall Study|Death|0
7642069|NCT01802632|12056884|FG004|Overall Study|Death|2
7642070|NCT01802632|12056885|FG005|Overall Study|Death|0
7642071|NCT01802632|12056880|FG000|Overall Study|Withdrawal by Subject|4
7642072|NCT01802632|12056881|FG001|Overall Study|Withdrawal by Subject|2
7642073|NCT01802632|12056882|FG002|Overall Study|Withdrawal by Subject|7
7642074|NCT01802632|12056883|FG003|Overall Study|Withdrawal by Subject|3
7642075|NCT01802632|12056884|FG004|Overall Study|Withdrawal by Subject|0
7642076|NCT01802632|12056885|FG005|Overall Study|Withdrawal by Subject|1
7642077|NCT01802632|12056880|FG000|Overall Study|Objective Disease Progression|1
7642078|NCT01802632|12056881|FG001|Overall Study|Objective Disease Progression|12
7642079|NCT01802632|12056882|FG002|Overall Study|Objective Disease Progression|104
7642080|NCT01802632|12056883|FG003|Overall Study|Objective Disease Progression|6
7642081|NCT01802632|12056884|FG004|Overall Study|Objective Disease Progression|4
7642082|NCT01802632|12056885|FG005|Overall Study|Objective Disease Progression|4
7642083|NCT01802632|12056880|FG000|Overall Study|Ongoing Study at Data Cut-off|168
7642084|NCT01802632|12056881|FG001|Overall Study|Ongoing Study at Data Cut-off|16
7642085|NCT01802632|12056882|FG002|Overall Study|Ongoing Study at Data Cut-off|115
7642086|NCT01802632|12056883|FG003|Overall Study|Ongoing Study at Data Cut-off|50
7642087|NCT01802632|12056884|FG004|Overall Study|Ongoing Study at Data Cut-off|6
7642088|NCT01802632|12056885|FG005|Overall Study|Ongoing Study at Data Cut-off|22
7642089|NCT01802632|12056880|FG000|Overall Study|Other (not specified)|0
7642090|NCT01802632|12056881|FG001|Overall Study|Other (not specified)|0
7642091|NCT01802632|12056882|FG002|Overall Study|Other (not specified)|7
7642092|NCT01802632|12056883|FG003|Overall Study|Other (not specified)|1
7642093|NCT01802632|12056884|FG004|Overall Study|Other (not specified)|0
7642094|NCT01802632|12056885|FG005|Overall Study|Other (not specified)|1
7642095|NCT01802281|12056899|FG000|Overall Study|Death|1
7642096|NCT01802281|12056900|FG001|Overall Study|Death|2
7642097|NCT01802281|12056899|FG000|Overall Study|Withdrawal by Subject|2
7642098|NCT01802281|12056900|FG001|Overall Study|Withdrawal by Subject|1
7642099|NCT01802281|12056899|FG000|Overall Study|Ineligible|5
7642100|NCT01802281|12056900|FG001|Overall Study|Ineligible|3
7642101|NCT01794338|12056930|FG000|Overall Study|Death|2
7642102|NCT01794338|12056931|FG001|Overall Study|Death|0
7642103|NCT01794338|12056930|FG000|Overall Study|Lost to Follow-up|6
7642104|NCT01794338|12056931|FG001|Overall Study|Lost to Follow-up|9
7642105|NCT01791985|12056937|FG000|Overall Study|Adverse Event|7
7642106|NCT01791985|12056937|FG000|Overall Study|Withdrawal by Subject|1
7642107|NCT01776840|12056974|FG000|Overall Study|Lost to Follow-up|4
7642108|NCT01776840|12056975|FG001|Overall Study|Lost to Follow-up|4
7642109|NCT01776840|12056974|FG000|Overall Study|Withdrawal by Subject|42
7642110|NCT01776840|12056975|FG001|Overall Study|Withdrawal by Subject|22
7642111|NCT01776840|12056974|FG000|Overall Study|Ongoing|112
7642112|NCT01776840|12056975|FG001|Overall Study|Ongoing|129
7642113|NCT01772472|12057008|FG000|Overall Study|Death|56
7642114|NCT01772472|12057009|FG001|Overall Study|Death|42
7642115|NCT01772472|12057008|FG000|Overall Study|Physician Decision|1
7642116|NCT01772472|12057009|FG001|Overall Study|Physician Decision|3
7642117|NCT01772472|12057008|FG000|Overall Study|Other|5
7642118|NCT01772472|12057009|FG001|Overall Study|Other|5
7642119|NCT01772472|12057008|FG000|Overall Study|Lost to Follow-up|12
7642120|NCT01772472|12057009|FG001|Overall Study|Lost to Follow-up|8
7642121|NCT01772472|12057008|FG000|Overall Study|Withdrawal by Subject|72
7642122|NCT01772472|12057009|FG001|Overall Study|Withdrawal by Subject|50
7642123|NCT01772472|12057008|FG000|Overall Study|Ongoing|597
7642124|NCT01772472|12057009|FG001|Overall Study|Ongoing|635
7642125|NCT01767194|12057017|FG000|Overall Study|Adverse Event|1
7642126|NCT01767194|12057018|FG001|Overall Study|Adverse Event|1
7642127|NCT01767194|12057017|FG000|Overall Study|Death|0
7642128|NCT01767194|12057018|FG001|Overall Study|Death|1
7642129|NCT01767194|12057017|FG000|Overall Study|Lack of Efficacy|12
7642130|NCT01767194|12057018|FG001|Overall Study|Lack of Efficacy|11
7642131|NCT01767194|12057017|FG000|Overall Study|Physician Decision|2
7642132|NCT01767194|12057018|FG001|Overall Study|Physician Decision|23
7642133|NCT01767194|12057017|FG000|Overall Study|Withdrawal by Subject|0
7642134|NCT01767194|12057018|FG001|Overall Study|Withdrawal by Subject|1
7642135|NCT01767194|12057017|FG000|Overall Study|Ineligible|1
7642136|NCT01767194|12057018|FG001|Overall Study|Ineligible|1
7642137|NCT01767194|12057017|FG000|Overall Study|Refusal by patient/parent|2
7642138|NCT01767194|12057018|FG001|Overall Study|Refusal by patient/parent|4
7642139|NCT01767194|12057017|FG000|Overall Study|Criteria not met on time for next cycle|0
7642140|NCT01767194|12057018|FG001|Overall Study|Criteria not met on time for next cycle|1
7642141|NCT01760447|12057029|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
7642142|NCT01760447|12057030|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
7642143|NCT01760447|12057031|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1
7642144|NCT01760447|12057032|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3
7642145|NCT01760447|12057029|FG000|Weeks 0-20|Withdrawal by Subject|2
7642146|NCT01760447|12057030|FG001|Weeks 0-20|Withdrawal by Subject|0
7642147|NCT01760447|12057031|FG002|Weeks 0-20|Withdrawal by Subject|1
7642148|NCT01760447|12057032|FG003|Weeks 0-20|Withdrawal by Subject|0
7642149|NCT01760447|12057029|FG000|Weeks 0-20|Lost to Follow-up|1
7642150|NCT01760447|12057030|FG001|Weeks 0-20|Lost to Follow-up|0
7642151|NCT01760447|12057031|FG002|Weeks 0-20|Lost to Follow-up|1
7642152|NCT01760447|12057032|FG003|Weeks 0-20|Lost to Follow-up|1
7642153|NCT01760447|12057029|FG000|Weeks 0-20|Randomized but not treated|0
7642154|NCT01760447|12057030|FG001|Weeks 0-20|Randomized but not treated|0
7642155|NCT01760447|12057031|FG002|Weeks 0-20|Randomized but not treated|2
7642156|NCT01760447|12057032|FG003|Weeks 0-20|Randomized but not treated|0
7642157|NCT01760447|12057029|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
7642158|NCT01760447|12057030|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
7642159|NCT01760447|12057031|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
7642160|NCT01760447|12057032|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0
7642161|NCT01760447|12057029|FG000|Weeks 20-54|Withdrawal by Subject|2
7642162|NCT01760447|12057030|FG001|Weeks 20-54|Withdrawal by Subject|1
7642163|NCT01760447|12057031|FG002|Weeks 20-54|Withdrawal by Subject|1
7642164|NCT01760447|12057032|FG003|Weeks 20-54|Withdrawal by Subject|2
7642165|NCT01760447|12057029|FG000|Weeks 20-54|Lost to Follow-up|0
7642166|NCT01760447|12057030|FG001|Weeks 20-54|Lost to Follow-up|0
7642167|NCT01760447|12057031|FG002|Weeks 20-54|Lost to Follow-up|1
7642168|NCT01760447|12057032|FG003|Weeks 20-54|Lost to Follow-up|2
7642169|NCT01757535|12057050|FG000|Overall Study|Disease Relapse|143
7642170|NCT01757535|12057051|FG001|Overall Study|Disease Relapse|180
7642171|NCT01757535|12057050|FG000|Overall Study|Adverse Event|29
7642172|NCT01757535|12057051|FG001|Overall Study|Adverse Event|11
7642173|NCT01757535|12057050|FG000|Overall Study|Withdrawal by Subject|9
7642174|NCT01757535|12057051|FG001|Overall Study|Withdrawal by Subject|13
7642175|NCT01757535|12057050|FG000|Overall Study|Miscellaneous|5
7642176|NCT01757535|12057051|FG001|Overall Study|Miscellaneous|2
7642177|NCT01757535|12057050|FG000|Overall Study|Physician Decision|6
7642178|NCT01757535|12057051|FG001|Overall Study|Physician Decision|0
7642179|NCT01757535|12057050|FG000|Overall Study|Death|1
7642180|NCT01757535|12057051|FG001|Overall Study|Death|2
7642181|NCT01750281|12057069|FG000|Overall Study|Discontinued Selumetinib/Placebo|37
7642182|NCT01750281|12057070|FG001|Overall Study|Discontinued Selumetinib/Placebo|77
7642183|NCT01750281|12057071|FG002|Overall Study|Discontinued Selumetinib/Placebo|75
7642184|NCT01750281|12057069|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
7642185|NCT01750281|12057070|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
7642186|NCT01750281|12057071|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
7642187|NCT01750281|12057069|FG000|Overall Study|Did not receive treatment|0
7642188|NCT01750281|12057070|FG001|Overall Study|Did not receive treatment|1
7642189|NCT01750281|12057071|FG002|Overall Study|Did not receive treatment|0
7642190|NCT01740427|12057093|FG000|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
7642191|NCT01740427|12057094|FG001|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
7642192|NCT01740427|12057093|FG000|Overall Study|Objective progression or relapse|172
7642193|NCT01740427|12057094|FG001|Overall Study|Objective progression or relapse|125
7642194|NCT01740427|12057093|FG000|Overall Study|Adverse Event|20
7642195|NCT01740427|12057094|FG001|Overall Study|Adverse Event|9
7642196|NCT01740427|12057093|FG000|Overall Study|Global deterioration of health status|16
7642197|NCT01740427|12057094|FG001|Overall Study|Global deterioration of health status|9
7642198|NCT01740427|12057093|FG000|Overall Study|Subject refused continued treatment|12
7642199|NCT01740427|12057094|FG001|Overall Study|Subject refused continued treatment|9
7642200|NCT01740427|12057093|FG000|Overall Study|Unspecified reasons|6
7642201|NCT01740427|12057094|FG001|Overall Study|Unspecified reasons|4
7642202|NCT01740427|12057093|FG000|Overall Study|Death|6
7642203|NCT01740427|12057094|FG001|Overall Study|Death|2
7642204|NCT01740427|12057093|FG000|Overall Study|Protocol Violation|5
7642205|NCT01740427|12057094|FG001|Overall Study|Protocol Violation|3
7642206|NCT01740427|12057093|FG000|Overall Study|Lost to Follow-up|1
7642207|NCT01740427|12057094|FG001|Overall Study|Lost to Follow-up|0
7642208|NCT01740427|12057093|FG000|Overall Study|Study terminated by Sponsor|1
7642209|NCT01740427|12057094|FG001|Overall Study|Study terminated by Sponsor|0
7642210|NCT01730118|12057107|FG000|Dose Escalation|Death on study|5
7642211|NCT01730118|12057108|FG001|Dose Escalation|Death on study|7
7642212|NCT01730118|12057109|FG002|Dose Escalation|Death on study|2
7642213|NCT01730118|12057110|FG003|Dose Escalation|Death on study|6
7642214|NCT01730118|12057111|FG004|Dose Escalation|Death on study|0
7642215|NCT01730118|12057112|FG005|Dose Escalation|Death on study|0
7642216|NCT01730118|12057113|FG006|Dose Escalation|Death on study|0
7642217|NCT01730118|12057107|FG000|Dose Escalation|Died before treatment|0
7642218|NCT01730118|12057108|FG001|Dose Escalation|Died before treatment|0
7642219|NCT01730118|12057109|FG002|Dose Escalation|Died before treatment|0
7642220|NCT01730118|12057110|FG003|Dose Escalation|Died before treatment|0
7642221|NCT01730118|12057111|FG004|Dose Escalation|Died before treatment|0
7642222|NCT01730118|12057112|FG005|Dose Escalation|Died before treatment|0
7642223|NCT01730118|12057113|FG006|Dose Escalation|Died before treatment|1
7642224|NCT01730118|12057107|FG000|Dose Escalation|Chose to start a different treatment|1
7642225|NCT01730118|12057108|FG001|Dose Escalation|Chose to start a different treatment|0
7642226|NCT01730118|12057109|FG002|Dose Escalation|Chose to start a different treatment|0
7642227|NCT01730118|12057110|FG003|Dose Escalation|Chose to start a different treatment|0
7642228|NCT01730118|12057111|FG004|Dose Escalation|Chose to start a different treatment|0
7642229|NCT01730118|12057112|FG005|Dose Escalation|Chose to start a different treatment|0
7642230|NCT01730118|12057113|FG006|Dose Escalation|Chose to start a different treatment|0
7642231|NCT01730118|12057107|FG000|Dose Escalation|Withdrawal by Subject|0
7642232|NCT01730118|12057108|FG001|Dose Escalation|Withdrawal by Subject|0
7642233|NCT01730118|12057109|FG002|Dose Escalation|Withdrawal by Subject|1
7642234|NCT01730118|12057110|FG003|Dose Escalation|Withdrawal by Subject|0
7642235|NCT01730118|12057111|FG004|Dose Escalation|Withdrawal by Subject|0
7642236|NCT01730118|12057112|FG005|Dose Escalation|Withdrawal by Subject|0
7642237|NCT01730118|12057113|FG006|Dose Escalation|Withdrawal by Subject|0
7642238|NCT01730118|12057107|FG000|Dose Escalation|Disease progression prior to treatment|0
7642239|NCT01730118|12057108|FG001|Dose Escalation|Disease progression prior to treatment|0
7642240|NCT01730118|12057109|FG002|Dose Escalation|Disease progression prior to treatment|0
7642241|NCT01730118|12057110|FG003|Dose Escalation|Disease progression prior to treatment|0
7642242|NCT01730118|12057111|FG004|Dose Escalation|Disease progression prior to treatment|0
7642243|NCT01730118|12057112|FG005|Dose Escalation|Disease progression prior to treatment|0
7642244|NCT01730118|12057113|FG006|Dose Escalation|Disease progression prior to treatment|1
7642245|NCT01730118|12057107|FG000|Dose Expansion|Death|0
7642246|NCT01730118|12057108|FG001|Dose Expansion|Death|0
7642247|NCT01730118|12057109|FG002|Dose Expansion|Death|0
7642248|NCT01730118|12057110|FG003|Dose Expansion|Death|0
7642249|NCT01730118|12057111|FG004|Dose Expansion|Death|1
7642250|NCT01730118|12057112|FG005|Dose Expansion|Death|0
7642251|NCT01730118|12057113|FG006|Dose Expansion|Death|0
7642252|NCT01730118|12057107|FG000|Dose Expansion|Other medical condition|0
7642253|NCT01730118|12057108|FG001|Dose Expansion|Other medical condition|0
7642254|NCT01730118|12057109|FG002|Dose Expansion|Other medical condition|0
7642255|NCT01730118|12057110|FG003|Dose Expansion|Other medical condition|0
7642256|NCT01730118|12057111|FG004|Dose Expansion|Other medical condition|1
7642257|NCT01730118|12057112|FG005|Dose Expansion|Other medical condition|0
7642258|NCT01730118|12057113|FG006|Dose Expansion|Other medical condition|0
7642259|NCT01730118|12057107|FG000|Dose Expansion|Withdrawal by Subject|0
7642260|NCT01730118|12057108|FG001|Dose Expansion|Withdrawal by Subject|0
7642261|NCT01730118|12057109|FG002|Dose Expansion|Withdrawal by Subject|0
7642262|NCT01730118|12057110|FG003|Dose Expansion|Withdrawal by Subject|0
7642263|NCT01730118|12057111|FG004|Dose Expansion|Withdrawal by Subject|1
7642264|NCT01730118|12057112|FG005|Dose Expansion|Withdrawal by Subject|0
7642265|NCT01730118|12057113|FG006|Dose Expansion|Withdrawal by Subject|0
7642266|NCT01730118|12057107|FG000|Dose Expansion|Disease progression|0
7642267|NCT01730118|12057108|FG001|Dose Expansion|Disease progression|0
7642268|NCT01730118|12057109|FG002|Dose Expansion|Disease progression|0
7642269|NCT01730118|12057110|FG003|Dose Expansion|Disease progression|0
7642270|NCT01730118|12057111|FG004|Dose Expansion|Disease progression|0
7642271|NCT01730118|12057112|FG005|Dose Expansion|Disease progression|1
7642272|NCT01730118|12057113|FG006|Dose Expansion|Disease progression|0
7642273|NCT01730118|12057107|FG000|Dose Expansion|Inability to return|0
7642274|NCT01730118|12057108|FG001|Dose Expansion|Inability to return|0
7642275|NCT01730118|12057109|FG002|Dose Expansion|Inability to return|0
7642276|NCT01730118|12057110|FG003|Dose Expansion|Inability to return|0
7642277|NCT01730118|12057111|FG004|Dose Expansion|Inability to return|0
7642278|NCT01730118|12057112|FG005|Dose Expansion|Inability to return|1
7642279|NCT01730118|12057113|FG006|Dose Expansion|Inability to return|0
7642280|NCT01730118|12057107|FG000|Dose Expansion|Physician Decision|0
7642281|NCT01730118|12057108|FG001|Dose Expansion|Physician Decision|0
7642282|NCT01730118|12057109|FG002|Dose Expansion|Physician Decision|0
7642283|NCT01730118|12057110|FG003|Dose Expansion|Physician Decision|0
7642284|NCT01730118|12057111|FG004|Dose Expansion|Physician Decision|0
7642285|NCT01730118|12057112|FG005|Dose Expansion|Physician Decision|1
7642286|NCT01730118|12057113|FG006|Dose Expansion|Physician Decision|0
7642287|NCT01723774|12057144|FG000|Neoadjuvant|Ki67 > 10%|4
7642288|NCT01723774|12057145|FG001|Neoadjuvant|Ki67 > 10%|0
7642289|NCT01723774|12057146|FG002|Neoadjuvant|Ki67 > 10%|10
7642290|NCT01723774|12057147|FG003|Neoadjuvant|Ki67 > 10%|0
7642291|NCT01723774|12057144|FG000|Neoadjuvant|Withdrawal by Subject|3
7642292|NCT01723774|12057145|FG001|Neoadjuvant|Withdrawal by Subject|1
7642293|NCT01723774|12057146|FG002|Neoadjuvant|Withdrawal by Subject|0
7642294|NCT01723774|12057147|FG003|Neoadjuvant|Withdrawal by Subject|0
7642295|NCT01723774|12057144|FG000|Neoadjuvant|Disease progression|0
7642296|NCT01723774|12057145|FG001|Neoadjuvant|Disease progression|1
7642297|NCT01723774|12057146|FG002|Neoadjuvant|Disease progression|1
7642298|NCT01723774|12057147|FG003|Neoadjuvant|Disease progression|0
7642299|NCT01723774|12057144|FG000|Neoadjuvant|Adverse Event|0
7642300|NCT01723774|12057145|FG001|Neoadjuvant|Adverse Event|1
7642301|NCT01723774|12057146|FG002|Neoadjuvant|Adverse Event|2
7642302|NCT01723774|12057147|FG003|Neoadjuvant|Adverse Event|0
7642303|NCT01723774|12057144|FG000|Neoadjuvant|High estradiol|0
7642304|NCT01723774|12057145|FG001|Neoadjuvant|High estradiol|1
7642305|NCT01723774|12057146|FG002|Neoadjuvant|High estradiol|0
7642306|NCT01723774|12057147|FG003|Neoadjuvant|High estradiol|0
7642307|NCT01723774|12057144|FG000|Adjuvant|Still on active treatment|0
7642308|NCT01723774|12057145|FG001|Adjuvant|Still on active treatment|0
7642309|NCT01723774|12057146|FG002|Adjuvant|Still on active treatment|0
7642310|NCT01723774|12057147|FG003|Adjuvant|Still on active treatment|1
7642311|NCT01719237|12057158|FG000|Overall Study|Physician Decision|0
7642312|NCT01719237|12057159|FG001|Overall Study|Physician Decision|1
7642313|NCT01711541|12057170|FG000|Overall Study|Cancel prior to treatment|0
7642314|NCT01711541|12057171|FG001|Overall Study|Cancel prior to treatment|0
7642315|NCT01711541|12057172|FG002|Overall Study|Cancel prior to treatment|0
7642316|NCT01711541|12057173|FG003|Overall Study|Cancel prior to treatment|1
7642317|NCT01711541|12057174|FG004|Overall Study|Cancel prior to treatment|0
7642318|NCT01711541|12057170|FG000|Overall Study|Ineligible|0
7642319|NCT01711541|12057171|FG001|Overall Study|Ineligible|1
7642320|NCT01711541|12057172|FG002|Overall Study|Ineligible|0
7642321|NCT01711541|12057173|FG003|Overall Study|Ineligible|0
7642322|NCT01711541|12057174|FG004|Overall Study|Ineligible|0
7642323|NCT01708954|12057194|FG000|Step 1|Disease progression|26
7642324|NCT01708954|12057195|FG001|Step 1|Disease progression|17
7642325|NCT01708954|12057196|FG002|Step 1|Disease progression|14
7642326|NCT01708954|12057194|FG000|Step 1|Adverse Event|3
7642327|NCT01708954|12057195|FG001|Step 1|Adverse Event|11
7642328|NCT01708954|12057196|FG002|Step 1|Adverse Event|13
7642329|NCT01708954|12057194|FG000|Step 1|Death|3
7642330|NCT01708954|12057195|FG001|Step 1|Death|2
7642331|NCT01708954|12057196|FG002|Step 1|Death|3
7642332|NCT01708954|12057194|FG000|Step 1|Withdrawal by Subject|2
7642333|NCT01708954|12057195|FG001|Step 1|Withdrawal by Subject|5
7642334|NCT01708954|12057196|FG002|Step 1|Withdrawal by Subject|3
7642335|NCT01708954|12057194|FG000|Step 1|Other complicating disease|0
7642336|NCT01708954|12057195|FG001|Step 1|Other complicating disease|2
7642337|NCT01708954|12057196|FG002|Step 1|Other complicating disease|0
7642338|NCT01708954|12057194|FG000|Step 1|Crossed over to Step 2|2
7642339|NCT01708954|12057195|FG001|Step 1|Crossed over to Step 2|0
7642340|NCT01708954|12057196|FG002|Step 1|Crossed over to Step 2|0
7642341|NCT01708954|12057194|FG000|Step 1|Symptomatic deterioration|1
7642342|NCT01708954|12057195|FG001|Step 1|Symptomatic deterioration|0
7642343|NCT01708954|12057196|FG002|Step 1|Symptomatic deterioration|1
7642344|NCT01708954|12057194|FG000|Step 1|Off-treatment reason not submitted|1
7642345|NCT01708954|12057195|FG001|Step 1|Off-treatment reason not submitted|1
7642346|NCT01708954|12057196|FG002|Step 1|Off-treatment reason not submitted|1
7642347|NCT01708954|12057194|FG000|Step 1|Ineligible or never received treatment|4
7642348|NCT01708954|12057195|FG001|Step 1|Ineligible or never received treatment|2
7642349|NCT01708954|12057196|FG002|Step 1|Ineligible or never received treatment|8
7642350|NCT01708954|12057194|FG000|Step 2|Disease progression|9
7642351|NCT01708954|12057195|FG001|Step 2|Disease progression|4
7642352|NCT01708954|12057196|FG002|Step 2|Disease progression|0
7642353|NCT01708954|12057194|FG000|Step 2|Adverse Event|3
7642354|NCT01708954|12057195|FG001|Step 2|Adverse Event|2
7642355|NCT01708954|12057196|FG002|Step 2|Adverse Event|0
7642356|NCT01708954|12057194|FG000|Step 2|Withdrawal by Subject|1
7642357|NCT01708954|12057195|FG001|Step 2|Withdrawal by Subject|1
7642358|NCT01708954|12057196|FG002|Step 2|Withdrawal by Subject|0
7642359|NCT01708941|12057209|FG000|Overall Study|Adverse Event|4
7642360|NCT01708941|12057210|FG001|Overall Study|Adverse Event|6
7642361|NCT01708941|12057211|FG002|Overall Study|Adverse Event|1
7642362|NCT01708941|12057212|FG003|Overall Study|Adverse Event|0
7642363|NCT01708941|12057209|FG000|Overall Study|Death|1
7642364|NCT01708941|12057210|FG001|Overall Study|Death|1
7642365|NCT01708941|12057211|FG002|Overall Study|Death|2
7642366|NCT01708941|12057212|FG003|Overall Study|Death|14
7642367|NCT01708941|12057209|FG000|Overall Study|Withdrawal by Subject|1
7642368|NCT01708941|12057210|FG001|Overall Study|Withdrawal by Subject|0
7642369|NCT01708941|12057211|FG002|Overall Study|Withdrawal by Subject|3
7642370|NCT01708941|12057212|FG003|Overall Study|Withdrawal by Subject|4
7642371|NCT01708941|12057209|FG000|Overall Study|Disease progression|9
7642372|NCT01708941|12057210|FG001|Overall Study|Disease progression|10
7642373|NCT01708941|12057211|FG002|Overall Study|Disease progression|8
7642374|NCT01708941|12057212|FG003|Overall Study|Disease progression|0
7642375|NCT01708941|12057209|FG000|Overall Study|Alternative therapy|0
7642376|NCT01708941|12057210|FG001|Overall Study|Alternative therapy|0
7642377|NCT01708941|12057211|FG002|Overall Study|Alternative therapy|2
7642378|NCT01708941|12057212|FG003|Overall Study|Alternative therapy|0
7642379|NCT01708941|12057209|FG000|Overall Study|Ineligible and never started treatment|1
7642380|NCT01708941|12057210|FG001|Overall Study|Ineligible and never started treatment|0
7642381|NCT01708941|12057211|FG002|Overall Study|Ineligible and never started treatment|1
7642382|NCT01708941|12057212|FG003|Overall Study|Ineligible and never started treatment|0
7642383|NCT01708941|12057209|FG000|Overall Study|Never started treatment|2
7642384|NCT01708941|12057210|FG001|Overall Study|Never started treatment|1
7642385|NCT01708941|12057211|FG002|Overall Study|Never started treatment|0
7642386|NCT01708941|12057212|FG003|Overall Study|Never started treatment|0
7642387|NCT01708941|12057209|FG000|Overall Study|Ineligible|0
7642388|NCT01708941|12057210|FG001|Overall Study|Ineligible|0
7642389|NCT01708941|12057211|FG002|Overall Study|Ineligible|2
7642390|NCT01708941|12057212|FG003|Overall Study|Ineligible|0
7642391|NCT01706939|12057224|FG000|Pre Randomization|Screen Failure|1
7642392|NCT01706939|12057225|FG001|Pre Randomization|Screen Failure|0
7642393|NCT01706939|12057226|FG002|Pre Randomization|Screen Failure|0
7642394|NCT01706939|12057224|FG000|Pre Randomization|Ineligible for Randomization|1
7642395|NCT01706939|12057225|FG001|Pre Randomization|Ineligible for Randomization|0
7642396|NCT01706939|12057226|FG002|Pre Randomization|Ineligible for Randomization|0
7642397|NCT01706939|12057224|FG000|Pre Randomization|Withdrawal by Subject|1
7642398|NCT01706939|12057225|FG001|Pre Randomization|Withdrawal by Subject|0
7642399|NCT01706939|12057226|FG002|Pre Randomization|Withdrawal by Subject|0
7642400|NCT01706939|12057224|FG000|Randomization|Insufficient QoL survey compliance|0
7642401|NCT01706939|12057225|FG001|Randomization|Insufficient QoL survey compliance|1
7642402|NCT01706939|12057226|FG002|Randomization|Insufficient QoL survey compliance|1
7642403|NCT01706939|12057224|FG000|Randomization|Progression of disease|0
7642404|NCT01706939|12057225|FG001|Randomization|Progression of disease|2
7642405|NCT01706939|12057226|FG002|Randomization|Progression of disease|1
7642406|NCT01700946|12057235|FG000|Overall Study|Lost to Follow-up|1
7642407|NCT01700946|12057236|FG001|Overall Study|Lost to Follow-up|0
7642408|NCT01700946|12057235|FG000|Overall Study|Physician Decision|7
7642409|NCT01700946|12057236|FG001|Overall Study|Physician Decision|12
7642410|NCT01700946|12057235|FG000|Overall Study|Withdrawal by Subject|0
7642411|NCT01700946|12057236|FG001|Overall Study|Withdrawal by Subject|2
7642412|NCT01700946|12057235|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0
7642413|NCT01700946|12057236|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2
7642414|NCT01700946|12057235|FG000|Overall Study|Relapse|2
7642415|NCT01700946|12057236|FG001|Overall Study|Relapse|1
7642416|NCT01700946|12057235|FG000|Overall Study|Unacceptable toxicity|1
7642417|NCT01700946|12057236|FG001|Overall Study|Unacceptable toxicity|0
7642418|NCT01696994|12057248|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
7642419|NCT01696994|12057249|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
7642420|NCT01696994|12057248|FG000|Overall Study|Died Before Randomization|1
7642421|NCT01696994|12057249|FG001|Overall Study|Died Before Randomization|2
7642422|NCT01696994|12057248|FG000|Overall Study|Died Before ASU (Control)|73
7642423|NCT01696994|12057249|FG001|Overall Study|Died Before ASU (Control)|0
7642424|NCT01696994|12057248|FG000|Overall Study|No Ovaries at Baseline|4807
7642425|NCT01696994|12057249|FG001|Overall Study|No Ovaries at Baseline|4851
7642426|NCT01696994|12057248|FG000|Overall Study|Refused ASU (Control)|311
7642427|NCT01696994|12057249|FG001|Overall Study|Refused ASU (Control)|0
7642428|NCT01696994|12057248|FG000|Overall Study|Refused Screen (Ovarian Screening)|0
7642429|NCT01696994|12057249|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582
7642430|NCT01696968|12057259|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0
7642431|NCT01696968|12057260|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8
7642432|NCT01696968|12057259|FG000|Overall Study|Died Before Randomization|3
7642433|NCT01696968|12057260|FG001|Overall Study|Died Before Randomization|8
7642434|NCT01696968|12057259|FG000|Overall Study|Died Before ASU (Control)|278
7642435|NCT01696968|12057260|FG001|Overall Study|Died Before ASU (Control)|0
7642436|NCT01696968|12057259|FG000|Overall Study|Refused ASU (Control)|920
7642437|NCT01696968|12057260|FG001|Overall Study|Refused ASU (Control)|0
7642438|NCT01696968|12057259|FG000|Overall Study|Refused Screen (Lung Screening)|0
7642439|NCT01696968|12057260|FG001|Overall Study|Refused Screen (Lung Screening)|6796
7642440|NCT01682226|12057267|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3
7642441|NCT01682226|12057267|FG000|Overall Study|Participants did not receive treatment|2
7642442|NCT01682226|12057267|FG000|Overall Study|Participants received a transplant under a different protocol|1
7642443|NCT01682148|12057273|FG000|Overall Study|Withdrawal by Subject|2
7642444|NCT01682148|12057274|FG001|Overall Study|Withdrawal by Subject|0
7642445|NCT01682148|12057273|FG000|Overall Study|Lost to Follow-up|1
7642446|NCT01682148|12057274|FG001|Overall Study|Lost to Follow-up|2
7642447|NCT01682148|12057273|FG000|Overall Study|Protocol Violation|1
7642448|NCT01682148|12057274|FG001|Overall Study|Protocol Violation|1
7642449|NCT01682083|12057287|FG000|Overall Study|Lost to Follow-up|11
7642450|NCT01682083|12057288|FG001|Overall Study|Lost to Follow-up|18
7642451|NCT01682083|12057287|FG000|Overall Study|Withdrawal by Subject|31
7642452|NCT01682083|12057288|FG001|Overall Study|Withdrawal by Subject|40
7642453|NCT01682083|12057287|FG000|Overall Study|Death|60
7642454|NCT01682083|12057288|FG001|Overall Study|Death|93
7642455|NCT01682083|12057287|FG000|Overall Study|Physician Decision|5
7642456|NCT01682083|12057288|FG001|Overall Study|Physician Decision|4
7642457|NCT01678131|12057297|FG000|Overall Study|Adverse Event|0
7642458|NCT01678131|12057298|FG001|Overall Study|Adverse Event|1
7642459|NCT01678131|12057299|FG002|Overall Study|Adverse Event|0
7642460|NCT01678131|12057297|FG000|Overall Study|Withdrawal by Subject|0
7642461|NCT01678131|12057298|FG001|Overall Study|Withdrawal by Subject|0
7642462|NCT01678131|12057299|FG002|Overall Study|Withdrawal by Subject|2
7642463|NCT01677858|12057312|FG000|Overall Study|Adverse Event|0
7642464|NCT01677858|12057313|FG001|Overall Study|Adverse Event|0
7642465|NCT01677858|12057314|FG002|Overall Study|Adverse Event|2
7642466|NCT01677858|12057315|FG003|Overall Study|Adverse Event|3
7642467|NCT01677858|12057316|FG004|Overall Study|Adverse Event|13
7642468|NCT01677858|12057312|FG000|Overall Study|Death|0
7642469|NCT01677858|12057313|FG001|Overall Study|Death|0
7642470|NCT01677858|12057314|FG002|Overall Study|Death|0
7642471|NCT01677858|12057315|FG003|Overall Study|Death|0
7642472|NCT01677858|12057316|FG004|Overall Study|Death|1
7642473|NCT01677858|12057312|FG000|Overall Study|Physician Decision|1
7642474|NCT01677858|12057313|FG001|Overall Study|Physician Decision|0
7642475|NCT01677858|12057314|FG002|Overall Study|Physician Decision|2
7642476|NCT01677858|12057315|FG003|Overall Study|Physician Decision|0
7642477|NCT01677858|12057316|FG004|Overall Study|Physician Decision|12
7642478|NCT01677858|12057312|FG000|Overall Study|Progressive Disease|2
7642479|NCT01677858|12057313|FG001|Overall Study|Progressive Disease|1
7642480|NCT01677858|12057314|FG002|Overall Study|Progressive Disease|9
7642481|NCT01677858|12057315|FG003|Overall Study|Progressive Disease|3
7642482|NCT01677858|12057316|FG004|Overall Study|Progressive Disease|43
7642483|NCT01677858|12057312|FG000|Overall Study|Withdrawal by Subject|0
7642484|NCT01677858|12057313|FG001|Overall Study|Withdrawal by Subject|1
7642485|NCT01677858|12057314|FG002|Overall Study|Withdrawal by Subject|1
7642486|NCT01677858|12057315|FG003|Overall Study|Withdrawal by Subject|0
7642487|NCT01677858|12057316|FG004|Overall Study|Withdrawal by Subject|15
7642488|NCT01677858|12057312|FG000|Overall Study|Lost to Follow-up|0
7642489|NCT01677858|12057313|FG001|Overall Study|Lost to Follow-up|0
7642490|NCT01677858|12057314|FG002|Overall Study|Lost to Follow-up|0
7642491|NCT01677858|12057315|FG003|Overall Study|Lost to Follow-up|0
7642492|NCT01677858|12057316|FG004|Overall Study|Lost to Follow-up|1
7642493|NCT01668784|12057339|FG000|Randomized (Pre-treatment)|Disease Progression|0
7642494|NCT01668784|12057340|FG001|Randomized (Pre-treatment)|Disease Progression|1
7642495|NCT01668784|12057339|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
7642496|NCT01668784|12057340|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
7642497|NCT01668784|12057339|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1
7642498|NCT01668784|12057340|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8
7642499|NCT01668784|12057339|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1
7642500|NCT01668784|12057340|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0
7642501|NCT01668784|12057339|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
7642502|NCT01668784|12057340|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
7642503|NCT01668784|12057339|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0
7642504|NCT01668784|12057340|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1
7642505|NCT01668784|12057339|FG000|Treatment Period|Disease Progression|316
7642506|NCT01668784|12057340|FG001|Treatment Period|Disease Progression|293
7642507|NCT01668784|12057339|FG000|Treatment Period|Study Drug Toxicity|46
7642508|NCT01668784|12057340|FG001|Treatment Period|Study Drug Toxicity|53
7642509|NCT01668784|12057339|FG000|Treatment Period|Death|1
7642510|NCT01668784|12057340|FG001|Treatment Period|Death|1
7642511|NCT01668784|12057339|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14
7642512|NCT01668784|12057340|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14
7642513|NCT01668784|12057339|FG000|Treatment Period|Request to Discontinue Study Treatment|14
7642514|NCT01668784|12057340|FG001|Treatment Period|Request to Discontinue Study Treatment|21
7642515|NCT01668784|12057339|FG000|Treatment Period|Withdrawal by Subject|5
7642516|NCT01668784|12057340|FG001|Treatment Period|Withdrawal by Subject|3
7642517|NCT01668784|12057339|FG000|Treatment Period|Maximal Clinical Benefit|3
7642518|NCT01668784|12057340|FG001|Treatment Period|Maximal Clinical Benefit|3
7642519|NCT01668784|12057339|FG000|Treatment Period|Other|2
7642520|NCT01668784|12057340|FG001|Treatment Period|Other|8
7642521|NCT01668784|12057339|FG000|Treatment Period|Administrative Reason by Sponsor|5
7642522|NCT01668784|12057340|FG001|Treatment Period|Administrative Reason by Sponsor|1
7642523|NCT01665144|12057348|FG000|Overall Study|New therapy for study indication|2
7642524|NCT01665144|12057349|FG001|Overall Study|New therapy for study indication|1
7642525|NCT01665144|12057348|FG000|Overall Study|Technical problems|2
7642526|NCT01665144|12057349|FG001|Overall Study|Technical problems|0
7642527|NCT01665144|12057348|FG000|Overall Study|Death|3
7642528|NCT01665144|12057349|FG001|Overall Study|Death|1
7642529|NCT01665144|12057348|FG000|Overall Study|Protocol deviation|3
7642530|NCT01665144|12057349|FG001|Overall Study|Protocol deviation|1
7642531|NCT01665144|12057348|FG000|Overall Study|Non-compliance w/study treatment|5
7642532|NCT01665144|12057349|FG001|Overall Study|Non-compliance w/study treatment|0
7642533|NCT01665144|12057348|FG000|Overall Study|Progressive disease|8
7642534|NCT01665144|12057349|FG001|Overall Study|Progressive disease|4
7642535|NCT01665144|12057348|FG000|Overall Study|Lost to Follow-up|9
7642536|NCT01665144|12057349|FG001|Overall Study|Lost to Follow-up|8
7642537|NCT01665144|12057348|FG000|Overall Study|Physician Decision|13
7642538|NCT01665144|12057349|FG001|Overall Study|Physician Decision|1
7642539|NCT01665144|12057348|FG000|Overall Study|Lack of Efficacy|16
7642540|NCT01665144|12057349|FG001|Overall Study|Lack of Efficacy|11
7642541|NCT01665144|12057348|FG000|Overall Study|Adverse Event|45
7642542|NCT01665144|12057349|FG001|Overall Study|Adverse Event|18
7642543|NCT01665144|12057348|FG000|Overall Study|Withdrawal by Subject|96
7642544|NCT01665144|12057349|FG001|Overall Study|Withdrawal by Subject|77
7642545|NCT01660451|12057358|FG000|Overall Study|Protocol Violation|0
7642546|NCT01660451|12057359|FG001|Overall Study|Protocol Violation|1
7642547|NCT01660451|12057360|FG002|Overall Study|Protocol Violation|1
7642548|NCT01660451|12057358|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11
7642549|NCT01660451|12057359|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8
7642550|NCT01660451|12057360|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26
7642551|NCT01660451|12057358|FG000|Overall Study|AE with Clinical PD|1
7642552|NCT01660451|12057359|FG001|Overall Study|AE with Clinical PD|3
7642553|NCT01660451|12057360|FG002|Overall Study|AE with Clinical PD|9
7642554|NCT01660451|12057358|FG000|Overall Study|Sponsor Decision|0
7642555|NCT01660451|12057359|FG001|Overall Study|Sponsor Decision|0
7642556|NCT01660451|12057360|FG002|Overall Study|Sponsor Decision|1
7642557|NCT01660451|12057358|FG000|Overall Study|Protocol Deviation|0
7642558|NCT01660451|12057359|FG001|Overall Study|Protocol Deviation|0
7642559|NCT01660451|12057360|FG002|Overall Study|Protocol Deviation|1
7642560|NCT01660451|12057358|FG000|Overall Study|Physician Decision|1
7642561|NCT01660451|12057359|FG001|Overall Study|Physician Decision|2
7642562|NCT01660451|12057360|FG002|Overall Study|Physician Decision|5
7642563|NCT01660451|12057358|FG000|Overall Study|Withdrawal by Subject|1
7642564|NCT01660451|12057359|FG001|Overall Study|Withdrawal by Subject|0
7642565|NCT01660451|12057360|FG002|Overall Study|Withdrawal by Subject|16
7642566|NCT01660451|12057358|FG000|Overall Study|Ongoing with treatment|3
7642567|NCT01660451|12057359|FG001|Overall Study|Ongoing with treatment|3
7642568|NCT01660451|12057360|FG002|Overall Study|Ongoing with treatment|46
7642569|NCT01659853|12057369|FG000|Washout , 3 to 7 Days|Adverse Event|1
7642570|NCT01659853|12057370|FG001|Washout , 3 to 7 Days|Adverse Event|0
7642571|NCT01659853|12057369|FG000|Washout , 3 to 7 Days|Protocol Violation|1
7642572|NCT01659853|12057370|FG001|Washout , 3 to 7 Days|Protocol Violation|0
7642573|NCT01652872|12057395|FG000|Overall Study|Death|36
7642574|NCT01652872|12057396|FG001|Overall Study|Death|39
7642575|NCT01652872|12057395|FG000|Overall Study|Lost to Follow-up|28
7642576|NCT01652872|12057396|FG001|Overall Study|Lost to Follow-up|23
7642577|NCT01652872|12057395|FG000|Overall Study|Decision by sponsor|5
7642578|NCT01652872|12057396|FG001|Overall Study|Decision by sponsor|7
7642579|NCT01652872|12057395|FG000|Overall Study|Withdrawal by Subject|76
7642580|NCT01652872|12057396|FG001|Overall Study|Withdrawal by Subject|84
7642581|NCT01652469|12057404|FG000|Overall Study|Withdrawal by Subject|1
7642582|NCT01652469|12057405|FG001|Overall Study|Withdrawal by Subject|4
7642583|NCT01652469|12057404|FG000|Overall Study|Lost to Follow-up|0
7642584|NCT01652469|12057405|FG001|Overall Study|Lost to Follow-up|2
7642585|NCT01650558|12057414|FG000|Overall Study|Migration out of study area|61
7642586|NCT01650558|12057415|FG001|Overall Study|Migration out of study area|71
7642587|NCT01650558|12057416|FG002|Overall Study|Migration out of study area|56
7642588|NCT01650558|12057414|FG000|Overall Study|Lost to Follow-up|10
7642589|NCT01650558|12057415|FG001|Overall Study|Lost to Follow-up|13
7642590|NCT01650558|12057416|FG002|Overall Study|Lost to Follow-up|6
7642591|NCT01650558|12057414|FG000|Overall Study|Death|10
7642592|NCT01650558|12057415|FG001|Overall Study|Death|6
7642593|NCT01650558|12057416|FG002|Overall Study|Death|8
7642594|NCT01650558|12057414|FG000|Overall Study|Withdrawal by Subject|1
7642595|NCT01650558|12057415|FG001|Overall Study|Withdrawal by Subject|1
7642596|NCT01650558|12057416|FG002|Overall Study|Withdrawal by Subject|3
7642597|NCT01650558|12057414|FG000|Overall Study|Non-compliant participant|1
7642598|NCT01650558|12057415|FG001|Overall Study|Non-compliant participant|0
7642599|NCT01650558|12057416|FG002|Overall Study|Non-compliant participant|2
7642600|NCT01650558|12057414|FG000|Overall Study|Physician Decision|0
7642601|NCT01650558|12057415|FG001|Overall Study|Physician Decision|1
7642602|NCT01650558|12057416|FG002|Overall Study|Physician Decision|0
7642603|NCT01639131|12057425|FG000|Overall Study|Disease Progression|6
7642604|NCT01626079|12057432|FG000|Overall Study|Death|117
7642605|NCT01626079|12057433|FG001|Overall Study|Death|153
7642606|NCT01626079|12057434|FG002|Overall Study|Death|39
7642607|NCT01626079|12057432|FG000|Overall Study|Withdrawal by Subject|15
7642608|NCT01626079|12057433|FG001|Overall Study|Withdrawal by Subject|39
7642609|NCT01626079|12057434|FG002|Overall Study|Withdrawal by Subject|5
7642610|NCT01626079|12057432|FG000|Overall Study|Lost to Follow-up|5
7642611|NCT01626079|12057433|FG001|Overall Study|Lost to Follow-up|4
7642612|NCT01626079|12057434|FG002|Overall Study|Lost to Follow-up|2
7642613|NCT01626079|12057432|FG000|Overall Study|Missed Visits|13
7642614|NCT01626079|12057433|FG001|Overall Study|Missed Visits|5
7642615|NCT01626079|12057434|FG002|Overall Study|Missed Visits|6
7642616|NCT01625611|12057447|FG000|Overall Study|No adlib drinks Lab 1|3
7642617|NCT01625611|12057448|FG001|Overall Study|No adlib drinks Lab 1|0
7642618|NCT01625611|12057447|FG000|Overall Study|Technical issues with PET|1
7642619|NCT01625611|12057448|FG001|Overall Study|Technical issues with PET|0
7642620|NCT01625611|12057447|FG000|Overall Study|Unable to complete study procedures|1
7642621|NCT01625611|12057448|FG001|Overall Study|Unable to complete study procedures|0
7642622|NCT01625611|12057447|FG000|Overall Study|Withdrawal by Subject|3
7642623|NCT01625611|12057448|FG001|Overall Study|Withdrawal by Subject|0
7642624|NCT01625286|12057462|FG000|Overall Study|Adverse Event|0
7642625|NCT01625286|12057463|FG001|Overall Study|Adverse Event|0
7642626|NCT01625286|12057464|FG002|Overall Study|Adverse Event|0
7642627|NCT01625286|12057465|FG003|Overall Study|Adverse Event|0
7642628|NCT01625286|12057466|FG004|Overall Study|Adverse Event|1
7642629|NCT01625286|12057467|FG005|Overall Study|Adverse Event|2
7642630|NCT01625286|12057468|FG006|Overall Study|Adverse Event|1
7642631|NCT01625286|12057462|FG000|Overall Study|Death|0
7642632|NCT01625286|12057463|FG001|Overall Study|Death|0
7642633|NCT01625286|12057464|FG002|Overall Study|Death|1
7642634|NCT01625286|12057465|FG003|Overall Study|Death|1
7642635|NCT01625286|12057466|FG004|Overall Study|Death|0
7642636|NCT01625286|12057467|FG005|Overall Study|Death|11
7642637|NCT01625286|12057468|FG006|Overall Study|Death|16
7642638|NCT01625286|12057462|FG000|Overall Study|Withdrawal by Subject|0
7642639|NCT01625286|12057463|FG001|Overall Study|Withdrawal by Subject|1
7642640|NCT01625286|12057464|FG002|Overall Study|Withdrawal by Subject|0
7642641|NCT01625286|12057465|FG003|Overall Study|Withdrawal by Subject|1
7642642|NCT01625286|12057466|FG004|Overall Study|Withdrawal by Subject|0
7642643|NCT01625286|12057467|FG005|Overall Study|Withdrawal by Subject|0
7642644|NCT01625286|12057468|FG006|Overall Study|Withdrawal by Subject|1
7642645|NCT01625286|12057462|FG000|Overall Study|Any reason not specifically recorded|0
7642646|NCT01625286|12057463|FG001|Overall Study|Any reason not specifically recorded|0
7642647|NCT01625286|12057464|FG002|Overall Study|Any reason not specifically recorded|0
7642648|NCT01625286|12057465|FG003|Overall Study|Any reason not specifically recorded|0
7642649|NCT01625286|12057466|FG004|Overall Study|Any reason not specifically recorded|0
7642650|NCT01625286|12057467|FG005|Overall Study|Any reason not specifically recorded|1
7642651|NCT01625286|12057468|FG006|Overall Study|Any reason not specifically recorded|0
7642652|NCT01625286|12057462|FG000|Overall Study|Progressive disease|6
7642653|NCT01625286|12057463|FG001|Overall Study|Progressive disease|3
7642654|NCT01625286|12057464|FG002|Overall Study|Progressive disease|4
7642655|NCT01625286|12057465|FG003|Overall Study|Progressive disease|5
7642656|NCT01625286|12057466|FG004|Overall Study|Progressive disease|5
7642657|NCT01625286|12057467|FG005|Overall Study|Progressive disease|0
7642658|NCT01625286|12057468|FG006|Overall Study|Progressive disease|0
7642659|NCT01625286|12057462|FG000|Overall Study|Lost to Follow-up|0
7642660|NCT01625286|12057463|FG001|Overall Study|Lost to Follow-up|0
7642661|NCT01625286|12057464|FG002|Overall Study|Lost to Follow-up|0
7642662|NCT01625286|12057465|FG003|Overall Study|Lost to Follow-up|0
7642663|NCT01625286|12057466|FG004|Overall Study|Lost to Follow-up|0
7642664|NCT01625286|12057467|FG005|Overall Study|Lost to Follow-up|0
7642665|NCT01625286|12057468|FG006|Overall Study|Lost to Follow-up|1
7642666|NCT01625286|12057462|FG000|Overall Study|Ongoing off-treatment at DCO|0
7642667|NCT01625286|12057463|FG001|Overall Study|Ongoing off-treatment at DCO|0
7642668|NCT01625286|12057464|FG002|Overall Study|Ongoing off-treatment at DCO|0
7642669|NCT01625286|12057465|FG003|Overall Study|Ongoing off-treatment at DCO|0
7642670|NCT01625286|12057466|FG004|Overall Study|Ongoing off-treatment at DCO|0
7642671|NCT01625286|12057467|FG005|Overall Study|Ongoing off-treatment at DCO|32
7642672|NCT01625286|12057468|FG006|Overall Study|Ongoing off-treatment at DCO|31
7642673|NCT01625286|12057462|FG000|Overall Study|Ongoing on-treatment at DCO|6
7642674|NCT01625286|12057463|FG001|Overall Study|Ongoing on-treatment at DCO|4
7642675|NCT01625286|12057464|FG002|Overall Study|Ongoing on-treatment at DCO|0
7642676|NCT01625286|12057465|FG003|Overall Study|Ongoing on-treatment at DCO|0
7642677|NCT01625286|12057466|FG004|Overall Study|Ongoing on-treatment at DCO|0
7642678|NCT01625286|12057467|FG005|Overall Study|Ongoing on-treatment at DCO|8
7642679|NCT01625286|12057468|FG006|Overall Study|Ongoing on-treatment at DCO|6
7642680|NCT01615029|12057508|FG000|Overall Study|Adverse Event|0
7642681|NCT01615029|12057509|FG001|Overall Study|Adverse Event|0
7642682|NCT01615029|12057510|FG002|Overall Study|Adverse Event|0
7642683|NCT01615029|12057511|FG003|Overall Study|Adverse Event|0
7642684|NCT01615029|12057512|FG004|Overall Study|Adverse Event|1
7642685|NCT01615029|12057508|FG000|Overall Study|Death|0
7642686|NCT01615029|12057509|FG001|Overall Study|Death|0
7642687|NCT01615029|12057510|FG002|Overall Study|Death|0
7642688|NCT01615029|12057511|FG003|Overall Study|Death|0
7642689|NCT01615029|12057512|FG004|Overall Study|Death|1
7642690|NCT01615029|12057508|FG000|Overall Study|Lost to Follow-up|0
7642691|NCT01615029|12057509|FG001|Overall Study|Lost to Follow-up|0
7642692|NCT01615029|12057510|FG002|Overall Study|Lost to Follow-up|0
7642693|NCT01615029|12057511|FG003|Overall Study|Lost to Follow-up|0
7642694|NCT01615029|12057512|FG004|Overall Study|Lost to Follow-up|1
7642695|NCT01615029|12057508|FG000|Overall Study|Progressive disease|2
7642696|NCT01615029|12057509|FG001|Overall Study|Progressive disease|1
7642697|NCT01615029|12057510|FG002|Overall Study|Progressive disease|1
7642698|NCT01615029|12057511|FG003|Overall Study|Progressive disease|1
7642699|NCT01615029|12057512|FG004|Overall Study|Progressive disease|5
7642700|NCT01615029|12057508|FG000|Overall Study|Physician Decision|0
7642701|NCT01615029|12057509|FG001|Overall Study|Physician Decision|0
7642702|NCT01615029|12057510|FG002|Overall Study|Physician Decision|0
7642703|NCT01615029|12057511|FG003|Overall Study|Physician Decision|0
7642704|NCT01615029|12057512|FG004|Overall Study|Physician Decision|1
7642705|NCT01615029|12057508|FG000|Overall Study|Ongoing|1
7642706|NCT01615029|12057509|FG001|Overall Study|Ongoing|2
7642707|NCT01615029|12057510|FG002|Overall Study|Ongoing|3
7642708|NCT01615029|12057511|FG003|Overall Study|Ongoing|2
7642709|NCT01615029|12057512|FG004|Overall Study|Ongoing|23
7642710|NCT01603407|12057545|FG000|Overall Study|Adverse Event|1
7642711|NCT01603407|12057546|FG001|Overall Study|Adverse Event|1
7642712|NCT01603407|12057547|FG002|Overall Study|Adverse Event|1
7642713|NCT01603407|12057545|FG000|Overall Study|Protocol Violation|2
7642714|NCT01603407|12057546|FG001|Overall Study|Protocol Violation|2
7642715|NCT01603407|12057547|FG002|Overall Study|Protocol Violation|0
7642716|NCT01603407|12057545|FG000|Overall Study|Withdrawal by Subject|8
7642717|NCT01603407|12057546|FG001|Overall Study|Withdrawal by Subject|5
7642718|NCT01603407|12057547|FG002|Overall Study|Withdrawal by Subject|7
7642719|NCT01603407|12057545|FG000|Overall Study|Lost to Follow-up|0
7642720|NCT01603407|12057546|FG001|Overall Study|Lost to Follow-up|3
7642721|NCT01603407|12057547|FG002|Overall Study|Lost to Follow-up|2
7642722|NCT01602380|12057557|FG000|Overall Study|Death|63
7642723|NCT01602380|12057558|FG001|Overall Study|Death|68
7642724|NCT01602380|12057557|FG000|Overall Study|Withdrawal by Subject|22
7642725|NCT01602380|12057558|FG001|Overall Study|Withdrawal by Subject|29
7642726|NCT01602380|12057557|FG000|Overall Study|Lost to Follow-up|6
7642727|NCT01602380|12057558|FG001|Overall Study|Lost to Follow-up|1
7642728|NCT01602380|12057557|FG000|Overall Study|Eligibility criteria not fulfilled|2
7642729|NCT01602380|12057558|FG001|Overall Study|Eligibility criteria not fulfilled|3
7642730|NCT01598311|12057566|FG000|Overall Study|Physician Decision|4
7642731|NCT01598311|12057567|FG001|Overall Study|Physician Decision|5
7642732|NCT01598311|12057566|FG000|Overall Study|Adverse Event|9
7642733|NCT01598311|12057567|FG001|Overall Study|Adverse Event|13
7642734|NCT01598311|12057566|FG000|Overall Study|Lost to Follow-up|7
7642735|NCT01598311|12057567|FG001|Overall Study|Lost to Follow-up|12
7642736|NCT01598311|12057566|FG000|Overall Study|Withdrawal by Subject|9
7642737|NCT01598311|12057567|FG001|Overall Study|Withdrawal by Subject|13
7642738|NCT01598311|12057566|FG000|Overall Study|No reason provided.|0
7642739|NCT01598311|12057567|FG001|Overall Study|No reason provided.|5
7642740|NCT01598311|12057566|FG000|Overall Study|Randomized but never treated|8
7642741|NCT01598311|12057567|FG001|Overall Study|Randomized but never treated|5
7642742|NCT01598311|12057566|FG000|Overall Study|Treated but no confirmed CDAD|9
7642743|NCT01598311|12057567|FG001|Overall Study|Treated but no confirmed CDAD|8
7642744|NCT01598311|12057566|FG000|Overall Study|Assigned to CB but received vancomycin|1
7642745|NCT01598311|12057567|FG001|Overall Study|Assigned to CB but received vancomycin|0
7642746|NCT01593761|12057627|FG000|Overall Study|Lost to Follow-up|1
7642747|NCT01593761|12057627|FG000|Overall Study|culture negative for MRSA at baseline|5
7642748|NCT01593761|12057627|FG000|Overall Study|positive for hepatitis C virus|1
7642749|NCT01593761|12057627|FG000|Overall Study|secondary cellulitis|1
7642800|NCT01592721|12057647|FG000|Long-term Follow-up|Death|1
7642801|NCT01592370|12057658|FG000|Overall Study|Disease Progression|62
7642802|NCT01592370|12057659|FG001|Overall Study|Disease Progression|16
7642803|NCT01592370|12057660|FG002|Overall Study|Disease Progression|52
7642804|NCT01592370|12057661|FG003|Overall Study|Disease Progression|3
7642805|NCT01592370|12057662|FG004|Overall Study|Disease Progression|3
7642806|NCT01592370|12057663|FG005|Overall Study|Disease Progression|31
7642807|NCT01592370|12057664|FG006|Overall Study|Disease Progression|14
7642808|NCT01592370|12057658|FG000|Overall Study|Study Drug Toxicity|14
7642809|NCT01592370|12057659|FG001|Overall Study|Study Drug Toxicity|3
7642810|NCT01592370|12057660|FG002|Overall Study|Study Drug Toxicity|0
7642811|NCT01592370|12057661|FG003|Overall Study|Study Drug Toxicity|0
7642812|NCT01592370|12057662|FG004|Overall Study|Study Drug Toxicity|0
7642813|NCT01592370|12057663|FG005|Overall Study|Study Drug Toxicity|0
7642814|NCT01592370|12057664|FG006|Overall Study|Study Drug Toxicity|1
7642815|NCT01592370|12057658|FG000|Overall Study|AE unrelated to study drug|4
7642816|NCT01592370|12057659|FG001|Overall Study|AE unrelated to study drug|3
7642817|NCT01592370|12057660|FG002|Overall Study|AE unrelated to study drug|0
7642818|NCT01592370|12057661|FG003|Overall Study|AE unrelated to study drug|0
7642819|NCT01592370|12057662|FG004|Overall Study|AE unrelated to study drug|0
7642820|NCT01592370|12057663|FG005|Overall Study|AE unrelated to study drug|0
7642821|NCT01592370|12057664|FG006|Overall Study|AE unrelated to study drug|1
7642822|NCT01592370|12057658|FG000|Overall Study|Request to discontinue study treatment|5
7642823|NCT01592370|12057659|FG001|Overall Study|Request to discontinue study treatment|0
7642824|NCT01592370|12057660|FG002|Overall Study|Request to discontinue study treatment|2
7642825|NCT01592370|12057661|FG003|Overall Study|Request to discontinue study treatment|0
7642826|NCT01592370|12057662|FG004|Overall Study|Request to discontinue study treatment|1
7642827|NCT01592370|12057663|FG005|Overall Study|Request to discontinue study treatment|2
7642828|NCT01592370|12057664|FG006|Overall Study|Request to discontinue study treatment|0
7642829|NCT01592370|12057658|FG000|Overall Study|Withdrew consent|1
7642830|NCT01592370|12057659|FG001|Overall Study|Withdrew consent|2
7642831|NCT01592370|12057660|FG002|Overall Study|Withdrew consent|1
7642832|NCT01592370|12057661|FG003|Overall Study|Withdrew consent|1
7642833|NCT01592370|12057662|FG004|Overall Study|Withdrew consent|0
7642834|NCT01592370|12057663|FG005|Overall Study|Withdrew consent|0
7642835|NCT01592370|12057664|FG006|Overall Study|Withdrew consent|0
7642836|NCT01592370|12057658|FG000|Overall Study|Maximum clinical benefit|11
7642837|NCT01592370|12057659|FG001|Overall Study|Maximum clinical benefit|1
7642838|NCT01592370|12057660|FG002|Overall Study|Maximum clinical benefit|7
7642839|NCT01592370|12057661|FG003|Overall Study|Maximum clinical benefit|1
7642840|NCT01592370|12057662|FG004|Overall Study|Maximum clinical benefit|0
7642841|NCT01592370|12057663|FG005|Overall Study|Maximum clinical benefit|0
7642842|NCT01592370|12057664|FG006|Overall Study|Maximum clinical benefit|0
7642843|NCT01592370|12057658|FG000|Overall Study|No longer meets study criteria|1
7642844|NCT01592370|12057659|FG001|Overall Study|No longer meets study criteria|0
7642845|NCT01592370|12057660|FG002|Overall Study|No longer meets study criteria|0
7642846|NCT01592370|12057661|FG003|Overall Study|No longer meets study criteria|0
7642847|NCT01592370|12057662|FG004|Overall Study|No longer meets study criteria|0
7642848|NCT01592370|12057663|FG005|Overall Study|No longer meets study criteria|0
7642849|NCT01592370|12057664|FG006|Overall Study|No longer meets study criteria|0
7642850|NCT01592370|12057658|FG000|Overall Study|Other Reasons|6
7642851|NCT01592370|12057659|FG001|Overall Study|Other Reasons|0
7642852|NCT01592370|12057660|FG002|Overall Study|Other Reasons|10
7642853|NCT01592370|12057661|FG003|Overall Study|Other Reasons|0
7642854|NCT01592370|12057662|FG004|Overall Study|Other Reasons|0
7642855|NCT01592370|12057663|FG005|Overall Study|Other Reasons|1
7642856|NCT01592370|12057664|FG006|Overall Study|Other Reasons|0
7642857|NCT01590017|12057684|FG000|Overall Study|Adverse Event|1
7642858|NCT01590017|12057684|FG000|Overall Study|Withdrawal by Subject|1
7642859|NCT01590017|12057684|FG000|Overall Study|Lack of Efficacy|1
7642860|NCT01590017|12057684|FG000|Overall Study|Physician Decision|1
7642861|NCT01582009|12057688|FG000|Overall Study|Withdrawal by Subject|1
7642862|NCT01582009|12057688|FG000|Overall Study|Physician Decision|1
7642863|NCT01575834|12057694|FG000|Overall Study|Withdrawal by Subject|352
7642864|NCT01575834|12057695|FG001|Overall Study|Withdrawal by Subject|390
7642865|NCT01575834|12057694|FG000|Overall Study|Death|81
7642866|NCT01575834|12057695|FG001|Overall Study|Death|74
7642867|NCT01575834|12057694|FG000|Overall Study|Other|70
7642868|NCT01575834|12057695|FG001|Overall Study|Other|70
7642869|NCT01575834|12057694|FG000|Overall Study|Adverse Event|63
7642870|NCT01575834|12057695|FG001|Overall Study|Adverse Event|61
7642871|NCT01575834|12057694|FG000|Overall Study|Lost to Follow-up|55
7642872|NCT01575834|12057695|FG001|Overall Study|Lost to Follow-up|68
7642873|NCT01575834|12057694|FG000|Overall Study|Noncompliance|52
7642874|NCT01575834|12057695|FG001|Overall Study|Noncompliance|27
7642875|NCT01575834|12057694|FG000|Overall Study|Administrative decision|15
7642876|NCT01575834|12057695|FG001|Overall Study|Administrative decision|33
7642877|NCT01575834|12057694|FG000|Overall Study|Ineligibility Determined|5
7642878|NCT01575834|12057695|FG001|Overall Study|Ineligibility Determined|8
7642879|NCT01575834|12057694|FG000|Overall Study|Protocol Deviation|4
7642880|NCT01575834|12057695|FG001|Overall Study|Protocol Deviation|3
7642881|NCT01575834|12057694|FG000|Overall Study|Requirement for Alternative Therapy|2
7642882|NCT01575834|12057695|FG001|Overall Study|Requirement for Alternative Therapy|4
7642901|NCT01572480|12057714|FG000|Participants Enrolled|Withdrawal by Subject|1
7642902|NCT01572480|12057714|FG000|Drug Administration|Discontinued drug/Off Study|1
7642903|NCT01572480|12057714|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1
7642904|NCT01572480|12057714|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2
7642905|NCT01568866|12057720|FG000|Overall Study|Disease Progression|208
7642906|NCT01568866|12057721|FG001|Overall Study|Disease Progression|183
7642907|NCT01568866|12057720|FG000|Overall Study|Adverse Event|94
7642908|NCT01568866|12057721|FG001|Overall Study|Adverse Event|96
7642909|NCT01568866|12057720|FG000|Overall Study|Patient Request|55
7642910|NCT01568866|12057721|FG001|Overall Study|Patient Request|71
7642911|NCT01568866|12057720|FG000|Overall Study|Physician Decision|40
7642912|NCT01568866|12057721|FG001|Overall Study|Physician Decision|32
7642913|NCT01568866|12057720|FG000|Overall Study|Withdrawal by Subject|19
7642914|NCT01568866|12057721|FG001|Overall Study|Withdrawal by Subject|11
7642915|NCT01568866|12057720|FG000|Overall Study|Death|10
7642916|NCT01568866|12057721|FG001|Overall Study|Death|18
7642917|NCT01568866|12057720|FG000|Overall Study|Protocol Non-compliance|2
7642918|NCT01568866|12057721|FG001|Overall Study|Protocol Non-compliance|4
7642919|NCT01568866|12057720|FG000|Overall Study|Lost to Follow-up|1
7642920|NCT01568866|12057721|FG001|Overall Study|Lost to Follow-up|0
7642921|NCT01568866|12057720|FG000|Overall Study|Randomized but Not Dosed|9
7642922|NCT01568866|12057721|FG001|Overall Study|Randomized but Not Dosed|1
7642923|NCT01566695|12057729|FG000|Overall Study|Lack of Efficacy|18
7642924|NCT01566695|12057730|FG001|Overall Study|Lack of Efficacy|45
7642925|NCT01566695|12057729|FG000|Overall Study|Adverse Event|28
7642926|NCT01566695|12057730|FG001|Overall Study|Adverse Event|27
7642927|NCT01566695|12057729|FG000|Overall Study|Death|20
7642928|NCT01566695|12057730|FG001|Overall Study|Death|8
7642929|NCT01566695|12057729|FG000|Overall Study|Withdrawal by Subject|14
7642930|NCT01566695|12057730|FG001|Overall Study|Withdrawal by Subject|7
7642931|NCT01566695|12057729|FG000|Overall Study|Progressive Disease|11
7642932|NCT01566695|12057730|FG001|Overall Study|Progressive Disease|6
7642933|NCT01566695|12057729|FG000|Overall Study|Miscellaneous|4
7642934|NCT01566695|12057730|FG001|Overall Study|Miscellaneous|6
7642935|NCT01562028|12057743|FG000|Overall Study|Withdrawal by Subject|1
7642936|NCT01562028|12057744|FG001|Overall Study|Withdrawal by Subject|1
7642937|NCT01562028|12057743|FG000|Overall Study|Lost to Follow-up|2
7642938|NCT01562028|12057744|FG001|Overall Study|Lost to Follow-up|1
7642939|NCT01553149|12057779|FG000|Overall Study|Adverse Event|0
7642940|NCT01553149|12057780|FG001|Overall Study|Adverse Event|9
7642941|NCT01553149|12057779|FG000|Overall Study|Physician Decision|5
7642942|NCT01553149|12057780|FG001|Overall Study|Physician Decision|10
7642943|NCT01553149|12057779|FG000|Overall Study|Ineligible|0
7642944|NCT01553149|12057780|FG001|Overall Study|Ineligible|1
7642945|NCT01535053|12057788|FG000|Overall Study|Ineligible|1
7642946|NCT01535053|12057789|FG001|Overall Study|Ineligible|2
7642947|NCT01522976|12057798|FG000|Overall Study|Ineligible|4
7642948|NCT01522976|12057799|FG001|Overall Study|Ineligible|0
7642949|NCT01522976|12057800|FG002|Overall Study|Ineligible|1
7642950|NCT01522976|12057798|FG000|Overall Study|Death|7
7642951|NCT01522976|12057799|FG001|Overall Study|Death|6
7642952|NCT01522976|12057800|FG002|Overall Study|Death|2
7642953|NCT01522976|12057798|FG000|Overall Study|Still on treatment|9
7642954|NCT01522976|12057799|FG001|Overall Study|Still on treatment|9
7642955|NCT01522976|12057800|FG002|Overall Study|Still on treatment|6
7642956|NCT01522976|12057798|FG000|Overall Study|Disease progression|28
7642957|NCT01522976|12057799|FG001|Overall Study|Disease progression|30
7642958|NCT01522976|12057800|FG002|Overall Study|Disease progression|25
7642959|NCT01522976|12057798|FG000|Overall Study|Adverse Event|17
7642960|NCT01522976|12057799|FG001|Overall Study|Adverse Event|7
7642961|NCT01522976|12057800|FG002|Overall Study|Adverse Event|18
7642962|NCT01522976|12057798|FG000|Overall Study|Refusal unrelated to adverse event|10
7642963|NCT01522976|12057799|FG001|Overall Study|Refusal unrelated to adverse event|13
7642964|NCT01522976|12057800|FG002|Overall Study|Refusal unrelated to adverse event|14
7642965|NCT01522976|12057798|FG000|Overall Study|Not protocol specified|22
7642966|NCT01522976|12057799|FG001|Overall Study|Not protocol specified|27
7642967|NCT01522976|12057800|FG002|Overall Study|Not protocol specified|27
7642968|NCT01522456|12057811|FG000|Overall Study|Adverse Event|2
7642969|NCT01522456|12057811|FG000|Overall Study|Lost to Follow-up|2
7642970|NCT01522456|12057811|FG000|Overall Study|Withdrawal by Subject|2
7642971|NCT01522456|12057811|FG000|Overall Study|Pregnancy|1
7642972|NCT01522456|12057811|FG000|Overall Study|Tolerability Assessment|1
7642973|NCT01522365|12057824|FG000|Overall Study|Withdrawal by Subject|1
7642974|NCT01522365|12057825|FG001|Overall Study|Withdrawal by Subject|1
7642975|NCT01522365|12057824|FG000|Overall Study|Lost to Follow-up|1
7642976|NCT01522365|12057825|FG001|Overall Study|Lost to Follow-up|1
7642977|NCT01496976|12057845|FG000|Overall Study|Withdrew - received stem cell transplant|1
7642978|NCT01485614|12057862|FG000|Randomization|Not Treated|1
7642979|NCT01485614|12057863|FG001|Randomization|Not Treated|0
7642980|NCT01485614|12057864|FG002|Randomization|Not Treated|0
7642981|NCT01485614|12057865|FG003|Randomization|Not Treated|0
7642982|NCT01485614|12057862|FG000|Weeks 0-20|Lost to Follow-up|2
7642983|NCT01485614|12057863|FG001|Weeks 0-20|Lost to Follow-up|0
7642984|NCT01485614|12057864|FG002|Weeks 0-20|Lost to Follow-up|0
7642985|NCT01485614|12057865|FG003|Weeks 0-20|Lost to Follow-up|0
7642986|NCT01485614|12057862|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5
7642987|NCT01485614|12057863|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2
7642988|NCT01485614|12057864|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0
7642989|NCT01485614|12057865|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0
7642990|NCT01485614|12057862|FG000|Weeks 0-20|Withdrawal by Subject|3
7642991|NCT01485614|12057863|FG001|Weeks 0-20|Withdrawal by Subject|2
7642992|NCT01485614|12057864|FG002|Weeks 0-20|Withdrawal by Subject|1
7642993|NCT01485614|12057865|FG003|Weeks 0-20|Withdrawal by Subject|0
7642994|NCT01485614|12057862|FG000|Weeks 20-54|Lost to Follow-up|4
7642995|NCT01485614|12057863|FG001|Weeks 20-54|Lost to Follow-up|3
7642996|NCT01485614|12057864|FG002|Weeks 20-54|Lost to Follow-up|1
7642997|NCT01485614|12057865|FG003|Weeks 20-54|Lost to Follow-up|0
7642998|NCT01485614|12057862|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2
7642999|NCT01485614|12057863|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2
7643000|NCT01485614|12057864|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1
7643001|NCT01485614|12057865|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0
7643002|NCT01485614|12057862|FG000|Weeks 20-54|Withdrawal by Subject|5
7643003|NCT01485614|12057863|FG001|Weeks 20-54|Withdrawal by Subject|3
7643004|NCT01485614|12057864|FG002|Weeks 20-54|Withdrawal by Subject|0
7643005|NCT01485614|12057865|FG003|Weeks 20-54|Withdrawal by Subject|0
7643006|NCT01471522|12057883|FG000|Overall Study|Withdrawal by Subject|28
7643007|NCT01471522|12057884|FG001|Overall Study|Withdrawal by Subject|22
7643008|NCT01471522|12057883|FG000|Overall Study|Lost to Follow-up|36
7643009|NCT01471522|12057884|FG001|Overall Study|Lost to Follow-up|26
7643010|NCT01462630|12057891|FG000|Overall Study|Did not initiate therapy|3
7643011|NCT01462630|12057891|FG000|Overall Study|Death|1
7643012|NCT01462630|12057891|FG000|Overall Study|Protocol Violation|2
7643013|NCT01462630|12057891|FG000|Overall Study|Adverse Event|1
7643014|NCT01458366|12057900|FG000|Period 1: 70mg/m^2|Physician Decision|2
7643015|NCT01458366|12057901|FG001|Period 1: 70mg/m^2|Physician Decision|0
7643016|NCT01458366|12057902|FG002|Period 1: 70mg/m^2|Physician Decision|0
7643017|NCT01458366|12057903|FG003|Period 1: 70mg/m^2|Physician Decision|0
7643018|NCT01458366|12057904|FG004|Period 1: 70mg/m^2|Physician Decision|0
7643019|NCT01458366|12057900|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7643020|NCT01458366|12057901|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7643021|NCT01458366|12057902|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7643022|NCT01458366|12057903|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7643023|NCT01458366|12057904|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1
7643024|NCT01452919|12057912|FG000|Open-Label Treatment|Adverse Event|5
7643025|NCT01452919|12057913|FG001|Open-Label Treatment|Adverse Event|0
7643026|NCT01452919|12057914|FG002|Open-Label Treatment|Adverse Event|0
7643027|NCT01452919|12057912|FG000|Open-Label Treatment|Lost to Follow-up|4
7643028|NCT01452919|12057913|FG001|Open-Label Treatment|Lost to Follow-up|0
7643029|NCT01452919|12057914|FG002|Open-Label Treatment|Lost to Follow-up|0
7643030|NCT01452919|12057912|FG000|Open-Label Treatment|Perceived lack of efficacy|3
7643031|NCT01452919|12057913|FG001|Open-Label Treatment|Perceived lack of efficacy|0
7643032|NCT01452919|12057914|FG002|Open-Label Treatment|Perceived lack of efficacy|0
7643033|NCT01452919|12057912|FG000|Open-Label Treatment|Protocol Violation|4
7643034|NCT01452919|12057913|FG001|Open-Label Treatment|Protocol Violation|0
7643035|NCT01452919|12057914|FG002|Open-Label Treatment|Protocol Violation|0
7643036|NCT01452919|12057912|FG000|Open-Label Treatment|Sponsor Decision|1
7643037|NCT01452919|12057913|FG001|Open-Label Treatment|Sponsor Decision|0
7643038|NCT01452919|12057914|FG002|Open-Label Treatment|Sponsor Decision|0
7643039|NCT01452919|12057912|FG000|Open-Label Treatment|Withdrawal by Subject|2
7643040|NCT01452919|12057913|FG001|Open-Label Treatment|Withdrawal by Subject|0
7643041|NCT01452919|12057914|FG002|Open-Label Treatment|Withdrawal by Subject|0
7643042|NCT01452919|12057912|FG000|Open-Label Treatment|Subject is moving or has moved|1
7643043|NCT01452919|12057913|FG001|Open-Label Treatment|Subject is moving or has moved|0
7643044|NCT01452919|12057914|FG002|Open-Label Treatment|Subject is moving or has moved|0
7643045|NCT01452919|12057912|FG000|Randomization Treatment|Adverse Event|0
7643046|NCT01452919|12057913|FG001|Randomization Treatment|Adverse Event|0
7643047|NCT01452919|12057914|FG002|Randomization Treatment|Adverse Event|2
7643048|NCT01452919|12057912|FG000|Randomization Treatment|Sponsor Decision|0
7643049|NCT01452919|12057913|FG001|Randomization Treatment|Sponsor Decision|1
7643050|NCT01452919|12057914|FG002|Randomization Treatment|Sponsor Decision|0
7643051|NCT01452919|12057912|FG000|Randomization Treatment|Withdrawal by Subject|0
7643052|NCT01452919|12057913|FG001|Randomization Treatment|Withdrawal by Subject|1
7643053|NCT01452919|12057914|FG002|Randomization Treatment|Withdrawal by Subject|0
7643054|NCT01452919|12057912|FG000|Randomization Treatment|Subject is moving or has moved|0
7643055|NCT01452919|12057913|FG001|Randomization Treatment|Subject is moving or has moved|1
7643056|NCT01452919|12057914|FG002|Randomization Treatment|Subject is moving or has moved|0
7643057|NCT01450631|12057926|FG000|Overall Study|Lost to Follow-up|2
7643058|NCT01450631|12057927|FG001|Overall Study|Lost to Follow-up|4
7643059|NCT01450631|12057926|FG000|Overall Study|Withdrawal by Subject|1
7643060|NCT01450631|12057927|FG001|Overall Study|Withdrawal by Subject|0
7643061|NCT01439880|12057935|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24
7643062|NCT01439880|12057936|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38
7643063|NCT01439880|12057935|FG000|SOC-controlled Period (Year 1)|Death|2
7643064|NCT01439880|12057936|FG001|SOC-controlled Period (Year 1)|Death|1
7643065|NCT01439880|12057935|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0
7643066|NCT01439880|12057936|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1
7643067|NCT01439880|12057935|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10
7643068|NCT01439880|12057936|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5
7643069|NCT01439880|12057935|FG000|SOC-controlled Period (Year 1)|Other|8
7643070|NCT01439880|12057936|FG001|SOC-controlled Period (Year 1)|Other|13
7643071|NCT01439880|12057935|FG000|SOC-controlled Period (Year 1)|Reason Missing|0
7643072|NCT01439880|12057936|FG001|SOC-controlled Period (Year 1)|Reason Missing|2
7643073|NCT01439880|12057935|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21
7643074|NCT01439880|12057936|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30
7643075|NCT01439880|12057935|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30
7643076|NCT01439880|12057936|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66
7643077|NCT01439880|12057935|FG000|All-IP Period (Years 2 to 5)|Death|3
7643078|NCT01439880|12057936|FG001|All-IP Period (Years 2 to 5)|Death|13
7643079|NCT01439880|12057935|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1
7643080|NCT01439880|12057936|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0
7643081|NCT01439880|12057935|FG000|All-IP Period (Years 2 to 5)|Other|14
7643082|NCT01439880|12057936|FG001|All-IP Period (Years 2 to 5)|Other|31
7643083|NCT01439880|12057935|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1
7643084|NCT01439880|12057936|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0
7643085|NCT01426269|12057979|FG000|Period 1: 12 Weeks|Adverse Event|5
7643086|NCT01426269|12057980|FG001|Period 1: 12 Weeks|Adverse Event|0
7643087|NCT01426269|12057981|FG002|Period 1: 12 Weeks|Adverse Event|0
7643088|NCT01426269|12057979|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22
7643089|NCT01426269|12057980|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0
7643090|NCT01426269|12057981|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0
7643091|NCT01426269|12057979|FG000|Period 1: 12 Weeks|Protocol Violation|5
7643092|NCT01426269|12057980|FG001|Period 1: 12 Weeks|Protocol Violation|0
7643093|NCT01426269|12057981|FG002|Period 1: 12 Weeks|Protocol Violation|0
7643094|NCT01426269|12057979|FG000|Period 1: 12 Weeks|Lost to Follow-up|22
7643095|NCT01426269|12057980|FG001|Period 1: 12 Weeks|Lost to Follow-up|0
7643096|NCT01426269|12057981|FG002|Period 1: 12 Weeks|Lost to Follow-up|0
7643097|NCT01426269|12057979|FG000|Period 1: 12 Weeks|Pregnancy|1
7643098|NCT01426269|12057980|FG001|Period 1: 12 Weeks|Pregnancy|0
7643099|NCT01426269|12057981|FG002|Period 1: 12 Weeks|Pregnancy|0
7643100|NCT01426269|12057979|FG000|Eligibility for Period 2, Randomization|Did not qualify|42
7643101|NCT01426269|12057980|FG001|Eligibility for Period 2, Randomization|Did not qualify|0
7643102|NCT01426269|12057981|FG002|Eligibility for Period 2, Randomization|Did not qualify|0
7643103|NCT01426269|12057979|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8
7643104|NCT01426269|12057980|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0
7643105|NCT01426269|12057981|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0
7643106|NCT01426269|12057979|FG000|Period 2: 40 Weeks|Adverse Event|0
7643107|NCT01426269|12057980|FG001|Period 2: 40 Weeks|Adverse Event|1
7643108|NCT01426269|12057981|FG002|Period 2: 40 Weeks|Adverse Event|2
7643109|NCT01426269|12057979|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0
7643110|NCT01426269|12057980|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9
7643111|NCT01426269|12057981|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11
7643112|NCT01426269|12057979|FG000|Period 2: 40 Weeks|Protocol Violation|0
7643113|NCT01426269|12057980|FG001|Period 2: 40 Weeks|Protocol Violation|5
7643114|NCT01426269|12057981|FG002|Period 2: 40 Weeks|Protocol Violation|5
7643115|NCT01426269|12057979|FG000|Period 2: 40 Weeks|Lost to Follow-up|0
7643116|NCT01426269|12057980|FG001|Period 2: 40 Weeks|Lost to Follow-up|8
7643117|NCT01426269|12057981|FG002|Period 2: 40 Weeks|Lost to Follow-up|6
7643118|NCT01426269|12057979|FG000|Period 2: 40 Weeks|Site closed|0
7643119|NCT01426269|12057980|FG001|Period 2: 40 Weeks|Site closed|6
7643120|NCT01426269|12057981|FG002|Period 2: 40 Weeks|Site closed|5
7643121|NCT01426269|12057979|FG000|Period 2: 40 Weeks|Relapsed|0
7643122|NCT01426269|12057980|FG001|Period 2: 40 Weeks|Relapsed|9
7643123|NCT01426269|12057981|FG002|Period 2: 40 Weeks|Relapsed|18
7643124|NCT01420926|12057994|FG000|Overall Study|Adverse Event|6
7643125|NCT01420926|12057995|FG001|Overall Study|Adverse Event|4
7643126|NCT01420926|12057994|FG000|Overall Study|Death|18
7643127|NCT01420926|12057995|FG001|Overall Study|Death|17
7643128|NCT01420926|12057994|FG000|Overall Study|Withdrawal by Subject|11
7643129|NCT01420926|12057995|FG001|Overall Study|Withdrawal by Subject|16
7643130|NCT01420926|12057994|FG000|Overall Study|Non-protocol treatment|17
7643131|NCT01420926|12057995|FG001|Overall Study|Non-protocol treatment|20
7643132|NCT01420926|12057994|FG000|Overall Study|Physician Decision|7
7643133|NCT01420926|12057995|FG001|Overall Study|Physician Decision|5
7643134|NCT01420926|12057994|FG000|Overall Study|Continues on active treatment|1
7643135|NCT01420926|12057995|FG001|Overall Study|Continues on active treatment|3
7643136|NCT01417234|12058001|FG000|Overall Study|Subject non-compliant|3
7643137|NCT01415440|12058008|FG000|Overall Study|Lost to Follow-up|0
7643138|NCT01415440|12058009|FG001|Overall Study|Lost to Follow-up|1
7643139|NCT01415440|12058010|FG002|Overall Study|Lost to Follow-up|2
7643140|NCT01415440|12058008|FG000|Overall Study|Physician Decision|3
7643141|NCT01415440|12058009|FG001|Overall Study|Physician Decision|0
7643142|NCT01415440|12058010|FG002|Overall Study|Physician Decision|0
7643143|NCT01415440|12058008|FG000|Overall Study|Withdrawal by Subject|1
7643144|NCT01415440|12058009|FG001|Overall Study|Withdrawal by Subject|0
7643145|NCT01415440|12058010|FG002|Overall Study|Withdrawal by Subject|0
7643146|NCT01386385|12058041|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1
7643147|NCT01386385|12058042|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7643148|NCT01386385|12058043|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7643149|NCT01386385|12058044|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7643150|NCT01386385|12058045|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7643151|NCT01386385|12058046|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7643152|NCT01386385|12058047|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7643153|NCT01386385|12058048|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7643154|NCT01386385|12058041|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1
7643155|NCT01386385|12058042|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7643156|NCT01386385|12058043|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7643157|NCT01386385|12058044|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7643158|NCT01386385|12058045|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7643159|NCT01386385|12058046|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7643160|NCT01386385|12058047|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7643161|NCT01386385|12058048|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7643162|NCT01386385|12058041|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0
7643163|NCT01386385|12058042|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0
7643164|NCT01386385|12058043|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2
7643165|NCT01386385|12058044|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0
7643166|NCT01386385|12058045|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0
7643167|NCT01386385|12058046|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0
7643168|NCT01386385|12058047|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0
7643169|NCT01386385|12058048|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0
7643170|NCT01386385|12058041|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7643171|NCT01386385|12058042|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7643172|NCT01386385|12058043|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7643173|NCT01386385|12058044|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7643174|NCT01386385|12058045|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1
7643175|NCT01386385|12058046|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7643176|NCT01386385|12058047|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7643177|NCT01386385|12058048|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7643178|NCT01386385|12058041|FG000|Phase II Concurrent CRT|Adverse Event|0
7643179|NCT01386385|12058042|FG001|Phase II Concurrent CRT|Adverse Event|0
7643180|NCT01386385|12058043|FG002|Phase II Concurrent CRT|Adverse Event|0
7643181|NCT01386385|12058044|FG003|Phase II Concurrent CRT|Adverse Event|0
7643182|NCT01386385|12058045|FG004|Phase II Concurrent CRT|Adverse Event|0
7643183|NCT01386385|12058046|FG005|Phase II Concurrent CRT|Adverse Event|0
7643184|NCT01386385|12058047|FG006|Phase II Concurrent CRT|Adverse Event|3
7643185|NCT01386385|12058048|FG007|Phase II Concurrent CRT|Adverse Event|3
7643186|NCT01386385|12058041|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0
7643187|NCT01386385|12058042|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0
7643188|NCT01386385|12058043|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0
7643189|NCT01386385|12058044|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0
7643190|NCT01386385|12058045|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0
7643191|NCT01386385|12058046|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0
7643192|NCT01386385|12058047|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3
7643193|NCT01386385|12058048|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0
7643194|NCT01386385|12058041|FG000|Phase II: Consolidation Therapy|Adverse Event|0
7643195|NCT01386385|12058042|FG001|Phase II: Consolidation Therapy|Adverse Event|0
7643196|NCT01386385|12058043|FG002|Phase II: Consolidation Therapy|Adverse Event|0
7643197|NCT01386385|12058044|FG003|Phase II: Consolidation Therapy|Adverse Event|0
7643198|NCT01386385|12058045|FG004|Phase II: Consolidation Therapy|Adverse Event|0
7643199|NCT01386385|12058046|FG005|Phase II: Consolidation Therapy|Adverse Event|0
7643200|NCT01386385|12058047|FG006|Phase II: Consolidation Therapy|Adverse Event|2
7643201|NCT01386385|12058048|FG007|Phase II: Consolidation Therapy|Adverse Event|1
7643202|NCT01386385|12058041|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7643203|NCT01386385|12058042|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7643204|NCT01386385|12058043|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7643205|NCT01386385|12058044|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7643206|NCT01386385|12058045|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7643207|NCT01386385|12058046|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7643208|NCT01386385|12058047|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2
7643209|NCT01386385|12058048|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7643210|NCT01386385|12058041|FG000|Phase II: Consolidation Therapy|Progression/relapse|0
7643211|NCT01386385|12058042|FG001|Phase II: Consolidation Therapy|Progression/relapse|0
7643212|NCT01386385|12058043|FG002|Phase II: Consolidation Therapy|Progression/relapse|0
7643213|NCT01386385|12058044|FG003|Phase II: Consolidation Therapy|Progression/relapse|0
7643214|NCT01386385|12058045|FG004|Phase II: Consolidation Therapy|Progression/relapse|0
7643215|NCT01386385|12058046|FG005|Phase II: Consolidation Therapy|Progression/relapse|0
7643216|NCT01386385|12058047|FG006|Phase II: Consolidation Therapy|Progression/relapse|1
7643217|NCT01386385|12058048|FG007|Phase II: Consolidation Therapy|Progression/relapse|1
7643218|NCT01385176|12058071|FG000|Randomization Phase|Death|1
7643219|NCT01385176|12058072|FG001|Randomization Phase|Death|2
7643220|NCT01385176|12058071|FG000|6-18 Month All VNS Active|Death|1
7643221|NCT01385176|12058072|FG001|6-18 Month All VNS Active|Death|2
7643222|NCT01385176|12058071|FG000|6-18 Month All VNS Active|Physician Decision|0
7643223|NCT01385176|12058072|FG001|6-18 Month All VNS Active|Physician Decision|1
7643224|NCT01385176|12058071|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2
7643225|NCT01385176|12058072|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0
7643226|NCT01385176|12058071|FG000|6-18 Month All VNS Active|Heart Transplant|1
7643227|NCT01385176|12058072|FG001|6-18 Month All VNS Active|Heart Transplant|0
7643228|NCT01372774|12058085|FG000|Overall Study|Withdrawal prior to treatment|4
7643229|NCT01372774|12058086|FG001|Overall Study|Withdrawal prior to treatment|5
7643230|NCT01371981|12058100|FG000|Overall Study|Adverse Event|12
7643231|NCT01371981|12058101|FG001|Overall Study|Adverse Event|17
7643232|NCT01371981|12058102|FG002|Overall Study|Adverse Event|0
7643233|NCT01371981|12058103|FG003|Overall Study|Adverse Event|4
7643234|NCT01371981|12058104|FG004|Overall Study|Adverse Event|1
7643235|NCT01371981|12058105|FG005|Overall Study|Adverse Event|0
7643236|NCT01371981|12058100|FG000|Overall Study|Death|22
7643237|NCT01371981|12058101|FG001|Overall Study|Death|16
7643238|NCT01371981|12058102|FG002|Overall Study|Death|0
7643239|NCT01371981|12058103|FG003|Overall Study|Death|0
7643240|NCT01371981|12058104|FG004|Overall Study|Death|2
7643241|NCT01371981|12058105|FG005|Overall Study|Death|2
7643242|NCT01371981|12058100|FG000|Overall Study|Lack of Efficacy|69
7643243|NCT01371981|12058101|FG001|Overall Study|Lack of Efficacy|61
7643244|NCT01371981|12058102|FG002|Overall Study|Lack of Efficacy|4
7643245|NCT01371981|12058103|FG003|Overall Study|Lack of Efficacy|8
7643246|NCT01371981|12058104|FG004|Overall Study|Lack of Efficacy|5
7643247|NCT01371981|12058105|FG005|Overall Study|Lack of Efficacy|0
7643248|NCT01371981|12058100|FG000|Overall Study|Physician Decision|48
7643249|NCT01371981|12058101|FG001|Overall Study|Physician Decision|63
7643250|NCT01371981|12058102|FG002|Overall Study|Physician Decision|1
7643251|NCT01371981|12058103|FG003|Overall Study|Physician Decision|7
7643252|NCT01371981|12058104|FG004|Overall Study|Physician Decision|14
7643253|NCT01371981|12058105|FG005|Overall Study|Physician Decision|3
7643254|NCT01371981|12058100|FG000|Overall Study|Withdrawal by Subject|12
7643255|NCT01371981|12058101|FG001|Overall Study|Withdrawal by Subject|19
7643256|NCT01371981|12058102|FG002|Overall Study|Withdrawal by Subject|1
7643257|NCT01371981|12058103|FG003|Overall Study|Withdrawal by Subject|2
7643258|NCT01371981|12058104|FG004|Overall Study|Withdrawal by Subject|10
7643259|NCT01371981|12058105|FG005|Overall Study|Withdrawal by Subject|3
7643260|NCT01371981|12058100|FG000|Overall Study|Ineligible|19
7643261|NCT01371981|12058101|FG001|Overall Study|Ineligible|13
7643262|NCT01371981|12058102|FG002|Overall Study|Ineligible|0
7643263|NCT01371981|12058103|FG003|Overall Study|Ineligible|0
7643264|NCT01371981|12058104|FG004|Overall Study|Ineligible|0
7643265|NCT01371981|12058105|FG005|Overall Study|Ineligible|4
7643266|NCT01371981|12058100|FG000|Overall Study|Did not start treatment|2
7643267|NCT01371981|12058101|FG001|Overall Study|Did not start treatment|3
7643268|NCT01371981|12058102|FG002|Overall Study|Did not start treatment|0
7643269|NCT01371981|12058103|FG003|Overall Study|Did not start treatment|0
7643270|NCT01371981|12058104|FG004|Overall Study|Did not start treatment|0
7643271|NCT01371981|12058105|FG005|Overall Study|Did not start treatment|2
7643272|NCT01364597|12058128|FG000|Overall Study|Adverse Event|4
7643273|NCT01364597|12058129|FG001|Overall Study|Adverse Event|5
7643274|NCT01364597|12058130|FG002|Overall Study|Adverse Event|16
7643275|NCT01364597|12058131|FG003|Overall Study|Adverse Event|7
7643276|NCT01364597|12058128|FG000|Overall Study|Lack of Efficacy|4
7643277|NCT01364597|12058129|FG001|Overall Study|Lack of Efficacy|4
7643278|NCT01364597|12058130|FG002|Overall Study|Lack of Efficacy|23
7643279|NCT01364597|12058131|FG003|Overall Study|Lack of Efficacy|8
7643280|NCT01364597|12058128|FG000|Overall Study|Protocol Violation|0
7643281|NCT01364597|12058129|FG001|Overall Study|Protocol Violation|0
7643282|NCT01364597|12058130|FG002|Overall Study|Protocol Violation|2
7643283|NCT01364597|12058131|FG003|Overall Study|Protocol Violation|0
7643284|NCT01364597|12058128|FG000|Overall Study|Lost to Follow-up|0
7643285|NCT01364597|12058129|FG001|Overall Study|Lost to Follow-up|0
7643286|NCT01364597|12058130|FG002|Overall Study|Lost to Follow-up|5
7643287|NCT01364597|12058131|FG003|Overall Study|Lost to Follow-up|3
7643288|NCT01364597|12058128|FG000|Overall Study|Withdrawal by Subject|4
7643289|NCT01364597|12058129|FG001|Overall Study|Withdrawal by Subject|1
7643290|NCT01364597|12058130|FG002|Overall Study|Withdrawal by Subject|18
7643291|NCT01364597|12058131|FG003|Overall Study|Withdrawal by Subject|6
7643292|NCT01364597|12058128|FG000|Overall Study|Non compliance|1
7643293|NCT01364597|12058129|FG001|Overall Study|Non compliance|0
7643294|NCT01364597|12058130|FG002|Overall Study|Non compliance|1
7643295|NCT01364597|12058131|FG003|Overall Study|Non compliance|0
7643296|NCT01364597|12058128|FG000|Overall Study|Lack of compliance|1
7643297|NCT01364597|12058129|FG001|Overall Study|Lack of compliance|0
7643298|NCT01364597|12058130|FG002|Overall Study|Lack of compliance|0
7643299|NCT01364597|12058131|FG003|Overall Study|Lack of compliance|0
7643300|NCT01364597|12058128|FG000|Overall Study|End of treatment epilepsy|1
7643301|NCT01364597|12058129|FG001|Overall Study|End of treatment epilepsy|0
7643302|NCT01364597|12058130|FG002|Overall Study|End of treatment epilepsy|0
7643303|NCT01364597|12058131|FG003|Overall Study|End of treatment epilepsy|0
7643304|NCT01364597|12058128|FG000|Overall Study|No Seizures|1
7643305|NCT01364597|12058129|FG001|Overall Study|No Seizures|0
7643306|NCT01364597|12058130|FG002|Overall Study|No Seizures|0
7643307|NCT01364597|12058131|FG003|Overall Study|No Seizures|0
7643308|NCT01364597|12058128|FG000|Overall Study|Lack of reliability from the subject's caregiver|1
7643309|NCT01364597|12058129|FG001|Overall Study|Lack of reliability from the subject's caregiver|0
7643310|NCT01364597|12058130|FG002|Overall Study|Lack of reliability from the subject's caregiver|0
7643311|NCT01364597|12058131|FG003|Overall Study|Lack of reliability from the subject's caregiver|0
7643312|NCT01364597|12058128|FG000|Overall Study|Cure|1
7643313|NCT01364597|12058129|FG001|Overall Study|Cure|0
7643314|NCT01364597|12058130|FG002|Overall Study|Cure|0
7643315|NCT01364597|12058131|FG003|Overall Study|Cure|0
7643316|NCT01364597|12058128|FG000|Overall Study|Patient was moving|0
7643317|NCT01364597|12058129|FG001|Overall Study|Patient was moving|1
7643318|NCT01364597|12058130|FG002|Overall Study|Patient was moving|0
7643319|NCT01364597|12058131|FG003|Overall Study|Patient was moving|0
7643320|NCT01364597|12058128|FG000|Overall Study|Seizures resolved|0
7643321|NCT01364597|12058129|FG001|Overall Study|Seizures resolved|0
7643322|NCT01364597|12058130|FG002|Overall Study|Seizures resolved|1
7643323|NCT01364597|12058131|FG003|Overall Study|Seizures resolved|0
7643324|NCT01364597|12058128|FG000|Overall Study|Patient became seizure-free after surgery|0
7643325|NCT01364597|12058129|FG001|Overall Study|Patient became seizure-free after surgery|0
7643326|NCT01364597|12058130|FG002|Overall Study|Patient became seizure-free after surgery|1
7643327|NCT01364597|12058131|FG003|Overall Study|Patient became seizure-free after surgery|0
7643328|NCT01364597|12058128|FG000|Overall Study|5 year without seizures. Treatment is finish|0
7643329|NCT01364597|12058129|FG001|Overall Study|5 year without seizures. Treatment is finish|0
7643330|NCT01364597|12058130|FG002|Overall Study|5 year without seizures. Treatment is finish|1
7643331|NCT01364597|12058131|FG003|Overall Study|5 year without seizures. Treatment is finish|0
7643332|NCT01364597|12058128|FG000|Overall Study|Patient cured from Epilepsy|0
7643333|NCT01364597|12058129|FG001|Overall Study|Patient cured from Epilepsy|0
7643334|NCT01364597|12058130|FG002|Overall Study|Patient cured from Epilepsy|1
7643335|NCT01364597|12058131|FG003|Overall Study|Patient cured from Epilepsy|0
7643336|NCT01364597|12058128|FG000|Overall Study|Investigator decision|0
7643337|NCT01364597|12058129|FG001|Overall Study|Investigator decision|0
7643338|NCT01364597|12058130|FG002|Overall Study|Investigator decision|1
7643339|NCT01364597|12058131|FG003|Overall Study|Investigator decision|0
7643340|NCT01364597|12058128|FG000|Overall Study|Sponsor recommended discontinuation|0
7643341|NCT01364597|12058129|FG001|Overall Study|Sponsor recommended discontinuation|0
7643342|NCT01364597|12058130|FG002|Overall Study|Sponsor recommended discontinuation|0
7643343|NCT01364597|12058131|FG003|Overall Study|Sponsor recommended discontinuation|1
7643344|NCT01364597|12058128|FG000|Overall Study|Parents went abroad with the patient|0
7643345|NCT01364597|12058129|FG001|Overall Study|Parents went abroad with the patient|0
7643346|NCT01364597|12058130|FG002|Overall Study|Parents went abroad with the patient|1
7643347|NCT01364597|12058131|FG003|Overall Study|Parents went abroad with the patient|0
7643348|NCT01364597|12058128|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0
7643349|NCT01364597|12058129|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0
7643350|NCT01364597|12058130|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1
7643351|NCT01364597|12058131|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0
7643352|NCT01364597|12058128|FG000|Overall Study|BRV administration dropout|0
7643353|NCT01364597|12058129|FG001|Overall Study|BRV administration dropout|0
7643354|NCT01364597|12058130|FG002|Overall Study|BRV administration dropout|1
7643355|NCT01364597|12058131|FG003|Overall Study|BRV administration dropout|0
7643356|NCT01364597|12058128|FG000|Overall Study|Dropout|0
7643357|NCT01364597|12058129|FG001|Overall Study|Dropout|0
7643358|NCT01364597|12058130|FG002|Overall Study|Dropout|3
7643359|NCT01364597|12058131|FG003|Overall Study|Dropout|1
7643360|NCT01364597|12058128|FG000|Overall Study|Unreliable subject|0
7643361|NCT01364597|12058129|FG001|Overall Study|Unreliable subject|0
7643362|NCT01364597|12058130|FG002|Overall Study|Unreliable subject|0
7643363|NCT01364597|12058131|FG003|Overall Study|Unreliable subject|1
7643364|NCT01364597|12058128|FG000|Overall Study|Other|0
7643365|NCT01364597|12058129|FG001|Overall Study|Other|0
7643366|NCT01364597|12058130|FG002|Overall Study|Other|0
7643367|NCT01364597|12058131|FG003|Overall Study|Other|1
7643368|NCT01359592|12058144|FG000|Initial Registration|Adverse Event|1
7643369|NCT01359592|12058145|FG001|Initial Registration|Adverse Event|0
7643370|NCT01359592|12058146|FG002|Initial Registration|Adverse Event|0
7643371|NCT01359592|12058147|FG003|Initial Registration|Adverse Event|0
7643372|NCT01359592|12058144|FG000|Initial Registration|Death|1
7643373|NCT01359592|12058145|FG001|Initial Registration|Death|0
7643374|NCT01359592|12058146|FG002|Initial Registration|Death|0
7643375|NCT01359592|12058147|FG003|Initial Registration|Death|0
7643376|NCT01359592|12058144|FG000|Initial Registration|Other reason not protocol specified|1
7643377|NCT01359592|12058145|FG001|Initial Registration|Other reason not protocol specified|0
7643378|NCT01359592|12058146|FG002|Initial Registration|Other reason not protocol specified|0
7643379|NCT01359592|12058147|FG003|Initial Registration|Other reason not protocol specified|0
7643380|NCT01359592|12058144|FG000|Initial Registration|Ineligible|26
7643381|NCT01359592|12058145|FG001|Initial Registration|Ineligible|0
7643382|NCT01359592|12058146|FG002|Initial Registration|Ineligible|0
7643383|NCT01359592|12058147|FG003|Initial Registration|Ineligible|0
7643384|NCT01359592|12058144|FG000|PET-Directed Therapy|Adverse Event|0
7643385|NCT01359592|12058145|FG001|PET-Directed Therapy|Adverse Event|0
7643386|NCT01359592|12058146|FG002|PET-Directed Therapy|Adverse Event|1
7643387|NCT01359592|12058147|FG003|PET-Directed Therapy|Adverse Event|0
7643388|NCT01359592|12058144|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0
7643389|NCT01359592|12058145|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0
7643390|NCT01359592|12058146|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1
7643391|NCT01359592|12058147|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0
7643392|NCT01359592|12058144|FG000|PET-Directed Therapy|Ineligible|0
7643393|NCT01359592|12058145|FG001|PET-Directed Therapy|Ineligible|0
7643394|NCT01359592|12058146|FG002|PET-Directed Therapy|Ineligible|24
7643395|NCT01359592|12058147|FG003|PET-Directed Therapy|Ineligible|0
7643396|NCT01357980|12058166|FG000|Overall Study|Lack of Efficacy|0
7643397|NCT01357980|12058167|FG001|Overall Study|Lack of Efficacy|1
7643398|NCT01357980|12058168|FG002|Overall Study|Lack of Efficacy|0
7643399|NCT01357980|12058169|FG003|Overall Study|Lack of Efficacy|0
7643400|NCT01357980|12058166|FG000|Overall Study|Consent withdrawn|0
7643401|NCT01357980|12058167|FG001|Overall Study|Consent withdrawn|0
7643402|NCT01357980|12058168|FG002|Overall Study|Consent withdrawn|1
7643403|NCT01357980|12058169|FG003|Overall Study|Consent withdrawn|0
7643404|NCT01354353|12058185|FG000|Overall Study|Adverse Event|1
7643405|NCT01354353|12058186|FG001|Overall Study|Adverse Event|0
7643406|NCT01354353|12058187|FG002|Overall Study|Adverse Event|0
7643407|NCT01354353|12058188|FG003|Overall Study|Adverse Event|4
7643408|NCT01354353|12058189|FG004|Overall Study|Adverse Event|0
7643409|NCT01354353|12058190|FG005|Overall Study|Adverse Event|5
7643410|NCT01354353|12058185|FG000|Overall Study|Entry Criteria Not Met|0
7643411|NCT01354353|12058186|FG001|Overall Study|Entry Criteria Not Met|0
7643412|NCT01354353|12058187|FG002|Overall Study|Entry Criteria Not Met|0
7643413|NCT01354353|12058188|FG003|Overall Study|Entry Criteria Not Met|1
7643414|NCT01354353|12058189|FG004|Overall Study|Entry Criteria Not Met|1
7643415|NCT01354353|12058190|FG005|Overall Study|Entry Criteria Not Met|0
7643416|NCT01354353|12058185|FG000|Overall Study|Physician Decision|0
7643417|NCT01354353|12058186|FG001|Overall Study|Physician Decision|1
7643418|NCT01354353|12058187|FG002|Overall Study|Physician Decision|1
7643419|NCT01354353|12058188|FG003|Overall Study|Physician Decision|0
7643420|NCT01354353|12058189|FG004|Overall Study|Physician Decision|0
7643421|NCT01354353|12058190|FG005|Overall Study|Physician Decision|0
7643422|NCT01354353|12058185|FG000|Overall Study|Withdrawal by Subject|2
7643423|NCT01354353|12058186|FG001|Overall Study|Withdrawal by Subject|0
7643424|NCT01354353|12058187|FG002|Overall Study|Withdrawal by Subject|1
7643425|NCT01354353|12058188|FG003|Overall Study|Withdrawal by Subject|0
7643426|NCT01354353|12058189|FG004|Overall Study|Withdrawal by Subject|0
7643427|NCT01354353|12058190|FG005|Overall Study|Withdrawal by Subject|1
7643428|NCT01353313|12058213|FG000|Overall Study|Lost to Follow-up|22
7643429|NCT01353313|12058214|FG001|Overall Study|Lost to Follow-up|23
7643430|NCT01353313|12058213|FG000|Overall Study|Incomplete Follow-up or No Study Data|12
7643431|NCT01353313|12058214|FG001|Overall Study|Incomplete Follow-up or No Study Data|15
7643432|NCT01333397|12058255|FG000|Overall Study|Lost to Follow-up|1
7643433|NCT01333397|12058256|FG001|Overall Study|Lost to Follow-up|0
7643434|NCT01333397|12058257|FG002|Overall Study|Lost to Follow-up|0
7643435|NCT01333397|12058258|FG003|Overall Study|Lost to Follow-up|1
7643436|NCT01333397|12058259|FG004|Overall Study|Lost to Follow-up|0
7643437|NCT01332968|12058282|FG000|Induction Period|Adverse Event|23
7643438|NCT01332968|12058283|FG001|Induction Period|Adverse Event|26
7643439|NCT01332968|12058284|FG002|Induction Period|Adverse Event|0
7643440|NCT01332968|12058285|FG003|Induction Period|Adverse Event|0
7643441|NCT01332968|12058286|FG004|Induction Period|Adverse Event|0
7643442|NCT01332968|12058287|FG005|Induction Period|Adverse Event|0
7643443|NCT01332968|12058288|FG006|Induction Period|Adverse Event|0
7643444|NCT01332968|12058289|FG007|Induction Period|Adverse Event|0
7643445|NCT01332968|12058282|FG000|Induction Period|Death|1
7643446|NCT01332968|12058283|FG001|Induction Period|Death|4
7643447|NCT01332968|12058284|FG002|Induction Period|Death|0
7643448|NCT01332968|12058285|FG003|Induction Period|Death|0
7643449|NCT01332968|12058286|FG004|Induction Period|Death|0
7643450|NCT01332968|12058287|FG005|Induction Period|Death|0
7643451|NCT01332968|12058288|FG006|Induction Period|Death|0
7643452|NCT01332968|12058289|FG007|Induction Period|Death|0
7643453|NCT01332968|12058282|FG000|Induction Period|Non-compliance|1
7643454|NCT01332968|12058283|FG001|Induction Period|Non-compliance|0
7643455|NCT01332968|12058284|FG002|Induction Period|Non-compliance|0
7643456|NCT01332968|12058285|FG003|Induction Period|Non-compliance|0
7643457|NCT01332968|12058286|FG004|Induction Period|Non-compliance|0
7643458|NCT01332968|12058287|FG005|Induction Period|Non-compliance|0
7643459|NCT01332968|12058288|FG006|Induction Period|Non-compliance|0
7643460|NCT01332968|12058289|FG007|Induction Period|Non-compliance|0
7643461|NCT01332968|12058282|FG000|Induction Period|Other|2
7643462|NCT01332968|12058283|FG001|Induction Period|Other|2
7643463|NCT01332968|12058284|FG002|Induction Period|Other|0
7643464|NCT01332968|12058285|FG003|Induction Period|Other|0
7643465|NCT01332968|12058286|FG004|Induction Period|Other|0
7643466|NCT01332968|12058287|FG005|Induction Period|Other|0
7643467|NCT01332968|12058288|FG006|Induction Period|Other|0
7643468|NCT01332968|12058289|FG007|Induction Period|Other|0
7643469|NCT01332968|12058282|FG000|Induction Period|Physician Decision|6
7643470|NCT01332968|12058283|FG001|Induction Period|Physician Decision|1
7643471|NCT01332968|12058284|FG002|Induction Period|Physician Decision|0
7643472|NCT01332968|12058285|FG003|Induction Period|Physician Decision|0
7643473|NCT01332968|12058286|FG004|Induction Period|Physician Decision|0
7643474|NCT01332968|12058287|FG005|Induction Period|Physician Decision|0
7643475|NCT01332968|12058288|FG006|Induction Period|Physician Decision|0
7643476|NCT01332968|12058289|FG007|Induction Period|Physician Decision|0
7643477|NCT01332968|12058282|FG000|Induction Period|Progressive Disease|15
7643478|NCT01332968|12058283|FG001|Induction Period|Progressive Disease|7
7643479|NCT01332968|12058284|FG002|Induction Period|Progressive Disease|0
7643480|NCT01332968|12058285|FG003|Induction Period|Progressive Disease|0
7643481|NCT01332968|12058286|FG004|Induction Period|Progressive Disease|0
7643482|NCT01332968|12058287|FG005|Induction Period|Progressive Disease|0
7643483|NCT01332968|12058288|FG006|Induction Period|Progressive Disease|0
7643484|NCT01332968|12058289|FG007|Induction Period|Progressive Disease|0
7643485|NCT01332968|12058282|FG000|Induction Period|Protocol Violation|3
7643486|NCT01332968|12058283|FG001|Induction Period|Protocol Violation|4
7643487|NCT01332968|12058284|FG002|Induction Period|Protocol Violation|0
7643488|NCT01332968|12058285|FG003|Induction Period|Protocol Violation|0
7643489|NCT01332968|12058286|FG004|Induction Period|Protocol Violation|0
7643490|NCT01332968|12058287|FG005|Induction Period|Protocol Violation|0
7643491|NCT01332968|12058288|FG006|Induction Period|Protocol Violation|0
7643492|NCT01332968|12058289|FG007|Induction Period|Protocol Violation|0
7643493|NCT01332968|12058282|FG000|Induction Period|Withdrawal by Subject|3
7643494|NCT01332968|12058283|FG001|Induction Period|Withdrawal by Subject|5
7643495|NCT01332968|12058284|FG002|Induction Period|Withdrawal by Subject|0
7643496|NCT01332968|12058285|FG003|Induction Period|Withdrawal by Subject|0
7643497|NCT01332968|12058286|FG004|Induction Period|Withdrawal by Subject|0
7643498|NCT01332968|12058287|FG005|Induction Period|Withdrawal by Subject|0
7643499|NCT01332968|12058288|FG006|Induction Period|Withdrawal by Subject|0
7643500|NCT01332968|12058289|FG007|Induction Period|Withdrawal by Subject|0
7643501|NCT01332968|12058282|FG000|Induction Period|Randomised but not treated|4
7643502|NCT01332968|12058283|FG001|Induction Period|Randomised but not treated|7
7643503|NCT01332968|12058284|FG002|Induction Period|Randomised but not treated|0
7643504|NCT01332968|12058285|FG003|Induction Period|Randomised but not treated|0
7643505|NCT01332968|12058286|FG004|Induction Period|Randomised but not treated|0
7643506|NCT01332968|12058287|FG005|Induction Period|Randomised but not treated|0
7643507|NCT01332968|12058288|FG006|Induction Period|Randomised but not treated|0
7643508|NCT01332968|12058289|FG007|Induction Period|Randomised but not treated|0
7643509|NCT01332968|12058282|FG000|Maintenance/Observation Period|Adverse Event|0
7643510|NCT01332968|12058283|FG001|Maintenance/Observation Period|Adverse Event|0
7643511|NCT01332968|12058284|FG002|Maintenance/Observation Period|Adverse Event|53
7643512|NCT01332968|12058285|FG003|Maintenance/Observation Period|Adverse Event|66
7643513|NCT01332968|12058286|FG004|Maintenance/Observation Period|Adverse Event|0
7643514|NCT01332968|12058287|FG005|Maintenance/Observation Period|Adverse Event|0
7643515|NCT01332968|12058288|FG006|Maintenance/Observation Period|Adverse Event|0
7643516|NCT01332968|12058289|FG007|Maintenance/Observation Period|Adverse Event|0
7643517|NCT01332968|12058282|FG000|Maintenance/Observation Period|Death|0
7643518|NCT01332968|12058283|FG001|Maintenance/Observation Period|Death|0
7643519|NCT01332968|12058284|FG002|Maintenance/Observation Period|Death|5
7643520|NCT01332968|12058285|FG003|Maintenance/Observation Period|Death|6
7643521|NCT01332968|12058286|FG004|Maintenance/Observation Period|Death|0
7643522|NCT01332968|12058287|FG005|Maintenance/Observation Period|Death|0
7643523|NCT01332968|12058288|FG006|Maintenance/Observation Period|Death|0
7643524|NCT01332968|12058289|FG007|Maintenance/Observation Period|Death|0
7643525|NCT01332968|12058282|FG000|Maintenance/Observation Period|Lost to Follow-up|0
7643526|NCT01332968|12058283|FG001|Maintenance/Observation Period|Lost to Follow-up|0
7643527|NCT01332968|12058284|FG002|Maintenance/Observation Period|Lost to Follow-up|1
7643528|NCT01332968|12058285|FG003|Maintenance/Observation Period|Lost to Follow-up|2
7643529|NCT01332968|12058286|FG004|Maintenance/Observation Period|Lost to Follow-up|0
7643530|NCT01332968|12058287|FG005|Maintenance/Observation Period|Lost to Follow-up|0
7643531|NCT01332968|12058288|FG006|Maintenance/Observation Period|Lost to Follow-up|0
7643532|NCT01332968|12058289|FG007|Maintenance/Observation Period|Lost to Follow-up|0
7643533|NCT01332968|12058282|FG000|Maintenance/Observation Period|Non-compliance|0
7643534|NCT01332968|12058283|FG001|Maintenance/Observation Period|Non-compliance|0
7643535|NCT01332968|12058284|FG002|Maintenance/Observation Period|Non-compliance|4
7643536|NCT01332968|12058285|FG003|Maintenance/Observation Period|Non-compliance|3
7643537|NCT01332968|12058286|FG004|Maintenance/Observation Period|Non-compliance|0
7643538|NCT01332968|12058287|FG005|Maintenance/Observation Period|Non-compliance|0
7643539|NCT01332968|12058288|FG006|Maintenance/Observation Period|Non-compliance|0
7643540|NCT01332968|12058289|FG007|Maintenance/Observation Period|Non-compliance|0
7643541|NCT01332968|12058282|FG000|Maintenance/Observation Period|Other|0
7643542|NCT01332968|12058283|FG001|Maintenance/Observation Period|Other|0
7643543|NCT01332968|12058284|FG002|Maintenance/Observation Period|Other|4
7643544|NCT01332968|12058285|FG003|Maintenance/Observation Period|Other|7
7643545|NCT01332968|12058286|FG004|Maintenance/Observation Period|Other|0
7643546|NCT01332968|12058287|FG005|Maintenance/Observation Period|Other|0
7643547|NCT01332968|12058288|FG006|Maintenance/Observation Period|Other|0
7643548|NCT01332968|12058289|FG007|Maintenance/Observation Period|Other|0
7643549|NCT01332968|12058282|FG000|Maintenance/Observation Period|Physician Decision|0
7643550|NCT01332968|12058283|FG001|Maintenance/Observation Period|Physician Decision|0
7643551|NCT01332968|12058284|FG002|Maintenance/Observation Period|Physician Decision|14
7643552|NCT01332968|12058285|FG003|Maintenance/Observation Period|Physician Decision|19
7643553|NCT01332968|12058286|FG004|Maintenance/Observation Period|Physician Decision|0
7643554|NCT01332968|12058287|FG005|Maintenance/Observation Period|Physician Decision|1
7643555|NCT01332968|12058288|FG006|Maintenance/Observation Period|Physician Decision|0
7643556|NCT01332968|12058289|FG007|Maintenance/Observation Period|Physician Decision|0
7643557|NCT01332968|12058282|FG000|Maintenance/Observation Period|Progressive Disease|0
7643558|NCT01332968|12058283|FG001|Maintenance/Observation Period|Progressive Disease|0
7643559|NCT01332968|12058284|FG002|Maintenance/Observation Period|Progressive Disease|72
7643560|NCT01332968|12058285|FG003|Maintenance/Observation Period|Progressive Disease|40
7643561|NCT01332968|12058286|FG004|Maintenance/Observation Period|Progressive Disease|0
7643562|NCT01332968|12058287|FG005|Maintenance/Observation Period|Progressive Disease|0
7643563|NCT01332968|12058288|FG006|Maintenance/Observation Period|Progressive Disease|0
7643564|NCT01332968|12058289|FG007|Maintenance/Observation Period|Progressive Disease|0
7643565|NCT01332968|12058282|FG000|Maintenance/Observation Period|Protocol Violation|0
7643566|NCT01332968|12058283|FG001|Maintenance/Observation Period|Protocol Violation|0
7643567|NCT01332968|12058284|FG002|Maintenance/Observation Period|Protocol Violation|1
7643568|NCT01332968|12058285|FG003|Maintenance/Observation Period|Protocol Violation|1
7643569|NCT01332968|12058286|FG004|Maintenance/Observation Period|Protocol Violation|0
7643570|NCT01332968|12058287|FG005|Maintenance/Observation Period|Protocol Violation|0
7643571|NCT01332968|12058288|FG006|Maintenance/Observation Period|Protocol Violation|0
7643572|NCT01332968|12058289|FG007|Maintenance/Observation Period|Protocol Violation|0
7643573|NCT01332968|12058282|FG000|Maintenance/Observation Period|Withdrawal by Subject|0
7643574|NCT01332968|12058283|FG001|Maintenance/Observation Period|Withdrawal by Subject|0
7643575|NCT01332968|12058284|FG002|Maintenance/Observation Period|Withdrawal by Subject|7
7643576|NCT01332968|12058285|FG003|Maintenance/Observation Period|Withdrawal by Subject|5
7643577|NCT01332968|12058286|FG004|Maintenance/Observation Period|Withdrawal by Subject|0
7643578|NCT01332968|12058287|FG005|Maintenance/Observation Period|Withdrawal by Subject|0
7643579|NCT01332968|12058288|FG006|Maintenance/Observation Period|Withdrawal by Subject|0
7643580|NCT01332968|12058289|FG007|Maintenance/Observation Period|Withdrawal by Subject|0
7643581|NCT01332968|12058282|FG000|Follow-Up Period|Adverse Event|0
7643582|NCT01332968|12058283|FG001|Follow-Up Period|Adverse Event|0
7643583|NCT01332968|12058284|FG002|Follow-Up Period|Adverse Event|0
7643584|NCT01332968|12058285|FG003|Follow-Up Period|Adverse Event|0
7643585|NCT01332968|12058286|FG004|Follow-Up Period|Adverse Event|0
7643586|NCT01332968|12058287|FG005|Follow-Up Period|Adverse Event|0
7643587|NCT01332968|12058288|FG006|Follow-Up Period|Adverse Event|0
7643588|NCT01332968|12058289|FG007|Follow-Up Period|Adverse Event|4
7643589|NCT01332968|12058282|FG000|Follow-Up Period|Death|0
7643590|NCT01332968|12058283|FG001|Follow-Up Period|Death|0
7643591|NCT01332968|12058284|FG002|Follow-Up Period|Death|0
7643592|NCT01332968|12058285|FG003|Follow-Up Period|Death|0
7643593|NCT01332968|12058286|FG004|Follow-Up Period|Death|0
7643594|NCT01332968|12058287|FG005|Follow-Up Period|Death|0
7643595|NCT01332968|12058288|FG006|Follow-Up Period|Death|27
7643596|NCT01332968|12058289|FG007|Follow-Up Period|Death|30
7643597|NCT01332968|12058282|FG000|Follow-Up Period|Lost to Follow-up|0
7643598|NCT01332968|12058283|FG001|Follow-Up Period|Lost to Follow-up|0
7643599|NCT01332968|12058284|FG002|Follow-Up Period|Lost to Follow-up|0
7643600|NCT01332968|12058285|FG003|Follow-Up Period|Lost to Follow-up|0
7643601|NCT01332968|12058286|FG004|Follow-Up Period|Lost to Follow-up|0
7643602|NCT01332968|12058287|FG005|Follow-Up Period|Lost to Follow-up|0
7643603|NCT01332968|12058288|FG006|Follow-Up Period|Lost to Follow-up|11
7643604|NCT01332968|12058289|FG007|Follow-Up Period|Lost to Follow-up|15
7643605|NCT01332968|12058282|FG000|Follow-Up Period|Non-compliance|0
7643606|NCT01332968|12058283|FG001|Follow-Up Period|Non-compliance|0
7643607|NCT01332968|12058284|FG002|Follow-Up Period|Non-compliance|0
7643608|NCT01332968|12058285|FG003|Follow-Up Period|Non-compliance|0
7643609|NCT01332968|12058286|FG004|Follow-Up Period|Non-compliance|0
7643610|NCT01332968|12058287|FG005|Follow-Up Period|Non-compliance|0
7643611|NCT01332968|12058288|FG006|Follow-Up Period|Non-compliance|4
7643612|NCT01332968|12058289|FG007|Follow-Up Period|Non-compliance|9
7643613|NCT01332968|12058282|FG000|Follow-Up Period|Other|0
7643614|NCT01332968|12058283|FG001|Follow-Up Period|Other|0
7643615|NCT01332968|12058284|FG002|Follow-Up Period|Other|0
7643616|NCT01332968|12058285|FG003|Follow-Up Period|Other|0
7643617|NCT01332968|12058286|FG004|Follow-Up Period|Other|0
7643618|NCT01332968|12058287|FG005|Follow-Up Period|Other|0
7643619|NCT01332968|12058288|FG006|Follow-Up Period|Other|18
7643620|NCT01332968|12058289|FG007|Follow-Up Period|Other|21
7643621|NCT01332968|12058282|FG000|Follow-Up Period|Physician Decision|0
7643622|NCT01332968|12058283|FG001|Follow-Up Period|Physician Decision|0
7643623|NCT01332968|12058284|FG002|Follow-Up Period|Physician Decision|0
7643624|NCT01332968|12058285|FG003|Follow-Up Period|Physician Decision|0
7643625|NCT01332968|12058286|FG004|Follow-Up Period|Physician Decision|0
7643626|NCT01332968|12058287|FG005|Follow-Up Period|Physician Decision|0
7643627|NCT01332968|12058288|FG006|Follow-Up Period|Physician Decision|12
7643628|NCT01332968|12058289|FG007|Follow-Up Period|Physician Decision|15
7643629|NCT01332968|12058282|FG000|Follow-Up Period|Progressive Disease|0
7643630|NCT01332968|12058283|FG001|Follow-Up Period|Progressive Disease|0
7643631|NCT01332968|12058284|FG002|Follow-Up Period|Progressive Disease|0
7643632|NCT01332968|12058285|FG003|Follow-Up Period|Progressive Disease|0
7643633|NCT01332968|12058286|FG004|Follow-Up Period|Progressive Disease|0
7643634|NCT01332968|12058287|FG005|Follow-Up Period|Progressive Disease|0
7643635|NCT01332968|12058288|FG006|Follow-Up Period|Progressive Disease|126
7643636|NCT01332968|12058289|FG007|Follow-Up Period|Progressive Disease|106
7643637|NCT01332968|12058282|FG000|Follow-Up Period|Protocol Violation|0
7643638|NCT01332968|12058283|FG001|Follow-Up Period|Protocol Violation|0
7643639|NCT01332968|12058284|FG002|Follow-Up Period|Protocol Violation|0
7643640|NCT01332968|12058285|FG003|Follow-Up Period|Protocol Violation|0
7643641|NCT01332968|12058286|FG004|Follow-Up Period|Protocol Violation|0
7643642|NCT01332968|12058287|FG005|Follow-Up Period|Protocol Violation|0
7643643|NCT01332968|12058288|FG006|Follow-Up Period|Protocol Violation|1
7643644|NCT01332968|12058289|FG007|Follow-Up Period|Protocol Violation|0
7643645|NCT01332968|12058282|FG000|Follow-Up Period|Withdrawal by Subject|0
7643646|NCT01332968|12058283|FG001|Follow-Up Period|Withdrawal by Subject|0
7643647|NCT01332968|12058284|FG002|Follow-Up Period|Withdrawal by Subject|0
7643648|NCT01332968|12058285|FG003|Follow-Up Period|Withdrawal by Subject|0
7643649|NCT01332968|12058286|FG004|Follow-Up Period|Withdrawal by Subject|0
7643650|NCT01332968|12058287|FG005|Follow-Up Period|Withdrawal by Subject|0
7643651|NCT01332968|12058288|FG006|Follow-Up Period|Withdrawal by Subject|29
7643652|NCT01332968|12058289|FG007|Follow-Up Period|Withdrawal by Subject|32
7643653|NCT01332968|12058282|FG000|Follow-Up Period|No reason provided|0
7643654|NCT01332968|12058283|FG001|Follow-Up Period|No reason provided|0
7643655|NCT01332968|12058284|FG002|Follow-Up Period|No reason provided|0
7643656|NCT01332968|12058285|FG003|Follow-Up Period|No reason provided|0
7643657|NCT01332968|12058286|FG004|Follow-Up Period|No reason provided|0
7643658|NCT01332968|12058287|FG005|Follow-Up Period|No reason provided|0
7643659|NCT01332968|12058288|FG006|Follow-Up Period|No reason provided|2
7643660|NCT01332968|12058289|FG007|Follow-Up Period|No reason provided|3
7643661|NCT01328093|12058312|FG000|Double-Blind Phase|Adverse Event|78
7643662|NCT01328093|12058313|FG001|Double-Blind Phase|Adverse Event|15
7643663|NCT01328093|12058312|FG000|Double-Blind Phase|Withdrawal by Subject|42
7643664|NCT01328093|12058313|FG001|Double-Blind Phase|Withdrawal by Subject|14
7643665|NCT01328093|12058312|FG000|Double-Blind Phase|Lost to Follow-up|39
7643666|NCT01328093|12058313|FG001|Double-Blind Phase|Lost to Follow-up|14
7643667|NCT01328093|12058312|FG000|Double-Blind Phase|Protocol Violation|30
7643668|NCT01328093|12058313|FG001|Double-Blind Phase|Protocol Violation|10
7643669|NCT01328093|12058312|FG000|Double-Blind Phase|Lack of Efficacy|55
7643670|NCT01328093|12058313|FG001|Double-Blind Phase|Lack of Efficacy|13
7643671|NCT01328093|12058312|FG000|Double-Blind Phase|Sponsor Decision|17
7643672|NCT01328093|12058313|FG001|Double-Blind Phase|Sponsor Decision|3
7643673|NCT01328093|12058312|FG000|Double-Blind Phase|Entry Criteria Not Met|7
7643674|NCT01328093|12058313|FG001|Double-Blind Phase|Entry Criteria Not Met|5
7643675|NCT01328093|12058312|FG000|Double-Blind Phase|Scheduling conflict|8
7643676|NCT01328093|12058313|FG001|Double-Blind Phase|Scheduling conflict|3
7643677|NCT01328093|12058312|FG000|Double-Blind Phase|Subject is moving or has moved|8
7643678|NCT01328093|12058313|FG001|Double-Blind Phase|Subject is moving or has moved|1
7643679|NCT01328093|12058312|FG000|Double-Blind Phase|Death|1
7643680|NCT01328093|12058313|FG001|Double-Blind Phase|Death|0
7643681|NCT01328093|12058312|FG000|Open-Label Phase|Sponsor Decision|98
7643682|NCT01328093|12058313|FG001|Open-Label Phase|Sponsor Decision|34
7643683|NCT01328093|12058312|FG000|Open-Label Phase|Protocol Violation|8
7643684|NCT01328093|12058313|FG001|Open-Label Phase|Protocol Violation|3
7643685|NCT01328093|12058312|FG000|Open-Label Phase|Lost to Follow-up|10
7643686|NCT01328093|12058313|FG001|Open-Label Phase|Lost to Follow-up|1
7643687|NCT01328093|12058312|FG000|Open-Label Phase|Adverse Event|10
7643688|NCT01328093|12058313|FG001|Open-Label Phase|Adverse Event|4
7643689|NCT01328093|12058312|FG000|Open-Label Phase|Lack of Efficacy|5
7643690|NCT01328093|12058313|FG001|Open-Label Phase|Lack of Efficacy|6
7643691|NCT01328093|12058312|FG000|Open-Label Phase|Withdrawal by Subject|4
7643692|NCT01328093|12058313|FG001|Open-Label Phase|Withdrawal by Subject|1
7643693|NCT01328093|12058312|FG000|Open-Label Phase|Scheduling conflict|2
7643694|NCT01328093|12058313|FG001|Open-Label Phase|Scheduling conflict|1
7643695|NCT01328093|12058312|FG000|Open-Label Phase|Subject is moving or has moved|2
7643696|NCT01328093|12058313|FG001|Open-Label Phase|Subject is moving or has moved|0
7643697|NCT01328093|12058312|FG000|Open-Label Phase|Entry Criteria Not Met|1
7643698|NCT01328093|12058313|FG001|Open-Label Phase|Entry Criteria Not Met|0
7643699|NCT01327651|12058329|FG000|Self-administered Dosing Period|Lost to Follow-up|3
7643700|NCT01327651|12058330|FG001|Self-administered Dosing Period|Lost to Follow-up|2
7643701|NCT01327651|12058331|FG002|Self-administered Dosing Period|Lost to Follow-up|4
7643702|NCT01327651|12058332|FG003|Self-administered Dosing Period|Lost to Follow-up|2
7643703|NCT01327651|12058333|FG004|Self-administered Dosing Period|Lost to Follow-up|3
7643704|NCT01327651|12058334|FG005|Self-administered Dosing Period|Lost to Follow-up|0
7643705|NCT01327651|12058335|FG006|Self-administered Dosing Period|Lost to Follow-up|8
7643706|NCT01327651|12058336|FG007|Self-administered Dosing Period|Lost to Follow-up|9
7643707|NCT01327651|12058337|FG008|Self-administered Dosing Period|Lost to Follow-up|10
7643708|NCT01327651|12058329|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1
7643709|NCT01327651|12058330|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643710|NCT01327651|12058331|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643711|NCT01327651|12058332|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643712|NCT01327651|12058333|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643713|NCT01327651|12058334|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643714|NCT01327651|12058335|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643715|NCT01327651|12058336|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643716|NCT01327651|12058337|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643717|NCT01327651|12058329|FG000|Self-administered Dosing Period|Withdrawal by Subject|0
7643718|NCT01327651|12058330|FG001|Self-administered Dosing Period|Withdrawal by Subject|1
7643719|NCT01327651|12058331|FG002|Self-administered Dosing Period|Withdrawal by Subject|0
7643720|NCT01327651|12058332|FG003|Self-administered Dosing Period|Withdrawal by Subject|1
7643721|NCT01327651|12058333|FG004|Self-administered Dosing Period|Withdrawal by Subject|0
7643722|NCT01327651|12058334|FG005|Self-administered Dosing Period|Withdrawal by Subject|0
7643723|NCT01327651|12058335|FG006|Self-administered Dosing Period|Withdrawal by Subject|2
7643724|NCT01327651|12058336|FG007|Self-administered Dosing Period|Withdrawal by Subject|1
7643725|NCT01327651|12058337|FG008|Self-administered Dosing Period|Withdrawal by Subject|1
7643726|NCT01327651|12058329|FG000|Post Study Follow-up|Lost to Follow-up|0
7643727|NCT01327651|12058330|FG001|Post Study Follow-up|Lost to Follow-up|1
7643728|NCT01327651|12058331|FG002|Post Study Follow-up|Lost to Follow-up|1
7643729|NCT01327651|12058332|FG003|Post Study Follow-up|Lost to Follow-up|0
7643730|NCT01327651|12058333|FG004|Post Study Follow-up|Lost to Follow-up|0
7643731|NCT01327651|12058334|FG005|Post Study Follow-up|Lost to Follow-up|0
7643732|NCT01327651|12058335|FG006|Post Study Follow-up|Lost to Follow-up|4
7643733|NCT01327651|12058336|FG007|Post Study Follow-up|Lost to Follow-up|1
7643734|NCT01327651|12058337|FG008|Post Study Follow-up|Lost to Follow-up|2
7643735|NCT01314118|12058413|FG000|Overall Study|Adverse Event|9
7643736|NCT01314118|12058413|FG000|Overall Study|Progressive disease|27
7643737|NCT01314118|12058413|FG000|Overall Study|Physician Decision|11
7643738|NCT01314118|12058413|FG000|Overall Study|Death|4
7643739|NCT01314118|12058413|FG000|Overall Study|Protocol Violation|5
7643740|NCT01314118|12058413|FG000|Overall Study|Withdrawal by Subject|11
7643741|NCT01314118|12058413|FG000|Overall Study|Other|2
7643742|NCT01314118|12058413|FG000|Overall Study|Ongoing|62
7643743|NCT01313312|12058417|FG000|Overall Study|Adverse Event|5
7643744|NCT01313312|12058417|FG000|Overall Study|Withdrawal by Subject|18
7643745|NCT01313312|12058417|FG000|Overall Study|Lack of Efficacy|3
7643746|NCT01313312|12058417|FG000|Overall Study|Investigator Decision|1
7643747|NCT01313312|12058417|FG000|Overall Study|Observational Phase|1
7643748|NCT01313312|12058417|FG000|Overall Study|Subject Withdrawn Early in Error|4
7643749|NCT01313312|12058417|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4
7643750|NCT01313299|12058424|FG000|Overall Study|Adverse Event|3
7643751|NCT01313299|12058425|FG001|Overall Study|Adverse Event|1
7643752|NCT01313299|12058426|FG002|Overall Study|Adverse Event|1
7643753|NCT01313299|12058424|FG000|Overall Study|Lost to Follow-up|1
7643754|NCT01313299|12058425|FG001|Overall Study|Lost to Follow-up|0
7643755|NCT01313299|12058426|FG002|Overall Study|Lost to Follow-up|0
7643756|NCT01313299|12058424|FG000|Overall Study|Protocol Violation|2
7643757|NCT01313299|12058425|FG001|Overall Study|Protocol Violation|0
7643758|NCT01313299|12058426|FG002|Overall Study|Protocol Violation|0
7643759|NCT01313299|12058424|FG000|Overall Study|Withdrawal by Subject|1
7643760|NCT01313299|12058425|FG001|Overall Study|Withdrawal by Subject|0
7643761|NCT01313299|12058426|FG002|Overall Study|Withdrawal by Subject|2
7643762|NCT01313299|12058424|FG000|Overall Study|Family reason and moved out of state|0
7643763|NCT01313299|12058425|FG001|Overall Study|Family reason and moved out of state|2
7643764|NCT01313299|12058426|FG002|Overall Study|Family reason and moved out of state|0
7643765|NCT01313299|12058424|FG000|Overall Study|Lack of subject compliance|0
7643766|NCT01313299|12058425|FG001|Overall Study|Lack of subject compliance|0
7643767|NCT01313299|12058426|FG002|Overall Study|Lack of subject compliance|1
7643768|NCT01308853|12058443|FG000|Overall Study|Adverse Event|1
7643769|NCT01308853|12058443|FG000|Overall Study|Lost to Follow-up|2
7643770|NCT01308853|12058443|FG000|Overall Study|Insertion of permanent implants|1
7643771|NCT01288911|12058460|FG000|Double-blind Period|Death|11
7643772|NCT01288911|12058461|FG001|Double-blind Period|Death|7
7643773|NCT01288911|12058460|FG000|Double-blind Period|Lost to Follow-up|0
7643774|NCT01288911|12058461|FG001|Double-blind Period|Lost to Follow-up|2
7643775|NCT01288911|12058460|FG000|Double-blind Period|Progressive Disease|75
7643776|NCT01288911|12058461|FG001|Double-blind Period|Progressive Disease|103
7643777|NCT01288911|12058460|FG000|Double-blind Period|Protocol Violation|1
7643778|NCT01288911|12058461|FG001|Double-blind Period|Protocol Violation|0
7643779|NCT01288911|12058460|FG000|Double-blind Period|Withdrawal by Subject|25
7643780|NCT01288911|12058461|FG001|Double-blind Period|Withdrawal by Subject|26
7643781|NCT01288911|12058460|FG000|Double-blind Period|Miscellaneous Reason|29
7643782|NCT01288911|12058461|FG001|Double-blind Period|Miscellaneous Reason|42
7643783|NCT01288911|12058460|FG000|Double-blind Period|Randomized but never received study drug|1
7643784|NCT01288911|12058461|FG001|Double-blind Period|Randomized but never received study drug|2
7643785|NCT01288911|12058460|FG000|Open-label Period (All Enzalutamide)|Death|0
7643786|NCT01288911|12058461|FG001|Open-label Period (All Enzalutamide)|Death|1
7643787|NCT01288911|12058460|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
7643788|NCT01288911|12058461|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
7643789|NCT01288911|12058460|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18
7643790|NCT01288911|12058461|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3
7643791|NCT01288911|12058460|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
7643792|NCT01288911|12058461|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
7643793|NCT01288911|12058460|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
7643794|NCT01288911|12058461|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
7643795|NCT01288911|12058460|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
7643796|NCT01288911|12058461|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
7643797|NCT01286272|12058472|FG000|Overall Study|Ineligible after beginning treatment|1
7643798|NCT01286272|12058473|FG001|Overall Study|Ineligible after beginning treatment|3
7643799|NCT01275677|12058481|FG000|Overall Study|Not at risk for recurrence.|1
7643800|NCT01275677|12058482|FG001|Overall Study|Not at risk for recurrence.|1
7643801|NCT01275677|12058481|FG000|Overall Study|No follow-up|26
7643802|NCT01275677|12058482|FG001|Overall Study|No follow-up|37
7643803|NCT01275677|12058481|FG000|Overall Study|No clinical follow up.|1
7643804|NCT01275677|12058482|FG001|Overall Study|No clinical follow up.|4
7643805|NCT01267955|12058498|FG000|Stage 1 (6 Months)|Death|3
7643806|NCT01267955|12058498|FG000|Stage 2 (6 Months)|Death|5
7643807|NCT01267955|12058498|FG000|Stage 2 (6 Months)|Protocol Violation|1
7643808|NCT01265849|12058505|FG000|Overall Study|Randomized//Treatment not initiated|1
7643809|NCT01265849|12058506|FG001|Overall Study|Randomized//Treatment not initiated|4
7643810|NCT01265849|12058507|FG002|Overall Study|Randomized//Treatment not initiated|0
7643811|NCT01265849|12058505|FG000|Overall Study|Physician Decision|1
7643812|NCT01265849|12058506|FG001|Overall Study|Physician Decision|2
7643813|NCT01265849|12058507|FG002|Overall Study|Physician Decision|0
7643814|NCT01265849|12058505|FG000|Overall Study|Lost to Follow-up|18
7643815|NCT01265849|12058506|FG001|Overall Study|Lost to Follow-up|15
7643816|NCT01265849|12058507|FG002|Overall Study|Lost to Follow-up|5
7643817|NCT01265849|12058505|FG000|Overall Study|Not otherwise specified|1
7643818|NCT01265849|12058506|FG001|Overall Study|Not otherwise specified|6
7643819|NCT01265849|12058507|FG002|Overall Study|Not otherwise specified|1
7643820|NCT01265849|12058505|FG000|Overall Study|Withdrawal by Subject|25
7643821|NCT01265849|12058506|FG001|Overall Study|Withdrawal by Subject|34
7643822|NCT01265849|12058507|FG002|Overall Study|Withdrawal by Subject|13
7643823|NCT01263769|12058544|FG000|Overall Study|Non-Compliant with treatment|1
7643824|NCT01261611|12058551|FG000|Treatment Cycle 1|Withdrawal by Subject|3
7643825|NCT01261611|12058552|FG001|Treatment Cycle 1|Withdrawal by Subject|2
7643826|NCT01261611|12058553|FG002|Treatment Cycle 1|Withdrawal by Subject|0
7643827|NCT01261611|12058551|FG000|Treatment Cycle 1|Lost to Follow-up|1
7643828|NCT01261611|12058552|FG001|Treatment Cycle 1|Lost to Follow-up|0
7643829|NCT01261611|12058553|FG002|Treatment Cycle 1|Lost to Follow-up|0
7643830|NCT01261611|12058551|FG000|Treatment Cycle 1|Adverse Event|0
7643831|NCT01261611|12058552|FG001|Treatment Cycle 1|Adverse Event|1
7643832|NCT01261611|12058553|FG002|Treatment Cycle 1|Adverse Event|0
7643833|NCT01261611|12058551|FG000|Treatment Cycle 1|Protocol Violation|0
7643834|NCT01261611|12058552|FG001|Treatment Cycle 1|Protocol Violation|0
7643835|NCT01261611|12058553|FG002|Treatment Cycle 1|Protocol Violation|2
7643836|NCT01261611|12058551|FG000|Treatment Cycle 2|Completed study|4
7643837|NCT01261611|12058552|FG001|Treatment Cycle 2|Completed study|0
7643838|NCT01261611|12058553|FG002|Treatment Cycle 2|Completed study|0
7643839|NCT01261611|12058551|FG000|Treatment Cycle 2|Withdrawal by Subject|4
7643840|NCT01261611|12058552|FG001|Treatment Cycle 2|Withdrawal by Subject|0
7643841|NCT01261611|12058553|FG002|Treatment Cycle 2|Withdrawal by Subject|0
7643842|NCT01261611|12058551|FG000|Treatment Cycle 2|Adverse Event|1
7643843|NCT01261611|12058552|FG001|Treatment Cycle 2|Adverse Event|0
7643844|NCT01261611|12058553|FG002|Treatment Cycle 2|Adverse Event|0
7643845|NCT01261611|12058551|FG000|Treatment Cycle 2|Protocol Violation|2
7643846|NCT01261611|12058552|FG001|Treatment Cycle 2|Protocol Violation|0
7643847|NCT01261611|12058553|FG002|Treatment Cycle 2|Protocol Violation|0
7643848|NCT01261611|12058551|FG000|Treatment Cycle 2|Not otherwise specified|2
7643849|NCT01261611|12058552|FG001|Treatment Cycle 2|Not otherwise specified|0
7643850|NCT01261611|12058553|FG002|Treatment Cycle 2|Not otherwise specified|0
7643851|NCT01261611|12058551|FG000|Treatment Cycle 3|Completed study|24
7643852|NCT01261611|12058552|FG001|Treatment Cycle 3|Completed study|0
7643853|NCT01261611|12058553|FG002|Treatment Cycle 3|Completed study|0
7643854|NCT01261611|12058551|FG000|Treatment Cycle 3|Withdrawal by Subject|4
7643855|NCT01261611|12058552|FG001|Treatment Cycle 3|Withdrawal by Subject|0
7643856|NCT01261611|12058553|FG002|Treatment Cycle 3|Withdrawal by Subject|0
7643857|NCT01261611|12058551|FG000|Treatment Cycle 3|Adverse Event|1
7643858|NCT01261611|12058552|FG001|Treatment Cycle 3|Adverse Event|0
7643859|NCT01261611|12058553|FG002|Treatment Cycle 3|Adverse Event|0
7643860|NCT01261611|12058551|FG000|Treatment Cycle 3|Lost to Follow-up|1
7643861|NCT01261611|12058552|FG001|Treatment Cycle 3|Lost to Follow-up|0
7643862|NCT01261611|12058553|FG002|Treatment Cycle 3|Lost to Follow-up|0
7643863|NCT01261611|12058551|FG000|Treatment Cycle 4|Completed study|87
7643864|NCT01261611|12058552|FG001|Treatment Cycle 4|Completed study|0
7643865|NCT01261611|12058553|FG002|Treatment Cycle 4|Completed study|0
7643866|NCT01261611|12058551|FG000|Treatment Cycle 4|Withdrawal by Subject|3
7643867|NCT01261611|12058552|FG001|Treatment Cycle 4|Withdrawal by Subject|0
7643868|NCT01261611|12058553|FG002|Treatment Cycle 4|Withdrawal by Subject|0
7643869|NCT01261611|12058551|FG000|Treatment Cycle 4|Adverse Event|1
7643870|NCT01261611|12058552|FG001|Treatment Cycle 4|Adverse Event|0
7643871|NCT01261611|12058553|FG002|Treatment Cycle 4|Adverse Event|0
7643872|NCT01261611|12058551|FG000|Treatment Cycle 4|Lost to Follow-up|2
7643873|NCT01261611|12058552|FG001|Treatment Cycle 4|Lost to Follow-up|0
7643874|NCT01261611|12058553|FG002|Treatment Cycle 4|Lost to Follow-up|0
7643875|NCT01261611|12058551|FG000|Treatment Cycle 4|Not otherwise specified|3
7643876|NCT01261611|12058552|FG001|Treatment Cycle 4|Not otherwise specified|0
7643877|NCT01261611|12058553|FG002|Treatment Cycle 4|Not otherwise specified|0
7643878|NCT01261611|12058551|FG000|Treatment Cycle 5|Withdrawal by Subject|1
7643879|NCT01261611|12058552|FG001|Treatment Cycle 5|Withdrawal by Subject|0
7643880|NCT01261611|12058553|FG002|Treatment Cycle 5|Withdrawal by Subject|0
7643881|NCT01261611|12058551|FG000|Treatment Cycle 5|Adverse Event|1
7643882|NCT01261611|12058552|FG001|Treatment Cycle 5|Adverse Event|0
7643883|NCT01261611|12058553|FG002|Treatment Cycle 5|Adverse Event|0
7643884|NCT01261611|12058551|FG000|Treatment Cycle 5|Lost to Follow-up|1
7643885|NCT01261611|12058552|FG001|Treatment Cycle 5|Lost to Follow-up|0
7643886|NCT01261611|12058553|FG002|Treatment Cycle 5|Lost to Follow-up|0
7643887|NCT01256398|12058565|FG000|Overall Study|Withdrawal by Subject|1
7643888|NCT01251861|12058585|FG000|Overall Study|Disease progression|6
7643889|NCT01251861|12058586|FG001|Overall Study|Disease progression|6
7643890|NCT01251861|12058585|FG000|Overall Study|Adverse Event|2
7643891|NCT01251861|12058586|FG001|Overall Study|Adverse Event|17
7643892|NCT01251861|12058585|FG000|Overall Study|Withdrawal by Subject|2
7643893|NCT01251861|12058586|FG001|Overall Study|Withdrawal by Subject|2
7643894|NCT01251861|12058585|FG000|Overall Study|Alternative therapy|1
7643895|NCT01251861|12058586|FG001|Overall Study|Alternative therapy|0
7643896|NCT01251861|12058585|FG000|Overall Study|Other complicating disease|0
7643897|NCT01251861|12058586|FG001|Overall Study|Other complicating disease|1
7643898|NCT01251861|12058585|FG000|Overall Study|Physician Decision|1
7643899|NCT01251861|12058586|FG001|Overall Study|Physician Decision|0
7643900|NCT01251861|12058585|FG000|Overall Study|Continued treatment beyond 18 cycles|1
7643901|NCT01251861|12058586|FG001|Overall Study|Continued treatment beyond 18 cycles|0
7643902|NCT01251861|12058585|FG000|Overall Study|Other|1
7643903|NCT01251861|12058586|FG001|Overall Study|Other|0
7643904|NCT01251861|12058585|FG000|Overall Study|Never started therapy|4
7643905|NCT01251861|12058586|FG001|Overall Study|Never started therapy|1
7643906|NCT01251861|12058585|FG000|Overall Study|Potential interaction of drugs|0
7643907|NCT01251861|12058586|FG001|Overall Study|Potential interaction of drugs|1
7643908|NCT01251380|12058592|FG000|Overall Study|Other (Not otherwise specified)|12
7643909|NCT01251380|12058592|FG000|Overall Study|Withdrawal by Subject|6
7643910|NCT01251380|12058592|FG000|Overall Study|Lack of Efficacy|1
7643911|NCT01251380|12058592|FG000|Overall Study|Adverse Event|1
7643912|NCT01251380|12058592|FG000|Overall Study|Lost to Follow-up|2
7643913|NCT01251367|12058601|FG000|Overall Study|Protocol Violation|1
7643914|NCT01251367|12058601|FG000|Overall Study|Lack of Efficacy|2
7643915|NCT01251367|12058601|FG000|Overall Study|Adverse Event|19
7643916|NCT01251367|12058601|FG000|Overall Study|Withdrawal by Subject|36
7643917|NCT01251367|12058601|FG000|Overall Study|Lost to Follow-up|5
7643918|NCT01251367|12058601|FG000|Overall Study|Subject Required Alternative Treatment|7
7643919|NCT01251367|12058601|FG000|Overall Study|No Study Drug Available|1
7643920|NCT01251367|12058601|FG000|Overall Study|Subject had Personal or Medical Issues|4
7643921|NCT01251367|12058601|FG000|Overall Study|End of Study Visit Performed in Error|1
7643922|NCT01251276|12058607|FG000|Overall Study|Protocol Violation|1
7643923|NCT01251276|12058608|FG001|Overall Study|Protocol Violation|0
7643924|NCT01251276|12058607|FG000|Overall Study|Lost to Follow-up|0
7643925|NCT01251276|12058608|FG001|Overall Study|Lost to Follow-up|1
7643926|NCT01249417|12058617|FG000|Randomised Population|Study treatment not received|0
7643927|NCT01249417|12058618|FG001|Randomised Population|Study treatment not received|0
7643928|NCT01249417|12058619|FG002|Randomised Population|Study treatment not received|2
7643929|NCT01249417|12058617|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1
7643930|NCT01249417|12058618|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1
7643931|NCT01249417|12058619|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2
7643932|NCT01249417|12058617|FG000|Treatment Phase - ITT Population|Other|0
7643933|NCT01249417|12058618|FG001|Treatment Phase - ITT Population|Other|0
7643934|NCT01249417|12058619|FG002|Treatment Phase - ITT Population|Other|1
7643935|NCT01249417|12058617|FG000|Treatment Phase - ITT Population|Adverse Event|0
7643936|NCT01249417|12058618|FG001|Treatment Phase - ITT Population|Adverse Event|0
7643937|NCT01249417|12058619|FG002|Treatment Phase - ITT Population|Adverse Event|1
7643938|NCT01249417|12058617|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1
7643939|NCT01249417|12058618|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3
7643940|NCT01249417|12058619|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1
7643941|NCT01249417|12058617|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0
7643942|NCT01249417|12058618|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1
7643943|NCT01249417|12058619|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1
7643944|NCT01249404|12058630|FG000|Overall Study|Study treatment not received|0
7643945|NCT01249404|12058631|FG001|Overall Study|Study treatment not received|1
7643946|NCT01249404|12058632|FG002|Overall Study|Study treatment not received|2
7643947|NCT01249404|12058630|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2
7643948|NCT01249404|12058631|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0
7643949|NCT01249404|12058632|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2
7643950|NCT01249404|12058630|FG000|Overall Study|Adverse Event|2
7643951|NCT01249404|12058631|FG001|Overall Study|Adverse Event|2
7643952|NCT01249404|12058632|FG002|Overall Study|Adverse Event|2
7643953|NCT01249404|12058630|FG000|Overall Study|Withdrawal by Subject|2
7643954|NCT01249404|12058631|FG001|Overall Study|Withdrawal by Subject|2
7643955|NCT01249404|12058632|FG002|Overall Study|Withdrawal by Subject|0
7643956|NCT01249404|12058630|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1
7643957|NCT01249404|12058631|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2
7643958|NCT01249404|12058632|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1
7643959|NCT01249404|12058630|FG000|Overall Study|Non compliance to visit schedule|0
7643960|NCT01249404|12058631|FG001|Overall Study|Non compliance to visit schedule|1
7643961|NCT01249404|12058632|FG002|Overall Study|Non compliance to visit schedule|0
7643962|NCT01238211|12058640|FG000|Overall Study|Continues active treatment|31
7643963|NCT01238211|12058640|FG000|Overall Study|Adverse Event|7
7643964|NCT01238211|12058640|FG000|Overall Study|Death|4
7643965|NCT01238211|12058640|FG000|Overall Study|Relapse/Progression|2
7643966|NCT01238211|12058640|FG000|Overall Study|Withdrawal by Subject|7
7643967|NCT01238211|12058640|FG000|Overall Study|Non-protocol treatment|4
7643968|NCT01238211|12058640|FG000|Overall Study|Investigator/Patient Decision|3
7643969|NCT01236560|12058650|FG000|Overall Study|Adverse Event|0
7643970|NCT01236560|12058651|FG001|Overall Study|Adverse Event|2
7643971|NCT01236560|12058652|FG002|Overall Study|Adverse Event|1
7643972|NCT01236560|12058653|FG003|Overall Study|Adverse Event|3
7643973|NCT01236560|12058654|FG004|Overall Study|Adverse Event|0
7643974|NCT01236560|12058655|FG005|Overall Study|Adverse Event|0
7643975|NCT01236560|12058650|FG000|Overall Study|Death|0
7643976|NCT01236560|12058651|FG001|Overall Study|Death|1
7643977|NCT01236560|12058652|FG002|Overall Study|Death|0
7643978|NCT01236560|12058653|FG003|Overall Study|Death|1
7643979|NCT01236560|12058654|FG004|Overall Study|Death|0
7643980|NCT01236560|12058655|FG005|Overall Study|Death|0
7643981|NCT01236560|12058650|FG000|Overall Study|Lost to Follow-up|0
7643982|NCT01236560|12058651|FG001|Overall Study|Lost to Follow-up|1
7643983|NCT01236560|12058652|FG002|Overall Study|Lost to Follow-up|1
7643984|NCT01236560|12058653|FG003|Overall Study|Lost to Follow-up|0
7643985|NCT01236560|12058654|FG004|Overall Study|Lost to Follow-up|0
7643986|NCT01236560|12058655|FG005|Overall Study|Lost to Follow-up|0
7643987|NCT01236560|12058650|FG000|Overall Study|Physician Decision|0
7643988|NCT01236560|12058651|FG001|Overall Study|Physician Decision|1
7643989|NCT01236560|12058652|FG002|Overall Study|Physician Decision|8
7643990|NCT01236560|12058653|FG003|Overall Study|Physician Decision|0
7643991|NCT01236560|12058654|FG004|Overall Study|Physician Decision|0
7643992|NCT01236560|12058655|FG005|Overall Study|Physician Decision|0
7643993|NCT01236560|12058650|FG000|Overall Study|Withdrawal by Subject|0
7643994|NCT01236560|12058651|FG001|Overall Study|Withdrawal by Subject|0
7643995|NCT01236560|12058652|FG002|Overall Study|Withdrawal by Subject|1
7643996|NCT01236560|12058653|FG003|Overall Study|Withdrawal by Subject|2
7643997|NCT01236560|12058654|FG004|Overall Study|Withdrawal by Subject|0
7643998|NCT01236560|12058655|FG005|Overall Study|Withdrawal by Subject|0
7643999|NCT01236560|12058650|FG000|Overall Study|Progressive disease|5
7644000|NCT01236560|12058651|FG001|Overall Study|Progressive disease|19
7644001|NCT01236560|12058652|FG002|Overall Study|Progressive disease|9
7644002|NCT01236560|12058653|FG003|Overall Study|Progressive disease|16
7644003|NCT01236560|12058654|FG004|Overall Study|Progressive disease|0
7644004|NCT01236560|12058655|FG005|Overall Study|Progressive disease|0
7644005|NCT01209949|12058694|FG000|Overall Study|Lost to Follow-up|3
7644006|NCT01207492|12058698|FG000|Overall Study|Still on study|1
7644007|NCT01207492|12058698|FG000|Overall Study|Withdrawal by Subject|9
7644008|NCT01207492|12058698|FG000|Overall Study|Physician Decision|1
7644009|NCT01207492|12058698|FG000|Overall Study|Progressive disease|3
7644010|NCT01207492|12058698|FG000|Overall Study|Toxicity|1
7644011|NCT01197950|12058705|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16
7644012|NCT01197950|12058706|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16
7644013|NCT01197950|12058707|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18
7644014|NCT01196390|12058717|FG000|Overall Study|Protocol Violation|4
7644015|NCT01196390|12058718|FG001|Overall Study|Protocol Violation|5
7644016|NCT01171898|12058730|FG000|Overall Study|Death|0
7644017|NCT01171898|12058731|FG001|Overall Study|Death|0
7644018|NCT01171898|12058732|FG002|Overall Study|Death|2
7644019|NCT01171898|12058733|FG003|Overall Study|Death|0
7644020|NCT01171898|12058730|FG000|Overall Study|Lost to Follow-up|0
7644021|NCT01171898|12058731|FG001|Overall Study|Lost to Follow-up|1
7644022|NCT01171898|12058732|FG002|Overall Study|Lost to Follow-up|1
7644023|NCT01171898|12058733|FG003|Overall Study|Lost to Follow-up|1
7644024|NCT01171898|12058730|FG000|Overall Study|Withdrawal by Subject|1
7644025|NCT01171898|12058731|FG001|Overall Study|Withdrawal by Subject|4
7644026|NCT01171898|12058732|FG002|Overall Study|Withdrawal by Subject|6
7644027|NCT01171898|12058733|FG003|Overall Study|Withdrawal by Subject|3
7644028|NCT01171898|12058730|FG000|Overall Study|Terminated by Sponsor|1
7644029|NCT01171898|12058731|FG001|Overall Study|Terminated by Sponsor|0
7644030|NCT01171898|12058732|FG002|Overall Study|Terminated by Sponsor|0
7644031|NCT01171898|12058733|FG003|Overall Study|Terminated by Sponsor|0
7644032|NCT01171898|12058730|FG000|Overall Study|Ongoing|1
7644033|NCT01171898|12058731|FG001|Overall Study|Ongoing|9
7644034|NCT01171898|12058732|FG002|Overall Study|Ongoing|3
7644035|NCT01171898|12058733|FG003|Overall Study|Ongoing|0
7644036|NCT01171898|12058730|FG000|Overall Study|Other|1
7644037|NCT01171898|12058731|FG001|Overall Study|Other|5
7644038|NCT01171898|12058732|FG002|Overall Study|Other|0
7644039|NCT01171898|12058733|FG003|Overall Study|Other|2
7644040|NCT01168219|12058746|FG000|Overall Study|off study before starting treatment|2
7644041|NCT01168219|12058746|FG000|Overall Study|withdrew before transplant|1
7644042|NCT01168219|12058746|FG000|Overall Study|ineligible due to CML|2
7644043|NCT01145495|12058764|FG000|Overall Study|Adverse Event|6
7644044|NCT01145495|12058764|FG000|Overall Study|Withdrawal by Subject|5
7644045|NCT01145495|12058764|FG000|Overall Study|Disease progression after respone|1
7644046|NCT01143038|12058785|FG000|Overall Study|Withdrawal by Subject|4
7644047|NCT01143038|12058785|FG000|Overall Study|Requirement for alternative therapy|5
7644048|NCT01143038|12058785|FG000|Overall Study|Adverse Event|3
7644049|NCT01143038|12058785|FG000|Overall Study|Lost to Follow-up|2
7644050|NCT01143038|12058785|FG000|Overall Study|Protocol Deviation|1
7644051|NCT01143038|12058785|FG000|Overall Study|Death|1
7644052|NCT01142388|12058791|FG000|Overall Study|Lack of Efficacy|21
7644053|NCT01142388|12058792|FG001|Overall Study|Lack of Efficacy|31
7644054|NCT01142388|12058791|FG000|Overall Study|Adverse Event|9
7644055|NCT01142388|12058792|FG001|Overall Study|Adverse Event|5
7644056|NCT01142388|12058791|FG000|Overall Study|Death|3
7644057|NCT01142388|12058792|FG001|Overall Study|Death|2
7644058|NCT01142388|12058791|FG000|Overall Study|Withdrawal by Subject|5
7644059|NCT01142388|12058792|FG001|Overall Study|Withdrawal by Subject|3
7644060|NCT01142388|12058791|FG000|Overall Study|Alternative therapy|1
7644061|NCT01142388|12058792|FG001|Overall Study|Alternative therapy|0
7644062|NCT01142388|12058791|FG000|Overall Study|Other complications|0
7644063|NCT01142388|12058792|FG001|Overall Study|Other complications|2
7644064|NCT01142388|12058791|FG000|Overall Study|Other|1
7644065|NCT01142388|12058792|FG001|Overall Study|Other|1
7644066|NCT01142388|12058791|FG000|Overall Study|Never started therapy|7
7644067|NCT01142388|12058792|FG001|Overall Study|Never started therapy|3
7644068|NCT01139047|12058798|FG000|Overall Study|Withdrawal by Subject|1
7644069|NCT01139008|12058805|FG000|Overall Study|Withdrawal by Subject|5
7644070|NCT01139008|12058805|FG000|Overall Study|Non-compliant, lost product|1
7644071|NCT01134614|12058814|FG000|Overall Study|Still on treatment as of March 2013|21
7644072|NCT01134614|12058815|FG001|Overall Study|Still on treatment as of March 2013|13
7644073|NCT01134614|12058814|FG000|Overall Study|Progressive disease|60
7644074|NCT01134614|12058815|FG001|Overall Study|Progressive disease|54
7644075|NCT01134614|12058814|FG000|Overall Study|Adverse Event|26
7644076|NCT01134614|12058815|FG001|Overall Study|Adverse Event|39
7644077|NCT01134614|12058814|FG000|Overall Study|Death|5
7644078|NCT01134614|12058815|FG001|Overall Study|Death|8
7644079|NCT01134614|12058814|FG000|Overall Study|Withdrawal by Subject|3
7644080|NCT01134614|12058815|FG001|Overall Study|Withdrawal by Subject|2
7644081|NCT01134614|12058814|FG000|Overall Study|Alternative therapy|2
7644082|NCT01134614|12058815|FG001|Overall Study|Alternative therapy|0
7644083|NCT01134614|12058814|FG000|Overall Study|Complicating disease|2
7644084|NCT01134614|12058815|FG001|Overall Study|Complicating disease|1
7644085|NCT01134614|12058814|FG000|Overall Study|Physician's decision|0
7644086|NCT01134614|12058815|FG001|Overall Study|Physician's decision|1
7644087|NCT01134614|12058814|FG000|Overall Study|Never started treatment|4
7644088|NCT01134614|12058815|FG001|Overall Study|Never started treatment|1
7644089|NCT01134614|12058814|FG000|Overall Study|Pt received tx not allowed on study|0
7644090|NCT01134614|12058815|FG001|Overall Study|Pt received tx not allowed on study|1
7644091|NCT01134614|12058814|FG000|Overall Study|Symptomatic deterioration|0
7644092|NCT01134614|12058815|FG001|Overall Study|Symptomatic deterioration|1
7644093|NCT01134614|12058814|FG000|Overall Study|Patient in hospice care|0
7644094|NCT01134614|12058815|FG001|Overall Study|Patient in hospice care|1
7644095|NCT01131182|12058823|FG000|Overall Study|Withdrawal by Subject|1
7644096|NCT01131182|12058824|FG001|Overall Study|Withdrawal by Subject|1
7644097|NCT01131182|12058823|FG000|Overall Study|Lost to Follow-up|14
7644098|NCT01131182|12058824|FG001|Overall Study|Lost to Follow-up|15
7644099|NCT01131182|12058823|FG000|Overall Study|Other Reason|1
7644100|NCT01131182|12058824|FG001|Overall Study|Other Reason|0
7644101|NCT01126736|12058835|FG000|Overall Study|Death|2
7644102|NCT01126736|12058836|FG001|Overall Study|Death|2
7644103|NCT01126736|12058837|FG002|Overall Study|Death|1
7644104|NCT01126736|12058838|FG003|Overall Study|Death|19
7644105|NCT01126736|12058839|FG004|Overall Study|Death|19
7644106|NCT01126736|12058835|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0
7644107|NCT01126736|12058836|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0
7644108|NCT01126736|12058837|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0
7644109|NCT01126736|12058838|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3
7644110|NCT01126736|12058839|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3
7644111|NCT01126736|12058835|FG000|Overall Study|Lost to Follow-up|0
7644112|NCT01126736|12058836|FG001|Overall Study|Lost to Follow-up|0
7644113|NCT01126736|12058837|FG002|Overall Study|Lost to Follow-up|0
7644114|NCT01126736|12058838|FG003|Overall Study|Lost to Follow-up|1
7644115|NCT01126736|12058839|FG004|Overall Study|Lost to Follow-up|1
7644116|NCT01126736|12058835|FG000|Overall Study|Administrative reasons|0
7644117|NCT01126736|12058836|FG001|Overall Study|Administrative reasons|0
7644118|NCT01126736|12058837|FG002|Overall Study|Administrative reasons|0
7644119|NCT01126736|12058838|FG003|Overall Study|Administrative reasons|0
7644120|NCT01126736|12058839|FG004|Overall Study|Administrative reasons|1
7644121|NCT01126736|12058835|FG000|Overall Study|Progressive disease|0
7644122|NCT01126736|12058836|FG001|Overall Study|Progressive disease|0
7644123|NCT01126736|12058837|FG002|Overall Study|Progressive disease|0
7644124|NCT01126736|12058838|FG003|Overall Study|Progressive disease|2
7644125|NCT01126736|12058839|FG004|Overall Study|Progressive disease|1
7644126|NCT01126736|12058835|FG000|Overall Study|Withdrawal by Subject|0
7644127|NCT01126736|12058836|FG001|Overall Study|Withdrawal by Subject|0
7644128|NCT01126736|12058837|FG002|Overall Study|Withdrawal by Subject|0
7644129|NCT01126736|12058838|FG003|Overall Study|Withdrawal by Subject|1
7644130|NCT01126736|12058839|FG004|Overall Study|Withdrawal by Subject|1
7644131|NCT01126736|12058835|FG000|Overall Study|Other|2
7644132|NCT01126736|12058836|FG001|Overall Study|Other|4
7644133|NCT01126736|12058837|FG002|Overall Study|Other|4
7644134|NCT01126736|12058838|FG003|Overall Study|Other|16
7644135|NCT01126736|12058839|FG004|Overall Study|Other|15
7644136|NCT01120964|12058862|FG000|Overall Study|Did not receive full treatment|1
7644137|NCT01120964|12058863|FG001|Overall Study|Did not receive full treatment|0
7644138|NCT01119066|12058873|FG000|Overall Study|Withdrawal by Subject|4
7644139|NCT01119066|12058874|FG001|Overall Study|Withdrawal by Subject|6
7644140|NCT01119066|12058875|FG002|Overall Study|Withdrawal by Subject|0
7644141|NCT01119066|12058876|FG003|Overall Study|Withdrawal by Subject|0
7644142|NCT01119066|12058873|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2
7644143|NCT01119066|12058874|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1
7644144|NCT01119066|12058875|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0
7644145|NCT01119066|12058876|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0
7644146|NCT01119066|12058873|FG000|Overall Study|Relapse identified before transplant|1
7644147|NCT01119066|12058874|FG001|Overall Study|Relapse identified before transplant|0
7644148|NCT01119066|12058875|FG002|Overall Study|Relapse identified before transplant|0
7644149|NCT01119066|12058876|FG003|Overall Study|Relapse identified before transplant|0
7644150|NCT01119066|12058873|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0
7644151|NCT01119066|12058874|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3
7644152|NCT01119066|12058875|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0
7644153|NCT01119066|12058876|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0
7644154|NCT01119066|12058873|FG000|Overall Study|Relapse identified before transplant|0
7644155|NCT01119066|12058874|FG001|Overall Study|Relapse identified before transplant|4
7644156|NCT01119066|12058875|FG002|Overall Study|Relapse identified before transplant|0
7644157|NCT01119066|12058876|FG003|Overall Study|Relapse identified before transplant|0
7644158|NCT01112306|12058886|FG000|Overall Study|Death|175
7644159|NCT01112306|12058886|FG000|Overall Study|Lost to Follow-up|9
7644160|NCT01112306|12058886|FG000|Overall Study|Withdrawal by Subject|31
7644161|NCT01112306|12058886|FG000|Overall Study|Other|70
7644162|NCT01081678|12058898|FG000|Overall Study|Ineligibility Determined|0
7644163|NCT01081678|12058899|FG001|Overall Study|Ineligibility Determined|0
7644164|NCT01081678|12058900|FG002|Overall Study|Ineligibility Determined|1
7644165|NCT01081678|12058901|FG003|Overall Study|Ineligibility Determined|1
7644166|NCT01081678|12058898|FG000|Overall Study|Noncompliance|3
7644167|NCT01081678|12058899|FG001|Overall Study|Noncompliance|4
7644168|NCT01081678|12058900|FG002|Overall Study|Noncompliance|5
7644169|NCT01081678|12058901|FG003|Overall Study|Noncompliance|2
7644170|NCT01081678|12058898|FG000|Overall Study|Adverse Event|2
7644171|NCT01081678|12058899|FG001|Overall Study|Adverse Event|1
7644172|NCT01081678|12058900|FG002|Overall Study|Adverse Event|2
7644173|NCT01081678|12058901|FG003|Overall Study|Adverse Event|2
7644174|NCT01081678|12058898|FG000|Overall Study|Withdrawal by Subject|15
7644175|NCT01081678|12058899|FG001|Overall Study|Withdrawal by Subject|7
7644176|NCT01081678|12058900|FG002|Overall Study|Withdrawal by Subject|17
7644177|NCT01081678|12058901|FG003|Overall Study|Withdrawal by Subject|14
7644178|NCT01081678|12058898|FG000|Overall Study|Administrative Decision|1
7644179|NCT01081678|12058899|FG001|Overall Study|Administrative Decision|0
7644180|NCT01081678|12058900|FG002|Overall Study|Administrative Decision|0
7644181|NCT01081678|12058901|FG003|Overall Study|Administrative Decision|1
7644182|NCT01081678|12058898|FG000|Overall Study|Lost to Follow-up|4
7644183|NCT01081678|12058899|FG001|Overall Study|Lost to Follow-up|1
7644184|NCT01081678|12058900|FG002|Overall Study|Lost to Follow-up|4
7644185|NCT01081678|12058901|FG003|Overall Study|Lost to Follow-up|3
7644186|NCT01081678|12058898|FG000|Overall Study|Death|2
7644187|NCT01081678|12058899|FG001|Overall Study|Death|2
7644188|NCT01081678|12058900|FG002|Overall Study|Death|2
7644189|NCT01081678|12058901|FG003|Overall Study|Death|6
7644190|NCT01081678|12058898|FG000|Overall Study|Other|0
7644191|NCT01081678|12058899|FG001|Overall Study|Other|1
7644192|NCT01081678|12058900|FG002|Overall Study|Other|0
7644193|NCT01081678|12058901|FG003|Overall Study|Other|0
7644194|NCT01080391|12058930|FG000|Overall Study|Randomized but not treated|7
7644195|NCT01080391|12058931|FG001|Overall Study|Randomized but not treated|4
7644196|NCT01065454|12058986|FG000|Treatment|Adverse Event|7
7644197|NCT01065454|12058987|FG001|Treatment|Adverse Event|4
7644198|NCT01065454|12058988|FG002|Treatment|Adverse Event|3
7644199|NCT01065454|12058989|FG003|Treatment|Adverse Event|6
7644200|NCT01065454|12058986|FG000|Treatment|Death|1
7644201|NCT01065454|12058987|FG001|Treatment|Death|0
7644202|NCT01065454|12058988|FG002|Treatment|Death|0
7644203|NCT01065454|12058989|FG003|Treatment|Death|0
7644204|NCT01065454|12058986|FG000|Treatment|Non-compliance|1
7644205|NCT01065454|12058987|FG001|Treatment|Non-compliance|0
7644206|NCT01065454|12058988|FG002|Treatment|Non-compliance|0
7644207|NCT01065454|12058989|FG003|Treatment|Non-compliance|1
7644208|NCT01065454|12058986|FG000|Treatment|Protocol Decision|0
7644209|NCT01065454|12058987|FG001|Treatment|Protocol Decision|0
7644210|NCT01065454|12058988|FG002|Treatment|Protocol Decision|3
7644211|NCT01065454|12058989|FG003|Treatment|Protocol Decision|2
7644212|NCT01065454|12058986|FG000|Treatment|Protocol Violation|1
7644213|NCT01065454|12058987|FG001|Treatment|Protocol Violation|0
7644214|NCT01065454|12058988|FG002|Treatment|Protocol Violation|1
7644215|NCT01065454|12058989|FG003|Treatment|Protocol Violation|0
7644216|NCT01065454|12058986|FG000|Treatment|Withdrawal by Subject|3
7644217|NCT01065454|12058987|FG001|Treatment|Withdrawal by Subject|1
7644218|NCT01065454|12058988|FG002|Treatment|Withdrawal by Subject|2
7644219|NCT01065454|12058989|FG003|Treatment|Withdrawal by Subject|3
7644220|NCT01065454|12058986|FG000|Follow up|Adverse Event|1
7644221|NCT01065454|12058987|FG001|Follow up|Adverse Event|0
7644222|NCT01065454|12058988|FG002|Follow up|Adverse Event|0
7644223|NCT01065454|12058989|FG003|Follow up|Adverse Event|1
7644224|NCT01065454|12058986|FG000|Follow up|Death|0
7644225|NCT01065454|12058987|FG001|Follow up|Death|1
7644226|NCT01065454|12058988|FG002|Follow up|Death|1
7644227|NCT01065454|12058989|FG003|Follow up|Death|0
7644228|NCT01065454|12058986|FG000|Follow up|Lost to Follow-up|0
7644229|NCT01065454|12058987|FG001|Follow up|Lost to Follow-up|0
7644230|NCT01065454|12058988|FG002|Follow up|Lost to Follow-up|0
7644231|NCT01065454|12058989|FG003|Follow up|Lost to Follow-up|1
7644232|NCT01065454|12058986|FG000|Follow up|Progressive disease|0
7644233|NCT01065454|12058987|FG001|Follow up|Progressive disease|0
7644234|NCT01065454|12058988|FG002|Follow up|Progressive disease|0
7644235|NCT01065454|12058989|FG003|Follow up|Progressive disease|1
7644236|NCT01065454|12058986|FG000|Follow up|Withdrawal by Subject|1
7644237|NCT01065454|12058987|FG001|Follow up|Withdrawal by Subject|1
7644238|NCT01065454|12058988|FG002|Follow up|Withdrawal by Subject|1
7644239|NCT01065454|12058989|FG003|Follow up|Withdrawal by Subject|0
7644240|NCT01065454|12058986|FG000|Follow up|study ongoing|37
7644241|NCT01065454|12058987|FG001|Follow up|study ongoing|22
7644242|NCT01065454|12058988|FG002|Follow up|study ongoing|15
7644243|NCT01065454|12058989|FG003|Follow up|study ongoing|41
7644244|NCT01064648|12059002|FG000|Phase I Cohort1: Dose Level 1|Progression|5
7644245|NCT01064648|12059003|FG001|Phase I Cohort1: Dose Level 1|Progression|0
7644246|NCT01064648|12059004|FG002|Phase I Cohort1: Dose Level 1|Progression|0
7644247|NCT01064648|12059005|FG003|Phase I Cohort1: Dose Level 1|Progression|0
7644248|NCT01064648|12059002|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2
7644249|NCT01064648|12059003|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
7644250|NCT01064648|12059004|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
7644251|NCT01064648|12059005|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
7644252|NCT01064648|12059002|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0
7644253|NCT01064648|12059003|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3
7644254|NCT01064648|12059004|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0
7644255|NCT01064648|12059005|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0
7644256|NCT01064648|12059002|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
7644257|NCT01064648|12059003|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1
7644258|NCT01064648|12059004|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
7644259|NCT01064648|12059005|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
7644260|NCT01064648|12059002|FG000|Phase I Cohort 2: Dose Level 2|Progression|0
7644261|NCT01064648|12059003|FG001|Phase I Cohort 2: Dose Level 2|Progression|5
7644262|NCT01064648|12059004|FG002|Phase I Cohort 2: Dose Level 2|Progression|0
7644263|NCT01064648|12059005|FG003|Phase I Cohort 2: Dose Level 2|Progression|0
7644264|NCT01064648|12059002|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
7644265|NCT01064648|12059003|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4
7644266|NCT01064648|12059004|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
7644267|NCT01064648|12059005|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
7644268|NCT01064648|12059002|FG000|Phase II|Adverse Event|0
7644269|NCT01064648|12059003|FG001|Phase II|Adverse Event|0
7644270|NCT01064648|12059004|FG002|Phase II|Adverse Event|15
7644271|NCT01064648|12059005|FG003|Phase II|Adverse Event|8
7644272|NCT01064648|12059002|FG000|Phase II|Death|0
7644273|NCT01064648|12059003|FG001|Phase II|Death|0
7644274|NCT01064648|12059004|FG002|Phase II|Death|4
7644275|NCT01064648|12059005|FG003|Phase II|Death|5
7644276|NCT01064648|12059002|FG000|Phase II|Withdrawal by Subject|0
7644277|NCT01064648|12059003|FG001|Phase II|Withdrawal by Subject|0
7644278|NCT01064648|12059004|FG002|Phase II|Withdrawal by Subject|2
7644279|NCT01064648|12059005|FG003|Phase II|Withdrawal by Subject|5
7644280|NCT01064648|12059002|FG000|Phase II|Progression|0
7644281|NCT01064648|12059003|FG001|Phase II|Progression|0
7644282|NCT01064648|12059004|FG002|Phase II|Progression|21
7644283|NCT01064648|12059005|FG003|Phase II|Progression|27
7644284|NCT01064648|12059002|FG000|Phase II|Non-protocol specified|0
7644285|NCT01064648|12059003|FG001|Phase II|Non-protocol specified|0
7644286|NCT01064648|12059004|FG002|Phase II|Non-protocol specified|5
7644287|NCT01064648|12059005|FG003|Phase II|Non-protocol specified|3
7644288|NCT01064648|12059002|FG000|Phase II|Under Review|0
7644289|NCT01064648|12059003|FG001|Phase II|Under Review|0
7644290|NCT01064648|12059004|FG002|Phase II|Under Review|2
7644291|NCT01064648|12059005|FG003|Phase II|Under Review|0
7644292|NCT01064479|12059020|FG000|Overall Study|Death|10
7644293|NCT01064479|12059021|FG001|Overall Study|Death|11
7644294|NCT01064479|12059020|FG000|Overall Study|Withdrawal by Subject|2
7644295|NCT01064479|12059021|FG001|Overall Study|Withdrawal by Subject|2
7644296|NCT01064479|12059020|FG000|Overall Study|Disease progression|1
7644297|NCT01064479|12059021|FG001|Overall Study|Disease progression|1
7644298|NCT01064479|12059020|FG000|Overall Study|Toxicity|1
7644299|NCT01064479|12059021|FG001|Overall Study|Toxicity|1
7644300|NCT01064479|12059020|FG000|Overall Study|Other|1
7644301|NCT01064479|12059021|FG001|Overall Study|Other|2
7644302|NCT01063517|12059029|FG000|Overall Study|Consent withdrawal|1
7644303|NCT01063517|12059030|FG001|Overall Study|Consent withdrawal|0
7644304|NCT01063517|12059029|FG000|Overall Study|Study reached data cut-off|19
7644305|NCT01063517|12059030|FG001|Overall Study|Study reached data cut-off|7
7644306|NCT01063517|12059029|FG000|Overall Study|Lost to Follow-up|4
7644307|NCT01063517|12059030|FG001|Overall Study|Lost to Follow-up|3
7644308|NCT01063517|12059029|FG000|Overall Study|Withdrawal by Subject|1
7644309|NCT01063517|12059030|FG001|Overall Study|Withdrawal by Subject|2
7644310|NCT01063517|12059029|FG000|Overall Study|Death|33
7644311|NCT01063517|12059030|FG001|Overall Study|Death|48
7644312|NCT01052103|12059038|FG000|Overall Study|Adverse Event|10
7644313|NCT01052103|12059039|FG001|Overall Study|Adverse Event|6
7644314|NCT01052103|12059038|FG000|Overall Study|Entry Criteria Not Met|3
7644315|NCT01052103|12059039|FG001|Overall Study|Entry Criteria Not Met|1
7644316|NCT01052103|12059038|FG000|Overall Study|Lost to Follow-up|3
7644317|NCT01052103|12059039|FG001|Overall Study|Lost to Follow-up|5
7644318|NCT01052103|12059038|FG000|Overall Study|Protocol Violation|10
7644319|NCT01052103|12059039|FG001|Overall Study|Protocol Violation|4
7644320|NCT01052103|12059038|FG000|Overall Study|Scheduling conflict|2
7644321|NCT01052103|12059039|FG001|Overall Study|Scheduling conflict|1
7644322|NCT01052103|12059038|FG000|Overall Study|Sponsor Decision|2
7644323|NCT01052103|12059039|FG001|Overall Study|Sponsor Decision|0
7644324|NCT01052103|12059038|FG000|Overall Study|Withdrawal by Subject|3
7644325|NCT01052103|12059039|FG001|Overall Study|Withdrawal by Subject|6
7644326|NCT01052103|12059038|FG000|Overall Study|Perceived Lack of Efficacy|1
7644327|NCT01052103|12059039|FG001|Overall Study|Perceived Lack of Efficacy|0
7644328|NCT01046565|12059046|FG000|Overall Study|Adverse Event|2
7644329|NCT01046565|12059046|FG000|Overall Study|Withdrawal by Subject|7
7644330|NCT01046396|12059055|FG000|Overall Study|Withdrawal by Subject|5
7644333|NCT01015833|12059081|FG000|Overall Study|Death|1
7644334|NCT01015833|12059082|FG001|Overall Study|Death|0
7644335|NCT01015833|12059081|FG000|Overall Study|Withdrawal by Subject|3
7644336|NCT01015833|12059082|FG001|Overall Study|Withdrawal by Subject|2
7644337|NCT01015833|12059081|FG000|Overall Study|Adverse Event|0
7644338|NCT01015833|12059082|FG001|Overall Study|Adverse Event|1
7644339|NCT01015833|12059081|FG000|Overall Study|Physician Decision|2
7644340|NCT01015833|12059082|FG001|Overall Study|Physician Decision|0
7644341|NCT01015833|12059081|FG000|Overall Study|Symptomatic deterioration|0
7644342|NCT01015833|12059082|FG001|Overall Study|Symptomatic deterioration|1
7644343|NCT01015833|12059081|FG000|Overall Study|Other|5
7644344|NCT01015833|12059082|FG001|Overall Study|Other|1
7644345|NCT01015833|12059081|FG000|Overall Study|Motor Vehicle Accidents|1
7644346|NCT01015833|12059082|FG001|Overall Study|Motor Vehicle Accidents|0
7644347|NCT01015833|12059081|FG000|Overall Study|Did not start treatment|1
7644348|NCT01015833|12059082|FG001|Overall Study|Did not start treatment|0
7644349|NCT01005745|12059159|FG000|Overall Study|No TIL growth|1
7644350|NCT01005745|12059159|FG000|Overall Study|Disease progressed during TIL growth|3
7644351|NCT01005745|12059159|FG000|Overall Study|Death prior to treatment|1
7644352|NCT01005745|12059159|FG000|Overall Study|Inappropriate antidiuretic hormone|1
7644353|NCT01002820|12059163|FG000|Overall Study|Adverse Event|1
7644354|NCT01002820|12059163|FG000|Overall Study|Withdrawal by Subject|2
7644355|NCT01002820|12059163|FG000|Overall Study|Lack of Efficacy|1
7644356|NCT01001377|12059169|FG000|Overall Study|Ineligibility determined|2
7644357|NCT01001377|12059170|FG001|Overall Study|Ineligibility determined|0
7644358|NCT01001377|12059169|FG000|Overall Study|Withdrawal by Subject|19
7644359|NCT01001377|12059170|FG001|Overall Study|Withdrawal by Subject|20
7644360|NCT01001377|12059169|FG000|Overall Study|Lost to Follow-up|14
7644361|NCT01001377|12059170|FG001|Overall Study|Lost to Follow-up|17
7644362|NCT01001377|12059169|FG000|Overall Study|Death|391
7644363|NCT01001377|12059170|FG001|Overall Study|Death|384
7644364|NCT00994162|12059178|FG000|Overall Study|Withdrawal by Subject|1
7644365|NCT00994162|12059178|FG000|Overall Study|Lost to Follow-up|2
7644366|NCT00994162|12059178|FG000|Overall Study|Product Complaint|1
7644367|NCT00994162|12059178|FG000|Overall Study|Poor Compliance|5
7644368|NCT00994162|12059178|FG000|Overall Study|Lack of Response|3
7644369|NCT00994162|12059178|FG000|Overall Study|Discharged from Hospital|4
7644370|NCT00994162|12059178|FG000|Overall Study|Death|2
7644371|NCT00994162|12059178|FG000|Overall Study|Care Transferred to Another Physician|2
7644372|NCT00994162|12059178|FG000|Overall Study|Discontinued and Changed to Iodoflex|1
7644373|NCT00994162|12059178|FG000|Overall Study|Physician Decision|2
7644374|NCT00994162|12059178|FG000|Overall Study|Surrounding Wound Erythematous|1
7644375|NCT00994162|12059178|FG000|Overall Study|Machine Losing Vaccum|1
7644376|NCT00994162|12059178|FG000|Overall Study|Patient Lived Too Far Away|1
7644377|NCT00994162|12059178|FG000|Overall Study|Above Knee Amputation|1
7644378|NCT00994162|12059178|FG000|Overall Study|Reason Not Reported By Site|1
7644379|NCT00988637|12059185|FG000|Overall Study|Lost to Follow-up|2
7644380|NCT00988637|12059186|FG001|Overall Study|Lost to Follow-up|1
7644381|NCT00988637|12059185|FG000|Overall Study|Withdrawal by Subject|1
7644382|NCT00988637|12059186|FG001|Overall Study|Withdrawal by Subject|1
7644383|NCT00988637|12059185|FG000|Overall Study|non-compliance with study drug|0
7644384|NCT00988637|12059186|FG001|Overall Study|non-compliance with study drug|1
7644385|NCT00980538|12059192|FG000|Overall Study|Lost to Follow-up|20
7644386|NCT00980538|12059192|FG000|Overall Study|Sponsor's Decision|4
7644387|NCT00980538|12059192|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34
7644388|NCT00980538|12059192|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12
7644389|NCT00980538|12059192|FG000|Overall Study|Switch to Commercially Available Medication|25
7644390|NCT00980538|12059192|FG000|Overall Study|Participant Non-Compliant|9
7644391|NCT00980538|12059192|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9
7644392|NCT00980538|12059192|FG000|Overall Study|Participant Ineligible to Continue the Trial|6
7644393|NCT00980538|12059192|FG000|Overall Study|Other|60
7644394|NCT00980538|12059192|FG000|Overall Study|Other|1
7644395|NCT00980460|12059201|FG000|Overall Study|Death|0
7644396|NCT00980460|12059202|FG001|Overall Study|Death|0
7644397|NCT00980460|12059203|FG002|Overall Study|Death|1
7644398|NCT00980460|12059204|FG003|Overall Study|Death|2
7644399|NCT00980460|12059205|FG004|Overall Study|Death|1
7644400|NCT00980460|12059201|FG000|Overall Study|Lack of Efficacy|0
7644401|NCT00980460|12059202|FG001|Overall Study|Lack of Efficacy|0
7644402|NCT00980460|12059203|FG002|Overall Study|Lack of Efficacy|10
7644403|NCT00980460|12059204|FG003|Overall Study|Lack of Efficacy|6
7644404|NCT00980460|12059205|FG004|Overall Study|Lack of Efficacy|8
7644405|NCT00980460|12059201|FG000|Overall Study|Lost to Follow-up|0
7644406|NCT00980460|12059202|FG001|Overall Study|Lost to Follow-up|0
7644407|NCT00980460|12059203|FG002|Overall Study|Lost to Follow-up|0
7644408|NCT00980460|12059204|FG003|Overall Study|Lost to Follow-up|1
7644409|NCT00980460|12059205|FG004|Overall Study|Lost to Follow-up|0
7644410|NCT00980460|12059201|FG000|Overall Study|Physician Decision|0
7644411|NCT00980460|12059202|FG001|Overall Study|Physician Decision|0
7644412|NCT00980460|12059203|FG002|Overall Study|Physician Decision|11
7644413|NCT00980460|12059204|FG003|Overall Study|Physician Decision|5
7644414|NCT00980460|12059205|FG004|Overall Study|Physician Decision|3
7644415|NCT00980460|12059201|FG000|Overall Study|Withdrawal by Subject|0
7644416|NCT00980460|12059202|FG001|Overall Study|Withdrawal by Subject|0
7644417|NCT00980460|12059203|FG002|Overall Study|Withdrawal by Subject|1
7644418|NCT00980460|12059204|FG003|Overall Study|Withdrawal by Subject|0
7644419|NCT00980460|12059205|FG004|Overall Study|Withdrawal by Subject|0
7644420|NCT00980460|12059201|FG000|Overall Study|Ineligible|0
7644421|NCT00980460|12059202|FG001|Overall Study|Ineligible|2
7644422|NCT00980460|12059203|FG002|Overall Study|Ineligible|3
7644423|NCT00980460|12059204|FG003|Overall Study|Ineligible|1
7644424|NCT00980460|12059205|FG004|Overall Study|Ineligible|4
7644425|NCT00980460|12059201|FG000|Overall Study|Refusal of further therapy|0
7644426|NCT00980460|12059202|FG001|Overall Study|Refusal of further therapy|2
7644427|NCT00980460|12059203|FG002|Overall Study|Refusal of further therapy|3
7644428|NCT00980460|12059204|FG003|Overall Study|Refusal of further therapy|2
7644429|NCT00980460|12059205|FG004|Overall Study|Refusal of further therapy|0
7644430|NCT00980460|12059201|FG000|Overall Study|No therapy within 42 days of resection|0
7644431|NCT00980460|12059202|FG001|Overall Study|No therapy within 42 days of resection|0
7644432|NCT00980460|12059203|FG002|Overall Study|No therapy within 42 days of resection|3
7644433|NCT00980460|12059204|FG003|Overall Study|No therapy within 42 days of resection|1
7644434|NCT00980460|12059205|FG004|Overall Study|No therapy within 42 days of resection|0
7644435|NCT00980460|12059201|FG000|Overall Study|No transplant by protocol timepoints|0
7644436|NCT00980460|12059202|FG001|Overall Study|No transplant by protocol timepoints|0
7644437|NCT00980460|12059203|FG002|Overall Study|No transplant by protocol timepoints|3
7644438|NCT00980460|12059204|FG003|Overall Study|No transplant by protocol timepoints|0
7644439|NCT00980460|12059205|FG004|Overall Study|No transplant by protocol timepoints|0
7644440|NCT00978562|12059224|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2
7644441|NCT00977574|12059233|FG000|Overall Study|Never Treated|4
7644442|NCT00977574|12059234|FG001|Overall Study|Never Treated|2
7644443|NCT00977574|12059235|FG002|Overall Study|Never Treated|4
7644444|NCT00972478|12059245|FG000|Overall Study|Adverse Event|3
7644445|NCT00972478|12059246|FG001|Overall Study|Adverse Event|16
7644446|NCT00972478|12059245|FG000|Overall Study|Withdrawal by Subject|1
7644447|NCT00972478|12059246|FG001|Overall Study|Withdrawal by Subject|8
7644448|NCT00972478|12059245|FG000|Overall Study|Progression/Relapse|0
7644449|NCT00972478|12059246|FG001|Overall Study|Progression/Relapse|2
7644450|NCT00972478|12059245|FG000|Overall Study|Death|0
7644451|NCT00972478|12059246|FG001|Overall Study|Death|2
7644452|NCT00972478|12059245|FG000|Overall Study|Not protocol specified|1
7644453|NCT00972478|12059246|FG001|Overall Study|Not protocol specified|1
7644454|NCT00972478|12059245|FG000|Overall Study|Ineligible|1
7644455|NCT00972478|12059246|FG001|Overall Study|Ineligible|7
7644456|NCT00972478|12059245|FG000|Overall Study|Not start protocol treatment|1
7644457|NCT00972478|12059246|FG001|Overall Study|Not start protocol treatment|2
7644458|NCT00972179|12059260|FG000|Overall Study|Noncompliance|1
7644459|NCT00972179|12059261|FG001|Overall Study|Noncompliance|0
7644460|NCT00972179|12059262|FG002|Overall Study|Noncompliance|0
7644461|NCT00972179|12059263|FG003|Overall Study|Noncompliance|0
7644462|NCT00972179|12059264|FG004|Overall Study|Noncompliance|1
7644463|NCT00972179|12059265|FG005|Overall Study|Noncompliance|0
7644464|NCT00972179|12059266|FG006|Overall Study|Noncompliance|1
7644465|NCT00972179|12059260|FG000|Overall Study|Withdrawal by Subject|0
7644466|NCT00972179|12059261|FG001|Overall Study|Withdrawal by Subject|3
7644467|NCT00972179|12059262|FG002|Overall Study|Withdrawal by Subject|0
7644468|NCT00972179|12059263|FG003|Overall Study|Withdrawal by Subject|1
7644469|NCT00972179|12059264|FG004|Overall Study|Withdrawal by Subject|0
7644470|NCT00972179|12059265|FG005|Overall Study|Withdrawal by Subject|0
7644471|NCT00972179|12059266|FG006|Overall Study|Withdrawal by Subject|2
7644472|NCT00972179|12059260|FG000|Overall Study|Administrative Decision|0
7644473|NCT00972179|12059261|FG001|Overall Study|Administrative Decision|0
7644474|NCT00972179|12059262|FG002|Overall Study|Administrative Decision|0
7644475|NCT00972179|12059263|FG003|Overall Study|Administrative Decision|0
7644476|NCT00972179|12059264|FG004|Overall Study|Administrative Decision|1
7644477|NCT00972179|12059265|FG005|Overall Study|Administrative Decision|0
7644478|NCT00972179|12059266|FG006|Overall Study|Administrative Decision|0
7644479|NCT00972179|12059260|FG000|Overall Study|Lost to Follow-up|0
7644480|NCT00972179|12059261|FG001|Overall Study|Lost to Follow-up|0
7644481|NCT00972179|12059262|FG002|Overall Study|Lost to Follow-up|1
7644482|NCT00972179|12059263|FG003|Overall Study|Lost to Follow-up|0
7644483|NCT00972179|12059264|FG004|Overall Study|Lost to Follow-up|0
7644484|NCT00972179|12059265|FG005|Overall Study|Lost to Follow-up|3
7644485|NCT00972179|12059266|FG006|Overall Study|Lost to Follow-up|1
7644486|NCT00970684|12059286|FG000|Overall Study|Lack of Efficacy|5
7644487|NCT00970684|12059286|FG000|Overall Study|Adverse Event|4
7644488|NCT00970684|12059286|FG000|Overall Study|Withdrawal by Subject|1
7644489|NCT00961064|12059290|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11
7644490|NCT00961064|12059290|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3
7644491|NCT00961064|12059290|FG000|Initial Treatment (Weeks 1 - 20)|Death|1
7644492|NCT00961064|12059290|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1
7644493|NCT00961064|12059290|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3
7644494|NCT00961064|12059290|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1
7644495|NCT00961064|12059290|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1
7644496|NCT00961064|12059290|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2
7644497|NCT00951080|12059296|FG000|Overall Study|Adverse Event|3
7644498|NCT00951080|12059297|FG001|Overall Study|Adverse Event|3
7644499|NCT00951080|12059296|FG000|Overall Study|Lost to Follow-up|0
7644500|NCT00951080|12059297|FG001|Overall Study|Lost to Follow-up|1
7644501|NCT00951080|12059296|FG000|Overall Study|Physician Decision|4
7644502|NCT00951080|12059297|FG001|Overall Study|Physician Decision|1
7644503|NCT00951080|12059296|FG000|Overall Study|Other|19
7644504|NCT00951080|12059297|FG001|Overall Study|Other|22
7644505|NCT00942331|12059305|FG000|Overall Study|Did not start treatment|15
7644506|NCT00942331|12059306|FG001|Overall Study|Did not start treatment|22
7644507|NCT00937937|12059312|FG000|Overall Study|Adverse Event|6
7644508|NCT00937937|12059312|FG000|Overall Study|Withdrawal by Subject|2
7644509|NCT00937937|12059312|FG000|Overall Study|Progression/relapse|61
7644510|NCT00937937|12059312|FG000|Overall Study|Death|1
7644511|NCT00937937|12059312|FG000|Overall Study|Other|2
7644512|NCT00931268|12059317|FG000|Overall Study|Lost to Follow-up|6
7644513|NCT00907478|12059324|FG000|Overall Study|Ineligibility determined|0
7644514|NCT00907478|12059325|FG001|Overall Study|Ineligibility determined|0
7644515|NCT00907478|12059326|FG002|Overall Study|Ineligibility determined|1
7644516|NCT00907478|12059324|FG000|Overall Study|Noncompliance|0
7644517|NCT00907478|12059325|FG001|Overall Study|Noncompliance|0
7644518|NCT00907478|12059326|FG002|Overall Study|Noncompliance|1
7644519|NCT00907478|12059324|FG000|Overall Study|Adverse Event|3
7644520|NCT00907478|12059325|FG001|Overall Study|Adverse Event|1
7644521|NCT00907478|12059326|FG002|Overall Study|Adverse Event|2
7644522|NCT00907478|12059324|FG000|Overall Study|Withdrawal by Subject|8
7644523|NCT00907478|12059325|FG001|Overall Study|Withdrawal by Subject|9
7644524|NCT00907478|12059326|FG002|Overall Study|Withdrawal by Subject|6
7644525|NCT00907478|12059324|FG000|Overall Study|Requirement for alternative therapy|1
7644526|NCT00907478|12059325|FG001|Overall Study|Requirement for alternative therapy|2
7644527|NCT00907478|12059326|FG002|Overall Study|Requirement for alternative therapy|3
7644528|NCT00907478|12059324|FG000|Overall Study|Physician Decision|2
7644529|NCT00907478|12059325|FG001|Overall Study|Physician Decision|0
7644530|NCT00907478|12059326|FG002|Overall Study|Physician Decision|3
7644531|NCT00907478|12059324|FG000|Overall Study|Death|4
7644532|NCT00907478|12059325|FG001|Overall Study|Death|2
7644533|NCT00907478|12059326|FG002|Overall Study|Death|1
7644534|NCT00907478|12059324|FG000|Overall Study|Protocol-specified criteria|5
7644535|NCT00907478|12059325|FG001|Overall Study|Protocol-specified criteria|2
7644536|NCT00907478|12059326|FG002|Overall Study|Protocol-specified criteria|3
7644537|NCT00907478|12059324|FG000|Overall Study|Pregnancy|0
7644538|NCT00907478|12059325|FG001|Overall Study|Pregnancy|1
7644539|NCT00907478|12059326|FG002|Overall Study|Pregnancy|1
7644540|NCT00907478|12059324|FG000|Overall Study|Lost to Follow-up|1
7644541|NCT00907478|12059325|FG001|Overall Study|Lost to Follow-up|0
7644542|NCT00907478|12059326|FG002|Overall Study|Lost to Follow-up|0
7644543|NCT00907478|12059324|FG000|Overall Study|Other|3
7644544|NCT00907478|12059325|FG001|Overall Study|Other|0
7644545|NCT00907478|12059326|FG002|Overall Study|Other|1
7644546|NCT00907296|12059346|FG000|Overall Study|Ineligibility Determined|1
7644547|NCT00907296|12059347|FG001|Overall Study|Ineligibility Determined|0
7644548|NCT00907296|12059348|FG002|Overall Study|Ineligibility Determined|0
7644549|NCT00907296|12059349|FG003|Overall Study|Ineligibility Determined|1
7644550|NCT00907296|12059350|FG004|Overall Study|Ineligibility Determined|0
7644551|NCT00907296|12059351|FG005|Overall Study|Ineligibility Determined|0
7644552|NCT00907296|12059352|FG006|Overall Study|Ineligibility Determined|0
7644553|NCT00907296|12059353|FG007|Overall Study|Ineligibility Determined|1
7644554|NCT00907296|12059354|FG008|Overall Study|Ineligibility Determined|0
7644555|NCT00907296|12059355|FG009|Overall Study|Ineligibility Determined|0
7644556|NCT00907296|12059346|FG000|Overall Study|Protocol Deviation|0
7644557|NCT00907296|12059347|FG001|Overall Study|Protocol Deviation|1
7644558|NCT00907296|12059348|FG002|Overall Study|Protocol Deviation|0
7644559|NCT00907296|12059349|FG003|Overall Study|Protocol Deviation|0
7644560|NCT00907296|12059350|FG004|Overall Study|Protocol Deviation|0
7644561|NCT00907296|12059351|FG005|Overall Study|Protocol Deviation|0
7644562|NCT00907296|12059352|FG006|Overall Study|Protocol Deviation|0
7644563|NCT00907296|12059353|FG007|Overall Study|Protocol Deviation|0
7644564|NCT00907296|12059354|FG008|Overall Study|Protocol Deviation|0
7644565|NCT00907296|12059355|FG009|Overall Study|Protocol Deviation|0
7644566|NCT00907296|12059346|FG000|Overall Study|Noncompliance|1
7644567|NCT00907296|12059347|FG001|Overall Study|Noncompliance|1
7644568|NCT00907296|12059348|FG002|Overall Study|Noncompliance|1
7644569|NCT00907296|12059349|FG003|Overall Study|Noncompliance|0
7644570|NCT00907296|12059350|FG004|Overall Study|Noncompliance|0
7644571|NCT00907296|12059351|FG005|Overall Study|Noncompliance|1
7644572|NCT00907296|12059352|FG006|Overall Study|Noncompliance|0
7644573|NCT00907296|12059353|FG007|Overall Study|Noncompliance|2
7644574|NCT00907296|12059354|FG008|Overall Study|Noncompliance|0
7644575|NCT00907296|12059355|FG009|Overall Study|Noncompliance|0
7644576|NCT00907296|12059346|FG000|Overall Study|Adverse Event|2
7644577|NCT00907296|12059347|FG001|Overall Study|Adverse Event|0
7644578|NCT00907296|12059348|FG002|Overall Study|Adverse Event|0
7644579|NCT00907296|12059349|FG003|Overall Study|Adverse Event|0
7644580|NCT00907296|12059350|FG004|Overall Study|Adverse Event|0
7644581|NCT00907296|12059351|FG005|Overall Study|Adverse Event|0
7644582|NCT00907296|12059352|FG006|Overall Study|Adverse Event|1
7644583|NCT00907296|12059353|FG007|Overall Study|Adverse Event|0
7644584|NCT00907296|12059354|FG008|Overall Study|Adverse Event|0
7644585|NCT00907296|12059355|FG009|Overall Study|Adverse Event|1
7644586|NCT00907296|12059346|FG000|Overall Study|Withdrawal by Subject|7
7644587|NCT00907296|12059347|FG001|Overall Study|Withdrawal by Subject|2
7644588|NCT00907296|12059348|FG002|Overall Study|Withdrawal by Subject|1
7644589|NCT00907296|12059349|FG003|Overall Study|Withdrawal by Subject|1
7644590|NCT00907296|12059350|FG004|Overall Study|Withdrawal by Subject|1
7644591|NCT00907296|12059351|FG005|Overall Study|Withdrawal by Subject|5
7644592|NCT00907296|12059352|FG006|Overall Study|Withdrawal by Subject|3
7644593|NCT00907296|12059353|FG007|Overall Study|Withdrawal by Subject|2
7644594|NCT00907296|12059354|FG008|Overall Study|Withdrawal by Subject|4
7644595|NCT00907296|12059355|FG009|Overall Study|Withdrawal by Subject|2
7644596|NCT00907296|12059346|FG000|Overall Study|Lost to Follow-up|9
7644597|NCT00907296|12059347|FG001|Overall Study|Lost to Follow-up|1
7644598|NCT00907296|12059348|FG002|Overall Study|Lost to Follow-up|0
7644599|NCT00907296|12059349|FG003|Overall Study|Lost to Follow-up|2
7644600|NCT00907296|12059350|FG004|Overall Study|Lost to Follow-up|0
7644601|NCT00907296|12059351|FG005|Overall Study|Lost to Follow-up|3
7644602|NCT00907296|12059352|FG006|Overall Study|Lost to Follow-up|2
7644603|NCT00907296|12059353|FG007|Overall Study|Lost to Follow-up|2
7644604|NCT00907296|12059354|FG008|Overall Study|Lost to Follow-up|0
7644605|NCT00907296|12059355|FG009|Overall Study|Lost to Follow-up|4
7644606|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644607|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644608|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644609|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
7644610|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644611|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
7644612|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644613|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644614|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644615|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644616|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644617|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644618|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644619|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644620|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644621|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644622|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644623|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644624|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644625|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644626|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644627|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644628|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644629|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
7644630|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
7644631|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
7644632|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
7644633|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
7644634|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
7644635|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
7644636|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644637|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644638|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644639|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644640|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644641|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644642|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644643|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644644|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644645|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644646|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644647|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644648|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644649|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644650|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644651|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644652|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
7644653|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
7644654|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
7644655|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
7644656|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
7644657|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
7644658|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
7644659|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
7644660|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644661|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644662|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644663|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644664|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644665|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644666|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644667|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644668|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644669|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644670|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644671|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644672|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644673|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644674|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644675|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644676|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644677|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
7644678|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644679|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
7644680|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644681|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644682|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644683|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644684|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644685|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644686|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644687|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644688|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644689|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644690|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644691|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644692|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644693|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644694|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644695|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644696|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644697|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644698|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1
7644699|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0
7644700|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0
7644701|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1
7644702|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0
7644703|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0
7644704|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0
7644705|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0
7644706|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0
7644707|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0
7644708|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0
7644709|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0
7644710|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0
7644711|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0
7644712|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0
7644713|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0
7644714|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0
7644715|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0
7644716|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0
7644717|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0
7644718|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0
7644719|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0
7644720|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0
7644721|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644722|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644723|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
7644724|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644725|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644726|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644727|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644728|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644729|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644730|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644731|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644732|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644733|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644734|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644735|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644736|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644737|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644738|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644739|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644740|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644741|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644742|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644743|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644744|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644745|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644746|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
7644747|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644748|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644749|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644750|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644751|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644752|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644753|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644754|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644755|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644756|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644757|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644758|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644759|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644760|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644761|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644762|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644763|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644764|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644765|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644766|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644767|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644768|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644769|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644770|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
7644771|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644772|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644773|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7645050|NCT00896532|12059396|FG007|Months 48-72: Follow-on Phase|Death|0
7644774|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644775|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644776|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644777|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644778|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644779|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644780|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644781|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644782|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644783|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644784|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644785|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644786|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644787|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644788|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644789|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644790|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0
7644791|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1
7644792|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0
7644793|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1
7644794|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1
7644795|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0
7644796|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0
7644797|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0
7644798|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0
7644799|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0
7644800|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0
7644801|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0
7644802|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0
7644803|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0
7644804|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0
7644805|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0
7644806|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0
7644807|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0
7644808|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0
7644809|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0
7644810|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0
7644811|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0
7644812|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0
7644813|NCT00896532|12059389|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644814|NCT00896532|12059390|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644815|NCT00896532|12059391|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644816|NCT00896532|12059392|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644817|NCT00896532|12059393|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644818|NCT00896532|12059394|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644819|NCT00896532|12059395|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644820|NCT00896532|12059396|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644821|NCT00896532|12059397|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
7644822|NCT00896532|12059398|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644823|NCT00896532|12059399|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644824|NCT00896532|12059400|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644825|NCT00896532|12059401|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644826|NCT00896532|12059402|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644827|NCT00896532|12059403|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644828|NCT00896532|12059404|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644829|NCT00896532|12059405|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644830|NCT00896532|12059406|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644831|NCT00896532|12059407|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644832|NCT00896532|12059408|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644833|NCT00896532|12059409|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644834|NCT00896532|12059410|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644835|NCT00896532|12059411|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644836|NCT00896532|12059389|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644837|NCT00896532|12059390|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644838|NCT00896532|12059391|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644839|NCT00896532|12059392|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644840|NCT00896532|12059393|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644841|NCT00896532|12059394|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644842|NCT00896532|12059395|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644843|NCT00896532|12059396|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644844|NCT00896532|12059397|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644845|NCT00896532|12059398|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644846|NCT00896532|12059399|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644847|NCT00896532|12059400|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644848|NCT00896532|12059401|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1
7644849|NCT00896532|12059402|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644850|NCT00896532|12059403|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644851|NCT00896532|12059404|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644852|NCT00896532|12059405|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644853|NCT00896532|12059406|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644854|NCT00896532|12059407|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644855|NCT00896532|12059408|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644856|NCT00896532|12059409|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644857|NCT00896532|12059410|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644858|NCT00896532|12059411|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644859|NCT00896532|12059389|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644860|NCT00896532|12059390|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644861|NCT00896532|12059391|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644862|NCT00896532|12059392|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644863|NCT00896532|12059393|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644864|NCT00896532|12059394|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644865|NCT00896532|12059395|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644866|NCT00896532|12059396|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644867|NCT00896532|12059397|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644868|NCT00896532|12059398|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644869|NCT00896532|12059399|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1
7644870|NCT00896532|12059400|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644871|NCT00896532|12059401|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1
7644872|NCT00896532|12059402|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644873|NCT00896532|12059403|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644874|NCT00896532|12059404|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644875|NCT00896532|12059405|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644876|NCT00896532|12059406|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644877|NCT00896532|12059407|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644878|NCT00896532|12059408|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644879|NCT00896532|12059409|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644880|NCT00896532|12059410|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644881|NCT00896532|12059411|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644882|NCT00896532|12059389|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644883|NCT00896532|12059390|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644884|NCT00896532|12059391|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644885|NCT00896532|12059392|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644886|NCT00896532|12059393|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644887|NCT00896532|12059394|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644888|NCT00896532|12059395|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644889|NCT00896532|12059396|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644890|NCT00896532|12059397|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644891|NCT00896532|12059398|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644892|NCT00896532|12059399|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644893|NCT00896532|12059400|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644894|NCT00896532|12059401|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
7644895|NCT00896532|12059402|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
7644896|NCT00896532|12059403|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644897|NCT00896532|12059404|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644898|NCT00896532|12059405|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644899|NCT00896532|12059406|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644900|NCT00896532|12059407|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644901|NCT00896532|12059408|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644902|NCT00896532|12059409|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644903|NCT00896532|12059410|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644904|NCT00896532|12059411|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644905|NCT00896532|12059389|FG000|Months 24-36: Denosumab Extension Phase|Other|0
7644906|NCT00896532|12059390|FG001|Months 24-36: Denosumab Extension Phase|Other|0
7644907|NCT00896532|12059391|FG002|Months 24-36: Denosumab Extension Phase|Other|0
7644908|NCT00896532|12059392|FG003|Months 24-36: Denosumab Extension Phase|Other|0
7644909|NCT00896532|12059393|FG004|Months 24-36: Denosumab Extension Phase|Other|0
7644910|NCT00896532|12059394|FG005|Months 24-36: Denosumab Extension Phase|Other|0
7644911|NCT00896532|12059395|FG006|Months 24-36: Denosumab Extension Phase|Other|0
7644912|NCT00896532|12059396|FG007|Months 24-36: Denosumab Extension Phase|Other|0
7644913|NCT00896532|12059397|FG008|Months 24-36: Denosumab Extension Phase|Other|0
7644914|NCT00896532|12059398|FG009|Months 24-36: Denosumab Extension Phase|Other|0
7644915|NCT00896532|12059399|FG010|Months 24-36: Denosumab Extension Phase|Other|1
7644916|NCT00896532|12059400|FG011|Months 24-36: Denosumab Extension Phase|Other|2
7644917|NCT00896532|12059401|FG012|Months 24-36: Denosumab Extension Phase|Other|2
7644918|NCT00896532|12059402|FG013|Months 24-36: Denosumab Extension Phase|Other|1
7644919|NCT00896532|12059403|FG014|Months 24-36: Denosumab Extension Phase|Other|0
7644920|NCT00896532|12059404|FG015|Months 24-36: Denosumab Extension Phase|Other|0
7644921|NCT00896532|12059405|FG016|Months 24-36: Denosumab Extension Phase|Other|0
7644922|NCT00896532|12059406|FG017|Months 24-36: Denosumab Extension Phase|Other|0
7644923|NCT00896532|12059407|FG018|Months 24-36: Denosumab Extension Phase|Other|0
7644924|NCT00896532|12059408|FG019|Months 24-36: Denosumab Extension Phase|Other|0
7644925|NCT00896532|12059409|FG020|Months 24-36: Denosumab Extension Phase|Other|0
7644926|NCT00896532|12059410|FG021|Months 24-36: Denosumab Extension Phase|Other|0
7644927|NCT00896532|12059411|FG022|Months 24-36: Denosumab Extension Phase|Other|0
7644928|NCT00896532|12059389|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644929|NCT00896532|12059390|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644930|NCT00896532|12059391|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644931|NCT00896532|12059392|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644932|NCT00896532|12059393|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644933|NCT00896532|12059394|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644934|NCT00896532|12059395|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644935|NCT00896532|12059396|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644936|NCT00896532|12059397|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644937|NCT00896532|12059398|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644938|NCT00896532|12059399|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644939|NCT00896532|12059400|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644940|NCT00896532|12059401|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644941|NCT00896532|12059402|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644942|NCT00896532|12059403|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644943|NCT00896532|12059404|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1
7644944|NCT00896532|12059405|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3
7644945|NCT00896532|12059406|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644946|NCT00896532|12059407|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644947|NCT00896532|12059408|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644948|NCT00896532|12059409|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644949|NCT00896532|12059410|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644950|NCT00896532|12059411|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644951|NCT00896532|12059389|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644952|NCT00896532|12059390|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644953|NCT00896532|12059391|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644954|NCT00896532|12059392|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644955|NCT00896532|12059393|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644956|NCT00896532|12059394|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644957|NCT00896532|12059395|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644958|NCT00896532|12059396|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644959|NCT00896532|12059397|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644960|NCT00896532|12059398|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644961|NCT00896532|12059399|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644962|NCT00896532|12059400|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644963|NCT00896532|12059401|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644964|NCT00896532|12059402|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644965|NCT00896532|12059403|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644966|NCT00896532|12059404|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
7644967|NCT00896532|12059405|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
7644968|NCT00896532|12059406|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
7644969|NCT00896532|12059407|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644970|NCT00896532|12059408|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644971|NCT00896532|12059409|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644972|NCT00896532|12059410|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644973|NCT00896532|12059411|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644974|NCT00896532|12059389|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644975|NCT00896532|12059390|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644976|NCT00896532|12059391|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644977|NCT00896532|12059392|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644978|NCT00896532|12059393|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644979|NCT00896532|12059394|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644980|NCT00896532|12059395|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644981|NCT00896532|12059396|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644982|NCT00896532|12059397|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644983|NCT00896532|12059398|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644984|NCT00896532|12059399|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644985|NCT00896532|12059400|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644986|NCT00896532|12059401|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644987|NCT00896532|12059402|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644988|NCT00896532|12059403|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644989|NCT00896532|12059404|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644990|NCT00896532|12059405|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
7644991|NCT00896532|12059406|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644992|NCT00896532|12059407|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644993|NCT00896532|12059408|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644994|NCT00896532|12059409|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644995|NCT00896532|12059410|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644996|NCT00896532|12059411|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644997|NCT00896532|12059389|FG000|Months 36-48: Romosozumab Retreatment|Other|0
7644998|NCT00896532|12059390|FG001|Months 36-48: Romosozumab Retreatment|Other|0
7644999|NCT00896532|12059391|FG002|Months 36-48: Romosozumab Retreatment|Other|0
7645000|NCT00896532|12059392|FG003|Months 36-48: Romosozumab Retreatment|Other|0
7645001|NCT00896532|12059393|FG004|Months 36-48: Romosozumab Retreatment|Other|0
7645002|NCT00896532|12059394|FG005|Months 36-48: Romosozumab Retreatment|Other|0
7645003|NCT00896532|12059395|FG006|Months 36-48: Romosozumab Retreatment|Other|0
7645004|NCT00896532|12059396|FG007|Months 36-48: Romosozumab Retreatment|Other|0
7645005|NCT00896532|12059397|FG008|Months 36-48: Romosozumab Retreatment|Other|0
7645006|NCT00896532|12059398|FG009|Months 36-48: Romosozumab Retreatment|Other|0
7645007|NCT00896532|12059399|FG010|Months 36-48: Romosozumab Retreatment|Other|0
7645008|NCT00896532|12059400|FG011|Months 36-48: Romosozumab Retreatment|Other|0
7645009|NCT00896532|12059401|FG012|Months 36-48: Romosozumab Retreatment|Other|0
7645010|NCT00896532|12059402|FG013|Months 36-48: Romosozumab Retreatment|Other|0
7645011|NCT00896532|12059403|FG014|Months 36-48: Romosozumab Retreatment|Other|0
7645012|NCT00896532|12059404|FG015|Months 36-48: Romosozumab Retreatment|Other|0
7645013|NCT00896532|12059405|FG016|Months 36-48: Romosozumab Retreatment|Other|0
7645014|NCT00896532|12059406|FG017|Months 36-48: Romosozumab Retreatment|Other|1
7645015|NCT00896532|12059407|FG018|Months 36-48: Romosozumab Retreatment|Other|0
7645016|NCT00896532|12059408|FG019|Months 36-48: Romosozumab Retreatment|Other|0
7645017|NCT00896532|12059409|FG020|Months 36-48: Romosozumab Retreatment|Other|0
7645018|NCT00896532|12059410|FG021|Months 36-48: Romosozumab Retreatment|Other|0
7645019|NCT00896532|12059411|FG022|Months 36-48: Romosozumab Retreatment|Other|0
7645020|NCT00896532|12059389|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645021|NCT00896532|12059390|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645022|NCT00896532|12059391|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645023|NCT00896532|12059392|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645024|NCT00896532|12059393|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645025|NCT00896532|12059394|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645026|NCT00896532|12059395|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645027|NCT00896532|12059396|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645028|NCT00896532|12059397|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645029|NCT00896532|12059398|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645030|NCT00896532|12059399|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645031|NCT00896532|12059400|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645032|NCT00896532|12059401|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645033|NCT00896532|12059402|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645034|NCT00896532|12059403|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645035|NCT00896532|12059404|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645036|NCT00896532|12059405|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
7645037|NCT00896532|12059406|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645038|NCT00896532|12059407|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645039|NCT00896532|12059408|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645040|NCT00896532|12059409|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645041|NCT00896532|12059410|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645042|NCT00896532|12059411|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645043|NCT00896532|12059389|FG000|Months 48-72: Follow-on Phase|Death|0
7645044|NCT00896532|12059390|FG001|Months 48-72: Follow-on Phase|Death|0
7645045|NCT00896532|12059391|FG002|Months 48-72: Follow-on Phase|Death|0
7645046|NCT00896532|12059392|FG003|Months 48-72: Follow-on Phase|Death|0
7645047|NCT00896532|12059393|FG004|Months 48-72: Follow-on Phase|Death|0
7645048|NCT00896532|12059394|FG005|Months 48-72: Follow-on Phase|Death|0
7645049|NCT00896532|12059395|FG006|Months 48-72: Follow-on Phase|Death|0
7645051|NCT00896532|12059397|FG008|Months 48-72: Follow-on Phase|Death|0
7645052|NCT00896532|12059398|FG009|Months 48-72: Follow-on Phase|Death|0
7645053|NCT00896532|12059399|FG010|Months 48-72: Follow-on Phase|Death|0
7645054|NCT00896532|12059400|FG011|Months 48-72: Follow-on Phase|Death|0
7645055|NCT00896532|12059401|FG012|Months 48-72: Follow-on Phase|Death|0
7645056|NCT00896532|12059402|FG013|Months 48-72: Follow-on Phase|Death|0
7645057|NCT00896532|12059403|FG014|Months 48-72: Follow-on Phase|Death|0
7645058|NCT00896532|12059404|FG015|Months 48-72: Follow-on Phase|Death|0
7645059|NCT00896532|12059405|FG016|Months 48-72: Follow-on Phase|Death|0
7645060|NCT00896532|12059406|FG017|Months 48-72: Follow-on Phase|Death|0
7645061|NCT00896532|12059407|FG018|Months 48-72: Follow-on Phase|Death|1
7645062|NCT00896532|12059408|FG019|Months 48-72: Follow-on Phase|Death|0
7645063|NCT00896532|12059409|FG020|Months 48-72: Follow-on Phase|Death|0
7645064|NCT00896532|12059410|FG021|Months 48-72: Follow-on Phase|Death|0
7645065|NCT00896532|12059411|FG022|Months 48-72: Follow-on Phase|Death|0
7645066|NCT00896532|12059389|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645067|NCT00896532|12059390|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645068|NCT00896532|12059391|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645069|NCT00896532|12059392|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645070|NCT00896532|12059393|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645071|NCT00896532|12059394|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645072|NCT00896532|12059395|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645073|NCT00896532|12059396|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645074|NCT00896532|12059397|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645075|NCT00896532|12059398|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645076|NCT00896532|12059399|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645077|NCT00896532|12059400|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645078|NCT00896532|12059401|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645079|NCT00896532|12059402|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645080|NCT00896532|12059403|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645081|NCT00896532|12059404|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645082|NCT00896532|12059405|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645083|NCT00896532|12059406|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645084|NCT00896532|12059407|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645085|NCT00896532|12059408|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645086|NCT00896532|12059409|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645087|NCT00896532|12059410|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1
7645088|NCT00896532|12059411|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645089|NCT00896532|12059389|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645090|NCT00896532|12059390|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645091|NCT00896532|12059391|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645092|NCT00896532|12059392|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645093|NCT00896532|12059393|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645094|NCT00896532|12059394|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645095|NCT00896532|12059395|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645096|NCT00896532|12059396|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645097|NCT00896532|12059397|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645098|NCT00896532|12059398|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645099|NCT00896532|12059399|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645100|NCT00896532|12059400|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645101|NCT00896532|12059401|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645102|NCT00896532|12059402|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645103|NCT00896532|12059403|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645104|NCT00896532|12059404|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645105|NCT00896532|12059405|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645106|NCT00896532|12059406|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645107|NCT00896532|12059407|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645108|NCT00896532|12059408|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645109|NCT00896532|12059409|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645110|NCT00896532|12059410|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
7645111|NCT00896532|12059411|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645112|NCT00892281|12059460|FG000|Overall Study|Adverse Event|65
7645113|NCT00892281|12059461|FG001|Overall Study|Adverse Event|8
7645114|NCT00892281|12059460|FG000|Overall Study|Lost to Follow-up|81
7645115|NCT00892281|12059461|FG001|Overall Study|Lost to Follow-up|8
7645116|NCT00892281|12059460|FG000|Overall Study|Pregnancy|1
7645117|NCT00892281|12059461|FG001|Overall Study|Pregnancy|0
7645118|NCT00892281|12059460|FG000|Overall Study|Protocol Violation|7
7645119|NCT00892281|12059461|FG001|Overall Study|Protocol Violation|2
7645120|NCT00892281|12059460|FG000|Overall Study|Withdrawal by Subject|86
7645121|NCT00892281|12059461|FG001|Overall Study|Withdrawal by Subject|14
7645122|NCT00892281|12059460|FG000|Overall Study|Subject failed to return for final visit|2
7645123|NCT00892281|12059461|FG001|Overall Study|Subject failed to return for final visit|0
7645124|NCT00892281|12059460|FG000|Overall Study|Subject unable to keep follow-up visits|1
7645125|NCT00892281|12059461|FG001|Overall Study|Subject unable to keep follow-up visits|0
7645126|NCT00892281|12059460|FG000|Overall Study|Final visit completed 4 weeks late|0
7645127|NCT00892281|12059461|FG001|Overall Study|Final visit completed 4 weeks late|1
7645128|NCT00892281|12059460|FG000|Overall Study|Subject completed day after study closed|1
7645129|NCT00892281|12059461|FG001|Overall Study|Subject completed day after study closed|0
7645130|NCT00892281|12059460|FG000|Overall Study|Family emergency|1
7645131|NCT00892281|12059461|FG001|Overall Study|Family emergency|0
7645132|NCT00892281|12059460|FG000|Overall Study|Last visit not done - death in family|1
7645133|NCT00892281|12059461|FG001|Overall Study|Last visit not done - death in family|0
7645134|NCT00892281|12059460|FG000|Overall Study|Did not meet incl/excl criteria|1
7645135|NCT00892281|12059461|FG001|Overall Study|Did not meet incl/excl criteria|0
7645136|NCT00892281|12059460|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1
7645137|NCT00892281|12059461|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0
7645138|NCT00892281|12059460|FG000|Overall Study|Unable to redeem the drug voucher|1
7645139|NCT00892281|12059461|FG001|Overall Study|Unable to redeem the drug voucher|0
7645140|NCT00892281|12059460|FG000|Overall Study|Subject not good candidate for study|1
7645141|NCT00892281|12059461|FG001|Overall Study|Subject not good candidate for study|0
7645142|NCT00892281|12059460|FG000|Overall Study|Subject did not return for any visits|1
7645143|NCT00892281|12059461|FG001|Overall Study|Subject did not return for any visits|0
7645144|NCT00892281|12059460|FG000|Overall Study|Subject missed several visits/lost meds|1
7645145|NCT00892281|12059461|FG001|Overall Study|Subject missed several visits/lost meds|0
7645146|NCT00892281|12059460|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1
7645147|NCT00892281|12059461|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1
7645148|NCT00892281|12059460|FG000|Overall Study|Scheduled for knee replacement|0
7645149|NCT00892281|12059461|FG001|Overall Study|Scheduled for knee replacement|1
7645150|NCT00892281|12059460|FG000|Overall Study|PI complained of inadequate compensation|3
7645151|NCT00892281|12059461|FG001|Overall Study|PI complained of inadequate compensation|0
7645152|NCT00892281|12059460|FG000|Overall Study|Subject lost interest in program|0
7645153|NCT00892281|12059461|FG001|Overall Study|Subject lost interest in program|1
7645154|NCT00892281|12059460|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0
7645155|NCT00892281|12059461|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1
7645156|NCT00892281|12059460|FG000|Overall Study|Death in family|1
7645157|NCT00892281|12059461|FG001|Overall Study|Death in family|0
7645158|NCT00892281|12059460|FG000|Overall Study|Lack of efficacy of study product|2
7645159|NCT00892281|12059461|FG001|Overall Study|Lack of efficacy of study product|0
7645160|NCT00892281|12059460|FG000|Overall Study|Subject not seen by PI at final visit|1
7645161|NCT00892281|12059461|FG001|Overall Study|Subject not seen by PI at final visit|0
7645162|NCT00892281|12059460|FG000|Overall Study|No show Visit 2; prescription not filled|1
7645163|NCT00892281|12059461|FG001|Overall Study|No show Visit 2; prescription not filled|0
7645164|NCT00892281|12059460|FG000|Overall Study|Missed multiple visits|1
7645165|NCT00892281|12059461|FG001|Overall Study|Missed multiple visits|0
7645166|NCT00892281|12059460|FG000|Overall Study|Missed visits rescheduled out of window|1
7645167|NCT00892281|12059461|FG001|Overall Study|Missed visits rescheduled out of window|0
7645168|NCT00892281|12059460|FG000|Overall Study|Non-compliant with visits as scheduled|1
7645169|NCT00892281|12059461|FG001|Overall Study|Non-compliant with visits as scheduled|0
7645170|NCT00892281|12059460|FG000|Overall Study|Subject had history of drug abuse|1
7645171|NCT00892281|12059461|FG001|Overall Study|Subject had history of drug abuse|0
7645172|NCT00892281|12059460|FG000|Overall Study|Rash on hand|1
7645173|NCT00892281|12059461|FG001|Overall Study|Rash on hand|0
7645174|NCT00892281|12059460|FG000|Overall Study|Visit 4 date out of window|1
7645175|NCT00892281|12059461|FG001|Overall Study|Visit 4 date out of window|0
7645176|NCT00881868|12059483|FG000|Overall Study|Adverse Event|0
7645177|NCT00881868|12059484|FG001|Overall Study|Adverse Event|1
7645178|NCT00881868|12059483|FG000|Overall Study|Lost to Follow-up|2
7645179|NCT00881868|12059484|FG001|Overall Study|Lost to Follow-up|1
7645180|NCT00881868|12059483|FG000|Overall Study|Physician Decision|4
7645181|NCT00881868|12059484|FG001|Overall Study|Physician Decision|0
7645182|NCT00881868|12059483|FG000|Overall Study|Protocol Violation|2
7645183|NCT00881868|12059484|FG001|Overall Study|Protocol Violation|0
7645184|NCT00861705|12059498|FG000|Overall Study|Never Began Treatment|7
7645185|NCT00861705|12059499|FG001|Overall Study|Never Began Treatment|3
7645186|NCT00861705|12059500|FG002|Overall Study|Never Began Treatment|0
7645187|NCT00861705|12059501|FG003|Overall Study|Never Began Treatment|1
7645188|NCT00847730|12059519|FG000|Overall Study|Multiple interruptions in therapy|8
7645189|NCT00846742|12059523|FG000|Overall Study|Withdrawal by Subject|1
7645190|NCT00845026|12059530|FG000|Study Period III|Adverse Event|23
7645191|NCT00845026|12059531|FG001|Study Period III|Adverse Event|19
7645192|NCT00845026|12059530|FG000|Study Period III|Perceived lack of efficacy|27
7645193|NCT00845026|12059531|FG001|Study Period III|Perceived lack of efficacy|15
7645194|NCT00845026|12059530|FG000|Study Period III|Withdrawal by Subject|19
7645195|NCT00845026|12059531|FG001|Study Period III|Withdrawal by Subject|15
7645196|NCT00845026|12059530|FG000|Study Period III|Entry Criteria not met|8
7645197|NCT00845026|12059531|FG001|Study Period III|Entry Criteria not met|11
7645198|NCT00845026|12059530|FG000|Study Period III|Lost to Follow-up|4
7645199|NCT00845026|12059531|FG001|Study Period III|Lost to Follow-up|5
7645200|NCT00845026|12059530|FG000|Study Period III|Protocol Violation|8
7645201|NCT00845026|12059531|FG001|Study Period III|Protocol Violation|1
7645202|NCT00845026|12059530|FG000|Study Period III|Scheduled conflict|3
7645203|NCT00845026|12059531|FG001|Study Period III|Scheduled conflict|1
7645204|NCT00845026|12059530|FG000|Study Period III|Subject is moving or has moved|2
7645205|NCT00845026|12059531|FG001|Study Period III|Subject is moving or has moved|4
7645206|NCT00845026|12059530|FG000|Study Period III|Transportation issues|1
7645207|NCT00845026|12059531|FG001|Study Period III|Transportation issues|1
7645208|NCT00845026|12059530|FG000|Study Period IV|Adverse Event|4
7645209|NCT00845026|12059531|FG001|Study Period IV|Adverse Event|0
7645210|NCT00845026|12059530|FG000|Study Period IV|Perceived lack of efficacy|2
7645211|NCT00845026|12059531|FG001|Study Period IV|Perceived lack of efficacy|1
7645212|NCT00845026|12059530|FG000|Study Period IV|Protocol Violation|3
7645213|NCT00845026|12059531|FG001|Study Period IV|Protocol Violation|1
7645214|NCT00845026|12059530|FG000|Study Period IV|Lost to Follow-up|1
7645215|NCT00845026|12059531|FG001|Study Period IV|Lost to Follow-up|0
7645216|NCT00845026|12059530|FG000|Study Period IV|Withdrawal by Subject|4
7645217|NCT00845026|12059531|FG001|Study Period IV|Withdrawal by Subject|1
7645218|NCT00845026|12059530|FG000|Study Period IV|Entry Criteria Not Met|1
7645219|NCT00845026|12059531|FG001|Study Period IV|Entry Criteria Not Met|0
7645220|NCT00845026|12059530|FG000|Study Period IV|Subject is moving or has moved|0
7645221|NCT00845026|12059531|FG001|Study Period IV|Subject is moving or has moved|1
7645222|NCT00845026|12059530|FG000|Study Period IV|Scheduling conflict|1
7645223|NCT00845026|12059531|FG001|Study Period IV|Scheduling conflict|0
7645224|NCT00843882|12059542|FG000|Step 1|Lack of Efficacy|14
7645225|NCT00843882|12059543|FG001|Step 1|Lack of Efficacy|10
7645226|NCT00843882|12059544|FG002|Step 1|Lack of Efficacy|21
7645227|NCT00843882|12059542|FG000|Step 1|Adverse Event|8
7645228|NCT00843882|12059543|FG001|Step 1|Adverse Event|17
7645229|NCT00843882|12059544|FG002|Step 1|Adverse Event|20
7645230|NCT00843882|12059542|FG000|Step 1|Death|1
7645231|NCT00843882|12059543|FG001|Step 1|Death|2
7645232|NCT00843882|12059544|FG002|Step 1|Death|4
7645233|NCT00843882|12059542|FG000|Step 1|Withdrawal by Subject|6
7645234|NCT00843882|12059543|FG001|Step 1|Withdrawal by Subject|12
7645235|NCT00843882|12059544|FG002|Step 1|Withdrawal by Subject|9
7645236|NCT00843882|12059542|FG000|Step 1|Physician Decision|0
7645237|NCT00843882|12059543|FG001|Step 1|Physician Decision|5
7645238|NCT00843882|12059544|FG002|Step 1|Physician Decision|1
7645239|NCT00843882|12059542|FG000|Step 1|Patient and physician's decision|0
7645240|NCT00843882|12059543|FG001|Step 1|Patient and physician's decision|0
7645241|NCT00843882|12059544|FG002|Step 1|Patient and physician's decision|1
7645242|NCT00843882|12059542|FG000|Step 1|Other complicating disease|1
7645243|NCT00843882|12059543|FG001|Step 1|Other complicating disease|3
7645244|NCT00843882|12059544|FG002|Step 1|Other complicating disease|4
7645245|NCT00843882|12059542|FG000|Step 1|Alternative therapy|0
7645246|NCT00843882|12059543|FG001|Step 1|Alternative therapy|1
7645247|NCT00843882|12059544|FG002|Step 1|Alternative therapy|1
7645248|NCT00843882|12059542|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0
7645249|NCT00843882|12059543|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4
7645250|NCT00843882|12059544|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0
7645251|NCT00843882|12059542|FG000|Step 1|Off treatment reason unknown|0
7645252|NCT00843882|12059543|FG001|Step 1|Off treatment reason unknown|1
7645253|NCT00843882|12059544|FG002|Step 1|Off treatment reason unknown|4
7645254|NCT00843882|12059542|FG000|Step 1|Never started treatment|2
7645255|NCT00843882|12059543|FG001|Step 1|Never started treatment|0
7645256|NCT00843882|12059544|FG002|Step 1|Never started treatment|0
7645257|NCT00843882|12059542|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1
7645258|NCT00843882|12059543|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9
7645259|NCT00843882|12059544|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0
7645260|NCT00843882|12059542|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0
7645261|NCT00843882|12059543|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6
7645262|NCT00843882|12059544|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0
7645263|NCT00843882|12059542|FG000|Step 2 (Cross-over to Arm B)|Death|0
7645264|NCT00843882|12059543|FG001|Step 2 (Cross-over to Arm B)|Death|3
7645265|NCT00843882|12059544|FG002|Step 2 (Cross-over to Arm B)|Death|0
7645266|NCT00843882|12059542|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2
7645267|NCT00843882|12059543|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5
7645268|NCT00843882|12059544|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0
7645269|NCT00843882|12059542|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1
7645270|NCT00843882|12059543|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1
7645271|NCT00843882|12059544|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0
7645272|NCT00843882|12059542|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0
7645273|NCT00843882|12059543|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1
7645274|NCT00843882|12059544|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0
7645275|NCT00843882|12059542|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0
7645276|NCT00843882|12059543|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1
7645277|NCT00843882|12059544|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0
7645278|NCT00837096|12059572|FG000|Overall Study|Physician Decision|1
7645279|NCT00837096|12059573|FG001|Overall Study|Physician Decision|1
7645280|NCT00837096|12059572|FG000|Overall Study|Not reported|9
7645281|NCT00837096|12059573|FG001|Overall Study|Not reported|8
7645282|NCT00836810|12059581|FG000|Overall Study|New diagnosis|1
7645283|NCT00836810|12059582|FG001|Overall Study|New diagnosis|0
7645284|NCT00822120|12059590|FG000|Initial Registration|Adverse Event|1
7645285|NCT00822120|12059591|FG001|Initial Registration|Adverse Event|0
7645286|NCT00822120|12059592|FG002|Initial Registration|Adverse Event|0
7645287|NCT00822120|12059593|FG003|Initial Registration|Adverse Event|0
7645288|NCT00822120|12059594|FG004|Initial Registration|Adverse Event|0
7645289|NCT00822120|12059595|FG005|Initial Registration|Adverse Event|0
7645290|NCT00822120|12059590|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1
7645291|NCT00822120|12059591|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0
7645292|NCT00822120|12059592|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0
7645293|NCT00822120|12059593|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0
7645294|NCT00822120|12059594|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0
7645295|NCT00822120|12059595|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0
7645296|NCT00822120|12059590|FG000|Initial Registration|Reasons not Protocol Specified|2
7645297|NCT00822120|12059591|FG001|Initial Registration|Reasons not Protocol Specified|0
7645298|NCT00822120|12059592|FG002|Initial Registration|Reasons not Protocol Specified|0
7645299|NCT00822120|12059593|FG003|Initial Registration|Reasons not Protocol Specified|0
7645300|NCT00822120|12059594|FG004|Initial Registration|Reasons not Protocol Specified|0
7645301|NCT00822120|12059595|FG005|Initial Registration|Reasons not Protocol Specified|0
7645302|NCT00822120|12059590|FG000|Initial Registration|Ineligible|22
7645303|NCT00822120|12059591|FG001|Initial Registration|Ineligible|1
7645304|NCT00822120|12059592|FG002|Initial Registration|Ineligible|0
7645305|NCT00822120|12059593|FG003|Initial Registration|Ineligible|0
7645306|NCT00822120|12059594|FG004|Initial Registration|Ineligible|0
7645307|NCT00822120|12059595|FG005|Initial Registration|Ineligible|0
7645308|NCT00822120|12059590|FG000|PET-directed Therapy|Adverse Event|0
7645309|NCT00822120|12059591|FG001|PET-directed Therapy|Adverse Event|0
7645310|NCT00822120|12059592|FG002|PET-directed Therapy|Adverse Event|0
7645311|NCT00822120|12059593|FG003|PET-directed Therapy|Adverse Event|1
7645312|NCT00822120|12059594|FG004|PET-directed Therapy|Adverse Event|0
7645313|NCT00822120|12059595|FG005|PET-directed Therapy|Adverse Event|0
7645314|NCT00822120|12059590|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
7645315|NCT00822120|12059591|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
7645316|NCT00822120|12059592|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
7645317|NCT00822120|12059593|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
7645318|NCT00822120|12059594|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
7645319|NCT00822120|12059595|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
7645320|NCT00822120|12059590|FG000|PET-directed Therapy|Death|0
7645321|NCT00822120|12059591|FG001|PET-directed Therapy|Death|0
7645322|NCT00822120|12059592|FG002|PET-directed Therapy|Death|0
7645323|NCT00822120|12059593|FG003|PET-directed Therapy|Death|2
7645324|NCT00822120|12059594|FG004|PET-directed Therapy|Death|0
7645325|NCT00822120|12059595|FG005|PET-directed Therapy|Death|0
7645326|NCT00822120|12059590|FG000|PET-directed Therapy|Protocol Violation|0
7645327|NCT00822120|12059591|FG001|PET-directed Therapy|Protocol Violation|0
7645328|NCT00822120|12059592|FG002|PET-directed Therapy|Protocol Violation|0
7645329|NCT00822120|12059593|FG003|PET-directed Therapy|Protocol Violation|6
7645330|NCT00822120|12059594|FG004|PET-directed Therapy|Protocol Violation|0
7645331|NCT00822120|12059595|FG005|PET-directed Therapy|Protocol Violation|0
7645332|NCT00819780|12059618|FG000|Overall Study|Did not receive study drug|3
7645333|NCT00819780|12059619|FG001|Overall Study|Did not receive study drug|4
7645334|NCT00819780|12059618|FG000|Overall Study|Still in treatment|25
7645335|NCT00819780|12059619|FG001|Overall Study|Still in treatment|17
7645336|NCT00792948|12059625|FG000|Overall Study|Adverse Event|6
7645337|NCT00792948|12059625|FG000|Overall Study|Death|4
7645338|NCT00792948|12059625|FG000|Overall Study|Withdrawal by Subject|3
7645339|NCT00792948|12059625|FG000|Overall Study|Ineligible|2
7645340|NCT00792948|12059625|FG000|Overall Study|Insurance denial - not treated|1
7645341|NCT00792948|12059625|FG000|Overall Study|Physician Decision|11
7645342|NCT00792948|12059625|FG000|Overall Study|Protocol Violation|1
7645343|NCT00785291|12059644|FG000|Overall Study|Never began treatment|8
7645344|NCT00785291|12059645|FG001|Overall Study|Never began treatment|4
7645345|NCT00785291|12059646|FG002|Overall Study|Never began treatment|4
7645346|NCT00785291|12059644|FG000|Overall Study|Adverse Event|39
7645347|NCT00785291|12059645|FG001|Overall Study|Adverse Event|70
7645348|NCT00785291|12059646|FG002|Overall Study|Adverse Event|56
7645349|NCT00785291|12059644|FG000|Overall Study|Death|7
7645350|NCT00785291|12059645|FG001|Overall Study|Death|4
7645351|NCT00785291|12059646|FG002|Overall Study|Death|3
7645352|NCT00785291|12059644|FG000|Overall Study|Withdrawal by Subject|35
7645353|NCT00785291|12059645|FG001|Overall Study|Withdrawal by Subject|36
7645354|NCT00785291|12059646|FG002|Overall Study|Withdrawal by Subject|17
7645355|NCT00785291|12059644|FG000|Overall Study|Alternative Therapy|12
7645356|NCT00785291|12059645|FG001|Overall Study|Alternative Therapy|6
7645357|NCT00785291|12059646|FG002|Overall Study|Alternative Therapy|7
7645358|NCT00785291|12059644|FG000|Overall Study|Complicating illness|6
7645359|NCT00785291|12059645|FG001|Overall Study|Complicating illness|4
7645360|NCT00785291|12059646|FG002|Overall Study|Complicating illness|4
7645361|NCT00785291|12059644|FG000|Overall Study|Other Medical Reasons|29
7645362|NCT00785291|12059645|FG001|Overall Study|Other Medical Reasons|25
7645363|NCT00785291|12059646|FG002|Overall Study|Other Medical Reasons|15
7645364|NCT00770809|12059678|FG000|Overall Study|Adverse Event|9
7645365|NCT00770809|12059679|FG001|Overall Study|Adverse Event|1
7645366|NCT00770809|12059680|FG002|Overall Study|Adverse Event|12
7645367|NCT00770809|12059678|FG000|Overall Study|Death|1
7645368|NCT00770809|12059679|FG001|Overall Study|Death|0
7645369|NCT00770809|12059680|FG002|Overall Study|Death|0
7645370|NCT00770809|12059678|FG000|Overall Study|Withdrawal by Subject|3
7645371|NCT00770809|12059679|FG001|Overall Study|Withdrawal by Subject|3
7645372|NCT00770809|12059680|FG002|Overall Study|Withdrawal by Subject|7
7645373|NCT00770809|12059678|FG000|Overall Study|Progression|2
7645374|NCT00770809|12059679|FG001|Overall Study|Progression|2
7645375|NCT00770809|12059680|FG002|Overall Study|Progression|0
7645376|NCT00770809|12059678|FG000|Overall Study|Complicating illness|0
7645377|NCT00770809|12059679|FG001|Overall Study|Complicating illness|0
7645378|NCT00770809|12059680|FG002|Overall Study|Complicating illness|1
7645379|NCT00770809|12059678|FG000|Overall Study|Other Medical Reasons|2
7645380|NCT00770809|12059679|FG001|Overall Study|Other Medical Reasons|4
7645381|NCT00770809|12059680|FG002|Overall Study|Other Medical Reasons|3
7645382|NCT00769379|12059690|FG000|Overall Study|No follow up data mapped to Other.|3
7645383|NCT00769379|12059691|FG001|Overall Study|No follow up data mapped to Other.|13
7645384|NCT00763555|12059699|FG000|Overall Study|Adverse Event|2
7645385|NCT00763555|12059700|FG001|Overall Study|Adverse Event|1
7645386|NCT00763555|12059699|FG000|Overall Study|Withdrawal by Subject|2
7645387|NCT00763555|12059700|FG001|Overall Study|Withdrawal by Subject|6
7645388|NCT00763555|12059699|FG000|Overall Study|Lost to Follow-up|0
7645389|NCT00763555|12059700|FG001|Overall Study|Lost to Follow-up|3
7645390|NCT00757042|12059717|FG000|Overall Study|Lost to Follow-up|0
7645391|NCT00757042|12059718|FG001|Overall Study|Lost to Follow-up|0
7645392|NCT00757042|12059719|FG002|Overall Study|Lost to Follow-up|0
7645393|NCT00757042|12059720|FG003|Overall Study|Lost to Follow-up|0
7645394|NCT00757042|12059721|FG004|Overall Study|Lost to Follow-up|0
7645395|NCT00757042|12059722|FG005|Overall Study|Lost to Follow-up|0
7645396|NCT00757042|12059723|FG006|Overall Study|Lost to Follow-up|0
7645397|NCT00757042|12059724|FG007|Overall Study|Lost to Follow-up|0
7645398|NCT00757042|12059725|FG008|Overall Study|Lost to Follow-up|1
7645399|NCT00757042|12059726|FG009|Overall Study|Lost to Follow-up|0
7645400|NCT00757042|12059727|FG010|Overall Study|Lost to Follow-up|0
7645401|NCT00757042|12059717|FG000|Overall Study|Ineligibility Determined|0
7645402|NCT00757042|12059718|FG001|Overall Study|Ineligibility Determined|0
7645403|NCT00757042|12059719|FG002|Overall Study|Ineligibility Determined|0
7645404|NCT00757042|12059720|FG003|Overall Study|Ineligibility Determined|0
7645405|NCT00757042|12059721|FG004|Overall Study|Ineligibility Determined|0
7645406|NCT00757042|12059722|FG005|Overall Study|Ineligibility Determined|0
7645407|NCT00757042|12059723|FG006|Overall Study|Ineligibility Determined|0
7645408|NCT00757042|12059724|FG007|Overall Study|Ineligibility Determined|0
7645409|NCT00757042|12059725|FG008|Overall Study|Ineligibility Determined|0
7645410|NCT00757042|12059726|FG009|Overall Study|Ineligibility Determined|0
7645411|NCT00757042|12059727|FG010|Overall Study|Ineligibility Determined|1
7645412|NCT00757042|12059717|FG000|Overall Study|Withdrawal by Subject|0
7645413|NCT00757042|12059718|FG001|Overall Study|Withdrawal by Subject|0
7645414|NCT00757042|12059719|FG002|Overall Study|Withdrawal by Subject|0
7645415|NCT00757042|12059720|FG003|Overall Study|Withdrawal by Subject|0
7645416|NCT00757042|12059721|FG004|Overall Study|Withdrawal by Subject|0
7645417|NCT00757042|12059722|FG005|Overall Study|Withdrawal by Subject|0
7645418|NCT00757042|12059723|FG006|Overall Study|Withdrawal by Subject|0
7645419|NCT00757042|12059724|FG007|Overall Study|Withdrawal by Subject|0
7645420|NCT00757042|12059725|FG008|Overall Study|Withdrawal by Subject|0
7645421|NCT00757042|12059726|FG009|Overall Study|Withdrawal by Subject|1
7645422|NCT00757042|12059727|FG010|Overall Study|Withdrawal by Subject|0
7645423|NCT00738920|12059761|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8
7645424|NCT00738920|12059762|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9
7645425|NCT00738920|12059763|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8
7645426|NCT00738920|12059761|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8
7645427|NCT00738920|12059762|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14
7645428|NCT00738920|12059763|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7
7645429|NCT00738920|12059761|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3
7645430|NCT00738920|12059762|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5
7645431|NCT00738920|12059763|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6
7645432|NCT00738920|12059761|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5
7645433|NCT00738920|12059762|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7
7645434|NCT00738920|12059763|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6
7645435|NCT00738920|12059761|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3
7645436|NCT00738920|12059762|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0
7645437|NCT00738920|12059763|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2
7645438|NCT00738920|12059761|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1
7645439|NCT00738920|12059762|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0
7645440|NCT00738920|12059763|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1
7645441|NCT00738920|12059761|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2
7645442|NCT00738920|12059762|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4
7645443|NCT00738920|12059763|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7
7645444|NCT00738920|12059761|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2
7645445|NCT00738920|12059762|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3
7645446|NCT00738920|12059763|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5
7645447|NCT00738920|12059761|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1
7645448|NCT00738920|12059762|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0
7645449|NCT00738920|12059763|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1
7645450|NCT00738920|12059761|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0
7645451|NCT00738920|12059762|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1
7645452|NCT00738920|12059763|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0
7645453|NCT00738582|12059771|FG000|Combination Therapy|Completed Combination Therapy|1
7645454|NCT00738582|12059772|FG001|Combination Therapy|Completed Combination Therapy|0
7645455|NCT00738582|12059771|FG000|Combination Therapy|Physician Decision|1
7645456|NCT00738582|12059772|FG001|Combination Therapy|Physician Decision|0
7645457|NCT00738582|12059771|FG000|Combination Therapy|Toxicity to Chemotherapy|1
7645458|NCT00738582|12059772|FG001|Combination Therapy|Toxicity to Chemotherapy|0
7645459|NCT00738582|12059771|FG000|Combination Therapy|Other|5
7645460|NCT00738582|12059772|FG001|Combination Therapy|Other|0
7645461|NCT00738582|12059771|FG000|Combination Therapy|Adverse Event|16
7645462|NCT00738582|12059772|FG001|Combination Therapy|Adverse Event|0
7645463|NCT00738582|12059771|FG000|Combination Therapy|Progressive Disease|9
7645464|NCT00738582|12059772|FG001|Combination Therapy|Progressive Disease|0
7645465|NCT00738582|12059771|FG000|Maintenance Therapy|Other|0
7645466|NCT00738582|12059772|FG001|Maintenance Therapy|Other|2
7645467|NCT00738582|12059771|FG000|Maintenance Therapy|Adverse Event|0
7645468|NCT00738582|12059772|FG001|Maintenance Therapy|Adverse Event|6
7645469|NCT00738582|12059771|FG000|Maintenance Therapy|Progressive Disease|0
7645470|NCT00738582|12059772|FG001|Maintenance Therapy|Progressive Disease|47
7645471|NCT00738582|12059771|FG000|Maintenance Therapy|Withdrawal by Subject|0
7645472|NCT00738582|12059772|FG001|Maintenance Therapy|Withdrawal by Subject|1
7645473|NCT00733954|12059781|FG000|Overall Study|Lost to Follow-up|5
7645474|NCT00733954|12059782|FG001|Overall Study|Lost to Follow-up|2
7645475|NCT00733954|12059781|FG000|Overall Study|Protocol Violation|1
7645476|NCT00733954|12059782|FG001|Overall Study|Protocol Violation|0
7645477|NCT00733954|12059781|FG000|Overall Study|Withdrawal by Subject|2
7645478|NCT00733954|12059782|FG001|Overall Study|Withdrawal by Subject|0
7645479|NCT00731731|12059791|FG000|Overall Study|Protocol Violation|0
7645480|NCT00731731|12059792|FG001|Overall Study|Protocol Violation|0
7645481|NCT00731731|12059793|FG002|Overall Study|Protocol Violation|1
7645482|NCT00731731|12059791|FG000|Overall Study|Cancel prior to treatment|0
7645483|NCT00731731|12059792|FG001|Overall Study|Cancel prior to treatment|0
7645484|NCT00731731|12059793|FG002|Overall Study|Cancel prior to treatment|2
7645485|NCT00728884|12059806|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13
7645486|NCT00728884|12059806|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4
7645487|NCT00680992|12059827|FG000|Overall Study|Complete Resection (as per protocol)|25
7645488|NCT00680992|12059828|FG001|Overall Study|Complete Resection (as per protocol)|121
7645489|NCT00680992|12059829|FG002|Overall Study|Complete Resection (as per protocol)|0
7645490|NCT00680992|12059827|FG000|Overall Study|Administrative Decision|83
7645491|NCT00680992|12059828|FG001|Overall Study|Administrative Decision|42
7645492|NCT00680992|12059829|FG002|Overall Study|Administrative Decision|5
7645493|NCT00680992|12059827|FG000|Overall Study|End of Trial|32
7645494|NCT00680992|12059828|FG001|Overall Study|End of Trial|12
7645495|NCT00680992|12059829|FG002|Overall Study|End of Trial|3
7645496|NCT00680992|12059827|FG000|Overall Study|Withdrawal by Subject|33
7645497|NCT00680992|12059828|FG001|Overall Study|Withdrawal by Subject|11
7645498|NCT00680992|12059829|FG002|Overall Study|Withdrawal by Subject|1
7645499|NCT00680992|12059827|FG000|Overall Study|Adverse Event|21
7645500|NCT00680992|12059828|FG001|Overall Study|Adverse Event|19
7645501|NCT00680992|12059829|FG002|Overall Study|Adverse Event|1
7645502|NCT00680992|12059827|FG000|Overall Study|Other|19
7645503|NCT00680992|12059828|FG001|Overall Study|Other|14
7645504|NCT00680992|12059829|FG002|Overall Study|Other|1
7645505|NCT00680992|12059827|FG000|Overall Study|Disease Progression|21
7645506|NCT00680992|12059828|FG001|Overall Study|Disease Progression|9
7645507|NCT00680992|12059829|FG002|Overall Study|Disease Progression|0
7645508|NCT00680992|12059827|FG000|Overall Study|Lost to Follow-up|12
7645509|NCT00680992|12059828|FG001|Overall Study|Lost to Follow-up|14
7645510|NCT00680992|12059829|FG002|Overall Study|Lost to Follow-up|0
7645511|NCT00680992|12059827|FG000|Overall Study|Noncompliance|4
7645512|NCT00680992|12059828|FG001|Overall Study|Noncompliance|6
7645513|NCT00680992|12059829|FG002|Overall Study|Noncompliance|0
7645514|NCT00680992|12059827|FG000|Overall Study|Requirement for Alternative Therapy|8
7645515|NCT00680992|12059828|FG001|Overall Study|Requirement for Alternative Therapy|2
7645516|NCT00680992|12059829|FG002|Overall Study|Requirement for Alternative Therapy|0
7645517|NCT00680992|12059827|FG000|Overall Study|Pregnancy|5
7645518|NCT00680992|12059828|FG001|Overall Study|Pregnancy|0
7645519|NCT00680992|12059829|FG002|Overall Study|Pregnancy|1
7645520|NCT00680992|12059827|FG000|Overall Study|Death|5
7645521|NCT00680992|12059828|FG001|Overall Study|Death|1
7645522|NCT00680992|12059829|FG002|Overall Study|Death|0
7645523|NCT00680992|12059827|FG000|Overall Study|Ineligibility Determined|0
7645524|NCT00680992|12059828|FG001|Overall Study|Ineligibility Determined|1
7645525|NCT00680992|12059829|FG002|Overall Study|Ineligibility Determined|0
7645526|NCT00679783|12059845|FG000|Overall Study|Adverse Event|0
7645527|NCT00679783|12059846|FG001|Overall Study|Adverse Event|0
7645528|NCT00679783|12059847|FG002|Overall Study|Adverse Event|0
7645529|NCT00679783|12059848|FG003|Overall Study|Adverse Event|3
7645530|NCT00679783|12059849|FG004|Overall Study|Adverse Event|0
7645531|NCT00679783|12059850|FG005|Overall Study|Adverse Event|0
7645532|NCT00679783|12059851|FG006|Overall Study|Adverse Event|1
7645533|NCT00679783|12059845|FG000|Overall Study|Lack of Efficacy|0
7645534|NCT00679783|12059846|FG001|Overall Study|Lack of Efficacy|1
7645535|NCT00679783|12059847|FG002|Overall Study|Lack of Efficacy|0
7645536|NCT00679783|12059848|FG003|Overall Study|Lack of Efficacy|2
7645537|NCT00679783|12059849|FG004|Overall Study|Lack of Efficacy|0
7645538|NCT00679783|12059850|FG005|Overall Study|Lack of Efficacy|0
7645539|NCT00679783|12059851|FG006|Overall Study|Lack of Efficacy|0
7645540|NCT00679783|12059845|FG000|Overall Study|Withdrawal by Subject|0
7645541|NCT00679783|12059846|FG001|Overall Study|Withdrawal by Subject|0
7645542|NCT00679783|12059847|FG002|Overall Study|Withdrawal by Subject|1
7645543|NCT00679783|12059848|FG003|Overall Study|Withdrawal by Subject|1
7645544|NCT00679783|12059849|FG004|Overall Study|Withdrawal by Subject|0
7645545|NCT00679783|12059850|FG005|Overall Study|Withdrawal by Subject|0
7645546|NCT00679783|12059851|FG006|Overall Study|Withdrawal by Subject|0
7645547|NCT00679783|12059845|FG000|Overall Study|Not Captured|0
7645548|NCT00679783|12059846|FG001|Overall Study|Not Captured|0
7645549|NCT00679783|12059847|FG002|Overall Study|Not Captured|0
7645550|NCT00679783|12059848|FG003|Overall Study|Not Captured|5
7645551|NCT00679783|12059849|FG004|Overall Study|Not Captured|0
7645552|NCT00679783|12059850|FG005|Overall Study|Not Captured|0
7645553|NCT00679783|12059851|FG006|Overall Study|Not Captured|0
7645554|NCT00679783|12059845|FG000|Overall Study|Ongoing at data cut-off|2
7645555|NCT00679783|12059846|FG001|Overall Study|Ongoing at data cut-off|2
7645556|NCT00679783|12059847|FG002|Overall Study|Ongoing at data cut-off|0
7645557|NCT00679783|12059848|FG003|Overall Study|Ongoing at data cut-off|9
7645558|NCT00679783|12059849|FG004|Overall Study|Ongoing at data cut-off|1
7645559|NCT00679783|12059850|FG005|Overall Study|Ongoing at data cut-off|0
7645560|NCT00679783|12059851|FG006|Overall Study|Ongoing at data cut-off|0
7645561|NCT00679042|12059867|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2
7645562|NCT00679042|12059867|FG000|5-Year Follow Up|In follow-up (ongoing)|6
7645563|NCT00679042|12059867|FG000|5-Year Follow Up|Death|1
7645564|NCT00679042|12059867|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7
7645565|NCT00679042|12059867|FG000|10-Year Follow Up|In follow-up (ongoing)|5
7645566|NCT00671749|12059871|FG000|Overall Study|Adverse Event|2
7645567|NCT00671749|12059871|FG000|Overall Study|Withdrawal by Subject|4
7645568|NCT00671749|12059871|FG000|Overall Study|Protocol Violation|1
7645569|NCT00671749|12059871|FG000|Overall Study|Lost to Follow-up|1
7645570|NCT00669071|12059875|FG000|Overall Study|Lost to Follow-up|3
7645571|NCT00669071|12059875|FG000|Overall Study|Final visit 40 days out of window|1
7645572|NCT00667251|12059883|FG000|Overall Study|Adverse Event|13
7645573|NCT00667251|12059884|FG001|Overall Study|Adverse Event|4
7645574|NCT00667251|12059883|FG000|Overall Study|Withdrawal by Subject|6
7645575|NCT00667251|12059884|FG001|Overall Study|Withdrawal by Subject|2
7645576|NCT00667251|12059883|FG000|Overall Study|Other/missing|46
7645577|NCT00667251|12059884|FG001|Overall Study|Other/missing|84
7645578|NCT00667251|12059883|FG000|Overall Study|Intercurrent Illness|4
7645579|NCT00667251|12059884|FG001|Overall Study|Intercurrent Illness|3
7645580|NCT00667251|12059883|FG000|Overall Study|Symptomatic progression|1
7645581|NCT00667251|12059884|FG001|Overall Study|Symptomatic progression|2
7645582|NCT00658814|12059892|FG000|Remission Induction Chemotherapy|Adverse Event|1
7645583|NCT00658814|12059893|FG001|Remission Induction Chemotherapy|Adverse Event|3
7645584|NCT00658814|12059892|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3
7645585|NCT00658814|12059893|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4
7645586|NCT00658814|12059892|FG000|Remission Induction Chemotherapy|Progression/Relapse|0
7645587|NCT00658814|12059893|FG001|Remission Induction Chemotherapy|Progression/Relapse|1
7645588|NCT00658814|12059892|FG000|Remission Induction Chemotherapy|Death|1
7645589|NCT00658814|12059893|FG001|Remission Induction Chemotherapy|Death|4
7645590|NCT00658814|12059892|FG000|Remission Induction Chemotherapy|Not protocol specified|2
7645591|NCT00658814|12059893|FG001|Remission Induction Chemotherapy|Not protocol specified|4
7645592|NCT00658814|12059892|FG000|Remission Induction Chemotherapy|Not eligible|1
7645593|NCT00658814|12059893|FG001|Remission Induction Chemotherapy|Not eligible|2
7645594|NCT00658814|12059892|FG000|Consolidation Therapy|Not protocol specified|0
7645595|NCT00658814|12059893|FG001|Consolidation Therapy|Not protocol specified|1
7645596|NCT00658814|12059892|FG000|Consolidation Therapy|Not eligible|2
7645597|NCT00658814|12059893|FG001|Consolidation Therapy|Not eligible|2
7645598|NCT00658814|12059892|FG000|Maintenance Therapy|Adverse Event|1
7645599|NCT00658814|12059893|FG001|Maintenance Therapy|Adverse Event|1
7645600|NCT00658814|12059892|FG000|Maintenance Therapy|Not protocol specified|1
7645601|NCT00658814|12059893|FG001|Maintenance Therapy|Not protocol specified|0
7645602|NCT00658814|12059892|FG000|Maintenance Therapy|Not eligible|1
7645603|NCT00658814|12059893|FG001|Maintenance Therapy|Not eligible|0
7645604|NCT00658788|12059903|FG000|Overall Study|Adverse Event|11
7645605|NCT00658788|12059903|FG000|Overall Study|Withdrawal by Subject|13
7645606|NCT00658788|12059903|FG000|Overall Study|Lost to Follow-up|18
7645607|NCT00658788|12059903|FG000|Overall Study|Treatment Discontinuation|32
7645608|NCT00647556|12059918|FG000|Overall Study|Adverse Event|0
7645609|NCT00647556|12059919|FG001|Overall Study|Adverse Event|1
7645610|NCT00647556|12059918|FG000|Overall Study|Lost to Follow-up|1
7645611|NCT00647556|12059919|FG001|Overall Study|Lost to Follow-up|0
7645612|NCT00647556|12059918|FG000|Overall Study|Protocol Violation|0
7645613|NCT00647556|12059919|FG001|Overall Study|Protocol Violation|1
7645614|NCT00647556|12059918|FG000|Overall Study|Withdrawal by Subject|1
7645615|NCT00647556|12059919|FG001|Overall Study|Withdrawal by Subject|0
7645616|NCT00647556|12059918|FG000|Overall Study|Surgery for pre-existing neck pain|1
7645617|NCT00647556|12059919|FG001|Overall Study|Surgery for pre-existing neck pain|0
7645618|NCT00641186|12059934|FG000|Overall Study|Adverse Event|3
7645619|NCT00625378|12059949|FG000|Overall Study|Adverse Event|22
7645620|NCT00625378|12059950|FG001|Overall Study|Adverse Event|0
7645621|NCT00625378|12059949|FG000|Overall Study|Withdrawal by Subject|16
7645622|NCT00625378|12059950|FG001|Overall Study|Withdrawal by Subject|0
7645623|NCT00625378|12059949|FG000|Overall Study|Death|38
7645624|NCT00625378|12059950|FG001|Overall Study|Death|0
7645625|NCT00625378|12059949|FG000|Overall Study|Disease progression, recurrence or relapse|88
7645626|NCT00625378|12059950|FG001|Overall Study|Disease progression, recurrence or relapse|0
7645627|NCT00625378|12059949|FG000|Overall Study|Lost to Follow-up|17
7645628|NCT00625378|12059950|FG001|Overall Study|Lost to Follow-up|0
7645629|NCT00625378|12059949|FG000|Overall Study|Non-compliant with study medication|3
7645630|NCT00625378|12059950|FG001|Overall Study|Non-compliant with study medication|0
7645631|NCT00625378|12059949|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1
7645632|NCT00625378|12059950|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0
7645633|NCT00625378|12059949|FG000|Overall Study|Medical decision|1
7645634|NCT00625378|12059950|FG001|Overall Study|Medical decision|0
7645635|NCT00625378|12059949|FG000|Overall Study|Multiple toxicities|1
7645636|NCT00625378|12059950|FG001|Overall Study|Multiple toxicities|0
7645637|NCT00625378|12059949|FG000|Overall Study|New cancer|1
7645638|NCT00625378|12059950|FG001|Overall Study|New cancer|0
7645639|NCT00625378|12059949|FG000|Overall Study|PTA program|2
7645640|NCT00625378|12059950|FG001|Overall Study|PTA program|0
7645641|NCT00625378|12059949|FG000|Overall Study|Recurrent rise in amylase and lipase|1
7645642|NCT00625378|12059950|FG001|Overall Study|Recurrent rise in amylase and lipase|0
7645643|NCT00625378|12059949|FG000|Overall Study|Sponsor decision|1
7645644|NCT00625378|12059950|FG001|Overall Study|Sponsor decision|0
7645645|NCT00625378|12059949|FG000|Overall Study|Sponsor's decision to stop the trial|1
7645646|NCT00625378|12059950|FG001|Overall Study|Sponsor's decision to stop the trial|0
7645647|NCT00625378|12059949|FG000|Overall Study|Switch to commercial drug|6
7645648|NCT00625378|12059950|FG001|Overall Study|Switch to commercial drug|1
7645649|NCT00625378|12059949|FG000|Overall Study|Missing|2
7645650|NCT00625378|12059950|FG001|Overall Study|Missing|0
7645651|NCT00625378|12059949|FG000|Overall Study|End of treatment not available|2
7645652|NCT00625378|12059950|FG001|Overall Study|End of treatment not available|0
7645653|NCT00625378|12059949|FG000|Overall Study|Never treated|2
7645654|NCT00625378|12059950|FG001|Overall Study|Never treated|0
7645655|NCT00609791|12059956|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1
7645656|NCT00605189|12059963|FG000|Overall Study|Adverse Event|1
7645657|NCT00605189|12059964|FG001|Overall Study|Adverse Event|0
7645658|NCT00605189|12059965|FG002|Overall Study|Adverse Event|0
7645659|NCT00605189|12059963|FG000|Overall Study|Other|2
7645660|NCT00605189|12059964|FG001|Overall Study|Other|2
7645661|NCT00605189|12059965|FG002|Overall Study|Other|0
7645662|NCT00602641|12059975|FG000|Overall Study|Never started protocol therapy|6
7645663|NCT00602641|12059976|FG001|Overall Study|Never started protocol therapy|2
7645664|NCT00602641|12059975|FG000|Overall Study|Still on treatment at time of analysis|8
7645665|NCT00602641|12059976|FG001|Overall Study|Still on treatment at time of analysis|15
7645666|NCT00602641|12059975|FG000|Overall Study|Adverse Event|62
7645667|NCT00602641|12059976|FG001|Overall Study|Adverse Event|53
7645668|NCT00602641|12059975|FG000|Overall Study|Disease progression|38
7645669|NCT00602641|12059976|FG001|Overall Study|Disease progression|55
7645670|NCT00602641|12059975|FG000|Overall Study|Death|6
7645671|NCT00602641|12059976|FG001|Overall Study|Death|5
7645672|NCT00602641|12059975|FG000|Overall Study|Withdrawal by Subject|15
7645673|NCT00602641|12059976|FG001|Overall Study|Withdrawal by Subject|12
7645674|NCT00602641|12059975|FG000|Overall Study|Alternative therapy|5
7645675|NCT00602641|12059976|FG001|Overall Study|Alternative therapy|2
7645676|NCT00602641|12059975|FG000|Overall Study|Other Complicating Disease|5
7645677|NCT00602641|12059976|FG001|Overall Study|Other Complicating Disease|2
7645678|NCT00602641|12059975|FG000|Overall Study|Physician Decision|5
7645679|NCT00602641|12059976|FG001|Overall Study|Physician Decision|4
7645680|NCT00602641|12059975|FG000|Overall Study|Administrative Closure|1
7645681|NCT00602641|12059976|FG001|Overall Study|Administrative Closure|1
7645682|NCT00602641|12059975|FG000|Overall Study|Other|3
7645683|NCT00602641|12059976|FG001|Overall Study|Other|1
7645684|NCT00602030|12060009|FG000|Lead-in Phase|Disease Progression|2
7645685|NCT00602030|12060010|FG001|Lead-in Phase|Disease Progression|3
7645686|NCT00602030|12060011|FG002|Lead-in Phase|Disease Progression|0
7645687|NCT00602030|12060012|FG003|Lead-in Phase|Disease Progression|0
7645688|NCT00602030|12060013|FG004|Lead-in Phase|Disease Progression|0
7645689|NCT00602030|12060009|FG000|Lead-in Phase|Adverse Event|0
7645690|NCT00602030|12060010|FG001|Lead-in Phase|Adverse Event|2
7645691|NCT00602030|12060011|FG002|Lead-in Phase|Adverse Event|0
7645692|NCT00602030|12060012|FG003|Lead-in Phase|Adverse Event|0
7645693|NCT00602030|12060013|FG004|Lead-in Phase|Adverse Event|0
7645694|NCT00602030|12060009|FG000|Double-blind Phase|Disease progression|0
7645695|NCT00602030|12060010|FG001|Double-blind Phase|Disease progression|0
7645696|NCT00602030|12060011|FG002|Double-blind Phase|Disease progression|33
7645697|NCT00602030|12060012|FG003|Double-blind Phase|Disease progression|30
7645698|NCT00602030|12060013|FG004|Double-blind Phase|Disease progression|0
7645699|NCT00602030|12060009|FG000|Double-blind Phase|Adverse Event|0
7645700|NCT00602030|12060010|FG001|Double-blind Phase|Adverse Event|0
7645701|NCT00602030|12060011|FG002|Double-blind Phase|Adverse Event|9
7645702|NCT00602030|12060012|FG003|Double-blind Phase|Adverse Event|18
7645703|NCT00602030|12060013|FG004|Double-blind Phase|Adverse Event|0
7645704|NCT00602030|12060009|FG000|Double-blind Phase|Consent withdrawal|0
7645705|NCT00602030|12060010|FG001|Double-blind Phase|Consent withdrawal|0
7645706|NCT00602030|12060011|FG002|Double-blind Phase|Consent withdrawal|4
7645707|NCT00602030|12060012|FG003|Double-blind Phase|Consent withdrawal|3
7645708|NCT00602030|12060013|FG004|Double-blind Phase|Consent withdrawal|0
7645709|NCT00602030|12060009|FG000|Double-blind Phase|Death|0
7645710|NCT00602030|12060010|FG001|Double-blind Phase|Death|0
7645711|NCT00602030|12060011|FG002|Double-blind Phase|Death|3
7645712|NCT00602030|12060012|FG003|Double-blind Phase|Death|3
7645713|NCT00602030|12060013|FG004|Double-blind Phase|Death|0
7645714|NCT00602030|12060009|FG000|Double-blind Phase|Administrative decision|0
7645715|NCT00602030|12060010|FG001|Double-blind Phase|Administrative decision|0
7645716|NCT00602030|12060011|FG002|Double-blind Phase|Administrative decision|0
7645717|NCT00602030|12060012|FG003|Double-blind Phase|Administrative decision|2
7645718|NCT00602030|12060013|FG004|Double-blind Phase|Administrative decision|0
7645719|NCT00602030|12060009|FG000|Double-blind Phase|Ineligibility|0
7645720|NCT00602030|12060010|FG001|Double-blind Phase|Ineligibility|0
7645721|NCT00602030|12060011|FG002|Double-blind Phase|Ineligibility|0
7645722|NCT00602030|12060012|FG003|Double-blind Phase|Ineligibility|1
7645723|NCT00602030|12060013|FG004|Double-blind Phase|Ineligibility|0
7645724|NCT00602030|12060009|FG000|Double-blind Phase|Protocol deviation/noncompliance|0
7645725|NCT00602030|12060010|FG001|Double-blind Phase|Protocol deviation/noncompliance|0
7645726|NCT00602030|12060011|FG002|Double-blind Phase|Protocol deviation/noncompliance|1
7645727|NCT00602030|12060012|FG003|Double-blind Phase|Protocol deviation/noncompliance|0
7645728|NCT00602030|12060013|FG004|Double-blind Phase|Protocol deviation/noncompliance|0
7645729|NCT00602030|12060009|FG000|Double-blind Phase|Reason not specified|0
7645730|NCT00602030|12060010|FG001|Double-blind Phase|Reason not specified|0
7645731|NCT00602030|12060011|FG002|Double-blind Phase|Reason not specified|4
7645732|NCT00602030|12060012|FG003|Double-blind Phase|Reason not specified|2
7645733|NCT00602030|12060013|FG004|Double-blind Phase|Reason not specified|0
7645734|NCT00602030|12060009|FG000|Crossover Phase|Disease Progression|0
7645735|NCT00602030|12060010|FG001|Crossover Phase|Disease Progression|0
7645736|NCT00602030|12060011|FG002|Crossover Phase|Disease Progression|0
7645737|NCT00602030|12060012|FG003|Crossover Phase|Disease Progression|0
7645738|NCT00602030|12060013|FG004|Crossover Phase|Disease Progression|11
7645739|NCT00602030|12060009|FG000|Crossover Phase|Adverse Event|0
7645740|NCT00602030|12060010|FG001|Crossover Phase|Adverse Event|0
7645741|NCT00602030|12060011|FG002|Crossover Phase|Adverse Event|0
7645742|NCT00602030|12060012|FG003|Crossover Phase|Adverse Event|0
7645743|NCT00602030|12060013|FG004|Crossover Phase|Adverse Event|3
7645744|NCT00602030|12060009|FG000|Crossover Phase|Consent withdrawal|0
7645745|NCT00602030|12060010|FG001|Crossover Phase|Consent withdrawal|0
7645746|NCT00602030|12060011|FG002|Crossover Phase|Consent withdrawal|0
7645747|NCT00602030|12060012|FG003|Crossover Phase|Consent withdrawal|0
7645748|NCT00602030|12060013|FG004|Crossover Phase|Consent withdrawal|2
7645749|NCT00601900|12060027|FG000|Overall Study|Withdrawal by Subject|0
7645750|NCT00601900|12060028|FG001|Overall Study|Withdrawal by Subject|3
7645751|NCT00597012|12060036|FG000|Overall Study|Death|1
7645752|NCT00597012|12060037|FG001|Overall Study|Death|1
7645753|NCT00597012|12060036|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3
7645754|NCT00597012|12060037|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1
7645755|NCT00597012|12060036|FG000|Overall Study|Withdrawal by Subject|7
7645756|NCT00597012|12060037|FG001|Overall Study|Withdrawal by Subject|4
7645757|NCT00597012|12060036|FG000|Overall Study|Ineligible|2
7645758|NCT00597012|12060037|FG001|Overall Study|Ineligible|0
7645759|NCT00597012|12060036|FG000|Overall Study|Lost to Follow-up|0
7645760|NCT00597012|12060037|FG001|Overall Study|Lost to Follow-up|2
7645761|NCT00588770|12060047|FG000|Overall Study|Disease progression|85
7645762|NCT00588770|12060048|FG001|Overall Study|Disease progression|68
7645763|NCT00588770|12060047|FG000|Overall Study|Adverse Event|29
7645764|NCT00588770|12060048|FG001|Overall Study|Adverse Event|58
7645765|NCT00588770|12060047|FG000|Overall Study|Death|13
7645766|NCT00588770|12060048|FG001|Overall Study|Death|22
7645767|NCT00588770|12060047|FG000|Overall Study|Withdrawal by Subject|15
7645768|NCT00588770|12060048|FG001|Overall Study|Withdrawal by Subject|25
7645769|NCT00588770|12060047|FG000|Overall Study|Alternative therapy|2
7645770|NCT00588770|12060048|FG001|Overall Study|Alternative therapy|4
7645771|NCT00588770|12060047|FG000|Overall Study|Other complicating disease|3
7645772|NCT00588770|12060048|FG001|Overall Study|Other complicating disease|2
7645773|NCT00588770|12060047|FG000|Overall Study|Not start protocol therapy|0
7645774|NCT00588770|12060048|FG001|Overall Study|Not start protocol therapy|9
7645775|NCT00588770|12060047|FG000|Overall Study|Lack of Efficacy|8
7645776|NCT00588770|12060048|FG001|Overall Study|Lack of Efficacy|10
7645777|NCT00588770|12060047|FG000|Overall Study|Physician discretion|2
7645778|NCT00588770|12060048|FG001|Overall Study|Physician discretion|0
7645779|NCT00588770|12060047|FG000|Overall Study|Patient non-compliance|2
7645780|NCT00588770|12060048|FG001|Overall Study|Patient non-compliance|2
7645781|NCT00569127|12060067|FG000|Overall Study|Adverse Event|57
7645782|NCT00569127|12060068|FG001|Overall Study|Adverse Event|47
7645783|NCT00569127|12060067|FG000|Overall Study|Withdrawal by Subject|13
7645784|NCT00569127|12060068|FG001|Overall Study|Withdrawal by Subject|27
7645785|NCT00569127|12060067|FG000|Overall Study|Progression|99
7645786|NCT00569127|12060068|FG001|Overall Study|Progression|100
7645787|NCT00569127|12060067|FG000|Overall Study|Death|4
7645788|NCT00569127|12060068|FG001|Overall Study|Death|3
7645789|NCT00569127|12060067|FG000|Overall Study|Other|20
7645790|NCT00569127|12060068|FG001|Overall Study|Other|19
7645791|NCT00569127|12060067|FG000|Overall Study|Lost to Follow-up|0
7645792|NCT00569127|12060068|FG001|Overall Study|Lost to Follow-up|3
7645793|NCT00569127|12060067|FG000|Overall Study|Not Eligible|14
7645794|NCT00569127|12060068|FG001|Overall Study|Not Eligible|11
7645795|NCT00569127|12060067|FG000|Overall Study|Still on Treatment|7
7645796|NCT00569127|12060068|FG001|Overall Study|Still on Treatment|3
7645797|NCT00565851|12060082|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9
7645798|NCT00565851|12060083|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9
7645799|NCT00565851|12060084|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3
7645800|NCT00565851|12060085|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18
7645801|NCT00565851|12060086|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0
7645802|NCT00565851|12060087|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2
7645803|NCT00565851|12060088|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0
7645804|NCT00565851|12060089|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2
7645805|NCT00565851|12060082|FG000|Chemotherapy Assignment|Still On Chemotherapy|0
7645806|NCT00565851|12060083|FG001|Chemotherapy Assignment|Still On Chemotherapy|14
7645807|NCT00565851|12060084|FG002|Chemotherapy Assignment|Still On Chemotherapy|0
7645808|NCT00565851|12060085|FG003|Chemotherapy Assignment|Still On Chemotherapy|18
7645809|NCT00565851|12060086|FG004|Chemotherapy Assignment|Still On Chemotherapy|0
7645810|NCT00565851|12060087|FG005|Chemotherapy Assignment|Still On Chemotherapy|1
7645811|NCT00565851|12060088|FG006|Chemotherapy Assignment|Still On Chemotherapy|0
7645812|NCT00565851|12060089|FG007|Chemotherapy Assignment|Still On Chemotherapy|1
7645813|NCT00557193|12060111|FG000|Induction|Adverse Event|2
7645814|NCT00557193|12060112|FG001|Induction|Adverse Event|0
7645815|NCT00557193|12060113|FG002|Induction|Adverse Event|0
7645816|NCT00557193|12060114|FG003|Induction|Adverse Event|0
7645817|NCT00557193|12060115|FG004|Induction|Adverse Event|0
7645818|NCT00557193|12060116|FG005|Induction|Adverse Event|0
7645819|NCT00557193|12060111|FG000|Induction|Death|6
7645820|NCT00557193|12060112|FG001|Induction|Death|0
7645821|NCT00557193|12060113|FG002|Induction|Death|0
7645822|NCT00557193|12060114|FG003|Induction|Death|0
7645823|NCT00557193|12060115|FG004|Induction|Death|0
7645824|NCT00557193|12060116|FG005|Induction|Death|0
7645825|NCT00557193|12060111|FG000|Induction|Physician Decision|3
7645826|NCT00557193|12060112|FG001|Induction|Physician Decision|0
7645827|NCT00557193|12060113|FG002|Induction|Physician Decision|0
7645828|NCT00557193|12060114|FG003|Induction|Physician Decision|0
7645829|NCT00557193|12060115|FG004|Induction|Physician Decision|0
7645830|NCT00557193|12060116|FG005|Induction|Physician Decision|0
7645831|NCT00557193|12060111|FG000|Induction|Withdrawal by Subject|1
7645832|NCT00557193|12060112|FG001|Induction|Withdrawal by Subject|0
7645833|NCT00557193|12060113|FG002|Induction|Withdrawal by Subject|0
7645834|NCT00557193|12060114|FG003|Induction|Withdrawal by Subject|0
7645835|NCT00557193|12060115|FG004|Induction|Withdrawal by Subject|0
7645836|NCT00557193|12060116|FG005|Induction|Withdrawal by Subject|0
7645837|NCT00557193|12060111|FG000|Induction|Refusal of Further Protocol Therapy|2
7645838|NCT00557193|12060112|FG001|Induction|Refusal of Further Protocol Therapy|0
7645839|NCT00557193|12060113|FG002|Induction|Refusal of Further Protocol Therapy|0
7645840|NCT00557193|12060114|FG003|Induction|Refusal of Further Protocol Therapy|0
7645841|NCT00557193|12060115|FG004|Induction|Refusal of Further Protocol Therapy|0
7645842|NCT00557193|12060116|FG005|Induction|Refusal of Further Protocol Therapy|0
7645843|NCT00557193|12060111|FG000|Induction|Ineligible|8
7645844|NCT00557193|12060112|FG001|Induction|Ineligible|0
7645845|NCT00557193|12060113|FG002|Induction|Ineligible|0
7645846|NCT00557193|12060114|FG003|Induction|Ineligible|0
7645847|NCT00557193|12060115|FG004|Induction|Ineligible|0
7645848|NCT00557193|12060116|FG005|Induction|Ineligible|0
7645849|NCT00557193|12060111|FG000|Induction|Inevaluable for post Induction|2
7645850|NCT00557193|12060112|FG001|Induction|Inevaluable for post Induction|0
7645851|NCT00557193|12060113|FG002|Induction|Inevaluable for post Induction|0
7645852|NCT00557193|12060114|FG003|Induction|Inevaluable for post Induction|0
7645853|NCT00557193|12060115|FG004|Induction|Inevaluable for post Induction|0
7645854|NCT00557193|12060116|FG005|Induction|Inevaluable for post Induction|0
7645855|NCT00557193|12060111|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2
7645856|NCT00557193|12060112|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0
7645857|NCT00557193|12060113|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0
7645858|NCT00557193|12060114|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0
7645859|NCT00557193|12060115|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0
7645860|NCT00557193|12060116|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0
7645861|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0
7645862|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1
7645863|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2
7645864|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1
7645865|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0
7645866|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3
7645867|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Death|0
7645868|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Death|0
7645869|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Death|2
7645870|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Death|0
7645871|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Death|2
7645872|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Death|2
7645873|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0
7645874|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3
7645875|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5
7645876|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1
7645877|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2
7645878|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2
7645879|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
7645880|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
7645881|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
7645882|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
7645883|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
7645884|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
7645885|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Relapse|0
7645886|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Relapse|5
7645887|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Relapse|16
7645888|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Relapse|3
7645889|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Relapse|1
7645890|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Relapse|20
7645891|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7645892|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7645893|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
7645894|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7645895|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7645896|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7645897|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7645898|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7645899|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
7645900|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7645901|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7645902|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7645903|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0
7645904|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0
7645905|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4
7645906|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0
7645907|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0
7645908|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5
7645909|NCT00556374|12060143|FG000|Overall Study|Withdrawal by Subject|190
7645910|NCT00556374|12060144|FG001|Overall Study|Withdrawal by Subject|172
7645911|NCT00556374|12060143|FG000|Overall Study|Death|50
7645912|NCT00556374|12060144|FG001|Overall Study|Death|43
7645913|NCT00556374|12060143|FG000|Overall Study|Lost to Follow-up|7
7645914|NCT00556374|12060144|FG001|Overall Study|Lost to Follow-up|5
7645915|NCT00549848|12060153|FG000|Overall Study|Death|1
7645916|NCT00549848|12060154|FG001|Overall Study|Death|4
7645917|NCT00549848|12060155|FG002|Overall Study|Death|13
7645918|NCT00549848|12060153|FG000|Overall Study|Physician Decision|0
7645919|NCT00549848|12060154|FG001|Overall Study|Physician Decision|0
7645920|NCT00549848|12060155|FG002|Overall Study|Physician Decision|4
7645921|NCT00549848|12060153|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3
7645922|NCT00549848|12060154|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4
7645923|NCT00549848|12060155|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4
7645924|NCT00549848|12060153|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1
7645925|NCT00549848|12060154|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0
7645926|NCT00549848|12060155|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1
7645927|NCT00549848|12060153|FG000|Overall Study|Participant/Family Withdraw|2
7645928|NCT00549848|12060154|FG001|Overall Study|Participant/Family Withdraw|3
7645929|NCT00549848|12060155|FG002|Overall Study|Participant/Family Withdraw|5
7645930|NCT00549848|12060153|FG000|Overall Study|Second Malignancy|1
7645931|NCT00549848|12060154|FG001|Overall Study|Second Malignancy|0
7645932|NCT00549848|12060155|FG002|Overall Study|Second Malignancy|0
7645933|NCT00549848|12060153|FG000|Overall Study|Transplant|3
7645934|NCT00549848|12060154|FG001|Overall Study|Transplant|3
7645935|NCT00549848|12060155|FG002|Overall Study|Transplant|18
7645936|NCT00549848|12060153|FG000|Overall Study|Unacceptable Toxicity|1
7645937|NCT00549848|12060154|FG001|Overall Study|Unacceptable Toxicity|6
7645938|NCT00549848|12060155|FG002|Overall Study|Unacceptable Toxicity|6
7645939|NCT00523341|12060179|FG000|Overall Study|Withdrawal by Subject|399
7645940|NCT00523341|12060180|FG001|Overall Study|Withdrawal by Subject|427
7645941|NCT00523341|12060179|FG000|Overall Study|Other|181
7645942|NCT00523341|12060180|FG001|Overall Study|Other|198
7645943|NCT00523341|12060179|FG000|Overall Study|Adverse Event|122
7645944|NCT00523341|12060180|FG001|Overall Study|Adverse Event|155
7645945|NCT00523341|12060179|FG000|Overall Study|Death|101
7645946|NCT00523341|12060180|FG001|Overall Study|Death|110
7645947|NCT00523341|12060179|FG000|Overall Study|Lost to Follow-up|73
7645948|NCT00523341|12060180|FG001|Overall Study|Lost to Follow-up|61
7645949|NCT00523341|12060179|FG000|Overall Study|Non-compliance|20
7645950|NCT00523341|12060180|FG001|Overall Study|Non-compliance|13
7645951|NCT00523341|12060179|FG000|Overall Study|Physician Decision|14
7645952|NCT00523341|12060180|FG001|Overall Study|Physician Decision|13
7645953|NCT00523341|12060179|FG000|Overall Study|Requirement for Alternative Therapy|4
7645954|NCT00523341|12060180|FG001|Overall Study|Requirement for Alternative Therapy|14
7645955|NCT00523341|12060179|FG000|Overall Study|Protocol Deviation|6
7645956|NCT00523341|12060180|FG001|Overall Study|Protocol Deviation|5
7645957|NCT00523341|12060179|FG000|Overall Study|Ineligibility Determined|3
7645958|NCT00523341|12060180|FG001|Overall Study|Ineligibility Determined|4
7645959|NCT00523341|12060179|FG000|Overall Study|Disease Progression|1
7645960|NCT00523341|12060180|FG001|Overall Study|Disease Progression|0
7645961|NCT00520767|12060186|FG000|Overall Study|Death|2
7645962|NCT00508820|12060192|FG000|Overall Study|Adverse Event|6
7645963|NCT00508820|12060193|FG001|Overall Study|Adverse Event|10
7645964|NCT00508820|12060192|FG000|Overall Study|Death|6
7645965|NCT00508820|12060193|FG001|Overall Study|Death|8
7645966|NCT00508820|12060192|FG000|Overall Study|Lost to Follow-up|1
7645967|NCT00508820|12060193|FG001|Overall Study|Lost to Follow-up|1
7645968|NCT00508820|12060192|FG000|Overall Study|Physician Decision|8
7645969|NCT00508820|12060193|FG001|Overall Study|Physician Decision|2
7645970|NCT00508820|12060192|FG000|Overall Study|Pregnancy|0
7645971|NCT00508820|12060193|FG001|Overall Study|Pregnancy|2
7645972|NCT00508820|12060192|FG000|Overall Study|Protocol Violation|2
7645973|NCT00508820|12060193|FG001|Overall Study|Protocol Violation|0
7645974|NCT00508820|12060192|FG000|Overall Study|Withdrawal by Subject|10
7645975|NCT00508820|12060193|FG001|Overall Study|Withdrawal by Subject|12
7645976|NCT00508820|12060192|FG000|Overall Study|Other|11
7645977|NCT00508820|12060193|FG001|Overall Study|Other|2
7645978|NCT00508820|12060192|FG000|Overall Study|Noncompliance|1
7645979|NCT00508820|12060193|FG001|Overall Study|Noncompliance|0
7645980|NCT00508820|12060192|FG000|Overall Study|Requirement for alternative therapy|7
7645981|NCT00508820|12060193|FG001|Overall Study|Requirement for alternative therapy|15
7645982|NCT00508820|12060192|FG000|Overall Study|Protocol-specified Criteria|3
7645983|NCT00508820|12060193|FG001|Overall Study|Protocol-specified Criteria|12
7645984|NCT00493467|12060199|FG000|Overall Study|Death|1
7645985|NCT00486889|12060203|FG000|Overall Study|Death|3
7645986|NCT00486889|12060203|FG000|Overall Study|Non-compliant|2
7645987|NCT00486889|12060203|FG000|Overall Study|Withdrawal by Subject|6
7645988|NCT00472212|12060209|FG000|Overall Study|Lost to Follow-up|6
7645989|NCT00472212|12060210|FG001|Overall Study|Lost to Follow-up|4
7645990|NCT00470704|12060218|FG000|Overall Study|Withdrawal by Subject|4
7645991|NCT00470704|12060219|FG001|Overall Study|Withdrawal by Subject|3
7645992|NCT00470704|12060218|FG000|Overall Study|Relapse/Progression|37
7645993|NCT00470704|12060219|FG001|Overall Study|Relapse/Progression|42
7645994|NCT00470704|12060218|FG000|Overall Study|toxicity|0
7645995|NCT00470704|12060219|FG001|Overall Study|toxicity|1
7645996|NCT00436566|12060229|FG000|Overall Study|Withdrawal by Subject|2
7645997|NCT00436566|12060229|FG000|Overall Study|Protocol Violation|1
7645998|NCT00433511|12060236|FG000|Step 1|Adverse Event|50
7645999|NCT00433511|12060237|FG001|Step 1|Adverse Event|157
7646000|NCT00433511|12060238|FG002|Step 1|Adverse Event|153
7646001|NCT00433511|12060236|FG000|Step 1|Withdrawal by Subject|45
7646002|NCT00433511|12060237|FG001|Step 1|Withdrawal by Subject|143
7646003|NCT00433511|12060238|FG002|Step 1|Withdrawal by Subject|154
7646004|NCT00433511|12060236|FG000|Step 1|Death|3
7646005|NCT00433511|12060237|FG001|Step 1|Death|1
7646006|NCT00433511|12060238|FG002|Step 1|Death|1
7646007|NCT00433511|12060236|FG000|Step 1|Physician Decision|1
7646008|NCT00433511|12060237|FG001|Step 1|Physician Decision|4
7646009|NCT00433511|12060238|FG002|Step 1|Physician Decision|3
7646010|NCT00433511|12060236|FG000|Step 1|Never started protocol therapy|28
7646011|NCT00433511|12060237|FG001|Step 1|Never started protocol therapy|64
7646012|NCT00433511|12060238|FG002|Step 1|Never started protocol therapy|66
7646013|NCT00433511|12060236|FG000|Step 1|Alternative therapy|2
7646014|NCT00433511|12060237|FG001|Step 1|Alternative therapy|1
7646015|NCT00433511|12060238|FG002|Step 1|Alternative therapy|3
7646016|NCT00433511|12060236|FG000|Step 1|Disease progression, relapse|5
7646017|NCT00433511|12060237|FG001|Step 1|Disease progression, relapse|3
7646018|NCT00433511|12060238|FG002|Step 1|Disease progression, relapse|3
7646019|NCT00433511|12060236|FG000|Step 1|Other complicating disease|2
7646020|NCT00433511|12060237|FG001|Step 1|Other complicating disease|6
7646021|NCT00433511|12060238|FG002|Step 1|Other complicating disease|3
7646022|NCT00433511|12060236|FG000|Step 1|Non-breast cancer surgery/wound issues|0
7646023|NCT00433511|12060237|FG001|Step 1|Non-breast cancer surgery/wound issues|4
7646024|NCT00433511|12060238|FG002|Step 1|Non-breast cancer surgery/wound issues|1
7646025|NCT00433511|12060236|FG000|Step 1|Suspected recurrence|0
7646026|NCT00433511|12060237|FG001|Step 1|Suspected recurrence|1
7646027|NCT00433511|12060238|FG002|Step 1|Suspected recurrence|0
7646028|NCT00433511|12060236|FG000|Step 1|Insurance/drug distribution issues|0
7646029|NCT00433511|12060237|FG001|Step 1|Insurance/drug distribution issues|1
7646030|NCT00433511|12060238|FG002|Step 1|Insurance/drug distribution issues|2
7646031|NCT00433511|12060236|FG000|Step 1|Patient moved|0
7646032|NCT00433511|12060237|FG001|Step 1|Patient moved|0
7646033|NCT00433511|12060238|FG002|Step 1|Patient moved|1
7646034|NCT00433511|12060236|FG000|Step 2 (Arm D)|Adverse Event|0
7646035|NCT00433511|12060237|FG001|Step 2 (Arm D)|Adverse Event|0
7646036|NCT00433511|12060238|FG002|Step 2 (Arm D)|Adverse Event|135
7646037|NCT00433511|12060236|FG000|Step 2 (Arm D)|Withdrawal by Subject|0
7646038|NCT00433511|12060237|FG001|Step 2 (Arm D)|Withdrawal by Subject|0
7646039|NCT00433511|12060238|FG002|Step 2 (Arm D)|Withdrawal by Subject|181
7646040|NCT00433511|12060236|FG000|Step 2 (Arm D)|Never started protocol therapy|0
7646041|NCT00433511|12060237|FG001|Step 2 (Arm D)|Never started protocol therapy|0
7646042|NCT00433511|12060238|FG002|Step 2 (Arm D)|Never started protocol therapy|148
7646043|NCT00433511|12060236|FG000|Step 2 (Arm D)|Physician Decision|0
7646044|NCT00433511|12060237|FG001|Step 2 (Arm D)|Physician Decision|0
7646045|NCT00433511|12060238|FG002|Step 2 (Arm D)|Physician Decision|9
7646046|NCT00433511|12060236|FG000|Step 2 (Arm D)|Disease progression, relapse|0
7646047|NCT00433511|12060237|FG001|Step 2 (Arm D)|Disease progression, relapse|0
7646048|NCT00433511|12060238|FG002|Step 2 (Arm D)|Disease progression, relapse|7
7646049|NCT00433511|12060236|FG000|Step 2 (Arm D)|Other complicating disease|0
7646050|NCT00433511|12060237|FG001|Step 2 (Arm D)|Other complicating disease|0
7646051|NCT00433511|12060238|FG002|Step 2 (Arm D)|Other complicating disease|3
7646052|NCT00433511|12060236|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
7646053|NCT00433511|12060237|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
7646054|NCT00433511|12060238|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2
7646055|NCT00433511|12060236|FG000|Step 2 (Arm D)|Suspected recurrence|0
7646056|NCT00433511|12060237|FG001|Step 2 (Arm D)|Suspected recurrence|0
7646057|NCT00433511|12060238|FG002|Step 2 (Arm D)|Suspected recurrence|1
7646058|NCT00433511|12060236|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0
7646059|NCT00433511|12060237|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0
7646060|NCT00433511|12060238|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4
7646061|NCT00433511|12060236|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
7646062|NCT00433511|12060237|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
7646063|NCT00433511|12060238|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1
7646064|NCT00432965|12060251|FG000|Overall Study|Lost to Follow-up|22
7646065|NCT00432965|12060252|FG001|Overall Study|Lost to Follow-up|19
7646066|NCT00432965|12060251|FG000|Overall Study|Withdrawal by Subject|13
7646067|NCT00432965|12060252|FG001|Overall Study|Withdrawal by Subject|13
7646068|NCT00432965|12060251|FG000|Overall Study|Physician Decision|14
7646069|NCT00432965|12060252|FG001|Overall Study|Physician Decision|13
7646070|NCT00432965|12060251|FG000|Overall Study|Lack of Efficacy|8
7646071|NCT00432965|12060252|FG001|Overall Study|Lack of Efficacy|13
7646072|NCT00432965|12060251|FG000|Overall Study|Non-compliance|7
7646073|NCT00432965|12060252|FG001|Overall Study|Non-compliance|0
7646074|NCT00432965|12060251|FG000|Overall Study|Adverse Event|22
7646075|NCT00432965|12060252|FG001|Overall Study|Adverse Event|19
7646076|NCT00432965|12060251|FG000|Overall Study|Death|3
7646077|NCT00432965|12060252|FG001|Overall Study|Death|4
7646078|NCT00432965|12060251|FG000|Overall Study|Exclusionary Methods|1
7646079|NCT00432965|12060252|FG001|Overall Study|Exclusionary Methods|2
7646080|NCT00432965|12060251|FG000|Overall Study|Incomplete Data|4
7646081|NCT00432965|12060252|FG001|Overall Study|Incomplete Data|3
7646082|NCT00415532|12060260|FG000|Treatment Period|Adverse Event|2
7646083|NCT00415532|12060261|FG001|Treatment Period|Adverse Event|3
7646084|NCT00415532|12060260|FG000|Treatment Period|Death|2
7646085|NCT00415532|12060261|FG001|Treatment Period|Death|1
7646086|NCT00415532|12060260|FG000|Treatment Period|Lost to Follow-up|1
7646087|NCT00415532|12060261|FG001|Treatment Period|Lost to Follow-up|1
7646088|NCT00415532|12060260|FG000|Treatment Period|Protocol Violation|1
7646089|NCT00415532|12060261|FG001|Treatment Period|Protocol Violation|0
7646090|NCT00415532|12060260|FG000|Treatment Period|Withdrawal by Subject|6
7646091|NCT00415532|12060261|FG001|Treatment Period|Withdrawal by Subject|6
7646092|NCT00415532|12060260|FG000|Treatment Period|Other|2
7646093|NCT00415532|12060261|FG001|Treatment Period|Other|2
7646094|NCT00415532|12060260|FG000|Treatment Period|Ineligibility determined|1
7646095|NCT00415532|12060261|FG001|Treatment Period|Ineligibility determined|1
7646096|NCT00415532|12060260|FG000|Treatment Period|Noncompliance|1
7646097|NCT00415532|12060261|FG001|Treatment Period|Noncompliance|1
7646098|NCT00415532|12060260|FG000|Treatment Period|Requirement for alternative therapy|1
7646099|NCT00415532|12060261|FG001|Treatment Period|Requirement for alternative therapy|0
7646100|NCT00415532|12060260|FG000|Safety Follow Up Period|Adverse Event|1
7646101|NCT00415532|12060261|FG001|Safety Follow Up Period|Adverse Event|3
7646102|NCT00415532|12060260|FG000|Safety Follow Up Period|Death|3
7646103|NCT00415532|12060261|FG001|Safety Follow Up Period|Death|0
7646104|NCT00415532|12060260|FG000|Safety Follow Up Period|Withdrawal by Subject|2
7646105|NCT00415532|12060261|FG001|Safety Follow Up Period|Withdrawal by Subject|3
7646106|NCT00415532|12060260|FG000|Safety Follow Up Period|Other|1
7646107|NCT00415532|12060261|FG001|Safety Follow Up Period|Other|4
7646108|NCT00415532|12060260|FG000|Safety Follow Up Period|Ineligibility determined|1
7646109|NCT00415532|12060261|FG001|Safety Follow Up Period|Ineligibility determined|1
7646110|NCT00415532|12060260|FG000|Safety Follow Up Period|Noncompliance|1
7646111|NCT00415532|12060261|FG001|Safety Follow Up Period|Noncompliance|0
7646112|NCT00415532|12060260|FG000|Safety Follow Up Period|Requirement for alternative therapy|0
7646113|NCT00415532|12060261|FG001|Safety Follow Up Period|Requirement for alternative therapy|1
7646114|NCT00408005|12060269|FG000|Induction|Adverse Event|19
7646115|NCT00408005|12060270|FG001|Induction|Adverse Event|3
7646116|NCT00408005|12060271|FG002|Induction|Adverse Event|0
7646117|NCT00408005|12060272|FG003|Induction|Adverse Event|0
7646118|NCT00408005|12060273|FG004|Induction|Adverse Event|0
7646119|NCT00408005|12060274|FG005|Induction|Adverse Event|0
7646120|NCT00408005|12060275|FG006|Induction|Adverse Event|0
7646121|NCT00408005|12060276|FG007|Induction|Adverse Event|0
7646122|NCT00408005|12060269|FG000|Induction|Death|6
7646123|NCT00408005|12060270|FG001|Induction|Death|0
7646124|NCT00408005|12060271|FG002|Induction|Death|0
7646125|NCT00408005|12060272|FG003|Induction|Death|0
7646126|NCT00408005|12060273|FG004|Induction|Death|0
7646127|NCT00408005|12060274|FG005|Induction|Death|0
7646128|NCT00408005|12060275|FG006|Induction|Death|0
7646129|NCT00408005|12060276|FG007|Induction|Death|0
7646130|NCT00408005|12060269|FG000|Induction|Physician Decision|83
7646131|NCT00408005|12060270|FG001|Induction|Physician Decision|9
7646132|NCT00408005|12060271|FG002|Induction|Physician Decision|0
7646133|NCT00408005|12060272|FG003|Induction|Physician Decision|0
7646134|NCT00408005|12060273|FG004|Induction|Physician Decision|0
7646135|NCT00408005|12060274|FG005|Induction|Physician Decision|0
7646136|NCT00408005|12060275|FG006|Induction|Physician Decision|0
7646137|NCT00408005|12060276|FG007|Induction|Physician Decision|0
7646138|NCT00408005|12060269|FG000|Induction|Withdrawal by Subject|2
7646139|NCT00408005|12060270|FG001|Induction|Withdrawal by Subject|4
7646140|NCT00408005|12060271|FG002|Induction|Withdrawal by Subject|0
7646141|NCT00408005|12060272|FG003|Induction|Withdrawal by Subject|0
7646142|NCT00408005|12060273|FG004|Induction|Withdrawal by Subject|0
7646143|NCT00408005|12060274|FG005|Induction|Withdrawal by Subject|0
7646144|NCT00408005|12060275|FG006|Induction|Withdrawal by Subject|0
7646145|NCT00408005|12060276|FG007|Induction|Withdrawal by Subject|0
7646146|NCT00408005|12060269|FG000|Induction|Ineligible|33
7646147|NCT00408005|12060270|FG001|Induction|Ineligible|14
7646148|NCT00408005|12060271|FG002|Induction|Ineligible|0
7646149|NCT00408005|12060272|FG003|Induction|Ineligible|0
7646150|NCT00408005|12060273|FG004|Induction|Ineligible|0
7646151|NCT00408005|12060274|FG005|Induction|Ineligible|0
7646152|NCT00408005|12060275|FG006|Induction|Ineligible|0
7646153|NCT00408005|12060276|FG007|Induction|Ineligible|0
7646154|NCT00408005|12060269|FG000|Induction|Refusal of Further Protocol Therapy|225
7646155|NCT00408005|12060270|FG001|Induction|Refusal of Further Protocol Therapy|44
7646156|NCT00408005|12060271|FG002|Induction|Refusal of Further Protocol Therapy|0
7646157|NCT00408005|12060272|FG003|Induction|Refusal of Further Protocol Therapy|0
7646158|NCT00408005|12060273|FG004|Induction|Refusal of Further Protocol Therapy|0
7646159|NCT00408005|12060274|FG005|Induction|Refusal of Further Protocol Therapy|0
7646160|NCT00408005|12060275|FG006|Induction|Refusal of Further Protocol Therapy|0
7646161|NCT00408005|12060276|FG007|Induction|Refusal of Further Protocol Therapy|0
7646162|NCT00408005|12060269|FG000|Induction|Entered another COG therapeutic protocol|4
7646163|NCT00408005|12060270|FG001|Induction|Entered another COG therapeutic protocol|0
7646164|NCT00408005|12060271|FG002|Induction|Entered another COG therapeutic protocol|0
7646165|NCT00408005|12060272|FG003|Induction|Entered another COG therapeutic protocol|0
7646166|NCT00408005|12060273|FG004|Induction|Entered another COG therapeutic protocol|0
7646167|NCT00408005|12060274|FG005|Induction|Entered another COG therapeutic protocol|0
7646168|NCT00408005|12060275|FG006|Induction|Entered another COG therapeutic protocol|0
7646169|NCT00408005|12060276|FG007|Induction|Entered another COG therapeutic protocol|0
7646170|NCT00408005|12060269|FG000|Induction|Patient transferred Tx to Non-COG Site|3
7646171|NCT00408005|12060270|FG001|Induction|Patient transferred Tx to Non-COG Site|2
7646172|NCT00408005|12060271|FG002|Induction|Patient transferred Tx to Non-COG Site|0
7646173|NCT00408005|12060272|FG003|Induction|Patient transferred Tx to Non-COG Site|0
7646174|NCT00408005|12060273|FG004|Induction|Patient transferred Tx to Non-COG Site|0
7646175|NCT00408005|12060274|FG005|Induction|Patient transferred Tx to Non-COG Site|0
7646176|NCT00408005|12060275|FG006|Induction|Patient transferred Tx to Non-COG Site|0
7646177|NCT00408005|12060276|FG007|Induction|Patient transferred Tx to Non-COG Site|0
7646178|NCT00408005|12060269|FG000|Induction|Identified as Philadelphia Chr. Positive|6
7646179|NCT00408005|12060270|FG001|Induction|Identified as Philadelphia Chr. Positive|0
7646180|NCT00408005|12060271|FG002|Induction|Identified as Philadelphia Chr. Positive|0
7646181|NCT00408005|12060272|FG003|Induction|Identified as Philadelphia Chr. Positive|0
7646182|NCT00408005|12060273|FG004|Induction|Identified as Philadelphia Chr. Positive|0
7646183|NCT00408005|12060274|FG005|Induction|Identified as Philadelphia Chr. Positive|0
7646184|NCT00408005|12060275|FG006|Induction|Identified as Philadelphia Chr. Positive|0
7646185|NCT00408005|12060276|FG007|Induction|Identified as Philadelphia Chr. Positive|0
7646186|NCT00408005|12060269|FG000|Induction|Progressive Disease|0
7646187|NCT00408005|12060270|FG001|Induction|Progressive Disease|1
7646188|NCT00408005|12060271|FG002|Induction|Progressive Disease|0
7646189|NCT00408005|12060272|FG003|Induction|Progressive Disease|0
7646190|NCT00408005|12060273|FG004|Induction|Progressive Disease|0
7646191|NCT00408005|12060274|FG005|Induction|Progressive Disease|0
7646192|NCT00408005|12060275|FG006|Induction|Progressive Disease|0
7646193|NCT00408005|12060276|FG007|Induction|Progressive Disease|0
7646194|NCT00408005|12060269|FG000|Induction|Inevaluable|18
7646195|NCT00408005|12060270|FG001|Induction|Inevaluable|14
7646196|NCT00408005|12060271|FG002|Induction|Inevaluable|0
7646197|NCT00408005|12060272|FG003|Induction|Inevaluable|0
7646198|NCT00408005|12060273|FG004|Induction|Inevaluable|0
7646199|NCT00408005|12060274|FG005|Induction|Inevaluable|0
7646200|NCT00408005|12060275|FG006|Induction|Inevaluable|0
7646201|NCT00408005|12060276|FG007|Induction|Inevaluable|0
7646202|NCT00408005|12060269|FG000|Induction|Failed to Complete Randomization|3
7646203|NCT00408005|12060270|FG001|Induction|Failed to Complete Randomization|2
7646204|NCT00408005|12060271|FG002|Induction|Failed to Complete Randomization|0
7646205|NCT00408005|12060272|FG003|Induction|Failed to Complete Randomization|0
7646206|NCT00408005|12060273|FG004|Induction|Failed to Complete Randomization|0
7646207|NCT00408005|12060274|FG005|Induction|Failed to Complete Randomization|0
7646208|NCT00408005|12060275|FG006|Induction|Failed to Complete Randomization|0
7646209|NCT00408005|12060276|FG007|Induction|Failed to Complete Randomization|0
7646210|NCT00408005|12060269|FG000|Induction|Protocol Deviation|3
7646211|NCT00408005|12060270|FG001|Induction|Protocol Deviation|1
7646212|NCT00408005|12060271|FG002|Induction|Protocol Deviation|0
7646213|NCT00408005|12060272|FG003|Induction|Protocol Deviation|0
7646214|NCT00408005|12060273|FG004|Induction|Protocol Deviation|0
7646215|NCT00408005|12060274|FG005|Induction|Protocol Deviation|0
7646216|NCT00408005|12060275|FG006|Induction|Protocol Deviation|0
7646217|NCT00408005|12060276|FG007|Induction|Protocol Deviation|0
7646218|NCT00408005|12060269|FG000|Induction|Hematopoietic Stem Cell Transplantation|1
7646219|NCT00408005|12060270|FG001|Induction|Hematopoietic Stem Cell Transplantation|0
7646220|NCT00408005|12060271|FG002|Induction|Hematopoietic Stem Cell Transplantation|0
7646221|NCT00408005|12060272|FG003|Induction|Hematopoietic Stem Cell Transplantation|0
7646222|NCT00408005|12060273|FG004|Induction|Hematopoietic Stem Cell Transplantation|0
7646223|NCT00408005|12060274|FG005|Induction|Hematopoietic Stem Cell Transplantation|0
7646224|NCT00408005|12060275|FG006|Induction|Hematopoietic Stem Cell Transplantation|0
7646225|NCT00408005|12060276|FG007|Induction|Hematopoietic Stem Cell Transplantation|0
7646226|NCT00408005|12060269|FG000|Induction|Recurrent leukemia|1
7646227|NCT00408005|12060270|FG001|Induction|Recurrent leukemia|0
7646228|NCT00408005|12060271|FG002|Induction|Recurrent leukemia|0
7646229|NCT00408005|12060272|FG003|Induction|Recurrent leukemia|0
7646230|NCT00408005|12060273|FG004|Induction|Recurrent leukemia|0
7646231|NCT00408005|12060274|FG005|Induction|Recurrent leukemia|0
7646232|NCT00408005|12060275|FG006|Induction|Recurrent leukemia|0
7646233|NCT00408005|12060276|FG007|Induction|Recurrent leukemia|0
7646234|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0
7646235|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0
7646236|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7
7646237|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4
7646238|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8
7646239|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12
7646240|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2
7646241|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0
7646242|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Death|0
7646243|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Death|0
7646244|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Death|3
7646245|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Death|0
7646246|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Death|5
7646247|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Death|5
7646248|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Death|3
7646249|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Death|1
7646250|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7646251|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7646252|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2
7646253|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7646254|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1
7646255|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7646256|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7646257|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7646258|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0
7646259|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0
7646260|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24
7646261|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19
7646262|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27
7646263|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45
7646264|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10
7646265|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4
7646266|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7646267|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7646268|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
7646269|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
7646270|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7646271|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2
7646272|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7646273|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7646274|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
7646275|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
7646276|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27
7646277|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10
7646278|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36
7646279|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16
7646280|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4
7646281|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2
7646282|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7646283|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7646284|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7646285|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7646286|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1
7646287|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7646288|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7646289|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7646290|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7646291|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7646292|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3
7646293|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
7646294|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
7646295|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7646296|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
7646297|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7646298|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7646299|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7646300|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7646301|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7646302|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1
7646303|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7646304|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7
7646305|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7
7646306|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0
7646307|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0
7646308|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0
7646309|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0
7646310|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0
7646311|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1
7646312|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0
7646313|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0
7646314|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
7646315|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
7646316|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
7646317|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
7646318|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
7646319|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
7646320|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
7646321|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
7646322|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7646323|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7646324|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7646325|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7646326|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1
7646327|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2
7646328|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7646329|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7646330|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
7646331|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
7646332|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13
7646333|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7
7646334|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49
7646335|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15
7646336|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1
7646337|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
7646338|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0
7646339|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0
7646340|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3
7646341|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1
7646342|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1
7646343|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1
7646344|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0
7646345|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0
7646346|NCT00389610|12060302|FG000|Overall Study|Disease Progression|0
7646347|NCT00389610|12060303|FG001|Overall Study|Disease Progression|19
7646348|NCT00389610|12060302|FG000|Overall Study|Death|0
7646349|NCT00389610|12060303|FG001|Overall Study|Death|1
7646350|NCT00389610|12060302|FG000|Overall Study|Physician Decision|0
7646351|NCT00389610|12060303|FG001|Overall Study|Physician Decision|1
7646352|NCT00389610|12060302|FG000|Overall Study|Withdrawal by Subject|0
7646353|NCT00389610|12060303|FG001|Overall Study|Withdrawal by Subject|1
7646354|NCT00383708|12060309|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1
7646355|NCT00383708|12060309|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32
7646356|NCT00383708|12060309|FG000|Run-in Period|Protocol Violation|4
7646357|NCT00383708|12060309|FG000|Run-in Period|Adverse Event|2
7646358|NCT00383708|12060309|FG000|Run-in Period|Claustrophobia|1
7646359|NCT00383708|12060309|FG000|Co-administration Period|Adverse Event|5
7646360|NCT00377156|12060316|FG000|Overall Study|Death|23
7646361|NCT00377156|12060317|FG001|Overall Study|Death|19
7646362|NCT00377156|12060316|FG000|Overall Study|Withdrawal by Subject|16
7646363|NCT00377156|12060317|FG001|Overall Study|Withdrawal by Subject|24
7646364|NCT00377156|12060316|FG000|Overall Study|Had follow-up <90 d|3
7646365|NCT00377156|12060317|FG001|Overall Study|Had follow-up <90 d|6
7646366|NCT00377156|12060316|FG000|Overall Study|Cancellation|1
7646367|NCT00377156|12060317|FG001|Overall Study|Cancellation|0
7646368|NCT00377156|12060316|FG000|Overall Study|Refused testing|0
7646369|NCT00377156|12060317|FG001|Overall Study|Refused testing|1
7646370|NCT00377156|12060316|FG000|Overall Study|Ineligible|0
7646371|NCT00377156|12060317|FG001|Overall Study|Ineligible|1
7646372|NCT00377156|12060316|FG000|Overall Study|Disability or language problem|0
7646373|NCT00377156|12060317|FG001|Overall Study|Disability or language problem|1
7646374|NCT00377156|12060316|FG000|Overall Study|Other|5
7646375|NCT00377156|12060317|FG001|Overall Study|Other|2
7646376|NCT00364013|12060336|FG000|Overall Study|Ineligibility determined|4
7646377|NCT00364013|12060337|FG001|Overall Study|Ineligibility determined|2
7646378|NCT00364013|12060336|FG000|Overall Study|Adverse Event|4
7646379|NCT00364013|12060337|FG001|Overall Study|Adverse Event|3
7646380|NCT00364013|12060336|FG000|Overall Study|Withdrawal by Subject|13
7646381|NCT00364013|12060337|FG001|Overall Study|Withdrawal by Subject|18
7646382|NCT00364013|12060336|FG000|Overall Study|Physician Decision|3
7646383|NCT00364013|12060337|FG001|Overall Study|Physician Decision|3
7646384|NCT00364013|12060336|FG000|Overall Study|Lost to Follow-up|10
7646385|NCT00364013|12060337|FG001|Overall Study|Lost to Follow-up|3
7646386|NCT00364013|12060336|FG000|Overall Study|Protocol-specified criteria|6
7646387|NCT00364013|12060337|FG001|Overall Study|Protocol-specified criteria|6
7646388|NCT00364013|12060336|FG000|Overall Study|Other|41
7646389|NCT00364013|12060337|FG001|Overall Study|Other|47
7646390|NCT00364013|12060336|FG000|Overall Study|Ongoing|20
7646391|NCT00364013|12060337|FG001|Overall Study|Ongoing|13
7646392|NCT00345839|12060349|FG000|Overall Study|Withdrawal by Subject|91
7646393|NCT00345839|12060350|FG001|Overall Study|Withdrawal by Subject|98
7646394|NCT00345839|12060349|FG000|Overall Study|Lost to Follow-up|58
7646395|NCT00345839|12060350|FG001|Overall Study|Lost to Follow-up|61
7646396|NCT00339183|12060358|FG000|Overall Study|Adverse Event|5
7646397|NCT00339183|12060359|FG001|Overall Study|Adverse Event|3
7646398|NCT00339183|12060358|FG000|Overall Study|Withdrawal by Subject|16
7646399|NCT00339183|12060359|FG001|Overall Study|Withdrawal by Subject|19
7646400|NCT00339183|12060358|FG000|Overall Study|Physician Decision|2
7646401|NCT00339183|12060359|FG001|Overall Study|Physician Decision|4
7646402|NCT00339183|12060358|FG000|Overall Study|Lost to Follow-up|17
7646403|NCT00339183|12060359|FG001|Overall Study|Lost to Follow-up|17
7646404|NCT00339183|12060358|FG000|Overall Study|Protocol-specified criteria|12
7646405|NCT00339183|12060359|FG001|Overall Study|Protocol-specified criteria|8
7646406|NCT00339183|12060358|FG000|Overall Study|Missing reason|3
7646407|NCT00339183|12060359|FG001|Overall Study|Missing reason|1
7646408|NCT00339183|12060358|FG000|Overall Study|Other|46
7646409|NCT00339183|12060359|FG001|Overall Study|Other|40
7646410|NCT00339183|12060358|FG000|Overall Study|Ongoing|20
7646411|NCT00339183|12060359|FG001|Overall Study|Ongoing|13
7646412|NCT00326625|12060384|FG000|Overall Study|Adverse Event|20
7646413|NCT00326625|12060385|FG001|Overall Study|Adverse Event|9
7646414|NCT00326625|12060384|FG000|Overall Study|Withdrawal by Subject|15
7646415|NCT00326625|12060385|FG001|Overall Study|Withdrawal by Subject|12
7646416|NCT00326625|12060384|FG000|Overall Study|Death|18
7646417|NCT00326625|12060385|FG001|Overall Study|Death|16
7646418|NCT00326625|12060384|FG000|Overall Study|Lost to Follow-up|1
7646419|NCT00326625|12060385|FG001|Overall Study|Lost to Follow-up|0
7646420|NCT00326625|12060384|FG000|Overall Study|prescheduled medical intervention|0
7646421|NCT00326625|12060385|FG001|Overall Study|prescheduled medical intervention|1
7646422|NCT00324805|12060393|FG000|Overall Study|Adverse Event|62
7646423|NCT00324805|12060394|FG001|Overall Study|Adverse Event|203
7646424|NCT00324805|12060393|FG000|Overall Study|Progression|7
7646425|NCT00324805|12060394|FG001|Overall Study|Progression|35
7646426|NCT00324805|12060393|FG000|Overall Study|Withdrawal by Subject|51
7646427|NCT00324805|12060394|FG001|Overall Study|Withdrawal by Subject|174
7646428|NCT00324805|12060393|FG000|Overall Study|Death|6
7646429|NCT00324805|12060394|FG001|Overall Study|Death|9
7646430|NCT00324805|12060393|FG000|Overall Study|Alternative therapy|4
7646431|NCT00324805|12060394|FG001|Overall Study|Alternative therapy|8
7646432|NCT00324805|12060393|FG000|Overall Study|Other complicating disease|1
7646433|NCT00324805|12060394|FG001|Overall Study|Other complicating disease|9
7646434|NCT00324805|12060393|FG000|Overall Study|Other reasons|7
7646435|NCT00324805|12060394|FG001|Overall Study|Other reasons|26
7646436|NCT00324805|12060393|FG000|Overall Study|Other|0
7646437|NCT00324805|12060394|FG001|Overall Study|Other|2
7646438|NCT00324805|12060393|FG000|Overall Study|Did not start therapy|12
7646439|NCT00324805|12060394|FG001|Overall Study|Did not start therapy|17
7646440|NCT00323063|12060402|FG000|Overall Study|Adverse Event|1
7646441|NCT00323063|12060403|FG001|Overall Study|Adverse Event|0
7646442|NCT00323063|12060402|FG000|Overall Study|brain mets discovered prior to treatment|1
7646443|NCT00323063|12060403|FG001|Overall Study|brain mets discovered prior to treatment|0
7646444|NCT00302952|12060428|FG000|Overall Study|Physician Decision|1
7646445|NCT00302952|12060429|FG001|Overall Study|Physician Decision|1
7646446|NCT00302952|12060428|FG000|Overall Study|Withdrawal by Subject|2
7646447|NCT00302952|12060429|FG001|Overall Study|Withdrawal by Subject|3
7646448|NCT00302952|12060428|FG000|Overall Study|Elevated SGOT (AST) lab value|0
7646449|NCT00302952|12060429|FG001|Overall Study|Elevated SGOT (AST) lab value|1
7646450|NCT00288509|12060444|FG000|Treatment Cycle 1|Adverse Event|1
7646451|NCT00288509|12060444|FG000|Treatment Cycle 1|Lack of Efficacy|1
7646452|NCT00288509|12060444|FG000|Treatment Cycle 1|Withdrawal by Subject|1
7646453|NCT00288509|12060444|FG000|Treatment Cycle 1|Lost to Follow-up|2
7646454|NCT00288509|12060444|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1
7646455|NCT00288509|12060444|FG000|Treatment Cycle 2|Lack of Efficacy|1
7646456|NCT00288509|12060444|FG000|Treatment Cycle 2|Withdrawal by Subject|2
7646457|NCT00288509|12060444|FG000|Treatment Cycle 3|Lack of Efficacy|1
7646458|NCT00288509|12060444|FG000|Treatment Cycle 3|Withdrawal by Subject|1
7646459|NCT00288509|12060444|FG000|Treatment Cycle 3|Lost to Follow-up|2
7646460|NCT00288509|12060444|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1
7646461|NCT00288509|12060444|FG000|Treatment Cycle 4|Withdrawal by Subject|3
7646462|NCT00288509|12060444|FG000|Treatment Cycle 4|Physician Decision|4
7646463|NCT00288509|12060444|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1
7646464|NCT00278915|12060448|FG000|Overall Study|Lack of Efficacy|1
7646465|NCT00257660|12060454|FG000|Overall Study|Lack of Efficacy|5
7646466|NCT00257660|12060455|FG001|Overall Study|Lack of Efficacy|23
7646467|NCT00257660|12060454|FG000|Overall Study|Withdrawal by Subject|2
7646468|NCT00257660|12060455|FG001|Overall Study|Withdrawal by Subject|0
7646469|NCT00257660|12060454|FG000|Overall Study|Lost to Follow-up|1
7646470|NCT00257660|12060455|FG001|Overall Study|Lost to Follow-up|0
7646471|NCT00257660|12060454|FG000|Overall Study|PI & Subject Schedule Conflicts|1
7646472|NCT00257660|12060455|FG001|Overall Study|PI & Subject Schedule Conflicts|0
7646473|NCT00257660|12060454|FG000|Overall Study|No longer wanted to do blood draws|1
7646474|NCT00257660|12060455|FG001|Overall Study|No longer wanted to do blood draws|0
7646475|NCT00127127|12060474|FG000|Overall Study|Adverse Event|0
7646476|NCT00127127|12060475|FG001|Overall Study|Adverse Event|2
7646477|NCT00127127|12060476|FG002|Overall Study|Adverse Event|0
7646478|NCT00127127|12060477|FG003|Overall Study|Adverse Event|1
7646479|NCT00127127|12060474|FG000|Overall Study|Lack of Efficacy|1
7646480|NCT00127127|12060475|FG001|Overall Study|Lack of Efficacy|3
7646481|NCT00127127|12060476|FG002|Overall Study|Lack of Efficacy|0
7646482|NCT00127127|12060477|FG003|Overall Study|Lack of Efficacy|2
7646483|NCT00113763|12060556|FG000|Overall Study|Adverse Event|5
7646484|NCT00113763|12060557|FG001|Overall Study|Adverse Event|2
7646485|NCT00113763|12060556|FG000|Overall Study|Disease Progression|28
7646486|NCT00113763|12060557|FG001|Overall Study|Disease Progression|14
7646487|NCT00113763|12060556|FG000|Overall Study|Lost to Follow-up|10
7646488|NCT00113763|12060557|FG001|Overall Study|Lost to Follow-up|0
7646489|NCT00113763|12060556|FG000|Overall Study|Withdrawal by Subject|1
7646490|NCT00113763|12060557|FG001|Overall Study|Withdrawal by Subject|4
7646491|NCT00113763|12060556|FG000|Overall Study|Other|27
7646492|NCT00113763|12060557|FG001|Overall Study|Other|6
7646493|NCT00113763|12060556|FG000|Overall Study|Non-compliance|1
7646494|NCT00113763|12060557|FG001|Overall Study|Non-compliance|0
7646495|NCT00113763|12060556|FG000|Overall Study|Ongoing|1
7646496|NCT00113763|12060557|FG001|Overall Study|Ongoing|0
7646497|NCT00101101|12060564|FG000|Overall Study|never received vaccine|20
7646498|NCT00099437|12060570|FG000|Overall Study|Lost to Follow-up|30
7646499|NCT00099437|12060571|FG001|Overall Study|Lost to Follow-up|33
7646500|NCT00099437|12060570|FG000|Overall Study|Death|293
7646501|NCT00099437|12060571|FG001|Overall Study|Death|261
7646502|NCT00099437|12060570|FG000|Overall Study|Withdrawal by Subject|6
7646503|NCT00099437|12060571|FG001|Overall Study|Withdrawal by Subject|10
7646504|NCT00099437|12060570|FG000|Overall Study|Ongoing in FU but not on treatment|37
7646505|NCT00099437|12060571|FG001|Overall Study|Ongoing in FU but not on treatment|45
7646506|NCT00098475|12060579|FG000|Step 1|Progressive disease|33
7646507|NCT00098475|12060580|FG001|Step 1|Progressive disease|35
7646508|NCT00098475|12060581|FG002|Step 1|Progressive disease|2
7646509|NCT00098475|12060582|FG003|Step 1|Progressive disease|1
7646510|NCT00098475|12060579|FG000|Step 1|Adverse Event|56
7646511|NCT00098475|12060580|FG001|Step 1|Adverse Event|37
7646512|NCT00098475|12060581|FG002|Step 1|Adverse Event|0
7646513|NCT00098475|12060582|FG003|Step 1|Adverse Event|1
7646514|NCT00098475|12060579|FG000|Step 1|Death|8
7646515|NCT00098475|12060580|FG001|Step 1|Death|5
7646516|NCT00098475|12060581|FG002|Step 1|Death|0
7646517|NCT00098475|12060582|FG003|Step 1|Death|1
7646518|NCT00098475|12060579|FG000|Step 1|Withdrawal by Subject|14
7646519|NCT00098475|12060580|FG001|Step 1|Withdrawal by Subject|11
7646520|NCT00098475|12060581|FG002|Step 1|Withdrawal by Subject|0
7646521|NCT00098475|12060582|FG003|Step 1|Withdrawal by Subject|0
7646522|NCT00098475|12060579|FG000|Step 1|Physician Decision|5
7646523|NCT00098475|12060580|FG001|Step 1|Physician Decision|2
7646524|NCT00098475|12060581|FG002|Step 1|Physician Decision|0
7646525|NCT00098475|12060582|FG003|Step 1|Physician Decision|0
7646526|NCT00098475|12060579|FG000|Step 1|Alternative therapy|31
7646527|NCT00098475|12060580|FG001|Step 1|Alternative therapy|43
7646528|NCT00098475|12060581|FG002|Step 1|Alternative therapy|1
7646529|NCT00098475|12060582|FG003|Step 1|Alternative therapy|0
7646530|NCT00098475|12060579|FG000|Step 1|Other disease|2
7646531|NCT00098475|12060580|FG001|Step 1|Other disease|1
7646532|NCT00098475|12060581|FG002|Step 1|Other disease|1
7646533|NCT00098475|12060582|FG003|Step 1|Other disease|0
7646534|NCT00098475|12060579|FG000|Step 1|Never started treatment|0
7646535|NCT00098475|12060580|FG001|Step 1|Never started treatment|2
7646536|NCT00098475|12060581|FG002|Step 1|Never started treatment|0
7646537|NCT00098475|12060582|FG003|Step 1|Never started treatment|0
7646538|NCT00098475|12060579|FG000|Step 1|Still on treatment as of this analysis|14
7646539|NCT00098475|12060580|FG001|Step 1|Still on treatment as of this analysis|27
7646540|NCT00098475|12060581|FG002|Step 1|Still on treatment as of this analysis|0
7646541|NCT00098475|12060582|FG003|Step 1|Still on treatment as of this analysis|0
7646542|NCT00098475|12060579|FG000|Step 1|Knee surgery|1
7646543|NCT00098475|12060580|FG001|Step 1|Knee surgery|0
7646544|NCT00098475|12060581|FG002|Step 1|Knee surgery|0
7646545|NCT00098475|12060582|FG003|Step 1|Knee surgery|0
7646546|NCT00098475|12060579|FG000|Step 1|Complications|1
7646547|NCT00098475|12060580|FG001|Step 1|Complications|0
7646548|NCT00098475|12060581|FG002|Step 1|Complications|0
7646549|NCT00098475|12060582|FG003|Step 1|Complications|0
7646550|NCT00098475|12060579|FG000|Step 1|Cannot comply due to other tx|0
7646551|NCT00098475|12060580|FG001|Step 1|Cannot comply due to other tx|1
7646552|NCT00098475|12060581|FG002|Step 1|Cannot comply due to other tx|0
7646553|NCT00098475|12060582|FG003|Step 1|Cannot comply due to other tx|0
7646554|NCT00098475|12060579|FG000|Step 1|Both patient and physician's decision|2
7646555|NCT00098475|12060580|FG001|Step 1|Both patient and physician's decision|1
7646556|NCT00098475|12060581|FG002|Step 1|Both patient and physician's decision|0
7646557|NCT00098475|12060582|FG003|Step 1|Both patient and physician's decision|0
7646558|NCT00098475|12060579|FG000|Step 1|Incorrect disease assessment|2
7646559|NCT00098475|12060580|FG001|Step 1|Incorrect disease assessment|0
7646560|NCT00098475|12060581|FG002|Step 1|Incorrect disease assessment|0
7646561|NCT00098475|12060582|FG003|Step 1|Incorrect disease assessment|0
7646562|NCT00098475|12060579|FG000|Step 1|Off treatment for > specified timeframe|1
7646563|NCT00098475|12060580|FG001|Step 1|Off treatment for > specified timeframe|1
7646564|NCT00098475|12060581|FG002|Step 1|Off treatment for > specified timeframe|0
7646565|NCT00098475|12060582|FG003|Step 1|Off treatment for > specified timeframe|0
7646566|NCT00098475|12060579|FG000|Step 1|Declining performance status|0
7646567|NCT00098475|12060580|FG001|Step 1|Declining performance status|1
7646568|NCT00098475|12060581|FG002|Step 1|Declining performance status|0
7646569|NCT00098475|12060582|FG003|Step 1|Declining performance status|0
7646570|NCT00098475|12060579|FG000|Step 1|Insurance issue|0
7646571|NCT00098475|12060580|FG001|Step 1|Insurance issue|1
7646572|NCT00098475|12060581|FG002|Step 1|Insurance issue|0
7646573|NCT00098475|12060582|FG003|Step 1|Insurance issue|0
7646574|NCT00098475|12060579|FG000|Step 1|Rising paraprotein|0
7646575|NCT00098475|12060580|FG001|Step 1|Rising paraprotein|1
7646576|NCT00098475|12060581|FG002|Step 1|Rising paraprotein|0
7646577|NCT00098475|12060582|FG003|Step 1|Rising paraprotein|0
7646578|NCT00098475|12060579|FG000|Step 1|Referred to other physicians|0
7646579|NCT00098475|12060580|FG001|Step 1|Referred to other physicians|1
7646580|NCT00098475|12060581|FG002|Step 1|Referred to other physicians|0
7646581|NCT00098475|12060582|FG003|Step 1|Referred to other physicians|0
7646582|NCT00098475|12060579|FG000|Step 1|Criteria to continue treatment not met|0
7646583|NCT00098475|12060580|FG001|Step 1|Criteria to continue treatment not met|1
7646584|NCT00098475|12060581|FG002|Step 1|Criteria to continue treatment not met|0
7646585|NCT00098475|12060582|FG003|Step 1|Criteria to continue treatment not met|0
7646586|NCT00098475|12060579|FG000|Step 1|Misinterpretation of lab data|0
7646587|NCT00098475|12060580|FG001|Step 1|Misinterpretation of lab data|1
7646588|NCT00098475|12060581|FG002|Step 1|Misinterpretation of lab data|0
7646589|NCT00098475|12060582|FG003|Step 1|Misinterpretation of lab data|0
7646590|NCT00098475|12060579|FG000|Step 1|Patient fell with fracture|1
7646591|NCT00098475|12060580|FG001|Step 1|Patient fell with fracture|0
7646592|NCT00098475|12060581|FG002|Step 1|Patient fell with fracture|0
7646593|NCT00098475|12060582|FG003|Step 1|Patient fell with fracture|0
7646594|NCT00098475|12060579|FG000|Step 1|Not documented|0
7646595|NCT00098475|12060580|FG001|Step 1|Not documented|1
7646596|NCT00098475|12060581|FG002|Step 1|Not documented|0
7646597|NCT00098475|12060582|FG003|Step 1|Not documented|0
7646598|NCT00098475|12060579|FG000|Step 2|Disease progression|1
7646599|NCT00098475|12060580|FG001|Step 2|Disease progression|4
7646600|NCT00098475|12060581|FG002|Step 2|Disease progression|0
7646601|NCT00098475|12060582|FG003|Step 2|Disease progression|0
7646602|NCT00098475|12060579|FG000|Step 2|Adverse Event|2
7646603|NCT00098475|12060580|FG001|Step 2|Adverse Event|0
7646604|NCT00098475|12060581|FG002|Step 2|Adverse Event|0
7646605|NCT00098475|12060582|FG003|Step 2|Adverse Event|0
7646606|NCT00098475|12060579|FG000|Step 2|Withdrawal by Subject|0
7646607|NCT00098475|12060580|FG001|Step 2|Withdrawal by Subject|2
7646608|NCT00098475|12060581|FG002|Step 2|Withdrawal by Subject|0
7646609|NCT00098475|12060582|FG003|Step 2|Withdrawal by Subject|0
7646610|NCT00098475|12060579|FG000|Step 2|Physician Decision|0
7646611|NCT00098475|12060580|FG001|Step 2|Physician Decision|1
7646612|NCT00098475|12060581|FG002|Step 2|Physician Decision|0
7646613|NCT00098475|12060582|FG003|Step 2|Physician Decision|0
7646614|NCT00098475|12060579|FG000|Step 2|Alternative therapy|1
7646615|NCT00098475|12060580|FG001|Step 2|Alternative therapy|2
7646616|NCT00098475|12060581|FG002|Step 2|Alternative therapy|0
7646617|NCT00098475|12060582|FG003|Step 2|Alternative therapy|0
7646618|NCT00098475|12060579|FG000|Step 2|Never started treatment|1
7646619|NCT00098475|12060580|FG001|Step 2|Never started treatment|1
7646620|NCT00098475|12060581|FG002|Step 2|Never started treatment|0
7646621|NCT00098475|12060582|FG003|Step 2|Never started treatment|0
7646622|NCT00093015|12060594|FG000|Overall Study|Withdrawal by Subject|194
7646623|NCT00093015|12060595|FG001|Overall Study|Withdrawal by Subject|171
7646624|NCT00093015|12060594|FG000|Overall Study|Lost to Follow-up|96
7646625|NCT00093015|12060595|FG001|Overall Study|Lost to Follow-up|108
7646626|NCT00093015|12060594|FG000|Overall Study|Death|375
7646627|NCT00093015|12060595|FG001|Overall Study|Death|385
7646628|NCT00092534|12060603|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5
7646629|NCT00092534|12060604|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5
7646630|NCT00092534|12060605|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0
7646631|NCT00092534|12060606|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0
7646632|NCT00092534|12060607|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0
7646633|NCT00092534|12060603|FG000|Base Study Vaccination Period|Adverse Event|3
7646634|NCT00092534|12060604|FG001|Base Study Vaccination Period|Adverse Event|1
7646635|NCT00092534|12060605|FG002|Base Study Vaccination Period|Adverse Event|0
7646636|NCT00092534|12060606|FG003|Base Study Vaccination Period|Adverse Event|0
7646637|NCT00092534|12060607|FG004|Base Study Vaccination Period|Adverse Event|0
7646638|NCT00092534|12060603|FG000|Base Study Vaccination Period|Death|5
7646639|NCT00092534|12060604|FG001|Base Study Vaccination Period|Death|4
7646640|NCT00092534|12060605|FG002|Base Study Vaccination Period|Death|0
7646641|NCT00092534|12060606|FG003|Base Study Vaccination Period|Death|0
7646642|NCT00092534|12060607|FG004|Base Study Vaccination Period|Death|0
7646643|NCT00092534|12060603|FG000|Base Study Vaccination Period|Lost to Follow-up|41
7646644|NCT00092534|12060604|FG001|Base Study Vaccination Period|Lost to Follow-up|37
7646645|NCT00092534|12060605|FG002|Base Study Vaccination Period|Lost to Follow-up|0
7646646|NCT00092534|12060606|FG003|Base Study Vaccination Period|Lost to Follow-up|0
7646647|NCT00092534|12060607|FG004|Base Study Vaccination Period|Lost to Follow-up|0
7646648|NCT00092534|12060603|FG000|Base Study Vaccination Period|Physician Decision|1
7646649|NCT00092534|12060604|FG001|Base Study Vaccination Period|Physician Decision|0
7646650|NCT00092534|12060605|FG002|Base Study Vaccination Period|Physician Decision|0
7646651|NCT00092534|12060606|FG003|Base Study Vaccination Period|Physician Decision|0
7646652|NCT00092534|12060607|FG004|Base Study Vaccination Period|Physician Decision|0
7646653|NCT00092534|12060603|FG000|Base Study Vaccination Period|Pregnancy|9
7646654|NCT00092534|12060604|FG001|Base Study Vaccination Period|Pregnancy|7
7646655|NCT00092534|12060605|FG002|Base Study Vaccination Period|Pregnancy|0
7646656|NCT00092534|12060606|FG003|Base Study Vaccination Period|Pregnancy|0
7646657|NCT00092534|12060607|FG004|Base Study Vaccination Period|Pregnancy|0
7646658|NCT00092534|12060603|FG000|Base Study Vaccination Period|Protocol Violation|2
7646659|NCT00092534|12060604|FG001|Base Study Vaccination Period|Protocol Violation|1
7646660|NCT00092534|12060605|FG002|Base Study Vaccination Period|Protocol Violation|0
7646661|NCT00092534|12060606|FG003|Base Study Vaccination Period|Protocol Violation|0
7646662|NCT00092534|12060607|FG004|Base Study Vaccination Period|Protocol Violation|0
7646663|NCT00092534|12060603|FG000|Base Study Vaccination Period|Withdrawal by Subject|85
7646664|NCT00092534|12060604|FG001|Base Study Vaccination Period|Withdrawal by Subject|58
7646665|NCT00092534|12060605|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
7646666|NCT00092534|12060606|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
7646667|NCT00092534|12060607|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
7646668|NCT00092534|12060603|FG000|Base Study Vaccination Period|Moved|14
7646669|NCT00092534|12060604|FG001|Base Study Vaccination Period|Moved|12
7646670|NCT00092534|12060605|FG002|Base Study Vaccination Period|Moved|0
7646671|NCT00092534|12060606|FG003|Base Study Vaccination Period|Moved|0
7646672|NCT00092534|12060607|FG004|Base Study Vaccination Period|Moved|0
7646673|NCT00092534|12060603|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5
7646674|NCT00092534|12060604|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0
7646675|NCT00092534|12060605|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0
7646676|NCT00092534|12060606|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0
7646677|NCT00092534|12060607|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0
7646678|NCT00092534|12060603|FG000|Base Study Vaccination Period|Travel|1
7646679|NCT00092534|12060604|FG001|Base Study Vaccination Period|Travel|0
7646680|NCT00092534|12060605|FG002|Base Study Vaccination Period|Travel|0
7646681|NCT00092534|12060606|FG003|Base Study Vaccination Period|Travel|0
7646682|NCT00092534|12060607|FG004|Base Study Vaccination Period|Travel|0
7646683|NCT00092534|12060603|FG000|Base Study Vaccination Period|Site Closed|0
7646684|NCT00092534|12060604|FG001|Base Study Vaccination Period|Site Closed|1
7646685|NCT00092534|12060605|FG002|Base Study Vaccination Period|Site Closed|0
7646686|NCT00092534|12060606|FG003|Base Study Vaccination Period|Site Closed|0
7646687|NCT00092534|12060607|FG004|Base Study Vaccination Period|Site Closed|0
7646688|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Adverse Event|2
7646689|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Adverse Event|4
7646690|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Adverse Event|0
7646691|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Adverse Event|0
7646692|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Adverse Event|0
7646693|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Death|2
7646694|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Death|1
7646695|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Death|0
7646696|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Death|0
7646697|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Death|0
7646698|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Lost to Follow-up|120
7646699|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Lost to Follow-up|146
7646700|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Lost to Follow-up|0
7646701|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Lost to Follow-up|0
7646702|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Lost to Follow-up|0
7646703|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Pregnancy|6
7646704|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Pregnancy|10
7646705|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Pregnancy|0
7646706|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Pregnancy|0
7646707|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Pregnancy|0
7646708|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Protocol Violation|1
7646709|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Protocol Violation|2
7646710|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Protocol Violation|0
7646711|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Protocol Violation|0
7646712|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Protocol Violation|0
7646713|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71
7646714|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62
7646715|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0
7646716|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0
7646717|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0
7646718|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Moved|62
7646719|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Moved|58
7646720|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Moved|0
7646721|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Moved|0
7646722|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Moved|0
7646723|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Travel|10
7646724|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Travel|7
7646725|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Travel|0
7646726|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Travel|0
7646727|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Travel|0
7646728|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Site Closed|0
7646729|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Site Closed|2
7646730|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Site Closed|0
7646731|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Site Closed|0
7646732|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Site Closed|0
7646733|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Subjects continuing|27
7646734|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Subjects continuing|31
7646735|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Subjects continuing|0
7646736|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Subjects continuing|0
7646737|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Subjects continuing|0
7646738|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Subjects in extension|15
7646739|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Subjects in extension|371
7646740|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Subjects in extension|0
7646741|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Subjects in extension|0
7646742|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Subjects in extension|0
7646743|NCT00092534|12060603|FG000|Base Study EXT|Lost to Follow-up|0
7646744|NCT00092534|12060604|FG001|Base Study EXT|Lost to Follow-up|0
7646745|NCT00092534|12060605|FG002|Base Study EXT|Lost to Follow-up|41
7646746|NCT00092534|12060606|FG003|Base Study EXT|Lost to Follow-up|0
7646747|NCT00092534|12060607|FG004|Base Study EXT|Lost to Follow-up|0
7646748|NCT00092534|12060603|FG000|Base Study EXT|Physician Decision|0
7646749|NCT00092534|12060604|FG001|Base Study EXT|Physician Decision|0
7646750|NCT00092534|12060605|FG002|Base Study EXT|Physician Decision|1
7646751|NCT00092534|12060606|FG003|Base Study EXT|Physician Decision|0
7646752|NCT00092534|12060607|FG004|Base Study EXT|Physician Decision|0
7646753|NCT00092534|12060603|FG000|Base Study EXT|Pregnancy|0
7646754|NCT00092534|12060604|FG001|Base Study EXT|Pregnancy|0
7646755|NCT00092534|12060605|FG002|Base Study EXT|Pregnancy|12
7646756|NCT00092534|12060606|FG003|Base Study EXT|Pregnancy|0
7646757|NCT00092534|12060607|FG004|Base Study EXT|Pregnancy|0
7646758|NCT00092534|12060603|FG000|Base Study EXT|Withdrawal by Subject|0
7646759|NCT00092534|12060604|FG001|Base Study EXT|Withdrawal by Subject|0
7646760|NCT00092534|12060605|FG002|Base Study EXT|Withdrawal by Subject|18
7646761|NCT00092534|12060606|FG003|Base Study EXT|Withdrawal by Subject|0
7646762|NCT00092534|12060607|FG004|Base Study EXT|Withdrawal by Subject|0
7646763|NCT00092534|12060603|FG000|Base Study EXT|Participant moved|0
7646764|NCT00092534|12060604|FG001|Base Study EXT|Participant moved|0
7646765|NCT00092534|12060605|FG002|Base Study EXT|Participant moved|6
7646766|NCT00092534|12060606|FG003|Base Study EXT|Participant moved|0
7646767|NCT00092534|12060607|FG004|Base Study EXT|Participant moved|0
7646768|NCT00092534|12060603|FG000|Base Study EXT|Travel|0
7646769|NCT00092534|12060604|FG001|Base Study EXT|Travel|0
7646770|NCT00092534|12060605|FG002|Base Study EXT|Travel|2
7646771|NCT00092534|12060606|FG003|Base Study EXT|Travel|0
7646772|NCT00092534|12060607|FG004|Base Study EXT|Travel|0
7646773|NCT00092534|12060603|FG000|Base Study EXT|Site closed|0
7646774|NCT00092534|12060604|FG001|Base Study EXT|Site closed|0
7646775|NCT00092534|12060605|FG002|Base Study EXT|Site closed|21
7646776|NCT00092534|12060606|FG003|Base Study EXT|Site closed|0
7646777|NCT00092534|12060607|FG004|Base Study EXT|Site closed|0
7646778|NCT00092534|12060603|FG000|Base Study EXT|Study ended|0
7646779|NCT00092534|12060604|FG001|Base Study EXT|Study ended|0
7646780|NCT00092534|12060605|FG002|Base Study EXT|Study ended|29
7646781|NCT00092534|12060606|FG003|Base Study EXT|Study ended|0
7646782|NCT00092534|12060607|FG004|Base Study EXT|Study ended|0
7646783|NCT00092534|12060603|FG000|Base Study EXT|Protocol Violation|0
7646784|NCT00092534|12060604|FG001|Base Study EXT|Protocol Violation|0
7646785|NCT00092534|12060605|FG002|Base Study EXT|Protocol Violation|15
7646786|NCT00092534|12060606|FG003|Base Study EXT|Protocol Violation|0
7646787|NCT00092534|12060607|FG004|Base Study EXT|Protocol Violation|0
7646788|NCT00092534|12060603|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
7646789|NCT00092534|12060604|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
7646790|NCT00092534|12060605|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
7646791|NCT00092534|12060606|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1
7646792|NCT00092534|12060607|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
7646793|NCT00089791|12060619|FG000|Overall Study|Physician Decision|6
7646794|NCT00089791|12060620|FG001|Overall Study|Physician Decision|3
7646795|NCT00089791|12060619|FG000|Overall Study|Adverse Event|81
7646796|NCT00089791|12060620|FG001|Overall Study|Adverse Event|93
7646797|NCT00089791|12060619|FG000|Overall Study|Withdrawal by Subject|403
7646798|NCT00089791|12060620|FG001|Overall Study|Withdrawal by Subject|344
7646799|NCT00089791|12060619|FG000|Overall Study|Death|78
7646800|NCT00089791|12060620|FG001|Overall Study|Death|62
7646801|NCT00089791|12060619|FG000|Overall Study|Disease progression|7
7646802|NCT00089791|12060620|FG001|Overall Study|Disease progression|3
7646803|NCT00089791|12060619|FG000|Overall Study|Ineligibility determined|12
7646804|NCT00089791|12060620|FG001|Overall Study|Ineligibility determined|9
7646805|NCT00089791|12060619|FG000|Overall Study|Lost to Follow-up|57
7646806|NCT00089791|12060620|FG001|Overall Study|Lost to Follow-up|57
7646807|NCT00089791|12060619|FG000|Overall Study|Noncompliance|17
7646808|NCT00089791|12060620|FG001|Overall Study|Noncompliance|13
7646809|NCT00089791|12060619|FG000|Overall Study|Other|20
7646810|NCT00089791|12060620|FG001|Overall Study|Other|32
7646811|NCT00089791|12060619|FG000|Overall Study|Protocol deviation|12
7646812|NCT00089791|12060620|FG001|Overall Study|Protocol deviation|10
7646813|NCT00089791|12060619|FG000|Overall Study|Requirement for alternative therapy|7
7646814|NCT00089791|12060620|FG001|Overall Study|Requirement for alternative therapy|4
7646815|NCT00087178|12060628|FG000|Overall Study|No follow up data|5
7646816|NCT00087178|12060629|FG001|Overall Study|No follow up data|15
7646817|NCT00087178|12060628|FG000|Overall Study|No clinical assessment|1
7646818|NCT00087178|12060629|FG001|Overall Study|No clinical assessment|2
7646819|NCT00087178|12060628|FG000|Overall Study|Patient not at risk for primary endpoint|0
7646820|NCT00087178|12060629|FG001|Overall Study|Patient not at risk for primary endpoint|1
7646821|NCT00074412|12060637|FG000|Overall Study|Death|30
7646822|NCT00074412|12060638|FG001|Overall Study|Death|26
7646823|NCT00074412|12060637|FG000|Overall Study|Lost to Follow-up|52
7646824|NCT00074412|12060638|FG001|Overall Study|Lost to Follow-up|58
7646825|NCT00070499|12060649|FG000|Overall Study|Adverse Event|6
7646826|NCT00070499|12060650|FG001|Overall Study|Adverse Event|6
7646827|NCT00070499|12060651|FG002|Overall Study|Adverse Event|19
7646828|NCT00070499|12060652|FG003|Overall Study|Adverse Event|15
7646829|NCT00070499|12060649|FG000|Overall Study|Refusal unrelated to adverse effects|7
7646830|NCT00070499|12060650|FG001|Overall Study|Refusal unrelated to adverse effects|5
7646831|NCT00070499|12060651|FG002|Overall Study|Refusal unrelated to adverse effects|5
7646832|NCT00070499|12060652|FG003|Overall Study|Refusal unrelated to adverse effects|8
7646833|NCT00070499|12060649|FG000|Overall Study|Progression/relapse|4
7646834|NCT00070499|12060650|FG001|Overall Study|Progression/relapse|2
7646835|NCT00070499|12060651|FG002|Overall Study|Progression/relapse|1
7646836|NCT00070499|12060652|FG003|Overall Study|Progression/relapse|4
7646837|NCT00070499|12060649|FG000|Overall Study|Death|1
7646838|NCT00070499|12060650|FG001|Overall Study|Death|1
7646839|NCT00070499|12060651|FG002|Overall Study|Death|1
7646840|NCT00070499|12060652|FG003|Overall Study|Death|2
7646841|NCT00070499|12060649|FG000|Overall Study|Other - not protocol specified|7
7646842|NCT00070499|12060650|FG001|Overall Study|Other - not protocol specified|3
7646843|NCT00070499|12060651|FG002|Overall Study|Other - not protocol specified|12
7646844|NCT00070499|12060652|FG003|Overall Study|Other - not protocol specified|20
7646845|NCT00070499|12060649|FG000|Overall Study|Still on protocol treatment|10
7646846|NCT00070499|12060650|FG001|Overall Study|Still on protocol treatment|4
7646847|NCT00070499|12060651|FG002|Overall Study|Still on protocol treatment|79
7646848|NCT00070499|12060652|FG003|Overall Study|Still on protocol treatment|57
7646849|NCT00070499|12060649|FG000|Overall Study|Did not start treatment|1
7646850|NCT00070499|12060650|FG001|Overall Study|Did not start treatment|0
7646851|NCT00070499|12060651|FG002|Overall Study|Did not start treatment|0
7646852|NCT00070499|12060652|FG003|Overall Study|Did not start treatment|2
7646853|NCT00070499|12060649|FG000|Overall Study|Not eligible|2
7646854|NCT00070499|12060650|FG001|Overall Study|Not eligible|5
7646855|NCT00070499|12060651|FG002|Overall Study|Not eligible|3
7646856|NCT00070499|12060652|FG003|Overall Study|Not eligible|2
7646857|NCT00026312|12060672|FG000|Overall Study|Adverse Event|0
7646858|NCT00026312|12060673|FG001|Overall Study|Adverse Event|32
7646859|NCT00026312|12060672|FG000|Overall Study|Death|1
7646860|NCT00026312|12060673|FG001|Overall Study|Death|7
7646861|NCT00026312|12060672|FG000|Overall Study|Lack of Efficacy|19
7646862|NCT00026312|12060673|FG001|Overall Study|Lack of Efficacy|114
7646863|NCT00026312|12060672|FG000|Overall Study|Lost to Follow-up|0
7646864|NCT00026312|12060673|FG001|Overall Study|Lost to Follow-up|5
7646865|NCT00026312|12060672|FG000|Overall Study|Physician Decision|1
7646866|NCT00026312|12060673|FG001|Overall Study|Physician Decision|37
7646867|NCT00026312|12060672|FG000|Overall Study|Protocol Violation|0
7646868|NCT00026312|12060673|FG001|Overall Study|Protocol Violation|3
7646869|NCT00026312|12060672|FG000|Overall Study|Withdrawal by Subject|1
7646870|NCT00026312|12060673|FG001|Overall Study|Withdrawal by Subject|6
7646871|NCT00026312|12060672|FG000|Overall Study|Ineligible|4
7646872|NCT00026312|12060673|FG001|Overall Study|Ineligible|5
7646873|NCT00026312|12060672|FG000|Overall Study|Entry onto another COG study|0
7646874|NCT00026312|12060673|FG001|Overall Study|Entry onto another COG study|1
7646875|NCT00026312|12060672|FG000|Overall Study|Refusal by patient/parent/guardian|8
7646876|NCT00026312|12060673|FG001|Overall Study|Refusal by patient/parent/guardian|59
7646877|NCT00006721|12060686|FG000|Overall Study|Adverse Event|0
7646878|NCT00006721|12060687|FG001|Overall Study|Adverse Event|4
7646879|NCT00006721|12060688|FG002|Overall Study|Adverse Event|4
7646880|NCT00006721|12060686|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
7646881|NCT00006721|12060687|FG001|Overall Study|Refusal Unrelated to Adverse Event|0
7646882|NCT00006721|12060688|FG002|Overall Study|Refusal Unrelated to Adverse Event|8
7646883|NCT00006721|12060686|FG000|Overall Study|Progression/Relapse|0
7646884|NCT00006721|12060687|FG001|Overall Study|Progression/Relapse|1
7646885|NCT00006721|12060688|FG002|Overall Study|Progression/Relapse|2
7646886|NCT00006721|12060686|FG000|Overall Study|Death|0
7646887|NCT00006721|12060687|FG001|Overall Study|Death|1
7646888|NCT00006721|12060688|FG002|Overall Study|Death|2
7646889|NCT00006721|12060686|FG000|Overall Study|Other - Not Protocol Specified|0
7646890|NCT00006721|12060687|FG001|Overall Study|Other - Not Protocol Specified|7
7646891|NCT00006721|12060688|FG002|Overall Study|Other - Not Protocol Specified|7
7646892|NCT00006721|12060686|FG000|Overall Study|Ineligible|2
7646893|NCT00006721|12060687|FG001|Overall Study|Ineligible|12
7646894|NCT00006721|12060688|FG002|Overall Study|Ineligible|10
7646895|NCT00006721|12060686|FG000|Overall Study|Eligible but no Treatment Received|1
7646896|NCT00006721|12060687|FG001|Overall Study|Eligible but no Treatment Received|0
7646897|NCT00006721|12060688|FG002|Overall Study|Eligible but no Treatment Received|0
7646898|NCT00006436|12060698|FG000|Overall Study|Refused further treatment|2
7646899|NCT00006436|12060698|FG000|Overall Study|Declined to participate (before treatment started)|1
7646900|NCT00002540|12060707|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0
7646901|NCT00002540|12060708|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25
7646902|NCT00002540|12060707|FG000|Overall Study|Died Before Randomization|2
7646903|NCT00002540|12060708|FG001|Overall Study|Died Before Randomization|6
7646904|NCT00002540|12060707|FG000|Overall Study|Died Before ASU (Control)|202
7646905|NCT00002540|12060708|FG001|Overall Study|Died Before ASU (Control)|0
7646906|NCT00002540|12060707|FG000|Overall Study|Refused ASU (Control)|597
7646907|NCT00002540|12060708|FG001|Overall Study|Refused ASU (Control)|0
7646908|NCT00002540|12060707|FG000|Overall Study|Refused Screen (Prostate Screening)|0
7646909|NCT00002540|12060708|FG001|Overall Study|Refused Screen (Prostate Screening)|2433
7646910|NCT04755595|12060743|FG000|Overall Study|Lost to Follow-up|1
7646911|NCT04749745|12060748|FG000|Overall Study|Withdrawal by Subject|1
7646912|NCT04749745|12060749|FG001|Overall Study|Withdrawal by Subject|0
7646913|NCT04748341|12060757|FG000|Overall Study|Lost to Follow-up|1
7646914|NCT04748341|12060758|FG001|Overall Study|Lost to Follow-up|1
7646915|NCT04737278|12060766|FG000|Overall Study|Lost to Follow-up|1
7646916|NCT04737278|12060767|FG001|Overall Study|Lost to Follow-up|1
7646917|NCT04737278|12060766|FG000|Overall Study|Withdrawal by Subject|1
7646918|NCT04737278|12060767|FG001|Overall Study|Withdrawal by Subject|0
7646919|NCT04737278|12060766|FG000|Overall Study|Protocol Violation|1
7646920|NCT04737278|12060767|FG001|Overall Study|Protocol Violation|1
7646921|NCT04737278|12060766|FG000|Overall Study|failure to complete questionnaire|1
7646922|NCT04737278|12060767|FG001|Overall Study|failure to complete questionnaire|1
7646923|NCT04334460|12060799|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4
7646924|NCT04334460|12060800|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1
7646925|NCT04334460|12060799|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4
7646926|NCT04334460|12060800|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1
7646927|NCT04247828|12060807|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9
7646928|NCT04084769|12060815|FG000|Overall Study|Protocol Violation|1
7646929|NCT04084769|12060816|FG001|Overall Study|Protocol Violation|3
7646930|NCT04084769|12060817|FG002|Overall Study|Protocol Violation|0
7646931|NCT04084769|12060818|FG003|Overall Study|Protocol Violation|1
7646932|NCT04084769|12060815|FG000|Overall Study|Withdrawal by Subject|0
7646933|NCT04084769|12060816|FG001|Overall Study|Withdrawal by Subject|1
7646934|NCT04084769|12060817|FG002|Overall Study|Withdrawal by Subject|0
7646935|NCT04084769|12060818|FG003|Overall Study|Withdrawal by Subject|0
7646936|NCT04084769|12060815|FG000|Overall Study|Withdrawal by parent/guardian|1
7646937|NCT04084769|12060816|FG001|Overall Study|Withdrawal by parent/guardian|0
7646938|NCT04084769|12060817|FG002|Overall Study|Withdrawal by parent/guardian|0
7646939|NCT04084769|12060818|FG003|Overall Study|Withdrawal by parent/guardian|1
7646940|NCT04084769|12060815|FG000|Overall Study|Lost to Follow-up|2
7646941|NCT04084769|12060816|FG001|Overall Study|Lost to Follow-up|0
7646942|NCT04084769|12060817|FG002|Overall Study|Lost to Follow-up|0
7646943|NCT04084769|12060818|FG003|Overall Study|Lost to Follow-up|0
7646944|NCT04024228|12060835|FG000|Overall Study|Adverse Event|1
7646945|NCT04024228|12060836|FG001|Overall Study|Adverse Event|0
7646946|NCT04024228|12060835|FG000|Overall Study|Protocol Deviation|0
7646947|NCT04024228|12060836|FG001|Overall Study|Protocol Deviation|2
7646948|NCT04024228|12060835|FG000|Overall Study|Withdrawal by Subject|3
7646949|NCT04024228|12060836|FG001|Overall Study|Withdrawal by Subject|4
7646950|NCT03980938|12060859|FG000|Treatment Period 1|Study Terminated|1
7646951|NCT03980938|12060860|FG001|Treatment Period 1|Study Terminated|1
7646952|NCT03980938|12060859|FG000|Treatment Period 2|Study Terminated|2
7646953|NCT03980938|12060860|FG001|Treatment Period 2|Study Terminated|2
7646954|NCT03863353|12060868|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24
7646955|NCT03863353|12060869|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20
7646956|NCT03333928|12060906|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0
7646957|NCT03333928|12060907|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0
7646958|NCT03333928|12060908|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1
7646959|NCT03333928|12060906|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0
7646960|NCT03333928|12060907|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1
7646961|NCT03333928|12060908|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1
7646962|NCT03333928|12060906|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1
7646963|NCT03333928|12060907|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0
7646964|NCT03333928|12060908|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1
7646965|NCT03333928|12060906|FG000|Initial Dosing Period (Period 1)|Adverse Event|0
7646966|NCT03333928|12060907|FG001|Initial Dosing Period (Period 1)|Adverse Event|3
7646967|NCT03333928|12060908|FG002|Initial Dosing Period (Period 1)|Adverse Event|1
7646968|NCT03333928|12060906|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2
7646969|NCT03333928|12060907|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1
7646970|NCT03333928|12060908|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0
7646971|NCT03333928|12060906|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1
7646972|NCT03333928|12060907|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0
7646973|NCT03333928|12060908|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0
7646974|NCT03333928|12060906|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1
7646975|NCT03333928|12060907|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0
7646976|NCT03333928|12060908|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0
7646977|NCT03333928|12060906|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1
7646978|NCT03333928|12060907|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0
7646979|NCT03333928|12060908|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1
7646980|NCT03298984|12060928|FG000|Overall Study|Physician Decision|1
7646981|NCT03298984|12060929|FG001|Overall Study|Physician Decision|0
7646982|NCT03298984|12060930|FG002|Overall Study|Physician Decision|0
7646983|NCT03298984|12060931|FG003|Overall Study|Physician Decision|6
7646984|NCT03298984|12060928|FG000|Overall Study|Lack of Efficacy|0
7646985|NCT03298984|12060929|FG001|Overall Study|Lack of Efficacy|1
7646986|NCT03298984|12060930|FG002|Overall Study|Lack of Efficacy|1
7646987|NCT03298984|12060931|FG003|Overall Study|Lack of Efficacy|4
7646988|NCT03298984|12060928|FG000|Overall Study|Relapsed disease (following remission)|0
7646989|NCT03298984|12060929|FG001|Overall Study|Relapsed disease (following remission)|0
7646990|NCT03298984|12060930|FG002|Overall Study|Relapsed disease (following remission)|1
7646991|NCT03298984|12060931|FG003|Overall Study|Relapsed disease (following remission)|1
7646992|NCT03298984|12060928|FG000|Overall Study|Adverse Event|0
7646993|NCT03298984|12060929|FG001|Overall Study|Adverse Event|0
7646994|NCT03298984|12060930|FG002|Overall Study|Adverse Event|0
7646995|NCT03298984|12060931|FG003|Overall Study|Adverse Event|1
7646996|NCT03298984|12060928|FG000|Overall Study|Death|0
7646997|NCT03298984|12060929|FG001|Overall Study|Death|0
7646998|NCT03298984|12060930|FG002|Overall Study|Death|0
7646999|NCT03298984|12060931|FG003|Overall Study|Death|2
7647000|NCT03298984|12060928|FG000|Overall Study|Insurance Company Decision|0
7647001|NCT03298984|12060929|FG001|Overall Study|Insurance Company Decision|0
7647002|NCT03298984|12060930|FG002|Overall Study|Insurance Company Decision|0
7647003|NCT03298984|12060931|FG003|Overall Study|Insurance Company Decision|1
7647004|NCT03175198|12060942|FG000|Overall Study|Adverse Event|480
7647005|NCT03175198|12060942|FG000|Overall Study|No actual visit|120
7647006|NCT03175198|12060942|FG000|Overall Study|Registration rule not followed|4
7647007|NCT03175198|12060942|FG000|Overall Study|Patients received Prazaxa treatment before|5
7647008|NCT03175198|12060942|FG000|Overall Study|Other personal reason|509
7647009|NCT03175198|12060942|FG000|Overall Study|To take a contraindication/careful administration drug|8
7647010|NCT03175198|12060942|FG000|Overall Study|Lost to follow-up (changing hospital)|373
7647011|NCT03175198|12060942|FG000|Overall Study|Lost to follow-up (unknown reason)|146
7647012|NCT03175198|12060942|FG000|Overall Study|To conduct invasive treatment of operation|53
7647013|NCT03175198|12060942|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629
7647014|NCT03158727|12060948|FG000|Overall Study|Withdrawal by Subject|2
7647015|NCT03158727|12060949|FG001|Overall Study|Withdrawal by Subject|6
7647016|NCT03158727|12060948|FG000|Overall Study|Death|11
7647017|NCT03158727|12060949|FG001|Overall Study|Death|12
7647018|NCT03158727|12060948|FG000|Overall Study|Lost to Follow-up|1
7647019|NCT03158727|12060949|FG001|Overall Study|Lost to Follow-up|0
7647020|NCT03158727|12060948|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2
7647021|NCT03158727|12060949|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0
7647022|NCT03158727|12060948|FG000|Overall Study|Visit 11 not done by mistake|0
7647023|NCT03158727|12060949|FG001|Overall Study|Visit 11 not done by mistake|1
7647024|NCT03158727|12060948|FG000|Overall Study|Enrolled, not treated|1
7647025|NCT03158727|12060949|FG001|Overall Study|Enrolled, not treated|0
7647026|NCT03075826|12060955|FG000|Overall Study|Withdrawal by Subject|1
7647027|NCT03075826|12060955|FG000|Overall Study|Received less than 3 cycles of study drug|5
7647028|NCT02993731|12060961|FG000|Overall Study|Study Termination|101
7647029|NCT02993731|12060962|FG001|Overall Study|Study Termination|105
7647030|NCT02520011|12060989|FG000|Overall Study|Adverse Event|0
7647031|NCT02520011|12060990|FG001|Overall Study|Adverse Event|1
7647032|NCT02520011|12060991|FG002|Overall Study|Adverse Event|2
7647033|NCT02520011|12060989|FG000|Overall Study|Death|0
7647034|NCT02520011|12060990|FG001|Overall Study|Death|8
7647035|NCT02520011|12060991|FG002|Overall Study|Death|1
7647036|NCT02520011|12060989|FG000|Overall Study|Lack of Efficacy|4
7647037|NCT02520011|12060990|FG001|Overall Study|Lack of Efficacy|26
7647038|NCT02520011|12060991|FG002|Overall Study|Lack of Efficacy|4
7647039|NCT02520011|12060989|FG000|Overall Study|Physician Decision|0
7647040|NCT02520011|12060990|FG001|Overall Study|Physician Decision|2
7647041|NCT02520011|12060991|FG002|Overall Study|Physician Decision|0
7647042|NCT02520011|12060989|FG000|Overall Study|Withdrawal by Subject|1
7647043|NCT02520011|12060990|FG001|Overall Study|Withdrawal by Subject|3
7647044|NCT02520011|12060991|FG002|Overall Study|Withdrawal by Subject|0
7647045|NCT02520011|12060989|FG000|Overall Study|Protocol Deviation|0
7647046|NCT02520011|12060990|FG001|Overall Study|Protocol Deviation|1
7647047|NCT02520011|12060991|FG002|Overall Study|Protocol Deviation|0
7647048|NCT02520011|12060989|FG000|Overall Study|Patient went to hospice|0
7647049|NCT02520011|12060990|FG001|Overall Study|Patient went to hospice|1
7647050|NCT02520011|12060991|FG002|Overall Study|Patient went to hospice|0
7647051|NCT02520011|12060989|FG000|Overall Study|Progressive disease following response|0
7647052|NCT02520011|12060990|FG001|Overall Study|Progressive disease following response|4
7647053|NCT02520011|12060991|FG002|Overall Study|Progressive disease following response|2
7647054|NCT02279719|12061028|FG000|Overall Study|Patients randomized but never treated|0
7647055|NCT02279719|12061029|FG001|Overall Study|Patients randomized but never treated|0
7647056|NCT02279719|12061030|FG002|Overall Study|Patients randomized but never treated|0
7647057|NCT02279719|12061031|FG003|Overall Study|Patients randomized but never treated|0
7647058|NCT02279719|12061032|FG004|Overall Study|Patients randomized but never treated|3
7647059|NCT02279719|12061033|FG005|Overall Study|Patients randomized but never treated|0
7647310|NCT00879086|12061946|FG001|Overall Study|Participant choice|2
7647060|NCT02279719|12061034|FG006|Overall Study|Patients randomized but never treated|3
7647061|NCT02178956|12061069|FG000|Overall Study|Lost to Follow-up|4
7647062|NCT02178956|12061070|FG001|Overall Study|Lost to Follow-up|4
7647063|NCT02178956|12061069|FG000|Overall Study|Sponsor terminated study|49
7647064|NCT02178956|12061070|FG001|Overall Study|Sponsor terminated study|58
7647065|NCT02178956|12061069|FG000|Overall Study|Withdrawal by Subject|15
7647066|NCT02178956|12061070|FG001|Overall Study|Withdrawal by Subject|11
7647067|NCT02178956|12061069|FG000|Overall Study|Various Reasons|3
7647068|NCT02178956|12061070|FG001|Overall Study|Various Reasons|5
7647069|NCT02097420|12061080|FG000|Overall Study|Death|4
7647070|NCT02097420|12061080|FG000|Overall Study|Device explanted|3
7647071|NCT02097420|12061080|FG000|Overall Study|Not reached 12-month visit|7
7647072|NCT01925131|12061137|FG000|Overall Study|Death|0
7647073|NCT01925131|12061138|FG001|Overall Study|Death|0
7647074|NCT01925131|12061139|FG002|Overall Study|Death|1
7647075|NCT01925131|12061140|FG003|Overall Study|Death|0
7647076|NCT01925131|12061141|FG004|Overall Study|Death|0
7647077|NCT01925131|12061142|FG005|Overall Study|Death|0
7647078|NCT01925131|12061137|FG000|Overall Study|Progression/Relapse|1
7647079|NCT01925131|12061138|FG001|Overall Study|Progression/Relapse|1
7647080|NCT01925131|12061139|FG002|Overall Study|Progression/Relapse|4
7647081|NCT01925131|12061140|FG003|Overall Study|Progression/Relapse|0
7647082|NCT01925131|12061141|FG004|Overall Study|Progression/Relapse|0
7647083|NCT01925131|12061142|FG005|Overall Study|Progression/Relapse|1
7647084|NCT01925131|12061137|FG000|Overall Study|Patient Refusal|1
7647085|NCT01925131|12061138|FG001|Overall Study|Patient Refusal|0
7647086|NCT01925131|12061139|FG002|Overall Study|Patient Refusal|0
7647087|NCT01925131|12061140|FG003|Overall Study|Patient Refusal|0
7647088|NCT01925131|12061141|FG004|Overall Study|Patient Refusal|0
7647089|NCT01925131|12061142|FG005|Overall Study|Patient Refusal|0
7647090|NCT01925131|12061137|FG000|Overall Study|Adverse Event|0
7647091|NCT01925131|12061138|FG001|Overall Study|Adverse Event|0
7647092|NCT01925131|12061139|FG002|Overall Study|Adverse Event|2
7647093|NCT01925131|12061140|FG003|Overall Study|Adverse Event|0
7647094|NCT01925131|12061141|FG004|Overall Study|Adverse Event|1
7647095|NCT01925131|12061142|FG005|Overall Study|Adverse Event|3
7647096|NCT01925131|12061137|FG000|Overall Study|Other - Not Protocol Specified|3
7647097|NCT01925131|12061138|FG001|Overall Study|Other - Not Protocol Specified|1
7647098|NCT01925131|12061139|FG002|Overall Study|Other - Not Protocol Specified|2
7647099|NCT01925131|12061140|FG003|Overall Study|Other - Not Protocol Specified|5
7647100|NCT01925131|12061141|FG004|Overall Study|Other - Not Protocol Specified|10
7647101|NCT01925131|12061142|FG005|Overall Study|Other - Not Protocol Specified|6
7647102|NCT01776307|12061161|FG000|Overall Study|Not dosed|0
7647103|NCT01776307|12061162|FG001|Overall Study|Not dosed|0
7647104|NCT01776307|12061163|FG002|Overall Study|Not dosed|1
7647105|NCT01535274|12061207|FG000|Overall Study|Determined to be ineligible|0
7647106|NCT01535274|12061208|FG001|Overall Study|Determined to be ineligible|1
7647107|NCT01535274|12061207|FG000|Overall Study|Misallocated to propofol intervention|0
7647108|NCT01535274|12061208|FG001|Overall Study|Misallocated to propofol intervention|1
7647109|NCT00539981|12061222|FG000|Overall Study|Adverse events (AE)|3
7647110|NCT00539981|12061223|FG001|Overall Study|Adverse events (AE)|3
7647111|NCT00539981|12061222|FG000|Overall Study|Lost to Follow-up|260
7647112|NCT00539981|12061223|FG001|Overall Study|Lost to Follow-up|251
7647113|NCT00539981|12061222|FG000|Overall Study|Withdrew consent|22
7647114|NCT00539981|12061223|FG001|Overall Study|Withdrew consent|14
7647115|NCT00539981|12061222|FG000|Overall Study|Death|1
7647116|NCT00539981|12061223|FG001|Overall Study|Death|1
7647117|NCT00539981|12061222|FG000|Overall Study|Other reason-unspecified|9
7647118|NCT00539981|12061223|FG001|Overall Study|Other reason-unspecified|13
7647119|NCT04732338|12061243|FG000|Overall Study|Lost to Follow-up|3
7647120|NCT04732338|12061244|FG001|Overall Study|Lost to Follow-up|3
7647121|NCT04728802|12061252|FG000|Overall Study|Withdrawal by Subject|4
7647122|NCT04728802|12061253|FG001|Overall Study|Withdrawal by Subject|20
7647123|NCT04728802|12061252|FG000|Overall Study|Physician Decision|7
7647124|NCT04728802|12061253|FG001|Overall Study|Physician Decision|7
7647125|NCT04728802|12061252|FG000|Overall Study|Protocol Violation|10
7647126|NCT04728802|12061253|FG001|Overall Study|Protocol Violation|4
7647127|NCT04728802|12061252|FG000|Overall Study|Transfer|1
7647128|NCT04728802|12061253|FG001|Overall Study|Transfer|0
7647129|NCT04728802|12061252|FG000|Overall Study|Death|4
7647130|NCT04728802|12061253|FG001|Overall Study|Death|5
7647131|NCT04728802|12061252|FG000|Overall Study|Other|3
7647132|NCT04728802|12061253|FG001|Overall Study|Other|0
7647133|NCT04725500|12061274|FG000|Screening|Screen Failure|26
7647134|NCT04725500|12061274|FG000|Screening|Withdrawal by Subject|1
7647135|NCT04725500|12061274|FG000|2 Week Take Home|Screen Fail|5
7647136|NCT04716426|12061289|FG000|Overall Study|Vaccination|1
7647137|NCT04716426|12061290|FG001|Overall Study|Vaccination|1
7647138|NCT04716426|12061289|FG000|Overall Study|Contamination|1
7647139|NCT04716426|12061290|FG001|Overall Study|Contamination|0
7647140|NCT04698993|12061311|FG000|Overall Study|PCR results not accessible|2
7647141|NCT04698993|12061312|FG001|Overall Study|PCR results not accessible|7
7647142|NCT04698993|12061311|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1
7647143|NCT04698993|12061312|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0
7647144|NCT04674644|12061339|FG000|Overall Study|with missing data|37
7647145|NCT04668989|12061357|FG000|First Intervention|Covid-19 related self-isolation|0
7647146|NCT04668989|12061358|FG001|First Intervention|Covid-19 related self-isolation|1
7647147|NCT04668989|12061357|FG000|Second Intervention|Adverse Event|0
7647148|NCT04668989|12061358|FG001|Second Intervention|Adverse Event|1
7647149|NCT04646109|12061394|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0
7647150|NCT04646109|12061395|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6
7647151|NCT04633642|12061430|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1
7647152|NCT04633642|12061431|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2
7647153|NCT04615507|12061486|FG000|Period 1|Covid-19 exposure|2
7647154|NCT04615507|12061487|FG001|Period 1|Covid-19 exposure|1
7647155|NCT04615507|12061486|FG000|Period 2|Covid-19 exposure|0
7647156|NCT04615507|12061487|FG001|Period 2|Covid-19 exposure|1
7647157|NCT04615507|12061486|FG000|Period 2|Protocol Violation|1
7647158|NCT04615507|12061487|FG001|Period 2|Protocol Violation|0
7647159|NCT04615507|12061486|FG000|Period 2|Withdrawal by Subject|1
7647160|NCT04615507|12061487|FG001|Period 2|Withdrawal by Subject|0
7647161|NCT04615507|12061486|FG000|Period 2|Adverse Event|0
7647162|NCT04615507|12061487|FG001|Period 2|Adverse Event|1
7647163|NCT04615507|12061486|FG000|Period 3|Covid-19 exposure|0
7647164|NCT04615507|12061487|FG001|Period 3|Covid-19 exposure|1
7647165|NCT04608500|12061500|FG000|Overall Study|Adverse Event|2
7647166|NCT04608500|12061501|FG001|Overall Study|Adverse Event|0
7647167|NCT04608500|12061500|FG000|Overall Study|Lost to Follow-up|15
7647168|NCT04608500|12061501|FG001|Overall Study|Lost to Follow-up|9
7647169|NCT04608500|12061500|FG000|Overall Study|Participant request|11
7647170|NCT04608500|12061501|FG001|Overall Study|Participant request|7
7647171|NCT04608500|12061500|FG000|Overall Study|Protocol Violation|1
7647172|NCT04608500|12061501|FG001|Overall Study|Protocol Violation|0
7647173|NCT04608500|12061500|FG000|Overall Study|Other|6
7647174|NCT04608500|12061501|FG001|Overall Study|Other|2
7647175|NCT04605588|12061513|FG000|Overall Study|Withdrawal by Subject|1
7647176|NCT04605588|12061514|FG001|Overall Study|Withdrawal by Subject|0
7647177|NCT04590027|12061539|FG000|Overall Study|Lost to Follow-up|17
7647178|NCT04590027|12061540|FG001|Overall Study|Lost to Follow-up|14
7647179|NCT04590027|12061539|FG000|Overall Study|Protocol Violation|0
7647180|NCT04590027|12061540|FG001|Overall Study|Protocol Violation|3
7647181|NCT04578457|12061550|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2
7647182|NCT04578457|12061550|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2
7647183|NCT04578457|12061550|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2
7647184|NCT04578457|12061550|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2
7647185|NCT04577183|12061562|FG000|Overall Study|Death|1
7647186|NCT04577183|12061562|FG000|Overall Study|Withdrawal by Subject|3
7647187|NCT04577183|12061562|FG000|Overall Study|Early termination|2
7647188|NCT04574999|12061568|FG000|Overall Study|Adverse Event|1
7647189|NCT04574999|12061569|FG001|Overall Study|Adverse Event|0
7647190|NCT04574999|12061568|FG000|Overall Study|Lack of Efficacy|2
7647191|NCT04574999|12061569|FG001|Overall Study|Lack of Efficacy|3
7647192|NCT04574999|12061568|FG000|Overall Study|Protocol Violation|1
7647193|NCT04574999|12061569|FG001|Overall Study|Protocol Violation|0
7647194|NCT04574999|12061568|FG000|Overall Study|Withdrawal by Subject|2
7647195|NCT04574999|12061569|FG001|Overall Study|Withdrawal by Subject|2
7647196|NCT04574999|12061568|FG000|Overall Study|Lost to Follow-up|1
7647197|NCT04574999|12061569|FG001|Overall Study|Lost to Follow-up|0
7647198|NCT04574999|12061568|FG000|Overall Study|Personal problems|1
7647199|NCT04574999|12061569|FG001|Overall Study|Personal problems|0
7647200|NCT04574999|12061568|FG000|Overall Study|Previous planned surgery|1
7647201|NCT04574999|12061569|FG001|Overall Study|Previous planned surgery|0
7647202|NCT04572997|12061575|FG000|Overall Study|Adverse Event|1
7647203|NCT04542694|12061654|FG000|Overall Study|The need for prohibited therapy|2
7647204|NCT04542694|12061655|FG001|Overall Study|The need for prohibited therapy|0
7647205|NCT04542694|12061654|FG000|Overall Study|Adverse Event|1
7647206|NCT04542694|12061655|FG001|Overall Study|Adverse Event|0
7647207|NCT04542694|12061654|FG000|Overall Study|Protocol Violation|1
7647208|NCT04542694|12061655|FG001|Overall Study|Protocol Violation|0
7647209|NCT04534491|12061697|FG000|Overall Study|Not completed end-of-study interview|24
7647210|NCT04534491|12061697|FG000|Overall Study|Non-users|70
7647211|NCT04534491|12061697|FG000|Overall Study|Non-verifiable users|58
7647212|NCT04533204|12061719|FG000|Overall Study|Unable to understand training instructions|1
7647213|NCT04533204|12061720|FG001|Overall Study|Unable to understand training instructions|1
7647214|NCT04532164|12061726|FG000|Overall Study|Adverse Event|1
7647215|NCT04532164|12061726|FG000|Overall Study|Protocol Violation|5
7647216|NCT04532164|12061726|FG000|Overall Study|Lost to Follow-up|1
7647217|NCT04532164|12061726|FG000|Overall Study|Found to be Ineligible|3
7647218|NCT04532164|12061726|FG000|Overall Study|Withdrawal by Subject|14
7647219|NCT04531813|12061731|FG000|Overall Study|Protocol Violation|1
7647220|NCT04531813|12061731|FG000|Overall Study|Withdrawal by Subject|1
7647221|NCT04531527|12061735|FG000|Overall Study|Found to be Ineligible|3
7647222|NCT04531540|12061739|FG000|Overall Study|Adverse Event|1
7647223|NCT04531540|12061739|FG000|Overall Study|Protocol Violation|3
7647224|NCT04531540|12061739|FG000|Overall Study|Withdrawal by Subject|4
7647225|NCT04531540|12061739|FG000|Overall Study|Found to be Ineligible|1
7647226|NCT04093258|12061751|FG000|Period 2|Subject no longer meets the eligibility criteria|1
7647227|NCT04093258|12061752|FG001|Period 2|Subject no longer meets the eligibility criteria|0
7647311|NCT00879086|12061945|FG000|Overall Study|Progression of disease|40
7647228|NCT03993379|12061766|FG000|Overall Study|The study was terminated early due to business decision.|0
7647229|NCT03993379|12061767|FG001|Overall Study|The study was terminated early due to business decision.|2
7647230|NCT03993379|12061768|FG002|Overall Study|The study was terminated early due to business decision.|0
7647231|NCT03993379|12061769|FG003|Overall Study|The study was terminated early due to business decision.|0
7647232|NCT03993379|12061766|FG000|Overall Study|Withdrawal by Subject|0
7647233|NCT03993379|12061767|FG001|Overall Study|Withdrawal by Subject|1
7647234|NCT03993379|12061768|FG002|Overall Study|Withdrawal by Subject|0
7647235|NCT03993379|12061769|FG003|Overall Study|Withdrawal by Subject|0
7647236|NCT03956615|12061779|FG000|Overall Study|No multiple myeloma confirmed|2
7647237|NCT03956615|12061779|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1
7647238|NCT03956615|12061779|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2
7647239|NCT03956615|12061779|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2
7647240|NCT03803059|12061783|FG000|Overall Study|Protocol Violation|2
7647241|NCT03803059|12061783|FG000|Overall Study|Lost to Follow-up|1
7647242|NCT03723590|12061788|FG000|Overall Study|Withdrawal by Subject|3
7647243|NCT03430895|12061801|FG000|Overall Study|Not Treated|2
7647244|NCT03230838|12061824|FG000|Overall Study|Withdrawal by Subject|3
7647245|NCT03230838|12061825|FG001|Overall Study|Withdrawal by Subject|0
7647246|NCT03230838|12061824|FG000|Overall Study|Temperature excursion|1
7647247|NCT03230838|12061825|FG001|Overall Study|Temperature excursion|0
7647248|NCT03183778|12061831|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1
7647249|NCT02700698|12061857|FG000|Overall Study|Withdrawal by Subject|1
7647250|NCT02700698|12061858|FG001|Overall Study|Withdrawal by Subject|0
7647251|NCT02698865|12061875|FG000|Overall Study|Other|11
7647252|NCT02698865|12061876|FG001|Overall Study|Other|11
7647253|NCT02698865|12061875|FG000|Overall Study|Withdrawal by Subject|20
7647254|NCT02698865|12061876|FG001|Overall Study|Withdrawal by Subject|16
7647255|NCT02698865|12061875|FG000|Overall Study|Physician Decision|0
7647256|NCT02698865|12061876|FG001|Overall Study|Physician Decision|4
7647257|NCT02698865|12061875|FG000|Overall Study|Lost to Follow-up|4
7647258|NCT02698865|12061876|FG001|Overall Study|Lost to Follow-up|2
7647259|NCT02660086|12061884|FG000|Overall Study- 12-month|Withdrawal by Subject|5
7647260|NCT02660086|12061885|FG001|Overall Study- 12-month|Withdrawal by Subject|5
7647261|NCT02660086|12061884|FG000|Overall Study- 12-month|Left full-time employment|12
7647262|NCT02660086|12061885|FG001|Overall Study- 12-month|Left full-time employment|20
7647263|NCT02660086|12061884|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8
7647264|NCT02660086|12061885|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4
7647265|NCT02660086|12061884|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1
7647266|NCT02660086|12061885|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0
7647267|NCT02660086|12061884|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17
7647268|NCT02660086|12061885|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8
7647269|NCT02660086|12061884|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9
7647270|NCT02660086|12061885|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16
7647271|NCT02129647|12061895|FG000|Overall Study|Adverse Event|2
7647272|NCT02129647|12061895|FG000|Overall Study|surgical intervention for clinically progressive disease|1
7647273|NCT01959139|12061907|FG000|Phase II|Disease progression|0
7647274|NCT01959139|12061908|FG001|Phase II|Disease progression|0
7647275|NCT01959139|12061909|FG002|Phase II|Disease progression|26
7647276|NCT01959139|12061910|FG003|Phase II|Disease progression|34
7647277|NCT01959139|12061907|FG000|Phase II|Adverse Event|0
7647278|NCT01959139|12061908|FG001|Phase II|Adverse Event|0
7647279|NCT01959139|12061909|FG002|Phase II|Adverse Event|10
7647280|NCT01959139|12061910|FG003|Phase II|Adverse Event|11
7647281|NCT01959139|12061907|FG000|Phase II|Patient Refusal|0
7647282|NCT01959139|12061908|FG001|Phase II|Patient Refusal|0
7647283|NCT01959139|12061909|FG002|Phase II|Patient Refusal|5
7647284|NCT01959139|12061910|FG003|Phase II|Patient Refusal|4
7647285|NCT01959139|12061907|FG000|Phase II|Death|0
7647286|NCT01959139|12061908|FG001|Phase II|Death|0
7647287|NCT01959139|12061909|FG002|Phase II|Death|3
7647288|NCT01959139|12061910|FG003|Phase II|Death|1
7647289|NCT01959139|12061907|FG000|Phase II|Other/Unknown|0
7647290|NCT01959139|12061908|FG001|Phase II|Other/Unknown|0
7647291|NCT01959139|12061909|FG002|Phase II|Other/Unknown|8
7647292|NCT01959139|12061910|FG003|Phase II|Other/Unknown|5
7647293|NCT01959139|12061907|FG000|Phase II|On treatment|0
7647294|NCT01959139|12061908|FG001|Phase II|On treatment|0
7647295|NCT01959139|12061909|FG002|Phase II|On treatment|4
7647296|NCT01959139|12061910|FG003|Phase II|On treatment|0
7647297|NCT01597778|12061927|FG000|Overall Study|Death|7
7647298|NCT01597778|12061928|FG001|Overall Study|Death|10
7647299|NCT01597778|12061927|FG000|Overall Study|Withdrawal by Subject|3
7647300|NCT01597778|12061928|FG001|Overall Study|Withdrawal by Subject|4
7647301|NCT01597778|12061927|FG000|Overall Study|Adverse Event|1
7647302|NCT01597778|12061928|FG001|Overall Study|Adverse Event|1
7647303|NCT01597778|12061927|FG000|Overall Study|Protocol Violation|1
7647304|NCT01597778|12061928|FG001|Overall Study|Protocol Violation|11
7647305|NCT01597778|12061927|FG000|Overall Study|Transplanted off protocol|2
7647306|NCT01597778|12061928|FG001|Overall Study|Transplanted off protocol|3
7647307|NCT00879086|12061945|FG000|Overall Study|Adverse Event|3
7647308|NCT00879086|12061946|FG001|Overall Study|Adverse Event|15
7647309|NCT00879086|12061945|FG000|Overall Study|Participant choice|2
7647312|NCT00879086|12061946|FG001|Overall Study|Progression of disease|26
7647313|NCT00879086|12061945|FG000|Overall Study|Withdrawal of consent|2
7647314|NCT00879086|12061946|FG001|Overall Study|Withdrawal of consent|1
7647315|NCT00879086|12061945|FG000|Overall Study|Other|4
7647316|NCT00879086|12061946|FG001|Overall Study|Other|6
7647317|NCT00879086|12061945|FG000|Overall Study|Death|1
7647318|NCT00879086|12061946|FG001|Overall Study|Death|2
7647319|NCT00864227|12061952|FG000|Overall Study|Withdrawal by Subject|1
7647320|NCT00864227|12061952|FG000|Overall Study|Disease Relapse/Progression|3
7647321|NCT00685360|12061959|FG000|Overall Study|Lost to Follow-up|0
7647322|NCT00685360|12061960|FG001|Overall Study|Lost to Follow-up|1
7647323|NCT00685360|12061961|FG002|Overall Study|Lost to Follow-up|2
7647324|NCT00685360|12061959|FG000|Overall Study|Adverse Event|4
7647325|NCT00685360|12061960|FG001|Overall Study|Adverse Event|6
7647326|NCT00685360|12061961|FG002|Overall Study|Adverse Event|4
7647327|NCT00685360|12061959|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1
7647328|NCT00685360|12061960|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0
7647329|NCT00685360|12061961|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2
7647330|NCT00685360|12061959|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0
7647331|NCT00685360|12061960|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4
7647332|NCT00685360|12061961|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1
7647333|NCT00685360|12061959|FG000|Overall Study|Subject Withdrew Consent to Participate|13
7647334|NCT00685360|12061960|FG001|Overall Study|Subject Withdrew Consent to Participate|2
7647335|NCT00685360|12061961|FG002|Overall Study|Subject Withdrew Consent to Participate|5
7647336|NCT00685360|12061959|FG000|Overall Study|Protocol Deviation|0
7647337|NCT00685360|12061960|FG001|Overall Study|Protocol Deviation|1
7647338|NCT00685360|12061961|FG002|Overall Study|Protocol Deviation|1
7647339|NCT00299728|12061971|FG000|Overall Study|Lost to Follow-up|0
7647340|NCT00299728|12061972|FG001|Overall Study|Lost to Follow-up|1
7647341|NCT00299728|12061971|FG000|Overall Study|Withdrawal by Subject|0
7647342|NCT00299728|12061972|FG001|Overall Study|Withdrawal by Subject|1
7647343|NCT00299728|12061971|FG000|Overall Study|Progressive disease|0
7647344|NCT00299728|12061972|FG001|Overall Study|Progressive disease|1
7647345|NCT04330157|12061999|FG000|Overall Study|Protocol Violation|4
7647346|NCT04330157|12061999|FG000|Overall Study|Not extubated within 24 h postoperatively|3
7647347|NCT04317690|12062013|FG000|Overall Study|did not have complete information for primary outcome|0
7647348|NCT04317690|12062014|FG001|Overall Study|did not have complete information for primary outcome|4
7647349|NCT04317690|12062015|FG002|Overall Study|did not have complete information for primary outcome|0
7647350|NCT04317690|12062016|FG003|Overall Study|did not have complete information for primary outcome|2
7647351|NCT04317690|12062017|FG004|Overall Study|did not have complete information for primary outcome|0
7647352|NCT04160988|12062041|FG000|Overall Study|poor image quality|28
7647353|NCT04079114|12062050|FG000|Overall Study|Study prematuely terminated.|166
7647354|NCT04461795|12062175|FG000|Overall Study|Lost to Follow-up|2
7647355|NCT04461795|12062175|FG000|Overall Study|Withdrawal by Subject|2
7647356|NCT04461795|12062175|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1
7647357|NCT04035473|12062196|FG000|Screening/Baseline|Death|0
7647358|NCT04035473|12062197|FG001|Screening/Baseline|Death|1
7647359|NCT04035473|12062196|FG000|Screening/Baseline|Adverse Event|0
7647360|NCT04035473|12062197|FG001|Screening/Baseline|Adverse Event|1
7647361|NCT04035473|12062196|FG000|Follow-up Period|Adverse Event|2
7647362|NCT04035473|12062197|FG001|Follow-up Period|Adverse Event|0
7647363|NCT03796676|12062206|FG000|Overall Study|Adverse Event|2
7647364|NCT03796676|12062207|FG001|Overall Study|Adverse Event|1
7647365|NCT03796676|12062208|FG002|Overall Study|Adverse Event|2
7647366|NCT03796676|12062206|FG000|Overall Study|Lost to Follow-up|2
7647367|NCT03796676|12062207|FG001|Overall Study|Lost to Follow-up|1
7647368|NCT03796676|12062208|FG002|Overall Study|Lost to Follow-up|0
7647369|NCT03796676|12062206|FG000|Overall Study|Protocol Violation|0
7647370|NCT03796676|12062207|FG001|Overall Study|Protocol Violation|0
7647371|NCT03796676|12062208|FG002|Overall Study|Protocol Violation|1
7647372|NCT03796676|12062206|FG000|Overall Study|Withdrawal by Subject|1
7647373|NCT03796676|12062207|FG001|Overall Study|Withdrawal by Subject|1
7647374|NCT03796676|12062208|FG002|Overall Study|Withdrawal by Subject|0
7647375|NCT03796676|12062206|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1
7647376|NCT03796676|12062207|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0
7647377|NCT03796676|12062208|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0
7647378|NCT02989857|12062230|FG000|Randomization Phase|Adverse Event|8
7647379|NCT02989857|12062231|FG001|Randomization Phase|Adverse Event|4
7647380|NCT02989857|12062232|FG002|Randomization Phase|Adverse Event|0
7647381|NCT02989857|12062230|FG000|Randomization Phase|Death|6
7647382|NCT02989857|12062231|FG001|Randomization Phase|Death|0
7647383|NCT02989857|12062232|FG002|Randomization Phase|Death|0
7647384|NCT02989857|12062230|FG000|Randomization Phase|Progressive Disease|98
7647385|NCT02989857|12062231|FG001|Randomization Phase|Progressive Disease|51
7647386|NCT02989857|12062232|FG002|Randomization Phase|Progressive Disease|0
7647387|NCT02989857|12062230|FG000|Randomization Phase|Withdrawal by Subject|6
7647388|NCT02989857|12062231|FG001|Randomization Phase|Withdrawal by Subject|2
7647389|NCT02989857|12062232|FG002|Randomization Phase|Withdrawal by Subject|0
7647390|NCT02989857|12062230|FG000|Randomization Phase|Withdrawal of Consent|2
7647391|NCT02989857|12062231|FG001|Randomization Phase|Withdrawal of Consent|1
7647392|NCT02989857|12062232|FG002|Randomization Phase|Withdrawal of Consent|0
7647393|NCT02989857|12062230|FG000|Randomization Phase|Reason not specified|3
7647394|NCT02989857|12062231|FG001|Randomization Phase|Reason not specified|1
7647395|NCT02989857|12062232|FG002|Randomization Phase|Reason not specified|0
7647396|NCT02989857|12062230|FG000|Randomization Phase|Not Treated|3
7647397|NCT02989857|12062231|FG001|Randomization Phase|Not Treated|2
7647398|NCT02989857|12062232|FG002|Randomization Phase|Not Treated|0
7647399|NCT02989857|12062230|FG000|Cross Over Phase|Adverse Event|0
7647400|NCT02989857|12062231|FG001|Cross Over Phase|Adverse Event|0
7647401|NCT02989857|12062232|FG002|Cross Over Phase|Adverse Event|2
7647402|NCT02989857|12062230|FG000|Cross Over Phase|Physician Decision|0
7647403|NCT02989857|12062231|FG001|Cross Over Phase|Physician Decision|0
7647404|NCT02989857|12062232|FG002|Cross Over Phase|Physician Decision|2
7647405|NCT02989857|12062230|FG000|Cross Over Phase|Progressive Disease|0
7647406|NCT02989857|12062231|FG001|Cross Over Phase|Progressive Disease|0
7647407|NCT02989857|12062232|FG002|Cross Over Phase|Progressive Disease|36
7647408|NCT02989857|12062230|FG000|Cross Over Phase|Withdrawal by Consent|0
7647409|NCT02989857|12062231|FG001|Cross Over Phase|Withdrawal by Consent|0
7647410|NCT02989857|12062232|FG002|Cross Over Phase|Withdrawal by Consent|3
7647411|NCT02983799|12062244|FG000|Overall Study|Withdrawn from study before data cut-off|28
7647412|NCT02983799|12062245|FG001|Overall Study|Withdrawn from study before data cut-off|12
7647413|NCT02983799|12062246|FG002|Overall Study|Withdrawn from study before data cut-off|23
7647414|NCT02983799|12062247|FG003|Overall Study|Withdrawn from study before data cut-off|25
7647415|NCT02983799|12062248|FG004|Overall Study|Withdrawn from study before data cut-off|1
7647416|NCT02983799|12062244|FG000|Overall Study|Death|20
7647417|NCT02983799|12062245|FG001|Overall Study|Death|5
7647418|NCT02983799|12062246|FG002|Overall Study|Death|23
7647419|NCT02983799|12062247|FG003|Overall Study|Death|47
7647420|NCT02983799|12062248|FG004|Overall Study|Death|7
7647421|NCT02983799|12062244|FG000|Overall Study|Withdrawal by Subject|1
7647422|NCT02983799|12062245|FG001|Overall Study|Withdrawal by Subject|0
7647423|NCT02983799|12062246|FG002|Overall Study|Withdrawal by Subject|3
7647424|NCT02983799|12062247|FG003|Overall Study|Withdrawal by Subject|4
7647425|NCT02983799|12062248|FG004|Overall Study|Withdrawal by Subject|1
7647426|NCT02983799|12062244|FG000|Overall Study|Protocol Violation|0
7647427|NCT02983799|12062245|FG001|Overall Study|Protocol Violation|1
7647428|NCT02983799|12062246|FG002|Overall Study|Protocol Violation|0
7647429|NCT02983799|12062247|FG003|Overall Study|Protocol Violation|0
7647430|NCT02983799|12062248|FG004|Overall Study|Protocol Violation|1
7647431|NCT02983799|12062244|FG000|Overall Study|Lost to Follow-up|1
7647432|NCT02983799|12062245|FG001|Overall Study|Lost to Follow-up|0
7647433|NCT02983799|12062246|FG002|Overall Study|Lost to Follow-up|1
7647434|NCT02983799|12062247|FG003|Overall Study|Lost to Follow-up|0
7647435|NCT02983799|12062248|FG004|Overall Study|Lost to Follow-up|0
7647436|NCT02631577|12062270|FG000|Overall Study|Death|1
7647437|NCT02631577|12062271|FG001|Overall Study|Death|7
7647438|NCT02631577|12062270|FG000|Overall Study|Withdrawal by Subject|0
7647439|NCT02631577|12062271|FG001|Overall Study|Withdrawal by Subject|3
7647440|NCT02300233|12062298|FG000|Overall Study|Adverse Event or Serious Adverse Event|3
7647441|NCT02300233|12062299|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
7647442|NCT02300233|12062300|FG002|Overall Study|Adverse Event or Serious Adverse Event|14
7647443|NCT02300233|12062298|FG000|Overall Study|Withdrawal by Subject|1
7647444|NCT02300233|12062299|FG001|Overall Study|Withdrawal by Subject|0
7647445|NCT02300233|12062300|FG002|Overall Study|Withdrawal by Subject|3
7647446|NCT02300233|12062298|FG000|Overall Study|Investigator Judgement|0
7647447|NCT02300233|12062299|FG001|Overall Study|Investigator Judgement|0
7647448|NCT02300233|12062300|FG002|Overall Study|Investigator Judgement|1
7647449|NCT02300233|12062298|FG000|Overall Study|Reason Not Specified|0
7647450|NCT02300233|12062299|FG001|Overall Study|Reason Not Specified|0
7647451|NCT02300233|12062300|FG002|Overall Study|Reason Not Specified|5
7647452|NCT02211209|12062311|FG000|Overall Study|Investigator judgment|0
7647453|NCT02211209|12062312|FG001|Overall Study|Investigator judgment|1
7647454|NCT02211209|12062311|FG000|Overall Study|Voluntary withdrawal|1
7647455|NCT02211209|12062312|FG001|Overall Study|Voluntary withdrawal|4
7647456|NCT02211209|12062311|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
7647457|NCT02211209|12062312|FG001|Overall Study|Adverse Event or Serious Adverse Event|9
7647458|NCT02211209|12062311|FG000|Overall Study|Reason Not Specified|1
7647459|NCT02211209|12062312|FG001|Overall Study|Reason Not Specified|0
7647460|NCT02000115|12062321|FG000|Overall Study|Death|56
7647461|NCT02000115|12062322|FG001|Overall Study|Death|45
7647462|NCT02000115|12062323|FG002|Overall Study|Death|0
7647463|NCT02000115|12062324|FG003|Overall Study|Death|0
7647464|NCT02000115|12062321|FG000|Overall Study|Missed Visit|6
7647465|NCT02000115|12062322|FG001|Overall Study|Missed Visit|8
7647466|NCT02000115|12062323|FG002|Overall Study|Missed Visit|1
7647467|NCT02000115|12062324|FG003|Overall Study|Missed Visit|0
7647468|NCT02000115|12062321|FG000|Overall Study|Protocol Violation|2
7647469|NCT02000115|12062322|FG001|Overall Study|Protocol Violation|1
7647470|NCT02000115|12062323|FG002|Overall Study|Protocol Violation|0
7647471|NCT02000115|12062324|FG003|Overall Study|Protocol Violation|0
7647472|NCT02000115|12062321|FG000|Overall Study|Physician Decision|2
7647473|NCT02000115|12062322|FG001|Overall Study|Physician Decision|0
7647474|NCT02000115|12062323|FG002|Overall Study|Physician Decision|0
7647475|NCT02000115|12062324|FG003|Overall Study|Physician Decision|0
7647476|NCT02000115|12062321|FG000|Overall Study|Withdrawal by Subject|11
7647477|NCT02000115|12062322|FG001|Overall Study|Withdrawal by Subject|11
7647478|NCT02000115|12062323|FG002|Overall Study|Withdrawal by Subject|0
7647479|NCT02000115|12062324|FG003|Overall Study|Withdrawal by Subject|0
7647480|NCT02000115|12062321|FG000|Overall Study|Lost to Follow-up|0
7647481|NCT02000115|12062322|FG001|Overall Study|Lost to Follow-up|1
7647482|NCT02000115|12062323|FG002|Overall Study|Lost to Follow-up|0
7647483|NCT02000115|12062324|FG003|Overall Study|Lost to Follow-up|0
7647484|NCT02000115|12062321|FG000|Overall Study|Non-compliance|2
7647485|NCT02000115|12062322|FG001|Overall Study|Non-compliance|1
7647486|NCT02000115|12062323|FG002|Overall Study|Non-compliance|0
7647487|NCT02000115|12062324|FG003|Overall Study|Non-compliance|0
7647488|NCT02000115|12062321|FG000|Overall Study|Withdrawn on day of randomization|0
7647489|NCT02000115|12062322|FG001|Overall Study|Withdrawn on day of randomization|1
7647490|NCT02000115|12062323|FG002|Overall Study|Withdrawn on day of randomization|0
7647491|NCT02000115|12062324|FG003|Overall Study|Withdrawn on day of randomization|0
7647492|NCT02000115|12062321|FG000|Overall Study|Still on Study|0
7647493|NCT02000115|12062322|FG001|Overall Study|Still on Study|0
7647494|NCT02000115|12062323|FG002|Overall Study|Still on Study|0
7647495|NCT02000115|12062324|FG003|Overall Study|Still on Study|53
7647496|NCT01695317|12062348|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2
7647497|NCT01695317|12062349|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1
7647498|NCT01695317|12062348|FG000|Cross-over to Period 2|Withdrawal by Subject|4
7647499|NCT01695317|12062349|FG001|Cross-over to Period 2|Withdrawal by Subject|34
7647500|NCT01127451|12062380|FG000|Overall Study|Other|2
7647501|NCT01127451|12062381|FG001|Overall Study|Other|1
7647502|NCT01127451|12062380|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14
7647503|NCT01127451|12062381|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12
7647504|NCT01127451|12062380|FG000|Overall Study|Death|22
7647505|NCT01127451|12062381|FG001|Overall Study|Death|17
7647506|NCT01127451|12062380|FG000|Overall Study|Lost to Follow-up|3
7647507|NCT01127451|12062381|FG001|Overall Study|Lost to Follow-up|0
7647508|NCT01127451|12062380|FG000|Overall Study|Administrative Reason by Sponsor|2
7647509|NCT01127451|12062381|FG001|Overall Study|Administrative Reason by Sponsor|2
7647510|NCT04559698|12062404|FG000|Overall Study|Lost to Follow-up|14
7647511|NCT04559698|12062405|FG001|Overall Study|Lost to Follow-up|15
7647512|NCT04559698|12062404|FG000|Overall Study|Withdrawal by Subject|0
7647513|NCT04559698|12062405|FG001|Overall Study|Withdrawal by Subject|1
7647514|NCT04492475|12062413|FG000|Overall Study|Enrolled but not treated|8
7647515|NCT04492475|12062414|FG001|Overall Study|Enrolled but not treated|8
7647516|NCT04492475|12062413|FG000|Overall Study|Withdrawal by Subject|4
7647517|NCT04492475|12062414|FG001|Overall Study|Withdrawal by Subject|0
7647518|NCT04492475|12062413|FG000|Overall Study|Became ineligible after enrollment|2
7647519|NCT04492475|12062414|FG001|Overall Study|Became ineligible after enrollment|0
7647520|NCT04401579|12062429|FG000|Overall Study|Death|23
7647521|NCT04401579|12062430|FG001|Overall Study|Death|36
7647522|NCT04401579|12062429|FG000|Overall Study|Lost to Follow-up|40
7647523|NCT04401579|12062430|FG001|Overall Study|Lost to Follow-up|41
7647524|NCT04401579|12062429|FG000|Overall Study|Withdrawal by Subject|8
7647525|NCT04401579|12062430|FG001|Overall Study|Withdrawal by Subject|16
7647526|NCT04401579|12062429|FG000|Overall Study|Physician Decision|1
7647527|NCT04401579|12062430|FG001|Overall Study|Physician Decision|2
7647528|NCT04401579|12062429|FG000|Overall Study|Became ineligible after enrollment|1
7647529|NCT04401579|12062430|FG001|Overall Study|Became ineligible after enrollment|1
7647530|NCT04401579|12062429|FG000|Overall Study|Enrolled but treatment not administered|7
7647531|NCT04401579|12062430|FG001|Overall Study|Enrolled but treatment not administered|9
7647532|NCT04401579|12062429|FG000|Overall Study|Adverse Event|2
7647533|NCT04401579|12062430|FG001|Overall Study|Adverse Event|1
7647534|NCT04401579|12062429|FG000|Overall Study|Scheduling error|1
7647535|NCT04401579|12062430|FG001|Overall Study|Scheduling error|2
7647536|NCT04401579|12062429|FG000|Overall Study|Transferred to another hospital|1
7647537|NCT04401579|12062430|FG001|Overall Study|Transferred to another hospital|2
7647538|NCT04321460|12062438|FG000|Overall Study|Participants who had no defecation or no data about it|1
7647539|NCT04321460|12062439|FG001|Overall Study|Participants who had no defecation or no data about it|1
7647540|NCT04280705|12062447|FG000|Overall Study|Enrolled but not treated|4
7647541|NCT04280705|12062448|FG001|Overall Study|Enrolled but not treated|10
7647542|NCT04280705|12062447|FG000|Overall Study|Physician Decision|1
7647543|NCT04280705|12062448|FG001|Overall Study|Physician Decision|0
7647544|NCT04280705|12062447|FG000|Overall Study|Withdrawal by Subject|7
7647545|NCT04280705|12062448|FG001|Overall Study|Withdrawal by Subject|9
7647546|NCT04280705|12062447|FG000|Overall Study|Adverse Event|0
7647547|NCT04280705|12062448|FG001|Overall Study|Adverse Event|4
7647548|NCT04280705|12062447|FG000|Overall Study|Transferred to another hospital|1
7647549|NCT04280705|12062448|FG001|Overall Study|Transferred to another hospital|1
7647550|NCT04208750|12062456|FG000|Overall Study|Lost to Follow-up|16
7647551|NCT04208750|12062457|FG001|Overall Study|Lost to Follow-up|15
7647552|NCT03713281|12062463|FG000|Overall Study|Lens handling difficuluties|2
7647553|NCT03713281|12062463|FG000|Overall Study|Subject was not dispensed enough lenses|1
7647554|NCT03608254|12062467|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2
7647555|NCT03608254|12062467|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1
7647556|NCT03512275|12062473|FG000|Overall Study|Withdrawal by Subject|1
7647557|NCT03512275|12062474|FG001|Overall Study|Withdrawal by Subject|3
7647558|NCT03512275|12062473|FG000|Overall Study|Physician Decision|0
7647559|NCT03512275|12062474|FG001|Overall Study|Physician Decision|1
7647560|NCT03512275|12062473|FG000|Overall Study|Lost to Follow-up|0
7647561|NCT03512275|12062474|FG001|Overall Study|Lost to Follow-up|3
7647562|NCT03512275|12062473|FG000|Overall Study|Other|1
7647563|NCT03512275|12062474|FG001|Overall Study|Other|0
7647564|NCT03414983|12062482|FG000|Pre-Treatment|Other reasons|1
7647565|NCT03414983|12062483|FG001|Pre-Treatment|Other reasons|0
7647566|NCT03414983|12062482|FG000|Pre-Treatment|Participant no longer meets study criteria|2
7647567|NCT03414983|12062483|FG001|Pre-Treatment|Participant no longer meets study criteria|3
7647568|NCT03414983|12062482|FG000|Pre-Treatment|Participant withdrew consent|1
7647569|NCT03414983|12062483|FG001|Pre-Treatment|Participant withdrew consent|3
7647570|NCT03414983|12062482|FG000|Treatment|Participant withdrew consent|4
7647571|NCT03414983|12062483|FG001|Treatment|Participant withdrew consent|3
7647572|NCT03414983|12062482|FG000|Treatment|Participant request to discontinue study treatment|8
7647573|NCT03414983|12062483|FG001|Treatment|Participant request to discontinue study treatment|10
7647574|NCT03414983|12062482|FG000|Treatment|Adverse Event Unrelated to Study Drug|5
7647575|NCT03414983|12062483|FG001|Treatment|Adverse Event Unrelated to Study Drug|2
7647576|NCT03414983|12062482|FG000|Treatment|Death|0
7647577|NCT03414983|12062483|FG001|Treatment|Death|2
7647578|NCT03414983|12062482|FG000|Treatment|Study Drug Toxicity|11
7647579|NCT03414983|12062483|FG001|Treatment|Study Drug Toxicity|4
7647580|NCT03414983|12062482|FG000|Treatment|Disease Progression|72
7647581|NCT03414983|12062483|FG001|Treatment|Disease Progression|27
7647582|NCT03414983|12062482|FG000|Treatment|Not reported|1
7647583|NCT03414983|12062483|FG001|Treatment|Not reported|0
7647584|NCT03414983|12062482|FG000|Treatment|Other reasons|3
7647585|NCT03414983|12062483|FG001|Treatment|Other reasons|2
7647586|NCT03414983|12062482|FG000|Treatment|Completed treatment as per protocol|8
7647587|NCT03414983|12062483|FG001|Treatment|Completed treatment as per protocol|0
7647588|NCT03414983|12062482|FG000|Treatment|Poor/non-compliance|2
7647589|NCT03414983|12062483|FG001|Treatment|Poor/non-compliance|0
7647590|NCT03414983|12062482|FG000|Treatment|Maximum clinical benefit|5
7647591|NCT03414983|12062483|FG001|Treatment|Maximum clinical benefit|9
7647592|NCT03414983|12062482|FG000|Treatment|Lost to Follow-up|0
7647593|NCT03414983|12062483|FG001|Treatment|Lost to Follow-up|1
7647594|NCT03383692|12062491|FG000|Overall Study|Progressive disease as per RECIST|3
7647595|NCT03383692|12062492|FG001|Overall Study|Progressive disease as per RECIST|3
7647596|NCT03383692|12062491|FG000|Overall Study|Clinical progression|0
7647597|NCT03383692|12062492|FG001|Overall Study|Clinical progression|1
7647598|NCT03383692|12062491|FG000|Overall Study|Adverse Event|3
7647599|NCT03383692|12062492|FG001|Overall Study|Adverse Event|0
7647600|NCT03371251|12062506|FG000|Overall Study|Withdrawal by Subject|1
7647601|NCT03371251|12062507|FG001|Overall Study|Withdrawal by Subject|0
7647602|NCT03371251|12062508|FG002|Overall Study|Withdrawal by Subject|1
7647603|NCT03371251|12062509|FG003|Overall Study|Withdrawal by Subject|0
7647604|NCT03371251|12062510|FG004|Overall Study|Withdrawal by Subject|2
7647605|NCT03371251|12062511|FG005|Overall Study|Withdrawal by Subject|2
7647606|NCT03371251|12062506|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1
7647607|NCT03371251|12062507|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0
7647608|NCT03371251|12062508|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0
7647609|NCT03371251|12062509|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0
7647610|NCT03371251|12062510|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2
7647611|NCT03371251|12062511|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3
7647612|NCT03371251|12062506|FG000|Overall Study|Adverse Event|0
7647613|NCT03371251|12062507|FG001|Overall Study|Adverse Event|0
7647614|NCT03371251|12062508|FG002|Overall Study|Adverse Event|0
7647615|NCT03371251|12062509|FG003|Overall Study|Adverse Event|0
7647616|NCT03371251|12062510|FG004|Overall Study|Adverse Event|1
7647617|NCT03371251|12062511|FG005|Overall Study|Adverse Event|0
7647618|NCT03371251|12062506|FG000|Overall Study|Decision by Sponsor|0
7647619|NCT03371251|12062507|FG001|Overall Study|Decision by Sponsor|0
7647620|NCT03371251|12062508|FG002|Overall Study|Decision by Sponsor|0
7647621|NCT03371251|12062509|FG003|Overall Study|Decision by Sponsor|0
7647622|NCT03371251|12062510|FG004|Overall Study|Decision by Sponsor|2
7647623|NCT03371251|12062511|FG005|Overall Study|Decision by Sponsor|0
7647624|NCT01252953|12062577|FG000|Overall Study|Withdrawal by Subject|16
7647625|NCT01252953|12062578|FG001|Overall Study|Withdrawal by Subject|17
7647626|NCT01252953|12062577|FG000|Overall Study|Lost to Follow-up|22
7647627|NCT01252953|12062578|FG001|Overall Study|Lost to Follow-up|21
7647628|NCT01012609|12062587|FG000|Overall Study|Withdrawal by Subject|1
7647629|NCT01012609|12062588|FG001|Overall Study|Withdrawal by Subject|1
7647630|NCT00403559|12062616|FG000|Overall Study|Adverse Event|0
7647631|NCT00403559|12062617|FG001|Overall Study|Adverse Event|1
7647632|NCT00403559|12062616|FG000|Overall Study|Lost to Follow-up|3
7647633|NCT00403559|12062617|FG001|Overall Study|Lost to Follow-up|3
7647634|NCT00403559|12062616|FG000|Overall Study|Withdrawal by Subject|1
7647635|NCT00403559|12062617|FG001|Overall Study|Withdrawal by Subject|0
7647636|NCT04702984|12062645|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1
7647637|NCT04633564|12062653|FG000|Period 1|Adverse Event|28
7647638|NCT04633564|12062654|FG001|Period 1|Adverse Event|19
7647639|NCT04633564|12062653|FG000|Period 1|Death|8
7647640|NCT04633564|12062654|FG001|Period 1|Death|7
7647641|NCT04633564|12062653|FG000|Period 1|Lost to Follow-up|3
7647642|NCT04633564|12062654|FG001|Period 1|Lost to Follow-up|5
7647643|NCT04633564|12062653|FG000|Period 1|Physician Decision|4
7647644|NCT04633564|12062654|FG001|Period 1|Physician Decision|12
7647645|NCT04633564|12062653|FG000|Period 1|Protocol Violation|0
7647646|NCT04633564|12062654|FG001|Period 1|Protocol Violation|1
7647647|NCT04633564|12062653|FG000|Period 1|Withdrawal by Subject|10
7647648|NCT04633564|12062654|FG001|Period 1|Withdrawal by Subject|8
7647649|NCT04633564|12062653|FG000|Period 1|Progressive disease|47
7647650|NCT04633564|12062654|FG001|Period 1|Progressive disease|51
7647651|NCT04633564|12062653|FG000|Period 1|Terminated by Sponsor|8
7647652|NCT04633564|12062654|FG001|Period 1|Terminated by Sponsor|6
7647653|NCT04633564|12062653|FG000|Period 2|Adverse Event|3
7647654|NCT04633564|12062654|FG001|Period 2|Adverse Event|4
7647655|NCT04633564|12062653|FG000|Period 2|Death|0
7647656|NCT04633564|12062654|FG001|Period 2|Death|2
7647657|NCT04633564|12062653|FG000|Period 2|Lost to Follow-up|0
7647658|NCT04633564|12062654|FG001|Period 2|Lost to Follow-up|1
7647659|NCT04633564|12062653|FG000|Period 2|Physician Decision|2
7647660|NCT04633564|12062654|FG001|Period 2|Physician Decision|4
7647661|NCT04633564|12062653|FG000|Period 2|Withdrawal by Subject|5
7647662|NCT04633564|12062654|FG001|Period 2|Withdrawal by Subject|1
7647663|NCT04633564|12062653|FG000|Period 2|Progressive Disease|74
7647664|NCT04633564|12062654|FG001|Period 2|Progressive Disease|82
7647665|NCT04633564|12062653|FG000|Period 2|Terminated by Sponsor|9
7647666|NCT04633564|12062654|FG001|Period 2|Terminated by Sponsor|3
7647667|NCT04191148|12062666|FG000|Overall Study|Withdrawal by Subject|1
7647668|NCT04191148|12062667|FG001|Overall Study|Withdrawal by Subject|0
7647669|NCT04191148|12062666|FG000|Overall Study|Adverse Event|1
7647670|NCT04191148|12062667|FG001|Overall Study|Adverse Event|0
7647671|NCT04022733|12062700|FG000|Overall Study|conversion to open surgery|3
7647672|NCT04022733|12062701|FG001|Overall Study|conversion to open surgery|2
7647673|NCT04022733|12062700|FG000|Overall Study|bradycardia|0
7647674|NCT04022733|12062701|FG001|Overall Study|bradycardia|1
7647675|NCT04021524|12062709|FG000|Overall Study|Change in surgical intervention|0
7647676|NCT04021524|12062710|FG001|Overall Study|Change in surgical intervention|1
7647677|NCT03605680|12062734|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6
7647678|NCT03605680|12062735|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0
7647679|NCT03605680|12062736|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0
7647680|NCT03605680|12062737|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0
7647681|NCT03605680|12062734|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1
7647682|NCT03605680|12062735|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
7647683|NCT03605680|12062736|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
7647684|NCT03605680|12062737|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
7647685|NCT03605680|12062734|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9
7647686|NCT03605680|12062735|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
7647687|NCT03605680|12062736|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
7647688|NCT03605680|12062737|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
7647689|NCT03605680|12062734|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3
7647690|NCT03605680|12062735|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
7647691|NCT03605680|12062736|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
7647692|NCT03605680|12062737|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
7647693|NCT03605680|12062734|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13
7647694|NCT03605680|12062735|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
7647695|NCT03605680|12062736|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
7647696|NCT03605680|12062737|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
7647697|NCT03605680|12062734|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12
7647698|NCT03605680|12062735|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
7647699|NCT03605680|12062736|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
7647700|NCT03605680|12062737|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
7647701|NCT03605680|12062734|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1
7647702|NCT03605680|12062735|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0
7647703|NCT03605680|12062736|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0
7647704|NCT03605680|12062737|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0
7647705|NCT03605680|12062734|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6
7647706|NCT03605680|12062735|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0
7647707|NCT03605680|12062736|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0
7647708|NCT03605680|12062737|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0
7647709|NCT03605680|12062734|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87
7647710|NCT03605680|12062735|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
7647711|NCT03605680|12062736|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
7647712|NCT03605680|12062737|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
7647713|NCT03605680|12062734|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0
7647714|NCT03605680|12062735|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5
7647715|NCT03605680|12062736|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7
7647716|NCT03605680|12062737|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8
7647717|NCT03605680|12062734|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0
7647718|NCT03605680|12062735|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8
7647719|NCT03605680|12062736|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8
7647720|NCT03605680|12062737|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3
7647721|NCT03605680|12062734|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7647722|NCT03605680|12062735|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7647723|NCT03605680|12062736|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7647724|NCT03605680|12062737|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
7647725|NCT03605680|12062734|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
7647726|NCT03605680|12062735|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3
7647727|NCT03605680|12062736|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4
7647728|NCT03605680|12062737|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3
7647729|NCT03605680|12062734|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0
7647730|NCT03605680|12062735|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3
7647731|NCT03605680|12062736|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1
7647732|NCT03605680|12062737|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2
7647733|NCT03605680|12062734|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0
7647734|NCT03605680|12062735|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14
7647735|NCT03605680|12062736|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7
7647736|NCT03605680|12062737|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5
7647737|NCT03605680|12062734|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0
7647738|NCT03605680|12062735|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
7647739|NCT03605680|12062736|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
7647740|NCT03605680|12062737|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7
7647741|NCT03605680|12062734|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0
7647742|NCT03605680|12062735|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1
7647743|NCT03605680|12062736|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2
7647744|NCT03605680|12062737|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0
7647745|NCT03605680|12062734|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0
7647746|NCT03605680|12062735|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5
7647747|NCT03605680|12062736|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4
7647748|NCT03605680|12062737|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3
7647749|NCT03605680|12062734|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0
7647750|NCT03605680|12062735|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1
7647751|NCT03605680|12062736|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2
7647752|NCT03605680|12062737|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3
7647753|NCT03485950|12062748|FG000|Overall Study|Adverse Event|1
7647754|NCT03485950|12062749|FG001|Overall Study|Adverse Event|0
7647755|NCT03485950|12062748|FG000|Overall Study|Death|3
7647756|NCT03485950|12062749|FG001|Overall Study|Death|2
7647757|NCT03485950|12062748|FG000|Overall Study|Withdrawal by Subject|3
7647758|NCT03485950|12062749|FG001|Overall Study|Withdrawal by Subject|0
7647759|NCT03404518|12062757|FG000|Overall Study|Lost to Follow-up|28
7647760|NCT03404518|12062758|FG001|Overall Study|Lost to Follow-up|30
7647761|NCT03404518|12062757|FG000|Overall Study|Protocol Violation|13
7647762|NCT03404518|12062758|FG001|Overall Study|Protocol Violation|6
7647763|NCT03289143|12062788|FG000|Overall Study|Caregiver Unavailability|1
7647764|NCT03289143|12062789|FG001|Overall Study|Caregiver Unavailability|1
7647765|NCT03289143|12062790|FG002|Overall Study|Caregiver Unavailability|0
7647766|NCT03289143|12062791|FG003|Overall Study|Caregiver Unavailability|0
7647767|NCT03289143|12062788|FG000|Overall Study|Research Department Closure|0
7647768|NCT03289143|12062789|FG001|Overall Study|Research Department Closure|0
7647769|NCT03289143|12062790|FG002|Overall Study|Research Department Closure|1
7647770|NCT03289143|12062791|FG003|Overall Study|Research Department Closure|0
7647771|NCT03289143|12062788|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0
7647772|NCT03289143|12062789|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0
7647773|NCT03289143|12062790|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1
7647774|NCT03289143|12062791|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0
7647775|NCT03289143|12062788|FG000|Overall Study|Medical Monitor Decision|1
7647776|NCT03289143|12062789|FG001|Overall Study|Medical Monitor Decision|0
7647777|NCT03289143|12062790|FG002|Overall Study|Medical Monitor Decision|0
7647778|NCT03289143|12062791|FG003|Overall Study|Medical Monitor Decision|0
7647779|NCT03289143|12062788|FG000|Overall Study|Participant Non-Compliance|0
7647780|NCT03289143|12062789|FG001|Overall Study|Participant Non-Compliance|0
7647781|NCT03289143|12062790|FG002|Overall Study|Participant Non-Compliance|1
7647782|NCT03289143|12062791|FG003|Overall Study|Participant Non-Compliance|0
7647783|NCT03289143|12062788|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0
7647784|NCT03289143|12062789|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0
7647785|NCT03289143|12062790|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1
7647786|NCT03289143|12062791|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0
7647787|NCT03289143|12062788|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0
7647788|NCT03289143|12062789|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0
7647789|NCT03289143|12062790|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1
7647790|NCT03289143|12062791|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0
7647791|NCT03289143|12062788|FG000|Overall Study|Caregiver Passed Away|1
7647792|NCT03289143|12062789|FG001|Overall Study|Caregiver Passed Away|0
7647793|NCT03289143|12062790|FG002|Overall Study|Caregiver Passed Away|0
7647794|NCT03289143|12062791|FG003|Overall Study|Caregiver Passed Away|0
7647795|NCT03289143|12062788|FG000|Overall Study|Physician Decision|0
7647796|NCT03289143|12062789|FG001|Overall Study|Physician Decision|2
7647797|NCT03289143|12062790|FG002|Overall Study|Physician Decision|2
7647798|NCT03289143|12062791|FG003|Overall Study|Physician Decision|2
7647799|NCT03289143|12062788|FG000|Overall Study|Protocol Deviation|2
7647800|NCT03289143|12062789|FG001|Overall Study|Protocol Deviation|1
7647801|NCT03289143|12062790|FG002|Overall Study|Protocol Deviation|3
7647802|NCT03289143|12062791|FG003|Overall Study|Protocol Deviation|1
7647803|NCT03289143|12062788|FG000|Overall Study|Study Terminated By Sponsor|101
7647804|NCT03289143|12062789|FG001|Overall Study|Study Terminated By Sponsor|75
7647805|NCT03289143|12062790|FG002|Overall Study|Study Terminated By Sponsor|100
7647806|NCT03289143|12062791|FG003|Overall Study|Study Terminated By Sponsor|69
7647807|NCT03289143|12062788|FG000|Overall Study|Withdrawal by Subject|14
7647808|NCT03289143|12062789|FG001|Overall Study|Withdrawal by Subject|6
7647809|NCT03289143|12062790|FG002|Overall Study|Withdrawal by Subject|14
7647810|NCT03289143|12062791|FG003|Overall Study|Withdrawal by Subject|12
7647811|NCT03289143|12062788|FG000|Overall Study|Adverse Event|10
7647812|NCT03289143|12062789|FG001|Overall Study|Adverse Event|7
7647813|NCT03289143|12062790|FG002|Overall Study|Adverse Event|6
7647814|NCT03289143|12062791|FG003|Overall Study|Adverse Event|5
7647815|NCT03289143|12062788|FG000|Overall Study|Death|2
7647816|NCT03289143|12062789|FG001|Overall Study|Death|0
7647817|NCT03289143|12062790|FG002|Overall Study|Death|2
7647818|NCT03289143|12062791|FG003|Overall Study|Death|1
7647819|NCT03289143|12062788|FG000|Overall Study|Lost to Follow-up|2
7647820|NCT03289143|12062789|FG001|Overall Study|Lost to Follow-up|1
7647821|NCT03289143|12062790|FG002|Overall Study|Lost to Follow-up|1
7647822|NCT03289143|12062791|FG003|Overall Study|Lost to Follow-up|0
7647823|NCT03289143|12062788|FG000|Overall Study|Participant No Longer Has Study Partner|0
7647824|NCT03289143|12062789|FG001|Overall Study|Participant No Longer Has Study Partner|0
7647825|NCT03289143|12062790|FG002|Overall Study|Participant No Longer Has Study Partner|0
7647826|NCT03289143|12062791|FG003|Overall Study|Participant No Longer Has Study Partner|1
7647827|NCT03289143|12062788|FG000|Overall Study|Withdrawal by Caregiver|0
7647828|NCT03289143|12062789|FG001|Overall Study|Withdrawal by Caregiver|1
7647829|NCT03289143|12062790|FG002|Overall Study|Withdrawal by Caregiver|0
7647830|NCT03289143|12062791|FG003|Overall Study|Withdrawal by Caregiver|0
7647831|NCT03289143|12062788|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0
7647832|NCT03289143|12062789|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0
7647833|NCT03289143|12062790|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1
7647834|NCT03289143|12062791|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0
7647835|NCT03289143|12062788|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0
7647836|NCT03289143|12062789|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0
7647837|NCT03289143|12062790|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0
7647838|NCT03289143|12062791|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1
7647839|NCT03156504|12062806|FG000|Overall Study|Withdrawal by Subject|1
7647840|NCT02993926|12062810|FG000|Enantone Treatment Phase|Adverse Event|1
7647841|NCT02993926|12062811|FG001|Enantone Treatment Phase|Adverse Event|0
7647842|NCT02993926|12062812|FG002|Enantone Treatment Phase|Adverse Event|0
7647843|NCT02993926|12062810|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26
7647844|NCT02993926|12062811|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
7647845|NCT02993926|12062812|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
7647846|NCT02993926|12062810|FG000|Enantone Treatment Phase|Investigator Judgment|1
7647847|NCT02993926|12062811|FG001|Enantone Treatment Phase|Investigator Judgment|0
7647848|NCT02993926|12062812|FG002|Enantone Treatment Phase|Investigator Judgment|0
7647849|NCT02993926|12062810|FG000|Enantone Treatment Phase|Reason Not Specified|4
7647850|NCT02993926|12062811|FG001|Enantone Treatment Phase|Reason Not Specified|0
7647851|NCT02993926|12062812|FG002|Enantone Treatment Phase|Reason Not Specified|0
7647852|NCT02932579|12062824|FG000|Overall Study|Withdrawal by Subject|4
7647853|NCT02932579|12062825|FG001|Overall Study|Withdrawal by Subject|1
7647854|NCT02852967|12062841|FG000|Overall Study|Adverse Event|3
7647855|NCT02852967|12062842|FG001|Overall Study|Adverse Event|1
7647856|NCT02852967|12062843|FG002|Overall Study|Adverse Event|0
7647857|NCT02852967|12062844|FG003|Overall Study|Adverse Event|1
7647858|NCT02852967|12062845|FG004|Overall Study|Adverse Event|0
7647859|NCT02852967|12062841|FG000|Overall Study|Death|1
7647860|NCT02852967|12062842|FG001|Overall Study|Death|0
7647861|NCT02852967|12062843|FG002|Overall Study|Death|0
7647862|NCT02852967|12062844|FG003|Overall Study|Death|0
7647863|NCT02852967|12062845|FG004|Overall Study|Death|0
7647864|NCT02852967|12062841|FG000|Overall Study|Lost to Follow-up|1
7647865|NCT02852967|12062842|FG001|Overall Study|Lost to Follow-up|2
7647866|NCT02852967|12062843|FG002|Overall Study|Lost to Follow-up|3
7647867|NCT02852967|12062844|FG003|Overall Study|Lost to Follow-up|4
7647868|NCT02852967|12062845|FG004|Overall Study|Lost to Follow-up|4
7647869|NCT02852967|12062841|FG000|Overall Study|Withdrawal by Subject|6
7647870|NCT02852967|12062842|FG001|Overall Study|Withdrawal by Subject|12
7647871|NCT02852967|12062843|FG002|Overall Study|Withdrawal by Subject|7
7647872|NCT02852967|12062844|FG003|Overall Study|Withdrawal by Subject|10
7647873|NCT02852967|12062845|FG004|Overall Study|Withdrawal by Subject|10
7647874|NCT02852967|12062841|FG000|Overall Study|SAE|0
7647875|NCT02852967|12062842|FG001|Overall Study|SAE|0
7647876|NCT02852967|12062843|FG002|Overall Study|SAE|0
7647877|NCT02852967|12062844|FG003|Overall Study|SAE|3
7647878|NCT02852967|12062845|FG004|Overall Study|SAE|0
7647879|NCT02852967|12062841|FG000|Overall Study|Elevated Liver Enzymes|2
7647880|NCT02852967|12062842|FG001|Overall Study|Elevated Liver Enzymes|0
7647881|NCT02852967|12062843|FG002|Overall Study|Elevated Liver Enzymes|0
7647882|NCT02852967|12062844|FG003|Overall Study|Elevated Liver Enzymes|2
7647883|NCT02852967|12062845|FG004|Overall Study|Elevated Liver Enzymes|2
7647884|NCT02852967|12062841|FG000|Overall Study|Physician Decision|0
7647885|NCT02852967|12062842|FG001|Overall Study|Physician Decision|0
7647886|NCT02852967|12062843|FG002|Overall Study|Physician Decision|0
7647887|NCT02852967|12062844|FG003|Overall Study|Physician Decision|1
7647888|NCT02852967|12062845|FG004|Overall Study|Physician Decision|0
7647889|NCT02852967|12062841|FG000|Overall Study|Lack of Efficacy|0
7647890|NCT02852967|12062842|FG001|Overall Study|Lack of Efficacy|1
7647891|NCT02852967|12062843|FG002|Overall Study|Lack of Efficacy|0
7647892|NCT02852967|12062844|FG003|Overall Study|Lack of Efficacy|0
7647893|NCT02852967|12062845|FG004|Overall Study|Lack of Efficacy|0
7647894|NCT02852967|12062841|FG000|Overall Study|Non-compliance|0
7647895|NCT02852967|12062842|FG001|Overall Study|Non-compliance|0
7647896|NCT02852967|12062843|FG002|Overall Study|Non-compliance|1
7647897|NCT02852967|12062844|FG003|Overall Study|Non-compliance|1
7647898|NCT02852967|12062845|FG004|Overall Study|Non-compliance|0
7647899|NCT02852967|12062841|FG000|Overall Study|Dispensing Drug Violation|0
7647900|NCT02852967|12062842|FG001|Overall Study|Dispensing Drug Violation|0
7647901|NCT02852967|12062843|FG002|Overall Study|Dispensing Drug Violation|1
7647902|NCT02852967|12062844|FG003|Overall Study|Dispensing Drug Violation|0
7647903|NCT02852967|12062845|FG004|Overall Study|Dispensing Drug Violation|0
7647904|NCT02852967|12062841|FG000|Overall Study|Inclusion/Exclusion Violation|1
7647905|NCT02852967|12062842|FG001|Overall Study|Inclusion/Exclusion Violation|0
7647906|NCT02852967|12062843|FG002|Overall Study|Inclusion/Exclusion Violation|0
7647907|NCT02852967|12062844|FG003|Overall Study|Inclusion/Exclusion Violation|0
7647908|NCT02852967|12062845|FG004|Overall Study|Inclusion/Exclusion Violation|0
7647909|NCT02810418|12062872|FG000|Arm A Dose Escalation|Adverse Event|2
7647910|NCT02810418|12062873|FG001|Arm A Dose Escalation|Adverse Event|1
7647911|NCT02810418|12062874|FG002|Arm A Dose Escalation|Adverse Event|0
7647912|NCT02810418|12062875|FG003|Arm A Dose Escalation|Adverse Event|0
7647913|NCT02810418|12062876|FG004|Arm A Dose Escalation|Adverse Event|0
7647914|NCT02810418|12062877|FG005|Arm A Dose Escalation|Adverse Event|0
7647915|NCT02810418|12062878|FG006|Arm A Dose Escalation|Adverse Event|0
7647916|NCT02810418|12062872|FG000|Dose Expansion|Adverse Event|0
7647917|NCT02810418|12062873|FG001|Dose Expansion|Adverse Event|1
7647918|NCT02810418|12062874|FG002|Dose Expansion|Adverse Event|1
7647919|NCT02810418|12062875|FG003|Dose Expansion|Adverse Event|0
7647920|NCT02810418|12062876|FG004|Dose Expansion|Adverse Event|0
7647921|NCT02810418|12062877|FG005|Dose Expansion|Adverse Event|0
7647922|NCT02810418|12062878|FG006|Dose Expansion|Adverse Event|0
7647923|NCT02810418|12062872|FG000|Dose Expansion|Physician Decision|0
7647924|NCT02810418|12062873|FG001|Dose Expansion|Physician Decision|0
7647925|NCT02810418|12062874|FG002|Dose Expansion|Physician Decision|2
7647926|NCT02810418|12062875|FG003|Dose Expansion|Physician Decision|0
7647927|NCT02810418|12062876|FG004|Dose Expansion|Physician Decision|0
7647928|NCT02810418|12062877|FG005|Dose Expansion|Physician Decision|0
7647929|NCT02810418|12062878|FG006|Dose Expansion|Physician Decision|0
7647930|NCT02810418|12062872|FG000|Arm B Dose Escalation|Adverse Event|0
7647931|NCT02810418|12062873|FG001|Arm B Dose Escalation|Adverse Event|0
7647932|NCT02810418|12062874|FG002|Arm B Dose Escalation|Adverse Event|0
7647933|NCT02810418|12062875|FG003|Arm B Dose Escalation|Adverse Event|0
7647934|NCT02810418|12062876|FG004|Arm B Dose Escalation|Adverse Event|1
7647935|NCT02810418|12062877|FG005|Arm B Dose Escalation|Adverse Event|2
7647936|NCT02810418|12062878|FG006|Arm B Dose Escalation|Adverse Event|0
7647937|NCT02781584|12062959|FG000|Pre-treatment Phase|Investigator's Discretion|0
7647938|NCT02781584|12062960|FG001|Pre-treatment Phase|Investigator's Discretion|0
7647939|NCT02781584|12062961|FG002|Pre-treatment Phase|Investigator's Discretion|0
7647940|NCT02781584|12062962|FG003|Pre-treatment Phase|Investigator's Discretion|0
7647941|NCT02781584|12062963|FG004|Pre-treatment Phase|Investigator's Discretion|0
7647942|NCT02781584|12062964|FG005|Pre-treatment Phase|Investigator's Discretion|0
7647943|NCT02781584|12062965|FG006|Pre-treatment Phase|Investigator's Discretion|0
7647944|NCT02781584|12062966|FG007|Pre-treatment Phase|Investigator's Discretion|0
7647945|NCT02781584|12062967|FG008|Pre-treatment Phase|Investigator's Discretion|0
7647946|NCT02781584|12062968|FG009|Pre-treatment Phase|Investigator's Discretion|0
7647947|NCT02781584|12062969|FG010|Pre-treatment Phase|Investigator's Discretion|0
7647948|NCT02781584|12062970|FG011|Pre-treatment Phase|Investigator's Discretion|2
7647949|NCT02781584|12062971|FG012|Pre-treatment Phase|Investigator's Discretion|1
7647950|NCT02781584|12062959|FG000|Pre-treatment Phase|Adverse Event|0
7647951|NCT02781584|12062960|FG001|Pre-treatment Phase|Adverse Event|0
7647952|NCT02781584|12062961|FG002|Pre-treatment Phase|Adverse Event|0
7647953|NCT02781584|12062962|FG003|Pre-treatment Phase|Adverse Event|0
7647954|NCT02781584|12062963|FG004|Pre-treatment Phase|Adverse Event|0
7647955|NCT02781584|12062964|FG005|Pre-treatment Phase|Adverse Event|0
7647956|NCT02781584|12062965|FG006|Pre-treatment Phase|Adverse Event|0
7647957|NCT02781584|12062966|FG007|Pre-treatment Phase|Adverse Event|0
7647958|NCT02781584|12062967|FG008|Pre-treatment Phase|Adverse Event|0
7647959|NCT02781584|12062968|FG009|Pre-treatment Phase|Adverse Event|0
7647960|NCT02781584|12062969|FG010|Pre-treatment Phase|Adverse Event|0
7647961|NCT02781584|12062970|FG011|Pre-treatment Phase|Adverse Event|1
7647962|NCT02781584|12062971|FG012|Pre-treatment Phase|Adverse Event|0
7647963|NCT02781584|12062959|FG000|Treatment Phase|Withdrew Consent|0
7647964|NCT02781584|12062960|FG001|Treatment Phase|Withdrew Consent|0
7647965|NCT02781584|12062961|FG002|Treatment Phase|Withdrew Consent|0
7647966|NCT02781584|12062962|FG003|Treatment Phase|Withdrew Consent|0
7647967|NCT02781584|12062963|FG004|Treatment Phase|Withdrew Consent|0
7647968|NCT02781584|12062964|FG005|Treatment Phase|Withdrew Consent|1
7647969|NCT02781584|12062965|FG006|Treatment Phase|Withdrew Consent|0
7647970|NCT02781584|12062966|FG007|Treatment Phase|Withdrew Consent|0
7647971|NCT02781584|12062967|FG008|Treatment Phase|Withdrew Consent|0
7647972|NCT02781584|12062968|FG009|Treatment Phase|Withdrew Consent|0
7647973|NCT02781584|12062969|FG010|Treatment Phase|Withdrew Consent|1
7647974|NCT02781584|12062970|FG011|Treatment Phase|Withdrew Consent|2
7647975|NCT02781584|12062971|FG012|Treatment Phase|Withdrew Consent|0
7647976|NCT02781584|12062959|FG000|Treatment Phase|Adverse Event|0
7647977|NCT02781584|12062960|FG001|Treatment Phase|Adverse Event|0
7647978|NCT02781584|12062961|FG002|Treatment Phase|Adverse Event|0
7647979|NCT02781584|12062962|FG003|Treatment Phase|Adverse Event|0
7647980|NCT02781584|12062963|FG004|Treatment Phase|Adverse Event|0
7647981|NCT02781584|12062964|FG005|Treatment Phase|Adverse Event|0
7647982|NCT02781584|12062965|FG006|Treatment Phase|Adverse Event|0
7647983|NCT02781584|12062966|FG007|Treatment Phase|Adverse Event|1
7647984|NCT02781584|12062967|FG008|Treatment Phase|Adverse Event|0
7647985|NCT02781584|12062968|FG009|Treatment Phase|Adverse Event|0
7647986|NCT02781584|12062969|FG010|Treatment Phase|Adverse Event|0
7647987|NCT02781584|12062970|FG011|Treatment Phase|Adverse Event|0
7647988|NCT02781584|12062971|FG012|Treatment Phase|Adverse Event|0
7647989|NCT02707055|12063005|FG000|Phase 1|Withdrawal by Subject|1
7647990|NCT02707055|12063006|FG001|Phase 1|Withdrawal by Subject|2
7647991|NCT02707055|12063005|FG000|Phase 1|Physician Decision|0
7647992|NCT02707055|12063006|FG001|Phase 1|Physician Decision|1
7647993|NCT02707055|12063005|FG000|Phase 2|Adverse Event|1
7647994|NCT02707055|12063006|FG001|Phase 2|Adverse Event|2
7647995|NCT02656290|12063016|FG000|Overall Study|Subjects Remain On Study|26
7647996|NCT02652130|12063020|FG000|Overall Study|Death|1
7647997|NCT02616393|12063027|FG000|Overall Study|Death|5
7647998|NCT02616393|12063028|FG001|Overall Study|Death|12
7647999|NCT02616393|12063029|FG002|Overall Study|Death|1
7648000|NCT02616393|12063027|FG000|Overall Study|Termination by Sponsor|4
7648001|NCT02616393|12063028|FG001|Overall Study|Termination by Sponsor|5
7648002|NCT02616393|12063029|FG002|Overall Study|Termination by Sponsor|2
7648003|NCT02616393|12063027|FG000|Overall Study|Other|3
7648004|NCT02616393|12063028|FG001|Overall Study|Other|0
7648005|NCT02616393|12063029|FG002|Overall Study|Other|0
7648006|NCT02616393|12063027|FG000|Overall Study|Withdrawal by Subject|1
7648007|NCT02616393|12063028|FG001|Overall Study|Withdrawal by Subject|1
7648008|NCT02616393|12063029|FG002|Overall Study|Withdrawal by Subject|0
7648009|NCT02616393|12063027|FG000|Overall Study|Lost to Follow-up|0
7648010|NCT02616393|12063028|FG001|Overall Study|Lost to Follow-up|2
7648011|NCT02616393|12063029|FG002|Overall Study|Lost to Follow-up|0
7648012|NCT02602288|12063055|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14
7648013|NCT02602288|12063056|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10
7648014|NCT02602288|12063055|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2
7648015|NCT02602288|12063056|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2
7648016|NCT02602288|12063055|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9
7648017|NCT02602288|12063056|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6
7648018|NCT02602288|12063055|FG000|12 Month Follow-up|Lost to Follow-up|0
7648019|NCT02602288|12063056|FG001|12 Month Follow-up|Lost to Follow-up|4
7648020|NCT02602288|12063055|FG000|12 Month Follow-up|Withdrawal by Subject|2
7648021|NCT02602288|12063056|FG001|12 Month Follow-up|Withdrawal by Subject|0
7648022|NCT02577523|12063064|FG000|Overall Study|Adverse Event|1
7648023|NCT02577523|12063065|FG001|Overall Study|Adverse Event|1
7648024|NCT02577523|12063064|FG000|Overall Study|Lack of Efficacy|1
7648025|NCT02577523|12063065|FG001|Overall Study|Lack of Efficacy|1
7648026|NCT02577523|12063064|FG000|Overall Study|Withdrawal by Subject|1
7648027|NCT02577523|12063065|FG001|Overall Study|Withdrawal by Subject|0
7648028|NCT02427958|12063080|FG000|Overall Study|Pretreatment Event (PTE) or AE|3
7648029|NCT02427958|12063080|FG000|Overall Study|Lost to Follow-up|6
7648030|NCT02427958|12063080|FG000|Overall Study|Withdrawal by Subject|14
7648031|NCT02427958|12063080|FG000|Overall Study|Lack of Efficacy|1
7648032|NCT02425826|12063086|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
7648033|NCT02425826|12063087|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
7648034|NCT02425826|12063088|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
7648035|NCT02425826|12063086|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
7648036|NCT02425826|12063087|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
7648037|NCT02425826|12063088|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
7648038|NCT02425826|12063086|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
7648039|NCT02425826|12063087|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
7648040|NCT02425826|12063088|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
7648041|NCT02425826|12063086|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
7648042|NCT02425826|12063087|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
7648043|NCT02425826|12063088|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
7648044|NCT02425826|12063086|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3
7648045|NCT02425826|12063087|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1
7648046|NCT02425826|12063088|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0
7648047|NCT02425826|12063086|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
7648048|NCT02425826|12063087|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
7648049|NCT02425826|12063088|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
7648050|NCT02425826|12063086|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
7648051|NCT02425826|12063087|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
7648052|NCT02425826|12063088|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
7648053|NCT02425826|12063086|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
7648054|NCT02425826|12063087|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
7648055|NCT02425826|12063088|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
7648056|NCT02425826|12063086|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
7648057|NCT02425826|12063087|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
7648058|NCT02425826|12063088|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
7648059|NCT02425826|12063086|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
7648060|NCT02425826|12063087|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
7648061|NCT02425826|12063088|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
7648062|NCT01927068|12063158|FG000|Overall Study|Death|37
7648063|NCT01927068|12063159|FG001|Overall Study|Death|3
7648064|NCT01927068|12063158|FG000|Overall Study|Withdrawal by Subject|50
7648065|NCT01927068|12063159|FG001|Overall Study|Withdrawal by Subject|3
7648066|NCT01927068|12063158|FG000|Overall Study|Lost to Follow-up|10
7648067|NCT01927068|12063159|FG001|Overall Study|Lost to Follow-up|2
7648068|NCT01927068|12063158|FG000|Overall Study|Physician Decision|9
7648069|NCT01927068|12063159|FG001|Overall Study|Physician Decision|0
7648070|NCT01927068|12063158|FG000|Overall Study|Missed last follow-up visit|2
7648071|NCT01927068|12063159|FG001|Overall Study|Missed last follow-up visit|0
7648072|NCT01813435|12063177|FG000|Overall Study|did not finish experimental regimen|1902
7648073|NCT01813435|12063178|FG001|Overall Study|did not finish experimental regimen|770
7648074|NCT01813435|12063177|FG000|Overall Study|Lost to Follow-up|268
7648075|NCT01813435|12063178|FG001|Overall Study|Lost to Follow-up|237
7648076|NCT01690299|12063192|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
7648077|NCT01690299|12063193|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
7648078|NCT01690299|12063194|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
7648079|NCT01690299|12063195|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
7648080|NCT01690299|12063196|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
7648081|NCT01690299|12063197|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
7648082|NCT01690299|12063192|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
7648083|NCT01690299|12063193|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7648084|NCT01690299|12063194|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7648085|NCT01690299|12063195|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7648086|NCT01690299|12063196|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7648087|NCT01690299|12063197|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7648088|NCT01690299|12063192|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
7648089|NCT01690299|12063193|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
7648090|NCT01690299|12063194|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7648091|NCT01690299|12063195|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7648092|NCT01690299|12063196|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7648093|NCT01690299|12063197|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7648094|NCT01690299|12063192|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2
7648095|NCT01690299|12063193|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1
7648096|NCT01690299|12063194|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1
7648097|NCT01690299|12063195|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0
7648098|NCT01690299|12063196|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0
7648099|NCT01690299|12063197|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0
7648100|NCT01690299|12063192|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
7648101|NCT01690299|12063193|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
7648102|NCT01690299|12063194|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
7648103|NCT01690299|12063195|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
7648104|NCT01690299|12063196|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
7648105|NCT01690299|12063197|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
7648106|NCT01690299|12063192|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
7648107|NCT01690299|12063193|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
7648108|NCT01690299|12063194|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
7648109|NCT01690299|12063195|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
7648110|NCT01690299|12063196|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
7648111|NCT01690299|12063197|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
7648112|NCT01690299|12063192|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
7648113|NCT01690299|12063193|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
7648114|NCT01690299|12063194|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
7648115|NCT01690299|12063195|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
7648116|NCT01690299|12063196|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
7648117|NCT01690299|12063197|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
7648118|NCT01690299|12063192|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
7648119|NCT01690299|12063193|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
7648120|NCT01690299|12063194|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
7648121|NCT01690299|12063195|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
7648122|NCT01690299|12063196|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
7648123|NCT01690299|12063197|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
7648124|NCT01690299|12063192|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
7648125|NCT01690299|12063193|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
7648126|NCT01690299|12063194|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
7648127|NCT01690299|12063195|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
7648128|NCT01690299|12063196|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
7648129|NCT01690299|12063197|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
7648130|NCT01690299|12063192|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
7648131|NCT01690299|12063193|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
7648132|NCT01690299|12063194|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
7648133|NCT01690299|12063195|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
7648134|NCT01690299|12063196|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
7648135|NCT01690299|12063197|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
7648136|NCT01452152|12063251|FG000|Overall Study|Study termination by sponsor|5
7648137|NCT01452152|12063252|FG001|Overall Study|Study termination by sponsor|0
7648138|NCT01452152|12063253|FG002|Overall Study|Study termination by sponsor|4
7648139|NCT01232283|12063268|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
7648140|NCT01232283|12063269|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
7648141|NCT01232283|12063270|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7648142|NCT01232283|12063271|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7648143|NCT01232283|12063272|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7648144|NCT01232283|12063273|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7648145|NCT01232283|12063274|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7648146|NCT01232283|12063275|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7648147|NCT01232283|12063276|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7648148|NCT01232283|12063277|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7648149|NCT01232283|12063268|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
7648150|NCT01232283|12063269|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
7648151|NCT01232283|12063270|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7648152|NCT01232283|12063271|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7648153|NCT01232283|12063272|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7648154|NCT01232283|12063273|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7648155|NCT01232283|12063274|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7648156|NCT01232283|12063275|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7648157|NCT01232283|12063276|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7648158|NCT01232283|12063277|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7648159|NCT01232283|12063268|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
7648160|NCT01232283|12063269|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7648161|NCT01232283|12063270|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7648162|NCT01232283|12063271|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7648163|NCT01232283|12063272|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7648164|NCT01232283|12063273|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7648165|NCT01232283|12063274|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7648166|NCT01232283|12063275|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7648167|NCT01232283|12063276|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7648168|NCT01232283|12063277|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7648169|NCT01232283|12063268|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
7648170|NCT01232283|12063269|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
7648171|NCT01232283|12063270|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7648595|NCT01194219|12063314|FG004|Maintenance Phase Weeks16-32|Other|0
7648172|NCT01232283|12063271|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7648173|NCT01232283|12063272|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7648174|NCT01232283|12063273|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7648175|NCT01232283|12063274|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7648176|NCT01232283|12063275|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7648177|NCT01232283|12063276|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7648178|NCT01232283|12063277|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7648179|NCT01232283|12063268|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
7648180|NCT01232283|12063269|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
7648181|NCT01232283|12063270|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7648182|NCT01232283|12063271|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7648183|NCT01232283|12063272|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7648184|NCT01232283|12063273|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7648185|NCT01232283|12063274|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7648186|NCT01232283|12063275|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7648187|NCT01232283|12063276|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7648188|NCT01232283|12063277|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7648189|NCT01232283|12063268|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
7648190|NCT01232283|12063269|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
7648191|NCT01232283|12063270|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7648192|NCT01232283|12063271|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7648193|NCT01232283|12063272|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7648194|NCT01232283|12063273|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7648195|NCT01232283|12063274|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7648196|NCT01232283|12063275|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7648197|NCT01232283|12063276|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7648198|NCT01232283|12063277|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7648199|NCT01232283|12063268|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2
7648200|NCT01232283|12063269|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1
7648201|NCT01232283|12063270|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0
7648202|NCT01232283|12063271|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0
7648203|NCT01232283|12063272|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0
7648204|NCT01232283|12063273|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0
7648205|NCT01232283|12063274|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0
7648206|NCT01232283|12063275|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0
7648207|NCT01232283|12063276|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0
7648208|NCT01232283|12063277|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0
7648209|NCT01232283|12063268|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0
7648210|NCT01232283|12063269|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0
7648211|NCT01232283|12063270|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8
7648212|NCT01232283|12063271|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2
7648213|NCT01232283|12063272|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0
7648214|NCT01232283|12063273|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0
7648215|NCT01232283|12063274|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0
7648216|NCT01232283|12063275|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0
7648217|NCT01232283|12063276|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0
7648218|NCT01232283|12063277|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0
7648219|NCT01232283|12063268|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7648220|NCT01232283|12063269|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7648221|NCT01232283|12063270|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
7648222|NCT01232283|12063271|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
7648223|NCT01232283|12063272|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7648224|NCT01232283|12063273|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7648225|NCT01232283|12063274|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7648226|NCT01232283|12063275|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7648227|NCT01232283|12063276|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7648228|NCT01232283|12063277|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7648229|NCT01232283|12063268|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7648230|NCT01232283|12063269|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7648231|NCT01232283|12063270|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
7648232|NCT01232283|12063271|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7648233|NCT01232283|12063272|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7648234|NCT01232283|12063273|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7648235|NCT01232283|12063274|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7648236|NCT01232283|12063275|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7648237|NCT01232283|12063276|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7648238|NCT01232283|12063277|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7648239|NCT01232283|12063268|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7648240|NCT01232283|12063269|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7648241|NCT01232283|12063270|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
7648242|NCT01232283|12063271|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
7648243|NCT01232283|12063272|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7648244|NCT01232283|12063273|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7648245|NCT01232283|12063274|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7648246|NCT01232283|12063275|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7648247|NCT01232283|12063276|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7648248|NCT01232283|12063277|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7648249|NCT01232283|12063268|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7648250|NCT01232283|12063269|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7648251|NCT01232283|12063270|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
7648252|NCT01232283|12063271|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
7648253|NCT01232283|12063272|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7648254|NCT01232283|12063273|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7648255|NCT01232283|12063274|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7648256|NCT01232283|12063275|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7648257|NCT01232283|12063276|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7648258|NCT01232283|12063277|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7648259|NCT01232283|12063268|FG000|Maintenance Phase (Weeks16-32)|Other|0
7648260|NCT01232283|12063269|FG001|Maintenance Phase (Weeks16-32)|Other|0
7648261|NCT01232283|12063270|FG002|Maintenance Phase (Weeks16-32)|Other|2
7648262|NCT01232283|12063271|FG003|Maintenance Phase (Weeks16-32)|Other|0
7648263|NCT01232283|12063272|FG004|Maintenance Phase (Weeks16-32)|Other|0
7648264|NCT01232283|12063273|FG005|Maintenance Phase (Weeks16-32)|Other|0
7648265|NCT01232283|12063274|FG006|Maintenance Phase (Weeks16-32)|Other|0
7648266|NCT01232283|12063275|FG007|Maintenance Phase (Weeks16-32)|Other|0
7648267|NCT01232283|12063276|FG008|Maintenance Phase (Weeks16-32)|Other|0
7648268|NCT01232283|12063277|FG009|Maintenance Phase (Weeks16-32)|Other|0
7648269|NCT01232283|12063268|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7648270|NCT01232283|12063269|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7648271|NCT01232283|12063270|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7648272|NCT01232283|12063271|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7648273|NCT01232283|12063272|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
7648274|NCT01232283|12063273|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
7648275|NCT01232283|12063274|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7648276|NCT01232283|12063275|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
7648277|NCT01232283|12063276|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7648278|NCT01232283|12063277|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7648279|NCT01232283|12063268|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7648280|NCT01232283|12063269|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7648281|NCT01232283|12063270|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7648282|NCT01232283|12063271|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7648283|NCT01232283|12063272|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
7648284|NCT01232283|12063273|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7648285|NCT01232283|12063274|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
7648286|NCT01232283|12063275|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
7648287|NCT01232283|12063276|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7648288|NCT01232283|12063277|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7648289|NCT01232283|12063268|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7648290|NCT01232283|12063269|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7648291|NCT01232283|12063270|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7648292|NCT01232283|12063271|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7648293|NCT01232283|12063272|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
7648294|NCT01232283|12063273|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
7648295|NCT01232283|12063274|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
7648296|NCT01232283|12063275|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
7648297|NCT01232283|12063276|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7648298|NCT01232283|12063277|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7648299|NCT01232283|12063268|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7648300|NCT01232283|12063269|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7648301|NCT01232283|12063270|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7648302|NCT01232283|12063271|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7648303|NCT01232283|12063272|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
7648304|NCT01232283|12063273|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7648305|NCT01232283|12063274|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7648306|NCT01232283|12063275|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7648307|NCT01232283|12063276|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7648308|NCT01232283|12063277|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7648309|NCT01232283|12063268|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7648310|NCT01232283|12063269|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7648311|NCT01232283|12063270|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7648312|NCT01232283|12063271|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7648313|NCT01232283|12063272|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
7648314|NCT01232283|12063273|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7648315|NCT01232283|12063274|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
7648316|NCT01232283|12063275|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
7648317|NCT01232283|12063276|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7648318|NCT01232283|12063277|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7648319|NCT01232283|12063268|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7648320|NCT01232283|12063269|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7648321|NCT01232283|12063270|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7648322|NCT01232283|12063271|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7648323|NCT01232283|12063272|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7648324|NCT01232283|12063273|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7648325|NCT01232283|12063274|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7648326|NCT01232283|12063275|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
7648327|NCT01232283|12063276|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7648328|NCT01232283|12063277|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7648329|NCT01232283|12063268|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7648330|NCT01232283|12063269|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7648331|NCT01232283|12063270|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7648332|NCT01232283|12063271|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7648333|NCT01232283|12063272|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7648334|NCT01232283|12063273|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
7648335|NCT01232283|12063274|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7648336|NCT01232283|12063275|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7648337|NCT01232283|12063276|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7648338|NCT01232283|12063277|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7648339|NCT01232283|12063268|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7648340|NCT01232283|12063269|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7648341|NCT01232283|12063270|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7648342|NCT01232283|12063271|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7648343|NCT01232283|12063272|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7648344|NCT01232283|12063273|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7648345|NCT01232283|12063274|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7648346|NCT01232283|12063275|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7648347|NCT01232283|12063276|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
7648348|NCT01232283|12063277|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
7648349|NCT01232283|12063268|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7648350|NCT01232283|12063269|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7648351|NCT01232283|12063270|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7648352|NCT01232283|12063271|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7648353|NCT01232283|12063272|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7648354|NCT01232283|12063273|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7648355|NCT01232283|12063274|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7648356|NCT01232283|12063275|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7648357|NCT01232283|12063276|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
7648358|NCT01232283|12063277|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
7648359|NCT01232283|12063268|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7648360|NCT01232283|12063269|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7648361|NCT01232283|12063270|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7648362|NCT01232283|12063271|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7648363|NCT01232283|12063272|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7648364|NCT01232283|12063273|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7648365|NCT01232283|12063274|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7648366|NCT01232283|12063275|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7648367|NCT01232283|12063276|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
7648368|NCT01232283|12063277|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
7648369|NCT01232283|12063268|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7648370|NCT01232283|12063269|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7648371|NCT01232283|12063270|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7648372|NCT01232283|12063271|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7648373|NCT01232283|12063272|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7648374|NCT01232283|12063273|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7648375|NCT01232283|12063274|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7648376|NCT01232283|12063275|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7648377|NCT01232283|12063276|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
7648378|NCT01232283|12063277|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
7648379|NCT01232283|12063268|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7648380|NCT01232283|12063269|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7648381|NCT01232283|12063270|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7648382|NCT01232283|12063271|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7648383|NCT01232283|12063272|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7648384|NCT01232283|12063273|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7648385|NCT01232283|12063274|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7648386|NCT01232283|12063275|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7648387|NCT01232283|12063276|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
7648388|NCT01232283|12063277|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
7648389|NCT01232283|12063268|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0
7648390|NCT01232283|12063269|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0
7648391|NCT01232283|12063270|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0
7648392|NCT01232283|12063271|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0
7648393|NCT01232283|12063272|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0
7648394|NCT01232283|12063273|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0
7648395|NCT01232283|12063274|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0
7648396|NCT01232283|12063275|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0
7648397|NCT01232283|12063276|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1
7648398|NCT01232283|12063277|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0
7648399|NCT01232283|12063268|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7648400|NCT01232283|12063269|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7648401|NCT01232283|12063270|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7648402|NCT01232283|12063271|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7648403|NCT01232283|12063272|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7648404|NCT01232283|12063273|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7648405|NCT01232283|12063274|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7648406|NCT01232283|12063275|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7648407|NCT01232283|12063276|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
7648408|NCT01232283|12063277|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7648409|NCT01232283|12063268|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7648410|NCT01232283|12063269|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7648411|NCT01232283|12063270|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7648412|NCT01232283|12063271|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7648413|NCT01232283|12063272|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7648414|NCT01232283|12063273|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7648415|NCT01232283|12063274|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7648416|NCT01232283|12063275|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7648417|NCT01232283|12063276|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
7648418|NCT01232283|12063277|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
7648419|NCT01231516|12063301|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4
7648420|NCT01231516|12063302|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11
7648421|NCT01231516|12063301|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20
7648422|NCT01231516|12063302|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42
7648423|NCT01231516|12063301|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9
7648424|NCT01231516|12063302|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6
7648425|NCT01231516|12063301|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5
7648426|NCT01231516|12063302|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3
7648427|NCT01231516|12063301|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5
7648428|NCT01231516|12063302|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10
7648429|NCT01231516|12063301|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1
7648430|NCT01231516|12063302|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1
7648431|NCT01231516|12063301|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11
7648432|NCT01231516|12063302|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5
7648433|NCT01231516|12063301|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3
7648434|NCT01231516|12063302|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1
7648435|NCT01231516|12063301|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3
7648436|NCT01231516|12063302|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2
7648437|NCT01231516|12063301|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5
7648438|NCT01231516|12063302|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0
7648439|NCT01231516|12063301|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27
7648440|NCT01231516|12063302|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11
7648441|NCT01231516|12063301|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10
7648442|NCT01231516|12063302|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0
7648443|NCT01231516|12063301|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6
7648444|NCT01231516|12063302|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3
7648445|NCT01231516|12063301|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2
7648446|NCT01231516|12063302|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0
7648447|NCT01231516|12063301|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6
7648448|NCT01231516|12063302|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1
7648449|NCT01231516|12063301|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12
7648450|NCT01231516|12063302|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2
7648596|NCT01194219|12063315|FG005|Maintenance Phase Weeks16-32|Other|0
7648451|NCT01194219|12063310|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
7648452|NCT01194219|12063311|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
7648453|NCT01194219|12063312|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7648454|NCT01194219|12063313|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7648455|NCT01194219|12063314|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7648456|NCT01194219|12063315|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7648457|NCT01194219|12063316|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7648458|NCT01194219|12063317|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7648459|NCT01194219|12063318|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7648460|NCT01194219|12063319|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7648461|NCT01194219|12063310|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
7648462|NCT01194219|12063311|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
7648463|NCT01194219|12063312|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7648464|NCT01194219|12063313|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7648465|NCT01194219|12063314|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7648466|NCT01194219|12063315|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7648467|NCT01194219|12063316|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7648468|NCT01194219|12063317|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7648469|NCT01194219|12063318|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7648470|NCT01194219|12063319|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7648471|NCT01194219|12063310|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
7648472|NCT01194219|12063311|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7648473|NCT01194219|12063312|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7648474|NCT01194219|12063313|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7648475|NCT01194219|12063314|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7648476|NCT01194219|12063315|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7648477|NCT01194219|12063316|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7648478|NCT01194219|12063317|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7648479|NCT01194219|12063318|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7648480|NCT01194219|12063319|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7648481|NCT01194219|12063310|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
7648482|NCT01194219|12063311|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
7648483|NCT01194219|12063312|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7648484|NCT01194219|12063313|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7648485|NCT01194219|12063314|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7648486|NCT01194219|12063315|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7648487|NCT01194219|12063316|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7648488|NCT01194219|12063317|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7648489|NCT01194219|12063318|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7648490|NCT01194219|12063319|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7648491|NCT01194219|12063310|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0
7648492|NCT01194219|12063311|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1
7648493|NCT01194219|12063312|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0
7648494|NCT01194219|12063313|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0
7648495|NCT01194219|12063314|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0
7648496|NCT01194219|12063315|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0
7648497|NCT01194219|12063316|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0
7648498|NCT01194219|12063317|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0
7648499|NCT01194219|12063318|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0
7648500|NCT01194219|12063319|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0
7648501|NCT01194219|12063310|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
7648502|NCT01194219|12063311|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
7648503|NCT01194219|12063312|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7648504|NCT01194219|12063313|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7648505|NCT01194219|12063314|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7648506|NCT01194219|12063315|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7648507|NCT01194219|12063316|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7648508|NCT01194219|12063317|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7648509|NCT01194219|12063318|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7648510|NCT01194219|12063319|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7648511|NCT01194219|12063310|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
7648512|NCT01194219|12063311|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
7648513|NCT01194219|12063312|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7648514|NCT01194219|12063313|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7648515|NCT01194219|12063314|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7648516|NCT01194219|12063315|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7648517|NCT01194219|12063316|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7648518|NCT01194219|12063317|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7648519|NCT01194219|12063318|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7648520|NCT01194219|12063319|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7648521|NCT01194219|12063310|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
7648597|NCT01194219|12063316|FG006|Maintenance Phase Weeks16-32|Other|0
7648522|NCT01194219|12063311|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
7648523|NCT01194219|12063312|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7648524|NCT01194219|12063313|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7648525|NCT01194219|12063314|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7648526|NCT01194219|12063315|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7648527|NCT01194219|12063316|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7648528|NCT01194219|12063317|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7648529|NCT01194219|12063318|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7648530|NCT01194219|12063319|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7648531|NCT01194219|12063310|FG000|Maintenance Phase Weeks16-32|Adverse Event|0
7648532|NCT01194219|12063311|FG001|Maintenance Phase Weeks16-32|Adverse Event|0
7648533|NCT01194219|12063312|FG002|Maintenance Phase Weeks16-32|Adverse Event|8
7648534|NCT01194219|12063313|FG003|Maintenance Phase Weeks16-32|Adverse Event|9
7648535|NCT01194219|12063314|FG004|Maintenance Phase Weeks16-32|Adverse Event|0
7648536|NCT01194219|12063315|FG005|Maintenance Phase Weeks16-32|Adverse Event|0
7648537|NCT01194219|12063316|FG006|Maintenance Phase Weeks16-32|Adverse Event|0
7648538|NCT01194219|12063317|FG007|Maintenance Phase Weeks16-32|Adverse Event|0
7648539|NCT01194219|12063318|FG008|Maintenance Phase Weeks16-32|Adverse Event|0
7648540|NCT01194219|12063319|FG009|Maintenance Phase Weeks16-32|Adverse Event|0
7648541|NCT01194219|12063310|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7648542|NCT01194219|12063311|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7648543|NCT01194219|12063312|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37
7648544|NCT01194219|12063313|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15
7648545|NCT01194219|12063314|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7648546|NCT01194219|12063315|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7648547|NCT01194219|12063316|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7648548|NCT01194219|12063317|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7648549|NCT01194219|12063318|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7648550|NCT01194219|12063319|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7648551|NCT01194219|12063310|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7648552|NCT01194219|12063311|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7648553|NCT01194219|12063312|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
7648554|NCT01194219|12063313|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
7648555|NCT01194219|12063314|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7648556|NCT01194219|12063315|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7648557|NCT01194219|12063316|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7648558|NCT01194219|12063317|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7648559|NCT01194219|12063318|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7648560|NCT01194219|12063319|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7648561|NCT01194219|12063310|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7648562|NCT01194219|12063311|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7648563|NCT01194219|12063312|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
7648564|NCT01194219|12063313|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
7648565|NCT01194219|12063314|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7648566|NCT01194219|12063315|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7648567|NCT01194219|12063316|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7648568|NCT01194219|12063317|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7648569|NCT01194219|12063318|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7648570|NCT01194219|12063319|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7648571|NCT01194219|12063310|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7648572|NCT01194219|12063311|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7648573|NCT01194219|12063312|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9
7648574|NCT01194219|12063313|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7648575|NCT01194219|12063314|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7648576|NCT01194219|12063315|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7648577|NCT01194219|12063316|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7648578|NCT01194219|12063317|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7648579|NCT01194219|12063318|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7648580|NCT01194219|12063319|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7648581|NCT01194219|12063310|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0
7648582|NCT01194219|12063311|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0
7648583|NCT01194219|12063312|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0
7648584|NCT01194219|12063313|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1
7648585|NCT01194219|12063314|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0
7648586|NCT01194219|12063315|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0
7648587|NCT01194219|12063316|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0
7648588|NCT01194219|12063317|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0
7648589|NCT01194219|12063318|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0
7648590|NCT01194219|12063319|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0
7648591|NCT01194219|12063310|FG000|Maintenance Phase Weeks16-32|Other|0
7648592|NCT01194219|12063311|FG001|Maintenance Phase Weeks16-32|Other|0
7648593|NCT01194219|12063312|FG002|Maintenance Phase Weeks16-32|Other|2
7648594|NCT01194219|12063313|FG003|Maintenance Phase Weeks16-32|Other|1
7648598|NCT01194219|12063317|FG007|Maintenance Phase Weeks16-32|Other|0
7648599|NCT01194219|12063318|FG008|Maintenance Phase Weeks16-32|Other|0
7648600|NCT01194219|12063319|FG009|Maintenance Phase Weeks16-32|Other|0
7648601|NCT01194219|12063310|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7648602|NCT01194219|12063311|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7648603|NCT01194219|12063312|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7648604|NCT01194219|12063313|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7648605|NCT01194219|12063314|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7648606|NCT01194219|12063315|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
7648607|NCT01194219|12063316|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
7648608|NCT01194219|12063317|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
7648609|NCT01194219|12063318|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7648610|NCT01194219|12063319|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7648611|NCT01194219|12063310|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7648612|NCT01194219|12063311|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7648613|NCT01194219|12063312|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7648614|NCT01194219|12063313|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7648615|NCT01194219|12063314|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
7648616|NCT01194219|12063315|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
7648617|NCT01194219|12063316|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
7648618|NCT01194219|12063317|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
7648619|NCT01194219|12063318|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7648620|NCT01194219|12063319|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7648621|NCT01194219|12063310|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7648622|NCT01194219|12063311|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7648623|NCT01194219|12063312|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7648624|NCT01194219|12063313|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7648625|NCT01194219|12063314|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
7648626|NCT01194219|12063315|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7648627|NCT01194219|12063316|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
7648628|NCT01194219|12063317|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7648629|NCT01194219|12063318|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7648630|NCT01194219|12063319|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7648631|NCT01194219|12063310|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7648632|NCT01194219|12063311|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7648633|NCT01194219|12063312|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7648634|NCT01194219|12063313|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7648635|NCT01194219|12063314|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
7648636|NCT01194219|12063315|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7648637|NCT01194219|12063316|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
7648638|NCT01194219|12063317|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
7648639|NCT01194219|12063318|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7648640|NCT01194219|12063319|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7648641|NCT01194219|12063310|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7648642|NCT01194219|12063311|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7648643|NCT01194219|12063312|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7648644|NCT01194219|12063313|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7648645|NCT01194219|12063314|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
7648646|NCT01194219|12063315|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
7648647|NCT01194219|12063316|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
7648648|NCT01194219|12063317|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7648649|NCT01194219|12063318|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7648650|NCT01194219|12063319|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7648651|NCT01194219|12063310|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7648652|NCT01194219|12063311|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7648653|NCT01194219|12063312|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7648654|NCT01194219|12063313|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7648655|NCT01194219|12063314|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7648656|NCT01194219|12063315|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7648657|NCT01194219|12063316|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7648658|NCT01194219|12063317|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
7648659|NCT01194219|12063318|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7648660|NCT01194219|12063319|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7648661|NCT01194219|12063310|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7648662|NCT01194219|12063311|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7648663|NCT01194219|12063312|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7648664|NCT01194219|12063313|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7648665|NCT01194219|12063314|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7648666|NCT01194219|12063315|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7648667|NCT01194219|12063316|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1
7648668|NCT01194219|12063317|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7648669|NCT01194219|12063318|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7648670|NCT01194219|12063319|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7648671|NCT01194219|12063310|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7648672|NCT01194219|12063311|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7648673|NCT01194219|12063312|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7648674|NCT01194219|12063313|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7648675|NCT01194219|12063314|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7648676|NCT01194219|12063315|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7648677|NCT01194219|12063316|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7648678|NCT01194219|12063317|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7648679|NCT01194219|12063318|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25
7648680|NCT01194219|12063319|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14
7648681|NCT01194219|12063310|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7648682|NCT01194219|12063311|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7648683|NCT01194219|12063312|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7648684|NCT01194219|12063313|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7648685|NCT01194219|12063314|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7648686|NCT01194219|12063315|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7648687|NCT01194219|12063316|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7648688|NCT01194219|12063317|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7648689|NCT01194219|12063318|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
7648690|NCT01194219|12063319|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
7648691|NCT01194219|12063310|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7648692|NCT01194219|12063311|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7648693|NCT01194219|12063312|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7648694|NCT01194219|12063313|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7648695|NCT01194219|12063314|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7648696|NCT01194219|12063315|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7648697|NCT01194219|12063316|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7648698|NCT01194219|12063317|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7648699|NCT01194219|12063318|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
7648700|NCT01194219|12063319|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
7648701|NCT01194219|12063310|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7648702|NCT01194219|12063311|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7648703|NCT01194219|12063312|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7648704|NCT01194219|12063313|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7648705|NCT01194219|12063314|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7648706|NCT01194219|12063315|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7648707|NCT01194219|12063316|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7648708|NCT01194219|12063317|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7648709|NCT01194219|12063318|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
7648710|NCT01194219|12063319|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
7648711|NCT01194219|12063310|FG000|Long-Term Extension Weeks 52 to 260|Death|0
7648712|NCT01194219|12063311|FG001|Long-Term Extension Weeks 52 to 260|Death|0
7648713|NCT01194219|12063312|FG002|Long-Term Extension Weeks 52 to 260|Death|0
7648714|NCT01194219|12063313|FG003|Long-Term Extension Weeks 52 to 260|Death|0
7648715|NCT01194219|12063314|FG004|Long-Term Extension Weeks 52 to 260|Death|0
7648716|NCT01194219|12063315|FG005|Long-Term Extension Weeks 52 to 260|Death|0
7648717|NCT01194219|12063316|FG006|Long-Term Extension Weeks 52 to 260|Death|0
7648718|NCT01194219|12063317|FG007|Long-Term Extension Weeks 52 to 260|Death|0
7648719|NCT01194219|12063318|FG008|Long-Term Extension Weeks 52 to 260|Death|1
7648720|NCT01194219|12063319|FG009|Long-Term Extension Weeks 52 to 260|Death|1
7648721|NCT01194219|12063310|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7648722|NCT01194219|12063311|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7648723|NCT01194219|12063312|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7648724|NCT01194219|12063313|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7648725|NCT01194219|12063314|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7648726|NCT01194219|12063315|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7648727|NCT01194219|12063316|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7648728|NCT01194219|12063317|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7648729|NCT01194219|12063318|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
7648730|NCT01194219|12063319|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
7648731|NCT01194219|12063310|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7648732|NCT01194219|12063311|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7648733|NCT01194219|12063312|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7648734|NCT01194219|12063313|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7648735|NCT01194219|12063314|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7648736|NCT01194219|12063315|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7648737|NCT01194219|12063316|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7648738|NCT01194219|12063317|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7648739|NCT01194219|12063318|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
7648740|NCT01194219|12063319|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7648741|NCT01194219|12063310|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7648742|NCT01194219|12063311|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7648743|NCT01194219|12063312|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7648744|NCT01194219|12063313|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7648745|NCT01194219|12063314|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7648746|NCT01194219|12063315|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7648747|NCT01194219|12063316|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7648748|NCT01194219|12063317|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7648749|NCT01194219|12063318|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
7648750|NCT01194219|12063319|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
7648751|NCT01193842|12063347|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
7648752|NCT01193842|12063348|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
7648753|NCT01193842|12063349|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
7648754|NCT01193842|12063350|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
7648755|NCT01193842|12063351|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
7648756|NCT01193842|12063347|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
7648757|NCT01193842|12063348|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
7648758|NCT01193842|12063349|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
7648759|NCT01193842|12063350|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
7648760|NCT01193842|12063351|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
7648761|NCT01193842|12063347|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
7648762|NCT01193842|12063348|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
7648763|NCT01193842|12063349|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
7648764|NCT01193842|12063350|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
7648765|NCT01193842|12063351|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
7648766|NCT01193842|12063347|FG000|Phase II: Randomized Groups|Death|0
7648767|NCT01193842|12063348|FG001|Phase II: Randomized Groups|Death|0
7648768|NCT01193842|12063349|FG002|Phase II: Randomized Groups|Death|0
7648769|NCT01193842|12063350|FG003|Phase II: Randomized Groups|Death|1
7648770|NCT01193842|12063351|FG004|Phase II: Randomized Groups|Death|1
7648771|NCT01193842|12063347|FG000|Phase II: Randomized Groups|Adverse Event|0
7648772|NCT01193842|12063348|FG001|Phase II: Randomized Groups|Adverse Event|0
7648773|NCT01193842|12063349|FG002|Phase II: Randomized Groups|Adverse Event|0
7648774|NCT01193842|12063350|FG003|Phase II: Randomized Groups|Adverse Event|5
7648775|NCT01193842|12063351|FG004|Phase II: Randomized Groups|Adverse Event|3
7648776|NCT01193842|12063347|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0
7648777|NCT01193842|12063348|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0
7648778|NCT01193842|12063349|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0
7648779|NCT01193842|12063350|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1
7648780|NCT01193842|12063351|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2
7648781|NCT01193842|12063347|FG000|Phase II: Randomized Groups|Ineligible|0
7648782|NCT01193842|12063348|FG001|Phase II: Randomized Groups|Ineligible|0
7648783|NCT01193842|12063349|FG002|Phase II: Randomized Groups|Ineligible|0
7648784|NCT01193842|12063350|FG003|Phase II: Randomized Groups|Ineligible|0
7648785|NCT01193842|12063351|FG004|Phase II: Randomized Groups|Ineligible|1
7648786|NCT01193842|12063347|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
7648787|NCT01193842|12063348|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
7648788|NCT01193842|12063349|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
7648789|NCT01193842|12063350|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
7648790|NCT01193842|12063351|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
7648791|NCT00855803|12063368|FG000|Overall Study|Death|2
7648792|NCT00855803|12063368|FG000|Overall Study|Lost to Follow-up|2
7648793|NCT00855803|12063368|FG000|Overall Study|Technical inability to undergo procedure|2
7648794|NCT00855803|12063368|FG000|Overall Study|Not evaluable at 3 month timepoint|2
7648795|NCT00855803|12063368|FG000|Overall Study|Withdrawal by Subject|3
7648796|NCT00855803|12063368|FG000|Overall Study|Physician Decision|3
7648797|NCT00740116|12063378|FG000|Overall Study|Withdrawal by Subject|1
7648798|NCT00740116|12063379|FG001|Overall Study|Withdrawal by Subject|1
7648799|NCT00740116|12063378|FG000|Overall Study|Protocol Violation|1
7648800|NCT00740116|12063379|FG001|Overall Study|Protocol Violation|4
7648801|NCT00565617|12063387|FG000|Overall Study|Withdrawal by Subject|1
7648802|NCT00142584|12063413|FG000|Overall Study|Sponsor Termination of Study, etc.|72
7648803|NCT00142584|12063414|FG001|Overall Study|Sponsor Termination of Study, etc.|16
7648804|NCT00142584|12063413|FG000|Overall Study|Withdrawal by Subject|30
7648805|NCT00142584|12063414|FG001|Overall Study|Withdrawal by Subject|16
7648806|NCT00142584|12063413|FG000|Overall Study|Lost to Follow-up|22
7648807|NCT00142584|12063414|FG001|Overall Study|Lost to Follow-up|12
7648808|NCT00142584|12063413|FG000|Overall Study|Adverse Event|14
7648809|NCT00142584|12063414|FG001|Overall Study|Adverse Event|5
7648810|NCT00142584|12063413|FG000|Overall Study|Protocol Violation|4
7648811|NCT00142584|12063414|FG001|Overall Study|Protocol Violation|7
7648812|NCT00142584|12063413|FG000|Overall Study|Treatment Failure|2
7648813|NCT00142584|12063414|FG001|Overall Study|Treatment Failure|0
7648814|NCT04551898|12063444|FG000|Overall Study|Participant randomized but did not receive study drug|0
7648815|NCT04551898|12063445|FG001|Overall Study|Participant randomized but did not receive study drug|1
7648816|NCT04551898|12063446|FG002|Overall Study|Participant randomized but did not receive study drug|3
7648817|NCT04551898|12063447|FG003|Overall Study|Participant randomized but did not receive study drug|1
7648818|NCT04551898|12063444|FG000|Overall Study|Withdrawal by Subject|5
7648819|NCT04551898|12063445|FG001|Overall Study|Withdrawal by Subject|1
7648820|NCT04551898|12063446|FG002|Overall Study|Withdrawal by Subject|2
7648821|NCT04551898|12063447|FG003|Overall Study|Withdrawal by Subject|2
7648822|NCT04551898|12063444|FG000|Overall Study|Lost to Follow-up|2
7648823|NCT04551898|12063445|FG001|Overall Study|Lost to Follow-up|1
7648824|NCT04551898|12063446|FG002|Overall Study|Lost to Follow-up|2
7648825|NCT04551898|12063447|FG003|Overall Study|Lost to Follow-up|2
7648826|NCT04551898|12063444|FG000|Overall Study|Death|1
7648827|NCT04551898|12063445|FG001|Overall Study|Death|0
7648828|NCT04551898|12063446|FG002|Overall Study|Death|0
7648829|NCT04551898|12063447|FG003|Overall Study|Death|0
7648830|NCT04551898|12063444|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0
7648831|NCT04551898|12063445|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0
7648832|NCT04551898|12063446|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1
7648833|NCT04551898|12063447|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0
7648834|NCT04402866|12063469|FG000|Overall Study|Discontinued Prior to Treatment|0
7648835|NCT04402866|12063470|FG001|Overall Study|Discontinued Prior to Treatment|0
7648836|NCT04402866|12063471|FG002|Overall Study|Discontinued Prior to Treatment|0
7648837|NCT04402866|12063472|FG003|Overall Study|Discontinued Prior to Treatment|0
7648838|NCT04402866|12063473|FG004|Overall Study|Discontinued Prior to Treatment|2
7648839|NCT04402866|12063474|FG005|Overall Study|Discontinued Prior to Treatment|3
7648840|NCT04402866|12063469|FG000|Overall Study|Adverse Event|2
7648841|NCT04402866|12063470|FG001|Overall Study|Adverse Event|1
7648842|NCT04402866|12063471|FG002|Overall Study|Adverse Event|0
7648843|NCT04402866|12063472|FG003|Overall Study|Adverse Event|0
7648844|NCT04402866|12063473|FG004|Overall Study|Adverse Event|13
7648845|NCT04402866|12063474|FG005|Overall Study|Adverse Event|8
7648846|NCT04402866|12063469|FG000|Overall Study|Miscellaneous|0
7648847|NCT04402866|12063470|FG001|Overall Study|Miscellaneous|0
7648848|NCT04402866|12063471|FG002|Overall Study|Miscellaneous|1
7648849|NCT04402866|12063472|FG003|Overall Study|Miscellaneous|0
7648850|NCT04402866|12063473|FG004|Overall Study|Miscellaneous|0
7648851|NCT04402866|12063474|FG005|Overall Study|Miscellaneous|0
7648852|NCT04402866|12063469|FG000|Overall Study|Lost to Follow-up|0
7648853|NCT04402866|12063470|FG001|Overall Study|Lost to Follow-up|0
7648854|NCT04402866|12063471|FG002|Overall Study|Lost to Follow-up|0
7648855|NCT04402866|12063472|FG003|Overall Study|Lost to Follow-up|0
7648856|NCT04402866|12063473|FG004|Overall Study|Lost to Follow-up|0
7648857|NCT04402866|12063474|FG005|Overall Study|Lost to Follow-up|1
7648858|NCT04402866|12063469|FG000|Overall Study|Withdrawal by Subject|0
7648859|NCT04402866|12063470|FG001|Overall Study|Withdrawal by Subject|0
7648860|NCT04402866|12063471|FG002|Overall Study|Withdrawal by Subject|0
7648861|NCT04402866|12063472|FG003|Overall Study|Withdrawal by Subject|0
7648862|NCT04402866|12063473|FG004|Overall Study|Withdrawal by Subject|0
7648863|NCT04402866|12063474|FG005|Overall Study|Withdrawal by Subject|2
7648864|NCT04327388|12063487|FG000|Overall Study|Adverse Event|17
7648865|NCT04327388|12063488|FG001|Overall Study|Adverse Event|18
7648866|NCT04327388|12063489|FG002|Overall Study|Adverse Event|9
7648867|NCT04327388|12063487|FG000|Overall Study|Other|1
7648868|NCT04327388|12063488|FG001|Overall Study|Other|2
7648869|NCT04327388|12063489|FG002|Overall Study|Other|0
7648870|NCT04327388|12063487|FG000|Overall Study|Randomized and not treated|2
7648871|NCT04327388|12063488|FG001|Overall Study|Randomized and not treated|0
7648872|NCT04327388|12063489|FG002|Overall Study|Randomized and not treated|2
7648873|NCT03860259|12063499|FG000|Overall Study|Lost to Follow-up|5
7648874|NCT03860259|12063500|FG001|Overall Study|Lost to Follow-up|5
7648875|NCT03860259|12063499|FG000|Overall Study|Protocol Violation|1
7648876|NCT03860259|12063500|FG001|Overall Study|Protocol Violation|0
7648877|NCT03388138|12063522|FG000|Overall Study|Protocol Violation|1
7648878|NCT03388138|12063523|FG001|Overall Study|Protocol Violation|0
7648879|NCT02981082|12063589|FG000|Overall Study|Withdrawal by Subject|2
7648880|NCT02981082|12063590|FG001|Overall Study|Withdrawal by Subject|0
7648881|NCT02981082|12063589|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1
7648882|NCT02981082|12063590|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0
7648883|NCT02981082|12063589|FG000|Overall Study|Adverse Event|0
7648884|NCT02981082|12063590|FG001|Overall Study|Adverse Event|1
7648893|NCT02741700|12063607|FG000|Overall Study|Lost to Follow-up|17
7648894|NCT02741700|12063608|FG001|Overall Study|Lost to Follow-up|8
7648895|NCT02741700|12063607|FG000|Overall Study|Withdrawal by Subject|2
7648896|NCT02741700|12063608|FG001|Overall Study|Withdrawal by Subject|5
7648897|NCT02741700|12063607|FG000|Overall Study|Physician Decision|3
7648898|NCT02741700|12063608|FG001|Overall Study|Physician Decision|0
7648899|NCT02741700|12063607|FG000|Overall Study|Moved out of State|0
7648900|NCT02741700|12063608|FG001|Overall Study|Moved out of State|1
7648901|NCT02741700|12063607|FG000|Overall Study|Death|4
7648902|NCT02741700|12063608|FG001|Overall Study|Death|5
7648903|NCT02635776|12063616|FG000|Overall Study|Physician Decision|1
7648904|NCT02635776|12063617|FG001|Overall Study|Physician Decision|0
7648905|NCT02635776|12063616|FG000|Overall Study|Adverse Event|51
7648906|NCT02635776|12063617|FG001|Overall Study|Adverse Event|3
7648907|NCT02635776|12063616|FG000|Overall Study|Withdrawal by Subject|41
7648908|NCT02635776|12063617|FG001|Overall Study|Withdrawal by Subject|7
7648909|NCT02635776|12063616|FG000|Overall Study|Lost to Follow-up|4
7648910|NCT02635776|12063617|FG001|Overall Study|Lost to Follow-up|0
7648911|NCT02635776|12063616|FG000|Overall Study|Other reasons|5
7648912|NCT02635776|12063617|FG001|Overall Study|Other reasons|1
7648913|NCT02609724|12063628|FG000|Overall Study|Death|2
7648914|NCT02609724|12063629|FG001|Overall Study|Death|0
7648915|NCT02609724|12063630|FG002|Overall Study|Death|1
7648916|NCT02609724|12063628|FG000|Overall Study|Withdrawal by Subject|1
7648917|NCT02609724|12063629|FG001|Overall Study|Withdrawal by Subject|2
7648918|NCT02609724|12063630|FG002|Overall Study|Withdrawal by Subject|3
7648919|NCT02609724|12063628|FG000|Overall Study|Illness|2
7648920|NCT02609724|12063629|FG001|Overall Study|Illness|1
7648921|NCT02609724|12063630|FG002|Overall Study|Illness|0
7648922|NCT02359994|12063640|FG000|Overall Population Study|Adverse Event|1
7648923|NCT02359994|12063641|FG001|Overall Population Study|Adverse Event|1
7648924|NCT02359994|12063640|FG000|Overall Population Study|Death|1
7648925|NCT02359994|12063641|FG001|Overall Population Study|Death|5
7648926|NCT02359994|12063640|FG000|Overall Population Study|Lost to Follow-up|1
7648927|NCT02359994|12063641|FG001|Overall Population Study|Lost to Follow-up|1
7648928|NCT02359994|12063640|FG000|Overall Population Study|Withdrawal by Subject|1
7648929|NCT02359994|12063641|FG001|Overall Population Study|Withdrawal by Subject|0
7648930|NCT02359994|12063640|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1
7648931|NCT02359994|12063641|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0
7648932|NCT02359994|12063640|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0
7648933|NCT02359994|12063641|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1
7648934|NCT02359994|12063640|FG000|Extended Oncology 24-Month Survival|Death|19
7648935|NCT02359994|12063641|FG001|Extended Oncology 24-Month Survival|Death|21
7648936|NCT02359994|12063640|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1
7648937|NCT02359994|12063641|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0
7648938|NCT02336230|12063647|FG000|Overall Study|Adverse Event|1
7648939|NCT02336230|12063647|FG000|Overall Study|Withdrawal of consent|1
7648940|NCT02336230|12063647|FG000|Overall Study|Death|9
7648941|NCT02336230|12063647|FG000|Overall Study|Dose not received due to shipping delay|1
7648942|NCT02336230|12063647|FG000|Overall Study|Discontinuation of MSC infusion|1
7648943|NCT01557751|12063651|FG000|Overall Study|Physician Decision|3
7648944|NCT03790917|12063686|FG000|Overall Study|Death|1
7648945|NCT05017493|12063702|FG000|Overall Study|Withdrawal by Subject|26
7648946|NCT05017493|12063703|FG001|Overall Study|Withdrawal by Subject|0
7648947|NCT05017493|12063702|FG000|Overall Study|Physician Decision|15
7648948|NCT05017493|12063703|FG001|Overall Study|Physician Decision|0
7648949|NCT05017493|12063702|FG000|Overall Study|Protocol Violation|81
7648950|NCT05017493|12063703|FG001|Overall Study|Protocol Violation|0
7648951|NCT04348500|12063736|FG000|Overall Study|Death|2
7648952|NCT04348500|12063737|FG001|Overall Study|Death|2
7648953|NCT04348500|12063736|FG000|Overall Study|Withdrawn by subject due to dementia|0
7648954|NCT04348500|12063737|FG001|Overall Study|Withdrawn by subject due to dementia|1
7648955|NCT03799198|12063780|FG000|Overall Study|Lost to Follow-up|4
7648956|NCT03799198|12063781|FG001|Overall Study|Lost to Follow-up|8
7648957|NCT03799198|12063780|FG000|Overall Study|Death|0
7648958|NCT03799198|12063781|FG001|Overall Study|Death|1
7648959|NCT03770728|12063791|FG000|Overall Study|Adverse Event|1
7648960|NCT03770728|12063792|FG001|Overall Study|Adverse Event|0
7648961|NCT03770728|12063793|FG002|Overall Study|Adverse Event|1
7648962|NCT03770728|12063794|FG003|Overall Study|Adverse Event|0
7648963|NCT03770728|12063791|FG000|Overall Study|Poor compliance to protocol|0
7648964|NCT03770728|12063792|FG001|Overall Study|Poor compliance to protocol|0
7648965|NCT03770728|12063793|FG002|Overall Study|Poor compliance to protocol|1
7648966|NCT03770728|12063794|FG003|Overall Study|Poor compliance to protocol|0
7648967|NCT03770728|12063791|FG000|Overall Study|Withdrawal by Subject|13
7648968|NCT03770728|12063792|FG001|Overall Study|Withdrawal by Subject|8
7648969|NCT03770728|12063793|FG002|Overall Study|Withdrawal by Subject|9
7648970|NCT03770728|12063794|FG003|Overall Study|Withdrawal by Subject|13
7648971|NCT03770728|12063791|FG000|Overall Study|Other than specified|24
7648972|NCT03770728|12063792|FG001|Overall Study|Other than specified|23
7648973|NCT03770728|12063793|FG002|Overall Study|Other than specified|21
7648974|NCT03770728|12063794|FG003|Overall Study|Other than specified|22
7648975|NCT03760146|12063812|FG000|Overall Study|Adverse Event|11
7648976|NCT03760146|12063813|FG001|Overall Study|Adverse Event|8
7648977|NCT03760146|12063814|FG002|Overall Study|Adverse Event|0
7648978|NCT03760146|12063815|FG003|Overall Study|Adverse Event|0
7648979|NCT03760146|12063816|FG004|Overall Study|Adverse Event|0
7648980|NCT03760146|12063817|FG005|Overall Study|Adverse Event|0
7648981|NCT03760146|12063812|FG000|Overall Study|Death|1
7648982|NCT03760146|12063813|FG001|Overall Study|Death|0
7648983|NCT03760146|12063814|FG002|Overall Study|Death|0
7648984|NCT03760146|12063815|FG003|Overall Study|Death|0
7648985|NCT03760146|12063816|FG004|Overall Study|Death|0
7648986|NCT03760146|12063817|FG005|Overall Study|Death|0
7648987|NCT03760146|12063812|FG000|Overall Study|Lost to Follow-up|41
7648988|NCT03760146|12063813|FG001|Overall Study|Lost to Follow-up|28
7648989|NCT03760146|12063814|FG002|Overall Study|Lost to Follow-up|9
7648990|NCT03760146|12063815|FG003|Overall Study|Lost to Follow-up|2
7648991|NCT03760146|12063816|FG004|Overall Study|Lost to Follow-up|14
7648992|NCT03760146|12063817|FG005|Overall Study|Lost to Follow-up|8
7648993|NCT03760146|12063812|FG000|Overall Study|No longer met eligibility criteria|3
7648994|NCT03760146|12063813|FG001|Overall Study|No longer met eligibility criteria|9
7648995|NCT03760146|12063814|FG002|Overall Study|No longer met eligibility criteria|0
7648996|NCT03760146|12063815|FG003|Overall Study|No longer met eligibility criteria|0
7648997|NCT03760146|12063816|FG004|Overall Study|No longer met eligibility criteria|1
7648998|NCT03760146|12063817|FG005|Overall Study|No longer met eligibility criteria|0
7648999|NCT03760146|12063812|FG000|Overall Study|Protocol Violation|21
7649000|NCT03760146|12063813|FG001|Overall Study|Protocol Violation|13
7649001|NCT03760146|12063814|FG002|Overall Study|Protocol Violation|1
7649002|NCT03760146|12063815|FG003|Overall Study|Protocol Violation|0
7649003|NCT03760146|12063816|FG004|Overall Study|Protocol Violation|1
7649004|NCT03760146|12063817|FG005|Overall Study|Protocol Violation|0
7649005|NCT03760146|12063812|FG000|Overall Study|Withdrawal by Subject|19
7649006|NCT03760146|12063813|FG001|Overall Study|Withdrawal by Subject|20
7649007|NCT03760146|12063814|FG002|Overall Study|Withdrawal by Subject|1
7649008|NCT03760146|12063815|FG003|Overall Study|Withdrawal by Subject|0
7649009|NCT03760146|12063816|FG004|Overall Study|Withdrawal by Subject|1
7649010|NCT03760146|12063817|FG005|Overall Study|Withdrawal by Subject|0
7649011|NCT03760081|12063837|FG000|Overall Study|Miscellaneous|0
7649012|NCT03760081|12063838|FG001|Overall Study|Miscellaneous|1
7649013|NCT03760081|12063837|FG000|Overall Study|Progressive Disease|5
7649014|NCT03760081|12063838|FG001|Overall Study|Progressive Disease|10
7649015|NCT03760081|12063837|FG000|Overall Study|Death|1
7649016|NCT03760081|12063838|FG001|Overall Study|Death|1
7649017|NCT03713684|12063850|FG000|Overall Study|Adverse Event|1
7649018|NCT03713684|12063851|FG001|Overall Study|Adverse Event|3
7649019|NCT03713684|12063852|FG002|Overall Study|Adverse Event|1
7649020|NCT03713684|12063853|FG003|Overall Study|Adverse Event|0
7649021|NCT03713684|12063850|FG000|Overall Study|Poor compliance to protocol|2
7649022|NCT03713684|12063851|FG001|Overall Study|Poor compliance to protocol|1
7649023|NCT03713684|12063852|FG002|Overall Study|Poor compliance to protocol|0
7649024|NCT03713684|12063853|FG003|Overall Study|Poor compliance to protocol|1
7649025|NCT03713684|12063850|FG000|Overall Study|Withdrawal by Subject|14
7649026|NCT03713684|12063851|FG001|Overall Study|Withdrawal by Subject|6
7649027|NCT03713684|12063852|FG002|Overall Study|Withdrawal by Subject|14
7649028|NCT03713684|12063853|FG003|Overall Study|Withdrawal by Subject|16
7649029|NCT03713684|12063850|FG000|Overall Study|Other than specified|69
7649030|NCT03713684|12063851|FG001|Overall Study|Other than specified|77
7649031|NCT03713684|12063852|FG002|Overall Study|Other than specified|73
7649032|NCT03713684|12063853|FG003|Overall Study|Other than specified|70
7649033|NCT03644550|12063863|FG000|Overall Study|Withdrawal by Subject|3
7649034|NCT03644550|12063863|FG000|Overall Study|Progressive disease|15
7649035|NCT03557970|12063870|FG000|Overall Study|Study closure|1
7649036|NCT03557970|12063871|FG001|Overall Study|Study closure|0
7649037|NCT03557970|12063870|FG000|Overall Study|Physician Decision|0
7649038|NCT03557970|12063871|FG001|Overall Study|Physician Decision|1
7649039|NCT03557970|12063870|FG000|Overall Study|Death|0
7649040|NCT03557970|12063871|FG001|Overall Study|Death|1
7649041|NCT02964039|12063889|FG000|Overall Study|Medical reason unrelated to study participation|1
7649042|NCT02964039|12063890|FG001|Overall Study|Medical reason unrelated to study participation|0
7649043|NCT02964039|12063891|FG002|Overall Study|Medical reason unrelated to study participation|3
7649044|NCT02964039|12063889|FG000|Overall Study|Research shutdown due to pandemic|2
7649045|NCT02964039|12063890|FG001|Overall Study|Research shutdown due to pandemic|0
7649046|NCT02964039|12063891|FG002|Overall Study|Research shutdown due to pandemic|1
7649047|NCT02964039|12063889|FG000|Overall Study|Withdrawal by Subject|0
7649048|NCT02964039|12063890|FG001|Overall Study|Withdrawal by Subject|1
7649049|NCT02964039|12063891|FG002|Overall Study|Withdrawal by Subject|0
7649050|NCT02964039|12063889|FG000|Overall Study|Lost to Follow-up|1
7649051|NCT02964039|12063890|FG001|Overall Study|Lost to Follow-up|0
7649052|NCT02964039|12063891|FG002|Overall Study|Lost to Follow-up|1
7649053|NCT02930889|12063899|FG000|Overall Study|Lost to Follow-up|2
7649054|NCT02930889|12063899|FG000|Overall Study|Withdrawal by Subject|6
7649055|NCT02930889|12063899|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8
7649056|NCT02919618|12063903|FG000|Overall Study|Death|1
7649057|NCT02844946|12063920|FG000|Overall Study|Lost to Follow-up|7
7649058|NCT02844946|12063921|FG001|Overall Study|Lost to Follow-up|0
7649059|NCT02564796|12063938|FG000|Overall Study|Physician Decision|2
7649060|NCT02564796|12063939|FG001|Overall Study|Physician Decision|2
7649061|NCT02562716|12063947|FG000|Overall Study|Adverse Event|7
7649062|NCT02562716|12063948|FG001|Overall Study|Adverse Event|14
7649063|NCT02562716|12063947|FG000|Overall Study|Withdrawal unrelated to AE|7
7649064|NCT02562716|12063948|FG001|Overall Study|Withdrawal unrelated to AE|1
7649065|NCT02562716|12063947|FG000|Overall Study|Progression|8
7649066|NCT02562716|12063948|FG001|Overall Study|Progression|10
7649067|NCT02562716|12063947|FG000|Overall Study|Death|2
7649068|NCT02562716|12063948|FG001|Overall Study|Death|1
7649069|NCT02562716|12063947|FG000|Overall Study|Not protocol specified|4
7649070|NCT02562716|12063948|FG001|Overall Study|Not protocol specified|2
7649071|NCT01472081|12063967|FG000|Overall Study|Continuing treatment at time of analysis|1
7649072|NCT01472081|12063968|FG001|Overall Study|Continuing treatment at time of analysis|4
7649073|NCT01472081|12063969|FG002|Overall Study|Continuing treatment at time of analysis|1
7649074|NCT01472081|12063970|FG003|Overall Study|Continuing treatment at time of analysis|8
7649075|NCT01472081|12063971|FG004|Overall Study|Continuing treatment at time of analysis|9
7649076|NCT01472081|12063972|FG005|Overall Study|Continuing treatment at time of analysis|0
7649077|NCT01472081|12063967|FG000|Overall Study|Disease Progression|4
7649078|NCT01472081|12063968|FG001|Overall Study|Disease Progression|10
7649079|NCT01472081|12063969|FG002|Overall Study|Disease Progression|12
7649080|NCT01472081|12063970|FG003|Overall Study|Disease Progression|31
7649081|NCT01472081|12063971|FG004|Overall Study|Disease Progression|22
7649082|NCT01472081|12063972|FG005|Overall Study|Disease Progression|3
7649083|NCT01472081|12063967|FG000|Overall Study|Study drug toxicity|2
7649084|NCT01472081|12063968|FG001|Overall Study|Study drug toxicity|9
7649085|NCT01472081|12063969|FG002|Overall Study|Study drug toxicity|4
7649086|NCT01472081|12063970|FG003|Overall Study|Study drug toxicity|6
7649087|NCT01472081|12063971|FG004|Overall Study|Study drug toxicity|13
7649088|NCT01472081|12063972|FG005|Overall Study|Study drug toxicity|2
7649089|NCT01472081|12063967|FG000|Overall Study|Death|0
7649090|NCT01472081|12063968|FG001|Overall Study|Death|0
7649091|NCT01472081|12063969|FG002|Overall Study|Death|0
7649092|NCT01472081|12063970|FG003|Overall Study|Death|0
7649093|NCT01472081|12063971|FG004|Overall Study|Death|1
7649094|NCT01472081|12063972|FG005|Overall Study|Death|0
7649095|NCT01472081|12063967|FG000|Overall Study|Adverse Event unrelated to study drug|0
7649096|NCT01472081|12063968|FG001|Overall Study|Adverse Event unrelated to study drug|0
7649097|NCT01472081|12063969|FG002|Overall Study|Adverse Event unrelated to study drug|0
7649098|NCT01472081|12063970|FG003|Overall Study|Adverse Event unrelated to study drug|0
7649099|NCT01472081|12063971|FG004|Overall Study|Adverse Event unrelated to study drug|1
7649100|NCT01472081|12063972|FG005|Overall Study|Adverse Event unrelated to study drug|0
7649101|NCT01472081|12063967|FG000|Overall Study|Withdrawal by Subject|0
7649102|NCT01472081|12063968|FG001|Overall Study|Withdrawal by Subject|0
7649103|NCT01472081|12063969|FG002|Overall Study|Withdrawal by Subject|0
7649104|NCT01472081|12063970|FG003|Overall Study|Withdrawal by Subject|0
7649105|NCT01472081|12063971|FG004|Overall Study|Withdrawal by Subject|0
7649106|NCT01472081|12063972|FG005|Overall Study|Withdrawal by Subject|1
7649107|NCT01472081|12063967|FG000|Overall Study|Poor/non-compliance|0
7649108|NCT01472081|12063968|FG001|Overall Study|Poor/non-compliance|0
7649109|NCT01472081|12063969|FG002|Overall Study|Poor/non-compliance|1
7649110|NCT01472081|12063970|FG003|Overall Study|Poor/non-compliance|0
7649111|NCT01472081|12063971|FG004|Overall Study|Poor/non-compliance|1
7649112|NCT01472081|12063972|FG005|Overall Study|Poor/non-compliance|0
7649113|NCT01472081|12063967|FG000|Overall Study|No longer meets study criteria|0
7649114|NCT01472081|12063968|FG001|Overall Study|No longer meets study criteria|0
7649115|NCT01472081|12063969|FG002|Overall Study|No longer meets study criteria|1
7649116|NCT01472081|12063970|FG003|Overall Study|No longer meets study criteria|0
7649117|NCT01472081|12063971|FG004|Overall Study|No longer meets study criteria|0
7649118|NCT01472081|12063972|FG005|Overall Study|No longer meets study criteria|0
7649119|NCT01472081|12063967|FG000|Overall Study|Subject request to discontinue treatment|0
7649120|NCT01472081|12063968|FG001|Overall Study|Subject request to discontinue treatment|3
7649121|NCT01472081|12063969|FG002|Overall Study|Subject request to discontinue treatment|1
7649122|NCT01472081|12063970|FG003|Overall Study|Subject request to discontinue treatment|1
7649123|NCT01472081|12063971|FG004|Overall Study|Subject request to discontinue treatment|0
7649124|NCT01472081|12063972|FG005|Overall Study|Subject request to discontinue treatment|0
7649125|NCT01309672|12063985|FG000|Overall Study|Lack of Efficacy|20
7649126|NCT01309672|12063985|FG000|Overall Study|Other|9
7649127|NCT01309672|12063985|FG000|Overall Study|Adverse Event|5
7649128|NCT01309672|12063985|FG000|Overall Study|Withdrawal by Subject|3
7649129|NCT00774345|12064002|FG000|Pre-treatment|Other reasons|2
7649130|NCT00774345|12064003|FG001|Pre-treatment|Other reasons|0
7649131|NCT00774345|12064002|FG000|Treatment|Adverse Event|61
7649132|NCT00774345|12064003|FG001|Treatment|Adverse Event|15
7649133|NCT00774345|12064002|FG000|Treatment|Progressive Disease without histologic transformation|51
7649134|NCT00774345|12064003|FG001|Treatment|Progressive Disease without histologic transformation|111
7649135|NCT00774345|12064002|FG000|Treatment|Progressive Disease with histologic transformation|4
7649136|NCT00774345|12064003|FG001|Treatment|Progressive Disease with histologic transformation|2
7649137|NCT00774345|12064002|FG000|Treatment|Withdrawal by Subject|5
7649138|NCT00774345|12064003|FG001|Treatment|Withdrawal by Subject|2
7649139|NCT00774345|12064002|FG000|Treatment|Lost to Follow-up|1
7649140|NCT00774345|12064003|FG001|Treatment|Lost to Follow-up|1
7649141|NCT00774345|12064002|FG000|Treatment|Death|4
7649142|NCT00774345|12064003|FG001|Treatment|Death|0
7649143|NCT00774345|12064002|FG000|Treatment|Other Reasons|32
7649144|NCT00774345|12064003|FG001|Treatment|Other Reasons|26
7649145|NCT00000135|12064087|FG000|Overall Study|Death|27
7649146|NCT00000135|12064088|FG001|Overall Study|Death|14
7649147|NCT00000378|12064136|FG000|Overall Study|Lack of Efficacy|16
7649148|NCT00000378|12064137|FG001|Overall Study|Lack of Efficacy|14
7649149|NCT00000620|12064184|FG000|Overall Study|Death|86
7649150|NCT00000620|12064185|FG001|Overall Study|Death|67
7649151|NCT00000620|12064186|FG002|Overall Study|Death|112
7649152|NCT00000620|12064187|FG003|Overall Study|Death|126
7649153|NCT00000620|12064188|FG004|Overall Study|Death|64
7649154|NCT00000620|12064189|FG005|Overall Study|Death|77
7649155|NCT00000620|12064190|FG006|Overall Study|Death|91
7649156|NCT00000620|12064191|FG007|Overall Study|Death|95
7649157|NCT00000620|12064184|FG000|Overall Study|Lost to Follow-up|14
7649158|NCT00000620|12064185|FG001|Overall Study|Lost to Follow-up|14
7649159|NCT00000620|12064186|FG002|Overall Study|Lost to Follow-up|14
7649160|NCT00000620|12064187|FG003|Overall Study|Lost to Follow-up|14
7649161|NCT00000620|12064188|FG004|Overall Study|Lost to Follow-up|15
7649162|NCT00000620|12064189|FG005|Overall Study|Lost to Follow-up|15
7649163|NCT00000620|12064190|FG006|Overall Study|Lost to Follow-up|13
7649164|NCT00000620|12064191|FG007|Overall Study|Lost to Follow-up|14
7649165|NCT00000620|12064184|FG000|Overall Study|Withdrawal by Subject|40
7649166|NCT00000620|12064185|FG001|Overall Study|Withdrawal by Subject|27
7649167|NCT00000620|12064186|FG002|Overall Study|Withdrawal by Subject|28
7649168|NCT00000620|12064187|FG003|Overall Study|Withdrawal by Subject|27
7649169|NCT00000620|12064188|FG004|Overall Study|Withdrawal by Subject|30
7649170|NCT00000620|12064189|FG005|Overall Study|Withdrawal by Subject|32
7649171|NCT00000620|12064190|FG006|Overall Study|Withdrawal by Subject|32
7649172|NCT00000620|12064191|FG007|Overall Study|Withdrawal by Subject|21
7649173|NCT00000620|12064184|FG000|Overall Study|missed closeout visit|22
7649174|NCT00000620|12064185|FG001|Overall Study|missed closeout visit|28
7649175|NCT00000620|12064186|FG002|Overall Study|missed closeout visit|16
7649176|NCT00000620|12064187|FG003|Overall Study|missed closeout visit|11
7649177|NCT00000620|12064188|FG004|Overall Study|missed closeout visit|26
7649178|NCT00000620|12064189|FG005|Overall Study|missed closeout visit|28
7649179|NCT00000620|12064190|FG006|Overall Study|missed closeout visit|13
7649180|NCT00000620|12064191|FG007|Overall Study|missed closeout visit|16
7649181|NCT00001213|12064207|FG000|Overall Study|Death|18
7649182|NCT00001262|12064214|FG000|Overall Study|Death|10
7649183|NCT00001262|12064215|FG001|Overall Study|Death|11
7649184|NCT00001262|12064216|FG002|Overall Study|Death|0
7649185|NCT00001262|12064214|FG000|Overall Study|Withdrawal by Subject|0
7649186|NCT00001262|12064215|FG001|Overall Study|Withdrawal by Subject|3
7649187|NCT00001262|12064216|FG002|Overall Study|Withdrawal by Subject|0
7649188|NCT00001566|12064237|FG000|Overall Study|patients' choice to discontinue protocol|3
7649189|NCT00001566|12064237|FG000|Overall Study|stopped after C3 due to symptomatic PD|1
7649190|NCT00001566|12064237|FG000|Overall Study|Death|13
7649191|NCT00001566|12064237|FG000|Overall Study|Lost to Follow-up|1
7649192|NCT00001566|12064237|FG000|Overall Study|unable to complete initial apheresis|1
7649193|NCT00001575|12064241|FG000|Overall Study|Screening failures-Ph I portion|22
7649194|NCT00001575|12064241|FG000|Overall Study|Withdrawn/deaths|23
7649195|NCT00001596|12064256|FG000|Overall Study|Death|1
7649196|NCT00001596|12064257|FG001|Overall Study|Death|0
7649197|NCT00001596|12064256|FG000|Overall Study|Withdrawal by Subject|3
7649198|NCT00001596|12064257|FG001|Overall Study|Withdrawal by Subject|1
7649199|NCT00001596|12064256|FG000|Overall Study|Study Termination|12
7649200|NCT00001596|12064257|FG001|Overall Study|Study Termination|9
7649201|NCT00001596|12064256|FG000|Overall Study|Adverse Event|1
7649202|NCT00001596|12064257|FG001|Overall Study|Adverse Event|0
7649203|NCT00001703|12064272|FG000|Overall Study|progressed disease|2
7649204|NCT00001703|12064272|FG000|Overall Study|No evidence of disease|1
7649205|NCT00001703|12064272|FG000|Overall Study|recurrent disease|2
7649206|NCT00001723|12064278|FG000|Overall Study|Lack of Efficacy|6
7649207|NCT00001723|12064279|FG001|Overall Study|Lack of Efficacy|7
7649208|NCT00001723|12064278|FG000|Overall Study|Lack of family interest|4
7649209|NCT00001723|12064279|FG001|Overall Study|Lack of family interest|5
7649210|NCT00001723|12064278|FG000|Overall Study|Lost to Follow-up|2
7649211|NCT00001723|12064279|FG001|Overall Study|Lost to Follow-up|2
7649212|NCT00001723|12064278|FG000|Overall Study|medication intolerance|1
7649213|NCT00001723|12064279|FG001|Overall Study|medication intolerance|2
7649214|NCT00001832|12064303|FG000|Apheresis Period|not able to manufacture treatment cells|60
7649215|NCT00001832|12064304|FG001|Apheresis Period|not able to manufacture treatment cells|0
7649216|NCT00001832|12064305|FG002|Apheresis Period|not able to manufacture treatment cells|0
7649217|NCT00001832|12064306|FG003|Apheresis Period|not able to manufacture treatment cells|0
7649218|NCT00001832|12064307|FG004|Apheresis Period|not able to manufacture treatment cells|0
7649219|NCT00001832|12064308|FG005|Apheresis Period|not able to manufacture treatment cells|0
7649220|NCT00001832|12064309|FG006|Apheresis Period|not able to manufacture treatment cells|0
7649221|NCT00001832|12064310|FG007|Apheresis Period|not able to manufacture treatment cells|0
7649222|NCT00001832|12064311|FG008|Apheresis Period|not able to manufacture treatment cells|0
7649223|NCT00001832|12064312|FG009|Apheresis Period|not able to manufacture treatment cells|0
7649224|NCT00001832|12064313|FG010|Apheresis Period|not able to manufacture treatment cells|0
7649225|NCT00001832|12064314|FG011|Apheresis Period|not able to manufacture treatment cells|0
7649226|NCT00001832|12064315|FG012|Apheresis Period|not able to manufacture treatment cells|0
7649227|NCT00001832|12064316|FG013|Apheresis Period|not able to manufacture treatment cells|0
7649228|NCT00001832|12064317|FG014|Apheresis Period|not able to manufacture treatment cells|0
7649229|NCT00001832|12064303|FG000|Treatment Period|Death during treatment|0
7649230|NCT00001832|12064304|FG001|Treatment Period|Death during treatment|0
7649231|NCT00001832|12064305|FG002|Treatment Period|Death during treatment|0
7649232|NCT00001832|12064306|FG003|Treatment Period|Death during treatment|0
7649233|NCT00001832|12064307|FG004|Treatment Period|Death during treatment|0
7649234|NCT00001832|12064308|FG005|Treatment Period|Death during treatment|1
7649235|NCT00001832|12064309|FG006|Treatment Period|Death during treatment|0
7649236|NCT00001832|12064310|FG007|Treatment Period|Death during treatment|0
7649237|NCT00001832|12064311|FG008|Treatment Period|Death during treatment|0
7649238|NCT00001832|12064312|FG009|Treatment Period|Death during treatment|0
7649239|NCT00001832|12064313|FG010|Treatment Period|Death during treatment|0
7649240|NCT00001832|12064314|FG011|Treatment Period|Death during treatment|0
7649241|NCT00001832|12064315|FG012|Treatment Period|Death during treatment|0
7649242|NCT00001832|12064316|FG013|Treatment Period|Death during treatment|0
7649243|NCT00001832|12064317|FG014|Treatment Period|Death during treatment|0
7649244|NCT00001832|12064303|FG000|Treatment Period|Not treated|0
7649245|NCT00001832|12064304|FG001|Treatment Period|Not treated|0
7649246|NCT00001832|12064305|FG002|Treatment Period|Not treated|0
7649247|NCT00001832|12064306|FG003|Treatment Period|Not treated|0
7649248|NCT00001832|12064307|FG004|Treatment Period|Not treated|0
7649249|NCT00001832|12064308|FG005|Treatment Period|Not treated|0
7649250|NCT00001832|12064309|FG006|Treatment Period|Not treated|0
7649251|NCT00001832|12064310|FG007|Treatment Period|Not treated|1
7649252|NCT00001832|12064311|FG008|Treatment Period|Not treated|0
7649253|NCT00001832|12064312|FG009|Treatment Period|Not treated|0
7649254|NCT00001832|12064313|FG010|Treatment Period|Not treated|0
7649255|NCT00001832|12064314|FG011|Treatment Period|Not treated|0
7649256|NCT00001832|12064315|FG012|Treatment Period|Not treated|0
7649257|NCT00001832|12064316|FG013|Treatment Period|Not treated|0
7649258|NCT00001832|12064317|FG014|Treatment Period|Not treated|0
7649259|NCT00001849|12064347|FG000|Overall Study|Death|4
7649260|NCT00001849|12064347|FG000|Overall Study|Lost to Follow-up|2
7649261|NCT00001849|12064347|FG000|Overall Study|Withdrawal by Subject|2
7649262|NCT00001849|12064347|FG000|Overall Study|tumor remained occult|6
7649263|NCT00001880|12064360|FG000|Overall Study|Death|14
7649264|NCT00001941|12064364|FG000|Overall Study|not treated- rapidly progressing disease|0
7649265|NCT00001941|12064365|FG001|Overall Study|not treated- rapidly progressing disease|0
7649266|NCT00001941|12064366|FG002|Overall Study|not treated- rapidly progressing disease|0
7649267|NCT00001941|12064367|FG003|Overall Study|not treated- rapidly progressing disease|0
7649268|NCT00001941|12064368|FG004|Overall Study|not treated- rapidly progressing disease|1
7649269|NCT00001959|12064373|FG000|Overall Study|newly diagnosed colon cancer|1
7649270|NCT00001959|12064373|FG000|Overall Study|disabling sedation|1
7649271|NCT00001959|12064373|FG000|Overall Study|non-compliance|1
7649272|NCT00001962|12064377|FG000|Overall Study|Lack of Efficacy|18
7649273|NCT00001962|12064377|FG000|Overall Study|Lack of Accrual|6
7649274|NCT00001962|12064377|FG000|Overall Study|Death|1
7649275|NCT00001962|12064377|FG000|Overall Study|Lost to Follow-up|2
7649276|NCT00001962|12064377|FG000|Overall Study|Adverse Event|1
7649277|NCT00002525|12064387|FG000|Overall Study|Adverse Event|36
7649278|NCT00002525|12064388|FG001|Overall Study|Adverse Event|0
7649279|NCT00002525|12064387|FG000|Overall Study|Death|5
7649280|NCT00002525|12064388|FG001|Overall Study|Death|0
7649281|NCT00002525|12064387|FG000|Overall Study|Withdrawal by Subject|11
7649282|NCT00002525|12064388|FG001|Overall Study|Withdrawal by Subject|0
7649283|NCT00002525|12064387|FG000|Overall Study|Start non-protocol therapy|1
7649284|NCT00002525|12064388|FG001|Overall Study|Start non-protocol therapy|0
7649285|NCT00002525|12064387|FG000|Overall Study|Other complicating disease|1
7649286|NCT00002525|12064388|FG001|Overall Study|Other complicating disease|0
7649287|NCT00002525|12064387|FG000|Overall Study|Duke's A, B1, D disease|92
7649288|NCT00002525|12064388|FG001|Overall Study|Duke's A, B1, D disease|0
7649289|NCT00002525|12064387|FG000|Overall Study|Error|6
7649290|NCT00002525|12064388|FG001|Overall Study|Error|0
7649291|NCT00002525|12064387|FG000|Overall Study|Other|26
7649292|NCT00002525|12064388|FG001|Overall Study|Other|0
7649293|NCT00002525|12064387|FG000|Overall Study|Never start protocol therapy|8
7649294|NCT00002525|12064388|FG001|Overall Study|Never start protocol therapy|0
7649295|NCT00002558|12064398|FG000|Overall Study|Withdrawal by Subject|0
7649296|NCT00002558|12064399|FG001|Overall Study|Withdrawal by Subject|1
7649297|NCT00002597|12064407|FG000|Overall Study|Protocol Violation|19
7649298|NCT00002597|12064408|FG001|Overall Study|Protocol Violation|17
7649299|NCT00002597|12064407|FG000|Overall Study|Withdrawal by Subject|7
7649300|NCT00002597|12064408|FG001|Overall Study|Withdrawal by Subject|6
7649301|NCT00002651|12064422|FG000|Induction|Adverse Event|44
7649302|NCT00002651|12064423|FG001|Induction|Adverse Event|0
7649303|NCT00002651|12064424|FG002|Induction|Adverse Event|0
7649304|NCT00002651|12064422|FG000|Induction|Refusal unrelated to adverse event|50
7649305|NCT00002651|12064423|FG001|Induction|Refusal unrelated to adverse event|0
7649306|NCT00002651|12064424|FG002|Induction|Refusal unrelated to adverse event|0
7649307|NCT00002651|12064422|FG000|Induction|Progression/relapse|274
7649308|NCT00002651|12064423|FG001|Induction|Progression/relapse|0
7649309|NCT00002651|12064424|FG002|Induction|Progression/relapse|0
7649310|NCT00002651|12064422|FG000|Induction|Death|62
7649311|NCT00002651|12064423|FG001|Induction|Death|0
7649312|NCT00002651|12064424|FG002|Induction|Death|0
7649313|NCT00002651|12064422|FG000|Induction|Other|823
7649314|NCT00002651|12064423|FG001|Induction|Other|0
7649315|NCT00002651|12064424|FG002|Induction|Other|0
7649316|NCT00002651|12064422|FG000|Induction|not eligible|90
7649317|NCT00002651|12064423|FG001|Induction|not eligible|0
7649318|NCT00002651|12064424|FG002|Induction|not eligible|0
7649319|NCT00002651|12064422|FG000|Consolidation and Randomization|Adverse Event|0
7649320|NCT00002651|12064423|FG001|Consolidation and Randomization|Adverse Event|36
7649321|NCT00002651|12064424|FG002|Consolidation and Randomization|Adverse Event|14
7649322|NCT00002651|12064422|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0
7649323|NCT00002651|12064423|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53
7649324|NCT00002651|12064424|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75
7649325|NCT00002651|12064422|FG000|Consolidation and Randomization|Progression/relapse|0
7649326|NCT00002651|12064423|FG001|Consolidation and Randomization|Progression/relapse|295
7649327|NCT00002651|12064424|FG002|Consolidation and Randomization|Progression/relapse|298
7649328|NCT00002651|12064422|FG000|Consolidation and Randomization|Death|0
7649329|NCT00002651|12064423|FG001|Consolidation and Randomization|Death|38
7649330|NCT00002651|12064424|FG002|Consolidation and Randomization|Death|48
7649331|NCT00002651|12064422|FG000|Consolidation and Randomization|Other|0
7649332|NCT00002651|12064423|FG001|Consolidation and Randomization|Other|314
7649333|NCT00002651|12064424|FG002|Consolidation and Randomization|Other|313
7649334|NCT00002651|12064422|FG000|Consolidation and Randomization|not eligible|0
7649335|NCT00002651|12064423|FG001|Consolidation and Randomization|not eligible|102
7649336|NCT00002651|12064424|FG002|Consolidation and Randomization|not eligible|112
7649337|NCT00002766|12064434|FG000|Overall Study|Withdrawal by Subject|0
7649338|NCT00002766|12064435|FG001|Overall Study|Withdrawal by Subject|1
7649339|NCT00002766|12064434|FG000|Overall Study|Patient Not Treated|1
7649340|NCT00002766|12064435|FG001|Overall Study|Patient Not Treated|2
7649341|NCT00002766|12064434|FG000|Overall Study|Adverse Event|1
7649342|NCT00002766|12064435|FG001|Overall Study|Adverse Event|1
7649343|NCT00002766|12064434|FG000|Overall Study|Protocol Violation|1
7649344|NCT00002766|12064435|FG001|Overall Study|Protocol Violation|0
7649345|NCT00002842|12064441|FG000|Overall Study|ineligible for surgical resection|27
7649346|NCT00002850|12064448|FG000|Overall Study|Death|4
7649347|NCT00002850|12064449|FG001|Overall Study|Death|1
7649348|NCT00002850|12064450|FG002|Overall Study|Death|3
7649349|NCT00002850|12064448|FG000|Overall Study|Protocol Violation|1
7649350|NCT00002850|12064449|FG001|Overall Study|Protocol Violation|0
7649351|NCT00002850|12064450|FG002|Overall Study|Protocol Violation|1
7649352|NCT00002850|12064448|FG000|Overall Study|Withdrawal by Subject|0
7649353|NCT00002850|12064449|FG001|Overall Study|Withdrawal by Subject|1
7649354|NCT00002850|12064450|FG002|Overall Study|Withdrawal by Subject|0
7649355|NCT03666988|12064464|FG000|Part 1 (Up to 28 Months)|Adverse Event|0
7649356|NCT03666988|12064465|FG001|Part 1 (Up to 28 Months)|Adverse Event|1
7649357|NCT03666988|12064466|FG002|Part 1 (Up to 28 Months)|Adverse Event|3
7649358|NCT03666988|12064467|FG003|Part 1 (Up to 28 Months)|Adverse Event|0
7649359|NCT03666988|12064468|FG004|Part 1 (Up to 28 Months)|Adverse Event|0
7649360|NCT03666988|12064469|FG005|Part 1 (Up to 28 Months)|Adverse Event|0
7649361|NCT03666988|12064464|FG000|Part 1 (Up to 28 Months)|Other|0
7649362|NCT03666988|12064465|FG001|Part 1 (Up to 28 Months)|Other|1
7649363|NCT03666988|12064466|FG002|Part 1 (Up to 28 Months)|Other|1
7649364|NCT03666988|12064467|FG003|Part 1 (Up to 28 Months)|Other|0
7649365|NCT03666988|12064468|FG004|Part 1 (Up to 28 Months)|Other|0
7649366|NCT03666988|12064469|FG005|Part 1 (Up to 28 Months)|Other|0
7649367|NCT03666988|12064464|FG000|Part 1 (Up to 28 Months)|Disease Progression|2
7649368|NCT03666988|12064465|FG001|Part 1 (Up to 28 Months)|Disease Progression|14
7649369|NCT03666988|12064466|FG002|Part 1 (Up to 28 Months)|Disease Progression|7
7649370|NCT03666988|12064467|FG003|Part 1 (Up to 28 Months)|Disease Progression|0
7649371|NCT03666988|12064468|FG004|Part 1 (Up to 28 Months)|Disease Progression|0
7649372|NCT03666988|12064469|FG005|Part 1 (Up to 28 Months)|Disease Progression|0
7649373|NCT03666988|12064464|FG000|Part 1 (Up to 28 Months)|Physician Decision|0
7649374|NCT03666988|12064465|FG001|Part 1 (Up to 28 Months)|Physician Decision|0
7649375|NCT03666988|12064466|FG002|Part 1 (Up to 28 Months)|Physician Decision|1
7649376|NCT03666988|12064467|FG003|Part 1 (Up to 28 Months)|Physician Decision|0
7649377|NCT03666988|12064468|FG004|Part 1 (Up to 28 Months)|Physician Decision|0
7649378|NCT03666988|12064469|FG005|Part 1 (Up to 28 Months)|Physician Decision|0
7649379|NCT03666988|12064464|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1
7649380|NCT03666988|12064465|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0
7649381|NCT03666988|12064466|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0
7649382|NCT03666988|12064467|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0
7649383|NCT03666988|12064468|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0
7649384|NCT03666988|12064469|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0
7649385|NCT03552029|12064489|FG000|Overall Study|Death|3
7649386|NCT03552029|12064490|FG001|Overall Study|Death|0
7649387|NCT03552029|12064489|FG000|Overall Study|Adverse Event|1
7649388|NCT03552029|12064490|FG001|Overall Study|Adverse Event|0
7649389|NCT03552029|12064489|FG000|Overall Study|Lack of Efficacy|0
7649390|NCT03552029|12064490|FG001|Overall Study|Lack of Efficacy|2
7649391|NCT03552029|12064489|FG000|Overall Study|Physician Decision|0
7649392|NCT03552029|12064490|FG001|Overall Study|Physician Decision|1
7649393|NCT03552029|12064489|FG000|Overall Study|Study terminated by Sponsor|0
7649394|NCT03552029|12064490|FG001|Overall Study|Study terminated by Sponsor|1
7649395|NCT03552029|12064489|FG000|Overall Study|Other|0
7649396|NCT03552029|12064490|FG001|Overall Study|Other|2
7649397|NCT03549104|12064498|FG000|Overall Study|Physician Decision|2
7649398|NCT03549104|12064499|FG001|Overall Study|Physician Decision|0
7649399|NCT03549104|12064498|FG000|Overall Study|Withdrawal by Subject|5
7649400|NCT03549104|12064499|FG001|Overall Study|Withdrawal by Subject|2
7649401|NCT03549104|12064498|FG000|Overall Study|Covid shelter in place|1
7649402|NCT03549104|12064499|FG001|Overall Study|Covid shelter in place|2
7649403|NCT03332589|12064508|FG000|Overall Study|Lack of Efficacy|2
7649404|NCT03332589|12064509|FG001|Overall Study|Lack of Efficacy|0
7649405|NCT03332589|12064510|FG002|Overall Study|Lack of Efficacy|0
7649406|NCT03332589|12064508|FG000|Overall Study|Adverse Event|1
7649407|NCT03332589|12064509|FG001|Overall Study|Adverse Event|0
7649408|NCT03332589|12064510|FG002|Overall Study|Adverse Event|0
7649409|NCT03332589|12064508|FG000|Overall Study|Death|1
7649410|NCT03332589|12064509|FG001|Overall Study|Death|0
7649411|NCT03332589|12064510|FG002|Overall Study|Death|0
7649412|NCT02301156|12064520|FG000|Overall Study|Adverse Event|13
7649413|NCT02301156|12064521|FG001|Overall Study|Adverse Event|14
7649414|NCT02301156|12064520|FG000|Overall Study|Death|1
7649415|NCT02301156|12064521|FG001|Overall Study|Death|5
7649416|NCT02301156|12064520|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2
7649417|NCT02301156|12064521|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2
7649418|NCT02301156|12064520|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27
7649419|NCT02301156|12064521|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16
7649420|NCT02301156|12064520|FG000|Overall Study|Withdrawal of Consent by Subject|4
7649421|NCT02301156|12064521|FG001|Overall Study|Withdrawal of Consent by Subject|12
7649422|NCT02301156|12064520|FG000|Overall Study|Reason not Specified|6
7649423|NCT02301156|12064521|FG001|Overall Study|Reason not Specified|3
7649424|NCT01590628|12064538|FG000|Overall Study|Death|2
7649425|NCT01590628|12064539|FG001|Overall Study|Death|0
7649426|NCT01533714|12064555|FG000|Overall Study|Adverse Event|0
7649427|NCT01533714|12064556|FG001|Overall Study|Adverse Event|1
7649428|NCT01533714|12064557|FG002|Overall Study|Adverse Event|2
7649429|NCT01533714|12064558|FG003|Overall Study|Adverse Event|2
7649430|NCT01533714|12064559|FG004|Overall Study|Adverse Event|2
7649431|NCT01533714|12064560|FG005|Overall Study|Adverse Event|1
7649432|NCT01533714|12064555|FG000|Overall Study|Lack of Efficacy|0
7649433|NCT01533714|12064556|FG001|Overall Study|Lack of Efficacy|0
7649434|NCT01533714|12064557|FG002|Overall Study|Lack of Efficacy|0
7649435|NCT01533714|12064558|FG003|Overall Study|Lack of Efficacy|0
7649436|NCT01533714|12064559|FG004|Overall Study|Lack of Efficacy|0
7649437|NCT01533714|12064560|FG005|Overall Study|Lack of Efficacy|1
7649438|NCT01533714|12064555|FG000|Overall Study|Withdrawal by Subject|0
7649439|NCT01533714|12064556|FG001|Overall Study|Withdrawal by Subject|1
7649440|NCT01533714|12064557|FG002|Overall Study|Withdrawal by Subject|0
7649441|NCT01533714|12064558|FG003|Overall Study|Withdrawal by Subject|1
7649442|NCT01533714|12064559|FG004|Overall Study|Withdrawal by Subject|1
7649443|NCT01533714|12064560|FG005|Overall Study|Withdrawal by Subject|0
7649444|NCT01533714|12064555|FG000|Overall Study|Exclusion criteria|0
7649445|NCT01533714|12064556|FG001|Overall Study|Exclusion criteria|1
7649446|NCT01533714|12064557|FG002|Overall Study|Exclusion criteria|0
7649447|NCT01533714|12064558|FG003|Overall Study|Exclusion criteria|0
7649448|NCT01533714|12064559|FG004|Overall Study|Exclusion criteria|0
7649449|NCT01533714|12064560|FG005|Overall Study|Exclusion criteria|0
7649450|NCT01533714|12064555|FG000|Overall Study|Positive for purified protein derivative|0
7649451|NCT01533714|12064556|FG001|Overall Study|Positive for purified protein derivative|0
7649452|NCT01533714|12064557|FG002|Overall Study|Positive for purified protein derivative|1
7649453|NCT01533714|12064558|FG003|Overall Study|Positive for purified protein derivative|0
7649454|NCT01533714|12064559|FG004|Overall Study|Positive for purified protein derivative|1
7649455|NCT01533714|12064560|FG005|Overall Study|Positive for purified protein derivative|0
7649456|NCT01533714|12064555|FG000|Overall Study|Withdrawal criteria|0
7649457|NCT01533714|12064556|FG001|Overall Study|Withdrawal criteria|0
7649458|NCT01533714|12064557|FG002|Overall Study|Withdrawal criteria|1
7649459|NCT01533714|12064558|FG003|Overall Study|Withdrawal criteria|0
7649460|NCT01533714|12064559|FG004|Overall Study|Withdrawal criteria|3
7649461|NCT01533714|12064560|FG005|Overall Study|Withdrawal criteria|1
7649462|NCT01533714|12064555|FG000|Overall Study|Ineligibility reason|0
7649463|NCT01533714|12064556|FG001|Overall Study|Ineligibility reason|0
7649464|NCT01533714|12064557|FG002|Overall Study|Ineligibility reason|0
7649465|NCT01533714|12064558|FG003|Overall Study|Ineligibility reason|1
7649466|NCT01533714|12064559|FG004|Overall Study|Ineligibility reason|0
7649467|NCT01533714|12064560|FG005|Overall Study|Ineligibility reason|0
7649468|NCT00002931|12064574|FG000|Overall Study|rapidly progressing disease during|2
7649469|NCT00003138|12064580|FG000|Step 1|Reasons off treatment not documented|60
7649470|NCT00003138|12064581|FG001|Step 1|Reasons off treatment not documented|57
7649471|NCT00003138|12064580|FG000|Step 1|Never started treatment|1
7649472|NCT00003138|12064581|FG001|Step 1|Never started treatment|0
7649473|NCT00003138|12064580|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26
7649474|NCT00003138|12064581|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0
7649475|NCT00003138|12064580|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
7649476|NCT00003138|12064581|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
7649477|NCT00003138|12064580|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
7649478|NCT00003138|12064581|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
7649479|NCT00003138|12064580|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
7649480|NCT00003138|12064581|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
7649481|NCT00003199|12064590|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5
7649482|NCT00003199|12064590|FG000|Overall Study|Lack of insurance clearance|2
7649483|NCT00003199|12064590|FG000|Overall Study|Screen fail|15
7649484|NCT00003222|12064596|FG000|Overall Study|Physician Decision|0
7649485|NCT00003222|12064597|FG001|Overall Study|Physician Decision|1
7649486|NCT04848662|12064632|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1
7649487|NCT04848662|12064633|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0
7649488|NCT03969719|12064646|FG000|Overall Study|Other reasons not specified|1
7649489|NCT03969719|12064647|FG001|Overall Study|Other reasons not specified|1
7649490|NCT03969719|12064648|FG002|Overall Study|Other reasons not specified|3
7649491|NCT03969719|12064646|FG000|Overall Study|Withdrawal by Subject|2
7649492|NCT03969719|12064647|FG001|Overall Study|Withdrawal by Subject|3
7649493|NCT03969719|12064648|FG002|Overall Study|Withdrawal by Subject|2
7649494|NCT03969719|12064646|FG000|Overall Study|Protocol Violation|1
7649495|NCT03969719|12064647|FG001|Overall Study|Protocol Violation|2
7649496|NCT03969719|12064648|FG002|Overall Study|Protocol Violation|0
7649497|NCT03969719|12064646|FG000|Overall Study|Adverse Event|0
7649498|NCT03969719|12064647|FG001|Overall Study|Adverse Event|2
7649499|NCT03969719|12064648|FG002|Overall Study|Adverse Event|0
7649500|NCT03969719|12064646|FG000|Overall Study|Lost to Follow-up|0
7649501|NCT03969719|12064647|FG001|Overall Study|Lost to Follow-up|1
7649502|NCT03969719|12064648|FG002|Overall Study|Lost to Follow-up|0
7649503|NCT03883477|12064658|FG000|Overall Study|Death|1
7649504|NCT03883477|12064659|FG001|Overall Study|Death|0
7649505|NCT03883477|12064658|FG000|Overall Study|Protocol Violation|0
7649506|NCT03883477|12064659|FG001|Overall Study|Protocol Violation|1
7649507|NCT03809611|12064688|FG000|Overall Study|Withdrawal by Subject|1
7649508|NCT03809611|12064689|FG001|Overall Study|Withdrawal by Subject|1
7649509|NCT03721705|12064698|FG000|Overall Study|Adverse Event|2
7649510|NCT03721705|12064699|FG001|Overall Study|Adverse Event|0
7649511|NCT03721705|12064698|FG000|Overall Study|Withdrawal by Subject|4
7649512|NCT03721705|12064699|FG001|Overall Study|Withdrawal by Subject|10
7649513|NCT03721705|12064698|FG000|Overall Study|No Suitable Study Partner|1
7649514|NCT03721705|12064699|FG001|Overall Study|No Suitable Study Partner|0
7649515|NCT03721705|12064698|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3
7649516|NCT03721705|12064699|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7
7649517|NCT03721705|12064698|FG000|Overall Study|Death|0
7649518|NCT03721705|12064699|FG001|Overall Study|Death|1
7649519|NCT03505021|12064707|FG000|Overall Study|Protocol Violation|1
7649520|NCT03505021|12064708|FG001|Overall Study|Protocol Violation|0
7649521|NCT03505021|12064707|FG000|Overall Study|Death|9
7649522|NCT03505021|12064708|FG001|Overall Study|Death|8
7649523|NCT03505021|12064707|FG000|Overall Study|Consent withdrawn by subject|6
7649524|NCT03505021|12064708|FG001|Overall Study|Consent withdrawn by subject|1
7649525|NCT03505021|12064707|FG000|Overall Study|Lost to Follow-up|5
7649526|NCT03505021|12064708|FG001|Overall Study|Lost to Follow-up|3
7649527|NCT03505021|12064707|FG000|Overall Study|Adverse Event|26
7649528|NCT03505021|12064708|FG001|Overall Study|Adverse Event|9
7649529|NCT03505021|12064707|FG000|Overall Study|Disease progression|33
7649530|NCT03505021|12064708|FG001|Overall Study|Disease progression|17
7649531|NCT03505021|12064707|FG000|Overall Study|Other|11
7649532|NCT03505021|12064708|FG001|Overall Study|Other|5
7649533|NCT03505021|12064707|FG000|Overall Study|Personal reason|21
7649534|NCT03505021|12064708|FG001|Overall Study|Personal reason|12
7649535|NCT03366194|12064737|FG000|Overall Study|Lost to Follow-up|2
7649536|NCT03203473|12064751|FG000|Induction Phase|Never started primary treatment|2
7649537|NCT03203473|12064752|FG001|Induction Phase|Never started primary treatment|0
7649538|NCT03203473|12064753|FG002|Induction Phase|Never started primary treatment|0
7649539|NCT03203473|12064751|FG000|Induction Phase|Withdrew from study due to progressive disease|7
7649540|NCT03203473|12064752|FG001|Induction Phase|Withdrew from study due to progressive disease|0
7649541|NCT03203473|12064753|FG002|Induction Phase|Withdrew from study due to progressive disease|0
7649542|NCT03203473|12064751|FG000|Induction Phase|Withdrew from study due to toxicity|7
7649543|NCT03203473|12064752|FG001|Induction Phase|Withdrew from study due to toxicity|0
7649544|NCT03203473|12064753|FG002|Induction Phase|Withdrew from study due to toxicity|0
7649545|NCT03203473|12064751|FG000|Arm Allocation Phase|Still on Arm A-observation|0
7649546|NCT03203473|12064752|FG001|Arm Allocation Phase|Still on Arm A-observation|7
7649547|NCT03203473|12064753|FG002|Arm Allocation Phase|Still on Arm A-observation|0
7649548|NCT03203473|12064751|FG000|Arm Allocation Phase|started salvage therapy|0
7649549|NCT03203473|12064752|FG001|Arm Allocation Phase|started salvage therapy|5
7649550|NCT03203473|12064753|FG002|Arm Allocation Phase|started salvage therapy|0
7649551|NCT03203473|12064751|FG000|Arm Allocation Phase|Disease progression|0
7649552|NCT03203473|12064752|FG001|Arm Allocation Phase|Disease progression|0
7649553|NCT03203473|12064753|FG002|Arm Allocation Phase|Disease progression|37
7649554|NCT03203473|12064751|FG000|Arm Allocation Phase|Adverse Event|0
7649555|NCT03203473|12064752|FG001|Arm Allocation Phase|Adverse Event|0
7649556|NCT03203473|12064753|FG002|Arm Allocation Phase|Adverse Event|11
7649557|NCT03203473|12064751|FG000|Arm Allocation Phase|Physician Decision|0
7649558|NCT03203473|12064752|FG001|Arm Allocation Phase|Physician Decision|0
7649559|NCT03203473|12064753|FG002|Arm Allocation Phase|Physician Decision|3
7649560|NCT03203473|12064751|FG000|Arm Allocation Phase|Death|0
7649561|NCT03203473|12064752|FG001|Arm Allocation Phase|Death|0
7649562|NCT03203473|12064753|FG002|Arm Allocation Phase|Death|1
7649563|NCT03203473|12064751|FG000|Arm Allocation Phase|Developed 2nd cancer|0
7649564|NCT03203473|12064752|FG001|Arm Allocation Phase|Developed 2nd cancer|0
7649565|NCT03203473|12064753|FG002|Arm Allocation Phase|Developed 2nd cancer|1
7649566|NCT03203473|12064751|FG000|Arm Allocation Phase|Intercurrent illness|0
7649567|NCT03203473|12064752|FG001|Arm Allocation Phase|Intercurrent illness|0
7649568|NCT03203473|12064753|FG002|Arm Allocation Phase|Intercurrent illness|1
7649569|NCT03203473|12064751|FG000|Arm Allocation Phase|Still on arm-B treatment|0
7649570|NCT03203473|12064752|FG001|Arm Allocation Phase|Still on arm-B treatment|0
7649571|NCT03203473|12064753|FG002|Arm Allocation Phase|Still on arm-B treatment|3
7649572|NCT03180736|12064766|FG000|Overall Study|Adverse Event|3
7649573|NCT03180736|12064767|FG001|Overall Study|Adverse Event|4
7649574|NCT03180736|12064766|FG000|Overall Study|Death|10
7649575|NCT03180736|12064767|FG001|Overall Study|Death|7
7649576|NCT03180736|12064766|FG000|Overall Study|Withdrawal by Subject|5
7649577|NCT03180736|12064767|FG001|Overall Study|Withdrawal by Subject|12
7649578|NCT03180736|12064766|FG000|Overall Study|Lost to Follow-up|1
7649579|NCT03180736|12064767|FG001|Overall Study|Lost to Follow-up|0
7649580|NCT03180736|12064766|FG000|Overall Study|Lack of Efficacy|66
7649581|NCT03180736|12064767|FG001|Overall Study|Lack of Efficacy|87
7649582|NCT03180736|12064766|FG000|Overall Study|Physician Decision|4
7649583|NCT03180736|12064767|FG001|Overall Study|Physician Decision|7
7649584|NCT03180736|12064766|FG000|Overall Study|randomized but not treated|2
7649585|NCT03180736|12064767|FG001|Overall Study|randomized but not treated|3
7649586|NCT03051659|12064780|FG000|Treatment Period|Withdrawal by Subject|0
7649587|NCT03051659|12064781|FG001|Treatment Period|Withdrawal by Subject|2
7649588|NCT03051659|12064780|FG000|Survival Follow-up|Lost to Follow-up|23
7649589|NCT03051659|12064781|FG001|Survival Follow-up|Lost to Follow-up|22
7649590|NCT02886884|12064808|FG000|Follow-up|Withdrawal by Subject|0
7649591|NCT02886884|12064809|FG001|Follow-up|Withdrawal by Subject|0
7649592|NCT02886884|12064810|FG002|Follow-up|Withdrawal by Subject|0
7649593|NCT02886884|12064811|FG003|Follow-up|Withdrawal by Subject|1
7649594|NCT02717832|12064839|FG000|Overall Study|Inability to place IV|3
7649595|NCT02677324|12064844|FG000|Overall Study|Disease Progression|6
7649596|NCT02677324|12064844|FG000|Overall Study|Inability to Swallow pills|1
7649597|NCT02677324|12064844|FG000|Overall Study|Non-compliance|1
7649598|NCT02677324|12064844|FG000|Overall Study|Lack of Efficacy|1
7649599|NCT02677324|12064844|FG000|Overall Study|Medical insurance coverage|1
7649600|NCT02677324|12064844|FG000|Overall Study|Adverse Event|1
7649601|NCT02677324|12064844|FG000|Overall Study|IgM Myeloma diagnosis|1
7649602|NCT02563028|12064850|FG000|Overall Study|Lack of equipment|1
7649603|NCT02563028|12064850|FG000|Overall Study|Unable to elicit VEP post induction|1
7649604|NCT02411448|12064875|FG000|Overall Study|Withdrawal by Subject|1
7649605|NCT02411448|12064876|FG001|Overall Study|Withdrawal by Subject|14
7649606|NCT02411448|12064877|FG002|Overall Study|Withdrawal by Subject|9
7649607|NCT02411448|12064875|FG000|Overall Study|Other|0
7649608|NCT02411448|12064876|FG001|Overall Study|Other|2
7649609|NCT02411448|12064877|FG002|Overall Study|Other|0
7649610|NCT02411448|12064875|FG000|Overall Study|Did not receive study treatment|0
7649611|NCT02411448|12064876|FG001|Overall Study|Did not receive study treatment|3
7649612|NCT02411448|12064877|FG002|Overall Study|Did not receive study treatment|0
7649613|NCT02411448|12064875|FG000|Overall Study|Alive on study treatment|3
7649614|NCT02411448|12064876|FG001|Overall Study|Alive on study treatment|64
7649615|NCT02411448|12064877|FG002|Overall Study|Alive on study treatment|43
7649616|NCT02371369|12064891|FG000|Part 1|Physician Decision|0
7649617|NCT02371369|12064892|FG001|Part 1|Physician Decision|3
7649618|NCT02371369|12064891|FG000|Part 1|Adverse Event|8
7649619|NCT02371369|12064892|FG001|Part 1|Adverse Event|0
7649620|NCT02371369|12064891|FG000|Part 1|Withdrawal by Subject|1
7649621|NCT02371369|12064892|FG001|Part 1|Withdrawal by Subject|6
7649622|NCT02371369|12064891|FG000|Part 1|Disease progression|0
7649623|NCT02371369|12064892|FG001|Part 1|Disease progression|1
7649624|NCT02371369|12064891|FG000|Part 1|Protocol Violation|0
7649625|NCT02371369|12064892|FG001|Part 1|Protocol Violation|1
7649626|NCT02371369|12064891|FG000|Part 2|Adverse Event|6
7649627|NCT02371369|12064892|FG001|Part 2|Adverse Event|5
7649628|NCT02371369|12064891|FG000|Part 2|Withdrawal by Subject|16
7649629|NCT02371369|12064892|FG001|Part 2|Withdrawal by Subject|6
7649630|NCT02371369|12064891|FG000|Part 2|Investigator decision|1
7649631|NCT02371369|12064892|FG001|Part 2|Investigator decision|2
7649632|NCT02371369|12064891|FG000|Part 2|Death|0
7649633|NCT02371369|12064892|FG001|Part 2|Death|1
7649634|NCT02371369|12064891|FG000|Part 2|Disease progression|1
7649635|NCT02371369|12064892|FG001|Part 2|Disease progression|0
7649636|NCT02371369|12064891|FG000|Part 2|Subject Noncompliance|1
7649637|NCT02371369|12064892|FG001|Part 2|Subject Noncompliance|0
7649638|NCT02371369|12064891|FG000|Part 2|Lost to Follow-up|1
7649639|NCT02371369|12064892|FG001|Part 2|Lost to Follow-up|1
7649640|NCT02371369|12064891|FG000|Part 2|Subject transitioned to commercial supply|6
7649641|NCT02371369|12064892|FG001|Part 2|Subject transitioned to commercial supply|4
7649642|NCT02371369|12064891|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15
7649643|NCT02371369|12064892|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9
7649644|NCT02371369|12064891|FG000|Part 2|Surgical resection of tumor|1
7649645|NCT02371369|12064892|FG001|Part 2|Surgical resection of tumor|1
7649646|NCT02371369|12064891|FG000|Part 2|Other|0
7649647|NCT02371369|12064892|FG001|Part 2|Other|1
7649648|NCT02282917|12064914|FG000|Overall Study|Withdrawal by Subject|1
7649649|NCT02282917|12064914|FG000|Overall Study|Screen Failure/Not Eligible|1
7649650|NCT01849783|12064918|FG000|Overall Study|Adverse Event|5
7649651|NCT01849783|12064918|FG000|Overall Study|Death|2
7649652|NCT01849783|12064918|FG000|Overall Study|Physician Decision|1
7649653|NCT01849783|12064918|FG000|Overall Study|Withdrawal by Subject|1
7649654|NCT01849783|12064918|FG000|Overall Study|Unable to comply|2
7649655|NCT01849783|12064918|FG000|Overall Study|Disease progression|11
7649656|NCT01737021|12064939|FG000|Overall Study|Lost to Follow-up|5
7649657|NCT01737021|12064940|FG001|Overall Study|Lost to Follow-up|3
7649658|NCT01333943|12064957|FG000|Overall Study|Known neuropathy|1
7649659|NCT01333943|12064958|FG001|Overall Study|Known neuropathy|0
7649660|NCT01090024|12064973|FG000|Period 1|Met exclusion criteria|0
7649661|NCT01090024|12064974|FG001|Period 1|Met exclusion criteria|0
7649662|NCT01090024|12064975|FG002|Period 1|Met exclusion criteria|0
7649663|NCT01090024|12064976|FG003|Period 1|Met exclusion criteria|0
7649664|NCT01090024|12064977|FG004|Period 1|Met exclusion criteria|0
7649665|NCT01090024|12064978|FG005|Period 1|Met exclusion criteria|0
7649666|NCT01090024|12064979|FG006|Period 1|Met exclusion criteria|0
7649667|NCT01090024|12064980|FG007|Period 1|Met exclusion criteria|0
7649668|NCT01090024|12064981|FG008|Period 1|Met exclusion criteria|0
7649669|NCT01090024|12064982|FG009|Period 1|Met exclusion criteria|0
7649670|NCT01090024|12064983|FG010|Period 1|Met exclusion criteria|0
7649671|NCT01090024|12064984|FG011|Period 1|Met exclusion criteria|0
7649672|NCT01090024|12064985|FG012|Period 1|Met exclusion criteria|0
7649673|NCT01090024|12064986|FG013|Period 1|Met exclusion criteria|0
7649674|NCT01090024|12064987|FG014|Period 1|Met exclusion criteria|1
7649675|NCT01090024|12064988|FG015|Period 1|Met exclusion criteria|0
7649676|NCT01090024|12064989|FG016|Period 1|Met exclusion criteria|0
7649677|NCT01090024|12064990|FG017|Period 1|Met exclusion criteria|0
7649678|NCT01090024|12064973|FG000|Period 1|Adverse Event|0
7649679|NCT01090024|12064974|FG001|Period 1|Adverse Event|0
7649680|NCT01090024|12064975|FG002|Period 1|Adverse Event|0
7649681|NCT01090024|12064976|FG003|Period 1|Adverse Event|0
7649682|NCT01090024|12064977|FG004|Period 1|Adverse Event|0
7649683|NCT01090024|12064978|FG005|Period 1|Adverse Event|0
7649684|NCT01090024|12064979|FG006|Period 1|Adverse Event|0
7649685|NCT01090024|12064980|FG007|Period 1|Adverse Event|0
7649686|NCT01090024|12064981|FG008|Period 1|Adverse Event|0
7649687|NCT01090024|12064982|FG009|Period 1|Adverse Event|1
7649688|NCT01090024|12064983|FG010|Period 1|Adverse Event|0
7649689|NCT01090024|12064984|FG011|Period 1|Adverse Event|1
7649690|NCT01090024|12064985|FG012|Period 1|Adverse Event|0
7649691|NCT01090024|12064986|FG013|Period 1|Adverse Event|0
7649692|NCT01090024|12064987|FG014|Period 1|Adverse Event|0
7649693|NCT01090024|12064988|FG015|Period 1|Adverse Event|0
7649694|NCT01090024|12064989|FG016|Period 1|Adverse Event|0
7649695|NCT01090024|12064990|FG017|Period 1|Adverse Event|1
7649696|NCT01090024|12064973|FG000|Period 1|Withdrawal by Subject|0
7649697|NCT01090024|12064974|FG001|Period 1|Withdrawal by Subject|0
7649698|NCT01090024|12064975|FG002|Period 1|Withdrawal by Subject|0
7649699|NCT01090024|12064976|FG003|Period 1|Withdrawal by Subject|1
7649700|NCT01090024|12064977|FG004|Period 1|Withdrawal by Subject|0
7649701|NCT01090024|12064978|FG005|Period 1|Withdrawal by Subject|0
7649702|NCT01090024|12064979|FG006|Period 1|Withdrawal by Subject|0
7649703|NCT01090024|12064980|FG007|Period 1|Withdrawal by Subject|0
7649704|NCT01090024|12064981|FG008|Period 1|Withdrawal by Subject|0
7649705|NCT01090024|12064982|FG009|Period 1|Withdrawal by Subject|0
7649706|NCT01090024|12064983|FG010|Period 1|Withdrawal by Subject|0
7649707|NCT01090024|12064984|FG011|Period 1|Withdrawal by Subject|0
7649708|NCT01090024|12064985|FG012|Period 1|Withdrawal by Subject|0
7649709|NCT01090024|12064986|FG013|Period 1|Withdrawal by Subject|0
7649710|NCT01090024|12064987|FG014|Period 1|Withdrawal by Subject|0
7649711|NCT01090024|12064988|FG015|Period 1|Withdrawal by Subject|0
7649712|NCT01090024|12064989|FG016|Period 1|Withdrawal by Subject|0
7649713|NCT01090024|12064990|FG017|Period 1|Withdrawal by Subject|0
7649714|NCT01090024|12064973|FG000|Period 1|Lost to Follow-up|0
7649715|NCT01090024|12064974|FG001|Period 1|Lost to Follow-up|1
7649716|NCT01090024|12064975|FG002|Period 1|Lost to Follow-up|0
7649717|NCT01090024|12064976|FG003|Period 1|Lost to Follow-up|0
7649718|NCT01090024|12064977|FG004|Period 1|Lost to Follow-up|0
7649719|NCT01090024|12064978|FG005|Period 1|Lost to Follow-up|0
7649720|NCT01090024|12064979|FG006|Period 1|Lost to Follow-up|0
7649721|NCT01090024|12064980|FG007|Period 1|Lost to Follow-up|0
7649722|NCT01090024|12064981|FG008|Period 1|Lost to Follow-up|0
7649723|NCT01090024|12064982|FG009|Period 1|Lost to Follow-up|0
7649724|NCT01090024|12064983|FG010|Period 1|Lost to Follow-up|0
7649725|NCT01090024|12064984|FG011|Period 1|Lost to Follow-up|0
7649726|NCT01090024|12064985|FG012|Period 1|Lost to Follow-up|0
7649727|NCT01090024|12064986|FG013|Period 1|Lost to Follow-up|0
7649728|NCT01090024|12064987|FG014|Period 1|Lost to Follow-up|0
7649729|NCT01090024|12064988|FG015|Period 1|Lost to Follow-up|0
7649730|NCT01090024|12064989|FG016|Period 1|Lost to Follow-up|0
7649731|NCT01090024|12064990|FG017|Period 1|Lost to Follow-up|0
7649732|NCT01090024|12064973|FG000|Period 2|Lost to Follow-up|0
7649733|NCT01090024|12064974|FG001|Period 2|Lost to Follow-up|0
7649734|NCT01090024|12064975|FG002|Period 2|Lost to Follow-up|0
7649735|NCT01090024|12064976|FG003|Period 2|Lost to Follow-up|1
7649736|NCT01090024|12064977|FG004|Period 2|Lost to Follow-up|0
7649737|NCT01090024|12064978|FG005|Period 2|Lost to Follow-up|0
7649738|NCT01090024|12064979|FG006|Period 2|Lost to Follow-up|0
7649739|NCT01090024|12064980|FG007|Period 2|Lost to Follow-up|0
7649740|NCT01090024|12064981|FG008|Period 2|Lost to Follow-up|0
7649741|NCT01090024|12064982|FG009|Period 2|Lost to Follow-up|0
7649742|NCT01090024|12064983|FG010|Period 2|Lost to Follow-up|0
7649743|NCT01090024|12064984|FG011|Period 2|Lost to Follow-up|0
7649744|NCT01090024|12064985|FG012|Period 2|Lost to Follow-up|0
7649745|NCT01090024|12064986|FG013|Period 2|Lost to Follow-up|0
7649746|NCT01090024|12064987|FG014|Period 2|Lost to Follow-up|0
7649747|NCT01090024|12064988|FG015|Period 2|Lost to Follow-up|0
7649748|NCT01090024|12064989|FG016|Period 2|Lost to Follow-up|0
7649749|NCT01090024|12064990|FG017|Period 2|Lost to Follow-up|0
7649750|NCT01090024|12064973|FG000|Period 2|Adverse Event|1
7649751|NCT01090024|12064974|FG001|Period 2|Adverse Event|0
7649752|NCT01090024|12064975|FG002|Period 2|Adverse Event|0
7649753|NCT01090024|12064976|FG003|Period 2|Adverse Event|0
7649754|NCT01090024|12064977|FG004|Period 2|Adverse Event|0
7649755|NCT01090024|12064978|FG005|Period 2|Adverse Event|0
7649756|NCT01090024|12064979|FG006|Period 2|Adverse Event|0
7649757|NCT01090024|12064980|FG007|Period 2|Adverse Event|0
7649758|NCT01090024|12064981|FG008|Period 2|Adverse Event|0
7649759|NCT01090024|12064982|FG009|Period 2|Adverse Event|0
7649760|NCT01090024|12064983|FG010|Period 2|Adverse Event|0
7649761|NCT01090024|12064984|FG011|Period 2|Adverse Event|0
7649762|NCT01090024|12064985|FG012|Period 2|Adverse Event|0
7649763|NCT01090024|12064986|FG013|Period 2|Adverse Event|0
7649764|NCT01090024|12064987|FG014|Period 2|Adverse Event|0
7649765|NCT01090024|12064988|FG015|Period 2|Adverse Event|0
7649766|NCT01090024|12064989|FG016|Period 2|Adverse Event|0
7649767|NCT01090024|12064990|FG017|Period 2|Adverse Event|0
7649768|NCT01090024|12064973|FG000|Period 3|Withdrawal by Subject|0
7649769|NCT01090024|12064974|FG001|Period 3|Withdrawal by Subject|0
7649770|NCT01090024|12064975|FG002|Period 3|Withdrawal by Subject|0
7649771|NCT01090024|12064976|FG003|Period 3|Withdrawal by Subject|0
7649772|NCT01090024|12064977|FG004|Period 3|Withdrawal by Subject|0
7649773|NCT01090024|12064978|FG005|Period 3|Withdrawal by Subject|0
7649774|NCT01090024|12064979|FG006|Period 3|Withdrawal by Subject|0
7649775|NCT01090024|12064980|FG007|Period 3|Withdrawal by Subject|0
7649776|NCT01090024|12064981|FG008|Period 3|Withdrawal by Subject|0
7649777|NCT01090024|12064982|FG009|Period 3|Withdrawal by Subject|0
7649778|NCT01090024|12064983|FG010|Period 3|Withdrawal by Subject|0
7649779|NCT01090024|12064984|FG011|Period 3|Withdrawal by Subject|0
7649780|NCT01090024|12064985|FG012|Period 3|Withdrawal by Subject|0
7649781|NCT01090024|12064986|FG013|Period 3|Withdrawal by Subject|0
7649782|NCT01090024|12064987|FG014|Period 3|Withdrawal by Subject|0
7649783|NCT01090024|12064988|FG015|Period 3|Withdrawal by Subject|1
7649784|NCT01090024|12064989|FG016|Period 3|Withdrawal by Subject|0
7649785|NCT01090024|12064990|FG017|Period 3|Withdrawal by Subject|0
7649786|NCT01090024|12064973|FG000|Period 3|Protocol Violation|0
7649787|NCT01090024|12064974|FG001|Period 3|Protocol Violation|0
7649788|NCT01090024|12064975|FG002|Period 3|Protocol Violation|0
7649789|NCT01090024|12064976|FG003|Period 3|Protocol Violation|0
7649790|NCT01090024|12064977|FG004|Period 3|Protocol Violation|0
7649791|NCT01090024|12064978|FG005|Period 3|Protocol Violation|0
7649792|NCT01090024|12064979|FG006|Period 3|Protocol Violation|0
7649793|NCT01090024|12064980|FG007|Period 3|Protocol Violation|0
7649794|NCT01090024|12064981|FG008|Period 3|Protocol Violation|1
7649795|NCT01090024|12064982|FG009|Period 3|Protocol Violation|0
7649796|NCT01090024|12064983|FG010|Period 3|Protocol Violation|0
7649797|NCT01090024|12064984|FG011|Period 3|Protocol Violation|0
7649798|NCT01090024|12064985|FG012|Period 3|Protocol Violation|0
7649799|NCT01090024|12064986|FG013|Period 3|Protocol Violation|0
7649800|NCT01090024|12064987|FG014|Period 3|Protocol Violation|0
7649801|NCT01090024|12064988|FG015|Period 3|Protocol Violation|0
7649802|NCT01090024|12064989|FG016|Period 3|Protocol Violation|0
7649803|NCT01090024|12064990|FG017|Period 3|Protocol Violation|0
7649804|NCT01090024|12064973|FG000|Period 3|Adverse Event|0
7649805|NCT01090024|12064974|FG001|Period 3|Adverse Event|0
7649806|NCT01090024|12064975|FG002|Period 3|Adverse Event|0
7649807|NCT01090024|12064976|FG003|Period 3|Adverse Event|0
7649808|NCT01090024|12064977|FG004|Period 3|Adverse Event|0
7649809|NCT01090024|12064978|FG005|Period 3|Adverse Event|1
7649810|NCT01090024|12064979|FG006|Period 3|Adverse Event|0
7649811|NCT01090024|12064980|FG007|Period 3|Adverse Event|0
7649812|NCT01090024|12064981|FG008|Period 3|Adverse Event|0
7649813|NCT01090024|12064982|FG009|Period 3|Adverse Event|0
7649814|NCT01090024|12064983|FG010|Period 3|Adverse Event|0
7649815|NCT01090024|12064984|FG011|Period 3|Adverse Event|0
7649816|NCT01090024|12064985|FG012|Period 3|Adverse Event|0
7649817|NCT01090024|12064986|FG013|Period 3|Adverse Event|0
7649818|NCT01090024|12064987|FG014|Period 3|Adverse Event|0
7649819|NCT01090024|12064988|FG015|Period 3|Adverse Event|0
7649820|NCT01090024|12064989|FG016|Period 3|Adverse Event|0
7649821|NCT01090024|12064990|FG017|Period 3|Adverse Event|0
7649822|NCT00943722|12065005|FG000|Base Study|Adverse Event|0
7649823|NCT00943722|12065006|FG001|Base Study|Adverse Event|0
7649824|NCT00943722|12065007|FG002|Base Study|Adverse Event|0
7649825|NCT00943722|12065008|FG003|Base Study|Adverse Event|1
7649826|NCT00943722|12065009|FG004|Base Study|Adverse Event|0
7649827|NCT00943722|12065010|FG005|Base Study|Adverse Event|0
7649828|NCT00943722|12065011|FG006|Base Study|Adverse Event|0
7649829|NCT00943722|12065005|FG000|Base Study|Lost to Follow-up|12
7649830|NCT00943722|12065006|FG001|Base Study|Lost to Follow-up|8
7649831|NCT00943722|12065007|FG002|Base Study|Lost to Follow-up|10
7649832|NCT00943722|12065008|FG003|Base Study|Lost to Follow-up|8
7649833|NCT00943722|12065009|FG004|Base Study|Lost to Follow-up|11
7649834|NCT00943722|12065010|FG005|Base Study|Lost to Follow-up|0
7649835|NCT00943722|12065011|FG006|Base Study|Lost to Follow-up|0
7649836|NCT00943722|12065005|FG000|Base Study|Physician Decision|1
7649837|NCT00943722|12065006|FG001|Base Study|Physician Decision|0
7649838|NCT00943722|12065007|FG002|Base Study|Physician Decision|0
7649839|NCT00943722|12065008|FG003|Base Study|Physician Decision|0
7649840|NCT00943722|12065009|FG004|Base Study|Physician Decision|1
7649841|NCT00943722|12065010|FG005|Base Study|Physician Decision|0
7649842|NCT00943722|12065011|FG006|Base Study|Physician Decision|0
7649843|NCT00943722|12065005|FG000|Base Study|Pregnancy|0
7649844|NCT00943722|12065006|FG001|Base Study|Pregnancy|0
7649845|NCT00943722|12065007|FG002|Base Study|Pregnancy|1
7649846|NCT00943722|12065008|FG003|Base Study|Pregnancy|0
7649847|NCT00943722|12065009|FG004|Base Study|Pregnancy|2
7649848|NCT00943722|12065010|FG005|Base Study|Pregnancy|0
7649849|NCT00943722|12065011|FG006|Base Study|Pregnancy|0
7649850|NCT00943722|12065005|FG000|Base Study|Protocol Violation|0
7649851|NCT00943722|12065006|FG001|Base Study|Protocol Violation|1
7649852|NCT00943722|12065007|FG002|Base Study|Protocol Violation|0
7649853|NCT00943722|12065008|FG003|Base Study|Protocol Violation|0
7649854|NCT00943722|12065009|FG004|Base Study|Protocol Violation|2
7649855|NCT00943722|12065010|FG005|Base Study|Protocol Violation|0
7649856|NCT00943722|12065011|FG006|Base Study|Protocol Violation|0
7649857|NCT00943722|12065005|FG000|Base Study|Withdrawal by Subject|12
7649858|NCT00943722|12065006|FG001|Base Study|Withdrawal by Subject|13
7649859|NCT00943722|12065007|FG002|Base Study|Withdrawal by Subject|2
7649860|NCT00943722|12065008|FG003|Base Study|Withdrawal by Subject|13
7649861|NCT00943722|12065009|FG004|Base Study|Withdrawal by Subject|8
7649862|NCT00943722|12065010|FG005|Base Study|Withdrawal by Subject|0
7649863|NCT00943722|12065011|FG006|Base Study|Withdrawal by Subject|0
7649864|NCT00943722|12065005|FG000|Base Study|Month 12 visit not completed|0
7649865|NCT00943722|12065006|FG001|Base Study|Month 12 visit not completed|0
7649866|NCT00943722|12065007|FG002|Base Study|Month 12 visit not completed|0
7649867|NCT00943722|12065008|FG003|Base Study|Month 12 visit not completed|0
7649868|NCT00943722|12065009|FG004|Base Study|Month 12 visit not completed|2
7649869|NCT00943722|12065010|FG005|Base Study|Month 12 visit not completed|0
7649870|NCT00943722|12065011|FG006|Base Study|Month 12 visit not completed|0
7649871|NCT00943722|12065005|FG000|First Extension Study: EXT 1|Adverse Event|0
7649872|NCT00943722|12065006|FG001|First Extension Study: EXT 1|Adverse Event|0
7649873|NCT00943722|12065007|FG002|First Extension Study: EXT 1|Adverse Event|0
7649874|NCT00943722|12065008|FG003|First Extension Study: EXT 1|Adverse Event|0
7649875|NCT00943722|12065009|FG004|First Extension Study: EXT 1|Adverse Event|0
7649876|NCT00943722|12065010|FG005|First Extension Study: EXT 1|Adverse Event|1
7649877|NCT00943722|12065011|FG006|First Extension Study: EXT 1|Adverse Event|0
7649878|NCT00943722|12065005|FG000|First Extension Study: EXT 1|Lost to Follow-up|0
7649879|NCT00943722|12065006|FG001|First Extension Study: EXT 1|Lost to Follow-up|0
7649880|NCT00943722|12065007|FG002|First Extension Study: EXT 1|Lost to Follow-up|0
7649881|NCT00943722|12065008|FG003|First Extension Study: EXT 1|Lost to Follow-up|0
7649882|NCT00943722|12065009|FG004|First Extension Study: EXT 1|Lost to Follow-up|0
7649883|NCT00943722|12065010|FG005|First Extension Study: EXT 1|Lost to Follow-up|38
7649884|NCT00943722|12065011|FG006|First Extension Study: EXT 1|Lost to Follow-up|10
7649885|NCT00943722|12065005|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0
7649886|NCT00943722|12065006|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0
7649887|NCT00943722|12065007|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0
7649888|NCT00943722|12065008|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0
7649889|NCT00943722|12065009|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0
7649890|NCT00943722|12065010|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32
7649891|NCT00943722|12065011|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10
7649892|NCT00943722|12065005|FG000|First Extension Study: EXT 1|Disposition Unknown|0
7649893|NCT00943722|12065006|FG001|First Extension Study: EXT 1|Disposition Unknown|0
7649894|NCT00943722|12065007|FG002|First Extension Study: EXT 1|Disposition Unknown|0
7649895|NCT00943722|12065008|FG003|First Extension Study: EXT 1|Disposition Unknown|0
7649896|NCT00943722|12065009|FG004|First Extension Study: EXT 1|Disposition Unknown|0
7649897|NCT00943722|12065010|FG005|First Extension Study: EXT 1|Disposition Unknown|44
7649898|NCT00943722|12065011|FG006|First Extension Study: EXT 1|Disposition Unknown|21
7649899|NCT00943722|12065005|FG000|Second Extension Study: EXT 2|Adverse Event|0
7649900|NCT00943722|12065006|FG001|Second Extension Study: EXT 2|Adverse Event|0
7649901|NCT00943722|12065007|FG002|Second Extension Study: EXT 2|Adverse Event|0
7649902|NCT00943722|12065008|FG003|Second Extension Study: EXT 2|Adverse Event|0
7649903|NCT00943722|12065009|FG004|Second Extension Study: EXT 2|Adverse Event|0
7649904|NCT00943722|12065010|FG005|Second Extension Study: EXT 2|Adverse Event|1
7649905|NCT00943722|12065011|FG006|Second Extension Study: EXT 2|Adverse Event|0
7649906|NCT00943722|12065005|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0
7649907|NCT00943722|12065006|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0
7649908|NCT00943722|12065007|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0
7649909|NCT00943722|12065008|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0
7649910|NCT00943722|12065009|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0
7649911|NCT00943722|12065010|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111
7649912|NCT00943722|12065011|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46
7649913|NCT00943722|12065005|FG000|Second Extension Study: EXT 2|Physician Decision|0
7649914|NCT00943722|12065006|FG001|Second Extension Study: EXT 2|Physician Decision|0
7649915|NCT00943722|12065007|FG002|Second Extension Study: EXT 2|Physician Decision|0
7649916|NCT00943722|12065008|FG003|Second Extension Study: EXT 2|Physician Decision|0
7649917|NCT00943722|12065009|FG004|Second Extension Study: EXT 2|Physician Decision|0
7649918|NCT00943722|12065010|FG005|Second Extension Study: EXT 2|Physician Decision|1
7649919|NCT00943722|12065011|FG006|Second Extension Study: EXT 2|Physician Decision|3
7649920|NCT00943722|12065005|FG000|Second Extension Study: EXT 2|Pregnancy|0
7649921|NCT00943722|12065006|FG001|Second Extension Study: EXT 2|Pregnancy|0
7649922|NCT00943722|12065007|FG002|Second Extension Study: EXT 2|Pregnancy|0
7649923|NCT00943722|12065008|FG003|Second Extension Study: EXT 2|Pregnancy|0
7649924|NCT00943722|12065009|FG004|Second Extension Study: EXT 2|Pregnancy|0
7649925|NCT00943722|12065010|FG005|Second Extension Study: EXT 2|Pregnancy|1
7649926|NCT00943722|12065011|FG006|Second Extension Study: EXT 2|Pregnancy|0
7649927|NCT00943722|12065005|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0
7649928|NCT00943722|12065006|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0
7649929|NCT00943722|12065007|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0
7649930|NCT00943722|12065008|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0
7649931|NCT00943722|12065009|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0
7649932|NCT00943722|12065010|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137
7649933|NCT00943722|12065011|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50
7649934|NCT00676663|12065036|FG000|Overall Study|Death|43
7649935|NCT00676663|12065037|FG001|Overall Study|Death|27
7649936|NCT00676663|12065036|FG000|Overall Study|Withdrew Consent|1
7649937|NCT00676663|12065037|FG001|Overall Study|Withdrew Consent|8
7649938|NCT00676663|12065036|FG000|Overall Study|Lost to Follow-up|1
7649939|NCT00676663|12065037|FG001|Overall Study|Lost to Follow-up|3
7649940|NCT04617860|12065058|FG000|Overall Study|Adverse Event|0
7649941|NCT04617860|12065059|FG001|Overall Study|Adverse Event|2
7649942|NCT04617860|12065060|FG002|Overall Study|Adverse Event|2
7649943|NCT04617860|12065058|FG000|Overall Study|Withdrawal by Subject|0
7649944|NCT04617860|12065059|FG001|Overall Study|Withdrawal by Subject|0
7649945|NCT04617860|12065060|FG002|Overall Study|Withdrawal by Subject|2
7649946|NCT04617860|12065058|FG000|Overall Study|Physician Decision|0
7649947|NCT04617860|12065059|FG001|Overall Study|Physician Decision|1
7649948|NCT04617860|12065060|FG002|Overall Study|Physician Decision|0
7649949|NCT04617860|12065058|FG000|Overall Study|Sponsor Decision|0
7649950|NCT04617860|12065059|FG001|Overall Study|Sponsor Decision|3
7649951|NCT04617860|12065060|FG002|Overall Study|Sponsor Decision|1
7649952|NCT04617860|12065058|FG000|Overall Study|Termination of Study by Sponsor|8
7649953|NCT04617860|12065059|FG001|Overall Study|Termination of Study by Sponsor|4
7649954|NCT04617860|12065060|FG002|Overall Study|Termination of Study by Sponsor|13
7649955|NCT04617847|12065072|FG000|Overall Study|Withdrawal by Subject|1
7649956|NCT04617847|12065073|FG001|Overall Study|Withdrawal by Subject|0
7649957|NCT04617847|12065072|FG000|Overall Study|Adverse Event|0
7649958|NCT04617847|12065073|FG001|Overall Study|Adverse Event|2
7649959|NCT04617847|12065072|FG000|Overall Study|Death|0
7649960|NCT04617847|12065073|FG001|Overall Study|Death|1
7649961|NCT04617847|12065072|FG000|Overall Study|Termination of Study by Sponsor|2
7649962|NCT04617847|12065073|FG001|Overall Study|Termination of Study by Sponsor|21
7649963|NCT04426318|12065083|FG000|Overall Study|failed attention checks and had their data removed from analyses|2
7649964|NCT04426318|12065084|FG001|Overall Study|failed attention checks and had their data removed from analyses|2
7649965|NCT04063657|12065092|FG000|Overall Study|Lost to Follow-up|1
7649966|NCT04063657|12065093|FG001|Overall Study|Lost to Follow-up|0
7649967|NCT03882047|12065106|FG000|Overall Study|Adverse Event|0
7649968|NCT03882047|12065107|FG001|Overall Study|Adverse Event|2
7649969|NCT03882047|12065108|FG002|Overall Study|Adverse Event|2
7649970|NCT03882047|12065106|FG000|Overall Study|Treatment Failure|3
7649971|NCT03882047|12065107|FG001|Overall Study|Treatment Failure|3
7649972|NCT03882047|12065108|FG002|Overall Study|Treatment Failure|12
7649973|NCT03882047|12065106|FG000|Overall Study|Lost to Follow-up|0
7649974|NCT03882047|12065107|FG001|Overall Study|Lost to Follow-up|1
7649975|NCT03882047|12065108|FG002|Overall Study|Lost to Follow-up|0
7649976|NCT03882047|12065106|FG000|Overall Study|Did Not Wish to Continue|1
7649977|NCT03882047|12065107|FG001|Overall Study|Did Not Wish to Continue|4
7649978|NCT03882047|12065108|FG002|Overall Study|Did Not Wish to Continue|1
7649979|NCT03882047|12065106|FG000|Overall Study|Noncompliance With Protocol|2
7649980|NCT03882047|12065107|FG001|Overall Study|Noncompliance With Protocol|0
7649981|NCT03882047|12065108|FG002|Overall Study|Noncompliance With Protocol|0
7649982|NCT03882047|12065106|FG000|Overall Study|Did Not Meet Eligibility|0
7649983|NCT03882047|12065107|FG001|Overall Study|Did Not Meet Eligibility|0
7649984|NCT03882047|12065108|FG002|Overall Study|Did Not Meet Eligibility|1
7649985|NCT03879772|12065121|FG000|Overall Study|Adverse Event|2
7649986|NCT03879772|12065122|FG001|Overall Study|Adverse Event|2
7649987|NCT03879772|12065123|FG002|Overall Study|Adverse Event|3
7649988|NCT03879772|12065124|FG003|Overall Study|Adverse Event|4
7649989|NCT03879772|12065125|FG004|Overall Study|Adverse Event|3
7649990|NCT03879772|12065121|FG000|Overall Study|Treatment Failure|1
7649991|NCT03879772|12065122|FG001|Overall Study|Treatment Failure|0
7649992|NCT03879772|12065123|FG002|Overall Study|Treatment Failure|0
7649993|NCT03879772|12065124|FG003|Overall Study|Treatment Failure|2
7649994|NCT03879772|12065125|FG004|Overall Study|Treatment Failure|1
7649995|NCT03879772|12065121|FG000|Overall Study|Lost to Follow-up|0
7649996|NCT03879772|12065122|FG001|Overall Study|Lost to Follow-up|0
7649997|NCT03879772|12065123|FG002|Overall Study|Lost to Follow-up|0
7649998|NCT03879772|12065124|FG003|Overall Study|Lost to Follow-up|0
7649999|NCT03879772|12065125|FG004|Overall Study|Lost to Follow-up|1
7650000|NCT03879772|12065121|FG000|Overall Study|Withdrawal by Subject|0
7650001|NCT03879772|12065122|FG001|Overall Study|Withdrawal by Subject|1
7650002|NCT03879772|12065123|FG002|Overall Study|Withdrawal by Subject|3
7650003|NCT03879772|12065124|FG003|Overall Study|Withdrawal by Subject|1
7650004|NCT03879772|12065125|FG004|Overall Study|Withdrawal by Subject|1
7650005|NCT03879772|12065121|FG000|Overall Study|Protocol Violation|0
7650006|NCT03879772|12065122|FG001|Overall Study|Protocol Violation|0
7650007|NCT03879772|12065123|FG002|Overall Study|Protocol Violation|3
7650008|NCT03879772|12065124|FG003|Overall Study|Protocol Violation|1
7650009|NCT03879772|12065125|FG004|Overall Study|Protocol Violation|2
7650010|NCT03879772|12065121|FG000|Overall Study|Did Not Meet Entry Requirements|1
7650011|NCT03879772|12065122|FG001|Overall Study|Did Not Meet Entry Requirements|0
7650012|NCT03879772|12065123|FG002|Overall Study|Did Not Meet Entry Requirements|1
7650013|NCT03879772|12065124|FG003|Overall Study|Did Not Meet Entry Requirements|0
7650014|NCT03879772|12065125|FG004|Overall Study|Did Not Meet Entry Requirements|0
7650015|NCT03861559|12065139|FG000|Overall Study|Adverse Event|0
7650016|NCT03861559|12065140|FG001|Overall Study|Adverse Event|2
7650017|NCT03861559|12065139|FG000|Overall Study|Treatment failure|0
7650018|NCT03861559|12065140|FG001|Overall Study|Treatment failure|2
7650019|NCT03861559|12065139|FG000|Overall Study|Noncompliance|1
7650020|NCT03861559|12065140|FG001|Overall Study|Noncompliance|1
7650021|NCT03861559|12065139|FG000|Overall Study|Did not meet eligibility requirements|1
7650022|NCT03861559|12065140|FG001|Overall Study|Did not meet eligibility requirements|0
7650023|NCT03855228|12065150|FG000|Overall Study|Adverse Event|2
7650024|NCT03855228|12065151|FG001|Overall Study|Adverse Event|4
7650025|NCT03855228|12065152|FG002|Overall Study|Adverse Event|4
7650026|NCT03855228|12065153|FG003|Overall Study|Adverse Event|8
7650027|NCT03855228|12065150|FG000|Overall Study|Treatment Failure|1
7650028|NCT03855228|12065151|FG001|Overall Study|Treatment Failure|2
7650029|NCT03855228|12065152|FG002|Overall Study|Treatment Failure|1
7650030|NCT03855228|12065153|FG003|Overall Study|Treatment Failure|8
7650031|NCT03855228|12065150|FG000|Overall Study|Lost to Follow-up|0
7650032|NCT03855228|12065151|FG001|Overall Study|Lost to Follow-up|0
7650033|NCT03855228|12065152|FG002|Overall Study|Lost to Follow-up|0
7650034|NCT03855228|12065153|FG003|Overall Study|Lost to Follow-up|1
7650035|NCT03855228|12065150|FG000|Overall Study|Protocol Violation|0
7650036|NCT03855228|12065151|FG001|Overall Study|Protocol Violation|1
7650037|NCT03855228|12065152|FG002|Overall Study|Protocol Violation|2
7650038|NCT03855228|12065153|FG003|Overall Study|Protocol Violation|1
7650039|NCT03855228|12065150|FG000|Overall Study|Did Not Meet Entry Requirements|0
7650040|NCT03855228|12065151|FG001|Overall Study|Did Not Meet Entry Requirements|2
7650041|NCT03855228|12065152|FG002|Overall Study|Did Not Meet Entry Requirements|1
7650042|NCT03855228|12065153|FG003|Overall Study|Did Not Meet Entry Requirements|1
7650043|NCT03855189|12065166|FG000|Overall Study|Adverse Event|5
7650044|NCT03855189|12065167|FG001|Overall Study|Adverse Event|2
7650045|NCT03855189|12065168|FG002|Overall Study|Adverse Event|4
7650046|NCT03855189|12065166|FG000|Overall Study|Treatment Failure|1
7650047|NCT03855189|12065167|FG001|Overall Study|Treatment Failure|1
7650048|NCT03855189|12065168|FG002|Overall Study|Treatment Failure|2
7650049|NCT03855189|12065166|FG000|Overall Study|Noncompliance with Protocol|0
7650050|NCT03855189|12065167|FG001|Overall Study|Noncompliance with Protocol|1
7650051|NCT03855189|12065168|FG002|Overall Study|Noncompliance with Protocol|0
7650052|NCT03855189|12065166|FG000|Overall Study|Did Not Return|4
7650053|NCT03855189|12065167|FG001|Overall Study|Did Not Return|3
7650054|NCT03855189|12065168|FG002|Overall Study|Did Not Return|0
7650055|NCT03764631|12065178|FG000|Overall Study|Personal Reasons|3
7650056|NCT03764631|12065179|FG001|Overall Study|Personal Reasons|2
7650057|NCT03764631|12065178|FG000|Overall Study|Switching Therapy|3
7650058|NCT03764631|12065179|FG001|Overall Study|Switching Therapy|3
7650059|NCT03764631|12065178|FG000|Overall Study|Adverse Event|0
7650060|NCT03764631|12065179|FG001|Overall Study|Adverse Event|1
7650061|NCT03764631|12065178|FG000|Overall Study|Lost to Follow-up|33
7650062|NCT03764631|12065179|FG001|Overall Study|Lost to Follow-up|41
7650063|NCT03764631|12065178|FG000|Overall Study|No data as study site was closed|2
7650064|NCT03764631|12065179|FG001|Overall Study|No data as study site was closed|6
7650065|NCT03764072|12065191|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
7650066|NCT03764072|12065192|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
7650067|NCT03764072|12065193|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
7650068|NCT03764072|12065194|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
7650069|NCT03764072|12065195|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
7650070|NCT03764072|12065196|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
7650071|NCT03764072|12065191|FG000|Overall Study|Withdrawal of consent (for other reason)|0
7650072|NCT03764072|12065192|FG001|Overall Study|Withdrawal of consent (for other reason)|0
7650073|NCT03764072|12065193|FG002|Overall Study|Withdrawal of consent (for other reason)|0
7650074|NCT03764072|12065194|FG003|Overall Study|Withdrawal of consent (for other reason)|0
7650075|NCT03764072|12065195|FG004|Overall Study|Withdrawal of consent (for other reason)|0
7650076|NCT03764072|12065196|FG005|Overall Study|Withdrawal of consent (for other reason)|1
7650077|NCT03764072|12065191|FG000|Overall Study|Lost to Follow-up|0
7650078|NCT03764072|12065192|FG001|Overall Study|Lost to Follow-up|0
7650079|NCT03764072|12065193|FG002|Overall Study|Lost to Follow-up|0
7650080|NCT03764072|12065194|FG003|Overall Study|Lost to Follow-up|0
7650081|NCT03764072|12065195|FG004|Overall Study|Lost to Follow-up|1
7650082|NCT03764072|12065196|FG005|Overall Study|Lost to Follow-up|0
7650083|NCT03578809|12065228|FG000|Overall Study|Death|0
7650084|NCT03578809|12065229|FG001|Overall Study|Death|2
7650085|NCT03578809|12065230|FG002|Overall Study|Death|0
7650086|NCT03578809|12065231|FG003|Overall Study|Death|1
7650087|NCT03578809|12065228|FG000|Overall Study|Lost to Follow-up|0
7650088|NCT03578809|12065229|FG001|Overall Study|Lost to Follow-up|1
7650089|NCT03578809|12065230|FG002|Overall Study|Lost to Follow-up|0
7650090|NCT03578809|12065231|FG003|Overall Study|Lost to Follow-up|0
7650091|NCT03578809|12065228|FG000|Overall Study|Withdrawal by Subject|3
7650092|NCT03578809|12065229|FG001|Overall Study|Withdrawal by Subject|5
7650093|NCT03578809|12065230|FG002|Overall Study|Withdrawal by Subject|2
7650094|NCT03578809|12065231|FG003|Overall Study|Withdrawal by Subject|0
7650095|NCT03578809|12065228|FG000|Overall Study|Other|3
7650096|NCT03578809|12065229|FG001|Overall Study|Other|6
7650097|NCT03578809|12065230|FG002|Overall Study|Other|2
7650098|NCT03578809|12065231|FG003|Overall Study|Other|8
7650099|NCT03571204|12065247|FG000|Overall Study|Stopped due to COVID-19 pandemic|1
7650100|NCT03571204|12065248|FG001|Overall Study|Stopped due to COVID-19 pandemic|1
7650101|NCT03571204|12065249|FG002|Overall Study|Stopped due to COVID-19 pandemic|0
7650102|NCT03571204|12065247|FG000|Overall Study|Physician Decision|0
7650103|NCT03571204|12065248|FG001|Overall Study|Physician Decision|1
7650104|NCT03571204|12065249|FG002|Overall Study|Physician Decision|0
7650105|NCT03523091|12065260|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1
7650106|NCT03523091|12065261|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0
7650107|NCT03523091|12065260|FG000|Overall Study|Withdrawal by Subject|0
7650108|NCT03523091|12065261|FG001|Overall Study|Withdrawal by Subject|3
7650109|NCT03523091|12065260|FG000|Overall Study|Increase Botox dose|0
7650110|NCT03523091|12065261|FG001|Overall Study|Increase Botox dose|1
7650111|NCT03391960|12065289|FG000|Overall Study|Protocol Violation|0
7650112|NCT03391960|12065290|FG001|Overall Study|Protocol Violation|
7650113|NCT03362190|12065309|FG000|Overall Study|Adverse Event|0
7650114|NCT03362190|12065310|FG001|Overall Study|Adverse Event|0
7650115|NCT03362190|12065311|FG002|Overall Study|Adverse Event|0
7650116|NCT03362190|12065312|FG003|Overall Study|Adverse Event|1
7650117|NCT03362190|12065309|FG000|Overall Study|Withdrawal by Subject|0
7650118|NCT03362190|12065310|FG001|Overall Study|Withdrawal by Subject|0
7650119|NCT03362190|12065311|FG002|Overall Study|Withdrawal by Subject|0
7650120|NCT03362190|12065312|FG003|Overall Study|Withdrawal by Subject|1
7650121|NCT03252522|12065327|FG000|Overall Study|Adverse Event|3
7650122|NCT03252522|12065328|FG001|Overall Study|Adverse Event|1
7650123|NCT03252522|12065329|FG002|Overall Study|Adverse Event|0
7650124|NCT03252522|12065327|FG000|Overall Study|Unable to swallow pills|4
7650125|NCT03252522|12065328|FG001|Overall Study|Unable to swallow pills|1
7650126|NCT03252522|12065329|FG002|Overall Study|Unable to swallow pills|0
7650127|NCT03252522|12065327|FG000|Overall Study|Commenced stimulant medication|1
7650128|NCT03252522|12065328|FG001|Overall Study|Commenced stimulant medication|1
7650129|NCT03252522|12065329|FG002|Overall Study|Commenced stimulant medication|0
7650130|NCT03252522|12065327|FG000|Overall Study|Protocol Violation|1
7650131|NCT03252522|12065328|FG001|Overall Study|Protocol Violation|0
7650132|NCT03252522|12065329|FG002|Overall Study|Protocol Violation|0
7650133|NCT03225833|12065346|FG000|Overall Study|Adverse Event|0
7650134|NCT03225833|12065347|FG001|Overall Study|Adverse Event|1
7650135|NCT03225833|12065348|FG002|Overall Study|Adverse Event|2
7650136|NCT03225833|12065349|FG003|Overall Study|Adverse Event|0
7650137|NCT03225833|12065350|FG004|Overall Study|Adverse Event|0
7650138|NCT03225833|12065351|FG005|Overall Study|Adverse Event|2
7650139|NCT03225833|12065346|FG000|Overall Study|Withdrawal by Subject|1
7650140|NCT03225833|12065347|FG001|Overall Study|Withdrawal by Subject|0
7650141|NCT03225833|12065348|FG002|Overall Study|Withdrawal by Subject|0
7650142|NCT03225833|12065349|FG003|Overall Study|Withdrawal by Subject|0
7650143|NCT03225833|12065350|FG004|Overall Study|Withdrawal by Subject|1
7650144|NCT03225833|12065351|FG005|Overall Study|Withdrawal by Subject|0
7650145|NCT03225833|12065346|FG000|Overall Study|Termination of Study by Sponsor|4
7650146|NCT03225833|12065347|FG001|Overall Study|Termination of Study by Sponsor|0
7650147|NCT03225833|12065348|FG002|Overall Study|Termination of Study by Sponsor|0
7650148|NCT03225833|12065349|FG003|Overall Study|Termination of Study by Sponsor|0
7650149|NCT03225833|12065350|FG004|Overall Study|Termination of Study by Sponsor|0
7650150|NCT03225833|12065351|FG005|Overall Study|Termination of Study by Sponsor|7
7650151|NCT03225833|12065346|FG000|Overall Study|Sponsor Decision|0
7650152|NCT03225833|12065347|FG001|Overall Study|Sponsor Decision|0
7650153|NCT03225833|12065348|FG002|Overall Study|Sponsor Decision|0
7650154|NCT03225833|12065349|FG003|Overall Study|Sponsor Decision|0
7650155|NCT03225833|12065350|FG004|Overall Study|Sponsor Decision|0
7650156|NCT03225833|12065351|FG005|Overall Study|Sponsor Decision|1
7650157|NCT03167242|12065382|FG000|Overall Study|Patient/Guardian Decision|0
7650158|NCT03167242|12065383|FG001|Overall Study|Patient/Guardian Decision|1
7650159|NCT03167242|12065384|FG002|Overall Study|Patient/Guardian Decision|2
7650160|NCT03167242|12065385|FG003|Overall Study|Patient/Guardian Decision|1
7650161|NCT03167242|12065386|FG004|Overall Study|Patient/Guardian Decision|1
7650162|NCT03167242|12065387|FG005|Overall Study|Patient/Guardian Decision|1
7650163|NCT03167242|12065388|FG006|Overall Study|Patient/Guardian Decision|0
7650164|NCT03167242|12065389|FG007|Overall Study|Patient/Guardian Decision|0
7650165|NCT03167242|12065390|FG008|Overall Study|Patient/Guardian Decision|0
7650166|NCT03167242|12065391|FG009|Overall Study|Patient/Guardian Decision|0
7650167|NCT03167242|12065392|FG010|Overall Study|Patient/Guardian Decision|1
7650168|NCT03167242|12065393|FG011|Overall Study|Patient/Guardian Decision|0
7650169|NCT03167242|12065382|FG000|Overall Study|Lost to Follow-up|0
7650170|NCT03167242|12065383|FG001|Overall Study|Lost to Follow-up|0
7650171|NCT03167242|12065384|FG002|Overall Study|Lost to Follow-up|1
7650172|NCT03167242|12065385|FG003|Overall Study|Lost to Follow-up|0
7650173|NCT03167242|12065386|FG004|Overall Study|Lost to Follow-up|0
7650174|NCT03167242|12065387|FG005|Overall Study|Lost to Follow-up|1
7650175|NCT03167242|12065388|FG006|Overall Study|Lost to Follow-up|2
7650176|NCT03167242|12065389|FG007|Overall Study|Lost to Follow-up|1
7650177|NCT03167242|12065390|FG008|Overall Study|Lost to Follow-up|0
7650178|NCT03167242|12065391|FG009|Overall Study|Lost to Follow-up|0
7650179|NCT03167242|12065392|FG010|Overall Study|Lost to Follow-up|1
7650180|NCT03167242|12065393|FG011|Overall Study|Lost to Follow-up|1
7650181|NCT03167242|12065382|FG000|Overall Study|Reason not provided|0
7650182|NCT03167242|12065383|FG001|Overall Study|Reason not provided|0
7650183|NCT03167242|12065384|FG002|Overall Study|Reason not provided|0
7650184|NCT03167242|12065385|FG003|Overall Study|Reason not provided|0
7650185|NCT03167242|12065386|FG004|Overall Study|Reason not provided|0
7650186|NCT03167242|12065387|FG005|Overall Study|Reason not provided|0
7650187|NCT03167242|12065388|FG006|Overall Study|Reason not provided|0
7650188|NCT03167242|12065389|FG007|Overall Study|Reason not provided|0
7650189|NCT03167242|12065390|FG008|Overall Study|Reason not provided|1
7650190|NCT03167242|12065391|FG009|Overall Study|Reason not provided|0
7650191|NCT03167242|12065392|FG010|Overall Study|Reason not provided|0
7650192|NCT03167242|12065393|FG011|Overall Study|Reason not provided|0
7650193|NCT03137537|12065431|FG000|Overall Study|Adverse Event|0
7650194|NCT03137537|12065432|FG001|Overall Study|Adverse Event|1
7650195|NCT03113383|12065438|FG000|Overall Study|Death|4
7650196|NCT03113383|12065439|FG001|Overall Study|Death|0
7650197|NCT02978326|12065461|FG000|Part B (Up to 45 Days)|Adverse Event|0
7650198|NCT02978326|12065462|FG001|Part B (Up to 45 Days)|Adverse Event|0
7650199|NCT02978326|12065463|FG002|Part B (Up to 45 Days)|Adverse Event|1
7650200|NCT02978326|12065461|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0
7650201|NCT02978326|12065462|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3
7650202|NCT02978326|12065463|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0
7650203|NCT02978326|12065461|FG000|Part B (Up to 45 Days)|Non-compliance|0
7650204|NCT02978326|12065462|FG001|Part B (Up to 45 Days)|Non-compliance|2
7650205|NCT02978326|12065463|FG002|Part B (Up to 45 Days)|Non-compliance|0
7650206|NCT02978326|12065461|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0
7650207|NCT02978326|12065462|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2
7650208|NCT02978326|12065463|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3
7650209|NCT02970929|12065473|FG000|Overall Study|Adverse Event|18
7650210|NCT02970929|12065473|FG000|Overall Study|Lack of Efficacy|8
7650211|NCT02970929|12065473|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1
7650212|NCT02970929|12065473|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1
7650213|NCT02970929|12065473|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1
7650214|NCT02970929|12065473|FG000|Overall Study|LOST TO FOLLOWUP|6
7650215|NCT02970929|12065473|FG000|Overall Study|MOVED OUT OF STATE|1
7650216|NCT02970929|12065473|FG000|Overall Study|Withdrawal by Subject|16
7650217|NCT02797951|12065494|FG000|Overall Study|Adverse Event|4
7650218|NCT02797951|12065494|FG000|Overall Study|Death|1
7650219|NCT02797951|12065494|FG000|Overall Study|Lack of Efficacy|19
7650220|NCT02797951|12065494|FG000|Overall Study|Lost to Follow-up|4
7650221|NCT02797951|12065494|FG000|Overall Study|Physician Decision|6
7650222|NCT02797951|12065494|FG000|Overall Study|Withdrawal by Subject|15
7650223|NCT02748057|12065509|FG000|Overall Study|Adverse Event|1
7650224|NCT02748057|12065510|FG001|Overall Study|Adverse Event|0
7650225|NCT02748057|12065509|FG000|Overall Study|Physician Decision|0
7650226|NCT02748057|12065510|FG001|Overall Study|Physician Decision|1
7650227|NCT02748057|12065509|FG000|Overall Study|Protocol Violation|2
7650228|NCT02748057|12065510|FG001|Overall Study|Protocol Violation|1
7650229|NCT02748057|12065509|FG000|Overall Study|Participant Moved|1
7650230|NCT02748057|12065510|FG001|Overall Study|Participant Moved|0
7650231|NCT02748057|12065509|FG000|Overall Study|Withdrawal by Subject|1
7650232|NCT02748057|12065510|FG001|Overall Study|Withdrawal by Subject|0
7650233|NCT02741271|12065518|FG000|Overall Study|Lost to Follow-up|2
7650234|NCT02741271|12065519|FG001|Overall Study|Lost to Follow-up|0
7650235|NCT02741271|12065518|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7650236|NCT02741271|12065519|FG001|Overall Study|Withdrawal by Parent/Guardian|2
7650237|NCT02741245|12065532|FG000|Overall Study|Adverse Event|0
7650238|NCT02741245|12065533|FG001|Overall Study|Adverse Event|0
7650239|NCT02741245|12065534|FG002|Overall Study|Adverse Event|0
7650240|NCT02741245|12065535|FG003|Overall Study|Adverse Event|2
7650241|NCT02741245|12065536|FG004|Overall Study|Adverse Event|2
7650242|NCT02741245|12065532|FG000|Overall Study|Protocol Violation|0
7650243|NCT02741245|12065533|FG001|Overall Study|Protocol Violation|1
7650244|NCT02741245|12065534|FG002|Overall Study|Protocol Violation|0
7650245|NCT02741245|12065535|FG003|Overall Study|Protocol Violation|1
7650246|NCT02741245|12065536|FG004|Overall Study|Protocol Violation|0
7650247|NCT02741245|12065532|FG000|Overall Study|Withdrawal by Subject|0
7650248|NCT02741245|12065533|FG001|Overall Study|Withdrawal by Subject|0
7650249|NCT02741245|12065534|FG002|Overall Study|Withdrawal by Subject|0
7650250|NCT02741245|12065535|FG003|Overall Study|Withdrawal by Subject|1
7650251|NCT02741245|12065536|FG004|Overall Study|Withdrawal by Subject|0
7650252|NCT02688608|12065548|FG000|Overall Study|Lost to Follow-up|1
7650253|NCT02605967|12065563|FG000|Overall Study|subject / guardian decision|1
7650254|NCT02605967|12065564|FG001|Overall Study|subject / guardian decision|2
7650255|NCT02605967|12065563|FG000|Overall Study|Physician Decision|10
7650256|NCT02605967|12065564|FG001|Overall Study|Physician Decision|1
7650257|NCT02605967|12065563|FG000|Overall Study|Death|4
7650258|NCT02605967|12065564|FG001|Overall Study|Death|2
7650259|NCT02605967|12065563|FG000|Overall Study|Adverse Event|1
7650260|NCT02605967|12065564|FG001|Overall Study|Adverse Event|0
7650261|NCT02605967|12065563|FG000|Overall Study|progressive disease|66
7650262|NCT02605967|12065564|FG001|Overall Study|progressive disease|35
7650263|NCT02553265|12065583|FG000|Enrollment|Death|0
7650264|NCT02553265|12065584|FG001|Enrollment|Death|0
7650265|NCT02553265|12065585|FG002|Enrollment|Death|1
7650266|NCT02553265|12065583|FG000|First Intervention (28 Days)|Adverse Event|1
7650267|NCT02553265|12065584|FG001|First Intervention (28 Days)|Adverse Event|0
7650268|NCT02553265|12065585|FG002|First Intervention (28 Days)|Adverse Event|0
7650269|NCT02553265|12065583|FG000|First Intervention (28 Days)|Withdrawal by Subject|0
7650270|NCT02553265|12065584|FG001|First Intervention (28 Days)|Withdrawal by Subject|0
7650271|NCT02553265|12065585|FG002|First Intervention (28 Days)|Withdrawal by Subject|1
7650272|NCT02553265|12065583|FG000|Second Intervention (28 Days)|Adverse Event|1
7650273|NCT02553265|12065584|FG001|Second Intervention (28 Days)|Adverse Event|0
7650274|NCT02553265|12065585|FG002|Second Intervention (28 Days)|Adverse Event|0
7650275|NCT02553265|12065583|FG000|Third Intervention (28 Days)|Adverse Event|1
7650276|NCT02553265|12065584|FG001|Third Intervention (28 Days)|Adverse Event|0
7650277|NCT02553265|12065585|FG002|Third Intervention (28 Days)|Adverse Event|0
7650278|NCT02553265|12065583|FG000|Third Intervention (28 Days)|Lost to Follow-up|0
7650279|NCT02553265|12065584|FG001|Third Intervention (28 Days)|Lost to Follow-up|0
7650280|NCT02553265|12065585|FG002|Third Intervention (28 Days)|Lost to Follow-up|1
7650281|NCT02550288|12065601|FG000|Overall Study|Adverse Event|0
7650282|NCT02550288|12065602|FG001|Overall Study|Adverse Event|1
7650283|NCT02550288|12065603|FG002|Overall Study|Adverse Event|0
7650284|NCT02550288|12065604|FG003|Overall Study|Adverse Event|0
7650285|NCT02550288|12065605|FG004|Overall Study|Adverse Event|0
7650286|NCT02550288|12065601|FG000|Overall Study|Physician Decision|0
7650287|NCT02550288|12065602|FG001|Overall Study|Physician Decision|0
7650288|NCT02550288|12065603|FG002|Overall Study|Physician Decision|0
7650289|NCT02550288|12065604|FG003|Overall Study|Physician Decision|1
7650290|NCT02550288|12065605|FG004|Overall Study|Physician Decision|0
7650291|NCT02550288|12065601|FG000|Overall Study|Protocol Violation|2
7650292|NCT02550288|12065602|FG001|Overall Study|Protocol Violation|2
7650293|NCT02550288|12065603|FG002|Overall Study|Protocol Violation|1
7650294|NCT02550288|12065604|FG003|Overall Study|Protocol Violation|0
7650295|NCT02550288|12065605|FG004|Overall Study|Protocol Violation|3
7650296|NCT02550288|12065601|FG000|Overall Study|Participant moved|0
7650297|NCT02550288|12065602|FG001|Overall Study|Participant moved|0
7650298|NCT02550288|12065603|FG002|Overall Study|Participant moved|0
7650299|NCT02550288|12065604|FG003|Overall Study|Participant moved|1
7650300|NCT02550288|12065605|FG004|Overall Study|Participant moved|0
7650301|NCT02550288|12065601|FG000|Overall Study|Withdrawal by Subject|0
7650302|NCT02550288|12065602|FG001|Overall Study|Withdrawal by Subject|0
7650303|NCT02550288|12065603|FG002|Overall Study|Withdrawal by Subject|0
7650304|NCT02550288|12065604|FG003|Overall Study|Withdrawal by Subject|1
7650305|NCT02550288|12065605|FG004|Overall Study|Withdrawal by Subject|0
7650306|NCT02510040|12065620|FG000|Overall Study|Deemed no longer eligible|18
7650307|NCT02510040|12065621|FG001|Overall Study|Deemed no longer eligible|3
7650308|NCT02510040|12065622|FG002|Overall Study|Deemed no longer eligible|1
7650309|NCT02460224|12065669|FG000|Overall Study|Adverse Event|0
7650310|NCT02460224|12065670|FG001|Overall Study|Adverse Event|0
7650311|NCT02460224|12065671|FG002|Overall Study|Adverse Event|0
7650312|NCT02460224|12065672|FG003|Overall Study|Adverse Event|0
7650313|NCT02460224|12065673|FG004|Overall Study|Adverse Event|0
7650314|NCT02460224|12065674|FG005|Overall Study|Adverse Event|0
7650315|NCT02460224|12065675|FG006|Overall Study|Adverse Event|1
7650316|NCT02460224|12065676|FG007|Overall Study|Adverse Event|0
7650317|NCT02460224|12065677|FG008|Overall Study|Adverse Event|0
7650318|NCT02460224|12065678|FG009|Overall Study|Adverse Event|0
7650319|NCT02460224|12065679|FG010|Overall Study|Adverse Event|0
7650320|NCT02460224|12065680|FG011|Overall Study|Adverse Event|0
7650321|NCT02460224|12065681|FG012|Overall Study|Adverse Event|1
7650322|NCT02460224|12065682|FG013|Overall Study|Adverse Event|0
7650323|NCT02460224|12065683|FG014|Overall Study|Adverse Event|0
7650324|NCT02460224|12065684|FG015|Overall Study|Adverse Event|0
7650325|NCT02460224|12065685|FG016|Overall Study|Adverse Event|1
7650326|NCT02460224|12065686|FG017|Overall Study|Adverse Event|0
7650327|NCT02460224|12065687|FG018|Overall Study|Adverse Event|1
7650328|NCT02460224|12065688|FG019|Overall Study|Adverse Event|0
7650329|NCT02460224|12065689|FG020|Overall Study|Adverse Event|1
7650330|NCT02460224|12065690|FG021|Overall Study|Adverse Event|1
7650331|NCT02460224|12065691|FG022|Overall Study|Adverse Event|1
7650332|NCT02460224|12065692|FG023|Overall Study|Adverse Event|0
7650333|NCT02460224|12065693|FG024|Overall Study|Adverse Event|0
7650334|NCT02460224|12065694|FG025|Overall Study|Adverse Event|0
7650335|NCT02460224|12065695|FG026|Overall Study|Adverse Event|11
7650336|NCT02460224|12065696|FG027|Overall Study|Adverse Event|1
7650337|NCT02460224|12065697|FG028|Overall Study|Adverse Event|6
7650338|NCT02460224|12065669|FG000|Overall Study|Death|0
7650339|NCT02460224|12065670|FG001|Overall Study|Death|0
7650340|NCT02460224|12065671|FG002|Overall Study|Death|0
7650341|NCT02460224|12065672|FG003|Overall Study|Death|0
7650342|NCT02460224|12065673|FG004|Overall Study|Death|0
7650343|NCT02460224|12065674|FG005|Overall Study|Death|2
7650344|NCT02460224|12065675|FG006|Overall Study|Death|1
7650345|NCT02460224|12065676|FG007|Overall Study|Death|0
7650346|NCT02460224|12065677|FG008|Overall Study|Death|0
7650347|NCT02460224|12065678|FG009|Overall Study|Death|1
7650348|NCT02460224|12065679|FG010|Overall Study|Death|0
7650349|NCT02460224|12065680|FG011|Overall Study|Death|0
7650350|NCT02460224|12065681|FG012|Overall Study|Death|0
7650351|NCT02460224|12065682|FG013|Overall Study|Death|1
7650352|NCT02460224|12065683|FG014|Overall Study|Death|0
7650353|NCT02460224|12065684|FG015|Overall Study|Death|0
7650354|NCT02460224|12065685|FG016|Overall Study|Death|2
7650355|NCT02460224|12065686|FG017|Overall Study|Death|1
7650356|NCT02460224|12065687|FG018|Overall Study|Death|0
7650357|NCT02460224|12065688|FG019|Overall Study|Death|2
7650358|NCT02460224|12065689|FG020|Overall Study|Death|0
7650359|NCT02460224|12065690|FG021|Overall Study|Death|0
7650360|NCT02460224|12065691|FG022|Overall Study|Death|0
7650361|NCT02460224|12065692|FG023|Overall Study|Death|0
7650362|NCT02460224|12065693|FG024|Overall Study|Death|1
7650363|NCT02460224|12065694|FG025|Overall Study|Death|1
7650364|NCT02460224|12065695|FG026|Overall Study|Death|5
7650365|NCT02460224|12065696|FG027|Overall Study|Death|0
7650366|NCT02460224|12065697|FG028|Overall Study|Death|1
7650367|NCT02460224|12065669|FG000|Overall Study|Lost to Follow-up|0
7650368|NCT02460224|12065670|FG001|Overall Study|Lost to Follow-up|0
7650369|NCT02460224|12065671|FG002|Overall Study|Lost to Follow-up|0
7650370|NCT02460224|12065672|FG003|Overall Study|Lost to Follow-up|0
7650371|NCT02460224|12065673|FG004|Overall Study|Lost to Follow-up|0
7650372|NCT02460224|12065674|FG005|Overall Study|Lost to Follow-up|0
7650373|NCT02460224|12065675|FG006|Overall Study|Lost to Follow-up|0
7650374|NCT02460224|12065676|FG007|Overall Study|Lost to Follow-up|0
7650375|NCT02460224|12065677|FG008|Overall Study|Lost to Follow-up|0
7650376|NCT02460224|12065678|FG009|Overall Study|Lost to Follow-up|0
7650377|NCT02460224|12065679|FG010|Overall Study|Lost to Follow-up|0
7650378|NCT02460224|12065680|FG011|Overall Study|Lost to Follow-up|0
7650379|NCT02460224|12065681|FG012|Overall Study|Lost to Follow-up|0
7650380|NCT02460224|12065682|FG013|Overall Study|Lost to Follow-up|0
7650381|NCT02460224|12065683|FG014|Overall Study|Lost to Follow-up|0
7650382|NCT02460224|12065684|FG015|Overall Study|Lost to Follow-up|0
7650383|NCT02460224|12065685|FG016|Overall Study|Lost to Follow-up|0
7650384|NCT02460224|12065686|FG017|Overall Study|Lost to Follow-up|0
7650385|NCT02460224|12065687|FG018|Overall Study|Lost to Follow-up|0
7650386|NCT02460224|12065688|FG019|Overall Study|Lost to Follow-up|0
7650387|NCT02460224|12065689|FG020|Overall Study|Lost to Follow-up|0
7650388|NCT02460224|12065690|FG021|Overall Study|Lost to Follow-up|0
7650389|NCT02460224|12065691|FG022|Overall Study|Lost to Follow-up|1
7650390|NCT02460224|12065692|FG023|Overall Study|Lost to Follow-up|0
7650391|NCT02460224|12065693|FG024|Overall Study|Lost to Follow-up|0
7650392|NCT02460224|12065694|FG025|Overall Study|Lost to Follow-up|0
7650393|NCT02460224|12065695|FG026|Overall Study|Lost to Follow-up|0
7650394|NCT02460224|12065696|FG027|Overall Study|Lost to Follow-up|0
7650395|NCT02460224|12065697|FG028|Overall Study|Lost to Follow-up|0
7650396|NCT02460224|12065669|FG000|Overall Study|Physician Decision|0
7650397|NCT02460224|12065670|FG001|Overall Study|Physician Decision|1
7650398|NCT02460224|12065671|FG002|Overall Study|Physician Decision|0
7650399|NCT02460224|12065672|FG003|Overall Study|Physician Decision|0
7650400|NCT02460224|12065673|FG004|Overall Study|Physician Decision|1
7650401|NCT02460224|12065674|FG005|Overall Study|Physician Decision|0
7650402|NCT02460224|12065675|FG006|Overall Study|Physician Decision|0
7650403|NCT02460224|12065676|FG007|Overall Study|Physician Decision|1
7650404|NCT02460224|12065677|FG008|Overall Study|Physician Decision|0
7650405|NCT02460224|12065678|FG009|Overall Study|Physician Decision|0
7650406|NCT02460224|12065679|FG010|Overall Study|Physician Decision|0
7650407|NCT02460224|12065680|FG011|Overall Study|Physician Decision|1
7650408|NCT02460224|12065681|FG012|Overall Study|Physician Decision|0
7650409|NCT02460224|12065682|FG013|Overall Study|Physician Decision|1
7650410|NCT02460224|12065683|FG014|Overall Study|Physician Decision|0
7650411|NCT02460224|12065684|FG015|Overall Study|Physician Decision|0
7650412|NCT02460224|12065685|FG016|Overall Study|Physician Decision|2
7650413|NCT02460224|12065686|FG017|Overall Study|Physician Decision|1
7650414|NCT02460224|12065687|FG018|Overall Study|Physician Decision|1
7650415|NCT02460224|12065688|FG019|Overall Study|Physician Decision|2
7650416|NCT02460224|12065689|FG020|Overall Study|Physician Decision|1
7650417|NCT02460224|12065690|FG021|Overall Study|Physician Decision|1
7650418|NCT02460224|12065691|FG022|Overall Study|Physician Decision|0
7650419|NCT02460224|12065692|FG023|Overall Study|Physician Decision|0
7650420|NCT02460224|12065693|FG024|Overall Study|Physician Decision|1
7650421|NCT02460224|12065694|FG025|Overall Study|Physician Decision|0
7650422|NCT02460224|12065695|FG026|Overall Study|Physician Decision|14
7650423|NCT02460224|12065696|FG027|Overall Study|Physician Decision|1
7650424|NCT02460224|12065697|FG028|Overall Study|Physician Decision|6
7650425|NCT02460224|12065669|FG000|Overall Study|Progressive disease|15
7650426|NCT02460224|12065670|FG001|Overall Study|Progressive disease|11
7650427|NCT02460224|12065671|FG002|Overall Study|Progressive disease|5
7650428|NCT02460224|12065672|FG003|Overall Study|Progressive disease|6
7650429|NCT02460224|12065673|FG004|Overall Study|Progressive disease|3
7650430|NCT02460224|12065674|FG005|Overall Study|Progressive disease|26
7650431|NCT02460224|12065675|FG006|Overall Study|Progressive disease|28
7650432|NCT02460224|12065676|FG007|Overall Study|Progressive disease|4
7650433|NCT02460224|12065677|FG008|Overall Study|Progressive disease|5
7650434|NCT02460224|12065678|FG009|Overall Study|Progressive disease|9
7650435|NCT02460224|12065679|FG010|Overall Study|Progressive disease|5
7650436|NCT02460224|12065680|FG011|Overall Study|Progressive disease|4
7650437|NCT02460224|12065681|FG012|Overall Study|Progressive disease|5
7650438|NCT02460224|12065682|FG013|Overall Study|Progressive disease|4
7650439|NCT02460224|12065683|FG014|Overall Study|Progressive disease|5
7650440|NCT02460224|12065684|FG015|Overall Study|Progressive disease|5
7650441|NCT02460224|12065685|FG016|Overall Study|Progressive disease|15
7650442|NCT02460224|12065686|FG017|Overall Study|Progressive disease|3
7650443|NCT02460224|12065687|FG018|Overall Study|Progressive disease|8
7650444|NCT02460224|12065688|FG019|Overall Study|Progressive disease|3
7650445|NCT02460224|12065689|FG020|Overall Study|Progressive disease|4
7650446|NCT02460224|12065690|FG021|Overall Study|Progressive disease|9
7650447|NCT02460224|12065691|FG022|Overall Study|Progressive disease|4
7650448|NCT02460224|12065692|FG023|Overall Study|Progressive disease|11
7650449|NCT02460224|12065693|FG024|Overall Study|Progressive disease|4
7650450|NCT02460224|12065694|FG025|Overall Study|Progressive disease|5
7650451|NCT02460224|12065695|FG026|Overall Study|Progressive disease|85
7650452|NCT02460224|12065696|FG027|Overall Study|Progressive disease|17
7650453|NCT02460224|12065697|FG028|Overall Study|Progressive disease|77
7650454|NCT02460224|12065669|FG000|Overall Study|Subject/guardian decision|2
7650455|NCT02460224|12065670|FG001|Overall Study|Subject/guardian decision|0
7650456|NCT02460224|12065671|FG002|Overall Study|Subject/guardian decision|1
7650457|NCT02460224|12065672|FG003|Overall Study|Subject/guardian decision|0
7650458|NCT02460224|12065673|FG004|Overall Study|Subject/guardian decision|2
7650459|NCT02460224|12065674|FG005|Overall Study|Subject/guardian decision|2
7650460|NCT02460224|12065675|FG006|Overall Study|Subject/guardian decision|0
7650461|NCT02460224|12065676|FG007|Overall Study|Subject/guardian decision|0
7650462|NCT02460224|12065677|FG008|Overall Study|Subject/guardian decision|1
7650463|NCT02460224|12065678|FG009|Overall Study|Subject/guardian decision|1
7650464|NCT02460224|12065679|FG010|Overall Study|Subject/guardian decision|0
7650465|NCT02460224|12065680|FG011|Overall Study|Subject/guardian decision|1
7650466|NCT02460224|12065681|FG012|Overall Study|Subject/guardian decision|0
7650467|NCT02460224|12065682|FG013|Overall Study|Subject/guardian decision|0
7650468|NCT02460224|12065683|FG014|Overall Study|Subject/guardian decision|0
7650469|NCT02460224|12065684|FG015|Overall Study|Subject/guardian decision|1
7650470|NCT02460224|12065685|FG016|Overall Study|Subject/guardian decision|0
7650471|NCT02460224|12065686|FG017|Overall Study|Subject/guardian decision|1
7650472|NCT02460224|12065687|FG018|Overall Study|Subject/guardian decision|2
7650473|NCT02460224|12065688|FG019|Overall Study|Subject/guardian decision|0
7650474|NCT02460224|12065689|FG020|Overall Study|Subject/guardian decision|0
7650475|NCT02460224|12065690|FG021|Overall Study|Subject/guardian decision|1
7650476|NCT02460224|12065691|FG022|Overall Study|Subject/guardian decision|0
7650477|NCT02460224|12065692|FG023|Overall Study|Subject/guardian decision|0
7650478|NCT02460224|12065693|FG024|Overall Study|Subject/guardian decision|0
7650479|NCT02460224|12065694|FG025|Overall Study|Subject/guardian decision|0
7650480|NCT02460224|12065695|FG026|Overall Study|Subject/guardian decision|6
7650481|NCT02460224|12065696|FG027|Overall Study|Subject/guardian decision|2
7650482|NCT02460224|12065697|FG028|Overall Study|Subject/guardian decision|3
7650483|NCT02460159|12065771|FG000|Overall Study|Adverse Event|4
7650484|NCT02460159|12065772|FG001|Overall Study|Adverse Event|1
7650485|NCT02460159|12065771|FG000|Overall Study|Withdrawal by Subject|2
7650486|NCT02460159|12065772|FG001|Overall Study|Withdrawal by Subject|0
7650487|NCT02320396|12065780|FG000|Overall Study|Adverse Event|2
7650488|NCT02320396|12065781|FG001|Overall Study|Adverse Event|2
7650489|NCT02320396|12065780|FG000|Overall Study|Pregnancy|0
7650490|NCT02320396|12065781|FG001|Overall Study|Pregnancy|1
7650491|NCT02320396|12065780|FG000|Overall Study|Protocol Violation|0
7650492|NCT02320396|12065781|FG001|Overall Study|Protocol Violation|1
7650493|NCT02320396|12065780|FG000|Overall Study|Withdrawal by Subject|2
7650494|NCT02320396|12065781|FG001|Overall Study|Withdrawal by Subject|0
7650495|NCT02230410|12065787|FG000|Overall Study|Screen Failure|3
7650496|NCT02053246|12065791|FG000|Overall Study|Withdrawal by Subject|3
7650497|NCT02053246|12065791|FG000|Overall Study|Physician Decision|1
7650498|NCT01980940|12065803|FG000|Overall Study|Protocol Violation|0
7650499|NCT01980940|12065804|FG001|Overall Study|Protocol Violation|0
7650500|NCT01980940|12065805|FG002|Overall Study|Protocol Violation|0
7650501|NCT01980940|12065806|FG003|Overall Study|Protocol Violation|0
7650502|NCT01980940|12065807|FG004|Overall Study|Protocol Violation|0
7650503|NCT01980940|12065808|FG005|Overall Study|Protocol Violation|2
7650504|NCT01980940|12065809|FG006|Overall Study|Protocol Violation|0
7650505|NCT01980940|12065810|FG007|Overall Study|Protocol Violation|0
7650506|NCT01918033|12065841|FG000|Overall Study|Adverse Event|1
7650507|NCT01918033|12065842|FG001|Overall Study|Adverse Event|0
7650508|NCT01918033|12065843|FG002|Overall Study|Adverse Event|2
7650509|NCT01918033|12065841|FG000|Overall Study|Lost to Follow-up|0
7650510|NCT01918033|12065842|FG001|Overall Study|Lost to Follow-up|1
7650511|NCT01918033|12065843|FG002|Overall Study|Lost to Follow-up|0
7650512|NCT01918033|12065841|FG000|Overall Study|Protocol Violation|2
7650513|NCT01918033|12065842|FG001|Overall Study|Protocol Violation|0
7650514|NCT01918033|12065843|FG002|Overall Study|Protocol Violation|1
7650515|NCT01918033|12065841|FG000|Overall Study|Withdrawal by Subject|2
7650516|NCT01918033|12065842|FG001|Overall Study|Withdrawal by Subject|1
7650517|NCT01918033|12065843|FG002|Overall Study|Withdrawal by Subject|0
7650518|NCT01916980|12065853|FG000|Overall Study|Adverse Event|4
7650519|NCT01916980|12065854|FG001|Overall Study|Adverse Event|2
7650520|NCT01916980|12065853|FG000|Overall Study|Lack of Efficacy|2
7650521|NCT01916980|12065854|FG001|Overall Study|Lack of Efficacy|2
7650522|NCT01916980|12065853|FG000|Overall Study|Withdrawal by Subject|1
7650523|NCT01916980|12065854|FG001|Overall Study|Withdrawal by Subject|0
7650524|NCT01916967|12065863|FG000|Overall Study|Adverse Event|0
7650525|NCT01916967|12065864|FG001|Overall Study|Adverse Event|0
7650526|NCT01916967|12065865|FG002|Overall Study|Adverse Event|2
7650527|NCT01916967|12065863|FG000|Overall Study|Lack of Efficacy|0
7650528|NCT01916967|12065864|FG001|Overall Study|Lack of Efficacy|0
7650529|NCT01916967|12065865|FG002|Overall Study|Lack of Efficacy|6
7650530|NCT01916967|12065863|FG000|Overall Study|Physician Decision|0
7650531|NCT01916967|12065864|FG001|Overall Study|Physician Decision|0
7650532|NCT01916967|12065865|FG002|Overall Study|Physician Decision|1
7650533|NCT01916967|12065863|FG000|Overall Study|Protocol Violation|0
7650534|NCT01916967|12065864|FG001|Overall Study|Protocol Violation|1
7650535|NCT01916967|12065865|FG002|Overall Study|Protocol Violation|0
7650536|NCT01870401|12065886|FG000|Overall Study|Death|48
7650537|NCT01870401|12065887|FG001|Overall Study|Death|24
7650538|NCT01870401|12065886|FG000|Overall Study|Withdrawal by Subject|39
7650539|NCT01870401|12065887|FG001|Overall Study|Withdrawal by Subject|26
7650540|NCT01870401|12065886|FG000|Overall Study|Lost to Follow-up|19
7650541|NCT01870401|12065887|FG001|Overall Study|Lost to Follow-up|14
7650542|NCT01870401|12065886|FG000|Overall Study|Other|9
7650543|NCT01870401|12065887|FG001|Overall Study|Other|7
7650544|NCT01870401|12065886|FG000|Overall Study|On-going in the Study|35
7650545|NCT01870401|12065887|FG001|Overall Study|On-going in the Study|25
7650546|NCT01867606|12065897|FG000|Overall Study|Withdrawal by Subject|10
7650547|NCT01867606|12065898|FG001|Overall Study|Withdrawal by Subject|14
7650548|NCT01867606|12065897|FG000|Overall Study|Protocol Violation|0
7650549|NCT01867606|12065898|FG001|Overall Study|Protocol Violation|1
7650550|NCT01857063|12065912|FG000|Period 1 (7 Days)|Adverse Event|0
7650551|NCT01857063|12065913|FG001|Period 1 (7 Days)|Adverse Event|1
7650552|NCT01857063|12065912|FG000|Period 1 (7 Days)|Physician Decision|1
7650553|NCT01857063|12065913|FG001|Period 1 (7 Days)|Physician Decision|0
7650554|NCT01857063|12065912|FG000|Period 1 (7 Days)|Withdrawal by Subject|1
7650555|NCT01857063|12065913|FG001|Period 1 (7 Days)|Withdrawal by Subject|3
7650556|NCT01857063|12065912|FG000|Period 2 (7 Days)|Adverse Event|2
7650557|NCT01857063|12065913|FG001|Period 2 (7 Days)|Adverse Event|1
7650558|NCT01857063|12065912|FG000|Period 2 (7 Days)|Physician Decision|1
7650559|NCT01857063|12065913|FG001|Period 2 (7 Days)|Physician Decision|1
7650560|NCT01857063|12065912|FG000|Period 2 (7 Days)|Withdrawal by Subject|1
7650561|NCT01857063|12065913|FG001|Period 2 (7 Days)|Withdrawal by Subject|0
7650562|NCT01852812|12065926|FG000|Overall Study|Adverse Event|0
7650563|NCT01852812|12065927|FG001|Overall Study|Adverse Event|0
7650564|NCT01852812|12065928|FG002|Overall Study|Adverse Event|1
7650565|NCT01852812|12065926|FG000|Overall Study|Non-compliance With Study Drug|0
7650566|NCT01852812|12065927|FG001|Overall Study|Non-compliance With Study Drug|1
7650567|NCT01852812|12065928|FG002|Overall Study|Non-compliance With Study Drug|0
7650568|NCT01828021|12065936|FG000|Overall Study|Adverse Event|5
7650569|NCT01828021|12065936|FG000|Overall Study|Lack of Efficacy|17
7650570|NCT01828021|12065936|FG000|Overall Study|Withdrawal by Subject|2
7650571|NCT01828021|12065936|FG000|Overall Study|Ileal obstruction, unrelated|1
7650572|NCT01709318|12065947|FG000|Overall Study|Adverse Event|3
7650573|NCT01709318|12065948|FG001|Overall Study|Adverse Event|4
7650574|NCT01709318|12065949|FG002|Overall Study|Adverse Event|2
7650575|NCT01709318|12065950|FG003|Overall Study|Adverse Event|2
7650576|NCT01709318|12065951|FG004|Overall Study|Adverse Event|0
7650577|NCT01709318|12065952|FG005|Overall Study|Adverse Event|1
7650578|NCT01709318|12065953|FG006|Overall Study|Adverse Event|2
7650579|NCT01709318|12065947|FG000|Overall Study|Lost to Follow-up|2
7650580|NCT01709318|12065948|FG001|Overall Study|Lost to Follow-up|0
7650581|NCT01709318|12065949|FG002|Overall Study|Lost to Follow-up|0
7650582|NCT01709318|12065950|FG003|Overall Study|Lost to Follow-up|0
7650583|NCT01709318|12065951|FG004|Overall Study|Lost to Follow-up|1
7650584|NCT01709318|12065952|FG005|Overall Study|Lost to Follow-up|1
7650585|NCT01709318|12065953|FG006|Overall Study|Lost to Follow-up|1
7650586|NCT01709318|12065947|FG000|Overall Study|Non-compliance with Study Drug|0
7650587|NCT01709318|12065948|FG001|Overall Study|Non-compliance with Study Drug|2
7650588|NCT01709318|12065949|FG002|Overall Study|Non-compliance with Study Drug|1
7650589|NCT01709318|12065950|FG003|Overall Study|Non-compliance with Study Drug|1
7650590|NCT01709318|12065951|FG004|Overall Study|Non-compliance with Study Drug|0
7650591|NCT01709318|12065952|FG005|Overall Study|Non-compliance with Study Drug|0
7650592|NCT01709318|12065953|FG006|Overall Study|Non-compliance with Study Drug|2
7650593|NCT01709318|12065947|FG000|Overall Study|Physician Decision|0
7650594|NCT01709318|12065948|FG001|Overall Study|Physician Decision|0
7650595|NCT01709318|12065949|FG002|Overall Study|Physician Decision|0
7650596|NCT01709318|12065950|FG003|Overall Study|Physician Decision|0
7650597|NCT01709318|12065951|FG004|Overall Study|Physician Decision|0
7650598|NCT01709318|12065952|FG005|Overall Study|Physician Decision|0
7650599|NCT01709318|12065953|FG006|Overall Study|Physician Decision|1
7650600|NCT01709318|12065947|FG000|Overall Study|Pregnancy|0
7650601|NCT01709318|12065948|FG001|Overall Study|Pregnancy|0
7650602|NCT01709318|12065949|FG002|Overall Study|Pregnancy|0
7650603|NCT01709318|12065950|FG003|Overall Study|Pregnancy|0
7650604|NCT01709318|12065951|FG004|Overall Study|Pregnancy|1
7650605|NCT01709318|12065952|FG005|Overall Study|Pregnancy|0
7650606|NCT01709318|12065953|FG006|Overall Study|Pregnancy|0
7650607|NCT01709318|12065947|FG000|Overall Study|Protocol Violation|0
7650608|NCT01709318|12065948|FG001|Overall Study|Protocol Violation|0
7650609|NCT01709318|12065949|FG002|Overall Study|Protocol Violation|0
7650610|NCT01709318|12065950|FG003|Overall Study|Protocol Violation|0
7650611|NCT01709318|12065951|FG004|Overall Study|Protocol Violation|2
7650612|NCT01709318|12065952|FG005|Overall Study|Protocol Violation|0
7650613|NCT01709318|12065953|FG006|Overall Study|Protocol Violation|1
7650614|NCT01709318|12065947|FG000|Overall Study|Technical Problems|1
7650615|NCT01709318|12065948|FG001|Overall Study|Technical Problems|0
7650616|NCT01709318|12065949|FG002|Overall Study|Technical Problems|0
7650617|NCT01709318|12065950|FG003|Overall Study|Technical Problems|0
7650618|NCT01709318|12065951|FG004|Overall Study|Technical Problems|0
7650619|NCT01709318|12065952|FG005|Overall Study|Technical Problems|0
7650620|NCT01709318|12065953|FG006|Overall Study|Technical Problems|0
7650621|NCT01709318|12065947|FG000|Overall Study|Withdrawal by Subject|3
7650622|NCT01709318|12065948|FG001|Overall Study|Withdrawal by Subject|0
7650623|NCT01709318|12065949|FG002|Overall Study|Withdrawal by Subject|3
7650624|NCT01709318|12065950|FG003|Overall Study|Withdrawal by Subject|3
7650625|NCT01709318|12065951|FG004|Overall Study|Withdrawal by Subject|0
7650626|NCT01709318|12065952|FG005|Overall Study|Withdrawal by Subject|2
7650627|NCT01709318|12065953|FG006|Overall Study|Withdrawal by Subject|4
7650628|NCT01709318|12065947|FG000|Overall Study|Other Protocol Specified Criteria|0
7650629|NCT01709318|12065948|FG001|Overall Study|Other Protocol Specified Criteria|1
7650630|NCT01709318|12065949|FG002|Overall Study|Other Protocol Specified Criteria|0
7650631|NCT01709318|12065950|FG003|Overall Study|Other Protocol Specified Criteria|0
7650632|NCT01709318|12065951|FG004|Overall Study|Other Protocol Specified Criteria|0
7650633|NCT01709318|12065952|FG005|Overall Study|Other Protocol Specified Criteria|0
7650634|NCT01709318|12065953|FG006|Overall Study|Other Protocol Specified Criteria|0
7650635|NCT01698918|12065969|FG000|First Line Treatment (Core+Extension)|Adverse Event|33
7650636|NCT01698918|12065969|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11
7650637|NCT01698918|12065969|FG000|First Line Treatment (Core+Extension)|Death|2
7650638|NCT01698918|12065969|FG000|First Line Treatment (Core+Extension)|Disease progression|120
7650639|NCT01698918|12065969|FG000|First Line Treatment (Core+Extension)|Physician Decision|7
7650640|NCT01698918|12065969|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3
7650641|NCT01698918|12065969|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1
7650642|NCT01698918|12065969|FG000|Second Line Treatment (Core+Extension)|Death|1
7650643|NCT01698918|12065969|FG000|Second Line Treatment (Core+Extension)|Disease progression|38
7650644|NCT01698918|12065969|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3
7650645|NCT01673620|12065983|FG000|Overall Study|Adverse Event|1
7650646|NCT01673620|12065984|FG001|Overall Study|Adverse Event|0
7650647|NCT01660243|12065994|FG000|Overall Study|Adverse Event|1
7650648|NCT01660243|12065995|FG001|Overall Study|Adverse Event|0
7650649|NCT01660243|12065996|FG002|Overall Study|Adverse Event|1
7650650|NCT01660243|12065997|FG003|Overall Study|Adverse Event|0
7650651|NCT01660243|12065994|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1
7650652|NCT01660243|12065995|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0
7650653|NCT01660243|12065996|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0
7650654|NCT01660243|12065997|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0
7650655|NCT01660243|12065994|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0
7650656|NCT01660243|12065995|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0
7650657|NCT01660243|12065996|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1
7650658|NCT01660243|12065997|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0
7650659|NCT01660243|12065994|FG000|Overall Study|Randomization error|0
7650660|NCT01660243|12065995|FG001|Overall Study|Randomization error|0
7650661|NCT01660243|12065996|FG002|Overall Study|Randomization error|0
7650662|NCT01660243|12065997|FG003|Overall Study|Randomization error|1
7650663|NCT01617187|12066011|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
7650664|NCT01617187|12066012|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
7650665|NCT01617187|12066013|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
7650666|NCT01617187|12066014|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
7650667|NCT01617187|12066011|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0
7650668|NCT01617187|12066012|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0
7650669|NCT01617187|12066013|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0
7650670|NCT01617187|12066014|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1
7650671|NCT01617187|12066011|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1
7650672|NCT01617187|12066012|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0
7650673|NCT01617187|12066013|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0
7650674|NCT01617187|12066014|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0
7650675|NCT01617187|12066011|FG000|Treatment Through Study Completion|Adverse Event|1
7650676|NCT01617187|12066012|FG001|Treatment Through Study Completion|Adverse Event|1
7650677|NCT01617187|12066013|FG002|Treatment Through Study Completion|Adverse Event|0
7650678|NCT01617187|12066014|FG003|Treatment Through Study Completion|Adverse Event|1
7650679|NCT01617187|12066011|FG000|Treatment Through Study Completion|Lost to Follow-up|4
7650680|NCT01617187|12066012|FG001|Treatment Through Study Completion|Lost to Follow-up|2
7650681|NCT01617187|12066013|FG002|Treatment Through Study Completion|Lost to Follow-up|2
7650682|NCT01617187|12066014|FG003|Treatment Through Study Completion|Lost to Follow-up|2
7650683|NCT01617187|12066011|FG000|Treatment Through Study Completion|Withdrawal by Subject|5
7650684|NCT01617187|12066012|FG001|Treatment Through Study Completion|Withdrawal by Subject|8
7650685|NCT01617187|12066013|FG002|Treatment Through Study Completion|Withdrawal by Subject|3
7650686|NCT01617187|12066014|FG003|Treatment Through Study Completion|Withdrawal by Subject|6
7650687|NCT01617187|12066011|FG000|Treatment Through Study Completion|Protocol Violation|1
7650688|NCT01617187|12066012|FG001|Treatment Through Study Completion|Protocol Violation|0
7650689|NCT01617187|12066013|FG002|Treatment Through Study Completion|Protocol Violation|0
7650690|NCT01617187|12066014|FG003|Treatment Through Study Completion|Protocol Violation|1
7650691|NCT01611883|12066026|FG000|Overall Study|Adverse Event|1
7650692|NCT01611883|12066027|FG001|Overall Study|Adverse Event|1
7650693|NCT01572675|12066035|FG000|Overall Study|End of prescribed treatment|140
7650694|NCT01572675|12066036|FG001|Overall Study|End of prescribed treatment|118
7650695|NCT01572675|12066035|FG000|Overall Study|Recovery|16
7650696|NCT01572675|12066036|FG001|Overall Study|Recovery|23
7650697|NCT01572675|12066035|FG000|Overall Study|Lack of Efficacy|31
7650698|NCT01572675|12066036|FG001|Overall Study|Lack of Efficacy|31
7650699|NCT01572675|12066035|FG000|Overall Study|Intolerance|6
7650700|NCT01572675|12066036|FG001|Overall Study|Intolerance|5
7650701|NCT01572675|12066035|FG000|Overall Study|Improved symptoms|8
7650702|NCT01572675|12066036|FG001|Overall Study|Improved symptoms|2
7650703|NCT01572675|12066035|FG000|Overall Study|Surgical intervention|3
7650704|NCT01572675|12066036|FG001|Overall Study|Surgical intervention|6
7650705|NCT01572675|12066035|FG000|Overall Study|Withdrawal by Subject|5
7650706|NCT01572675|12066036|FG001|Overall Study|Withdrawal by Subject|1
7650707|NCT01572675|12066035|FG000|Overall Study|Physician Decision|2
7650708|NCT01572675|12066036|FG001|Overall Study|Physician Decision|2
7650709|NCT01572675|12066035|FG000|Overall Study|Death unrelated to coxibs|1
7650710|NCT01572675|12066036|FG001|Overall Study|Death unrelated to coxibs|1
7650711|NCT01572675|12066035|FG000|Overall Study|Other disease detected|1
7650712|NCT01572675|12066036|FG001|Overall Study|Other disease detected|1
7650713|NCT01572675|12066035|FG000|Overall Study|Unknown reason|1
7650714|NCT01572675|12066036|FG001|Overall Study|Unknown reason|1
7650715|NCT01572675|12066035|FG000|Overall Study|Rheumatologist new evaluation|0
7650716|NCT01572675|12066036|FG001|Overall Study|Rheumatologist new evaluation|1
7650717|NCT01572675|12066035|FG000|Overall Study|Missing data|1
7650718|NCT01572675|12066036|FG001|Overall Study|Missing data|4
7650719|NCT01572675|12066035|FG000|Overall Study|Lost to Follow-up|22
7650720|NCT01572675|12066036|FG001|Overall Study|Lost to Follow-up|27
7650721|NCT01554163|12066057|FG000|Overall Study|Adverse Event|3
7650722|NCT01554163|12066058|FG001|Overall Study|Adverse Event|0
7650723|NCT01554163|12066057|FG000|Overall Study|Lack of Efficacy|1
7650724|NCT01554163|12066058|FG001|Overall Study|Lack of Efficacy|0
7650725|NCT01554163|12066057|FG000|Overall Study|Lost to Follow-up|1
7650726|NCT01554163|12066058|FG001|Overall Study|Lost to Follow-up|0
7650727|NCT01554163|12066057|FG000|Overall Study|Non-Compliance With Study Drug|1
7650728|NCT01554163|12066058|FG001|Overall Study|Non-Compliance With Study Drug|1
7650729|NCT01554163|12066057|FG000|Overall Study|Protocol Violation|0
7650730|NCT01554163|12066058|FG001|Overall Study|Protocol Violation|4
7650731|NCT01554163|12066057|FG000|Overall Study|Withdrawal by Subject|1
7650732|NCT01554163|12066058|FG001|Overall Study|Withdrawal by Subject|5
7650733|NCT01554163|12066057|FG000|Overall Study|Not Treated|1
7650734|NCT01554163|12066058|FG001|Overall Study|Not Treated|0
7650735|NCT01502371|12066069|FG000|Overall Study|Withdrawal by Subject|1
7650736|NCT01502371|12066070|FG001|Overall Study|Withdrawal by Subject|2
7650737|NCT01502371|12066071|FG002|Overall Study|Withdrawal by Subject|1
7650738|NCT01502371|12066072|FG003|Overall Study|Withdrawal by Subject|1
7650739|NCT01502371|12066073|FG004|Overall Study|Withdrawal by Subject|1
7650740|NCT01502371|12066069|FG000|Overall Study|Adverse Event|2
7650741|NCT01502371|12066070|FG001|Overall Study|Adverse Event|1
7650742|NCT01502371|12066071|FG002|Overall Study|Adverse Event|0
7650743|NCT01502371|12066072|FG003|Overall Study|Adverse Event|4
7650744|NCT01502371|12066073|FG004|Overall Study|Adverse Event|3
7650745|NCT01502371|12066069|FG000|Overall Study|Treatment Failure|22
7650746|NCT01502371|12066070|FG001|Overall Study|Treatment Failure|20
7650747|NCT01502371|12066071|FG002|Overall Study|Treatment Failure|12
7650748|NCT01502371|12066072|FG003|Overall Study|Treatment Failure|19
7650749|NCT01502371|12066073|FG004|Overall Study|Treatment Failure|30
7650750|NCT01502371|12066069|FG000|Overall Study|Lack of Efficacy|3
7650751|NCT01502371|12066070|FG001|Overall Study|Lack of Efficacy|3
7650752|NCT01502371|12066071|FG002|Overall Study|Lack of Efficacy|2
7650753|NCT01502371|12066072|FG003|Overall Study|Lack of Efficacy|2
7650754|NCT01502371|12066073|FG004|Overall Study|Lack of Efficacy|4
7650755|NCT01502371|12066069|FG000|Overall Study|Physician Decision|3
7650756|NCT01502371|12066070|FG001|Overall Study|Physician Decision|0
7650757|NCT01502371|12066071|FG002|Overall Study|Physician Decision|0
7650758|NCT01502371|12066072|FG003|Overall Study|Physician Decision|0
7650759|NCT01502371|12066073|FG004|Overall Study|Physician Decision|1
7650760|NCT01502371|12066069|FG000|Overall Study|Noncompliance with Study Drug|0
7650761|NCT01502371|12066070|FG001|Overall Study|Noncompliance with Study Drug|0
7650762|NCT01502371|12066071|FG002|Overall Study|Noncompliance with Study Drug|1
7650763|NCT01502371|12066072|FG003|Overall Study|Noncompliance with Study Drug|2
7650764|NCT01502371|12066073|FG004|Overall Study|Noncompliance with Study Drug|1
7650765|NCT01502371|12066069|FG000|Overall Study|Technical Problems|1
7650766|NCT01502371|12066070|FG001|Overall Study|Technical Problems|0
7650767|NCT01502371|12066071|FG002|Overall Study|Technical Problems|2
7650768|NCT01502371|12066072|FG003|Overall Study|Technical Problems|4
7650769|NCT01502371|12066073|FG004|Overall Study|Technical Problems|1
7650770|NCT01502371|12066069|FG000|Overall Study|Protocol Violation|9
7650771|NCT01502371|12066070|FG001|Overall Study|Protocol Violation|5
7650772|NCT01502371|12066071|FG002|Overall Study|Protocol Violation|6
7650773|NCT01502371|12066072|FG003|Overall Study|Protocol Violation|5
7650774|NCT01502371|12066073|FG004|Overall Study|Protocol Violation|10
7650775|NCT01502371|12066069|FG000|Overall Study|Excluded Medication|0
7650776|NCT01502371|12066070|FG001|Overall Study|Excluded Medication|1
7650777|NCT01502371|12066071|FG002|Overall Study|Excluded Medication|1
7650778|NCT01502371|12066072|FG003|Overall Study|Excluded Medication|0
7650779|NCT01502371|12066073|FG004|Overall Study|Excluded Medication|1
7650780|NCT01490190|12066086|FG000|Overall Study|Withdrawal by Subject|9
7650781|NCT01490190|12066086|FG000|Overall Study|Adverse Event|17
7650782|NCT01490190|12066086|FG000|Overall Study|Protocol Violation|5
7650783|NCT01490190|12066086|FG000|Overall Study|Lost to Follow-up|13
7650784|NCT01490190|12066086|FG000|Overall Study|Relocation|1
7650785|NCT01490190|12066086|FG000|Overall Study|Inconvenience|1
7650786|NCT01490190|12066086|FG000|Overall Study|Ring expulsion|2
7650787|NCT01471340|12066092|FG000|Overall Study|Death|5
7650788|NCT01471340|12066093|FG001|Overall Study|Death|4
7650789|NCT01471340|12066092|FG000|Overall Study|Lost to Follow-up|0
7650790|NCT01471340|12066093|FG001|Overall Study|Lost to Follow-up|1
7650791|NCT01471340|12066092|FG000|Overall Study|Investigational site closure|0
7650792|NCT01471340|12066093|FG001|Overall Study|Investigational site closure|1
7650793|NCT01471340|12066092|FG000|Overall Study|Invalid informed consent|1
7650794|NCT01471340|12066093|FG001|Overall Study|Invalid informed consent|0
7650795|NCT01462370|12066099|FG000|Overall Study|Lack of Qualifying Event|1
7650796|NCT01462370|12066100|FG001|Overall Study|Lack of Qualifying Event|1
7650797|NCT01462370|12066099|FG000|Overall Study|Physician Decision|0
7650798|NCT01462370|12066100|FG001|Overall Study|Physician Decision|1
7650799|NCT01462370|12066099|FG000|Overall Study|Withdrawal by Subject|0
7650800|NCT01462370|12066100|FG001|Overall Study|Withdrawal by Subject|3
7650801|NCT01436253|12066106|FG000|Overall Study|Lost to Follow-up|182
7650802|NCT01436253|12066106|FG000|Overall Study|Not meeting all eligibility criteria|117
7650803|NCT01381679|12066140|FG000|Overall Study|Adverse Event|3
7650804|NCT01381679|12066140|FG000|Overall Study|Lost to Follow-up|885
7650805|NCT01370603|12066146|FG000|Period 1|Adverse Event|5
7650806|NCT01370603|12066147|FG001|Period 1|Adverse Event|3
7650807|NCT01370603|12066146|FG000|Period 1|Lost to Follow-up|2
7650808|NCT01370603|12066147|FG001|Period 1|Lost to Follow-up|0
7650809|NCT01370603|12066146|FG000|Period 1|Protocol Violation|2
7650810|NCT01370603|12066147|FG001|Period 1|Protocol Violation|2
7650811|NCT01370603|12066146|FG000|Period 1|Withdrawal by Subject|5
7650812|NCT01370603|12066147|FG001|Period 1|Withdrawal by Subject|5
7650813|NCT01370603|12066146|FG000|Crossover Washout|Adverse Event|2
7650814|NCT01370603|12066147|FG001|Crossover Washout|Adverse Event|1
7650815|NCT01370603|12066146|FG000|Crossover Washout|Lost to Follow-up|2
7650816|NCT01370603|12066147|FG001|Crossover Washout|Lost to Follow-up|0
7650817|NCT01370603|12066146|FG000|Crossover Washout|Protocol Violation|1
7650818|NCT01370603|12066147|FG001|Crossover Washout|Protocol Violation|0
7650819|NCT01370603|12066146|FG000|Crossover Washout|Withdrawal by Subject|4
7650820|NCT01370603|12066147|FG001|Crossover Washout|Withdrawal by Subject|1
7650821|NCT01370603|12066146|FG000|Crossover Washout|Non-compliance with Study Drug|0
7650822|NCT01370603|12066147|FG001|Crossover Washout|Non-compliance with Study Drug|2
7650823|NCT01370603|12066146|FG000|Period 2|Adverse Event|1
7650824|NCT01370603|12066147|FG001|Period 2|Adverse Event|4
7650825|NCT01370603|12066146|FG000|Period 2|Lost to Follow-up|1
7650826|NCT01370603|12066147|FG001|Period 2|Lost to Follow-up|0
7650827|NCT01370603|12066146|FG000|Period 2|Withdrawal by Subject|1
7650828|NCT01370603|12066147|FG001|Period 2|Withdrawal by Subject|0
7650829|NCT01370590|12066155|FG000|Period 1|Adverse Event|8
7650830|NCT01370590|12066156|FG001|Period 1|Adverse Event|4
7650831|NCT01370590|12066155|FG000|Period 1|Lost to Follow-up|2
7650832|NCT01370590|12066156|FG001|Period 1|Lost to Follow-up|2
7650833|NCT01370590|12066155|FG000|Period 1|Protocol Violation|2
7650834|NCT01370590|12066156|FG001|Period 1|Protocol Violation|2
7650835|NCT01370590|12066155|FG000|Period 1|Withdrawal by Subject|4
7650836|NCT01370590|12066156|FG001|Period 1|Withdrawal by Subject|2
7650837|NCT01370590|12066155|FG000|Period 1|Could not access randomization system|0
7650838|NCT01370590|12066156|FG001|Period 1|Could not access randomization system|1
7650839|NCT01370590|12066155|FG000|Crossover Washout Period|Adverse Event|1
7650840|NCT01370590|12066156|FG001|Crossover Washout Period|Adverse Event|4
7650841|NCT01370590|12066155|FG000|Crossover Washout Period|Lost to Follow-up|2
7650842|NCT01370590|12066156|FG001|Crossover Washout Period|Lost to Follow-up|0
7650843|NCT01370590|12066155|FG000|Crossover Washout Period|Non-compliance with Study Drug|1
7650844|NCT01370590|12066156|FG001|Crossover Washout Period|Non-compliance with Study Drug|0
7650845|NCT01370590|12066155|FG000|Crossover Washout Period|Withdrawal by Subject|2
7650846|NCT01370590|12066156|FG001|Crossover Washout Period|Withdrawal by Subject|2
7650847|NCT01370590|12066155|FG000|Period 2|Adverse Event|0
7650848|NCT01370590|12066156|FG001|Period 2|Adverse Event|1
7650849|NCT01370590|12066155|FG000|Period 2|Withdrawal by Subject|1
7650850|NCT01370590|12066156|FG001|Period 2|Withdrawal by Subject|1
7650851|NCT01349907|12066168|FG000|Overall Study|Adverse Event|37
7650852|NCT01349907|12066169|FG001|Overall Study|Adverse Event|11
7650853|NCT01349907|12066168|FG000|Overall Study|Treatment failure|13
7650854|NCT01349907|12066169|FG001|Overall Study|Treatment failure|4
7650855|NCT01349907|12066168|FG000|Overall Study|Lost to Follow-up|25
7650856|NCT01349907|12066169|FG001|Overall Study|Lost to Follow-up|6
7650857|NCT01349907|12066168|FG000|Overall Study|Withdrawal by Subject|30
7650858|NCT01349907|12066169|FG001|Overall Study|Withdrawal by Subject|8
7650859|NCT01349907|12066168|FG000|Overall Study|Protocol Violation|33
7650860|NCT01349907|12066169|FG001|Overall Study|Protocol Violation|13
7650861|NCT01349907|12066168|FG000|Overall Study|Administrative|1
7650862|NCT01349907|12066169|FG001|Overall Study|Administrative|1
7650863|NCT01345786|12066179|FG000|Overall Study|Adverse Event|0
7650864|NCT01345786|12066180|FG001|Overall Study|Adverse Event|1
7650865|NCT01345786|12066181|FG002|Overall Study|Adverse Event|3
7650866|NCT01345786|12066182|FG003|Overall Study|Adverse Event|1
7650867|NCT01345786|12066179|FG000|Overall Study|Subject withdrew consent|2
7650868|NCT01345786|12066180|FG001|Overall Study|Subject withdrew consent|2
7650869|NCT01345786|12066181|FG002|Overall Study|Subject withdrew consent|1
7650870|NCT01345786|12066182|FG003|Overall Study|Subject withdrew consent|0
7650871|NCT01345786|12066179|FG000|Overall Study|Noncompliance with protocol|1
7650872|NCT01345786|12066180|FG001|Overall Study|Noncompliance with protocol|0
7650873|NCT01345786|12066181|FG002|Overall Study|Noncompliance with protocol|1
7650874|NCT01345786|12066182|FG003|Overall Study|Noncompliance with protocol|0
7650875|NCT01345786|12066179|FG000|Overall Study|Administrative|3
7650876|NCT01345786|12066180|FG001|Overall Study|Administrative|5
7650877|NCT01345786|12066181|FG002|Overall Study|Administrative|0
7650878|NCT01345786|12066182|FG003|Overall Study|Administrative|0
7650879|NCT01345786|12066179|FG000|Overall Study|Lost to Follow-up|0
7650880|NCT01345786|12066180|FG001|Overall Study|Lost to Follow-up|0
7650881|NCT01345786|12066181|FG002|Overall Study|Lost to Follow-up|0
7650882|NCT01345786|12066182|FG003|Overall Study|Lost to Follow-up|2
7650883|NCT01306929|12066192|FG000|Overall Study|Withdrawal by Subject|23
7650884|NCT01306929|12066192|FG000|Overall Study|Adverse Event|21
7650885|NCT01306929|12066192|FG000|Overall Study|Physician Decision|13
7650886|NCT01306929|12066192|FG000|Overall Study|Death|8
7650887|NCT01306929|12066192|FG000|Overall Study|Withdrawal by parent/guardian|5
7650888|NCT01306929|12066192|FG000|Overall Study|Protocol Violation|3
7650889|NCT01306929|12066192|FG000|Overall Study|Non-compliance with study drug|2
7650890|NCT01306929|12066192|FG000|Overall Study|Lost to Follow-up|2
7650891|NCT01306929|12066192|FG000|Overall Study|Various|17
7650892|NCT01294696|12066198|FG000|Overall Study|Screening failures|7
7650893|NCT01294696|12066198|FG000|Overall Study|Protocol Violation|8
7650894|NCT01294696|12066198|FG000|Overall Study|Missing BPI Response|7
7650895|NCT01294696|12066198|FG000|Overall Study|Site closure|52
7650896|NCT01277822|12066205|FG000|Overall Study|Adverse Event|2
7650897|NCT01277822|12066206|FG001|Overall Study|Adverse Event|1
7650898|NCT01277822|12066205|FG000|Overall Study|Withdrawal by Subject|6
7650899|NCT01277822|12066206|FG001|Overall Study|Withdrawal by Subject|7
7650900|NCT01277822|12066205|FG000|Overall Study|Physician Decision|1
7650901|NCT01277822|12066206|FG001|Overall Study|Physician Decision|1
7650902|NCT01277822|12066205|FG000|Overall Study|Protocol Violation|1
7650903|NCT01277822|12066206|FG001|Overall Study|Protocol Violation|0
7650904|NCT01277822|12066205|FG000|Overall Study|Lost to Follow-up|2
7650905|NCT01277822|12066206|FG001|Overall Study|Lost to Follow-up|1
7650906|NCT01277822|12066205|FG000|Overall Study|Contraindicated medication used|2
7650907|NCT01277822|12066206|FG001|Overall Study|Contraindicated medication used|1
7650908|NCT01277822|12066205|FG000|Overall Study|Participant moved|1
7650909|NCT01277822|12066206|FG001|Overall Study|Participant moved|0
7650910|NCT01244763|12066218|FG000|Overall Study|Adverse Event|1
7650911|NCT01244763|12066219|FG001|Overall Study|Adverse Event|0
7650912|NCT01244763|12066220|FG002|Overall Study|Adverse Event|0
7650913|NCT01244763|12066221|FG003|Overall Study|Adverse Event|0
7650914|NCT01244763|12066222|FG004|Overall Study|Adverse Event|0
7650915|NCT01244763|12066223|FG005|Overall Study|Adverse Event|1
7650916|NCT01244763|12066218|FG000|Overall Study|Death|1
7650917|NCT01244763|12066219|FG001|Overall Study|Death|0
7650918|NCT01244763|12066220|FG002|Overall Study|Death|1
7650919|NCT01244763|12066221|FG003|Overall Study|Death|0
7650920|NCT01244763|12066222|FG004|Overall Study|Death|2
7650921|NCT01244763|12066223|FG005|Overall Study|Death|0
7650922|NCT01244763|12066218|FG000|Overall Study|Physician Decision|0
7650923|NCT01244763|12066219|FG001|Overall Study|Physician Decision|0
7650924|NCT01244763|12066220|FG002|Overall Study|Physician Decision|1
7650925|NCT01244763|12066221|FG003|Overall Study|Physician Decision|0
7650926|NCT01244763|12066222|FG004|Overall Study|Physician Decision|0
7650927|NCT01244763|12066223|FG005|Overall Study|Physician Decision|0
7650928|NCT01244763|12066218|FG000|Overall Study|Withdrawal by Subject|1
7650929|NCT01244763|12066219|FG001|Overall Study|Withdrawal by Subject|2
7650930|NCT01244763|12066220|FG002|Overall Study|Withdrawal by Subject|0
7650931|NCT01244763|12066221|FG003|Overall Study|Withdrawal by Subject|1
7650932|NCT01244763|12066222|FG004|Overall Study|Withdrawal by Subject|1
7650933|NCT01244763|12066223|FG005|Overall Study|Withdrawal by Subject|2
7650934|NCT01244763|12066218|FG000|Overall Study|Lost to Follow-up|0
7650935|NCT01244763|12066219|FG001|Overall Study|Lost to Follow-up|1
7650936|NCT01244763|12066220|FG002|Overall Study|Lost to Follow-up|0
7650937|NCT01244763|12066221|FG003|Overall Study|Lost to Follow-up|0
7650938|NCT01244763|12066222|FG004|Overall Study|Lost to Follow-up|0
7650939|NCT01244763|12066223|FG005|Overall Study|Lost to Follow-up|0
7650940|NCT01244763|12066218|FG000|Overall Study|Enrolled into the Extension Study|0
7650941|NCT01244763|12066219|FG001|Overall Study|Enrolled into the Extension Study|0
7650942|NCT01244763|12066220|FG002|Overall Study|Enrolled into the Extension Study|0
7650943|NCT01244763|12066221|FG003|Overall Study|Enrolled into the Extension Study|0
7650944|NCT01244763|12066222|FG004|Overall Study|Enrolled into the Extension Study|0
7650945|NCT01244763|12066223|FG005|Overall Study|Enrolled into the Extension Study|1
7650946|NCT01208207|12066240|FG000|Part I|Adverse Event|19
7650947|NCT01208207|12066241|FG001|Part I|Adverse Event|2
7650948|NCT01208207|12066242|FG002|Part I|Adverse Event|6
7650949|NCT01208207|12066243|FG003|Part I|Adverse Event|0
7650950|NCT01208207|12066244|FG004|Part I|Adverse Event|0
7650951|NCT01208207|12066245|FG005|Part I|Adverse Event|0
7650952|NCT01208207|12066246|FG006|Part I|Adverse Event|0
7650953|NCT01208207|12066240|FG000|Part I|Lack of Efficacy|21
7650954|NCT01208207|12066241|FG001|Part I|Lack of Efficacy|3
7650955|NCT01208207|12066242|FG002|Part I|Lack of Efficacy|2
7650956|NCT01208207|12066243|FG003|Part I|Lack of Efficacy|0
7650957|NCT01208207|12066244|FG004|Part I|Lack of Efficacy|0
7650958|NCT01208207|12066245|FG005|Part I|Lack of Efficacy|0
7650959|NCT01208207|12066246|FG006|Part I|Lack of Efficacy|0
7650960|NCT01208207|12066240|FG000|Part I|Lost to Follow-up|6
7650961|NCT01208207|12066241|FG001|Part I|Lost to Follow-up|1
7650962|NCT01208207|12066242|FG002|Part I|Lost to Follow-up|0
7650963|NCT01208207|12066243|FG003|Part I|Lost to Follow-up|0
7650964|NCT01208207|12066244|FG004|Part I|Lost to Follow-up|0
7650965|NCT01208207|12066245|FG005|Part I|Lost to Follow-up|0
7650966|NCT01208207|12066246|FG006|Part I|Lost to Follow-up|0
7650967|NCT01208207|12066240|FG000|Part I|Non-Compliance With Study Drug|1
7650968|NCT01208207|12066241|FG001|Part I|Non-Compliance With Study Drug|0
7650969|NCT01208207|12066242|FG002|Part I|Non-Compliance With Study Drug|1
7650970|NCT01208207|12066243|FG003|Part I|Non-Compliance With Study Drug|0
7650971|NCT01208207|12066244|FG004|Part I|Non-Compliance With Study Drug|0
7650972|NCT01208207|12066245|FG005|Part I|Non-Compliance With Study Drug|0
7650973|NCT01208207|12066246|FG006|Part I|Non-Compliance With Study Drug|0
7650974|NCT01208207|12066240|FG000|Part I|Physician Decision|0
7650975|NCT01208207|12066241|FG001|Part I|Physician Decision|1
7650976|NCT01208207|12066242|FG002|Part I|Physician Decision|0
7650977|NCT01208207|12066243|FG003|Part I|Physician Decision|0
7650978|NCT01208207|12066244|FG004|Part I|Physician Decision|0
7650979|NCT01208207|12066245|FG005|Part I|Physician Decision|0
7650980|NCT01208207|12066246|FG006|Part I|Physician Decision|0
7650981|NCT01208207|12066240|FG000|Part I|Progressive Disease|1
7650982|NCT01208207|12066241|FG001|Part I|Progressive Disease|0
7650983|NCT01208207|12066242|FG002|Part I|Progressive Disease|0
7650984|NCT01208207|12066243|FG003|Part I|Progressive Disease|0
7650985|NCT01208207|12066244|FG004|Part I|Progressive Disease|0
7650986|NCT01208207|12066245|FG005|Part I|Progressive Disease|0
7650987|NCT01208207|12066246|FG006|Part I|Progressive Disease|0
7650988|NCT01208207|12066240|FG000|Part I|Protocol Violation|8
7650989|NCT01208207|12066241|FG001|Part I|Protocol Violation|0
7650990|NCT01208207|12066242|FG002|Part I|Protocol Violation|2
7650991|NCT01208207|12066243|FG003|Part I|Protocol Violation|0
7650992|NCT01208207|12066244|FG004|Part I|Protocol Violation|0
7650993|NCT01208207|12066245|FG005|Part I|Protocol Violation|0
7650994|NCT01208207|12066246|FG006|Part I|Protocol Violation|0
7650995|NCT01208207|12066240|FG000|Part I|Withdrawal by Subject|14
7650996|NCT01208207|12066241|FG001|Part I|Withdrawal by Subject|4
7650997|NCT01208207|12066242|FG002|Part I|Withdrawal by Subject|4
7650998|NCT01208207|12066243|FG003|Part I|Withdrawal by Subject|0
7650999|NCT01208207|12066244|FG004|Part I|Withdrawal by Subject|0
7651000|NCT01208207|12066245|FG005|Part I|Withdrawal by Subject|0
7651001|NCT01208207|12066246|FG006|Part I|Withdrawal by Subject|0
7651002|NCT01208207|12066240|FG000|Part II|Withdrawal by Subject|0
7651003|NCT01208207|12066241|FG001|Part II|Withdrawal by Subject|0
7651004|NCT01208207|12066242|FG002|Part II|Withdrawal by Subject|0
7651005|NCT01208207|12066243|FG003|Part II|Withdrawal by Subject|10
7651006|NCT01208207|12066244|FG004|Part II|Withdrawal by Subject|9
7651007|NCT01208207|12066245|FG005|Part II|Withdrawal by Subject|3
7651008|NCT01208207|12066246|FG006|Part II|Withdrawal by Subject|5
7651009|NCT01208207|12066240|FG000|Part II|Adverse Event|0
7651010|NCT01208207|12066241|FG001|Part II|Adverse Event|0
7651011|NCT01208207|12066242|FG002|Part II|Adverse Event|0
7651012|NCT01208207|12066243|FG003|Part II|Adverse Event|5
7651013|NCT01208207|12066244|FG004|Part II|Adverse Event|9
7651014|NCT01208207|12066245|FG005|Part II|Adverse Event|4
7651015|NCT01208207|12066246|FG006|Part II|Adverse Event|2
7651016|NCT01208207|12066240|FG000|Part II|Lack of Efficacy|0
7651017|NCT01208207|12066241|FG001|Part II|Lack of Efficacy|0
7651018|NCT01208207|12066242|FG002|Part II|Lack of Efficacy|0
7651019|NCT01208207|12066243|FG003|Part II|Lack of Efficacy|6
7651020|NCT01208207|12066244|FG004|Part II|Lack of Efficacy|4
7651021|NCT01208207|12066245|FG005|Part II|Lack of Efficacy|3
7651022|NCT01208207|12066246|FG006|Part II|Lack of Efficacy|3
7651023|NCT01208207|12066240|FG000|Part II|Lost to Follow-up|0
7651024|NCT01208207|12066241|FG001|Part II|Lost to Follow-up|0
7651025|NCT01208207|12066242|FG002|Part II|Lost to Follow-up|0
7651026|NCT01208207|12066243|FG003|Part II|Lost to Follow-up|4
7651027|NCT01208207|12066244|FG004|Part II|Lost to Follow-up|0
7651028|NCT01208207|12066245|FG005|Part II|Lost to Follow-up|2
7651029|NCT01208207|12066246|FG006|Part II|Lost to Follow-up|1
7651030|NCT01208207|12066240|FG000|Part II|Non-Compliance With Study Drug|0
7651031|NCT01208207|12066241|FG001|Part II|Non-Compliance With Study Drug|0
7651032|NCT01208207|12066242|FG002|Part II|Non-Compliance With Study Drug|0
7651033|NCT01208207|12066243|FG003|Part II|Non-Compliance With Study Drug|4
7651034|NCT01208207|12066244|FG004|Part II|Non-Compliance With Study Drug|1
7651035|NCT01208207|12066245|FG005|Part II|Non-Compliance With Study Drug|1
7651036|NCT01208207|12066246|FG006|Part II|Non-Compliance With Study Drug|0
7651037|NCT01208207|12066240|FG000|Part II|Physician Decision|0
7651038|NCT01208207|12066241|FG001|Part II|Physician Decision|0
7651039|NCT01208207|12066242|FG002|Part II|Physician Decision|0
7651040|NCT01208207|12066243|FG003|Part II|Physician Decision|1
7651041|NCT01208207|12066244|FG004|Part II|Physician Decision|0
7651042|NCT01208207|12066245|FG005|Part II|Physician Decision|2
7651043|NCT01208207|12066246|FG006|Part II|Physician Decision|0
7651044|NCT01208207|12066240|FG000|Part II|Protocol Violation|0
7651045|NCT01208207|12066241|FG001|Part II|Protocol Violation|0
7651046|NCT01208207|12066242|FG002|Part II|Protocol Violation|0
7651047|NCT01208207|12066243|FG003|Part II|Protocol Violation|1
7651048|NCT01208207|12066244|FG004|Part II|Protocol Violation|0
7651049|NCT01208207|12066245|FG005|Part II|Protocol Violation|0
7651050|NCT01208207|12066246|FG006|Part II|Protocol Violation|0
7651051|NCT01208207|12066240|FG000|Part II|Technical Problems|0
7651052|NCT01208207|12066241|FG001|Part II|Technical Problems|0
7651053|NCT01208207|12066242|FG002|Part II|Technical Problems|0
7651054|NCT01208207|12066243|FG003|Part II|Technical Problems|1
7651055|NCT01208207|12066244|FG004|Part II|Technical Problems|0
7651056|NCT01208207|12066245|FG005|Part II|Technical Problems|1
7651057|NCT01208207|12066246|FG006|Part II|Technical Problems|0
7651058|NCT01208181|12066271|FG000|Part 1|Withdrawal by Subject|11
7651059|NCT01208181|12066272|FG001|Part 1|Withdrawal by Subject|10
7651060|NCT01208181|12066273|FG002|Part 1|Withdrawal by Subject|0
7651061|NCT01208181|12066274|FG003|Part 1|Withdrawal by Subject|0
7651062|NCT01208181|12066275|FG004|Part 1|Withdrawal by Subject|0
7651063|NCT01208181|12066271|FG000|Part 1|Technical problem|5
7651064|NCT01208181|12066272|FG001|Part 1|Technical problem|0
7651065|NCT01208181|12066273|FG002|Part 1|Technical problem|0
7651066|NCT01208181|12066274|FG003|Part 1|Technical problem|0
7651067|NCT01208181|12066275|FG004|Part 1|Technical problem|0
7651068|NCT01208181|12066271|FG000|Part 1|Protocol Violation|10
7651069|NCT01208181|12066272|FG001|Part 1|Protocol Violation|5
7651070|NCT01208181|12066273|FG002|Part 1|Protocol Violation|0
7651071|NCT01208181|12066274|FG003|Part 1|Protocol Violation|0
7651072|NCT01208181|12066275|FG004|Part 1|Protocol Violation|0
7651073|NCT01208181|12066271|FG000|Part 1|Physician Decision|4
7651074|NCT01208181|12066272|FG001|Part 1|Physician Decision|0
7651075|NCT01208181|12066273|FG002|Part 1|Physician Decision|0
7651076|NCT01208181|12066274|FG003|Part 1|Physician Decision|0
7651077|NCT01208181|12066275|FG004|Part 1|Physician Decision|0
7651078|NCT01208181|12066271|FG000|Part 1|Non-compliance with study drug|1
7651079|NCT01208181|12066272|FG001|Part 1|Non-compliance with study drug|1
7651080|NCT01208181|12066273|FG002|Part 1|Non-compliance with study drug|0
7651081|NCT01208181|12066274|FG003|Part 1|Non-compliance with study drug|0
7651082|NCT01208181|12066275|FG004|Part 1|Non-compliance with study drug|0
7651083|NCT01208181|12066271|FG000|Part 1|Lost to Follow-up|5
7651084|NCT01208181|12066272|FG001|Part 1|Lost to Follow-up|3
7651085|NCT01208181|12066273|FG002|Part 1|Lost to Follow-up|0
7651086|NCT01208181|12066274|FG003|Part 1|Lost to Follow-up|0
7651087|NCT01208181|12066275|FG004|Part 1|Lost to Follow-up|1
7651088|NCT01208181|12066271|FG000|Part 1|Lack of Efficacy|37
7651089|NCT01208181|12066272|FG001|Part 1|Lack of Efficacy|12
7651090|NCT01208181|12066273|FG002|Part 1|Lack of Efficacy|0
7651091|NCT01208181|12066274|FG003|Part 1|Lack of Efficacy|0
7651092|NCT01208181|12066275|FG004|Part 1|Lack of Efficacy|17
7651093|NCT01208181|12066271|FG000|Part 1|Adverse Event|26
7651094|NCT01208181|12066272|FG001|Part 1|Adverse Event|24
7651095|NCT01208181|12066273|FG002|Part 1|Adverse Event|0
7651096|NCT01208181|12066274|FG003|Part 1|Adverse Event|0
7651097|NCT01208181|12066275|FG004|Part 1|Adverse Event|4
7651098|NCT01208181|12066271|FG000|Part 2|Adverse Event|0
7651099|NCT01208181|12066272|FG001|Part 2|Adverse Event|0
7651100|NCT01208181|12066273|FG002|Part 2|Adverse Event|6
7651101|NCT01208181|12066274|FG003|Part 2|Adverse Event|7
7651102|NCT01208181|12066275|FG004|Part 2|Adverse Event|0
7651103|NCT01208181|12066271|FG000|Part 2|Withdrawal by Subject|0
7651104|NCT01208181|12066272|FG001|Part 2|Withdrawal by Subject|0
7651105|NCT01208181|12066273|FG002|Part 2|Withdrawal by Subject|1
7651106|NCT01208181|12066274|FG003|Part 2|Withdrawal by Subject|1
7651107|NCT01208181|12066275|FG004|Part 2|Withdrawal by Subject|0
7651108|NCT01208181|12066271|FG000|Part 2|Protocol Violation|0
7651109|NCT01208181|12066272|FG001|Part 2|Protocol Violation|0
7651110|NCT01208181|12066273|FG002|Part 2|Protocol Violation|1
7651111|NCT01208181|12066274|FG003|Part 2|Protocol Violation|0
7651112|NCT01208181|12066275|FG004|Part 2|Protocol Violation|0
7651113|NCT01208181|12066271|FG000|Part 2|Physician Decision|0
7651114|NCT01208181|12066272|FG001|Part 2|Physician Decision|0
7651115|NCT01208181|12066273|FG002|Part 2|Physician Decision|1
7651116|NCT01208181|12066274|FG003|Part 2|Physician Decision|2
7651117|NCT01208181|12066275|FG004|Part 2|Physician Decision|0
7651118|NCT01208181|12066271|FG000|Part 2|Non-compliance with study drug|0
7651119|NCT01208181|12066272|FG001|Part 2|Non-compliance with study drug|0
7651120|NCT01208181|12066273|FG002|Part 2|Non-compliance with study drug|1
7651121|NCT01208181|12066274|FG003|Part 2|Non-compliance with study drug|1
7651122|NCT01208181|12066275|FG004|Part 2|Non-compliance with study drug|0
7651123|NCT01208181|12066271|FG000|Part 2|Lost to Follow-up|0
7651124|NCT01208181|12066272|FG001|Part 2|Lost to Follow-up|0
7651125|NCT01208181|12066273|FG002|Part 2|Lost to Follow-up|1
7651126|NCT01208181|12066274|FG003|Part 2|Lost to Follow-up|2
7651127|NCT01208181|12066275|FG004|Part 2|Lost to Follow-up|0
7651128|NCT01208181|12066271|FG000|Part 2|Lack of Efficacy|0
7651129|NCT01208181|12066272|FG001|Part 2|Lack of Efficacy|0
7651130|NCT01208181|12066273|FG002|Part 2|Lack of Efficacy|5
7651131|NCT01208181|12066274|FG003|Part 2|Lack of Efficacy|7
7651132|NCT01208181|12066275|FG004|Part 2|Lack of Efficacy|0
7651133|NCT01206517|12066298|FG000|Overall Study|Withdrawal by Subject|0
7651134|NCT01206517|12066299|FG001|Overall Study|Withdrawal by Subject|0
7651135|NCT01206517|12066300|FG002|Overall Study|Withdrawal by Subject|2
7651136|NCT01206517|12066301|FG003|Overall Study|Withdrawal by Subject|0
7651137|NCT01206517|12066302|FG004|Overall Study|Withdrawal by Subject|1
7651138|NCT01206517|12066303|FG005|Overall Study|Withdrawal by Subject|0
7651139|NCT01190267|12066316|FG000|Overall Study|Adverse Event|10
7651140|NCT01190267|12066317|FG001|Overall Study|Adverse Event|0
7651141|NCT01190267|12066316|FG000|Overall Study|Treatment Failure|8
7651142|NCT01190267|12066317|FG001|Overall Study|Treatment Failure|2
7651143|NCT01190267|12066316|FG000|Overall Study|Lost to Follow-up|2
7651144|NCT01190267|12066317|FG001|Overall Study|Lost to Follow-up|0
7651145|NCT01190267|12066316|FG000|Overall Study|Withdrawal by Subject|13
7651146|NCT01190267|12066317|FG001|Overall Study|Withdrawal by Subject|1
7651147|NCT01190267|12066316|FG000|Overall Study|Protocol Violation|8
7651148|NCT01190267|12066317|FG001|Overall Study|Protocol Violation|1
7651149|NCT01190254|12066326|FG000|Overall Study|Adverse Event|3
7651150|NCT01190254|12066327|FG001|Overall Study|Adverse Event|6
7651151|NCT01190254|12066328|FG002|Overall Study|Adverse Event|8
7651152|NCT01190254|12066326|FG000|Overall Study|Lack of Efficacy|7
7651153|NCT01190254|12066327|FG001|Overall Study|Lack of Efficacy|4
7651154|NCT01190254|12066328|FG002|Overall Study|Lack of Efficacy|5
7651155|NCT01190254|12066326|FG000|Overall Study|Lost to Follow-up|4
7651156|NCT01190254|12066327|FG001|Overall Study|Lost to Follow-up|2
7651157|NCT01190254|12066328|FG002|Overall Study|Lost to Follow-up|0
7651158|NCT01190254|12066326|FG000|Overall Study|Withdrawal by Subject|4
7651159|NCT01190254|12066327|FG001|Overall Study|Withdrawal by Subject|5
7651160|NCT01190254|12066328|FG002|Overall Study|Withdrawal by Subject|7
7651161|NCT01190254|12066326|FG000|Overall Study|Protocol Violation|2
7651162|NCT01190254|12066327|FG001|Overall Study|Protocol Violation|0
7651163|NCT01190254|12066328|FG002|Overall Study|Protocol Violation|2
7651164|NCT01190254|12066326|FG000|Overall Study|Did not meet protocol eligibility|1
7651165|NCT01190254|12066327|FG001|Overall Study|Did not meet protocol eligibility|0
7651166|NCT01190254|12066328|FG002|Overall Study|Did not meet protocol eligibility|0
7651167|NCT01154036|12066339|FG000|Phase I|Physician Decision|0
7651168|NCT01154036|12066340|FG001|Phase I|Physician Decision|1
7651169|NCT01154036|12066341|FG002|Phase I|Physician Decision|0
7651170|NCT01154036|12066342|FG003|Phase I|Physician Decision|0
7651171|NCT01154036|12066343|FG004|Phase I|Physician Decision|0
7651172|NCT01154036|12066344|FG005|Phase I|Physician Decision|0
7651173|NCT01154036|12066345|FG006|Phase I|Physician Decision|0
7651174|NCT01154036|12066346|FG007|Phase I|Physician Decision|0
7651175|NCT01154036|12066339|FG000|Phase I|Lost to Follow-up|0
7651176|NCT01154036|12066340|FG001|Phase I|Lost to Follow-up|3
7651177|NCT01154036|12066341|FG002|Phase I|Lost to Follow-up|6
7651178|NCT01154036|12066342|FG003|Phase I|Lost to Follow-up|0
7651179|NCT01154036|12066343|FG004|Phase I|Lost to Follow-up|0
7651180|NCT01154036|12066344|FG005|Phase I|Lost to Follow-up|0
7651181|NCT01154036|12066345|FG006|Phase I|Lost to Follow-up|0
7651182|NCT01154036|12066346|FG007|Phase I|Lost to Follow-up|0
7651183|NCT01154036|12066339|FG000|Phase I|Protocol Violation|0
7651184|NCT01154036|12066340|FG001|Phase I|Protocol Violation|3
7651185|NCT01154036|12066341|FG002|Phase I|Protocol Violation|9
7651186|NCT01154036|12066342|FG003|Phase I|Protocol Violation|0
7651187|NCT01154036|12066343|FG004|Phase I|Protocol Violation|0
7651188|NCT01154036|12066344|FG005|Phase I|Protocol Violation|0
7651189|NCT01154036|12066345|FG006|Phase I|Protocol Violation|0
7651190|NCT01154036|12066346|FG007|Phase I|Protocol Violation|0
7651191|NCT01154036|12066339|FG000|Phase I|Withdrawal by Subject|2
7651192|NCT01154036|12066340|FG001|Phase I|Withdrawal by Subject|10
7651193|NCT01154036|12066341|FG002|Phase I|Withdrawal by Subject|29
7651194|NCT01154036|12066342|FG003|Phase I|Withdrawal by Subject|0
7651195|NCT01154036|12066343|FG004|Phase I|Withdrawal by Subject|0
7651196|NCT01154036|12066344|FG005|Phase I|Withdrawal by Subject|0
7651197|NCT01154036|12066345|FG006|Phase I|Withdrawal by Subject|0
7651198|NCT01154036|12066346|FG007|Phase I|Withdrawal by Subject|0
7651199|NCT01154036|12066339|FG000|Phase I|Adverse Event|1
7651200|NCT01154036|12066340|FG001|Phase I|Adverse Event|11
7651201|NCT01154036|12066341|FG002|Phase I|Adverse Event|12
7651202|NCT01154036|12066342|FG003|Phase I|Adverse Event|0
7651203|NCT01154036|12066343|FG004|Phase I|Adverse Event|0
7651204|NCT01154036|12066344|FG005|Phase I|Adverse Event|0
7651205|NCT01154036|12066345|FG006|Phase I|Adverse Event|0
7651206|NCT01154036|12066346|FG007|Phase I|Adverse Event|0
7651207|NCT01154036|12066339|FG000|Phase II|Adverse Event|0
7651208|NCT01154036|12066340|FG001|Phase II|Adverse Event|0
7651209|NCT01154036|12066341|FG002|Phase II|Adverse Event|0
7651210|NCT01154036|12066342|FG003|Phase II|Adverse Event|0
7651211|NCT01154036|12066343|FG004|Phase II|Adverse Event|1
7651212|NCT01154036|12066344|FG005|Phase II|Adverse Event|1
7651213|NCT01154036|12066345|FG006|Phase II|Adverse Event|1
7651214|NCT01154036|12066346|FG007|Phase II|Adverse Event|1
7651215|NCT01154036|12066339|FG000|Phase II|Physician Decision|0
7651216|NCT01154036|12066340|FG001|Phase II|Physician Decision|0
7651217|NCT01154036|12066341|FG002|Phase II|Physician Decision|0
7651218|NCT01154036|12066342|FG003|Phase II|Physician Decision|0
7651219|NCT01154036|12066343|FG004|Phase II|Physician Decision|0
7651220|NCT01154036|12066344|FG005|Phase II|Physician Decision|0
7651221|NCT01154036|12066345|FG006|Phase II|Physician Decision|1
7651222|NCT01154036|12066346|FG007|Phase II|Physician Decision|0
7651223|NCT01154036|12066339|FG000|Phase II|Lost to Follow-up|0
7651224|NCT01154036|12066340|FG001|Phase II|Lost to Follow-up|0
7651225|NCT01154036|12066341|FG002|Phase II|Lost to Follow-up|0
7651226|NCT01154036|12066342|FG003|Phase II|Lost to Follow-up|1
7651227|NCT01154036|12066343|FG004|Phase II|Lost to Follow-up|2
7651228|NCT01154036|12066344|FG005|Phase II|Lost to Follow-up|0
7651229|NCT01154036|12066345|FG006|Phase II|Lost to Follow-up|2
7651230|NCT01154036|12066346|FG007|Phase II|Lost to Follow-up|1
7651231|NCT01154036|12066339|FG000|Phase II|Protocol Violation|0
7651232|NCT01154036|12066340|FG001|Phase II|Protocol Violation|0
7651233|NCT01154036|12066341|FG002|Phase II|Protocol Violation|0
7651234|NCT01154036|12066342|FG003|Phase II|Protocol Violation|0
7651235|NCT01154036|12066343|FG004|Phase II|Protocol Violation|1
7651236|NCT01154036|12066344|FG005|Phase II|Protocol Violation|2
7651237|NCT01154036|12066345|FG006|Phase II|Protocol Violation|0
7651238|NCT01154036|12066346|FG007|Phase II|Protocol Violation|0
7651239|NCT01154036|12066339|FG000|Phase II|Withdrawal by Subject|0
7651240|NCT01154036|12066340|FG001|Phase II|Withdrawal by Subject|0
7651241|NCT01154036|12066341|FG002|Phase II|Withdrawal by Subject|0
7651242|NCT01154036|12066342|FG003|Phase II|Withdrawal by Subject|0
7651243|NCT01154036|12066343|FG004|Phase II|Withdrawal by Subject|4
7651244|NCT01154036|12066344|FG005|Phase II|Withdrawal by Subject|2
7651245|NCT01154036|12066345|FG006|Phase II|Withdrawal by Subject|5
7651246|NCT01154036|12066346|FG007|Phase II|Withdrawal by Subject|4
7651247|NCT01098071|12066377|FG000|Overall Study|Surgery (adenoidectomy)|2
7651248|NCT01098071|12066377|FG000|Overall Study|Lost to Follow-up|13
7651249|NCT01070966|12066390|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59
7651250|NCT01070966|12066390|FG000|Participants for Safety Evaluation|Off-label use|9
7651251|NCT01070966|12066390|FG000|Participants for Safety Evaluation|Duplicate Participants|4
7651252|NCT01070966|12066390|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
7651253|NCT01070966|12066390|FG000|Participants for Safety Evaluation|TMT given before date of contract|3
7651254|NCT01070966|12066390|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
7651255|NCT01070966|12066390|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19
7651256|NCT01070966|12066390|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
7651257|NCT01070953|12066401|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612
7651258|NCT01070953|12066401|FG000|Participants for Safety Evaluation|Off-label use|283
7651259|NCT01070953|12066401|FG000|Participants for Safety Evaluation|Duplicated participants|22
7651260|NCT01070953|12066401|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8
7651261|NCT01070953|12066401|FG000|Participants for Safety Evaluation|Uncontracted participants|4
7651262|NCT01070953|12066401|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1
7651263|NCT01070953|12066401|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1
7651264|NCT01070953|12066401|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119
7651265|NCT01070953|12066401|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
7651266|NCT01070953|12066401|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
7651267|NCT01030341|12066411|FG000|Overall Study|Withdrawal by Subject|1
7651268|NCT01030341|12066411|FG000|Overall Study|Lost to Follow-up|2
7651269|NCT00979901|12066419|FG000|Overall Study|Adverse Event|1
7651270|NCT00979901|12066420|FG001|Overall Study|Adverse Event|3
7651271|NCT00979901|12066421|FG002|Overall Study|Adverse Event|9
7651272|NCT00979901|12066422|FG003|Overall Study|Adverse Event|2
7651273|NCT00979901|12066419|FG000|Overall Study|Lack of Efficacy|8
7651274|NCT00979901|12066420|FG001|Overall Study|Lack of Efficacy|4
7651275|NCT00979901|12066421|FG002|Overall Study|Lack of Efficacy|9
7651276|NCT00979901|12066422|FG003|Overall Study|Lack of Efficacy|0
7651277|NCT00979901|12066419|FG000|Overall Study|Lost to Follow-up|1
7651278|NCT00979901|12066420|FG001|Overall Study|Lost to Follow-up|1
7651279|NCT00979901|12066421|FG002|Overall Study|Lost to Follow-up|2
7651280|NCT00979901|12066422|FG003|Overall Study|Lost to Follow-up|0
7651281|NCT00979901|12066419|FG000|Overall Study|Protocol Violation|2
7651282|NCT00979901|12066420|FG001|Overall Study|Protocol Violation|2
7651283|NCT00979901|12066421|FG002|Overall Study|Protocol Violation|7
7651284|NCT00979901|12066422|FG003|Overall Study|Protocol Violation|1
7651285|NCT00979901|12066419|FG000|Overall Study|Withdrawal by Subject|2
7651286|NCT00979901|12066420|FG001|Overall Study|Withdrawal by Subject|1
7651287|NCT00979901|12066421|FG002|Overall Study|Withdrawal by Subject|1
7651288|NCT00979901|12066422|FG003|Overall Study|Withdrawal by Subject|1
7651289|NCT00979901|12066419|FG000|Overall Study|Noncompliance|1
7651290|NCT00979901|12066420|FG001|Overall Study|Noncompliance|0
7651291|NCT00979901|12066421|FG002|Overall Study|Noncompliance|0
7651292|NCT00979901|12066422|FG003|Overall Study|Noncompliance|0
7651293|NCT00979901|12066419|FG000|Overall Study|out-of-state|1
7651294|NCT00979901|12066420|FG001|Overall Study|out-of-state|0
7651295|NCT00979901|12066421|FG002|Overall Study|out-of-state|0
7651296|NCT00979901|12066422|FG003|Overall Study|out-of-state|0
7651297|NCT00979901|12066419|FG000|Overall Study|vacation|1
7651298|NCT00979901|12066420|FG001|Overall Study|vacation|0
7651299|NCT00979901|12066421|FG002|Overall Study|vacation|0
7651300|NCT00979901|12066422|FG003|Overall Study|vacation|0
7651301|NCT00979901|12066419|FG000|Overall Study|elevated lab values pre-randomization|1
7651302|NCT00979901|12066420|FG001|Overall Study|elevated lab values pre-randomization|0
7651303|NCT00979901|12066421|FG002|Overall Study|elevated lab values pre-randomization|0
7651304|NCT00979901|12066422|FG003|Overall Study|elevated lab values pre-randomization|0
7651305|NCT00979901|12066419|FG000|Overall Study|Discontinued in Error|0
7651306|NCT00979901|12066420|FG001|Overall Study|Discontinued in Error|1
7651307|NCT00979901|12066421|FG002|Overall Study|Discontinued in Error|0
7651308|NCT00979901|12066422|FG003|Overall Study|Discontinued in Error|0
7651309|NCT00979901|12066419|FG000|Overall Study|Left Country|0
7651310|NCT00979901|12066420|FG001|Overall Study|Left Country|0
7651311|NCT00979901|12066421|FG002|Overall Study|Left Country|1
7651312|NCT00979901|12066422|FG003|Overall Study|Left Country|0
7651313|NCT00979901|12066419|FG000|Overall Study|Treatment Group Terminated by Sponsor|0
7651314|NCT00979901|12066420|FG001|Overall Study|Treatment Group Terminated by Sponsor|0
7651315|NCT00979901|12066421|FG002|Overall Study|Treatment Group Terminated by Sponsor|0
7651316|NCT00979901|12066422|FG003|Overall Study|Treatment Group Terminated by Sponsor|112
7651317|NCT00963599|12066435|FG000|Overall Study|Adverse Event|2
7651318|NCT00963599|12066436|FG001|Overall Study|Adverse Event|0
7651319|NCT00963599|12066437|FG002|Overall Study|Adverse Event|1
7651320|NCT00963599|12066438|FG003|Overall Study|Adverse Event|2
7651321|NCT00963599|12066435|FG000|Overall Study|Lack of Efficacy|0
7651322|NCT00963599|12066436|FG001|Overall Study|Lack of Efficacy|2
7651323|NCT00963599|12066437|FG002|Overall Study|Lack of Efficacy|1
7651324|NCT00963599|12066438|FG003|Overall Study|Lack of Efficacy|4
7651325|NCT00963599|12066435|FG000|Overall Study|Lost to Follow-up|0
7651326|NCT00963599|12066436|FG001|Overall Study|Lost to Follow-up|1
7651327|NCT00963599|12066437|FG002|Overall Study|Lost to Follow-up|1
7651328|NCT00963599|12066438|FG003|Overall Study|Lost to Follow-up|1
7651329|NCT00963599|12066435|FG000|Overall Study|Protocol Violation|2
7651330|NCT00963599|12066436|FG001|Overall Study|Protocol Violation|2
7651331|NCT00963599|12066437|FG002|Overall Study|Protocol Violation|3
7651332|NCT00963599|12066438|FG003|Overall Study|Protocol Violation|4
7651333|NCT00963599|12066435|FG000|Overall Study|Withdrawal by Subject|2
7651334|NCT00963599|12066436|FG001|Overall Study|Withdrawal by Subject|1
7651335|NCT00963599|12066437|FG002|Overall Study|Withdrawal by Subject|3
7651336|NCT00963599|12066438|FG003|Overall Study|Withdrawal by Subject|3
7651337|NCT00953680|12066453|FG000|Period 1|Withdrawal by Subject|0
7651338|NCT00953680|12066454|FG001|Period 1|Withdrawal by Subject|1
7651339|NCT00943852|12066467|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7651340|NCT00943852|12066468|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7651341|NCT00943852|12066469|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7651342|NCT00943852|12066470|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
7651343|NCT00943852|12066471|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7651344|NCT00943852|12066472|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7651345|NCT00943852|12066473|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7651346|NCT00943852|12066474|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7651347|NCT00943852|12066475|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7651348|NCT00943852|12066476|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7651349|NCT00943852|12066467|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0
7651350|NCT00943852|12066468|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0
7651351|NCT00943852|12066469|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0
7651352|NCT00943852|12066470|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0
7651353|NCT00943852|12066471|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0
7651354|NCT00943852|12066472|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1
7651355|NCT00943852|12066473|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0
7651356|NCT00943852|12066474|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0
7651357|NCT00943852|12066475|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0
7651358|NCT00943852|12066476|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0
7651359|NCT00943852|12066467|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7651360|NCT00943852|12066468|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7651361|NCT00943852|12066469|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7651362|NCT00943852|12066470|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7651363|NCT00943852|12066471|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7651364|NCT00943852|12066472|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7651365|NCT00943852|12066473|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
7651366|NCT00943852|12066474|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7651367|NCT00943852|12066475|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7651368|NCT00943852|12066476|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7651369|NCT00943852|12066467|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7651370|NCT00943852|12066468|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7651371|NCT00943852|12066469|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7651372|NCT00943852|12066470|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7651373|NCT00943852|12066471|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7651374|NCT00943852|12066472|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7651375|NCT00943852|12066473|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7651376|NCT00943852|12066474|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
7651377|NCT00943852|12066475|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7651378|NCT00943852|12066476|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7651379|NCT00943852|12066467|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1
7651380|NCT00943852|12066468|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0
7651381|NCT00943852|12066469|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1
7651382|NCT00943852|12066470|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1
7651383|NCT00943852|12066471|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0
7651384|NCT00943852|12066472|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0
7651385|NCT00943852|12066473|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1
7651386|NCT00943852|12066474|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0
7651387|NCT00943852|12066475|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0
7651388|NCT00943852|12066476|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0
7651389|NCT00927953|12066488|FG000|Overall Study|Death|2
7651390|NCT00927953|12066489|FG001|Overall Study|Death|1
7651391|NCT00909389|12066496|FG000|Overall Study|Adverse Event|6
7651392|NCT00909389|12066496|FG000|Overall Study|Death|4
7651393|NCT00909389|12066496|FG000|Overall Study|Poor Compliance|16
7651394|NCT00909389|12066496|FG000|Overall Study|Lost to Follow-up|4
7651395|NCT00909389|12066496|FG000|Overall Study|No Information|103
7651396|NCT00820027|12066504|FG000|Overall Study|Adverse Event|15
7651397|NCT00820027|12066505|FG001|Overall Study|Adverse Event|8
7651398|NCT00820027|12066506|FG002|Overall Study|Adverse Event|10
7651399|NCT00820027|12066507|FG003|Overall Study|Adverse Event|5
7651400|NCT00820027|12066504|FG000|Overall Study|Lack of Efficacy|2
7651401|NCT00820027|12066505|FG001|Overall Study|Lack of Efficacy|1
7651402|NCT00820027|12066506|FG002|Overall Study|Lack of Efficacy|2
7651403|NCT00820027|12066507|FG003|Overall Study|Lack of Efficacy|2
7651404|NCT00820027|12066504|FG000|Overall Study|Physician Decision|0
7651405|NCT00820027|12066505|FG001|Overall Study|Physician Decision|1
7651406|NCT00820027|12066506|FG002|Overall Study|Physician Decision|1
7651407|NCT00820027|12066507|FG003|Overall Study|Physician Decision|0
7651408|NCT00820027|12066504|FG000|Overall Study|Protocol Violation|3
7651409|NCT00820027|12066505|FG001|Overall Study|Protocol Violation|0
7651410|NCT00820027|12066506|FG002|Overall Study|Protocol Violation|4
7651411|NCT00820027|12066507|FG003|Overall Study|Protocol Violation|0
7651412|NCT00820027|12066504|FG000|Overall Study|Withdrawal by Subject|6
7651413|NCT00820027|12066505|FG001|Overall Study|Withdrawal by Subject|4
7651414|NCT00820027|12066506|FG002|Overall Study|Withdrawal by Subject|4
7651415|NCT00820027|12066507|FG003|Overall Study|Withdrawal by Subject|6
7651416|NCT00788710|12066521|FG000|Overall Study|Adverse Event|1
7651417|NCT00788710|12066522|FG001|Overall Study|Adverse Event|3
7651418|NCT00788710|12066523|FG002|Overall Study|Adverse Event|4
7651419|NCT00788710|12066521|FG000|Overall Study|Lack of Efficacy|0
7651420|NCT00788710|12066522|FG001|Overall Study|Lack of Efficacy|0
7651421|NCT00788710|12066523|FG002|Overall Study|Lack of Efficacy|1
7651422|NCT00788710|12066521|FG000|Overall Study|Lost to Follow-up|0
7651423|NCT00788710|12066522|FG001|Overall Study|Lost to Follow-up|1
7651424|NCT00788710|12066523|FG002|Overall Study|Lost to Follow-up|0
7651425|NCT00788710|12066521|FG000|Overall Study|Physician Decision|2
7651426|NCT00788710|12066522|FG001|Overall Study|Physician Decision|1
7651427|NCT00788710|12066523|FG002|Overall Study|Physician Decision|0
7651428|NCT00788710|12066521|FG000|Overall Study|Protocol Violation|0
7651429|NCT00788710|12066522|FG001|Overall Study|Protocol Violation|1
7651430|NCT00788710|12066523|FG002|Overall Study|Protocol Violation|1
7651431|NCT00788710|12066521|FG000|Overall Study|Withdrawal by Subject|2
7651432|NCT00788710|12066522|FG001|Overall Study|Withdrawal by Subject|2
7651433|NCT00788710|12066523|FG002|Overall Study|Withdrawal by Subject|0
7651434|NCT00783224|12066535|FG000|Overall Study|Adverse Event|0
7651435|NCT00783224|12066536|FG001|Overall Study|Adverse Event|0
7651436|NCT00783224|12066537|FG002|Overall Study|Adverse Event|1
7651437|NCT00783224|12066538|FG003|Overall Study|Adverse Event|0
7651438|NCT00783224|12066535|FG000|Overall Study|Discarded the Investigational Drug Used|0
7651439|NCT00783224|12066536|FG001|Overall Study|Discarded the Investigational Drug Used|0
7651440|NCT00783224|12066537|FG002|Overall Study|Discarded the Investigational Drug Used|0
7651441|NCT00783224|12066538|FG003|Overall Study|Discarded the Investigational Drug Used|1
7651442|NCT00783224|12066535|FG000|Overall Study|Inappropriate as a study subject|0
7651443|NCT00783224|12066536|FG001|Overall Study|Inappropriate as a study subject|0
7651444|NCT00783224|12066537|FG002|Overall Study|Inappropriate as a study subject|0
7651445|NCT00783224|12066538|FG003|Overall Study|Inappropriate as a study subject|1
7651446|NCT00778700|12066567|FG000|Overall Study|Adverse Event|6
7651447|NCT00778700|12066568|FG001|Overall Study|Adverse Event|1
7651448|NCT00778700|12066569|FG002|Overall Study|Adverse Event|3
7651449|NCT00778700|12066570|FG003|Overall Study|Adverse Event|5
7651450|NCT00778700|12066567|FG000|Overall Study|Protocol Violation|1
7651451|NCT00778700|12066568|FG001|Overall Study|Protocol Violation|1
7651452|NCT00778700|12066569|FG002|Overall Study|Protocol Violation|0
7651453|NCT00778700|12066570|FG003|Overall Study|Protocol Violation|0
7651454|NCT00778700|12066567|FG000|Overall Study|Subject Withdrew Consent|6
7651455|NCT00778700|12066568|FG001|Overall Study|Subject Withdrew Consent|4
7651456|NCT00778700|12066569|FG002|Overall Study|Subject Withdrew Consent|1
7651457|NCT00778700|12066570|FG003|Overall Study|Subject Withdrew Consent|4
7651458|NCT00778700|12066567|FG000|Overall Study|Lost to Follow-up|3
7651459|NCT00778700|12066568|FG001|Overall Study|Lost to Follow-up|1
7651460|NCT00778700|12066569|FG002|Overall Study|Lost to Follow-up|0
7651461|NCT00778700|12066570|FG003|Overall Study|Lost to Follow-up|1
7651462|NCT00778700|12066567|FG000|Overall Study|Reason not Specified|2
7651463|NCT00778700|12066568|FG001|Overall Study|Reason not Specified|0
7651464|NCT00778700|12066569|FG002|Overall Study|Reason not Specified|1
7651465|NCT00778700|12066570|FG003|Overall Study|Reason not Specified|3
7651466|NCT00778700|12066567|FG000|Overall Study|Other|0
7651467|NCT00778700|12066568|FG001|Overall Study|Other|0
7651468|NCT00778700|12066569|FG002|Overall Study|Other|1
7651469|NCT00778700|12066570|FG003|Overall Study|Other|0
7651470|NCT00764478|12066587|FG000|Overall Study|Adverse Event|1
7651471|NCT00764478|12066588|FG001|Overall Study|Adverse Event|1
7651472|NCT00764478|12066589|FG002|Overall Study|Adverse Event|1
7651473|NCT00764478|12066587|FG000|Overall Study|Withdrawal by Subject|7
7651474|NCT00764478|12066588|FG001|Overall Study|Withdrawal by Subject|12
7651475|NCT00764478|12066589|FG002|Overall Study|Withdrawal by Subject|1
7651476|NCT00764478|12066587|FG000|Overall Study|Lost to Follow-up|7
7651477|NCT00764478|12066588|FG001|Overall Study|Lost to Follow-up|8
7651478|NCT00764478|12066589|FG002|Overall Study|Lost to Follow-up|5
7651479|NCT00764478|12066587|FG000|Overall Study|Protocol Violation|0
7651480|NCT00764478|12066588|FG001|Overall Study|Protocol Violation|1
7651481|NCT00764478|12066589|FG002|Overall Study|Protocol Violation|1
7651482|NCT00761527|12066597|FG000|Overall Study|Adverse Event|3
7651483|NCT00761527|12066597|FG000|Overall Study|Poor Compliance|8
7651484|NCT00761527|12066597|FG000|Overall Study|Lost to Follow-up|9
7651485|NCT00761527|12066597|FG000|Overall Study|Unknown reason|2
7651486|NCT00757627|12066601|FG000|Overall Study|Adverse Event|15
7651487|NCT00757627|12066601|FG000|Overall Study|Lack of Efficacy|10
7651488|NCT00757627|12066601|FG000|Overall Study|Lost to Follow-up|28
7651489|NCT00757627|12066601|FG000|Overall Study|Withdrawal by Subject|27
7651490|NCT00757627|12066601|FG000|Overall Study|Other|1
7651491|NCT00756938|12066613|FG000|12-week Base Study|Protocol-specific Criteria Met|1
7651492|NCT00756938|12066614|FG001|12-week Base Study|Protocol-specific Criteria Met|0
7651493|NCT00756938|12066615|FG002|12-week Base Study|Protocol-specific Criteria Met|1
7651494|NCT00756938|12066616|FG003|12-week Base Study|Protocol-specific Criteria Met|0
7651495|NCT00756938|12066613|FG000|12-week Base Study|Protocol Violation|0
7651496|NCT00756938|12066614|FG001|12-week Base Study|Protocol Violation|0
7651497|NCT00756938|12066615|FG002|12-week Base Study|Protocol Violation|1
7651498|NCT00756938|12066616|FG003|12-week Base Study|Protocol Violation|0
7651499|NCT00756938|12066613|FG000|12-week Base Study|Lost to Follow-up|1
7651500|NCT00756938|12066614|FG001|12-week Base Study|Lost to Follow-up|0
7651501|NCT00756938|12066615|FG002|12-week Base Study|Lost to Follow-up|0
7651502|NCT00756938|12066616|FG003|12-week Base Study|Lost to Follow-up|0
7651503|NCT00756938|12066613|FG000|Optional Extension|Lack of Efficacy|0
7651504|NCT00756938|12066614|FG001|Optional Extension|Lack of Efficacy|0
7651505|NCT00756938|12066615|FG002|Optional Extension|Lack of Efficacy|0
7651506|NCT00756938|12066616|FG003|Optional Extension|Lack of Efficacy|1
7651507|NCT00756938|12066613|FG000|Optional Extension|End of Study|0
7651508|NCT00756938|12066614|FG001|Optional Extension|End of Study|0
7651509|NCT00756938|12066615|FG002|Optional Extension|End of Study|0
7651510|NCT00756938|12066616|FG003|Optional Extension|End of Study|11
7651511|NCT00756938|12066613|FG000|Optional Extension|Protocol-specific criteria met|0
7651512|NCT00756938|12066614|FG001|Optional Extension|Protocol-specific criteria met|0
7651513|NCT00756938|12066615|FG002|Optional Extension|Protocol-specific criteria met|0
7651514|NCT00756938|12066616|FG003|Optional Extension|Protocol-specific criteria met|9
7651515|NCT00756938|12066613|FG000|Optional Extension|Physician Decision|0
7651516|NCT00756938|12066614|FG001|Optional Extension|Physician Decision|0
7651517|NCT00756938|12066615|FG002|Optional Extension|Physician Decision|0
7651518|NCT00756938|12066616|FG003|Optional Extension|Physician Decision|3
7651519|NCT00756938|12066613|FG000|Optional Extension|Lost to Follow-up|0
7651520|NCT00756938|12066614|FG001|Optional Extension|Lost to Follow-up|0
7651521|NCT00756938|12066615|FG002|Optional Extension|Lost to Follow-up|0
7651522|NCT00756938|12066616|FG003|Optional Extension|Lost to Follow-up|1
7651523|NCT00756938|12066613|FG000|Optional Extension|Protocol Violation|0
7651524|NCT00756938|12066614|FG001|Optional Extension|Protocol Violation|0
7651525|NCT00756938|12066615|FG002|Optional Extension|Protocol Violation|0
7651526|NCT00756938|12066616|FG003|Optional Extension|Protocol Violation|1
7651527|NCT00756938|12066613|FG000|Optional Extension|Withdrawal by Subject|0
7651528|NCT00756938|12066614|FG001|Optional Extension|Withdrawal by Subject|0
7651529|NCT00756938|12066615|FG002|Optional Extension|Withdrawal by Subject|0
7651530|NCT00756938|12066616|FG003|Optional Extension|Withdrawal by Subject|10
7651531|NCT00756938|12066613|FG000|Optional Extension|Adverse Event|0
7651532|NCT00756938|12066614|FG001|Optional Extension|Adverse Event|0
7651533|NCT00756938|12066615|FG002|Optional Extension|Adverse Event|0
7651534|NCT00756938|12066616|FG003|Optional Extension|Adverse Event|1
7651535|NCT00730132|12066634|FG000|Overall Study|Protocol Violation|154
7651536|NCT00730132|12066634|FG000|Overall Study|Death|1
7651537|NCT00728416|12066643|FG000|Overall Study|Adverse Event|1
7651538|NCT00728416|12066644|FG001|Overall Study|Adverse Event|1
7651539|NCT00728416|12066643|FG000|Overall Study|Treatment Failure|0
7651540|NCT00728416|12066644|FG001|Overall Study|Treatment Failure|1
7651541|NCT00728416|12066643|FG000|Overall Study|Withdrawal by Subject|1
7651542|NCT00728416|12066644|FG001|Overall Study|Withdrawal by Subject|0
7651543|NCT00704535|12066671|FG000|Overall Study|Adverse Event|2
7651544|NCT00704535|12066671|FG000|Overall Study|Death|2
7651545|NCT00704535|12066671|FG000|Overall Study|Lost to Follow-up|8
7651546|NCT00704535|12066671|FG000|Overall Study|Protocol Violation|10
7651547|NCT00704535|12066671|FG000|Overall Study|Completed status not on Case Report Form|124
7651548|NCT00694369|12066680|FG000|Overall Study|Adverse Event|0
7651549|NCT00694369|12066681|FG001|Overall Study|Adverse Event|1
7651550|NCT00694369|12066682|FG002|Overall Study|Adverse Event|0
7651551|NCT00694369|12066683|FG003|Overall Study|Adverse Event|1
7651552|NCT00694369|12066684|FG004|Overall Study|Adverse Event|3
7651553|NCT00694369|12066680|FG000|Overall Study|Lost to Follow-up|0
7651554|NCT00694369|12066681|FG001|Overall Study|Lost to Follow-up|0
7651555|NCT00694369|12066682|FG002|Overall Study|Lost to Follow-up|1
7651556|NCT00694369|12066683|FG003|Overall Study|Lost to Follow-up|1
7651557|NCT00694369|12066684|FG004|Overall Study|Lost to Follow-up|0
7651558|NCT00694369|12066680|FG000|Overall Study|Physician Decision|0
7651559|NCT00694369|12066681|FG001|Overall Study|Physician Decision|0
7651560|NCT00694369|12066682|FG002|Overall Study|Physician Decision|0
7651561|NCT00694369|12066683|FG003|Overall Study|Physician Decision|0
7651562|NCT00694369|12066684|FG004|Overall Study|Physician Decision|1
7651563|NCT00694369|12066680|FG000|Overall Study|Protocol Violation|0
7651564|NCT00694369|12066681|FG001|Overall Study|Protocol Violation|1
7651565|NCT00694369|12066682|FG002|Overall Study|Protocol Violation|0
7651566|NCT00694369|12066683|FG003|Overall Study|Protocol Violation|0
7651567|NCT00694369|12066684|FG004|Overall Study|Protocol Violation|0
7651568|NCT00694369|12066680|FG000|Overall Study|Withdrawal by Subject|1
7651569|NCT00694369|12066681|FG001|Overall Study|Withdrawal by Subject|1
7651570|NCT00694369|12066682|FG002|Overall Study|Withdrawal by Subject|1
7651571|NCT00694369|12066683|FG003|Overall Study|Withdrawal by Subject|1
7651572|NCT00694369|12066684|FG004|Overall Study|Withdrawal by Subject|2
7651573|NCT00667823|12066709|FG000|Overall Study|Lost to Follow-up|5
7651574|NCT00667823|12066709|FG000|Overall Study|Adverse Event|7
7651575|NCT00667823|12066709|FG000|Overall Study|Death|182
7651576|NCT00667823|12066709|FG000|Overall Study|Withdrawal by Subject|12
7651577|NCT00667823|12066709|FG000|Overall Study|Other|8
7651578|NCT00667823|12066709|FG000|Overall Study|Missing (completion page missing)|2
7651579|NCT00652327|12066715|FG000|Overall Study|Adverse Event|0
7651580|NCT00652327|12066716|FG001|Overall Study|Adverse Event|2
7651581|NCT00652327|12066715|FG000|Overall Study|Lost to Follow-up|0
7651582|NCT00652327|12066716|FG001|Overall Study|Lost to Follow-up|3
7651583|NCT00604500|12066722|FG000|Overall Study|Adverse Event|2
7651584|NCT00604500|12066722|FG000|Overall Study|Protocol Violation|2
7651585|NCT00604500|12066722|FG000|Overall Study|Treatment Failure|1
7651586|NCT00604500|12066722|FG000|Overall Study|Withdrawal by Subject|4
7651587|NCT00604500|12066722|FG000|Overall Study|Administrative|1
7651588|NCT00604500|12066722|FG000|Overall Study|Did not meet protocol eligibility|1
7651589|NCT00568178|12066728|FG000|Double Blind Base Study|Adverse Event|0
7651590|NCT00568178|12066729|FG001|Double Blind Base Study|Adverse Event|2
7651591|NCT00568178|12066730|FG002|Double Blind Base Study|Adverse Event|1
7651592|NCT00568178|12066731|FG003|Double Blind Base Study|Adverse Event|2
7651593|NCT00568178|12066732|FG004|Double Blind Base Study|Adverse Event|0
7651594|NCT00568178|12066733|FG005|Double Blind Base Study|Adverse Event|0
7651595|NCT00568178|12066728|FG000|Double Blind Base Study|Lost to Follow-up|1
7651596|NCT00568178|12066729|FG001|Double Blind Base Study|Lost to Follow-up|0
7651597|NCT00568178|12066730|FG002|Double Blind Base Study|Lost to Follow-up|0
7651598|NCT00568178|12066731|FG003|Double Blind Base Study|Lost to Follow-up|1
7651599|NCT00568178|12066732|FG004|Double Blind Base Study|Lost to Follow-up|0
7651600|NCT00568178|12066733|FG005|Double Blind Base Study|Lost to Follow-up|0
7651601|NCT00568178|12066728|FG000|Double Blind Base Study|Physician Decision|1
7651602|NCT00568178|12066729|FG001|Double Blind Base Study|Physician Decision|1
7651603|NCT00568178|12066730|FG002|Double Blind Base Study|Physician Decision|0
7651604|NCT00568178|12066731|FG003|Double Blind Base Study|Physician Decision|1
7651605|NCT00568178|12066732|FG004|Double Blind Base Study|Physician Decision|0
7651606|NCT00568178|12066733|FG005|Double Blind Base Study|Physician Decision|0
7651607|NCT00568178|12066728|FG000|Double Blind Base Study|Protocol Violation|3
7651608|NCT00568178|12066729|FG001|Double Blind Base Study|Protocol Violation|2
7651609|NCT00568178|12066730|FG002|Double Blind Base Study|Protocol Violation|0
7651610|NCT00568178|12066731|FG003|Double Blind Base Study|Protocol Violation|0
7651611|NCT00568178|12066732|FG004|Double Blind Base Study|Protocol Violation|0
7651612|NCT00568178|12066733|FG005|Double Blind Base Study|Protocol Violation|0
7651613|NCT00568178|12066728|FG000|Double Blind Base Study|Withdrawal by Subject|1
7651614|NCT00568178|12066729|FG001|Double Blind Base Study|Withdrawal by Subject|1
7651615|NCT00568178|12066730|FG002|Double Blind Base Study|Withdrawal by Subject|0
7651616|NCT00568178|12066731|FG003|Double Blind Base Study|Withdrawal by Subject|0
7651617|NCT00568178|12066732|FG004|Double Blind Base Study|Withdrawal by Subject|0
7651618|NCT00568178|12066733|FG005|Double Blind Base Study|Withdrawal by Subject|0
7651619|NCT00568178|12066728|FG000|Double Blind Base Study|Progressive Disease|0
7651620|NCT00568178|12066729|FG001|Double Blind Base Study|Progressive Disease|0
7651621|NCT00568178|12066730|FG002|Double Blind Base Study|Progressive Disease|0
7651622|NCT00568178|12066731|FG003|Double Blind Base Study|Progressive Disease|1
7651623|NCT00568178|12066732|FG004|Double Blind Base Study|Progressive Disease|0
7651624|NCT00568178|12066733|FG005|Double Blind Base Study|Progressive Disease|0
7651625|NCT00568178|12066728|FG000|Open Label Extension|Adverse Event|0
7651626|NCT00568178|12066729|FG001|Open Label Extension|Adverse Event|0
7651627|NCT00568178|12066730|FG002|Open Label Extension|Adverse Event|0
7651628|NCT00568178|12066731|FG003|Open Label Extension|Adverse Event|0
7651629|NCT00568178|12066732|FG004|Open Label Extension|Adverse Event|11
7651630|NCT00568178|12066733|FG005|Open Label Extension|Adverse Event|8
7651631|NCT00568178|12066728|FG000|Open Label Extension|Protocol Violation|0
7651632|NCT00568178|12066729|FG001|Open Label Extension|Protocol Violation|0
7651633|NCT00568178|12066730|FG002|Open Label Extension|Protocol Violation|0
7651634|NCT00568178|12066731|FG003|Open Label Extension|Protocol Violation|0
7651635|NCT00568178|12066732|FG004|Open Label Extension|Protocol Violation|1
7651636|NCT00568178|12066733|FG005|Open Label Extension|Protocol Violation|0
7651637|NCT00568178|12066728|FG000|Open Label Extension|Lost to Follow-up|0
7651638|NCT00568178|12066729|FG001|Open Label Extension|Lost to Follow-up|0
7651639|NCT00568178|12066730|FG002|Open Label Extension|Lost to Follow-up|0
7651640|NCT00568178|12066731|FG003|Open Label Extension|Lost to Follow-up|0
7651641|NCT00568178|12066732|FG004|Open Label Extension|Lost to Follow-up|6
7651642|NCT00568178|12066733|FG005|Open Label Extension|Lost to Follow-up|11
7651643|NCT00568178|12066728|FG000|Open Label Extension|Physician Decision|0
7651644|NCT00568178|12066729|FG001|Open Label Extension|Physician Decision|0
7651645|NCT00568178|12066730|FG002|Open Label Extension|Physician Decision|0
7651646|NCT00568178|12066731|FG003|Open Label Extension|Physician Decision|0
7651647|NCT00568178|12066732|FG004|Open Label Extension|Physician Decision|9
7651648|NCT00568178|12066733|FG005|Open Label Extension|Physician Decision|8
7651649|NCT00568178|12066728|FG000|Open Label Extension|Pregnancy|0
7651650|NCT00568178|12066729|FG001|Open Label Extension|Pregnancy|0
7651651|NCT00568178|12066730|FG002|Open Label Extension|Pregnancy|0
7651652|NCT00568178|12066731|FG003|Open Label Extension|Pregnancy|0
7651653|NCT00568178|12066732|FG004|Open Label Extension|Pregnancy|0
7651654|NCT00568178|12066733|FG005|Open Label Extension|Pregnancy|1
7651655|NCT00568178|12066728|FG000|Open Label Extension|Progressive Disease|0
7651656|NCT00568178|12066729|FG001|Open Label Extension|Progressive Disease|0
7651657|NCT00568178|12066730|FG002|Open Label Extension|Progressive Disease|0
7651658|NCT00568178|12066731|FG003|Open Label Extension|Progressive Disease|0
7651659|NCT00568178|12066732|FG004|Open Label Extension|Progressive Disease|3
7651660|NCT00568178|12066733|FG005|Open Label Extension|Progressive Disease|1
7651661|NCT00568178|12066728|FG000|Open Label Extension|Termination of Trial|0
7651662|NCT00568178|12066729|FG001|Open Label Extension|Termination of Trial|0
7651663|NCT00568178|12066730|FG002|Open Label Extension|Termination of Trial|0
7651664|NCT00568178|12066731|FG003|Open Label Extension|Termination of Trial|0
7651665|NCT00568178|12066732|FG004|Open Label Extension|Termination of Trial|45
7651666|NCT00568178|12066733|FG005|Open Label Extension|Termination of Trial|47
7651667|NCT00568178|12066728|FG000|Open Label Extension|Withdrawal by Subject|0
7651668|NCT00568178|12066729|FG001|Open Label Extension|Withdrawal by Subject|0
7651669|NCT00568178|12066730|FG002|Open Label Extension|Withdrawal by Subject|0
7651670|NCT00568178|12066731|FG003|Open Label Extension|Withdrawal by Subject|0
7651671|NCT00568178|12066732|FG004|Open Label Extension|Withdrawal by Subject|4
7651672|NCT00568178|12066733|FG005|Open Label Extension|Withdrawal by Subject|4
7651673|NCT00545844|12066747|FG000|Overall Study|Lost to Follow-up|9
7651674|NCT00545844|12066747|FG000|Overall Study|Protocol Violation|1
7651675|NCT00545844|12066747|FG000|Overall Study|Withdrawal by Subject|2
7651676|NCT00511433|12066755|FG000|Overall Study|Adverse Event|5
7651677|NCT00511433|12066756|FG001|Overall Study|Adverse Event|0
7651678|NCT00511433|12066755|FG000|Overall Study|Other Reason|1
7651679|NCT00511433|12066756|FG001|Overall Study|Other Reason|1
7651680|NCT00511355|12066766|FG000|Overall Study|Adverse Event|4
7651681|NCT00511355|12066767|FG001|Overall Study|Adverse Event|4
7651682|NCT00511355|12066766|FG000|Overall Study|Pregnancy Wish|1
7651683|NCT00511355|12066767|FG001|Overall Study|Pregnancy Wish|0
7651684|NCT00511355|12066766|FG000|Overall Study|Lost to Follow-up|2
7651685|NCT00511355|12066767|FG001|Overall Study|Lost to Follow-up|1
7651686|NCT00511355|12066766|FG000|Overall Study|Other Reason|0
7651687|NCT00511355|12066767|FG001|Overall Study|Other Reason|1
7651688|NCT00511355|12066766|FG000|Overall Study|Pre-treatment (serious) adverse event|0
7651689|NCT00511355|12066767|FG001|Overall Study|Pre-treatment (serious) adverse event|1
7651690|NCT00511355|12066766|FG000|Overall Study|Withdrawal of informed consent|0
7651691|NCT00511355|12066767|FG001|Overall Study|Withdrawal of informed consent|1
7651692|NCT00511355|12066766|FG000|Overall Study|Other reason pre-treatment|0
7651693|NCT00511355|12066767|FG001|Overall Study|Other reason pre-treatment|1
7651694|NCT00511342|12066777|FG000|Overall Study|Unacceptable vaginal bleeding|2
7651695|NCT00511342|12066778|FG001|Overall Study|Unacceptable vaginal bleeding|1
7651696|NCT00511342|12066777|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8
7651697|NCT00511342|12066778|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12
7651698|NCT00511342|12066777|FG000|Overall Study|Pregnancy|0
7651699|NCT00511342|12066778|FG001|Overall Study|Pregnancy|1
7651700|NCT00511342|12066777|FG000|Overall Study|Pregnancy wish|0
7651701|NCT00511342|12066778|FG001|Overall Study|Pregnancy wish|1
7651702|NCT00511342|12066777|FG000|Overall Study|Lost to Follow-up|1
7651703|NCT00511342|12066778|FG001|Overall Study|Lost to Follow-up|5
7651704|NCT00511342|12066777|FG000|Overall Study|Other Reason|2
7651705|NCT00511342|12066778|FG001|Overall Study|Other Reason|2
7651706|NCT00511199|12066786|FG000|Overall Study|Unacceptable Vaginal Bleeding|63
7651707|NCT00511199|12066787|FG001|Overall Study|Unacceptable Vaginal Bleeding|4
7651708|NCT00511199|12066786|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227
7651709|NCT00511199|12066787|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52
7651710|NCT00511199|12066786|FG000|Overall Study|Withdrawal of Informed Consent|19
7651711|NCT00511199|12066787|FG001|Overall Study|Withdrawal of Informed Consent|4
7651712|NCT00511199|12066786|FG000|Overall Study|Pregnancy|6
7651713|NCT00511199|12066787|FG001|Overall Study|Pregnancy|3
7651714|NCT00511199|12066786|FG000|Overall Study|Pregnancy Wish|16
7651715|NCT00511199|12066787|FG001|Overall Study|Pregnancy Wish|8
7651716|NCT00511199|12066786|FG000|Overall Study|Lost to Follow-up|40
7651717|NCT00511199|12066787|FG001|Overall Study|Lost to Follow-up|17
7651718|NCT00511199|12066786|FG000|Overall Study|Other Reason|78
7651719|NCT00511199|12066787|FG001|Overall Study|Other Reason|37
7651720|NCT00491504|12066799|FG000|Overall Study|Adverse Event|0
7651721|NCT00491504|12066800|FG001|Overall Study|Adverse Event|1
7651722|NCT00491504|12066801|FG002|Overall Study|Adverse Event|0
7651723|NCT00491504|12066802|FG003|Overall Study|Adverse Event|0
7651724|NCT00491504|12066799|FG000|Overall Study|Withdrawal by Subject|0
7651725|NCT00491504|12066800|FG001|Overall Study|Withdrawal by Subject|0
7651726|NCT00491504|12066801|FG002|Overall Study|Withdrawal by Subject|1
7651727|NCT00491504|12066802|FG003|Overall Study|Withdrawal by Subject|2
7651728|NCT00491504|12066799|FG000|Overall Study|Protocol Violation|0
7651729|NCT00491504|12066800|FG001|Overall Study|Protocol Violation|0
7651730|NCT00491504|12066801|FG002|Overall Study|Protocol Violation|3
7651731|NCT00491504|12066802|FG003|Overall Study|Protocol Violation|2
7651732|NCT00468312|12066812|FG000|Overall Study|Adverse Event|2
7651733|NCT00468312|12066813|FG001|Overall Study|Adverse Event|1
7651734|NCT00468312|12066812|FG000|Overall Study|Lack of Efficacy|0
7651735|NCT00468312|12066813|FG001|Overall Study|Lack of Efficacy|1
7651736|NCT00468312|12066812|FG000|Overall Study|Withdrawal by Subject|0
7651737|NCT00468312|12066813|FG001|Overall Study|Withdrawal by Subject|1
7651738|NCT00468312|12066812|FG000|Overall Study|Protocol Violation|2
7651739|NCT00468312|12066813|FG001|Overall Study|Protocol Violation|1
7651740|NCT00468312|12066812|FG000|Overall Study|Did not meet protocol eligibility|0
7651741|NCT00468312|12066813|FG001|Overall Study|Did not meet protocol eligibility|1
7651742|NCT00453063|12066821|FG000|Overall Study|Adverse Event|1
7651743|NCT00453063|12066822|FG001|Overall Study|Adverse Event|2
7651744|NCT00453063|12066821|FG000|Overall Study|Withdrawal by Subject|1
7651745|NCT00453063|12066822|FG001|Overall Study|Withdrawal by Subject|1
7651746|NCT00453063|12066821|FG000|Overall Study|Protocol Violation|1
7651747|NCT00453063|12066822|FG001|Overall Study|Protocol Violation|0
7651748|NCT00447603|12066828|FG000|Screening|Withdrawal by Subject|1
7651749|NCT00447603|12066829|FG001|Screening|Withdrawal by Subject|0
7651750|NCT00447603|12066830|FG002|Screening|Withdrawal by Subject|0
7651751|NCT00447603|12066828|FG000|Screening|Protocol Violation|1
7651752|NCT00447603|12066829|FG001|Screening|Protocol Violation|0
7651753|NCT00447603|12066830|FG002|Screening|Protocol Violation|0
7651754|NCT00447603|12066828|FG000|Screening|Screen Failure|4
7651755|NCT00447603|12066829|FG001|Screening|Screen Failure|0
7651756|NCT00447603|12066830|FG002|Screening|Screen Failure|0
7651757|NCT00447603|12066828|FG000|Screening|Study Terminated by Sponsor|15
7651758|NCT00447603|12066829|FG001|Screening|Study Terminated by Sponsor|0
7651759|NCT00447603|12066830|FG002|Screening|Study Terminated by Sponsor|0
7651760|NCT00447603|12066828|FG000|Filter Period|Adverse Event|0
7651761|NCT00447603|12066829|FG001|Filter Period|Adverse Event|0
7651762|NCT00447603|12066830|FG002|Filter Period|Adverse Event|1
7651763|NCT00447603|12066828|FG000|Filter Period|Screen Failure|0
7651764|NCT00447603|12066829|FG001|Filter Period|Screen Failure|3
7651765|NCT00447603|12066830|FG002|Filter Period|Screen Failure|4
7651766|NCT00447603|12066828|FG000|Filter Period|Study terminated by Sponsor|0
7651767|NCT00447603|12066829|FG001|Filter Period|Study terminated by Sponsor|1
7651768|NCT00447603|12066830|FG002|Filter Period|Study terminated by Sponsor|10
7651769|NCT00442351|12066840|FG000|Overall Study|Administrative|6
7651770|NCT00442351|12066841|FG001|Overall Study|Administrative|5
7651771|NCT00442351|12066840|FG000|Overall Study|Did not meet protocol eligibility|1
7651772|NCT00442351|12066841|FG001|Overall Study|Did not meet protocol eligibility|0
7651773|NCT00442351|12066840|FG000|Overall Study|Other|0
7651774|NCT00442351|12066841|FG001|Overall Study|Other|1
7651775|NCT00423488|12066849|FG000|Overall Study|No evidence of study drug intake|2
7651776|NCT00423488|12066850|FG001|Overall Study|No evidence of study drug intake|1
7651777|NCT00423488|12066849|FG000|Overall Study|No post baseline data|3
7651778|NCT00423488|12066850|FG001|Overall Study|No post baseline data|0
7651779|NCT00413972|12066860|FG000|Overall Study|Adverse Event|2
7651780|NCT00413972|12066861|FG001|Overall Study|Adverse Event|1
7651781|NCT00413972|12066862|FG002|Overall Study|Adverse Event|0
7651782|NCT00413972|12066863|FG003|Overall Study|Adverse Event|0
7651783|NCT00413972|12066860|FG000|Overall Study|Lost to Follow-up|1
7651784|NCT00413972|12066861|FG001|Overall Study|Lost to Follow-up|2
7651785|NCT00413972|12066862|FG002|Overall Study|Lost to Follow-up|1
7651786|NCT00413972|12066863|FG003|Overall Study|Lost to Follow-up|0
7651787|NCT00413972|12066860|FG000|Overall Study|Withdrawal by Subject|4
7651788|NCT00413972|12066861|FG001|Overall Study|Withdrawal by Subject|5
7651789|NCT00413972|12066862|FG002|Overall Study|Withdrawal by Subject|7
7651790|NCT00413972|12066863|FG003|Overall Study|Withdrawal by Subject|2
7651791|NCT00413972|12066860|FG000|Overall Study|Protocol Violation|0
7651792|NCT00413972|12066861|FG001|Overall Study|Protocol Violation|0
7651793|NCT00413972|12066862|FG002|Overall Study|Protocol Violation|2
7651794|NCT00413972|12066863|FG003|Overall Study|Protocol Violation|0
7651795|NCT00413972|12066860|FG000|Overall Study|Other|0
7651796|NCT00413972|12066861|FG001|Overall Study|Other|0
7651797|NCT00413972|12066862|FG002|Overall Study|Other|0
7651798|NCT00413972|12066863|FG003|Overall Study|Other|1
7651799|NCT00413062|12066875|FG000|Overall Study|Adverse event/serious adverse event|289
7651800|NCT00413062|12066876|FG001|Overall Study|Adverse event/serious adverse event|56
7651801|NCT00413062|12066875|FG000|Overall Study|Pre-treatment (serious) adverse event|1
7651802|NCT00413062|12066876|FG001|Overall Study|Pre-treatment (serious) adverse event|0
7651803|NCT00413062|12066875|FG000|Overall Study|Withdrawal of informed consent|111
7651804|NCT00413062|12066876|FG001|Overall Study|Withdrawal of informed consent|36
7651805|NCT00413062|12066875|FG000|Overall Study|Pregnancy|15
7651806|NCT00413062|12066876|FG001|Overall Study|Pregnancy|5
7651807|NCT00413062|12066875|FG000|Overall Study|Pregnancy wish|17
7651808|NCT00413062|12066876|FG001|Overall Study|Pregnancy wish|6
7651809|NCT00413062|12066875|FG000|Overall Study|Lost to Follow-up|175
7651810|NCT00413062|12066876|FG001|Overall Study|Lost to Follow-up|73
7651811|NCT00413062|12066875|FG000|Overall Study|Other reason|70
7651812|NCT00413062|12066876|FG001|Overall Study|Other reason|34
7651813|NCT00391170|12066886|FG000|Overall Study|Withdrawal by Subject|1
7651814|NCT00391170|12066887|FG001|Overall Study|Withdrawal by Subject|0
7651815|NCT00391170|12066886|FG000|Overall Study|Adverse Event|3
7651816|NCT00391170|12066887|FG001|Overall Study|Adverse Event|2
7651817|NCT00391170|12066886|FG000|Overall Study|Physician Decision|2
7651818|NCT00391170|12066887|FG001|Overall Study|Physician Decision|2
7651819|NCT00319449|12066921|FG000|Overall Study|Subject did not wish to continue|1
7651820|NCT00319449|12066922|FG001|Overall Study|Subject did not wish to continue|0
7651821|NCT00319449|12066921|FG000|Overall Study|Noncompliance with the protocol|1
7651822|NCT00319449|12066922|FG001|Overall Study|Noncompliance with the protocol|0
7651823|NCT00289887|12066934|FG000|Overall Study|Adverse Event|3
7651824|NCT00289887|12066935|FG001|Overall Study|Adverse Event|3
7651825|NCT00289887|12066934|FG000|Overall Study|Lack of Efficacy|3
7651826|NCT00289887|12066935|FG001|Overall Study|Lack of Efficacy|11
7651827|NCT00289887|12066934|FG000|Overall Study|Lost to Follow-up|3
7651828|NCT00289887|12066935|FG001|Overall Study|Lost to Follow-up|3
7651829|NCT00289887|12066934|FG000|Overall Study|Protocol Violation|3
7651830|NCT00289887|12066935|FG001|Overall Study|Protocol Violation|1
7651831|NCT00289887|12066934|FG000|Overall Study|Withdrawal by Subject|3
7651832|NCT00289887|12066935|FG001|Overall Study|Withdrawal by Subject|8
7651833|NCT00289887|12066934|FG000|Overall Study|Other|7
7651834|NCT00289887|12066935|FG001|Overall Study|Other|3
7651835|NCT00281320|12066943|FG000|Overall Study|Adverse Event|12
7651836|NCT00281320|12066944|FG001|Overall Study|Adverse Event|9
7651837|NCT00281320|12066943|FG000|Overall Study|Lack of Efficacy|4
7651838|NCT00281320|12066944|FG001|Overall Study|Lack of Efficacy|3
7651839|NCT00281320|12066943|FG000|Overall Study|Withdrawal by Subject|5
7651840|NCT00281320|12066944|FG001|Overall Study|Withdrawal by Subject|6
7651841|NCT00281320|12066943|FG000|Overall Study|Lost to Follow-up|1
7651842|NCT00281320|12066944|FG001|Overall Study|Lost to Follow-up|2
7651843|NCT00281320|12066943|FG000|Overall Study|Other|3
7651844|NCT00281320|12066944|FG001|Overall Study|Other|1
7651845|NCT00276016|12066962|FG000|Intervention 1|Withdrawal by Subject|0
7651846|NCT00276016|12066963|FG001|Intervention 1|Withdrawal by Subject|1
7651847|NCT00276016|12066964|FG002|Intervention 1|Withdrawal by Subject|0
7651848|NCT00276016|12066965|FG003|Intervention 1|Withdrawal by Subject|0
7651849|NCT00276016|12066966|FG004|Intervention 1|Withdrawal by Subject|0
7651850|NCT00276016|12066967|FG005|Intervention 1|Withdrawal by Subject|0
7651851|NCT00265343|12066978|FG000|Overall Study|Adverse Event|10
7651852|NCT00265343|12066979|FG001|Overall Study|Adverse Event|7
7651853|NCT00265343|12066978|FG000|Overall Study|Withdrawal by Subject|3
7651854|NCT00265343|12066979|FG001|Overall Study|Withdrawal by Subject|9
7651855|NCT00265343|12066978|FG000|Overall Study|Other|8
7651856|NCT00265343|12066979|FG001|Overall Study|Other|3
7651857|NCT00264147|12066990|FG000|Treatment I Period|Adverse Event|3
7651858|NCT00264147|12066991|FG001|Treatment I Period|Adverse Event|6
7651859|NCT00264147|12066992|FG002|Treatment I Period|Adverse Event|3
7651860|NCT00264147|12066993|FG003|Treatment I Period|Adverse Event|5
7651861|NCT00264147|12066994|FG004|Treatment I Period|Adverse Event|7
7651862|NCT00264147|12066995|FG005|Treatment I Period|Adverse Event|0
7651863|NCT00264147|12066990|FG000|Treatment I Period|Laboratory Adverse Event|0
7651864|NCT00264147|12066991|FG001|Treatment I Period|Laboratory Adverse Event|0
7651865|NCT00264147|12066992|FG002|Treatment I Period|Laboratory Adverse Event|0
7651866|NCT00264147|12066993|FG003|Treatment I Period|Laboratory Adverse Event|1
7651867|NCT00264147|12066994|FG004|Treatment I Period|Laboratory Adverse Event|0
7651868|NCT00264147|12066995|FG005|Treatment I Period|Laboratory Adverse Event|0
7651869|NCT00264147|12066990|FG000|Treatment I Period|Lack of Efficacy|6
7651870|NCT00264147|12066991|FG001|Treatment I Period|Lack of Efficacy|2
7651871|NCT00264147|12066992|FG002|Treatment I Period|Lack of Efficacy|8
7651872|NCT00264147|12066993|FG003|Treatment I Period|Lack of Efficacy|0
7651873|NCT00264147|12066994|FG004|Treatment I Period|Lack of Efficacy|1
7651874|NCT00264147|12066995|FG005|Treatment I Period|Lack of Efficacy|0
7651875|NCT00264147|12066990|FG000|Treatment I Period|Lost to Follow-up|1
7651876|NCT00264147|12066991|FG001|Treatment I Period|Lost to Follow-up|0
7651877|NCT00264147|12066992|FG002|Treatment I Period|Lost to Follow-up|0
7651878|NCT00264147|12066993|FG003|Treatment I Period|Lost to Follow-up|1
7651879|NCT00264147|12066994|FG004|Treatment I Period|Lost to Follow-up|1
7651880|NCT00264147|12066995|FG005|Treatment I Period|Lost to Follow-up|0
7651881|NCT00264147|12066990|FG000|Treatment I Period|Protocol Violation|2
7651882|NCT00264147|12066991|FG001|Treatment I Period|Protocol Violation|2
7651883|NCT00264147|12066992|FG002|Treatment I Period|Protocol Violation|0
7651884|NCT00264147|12066993|FG003|Treatment I Period|Protocol Violation|0
7651885|NCT00264147|12066994|FG004|Treatment I Period|Protocol Violation|0
7651886|NCT00264147|12066995|FG005|Treatment I Period|Protocol Violation|0
7651887|NCT00264147|12066990|FG000|Treatment I Period|Withdrawal by Subject|2
7651888|NCT00264147|12066991|FG001|Treatment I Period|Withdrawal by Subject|0
7651889|NCT00264147|12066992|FG002|Treatment I Period|Withdrawal by Subject|0
7651890|NCT00264147|12066993|FG003|Treatment I Period|Withdrawal by Subject|2
7651891|NCT00264147|12066994|FG004|Treatment I Period|Withdrawal by Subject|2
7651892|NCT00264147|12066995|FG005|Treatment I Period|Withdrawal by Subject|0
7651893|NCT00264147|12066990|FG000|Treatment I Period|Patient out of town for an extended time|0
7651894|NCT00264147|12066991|FG001|Treatment I Period|Patient out of town for an extended time|1
7651895|NCT00264147|12066992|FG002|Treatment I Period|Patient out of town for an extended time|0
7651896|NCT00264147|12066993|FG003|Treatment I Period|Patient out of town for an extended time|0
7651897|NCT00264147|12066994|FG004|Treatment I Period|Patient out of town for an extended time|0
7651898|NCT00264147|12066995|FG005|Treatment I Period|Patient out of town for an extended time|0
7651899|NCT00264147|12066990|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0
7651900|NCT00264147|12066991|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0
7651901|NCT00264147|12066992|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1
7651902|NCT00264147|12066993|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0
7651903|NCT00264147|12066994|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0
7651904|NCT00264147|12066995|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0
7651905|NCT00264147|12066990|FG000|Treatment I Period|Reassigned to Treatment II Period|84
7651906|NCT00264147|12066991|FG001|Treatment I Period|Reassigned to Treatment II Period|72
7651907|NCT00264147|12066992|FG002|Treatment I Period|Reassigned to Treatment II Period|65
7651908|NCT00264147|12066993|FG003|Treatment I Period|Reassigned to Treatment II Period|63
7651909|NCT00264147|12066994|FG004|Treatment I Period|Reassigned to Treatment II Period|45
7651910|NCT00264147|12066995|FG005|Treatment I Period|Reassigned to Treatment II Period|0
7651911|NCT00264147|12066990|FG000|Treatment II Period|Adverse Event|0
7651912|NCT00264147|12066991|FG001|Treatment II Period|Adverse Event|0
7651913|NCT00264147|12066992|FG002|Treatment II Period|Adverse Event|0
7651914|NCT00264147|12066993|FG003|Treatment II Period|Adverse Event|0
7651915|NCT00264147|12066994|FG004|Treatment II Period|Adverse Event|9
7651916|NCT00264147|12066995|FG005|Treatment II Period|Adverse Event|9
7651917|NCT00264147|12066990|FG000|Treatment II Period|Laboratory Adverse Event|0
7651918|NCT00264147|12066991|FG001|Treatment II Period|Laboratory Adverse Event|0
7651919|NCT00264147|12066992|FG002|Treatment II Period|Laboratory Adverse Event|0
7651920|NCT00264147|12066993|FG003|Treatment II Period|Laboratory Adverse Event|0
7651921|NCT00264147|12066994|FG004|Treatment II Period|Laboratory Adverse Event|0
7651922|NCT00264147|12066995|FG005|Treatment II Period|Laboratory Adverse Event|1
7651923|NCT00264147|12066990|FG000|Treatment II Period|Lack of Efficacy|0
7651924|NCT00264147|12066991|FG001|Treatment II Period|Lack of Efficacy|0
7651925|NCT00264147|12066992|FG002|Treatment II Period|Lack of Efficacy|0
7651926|NCT00264147|12066993|FG003|Treatment II Period|Lack of Efficacy|0
7651927|NCT00264147|12066994|FG004|Treatment II Period|Lack of Efficacy|20
7651928|NCT00264147|12066995|FG005|Treatment II Period|Lack of Efficacy|19
7651929|NCT00264147|12066990|FG000|Treatment II Period|Lost to Follow-up|0
7651930|NCT00264147|12066991|FG001|Treatment II Period|Lost to Follow-up|0
7651931|NCT00264147|12066992|FG002|Treatment II Period|Lost to Follow-up|0
7651932|NCT00264147|12066993|FG003|Treatment II Period|Lost to Follow-up|0
7651933|NCT00264147|12066994|FG004|Treatment II Period|Lost to Follow-up|1
7651934|NCT00264147|12066995|FG005|Treatment II Period|Lost to Follow-up|1
7651935|NCT00264147|12066990|FG000|Treatment II Period|Withdrawal by Subject|0
7651936|NCT00264147|12066991|FG001|Treatment II Period|Withdrawal by Subject|0
7651937|NCT00264147|12066992|FG002|Treatment II Period|Withdrawal by Subject|0
7651938|NCT00264147|12066993|FG003|Treatment II Period|Withdrawal by Subject|0
7651939|NCT00264147|12066994|FG004|Treatment II Period|Withdrawal by Subject|3
7651940|NCT00264147|12066995|FG005|Treatment II Period|Withdrawal by Subject|2
7651941|NCT00264147|12066990|FG000|Treatment II Period|Pre-scheduled total hip replacement|0
7651942|NCT00264147|12066991|FG001|Treatment II Period|Pre-scheduled total hip replacement|0
7651943|NCT00264147|12066992|FG002|Treatment II Period|Pre-scheduled total hip replacement|0
7651944|NCT00264147|12066993|FG003|Treatment II Period|Pre-scheduled total hip replacement|0
7651945|NCT00264147|12066994|FG004|Treatment II Period|Pre-scheduled total hip replacement|0
7651946|NCT00264147|12066995|FG005|Treatment II Period|Pre-scheduled total hip replacement|1
7651947|NCT00202878|12067011|FG000|Overall Study|Death|964
7651948|NCT00202878|12067012|FG001|Overall Study|Death|968
7651949|NCT00202878|12067011|FG000|Overall Study|Only Vital Status Known|357
7651950|NCT00202878|12067012|FG001|Overall Study|Only Vital Status Known|356
7651951|NCT00202878|12067011|FG000|Overall Study|Lost to Follow-up|44
7651952|NCT00202878|12067012|FG001|Overall Study|Lost to Follow-up|49
7651953|NCT00202878|12067011|FG000|Overall Study|Site Closure|39
7651954|NCT00202878|12067012|FG001|Overall Study|Site Closure|36
7651955|NCT00202878|12067011|FG000|Overall Study|Withdrawal by Subject|795
7651956|NCT00202878|12067012|FG001|Overall Study|Withdrawal by Subject|808
7651957|NCT00174265|12067020|FG000|Overall Study|Adverse Event|7
7651958|NCT00174265|12067021|FG001|Overall Study|Adverse Event|4
7651959|NCT00174265|12067020|FG000|Overall Study|Lack of Efficacy|2
7651960|NCT00174265|12067021|FG001|Overall Study|Lack of Efficacy|2
7651961|NCT00174265|12067020|FG000|Overall Study|Withdrawal by Subject|3
7651962|NCT00174265|12067021|FG001|Overall Study|Withdrawal by Subject|5
7651963|NCT00174265|12067020|FG000|Overall Study|Lost to Follow-up|1
7651964|NCT00174265|12067021|FG001|Overall Study|Lost to Follow-up|0
7651965|NCT00174265|12067020|FG000|Overall Study|Other (Not specified)|16
7651966|NCT00174265|12067021|FG001|Overall Study|Other (Not specified)|10
7651967|NCT00159783|12067030|FG000|Overall Study|Adverse Event|5
7651968|NCT00159783|12067031|FG001|Overall Study|Adverse Event|7
7651969|NCT00159783|12067032|FG002|Overall Study|Adverse Event|9
7651970|NCT00159783|12067030|FG000|Overall Study|Lack of Efficacy|1
7651971|NCT00159783|12067031|FG001|Overall Study|Lack of Efficacy|2
7651972|NCT00159783|12067032|FG002|Overall Study|Lack of Efficacy|3
7651973|NCT00159783|12067030|FG000|Overall Study|Withdrawal by Subject|7
7651974|NCT00159783|12067031|FG001|Overall Study|Withdrawal by Subject|11
7651975|NCT00159783|12067032|FG002|Overall Study|Withdrawal by Subject|12
7651976|NCT00159783|12067030|FG000|Overall Study|Lost to Follow-up|6
7651977|NCT00159783|12067031|FG001|Overall Study|Lost to Follow-up|5
7651978|NCT00159783|12067032|FG002|Overall Study|Lost to Follow-up|11
7651979|NCT00159783|12067030|FG000|Overall Study|Other|0
7651980|NCT00159783|12067031|FG001|Overall Study|Other|2
7651981|NCT00159783|12067032|FG002|Overall Study|Other|4
7651982|NCT00092677|12067043|FG000|Overall Study|Lost to Follow-up|0
7651983|NCT00092677|12067044|FG001|Overall Study|Lost to Follow-up|2
7651984|NCT00092677|12067043|FG000|Overall Study|Adminstrative|5
7651985|NCT00092677|12067044|FG001|Overall Study|Adminstrative|9
7651986|NCT00090259|12067052|FG000|Overall Study|Lost to Follow-up|30
7651987|NCT00090259|12067053|FG001|Overall Study|Lost to Follow-up|26
7651988|NCT00090259|12067052|FG000|Overall Study|Withdrawal by Subject|21
7651989|NCT00090259|12067053|FG001|Overall Study|Withdrawal by Subject|15
7651990|NCT00090259|12067052|FG000|Overall Study|Investigator site closed|11
7651991|NCT00090259|12067053|FG001|Overall Study|Investigator site closed|7
7651992|NCT00003298|12067059|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
7651993|NCT00003298|12067059|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
7651994|NCT00003298|12067059|FG000|Surgery|Unresectable at surgery|3
7651995|NCT00003298|12067059|FG000|Surgery|Progression before surgery|2
7651996|NCT00003298|12067059|FG000|Surgery|Unevaluable and off study|2
7651997|NCT00003298|12067059|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
7651998|NCT00003298|12067059|FG000|Re-register to Step 2 After Surgery|Positive margins|5
7651999|NCT00003298|12067059|FG000|Re-register to Step 2 After Surgery|Other complications|2
7652000|NCT00003298|12067059|FG000|Re-register to Step 2 After Surgery|Reason unknown|1
7652001|NCT00003298|12067059|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
7652002|NCT00003298|12067059|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1
7652003|NCT00003298|12067059|FG000|Step 2 (Adjuvant Therapy)|Death|1
7652004|NCT00003298|12067059|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
7652005|NCT00003298|12067059|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1
7652006|NCT00003298|12067059|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
7652007|NCT00003377|12067069|FG000|Period I|Dose Limiting Toxicity(DLT)|0
7652008|NCT00003377|12067070|FG001|Period I|Dose Limiting Toxicity(DLT)|0
7652009|NCT00003377|12067071|FG002|Period I|Dose Limiting Toxicity(DLT)|1
7652010|NCT00003377|12067072|FG003|Period I|Dose Limiting Toxicity(DLT)|1
7652011|NCT00003377|12067073|FG004|Period I|Dose Limiting Toxicity(DLT)|0
7652012|NCT00003377|12067069|FG000|Period II|Ureteral stent complications|0
7652013|NCT00003377|12067070|FG001|Period II|Ureteral stent complications|0
7652014|NCT00003377|12067071|FG002|Period II|Ureteral stent complications|0
7652015|NCT00003377|12067072|FG003|Period II|Ureteral stent complications|0
7652016|NCT00003377|12067073|FG004|Period II|Ureteral stent complications|1
7652017|NCT00003389|12067088|FG000|Overall Study|Disease progression|6
7652018|NCT00003389|12067089|FG001|Overall Study|Disease progression|1
7652019|NCT00003389|12067088|FG000|Overall Study|Adverse Event|13
7652020|NCT00003389|12067089|FG001|Overall Study|Adverse Event|2
7652021|NCT00003389|12067088|FG000|Overall Study|Death|0
7652022|NCT00003389|12067089|FG001|Overall Study|Death|3
7652023|NCT00003389|12067088|FG000|Overall Study|Withdrawal by Subject|12
7652024|NCT00003389|12067089|FG001|Overall Study|Withdrawal by Subject|5
7652025|NCT00003389|12067088|FG000|Overall Study|Alternative therapy|2
7652026|NCT00003389|12067089|FG001|Overall Study|Alternative therapy|1
7652027|NCT00003389|12067088|FG000|Overall Study|Complicating disease|1
7652028|NCT00003389|12067089|FG001|Overall Study|Complicating disease|0
7652029|NCT00003389|12067088|FG000|Overall Study|Off-treatment reason missing|31
7652030|NCT00003389|12067089|FG001|Overall Study|Off-treatment reason missing|21
7652031|NCT00003389|12067088|FG000|Overall Study|Ineligible|33
7652032|NCT00003389|12067089|FG001|Overall Study|Ineligible|27
7652033|NCT00003456|12067104|FG000|Overall Study|Not evaluable|8
7652034|NCT00003457|12067108|FG000|Overall Study|Not evaluable|9
7652035|NCT00003470|12067128|FG000|Overall Study|Not evaluable|6
7652036|NCT00003471|12067132|FG000|Overall Study|Not evaluable|4
7652037|NCT00003472|12067136|FG000|Overall Study|Not evaluable|3
7652038|NCT00003473|12067140|FG000|Overall Study|Three patients were not evaluable.|3
7652039|NCT00003474|12067144|FG000|Overall Study|Not Evaluable|14
7652040|NCT00003475|12067148|FG000|Overall Study|Not evaluable|13
7652041|NCT00003476|12067153|FG000|Overall Study|Not evaluable|1
7652042|NCT00003477|12067157|FG000|Overall Study|Not evalauable|4
7652043|NCT00003483|12067161|FG000|Overall Study|Not evaluable|1
7652044|NCT00003487|12067165|FG000|Overall Study|Not evaluable|2
7652045|NCT00003492|12067169|FG000|Overall Study|Not evaluable|6
7652046|NCT00003498|12067173|FG000|Overall Study|Not evaluable.|4
7652047|NCT00003499|12067177|FG000|Overall Study|Not evaluable|8
7652048|NCT00003508|12067181|FG000|Overall Study|Not evaluable|5
7652049|NCT00003509|12067185|FG000|Overall Study|Not evaluable|5
7652050|NCT00003511|12067189|FG000|Overall Study|Not evaluable|4
7652051|NCT00003526|12067193|FG000|Overall Study|Not evaluable|6
7652052|NCT00003531|12067197|FG000|Overall Study|Not evaluable|10
7652053|NCT00003535|12067201|FG000|Overall Study|Not evaluable|5
7652054|NCT00003537|12067205|FG000|Overall Study|Not evalauable|1
7652055|NCT00003590|12067209|FG000|Overall Study|Ineligible Patient|1
7652056|NCT00003590|12067209|FG000|Overall Study|Adverse Event|7
7652057|NCT00003590|12067209|FG000|Overall Study|Withdrawal by Subject|1
7652058|NCT00003590|12067209|FG000|Overall Study|Lack of Efficacy|11
7652059|NCT00003590|12067209|FG000|Overall Study|Death|1
7652060|NCT00003590|12067209|FG000|Overall Study|Physician Decision|1
7652061|NCT00003631|12067216|FG000|Overall Study|Patient not treated|1
7652062|NCT00003631|12067217|FG001|Overall Study|Patient not treated|0
7652063|NCT00003631|12067218|FG002|Overall Study|Patient not treated|1
7652064|NCT00003631|12067216|FG000|Overall Study|Protocol Violation|1
7652065|NCT00003631|12067217|FG001|Overall Study|Protocol Violation|0
7652066|NCT00003631|12067218|FG002|Overall Study|Protocol Violation|0
7652067|NCT00003631|12067216|FG000|Overall Study|Adverse Event|1
7652068|NCT00003631|12067217|FG001|Overall Study|Adverse Event|1
7652069|NCT00003631|12067218|FG002|Overall Study|Adverse Event|5
7652070|NCT00003631|12067216|FG000|Overall Study|Death|0
7652071|NCT00003631|12067217|FG001|Overall Study|Death|0
7652072|NCT00003631|12067218|FG002|Overall Study|Death|1
7652073|NCT00003631|12067216|FG000|Overall Study|Evaluable for toxicity only|0
7652074|NCT00003631|12067217|FG001|Overall Study|Evaluable for toxicity only|0
7652075|NCT00003631|12067218|FG002|Overall Study|Evaluable for toxicity only|2
7652076|NCT00003645|12067239|FG000|Overall Study|Death|4
7652077|NCT00003645|12067240|FG001|Overall Study|Death|1
7652078|NCT00003645|12067239|FG000|Overall Study|Lost to Follow-up|7
7652079|NCT00003645|12067240|FG001|Overall Study|Lost to Follow-up|8
7652080|NCT00003645|12067239|FG000|Overall Study|Withdrawal by Subject|1
7652081|NCT00003645|12067240|FG001|Overall Study|Withdrawal by Subject|3
7652082|NCT00003659|12067248|FG000|Overall Study|Withdrawal by Subject|3
7652083|NCT00003702|12067254|FG000|Overall Study|Ineligible cell types|2
7652084|NCT00003702|12067255|FG001|Overall Study|Ineligible cell types|2
7652085|NCT00003702|12067254|FG000|Overall Study|Did not meet criteria for persistence|8
7652086|NCT00003702|12067255|FG001|Overall Study|Did not meet criteria for persistence|5
7652087|NCT00003702|12067254|FG000|Overall Study|WHO score > 6|2
7652088|NCT00003702|12067255|FG001|Overall Study|WHO score > 6|1
7652089|NCT00003702|12067254|FG000|Overall Study|Inadequate documentation of disease|1
7652090|NCT00003702|12067255|FG001|Overall Study|Inadequate documentation of disease|3
7652091|NCT00003782|12067265|FG000|Overall Study|No follow up data|30
7652092|NCT00003782|12067266|FG001|Overall Study|No follow up data|31
7652093|NCT00003782|12067267|FG002|Overall Study|No follow up data|26
7652094|NCT00003830|12067305|FG000|Overall Study|No follow up data|3
7652095|NCT00003830|12067306|FG001|Overall Study|No follow up data|0
7652096|NCT00003830|12067305|FG000|Overall Study|Sentinel node positive patients|829
7652097|NCT00003830|12067306|FG001|Overall Study|Sentinel node positive patients|793
7652098|NCT00003869|12067316|FG000|Overall Study|Adverse Event|14
7652099|NCT00003869|12067317|FG001|Overall Study|Adverse Event|3
7652100|NCT00003869|12067316|FG000|Overall Study|Withdrawal by Subject|21
7652101|NCT00003869|12067317|FG001|Overall Study|Withdrawal by Subject|3
7652102|NCT00003869|12067316|FG000|Overall Study|Death|1
7652103|NCT00003869|12067317|FG001|Overall Study|Death|2
7652104|NCT00003869|12067316|FG000|Overall Study|Alternative treatmnt, medical problems|5
7652105|NCT00003869|12067317|FG001|Overall Study|Alternative treatmnt, medical problems|4
7652106|NCT00003875|12067323|FG000|Overall Study|Screen Failed|1
7652107|NCT00003895|12067329|FG000|Overall Study|Adverse Event|4
7652108|NCT00003895|12067330|FG001|Overall Study|Adverse Event|0
7652109|NCT00003895|12067329|FG000|Overall Study|Lack of Efficacy|1
7652110|NCT00003895|12067330|FG001|Overall Study|Lack of Efficacy|1
7652111|NCT00003895|12067329|FG000|Overall Study|Patient Vacation|2
7652112|NCT00003895|12067330|FG001|Overall Study|Patient Vacation|0
7652113|NCT00003895|12067329|FG000|Overall Study|Withdrawal by Subject|0
7652114|NCT00003895|12067330|FG001|Overall Study|Withdrawal by Subject|3
7652115|NCT00003896|12067336|FG000|Overall Study|Adverse Event|16
7652116|NCT00003896|12067336|FG000|Overall Study|Withdrawal by Subject|1
7652117|NCT00003896|12067336|FG000|Overall Study|Lack of Efficacy|1
7652118|NCT00003896|12067336|FG000|Overall Study|Death|3
7652119|NCT00003896|12067336|FG000|Overall Study|not protocol specified|3
7652120|NCT00003896|12067336|FG000|Overall Study|ineligible|5
7652121|NCT00003901|12067341|FG000|Overall Study|Adverse Event|1
7652122|NCT00003901|12067341|FG000|Overall Study|Withdrawal by Subject|1
7652123|NCT00003901|12067341|FG000|Overall Study|Ineligible|6
7652124|NCT00003901|12067341|FG000|Overall Study|CT Scan not within protocol requirement|2
7652125|NCT00003901|12067341|FG000|Overall Study|Chest X-Ray not done prior registration|1
7652126|NCT00003901|12067341|FG000|Overall Study|Medical problems|6
7652127|NCT00003907|12067350|FG000|Overall Study|Adverse Event|2
7652128|NCT00003907|12067351|FG001|Overall Study|Adverse Event|11
7652129|NCT00003907|12067350|FG000|Overall Study|Death|2
7652130|NCT00003907|12067351|FG001|Overall Study|Death|0
7652131|NCT00003907|12067350|FG000|Overall Study|Withdrawal by Subject|1
7652132|NCT00003907|12067351|FG001|Overall Study|Withdrawal by Subject|3
7652133|NCT00003907|12067350|FG000|Overall Study|Progressive disease|4
7652134|NCT00003907|12067351|FG001|Overall Study|Progressive disease|4
7652135|NCT00003907|12067350|FG000|Overall Study|Complicating disease|1
7652136|NCT00003907|12067351|FG001|Overall Study|Complicating disease|0
7652137|NCT00003907|12067350|FG000|Overall Study|Other|1
7652138|NCT00003907|12067351|FG001|Overall Study|Other|3
7652139|NCT00003907|12067350|FG000|Overall Study|ineligible or not treated|2
7652140|NCT00003907|12067351|FG001|Overall Study|ineligible or not treated|2
7652141|NCT00004031|12067366|FG000|Overall Study|Adverse Event|5
7652142|NCT00004031|12067367|FG001|Overall Study|Adverse Event|0
7652143|NCT00004031|12067366|FG000|Overall Study|Refusal unrelated to adverse events|2
7652144|NCT00004031|12067367|FG001|Overall Study|Refusal unrelated to adverse events|11
7652145|NCT00004031|12067366|FG000|Overall Study|Progression/relapse|9
7652146|NCT00004031|12067367|FG001|Overall Study|Progression/relapse|4
7652147|NCT00004031|12067366|FG000|Overall Study|Death|3
7652148|NCT00004031|12067367|FG001|Overall Study|Death|1
7652149|NCT00004031|12067366|FG000|Overall Study|Other- not protocol specified|3
7652150|NCT00004031|12067367|FG001|Overall Study|Other- not protocol specified|3
7652151|NCT00004031|12067366|FG000|Overall Study|Reason under review|3
7652152|NCT00004031|12067367|FG001|Overall Study|Reason under review|2
7652153|NCT00004088|12067384|FG000|Overall Study|No C2 given due to study on hold by IRB|4
7652154|NCT00004088|12067384|FG000|Overall Study|Withdrawal by Subject|1
7652155|NCT00004088|12067384|FG000|Overall Study|Protocol Violation|3
7652156|NCT00004088|12067384|FG000|Overall Study|Physician Decision|1
7652157|NCT00004124|12067399|FG000|Overall Study|Received no protocol therapy|12
7652158|NCT00004124|12067400|FG001|Overall Study|Received no protocol therapy|20
7652159|NCT00004228|12067423|FG000|Overall Study|Adverse Event|0
7652160|NCT00004228|12067424|FG001|Overall Study|Adverse Event|1
7652161|NCT00004228|12067425|FG002|Overall Study|Adverse Event|0
7652162|NCT00004228|12067426|FG003|Overall Study|Adverse Event|0
7652163|NCT00004228|12067427|FG004|Overall Study|Adverse Event|1
7652164|NCT00004228|12067428|FG005|Overall Study|Adverse Event|0
7652165|NCT00004228|12067429|FG006|Overall Study|Adverse Event|0
7652166|NCT00004228|12067423|FG000|Overall Study|Death|0
7652167|NCT00004228|12067424|FG001|Overall Study|Death|1
7652168|NCT00004228|12067425|FG002|Overall Study|Death|2
7652169|NCT00004228|12067426|FG003|Overall Study|Death|0
7652170|NCT00004228|12067427|FG004|Overall Study|Death|1
7652171|NCT00004228|12067428|FG005|Overall Study|Death|0
7652172|NCT00004228|12067429|FG006|Overall Study|Death|0
7652173|NCT00004228|12067423|FG000|Overall Study|Lack of Efficacy|1
7652174|NCT00004228|12067424|FG001|Overall Study|Lack of Efficacy|6
7652175|NCT00004228|12067425|FG002|Overall Study|Lack of Efficacy|5
7652176|NCT00004228|12067426|FG003|Overall Study|Lack of Efficacy|3
7652177|NCT00004228|12067427|FG004|Overall Study|Lack of Efficacy|9
7652178|NCT00004228|12067428|FG005|Overall Study|Lack of Efficacy|8
7652179|NCT00004228|12067429|FG006|Overall Study|Lack of Efficacy|4
7652180|NCT00004228|12067423|FG000|Overall Study|Lost to Follow-up|0
7652181|NCT00004228|12067424|FG001|Overall Study|Lost to Follow-up|0
7652182|NCT00004228|12067425|FG002|Overall Study|Lost to Follow-up|1
7652183|NCT00004228|12067426|FG003|Overall Study|Lost to Follow-up|0
7652184|NCT00004228|12067427|FG004|Overall Study|Lost to Follow-up|0
7652185|NCT00004228|12067428|FG005|Overall Study|Lost to Follow-up|0
7652186|NCT00004228|12067429|FG006|Overall Study|Lost to Follow-up|0
7652187|NCT00004228|12067423|FG000|Overall Study|Physician Decision|1
7652188|NCT00004228|12067424|FG001|Overall Study|Physician Decision|0
7652189|NCT00004228|12067425|FG002|Overall Study|Physician Decision|3
7652190|NCT00004228|12067426|FG003|Overall Study|Physician Decision|2
7652191|NCT00004228|12067427|FG004|Overall Study|Physician Decision|1
7652192|NCT00004228|12067428|FG005|Overall Study|Physician Decision|1
7652193|NCT00004228|12067429|FG006|Overall Study|Physician Decision|1
7652194|NCT00004228|12067423|FG000|Overall Study|Protocol Violation|0
7652195|NCT00004228|12067424|FG001|Overall Study|Protocol Violation|5
7652196|NCT00004228|12067425|FG002|Overall Study|Protocol Violation|2
7652197|NCT00004228|12067426|FG003|Overall Study|Protocol Violation|1
7652198|NCT00004228|12067427|FG004|Overall Study|Protocol Violation|1
7652199|NCT00004228|12067428|FG005|Overall Study|Protocol Violation|2
7652200|NCT00004228|12067429|FG006|Overall Study|Protocol Violation|0
7652201|NCT00004228|12067423|FG000|Overall Study|Withdrawal by Subject|3
7652202|NCT00004228|12067424|FG001|Overall Study|Withdrawal by Subject|0
7652203|NCT00004228|12067425|FG002|Overall Study|Withdrawal by Subject|1
7652204|NCT00004228|12067426|FG003|Overall Study|Withdrawal by Subject|0
7652205|NCT00004228|12067427|FG004|Overall Study|Withdrawal by Subject|2
7652206|NCT00004228|12067428|FG005|Overall Study|Withdrawal by Subject|1
7652207|NCT00004228|12067429|FG006|Overall Study|Withdrawal by Subject|2
7652208|NCT00004228|12067423|FG000|Overall Study|Other|0
7652209|NCT00004228|12067424|FG001|Overall Study|Other|0
7652210|NCT00004228|12067425|FG002|Overall Study|Other|1
7652211|NCT00004228|12067426|FG003|Overall Study|Other|0
7652212|NCT00004228|12067427|FG004|Overall Study|Other|0
7652213|NCT00004228|12067428|FG005|Overall Study|Other|0
7652214|NCT00004228|12067429|FG006|Overall Study|Other|0
7652215|NCT00004228|12067423|FG000|Overall Study|ineligible|4
7652216|NCT00004228|12067424|FG001|Overall Study|ineligible|2
7652217|NCT00004228|12067425|FG002|Overall Study|ineligible|4
7652218|NCT00004228|12067426|FG003|Overall Study|ineligible|1
7652219|NCT00004228|12067427|FG004|Overall Study|ineligible|1
7652220|NCT00004228|12067428|FG005|Overall Study|ineligible|2
7652221|NCT00004228|12067429|FG006|Overall Study|ineligible|5
7652222|NCT00004259|12067450|FG000|Overall Study|Protocol Violation|1
7652223|NCT00004259|12067451|FG001|Overall Study|Protocol Violation|2
7652224|NCT00004259|12067452|FG002|Overall Study|Protocol Violation|0
7652225|NCT00004259|12067453|FG003|Overall Study|Protocol Violation|0
7652226|NCT00004259|12067450|FG000|Overall Study|Withdrawal by Subject|0
7652227|NCT00004259|12067451|FG001|Overall Study|Withdrawal by Subject|2
7652228|NCT00004259|12067452|FG002|Overall Study|Withdrawal by Subject|0
7652229|NCT00004259|12067453|FG003|Overall Study|Withdrawal by Subject|0
7652230|NCT00004412|12067469|FG000|Randomized Period|Moved to Crossover Period|3
7652231|NCT00004412|12067470|FG001|Randomized Period|Moved to Crossover Period|0
7652232|NCT00004412|12067471|FG002|Randomized Period|Moved to Crossover Period|0
7652233|NCT00004445|12067481|FG000|Overall Study|Physician Decision|2
7652234|NCT00004445|12067481|FG000|Overall Study|Withdrawal by Subject|1
7652235|NCT00004562|12067510|FG000|Overall Study|Lost to Follow-up|102
7652236|NCT00004562|12067511|FG001|Overall Study|Lost to Follow-up|91
7652237|NCT00004563|12067519|FG000|Overall Study|Withdrawal by Subject|20
7652238|NCT00004563|12067520|FG001|Overall Study|Withdrawal by Subject|16
7652239|NCT00004563|12067519|FG000|Overall Study|Lack of Efficacy|3
7652240|NCT00004563|12067520|FG001|Overall Study|Lack of Efficacy|5
7652241|NCT00004563|12067519|FG000|Overall Study|Death|2
7652242|NCT00004563|12067520|FG001|Overall Study|Death|3
7652243|NCT00004635|12067528|FG000|Period One|refused|2
7652244|NCT00004635|12067529|FG001|Period One|refused|1
7652245|NCT00004635|12067528|FG000|Period One|Withdrawal by Subject|1
7652246|NCT00004635|12067529|FG001|Period One|Withdrawal by Subject|1
7652247|NCT00004635|12067528|FG000|Period One|Protocol Violation|1
7652248|NCT00004635|12067529|FG001|Period One|Protocol Violation|0
7652249|NCT00004635|12067528|FG000|Period One|PSA did not go <5 ng/mL|1
7652250|NCT00004635|12067529|FG001|Period One|PSA did not go <5 ng/mL|0
7652251|NCT00004635|12067528|FG000|Period One|second malignancy|1
7652252|NCT00004635|12067529|FG001|Period One|second malignancy|0
7652253|NCT00004635|12067528|FG000|Period One|progressed|0
7652254|NCT00004635|12067529|FG001|Period One|progressed|2
7652255|NCT00004635|12067528|FG000|Period One|health problem|0
7652256|NCT00004635|12067529|FG001|Period One|health problem|1
7652257|NCT00004635|12067528|FG000|Period One|discrepancy in data entry|0
7652258|NCT00004635|12067529|FG001|Period One|discrepancy in data entry|1
7652259|NCT00004635|12067528|FG000|Period Two|progression|2
7652260|NCT00004635|12067529|FG001|Period Two|progression|3
7652261|NCT00004635|12067528|FG000|Period Two|Adverse Event|1
7652262|NCT00004635|12067529|FG001|Period Two|Adverse Event|0
7652263|NCT00004635|12067528|FG000|Period Two|refused|0
7652264|NCT00004635|12067529|FG001|Period Two|refused|2
7652265|NCT00004635|12067528|FG000|Period Two|health problem|1
7652266|NCT00004635|12067529|FG001|Period Two|health problem|1
7652267|NCT00004635|12067528|FG000|Period Two|travel issues|0
7652268|NCT00004635|12067529|FG001|Period Two|travel issues|1
7652269|NCT00004635|12067528|FG000|Period Two|secondary malignancy|1
7652270|NCT00004635|12067529|FG001|Period Two|secondary malignancy|1
7652271|NCT00004635|12067528|FG000|Period Two|Lost to Follow-up|1
7652272|NCT00004635|12067529|FG001|Period Two|Lost to Follow-up|0
7652273|NCT00004635|12067528|FG000|Period Two|discrepancy in data entry|0
7652274|NCT00004635|12067529|FG001|Period Two|discrepancy in data entry|1
7652275|NCT00004732|12067540|FG000|Overall Study|Withdrawal by Subject|36
7652276|NCT00004732|12067541|FG001|Overall Study|Withdrawal by Subject|64
7652277|NCT00004732|12067540|FG000|Overall Study|Lost to Follow-up|33
7652278|NCT00004732|12067541|FG001|Overall Study|Lost to Follow-up|47
7652279|NCT00004859|12067551|FG000|Overall Study|Lack of Efficacy|43
7652280|NCT00004859|12067552|FG001|Overall Study|Lack of Efficacy|113
7652281|NCT00004859|12067551|FG000|Overall Study|Adverse Event|31
7652282|NCT00004859|12067552|FG001|Overall Study|Adverse Event|93
7652283|NCT00004859|12067551|FG000|Overall Study|Death|5
7652284|NCT00004859|12067552|FG001|Overall Study|Death|5
7652285|NCT00004859|12067551|FG000|Overall Study|Withdrawal by Subject|7
7652286|NCT00004859|12067552|FG001|Overall Study|Withdrawal by Subject|33
7652287|NCT00004859|12067551|FG000|Overall Study|Protocol Violation|2
7652288|NCT00004859|12067552|FG001|Overall Study|Protocol Violation|2
7652289|NCT00004859|12067551|FG000|Overall Study|other disease|0
7652290|NCT00004859|12067552|FG001|Overall Study|other disease|3
7652291|NCT00004859|12067551|FG000|Overall Study|error|3
7652292|NCT00004859|12067552|FG001|Overall Study|error|1
7652293|NCT00004859|12067551|FG000|Overall Study|missing data|14
7652294|NCT00004859|12067552|FG001|Overall Study|missing data|11
7652295|NCT00004859|12067551|FG000|Overall Study|Other|13
7652296|NCT00004859|12067552|FG001|Overall Study|Other|21
7652297|NCT00004888|12067562|FG000|Overall Study|Adverse Event|5
7652298|NCT00004888|12067563|FG001|Overall Study|Adverse Event|10
7652299|NCT00004888|12067562|FG000|Overall Study|Withdrawal by Subject|0
7652300|NCT00004888|12067563|FG001|Overall Study|Withdrawal by Subject|3
7652301|NCT00004888|12067562|FG000|Overall Study|Physician Decision|1
7652302|NCT00004888|12067563|FG001|Overall Study|Physician Decision|1
7652303|NCT00004888|12067562|FG000|Overall Study|Progressive Disease|4
7652304|NCT00004888|12067563|FG001|Overall Study|Progressive Disease|9
7652305|NCT00004888|12067562|FG000|Overall Study|Death without progressive disease|0
7652306|NCT00004888|12067563|FG001|Overall Study|Death without progressive disease|1
7652307|NCT00004888|12067562|FG000|Overall Study|Toxic death|1
7652308|NCT00004888|12067563|FG001|Overall Study|Toxic death|0
7652309|NCT00004978|12067571|FG000|Overall Study|Death|107
7652310|NCT00004978|12067572|FG001|Overall Study|Death|116
7652311|NCT00004978|12067571|FG000|Overall Study|Lost to Follow-up|101
7652312|NCT00004978|12067572|FG001|Overall Study|Lost to Follow-up|108
7652313|NCT00004978|12067571|FG000|Overall Study|Withdrawal by Subject|17
7652314|NCT00004978|12067572|FG001|Overall Study|Withdrawal by Subject|26
7652315|NCT00004978|12067571|FG000|Overall Study|site closure - not in analysis cohort|19
7652316|NCT00004978|12067572|FG001|Overall Study|site closure - not in analysis cohort|20
7652317|NCT00004980|12067580|FG000|Overall Study|Withdrawal by Subject|1
7652318|NCT00004980|12067581|FG001|Overall Study|Withdrawal by Subject|0
7652319|NCT00004980|12067580|FG000|Overall Study|memory difficulties|1
7652320|NCT00004980|12067581|FG001|Overall Study|memory difficulties|1
7652321|NCT00004980|12067580|FG000|Overall Study|Physician Decision|0
7652322|NCT00004980|12067581|FG001|Overall Study|Physician Decision|1
7652323|NCT00005047|12067591|FG000|Overall Study|Withdrawal by Subject|12
7652324|NCT00005047|12067592|FG001|Overall Study|Withdrawal by Subject|0
7652325|NCT00005047|12067593|FG002|Overall Study|Withdrawal by Subject|0
7652326|NCT00005047|12067594|FG003|Overall Study|Withdrawal by Subject|0
7652327|NCT00005047|12067591|FG000|Overall Study|Adverse Event|5
7652328|NCT00005047|12067592|FG001|Overall Study|Adverse Event|0
7652329|NCT00005047|12067593|FG002|Overall Study|Adverse Event|0
7652330|NCT00005047|12067594|FG003|Overall Study|Adverse Event|0
7652331|NCT00005047|12067591|FG000|Overall Study|Lost to Follow-up|1
7652332|NCT00005047|12067592|FG001|Overall Study|Lost to Follow-up|0
7652333|NCT00005047|12067593|FG002|Overall Study|Lost to Follow-up|0
7652334|NCT00005047|12067594|FG003|Overall Study|Lost to Follow-up|0
7652335|NCT00005047|12067591|FG000|Overall Study|Lack of Efficacy|1
7652336|NCT00005047|12067592|FG001|Overall Study|Lack of Efficacy|0
7652337|NCT00005047|12067593|FG002|Overall Study|Lack of Efficacy|0
7652338|NCT00005047|12067594|FG003|Overall Study|Lack of Efficacy|0
7652339|NCT00005879|12067622|FG000|Overall Study|Withdrawal by Subject|8
7652340|NCT00005879|12067623|FG001|Overall Study|Withdrawal by Subject|10
7652341|NCT00005906|12067638|FG000|Overall Study|Lack of Efficacy|3
7652342|NCT00005908|12067642|FG000|Overall Study|Withdrawal by Subject|1
7652343|NCT00005908|12067643|FG001|Overall Study|Withdrawal by Subject|0
7652344|NCT00005937|12067652|FG000|Overall Study|Lack of Efficacy|5
7652345|NCT00005947|12067658|FG000|Overall Study|Death|54
7652346|NCT00005947|12067659|FG001|Overall Study|Death|40
7652347|NCT00005947|12067658|FG000|Overall Study|Patient Refused to Continue|2
7652348|NCT00005947|12067659|FG001|Overall Study|Patient Refused to Continue|1
7652349|NCT00005947|12067658|FG000|Overall Study|Site Closure|1
7652350|NCT00005947|12067659|FG001|Overall Study|Site Closure|0
7652351|NCT00005957|12067669|FG000|Overall Study|No treated|3
7652352|NCT00005957|12067670|FG001|Overall Study|No treated|9
7652353|NCT00005957|12067669|FG000|Overall Study|Crossover to the other arm|5
7652354|NCT00005957|12067670|FG001|Overall Study|Crossover to the other arm|19
7652355|NCT00006011|12067679|FG000|Overall Study|Disease progression|13
7652356|NCT00006011|12067680|FG001|Overall Study|Disease progression|6
7652357|NCT00006011|12067681|FG002|Overall Study|Disease progression|26
7652358|NCT00006011|12067679|FG000|Overall Study|Refused further treatment|15
7652359|NCT00006011|12067680|FG001|Overall Study|Refused further treatment|13
7652360|NCT00006011|12067681|FG002|Overall Study|Refused further treatment|26
7652361|NCT00006011|12067679|FG000|Overall Study|Adverse Event|15
7652362|NCT00006011|12067680|FG001|Overall Study|Adverse Event|39
7652363|NCT00006011|12067681|FG002|Overall Study|Adverse Event|5
7652364|NCT00006011|12067679|FG000|Overall Study|Death|0
7652365|NCT00006011|12067680|FG001|Overall Study|Death|1
7652366|NCT00006011|12067681|FG002|Overall Study|Death|2
7652367|NCT00006011|12067679|FG000|Overall Study|Other|4
7652368|NCT00006011|12067680|FG001|Overall Study|Other|2
7652369|NCT00006011|12067681|FG002|Overall Study|Other|5
7652370|NCT00006011|12067679|FG000|Overall Study|Ineligible|18
7652371|NCT00006011|12067680|FG001|Overall Study|Ineligible|16
7652372|NCT00006011|12067681|FG002|Overall Study|Ineligible|9
7652373|NCT00006046|12067692|FG000|Overall Study|Adverse Event|3
7652374|NCT00006046|12067693|FG001|Overall Study|Adverse Event|0
7652375|NCT00006046|12067694|FG002|Overall Study|Adverse Event|0
7652376|NCT00006046|12067695|FG003|Overall Study|Adverse Event|0
7652377|NCT00006046|12067696|FG004|Overall Study|Adverse Event|0
7652378|NCT00006046|12067692|FG000|Overall Study|Disease Progression|2
7652379|NCT00006046|12067693|FG001|Overall Study|Disease Progression|0
7652380|NCT00006046|12067694|FG002|Overall Study|Disease Progression|0
7652381|NCT00006046|12067695|FG003|Overall Study|Disease Progression|0
7652382|NCT00006046|12067696|FG004|Overall Study|Disease Progression|0
7652383|NCT00006164|12067760|FG000|Overall Study|Withdrew or lost to follow-up|70
7652384|NCT00006164|12067761|FG001|Overall Study|Withdrew or lost to follow-up|81
7652385|NCT04323800|12067786|FG000|Overall Study|Withdrawal by Subject|4
7652386|NCT04323800|12067787|FG001|Overall Study|Withdrawal by Subject|4
7652387|NCT04323800|12067786|FG000|Overall Study|Incomplete transfusion|1
7652388|NCT04323800|12067787|FG001|Overall Study|Incomplete transfusion|0
7652389|NCT04323800|12067786|FG000|Overall Study|Other|0
7652390|NCT04323800|12067787|FG001|Overall Study|Other|1
7652391|NCT04323800|12067786|FG000|Overall Study|Positive RT-PCR at transfusion|1
7652392|NCT04323800|12067787|FG001|Overall Study|Positive RT-PCR at transfusion|1
7652393|NCT04110145|12067807|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
7652394|NCT04110145|12067808|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
7652395|NCT04110145|12067809|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
7652396|NCT04110145|12067810|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1
7652397|NCT04110145|12067811|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
7652398|NCT03986866|12067825|FG000|Overall Study|Withdrawal by Subject|0
7652399|NCT03986866|12067826|FG001|Overall Study|Withdrawal by Subject|3
7652400|NCT03986866|12067825|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2
7652401|NCT03986866|12067826|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2
7652402|NCT03636269|12067834|FG000|Period 1: Double-blind Phase|Adverse Event|13
7652403|NCT03636269|12067835|FG001|Period 1: Double-blind Phase|Adverse Event|7
7652404|NCT03636269|12067836|FG002|Period 1: Double-blind Phase|Adverse Event|0
7652405|NCT03636269|12067834|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1
7652406|NCT03636269|12067835|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0
7652407|NCT03636269|12067836|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0
7652408|NCT03636269|12067834|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2
7652409|NCT03636269|12067835|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0
7652410|NCT03636269|12067836|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0
7652411|NCT03636269|12067834|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5
7652412|NCT03636269|12067835|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1
7652413|NCT03636269|12067836|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0
7652414|NCT03636269|12067834|FG000|Period 1: Double-blind Phase|Other|6
7652415|NCT03636269|12067835|FG001|Period 1: Double-blind Phase|Other|3
7652416|NCT03636269|12067836|FG002|Period 1: Double-blind Phase|Other|0
7652417|NCT03636269|12067834|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1
7652418|NCT03636269|12067835|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0
7652419|NCT03636269|12067836|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0
7652420|NCT03636269|12067834|FG000|Period 1: Double-blind Phase|Subject non-compliance|1
7652421|NCT03636269|12067835|FG001|Period 1: Double-blind Phase|Subject non-compliance|2
7652422|NCT03636269|12067836|FG002|Period 1: Double-blind Phase|Subject non-compliance|0
7652423|NCT03636269|12067834|FG000|Period 2: Open-label Phase|Adverse Event|0
7652424|NCT03636269|12067835|FG001|Period 2: Open-label Phase|Adverse Event|0
7652425|NCT03636269|12067836|FG002|Period 2: Open-label Phase|Adverse Event|21
7652426|NCT03636269|12067834|FG000|Period 2: Open-label Phase|Lack of Efficacy|0
7652427|NCT03636269|12067835|FG001|Period 2: Open-label Phase|Lack of Efficacy|0
7652428|NCT03636269|12067836|FG002|Period 2: Open-label Phase|Lack of Efficacy|2
7652429|NCT03636269|12067834|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0
7652430|NCT03636269|12067835|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0
7652431|NCT03636269|12067836|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2
7652432|NCT03636269|12067834|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0
7652433|NCT03636269|12067835|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0
7652434|NCT03636269|12067836|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11
7652435|NCT03636269|12067834|FG000|Period 2: Open-label Phase|Administrative|0
7652436|NCT03636269|12067835|FG001|Period 2: Open-label Phase|Administrative|0
7652437|NCT03636269|12067836|FG002|Period 2: Open-label Phase|Administrative|36
7652438|NCT03636269|12067834|FG000|Period 2: Open-label Phase|Other|0
7652439|NCT03636269|12067835|FG001|Period 2: Open-label Phase|Other|0
7652440|NCT03636269|12067836|FG002|Period 2: Open-label Phase|Other|9
7652441|NCT03636269|12067834|FG000|Period 2: Open-label Phase|Sponsor stopping study|0
7652442|NCT03636269|12067835|FG001|Period 2: Open-label Phase|Sponsor stopping study|0
7652443|NCT03636269|12067836|FG002|Period 2: Open-label Phase|Sponsor stopping study|313
7652444|NCT03447314|12067876|FG000|Part 1 (Up to 27 Months)|Death|6
7652445|NCT03447314|12067877|FG001|Part 1 (Up to 27 Months)|Death|5
7652446|NCT03447314|12067878|FG002|Part 1 (Up to 27 Months)|Death|3
7652447|NCT03447314|12067879|FG003|Part 1 (Up to 27 Months)|Death|3
7652448|NCT03447314|12067880|FG004|Part 1 (Up to 27 Months)|Death|0
7652449|NCT03447314|12067881|FG005|Part 1 (Up to 27 Months)|Death|4
7652450|NCT03447314|12067882|FG006|Part 1 (Up to 27 Months)|Death|3
7652451|NCT03447314|12067883|FG007|Part 1 (Up to 27 Months)|Death|0
7652452|NCT03447314|12067884|FG008|Part 1 (Up to 27 Months)|Death|0
7652453|NCT03447314|12067885|FG009|Part 1 (Up to 27 Months)|Death|0
7652454|NCT03447314|12067886|FG010|Part 1 (Up to 27 Months)|Death|4
7652455|NCT03447314|12067887|FG011|Part 1 (Up to 27 Months)|Death|2
7652456|NCT03447314|12067888|FG012|Part 1 (Up to 27 Months)|Death|0
7652457|NCT03447314|12067889|FG013|Part 1 (Up to 27 Months)|Death|0
7652458|NCT03447314|12067890|FG014|Part 1 (Up to 27 Months)|Death|0
7652459|NCT03447314|12067891|FG015|Part 1 (Up to 27 Months)|Death|0
7652460|NCT03447314|12067892|FG016|Part 1 (Up to 27 Months)|Death|0
7652461|NCT03447314|12067893|FG017|Part 1 (Up to 27 Months)|Death|0
7652462|NCT03447314|12067876|FG000|Part 1 (Up to 27 Months)|Ongoing in the study|2
7652463|NCT03447314|12067877|FG001|Part 1 (Up to 27 Months)|Ongoing in the study|1
7652464|NCT03447314|12067878|FG002|Part 1 (Up to 27 Months)|Ongoing in the study|3
7652465|NCT03447314|12067879|FG003|Part 1 (Up to 27 Months)|Ongoing in the study|1
7652466|NCT03447314|12067880|FG004|Part 1 (Up to 27 Months)|Ongoing in the study|2
7652467|NCT03447314|12067881|FG005|Part 1 (Up to 27 Months)|Ongoing in the study|1
7652468|NCT03447314|12067882|FG006|Part 1 (Up to 27 Months)|Ongoing in the study|2
7652469|NCT03447314|12067883|FG007|Part 1 (Up to 27 Months)|Ongoing in the study|0
7652470|NCT03447314|12067884|FG008|Part 1 (Up to 27 Months)|Ongoing in the study|0
7652471|NCT03447314|12067885|FG009|Part 1 (Up to 27 Months)|Ongoing in the study|0
7652472|NCT03447314|12067886|FG010|Part 1 (Up to 27 Months)|Ongoing in the study|3
7652473|NCT03447314|12067887|FG011|Part 1 (Up to 27 Months)|Ongoing in the study|4
7652474|NCT03447314|12067888|FG012|Part 1 (Up to 27 Months)|Ongoing in the study|0
7652475|NCT03447314|12067889|FG013|Part 1 (Up to 27 Months)|Ongoing in the study|0
7652476|NCT03447314|12067890|FG014|Part 1 (Up to 27 Months)|Ongoing in the study|0
7652477|NCT03447314|12067891|FG015|Part 1 (Up to 27 Months)|Ongoing in the study|0
7652478|NCT03447314|12067892|FG016|Part 1 (Up to 27 Months)|Ongoing in the study|0
7652479|NCT03447314|12067893|FG017|Part 1 (Up to 27 Months)|Ongoing in the study|0
7652480|NCT03447314|12067876|FG000|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
7652481|NCT03447314|12067877|FG001|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7652482|NCT03447314|12067878|FG002|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
7652483|NCT03447314|12067879|FG003|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7652484|NCT03447314|12067880|FG004|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7652485|NCT03447314|12067881|FG005|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
7652486|NCT03447314|12067882|FG006|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7652487|NCT03447314|12067883|FG007|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7652488|NCT03447314|12067884|FG008|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7652489|NCT03447314|12067885|FG009|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7652490|NCT03447314|12067886|FG010|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7652491|NCT03447314|12067887|FG011|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7652492|NCT03447314|12067888|FG012|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7652493|NCT03447314|12067889|FG013|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7652494|NCT03447314|12067890|FG014|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7652495|NCT03447314|12067891|FG015|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7652496|NCT03447314|12067892|FG016|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7652497|NCT03447314|12067893|FG017|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7652498|NCT03447314|12067876|FG000|Part 1 (Up to 27 Months)|Disease progression|0
7652499|NCT03447314|12067877|FG001|Part 1 (Up to 27 Months)|Disease progression|0
7652500|NCT03447314|12067878|FG002|Part 1 (Up to 27 Months)|Disease progression|1
7652501|NCT03447314|12067879|FG003|Part 1 (Up to 27 Months)|Disease progression|0
7652502|NCT03447314|12067880|FG004|Part 1 (Up to 27 Months)|Disease progression|0
7652503|NCT03447314|12067881|FG005|Part 1 (Up to 27 Months)|Disease progression|0
7652504|NCT03447314|12067882|FG006|Part 1 (Up to 27 Months)|Disease progression|0
7652505|NCT03447314|12067883|FG007|Part 1 (Up to 27 Months)|Disease progression|0
7652506|NCT03447314|12067884|FG008|Part 1 (Up to 27 Months)|Disease progression|0
7652507|NCT03447314|12067885|FG009|Part 1 (Up to 27 Months)|Disease progression|0
7652508|NCT03447314|12067886|FG010|Part 1 (Up to 27 Months)|Disease progression|0
7652509|NCT03447314|12067887|FG011|Part 1 (Up to 27 Months)|Disease progression|0
7652510|NCT03447314|12067888|FG012|Part 1 (Up to 27 Months)|Disease progression|0
7652511|NCT03447314|12067889|FG013|Part 1 (Up to 27 Months)|Disease progression|0
7652512|NCT03447314|12067890|FG014|Part 1 (Up to 27 Months)|Disease progression|0
7652513|NCT03447314|12067891|FG015|Part 1 (Up to 27 Months)|Disease progression|0
7652514|NCT03447314|12067892|FG016|Part 1 (Up to 27 Months)|Disease progression|0
7652515|NCT03447314|12067893|FG017|Part 1 (Up to 27 Months)|Disease progression|0
7652516|NCT03447314|12067876|FG000|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652517|NCT03447314|12067877|FG001|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652518|NCT03447314|12067878|FG002|Part 1 (Up to 27 Months)|Lost to Follow-up|1
7652519|NCT03447314|12067879|FG003|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652520|NCT03447314|12067880|FG004|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652521|NCT03447314|12067881|FG005|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652522|NCT03447314|12067882|FG006|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652523|NCT03447314|12067883|FG007|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652524|NCT03447314|12067884|FG008|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652525|NCT03447314|12067885|FG009|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652526|NCT03447314|12067886|FG010|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652527|NCT03447314|12067887|FG011|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652528|NCT03447314|12067888|FG012|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652529|NCT03447314|12067889|FG013|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652530|NCT03447314|12067890|FG014|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652531|NCT03447314|12067891|FG015|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652532|NCT03447314|12067892|FG016|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652533|NCT03447314|12067893|FG017|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7652534|NCT03320330|12067950|FG000|Overall Study|Lack of Efficacy|5
7652535|NCT03320330|12067951|FG001|Overall Study|Lack of Efficacy|5
7652536|NCT03320330|12067952|FG002|Overall Study|Lack of Efficacy|14
7652537|NCT03320330|12067950|FG000|Overall Study|Physician Decision|1
7652538|NCT03320330|12067951|FG001|Overall Study|Physician Decision|0
7652539|NCT03320330|12067952|FG002|Overall Study|Physician Decision|0
7652540|NCT03271151|12067963|FG000|Overall Study|Lost to Follow-up|1
7652541|NCT03271151|12067964|FG001|Overall Study|Lost to Follow-up|3
7652542|NCT03271151|12067963|FG000|Overall Study|Withdrawal by Subject|1
7652543|NCT03271151|12067964|FG001|Overall Study|Withdrawal by Subject|0
7652544|NCT03023813|12067973|FG000|Overall Study|Lost to Follow-up|1
7652545|NCT03023813|12067974|FG001|Overall Study|Lost to Follow-up|2
7652546|NCT03023813|12067975|FG002|Overall Study|Lost to Follow-up|0
7652547|NCT02993822|12067988|FG000|Overall Study|Lack of Efficacy|1
7652548|NCT02993822|12067989|FG001|Overall Study|Lack of Efficacy|1
7652549|NCT02993822|12067990|FG002|Overall Study|Lack of Efficacy|0
7652550|NCT02993822|12067991|FG003|Overall Study|Lack of Efficacy|0
7652551|NCT02993822|12067988|FG000|Overall Study|Protocol Violation|1
7652552|NCT02993822|12067989|FG001|Overall Study|Protocol Violation|0
7652553|NCT02993822|12067990|FG002|Overall Study|Protocol Violation|0
7652554|NCT02993822|12067991|FG003|Overall Study|Protocol Violation|0
7652555|NCT02993822|12067988|FG000|Overall Study|Unable to attend follow-up due to illness|0
7652556|NCT02993822|12067989|FG001|Overall Study|Unable to attend follow-up due to illness|0
7652557|NCT02993822|12067990|FG002|Overall Study|Unable to attend follow-up due to illness|0
7652558|NCT02993822|12067991|FG003|Overall Study|Unable to attend follow-up due to illness|1
7652559|NCT02993822|12067988|FG000|Overall Study|Adverse Event|3
7652560|NCT02993822|12067989|FG001|Overall Study|Adverse Event|1
7652561|NCT02993822|12067990|FG002|Overall Study|Adverse Event|7
7652562|NCT02993822|12067991|FG003|Overall Study|Adverse Event|0
7652563|NCT02993822|12067988|FG000|Overall Study|Withdrawal by Subject|4
7652564|NCT02993822|12067989|FG001|Overall Study|Withdrawal by Subject|2
7652565|NCT02993822|12067990|FG002|Overall Study|Withdrawal by Subject|2
7652566|NCT02993822|12067991|FG003|Overall Study|Withdrawal by Subject|3
7652567|NCT02993822|12067988|FG000|Overall Study|Lost to Follow-up|1
7652568|NCT02993822|12067989|FG001|Overall Study|Lost to Follow-up|0
7652569|NCT02993822|12067990|FG002|Overall Study|Lost to Follow-up|1
7652570|NCT02993822|12067991|FG003|Overall Study|Lost to Follow-up|0
7652571|NCT02753127|12068016|FG000|Overall Study|Lost to Follow-up|13
7652572|NCT02753127|12068017|FG001|Overall Study|Lost to Follow-up|11
7652573|NCT02753127|12068016|FG000|Overall Study|Withdrawal by Subject|37
7652574|NCT02753127|12068017|FG001|Overall Study|Withdrawal by Subject|47
7652575|NCT02753127|12068016|FG000|Overall Study|Other|3
7652576|NCT02753127|12068017|FG001|Overall Study|Other|8
7652577|NCT02753127|12068016|FG000|Overall Study|Hospice|0
7652578|NCT02753127|12068017|FG001|Overall Study|Hospice|2
7652579|NCT01516216|12068096|FG000|Overall Study|Adverse Event|2
7652580|NCT01516216|12068097|FG001|Overall Study|Adverse Event|4
7652581|NCT01516216|12068096|FG000|Overall Study|Disease Progression|38
7652582|NCT01516216|12068097|FG001|Overall Study|Disease Progression|34
7652583|NCT01516216|12068096|FG000|Overall Study|Withdrawal by Subject|9
7652584|NCT01516216|12068097|FG001|Overall Study|Withdrawal by Subject|11
7652585|NCT01516216|12068096|FG000|Overall Study|Potentially Curative Resection|6
7652586|NCT01516216|12068097|FG001|Overall Study|Potentially Curative Resection|12
7652587|NCT01516216|12068096|FG000|Overall Study|Nonadherence|2
7652588|NCT01516216|12068097|FG001|Overall Study|Nonadherence|3
7652589|NCT01516216|12068096|FG000|Overall Study|Physician Decision|6
7652590|NCT01516216|12068097|FG001|Overall Study|Physician Decision|3
7652591|NCT01516216|12068096|FG000|Overall Study|Prolonged Treatment Delay|5
7652592|NCT01516216|12068097|FG001|Overall Study|Prolonged Treatment Delay|1
7652593|NCT01516216|12068096|FG000|Overall Study|Intercurrent Illness|1
7652594|NCT01516216|12068097|FG001|Overall Study|Intercurrent Illness|0
7652595|NCT01516216|12068096|FG000|Overall Study|Death|1
7652596|NCT01516216|12068097|FG001|Overall Study|Death|1
7652597|NCT00006184|12068117|FG000|Overall Study|Death|1
7652598|NCT00006184|12068118|FG001|Overall Study|Death|0
7652599|NCT00006237|12068130|FG000|Overall Study|Adverse Event|39
7652600|NCT00006237|12068131|FG001|Overall Study|Adverse Event|29
7652601|NCT00006237|12068130|FG000|Overall Study|Death|1
7652602|NCT00006237|12068131|FG001|Overall Study|Death|0
7652603|NCT00006237|12068130|FG000|Overall Study|Refusal unrelated to adverse effects|8
7652604|NCT00006237|12068131|FG001|Overall Study|Refusal unrelated to adverse effects|4
7652605|NCT00006237|12068130|FG000|Overall Study|Progression/relapse|54
7652606|NCT00006237|12068131|FG001|Overall Study|Progression/relapse|2
7652607|NCT00006237|12068130|FG000|Overall Study|Not eligible|9
7652608|NCT00006237|12068131|FG001|Overall Study|Not eligible|20
7652609|NCT00006237|12068130|FG000|Overall Study|Withdrawal by Subject|0
7652610|NCT00006237|12068131|FG001|Overall Study|Withdrawal by Subject|1
7652611|NCT00006237|12068130|FG000|Overall Study|Not protocol specified|14
7652612|NCT00006237|12068131|FG001|Overall Study|Not protocol specified|5
7652613|NCT00006289|12068146|FG000|First Intervention (5 Weeks)|Adverse Event|1
7652614|NCT00006289|12068147|FG001|First Intervention (5 Weeks)|Adverse Event|0
7652615|NCT00006289|12068146|FG000|Second Intervention (5 Weeks)|Protocol Violation|1
7652616|NCT00006289|12068147|FG001|Second Intervention (5 Weeks)|Protocol Violation|1
7652617|NCT00006305|12068167|FG000|Overall Study|Withdrawal by Subject|17
7652618|NCT00006305|12068168|FG001|Overall Study|Withdrawal by Subject|10
7652619|NCT00006305|12068169|FG002|Overall Study|Withdrawal by Subject|15
7652620|NCT00006305|12068170|FG003|Overall Study|Withdrawal by Subject|14
7652621|NCT00006389|12068180|FG000|Overall Study|Adverse Event|1
7652622|NCT00006392|12068189|FG000|Overall Study|Ineligible|11
7652623|NCT00006392|12068190|FG001|Overall Study|Ineligible|3
7652624|NCT00006392|12068191|FG002|Overall Study|Ineligible|5
7652625|NCT00006392|12068192|FG003|Overall Study|Ineligible|5
7652626|NCT00006392|12068189|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156
7652627|NCT00006392|12068190|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155
7652628|NCT00006392|12068191|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155
7652629|NCT00006392|12068192|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155
7652630|NCT00006409|12068217|FG000|Baseline|Protocol Violation|48
7652631|NCT00006409|12068218|FG001|Baseline|Protocol Violation|70
7652632|NCT00006409|12068219|FG002|Baseline|Protocol Violation|0
7652633|NCT00006409|12068220|FG003|Baseline|Protocol Violation|0
7652634|NCT00006409|12068221|FG004|Baseline|Protocol Violation|0
7652635|NCT00006409|12068222|FG005|Baseline|Protocol Violation|0
7652636|NCT00006409|12068217|FG000|Post-2 Year Intervention|Protocol Violation|0
7652637|NCT00006409|12068218|FG001|Post-2 Year Intervention|Protocol Violation|0
7652638|NCT00006409|12068219|FG002|Post-2 Year Intervention|Protocol Violation|251
7652639|NCT00006409|12068220|FG003|Post-2 Year Intervention|Protocol Violation|168
7652640|NCT00006409|12068221|FG004|Post-2 Year Intervention|Protocol Violation|0
7652641|NCT00006409|12068222|FG005|Post-2 Year Intervention|Protocol Violation|0
7652642|NCT00006409|12068217|FG000|Post-3 Year Intervention|Protocol Violation|0
7652643|NCT00006409|12068218|FG001|Post-3 Year Intervention|Protocol Violation|0
7652644|NCT00006409|12068219|FG002|Post-3 Year Intervention|Protocol Violation|0
7652645|NCT00006409|12068220|FG003|Post-3 Year Intervention|Protocol Violation|0
7652646|NCT00006409|12068221|FG004|Post-3 Year Intervention|Protocol Violation|62
7652647|NCT00006409|12068222|FG005|Post-3 Year Intervention|Protocol Violation|62
7652648|NCT00006489|12068249|FG000|Overall Study|Adverse Event|3
7652649|NCT00006489|12068250|FG001|Overall Study|Adverse Event|2
7652650|NCT00006489|12068251|FG002|Overall Study|Adverse Event|4
7652651|NCT00006489|12068252|FG003|Overall Study|Adverse Event|3
7652652|NCT00006489|12068249|FG000|Overall Study|Withdrawal by Subject|10
7652653|NCT00006489|12068250|FG001|Overall Study|Withdrawal by Subject|9
7652654|NCT00006489|12068251|FG002|Overall Study|Withdrawal by Subject|9
7652655|NCT00006489|12068252|FG003|Overall Study|Withdrawal by Subject|6
7652656|NCT00006489|12068249|FG000|Overall Study|Scheduling Conflict|0
7652657|NCT00006489|12068250|FG001|Overall Study|Scheduling Conflict|3
7652658|NCT00006489|12068251|FG002|Overall Study|Scheduling Conflict|2
7652659|NCT00006489|12068252|FG003|Overall Study|Scheduling Conflict|1
7652660|NCT00006489|12068249|FG000|Overall Study|Death|0
7652661|NCT00006489|12068250|FG001|Overall Study|Death|0
7652662|NCT00006489|12068251|FG002|Overall Study|Death|0
7652663|NCT00006489|12068252|FG003|Overall Study|Death|1
7652664|NCT00006604|12068269|FG000|Overall Study|Met study objective - no further FU|1
7652665|NCT00006604|12068270|FG001|Overall Study|Met study objective - no further FU|0
7652666|NCT00006604|12068271|FG002|Overall Study|Met study objective - no further FU|0
7652667|NCT00006604|12068272|FG003|Overall Study|Met study objective - no further FU|0
7652668|NCT00006604|12068273|FG004|Overall Study|Met study objective - no further FU|0
7652669|NCT00006604|12068274|FG005|Overall Study|Met study objective - no further FU|0
7652670|NCT00006604|12068275|FG006|Overall Study|Met study objective - no further FU|0
7652671|NCT00006604|12068276|FG007|Overall Study|Met study objective - no further FU|0
7652672|NCT00006604|12068277|FG008|Overall Study|Met study objective - no further FU|0
7652673|NCT00006604|12068278|FG009|Overall Study|Met study objective - no further FU|0
7652674|NCT00006604|12068279|FG010|Overall Study|Met study objective - no further FU|0
7652675|NCT00006604|12068280|FG011|Overall Study|Met study objective - no further FU|0
7652676|NCT00006604|12068281|FG012|Overall Study|Met study objective - no further FU|0
7652677|NCT00006604|12068282|FG013|Overall Study|Met study objective - no further FU|0
7652678|NCT00006604|12068283|FG014|Overall Study|Met study objective - no further FU|1
7652679|NCT00006604|12068284|FG015|Overall Study|Met study objective - no further FU|1
7652680|NCT00006604|12068285|FG016|Overall Study|Met study objective - no further FU|0
7652681|NCT00006604|12068269|FG000|Overall Study|Randomization entry error-no RX, no FU|0
7652682|NCT00006604|12068270|FG001|Overall Study|Randomization entry error-no RX, no FU|0
7652683|NCT00006604|12068271|FG002|Overall Study|Randomization entry error-no RX, no FU|0
7652684|NCT00006604|12068272|FG003|Overall Study|Randomization entry error-no RX, no FU|0
7652685|NCT00006604|12068273|FG004|Overall Study|Randomization entry error-no RX, no FU|0
7652686|NCT00006604|12068274|FG005|Overall Study|Randomization entry error-no RX, no FU|0
7652687|NCT00006604|12068275|FG006|Overall Study|Randomization entry error-no RX, no FU|0
7652688|NCT00006604|12068276|FG007|Overall Study|Randomization entry error-no RX, no FU|0
7652689|NCT00006604|12068277|FG008|Overall Study|Randomization entry error-no RX, no FU|0
7652690|NCT00006604|12068278|FG009|Overall Study|Randomization entry error-no RX, no FU|0
7652691|NCT00006604|12068279|FG010|Overall Study|Randomization entry error-no RX, no FU|0
7652692|NCT00006604|12068280|FG011|Overall Study|Randomization entry error-no RX, no FU|1
7652693|NCT00006604|12068281|FG012|Overall Study|Randomization entry error-no RX, no FU|0
7652694|NCT00006604|12068282|FG013|Overall Study|Randomization entry error-no RX, no FU|0
7652695|NCT00006604|12068283|FG014|Overall Study|Randomization entry error-no RX, no FU|0
7652696|NCT00006604|12068284|FG015|Overall Study|Randomization entry error-no RX, no FU|0
7652697|NCT00006604|12068285|FG016|Overall Study|Randomization entry error-no RX, no FU|0
7652698|NCT00006604|12068269|FG000|Overall Study|Death|0
7652699|NCT00006604|12068270|FG001|Overall Study|Death|0
7652700|NCT00006604|12068271|FG002|Overall Study|Death|0
7652701|NCT00006604|12068272|FG003|Overall Study|Death|0
7652702|NCT00006604|12068273|FG004|Overall Study|Death|0
7652703|NCT00006604|12068274|FG005|Overall Study|Death|0
7652704|NCT00006604|12068275|FG006|Overall Study|Death|0
7652705|NCT00006604|12068276|FG007|Overall Study|Death|0
7652706|NCT00006604|12068277|FG008|Overall Study|Death|0
7652707|NCT00006604|12068278|FG009|Overall Study|Death|1
7652708|NCT00006604|12068279|FG010|Overall Study|Death|1
7652709|NCT00006604|12068280|FG011|Overall Study|Death|1
7652710|NCT00006604|12068281|FG012|Overall Study|Death|0
7652711|NCT00006604|12068282|FG013|Overall Study|Death|0
7652712|NCT00006604|12068283|FG014|Overall Study|Death|0
7652713|NCT00006604|12068284|FG015|Overall Study|Death|0
7652714|NCT00006604|12068285|FG016|Overall Study|Death|0
7652715|NCT00006604|12068269|FG000|Overall Study|Severe debilitation, unable to continue|0
7652716|NCT00006604|12068270|FG001|Overall Study|Severe debilitation, unable to continue|0
7652717|NCT00006604|12068271|FG002|Overall Study|Severe debilitation, unable to continue|0
7652718|NCT00006604|12068272|FG003|Overall Study|Severe debilitation, unable to continue|0
7652719|NCT00006604|12068273|FG004|Overall Study|Severe debilitation, unable to continue|0
7652720|NCT00006604|12068274|FG005|Overall Study|Severe debilitation, unable to continue|0
7652721|NCT00006604|12068275|FG006|Overall Study|Severe debilitation, unable to continue|3
7652722|NCT00006604|12068276|FG007|Overall Study|Severe debilitation, unable to continue|0
7652723|NCT00006604|12068277|FG008|Overall Study|Severe debilitation, unable to continue|0
7652724|NCT00006604|12068278|FG009|Overall Study|Severe debilitation, unable to continue|5
7652725|NCT00006604|12068279|FG010|Overall Study|Severe debilitation, unable to continue|0
7652726|NCT00006604|12068280|FG011|Overall Study|Severe debilitation, unable to continue|2
7652727|NCT00006604|12068281|FG012|Overall Study|Severe debilitation, unable to continue|1
7652728|NCT00006604|12068282|FG013|Overall Study|Severe debilitation, unable to continue|0
7652729|NCT00006604|12068283|FG014|Overall Study|Severe debilitation, unable to continue|2
7652730|NCT00006604|12068284|FG015|Overall Study|Severe debilitation, unable to continue|0
7652731|NCT00006604|12068285|FG016|Overall Study|Severe debilitation, unable to continue|0
7652732|NCT00006604|12068269|FG000|Overall Study|Subj/Parent not able to get to clinic|0
7652733|NCT00006604|12068270|FG001|Overall Study|Subj/Parent not able to get to clinic|0
7652734|NCT00006604|12068271|FG002|Overall Study|Subj/Parent not able to get to clinic|0
7652735|NCT00006604|12068272|FG003|Overall Study|Subj/Parent not able to get to clinic|1
7652736|NCT00006604|12068273|FG004|Overall Study|Subj/Parent not able to get to clinic|1
7652737|NCT00006604|12068274|FG005|Overall Study|Subj/Parent not able to get to clinic|0
7652738|NCT00006604|12068275|FG006|Overall Study|Subj/Parent not able to get to clinic|1
7652739|NCT00006604|12068276|FG007|Overall Study|Subj/Parent not able to get to clinic|0
7652740|NCT00006604|12068277|FG008|Overall Study|Subj/Parent not able to get to clinic|0
7652741|NCT00006604|12068278|FG009|Overall Study|Subj/Parent not able to get to clinic|1
7652742|NCT00006604|12068279|FG010|Overall Study|Subj/Parent not able to get to clinic|2
7652743|NCT00006604|12068280|FG011|Overall Study|Subj/Parent not able to get to clinic|1
7652744|NCT00006604|12068281|FG012|Overall Study|Subj/Parent not able to get to clinic|1
7652745|NCT00006604|12068282|FG013|Overall Study|Subj/Parent not able to get to clinic|1
7652746|NCT00006604|12068283|FG014|Overall Study|Subj/Parent not able to get to clinic|3
7652747|NCT00006604|12068284|FG015|Overall Study|Subj/Parent not able to get to clinic|0
7652748|NCT00006604|12068285|FG016|Overall Study|Subj/Parent not able to get to clinic|0
7652749|NCT00006604|12068269|FG000|Overall Study|Site closing|0
7652750|NCT00006604|12068270|FG001|Overall Study|Site closing|0
7652751|NCT00006604|12068271|FG002|Overall Study|Site closing|1
7652752|NCT00006604|12068272|FG003|Overall Study|Site closing|1
7652753|NCT00006604|12068273|FG004|Overall Study|Site closing|0
7652754|NCT00006604|12068274|FG005|Overall Study|Site closing|0
7652755|NCT00006604|12068275|FG006|Overall Study|Site closing|0
7652756|NCT00006604|12068276|FG007|Overall Study|Site closing|1
7652757|NCT00006604|12068277|FG008|Overall Study|Site closing|0
7652758|NCT00006604|12068278|FG009|Overall Study|Site closing|0
7652759|NCT00006604|12068279|FG010|Overall Study|Site closing|0
7652760|NCT00006604|12068280|FG011|Overall Study|Site closing|1
7652761|NCT00006604|12068281|FG012|Overall Study|Site closing|1
7652762|NCT00006604|12068282|FG013|Overall Study|Site closing|1
7652763|NCT00006604|12068283|FG014|Overall Study|Site closing|0
7652764|NCT00006604|12068284|FG015|Overall Study|Site closing|0
7652765|NCT00006604|12068285|FG016|Overall Study|Site closing|1
7652766|NCT00006604|12068269|FG000|Overall Study|Withdrawal by Subject|1
7652767|NCT00006604|12068270|FG001|Overall Study|Withdrawal by Subject|0
7652768|NCT00006604|12068271|FG002|Overall Study|Withdrawal by Subject|2
7652769|NCT00006604|12068272|FG003|Overall Study|Withdrawal by Subject|0
7652770|NCT00006604|12068273|FG004|Overall Study|Withdrawal by Subject|1
7652771|NCT00006604|12068274|FG005|Overall Study|Withdrawal by Subject|2
7652772|NCT00006604|12068275|FG006|Overall Study|Withdrawal by Subject|2
7652773|NCT00006604|12068276|FG007|Overall Study|Withdrawal by Subject|0
7652774|NCT00006604|12068277|FG008|Overall Study|Withdrawal by Subject|1
7652775|NCT00006604|12068278|FG009|Overall Study|Withdrawal by Subject|3
7652776|NCT00006604|12068279|FG010|Overall Study|Withdrawal by Subject|2
7652777|NCT00006604|12068280|FG011|Overall Study|Withdrawal by Subject|0
7652778|NCT00006604|12068281|FG012|Overall Study|Withdrawal by Subject|1
7652779|NCT00006604|12068282|FG013|Overall Study|Withdrawal by Subject|2
7652780|NCT00006604|12068283|FG014|Overall Study|Withdrawal by Subject|1
7652781|NCT00006604|12068284|FG015|Overall Study|Withdrawal by Subject|0
7652782|NCT00006604|12068285|FG016|Overall Study|Withdrawal by Subject|1
7652783|NCT00006604|12068269|FG000|Overall Study|Subj/parent not willing to adhere to req|0
7652784|NCT00006604|12068270|FG001|Overall Study|Subj/parent not willing to adhere to req|0
7652785|NCT00006604|12068271|FG002|Overall Study|Subj/parent not willing to adhere to req|1
7652786|NCT00006604|12068272|FG003|Overall Study|Subj/parent not willing to adhere to req|3
7652787|NCT00006604|12068273|FG004|Overall Study|Subj/parent not willing to adhere to req|0
7652788|NCT00006604|12068274|FG005|Overall Study|Subj/parent not willing to adhere to req|0
7652789|NCT00006604|12068275|FG006|Overall Study|Subj/parent not willing to adhere to req|3
7652790|NCT00006604|12068276|FG007|Overall Study|Subj/parent not willing to adhere to req|1
7652791|NCT00006604|12068277|FG008|Overall Study|Subj/parent not willing to adhere to req|0
7652792|NCT00006604|12068278|FG009|Overall Study|Subj/parent not willing to adhere to req|6
7652793|NCT00006604|12068279|FG010|Overall Study|Subj/parent not willing to adhere to req|3
7652794|NCT00006604|12068280|FG011|Overall Study|Subj/parent not willing to adhere to req|0
7652795|NCT00006604|12068281|FG012|Overall Study|Subj/parent not willing to adhere to req|0
7652796|NCT00006604|12068282|FG013|Overall Study|Subj/parent not willing to adhere to req|2
7652797|NCT00006604|12068283|FG014|Overall Study|Subj/parent not willing to adhere to req|3
7652798|NCT00006604|12068284|FG015|Overall Study|Subj/parent not willing to adhere to req|3
7652799|NCT00006604|12068285|FG016|Overall Study|Subj/parent not willing to adhere to req|4
7652800|NCT00006604|12068269|FG000|Overall Study|Lost to Follow-up|0
7652801|NCT00006604|12068270|FG001|Overall Study|Lost to Follow-up|0
7652802|NCT00006604|12068271|FG002|Overall Study|Lost to Follow-up|0
7652803|NCT00006604|12068272|FG003|Overall Study|Lost to Follow-up|0
7652804|NCT00006604|12068273|FG004|Overall Study|Lost to Follow-up|0
7652805|NCT00006604|12068274|FG005|Overall Study|Lost to Follow-up|0
7652806|NCT00006604|12068275|FG006|Overall Study|Lost to Follow-up|0
7652807|NCT00006604|12068276|FG007|Overall Study|Lost to Follow-up|1
7652808|NCT00006604|12068277|FG008|Overall Study|Lost to Follow-up|0
7652809|NCT00006604|12068278|FG009|Overall Study|Lost to Follow-up|2
7652810|NCT00006604|12068279|FG010|Overall Study|Lost to Follow-up|0
7652811|NCT00006604|12068280|FG011|Overall Study|Lost to Follow-up|0
7652812|NCT00006604|12068281|FG012|Overall Study|Lost to Follow-up|0
7652813|NCT00006604|12068282|FG013|Overall Study|Lost to Follow-up|0
7652814|NCT00006604|12068283|FG014|Overall Study|Lost to Follow-up|0
7652815|NCT00006604|12068284|FG015|Overall Study|Lost to Follow-up|1
7652816|NCT00006604|12068285|FG016|Overall Study|Lost to Follow-up|3
7652817|NCT00006604|12068269|FG000|Overall Study|Other Reason|0
7652818|NCT00006604|12068270|FG001|Overall Study|Other Reason|0
7652819|NCT00006604|12068271|FG002|Overall Study|Other Reason|0
7652820|NCT00006604|12068272|FG003|Overall Study|Other Reason|0
7652821|NCT00006604|12068273|FG004|Overall Study|Other Reason|0
7652822|NCT00006604|12068274|FG005|Overall Study|Other Reason|1
7652823|NCT00006604|12068275|FG006|Overall Study|Other Reason|0
7652824|NCT00006604|12068276|FG007|Overall Study|Other Reason|0
7652825|NCT00006604|12068277|FG008|Overall Study|Other Reason|0
7652826|NCT00006604|12068278|FG009|Overall Study|Other Reason|1
7652827|NCT00006604|12068279|FG010|Overall Study|Other Reason|0
7652828|NCT00006604|12068280|FG011|Overall Study|Other Reason|0
7652829|NCT00006604|12068281|FG012|Overall Study|Other Reason|0
7652830|NCT00006604|12068282|FG013|Overall Study|Other Reason|0
7652831|NCT00006604|12068283|FG014|Overall Study|Other Reason|0
7652832|NCT00006604|12068284|FG015|Overall Study|Other Reason|0
7652833|NCT00006604|12068285|FG016|Overall Study|Other Reason|0
7652834|NCT00006903|12068310|FG000|Overall Study|Still receiving treatment|0
7652835|NCT00006903|12068311|FG001|Overall Study|Still receiving treatment|0
7652836|NCT00006903|12068312|FG002|Overall Study|Still receiving treatment|1
7652837|NCT00006903|12068310|FG000|Overall Study|Refused further treatment|0
7652838|NCT00006903|12068311|FG001|Overall Study|Refused further treatment|2
7652839|NCT00006903|12068312|FG002|Overall Study|Refused further treatment|1
7652840|NCT00006903|12068310|FG000|Overall Study|Adverse Event|0
7652841|NCT00006903|12068311|FG001|Overall Study|Adverse Event|0
7652842|NCT00006903|12068312|FG002|Overall Study|Adverse Event|1
7652843|NCT00006903|12068310|FG000|Overall Study|Death|0
7652844|NCT00006903|12068311|FG001|Overall Study|Death|1
7652845|NCT00006903|12068312|FG002|Overall Study|Death|0
7652846|NCT00006903|12068310|FG000|Overall Study|Patient never treated|0
7652847|NCT00006903|12068311|FG001|Overall Study|Patient never treated|0
7652848|NCT00006903|12068312|FG002|Overall Study|Patient never treated|1
7652849|NCT00006903|12068310|FG000|Overall Study|Ineligible|10
7652850|NCT00006903|12068311|FG001|Overall Study|Ineligible|1
7652851|NCT00006903|12068312|FG002|Overall Study|Ineligible|2
7652852|NCT00007020|12068320|FG000|Overall Study|Death|16
7652853|NCT00007020|12068320|FG000|Overall Study|Lost to Follow-up|13
7652854|NCT00007020|12068320|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1
7652855|NCT00007020|12068320|FG000|Overall Study|Pt withdrawn (liver transplant)|4
7652856|NCT00007020|12068320|FG000|Overall Study|Pt cared for by outside physician|4
7652857|NCT00007020|12068320|FG000|Overall Study|No evidence of treatment|6
7652858|NCT00007345|12068328|FG000|Overall Study|Refused further treatment|0
7652859|NCT00007345|12068329|FG001|Overall Study|Refused further treatment|7
7652860|NCT00007345|12068328|FG000|Overall Study|Switched to alternative treatment|0
7652861|NCT00007345|12068329|FG001|Overall Study|Switched to alternative treatment|3
7652862|NCT00007345|12068328|FG000|Overall Study|Intercurrent illness|1
7652863|NCT00007345|12068329|FG001|Overall Study|Intercurrent illness|0
7652864|NCT00007345|12068328|FG000|Overall Study|Death on study|1
7652865|NCT00007345|12068329|FG001|Overall Study|Death on study|1
7652866|NCT00007475|12068338|FG000|Overall Study|Withdrawal by Subject|1
7652867|NCT00007475|12068339|FG001|Overall Study|Withdrawal by Subject|0
7652868|NCT00007475|12068340|FG002|Overall Study|Withdrawal by Subject|0
7652869|NCT00007475|12068341|FG003|Overall Study|Withdrawal by Subject|0
7652870|NCT00007475|12068338|FG000|Overall Study|Adverse Event|3
7652871|NCT00007475|12068339|FG001|Overall Study|Adverse Event|0
7652872|NCT00007475|12068340|FG002|Overall Study|Adverse Event|0
7652873|NCT00007475|12068341|FG003|Overall Study|Adverse Event|0
7652874|NCT00008138|12068360|FG000|Neoadjuvant Chemotherapy|Adverse Event|3
7652875|NCT00008138|12068360|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
7652876|NCT00008138|12068360|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6
7652877|NCT00008138|12068360|FG000|Neoadjuvant Chemotherapy|not protocol specified|8
7652878|NCT00008138|12068360|FG000|Interval Debulking|Withdrawal by Subject|2
7652879|NCT00008138|12068360|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6
7652880|NCT00008138|12068360|FG000|Post-Cytoreduction Chemotherapy|Progression|1
7652881|NCT00008138|12068360|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1
7652882|NCT00008385|12068367|FG000|Overall Study|Off treatment reasons not reported|79
7652883|NCT00008385|12068368|FG001|Overall Study|Off treatment reasons not reported|70
7652884|NCT00008385|12068367|FG000|Overall Study|Progressive disease|52
7652885|NCT00008385|12068368|FG001|Overall Study|Progressive disease|117
7652886|NCT00008385|12068367|FG000|Overall Study|Adverse Event|8
7652887|NCT00008385|12068368|FG001|Overall Study|Adverse Event|20
7652888|NCT00008385|12068367|FG000|Overall Study|Death|12
7652889|NCT00008385|12068368|FG001|Overall Study|Death|18
7652890|NCT00008385|12068367|FG000|Overall Study|Withdrawal by Subject|67
7652891|NCT00008385|12068368|FG001|Overall Study|Withdrawal by Subject|157
7652892|NCT00008385|12068367|FG000|Overall Study|Start non-protocol therapy|3
7652893|NCT00008385|12068368|FG001|Overall Study|Start non-protocol therapy|1
7652894|NCT00008385|12068367|FG000|Overall Study|Other complicating disease|17
7652895|NCT00008385|12068368|FG001|Overall Study|Other complicating disease|30
7652896|NCT00008385|12068367|FG000|Overall Study|Maximum dose reached|0
7652897|NCT00008385|12068368|FG001|Overall Study|Maximum dose reached|2
7652898|NCT00008385|12068367|FG000|Overall Study|Other|105
7652899|NCT00008385|12068368|FG001|Overall Study|Other|212
7652900|NCT00008385|12068367|FG000|Overall Study|Not start protocol therapy|44
7652901|NCT00008385|12068368|FG001|Overall Study|Not start protocol therapy|175
7652902|NCT00009737|12068376|FG000|Overall Study|Adverse Event|112
7652903|NCT00009737|12068377|FG001|Overall Study|Adverse Event|75
7652904|NCT00009737|12068376|FG000|Overall Study|Death|4
7652905|NCT00009737|12068377|FG001|Overall Study|Death|6
7652906|NCT00009737|12068376|FG000|Overall Study|Lack of Efficacy|17
7652907|NCT00009737|12068377|FG001|Overall Study|Lack of Efficacy|15
7652908|NCT00009737|12068376|FG000|Overall Study|Violation of Selection Criteria at Entry|13
7652909|NCT00009737|12068377|FG001|Overall Study|Violation of Selection Criteria at Entry|9
7652910|NCT00009737|12068376|FG000|Overall Study|Other Protocol Violation|1
7652911|NCT00009737|12068377|FG001|Overall Study|Other Protocol Violation|0
7652912|NCT00009737|12068376|FG000|Overall Study|Refused Treatment|15
7652913|NCT00009737|12068377|FG001|Overall Study|Refused Treatment|16
7652914|NCT00009737|12068376|FG000|Overall Study|Lost to Follow-up|1
7652915|NCT00009737|12068377|FG001|Overall Study|Lost to Follow-up|1
7652916|NCT00009737|12068376|FG000|Overall Study|Administrative/Other Reasons|7
7652917|NCT00009737|12068377|FG001|Overall Study|Administrative/Other Reasons|1
7652918|NCT00009945|12068385|FG000|Overall Study|no follow up data|7
7652919|NCT00009945|12068386|FG001|Overall Study|no follow up data|5
7652920|NCT00010257|12068394|FG000|Overall Study|Withdrawal by Subject|1
7652921|NCT00010257|12068395|FG001|Overall Study|Withdrawal by Subject|0
7652922|NCT00010374|12068401|FG000|Overall Study|False positive phrenic nerve test|1
7652923|NCT00010803|12068412|FG000|Overall Study|Withdrawal by Subject|97
7652924|NCT00010803|12068413|FG001|Overall Study|Withdrawal by Subject|98
7652925|NCT00012012|12068447|FG000|Overall Study|Protocol Violation|1
7652926|NCT00012012|12068448|FG001|Overall Study|Protocol Violation|1
7652927|NCT00012012|12068447|FG000|Overall Study|Withdrawal by Subject|0
7652928|NCT00012012|12068448|FG001|Overall Study|Withdrawal by Subject|2
7652929|NCT00013611|12068487|FG000|Overall Study|Lost to Follow-up|91
7652930|NCT00013611|12068488|FG001|Overall Study|Lost to Follow-up|100
7652931|NCT00014495|12068511|FG000|Overall Study|Death|0
7652932|NCT00014495|12068512|FG001|Overall Study|Death|0
7652933|NCT00014495|12068513|FG002|Overall Study|Death|1
7652934|NCT00014495|12068514|FG003|Overall Study|Death|0
7652935|NCT00014495|12068511|FG000|Overall Study|Clinical deterioration|0
7652936|NCT00014495|12068512|FG001|Overall Study|Clinical deterioration|0
7652937|NCT00014495|12068513|FG002|Overall Study|Clinical deterioration|0
7652938|NCT00014495|12068514|FG003|Overall Study|Clinical deterioration|1
7652939|NCT00014911|12068521|FG000|Overall Study|Adverse Event|1
7652940|NCT00014911|12068521|FG000|Overall Study|Lost to Follow-up|1
7652941|NCT00014911|12068521|FG000|Overall Study|Withdrawal by Subject|6
7652942|NCT00014911|12068521|FG000|Overall Study|Unknown Reasons|2
7652943|NCT00014911|12068521|FG000|Overall Study|Immunosuppression-related Side Effects|1
7652944|NCT00015457|12068525|FG000|First Intervention|Adverse Event|0
7652945|NCT00015457|12068526|FG001|First Intervention|Adverse Event|2
7652946|NCT00015457|12068525|FG000|First Intervention|Lack of Efficacy|0
7652947|NCT00015457|12068526|FG001|First Intervention|Lack of Efficacy|1
7652948|NCT00015457|12068525|FG000|Second Intervention|Withdrawal by Subject|1
7652949|NCT00015457|12068526|FG001|Second Intervention|Withdrawal by Subject|0
7652950|NCT00016354|12068536|FG000|Overall Study|Lack of Efficacy|0
7652951|NCT00016354|12068537|FG001|Overall Study|Lack of Efficacy|0
7652952|NCT00016354|12068538|FG002|Overall Study|Lack of Efficacy|0
7652953|NCT00016354|12068539|FG003|Overall Study|Lack of Efficacy|0
7652954|NCT00016354|12068540|FG004|Overall Study|Lack of Efficacy|0
7652955|NCT00016354|12068541|FG005|Overall Study|Lack of Efficacy|0
7652956|NCT00016354|12068542|FG006|Overall Study|Lack of Efficacy|0
7652957|NCT00016354|12068543|FG007|Overall Study|Lack of Efficacy|1
7652958|NCT00019604|12068572|FG000|Overall Study|Death|1
7652959|NCT00019604|12068572|FG000|Overall Study|Progressive disease|23
7652960|NCT00019604|12068572|FG000|Overall Study|Refused treatment|1
7652961|NCT00019604|12068572|FG000|Overall Study|Carcinoid tumor, not treatable|1
7652962|NCT00019604|12068572|FG000|Overall Study|Going to have liver transplant|1
7652963|NCT00019604|12068572|FG000|Overall Study|Move to a different study|1
7652964|NCT00019604|12068572|FG000|Overall Study|Non compliant on systemic CH|1
7652965|NCT00019604|12068572|FG000|Overall Study|Non compliant|1
7652966|NCT00019604|12068572|FG000|Overall Study|Resectable disease|1
7652967|NCT00019604|12068572|FG000|Overall Study|Started new chemo regimen|1
7652968|NCT00019604|12068572|FG000|Overall Study|Pt going to immunotherapy study|1
7652969|NCT00019604|12068572|FG000|Overall Study|Too much disease|1
7652970|NCT00019604|12068572|FG000|Overall Study|Unable to evaluate|1
7652971|NCT00019604|12068572|FG000|Overall Study|Details for other not available|4
7652972|NCT00021229|12068588|FG000|Overall Study|Adverse Event|10
7652973|NCT00021229|12068589|FG001|Overall Study|Adverse Event|5
7652974|NCT00021229|12068590|FG002|Overall Study|Adverse Event|2
7652975|NCT00021229|12068588|FG000|Overall Study|Death|0
7652976|NCT00021229|12068589|FG001|Overall Study|Death|1
7652977|NCT00021229|12068590|FG002|Overall Study|Death|0
7652978|NCT00021229|12068588|FG000|Overall Study|Withdrawal by Subject|7
7652979|NCT00021229|12068589|FG001|Overall Study|Withdrawal by Subject|7
7652980|NCT00021229|12068590|FG002|Overall Study|Withdrawal by Subject|1
7652981|NCT00021229|12068588|FG000|Overall Study|Progressive Disease|15
7652982|NCT00021229|12068589|FG001|Overall Study|Progressive Disease|19
7652983|NCT00021229|12068590|FG002|Overall Study|Progressive Disease|12
7652984|NCT00021229|12068588|FG000|Overall Study|Protocol Violation|1
7652985|NCT00021229|12068589|FG001|Overall Study|Protocol Violation|1
7652986|NCT00021229|12068590|FG002|Overall Study|Protocol Violation|0
7652987|NCT00021229|12068588|FG000|Overall Study|Physician Decision|0
7652988|NCT00021229|12068589|FG001|Overall Study|Physician Decision|0
7652989|NCT00021229|12068590|FG002|Overall Study|Physician Decision|1
7652990|NCT00021229|12068588|FG000|Overall Study|Punctate hemmorrhage post RT|2
7652991|NCT00021229|12068589|FG001|Overall Study|Punctate hemmorrhage post RT|0
7652992|NCT00021229|12068590|FG002|Overall Study|Punctate hemmorrhage post RT|0
7652993|NCT00021255|12068603|FG000|Overall Study|Death|1
7652994|NCT00021255|12068604|FG001|Overall Study|Death|0
7652995|NCT00021255|12068605|FG002|Overall Study|Death|2
7652996|NCT00021255|12068603|FG000|Overall Study|Breast cancer relapse|5
7652997|NCT00021255|12068604|FG001|Overall Study|Breast cancer relapse|18
7652998|NCT00021255|12068605|FG002|Overall Study|Breast cancer relapse|11
7652999|NCT00021255|12068603|FG000|Overall Study|Second primary malignancy|0
7653000|NCT00021255|12068604|FG001|Overall Study|Second primary malignancy|4
7653001|NCT00021255|12068605|FG002|Overall Study|Second primary malignancy|1
7653002|NCT00021255|12068603|FG000|Overall Study|Withdrawal by Subject|41
7653003|NCT00021255|12068604|FG001|Overall Study|Withdrawal by Subject|64
7653004|NCT00021255|12068605|FG002|Overall Study|Withdrawal by Subject|26
7653005|NCT00021255|12068603|FG000|Overall Study|Lost to Follow-up|0
7653006|NCT00021255|12068604|FG001|Overall Study|Lost to Follow-up|2
7653007|NCT00021255|12068605|FG002|Overall Study|Lost to Follow-up|3
7653008|NCT00021255|12068603|FG000|Overall Study|Cardiac toxicity|0
7653009|NCT00021255|12068604|FG001|Overall Study|Cardiac toxicity|61
7653010|NCT00021255|12068605|FG002|Overall Study|Cardiac toxicity|32
7653011|NCT00021255|12068603|FG000|Overall Study|Herceptin toxicity|0
7653012|NCT00021255|12068604|FG001|Overall Study|Herceptin toxicity|22
7653013|NCT00021255|12068605|FG002|Overall Study|Herceptin toxicity|6
7653014|NCT00021255|12068603|FG000|Overall Study|Adverse Event|46
7653015|NCT00021255|12068604|FG001|Overall Study|Adverse Event|30
7653016|NCT00021255|12068605|FG002|Overall Study|Adverse Event|18
7653017|NCT00021255|12068603|FG000|Overall Study|Protocol Violation|0
7653018|NCT00021255|12068604|FG001|Overall Study|Protocol Violation|2
7653019|NCT00021255|12068605|FG002|Overall Study|Protocol Violation|0
7653020|NCT00021255|12068603|FG000|Overall Study|Other than specified above|0
7653021|NCT00021255|12068604|FG001|Overall Study|Other than specified above|38
7653022|NCT00021255|12068605|FG002|Overall Study|Other than specified above|19
7653023|NCT00021255|12068603|FG000|Overall Study|Missing|0
7653024|NCT00021255|12068604|FG001|Overall Study|Missing|27
7653025|NCT00021255|12068605|FG002|Overall Study|Missing|13
7653026|NCT00021255|12068603|FG000|Overall Study|Randomized but not treated|28
7653027|NCT00021255|12068604|FG001|Overall Study|Randomized but not treated|2
7653028|NCT00021255|12068605|FG002|Overall Study|Randomized but not treated|18
7653029|NCT00021541|12068615|FG000|Period 1-First Treatment|Withdrawal by Subject|3
7653030|NCT00021541|12068616|FG001|Period 1-First Treatment|Withdrawal by Subject|3
7653031|NCT00021541|12068615|FG000|Period 1-First Treatment|Adverse Event|2
7653032|NCT00021541|12068616|FG001|Period 1-First Treatment|Adverse Event|1
7653033|NCT00021541|12068615|FG000|Period 1-First Treatment|non-adherence|3
7653034|NCT00021541|12068616|FG001|Period 1-First Treatment|non-adherence|0
7653035|NCT00021541|12068615|FG000|Period 1-First Treatment|Death|1
7653036|NCT00021541|12068616|FG001|Period 1-First Treatment|Death|0
7653037|NCT00021541|12068615|FG000|Period 1-First Treatment|Pts that did not progress|2
7653038|NCT00021541|12068616|FG001|Period 1-First Treatment|Pts that did not progress|2
7653039|NCT00021541|12068615|FG000|Period 1-First Treatment|Ineligible|0
7653040|NCT00021541|12068616|FG001|Period 1-First Treatment|Ineligible|2
7653041|NCT00021541|12068615|FG000|Period 2-crossover|refused phase B|2
7653042|NCT00021541|12068616|FG001|Period 2-crossover|refused phase B|2
7653043|NCT00021541|12068615|FG000|Period 2-crossover|Withdrawal by Subject|3
7653044|NCT00021541|12068616|FG001|Period 2-crossover|Withdrawal by Subject|4
7653045|NCT00021541|12068615|FG000|Period 2-crossover|Adverse Event|2
7653046|NCT00021541|12068616|FG001|Period 2-crossover|Adverse Event|2
7653047|NCT00021541|12068615|FG000|Period 2-crossover|non-adherence|1
7653048|NCT00021541|12068616|FG001|Period 2-crossover|non-adherence|0
7653049|NCT00021541|12068615|FG000|Period 2-crossover|Pts that did not progress|2
7653050|NCT00021541|12068616|FG001|Period 2-crossover|Pts that did not progress|3
7653051|NCT00022516|12068630|FG000|Overall Study|Adverse Event|0
7653052|NCT00022516|12068631|FG001|Overall Study|Adverse Event|59
7653053|NCT00022516|12068630|FG000|Overall Study|Lack of Efficacy|0
7653054|NCT00022516|12068631|FG001|Overall Study|Lack of Efficacy|27
7653055|NCT00022516|12068630|FG000|Overall Study|Physician Decision|0
7653056|NCT00022516|12068631|FG001|Overall Study|Physician Decision|1
7653057|NCT00022516|12068630|FG000|Overall Study|Protocol Violation|1
7653058|NCT00022516|12068631|FG001|Overall Study|Protocol Violation|3
7653059|NCT00022516|12068630|FG000|Overall Study|Withdrawal by Subject|2
7653060|NCT00022516|12068631|FG001|Overall Study|Withdrawal by Subject|113
7653061|NCT00022516|12068630|FG000|Overall Study|Incomplete documentation|0
7653062|NCT00022516|12068631|FG001|Overall Study|Incomplete documentation|27
7653063|NCT00022633|12068639|FG000|Overall Study|Adverse Event|11
7653064|NCT00022633|12068640|FG001|Overall Study|Adverse Event|1
7653065|NCT00022633|12068639|FG000|Overall Study|Refusal unrelated to adverse event|1
7653066|NCT00022633|12068640|FG001|Overall Study|Refusal unrelated to adverse event|0
7653067|NCT00022633|12068639|FG000|Overall Study|Progression/relapse|9
7653068|NCT00022633|12068640|FG001|Overall Study|Progression/relapse|2
7653069|NCT00022633|12068639|FG000|Overall Study|Death|4
7653070|NCT00022633|12068640|FG001|Overall Study|Death|0
7653071|NCT00022633|12068639|FG000|Overall Study|Other - not protocol specified|3
7653072|NCT00022633|12068640|FG001|Overall Study|Other - not protocol specified|2
7653073|NCT00022633|12068639|FG000|Overall Study|Ineligible|4
7653074|NCT00022633|12068640|FG001|Overall Study|Ineligible|0
7653075|NCT00022659|12068645|FG000|Overall Study|Ineligible: wrong primary|1
7653076|NCT00022659|12068645|FG000|Overall Study|Never treated|1
7653077|NCT00022672|12068655|FG000|Main Phase: 24 Months|Adverse Event|6
7653078|NCT00022672|12068656|FG001|Main Phase: 24 Months|Adverse Event|0
7653079|NCT00022672|12068655|FG000|Main Phase: 24 Months|Death|0
7653080|NCT00022672|12068656|FG001|Main Phase: 24 Months|Death|3
7653081|NCT00022672|12068655|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75
7653082|NCT00022672|12068656|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91
7653083|NCT00022672|12068655|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
7653084|NCT00022672|12068656|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
7653085|NCT00022672|12068655|FG000|Main Phase: 24 Months|Other Protocol Violation|1
7653086|NCT00022672|12068656|FG001|Main Phase: 24 Months|Other Protocol Violation|0
7653087|NCT00022672|12068655|FG000|Main Phase: 24 Months|Refused Treatment|3
7653088|NCT00022672|12068656|FG001|Main Phase: 24 Months|Refused Treatment|4
7653089|NCT00022672|12068655|FG000|Main Phase: 24 Months|Failure to Return|1
7653090|NCT00022672|12068656|FG001|Main Phase: 24 Months|Failure to Return|1
7653091|NCT00022672|12068655|FG000|Main Phase: 24 Months|Other|1
7653092|NCT00022672|12068656|FG001|Main Phase: 24 Months|Other|0
7653093|NCT00022672|12068655|FG000|Extension Phase|Adverse Event|1
7653094|NCT00022672|12068656|FG001|Extension Phase|Adverse Event|3
7653095|NCT00022672|12068655|FG000|Extension Phase|Death|0
7653096|NCT00022672|12068656|FG001|Extension Phase|Death|1
7653097|NCT00022672|12068655|FG000|Extension Phase|Insufficient Therapeutic Response|1
7653098|NCT00022672|12068656|FG001|Extension Phase|Insufficient Therapeutic Response|44
7653099|NCT00022672|12068655|FG000|Extension Phase|Refused Treatment|0
7653100|NCT00022672|12068656|FG001|Extension Phase|Refused Treatment|2
7653101|NCT00022672|12068655|FG000|Extension Phase|Other|1
7653102|NCT00022672|12068656|FG001|Extension Phase|Other|1
7653103|NCT00022698|12068665|FG000|Overall Study|Adverse Event|5
7653104|NCT00022698|12068666|FG001|Overall Study|Adverse Event|9
7653105|NCT00022698|12068665|FG000|Overall Study|Death|0
7653106|NCT00022698|12068666|FG001|Overall Study|Death|2
7653107|NCT00022698|12068665|FG000|Overall Study|Failure to return|0
7653108|NCT00022698|12068666|FG001|Overall Study|Failure to return|1
7653109|NCT00022698|12068665|FG000|Overall Study|Refused treatment|0
7653110|NCT00022698|12068666|FG001|Overall Study|Refused treatment|2
7653111|NCT00022698|12068665|FG000|Overall Study|Insufficient therapeutic response|2
7653112|NCT00022698|12068666|FG001|Overall Study|Insufficient therapeutic response|14
7653113|NCT00022698|12068665|FG000|Overall Study|Administrative /other|1
7653114|NCT00022698|12068666|FG001|Overall Study|Administrative /other|7
7653115|NCT00022763|12068676|FG000|Overall Study|Adverse Event|1
7653116|NCT00022763|12068677|FG001|Overall Study|Adverse Event|2
7653117|NCT00022763|12068676|FG000|Overall Study|Injection Site Reactions|0
7653118|NCT00022763|12068677|FG001|Overall Study|Injection Site Reactions|2
7653119|NCT00022763|12068676|FG000|Overall Study|Death|0
7653120|NCT00022763|12068677|FG001|Overall Study|Death|1
7653121|NCT00022763|12068676|FG000|Overall Study|Lost to Follow-up|0
7653122|NCT00022763|12068677|FG001|Overall Study|Lost to Follow-up|3
7653123|NCT00022763|12068676|FG000|Overall Study|Withdrawal by Subject|4
7653124|NCT00022763|12068677|FG001|Overall Study|Withdrawal by Subject|7
7653125|NCT00022763|12068676|FG000|Overall Study|Insufficient Therapy|1
7653126|NCT00022763|12068677|FG001|Overall Study|Insufficient Therapy|0
7653127|NCT00022763|12068676|FG000|Overall Study|Admin|3
7653128|NCT00022763|12068677|FG001|Overall Study|Admin|2
7653129|NCT00023322|12068691|FG000|Overall Study|Lost to Follow-up|1
7653130|NCT00023452|12068697|FG000|Overall Study|Ineligible for Study|163
7653131|NCT00023452|12068698|FG001|Overall Study|Ineligible for Study|159
7653132|NCT00023452|12068697|FG000|Overall Study|Out of Window|129
7653133|NCT00023452|12068698|FG001|Overall Study|Out of Window|69
7653134|NCT00023452|12068697|FG000|Overall Study|Death|2
7653135|NCT00023452|12068698|FG001|Overall Study|Death|0
7653136|NCT00023452|12068697|FG000|Overall Study|Withdrawal by Subject|66
7653137|NCT00023452|12068698|FG001|Overall Study|Withdrawal by Subject|54
7653138|NCT00023452|12068697|FG000|Overall Study|Adverse Event|139
7653139|NCT00023452|12068698|FG001|Overall Study|Adverse Event|196
7653140|NCT00023452|12068697|FG000|Overall Study|Lost to Follow-up|293
7653141|NCT00023452|12068698|FG001|Overall Study|Lost to Follow-up|60
7653142|NCT00023452|12068697|FG000|Overall Study|Physician Decision|49
7653143|NCT00023452|12068698|FG001|Overall Study|Physician Decision|21
7653144|NCT00023452|12068697|FG000|Overall Study|Refused Treatment (continued follow-up)|225
7653145|NCT00023452|12068698|FG001|Overall Study|Refused Treatment (continued follow-up)|224
7653146|NCT00023452|12068697|FG000|Overall Study|Pregnant|53
7653147|NCT00023452|12068698|FG001|Overall Study|Pregnant|20
7653148|NCT00023452|12068697|FG000|Overall Study|Other|204
7653149|NCT00023452|12068698|FG001|Overall Study|Other|69
7653150|NCT00023595|12068713|FG000|5 Year Follow up|Lost to Follow-up|2
7653151|NCT00023595|12068714|FG001|5 Year Follow up|Lost to Follow-up|2
7653152|NCT00023595|12068715|FG002|5 Year Follow up|Lost to Follow-up|1
7653153|NCT00023595|12068716|FG003|5 Year Follow up|Lost to Follow-up|7
7653154|NCT00023595|12068717|FG004|5 Year Follow up|Lost to Follow-up|3
7653155|NCT00023595|12068713|FG000|10 Year Follow up|Lost to Follow-up|12
7653156|NCT00023595|12068714|FG001|10 Year Follow up|Lost to Follow-up|10
7653157|NCT00023595|12068715|FG002|10 Year Follow up|Lost to Follow-up|3
7653158|NCT00023595|12068716|FG003|10 Year Follow up|Lost to Follow-up|0
7653159|NCT00023595|12068717|FG004|10 Year Follow up|Lost to Follow-up|0
7653160|NCT00023673|12068743|FG000|Overall Study|Ineligible / no protocol treatment|0
7653161|NCT00023673|12068744|FG001|Overall Study|Ineligible / no protocol treatment|0
7653162|NCT00023673|12068745|FG002|Overall Study|Ineligible / no protocol treatment|0
7653163|NCT00023673|12068746|FG003|Overall Study|Ineligible / no protocol treatment|1
7653164|NCT00023673|12068743|FG000|Overall Study|Patient withdrew consent|0
7653165|NCT00023673|12068744|FG001|Overall Study|Patient withdrew consent|0
7653166|NCT00023673|12068745|FG002|Overall Study|Patient withdrew consent|0
7653167|NCT00023673|12068746|FG003|Overall Study|Patient withdrew consent|1
7653168|NCT00023712|12068758|FG000|Overall Study|Not platinum sensitive|1
7653169|NCT00023712|12068759|FG001|Overall Study|Not platinum sensitive|0
7653170|NCT00023712|12068758|FG000|Overall Study|Never treated|1
7653171|NCT00023712|12068759|FG001|Overall Study|Never treated|1
7653172|NCT00023764|12068775|FG000|Overall Study|Other|1
7653173|NCT00023764|12068775|FG000|Overall Study|Adverse Event|4
7653174|NCT00023764|12068775|FG000|Overall Study|Withdrawal by Subject|1
7653175|NCT00023764|12068775|FG000|Overall Study|Progression of disease|6
7653176|NCT00023764|12068775|FG000|Overall Study|patient received other treatment|1
7653177|NCT00023764|12068775|FG000|Overall Study|delay in obtaining staging images|1
7653178|NCT00024167|12068796|FG000|Overall Study|Death|53
7653179|NCT00024167|12068797|FG001|Overall Study|Death|47
7653180|NCT00024258|12068804|FG000|Overall Study|Withdrawal by Subject|1
7653181|NCT00024258|12068804|FG000|Overall Study|Disease Progression|8
7653182|NCT00025155|12068808|FG000|Overall Study|Ineligible: Wrong primary cancer site|1
7653183|NCT00025155|12068808|FG000|Overall Study|Ineligible: Second primary cancer site|1
7653184|NCT00025233|12068817|FG000|Overall Study|Ineligible: wrong cell type|1
7653185|NCT00025233|12068817|FG000|Overall Study|Ineligible: wrong primary|1
7653186|NCT00025233|12068817|FG000|Overall Study|Ineligible: improper prior treatment|1
7653187|NCT00025233|12068817|FG000|Overall Study|Never treated|1
7653188|NCT00025259|12068834|FG000|Overall Study|Death|1
7653189|NCT00025259|12068835|FG001|Overall Study|Death|3
7653190|NCT00025259|12068836|FG002|Overall Study|Death|0
7653191|NCT00025259|12068837|FG003|Overall Study|Death|3
7653192|NCT00025259|12068838|FG004|Overall Study|Death|0
7653193|NCT00025259|12068839|FG005|Overall Study|Death|1
7653194|NCT00025259|12068840|FG006|Overall Study|Death|2
7653195|NCT00025259|12068834|FG000|Overall Study|Lack of Efficacy|2
7653196|NCT00025259|12068835|FG001|Overall Study|Lack of Efficacy|46
7653197|NCT00025259|12068836|FG002|Overall Study|Lack of Efficacy|60
7653198|NCT00025259|12068837|FG003|Overall Study|Lack of Efficacy|78
7653199|NCT00025259|12068838|FG004|Overall Study|Lack of Efficacy|11
7653200|NCT00025259|12068839|FG005|Overall Study|Lack of Efficacy|30
7653201|NCT00025259|12068840|FG006|Overall Study|Lack of Efficacy|38
7653202|NCT00025259|12068834|FG000|Overall Study|Lost to Follow-up|2
7653203|NCT00025259|12068835|FG001|Overall Study|Lost to Follow-up|9
7653204|NCT00025259|12068836|FG002|Overall Study|Lost to Follow-up|13
7653205|NCT00025259|12068837|FG003|Overall Study|Lost to Follow-up|13
7653206|NCT00025259|12068838|FG004|Overall Study|Lost to Follow-up|1
7653207|NCT00025259|12068839|FG005|Overall Study|Lost to Follow-up|3
7653208|NCT00025259|12068840|FG006|Overall Study|Lost to Follow-up|1
7653209|NCT00025259|12068834|FG000|Overall Study|Physician Decision|12
7653210|NCT00025259|12068835|FG001|Overall Study|Physician Decision|1
7653211|NCT00025259|12068836|FG002|Overall Study|Physician Decision|0
7653212|NCT00025259|12068837|FG003|Overall Study|Physician Decision|5
7653213|NCT00025259|12068838|FG004|Overall Study|Physician Decision|4
7653214|NCT00025259|12068839|FG005|Overall Study|Physician Decision|2
7653215|NCT00025259|12068840|FG006|Overall Study|Physician Decision|1
7653216|NCT00025259|12068834|FG000|Overall Study|Protocol Violation|3
7653217|NCT00025259|12068835|FG001|Overall Study|Protocol Violation|2
7653218|NCT00025259|12068836|FG002|Overall Study|Protocol Violation|2
7653219|NCT00025259|12068837|FG003|Overall Study|Protocol Violation|1
7653220|NCT00025259|12068838|FG004|Overall Study|Protocol Violation|2
7653221|NCT00025259|12068839|FG005|Overall Study|Protocol Violation|1
7653222|NCT00025259|12068840|FG006|Overall Study|Protocol Violation|3
7653223|NCT00025259|12068834|FG000|Overall Study|Withdrawal by Subject|9
7653224|NCT00025259|12068835|FG001|Overall Study|Withdrawal by Subject|27
7653225|NCT00025259|12068836|FG002|Overall Study|Withdrawal by Subject|6
7653226|NCT00025259|12068837|FG003|Overall Study|Withdrawal by Subject|14
7653227|NCT00025259|12068838|FG004|Overall Study|Withdrawal by Subject|11
7653228|NCT00025259|12068839|FG005|Overall Study|Withdrawal by Subject|8
7653229|NCT00025259|12068840|FG006|Overall Study|Withdrawal by Subject|3
7653230|NCT00025259|12068834|FG000|Overall Study|Ineligible|14
7653231|NCT00025259|12068835|FG001|Overall Study|Ineligible|1
7653232|NCT00025259|12068836|FG002|Overall Study|Ineligible|0
7653233|NCT00025259|12068837|FG003|Overall Study|Ineligible|0
7653234|NCT00025259|12068838|FG004|Overall Study|Ineligible|6
7653235|NCT00025259|12068839|FG005|Overall Study|Ineligible|0
7653236|NCT00025259|12068840|FG006|Overall Study|Ineligible|1
7653237|NCT00025259|12068834|FG000|Overall Study|Randomization error|1
7653238|NCT00025259|12068835|FG001|Overall Study|Randomization error|0
7653239|NCT00025259|12068836|FG002|Overall Study|Randomization error|0
7653240|NCT00025259|12068837|FG003|Overall Study|Randomization error|0
7653241|NCT00025259|12068838|FG004|Overall Study|Randomization error|1
7653242|NCT00025259|12068839|FG005|Overall Study|Randomization error|7
7653243|NCT00025259|12068840|FG006|Overall Study|Randomization error|2
7653244|NCT00025259|12068834|FG000|Overall Study|Adverse Event|1
7653245|NCT00025259|12068835|FG001|Overall Study|Adverse Event|0
7653246|NCT00025259|12068836|FG002|Overall Study|Adverse Event|0
7653247|NCT00025259|12068837|FG003|Overall Study|Adverse Event|0
7653248|NCT00025259|12068838|FG004|Overall Study|Adverse Event|0
7653249|NCT00025259|12068839|FG005|Overall Study|Adverse Event|0
7653250|NCT00025259|12068840|FG006|Overall Study|Adverse Event|0
7653251|NCT00025506|12068859|FG000|Overall Study|Ineligible: clerical error|1
7653252|NCT00025506|12068859|FG000|Overall Study|Ineligible: wrong cell type|5
7653253|NCT00025506|12068859|FG000|Overall Study|Ineligible: inadequate pathology|2
7653254|NCT00025506|12068859|FG000|Overall Study|Never Treated|2
7653255|NCT00025662|12068868|FG000|Overall Study|Withdrawal by Subject|2
7653256|NCT00025662|12068868|FG000|Overall Study|Technical failure of manipulation|1
7653257|NCT00025883|12068874|FG000|Overall Study|had atypical progeriod lipodystrophy|4
7653258|NCT00025883|12068874|FG000|Overall Study|no baseline data|1
7653259|NCT00025883|12068874|FG000|Overall Study|Death|1
7653260|NCT00025883|12068874|FG000|Overall Study|Adverse Event|1
7653261|NCT00025883|12068874|FG000|Overall Study|didn't reach 6 months of Metreleptin|10
7653262|NCT00026208|12068881|FG000|Overall Study|Complications of auto accident|1
7653263|NCT00026208|12068882|FG001|Overall Study|Complications of auto accident|0
7653264|NCT00026494|12068905|FG000|Overall Study|Withdrawal by Subject|1
7653265|NCT00026494|12068906|FG001|Overall Study|Withdrawal by Subject|0
7653266|NCT00026494|12068907|FG002|Overall Study|Withdrawal by Subject|1
7653267|NCT00026494|12068908|FG003|Overall Study|Withdrawal by Subject|0
7653268|NCT00026494|12068905|FG000|Overall Study|Patient non-compliance|1
7653269|NCT00026494|12068906|FG001|Overall Study|Patient non-compliance|0
7653270|NCT00026494|12068907|FG002|Overall Study|Patient non-compliance|0
7653271|NCT00026494|12068908|FG003|Overall Study|Patient non-compliance|0
7653272|NCT00026494|12068905|FG000|Overall Study|Patient not treated|0
7653273|NCT00026494|12068906|FG001|Overall Study|Patient not treated|0
7653274|NCT00026494|12068907|FG002|Overall Study|Patient not treated|2
7653275|NCT00026494|12068908|FG003|Overall Study|Patient not treated|0
7653276|NCT00026494|12068905|FG000|Overall Study|Clinical progression|0
7653277|NCT00026494|12068906|FG001|Overall Study|Clinical progression|0
7653278|NCT00026494|12068907|FG002|Overall Study|Clinical progression|3
7653279|NCT00026494|12068908|FG003|Overall Study|Clinical progression|0
7653280|NCT00026793|12068918|FG000|Overall Study|Death on study due to underlying disease|4
7653281|NCT00026793|12068918|FG000|Overall Study|Physician Decision|2
7653282|NCT00026793|12068918|FG000|Overall Study|Off study|2
7653283|NCT00027027|12068927|FG000|Overall Study|Adverse Event|0
7653284|NCT00027027|12068928|FG001|Overall Study|Adverse Event|0
7653285|NCT00027027|12068929|FG002|Overall Study|Adverse Event|1
7653286|NCT00027027|12068930|FG003|Overall Study|Adverse Event|0
7653287|NCT00027027|12068931|FG004|Overall Study|Adverse Event|1
7653288|NCT00027027|12068927|FG000|Overall Study|Admitted for Signs of PD|0
7653289|NCT00027027|12068928|FG001|Overall Study|Admitted for Signs of PD|0
7653290|NCT00027027|12068929|FG002|Overall Study|Admitted for Signs of PD|0
7653291|NCT00027027|12068930|FG003|Overall Study|Admitted for Signs of PD|0
7653292|NCT00027027|12068931|FG004|Overall Study|Admitted for Signs of PD|1
7653293|NCT00027027|12068927|FG000|Overall Study|Clinical Symptoms Progression not PD|1
7653294|NCT00027027|12068928|FG001|Overall Study|Clinical Symptoms Progression not PD|0
7653295|NCT00027027|12068929|FG002|Overall Study|Clinical Symptoms Progression not PD|0
7653296|NCT00027027|12068930|FG003|Overall Study|Clinical Symptoms Progression not PD|0
7653297|NCT00027027|12068931|FG004|Overall Study|Clinical Symptoms Progression not PD|0
7653298|NCT00027027|12068927|FG000|Overall Study|PD Requiring Surgery|0
7653299|NCT00027027|12068928|FG001|Overall Study|PD Requiring Surgery|0
7653300|NCT00027027|12068929|FG002|Overall Study|PD Requiring Surgery|1
7653301|NCT00027027|12068930|FG003|Overall Study|PD Requiring Surgery|0
7653302|NCT00027027|12068931|FG004|Overall Study|PD Requiring Surgery|0
7653303|NCT00027027|12068927|FG000|Overall Study|Physician Decision Due To PD|2
7653304|NCT00027027|12068928|FG001|Overall Study|Physician Decision Due To PD|3
7653305|NCT00027027|12068929|FG002|Overall Study|Physician Decision Due To PD|2
7653306|NCT00027027|12068930|FG003|Overall Study|Physician Decision Due To PD|3
7653307|NCT00027027|12068931|FG004|Overall Study|Physician Decision Due To PD|5
7653308|NCT00027027|12068927|FG000|Overall Study|Withdrawal by Subject|0
7653309|NCT00027027|12068928|FG001|Overall Study|Withdrawal by Subject|0
7653310|NCT00027027|12068929|FG002|Overall Study|Withdrawal by Subject|0
7653311|NCT00027027|12068930|FG003|Overall Study|Withdrawal by Subject|0
7653312|NCT00027027|12068931|FG004|Overall Study|Withdrawal by Subject|1
7653313|NCT00027378|12068949|FG000|Overall Study|Physician Decision|0
7653314|NCT00027378|12068950|FG001|Overall Study|Physician Decision|3
7653315|NCT00027560|12068956|FG000|Overall Study|Withdrawal by Subject|1
7653316|NCT00027846|12068965|FG000|Overall Study|Lost to Follow-up|0
7653317|NCT00027846|12068966|FG001|Overall Study|Lost to Follow-up|41
7653318|NCT00027846|12068967|FG002|Overall Study|Lost to Follow-up|9
7653319|NCT00027846|12068965|FG000|Overall Study|Withdrawal by Subject|0
7653320|NCT00027846|12068966|FG001|Overall Study|Withdrawal by Subject|14
7653321|NCT00027846|12068967|FG002|Overall Study|Withdrawal by Subject|7
7653322|NCT00027846|12068965|FG000|Overall Study|Ineligible for study|2
7653323|NCT00027846|12068966|FG001|Overall Study|Ineligible for study|6
7653324|NCT00027846|12068967|FG002|Overall Study|Ineligible for study|14
7653325|NCT00027846|12068965|FG000|Overall Study|Entry into another COG therapeutic study|0
7653326|NCT00027846|12068966|FG001|Overall Study|Entry into another COG therapeutic study|5
7653327|NCT00027846|12068967|FG002|Overall Study|Entry into another COG therapeutic study|2
7653328|NCT00027846|12068965|FG000|Overall Study|Neuraxis dissemination during/after ther|0
7653329|NCT00027846|12068966|FG001|Overall Study|Neuraxis dissemination during/after ther|2
7653330|NCT00027846|12068967|FG002|Overall Study|Neuraxis dissemination during/after ther|5
7653331|NCT00028002|12068977|FG000|Overall Study|Withdrawal by Subject|3
7653332|NCT00028002|12068977|FG000|Overall Study|Ineligible|8
7653333|NCT00028769|12068995|FG000|Overall Study|Adverse Event|2
7653334|NCT00028769|12068995|FG000|Overall Study|Refusal Unrelated to Adverse Events|1
7653335|NCT00028769|12068995|FG000|Overall Study|Progression or Death|31
7653336|NCT00028769|12068995|FG000|Overall Study|Other - Not Protocol Specified|1
7653337|NCT00028769|12068995|FG000|Overall Study|Ineligible|5
7653338|NCT00028769|12068995|FG000|Overall Study|Not Analyzable|1
7653339|NCT00029146|12069010|FG000|Overall Study|Lost to Follow-up|2
7653340|NCT00029146|12069011|FG001|Overall Study|Lost to Follow-up|1
7653341|NCT00030823|12069061|FG000|Overall Study|Withdrawal by Subject|1
7653342|NCT00030901|12069067|FG000|Initial Registration|Ineligible|167
7653343|NCT00030901|12069068|FG001|Initial Registration|Ineligible|0
7653344|NCT00030901|12069069|FG002|Initial Registration|Ineligible|0
7653345|NCT00030901|12069067|FG000|Randomization|Adverse Event|0
7653346|NCT00030901|12069068|FG001|Randomization|Adverse Event|11
7653347|NCT00030901|12069069|FG002|Randomization|Adverse Event|7
7653348|NCT00030901|12069067|FG000|Randomization|Refusal Unrelated to Adverse Event|0
7653349|NCT00030901|12069068|FG001|Randomization|Refusal Unrelated to Adverse Event|16
7653350|NCT00030901|12069069|FG002|Randomization|Refusal Unrelated to Adverse Event|10
7653351|NCT00030901|12069067|FG000|Randomization|Progression/Relapse|0
7653352|NCT00030901|12069068|FG001|Randomization|Progression/Relapse|22
7653353|NCT00030901|12069069|FG002|Randomization|Progression/Relapse|21
7653354|NCT00030901|12069067|FG000|Randomization|Death|0
7653355|NCT00030901|12069068|FG001|Randomization|Death|1
7653356|NCT00030901|12069069|FG002|Randomization|Death|3
7653357|NCT00030901|12069067|FG000|Randomization|Other|0
7653358|NCT00030901|12069068|FG001|Randomization|Other|36
7653359|NCT00030901|12069069|FG002|Randomization|Other|33
7653360|NCT00030901|12069067|FG000|Randomization|Ineligible|0
7653361|NCT00030901|12069068|FG001|Randomization|Ineligible|15
7653362|NCT00030901|12069069|FG002|Randomization|Ineligible|14
7653363|NCT00031447|12069081|FG000|Overall Study|Lost to Follow-up|0
7653364|NCT00031447|12069082|FG001|Overall Study|Lost to Follow-up|1
7653365|NCT00031447|12069081|FG000|Overall Study|Non-compliant|1
7653366|NCT00031447|12069082|FG001|Overall Study|Non-compliant|1
7653367|NCT00031447|12069081|FG000|Overall Study|Re-activation of Disease|2
7653368|NCT00031447|12069082|FG001|Overall Study|Re-activation of Disease|1
7653369|NCT00031447|12069081|FG000|Overall Study|Disruption of blinded study drug supply|7
7653370|NCT00031447|12069082|FG001|Overall Study|Disruption of blinded study drug supply|4
7653371|NCT00031460|12069090|FG000|Overall Study|Lost to Follow-up|0
7653372|NCT00031460|12069091|FG001|Overall Study|Lost to Follow-up|1
7653373|NCT00031460|12069090|FG000|Overall Study|Withdrawal by Subject|1
7653374|NCT00031460|12069091|FG001|Overall Study|Withdrawal by Subject|1
7653375|NCT00031460|12069090|FG000|Overall Study|Non-Compliant|1
7653376|NCT00031460|12069091|FG001|Overall Study|Non-Compliant|1
7653377|NCT00031460|12069090|FG000|Overall Study|Death|0
7653378|NCT00031460|12069091|FG001|Overall Study|Death|1
7653379|NCT00031460|12069090|FG000|Overall Study|Reactivation of Disease|5
7653380|NCT00031460|12069091|FG001|Overall Study|Reactivation of Disease|9
7653381|NCT00031460|12069090|FG000|Overall Study|Disruption of blinded drug supply|2
7653382|NCT00031460|12069091|FG001|Overall Study|Disruption of blinded drug supply|0
7653383|NCT00031460|12069090|FG000|Overall Study|Confirmed unevaluable|0
7653384|NCT00031460|12069091|FG001|Overall Study|Confirmed unevaluable|1
7653385|NCT00031486|12069099|FG000|Overall Study|Adverse Event|1
7653386|NCT00031486|12069100|FG001|Overall Study|Adverse Event|0
7653387|NCT00031486|12069099|FG000|Overall Study|Lost to Follow-up|0
7653388|NCT00031486|12069100|FG001|Overall Study|Lost to Follow-up|1
7653389|NCT00031486|12069099|FG000|Overall Study|Withdrawal by Subject|3
7653390|NCT00031486|12069100|FG001|Overall Study|Withdrawal by Subject|2
7653391|NCT00031486|12069099|FG000|Overall Study|Death|0
7653392|NCT00031486|12069100|FG001|Overall Study|Death|3
7653393|NCT00031486|12069099|FG000|Overall Study|Non-compliant|0
7653394|NCT00031486|12069100|FG001|Overall Study|Non-compliant|4
7653395|NCT00031486|12069099|FG000|Overall Study|Did not meet eligibility requirement|2
7653396|NCT00031486|12069100|FG001|Overall Study|Did not meet eligibility requirement|1
7653397|NCT00031486|12069099|FG000|Overall Study|Other|1
7653398|NCT00031486|12069100|FG001|Overall Study|Other|1
7653399|NCT00031551|12069110|FG000|Overall Study|Withdrew due to chemotherapy effects|2
7653400|NCT00031551|12069111|FG001|Overall Study|Withdrew due to chemotherapy effects|0
7653401|NCT00031590|12069121|FG000|Overall Study|Adverse Event|1
7653402|NCT00031590|12069121|FG000|Overall Study|Withdrawal by parents|2
7653403|NCT00031694|12069126|FG000|Overall Study|Adverse Event|12
7653404|NCT00031694|12069126|FG000|Overall Study|Death|2
7653405|NCT00031694|12069126|FG000|Overall Study|Withdrawal by Subject|5
7653406|NCT00032487|12069133|FG000|Overall Study|Withdrawal by Subject|67
7653407|NCT00032487|12069134|FG001|Overall Study|Withdrawal by Subject|43
7653408|NCT00032487|12069133|FG000|Overall Study|Adverse Event|3
7653409|NCT00032487|12069134|FG001|Overall Study|Adverse Event|7
7653410|NCT00032487|12069133|FG000|Overall Study|Lost to Follow-up|57
7653411|NCT00032487|12069134|FG001|Overall Study|Lost to Follow-up|58
7653412|NCT00032487|12069133|FG000|Overall Study|Had other reason|12
7653413|NCT00032487|12069134|FG001|Overall Study|Had other reason|12
7653414|NCT00033371|12069160|FG000|Overall Study|Adverse Event|1
7653415|NCT00033371|12069161|FG001|Overall Study|Adverse Event|5
7653416|NCT00033371|12069160|FG000|Overall Study|Lost to Follow-up|2
7653417|NCT00033371|12069161|FG001|Overall Study|Lost to Follow-up|1
7653418|NCT00033371|12069160|FG000|Overall Study|Withdrawal by Subject|3
7653419|NCT00033371|12069161|FG001|Overall Study|Withdrawal by Subject|3
7653420|NCT00033371|12069160|FG000|Overall Study|Disease Progression|0
7653421|NCT00033371|12069161|FG001|Overall Study|Disease Progression|1
7653422|NCT00033514|12069173|FG000|Overall Study|Lost to Follow-up|1
7653423|NCT00033514|12069174|FG001|Overall Study|Lost to Follow-up|1
7653424|NCT00033514|12069173|FG000|Overall Study|Withdrawal by Subject|0
7653425|NCT00033514|12069174|FG001|Overall Study|Withdrawal by Subject|3
7653426|NCT00033540|12069181|FG000|Overall Study|Adverse Event|14
7653427|NCT00033540|12069181|FG000|Overall Study|Death|1
7653428|NCT00033540|12069181|FG000|Overall Study|Progression|26
7653429|NCT00033540|12069181|FG000|Overall Study|Withdrawal by Subject|6
7653430|NCT00033540|12069181|FG000|Overall Study|Other|5
7653431|NCT00033540|12069181|FG000|Overall Study|Ineligible|3
7653432|NCT00033540|12069181|FG000|Overall Study|Never received treatment|2
7653433|NCT00033657|12069188|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1
7653434|NCT00033657|12069189|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2
7653435|NCT00033657|12069188|FG000|Neoadjuvant Chemotherapy|Adverse Event|0
7653436|NCT00033657|12069189|FG001|Neoadjuvant Chemotherapy|Adverse Event|2
7653437|NCT00033657|12069188|FG000|Neoadjuvant Chemotherapy|Death|1
7653438|NCT00033657|12069189|FG001|Neoadjuvant Chemotherapy|Death|1
7653439|NCT00033657|12069188|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
7653440|NCT00033657|12069189|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
7653441|NCT00033657|12069188|FG000|Neoadjuvant Chemotherapy|other complicating disease|0
7653442|NCT00033657|12069189|FG001|Neoadjuvant Chemotherapy|other complicating disease|1
7653443|NCT00033657|12069188|FG000|Neoadjuvant Chemotherapy|Ineligible|8
7653444|NCT00033657|12069189|FG001|Neoadjuvant Chemotherapy|Ineligible|4
7653445|NCT00033657|12069188|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3
7653446|NCT00033657|12069189|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1
7653447|NCT00033657|12069188|FG000|Surgical Resection|not complete resection|0
7653448|NCT00033657|12069189|FG001|Surgical Resection|not complete resection|3
7653449|NCT00033657|12069188|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3
7653450|NCT00033657|12069189|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1
7653451|NCT00033657|12069188|FG000|Adjuvant Chemotherapy|Adverse Event|7
7653452|NCT00033657|12069189|FG001|Adjuvant Chemotherapy|Adverse Event|10
7653453|NCT00033657|12069188|FG000|Adjuvant Chemotherapy|Death|2
7653454|NCT00033657|12069189|FG001|Adjuvant Chemotherapy|Death|1
7653455|NCT00033657|12069188|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5
7653456|NCT00033657|12069189|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3
7653457|NCT00033657|12069188|FG000|Adjuvant Chemotherapy|alternative therapy|1
7653458|NCT00033657|12069189|FG001|Adjuvant Chemotherapy|alternative therapy|0
7653459|NCT00033657|12069188|FG000|Adjuvant Chemotherapy|Other|0
7653460|NCT00033657|12069189|FG001|Adjuvant Chemotherapy|Other|2
7653461|NCT00035555|12069213|FG000|Overall Study|Adverse Event|5
7653462|NCT00035555|12069214|FG001|Overall Study|Adverse Event|8
7653463|NCT00035555|12069215|FG002|Overall Study|Adverse Event|9
7653464|NCT00035555|12069213|FG000|Overall Study|Allograft loss|1
7653465|NCT00035555|12069214|FG001|Overall Study|Allograft loss|1
7653466|NCT00035555|12069215|FG002|Overall Study|Allograft loss|2
7653467|NCT00035555|12069213|FG000|Overall Study|Death|0
7653468|NCT00035555|12069214|FG001|Overall Study|Death|0
7653469|NCT00035555|12069215|FG002|Overall Study|Death|2
7653470|NCT00035555|12069213|FG000|Overall Study|Lost to Follow-up|0
7653471|NCT00035555|12069214|FG001|Overall Study|Lost to Follow-up|0
7653472|NCT00035555|12069215|FG002|Overall Study|Lost to Follow-up|1
7653473|NCT00035555|12069213|FG000|Overall Study|Noncompliance|0
7653474|NCT00035555|12069214|FG001|Overall Study|Noncompliance|1
7653475|NCT00035555|12069215|FG002|Overall Study|Noncompliance|1
7653476|NCT00035555|12069213|FG000|Overall Study|Prohibited medication|1
7653477|NCT00035555|12069214|FG001|Overall Study|Prohibited medication|1
7653478|NCT00035555|12069215|FG002|Overall Study|Prohibited medication|0
7653479|NCT00035555|12069213|FG000|Overall Study|Treatment failure/lack of efficacy|7
7653480|NCT00035555|12069214|FG001|Overall Study|Treatment failure/lack of efficacy|5
7653481|NCT00035555|12069215|FG002|Overall Study|Treatment failure/lack of efficacy|3
7653482|NCT00035555|12069213|FG000|Overall Study|Withdrawal by Subject|2
7653483|NCT00035555|12069214|FG001|Overall Study|Withdrawal by Subject|0
7653484|NCT00035555|12069215|FG002|Overall Study|Withdrawal by Subject|2
7653485|NCT00035555|12069213|FG000|Overall Study|Investigator deemed not a good candidate|0
7653486|NCT00035555|12069214|FG001|Overall Study|Investigator deemed not a good candidate|0
7653566|NCT00038103|12069285|FG000|Overall Study|Randomized/never treated|2
7653487|NCT00035555|12069215|FG002|Overall Study|Investigator deemed not a good candidate|1
7653488|NCT00035555|12069213|FG000|Overall Study|Received cyclosporin in error|0
7653489|NCT00035555|12069214|FG001|Overall Study|Received cyclosporin in error|0
7653490|NCT00035555|12069215|FG002|Overall Study|Received cyclosporin in error|1
7653491|NCT00035815|12069226|FG000|Overall Study|Withdrawal by Subject|17
7653492|NCT00035815|12069227|FG001|Overall Study|Withdrawal by Subject|11
7653493|NCT00035932|12069236|FG000|Overall Study|Adverse Event|10
7653494|NCT00035932|12069237|FG001|Overall Study|Adverse Event|9
7653495|NCT00035932|12069238|FG002|Overall Study|Adverse Event|9
7653496|NCT00035932|12069236|FG000|Overall Study|Death|0
7653497|NCT00035932|12069237|FG001|Overall Study|Death|0
7653498|NCT00035932|12069238|FG002|Overall Study|Death|1
7653499|NCT00035932|12069236|FG000|Overall Study|Disease Progression / Relapse|1
7653500|NCT00035932|12069237|FG001|Overall Study|Disease Progression / Relapse|1
7653501|NCT00035932|12069238|FG002|Overall Study|Disease Progression / Relapse|0
7653502|NCT00035932|12069236|FG000|Overall Study|Lost to Follow-up|4
7653503|NCT00035932|12069237|FG001|Overall Study|Lost to Follow-up|4
7653504|NCT00035932|12069238|FG002|Overall Study|Lost to Follow-up|3
7653505|NCT00035932|12069236|FG000|Overall Study|Noncompliance|6
7653506|NCT00035932|12069237|FG001|Overall Study|Noncompliance|7
7653507|NCT00035932|12069238|FG002|Overall Study|Noncompliance|6
7653508|NCT00035932|12069236|FG000|Overall Study|Protocol Violation While on Study|0
7653509|NCT00035932|12069237|FG001|Overall Study|Protocol Violation While on Study|1
7653510|NCT00035932|12069238|FG002|Overall Study|Protocol Violation While on Study|2
7653511|NCT00035932|12069236|FG000|Overall Study|Withdrawal by Subject|1
7653512|NCT00035932|12069237|FG001|Overall Study|Withdrawal by Subject|5
7653513|NCT00035932|12069238|FG002|Overall Study|Withdrawal by Subject|0
7653514|NCT00035932|12069236|FG000|Overall Study|Study Termination by Sponsor|1
7653515|NCT00035932|12069237|FG001|Overall Study|Study Termination by Sponsor|0
7653516|NCT00035932|12069238|FG002|Overall Study|Study Termination by Sponsor|0
7653517|NCT00035932|12069236|FG000|Overall Study|Lack of Efficacy|33
7653518|NCT00035932|12069237|FG001|Overall Study|Lack of Efficacy|33
7653519|NCT00035932|12069238|FG002|Overall Study|Lack of Efficacy|28
7653520|NCT00036270|12069253|FG000|Randomized to Study Treatment|Withdrawal by Subject|6
7653521|NCT00036270|12069254|FG001|Randomized to Study Treatment|Withdrawal by Subject|7
7653522|NCT00036270|12069253|FG000|Study Treatment to 5 Year Report|Ongoing|1081
7653523|NCT00036270|12069254|FG001|Study Treatment to 5 Year Report|Ongoing|736
7653524|NCT00036270|12069253|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
7653525|NCT00036270|12069254|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
7653526|NCT00036270|12069253|FG000|Study Treatment to 5 Year Report|Adverse Event|501
7653527|NCT00036270|12069254|FG001|Study Treatment to 5 Year Report|Adverse Event|782
7653528|NCT00036270|12069253|FG000|Study Treatment to 5 Year Report|Other|277
7653529|NCT00036270|12069254|FG001|Study Treatment to 5 Year Report|Other|288
7653530|NCT00036270|12069253|FG000|Study Treatment to 5 Year Report|Treatment refusal|113
7653531|NCT00036270|12069254|FG001|Study Treatment to 5 Year Report|Treatment refusal|208
7653532|NCT00036270|12069253|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46
7653533|NCT00036270|12069254|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54
7653534|NCT00036270|12069253|FG000|Study Treatment to 5 Year Report|Protocol Violation|23
7653535|NCT00036270|12069254|FG001|Study Treatment to 5 Year Report|Protocol Violation|91
7653536|NCT00036270|12069253|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17
7653537|NCT00036270|12069254|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29
7653538|NCT00036270|12069253|FG000|Study Treatment to 5 Year Report|Too early switch|0
7653539|NCT00036270|12069254|FG001|Study Treatment to 5 Year Report|Too early switch|103
7653540|NCT00036270|12069253|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
7653541|NCT00036270|12069254|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
7653542|NCT00037830|12069273|FG000|Overall Study|Adverse Event|2
7653543|NCT00037830|12069274|FG001|Overall Study|Adverse Event|0
7653544|NCT00037830|12069275|FG002|Overall Study|Adverse Event|0
7653545|NCT00037830|12069273|FG000|Overall Study|Withdrawal by Subject|4
7653546|NCT00037830|12069274|FG001|Overall Study|Withdrawal by Subject|5
7653547|NCT00037830|12069275|FG002|Overall Study|Withdrawal by Subject|1
7653548|NCT00037830|12069273|FG000|Overall Study|Protocol Violation|2
7653549|NCT00037830|12069274|FG001|Overall Study|Protocol Violation|2
7653550|NCT00037830|12069275|FG002|Overall Study|Protocol Violation|0
7653551|NCT00037830|12069273|FG000|Overall Study|Unrelated Medical Problem|2
7653552|NCT00037830|12069274|FG001|Overall Study|Unrelated Medical Problem|0
7653553|NCT00037830|12069275|FG002|Overall Study|Unrelated Medical Problem|0
7653554|NCT00038103|12069285|FG000|Overall Study|Adverse Event|5
7653555|NCT00038103|12069286|FG001|Overall Study|Adverse Event|6
7653556|NCT00038103|12069285|FG000|Overall Study|Lack of Efficacy|48
7653557|NCT00038103|12069286|FG001|Overall Study|Lack of Efficacy|41
7653558|NCT00038103|12069285|FG000|Overall Study|Withdrawal by Subject|0
7653559|NCT00038103|12069286|FG001|Overall Study|Withdrawal by Subject|3
7653560|NCT00038103|12069285|FG000|Overall Study|Lost to Follow-up|0
7653561|NCT00038103|12069286|FG001|Overall Study|Lost to Follow-up|3
7653562|NCT00038103|12069285|FG000|Overall Study|Protocol Violation|0
7653563|NCT00038103|12069286|FG001|Overall Study|Protocol Violation|2
7653564|NCT00038103|12069285|FG000|Overall Study|Sponsor Decision|0
7653565|NCT00038103|12069286|FG001|Overall Study|Sponsor Decision|1
7653567|NCT00038103|12069286|FG001|Overall Study|Randomized/never treated|0
7653568|NCT00038467|12069294|FG000|Overall Study|Adverse Event|170
7653569|NCT00038467|12069295|FG001|Overall Study|Adverse Event|145
7653570|NCT00038467|12069294|FG000|Overall Study|Withdrawal by Subject|150
7653571|NCT00038467|12069295|FG001|Overall Study|Withdrawal by Subject|107
7653572|NCT00038467|12069294|FG000|Overall Study|Protocol Violation|19
7653573|NCT00038467|12069295|FG001|Overall Study|Protocol Violation|22
7653574|NCT00038467|12069294|FG000|Overall Study|Death|22
7653575|NCT00038467|12069295|FG001|Overall Study|Death|16
7653576|NCT00038467|12069294|FG000|Overall Study|Lost to Follow-up|15
7653577|NCT00038467|12069295|FG001|Overall Study|Lost to Follow-up|10
7653578|NCT00038467|12069294|FG000|Overall Study|Recurrence|109
7653579|NCT00038467|12069295|FG001|Overall Study|Recurrence|179
7653580|NCT00038467|12069294|FG000|Overall Study|Randomized, but not treated|31
7653581|NCT00038467|12069295|FG001|Overall Study|Randomized, but not treated|35
7653582|NCT00038467|12069294|FG000|Overall Study|Other|26
7653583|NCT00038467|12069295|FG001|Overall Study|Other|28
7653584|NCT00038649|12069305|FG000|Overall Study|Adverse Event|9
7653585|NCT00038948|12069315|FG000|Overall Study|Adverse Event|131
7653586|NCT00038948|12069316|FG001|Overall Study|Adverse Event|43
7653587|NCT00038948|12069315|FG000|Overall Study|Lost to Follow-up|4
7653588|NCT00038948|12069316|FG001|Overall Study|Lost to Follow-up|4
7653589|NCT00038948|12069315|FG000|Overall Study|Nonmedical event|5
7653590|NCT00038948|12069316|FG001|Overall Study|Nonmedical event|7
7653591|NCT00038948|12069315|FG000|Overall Study|Withdrawal by Subject|23
7653592|NCT00038948|12069316|FG001|Overall Study|Withdrawal by Subject|10
7653593|NCT00038948|12069315|FG000|Overall Study|Protocol Violation|3
7653594|NCT00038948|12069316|FG001|Overall Study|Protocol Violation|7
7653595|NCT00038948|12069315|FG000|Overall Study|Lack of Efficacy|3
7653596|NCT00038948|12069316|FG001|Overall Study|Lack of Efficacy|6
7653597|NCT00039130|12069328|FG000|Overall Study|Adverse Event|11
7653598|NCT00039130|12069328|FG000|Overall Study|Death|9
7653599|NCT00039130|12069328|FG000|Overall Study|Withdrawal by Subject|3
7653600|NCT00039130|12069328|FG000|Overall Study|Progression|2
7653601|NCT00039130|12069328|FG000|Overall Study|Subsequent treatment|2
7653602|NCT00039130|12069328|FG000|Overall Study|Physician Decision|3
7653603|NCT00039377|12069336|FG000|Initial Registration|Adverse Event|2
7653604|NCT00039377|12069337|FG001|Initial Registration|Adverse Event|0
7653605|NCT00039377|12069338|FG002|Initial Registration|Adverse Event|0
7653606|NCT00039377|12069339|FG003|Initial Registration|Adverse Event|0
7653607|NCT00039377|12069336|FG000|Initial Registration|Relapsed|6
7653608|NCT00039377|12069337|FG001|Initial Registration|Relapsed|0
7653609|NCT00039377|12069338|FG002|Initial Registration|Relapsed|0
7653610|NCT00039377|12069339|FG003|Initial Registration|Relapsed|0
7653611|NCT00039377|12069336|FG000|Initial Registration|Received non-protocol therapy|11
7653612|NCT00039377|12069337|FG001|Initial Registration|Received non-protocol therapy|0
7653613|NCT00039377|12069338|FG002|Initial Registration|Received non-protocol therapy|0
7653614|NCT00039377|12069339|FG003|Initial Registration|Received non-protocol therapy|0
7653615|NCT00039377|12069336|FG000|Initial Registration|Withdrawal by Subject|3
7653616|NCT00039377|12069337|FG001|Initial Registration|Withdrawal by Subject|0
7653617|NCT00039377|12069338|FG002|Initial Registration|Withdrawal by Subject|0
7653618|NCT00039377|12069339|FG003|Initial Registration|Withdrawal by Subject|0
7653619|NCT00039741|12069351|FG000|Overall Study|Death|0
7653620|NCT00039741|12069352|FG001|Overall Study|Death|1
7653621|NCT00039741|12069353|FG002|Overall Study|Death|0
7653622|NCT00039741|12069354|FG003|Overall Study|Death|0
7653623|NCT00039741|12069351|FG000|Overall Study|Lost to Follow-up|3
7653624|NCT00039741|12069352|FG001|Overall Study|Lost to Follow-up|1
7653625|NCT00039741|12069353|FG002|Overall Study|Lost to Follow-up|5
7653626|NCT00039741|12069354|FG003|Overall Study|Lost to Follow-up|2
7653627|NCT00039741|12069351|FG000|Overall Study|Confounding medical condition|1
7653628|NCT00039741|12069352|FG001|Overall Study|Confounding medical condition|0
7653629|NCT00039741|12069353|FG002|Overall Study|Confounding medical condition|0
7653630|NCT00039741|12069354|FG003|Overall Study|Confounding medical condition|0
7653631|NCT00039741|12069351|FG000|Overall Study|Not able to get to clinic|5
7653632|NCT00039741|12069352|FG001|Overall Study|Not able to get to clinic|2
7653633|NCT00039741|12069353|FG002|Overall Study|Not able to get to clinic|0
7653634|NCT00039741|12069354|FG003|Overall Study|Not able to get to clinic|3
7653635|NCT00039741|12069351|FG000|Overall Study|Moved|3
7653636|NCT00039741|12069352|FG001|Overall Study|Moved|2
7653637|NCT00039741|12069353|FG002|Overall Study|Moved|3
7653638|NCT00039741|12069354|FG003|Overall Study|Moved|6
7653639|NCT00039741|12069351|FG000|Overall Study|Non-compliance with protocol|1
7653640|NCT00039741|12069352|FG001|Overall Study|Non-compliance with protocol|0
7653641|NCT00039741|12069353|FG002|Overall Study|Non-compliance with protocol|1
7653642|NCT00039741|12069354|FG003|Overall Study|Non-compliance with protocol|0
7653643|NCT00039741|12069351|FG000|Overall Study|Withdrew consent|0
7653644|NCT00039741|12069352|FG001|Overall Study|Withdrew consent|5
7653645|NCT00039741|12069353|FG002|Overall Study|Withdrew consent|0
7653646|NCT00039741|12069354|FG003|Overall Study|Withdrew consent|1
7653647|NCT00039741|12069351|FG000|Overall Study|Missed final visit|2
7653648|NCT00039741|12069352|FG001|Overall Study|Missed final visit|1
7653649|NCT00039741|12069353|FG002|Overall Study|Missed final visit|2
7653650|NCT00039741|12069354|FG003|Overall Study|Missed final visit|2
7653651|NCT00039871|12069364|FG000|Overall Study|Adverse Event|165
7653652|NCT00039871|12069364|FG000|Overall Study|Lost to Follow-up|18
7653653|NCT00039871|12069364|FG000|Overall Study|Protocol Violation|24
7653654|NCT00039871|12069364|FG000|Overall Study|Withdrawal by Subject|97
7653655|NCT00039871|12069364|FG000|Overall Study|Did not meet eligibility criteria|11
7653656|NCT00039871|12069364|FG000|Overall Study|Administrative|1
7653657|NCT00039871|12069364|FG000|Overall Study|Discontinued at Week 12 per protocol|1061
7653658|NCT00039871|12069364|FG000|Overall Study|Never entered follow-up|7
7653659|NCT00040365|12069368|FG000|Overall Study|Death|1
7653660|NCT00040365|12069368|FG000|Overall Study|Progressive disease|7
7653661|NCT00040365|12069368|FG000|Overall Study|Lost to Follow-up|3
7653662|NCT00040664|12069381|FG000|Overall Study|Adverse Event|12
7653663|NCT00040664|12069382|FG001|Overall Study|Adverse Event|3
7653664|NCT00040664|12069383|FG002|Overall Study|Adverse Event|2
7653665|NCT00040664|12069384|FG003|Overall Study|Adverse Event|7
7653666|NCT00040664|12069381|FG000|Overall Study|Lack of Efficacy|9
7653667|NCT00040664|12069382|FG001|Overall Study|Lack of Efficacy|2
7653668|NCT00040664|12069383|FG002|Overall Study|Lack of Efficacy|3
7653669|NCT00040664|12069384|FG003|Overall Study|Lack of Efficacy|4
7653670|NCT00040664|12069381|FG000|Overall Study|Insufficient CD4 response|1
7653671|NCT00040664|12069382|FG001|Overall Study|Insufficient CD4 response|0
7653672|NCT00040664|12069383|FG002|Overall Study|Insufficient CD4 response|1
7653673|NCT00040664|12069384|FG003|Overall Study|Insufficient CD4 response|0
7653674|NCT00040664|12069381|FG000|Overall Study|Lost to Follow-up|4
7653675|NCT00040664|12069382|FG001|Overall Study|Lost to Follow-up|2
7653676|NCT00040664|12069383|FG002|Overall Study|Lost to Follow-up|0
7653677|NCT00040664|12069384|FG003|Overall Study|Lost to Follow-up|2
7653678|NCT00040664|12069381|FG000|Overall Study|Protocol Violation|2
7653679|NCT00040664|12069382|FG001|Overall Study|Protocol Violation|1
7653680|NCT00040664|12069383|FG002|Overall Study|Protocol Violation|0
7653681|NCT00040664|12069384|FG003|Overall Study|Protocol Violation|1
7653682|NCT00040664|12069381|FG000|Overall Study|Withdrawal by Subject|7
7653683|NCT00040664|12069382|FG001|Overall Study|Withdrawal by Subject|0
7653684|NCT00040664|12069383|FG002|Overall Study|Withdrawal by Subject|3
7653685|NCT00040664|12069384|FG003|Overall Study|Withdrawal by Subject|4
7653686|NCT00040664|12069381|FG000|Overall Study|Pregnancy|3
7653687|NCT00040664|12069382|FG001|Overall Study|Pregnancy|0
7653688|NCT00040664|12069383|FG002|Overall Study|Pregnancy|0
7653689|NCT00040664|12069384|FG003|Overall Study|Pregnancy|3
7653690|NCT00040664|12069381|FG000|Overall Study|Medication adherence/compliance problems|8
7653691|NCT00040664|12069382|FG001|Overall Study|Medication adherence/compliance problems|2
7653692|NCT00040664|12069383|FG002|Overall Study|Medication adherence/compliance problems|1
7653693|NCT00040664|12069384|FG003|Overall Study|Medication adherence/compliance problems|5
7653694|NCT00040664|12069381|FG000|Overall Study|Poor taste|2
7653695|NCT00040664|12069382|FG001|Overall Study|Poor taste|0
7653696|NCT00040664|12069383|FG002|Overall Study|Poor taste|2
7653697|NCT00040664|12069384|FG003|Overall Study|Poor taste|0
7653698|NCT00040664|12069381|FG000|Overall Study|Pharmacokinetic target not achieved|2
7653699|NCT00040664|12069382|FG001|Overall Study|Pharmacokinetic target not achieved|1
7653700|NCT00040664|12069383|FG002|Overall Study|Pharmacokinetic target not achieved|0
7653701|NCT00040664|12069384|FG003|Overall Study|Pharmacokinetic target not achieved|1
7653702|NCT00040664|12069381|FG000|Overall Study|Change of formulation|2
7653703|NCT00040664|12069382|FG001|Overall Study|Change of formulation|2
7653704|NCT00040664|12069383|FG002|Overall Study|Change of formulation|0
7653705|NCT00040664|12069384|FG003|Overall Study|Change of formulation|0
7653706|NCT00040664|12069381|FG000|Overall Study|Non-viability of oral suspension|1
7653707|NCT00040664|12069382|FG001|Overall Study|Non-viability of oral suspension|0
7653708|NCT00040664|12069383|FG002|Overall Study|Non-viability of oral suspension|1
7653709|NCT00040664|12069384|FG003|Overall Study|Non-viability of oral suspension|0
7653710|NCT00040742|12069406|FG000|Overall Study|Death|0
7653711|NCT00040742|12069407|FG001|Overall Study|Death|0
7653712|NCT00040742|12069408|FG002|Overall Study|Death|1
7653713|NCT00040742|12069409|FG003|Overall Study|Death|0
7653714|NCT00040742|12069406|FG000|Overall Study|Adverse Event|15
7653715|NCT00040742|12069407|FG001|Overall Study|Adverse Event|16
7653716|NCT00040742|12069408|FG002|Overall Study|Adverse Event|21
7653717|NCT00040742|12069409|FG003|Overall Study|Adverse Event|9
7653718|NCT00040742|12069406|FG000|Overall Study|Withdrawal by Subject|7
7653719|NCT00040742|12069407|FG001|Overall Study|Withdrawal by Subject|15
7653720|NCT00040742|12069408|FG002|Overall Study|Withdrawal by Subject|10
7653721|NCT00040742|12069409|FG003|Overall Study|Withdrawal by Subject|13
7653722|NCT00040742|12069406|FG000|Overall Study|Chemotoxicity|4
7653723|NCT00040742|12069407|FG001|Overall Study|Chemotoxicity|3
7653724|NCT00040742|12069408|FG002|Overall Study|Chemotoxicity|5
7653725|NCT00040742|12069409|FG003|Overall Study|Chemotoxicity|2
7653726|NCT00040742|12069406|FG000|Overall Study|Incomplete Forms|6
7653727|NCT00040742|12069407|FG001|Overall Study|Incomplete Forms|10
7653728|NCT00040742|12069408|FG002|Overall Study|Incomplete Forms|4
7653729|NCT00040742|12069409|FG003|Overall Study|Incomplete Forms|5
7653730|NCT00040742|12069406|FG000|Overall Study|Other medical|7
7653731|NCT00040742|12069407|FG001|Overall Study|Other medical|5
7653732|NCT00040742|12069408|FG002|Overall Study|Other medical|5
7653733|NCT00040742|12069409|FG003|Overall Study|Other medical|5
7653734|NCT00041067|12069451|FG000|Overall Study|Adverse Event|20
7653735|NCT00041067|12069451|FG000|Overall Study|Progression|19
7653736|NCT00041067|12069451|FG000|Overall Study|Patient refusal|12
7653737|NCT00041067|12069451|FG000|Overall Study|Other reasons|23
7653738|NCT00041067|12069451|FG000|Overall Study|Ineligible|2
7653739|NCT00041080|12069458|FG000|Overall Study|Adverse Event|21
7653740|NCT00041080|12069459|FG001|Overall Study|Adverse Event|1
7653741|NCT00041080|12069458|FG000|Overall Study|Withdrawal by Subject|6
7653742|NCT00041080|12069459|FG001|Overall Study|Withdrawal by Subject|6
7653743|NCT00041080|12069458|FG000|Overall Study|Concommitant Illness/Other|1
7653744|NCT00041080|12069459|FG001|Overall Study|Concommitant Illness/Other|2
7653745|NCT00041080|12069458|FG000|Overall Study|Did not start therapy|1
7653746|NCT00041080|12069459|FG001|Overall Study|Did not start therapy|1
7653747|NCT00041080|12069458|FG000|Overall Study|Ineligible|1
7653748|NCT00041080|12069459|FG001|Overall Study|Ineligible|0
7653749|NCT00041132|12069486|FG000|Overall Study|Adverse Event|19
7653750|NCT00041132|12069486|FG000|Overall Study|Death|1
7653751|NCT00041132|12069486|FG000|Overall Study|Not Eligible|7
7653752|NCT00041132|12069486|FG000|Overall Study|Withdrawal by Subject|1
7653753|NCT00041132|12069486|FG000|Overall Study|Physician Decision|2
7653754|NCT00041470|12069490|FG000|Overall Study|Loss of Funding|38
7653755|NCT00041756|12069508|FG000|Overall Study|Adverse Event|4
7653756|NCT00041756|12069509|FG001|Overall Study|Adverse Event|10
7653757|NCT00041756|12069510|FG002|Overall Study|Adverse Event|6
7653758|NCT00041756|12069511|FG003|Overall Study|Adverse Event|11
7653759|NCT00041756|12069512|FG004|Overall Study|Adverse Event|34
7653760|NCT00041756|12069508|FG000|Overall Study|Protocol Violation|1
7653761|NCT00041756|12069509|FG001|Overall Study|Protocol Violation|1
7653762|NCT00041756|12069510|FG002|Overall Study|Protocol Violation|2
7653763|NCT00041756|12069511|FG003|Overall Study|Protocol Violation|2
7653764|NCT00041756|12069512|FG004|Overall Study|Protocol Violation|1
7653765|NCT00041756|12069508|FG000|Overall Study|Withdrawal by Subject|3
7653766|NCT00041756|12069509|FG001|Overall Study|Withdrawal by Subject|3
7653767|NCT00041756|12069510|FG002|Overall Study|Withdrawal by Subject|4
7653768|NCT00041756|12069511|FG003|Overall Study|Withdrawal by Subject|2
7653769|NCT00041756|12069512|FG004|Overall Study|Withdrawal by Subject|3
7653770|NCT00041756|12069508|FG000|Overall Study|Lost to Follow-up|0
7653771|NCT00041756|12069509|FG001|Overall Study|Lost to Follow-up|1
7653772|NCT00041756|12069510|FG002|Overall Study|Lost to Follow-up|0
7653773|NCT00041756|12069511|FG003|Overall Study|Lost to Follow-up|1
7653774|NCT00041756|12069512|FG004|Overall Study|Lost to Follow-up|0
7653775|NCT00041756|12069508|FG000|Overall Study|Unable to meet protocol criteria|0
7653776|NCT00041756|12069509|FG001|Overall Study|Unable to meet protocol criteria|0
7653777|NCT00041756|12069510|FG002|Overall Study|Unable to meet protocol criteria|1
7653778|NCT00041756|12069511|FG003|Overall Study|Unable to meet protocol criteria|0
7653779|NCT00041756|12069512|FG004|Overall Study|Unable to meet protocol criteria|1
7653780|NCT00041756|12069508|FG000|Overall Study|Data Monitoring Committee Recommendation|0
7653781|NCT00041756|12069509|FG001|Overall Study|Data Monitoring Committee Recommendation|0
7653782|NCT00041756|12069510|FG002|Overall Study|Data Monitoring Committee Recommendation|0
7653783|NCT00041756|12069511|FG003|Overall Study|Data Monitoring Committee Recommendation|0
7653784|NCT00041756|12069512|FG004|Overall Study|Data Monitoring Committee Recommendation|21
7653785|NCT00042432|12069544|FG000|Overall Study|Adverse Event|4
7653786|NCT00042432|12069545|FG001|Overall Study|Adverse Event|1
7653787|NCT00042432|12069544|FG000|Overall Study|Withdrawal by Subject|1
7653788|NCT00042432|12069545|FG001|Overall Study|Withdrawal by Subject|3
7653789|NCT00042432|12069544|FG000|Overall Study|Death|0
7653790|NCT00042432|12069545|FG001|Overall Study|Death|2
7653791|NCT00042432|12069544|FG000|Overall Study|Ineligibility determined|1
7653792|NCT00042432|12069545|FG001|Overall Study|Ineligibility determined|0
7653793|NCT00042432|12069544|FG000|Overall Study|Initiation of maintenance dialysis|1
7653794|NCT00042432|12069545|FG001|Overall Study|Initiation of maintenance dialysis|1
7653795|NCT00042432|12069544|FG000|Overall Study|Other|2
7653796|NCT00042432|12069545|FG001|Overall Study|Other|0
7653797|NCT00042666|12069551|FG000|Overall Study|Adverse Event|2
7653798|NCT00042666|12069551|FG000|Overall Study|Death|4
7653799|NCT00042666|12069551|FG000|Overall Study|Protocol Violation|1
7653800|NCT00042666|12069551|FG000|Overall Study|Participant/Physician Perception|1
7653801|NCT00042666|12069551|FG000|Overall Study|Progressive Disease|41
7653802|NCT00042666|12069551|FG000|Overall Study|Other|1
7653803|NCT00042666|12069551|FG000|Overall Study|Other|4
7653804|NCT00042939|12069558|FG000|Overall Study|Adverse Event|6
7653805|NCT00042939|12069559|FG001|Overall Study|Adverse Event|7
7653806|NCT00042939|12069558|FG000|Overall Study|Death|3
7653807|NCT00042939|12069559|FG001|Overall Study|Death|2
7653808|NCT00042939|12069558|FG000|Overall Study|Withdrawal by Subject|3
7653809|NCT00042939|12069559|FG001|Overall Study|Withdrawal by Subject|4
7653810|NCT00042939|12069558|FG000|Overall Study|Other disease|1
7653811|NCT00042939|12069559|FG001|Overall Study|Other disease|0
7653812|NCT00042939|12069558|FG000|Overall Study|Ineligible|2
7653813|NCT00042939|12069559|FG001|Overall Study|Ineligible|2
7653814|NCT00042939|12069558|FG000|Overall Study|Deterioration of health|3
7653815|NCT00042939|12069559|FG001|Overall Study|Deterioration of health|4
7653816|NCT00042939|12069558|FG000|Overall Study|QOL diminished|1
7653817|NCT00042939|12069559|FG001|Overall Study|QOL diminished|0
7653818|NCT00042939|12069558|FG000|Overall Study|Rising ca 19-9|1
7653819|NCT00042939|12069559|FG001|Overall Study|Rising ca 19-9|0
7653820|NCT00042939|12069558|FG000|Overall Study|Patient non-compliance|1
7653821|NCT00042939|12069559|FG001|Overall Study|Patient non-compliance|0
7653822|NCT00042939|12069558|FG000|Overall Study|Still on treatment|1
7653823|NCT00042939|12069559|FG001|Overall Study|Still on treatment|0
7653824|NCT00042939|12069558|FG000|Overall Study|Treatment break > 4 weeks|0
7653825|NCT00042939|12069559|FG001|Overall Study|Treatment break > 4 weeks|1
7653826|NCT00042939|12069558|FG000|Overall Study|Did not start treatment|2
7653827|NCT00042939|12069559|FG001|Overall Study|Did not start treatment|1
7653828|NCT00042991|12069572|FG000|Overall Study|Adverse Event|1
7653829|NCT00042991|12069573|FG001|Overall Study|Adverse Event|4
7653830|NCT00042991|12069574|FG002|Overall Study|Adverse Event|2
7653831|NCT00042991|12069575|FG003|Overall Study|Adverse Event|0
7653832|NCT00042991|12069576|FG004|Overall Study|Adverse Event|0
7653833|NCT00042991|12069577|FG005|Overall Study|Adverse Event|1
7653834|NCT00042991|12069578|FG006|Overall Study|Adverse Event|0
7653835|NCT00042991|12069572|FG000|Overall Study|Withdrawal by Subject|0
7653836|NCT00042991|12069573|FG001|Overall Study|Withdrawal by Subject|7
7653837|NCT00042991|12069574|FG002|Overall Study|Withdrawal by Subject|2
7653838|NCT00042991|12069575|FG003|Overall Study|Withdrawal by Subject|0
7653839|NCT00042991|12069576|FG004|Overall Study|Withdrawal by Subject|1
7653840|NCT00042991|12069577|FG005|Overall Study|Withdrawal by Subject|0
7653841|NCT00042991|12069578|FG006|Overall Study|Withdrawal by Subject|0
7653842|NCT00042991|12069572|FG000|Overall Study|Disease Progression|5
7653843|NCT00042991|12069573|FG001|Overall Study|Disease Progression|29
7653844|NCT00042991|12069574|FG002|Overall Study|Disease Progression|2
7653845|NCT00042991|12069575|FG003|Overall Study|Disease Progression|2
7653846|NCT00042991|12069576|FG004|Overall Study|Disease Progression|1
7653847|NCT00042991|12069577|FG005|Overall Study|Disease Progression|4
7653848|NCT00042991|12069578|FG006|Overall Study|Disease Progression|2
7653849|NCT00042991|12069572|FG000|Overall Study|Alternative Therapy|0
7653850|NCT00042991|12069573|FG001|Overall Study|Alternative Therapy|0
7653851|NCT00042991|12069574|FG002|Overall Study|Alternative Therapy|0
7653852|NCT00042991|12069575|FG003|Overall Study|Alternative Therapy|0
7653853|NCT00042991|12069576|FG004|Overall Study|Alternative Therapy|1
7653854|NCT00042991|12069577|FG005|Overall Study|Alternative Therapy|0
7653855|NCT00042991|12069578|FG006|Overall Study|Alternative Therapy|0
7653856|NCT00043186|12069605|FG000|Overall Study|Physician Decision|0
7653857|NCT00043186|12069606|FG001|Overall Study|Physician Decision|0
7653858|NCT00043186|12069607|FG002|Overall Study|Physician Decision|3
7653859|NCT00043186|12069608|FG003|Overall Study|Physician Decision|0
7653860|NCT00043186|12069609|FG004|Overall Study|Physician Decision|1
7653861|NCT00043186|12069610|FG005|Overall Study|Physician Decision|0
7653862|NCT00043186|12069611|FG006|Overall Study|Physician Decision|0
7653863|NCT00043186|12069612|FG007|Overall Study|Physician Decision|1
7653864|NCT00043186|12069613|FG008|Overall Study|Physician Decision|1
7653865|NCT00043186|12069605|FG000|Overall Study|Adverse Event|2
7653866|NCT00043186|12069606|FG001|Overall Study|Adverse Event|2
7653867|NCT00043186|12069607|FG002|Overall Study|Adverse Event|2
7653868|NCT00043186|12069608|FG003|Overall Study|Adverse Event|3
7653869|NCT00043186|12069609|FG004|Overall Study|Adverse Event|2
7653870|NCT00043186|12069610|FG005|Overall Study|Adverse Event|1
7653871|NCT00043186|12069611|FG006|Overall Study|Adverse Event|2
7653872|NCT00043186|12069612|FG007|Overall Study|Adverse Event|1
7653873|NCT00043186|12069613|FG008|Overall Study|Adverse Event|3
7653874|NCT00043186|12069605|FG000|Overall Study|Withdrawal by Subject|11
7653875|NCT00043186|12069606|FG001|Overall Study|Withdrawal by Subject|8
7653876|NCT00043186|12069607|FG002|Overall Study|Withdrawal by Subject|11
7653877|NCT00043186|12069608|FG003|Overall Study|Withdrawal by Subject|13
7653878|NCT00043186|12069609|FG004|Overall Study|Withdrawal by Subject|14
7653879|NCT00043186|12069610|FG005|Overall Study|Withdrawal by Subject|6
7653880|NCT00043186|12069611|FG006|Overall Study|Withdrawal by Subject|12
7653881|NCT00043186|12069612|FG007|Overall Study|Withdrawal by Subject|9
7653882|NCT00043186|12069613|FG008|Overall Study|Withdrawal by Subject|10
7653883|NCT00043186|12069605|FG000|Overall Study|Death|0
7653884|NCT00043186|12069606|FG001|Overall Study|Death|0
7653885|NCT00043186|12069607|FG002|Overall Study|Death|1
7653886|NCT00043186|12069608|FG003|Overall Study|Death|0
7653887|NCT00043186|12069609|FG004|Overall Study|Death|0
7653888|NCT00043186|12069610|FG005|Overall Study|Death|0
7653889|NCT00043186|12069611|FG006|Overall Study|Death|2
7653890|NCT00043186|12069612|FG007|Overall Study|Death|0
7653891|NCT00043186|12069613|FG008|Overall Study|Death|0
7653892|NCT00043186|12069605|FG000|Overall Study|Disease progression|1
7653893|NCT00043186|12069606|FG001|Overall Study|Disease progression|0
7653894|NCT00043186|12069607|FG002|Overall Study|Disease progression|0
7653895|NCT00043186|12069608|FG003|Overall Study|Disease progression|3
7653896|NCT00043186|12069609|FG004|Overall Study|Disease progression|0
7653897|NCT00043186|12069610|FG005|Overall Study|Disease progression|0
7653898|NCT00043186|12069611|FG006|Overall Study|Disease progression|0
7653899|NCT00043186|12069612|FG007|Overall Study|Disease progression|4
7653900|NCT00043186|12069613|FG008|Overall Study|Disease progression|0
7653901|NCT00043186|12069605|FG000|Overall Study|Ineligibility determined|0
7653902|NCT00043186|12069606|FG001|Overall Study|Ineligibility determined|0
7653903|NCT00043186|12069607|FG002|Overall Study|Ineligibility determined|0
7653904|NCT00043186|12069608|FG003|Overall Study|Ineligibility determined|0
7653905|NCT00043186|12069609|FG004|Overall Study|Ineligibility determined|0
7653906|NCT00043186|12069610|FG005|Overall Study|Ineligibility determined|0
7653907|NCT00043186|12069611|FG006|Overall Study|Ineligibility determined|0
7653908|NCT00043186|12069612|FG007|Overall Study|Ineligibility determined|0
7653909|NCT00043186|12069613|FG008|Overall Study|Ineligibility determined|1
7653910|NCT00043186|12069605|FG000|Overall Study|Lost to Follow-up|3
7653911|NCT00043186|12069606|FG001|Overall Study|Lost to Follow-up|5
7653912|NCT00043186|12069607|FG002|Overall Study|Lost to Follow-up|1
7653913|NCT00043186|12069608|FG003|Overall Study|Lost to Follow-up|1
7653914|NCT00043186|12069609|FG004|Overall Study|Lost to Follow-up|1
7653915|NCT00043186|12069610|FG005|Overall Study|Lost to Follow-up|1
7653916|NCT00043186|12069611|FG006|Overall Study|Lost to Follow-up|1
7653917|NCT00043186|12069612|FG007|Overall Study|Lost to Follow-up|1
7653918|NCT00043186|12069613|FG008|Overall Study|Lost to Follow-up|2
7653919|NCT00043186|12069605|FG000|Overall Study|Noncompliance|0
7653920|NCT00043186|12069606|FG001|Overall Study|Noncompliance|0
7653921|NCT00043186|12069607|FG002|Overall Study|Noncompliance|1
7653922|NCT00043186|12069608|FG003|Overall Study|Noncompliance|1
7653923|NCT00043186|12069609|FG004|Overall Study|Noncompliance|0
7653924|NCT00043186|12069610|FG005|Overall Study|Noncompliance|0
7653925|NCT00043186|12069611|FG006|Overall Study|Noncompliance|0
7653926|NCT00043186|12069612|FG007|Overall Study|Noncompliance|0
7653927|NCT00043186|12069613|FG008|Overall Study|Noncompliance|0
7653928|NCT00043186|12069605|FG000|Overall Study|Other|0
7653929|NCT00043186|12069606|FG001|Overall Study|Other|0
7653930|NCT00043186|12069607|FG002|Overall Study|Other|1
7653931|NCT00043186|12069608|FG003|Overall Study|Other|1
7653932|NCT00043186|12069609|FG004|Overall Study|Other|0
7653933|NCT00043186|12069610|FG005|Overall Study|Other|0
7653934|NCT00043186|12069611|FG006|Overall Study|Other|0
7653935|NCT00043186|12069612|FG007|Overall Study|Other|0
7653936|NCT00043186|12069613|FG008|Overall Study|Other|0
7653937|NCT00043550|12069637|FG000|Overall Study|Withdrawal by Subject|22
7653938|NCT00043550|12069638|FG001|Overall Study|Withdrawal by Subject|12
7653939|NCT00043550|12069639|FG002|Overall Study|Withdrawal by Subject|20
7653940|NCT00043979|12069649|FG000|Period 1|recipient with progressive disease|7
7653941|NCT00043979|12069650|FG001|Period 1|recipient with progressive disease|4
7653942|NCT00043979|12069651|FG002|Period 1|recipient with progressive disease|3
7653943|NCT00044083|12069693|FG000|First Intervention (One Week)- HV's|Adverse Event|1
7653944|NCT00044083|12069694|FG001|First Intervention (One Week)- HV's|Adverse Event|0
7653945|NCT00044083|12069693|FG000|First Intervention (One Week)- HV's|Not follow directions|2
7653946|NCT00044083|12069694|FG001|First Intervention (One Week)- HV's|Not follow directions|2
7653947|NCT00044083|12069693|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5
7653948|NCT00044083|12069694|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3
7653949|NCT00044083|12069693|FG000|First Intervention (One Week)- HV's|Pregnancy|1
7653950|NCT00044083|12069694|FG001|First Intervention (One Week)- HV's|Pregnancy|0
7653951|NCT00044083|12069693|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1
7653952|NCT00044083|12069694|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0
7653953|NCT00044083|12069693|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0
7653954|NCT00044083|12069694|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1
7653955|NCT00044083|12069693|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0
7653956|NCT00044083|12069694|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1
7653957|NCT00044083|12069693|FG000|First Intervention (One Week) Patients|Not follow directions|0
7653958|NCT00044083|12069694|FG001|First Intervention (One Week) Patients|Not follow directions|2
7653959|NCT00044083|12069693|FG000|First Intervention (One Week) Patients|Used illegal drug|1
7653960|NCT00044083|12069694|FG001|First Intervention (One Week) Patients|Used illegal drug|0
7653961|NCT00044083|12069693|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0
7653962|NCT00044083|12069694|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1
7653963|NCT00044213|12069731|FG000|Overall Study|Withdrawal by Subject|50
7653964|NCT00044213|12069732|FG001|Overall Study|Withdrawal by Subject|65
7653965|NCT00044213|12069733|FG002|Overall Study|Withdrawal by Subject|91
7653966|NCT00044213|12069734|FG003|Overall Study|Withdrawal by Subject|83
7653967|NCT00044213|12069731|FG000|Overall Study|Death|42
7653968|NCT00044213|12069732|FG001|Overall Study|Death|42
7653969|NCT00044213|12069733|FG002|Overall Study|Death|42
7653970|NCT00044213|12069734|FG003|Overall Study|Death|49
7653971|NCT00044213|12069731|FG000|Overall Study|Lost to Follow-up|8
7653972|NCT00044213|12069732|FG001|Overall Study|Lost to Follow-up|5
7653973|NCT00044213|12069733|FG002|Overall Study|Lost to Follow-up|5
7653974|NCT00044213|12069734|FG003|Overall Study|Lost to Follow-up|4
7653975|NCT00044512|12069744|FG000|Follow Up|Lost to Follow-up|2
7653976|NCT00045032|12069760|FG000|Overall Study|Adverse Event/Intercurrent Illness|2
7653977|NCT00045032|12069761|FG001|Overall Study|Adverse Event/Intercurrent Illness|2
7653978|NCT00045032|12069762|FG002|Overall Study|Adverse Event/Intercurrent Illness|7
7653979|NCT00045032|12069760|FG000|Overall Study|Death|22
7653980|NCT00045032|12069761|FG001|Overall Study|Death|24
7653981|NCT00045032|12069762|FG002|Overall Study|Death|17
7653982|NCT00045032|12069760|FG000|Overall Study|Insufficient Therapeutic Response|542
7653983|NCT00045032|12069761|FG001|Overall Study|Insufficient Therapeutic Response|437
7653984|NCT00045032|12069762|FG002|Overall Study|Insufficient Therapeutic Response|445
7653985|NCT00045032|12069760|FG000|Overall Study|Violation of Selection Criteria at Entry|3
7653986|NCT00045032|12069761|FG001|Overall Study|Violation of Selection Criteria at Entry|6
7653987|NCT00045032|12069762|FG002|Overall Study|Violation of Selection Criteria at Entry|6
7653988|NCT00045032|12069760|FG000|Overall Study|Other Protocol Violation|2
7653989|NCT00045032|12069761|FG001|Overall Study|Other Protocol Violation|0
7653990|NCT00045032|12069762|FG002|Overall Study|Other Protocol Violation|1
7653991|NCT00045032|12069760|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142
7653992|NCT00045032|12069761|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93
7653993|NCT00045032|12069762|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84
7653994|NCT00045032|12069760|FG000|Overall Study|Failure to Return|57
7653995|NCT00045032|12069761|FG001|Overall Study|Failure to Return|62
7653996|NCT00045032|12069762|FG002|Overall Study|Failure to Return|61
7653997|NCT00045032|12069760|FG000|Overall Study|Other|93
7653998|NCT00045032|12069761|FG001|Overall Study|Other|84
7653999|NCT00045032|12069762|FG002|Overall Study|Other|105
7654000|NCT00045110|12069775|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
7654001|NCT00045110|12069776|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
7654002|NCT00045110|12069777|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
7654003|NCT00045110|12069775|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0
7654004|NCT00045110|12069776|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4
7654005|NCT00045110|12069777|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0
7654006|NCT00045110|12069775|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0
7654007|NCT00045110|12069776|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0
7654008|NCT00045110|12069777|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1
7654009|NCT00045162|12069796|FG000|Overall Study|Ineligible|12
7654010|NCT00045162|12069797|FG001|Overall Study|Ineligible|8
7654011|NCT00045162|12069796|FG000|Overall Study|Not treated|7
7654012|NCT00045162|12069797|FG001|Overall Study|Not treated|2
7654013|NCT00045162|12069796|FG000|Overall Study|Adverse Event|55
7654014|NCT00045162|12069797|FG001|Overall Study|Adverse Event|50
7654015|NCT00045162|12069796|FG000|Overall Study|Lack of Efficacy|32
7654016|NCT00045162|12069797|FG001|Overall Study|Lack of Efficacy|29
7654017|NCT00045162|12069796|FG000|Overall Study|Death|10
7654018|NCT00045162|12069797|FG001|Overall Study|Death|10
7654019|NCT00045162|12069796|FG000|Overall Study|Withdrawal by Subject|5
7654020|NCT00045162|12069797|FG001|Overall Study|Withdrawal by Subject|3
7654021|NCT00045162|12069796|FG000|Overall Study|Other|21
7654022|NCT00045162|12069797|FG001|Overall Study|Other|16
7654023|NCT00045305|12069803|FG000|Overall Study|Lack of Efficacy|6
7654024|NCT00045305|12069803|FG000|Overall Study|Adverse Event|3
7654025|NCT00045305|12069803|FG000|Overall Study|Death|3
7654026|NCT00045305|12069803|FG000|Overall Study|site error|2
7654027|NCT00045630|12069815|FG000|Overall Study|Adverse Event|1
7654028|NCT00045630|12069815|FG000|Overall Study|Refusal unrelated to adverse event|1
7654029|NCT00045630|12069815|FG000|Overall Study|Progression/relapse|1
7654030|NCT00045630|12069815|FG000|Overall Study|Death|1
7654031|NCT00045630|12069815|FG000|Overall Study|Ineligible|2
7654032|NCT00045708|12069822|FG000|Phase 1|early progressive disease|0
7654033|NCT00045708|12069823|FG001|Phase 1|early progressive disease|1
7654034|NCT00045708|12069824|FG002|Phase 1|early progressive disease|0
7654035|NCT00045734|12069841|FG000|Overall Study|Protocol Violation|1
7654036|NCT00045942|12069854|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1
7654037|NCT00045942|12069855|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0
7654038|NCT00045942|12069856|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0
7654039|NCT00045942|12069857|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0
7654040|NCT00045942|12069858|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0
7654041|NCT00045942|12069859|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0
7654042|NCT00045942|12069860|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0
7654043|NCT00045942|12069861|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0
7654044|NCT00045942|12069862|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0
7654045|NCT00045942|12069854|FG000|PKC412A2104 (Core)|Adverse Event|5
7654046|NCT00045942|12069855|FG001|PKC412A2104 (Core)|Adverse Event|0
7654047|NCT00045942|12069856|FG002|PKC412A2104 (Core)|Adverse Event|0
7654048|NCT00045942|12069857|FG003|PKC412A2104 (Core)|Adverse Event|0
7654049|NCT00045942|12069858|FG004|PKC412A2104 (Core)|Adverse Event|0
7654050|NCT00045942|12069859|FG005|PKC412A2104 (Core)|Adverse Event|0
7654051|NCT00045942|12069860|FG006|PKC412A2104 (Core)|Adverse Event|0
7654052|NCT00045942|12069861|FG007|PKC412A2104 (Core)|Adverse Event|0
7654053|NCT00045942|12069862|FG008|PKC412A2104 (Core)|Adverse Event|0
7654054|NCT00045942|12069854|FG000|PKC412A2104 (Core)|Lack of Efficacy|13
7654055|NCT00045942|12069855|FG001|PKC412A2104 (Core)|Lack of Efficacy|0
7654056|NCT00045942|12069856|FG002|PKC412A2104 (Core)|Lack of Efficacy|0
7654057|NCT00045942|12069857|FG003|PKC412A2104 (Core)|Lack of Efficacy|0
7654058|NCT00045942|12069858|FG004|PKC412A2104 (Core)|Lack of Efficacy|0
7654059|NCT00045942|12069859|FG005|PKC412A2104 (Core)|Lack of Efficacy|0
7654060|NCT00045942|12069860|FG006|PKC412A2104 (Core)|Lack of Efficacy|0
7654061|NCT00045942|12069861|FG007|PKC412A2104 (Core)|Lack of Efficacy|0
7654062|NCT00045942|12069862|FG008|PKC412A2104 (Core)|Lack of Efficacy|0
7654063|NCT00045942|12069854|FG000|PKC412A2104 (Core)|Death|1
7654064|NCT00045942|12069855|FG001|PKC412A2104 (Core)|Death|0
7654065|NCT00045942|12069856|FG002|PKC412A2104 (Core)|Death|0
7654066|NCT00045942|12069857|FG003|PKC412A2104 (Core)|Death|0
7654067|NCT00045942|12069858|FG004|PKC412A2104 (Core)|Death|0
7654068|NCT00045942|12069859|FG005|PKC412A2104 (Core)|Death|0
7654069|NCT00045942|12069860|FG006|PKC412A2104 (Core)|Death|0
7654070|NCT00045942|12069861|FG007|PKC412A2104 (Core)|Death|0
7654071|NCT00045942|12069862|FG008|PKC412A2104 (Core)|Death|0
7654072|NCT00045942|12069854|FG000|PKC412A2104E1|Withdrawal by Subject|0
7654073|NCT00045942|12069855|FG001|PKC412A2104E1|Withdrawal by Subject|0
7654074|NCT00045942|12069856|FG002|PKC412A2104E1|Withdrawal by Subject|2
7654075|NCT00045942|12069857|FG003|PKC412A2104E1|Withdrawal by Subject|5
7654076|NCT00045942|12069858|FG004|PKC412A2104E1|Withdrawal by Subject|2
7654077|NCT00045942|12069859|FG005|PKC412A2104E1|Withdrawal by Subject|0
7654078|NCT00045942|12069860|FG006|PKC412A2104E1|Withdrawal by Subject|0
7654079|NCT00045942|12069861|FG007|PKC412A2104E1|Withdrawal by Subject|0
7654080|NCT00045942|12069862|FG008|PKC412A2104E1|Withdrawal by Subject|0
7654081|NCT00045942|12069854|FG000|PKC412A2104E1|Condition no longer requires study drug|0
7654082|NCT00045942|12069855|FG001|PKC412A2104E1|Condition no longer requires study drug|1
7654083|NCT00045942|12069856|FG002|PKC412A2104E1|Condition no longer requires study drug|1
7654084|NCT00045942|12069857|FG003|PKC412A2104E1|Condition no longer requires study drug|0
7654085|NCT00045942|12069858|FG004|PKC412A2104E1|Condition no longer requires study drug|1
7654086|NCT00045942|12069859|FG005|PKC412A2104E1|Condition no longer requires study drug|0
7654087|NCT00045942|12069860|FG006|PKC412A2104E1|Condition no longer requires study drug|0
7654088|NCT00045942|12069861|FG007|PKC412A2104E1|Condition no longer requires study drug|0
7654089|NCT00045942|12069862|FG008|PKC412A2104E1|Condition no longer requires study drug|0
7654090|NCT00045942|12069854|FG000|PKC412A2104E1|Lack of Efficacy|0
7654091|NCT00045942|12069855|FG001|PKC412A2104E1|Lack of Efficacy|11
7654092|NCT00045942|12069856|FG002|PKC412A2104E1|Lack of Efficacy|11
7654093|NCT00045942|12069857|FG003|PKC412A2104E1|Lack of Efficacy|23
7654094|NCT00045942|12069858|FG004|PKC412A2104E1|Lack of Efficacy|17
7654095|NCT00045942|12069859|FG005|PKC412A2104E1|Lack of Efficacy|0
7654096|NCT00045942|12069860|FG006|PKC412A2104E1|Lack of Efficacy|0
7654097|NCT00045942|12069861|FG007|PKC412A2104E1|Lack of Efficacy|0
7654098|NCT00045942|12069862|FG008|PKC412A2104E1|Lack of Efficacy|0
7654099|NCT00045942|12069854|FG000|PKC412A2104E1|Abnormal laboratory value|0
7654100|NCT00045942|12069855|FG001|PKC412A2104E1|Abnormal laboratory value|1
7654101|NCT00045942|12069856|FG002|PKC412A2104E1|Abnormal laboratory value|0
7654102|NCT00045942|12069857|FG003|PKC412A2104E1|Abnormal laboratory value|0
7654103|NCT00045942|12069858|FG004|PKC412A2104E1|Abnormal laboratory value|0
7654104|NCT00045942|12069859|FG005|PKC412A2104E1|Abnormal laboratory value|0
7654105|NCT00045942|12069860|FG006|PKC412A2104E1|Abnormal laboratory value|0
7654106|NCT00045942|12069861|FG007|PKC412A2104E1|Abnormal laboratory value|0
7654107|NCT00045942|12069862|FG008|PKC412A2104E1|Abnormal laboratory value|0
7654108|NCT00045942|12069854|FG000|PKC412A2104E1|Adverse Event|0
7654109|NCT00045942|12069855|FG001|PKC412A2104E1|Adverse Event|1
7654110|NCT00045942|12069856|FG002|PKC412A2104E1|Adverse Event|1
7654111|NCT00045942|12069857|FG003|PKC412A2104E1|Adverse Event|3
7654112|NCT00045942|12069858|FG004|PKC412A2104E1|Adverse Event|6
7654113|NCT00045942|12069859|FG005|PKC412A2104E1|Adverse Event|0
7654114|NCT00045942|12069860|FG006|PKC412A2104E1|Adverse Event|0
7654115|NCT00045942|12069861|FG007|PKC412A2104E1|Adverse Event|0
7654116|NCT00045942|12069862|FG008|PKC412A2104E1|Adverse Event|0
7654117|NCT00045942|12069854|FG000|PKC412A2104E1|Death|0
7654118|NCT00045942|12069855|FG001|PKC412A2104E1|Death|4
7654119|NCT00045942|12069856|FG002|PKC412A2104E1|Death|1
7654120|NCT00045942|12069857|FG003|PKC412A2104E1|Death|1
7654121|NCT00045942|12069858|FG004|PKC412A2104E1|Death|1
7654122|NCT00045942|12069859|FG005|PKC412A2104E1|Death|0
7654123|NCT00045942|12069860|FG006|PKC412A2104E1|Death|0
7654124|NCT00045942|12069861|FG007|PKC412A2104E1|Death|0
7654125|NCT00045942|12069862|FG008|PKC412A2104E1|Death|0
7654126|NCT00045942|12069854|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7654127|NCT00045942|12069855|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7654128|NCT00045942|12069856|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1
7654129|NCT00045942|12069857|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1
7654130|NCT00045942|12069858|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7654131|NCT00045942|12069859|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7654132|NCT00045942|12069860|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7654133|NCT00045942|12069861|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7654134|NCT00045942|12069862|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7654135|NCT00045942|12069854|FG000|PKC412A2104E2|Lost to Follow-up|0
7654136|NCT00045942|12069855|FG001|PKC412A2104E2|Lost to Follow-up|0
7654137|NCT00045942|12069856|FG002|PKC412A2104E2|Lost to Follow-up|0
7654138|NCT00045942|12069857|FG003|PKC412A2104E2|Lost to Follow-up|0
7654139|NCT00045942|12069858|FG004|PKC412A2104E2|Lost to Follow-up|0
7654140|NCT00045942|12069859|FG005|PKC412A2104E2|Lost to Follow-up|0
7654141|NCT00045942|12069860|FG006|PKC412A2104E2|Lost to Follow-up|0
7654142|NCT00045942|12069861|FG007|PKC412A2104E2|Lost to Follow-up|3
7654143|NCT00045942|12069862|FG008|PKC412A2104E2|Lost to Follow-up|0
7654144|NCT00045942|12069854|FG000|PKC412A2104E2|Withdrawal by Subject|0
7654145|NCT00045942|12069855|FG001|PKC412A2104E2|Withdrawal by Subject|0
7654146|NCT00045942|12069856|FG002|PKC412A2104E2|Withdrawal by Subject|0
7654147|NCT00045942|12069857|FG003|PKC412A2104E2|Withdrawal by Subject|0
7654148|NCT00045942|12069858|FG004|PKC412A2104E2|Withdrawal by Subject|0
7654149|NCT00045942|12069859|FG005|PKC412A2104E2|Withdrawal by Subject|1
7654150|NCT00045942|12069860|FG006|PKC412A2104E2|Withdrawal by Subject|0
7654151|NCT00045942|12069861|FG007|PKC412A2104E2|Withdrawal by Subject|1
7654152|NCT00045942|12069862|FG008|PKC412A2104E2|Withdrawal by Subject|0
7654153|NCT00045942|12069854|FG000|PKC412A2104E2|Lack of Efficacy|0
7654154|NCT00045942|12069855|FG001|PKC412A2104E2|Lack of Efficacy|0
7654155|NCT00045942|12069856|FG002|PKC412A2104E2|Lack of Efficacy|0
7654156|NCT00045942|12069857|FG003|PKC412A2104E2|Lack of Efficacy|0
7654157|NCT00045942|12069858|FG004|PKC412A2104E2|Lack of Efficacy|0
7654158|NCT00045942|12069859|FG005|PKC412A2104E2|Lack of Efficacy|3
7654159|NCT00045942|12069860|FG006|PKC412A2104E2|Lack of Efficacy|2
7654160|NCT00045942|12069861|FG007|PKC412A2104E2|Lack of Efficacy|2
7654161|NCT00045942|12069862|FG008|PKC412A2104E2|Lack of Efficacy|6
7654162|NCT00045942|12069854|FG000|PKC412A2104E2|Adverse Event|0
7654163|NCT00045942|12069855|FG001|PKC412A2104E2|Adverse Event|0
7654164|NCT00045942|12069856|FG002|PKC412A2104E2|Adverse Event|0
7654165|NCT00045942|12069857|FG003|PKC412A2104E2|Adverse Event|0
7654166|NCT00045942|12069858|FG004|PKC412A2104E2|Adverse Event|0
7654167|NCT00045942|12069859|FG005|PKC412A2104E2|Adverse Event|4
7654168|NCT00045942|12069860|FG006|PKC412A2104E2|Adverse Event|3
7654169|NCT00045942|12069861|FG007|PKC412A2104E2|Adverse Event|1
7654170|NCT00045942|12069862|FG008|PKC412A2104E2|Adverse Event|0
7654171|NCT00045942|12069854|FG000|PKC412A2104E2|Death|0
7654172|NCT00045942|12069855|FG001|PKC412A2104E2|Death|0
7654173|NCT00045942|12069856|FG002|PKC412A2104E2|Death|0
7654174|NCT00045942|12069857|FG003|PKC412A2104E2|Death|0
7654175|NCT00045942|12069858|FG004|PKC412A2104E2|Death|0
7654176|NCT00045942|12069859|FG005|PKC412A2104E2|Death|1
7654177|NCT00045942|12069860|FG006|PKC412A2104E2|Death|2
7654178|NCT00045942|12069861|FG007|PKC412A2104E2|Death|0
7654179|NCT00045942|12069862|FG008|PKC412A2104E2|Death|0
7654180|NCT00046839|12069929|FG000|Overall Study|Ineligible / No protocol treatment|0
7654181|NCT00046839|12069930|FG001|Overall Study|Ineligible / No protocol treatment|2
7654182|NCT00046839|12069929|FG000|Overall Study|Withdrawal of consent|1
7654183|NCT00046839|12069930|FG001|Overall Study|Withdrawal of consent|0
7654184|NCT00046891|12069939|FG000|Overall Study|Cancels|5
7654185|NCT00046891|12069940|FG001|Overall Study|Cancels|9
7654186|NCT00046891|12069939|FG000|Overall Study|Ineligible|1
7654187|NCT00046891|12069940|FG001|Overall Study|Ineligible|1
7654188|NCT00046891|12069939|FG000|Overall Study|Withdrawal by Subject|18
7654189|NCT00046891|12069940|FG001|Overall Study|Withdrawal by Subject|15
7654190|NCT00046891|12069939|FG000|Overall Study|Adverse Event|5
7654191|NCT00046891|12069940|FG001|Overall Study|Adverse Event|5
7654192|NCT00046930|12069956|FG000|Overall Study|Ineligible|12
7654193|NCT00046930|12069957|FG001|Overall Study|Ineligible|4
7654194|NCT00047320|12069970|FG000|Overall Study|Lack of Efficacy|8
7654195|NCT00047320|12069970|FG000|Overall Study|Lost to Follow-up|1
7654196|NCT00047320|12069970|FG000|Overall Study|Physician Decision|8
7654197|NCT00047320|12069970|FG000|Overall Study|Withdrawal by Subject|9
7654198|NCT00047320|12069970|FG000|Overall Study|Ineligible|2
7654199|NCT00047385|12069976|FG000|Overall Study|Death before any screening|2
7654200|NCT00047385|12069977|FG001|Overall Study|Death before any screening|5
7654201|NCT00047385|12069976|FG000|Overall Study|Lung Cancer diagnosed before screening|5
7654202|NCT00047385|12069977|FG001|Overall Study|Lung Cancer diagnosed before screening|3
7654203|NCT00047385|12069976|FG000|Overall Study|Eligible for screening but had no screen|260
7654204|NCT00047385|12069977|FG001|Overall Study|Eligible for screening but had no screen|492
7654205|NCT00047463|12069985|FG000|Overall Study|Withdrawal by Subject|0
7654206|NCT00047463|12069986|FG001|Overall Study|Withdrawal by Subject|3
7654207|NCT00047879|12070016|FG000|Overall Study|Progressive disease|4
7654208|NCT00047879|12070017|FG001|Overall Study|Progressive disease|3
7654209|NCT00048035|12070029|FG000|Core Period|Early Withdrawals|4
7654210|NCT00048035|12070030|FG001|Core Period|Early Withdrawals|2
7654211|NCT00048035|12070031|FG002|Core Period|Early Withdrawals|1
7654212|NCT00048035|12070032|FG003|Core Period|Early Withdrawals|1
7654213|NCT00048035|12070033|FG004|Core Period|Early Withdrawals|1
7654214|NCT00048035|12070034|FG005|Core Period|Early Withdrawals|1
7654215|NCT00048035|12070035|FG006|Core Period|Early Withdrawals|0
7654216|NCT00048035|12070036|FG007|Core Period|Early Withdrawals|0
7654217|NCT00048035|12070029|FG000|Extension Year 1|Early Withdrawals|0
7654218|NCT00048035|12070030|FG001|Extension Year 1|Early Withdrawals|0
7654219|NCT00048035|12070031|FG002|Extension Year 1|Early Withdrawals|0
7654220|NCT00048035|12070032|FG003|Extension Year 1|Early Withdrawals|0
7654221|NCT00048035|12070033|FG004|Extension Year 1|Early Withdrawals|0
7654222|NCT00048035|12070034|FG005|Extension Year 1|Early Withdrawals|0
7654223|NCT00048035|12070035|FG006|Extension Year 1|Early Withdrawals|11
7654224|NCT00048035|12070036|FG007|Extension Year 1|Early Withdrawals|11
7654225|NCT00048035|12070029|FG000|Extension Year 2|Early Withdrawals|0
7654226|NCT00048035|12070030|FG001|Extension Year 2|Early Withdrawals|0
7654227|NCT00048035|12070031|FG002|Extension Year 2|Early Withdrawals|0
7654228|NCT00048035|12070032|FG003|Extension Year 2|Early Withdrawals|0
7654229|NCT00048035|12070033|FG004|Extension Year 2|Early Withdrawals|0
7654230|NCT00048035|12070034|FG005|Extension Year 2|Early Withdrawals|0
7654231|NCT00048035|12070035|FG006|Extension Year 2|Early Withdrawals|3
7654232|NCT00048035|12070036|FG007|Extension Year 2|Early Withdrawals|3
7654233|NCT00048048|12070060|FG000|Core Treatment|Withdrawal by Subject|0
7654234|NCT00048048|12070061|FG001|Core Treatment|Withdrawal by Subject|0
7654235|NCT00048048|12070062|FG002|Core Treatment|Withdrawal by Subject|1
7654236|NCT00048048|12070063|FG003|Core Treatment|Withdrawal by Subject|0
7654237|NCT00048048|12070064|FG004|Core Treatment|Withdrawal by Subject|0
7654238|NCT00048048|12070065|FG005|Core Treatment|Withdrawal by Subject|0
7654239|NCT00048048|12070066|FG006|Core Treatment|Withdrawal by Subject|0
7654240|NCT00048048|12070067|FG007|Core Treatment|Withdrawal by Subject|0
7654241|NCT00048048|12070068|FG008|Core Treatment|Withdrawal by Subject|0
7654242|NCT00048048|12070069|FG009|Core Treatment|Withdrawal by Subject|0
7654243|NCT00048048|12070070|FG010|Core Treatment|Withdrawal by Subject|0
7654244|NCT00048048|12070071|FG011|Core Treatment|Withdrawal by Subject|0
7654245|NCT00048048|12070060|FG000|Core Treatment|Adverse Event|0
7654246|NCT00048048|12070061|FG001|Core Treatment|Adverse Event|0
7654247|NCT00048048|12070062|FG002|Core Treatment|Adverse Event|0
7654248|NCT00048048|12070063|FG003|Core Treatment|Adverse Event|0
7654249|NCT00048048|12070064|FG004|Core Treatment|Adverse Event|0
7654250|NCT00048048|12070065|FG005|Core Treatment|Adverse Event|0
7654251|NCT00048048|12070066|FG006|Core Treatment|Adverse Event|0
7654252|NCT00048048|12070067|FG007|Core Treatment|Adverse Event|1
7654253|NCT00048048|12070068|FG008|Core Treatment|Adverse Event|0
7654254|NCT00048048|12070069|FG009|Core Treatment|Adverse Event|0
7654255|NCT00048048|12070070|FG010|Core Treatment|Adverse Event|0
7654256|NCT00048048|12070071|FG011|Core Treatment|Adverse Event|0
7654257|NCT00048048|12070060|FG000|Extension Year 1|Early withdrawals|0
7654258|NCT00048048|12070061|FG001|Extension Year 1|Early withdrawals|0
7654259|NCT00048048|12070062|FG002|Extension Year 1|Early withdrawals|0
7654260|NCT00048048|12070063|FG003|Extension Year 1|Early withdrawals|0
7654261|NCT00048048|12070064|FG004|Extension Year 1|Early withdrawals|0
7654262|NCT00048048|12070065|FG005|Extension Year 1|Early withdrawals|0
7654263|NCT00048048|12070066|FG006|Extension Year 1|Early withdrawals|0
7654264|NCT00048048|12070067|FG007|Extension Year 1|Early withdrawals|0
7654265|NCT00048048|12070068|FG008|Extension Year 1|Early withdrawals|0
7654266|NCT00048048|12070069|FG009|Extension Year 1|Early withdrawals|2
7654267|NCT00048048|12070070|FG010|Extension Year 1|Early withdrawals|2
7654268|NCT00048048|12070071|FG011|Extension Year 1|Early withdrawals|4
7654269|NCT00048048|12070060|FG000|Extension Year 2|Early withdrawals|0
7654270|NCT00048048|12070061|FG001|Extension Year 2|Early withdrawals|0
7654271|NCT00048048|12070062|FG002|Extension Year 2|Early withdrawals|0
7654272|NCT00048048|12070063|FG003|Extension Year 2|Early withdrawals|0
7654273|NCT00048048|12070064|FG004|Extension Year 2|Early withdrawals|0
7654274|NCT00048048|12070065|FG005|Extension Year 2|Early withdrawals|0
7654275|NCT00048048|12070066|FG006|Extension Year 2|Early withdrawals|0
7654276|NCT00048048|12070067|FG007|Extension Year 2|Early withdrawals|0
7654277|NCT00048048|12070068|FG008|Extension Year 2|Early withdrawals|0
7654278|NCT00048048|12070069|FG009|Extension Year 2|Early withdrawals|0
7654279|NCT00048048|12070070|FG010|Extension Year 2|Early withdrawals|4
7654280|NCT00048048|12070071|FG011|Extension Year 2|Early withdrawals|2
7654281|NCT00048061|12070102|FG000|Overall Study|Adverse Event|41
7654282|NCT00048061|12070103|FG001|Overall Study|Adverse Event|32
7654283|NCT00048061|12070104|FG002|Overall Study|Adverse Event|44
7654284|NCT00048061|12070105|FG003|Overall Study|Adverse Event|37
7654285|NCT00048061|12070102|FG000|Overall Study|Lost to Follow-up|3
7654286|NCT00048061|12070103|FG001|Overall Study|Lost to Follow-up|2
7654287|NCT00048061|12070104|FG002|Overall Study|Lost to Follow-up|4
7654288|NCT00048061|12070105|FG003|Overall Study|Lost to Follow-up|5
7654289|NCT00048061|12070102|FG000|Overall Study|Withdrawal by Subject|20
7654290|NCT00048061|12070103|FG001|Overall Study|Withdrawal by Subject|29
7654291|NCT00048061|12070104|FG002|Overall Study|Withdrawal by Subject|29
7654292|NCT00048061|12070105|FG003|Overall Study|Withdrawal by Subject|32
7654293|NCT00048061|12070102|FG000|Overall Study|Did not follow-up|5
7654294|NCT00048061|12070103|FG001|Overall Study|Did not follow-up|5
7654295|NCT00048061|12070104|FG002|Overall Study|Did not follow-up|4
7654296|NCT00048061|12070105|FG003|Overall Study|Did not follow-up|5
7654297|NCT00048061|12070102|FG000|Overall Study|Early improvement|6
7654298|NCT00048061|12070103|FG001|Overall Study|Early improvement|5
7654299|NCT00048061|12070104|FG002|Overall Study|Early improvement|3
7654300|NCT00048061|12070105|FG003|Overall Study|Early improvement|0
7654301|NCT00048074|12070118|FG000|Overall Study|Adverse Event|46
7654302|NCT00048074|12070119|FG001|Overall Study|Adverse Event|41
7654303|NCT00048074|12070120|FG002|Overall Study|Adverse Event|53
7654304|NCT00048074|12070118|FG000|Overall Study|Death|3
7654305|NCT00048074|12070119|FG001|Overall Study|Death|3
7654306|NCT00048074|12070120|FG002|Overall Study|Death|2
7654307|NCT00048074|12070118|FG000|Overall Study|Lost to Follow-up|2
7654308|NCT00048074|12070119|FG001|Overall Study|Lost to Follow-up|6
7654309|NCT00048074|12070120|FG002|Overall Study|Lost to Follow-up|6
7654310|NCT00048074|12070118|FG000|Overall Study|Withdrawal by Subject|28
7654311|NCT00048074|12070119|FG001|Overall Study|Withdrawal by Subject|30
7654312|NCT00048074|12070120|FG002|Overall Study|Withdrawal by Subject|35
7654313|NCT00048074|12070118|FG000|Overall Study|Protocol Violation|1
7654314|NCT00048074|12070119|FG001|Overall Study|Protocol Violation|3
7654315|NCT00048074|12070120|FG002|Overall Study|Protocol Violation|0
7654316|NCT00048074|12070118|FG000|Overall Study|Study participation was terminated|0
7654317|NCT00048074|12070119|FG001|Overall Study|Study participation was terminated|1
7654318|NCT00048074|12070120|FG002|Overall Study|Study participation was terminated|0
7654319|NCT00048074|12070118|FG000|Overall Study|Husband ill|0
7654320|NCT00048074|12070119|FG001|Overall Study|Husband ill|1
7654321|NCT00048074|12070120|FG002|Overall Study|Husband ill|0
7654322|NCT00048074|12070118|FG000|Overall Study|Poor compliance|0
7654323|NCT00048074|12070119|FG001|Overall Study|Poor compliance|1
7654324|NCT00048074|12070120|FG002|Overall Study|Poor compliance|0
7654325|NCT00048074|12070118|FG000|Overall Study|Out of station|0
7654326|NCT00048074|12070119|FG001|Overall Study|Out of station|1
7654327|NCT00048074|12070120|FG002|Overall Study|Out of station|1
7654328|NCT00048074|12070118|FG000|Overall Study|Social reasons|1
7654329|NCT00048074|12070119|FG001|Overall Study|Social reasons|0
7654330|NCT00048074|12070120|FG002|Overall Study|Social reasons|0
7654331|NCT00048165|12070130|FG000|Completed 6 Months Study|Administration/Other|8
7654332|NCT00048165|12070131|FG001|Completed 6 Months Study|Administration/Other|8
7654333|NCT00048165|12070130|FG000|Completed 6 Months Study|Abnormality of laboratory test|1
7654334|NCT00048165|12070131|FG001|Completed 6 Months Study|Abnormality of laboratory test|0
7654335|NCT00048165|12070130|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14
7654336|NCT00048165|12070131|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11
7654337|NCT00048165|12070130|FG000|Completed 6 Months Study|Death|12
7654338|NCT00048165|12070131|FG001|Completed 6 Months Study|Death|6
7654339|NCT00048165|12070130|FG000|Completed 6 Months Study|Insufficient therapy|1
7654340|NCT00048165|12070131|FG001|Completed 6 Months Study|Insufficient therapy|4
7654341|NCT00048165|12070130|FG000|Completed 6 Months Study|Other violation|4
7654342|NCT00048165|12070131|FG001|Completed 6 Months Study|Other violation|6
7654343|NCT00048165|12070130|FG000|Completed 6 Months Study|Refused treatment|5
7654344|NCT00048165|12070131|FG001|Completed 6 Months Study|Refused treatment|5
7654345|NCT00048165|12070130|FG000|Completed 6 Months Study|Violation criteria|0
7654346|NCT00048165|12070131|FG001|Completed 6 Months Study|Violation criteria|2
7654347|NCT00048165|12070130|FG000|Completed 6 Months Study|Did not receive study drug|6
7654348|NCT00048165|12070131|FG001|Completed 6 Months Study|Did not receive study drug|6
7654349|NCT00048165|12070130|FG000|Completed 12 Months Study|Administration/Other|0
7654350|NCT00048165|12070131|FG001|Completed 12 Months Study|Administration/Other|2
7654351|NCT00048165|12070130|FG000|Completed 12 Months Study|Death|2
7654352|NCT00048165|12070131|FG001|Completed 12 Months Study|Death|1
7654353|NCT00048165|12070130|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1
7654354|NCT00048165|12070131|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0
7654355|NCT00048347|12070139|FG000|Overall Study|Screen failure|2
7654356|NCT00048542|12070147|FG000|Double-Blind Phase|Withdrawal by Subject|0
7654357|NCT00048542|12070148|FG001|Double-Blind Phase|Withdrawal by Subject|1
7654358|NCT00048542|12070149|FG002|Double-Blind Phase|Withdrawal by Subject|0
7654359|NCT00048542|12070150|FG003|Double-Blind Phase|Withdrawal by Subject|0
7654360|NCT00048542|12070151|FG004|Double-Blind Phase|Withdrawal by Subject|0
7654361|NCT00048542|12070152|FG005|Double-Blind Phase|Withdrawal by Subject|0
7654362|NCT00048542|12070153|FG006|Double-Blind Phase|Withdrawal by Subject|0
7654363|NCT00048542|12070154|FG007|Double-Blind Phase|Withdrawal by Subject|0
7654364|NCT00048542|12070147|FG000|Double-Blind Phase|Protocol Violation|0
7654365|NCT00048542|12070148|FG001|Double-Blind Phase|Protocol Violation|0
7654366|NCT00048542|12070149|FG002|Double-Blind Phase|Protocol Violation|1
7654367|NCT00048542|12070150|FG003|Double-Blind Phase|Protocol Violation|0
7654368|NCT00048542|12070151|FG004|Double-Blind Phase|Protocol Violation|0
7654369|NCT00048542|12070152|FG005|Double-Blind Phase|Protocol Violation|0
7654370|NCT00048542|12070153|FG006|Double-Blind Phase|Protocol Violation|0
7654371|NCT00048542|12070154|FG007|Double-Blind Phase|Protocol Violation|0
7654372|NCT00048542|12070147|FG000|Double-Blind Phase|Sponsor request or decision|2
7654373|NCT00048542|12070148|FG001|Double-Blind Phase|Sponsor request or decision|0
7654374|NCT00048542|12070149|FG002|Double-Blind Phase|Sponsor request or decision|0
7654375|NCT00048542|12070150|FG003|Double-Blind Phase|Sponsor request or decision|0
7654376|NCT00048542|12070151|FG004|Double-Blind Phase|Sponsor request or decision|0
7654377|NCT00048542|12070152|FG005|Double-Blind Phase|Sponsor request or decision|0
7654378|NCT00048542|12070153|FG006|Double-Blind Phase|Sponsor request or decision|0
7654379|NCT00048542|12070154|FG007|Double-Blind Phase|Sponsor request or decision|0
7654380|NCT00048542|12070147|FG000|Double-Blind Phase|Randomized in error|1
7654381|NCT00048542|12070148|FG001|Double-Blind Phase|Randomized in error|0
7654382|NCT00048542|12070149|FG002|Double-Blind Phase|Randomized in error|0
7654383|NCT00048542|12070150|FG003|Double-Blind Phase|Randomized in error|0
7654384|NCT00048542|12070151|FG004|Double-Blind Phase|Randomized in error|0
7654385|NCT00048542|12070152|FG005|Double-Blind Phase|Randomized in error|0
7654386|NCT00048542|12070153|FG006|Double-Blind Phase|Randomized in error|0
7654387|NCT00048542|12070154|FG007|Double-Blind Phase|Randomized in error|0
7654388|NCT00048542|12070147|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7654389|NCT00048542|12070148|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7654390|NCT00048542|12070149|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7654391|NCT00048542|12070150|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7654392|NCT00048542|12070151|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3
7654393|NCT00048542|12070152|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6
7654394|NCT00048542|12070153|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7654395|NCT00048542|12070154|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7654396|NCT00048542|12070147|FG000|Open-Label Extension BSA Phase|Protocol Violation|0
7654397|NCT00048542|12070148|FG001|Open-Label Extension BSA Phase|Protocol Violation|0
7654398|NCT00048542|12070149|FG002|Open-Label Extension BSA Phase|Protocol Violation|0
7654399|NCT00048542|12070150|FG003|Open-Label Extension BSA Phase|Protocol Violation|0
7654400|NCT00048542|12070151|FG004|Open-Label Extension BSA Phase|Protocol Violation|0
7654401|NCT00048542|12070152|FG005|Open-Label Extension BSA Phase|Protocol Violation|1
7654402|NCT00048542|12070153|FG006|Open-Label Extension BSA Phase|Protocol Violation|0
7654403|NCT00048542|12070154|FG007|Open-Label Extension BSA Phase|Protocol Violation|0
7654404|NCT00048542|12070147|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0
7654405|NCT00048542|12070148|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0
7654406|NCT00048542|12070149|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0
7654407|NCT00048542|12070150|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0
7654408|NCT00048542|12070151|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5
7654409|NCT00048542|12070152|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1
7654410|NCT00048542|12070153|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0
7654411|NCT00048542|12070154|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0
7654412|NCT00048542|12070147|FG000|Open-Label Extension BSA Phase|Adverse Event|0
7654413|NCT00048542|12070148|FG001|Open-Label Extension BSA Phase|Adverse Event|0
7654414|NCT00048542|12070149|FG002|Open-Label Extension BSA Phase|Adverse Event|0
7654415|NCT00048542|12070150|FG003|Open-Label Extension BSA Phase|Adverse Event|0
7654416|NCT00048542|12070151|FG004|Open-Label Extension BSA Phase|Adverse Event|1
7654417|NCT00048542|12070152|FG005|Open-Label Extension BSA Phase|Adverse Event|1
7654418|NCT00048542|12070153|FG006|Open-Label Extension BSA Phase|Adverse Event|0
7654419|NCT00048542|12070154|FG007|Open-Label Extension BSA Phase|Adverse Event|0
7654420|NCT00048542|12070147|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0
7654421|NCT00048542|12070148|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0
7654422|NCT00048542|12070149|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0
7654423|NCT00048542|12070150|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0
7654424|NCT00048542|12070151|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3
7654425|NCT00048542|12070152|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1
7654426|NCT00048542|12070153|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0
7654427|NCT00048542|12070154|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0
7654428|NCT00048542|12070147|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7654429|NCT00048542|12070148|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7654430|NCT00048542|12070149|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7654431|NCT00048542|12070150|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7654432|NCT00048542|12070151|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7654433|NCT00048542|12070152|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7654434|NCT00048542|12070153|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
7654435|NCT00048542|12070154|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
7654436|NCT00048542|12070147|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7654437|NCT00048542|12070148|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7654438|NCT00048542|12070149|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7654439|NCT00048542|12070150|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7654440|NCT00048542|12070151|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7654441|NCT00048542|12070152|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7654442|NCT00048542|12070153|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
7654443|NCT00048542|12070154|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
7654444|NCT00048542|12070147|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7654445|NCT00048542|12070148|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7654446|NCT00048542|12070149|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7654447|NCT00048542|12070150|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7654448|NCT00048542|12070151|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7654449|NCT00048542|12070152|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7654450|NCT00048542|12070153|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
7654451|NCT00048542|12070154|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
7654452|NCT00048542|12070147|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7654453|NCT00048542|12070148|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7654454|NCT00048542|12070149|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7654455|NCT00048542|12070150|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7654456|NCT00048542|12070151|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7654457|NCT00048542|12070152|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7654458|NCT00048542|12070153|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2
7654459|NCT00048542|12070154|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2
7654460|NCT00048542|12070147|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7654461|NCT00048542|12070148|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7654462|NCT00048542|12070149|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7654463|NCT00048542|12070150|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7654464|NCT00048542|12070151|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7654465|NCT00048542|12070152|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7654466|NCT00048542|12070153|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
7654467|NCT00048542|12070154|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
7654468|NCT00048542|12070147|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7654469|NCT00048542|12070148|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7654470|NCT00048542|12070149|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7654471|NCT00048542|12070150|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7654472|NCT00048542|12070151|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7654473|NCT00048542|12070152|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7654474|NCT00048542|12070153|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
7654475|NCT00048542|12070154|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
7654476|NCT00048568|12070185|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11
7654477|NCT00048568|12070186|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3
7654478|NCT00048568|12070187|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0
7654479|NCT00048568|12070185|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
7654480|NCT00048568|12070186|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
7654481|NCT00048568|12070187|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
7654482|NCT00048568|12070185|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
7654483|NCT00048568|12070186|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
7654484|NCT00048568|12070187|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
7654485|NCT00048568|12070185|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
7654486|NCT00048568|12070186|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
7654487|NCT00048568|12070187|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
7654488|NCT00048568|12070185|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2
7654489|NCT00048568|12070186|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4
7654490|NCT00048568|12070187|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0
7654491|NCT00048568|12070185|FG000|Double-Blind Period Days 170 to 365|Death|1
7654492|NCT00048568|12070186|FG001|Double-Blind Period Days 170 to 365|Death|1
7654493|NCT00048568|12070187|FG002|Double-Blind Period Days 170 to 365|Death|0
7654494|NCT00048568|12070185|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7
7654495|NCT00048568|12070186|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1
7654496|NCT00048568|12070187|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0
7654497|NCT00048568|12070185|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
7654498|NCT00048568|12070186|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
7654499|NCT00048568|12070187|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
7654500|NCT00048568|12070185|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
7654501|NCT00048568|12070186|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
7654502|NCT00048568|12070187|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
7654503|NCT00048568|12070185|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
7654504|NCT00048568|12070186|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
7654505|NCT00048568|12070187|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
7654506|NCT00048568|12070185|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2
7654507|NCT00048568|12070186|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0
7654508|NCT00048568|12070187|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0
7654509|NCT00048568|12070185|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
7654510|NCT00048568|12070186|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
7654511|NCT00048568|12070187|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
7654512|NCT00048568|12070185|FG000|Open-Label Period|Death|0
7654513|NCT00048568|12070186|FG001|Open-Label Period|Death|0
7654514|NCT00048568|12070187|FG002|Open-Label Period|Death|13
7654515|NCT00048568|12070185|FG000|Open-Label Period|Adverse Event|0
7654516|NCT00048568|12070186|FG001|Open-Label Period|Adverse Event|0
7654517|NCT00048568|12070187|FG002|Open-Label Period|Adverse Event|49
7654518|NCT00048568|12070185|FG000|Open-Label Period|Lack of Efficacy|0
7654519|NCT00048568|12070186|FG001|Open-Label Period|Lack of Efficacy|0
7654520|NCT00048568|12070187|FG002|Open-Label Period|Lack of Efficacy|32
7654521|NCT00048568|12070185|FG000|Open-Label Period|Withdrawal by Subject|0
7654522|NCT00048568|12070186|FG001|Open-Label Period|Withdrawal by Subject|0
7654523|NCT00048568|12070187|FG002|Open-Label Period|Withdrawal by Subject|26
7654524|NCT00048568|12070185|FG000|Open-Label Period|Pregnancy|0
7654525|NCT00048568|12070186|FG001|Open-Label Period|Pregnancy|0
7654526|NCT00048568|12070187|FG002|Open-Label Period|Pregnancy|5
7654527|NCT00048568|12070185|FG000|Open-Label Period|No Longer Met Study Criteria|0
7654528|NCT00048568|12070186|FG001|Open-Label Period|No Longer Met Study Criteria|0
7654529|NCT00048568|12070187|FG002|Open-Label Period|No Longer Met Study Criteria|2
7654530|NCT00048568|12070185|FG000|Open-Label Period|Administrative Decision By Sponsor|0
7654531|NCT00048568|12070186|FG001|Open-Label Period|Administrative Decision By Sponsor|0
7654532|NCT00048568|12070187|FG002|Open-Label Period|Administrative Decision By Sponsor|1
7654533|NCT00048568|12070185|FG000|Open-Label Period|Unknown Reasons|0
7654534|NCT00048568|12070186|FG001|Open-Label Period|Unknown Reasons|0
7654535|NCT00048568|12070187|FG002|Open-Label Period|Unknown Reasons|25
7654536|NCT00048568|12070185|FG000|Open-Label Period|Lost to Follow-up|0
7654537|NCT00048568|12070186|FG001|Open-Label Period|Lost to Follow-up|0
7654538|NCT00048568|12070187|FG002|Open-Label Period|Lost to Follow-up|7
7654539|NCT00048581|12070210|FG000|Double-Blind Period|Adverse Event|9
7654540|NCT00048581|12070211|FG001|Double-Blind Period|Adverse Event|5
7654541|NCT00048581|12070212|FG002|Double-Blind Period|Adverse Event|0
7654542|NCT00048581|12070210|FG000|Double-Blind Period|Lack of Efficacy|14
7654543|NCT00048581|12070211|FG001|Double-Blind Period|Lack of Efficacy|27
7654544|NCT00048581|12070212|FG002|Double-Blind Period|Lack of Efficacy|0
7654545|NCT00048581|12070210|FG000|Double-Blind Period|Lost to Follow-up|5
7654546|NCT00048581|12070211|FG001|Double-Blind Period|Lost to Follow-up|0
7654547|NCT00048581|12070212|FG002|Double-Blind Period|Lost to Follow-up|0
7654548|NCT00048581|12070210|FG000|Double-Blind Period|Withdrawal by Subject|5
7654549|NCT00048581|12070211|FG001|Double-Blind Period|Withdrawal by Subject|2
7654550|NCT00048581|12070212|FG002|Double-Blind Period|Withdrawal by Subject|0
7654551|NCT00048581|12070210|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1
7654552|NCT00048581|12070211|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0
7654553|NCT00048581|12070212|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0
7654554|NCT00048581|12070210|FG000|Double-Blind Period|Investigator Decision|1
7654555|NCT00048581|12070211|FG001|Double-Blind Period|Investigator Decision|0
7654556|NCT00048581|12070212|FG002|Double-Blind Period|Investigator Decision|0
7654557|NCT00048581|12070210|FG000|Open-Label Period|Death|0
7654558|NCT00048581|12070211|FG001|Open-Label Period|Death|0
7654559|NCT00048581|12070212|FG002|Open-Label Period|Death|4
7654560|NCT00048581|12070210|FG000|Open-Label Period|Adverse Event|0
7654561|NCT00048581|12070211|FG001|Open-Label Period|Adverse Event|0
7654562|NCT00048581|12070212|FG002|Open-Label Period|Adverse Event|37
7654563|NCT00048581|12070210|FG000|Open-Label Period|Lack of Efficacy|0
7654564|NCT00048581|12070211|FG001|Open-Label Period|Lack of Efficacy|0
7654565|NCT00048581|12070212|FG002|Open-Label Period|Lack of Efficacy|69
7654566|NCT00048581|12070210|FG000|Open-Label Period|Lost to Follow-up|0
7654567|NCT00048581|12070211|FG001|Open-Label Period|Lost to Follow-up|0
7654568|NCT00048581|12070212|FG002|Open-Label Period|Lost to Follow-up|14
7654569|NCT00048581|12070210|FG000|Open-Label Period|Withdrawal by Subject|0
7654570|NCT00048581|12070211|FG001|Open-Label Period|Withdrawal by Subject|0
7654571|NCT00048581|12070212|FG002|Open-Label Period|Withdrawal by Subject|20
7654572|NCT00048581|12070210|FG000|Open-Label Period|No Longer Meets Study Criteria|0
7654573|NCT00048581|12070211|FG001|Open-Label Period|No Longer Meets Study Criteria|0
7654574|NCT00048581|12070212|FG002|Open-Label Period|No Longer Meets Study Criteria|2
7654575|NCT00048581|12070210|FG000|Open-Label Period|Poor/Non-compliance|0
7654576|NCT00048581|12070211|FG001|Open-Label Period|Poor/Non-compliance|0
7654577|NCT00048581|12070212|FG002|Open-Label Period|Poor/Non-compliance|5
7654578|NCT00048581|12070210|FG000|Open-Label Period|Pregnancy|0
7654579|NCT00048581|12070211|FG001|Open-Label Period|Pregnancy|0
7654580|NCT00048581|12070212|FG002|Open-Label Period|Pregnancy|7
7654581|NCT00048581|12070210|FG000|Open-Label Period|Study Site Closure|0
7654582|NCT00048581|12070211|FG001|Open-Label Period|Study Site Closure|0
7654583|NCT00048581|12070212|FG002|Open-Label Period|Study Site Closure|2
7654584|NCT00048581|12070210|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0
7654585|NCT00048581|12070211|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0
7654586|NCT00048581|12070212|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3
7654587|NCT00048581|12070210|FG000|Open-Label Period|Problem With Transportation To Site|0
7654588|NCT00048581|12070211|FG001|Open-Label Period|Problem With Transportation To Site|0
7654589|NCT00048581|12070212|FG002|Open-Label Period|Problem With Transportation To Site|1
7654590|NCT00048581|12070210|FG000|Open-Label Period|Primary Investigator Retired|0
7654591|NCT00048581|12070211|FG001|Open-Label Period|Primary Investigator Retired|0
7654592|NCT00048581|12070212|FG002|Open-Label Period|Primary Investigator Retired|2
7654593|NCT00048581|12070210|FG000|Open-Label Period|Study Ended By Sponsor|0
7654594|NCT00048581|12070211|FG001|Open-Label Period|Study Ended By Sponsor|0
7654595|NCT00048581|12070212|FG002|Open-Label Period|Study Ended By Sponsor|1
7654596|NCT00048724|12070227|FG000|Overall Study|Adverse Event|53
7654597|NCT00048724|12070228|FG001|Overall Study|Adverse Event|12
7654598|NCT00048724|12070227|FG000|Overall Study|Withdrawal by Subject|34
7654599|NCT00048724|12070228|FG001|Overall Study|Withdrawal by Subject|54
7654600|NCT00048724|12070227|FG000|Overall Study|Lost to Follow-up|5
7654601|NCT00048724|12070228|FG001|Overall Study|Lost to Follow-up|5
7654602|NCT00048724|12070227|FG000|Overall Study|Protocol-defined Clinical Event|17
7654603|NCT00048724|12070228|FG001|Overall Study|Protocol-defined Clinical Event|32
7654604|NCT00048724|12070227|FG000|Overall Study|Noncompliance With Protocol|4
7654605|NCT00048724|12070228|FG001|Overall Study|Noncompliance With Protocol|12
7654606|NCT00048724|12070227|FG000|Overall Study|Did Not Meet Protocol Eligibility|2
7654607|NCT00048724|12070228|FG001|Overall Study|Did Not Meet Protocol Eligibility|2
7654608|NCT00048724|12070227|FG000|Overall Study|Administrative|1
7654609|NCT00048724|12070228|FG001|Overall Study|Administrative|1
7654610|NCT00048932|12070257|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1
7654611|NCT00048932|12070258|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0
7654612|NCT00048932|12070259|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0
7654613|NCT00048932|12070257|FG000|Double Blind Period (DB)|Adverse Event|51
7654614|NCT00048932|12070258|FG001|Double Blind Period (DB)|Adverse Event|19
7654615|NCT00048932|12070259|FG002|Double Blind Period (DB)|Adverse Event|0
7654616|NCT00048932|12070257|FG000|Double Blind Period (DB)|Death|5
7654617|NCT00048932|12070258|FG001|Double Blind Period (DB)|Death|3
7654618|NCT00048932|12070259|FG002|Double Blind Period (DB)|Death|0
7654619|NCT00048932|12070257|FG000|Double Blind Period (DB)|Lack of Efficacy|26
7654620|NCT00048932|12070258|FG001|Double Blind Period (DB)|Lack of Efficacy|44
7654621|NCT00048932|12070259|FG002|Double Blind Period (DB)|Lack of Efficacy|0
7654622|NCT00048932|12070257|FG000|Double Blind Period (DB)|Lost to Follow-up|3
7654623|NCT00048932|12070258|FG001|Double Blind Period (DB)|Lost to Follow-up|4
7654624|NCT00048932|12070259|FG002|Double Blind Period (DB)|Lost to Follow-up|0
7654625|NCT00048932|12070257|FG000|Double Blind Period (DB)|Relocation|1
7654626|NCT00048932|12070258|FG001|Double Blind Period (DB)|Relocation|0
7654627|NCT00048932|12070259|FG002|Double Blind Period (DB)|Relocation|0
7654628|NCT00048932|12070257|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0
7654629|NCT00048932|12070258|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1
7654630|NCT00048932|12070259|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0
7654631|NCT00048932|12070257|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
7654632|NCT00048932|12070258|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
7654633|NCT00048932|12070259|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
7654634|NCT00048932|12070257|FG000|Double Blind Period (DB)|Pregnancy|1
7654635|NCT00048932|12070258|FG001|Double Blind Period (DB)|Pregnancy|0
7654636|NCT00048932|12070259|FG002|Double Blind Period (DB)|Pregnancy|0
7654637|NCT00048932|12070257|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8
7654638|NCT00048932|12070258|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2
7654639|NCT00048932|12070259|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0
7654640|NCT00048932|12070257|FG000|Double Blind Period (DB)|Withdrawal by Subject|24
7654641|NCT00048932|12070258|FG001|Double Blind Period (DB)|Withdrawal by Subject|10
7654642|NCT00048932|12070259|FG002|Double Blind Period (DB)|Withdrawal by Subject|0
7654643|NCT00048932|12070257|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2
7654644|NCT00048932|12070258|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4
7654645|NCT00048932|12070259|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0
7654646|NCT00048932|12070257|FG000|Open Label Period (OL)|Death|0
7654647|NCT00048932|12070258|FG001|Open Label Period (OL)|Death|0
7654648|NCT00048932|12070259|FG002|Open Label Period (OL)|Death|25
7654649|NCT00048932|12070257|FG000|Open Label Period (OL)|Adverse Event|0
7654650|NCT00048932|12070258|FG001|Open Label Period (OL)|Adverse Event|0
7654651|NCT00048932|12070259|FG002|Open Label Period (OL)|Adverse Event|103
7654652|NCT00048932|12070257|FG000|Open Label Period (OL)|Lack of Efficacy|0
7654653|NCT00048932|12070258|FG001|Open Label Period (OL)|Lack of Efficacy|0
7654654|NCT00048932|12070259|FG002|Open Label Period (OL)|Lack of Efficacy|81
7654655|NCT00048932|12070257|FG000|Open Label Period (OL)|Lost to Follow-up|0
7654656|NCT00048932|12070258|FG001|Open Label Period (OL)|Lost to Follow-up|0
7654657|NCT00048932|12070259|FG002|Open Label Period (OL)|Lost to Follow-up|27
7654658|NCT00048932|12070257|FG000|Open Label Period (OL)|Withdrawal by Subject|0
7654659|NCT00048932|12070258|FG001|Open Label Period (OL)|Withdrawal by Subject|0
7654660|NCT00048932|12070259|FG002|Open Label Period (OL)|Withdrawal by Subject|117
7654661|NCT00048932|12070257|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0
7654662|NCT00048932|12070258|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0
7654663|NCT00048932|12070259|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5
7654664|NCT00048932|12070257|FG000|Open Label Period (OL)|Poor/Non-Compliance|0
7654665|NCT00048932|12070258|FG001|Open Label Period (OL)|Poor/Non-Compliance|0
7654666|NCT00048932|12070259|FG002|Open Label Period (OL)|Poor/Non-Compliance|13
7654667|NCT00048932|12070257|FG000|Open Label Period (OL)|Pregnancy|0
7654668|NCT00048932|12070258|FG001|Open Label Period (OL)|Pregnancy|0
7654669|NCT00048932|12070259|FG002|Open Label Period (OL)|Pregnancy|6
7654670|NCT00048932|12070257|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0
7654671|NCT00048932|12070258|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0
7654672|NCT00048932|12070259|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20
7654673|NCT00048932|12070257|FG000|Open Label Period (OL)|Investigator Retiring|0
7654674|NCT00048932|12070258|FG001|Open Label Period (OL)|Investigator Retiring|0
7654675|NCT00048932|12070259|FG002|Open Label Period (OL)|Investigator Retiring|2
7654676|NCT00048932|12070257|FG000|Open Label Period (OL)|Participant Transportation Issues|0
7654677|NCT00048932|12070258|FG001|Open Label Period (OL)|Participant Transportation Issues|0
7654678|NCT00048932|12070259|FG002|Open Label Period (OL)|Participant Transportation Issues|1
7654679|NCT00048932|12070257|FG000|Open Label Period (OL)|Participant Relocated|0
7654680|NCT00048932|12070258|FG001|Open Label Period (OL)|Participant Relocated|0
7654681|NCT00048932|12070259|FG002|Open Label Period (OL)|Participant Relocated|6
7654682|NCT00048932|12070257|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0
7654683|NCT00048932|12070258|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0
7654684|NCT00048932|12070259|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1
7654685|NCT00048932|12070257|FG000|Open Label Period (OL)|Site Closure|0
7654686|NCT00048932|12070258|FG001|Open Label Period (OL)|Site Closure|0
7654687|NCT00048932|12070259|FG002|Open Label Period (OL)|Site Closure|3
7654688|NCT00048932|12070257|FG000|Open Label Period (OL)|Trial Terminated|0
7654689|NCT00048932|12070258|FG001|Open Label Period (OL)|Trial Terminated|0
7654690|NCT00048932|12070259|FG002|Open Label Period (OL)|Trial Terminated|1
7654691|NCT00048932|12070257|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0
7654692|NCT00048932|12070258|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0
7654693|NCT00048932|12070259|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1
7654694|NCT00048932|12070257|FG000|Open Label Period (OL)|Patient Decision|0
7654695|NCT00048932|12070258|FG001|Open Label Period (OL)|Patient Decision|0
7654696|NCT00048932|12070259|FG002|Open Label Period (OL)|Patient Decision|4
7654697|NCT00048932|12070257|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0
7654698|NCT00048932|12070258|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0
7654699|NCT00048932|12070259|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1
7654700|NCT00048932|12070257|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0
7654701|NCT00048932|12070258|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0
7654702|NCT00048932|12070259|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2
7654703|NCT00048932|12070257|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0
7654704|NCT00048932|12070258|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0
7654705|NCT00048932|12070259|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5
7654706|NCT00048932|12070257|FG000|Open Label Period (OL)|Medication Lost Efficacy|0
7654707|NCT00048932|12070258|FG001|Open Label Period (OL)|Medication Lost Efficacy|0
7654708|NCT00048932|12070259|FG002|Open Label Period (OL)|Medication Lost Efficacy|1
7654709|NCT00048932|12070257|FG000|Open Label Period (OL)|Investigator Decision|0
7654710|NCT00048932|12070258|FG001|Open Label Period (OL)|Investigator Decision|0
7654711|NCT00048932|12070259|FG002|Open Label Period (OL)|Investigator Decision|4
7654712|NCT00048932|12070257|FG000|Open Label Period (OL)|Site Staff Issues|0
7654713|NCT00048932|12070258|FG001|Open Label Period (OL)|Site Staff Issues|0
7654714|NCT00048932|12070259|FG002|Open Label Period (OL)|Site Staff Issues|2
7654715|NCT00048932|12070257|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0
7654716|NCT00048932|12070258|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0
7654717|NCT00048932|12070259|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9
7654718|NCT00048932|12070257|FG000|Open Label Period (OL)|Participant Surgery|0
7654719|NCT00048932|12070258|FG001|Open Label Period (OL)|Participant Surgery|0
7654720|NCT00048932|12070259|FG002|Open Label Period (OL)|Participant Surgery|1
7654721|NCT00048997|12070270|FG000|Overall Study|Protocol Violation|7
7654722|NCT00048997|12070271|FG001|Overall Study|Protocol Violation|2
7654723|NCT00048997|12070270|FG000|Overall Study|Withdrawal by Subject|6
7654724|NCT00048997|12070271|FG001|Overall Study|Withdrawal by Subject|1
7654725|NCT00049127|12070290|FG000|Overall Study|Withdrawal by Subject|0
7654726|NCT00049127|12070291|FG001|Overall Study|Withdrawal by Subject|0
7654727|NCT00049127|12070292|FG002|Overall Study|Withdrawal by Subject|1
7654728|NCT00049127|12070293|FG003|Overall Study|Withdrawal by Subject|0
7654729|NCT00049127|12070294|FG004|Overall Study|Withdrawal by Subject|0
7654730|NCT00049257|12070306|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10
7654731|NCT00049257|12070306|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1
7654732|NCT00049257|12070306|FG000|Carboplatin, Paclitaxel|Death|2
7654733|NCT00049257|12070306|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4
7654734|NCT00049322|12070312|FG000|Overall Study|disease burden|0
7654735|NCT00049322|12070313|FG001|Overall Study|disease burden|3
7654736|NCT00049322|12070312|FG000|Overall Study|Adverse Event|1
7654737|NCT00049322|12070313|FG001|Overall Study|Adverse Event|0
7654738|NCT00049322|12070312|FG000|Overall Study|refused angio|0
7654739|NCT00049322|12070313|FG001|Overall Study|refused angio|3
7654740|NCT00049517|12070327|FG000|Induction|Disease progression|0
7654741|NCT00049517|12070328|FG001|Induction|Disease progression|0
7654742|NCT00049517|12070329|FG002|Induction|Disease progression|0
7654743|NCT00049517|12070330|FG003|Induction|Disease progression|0
7654744|NCT00049517|12070331|FG004|Induction|Disease progression|18
7654745|NCT00049517|12070332|FG005|Induction|Disease progression|11
7654746|NCT00049517|12070327|FG000|Induction|Adverse Event|0
7654747|NCT00049517|12070328|FG001|Induction|Adverse Event|0
7654748|NCT00049517|12070329|FG002|Induction|Adverse Event|0
7654749|NCT00049517|12070330|FG003|Induction|Adverse Event|0
7654750|NCT00049517|12070331|FG004|Induction|Adverse Event|5
7654751|NCT00049517|12070332|FG005|Induction|Adverse Event|7
7654752|NCT00049517|12070327|FG000|Induction|Death|0
7654753|NCT00049517|12070328|FG001|Induction|Death|0
7654754|NCT00049517|12070329|FG002|Induction|Death|0
7654755|NCT00049517|12070330|FG003|Induction|Death|0
7654756|NCT00049517|12070331|FG004|Induction|Death|9
7654757|NCT00049517|12070332|FG005|Induction|Death|6
7654758|NCT00049517|12070327|FG000|Induction|Withdrawal by Subject|0
7654759|NCT00049517|12070328|FG001|Induction|Withdrawal by Subject|0
7654760|NCT00049517|12070329|FG002|Induction|Withdrawal by Subject|0
7654761|NCT00049517|12070330|FG003|Induction|Withdrawal by Subject|0
7654762|NCT00049517|12070331|FG004|Induction|Withdrawal by Subject|1
7654763|NCT00049517|12070332|FG005|Induction|Withdrawal by Subject|3
7654764|NCT00049517|12070327|FG000|Induction|Alternative therapy|0
7654765|NCT00049517|12070328|FG001|Induction|Alternative therapy|0
7654766|NCT00049517|12070329|FG002|Induction|Alternative therapy|0
7654767|NCT00049517|12070330|FG003|Induction|Alternative therapy|0
7654768|NCT00049517|12070331|FG004|Induction|Alternative therapy|2
7654769|NCT00049517|12070332|FG005|Induction|Alternative therapy|2
7654770|NCT00049517|12070327|FG000|Induction|Other complicating disease|0
7654771|NCT00049517|12070328|FG001|Induction|Other complicating disease|0
7654772|NCT00049517|12070329|FG002|Induction|Other complicating disease|0
7654773|NCT00049517|12070330|FG003|Induction|Other complicating disease|0
7654774|NCT00049517|12070331|FG004|Induction|Other complicating disease|3
7654775|NCT00049517|12070332|FG005|Induction|Other complicating disease|0
7654776|NCT00049517|12070327|FG000|Induction|Reasons not reported|0
7654777|NCT00049517|12070328|FG001|Induction|Reasons not reported|0
7654778|NCT00049517|12070329|FG002|Induction|Reasons not reported|0
7654779|NCT00049517|12070330|FG003|Induction|Reasons not reported|0
7654780|NCT00049517|12070331|FG004|Induction|Reasons not reported|22
7654781|NCT00049517|12070332|FG005|Induction|Reasons not reported|25
7654782|NCT00049517|12070327|FG000|Conditioning/Transplant|Disease progression|14
7654783|NCT00049517|12070328|FG001|Conditioning/Transplant|Disease progression|6
7654784|NCT00049517|12070329|FG002|Conditioning/Transplant|Disease progression|10
7654785|NCT00049517|12070330|FG003|Conditioning/Transplant|Disease progression|6
7654786|NCT00049517|12070331|FG004|Conditioning/Transplant|Disease progression|0
7654787|NCT00049517|12070332|FG005|Conditioning/Transplant|Disease progression|0
7654788|NCT00049517|12070327|FG000|Conditioning/Transplant|Adverse Event|2
7654789|NCT00049517|12070328|FG001|Conditioning/Transplant|Adverse Event|1
7654790|NCT00049517|12070329|FG002|Conditioning/Transplant|Adverse Event|4
7654791|NCT00049517|12070330|FG003|Conditioning/Transplant|Adverse Event|8
7654792|NCT00049517|12070331|FG004|Conditioning/Transplant|Adverse Event|0
7654793|NCT00049517|12070332|FG005|Conditioning/Transplant|Adverse Event|0
7654794|NCT00049517|12070327|FG000|Conditioning/Transplant|Death|1
7654795|NCT00049517|12070328|FG001|Conditioning/Transplant|Death|0
7654796|NCT00049517|12070329|FG002|Conditioning/Transplant|Death|0
7654797|NCT00049517|12070330|FG003|Conditioning/Transplant|Death|2
7654798|NCT00049517|12070331|FG004|Conditioning/Transplant|Death|0
7654799|NCT00049517|12070332|FG005|Conditioning/Transplant|Death|0
7654800|NCT00049517|12070327|FG000|Conditioning/Transplant|Withdrawal by Subject|4
7654801|NCT00049517|12070328|FG001|Conditioning/Transplant|Withdrawal by Subject|8
7654802|NCT00049517|12070329|FG002|Conditioning/Transplant|Withdrawal by Subject|4
7654803|NCT00049517|12070330|FG003|Conditioning/Transplant|Withdrawal by Subject|7
7654804|NCT00049517|12070331|FG004|Conditioning/Transplant|Withdrawal by Subject|0
7654805|NCT00049517|12070332|FG005|Conditioning/Transplant|Withdrawal by Subject|0
7654806|NCT00049517|12070327|FG000|Conditioning/Transplant|Alternative therapy|4
7654807|NCT00049517|12070328|FG001|Conditioning/Transplant|Alternative therapy|4
7654808|NCT00049517|12070329|FG002|Conditioning/Transplant|Alternative therapy|2
7654809|NCT00049517|12070330|FG003|Conditioning/Transplant|Alternative therapy|1
7654810|NCT00049517|12070331|FG004|Conditioning/Transplant|Alternative therapy|1
7654811|NCT00049517|12070332|FG005|Conditioning/Transplant|Alternative therapy|0
7654812|NCT00049517|12070327|FG000|Conditioning/Transplant|Other complicating disease|2
7654813|NCT00049517|12070328|FG001|Conditioning/Transplant|Other complicating disease|0
7654814|NCT00049517|12070329|FG002|Conditioning/Transplant|Other complicating disease|0
7654815|NCT00049517|12070330|FG003|Conditioning/Transplant|Other complicating disease|4
7654816|NCT00049517|12070331|FG004|Conditioning/Transplant|Other complicating disease|0
7654817|NCT00049517|12070332|FG005|Conditioning/Transplant|Other complicating disease|1
7654818|NCT00049517|12070327|FG000|Conditioning/Transplant|Reasons not reported|25
7654819|NCT00049517|12070328|FG001|Conditioning/Transplant|Reasons not reported|31
7654820|NCT00049517|12070329|FG002|Conditioning/Transplant|Reasons not reported|18
7654821|NCT00049517|12070330|FG003|Conditioning/Transplant|Reasons not reported|15
7654822|NCT00049517|12070331|FG004|Conditioning/Transplant|Reasons not reported|5
7654823|NCT00049517|12070332|FG005|Conditioning/Transplant|Reasons not reported|5
7654824|NCT00049530|12070340|FG000|Overall Study|Lack of Efficacy|25
7654825|NCT00049530|12070340|FG000|Overall Study|Adverse Event|2
7654826|NCT00049530|12070340|FG000|Overall Study|Death|1
7654827|NCT00049530|12070340|FG000|Overall Study|symptomatic deterioration|1
7654828|NCT00049530|12070340|FG000|Overall Study|ineligible|3
7654829|NCT00049543|12070346|FG000|Overall Study|still on treatment|2
7654830|NCT00049543|12070347|FG001|Overall Study|still on treatment|9
7654831|NCT00049673|12070355|FG000|Overall Study|No receive treatment/lost to follow-up|1
7654832|NCT00049673|12070356|FG001|Overall Study|No receive treatment/lost to follow-up|3
7654833|NCT00049842|12070364|FG000|Treatment Phase|Adverse Event|47
7654834|NCT00049842|12070365|FG001|Treatment Phase|Adverse Event|12
7654835|NCT00049842|12070364|FG000|Treatment Phase|Withdrawal by Subject|35
7654836|NCT00049842|12070365|FG001|Treatment Phase|Withdrawal by Subject|46
7654837|NCT00049842|12070364|FG000|Treatment Phase|Non-compliance with protocol|7
7654838|NCT00049842|12070365|FG001|Treatment Phase|Non-compliance with protocol|8
7654839|NCT00049842|12070364|FG000|Treatment Phase|Lost to Follow-up|4
7654840|NCT00049842|12070365|FG001|Treatment Phase|Lost to Follow-up|8
7654841|NCT00049842|12070364|FG000|Treatment Phase|Administrative|0
7654842|NCT00049842|12070365|FG001|Treatment Phase|Administrative|3
7654843|NCT00049842|12070364|FG000|Treatment Phase|Did not meet protocol eligibility|0
7654844|NCT00049842|12070365|FG001|Treatment Phase|Did not meet protocol eligibility|1
7654845|NCT00049842|12070364|FG000|Follow-up Phase|Adverse Event|6
7654846|NCT00049842|12070365|FG001|Follow-up Phase|Adverse Event|1
7654847|NCT00049842|12070364|FG000|Follow-up Phase|Other|1
7654848|NCT00049842|12070365|FG001|Follow-up Phase|Other|4
7654849|NCT00050011|12070373|FG000|Overall Study|Adverse Event|41
7654850|NCT00050011|12070374|FG001|Overall Study|Adverse Event|46
7654851|NCT00050011|12070373|FG000|Overall Study|Abnormal laboratory value(s)|1
7654852|NCT00050011|12070374|FG001|Overall Study|Abnormal laboratory value(s)|1
7654853|NCT00050011|12070373|FG000|Overall Study|Abnormal test procedure results|0
7654854|NCT00050011|12070374|FG001|Overall Study|Abnormal test procedure results|1
7654855|NCT00050011|12070373|FG000|Overall Study|Lack of Efficacy|16
7654856|NCT00050011|12070374|FG001|Overall Study|Lack of Efficacy|21
7654857|NCT00050011|12070373|FG000|Overall Study|Participant condition no longer required|1
7654858|NCT00050011|12070374|FG001|Overall Study|Participant condition no longer required|0
7654859|NCT00050011|12070373|FG000|Overall Study|Protocol Violation|4
7654860|NCT00050011|12070374|FG001|Overall Study|Protocol Violation|10
7654861|NCT00050011|12070373|FG000|Overall Study|Withdrawal by Subject|34
7654862|NCT00050011|12070374|FG001|Overall Study|Withdrawal by Subject|26
7654863|NCT00050011|12070373|FG000|Overall Study|Lost to Follow-up|7
7654864|NCT00050011|12070374|FG001|Overall Study|Lost to Follow-up|9
7654865|NCT00050011|12070373|FG000|Overall Study|Administrative problems|10
7654866|NCT00050011|12070374|FG001|Overall Study|Administrative problems|6
7654867|NCT00050011|12070373|FG000|Overall Study|Death|7
7654868|NCT00050011|12070374|FG001|Overall Study|Death|4
7654869|NCT00050011|12070373|FG000|Overall Study|Unknown - Reason is missing|0
7654870|NCT00050011|12070374|FG001|Overall Study|Unknown - Reason is missing|2
7654871|NCT00050167|12070404|FG000|Overall Study|not eligible not invasive|1
7654872|NCT00050167|12070405|FG001|Overall Study|not eligible not invasive|1
7654873|NCT00050622|12070411|FG000|Overall Study|Adverse Event|1
7654874|NCT00050778|12070438|FG000|Overall Study|Adverse Event|13
7654875|NCT00050778|12070439|FG001|Overall Study|Adverse Event|3
7654876|NCT00050778|12070440|FG002|Overall Study|Adverse Event|2
7654877|NCT00050778|12070438|FG000|Overall Study|Death|0
7654878|NCT00050778|12070439|FG001|Overall Study|Death|1
7654879|NCT00050778|12070440|FG002|Overall Study|Death|1
7654880|NCT00050778|12070438|FG000|Overall Study|Lack of Efficacy|16
7654881|NCT00050778|12070439|FG001|Overall Study|Lack of Efficacy|2
7654882|NCT00050778|12070440|FG002|Overall Study|Lack of Efficacy|2
7654883|NCT00050778|12070438|FG000|Overall Study|Lost to Follow-up|0
7654884|NCT00050778|12070439|FG001|Overall Study|Lost to Follow-up|2
7654885|NCT00050778|12070440|FG002|Overall Study|Lost to Follow-up|4
7654886|NCT00050778|12070438|FG000|Overall Study|Physician Decision|3
7654887|NCT00050778|12070439|FG001|Overall Study|Physician Decision|0
7654888|NCT00050778|12070440|FG002|Overall Study|Physician Decision|2
7654889|NCT00050778|12070438|FG000|Overall Study|Protocol Violation|2
7654890|NCT00050778|12070439|FG001|Overall Study|Protocol Violation|0
7654891|NCT00050778|12070440|FG002|Overall Study|Protocol Violation|1
7654892|NCT00050778|12070438|FG000|Overall Study|Withdrawal by Subject|6
7654893|NCT00050778|12070439|FG001|Overall Study|Withdrawal by Subject|8
7654894|NCT00050778|12070440|FG002|Overall Study|Withdrawal by Subject|4
7654895|NCT00050778|12070438|FG000|Overall Study|Randomized but not treated|4
7654896|NCT00050778|12070439|FG001|Overall Study|Randomized but not treated|5
7654897|NCT00050778|12070440|FG002|Overall Study|Randomized but not treated|2
7654898|NCT00050778|12070438|FG000|Overall Study|Familial and personal reasons|1
7654899|NCT00050778|12070439|FG001|Overall Study|Familial and personal reasons|0
7654900|NCT00050778|12070440|FG002|Overall Study|Familial and personal reasons|0
7654901|NCT00050960|12070452|FG000|Overall Study|Progressive Disease|137
7654902|NCT00050960|12070453|FG001|Overall Study|Progressive Disease|93
7654903|NCT00050960|12070452|FG000|Overall Study|Stable Disease|19
7654904|NCT00050960|12070453|FG001|Overall Study|Stable Disease|48
7654905|NCT00050960|12070452|FG000|Overall Study|Partial Response|14
7654906|NCT00050960|12070453|FG001|Overall Study|Partial Response|19
7654907|NCT00050960|12070452|FG000|Overall Study|Complete Response|0
7654908|NCT00050960|12070453|FG001|Overall Study|Complete Response|2
7654909|NCT00050960|12070452|FG000|Overall Study|Adverse Event|62
7654910|NCT00050960|12070453|FG001|Overall Study|Adverse Event|61
7654911|NCT00050960|12070452|FG000|Overall Study|Lost to Follow-up|0
7654912|NCT00050960|12070453|FG001|Overall Study|Lost to Follow-up|1
7654913|NCT00050960|12070452|FG000|Overall Study|Withdrawal by Subject|23
7654914|NCT00050960|12070453|FG001|Overall Study|Withdrawal by Subject|18
7654915|NCT00050960|12070452|FG000|Overall Study|Administrative|31
7654916|NCT00050960|12070453|FG001|Overall Study|Administrative|46
7654917|NCT00050960|12070452|FG000|Overall Study|Non-compliance|3
7654918|NCT00050960|12070453|FG001|Overall Study|Non-compliance|1
7654919|NCT00050960|12070452|FG000|Overall Study|Death|13
7654920|NCT00050960|12070453|FG001|Overall Study|Death|15
7654921|NCT00051025|12070465|FG000|Overall Study|Progressive Disease|1
7654922|NCT00051025|12070466|FG001|Overall Study|Progressive Disease|1
7654923|NCT00051025|12070465|FG000|Overall Study|Adverse Event|1
7654924|NCT00051025|12070466|FG001|Overall Study|Adverse Event|1
7654925|NCT00051025|12070465|FG000|Overall Study|Withdrawal by Subject|0
7654926|NCT00051025|12070466|FG001|Overall Study|Withdrawal by Subject|1
7654927|NCT00051025|12070465|FG000|Overall Study|Death|0
7654928|NCT00051025|12070466|FG001|Overall Study|Death|1
7654929|NCT00051311|12070478|FG000|Overall Study|Starting new study|0
7654930|NCT00051311|12070479|FG001|Overall Study|Starting new study|1
7654931|NCT00051311|12070478|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0
7654932|NCT00051311|12070479|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1
7654933|NCT00051311|12070478|FG000|Overall Study|Death of recipient|8
7654934|NCT00051311|12070479|FG001|Overall Study|Death of recipient|8
7654935|NCT00051311|12070478|FG000|Overall Study|Recipient taken off study|4
7654936|NCT00051311|12070479|FG001|Overall Study|Recipient taken off study|4
7654937|NCT00051363|12070485|FG000|Overall Study|Dropped Post-Rand for Any Reason|102
7654938|NCT00051363|12070486|FG001|Overall Study|Dropped Post-Rand for Any Reason|126
7654939|NCT00051363|12070485|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9
7654940|NCT00051363|12070486|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11
7654941|NCT00051363|12070485|FG000|Overall Study|Death|2
7654942|NCT00051363|12070486|FG001|Overall Study|Death|2
7654943|NCT00051363|12070485|FG000|Overall Study|Excluded Pre-Randomization|2
7654944|NCT00051363|12070486|FG001|Overall Study|Excluded Pre-Randomization|5
7654945|NCT00051558|12070494|FG000|Overall Study|Adverse Event|30
7654946|NCT00051558|12070495|FG001|Overall Study|Adverse Event|18
7654947|NCT00051558|12070494|FG000|Overall Study|Withdrawal by Subject|29
7654948|NCT00051558|12070495|FG001|Overall Study|Withdrawal by Subject|42
7654949|NCT00051558|12070494|FG000|Overall Study|Death|9
7654950|NCT00051558|12070495|FG001|Overall Study|Death|15
7654951|NCT00051558|12070494|FG000|Overall Study|Lost to Follow-up|4
7654952|NCT00051558|12070495|FG001|Overall Study|Lost to Follow-up|13
7654953|NCT00051558|12070494|FG000|Overall Study|Protocol Violation|3
7654954|NCT00051558|12070495|FG001|Overall Study|Protocol Violation|4
7654955|NCT00051558|12070494|FG000|Overall Study|Protocol Entry Criteria Unmet|1
7654956|NCT00051558|12070495|FG001|Overall Study|Protocol Entry Criteria Unmet|2
7654957|NCT00051558|12070494|FG000|Overall Study|Sponsor Decision|6
7654958|NCT00051558|12070495|FG001|Overall Study|Sponsor Decision|1
7654959|NCT00051558|12070494|FG000|Overall Study|Other|2
7654960|NCT00051558|12070495|FG001|Overall Study|Other|1
7654961|NCT00051558|12070494|FG000|Overall Study|Significant Lab Value|2
7654962|NCT00051558|12070495|FG001|Overall Study|Significant Lab Value|0
7654963|NCT00051558|12070494|FG000|Overall Study|Physician Decision|5
7654964|NCT00051558|12070495|FG001|Overall Study|Physician Decision|0
7654965|NCT00051636|12070503|FG000|Period 1 - Core|Adverse Event|2
7654966|NCT00051636|12070504|FG001|Period 1 - Core|Adverse Event|2
7654967|NCT00051636|12070503|FG000|Period 1 - Core|Protocol Violation|1
7654968|NCT00051636|12070504|FG001|Period 1 - Core|Protocol Violation|0
7654969|NCT00051636|12070503|FG000|Period 1 - Core|Withdrawal by Subject|1
7654970|NCT00051636|12070504|FG001|Period 1 - Core|Withdrawal by Subject|2
7654971|NCT00051636|12070503|FG000|Period 1 - Core|Lost to Follow-up|0
7654972|NCT00051636|12070504|FG001|Period 1 - Core|Lost to Follow-up|2
7654973|NCT00051636|12070503|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5
7654974|NCT00051636|12070504|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4
7654975|NCT00051636|12070503|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
7654976|NCT00051636|12070504|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
7654977|NCT00051636|12070503|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
7654978|NCT00051636|12070504|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
7654979|NCT00051636|12070503|FG000|Period 2- Extended Observation Period|Death|4
7654980|NCT00051636|12070504|FG001|Period 2- Extended Observation Period|Death|5
7654981|NCT00051636|12070503|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
7654982|NCT00051636|12070504|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
7654983|NCT00052715|12070552|FG000|Overall Study|wrong histology|1
7654984|NCT00052962|12070567|FG000|Overall Study|Not evaluable|0
7654985|NCT00052962|12070568|FG001|Overall Study|Not evaluable|2
7654986|NCT00052962|12070567|FG000|Overall Study|Not randomized/not evaluable|1
7654987|NCT00052962|12070568|FG001|Overall Study|Not randomized/not evaluable|0
7654988|NCT00053352|12070580|FG000|Overall Study|Lost to Follow-up|0
7654989|NCT00053352|12070581|FG001|Overall Study|Lost to Follow-up|1
7654990|NCT00053352|12070580|FG000|Overall Study|Physician Decision|11
7654991|NCT00053352|12070581|FG001|Overall Study|Physician Decision|1
7654992|NCT00053352|12070580|FG000|Overall Study|Withdrawal by Subject|1
7654993|NCT00053352|12070581|FG001|Overall Study|Withdrawal by Subject|0
7654994|NCT00053352|12070580|FG000|Overall Study|Ineligible|8
7654995|NCT00053352|12070581|FG001|Overall Study|Ineligible|8
7654996|NCT00053352|12070580|FG000|Overall Study|Disease at new site|1
7654997|NCT00053352|12070581|FG001|Overall Study|Disease at new site|0
7654998|NCT00053365|12070588|FG000|Overall Study|Incorrect cell type|1
7654999|NCT00053365|12070588|FG000|Overall Study|Platinum-sensitive interval >12 months|1
7655000|NCT00053365|12070588|FG000|Overall Study|Never treated|4
7655001|NCT00053417|12070598|FG000|Overall Study|Adverse Event|1
7655002|NCT00053417|12070599|FG001|Overall Study|Adverse Event|0
7655003|NCT00053417|12070600|FG002|Overall Study|Adverse Event|1
7655004|NCT00053417|12070601|FG003|Overall Study|Adverse Event|5
7655005|NCT00053417|12070598|FG000|Overall Study|Non-Compliance|0
7655006|NCT00053417|12070599|FG001|Overall Study|Non-Compliance|0
7655007|NCT00053417|12070600|FG002|Overall Study|Non-Compliance|0
7655008|NCT00053417|12070601|FG003|Overall Study|Non-Compliance|1
7655009|NCT00053417|12070598|FG000|Overall Study|Withdrawal by Subject|0
7655010|NCT00053417|12070599|FG001|Overall Study|Withdrawal by Subject|1
7655011|NCT00053417|12070600|FG002|Overall Study|Withdrawal by Subject|0
7655012|NCT00053417|12070601|FG003|Overall Study|Withdrawal by Subject|0
7655013|NCT00053417|12070598|FG000|Overall Study|Lost to Follow-up|1
7655014|NCT00053417|12070599|FG001|Overall Study|Lost to Follow-up|1
7655015|NCT00053417|12070600|FG002|Overall Study|Lost to Follow-up|0
7655016|NCT00053417|12070601|FG003|Overall Study|Lost to Follow-up|0
7655017|NCT00053846|12070686|FG000|Overall Study|Changed mind|8
7655018|NCT00053846|12070687|FG001|Overall Study|Changed mind|13
7655019|NCT00053846|12070686|FG000|Overall Study|Became too ill|8
7655020|NCT00053846|12070687|FG001|Overall Study|Became too ill|7
7655021|NCT00053846|12070686|FG000|Overall Study|Expired|5
7655022|NCT00053846|12070687|FG001|Overall Study|Expired|0
7655023|NCT00053846|12070686|FG000|Overall Study|Became ineligible|3
7655024|NCT00053846|12070687|FG001|Overall Study|Became ineligible|1
7655025|NCT00053846|12070686|FG000|Overall Study|Did not return data|1
7655026|NCT00053846|12070687|FG001|Overall Study|Did not return data|2
7655027|NCT00053846|12070686|FG000|Overall Study|Quit due to side effects|1
7655028|NCT00053846|12070687|FG001|Overall Study|Quit due to side effects|3
7655029|NCT00053846|12070686|FG000|Overall Study|Pills too large|0
7655030|NCT00053846|12070687|FG001|Overall Study|Pills too large|1
7655031|NCT00053898|12070695|FG000|Overall Study|No follow-up data from any source|9
7655032|NCT00053898|12070696|FG001|Overall Study|No follow-up data from any source|12
7655033|NCT00053898|12070695|FG000|Overall Study|Follow-up from telephone contact only|5
7655034|NCT00053898|12070696|FG001|Overall Study|Follow-up from telephone contact only|1
7655035|NCT00054132|12070713|FG000|Overall Study|Not Treated|1
7655036|NCT00054275|12070718|FG000|Overall Study|Withdrawal by Subject|4
7655037|NCT00054275|12070718|FG000|Overall Study|Adverse Event|5
7655038|NCT00054275|12070718|FG000|Overall Study|Progressive disease in cycle 1|1
7655039|NCT00054275|12070718|FG000|Overall Study|Physician Decision|1
7655040|NCT00054327|12070728|FG000|Overall Study|Engraftment failure|1
7655041|NCT00054327|12070729|FG001|Overall Study|Engraftment failure|0
7655042|NCT00054327|12070730|FG002|Overall Study|Engraftment failure|0
7655043|NCT00054327|12070731|FG003|Overall Study|Engraftment failure|0
7655044|NCT00054327|12070732|FG004|Overall Study|Engraftment failure|0
7655045|NCT00054327|12070733|FG005|Overall Study|Engraftment failure|0
7655046|NCT00054639|12070760|FG000|Overall Study|Lack of Efficacy|1
7655047|NCT00054639|12070760|FG000|Overall Study|Physician Decision|1
7655048|NCT00054691|12070773|FG000|Overall Study|Unmeasurable Disease|2
7655049|NCT00054691|12070773|FG000|Overall Study|Noncompliant|1
7655050|NCT00054704|12070779|FG000|Overall Study|Lack of Efficacy|2
7655051|NCT00054704|12070780|FG001|Overall Study|Lack of Efficacy|3
7655052|NCT00054704|12070779|FG000|Overall Study|Adverse Event|3
7655053|NCT00054704|12070780|FG001|Overall Study|Adverse Event|1
7655054|NCT00054704|12070779|FG000|Overall Study|Lost to Follow-up|0
7655055|NCT00054704|12070780|FG001|Overall Study|Lost to Follow-up|1
7655056|NCT00054717|12070788|FG000|Overall Study|Randomized but not treated|2
7655057|NCT00054717|12070789|FG001|Overall Study|Randomized but not treated|8
7655058|NCT00054717|12070788|FG000|Overall Study|Adverse Event|70
7655059|NCT00054717|12070789|FG001|Overall Study|Adverse Event|22
7655060|NCT00054717|12070788|FG000|Overall Study|Protocol Violation|18
7655061|NCT00054717|12070789|FG001|Overall Study|Protocol Violation|19
7655062|NCT00054717|12070788|FG000|Overall Study|Lost to Follow-up|23
7655063|NCT00054717|12070789|FG001|Overall Study|Lost to Follow-up|13
7655064|NCT00054717|12070788|FG000|Overall Study|Withdrawal by Subject|32
7655065|NCT00054717|12070789|FG001|Overall Study|Withdrawal by Subject|20
7655066|NCT00054717|12070788|FG000|Overall Study|Other reason not defined above|117
7655067|NCT00054717|12070789|FG001|Overall Study|Other reason not defined above|217
7655068|NCT00055471|12070823|FG000|Period 1: Dose Escalation Period|Adverse Event|0
7655069|NCT00055471|12070824|FG001|Period 1: Dose Escalation Period|Adverse Event|1
7655070|NCT00055471|12070825|FG002|Period 1: Dose Escalation Period|Adverse Event|2
7655071|NCT00055471|12070823|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
7655072|NCT00055471|12070824|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
7655073|NCT00055471|12070825|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
7655074|NCT00055471|12070823|FG000|Period 1: Dose Escalation Period|Disease progression|0
7655075|NCT00055471|12070824|FG001|Period 1: Dose Escalation Period|Disease progression|1
7655076|NCT00055471|12070825|FG002|Period 1: Dose Escalation Period|Disease progression|0
7655077|NCT00055497|12070837|FG000|Overall Study|Adverse Event|1
7655078|NCT00055497|12070838|FG001|Overall Study|Adverse Event|1
7655079|NCT00055497|12070839|FG002|Overall Study|Adverse Event|1
7655080|NCT00055497|12070840|FG003|Overall Study|Adverse Event|28
7655081|NCT00055497|12070837|FG000|Overall Study|Withdrawal by Subject|3
7655082|NCT00055497|12070838|FG001|Overall Study|Withdrawal by Subject|1
7655083|NCT00055497|12070839|FG002|Overall Study|Withdrawal by Subject|1
7655084|NCT00055497|12070840|FG003|Overall Study|Withdrawal by Subject|15
7655085|NCT00055497|12070837|FG000|Overall Study|Lost to Follow-up|0
7655086|NCT00055497|12070838|FG001|Overall Study|Lost to Follow-up|1
7655087|NCT00055497|12070839|FG002|Overall Study|Lost to Follow-up|0
7655088|NCT00055497|12070840|FG003|Overall Study|Lost to Follow-up|5
7655089|NCT00055497|12070837|FG000|Overall Study|Protocol Violation|0
7655090|NCT00055497|12070838|FG001|Overall Study|Protocol Violation|0
7655091|NCT00055497|12070839|FG002|Overall Study|Protocol Violation|0
7655092|NCT00055497|12070840|FG003|Overall Study|Protocol Violation|3
7655093|NCT00055497|12070837|FG000|Overall Study|Lack of Efficacy|1
7655094|NCT00055497|12070838|FG001|Overall Study|Lack of Efficacy|0
7655095|NCT00055497|12070839|FG002|Overall Study|Lack of Efficacy|0
7655096|NCT00055497|12070840|FG003|Overall Study|Lack of Efficacy|27
7655097|NCT00055497|12070837|FG000|Overall Study|Administrative Reasons|0
7655098|NCT00055497|12070838|FG001|Overall Study|Administrative Reasons|0
7655099|NCT00055497|12070839|FG002|Overall Study|Administrative Reasons|0
7655100|NCT00055497|12070840|FG003|Overall Study|Administrative Reasons|1
7655101|NCT00055497|12070837|FG000|Overall Study|Other|0
7655102|NCT00055497|12070838|FG001|Overall Study|Other|0
7655103|NCT00055497|12070839|FG002|Overall Study|Other|0
7655104|NCT00055497|12070840|FG003|Overall Study|Other|11
7655105|NCT00055601|12070857|FG000|Overall Study|Protocol Violation|1
7655106|NCT00055601|12070858|FG001|Overall Study|Protocol Violation|1
7655107|NCT00055601|12070857|FG000|Overall Study|No protocol treatment received|1
7655108|NCT00055601|12070858|FG001|Overall Study|No protocol treatment received|1
7655109|NCT00056160|12070872|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35
7655110|NCT00056160|12070873|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18
7655111|NCT00056160|12070872|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57
7655112|NCT00056160|12070873|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124
7655113|NCT00056160|12070872|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
7655114|NCT00056160|12070873|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
7655115|NCT00056160|12070872|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
7655116|NCT00056160|12070873|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
7655117|NCT00056160|12070872|FG000|Up to Unblinding (07 Jun 2005)|Death|2
7655118|NCT00056160|12070873|FG001|Up to Unblinding (07 Jun 2005)|Death|1
7655119|NCT00056160|12070872|FG000|Up to Unblinding (07 Jun 2005)|Other|8
7655120|NCT00056160|12070873|FG001|Up to Unblinding (07 Jun 2005)|Other|7
7655121|NCT00056160|12070872|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
7655122|NCT00056160|12070873|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
7655123|NCT00056160|12070872|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
7655124|NCT00056160|12070873|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
7655125|NCT00056160|12070872|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
7655126|NCT00056160|12070873|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
7655127|NCT00056160|12070872|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
7655128|NCT00056160|12070873|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
7655129|NCT00056160|12070872|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
7655130|NCT00056160|12070873|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
7655131|NCT00056160|12070872|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21
7655132|NCT00056160|12070873|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0
7655133|NCT00056160|12070872|FG000|Final Follow-up|Transferred into expanded access study.|3
7655134|NCT00056160|12070873|FG001|Final Follow-up|Transferred into expanded access study.|0
7655135|NCT00056160|12070872|FG000|Final Follow-up|Transferred into RevAssist Program|2
7655136|NCT00056160|12070873|FG001|Final Follow-up|Transferred into RevAssist Program|0
7655137|NCT00056160|12070872|FG000|Final Follow-up|Adverse Event|1
7655138|NCT00056160|12070873|FG001|Final Follow-up|Adverse Event|0
7655139|NCT00056316|12070881|FG000|Overall Study|Withdrawal by Subject|2
7655140|NCT00056316|12070882|FG001|Overall Study|Withdrawal by Subject|2
7655141|NCT00056316|12070881|FG000|Overall Study|Death/NH placement of pt|1
7655142|NCT00056316|12070882|FG001|Overall Study|Death/NH placement of pt|1
7655143|NCT00056407|12070890|FG000|Overall Study|Adverse Event|282
7655144|NCT00056407|12070891|FG001|Overall Study|Adverse Event|364
7655145|NCT00056407|12070890|FG000|Overall Study|Withdrawal by Subject|377
7655146|NCT00056407|12070891|FG001|Overall Study|Withdrawal by Subject|361
7655147|NCT00056407|12070890|FG000|Overall Study|Lost to Follow-up|123
7655148|NCT00056407|12070891|FG001|Overall Study|Lost to Follow-up|113
7655149|NCT00056407|12070890|FG000|Overall Study|Protocol Violation|104
7655150|NCT00056407|12070891|FG001|Overall Study|Protocol Violation|95
7655151|NCT00056407|12070890|FG000|Overall Study|Diagnosed with Prostate Cancer|202
7655152|NCT00056407|12070891|FG001|Overall Study|Diagnosed with Prostate Cancer|166
7655153|NCT00056407|12070890|FG000|Overall Study|"Listed as Other on Case Report Form"|98
7655154|NCT00056407|12070891|FG001|Overall Study|"Listed as Other on Case Report Form"|60
7655155|NCT00056407|12070890|FG000|Overall Study|Missing|25
7655156|NCT00056407|12070891|FG001|Overall Study|Missing|34
7655157|NCT00056862|12070931|FG000|Overall Study|Protocol Violation|1
7655158|NCT00056862|12070932|FG001|Overall Study|Protocol Violation|0
7655159|NCT00057330|12070940|FG000|Overall Study|Adverse Event|9
7655160|NCT00057330|12070941|FG001|Overall Study|Adverse Event|12
7655161|NCT00057330|12070940|FG000|Overall Study|Death|1
7655162|NCT00057330|12070941|FG001|Overall Study|Death|0
7655163|NCT00057330|12070940|FG000|Overall Study|Protocol Violation|1
7655164|NCT00057330|12070941|FG001|Overall Study|Protocol Violation|1
7655165|NCT00057330|12070940|FG000|Overall Study|Withdrawal by Subject|115
7655166|NCT00057330|12070941|FG001|Overall Study|Withdrawal by Subject|84
7655167|NCT00057330|12070940|FG000|Overall Study|Lost to Follow-up|745
7655168|NCT00057330|12070941|FG001|Overall Study|Lost to Follow-up|617
7655169|NCT00057330|12070940|FG000|Overall Study|Physician Decision|1
7655170|NCT00057330|12070941|FG001|Overall Study|Physician Decision|0
7655171|NCT00057330|12070940|FG000|Overall Study|Other|260
7655172|NCT00057330|12070941|FG001|Overall Study|Other|206
7655173|NCT00057746|12070990|FG000|Overall Study|Withdrawal by Subject|0
7655174|NCT00057746|12070991|FG001|Overall Study|Withdrawal by Subject|0
7655175|NCT00057746|12070992|FG002|Overall Study|Withdrawal by Subject|1
7655176|NCT00057811|12071006|FG000|Overall Study|Lack of Efficacy|1
7655177|NCT00057811|12071007|FG001|Overall Study|Lack of Efficacy|4
7655178|NCT00057811|12071006|FG000|Overall Study|Physician Decision|1
7655179|NCT00057811|12071007|FG001|Overall Study|Physician Decision|0
7655180|NCT00057811|12071006|FG000|Overall Study|Withdrawal by Subject|3
7655181|NCT00057811|12071007|FG001|Overall Study|Withdrawal by Subject|4
7655182|NCT00057811|12071006|FG000|Overall Study|Ineligible|4
7655183|NCT00057811|12071007|FG001|Overall Study|Ineligible|2
7655184|NCT00057811|12071006|FG000|Overall Study|Inevaluable|1
7655185|NCT00057811|12071007|FG001|Overall Study|Inevaluable|2
7655186|NCT00057837|12071015|FG000|Overall Study|Progression/relapse|12
7655187|NCT00057837|12071016|FG001|Overall Study|Progression/relapse|14
7655188|NCT00057837|12071015|FG000|Overall Study|Adverse Event|2
7655189|NCT00057837|12071016|FG001|Overall Study|Adverse Event|12
7655190|NCT00057837|12071015|FG000|Overall Study|Death|5
7655191|NCT00057837|12071016|FG001|Overall Study|Death|4
7655192|NCT00057837|12071015|FG000|Overall Study|Withdrawal by Subject|5
7655193|NCT00057837|12071016|FG001|Overall Study|Withdrawal by Subject|3
7655194|NCT00057837|12071015|FG000|Overall Study|Alternative therapy|0
7655195|NCT00057837|12071016|FG001|Overall Study|Alternative therapy|1
7655196|NCT00057837|12071015|FG000|Overall Study|Other complicating disease|2
7655197|NCT00057837|12071016|FG001|Overall Study|Other complicating disease|1
7655198|NCT00057837|12071015|FG000|Overall Study|Physician Decision|1
7655199|NCT00057837|12071016|FG001|Overall Study|Physician Decision|0
7655200|NCT00057837|12071015|FG000|Overall Study|Ineligible|3
7655201|NCT00057837|12071016|FG001|Overall Study|Ineligible|3
7655202|NCT00057837|12071015|FG000|Overall Study|Never started treatment|1
7655203|NCT00057837|12071016|FG001|Overall Study|Never started treatment|1
7655204|NCT00057863|12071022|FG000|Overall Study|Death|1
7655205|NCT00057863|12071022|FG000|Overall Study|Withdrawal by Subject|2
7655206|NCT00057876|12071028|FG000|Overall Study|Adverse Event|8
7655207|NCT00057876|12071029|FG001|Overall Study|Adverse Event|8
7655208|NCT00057876|12071028|FG000|Overall Study|Death|2
7655209|NCT00057876|12071029|FG001|Overall Study|Death|1
7655210|NCT00057876|12071028|FG000|Overall Study|Withdrawal by Subject|5
7655211|NCT00057876|12071029|FG001|Overall Study|Withdrawal by Subject|6
7655212|NCT00057876|12071028|FG000|Overall Study|Lack of Efficacy|10
7655213|NCT00057876|12071029|FG001|Overall Study|Lack of Efficacy|8
7655214|NCT00057876|12071028|FG000|Overall Study|Ineligible|1
7655215|NCT00057876|12071029|FG001|Overall Study|Ineligible|2
7655216|NCT00057876|12071028|FG000|Overall Study|other reason|2
7655217|NCT00057876|12071029|FG001|Overall Study|other reason|2
7655218|NCT00057876|12071028|FG000|Overall Study|other complicating disease|1
7655219|NCT00057876|12071029|FG001|Overall Study|other complicating disease|0
7655220|NCT00057941|12071037|FG000|Overall Study|Death|1
7655221|NCT00057941|12071038|FG001|Overall Study|Death|2
7655222|NCT00057941|12071037|FG000|Overall Study|Adverse Event|7
7655223|NCT00057941|12071038|FG001|Overall Study|Adverse Event|9
7655224|NCT00057941|12071037|FG000|Overall Study|Lack of Efficacy|54
7655225|NCT00057941|12071038|FG001|Overall Study|Lack of Efficacy|53
7655226|NCT00057941|12071037|FG000|Overall Study|Withdrawal by Subject|6
7655227|NCT00057941|12071038|FG001|Overall Study|Withdrawal by Subject|1
7655228|NCT00057941|12071037|FG000|Overall Study|still on treatment|3
7655229|NCT00057941|12071038|FG001|Overall Study|still on treatment|1
7655230|NCT00057941|12071037|FG000|Overall Study|insurance, symptomatic deterioration|1
7655231|NCT00057941|12071038|FG001|Overall Study|insurance, symptomatic deterioration|3
7655232|NCT00057941|12071037|FG000|Overall Study|Ineligible|2
7655233|NCT00057941|12071038|FG001|Overall Study|Ineligible|5
7655234|NCT00057954|12071044|FG000|Overall Study|Death|1
7655235|NCT00057954|12071044|FG000|Overall Study|Disease progression|1
7655236|NCT00058058|12071056|FG000|Overall Study|Withdrawal by Subject|4
7655237|NCT00058058|12071056|FG000|Overall Study|Ineligible|20
7655238|NCT00058058|12071056|FG000|Overall Study|Claustrophobic|5
7655239|NCT00058058|12071056|FG000|Overall Study|technical issues|6
7655240|NCT00058058|12071056|FG000|Overall Study|Poor positioning, illness,pain|3
7655241|NCT00058123|12071061|FG000|Overall Study|Wrong histology|9
7655242|NCT00058123|12071061|FG000|Overall Study|Received >3 prior treatments|1
7655243|NCT00058214|12071066|FG000|Overall Study|Adverse Event|1
7655244|NCT00058422|12071091|FG000|Overall Study|Not treated|2
7655245|NCT00058539|12071095|FG000|Overall Study|Disease progression|24
7655246|NCT00058539|12071095|FG000|Overall Study|Adverse Event|3
7655247|NCT00058539|12071095|FG000|Overall Study|Withdrawal by Subject|5
7655248|NCT00058539|12071095|FG000|Overall Study|Physician Decision|9
7655249|NCT00058539|12071095|FG000|Overall Study|Death|1
7655250|NCT00058552|12071101|FG000|Overall Study|Died prior to receiving treatment|4
7655251|NCT00058552|12071102|FG001|Overall Study|Died prior to receiving treatment|2
7655252|NCT00058552|12071101|FG000|Overall Study|Disease progression|52
7655253|NCT00058552|12071102|FG001|Overall Study|Disease progression|44
7655254|NCT00058552|12071101|FG000|Overall Study|Adverse Event|4
7655255|NCT00058552|12071102|FG001|Overall Study|Adverse Event|2
7655256|NCT00058552|12071101|FG000|Overall Study|Withdrawal by Subject|3
7655257|NCT00058552|12071102|FG001|Overall Study|Withdrawal by Subject|5
7655258|NCT00058552|12071101|FG000|Overall Study|Physician Decision|2
7655259|NCT00058552|12071102|FG001|Overall Study|Physician Decision|5
7655260|NCT00058552|12071101|FG000|Overall Study|Clinical disease progression|0
7655261|NCT00058552|12071102|FG001|Overall Study|Clinical disease progression|4
7655262|NCT00058825|12071110|FG000|Overall Study|Relapse|9
7655263|NCT00058825|12071110|FG000|Overall Study|Progressive Disease|5
7655264|NCT00058825|12071110|FG000|Overall Study|Graft Failure|5
7655265|NCT00058825|12071110|FG000|Overall Study|Death|3
7655266|NCT00059202|12071118|FG000|Overall Study|Withdrawal by Subject|5
7655267|NCT00059202|12071119|FG001|Overall Study|Withdrawal by Subject|9
7655268|NCT00059202|12071118|FG000|Overall Study|Protocol Violation|1
7655269|NCT00059202|12071119|FG001|Overall Study|Protocol Violation|3
7655270|NCT00059202|12071118|FG000|Overall Study|drug toxicity|0
7655271|NCT00059202|12071119|FG001|Overall Study|drug toxicity|3
7655272|NCT00059215|12071132|FG000|Overall Study|Adverse Event|5
7655273|NCT00059215|12071133|FG001|Overall Study|Adverse Event|5
7655274|NCT00059215|12071134|FG002|Overall Study|Adverse Event|9
7655275|NCT00059215|12071135|FG003|Overall Study|Adverse Event|9
7655276|NCT00059215|12071132|FG000|Overall Study|Death|0
7655277|NCT00059215|12071133|FG001|Overall Study|Death|0
7655278|NCT00059215|12071134|FG002|Overall Study|Death|3
7655279|NCT00059215|12071135|FG003|Overall Study|Death|0
7655280|NCT00059215|12071132|FG000|Overall Study|Lost to Follow-up|1
7655281|NCT00059215|12071133|FG001|Overall Study|Lost to Follow-up|2
7655282|NCT00059215|12071134|FG002|Overall Study|Lost to Follow-up|0
7655283|NCT00059215|12071135|FG003|Overall Study|Lost to Follow-up|0
7655284|NCT00059215|12071132|FG000|Overall Study|Withdrawal by Subject|4
7655285|NCT00059215|12071133|FG001|Overall Study|Withdrawal by Subject|4
7655286|NCT00059215|12071134|FG002|Overall Study|Withdrawal by Subject|1
7655287|NCT00059215|12071135|FG003|Overall Study|Withdrawal by Subject|3
7655288|NCT00059215|12071132|FG000|Overall Study|Protocol Violation|1
7655289|NCT00059215|12071133|FG001|Overall Study|Protocol Violation|0
7655290|NCT00059215|12071134|FG002|Overall Study|Protocol Violation|1
7655291|NCT00059215|12071135|FG003|Overall Study|Protocol Violation|0
7655292|NCT00059215|12071132|FG000|Overall Study|Protocol entry criteria not met|1
7655293|NCT00059215|12071133|FG001|Overall Study|Protocol entry criteria not met|1
7655294|NCT00059215|12071134|FG002|Overall Study|Protocol entry criteria not met|0
7655295|NCT00059215|12071135|FG003|Overall Study|Protocol entry criteria not met|2
7655296|NCT00059215|12071132|FG000|Overall Study|Physician Decision|1
7655297|NCT00059215|12071133|FG001|Overall Study|Physician Decision|2
7655298|NCT00059215|12071134|FG002|Overall Study|Physician Decision|1
7655299|NCT00059215|12071135|FG003|Overall Study|Physician Decision|1
7655300|NCT00059332|12071157|FG000|Overall Study|Withdrawal by Subject|2
7655301|NCT00059332|12071158|FG001|Overall Study|Withdrawal by Subject|1
7655302|NCT00059332|12071157|FG000|Overall Study|Lost to Follow-up|1
7655303|NCT00059332|12071158|FG001|Overall Study|Lost to Follow-up|1
7655304|NCT00059787|12071204|FG000|Overall Study|Adverse Event|13
7655305|NCT00059787|12071204|FG000|Overall Study|disease progression|2
7655306|NCT00059787|12071204|FG000|Overall Study|ineligible|1
7655307|NCT00059787|12071204|FG000|Overall Study|Other|4
7655308|NCT00059839|12071211|FG000|Overall Study|Death|1
7655309|NCT00059839|12071212|FG001|Overall Study|Death|1
7655310|NCT00059839|12071211|FG000|Overall Study|Lack of Efficacy|6
7655311|NCT00059839|12071212|FG001|Overall Study|Lack of Efficacy|5
7655312|NCT00059839|12071211|FG000|Overall Study|Lost to Follow-up|2
7655313|NCT00059839|12071212|FG001|Overall Study|Lost to Follow-up|0
7655314|NCT00059839|12071211|FG000|Overall Study|Physician Decision|1
7655315|NCT00059839|12071212|FG001|Overall Study|Physician Decision|2
7655316|NCT00059839|12071211|FG000|Overall Study|Withdrawal by Subject|1
7655317|NCT00059839|12071212|FG001|Overall Study|Withdrawal by Subject|6
7655318|NCT00059839|12071211|FG000|Overall Study|Ineligible|1
7655319|NCT00059839|12071212|FG001|Overall Study|Ineligible|3
7655320|NCT00060840|12071265|FG000|Overall Study|Change in surgical plan|2
7655321|NCT00060840|12071266|FG001|Overall Study|Change in surgical plan|6
7655322|NCT00060840|12071265|FG000|Overall Study|Death|0
7655323|NCT00060840|12071266|FG001|Overall Study|Death|1
7655324|NCT00060840|12071265|FG000|Overall Study|Withdrawal by Subject|0
7655325|NCT00060840|12071266|FG001|Overall Study|Withdrawal by Subject|1
7655326|NCT00060840|12071265|FG000|Overall Study|Subinvestigator unavailable|0
7655327|NCT00060840|12071266|FG001|Overall Study|Subinvestigator unavailable|1
7655328|NCT00060840|12071265|FG000|Overall Study|Physician Decision|1
7655329|NCT00060840|12071266|FG001|Overall Study|Physician Decision|0
7655330|NCT00060840|12071265|FG000|Overall Study|Other|1
7655331|NCT00060840|12071266|FG001|Overall Study|Other|0
7655332|NCT00060944|12071274|FG000|Overall Study|Adverse Event|12
7655333|NCT00060944|12071275|FG001|Overall Study|Adverse Event|10
7655334|NCT00060944|12071274|FG000|Overall Study|Death|2
7655335|NCT00060944|12071275|FG001|Overall Study|Death|3
7655336|NCT00060944|12071274|FG000|Overall Study|Withdrawal by Subject|18
7655337|NCT00060944|12071275|FG001|Overall Study|Withdrawal by Subject|5
7655338|NCT00060944|12071274|FG000|Overall Study|Disease Progression|93
7655339|NCT00060944|12071275|FG001|Overall Study|Disease Progression|94
7655340|NCT00060944|12071274|FG000|Overall Study|Lost to Follow-up|1
7655341|NCT00060944|12071275|FG001|Overall Study|Lost to Follow-up|0
7655342|NCT00060944|12071274|FG000|Overall Study|Subject Ineligible To Continue|2
7655343|NCT00060944|12071275|FG001|Overall Study|Subject Ineligible To Continue|1
7655344|NCT00060944|12071274|FG000|Overall Study|Treatment Switch|0
7655345|NCT00060944|12071275|FG001|Overall Study|Treatment Switch|13
7655346|NCT00060944|12071274|FG000|Overall Study|Other|2
7655347|NCT00060944|12071275|FG001|Overall Study|Other|4
7655348|NCT00060944|12071274|FG000|Overall Study|randomized but not treated|6
7655349|NCT00060944|12071275|FG001|Overall Study|randomized but not treated|4
7655350|NCT00061048|12071281|FG000|Overall Study|Adverse Event|2
7655351|NCT00061048|12071281|FG000|Overall Study|disease progression|20
7655352|NCT00061633|12071296|FG000|Overall Study|Adverse Event|1
7655353|NCT00061633|12071297|FG001|Overall Study|Adverse Event|2
7655354|NCT00061633|12071296|FG000|Overall Study|Withdrawal by Subject|2
7655355|NCT00061633|12071297|FG001|Overall Study|Withdrawal by Subject|2
7655356|NCT00061633|12071296|FG000|Overall Study|Lost to Follow-up|1
7655357|NCT00061633|12071297|FG001|Overall Study|Lost to Follow-up|4
7655358|NCT00061633|12071296|FG000|Overall Study|Other|1
7655359|NCT00061633|12071297|FG001|Overall Study|Other|1
7655360|NCT00061633|12071296|FG000|Overall Study|Never received study treatment|0
7655361|NCT00061633|12071297|FG001|Overall Study|Never received study treatment|2
7655362|NCT00061932|12071309|FG000|Overall Study|Withdrawal by Subject|13
7655363|NCT00061932|12071310|FG001|Overall Study|Withdrawal by Subject|4
7655364|NCT00062010|12071317|FG000|Overall Study|Ineligible|3
7655365|NCT00062166|12071321|FG000|Overall Study|Withdrawal by Subject|6
7655366|NCT00062374|12071326|FG000|Overall Study|Not treated|12
7655367|NCT00062439|12071330|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1
7655368|NCT00062439|12071330|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
7655369|NCT00062439|12071330|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3
7655370|NCT00062439|12071330|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
7655371|NCT00062439|12071330|FG000|Post Chemoradiation Assessment|Death|1
7655372|NCT00062439|12071330|FG000|Post Chemoradiation Assessment|Disease progression|2
7655373|NCT00062439|12071330|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1
7655374|NCT00062439|12071330|FG000|Post Chemoradiation Assessment|Physician Decision|1
7655375|NCT00062439|12071330|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
7655376|NCT00062439|12071330|FG000|Surgery|Physician Decision|4
7655377|NCT00062439|12071330|FG000|Surgery|Death|1
7655378|NCT00062439|12071330|FG000|Surgery|Adverse Event|2
7655379|NCT00062439|12071330|FG000|Consolidation Chemotherapy|Adverse Event|2
7655380|NCT00062647|12071341|FG000|Overall Study|Death|2
7655381|NCT00062647|12071342|FG001|Overall Study|Death|2
7655382|NCT00062647|12071341|FG000|Overall Study|Adverse Event|1
7655383|NCT00062647|12071342|FG001|Overall Study|Adverse Event|1
7655384|NCT00062647|12071341|FG000|Overall Study|Withdrawal by Subject|2
7655385|NCT00062647|12071342|FG001|Overall Study|Withdrawal by Subject|1
7655386|NCT00062647|12071341|FG000|Overall Study|Protocol Violation|1
7655387|NCT00062647|12071342|FG001|Overall Study|Protocol Violation|0
7655388|NCT00062647|12071341|FG000|Overall Study|Lost to Follow-up|1
7655389|NCT00062647|12071342|FG001|Overall Study|Lost to Follow-up|2
7655390|NCT00062647|12071341|FG000|Overall Study|Failed continuation criteria|4
7655391|NCT00062647|12071342|FG001|Overall Study|Failed continuation criteria|2
7655392|NCT00062647|12071341|FG000|Overall Study|Other|4
7655393|NCT00062647|12071342|FG001|Overall Study|Other|4
7655394|NCT00062647|12071341|FG000|Overall Study|Never received study treatment|1
7655395|NCT00062647|12071342|FG001|Overall Study|Never received study treatment|1
7655396|NCT00062868|12071389|FG000|Dose Level 1|Death|2
7655397|NCT00062868|12071390|FG001|Dose Level 1|Death|0
7655398|NCT00062868|12071391|FG002|Dose Level 1|Death|0
7655399|NCT00062868|12071392|FG003|Dose Level 1|Death|2
7655400|NCT00062868|12071393|FG004|Dose Level 1|Death|0
7655401|NCT00062868|12071394|FG005|Dose Level 1|Death|0
7655402|NCT00062868|12071395|FG006|Dose Level 1|Death|3
7655403|NCT00062868|12071396|FG007|Dose Level 1|Death|0
7655404|NCT00062868|12071397|FG008|Dose Level 1|Death|0
7655405|NCT00062868|12071398|FG009|Dose Level 1|Death|0
7655406|NCT00062868|12071399|FG010|Dose Level 1|Death|0
7655407|NCT00062868|12071400|FG011|Dose Level 1|Death|0
7655408|NCT00062868|12071401|FG012|Dose Level 1|Death|0
7655409|NCT00062868|12071402|FG013|Dose Level 1|Death|0
7655410|NCT00062868|12071403|FG014|Dose Level 1|Death|0
7655411|NCT00062868|12071404|FG015|Dose Level 1|Death|0
7655412|NCT00062868|12071405|FG016|Dose Level 1|Death|0
7655413|NCT00062868|12071406|FG017|Dose Level 1|Death|0
7655414|NCT00062868|12071407|FG018|Dose Level 1|Death|7
7655415|NCT00062868|12071408|FG019|Dose Level 1|Death|0
7655416|NCT00062868|12071409|FG020|Dose Level 1|Death|1
7655417|NCT00062868|12071389|FG000|Dose Level 1|Lost to Follow-up|0
7655418|NCT00062868|12071390|FG001|Dose Level 1|Lost to Follow-up|0
7655419|NCT00062868|12071391|FG002|Dose Level 1|Lost to Follow-up|0
7655420|NCT00062868|12071392|FG003|Dose Level 1|Lost to Follow-up|0
7655421|NCT00062868|12071393|FG004|Dose Level 1|Lost to Follow-up|0
7655422|NCT00062868|12071394|FG005|Dose Level 1|Lost to Follow-up|0
7655423|NCT00062868|12071395|FG006|Dose Level 1|Lost to Follow-up|0
7655424|NCT00062868|12071396|FG007|Dose Level 1|Lost to Follow-up|0
7655425|NCT00062868|12071397|FG008|Dose Level 1|Lost to Follow-up|0
7655426|NCT00062868|12071398|FG009|Dose Level 1|Lost to Follow-up|0
7655427|NCT00062868|12071399|FG010|Dose Level 1|Lost to Follow-up|0
7655428|NCT00062868|12071400|FG011|Dose Level 1|Lost to Follow-up|0
7655429|NCT00062868|12071401|FG012|Dose Level 1|Lost to Follow-up|1
7655430|NCT00062868|12071402|FG013|Dose Level 1|Lost to Follow-up|0
7655431|NCT00062868|12071403|FG014|Dose Level 1|Lost to Follow-up|0
7655432|NCT00062868|12071404|FG015|Dose Level 1|Lost to Follow-up|0
7655433|NCT00062868|12071405|FG016|Dose Level 1|Lost to Follow-up|0
7655434|NCT00062868|12071406|FG017|Dose Level 1|Lost to Follow-up|0
7655435|NCT00062868|12071407|FG018|Dose Level 1|Lost to Follow-up|2
7655436|NCT00062868|12071408|FG019|Dose Level 1|Lost to Follow-up|0
7655437|NCT00062868|12071409|FG020|Dose Level 1|Lost to Follow-up|1
7655438|NCT00062868|12071389|FG000|Dose Level 2|Death|0
7655439|NCT00062868|12071390|FG001|Dose Level 2|Death|3
7655440|NCT00062868|12071391|FG002|Dose Level 2|Death|0
7655441|NCT00062868|12071392|FG003|Dose Level 2|Death|0
7655442|NCT00062868|12071393|FG004|Dose Level 2|Death|2
7655443|NCT00062868|12071394|FG005|Dose Level 2|Death|0
7655444|NCT00062868|12071395|FG006|Dose Level 2|Death|0
7655445|NCT00062868|12071396|FG007|Dose Level 2|Death|0
7655446|NCT00062868|12071397|FG008|Dose Level 2|Death|0
7655447|NCT00062868|12071398|FG009|Dose Level 2|Death|0
7655448|NCT00062868|12071399|FG010|Dose Level 2|Death|1
7655449|NCT00062868|12071400|FG011|Dose Level 2|Death|0
7655450|NCT00062868|12071401|FG012|Dose Level 2|Death|0
7655451|NCT00062868|12071402|FG013|Dose Level 2|Death|0
7655452|NCT00062868|12071403|FG014|Dose Level 2|Death|0
7655453|NCT00062868|12071404|FG015|Dose Level 2|Death|0
7655454|NCT00062868|12071405|FG016|Dose Level 2|Death|2
7655455|NCT00062868|12071406|FG017|Dose Level 2|Death|0
7655456|NCT00062868|12071407|FG018|Dose Level 2|Death|0
7655457|NCT00062868|12071408|FG019|Dose Level 2|Death|0
7655458|NCT00062868|12071409|FG020|Dose Level 2|Death|0
7655459|NCT00062868|12071389|FG000|Dose Level 2|Lost to Follow-up|0
7655460|NCT00062868|12071390|FG001|Dose Level 2|Lost to Follow-up|0
7655461|NCT00062868|12071391|FG002|Dose Level 2|Lost to Follow-up|0
7655462|NCT00062868|12071392|FG003|Dose Level 2|Lost to Follow-up|0
7655463|NCT00062868|12071393|FG004|Dose Level 2|Lost to Follow-up|0
7655464|NCT00062868|12071394|FG005|Dose Level 2|Lost to Follow-up|0
7655465|NCT00062868|12071395|FG006|Dose Level 2|Lost to Follow-up|0
7655466|NCT00062868|12071396|FG007|Dose Level 2|Lost to Follow-up|0
7655467|NCT00062868|12071397|FG008|Dose Level 2|Lost to Follow-up|0
7655468|NCT00062868|12071398|FG009|Dose Level 2|Lost to Follow-up|0
7655469|NCT00062868|12071399|FG010|Dose Level 2|Lost to Follow-up|0
7655470|NCT00062868|12071400|FG011|Dose Level 2|Lost to Follow-up|0
7655471|NCT00062868|12071401|FG012|Dose Level 2|Lost to Follow-up|0
7655472|NCT00062868|12071402|FG013|Dose Level 2|Lost to Follow-up|1
7655473|NCT00062868|12071403|FG014|Dose Level 2|Lost to Follow-up|0
7655474|NCT00062868|12071404|FG015|Dose Level 2|Lost to Follow-up|0
7655475|NCT00062868|12071405|FG016|Dose Level 2|Lost to Follow-up|1
7655476|NCT00062868|12071406|FG017|Dose Level 2|Lost to Follow-up|0
7655477|NCT00062868|12071407|FG018|Dose Level 2|Lost to Follow-up|0
7655478|NCT00062868|12071408|FG019|Dose Level 2|Lost to Follow-up|0
7655479|NCT00062868|12071409|FG020|Dose Level 2|Lost to Follow-up|0
7655480|NCT00062868|12071389|FG000|Dose Level 3|Death|0
7655481|NCT00062868|12071390|FG001|Dose Level 3|Death|0
7655482|NCT00062868|12071391|FG002|Dose Level 3|Death|0
7655483|NCT00062868|12071392|FG003|Dose Level 3|Death|0
7655484|NCT00062868|12071393|FG004|Dose Level 3|Death|0
7655485|NCT00062868|12071394|FG005|Dose Level 3|Death|0
7655486|NCT00062868|12071395|FG006|Dose Level 3|Death|0
7655487|NCT00062868|12071396|FG007|Dose Level 3|Death|0
7655488|NCT00062868|12071397|FG008|Dose Level 3|Death|0
7655489|NCT00062868|12071398|FG009|Dose Level 3|Death|0
7655490|NCT00062868|12071399|FG010|Dose Level 3|Death|0
7655491|NCT00062868|12071400|FG011|Dose Level 3|Death|1
7655492|NCT00062868|12071401|FG012|Dose Level 3|Death|0
7655493|NCT00062868|12071402|FG013|Dose Level 3|Death|0
7655494|NCT00062868|12071403|FG014|Dose Level 3|Death|0
7655495|NCT00062868|12071404|FG015|Dose Level 3|Death|0
7655496|NCT00062868|12071405|FG016|Dose Level 3|Death|0
7655497|NCT00062868|12071406|FG017|Dose Level 3|Death|1
7655498|NCT00062868|12071407|FG018|Dose Level 3|Death|0
7655499|NCT00062868|12071408|FG019|Dose Level 3|Death|0
7655500|NCT00062868|12071409|FG020|Dose Level 3|Death|0
7655501|NCT00062868|12071389|FG000|Dose Level 3|Lost to Follow-up|0
7655502|NCT00062868|12071390|FG001|Dose Level 3|Lost to Follow-up|0
7655503|NCT00062868|12071391|FG002|Dose Level 3|Lost to Follow-up|0
7655504|NCT00062868|12071392|FG003|Dose Level 3|Lost to Follow-up|0
7655505|NCT00062868|12071393|FG004|Dose Level 3|Lost to Follow-up|0
7655506|NCT00062868|12071394|FG005|Dose Level 3|Lost to Follow-up|0
7655507|NCT00062868|12071395|FG006|Dose Level 3|Lost to Follow-up|0
7655508|NCT00062868|12071396|FG007|Dose Level 3|Lost to Follow-up|0
7655509|NCT00062868|12071397|FG008|Dose Level 3|Lost to Follow-up|0
7655510|NCT00062868|12071398|FG009|Dose Level 3|Lost to Follow-up|0
7655511|NCT00062868|12071399|FG010|Dose Level 3|Lost to Follow-up|0
7655512|NCT00062868|12071400|FG011|Dose Level 3|Lost to Follow-up|0
7655513|NCT00062868|12071401|FG012|Dose Level 3|Lost to Follow-up|0
7655514|NCT00062868|12071402|FG013|Dose Level 3|Lost to Follow-up|0
7655515|NCT00062868|12071403|FG014|Dose Level 3|Lost to Follow-up|1
7655516|NCT00062868|12071404|FG015|Dose Level 3|Lost to Follow-up|0
7655517|NCT00062868|12071405|FG016|Dose Level 3|Lost to Follow-up|0
7655518|NCT00062868|12071406|FG017|Dose Level 3|Lost to Follow-up|0
7655519|NCT00062868|12071407|FG018|Dose Level 3|Lost to Follow-up|0
7655520|NCT00062868|12071408|FG019|Dose Level 3|Lost to Follow-up|0
7655521|NCT00062868|12071409|FG020|Dose Level 3|Lost to Follow-up|0
7655522|NCT00062868|12071389|FG000|Dose Level 3|Withdrew|0
7655523|NCT00062868|12071390|FG001|Dose Level 3|Withdrew|0
7655524|NCT00062868|12071391|FG002|Dose Level 3|Withdrew|2
7655525|NCT00062868|12071392|FG003|Dose Level 3|Withdrew|0
7655526|NCT00062868|12071393|FG004|Dose Level 3|Withdrew|0
7655527|NCT00062868|12071394|FG005|Dose Level 3|Withdrew|0
7655528|NCT00062868|12071395|FG006|Dose Level 3|Withdrew|0
7655529|NCT00062868|12071396|FG007|Dose Level 3|Withdrew|0
7655530|NCT00062868|12071397|FG008|Dose Level 3|Withdrew|0
7655531|NCT00062868|12071398|FG009|Dose Level 3|Withdrew|0
7655532|NCT00062868|12071399|FG010|Dose Level 3|Withdrew|0
7655533|NCT00062868|12071400|FG011|Dose Level 3|Withdrew|0
7655534|NCT00062868|12071401|FG012|Dose Level 3|Withdrew|0
7655535|NCT00062868|12071402|FG013|Dose Level 3|Withdrew|0
7655536|NCT00062868|12071403|FG014|Dose Level 3|Withdrew|0
7655537|NCT00062868|12071404|FG015|Dose Level 3|Withdrew|0
7655538|NCT00062868|12071405|FG016|Dose Level 3|Withdrew|0
7655539|NCT00062868|12071406|FG017|Dose Level 3|Withdrew|0
7655540|NCT00062868|12071407|FG018|Dose Level 3|Withdrew|0
7655541|NCT00062868|12071408|FG019|Dose Level 3|Withdrew|0
7655542|NCT00062868|12071409|FG020|Dose Level 3|Withdrew|0
7655543|NCT00063154|12071453|FG000|Overall Study|Disease progression|27
7655544|NCT00063154|12071453|FG000|Overall Study|Adverse Event|2
7655545|NCT00063154|12071453|FG000|Overall Study|Physician Decision|10
7655546|NCT00063154|12071453|FG000|Overall Study|Death|3
7655547|NCT00063154|12071453|FG000|Overall Study|Reason unspecified|1
7655548|NCT00063154|12071453|FG000|Overall Study|Did not receive treatment|8
7655549|NCT00063258|12071463|FG000|Overall Study|Physician Decision|2
7655550|NCT00063258|12071464|FG001|Overall Study|Physician Decision|0
7655551|NCT00063258|12071463|FG000|Overall Study|Lack of Efficacy|2
7655552|NCT00063258|12071464|FG001|Overall Study|Lack of Efficacy|0
7655553|NCT00063882|12071516|FG000|Overall Study|Protocol Violation|3
7655554|NCT00063882|12071517|FG001|Overall Study|Protocol Violation|3
7655555|NCT00063882|12071516|FG000|Overall Study|Withdrawal by Subject|2
7655556|NCT00063882|12071517|FG001|Overall Study|Withdrawal by Subject|1
7655557|NCT00063934|12071523|FG000|Overall Study|Ineligible|1
7655558|NCT00063986|12071527|FG000|Overall Study|Withdrawal by Subject|1
7655559|NCT00063986|12071527|FG000|Overall Study|Ineligible|1
7655560|NCT00063986|12071527|FG000|Overall Study|Intra-operatively ineligible|4
7655561|NCT00063999|12071533|FG000|Overall Study|Withdrawal by Subject|1
7655562|NCT00063999|12071534|FG001|Overall Study|Withdrawal by Subject|0
7655563|NCT00063999|12071533|FG000|Overall Study|Ineligible|44
7655564|NCT00063999|12071534|FG001|Overall Study|Ineligible|24
7655565|NCT00064025|12071547|FG000|Overall Study|Ineligible|4
7655566|NCT00064025|12071547|FG000|Overall Study|Inevaluable|3
7655567|NCT00064077|12071570|FG000|Overall Study|Improper prior treatment|1
7655568|NCT00064077|12071571|FG001|Overall Study|Improper prior treatment|0
7655569|NCT00064077|12071572|FG002|Overall Study|Improper prior treatment|0
7655570|NCT00064077|12071573|FG003|Overall Study|Improper prior treatment|0
7655571|NCT00064077|12071570|FG000|Overall Study|Poor risk|2
7655572|NCT00064077|12071571|FG001|Overall Study|Poor risk|0
7655573|NCT00064077|12071572|FG002|Overall Study|Poor risk|1
7655574|NCT00064077|12071573|FG003|Overall Study|Poor risk|1
7655575|NCT00064077|12071570|FG000|Overall Study|Pathology|10
7655576|NCT00064077|12071571|FG001|Overall Study|Pathology|7
7655577|NCT00064077|12071572|FG002|Overall Study|Pathology|3
7655578|NCT00064077|12071573|FG003|Overall Study|Pathology|4
7655579|NCT00064077|12071570|FG000|Overall Study|No surgery|0
7655580|NCT00064077|12071571|FG001|Overall Study|No surgery|0
7655581|NCT00064077|12071572|FG002|Overall Study|No surgery|1
7655582|NCT00064077|12071573|FG003|Overall Study|No surgery|0
7655583|NCT00064077|12071570|FG000|Overall Study|No tumor|0
7655584|NCT00064077|12071571|FG001|Overall Study|No tumor|0
7655585|NCT00064077|12071572|FG002|Overall Study|No tumor|1
7655586|NCT00064077|12071573|FG003|Overall Study|No tumor|0
7655587|NCT00064077|12071570|FG000|Overall Study|Other reasons|2
7655588|NCT00064077|12071571|FG001|Overall Study|Other reasons|2
7655589|NCT00064077|12071572|FG002|Overall Study|Other reasons|1
7655590|NCT00064077|12071573|FG003|Overall Study|Other reasons|2
7655591|NCT00064259|12071583|FG000|Overall Study|Adverse Event|1
7655592|NCT00064259|12071584|FG001|Overall Study|Adverse Event|0
7655593|NCT00064259|12071585|FG002|Overall Study|Adverse Event|0
7655594|NCT00064259|12071586|FG003|Overall Study|Adverse Event|1
7655595|NCT00064298|12071593|FG000|Overall Study|Withdrawal by Subject|2
7655596|NCT00064298|12071594|FG001|Overall Study|Withdrawal by Subject|1
7655597|NCT00064298|12071593|FG000|Overall Study|Lost to Follow-up|2
7655598|NCT00064298|12071594|FG001|Overall Study|Lost to Follow-up|2
7655599|NCT00064298|12071593|FG000|Overall Study|Death|0
7655600|NCT00064298|12071594|FG001|Overall Study|Death|1
7655601|NCT00064298|12071593|FG000|Overall Study|Disease Progression|2
7655602|NCT00064298|12071594|FG001|Overall Study|Disease Progression|1
7655603|NCT00064337|12071600|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7
7655604|NCT00064337|12071600|FG000|PBSCC or Induction/PBSCC|Adverse Event|6
7655605|NCT00064337|12071600|FG000|PBSCC or Induction/PBSCC|Progression|3
7655606|NCT00064337|12071600|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2
7655607|NCT00064337|12071600|FG000|PBSCC or Induction/PBSCC|Death|2
7655608|NCT00064337|12071600|FG000|Transplant|Adverse Event|9
7655609|NCT00064337|12071600|FG000|Transplant|Not protocol-specified|5
7655610|NCT00064337|12071600|FG000|Transplant|Death|3
7655611|NCT00064337|12071600|FG000|Transplant|Patient Refusal|2
7655612|NCT00064337|12071600|FG000|Transplant|Progression|2
7655613|NCT00064337|12071600|FG000|Maintenance|Adverse Event|3
7655614|NCT00064337|12071600|FG000|Maintenance|Progression|2
7655615|NCT00064337|12071600|FG000|Maintenance|On treatment at time of analysis|2
7655616|NCT00064337|12071600|FG000|Maintenance|Not protocol-specified|2
7655617|NCT00064337|12071600|FG000|Maintenance|Death|1
7655618|NCT00064350|12071610|FG000|Induction Treatment|Disease Progression|5
7655619|NCT00064350|12071611|FG001|Induction Treatment|Disease Progression|1
7655620|NCT00064350|12071612|FG002|Induction Treatment|Disease Progression|110
7655621|NCT00064350|12071610|FG000|Induction Treatment|Adverse Event|0
7655622|NCT00064350|12071611|FG001|Induction Treatment|Adverse Event|2
7655623|NCT00064350|12071612|FG002|Induction Treatment|Adverse Event|49
7655624|NCT00064350|12071610|FG000|Induction Treatment|Death|0
7655625|NCT00064350|12071611|FG001|Induction Treatment|Death|0
7655626|NCT00064350|12071612|FG002|Induction Treatment|Death|9
7655627|NCT00064350|12071610|FG000|Induction Treatment|Withdrawal by Subject|0
7655628|NCT00064350|12071611|FG001|Induction Treatment|Withdrawal by Subject|0
7655629|NCT00064350|12071612|FG002|Induction Treatment|Withdrawal by Subject|21
7655630|NCT00064350|12071610|FG000|Induction Treatment|Ineligible or never started treatment|3
7655631|NCT00064350|12071611|FG001|Induction Treatment|Ineligible or never started treatment|6
7655632|NCT00064350|12071612|FG002|Induction Treatment|Ineligible or never started treatment|34
7655633|NCT00064350|12071610|FG000|Induction Treatment|Other|0
7655634|NCT00064350|12071611|FG001|Induction Treatment|Other|0
7655635|NCT00064350|12071612|FG002|Induction Treatment|Other|13
7655636|NCT00064350|12071610|FG000|Randomization|Adverse Event|8
7655637|NCT00064350|12071611|FG001|Randomization|Adverse Event|3
7655638|NCT00064350|12071612|FG002|Randomization|Adverse Event|0
7655639|NCT00064350|12071610|FG000|Randomization|Death|3
7655640|NCT00064350|12071611|FG001|Randomization|Death|0
7655641|NCT00064350|12071612|FG002|Randomization|Death|0
7655642|NCT00064350|12071610|FG000|Randomization|Withdrawal by Subject|1
7655643|NCT00064350|12071611|FG001|Randomization|Withdrawal by Subject|0
7655644|NCT00064350|12071612|FG002|Randomization|Withdrawal by Subject|0
7655645|NCT00064350|12071610|FG000|Randomization|Ineligible or never started treatment|9
7655646|NCT00064350|12071611|FG001|Randomization|Ineligible or never started treatment|15
7655647|NCT00064350|12071612|FG002|Randomization|Ineligible or never started treatment|0
7655648|NCT00064350|12071610|FG000|Randomization|Other|5
7655649|NCT00064350|12071611|FG001|Randomization|Other|0
7655650|NCT00064350|12071612|FG002|Randomization|Other|0
7655651|NCT00064350|12071610|FG000|Cross-Over|Adverse Event|0
7655652|NCT00064350|12071611|FG001|Cross-Over|Adverse Event|1
7655653|NCT00064350|12071612|FG002|Cross-Over|Adverse Event|0
7655654|NCT00064350|12071610|FG000|Cross-Over|Death|1
7655655|NCT00064350|12071611|FG001|Cross-Over|Death|3
7655656|NCT00064350|12071612|FG002|Cross-Over|Death|0
7655657|NCT00064350|12071610|FG000|Cross-Over|Withdrawal by Subject|2
7655658|NCT00064350|12071611|FG001|Cross-Over|Withdrawal by Subject|2
7655659|NCT00064350|12071612|FG002|Cross-Over|Withdrawal by Subject|0
7655660|NCT00064350|12071610|FG000|Cross-Over|Ineligible or never started treatment|3
7655661|NCT00064350|12071611|FG001|Cross-Over|Ineligible or never started treatment|6
7655662|NCT00064350|12071612|FG002|Cross-Over|Ineligible or never started treatment|0
7655663|NCT00064350|12071610|FG000|Cross-Over|Other|0
7655664|NCT00064350|12071611|FG001|Cross-Over|Other|2
7655665|NCT00064350|12071612|FG002|Cross-Over|Other|0
7655666|NCT00064662|12071623|FG000|Overall Study|Death|1
7655667|NCT00064662|12071624|FG001|Overall Study|Death|1
7655668|NCT00064662|12071623|FG000|Overall Study|Lost to Follow-up|57
7655669|NCT00064662|12071624|FG001|Overall Study|Lost to Follow-up|44
7655670|NCT00064662|12071623|FG000|Overall Study|Withdrawal by Subject|14
7655671|NCT00064662|12071624|FG001|Overall Study|Withdrawal by Subject|14
7655672|NCT00064662|12071623|FG000|Overall Study|Administratively withdrawn|2
7655673|NCT00064662|12071624|FG001|Overall Study|Administratively withdrawn|2
7655674|NCT00064701|12071633|FG000|One Year Post-transplant|Did not receive study drug|7
7655675|NCT00064701|12071634|FG001|One Year Post-transplant|Did not receive study drug|12
7655676|NCT00064701|12071635|FG002|One Year Post-transplant|Did not receive study drug|11
7655677|NCT00064701|12071633|FG000|One Year Post-transplant|Adverse Event|23
7655678|NCT00064701|12071634|FG001|One Year Post-transplant|Adverse Event|19
7655679|NCT00064701|12071635|FG002|One Year Post-transplant|Adverse Event|37
7655680|NCT00064701|12071633|FG000|One Year Post-transplant|Rejection|0
7655681|NCT00064701|12071634|FG001|One Year Post-transplant|Rejection|1
7655682|NCT00064701|12071635|FG002|One Year Post-transplant|Rejection|16
7655683|NCT00064701|12071633|FG000|One Year Post-transplant|Non-compliance|4
7655684|NCT00064701|12071634|FG001|One Year Post-transplant|Non-compliance|2
7655685|NCT00064701|12071635|FG002|One Year Post-transplant|Non-compliance|5
7655686|NCT00064701|12071633|FG000|One Year Post-transplant|Graft Failure|3
7655687|NCT00064701|12071634|FG001|One Year Post-transplant|Graft Failure|2
7655688|NCT00064701|12071635|FG002|One Year Post-transplant|Graft Failure|1
7655689|NCT00064701|12071633|FG000|One Year Post-transplant|Withdrawal by Subject|0
7655690|NCT00064701|12071634|FG001|One Year Post-transplant|Withdrawal by Subject|4
7655691|NCT00064701|12071635|FG002|One Year Post-transplant|Withdrawal by Subject|1
7655692|NCT00064701|12071633|FG000|One Year Post-transplant|Lost to Follow-up|1
7655693|NCT00064701|12071634|FG001|One Year Post-transplant|Lost to Follow-up|0
7655694|NCT00064701|12071635|FG002|One Year Post-transplant|Lost to Follow-up|0
7655695|NCT00064701|12071633|FG000|One Year Post-transplant|Converted to rapamycin|1
7655696|NCT00064701|12071634|FG001|One Year Post-transplant|Converted to rapamycin|0
7655697|NCT00064701|12071635|FG002|One Year Post-transplant|Converted to rapamycin|0
7655698|NCT00064701|12071633|FG000|One Year Post-transplant|Acute tubular necrosis|1
7655699|NCT00064701|12071634|FG001|One Year Post-transplant|Acute tubular necrosis|0
7655700|NCT00064701|12071635|FG002|One Year Post-transplant|Acute tubular necrosis|0
7655701|NCT00064701|12071633|FG000|One Year Post-transplant|Incorrect study drug dispensed|0
7655702|NCT00064701|12071634|FG001|One Year Post-transplant|Incorrect study drug dispensed|1
7655703|NCT00064701|12071635|FG002|One Year Post-transplant|Incorrect study drug dispensed|0
7655704|NCT00064701|12071633|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0
7655705|NCT00064701|12071634|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1
7655706|NCT00064701|12071635|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0
7655707|NCT00064701|12071633|FG000|One Year Post-transplant|Poor absorption|0
7655708|NCT00064701|12071634|FG001|One Year Post-transplant|Poor absorption|1
7655709|NCT00064701|12071635|FG002|One Year Post-transplant|Poor absorption|0
7655710|NCT00064701|12071633|FG000|One Year Post-transplant|Pancreas transplant|0
7655711|NCT00064701|12071634|FG001|One Year Post-transplant|Pancreas transplant|0
7655712|NCT00064701|12071635|FG002|One Year Post-transplant|Pancreas transplant|1
7655713|NCT00064701|12071633|FG000|Clinical Continuation Phase|Adverse Event|12
7655714|NCT00064701|12071634|FG001|Clinical Continuation Phase|Adverse Event|21
7655715|NCT00064701|12071635|FG002|Clinical Continuation Phase|Adverse Event|14
7655716|NCT00064701|12071633|FG000|Clinical Continuation Phase|Non-compliance|8
7655717|NCT00064701|12071634|FG001|Clinical Continuation Phase|Non-compliance|6
7655718|NCT00064701|12071635|FG002|Clinical Continuation Phase|Non-compliance|7
7655719|NCT00064701|12071633|FG000|Clinical Continuation Phase|Withdrawal by Subject|22
7655720|NCT00064701|12071634|FG001|Clinical Continuation Phase|Withdrawal by Subject|3
7655721|NCT00064701|12071635|FG002|Clinical Continuation Phase|Withdrawal by Subject|22
7655722|NCT00064701|12071633|FG000|Clinical Continuation Phase|Lost to Follow-up|6
7655723|NCT00064701|12071634|FG001|Clinical Continuation Phase|Lost to Follow-up|3
7655724|NCT00064701|12071635|FG002|Clinical Continuation Phase|Lost to Follow-up|6
7655725|NCT00064701|12071633|FG000|Clinical Continuation Phase|Graft Failure|5
7655726|NCT00064701|12071634|FG001|Clinical Continuation Phase|Graft Failure|5
7655727|NCT00064701|12071635|FG002|Clinical Continuation Phase|Graft Failure|2
7655728|NCT00064701|12071633|FG000|Clinical Continuation Phase|Rejection|1
7655729|NCT00064701|12071634|FG001|Clinical Continuation Phase|Rejection|2
7655730|NCT00064701|12071635|FG002|Clinical Continuation Phase|Rejection|2
7655731|NCT00064701|12071633|FG000|Clinical Continuation Phase|Sponsor discontinued study|113
7655732|NCT00064701|12071634|FG001|Clinical Continuation Phase|Sponsor discontinued study|129
7655733|NCT00064701|12071635|FG002|Clinical Continuation Phase|Sponsor discontinued study|79
7655734|NCT00064701|12071633|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
7655735|NCT00064701|12071634|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
7655736|NCT00064701|12071635|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
7655737|NCT00064701|12071633|FG000|Clinical Continuation Phase|Physician Decision|1
7655738|NCT00064701|12071634|FG001|Clinical Continuation Phase|Physician Decision|3
7655739|NCT00064701|12071635|FG002|Clinical Continuation Phase|Physician Decision|0
7655740|NCT00064701|12071633|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1
7655741|NCT00064701|12071634|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0
7655742|NCT00064701|12071635|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1
7655743|NCT00064701|12071633|FG000|Clinical Continuation Phase|Pancreas transplant|1
7655744|NCT00064701|12071634|FG001|Clinical Continuation Phase|Pancreas transplant|0
7655745|NCT00064701|12071635|FG002|Clinical Continuation Phase|Pancreas transplant|0
7655746|NCT00064701|12071633|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
7655747|NCT00064701|12071634|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
7655748|NCT00064701|12071635|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
7655749|NCT00064701|12071633|FG000|Clinical Continuation Phase|Discharged to nursing home|0
7655750|NCT00064701|12071634|FG001|Clinical Continuation Phase|Discharged to nursing home|1
7655751|NCT00064701|12071635|FG002|Clinical Continuation Phase|Discharged to nursing home|0
7655752|NCT00064701|12071633|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0
7655753|NCT00064701|12071634|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1
7655754|NCT00064701|12071635|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0
7655755|NCT00064701|12071633|FG000|Clinical Continuation Phase|Patient opted out|0
7655756|NCT00064701|12071634|FG001|Clinical Continuation Phase|Patient opted out|0
7655757|NCT00064701|12071635|FG002|Clinical Continuation Phase|Patient opted out|1
7655758|NCT00064753|12071645|FG000|Overall Study|Death|251
7655759|NCT00064753|12071646|FG001|Overall Study|Death|242
7655760|NCT00064753|12071645|FG000|Overall Study|Withdrawal by Subject|198
7655761|NCT00064753|12071646|FG001|Overall Study|Withdrawal by Subject|171
7655762|NCT00064753|12071645|FG000|Overall Study|Lost to Follow-up|225
7655763|NCT00064753|12071646|FG001|Overall Study|Lost to Follow-up|235
7655764|NCT00064792|12071654|FG000|Overall Study|Withdrawal by Subject|2
7655765|NCT00064792|12071655|FG001|Overall Study|Withdrawal by Subject|0
7655766|NCT00064792|12071654|FG000|Overall Study|Adverse Event|3
7655767|NCT00064792|12071655|FG001|Overall Study|Adverse Event|0
7655768|NCT00064987|12071672|FG000|Overall Study|Physician Decision|3
7655769|NCT00064987|12071673|FG001|Overall Study|Physician Decision|0
7655770|NCT00065065|12071681|FG000|Overall Study|Adverse Event|3
7655771|NCT00065065|12071682|FG001|Overall Study|Adverse Event|2
7655772|NCT00065065|12071681|FG000|Overall Study|Withdrawal by Subject|1
7655773|NCT00065065|12071682|FG001|Overall Study|Withdrawal by Subject|5
7655774|NCT00065065|12071681|FG000|Overall Study|Lack of Efficacy|4
7655775|NCT00065065|12071682|FG001|Overall Study|Lack of Efficacy|11
7655776|NCT00065065|12071681|FG000|Overall Study|Other|2
7655777|NCT00065065|12071682|FG001|Overall Study|Other|2
7655778|NCT00065156|12071690|FG000|Overall Study|Adverse Event|37
7655779|NCT00065156|12071690|FG000|Overall Study|Lack of Efficacy|52
7655780|NCT00065156|12071690|FG000|Overall Study|Withdrawal by Subject|8
7655781|NCT00065156|12071690|FG000|Overall Study|Lost to Follow-up|1
7655782|NCT00065156|12071690|FG000|Overall Study|Death|11
7655783|NCT00065156|12071690|FG000|Overall Study|Study Closed by Sponsor|2
7655784|NCT00065156|12071690|FG000|Overall Study|Disease Progression|7
7655785|NCT00065156|12071690|FG000|Overall Study|Investigator Decision|2
7655786|NCT00065156|12071690|FG000|Overall Study|Non-Compliance|2
7655787|NCT00065156|12071690|FG000|Overall Study|Loss of Response|1
7655788|NCT00065156|12071690|FG000|Overall Study|Secondary Malign Disease|1
7655789|NCT00065182|12071696|FG000|Overall Study|Adverse Event|24
7655790|NCT00065182|12071697|FG001|Overall Study|Adverse Event|17
7655791|NCT00065182|12071696|FG000|Overall Study|Lost to Follow-up|0
7655792|NCT00065182|12071697|FG001|Overall Study|Lost to Follow-up|4
7655793|NCT00065182|12071696|FG000|Overall Study|Protocol Violation|3
7655794|NCT00065182|12071697|FG001|Overall Study|Protocol Violation|4
7655795|NCT00065182|12071696|FG000|Overall Study|Serious adverse events (SAE)|1
7655796|NCT00065182|12071697|FG001|Overall Study|Serious adverse events (SAE)|0
7655797|NCT00065182|12071696|FG000|Overall Study|Sponsor Decision|11
7655798|NCT00065182|12071697|FG001|Overall Study|Sponsor Decision|7
7655799|NCT00065182|12071696|FG000|Overall Study|Withdrawal by Subject|8
7655800|NCT00065182|12071697|FG001|Overall Study|Withdrawal by Subject|3
7655801|NCT00065182|12071696|FG000|Overall Study|No clinical benefit|1
7655802|NCT00065182|12071697|FG001|Overall Study|No clinical benefit|0
7655803|NCT00065182|12071696|FG000|Overall Study|Death|0
7655804|NCT00065182|12071697|FG001|Overall Study|Death|1
7655805|NCT00065182|12071696|FG000|Overall Study|Decline in Status|0
7655806|NCT00065182|12071697|FG001|Overall Study|Decline in Status|1
7655807|NCT00065260|12071705|FG000|Overall Study|Death|0
7655808|NCT00065260|12071706|FG001|Overall Study|Death|1
7655809|NCT00065429|12071719|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7655810|NCT00065429|12071720|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7655811|NCT00065429|12071721|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7655812|NCT00065429|12071722|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7655813|NCT00065429|12071723|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7655814|NCT00065429|12071724|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
7655815|NCT00065429|12071725|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7655816|NCT00065429|12071719|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7655817|NCT00065429|12071720|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7655818|NCT00065429|12071721|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
7655819|NCT00065429|12071722|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7655820|NCT00065429|12071723|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7655821|NCT00065429|12071724|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7655822|NCT00065429|12071725|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7655823|NCT00065429|12071719|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1
7655824|NCT00065429|12071720|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0
7655825|NCT00065429|12071721|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0
7655826|NCT00065429|12071722|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0
7655827|NCT00065429|12071723|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0
7655828|NCT00065429|12071724|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0
7655829|NCT00065429|12071725|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0
7655830|NCT00065429|12071719|FG000|Phase I - May 2001 - Oct 2002|Death|0
7655831|NCT00065429|12071720|FG001|Phase I - May 2001 - Oct 2002|Death|0
7655832|NCT00065429|12071721|FG002|Phase I - May 2001 - Oct 2002|Death|0
7655833|NCT00065429|12071722|FG003|Phase I - May 2001 - Oct 2002|Death|0
7655834|NCT00065429|12071723|FG004|Phase I - May 2001 - Oct 2002|Death|1
7655835|NCT00065429|12071724|FG005|Phase I - May 2001 - Oct 2002|Death|0
7655836|NCT00065429|12071725|FG006|Phase I - May 2001 - Oct 2002|Death|0
7655837|NCT00065429|12071719|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0
7655838|NCT00065429|12071720|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0
7655839|NCT00065429|12071721|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0
7655840|NCT00065429|12071722|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1
7655841|NCT00065429|12071723|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0
7655842|NCT00065429|12071724|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1
7655843|NCT00065429|12071725|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2
7655844|NCT00065429|12071719|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7655845|NCT00065429|12071720|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7655846|NCT00065429|12071721|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7655847|NCT00065429|12071722|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7655848|NCT00065429|12071723|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
7655849|NCT00065429|12071724|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7655850|NCT00065429|12071725|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7655851|NCT00065429|12071719|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7655852|NCT00065429|12071720|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7655853|NCT00065429|12071721|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7655854|NCT00065429|12071722|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7655855|NCT00065429|12071723|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
7655856|NCT00065429|12071724|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7655857|NCT00065429|12071725|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7655858|NCT00065442|12071738|FG000|Overall Study|Lost to Follow-up|1
7655859|NCT00065442|12071739|FG001|Overall Study|Lost to Follow-up|1
7655860|NCT00065442|12071738|FG000|Overall Study|Death|121
7655861|NCT00065442|12071739|FG001|Overall Study|Death|210
7655862|NCT00065442|12071738|FG000|Overall Study|Withdrawal by Subject|3
7655863|NCT00065442|12071739|FG001|Overall Study|Withdrawal by Subject|9
7655864|NCT00065468|12071748|FG000|Overall Study|Death|172
7655865|NCT00065468|12071749|FG001|Overall Study|Death|169
7655866|NCT00065468|12071750|FG002|Overall Study|Death|171
7655867|NCT00065468|12071748|FG000|Overall Study|Withdrawal by Subject|3
7655868|NCT00065468|12071749|FG001|Overall Study|Withdrawal by Subject|4
7655869|NCT00065468|12071750|FG002|Overall Study|Withdrawal by Subject|5
7655870|NCT00065468|12071748|FG000|Overall Study|Lost to Follow-up|5
7655871|NCT00065468|12071749|FG001|Overall Study|Lost to Follow-up|3
7655872|NCT00065468|12071750|FG002|Overall Study|Lost to Follow-up|2
7655873|NCT00065468|12071748|FG000|Overall Study|Discontinuation of study by Sponsor|13
7655874|NCT00065468|12071749|FG001|Overall Study|Discontinuation of study by Sponsor|9
7655875|NCT00065468|12071750|FG002|Overall Study|Discontinuation of study by Sponsor|13
7655876|NCT00065468|12071748|FG000|Overall Study|Disease progression|0
7655877|NCT00065468|12071749|FG001|Overall Study|Disease progression|0
7655878|NCT00065468|12071750|FG002|Overall Study|Disease progression|1
7655879|NCT00065468|12071748|FG000|Overall Study|Other|14
7655880|NCT00065468|12071749|FG001|Overall Study|Other|24
7655881|NCT00065468|12071750|FG002|Overall Study|Other|18
7655882|NCT00065507|12071760|FG000|Overall Study|Death|16
7655883|NCT00065507|12071761|FG001|Overall Study|Death|17
7655884|NCT00065507|12071760|FG000|Overall Study|Adverse Event|4
7655885|NCT00065507|12071761|FG001|Overall Study|Adverse Event|3
7655886|NCT00065507|12071760|FG000|Overall Study|Lack of Efficacy|0
7655887|NCT00065507|12071761|FG001|Overall Study|Lack of Efficacy|6
7655888|NCT00065507|12071760|FG000|Overall Study|Poor/Non-compliance|3
7655889|NCT00065507|12071761|FG001|Overall Study|Poor/Non-compliance|2
7655890|NCT00065507|12071760|FG000|Overall Study|Lost to Follow-up|3
7655891|NCT00065507|12071761|FG001|Overall Study|Lost to Follow-up|0
7655892|NCT00065507|12071760|FG000|Overall Study|Subject Withdrew Consent|2
7655893|NCT00065507|12071761|FG001|Overall Study|Subject Withdrew Consent|1
7655894|NCT00065507|12071760|FG000|Overall Study|Subject No Longer Meets Study Criteria|1
7655895|NCT00065507|12071761|FG001|Overall Study|Subject No Longer Meets Study Criteria|0
7655896|NCT00066066|12071792|FG000|Overall Study|Lost to Follow-up|6
7655897|NCT00066066|12071793|FG001|Overall Study|Lost to Follow-up|4
7655898|NCT00066066|12071794|FG002|Overall Study|Lost to Follow-up|7
7655899|NCT00066066|12071795|FG003|Overall Study|Lost to Follow-up|4
7655900|NCT00066066|12071796|FG004|Overall Study|Lost to Follow-up|3
7655901|NCT00066066|12071797|FG005|Overall Study|Lost to Follow-up|5
7655902|NCT00066170|12071815|FG000|Overall Study|Adverse Event|2
7655903|NCT00066170|12071816|FG001|Overall Study|Adverse Event|4
7655904|NCT00066170|12071817|FG002|Overall Study|Adverse Event|1
7655905|NCT00066170|12071818|FG003|Overall Study|Adverse Event|7
7655906|NCT00066170|12071815|FG000|Overall Study|Serious Adverse Event|0
7655907|NCT00066170|12071816|FG001|Overall Study|Serious Adverse Event|0
7655908|NCT00066170|12071817|FG002|Overall Study|Serious Adverse Event|1
7655909|NCT00066170|12071818|FG003|Overall Study|Serious Adverse Event|1
7655910|NCT00066170|12071815|FG000|Overall Study|Lost to Follow-up|0
7655911|NCT00066170|12071816|FG001|Overall Study|Lost to Follow-up|1
7655912|NCT00066170|12071817|FG002|Overall Study|Lost to Follow-up|0
7655913|NCT00066170|12071818|FG003|Overall Study|Lost to Follow-up|0
7655914|NCT00066170|12071815|FG000|Overall Study|Non-Compliance with Trial Medicine|1
7655915|NCT00066170|12071816|FG001|Overall Study|Non-Compliance with Trial Medicine|0
7655916|NCT00066170|12071817|FG002|Overall Study|Non-Compliance with Trial Medicine|0
7655917|NCT00066170|12071818|FG003|Overall Study|Non-Compliance with Trial Medicine|1
7655918|NCT00066170|12071815|FG000|Overall Study|Protocol Violation|3
7655919|NCT00066170|12071816|FG001|Overall Study|Protocol Violation|0
7655920|NCT00066170|12071817|FG002|Overall Study|Protocol Violation|0
7655921|NCT00066170|12071818|FG003|Overall Study|Protocol Violation|0
7655922|NCT00066170|12071815|FG000|Overall Study|Other|1
7655923|NCT00066170|12071816|FG001|Overall Study|Other|5
7655924|NCT00066170|12071817|FG002|Overall Study|Other|2
7655925|NCT00066170|12071818|FG003|Overall Study|Other|0
7655926|NCT00066222|12071828|FG000|Overall Study|No protocol treatment received|1
7655927|NCT00066365|12071834|FG000|Overall Study|Adverse Event|1
7655928|NCT00066365|12071835|FG001|Overall Study|Adverse Event|0
7655929|NCT00066365|12071834|FG000|Overall Study|Lack of Efficacy|15
7655930|NCT00066365|12071835|FG001|Overall Study|Lack of Efficacy|12
7655931|NCT00066365|12071834|FG000|Overall Study|Physician Decision|1
7655932|NCT00066365|12071835|FG001|Overall Study|Physician Decision|0
7655933|NCT00066365|12071834|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2
7655934|NCT00066365|12071835|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0
7655935|NCT00066365|12071834|FG000|Overall Study|Ineligible|4
7655936|NCT00066365|12071835|FG001|Overall Study|Ineligible|2
7655937|NCT00066469|12071843|FG000|Overall Study|Death|3
7655938|NCT00066469|12071843|FG000|Overall Study|Lack of Efficacy|9
7655939|NCT00066469|12071843|FG000|Overall Study|Lost to Follow-up|1
7655940|NCT00066469|12071843|FG000|Overall Study|Physician Decision|1
7655941|NCT00066469|12071843|FG000|Overall Study|Withdrawal by Subject|1
7655942|NCT00066469|12071843|FG000|Overall Study|ineligible|1
7655943|NCT00066573|12071849|FG000|Overall Study|Did not received protocol treatment|28
7655944|NCT00066573|12071850|FG001|Overall Study|Did not received protocol treatment|28
7655945|NCT00066690|12071868|FG000|Overall Study|Adverse Event|145
7655946|NCT00066690|12071869|FG001|Overall Study|Adverse Event|58
7655947|NCT00066690|12071870|FG002|Overall Study|Adverse Event|126
7655948|NCT00066690|12071868|FG000|Overall Study|Death|3
7655949|NCT00066690|12071869|FG001|Overall Study|Death|0
7655950|NCT00066690|12071870|FG002|Overall Study|Death|2
7655951|NCT00066690|12071868|FG000|Overall Study|Lack of Efficacy|114
7655952|NCT00066690|12071869|FG001|Overall Study|Lack of Efficacy|110
7655953|NCT00066690|12071870|FG002|Overall Study|Lack of Efficacy|76
7655954|NCT00066690|12071868|FG000|Overall Study|Lost to Follow-up|40
7655955|NCT00066690|12071869|FG001|Overall Study|Lost to Follow-up|21
7655956|NCT00066690|12071870|FG002|Overall Study|Lost to Follow-up|29
7655957|NCT00066690|12071868|FG000|Overall Study|Withdrawal by Subject|50
7655958|NCT00066690|12071869|FG001|Overall Study|Withdrawal by Subject|55
7655959|NCT00066690|12071870|FG002|Overall Study|Withdrawal by Subject|49
7655960|NCT00066690|12071868|FG000|Overall Study|Treatment Ongoing|246
7655961|NCT00066690|12071869|FG001|Overall Study|Treatment Ongoing|278
7655962|NCT00066690|12071870|FG002|Overall Study|Treatment Ongoing|282
7655963|NCT00066703|12071883|FG000|Overall Study|Adverse Event|80
7655964|NCT00066703|12071884|FG001|Overall Study|Adverse Event|111
7655965|NCT00066703|12071883|FG000|Overall Study|Death|3
7655966|NCT00066703|12071884|FG001|Overall Study|Death|0
7655967|NCT00066703|12071883|FG000|Overall Study|Lack of Efficacy|114
7655968|NCT00066703|12071884|FG001|Overall Study|Lack of Efficacy|69
7655969|NCT00066703|12071883|FG000|Overall Study|Lost to Follow-up|31
7655970|NCT00066703|12071884|FG001|Overall Study|Lost to Follow-up|28
7655971|NCT00066703|12071883|FG000|Overall Study|Withdrawal by Subject|38
7655972|NCT00066703|12071884|FG001|Overall Study|Withdrawal by Subject|63
7655973|NCT00066703|12071883|FG000|Overall Study|Treatment ongoing|346
7655974|NCT00066703|12071884|FG001|Overall Study|Treatment ongoing|311
7655975|NCT00066729|12071890|FG000|Overall Study|Lost to Follow-up|1
7655976|NCT00066729|12071890|FG000|Overall Study|Disease progression|1
7655977|NCT00066742|12071894|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
7655978|NCT00066742|12071894|FG000|Induction Chemoradiotherapy|Adverse Event|21
7655979|NCT00066742|12071894|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2
7655980|NCT00066742|12071894|FG000|Induction Chemoradiotherapy|not protocol specified|2
7655981|NCT00066742|12071894|FG000|Induction Chemoradiotherapy|Ineligible|3
7655982|NCT00066742|12071894|FG000|Consolidation Chemotherapy|not protocol specified|1
7655983|NCT00066742|12071894|FG000|Consolidation Chemotherapy|Ineligible|2
7655984|NCT00067002|12071928|FG000|Overall Study|Early Death|1
7655985|NCT00067002|12071929|FG001|Overall Study|Early Death|2
7655986|NCT00067002|12071928|FG000|Overall Study|Delayed|1
7655987|NCT00067002|12071929|FG001|Overall Study|Delayed|1
7655988|NCT00067002|12071928|FG000|Overall Study|Graft Failure|5
7655989|NCT00067002|12071929|FG001|Overall Study|Graft Failure|6
7655990|NCT00067470|12071961|FG000|Overall Study|Withdrawal by Subject|0
7655991|NCT00067470|12071962|FG001|Overall Study|Withdrawal by Subject|1
7655992|NCT00067990|12071983|FG000|Overall Study|Death|5
7655993|NCT00067990|12071984|FG001|Overall Study|Death|7
7655994|NCT00067990|12071983|FG000|Overall Study|ESRD, Non IF/TA|1
7655995|NCT00067990|12071984|FG001|Overall Study|ESRD, Non IF/TA|3
7655996|NCT00067990|12071983|FG000|Overall Study|Withdrawal by Subject|4
7655997|NCT00067990|12071984|FG001|Overall Study|Withdrawal by Subject|12
7655998|NCT00068107|12071990|FG000|Overall Study|end-stage renal disease|6
7655999|NCT00068107|12071990|FG000|Overall Study|Death|2
7656000|NCT00068107|12071990|FG000|Overall Study|Withdrawal by Subject|1
7656001|NCT00068237|12071997|FG000|Overall Study|Ineligible|3
7656002|NCT00068237|12071997|FG000|Overall Study|No protocol treatment received|2
7656003|NCT00068250|12072004|FG000|Phase I: Dose Level 2|Protocol Violation|0
7656004|NCT00068250|12072005|FG001|Phase I: Dose Level 2|Protocol Violation|1
7656005|NCT00068250|12072006|FG002|Phase I: Dose Level 2|Protocol Violation|0
7656006|NCT00068250|12072007|FG003|Phase I: Dose Level 2|Protocol Violation|0
7656007|NCT00068380|12072045|FG000|Overall Study|Withdrawal by Subject|3
7656008|NCT00068380|12072045|FG000|Overall Study|Adverse Event|2
7656009|NCT00068393|12072049|FG000|Overall Study|Adverse Event|2
7656010|NCT00068393|12072049|FG000|Overall Study|Death|3
7656011|NCT00068393|12072049|FG000|Overall Study|Withdrawal by Subject|3
7656012|NCT00068393|12072049|FG000|Overall Study|Alternative treatment|1
7656013|NCT00068393|12072049|FG000|Overall Study|Quality of life worsening|1
7656014|NCT00068406|12072053|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1
7656015|NCT00068406|12072053|FG000|Overall Study|Ineligible-Inadequate Pathology|2
7656016|NCT00068419|12072057|FG000|Overall Study|Adverse Event|3
7656017|NCT00068419|12072057|FG000|Overall Study|Lack of Efficacy|24
7656018|NCT00068419|12072057|FG000|Overall Study|Lost to Follow-up|1
7656019|NCT00068419|12072057|FG000|Overall Study|Physician Decision|7
7656020|NCT00068419|12072057|FG000|Overall Study|Withdrawal by Subject|14
7656021|NCT00068419|12072057|FG000|Overall Study|Ineligible|11
7656022|NCT00068445|12072063|FG000|Randomization|Cancel|1
7656023|NCT00068445|12072064|FG001|Randomization|Cancel|3
7656024|NCT00068445|12072063|FG000|Randomization|Ineligible|1
7656025|NCT00068445|12072064|FG001|Randomization|Ineligible|1
7656026|NCT00068445|12072063|FG000|Treatment|Refused Further Treatment|13
7656027|NCT00068445|12072064|FG001|Treatment|Refused Further Treatment|10
7656028|NCT00068445|12072063|FG000|Treatment|Adverse Event|7
7656029|NCT00068445|12072064|FG001|Treatment|Adverse Event|1
7656030|NCT00068445|12072063|FG000|Treatment|Other (Specifics not available)|9
7656031|NCT00068445|12072064|FG001|Treatment|Other (Specifics not available)|5
7656032|NCT00068588|12072077|FG000|Overall Study|Adverse Event|0
7656033|NCT00068588|12072078|FG001|Overall Study|Adverse Event|0
7656034|NCT00068588|12072079|FG002|Overall Study|Adverse Event|2
7656035|NCT00068588|12072077|FG000|Overall Study|Withdrawal by Subject|0
7656036|NCT00068588|12072078|FG001|Overall Study|Withdrawal by Subject|0
7656037|NCT00068588|12072079|FG002|Overall Study|Withdrawal by Subject|1
7656038|NCT00068588|12072077|FG000|Overall Study|Poor KPS|0
7656039|NCT00068588|12072078|FG001|Overall Study|Poor KPS|0
7656040|NCT00068588|12072079|FG002|Overall Study|Poor KPS|1
7656041|NCT00068601|12072088|FG000|Overall Study|Ineligible|11
7656042|NCT00068601|12072089|FG001|Overall Study|Ineligible|13
7656043|NCT00068601|12072088|FG000|Overall Study|Not evaluable: withdrew consent|5
7656044|NCT00068601|12072089|FG001|Overall Study|Not evaluable: withdrew consent|4
7656045|NCT00068601|12072088|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
7656046|NCT00068601|12072089|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
7656047|NCT00068601|12072088|FG000|Overall Study|Death|11
7656048|NCT00068601|12072089|FG001|Overall Study|Death|3
7656049|NCT00068601|12072088|FG000|Overall Study|Lost to Follow-up|3
7656050|NCT00068601|12072089|FG001|Overall Study|Lost to Follow-up|2
7656051|NCT00068601|12072088|FG000|Overall Study|Missing primary outcome data|30
7656052|NCT00068601|12072089|FG001|Overall Study|Missing primary outcome data|34
7656053|NCT00068692|12072098|FG000|Step 1: Registration|Disese progression/relapse|5
7656054|NCT00068692|12072099|FG001|Step 1: Registration|Disese progression/relapse|0
7656055|NCT00068692|12072100|FG002|Step 1: Registration|Disese progression/relapse|0
7656056|NCT00068692|12072101|FG003|Step 1: Registration|Disese progression/relapse|0
7656057|NCT00068692|12072102|FG004|Step 1: Registration|Disese progression/relapse|0
7656058|NCT00068692|12072103|FG005|Step 1: Registration|Disese progression/relapse|0
7656059|NCT00068692|12072104|FG006|Step 1: Registration|Disese progression/relapse|0
7656060|NCT00068692|12072105|FG007|Step 1: Registration|Disese progression/relapse|0
7656061|NCT00068692|12072098|FG000|Step 1: Registration|Adverse Event|7
7656062|NCT00068692|12072099|FG001|Step 1: Registration|Adverse Event|0
7656063|NCT00068692|12072100|FG002|Step 1: Registration|Adverse Event|0
7656064|NCT00068692|12072101|FG003|Step 1: Registration|Adverse Event|0
7656065|NCT00068692|12072102|FG004|Step 1: Registration|Adverse Event|0
7656066|NCT00068692|12072103|FG005|Step 1: Registration|Adverse Event|0
7656067|NCT00068692|12072104|FG006|Step 1: Registration|Adverse Event|0
7656068|NCT00068692|12072105|FG007|Step 1: Registration|Adverse Event|0
7656069|NCT00068692|12072098|FG000|Step 1: Registration|Death|1
7656070|NCT00068692|12072099|FG001|Step 1: Registration|Death|0
7656071|NCT00068692|12072100|FG002|Step 1: Registration|Death|0
7656072|NCT00068692|12072101|FG003|Step 1: Registration|Death|0
7656073|NCT00068692|12072102|FG004|Step 1: Registration|Death|0
7656074|NCT00068692|12072103|FG005|Step 1: Registration|Death|0
7656075|NCT00068692|12072104|FG006|Step 1: Registration|Death|0
7656076|NCT00068692|12072105|FG007|Step 1: Registration|Death|0
7656077|NCT00068692|12072098|FG000|Step 1: Registration|Withdrawal by Subject|11
7656078|NCT00068692|12072099|FG001|Step 1: Registration|Withdrawal by Subject|0
7656079|NCT00068692|12072100|FG002|Step 1: Registration|Withdrawal by Subject|0
7656080|NCT00068692|12072101|FG003|Step 1: Registration|Withdrawal by Subject|0
7656081|NCT00068692|12072102|FG004|Step 1: Registration|Withdrawal by Subject|0
7656082|NCT00068692|12072103|FG005|Step 1: Registration|Withdrawal by Subject|0
7656083|NCT00068692|12072104|FG006|Step 1: Registration|Withdrawal by Subject|0
7656084|NCT00068692|12072105|FG007|Step 1: Registration|Withdrawal by Subject|0
7656085|NCT00068692|12072098|FG000|Step 1: Registration|Alternative therapy|2
7656086|NCT00068692|12072099|FG001|Step 1: Registration|Alternative therapy|0
7656087|NCT00068692|12072100|FG002|Step 1: Registration|Alternative therapy|0
7656088|NCT00068692|12072101|FG003|Step 1: Registration|Alternative therapy|0
7656089|NCT00068692|12072102|FG004|Step 1: Registration|Alternative therapy|0
7656090|NCT00068692|12072103|FG005|Step 1: Registration|Alternative therapy|0
7656091|NCT00068692|12072104|FG006|Step 1: Registration|Alternative therapy|0
7656092|NCT00068692|12072105|FG007|Step 1: Registration|Alternative therapy|0
7656093|NCT00068692|12072098|FG000|Step 1: Registration|Complicating disease|2
7656094|NCT00068692|12072099|FG001|Step 1: Registration|Complicating disease|0
7656095|NCT00068692|12072100|FG002|Step 1: Registration|Complicating disease|0
7656096|NCT00068692|12072101|FG003|Step 1: Registration|Complicating disease|0
7656097|NCT00068692|12072102|FG004|Step 1: Registration|Complicating disease|0
7656098|NCT00068692|12072103|FG005|Step 1: Registration|Complicating disease|0
7656099|NCT00068692|12072104|FG006|Step 1: Registration|Complicating disease|0
7656100|NCT00068692|12072105|FG007|Step 1: Registration|Complicating disease|0
7656101|NCT00068692|12072098|FG000|Step 1: Registration|Protocol Violation|1
7656102|NCT00068692|12072099|FG001|Step 1: Registration|Protocol Violation|0
7656103|NCT00068692|12072100|FG002|Step 1: Registration|Protocol Violation|0
7656104|NCT00068692|12072101|FG003|Step 1: Registration|Protocol Violation|0
7656105|NCT00068692|12072102|FG004|Step 1: Registration|Protocol Violation|0
7656106|NCT00068692|12072103|FG005|Step 1: Registration|Protocol Violation|0
7656107|NCT00068692|12072104|FG006|Step 1: Registration|Protocol Violation|0
7656108|NCT00068692|12072105|FG007|Step 1: Registration|Protocol Violation|0
7656109|NCT00068692|12072098|FG000|Step 1: Registration|Not eligible|6
7656110|NCT00068692|12072099|FG001|Step 1: Registration|Not eligible|0
7656111|NCT00068692|12072100|FG002|Step 1: Registration|Not eligible|0
7656112|NCT00068692|12072101|FG003|Step 1: Registration|Not eligible|0
7656113|NCT00068692|12072102|FG004|Step 1: Registration|Not eligible|0
7656114|NCT00068692|12072103|FG005|Step 1: Registration|Not eligible|0
7656115|NCT00068692|12072104|FG006|Step 1: Registration|Not eligible|0
7656116|NCT00068692|12072105|FG007|Step 1: Registration|Not eligible|0
7656117|NCT00068692|12072098|FG000|Step 1: Registration|Other|2
7656118|NCT00068692|12072099|FG001|Step 1: Registration|Other|0
7656119|NCT00068692|12072100|FG002|Step 1: Registration|Other|0
7656120|NCT00068692|12072101|FG003|Step 1: Registration|Other|0
7656121|NCT00068692|12072102|FG004|Step 1: Registration|Other|0
7656122|NCT00068692|12072103|FG005|Step 1: Registration|Other|0
7656123|NCT00068692|12072104|FG006|Step 1: Registration|Other|0
7656124|NCT00068692|12072105|FG007|Step 1: Registration|Other|0
7656125|NCT00068692|12072098|FG000|Step 1: Registration|Not start protocol therapy|3
7656126|NCT00068692|12072099|FG001|Step 1: Registration|Not start protocol therapy|0
7656127|NCT00068692|12072100|FG002|Step 1: Registration|Not start protocol therapy|0
7656128|NCT00068692|12072101|FG003|Step 1: Registration|Not start protocol therapy|0
7656129|NCT00068692|12072102|FG004|Step 1: Registration|Not start protocol therapy|0
7656130|NCT00068692|12072103|FG005|Step 1: Registration|Not start protocol therapy|0
7656131|NCT00068692|12072104|FG006|Step 1: Registration|Not start protocol therapy|0
7656132|NCT00068692|12072105|FG007|Step 1: Registration|Not start protocol therapy|0
7656133|NCT00068692|12072098|FG000|Step 1: Registration|Registered but not randomized|0
7656134|NCT00068692|12072099|FG001|Step 1: Registration|Registered but not randomized|1
7656135|NCT00068692|12072100|FG002|Step 1: Registration|Registered but not randomized|0
7656136|NCT00068692|12072101|FG003|Step 1: Registration|Registered but not randomized|0
7656137|NCT00068692|12072102|FG004|Step 1: Registration|Registered but not randomized|0
7656138|NCT00068692|12072103|FG005|Step 1: Registration|Registered but not randomized|0
7656139|NCT00068692|12072104|FG006|Step 1: Registration|Registered but not randomized|0
7656140|NCT00068692|12072105|FG007|Step 1: Registration|Registered but not randomized|0
7656141|NCT00068692|12072098|FG000|Step 2: Randomization|Disesae progression/replase|0
7656142|NCT00068692|12072099|FG001|Step 2: Randomization|Disesae progression/replase|0
7656143|NCT00068692|12072100|FG002|Step 2: Randomization|Disesae progression/replase|1
7656144|NCT00068692|12072101|FG003|Step 2: Randomization|Disesae progression/replase|1
7656145|NCT00068692|12072102|FG004|Step 2: Randomization|Disesae progression/replase|0
7656146|NCT00068692|12072103|FG005|Step 2: Randomization|Disesae progression/replase|0
7656147|NCT00068692|12072104|FG006|Step 2: Randomization|Disesae progression/replase|0
7656148|NCT00068692|12072105|FG007|Step 2: Randomization|Disesae progression/replase|0
7656149|NCT00068692|12072098|FG000|Step 2: Randomization|Adverse Event|0
7656150|NCT00068692|12072099|FG001|Step 2: Randomization|Adverse Event|0
7656151|NCT00068692|12072100|FG002|Step 2: Randomization|Adverse Event|4
7656152|NCT00068692|12072101|FG003|Step 2: Randomization|Adverse Event|2
7656153|NCT00068692|12072102|FG004|Step 2: Randomization|Adverse Event|2
7656154|NCT00068692|12072103|FG005|Step 2: Randomization|Adverse Event|3
7656155|NCT00068692|12072104|FG006|Step 2: Randomization|Adverse Event|4
7656156|NCT00068692|12072105|FG007|Step 2: Randomization|Adverse Event|4
7656157|NCT00068692|12072098|FG000|Step 2: Randomization|Death|0
7656158|NCT00068692|12072099|FG001|Step 2: Randomization|Death|0
7656159|NCT00068692|12072100|FG002|Step 2: Randomization|Death|0
7656160|NCT00068692|12072101|FG003|Step 2: Randomization|Death|0
7656161|NCT00068692|12072102|FG004|Step 2: Randomization|Death|1
7656162|NCT00068692|12072103|FG005|Step 2: Randomization|Death|0
7656163|NCT00068692|12072104|FG006|Step 2: Randomization|Death|0
7656164|NCT00068692|12072105|FG007|Step 2: Randomization|Death|1
7656165|NCT00068692|12072098|FG000|Step 2: Randomization|Withdrawal by Subject|0
7656166|NCT00068692|12072099|FG001|Step 2: Randomization|Withdrawal by Subject|0
7656167|NCT00068692|12072100|FG002|Step 2: Randomization|Withdrawal by Subject|4
7656168|NCT00068692|12072101|FG003|Step 2: Randomization|Withdrawal by Subject|6
7656169|NCT00068692|12072102|FG004|Step 2: Randomization|Withdrawal by Subject|3
7656170|NCT00068692|12072103|FG005|Step 2: Randomization|Withdrawal by Subject|2
7656171|NCT00068692|12072104|FG006|Step 2: Randomization|Withdrawal by Subject|0
7656172|NCT00068692|12072105|FG007|Step 2: Randomization|Withdrawal by Subject|3
7656173|NCT00068692|12072098|FG000|Step 2: Randomization|alternative therapy|0
7656174|NCT00068692|12072099|FG001|Step 2: Randomization|alternative therapy|0
7656175|NCT00068692|12072100|FG002|Step 2: Randomization|alternative therapy|0
7656176|NCT00068692|12072101|FG003|Step 2: Randomization|alternative therapy|1
7656177|NCT00068692|12072102|FG004|Step 2: Randomization|alternative therapy|1
7656178|NCT00068692|12072103|FG005|Step 2: Randomization|alternative therapy|0
7656179|NCT00068692|12072104|FG006|Step 2: Randomization|alternative therapy|0
7656180|NCT00068692|12072105|FG007|Step 2: Randomization|alternative therapy|0
7656181|NCT00068692|12072098|FG000|Step 2: Randomization|Physician Decision|0
7656182|NCT00068692|12072099|FG001|Step 2: Randomization|Physician Decision|0
7656183|NCT00068692|12072100|FG002|Step 2: Randomization|Physician Decision|0
7656184|NCT00068692|12072101|FG003|Step 2: Randomization|Physician Decision|1
7656185|NCT00068692|12072102|FG004|Step 2: Randomization|Physician Decision|1
7656186|NCT00068692|12072103|FG005|Step 2: Randomization|Physician Decision|0
7656187|NCT00068692|12072104|FG006|Step 2: Randomization|Physician Decision|0
7656188|NCT00068692|12072105|FG007|Step 2: Randomization|Physician Decision|0
7656189|NCT00068692|12072098|FG000|Step 2: Randomization|Other|0
7656190|NCT00068692|12072099|FG001|Step 2: Randomization|Other|0
7656191|NCT00068692|12072100|FG002|Step 2: Randomization|Other|0
7656192|NCT00068692|12072101|FG003|Step 2: Randomization|Other|1
7656193|NCT00068692|12072102|FG004|Step 2: Randomization|Other|0
7656194|NCT00068692|12072103|FG005|Step 2: Randomization|Other|1
7656195|NCT00068692|12072104|FG006|Step 2: Randomization|Other|0
7656196|NCT00068692|12072105|FG007|Step 2: Randomization|Other|0
7656197|NCT00068692|12072098|FG000|Step 2: Randomization|never start protocol therapy|0
7656198|NCT00068692|12072099|FG001|Step 2: Randomization|never start protocol therapy|0
7656199|NCT00068692|12072100|FG002|Step 2: Randomization|never start protocol therapy|1
7656200|NCT00068692|12072101|FG003|Step 2: Randomization|never start protocol therapy|0
7656201|NCT00068692|12072102|FG004|Step 2: Randomization|never start protocol therapy|1
7656202|NCT00068692|12072103|FG005|Step 2: Randomization|never start protocol therapy|0
7656203|NCT00068692|12072104|FG006|Step 2: Randomization|never start protocol therapy|0
7656204|NCT00068692|12072105|FG007|Step 2: Randomization|never start protocol therapy|0
7656205|NCT00068822|12072135|FG000|First Randomized Intervention|Lost to Follow-up|1
7656206|NCT00068822|12072136|FG001|First Randomized Intervention|Lost to Follow-up|2
7656207|NCT00069095|12072148|FG000|Primary Treatment Phase|Ongoing|0
7656208|NCT00069095|12072149|FG001|Primary Treatment Phase|Ongoing|0
7656209|NCT00069095|12072150|FG002|Primary Treatment Phase|Ongoing|5
7656210|NCT00069095|12072151|FG003|Primary Treatment Phase|Ongoing|7
7656211|NCT00069095|12072152|FG004|Primary Treatment Phase|Ongoing|7
7656212|NCT00069095|12072153|FG005|Primary Treatment Phase|Ongoing|4
7656213|NCT00069095|12072148|FG000|Primary Treatment Phase|Admin/Other|29
7656214|NCT00069095|12072149|FG001|Primary Treatment Phase|Admin/Other|38
7656215|NCT00069095|12072150|FG002|Primary Treatment Phase|Admin/Other|31
7656216|NCT00069095|12072151|FG003|Primary Treatment Phase|Admin/Other|45
7656217|NCT00069095|12072152|FG004|Primary Treatment Phase|Admin/Other|48
7656218|NCT00069095|12072153|FG005|Primary Treatment Phase|Admin/Other|42
7656219|NCT00069095|12072148|FG000|Primary Treatment Phase|Adverse Event|99
7656220|NCT00069095|12072149|FG001|Primary Treatment Phase|Adverse Event|92
7656221|NCT00069095|12072150|FG002|Primary Treatment Phase|Adverse Event|71
7656222|NCT00069095|12072151|FG003|Primary Treatment Phase|Adverse Event|72
7656223|NCT00069095|12072152|FG004|Primary Treatment Phase|Adverse Event|109
7656224|NCT00069095|12072153|FG005|Primary Treatment Phase|Adverse Event|101
7656225|NCT00069095|12072148|FG000|Primary Treatment Phase|Death|14
7656226|NCT00069095|12072149|FG001|Primary Treatment Phase|Death|8
7656227|NCT00069095|12072150|FG002|Primary Treatment Phase|Death|2
7656228|NCT00069095|12072151|FG003|Primary Treatment Phase|Death|5
7656229|NCT00069095|12072152|FG004|Primary Treatment Phase|Death|8
7656230|NCT00069095|12072153|FG005|Primary Treatment Phase|Death|8
7656231|NCT00069095|12072148|FG000|Primary Treatment Phase|Failure to return|5
7656232|NCT00069095|12072149|FG001|Primary Treatment Phase|Failure to return|5
7656233|NCT00069095|12072150|FG002|Primary Treatment Phase|Failure to return|0
7656234|NCT00069095|12072151|FG003|Primary Treatment Phase|Failure to return|0
7656235|NCT00069095|12072152|FG004|Primary Treatment Phase|Failure to return|0
7656236|NCT00069095|12072153|FG005|Primary Treatment Phase|Failure to return|2
7656237|NCT00069095|12072148|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131
7656238|NCT00069095|12072149|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127
7656239|NCT00069095|12072150|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175
7656240|NCT00069095|12072151|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154
7656241|NCT00069095|12072152|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101
7656242|NCT00069095|12072153|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102
7656243|NCT00069095|12072148|FG000|Primary Treatment Phase|Refused treatment|15
7656244|NCT00069095|12072149|FG001|Primary Treatment Phase|Refused treatment|26
7656245|NCT00069095|12072150|FG002|Primary Treatment Phase|Refused treatment|17
7656246|NCT00069095|12072151|FG003|Primary Treatment Phase|Refused treatment|31
7656247|NCT00069095|12072152|FG004|Primary Treatment Phase|Refused treatment|24
7656248|NCT00069095|12072153|FG005|Primary Treatment Phase|Refused treatment|27
7656249|NCT00069095|12072148|FG000|Primary Treatment Phase|Withdrew|2
7656250|NCT00069095|12072149|FG001|Primary Treatment Phase|Withdrew|3
7656251|NCT00069095|12072150|FG002|Primary Treatment Phase|Withdrew|8
7656252|NCT00069095|12072151|FG003|Primary Treatment Phase|Withdrew|2
7656253|NCT00069095|12072152|FG004|Primary Treatment Phase|Withdrew|4
7656254|NCT00069095|12072153|FG005|Primary Treatment Phase|Withdrew|9
7656255|NCT00069095|12072148|FG000|Primary Treatment Phase|Other Violation|0
7656256|NCT00069095|12072149|FG001|Primary Treatment Phase|Other Violation|1
7656257|NCT00069095|12072150|FG002|Primary Treatment Phase|Other Violation|1
7656258|NCT00069095|12072151|FG003|Primary Treatment Phase|Other Violation|1
7656259|NCT00069095|12072152|FG004|Primary Treatment Phase|Other Violation|0
7656260|NCT00069095|12072153|FG005|Primary Treatment Phase|Other Violation|1
7656261|NCT00069095|12072148|FG000|Primary Treatment Phase|Violation criteria|0
7656262|NCT00069095|12072149|FG001|Primary Treatment Phase|Violation criteria|2
7656263|NCT00069095|12072150|FG002|Primary Treatment Phase|Violation criteria|4
7656264|NCT00069095|12072151|FG003|Primary Treatment Phase|Violation criteria|3
7656265|NCT00069095|12072152|FG004|Primary Treatment Phase|Violation criteria|1
7656266|NCT00069095|12072153|FG005|Primary Treatment Phase|Violation criteria|5
7656267|NCT00069095|12072148|FG000|Post-study Treatment Phase|Missing reason|1
7656268|NCT00069095|12072149|FG001|Post-study Treatment Phase|Missing reason|3
7656269|NCT00069095|12072150|FG002|Post-study Treatment Phase|Missing reason|12
7656270|NCT00069095|12072151|FG003|Post-study Treatment Phase|Missing reason|8
7656271|NCT00069095|12072152|FG004|Post-study Treatment Phase|Missing reason|18
7656272|NCT00069095|12072153|FG005|Post-study Treatment Phase|Missing reason|17
7656273|NCT00069095|12072148|FG000|Post-study Treatment Phase|Adverse Event|2
7656274|NCT00069095|12072149|FG001|Post-study Treatment Phase|Adverse Event|3
7656275|NCT00069095|12072150|FG002|Post-study Treatment Phase|Adverse Event|1
7656276|NCT00069095|12072151|FG003|Post-study Treatment Phase|Adverse Event|0
7656277|NCT00069095|12072152|FG004|Post-study Treatment Phase|Adverse Event|5
7656278|NCT00069095|12072153|FG005|Post-study Treatment Phase|Adverse Event|1
7656279|NCT00069095|12072148|FG000|Post-study Treatment Phase|Eligible for surgery|2
7656280|NCT00069095|12072149|FG001|Post-study Treatment Phase|Eligible for surgery|0
7656281|NCT00069095|12072150|FG002|Post-study Treatment Phase|Eligible for surgery|0
7656282|NCT00069095|12072151|FG003|Post-study Treatment Phase|Eligible for surgery|0
7656283|NCT00069095|12072152|FG004|Post-study Treatment Phase|Eligible for surgery|0
7656284|NCT00069095|12072153|FG005|Post-study Treatment Phase|Eligible for surgery|0
7656285|NCT00069095|12072148|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1
7656286|NCT00069095|12072149|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4
7656287|NCT00069095|12072150|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5
7656288|NCT00069095|12072151|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6
7656289|NCT00069095|12072152|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7
7656290|NCT00069095|12072153|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9
7656291|NCT00069095|12072148|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1
7656292|NCT00069095|12072149|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0
7656293|NCT00069095|12072150|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0
7656294|NCT00069095|12072151|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0
7656295|NCT00069095|12072152|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0
7656449|NCT00070109|12072283|FG004|Overall Study|Adverse Event|2
7656296|NCT00069095|12072153|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1
7656297|NCT00069095|12072148|FG000|Post-study Treatment Phase|Participant had complete response|1
7656298|NCT00069095|12072149|FG001|Post-study Treatment Phase|Participant had complete response|1
7656299|NCT00069095|12072150|FG002|Post-study Treatment Phase|Participant had complete response|0
7656300|NCT00069095|12072151|FG003|Post-study Treatment Phase|Participant had complete response|0
7656301|NCT00069095|12072152|FG004|Post-study Treatment Phase|Participant had complete response|0
7656302|NCT00069095|12072153|FG005|Post-study Treatment Phase|Participant had complete response|0
7656303|NCT00069095|12072148|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0
7656304|NCT00069095|12072149|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1
7656305|NCT00069095|12072150|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0
7656306|NCT00069095|12072151|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0
7656307|NCT00069095|12072152|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0
7656308|NCT00069095|12072153|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0
7656309|NCT00069095|12072148|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0
7656310|NCT00069095|12072149|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1
7656311|NCT00069095|12072150|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1
7656312|NCT00069095|12072151|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0
7656313|NCT00069095|12072152|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1
7656314|NCT00069095|12072153|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0
7656315|NCT00069095|12072148|FG000|Post-study Treatment Phase|Participant withdrew consent|0
7656316|NCT00069095|12072149|FG001|Post-study Treatment Phase|Participant withdrew consent|0
7656317|NCT00069095|12072150|FG002|Post-study Treatment Phase|Participant withdrew consent|1
7656318|NCT00069095|12072151|FG003|Post-study Treatment Phase|Participant withdrew consent|0
7656319|NCT00069095|12072152|FG004|Post-study Treatment Phase|Participant withdrew consent|0
7656320|NCT00069095|12072153|FG005|Post-study Treatment Phase|Participant withdrew consent|0
7656321|NCT00069095|12072148|FG000|Post-study Treatment Phase|Participant will start new treatment|0
7656322|NCT00069095|12072149|FG001|Post-study Treatment Phase|Participant will start new treatment|0
7656323|NCT00069095|12072150|FG002|Post-study Treatment Phase|Participant will start new treatment|1
7656324|NCT00069095|12072151|FG003|Post-study Treatment Phase|Participant will start new treatment|0
7656325|NCT00069095|12072152|FG004|Post-study Treatment Phase|Participant will start new treatment|0
7656326|NCT00069095|12072153|FG005|Post-study Treatment Phase|Participant will start new treatment|0
7656327|NCT00069095|12072148|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0
7656328|NCT00069095|12072149|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0
7656329|NCT00069095|12072150|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0
7656330|NCT00069095|12072151|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1
7656331|NCT00069095|12072152|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0
7656332|NCT00069095|12072153|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0
7656333|NCT00069095|12072148|FG000|Post-study Treatment Phase|Participant completed treatment|0
7656334|NCT00069095|12072149|FG001|Post-study Treatment Phase|Participant completed treatment|0
7656335|NCT00069095|12072150|FG002|Post-study Treatment Phase|Participant completed treatment|0
7656336|NCT00069095|12072151|FG003|Post-study Treatment Phase|Participant completed treatment|1
7656337|NCT00069095|12072152|FG004|Post-study Treatment Phase|Participant completed treatment|0
7656338|NCT00069095|12072153|FG005|Post-study Treatment Phase|Participant completed treatment|0
7656339|NCT00069095|12072148|FG000|Post-study Treatment Phase|Surgery|0
7656340|NCT00069095|12072149|FG001|Post-study Treatment Phase|Surgery|0
7656341|NCT00069095|12072150|FG002|Post-study Treatment Phase|Surgery|0
7656342|NCT00069095|12072151|FG003|Post-study Treatment Phase|Surgery|1
7656343|NCT00069095|12072152|FG004|Post-study Treatment Phase|Surgery|1
7656344|NCT00069095|12072153|FG005|Post-study Treatment Phase|Surgery|0
7656345|NCT00069095|12072148|FG000|Post-study Treatment Phase|Death|0
7656346|NCT00069095|12072149|FG001|Post-study Treatment Phase|Death|0
7656347|NCT00069095|12072150|FG002|Post-study Treatment Phase|Death|0
7656348|NCT00069095|12072151|FG003|Post-study Treatment Phase|Death|0
7656349|NCT00069095|12072152|FG004|Post-study Treatment Phase|Death|1
7656350|NCT00069095|12072153|FG005|Post-study Treatment Phase|Death|0
7656351|NCT00069095|12072148|FG000|Post-study Treatment Phase|Participant had progressive disease|0
7656352|NCT00069095|12072149|FG001|Post-study Treatment Phase|Participant had progressive disease|0
7656353|NCT00069095|12072150|FG002|Post-study Treatment Phase|Participant had progressive disease|0
7656354|NCT00069095|12072151|FG003|Post-study Treatment Phase|Participant had progressive disease|0
7656355|NCT00069095|12072152|FG004|Post-study Treatment Phase|Participant had progressive disease|1
7656356|NCT00069095|12072153|FG005|Post-study Treatment Phase|Participant had progressive disease|0
7656357|NCT00069095|12072148|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0
7656358|NCT00069095|12072149|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0
7656359|NCT00069095|12072150|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0
7656360|NCT00069095|12072151|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0
7656361|NCT00069095|12072152|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1
7656362|NCT00069095|12072153|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0
7656363|NCT00069095|12072148|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
7656364|NCT00069095|12072149|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
7656365|NCT00069095|12072150|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
7656366|NCT00069095|12072151|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
7656367|NCT00069095|12072152|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
7656368|NCT00069095|12072153|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
7656369|NCT00069095|12072148|FG000|Post-study Treatment Phase|Investigator decision|0
7656370|NCT00069095|12072149|FG001|Post-study Treatment Phase|Investigator decision|0
7656371|NCT00069095|12072150|FG002|Post-study Treatment Phase|Investigator decision|0
7656372|NCT00069095|12072151|FG003|Post-study Treatment Phase|Investigator decision|0
7656373|NCT00069095|12072152|FG004|Post-study Treatment Phase|Investigator decision|0
7656374|NCT00069095|12072153|FG005|Post-study Treatment Phase|Investigator decision|1
7656375|NCT00069095|12072148|FG000|Follow-up Phase|Death|174
7656376|NCT00069095|12072149|FG001|Follow-up Phase|Death|206
7656377|NCT00069095|12072150|FG002|Follow-up Phase|Death|120
7656378|NCT00069095|12072151|FG003|Follow-up Phase|Death|112
7656379|NCT00069095|12072152|FG004|Follow-up Phase|Death|92
7656380|NCT00069095|12072153|FG005|Follow-up Phase|Death|101
7656381|NCT00069108|12072167|FG000|Overall Study|Withdrawal by Subject|5
7656382|NCT00069108|12072168|FG001|Overall Study|Withdrawal by Subject|9
7656383|NCT00069108|12072167|FG000|Overall Study|Adverse Event|64
7656384|NCT00069108|12072168|FG001|Overall Study|Adverse Event|42
7656385|NCT00069108|12072167|FG000|Overall Study|Death|6
7656386|NCT00069108|12072168|FG001|Overall Study|Death|6
7656387|NCT00069108|12072167|FG000|Overall Study|Administration|15
7656388|NCT00069108|12072168|FG001|Overall Study|Administration|4
7656389|NCT00069108|12072167|FG000|Overall Study|Insufficient therapy|117
7656390|NCT00069108|12072168|FG001|Overall Study|Insufficient therapy|144
7656391|NCT00069108|12072167|FG000|Overall Study|Violation criteria|1
7656392|NCT00069108|12072168|FG001|Overall Study|Violation criteria|4
7656393|NCT00069108|12072167|FG000|Overall Study|Refused treatment|5
7656394|NCT00069108|12072168|FG001|Overall Study|Refused treatment|10
7656395|NCT00069121|12072177|FG000|Overall Study|Death|286
7656396|NCT00069121|12072178|FG001|Overall Study|Death|242
7656397|NCT00069121|12072177|FG000|Overall Study|Withdrawal by Subject|18
7656398|NCT00069121|12072178|FG001|Overall Study|Withdrawal by Subject|20
7656399|NCT00069121|12072177|FG000|Overall Study|Lost to Follow-up|63
7656400|NCT00069121|12072178|FG001|Overall Study|Lost to Follow-up|63
7656401|NCT00069264|12072200|FG000|Overall Study|Adverse Event|3
7656402|NCT00069264|12072200|FG000|Overall Study|Progressive Disease|23
7656403|NCT00069264|12072200|FG000|Overall Study|Withdrawal by Subject|3
7656404|NCT00069264|12072200|FG000|Overall Study|Discon Therapy|3
7656405|NCT00069277|12072204|FG000|Overall Study|Adverse Event|3
7656406|NCT00069277|12072204|FG000|Overall Study|Withdrawal by Subject|1
7656407|NCT00069277|12072204|FG000|Overall Study|Progressive Disease|15
7656408|NCT00069277|12072204|FG000|Overall Study|Physician Decision|2
7656409|NCT00069576|12072214|FG000|Original Trial|Lost to Follow-up|25
7656410|NCT00069576|12072215|FG001|Original Trial|Lost to Follow-up|33
7656411|NCT00069576|12072214|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196
7656412|NCT00069576|12072215|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204
7656413|NCT00069641|12072224|FG000|Overall Study|Death|1
7656414|NCT00069641|12072225|FG001|Overall Study|Death|0
7656415|NCT00069641|12072226|FG002|Overall Study|Death|1
7656416|NCT00069784|12072237|FG000|Overall Study|Adverse Event|105
7656417|NCT00069784|12072238|FG001|Overall Study|Adverse Event|0
7656418|NCT00069784|12072237|FG000|Overall Study|Withdrawal by Subject|1090
7656419|NCT00069784|12072238|FG001|Overall Study|Withdrawal by Subject|0
7656420|NCT00069784|12072237|FG000|Overall Study|Other|17
7656421|NCT00069784|12072238|FG001|Overall Study|Other|0
7656422|NCT00069823|12072246|FG000|Overall Study|Did not have follow-up diary cards|6
7656423|NCT00069823|12072247|FG001|Overall Study|Did not have follow-up diary cards|3
7656424|NCT00069953|12072253|FG000|Overall Study|Protocol Violation|2
7656425|NCT00070109|12072279|FG000|Overall Study|Death|1
7656426|NCT00070109|12072280|FG001|Overall Study|Death|1
7656427|NCT00070109|12072281|FG002|Overall Study|Death|0
7656428|NCT00070109|12072282|FG003|Overall Study|Death|0
7656429|NCT00070109|12072283|FG004|Overall Study|Death|1
7656430|NCT00070109|12072279|FG000|Overall Study|Lack of Efficacy|6
7656431|NCT00070109|12072280|FG001|Overall Study|Lack of Efficacy|4
7656432|NCT00070109|12072281|FG002|Overall Study|Lack of Efficacy|5
7656433|NCT00070109|12072282|FG003|Overall Study|Lack of Efficacy|15
7656434|NCT00070109|12072283|FG004|Overall Study|Lack of Efficacy|5
7656435|NCT00070109|12072279|FG000|Overall Study|Physician Decision|1
7656436|NCT00070109|12072280|FG001|Overall Study|Physician Decision|0
7656437|NCT00070109|12072281|FG002|Overall Study|Physician Decision|0
7656438|NCT00070109|12072282|FG003|Overall Study|Physician Decision|0
7656439|NCT00070109|12072283|FG004|Overall Study|Physician Decision|0
7656440|NCT00070109|12072279|FG000|Overall Study|Withdrawal by Subject|0
7656441|NCT00070109|12072280|FG001|Overall Study|Withdrawal by Subject|1
7656442|NCT00070109|12072281|FG002|Overall Study|Withdrawal by Subject|1
7656443|NCT00070109|12072282|FG003|Overall Study|Withdrawal by Subject|0
7656444|NCT00070109|12072283|FG004|Overall Study|Withdrawal by Subject|0
7656445|NCT00070109|12072279|FG000|Overall Study|Adverse Event|0
7656446|NCT00070109|12072280|FG001|Overall Study|Adverse Event|0
7656447|NCT00070109|12072281|FG002|Overall Study|Adverse Event|2
7656448|NCT00070109|12072282|FG003|Overall Study|Adverse Event|4
7656450|NCT00070109|12072279|FG000|Overall Study|removed from prot thpy prior to chemo|0
7656451|NCT00070109|12072280|FG001|Overall Study|removed from prot thpy prior to chemo|0
7656452|NCT00070109|12072281|FG002|Overall Study|removed from prot thpy prior to chemo|0
7656453|NCT00070109|12072282|FG003|Overall Study|removed from prot thpy prior to chemo|1
7656454|NCT00070109|12072283|FG004|Overall Study|removed from prot thpy prior to chemo|0
7656455|NCT00070291|12072306|FG000|Step 1|Withdrawal by Subject|1
7656456|NCT00070291|12072306|FG000|Step 1|Adverse Event|1
7656457|NCT00070291|12072306|FG000|Step 2|Adverse Event|1
7656458|NCT00070317|12072310|FG000|Overall Study|Inevaluable (Never Treated)|1
7656459|NCT00070317|12072310|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3
7656460|NCT00070317|12072310|FG000|Overall Study|Ineligible required test not done|1
7656461|NCT00070317|12072310|FG000|Overall Study|Ineligible-Improper prior treatment|2
7656462|NCT00070317|12072310|FG000|Overall Study|Ineligible-Inadequate pathology|6
7656463|NCT00070941|12072317|FG000|Overall Study|Adverse Event|10
7656464|NCT00070941|12072318|FG001|Overall Study|Adverse Event|8
7656465|NCT00070941|12072319|FG002|Overall Study|Adverse Event|4
7656466|NCT00071006|12072327|FG000|Overall Study|Lack of Efficacy|7
7656467|NCT00071006|12072327|FG000|Overall Study|Adverse Event|1
7656468|NCT00071006|12072327|FG000|Overall Study|Withdrawal by Subject|1
7656469|NCT00071006|12072327|FG000|Overall Study|Other|3
7656470|NCT00071032|12072333|FG000|Overall Study|Lost to Follow-up|1
7656471|NCT00071032|12072334|FG001|Overall Study|Lost to Follow-up|1
7656472|NCT00071032|12072333|FG000|Overall Study|Withdrawal by Subject|8
7656473|NCT00071032|12072334|FG001|Overall Study|Withdrawal by Subject|6
7656474|NCT00071032|12072333|FG000|Overall Study|Missing Primary Outcome|0
7656475|NCT00071032|12072334|FG001|Overall Study|Missing Primary Outcome|1
7656476|NCT00071058|12072341|FG000|Overall Study|brain tumor-removed from study|1
7656477|NCT00071110|12072348|FG000|Overall Study|Protocol Violation|0
7656478|NCT00071110|12072349|FG001|Overall Study|Protocol Violation|4
7656479|NCT00071396|12072355|FG000|Overall Study|Withdrawal by Subject|1
7656480|NCT00071396|12072355|FG000|Overall Study|Physician Decision|2
7656481|NCT00071487|12072363|FG000|52-Week Double-Blind Period|Adverse Event|5
7656482|NCT00071487|12072364|FG001|52-Week Double-Blind Period|Adverse Event|8
7656483|NCT00071487|12072365|FG002|52-Week Double-Blind Period|Adverse Event|4
7656484|NCT00071487|12072366|FG003|52-Week Double-Blind Period|Adverse Event|8
7656485|NCT00071487|12072363|FG000|52-Week Double-Blind Period|Lack of Efficacy|1
7656486|NCT00071487|12072364|FG001|52-Week Double-Blind Period|Lack of Efficacy|2
7656487|NCT00071487|12072365|FG002|52-Week Double-Blind Period|Lack of Efficacy|0
7656488|NCT00071487|12072366|FG003|52-Week Double-Blind Period|Lack of Efficacy|1
7656489|NCT00071487|12072363|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7
7656490|NCT00071487|12072364|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11
7656491|NCT00071487|12072365|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7
7656492|NCT00071487|12072366|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7
7656493|NCT00071487|12072363|FG000|52-Week Double-Blind Period|Physician Decision|1
7656494|NCT00071487|12072364|FG001|52-Week Double-Blind Period|Physician Decision|0
7656495|NCT00071487|12072365|FG002|52-Week Double-Blind Period|Physician Decision|0
7656496|NCT00071487|12072366|FG003|52-Week Double-Blind Period|Physician Decision|0
7656497|NCT00071487|12072363|FG000|52-Week Double-Blind Period|Lost to Follow-up|0
7656498|NCT00071487|12072364|FG001|52-Week Double-Blind Period|Lost to Follow-up|0
7656499|NCT00071487|12072365|FG002|52-Week Double-Blind Period|Lost to Follow-up|2
7656500|NCT00071487|12072366|FG003|52-Week Double-Blind Period|Lost to Follow-up|2
7656501|NCT00071487|12072363|FG000|52-Week Double-Blind Period|Pregnancy|0
7656502|NCT00071487|12072364|FG001|52-Week Double-Blind Period|Pregnancy|1
7656503|NCT00071487|12072365|FG002|52-Week Double-Blind Period|Pregnancy|0
7656504|NCT00071487|12072366|FG003|52-Week Double-Blind Period|Pregnancy|0
7656505|NCT00071487|12072363|FG000|52-Week Double-Blind Period|Protocol Violation|0
7656506|NCT00071487|12072364|FG001|52-Week Double-Blind Period|Protocol Violation|1
7656507|NCT00071487|12072365|FG002|52-Week Double-Blind Period|Protocol Violation|1
7656508|NCT00071487|12072366|FG003|52-Week Double-Blind Period|Protocol Violation|0
7656509|NCT00071487|12072363|FG000|52-Week Double-Blind Period|Death|0
7656510|NCT00071487|12072364|FG001|52-Week Double-Blind Period|Death|1
7656511|NCT00071487|12072365|FG002|52-Week Double-Blind Period|Death|0
7656512|NCT00071487|12072366|FG003|52-Week Double-Blind Period|Death|0
7656513|NCT00071487|12072363|FG000|52-Week Double-Blind Period|Lack of Compliance|6
7656514|NCT00071487|12072364|FG001|52-Week Double-Blind Period|Lack of Compliance|3
7656515|NCT00071487|12072365|FG002|52-Week Double-Blind Period|Lack of Compliance|3
7656516|NCT00071487|12072366|FG003|52-Week Double-Blind Period|Lack of Compliance|3
7656517|NCT00071487|12072363|FG000|24-Week Open-Label Extension Period|Adverse Event|0
7656518|NCT00071487|12072364|FG001|24-Week Open-Label Extension Period|Adverse Event|0
7656519|NCT00071487|12072365|FG002|24-Week Open-Label Extension Period|Adverse Event|1
7656520|NCT00071487|12072366|FG003|24-Week Open-Label Extension Period|Adverse Event|6
7656521|NCT00071487|12072363|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0
7656522|NCT00071487|12072364|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0
7656523|NCT00071487|12072365|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0
7656524|NCT00071487|12072366|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3
7656525|NCT00071487|12072363|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7656526|NCT00071487|12072364|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7656527|NCT00071487|12072365|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7656528|NCT00071487|12072366|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9
7656529|NCT00071487|12072363|FG000|24-Week Open-Label Extension Period|Pregnancy|0
7656530|NCT00071487|12072364|FG001|24-Week Open-Label Extension Period|Pregnancy|0
7656531|NCT00071487|12072365|FG002|24-Week Open-Label Extension Period|Pregnancy|0
7656532|NCT00071487|12072366|FG003|24-Week Open-Label Extension Period|Pregnancy|1
7656533|NCT00071487|12072363|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0
7656534|NCT00071487|12072364|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0
7656535|NCT00071487|12072365|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0
7656536|NCT00071487|12072366|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2
7656537|NCT00071487|12072363|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0
7656538|NCT00071487|12072364|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0
7656539|NCT00071487|12072365|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0
7656540|NCT00071487|12072366|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2
7656541|NCT00071513|12072380|FG000|Intervention Component|Withdrawal by Subject|2
7656542|NCT00071513|12072381|FG001|Intervention Component|Withdrawal by Subject|3
7656543|NCT00071513|12072380|FG000|Follow-up Assessment|Withdrawal by Subject|6
7656544|NCT00071513|12072381|FG001|Follow-up Assessment|Withdrawal by Subject|6
7656545|NCT00071760|12072398|FG000|Overall Study|Adverse Event|3
7656546|NCT00071760|12072398|FG000|Overall Study|Lost to Follow-up|4
7656547|NCT00071760|12072398|FG000|Overall Study|Protocol Violation|1
7656548|NCT00071760|12072398|FG000|Overall Study|Withdrawal by Subject|3
7656549|NCT00071760|12072398|FG000|Overall Study|Insufficient Viral Load Response|3
7656550|NCT00071760|12072398|FG000|Overall Study|Pulmonary Tuberculosis|1
7656551|NCT00071760|12072398|FG000|Overall Study|Unavailability of RTV|8
7656552|NCT00071760|12072398|FG000|Overall Study|Relocation|1
7656553|NCT00071760|12072398|FG000|Overall Study|Investigator's Recommendation (Rec.)|4
7656554|NCT00071760|12072398|FG000|Overall Study|Study Team Rec./Resistance|1
7656555|NCT00071760|12072398|FG000|Overall Study|Ongoing|25
7656556|NCT00071799|12072410|FG000|Overall Study|Adverse Event|19
7656557|NCT00071799|12072411|FG001|Overall Study|Adverse Event|10
7656558|NCT00071799|12072410|FG000|Overall Study|Protocol Violation|1
7656559|NCT00071799|12072411|FG001|Overall Study|Protocol Violation|7
7656560|NCT00071799|12072410|FG000|Overall Study|Lost to Follow-up|1
7656561|NCT00071799|12072411|FG001|Overall Study|Lost to Follow-up|1
7656562|NCT00071799|12072410|FG000|Overall Study|Withdrawal by Subject|15
7656563|NCT00071799|12072411|FG001|Overall Study|Withdrawal by Subject|37
7656564|NCT00071799|12072410|FG000|Overall Study|Physician Decision|0
7656565|NCT00071799|12072411|FG001|Overall Study|Physician Decision|2
7656566|NCT00071799|12072410|FG000|Overall Study|Lack of Efficacy|11
7656567|NCT00071799|12072411|FG001|Overall Study|Lack of Efficacy|18
7656568|NCT00071799|12072410|FG000|Overall Study|Disease Progression|23
7656569|NCT00071799|12072411|FG001|Overall Study|Disease Progression|20
7656570|NCT00071799|12072410|FG000|Overall Study|Different Central+Local Pathology Review|0
7656571|NCT00071799|12072411|FG001|Overall Study|Different Central+Local Pathology Review|1
7656572|NCT00071799|12072410|FG000|Overall Study|Not Documented|0
7656573|NCT00071799|12072411|FG001|Overall Study|Not Documented|2
7656574|NCT00071812|12072427|FG000|24-Week Double-Blind Period|Adverse Event|2
7656575|NCT00071812|12072428|FG001|24-Week Double-Blind Period|Adverse Event|3
7656576|NCT00071812|12072429|FG002|24-Week Double-Blind Period|Adverse Event|4
7656577|NCT00071812|12072430|FG003|24-Week Double-Blind Period|Adverse Event|4
7656578|NCT00071812|12072427|FG000|24-Week Double-Blind Period|Lack of Efficacy|3
7656579|NCT00071812|12072428|FG001|24-Week Double-Blind Period|Lack of Efficacy|1
7656580|NCT00071812|12072429|FG002|24-Week Double-Blind Period|Lack of Efficacy|2
7656581|NCT00071812|12072430|FG003|24-Week Double-Blind Period|Lack of Efficacy|1
7656582|NCT00071812|12072427|FG000|24-Week Double-Blind Period|Lost to Follow-up|0
7656583|NCT00071812|12072428|FG001|24-Week Double-Blind Period|Lost to Follow-up|1
7656584|NCT00071812|12072429|FG002|24-Week Double-Blind Period|Lost to Follow-up|1
7656585|NCT00071812|12072430|FG003|24-Week Double-Blind Period|Lost to Follow-up|0
7656586|NCT00071812|12072427|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5
7656587|NCT00071812|12072428|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1
7656588|NCT00071812|12072429|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1
7656589|NCT00071812|12072430|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5
7656590|NCT00071812|12072427|FG000|24-Week Double-Blind Period|Protocol Violation|0
7656591|NCT00071812|12072428|FG001|24-Week Double-Blind Period|Protocol Violation|0
7656592|NCT00071812|12072429|FG002|24-Week Double-Blind Period|Protocol Violation|0
7656593|NCT00071812|12072430|FG003|24-Week Double-Blind Period|Protocol Violation|1
7656594|NCT00071812|12072427|FG000|24-Week Open-Label Extension Period|Adverse Event|0
7656595|NCT00071812|12072428|FG001|24-Week Open-Label Extension Period|Adverse Event|0
7656596|NCT00071812|12072429|FG002|24-Week Open-Label Extension Period|Adverse Event|0
7656597|NCT00071812|12072430|FG003|24-Week Open-Label Extension Period|Adverse Event|7
7656598|NCT00071812|12072427|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0
7656599|NCT00071812|12072428|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0
7656600|NCT00071812|12072429|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0
7656601|NCT00071812|12072430|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17
7656602|NCT00071812|12072427|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0
7656603|NCT00071812|12072428|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0
7656604|NCT00071812|12072429|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0
7656757|NCT00073749|12072595|FG002|Overall Study|Death|1
7656605|NCT00071812|12072430|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2
7656606|NCT00071812|12072427|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7656607|NCT00071812|12072428|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7656608|NCT00071812|12072429|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7656609|NCT00071812|12072430|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12
7656610|NCT00071812|12072427|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0
7656611|NCT00071812|12072428|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0
7656612|NCT00071812|12072429|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1
7656613|NCT00071812|12072430|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2
7656614|NCT00071981|12072455|FG000|Overall Study|Lack of Efficacy|37
7656615|NCT00071981|12072456|FG001|Overall Study|Lack of Efficacy|29
7656616|NCT00071981|12072457|FG002|Overall Study|Lack of Efficacy|30
7656617|NCT00071981|12072458|FG003|Overall Study|Lack of Efficacy|43
7656618|NCT00071981|12072455|FG000|Overall Study|Adverse Event|4
7656619|NCT00071981|12072456|FG001|Overall Study|Adverse Event|4
7656620|NCT00071981|12072457|FG002|Overall Study|Adverse Event|3
7656621|NCT00071981|12072458|FG003|Overall Study|Adverse Event|1
7656622|NCT00071981|12072455|FG000|Overall Study|Death|0
7656623|NCT00071981|12072456|FG001|Overall Study|Death|0
7656624|NCT00071981|12072457|FG002|Overall Study|Death|1
7656625|NCT00071981|12072458|FG003|Overall Study|Death|1
7656626|NCT00071981|12072455|FG000|Overall Study|Withdrawal by Subject|3
7656627|NCT00071981|12072456|FG001|Overall Study|Withdrawal by Subject|1
7656628|NCT00071981|12072457|FG002|Overall Study|Withdrawal by Subject|0
7656629|NCT00071981|12072458|FG003|Overall Study|Withdrawal by Subject|0
7656630|NCT00071981|12072455|FG000|Overall Study|No protocol therapy|2
7656631|NCT00071981|12072456|FG001|Overall Study|No protocol therapy|5
7656632|NCT00071981|12072457|FG002|Overall Study|No protocol therapy|1
7656633|NCT00071981|12072458|FG003|Overall Study|No protocol therapy|0
7656634|NCT00071981|12072455|FG000|Overall Study|others (not specified in the study)|0
7656635|NCT00071981|12072456|FG001|Overall Study|others (not specified in the study)|2
7656636|NCT00071981|12072457|FG002|Overall Study|others (not specified in the study)|2
7656637|NCT00071981|12072458|FG003|Overall Study|others (not specified in the study)|0
7656638|NCT00072176|12072470|FG000|Overall Study|Withdrawal by Subject|1
7656639|NCT00072176|12072471|FG001|Overall Study|Withdrawal by Subject|0
7656640|NCT00072176|12072470|FG000|Overall Study|Protocol Violation|0
7656641|NCT00072176|12072471|FG001|Overall Study|Protocol Violation|1
7656642|NCT00072189|12072477|FG000|Overall Study|Withdrawal by Subject|1
7656643|NCT00072280|12072483|FG000|Treatment|Found ineligible|1
7656644|NCT00072280|12072484|FG001|Treatment|Found ineligible|2
7656645|NCT00072280|12072483|FG000|Follow-up|Early termination of study|2
7656646|NCT00072280|12072484|FG001|Follow-up|Early termination of study|2
7656647|NCT00072293|12072491|FG000|Overall Study|Lost to Follow-up|1
7656648|NCT00072293|12072492|FG001|Overall Study|Lost to Follow-up|1
7656649|NCT00072293|12072491|FG000|Overall Study|Withdrawal by Subject|0
7656650|NCT00072293|12072492|FG001|Overall Study|Withdrawal by Subject|1
7656651|NCT00072384|12072498|FG000|Overall Study|Physician Decision|1
7656652|NCT00072384|12072498|FG000|Overall Study|Ineligible|8
7656653|NCT00072475|12072508|FG000|Overall Study|Adverse Event|44
7656654|NCT00072475|12072508|FG000|Overall Study|Death|3
7656655|NCT00072475|12072508|FG000|Overall Study|Withdrawal by Subject|46
7656656|NCT00072475|12072508|FG000|Overall Study|Patient/Investigator Decision|4
7656657|NCT00073008|12072531|FG000|Overall Study|Missing|6
7656658|NCT00073008|12072532|FG001|Overall Study|Missing|6
7656659|NCT00073008|12072531|FG000|Overall Study|Withdrawal by Subject|2
7656660|NCT00073008|12072532|FG001|Overall Study|Withdrawal by Subject|2
7656661|NCT00073008|12072531|FG000|Overall Study|Lost to Follow-up|1
7656662|NCT00073008|12072532|FG001|Overall Study|Lost to Follow-up|3
7656663|NCT00073008|12072531|FG000|Overall Study|Death|46
7656664|NCT00073008|12072532|FG001|Overall Study|Death|47
7656665|NCT00073008|12072531|FG000|Overall Study|"Other selected on Case Report Form"|7
7656666|NCT00073008|12072532|FG001|Overall Study|"Other selected on Case Report Form"|5
7656667|NCT00073021|12072540|FG000|Overall Study|Protocol Violation|2
7656668|NCT00073021|12072541|FG001|Overall Study|Protocol Violation|1
7656669|NCT00073021|12072540|FG000|Overall Study|Adverse Event|4
7656670|NCT00073021|12072541|FG001|Overall Study|Adverse Event|4
7656671|NCT00073021|12072540|FG000|Overall Study|Withdrawal by Subject|6
7656672|NCT00073021|12072541|FG001|Overall Study|Withdrawal by Subject|5
7656673|NCT00073021|12072540|FG000|Overall Study|Physician Decision|3
7656674|NCT00073021|12072541|FG001|Overall Study|Physician Decision|1
7656675|NCT00073021|12072540|FG000|Overall Study|Lack of Efficacy|11
7656676|NCT00073021|12072541|FG001|Overall Study|Lack of Efficacy|5
7656677|NCT00073307|12072553|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
7656678|NCT00073307|12072554|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
7656679|NCT00073307|12072555|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
7656680|NCT00073307|12072553|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
7656681|NCT00073307|12072554|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
7656682|NCT00073307|12072555|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
7656683|NCT00073307|12072553|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
7656684|NCT00073307|12072554|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
7656685|NCT00073307|12072555|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
7656686|NCT00073307|12072553|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
7656687|NCT00073307|12072554|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
7656688|NCT00073307|12072555|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
7656689|NCT00073307|12072553|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
7656690|NCT00073307|12072554|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
7656691|NCT00073307|12072555|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
7656692|NCT00073307|12072553|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
7656693|NCT00073307|12072554|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
7656694|NCT00073307|12072555|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
7656695|NCT00073307|12072553|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
7656696|NCT00073307|12072554|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
7656697|NCT00073307|12072555|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
7656698|NCT00073307|12072553|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
7656699|NCT00073307|12072554|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
7656700|NCT00073307|12072555|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
7656701|NCT00073307|12072553|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
7656702|NCT00073307|12072554|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
7656703|NCT00073307|12072555|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
7656704|NCT00073307|12072553|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
7656705|NCT00073307|12072554|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
7656706|NCT00073307|12072555|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
7656707|NCT00073307|12072553|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
7656708|NCT00073307|12072554|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
7656709|NCT00073307|12072555|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
7656710|NCT00073307|12072553|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
7656711|NCT00073307|12072554|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
7656712|NCT00073307|12072555|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
7656713|NCT00073307|12072553|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
7656714|NCT00073307|12072554|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
7656715|NCT00073307|12072555|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
7656716|NCT00073307|12072553|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
7656717|NCT00073307|12072554|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
7656718|NCT00073307|12072555|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
7656719|NCT00073307|12072553|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
7656720|NCT00073307|12072554|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
7656721|NCT00073307|12072555|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
7656722|NCT00073307|12072553|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
7656723|NCT00073307|12072554|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
7656724|NCT00073307|12072555|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
7656725|NCT00073307|12072553|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3
7656726|NCT00073307|12072554|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0
7656727|NCT00073307|12072555|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1
7656728|NCT00073307|12072553|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
7656729|NCT00073307|12072554|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
7656730|NCT00073307|12072555|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
7656731|NCT00073307|12072553|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
7656732|NCT00073307|12072554|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
7656733|NCT00073307|12072555|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
7656734|NCT00073528|12072579|FG000|Overall Study|Death|488
7656735|NCT00073528|12072580|FG001|Overall Study|Death|473
7656736|NCT00073528|12072579|FG000|Overall Study|Lost to Follow-up|52
7656737|NCT00073528|12072580|FG001|Overall Study|Lost to Follow-up|45
7656738|NCT00073528|12072579|FG000|Overall Study|Withdrawal by Subject|50
7656739|NCT00073528|12072580|FG001|Overall Study|Withdrawal by Subject|45
7656740|NCT00073528|12072579|FG000|Overall Study|Study terminated by Sponsor|10
7656741|NCT00073528|12072580|FG001|Overall Study|Study terminated by Sponsor|29
7656742|NCT00073528|12072579|FG000|Overall Study|Other|18
7656743|NCT00073528|12072580|FG001|Overall Study|Other|19
7656744|NCT00073528|12072579|FG000|Overall Study|Other|9
7656745|NCT00073528|12072580|FG001|Overall Study|Other|12
7656746|NCT00073528|12072579|FG000|Overall Study|Protocol Violation|3
7656747|NCT00073528|12072580|FG001|Overall Study|Protocol Violation|5
7656748|NCT00073749|12072593|FG000|Overall Study|Disease Progression|2
7656749|NCT00073749|12072594|FG001|Overall Study|Disease Progression|0
7656750|NCT00073749|12072595|FG002|Overall Study|Disease Progression|3
7656751|NCT00073749|12072596|FG003|Overall Study|Disease Progression|2
7656752|NCT00073749|12072597|FG004|Overall Study|Disease Progression|3
7656753|NCT00073749|12072598|FG005|Overall Study|Disease Progression|1
7656754|NCT00073749|12072599|FG006|Overall Study|Disease Progression|3
7656755|NCT00073749|12072593|FG000|Overall Study|Death|0
7656756|NCT00073749|12072594|FG001|Overall Study|Death|1
7656758|NCT00073749|12072596|FG003|Overall Study|Death|0
7656759|NCT00073749|12072597|FG004|Overall Study|Death|0
7656760|NCT00073749|12072598|FG005|Overall Study|Death|0
7656761|NCT00073749|12072599|FG006|Overall Study|Death|29
7656762|NCT00073749|12072593|FG000|Overall Study|Adverse Event|0
7656763|NCT00073749|12072594|FG001|Overall Study|Adverse Event|3
7656764|NCT00073749|12072595|FG002|Overall Study|Adverse Event|6
7656765|NCT00073749|12072596|FG003|Overall Study|Adverse Event|4
7656766|NCT00073749|12072597|FG004|Overall Study|Adverse Event|2
7656767|NCT00073749|12072598|FG005|Overall Study|Adverse Event|1
7656768|NCT00073749|12072599|FG006|Overall Study|Adverse Event|0
7656769|NCT00073749|12072593|FG000|Overall Study|Physician Decision|0
7656770|NCT00073749|12072594|FG001|Overall Study|Physician Decision|0
7656771|NCT00073749|12072595|FG002|Overall Study|Physician Decision|1
7656772|NCT00073749|12072596|FG003|Overall Study|Physician Decision|0
7656773|NCT00073749|12072597|FG004|Overall Study|Physician Decision|0
7656774|NCT00073749|12072598|FG005|Overall Study|Physician Decision|2
7656775|NCT00073749|12072599|FG006|Overall Study|Physician Decision|0
7656776|NCT00073749|12072593|FG000|Overall Study|Withdrawal by Subject|0
7656777|NCT00073749|12072594|FG001|Overall Study|Withdrawal by Subject|1
7656778|NCT00073749|12072595|FG002|Overall Study|Withdrawal by Subject|0
7656779|NCT00073749|12072596|FG003|Overall Study|Withdrawal by Subject|0
7656780|NCT00073749|12072597|FG004|Overall Study|Withdrawal by Subject|1
7656781|NCT00073749|12072598|FG005|Overall Study|Withdrawal by Subject|0
7656782|NCT00073749|12072599|FG006|Overall Study|Withdrawal by Subject|2
7656783|NCT00073749|12072593|FG000|Overall Study|Discontinuation of Study by Sponsor|0
7656784|NCT00073749|12072594|FG001|Overall Study|Discontinuation of Study by Sponsor|0
7656785|NCT00073749|12072595|FG002|Overall Study|Discontinuation of Study by Sponsor|0
7656786|NCT00073749|12072596|FG003|Overall Study|Discontinuation of Study by Sponsor|0
7656787|NCT00073749|12072597|FG004|Overall Study|Discontinuation of Study by Sponsor|0
7656788|NCT00073749|12072598|FG005|Overall Study|Discontinuation of Study by Sponsor|0
7656789|NCT00073749|12072599|FG006|Overall Study|Discontinuation of Study by Sponsor|4
7656790|NCT00073749|12072593|FG000|Overall Study|Lost to Follow-up|0
7656791|NCT00073749|12072594|FG001|Overall Study|Lost to Follow-up|0
7656792|NCT00073749|12072595|FG002|Overall Study|Lost to Follow-up|0
7656793|NCT00073749|12072596|FG003|Overall Study|Lost to Follow-up|0
7656794|NCT00073749|12072597|FG004|Overall Study|Lost to Follow-up|0
7656795|NCT00073749|12072598|FG005|Overall Study|Lost to Follow-up|0
7656796|NCT00073749|12072599|FG006|Overall Study|Lost to Follow-up|2
7656797|NCT00073749|12072593|FG000|Overall Study|Other|0
7656798|NCT00073749|12072594|FG001|Overall Study|Other|0
7656799|NCT00073749|12072595|FG002|Overall Study|Other|0
7656800|NCT00073749|12072596|FG003|Overall Study|Other|0
7656801|NCT00073749|12072597|FG004|Overall Study|Other|0
7656802|NCT00073749|12072598|FG005|Overall Study|Other|2
7656803|NCT00073749|12072599|FG006|Overall Study|Other|0
7656804|NCT00073918|12072618|FG000|Overall Study|Eligibility requirement not met - HAMA+|1
7656805|NCT00073918|12072618|FG000|Overall Study|Rapid disease progression|2
7656806|NCT00073918|12072618|FG000|Overall Study|Eligibility requirement not met-low CD20|1
7656807|NCT00073983|12072628|FG000|Overall Study|not evaluable|1
7656808|NCT00074152|12072640|FG000|Overall Study|Death|21
7656809|NCT00074152|12072641|FG001|Overall Study|Death|9
7656810|NCT00074152|12072640|FG000|Overall Study|Lack of Efficacy|34
7656811|NCT00074152|12072641|FG001|Overall Study|Lack of Efficacy|24
7656812|NCT00074282|12072660|FG000|Step 1|Adverse Event|32
7656813|NCT00074282|12072661|FG001|Step 1|Adverse Event|0
7656814|NCT00074282|12072662|FG002|Step 1|Adverse Event|0
7656815|NCT00074282|12072660|FG000|Step 1|Death|6
7656816|NCT00074282|12072661|FG001|Step 1|Death|0
7656817|NCT00074282|12072662|FG002|Step 1|Death|0
7656818|NCT00074282|12072660|FG000|Step 1|Withdrawal by Subject|7
7656819|NCT00074282|12072661|FG001|Step 1|Withdrawal by Subject|0
7656820|NCT00074282|12072662|FG002|Step 1|Withdrawal by Subject|0
7656821|NCT00074282|12072660|FG000|Step 1|Disease progression|2
7656822|NCT00074282|12072661|FG001|Step 1|Disease progression|0
7656823|NCT00074282|12072662|FG002|Step 1|Disease progression|0
7656824|NCT00074282|12072660|FG000|Step 1|Alternative therapy|2
7656825|NCT00074282|12072661|FG001|Step 1|Alternative therapy|0
7656826|NCT00074282|12072662|FG002|Step 1|Alternative therapy|0
7656827|NCT00074282|12072660|FG000|Step 1|Other complicating disease|2
7656828|NCT00074282|12072661|FG001|Step 1|Other complicating disease|0
7656829|NCT00074282|12072662|FG002|Step 1|Other complicating disease|0
7656830|NCT00074282|12072660|FG000|Step 1|Physician Decision|1
7656831|NCT00074282|12072661|FG001|Step 1|Physician Decision|0
7656832|NCT00074282|12072662|FG002|Step 1|Physician Decision|0
7656833|NCT00074282|12072660|FG000|Step 1|Ineligible|4
7656834|NCT00074282|12072661|FG001|Step 1|Ineligible|0
7656835|NCT00074282|12072662|FG002|Step 1|Ineligible|0
7656836|NCT00074282|12072660|FG000|Step 1|Never started treatment|2
7656837|NCT00074282|12072661|FG001|Step 1|Never started treatment|0
7656838|NCT00074282|12072662|FG002|Step 1|Never started treatment|0
7656839|NCT00074282|12072660|FG000|Step 2|Adverse Event|0
7656840|NCT00074282|12072661|FG001|Step 2|Adverse Event|2
7656841|NCT00074282|12072662|FG002|Step 2|Adverse Event|12
7656842|NCT00074282|12072660|FG000|Step 2|Disease progression|0
7656843|NCT00074282|12072661|FG001|Step 2|Disease progression|0
7656844|NCT00074282|12072662|FG002|Step 2|Disease progression|5
7656845|NCT00074282|12072660|FG000|Step 2|Death|0
7656846|NCT00074282|12072661|FG001|Step 2|Death|0
7656847|NCT00074282|12072662|FG002|Step 2|Death|3
7656848|NCT00074282|12072660|FG000|Step 2|Withdrawal by Subject|0
7656849|NCT00074282|12072661|FG001|Step 2|Withdrawal by Subject|0
7656850|NCT00074282|12072662|FG002|Step 2|Withdrawal by Subject|2
7656851|NCT00074282|12072660|FG000|Step 2|Physician Decision|0
7656852|NCT00074282|12072661|FG001|Step 2|Physician Decision|0
7656853|NCT00074282|12072662|FG002|Step 2|Physician Decision|1
7656854|NCT00074282|12072660|FG000|Step 2|Ineligible|0
7656855|NCT00074282|12072661|FG001|Step 2|Ineligible|0
7656856|NCT00074282|12072662|FG002|Step 2|Ineligible|1
7656857|NCT00074490|12072691|FG000|Overall Study|Progressive malignancy|0
7656858|NCT00074490|12072692|FG001|Overall Study|Progressive malignancy|7
7656859|NCT00074490|12072693|FG002|Overall Study|Progressive malignancy|0
7656860|NCT00074490|12072694|FG003|Overall Study|Progressive malignancy|0
7656861|NCT00074490|12072695|FG004|Overall Study|Progressive malignancy|3
7656862|NCT00074490|12072696|FG005|Overall Study|Progressive malignancy|0
7656863|NCT00074581|12072711|FG000|Overall Study|Death|15
7656864|NCT00074581|12072712|FG001|Overall Study|Death|16
7656865|NCT00074581|12072711|FG000|Overall Study|Withdrawal by Subject|50
7656866|NCT00074581|12072712|FG001|Overall Study|Withdrawal by Subject|49
7656867|NCT00074581|12072711|FG000|Overall Study|Unable to adhere to visit schedule|13
7656868|NCT00074581|12072712|FG001|Overall Study|Unable to adhere to visit schedule|14
7656869|NCT00074581|12072711|FG000|Overall Study|Relocated|14
7656870|NCT00074581|12072712|FG001|Overall Study|Relocated|9
7656871|NCT00074581|12072711|FG000|Overall Study|Were withdrawn by investigator|5
7656872|NCT00074581|12072712|FG001|Overall Study|Were withdrawn by investigator|2
7656873|NCT00074581|12072711|FG000|Overall Study|Lost to Follow-up|16
7656874|NCT00074581|12072712|FG001|Overall Study|Lost to Follow-up|11
7656875|NCT00074581|12072711|FG000|Overall Study|Ended relationship w. index participant|117
7656876|NCT00074581|12072712|FG001|Overall Study|Ended relationship w. index participant|106
7656877|NCT00074581|12072711|FG000|Overall Study|Other|14
7656878|NCT00074581|12072712|FG001|Overall Study|Other|19
7656879|NCT00074711|12072720|FG000|Overall Study|Withdrawal by Subject|1
7656880|NCT00074711|12072721|FG001|Overall Study|Withdrawal by Subject|1
7656881|NCT00074711|12072720|FG000|Overall Study|Lost to Follow-up|10
7656882|NCT00074711|12072721|FG001|Overall Study|Lost to Follow-up|8
7656883|NCT00074711|12072720|FG000|Overall Study|Participant stopped study drug|4
7656884|NCT00074711|12072721|FG001|Overall Study|Participant stopped study drug|6
7656885|NCT00074958|12072749|FG000|Overall Study|Adverse Event|1
7656886|NCT00074984|12072755|FG000|Overall Study|Death|1
7656887|NCT00074984|12072756|FG001|Overall Study|Death|2
7656888|NCT00074984|12072755|FG000|Overall Study|Withdrawal by Subject|2
7656889|NCT00074984|12072756|FG001|Overall Study|Withdrawal by Subject|3
7656890|NCT00074984|12072755|FG000|Overall Study|Patient Withdrawn Per Protocol|0
7656891|NCT00074984|12072756|FG001|Overall Study|Patient Withdrawn Per Protocol|3
7656892|NCT00075023|12072765|FG000|Pilot Study|Physician Decision|1
7656893|NCT00075023|12072766|FG001|Pilot Study|Physician Decision|2
7656894|NCT00075023|12072765|FG000|Pilot Study|Withdrawal by Subject|1
7656895|NCT00075023|12072766|FG001|Pilot Study|Withdrawal by Subject|0
7656896|NCT00075218|12072785|FG000|Double-Blind Treatment|Adverse Event|23
7656897|NCT00075218|12072786|FG001|Double-Blind Treatment|Adverse Event|4
7656898|NCT00075218|12072787|FG002|Double-Blind Treatment|Adverse Event|0
7656899|NCT00075218|12072785|FG000|Double-Blind Treatment|Withdrawal by Subject|7
7656900|NCT00075218|12072786|FG001|Double-Blind Treatment|Withdrawal by Subject|4
7656901|NCT00075218|12072787|FG002|Double-Blind Treatment|Withdrawal by Subject|0
7656902|NCT00075218|12072785|FG000|Double-Blind Treatment|Lost to Follow-up|1
7656903|NCT00075218|12072786|FG001|Double-Blind Treatment|Lost to Follow-up|0
7656904|NCT00075218|12072787|FG002|Double-Blind Treatment|Lost to Follow-up|0
7656905|NCT00075218|12072785|FG000|Double-Blind Treatment|Lack of Efficacy|58
7656906|NCT00075218|12072786|FG001|Double-Blind Treatment|Lack of Efficacy|6
7656907|NCT00075218|12072787|FG002|Double-Blind Treatment|Lack of Efficacy|0
7656908|NCT00075218|12072785|FG000|Double-Blind Treatment|Decision of Sponsor|0
7656909|NCT00075218|12072786|FG001|Double-Blind Treatment|Decision of Sponsor|1
7656910|NCT00075218|12072787|FG002|Double-Blind Treatment|Decision of Sponsor|0
7656911|NCT00075218|12072785|FG000|Double-Blind Treatment|No study medication taken|2
7656912|NCT00075218|12072786|FG001|Double-Blind Treatment|No study medication taken|0
7656913|NCT00075218|12072787|FG002|Double-Blind Treatment|No study medication taken|0
7656914|NCT00075218|12072785|FG000|Open-Label Treatment|Lack of Efficacy|0
7656915|NCT00075218|12072786|FG001|Open-Label Treatment|Lack of Efficacy|0
7656916|NCT00075218|12072787|FG002|Open-Label Treatment|Lack of Efficacy|174
7656917|NCT00075218|12072785|FG000|Open-Label Treatment|Adverse Event|0
7656918|NCT00075218|12072786|FG001|Open-Label Treatment|Adverse Event|0
7656919|NCT00075218|12072787|FG002|Open-Label Treatment|Adverse Event|51
7656920|NCT00075218|12072785|FG000|Open-Label Treatment|Withdrawal by Subject|0
7656921|NCT00075218|12072786|FG001|Open-Label Treatment|Withdrawal by Subject|0
7656922|NCT00075218|12072787|FG002|Open-Label Treatment|Withdrawal by Subject|12
7656923|NCT00075218|12072785|FG000|Open-Label Treatment|Decision of Sponsor|0
7656924|NCT00075218|12072786|FG001|Open-Label Treatment|Decision of Sponsor|0
7656925|NCT00075218|12072787|FG002|Open-Label Treatment|Decision of Sponsor|8
7656926|NCT00075218|12072785|FG000|Open-Label Treatment|Protocol Violation|0
7656927|NCT00075218|12072786|FG001|Open-Label Treatment|Protocol Violation|0
7656928|NCT00075218|12072787|FG002|Open-Label Treatment|Protocol Violation|1
7656929|NCT00075218|12072785|FG000|Open-Label Treatment|enrolled in a separate continuation|0
7656930|NCT00075218|12072786|FG001|Open-Label Treatment|enrolled in a separate continuation|0
7656931|NCT00075218|12072787|FG002|Open-Label Treatment|enrolled in a separate continuation|9
7656932|NCT00075270|12072796|FG000|Overall Study|Withdrawal by Subject|28
7656933|NCT00075270|12072797|FG001|Overall Study|Withdrawal by Subject|21
7656934|NCT00075270|12072796|FG000|Overall Study|Lost to Follow-up|25
7656935|NCT00075270|12072797|FG001|Overall Study|Lost to Follow-up|28
7656936|NCT00075270|12072796|FG000|Overall Study|Protocol Violation|0
7656937|NCT00075270|12072797|FG001|Overall Study|Protocol Violation|2
7656938|NCT00075270|12072796|FG000|Overall Study|Death|198
7656939|NCT00075270|12072797|FG001|Overall Study|Death|215
7656940|NCT00075270|12072796|FG000|Overall Study|Other/Unknown|9
7656941|NCT00075270|12072797|FG001|Overall Study|Other/Unknown|5
7656942|NCT00075270|12072796|FG000|Overall Study|Missing|26
7656943|NCT00075270|12072797|FG001|Overall Study|Missing|13
7656944|NCT00075400|12072808|FG000|Overall Study|Ineligible: wrong primary|1
7656945|NCT00075400|12072808|FG000|Overall Study|Never treated|2
7656946|NCT00075478|12072819|FG000|Overall Study|not eligible|1
7656947|NCT00075478|12072820|FG001|Overall Study|not eligible|0
7656948|NCT00075478|12072819|FG000|Overall Study|Physician Decision|0
7656949|NCT00075478|12072820|FG001|Overall Study|Physician Decision|1
7656950|NCT00075504|12072828|FG000|Overall Study|Withdrawal by Subject|9
7656951|NCT00075504|12072829|FG001|Overall Study|Withdrawal by Subject|7
7656952|NCT00075582|12072837|FG000|Overall Study|Adverse Event|3
7656953|NCT00075582|12072838|FG001|Overall Study|Adverse Event|1
7656954|NCT00075582|12072837|FG000|Overall Study|Lack of Efficacy|4
7656955|NCT00075582|12072838|FG001|Overall Study|Lack of Efficacy|8
7656956|NCT00075582|12072837|FG000|Overall Study|Physician Decision|5
7656957|NCT00075582|12072838|FG001|Overall Study|Physician Decision|8
7656958|NCT00075582|12072837|FG000|Overall Study|Withdrawal by Subject|2
7656959|NCT00075582|12072838|FG001|Overall Study|Withdrawal by Subject|2
7656960|NCT00075582|12072837|FG000|Overall Study|Ineligible for study|36
7656961|NCT00075582|12072838|FG001|Overall Study|Ineligible for study|16
7656962|NCT00075725|12072860|FG000|Overall Study|Adverse Event|6
7656963|NCT00075725|12072861|FG001|Overall Study|Adverse Event|6
7656964|NCT00075725|12072862|FG002|Overall Study|Adverse Event|20
7656965|NCT00075725|12072863|FG003|Overall Study|Adverse Event|8
7656966|NCT00075725|12072864|FG004|Overall Study|Adverse Event|4
7656967|NCT00075725|12072865|FG005|Overall Study|Adverse Event|38
7656968|NCT00075725|12072866|FG006|Overall Study|Adverse Event|3
7656969|NCT00075725|12072867|FG007|Overall Study|Adverse Event|51
7656970|NCT00075725|12072868|FG008|Overall Study|Adverse Event|15
7656971|NCT00075725|12072869|FG009|Overall Study|Adverse Event|4
7656972|NCT00075725|12072870|FG010|Overall Study|Adverse Event|2
7656973|NCT00075725|12072871|FG011|Overall Study|Adverse Event|2
7656974|NCT00075725|12072860|FG000|Overall Study|Death|3
7656975|NCT00075725|12072861|FG001|Overall Study|Death|5
7656976|NCT00075725|12072862|FG002|Overall Study|Death|10
7656977|NCT00075725|12072863|FG003|Overall Study|Death|2
7656978|NCT00075725|12072864|FG004|Overall Study|Death|3
7656979|NCT00075725|12072865|FG005|Overall Study|Death|25
7656980|NCT00075725|12072866|FG006|Overall Study|Death|4
7656981|NCT00075725|12072867|FG007|Overall Study|Death|22
7656982|NCT00075725|12072868|FG008|Overall Study|Death|14
7656983|NCT00075725|12072869|FG009|Overall Study|Death|4
7656984|NCT00075725|12072870|FG010|Overall Study|Death|3
7656985|NCT00075725|12072871|FG011|Overall Study|Death|0
7656986|NCT00075725|12072860|FG000|Overall Study|Lost to Follow-up|1
7656987|NCT00075725|12072861|FG001|Overall Study|Lost to Follow-up|1
7656988|NCT00075725|12072862|FG002|Overall Study|Lost to Follow-up|4
7656989|NCT00075725|12072863|FG003|Overall Study|Lost to Follow-up|1
7656990|NCT00075725|12072864|FG004|Overall Study|Lost to Follow-up|0
7656991|NCT00075725|12072865|FG005|Overall Study|Lost to Follow-up|13
7656992|NCT00075725|12072866|FG006|Overall Study|Lost to Follow-up|2
7656993|NCT00075725|12072867|FG007|Overall Study|Lost to Follow-up|4
7656994|NCT00075725|12072868|FG008|Overall Study|Lost to Follow-up|1
7656995|NCT00075725|12072869|FG009|Overall Study|Lost to Follow-up|0
7656996|NCT00075725|12072870|FG010|Overall Study|Lost to Follow-up|0
7656997|NCT00075725|12072871|FG011|Overall Study|Lost to Follow-up|0
7656998|NCT00075725|12072860|FG000|Overall Study|Physician Decision|2
7656999|NCT00075725|12072861|FG001|Overall Study|Physician Decision|6
7657000|NCT00075725|12072862|FG002|Overall Study|Physician Decision|5
7657001|NCT00075725|12072863|FG003|Overall Study|Physician Decision|8
7657002|NCT00075725|12072864|FG004|Overall Study|Physician Decision|4
7657003|NCT00075725|12072865|FG005|Overall Study|Physician Decision|19
7657004|NCT00075725|12072866|FG006|Overall Study|Physician Decision|3
7657005|NCT00075725|12072867|FG007|Overall Study|Physician Decision|17
7657006|NCT00075725|12072868|FG008|Overall Study|Physician Decision|5
7657007|NCT00075725|12072869|FG009|Overall Study|Physician Decision|0
7657008|NCT00075725|12072870|FG010|Overall Study|Physician Decision|1
7657009|NCT00075725|12072871|FG011|Overall Study|Physician Decision|0
7657010|NCT00075725|12072860|FG000|Overall Study|Pregnancy|0
7657011|NCT00075725|12072861|FG001|Overall Study|Pregnancy|0
7657012|NCT00075725|12072862|FG002|Overall Study|Pregnancy|0
7657013|NCT00075725|12072863|FG003|Overall Study|Pregnancy|0
7657014|NCT00075725|12072864|FG004|Overall Study|Pregnancy|0
7657015|NCT00075725|12072865|FG005|Overall Study|Pregnancy|1
7657016|NCT00075725|12072866|FG006|Overall Study|Pregnancy|0
7657017|NCT00075725|12072867|FG007|Overall Study|Pregnancy|1
7657018|NCT00075725|12072868|FG008|Overall Study|Pregnancy|0
7657019|NCT00075725|12072869|FG009|Overall Study|Pregnancy|0
7657020|NCT00075725|12072870|FG010|Overall Study|Pregnancy|0
7657021|NCT00075725|12072871|FG011|Overall Study|Pregnancy|0
7657022|NCT00075725|12072860|FG000|Overall Study|Protocol Violation|1
7657023|NCT00075725|12072861|FG001|Overall Study|Protocol Violation|1
7657024|NCT00075725|12072862|FG002|Overall Study|Protocol Violation|0
7657025|NCT00075725|12072863|FG003|Overall Study|Protocol Violation|3
7657026|NCT00075725|12072864|FG004|Overall Study|Protocol Violation|3
7657027|NCT00075725|12072865|FG005|Overall Study|Protocol Violation|2
7657028|NCT00075725|12072866|FG006|Overall Study|Protocol Violation|1
7657029|NCT00075725|12072867|FG007|Overall Study|Protocol Violation|2
7657030|NCT00075725|12072868|FG008|Overall Study|Protocol Violation|3
7657031|NCT00075725|12072869|FG009|Overall Study|Protocol Violation|0
7657032|NCT00075725|12072870|FG010|Overall Study|Protocol Violation|0
7657033|NCT00075725|12072871|FG011|Overall Study|Protocol Violation|1
7657034|NCT00075725|12072860|FG000|Overall Study|Withdrawal by Subject|12
7657035|NCT00075725|12072861|FG001|Overall Study|Withdrawal by Subject|3
7657036|NCT00075725|12072862|FG002|Overall Study|Withdrawal by Subject|6
7657037|NCT00075725|12072863|FG003|Overall Study|Withdrawal by Subject|10
7657038|NCT00075725|12072864|FG004|Overall Study|Withdrawal by Subject|6
7657039|NCT00075725|12072865|FG005|Overall Study|Withdrawal by Subject|27
7657040|NCT00075725|12072866|FG006|Overall Study|Withdrawal by Subject|7
7657041|NCT00075725|12072867|FG007|Overall Study|Withdrawal by Subject|31
7657042|NCT00075725|12072868|FG008|Overall Study|Withdrawal by Subject|10
7657043|NCT00075725|12072869|FG009|Overall Study|Withdrawal by Subject|2
7657044|NCT00075725|12072870|FG010|Overall Study|Withdrawal by Subject|0
7657045|NCT00075725|12072871|FG011|Overall Study|Withdrawal by Subject|0
7657046|NCT00075725|12072860|FG000|Overall Study|Disease Progression, all other reasons|17
7657047|NCT00075725|12072861|FG001|Overall Study|Disease Progression, all other reasons|5
7657048|NCT00075725|12072862|FG002|Overall Study|Disease Progression, all other reasons|33
7657049|NCT00075725|12072863|FG003|Overall Study|Disease Progression, all other reasons|6
7657050|NCT00075725|12072864|FG004|Overall Study|Disease Progression, all other reasons|21
7657051|NCT00075725|12072865|FG005|Overall Study|Disease Progression, all other reasons|59
7657052|NCT00075725|12072866|FG006|Overall Study|Disease Progression, all other reasons|20
7657053|NCT00075725|12072867|FG007|Overall Study|Disease Progression, all other reasons|46
7657054|NCT00075725|12072868|FG008|Overall Study|Disease Progression, all other reasons|21
7657055|NCT00075725|12072869|FG009|Overall Study|Disease Progression, all other reasons|4
7657056|NCT00075725|12072870|FG010|Overall Study|Disease Progression, all other reasons|0
7657057|NCT00075725|12072871|FG011|Overall Study|Disease Progression, all other reasons|5
7657058|NCT00075725|12072860|FG000|Overall Study|Patient off treatment|0
7657059|NCT00075725|12072861|FG001|Overall Study|Patient off treatment|0
7657060|NCT00075725|12072862|FG002|Overall Study|Patient off treatment|1
7657061|NCT00075725|12072863|FG003|Overall Study|Patient off treatment|2
7657062|NCT00075725|12072864|FG004|Overall Study|Patient off treatment|1
7657063|NCT00075725|12072865|FG005|Overall Study|Patient off treatment|0
7657064|NCT00075725|12072866|FG006|Overall Study|Patient off treatment|0
7657065|NCT00075725|12072867|FG007|Overall Study|Patient off treatment|2
7657066|NCT00075725|12072868|FG008|Overall Study|Patient off treatment|1
7657067|NCT00075725|12072869|FG009|Overall Study|Patient off treatment|0
7657068|NCT00075725|12072870|FG010|Overall Study|Patient off treatment|0
7657069|NCT00075725|12072871|FG011|Overall Study|Patient off treatment|0
7657070|NCT00075725|12072860|FG000|Overall Study|Ineligible or wrong diagnosis|8
7657071|NCT00075725|12072861|FG001|Overall Study|Ineligible or wrong diagnosis|3
7657072|NCT00075725|12072862|FG002|Overall Study|Ineligible or wrong diagnosis|3
7657073|NCT00075725|12072863|FG003|Overall Study|Ineligible or wrong diagnosis|10
7657074|NCT00075725|12072864|FG004|Overall Study|Ineligible or wrong diagnosis|3
7657075|NCT00075725|12072865|FG005|Overall Study|Ineligible or wrong diagnosis|17
7657076|NCT00075725|12072866|FG006|Overall Study|Ineligible or wrong diagnosis|6
7657077|NCT00075725|12072867|FG007|Overall Study|Ineligible or wrong diagnosis|9
7657078|NCT00075725|12072868|FG008|Overall Study|Ineligible or wrong diagnosis|10
7657079|NCT00075725|12072869|FG009|Overall Study|Ineligible or wrong diagnosis|1
7657080|NCT00075725|12072870|FG010|Overall Study|Ineligible or wrong diagnosis|2
7657081|NCT00075725|12072871|FG011|Overall Study|Ineligible or wrong diagnosis|4
7657082|NCT00075725|12072860|FG000|Overall Study|Pt/Guardian refused RT therapy|1
7657083|NCT00075725|12072861|FG001|Overall Study|Pt/Guardian refused RT therapy|0
7657084|NCT00075725|12072862|FG002|Overall Study|Pt/Guardian refused RT therapy|1
7657085|NCT00075725|12072863|FG003|Overall Study|Pt/Guardian refused RT therapy|2
7657086|NCT00075725|12072864|FG004|Overall Study|Pt/Guardian refused RT therapy|1
7657087|NCT00075725|12072865|FG005|Overall Study|Pt/Guardian refused RT therapy|0
7657088|NCT00075725|12072866|FG006|Overall Study|Pt/Guardian refused RT therapy|0
7657089|NCT00075725|12072867|FG007|Overall Study|Pt/Guardian refused RT therapy|0
7657090|NCT00075725|12072868|FG008|Overall Study|Pt/Guardian refused RT therapy|0
7657091|NCT00075725|12072869|FG009|Overall Study|Pt/Guardian refused RT therapy|0
7657092|NCT00075725|12072870|FG010|Overall Study|Pt/Guardian refused RT therapy|0
7657093|NCT00075725|12072871|FG011|Overall Study|Pt/Guardian refused RT therapy|0
7657094|NCT00075725|12072860|FG000|Overall Study|Pt non compliant with therapy|2
7657095|NCT00075725|12072861|FG001|Overall Study|Pt non compliant with therapy|1
7657096|NCT00075725|12072862|FG002|Overall Study|Pt non compliant with therapy|1
7657255|NCT00075725|12072865|FG005|Overall Study|Pt relocated|1
7657097|NCT00075725|12072863|FG003|Overall Study|Pt non compliant with therapy|0
7657098|NCT00075725|12072864|FG004|Overall Study|Pt non compliant with therapy|2
7657099|NCT00075725|12072865|FG005|Overall Study|Pt non compliant with therapy|14
7657100|NCT00075725|12072866|FG006|Overall Study|Pt non compliant with therapy|2
7657101|NCT00075725|12072867|FG007|Overall Study|Pt non compliant with therapy|5
7657102|NCT00075725|12072868|FG008|Overall Study|Pt non compliant with therapy|3
7657103|NCT00075725|12072869|FG009|Overall Study|Pt non compliant with therapy|0
7657104|NCT00075725|12072870|FG010|Overall Study|Pt non compliant with therapy|0
7657105|NCT00075725|12072871|FG011|Overall Study|Pt non compliant with therapy|0
7657106|NCT00075725|12072860|FG000|Overall Study|Pt age out of range for treatment|0
7657107|NCT00075725|12072861|FG001|Overall Study|Pt age out of range for treatment|1
7657108|NCT00075725|12072862|FG002|Overall Study|Pt age out of range for treatment|0
7657109|NCT00075725|12072863|FG003|Overall Study|Pt age out of range for treatment|0
7657110|NCT00075725|12072864|FG004|Overall Study|Pt age out of range for treatment|0
7657111|NCT00075725|12072865|FG005|Overall Study|Pt age out of range for treatment|1
7657112|NCT00075725|12072866|FG006|Overall Study|Pt age out of range for treatment|0
7657113|NCT00075725|12072867|FG007|Overall Study|Pt age out of range for treatment|1
7657114|NCT00075725|12072868|FG008|Overall Study|Pt age out of range for treatment|0
7657115|NCT00075725|12072869|FG009|Overall Study|Pt age out of range for treatment|0
7657116|NCT00075725|12072870|FG010|Overall Study|Pt age out of range for treatment|0
7657117|NCT00075725|12072871|FG011|Overall Study|Pt age out of range for treatment|0
7657118|NCT00075725|12072860|FG000|Overall Study|Insurance issues|0
7657119|NCT00075725|12072861|FG001|Overall Study|Insurance issues|1
7657120|NCT00075725|12072862|FG002|Overall Study|Insurance issues|0
7657121|NCT00075725|12072863|FG003|Overall Study|Insurance issues|1
7657122|NCT00075725|12072864|FG004|Overall Study|Insurance issues|1
7657123|NCT00075725|12072865|FG005|Overall Study|Insurance issues|1
7657124|NCT00075725|12072866|FG006|Overall Study|Insurance issues|0
7657125|NCT00075725|12072867|FG007|Overall Study|Insurance issues|1
7657126|NCT00075725|12072868|FG008|Overall Study|Insurance issues|0
7657127|NCT00075725|12072869|FG009|Overall Study|Insurance issues|0
7657128|NCT00075725|12072870|FG010|Overall Study|Insurance issues|0
7657129|NCT00075725|12072871|FG011|Overall Study|Insurance issues|0
7657130|NCT00075725|12072860|FG000|Overall Study|MRD positive after extended ind|0
7657131|NCT00075725|12072861|FG001|Overall Study|MRD positive after extended ind|1
7657132|NCT00075725|12072862|FG002|Overall Study|MRD positive after extended ind|1
7657133|NCT00075725|12072863|FG003|Overall Study|MRD positive after extended ind|0
7657134|NCT00075725|12072864|FG004|Overall Study|MRD positive after extended ind|1
7657135|NCT00075725|12072865|FG005|Overall Study|MRD positive after extended ind|2
7657136|NCT00075725|12072866|FG006|Overall Study|MRD positive after extended ind|0
7657137|NCT00075725|12072867|FG007|Overall Study|MRD positive after extended ind|1
7657138|NCT00075725|12072868|FG008|Overall Study|MRD positive after extended ind|0
7657139|NCT00075725|12072869|FG009|Overall Study|MRD positive after extended ind|0
7657140|NCT00075725|12072870|FG010|Overall Study|MRD positive after extended ind|0
7657141|NCT00075725|12072871|FG011|Overall Study|MRD positive after extended ind|0
7657142|NCT00075725|12072860|FG000|Overall Study|Pt has very high risk ALL characteristic|15
7657143|NCT00075725|12072861|FG001|Overall Study|Pt has very high risk ALL characteristic|11
7657144|NCT00075725|12072862|FG002|Overall Study|Pt has very high risk ALL characteristic|26
7657145|NCT00075725|12072863|FG003|Overall Study|Pt has very high risk ALL characteristic|18
7657146|NCT00075725|12072864|FG004|Overall Study|Pt has very high risk ALL characteristic|11
7657147|NCT00075725|12072865|FG005|Overall Study|Pt has very high risk ALL characteristic|75
7657148|NCT00075725|12072866|FG006|Overall Study|Pt has very high risk ALL characteristic|23
7657149|NCT00075725|12072867|FG007|Overall Study|Pt has very high risk ALL characteristic|74
7657150|NCT00075725|12072868|FG008|Overall Study|Pt has very high risk ALL characteristic|29
7657151|NCT00075725|12072869|FG009|Overall Study|Pt has very high risk ALL characteristic|1
7657152|NCT00075725|12072870|FG010|Overall Study|Pt has very high risk ALL characteristic|0
7657153|NCT00075725|12072871|FG011|Overall Study|Pt has very high risk ALL characteristic|3
7657154|NCT00075725|12072860|FG000|Overall Study|Inevaluable|1
7657155|NCT00075725|12072861|FG001|Overall Study|Inevaluable|1
7657156|NCT00075725|12072862|FG002|Overall Study|Inevaluable|4
7657157|NCT00075725|12072863|FG003|Overall Study|Inevaluable|2
7657158|NCT00075725|12072864|FG004|Overall Study|Inevaluable|2
7657159|NCT00075725|12072865|FG005|Overall Study|Inevaluable|9
7657160|NCT00075725|12072866|FG006|Overall Study|Inevaluable|1
7657161|NCT00075725|12072867|FG007|Overall Study|Inevaluable|11
7657162|NCT00075725|12072868|FG008|Overall Study|Inevaluable|2
7657163|NCT00075725|12072869|FG009|Overall Study|Inevaluable|0
7657164|NCT00075725|12072870|FG010|Overall Study|Inevaluable|1
7657165|NCT00075725|12072871|FG011|Overall Study|Inevaluable|0
7657166|NCT00075725|12072860|FG000|Overall Study|Other|4
7657167|NCT00075725|12072861|FG001|Overall Study|Other|2
7657168|NCT00075725|12072862|FG002|Overall Study|Other|1
7657169|NCT00075725|12072863|FG003|Overall Study|Other|1
7657170|NCT00075725|12072864|FG004|Overall Study|Other|1
7657171|NCT00075725|12072865|FG005|Overall Study|Other|4
7657172|NCT00075725|12072866|FG006|Overall Study|Other|2
7657173|NCT00075725|12072867|FG007|Overall Study|Other|9
7657174|NCT00075725|12072868|FG008|Overall Study|Other|2
7657175|NCT00075725|12072869|FG009|Overall Study|Other|1
7657176|NCT00075725|12072870|FG010|Overall Study|Other|0
7657177|NCT00075725|12072871|FG011|Overall Study|Other|3
7657178|NCT00075725|12072860|FG000|Overall Study|Pt trying to find a BM donor|0
7657179|NCT00075725|12072861|FG001|Overall Study|Pt trying to find a BM donor|1
7657180|NCT00075725|12072862|FG002|Overall Study|Pt trying to find a BM donor|0
7657181|NCT00075725|12072863|FG003|Overall Study|Pt trying to find a BM donor|0
7657182|NCT00075725|12072864|FG004|Overall Study|Pt trying to find a BM donor|0
7657183|NCT00075725|12072865|FG005|Overall Study|Pt trying to find a BM donor|0
7657184|NCT00075725|12072866|FG006|Overall Study|Pt trying to find a BM donor|0
7657185|NCT00075725|12072867|FG007|Overall Study|Pt trying to find a BM donor|0
7657186|NCT00075725|12072868|FG008|Overall Study|Pt trying to find a BM donor|0
7657187|NCT00075725|12072869|FG009|Overall Study|Pt trying to find a BM donor|0
7657188|NCT00075725|12072870|FG010|Overall Study|Pt trying to find a BM donor|0
7657189|NCT00075725|12072871|FG011|Overall Study|Pt trying to find a BM donor|0
7657190|NCT00075725|12072860|FG000|Overall Study|Clinic chart lost unable to recreate|0
7657191|NCT00075725|12072861|FG001|Overall Study|Clinic chart lost unable to recreate|0
7657192|NCT00075725|12072862|FG002|Overall Study|Clinic chart lost unable to recreate|1
7657193|NCT00075725|12072863|FG003|Overall Study|Clinic chart lost unable to recreate|0
7657194|NCT00075725|12072864|FG004|Overall Study|Clinic chart lost unable to recreate|0
7657195|NCT00075725|12072865|FG005|Overall Study|Clinic chart lost unable to recreate|0
7657196|NCT00075725|12072866|FG006|Overall Study|Clinic chart lost unable to recreate|0
7657197|NCT00075725|12072867|FG007|Overall Study|Clinic chart lost unable to recreate|0
7657198|NCT00075725|12072868|FG008|Overall Study|Clinic chart lost unable to recreate|0
7657199|NCT00075725|12072869|FG009|Overall Study|Clinic chart lost unable to recreate|0
7657200|NCT00075725|12072870|FG010|Overall Study|Clinic chart lost unable to recreate|0
7657201|NCT00075725|12072871|FG011|Overall Study|Clinic chart lost unable to recreate|0
7657202|NCT00075725|12072860|FG000|Overall Study|Unsuccessful institutional transfer|0
7657203|NCT00075725|12072861|FG001|Overall Study|Unsuccessful institutional transfer|0
7657204|NCT00075725|12072862|FG002|Overall Study|Unsuccessful institutional transfer|2
7657205|NCT00075725|12072863|FG003|Overall Study|Unsuccessful institutional transfer|0
7657206|NCT00075725|12072864|FG004|Overall Study|Unsuccessful institutional transfer|0
7657207|NCT00075725|12072865|FG005|Overall Study|Unsuccessful institutional transfer|0
7657208|NCT00075725|12072866|FG006|Overall Study|Unsuccessful institutional transfer|0
7657209|NCT00075725|12072867|FG007|Overall Study|Unsuccessful institutional transfer|0
7657210|NCT00075725|12072868|FG008|Overall Study|Unsuccessful institutional transfer|0
7657211|NCT00075725|12072869|FG009|Overall Study|Unsuccessful institutional transfer|1
7657212|NCT00075725|12072870|FG010|Overall Study|Unsuccessful institutional transfer|0
7657213|NCT00075725|12072871|FG011|Overall Study|Unsuccessful institutional transfer|0
7657214|NCT00075725|12072860|FG000|Overall Study|specimen(s) not submitted|0
7657215|NCT00075725|12072861|FG001|Overall Study|specimen(s) not submitted|0
7657216|NCT00075725|12072862|FG002|Overall Study|specimen(s) not submitted|2
7657217|NCT00075725|12072863|FG003|Overall Study|specimen(s) not submitted|0
7657218|NCT00075725|12072864|FG004|Overall Study|specimen(s) not submitted|0
7657219|NCT00075725|12072865|FG005|Overall Study|specimen(s) not submitted|0
7657220|NCT00075725|12072866|FG006|Overall Study|specimen(s) not submitted|0
7657221|NCT00075725|12072867|FG007|Overall Study|specimen(s) not submitted|0
7657222|NCT00075725|12072868|FG008|Overall Study|specimen(s) not submitted|0
7657223|NCT00075725|12072869|FG009|Overall Study|specimen(s) not submitted|0
7657224|NCT00075725|12072870|FG010|Overall Study|specimen(s) not submitted|0
7657225|NCT00075725|12072871|FG011|Overall Study|specimen(s) not submitted|0
7657226|NCT00075725|12072860|FG000|Overall Study|Pt went to transplant|0
7657227|NCT00075725|12072861|FG001|Overall Study|Pt went to transplant|0
7657228|NCT00075725|12072862|FG002|Overall Study|Pt went to transplant|0
7657229|NCT00075725|12072863|FG003|Overall Study|Pt went to transplant|1
7657230|NCT00075725|12072864|FG004|Overall Study|Pt went to transplant|0
7657231|NCT00075725|12072865|FG005|Overall Study|Pt went to transplant|1
7657232|NCT00075725|12072866|FG006|Overall Study|Pt went to transplant|0
7657233|NCT00075725|12072867|FG007|Overall Study|Pt went to transplant|0
7657234|NCT00075725|12072868|FG008|Overall Study|Pt went to transplant|0
7657235|NCT00075725|12072869|FG009|Overall Study|Pt went to transplant|0
7657236|NCT00075725|12072870|FG010|Overall Study|Pt went to transplant|0
7657237|NCT00075725|12072871|FG011|Overall Study|Pt went to transplant|0
7657238|NCT00075725|12072860|FG000|Overall Study|Pt received additional steroids|0
7657239|NCT00075725|12072861|FG001|Overall Study|Pt received additional steroids|0
7657240|NCT00075725|12072862|FG002|Overall Study|Pt received additional steroids|0
7657241|NCT00075725|12072863|FG003|Overall Study|Pt received additional steroids|1
7657242|NCT00075725|12072864|FG004|Overall Study|Pt received additional steroids|0
7657243|NCT00075725|12072865|FG005|Overall Study|Pt received additional steroids|0
7657244|NCT00075725|12072866|FG006|Overall Study|Pt received additional steroids|0
7657245|NCT00075725|12072867|FG007|Overall Study|Pt received additional steroids|0
7657246|NCT00075725|12072868|FG008|Overall Study|Pt received additional steroids|0
7657247|NCT00075725|12072869|FG009|Overall Study|Pt received additional steroids|0
7657248|NCT00075725|12072870|FG010|Overall Study|Pt received additional steroids|0
7657249|NCT00075725|12072871|FG011|Overall Study|Pt received additional steroids|0
7657250|NCT00075725|12072860|FG000|Overall Study|Pt relocated|0
7657251|NCT00075725|12072861|FG001|Overall Study|Pt relocated|0
7657252|NCT00075725|12072862|FG002|Overall Study|Pt relocated|0
7657253|NCT00075725|12072863|FG003|Overall Study|Pt relocated|2
7657254|NCT00075725|12072864|FG004|Overall Study|Pt relocated|0
7657256|NCT00075725|12072866|FG006|Overall Study|Pt relocated|1
7657257|NCT00075725|12072867|FG007|Overall Study|Pt relocated|2
7657258|NCT00075725|12072868|FG008|Overall Study|Pt relocated|1
7657259|NCT00075725|12072869|FG009|Overall Study|Pt relocated|0
7657260|NCT00075725|12072870|FG010|Overall Study|Pt relocated|0
7657261|NCT00075725|12072871|FG011|Overall Study|Pt relocated|0
7657262|NCT00075725|12072860|FG000|Overall Study|Institution Terminated|0
7657263|NCT00075725|12072861|FG001|Overall Study|Institution Terminated|0
7657264|NCT00075725|12072862|FG002|Overall Study|Institution Terminated|0
7657265|NCT00075725|12072863|FG003|Overall Study|Institution Terminated|0
7657266|NCT00075725|12072864|FG004|Overall Study|Institution Terminated|1
7657267|NCT00075725|12072865|FG005|Overall Study|Institution Terminated|0
7657268|NCT00075725|12072866|FG006|Overall Study|Institution Terminated|0
7657269|NCT00075725|12072867|FG007|Overall Study|Institution Terminated|3
7657270|NCT00075725|12072868|FG008|Overall Study|Institution Terminated|0
7657271|NCT00075725|12072869|FG009|Overall Study|Institution Terminated|0
7657272|NCT00075725|12072870|FG010|Overall Study|Institution Terminated|0
7657273|NCT00075725|12072871|FG011|Overall Study|Institution Terminated|0
7657274|NCT00075725|12072860|FG000|Overall Study|Study Closure|1
7657275|NCT00075725|12072861|FG001|Overall Study|Study Closure|0
7657276|NCT00075725|12072862|FG002|Overall Study|Study Closure|0
7657277|NCT00075725|12072863|FG003|Overall Study|Study Closure|0
7657278|NCT00075725|12072864|FG004|Overall Study|Study Closure|1
7657279|NCT00075725|12072865|FG005|Overall Study|Study Closure|3
7657280|NCT00075725|12072866|FG006|Overall Study|Study Closure|0
7657281|NCT00075725|12072867|FG007|Overall Study|Study Closure|1
7657282|NCT00075725|12072868|FG008|Overall Study|Study Closure|0
7657283|NCT00075725|12072869|FG009|Overall Study|Study Closure|0
7657284|NCT00075725|12072870|FG010|Overall Study|Study Closure|0
7657285|NCT00075725|12072871|FG011|Overall Study|Study Closure|0
7657286|NCT00075725|12072860|FG000|Overall Study|Other complications|0
7657287|NCT00075725|12072861|FG001|Overall Study|Other complications|0
7657288|NCT00075725|12072862|FG002|Overall Study|Other complications|0
7657289|NCT00075725|12072863|FG003|Overall Study|Other complications|0
7657290|NCT00075725|12072864|FG004|Overall Study|Other complications|0
7657291|NCT00075725|12072865|FG005|Overall Study|Other complications|1
7657292|NCT00075725|12072866|FG006|Overall Study|Other complications|0
7657293|NCT00075725|12072867|FG007|Overall Study|Other complications|0
7657294|NCT00075725|12072868|FG008|Overall Study|Other complications|0
7657295|NCT00075725|12072869|FG009|Overall Study|Other complications|0
7657296|NCT00075725|12072870|FG010|Overall Study|Other complications|0
7657297|NCT00075725|12072871|FG011|Overall Study|Other complications|0
7657298|NCT00075725|12072860|FG000|Overall Study|Pt care terminated due to pt behavior|0
7657299|NCT00075725|12072861|FG001|Overall Study|Pt care terminated due to pt behavior|0
7657300|NCT00075725|12072862|FG002|Overall Study|Pt care terminated due to pt behavior|0
7657301|NCT00075725|12072863|FG003|Overall Study|Pt care terminated due to pt behavior|0
7657302|NCT00075725|12072864|FG004|Overall Study|Pt care terminated due to pt behavior|0
7657303|NCT00075725|12072865|FG005|Overall Study|Pt care terminated due to pt behavior|0
7657304|NCT00075725|12072866|FG006|Overall Study|Pt care terminated due to pt behavior|0
7657305|NCT00075725|12072867|FG007|Overall Study|Pt care terminated due to pt behavior|1
7657306|NCT00075725|12072868|FG008|Overall Study|Pt care terminated due to pt behavior|0
7657307|NCT00075725|12072869|FG009|Overall Study|Pt care terminated due to pt behavior|0
7657308|NCT00075725|12072870|FG010|Overall Study|Pt care terminated due to pt behavior|0
7657309|NCT00075725|12072871|FG011|Overall Study|Pt care terminated due to pt behavior|0
7657310|NCT00075725|12072860|FG000|Overall Study|Pt incarcerated|0
7657311|NCT00075725|12072861|FG001|Overall Study|Pt incarcerated|0
7657312|NCT00075725|12072862|FG002|Overall Study|Pt incarcerated|0
7657313|NCT00075725|12072863|FG003|Overall Study|Pt incarcerated|0
7657314|NCT00075725|12072864|FG004|Overall Study|Pt incarcerated|0
7657315|NCT00075725|12072865|FG005|Overall Study|Pt incarcerated|0
7657316|NCT00075725|12072866|FG006|Overall Study|Pt incarcerated|0
7657317|NCT00075725|12072867|FG007|Overall Study|Pt incarcerated|1
7657318|NCT00075725|12072868|FG008|Overall Study|Pt incarcerated|0
7657319|NCT00075725|12072869|FG009|Overall Study|Pt incarcerated|0
7657320|NCT00075725|12072870|FG010|Overall Study|Pt incarcerated|0
7657321|NCT00075725|12072871|FG011|Overall Study|Pt incarcerated|0
7657322|NCT00075764|12072904|FG000|Overall Study|Adverse Event|5
7657323|NCT00075764|12072905|FG001|Overall Study|Adverse Event|12
7657324|NCT00075764|12072904|FG000|Overall Study|Death|4
7657325|NCT00075764|12072905|FG001|Overall Study|Death|8
7657326|NCT00075764|12072904|FG000|Overall Study|Withdrawal by Subject|28
7657327|NCT00075764|12072905|FG001|Overall Study|Withdrawal by Subject|18
7657328|NCT00075764|12072904|FG000|Overall Study|Progression|269
7657329|NCT00075764|12072905|FG001|Overall Study|Progression|274
7657330|NCT00075764|12072904|FG000|Overall Study|Still on treatment|8
7657331|NCT00075764|12072905|FG001|Overall Study|Still on treatment|15
7657332|NCT00075764|12072904|FG000|Overall Study|Delinquent|4
7657333|NCT00075764|12072905|FG001|Overall Study|Delinquent|2
7657334|NCT00075764|12072904|FG000|Overall Study|Not protocol specified|27
7657335|NCT00075764|12072905|FG001|Overall Study|Not protocol specified|19
7657336|NCT00075764|12072904|FG000|Overall Study|Under review|0
7657337|NCT00075764|12072905|FG001|Overall Study|Under review|1
7657338|NCT00075816|12072924|FG000|Overall Study|Did not undergo transplantation|14
7657339|NCT00075816|12072925|FG001|Overall Study|Did not undergo transplantation|11
7657340|NCT00075881|12072953|FG000|Overall Study|Lack of Efficacy|18
7657341|NCT00075881|12072953|FG000|Overall Study|Adverse Event|7
7657342|NCT00075881|12072953|FG000|Overall Study|Death|1
7657343|NCT00075881|12072953|FG000|Overall Study|Withdrawal by Subject|2
7657344|NCT00075881|12072953|FG000|Overall Study|Protocol Violation|4
7657345|NCT00075881|12072953|FG000|Overall Study|other complicating disease|3
7657346|NCT00075881|12072953|FG000|Overall Study|other|4
7657347|NCT00075881|12072953|FG000|Overall Study|missing data|2
7657348|NCT00075881|12072953|FG000|Overall Study|Ineligible|1
7657349|NCT00075881|12072953|FG000|Overall Study|never start protocol therapy|1
7657350|NCT00076011|12072959|FG000|Overall Study|Death|1
7657351|NCT00076011|12072959|FG000|Overall Study|Adverse Event|10
7657352|NCT00076011|12072959|FG000|Overall Study|Lack of Efficacy|25
7657353|NCT00076011|12072959|FG000|Overall Study|Withdrawal by Subject|1
7657354|NCT00076011|12072959|FG000|Overall Study|Study terminated by sponsor|3
7657355|NCT00076011|12072959|FG000|Overall Study|Other|11
7657356|NCT00076011|12072959|FG000|Overall Study|Ongoing|1
7657357|NCT00076024|12072966|FG000|Phase 1, Lead-in|Lack of Efficacy|4
7657358|NCT00076024|12072967|FG001|Phase 1, Lead-in|Lack of Efficacy|0
7657359|NCT00076024|12072968|FG002|Phase 1, Lead-in|Lack of Efficacy|0
7657360|NCT00076024|12072969|FG003|Phase 1, Lead-in|Lack of Efficacy|0
7657361|NCT00076024|12072966|FG000|Phase 1, Lead-in|Adverse Event|1
7657362|NCT00076024|12072967|FG001|Phase 1, Lead-in|Adverse Event|0
7657363|NCT00076024|12072968|FG002|Phase 1, Lead-in|Adverse Event|0
7657364|NCT00076024|12072969|FG003|Phase 1, Lead-in|Adverse Event|0
7657365|NCT00076024|12072966|FG000|Phase 1, Lead-in|Clinical progression|1
7657366|NCT00076024|12072967|FG001|Phase 1, Lead-in|Clinical progression|0
7657367|NCT00076024|12072968|FG002|Phase 1, Lead-in|Clinical progression|0
7657368|NCT00076024|12072969|FG003|Phase 1, Lead-in|Clinical progression|0
7657369|NCT00076024|12072966|FG000|Phase 2, Double-blind|Lack of Efficacy|0
7657370|NCT00076024|12072967|FG001|Phase 2, Double-blind|Lack of Efficacy|59
7657371|NCT00076024|12072968|FG002|Phase 2, Double-blind|Lack of Efficacy|40
7657372|NCT00076024|12072969|FG003|Phase 2, Double-blind|Lack of Efficacy|0
7657373|NCT00076024|12072966|FG000|Phase 2, Double-blind|Withdrawal by Subject|0
7657374|NCT00076024|12072967|FG001|Phase 2, Double-blind|Withdrawal by Subject|13
7657375|NCT00076024|12072968|FG002|Phase 2, Double-blind|Withdrawal by Subject|4
7657376|NCT00076024|12072969|FG003|Phase 2, Double-blind|Withdrawal by Subject|0
7657377|NCT00076024|12072966|FG000|Phase 2, Double-blind|Adverse Event|0
7657378|NCT00076024|12072967|FG001|Phase 2, Double-blind|Adverse Event|25
7657379|NCT00076024|12072968|FG002|Phase 2, Double-blind|Adverse Event|6
7657380|NCT00076024|12072969|FG003|Phase 2, Double-blind|Adverse Event|0
7657381|NCT00076024|12072966|FG000|Phase 2, Double-blind|Un-specified|0
7657382|NCT00076024|12072967|FG001|Phase 2, Double-blind|Un-specified|14
7657383|NCT00076024|12072968|FG002|Phase 2, Double-blind|Un-specified|6
7657384|NCT00076024|12072969|FG003|Phase 2, Double-blind|Un-specified|0
7657385|NCT00076024|12072966|FG000|Phase 2, Double-blind|Randomized but not treated|0
7657386|NCT00076024|12072967|FG001|Phase 2, Double-blind|Randomized but not treated|1
7657387|NCT00076024|12072968|FG002|Phase 2, Double-blind|Randomized but not treated|0
7657388|NCT00076024|12072969|FG003|Phase 2, Double-blind|Randomized but not treated|0
7657389|NCT00076024|12072966|FG000|Phase 2, Open-label|Adverse Event|0
7657390|NCT00076024|12072967|FG001|Phase 2, Open-label|Adverse Event|0
7657391|NCT00076024|12072968|FG002|Phase 2, Open-label|Adverse Event|0
7657392|NCT00076024|12072969|FG003|Phase 2, Open-label|Adverse Event|2
7657393|NCT00076024|12072966|FG000|Phase 2, Open-label|Lack of Efficacy|0
7657394|NCT00076024|12072967|FG001|Phase 2, Open-label|Lack of Efficacy|0
7657395|NCT00076024|12072968|FG002|Phase 2, Open-label|Lack of Efficacy|0
7657396|NCT00076024|12072969|FG003|Phase 2, Open-label|Lack of Efficacy|11
7657397|NCT00076024|12072966|FG000|Phase 2, Open-label|Withdrawal by Subject|0
7657398|NCT00076024|12072967|FG001|Phase 2, Open-label|Withdrawal by Subject|0
7657399|NCT00076024|12072968|FG002|Phase 2, Open-label|Withdrawal by Subject|0
7657400|NCT00076024|12072969|FG003|Phase 2, Open-label|Withdrawal by Subject|1
7657401|NCT00076024|12072966|FG000|Phase 2, Open-label|Other|0
7657402|NCT00076024|12072967|FG001|Phase 2, Open-label|Other|0
7657403|NCT00076024|12072968|FG002|Phase 2, Open-label|Other|0
7657404|NCT00076024|12072969|FG003|Phase 2, Open-label|Other|2
7657405|NCT00076102|12072987|FG000|Overall Study|Clinical progression|1
7657406|NCT00076102|12072987|FG000|Overall Study|Progression in pre-existing brain tumor|1
7657407|NCT00076102|12072987|FG000|Overall Study|plexiform neurofibroma surgery|1
7657408|NCT00076102|12072987|FG000|Overall Study|refusal of further therapy|2
7657409|NCT00076336|12073030|FG000|Overall Study|Death|13
7657410|NCT00076336|12073031|FG001|Overall Study|Death|17
7657411|NCT00076336|12073030|FG000|Overall Study|Adverse Event|4
7657412|NCT00076336|12073031|FG001|Overall Study|Adverse Event|4
7657413|NCT00076336|12073030|FG000|Overall Study|Lost to Follow-up|4
7657414|NCT00076336|12073031|FG001|Overall Study|Lost to Follow-up|4
7657415|NCT00076336|12073030|FG000|Overall Study|Non-Compliance|2
7657416|NCT00076336|12073031|FG001|Overall Study|Non-Compliance|0
7657417|NCT00076336|12073030|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0
7657418|NCT00076336|12073031|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1
7657419|NCT00076336|12073030|FG000|Overall Study|Patient, Investigator, Sponsor request|8
7657420|NCT00076336|12073031|FG001|Overall Study|Patient, Investigator, Sponsor request|6
7657421|NCT00076336|12073030|FG000|Overall Study|Liver Transplantation|3
7657422|NCT00076336|12073031|FG001|Overall Study|Liver Transplantation|3
7657423|NCT00076336|12073030|FG000|Overall Study|Virologic Breakthrough|14
7657424|NCT00076336|12073031|FG001|Overall Study|Virologic Breakthrough|16
7657425|NCT00076336|12073030|FG000|Overall Study|Treatment failure|4
7657426|NCT00076336|12073031|FG001|Overall Study|Treatment failure|5
7657427|NCT00076570|12073039|FG000|Overall Study|Drug intolerance|8
7657428|NCT00076570|12073040|FG001|Overall Study|Drug intolerance|8
7657429|NCT00076752|12073080|FG000|Overall Study|Death|2
7657430|NCT00076752|12073080|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1
7657431|NCT00076804|12073087|FG000|Overall Study|Death|9
7657432|NCT00076804|12073088|FG001|Overall Study|Death|20
7657433|NCT00076804|12073087|FG000|Overall Study|Lost to Follow-up|9
7657434|NCT00076804|12073088|FG001|Overall Study|Lost to Follow-up|9
7657435|NCT00076804|12073087|FG000|Overall Study|Withdrawal by Subject|10
7657436|NCT00076804|12073088|FG001|Overall Study|Withdrawal by Subject|8
7657437|NCT00076804|12073087|FG000|Overall Study|Early study Closure|32
7657438|NCT00076804|12073088|FG001|Overall Study|Early study Closure|32
7657439|NCT00076999|12073098|FG000|Overall Study|Adverse Event|2
7657440|NCT00076999|12073099|FG001|Overall Study|Adverse Event|8
7657441|NCT00076999|12073100|FG002|Overall Study|Adverse Event|6
7657442|NCT00076999|12073101|FG003|Overall Study|Adverse Event|0
7657443|NCT00076999|12073102|FG004|Overall Study|Adverse Event|2
7657444|NCT00076999|12073098|FG000|Overall Study|Protocol Violation|0
7657445|NCT00076999|12073099|FG001|Overall Study|Protocol Violation|3
7657446|NCT00076999|12073100|FG002|Overall Study|Protocol Violation|4
7657447|NCT00076999|12073101|FG003|Overall Study|Protocol Violation|0
7657448|NCT00076999|12073102|FG004|Overall Study|Protocol Violation|9
7657449|NCT00076999|12073098|FG000|Overall Study|Lost to Follow-up|2
7657450|NCT00076999|12073099|FG001|Overall Study|Lost to Follow-up|1
7657451|NCT00076999|12073100|FG002|Overall Study|Lost to Follow-up|0
7657452|NCT00076999|12073101|FG003|Overall Study|Lost to Follow-up|0
7657453|NCT00076999|12073102|FG004|Overall Study|Lost to Follow-up|0
7657454|NCT00076999|12073098|FG000|Overall Study|Withdrawal by Subject|0
7657455|NCT00076999|12073099|FG001|Overall Study|Withdrawal by Subject|4
7657456|NCT00076999|12073100|FG002|Overall Study|Withdrawal by Subject|3
7657457|NCT00076999|12073101|FG003|Overall Study|Withdrawal by Subject|0
7657458|NCT00076999|12073102|FG004|Overall Study|Withdrawal by Subject|1
7657459|NCT00076999|12073098|FG000|Overall Study|Other reason (not specified)|8
7657460|NCT00076999|12073099|FG001|Overall Study|Other reason (not specified)|8
7657461|NCT00076999|12073100|FG002|Overall Study|Other reason (not specified)|4
7657462|NCT00076999|12073101|FG003|Overall Study|Other reason (not specified)|1
7657463|NCT00076999|12073102|FG004|Overall Study|Other reason (not specified)|13
7657464|NCT00077064|12073117|FG000|Overall Study|Adverse Event|0
7657465|NCT00077064|12073118|FG001|Overall Study|Adverse Event|4
7657466|NCT00077064|12073117|FG000|Overall Study|Patient refusal|0
7657467|NCT00077064|12073118|FG001|Overall Study|Patient refusal|2
7657468|NCT00077207|12073125|FG000|Overall Study|Adverse Event|5
7657469|NCT00077207|12073125|FG000|Overall Study|Lack of Efficacy|12
7657470|NCT00077207|12073125|FG000|Overall Study|Physician Decision|6
7657471|NCT00077207|12073125|FG000|Overall Study|Withdrawal by Subject|6
7657472|NCT00077207|12073125|FG000|Overall Study|Ineligible|1
7657473|NCT00077376|12073130|FG000|Overall Study|Adverse Event|8
7657474|NCT00077376|12073130|FG000|Overall Study|Withdrawal by Subject|2
7657475|NCT00077376|12073130|FG000|Overall Study|Death|1
7657476|NCT00077376|12073130|FG000|Overall Study|Physician Decision|1
7657477|NCT00077376|12073130|FG000|Overall Study|Alternative therapy|5
7657478|NCT00077376|12073130|FG000|Overall Study|Complicating disease|1
7657479|NCT00077376|12073130|FG000|Overall Study|Still on treatment|1
7657480|NCT00077376|12073130|FG000|Overall Study|Symptomatic deterioration|1
7657481|NCT00077376|12073130|FG000|Overall Study|Surgery|1
7657482|NCT00077376|12073130|FG000|Overall Study|Insurance ran out|1
7657483|NCT00077610|12073137|FG000|Overall Study|Adverse Event|9
7657484|NCT00077610|12073138|FG001|Overall Study|Adverse Event|7
7657485|NCT00077610|12073139|FG002|Overall Study|Adverse Event|1
7657486|NCT00077610|12073137|FG000|Overall Study|Lost to Follow-up|0
7657487|NCT00077610|12073138|FG001|Overall Study|Lost to Follow-up|1
7657488|NCT00077610|12073139|FG002|Overall Study|Lost to Follow-up|2
7657489|NCT00077610|12073137|FG000|Overall Study|Withdrawal by Subject|4
7657490|NCT00077610|12073138|FG001|Overall Study|Withdrawal by Subject|10
7657491|NCT00077610|12073139|FG002|Overall Study|Withdrawal by Subject|6
7657492|NCT00077610|12073137|FG000|Overall Study|Death|17
7657493|NCT00077610|12073138|FG001|Overall Study|Death|13
7657494|NCT00077610|12073139|FG002|Overall Study|Death|13
7657495|NCT00077610|12073137|FG000|Overall Study|Renal transplant|12
7657496|NCT00077610|12073138|FG001|Overall Study|Renal transplant|15
7657497|NCT00077610|12073139|FG002|Overall Study|Renal transplant|11
7657498|NCT00077610|12073137|FG000|Overall Study|Withdrew from dialysis care|5
7657499|NCT00077610|12073138|FG001|Overall Study|Withdrew from dialysis care|0
7657500|NCT00077610|12073139|FG002|Overall Study|Withdrew from dialysis care|3
7657501|NCT00077610|12073137|FG000|Overall Study|Insufficient Therapeutic Response|1
7657502|NCT00077610|12073138|FG001|Overall Study|Insufficient Therapeutic Response|0
7657503|NCT00077610|12073139|FG002|Overall Study|Insufficient Therapeutic Response|0
7657504|NCT00077610|12073137|FG000|Overall Study|Multiple blood transfusions|0
7657505|NCT00077610|12073138|FG001|Overall Study|Multiple blood transfusions|0
7657506|NCT00077610|12073139|FG002|Overall Study|Multiple blood transfusions|1
7657507|NCT00077610|12073137|FG000|Overall Study|Principal Investigator's decision|1
7657508|NCT00077610|12073138|FG001|Overall Study|Principal Investigator's decision|0
7657509|NCT00077610|12073139|FG002|Overall Study|Principal Investigator's decision|1
7657510|NCT00077610|12073137|FG000|Overall Study|Worsening of health condition|1
7657511|NCT00077610|12073138|FG001|Overall Study|Worsening of health condition|1
7657512|NCT00077610|12073139|FG002|Overall Study|Worsening of health condition|0
7657513|NCT00077610|12073137|FG000|Overall Study|Given Epogen in hospital|1
7657514|NCT00077610|12073138|FG001|Overall Study|Given Epogen in hospital|0
7657515|NCT00077610|12073139|FG002|Overall Study|Given Epogen in hospital|0
7657516|NCT00077610|12073137|FG000|Overall Study|Transferred to other unit|0
7657517|NCT00077610|12073138|FG001|Overall Study|Transferred to other unit|0
7657518|NCT00077610|12073139|FG002|Overall Study|Transferred to other unit|1
7657519|NCT00077610|12073137|FG000|Overall Study|Transferred to nursing home|0
7657520|NCT00077610|12073138|FG001|Overall Study|Transferred to nursing home|0
7657521|NCT00077610|12073139|FG002|Overall Study|Transferred to nursing home|1
7657522|NCT00077610|12073137|FG000|Overall Study|Transfer to satellite unit|1
7657523|NCT00077610|12073138|FG001|Overall Study|Transfer to satellite unit|0
7657524|NCT00077610|12073139|FG002|Overall Study|Transfer to satellite unit|0
7657525|NCT00077610|12073137|FG000|Overall Study|Transfer to other center for surgery|1
7657526|NCT00077610|12073138|FG001|Overall Study|Transfer to other center for surgery|0
7657527|NCT00077610|12073139|FG002|Overall Study|Transfer to other center for surgery|0
7657528|NCT00077610|12073137|FG000|Overall Study|Change in dialysis modality|1
7657529|NCT00077610|12073138|FG001|Overall Study|Change in dialysis modality|0
7657530|NCT00077610|12073139|FG002|Overall Study|Change in dialysis modality|0
7657531|NCT00077610|12073137|FG000|Overall Study|Relocation|0
7657532|NCT00077610|12073138|FG001|Overall Study|Relocation|8
7657533|NCT00077610|12073139|FG002|Overall Study|Relocation|5
7657534|NCT00077610|12073137|FG000|Overall Study|Financial issues|0
7657535|NCT00077610|12073138|FG001|Overall Study|Financial issues|1
7657536|NCT00077610|12073139|FG002|Overall Study|Financial issues|0
7657537|NCT00077610|12073137|FG000|Overall Study|Sponsors decision to withdraw|0
7657538|NCT00077610|12073138|FG001|Overall Study|Sponsors decision to withdraw|0
7657539|NCT00077610|12073139|FG002|Overall Study|Sponsors decision to withdraw|1
7657540|NCT00077623|12073155|FG000|Overall Study|Adverse Event|1
7657541|NCT00077623|12073156|FG001|Overall Study|Adverse Event|0
7657542|NCT00077623|12073157|FG002|Overall Study|Adverse Event|1
7657543|NCT00077623|12073155|FG000|Overall Study|Withdrawal by Subject|2
7657544|NCT00077623|12073156|FG001|Overall Study|Withdrawal by Subject|10
7657545|NCT00077623|12073157|FG002|Overall Study|Withdrawal by Subject|1
7657546|NCT00077623|12073155|FG000|Overall Study|Other-Non safety reason|18
7657547|NCT00077623|12073156|FG001|Overall Study|Other-Non safety reason|15
7657548|NCT00077623|12073157|FG002|Overall Study|Other-Non safety reason|19
7657549|NCT00077623|12073155|FG000|Overall Study|Insufficient therapeutic response|2
7657550|NCT00077623|12073156|FG001|Overall Study|Insufficient therapeutic response|0
7657551|NCT00077623|12073157|FG002|Overall Study|Insufficient therapeutic response|0
7657552|NCT00077623|12073155|FG000|Overall Study|Death|12
7657553|NCT00077623|12073156|FG001|Overall Study|Death|18
7657554|NCT00077623|12073157|FG002|Overall Study|Death|11
7657555|NCT00077623|12073155|FG000|Overall Study|Failure to return|1
7657556|NCT00077623|12073156|FG001|Overall Study|Failure to return|0
7657557|NCT00077623|12073157|FG002|Overall Study|Failure to return|0
7657558|NCT00077636|12073167|FG000|Overall Study|Refused Treatment|9
7657559|NCT00077636|12073168|FG001|Overall Study|Refused Treatment|31
7657560|NCT00077636|12073167|FG000|Overall Study|Admin|3
7657561|NCT00077636|12073168|FG001|Overall Study|Admin|3
7657562|NCT00077636|12073167|FG000|Overall Study|Withdrawal by Subject|2
7657563|NCT00077636|12073168|FG001|Overall Study|Withdrawal by Subject|2
7657564|NCT00077636|12073167|FG000|Overall Study|Adverse Event|17
7657565|NCT00077636|12073168|FG001|Overall Study|Adverse Event|34
7657566|NCT00077636|12073167|FG000|Overall Study|Protocol Violation|0
7657567|NCT00077636|12073168|FG001|Overall Study|Protocol Violation|2
7657568|NCT00077636|12073167|FG000|Overall Study|Lost to Follow-up|10
7657569|NCT00077636|12073168|FG001|Overall Study|Lost to Follow-up|18
7657570|NCT00077636|12073167|FG000|Overall Study|Abnormality Of Laboratory Test|3
7657571|NCT00077636|12073168|FG001|Overall Study|Abnormality Of Laboratory Test|2
7657572|NCT00077649|12073179|FG000|Overall Study|Adverse Event|5
7657573|NCT00077649|12073180|FG001|Overall Study|Adverse Event|1
7657574|NCT00077649|12073181|FG002|Overall Study|Adverse Event|7
7657575|NCT00077649|12073182|FG003|Overall Study|Adverse Event|9
7657576|NCT00077649|12073179|FG000|Overall Study|Lack of Efficacy|5
7657577|NCT00077649|12073180|FG001|Overall Study|Lack of Efficacy|3
7657578|NCT00077649|12073181|FG002|Overall Study|Lack of Efficacy|3
7657579|NCT00077649|12073182|FG003|Overall Study|Lack of Efficacy|2
7657580|NCT00077649|12073179|FG000|Overall Study|Withdrawal by Subject|0
7657581|NCT00077649|12073180|FG001|Overall Study|Withdrawal by Subject|1
7657582|NCT00077649|12073181|FG002|Overall Study|Withdrawal by Subject|1
7657583|NCT00077649|12073182|FG003|Overall Study|Withdrawal by Subject|2
7657584|NCT00077649|12073179|FG000|Overall Study|Lost to Follow-up|2
7657585|NCT00077649|12073180|FG001|Overall Study|Lost to Follow-up|2
7657586|NCT00077649|12073181|FG002|Overall Study|Lost to Follow-up|3
7657587|NCT00077649|12073182|FG003|Overall Study|Lost to Follow-up|2
7657588|NCT00077649|12073179|FG000|Overall Study|Abnormality of Laboratory Test|1
7657589|NCT00077649|12073180|FG001|Overall Study|Abnormality of Laboratory Test|2
7657590|NCT00077649|12073181|FG002|Overall Study|Abnormality of Laboratory Test|1
7657591|NCT00077649|12073182|FG003|Overall Study|Abnormality of Laboratory Test|2
7657592|NCT00077649|12073179|FG000|Overall Study|Randomized but never dosed|1
7657593|NCT00077649|12073180|FG001|Overall Study|Randomized but never dosed|0
7657594|NCT00077649|12073181|FG002|Overall Study|Randomized but never dosed|0
7657595|NCT00077649|12073182|FG003|Overall Study|Randomized but never dosed|0
7657596|NCT00077675|12073198|FG000|Overall Study|Adverse Event|1
7657597|NCT00077675|12073199|FG001|Overall Study|Adverse Event|2
7657598|NCT00077675|12073198|FG000|Overall Study|Lost to Follow-up|6
7657599|NCT00077675|12073199|FG001|Overall Study|Lost to Follow-up|3
7657600|NCT00077675|12073198|FG000|Overall Study|Withdrawal by Subject|1
7657601|NCT00077675|12073199|FG001|Overall Study|Withdrawal by Subject|0
7657602|NCT00077675|12073198|FG000|Overall Study|Other|0
7657603|NCT00077675|12073199|FG001|Overall Study|Other|1
7657604|NCT00077675|12073198|FG000|Overall Study|Never received study treatment|3
7657605|NCT00077675|12073199|FG001|Overall Study|Never received study treatment|3
7657606|NCT00077766|12073207|FG000|Overall Study|Adverse Event|1
7657607|NCT00077766|12073208|FG001|Overall Study|Adverse Event|1
7657608|NCT00077766|12073207|FG000|Overall Study|Withdrawal by Subject|4
7657609|NCT00077766|12073208|FG001|Overall Study|Withdrawal by Subject|3
7657610|NCT00077766|12073207|FG000|Overall Study|Death|12
7657611|NCT00077766|12073208|FG001|Overall Study|Death|10
7657612|NCT00077766|12073207|FG000|Overall Study|Lost to Follow-up|2
7657613|NCT00077766|12073208|FG001|Overall Study|Lost to Follow-up|0
7657614|NCT00077766|12073207|FG000|Overall Study|Protocol Violation|1
7657615|NCT00077766|12073208|FG001|Overall Study|Protocol Violation|0
7657616|NCT00077766|12073207|FG000|Overall Study|Kidney Transplantation|9
7657617|NCT00077766|12073208|FG001|Overall Study|Kidney Transplantation|5
7657618|NCT00077766|12073207|FG000|Overall Study|Transplantation|5
7657619|NCT00077766|12073208|FG001|Overall Study|Transplantation|1
7657620|NCT00077766|12073207|FG000|Overall Study|Investigators Discretion|1
7657621|NCT00077766|12073208|FG001|Overall Study|Investigators Discretion|0
7657622|NCT00077766|12073207|FG000|Overall Study|Participant's decision|1
7657623|NCT00077766|12073208|FG001|Overall Study|Participant's decision|0
7657624|NCT00077766|12073207|FG000|Overall Study|Dialysis Discontinued|1
7657625|NCT00077766|12073208|FG001|Overall Study|Dialysis Discontinued|0
7657626|NCT00077766|12073207|FG000|Overall Study|Dialysis|0
7657627|NCT00077766|12073208|FG001|Overall Study|Dialysis|1
7657628|NCT00077766|12073207|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
7657629|NCT00077766|12073208|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
7657630|NCT00077766|12073207|FG000|Overall Study|Started Nocturnal Dialysis|0
7657631|NCT00077766|12073208|FG001|Overall Study|Started Nocturnal Dialysis|1
7657632|NCT00077766|12073207|FG000|Overall Study|Stop Dialysis|0
7657633|NCT00077766|12073208|FG001|Overall Study|Stop Dialysis|1
7657634|NCT00077766|12073207|FG000|Overall Study|Participants Vacation|2
7657635|NCT00077766|12073208|FG001|Overall Study|Participants Vacation|1
7657636|NCT00077857|12073217|FG000|Overall Study|Adverse Event|30
7657637|NCT00077857|12073218|FG001|Overall Study|Adverse Event|32
7657638|NCT00077857|12073217|FG000|Overall Study|Death|7
7657639|NCT00077857|12073218|FG001|Overall Study|Death|3
7657640|NCT00077857|12073217|FG000|Overall Study|Insufficient therapeutic response|112
7657641|NCT00077857|12073218|FG001|Overall Study|Insufficient therapeutic response|128
7657642|NCT00077857|12073217|FG000|Overall Study|Violation of selection criteria at entry|3
7657643|NCT00077857|12073218|FG001|Overall Study|Violation of selection criteria at entry|1
7657644|NCT00077857|12073217|FG000|Overall Study|Other protocol violation|0
7657645|NCT00077857|12073218|FG001|Overall Study|Other protocol violation|1
7657646|NCT00077857|12073217|FG000|Overall Study|Refused treatment|29
7657647|NCT00077857|12073218|FG001|Overall Study|Refused treatment|21
7657648|NCT00077857|12073217|FG000|Overall Study|Failure to return|5
7657649|NCT00077857|12073218|FG001|Overall Study|Failure to return|5
7657650|NCT00077857|12073217|FG000|Overall Study|Other|15
7657651|NCT00077857|12073218|FG001|Overall Study|Other|13
7657652|NCT00077974|12073228|FG000|Overall Study|Adverse Event|22
7657653|NCT00077974|12073228|FG000|Overall Study|Protocol Violation|1
7657654|NCT00077974|12073228|FG000|Overall Study|Withdrawal by Subject|3
7657655|NCT00077974|12073228|FG000|Overall Study|Lack of Efficacy|76
7657656|NCT00077974|12073228|FG000|Overall Study|Decision of Sponsor|2
7657657|NCT00078312|12073241|FG000|Overall Study|Adverse Event|43
7657658|NCT00078312|12073241|FG000|Overall Study|Lack of Efficacy|15
7657659|NCT00078312|12073241|FG000|Overall Study|Lost to Follow-up|41
7657660|NCT00078312|12073241|FG000|Overall Study|Physician Decision|9
7657661|NCT00078312|12073241|FG000|Overall Study|Protocol Violation|3
7657662|NCT00078312|12073241|FG000|Overall Study|Withdrawal by Subject|33
7657663|NCT00078312|12073241|FG000|Overall Study|Miscellaneous|33
7657664|NCT00078325|12073248|FG000|Overall Study|Adverse Event|15
7657665|NCT00078325|12073249|FG001|Overall Study|Adverse Event|10
7657666|NCT00078325|12073250|FG002|Overall Study|Adverse Event|5
7657667|NCT00078325|12073248|FG000|Overall Study|Protocol Violation|2
7657668|NCT00078325|12073249|FG001|Overall Study|Protocol Violation|2
7657669|NCT00078325|12073250|FG002|Overall Study|Protocol Violation|0
7657670|NCT00078325|12073248|FG000|Overall Study|Withdrawal by Subject|1
7657671|NCT00078325|12073249|FG001|Overall Study|Withdrawal by Subject|5
7657672|NCT00078325|12073250|FG002|Overall Study|Withdrawal by Subject|3
7657673|NCT00078325|12073248|FG000|Overall Study|Lost to Follow-up|0
7657674|NCT00078325|12073249|FG001|Overall Study|Lost to Follow-up|1
7657675|NCT00078325|12073250|FG002|Overall Study|Lost to Follow-up|1
7657676|NCT00078325|12073248|FG000|Overall Study|Physician Decision|2
7657677|NCT00078325|12073249|FG001|Overall Study|Physician Decision|0
7657678|NCT00078325|12073250|FG002|Overall Study|Physician Decision|1
7657679|NCT00078325|12073248|FG000|Overall Study|Miscellaneous|1
7657680|NCT00078325|12073249|FG001|Overall Study|Miscellaneous|1
7657681|NCT00078325|12073250|FG002|Overall Study|Miscellaneous|1
7657682|NCT00078338|12073260|FG000|Overall Study|Adverse Event|31
7657683|NCT00078338|12073261|FG001|Overall Study|Adverse Event|24
7657684|NCT00078338|12073260|FG000|Overall Study|Lost to Follow-up|17
7657685|NCT00078338|12073261|FG001|Overall Study|Lost to Follow-up|2
7657686|NCT00078338|12073260|FG000|Overall Study|Protocol Violation|2
7657687|NCT00078338|12073261|FG001|Overall Study|Protocol Violation|2
7657688|NCT00078338|12073260|FG000|Overall Study|Disease Progression|4
7657689|NCT00078338|12073261|FG001|Overall Study|Disease Progression|7
7657690|NCT00078338|12073260|FG000|Overall Study|Other|28
7657691|NCT00078338|12073261|FG001|Overall Study|Other|16
7657692|NCT00078338|12073260|FG000|Overall Study|Subjects randomized, but not treated|3
7657693|NCT00078338|12073261|FG001|Overall Study|Subjects randomized, but not treated|3
7657694|NCT00078377|12073270|FG000|Overall Study|Adverse Event|2
7657695|NCT00078377|12073271|FG001|Overall Study|Adverse Event|5
7657696|NCT00078377|12073272|FG002|Overall Study|Adverse Event|1
7657697|NCT00078377|12073270|FG000|Overall Study|Lack of Efficacy|2
7657698|NCT00078377|12073271|FG001|Overall Study|Lack of Efficacy|0
7657699|NCT00078377|12073272|FG002|Overall Study|Lack of Efficacy|2
7657700|NCT00078377|12073270|FG000|Overall Study|Lost to Follow-up|0
7657701|NCT00078377|12073271|FG001|Overall Study|Lost to Follow-up|1
7657702|NCT00078377|12073272|FG002|Overall Study|Lost to Follow-up|1
7657703|NCT00078377|12073270|FG000|Overall Study|Physician Decision|2
7657704|NCT00078377|12073271|FG001|Overall Study|Physician Decision|0
7657705|NCT00078377|12073272|FG002|Overall Study|Physician Decision|0
7657706|NCT00078377|12073270|FG000|Overall Study|Withdrawal by Subject|3
7657707|NCT00078377|12073271|FG001|Overall Study|Withdrawal by Subject|4
7657708|NCT00078377|12073272|FG002|Overall Study|Withdrawal by Subject|4
7657709|NCT00078377|12073270|FG000|Overall Study|Miscellaneous|2
7657710|NCT00078377|12073271|FG001|Overall Study|Miscellaneous|6
7657711|NCT00078377|12073272|FG002|Overall Study|Miscellaneous|1
7657712|NCT00078767|12073337|FG000|Overall Study|Withdrawal by Subject|1
7657713|NCT00078767|12073338|FG001|Overall Study|Withdrawal by Subject|1
7657714|NCT00078819|12073346|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0
7657715|NCT00078819|12073347|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1
7657716|NCT00078819|12073348|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0
7657717|NCT00078819|12073349|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0
7657718|NCT00078819|12073346|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1
7657719|NCT00078819|12073347|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
7657720|NCT00078819|12073348|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
7657721|NCT00078819|12073349|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
7657722|NCT00078819|12073346|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
7657723|NCT00078819|12073347|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
7657724|NCT00078819|12073348|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
7657725|NCT00078819|12073349|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
7657726|NCT00078819|12073346|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3
7657727|NCT00078819|12073347|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2
7657728|NCT00078819|12073348|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
7657729|NCT00078819|12073349|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
7657730|NCT00078819|12073346|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
7657731|NCT00078819|12073347|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
7657732|NCT00078819|12073348|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
7657733|NCT00078819|12073349|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
7657734|NCT00078819|12073346|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34
7657735|NCT00078819|12073347|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25
7657736|NCT00078819|12073348|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
7657737|NCT00078819|12073349|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
7657738|NCT00078819|12073346|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
7657739|NCT00078819|12073347|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
7657740|NCT00078819|12073348|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29
7657741|NCT00078819|12073349|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13
7657742|NCT00078819|12073346|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
7657743|NCT00078819|12073347|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
7657744|NCT00078819|12073348|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
7657745|NCT00078819|12073349|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1
7657746|NCT00078949|12073379|FG000|Overall Study|No treated|4
7657747|NCT00078949|12073380|FG001|Overall Study|No treated|5
7657748|NCT00078949|12073381|FG002|Overall Study|No treated|3
7657749|NCT00078949|12073382|FG003|Overall Study|No treated|3
7657750|NCT00079040|12073403|FG000|Overall Study|Withdrew before treatment|1
7657751|NCT00079040|12073403|FG000|Overall Study|Ineligible|1
7657752|NCT00079183|12073407|FG000|Overall Study|Withdrawal by Subject|4
7657753|NCT00079183|12073407|FG000|Overall Study|Study medication non-compliance|2
7657754|NCT00079183|12073407|FG000|Overall Study|Specimen collection non-compliance|1
7657755|NCT00079274|12073419|FG000|Overall Study|Withdrawal by Subject|111
7657756|NCT00079274|12073420|FG001|Overall Study|Withdrawal by Subject|10
7657757|NCT00079274|12073421|FG002|Overall Study|Withdrawal by Subject|12
7657758|NCT00079274|12073422|FG003|Overall Study|Withdrawal by Subject|163
7657759|NCT00079274|12073423|FG004|Overall Study|Withdrawal by Subject|7
7657760|NCT00079274|12073424|FG005|Overall Study|Withdrawal by Subject|8
7657761|NCT00079274|12073425|FG006|Overall Study|Withdrawal by Subject|0
7657762|NCT00079274|12073419|FG000|Overall Study|Adverse Event|130
7657763|NCT00079274|12073420|FG001|Overall Study|Adverse Event|8
7657764|NCT00079274|12073421|FG002|Overall Study|Adverse Event|8
7657765|NCT00079274|12073422|FG003|Overall Study|Adverse Event|184
7657766|NCT00079274|12073423|FG004|Overall Study|Adverse Event|7
7657767|NCT00079274|12073424|FG005|Overall Study|Adverse Event|8
7657768|NCT00079274|12073425|FG006|Overall Study|Adverse Event|0
7657769|NCT00079274|12073419|FG000|Overall Study|Recurrence|21
7657770|NCT00079274|12073420|FG001|Overall Study|Recurrence|0
7657771|NCT00079274|12073421|FG002|Overall Study|Recurrence|1
7657772|NCT00079274|12073422|FG003|Overall Study|Recurrence|15
7657773|NCT00079274|12073423|FG004|Overall Study|Recurrence|0
7657774|NCT00079274|12073424|FG005|Overall Study|Recurrence|2
7657775|NCT00079274|12073425|FG006|Overall Study|Recurrence|0
7657776|NCT00079274|12073419|FG000|Overall Study|Alternate Treatment|6
7657777|NCT00079274|12073420|FG001|Overall Study|Alternate Treatment|1
7657778|NCT00079274|12073421|FG002|Overall Study|Alternate Treatment|0
7657779|NCT00079274|12073422|FG003|Overall Study|Alternate Treatment|3
7657780|NCT00079274|12073423|FG004|Overall Study|Alternate Treatment|0
7657781|NCT00079274|12073424|FG005|Overall Study|Alternate Treatment|0
7657782|NCT00079274|12073425|FG006|Overall Study|Alternate Treatment|0
7657783|NCT00079274|12073419|FG000|Overall Study|Other Medical Problems|6
7657784|NCT00079274|12073420|FG001|Overall Study|Other Medical Problems|1
7657785|NCT00079274|12073421|FG002|Overall Study|Other Medical Problems|0
7657786|NCT00079274|12073422|FG003|Overall Study|Other Medical Problems|7
7657787|NCT00079274|12073423|FG004|Overall Study|Other Medical Problems|0
7657788|NCT00079274|12073424|FG005|Overall Study|Other Medical Problems|0
7657789|NCT00079274|12073425|FG006|Overall Study|Other Medical Problems|0
7657790|NCT00079274|12073419|FG000|Overall Study|Death|4
7657791|NCT00079274|12073420|FG001|Overall Study|Death|0
7657792|NCT00079274|12073421|FG002|Overall Study|Death|1
7657793|NCT00079274|12073422|FG003|Overall Study|Death|15
7657794|NCT00079274|12073423|FG004|Overall Study|Death|0
7657795|NCT00079274|12073424|FG005|Overall Study|Death|0
7657796|NCT00079274|12073425|FG006|Overall Study|Death|0
7657797|NCT00079274|12073419|FG000|Overall Study|Cytogenetic resistance|0
7657798|NCT00079274|12073420|FG001|Overall Study|Cytogenetic resistance|0
7657799|NCT00079274|12073421|FG002|Overall Study|Cytogenetic resistance|0
7657800|NCT00079274|12073422|FG003|Overall Study|Cytogenetic resistance|2
7657801|NCT00079274|12073423|FG004|Overall Study|Cytogenetic resistance|0
7657802|NCT00079274|12073424|FG005|Overall Study|Cytogenetic resistance|0
7657803|NCT00079274|12073425|FG006|Overall Study|Cytogenetic resistance|0
7657804|NCT00079274|12073419|FG000|Overall Study|Other|43
7657805|NCT00079274|12073420|FG001|Overall Study|Other|7
7657806|NCT00079274|12073421|FG002|Overall Study|Other|5
7657807|NCT00079274|12073422|FG003|Overall Study|Other|55
7657808|NCT00079274|12073423|FG004|Overall Study|Other|1
7657809|NCT00079274|12073424|FG005|Overall Study|Other|2
7657810|NCT00079274|12073425|FG006|Overall Study|Other|0
7657811|NCT00079339|12073449|FG000|Overall Study|Adverse Event|1
7657812|NCT00079339|12073450|FG001|Overall Study|Adverse Event|7
7657813|NCT00079339|12073451|FG002|Overall Study|Adverse Event|2
7657814|NCT00079339|12073449|FG000|Overall Study|Death|1
7657815|NCT00079339|12073450|FG001|Overall Study|Death|0
7657816|NCT00079339|12073451|FG002|Overall Study|Death|0
7657817|NCT00079339|12073449|FG000|Overall Study|Non-compliance|0
7657818|NCT00079339|12073450|FG001|Overall Study|Non-compliance|0
7657819|NCT00079339|12073451|FG002|Overall Study|Non-compliance|1
7657820|NCT00079339|12073449|FG000|Overall Study|Withdrawal by Subject|0
7657821|NCT00079339|12073450|FG001|Overall Study|Withdrawal by Subject|4
7657822|NCT00079339|12073451|FG002|Overall Study|Withdrawal by Subject|1
7657823|NCT00079339|12073449|FG000|Overall Study|Disease progression|3
7657824|NCT00079339|12073450|FG001|Overall Study|Disease progression|28
7657825|NCT00079339|12073451|FG002|Overall Study|Disease progression|2
7657826|NCT00079391|12073464|FG000|Overall Study|Withdrawal by Subject|1
7657827|NCT00079417|12073470|FG000|Overall Study|Physician Decision|2
7657828|NCT00079417|12073470|FG000|Overall Study|Ineligible|7
7657829|NCT00079677|12073476|FG000|Overall Study|Adverse Event|5
7657830|NCT00079677|12073477|FG001|Overall Study|Adverse Event|6
7657831|NCT00079677|12073476|FG000|Overall Study|Lack of Efficacy|1
7657832|NCT00079677|12073477|FG001|Overall Study|Lack of Efficacy|0
7657833|NCT00079677|12073476|FG000|Overall Study|Lost to Follow-up|2
7657834|NCT00079677|12073477|FG001|Overall Study|Lost to Follow-up|2
7657835|NCT00079677|12073476|FG000|Overall Study|Physician Decision|3
7657836|NCT00079677|12073477|FG001|Overall Study|Physician Decision|0
7657837|NCT00079677|12073476|FG000|Overall Study|Protocol Violation|2
7657838|NCT00079677|12073477|FG001|Overall Study|Protocol Violation|3
7657839|NCT00079677|12073476|FG000|Overall Study|Withdrawal by Subject|5
7657840|NCT00079677|12073477|FG001|Overall Study|Withdrawal by Subject|3
7657841|NCT00079677|12073476|FG000|Overall Study|Miscellaneous|2
7657842|NCT00079677|12073477|FG001|Overall Study|Miscellaneous|0
7657843|NCT00079781|12073486|FG000|Pre-implant Period|Withdrawal by Subject|2
7657844|NCT00079781|12073487|FG001|Pre-implant Period|Withdrawal by Subject|0
7657845|NCT00079781|12073488|FG002|Pre-implant Period|Withdrawal by Subject|0
7657846|NCT00079781|12073486|FG000|Pre-implant Period|Did not meet I/E criteria|1
7657847|NCT00079781|12073487|FG001|Pre-implant Period|Did not meet I/E criteria|1
7657848|NCT00079781|12073488|FG002|Pre-implant Period|Did not meet I/E criteria|1
7657849|NCT00079781|12073486|FG000|Follow-up Period|Withdrawal by Subject|3
7657850|NCT00079781|12073487|FG001|Follow-up Period|Withdrawal by Subject|0
7657851|NCT00079781|12073488|FG002|Follow-up Period|Withdrawal by Subject|1
7657852|NCT00079781|12073486|FG000|Follow-up Period|Lost to Follow-up|1
7657853|NCT00079781|12073487|FG001|Follow-up Period|Lost to Follow-up|0
7657854|NCT00079781|12073488|FG002|Follow-up Period|Lost to Follow-up|0
7657855|NCT00079781|12073486|FG000|Follow-up Period|Death|0
7657856|NCT00079781|12073487|FG001|Follow-up Period|Death|0
7657857|NCT00079781|12073488|FG002|Follow-up Period|Death|1
7657858|NCT00079937|12073496|FG000|Overall Study|Adverse Event|2
7657859|NCT00079937|12073497|FG001|Overall Study|Adverse Event|1
7657860|NCT00079937|12073496|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7657861|NCT00079937|12073497|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7657862|NCT00079937|12073496|FG000|Overall Study|Subject no longer requires study drug|3
7657863|NCT00079937|12073497|FG001|Overall Study|Subject no longer requires study drug|0
7657864|NCT00079937|12073496|FG000|Overall Study|Protocol Violation|8
7657865|NCT00079937|12073497|FG001|Overall Study|Protocol Violation|6
7657866|NCT00079937|12073496|FG000|Overall Study|Withdrawal by Subject|21
7657867|NCT00079937|12073497|FG001|Overall Study|Withdrawal by Subject|7
7657868|NCT00079937|12073496|FG000|Overall Study|Lost to Follow-up|12
7657869|NCT00079937|12073497|FG001|Overall Study|Lost to Follow-up|5
7657870|NCT00079937|12073496|FG000|Overall Study|Administrative problems|22
7657871|NCT00079937|12073497|FG001|Overall Study|Administrative problems|11
7657872|NCT00080119|12073507|FG000|Overall Study|Discontinued because of study closure|0
7657873|NCT00080119|12073508|FG001|Overall Study|Discontinued because of study closure|0
7657874|NCT00080119|12073509|FG002|Overall Study|Discontinued because of study closure|130
7657875|NCT00080119|12073510|FG003|Overall Study|Discontinued because of study closure|141
7657876|NCT00080119|12073507|FG000|Overall Study|Unable to get to clinic|24
7657877|NCT00080119|12073508|FG001|Overall Study|Unable to get to clinic|24
7657878|NCT00080119|12073509|FG002|Overall Study|Unable to get to clinic|7
7657879|NCT00080119|12073510|FG003|Overall Study|Unable to get to clinic|1
7657880|NCT00080119|12073507|FG000|Overall Study|Consent withdrawn|13
7657881|NCT00080119|12073508|FG001|Overall Study|Consent withdrawn|17
7657882|NCT00080119|12073509|FG002|Overall Study|Consent withdrawn|4
7657883|NCT00080119|12073510|FG003|Overall Study|Consent withdrawn|6
7657884|NCT00080119|12073507|FG000|Overall Study|Unwilling to adhere to study requirement|3
7657885|NCT00080119|12073508|FG001|Overall Study|Unwilling to adhere to study requirement|2
7657886|NCT00080119|12073509|FG002|Overall Study|Unwilling to adhere to study requirement|5
7657887|NCT00080119|12073510|FG003|Overall Study|Unwilling to adhere to study requirement|1
7657888|NCT00080119|12073507|FG000|Overall Study|Lost to Follow-up|16
7657889|NCT00080119|12073508|FG001|Overall Study|Lost to Follow-up|19
7657890|NCT00080119|12073509|FG002|Overall Study|Lost to Follow-up|19
7657891|NCT00080119|12073510|FG003|Overall Study|Lost to Follow-up|14
7657892|NCT00080223|12073522|FG000|Overall Study|Adverse Event|23
7657893|NCT00080223|12073522|FG000|Overall Study|Death|21
7657894|NCT00080223|12073522|FG000|Overall Study|Withdrawal by Subject|13
7657895|NCT00080223|12073522|FG000|Overall Study|Lung Transplantation|9
7657896|NCT00080223|12073522|FG000|Overall Study|Non-compliance With Study Treatment|7
7657897|NCT00080223|12073522|FG000|Overall Study|Participant unwilling to continue|2
7657898|NCT00080223|12073522|FG000|Overall Study|Physician Decision|1
7657899|NCT00080288|12073528|FG000|Overall Study|Adverse Event|7
7657900|NCT00080288|12073529|FG001|Overall Study|Adverse Event|4
7657901|NCT00080288|12073528|FG000|Overall Study|Lost to Follow-up|3
7657902|NCT00080288|12073529|FG001|Overall Study|Lost to Follow-up|5
7657903|NCT00080288|12073528|FG000|Overall Study|Physician Decision|6
7657904|NCT00080288|12073529|FG001|Overall Study|Physician Decision|2
7657905|NCT00080288|12073528|FG000|Overall Study|Withdrawal by Subject|3
7657906|NCT00080288|12073529|FG001|Overall Study|Withdrawal by Subject|16
7657907|NCT00080288|12073528|FG000|Overall Study|Miscellaneous|11
7657908|NCT00080288|12073529|FG001|Overall Study|Miscellaneous|11
7657909|NCT00080301|12073537|FG000|Overall Study|Randomized but Never Treated|5
7657910|NCT00080301|12073538|FG001|Overall Study|Randomized but Never Treated|10
7657911|NCT00080301|12073537|FG000|Overall Study|Still on Treatment as of CSR date|0
7657912|NCT00080301|12073538|FG001|Overall Study|Still on Treatment as of CSR date|1
7657913|NCT00080483|12073558|FG000|Overall Study|Lost to Follow-up|1
7657914|NCT00080483|12073559|FG001|Overall Study|Lost to Follow-up|1
7657915|NCT00080483|12073558|FG000|Overall Study|Physician Decision|1
7657916|NCT00080483|12073559|FG001|Overall Study|Physician Decision|1
7657917|NCT00080899|12073569|FG000|Overall Study|Adverse Event|1
7657918|NCT00080938|12073582|FG000|Overall Study|Adverse Event|3
7657919|NCT00080938|12073582|FG000|Overall Study|Withdrawal by Subject|6
7657920|NCT00080938|12073582|FG000|Overall Study|Death|2
7657921|NCT00080938|12073582|FG000|Overall Study|Lack of Efficacy|7
7657922|NCT00080938|12073582|FG000|Overall Study|other disease|1
7657923|NCT00080938|12073582|FG000|Overall Study|Not started protocol therapy|1
7657924|NCT00080938|12073582|FG000|Overall Study|Ineligible|4
7657925|NCT00081159|12073588|FG000|Overall Study|Withdrawal by Subject|0
7657926|NCT00081159|12073589|FG001|Overall Study|Withdrawal by Subject|3
7657927|NCT00081159|12073588|FG000|Overall Study|Myelosuppression prior to treatment|0
7657928|NCT00081159|12073589|FG001|Overall Study|Myelosuppression prior to treatment|1
7657929|NCT00081159|12073588|FG000|Overall Study|Lost to Follow-up|2
7657930|NCT00081159|12073589|FG001|Overall Study|Lost to Follow-up|1
7657931|NCT00081263|12073597|FG000|Overall Study|clerical error|1
7657932|NCT00081263|12073598|FG001|Overall Study|clerical error|0
7657933|NCT00081263|12073597|FG000|Overall Study|wrong cell type|7
7657934|NCT00081263|12073598|FG001|Overall Study|wrong cell type|5
7657935|NCT00081263|12073597|FG000|Overall Study|improper pre-protocol therapy|0
7657936|NCT00081263|12073598|FG001|Overall Study|improper pre-protocol therapy|1
7657937|NCT00081263|12073597|FG000|Overall Study|Inadequate pathology|0
7657938|NCT00081263|12073598|FG001|Overall Study|Inadequate pathology|1
7657939|NCT00081263|12073597|FG000|Overall Study|Never treated|4
7657940|NCT00081263|12073598|FG001|Overall Study|Never treated|5
7657941|NCT00081263|12073597|FG000|Overall Study|Inadequate data|5
7657942|NCT00081263|12073598|FG001|Overall Study|Inadequate data|10
7657943|NCT00081289|12073606|FG000|Overall Study|Accrued prior to chemotherapy amendment|18
7657944|NCT00081289|12073607|FG001|Overall Study|Accrued prior to chemotherapy amendment|17
7657945|NCT00081289|12073606|FG000|Overall Study|Ineligible / no protocol treatment|3
7657946|NCT00081289|12073607|FG001|Overall Study|Ineligible / no protocol treatment|4
7657947|NCT00081458|12073631|FG000|Overall Study|Adverse Event|1
7657948|NCT00081458|12073632|FG001|Overall Study|Adverse Event|5
7657949|NCT00081458|12073633|FG002|Overall Study|Adverse Event|2
7657950|NCT00081458|12073631|FG000|Overall Study|Withdrawal by Subject|0
7657951|NCT00081458|12073632|FG001|Overall Study|Withdrawal by Subject|3
7657952|NCT00081458|12073633|FG002|Overall Study|Withdrawal by Subject|1
7657953|NCT00081458|12073631|FG000|Overall Study|Randomized but not dosed|0
7657954|NCT00081458|12073632|FG001|Overall Study|Randomized but not dosed|0
7657955|NCT00081458|12073633|FG002|Overall Study|Randomized but not dosed|1
7657956|NCT00081497|12073644|FG000|Overall Study|Adverse Event|2
7657957|NCT00081497|12073645|FG001|Overall Study|Adverse Event|0
7657958|NCT00081497|12073644|FG000|Overall Study|Death|0
7657959|NCT00081497|12073645|FG001|Overall Study|Death|1
7657960|NCT00081497|12073644|FG000|Overall Study|Withdrawal by Subject|1
7657961|NCT00081497|12073645|FG001|Overall Study|Withdrawal by Subject|0
7657962|NCT00081497|12073644|FG000|Overall Study|Non-compliance|0
7657963|NCT00081497|12073645|FG001|Overall Study|Non-compliance|1
7657964|NCT00081653|12073659|FG000|Overall Study|Adverse Event|23
7657965|NCT00081653|12073660|FG001|Overall Study|Adverse Event|17
7657966|NCT00081653|12073659|FG000|Overall Study|Lost to Follow-up|2
7657967|NCT00081653|12073660|FG001|Overall Study|Lost to Follow-up|4
7657968|NCT00081653|12073659|FG000|Overall Study|Refused Treatment|18
7657969|NCT00081653|12073660|FG001|Overall Study|Refused Treatment|14
7657970|NCT00081653|12073659|FG000|Overall Study|Low bone mineral density|1
7657971|NCT00081653|12073660|FG001|Overall Study|Low bone mineral density|0
7657972|NCT00081653|12073659|FG000|Overall Study|Bone loss|2
7657973|NCT00081653|12073660|FG001|Overall Study|Bone loss|0
7657974|NCT00081653|12073659|FG000|Overall Study|Participant leaving country|1
7657975|NCT00081653|12073660|FG001|Overall Study|Participant leaving country|0
7657976|NCT00081653|12073659|FG000|Overall Study|Loss of bone mass|0
7657977|NCT00081653|12073660|FG001|Overall Study|Loss of bone mass|2
7657978|NCT00081731|12073669|FG000|Overall Study|scientific integrity issue|8
7657979|NCT00081731|12073670|FG001|Overall Study|scientific integrity issue|8
7657980|NCT00081770|12073679|FG000|Overall Study|Adverse Event|130
7657981|NCT00081770|12073680|FG001|Overall Study|Adverse Event|98
7657982|NCT00081770|12073681|FG002|Overall Study|Adverse Event|136
7657983|NCT00081770|12073679|FG000|Overall Study|Lack of Efficacy|262
7657984|NCT00081770|12073680|FG001|Overall Study|Lack of Efficacy|357
7657985|NCT00081770|12073681|FG002|Overall Study|Lack of Efficacy|211
7657986|NCT00081770|12073679|FG000|Overall Study|Lost to Follow-up|45
7657987|NCT00081770|12073680|FG001|Overall Study|Lost to Follow-up|34
7657988|NCT00081770|12073681|FG002|Overall Study|Lost to Follow-up|45
7657989|NCT00081770|12073679|FG000|Overall Study|Protocol Violation|15
7657990|NCT00081770|12073680|FG001|Overall Study|Protocol Violation|10
7657991|NCT00081770|12073681|FG002|Overall Study|Protocol Violation|10
7657992|NCT00081770|12073679|FG000|Overall Study|Withdrawal by Subject|45
7657993|NCT00081770|12073680|FG001|Overall Study|Withdrawal by Subject|40
7657994|NCT00081770|12073681|FG002|Overall Study|Withdrawal by Subject|42
7657995|NCT00081770|12073679|FG000|Overall Study|Did not meet protocol eligibility|2
7657996|NCT00081770|12073680|FG001|Overall Study|Did not meet protocol eligibility|0
7657997|NCT00081770|12073681|FG002|Overall Study|Did not meet protocol eligibility|3
7657998|NCT00081770|12073679|FG000|Overall Study|Administrative|1
7657999|NCT00081770|12073680|FG001|Overall Study|Administrative|0
7658000|NCT00081770|12073681|FG002|Overall Study|Administrative|1
7658001|NCT00081770|12073679|FG000|Overall Study|Other|2
7658002|NCT00081770|12073680|FG001|Overall Study|Other|7
7658003|NCT00081770|12073681|FG002|Overall Study|Other|8
7658004|NCT00082173|12073706|FG000|Overall Study|Withdrawal by Subject|3
7658005|NCT00082173|12073707|FG001|Overall Study|Withdrawal by Subject|5
7658006|NCT00082173|12073706|FG000|Overall Study|Lost to Follow-up|1
7658007|NCT00082173|12073707|FG001|Overall Study|Lost to Follow-up|0
7658008|NCT00082173|12073706|FG000|Overall Study|Adverse Event|1
7658009|NCT00082173|12073707|FG001|Overall Study|Adverse Event|0
7658010|NCT00082173|12073706|FG000|Overall Study|Culture negative or resistant at baselin|5
7658011|NCT00082173|12073707|FG001|Overall Study|Culture negative or resistant at baselin|6
7658012|NCT00082355|12073740|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
7658013|NCT00082355|12073740|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
7658014|NCT00082355|12073740|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
7658015|NCT00082368|12073744|FG000|Overall Study|Not treated-pt had poor IV access|1
7658016|NCT00082381|12073750|FG000|Overall Study|Adverse Event|27
7658017|NCT00082381|12073751|FG001|Overall Study|Adverse Event|2
7658018|NCT00082381|12073750|FG000|Overall Study|Lost to Follow-up|5
7658019|NCT00082381|12073751|FG001|Overall Study|Lost to Follow-up|7
7658020|NCT00082381|12073750|FG000|Overall Study|Patient Decision|8
7658021|NCT00082381|12073751|FG001|Overall Study|Patient Decision|4
7658022|NCT00082381|12073750|FG000|Overall Study|Physician Decision|1
7658023|NCT00082381|12073751|FG001|Overall Study|Physician Decision|2
7658024|NCT00082381|12073750|FG000|Overall Study|Protocol Violation|10
7658025|NCT00082381|12073751|FG001|Overall Study|Protocol Violation|11
7658026|NCT00082381|12073750|FG000|Overall Study|Loss of Glucose Control|4
7658027|NCT00082381|12073751|FG001|Overall Study|Loss of Glucose Control|0
7658028|NCT00082407|12073759|FG000|Overall Study|Adverse Event|20
7658029|NCT00082407|12073760|FG001|Overall Study|Adverse Event|0
7658030|NCT00082407|12073759|FG000|Overall Study|Protocol Violation|14
7658031|NCT00082407|12073760|FG001|Overall Study|Protocol Violation|12
7658032|NCT00082407|12073759|FG000|Overall Study|Patient Decision|13
7658033|NCT00082407|12073760|FG001|Overall Study|Patient Decision|6
7658034|NCT00082407|12073759|FG000|Overall Study|Physician Decision|5
7658035|NCT00082407|12073760|FG001|Overall Study|Physician Decision|3
7658036|NCT00082407|12073759|FG000|Overall Study|Loss of Glucose Control|2
7658037|NCT00082407|12073760|FG001|Overall Study|Loss of Glucose Control|2
7658038|NCT00082407|12073759|FG000|Overall Study|Death|2
7658039|NCT00082407|12073760|FG001|Overall Study|Death|1
7658040|NCT00082407|12073759|FG000|Overall Study|Lost to Follow-up|0
7658041|NCT00082407|12073760|FG001|Overall Study|Lost to Follow-up|3
7658042|NCT00082433|12073768|FG000|Overall Study|Adverse Event|12
7658043|NCT00082433|12073769|FG001|Overall Study|Adverse Event|17
7658044|NCT00082433|12073768|FG000|Overall Study|Death|8
7658045|NCT00082433|12073769|FG001|Overall Study|Death|18
7658046|NCT00082433|12073768|FG000|Overall Study|Disease Progression/Relapse|270
7658047|NCT00082433|12073769|FG001|Overall Study|Disease Progression/Relapse|388
7658048|NCT00082433|12073768|FG000|Overall Study|Physician Decision|50
7658049|NCT00082433|12073769|FG001|Overall Study|Physician Decision|61
7658050|NCT00082433|12073768|FG000|Overall Study|Lost to Follow-up|1
7658051|NCT00082433|12073769|FG001|Overall Study|Lost to Follow-up|2
7658052|NCT00082433|12073768|FG000|Overall Study|Study Drug Toxicity|179
7658053|NCT00082433|12073769|FG001|Overall Study|Study Drug Toxicity|66
7658054|NCT00082433|12073768|FG000|Overall Study|Withdrawal by Subject|55
7658055|NCT00082433|12073769|FG001|Overall Study|Withdrawal by Subject|30
7658056|NCT00082433|12073768|FG000|Overall Study|Still On Treatment|2
7658057|NCT00082433|12073769|FG001|Overall Study|Still On Treatment|1
7658058|NCT00082433|12073768|FG000|Overall Study|Not Treated|12
7658059|NCT00082433|12073769|FG001|Overall Study|Not Treated|11
7658060|NCT00082433|12073768|FG000|Overall Study|Ineligible|2
7658061|NCT00082433|12073769|FG001|Overall Study|Ineligible|1
7658062|NCT00082433|12073768|FG000|Overall Study|Noncompliance|2
7658063|NCT00082433|12073769|FG001|Overall Study|Noncompliance|1
7658064|NCT00082433|12073768|FG000|Overall Study|New primary cancer|1
7658065|NCT00082433|12073769|FG001|Overall Study|New primary cancer|0
7658066|NCT00082433|12073768|FG000|Overall Study|Impending surgery|0
7658067|NCT00082433|12073769|FG001|Overall Study|Impending surgery|1
7658068|NCT00082628|12073777|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
7658069|NCT00082628|12073778|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
7658070|NCT00082628|12073779|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
7658071|NCT00082628|12073780|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
7658072|NCT00082628|12073781|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
7658073|NCT00082628|12073777|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
7658074|NCT00082628|12073778|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
7658075|NCT00082628|12073779|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
7658076|NCT00082628|12073780|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
7658077|NCT00082628|12073781|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
7658078|NCT00082628|12073777|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
7658079|NCT00082628|12073778|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
7658080|NCT00082628|12073779|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
7658081|NCT00082628|12073780|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
7658082|NCT00082628|12073781|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
7658083|NCT00082628|12073777|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
7658084|NCT00082628|12073778|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
7658085|NCT00082628|12073779|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
7658166|NCT00084136|12073905|FG002|PI Comparison|Clinic site closed|0
7658086|NCT00082628|12073780|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
7658087|NCT00082628|12073781|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
7658088|NCT00082628|12073777|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
7658089|NCT00082628|12073778|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
7658090|NCT00082628|12073779|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
7658091|NCT00082628|12073780|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
7658092|NCT00082628|12073781|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
7658093|NCT00082628|12073777|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
7658094|NCT00082628|12073778|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
7658095|NCT00082628|12073779|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
7658096|NCT00082628|12073780|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
7658097|NCT00082628|12073781|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
7658098|NCT00082628|12073777|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
7658099|NCT00082628|12073778|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
7658100|NCT00082628|12073779|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
7658101|NCT00082628|12073780|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
7658102|NCT00082628|12073781|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
7658103|NCT00082758|12073806|FG000|Overall Study|Adverse Event|0
7658104|NCT00082758|12073807|FG001|Overall Study|Adverse Event|2
7658105|NCT00082758|12073808|FG002|Overall Study|Adverse Event|0
7658106|NCT00082758|12073806|FG000|Overall Study|Lack of Efficacy|12
7658107|NCT00082758|12073807|FG001|Overall Study|Lack of Efficacy|13
7658108|NCT00082758|12073808|FG002|Overall Study|Lack of Efficacy|0
7658109|NCT00082758|12073806|FG000|Overall Study|Physician Decision|0
7658110|NCT00082758|12073807|FG001|Overall Study|Physician Decision|1
7658111|NCT00082758|12073808|FG002|Overall Study|Physician Decision|0
7658112|NCT00082758|12073806|FG000|Overall Study|Withdrawal by Subject|3
7658113|NCT00082758|12073807|FG001|Overall Study|Withdrawal by Subject|0
7658114|NCT00082758|12073808|FG002|Overall Study|Withdrawal by Subject|0
7658115|NCT00082758|12073806|FG000|Overall Study|Protocol Violation|0
7658116|NCT00082758|12073807|FG001|Overall Study|Protocol Violation|1
7658117|NCT00082758|12073808|FG002|Overall Study|Protocol Violation|0
7658118|NCT00082810|12073816|FG000|Overall Study|Adverse Event|3
7658119|NCT00082810|12073816|FG000|Overall Study|Progressive disease|24
7658120|NCT00082810|12073816|FG000|Overall Study|Withdrawal by Subject|4
7658121|NCT00082888|12073824|FG000|Overall Study|Ineligible|1
7658122|NCT00082888|12073825|FG001|Overall Study|Ineligible|0
7658123|NCT00082888|12073826|FG002|Overall Study|Ineligible|0
7658124|NCT00083226|12073858|FG000|Overall Study|Lack of Efficacy|19
7658125|NCT00083226|12073858|FG000|Overall Study|Adverse Event|9
7658126|NCT00083226|12073858|FG000|Overall Study|Death|4
7658127|NCT00083226|12073858|FG000|Overall Study|Withdrawal by Subject|4
7658128|NCT00083226|12073858|FG000|Overall Study|Other|2
7658129|NCT00083226|12073858|FG000|Overall Study|ineligible or not receiving treatment|4
7658130|NCT00083616|12073875|FG000|Overall Study|Disease Progression|16
7658131|NCT00083616|12073875|FG000|Overall Study|Lost to Follow-up|1
7658132|NCT00083616|12073875|FG000|Overall Study|Physician Decision|2
7658133|NCT00083616|12073875|FG000|Overall Study|Withdrawal by Subject|3
7658134|NCT00083616|12073875|FG000|Overall Study|Ineligibility determined|2
7658135|NCT00083616|12073875|FG000|Overall Study|Non-compliance|1
7658136|NCT00083616|12073875|FG000|Overall Study|Other|6
7658137|NCT00083889|12073885|FG000|Overall Study|Adverse Event|76
7658138|NCT00083889|12073886|FG001|Overall Study|Adverse Event|86
7658139|NCT00083889|12073885|FG000|Overall Study|Protocol Violation|2
7658140|NCT00083889|12073886|FG001|Overall Study|Protocol Violation|2
7658141|NCT00083889|12073885|FG000|Overall Study|Withdrawal by Subject|22
7658142|NCT00083889|12073886|FG001|Overall Study|Withdrawal by Subject|24
7658143|NCT00083889|12073885|FG000|Overall Study|Lack of Efficacy|240
7658144|NCT00083889|12073886|FG001|Overall Study|Lack of Efficacy|219
7658145|NCT00083889|12073885|FG000|Overall Study|Decision of sponsor|32
7658146|NCT00083889|12073886|FG001|Overall Study|Decision of sponsor|4
7658147|NCT00083889|12073885|FG000|Overall Study|Randomized: did not take study drug|0
7658148|NCT00083889|12073886|FG001|Overall Study|Randomized: did not take study drug|15
7658149|NCT00083889|12073885|FG000|Overall Study|Completed on marketed sunitinub|3
7658150|NCT00083889|12073886|FG001|Overall Study|Completed on marketed sunitinub|0
7658151|NCT00083889|12073885|FG000|Overall Study|Crossover to SU011248|0
7658152|NCT00083889|12073886|FG001|Overall Study|Crossover to SU011248|25
7658153|NCT00084084|12073895|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
7658154|NCT00084084|12073895|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
7658155|NCT00084136|12073903|FG000|PI Comparison|Death|10
7658156|NCT00084136|12073904|FG001|PI Comparison|Death|9
7658157|NCT00084136|12073905|FG002|PI Comparison|Death|0
7658158|NCT00084136|12073903|FG000|PI Comparison|Lost to Follow-up|11
7658159|NCT00084136|12073904|FG001|PI Comparison|Lost to Follow-up|8
7658160|NCT00084136|12073905|FG002|PI Comparison|Lost to Follow-up|0
7658161|NCT00084136|12073903|FG000|PI Comparison|Withdrawal by Subject|33
7658162|NCT00084136|12073904|FG001|PI Comparison|Withdrawal by Subject|30
7658163|NCT00084136|12073905|FG002|PI Comparison|Withdrawal by Subject|0
7658164|NCT00084136|12073903|FG000|PI Comparison|Clinic site closed|1
7658165|NCT00084136|12073904|FG001|PI Comparison|Clinic site closed|0
7658167|NCT00084136|12073903|FG000|NRTI Comparison|Death|20
7658168|NCT00084136|12073904|FG001|NRTI Comparison|Death|0
7658169|NCT00084136|12073905|FG002|NRTI Comparison|Death|18
7658170|NCT00084136|12073903|FG000|NRTI Comparison|Lost to Follow-up|14
7658171|NCT00084136|12073904|FG001|NRTI Comparison|Lost to Follow-up|0
7658172|NCT00084136|12073905|FG002|NRTI Comparison|Lost to Follow-up|12
7658173|NCT00084136|12073903|FG000|NRTI Comparison|Withdrawal by Subject|54
7658174|NCT00084136|12073904|FG001|NRTI Comparison|Withdrawal by Subject|0
7658175|NCT00084136|12073905|FG002|NRTI Comparison|Withdrawal by Subject|38
7658176|NCT00084136|12073903|FG000|NRTI Comparison|Clinic site closed|12
7658177|NCT00084136|12073904|FG001|NRTI Comparison|Clinic site closed|0
7658178|NCT00084136|12073905|FG002|NRTI Comparison|Clinic site closed|14
7658179|NCT00084136|12073903|FG000|NRTI Comparison|Not reason above|1
7658180|NCT00084136|12073904|FG001|NRTI Comparison|Not reason above|0
7658181|NCT00084136|12073905|FG002|NRTI Comparison|Not reason above|0
7658182|NCT00084266|12073929|FG000|Overall Study|Death|42
7658183|NCT00084266|12073930|FG001|Overall Study|Death|39
7658184|NCT00084266|12073929|FG000|Overall Study|Adverse Event|8
7658185|NCT00084266|12073930|FG001|Overall Study|Adverse Event|5
7658186|NCT00084266|12073929|FG000|Overall Study|Lack of Efficacy|2
7658187|NCT00084266|12073930|FG001|Overall Study|Lack of Efficacy|4
7658188|NCT00084266|12073929|FG000|Overall Study|Lost to Follow-up|5
7658189|NCT00084266|12073930|FG001|Overall Study|Lost to Follow-up|3
7658190|NCT00084266|12073929|FG000|Overall Study|Participant not willing to participate|3
7658191|NCT00084266|12073930|FG001|Overall Study|Participant not willing to participate|8
7658192|NCT00084266|12073929|FG000|Overall Study|Other|360
7658193|NCT00084266|12073930|FG001|Overall Study|Other|344
7658194|NCT00084266|12073929|FG000|Overall Study|Randomized not treated|21
7658195|NCT00084266|12073930|FG001|Overall Study|Randomized not treated|20
7658196|NCT00084318|12073938|FG000|Overall Study|Withdrawal by Subject|5
7658197|NCT00084318|12073939|FG001|Overall Study|Withdrawal by Subject|2
7658198|NCT00084318|12073938|FG000|Overall Study|Protocol Violation|15
7658199|NCT00084318|12073939|FG001|Overall Study|Protocol Violation|11
7658200|NCT00084318|12073938|FG000|Overall Study|No protocol treatment|2
7658201|NCT00084318|12073939|FG001|Overall Study|No protocol treatment|0
7658202|NCT00084487|12073962|FG000|Overall Study|Death|1
7658203|NCT00084617|12073975|FG000|Overall Study|Withdrawal by Subject|7
7658204|NCT00084617|12073975|FG000|Overall Study|Lack of Efficacy|1
7658205|NCT00084617|12073975|FG000|Overall Study|Protocol Violation|1
7658206|NCT00084682|12073979|FG000|Overall Study|Withdrawal by Subject|1
7658207|NCT00084747|12073984|FG000|Overall Study|Relapsed|8
7658208|NCT00084747|12073984|FG000|Overall Study|Death|3
7658209|NCT00084747|12073984|FG000|Overall Study|Withdrawal by Subject|2
7658210|NCT00084838|12073989|FG000|Overall Study|Death|1
7658211|NCT00084838|12073989|FG000|Overall Study|Adverse Event|2
7658212|NCT00084838|12073989|FG000|Overall Study|Withdrawal by Subject|1
7658213|NCT00084838|12073989|FG000|Overall Study|Progressive Disease|4
7658214|NCT00084838|12073989|FG000|Overall Study|Pt Non-Compliance|1
7658215|NCT00084838|12073989|FG000|Overall Study|Ineligible|4
7658216|NCT00084864|12073999|FG000|Overall Study|Adverse Event|1
7658217|NCT00084864|12074000|FG001|Overall Study|Adverse Event|0
7658218|NCT00084864|12074001|FG002|Overall Study|Adverse Event|0
7658219|NCT00084864|12074002|FG003|Overall Study|Adverse Event|0
7658220|NCT00084929|12074012|FG000|Overall Study|ineligible - medical contraindication|1
7658221|NCT00084929|12074012|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1
7658222|NCT00084929|12074012|FG000|Overall Study|Ineligible - Medical history|6
7658223|NCT00084929|12074012|FG000|Overall Study|Withdrawal by Subject|10
7658224|NCT00084929|12074012|FG000|Overall Study|Missing/incomplete CTC exam|9
7658225|NCT00084929|12074012|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42
7658226|NCT00085098|12074022|FG000|Overall Study|Withdrawal by Subject|0
7658227|NCT00085098|12074023|FG001|Overall Study|Withdrawal by Subject|1
7658228|NCT00085098|12074022|FG000|Overall Study|Ineligible|1
7658229|NCT00085098|12074023|FG001|Overall Study|Ineligible|1
7658230|NCT00085423|12074060|FG000|Overall Study|Withdrawal by Subject|1
7658231|NCT00085423|12074060|FG000|Overall Study|screen failure|1
7658232|NCT00085540|12074071|FG000|Overall Study|Withdrawal by Subject|0
7658233|NCT00085540|12074072|FG001|Overall Study|Withdrawal by Subject|1
7658234|NCT00085540|12074071|FG000|Overall Study|Protocol Violation|0
7658235|NCT00085540|12074072|FG001|Overall Study|Protocol Violation|1
7658236|NCT00085566|12074081|FG000|Overall Study|Adverse Event|0
7658237|NCT00085566|12074082|FG001|Overall Study|Adverse Event|0
7658238|NCT00085566|12074083|FG002|Overall Study|Adverse Event|10
7658239|NCT00085566|12074081|FG000|Overall Study|Patient Not treated|0
7658240|NCT00085566|12074082|FG001|Overall Study|Patient Not treated|0
7658241|NCT00085566|12074083|FG002|Overall Study|Patient Not treated|3
7658242|NCT00085566|12074081|FG000|Overall Study|Clinical progression|0
7658243|NCT00085566|12074082|FG001|Overall Study|Clinical progression|0
7658244|NCT00085566|12074083|FG002|Overall Study|Clinical progression|1
7658245|NCT00085644|12074093|FG000|Double-Blind Period|Adverse Event|5
7658246|NCT00085644|12074094|FG001|Double-Blind Period|Adverse Event|2
7658247|NCT00085644|12074095|FG002|Double-Blind Period|Adverse Event|0
7658248|NCT00085644|12074093|FG000|Double-Blind Period|Withdrawal by Subject|3
7658249|NCT00085644|12074094|FG001|Double-Blind Period|Withdrawal by Subject|0
7658250|NCT00085644|12074095|FG002|Double-Blind Period|Withdrawal by Subject|0
7658251|NCT00085644|12074093|FG000|Double-Blind Period|Lost to Follow-up|2
7658252|NCT00085644|12074094|FG001|Double-Blind Period|Lost to Follow-up|1
7658253|NCT00085644|12074095|FG002|Double-Blind Period|Lost to Follow-up|0
7658254|NCT00085644|12074093|FG000|Double-Blind Period|Lack/loss of efficacy|2
7658255|NCT00085644|12074094|FG001|Double-Blind Period|Lack/loss of efficacy|2
7658256|NCT00085644|12074095|FG002|Double-Blind Period|Lack/loss of efficacy|0
7658257|NCT00085644|12074093|FG000|Double-Blind Period|Contemplating pregnancy|1
7658258|NCT00085644|12074094|FG001|Double-Blind Period|Contemplating pregnancy|0
7658259|NCT00085644|12074095|FG002|Double-Blind Period|Contemplating pregnancy|0
7658260|NCT00085644|12074093|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0
7658261|NCT00085644|12074094|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1
7658262|NCT00085644|12074095|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0
7658263|NCT00085644|12074093|FG000|Open-Label Period|Adverse Event|0
7658264|NCT00085644|12074094|FG001|Open-Label Period|Adverse Event|0
7658265|NCT00085644|12074095|FG002|Open-Label Period|Adverse Event|38
7658266|NCT00085644|12074093|FG000|Open-Label Period|Withdrawal by Subject|0
7658267|NCT00085644|12074094|FG001|Open-Label Period|Withdrawal by Subject|0
7658268|NCT00085644|12074095|FG002|Open-Label Period|Withdrawal by Subject|29
7658269|NCT00085644|12074093|FG000|Open-Label Period|Lost to Follow-up|0
7658270|NCT00085644|12074094|FG001|Open-Label Period|Lost to Follow-up|0
7658271|NCT00085644|12074095|FG002|Open-Label Period|Lost to Follow-up|13
7658272|NCT00085644|12074093|FG000|Open-Label Period|Lack of Efficacy|0
7658273|NCT00085644|12074094|FG001|Open-Label Period|Lack of Efficacy|0
7658274|NCT00085644|12074095|FG002|Open-Label Period|Lack of Efficacy|15
7658275|NCT00085644|12074093|FG000|Open-Label Period|Pregnancy|0
7658276|NCT00085644|12074094|FG001|Open-Label Period|Pregnancy|0
7658277|NCT00085644|12074095|FG002|Open-Label Period|Pregnancy|3
7658278|NCT00085644|12074093|FG000|Open-Label Period|Contemplating pregnancy|0
7658279|NCT00085644|12074094|FG001|Open-Label Period|Contemplating pregnancy|0
7658280|NCT00085644|12074095|FG002|Open-Label Period|Contemplating pregnancy|3
7658281|NCT00085644|12074093|FG000|Open-Label Period|Protocol Violation|0
7658282|NCT00085644|12074094|FG001|Open-Label Period|Protocol Violation|0
7658283|NCT00085644|12074095|FG002|Open-Label Period|Protocol Violation|4
7658284|NCT00085644|12074093|FG000|Open-Label Period|Personal reason|0
7658285|NCT00085644|12074094|FG001|Open-Label Period|Personal reason|0
7658286|NCT00085644|12074095|FG002|Open-Label Period|Personal reason|4
7658287|NCT00085709|12074104|FG000|Overall Study|Adverse Event|8
7658288|NCT00085709|12074105|FG001|Overall Study|Adverse Event|0
7658289|NCT00085709|12074104|FG000|Overall Study|Death|8
7658290|NCT00085709|12074105|FG001|Overall Study|Death|2
7658291|NCT00085709|12074104|FG000|Overall Study|Refusal unrelated to adverse events|1
7658292|NCT00085709|12074105|FG001|Overall Study|Refusal unrelated to adverse events|2
7658293|NCT00085709|12074104|FG000|Overall Study|Progression|3
7658294|NCT00085709|12074105|FG001|Overall Study|Progression|4
7658295|NCT00085709|12074104|FG000|Overall Study|Not protocol specified|12
7658296|NCT00085709|12074105|FG001|Overall Study|Not protocol specified|22
7658297|NCT00085709|12074104|FG000|Overall Study|Not eligible|19
7658298|NCT00085709|12074105|FG001|Overall Study|Not eligible|19
7658299|NCT00085709|12074104|FG000|Overall Study|Withdrawal by Subject|2
7658300|NCT00085709|12074105|FG001|Overall Study|Withdrawal by Subject|1
7658301|NCT00085917|12074130|FG000|Overall Study|Adverse Event|4
7658302|NCT00085917|12074131|FG001|Overall Study|Adverse Event|3
7658303|NCT00086047|12074139|FG000|Overall Study|Lost to Follow-up|7
7658304|NCT00086047|12074140|FG001|Overall Study|Lost to Follow-up|6
7658305|NCT00086047|12074139|FG000|Overall Study|Physician Decision|0
7658306|NCT00086047|12074140|FG001|Overall Study|Physician Decision|1
7658307|NCT00086190|12074158|FG000|Overall Study|Adverse Event|6
7658308|NCT00086190|12074159|FG001|Overall Study|Adverse Event|2
7658309|NCT00086190|12074160|FG002|Overall Study|Adverse Event|2
7658310|NCT00086190|12074158|FG000|Overall Study|Withdrawal by Subject|0
7658311|NCT00086190|12074159|FG001|Overall Study|Withdrawal by Subject|2
7658312|NCT00086190|12074160|FG002|Overall Study|Withdrawal by Subject|2
7658313|NCT00086190|12074158|FG000|Overall Study|Protocol Violation|1
7658314|NCT00086190|12074159|FG001|Overall Study|Protocol Violation|0
7658315|NCT00086190|12074160|FG002|Overall Study|Protocol Violation|0
7658316|NCT00086190|12074158|FG000|Overall Study|Moved|1
7658317|NCT00086190|12074159|FG001|Overall Study|Moved|0
7658318|NCT00086190|12074160|FG002|Overall Study|Moved|0
7658319|NCT00086190|12074158|FG000|Overall Study|Worsening depression|0
7658320|NCT00086190|12074159|FG001|Overall Study|Worsening depression|0
7658321|NCT00086190|12074160|FG002|Overall Study|Worsening depression|2
7658322|NCT00086281|12074183|FG000|Phase 1|Adverse Event|0
7658323|NCT00086281|12074184|FG001|Phase 1|Adverse Event|0
7658324|NCT00086281|12074185|FG002|Phase 1|Adverse Event|0
7658325|NCT00086281|12074186|FG003|Phase 1|Adverse Event|0
7658326|NCT00086281|12074187|FG004|Phase 1|Adverse Event|0
7658327|NCT00086281|12074188|FG005|Phase 1|Adverse Event|0
7658328|NCT00086281|12074189|FG006|Phase 1|Adverse Event|0
7658329|NCT00086281|12074190|FG007|Phase 1|Adverse Event|0
7658330|NCT00086281|12074191|FG008|Phase 1|Adverse Event|0
7658331|NCT00086281|12074192|FG009|Phase 1|Adverse Event|1
7658332|NCT00086281|12074193|FG010|Phase 1|Adverse Event|2
7658333|NCT00086281|12074194|FG011|Phase 1|Adverse Event|1
7658334|NCT00086281|12074195|FG012|Phase 1|Adverse Event|1
7658335|NCT00086281|12074196|FG013|Phase 1|Adverse Event|1
7658336|NCT00086281|12074197|FG014|Phase 1|Adverse Event|2
7658337|NCT00086281|12074183|FG000|Phase 1|Protocol Violation|0
7658338|NCT00086281|12074184|FG001|Phase 1|Protocol Violation|0
7658339|NCT00086281|12074185|FG002|Phase 1|Protocol Violation|0
7658340|NCT00086281|12074186|FG003|Phase 1|Protocol Violation|0
7658341|NCT00086281|12074187|FG004|Phase 1|Protocol Violation|0
7658342|NCT00086281|12074188|FG005|Phase 1|Protocol Violation|0
7658343|NCT00086281|12074189|FG006|Phase 1|Protocol Violation|0
7658344|NCT00086281|12074190|FG007|Phase 1|Protocol Violation|0
7658345|NCT00086281|12074191|FG008|Phase 1|Protocol Violation|0
7658346|NCT00086281|12074192|FG009|Phase 1|Protocol Violation|0
7658347|NCT00086281|12074193|FG010|Phase 1|Protocol Violation|1
7658348|NCT00086281|12074194|FG011|Phase 1|Protocol Violation|0
7658349|NCT00086281|12074195|FG012|Phase 1|Protocol Violation|0
7658350|NCT00086281|12074196|FG013|Phase 1|Protocol Violation|0
7658351|NCT00086281|12074197|FG014|Phase 1|Protocol Violation|0
7658352|NCT00086281|12074183|FG000|Phase 1|Serious Adverse Event|0
7658353|NCT00086281|12074184|FG001|Phase 1|Serious Adverse Event|0
7658354|NCT00086281|12074185|FG002|Phase 1|Serious Adverse Event|0
7658355|NCT00086281|12074186|FG003|Phase 1|Serious Adverse Event|0
7658356|NCT00086281|12074187|FG004|Phase 1|Serious Adverse Event|0
7658357|NCT00086281|12074188|FG005|Phase 1|Serious Adverse Event|0
7658358|NCT00086281|12074189|FG006|Phase 1|Serious Adverse Event|0
7658359|NCT00086281|12074190|FG007|Phase 1|Serious Adverse Event|0
7658360|NCT00086281|12074191|FG008|Phase 1|Serious Adverse Event|0
7658361|NCT00086281|12074192|FG009|Phase 1|Serious Adverse Event|0
7658362|NCT00086281|12074193|FG010|Phase 1|Serious Adverse Event|0
7658363|NCT00086281|12074194|FG011|Phase 1|Serious Adverse Event|0
7658364|NCT00086281|12074195|FG012|Phase 1|Serious Adverse Event|0
7658365|NCT00086281|12074196|FG013|Phase 1|Serious Adverse Event|0
7658366|NCT00086281|12074197|FG014|Phase 1|Serious Adverse Event|1
7658367|NCT00086281|12074183|FG000|Phase 2|Adverse Event|0
7658368|NCT00086281|12074184|FG001|Phase 2|Adverse Event|0
7658369|NCT00086281|12074185|FG002|Phase 2|Adverse Event|0
7658370|NCT00086281|12074186|FG003|Phase 2|Adverse Event|0
7658371|NCT00086281|12074187|FG004|Phase 2|Adverse Event|0
7658372|NCT00086281|12074188|FG005|Phase 2|Adverse Event|0
7658373|NCT00086281|12074189|FG006|Phase 2|Adverse Event|0
7658374|NCT00086281|12074190|FG007|Phase 2|Adverse Event|0
7658375|NCT00086281|12074191|FG008|Phase 2|Adverse Event|0
7658376|NCT00086281|12074192|FG009|Phase 2|Adverse Event|0
7658377|NCT00086281|12074193|FG010|Phase 2|Adverse Event|0
7658378|NCT00086281|12074194|FG011|Phase 2|Adverse Event|0
7658379|NCT00086281|12074195|FG012|Phase 2|Adverse Event|1
7658380|NCT00086281|12074196|FG013|Phase 2|Adverse Event|1
7658381|NCT00086281|12074197|FG014|Phase 2|Adverse Event|0
7658382|NCT00086307|12074210|FG000|Overall Study|Lack of Efficacy|1
7658383|NCT00086307|12074211|FG001|Overall Study|Lack of Efficacy|1
7658384|NCT00086307|12074212|FG002|Overall Study|Lack of Efficacy|2
7658385|NCT00086307|12074210|FG000|Overall Study|Shortness of breath and muscle spasms|1
7658386|NCT00086307|12074211|FG001|Overall Study|Shortness of breath and muscle spasms|0
7658387|NCT00086307|12074212|FG002|Overall Study|Shortness of breath and muscle spasms|0
7658388|NCT00086307|12074210|FG000|Overall Study|Nausea and headaches|0
7658389|NCT00086307|12074211|FG001|Overall Study|Nausea and headaches|0
7658390|NCT00086307|12074212|FG002|Overall Study|Nausea and headaches|1
7658391|NCT00086307|12074210|FG000|Overall Study|Constipation and sleepiness|0
7658392|NCT00086307|12074211|FG001|Overall Study|Constipation and sleepiness|0
7658393|NCT00086307|12074212|FG002|Overall Study|Constipation and sleepiness|1
7658394|NCT00086307|12074210|FG000|Overall Study|Suicidal ideation|0
7658395|NCT00086307|12074211|FG001|Overall Study|Suicidal ideation|0
7658396|NCT00086307|12074212|FG002|Overall Study|Suicidal ideation|1
7658397|NCT00086307|12074210|FG000|Overall Study|Fatigue and difficulty falling asleep|0
7658398|NCT00086307|12074211|FG001|Overall Study|Fatigue and difficulty falling asleep|0
7658399|NCT00086307|12074212|FG002|Overall Study|Fatigue and difficulty falling asleep|1
7658400|NCT00086307|12074210|FG000|Overall Study|Withdrawal by Subject|0
7658401|NCT00086307|12074211|FG001|Overall Study|Withdrawal by Subject|0
7658402|NCT00086307|12074212|FG002|Overall Study|Withdrawal by Subject|2
7658403|NCT00086346|12074222|FG000|Randomization|Did not receive test article|4
7658404|NCT00086346|12074223|FG001|Randomization|Did not receive test article|4
7658405|NCT00086346|12074222|FG000|Patients Dosed With Test Article|Adverse Event|94
7658406|NCT00086346|12074223|FG001|Patients Dosed With Test Article|Adverse Event|11
7658407|NCT00086346|12074222|FG000|Patients Dosed With Test Article|Lost to Follow-up|1
7658408|NCT00086346|12074223|FG001|Patients Dosed With Test Article|Lost to Follow-up|3
7658409|NCT00086346|12074222|FG000|Patients Dosed With Test Article|Nonmedical event|7
7658410|NCT00086346|12074223|FG001|Patients Dosed With Test Article|Nonmedical event|3
7658411|NCT00086346|12074222|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16
7658412|NCT00086346|12074223|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3
7658413|NCT00086346|12074222|FG000|Patients Dosed With Test Article|Protocol Violation|11
7658414|NCT00086346|12074223|FG001|Patients Dosed With Test Article|Protocol Violation|3
7658415|NCT00086346|12074222|FG000|Patients Dosed With Test Article|Lack of Efficacy|11
7658416|NCT00086346|12074223|FG001|Patients Dosed With Test Article|Lack of Efficacy|0
7658417|NCT00086385|12074233|FG000|Overall Study|Death|2
7658418|NCT00086385|12074234|FG001|Overall Study|Death|2
7658419|NCT00086385|12074235|FG002|Overall Study|Death|1
7658420|NCT00086385|12074236|FG003|Overall Study|Death|1
7658421|NCT00086411|12074250|FG000|Overall Study|Lost to Follow-up|11
7658422|NCT00086411|12074251|FG001|Overall Study|Lost to Follow-up|11
7658423|NCT00086411|12074252|FG002|Overall Study|Lost to Follow-up|13
7658424|NCT00086411|12074253|FG003|Overall Study|Lost to Follow-up|12
7658425|NCT00086502|12074275|FG000|Overall Study|Adverse Event|11
7658426|NCT00086502|12074276|FG001|Overall Study|Adverse Event|2
7658427|NCT00086502|12074275|FG000|Overall Study|Lack of Efficacy|0
7658428|NCT00086502|12074276|FG001|Overall Study|Lack of Efficacy|2
7658429|NCT00086502|12074275|FG000|Overall Study|Lost to Follow-up|3
7658430|NCT00086502|12074276|FG001|Overall Study|Lost to Follow-up|1
7658431|NCT00086502|12074275|FG000|Overall Study|Physician Decision|1
7658432|NCT00086502|12074276|FG001|Overall Study|Physician Decision|1
7658433|NCT00086502|12074275|FG000|Overall Study|Pregnancy|0
7658434|NCT00086502|12074276|FG001|Overall Study|Pregnancy|1
7658435|NCT00086502|12074275|FG000|Overall Study|Protocol Violation|3
7658436|NCT00086502|12074276|FG001|Overall Study|Protocol Violation|3
7658437|NCT00086502|12074275|FG000|Overall Study|Withdrawal by Subject|5
7658438|NCT00086502|12074276|FG001|Overall Study|Withdrawal by Subject|6
7658439|NCT00086502|12074275|FG000|Overall Study|Patient Moved|1
7658440|NCT00086502|12074276|FG001|Overall Study|Patient Moved|1
7658441|NCT00086502|12074275|FG000|Overall Study|Protocol Discontinuation Criteria|1
7658442|NCT00086502|12074276|FG001|Overall Study|Protocol Discontinuation Criteria|3
7658443|NCT00086502|12074275|FG000|Overall Study|Patient Accidentally Unblinded|1
7658444|NCT00086502|12074276|FG001|Overall Study|Patient Accidentally Unblinded|0
7658445|NCT00086515|12074284|FG000|Phase A (Weeks 0-24)|Adverse Event|17
7658446|NCT00086515|12074285|FG001|Phase A (Weeks 0-24)|Adverse Event|9
7658447|NCT00086515|12074284|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7
7658448|NCT00086515|12074285|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13
7658449|NCT00086515|12074284|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4
7658450|NCT00086515|12074285|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5
7658451|NCT00086515|12074284|FG000|Phase A (Weeks 0-24)|Protocol Violation|3
7658452|NCT00086515|12074285|FG001|Phase A (Weeks 0-24)|Protocol Violation|1
7658453|NCT00086515|12074284|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10
7658454|NCT00086515|12074285|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10
7658455|NCT00086515|12074284|FG000|Phase A (Weeks 0-24)|Patient Moved|2
7658456|NCT00086515|12074285|FG001|Phase A (Weeks 0-24)|Patient Moved|3
7658457|NCT00086515|12074284|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
7658458|NCT00086515|12074285|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
7658459|NCT00086515|12074284|FG000|Phase A (Weeks 0-24)|Poor compliance|1
7658460|NCT00086515|12074285|FG001|Phase A (Weeks 0-24)|Poor compliance|0
7658461|NCT00086515|12074284|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
7658462|NCT00086515|12074285|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
7658463|NCT00086515|12074284|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1
7658464|NCT00086515|12074285|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0
7658465|NCT00086515|12074284|FG000|Phase A to Phase B Transition Period|Adverse Event|2
7658466|NCT00086515|12074285|FG001|Phase A to Phase B Transition Period|Adverse Event|1
7658467|NCT00086515|12074284|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2
7658468|NCT00086515|12074285|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2
7658469|NCT00086515|12074284|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1
7658470|NCT00086515|12074285|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0
7658471|NCT00086515|12074284|FG000|Phase A to Phase B Transition Period|Protocol Violation|0
7658472|NCT00086515|12074285|FG001|Phase A to Phase B Transition Period|Protocol Violation|1
7658473|NCT00086515|12074284|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
7658474|NCT00086515|12074285|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
7658475|NCT00086515|12074284|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
7658476|NCT00086515|12074285|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
7658477|NCT00086515|12074284|FG000|Phase A to Phase B Transition Period|Poor compliance|1
7658478|NCT00086515|12074285|FG001|Phase A to Phase B Transition Period|Poor compliance|0
7658479|NCT00086515|12074284|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
7658480|NCT00086515|12074285|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
7658481|NCT00086515|12074284|FG000|Phase B (Weeks 24-104)|Adverse Event|16
7658482|NCT00086515|12074285|FG001|Phase B (Weeks 24-104)|Adverse Event|10
7658483|NCT00086515|12074284|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94
7658484|NCT00086515|12074285|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19
7658485|NCT00086515|12074284|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13
7658486|NCT00086515|12074285|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4
7658487|NCT00086515|12074284|FG000|Phase B (Weeks 24-104)|Physician Decision|3
7658488|NCT00086515|12074285|FG001|Phase B (Weeks 24-104)|Physician Decision|0
7658489|NCT00086515|12074284|FG000|Phase B (Weeks 24-104)|Protocol Violation|1
7658490|NCT00086515|12074285|FG001|Phase B (Weeks 24-104)|Protocol Violation|0
7658491|NCT00086515|12074284|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15
7658492|NCT00086515|12074285|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5
7658493|NCT00086515|12074284|FG000|Phase B (Weeks 24-104)|Patient Moved|2
7658494|NCT00086515|12074285|FG001|Phase B (Weeks 24-104)|Patient Moved|2
7658495|NCT00086515|12074284|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
7658496|NCT00086515|12074285|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
7658497|NCT00086515|12074284|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
7658498|NCT00086515|12074285|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
7658499|NCT00086515|12074284|FG000|Phase B (Weeks 24-104)|Patient Died|3
7658500|NCT00086515|12074285|FG001|Phase B (Weeks 24-104)|Patient Died|1
7658501|NCT00086515|12074284|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
7658502|NCT00086515|12074285|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
7658503|NCT00086515|12074284|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1
7658504|NCT00086515|12074285|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0
7658505|NCT00086515|12074284|FG000|Phase B (Weeks 24-104)|Discontinued in error|1
7658506|NCT00086515|12074285|FG001|Phase B (Weeks 24-104)|Discontinued in error|0
7658507|NCT00086580|12074293|FG000|Treatment Period|Disease progression|9
7658508|NCT00086580|12074294|FG001|Treatment Period|Disease progression|8
7658509|NCT00086580|12074293|FG000|Treatment Period|Unable to comply with protocol|3
7658510|NCT00086580|12074294|FG001|Treatment Period|Unable to comply with protocol|1
7658511|NCT00086580|12074293|FG000|Treatment Period|Withdrawal by Subject|7
7658512|NCT00086580|12074294|FG001|Treatment Period|Withdrawal by Subject|8
7658513|NCT00086580|12074293|FG000|Treatment Period|Physician Decision|13
7658514|NCT00086580|12074294|FG001|Treatment Period|Physician Decision|7
7658515|NCT00086580|12074293|FG000|Treatment Period|AE - not treatment related|7
7658516|NCT00086580|12074294|FG001|Treatment Period|AE - not treatment related|7
7658517|NCT00086580|12074293|FG000|Treatment Period|Toxicity - treatment related|15
7658518|NCT00086580|12074294|FG001|Treatment Period|Toxicity - treatment related|15
7658519|NCT00086580|12074293|FG000|Treatment Period|Anemia or thrombocytopenia|1
7658520|NCT00086580|12074294|FG001|Treatment Period|Anemia or thrombocytopenia|4
7658521|NCT00086580|12074293|FG000|Treatment Period|Death|5
7658522|NCT00086580|12074294|FG001|Treatment Period|Death|7
7658523|NCT00086580|12074293|FG000|Treatment Period|Other|5
7658524|NCT00086580|12074294|FG001|Treatment Period|Other|3
7658525|NCT00086580|12074293|FG000|Follow-up Period|Disease progression|72
7658526|NCT00086580|12074294|FG001|Follow-up Period|Disease progression|99
7658527|NCT00086580|12074293|FG000|Follow-up Period|Unable to comply with protocol|5
7658528|NCT00086580|12074294|FG001|Follow-up Period|Unable to comply with protocol|0
7658529|NCT00086580|12074293|FG000|Follow-up Period|Withdrawal by Subject|6
7658530|NCT00086580|12074294|FG001|Follow-up Period|Withdrawal by Subject|6
7658531|NCT00086580|12074293|FG000|Follow-up Period|Physician Decision|0
7658532|NCT00086580|12074294|FG001|Follow-up Period|Physician Decision|1
7658533|NCT00086580|12074293|FG000|Follow-up Period|AE - not related|1
7658534|NCT00086580|12074294|FG001|Follow-up Period|AE - not related|0
7658535|NCT00086580|12074293|FG000|Follow-up Period|Death|13
7658536|NCT00086580|12074294|FG001|Follow-up Period|Death|7
7658537|NCT00086580|12074293|FG000|Follow-up Period|Other|7
7658538|NCT00086580|12074294|FG001|Follow-up Period|Other|6
7658539|NCT00086580|12074293|FG000|Observation Period|Unable to comply with protocol|1
7658540|NCT00086580|12074294|FG001|Observation Period|Unable to comply with protocol|1
7658541|NCT00086580|12074293|FG000|Observation Period|Withdrawal by Subject|4
7658542|NCT00086580|12074294|FG001|Observation Period|Withdrawal by Subject|2
7658543|NCT00086580|12074293|FG000|Observation Period|Death|33
7658544|NCT00086580|12074294|FG001|Observation Period|Death|55
7658545|NCT00086580|12074293|FG000|Observation Period|Other|8
7658546|NCT00086580|12074294|FG001|Observation Period|Other|7
7658547|NCT00086619|12074302|FG000|Overall Study|Withdrawal by Subject|6
7658548|NCT00086619|12074303|FG001|Overall Study|Withdrawal by Subject|6
7658549|NCT00086619|12074302|FG000|Overall Study|Adverse Event|8
7658550|NCT00086619|12074303|FG001|Overall Study|Adverse Event|10
7658551|NCT00086619|12074302|FG000|Overall Study|Protocol Violation|1
7658552|NCT00086619|12074303|FG001|Overall Study|Protocol Violation|1
7658553|NCT00086684|12074312|FG000|Overall Study|Adverse Event|12
7658554|NCT00086684|12074313|FG001|Overall Study|Adverse Event|17
7658555|NCT00086684|12074314|FG002|Overall Study|Adverse Event|14
7658556|NCT00086684|12074312|FG000|Overall Study|Lack of Efficacy|6
7658557|NCT00086684|12074313|FG001|Overall Study|Lack of Efficacy|6
7658558|NCT00086684|12074314|FG002|Overall Study|Lack of Efficacy|5
7658559|NCT00086684|12074312|FG000|Overall Study|Lost to Follow-up|15
7658560|NCT00086684|12074313|FG001|Overall Study|Lost to Follow-up|8
7658561|NCT00086684|12074314|FG002|Overall Study|Lost to Follow-up|10
7658562|NCT00086684|12074312|FG000|Overall Study|Protocol Violation|8
7658563|NCT00086684|12074313|FG001|Overall Study|Protocol Violation|3
7658564|NCT00086684|12074314|FG002|Overall Study|Protocol Violation|0
7658565|NCT00086684|12074312|FG000|Overall Study|Withdrawal by Subject|0
7658566|NCT00086684|12074313|FG001|Overall Study|Withdrawal by Subject|4
7658567|NCT00086684|12074314|FG002|Overall Study|Withdrawal by Subject|10
7658568|NCT00086684|12074312|FG000|Overall Study|NONCOMPLIANCE|5
7658569|NCT00086684|12074313|FG001|Overall Study|NONCOMPLIANCE|7
7658570|NCT00086684|12074314|FG002|Overall Study|NONCOMPLIANCE|6
7658571|NCT00086684|12074312|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0
7658572|NCT00086684|12074313|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1
7658573|NCT00086684|12074314|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0
7658574|NCT00086684|12074312|FG000|Overall Study|WITHDRAWAL OF CONSENT|5
7658575|NCT00086684|12074313|FG001|Overall Study|WITHDRAWAL OF CONSENT|7
7658576|NCT00086684|12074314|FG002|Overall Study|WITHDRAWAL OF CONSENT|5
7658577|NCT00086684|12074312|FG000|Overall Study|Other|4
7658578|NCT00086684|12074313|FG001|Overall Study|Other|2
7658579|NCT00086684|12074314|FG002|Overall Study|Other|3
7658580|NCT00086996|12074333|FG000|Overall Study|Adverse Event|29
7658581|NCT00086996|12074333|FG000|Overall Study|Death|4
7658582|NCT00086996|12074333|FG000|Overall Study|progression/relapse|7
7658583|NCT00086996|12074333|FG000|Overall Study|Withdrawal by Subject|13
7658584|NCT00086996|12074333|FG000|Overall Study|Other|6
7658585|NCT00086996|12074333|FG000|Overall Study|not eligible|5
7658586|NCT00087126|12074346|FG000|Overall Study|Ineligible - second primary|1
7658587|NCT00087126|12074346|FG000|Overall Study|Never treated|1
7658588|NCT00087139|12074358|FG000|Overall Study|Adverse Event|18
7658589|NCT00087139|12074359|FG001|Overall Study|Adverse Event|17
7658590|NCT00087139|12074360|FG002|Overall Study|Adverse Event|13
7658591|NCT00087139|12074358|FG000|Overall Study|Death|2
7658592|NCT00087139|12074359|FG001|Overall Study|Death|1
7658593|NCT00087139|12074360|FG002|Overall Study|Death|0
7658594|NCT00087139|12074358|FG000|Overall Study|Withdrawal by Subject|3
7658595|NCT00087139|12074359|FG001|Overall Study|Withdrawal by Subject|2
7658596|NCT00087139|12074360|FG002|Overall Study|Withdrawal by Subject|2
7658597|NCT00087139|12074358|FG000|Overall Study|Physician Decision|1
7658598|NCT00087139|12074359|FG001|Overall Study|Physician Decision|1
7658599|NCT00087139|12074360|FG002|Overall Study|Physician Decision|1
7658600|NCT00087139|12074358|FG000|Overall Study|Disease progression|9
7658601|NCT00087139|12074359|FG001|Overall Study|Disease progression|19
7658602|NCT00087139|12074360|FG002|Overall Study|Disease progression|12
7658603|NCT00087139|12074358|FG000|Overall Study|Ineligible|4
7658604|NCT00087139|12074359|FG001|Overall Study|Ineligible|7
7658605|NCT00087139|12074360|FG002|Overall Study|Ineligible|4
7658606|NCT00087139|12074358|FG000|Overall Study|Symptomatic deterioration|1
7658607|NCT00087139|12074359|FG001|Overall Study|Symptomatic deterioration|1
7658608|NCT00087139|12074360|FG002|Overall Study|Symptomatic deterioration|3
7658609|NCT00087139|12074358|FG000|Overall Study|Use of coumadin|1
7658610|NCT00087139|12074359|FG001|Overall Study|Use of coumadin|0
7658611|NCT00087139|12074360|FG002|Overall Study|Use of coumadin|0
7658612|NCT00087139|12074358|FG000|Overall Study|Response achieved|0
7658613|NCT00087139|12074359|FG001|Overall Study|Response achieved|1
7658614|NCT00087139|12074360|FG002|Overall Study|Response achieved|0
7658615|NCT00087139|12074358|FG000|Overall Study|Extradural disease|0
7658616|NCT00087139|12074359|FG001|Overall Study|Extradural disease|0
7658617|NCT00087139|12074360|FG002|Overall Study|Extradural disease|1
7658618|NCT00087152|12074366|FG000|Overall Study|Ineligible|6
7658619|NCT00087438|12074371|FG000|Overall Study|Ineligible / No protocol treatment|4
7658620|NCT00087490|12074379|FG000|Overall Study|Death|6
7658621|NCT00087490|12074380|FG001|Overall Study|Death|4
7658622|NCT00087490|12074379|FG000|Overall Study|Adverse Event|3
7658623|NCT00087490|12074380|FG001|Overall Study|Adverse Event|8
7658624|NCT00087490|12074379|FG000|Overall Study|Lack of Efficacy|0
7658625|NCT00087490|12074380|FG001|Overall Study|Lack of Efficacy|2
7658626|NCT00087490|12074379|FG000|Overall Study|Protocol Violation or (/) Unspecified|214
7658627|NCT00087490|12074380|FG001|Overall Study|Protocol Violation or (/) Unspecified|201
7658628|NCT00087490|12074379|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28
7658629|NCT00087490|12074380|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36
7658630|NCT00087490|12074379|FG000|Overall Study|Randomized but not treated|7
7658631|NCT00087490|12074380|FG001|Overall Study|Randomized but not treated|18
7658632|NCT00087516|12074389|FG000|Overall Study|Adverse Event|10
7658633|NCT00087516|12074390|FG001|Overall Study|Adverse Event|10
7658634|NCT00087516|12074391|FG002|Overall Study|Adverse Event|3
7658635|NCT00087516|12074392|FG003|Overall Study|Adverse Event|6
7658636|NCT00087516|12074389|FG000|Overall Study|Lack of Efficacy|82
7658637|NCT00087516|12074390|FG001|Overall Study|Lack of Efficacy|80
7658638|NCT00087516|12074391|FG002|Overall Study|Lack of Efficacy|39
7658639|NCT00087516|12074392|FG003|Overall Study|Lack of Efficacy|29
7658640|NCT00087516|12074389|FG000|Overall Study|Lost to Follow-up|8
7658641|NCT00087516|12074390|FG001|Overall Study|Lost to Follow-up|6
7658642|NCT00087516|12074391|FG002|Overall Study|Lost to Follow-up|5
7658643|NCT00087516|12074392|FG003|Overall Study|Lost to Follow-up|5
7658644|NCT00087516|12074389|FG000|Overall Study|Protocol Violation|4
7658645|NCT00087516|12074390|FG001|Overall Study|Protocol Violation|8
7658646|NCT00087516|12074391|FG002|Overall Study|Protocol Violation|3
7658647|NCT00087516|12074392|FG003|Overall Study|Protocol Violation|6
7658648|NCT00087516|12074389|FG000|Overall Study|Withdrawal by Subject|16
7658649|NCT00087516|12074390|FG001|Overall Study|Withdrawal by Subject|27
7658650|NCT00087516|12074391|FG002|Overall Study|Withdrawal by Subject|11
7658651|NCT00087516|12074392|FG003|Overall Study|Withdrawal by Subject|12
7658652|NCT00087516|12074389|FG000|Overall Study|Site terminated|0
7658653|NCT00087516|12074390|FG001|Overall Study|Site terminated|2
7658654|NCT00087516|12074391|FG002|Overall Study|Site terminated|1
7658655|NCT00087516|12074392|FG003|Overall Study|Site terminated|0
7658656|NCT00087516|12074389|FG000|Overall Study|Protocol specified discontinuation|35
7658657|NCT00087516|12074390|FG001|Overall Study|Protocol specified discontinuation|33
7658658|NCT00087516|12074391|FG002|Overall Study|Protocol specified discontinuation|33
7658659|NCT00087516|12074392|FG003|Overall Study|Protocol specified discontinuation|26
7658660|NCT00087516|12074389|FG000|Overall Study|Patient moved|3
7658661|NCT00087516|12074390|FG001|Overall Study|Patient moved|2
7658662|NCT00087516|12074391|FG002|Overall Study|Patient moved|1
7658663|NCT00087516|12074392|FG003|Overall Study|Patient moved|0
7658664|NCT00087516|12074389|FG000|Overall Study|Patient was non-compliant|3
7658665|NCT00087516|12074390|FG001|Overall Study|Patient was non-compliant|1
7658666|NCT00087516|12074391|FG002|Overall Study|Patient was non-compliant|0
7658667|NCT00087516|12074392|FG003|Overall Study|Patient was non-compliant|0
7658668|NCT00087516|12074389|FG000|Overall Study|Recommendation of Primary Care Physician|0
7658669|NCT00087516|12074390|FG001|Overall Study|Recommendation of Primary Care Physician|0
7658670|NCT00087516|12074391|FG002|Overall Study|Recommendation of Primary Care Physician|0
7658671|NCT00087516|12074392|FG003|Overall Study|Recommendation of Primary Care Physician|1
7658672|NCT00087516|12074389|FG000|Overall Study|Other|0
7658673|NCT00087516|12074390|FG001|Overall Study|Other|0
7658674|NCT00087516|12074391|FG002|Overall Study|Other|1
7658675|NCT00087516|12074392|FG003|Overall Study|Other|0
7658676|NCT00087529|12074408|FG000|Overall Study|Death|1
7658677|NCT00087529|12074409|FG001|Overall Study|Death|0
7658678|NCT00087529|12074408|FG000|Overall Study|Adverse Event|0
7658679|NCT00087529|12074409|FG001|Overall Study|Adverse Event|8
7658680|NCT00087529|12074408|FG000|Overall Study|Pregnancy|0
7658681|NCT00087529|12074409|FG001|Overall Study|Pregnancy|1
7658682|NCT00087529|12074408|FG000|Overall Study|Lost to Follow-up|2
7658683|NCT00087529|12074409|FG001|Overall Study|Lost to Follow-up|3
7658684|NCT00087529|12074408|FG000|Overall Study|Participant Decision|14
7658685|NCT00087529|12074409|FG001|Overall Study|Participant Decision|37
7658686|NCT00087529|12074408|FG000|Overall Study|Physician Decision|4
7658687|NCT00087529|12074409|FG001|Overall Study|Physician Decision|8
7658688|NCT00087529|12074408|FG000|Overall Study|Initiation of Excluded Therapy|0
7658689|NCT00087529|12074409|FG001|Overall Study|Initiation of Excluded Therapy|1
7658690|NCT00087529|12074408|FG000|Overall Study|Participant Noncompliance|0
7658691|NCT00087529|12074409|FG001|Overall Study|Participant Noncompliance|1
7658692|NCT00087529|12074408|FG000|Overall Study|Disease Progression|5
7658693|NCT00087529|12074409|FG001|Overall Study|Disease Progression|4
7658694|NCT00087529|12074408|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5
7658695|NCT00087529|12074409|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5
7658696|NCT00087555|12074418|FG000|Overall Study|Adverse Event|3
7658697|NCT00087555|12074419|FG001|Overall Study|Adverse Event|6
7658698|NCT00087555|12074420|FG002|Overall Study|Adverse Event|14
7658699|NCT00087555|12074418|FG000|Overall Study|Lost to Follow-up|0
7658700|NCT00087555|12074419|FG001|Overall Study|Lost to Follow-up|1
7658701|NCT00087555|12074420|FG002|Overall Study|Lost to Follow-up|1
7658702|NCT00087555|12074418|FG000|Overall Study|Non - Compliance|1
7658703|NCT00087555|12074419|FG001|Overall Study|Non - Compliance|0
7658704|NCT00087555|12074420|FG002|Overall Study|Non - Compliance|0
7658705|NCT00087555|12074418|FG000|Overall Study|Protocol Violation|0
7658706|NCT00087555|12074419|FG001|Overall Study|Protocol Violation|0
7658707|NCT00087555|12074420|FG002|Overall Study|Protocol Violation|2
7658708|NCT00087555|12074418|FG000|Overall Study|Screen Failure|1
7658709|NCT00087555|12074419|FG001|Overall Study|Screen Failure|1
7658710|NCT00087555|12074420|FG002|Overall Study|Screen Failure|0
7658711|NCT00087555|12074418|FG000|Overall Study|Pregnancy|0
7658712|NCT00087555|12074419|FG001|Overall Study|Pregnancy|1
7658713|NCT00087555|12074420|FG002|Overall Study|Pregnancy|1
7658714|NCT00087555|12074418|FG000|Overall Study|Withdrawal by Subject|3
7658715|NCT00087555|12074419|FG001|Overall Study|Withdrawal by Subject|2
7658716|NCT00087555|12074420|FG002|Overall Study|Withdrawal by Subject|1
7658717|NCT00087555|12074418|FG000|Overall Study|Lack of Efficacy|2
7658718|NCT00087555|12074419|FG001|Overall Study|Lack of Efficacy|0
7658719|NCT00087555|12074420|FG002|Overall Study|Lack of Efficacy|1
7658720|NCT00087555|12074418|FG000|Overall Study|Non Compliance|0
7658721|NCT00087555|12074419|FG001|Overall Study|Non Compliance|0
7658722|NCT00087555|12074420|FG002|Overall Study|Non Compliance|1
7658723|NCT00087555|12074418|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1
7658724|NCT00087555|12074419|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0
7658725|NCT00087555|12074420|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0
7658726|NCT00087555|12074418|FG000|Overall Study|Patient wanted to go back on Med|1
7658727|NCT00087555|12074419|FG001|Overall Study|Patient wanted to go back on Med|0
7658728|NCT00087555|12074420|FG002|Overall Study|Patient wanted to go back on Med|0
7658729|NCT00087568|12074430|FG000|Overall Study|Adverse Event|4
7658730|NCT00087568|12074431|FG001|Overall Study|Adverse Event|0
7658731|NCT00087568|12074430|FG000|Overall Study|Withdrawal by Subject|1
7658732|NCT00087568|12074431|FG001|Overall Study|Withdrawal by Subject|1
7658733|NCT00087568|12074430|FG000|Overall Study|Lost to Follow-up|1
7658734|NCT00087568|12074431|FG001|Overall Study|Lost to Follow-up|0
7658735|NCT00087568|12074430|FG000|Overall Study|Lack of Efficacy|24
7658736|NCT00087568|12074431|FG001|Overall Study|Lack of Efficacy|1
7658737|NCT00087594|12074439|FG000|Overall Study|Adverse Event|2
7658738|NCT00087594|12074440|FG001|Overall Study|Adverse Event|3
7658739|NCT00087594|12074439|FG000|Overall Study|Lost to Follow-up|0
7658740|NCT00087594|12074440|FG001|Overall Study|Lost to Follow-up|2
7658741|NCT00087594|12074439|FG000|Overall Study|Withdrawal by Subject|4
7658742|NCT00087594|12074440|FG001|Overall Study|Withdrawal by Subject|2
7658743|NCT00087594|12074439|FG000|Overall Study|Lack of Efficacy|2
7658744|NCT00087594|12074440|FG001|Overall Study|Lack of Efficacy|5
7658745|NCT00087607|12074448|FG000|Overall Study|Adverse Event|14
7658746|NCT00087607|12074449|FG001|Overall Study|Adverse Event|24
7658747|NCT00087607|12074448|FG000|Overall Study|Death|0
7658748|NCT00087607|12074449|FG001|Overall Study|Death|1
7658749|NCT00087607|12074448|FG000|Overall Study|Insufficient Therapeutic Response|53
7658750|NCT00087607|12074449|FG001|Overall Study|Insufficient Therapeutic Response|42
7658751|NCT00087607|12074448|FG000|Overall Study|Failure to return|21
7658752|NCT00087607|12074449|FG001|Overall Study|Failure to return|17
7658753|NCT00087607|12074448|FG000|Overall Study|Withdrew Consent|12
7658754|NCT00087607|12074449|FG001|Overall Study|Withdrew Consent|16
7658755|NCT00087607|12074448|FG000|Overall Study|Administrative|12
7658756|NCT00087607|12074449|FG001|Overall Study|Administrative|12
7658757|NCT00087607|12074448|FG000|Overall Study|Refused Treatment|5
7658758|NCT00087607|12074449|FG001|Overall Study|Refused Treatment|7
7658759|NCT00087607|12074448|FG000|Overall Study|Other Protocol Violation|5
7658760|NCT00087607|12074449|FG001|Overall Study|Other Protocol Violation|2
7658761|NCT00087607|12074448|FG000|Overall Study|Violation of Selection Criteria at Entry|0
7658762|NCT00087607|12074449|FG001|Overall Study|Violation of Selection Criteria at Entry|1
7658763|NCT00087646|12074472|FG000|Overall Study|Adverse Event|37
7658764|NCT00087646|12074473|FG001|Overall Study|Adverse Event|6
7658765|NCT00087646|12074474|FG002|Overall Study|Adverse Event|18
7658766|NCT00087646|12074475|FG003|Overall Study|Adverse Event|20
7658767|NCT00087646|12074472|FG000|Overall Study|Death|0
7658768|NCT00087646|12074473|FG001|Overall Study|Death|1
7658769|NCT00087646|12074474|FG002|Overall Study|Death|0
7658770|NCT00087646|12074475|FG003|Overall Study|Death|0
7658771|NCT00087646|12074472|FG000|Overall Study|Withdrawal by Subject|6
7658772|NCT00087646|12074473|FG001|Overall Study|Withdrawal by Subject|1
7658773|NCT00087646|12074474|FG002|Overall Study|Withdrawal by Subject|2
7658774|NCT00087646|12074475|FG003|Overall Study|Withdrawal by Subject|2
7658775|NCT00087646|12074472|FG000|Overall Study|Insufficient therapeutic response|64
7658776|NCT00087646|12074473|FG001|Overall Study|Insufficient therapeutic response|24
7658777|NCT00087646|12074474|FG002|Overall Study|Insufficient therapeutic response|38
7658778|NCT00087646|12074475|FG003|Overall Study|Insufficient therapeutic response|51
7658779|NCT00087646|12074472|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13
7658780|NCT00087646|12074473|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6
7658781|NCT00087646|12074474|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4
7658782|NCT00087646|12074475|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5
7658783|NCT00087646|12074472|FG000|Overall Study|Failure to Return|5
7658784|NCT00087646|12074473|FG001|Overall Study|Failure to Return|2
7658785|NCT00087646|12074474|FG002|Overall Study|Failure to Return|2
7658786|NCT00087646|12074475|FG003|Overall Study|Failure to Return|3
7658787|NCT00087646|12074472|FG000|Overall Study|Administrative/Other|6
7658788|NCT00087646|12074473|FG001|Overall Study|Administrative/Other|1
7658789|NCT00087646|12074474|FG002|Overall Study|Administrative/Other|1
7658790|NCT00087646|12074475|FG003|Overall Study|Administrative/Other|2
7658791|NCT00087646|12074472|FG000|Overall Study|Other Protocol Violation|3
7658792|NCT00087646|12074473|FG001|Overall Study|Other Protocol Violation|1
7658793|NCT00087646|12074474|FG002|Overall Study|Other Protocol Violation|0
7658794|NCT00087646|12074475|FG003|Overall Study|Other Protocol Violation|0
7658795|NCT00087646|12074472|FG000|Overall Study|Violation of Selection Criteria at Entry|1
7658796|NCT00087646|12074473|FG001|Overall Study|Violation of Selection Criteria at Entry|0
7658797|NCT00087646|12074474|FG002|Overall Study|Violation of Selection Criteria at Entry|0
7658798|NCT00087646|12074475|FG003|Overall Study|Violation of Selection Criteria at Entry|1
7658799|NCT00087685|12074494|FG000|Overall Study|Adverse Event|5
7658800|NCT00087685|12074494|FG000|Overall Study|Non-Compliance|1
7658801|NCT00087685|12074494|FG000|Overall Study|Progressive Disease|5
7658802|NCT00087685|12074494|FG000|Overall Study|Withdrawal by Subject|3
7658803|NCT00087698|12074498|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14
7658804|NCT00087698|12074498|FG000|Overall Study|Death from Other Causes|3
7658805|NCT00087698|12074498|FG000|Overall Study|Adverse Event|4
7658806|NCT00087698|12074498|FG000|Overall Study|Withdrawal by Subject|4
7658807|NCT00087698|12074498|FG000|Overall Study|Lack of Efficacy, Physician Perception|3
7658808|NCT00087698|12074498|FG000|Overall Study|Protocol Entry Criteria Not Met|2
7658809|NCT00087698|12074498|FG000|Overall Study|Clinical Relapse|1
7658810|NCT00087698|12074498|FG000|Overall Study|Death from Study Disease|2
7658811|NCT00087698|12074498|FG000|Overall Study|Death from Study Drug Toxicity|2
7658812|NCT00087698|12074498|FG000|Overall Study|Protocol Violation|1
7658813|NCT00088153|12074504|FG000|Overall Study|Physician Decision|3
7658814|NCT00088153|12074505|FG001|Overall Study|Physician Decision|3
7658815|NCT00088153|12074504|FG000|Overall Study|Withdrawal by Subject|10
7658816|NCT00088153|12074505|FG001|Overall Study|Withdrawal by Subject|10
7658817|NCT00088153|12074504|FG000|Overall Study|Lost to Follow-up|11
7658818|NCT00088153|12074505|FG001|Overall Study|Lost to Follow-up|12
7658819|NCT00088166|12074513|FG000|Overall Study|Adverse Event|11
7658820|NCT00088166|12074514|FG001|Overall Study|Adverse Event|9
7658821|NCT00088166|12074513|FG000|Overall Study|Death|3
7658822|NCT00088166|12074514|FG001|Overall Study|Death|1
7658823|NCT00088166|12074513|FG000|Overall Study|Lost to Follow-up|0
7658824|NCT00088166|12074514|FG001|Overall Study|Lost to Follow-up|1
7658825|NCT00088166|12074513|FG000|Overall Study|Physician Decision|4
7658826|NCT00088166|12074514|FG001|Overall Study|Physician Decision|1
7658827|NCT00088166|12074513|FG000|Overall Study|Protocol Violation|1
7658828|NCT00088166|12074514|FG001|Overall Study|Protocol Violation|5
7658829|NCT00088166|12074513|FG000|Overall Study|Patient deterioration|29
7658830|NCT00088166|12074514|FG001|Overall Study|Patient deterioration|39
7658831|NCT00088166|12074513|FG000|Overall Study|Withdrawal by Subject|5
7658832|NCT00088166|12074514|FG001|Overall Study|Withdrawal by Subject|5
7658833|NCT00088205|12074520|FG000|Overall Study|Adverse Event|4
7658834|NCT00088205|12074520|FG000|Overall Study|Progressive Disease|51
7658835|NCT00088205|12074520|FG000|Overall Study|Physician Decision|1
7658836|NCT00088205|12074520|FG000|Overall Study|Death Due to Study Disease|4
7658837|NCT00088374|12074533|FG000|Overall Study|patient did not receive any 17AAG|1
7658838|NCT00088374|12074533|FG000|Overall Study|patient received <1 cycle only of 17AAG|1
7658839|NCT00088413|12074541|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
7658840|NCT00088413|12074542|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
7658841|NCT00088413|12074543|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1
7658842|NCT00088413|12074544|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
7658843|NCT00088413|12074541|FG000|Overall Study|Adverse Events/Side Effects|0
7658844|NCT00088413|12074542|FG001|Overall Study|Adverse Events/Side Effects|1
7658845|NCT00088413|12074543|FG002|Overall Study|Adverse Events/Side Effects|1
7658846|NCT00088413|12074544|FG003|Overall Study|Adverse Events/Side Effects|0
7658847|NCT00088413|12074541|FG000|Overall Study|Refused trmt Off-study per pt wishes|0
7658848|NCT00088413|12074542|FG001|Overall Study|Refused trmt Off-study per pt wishes|1
7658849|NCT00088413|12074543|FG002|Overall Study|Refused trmt Off-study per pt wishes|1
7658850|NCT00088413|12074544|FG003|Overall Study|Refused trmt Off-study per pt wishes|0
7658851|NCT00088413|12074541|FG000|Overall Study|Off study due to missing a vaccine dose|1
7658852|NCT00088413|12074542|FG001|Overall Study|Off study due to missing a vaccine dose|0
7658853|NCT00088413|12074543|FG002|Overall Study|Off study due to missing a vaccine dose|0
7658854|NCT00088413|12074544|FG003|Overall Study|Off study due to missing a vaccine dose|0
7658855|NCT00088413|12074541|FG000|Overall Study|Death|0
7658856|NCT00088413|12074542|FG001|Overall Study|Death|1
7658857|NCT00088413|12074543|FG002|Overall Study|Death|0
7658858|NCT00088413|12074544|FG003|Overall Study|Death|0
7658859|NCT00088413|12074541|FG000|Overall Study|Progressive disease|9
7658860|NCT00088413|12074542|FG001|Overall Study|Progressive disease|11
7658861|NCT00088413|12074543|FG002|Overall Study|Progressive disease|8
7658862|NCT00088413|12074544|FG003|Overall Study|Progressive disease|14
7658863|NCT00088413|12074541|FG000|Overall Study|Other|0
7658864|NCT00088413|12074542|FG001|Overall Study|Other|1
7658865|NCT00088413|12074543|FG002|Overall Study|Other|0
7658866|NCT00088413|12074544|FG003|Overall Study|Other|0
7658867|NCT00088413|12074541|FG000|Overall Study|Patient unevaluable due to adverse event|0
7658868|NCT00088413|12074542|FG001|Overall Study|Patient unevaluable due to adverse event|0
7658869|NCT00088413|12074543|FG002|Overall Study|Patient unevaluable due to adverse event|1
7658870|NCT00088413|12074544|FG003|Overall Study|Patient unevaluable due to adverse event|0
7658871|NCT00088452|12074559|FG000|Overall Study|Did not receive intervention|1
7658872|NCT00088452|12074560|FG001|Overall Study|Did not receive intervention|0
7658873|NCT00088452|12074561|FG002|Overall Study|Did not receive intervention|1
7658874|NCT00088465|12074569|FG000|Overall Study|Withdrawal by Subject|290
7658875|NCT00088465|12074569|FG000|Overall Study|Adverse Event|77
7658876|NCT00088465|12074569|FG000|Overall Study|Lost to Follow-up|57
7658877|NCT00088465|12074569|FG000|Overall Study|Physician Decision|45
7658878|NCT00088465|12074569|FG000|Overall Study|Sponsor Decision|37
7658879|NCT00088465|12074569|FG000|Overall Study|Lack of Efficacy|27
7658880|NCT00088465|12074569|FG000|Overall Study|Protocol Violation|17
7658881|NCT00088465|12074569|FG000|Overall Study|Death|11
7658882|NCT00088530|12074575|FG000|Overall Study|Progressive/Relapsed Disease|28
7658883|NCT00088530|12074576|FG001|Overall Study|Progressive/Relapsed Disease|39
7658884|NCT00088530|12074575|FG000|Overall Study|Adverse Event|15
7658885|NCT00088530|12074576|FG001|Overall Study|Adverse Event|9
7658886|NCT00088530|12074575|FG000|Overall Study|Withdrawal by Subject|2
7658887|NCT00088530|12074576|FG001|Overall Study|Withdrawal by Subject|5
7658888|NCT00088530|12074575|FG000|Overall Study|Lost to Follow-up|2
7658889|NCT00088530|12074576|FG001|Overall Study|Lost to Follow-up|0
7658890|NCT00088530|12074575|FG000|Overall Study|Physician Decision|2
7658891|NCT00088530|12074576|FG001|Overall Study|Physician Decision|0
7658892|NCT00088530|12074575|FG000|Overall Study|Sponsor decision|0
7658893|NCT00088530|12074576|FG001|Overall Study|Sponsor decision|1
7658894|NCT00088530|12074575|FG000|Overall Study|Patient never treated|1
7658895|NCT00088530|12074576|FG001|Overall Study|Patient never treated|0
7658896|NCT00088595|12074582|FG000|Overall Study|Adverse Event|11
7658897|NCT00088595|12074582|FG000|Overall Study|Withdrawal by Subject|8
7658898|NCT00088595|12074582|FG000|Overall Study|Ongoing (After Core)|7
7658899|NCT00088595|12074582|FG000|Overall Study|New Cancer Therapy|2
7658900|NCT00088881|12074624|FG000|Step 1 - R-CHOP|Patient ineligible|9
7658901|NCT00088881|12074624|FG000|Step 1 - R-CHOP|Adverse Event|1
7658902|NCT00088881|12074624|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2
7658903|NCT00088881|12074624|FG000|Step 1 - R-CHOP|Physician Decision|1
7658904|NCT00088881|12074624|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1
7658905|NCT00088881|12074624|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
7658906|NCT00088881|12074624|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
7658907|NCT00088907|12074632|FG000|Randomized Study (Step 1)|Lack of Efficacy|55
7658908|NCT00088907|12074633|FG001|Randomized Study (Step 1)|Lack of Efficacy|62
7658909|NCT00088907|12074632|FG000|Randomized Study (Step 1)|Adverse Event|14
7658910|NCT00088907|12074633|FG001|Randomized Study (Step 1)|Adverse Event|19
7658911|NCT00088907|12074632|FG000|Randomized Study (Step 1)|Death|11
7658912|NCT00088907|12074633|FG001|Randomized Study (Step 1)|Death|12
7658913|NCT00088907|12074632|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10
7658914|NCT00088907|12074633|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15
7658915|NCT00088907|12074632|FG000|Randomized Study (Step 1)|complicating disease|3
7658916|NCT00088907|12074633|FG001|Randomized Study (Step 1)|complicating disease|1
7658917|NCT00088907|12074632|FG000|Randomized Study (Step 1)|unknown/not specify|24
7658918|NCT00088907|12074633|FG001|Randomized Study (Step 1)|unknown/not specify|13
7658919|NCT00088907|12074632|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
7658920|NCT00088907|12074633|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
7658921|NCT00088907|12074632|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
7658922|NCT00088907|12074633|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
7658923|NCT00088907|12074632|FG000|Single Gefitinib Treatment (Step 2)|Death|1
7658924|NCT00088907|12074633|FG001|Single Gefitinib Treatment (Step 2)|Death|0
7658925|NCT00088907|12074632|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
7658926|NCT00088907|12074633|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
7658927|NCT00088907|12074632|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
7658928|NCT00088907|12074633|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
7658929|NCT00089076|12074657|FG000|Overall Study|Alternate Therapy|1
7658930|NCT00089076|12074657|FG000|Overall Study|Withdrawal by Subject|2
7658931|NCT00089076|12074657|FG000|Overall Study|Progression|7
7658932|NCT00089284|12074670|FG000|Overall Study|Adverse event before starting treatment|0
7658933|NCT00089284|12074671|FG001|Overall Study|Adverse event before starting treatment|0
7658934|NCT00089284|12074672|FG002|Overall Study|Adverse event before starting treatment|0
7658935|NCT00089284|12074673|FG003|Overall Study|Adverse event before starting treatment|0
7658936|NCT00089284|12074674|FG004|Overall Study|Adverse event before starting treatment|0
7658937|NCT00089284|12074675|FG005|Overall Study|Adverse event before starting treatment|0
7658938|NCT00089284|12074676|FG006|Overall Study|Adverse event before starting treatment|1
7658939|NCT00089297|12074698|FG000|Overall Study|Adverse Event|9
7658940|NCT00089297|12074698|FG000|Overall Study|Death|1
7658941|NCT00089297|12074698|FG000|Overall Study|Withdrawal by Subject|12
7658942|NCT00089297|12074698|FG000|Overall Study|Disease progression|2
7658943|NCT00089297|12074698|FG000|Overall Study|Ineligible|11
7658944|NCT00089297|12074698|FG000|Overall Study|Secondary malignancy|1
7658945|NCT00089297|12074698|FG000|Overall Study|IRB approval not ready|1
7658946|NCT00089297|12074698|FG000|Overall Study|Non-compliance|1
7658947|NCT00089479|12074704|FG000|Overall Study|Death|108
7658948|NCT00089479|12074705|FG001|Overall Study|Death|75
7658949|NCT00089479|12074704|FG000|Overall Study|Withdrawal by Subject|86
7658950|NCT00089479|12074705|FG001|Overall Study|Withdrawal by Subject|107
7658951|NCT00089479|12074704|FG000|Overall Study|Lost to Follow-up|137
7658952|NCT00089479|12074705|FG001|Overall Study|Lost to Follow-up|107
7658953|NCT00089505|12074715|FG000|Overall Study|Death|4
7658954|NCT00089505|12074716|FG001|Overall Study|Death|1
7658955|NCT00089505|12074717|FG002|Overall Study|Death|5
7658956|NCT00089505|12074718|FG003|Overall Study|Death|8
7658957|NCT00089505|12074715|FG000|Overall Study|Withdrawal by Subject|3
7658958|NCT00089505|12074716|FG001|Overall Study|Withdrawal by Subject|0
7658959|NCT00089505|12074717|FG002|Overall Study|Withdrawal by Subject|6
7658960|NCT00089505|12074718|FG003|Overall Study|Withdrawal by Subject|6
7658961|NCT00089505|12074715|FG000|Overall Study|Lost to Follow-up|1
7658962|NCT00089505|12074716|FG001|Overall Study|Lost to Follow-up|1
7658963|NCT00089505|12074717|FG002|Overall Study|Lost to Follow-up|9
7658964|NCT00089505|12074718|FG003|Overall Study|Lost to Follow-up|7
7658965|NCT00089505|12074715|FG000|Overall Study|Physician Decision|1
7658966|NCT00089505|12074716|FG001|Overall Study|Physician Decision|0
7658967|NCT00089505|12074717|FG002|Overall Study|Physician Decision|0
7658968|NCT00089505|12074718|FG003|Overall Study|Physician Decision|0
7658969|NCT00089505|12074715|FG000|Overall Study|Protocol Violation|0
7658970|NCT00089505|12074716|FG001|Overall Study|Protocol Violation|0
7658971|NCT00089505|12074717|FG002|Overall Study|Protocol Violation|1
7658972|NCT00089505|12074718|FG003|Overall Study|Protocol Violation|0
7658973|NCT00089544|12074730|FG000|Overall Study|Ineligible|1
7658974|NCT00089544|12074731|FG001|Overall Study|Ineligible|0
7658975|NCT00089583|12074739|FG000|Overall Study|Adverse Event|0
7658976|NCT00089583|12074740|FG001|Overall Study|Adverse Event|3
7658977|NCT00089583|12074739|FG000|Overall Study|Insufficient Viral Load Response|5
7658978|NCT00089583|12074740|FG001|Overall Study|Insufficient Viral Load Response|5
7658979|NCT00089583|12074739|FG000|Overall Study|Withdrawal by Subject|0
7658980|NCT00089583|12074740|FG001|Overall Study|Withdrawal by Subject|4
7658981|NCT00089583|12074739|FG000|Overall Study|Participant (Par) Didn't Take Medication|1
7658982|NCT00089583|12074740|FG001|Overall Study|Participant (Par) Didn't Take Medication|0
7658983|NCT00089583|12074739|FG000|Overall Study|Participant Refused Study Medication|0
7658984|NCT00089583|12074740|FG001|Overall Study|Participant Refused Study Medication|2
7658985|NCT00089583|12074739|FG000|Overall Study|Non-Compliance|0
7658986|NCT00089583|12074740|FG001|Overall Study|Non-Compliance|4
7658987|NCT00089583|12074739|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0
7658988|NCT00089583|12074740|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3
7658989|NCT00089583|12074739|FG000|Overall Study|Participant Management Criteria Met|0
7658990|NCT00089583|12074740|FG001|Overall Study|Participant Management Criteria Met|1
7658991|NCT00089583|12074739|FG000|Overall Study|Reason Not Provided|0
7658992|NCT00089583|12074740|FG001|Overall Study|Reason Not Provided|1
7658993|NCT00089583|12074739|FG000|Overall Study|Protocol Violation|0
7658994|NCT00089583|12074740|FG001|Overall Study|Protocol Violation|3
7658995|NCT00089583|12074739|FG000|Overall Study|Principal Investigator Decision|0
7658996|NCT00089583|12074740|FG001|Overall Study|Principal Investigator Decision|10
7659082|NCT00089986|12074841|FG001|Overall Study|Hemohlobin stopping rule|1
7658997|NCT00089583|12074739|FG000|Overall Study|Start of Disallowed Medication|0
7658998|NCT00089583|12074740|FG001|Overall Study|Start of Disallowed Medication|1
7658999|NCT00089583|12074739|FG000|Overall Study|Necessity to Use Prohibited Drug|1
7659000|NCT00089583|12074740|FG001|Overall Study|Necessity to Use Prohibited Drug|0
7659001|NCT00089583|12074739|FG000|Overall Study|Participant Incarcerated|0
7659002|NCT00089583|12074740|FG001|Overall Study|Participant Incarcerated|1
7659003|NCT00089609|12074754|FG000|Overall Study|Withdrawal by Subject|3
7659004|NCT00089609|12074755|FG001|Overall Study|Withdrawal by Subject|1
7659005|NCT00089635|12074764|FG000|Overall Study|Adverse Event|2
7659006|NCT00089635|12074764|FG000|Overall Study|Death|17
7659007|NCT00089635|12074764|FG000|Overall Study|Disease Progression|12
7659008|NCT00089635|12074764|FG000|Overall Study|Lost to Follow-up|3
7659009|NCT00089635|12074764|FG000|Overall Study|Withdrawal by Subject|6
7659010|NCT00089635|12074764|FG000|Overall Study|Ineligibility determined|1
7659011|NCT00089635|12074764|FG000|Overall Study|Other|2
7659012|NCT00089648|12074768|FG000|Overall Study|Adverse Event|7
7659013|NCT00089648|12074768|FG000|Overall Study|Withdrawal by Subject|1
7659014|NCT00089648|12074768|FG000|Overall Study|Lack of Efficacy|33
7659015|NCT00089661|12074774|FG000|Overall Study|Adverse Event|0
7659016|NCT00089661|12074775|FG001|Overall Study|Adverse Event|2
7659017|NCT00089661|12074774|FG000|Overall Study|Death|1
7659018|NCT00089661|12074775|FG001|Overall Study|Death|0
7659019|NCT00089661|12074774|FG000|Overall Study|Lost to Follow-up|0
7659020|NCT00089661|12074775|FG001|Overall Study|Lost to Follow-up|3
7659021|NCT00089661|12074774|FG000|Overall Study|Withdrawal by Subject|11
7659022|NCT00089661|12074775|FG001|Overall Study|Withdrawal by Subject|9
7659023|NCT00089661|12074774|FG000|Overall Study|Disease progression|1
7659024|NCT00089661|12074775|FG001|Overall Study|Disease progression|3
7659025|NCT00089661|12074774|FG000|Overall Study|Ineligibility determined|4
7659026|NCT00089661|12074775|FG001|Overall Study|Ineligibility determined|4
7659027|NCT00089661|12074774|FG000|Overall Study|Noncompliance|2
7659028|NCT00089661|12074775|FG001|Overall Study|Noncompliance|4
7659029|NCT00089661|12074774|FG000|Overall Study|Other|2
7659030|NCT00089661|12074775|FG001|Overall Study|Other|1
7659031|NCT00089674|12074783|FG000|Overall Study|Physician Decision|4
7659032|NCT00089674|12074784|FG001|Overall Study|Physician Decision|2
7659033|NCT00089674|12074783|FG000|Overall Study|Adverse Event|23
7659034|NCT00089674|12074784|FG001|Overall Study|Adverse Event|29
7659035|NCT00089674|12074783|FG000|Overall Study|Withdrawal by Subject|143
7659036|NCT00089674|12074784|FG001|Overall Study|Withdrawal by Subject|127
7659037|NCT00089674|12074783|FG000|Overall Study|Death|43
7659038|NCT00089674|12074784|FG001|Overall Study|Death|43
7659039|NCT00089674|12074783|FG000|Overall Study|Disease progression|21
7659040|NCT00089674|12074784|FG001|Overall Study|Disease progression|23
7659041|NCT00089674|12074783|FG000|Overall Study|Ineligibility determined|8
7659042|NCT00089674|12074784|FG001|Overall Study|Ineligibility determined|10
7659043|NCT00089674|12074783|FG000|Overall Study|Lost to Follow-up|21
7659044|NCT00089674|12074784|FG001|Overall Study|Lost to Follow-up|17
7659045|NCT00089674|12074783|FG000|Overall Study|Noncompliance|7
7659046|NCT00089674|12074784|FG001|Overall Study|Noncompliance|3
7659047|NCT00089674|12074783|FG000|Overall Study|Other|5
7659048|NCT00089674|12074784|FG001|Overall Study|Other|9
7659049|NCT00089674|12074783|FG000|Overall Study|Requirement for alternative therapy|14
7659050|NCT00089674|12074784|FG001|Overall Study|Requirement for alternative therapy|4
7659051|NCT00089778|12074804|FG000|Overall Study|Protocol Violation|0
7659052|NCT00089778|12074805|FG001|Overall Study|Protocol Violation|0
7659053|NCT00089778|12074806|FG002|Overall Study|Protocol Violation|1
7659054|NCT00089843|12074820|FG000|Overall Study|Withdrawal by Subject|1
7659055|NCT00089843|12074821|FG001|Overall Study|Withdrawal by Subject|4
7659056|NCT00089843|12074822|FG002|Overall Study|Withdrawal by Subject|5
7659057|NCT00089843|12074823|FG003|Overall Study|Withdrawal by Subject|6
7659058|NCT00089843|12074820|FG000|Overall Study|Physician Decision|1
7659059|NCT00089843|12074821|FG001|Overall Study|Physician Decision|0
7659060|NCT00089843|12074822|FG002|Overall Study|Physician Decision|0
7659061|NCT00089843|12074823|FG003|Overall Study|Physician Decision|1
7659062|NCT00089973|12074833|FG000|Overall Study|Adverse Event|3
7659063|NCT00089973|12074833|FG000|Overall Study|Withdrawal by Subject|1
7659064|NCT00089973|12074833|FG000|Overall Study|Disease progression|45
7659065|NCT00089973|12074833|FG000|Overall Study|Death|1
7659066|NCT00089986|12074840|FG000|Overall Study|Adverse Event|6
7659067|NCT00089986|12074841|FG001|Overall Study|Adverse Event|9
7659068|NCT00089986|12074842|FG002|Overall Study|Adverse Event|6
7659069|NCT00089986|12074840|FG000|Overall Study|Lost to Follow-up|3
7659070|NCT00089986|12074841|FG001|Overall Study|Lost to Follow-up|1
7659071|NCT00089986|12074842|FG002|Overall Study|Lost to Follow-up|1
7659072|NCT00089986|12074840|FG000|Overall Study|Protocol Violation|0
7659073|NCT00089986|12074841|FG001|Overall Study|Protocol Violation|1
7659074|NCT00089986|12074842|FG002|Overall Study|Protocol Violation|0
7659075|NCT00089986|12074840|FG000|Overall Study|Patient transferred to another hospital|2
7659076|NCT00089986|12074841|FG001|Overall Study|Patient transferred to another hospital|1
7659077|NCT00089986|12074842|FG002|Overall Study|Patient transferred to another hospital|0
7659078|NCT00089986|12074840|FG000|Overall Study|Subject withdrew but agreed follow up|1
7659079|NCT00089986|12074841|FG001|Overall Study|Subject withdrew but agreed follow up|2
7659080|NCT00089986|12074842|FG002|Overall Study|Subject withdrew but agreed follow up|0
7659081|NCT00089986|12074840|FG000|Overall Study|Hemohlobin stopping rule|0
7659083|NCT00089986|12074842|FG002|Overall Study|Hemohlobin stopping rule|0
7659084|NCT00089986|12074840|FG000|Overall Study|Investigator decision to withdrew|0
7659085|NCT00089986|12074841|FG001|Overall Study|Investigator decision to withdrew|1
7659086|NCT00089986|12074842|FG002|Overall Study|Investigator decision to withdrew|0
7659087|NCT00089986|12074840|FG000|Overall Study|Enrollment in another study|0
7659088|NCT00089986|12074841|FG001|Overall Study|Enrollment in another study|1
7659089|NCT00089986|12074842|FG002|Overall Study|Enrollment in another study|0
7659090|NCT00089986|12074840|FG000|Overall Study|Family decision|0
7659091|NCT00089986|12074841|FG001|Overall Study|Family decision|1
7659092|NCT00089986|12074842|FG002|Overall Study|Family decision|0
7659093|NCT00089986|12074840|FG000|Overall Study|Do not resuscitate (DNR)|0
7659094|NCT00089986|12074841|FG001|Overall Study|Do not resuscitate (DNR)|0
7659095|NCT00089986|12074842|FG002|Overall Study|Do not resuscitate (DNR)|1
7659096|NCT00089986|12074840|FG000|Overall Study|Withdrawal by Subject|3
7659097|NCT00089986|12074841|FG001|Overall Study|Withdrawal by Subject|6
7659098|NCT00089986|12074842|FG002|Overall Study|Withdrawal by Subject|2
7659099|NCT00089999|12074852|FG000|Overall Study|Adverse Event|4
7659100|NCT00089999|12074853|FG001|Overall Study|Adverse Event|7
7659101|NCT00089999|12074852|FG000|Overall Study|Withdrawal by Subject|0
7659102|NCT00089999|12074853|FG001|Overall Study|Withdrawal by Subject|4
7659103|NCT00089999|12074852|FG000|Overall Study|Lost to Follow-up|2
7659104|NCT00089999|12074853|FG001|Overall Study|Lost to Follow-up|1
7659105|NCT00089999|12074852|FG000|Overall Study|Radiological Progression of Cancer|52
7659106|NCT00089999|12074853|FG001|Overall Study|Radiological Progression of Cancer|44
7659107|NCT00089999|12074852|FG000|Overall Study|Symptomatic Progression of Cancer|2
7659108|NCT00089999|12074853|FG001|Overall Study|Symptomatic Progression of Cancer|5
7659109|NCT00089999|12074852|FG000|Overall Study|Death|3
7659110|NCT00089999|12074853|FG001|Overall Study|Death|3
7659111|NCT00089999|12074852|FG000|Overall Study|Poor General Condition|1
7659112|NCT00089999|12074853|FG001|Overall Study|Poor General Condition|0
7659113|NCT00089999|12074852|FG000|Overall Study|Clinical Progression|1
7659114|NCT00089999|12074853|FG001|Overall Study|Clinical Progression|2
7659115|NCT00089999|12074852|FG000|Overall Study|Physician Decision|2
7659116|NCT00089999|12074853|FG001|Overall Study|Physician Decision|2
7659117|NCT00089999|12074852|FG000|Overall Study|Patient Underwent Surgery|2
7659118|NCT00089999|12074853|FG001|Overall Study|Patient Underwent Surgery|0
7659119|NCT00089999|12074852|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0
7659120|NCT00089999|12074853|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1
7659121|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211
7659122|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185
7659123|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210
7659124|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
7659125|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
7659126|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
7659127|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
7659128|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
7659129|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
7659130|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29
7659131|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29
7659132|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34
7659133|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
7659134|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
7659135|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
7659136|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7
7659137|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2
7659138|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8
7659139|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
7659140|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
7659141|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
7659142|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
7659143|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
7659144|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
7659145|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
7659146|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
7659147|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
7659148|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
7659149|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
7659150|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
7659151|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
7659152|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
7659153|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
7659154|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
7659155|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
7659156|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
7659157|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2
7659158|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0
7659159|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0
7659160|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
7659161|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
7659162|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
7659163|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1
7659164|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0
7659165|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0
7659166|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1
7659167|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0
7659168|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0
7659169|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
7659170|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
7659171|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
7659172|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1
7659173|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0
7659174|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0
7659175|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1
7659176|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0
7659177|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0
7659178|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
7659179|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
7659180|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
7659181|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0
7659182|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1
7659183|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0
7659184|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
7659185|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
7659186|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
7659187|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
7659188|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
7659189|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
7659190|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
7659191|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
7659192|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
7659193|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0
7659194|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1
7659195|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0
7659196|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
7659197|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
7659198|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
7659199|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
7659200|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
7659201|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
7659202|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0
7659203|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1
7659204|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3
7659205|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0
7659206|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0
7659207|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2
7659208|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
7659209|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
7659210|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
7659211|NCT00090103|12074872|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
7659212|NCT00090103|12074873|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
7659213|NCT00090103|12074874|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
7659214|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Adverse Event|34
7659215|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Adverse Event|39
7659216|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Adverse Event|44
7659217|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185
7659218|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212
7659219|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229
7659220|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101
7659221|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97
7659222|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111
7659223|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Protocol Violation|18
7659224|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Protocol Violation|18
7659225|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Protocol Violation|17
7659226|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
7659227|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
7659228|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
7659229|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
7659230|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
7659231|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
7659232|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Loss of Contact|4
7659233|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Loss of Contact|0
7659234|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Loss of Contact|2
7659235|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
7659236|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
7659237|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
7659238|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Participant relocated|2
7659239|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Participant relocated|3
7659240|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Participant relocated|1
7659241|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
7659242|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
7659243|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
7659244|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2
7659245|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3
7659246|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5
7659247|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1
7659248|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0
7659249|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1
7659250|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
7659251|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
7659252|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
7659253|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Loss of Libido|1
7659254|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Loss of Libido|0
7659255|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Loss of Libido|0
7659256|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Enrollment Error|1
7659257|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Enrollment Error|0
7659258|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Enrollment Error|2
7659259|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
7659260|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
7659261|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
7659262|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Death|1
7659263|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Death|0
7659264|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Death|1
7659265|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Gyneomastia|1
7659266|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Gyneomastia|0
7659267|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Gyneomastia|0
7659268|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
7659269|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
7659270|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
7659271|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
7659272|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
7659273|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
7659274|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0
7659275|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1
7659276|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0
7659277|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Back Pain|0
7659278|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Back Pain|1
7659279|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Back Pain|0
7659280|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0
7659281|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2
7659282|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4
7659283|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
7659284|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
7659285|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
7659286|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Depression|0
7659287|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Depression|1
7659288|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Depression|0
7659289|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
7659290|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
7659291|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
7659292|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Jailed|0
7659293|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Jailed|1
7659294|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Jailed|0
7659295|NCT00090103|12074872|FG000|16-Week Safety Follow-up Period|Other|0
7659296|NCT00090103|12074873|FG001|16-Week Safety Follow-up Period|Other|1
7659297|NCT00090103|12074874|FG002|16-Week Safety Follow-up Period|Other|0
7659298|NCT00090220|12074884|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1
7659299|NCT00090220|12074885|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1
7659300|NCT00090220|12074886|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0
7659301|NCT00090220|12074887|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0
7659302|NCT00090220|12074888|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0
7659303|NCT00090220|12074889|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0
7659304|NCT00090220|12074884|FG000|Base Study Vaccination Period|Adverse Event|6
7659305|NCT00090220|12074885|FG001|Base Study Vaccination Period|Adverse Event|1
7659306|NCT00090220|12074886|FG002|Base Study Vaccination Period|Adverse Event|0
7659307|NCT00090220|12074887|FG003|Base Study Vaccination Period|Adverse Event|0
7659308|NCT00090220|12074888|FG004|Base Study Vaccination Period|Adverse Event|0
7659309|NCT00090220|12074889|FG005|Base Study Vaccination Period|Adverse Event|0
7659310|NCT00090220|12074884|FG000|Base Study Vaccination Period|Lost to Follow-up|24
7659311|NCT00090220|12074885|FG001|Base Study Vaccination Period|Lost to Follow-up|28
7659312|NCT00090220|12074886|FG002|Base Study Vaccination Period|Lost to Follow-up|0
7659313|NCT00090220|12074887|FG003|Base Study Vaccination Period|Lost to Follow-up|0
7659314|NCT00090220|12074888|FG004|Base Study Vaccination Period|Lost to Follow-up|0
7659315|NCT00090220|12074889|FG005|Base Study Vaccination Period|Lost to Follow-up|0
7659316|NCT00090220|12074884|FG000|Base Study Vaccination Period|Withdrawal by Subject|23
7659317|NCT00090220|12074885|FG001|Base Study Vaccination Period|Withdrawal by Subject|27
7659318|NCT00090220|12074886|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
7659319|NCT00090220|12074887|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
7659320|NCT00090220|12074888|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
7659321|NCT00090220|12074889|FG005|Base Study Vaccination Period|Withdrawal by Subject|0
7659322|NCT00090220|12074884|FG000|Base Study Vaccination Period|Patient Moved|6
7659323|NCT00090220|12074885|FG001|Base Study Vaccination Period|Patient Moved|2
7659324|NCT00090220|12074886|FG002|Base Study Vaccination Period|Patient Moved|0
7659325|NCT00090220|12074887|FG003|Base Study Vaccination Period|Patient Moved|0
7659326|NCT00090220|12074888|FG004|Base Study Vaccination Period|Patient Moved|0
7659327|NCT00090220|12074889|FG005|Base Study Vaccination Period|Patient Moved|0
7659328|NCT00090220|12074884|FG000|Base Study Vaccination Period|Other|4
7659329|NCT00090220|12074885|FG001|Base Study Vaccination Period|Other|4
7659330|NCT00090220|12074886|FG002|Base Study Vaccination Period|Other|0
7659331|NCT00090220|12074887|FG003|Base Study Vaccination Period|Other|0
7659332|NCT00090220|12074888|FG004|Base Study Vaccination Period|Other|0
7659333|NCT00090220|12074889|FG005|Base Study Vaccination Period|Other|0
7659334|NCT00090220|12074884|FG000|Base Study Follow-up Period|Adverse Event|6
7659335|NCT00090220|12074885|FG001|Base Study Follow-up Period|Adverse Event|1
7659336|NCT00090220|12074886|FG002|Base Study Follow-up Period|Adverse Event|0
7659337|NCT00090220|12074887|FG003|Base Study Follow-up Period|Adverse Event|0
7659338|NCT00090220|12074888|FG004|Base Study Follow-up Period|Adverse Event|0
7659339|NCT00090220|12074889|FG005|Base Study Follow-up Period|Adverse Event|0
7659340|NCT00090220|12074884|FG000|Base Study Follow-up Period|Lost to Follow-up|88
7659341|NCT00090220|12074885|FG001|Base Study Follow-up Period|Lost to Follow-up|78
7659342|NCT00090220|12074886|FG002|Base Study Follow-up Period|Lost to Follow-up|0
7659343|NCT00090220|12074887|FG003|Base Study Follow-up Period|Lost to Follow-up|0
7659344|NCT00090220|12074888|FG004|Base Study Follow-up Period|Lost to Follow-up|0
7659345|NCT00090220|12074889|FG005|Base Study Follow-up Period|Lost to Follow-up|0
7659346|NCT00090220|12074884|FG000|Base Study Follow-up Period|Withdrawal by Subject|27
7659347|NCT00090220|12074885|FG001|Base Study Follow-up Period|Withdrawal by Subject|36
7659348|NCT00090220|12074886|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
7659349|NCT00090220|12074887|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
7659350|NCT00090220|12074888|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
7659351|NCT00090220|12074889|FG005|Base Study Follow-up Period|Withdrawal by Subject|0
7659352|NCT00090220|12074884|FG000|Base Study Follow-up Period|Patient Moved|20
7659353|NCT00090220|12074885|FG001|Base Study Follow-up Period|Patient Moved|28
7659354|NCT00090220|12074886|FG002|Base Study Follow-up Period|Patient Moved|0
7659355|NCT00090220|12074887|FG003|Base Study Follow-up Period|Patient Moved|0
7659356|NCT00090220|12074888|FG004|Base Study Follow-up Period|Patient Moved|0
7659357|NCT00090220|12074889|FG005|Base Study Follow-up Period|Patient Moved|0
7659358|NCT00090220|12074884|FG000|Base Study Follow-up Period|Other|19
7659359|NCT00090220|12074885|FG001|Base Study Follow-up Period|Other|21
7659360|NCT00090220|12074886|FG002|Base Study Follow-up Period|Other|0
7659361|NCT00090220|12074887|FG003|Base Study Follow-up Period|Other|0
7659362|NCT00090220|12074888|FG004|Base Study Follow-up Period|Other|0
7659363|NCT00090220|12074889|FG005|Base Study Follow-up Period|Other|0
7659364|NCT00090220|12074884|FG000|Extension 1 (EXT1)|Adverse Event|0
7659365|NCT00090220|12074885|FG001|Extension 1 (EXT1)|Adverse Event|0
7659366|NCT00090220|12074886|FG002|Extension 1 (EXT1)|Adverse Event|4
7659367|NCT00090220|12074887|FG003|Extension 1 (EXT1)|Adverse Event|0
7659368|NCT00090220|12074888|FG004|Extension 1 (EXT1)|Adverse Event|0
7659369|NCT00090220|12074889|FG005|Extension 1 (EXT1)|Adverse Event|0
7659370|NCT00090220|12074884|FG000|Extension 1 (EXT1)|Lost to Follow-up|0
7659371|NCT00090220|12074885|FG001|Extension 1 (EXT1)|Lost to Follow-up|0
7659372|NCT00090220|12074886|FG002|Extension 1 (EXT1)|Lost to Follow-up|22
7659373|NCT00090220|12074887|FG003|Extension 1 (EXT1)|Lost to Follow-up|0
7659374|NCT00090220|12074888|FG004|Extension 1 (EXT1)|Lost to Follow-up|0
7659375|NCT00090220|12074889|FG005|Extension 1 (EXT1)|Lost to Follow-up|0
7659376|NCT00090220|12074884|FG000|Extension 1 (EXT1)|Moved|0
7659377|NCT00090220|12074885|FG001|Extension 1 (EXT1)|Moved|0
7659378|NCT00090220|12074886|FG002|Extension 1 (EXT1)|Moved|2
7659379|NCT00090220|12074887|FG003|Extension 1 (EXT1)|Moved|1
7659380|NCT00090220|12074888|FG004|Extension 1 (EXT1)|Moved|0
7659381|NCT00090220|12074889|FG005|Extension 1 (EXT1)|Moved|0
7659382|NCT00090220|12074884|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0
7659383|NCT00090220|12074885|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0
7659384|NCT00090220|12074886|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25
7659385|NCT00090220|12074887|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0
7659386|NCT00090220|12074888|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0
7659387|NCT00090220|12074889|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0
7659388|NCT00090220|12074884|FG000|Extension 1 (EXT1)|Protocol Violation|0
7659389|NCT00090220|12074885|FG001|Extension 1 (EXT1)|Protocol Violation|0
7659390|NCT00090220|12074886|FG002|Extension 1 (EXT1)|Protocol Violation|0
7659391|NCT00090220|12074887|FG003|Extension 1 (EXT1)|Protocol Violation|1
7659392|NCT00090220|12074888|FG004|Extension 1 (EXT1)|Protocol Violation|0
7659393|NCT00090220|12074889|FG005|Extension 1 (EXT1)|Protocol Violation|0
7659394|NCT00090220|12074884|FG000|Extension 1 (EXT1)|Other reason|0
7659395|NCT00090220|12074885|FG001|Extension 1 (EXT1)|Other reason|0
7659396|NCT00090220|12074886|FG002|Extension 1 (EXT1)|Other reason|2
7659397|NCT00090220|12074887|FG003|Extension 1 (EXT1)|Other reason|0
7659398|NCT00090220|12074888|FG004|Extension 1 (EXT1)|Other reason|0
7659399|NCT00090220|12074889|FG005|Extension 1 (EXT1)|Other reason|0
7659400|NCT00090220|12074884|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7659401|NCT00090220|12074885|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7659402|NCT00090220|12074886|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7659403|NCT00090220|12074887|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7659404|NCT00090220|12074888|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38
7659405|NCT00090220|12074889|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23
7659406|NCT00090220|12074884|FG000|Long-term Follow-up (EXT2)|Death|0
7659407|NCT00090220|12074885|FG001|Long-term Follow-up (EXT2)|Death|0
7659408|NCT00090220|12074886|FG002|Long-term Follow-up (EXT2)|Death|0
7659409|NCT00090220|12074887|FG003|Long-term Follow-up (EXT2)|Death|0
7659410|NCT00090220|12074888|FG004|Long-term Follow-up (EXT2)|Death|1
7659411|NCT00090220|12074889|FG005|Long-term Follow-up (EXT2)|Death|1
7659412|NCT00090220|12074884|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7659413|NCT00090220|12074885|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7659414|NCT00090220|12074886|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7659415|NCT00090220|12074887|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7659416|NCT00090220|12074888|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
7659417|NCT00090220|12074889|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
7659418|NCT00090220|12074884|FG000|Long-term Follow-up (EXT2)|Other|0
7659419|NCT00090220|12074885|FG001|Long-term Follow-up (EXT2)|Other|0
7659420|NCT00090220|12074886|FG002|Long-term Follow-up (EXT2)|Other|0
7659421|NCT00090220|12074887|FG003|Long-term Follow-up (EXT2)|Other|0
7659422|NCT00090220|12074888|FG004|Long-term Follow-up (EXT2)|Other|1
7659423|NCT00090220|12074889|FG005|Long-term Follow-up (EXT2)|Other|0
7659424|NCT00090233|12074908|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609
7659425|NCT00090233|12074909|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627
7659426|NCT00090233|12074908|FG000|Overall Study|Adverse Event|214
7659427|NCT00090233|12074909|FG001|Overall Study|Adverse Event|198
7659428|NCT00090233|12074908|FG000|Overall Study|Lost to Follow-up|68
7659429|NCT00090233|12074909|FG001|Overall Study|Lost to Follow-up|95
7659430|NCT00090233|12074908|FG000|Overall Study|Protocol Violation|960
7659431|NCT00090233|12074909|FG001|Overall Study|Protocol Violation|1022
7659432|NCT00090233|12074908|FG000|Overall Study|Withdrawal by Subject|182
7659433|NCT00090233|12074909|FG001|Overall Study|Withdrawal by Subject|211
7659434|NCT00090233|12074908|FG000|Overall Study|Moved|203
7659435|NCT00090233|12074909|FG001|Overall Study|Moved|189
7659436|NCT00090233|12074908|FG000|Overall Study|Other|1211
7659437|NCT00090233|12074909|FG001|Overall Study|Other|1160
7659438|NCT00090233|12074908|FG000|Overall Study|Data not available at data cut-off point|1552
7659439|NCT00090233|12074909|FG001|Overall Study|Data not available at data cut-off point|1563
7659440|NCT00090285|12074921|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7
7659441|NCT00090285|12074922|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3
7659442|NCT00090285|12074923|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0
7659443|NCT00090285|12074924|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0
7659444|NCT00090285|12074925|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0
7659445|NCT00090285|12074926|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0
7659446|NCT00090285|12074921|FG000|Base Study Vaccination Period|Adverse Event|2
7659447|NCT00090285|12074922|FG001|Base Study Vaccination Period|Adverse Event|4
7659448|NCT00090285|12074923|FG002|Base Study Vaccination Period|Adverse Event|0
7659449|NCT00090285|12074924|FG003|Base Study Vaccination Period|Adverse Event|0
7659450|NCT00090285|12074925|FG004|Base Study Vaccination Period|Adverse Event|0
7659451|NCT00090285|12074926|FG005|Base Study Vaccination Period|Adverse Event|0
7659452|NCT00090285|12074921|FG000|Base Study Vaccination Period|Lost to Follow-up|111
7659453|NCT00090285|12074922|FG001|Base Study Vaccination Period|Lost to Follow-up|112
7659454|NCT00090285|12074923|FG002|Base Study Vaccination Period|Lost to Follow-up|0
7659455|NCT00090285|12074924|FG003|Base Study Vaccination Period|Lost to Follow-up|0
7659456|NCT00090285|12074925|FG004|Base Study Vaccination Period|Lost to Follow-up|0
7659457|NCT00090285|12074926|FG005|Base Study Vaccination Period|Lost to Follow-up|0
7659458|NCT00090285|12074921|FG000|Base Study Vaccination Period|Protocol Violation|2
7659459|NCT00090285|12074922|FG001|Base Study Vaccination Period|Protocol Violation|3
7659460|NCT00090285|12074923|FG002|Base Study Vaccination Period|Protocol Violation|0
7659461|NCT00090285|12074924|FG003|Base Study Vaccination Period|Protocol Violation|0
7659462|NCT00090285|12074925|FG004|Base Study Vaccination Period|Protocol Violation|0
7659463|NCT00090285|12074926|FG005|Base Study Vaccination Period|Protocol Violation|0
7659464|NCT00090285|12074921|FG000|Base Study Vaccination Period|Withdrawal by Subject|64
7659465|NCT00090285|12074922|FG001|Base Study Vaccination Period|Withdrawal by Subject|69
7659466|NCT00090285|12074923|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
7659467|NCT00090285|12074924|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
7659468|NCT00090285|12074925|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
7659469|NCT00090285|12074926|FG005|Base Study Vaccination Period|Withdrawal by Subject|0
7659470|NCT00090285|12074921|FG000|Base Study Vaccination Period|Uncooperative|2
7659471|NCT00090285|12074922|FG001|Base Study Vaccination Period|Uncooperative|2
7659472|NCT00090285|12074923|FG002|Base Study Vaccination Period|Uncooperative|0
7659473|NCT00090285|12074924|FG003|Base Study Vaccination Period|Uncooperative|0
7659474|NCT00090285|12074925|FG004|Base Study Vaccination Period|Uncooperative|0
7659475|NCT00090285|12074926|FG005|Base Study Vaccination Period|Uncooperative|0
7659476|NCT00090285|12074921|FG000|Base Study Vaccination Period|Moved|20
7659477|NCT00090285|12074922|FG001|Base Study Vaccination Period|Moved|21
7659478|NCT00090285|12074923|FG002|Base Study Vaccination Period|Moved|0
7659479|NCT00090285|12074924|FG003|Base Study Vaccination Period|Moved|0
7659480|NCT00090285|12074925|FG004|Base Study Vaccination Period|Moved|0
7659481|NCT00090285|12074926|FG005|Base Study Vaccination Period|Moved|0
7659482|NCT00090285|12074921|FG000|Base Study Vaccination Period|Site Terminated|1
7659483|NCT00090285|12074922|FG001|Base Study Vaccination Period|Site Terminated|0
7659484|NCT00090285|12074923|FG002|Base Study Vaccination Period|Site Terminated|0
7659485|NCT00090285|12074924|FG003|Base Study Vaccination Period|Site Terminated|0
7659486|NCT00090285|12074925|FG004|Base Study Vaccination Period|Site Terminated|0
7659487|NCT00090285|12074926|FG005|Base Study Vaccination Period|Site Terminated|0
7659488|NCT00090285|12074921|FG000|Base Study Vaccination Period|Other|2
7659489|NCT00090285|12074922|FG001|Base Study Vaccination Period|Other|2
7659490|NCT00090285|12074923|FG002|Base Study Vaccination Period|Other|0
7659491|NCT00090285|12074924|FG003|Base Study Vaccination Period|Other|0
7659492|NCT00090285|12074925|FG004|Base Study Vaccination Period|Other|0
7659493|NCT00090285|12074926|FG005|Base Study Vaccination Period|Other|0
7659494|NCT00090285|12074921|FG000|Base Study Vaccination Period|Subject Incarcerated|2
7659495|NCT00090285|12074922|FG001|Base Study Vaccination Period|Subject Incarcerated|2
7659496|NCT00090285|12074923|FG002|Base Study Vaccination Period|Subject Incarcerated|0
7659497|NCT00090285|12074924|FG003|Base Study Vaccination Period|Subject Incarcerated|0
7659498|NCT00090285|12074925|FG004|Base Study Vaccination Period|Subject Incarcerated|0
7659499|NCT00090285|12074926|FG005|Base Study Vaccination Period|Subject Incarcerated|0
7659500|NCT00090285|12074921|FG000|Base Study Vaccination Period|HIV positive|1
7659501|NCT00090285|12074922|FG001|Base Study Vaccination Period|HIV positive|1
7659502|NCT00090285|12074923|FG002|Base Study Vaccination Period|HIV positive|0
7659503|NCT00090285|12074924|FG003|Base Study Vaccination Period|HIV positive|0
7659504|NCT00090285|12074925|FG004|Base Study Vaccination Period|HIV positive|0
7659505|NCT00090285|12074926|FG005|Base Study Vaccination Period|HIV positive|0
7659506|NCT00090285|12074921|FG000|Base Study Follow-up Period|Adverse Event|3
7659507|NCT00090285|12074922|FG001|Base Study Follow-up Period|Adverse Event|10
7659508|NCT00090285|12074923|FG002|Base Study Follow-up Period|Adverse Event|0
7659509|NCT00090285|12074924|FG003|Base Study Follow-up Period|Adverse Event|0
7659510|NCT00090285|12074925|FG004|Base Study Follow-up Period|Adverse Event|0
7659511|NCT00090285|12074926|FG005|Base Study Follow-up Period|Adverse Event|0
7659512|NCT00090285|12074921|FG000|Base Study Follow-up Period|Lost to Follow-up|232
7659513|NCT00090285|12074922|FG001|Base Study Follow-up Period|Lost to Follow-up|226
7659514|NCT00090285|12074923|FG002|Base Study Follow-up Period|Lost to Follow-up|0
7659515|NCT00090285|12074924|FG003|Base Study Follow-up Period|Lost to Follow-up|0
7659516|NCT00090285|12074925|FG004|Base Study Follow-up Period|Lost to Follow-up|0
7659517|NCT00090285|12074926|FG005|Base Study Follow-up Period|Lost to Follow-up|0
7659518|NCT00090285|12074921|FG000|Base Study Follow-up Period|Withdrawal by Subject|53
7659519|NCT00090285|12074922|FG001|Base Study Follow-up Period|Withdrawal by Subject|64
7659520|NCT00090285|12074923|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
7659521|NCT00090285|12074924|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
7659522|NCT00090285|12074925|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
7659523|NCT00090285|12074926|FG005|Base Study Follow-up Period|Withdrawal by Subject|0
7659524|NCT00090285|12074921|FG000|Base Study Follow-up Period|Moved|41
7659525|NCT00090285|12074922|FG001|Base Study Follow-up Period|Moved|36
7659526|NCT00090285|12074923|FG002|Base Study Follow-up Period|Moved|0
7659527|NCT00090285|12074924|FG003|Base Study Follow-up Period|Moved|0
7659528|NCT00090285|12074925|FG004|Base Study Follow-up Period|Moved|0
7659529|NCT00090285|12074926|FG005|Base Study Follow-up Period|Moved|0
7659530|NCT00090285|12074921|FG000|Base Study Follow-up Period|Other|2
7659531|NCT00090285|12074922|FG001|Base Study Follow-up Period|Other|0
7659532|NCT00090285|12074923|FG002|Base Study Follow-up Period|Other|0
7659533|NCT00090285|12074924|FG003|Base Study Follow-up Period|Other|0
7659534|NCT00090285|12074925|FG004|Base Study Follow-up Period|Other|0
7659535|NCT00090285|12074926|FG005|Base Study Follow-up Period|Other|0
7659536|NCT00090285|12074921|FG000|Base Study Follow-up Period|Protocol Violation|1
7659537|NCT00090285|12074922|FG001|Base Study Follow-up Period|Protocol Violation|0
7659538|NCT00090285|12074923|FG002|Base Study Follow-up Period|Protocol Violation|0
7659539|NCT00090285|12074924|FG003|Base Study Follow-up Period|Protocol Violation|0
7659540|NCT00090285|12074925|FG004|Base Study Follow-up Period|Protocol Violation|0
7659541|NCT00090285|12074926|FG005|Base Study Follow-up Period|Protocol Violation|0
7659542|NCT00090285|12074921|FG000|Base Study Follow-up Period|Uncooperative|3
7659543|NCT00090285|12074922|FG001|Base Study Follow-up Period|Uncooperative|4
7659544|NCT00090285|12074923|FG002|Base Study Follow-up Period|Uncooperative|0
7659545|NCT00090285|12074924|FG003|Base Study Follow-up Period|Uncooperative|0
7659546|NCT00090285|12074925|FG004|Base Study Follow-up Period|Uncooperative|0
7659547|NCT00090285|12074926|FG005|Base Study Follow-up Period|Uncooperative|0
7659548|NCT00090285|12074921|FG000|Base Study Follow-up Period|Subject Incarcerated|0
7659549|NCT00090285|12074922|FG001|Base Study Follow-up Period|Subject Incarcerated|2
7659550|NCT00090285|12074923|FG002|Base Study Follow-up Period|Subject Incarcerated|0
7659551|NCT00090285|12074924|FG003|Base Study Follow-up Period|Subject Incarcerated|0
7659552|NCT00090285|12074925|FG004|Base Study Follow-up Period|Subject Incarcerated|0
7659553|NCT00090285|12074926|FG005|Base Study Follow-up Period|Subject Incarcerated|0
7659554|NCT00090285|12074921|FG000|Extension 1|Adverse Event|0
7659555|NCT00090285|12074922|FG001|Extension 1|Adverse Event|0
7659556|NCT00090285|12074923|FG002|Extension 1|Adverse Event|2
7659557|NCT00090285|12074924|FG003|Extension 1|Adverse Event|0
7659558|NCT00090285|12074925|FG004|Extension 1|Adverse Event|0
7659559|NCT00090285|12074926|FG005|Extension 1|Adverse Event|0
7659560|NCT00090285|12074921|FG000|Extension 1|Lost to Follow-up|0
7659561|NCT00090285|12074922|FG001|Extension 1|Lost to Follow-up|0
7659562|NCT00090285|12074923|FG002|Extension 1|Lost to Follow-up|35
7659563|NCT00090285|12074924|FG003|Extension 1|Lost to Follow-up|0
7659564|NCT00090285|12074925|FG004|Extension 1|Lost to Follow-up|0
7659565|NCT00090285|12074926|FG005|Extension 1|Lost to Follow-up|0
7659566|NCT00090285|12074921|FG000|Extension 1|Withdrawal by Subject|0
7659567|NCT00090285|12074922|FG001|Extension 1|Withdrawal by Subject|0
7659568|NCT00090285|12074923|FG002|Extension 1|Withdrawal by Subject|13
7659569|NCT00090285|12074924|FG003|Extension 1|Withdrawal by Subject|1
7659570|NCT00090285|12074925|FG004|Extension 1|Withdrawal by Subject|0
7659571|NCT00090285|12074926|FG005|Extension 1|Withdrawal by Subject|0
7659572|NCT00090285|12074921|FG000|Extension 1|Other|0
7659573|NCT00090285|12074922|FG001|Extension 1|Other|0
7659574|NCT00090285|12074923|FG002|Extension 1|Other|4
7659575|NCT00090285|12074924|FG003|Extension 1|Other|0
7659576|NCT00090285|12074925|FG004|Extension 1|Other|0
7659577|NCT00090285|12074926|FG005|Extension 1|Other|0
7659578|NCT00090285|12074921|FG000|Extension 1|Moved|0
7659579|NCT00090285|12074922|FG001|Extension 1|Moved|0
7659580|NCT00090285|12074923|FG002|Extension 1|Moved|3
7659581|NCT00090285|12074924|FG003|Extension 1|Moved|0
7659582|NCT00090285|12074925|FG004|Extension 1|Moved|0
7659583|NCT00090285|12074926|FG005|Extension 1|Moved|0
7659584|NCT00090285|12074921|FG000|Long-term Follow-up (EXT2)|Adverse Event|0
7659585|NCT00090285|12074922|FG001|Long-term Follow-up (EXT2)|Adverse Event|0
7659586|NCT00090285|12074923|FG002|Long-term Follow-up (EXT2)|Adverse Event|0
7659587|NCT00090285|12074924|FG003|Long-term Follow-up (EXT2)|Adverse Event|0
7659588|NCT00090285|12074925|FG004|Long-term Follow-up (EXT2)|Adverse Event|5
7659589|NCT00090285|12074926|FG005|Long-term Follow-up (EXT2)|Adverse Event|2
7659590|NCT00090285|12074921|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7659591|NCT00090285|12074922|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7659592|NCT00090285|12074923|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7659593|NCT00090285|12074924|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7659594|NCT00090285|12074925|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156
7659595|NCT00090285|12074926|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143
7659596|NCT00090285|12074921|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7659597|NCT00090285|12074922|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7659598|NCT00090285|12074923|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7659599|NCT00090285|12074924|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7659600|NCT00090285|12074925|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
7659601|NCT00090285|12074926|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
7659602|NCT00090285|12074921|FG000|Long-term Follow-up (EXT2)|Physician Decision|0
7659603|NCT00090285|12074922|FG001|Long-term Follow-up (EXT2)|Physician Decision|0
7659604|NCT00090285|12074923|FG002|Long-term Follow-up (EXT2)|Physician Decision|0
7659605|NCT00090285|12074924|FG003|Long-term Follow-up (EXT2)|Physician Decision|0
7659606|NCT00090285|12074925|FG004|Long-term Follow-up (EXT2)|Physician Decision|6
7659607|NCT00090285|12074926|FG005|Long-term Follow-up (EXT2)|Physician Decision|5
7659608|NCT00090363|12074944|FG000|Overall Study|Lost to Follow-up|1
7659609|NCT00090363|12074945|FG001|Overall Study|Lost to Follow-up|2
7659610|NCT00090363|12074946|FG002|Overall Study|Lost to Follow-up|1
7659611|NCT00090363|12074944|FG000|Overall Study|Withdrawal by Subject|7
7659612|NCT00090363|12074945|FG001|Overall Study|Withdrawal by Subject|7
7659613|NCT00090363|12074946|FG002|Overall Study|Withdrawal by Subject|6
7659614|NCT00090363|12074944|FG000|Overall Study|Study-specific discontinuation criteria|75
7659615|NCT00090363|12074945|FG001|Overall Study|Study-specific discontinuation criteria|74
7659616|NCT00090363|12074946|FG002|Overall Study|Study-specific discontinuation criteria|62
7659617|NCT00090363|12074944|FG000|Overall Study|Eligibility criteria not fulfilled|0
7659618|NCT00090363|12074945|FG001|Overall Study|Eligibility criteria not fulfilled|0
7659619|NCT00090363|12074946|FG002|Overall Study|Eligibility criteria not fulfilled|1
7659620|NCT00090363|12074944|FG000|Overall Study|Consent expired|7
7659621|NCT00090363|12074945|FG001|Overall Study|Consent expired|10
7659622|NCT00090363|12074946|FG002|Overall Study|Consent expired|9
7659623|NCT00090363|12074944|FG000|Overall Study|Reasons not specified|2
7659624|NCT00090363|12074945|FG001|Overall Study|Reasons not specified|1
7659625|NCT00090363|12074946|FG002|Overall Study|Reasons not specified|1
7659626|NCT00090363|12074944|FG000|Overall Study|Continuing on study off treatment|14
7659627|NCT00090363|12074945|FG001|Overall Study|Continuing on study off treatment|13
7659628|NCT00090363|12074946|FG002|Overall Study|Continuing on study off treatment|16
7659629|NCT00090402|12074957|FG000|Overall Study|Death|1
7659630|NCT00090402|12074958|FG001|Overall Study|Death|1
7659631|NCT00090402|12074959|FG002|Overall Study|Death|0
7659632|NCT00090402|12074957|FG000|Overall Study|subject moved|0
7659633|NCT00090402|12074958|FG001|Overall Study|subject moved|1
7659634|NCT00090402|12074959|FG002|Overall Study|subject moved|0
7659635|NCT00090402|12074957|FG000|Overall Study|stopped taking study medication|1
7659636|NCT00090402|12074958|FG001|Overall Study|stopped taking study medication|0
7659637|NCT00090402|12074959|FG002|Overall Study|stopped taking study medication|1
7659638|NCT00090493|12074970|FG000|Overall Study|Physician Decision|2
7659639|NCT00090519|12074976|FG000|Overall Study|Adverse Event|5
7659640|NCT00090519|12074977|FG001|Overall Study|Adverse Event|4
7659641|NCT00090519|12074976|FG000|Overall Study|Death|9
7659642|NCT00090519|12074977|FG001|Overall Study|Death|9
7659643|NCT00090519|12074976|FG000|Overall Study|Lost to Follow-up|26
7659644|NCT00090519|12074977|FG001|Overall Study|Lost to Follow-up|29
7659645|NCT00090519|12074976|FG000|Overall Study|Withdrawal by Subject|28
7659646|NCT00090519|12074977|FG001|Overall Study|Withdrawal by Subject|29
7659647|NCT00090519|12074976|FG000|Overall Study|Physician Decision|2
7659648|NCT00090519|12074977|FG001|Overall Study|Physician Decision|3
7659649|NCT00090519|12074976|FG000|Overall Study|Sponsor Decision|3
7659650|NCT00090519|12074977|FG001|Overall Study|Sponsor Decision|1
7659651|NCT00090545|12074985|FG000|Overall Study|Disease progression on study|21
7659652|NCT00090545|12074986|FG001|Overall Study|Disease progression on study|17
7659653|NCT00090545|12074985|FG000|Overall Study|Refused further treatment|1
7659654|NCT00090545|12074986|FG001|Overall Study|Refused further treatment|4
7659655|NCT00090545|12074985|FG000|Overall Study|Death|0
7659656|NCT00090545|12074986|FG001|Overall Study|Death|1
7659657|NCT00090545|12074985|FG000|Overall Study|Adverse Event|0
7659658|NCT00090545|12074986|FG001|Overall Study|Adverse Event|2
7659659|NCT00090584|12074996|FG000|Baseline to 10 Weeks|Lost to Follow-up|15
7659660|NCT00090584|12074997|FG001|Baseline to 10 Weeks|Lost to Follow-up|12
7659661|NCT00090584|12074996|FG000|Baseline to 8 Months|Lost to Follow-up|44
7659662|NCT00090584|12074997|FG001|Baseline to 8 Months|Lost to Follow-up|41
7659663|NCT00090610|12075013|FG000|Overall Study|Withdrawal by Subject|1
7659664|NCT00090610|12075014|FG001|Overall Study|Withdrawal by Subject|1
7659665|NCT00090753|12075022|FG000|First Treatment Period|Adverse Event|20
7659666|NCT00090753|12075023|FG001|First Treatment Period|Adverse Event|8
7659667|NCT00090753|12075022|FG000|First Treatment Period|Death|88
7659668|NCT00090753|12075023|FG001|First Treatment Period|Death|62
7659669|NCT00090753|12075022|FG000|First Treatment Period|Lack of Efficacy|2
7659670|NCT00090753|12075023|FG001|First Treatment Period|Lack of Efficacy|1
7659671|NCT00090753|12075022|FG000|First Treatment Period|Refused Treatment|32
7659672|NCT00090753|12075023|FG001|First Treatment Period|Refused Treatment|25
7659673|NCT00090753|12075022|FG000|First Treatment Period|Lost to Follow-up|4
7659674|NCT00090753|12075023|FG001|First Treatment Period|Lost to Follow-up|4
7659675|NCT00090753|12075022|FG000|First Treatment Period|Renal Transplant|70
7659676|NCT00090753|12075023|FG001|First Treatment Period|Renal Transplant|50
7659677|NCT00090753|12075022|FG000|First Treatment Period|Mircera Commercialization|1
7659678|NCT00090753|12075023|FG001|First Treatment Period|Mircera Commercialization|0
7659679|NCT00090753|12075022|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39
7659680|NCT00090753|12075023|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28
7659681|NCT00090753|12075022|FG000|Extended Treatment Period|Adverse Event|11
7659682|NCT00090753|12075023|FG001|Extended Treatment Period|Adverse Event|0
7659683|NCT00090753|12075022|FG000|Extended Treatment Period|Death|58
7659684|NCT00090753|12075023|FG001|Extended Treatment Period|Death|30
7659685|NCT00090753|12075022|FG000|Extended Treatment Period|Lack of Efficacy|1
7659686|NCT00090753|12075023|FG001|Extended Treatment Period|Lack of Efficacy|0
7659687|NCT00090753|12075022|FG000|Extended Treatment Period|Refused Treatment|18
7659688|NCT00090753|12075023|FG001|Extended Treatment Period|Refused Treatment|12
7659689|NCT00090753|12075022|FG000|Extended Treatment Period|Lost to Follow-up|3
7659690|NCT00090753|12075023|FG001|Extended Treatment Period|Lost to Follow-up|1
7659691|NCT00090753|12075022|FG000|Extended Treatment Period|Renal Transplant|15
7659692|NCT00090753|12075023|FG001|Extended Treatment Period|Renal Transplant|12
7659693|NCT00090753|12075022|FG000|Extended Treatment Period|Mircera Commercialization|188
7659694|NCT00090753|12075023|FG001|Extended Treatment Period|Mircera Commercialization|93
7659695|NCT00090753|12075022|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
7659696|NCT00090753|12075023|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
7659697|NCT00090766|12075032|FG000|Overall Study|Nephrectomy Planned|0
7659698|NCT00090766|12075033|FG001|Overall Study|Nephrectomy Planned|0
7659699|NCT00090766|12075034|FG002|Overall Study|Nephrectomy Planned|1
7659700|NCT00090766|12075032|FG000|Overall Study|Death|1
7659701|NCT00090766|12075033|FG001|Overall Study|Death|0
7659702|NCT00090766|12075034|FG002|Overall Study|Death|0
7659703|NCT00090766|12075032|FG000|Overall Study|Admin|0
7659704|NCT00090766|12075033|FG001|Overall Study|Admin|2
7659705|NCT00090766|12075034|FG002|Overall Study|Admin|0
7659706|NCT00090766|12075032|FG000|Overall Study|Lost to Follow-up|2
7659707|NCT00090766|12075033|FG001|Overall Study|Lost to Follow-up|0
7659708|NCT00090766|12075034|FG002|Overall Study|Lost to Follow-up|2
7659709|NCT00090779|12075046|FG000|Step 1|Withdrawal by Subject|4
7659710|NCT00090779|12075047|FG001|Step 1|Withdrawal by Subject|2
7659711|NCT00090779|12075046|FG000|Step 1|Lost to Follow-up|3
7659712|NCT00090779|12075047|FG001|Step 1|Lost to Follow-up|2
7659713|NCT00090779|12075046|FG000|Step 1|Death|0
7659714|NCT00090779|12075047|FG001|Step 1|Death|2
7659715|NCT00090779|12075046|FG000|Step 1|Physician Decision|1
7659716|NCT00090779|12075047|FG001|Step 1|Physician Decision|0
7659717|NCT00090779|12075046|FG000|Step 1|Pregnancy|1
7659718|NCT00090779|12075047|FG001|Step 1|Pregnancy|0
7659719|NCT00090779|12075046|FG000|Step 1|Non-compliance to study requirements|0
7659720|NCT00090779|12075047|FG001|Step 1|Non-compliance to study requirements|1
7659721|NCT00090779|12075046|FG000|Step 1|Subject relocated|2
7659722|NCT00090779|12075047|FG001|Step 1|Subject relocated|8
7659723|NCT00090779|12075046|FG000|Step 2|Off study per study closure|6
7659724|NCT00090779|12075047|FG001|Step 2|Off study per study closure|16
7659725|NCT00090779|12075046|FG000|Step 2|Subject relocated|0
7659726|NCT00090779|12075047|FG001|Step 2|Subject relocated|1
7659727|NCT00090779|12075046|FG000|Step 2|Non-compliance to study requirements|0
7659728|NCT00090779|12075047|FG001|Step 2|Non-compliance to study requirements|1
7659729|NCT00090779|12075046|FG000|Step 3|Initiation of ART and off extended study|3
7659730|NCT00090779|12075047|FG001|Step 3|Initiation of ART and off extended study|2
7659731|NCT00090779|12075046|FG000|Step 3|Off extended study due to study closure|4
7659732|NCT00090779|12075047|FG001|Step 3|Off extended study due to study closure|3
7659733|NCT00090857|12075065|FG000|Overall Study|Lost to Follow-up|0
7659734|NCT00090857|12075066|FG001|Overall Study|Lost to Follow-up|1
7659735|NCT00090857|12075065|FG000|Overall Study|Withdrawal by Subject|2
7659736|NCT00090857|12075066|FG001|Overall Study|Withdrawal by Subject|0
7659737|NCT00090857|12075065|FG000|Overall Study|Adverse Event|2
7659738|NCT00090857|12075066|FG001|Overall Study|Adverse Event|2
7659739|NCT00090987|12075072|FG000|Overall Study|Adverse Event|5
7659740|NCT00090987|12075072|FG000|Overall Study|Lack of Efficacy|7
7659741|NCT00090987|12075072|FG000|Overall Study|Withdrawal by Subject|3
7659742|NCT00090987|12075072|FG000|Overall Study|alternative therapy|1
7659743|NCT00090987|12075072|FG000|Overall Study|Non-compliance|4
7659744|NCT00090987|12075072|FG000|Overall Study|Incarcerated|1
7659745|NCT00091026|12075078|FG000|Overall Study|Patient deemed non eligible-never receiv|1
7659746|NCT00091026|12075079|FG001|Overall Study|Patient deemed non eligible-never receiv|0
7659747|NCT00091026|12075078|FG000|Overall Study|Patient withdrew and never received trea|0
7659748|NCT00091026|12075079|FG001|Overall Study|Patient withdrew and never received trea|2
7659749|NCT00091026|12075078|FG000|Overall Study|Unknown-never received treatment|0
7659750|NCT00091026|12075079|FG001|Overall Study|Unknown-never received treatment|1
7659751|NCT00091169|12075087|FG000|Overall Study|Disease progression|3
7659752|NCT00091169|12075088|FG001|Overall Study|Disease progression|1
7659753|NCT00091169|12075087|FG000|Overall Study|Adverse Event|11
7659754|NCT00091169|12075088|FG001|Overall Study|Adverse Event|17
7659755|NCT00091169|12075087|FG000|Overall Study|Death|4
7659756|NCT00091169|12075088|FG001|Overall Study|Death|1
7659757|NCT00091169|12075087|FG000|Overall Study|Withdrawal by Subject|10
7659758|NCT00091169|12075088|FG001|Overall Study|Withdrawal by Subject|13
7659759|NCT00091169|12075087|FG000|Overall Study|Other|3
7659760|NCT00091169|12075088|FG001|Overall Study|Other|4
7659761|NCT00091169|12075087|FG000|Overall Study|Not start protocol therapy|26
7659762|NCT00091169|12075088|FG001|Overall Study|Not start protocol therapy|17
7659763|NCT00091390|12075105|FG000|Overall Study|Protocol Violation|1
7659764|NCT00091390|12075105|FG000|Overall Study|No protocol treatment|3
7659765|NCT00091442|12075111|FG000|Overall Study|Progressive Disease|220
7659766|NCT00091442|12075112|FG001|Overall Study|Progressive Disease|189
7659767|NCT00091442|12075111|FG000|Overall Study|Physician Decision|61
7659768|NCT00091442|12075112|FG001|Overall Study|Physician Decision|58
7659769|NCT00091442|12075111|FG000|Overall Study|Withdrawal by Subject|38
7659770|NCT00091442|12075112|FG001|Overall Study|Withdrawal by Subject|46
7659771|NCT00091442|12075111|FG000|Overall Study|Adverse Event|29
7659772|NCT00091442|12075112|FG001|Overall Study|Adverse Event|48
7659773|NCT00091442|12075111|FG000|Overall Study|2cycles therapy beyond Complete response|9
7659774|NCT00091442|12075112|FG001|Overall Study|2cycles therapy beyond Complete response|16
7659775|NCT00091442|12075111|FG000|Overall Study|Death|9
7659776|NCT00091442|12075112|FG001|Overall Study|Death|7
7659777|NCT00091442|12075111|FG000|Overall Study|Lost to Follow-up|1
7659778|NCT00091442|12075112|FG001|Overall Study|Lost to Follow-up|3
7659779|NCT00091442|12075111|FG000|Overall Study|Other|2
7659780|NCT00091442|12075112|FG001|Overall Study|Other|6
7659781|NCT00091572|12075129|FG000|Overall Study|Lost to Follow-up|1
7659782|NCT00091572|12075130|FG001|Overall Study|Lost to Follow-up|1
7659783|NCT00091572|12075129|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14
7659784|NCT00091572|12075130|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22
7659785|NCT00091572|12075129|FG000|Overall Study|Death not due to malignancy/toxicity|1
7659786|NCT00091572|12075130|FG001|Overall Study|Death not due to malignancy/toxicity|3
7659787|NCT00091572|12075129|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10
7659788|NCT00091572|12075130|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22
7659789|NCT00091572|12075129|FG000|Overall Study|Other Reason|6
7659790|NCT00091572|12075130|FG001|Overall Study|Other Reason|13
7659791|NCT00091572|12075129|FG000|Overall Study|Ongoing (still on treatment)|8
7659792|NCT00091572|12075130|FG001|Overall Study|Ongoing (still on treatment)|12
7659793|NCT00091572|12075129|FG000|Overall Study|Major Protocol Violation|2
7659794|NCT00091572|12075130|FG001|Overall Study|Major Protocol Violation|0
7659795|NCT00091572|12075129|FG000|Overall Study|Toxicity (Related AE)|53
7659796|NCT00091572|12075130|FG001|Overall Study|Toxicity (Related AE)|9
7659797|NCT00091793|12075138|FG000|Overall Study|Adverse Event|1
7659798|NCT00091793|12075139|FG001|Overall Study|Adverse Event|2
7659799|NCT00091793|12075138|FG000|Overall Study|Withdrawal by Subject|10
7659800|NCT00091793|12075139|FG001|Overall Study|Withdrawal by Subject|15
7659801|NCT00091793|12075138|FG000|Overall Study|Ineligibility determined|2
7659802|NCT00091793|12075139|FG001|Overall Study|Ineligibility determined|0
7659803|NCT00091793|12075138|FG000|Overall Study|Lost to Follow-up|7
7659804|NCT00091793|12075139|FG001|Overall Study|Lost to Follow-up|5
7659805|NCT00091793|12075138|FG000|Overall Study|Noncompliance|2
7659806|NCT00091793|12075139|FG001|Overall Study|Noncompliance|0
7659807|NCT00091793|12075138|FG000|Overall Study|Other|2
7659808|NCT00091793|12075139|FG001|Overall Study|Other|0
7659809|NCT00091819|12075147|FG000|Overall Study|Adverse Event|1
7659810|NCT00091819|12075148|FG001|Overall Study|Adverse Event|1
7659811|NCT00091819|12075147|FG000|Overall Study|Death|4
7659812|NCT00091819|12075148|FG001|Overall Study|Death|5
7659813|NCT00091819|12075147|FG000|Overall Study|Lost to Follow-up|26
7659814|NCT00091819|12075148|FG001|Overall Study|Lost to Follow-up|23
7659815|NCT00091819|12075147|FG000|Overall Study|Withdrawal by Subject|5
7659816|NCT00091819|12075148|FG001|Overall Study|Withdrawal by Subject|8
7659817|NCT00091819|12075147|FG000|Overall Study|Protocol Violation|1
7659818|NCT00091819|12075148|FG001|Overall Study|Protocol Violation|2
7659819|NCT00091819|12075147|FG000|Overall Study|Other|2
7659820|NCT00091819|12075148|FG001|Overall Study|Other|3
7659821|NCT00091819|12075147|FG000|Overall Study|Never received study treatment|3
7659822|NCT00091819|12075148|FG001|Overall Study|Never received study treatment|4
7659823|NCT00091832|12075160|FG000|Overall Study|Physician Decision|1
7659824|NCT00091832|12075161|FG001|Overall Study|Physician Decision|0
7659825|NCT00091832|12075162|FG002|Overall Study|Physician Decision|0
7659826|NCT00091832|12075163|FG003|Overall Study|Physician Decision|0
7659827|NCT00091832|12075164|FG004|Overall Study|Physician Decision|0
7659828|NCT00091832|12075165|FG005|Overall Study|Physician Decision|0
7659829|NCT00091832|12075160|FG000|Overall Study|Adverse Event|0
7659830|NCT00091832|12075161|FG001|Overall Study|Adverse Event|0
7659831|NCT00091832|12075162|FG002|Overall Study|Adverse Event|0
7659832|NCT00091832|12075163|FG003|Overall Study|Adverse Event|1
7659833|NCT00091832|12075164|FG004|Overall Study|Adverse Event|3
7659834|NCT00091832|12075165|FG005|Overall Study|Adverse Event|0
7659835|NCT00091832|12075160|FG000|Overall Study|Withdrawal by Subject|4
7659836|NCT00091832|12075161|FG001|Overall Study|Withdrawal by Subject|5
7659837|NCT00091832|12075162|FG002|Overall Study|Withdrawal by Subject|0
7659838|NCT00091832|12075163|FG003|Overall Study|Withdrawal by Subject|1
7659839|NCT00091832|12075164|FG004|Overall Study|Withdrawal by Subject|3
7659840|NCT00091832|12075165|FG005|Overall Study|Withdrawal by Subject|1
7659841|NCT00091832|12075160|FG000|Overall Study|Death|6
7659842|NCT00091832|12075161|FG001|Overall Study|Death|4
7659843|NCT00091832|12075162|FG002|Overall Study|Death|5
7659844|NCT00091832|12075163|FG003|Overall Study|Death|8
7659845|NCT00091832|12075164|FG004|Overall Study|Death|5
7659846|NCT00091832|12075165|FG005|Overall Study|Death|6
7659847|NCT00091832|12075160|FG000|Overall Study|Disease Progression|2
7659848|NCT00091832|12075161|FG001|Overall Study|Disease Progression|0
7659849|NCT00091832|12075162|FG002|Overall Study|Disease Progression|0
7659850|NCT00091832|12075163|FG003|Overall Study|Disease Progression|1
7659851|NCT00091832|12075164|FG004|Overall Study|Disease Progression|1
7659852|NCT00091832|12075165|FG005|Overall Study|Disease Progression|2
7659853|NCT00091832|12075160|FG000|Overall Study|Ineligibility Determined|0
7659854|NCT00091832|12075161|FG001|Overall Study|Ineligibility Determined|0
7659855|NCT00091832|12075162|FG002|Overall Study|Ineligibility Determined|1
7659856|NCT00091832|12075163|FG003|Overall Study|Ineligibility Determined|0
7659857|NCT00091832|12075164|FG004|Overall Study|Ineligibility Determined|1
7659858|NCT00091832|12075165|FG005|Overall Study|Ineligibility Determined|0
7659859|NCT00091832|12075160|FG000|Overall Study|Lost to Follow-up|1
7659860|NCT00091832|12075161|FG001|Overall Study|Lost to Follow-up|0
7659861|NCT00091832|12075162|FG002|Overall Study|Lost to Follow-up|3
7659862|NCT00091832|12075163|FG003|Overall Study|Lost to Follow-up|3
7659863|NCT00091832|12075164|FG004|Overall Study|Lost to Follow-up|2
7659864|NCT00091832|12075165|FG005|Overall Study|Lost to Follow-up|1
7659865|NCT00091832|12075160|FG000|Overall Study|Noncompliance|0
7659866|NCT00091832|12075161|FG001|Overall Study|Noncompliance|1
7659867|NCT00091832|12075162|FG002|Overall Study|Noncompliance|0
7659868|NCT00091832|12075163|FG003|Overall Study|Noncompliance|0
7659869|NCT00091832|12075164|FG004|Overall Study|Noncompliance|0
7659870|NCT00091832|12075165|FG005|Overall Study|Noncompliance|0
7659871|NCT00091832|12075160|FG000|Overall Study|Other|0
7659872|NCT00091832|12075161|FG001|Overall Study|Other|1
7659873|NCT00091832|12075162|FG002|Overall Study|Other|2
7659874|NCT00091832|12075163|FG003|Overall Study|Other|0
7659875|NCT00091832|12075164|FG004|Overall Study|Other|0
7659876|NCT00091832|12075165|FG005|Overall Study|Other|0
7659877|NCT00091832|12075160|FG000|Overall Study|Protocol Violation|0
7659878|NCT00091832|12075161|FG001|Overall Study|Protocol Violation|0
7659879|NCT00091832|12075162|FG002|Overall Study|Protocol Violation|1
7659880|NCT00091832|12075163|FG003|Overall Study|Protocol Violation|0
7659881|NCT00091832|12075164|FG004|Overall Study|Protocol Violation|0
7659882|NCT00091832|12075165|FG005|Overall Study|Protocol Violation|1
7659883|NCT00091949|12075181|FG000|Overall Study|Withdrawal by Subject|117
7659884|NCT00091949|12075182|FG001|Overall Study|Withdrawal by Subject|110
7659885|NCT00091949|12075181|FG000|Overall Study|Lost to Follow-up|58
7659886|NCT00091949|12075182|FG001|Overall Study|Lost to Follow-up|41
7659887|NCT00092417|12075206|FG000|Overall Study|Lost to Follow-up|2
7659888|NCT00092417|12075207|FG001|Overall Study|Lost to Follow-up|0
7659889|NCT00092417|12075206|FG000|Overall Study|Withdrawal by Subject|2
7659890|NCT00092417|12075207|FG001|Overall Study|Withdrawal by Subject|1
7659891|NCT00092417|12075206|FG000|Overall Study|Other|1
7659892|NCT00092417|12075207|FG001|Overall Study|Other|0
7659893|NCT00092443|12075215|FG000|Overall Study|Adverse Event|9
7659894|NCT00092443|12075216|FG001|Overall Study|Adverse Event|13
7659895|NCT00092443|12075215|FG000|Overall Study|Lost to Follow-up|7
7659896|NCT00092443|12075216|FG001|Overall Study|Lost to Follow-up|3
7659897|NCT00092443|12075215|FG000|Overall Study|Protocol Violation|11
7659898|NCT00092443|12075216|FG001|Overall Study|Protocol Violation|9
7659899|NCT00092443|12075215|FG000|Overall Study|Withdrawal by Subject|9
7659900|NCT00092443|12075216|FG001|Overall Study|Withdrawal by Subject|11
7659901|NCT00092443|12075215|FG000|Overall Study|Moved|5
7659902|NCT00092443|12075216|FG001|Overall Study|Moved|5
7659903|NCT00092443|12075215|FG000|Overall Study|Other|17
7659904|NCT00092443|12075216|FG001|Overall Study|Other|13
7659905|NCT00092456|12075236|FG000|Overall Study|Adverse Event|0
7659906|NCT00092456|12075237|FG001|Overall Study|Adverse Event|0
7659907|NCT00092456|12075238|FG002|Overall Study|Adverse Event|1
7659908|NCT00092456|12075239|FG003|Overall Study|Adverse Event|1
7659909|NCT00092456|12075236|FG000|Overall Study|Lost to Follow-up|2
7659910|NCT00092456|12075237|FG001|Overall Study|Lost to Follow-up|2
7659911|NCT00092456|12075238|FG002|Overall Study|Lost to Follow-up|1
7659912|NCT00092456|12075239|FG003|Overall Study|Lost to Follow-up|2
7659913|NCT00092456|12075236|FG000|Overall Study|Protocol Violation|5
7659914|NCT00092456|12075237|FG001|Overall Study|Protocol Violation|7
7659915|NCT00092456|12075238|FG002|Overall Study|Protocol Violation|8
7659916|NCT00092456|12075239|FG003|Overall Study|Protocol Violation|6
7659917|NCT00092456|12075236|FG000|Overall Study|Withdrawal by Subject|13
7659918|NCT00092456|12075237|FG001|Overall Study|Withdrawal by Subject|5
7659919|NCT00092456|12075238|FG002|Overall Study|Withdrawal by Subject|16
7659920|NCT00092456|12075239|FG003|Overall Study|Withdrawal by Subject|6
7659921|NCT00092456|12075236|FG000|Overall Study|Moved|1
7659922|NCT00092456|12075237|FG001|Overall Study|Moved|1
7659923|NCT00092456|12075238|FG002|Overall Study|Moved|0
7659924|NCT00092456|12075239|FG003|Overall Study|Moved|1
7659925|NCT00092456|12075236|FG000|Overall Study|Other|4
7659926|NCT00092456|12075237|FG001|Overall Study|Other|2
7659927|NCT00092456|12075238|FG002|Overall Study|Other|3
7659928|NCT00092456|12075239|FG003|Overall Study|Other|0
7659929|NCT00092495|12075253|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1
7659930|NCT00092495|12075254|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1
7659931|NCT00092495|12075255|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0
7659932|NCT00092495|12075256|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4
7659933|NCT00092495|12075257|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0
7659934|NCT00092495|12075253|FG000|Base Study Vaccination Period|Extended|0
7659935|NCT00092495|12075254|FG001|Base Study Vaccination Period|Extended|0
7659936|NCT00092495|12075255|FG002|Base Study Vaccination Period|Extended|0
7659937|NCT00092495|12075256|FG003|Base Study Vaccination Period|Extended|1
7659938|NCT00092495|12075257|FG004|Base Study Vaccination Period|Extended|0
7659939|NCT00092495|12075253|FG000|Base Study Vaccination Period|*Clinical AE|1
7659940|NCT00092495|12075254|FG001|Base Study Vaccination Period|*Clinical AE|0
7659941|NCT00092495|12075255|FG002|Base Study Vaccination Period|*Clinical AE|1
7659942|NCT00092495|12075256|FG003|Base Study Vaccination Period|*Clinical AE|2
7659943|NCT00092495|12075257|FG004|Base Study Vaccination Period|*Clinical AE|0
7659944|NCT00092495|12075253|FG000|Base Study Vaccination Period|*Other reasons|1
7659945|NCT00092495|12075254|FG001|Base Study Vaccination Period|*Other reasons|0
7659946|NCT00092495|12075255|FG002|Base Study Vaccination Period|*Other reasons|0
7659947|NCT00092495|12075256|FG003|Base Study Vaccination Period|*Other reasons|1
7659948|NCT00092495|12075257|FG004|Base Study Vaccination Period|*Other reasons|0
7659949|NCT00092495|12075253|FG000|Base Study Vaccination Period|*Pregnancy|0
7659950|NCT00092495|12075254|FG001|Base Study Vaccination Period|*Pregnancy|2
7659951|NCT00092495|12075255|FG002|Base Study Vaccination Period|*Pregnancy|5
7659952|NCT00092495|12075256|FG003|Base Study Vaccination Period|*Pregnancy|7
7659953|NCT00092495|12075257|FG004|Base Study Vaccination Period|*Pregnancy|0
7659954|NCT00092495|12075253|FG000|Base Study Vaccination Period|Adverse Event|1
7659955|NCT00092495|12075254|FG001|Base Study Vaccination Period|Adverse Event|0
7659956|NCT00092495|12075255|FG002|Base Study Vaccination Period|Adverse Event|0
7659957|NCT00092495|12075256|FG003|Base Study Vaccination Period|Adverse Event|3
7659958|NCT00092495|12075257|FG004|Base Study Vaccination Period|Adverse Event|0
7659959|NCT00092495|12075253|FG000|Base Study Vaccination Period|Lost to Follow-up|16
7659960|NCT00092495|12075254|FG001|Base Study Vaccination Period|Lost to Follow-up|6
7659961|NCT00092495|12075255|FG002|Base Study Vaccination Period|Lost to Follow-up|11
7659962|NCT00092495|12075256|FG003|Base Study Vaccination Period|Lost to Follow-up|36
7659963|NCT00092495|12075257|FG004|Base Study Vaccination Period|Lost to Follow-up|0
7659964|NCT00092495|12075253|FG000|Base Study Vaccination Period|Moved|3
7659965|NCT00092495|12075254|FG001|Base Study Vaccination Period|Moved|1
7659966|NCT00092495|12075255|FG002|Base Study Vaccination Period|Moved|2
7659967|NCT00092495|12075256|FG003|Base Study Vaccination Period|Moved|2
7659968|NCT00092495|12075257|FG004|Base Study Vaccination Period|Moved|0
7659969|NCT00092495|12075253|FG000|Base Study Vaccination Period|Other|1
7659970|NCT00092495|12075254|FG001|Base Study Vaccination Period|Other|1
7659971|NCT00092495|12075255|FG002|Base Study Vaccination Period|Other|0
7659972|NCT00092495|12075256|FG003|Base Study Vaccination Period|Other|2
7659973|NCT00092495|12075257|FG004|Base Study Vaccination Period|Other|0
7659974|NCT00092495|12075253|FG000|Base Study Vaccination Period|Pregnancy|2
7659975|NCT00092495|12075254|FG001|Base Study Vaccination Period|Pregnancy|0
7659976|NCT00092495|12075255|FG002|Base Study Vaccination Period|Pregnancy|0
7659977|NCT00092495|12075256|FG003|Base Study Vaccination Period|Pregnancy|0
7659978|NCT00092495|12075257|FG004|Base Study Vaccination Period|Pregnancy|0
7659979|NCT00092495|12075253|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1
7659980|NCT00092495|12075254|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1
7659981|NCT00092495|12075255|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1
7659982|NCT00092495|12075256|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5
7659983|NCT00092495|12075257|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0
7659984|NCT00092495|12075253|FG000|Base Study Vaccination Period|Protocol Violation|1
7659985|NCT00092495|12075254|FG001|Base Study Vaccination Period|Protocol Violation|0
7659986|NCT00092495|12075255|FG002|Base Study Vaccination Period|Protocol Violation|0
7659987|NCT00092495|12075256|FG003|Base Study Vaccination Period|Protocol Violation|0
7659988|NCT00092495|12075257|FG004|Base Study Vaccination Period|Protocol Violation|0
7659989|NCT00092495|12075253|FG000|Base Study Vaccination Period|Withdrawal by Subject|9
7659990|NCT00092495|12075254|FG001|Base Study Vaccination Period|Withdrawal by Subject|10
7659991|NCT00092495|12075255|FG002|Base Study Vaccination Period|Withdrawal by Subject|14
7659992|NCT00092495|12075256|FG003|Base Study Vaccination Period|Withdrawal by Subject|25
7659993|NCT00092495|12075257|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
7659994|NCT00092495|12075253|FG000|Base Study Follow-up Period|Extended|0
7659995|NCT00092495|12075254|FG001|Base Study Follow-up Period|Extended|0
7659996|NCT00092495|12075255|FG002|Base Study Follow-up Period|Extended|1
7659997|NCT00092495|12075256|FG003|Base Study Follow-up Period|Extended|2
7659998|NCT00092495|12075257|FG004|Base Study Follow-up Period|Extended|0
7659999|NCT00092495|12075253|FG000|Base Study Follow-up Period|Lost to Follow-up|1
7660000|NCT00092495|12075254|FG001|Base Study Follow-up Period|Lost to Follow-up|3
7660001|NCT00092495|12075255|FG002|Base Study Follow-up Period|Lost to Follow-up|3
7660002|NCT00092495|12075256|FG003|Base Study Follow-up Period|Lost to Follow-up|12
7660003|NCT00092495|12075257|FG004|Base Study Follow-up Period|Lost to Follow-up|0
7660004|NCT00092495|12075253|FG000|Base Study Follow-up Period|Withdrawal by Subject|2
7660005|NCT00092495|12075254|FG001|Base Study Follow-up Period|Withdrawal by Subject|0
7660006|NCT00092495|12075255|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
7660007|NCT00092495|12075256|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
7660008|NCT00092495|12075257|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
7660009|NCT00092521|12075273|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
7660010|NCT00092521|12075274|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
7660011|NCT00092521|12075275|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
7660012|NCT00092521|12075276|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
7660013|NCT00092521|12075273|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1
7660014|NCT00092521|12075274|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0
7660015|NCT00092521|12075275|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7
7660016|NCT00092521|12075276|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0
7660017|NCT00092521|12075273|FG000|Vaccination (Day 1 Through Month 7)|Death|0
7660018|NCT00092521|12075274|FG001|Vaccination (Day 1 Through Month 7)|Death|0
7660019|NCT00092521|12075275|FG002|Vaccination (Day 1 Through Month 7)|Death|1
7660020|NCT00092521|12075276|FG003|Vaccination (Day 1 Through Month 7)|Death|0
7660021|NCT00092521|12075273|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
7660022|NCT00092521|12075274|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
7660023|NCT00092521|12075275|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
7660024|NCT00092521|12075276|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
7660025|NCT00092521|12075273|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5
7660026|NCT00092521|12075274|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0
7660027|NCT00092521|12075275|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7
7660028|NCT00092521|12075276|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0
7660029|NCT00092521|12075273|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
7660030|NCT00092521|12075274|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
7660031|NCT00092521|12075275|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
7660032|NCT00092521|12075276|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
7660033|NCT00092521|12075273|FG000|Vaccination (Day 1 Through Month 7)|Moved|14
7660034|NCT00092521|12075274|FG001|Vaccination (Day 1 Through Month 7)|Moved|1
7660035|NCT00092521|12075275|FG002|Vaccination (Day 1 Through Month 7)|Moved|18
7660036|NCT00092521|12075276|FG003|Vaccination (Day 1 Through Month 7)|Moved|0
7660037|NCT00092521|12075273|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2
7660038|NCT00092521|12075274|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0
7660039|NCT00092521|12075275|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0
7660040|NCT00092521|12075276|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0
7660041|NCT00092521|12075273|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
7660042|NCT00092521|12075274|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
7660043|NCT00092521|12075275|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
7660044|NCT00092521|12075276|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
7660045|NCT00092521|12075273|FG000|Follow-Up (After Month 7)|Subjects Continuing|34
7660046|NCT00092521|12075274|FG001|Follow-Up (After Month 7)|Subjects Continuing|4
7660047|NCT00092521|12075275|FG002|Follow-Up (After Month 7)|Subjects Continuing|35
7660048|NCT00092521|12075276|FG003|Follow-Up (After Month 7)|Subjects Continuing|0
7660049|NCT00092521|12075273|FG000|Follow-Up (After Month 7)|Subjects in Extension|13
7660050|NCT00092521|12075274|FG001|Follow-Up (After Month 7)|Subjects in Extension|109
7660051|NCT00092521|12075275|FG002|Follow-Up (After Month 7)|Subjects in Extension|412
7660052|NCT00092521|12075276|FG003|Follow-Up (After Month 7)|Subjects in Extension|0
7660053|NCT00092521|12075273|FG000|Follow-Up (After Month 7)|Adverse Event|1
7660054|NCT00092521|12075274|FG001|Follow-Up (After Month 7)|Adverse Event|0
7660055|NCT00092521|12075275|FG002|Follow-Up (After Month 7)|Adverse Event|0
7660056|NCT00092521|12075276|FG003|Follow-Up (After Month 7)|Adverse Event|0
7660057|NCT00092521|12075273|FG000|Follow-Up (After Month 7)|Death|2
7660058|NCT00092521|12075274|FG001|Follow-Up (After Month 7)|Death|0
7660059|NCT00092521|12075275|FG002|Follow-Up (After Month 7)|Death|1
7660060|NCT00092521|12075276|FG003|Follow-Up (After Month 7)|Death|0
7660061|NCT00092521|12075273|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113
7660062|NCT00092521|12075274|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14
7660063|NCT00092521|12075275|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108
7660064|NCT00092521|12075276|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0
7660065|NCT00092521|12075273|FG000|Follow-Up (After Month 7)|Protocol Violation|1
7660066|NCT00092521|12075274|FG001|Follow-Up (After Month 7)|Protocol Violation|1
7660067|NCT00092521|12075275|FG002|Follow-Up (After Month 7)|Protocol Violation|5
7660068|NCT00092521|12075276|FG003|Follow-Up (After Month 7)|Protocol Violation|0
7660069|NCT00092521|12075273|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40
7660070|NCT00092521|12075274|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6
7660071|NCT00092521|12075275|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51
7660072|NCT00092521|12075276|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0
7660073|NCT00092521|12075273|FG000|Follow-Up (After Month 7)|Moved|32
7660074|NCT00092521|12075274|FG001|Follow-Up (After Month 7)|Moved|2
7660075|NCT00092521|12075275|FG002|Follow-Up (After Month 7)|Moved|28
7660076|NCT00092521|12075276|FG003|Follow-Up (After Month 7)|Moved|0
7660077|NCT00092521|12075273|FG000|Follow-Up (After Month 7)|Site Terminated|3
7660078|NCT00092521|12075274|FG001|Follow-Up (After Month 7)|Site Terminated|0
7660079|NCT00092521|12075275|FG002|Follow-Up (After Month 7)|Site Terminated|3
7660080|NCT00092521|12075276|FG003|Follow-Up (After Month 7)|Site Terminated|0
7660081|NCT00092521|12075273|FG000|Follow-Up (After Month 7)|Travel|2
7660082|NCT00092521|12075274|FG001|Follow-Up (After Month 7)|Travel|0
7660083|NCT00092521|12075275|FG002|Follow-Up (After Month 7)|Travel|0
7660084|NCT00092521|12075276|FG003|Follow-Up (After Month 7)|Travel|0
7660085|NCT00092521|12075273|FG000|Follow-Up (After Month 7)|Visits Compressed|5
7660086|NCT00092521|12075274|FG001|Follow-Up (After Month 7)|Visits Compressed|0
7660087|NCT00092521|12075275|FG002|Follow-Up (After Month 7)|Visits Compressed|5
7660088|NCT00092521|12075276|FG003|Follow-Up (After Month 7)|Visits Compressed|0
7660089|NCT00092521|12075273|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0
7660090|NCT00092521|12075274|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0
7660091|NCT00092521|12075275|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0
7660092|NCT00092521|12075276|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23
7660093|NCT00092521|12075273|FG000|Extension Study (Group 4)|Adverse Event|0
7660094|NCT00092521|12075274|FG001|Extension Study (Group 4)|Adverse Event|0
7660095|NCT00092521|12075275|FG002|Extension Study (Group 4)|Adverse Event|0
7660096|NCT00092521|12075276|FG003|Extension Study (Group 4)|Adverse Event|2
7660097|NCT00092521|12075273|FG000|Extension Study (Group 4)|Lost to Follow-up|0
7660098|NCT00092521|12075274|FG001|Extension Study (Group 4)|Lost to Follow-up|0
7660099|NCT00092521|12075275|FG002|Extension Study (Group 4)|Lost to Follow-up|0
7660100|NCT00092521|12075276|FG003|Extension Study (Group 4)|Lost to Follow-up|87
7660101|NCT00092521|12075273|FG000|Extension Study (Group 4)|Pregnancy|0
7660102|NCT00092521|12075274|FG001|Extension Study (Group 4)|Pregnancy|0
7660103|NCT00092521|12075275|FG002|Extension Study (Group 4)|Pregnancy|0
7660104|NCT00092521|12075276|FG003|Extension Study (Group 4)|Pregnancy|4
7660105|NCT00092521|12075273|FG000|Extension Study (Group 4)|Protocol Violation|0
7660106|NCT00092521|12075274|FG001|Extension Study (Group 4)|Protocol Violation|0
7660107|NCT00092521|12075275|FG002|Extension Study (Group 4)|Protocol Violation|0
7660108|NCT00092521|12075276|FG003|Extension Study (Group 4)|Protocol Violation|2
7660109|NCT00092521|12075273|FG000|Extension Study (Group 4)|Withdrawal by Subject|0
7660110|NCT00092521|12075274|FG001|Extension Study (Group 4)|Withdrawal by Subject|0
7660111|NCT00092521|12075275|FG002|Extension Study (Group 4)|Withdrawal by Subject|0
7660112|NCT00092521|12075276|FG003|Extension Study (Group 4)|Withdrawal by Subject|46
7660113|NCT00092521|12075273|FG000|Extension Study (Group 4)|Moved|0
7660114|NCT00092521|12075274|FG001|Extension Study (Group 4)|Moved|0
7660115|NCT00092521|12075275|FG002|Extension Study (Group 4)|Moved|0
7660116|NCT00092521|12075276|FG003|Extension Study (Group 4)|Moved|16
7660117|NCT00092521|12075273|FG000|Extension Study (Group 4)|Site Terminated|0
7660118|NCT00092521|12075274|FG001|Extension Study (Group 4)|Site Terminated|0
7660119|NCT00092521|12075275|FG002|Extension Study (Group 4)|Site Terminated|0
7660120|NCT00092521|12075276|FG003|Extension Study (Group 4)|Site Terminated|4
7660121|NCT00092521|12075273|FG000|Extension Study (Group 4)|Unable/unwilling to return|0
7660122|NCT00092521|12075274|FG001|Extension Study (Group 4)|Unable/unwilling to return|0
7660123|NCT00092521|12075275|FG002|Extension Study (Group 4)|Unable/unwilling to return|0
7660124|NCT00092521|12075276|FG003|Extension Study (Group 4)|Unable/unwilling to return|25
7660125|NCT00092547|12075286|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
7660126|NCT00092547|12075287|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
7660127|NCT00092547|12075288|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
7660128|NCT00092547|12075286|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
7660129|NCT00092547|12075287|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
7660130|NCT00092547|12075288|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
7660131|NCT00092547|12075286|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
7660132|NCT00092547|12075287|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
7660133|NCT00092547|12075288|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
7660134|NCT00092547|12075286|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
7660135|NCT00092547|12075287|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
7660136|NCT00092547|12075288|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
7660137|NCT00092547|12075286|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
7660138|NCT00092547|12075287|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
7660139|NCT00092547|12075288|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
7660140|NCT00092547|12075286|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
7660141|NCT00092547|12075287|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
7660142|NCT00092547|12075288|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
7660143|NCT00092547|12075286|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
7660144|NCT00092547|12075287|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
7660145|NCT00092547|12075288|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
7660146|NCT00092547|12075286|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
7660147|NCT00092547|12075287|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
7660148|NCT00092547|12075288|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
7660149|NCT00092547|12075286|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
7660150|NCT00092547|12075287|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
7660151|NCT00092547|12075288|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
7660152|NCT00092547|12075286|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
7660153|NCT00092547|12075287|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
7660154|NCT00092547|12075288|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
7660155|NCT00092547|12075286|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
7660156|NCT00092547|12075287|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
7660157|NCT00092547|12075288|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
7660158|NCT00092547|12075286|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
7660159|NCT00092547|12075287|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
7660160|NCT00092547|12075288|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
7660161|NCT00092547|12075286|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
7660162|NCT00092547|12075287|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
7660163|NCT00092547|12075288|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
7660164|NCT00092547|12075286|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
7660165|NCT00092547|12075287|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
7660166|NCT00092547|12075288|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
7660167|NCT00092547|12075286|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
7660168|NCT00092547|12075287|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
7660169|NCT00092547|12075288|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
7660170|NCT00092547|12075286|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
7660171|NCT00092547|12075287|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
7660172|NCT00092547|12075288|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
7660173|NCT00092547|12075286|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
7660174|NCT00092547|12075287|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
7660175|NCT00092547|12075288|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
7660176|NCT00092547|12075286|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
7660177|NCT00092547|12075287|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
7660178|NCT00092547|12075288|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
7660179|NCT00092547|12075286|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
7660180|NCT00092547|12075287|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
7660181|NCT00092547|12075288|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
7660182|NCT00092547|12075286|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
7660183|NCT00092547|12075287|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
7660184|NCT00092547|12075288|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
7660185|NCT00092547|12075286|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
7660186|NCT00092547|12075287|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
7660187|NCT00092547|12075288|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
7660188|NCT00093145|12075324|FG000|Overall Study|Unacceptable Toxicity Only|2
7660189|NCT00093145|12075324|FG000|Overall Study|Physician Decision|5
7660190|NCT00093145|12075324|FG000|Overall Study|Withdrawal by Subject|9
7660191|NCT00093145|12075324|FG000|Overall Study|Other|1
7660192|NCT00093470|12075334|FG000|Overall Study|Disease progression|39
7660193|NCT00093470|12075335|FG001|Overall Study|Disease progression|0
7660194|NCT00093470|12075334|FG000|Overall Study|Adverse Event|15
7660195|NCT00093470|12075335|FG001|Overall Study|Adverse Event|0
7660196|NCT00093470|12075334|FG000|Overall Study|Death|2
7660197|NCT00093470|12075335|FG001|Overall Study|Death|0
7660198|NCT00093470|12075334|FG000|Overall Study|Withdrawal by Subject|8
7660199|NCT00093470|12075335|FG001|Overall Study|Withdrawal by Subject|0
7660200|NCT00093470|12075334|FG000|Overall Study|Alternative therapy|2
7660201|NCT00093470|12075335|FG001|Overall Study|Alternative therapy|0
7660202|NCT00093470|12075334|FG000|Overall Study|Other complicating disease|3
7660203|NCT00093470|12075335|FG001|Overall Study|Other complicating disease|0
7660204|NCT00093470|12075334|FG000|Overall Study|Physician Decision|2
7660205|NCT00093470|12075335|FG001|Overall Study|Physician Decision|0
7660206|NCT00093470|12075334|FG000|Overall Study|Never started treatment|1
7660207|NCT00093470|12075335|FG001|Overall Study|Never started treatment|0
7660208|NCT00093470|12075334|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1
7660209|NCT00093470|12075335|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0
7660210|NCT00093496|12075343|FG000|Overall Study|Protocol Violation|1
7660211|NCT00093496|12075344|FG001|Overall Study|Protocol Violation|3
7660212|NCT00093795|12075367|FG000|Overall Study|No follow up data|20
7660213|NCT00093795|12075368|FG001|Overall Study|No follow up data|16
7660214|NCT00093795|12075369|FG002|Overall Study|No follow up data|17
7660215|NCT00093808|12075377|FG000|Overall Study|Cancel participation before receiving tx|1
7660216|NCT00093808|12075377|FG000|Overall Study|Protocol Violation|1
7660217|NCT00094055|12075401|FG000|Overall Study|Adverse Event|11
7660218|NCT00094055|12075401|FG000|Overall Study|Death|4
7660219|NCT00094055|12075401|FG000|Overall Study|Lack of Efficacy|17
7660220|NCT00094055|12075401|FG000|Overall Study|Lost to Follow-up|2
7660221|NCT00094055|12075401|FG000|Overall Study|progressive disease|2
7660222|NCT00094055|12075401|FG000|Overall Study|clinical progression|1
7660223|NCT00094055|12075401|FG000|Overall Study|roll-over to another study|14
7660224|NCT00094055|12075401|FG000|Overall Study|Withdrawal by Subject|9
7660225|NCT00094094|12075405|FG000|Overall Study|Death|2
7660226|NCT00094094|12075405|FG000|Overall Study|Lack of Efficacy|23
7660227|NCT00094094|12075405|FG000|Overall Study|Adverse Event|7
7660228|NCT00094107|12075409|FG000|Overall Study|Lack of Efficacy|23
7660229|NCT00094107|12075409|FG000|Overall Study|Death|5
7660230|NCT00094107|12075409|FG000|Overall Study|Adverse Event|3
7660231|NCT00094107|12075409|FG000|Overall Study|Withdrawal due to Disease Progression|1
7660232|NCT00094172|12075415|FG000|Overall Study|Adverse Event|0
7660233|NCT00094172|12075416|FG001|Overall Study|Adverse Event|1
7660234|NCT00094172|12075415|FG000|Overall Study|Lost to Follow-up|2
7660235|NCT00094172|12075416|FG001|Overall Study|Lost to Follow-up|0
7660236|NCT00094172|12075415|FG000|Overall Study|Protocol Violation|0
7660237|NCT00094172|12075416|FG001|Overall Study|Protocol Violation|1
7660238|NCT00094172|12075415|FG000|Overall Study|Withdrawal by Subject|10
7660239|NCT00094172|12075416|FG001|Overall Study|Withdrawal by Subject|5
7660240|NCT00094172|12075415|FG000|Overall Study|Primary endpoint met.|1
7660241|NCT00094172|12075416|FG001|Overall Study|Primary endpoint met.|0
7660242|NCT00094172|12075415|FG000|Overall Study|Started other MS therapy due to disease|1
7660243|NCT00094172|12075416|FG001|Overall Study|Started other MS therapy due to disease|0
7660244|NCT00094302|12075445|FG000|Overall Study|Lost to Follow-up|43
7660245|NCT00094302|12075446|FG001|Overall Study|Lost to Follow-up|41
7660246|NCT00094302|12075445|FG000|Overall Study|Physician Decision|5
7660247|NCT00094302|12075446|FG001|Overall Study|Physician Decision|8
7660248|NCT00094302|12075445|FG000|Overall Study|Withdrawal by Subject|103
7660249|NCT00094302|12075446|FG001|Overall Study|Withdrawal by Subject|111
7660250|NCT00094302|12075445|FG000|Overall Study|Death|266
7660251|NCT00094302|12075446|FG001|Overall Study|Death|246
7660252|NCT00094328|12075452|FG000|Overall Study|Lost to Follow-up|1
7660253|NCT00094445|12075456|FG000|Overall Study|Withdrawal by Subject|3
7660254|NCT00094445|12075456|FG000|Overall Study|Lost to Follow-up|1
7660255|NCT00094445|12075456|FG000|Overall Study|Progressive Disease|2
7660256|NCT00094458|12075463|FG000|Main Study: Through Week 30|Eligibility criteria not met|3
7660257|NCT00094458|12075464|FG001|Main Study: Through Week 30|Eligibility criteria not met|8
7660258|NCT00094458|12075465|FG002|Main Study: Through Week 30|Eligibility criteria not met|2
7660259|NCT00094458|12075466|FG003|Main Study: Through Week 30|Eligibility criteria not met|0
7660260|NCT00094458|12075467|FG004|Main Study: Through Week 30|Eligibility criteria not met|0
7660261|NCT00094458|12075468|FG005|Main Study: Through Week 30|Eligibility criteria not met|0
7660262|NCT00094458|12075463|FG000|Main Study: Through Week 30|Lost to Follow-up|5
7660263|NCT00094458|12075464|FG001|Main Study: Through Week 30|Lost to Follow-up|5
7660264|NCT00094458|12075465|FG002|Main Study: Through Week 30|Lost to Follow-up|2
7660265|NCT00094458|12075466|FG003|Main Study: Through Week 30|Lost to Follow-up|0
7660266|NCT00094458|12075467|FG004|Main Study: Through Week 30|Lost to Follow-up|0
7660267|NCT00094458|12075468|FG005|Main Study: Through Week 30|Lost to Follow-up|0
7660268|NCT00094458|12075463|FG000|Main Study: Through Week 30|Withdrawal by Subject|18
7660269|NCT00094458|12075464|FG001|Main Study: Through Week 30|Withdrawal by Subject|9
7660270|NCT00094458|12075465|FG002|Main Study: Through Week 30|Withdrawal by Subject|7
7660271|NCT00094458|12075466|FG003|Main Study: Through Week 30|Withdrawal by Subject|0
7660272|NCT00094458|12075467|FG004|Main Study: Through Week 30|Withdrawal by Subject|0
7660273|NCT00094458|12075468|FG005|Main Study: Through Week 30|Withdrawal by Subject|0
7660274|NCT00094458|12075463|FG000|Main Study: Through Week 30|Adverse Event|38
7660275|NCT00094458|12075464|FG001|Main Study: Through Week 30|Adverse Event|20
7660276|NCT00094458|12075465|FG002|Main Study: Through Week 30|Adverse Event|28
7660277|NCT00094458|12075466|FG003|Main Study: Through Week 30|Adverse Event|0
7660278|NCT00094458|12075467|FG004|Main Study: Through Week 30|Adverse Event|0
7660279|NCT00094458|12075468|FG005|Main Study: Through Week 30|Adverse Event|0
7660280|NCT00094458|12075463|FG000|Main Study: Through Week 30|Death|1
7660281|NCT00094458|12075464|FG001|Main Study: Through Week 30|Death|0
7660282|NCT00094458|12075465|FG002|Main Study: Through Week 30|Death|0
7660283|NCT00094458|12075466|FG003|Main Study: Through Week 30|Death|0
7660284|NCT00094458|12075467|FG004|Main Study: Through Week 30|Death|0
7660285|NCT00094458|12075468|FG005|Main Study: Through Week 30|Death|0
7660286|NCT00094458|12075463|FG000|Main Study: Through Week 30|Other|19
7660287|NCT00094458|12075464|FG001|Main Study: Through Week 30|Other|16
7660288|NCT00094458|12075465|FG002|Main Study: Through Week 30|Other|9
7660289|NCT00094458|12075466|FG003|Main Study: Through Week 30|Other|0
7660290|NCT00094458|12075467|FG004|Main Study: Through Week 30|Other|0
7660291|NCT00094458|12075468|FG005|Main Study: Through Week 30|Other|0
7660292|NCT00094458|12075463|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
7660293|NCT00094458|12075464|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
7660294|NCT00094458|12075465|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
7660295|NCT00094458|12075466|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
7660296|NCT00094458|12075467|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
7660297|NCT00094458|12075468|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
7660298|NCT00094458|12075463|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
7660299|NCT00094458|12075464|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
7660300|NCT00094458|12075465|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
7660301|NCT00094458|12075466|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
7660302|NCT00094458|12075467|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
7660303|NCT00094458|12075468|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
7660304|NCT00094458|12075463|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3
7660305|NCT00094458|12075464|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9
7660306|NCT00094458|12075465|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7
7660307|NCT00094458|12075466|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0
7660308|NCT00094458|12075467|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0
7660309|NCT00094458|12075468|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0
7660310|NCT00094458|12075463|FG000|Study Extension: Week 30 Through Week 50|Other|1
7660311|NCT00094458|12075464|FG001|Study Extension: Week 30 Through Week 50|Other|2
7660312|NCT00094458|12075465|FG002|Study Extension: Week 30 Through Week 50|Other|3
7660313|NCT00094458|12075466|FG003|Study Extension: Week 30 Through Week 50|Other|0
7660314|NCT00094458|12075467|FG004|Study Extension: Week 30 Through Week 50|Other|0
7660315|NCT00094458|12075468|FG005|Study Extension: Week 30 Through Week 50|Other|0
7660316|NCT00094458|12075463|FG000|OLE: Open-Label Extension|Adverse Event|0
7660317|NCT00094458|12075464|FG001|OLE: Open-Label Extension|Adverse Event|0
7660318|NCT00094458|12075465|FG002|OLE: Open-Label Extension|Adverse Event|0
7660319|NCT00094458|12075466|FG003|OLE: Open-Label Extension|Adverse Event|0
7660320|NCT00094458|12075467|FG004|OLE: Open-Label Extension|Adverse Event|3
7660321|NCT00094458|12075468|FG005|OLE: Open-Label Extension|Adverse Event|4
7660322|NCT00094458|12075463|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0
7660323|NCT00094458|12075464|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0
7660324|NCT00094458|12075465|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0
7660325|NCT00094458|12075466|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1
7660326|NCT00094458|12075467|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1
7660327|NCT00094458|12075468|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0
7660328|NCT00094458|12075463|FG000|OLE: Open-Label Extension|Patient decision|0
7660329|NCT00094458|12075464|FG001|OLE: Open-Label Extension|Patient decision|0
7660330|NCT00094458|12075465|FG002|OLE: Open-Label Extension|Patient decision|0
7660331|NCT00094458|12075466|FG003|OLE: Open-Label Extension|Patient decision|0
7660332|NCT00094458|12075467|FG004|OLE: Open-Label Extension|Patient decision|1
7660333|NCT00094458|12075468|FG005|OLE: Open-Label Extension|Patient decision|0
7660334|NCT00094536|12075491|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
7660335|NCT00094536|12075491|FG000|Treatment and Follow-up|Adverse Event|4
7660336|NCT00094536|12075491|FG000|Treatment and Follow-up|Lack of Efficacy|9
7660337|NCT00094536|12075491|FG000|Treatment and Follow-up|Lost to Follow-up|7
7660338|NCT00094536|12075491|FG000|Treatment and Follow-up|Withdrawal by Subject|1
7660339|NCT00094536|12075491|FG000|Treatment and Follow-up|Subject non-compliance|9
7660340|NCT00094536|12075491|FG000|Treatment and Follow-up|Unable to attend visits|1
7660341|NCT00094575|12075497|FG000|Overall Study|Death|146
7660342|NCT00094575|12075498|FG001|Overall Study|Death|146
7660343|NCT00094653|12075509|FG000|Overall Study|Death|306
7660344|NCT00094653|12075510|FG001|Overall Study|Death|100
7660345|NCT00094653|12075511|FG002|Overall Study|Death|119
7660346|NCT00094653|12075509|FG000|Overall Study|Subject Withdrew Consent|10
7660347|NCT00094653|12075510|FG001|Overall Study|Subject Withdrew Consent|2
7660348|NCT00094653|12075511|FG002|Overall Study|Subject Withdrew Consent|3
7660349|NCT00094653|12075509|FG000|Overall Study|Other|2
7660350|NCT00094653|12075510|FG001|Overall Study|Other|2
7660351|NCT00094653|12075511|FG002|Overall Study|Other|2
7660352|NCT00094653|12075509|FG000|Overall Study|Lost to Follow-up|3
7660353|NCT00094653|12075510|FG001|Overall Study|Lost to Follow-up|2
7660354|NCT00094653|12075511|FG002|Overall Study|Lost to Follow-up|1
7660355|NCT00094653|12075509|FG000|Overall Study|Protocol Violation|0
7660356|NCT00094653|12075510|FG001|Overall Study|Protocol Violation|0
7660357|NCT00094653|12075511|FG002|Overall Study|Protocol Violation|1
7660358|NCT00094757|12075523|FG000|Overall Study|Adverse Event|11
7660359|NCT00094757|12075524|FG001|Overall Study|Adverse Event|9
7660360|NCT00094757|12075525|FG002|Overall Study|Adverse Event|6
7660361|NCT00094757|12075523|FG000|Overall Study|Lack of Efficacy|11
7660362|NCT00094757|12075524|FG001|Overall Study|Lack of Efficacy|15
7660363|NCT00094757|12075525|FG002|Overall Study|Lack of Efficacy|8
7660364|NCT00094757|12075523|FG000|Overall Study|Lost to Follow-up|3
7660365|NCT00094757|12075524|FG001|Overall Study|Lost to Follow-up|5
7660366|NCT00094757|12075525|FG002|Overall Study|Lost to Follow-up|6
7660367|NCT00094757|12075523|FG000|Overall Study|Patient Moved|2
7660368|NCT00094757|12075524|FG001|Overall Study|Patient Moved|1
7660369|NCT00094757|12075525|FG002|Overall Study|Patient Moved|1
7660370|NCT00094757|12075523|FG000|Overall Study|Protocol Violation|8
7660371|NCT00094757|12075524|FG001|Overall Study|Protocol Violation|5
7660372|NCT00094757|12075525|FG002|Overall Study|Protocol Violation|3
7660373|NCT00094757|12075523|FG000|Overall Study|Withdrawal by Subject|14
7660374|NCT00094757|12075524|FG001|Overall Study|Withdrawal by Subject|21
7660375|NCT00094757|12075525|FG002|Overall Study|Withdrawal by Subject|5
7660376|NCT00094757|12075523|FG000|Overall Study|Other|3
7660377|NCT00094757|12075524|FG001|Overall Study|Other|3
7660378|NCT00094757|12075525|FG002|Overall Study|Other|1
7660379|NCT00094757|12075523|FG000|Overall Study|Protocol specified discontinuation|1
7660380|NCT00094757|12075524|FG001|Overall Study|Protocol specified discontinuation|3
7660381|NCT00094757|12075525|FG002|Overall Study|Protocol specified discontinuation|0
7660382|NCT00094770|12075535|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25
7660383|NCT00094770|12075536|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26
7660384|NCT00094770|12075535|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
7660385|NCT00094770|12075536|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
7660386|NCT00094770|12075535|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
7660387|NCT00094770|12075536|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
7660388|NCT00094770|12075535|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
7660389|NCT00094770|12075536|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
7660390|NCT00094770|12075535|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
7660391|NCT00094770|12075536|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
7660392|NCT00094770|12075535|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6
7660393|NCT00094770|12075536|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2
7660394|NCT00094770|12075535|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
7660395|NCT00094770|12075536|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
7660396|NCT00094770|12075535|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2
7660397|NCT00094770|12075536|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2
7660398|NCT00094770|12075535|FG000|Year 1 ( Week 0 to Week 52)|Other|10
7660399|NCT00094770|12075536|FG001|Year 1 ( Week 0 to Week 52)|Other|11
7660400|NCT00094770|12075535|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35
7660401|NCT00094770|12075536|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36
7660402|NCT00094770|12075535|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
7660403|NCT00094770|12075536|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
7660404|NCT00094770|12075535|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
7660405|NCT00094770|12075536|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
7660406|NCT00094770|12075535|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13
7660407|NCT00094770|12075536|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12
7660408|NCT00094770|12075535|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
7660409|NCT00094770|12075536|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
7660410|NCT00094770|12075535|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6
7660411|NCT00094770|12075536|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2
7660412|NCT00094770|12075535|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
7660413|NCT00094770|12075536|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
7660414|NCT00094770|12075535|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2
7660415|NCT00094770|12075536|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2
7660416|NCT00094770|12075535|FG000|Year 2 (Week 0 to Week 104)|Other|15
7660417|NCT00094770|12075536|FG001|Year 2 (Week 0 to Week 104)|Other|23
7660418|NCT00094809|12075544|FG000|Overall Study|Protocol deviation|2
7660419|NCT00094809|12075545|FG001|Overall Study|Protocol deviation|2
7660420|NCT00094809|12075544|FG000|Overall Study|Noncompliance|1
7660421|NCT00094809|12075545|FG001|Overall Study|Noncompliance|0
7660422|NCT00094809|12075544|FG000|Overall Study|Adverse Event|3
7660423|NCT00094809|12075545|FG001|Overall Study|Adverse Event|1
7660424|NCT00094809|12075544|FG000|Overall Study|Withdrawal by Subject|8
7660425|NCT00094809|12075545|FG001|Overall Study|Withdrawal by Subject|9
7660426|NCT00094809|12075544|FG000|Overall Study|Disease progression|3
7660427|NCT00094809|12075545|FG001|Overall Study|Disease progression|3
7660428|NCT00094809|12075544|FG000|Overall Study|Physician Decision|3
7660429|NCT00094809|12075545|FG001|Overall Study|Physician Decision|5
7660430|NCT00094809|12075544|FG000|Overall Study|Lost to Follow-up|6
7660431|NCT00094809|12075545|FG001|Overall Study|Lost to Follow-up|6
7660432|NCT00094809|12075544|FG000|Overall Study|Death|19
7660433|NCT00094809|12075545|FG001|Overall Study|Death|25
7660434|NCT00094809|12075544|FG000|Overall Study|Protocol-specified criteria|1
7660435|NCT00094809|12075545|FG001|Overall Study|Protocol-specified criteria|1
7660436|NCT00094809|12075544|FG000|Overall Study|Other|2
7660437|NCT00094809|12075545|FG001|Overall Study|Other|4
7660438|NCT00094809|12075544|FG000|Overall Study|Informed consent signed after treatment|1
7660439|NCT00094809|12075545|FG001|Overall Study|Informed consent signed after treatment|0
7660440|NCT00094809|12075544|FG000|Overall Study|Study drug not received|2
7660441|NCT00094809|12075545|FG001|Overall Study|Study drug not received|8
7660442|NCT00094809|12075544|FG000|Overall Study|Other|1
7660443|NCT00094809|12075545|FG001|Overall Study|Other|1
7660444|NCT00094835|12075558|FG000|Overall Study|Physician Decision|1
7660445|NCT00094835|12075559|FG001|Overall Study|Physician Decision|0
7660446|NCT00094835|12075560|FG002|Overall Study|Physician Decision|0
7660447|NCT00094835|12075561|FG003|Overall Study|Physician Decision|0
7660448|NCT00094835|12075562|FG004|Overall Study|Physician Decision|0
7660449|NCT00094835|12075563|FG005|Overall Study|Physician Decision|1
7660450|NCT00094835|12075564|FG006|Overall Study|Physician Decision|0
7660451|NCT00094835|12075558|FG000|Overall Study|Withdrawal by Subject|0
7660452|NCT00094835|12075559|FG001|Overall Study|Withdrawal by Subject|0
7660453|NCT00094835|12075560|FG002|Overall Study|Withdrawal by Subject|0
7660454|NCT00094835|12075561|FG003|Overall Study|Withdrawal by Subject|0
7660455|NCT00094835|12075562|FG004|Overall Study|Withdrawal by Subject|0
7660456|NCT00094835|12075563|FG005|Overall Study|Withdrawal by Subject|0
7660457|NCT00094835|12075564|FG006|Overall Study|Withdrawal by Subject|1
7660458|NCT00094835|12075558|FG000|Overall Study|Lost to Follow-up|0
7660459|NCT00094835|12075559|FG001|Overall Study|Lost to Follow-up|0
7660460|NCT00094835|12075560|FG002|Overall Study|Lost to Follow-up|0
7660461|NCT00094835|12075561|FG003|Overall Study|Lost to Follow-up|0
7660462|NCT00094835|12075562|FG004|Overall Study|Lost to Follow-up|1
7660463|NCT00094835|12075563|FG005|Overall Study|Lost to Follow-up|0
7660464|NCT00094835|12075564|FG006|Overall Study|Lost to Follow-up|0
7660465|NCT00094835|12075558|FG000|Overall Study|Death|1
7660466|NCT00094835|12075559|FG001|Overall Study|Death|0
7660467|NCT00094835|12075560|FG002|Overall Study|Death|0
7660468|NCT00094835|12075561|FG003|Overall Study|Death|0
7660469|NCT00094835|12075562|FG004|Overall Study|Death|1
7660470|NCT00094835|12075563|FG005|Overall Study|Death|0
7660471|NCT00094835|12075564|FG006|Overall Study|Death|0
7660472|NCT00094835|12075558|FG000|Overall Study|Non-compliance|1
7660473|NCT00094835|12075559|FG001|Overall Study|Non-compliance|2
7660474|NCT00094835|12075560|FG002|Overall Study|Non-compliance|2
7660475|NCT00094835|12075561|FG003|Overall Study|Non-compliance|0
7660476|NCT00094835|12075562|FG004|Overall Study|Non-compliance|2
7660477|NCT00094835|12075563|FG005|Overall Study|Non-compliance|2
7660478|NCT00094835|12075564|FG006|Overall Study|Non-compliance|1
7660479|NCT00094835|12075558|FG000|Overall Study|Other|1
7660480|NCT00094835|12075559|FG001|Overall Study|Other|1
7660481|NCT00094835|12075560|FG002|Overall Study|Other|1
7660482|NCT00094835|12075561|FG003|Overall Study|Other|1
7660483|NCT00094835|12075562|FG004|Overall Study|Other|0
7660484|NCT00094835|12075563|FG005|Overall Study|Other|0
7660485|NCT00094835|12075564|FG006|Overall Study|Other|0
7660486|NCT00094861|12075587|FG000|Overall Study|Adverse Event|5
7660487|NCT00094861|12075588|FG001|Overall Study|Adverse Event|2
7660488|NCT00094861|12075587|FG000|Overall Study|Withdrawal by Subject|5
7660489|NCT00094861|12075588|FG001|Overall Study|Withdrawal by Subject|3
7660490|NCT00094861|12075587|FG000|Overall Study|Physician Decision|1
7660491|NCT00094861|12075588|FG001|Overall Study|Physician Decision|1
7660492|NCT00094861|12075587|FG000|Overall Study|Lost to Follow-up|0
7660493|NCT00094861|12075588|FG001|Overall Study|Lost to Follow-up|1
7660494|NCT00094861|12075587|FG000|Overall Study|Death|4
7660495|NCT00094861|12075588|FG001|Overall Study|Death|2
7660496|NCT00094861|12075587|FG000|Overall Study|Other|3
7660497|NCT00094861|12075588|FG001|Overall Study|Other|0
7660498|NCT00095056|12075609|FG000|Phase A (Weeks 0-12)|Adverse Event|1
7660499|NCT00095056|12075610|FG001|Phase A (Weeks 0-12)|Adverse Event|1
7660500|NCT00095056|12075609|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3
7660501|NCT00095056|12075610|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0
7660502|NCT00095056|12075609|FG000|Phase A (Weeks 0-12)|Death|1
7660503|NCT00095056|12075610|FG001|Phase A (Weeks 0-12)|Death|0
7660504|NCT00095056|12075609|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2
7660505|NCT00095056|12075610|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0
7660506|NCT00095056|12075609|FG000|Phase B (Weeks 12-54)|Adverse Event|2
7660507|NCT00095056|12075610|FG001|Phase B (Weeks 12-54)|Adverse Event|2
7660508|NCT00095056|12075609|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1
7660509|NCT00095056|12075610|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0
7660510|NCT00095056|12075609|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2
7660511|NCT00095056|12075610|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1
7660512|NCT00095056|12075609|FG000|Phase B (Weeks 12-54)|Patient Moved|1
7660513|NCT00095056|12075610|FG001|Phase B (Weeks 12-54)|Patient Moved|0
7660514|NCT00095056|12075609|FG000|Phase B (Weeks 12-54)|Death|3
7660515|NCT00095056|12075610|FG001|Phase B (Weeks 12-54)|Death|1
7660516|NCT00095056|12075609|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1
7660517|NCT00095056|12075610|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0
7660518|NCT00095056|12075609|FG000|Phase B (Weeks 12-54)|Protocol Violation|0
7660519|NCT00095056|12075610|FG001|Phase B (Weeks 12-54)|Protocol Violation|1
7660520|NCT00095121|12075618|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
7660521|NCT00095121|12075619|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
7660522|NCT00095121|12075618|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
7660523|NCT00095121|12075619|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
7660524|NCT00095147|12075638|FG000|Double-blind Period 1 (Days 1-197)|Death|1
7660525|NCT00095147|12075639|FG001|Double-blind Period 1 (Days 1-197)|Death|0
7660526|NCT00095147|12075640|FG002|Double-blind Period 1 (Days 1-197)|Death|0
7660527|NCT00095147|12075641|FG003|Double-blind Period 1 (Days 1-197)|Death|0
7660528|NCT00095147|12075642|FG004|Double-blind Period 1 (Days 1-197)|Death|0
7660529|NCT00095147|12075638|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2
7660530|NCT00095147|12075639|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8
7660531|NCT00095147|12075640|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1
7660532|NCT00095147|12075641|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0
7660533|NCT00095147|12075642|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0
7660534|NCT00095147|12075638|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
7660535|NCT00095147|12075639|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
7660536|NCT00095147|12075640|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
7660537|NCT00095147|12075641|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
7660538|NCT00095147|12075642|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
7660539|NCT00095147|12075638|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
7660540|NCT00095147|12075639|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
7660541|NCT00095147|12075640|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
7660542|NCT00095147|12075641|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
7660543|NCT00095147|12075642|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
7660544|NCT00095147|12075638|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
7660545|NCT00095147|12075639|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
7660546|NCT00095147|12075640|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
7660547|NCT00095147|12075641|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
7660548|NCT00095147|12075642|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
7660549|NCT00095147|12075638|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1
7660550|NCT00095147|12075639|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1
7660551|NCT00095147|12075640|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0
7660552|NCT00095147|12075641|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0
7660553|NCT00095147|12075642|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0
7660554|NCT00095147|12075638|FG000|Double-blind Period 2 (Days 198-365)|Death|0
7660555|NCT00095147|12075639|FG001|Double-blind Period 2 (Days 198-365)|Death|1
7660556|NCT00095147|12075640|FG002|Double-blind Period 2 (Days 198-365)|Death|0
7660557|NCT00095147|12075641|FG003|Double-blind Period 2 (Days 198-365)|Death|1
7660558|NCT00095147|12075642|FG004|Double-blind Period 2 (Days 198-365)|Death|0
7660559|NCT00095147|12075638|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2
7660560|NCT00095147|12075639|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4
7660561|NCT00095147|12075640|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0
7660562|NCT00095147|12075641|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0
7660563|NCT00095147|12075642|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0
7660564|NCT00095147|12075638|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
7660565|NCT00095147|12075639|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
7660566|NCT00095147|12075640|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
7660567|NCT00095147|12075641|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
7660568|NCT00095147|12075642|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
7660569|NCT00095147|12075638|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
7660570|NCT00095147|12075639|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
7660571|NCT00095147|12075640|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
7660572|NCT00095147|12075641|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
7660573|NCT00095147|12075642|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
7660574|NCT00095147|12075638|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1
7660575|NCT00095147|12075639|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0
7660576|NCT00095147|12075640|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0
7660577|NCT00095147|12075641|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1
7660578|NCT00095147|12075642|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0
7660579|NCT00095147|12075638|FG000|Long-term Extension Period|Death|0
7660580|NCT00095147|12075639|FG001|Long-term Extension Period|Death|0
7660581|NCT00095147|12075640|FG002|Long-term Extension Period|Death|0
7660582|NCT00095147|12075641|FG003|Long-term Extension Period|Death|0
7660583|NCT00095147|12075642|FG004|Long-term Extension Period|Death|3
7660584|NCT00095147|12075638|FG000|Long-term Extension Period|Adverse Event|0
7660585|NCT00095147|12075639|FG001|Long-term Extension Period|Adverse Event|0
7660586|NCT00095147|12075640|FG002|Long-term Extension Period|Adverse Event|0
7660587|NCT00095147|12075641|FG003|Long-term Extension Period|Adverse Event|0
7660588|NCT00095147|12075642|FG004|Long-term Extension Period|Adverse Event|11
7660589|NCT00095147|12075638|FG000|Long-term Extension Period|Lack of Efficacy|0
7660590|NCT00095147|12075639|FG001|Long-term Extension Period|Lack of Efficacy|0
7660591|NCT00095147|12075640|FG002|Long-term Extension Period|Lack of Efficacy|0
7660592|NCT00095147|12075641|FG003|Long-term Extension Period|Lack of Efficacy|0
7660593|NCT00095147|12075642|FG004|Long-term Extension Period|Lack of Efficacy|9
7660594|NCT00095147|12075638|FG000|Long-term Extension Period|Lost to Follow-up|0
7660595|NCT00095147|12075639|FG001|Long-term Extension Period|Lost to Follow-up|0
7660596|NCT00095147|12075640|FG002|Long-term Extension Period|Lost to Follow-up|0
7660597|NCT00095147|12075641|FG003|Long-term Extension Period|Lost to Follow-up|0
7660598|NCT00095147|12075642|FG004|Long-term Extension Period|Lost to Follow-up|6
7660599|NCT00095147|12075638|FG000|Long-term Extension Period|Withdrawal of consent|0
7660600|NCT00095147|12075639|FG001|Long-term Extension Period|Withdrawal of consent|0
7660601|NCT00095147|12075640|FG002|Long-term Extension Period|Withdrawal of consent|0
7660602|NCT00095147|12075641|FG003|Long-term Extension Period|Withdrawal of consent|0
7660603|NCT00095147|12075642|FG004|Long-term Extension Period|Withdrawal of consent|12
7660604|NCT00095147|12075638|FG000|Long-term Extension Period|Pregnancy|0
7660605|NCT00095147|12075639|FG001|Long-term Extension Period|Pregnancy|0
7660606|NCT00095147|12075640|FG002|Long-term Extension Period|Pregnancy|0
7660607|NCT00095147|12075641|FG003|Long-term Extension Period|Pregnancy|0
7660608|NCT00095147|12075642|FG004|Long-term Extension Period|Pregnancy|1
7660609|NCT00095147|12075638|FG000|Long-term Extension Period|No longer meets study criteria|0
7660610|NCT00095147|12075639|FG001|Long-term Extension Period|No longer meets study criteria|0
7660611|NCT00095147|12075640|FG002|Long-term Extension Period|No longer meets study criteria|0
7660612|NCT00095147|12075641|FG003|Long-term Extension Period|No longer meets study criteria|0
7660613|NCT00095147|12075642|FG004|Long-term Extension Period|No longer meets study criteria|1
7660614|NCT00095147|12075638|FG000|Long-term Extension Period|Participant chose to use Revellex|0
7660615|NCT00095147|12075639|FG001|Long-term Extension Period|Participant chose to use Revellex|0
7660616|NCT00095147|12075640|FG002|Long-term Extension Period|Participant chose to use Revellex|0
7660617|NCT00095147|12075641|FG003|Long-term Extension Period|Participant chose to use Revellex|0
7660618|NCT00095147|12075642|FG004|Long-term Extension Period|Participant chose to use Revellex|1
7660619|NCT00095147|12075638|FG000|Long-term Extension Period|Leaving country|0
7660620|NCT00095147|12075639|FG001|Long-term Extension Period|Leaving country|0
7660621|NCT00095147|12075640|FG002|Long-term Extension Period|Leaving country|0
7660622|NCT00095147|12075641|FG003|Long-term Extension Period|Leaving country|0
7660623|NCT00095147|12075642|FG004|Long-term Extension Period|Leaving country|1
7660624|NCT00095173|12075660|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1
7660625|NCT00095173|12075661|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0
7660626|NCT00095173|12075662|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0
7660627|NCT00095173|12075663|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0
7660628|NCT00095173|12075664|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0
7660629|NCT00095173|12075665|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0
7660630|NCT00095173|12075660|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
7660631|NCT00095173|12075661|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
7660632|NCT00095173|12075662|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
7660633|NCT00095173|12075663|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
7660634|NCT00095173|12075664|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
7660635|NCT00095173|12075665|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
7660636|NCT00095173|12075660|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
7660637|NCT00095173|12075661|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
7660638|NCT00095173|12075662|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
7660639|NCT00095173|12075663|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
7660640|NCT00095173|12075664|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
7660641|NCT00095173|12075665|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
7660642|NCT00095173|12075660|FG000|Open-Label Lead-In Phase (Period A)|Other|1
7660643|NCT00095173|12075661|FG001|Open-Label Lead-In Phase (Period A)|Other|0
7660644|NCT00095173|12075662|FG002|Open-Label Lead-In Phase (Period A)|Other|0
7660645|NCT00095173|12075663|FG003|Open-Label Lead-In Phase (Period A)|Other|0
7660646|NCT00095173|12075664|FG004|Open-Label Lead-In Phase (Period A)|Other|0
7660647|NCT00095173|12075665|FG005|Open-Label Lead-In Phase (Period A)|Other|0
7660648|NCT00095173|12075660|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0
7660649|NCT00095173|12075661|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10
7660650|NCT00095173|12075662|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31
7660651|NCT00095173|12075663|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0
7660652|NCT00095173|12075664|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0
7660653|NCT00095173|12075665|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0
7660654|NCT00095173|12075660|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0
7660655|NCT00095173|12075661|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1
7660656|NCT00095173|12075662|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0
7660657|NCT00095173|12075663|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0
7660658|NCT00095173|12075664|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0
7660659|NCT00095173|12075665|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0
7660660|NCT00095173|12075660|FG000|Open-Label Extension Phase (Period C)|Death|0
7660661|NCT00095173|12075661|FG001|Open-Label Extension Phase (Period C)|Death|0
7660662|NCT00095173|12075662|FG002|Open-Label Extension Phase (Period C)|Death|0
7660663|NCT00095173|12075663|FG003|Open-Label Extension Phase (Period C)|Death|0
7660664|NCT00095173|12075664|FG004|Open-Label Extension Phase (Period C)|Death|0
7660665|NCT00095173|12075665|FG005|Open-Label Extension Phase (Period C)|Death|1
7660666|NCT00095173|12075660|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0
7660667|NCT00095173|12075661|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0
7660668|NCT00095173|12075662|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0
7660669|NCT00095173|12075663|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1
7660670|NCT00095173|12075664|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2
7660671|NCT00095173|12075665|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3
7660672|NCT00095173|12075660|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
7660673|NCT00095173|12075661|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
7660674|NCT00095173|12075662|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
7660675|NCT00095173|12075663|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
7660676|NCT00095173|12075664|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
7660677|NCT00095173|12075665|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
7660678|NCT00095173|12075660|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
7660679|NCT00095173|12075661|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
7660680|NCT00095173|12075662|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
7660681|NCT00095173|12075663|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
7660682|NCT00095173|12075664|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
7660683|NCT00095173|12075665|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
7660684|NCT00095173|12075660|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
7660685|NCT00095173|12075661|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
7660686|NCT00095173|12075662|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
7660687|NCT00095173|12075663|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
7660688|NCT00095173|12075664|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
7660689|NCT00095173|12075665|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
7660690|NCT00095173|12075660|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
7660691|NCT00095173|12075661|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
7660692|NCT00095173|12075662|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
7660693|NCT00095173|12075663|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
7660694|NCT00095173|12075664|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
7660695|NCT00095173|12075665|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
7660696|NCT00095173|12075660|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
7660697|NCT00095173|12075661|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
7660698|NCT00095173|12075662|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
7660699|NCT00095173|12075663|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
7660700|NCT00095173|12075664|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
7660701|NCT00095173|12075665|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
7660702|NCT00095173|12075660|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0
7660703|NCT00095173|12075661|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0
7660704|NCT00095173|12075662|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0
7660705|NCT00095173|12075663|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1
7660706|NCT00095173|12075664|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2
7660707|NCT00095173|12075665|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3
7660708|NCT00095173|12075660|FG000|Open-Label Extension Phase (Period C)|Other|0
7660709|NCT00095173|12075661|FG001|Open-Label Extension Phase (Period C)|Other|0
7660710|NCT00095173|12075662|FG002|Open-Label Extension Phase (Period C)|Other|0
7660711|NCT00095173|12075663|FG003|Open-Label Extension Phase (Period C)|Other|4
7660712|NCT00095173|12075664|FG004|Open-Label Extension Phase (Period C)|Other|6
7660713|NCT00095173|12075665|FG005|Open-Label Extension Phase (Period C)|Other|8
7660714|NCT00095199|12075683|FG000|Overall Study|Adverse Event|40
7660715|NCT00095199|12075684|FG001|Overall Study|Adverse Event|22
7660716|NCT00095199|12075685|FG002|Overall Study|Adverse Event|26
7660717|NCT00095199|12075686|FG003|Overall Study|Adverse Event|11
7660718|NCT00095199|12075683|FG000|Overall Study|Progressive disease|213
7660719|NCT00095199|12075684|FG001|Overall Study|Progressive disease|179
7660720|NCT00095199|12075685|FG002|Overall Study|Progressive disease|105
7660721|NCT00095199|12075686|FG003|Overall Study|Progressive disease|98
7660722|NCT00095199|12075683|FG000|Overall Study|Death|10
7660723|NCT00095199|12075684|FG001|Overall Study|Death|6
7660724|NCT00095199|12075685|FG002|Overall Study|Death|11
7660725|NCT00095199|12075686|FG003|Overall Study|Death|9
7660726|NCT00095199|12075683|FG000|Overall Study|Withdrawal by Subject|21
7660727|NCT00095199|12075684|FG001|Overall Study|Withdrawal by Subject|16
7660728|NCT00095199|12075685|FG002|Overall Study|Withdrawal by Subject|13
7660729|NCT00095199|12075686|FG003|Overall Study|Withdrawal by Subject|22
7660730|NCT00095199|12075683|FG000|Overall Study|Protocol Violation|4
7660731|NCT00095199|12075684|FG001|Overall Study|Protocol Violation|4
7660732|NCT00095199|12075685|FG002|Overall Study|Protocol Violation|2
7660733|NCT00095199|12075686|FG003|Overall Study|Protocol Violation|0
7660734|NCT00095199|12075683|FG000|Overall Study|Liver function test results elevated|0
7660735|NCT00095199|12075684|FG001|Overall Study|Liver function test results elevated|0
7660736|NCT00095199|12075685|FG002|Overall Study|Liver function test results elevated|1
7660737|NCT00095199|12075686|FG003|Overall Study|Liver function test results elevated|1
7660738|NCT00095199|12075683|FG000|Overall Study|Surgery needed could not start in 7 days|0
7660739|NCT00095199|12075684|FG001|Overall Study|Surgery needed could not start in 7 days|0
7660740|NCT00095199|12075685|FG002|Overall Study|Surgery needed could not start in 7 days|1
7660741|NCT00095199|12075686|FG003|Overall Study|Surgery needed could not start in 7 days|0
7660742|NCT00095199|12075683|FG000|Overall Study|Physician Decision|5
7660743|NCT00095199|12075684|FG001|Overall Study|Physician Decision|6
7660744|NCT00095199|12075685|FG002|Overall Study|Physician Decision|1
7660745|NCT00095199|12075686|FG003|Overall Study|Physician Decision|1
7660746|NCT00095199|12075683|FG000|Overall Study|Not eligible|1
7660747|NCT00095199|12075684|FG001|Overall Study|Not eligible|7
7660748|NCT00095199|12075685|FG002|Overall Study|Not eligible|0
7660749|NCT00095199|12075686|FG003|Overall Study|Not eligible|1
7660750|NCT00095199|12075683|FG000|Overall Study|Started Palliative Radiotherapy|1
7660751|NCT00095199|12075684|FG001|Overall Study|Started Palliative Radiotherapy|0
7660752|NCT00095199|12075685|FG002|Overall Study|Started Palliative Radiotherapy|0
7660753|NCT00095199|12075686|FG003|Overall Study|Started Palliative Radiotherapy|0
7660754|NCT00095199|12075683|FG000|Overall Study|Started radiotherapy regimen|0
7660755|NCT00095199|12075684|FG001|Overall Study|Started radiotherapy regimen|1
7660756|NCT00095199|12075685|FG002|Overall Study|Started radiotherapy regimen|0
7660757|NCT00095199|12075686|FG003|Overall Study|Started radiotherapy regimen|0
7660758|NCT00095199|12075683|FG000|Overall Study|Primary tumor removed in other surgery|0
7660759|NCT00095199|12075684|FG001|Overall Study|Primary tumor removed in other surgery|1
7660760|NCT00095199|12075685|FG002|Overall Study|Primary tumor removed in other surgery|0
7660761|NCT00095199|12075686|FG003|Overall Study|Primary tumor removed in other surgery|0
7660762|NCT00095199|12075683|FG000|Overall Study|Data inadvertently lost by site|1
7660763|NCT00095199|12075684|FG001|Overall Study|Data inadvertently lost by site|0
7660764|NCT00095199|12075685|FG002|Overall Study|Data inadvertently lost by site|0
7660765|NCT00095199|12075686|FG003|Overall Study|Data inadvertently lost by site|0
7660766|NCT00095212|12075703|FG000|Overall Study|Withdrawal by Subject|1
7660767|NCT00095212|12075704|FG001|Overall Study|Withdrawal by Subject|3
7660768|NCT00095238|12075712|FG000|Overall Study|Lack of Efficacy|9
7660769|NCT00095238|12075713|FG001|Overall Study|Lack of Efficacy|9
7660770|NCT00095238|12075712|FG000|Overall Study|Adverse Event|331
7660771|NCT00095238|12075713|FG001|Overall Study|Adverse Event|287
7660772|NCT00095238|12075712|FG000|Overall Study|Subject Withdrew Consent|208
7660773|NCT00095238|12075713|FG001|Overall Study|Subject Withdrew Consent|223
7660774|NCT00095238|12075712|FG000|Overall Study|Death|154
7660775|NCT00095238|12075713|FG001|Overall Study|Death|170
7660776|NCT00095238|12075712|FG000|Overall Study|Lost to Follow-up|19
7660777|NCT00095238|12075713|FG001|Overall Study|Lost to Follow-up|24
7660778|NCT00095238|12075712|FG000|Overall Study|Noncompliance|44
7660779|NCT00095238|12075713|FG001|Overall Study|Noncompliance|45
7660780|NCT00095238|12075712|FG000|Overall Study|No longer met study criteria|4
7660781|NCT00095238|12075713|FG001|Overall Study|No longer met study criteria|5
7660782|NCT00095238|12075712|FG000|Overall Study|Study terminated by sponsor|0
7660783|NCT00095238|12075713|FG001|Overall Study|Study terminated by sponsor|1
7660784|NCT00095238|12075712|FG000|Overall Study|Missing|1
7660785|NCT00095238|12075713|FG001|Overall Study|Missing|0
7660786|NCT00095238|12075712|FG000|Overall Study|Other Reasons|87
7660787|NCT00095238|12075713|FG001|Overall Study|Other Reasons|88
7660788|NCT00095303|12075753|FG000|Main Study|Lost to Follow-up|91
7660789|NCT00095303|12075754|FG001|Main Study|Lost to Follow-up|87
7660790|NCT00095303|12075753|FG000|Follow Up Study|Lost to Follow-up|59
7660791|NCT00095303|12075754|FG001|Follow Up Study|Lost to Follow-up|58
7660792|NCT00095498|12075763|FG000|Overall Study|Physician Decision|9
7660793|NCT00095498|12075764|FG001|Overall Study|Physician Decision|10
7660794|NCT00095498|12075765|FG002|Overall Study|Physician Decision|8
7660795|NCT00095498|12075763|FG000|Overall Study|Adverse Event|1
7660796|NCT00095498|12075764|FG001|Overall Study|Adverse Event|0
7660797|NCT00095498|12075765|FG002|Overall Study|Adverse Event|1
7660798|NCT00095498|12075763|FG000|Overall Study|Withdrawal by Subject|15
7660799|NCT00095498|12075764|FG001|Overall Study|Withdrawal by Subject|16
7660800|NCT00095498|12075765|FG002|Overall Study|Withdrawal by Subject|15
7660801|NCT00095498|12075763|FG000|Overall Study|Disease progression|0
7660802|NCT00095498|12075764|FG001|Overall Study|Disease progression|1
7660803|NCT00095498|12075765|FG002|Overall Study|Disease progression|1
7660804|NCT00095498|12075763|FG000|Overall Study|Ineligibility determined|3
7660805|NCT00095498|12075764|FG001|Overall Study|Ineligibility determined|0
7660806|NCT00095498|12075765|FG002|Overall Study|Ineligibility determined|2
7660807|NCT00095498|12075763|FG000|Overall Study|Lost to Follow-up|1
7660808|NCT00095498|12075764|FG001|Overall Study|Lost to Follow-up|1
7660809|NCT00095498|12075765|FG002|Overall Study|Lost to Follow-up|2
7660810|NCT00095498|12075763|FG000|Overall Study|Noncompliance|1
7660811|NCT00095498|12075764|FG001|Overall Study|Noncompliance|0
7660812|NCT00095498|12075765|FG002|Overall Study|Noncompliance|1
7660813|NCT00095498|12075763|FG000|Overall Study|Other|6
7660814|NCT00095498|12075764|FG001|Overall Study|Other|7
7660815|NCT00095498|12075765|FG002|Overall Study|Other|6
7660816|NCT00095498|12075763|FG000|Overall Study|Protocol Violation|0
7660817|NCT00095498|12075764|FG001|Overall Study|Protocol Violation|0
7660818|NCT00095498|12075765|FG002|Overall Study|Protocol Violation|1
7660819|NCT00095498|12075763|FG000|Overall Study|Requirement for alternative therapy|1
7660820|NCT00095498|12075764|FG001|Overall Study|Requirement for alternative therapy|0
7660821|NCT00095498|12075765|FG002|Overall Study|Requirement for alternative therapy|2
7660822|NCT00095576|12075779|FG000|Overall Study|Adverse Event|5
7660823|NCT00095576|12075780|FG001|Overall Study|Adverse Event|3
7660824|NCT00095576|12075779|FG000|Overall Study|Lost to Follow-up|233
7660825|NCT00095576|12075780|FG001|Overall Study|Lost to Follow-up|229
7660826|NCT00095576|12075779|FG000|Overall Study|Protocol Violation|1
7660827|NCT00095576|12075780|FG001|Overall Study|Protocol Violation|0
7660828|NCT00095576|12075779|FG000|Overall Study|Withdrawal by Subject|34
7660829|NCT00095576|12075780|FG001|Overall Study|Withdrawal by Subject|47
7660830|NCT00095576|12075779|FG000|Overall Study|Option to switch to a rollover study|1097
7660831|NCT00095576|12075780|FG001|Overall Study|Option to switch to a rollover study|1099
7660832|NCT00095576|12075779|FG000|Overall Study|Site terminated|75
7660833|NCT00095576|12075780|FG001|Overall Study|Site terminated|67
7660834|NCT00095576|12075779|FG000|Overall Study|Subject moved|30
7660835|NCT00095576|12075780|FG001|Overall Study|Subject moved|36
7660836|NCT00095628|12075786|FG000|Overall Study|Disease progression prior to treatment|1
7660837|NCT00095836|12075790|FG000|Overall Study|Lost to Follow-up|1
7660838|NCT00095836|12075790|FG000|Overall Study|Adverse Event|1
7660839|NCT00095836|12075790|FG000|Overall Study|Death|2
7660840|NCT00095940|12075810|FG000|Lapatinib Continuation/Phase II|Disease Progression|1
7660841|NCT00095940|12075811|FG001|Lapatinib Continuation/Phase II|Disease Progression|1
7660842|NCT00095940|12075812|FG002|Lapatinib Continuation/Phase II|Disease Progression|15
7660843|NCT00095940|12075813|FG003|Lapatinib Continuation/Phase II|Disease Progression|0
7660844|NCT00095940|12075814|FG004|Lapatinib Continuation/Phase II|Disease Progression|0
7660845|NCT00095940|12075815|FG005|Lapatinib Continuation/Phase II|Disease Progression|13
7660846|NCT00095940|12075816|FG006|Lapatinib Continuation/Phase II|Disease Progression|2
7660847|NCT00095940|12075817|FG007|Lapatinib Continuation/Phase II|Disease Progression|1
7660848|NCT00095940|12075818|FG008|Lapatinib Continuation/Phase II|Disease Progression|12
7660849|NCT00095940|12075810|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
7660850|NCT00095940|12075811|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
7660851|NCT00095940|12075812|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
7660852|NCT00095940|12075813|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
7660853|NCT00095940|12075814|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
7660854|NCT00095940|12075815|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
7660855|NCT00095940|12075816|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
7660856|NCT00095940|12075817|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
7660857|NCT00095940|12075818|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
7660858|NCT00095940|12075810|FG000|Lapatinib Continuation/Phase II|Adverse Event|0
7660859|NCT00095940|12075811|FG001|Lapatinib Continuation/Phase II|Adverse Event|0
7660860|NCT00095940|12075812|FG002|Lapatinib Continuation/Phase II|Adverse Event|0
7660861|NCT00095940|12075813|FG003|Lapatinib Continuation/Phase II|Adverse Event|0
7660862|NCT00095940|12075814|FG004|Lapatinib Continuation/Phase II|Adverse Event|0
7660863|NCT00095940|12075815|FG005|Lapatinib Continuation/Phase II|Adverse Event|0
7660864|NCT00095940|12075816|FG006|Lapatinib Continuation/Phase II|Adverse Event|0
7660865|NCT00095940|12075817|FG007|Lapatinib Continuation/Phase II|Adverse Event|1
7660866|NCT00095940|12075818|FG008|Lapatinib Continuation/Phase II|Adverse Event|0
7660867|NCT00095979|12075836|FG000|Overall Study|Ineligible: Second primary cancer site|2
7660868|NCT00096018|12075847|FG000|Overall Study|Became Ineligible (not treated)|0
7660869|NCT00096018|12075848|FG001|Overall Study|Became Ineligible (not treated)|3
7660870|NCT00096018|12075847|FG000|Overall Study|Miscellaneous (not treated)|0
7660871|NCT00096018|12075848|FG001|Overall Study|Miscellaneous (not treated)|2
7660872|NCT00096018|12075847|FG000|Overall Study|Adverse Event|0
7660873|NCT00096018|12075848|FG001|Overall Study|Adverse Event|5
7660874|NCT00096018|12075847|FG000|Overall Study|Death|0
7660875|NCT00096018|12075848|FG001|Overall Study|Death|1
7660876|NCT00096018|12075847|FG000|Overall Study|Withdrawal by Subject|0
7660877|NCT00096018|12075848|FG001|Overall Study|Withdrawal by Subject|2
7660878|NCT00096018|12075847|FG000|Overall Study|Miscellaneous|2
7660879|NCT00096018|12075848|FG001|Overall Study|Miscellaneous|1
7660880|NCT00096031|12075854|FG000|Overall Study|Adverse Event|3
7660881|NCT00096031|12075854|FG000|Overall Study|Lack of Efficacy|42
7660882|NCT00096031|12075854|FG000|Overall Study|Death|4
7660883|NCT00096031|12075854|FG000|Overall Study|Withdrawal by Subject|1
7660884|NCT00096031|12075854|FG000|Overall Study|Ineligible|8
7660885|NCT00096031|12075854|FG000|Overall Study|Not protocol specified|5
7660886|NCT00096044|12075858|FG000|Overall Study|Withdrawal by Subject|9
7660887|NCT00096044|12075858|FG000|Overall Study|Adverse Event|21
7660888|NCT00096044|12075858|FG000|Overall Study|Disease Progression|4
7660889|NCT00096135|12075872|FG000|Overall Study|Physician Decision|20
7660890|NCT00096135|12075873|FG001|Overall Study|Physician Decision|4
7660891|NCT00096135|12075872|FG000|Overall Study|Refusal of further protocol therapy|4
7660892|NCT00096135|12075873|FG001|Overall Study|Refusal of further protocol therapy|1
7660893|NCT00096135|12075872|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
7660894|NCT00096135|12075873|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
7660895|NCT00096135|12075872|FG000|Overall Study|Other, specify|15
7660896|NCT00096135|12075873|FG001|Overall Study|Other, specify|3
7660897|NCT00096135|12075872|FG000|Overall Study|Ineligible|2
7660898|NCT00096135|12075873|FG001|Overall Study|Ineligible|0
7660899|NCT00096174|12075896|FG000|Overall Study|Lack of Efficacy|9
7660900|NCT00096174|12075896|FG000|Overall Study|Adverse Event|15
7660901|NCT00096174|12075896|FG000|Overall Study|Death|6
7660902|NCT00096174|12075896|FG000|Overall Study|Withdrawal by Subject|15
7660903|NCT00096174|12075896|FG000|Overall Study|Not started protocol therapy|3
7660904|NCT00096174|12075896|FG000|Overall Study|Ineligible|6
7660905|NCT00096174|12075896|FG000|Overall Study|other reason|8
7660906|NCT00096226|12075900|FG000|Overall Study|Ineligible|2
7660907|NCT00096226|12075900|FG000|Overall Study|Protocol treatment not started|1
7660908|NCT00096265|12075907|FG000|Overall Study|Ineligible|1
7660909|NCT00096265|12075908|FG001|Overall Study|Ineligible|0
7660910|NCT00096265|12075909|FG002|Overall Study|Ineligible|0
7660911|NCT00096278|12075920|FG000|Overall Study|No follow-up data|15
7660912|NCT00096278|12075921|FG001|Overall Study|No follow-up data|18
7660913|NCT00096278|12075920|FG000|Overall Study|Patient not at risk for primary endpoint|3
7660914|NCT00096278|12075921|FG001|Overall Study|Patient not at risk for primary endpoint|2
7660915|NCT00096356|12075931|FG000|Overall Study|Adverse Event|11
7660916|NCT00096356|12075932|FG001|Overall Study|Adverse Event|9
7660917|NCT00096356|12075931|FG000|Overall Study|Physician Decision|5
7660918|NCT00096356|12075932|FG001|Overall Study|Physician Decision|3
7660919|NCT00096356|12075931|FG000|Overall Study|Withdrawal by Subject|17
7660920|NCT00096356|12075932|FG001|Overall Study|Withdrawal by Subject|23
7660921|NCT00096356|12075931|FG000|Overall Study|Lack of Efficacy|1
7660922|NCT00096356|12075932|FG001|Overall Study|Lack of Efficacy|0
7660923|NCT00096356|12075931|FG000|Overall Study|multiple reasons|10
7660924|NCT00096356|12075932|FG001|Overall Study|multiple reasons|18
7660925|NCT00096382|12075941|FG000|Overall Study|Not treated|1
7660926|NCT00096382|12075942|FG001|Overall Study|Not treated|0
7660927|NCT00096382|12075941|FG000|Overall Study|Death during treatment|1
7660928|NCT00096382|12075942|FG001|Overall Study|Death during treatment|0
7660929|NCT00096447|12075948|FG000|Overall Study|Never treated|1
7660930|NCT00096486|12075970|FG000|Overall Study|Withdrawal by Subject|0
7660931|NCT00096486|12075971|FG001|Overall Study|Withdrawal by Subject|0
7660932|NCT00096486|12075972|FG002|Overall Study|Withdrawal by Subject|1
7660933|NCT00096486|12075973|FG003|Overall Study|Withdrawal by Subject|1
7660934|NCT00096486|12075970|FG000|Overall Study|Not Treated|0
7660935|NCT00096486|12075971|FG001|Overall Study|Not Treated|0
7660936|NCT00096486|12075972|FG002|Overall Study|Not Treated|1
7660937|NCT00096486|12075973|FG003|Overall Study|Not Treated|1
7660938|NCT00096538|12075983|FG000|Overall Study|Withdrawal by Subject|1
7660939|NCT00096785|12075993|FG000|Overall Study|Lost to Follow-up|1
7660940|NCT00096785|12075994|FG001|Overall Study|Lost to Follow-up|0
7660941|NCT00096785|12075993|FG000|Overall Study|Withdrawal by Subject|0
7660942|NCT00096785|12075994|FG001|Overall Study|Withdrawal by Subject|1
7660943|NCT00096785|12075993|FG000|Overall Study|Relocated|1
7660944|NCT00096785|12075994|FG001|Overall Study|Relocated|0
7660945|NCT00096941|12076000|FG000|Overall Study|disease progression|3
7660946|NCT00096954|12076006|FG000|Overall Study|Adverse Event|3
7660947|NCT00096954|12076007|FG001|Overall Study|Adverse Event|1
7660948|NCT00096954|12076006|FG000|Overall Study|Withdrawal by Subject|9
7660949|NCT00096954|12076007|FG001|Overall Study|Withdrawal by Subject|8
7660950|NCT00096954|12076006|FG000|Overall Study|Physician Decision|1
7660951|NCT00096954|12076007|FG001|Overall Study|Physician Decision|1
7660952|NCT00096954|12076006|FG000|Overall Study|Sponsors Decision|1
7660953|NCT00096954|12076007|FG001|Overall Study|Sponsors Decision|1
7660954|NCT00096954|12076006|FG000|Overall Study|Pregnancy|1
7660955|NCT00096954|12076007|FG001|Overall Study|Pregnancy|1
7660956|NCT00096954|12076006|FG000|Overall Study|Initiation of immunotherapy|1
7660957|NCT00096954|12076007|FG001|Overall Study|Initiation of immunotherapy|0
7660958|NCT00096954|12076006|FG000|Overall Study|Non-compliance|0
7660959|NCT00096954|12076007|FG001|Overall Study|Non-compliance|3
7660960|NCT00096954|12076006|FG000|Overall Study|Lost to Follow-up|8
7660961|NCT00096954|12076007|FG001|Overall Study|Lost to Follow-up|5
7660962|NCT00096993|12076015|FG000|Overall Study|Death|1
7660963|NCT00096993|12076016|FG001|Overall Study|Death|0
7660964|NCT00096993|12076015|FG000|Overall Study|Disease progression|56
7660965|NCT00096993|12076016|FG001|Overall Study|Disease progression|53
7660966|NCT00096993|12076015|FG000|Overall Study|Adverse Event|2
7660967|NCT00096993|12076016|FG001|Overall Study|Adverse Event|8
7660968|NCT00096993|12076015|FG000|Overall Study|Subject's decision|3
7660969|NCT00096993|12076016|FG001|Overall Study|Subject's decision|1
7660970|NCT00096993|12076015|FG000|Overall Study|Physician Decision|2
7660971|NCT00096993|12076016|FG001|Overall Study|Physician Decision|1
7660972|NCT00096993|12076015|FG000|Overall Study|Non-compliance|0
7660973|NCT00096993|12076016|FG001|Overall Study|Non-compliance|1
7660974|NCT00096993|12076015|FG000|Overall Study|Other unspecified|1
7660975|NCT00096993|12076016|FG001|Overall Study|Other unspecified|1
7660976|NCT00097370|12076030|FG000|Stage 1|Adverse Event|3
7660977|NCT00097370|12076030|FG000|Stage 1|Withdrawal by Subject|1
7660978|NCT00097370|12076030|FG000|Stage 1|Lack of Efficacy|2
7660979|NCT00097370|12076030|FG000|Stage 2|Adverse Event|5
7660980|NCT00097370|12076030|FG000|Stage 2|Withdrawal by Subject|1
7660981|NCT00097370|12076030|FG000|Stage 2|Lack of Efficacy|3
7660982|NCT00097370|12076030|FG000|Stage 2|Pregnancy|1
7660983|NCT00097370|12076030|FG000|Stage 2|Sponsor Terminated Study|2
7660984|NCT00097370|12076030|FG000|Stage 2|Lost to Follow-up|1
7660985|NCT00097370|12076030|FG000|Stage 3|Adverse Event|2
7660986|NCT00097370|12076030|FG000|Stage 3|Withdrawal by Subject|3
7660987|NCT00097370|12076030|FG000|Stage 3|Lack of Efficacy|1
7660988|NCT00097370|12076030|FG000|Stage 3|Sponsor Terminated Study|52
7660989|NCT00097370|12076030|FG000|Stage 3|Lost to Follow-up|1
7660990|NCT00097500|12076045|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
7660991|NCT00097500|12076046|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
7660992|NCT00097500|12076045|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5
7660993|NCT00097500|12076046|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0
7660994|NCT00097500|12076045|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0
7660995|NCT00097500|12076046|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1
7660996|NCT00097500|12076045|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
7660997|NCT00097500|12076046|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
7660998|NCT00097500|12076045|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
7660999|NCT00097500|12076046|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
7661000|NCT00097500|12076045|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
7661001|NCT00097500|12076046|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
7661002|NCT00097500|12076045|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
7661003|NCT00097500|12076046|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
7661004|NCT00097539|12076059|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959
7661005|NCT00097539|12076060|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948
7661006|NCT00097539|12076061|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646
7661007|NCT00097539|12076062|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170
7661008|NCT00097539|12076063|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106
7661009|NCT00097539|12076064|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546
7661010|NCT00097539|12076065|FG006|Overall Study|Status Unknown (Or no final evaluation)|108
7661011|NCT00097539|12076059|FG000|Overall Study|Withdrawal by Subject|925
7661012|NCT00097539|12076060|FG001|Overall Study|Withdrawal by Subject|323
7661013|NCT00097539|12076061|FG002|Overall Study|Withdrawal by Subject|346
7661014|NCT00097539|12076062|FG003|Overall Study|Withdrawal by Subject|217
7661015|NCT00097539|12076063|FG004|Overall Study|Withdrawal by Subject|68
7661016|NCT00097539|12076064|FG005|Overall Study|Withdrawal by Subject|229
7661017|NCT00097539|12076065|FG006|Overall Study|Withdrawal by Subject|3
7661018|NCT00097539|12076059|FG000|Overall Study|Participant Non-compliant|2140
7661019|NCT00097539|12076060|FG001|Overall Study|Participant Non-compliant|567
7661020|NCT00097539|12076061|FG002|Overall Study|Participant Non-compliant|1067
7661021|NCT00097539|12076062|FG003|Overall Study|Participant Non-compliant|353
7661022|NCT00097539|12076063|FG004|Overall Study|Participant Non-compliant|136
7661023|NCT00097539|12076064|FG005|Overall Study|Participant Non-compliant|543
7661024|NCT00097539|12076065|FG006|Overall Study|Participant Non-compliant|18
7661025|NCT00097539|12076059|FG000|Overall Study|Lack of Efficacy|249
7661026|NCT00097539|12076060|FG001|Overall Study|Lack of Efficacy|122
7661027|NCT00097539|12076061|FG002|Overall Study|Lack of Efficacy|202
7661028|NCT00097539|12076062|FG003|Overall Study|Lack of Efficacy|105
7661029|NCT00097539|12076063|FG004|Overall Study|Lack of Efficacy|45
7661030|NCT00097539|12076064|FG005|Overall Study|Lack of Efficacy|228
7661031|NCT00097539|12076065|FG006|Overall Study|Lack of Efficacy|5
7661032|NCT00097539|12076059|FG000|Overall Study|Adverse Event|78
7661033|NCT00097539|12076060|FG001|Overall Study|Adverse Event|133
7661034|NCT00097539|12076061|FG002|Overall Study|Adverse Event|37
7661035|NCT00097539|12076062|FG003|Overall Study|Adverse Event|27
7661036|NCT00097539|12076063|FG004|Overall Study|Adverse Event|30
7661037|NCT00097539|12076064|FG005|Overall Study|Adverse Event|59
7661038|NCT00097539|12076065|FG006|Overall Study|Adverse Event|1
7661039|NCT00097539|12076059|FG000|Overall Study|Death|2
7661040|NCT00097539|12076060|FG001|Overall Study|Death|7
7661041|NCT00097539|12076061|FG002|Overall Study|Death|0
7661042|NCT00097539|12076062|FG003|Overall Study|Death|0
7661043|NCT00097539|12076063|FG004|Overall Study|Death|1
7661044|NCT00097539|12076064|FG005|Overall Study|Death|3
7661045|NCT00097539|12076065|FG006|Overall Study|Death|0
7661046|NCT00097539|12076059|FG000|Overall Study|Reasons Other Than Above|3602
7661047|NCT00097539|12076060|FG001|Overall Study|Reasons Other Than Above|1382
7661048|NCT00097539|12076061|FG002|Overall Study|Reasons Other Than Above|1757
7661049|NCT00097539|12076062|FG003|Overall Study|Reasons Other Than Above|692
7661050|NCT00097539|12076063|FG004|Overall Study|Reasons Other Than Above|361
7661051|NCT00097539|12076064|FG005|Overall Study|Reasons Other Than Above|1244
7661052|NCT00097539|12076065|FG006|Overall Study|Reasons Other Than Above|34
7661053|NCT00097539|12076059|FG000|Overall Study|Reason not Specified|111
7661054|NCT00097539|12076060|FG001|Overall Study|Reason not Specified|49
7661055|NCT00097539|12076061|FG002|Overall Study|Reason not Specified|53
7661056|NCT00097539|12076062|FG003|Overall Study|Reason not Specified|21
7661057|NCT00097539|12076063|FG004|Overall Study|Reason not Specified|11
7661058|NCT00097539|12076064|FG005|Overall Study|Reason not Specified|40
7661059|NCT00097539|12076065|FG006|Overall Study|Reason not Specified|2
7661060|NCT00097591|12076083|FG000|Overall Study|Withdrawal of consent|342
7661061|NCT00097591|12076084|FG001|Overall Study|Withdrawal of consent|323
7661062|NCT00097591|12076083|FG000|Overall Study|Less than 6 months on study drug|9
7661063|NCT00097591|12076084|FG001|Overall Study|Less than 6 months on study drug|7
7661064|NCT00097591|12076083|FG000|Overall Study|Unable to attend termination visit|53
7661065|NCT00097591|12076084|FG001|Overall Study|Unable to attend termination visit|51
7661066|NCT00097591|12076083|FG000|Overall Study|Lost to follow up|6
7661067|NCT00097591|12076084|FG001|Overall Study|Lost to follow up|10
7661068|NCT00097591|12076083|FG000|Overall Study|Other|0
7661069|NCT00097591|12076084|FG001|Overall Study|Other|3
7661070|NCT00097721|12076133|FG000|Overall Study|Adverse Event|8
7661071|NCT00097721|12076134|FG001|Overall Study|Adverse Event|1
7661072|NCT00097721|12076133|FG000|Overall Study|Withdrawal by Subject|6
7661073|NCT00097721|12076134|FG001|Overall Study|Withdrawal by Subject|1
7661074|NCT00097721|12076133|FG000|Overall Study|Progressive Disease|55
7661075|NCT00097721|12076134|FG001|Overall Study|Progressive Disease|27
7661076|NCT00097721|12076133|FG000|Overall Study|Physician Decision|1
7661077|NCT00097721|12076134|FG001|Overall Study|Physician Decision|3
7661078|NCT00097721|12076133|FG000|Overall Study|Reason not given|1
7661079|NCT00097721|12076134|FG001|Overall Study|Reason not given|1
7661080|NCT00097773|12076144|FG000|Overall Study|Lost to Follow-up|2
7661081|NCT00097773|12076145|FG001|Overall Study|Lost to Follow-up|2
7661082|NCT00097773|12076146|FG002|Overall Study|Lost to Follow-up|0
7661083|NCT00097773|12076147|FG003|Overall Study|Lost to Follow-up|1
7661084|NCT00097773|12076144|FG000|Overall Study|Physician Decision|2
7661085|NCT00097773|12076145|FG001|Overall Study|Physician Decision|2
7661086|NCT00097773|12076146|FG002|Overall Study|Physician Decision|3
7661087|NCT00097773|12076147|FG003|Overall Study|Physician Decision|1
7661088|NCT00097773|12076144|FG000|Overall Study|Withdrawal by Subject|3
7661089|NCT00097773|12076145|FG001|Overall Study|Withdrawal by Subject|3
7661090|NCT00097773|12076146|FG002|Overall Study|Withdrawal by Subject|3
7661091|NCT00097773|12076147|FG003|Overall Study|Withdrawal by Subject|1
7661092|NCT00097773|12076144|FG000|Overall Study|Adverse Event|0
7661093|NCT00097773|12076145|FG001|Overall Study|Adverse Event|1
7661094|NCT00097773|12076146|FG002|Overall Study|Adverse Event|0
7661095|NCT00097773|12076147|FG003|Overall Study|Adverse Event|0
7661096|NCT00097773|12076144|FG000|Overall Study|Other|1
7661097|NCT00097773|12076145|FG001|Overall Study|Other|0
7661098|NCT00097773|12076146|FG002|Overall Study|Other|2
7661099|NCT00097773|12076147|FG003|Overall Study|Other|0
7661100|NCT00097786|12076166|FG000|Overall Study|lost to follow-up for all-cause death|296
7661101|NCT00097786|12076167|FG001|Overall Study|lost to follow-up for all-cause death|292
7661102|NCT00097786|12076168|FG002|Overall Study|lost to follow-up for all-cause death|313
7661103|NCT00097786|12076169|FG003|Overall Study|lost to follow-up for all-cause death|310
7661104|NCT00097981|12076181|FG000|Overall Study|Adverse Event|31
7661105|NCT00097981|12076182|FG001|Overall Study|Adverse Event|44
7661106|NCT00097981|12076181|FG000|Overall Study|Withdrawal by Subject|10
7661107|NCT00097981|12076182|FG001|Overall Study|Withdrawal by Subject|8
7661108|NCT00097981|12076181|FG000|Overall Study|Protocol Violation|1
7661109|NCT00097981|12076182|FG001|Overall Study|Protocol Violation|1
7661110|NCT00097981|12076181|FG000|Overall Study|Death|2
7661111|NCT00097981|12076182|FG001|Overall Study|Death|4
7661112|NCT00097981|12076181|FG000|Overall Study|Physician Decision|7
7661113|NCT00097981|12076182|FG001|Overall Study|Physician Decision|1
7661114|NCT00097981|12076181|FG000|Overall Study|Disease Progression|8
7661115|NCT00097981|12076182|FG001|Overall Study|Disease Progression|2
7661116|NCT00097981|12076181|FG000|Overall Study|Transplant planned|28
7661117|NCT00097981|12076182|FG001|Overall Study|Transplant planned|27
7661118|NCT00097981|12076181|FG000|Overall Study|Other|19
7661119|NCT00097981|12076182|FG001|Overall Study|Other|13
7661120|NCT00098020|12076188|FG000|Overall Study|Adverse Event|2
7661121|NCT00098020|12076188|FG000|Overall Study|Lost to Follow-up|1
7661122|NCT00098020|12076188|FG000|Overall Study|elevated liver enzymes|1
7661123|NCT00098020|12076188|FG000|Overall Study|Low urine PCR|1
7661124|NCT00098020|12076188|FG000|Overall Study|Low epidermal growth factor receptor|1
7661125|NCT00098254|12076206|FG000|Overall Study|Adverse Event|2
7661126|NCT00098254|12076206|FG000|Overall Study|Death|1
7661127|NCT00098293|12076213|FG000|Double-blind (DB) Phase|Adverse Event|14
7661128|NCT00098293|12076214|FG001|Double-blind (DB) Phase|Adverse Event|27
7661129|NCT00098293|12076215|FG002|Double-blind (DB) Phase|Adverse Event|60
7661130|NCT00098293|12076216|FG003|Double-blind (DB) Phase|Adverse Event|0
7661131|NCT00098293|12076217|FG004|Double-blind (DB) Phase|Adverse Event|0
7661132|NCT00098293|12076213|FG000|Double-blind (DB) Phase|Pregnancy|0
7661133|NCT00098293|12076214|FG001|Double-blind (DB) Phase|Pregnancy|7
7661134|NCT00098293|12076215|FG002|Double-blind (DB) Phase|Pregnancy|9
7661135|NCT00098293|12076216|FG003|Double-blind (DB) Phase|Pregnancy|0
7661136|NCT00098293|12076217|FG004|Double-blind (DB) Phase|Pregnancy|0
7661137|NCT00098293|12076213|FG000|Double-blind (DB) Phase|Participant Defaulted|11
7661138|NCT00098293|12076214|FG001|Double-blind (DB) Phase|Participant Defaulted|40
7661139|NCT00098293|12076215|FG002|Double-blind (DB) Phase|Participant Defaulted|36
7661140|NCT00098293|12076216|FG003|Double-blind (DB) Phase|Participant Defaulted|0
7661141|NCT00098293|12076217|FG004|Double-blind (DB) Phase|Participant Defaulted|0
7661142|NCT00098293|12076213|FG000|Double-blind (DB) Phase|Lack of Efficacy|11
7661143|NCT00098293|12076214|FG001|Double-blind (DB) Phase|Lack of Efficacy|64
7661144|NCT00098293|12076215|FG002|Double-blind (DB) Phase|Lack of Efficacy|30
7661145|NCT00098293|12076216|FG003|Double-blind (DB) Phase|Lack of Efficacy|0
7661146|NCT00098293|12076217|FG004|Double-blind (DB) Phase|Lack of Efficacy|0
7661147|NCT00098293|12076213|FG000|Double-blind (DB) Phase|Death|1
7661148|NCT00098293|12076214|FG001|Double-blind (DB) Phase|Death|2
7661149|NCT00098293|12076215|FG002|Double-blind (DB) Phase|Death|2
7661150|NCT00098293|12076216|FG003|Double-blind (DB) Phase|Death|0
7661151|NCT00098293|12076217|FG004|Double-blind (DB) Phase|Death|0
7661152|NCT00098293|12076213|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3
7661153|NCT00098293|12076214|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8
7661154|NCT00098293|12076215|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11
7661155|NCT00098293|12076216|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0
7661156|NCT00098293|12076217|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0
7661157|NCT00098293|12076213|FG000|Double-blind (DB) Phase|Protocol Violation|2
7661158|NCT00098293|12076214|FG001|Double-blind (DB) Phase|Protocol Violation|18
7661159|NCT00098293|12076215|FG002|Double-blind (DB) Phase|Protocol Violation|22
7661160|NCT00098293|12076216|FG003|Double-blind (DB) Phase|Protocol Violation|0
7661161|NCT00098293|12076217|FG004|Double-blind (DB) Phase|Protocol Violation|0
7661162|NCT00098293|12076213|FG000|Double-blind (DB) Phase|Terminated by sponsor|135
7661163|NCT00098293|12076214|FG001|Double-blind (DB) Phase|Terminated by sponsor|0
7661164|NCT00098293|12076215|FG002|Double-blind (DB) Phase|Terminated by sponsor|0
7661165|NCT00098293|12076216|FG003|Double-blind (DB) Phase|Terminated by sponsor|0
7661166|NCT00098293|12076217|FG004|Double-blind (DB) Phase|Terminated by sponsor|0
7661167|NCT00098293|12076213|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0
7661168|NCT00098293|12076214|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0
7661169|NCT00098293|12076215|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3
7661170|NCT00098293|12076216|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0
7661171|NCT00098293|12076217|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0
7661172|NCT00098293|12076213|FG000|Open-label (OL) Phase|Adverse Event|0
7661173|NCT00098293|12076214|FG001|Open-label (OL) Phase|Adverse Event|3
7661174|NCT00098293|12076215|FG002|Open-label (OL) Phase|Adverse Event|7
7661175|NCT00098293|12076216|FG003|Open-label (OL) Phase|Adverse Event|6
7661176|NCT00098293|12076217|FG004|Open-label (OL) Phase|Adverse Event|0
7661177|NCT00098293|12076213|FG000|Open-label (OL) Phase|Lack of Efficacy|0
7661178|NCT00098293|12076214|FG001|Open-label (OL) Phase|Lack of Efficacy|7
7661179|NCT00098293|12076215|FG002|Open-label (OL) Phase|Lack of Efficacy|2
7661180|NCT00098293|12076216|FG003|Open-label (OL) Phase|Lack of Efficacy|20
7661181|NCT00098293|12076217|FG004|Open-label (OL) Phase|Lack of Efficacy|0
7661182|NCT00098293|12076213|FG000|Open-label (OL) Phase|Pregnancy|0
7661183|NCT00098293|12076214|FG001|Open-label (OL) Phase|Pregnancy|1
7661184|NCT00098293|12076215|FG002|Open-label (OL) Phase|Pregnancy|0
7661185|NCT00098293|12076216|FG003|Open-label (OL) Phase|Pregnancy|3
7661186|NCT00098293|12076217|FG004|Open-label (OL) Phase|Pregnancy|0
7661187|NCT00098293|12076213|FG000|Open-label (OL) Phase|Protocol Violation|0
7661188|NCT00098293|12076214|FG001|Open-label (OL) Phase|Protocol Violation|6
7661189|NCT00098293|12076215|FG002|Open-label (OL) Phase|Protocol Violation|13
7661190|NCT00098293|12076216|FG003|Open-label (OL) Phase|Protocol Violation|16
7661191|NCT00098293|12076217|FG004|Open-label (OL) Phase|Protocol Violation|0
7661192|NCT00098293|12076213|FG000|Open-label (OL) Phase|Participant Defaulted|0
7661193|NCT00098293|12076214|FG001|Open-label (OL) Phase|Participant Defaulted|6
7661194|NCT00098293|12076215|FG002|Open-label (OL) Phase|Participant Defaulted|16
7661195|NCT00098293|12076216|FG003|Open-label (OL) Phase|Participant Defaulted|20
7661196|NCT00098293|12076217|FG004|Open-label (OL) Phase|Participant Defaulted|0
7661197|NCT00098293|12076213|FG000|Open-label (OL) Phase|Death|0
7661198|NCT00098293|12076214|FG001|Open-label (OL) Phase|Death|2
7661199|NCT00098293|12076215|FG002|Open-label (OL) Phase|Death|3
7661200|NCT00098293|12076216|FG003|Open-label (OL) Phase|Death|0
7661201|NCT00098293|12076217|FG004|Open-label (OL) Phase|Death|0
7661202|NCT00098293|12076213|FG000|Supplemental Phase (SP)|Death|0
7661203|NCT00098293|12076214|FG001|Supplemental Phase (SP)|Death|0
7661204|NCT00098293|12076215|FG002|Supplemental Phase (SP)|Death|0
7661205|NCT00098293|12076216|FG003|Supplemental Phase (SP)|Death|0
7661206|NCT00098293|12076217|FG004|Supplemental Phase (SP)|Death|1
7661207|NCT00098293|12076213|FG000|Supplemental Phase (SP)|Lost to Follow-up|0
7661208|NCT00098293|12076214|FG001|Supplemental Phase (SP)|Lost to Follow-up|0
7661209|NCT00098293|12076215|FG002|Supplemental Phase (SP)|Lost to Follow-up|0
7661210|NCT00098293|12076216|FG003|Supplemental Phase (SP)|Lost to Follow-up|0
7661211|NCT00098293|12076217|FG004|Supplemental Phase (SP)|Lost to Follow-up|2
7661212|NCT00098293|12076213|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0
7661213|NCT00098293|12076214|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0
7661214|NCT00098293|12076215|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0
7661215|NCT00098293|12076216|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0
7661216|NCT00098293|12076217|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8
7661217|NCT00098293|12076213|FG000|Supplemental Phase (SP)|Other|0
7661218|NCT00098293|12076214|FG001|Supplemental Phase (SP)|Other|0
7661219|NCT00098293|12076215|FG002|Supplemental Phase (SP)|Other|0
7661220|NCT00098293|12076216|FG003|Supplemental Phase (SP)|Other|0
7661221|NCT00098293|12076217|FG004|Supplemental Phase (SP)|Other|22
7661222|NCT00098306|12076231|FG000|Double Blind|Randomized, not treated|9
7661223|NCT00098306|12076232|FG001|Double Blind|Randomized, not treated|5
7661224|NCT00098306|12076233|FG002|Double Blind|Randomized, not treated|2
7661225|NCT00098306|12076234|FG003|Double Blind|Randomized, not treated|0
7661226|NCT00098306|12076235|FG004|Double Blind|Randomized, not treated|0
7661227|NCT00098306|12076236|FG005|Double Blind|Randomized, not treated|0
7661228|NCT00098306|12076237|FG006|Double Blind|Randomized, not treated|0
7661229|NCT00098306|12076231|FG000|Double Blind|Ongoing at cut-off date|151
7661230|NCT00098306|12076232|FG001|Double Blind|Ongoing at cut-off date|166
7661231|NCT00098306|12076233|FG002|Double Blind|Ongoing at cut-off date|72
7661232|NCT00098306|12076234|FG003|Double Blind|Ongoing at cut-off date|0
7661233|NCT00098306|12076235|FG004|Double Blind|Ongoing at cut-off date|0
7661234|NCT00098306|12076236|FG005|Double Blind|Ongoing at cut-off date|0
7661235|NCT00098306|12076237|FG006|Double Blind|Ongoing at cut-off date|0
7661236|NCT00098306|12076231|FG000|Double Blind|Adverse Event|11
7661237|NCT00098306|12076232|FG001|Double Blind|Adverse Event|10
7661238|NCT00098306|12076233|FG002|Double Blind|Adverse Event|6
7661239|NCT00098306|12076234|FG003|Double Blind|Adverse Event|0
7661240|NCT00098306|12076235|FG004|Double Blind|Adverse Event|0
7661241|NCT00098306|12076236|FG005|Double Blind|Adverse Event|0
7661242|NCT00098306|12076237|FG006|Double Blind|Adverse Event|0
7661243|NCT00098306|12076231|FG000|Double Blind|Lack of Efficacy|43
7661244|NCT00098306|12076232|FG001|Double Blind|Lack of Efficacy|34
7661245|NCT00098306|12076233|FG002|Double Blind|Lack of Efficacy|17
7661246|NCT00098306|12076234|FG003|Double Blind|Lack of Efficacy|0
7661247|NCT00098306|12076235|FG004|Double Blind|Lack of Efficacy|0
7661248|NCT00098306|12076236|FG005|Double Blind|Lack of Efficacy|0
7661249|NCT00098306|12076237|FG006|Double Blind|Lack of Efficacy|0
7661250|NCT00098306|12076231|FG000|Double Blind|Death|1
7661251|NCT00098306|12076232|FG001|Double Blind|Death|4
7661252|NCT00098306|12076233|FG002|Double Blind|Death|1
7661253|NCT00098306|12076234|FG003|Double Blind|Death|0
7661254|NCT00098306|12076235|FG004|Double Blind|Death|0
7661255|NCT00098306|12076236|FG005|Double Blind|Death|0
7661256|NCT00098306|12076237|FG006|Double Blind|Death|0
7661257|NCT00098306|12076231|FG000|Double Blind|Participant defaulted|19
7661258|NCT00098306|12076232|FG001|Double Blind|Participant defaulted|18
7661259|NCT00098306|12076233|FG002|Double Blind|Participant defaulted|11
7661260|NCT00098306|12076234|FG003|Double Blind|Participant defaulted|0
7661261|NCT00098306|12076235|FG004|Double Blind|Participant defaulted|0
7661262|NCT00098306|12076236|FG005|Double Blind|Participant defaulted|0
7661263|NCT00098306|12076237|FG006|Double Blind|Participant defaulted|0
7661264|NCT00098306|12076231|FG000|Double Blind|Un-specified|7
7661265|NCT00098306|12076232|FG001|Double Blind|Un-specified|3
7661266|NCT00098306|12076233|FG002|Double Blind|Un-specified|11
7661267|NCT00098306|12076234|FG003|Double Blind|Un-specified|0
7661268|NCT00098306|12076235|FG004|Double Blind|Un-specified|0
7661269|NCT00098306|12076236|FG005|Double Blind|Un-specified|0
7661270|NCT00098306|12076237|FG006|Double Blind|Un-specified|0
7661271|NCT00098306|12076231|FG000|Open Label|Lack of Efficacy|0
7661272|NCT00098306|12076232|FG001|Open Label|Lack of Efficacy|0
7661273|NCT00098306|12076233|FG002|Open Label|Lack of Efficacy|0
7661274|NCT00098306|12076234|FG003|Open Label|Lack of Efficacy|13
7661275|NCT00098306|12076235|FG004|Open Label|Lack of Efficacy|0
7661276|NCT00098306|12076236|FG005|Open Label|Lack of Efficacy|0
7661277|NCT00098306|12076237|FG006|Open Label|Lack of Efficacy|0
7661278|NCT00098306|12076231|FG000|Open Label|Adverse Event|0
7661279|NCT00098306|12076232|FG001|Open Label|Adverse Event|0
7661280|NCT00098306|12076233|FG002|Open Label|Adverse Event|0
7661281|NCT00098306|12076234|FG003|Open Label|Adverse Event|2
7661282|NCT00098306|12076235|FG004|Open Label|Adverse Event|0
7661283|NCT00098306|12076236|FG005|Open Label|Adverse Event|0
7661284|NCT00098306|12076237|FG006|Open Label|Adverse Event|0
7661285|NCT00098306|12076231|FG000|Open Label|Death|0
7661286|NCT00098306|12076232|FG001|Open Label|Death|0
7661287|NCT00098306|12076233|FG002|Open Label|Death|0
7661288|NCT00098306|12076234|FG003|Open Label|Death|4
7661289|NCT00098306|12076235|FG004|Open Label|Death|0
7661290|NCT00098306|12076236|FG005|Open Label|Death|0
7661291|NCT00098306|12076237|FG006|Open Label|Death|0
7661292|NCT00098306|12076231|FG000|Open Label|Participant defaulted|0
7661293|NCT00098306|12076232|FG001|Open Label|Participant defaulted|0
7661294|NCT00098306|12076233|FG002|Open Label|Participant defaulted|0
7661295|NCT00098306|12076234|FG003|Open Label|Participant defaulted|24
7661296|NCT00098306|12076235|FG004|Open Label|Participant defaulted|0
7661297|NCT00098306|12076236|FG005|Open Label|Participant defaulted|0
7661298|NCT00098306|12076237|FG006|Open Label|Participant defaulted|0
7661299|NCT00098306|12076231|FG000|Open Label|Un-specified|0
7661300|NCT00098306|12076232|FG001|Open Label|Un-specified|0
7661301|NCT00098306|12076233|FG002|Open Label|Un-specified|0
7661302|NCT00098306|12076234|FG003|Open Label|Un-specified|15
7661303|NCT00098306|12076235|FG004|Open Label|Un-specified|0
7661304|NCT00098306|12076236|FG005|Open Label|Un-specified|0
7661305|NCT00098306|12076237|FG006|Open Label|Un-specified|0
7661306|NCT00098306|12076231|FG000|Open Label|Ongoing at cut-off date|0
7661307|NCT00098306|12076232|FG001|Open Label|Ongoing at cut-off date|0
7661308|NCT00098306|12076233|FG002|Open Label|Ongoing at cut-off date|0
7661309|NCT00098306|12076234|FG003|Open Label|Ongoing at cut-off date|269
7661310|NCT00098306|12076235|FG004|Open Label|Ongoing at cut-off date|62
7661311|NCT00098306|12076236|FG005|Open Label|Ongoing at cut-off date|0
7661312|NCT00098306|12076237|FG006|Open Label|Ongoing at cut-off date|0
7661313|NCT00098306|12076231|FG000|Observational Phase|Death|0
7661314|NCT00098306|12076232|FG001|Observational Phase|Death|0
7661315|NCT00098306|12076233|FG002|Observational Phase|Death|0
7661316|NCT00098306|12076234|FG003|Observational Phase|Death|0
7661317|NCT00098306|12076235|FG004|Observational Phase|Death|0
7661318|NCT00098306|12076236|FG005|Observational Phase|Death|5
7661319|NCT00098306|12076237|FG006|Observational Phase|Death|4
7661320|NCT00098306|12076231|FG000|Observational Phase|Participant defaulted|0
7661321|NCT00098306|12076232|FG001|Observational Phase|Participant defaulted|0
7661322|NCT00098306|12076233|FG002|Observational Phase|Participant defaulted|0
7661323|NCT00098306|12076234|FG003|Observational Phase|Participant defaulted|0
7661324|NCT00098306|12076235|FG004|Observational Phase|Participant defaulted|0
7661325|NCT00098306|12076236|FG005|Observational Phase|Participant defaulted|34
7661326|NCT00098306|12076237|FG006|Observational Phase|Participant defaulted|18
7661327|NCT00098306|12076231|FG000|Observational Phase|Un-specified|0
7661328|NCT00098306|12076232|FG001|Observational Phase|Un-specified|0
7661329|NCT00098306|12076233|FG002|Observational Phase|Un-specified|0
7661330|NCT00098306|12076234|FG003|Observational Phase|Un-specified|0
7661331|NCT00098306|12076235|FG004|Observational Phase|Un-specified|0
7661332|NCT00098306|12076236|FG005|Observational Phase|Un-specified|7
7661333|NCT00098306|12076237|FG006|Observational Phase|Un-specified|4
7661334|NCT00098345|12076250|FG000|Overall Study|Adverse Event|7
7661335|NCT00098345|12076250|FG000|Overall Study|Withdrawal by Subject|2
7661336|NCT00098345|12076250|FG000|Overall Study|progression|4
7661337|NCT00098722|12076277|FG000|Double Blind Phase|Adverse Event|7
7661338|NCT00098722|12076278|FG001|Double Blind Phase|Adverse Event|7
7661339|NCT00098722|12076279|FG002|Double Blind Phase|Adverse Event|3
7661340|NCT00098722|12076280|FG003|Double Blind Phase|Adverse Event|0
7661341|NCT00098722|12076281|FG004|Double Blind Phase|Adverse Event|0
7661342|NCT00098722|12076282|FG005|Double Blind Phase|Adverse Event|0
7661343|NCT00098722|12076283|FG006|Double Blind Phase|Adverse Event|0
7661344|NCT00098722|12076277|FG000|Double Blind Phase|Death|2
7661345|NCT00098722|12076278|FG001|Double Blind Phase|Death|5
7661346|NCT00098722|12076279|FG002|Double Blind Phase|Death|0
7661347|NCT00098722|12076280|FG003|Double Blind Phase|Death|0
7661348|NCT00098722|12076281|FG004|Double Blind Phase|Death|0
7661349|NCT00098722|12076282|FG005|Double Blind Phase|Death|0
7661350|NCT00098722|12076283|FG006|Double Blind Phase|Death|0
7661351|NCT00098722|12076277|FG000|Double Blind Phase|Lack of Efficacy|21
7661352|NCT00098722|12076278|FG001|Double Blind Phase|Lack of Efficacy|23
7661353|NCT00098722|12076279|FG002|Double Blind Phase|Lack of Efficacy|15
7661354|NCT00098722|12076280|FG003|Double Blind Phase|Lack of Efficacy|0
7661355|NCT00098722|12076281|FG004|Double Blind Phase|Lack of Efficacy|0
7661356|NCT00098722|12076282|FG005|Double Blind Phase|Lack of Efficacy|0
7661357|NCT00098722|12076283|FG006|Double Blind Phase|Lack of Efficacy|0
7661358|NCT00098722|12076277|FG000|Double Blind Phase|Participant defaulted|16
7661359|NCT00098722|12076278|FG001|Double Blind Phase|Participant defaulted|11
7661360|NCT00098722|12076279|FG002|Double Blind Phase|Participant defaulted|9
7661361|NCT00098722|12076280|FG003|Double Blind Phase|Participant defaulted|0
7661362|NCT00098722|12076281|FG004|Double Blind Phase|Participant defaulted|0
7661363|NCT00098722|12076282|FG005|Double Blind Phase|Participant defaulted|0
7661364|NCT00098722|12076283|FG006|Double Blind Phase|Participant defaulted|0
7661365|NCT00098722|12076277|FG000|Double Blind Phase|Pregnancy|1
7661366|NCT00098722|12076278|FG001|Double Blind Phase|Pregnancy|0
7661367|NCT00098722|12076279|FG002|Double Blind Phase|Pregnancy|0
7661368|NCT00098722|12076280|FG003|Double Blind Phase|Pregnancy|0
7661369|NCT00098722|12076281|FG004|Double Blind Phase|Pregnancy|0
7661370|NCT00098722|12076282|FG005|Double Blind Phase|Pregnancy|0
7661371|NCT00098722|12076283|FG006|Double Blind Phase|Pregnancy|0
7661372|NCT00098722|12076277|FG000|Double Blind Phase|Randomized, not treated|4
7661373|NCT00098722|12076278|FG001|Double Blind Phase|Randomized, not treated|3
7661374|NCT00098722|12076279|FG002|Double Blind Phase|Randomized, not treated|3
7661375|NCT00098722|12076280|FG003|Double Blind Phase|Randomized, not treated|0
7661376|NCT00098722|12076281|FG004|Double Blind Phase|Randomized, not treated|0
7661377|NCT00098722|12076282|FG005|Double Blind Phase|Randomized, not treated|0
7661378|NCT00098722|12076283|FG006|Double Blind Phase|Randomized, not treated|0
7661379|NCT00098722|12076277|FG000|Double Blind Phase|Ongoing at cut-off date|128
7661380|NCT00098722|12076278|FG001|Double Blind Phase|Ongoing at cut-off date|137
7661381|NCT00098722|12076279|FG002|Double Blind Phase|Ongoing at cut-off date|57
7661382|NCT00098722|12076280|FG003|Double Blind Phase|Ongoing at cut-off date|0
7661383|NCT00098722|12076281|FG004|Double Blind Phase|Ongoing at cut-off date|0
7661384|NCT00098722|12076282|FG005|Double Blind Phase|Ongoing at cut-off date|0
7661385|NCT00098722|12076283|FG006|Double Blind Phase|Ongoing at cut-off date|0
7661386|NCT00098722|12076277|FG000|Double Blind Phase|Other|7
7661387|NCT00098722|12076278|FG001|Double Blind Phase|Other|8
7661388|NCT00098722|12076279|FG002|Double Blind Phase|Other|7
7661389|NCT00098722|12076280|FG003|Double Blind Phase|Other|0
7661390|NCT00098722|12076281|FG004|Double Blind Phase|Other|0
7661391|NCT00098722|12076282|FG005|Double Blind Phase|Other|0
7661392|NCT00098722|12076283|FG006|Double Blind Phase|Other|0
7661393|NCT00098722|12076277|FG000|Open Label Phase|Adverse Event|0
7661394|NCT00098722|12076278|FG001|Open Label Phase|Adverse Event|0
7661395|NCT00098722|12076279|FG002|Open Label Phase|Adverse Event|0
7661396|NCT00098722|12076280|FG003|Open Label Phase|Adverse Event|5
7661397|NCT00098722|12076281|FG004|Open Label Phase|Adverse Event|0
7661398|NCT00098722|12076282|FG005|Open Label Phase|Adverse Event|0
7661399|NCT00098722|12076283|FG006|Open Label Phase|Adverse Event|0
7661400|NCT00098722|12076277|FG000|Open Label Phase|Death|0
7661401|NCT00098722|12076278|FG001|Open Label Phase|Death|0
7661402|NCT00098722|12076279|FG002|Open Label Phase|Death|0
7661403|NCT00098722|12076280|FG003|Open Label Phase|Death|2
7661404|NCT00098722|12076281|FG004|Open Label Phase|Death|0
7661405|NCT00098722|12076282|FG005|Open Label Phase|Death|0
7661406|NCT00098722|12076283|FG006|Open Label Phase|Death|0
7661407|NCT00098722|12076277|FG000|Open Label Phase|Lack of Efficacy|0
7661408|NCT00098722|12076278|FG001|Open Label Phase|Lack of Efficacy|0
7661409|NCT00098722|12076279|FG002|Open Label Phase|Lack of Efficacy|0
7661410|NCT00098722|12076280|FG003|Open Label Phase|Lack of Efficacy|8
7661411|NCT00098722|12076281|FG004|Open Label Phase|Lack of Efficacy|0
7661412|NCT00098722|12076282|FG005|Open Label Phase|Lack of Efficacy|0
7661413|NCT00098722|12076283|FG006|Open Label Phase|Lack of Efficacy|0
7661414|NCT00098722|12076277|FG000|Open Label Phase|Pregnancy|0
7661415|NCT00098722|12076278|FG001|Open Label Phase|Pregnancy|0
7661416|NCT00098722|12076279|FG002|Open Label Phase|Pregnancy|0
7661417|NCT00098722|12076280|FG003|Open Label Phase|Pregnancy|1
7661418|NCT00098722|12076281|FG004|Open Label Phase|Pregnancy|0
7661419|NCT00098722|12076282|FG005|Open Label Phase|Pregnancy|0
7661420|NCT00098722|12076283|FG006|Open Label Phase|Pregnancy|0
7661421|NCT00098722|12076277|FG000|Open Label Phase|Participant defaulted|0
7661422|NCT00098722|12076278|FG001|Open Label Phase|Participant defaulted|0
7661423|NCT00098722|12076279|FG002|Open Label Phase|Participant defaulted|0
7661424|NCT00098722|12076280|FG003|Open Label Phase|Participant defaulted|18
7661425|NCT00098722|12076281|FG004|Open Label Phase|Participant defaulted|0
7661426|NCT00098722|12076282|FG005|Open Label Phase|Participant defaulted|0
7661427|NCT00098722|12076283|FG006|Open Label Phase|Participant defaulted|0
7661428|NCT00098722|12076277|FG000|Open Label Phase|Ongoing at cut-off date|0
7661429|NCT00098722|12076278|FG001|Open Label Phase|Ongoing at cut-off date|0
7661430|NCT00098722|12076279|FG002|Open Label Phase|Ongoing at cut-off date|0
7661431|NCT00098722|12076280|FG003|Open Label Phase|Ongoing at cut-off date|220
7661432|NCT00098722|12076281|FG004|Open Label Phase|Ongoing at cut-off date|50
7661433|NCT00098722|12076282|FG005|Open Label Phase|Ongoing at cut-off date|0
7661434|NCT00098722|12076283|FG006|Open Label Phase|Ongoing at cut-off date|0
7661435|NCT00098722|12076277|FG000|Open Label Phase|Other|0
7661436|NCT00098722|12076278|FG001|Open Label Phase|Other|0
7661437|NCT00098722|12076279|FG002|Open Label Phase|Other|0
7661438|NCT00098722|12076280|FG003|Open Label Phase|Other|18
7661439|NCT00098722|12076281|FG004|Open Label Phase|Other|0
7661440|NCT00098722|12076282|FG005|Open Label Phase|Other|0
7661441|NCT00098722|12076283|FG006|Open Label Phase|Other|0
7661442|NCT00098722|12076277|FG000|Observation Phase|Death|0
7661443|NCT00098722|12076278|FG001|Observation Phase|Death|0
7661444|NCT00098722|12076279|FG002|Observation Phase|Death|0
7661445|NCT00098722|12076280|FG003|Observation Phase|Death|0
7661446|NCT00098722|12076281|FG004|Observation Phase|Death|0
7661447|NCT00098722|12076282|FG005|Observation Phase|Death|5
7661448|NCT00098722|12076283|FG006|Observation Phase|Death|3
7661449|NCT00098722|12076277|FG000|Observation Phase|Lack of Efficacy|0
7661450|NCT00098722|12076278|FG001|Observation Phase|Lack of Efficacy|0
7661451|NCT00098722|12076279|FG002|Observation Phase|Lack of Efficacy|0
7661452|NCT00098722|12076280|FG003|Observation Phase|Lack of Efficacy|0
7661453|NCT00098722|12076281|FG004|Observation Phase|Lack of Efficacy|0
7661454|NCT00098722|12076282|FG005|Observation Phase|Lack of Efficacy|2
7661455|NCT00098722|12076283|FG006|Observation Phase|Lack of Efficacy|0
7661456|NCT00098722|12076277|FG000|Observation Phase|Participant defaulted|0
7661457|NCT00098722|12076278|FG001|Observation Phase|Participant defaulted|0
7661458|NCT00098722|12076279|FG002|Observation Phase|Participant defaulted|0
7661459|NCT00098722|12076280|FG003|Observation Phase|Participant defaulted|0
7661460|NCT00098722|12076281|FG004|Observation Phase|Participant defaulted|0
7661461|NCT00098722|12076282|FG005|Observation Phase|Participant defaulted|17
7661462|NCT00098722|12076283|FG006|Observation Phase|Participant defaulted|4
7661463|NCT00098722|12076277|FG000|Observation Phase|Other|0
7661464|NCT00098722|12076278|FG001|Observation Phase|Other|0
7661465|NCT00098722|12076279|FG002|Observation Phase|Other|0
7661466|NCT00098722|12076280|FG003|Observation Phase|Other|0
7661467|NCT00098722|12076281|FG004|Observation Phase|Other|0
7661468|NCT00098722|12076282|FG005|Observation Phase|Other|21
7661469|NCT00098722|12076283|FG006|Observation Phase|Other|10
7661470|NCT00098748|12076298|FG000|Assigned to Study Treatment|Randomized, but not treated|0
7661471|NCT00098748|12076299|FG001|Assigned to Study Treatment|Randomized, but not treated|2
7661472|NCT00098748|12076300|FG002|Assigned to Study Treatment|Randomized, but not treated|2
7661473|NCT00098748|12076298|FG000|Received Study Treatment|Death|2
7661474|NCT00098748|12076299|FG001|Received Study Treatment|Death|1
7661475|NCT00098748|12076300|FG002|Received Study Treatment|Death|2
7661476|NCT00098748|12076298|FG000|Received Study Treatment|Adverse Event|1
7661477|NCT00098748|12076299|FG001|Received Study Treatment|Adverse Event|2
7661478|NCT00098748|12076300|FG002|Received Study Treatment|Adverse Event|5
7661479|NCT00098748|12076298|FG000|Received Study Treatment|Lack of Efficacy|40
7661480|NCT00098748|12076299|FG001|Received Study Treatment|Lack of Efficacy|27
7661481|NCT00098748|12076300|FG002|Received Study Treatment|Lack of Efficacy|27
7661482|NCT00098748|12076298|FG000|Received Study Treatment|Other|2
7661483|NCT00098748|12076299|FG001|Received Study Treatment|Other|2
7661484|NCT00098748|12076300|FG002|Received Study Treatment|Other|6
7661485|NCT00098748|12076298|FG000|Received Study Treatment|Subject defaulted|3
7661486|NCT00098748|12076299|FG001|Received Study Treatment|Subject defaulted|4
7661487|NCT00098748|12076300|FG002|Received Study Treatment|Subject defaulted|4
7661488|NCT00098748|12076298|FG000|Continued on Open-Label Treatment|Adverse Event|0
7661489|NCT00098748|12076299|FG001|Continued on Open-Label Treatment|Adverse Event|1
7661490|NCT00098748|12076300|FG002|Continued on Open-Label Treatment|Adverse Event|0
7661491|NCT00098748|12076298|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1
7661492|NCT00098748|12076299|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2
7661493|NCT00098748|12076300|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0
7661494|NCT00098748|12076298|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6
7661495|NCT00098748|12076299|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7
7661496|NCT00098748|12076300|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0
7661497|NCT00098748|12076298|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1
7661498|NCT00098748|12076299|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1
7661499|NCT00098748|12076300|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0
7661500|NCT00098748|12076298|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0
7661501|NCT00098748|12076299|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4
7661502|NCT00098748|12076300|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0
7661503|NCT00098774|12076308|FG000|Overall Study|Adverse Event|2
7661504|NCT00098774|12076308|FG000|Overall Study|Disease Progression|9
7661505|NCT00098774|12076308|FG000|Overall Study|Withdrawal by Subject|1
7661506|NCT00098774|12076308|FG000|Overall Study|Failed (to respond) during induction|4
7661507|NCT00098774|12076308|FG000|Overall Study|Physician Decision|2
7661508|NCT00098787|12076315|FG000|Overall Study|Never started treatment|3
7661509|NCT00098787|12076316|FG001|Overall Study|Never started treatment|2
7661510|NCT00098787|12076317|FG002|Overall Study|Never started treatment|1
7661511|NCT00098787|12076315|FG000|Overall Study|Ineligible|9
7661512|NCT00098787|12076316|FG001|Overall Study|Ineligible|7
7661513|NCT00098787|12076317|FG002|Overall Study|Ineligible|3
7661514|NCT00098787|12076315|FG000|Overall Study|Disease progression|28
7661515|NCT00098787|12076316|FG001|Overall Study|Disease progression|17
7661516|NCT00098787|12076317|FG002|Overall Study|Disease progression|23
7661517|NCT00098787|12076315|FG000|Overall Study|Adverse Event|8
7661518|NCT00098787|12076316|FG001|Overall Study|Adverse Event|17
7661519|NCT00098787|12076317|FG002|Overall Study|Adverse Event|8
7661520|NCT00098787|12076315|FG000|Overall Study|Death|6
7661521|NCT00098787|12076316|FG001|Overall Study|Death|1
7661522|NCT00098787|12076317|FG002|Overall Study|Death|0
7661523|NCT00098787|12076315|FG000|Overall Study|Withdrawal by Subject|4
7661524|NCT00098787|12076316|FG001|Overall Study|Withdrawal by Subject|12
7661525|NCT00098787|12076317|FG002|Overall Study|Withdrawal by Subject|6
7661526|NCT00098787|12076315|FG000|Overall Study|Alternative therapy|8
7661527|NCT00098787|12076316|FG001|Overall Study|Alternative therapy|13
7661528|NCT00098787|12076317|FG002|Overall Study|Alternative therapy|13
7661529|NCT00098787|12076315|FG000|Overall Study|Other|7
7661530|NCT00098787|12076316|FG001|Overall Study|Other|6
7661531|NCT00098787|12076317|FG002|Overall Study|Other|9
7661532|NCT00098813|12076325|FG000|Overall Study|Death|8
7661533|NCT00098813|12076325|FG000|Overall Study|Protocol Violation|1
7661534|NCT00098813|12076325|FG000|Overall Study|Withdrawal by Subject|7
7661535|NCT00098813|12076325|FG000|Overall Study|Progression of Disease|1
7661536|NCT00098813|12076325|FG000|Overall Study|Other complicating disease|1
7661537|NCT00098813|12076325|FG000|Overall Study|Reversal of RAI resistance|1
7661538|NCT00098839|12076331|FG000|Overall Study|Adverse Event|5
7661539|NCT00098839|12076332|FG001|Overall Study|Adverse Event|2
7661540|NCT00098839|12076331|FG000|Overall Study|Death|1
7661541|NCT00098839|12076332|FG001|Overall Study|Death|2
7661542|NCT00098839|12076331|FG000|Overall Study|Physician Decision|4
7661543|NCT00098839|12076332|FG001|Overall Study|Physician Decision|14
7661544|NCT00098839|12076331|FG000|Overall Study|Withdrawal by Subject|1
7661545|NCT00098839|12076332|FG001|Overall Study|Withdrawal by Subject|0
7661546|NCT00098839|12076331|FG000|Overall Study|Refusal of further protocol therapy|3
7661547|NCT00098839|12076332|FG001|Overall Study|Refusal of further protocol therapy|1
7661548|NCT00098839|12076331|FG000|Overall Study|Relapse|6
7661549|NCT00098839|12076332|FG001|Overall Study|Relapse|3
7661550|NCT00098839|12076331|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
7661551|NCT00098839|12076332|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
7661552|NCT00098839|12076331|FG000|Overall Study|Ineligible|2
7661553|NCT00098839|12076332|FG001|Overall Study|Ineligible|0
7661554|NCT00098865|12076339|FG000|Overall Study|Progressive Disease|6
7661555|NCT00098865|12076339|FG000|Overall Study|Adverse Event|2
7661556|NCT00098865|12076339|FG000|Overall Study|Alternative Therapy|1
7661557|NCT00099268|12076362|FG000|Overall Study|Withdrawal by Subject|46
7661558|NCT00099268|12076363|FG001|Overall Study|Withdrawal by Subject|28
7661559|NCT00099268|12076362|FG000|Overall Study|Adverse Event|19
7661560|NCT00099268|12076363|FG001|Overall Study|Adverse Event|19
7661561|NCT00099268|12076362|FG000|Overall Study|Protocol Violation|9
7661562|NCT00099268|12076363|FG001|Overall Study|Protocol Violation|8
7661563|NCT00099268|12076362|FG000|Overall Study|Lost to Follow-up|6
7661564|NCT00099268|12076363|FG001|Overall Study|Lost to Follow-up|4
7661565|NCT00099268|12076362|FG000|Overall Study|Lack of Efficacy|5
7661566|NCT00099268|12076363|FG001|Overall Study|Lack of Efficacy|18
7661567|NCT00099268|12076362|FG000|Overall Study|Administrative problems|4
7661568|NCT00099268|12076363|FG001|Overall Study|Administrative problems|4
7661569|NCT00099268|12076362|FG000|Overall Study|Death|3
7661570|NCT00099268|12076363|FG001|Overall Study|Death|1
7661571|NCT00099359|12076372|FG000|Overall Study|Death|11
7661572|NCT00099359|12076373|FG001|Overall Study|Death|15
7661573|NCT00099359|12076374|FG002|Overall Study|Death|17
7661574|NCT00099359|12076372|FG000|Overall Study|Withdrawal by Subject|19
7661575|NCT00099359|12076373|FG001|Overall Study|Withdrawal by Subject|19
7661576|NCT00099359|12076374|FG002|Overall Study|Withdrawal by Subject|23
7661577|NCT00099359|12076372|FG000|Overall Study|Lost to Follow-up|15
7661578|NCT00099359|12076373|FG001|Overall Study|Lost to Follow-up|24
7661579|NCT00099359|12076374|FG002|Overall Study|Lost to Follow-up|24
7661580|NCT00099359|12076372|FG000|Overall Study|moved out of area|9
7661581|NCT00099359|12076373|FG001|Overall Study|moved out of area|7
7661582|NCT00099359|12076374|FG002|Overall Study|moved out of area|4
7661583|NCT00099632|12076409|FG000|Overall Study|Lost to Follow-up|1
7661584|NCT00099632|12076410|FG001|Overall Study|Lost to Follow-up|0
7661585|NCT00099632|12076411|FG002|Overall Study|Lost to Follow-up|3
7661586|NCT00099632|12076412|FG003|Overall Study|Lost to Follow-up|1
7661587|NCT00099632|12076413|FG004|Overall Study|Lost to Follow-up|1
7661588|NCT00099632|12076414|FG005|Overall Study|Lost to Follow-up|0
7661589|NCT00099632|12076409|FG000|Overall Study|Withdrawal by Subject|0
7661590|NCT00099632|12076410|FG001|Overall Study|Withdrawal by Subject|1
7661591|NCT00099632|12076411|FG002|Overall Study|Withdrawal by Subject|0
7661592|NCT00099632|12076412|FG003|Overall Study|Withdrawal by Subject|0
7661593|NCT00099632|12076413|FG004|Overall Study|Withdrawal by Subject|0
7661594|NCT00099632|12076414|FG005|Overall Study|Withdrawal by Subject|1
7661595|NCT00099632|12076409|FG000|Overall Study|Protocol Violation|0
7661596|NCT00099632|12076410|FG001|Overall Study|Protocol Violation|0
7661597|NCT00099632|12076411|FG002|Overall Study|Protocol Violation|0
7661598|NCT00099632|12076412|FG003|Overall Study|Protocol Violation|0
7661599|NCT00099632|12076413|FG004|Overall Study|Protocol Violation|0
7661600|NCT00099632|12076414|FG005|Overall Study|Protocol Violation|1
7661601|NCT00099983|12076430|FG000|Overall Study|Lost to Follow-up|2
7661602|NCT00099983|12076431|FG001|Overall Study|Lost to Follow-up|3
7661603|NCT00099983|12076430|FG000|Overall Study|Missing Source Documents|14
7661604|NCT00099983|12076431|FG001|Overall Study|Missing Source Documents|15
7661605|NCT00099983|12076430|FG000|Overall Study|Withdrawal by Subject|3
7661606|NCT00099983|12076431|FG001|Overall Study|Withdrawal by Subject|2
7661607|NCT00099983|12076430|FG000|Overall Study|Adverse Event|1
7661608|NCT00099983|12076431|FG001|Overall Study|Adverse Event|1
7661609|NCT00099983|12076430|FG000|Overall Study|Lack of Efficacy|0
7661610|NCT00099983|12076431|FG001|Overall Study|Lack of Efficacy|1
7661611|NCT00099983|12076430|FG000|Overall Study|Unable to return for appointments|1
7661612|NCT00099983|12076431|FG001|Overall Study|Unable to return for appointments|1
7661613|NCT00099983|12076430|FG000|Overall Study|Moved|1
7661614|NCT00099983|12076431|FG001|Overall Study|Moved|0
7661615|NCT00099983|12076430|FG000|Overall Study|Other psychiatric problem|1
7661616|NCT00099983|12076431|FG001|Overall Study|Other psychiatric problem|0
7661617|NCT00099983|12076430|FG000|Overall Study|Incarcerated|0
7661618|NCT00099983|12076431|FG001|Overall Study|Incarcerated|1
7661619|NCT00099983|12076430|FG000|Overall Study|Intolerant of burden of visits|0
7661620|NCT00099983|12076431|FG001|Overall Study|Intolerant of burden of visits|1
7661621|NCT00099983|12076430|FG000|Overall Study|Other issue|1
7661622|NCT00099983|12076431|FG001|Overall Study|Other issue|0
7661623|NCT00100048|12076442|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2
7661624|NCT00100048|12076443|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0
7661625|NCT00100048|12076444|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0
7661626|NCT00100048|12076445|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0
7661627|NCT00100048|12076446|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0
7661628|NCT00100048|12076447|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1
7661629|NCT00100048|12076442|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0
7661630|NCT00100048|12076443|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1
7661631|NCT00100048|12076444|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2
7661632|NCT00100048|12076445|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0
7661633|NCT00100048|12076446|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0
7661634|NCT00100048|12076447|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1
7661635|NCT00100048|12076442|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
7661636|NCT00100048|12076443|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
7661637|NCT00100048|12076444|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
7661638|NCT00100048|12076445|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
7661639|NCT00100048|12076446|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
7661640|NCT00100048|12076447|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
7661641|NCT00100048|12076442|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
7661642|NCT00100048|12076443|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
7661643|NCT00100048|12076444|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
7661644|NCT00100048|12076445|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
7661645|NCT00100048|12076446|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
7661646|NCT00100048|12076447|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
7661647|NCT00100048|12076442|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
7661648|NCT00100048|12076443|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
7661649|NCT00100048|12076444|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
7661650|NCT00100048|12076445|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
7661651|NCT00100048|12076446|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
7661652|NCT00100048|12076447|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
7661653|NCT00100048|12076442|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7
7661654|NCT00100048|12076443|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1
7661655|NCT00100048|12076444|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4
7661656|NCT00100048|12076445|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2
7661657|NCT00100048|12076446|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0
7661658|NCT00100048|12076447|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0
7661659|NCT00100048|12076442|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
7661660|NCT00100048|12076443|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
7661661|NCT00100048|12076444|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
7661662|NCT00100048|12076445|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
7661663|NCT00100048|12076446|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
7661664|NCT00100048|12076447|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
7661665|NCT00100048|12076442|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
7661666|NCT00100048|12076443|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
7661667|NCT00100048|12076444|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
7661668|NCT00100048|12076445|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
7661669|NCT00100048|12076446|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
7661670|NCT00100048|12076447|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
7661671|NCT00100178|12076491|FG000|Overall Study|Lost to Follow-up|0
7661672|NCT00100178|12076492|FG001|Overall Study|Lost to Follow-up|6
7661673|NCT00100178|12076493|FG002|Overall Study|Lost to Follow-up|5
7661674|NCT00100178|12076491|FG000|Overall Study|Adverse Event|2
7661675|NCT00100178|12076492|FG001|Overall Study|Adverse Event|2
7661676|NCT00100178|12076493|FG002|Overall Study|Adverse Event|1
7661677|NCT00100178|12076491|FG000|Overall Study|Withdrawal by Subject|1
7661678|NCT00100178|12076492|FG001|Overall Study|Withdrawal by Subject|1
7661679|NCT00100178|12076493|FG002|Overall Study|Withdrawal by Subject|1
7661680|NCT00100178|12076491|FG000|Overall Study|Physician Decision|6
7661681|NCT00100178|12076492|FG001|Overall Study|Physician Decision|1
7661682|NCT00100178|12076493|FG002|Overall Study|Physician Decision|3
7661683|NCT00100789|12076532|FG000|Overall Study|Adverse Event|10
7661684|NCT00100789|12076532|FG000|Overall Study|Withdrawal by Subject|1
7661685|NCT00100789|12076532|FG000|Overall Study|Progression/relapse|42
7661686|NCT00100789|12076532|FG000|Overall Study|Death|2
7661687|NCT00100789|12076532|FG000|Overall Study|Not protocol specified|5
7661688|NCT00100789|12076532|FG000|Overall Study|Ineligible|3
7661689|NCT00100789|12076532|FG000|Overall Study|Never received treatment|1
7661690|NCT00100802|12076537|FG000|Overall Study|Adverse Event|9
7661691|NCT00100802|12076537|FG000|Overall Study|Death|1
7661692|NCT00100802|12076537|FG000|Overall Study|Lack of Efficacy|47
7661693|NCT00100802|12076537|FG000|Overall Study|Physician Decision|5
7661694|NCT00100802|12076537|FG000|Overall Study|Protocol Violation|1
7661695|NCT00100802|12076537|FG000|Overall Study|Withdrawal by Subject|5
7661696|NCT00100802|12076537|FG000|Overall Study|Ineligible|12
7661697|NCT00100815|12076541|FG000|Overall Study|Progression|24
7661698|NCT00100815|12076541|FG000|Overall Study|Adverse Event|18
7661699|NCT00100815|12076541|FG000|Overall Study|Death|4
7661700|NCT00100815|12076541|FG000|Overall Study|Other|3
7661701|NCT00100932|12076551|FG000|Overall Study|Adverse Event|11
7661702|NCT00100932|12076552|FG001|Overall Study|Adverse Event|2
7661703|NCT00100932|12076551|FG000|Overall Study|Withdrawal by Subject|6
7661704|NCT00100932|12076552|FG001|Overall Study|Withdrawal by Subject|0
7661705|NCT00100932|12076551|FG000|Overall Study|Progressive Disease|44
7661706|NCT00100932|12076552|FG001|Overall Study|Progressive Disease|18
7661707|NCT00100932|12076551|FG000|Overall Study|Physician Decision|7
7661708|NCT00100932|12076552|FG001|Overall Study|Physician Decision|5
7661709|NCT00100932|12076551|FG000|Overall Study|Other|5
7661710|NCT00100932|12076552|FG001|Overall Study|Other|2
7661711|NCT00101010|12076558|FG000|Overall Study|Physician Decision|1
7661712|NCT00101166|12076571|FG000|Overall Study|progressive disease|10
7661713|NCT00101192|12076575|FG000|Overall Study|Ineligible|6
7661714|NCT00101192|12076575|FG000|Overall Study|Inevaluable|1
7661715|NCT00101283|12076581|FG000|Overall Study|Withdrawal by Subject|0
7661716|NCT00101283|12076582|FG001|Overall Study|Withdrawal by Subject|1
7661717|NCT00101283|12076581|FG000|Overall Study|Insurance Refusal|0
7661718|NCT00101283|12076582|FG001|Overall Study|Insurance Refusal|1
7661719|NCT00101283|12076581|FG000|Overall Study|Prostate Cancer Recurrence|0
7661720|NCT00101283|12076582|FG001|Overall Study|Prostate Cancer Recurrence|1
7661721|NCT00101400|12076597|FG000|Survival Follow-Up|Alive|7
7661722|NCT00101452|12076608|FG000|Overall Study|Adverse Event|2
7661723|NCT00101452|12076609|FG001|Overall Study|Adverse Event|0
7661724|NCT00101452|12076610|FG002|Overall Study|Adverse Event|1
7661725|NCT00101452|12076608|FG000|Overall Study|Lost to Follow-up|13
7661726|NCT00101452|12076609|FG001|Overall Study|Lost to Follow-up|8
7661727|NCT00101452|12076610|FG002|Overall Study|Lost to Follow-up|14
7661728|NCT00101452|12076608|FG000|Overall Study|Withdrawal by Subject|10
7661729|NCT00101452|12076609|FG001|Overall Study|Withdrawal by Subject|14
7661730|NCT00101452|12076610|FG002|Overall Study|Withdrawal by Subject|9
7661731|NCT00101452|12076608|FG000|Overall Study|Baseline Fail|2
7661732|NCT00101452|12076609|FG001|Overall Study|Baseline Fail|1
7661733|NCT00101452|12076610|FG002|Overall Study|Baseline Fail|2
7661734|NCT00101452|12076608|FG000|Overall Study|Physician Decision|0
7661735|NCT00101452|12076609|FG001|Overall Study|Physician Decision|3
7661736|NCT00101452|12076610|FG002|Overall Study|Physician Decision|2
7661737|NCT00101452|12076608|FG000|Overall Study|Protocol Violation|2
7661738|NCT00101452|12076609|FG001|Overall Study|Protocol Violation|1
7661739|NCT00101452|12076610|FG002|Overall Study|Protocol Violation|3
7661740|NCT00101452|12076608|FG000|Overall Study|Other|15
7661741|NCT00101452|12076609|FG001|Overall Study|Other|16
7661742|NCT00101452|12076610|FG002|Overall Study|Other|12
7661743|NCT00101582|12076624|FG000|Overall Study|Ineligibility determined|0
7661744|NCT00101582|12076625|FG001|Overall Study|Ineligibility determined|1
7661745|NCT00101582|12076624|FG000|Overall Study|Adverse Event|1
7661746|NCT00101582|12076625|FG001|Overall Study|Adverse Event|4
7661747|NCT00101582|12076624|FG000|Overall Study|Withdrawal by Subject|6
7661748|NCT00101582|12076625|FG001|Overall Study|Withdrawal by Subject|4
7661749|NCT00101582|12076624|FG000|Overall Study|Physician Decision|1
7661750|NCT00101582|12076625|FG001|Overall Study|Physician Decision|0
7661751|NCT00101582|12076624|FG000|Overall Study|Death|3
7661752|NCT00101582|12076625|FG001|Overall Study|Death|5
7661753|NCT00101582|12076624|FG000|Overall Study|Other|0
7661754|NCT00101582|12076625|FG001|Overall Study|Other|1
7661755|NCT00101686|12076675|FG000|Overall Study|Progressive Disease|37
7661756|NCT00101686|12076676|FG001|Overall Study|Progressive Disease|28
7661757|NCT00101686|12076677|FG002|Overall Study|Progressive Disease|37
7661758|NCT00101686|12076678|FG003|Overall Study|Progressive Disease|38
7661759|NCT00101686|12076679|FG004|Overall Study|Progressive Disease|28
7661760|NCT00101686|12076680|FG005|Overall Study|Progressive Disease|25
7661761|NCT00101686|12076681|FG006|Overall Study|Progressive Disease|5
7661762|NCT00101686|12076682|FG007|Overall Study|Progressive Disease|7
7661763|NCT00101686|12076683|FG008|Overall Study|Progressive Disease|10
7661764|NCT00101686|12076684|FG009|Overall Study|Progressive Disease|8
7661765|NCT00101686|12076675|FG000|Overall Study|initiation other anti-cancer treatment|4
7661766|NCT00101686|12076676|FG001|Overall Study|initiation other anti-cancer treatment|3
7661767|NCT00101686|12076677|FG002|Overall Study|initiation other anti-cancer treatment|4
7661768|NCT00101686|12076678|FG003|Overall Study|initiation other anti-cancer treatment|3
7661769|NCT00101686|12076679|FG004|Overall Study|initiation other anti-cancer treatment|1
7661770|NCT00101686|12076680|FG005|Overall Study|initiation other anti-cancer treatment|1
7661771|NCT00101686|12076681|FG006|Overall Study|initiation other anti-cancer treatment|2
7661772|NCT00101686|12076682|FG007|Overall Study|initiation other anti-cancer treatment|2
7661773|NCT00101686|12076683|FG008|Overall Study|initiation other anti-cancer treatment|3
7661774|NCT00101686|12076684|FG009|Overall Study|initiation other anti-cancer treatment|3
7661775|NCT00101686|12076675|FG000|Overall Study|>3 week delay treatment due toxicity|6
7661776|NCT00101686|12076676|FG001|Overall Study|>3 week delay treatment due toxicity|2
7661777|NCT00101686|12076677|FG002|Overall Study|>3 week delay treatment due toxicity|1
7661778|NCT00101686|12076678|FG003|Overall Study|>3 week delay treatment due toxicity|2
7661779|NCT00101686|12076679|FG004|Overall Study|>3 week delay treatment due toxicity|7
7661780|NCT00101686|12076680|FG005|Overall Study|>3 week delay treatment due toxicity|3
7661781|NCT00101686|12076681|FG006|Overall Study|>3 week delay treatment due toxicity|2
7661782|NCT00101686|12076682|FG007|Overall Study|>3 week delay treatment due toxicity|1
7661783|NCT00101686|12076683|FG008|Overall Study|>3 week delay treatment due toxicity|3
7661784|NCT00101686|12076684|FG009|Overall Study|>3 week delay treatment due toxicity|0
7661785|NCT00101686|12076675|FG000|Overall Study|unacceptable toxicity|3
7661786|NCT00101686|12076676|FG001|Overall Study|unacceptable toxicity|9
7661787|NCT00101686|12076677|FG002|Overall Study|unacceptable toxicity|10
7661788|NCT00101686|12076678|FG003|Overall Study|unacceptable toxicity|6
7661789|NCT00101686|12076679|FG004|Overall Study|unacceptable toxicity|16
7661790|NCT00101686|12076680|FG005|Overall Study|unacceptable toxicity|10
7661791|NCT00101686|12076681|FG006|Overall Study|unacceptable toxicity|4
7661792|NCT00101686|12076682|FG007|Overall Study|unacceptable toxicity|2
7661793|NCT00101686|12076683|FG008|Overall Study|unacceptable toxicity|1
7661794|NCT00101686|12076684|FG009|Overall Study|unacceptable toxicity|4
7661795|NCT00101686|12076675|FG000|Overall Study|Randomized but did not receive treament|1
7661796|NCT00101686|12076676|FG001|Overall Study|Randomized but did not receive treament|6
7661797|NCT00101686|12076677|FG002|Overall Study|Randomized but did not receive treament|2
7661798|NCT00101686|12076678|FG003|Overall Study|Randomized but did not receive treament|2
7661799|NCT00101686|12076679|FG004|Overall Study|Randomized but did not receive treament|2
7661800|NCT00101686|12076680|FG005|Overall Study|Randomized but did not receive treament|2
7661801|NCT00101686|12076681|FG006|Overall Study|Randomized but did not receive treament|0
7661802|NCT00101686|12076682|FG007|Overall Study|Randomized but did not receive treament|1
7661803|NCT00101686|12076683|FG008|Overall Study|Randomized but did not receive treament|0
7661804|NCT00101686|12076684|FG009|Overall Study|Randomized but did not receive treament|1
7661805|NCT00101686|12076675|FG000|Overall Study|intercurrent non-cancer related illness|0
7661806|NCT00101686|12076676|FG001|Overall Study|intercurrent non-cancer related illness|0
7661807|NCT00101686|12076677|FG002|Overall Study|intercurrent non-cancer related illness|2
7661808|NCT00101686|12076678|FG003|Overall Study|intercurrent non-cancer related illness|0
7661809|NCT00101686|12076679|FG004|Overall Study|intercurrent non-cancer related illness|1
7661810|NCT00101686|12076680|FG005|Overall Study|intercurrent non-cancer related illness|3
7661811|NCT00101686|12076681|FG006|Overall Study|intercurrent non-cancer related illness|1
7661812|NCT00101686|12076682|FG007|Overall Study|intercurrent non-cancer related illness|0
7661813|NCT00101686|12076683|FG008|Overall Study|intercurrent non-cancer related illness|1
7661814|NCT00101686|12076684|FG009|Overall Study|intercurrent non-cancer related illness|1
7661815|NCT00101686|12076675|FG000|Overall Study|Physician Decision|10
7661816|NCT00101686|12076676|FG001|Overall Study|Physician Decision|13
7661817|NCT00101686|12076677|FG002|Overall Study|Physician Decision|6
7661818|NCT00101686|12076678|FG003|Overall Study|Physician Decision|7
7661819|NCT00101686|12076679|FG004|Overall Study|Physician Decision|8
7661820|NCT00101686|12076680|FG005|Overall Study|Physician Decision|9
7661821|NCT00101686|12076681|FG006|Overall Study|Physician Decision|5
7661822|NCT00101686|12076682|FG007|Overall Study|Physician Decision|5
7661823|NCT00101686|12076683|FG008|Overall Study|Physician Decision|1
7661824|NCT00101686|12076684|FG009|Overall Study|Physician Decision|1
7661825|NCT00101686|12076675|FG000|Overall Study|Other|1
7661826|NCT00101686|12076676|FG001|Overall Study|Other|4
7661827|NCT00101686|12076677|FG002|Overall Study|Other|1
7661828|NCT00101686|12076678|FG003|Overall Study|Other|6
7661829|NCT00101686|12076679|FG004|Overall Study|Other|2
7661830|NCT00101686|12076680|FG005|Overall Study|Other|12
7661831|NCT00101686|12076681|FG006|Overall Study|Other|1
7661832|NCT00101686|12076682|FG007|Overall Study|Other|5
7661833|NCT00101686|12076683|FG008|Overall Study|Other|3
7661834|NCT00101686|12076684|FG009|Overall Study|Other|3
7661835|NCT00101686|12076675|FG000|Overall Study|Withdrawal by Subject|9
7661836|NCT00101686|12076676|FG001|Overall Study|Withdrawal by Subject|8
7661837|NCT00101686|12076677|FG002|Overall Study|Withdrawal by Subject|6
7661838|NCT00101686|12076678|FG003|Overall Study|Withdrawal by Subject|8
7661839|NCT00101686|12076679|FG004|Overall Study|Withdrawal by Subject|8
7661840|NCT00101686|12076680|FG005|Overall Study|Withdrawal by Subject|7
7661841|NCT00101686|12076681|FG006|Overall Study|Withdrawal by Subject|7
7661842|NCT00101686|12076682|FG007|Overall Study|Withdrawal by Subject|7
7661843|NCT00101686|12076683|FG008|Overall Study|Withdrawal by Subject|8
7661844|NCT00101686|12076684|FG009|Overall Study|Withdrawal by Subject|9
7661845|NCT00101868|12076720|FG000|Overall Study|Death|10
7661846|NCT00101868|12076721|FG001|Overall Study|Death|10
7661847|NCT00101868|12076720|FG000|Overall Study|Withdrawal by Subject|8
7661848|NCT00101868|12076721|FG001|Overall Study|Withdrawal by Subject|9
7661849|NCT00101868|12076720|FG000|Overall Study|Protocol Violation|3
7661850|NCT00101868|12076721|FG001|Overall Study|Protocol Violation|0
7661851|NCT00101868|12076720|FG000|Overall Study|Lost to Follow-up|8
7661852|NCT00101868|12076721|FG001|Overall Study|Lost to Follow-up|13
7661853|NCT00101907|12076735|FG000|Overall Study|Adverse Event|1
7661854|NCT00101907|12076736|FG001|Overall Study|Adverse Event|0
7661855|NCT00101907|12076737|FG002|Overall Study|Adverse Event|0
7661856|NCT00101907|12076738|FG003|Overall Study|Adverse Event|0
7661857|NCT00101907|12076739|FG004|Overall Study|Adverse Event|0
7661858|NCT00101907|12076740|FG005|Overall Study|Adverse Event|0
7661859|NCT00101907|12076735|FG000|Overall Study|Death|0
7661860|NCT00101907|12076736|FG001|Overall Study|Death|1
7661861|NCT00101907|12076737|FG002|Overall Study|Death|0
7661862|NCT00101907|12076738|FG003|Overall Study|Death|0
7661863|NCT00101907|12076739|FG004|Overall Study|Death|3
7661864|NCT00101907|12076740|FG005|Overall Study|Death|0
7661865|NCT00101907|12076735|FG000|Overall Study|Physician Decision|0
7661866|NCT00101907|12076736|FG001|Overall Study|Physician Decision|0
7661867|NCT00101907|12076737|FG002|Overall Study|Physician Decision|0
7661868|NCT00101907|12076738|FG003|Overall Study|Physician Decision|1
7661869|NCT00101907|12076739|FG004|Overall Study|Physician Decision|1
7661870|NCT00101907|12076740|FG005|Overall Study|Physician Decision|0
7661871|NCT00101907|12076735|FG000|Overall Study|Withdrawal by Subject|1
7661872|NCT00101907|12076736|FG001|Overall Study|Withdrawal by Subject|0
7661873|NCT00101907|12076737|FG002|Overall Study|Withdrawal by Subject|1
7661874|NCT00101907|12076738|FG003|Overall Study|Withdrawal by Subject|0
7661875|NCT00101907|12076739|FG004|Overall Study|Withdrawal by Subject|1
7661876|NCT00101907|12076740|FG005|Overall Study|Withdrawal by Subject|0
7661877|NCT00102063|12076774|FG000|Overall Study|Lack of Efficacy|5
7661878|NCT00102063|12076775|FG001|Overall Study|Lack of Efficacy|1
7661879|NCT00102063|12076776|FG002|Overall Study|Lack of Efficacy|1
7661880|NCT00102063|12076774|FG000|Overall Study|Adverse Event|7
7661881|NCT00102063|12076775|FG001|Overall Study|Adverse Event|4
7661882|NCT00102063|12076776|FG002|Overall Study|Adverse Event|2
7661883|NCT00102063|12076774|FG000|Overall Study|Withdrawal by Subject|4
7661884|NCT00102063|12076775|FG001|Overall Study|Withdrawal by Subject|12
7661885|NCT00102063|12076776|FG002|Overall Study|Withdrawal by Subject|5
7661886|NCT00102063|12076774|FG000|Overall Study|Lost to Follow-up|0
7661887|NCT00102063|12076775|FG001|Overall Study|Lost to Follow-up|0
7661888|NCT00102063|12076776|FG002|Overall Study|Lost to Follow-up|1
7661889|NCT00102063|12076774|FG000|Overall Study|Protocol Violation|0
7661890|NCT00102063|12076775|FG001|Overall Study|Protocol Violation|1
7661891|NCT00102063|12076776|FG002|Overall Study|Protocol Violation|1
7661892|NCT00102440|12076787|FG000|Overall Study|Lost to Follow-up|25
7661893|NCT00102440|12076788|FG001|Overall Study|Lost to Follow-up|18
7661894|NCT00102440|12076789|FG002|Overall Study|Lost to Follow-up|21
7661895|NCT00102440|12076787|FG000|Overall Study|Adverse Event|16
7661896|NCT00102440|12076788|FG001|Overall Study|Adverse Event|23
7661897|NCT00102440|12076789|FG002|Overall Study|Adverse Event|8
7661898|NCT00102440|12076787|FG000|Overall Study|Gout Flare|10
7661899|NCT00102440|12076788|FG001|Overall Study|Gout Flare|28
7661900|NCT00102440|12076789|FG002|Overall Study|Gout Flare|9
7661901|NCT00102440|12076787|FG000|Overall Study|Personal Reason(s)|19
7661902|NCT00102440|12076788|FG001|Overall Study|Personal Reason(s)|13
7661903|NCT00102440|12076789|FG002|Overall Study|Personal Reason(s)|13
7661904|NCT00102440|12076787|FG000|Overall Study|Other|11
7661905|NCT00102440|12076788|FG001|Overall Study|Other|14
7661906|NCT00102440|12076789|FG002|Overall Study|Other|14
7661907|NCT00102440|12076787|FG000|Overall Study|Protocol Violation|7
7661908|NCT00102440|12076788|FG001|Overall Study|Protocol Violation|2
7661909|NCT00102440|12076789|FG002|Overall Study|Protocol Violation|1
7661910|NCT00102531|12076803|FG000|Overall Study|Adverse Event|0
7661911|NCT00102531|12076804|FG001|Overall Study|Adverse Event|1
7661912|NCT00102531|12076803|FG000|Overall Study|Disease Progression|5
7661913|NCT00102531|12076804|FG001|Overall Study|Disease Progression|9
7661914|NCT00102531|12076803|FG000|Overall Study|Physician Decision|0
7661915|NCT00102531|12076804|FG001|Overall Study|Physician Decision|1
7661916|NCT00102596|12076810|FG000|Part A|Screen failures|6
7661917|NCT00102596|12076811|FG001|Part A|Screen failures|0
7661918|NCT00102596|12076810|FG000|Part A|Adverse Event|1
7661919|NCT00102596|12076811|FG001|Part A|Adverse Event|0
7661920|NCT00102687|12076821|FG000|Initial Period|Withdrawal by Subject|6
7661921|NCT00102687|12076822|FG001|Initial Period|Withdrawal by Subject|3
7661922|NCT00102687|12076823|FG002|Initial Period|Withdrawal by Subject|5
7661923|NCT00102687|12076824|FG003|Initial Period|Withdrawal by Subject|0
7661924|NCT00102687|12076825|FG004|Initial Period|Withdrawal by Subject|0
7661925|NCT00102687|12076821|FG000|Initial Period|Adverse Event|4
7661926|NCT00102687|12076822|FG001|Initial Period|Adverse Event|7
7661927|NCT00102687|12076823|FG002|Initial Period|Adverse Event|9
7661928|NCT00102687|12076824|FG003|Initial Period|Adverse Event|0
7661929|NCT00102687|12076825|FG004|Initial Period|Adverse Event|0
7661930|NCT00102687|12076821|FG000|Initial Period|Transformation to AML (blast > 30%)|1
7661931|NCT00102687|12076822|FG001|Initial Period|Transformation to AML (blast > 30%)|3
7661932|NCT00102687|12076823|FG002|Initial Period|Transformation to AML (blast > 30%)|0
7661933|NCT00102687|12076824|FG003|Initial Period|Transformation to AML (blast > 30%)|0
7661934|NCT00102687|12076825|FG004|Initial Period|Transformation to AML (blast > 30%)|0
7661935|NCT00102687|12076821|FG000|Initial Period|Protocol Violation|0
7661936|NCT00102687|12076822|FG001|Initial Period|Protocol Violation|0
7661937|NCT00102687|12076823|FG002|Initial Period|Protocol Violation|2
7661938|NCT00102687|12076824|FG003|Initial Period|Protocol Violation|0
7661939|NCT00102687|12076825|FG004|Initial Period|Protocol Violation|0
7661940|NCT00102687|12076821|FG000|Initial Period|Physician Decision|2
7661941|NCT00102687|12076822|FG001|Initial Period|Physician Decision|9
7661942|NCT00102687|12076823|FG002|Initial Period|Physician Decision|6
7661943|NCT00102687|12076824|FG003|Initial Period|Physician Decision|0
7661944|NCT00102687|12076825|FG004|Initial Period|Physician Decision|0
7661945|NCT00102687|12076821|FG000|Initial Period|Sponsor's decision|0
7661946|NCT00102687|12076822|FG001|Initial Period|Sponsor's decision|1
7661947|NCT00102687|12076823|FG002|Initial Period|Sponsor's decision|1
7661948|NCT00102687|12076824|FG003|Initial Period|Sponsor's decision|0
7661949|NCT00102687|12076825|FG004|Initial Period|Sponsor's decision|0
7661950|NCT00102687|12076821|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4
7661951|NCT00102687|12076822|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4
7661952|NCT00102687|12076823|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2
7661953|NCT00102687|12076824|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0
7661954|NCT00102687|12076825|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0
7661955|NCT00102687|12076821|FG000|Initial Period|Death|1
7661956|NCT00102687|12076822|FG001|Initial Period|Death|1
7661957|NCT00102687|12076823|FG002|Initial Period|Death|1
7661958|NCT00102687|12076824|FG003|Initial Period|Death|0
7661959|NCT00102687|12076825|FG004|Initial Period|Death|0
7661960|NCT00102687|12076821|FG000|Maintenance Period|Withdrawal by Subject|4
7661961|NCT00102687|12076822|FG001|Maintenance Period|Withdrawal by Subject|0
7661962|NCT00102687|12076823|FG002|Maintenance Period|Withdrawal by Subject|2
7661963|NCT00102687|12076824|FG003|Maintenance Period|Withdrawal by Subject|3
7661964|NCT00102687|12076825|FG004|Maintenance Period|Withdrawal by Subject|1
7661965|NCT00102687|12076821|FG000|Maintenance Period|Adverse Event|1
7661966|NCT00102687|12076822|FG001|Maintenance Period|Adverse Event|0
7661967|NCT00102687|12076823|FG002|Maintenance Period|Adverse Event|0
7661968|NCT00102687|12076824|FG003|Maintenance Period|Adverse Event|1
7661969|NCT00102687|12076825|FG004|Maintenance Period|Adverse Event|3
7661970|NCT00102687|12076821|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0
7661971|NCT00102687|12076822|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1
7661972|NCT00102687|12076823|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0
7661973|NCT00102687|12076824|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2
7661974|NCT00102687|12076825|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0
7661975|NCT00102687|12076821|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1
7661976|NCT00102687|12076822|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1
7661977|NCT00102687|12076823|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1
7661978|NCT00102687|12076824|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3
7661979|NCT00102687|12076825|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4
7661980|NCT00102687|12076821|FG000|Maintenance Period|Death|0
7661981|NCT00102687|12076822|FG001|Maintenance Period|Death|0
7661982|NCT00102687|12076823|FG002|Maintenance Period|Death|0
7661983|NCT00102687|12076824|FG003|Maintenance Period|Death|1
7661984|NCT00102687|12076825|FG004|Maintenance Period|Death|1
7661985|NCT00102687|12076821|FG000|Maintenance Period|Physician Decision|1
7661986|NCT00102687|12076822|FG001|Maintenance Period|Physician Decision|2
7661987|NCT00102687|12076823|FG002|Maintenance Period|Physician Decision|3
7661988|NCT00102687|12076824|FG003|Maintenance Period|Physician Decision|0
7661989|NCT00102687|12076825|FG004|Maintenance Period|Physician Decision|4
7661990|NCT00102804|12076843|FG000|Overall Study|Progressive Disease (PD)|307
7661991|NCT00102804|12076844|FG001|Overall Study|Progressive Disease (PD)|196
7661992|NCT00102804|12076843|FG000|Overall Study|Withdrawal by Subject|46
7661993|NCT00102804|12076844|FG001|Overall Study|Withdrawal by Subject|7
7661994|NCT00102804|12076843|FG000|Overall Study|Adverse Event|37
7661995|NCT00102804|12076844|FG001|Overall Study|Adverse Event|3
7661996|NCT00102804|12076843|FG000|Overall Study|Physician Decision|24
7661997|NCT00102804|12076844|FG001|Overall Study|Physician Decision|6
7661998|NCT00102804|12076843|FG000|Overall Study|Death|5
7661999|NCT00102804|12076844|FG001|Overall Study|Death|6
7662000|NCT00102804|12076843|FG000|Overall Study|Enrollment Criteria Not Met|6
7662001|NCT00102804|12076844|FG001|Overall Study|Enrollment Criteria Not Met|0
7662002|NCT00102804|12076843|FG000|Overall Study|Lost to Follow-up|4
7662003|NCT00102804|12076844|FG001|Overall Study|Lost to Follow-up|1
7662004|NCT00102804|12076843|FG000|Overall Study|Protocol Violation|2
7662005|NCT00102804|12076844|FG001|Overall Study|Protocol Violation|1
7662006|NCT00102804|12076843|FG000|Overall Study|Satisfactory Response|2
7662007|NCT00102804|12076844|FG001|Overall Study|Satisfactory Response|0
7662008|NCT00102804|12076843|FG000|Overall Study|Sponsor Decision|1
7662009|NCT00102804|12076844|FG001|Overall Study|Sponsor Decision|0
7662010|NCT00102804|12076843|FG000|Overall Study|Alive, Receiving Treatment|7
7662011|NCT00102804|12076844|FG001|Overall Study|Alive, Receiving Treatment|2
7662012|NCT00102960|12076853|FG000|Overall Study|Death|23
7662013|NCT00102960|12076854|FG001|Overall Study|Death|11
7662014|NCT00102960|12076855|FG002|Overall Study|Death|11
7662015|NCT00102960|12076853|FG000|Overall Study|Lost to Follow-up|6
7662016|NCT00102960|12076854|FG001|Overall Study|Lost to Follow-up|12
7662017|NCT00102960|12076855|FG002|Overall Study|Lost to Follow-up|16
7662018|NCT00102960|12076853|FG000|Overall Study|Withdrawal by Subject|1
7662019|NCT00102960|12076854|FG001|Overall Study|Withdrawal by Subject|0
7662020|NCT00102960|12076855|FG002|Overall Study|Withdrawal by Subject|1
7662021|NCT00103012|12076870|FG000|Overall Study|Withdrawal by Subject|2
7662022|NCT00103012|12076871|FG001|Overall Study|Withdrawal by Subject|1
7662023|NCT00103012|12076872|FG002|Overall Study|Withdrawal by Subject|2
7662024|NCT00103012|12076870|FG000|Overall Study|Pregnancy|1
7662025|NCT00103012|12076871|FG001|Overall Study|Pregnancy|0
7662026|NCT00103012|12076872|FG002|Overall Study|Pregnancy|0
7662027|NCT00103012|12076870|FG000|Overall Study|Adverse Event|0
7662028|NCT00103012|12076871|FG001|Overall Study|Adverse Event|0
7662029|NCT00103012|12076872|FG002|Overall Study|Adverse Event|1
7662030|NCT00103012|12076870|FG000|Overall Study|Subject non-compliant with medications|0
7662031|NCT00103012|12076871|FG001|Overall Study|Subject non-compliant with medications|0
7662032|NCT00103012|12076872|FG002|Overall Study|Subject non-compliant with medications|1
7662033|NCT00103142|12076886|FG000|Overall Study|Adverse Event|1
7662034|NCT00103142|12076887|FG001|Overall Study|Adverse Event|0
7662035|NCT00103142|12076886|FG000|Overall Study|Progression of disease|2
7662036|NCT00103142|12076887|FG001|Overall Study|Progression of disease|1
7662037|NCT00103207|12076899|FG000|Overall Study|Adverse Event|3
7662038|NCT00103207|12076899|FG000|Overall Study|Death|1
7662039|NCT00103207|12076899|FG000|Overall Study|Withdrawal by Subject|2
7662040|NCT00103207|12076899|FG000|Overall Study|Other complicating disease|1
7662041|NCT00103207|12076899|FG000|Overall Study|Ineligible|4
7662042|NCT00103207|12076899|FG000|Overall Study|Diagnosis of BAC not confirmed|27
7662043|NCT00103259|12076907|FG000|Overall Study|Death|3
7662044|NCT00103259|12076908|FG001|Overall Study|Death|2
7662045|NCT00103259|12076907|FG000|Overall Study|Withdrawal by Subject|2
7662046|NCT00103259|12076908|FG001|Overall Study|Withdrawal by Subject|3
7662047|NCT00103259|12076907|FG000|Overall Study|alternative therapy|1
7662048|NCT00103259|12076908|FG001|Overall Study|alternative therapy|0
7662049|NCT00103259|12076907|FG000|Overall Study|other (reasons were not specified)|2
7662050|NCT00103259|12076908|FG001|Overall Study|other (reasons were not specified)|1
7662051|NCT00103259|12076907|FG000|Overall Study|ineligible/no protocol therapy|4
7662052|NCT00103259|12076908|FG001|Overall Study|ineligible/no protocol therapy|6
7662053|NCT00103285|12076916|FG000|Induction|Adverse Event|14
7662054|NCT00103285|12076917|FG001|Induction|Adverse Event|0
7662055|NCT00103285|12076918|FG002|Induction|Adverse Event|0
7662056|NCT00103285|12076919|FG003|Induction|Adverse Event|0
7662057|NCT00103285|12076920|FG004|Induction|Adverse Event|0
7662058|NCT00103285|12076921|FG005|Induction|Adverse Event|0
7662059|NCT00103285|12076922|FG006|Induction|Adverse Event|0
7662060|NCT00103285|12076923|FG007|Induction|Adverse Event|0
7662061|NCT00103285|12076916|FG000|Induction|Death|24
7662062|NCT00103285|12076917|FG001|Induction|Death|0
7662063|NCT00103285|12076918|FG002|Induction|Death|0
7662064|NCT00103285|12076919|FG003|Induction|Death|0
7662065|NCT00103285|12076920|FG004|Induction|Death|0
7662066|NCT00103285|12076921|FG005|Induction|Death|0
7662067|NCT00103285|12076922|FG006|Induction|Death|0
7662068|NCT00103285|12076923|FG007|Induction|Death|0
7662069|NCT00103285|12076916|FG000|Induction|Physician Decision|103
7662070|NCT00103285|12076917|FG001|Induction|Physician Decision|0
7662071|NCT00103285|12076918|FG002|Induction|Physician Decision|0
7662072|NCT00103285|12076919|FG003|Induction|Physician Decision|0
7662073|NCT00103285|12076920|FG004|Induction|Physician Decision|0
7662074|NCT00103285|12076921|FG005|Induction|Physician Decision|0
7662075|NCT00103285|12076922|FG006|Induction|Physician Decision|0
7662076|NCT00103285|12076923|FG007|Induction|Physician Decision|0
7662077|NCT00103285|12076916|FG000|Induction|Withdrawal by Subject|1
7662078|NCT00103285|12076917|FG001|Induction|Withdrawal by Subject|0
7662079|NCT00103285|12076918|FG002|Induction|Withdrawal by Subject|0
7662080|NCT00103285|12076919|FG003|Induction|Withdrawal by Subject|0
7662081|NCT00103285|12076920|FG004|Induction|Withdrawal by Subject|0
7662082|NCT00103285|12076921|FG005|Induction|Withdrawal by Subject|0
7662083|NCT00103285|12076922|FG006|Induction|Withdrawal by Subject|0
7662084|NCT00103285|12076923|FG007|Induction|Withdrawal by Subject|0
7662085|NCT00103285|12076916|FG000|Induction|Ineligible|43
7662086|NCT00103285|12076917|FG001|Induction|Ineligible|0
7662087|NCT00103285|12076918|FG002|Induction|Ineligible|0
7662088|NCT00103285|12076919|FG003|Induction|Ineligible|0
7662089|NCT00103285|12076920|FG004|Induction|Ineligible|0
7662090|NCT00103285|12076921|FG005|Induction|Ineligible|0
7662091|NCT00103285|12076922|FG006|Induction|Ineligible|0
7662092|NCT00103285|12076923|FG007|Induction|Ineligible|0
7662093|NCT00103285|12076916|FG000|Induction|Refusal|906
7662094|NCT00103285|12076917|FG001|Induction|Refusal|0
7662095|NCT00103285|12076918|FG002|Induction|Refusal|0
7662096|NCT00103285|12076919|FG003|Induction|Refusal|0
7662097|NCT00103285|12076920|FG004|Induction|Refusal|0
7662098|NCT00103285|12076921|FG005|Induction|Refusal|0
7662099|NCT00103285|12076922|FG006|Induction|Refusal|0
7662100|NCT00103285|12076923|FG007|Induction|Refusal|0
7662101|NCT00103285|12076916|FG000|Induction|Other|258
7662102|NCT00103285|12076917|FG001|Induction|Other|0
7662103|NCT00103285|12076918|FG002|Induction|Other|0
7662104|NCT00103285|12076919|FG003|Induction|Other|0
7662105|NCT00103285|12076920|FG004|Induction|Other|0
7662106|NCT00103285|12076921|FG005|Induction|Other|0
7662107|NCT00103285|12076922|FG006|Induction|Other|0
7662108|NCT00103285|12076923|FG007|Induction|Other|0
7662109|NCT00103285|12076916|FG000|Response Assignment|Adverse Event|0
7662110|NCT00103285|12076917|FG001|Response Assignment|Adverse Event|8
7662111|NCT00103285|12076918|FG002|Response Assignment|Adverse Event|3
7662112|NCT00103285|12076919|FG003|Response Assignment|Adverse Event|2
7662113|NCT00103285|12076920|FG004|Response Assignment|Adverse Event|3
7662114|NCT00103285|12076921|FG005|Response Assignment|Adverse Event|1
7662115|NCT00103285|12076922|FG006|Response Assignment|Adverse Event|1
7662116|NCT00103285|12076923|FG007|Response Assignment|Adverse Event|2
7662117|NCT00103285|12076916|FG000|Response Assignment|Death|0
7662118|NCT00103285|12076917|FG001|Response Assignment|Death|5
7662119|NCT00103285|12076918|FG002|Response Assignment|Death|2
7662120|NCT00103285|12076919|FG003|Response Assignment|Death|2
7662121|NCT00103285|12076920|FG004|Response Assignment|Death|3
7662122|NCT00103285|12076921|FG005|Response Assignment|Death|1
7662123|NCT00103285|12076922|FG006|Response Assignment|Death|0
7662124|NCT00103285|12076923|FG007|Response Assignment|Death|8
7662125|NCT00103285|12076916|FG000|Response Assignment|Lost to Follow-up|0
7662126|NCT00103285|12076917|FG001|Response Assignment|Lost to Follow-up|9
7662127|NCT00103285|12076918|FG002|Response Assignment|Lost to Follow-up|5
7662128|NCT00103285|12076919|FG003|Response Assignment|Lost to Follow-up|5
7662129|NCT00103285|12076920|FG004|Response Assignment|Lost to Follow-up|1
7662130|NCT00103285|12076921|FG005|Response Assignment|Lost to Follow-up|2
7662131|NCT00103285|12076922|FG006|Response Assignment|Lost to Follow-up|2
7662132|NCT00103285|12076923|FG007|Response Assignment|Lost to Follow-up|5
7662133|NCT00103285|12076916|FG000|Response Assignment|Physician Decision|0
7662134|NCT00103285|12076917|FG001|Response Assignment|Physician Decision|13
7662135|NCT00103285|12076918|FG002|Response Assignment|Physician Decision|14
7662136|NCT00103285|12076919|FG003|Response Assignment|Physician Decision|9
7662137|NCT00103285|12076920|FG004|Response Assignment|Physician Decision|13
7662138|NCT00103285|12076921|FG005|Response Assignment|Physician Decision|7
7662139|NCT00103285|12076922|FG006|Response Assignment|Physician Decision|4
7662140|NCT00103285|12076923|FG007|Response Assignment|Physician Decision|35
7662141|NCT00103285|12076916|FG000|Response Assignment|Protocol Violation|0
7662142|NCT00103285|12076917|FG001|Response Assignment|Protocol Violation|2
7662143|NCT00103285|12076918|FG002|Response Assignment|Protocol Violation|0
7662144|NCT00103285|12076919|FG003|Response Assignment|Protocol Violation|0
7662145|NCT00103285|12076920|FG004|Response Assignment|Protocol Violation|0
7662146|NCT00103285|12076921|FG005|Response Assignment|Protocol Violation|0
7662147|NCT00103285|12076922|FG006|Response Assignment|Protocol Violation|0
7662148|NCT00103285|12076923|FG007|Response Assignment|Protocol Violation|0
7662149|NCT00103285|12076916|FG000|Response Assignment|Withdrawal by Subject|0
7662150|NCT00103285|12076917|FG001|Response Assignment|Withdrawal by Subject|4
7662151|NCT00103285|12076918|FG002|Response Assignment|Withdrawal by Subject|1
7662152|NCT00103285|12076919|FG003|Response Assignment|Withdrawal by Subject|1
7662153|NCT00103285|12076920|FG004|Response Assignment|Withdrawal by Subject|2
7662154|NCT00103285|12076921|FG005|Response Assignment|Withdrawal by Subject|2
7662155|NCT00103285|12076922|FG006|Response Assignment|Withdrawal by Subject|0
7662156|NCT00103285|12076923|FG007|Response Assignment|Withdrawal by Subject|2
7662157|NCT00103285|12076916|FG000|Response Assignment|Ineligible|0
7662158|NCT00103285|12076917|FG001|Response Assignment|Ineligible|8
7662159|NCT00103285|12076918|FG002|Response Assignment|Ineligible|6
7662160|NCT00103285|12076919|FG003|Response Assignment|Ineligible|2
7662161|NCT00103285|12076920|FG004|Response Assignment|Ineligible|0
7662162|NCT00103285|12076921|FG005|Response Assignment|Ineligible|3
7662163|NCT00103285|12076922|FG006|Response Assignment|Ineligible|1
7662164|NCT00103285|12076923|FG007|Response Assignment|Ineligible|5
7662165|NCT00103285|12076916|FG000|Response Assignment|Refusal|0
7662166|NCT00103285|12076917|FG001|Response Assignment|Refusal|53
7662167|NCT00103285|12076918|FG002|Response Assignment|Refusal|5
7662168|NCT00103285|12076919|FG003|Response Assignment|Refusal|3
7662169|NCT00103285|12076920|FG004|Response Assignment|Refusal|25
7662170|NCT00103285|12076921|FG005|Response Assignment|Refusal|15
7662171|NCT00103285|12076922|FG006|Response Assignment|Refusal|30
7662172|NCT00103285|12076923|FG007|Response Assignment|Refusal|10
7662173|NCT00103285|12076916|FG000|Response Assignment|Other|0
7662174|NCT00103285|12076917|FG001|Response Assignment|Other|30
7662175|NCT00103285|12076918|FG002|Response Assignment|Other|48
7662176|NCT00103285|12076919|FG003|Response Assignment|Other|38
7662177|NCT00103285|12076920|FG004|Response Assignment|Other|37
7662178|NCT00103285|12076921|FG005|Response Assignment|Other|17
7662179|NCT00103285|12076922|FG006|Response Assignment|Other|11
7662180|NCT00103285|12076923|FG007|Response Assignment|Other|53
7662181|NCT00103311|12076950|FG000|Overall Study|Lost to Follow-up|1
7662182|NCT00103311|12076951|FG001|Overall Study|Lost to Follow-up|0
7662183|NCT00103311|12076950|FG000|Overall Study|Withdrawal by Subject|2
7662184|NCT00103311|12076951|FG001|Overall Study|Withdrawal by Subject|1
7662185|NCT00103311|12076950|FG000|Overall Study|Adverse Event|1
7662186|NCT00103311|12076951|FG001|Overall Study|Adverse Event|0
7662187|NCT00103402|12076978|FG000|Overall Study|Adverse Event|3
7662188|NCT00103402|12076979|FG001|Overall Study|Adverse Event|4
7662189|NCT00103402|12076978|FG000|Overall Study|Lost to Follow-up|8
7662190|NCT00103402|12076979|FG001|Overall Study|Lost to Follow-up|7
7662191|NCT00103402|12076978|FG000|Overall Study|Dissatisfied/No longer interested|6
7662192|NCT00103402|12076979|FG001|Overall Study|Dissatisfied/No longer interested|6
7662193|NCT00103402|12076978|FG000|Overall Study|Personal constraints/Other|5
7662194|NCT00103402|12076979|FG001|Overall Study|Personal constraints/Other|0
7662195|NCT00103506|12076987|FG000|Overall Study|Study closed by sponsor|34
7662196|NCT00103506|12076988|FG001|Overall Study|Study closed by sponsor|37
7662197|NCT00103506|12076987|FG000|Overall Study|Death|257
7662198|NCT00103506|12076988|FG001|Overall Study|Death|253
7662199|NCT00103506|12076987|FG000|Overall Study|Lost to Follow-up|13
7662200|NCT00103506|12076988|FG001|Overall Study|Lost to Follow-up|13
7662201|NCT00103506|12076987|FG000|Overall Study|Withdrawal by Subject|18
7662202|NCT00103506|12076988|FG001|Overall Study|Withdrawal by Subject|21
7662203|NCT00103610|12076996|FG000|Overall Study|Entered Rescue Procedure|10
7662204|NCT00103610|12076997|FG001|Overall Study|Entered Rescue Procedure|52
7662205|NCT00103610|12076996|FG000|Overall Study|Death|16
7662206|NCT00103610|12076997|FG001|Overall Study|Death|12
7662207|NCT00103610|12076996|FG000|Overall Study|Elective Withdrawal|4
7662208|NCT00103610|12076997|FG001|Overall Study|Elective Withdrawal|0
7662209|NCT00103610|12076996|FG000|Overall Study|Lost to Follow-up|3
7662210|NCT00103610|12076997|FG001|Overall Study|Lost to Follow-up|1
7662211|NCT00103610|12076996|FG000|Overall Study|Adverse Event|2
7662212|NCT00103610|12076997|FG001|Overall Study|Adverse Event|2
7662213|NCT00103610|12076996|FG000|Overall Study|Other|2
7662214|NCT00103610|12076997|FG001|Overall Study|Other|7
7662215|NCT00103610|12076996|FG000|Overall Study|Failed mobilization|1
7662216|NCT00103610|12076997|FG001|Overall Study|Failed mobilization|5
7662217|NCT00103610|12076996|FG000|Overall Study|Noncompliance|0
7662218|NCT00103610|12076997|FG001|Overall Study|Noncompliance|1
7662219|NCT00103662|12077006|FG000|Overall Study|Entered Rescue Procedure|0
7662220|NCT00103662|12077007|FG001|Overall Study|Entered Rescue Procedure|7
7662221|NCT00103662|12077006|FG000|Overall Study|Death|7
7662222|NCT00103662|12077007|FG001|Overall Study|Death|7
7662223|NCT00103662|12077006|FG000|Overall Study|Elective Withdrawal|5
7662224|NCT00103662|12077007|FG001|Overall Study|Elective Withdrawal|5
7662225|NCT00103662|12077006|FG000|Overall Study|Lost to Follow-up|0
7662226|NCT00103662|12077007|FG001|Overall Study|Lost to Follow-up|1
7662227|NCT00103662|12077006|FG000|Overall Study|Other|6
7662228|NCT00103662|12077007|FG001|Overall Study|Other|9
7662229|NCT00103662|12077006|FG000|Overall Study|Failed mobilization|0
7662230|NCT00103662|12077007|FG001|Overall Study|Failed mobilization|4
7662231|NCT00103662|12077006|FG000|Overall Study|Intercurrent illness|1
7662232|NCT00103662|12077007|FG001|Overall Study|Intercurrent illness|0
7662233|NCT00103740|12077015|FG000|Period 1 - Core|Adverse Event|1
7662234|NCT00103740|12077016|FG001|Period 1 - Core|Adverse Event|0
7662235|NCT00103740|12077015|FG000|Period 1 - Core|Protocol Violation|3
7662236|NCT00103740|12077016|FG001|Period 1 - Core|Protocol Violation|2
7662237|NCT00103740|12077015|FG000|Period 1 - Core|Patient withdrew consent|3
7662238|NCT00103740|12077016|FG001|Period 1 - Core|Patient withdrew consent|2
7662239|NCT00103740|12077015|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7
7662240|NCT00103740|12077016|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6
7662241|NCT00103740|12077015|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
7662242|NCT00103740|12077016|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
7662243|NCT00103740|12077015|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
7662244|NCT00103740|12077016|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
7662245|NCT00103740|12077015|FG000|Period 2 - Extended Observation Period|Death|6
7662246|NCT00103740|12077016|FG001|Period 2 - Extended Observation Period|Death|2
7662247|NCT00103740|12077015|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
7662248|NCT00103740|12077016|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
7662249|NCT00103857|12077038|FG000|54-Week Base Study|Adverse Event|12
7662250|NCT00103857|12077039|FG001|54-Week Base Study|Adverse Event|9
7662251|NCT00103857|12077040|FG002|54-Week Base Study|Adverse Event|11
7662252|NCT00103857|12077041|FG003|54-Week Base Study|Adverse Event|6
7662253|NCT00103857|12077042|FG004|54-Week Base Study|Adverse Event|5
7662254|NCT00103857|12077043|FG005|54-Week Base Study|Adverse Event|11
7662255|NCT00103857|12077044|FG006|54-Week Base Study|Adverse Event|3
7662256|NCT00103857|12077038|FG000|54-Week Base Study|Death|0
7662257|NCT00103857|12077039|FG001|54-Week Base Study|Death|0
7662258|NCT00103857|12077040|FG002|54-Week Base Study|Death|0
7662259|NCT00103857|12077041|FG003|54-Week Base Study|Death|0
7662260|NCT00103857|12077042|FG004|54-Week Base Study|Death|1
7662261|NCT00103857|12077043|FG005|54-Week Base Study|Death|1
7662262|NCT00103857|12077044|FG006|54-Week Base Study|Death|0
7662263|NCT00103857|12077038|FG000|54-Week Base Study|Lack of Efficacy|11
7662264|NCT00103857|12077039|FG001|54-Week Base Study|Lack of Efficacy|14
7662265|NCT00103857|12077040|FG002|54-Week Base Study|Lack of Efficacy|8
7662266|NCT00103857|12077041|FG003|54-Week Base Study|Lack of Efficacy|4
7662267|NCT00103857|12077042|FG004|54-Week Base Study|Lack of Efficacy|3
7662268|NCT00103857|12077043|FG005|54-Week Base Study|Lack of Efficacy|14
7662269|NCT00103857|12077044|FG006|54-Week Base Study|Lack of Efficacy|19
7662270|NCT00103857|12077038|FG000|54-Week Base Study|Lost to Follow-up|5
7662271|NCT00103857|12077039|FG001|54-Week Base Study|Lost to Follow-up|4
7662272|NCT00103857|12077040|FG002|54-Week Base Study|Lost to Follow-up|7
7662273|NCT00103857|12077041|FG003|54-Week Base Study|Lost to Follow-up|5
7662274|NCT00103857|12077042|FG004|54-Week Base Study|Lost to Follow-up|10
7662275|NCT00103857|12077043|FG005|54-Week Base Study|Lost to Follow-up|9
7662276|NCT00103857|12077044|FG006|54-Week Base Study|Lost to Follow-up|3
7662277|NCT00103857|12077038|FG000|54-Week Base Study|Physician Decision|1
7662278|NCT00103857|12077039|FG001|54-Week Base Study|Physician Decision|1
7662279|NCT00103857|12077040|FG002|54-Week Base Study|Physician Decision|0
7662280|NCT00103857|12077041|FG003|54-Week Base Study|Physician Decision|0
7662281|NCT00103857|12077042|FG004|54-Week Base Study|Physician Decision|1
7662282|NCT00103857|12077043|FG005|54-Week Base Study|Physician Decision|0
7662283|NCT00103857|12077044|FG006|54-Week Base Study|Physician Decision|0
7662284|NCT00103857|12077038|FG000|54-Week Base Study|Pregnancy|1
7662285|NCT00103857|12077039|FG001|54-Week Base Study|Pregnancy|0
7662286|NCT00103857|12077040|FG002|54-Week Base Study|Pregnancy|0
7662287|NCT00103857|12077041|FG003|54-Week Base Study|Pregnancy|0
7662288|NCT00103857|12077042|FG004|54-Week Base Study|Pregnancy|1
7662289|NCT00103857|12077043|FG005|54-Week Base Study|Pregnancy|0
7662290|NCT00103857|12077044|FG006|54-Week Base Study|Pregnancy|1
7662291|NCT00103857|12077038|FG000|54-Week Base Study|Protocol Violation|6
7662292|NCT00103857|12077039|FG001|54-Week Base Study|Protocol Violation|4
7662293|NCT00103857|12077040|FG002|54-Week Base Study|Protocol Violation|2
7662294|NCT00103857|12077041|FG003|54-Week Base Study|Protocol Violation|4
7662295|NCT00103857|12077042|FG004|54-Week Base Study|Protocol Violation|0
7662296|NCT00103857|12077043|FG005|54-Week Base Study|Protocol Violation|3
7662297|NCT00103857|12077044|FG006|54-Week Base Study|Protocol Violation|3
7662298|NCT00103857|12077038|FG000|54-Week Base Study|Withdrawal by Subject|17
7662299|NCT00103857|12077039|FG001|54-Week Base Study|Withdrawal by Subject|16
7662300|NCT00103857|12077040|FG002|54-Week Base Study|Withdrawal by Subject|16
7662301|NCT00103857|12077041|FG003|54-Week Base Study|Withdrawal by Subject|15
7662302|NCT00103857|12077042|FG004|54-Week Base Study|Withdrawal by Subject|10
7662303|NCT00103857|12077043|FG005|54-Week Base Study|Withdrawal by Subject|15
7662304|NCT00103857|12077044|FG006|54-Week Base Study|Withdrawal by Subject|4
7662305|NCT00103857|12077038|FG000|54-Week Base Study|protocol discontinuation criteria|2
7662306|NCT00103857|12077039|FG001|54-Week Base Study|protocol discontinuation criteria|5
7662307|NCT00103857|12077040|FG002|54-Week Base Study|protocol discontinuation criteria|2
7662308|NCT00103857|12077041|FG003|54-Week Base Study|protocol discontinuation criteria|6
7662309|NCT00103857|12077042|FG004|54-Week Base Study|protocol discontinuation criteria|5
7662310|NCT00103857|12077043|FG005|54-Week Base Study|protocol discontinuation criteria|3
7662311|NCT00103857|12077044|FG006|54-Week Base Study|protocol discontinuation criteria|5
7662312|NCT00103857|12077038|FG000|54-Week Base Study|patient moved|0
7662313|NCT00103857|12077039|FG001|54-Week Base Study|patient moved|1
7662314|NCT00103857|12077040|FG002|54-Week Base Study|patient moved|1
7662315|NCT00103857|12077041|FG003|54-Week Base Study|patient moved|2
7662316|NCT00103857|12077042|FG004|54-Week Base Study|patient moved|3
7662317|NCT00103857|12077043|FG005|54-Week Base Study|patient moved|1
7662318|NCT00103857|12077044|FG006|54-Week Base Study|patient moved|0
7662319|NCT00103857|12077038|FG000|54-Week Base Study|non-compliance with study procedures|1
7662320|NCT00103857|12077039|FG001|54-Week Base Study|non-compliance with study procedures|2
7662321|NCT00103857|12077040|FG002|54-Week Base Study|non-compliance with study procedures|0
7662322|NCT00103857|12077041|FG003|54-Week Base Study|non-compliance with study procedures|0
7662323|NCT00103857|12077042|FG004|54-Week Base Study|non-compliance with study procedures|0
7662324|NCT00103857|12077043|FG005|54-Week Base Study|non-compliance with study procedures|2
7662325|NCT00103857|12077044|FG006|54-Week Base Study|non-compliance with study procedures|0
7662326|NCT00103857|12077038|FG000|54-Week Base Study|patient incarcerated|0
7662327|NCT00103857|12077039|FG001|54-Week Base Study|patient incarcerated|0
7662328|NCT00103857|12077040|FG002|54-Week Base Study|patient incarcerated|0
7662329|NCT00103857|12077041|FG003|54-Week Base Study|patient incarcerated|0
7662330|NCT00103857|12077042|FG004|54-Week Base Study|patient incarcerated|1
7662331|NCT00103857|12077043|FG005|54-Week Base Study|patient incarcerated|1
7662332|NCT00103857|12077044|FG006|54-Week Base Study|patient incarcerated|0
7662333|NCT00103857|12077038|FG000|54-Week Base Study|laboratory reporting error|0
7662334|NCT00103857|12077039|FG001|54-Week Base Study|laboratory reporting error|0
7662335|NCT00103857|12077040|FG002|54-Week Base Study|laboratory reporting error|0
7662336|NCT00103857|12077041|FG003|54-Week Base Study|laboratory reporting error|0
7662337|NCT00103857|12077042|FG004|54-Week Base Study|laboratory reporting error|1
7662338|NCT00103857|12077043|FG005|54-Week Base Study|laboratory reporting error|0
7662339|NCT00103857|12077044|FG006|54-Week Base Study|laboratory reporting error|0
7662340|NCT00103857|12077038|FG000|54-Week Base Study|site error|0
7662341|NCT00103857|12077039|FG001|54-Week Base Study|site error|0
7662342|NCT00103857|12077040|FG002|54-Week Base Study|site error|0
7662343|NCT00103857|12077041|FG003|54-Week Base Study|site error|0
7662344|NCT00103857|12077042|FG004|54-Week Base Study|site error|0
7662345|NCT00103857|12077043|FG005|54-Week Base Study|site error|1
7662346|NCT00103857|12077044|FG006|54-Week Base Study|site error|0
7662347|NCT00103857|12077038|FG000|54-Week Base Study|patient intolerance to rescue therapy|1
7662348|NCT00103857|12077039|FG001|54-Week Base Study|patient intolerance to rescue therapy|0
7662349|NCT00103857|12077040|FG002|54-Week Base Study|patient intolerance to rescue therapy|0
7662350|NCT00103857|12077041|FG003|54-Week Base Study|patient intolerance to rescue therapy|0
7662351|NCT00103857|12077042|FG004|54-Week Base Study|patient intolerance to rescue therapy|0
7662352|NCT00103857|12077043|FG005|54-Week Base Study|patient intolerance to rescue therapy|0
7662353|NCT00103857|12077044|FG006|54-Week Base Study|patient intolerance to rescue therapy|0
7662354|NCT00103857|12077038|FG000|50-Week Extension Study|Adverse Event|2
7662355|NCT00103857|12077039|FG001|50-Week Extension Study|Adverse Event|3
7662356|NCT00103857|12077040|FG002|50-Week Extension Study|Adverse Event|2
7662357|NCT00103857|12077041|FG003|50-Week Extension Study|Adverse Event|0
7662358|NCT00103857|12077042|FG004|50-Week Extension Study|Adverse Event|1
7662359|NCT00103857|12077043|FG005|50-Week Extension Study|Adverse Event|1
7662360|NCT00103857|12077044|FG006|50-Week Extension Study|Adverse Event|0
7662361|NCT00103857|12077038|FG000|50-Week Extension Study|Death|0
7662362|NCT00103857|12077039|FG001|50-Week Extension Study|Death|0
7662363|NCT00103857|12077040|FG002|50-Week Extension Study|Death|0
7662364|NCT00103857|12077041|FG003|50-Week Extension Study|Death|1
7662365|NCT00103857|12077042|FG004|50-Week Extension Study|Death|0
7662366|NCT00103857|12077043|FG005|50-Week Extension Study|Death|1
7662367|NCT00103857|12077044|FG006|50-Week Extension Study|Death|0
7662368|NCT00103857|12077038|FG000|50-Week Extension Study|Lack of Efficacy|26
7662369|NCT00103857|12077039|FG001|50-Week Extension Study|Lack of Efficacy|15
7662370|NCT00103857|12077040|FG002|50-Week Extension Study|Lack of Efficacy|13
7662371|NCT00103857|12077041|FG003|50-Week Extension Study|Lack of Efficacy|16
7662372|NCT00103857|12077042|FG004|50-Week Extension Study|Lack of Efficacy|8
7662373|NCT00103857|12077043|FG005|50-Week Extension Study|Lack of Efficacy|8
7662374|NCT00103857|12077044|FG006|50-Week Extension Study|Lack of Efficacy|0
7662375|NCT00103857|12077038|FG000|50-Week Extension Study|Lost to Follow-up|4
7662376|NCT00103857|12077039|FG001|50-Week Extension Study|Lost to Follow-up|0
7662377|NCT00103857|12077040|FG002|50-Week Extension Study|Lost to Follow-up|1
7662378|NCT00103857|12077041|FG003|50-Week Extension Study|Lost to Follow-up|4
7662379|NCT00103857|12077042|FG004|50-Week Extension Study|Lost to Follow-up|3
7662380|NCT00103857|12077043|FG005|50-Week Extension Study|Lost to Follow-up|3
7662381|NCT00103857|12077044|FG006|50-Week Extension Study|Lost to Follow-up|0
7662382|NCT00103857|12077038|FG000|50-Week Extension Study|Physician Decision|0
7662383|NCT00103857|12077039|FG001|50-Week Extension Study|Physician Decision|1
7662384|NCT00103857|12077040|FG002|50-Week Extension Study|Physician Decision|1
7662385|NCT00103857|12077041|FG003|50-Week Extension Study|Physician Decision|0
7662386|NCT00103857|12077042|FG004|50-Week Extension Study|Physician Decision|0
7662387|NCT00103857|12077043|FG005|50-Week Extension Study|Physician Decision|0
7662388|NCT00103857|12077044|FG006|50-Week Extension Study|Physician Decision|0
7662389|NCT00103857|12077038|FG000|50-Week Extension Study|Pregnancy|0
7662390|NCT00103857|12077039|FG001|50-Week Extension Study|Pregnancy|0
7662391|NCT00103857|12077040|FG002|50-Week Extension Study|Pregnancy|1
7662392|NCT00103857|12077041|FG003|50-Week Extension Study|Pregnancy|0
7662393|NCT00103857|12077042|FG004|50-Week Extension Study|Pregnancy|1
7662394|NCT00103857|12077043|FG005|50-Week Extension Study|Pregnancy|0
7662395|NCT00103857|12077044|FG006|50-Week Extension Study|Pregnancy|0
7662396|NCT00103857|12077038|FG000|50-Week Extension Study|Protocol Violation|1
7662397|NCT00103857|12077039|FG001|50-Week Extension Study|Protocol Violation|1
7662398|NCT00103857|12077040|FG002|50-Week Extension Study|Protocol Violation|1
7662399|NCT00103857|12077041|FG003|50-Week Extension Study|Protocol Violation|2
7662400|NCT00103857|12077042|FG004|50-Week Extension Study|Protocol Violation|0
7662401|NCT00103857|12077043|FG005|50-Week Extension Study|Protocol Violation|1
7662402|NCT00103857|12077044|FG006|50-Week Extension Study|Protocol Violation|0
7662403|NCT00103857|12077038|FG000|50-Week Extension Study|Withdrawal by Subject|2
7662404|NCT00103857|12077039|FG001|50-Week Extension Study|Withdrawal by Subject|5
7662405|NCT00103857|12077040|FG002|50-Week Extension Study|Withdrawal by Subject|2
7662406|NCT00103857|12077041|FG003|50-Week Extension Study|Withdrawal by Subject|8
7662407|NCT00103857|12077042|FG004|50-Week Extension Study|Withdrawal by Subject|3
7662408|NCT00103857|12077043|FG005|50-Week Extension Study|Withdrawal by Subject|3
7662409|NCT00103857|12077044|FG006|50-Week Extension Study|Withdrawal by Subject|0
7662410|NCT00103857|12077038|FG000|50-Week Extension Study|protocol discontinuation criteria|2
7662411|NCT00103857|12077039|FG001|50-Week Extension Study|protocol discontinuation criteria|2
7662412|NCT00103857|12077040|FG002|50-Week Extension Study|protocol discontinuation criteria|3
7662413|NCT00103857|12077041|FG003|50-Week Extension Study|protocol discontinuation criteria|2
7662414|NCT00103857|12077042|FG004|50-Week Extension Study|protocol discontinuation criteria|3
7662415|NCT00103857|12077043|FG005|50-Week Extension Study|protocol discontinuation criteria|3
7662416|NCT00103857|12077044|FG006|50-Week Extension Study|protocol discontinuation criteria|0
7662417|NCT00103857|12077038|FG000|50-Week Extension Study|non-compliance with study procedures|1
7662418|NCT00103857|12077039|FG001|50-Week Extension Study|non-compliance with study procedures|0
7662419|NCT00103857|12077040|FG002|50-Week Extension Study|non-compliance with study procedures|0
7662420|NCT00103857|12077041|FG003|50-Week Extension Study|non-compliance with study procedures|1
7662421|NCT00103857|12077042|FG004|50-Week Extension Study|non-compliance with study procedures|1
7662422|NCT00103857|12077043|FG005|50-Week Extension Study|non-compliance with study procedures|0
7662423|NCT00103857|12077044|FG006|50-Week Extension Study|non-compliance with study procedures|0
7662424|NCT00103857|12077038|FG000|50-Week Extension Study|patient moved|0
7662425|NCT00103857|12077039|FG001|50-Week Extension Study|patient moved|0
7662426|NCT00103857|12077040|FG002|50-Week Extension Study|patient moved|1
7662427|NCT00103857|12077041|FG003|50-Week Extension Study|patient moved|2
7662428|NCT00103857|12077042|FG004|50-Week Extension Study|patient moved|0
7662429|NCT00103857|12077043|FG005|50-Week Extension Study|patient moved|0
7662430|NCT00103857|12077044|FG006|50-Week Extension Study|patient moved|0
7662431|NCT00103857|12077038|FG000|50-Week Extension Study|patient scheduled for elective surgery|0
7662432|NCT00103857|12077039|FG001|50-Week Extension Study|patient scheduled for elective surgery|0
7662433|NCT00103857|12077040|FG002|50-Week Extension Study|patient scheduled for elective surgery|1
7662434|NCT00103857|12077041|FG003|50-Week Extension Study|patient scheduled for elective surgery|0
7662435|NCT00103857|12077042|FG004|50-Week Extension Study|patient scheduled for elective surgery|0
7662436|NCT00103857|12077043|FG005|50-Week Extension Study|patient scheduled for elective surgery|0
7662437|NCT00103857|12077044|FG006|50-Week Extension Study|patient scheduled for elective surgery|0
7662438|NCT00103857|12077038|FG000|50-Week Extension Study|reason unspecified|0
7662439|NCT00103857|12077039|FG001|50-Week Extension Study|reason unspecified|0
7662440|NCT00103857|12077040|FG002|50-Week Extension Study|reason unspecified|0
7662441|NCT00103857|12077041|FG003|50-Week Extension Study|reason unspecified|0
7662442|NCT00103857|12077042|FG004|50-Week Extension Study|reason unspecified|1
7662443|NCT00103857|12077043|FG005|50-Week Extension Study|reason unspecified|0
7662444|NCT00103857|12077044|FG006|50-Week Extension Study|reason unspecified|0
7662445|NCT00104052|12077059|FG000|Overall Study|Adverse Event|1
7662446|NCT00104052|12077059|FG000|Overall Study|Lack of Efficacy|26
7662447|NCT00104052|12077059|FG000|Overall Study|Discontinuation unrelated to treatment|2
7662448|NCT00104104|12077065|FG000|Overall Study|Adverse Event|8
7662449|NCT00104104|12077066|FG001|Overall Study|Adverse Event|8
7662450|NCT00104104|12077065|FG000|Overall Study|Abnormal laboratory value(s)|20
7662451|NCT00104104|12077066|FG001|Overall Study|Abnormal laboratory value(s)|14
7662452|NCT00104104|12077065|FG000|Overall Study|Lack of Efficacy|0
7662453|NCT00104104|12077066|FG001|Overall Study|Lack of Efficacy|3
7662454|NCT00104104|12077065|FG000|Overall Study|Condition no longer requires study drug|7
7662455|NCT00104104|12077066|FG001|Overall Study|Condition no longer requires study drug|4
7662456|NCT00104104|12077065|FG000|Overall Study|Protocol Violation|5
7662457|NCT00104104|12077066|FG001|Overall Study|Protocol Violation|2
7662458|NCT00104104|12077065|FG000|Overall Study|Withdrawal by Subject|11
7662459|NCT00104104|12077066|FG001|Overall Study|Withdrawal by Subject|15
7662460|NCT00104104|12077065|FG000|Overall Study|Lost to Follow-up|3
7662461|NCT00104104|12077066|FG001|Overall Study|Lost to Follow-up|7
7662462|NCT00104104|12077065|FG000|Overall Study|Administrative problems|12
7662463|NCT00104104|12077066|FG001|Overall Study|Administrative problems|13
7662464|NCT00104104|12077065|FG000|Overall Study|Death|9
7662465|NCT00104104|12077066|FG001|Overall Study|Death|6
7662466|NCT00104247|12077083|FG000|Overall Study|Withdrawal by Subject|1
7662467|NCT00104247|12077084|FG001|Overall Study|Withdrawal by Subject|0
7662468|NCT00104247|12077083|FG000|Overall Study|Noncompliant with dosing|0
7662469|NCT00104247|12077084|FG001|Overall Study|Noncompliant with dosing|1
7662470|NCT00104299|12077092|FG000|Overall Study|Adverse Event|3
7662471|NCT00104299|12077093|FG001|Overall Study|Adverse Event|1
7662472|NCT00104299|12077092|FG000|Overall Study|Death|2
7662473|NCT00104299|12077093|FG001|Overall Study|Death|2
7662474|NCT00104299|12077092|FG000|Overall Study|Withdrawal by Subject|2
7662475|NCT00104299|12077093|FG001|Overall Study|Withdrawal by Subject|6
7662476|NCT00104299|12077092|FG000|Overall Study|Physician Decision|1
7662477|NCT00104299|12077093|FG001|Overall Study|Physician Decision|1
7662478|NCT00104299|12077092|FG000|Overall Study|To have renal transplant|1
7662479|NCT00104299|12077093|FG001|Overall Study|To have renal transplant|0
7662480|NCT00104416|12077101|FG000|Double-Blind Phase|Adverse Event|2
7662481|NCT00104416|12077102|FG001|Double-Blind Phase|Adverse Event|1
7662482|NCT00104416|12077103|FG002|Double-Blind Phase|Adverse Event|0
7662483|NCT00104416|12077104|FG003|Double-Blind Phase|Adverse Event|0
7662484|NCT00104416|12077105|FG004|Double-Blind Phase|Adverse Event|0
7662485|NCT00104416|12077101|FG000|Double-Blind Phase|Lost to Follow-up|0
7662486|NCT00104416|12077102|FG001|Double-Blind Phase|Lost to Follow-up|1
7662487|NCT00104416|12077103|FG002|Double-Blind Phase|Lost to Follow-up|0
7662488|NCT00104416|12077104|FG003|Double-Blind Phase|Lost to Follow-up|0
7662489|NCT00104416|12077105|FG004|Double-Blind Phase|Lost to Follow-up|0
7662490|NCT00104416|12077101|FG000|Double-Blind Phase|Protocol Violation|0
7662491|NCT00104416|12077102|FG001|Double-Blind Phase|Protocol Violation|1
7662492|NCT00104416|12077103|FG002|Double-Blind Phase|Protocol Violation|0
7662493|NCT00104416|12077104|FG003|Double-Blind Phase|Protocol Violation|0
7662494|NCT00104416|12077105|FG004|Double-Blind Phase|Protocol Violation|0
7662495|NCT00104416|12077101|FG000|Double-Blind Phase|Withdrawal by Subject|2
7662496|NCT00104416|12077102|FG001|Double-Blind Phase|Withdrawal by Subject|3
7662497|NCT00104416|12077103|FG002|Double-Blind Phase|Withdrawal by Subject|0
7662498|NCT00104416|12077104|FG003|Double-Blind Phase|Withdrawal by Subject|0
7662499|NCT00104416|12077105|FG004|Double-Blind Phase|Withdrawal by Subject|0
7662500|NCT00104416|12077101|FG000|Double-Blind Phase|Pregnancy|1
7662501|NCT00104416|12077102|FG001|Double-Blind Phase|Pregnancy|0
7662502|NCT00104416|12077103|FG002|Double-Blind Phase|Pregnancy|0
7662503|NCT00104416|12077104|FG003|Double-Blind Phase|Pregnancy|0
7662504|NCT00104416|12077105|FG004|Double-Blind Phase|Pregnancy|0
7662505|NCT00104416|12077101|FG000|Double-Blind Phase|Participant Did Not Take Drug|3
7662506|NCT00104416|12077102|FG001|Double-Blind Phase|Participant Did Not Take Drug|4
7662507|NCT00104416|12077103|FG002|Double-Blind Phase|Participant Did Not Take Drug|0
7662508|NCT00104416|12077104|FG003|Double-Blind Phase|Participant Did Not Take Drug|0
7662509|NCT00104416|12077105|FG004|Double-Blind Phase|Participant Did Not Take Drug|0
7662510|NCT00104416|12077101|FG000|Continuation Phase|Adverse Event|0
7662511|NCT00104416|12077102|FG001|Continuation Phase|Adverse Event|0
7662512|NCT00104416|12077103|FG002|Continuation Phase|Adverse Event|2
7662513|NCT00104416|12077104|FG003|Continuation Phase|Adverse Event|0
7662514|NCT00104416|12077105|FG004|Continuation Phase|Adverse Event|2
7662515|NCT00104416|12077101|FG000|Continuation Phase|Lost to Follow-up|0
7662516|NCT00104416|12077102|FG001|Continuation Phase|Lost to Follow-up|0
7662517|NCT00104416|12077103|FG002|Continuation Phase|Lost to Follow-up|1
7662518|NCT00104416|12077104|FG003|Continuation Phase|Lost to Follow-up|0
7662519|NCT00104416|12077105|FG004|Continuation Phase|Lost to Follow-up|1
7662520|NCT00104416|12077101|FG000|Continuation Phase|Withdrawal by Subject|0
7662521|NCT00104416|12077102|FG001|Continuation Phase|Withdrawal by Subject|0
7662522|NCT00104416|12077103|FG002|Continuation Phase|Withdrawal by Subject|2
7662523|NCT00104416|12077104|FG003|Continuation Phase|Withdrawal by Subject|1
7662524|NCT00104416|12077105|FG004|Continuation Phase|Withdrawal by Subject|1
7662525|NCT00104416|12077101|FG000|Continuation Phase|Pregnancy|0
7662526|NCT00104416|12077102|FG001|Continuation Phase|Pregnancy|0
7662527|NCT00104416|12077103|FG002|Continuation Phase|Pregnancy|1
7662528|NCT00104416|12077104|FG003|Continuation Phase|Pregnancy|1
7662529|NCT00104416|12077105|FG004|Continuation Phase|Pregnancy|0
7662530|NCT00104416|12077101|FG000|Continuation Phase|Non-compliance|0
7662531|NCT00104416|12077102|FG001|Continuation Phase|Non-compliance|0
7662532|NCT00104416|12077103|FG002|Continuation Phase|Non-compliance|0
7662533|NCT00104416|12077104|FG003|Continuation Phase|Non-compliance|0
7662534|NCT00104416|12077105|FG004|Continuation Phase|Non-compliance|1
7662535|NCT00104520|12077119|FG000|Overall Study|Unrelated adverse event|34
7662536|NCT00104520|12077120|FG001|Overall Study|Unrelated adverse event|47
7662537|NCT00104520|12077119|FG000|Overall Study|Study drug intolerance|0
7662538|NCT00104520|12077120|FG001|Overall Study|Study drug intolerance|1
7662539|NCT00104520|12077119|FG000|Overall Study|Related adverse event|13
7662540|NCT00104520|12077120|FG001|Overall Study|Related adverse event|15
7662541|NCT00104520|12077119|FG000|Overall Study|Lost to Follow-up|1
7662542|NCT00104520|12077120|FG001|Overall Study|Lost to Follow-up|0
7662543|NCT00104520|12077119|FG000|Overall Study|Noncompliance|0
7662544|NCT00104520|12077120|FG001|Overall Study|Noncompliance|2
7662545|NCT00104520|12077119|FG000|Overall Study|Personal/administrative|1
7662546|NCT00104520|12077120|FG001|Overall Study|Personal/administrative|1
7662547|NCT00104520|12077119|FG000|Overall Study|Other|1
7662548|NCT00104520|12077120|FG001|Overall Study|Other|5
7662549|NCT00104572|12077129|FG000|Overall Study|Withdrawal by Subject|3
7662550|NCT00104572|12077130|FG001|Overall Study|Withdrawal by Subject|3
7662551|NCT00104572|12077131|FG002|Overall Study|Withdrawal by Subject|0
7662552|NCT00104637|12077139|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
7662553|NCT00104637|12077140|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
7662554|NCT00104650|12077152|FG000|Treatment Period (25 Weeks)|Physician Decision|0
7662555|NCT00104650|12077153|FG001|Treatment Period (25 Weeks)|Physician Decision|0
7662556|NCT00104650|12077154|FG002|Treatment Period (25 Weeks)|Physician Decision|1
7662557|NCT00104650|12077152|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2
7662558|NCT00104650|12077153|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1
7662559|NCT00104650|12077154|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1
7662560|NCT00104650|12077152|FG000|Treatment Period (25 Weeks)|Death|7
7662561|NCT00104650|12077153|FG001|Treatment Period (25 Weeks)|Death|5
7662562|NCT00104650|12077154|FG002|Treatment Period (25 Weeks)|Death|6
7662563|NCT00104650|12077152|FG000|Treatment Period (25 Weeks)|Disease progression|2
7662564|NCT00104650|12077153|FG001|Treatment Period (25 Weeks)|Disease progression|3
7662565|NCT00104650|12077154|FG002|Treatment Period (25 Weeks)|Disease progression|2
7662566|NCT00104650|12077152|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0
7662567|NCT00104650|12077153|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1
7662568|NCT00104650|12077154|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0
7662569|NCT00104650|12077152|FG000|Treatment Period (25 Weeks)|Other|1
7662570|NCT00104650|12077153|FG001|Treatment Period (25 Weeks)|Other|0
7662571|NCT00104650|12077154|FG002|Treatment Period (25 Weeks)|Other|0
7662572|NCT00104650|12077152|FG000|Treatment Period (25 Weeks)|Protocol deviation|0
7662573|NCT00104650|12077153|FG001|Treatment Period (25 Weeks)|Protocol deviation|1
7662574|NCT00104650|12077154|FG002|Treatment Period (25 Weeks)|Protocol deviation|0
7662575|NCT00104650|12077152|FG000|Follow-up Period|Physician Decision|1
7662576|NCT00104650|12077153|FG001|Follow-up Period|Physician Decision|1
7662577|NCT00104650|12077154|FG002|Follow-up Period|Physician Decision|0
7662578|NCT00104650|12077152|FG000|Follow-up Period|Adverse Event|1
7662579|NCT00104650|12077153|FG001|Follow-up Period|Adverse Event|0
7662580|NCT00104650|12077154|FG002|Follow-up Period|Adverse Event|1
7662581|NCT00104650|12077152|FG000|Follow-up Period|Withdrawal by Subject|0
7662582|NCT00104650|12077153|FG001|Follow-up Period|Withdrawal by Subject|3
7662583|NCT00104650|12077154|FG002|Follow-up Period|Withdrawal by Subject|3
7662584|NCT00104650|12077152|FG000|Follow-up Period|Death|6
7662585|NCT00104650|12077153|FG001|Follow-up Period|Death|6
7662586|NCT00104650|12077154|FG002|Follow-up Period|Death|4
7662587|NCT00104650|12077152|FG000|Follow-up Period|Disease progression|3
7662588|NCT00104650|12077153|FG001|Follow-up Period|Disease progression|1
7662589|NCT00104650|12077154|FG002|Follow-up Period|Disease progression|0
7662590|NCT00104650|12077152|FG000|Follow-up Period|Lost to Follow-up|0
7662591|NCT00104650|12077153|FG001|Follow-up Period|Lost to Follow-up|1
7662592|NCT00104650|12077154|FG002|Follow-up Period|Lost to Follow-up|2
7662593|NCT00104650|12077152|FG000|Follow-up Period|Other|0
7662594|NCT00104650|12077153|FG001|Follow-up Period|Other|1
7662595|NCT00104650|12077154|FG002|Follow-up Period|Other|0
7662596|NCT00104871|12077168|FG000|Overall Study|Not evaluable|1
7662597|NCT00104884|12077172|FG000|Overall Study|Disease progression|4
7662598|NCT00105066|12077216|FG000|Overall Study|Adverse Event|2
7662599|NCT00105066|12077217|FG001|Overall Study|Adverse Event|5
7662600|NCT00105079|12077225|FG000|Overall Study|Adverse Event|5
7662601|NCT00105079|12077226|FG001|Overall Study|Adverse Event|12
7662602|NCT00105079|12077225|FG000|Overall Study|Death|3
7662603|NCT00105079|12077226|FG001|Overall Study|Death|1
7662604|NCT00105079|12077225|FG000|Overall Study|Lost to Follow-up|12
7662605|NCT00105079|12077226|FG001|Overall Study|Lost to Follow-up|12
7662606|NCT00105079|12077225|FG000|Overall Study|Lack of Efficacy|9
7662607|NCT00105079|12077226|FG001|Overall Study|Lack of Efficacy|3
7662608|NCT00105079|12077225|FG000|Overall Study|Refused treatment|6
7662609|NCT00105079|12077226|FG001|Overall Study|Refused treatment|4
7662610|NCT00105079|12077225|FG000|Overall Study|Violation of selection criteria at entry|0
7662611|NCT00105079|12077226|FG001|Overall Study|Violation of selection criteria at entry|2
7662612|NCT00105079|12077225|FG000|Overall Study|Protocol Violation|1
7662613|NCT00105079|12077226|FG001|Overall Study|Protocol Violation|0
7662614|NCT00105079|12077225|FG000|Overall Study|Other|3
7662615|NCT00105079|12077226|FG001|Overall Study|Other|1
7662616|NCT00105157|12077236|FG000|Double-Blind (DB)|Never Treated|1
7662617|NCT00105157|12077237|FG001|Double-Blind (DB)|Never Treated|0
7662618|NCT00105157|12077238|FG002|Double-Blind (DB)|Never Treated|0
7662619|NCT00105157|12077239|FG003|Double-Blind (DB)|Never Treated|0
7662620|NCT00105157|12077236|FG000|Double-Blind (DB)|Adverse Event|2
7662621|NCT00105157|12077237|FG001|Double-Blind (DB)|Adverse Event|0
7662622|NCT00105157|12077238|FG002|Double-Blind (DB)|Adverse Event|1
7662623|NCT00105157|12077239|FG003|Double-Blind (DB)|Adverse Event|1
7662624|NCT00105157|12077236|FG000|Double-Blind (DB)|Lack of Efficacy|11
7662625|NCT00105157|12077237|FG001|Double-Blind (DB)|Lack of Efficacy|14
7662626|NCT00105157|12077238|FG002|Double-Blind (DB)|Lack of Efficacy|11
7662627|NCT00105157|12077239|FG003|Double-Blind (DB)|Lack of Efficacy|38
7662628|NCT00105157|12077236|FG000|Open-Label Continuation of DB|Adverse Event|3
7662629|NCT00105157|12077237|FG001|Open-Label Continuation of DB|Adverse Event|1
7662630|NCT00105157|12077238|FG002|Open-Label Continuation of DB|Adverse Event|0
7662631|NCT00105157|12077239|FG003|Open-Label Continuation of DB|Adverse Event|0
7662632|NCT00105157|12077236|FG000|Open-Label Continuation of DB|Lack of Efficacy|1
7662633|NCT00105157|12077237|FG001|Open-Label Continuation of DB|Lack of Efficacy|4
7662634|NCT00105157|12077238|FG002|Open-Label Continuation of DB|Lack of Efficacy|3
7662635|NCT00105157|12077239|FG003|Open-Label Continuation of DB|Lack of Efficacy|1
7662636|NCT00105157|12077236|FG000|Open-Label Continuation of DB|Lost to Follow-up|1
7662637|NCT00105157|12077237|FG001|Open-Label Continuation of DB|Lost to Follow-up|1
7662638|NCT00105157|12077238|FG002|Open-Label Continuation of DB|Lost to Follow-up|1
7662639|NCT00105157|12077239|FG003|Open-Label Continuation of DB|Lost to Follow-up|0
7662640|NCT00105157|12077236|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0
7662641|NCT00105157|12077237|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1
7662642|NCT00105157|12077238|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3
7662643|NCT00105157|12077239|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0
7662644|NCT00105157|12077236|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1
7662645|NCT00105157|12077237|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0
7662646|NCT00105157|12077238|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0
7662647|NCT00105157|12077239|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0
7662648|NCT00105157|12077236|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1
7662649|NCT00105157|12077237|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3
7662650|NCT00105157|12077238|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2
7662651|NCT00105157|12077239|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0
7662652|NCT00105157|12077236|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
7662653|NCT00105157|12077237|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
7662654|NCT00105157|12077238|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
7662655|NCT00105157|12077239|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
7662656|NCT00105157|12077236|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
7662657|NCT00105157|12077237|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
7662658|NCT00105157|12077238|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
7662659|NCT00105157|12077239|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
7662660|NCT00105157|12077236|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
7662661|NCT00105157|12077237|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
7662662|NCT00105157|12077238|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
7662663|NCT00105157|12077239|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
7662664|NCT00105157|12077236|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
7662665|NCT00105157|12077237|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
7662666|NCT00105157|12077238|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
7662667|NCT00105157|12077239|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
7662668|NCT00105157|12077236|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
7662669|NCT00105157|12077237|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
7662670|NCT00105157|12077238|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
7662671|NCT00105157|12077239|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
7662672|NCT00105183|12077250|FG000|Overall Study|Death|19
7662673|NCT00105183|12077251|FG001|Overall Study|Death|13
7662674|NCT00105183|12077252|FG002|Overall Study|Death|15
7662675|NCT00105183|12077250|FG000|Overall Study|Withdrawal by Subject|1
7662676|NCT00105183|12077251|FG001|Overall Study|Withdrawal by Subject|1
7662677|NCT00105183|12077252|FG002|Overall Study|Withdrawal by Subject|4
7662678|NCT00105183|12077250|FG000|Overall Study|Physician Decision|1
7662679|NCT00105183|12077251|FG001|Overall Study|Physician Decision|2
7662680|NCT00105183|12077252|FG002|Overall Study|Physician Decision|3
7662681|NCT00105183|12077250|FG000|Overall Study|Lost to Follow-up|0
7662682|NCT00105183|12077251|FG001|Overall Study|Lost to Follow-up|1
7662683|NCT00105183|12077252|FG002|Overall Study|Lost to Follow-up|1
7662684|NCT00105183|12077250|FG000|Overall Study|Other reason|1
7662685|NCT00105183|12077251|FG001|Overall Study|Other reason|2
7662686|NCT00105183|12077252|FG002|Overall Study|Other reason|0
7662687|NCT00105196|12077262|FG000|Overall Study|Lack of Efficacy|2
7662688|NCT00105196|12077263|FG001|Overall Study|Lack of Efficacy|3
7662689|NCT00105196|12077262|FG000|Overall Study|Adverse Event|11
7662690|NCT00105196|12077263|FG001|Overall Study|Adverse Event|3
7662691|NCT00105196|12077262|FG000|Overall Study|Withdrawal by Subject|6
7662692|NCT00105196|12077263|FG001|Overall Study|Withdrawal by Subject|6
7662693|NCT00105196|12077262|FG000|Overall Study|Lost to Follow-up|3
7662694|NCT00105196|12077263|FG001|Overall Study|Lost to Follow-up|2
7662695|NCT00105196|12077262|FG000|Overall Study|Poor/noncompliance|3
7662696|NCT00105196|12077263|FG001|Overall Study|Poor/noncompliance|4
7662697|NCT00105196|12077262|FG000|Overall Study|Protocol Violation|5
7662698|NCT00105196|12077263|FG001|Overall Study|Protocol Violation|2
7662699|NCT00105196|12077262|FG000|Overall Study|pending surgery|0
7662700|NCT00105196|12077263|FG001|Overall Study|pending surgery|1
7662701|NCT00105196|12077262|FG000|Overall Study|marijuana use|0
7662702|NCT00105196|12077263|FG001|Overall Study|marijuana use|1
7662703|NCT00105196|12077262|FG000|Overall Study|Subject became unblinded|0
7662704|NCT00105196|12077263|FG001|Overall Study|Subject became unblinded|1
7662705|NCT00105235|12077269|FG000|Overall Study|Death|4
7662706|NCT00105235|12077269|FG000|Overall Study|Physician Decision|1
7662707|NCT00105235|12077269|FG000|Overall Study|Withdrawal by Subject|2
7662708|NCT00105443|12077279|FG000|Double-Blind Treatment|Adverse Event|1
7662709|NCT00105443|12077280|FG001|Double-Blind Treatment|Adverse Event|0
7662710|NCT00105443|12077281|FG002|Double-Blind Treatment|Adverse Event|0
7662711|NCT00105443|12077282|FG003|Double-Blind Treatment|Adverse Event|0
7662712|NCT00105443|12077279|FG000|Double-Blind Treatment|Lost to Follow-up|0
7662713|NCT00105443|12077280|FG001|Double-Blind Treatment|Lost to Follow-up|0
7662714|NCT00105443|12077281|FG002|Double-Blind Treatment|Lost to Follow-up|1
7662715|NCT00105443|12077282|FG003|Double-Blind Treatment|Lost to Follow-up|0
7662716|NCT00105443|12077279|FG000|Double-Blind Treatment|Withdrawal by Subject|8
7662717|NCT00105443|12077280|FG001|Double-Blind Treatment|Withdrawal by Subject|0
7662718|NCT00105443|12077281|FG002|Double-Blind Treatment|Withdrawal by Subject|7
7662719|NCT00105443|12077282|FG003|Double-Blind Treatment|Withdrawal by Subject|0
7662720|NCT00105443|12077279|FG000|Double-Blind Treatment|Physician Decision|1
7662721|NCT00105443|12077280|FG001|Double-Blind Treatment|Physician Decision|0
7662722|NCT00105443|12077281|FG002|Double-Blind Treatment|Physician Decision|2
7662723|NCT00105443|12077282|FG003|Double-Blind Treatment|Physician Decision|0
7662724|NCT00105443|12077279|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4
7662725|NCT00105443|12077280|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0
7662726|NCT00105443|12077281|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1
7662727|NCT00105443|12077282|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0
7662728|NCT00105443|12077279|FG000|Follow-up and/or Open Label Nexavar|Death|180
7662729|NCT00105443|12077280|FG001|Follow-up and/or Open Label Nexavar|Death|7
7662730|NCT00105443|12077281|FG002|Follow-up and/or Open Label Nexavar|Death|219
7662731|NCT00105443|12077282|FG003|Follow-up and/or Open Label Nexavar|Death|4
7662732|NCT00105443|12077279|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
7662733|NCT00105443|12077280|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
7662734|NCT00105443|12077281|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
7662735|NCT00105443|12077282|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
7662736|NCT00105443|12077279|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
7662737|NCT00105443|12077280|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
7662738|NCT00105443|12077281|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
7662739|NCT00105443|12077282|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
7662740|NCT00105443|12077279|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0
7662741|NCT00105443|12077280|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14
7662742|NCT00105443|12077281|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0
7662743|NCT00105443|12077282|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16
7662744|NCT00105443|12077279|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1
7662745|NCT00105443|12077280|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0
7662746|NCT00105443|12077281|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1
7662747|NCT00105443|12077282|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0
7662748|NCT00105443|12077279|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0
7662749|NCT00105443|12077280|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2
7662750|NCT00105443|12077281|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0
7662751|NCT00105443|12077282|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0
7662752|NCT00105443|12077279|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
7662753|NCT00105443|12077280|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
7662754|NCT00105443|12077281|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
7662755|NCT00105443|12077282|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
7662756|NCT00105443|12077279|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
7662757|NCT00105443|12077280|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
7662758|NCT00105443|12077281|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
7662759|NCT00105443|12077282|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
7662760|NCT00105443|12077279|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
7662761|NCT00105443|12077280|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
7662762|NCT00105443|12077281|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
7662763|NCT00105443|12077282|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
7662764|NCT00105443|12077279|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
7662765|NCT00105443|12077280|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
7662766|NCT00105443|12077281|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
7662767|NCT00105443|12077282|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
7662768|NCT00105443|12077279|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
7662769|NCT00105443|12077280|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
7662770|NCT00105443|12077281|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
7662771|NCT00105443|12077282|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
7662772|NCT00105443|12077279|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
7662773|NCT00105443|12077280|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
7662774|NCT00105443|12077281|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
7662775|NCT00105443|12077282|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
7662776|NCT00105443|12077279|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
7662777|NCT00105443|12077280|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
7662778|NCT00105443|12077281|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
7662779|NCT00105443|12077282|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
7662780|NCT00105443|12077279|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
7662781|NCT00105443|12077280|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
7662782|NCT00105443|12077281|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
7662783|NCT00105443|12077282|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
7662784|NCT00105469|12077293|FG000|Overall Study|Adverse Event|9
7662785|NCT00105469|12077294|FG001|Overall Study|Adverse Event|8
7662786|NCT00105469|12077293|FG000|Overall Study|Protocol Violation|4
7662787|NCT00105469|12077294|FG001|Overall Study|Protocol Violation|0
7662788|NCT00105469|12077293|FG000|Overall Study|Withdrawal by Subject|2
7662789|NCT00105469|12077294|FG001|Overall Study|Withdrawal by Subject|3
7662790|NCT00105469|12077293|FG000|Overall Study|Lost to Follow-up|1
7662791|NCT00105469|12077294|FG001|Overall Study|Lost to Follow-up|0
7662792|NCT00105469|12077293|FG000|Overall Study|Lack of Efficacy|2
7662793|NCT00105469|12077294|FG001|Overall Study|Lack of Efficacy|0
7662794|NCT00105469|12077293|FG000|Overall Study|Other Reason|4
7662795|NCT00105469|12077294|FG001|Overall Study|Other Reason|0
7662796|NCT00105482|12077302|FG000|Overall Study|Adverse Event|1
7662797|NCT00105482|12077303|FG001|Overall Study|Adverse Event|1
7662798|NCT00105482|12077302|FG000|Overall Study|Lost to Follow-up|26
7662799|NCT00105482|12077303|FG001|Overall Study|Lost to Follow-up|17
7662800|NCT00105482|12077302|FG000|Overall Study|Withdrawal by Subject|0
7662801|NCT00105482|12077303|FG001|Overall Study|Withdrawal by Subject|1
7662802|NCT00105482|12077302|FG000|Overall Study|Lost Interest|29
7662803|NCT00105482|12077303|FG001|Overall Study|Lost Interest|32
7662804|NCT00105482|12077302|FG000|Overall Study|Scheduling Conflict|2
7662805|NCT00105482|12077303|FG001|Overall Study|Scheduling Conflict|3
7662806|NCT00105482|12077302|FG000|Overall Study|Withdrawn by PI|1
7662807|NCT00105482|12077303|FG001|Overall Study|Withdrawn by PI|1
7662808|NCT00105508|12077311|FG000|Overall Study|Prephase Dropout|1
7662809|NCT00105508|12077312|FG001|Overall Study|Prephase Dropout|0
7662810|NCT00105508|12077311|FG000|Overall Study|Adverse Event|16
7662811|NCT00105508|12077312|FG001|Overall Study|Adverse Event|19
7662812|NCT00105508|12077311|FG000|Overall Study|Insufficient Efficacy|1
7662813|NCT00105508|12077312|FG001|Overall Study|Insufficient Efficacy|0
7662814|NCT00105508|12077311|FG000|Overall Study|Withdrawal by Subject|10
7662815|NCT00105508|12077312|FG001|Overall Study|Withdrawal by Subject|6
7662816|NCT00105508|12077311|FG000|Overall Study|Lost to Follow-up|3
7662817|NCT00105508|12077312|FG001|Overall Study|Lost to Follow-up|0
7662818|NCT00105508|12077311|FG000|Overall Study|Protocol Violation|1
7662819|NCT00105508|12077312|FG001|Overall Study|Protocol Violation|2
7662820|NCT00105508|12077311|FG000|Overall Study|Other|8
7662821|NCT00105508|12077312|FG001|Overall Study|Other|9
7662822|NCT00105521|12077322|FG000|Overall Study|Other|1
7662823|NCT00105521|12077323|FG001|Overall Study|Other|1
7662824|NCT00105521|12077324|FG002|Overall Study|Other|2
7662825|NCT00105521|12077325|FG003|Overall Study|Other|0
7662826|NCT00105521|12077322|FG000|Overall Study|Adverse Event|10
7662827|NCT00105521|12077323|FG001|Overall Study|Adverse Event|4
7662828|NCT00105521|12077324|FG002|Overall Study|Adverse Event|10
7662829|NCT00105521|12077325|FG003|Overall Study|Adverse Event|8
7662830|NCT00105521|12077322|FG000|Overall Study|Withdrawal by Subject|1
7662831|NCT00105521|12077323|FG001|Overall Study|Withdrawal by Subject|0
7662832|NCT00105521|12077324|FG002|Overall Study|Withdrawal by Subject|1
7662833|NCT00105521|12077325|FG003|Overall Study|Withdrawal by Subject|4
7662834|NCT00105521|12077322|FG000|Overall Study|Lack of Efficacy|0
7662835|NCT00105521|12077323|FG001|Overall Study|Lack of Efficacy|0
7662836|NCT00105521|12077324|FG002|Overall Study|Lack of Efficacy|0
7662837|NCT00105521|12077325|FG003|Overall Study|Lack of Efficacy|1
7662838|NCT00105521|12077322|FG000|Overall Study|Protocol Violation|3
7662839|NCT00105521|12077323|FG001|Overall Study|Protocol Violation|5
7662840|NCT00105521|12077324|FG002|Overall Study|Protocol Violation|4
7662841|NCT00105521|12077325|FG003|Overall Study|Protocol Violation|4
7662842|NCT00105521|12077322|FG000|Overall Study|Lost to Follow-up|0
7662843|NCT00105521|12077323|FG001|Overall Study|Lost to Follow-up|1
7662844|NCT00105521|12077324|FG002|Overall Study|Lost to Follow-up|0
7662845|NCT00105521|12077325|FG003|Overall Study|Lost to Follow-up|0
7662846|NCT00105534|12077337|FG000|Overall Study|Adverse Event|2
7662847|NCT00105534|12077338|FG001|Overall Study|Adverse Event|5
7662848|NCT00105534|12077337|FG000|Overall Study|Protocol Violation|1
7662849|NCT00105534|12077338|FG001|Overall Study|Protocol Violation|4
7662850|NCT00105534|12077337|FG000|Overall Study|Withdrawal by Subject|6
7662851|NCT00105534|12077338|FG001|Overall Study|Withdrawal by Subject|6
7662852|NCT00105534|12077337|FG000|Overall Study|Lost to Follow-up|5
7662853|NCT00105534|12077338|FG001|Overall Study|Lost to Follow-up|1
7662854|NCT00105534|12077337|FG000|Overall Study|Lack of Efficacy|7
7662855|NCT00105534|12077338|FG001|Overall Study|Lack of Efficacy|15
7662856|NCT00105534|12077337|FG000|Overall Study|Treatment unmasked|1
7662857|NCT00105534|12077338|FG001|Overall Study|Treatment unmasked|0
7662858|NCT00105534|12077337|FG000|Overall Study|Other Reason|0
7662859|NCT00105534|12077338|FG001|Overall Study|Other Reason|2
7662860|NCT00105586|12077346|FG000|Overall Study|Adverse Event|4
7662861|NCT00105586|12077347|FG001|Overall Study|Adverse Event|3
7662862|NCT00105586|12077346|FG000|Overall Study|Physician Decision|13
7662863|NCT00105586|12077347|FG001|Overall Study|Physician Decision|13
7662864|NCT00105989|12077355|FG000|Acute - Open Label: Week 0-10|Adverse Event|33
7662865|NCT00105989|12077356|FG001|Acute - Open Label: Week 0-10|Adverse Event|0
7662866|NCT00105989|12077355|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
7662867|NCT00105989|12077356|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
7662868|NCT00105989|12077355|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17
7662869|NCT00105989|12077356|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0
7662870|NCT00105989|12077355|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
7662871|NCT00105989|12077356|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
7662872|NCT00105989|12077355|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8
7662873|NCT00105989|12077356|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0
7662874|NCT00105989|12077355|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4
7662875|NCT00105989|12077356|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0
7662876|NCT00105989|12077355|FG000|Acute - Open Label: Week 0-10|Physician Decision|0
7662877|NCT00105989|12077356|FG001|Acute - Open Label: Week 0-10|Physician Decision|0
7662878|NCT00105989|12077355|FG000|Acute - Open Label: Week 0-10|Death|1
7662879|NCT00105989|12077356|FG001|Acute - Open Label: Week 0-10|Death|0
7662880|NCT00105989|12077355|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
7662881|NCT00105989|12077356|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
7662882|NCT00105989|12077355|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
7662883|NCT00105989|12077356|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
7662884|NCT00105989|12077355|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25
7662885|NCT00105989|12077356|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0
7662886|NCT00105989|12077355|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
7662887|NCT00105989|12077356|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
7662888|NCT00105989|12077355|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
7662889|NCT00105989|12077356|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
7662890|NCT00105989|12077355|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
7662891|NCT00105989|12077356|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
7662892|NCT00105989|12077355|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5
7662893|NCT00105989|12077356|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0
7662894|NCT00105989|12077355|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
7662895|NCT00105989|12077356|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
7662896|NCT00105989|12077355|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3
7662897|NCT00105989|12077356|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0
7662898|NCT00105989|12077355|FG000|Continuation - Open Label:Week 10-34|Death|0
7662899|NCT00105989|12077356|FG001|Continuation - Open Label:Week 10-34|Death|0
7662900|NCT00105989|12077355|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
7662901|NCT00105989|12077356|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
7662902|NCT00105989|12077355|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
7662903|NCT00105989|12077356|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
7662904|NCT00105989|12077355|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
7662905|NCT00105989|12077356|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
7662906|NCT00105989|12077355|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
7662907|NCT00105989|12077356|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
7662908|NCT00105989|12077355|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
7662909|NCT00105989|12077356|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
7662910|NCT00105989|12077355|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
7662911|NCT00105989|12077356|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
7662912|NCT00105989|12077355|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
7662913|NCT00105989|12077356|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
7662914|NCT00105989|12077355|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
7662915|NCT00105989|12077356|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
7662916|NCT00105989|12077355|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
7662917|NCT00105989|12077356|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
7662918|NCT00105989|12077355|FG000|Maintenance - Double-Blind:Week 34-86|Death|0
7662919|NCT00105989|12077356|FG001|Maintenance - Double-Blind:Week 34-86|Death|0
7662920|NCT00105989|12077355|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
7662921|NCT00105989|12077356|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
7662922|NCT00105989|12077355|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
7662923|NCT00105989|12077356|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
7662924|NCT00106002|12077372|FG000|Overall Study|Did not take any study drug|1
7662925|NCT00106002|12077372|FG000|Overall Study|Ineligible after Registration|1
7662926|NCT00106028|12077378|FG000|Overall Study|Adverse Event|3
7662927|NCT00106028|12077379|FG001|Overall Study|Adverse Event|2
7662928|NCT00106028|12077378|FG000|Overall Study|Protocol Violation|1
7662929|NCT00106028|12077379|FG001|Overall Study|Protocol Violation|1
7662930|NCT00106028|12077378|FG000|Overall Study|Withdrawal by Subject|2
7662931|NCT00106028|12077379|FG001|Overall Study|Withdrawal by Subject|8
7662932|NCT00106028|12077378|FG000|Overall Study|Lost to Follow-up|0
7662933|NCT00106028|12077379|FG001|Overall Study|Lost to Follow-up|1
7662934|NCT00106080|12077389|FG000|Overall Study|Withdrew/Loss to follow-up|43
7662935|NCT00106080|12077390|FG001|Overall Study|Withdrew/Loss to follow-up|27
7662936|NCT00106184|12077414|FG000|Overall Study|Withdrawal by Subject|3
7662937|NCT00106184|12077415|FG001|Overall Study|Withdrawal by Subject|2
7662938|NCT00106249|12077425|FG000|Overall Study|Lost to Follow-up|3
7662939|NCT00106249|12077426|FG001|Overall Study|Lost to Follow-up|2
7662940|NCT00106353|12077434|FG000|Part 1|Disease progression|3
7662941|NCT00106353|12077435|FG001|Part 1|Disease progression|4
7662942|NCT00106353|12077436|FG002|Part 1|Disease progression|1
7662943|NCT00106353|12077437|FG003|Part 1|Disease progression|3
7662944|NCT00106353|12077438|FG004|Part 1|Disease progression|0
7662945|NCT00106353|12077439|FG005|Part 1|Disease progression|0
7662946|NCT00106353|12077440|FG006|Part 1|Disease progression|0
7662947|NCT00106353|12077434|FG000|Part 1|Withdrawal by Subject|0
7662948|NCT00106353|12077435|FG001|Part 1|Withdrawal by Subject|0
7662949|NCT00106353|12077436|FG002|Part 1|Withdrawal by Subject|1
7662950|NCT00106353|12077437|FG003|Part 1|Withdrawal by Subject|2
7662951|NCT00106353|12077438|FG004|Part 1|Withdrawal by Subject|0
7662952|NCT00106353|12077439|FG005|Part 1|Withdrawal by Subject|0
7662953|NCT00106353|12077440|FG006|Part 1|Withdrawal by Subject|0
7662954|NCT00106353|12077434|FG000|Part 1|Symptomatic deterioration|0
7662955|NCT00106353|12077435|FG001|Part 1|Symptomatic deterioration|0
7662956|NCT00106353|12077436|FG002|Part 1|Symptomatic deterioration|1
7662957|NCT00106353|12077437|FG003|Part 1|Symptomatic deterioration|0
7662958|NCT00106353|12077438|FG004|Part 1|Symptomatic deterioration|0
7662959|NCT00106353|12077439|FG005|Part 1|Symptomatic deterioration|0
7662960|NCT00106353|12077440|FG006|Part 1|Symptomatic deterioration|0
7662961|NCT00106353|12077434|FG000|Part 1|Entered follow-up phase|1
7662962|NCT00106353|12077435|FG001|Part 1|Entered follow-up phase|1
7662963|NCT00106353|12077436|FG002|Part 1|Entered follow-up phase|0
7662964|NCT00106353|12077437|FG003|Part 1|Entered follow-up phase|1
7662965|NCT00106353|12077438|FG004|Part 1|Entered follow-up phase|0
7662966|NCT00106353|12077439|FG005|Part 1|Entered follow-up phase|0
7662967|NCT00106353|12077440|FG006|Part 1|Entered follow-up phase|0
7662968|NCT00106353|12077434|FG000|Part 1|Adverse Event|0
7662969|NCT00106353|12077435|FG001|Part 1|Adverse Event|0
7662970|NCT00106353|12077436|FG002|Part 1|Adverse Event|0
7662971|NCT00106353|12077437|FG003|Part 1|Adverse Event|1
7662972|NCT00106353|12077438|FG004|Part 1|Adverse Event|0
7662973|NCT00106353|12077439|FG005|Part 1|Adverse Event|0
7662974|NCT00106353|12077440|FG006|Part 1|Adverse Event|0
7662975|NCT00106353|12077434|FG000|Part 2|Disease progression|0
7662976|NCT00106353|12077435|FG001|Part 2|Disease progression|0
7662977|NCT00106353|12077436|FG002|Part 2|Disease progression|0
7662978|NCT00106353|12077437|FG003|Part 2|Disease progression|0
7662979|NCT00106353|12077438|FG004|Part 2|Disease progression|8
7662980|NCT00106353|12077439|FG005|Part 2|Disease progression|14
7662981|NCT00106353|12077440|FG006|Part 2|Disease progression|13
7662982|NCT00106353|12077434|FG000|Part 2|Death|0
7662983|NCT00106353|12077435|FG001|Part 2|Death|0
7662984|NCT00106353|12077436|FG002|Part 2|Death|0
7662985|NCT00106353|12077437|FG003|Part 2|Death|0
7662986|NCT00106353|12077438|FG004|Part 2|Death|3
7662987|NCT00106353|12077439|FG005|Part 2|Death|0
7662988|NCT00106353|12077440|FG006|Part 2|Death|1
7662989|NCT00106353|12077434|FG000|Part 2|Symptomatic deterioration|0
7662990|NCT00106353|12077435|FG001|Part 2|Symptomatic deterioration|0
7662991|NCT00106353|12077436|FG002|Part 2|Symptomatic deterioration|0
7662992|NCT00106353|12077437|FG003|Part 2|Symptomatic deterioration|0
7662993|NCT00106353|12077438|FG004|Part 2|Symptomatic deterioration|3
7662994|NCT00106353|12077439|FG005|Part 2|Symptomatic deterioration|0
7662995|NCT00106353|12077440|FG006|Part 2|Symptomatic deterioration|0
7662996|NCT00106353|12077434|FG000|Part 2|Adverse Event|0
7662997|NCT00106353|12077435|FG001|Part 2|Adverse Event|0
7662998|NCT00106353|12077436|FG002|Part 2|Adverse Event|0
7662999|NCT00106353|12077437|FG003|Part 2|Adverse Event|0
7663000|NCT00106353|12077438|FG004|Part 2|Adverse Event|0
7663001|NCT00106353|12077439|FG005|Part 2|Adverse Event|2
7663002|NCT00106353|12077440|FG006|Part 2|Adverse Event|1
7663003|NCT00106353|12077434|FG000|Part 2|Other|0
7663004|NCT00106353|12077435|FG001|Part 2|Other|0
7663005|NCT00106353|12077436|FG002|Part 2|Other|0
7663006|NCT00106353|12077437|FG003|Part 2|Other|0
7663007|NCT00106353|12077438|FG004|Part 2|Other|1
7663008|NCT00106353|12077439|FG005|Part 2|Other|1
7663009|NCT00106353|12077440|FG006|Part 2|Other|1
7663010|NCT00106353|12077434|FG000|Part 2|Withdrawal by Subject|0
7663011|NCT00106353|12077435|FG001|Part 2|Withdrawal by Subject|0
7663012|NCT00106353|12077436|FG002|Part 2|Withdrawal by Subject|0
7663013|NCT00106353|12077437|FG003|Part 2|Withdrawal by Subject|0
7663014|NCT00106353|12077438|FG004|Part 2|Withdrawal by Subject|1
7663015|NCT00106353|12077439|FG005|Part 2|Withdrawal by Subject|0
7663016|NCT00106353|12077440|FG006|Part 2|Withdrawal by Subject|0
7663017|NCT00106353|12077434|FG000|Part 2|Physician Decision|0
7663018|NCT00106353|12077435|FG001|Part 2|Physician Decision|0
7663019|NCT00106353|12077436|FG002|Part 2|Physician Decision|0
7663020|NCT00106353|12077437|FG003|Part 2|Physician Decision|0
7663021|NCT00106353|12077438|FG004|Part 2|Physician Decision|0
7663022|NCT00106353|12077439|FG005|Part 2|Physician Decision|1
7663023|NCT00106353|12077440|FG006|Part 2|Physician Decision|0
7663024|NCT00106639|12077495|FG000|Overall Study|Adverse Event|3
7663025|NCT00106639|12077496|FG001|Overall Study|Adverse Event|4
7663026|NCT00106639|12077497|FG002|Overall Study|Adverse Event|1
7663027|NCT00106639|12077495|FG000|Overall Study|Protocol Violation|0
7663028|NCT00106639|12077496|FG001|Overall Study|Protocol Violation|1
7663029|NCT00106639|12077497|FG002|Overall Study|Protocol Violation|0
7663030|NCT00106639|12077495|FG000|Overall Study|Withdrawal by Subject|0
7663031|NCT00106639|12077496|FG001|Overall Study|Withdrawal by Subject|1
7663032|NCT00106639|12077497|FG002|Overall Study|Withdrawal by Subject|0
7663033|NCT00106639|12077495|FG000|Overall Study|Participant defaulted|0
7663034|NCT00106639|12077496|FG001|Overall Study|Participant defaulted|1
7663035|NCT00106639|12077497|FG002|Overall Study|Participant defaulted|1
7663036|NCT00106704|12077508|FG000|Overall Study|Adverse Event|10
7663037|NCT00106704|12077509|FG001|Overall Study|Adverse Event|7
7663038|NCT00106704|12077508|FG000|Overall Study|Death|2
7663039|NCT00106704|12077509|FG001|Overall Study|Death|1
7663040|NCT00106704|12077508|FG000|Overall Study|Lack of Efficacy|67
7663041|NCT00106704|12077509|FG001|Overall Study|Lack of Efficacy|69
7663042|NCT00106704|12077508|FG000|Overall Study|Lost to Follow-up|7
7663043|NCT00106704|12077509|FG001|Overall Study|Lost to Follow-up|3
7663044|NCT00106704|12077508|FG000|Overall Study|Pregnancy|1
7663045|NCT00106704|12077509|FG001|Overall Study|Pregnancy|0
7663046|NCT00106704|12077508|FG000|Overall Study|Protocol Violation|4
7663047|NCT00106704|12077509|FG001|Overall Study|Protocol Violation|7
7663048|NCT00106704|12077508|FG000|Overall Study|Withdrawal by Subject|14
7663049|NCT00106704|12077509|FG001|Overall Study|Withdrawal by Subject|21
7663050|NCT00106704|12077508|FG000|Overall Study|Patient moved|1
7663051|NCT00106704|12077509|FG001|Overall Study|Patient moved|0
7663052|NCT00106704|12077508|FG000|Overall Study|Site terminated|0
7663053|NCT00106704|12077509|FG001|Overall Study|Site terminated|1
7663054|NCT00106704|12077508|FG000|Overall Study|Planned major surgery|1
7663055|NCT00106704|12077509|FG001|Overall Study|Planned major surgery|0
7663056|NCT00106704|12077508|FG000|Overall Study|Patient Received Glycemic Medication|22
7663057|NCT00106704|12077509|FG001|Overall Study|Patient Received Glycemic Medication|41
7663058|NCT00106704|12077508|FG000|Overall Study|Unable to re-enter US|1
7663059|NCT00106704|12077509|FG001|Overall Study|Unable to re-enter US|0
7663060|NCT00106704|12077508|FG000|Overall Study|Laboratory test|1
7663061|NCT00106704|12077509|FG001|Overall Study|Laboratory test|1
7663062|NCT00106964|12077527|FG000|Overall Study|Lost to Follow-up|8
7663063|NCT00106964|12077528|FG001|Overall Study|Lost to Follow-up|6
7663064|NCT00106964|12077529|FG002|Overall Study|Lost to Follow-up|2
7663065|NCT00106964|12077527|FG000|Overall Study|Pregnancy|2
7663066|NCT00106964|12077528|FG001|Overall Study|Pregnancy|3
7663067|NCT00106964|12077529|FG002|Overall Study|Pregnancy|2
7663068|NCT00106964|12077527|FG000|Overall Study|Death|1
7663069|NCT00106964|12077528|FG001|Overall Study|Death|1
7663070|NCT00106964|12077529|FG002|Overall Study|Death|0
7663071|NCT00106964|12077527|FG000|Overall Study|Incarceration|0
7663072|NCT00106964|12077528|FG001|Overall Study|Incarceration|1
7663073|NCT00106964|12077529|FG002|Overall Study|Incarceration|0
7663074|NCT00106964|12077527|FG000|Overall Study|Site Funding Terminated|0
7663075|NCT00106964|12077528|FG001|Overall Study|Site Funding Terminated|1
7663076|NCT00106964|12077529|FG002|Overall Study|Site Funding Terminated|1
7663077|NCT00106964|12077527|FG000|Overall Study|Failure to adhere|2
7663078|NCT00106964|12077528|FG001|Overall Study|Failure to adhere|0
7663079|NCT00106964|12077529|FG002|Overall Study|Failure to adhere|0
7663080|NCT00106964|12077527|FG000|Overall Study|Did not meet eligibility criteria|0
7663081|NCT00106964|12077528|FG001|Overall Study|Did not meet eligibility criteria|2
7663082|NCT00106964|12077529|FG002|Overall Study|Did not meet eligibility criteria|2
7663083|NCT00106964|12077527|FG000|Overall Study|Required disallowed medication|0
7663084|NCT00106964|12077528|FG001|Overall Study|Required disallowed medication|1
7663085|NCT00106964|12077529|FG002|Overall Study|Required disallowed medication|0
7663086|NCT00107042|12077548|FG000|Overall Study|Lost to Follow-up|9
7663087|NCT00107042|12077549|FG001|Overall Study|Lost to Follow-up|7
7663088|NCT00107042|12077548|FG000|Overall Study|Withdrawal by Subject|6
7663089|NCT00107042|12077549|FG001|Overall Study|Withdrawal by Subject|1
7663090|NCT00107042|12077548|FG000|Overall Study|Moved out of area|5
7663091|NCT00107042|12077549|FG001|Overall Study|Moved out of area|3
7663092|NCT00107042|12077548|FG000|Overall Study|Pregnancy|1
7663093|NCT00107042|12077549|FG001|Overall Study|Pregnancy|1
7663094|NCT00107042|12077548|FG000|Overall Study|Inadvertent enrollment|0
7663095|NCT00107042|12077549|FG001|Overall Study|Inadvertent enrollment|1
7663096|NCT00107042|12077548|FG000|Overall Study|vaccinated outside window|1
7663097|NCT00107042|12077549|FG001|Overall Study|vaccinated outside window|1
7663098|NCT00107042|12077548|FG000|Overall Study|Disallowed medications|0
7663099|NCT00107042|12077549|FG001|Overall Study|Disallowed medications|2
7663100|NCT00107120|12077599|FG000|Overall Study|Adverse Event|4
7663101|NCT00107120|12077600|FG001|Overall Study|Adverse Event|1
7663102|NCT00107120|12077599|FG000|Overall Study|Lack of Efficacy|5
7663103|NCT00107120|12077600|FG001|Overall Study|Lack of Efficacy|5
7663104|NCT00107120|12077599|FG000|Overall Study|Protocol Violation|3
7663105|NCT00107120|12077600|FG001|Overall Study|Protocol Violation|0
7663106|NCT00107120|12077599|FG000|Overall Study|Withdrawal by Subject|8
7663107|NCT00107120|12077600|FG001|Overall Study|Withdrawal by Subject|9
7663108|NCT00107120|12077599|FG000|Overall Study|Lost to Follow-up|8
7663109|NCT00107120|12077600|FG001|Overall Study|Lost to Follow-up|6
7663110|NCT00107120|12077599|FG000|Overall Study|Pregnancy|0
7663111|NCT00107120|12077600|FG001|Overall Study|Pregnancy|1
7663112|NCT00107120|12077599|FG000|Overall Study|moving away from site|1
7663113|NCT00107120|12077600|FG001|Overall Study|moving away from site|1
7663114|NCT00107120|12077599|FG000|Overall Study|death of parent|0
7663115|NCT00107120|12077600|FG001|Overall Study|death of parent|1
7663116|NCT00107172|12077608|FG000|Overall Study|Withdrawal by Subject|1
7663117|NCT00107172|12077609|FG001|Overall Study|Withdrawal by Subject|0
7663118|NCT00107172|12077608|FG000|Overall Study|Death|0
7663119|NCT00107172|12077609|FG001|Overall Study|Death|2
7663120|NCT00107172|12077608|FG000|Overall Study|Other Reason|4
7663121|NCT00107172|12077609|FG001|Overall Study|Other Reason|3
7663122|NCT00107276|12077615|FG000|Overall Study|Progression|46
7663123|NCT00107276|12077615|FG000|Overall Study|Adverse Event|6
7663124|NCT00107276|12077615|FG000|Overall Study|M.D. decision|2
7663125|NCT00107276|12077615|FG000|Overall Study|Patient refusal|1
7663126|NCT00107276|12077615|FG000|Overall Study|Death|1
7663127|NCT00107276|12077615|FG000|Overall Study|Ineligible|16
7663128|NCT00107380|12077620|FG000|Overall Study|Adverse Event|7
7663129|NCT00107380|12077620|FG000|Overall Study|Refusal Unrelated to Adverse Event|7
7663130|NCT00107380|12077620|FG000|Overall Study|Progression/relapse|4
7663131|NCT00107380|12077620|FG000|Overall Study|Death|3
7663132|NCT00107380|12077620|FG000|Overall Study|Other - not protocol specified|7
7663133|NCT00107380|12077620|FG000|Overall Study|Ineligible|2
7663134|NCT00107653|12077640|FG000|Overall Study|Adverse Event|24
7663135|NCT00107653|12077641|FG001|Overall Study|Adverse Event|43
7663136|NCT00107653|12077640|FG000|Overall Study|Insufficient Therapeutic Response|25
7663137|NCT00107653|12077641|FG001|Overall Study|Insufficient Therapeutic Response|11
7663138|NCT00107653|12077640|FG000|Overall Study|Violation of Selection Criteria at Entry|1
7663139|NCT00107653|12077641|FG001|Overall Study|Violation of Selection Criteria at Entry|1
7663140|NCT00107653|12077640|FG000|Overall Study|Protocol Violation|1
7663141|NCT00107653|12077641|FG001|Overall Study|Protocol Violation|0
7663142|NCT00107653|12077640|FG000|Overall Study|Withdrawal by Subject|12
7663143|NCT00107653|12077641|FG001|Overall Study|Withdrawal by Subject|13
7663144|NCT00107653|12077640|FG000|Overall Study|Lost to Follow-up|13
7663145|NCT00107653|12077641|FG001|Overall Study|Lost to Follow-up|5
7663146|NCT00107653|12077640|FG000|Overall Study|Administrative Reasons|3
7663147|NCT00107653|12077641|FG001|Overall Study|Administrative Reasons|3
7663148|NCT00107783|12077662|FG000|Overall Study|Adverse Event|0
7663149|NCT00107783|12077663|FG001|Overall Study|Adverse Event|2
7663150|NCT00107783|12077662|FG000|Overall Study|Death|0
7663151|NCT00107783|12077663|FG001|Overall Study|Death|1
7663152|NCT00107783|12077662|FG000|Overall Study|Withdrawal by Subject|2
7663153|NCT00107783|12077663|FG001|Overall Study|Withdrawal by Subject|0
7663154|NCT00107783|12077662|FG000|Overall Study|Second hip replacement|1
7663155|NCT00107783|12077663|FG001|Overall Study|Second hip replacement|1
7663156|NCT00107900|12077675|FG000|Overall Study|Adverse Event|3
7663157|NCT00107900|12077676|FG001|Overall Study|Adverse Event|2
7663158|NCT00107900|12077677|FG002|Overall Study|Adverse Event|10
7663159|NCT00107900|12077678|FG003|Overall Study|Adverse Event|3
7663160|NCT00107900|12077679|FG004|Overall Study|Adverse Event|5
7663161|NCT00107900|12077680|FG005|Overall Study|Adverse Event|3
7663162|NCT00107900|12077675|FG000|Overall Study|Death|0
7663163|NCT00107900|12077676|FG001|Overall Study|Death|0
7663164|NCT00107900|12077677|FG002|Overall Study|Death|0
7663165|NCT00107900|12077678|FG003|Overall Study|Death|0
7663166|NCT00107900|12077679|FG004|Overall Study|Death|1
7663167|NCT00107900|12077680|FG005|Overall Study|Death|0
7663168|NCT00107900|12077675|FG000|Overall Study|Lost to Follow-up|4
7663169|NCT00107900|12077676|FG001|Overall Study|Lost to Follow-up|1
7663170|NCT00107900|12077677|FG002|Overall Study|Lost to Follow-up|3
7663171|NCT00107900|12077678|FG003|Overall Study|Lost to Follow-up|2
7663172|NCT00107900|12077679|FG004|Overall Study|Lost to Follow-up|5
7663173|NCT00107900|12077680|FG005|Overall Study|Lost to Follow-up|5
7663174|NCT00107900|12077675|FG000|Overall Study|Protocol Violation|1
7663175|NCT00107900|12077676|FG001|Overall Study|Protocol Violation|0
7663176|NCT00107900|12077677|FG002|Overall Study|Protocol Violation|5
7663177|NCT00107900|12077678|FG003|Overall Study|Protocol Violation|5
7663178|NCT00107900|12077679|FG004|Overall Study|Protocol Violation|7
7663179|NCT00107900|12077680|FG005|Overall Study|Protocol Violation|0
7663180|NCT00107900|12077675|FG000|Overall Study|Withdrawal by Subject|1
7663181|NCT00107900|12077676|FG001|Overall Study|Withdrawal by Subject|0
7663182|NCT00107900|12077677|FG002|Overall Study|Withdrawal by Subject|5
7663183|NCT00107900|12077678|FG003|Overall Study|Withdrawal by Subject|0
7663184|NCT00107900|12077679|FG004|Overall Study|Withdrawal by Subject|1
7663185|NCT00107900|12077680|FG005|Overall Study|Withdrawal by Subject|1
7663186|NCT00107900|12077675|FG000|Overall Study|Administrative Reasons|1
7663187|NCT00107900|12077676|FG001|Overall Study|Administrative Reasons|0
7663188|NCT00107900|12077677|FG002|Overall Study|Administrative Reasons|2
7663189|NCT00107900|12077678|FG003|Overall Study|Administrative Reasons|2
7663190|NCT00107900|12077679|FG004|Overall Study|Administrative Reasons|2
7663191|NCT00107900|12077680|FG005|Overall Study|Administrative Reasons|0
7663192|NCT00107952|12077696|FG000|Overall Study|Death|75
7663193|NCT00107952|12077697|FG001|Overall Study|Death|61
7663194|NCT00107952|12077696|FG000|Overall Study|Lost to Follow-up|0
7663195|NCT00107952|12077697|FG001|Overall Study|Lost to Follow-up|3
7663196|NCT00107952|12077696|FG000|Overall Study|Withdrawal by Subject|9
7663197|NCT00107952|12077697|FG001|Overall Study|Withdrawal by Subject|6
7663198|NCT00107952|12077696|FG000|Overall Study|Other|2
7663199|NCT00107952|12077697|FG001|Overall Study|Other|5
7663200|NCT00107952|12077696|FG000|Overall Study|Never received study treatment|9
7663201|NCT00107952|12077697|FG001|Overall Study|Never received study treatment|6
7663202|NCT00107978|12077705|FG000|Overall Study|Adverse Event|1
7663203|NCT00107978|12077706|FG001|Overall Study|Adverse Event|5
7663204|NCT00107978|12077705|FG000|Overall Study|Death|3
7663205|NCT00107978|12077706|FG001|Overall Study|Death|3
7663206|NCT00107978|12077705|FG000|Overall Study|Lost to Follow-up|20
7663207|NCT00107978|12077706|FG001|Overall Study|Lost to Follow-up|28
7663208|NCT00107978|12077705|FG000|Overall Study|Withdrawal by Subject|4
7663209|NCT00107978|12077706|FG001|Overall Study|Withdrawal by Subject|9
7663210|NCT00107978|12077705|FG000|Overall Study|Protocol Violation|0
7663211|NCT00107978|12077706|FG001|Overall Study|Protocol Violation|1
7663212|NCT00107978|12077705|FG000|Overall Study|Other|5
7663213|NCT00107978|12077706|FG001|Overall Study|Other|4
7663214|NCT00107991|12077712|FG000|Eligibility Assessment|Disease not severe enough|7
7663215|NCT00107991|12077712|FG000|Eligibility Assessment|Unwilling to participate|7
7663216|NCT00107991|12077712|FG000|Eligibility Assessment|Positive purified protein derivative|4
7663217|NCT00107991|12077712|FG000|Eligibility Assessment|Abnormal labs|2
7663218|NCT00107991|12077712|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1
7663219|NCT00107991|12077712|FG000|Eligibility Assessment|chronic uncontrolled asthma|1
7663220|NCT00107991|12077712|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
7663221|NCT00107991|12077712|FG000|12 Week Treatment Period|Lack of Efficacy|2
7663222|NCT00107991|12077712|FG000|12 Week Treatment Period|Adverse Event|1
7663223|NCT00107991|12077712|FG000|12 Week Treatment Period|Protocol Violation|1
7663224|NCT00107991|12077712|FG000|12 Week Treatment Period|Incarcerated|1
7663225|NCT00107991|12077712|FG000|18-Week Post Treatment Assessment|Adverse Event|2
7663226|NCT00108069|12077718|FG000|Overall Study|Never rec'd study drug|0
7663227|NCT00108069|12077719|FG001|Overall Study|Never rec'd study drug|1
7663228|NCT00108069|12077718|FG000|Overall Study|Adverse Event|1
7663229|NCT00108069|12077719|FG001|Overall Study|Adverse Event|1
7663230|NCT00108069|12077718|FG000|Overall Study|Withdrawal by Subject|1
7663231|NCT00108069|12077719|FG001|Overall Study|Withdrawal by Subject|0
7663232|NCT00108069|12077718|FG000|Overall Study|Death|1
7663233|NCT00108069|12077719|FG001|Overall Study|Death|0
7663234|NCT00108069|12077718|FG000|Overall Study|Progessive disease|27
7663235|NCT00108069|12077719|FG001|Overall Study|Progessive disease|11
7663236|NCT00108082|12077734|FG000|Overall Study|Adverse Event|14
7663237|NCT00108082|12077735|FG001|Overall Study|Adverse Event|12
7663238|NCT00108082|12077736|FG002|Overall Study|Adverse Event|17
7663239|NCT00108082|12077734|FG000|Overall Study|Lost to Follow-up|6
7663240|NCT00108082|12077735|FG001|Overall Study|Lost to Follow-up|3
7663241|NCT00108082|12077736|FG002|Overall Study|Lost to Follow-up|7
7663242|NCT00108082|12077734|FG000|Overall Study|Consent Withdrawn|3
7663243|NCT00108082|12077735|FG001|Overall Study|Consent Withdrawn|3
7663244|NCT00108082|12077736|FG002|Overall Study|Consent Withdrawn|5
7663245|NCT00108082|12077734|FG000|Overall Study|Protocol Violation|1
7663246|NCT00108082|12077735|FG001|Overall Study|Protocol Violation|2
7663247|NCT00108082|12077736|FG002|Overall Study|Protocol Violation|0
7663248|NCT00108082|12077734|FG000|Overall Study|Lack of Efficacy|3
7663249|NCT00108082|12077735|FG001|Overall Study|Lack of Efficacy|1
7663250|NCT00108082|12077736|FG002|Overall Study|Lack of Efficacy|2
7663251|NCT00108082|12077734|FG000|Overall Study|Amendment 4: > Month 12|5
7663252|NCT00108082|12077735|FG001|Overall Study|Amendment 4: > Month 12|7
7663253|NCT00108082|12077736|FG002|Overall Study|Amendment 4: > Month 12|5
7663254|NCT00108082|12077734|FG000|Overall Study|Woman of Child-bearing Potential|2
7663255|NCT00108082|12077735|FG001|Overall Study|Woman of Child-bearing Potential|0
7663256|NCT00108082|12077736|FG002|Overall Study|Woman of Child-bearing Potential|2
7663257|NCT00108082|12077734|FG000|Overall Study|Incorrectly Randomized|0
7663258|NCT00108082|12077735|FG001|Overall Study|Incorrectly Randomized|0
7663259|NCT00108082|12077736|FG002|Overall Study|Incorrectly Randomized|2
7663260|NCT00108082|12077734|FG000|Overall Study|Non-compliance|1
7663261|NCT00108082|12077735|FG001|Overall Study|Non-compliance|0
7663262|NCT00108082|12077736|FG002|Overall Study|Non-compliance|2
7663263|NCT00108082|12077734|FG000|Overall Study|Stopped Study Medication|0
7663264|NCT00108082|12077735|FG001|Overall Study|Stopped Study Medication|0
7663265|NCT00108082|12077736|FG002|Overall Study|Stopped Study Medication|1
7663266|NCT00108082|12077734|FG000|Overall Study|Site Closed Study|0
7663267|NCT00108082|12077735|FG001|Overall Study|Site Closed Study|2
7663268|NCT00108082|12077736|FG002|Overall Study|Site Closed Study|0
7663269|NCT00108082|12077734|FG000|Overall Study|Protocol Amendment|0
7663270|NCT00108082|12077735|FG001|Overall Study|Protocol Amendment|1
7663271|NCT00108082|12077736|FG002|Overall Study|Protocol Amendment|0
7663272|NCT00108082|12077734|FG000|Overall Study|Study Medication Not Tapered|0
7663273|NCT00108082|12077735|FG001|Overall Study|Study Medication Not Tapered|1
7663274|NCT00108082|12077736|FG002|Overall Study|Study Medication Not Tapered|0
7663275|NCT00108082|12077734|FG000|Overall Study|Subject Left Site Location|1
7663276|NCT00108082|12077735|FG001|Overall Study|Subject Left Site Location|0
7663277|NCT00108082|12077736|FG002|Overall Study|Subject Left Site Location|0
7663278|NCT00108082|12077734|FG000|Overall Study|Investigator Not at Site|1
7663279|NCT00108082|12077735|FG001|Overall Study|Investigator Not at Site|0
7663280|NCT00108082|12077736|FG002|Overall Study|Investigator Not at Site|0
7663281|NCT00108082|12077734|FG000|Overall Study|Blood Pressure Not Controlled|1
7663282|NCT00108082|12077735|FG001|Overall Study|Blood Pressure Not Controlled|0
7663283|NCT00108082|12077736|FG002|Overall Study|Blood Pressure Not Controlled|0
7663284|NCT00108160|12077746|FG000|Overall Study|Lost to Follow-up|25
7663285|NCT00108160|12077747|FG001|Overall Study|Lost to Follow-up|12
7663286|NCT00108160|12077746|FG000|Overall Study|Death|1
7663287|NCT00108160|12077747|FG001|Overall Study|Death|2
7663288|NCT00108160|12077746|FG000|Overall Study|Withdrawal by Subject|4
7663289|NCT00108160|12077747|FG001|Overall Study|Withdrawal by Subject|2
7663290|NCT00108160|12077746|FG000|Overall Study|Protocol Violation|9
7663291|NCT00108160|12077747|FG001|Overall Study|Protocol Violation|5
7663292|NCT00108355|12077787|FG000|Overall Study|Peritonitis at index paracentesis|1
7663293|NCT00108355|12077788|FG001|Overall Study|Peritonitis at index paracentesis|1
7663294|NCT00108355|12077787|FG000|Overall Study|Loculated ascites, limiting paracentesis|1
7663295|NCT00108355|12077788|FG001|Overall Study|Loculated ascites, limiting paracentesis|1
7663296|NCT00108485|12077796|FG000|Overall Study|Withdrawal by Subject|3
7663297|NCT00108485|12077797|FG001|Overall Study|Withdrawal by Subject|0
7663298|NCT00108485|12077796|FG000|Overall Study|Lost to Follow-up|0
7663299|NCT00108485|12077797|FG001|Overall Study|Lost to Follow-up|2
7663300|NCT00108628|12077823|FG000|Overall Study|Withdrawal by Subject|17
7663301|NCT00108628|12077824|FG001|Overall Study|Withdrawal by Subject|9
7663302|NCT00108628|12077823|FG000|Overall Study|Lack of Efficacy|2
7663303|NCT00108628|12077824|FG001|Overall Study|Lack of Efficacy|1
7663304|NCT00108628|12077823|FG000|Overall Study|Death|1
7663305|NCT00108628|12077824|FG001|Overall Study|Death|0
7663306|NCT00108732|12077830|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
7663307|NCT00108732|12077830|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
7663308|NCT00108732|12077830|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
7663309|NCT00108732|12077830|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
7663310|NCT00108732|12077830|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
7663311|NCT00108732|12077830|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
7663312|NCT00108732|12077830|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1
7663313|NCT00108745|12077837|FG000|Overall Study|Withdrawal by Subject|19
7663314|NCT00108745|12077838|FG001|Overall Study|Withdrawal by Subject|12
7663315|NCT00108745|12077839|FG002|Overall Study|Withdrawal by Subject|12
7663316|NCT00108745|12077837|FG000|Overall Study|Never Treated|8
7663317|NCT00108745|12077838|FG001|Overall Study|Never Treated|10
7663318|NCT00108745|12077839|FG002|Overall Study|Never Treated|12
7663319|NCT00108745|12077837|FG000|Overall Study|Ineligible|7
7663320|NCT00108745|12077838|FG001|Overall Study|Ineligible|13
7663321|NCT00108745|12077839|FG002|Overall Study|Ineligible|13
7663322|NCT00108862|12077849|FG000|Overall Study|Death|31
7663323|NCT00108862|12077850|FG001|Overall Study|Death|37
7663324|NCT00108862|12077849|FG000|Overall Study|Withdrawal by Subject|10
7663325|NCT00108862|12077850|FG001|Overall Study|Withdrawal by Subject|6
7663326|NCT00108862|12077849|FG000|Overall Study|Lost to Follow-up|27
7663327|NCT00108862|12077850|FG001|Overall Study|Lost to Follow-up|19
7663328|NCT00108953|12077858|FG000|Follow-up|Death|18
7663329|NCT00108953|12077859|FG001|Follow-up|Death|26
7663330|NCT00108953|12077858|FG000|Follow-up|Lost to Follow-up|1
7663331|NCT00108953|12077859|FG001|Follow-up|Lost to Follow-up|1
7663332|NCT00108953|12077858|FG000|Follow-up|Study terminated by sponsor|10
7663333|NCT00108953|12077859|FG001|Follow-up|Study terminated by sponsor|6
7663334|NCT00109031|12077881|FG000|Overall Study|Adverse Event|0
7663335|NCT00109031|12077882|FG001|Overall Study|Adverse Event|0
7663336|NCT00109031|12077883|FG002|Overall Study|Adverse Event|1
7663337|NCT00109031|12077884|FG003|Overall Study|Adverse Event|0
7663338|NCT00109031|12077881|FG000|Overall Study|Withdrawal by Subject|0
7663339|NCT00109031|12077882|FG001|Overall Study|Withdrawal by Subject|1
7663340|NCT00109031|12077883|FG002|Overall Study|Withdrawal by Subject|0
7663341|NCT00109031|12077884|FG003|Overall Study|Withdrawal by Subject|0
7663342|NCT00109031|12077881|FG000|Overall Study|Physician Decision|0
7663343|NCT00109031|12077882|FG001|Overall Study|Physician Decision|1
7663344|NCT00109031|12077883|FG002|Overall Study|Physician Decision|0
7663345|NCT00109031|12077884|FG003|Overall Study|Physician Decision|0
7663346|NCT00109031|12077881|FG000|Overall Study|Protocol Violation|0
7663347|NCT00109031|12077882|FG001|Overall Study|Protocol Violation|0
7663348|NCT00109031|12077883|FG002|Overall Study|Protocol Violation|1
7663349|NCT00109031|12077884|FG003|Overall Study|Protocol Violation|0
7663350|NCT00109343|12077897|FG000|Overall Study|Adverse Event|1
7663351|NCT00109343|12077898|FG001|Overall Study|Adverse Event|0
7663352|NCT00109343|12077899|FG002|Overall Study|Adverse Event|2
7663353|NCT00109343|12077897|FG000|Overall Study|Lack of Efficacy|1
7663354|NCT00109343|12077898|FG001|Overall Study|Lack of Efficacy|0
7663355|NCT00109343|12077899|FG002|Overall Study|Lack of Efficacy|0
7663356|NCT00109343|12077897|FG000|Overall Study|Lost to Follow-up|35
7663357|NCT00109343|12077898|FG001|Overall Study|Lost to Follow-up|20
7663358|NCT00109343|12077899|FG002|Overall Study|Lost to Follow-up|14
7663359|NCT00109343|12077897|FG000|Overall Study|Protocol Violation|1
7663360|NCT00109343|12077898|FG001|Overall Study|Protocol Violation|2
7663361|NCT00109343|12077899|FG002|Overall Study|Protocol Violation|2
7663362|NCT00109343|12077897|FG000|Overall Study|Withdrawal by Subject|15
7663363|NCT00109343|12077898|FG001|Overall Study|Withdrawal by Subject|11
7663364|NCT00109343|12077899|FG002|Overall Study|Withdrawal by Subject|10
7663365|NCT00109343|12077897|FG000|Overall Study|Subject Moved|6
7663366|NCT00109343|12077898|FG001|Overall Study|Subject Moved|2
7663367|NCT00109343|12077899|FG002|Overall Study|Subject Moved|1
7663368|NCT00109343|12077897|FG000|Overall Study|Other|5
7663369|NCT00109343|12077898|FG001|Overall Study|Other|2
7663370|NCT00109343|12077899|FG002|Overall Study|Other|1
7663371|NCT00109577|12077921|FG000|Overall Study|Withdrawal by Subject|3
7663372|NCT00109577|12077922|FG001|Overall Study|Withdrawal by Subject|3
7663373|NCT00109590|12077931|FG000|Overall Study|Lost to Follow-up|1
7663374|NCT00109590|12077932|FG001|Overall Study|Lost to Follow-up|0
7663375|NCT00109590|12077933|FG002|Overall Study|Lost to Follow-up|1
7663376|NCT00109590|12077931|FG000|Overall Study|Never Started Treatment|1
7663377|NCT00109590|12077932|FG001|Overall Study|Never Started Treatment|2
7663378|NCT00109590|12077933|FG002|Overall Study|Never Started Treatment|3
7663379|NCT00109707|12077958|FG000|Overall Study|Discontinued in core study without entering the extension study|215
7663380|NCT00109707|12077959|FG001|Overall Study|Discontinued in core study without entering the extension study|122
7663381|NCT00109707|12077960|FG002|Overall Study|Discontinued in core study without entering the extension study|34
7663382|NCT00109707|12077958|FG000|Overall Study|Abnormal laboratory values|1
7663383|NCT00109707|12077959|FG001|Overall Study|Abnormal laboratory values|0
7663384|NCT00109707|12077960|FG002|Overall Study|Abnormal laboratory values|0
7663385|NCT00109707|12077958|FG000|Overall Study|Administrative problems|2
7663386|NCT00109707|12077959|FG001|Overall Study|Administrative problems|0
7663387|NCT00109707|12077960|FG002|Overall Study|Administrative problems|1
7663388|NCT00109707|12077958|FG000|Overall Study|Adverse Event|10
7663389|NCT00109707|12077959|FG001|Overall Study|Adverse Event|2
7663390|NCT00109707|12077960|FG002|Overall Study|Adverse Event|3
7663391|NCT00109707|12077958|FG000|Overall Study|Death|4
7663392|NCT00109707|12077959|FG001|Overall Study|Death|0
7663393|NCT00109707|12077960|FG002|Overall Study|Death|0
7663394|NCT00109707|12077958|FG000|Overall Study|Disease progression|12
7663395|NCT00109707|12077959|FG001|Overall Study|Disease progression|4
7663396|NCT00109707|12077960|FG002|Overall Study|Disease progression|3
7663397|NCT00109707|12077958|FG000|Overall Study|Lost to Follow-up|3
7663398|NCT00109707|12077959|FG001|Overall Study|Lost to Follow-up|0
7663399|NCT00109707|12077960|FG002|Overall Study|Lost to Follow-up|0
7663400|NCT00109707|12077958|FG000|Overall Study|Protocol Violation|1
7663401|NCT00109707|12077959|FG001|Overall Study|Protocol Violation|0
7663402|NCT00109707|12077960|FG002|Overall Study|Protocol Violation|0
7663403|NCT00109707|12077958|FG000|Overall Study|Patient withdrew consent|6
7663404|NCT00109707|12077959|FG001|Overall Study|Patient withdrew consent|1
7663405|NCT00109707|12077960|FG002|Overall Study|Patient withdrew consent|0
7663406|NCT00109733|12077974|FG000|Overall Study|Protocol Violation|0
7663407|NCT00109733|12077975|FG001|Overall Study|Protocol Violation|1
7663408|NCT00109733|12077974|FG000|Overall Study|Stopped taking study drug|1
7663409|NCT00109733|12077975|FG001|Overall Study|Stopped taking study drug|1
7663410|NCT00109733|12077974|FG000|Overall Study|Non-compliant|0
7663411|NCT00109733|12077975|FG001|Overall Study|Non-compliant|1
7663412|NCT00109733|12077974|FG000|Overall Study|Could not commit time for study|1
7663413|NCT00109733|12077975|FG001|Overall Study|Could not commit time for study|1
7663414|NCT00109772|12077983|FG000|Double-blind Treatment|Adverse Event|14
7663415|NCT00109772|12077984|FG001|Double-blind Treatment|Adverse Event|5
7663416|NCT00109772|12077983|FG000|Double-blind Treatment|Lack of Efficacy|1
7663417|NCT00109772|12077984|FG001|Double-blind Treatment|Lack of Efficacy|0
7663418|NCT00109772|12077983|FG000|Double-blind Treatment|Withdrawal by Subject|2
7663419|NCT00109772|12077984|FG001|Double-blind Treatment|Withdrawal by Subject|1
7663420|NCT00109772|12077983|FG000|Double-blind Treatment|Lost to Follow-up|2
7663421|NCT00109772|12077984|FG001|Double-blind Treatment|Lost to Follow-up|3
7663422|NCT00109772|12077983|FG000|Double-blind Treatment|Protocol Violation|0
7663423|NCT00109772|12077984|FG001|Double-blind Treatment|Protocol Violation|1
7663424|NCT00109772|12077983|FG000|Double-blind Treatment|Other|0
7663425|NCT00109772|12077984|FG001|Double-blind Treatment|Other|4
7663426|NCT00109772|12077983|FG000|Double-blind Treatment|Withdrew prior to treatment|3
7663427|NCT00109772|12077984|FG001|Double-blind Treatment|Withdrew prior to treatment|1
7663428|NCT00109772|12077983|FG000|Open-label Extension|Adverse Event|10
7663429|NCT00109772|12077984|FG001|Open-label Extension|Adverse Event|19
7663430|NCT00109772|12077983|FG000|Open-label Extension|Lack of Efficacy|19
7663431|NCT00109772|12077984|FG001|Open-label Extension|Lack of Efficacy|11
7663432|NCT00109772|12077983|FG000|Open-label Extension|Withdrawal by Subject|9
7663433|NCT00109772|12077984|FG001|Open-label Extension|Withdrawal by Subject|6
7663434|NCT00109772|12077983|FG000|Open-label Extension|Lost to Follow-up|1
7663435|NCT00109772|12077984|FG001|Open-label Extension|Lost to Follow-up|0
7663436|NCT00109772|12077983|FG000|Open-label Extension|Death|0
7663437|NCT00109772|12077984|FG001|Open-label Extension|Death|1
7663438|NCT00109772|12077983|FG000|Open-label Extension|Protocol Violation|2
7663439|NCT00109772|12077984|FG001|Open-label Extension|Protocol Violation|2
7663440|NCT00109772|12077983|FG000|Open-label Extension|Other|4
7663441|NCT00109772|12077984|FG001|Open-label Extension|Other|10
7663442|NCT00109837|12077990|FG000|Overall Study|Adverse Event|2
7663443|NCT00109837|12077990|FG000|Overall Study|Refusal unrelated to adverse effects|1
7663444|NCT00109837|12077990|FG000|Overall Study|Death|1
7663445|NCT00109837|12077990|FG000|Overall Study|BCR/ABL+ or Ph+|17
7663446|NCT00109837|12077990|FG000|Overall Study|Not treated|1
7663447|NCT00109837|12077990|FG000|Overall Study|Ineligible|1
7663448|NCT00109850|12077998|FG000|Overall Study|Adverse Event|1
7663449|NCT00109850|12077998|FG000|Overall Study|Death|2
7663450|NCT00109850|12077998|FG000|Overall Study|Ineligible|1
7663451|NCT00109928|12078006|FG000|Overall Study|Adverse Event|2
7663452|NCT00109928|12078006|FG000|Overall Study|Progression|6
7663453|NCT00109928|12078006|FG000|Overall Study|Death|2
7663454|NCT00109928|12078006|FG000|Overall Study|not protocol specified|2
7663455|NCT00109928|12078006|FG000|Overall Study|not eligible|1
7663456|NCT00109967|12078013|FG000|Overall Study|Cancel Prior to Treatment|2
7663457|NCT00109967|12078014|FG001|Overall Study|Cancel Prior to Treatment|0
7663458|NCT00109967|12078013|FG000|Overall Study|Adverse Event|12
7663459|NCT00109967|12078014|FG001|Overall Study|Adverse Event|1
7663460|NCT00109967|12078013|FG000|Overall Study|Withdrawal by Subject|5
7663461|NCT00109967|12078014|FG001|Overall Study|Withdrawal by Subject|0
7663462|NCT00109967|12078013|FG000|Overall Study|Physician Decision|1
7663463|NCT00109967|12078014|FG001|Overall Study|Physician Decision|3
7663464|NCT00109967|12078013|FG000|Overall Study|Death|0
7663465|NCT00109967|12078014|FG001|Overall Study|Death|2
7663466|NCT00110019|12078022|FG000|Overall Study|Lack of Efficacy|253
7663467|NCT00110019|12078023|FG001|Overall Study|Lack of Efficacy|285
7663468|NCT00110019|12078022|FG000|Overall Study|Adverse Event|61
7663469|NCT00110019|12078023|FG001|Overall Study|Adverse Event|40
7663470|NCT00110019|12078022|FG000|Overall Study|Death|13
7663471|NCT00110019|12078023|FG001|Overall Study|Death|15
7663472|NCT00110019|12078022|FG000|Overall Study|Withdrawal by Subject|21
7663473|NCT00110019|12078023|FG001|Overall Study|Withdrawal by Subject|9
7663474|NCT00110019|12078022|FG000|Overall Study|alternative therapy|5
7663475|NCT00110019|12078023|FG001|Overall Study|alternative therapy|1
7663476|NCT00110019|12078022|FG000|Overall Study|complicating disease|1
7663477|NCT00110019|12078023|FG001|Overall Study|complicating disease|1
7663478|NCT00110019|12078022|FG000|Overall Study|symptom deterioration|13
7663479|NCT00110019|12078023|FG001|Overall Study|symptom deterioration|16
7663480|NCT00110019|12078022|FG000|Overall Study|Not start protocol therapy|17
7663481|NCT00110019|12078023|FG001|Overall Study|Not start protocol therapy|16
7663482|NCT00110019|12078022|FG000|Overall Study|other reasons|22
7663483|NCT00110019|12078023|FG001|Overall Study|other reasons|30
7663484|NCT00110084|12078029|FG000|Overall Study|Adverse Event|9
7663485|NCT00110084|12078029|FG000|Overall Study|Death|1
7663486|NCT00110084|12078029|FG000|Overall Study|Patient Refusal|10
7663487|NCT00110084|12078029|FG000|Overall Study|Alternate Therapy|5
7663488|NCT00110084|12078029|FG000|Overall Study|Intercurrent Illness|1
7663489|NCT00110084|12078029|FG000|Overall Study|Other|2
7663490|NCT00110149|12078038|FG000|Overall Study|Physician Decision|3
7663491|NCT00110214|12078045|FG000|Overall Study|Never started treatment|21
7663492|NCT00110214|12078046|FG001|Overall Study|Never started treatment|20
7663493|NCT00110214|12078045|FG000|Overall Study|Disease progression or death|260
7663494|NCT00110214|12078046|FG001|Overall Study|Disease progression or death|151
7663495|NCT00110214|12078045|FG000|Overall Study|Adverse Event|115
7663496|NCT00110214|12078046|FG001|Overall Study|Adverse Event|192
7663497|NCT00110214|12078045|FG000|Overall Study|Refused further treatment|52
7663498|NCT00110214|12078046|FG001|Overall Study|Refused further treatment|65
7663499|NCT00110214|12078045|FG000|Overall Study|Other (not specified)|61
7663500|NCT00110214|12078046|FG001|Overall Study|Other (not specified)|75
7663501|NCT00110266|12078052|FG000|Overall Study|Adverse Event|27
7663502|NCT00110266|12078052|FG000|Overall Study|Abnormal laboratory value|15
7663503|NCT00110266|12078052|FG000|Overall Study|Withdrawal by Subject|16
7663504|NCT00110266|12078052|FG000|Overall Study|Death|17
7663505|NCT00110266|12078052|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7663506|NCT00110266|12078052|FG000|Overall Study|Participant condition no longer requires study drug|1
7663507|NCT00110305|12078061|FG000|Overall Study|Adverse Event|46
7663508|NCT00110305|12078062|FG001|Overall Study|Adverse Event|13
7663509|NCT00110305|12078061|FG000|Overall Study|Sponsors Decision|1
7663510|NCT00110305|12078062|FG001|Overall Study|Sponsors Decision|0
7663511|NCT00110305|12078061|FG000|Overall Study|Subject Non-Compliant|9
7663512|NCT00110305|12078062|FG001|Overall Study|Subject Non-Compliant|2
7663513|NCT00110305|12078061|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
7663514|NCT00110305|12078062|FG001|Overall Study|Subject Ineligible To Continue The Trial|1
7663515|NCT00110305|12078061|FG000|Overall Study|Subject Reached A Virologic Endpoint|21
7663516|NCT00110305|12078062|FG001|Overall Study|Subject Reached A Virologic Endpoint|3
7663517|NCT00110305|12078061|FG000|Overall Study|Protocol Violation|0
7663518|NCT00110305|12078062|FG001|Overall Study|Protocol Violation|1
7663519|NCT00110305|12078061|FG000|Overall Study|Withdrawal by Subject|7
7663520|NCT00110305|12078062|FG001|Overall Study|Withdrawal by Subject|7
7663521|NCT00110305|12078061|FG000|Overall Study|Lost to Follow-up|20
7663522|NCT00110305|12078062|FG001|Overall Study|Lost to Follow-up|3
7663523|NCT00110305|12078061|FG000|Overall Study|Other|8
7663524|NCT00110305|12078062|FG001|Overall Study|Other|2
7663525|NCT00110357|12078081|FG000|Overall Study|Deterioration without progression|2
7663526|NCT00110357|12078082|FG001|Overall Study|Deterioration without progression|0
7663527|NCT00110357|12078081|FG000|Overall Study|Disease progression/relapse|20
7663528|NCT00110357|12078082|FG001|Overall Study|Disease progression/relapse|15
7663529|NCT00110357|12078081|FG000|Overall Study|Study Closure|1
7663530|NCT00110357|12078082|FG001|Overall Study|Study Closure|0
7663531|NCT00110357|12078081|FG000|Overall Study|Study Drug Toxicity|1
7663532|NCT00110357|12078082|FG001|Overall Study|Study Drug Toxicity|3
7663533|NCT00110357|12078081|FG000|Overall Study|Withdrawal by Subject|3
7663534|NCT00110357|12078082|FG001|Overall Study|Withdrawal by Subject|1
7663535|NCT00110396|12078115|FG000|Overall Study|Adverse Event|15
7663536|NCT00110396|12078115|FG000|Overall Study|Lost to Follow-up|1
7663537|NCT00110396|12078115|FG000|Overall Study|Administration of plasmapheresis|1
7663538|NCT00110396|12078115|FG000|Overall Study|Initiated mitoxantrone therapy|1
7663539|NCT00110396|12078115|FG000|Overall Study|Lack of Efficacy|1
7663540|NCT00110396|12078115|FG000|Overall Study|Decided not to continue treatment|1
7663541|NCT00110396|12078115|FG000|Overall Study|Patient non-compliance|1
7663542|NCT00110396|12078115|FG000|Overall Study|Patient refused to continue|1
7663543|NCT00110396|12078115|FG000|Overall Study|Patient refused to participate|1
7663544|NCT00110396|12078115|FG000|Overall Study|Patient will|1
7663545|NCT00110396|12078115|FG000|Overall Study|Patient's decision|1
7663546|NCT00110396|12078115|FG000|Overall Study|Participation in MS vaccine study|1
7663547|NCT00110396|12078115|FG000|Overall Study|Pregnancy|1
7663548|NCT00110396|12078115|FG000|Overall Study|Pregnancy (Protocol violation)|2
7663549|NCT00110396|12078115|FG000|Overall Study|Protocol Violation|2
7663550|NCT00110396|12078115|FG000|Overall Study|Patient refused to come back|1
7663551|NCT00110396|12078115|FG000|Overall Study|The patient has refused|2
7663552|NCT00110396|12078115|FG000|Overall Study|The patient has refused to visit site|1
7663553|NCT00110396|12078115|FG000|Overall Study|Patient is to be administered copaxone|1
7663554|NCT00110617|12078138|FG000|Overall Study|Adverse Event|2
7663555|NCT00110617|12078139|FG001|Overall Study|Adverse Event|4
7663556|NCT00110617|12078138|FG000|Overall Study|Abnormal Laboratory Value|4
7663557|NCT00110617|12078139|FG001|Overall Study|Abnormal Laboratory Value|2
7663558|NCT00110617|12078138|FG000|Overall Study|Lack of Efficacy|1
7663559|NCT00110617|12078139|FG001|Overall Study|Lack of Efficacy|0
7663560|NCT00110617|12078138|FG000|Overall Study|Patient no longer requires study drug|1
7663561|NCT00110617|12078139|FG001|Overall Study|Patient no longer requires study drug|0
7663562|NCT00110617|12078138|FG000|Overall Study|Protocol Violation|5
7663563|NCT00110617|12078139|FG001|Overall Study|Protocol Violation|0
7663564|NCT00110617|12078138|FG000|Overall Study|Withdrawal by Subject|10
7663565|NCT00110617|12078139|FG001|Overall Study|Withdrawal by Subject|4
7663566|NCT00110617|12078138|FG000|Overall Study|Lost to Follow-up|9
7663567|NCT00110617|12078139|FG001|Overall Study|Lost to Follow-up|1
7663568|NCT00110617|12078138|FG000|Overall Study|Administrative problems|6
7663569|NCT00110617|12078139|FG001|Overall Study|Administrative problems|5
7663570|NCT00110617|12078138|FG000|Overall Study|Death|1
7663571|NCT00110617|12078139|FG001|Overall Study|Death|1
7663572|NCT00110617|12078138|FG000|Overall Study|Did not receive study drug|0
7663573|NCT00110617|12078139|FG001|Overall Study|Did not receive study drug|12
7663574|NCT00110812|12078150|FG000|Main Study|Death|0
7663575|NCT00110812|12078151|FG001|Main Study|Death|0
7663576|NCT00110812|12078152|FG002|Main Study|Death|2
7663577|NCT00110812|12078150|FG000|Main Study|Withdrawal by Subject|0
7663578|NCT00110812|12078151|FG001|Main Study|Withdrawal by Subject|0
7663579|NCT00110812|12078152|FG002|Main Study|Withdrawal by Subject|1
7663580|NCT00110812|12078150|FG000|Main Study|Lost to Follow-up|8
7663581|NCT00110812|12078151|FG001|Main Study|Lost to Follow-up|11
7663582|NCT00110812|12078152|FG002|Main Study|Lost to Follow-up|10
7663583|NCT00110812|12078150|FG000|Extended Follow-up|Death|1
7663584|NCT00110812|12078151|FG001|Extended Follow-up|Death|0
7663585|NCT00110812|12078152|FG002|Extended Follow-up|Death|3
7663586|NCT00110812|12078150|FG000|Extended Follow-up|Withdrawal by Subject|0
7663587|NCT00110812|12078151|FG001|Extended Follow-up|Withdrawal by Subject|1
7663588|NCT00110812|12078152|FG002|Extended Follow-up|Withdrawal by Subject|0
7663589|NCT00110812|12078150|FG000|Extended Follow-up|Lost to Follow-up|1
7663590|NCT00110812|12078151|FG001|Extended Follow-up|Lost to Follow-up|3
7663591|NCT00110812|12078152|FG002|Extended Follow-up|Lost to Follow-up|1
7663592|NCT00110890|12078167|FG000|Overall Study|Adverse Event|30
7663593|NCT00110890|12078168|FG001|Overall Study|Adverse Event|7
7663594|NCT00110890|12078167|FG000|Overall Study|Death|16
7663595|NCT00110890|12078168|FG001|Overall Study|Death|9
7663596|NCT00110890|12078167|FG000|Overall Study|Lost to Follow-up|3
7663597|NCT00110890|12078168|FG001|Overall Study|Lost to Follow-up|1
7663598|NCT00110890|12078167|FG000|Overall Study|Physician Decision|4
7663599|NCT00110890|12078168|FG001|Overall Study|Physician Decision|5
7663600|NCT00110890|12078167|FG000|Overall Study|Withdrawal by Subject|17
7663601|NCT00110890|12078168|FG001|Overall Study|Withdrawal by Subject|5
7663602|NCT00110890|12078167|FG000|Overall Study|Protocol Deviation|1
7663603|NCT00110890|12078168|FG001|Overall Study|Protocol Deviation|0
7663604|NCT00110890|12078167|FG000|Overall Study|Noncompliance|10
7663605|NCT00110890|12078168|FG001|Overall Study|Noncompliance|0
7663606|NCT00110890|12078167|FG000|Overall Study|Kidney Transplant|16
7663607|NCT00110890|12078168|FG001|Overall Study|Kidney Transplant|12
7663608|NCT00110890|12078167|FG000|Overall Study|Invest. Product Commercially Available|217
7663609|NCT00110890|12078168|FG001|Overall Study|Invest. Product Commercially Available|110
7663610|NCT00110890|12078167|FG000|Overall Study|Other|34
7663611|NCT00110890|12078168|FG001|Overall Study|Other|23
7663612|NCT00110890|12078167|FG000|Overall Study|Ineligibility determined|3
7663613|NCT00110890|12078168|FG001|Overall Study|Ineligibility determined|0
7663614|NCT00110890|12078167|FG000|Overall Study|Requirement for alternative therapy|0
7663615|NCT00110890|12078168|FG001|Overall Study|Requirement for alternative therapy|1
7663616|NCT00110890|12078167|FG000|Overall Study|Disease progression|0
7663617|NCT00110890|12078168|FG001|Overall Study|Disease progression|1
7663618|NCT00110890|12078167|FG000|Overall Study|Parathyroidectomy|0
7663619|NCT00110890|12078168|FG001|Overall Study|Parathyroidectomy|1
7663620|NCT00110890|12078167|FG000|Overall Study|Did not enter follow-up phase|10
7663621|NCT00110890|12078168|FG001|Overall Study|Did not enter follow-up phase|4
7663622|NCT00110994|12078176|FG000|Double-blind (DB) Treatment|Adverse Event|3
7663623|NCT00110994|12078177|FG001|Double-blind (DB) Treatment|Adverse Event|0
7663624|NCT00110994|12078176|FG000|Double-blind (DB) Treatment|Death|1
7663625|NCT00110994|12078177|FG001|Double-blind (DB) Treatment|Death|0
7663626|NCT00110994|12078176|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0
7663627|NCT00110994|12078177|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2
7663628|NCT00110994|12078176|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2
7663629|NCT00110994|12078177|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1
7663630|NCT00110994|12078176|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
7663631|NCT00110994|12078177|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
7663632|NCT00110994|12078176|FG000|Double-blind (DB) Treatment|other reasons|2
7663633|NCT00110994|12078177|FG001|Double-blind (DB) Treatment|other reasons|3
7663634|NCT00110994|12078176|FG000|Active Follow-up|Disease progression/recurrence/replace|1
7663635|NCT00110994|12078177|FG001|Active Follow-up|Disease progression/recurrence/replace|0
7663636|NCT00110994|12078176|FG000|Active Follow-up|Other reasons|0
7663637|NCT00110994|12078177|FG001|Active Follow-up|Other reasons|2
7663638|NCT00110994|12078176|FG000|Long Term Follow-up|Death|19
7663639|NCT00110994|12078177|FG001|Long Term Follow-up|Death|17
7663640|NCT00111007|12078185|FG000|Double-blind (DB) Treatment|Adverse Event|12
7663641|NCT00111007|12078186|FG001|Double-blind (DB) Treatment|Adverse Event|4
7663642|NCT00111007|12078185|FG000|Double-blind (DB) Treatment|Death|5
7663643|NCT00111007|12078186|FG001|Double-blind (DB) Treatment|Death|2
7663644|NCT00111007|12078185|FG000|Double-blind (DB) Treatment|Protocol Violation|0
7663645|NCT00111007|12078186|FG001|Double-blind (DB) Treatment|Protocol Violation|1
7663646|NCT00111007|12078185|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6
7663647|NCT00111007|12078186|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8
7663648|NCT00111007|12078185|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
7663649|NCT00111007|12078186|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
7663650|NCT00111007|12078185|FG000|Double-blind (DB) Treatment|Relapse|1
7663651|NCT00111007|12078186|FG001|Double-blind (DB) Treatment|Relapse|0
7663652|NCT00111007|12078185|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0
7663653|NCT00111007|12078186|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2
7663654|NCT00111007|12078185|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
7663655|NCT00111007|12078186|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
7663656|NCT00111007|12078185|FG000|Double-blind (DB) Treatment|Primary reason with other category|0
7663657|NCT00111007|12078186|FG001|Double-blind (DB) Treatment|Primary reason with other category|1
7663658|NCT00111007|12078185|FG000|Active Follow-up|Adverse Event|1
7663659|NCT00111007|12078186|FG001|Active Follow-up|Adverse Event|0
7663660|NCT00111007|12078185|FG000|Active Follow-up|Death|2
7663661|NCT00111007|12078186|FG001|Active Follow-up|Death|0
7663662|NCT00111007|12078185|FG000|Active Follow-up|Disease progression/recurrence/relapse|3
7663663|NCT00111007|12078186|FG001|Active Follow-up|Disease progression/recurrence/relapse|2
7663664|NCT00111007|12078185|FG000|Long Term Follow-up|Death|34
7663665|NCT00111007|12078186|FG001|Long Term Follow-up|Death|39
7663666|NCT00111007|12078185|FG000|Long Term Follow-up|Lost to Follow-up|1
7663667|NCT00111007|12078186|FG001|Long Term Follow-up|Lost to Follow-up|1
7663668|NCT00111007|12078185|FG000|Long Term Follow-up|Withdrawal by Subject|0
7663669|NCT00111007|12078186|FG001|Long Term Follow-up|Withdrawal by Subject|1
7663670|NCT00111007|12078185|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2
7663671|NCT00111007|12078186|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1
7663672|NCT00111007|12078185|FG000|Long Term Follow-up|Missing|10
7663673|NCT00111007|12078186|FG001|Long Term Follow-up|Missing|3
7663674|NCT00111228|12078195|FG000|Overall Study|Withdrawal by Subject|5
7663675|NCT00111228|12078196|FG001|Overall Study|Withdrawal by Subject|1
7663676|NCT00111228|12078197|FG002|Overall Study|Withdrawal by Subject|0
7663677|NCT00111241|12078207|FG000|Overall Study|Lost to Follow-up|1
7663678|NCT00111241|12078208|FG001|Overall Study|Lost to Follow-up|0
7663679|NCT00111241|12078207|FG000|Overall Study|Withdrawal by Subject|4
7663680|NCT00111241|12078208|FG001|Overall Study|Withdrawal by Subject|0
7663681|NCT00111241|12078207|FG000|Overall Study|Protocol Violation|9
7663682|NCT00111241|12078208|FG001|Overall Study|Protocol Violation|8
7663683|NCT00111241|12078207|FG000|Overall Study|Adverse Event|1
7663684|NCT00111241|12078208|FG001|Overall Study|Adverse Event|0
7663685|NCT00111475|12078226|FG000|Overall Study|Lost to Follow-up|0
7663686|NCT00111475|12078227|FG001|Overall Study|Lost to Follow-up|0
7663687|NCT00111475|12078228|FG002|Overall Study|Lost to Follow-up|0
7663688|NCT00111475|12078229|FG003|Overall Study|Lost to Follow-up|0
7663689|NCT00111475|12078230|FG004|Overall Study|Lost to Follow-up|0
7663690|NCT00111475|12078231|FG005|Overall Study|Lost to Follow-up|1
7663691|NCT00111475|12078232|FG006|Overall Study|Lost to Follow-up|0
7663692|NCT00111475|12078233|FG007|Overall Study|Lost to Follow-up|0
7663693|NCT00111475|12078234|FG008|Overall Study|Lost to Follow-up|0
7663694|NCT00111475|12078235|FG009|Overall Study|Lost to Follow-up|0
7663695|NCT00111761|12078270|FG000|Part 1|Physician Decision|0
7663696|NCT00111761|12078271|FG001|Part 1|Physician Decision|1
7663697|NCT00111761|12078270|FG000|Part 1|Death|0
7663698|NCT00111761|12078271|FG001|Part 1|Death|2
7663699|NCT00111761|12078270|FG000|Part 1|Other|0
7663700|NCT00111761|12078271|FG001|Part 1|Other|1
7663701|NCT00111761|12078270|FG000|Part 1|Withdrawal by Subject|0
7663702|NCT00111761|12078271|FG001|Part 1|Withdrawal by Subject|1
7663703|NCT00111761|12078270|FG000|Part 2|Adverse Event|1
7663704|NCT00111761|12078271|FG001|Part 2|Adverse Event|0
7663705|NCT00111761|12078270|FG000|Part 2|Physician Decision|1
7663706|NCT00111761|12078271|FG001|Part 2|Physician Decision|0
7663707|NCT00111761|12078270|FG000|Part 2|Death|1
7663708|NCT00111761|12078271|FG001|Part 2|Death|0
7663709|NCT00111761|12078270|FG000|Part 2|Disease progression|3
7663710|NCT00111761|12078271|FG001|Part 2|Disease progression|0
7663711|NCT00111761|12078270|FG000|Part 2|Protocol-specified criteria|1
7663712|NCT00111761|12078271|FG001|Part 2|Protocol-specified criteria|0
7663713|NCT00111761|12078270|FG000|Part 2|Other|1
7663714|NCT00111761|12078271|FG001|Part 2|Other|0
7663715|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5
7663716|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4
7663717|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0
7663718|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0
7663719|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1
7663720|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0
7663721|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
7663722|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
7663723|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
7663724|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
7663725|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
7663726|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
7663727|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
7663728|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
7663729|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
7663730|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
7663731|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
7663732|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
7663733|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
7663734|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
7663735|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
7663736|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
7663737|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
7663738|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
7663739|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
7663740|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
7663741|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
7663742|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
7663743|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
7663744|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
7663745|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
7663746|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
7663747|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
7663748|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
7663749|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
7663750|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
7663751|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
7663752|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
7663753|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
7663754|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
7663755|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
7663756|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
7663757|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
7663758|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
7663759|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
7663760|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
7663761|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
7663762|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
7663763|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
7663764|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
7663765|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
7663766|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
7663767|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
7663768|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
7663769|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7663770|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
7663771|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7663772|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7663773|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7663915|NCT00111839|12078336|FG002|Overall Study|Logistical Constraint|0
7663774|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7663775|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7663776|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
7663777|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7663778|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7663779|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7663780|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7663781|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7663782|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
7663783|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7663784|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7663785|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7663786|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7663787|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
7663788|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
7663789|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
7663790|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
7663791|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
7663792|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
7663793|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7663794|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7663795|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7663796|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
7663797|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7663798|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7663799|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
7663800|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
7663801|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
7663802|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
7663803|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
7663804|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
7663805|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
7663806|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
7663807|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
7663808|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
7663809|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
7663810|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
7663811|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
7663812|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
7663813|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
7663814|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
7663815|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
7663816|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
7663817|NCT00111800|12078283|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
7663818|NCT00111800|12078284|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
7663819|NCT00111800|12078285|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
7663820|NCT00111800|12078286|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
7663821|NCT00111800|12078287|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
7663822|NCT00111800|12078288|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
7663823|NCT00111800|12078283|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
7663824|NCT00111800|12078284|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
7663825|NCT00111800|12078285|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
7663826|NCT00111800|12078286|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
7663827|NCT00111800|12078287|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
7663828|NCT00111800|12078288|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
7663829|NCT00111800|12078283|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
7663830|NCT00111800|12078284|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
7663831|NCT00111800|12078285|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
7663832|NCT00111800|12078286|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
7663833|NCT00111800|12078287|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
7663834|NCT00111800|12078288|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
7663835|NCT00111800|12078283|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
7663836|NCT00111800|12078284|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
7663837|NCT00111800|12078285|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
7663838|NCT00111800|12078286|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
7663916|NCT00111839|12078334|FG000|Overall Study|Other|6
7663839|NCT00111800|12078287|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
7663840|NCT00111800|12078288|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
7663841|NCT00111800|12078283|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
7663842|NCT00111800|12078284|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
7663843|NCT00111800|12078285|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
7663844|NCT00111800|12078286|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
7663845|NCT00111800|12078287|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
7663846|NCT00111800|12078288|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
7663847|NCT00111800|12078283|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
7663848|NCT00111800|12078284|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
7663849|NCT00111800|12078285|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
7663850|NCT00111800|12078286|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
7663851|NCT00111800|12078287|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
7663852|NCT00111800|12078288|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
7663853|NCT00111800|12078283|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7663854|NCT00111800|12078284|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
7663855|NCT00111800|12078285|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7663856|NCT00111800|12078286|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7663857|NCT00111800|12078287|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7663858|NCT00111800|12078288|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7663859|NCT00111800|12078283|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
7663860|NCT00111800|12078284|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
7663861|NCT00111800|12078285|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
7663862|NCT00111800|12078286|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
7663863|NCT00111800|12078287|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
7663864|NCT00111800|12078288|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
7663865|NCT00111800|12078283|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
7663866|NCT00111800|12078284|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
7663867|NCT00111800|12078285|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
7663868|NCT00111800|12078286|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
7663869|NCT00111800|12078287|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
7663870|NCT00111800|12078288|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
7663871|NCT00111813|12078311|FG000|Overall Study|Adverse Event|1
7663872|NCT00111813|12078312|FG001|Overall Study|Adverse Event|2
7663873|NCT00111813|12078313|FG002|Overall Study|Adverse Event|4
7663874|NCT00111813|12078314|FG003|Overall Study|Adverse Event|2
7663875|NCT00111813|12078315|FG004|Overall Study|Adverse Event|2
7663876|NCT00111813|12078316|FG005|Overall Study|Adverse Event|2
7663877|NCT00111813|12078311|FG000|Overall Study|Progressive disease|2
7663878|NCT00111813|12078312|FG001|Overall Study|Progressive disease|1
7663879|NCT00111813|12078313|FG002|Overall Study|Progressive disease|5
7663880|NCT00111813|12078314|FG003|Overall Study|Progressive disease|3
7663881|NCT00111813|12078315|FG004|Overall Study|Progressive disease|4
7663882|NCT00111813|12078316|FG005|Overall Study|Progressive disease|3
7663883|NCT00111813|12078311|FG000|Overall Study|Lack of Efficacy|0
7663884|NCT00111813|12078312|FG001|Overall Study|Lack of Efficacy|0
7663885|NCT00111813|12078313|FG002|Overall Study|Lack of Efficacy|0
7663886|NCT00111813|12078314|FG003|Overall Study|Lack of Efficacy|0
7663887|NCT00111813|12078315|FG004|Overall Study|Lack of Efficacy|0
7663888|NCT00111813|12078316|FG005|Overall Study|Lack of Efficacy|1
7663889|NCT00111813|12078311|FG000|Overall Study|Other|0
7663890|NCT00111813|12078312|FG001|Overall Study|Other|0
7663891|NCT00111813|12078313|FG002|Overall Study|Other|1
7663892|NCT00111813|12078314|FG003|Overall Study|Other|0
7663893|NCT00111813|12078315|FG004|Overall Study|Other|0
7663894|NCT00111813|12078316|FG005|Overall Study|Other|0
7663895|NCT00111839|12078334|FG000|Overall Study|Disease Progression|30
7663896|NCT00111839|12078335|FG001|Overall Study|Disease Progression|33
7663897|NCT00111839|12078336|FG002|Overall Study|Disease Progression|33
7663898|NCT00111839|12078334|FG000|Overall Study|Adverse Event|5
7663899|NCT00111839|12078335|FG001|Overall Study|Adverse Event|3
7663900|NCT00111839|12078336|FG002|Overall Study|Adverse Event|1
7663901|NCT00111839|12078334|FG000|Overall Study|Protocol Violation|2
7663902|NCT00111839|12078335|FG001|Overall Study|Protocol Violation|4
7663903|NCT00111839|12078336|FG002|Overall Study|Protocol Violation|2
7663904|NCT00111839|12078334|FG000|Overall Study|Death|1
7663905|NCT00111839|12078335|FG001|Overall Study|Death|1
7663906|NCT00111839|12078336|FG002|Overall Study|Death|6
7663907|NCT00111839|12078334|FG000|Overall Study|Withdrawal by Subject|2
7663908|NCT00111839|12078335|FG001|Overall Study|Withdrawal by Subject|2
7663909|NCT00111839|12078336|FG002|Overall Study|Withdrawal by Subject|2
7663910|NCT00111839|12078334|FG000|Overall Study|Lost to Follow-up|1
7663911|NCT00111839|12078335|FG001|Overall Study|Lost to Follow-up|0
7663912|NCT00111839|12078336|FG002|Overall Study|Lost to Follow-up|0
7663913|NCT00111839|12078334|FG000|Overall Study|Logistical Constraint|1
7663914|NCT00111839|12078335|FG001|Overall Study|Logistical Constraint|0
7663917|NCT00111839|12078335|FG001|Overall Study|Other|3
7663918|NCT00111839|12078336|FG002|Overall Study|Other|3
7663919|NCT00111839|12078334|FG000|Overall Study|Randomized but Not Treated|0
7663920|NCT00111839|12078335|FG001|Overall Study|Randomized but Not Treated|0
7663921|NCT00111839|12078336|FG002|Overall Study|Randomized but Not Treated|2
7663922|NCT00111917|12078346|FG000|Overall Study|Withdrawal by Subject|1
7663923|NCT00111917|12078347|FG001|Overall Study|Withdrawal by Subject|1
7663924|NCT00112047|12078359|FG000|Randomized Phase|Lost to Follow-up|26
7663925|NCT00112047|12078360|FG001|Randomized Phase|Lost to Follow-up|33
7663926|NCT00112047|12078359|FG000|Randomized Phase|Adverse Event|10
7663927|NCT00112047|12078360|FG001|Randomized Phase|Adverse Event|10
7663928|NCT00112047|12078359|FG000|Randomized Phase|Withrawal of consent|10
7663929|NCT00112047|12078360|FG001|Randomized Phase|Withrawal of consent|18
7663930|NCT00112047|12078359|FG000|Randomized Phase|Sub-optimal virological response|3
7663931|NCT00112047|12078360|FG001|Randomized Phase|Sub-optimal virological response|13
7663932|NCT00112047|12078359|FG000|Randomized Phase|Noncompliance|8
7663933|NCT00112047|12078360|FG001|Randomized Phase|Noncompliance|4
7663934|NCT00112047|12078359|FG000|Randomized Phase|Protocol Violation|2
7663935|NCT00112047|12078360|FG001|Randomized Phase|Protocol Violation|0
7663936|NCT00112047|12078359|FG000|Randomized Phase|Pregnancy|3
7663937|NCT00112047|12078360|FG001|Randomized Phase|Pregnancy|1
7663938|NCT00112047|12078359|FG000|Randomized Phase|Death|1
7663939|NCT00112047|12078360|FG001|Randomized Phase|Death|3
7663940|NCT00112047|12078359|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0
7663941|NCT00112047|12078360|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1
7663942|NCT00112047|12078359|FG000|Randomized Phase|Inability to swallow pills|0
7663943|NCT00112047|12078360|FG001|Randomized Phase|Inability to swallow pills|1
7663944|NCT00112047|12078359|FG000|Randomized Phase|Incarceration|3
7663945|NCT00112047|12078360|FG001|Randomized Phase|Incarceration|2
7663946|NCT00112047|12078359|FG000|Randomized Phase|Moved out of State|0
7663947|NCT00112047|12078360|FG001|Randomized Phase|Moved out of State|1
7663948|NCT00112047|12078359|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4
7663949|NCT00112047|12078360|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0
7663950|NCT00112047|12078359|FG000|Randomized Phase|High Hepatitis B DNA|0
7663951|NCT00112047|12078360|FG001|Randomized Phase|High Hepatitis B DNA|1
7663952|NCT00112047|12078359|FG000|Atripla Phase|Adverse Event|2
7663953|NCT00112047|12078360|FG001|Atripla Phase|Adverse Event|1
7663954|NCT00112047|12078359|FG000|Atripla Phase|Lost to Follow-up|5
7663955|NCT00112047|12078360|FG001|Atripla Phase|Lost to Follow-up|7
7663956|NCT00112047|12078359|FG000|Atripla Phase|Pregnancy|0
7663957|NCT00112047|12078360|FG001|Atripla Phase|Pregnancy|1
7663958|NCT00112047|12078359|FG000|Atripla Phase|Death|0
7663959|NCT00112047|12078360|FG001|Atripla Phase|Death|2
7663960|NCT00112047|12078359|FG000|Atripla Phase|Withdrew consent|7
7663961|NCT00112047|12078360|FG001|Atripla Phase|Withdrew consent|7
7663962|NCT00112047|12078359|FG000|Atripla Phase|Sub-optimal virological response|0
7663963|NCT00112047|12078360|FG001|Atripla Phase|Sub-optimal virological response|1
7663964|NCT00112047|12078359|FG000|Atripla Phase|Non-compliance|1
7663965|NCT00112047|12078360|FG001|Atripla Phase|Non-compliance|0
7663966|NCT00112047|12078359|FG000|Atripla Phase|Other|3
7663967|NCT00112047|12078360|FG001|Atripla Phase|Other|1
7663968|NCT00112294|12078442|FG000|Overall Study|Still on study|5
7663969|NCT00112294|12078443|FG001|Overall Study|Still on study|0
7663970|NCT00112359|12078451|FG000|Overall Study|Unrelated adverse event|16
7663971|NCT00112359|12078452|FG001|Overall Study|Unrelated adverse event|8
7663972|NCT00112359|12078451|FG000|Overall Study|Trial drug intolerance (adverse event)|2
7663973|NCT00112359|12078452|FG001|Overall Study|Trial drug intolerance (adverse event)|0
7663974|NCT00112359|12078451|FG000|Overall Study|Related adverse event|5
7663975|NCT00112359|12078452|FG001|Overall Study|Related adverse event|3
7663976|NCT00112359|12078451|FG000|Overall Study|Lost to Follow-up|0
7663977|NCT00112359|12078452|FG001|Overall Study|Lost to Follow-up|1
7663978|NCT00112359|12078451|FG000|Overall Study|Personal/administrative|1
7663979|NCT00112359|12078452|FG001|Overall Study|Personal/administrative|1
7663980|NCT00112359|12078451|FG000|Overall Study|Other|3
7663981|NCT00112359|12078452|FG001|Overall Study|Other|0
7663982|NCT00112385|12078460|FG000|Overall Study|Lost to Follow-up|1
7663983|NCT00112385|12078461|FG001|Overall Study|Lost to Follow-up|0
7663984|NCT00112385|12078460|FG000|Overall Study|Withdrawal by Subject|0
7663985|NCT00112385|12078461|FG001|Overall Study|Withdrawal by Subject|1
7663986|NCT00112437|12078472|FG000|Year 1 (12-Month Base Study)|Adverse Event|9
7663987|NCT00112437|12078473|FG001|Year 1 (12-Month Base Study)|Adverse Event|10
7663988|NCT00112437|12078474|FG002|Year 1 (12-Month Base Study)|Adverse Event|6
7663989|NCT00112437|12078475|FG003|Year 1 (12-Month Base Study)|Adverse Event|4
7663990|NCT00112437|12078476|FG004|Year 1 (12-Month Base Study)|Adverse Event|3
7663991|NCT00112437|12078477|FG005|Year 1 (12-Month Base Study)|Adverse Event|0
7663992|NCT00112437|12078478|FG006|Year 1 (12-Month Base Study)|Adverse Event|0
7663993|NCT00112437|12078479|FG007|Year 1 (12-Month Base Study)|Adverse Event|0
7663994|NCT00112437|12078480|FG008|Year 1 (12-Month Base Study)|Adverse Event|0
7663995|NCT00112437|12078481|FG009|Year 1 (12-Month Base Study)|Adverse Event|0
7663996|NCT00112437|12078482|FG010|Year 1 (12-Month Base Study)|Adverse Event|0
7663997|NCT00112437|12078483|FG011|Year 1 (12-Month Base Study)|Adverse Event|0
7663998|NCT00112437|12078484|FG012|Year 1 (12-Month Base Study)|Adverse Event|0
7663999|NCT00112437|12078485|FG013|Year 1 (12-Month Base Study)|Adverse Event|0
7664000|NCT00112437|12078486|FG014|Year 1 (12-Month Base Study)|Adverse Event|0
7664001|NCT00112437|12078487|FG015|Year 1 (12-Month Base Study)|Adverse Event|0
7664002|NCT00112437|12078488|FG016|Year 1 (12-Month Base Study)|Adverse Event|0
7664003|NCT00112437|12078489|FG017|Year 1 (12-Month Base Study)|Adverse Event|0
7664004|NCT00112437|12078490|FG018|Year 1 (12-Month Base Study)|Adverse Event|0
7664005|NCT00112437|12078491|FG019|Year 1 (12-Month Base Study)|Adverse Event|0
7664006|NCT00112437|12078492|FG020|Year 1 (12-Month Base Study)|Adverse Event|0
7664007|NCT00112437|12078493|FG021|Year 1 (12-Month Base Study)|Adverse Event|0
7664008|NCT00112437|12078494|FG022|Year 1 (12-Month Base Study)|Adverse Event|0
7664009|NCT00112437|12078495|FG023|Year 1 (12-Month Base Study)|Adverse Event|0
7664010|NCT00112437|12078496|FG024|Year 1 (12-Month Base Study)|Adverse Event|0
7664011|NCT00112437|12078497|FG025|Year 1 (12-Month Base Study)|Adverse Event|0
7664012|NCT00112437|12078472|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664013|NCT00112437|12078473|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1
7664014|NCT00112437|12078474|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664015|NCT00112437|12078475|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664016|NCT00112437|12078476|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664017|NCT00112437|12078477|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664018|NCT00112437|12078478|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664019|NCT00112437|12078479|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664020|NCT00112437|12078480|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664021|NCT00112437|12078481|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664022|NCT00112437|12078482|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664023|NCT00112437|12078483|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664024|NCT00112437|12078484|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664025|NCT00112437|12078485|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664026|NCT00112437|12078486|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664027|NCT00112437|12078487|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664028|NCT00112437|12078488|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664029|NCT00112437|12078489|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664030|NCT00112437|12078490|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664031|NCT00112437|12078491|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664032|NCT00112437|12078492|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664033|NCT00112437|12078493|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664034|NCT00112437|12078494|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664035|NCT00112437|12078495|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664036|NCT00112437|12078496|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664037|NCT00112437|12078497|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7664038|NCT00112437|12078472|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664039|NCT00112437|12078473|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1
7664040|NCT00112437|12078474|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664041|NCT00112437|12078475|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664042|NCT00112437|12078476|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664043|NCT00112437|12078477|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664044|NCT00112437|12078478|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664045|NCT00112437|12078479|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664046|NCT00112437|12078480|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664047|NCT00112437|12078481|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664048|NCT00112437|12078482|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664049|NCT00112437|12078483|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664050|NCT00112437|12078484|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664051|NCT00112437|12078485|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664052|NCT00112437|12078486|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664053|NCT00112437|12078487|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664054|NCT00112437|12078488|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664055|NCT00112437|12078489|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664056|NCT00112437|12078490|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664057|NCT00112437|12078491|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664058|NCT00112437|12078492|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664059|NCT00112437|12078493|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664060|NCT00112437|12078494|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664061|NCT00112437|12078495|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664062|NCT00112437|12078496|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664063|NCT00112437|12078497|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7664064|NCT00112437|12078472|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1
7664065|NCT00112437|12078473|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0
7664066|NCT00112437|12078474|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3
7664067|NCT00112437|12078475|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1
7664068|NCT00112437|12078476|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1
7664069|NCT00112437|12078477|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0
7664070|NCT00112437|12078478|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0
7664071|NCT00112437|12078479|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0
7664072|NCT00112437|12078480|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0
7664073|NCT00112437|12078481|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0
7664074|NCT00112437|12078482|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0
7664075|NCT00112437|12078483|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0
7664076|NCT00112437|12078484|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0
7664077|NCT00112437|12078485|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0
7664078|NCT00112437|12078486|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0
7664079|NCT00112437|12078487|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0
7664080|NCT00112437|12078488|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0
7664081|NCT00112437|12078489|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0
7664082|NCT00112437|12078490|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0
7664083|NCT00112437|12078491|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0
7664084|NCT00112437|12078492|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0
7664085|NCT00112437|12078493|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0
7664086|NCT00112437|12078494|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0
7664087|NCT00112437|12078495|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0
7664088|NCT00112437|12078496|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0
7664089|NCT00112437|12078497|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0
7664090|NCT00112437|12078472|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
7664091|NCT00112437|12078473|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
7664092|NCT00112437|12078474|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
7664093|NCT00112437|12078475|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
7664094|NCT00112437|12078476|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
7664095|NCT00112437|12078477|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664096|NCT00112437|12078478|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664097|NCT00112437|12078479|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664098|NCT00112437|12078480|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664099|NCT00112437|12078481|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664100|NCT00112437|12078482|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664101|NCT00112437|12078483|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664102|NCT00112437|12078484|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664103|NCT00112437|12078485|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664104|NCT00112437|12078486|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664105|NCT00112437|12078487|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664106|NCT00112437|12078488|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664107|NCT00112437|12078489|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664108|NCT00112437|12078490|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664109|NCT00112437|12078491|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664110|NCT00112437|12078492|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664111|NCT00112437|12078493|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664112|NCT00112437|12078494|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664113|NCT00112437|12078495|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664114|NCT00112437|12078496|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664115|NCT00112437|12078497|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7664116|NCT00112437|12078472|FG000|Year 1 (12-Month Base Study)|moved|0
7664117|NCT00112437|12078473|FG001|Year 1 (12-Month Base Study)|moved|1
7664118|NCT00112437|12078474|FG002|Year 1 (12-Month Base Study)|moved|1
7664119|NCT00112437|12078475|FG003|Year 1 (12-Month Base Study)|moved|0
7664120|NCT00112437|12078476|FG004|Year 1 (12-Month Base Study)|moved|0
7664121|NCT00112437|12078477|FG005|Year 1 (12-Month Base Study)|moved|0
7664122|NCT00112437|12078478|FG006|Year 1 (12-Month Base Study)|moved|0
7664123|NCT00112437|12078479|FG007|Year 1 (12-Month Base Study)|moved|0
7664124|NCT00112437|12078480|FG008|Year 1 (12-Month Base Study)|moved|0
7664125|NCT00112437|12078481|FG009|Year 1 (12-Month Base Study)|moved|0
7664126|NCT00112437|12078482|FG010|Year 1 (12-Month Base Study)|moved|0
7664127|NCT00112437|12078483|FG011|Year 1 (12-Month Base Study)|moved|0
7664128|NCT00112437|12078484|FG012|Year 1 (12-Month Base Study)|moved|0
7664129|NCT00112437|12078485|FG013|Year 1 (12-Month Base Study)|moved|0
7664130|NCT00112437|12078486|FG014|Year 1 (12-Month Base Study)|moved|0
7664131|NCT00112437|12078487|FG015|Year 1 (12-Month Base Study)|moved|0
7664132|NCT00112437|12078488|FG016|Year 1 (12-Month Base Study)|moved|0
7664133|NCT00112437|12078489|FG017|Year 1 (12-Month Base Study)|moved|0
7664134|NCT00112437|12078490|FG018|Year 1 (12-Month Base Study)|moved|0
7664135|NCT00112437|12078491|FG019|Year 1 (12-Month Base Study)|moved|0
7664136|NCT00112437|12078492|FG020|Year 1 (12-Month Base Study)|moved|0
7664137|NCT00112437|12078493|FG021|Year 1 (12-Month Base Study)|moved|0
7664138|NCT00112437|12078494|FG022|Year 1 (12-Month Base Study)|moved|0
7664139|NCT00112437|12078495|FG023|Year 1 (12-Month Base Study)|moved|0
7664140|NCT00112437|12078496|FG024|Year 1 (12-Month Base Study)|moved|0
7664141|NCT00112437|12078497|FG025|Year 1 (12-Month Base Study)|moved|0
7664142|NCT00112437|12078472|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664143|NCT00112437|12078473|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664144|NCT00112437|12078474|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664145|NCT00112437|12078475|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
7664146|NCT00112437|12078476|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664147|NCT00112437|12078477|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664148|NCT00112437|12078478|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664149|NCT00112437|12078479|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664150|NCT00112437|12078480|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664151|NCT00112437|12078481|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664152|NCT00112437|12078482|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664153|NCT00112437|12078483|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664154|NCT00112437|12078484|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664155|NCT00112437|12078485|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664156|NCT00112437|12078486|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664157|NCT00112437|12078487|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664158|NCT00112437|12078488|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664159|NCT00112437|12078489|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664160|NCT00112437|12078490|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664161|NCT00112437|12078491|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664162|NCT00112437|12078492|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664163|NCT00112437|12078493|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664164|NCT00112437|12078494|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664165|NCT00112437|12078495|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664166|NCT00112437|12078496|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664167|NCT00112437|12078497|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7664168|NCT00112437|12078472|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664169|NCT00112437|12078473|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664170|NCT00112437|12078474|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664171|NCT00112437|12078475|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664172|NCT00112437|12078476|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
7664173|NCT00112437|12078477|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664174|NCT00112437|12078478|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664175|NCT00112437|12078479|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664176|NCT00112437|12078480|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664177|NCT00112437|12078481|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664178|NCT00112437|12078482|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664179|NCT00112437|12078483|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664180|NCT00112437|12078484|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664181|NCT00112437|12078485|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664182|NCT00112437|12078486|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664183|NCT00112437|12078487|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664184|NCT00112437|12078488|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664185|NCT00112437|12078489|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664186|NCT00112437|12078490|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664187|NCT00112437|12078491|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664188|NCT00112437|12078492|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664189|NCT00112437|12078493|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664190|NCT00112437|12078494|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664191|NCT00112437|12078495|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664192|NCT00112437|12078496|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664193|NCT00112437|12078497|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7664194|NCT00112437|12078472|FG000|Year 2 (12-Month Extension)|Adverse Event|0
7664195|NCT00112437|12078473|FG001|Year 2 (12-Month Extension)|Adverse Event|0
7664196|NCT00112437|12078474|FG002|Year 2 (12-Month Extension)|Adverse Event|0
7664197|NCT00112437|12078475|FG003|Year 2 (12-Month Extension)|Adverse Event|0
7664198|NCT00112437|12078476|FG004|Year 2 (12-Month Extension)|Adverse Event|0
7664199|NCT00112437|12078477|FG005|Year 2 (12-Month Extension)|Adverse Event|1
7664200|NCT00112437|12078478|FG006|Year 2 (12-Month Extension)|Adverse Event|2
7664201|NCT00112437|12078479|FG007|Year 2 (12-Month Extension)|Adverse Event|6
7664202|NCT00112437|12078480|FG008|Year 2 (12-Month Extension)|Adverse Event|1
7664203|NCT00112437|12078481|FG009|Year 2 (12-Month Extension)|Adverse Event|7
7664204|NCT00112437|12078482|FG010|Year 2 (12-Month Extension)|Adverse Event|0
7664205|NCT00112437|12078483|FG011|Year 2 (12-Month Extension)|Adverse Event|0
7664206|NCT00112437|12078484|FG012|Year 2 (12-Month Extension)|Adverse Event|0
7664207|NCT00112437|12078485|FG013|Year 2 (12-Month Extension)|Adverse Event|0
7664208|NCT00112437|12078486|FG014|Year 2 (12-Month Extension)|Adverse Event|0
7664209|NCT00112437|12078487|FG015|Year 2 (12-Month Extension)|Adverse Event|0
7664210|NCT00112437|12078488|FG016|Year 2 (12-Month Extension)|Adverse Event|0
7664211|NCT00112437|12078489|FG017|Year 2 (12-Month Extension)|Adverse Event|0
7664212|NCT00112437|12078490|FG018|Year 2 (12-Month Extension)|Adverse Event|0
7664213|NCT00112437|12078491|FG019|Year 2 (12-Month Extension)|Adverse Event|0
7664214|NCT00112437|12078492|FG020|Year 2 (12-Month Extension)|Adverse Event|0
7664215|NCT00112437|12078493|FG021|Year 2 (12-Month Extension)|Adverse Event|0
7664216|NCT00112437|12078494|FG022|Year 2 (12-Month Extension)|Adverse Event|0
7664217|NCT00112437|12078495|FG023|Year 2 (12-Month Extension)|Adverse Event|0
7664218|NCT00112437|12078496|FG024|Year 2 (12-Month Extension)|Adverse Event|0
7664219|NCT00112437|12078497|FG025|Year 2 (12-Month Extension)|Adverse Event|0
7664220|NCT00112437|12078472|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664221|NCT00112437|12078473|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664222|NCT00112437|12078474|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664223|NCT00112437|12078475|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664224|NCT00112437|12078476|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664225|NCT00112437|12078477|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1
7664226|NCT00112437|12078478|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6
7664227|NCT00112437|12078479|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664228|NCT00112437|12078480|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664229|NCT00112437|12078481|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2
7664230|NCT00112437|12078482|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664231|NCT00112437|12078483|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664232|NCT00112437|12078484|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664233|NCT00112437|12078485|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664234|NCT00112437|12078486|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664235|NCT00112437|12078487|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664236|NCT00112437|12078488|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664237|NCT00112437|12078489|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664238|NCT00112437|12078490|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664239|NCT00112437|12078491|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664240|NCT00112437|12078492|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664241|NCT00112437|12078493|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664242|NCT00112437|12078494|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664243|NCT00112437|12078495|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664244|NCT00112437|12078496|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664245|NCT00112437|12078497|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0
7664246|NCT00112437|12078472|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664247|NCT00112437|12078473|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664248|NCT00112437|12078474|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664249|NCT00112437|12078475|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664250|NCT00112437|12078476|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664251|NCT00112437|12078477|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664252|NCT00112437|12078478|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664253|NCT00112437|12078479|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664254|NCT00112437|12078480|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1
7664255|NCT00112437|12078481|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664256|NCT00112437|12078482|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664257|NCT00112437|12078483|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664258|NCT00112437|12078484|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664259|NCT00112437|12078485|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664260|NCT00112437|12078486|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664261|NCT00112437|12078487|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664262|NCT00112437|12078488|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664263|NCT00112437|12078489|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664264|NCT00112437|12078490|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664265|NCT00112437|12078491|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664266|NCT00112437|12078492|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664267|NCT00112437|12078493|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664268|NCT00112437|12078494|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664269|NCT00112437|12078495|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664270|NCT00112437|12078496|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664271|NCT00112437|12078497|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0
7664272|NCT00112437|12078472|FG000|Year 2 (12-Month Extension)|Protocol Violation|0
7664273|NCT00112437|12078473|FG001|Year 2 (12-Month Extension)|Protocol Violation|0
7664274|NCT00112437|12078474|FG002|Year 2 (12-Month Extension)|Protocol Violation|0
7664275|NCT00112437|12078475|FG003|Year 2 (12-Month Extension)|Protocol Violation|0
7664276|NCT00112437|12078476|FG004|Year 2 (12-Month Extension)|Protocol Violation|0
7664277|NCT00112437|12078477|FG005|Year 2 (12-Month Extension)|Protocol Violation|0
7664278|NCT00112437|12078478|FG006|Year 2 (12-Month Extension)|Protocol Violation|0
7664279|NCT00112437|12078479|FG007|Year 2 (12-Month Extension)|Protocol Violation|0
7664280|NCT00112437|12078480|FG008|Year 2 (12-Month Extension)|Protocol Violation|1
7664281|NCT00112437|12078481|FG009|Year 2 (12-Month Extension)|Protocol Violation|0
7664282|NCT00112437|12078482|FG010|Year 2 (12-Month Extension)|Protocol Violation|0
7664283|NCT00112437|12078483|FG011|Year 2 (12-Month Extension)|Protocol Violation|0
7664284|NCT00112437|12078484|FG012|Year 2 (12-Month Extension)|Protocol Violation|0
7664285|NCT00112437|12078485|FG013|Year 2 (12-Month Extension)|Protocol Violation|0
7664286|NCT00112437|12078486|FG014|Year 2 (12-Month Extension)|Protocol Violation|0
7664287|NCT00112437|12078487|FG015|Year 2 (12-Month Extension)|Protocol Violation|0
7664288|NCT00112437|12078488|FG016|Year 2 (12-Month Extension)|Protocol Violation|0
7664289|NCT00112437|12078489|FG017|Year 2 (12-Month Extension)|Protocol Violation|0
7664290|NCT00112437|12078490|FG018|Year 2 (12-Month Extension)|Protocol Violation|0
7664291|NCT00112437|12078491|FG019|Year 2 (12-Month Extension)|Protocol Violation|0
7664292|NCT00112437|12078492|FG020|Year 2 (12-Month Extension)|Protocol Violation|0
7664293|NCT00112437|12078493|FG021|Year 2 (12-Month Extension)|Protocol Violation|0
7664294|NCT00112437|12078494|FG022|Year 2 (12-Month Extension)|Protocol Violation|0
7664295|NCT00112437|12078495|FG023|Year 2 (12-Month Extension)|Protocol Violation|0
7664296|NCT00112437|12078496|FG024|Year 2 (12-Month Extension)|Protocol Violation|0
7664297|NCT00112437|12078497|FG025|Year 2 (12-Month Extension)|Protocol Violation|0
7664298|NCT00112437|12078472|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664299|NCT00112437|12078473|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664300|NCT00112437|12078474|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664301|NCT00112437|12078475|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664302|NCT00112437|12078476|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664303|NCT00112437|12078477|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1
7664304|NCT00112437|12078478|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1
7664305|NCT00112437|12078479|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2
7664306|NCT00112437|12078480|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4
7664307|NCT00112437|12078481|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1
7664308|NCT00112437|12078482|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664309|NCT00112437|12078483|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664310|NCT00112437|12078484|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664311|NCT00112437|12078485|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664312|NCT00112437|12078486|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664313|NCT00112437|12078487|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664314|NCT00112437|12078488|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664315|NCT00112437|12078489|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664316|NCT00112437|12078490|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664317|NCT00112437|12078491|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664318|NCT00112437|12078492|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664319|NCT00112437|12078493|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664320|NCT00112437|12078494|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664321|NCT00112437|12078495|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664322|NCT00112437|12078496|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664323|NCT00112437|12078497|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7664324|NCT00112437|12078472|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664325|NCT00112437|12078473|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664326|NCT00112437|12078474|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664327|NCT00112437|12078475|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664328|NCT00112437|12078476|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664329|NCT00112437|12078477|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664330|NCT00112437|12078478|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664331|NCT00112437|12078479|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664332|NCT00112437|12078480|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664333|NCT00112437|12078481|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1
7664334|NCT00112437|12078482|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664335|NCT00112437|12078483|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664336|NCT00112437|12078484|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664337|NCT00112437|12078485|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664338|NCT00112437|12078486|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664339|NCT00112437|12078487|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664340|NCT00112437|12078488|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664341|NCT00112437|12078489|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664342|NCT00112437|12078490|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664343|NCT00112437|12078491|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664344|NCT00112437|12078492|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664345|NCT00112437|12078493|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664346|NCT00112437|12078494|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664347|NCT00112437|12078495|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664348|NCT00112437|12078496|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664349|NCT00112437|12078497|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7664350|NCT00112437|12078472|FG000|Year 2 (12-Month Extension)|patient was out of windows|0
7664351|NCT00112437|12078473|FG001|Year 2 (12-Month Extension)|patient was out of windows|0
7664352|NCT00112437|12078474|FG002|Year 2 (12-Month Extension)|patient was out of windows|0
7664353|NCT00112437|12078475|FG003|Year 2 (12-Month Extension)|patient was out of windows|0
7664354|NCT00112437|12078476|FG004|Year 2 (12-Month Extension)|patient was out of windows|0
7664355|NCT00112437|12078477|FG005|Year 2 (12-Month Extension)|patient was out of windows|0
7664356|NCT00112437|12078478|FG006|Year 2 (12-Month Extension)|patient was out of windows|0
7664357|NCT00112437|12078479|FG007|Year 2 (12-Month Extension)|patient was out of windows|0
7664358|NCT00112437|12078480|FG008|Year 2 (12-Month Extension)|patient was out of windows|0
7664359|NCT00112437|12078481|FG009|Year 2 (12-Month Extension)|patient was out of windows|1
7664360|NCT00112437|12078482|FG010|Year 2 (12-Month Extension)|patient was out of windows|0
7664361|NCT00112437|12078483|FG011|Year 2 (12-Month Extension)|patient was out of windows|0
7664362|NCT00112437|12078484|FG012|Year 2 (12-Month Extension)|patient was out of windows|0
7664363|NCT00112437|12078485|FG013|Year 2 (12-Month Extension)|patient was out of windows|0
7664364|NCT00112437|12078486|FG014|Year 2 (12-Month Extension)|patient was out of windows|0
7664365|NCT00112437|12078487|FG015|Year 2 (12-Month Extension)|patient was out of windows|0
7664366|NCT00112437|12078488|FG016|Year 2 (12-Month Extension)|patient was out of windows|0
7664367|NCT00112437|12078489|FG017|Year 2 (12-Month Extension)|patient was out of windows|0
7664368|NCT00112437|12078490|FG018|Year 2 (12-Month Extension)|patient was out of windows|0
7664369|NCT00112437|12078491|FG019|Year 2 (12-Month Extension)|patient was out of windows|0
7664370|NCT00112437|12078492|FG020|Year 2 (12-Month Extension)|patient was out of windows|0
7664371|NCT00112437|12078493|FG021|Year 2 (12-Month Extension)|patient was out of windows|0
7664372|NCT00112437|12078494|FG022|Year 2 (12-Month Extension)|patient was out of windows|0
7664373|NCT00112437|12078495|FG023|Year 2 (12-Month Extension)|patient was out of windows|0
7664374|NCT00112437|12078496|FG024|Year 2 (12-Month Extension)|patient was out of windows|0
7664375|NCT00112437|12078497|FG025|Year 2 (12-Month Extension)|patient was out of windows|0
7664376|NCT00112437|12078472|FG000|Year 2 (12-Month Extension)|Moved|0
7664377|NCT00112437|12078473|FG001|Year 2 (12-Month Extension)|Moved|0
7664378|NCT00112437|12078474|FG002|Year 2 (12-Month Extension)|Moved|0
7664379|NCT00112437|12078475|FG003|Year 2 (12-Month Extension)|Moved|0
7664380|NCT00112437|12078476|FG004|Year 2 (12-Month Extension)|Moved|0
7664381|NCT00112437|12078477|FG005|Year 2 (12-Month Extension)|Moved|0
7664382|NCT00112437|12078478|FG006|Year 2 (12-Month Extension)|Moved|0
7664383|NCT00112437|12078479|FG007|Year 2 (12-Month Extension)|Moved|0
7664384|NCT00112437|12078480|FG008|Year 2 (12-Month Extension)|Moved|0
7664385|NCT00112437|12078481|FG009|Year 2 (12-Month Extension)|Moved|1
7664386|NCT00112437|12078482|FG010|Year 2 (12-Month Extension)|Moved|0
7664387|NCT00112437|12078483|FG011|Year 2 (12-Month Extension)|Moved|0
7664388|NCT00112437|12078484|FG012|Year 2 (12-Month Extension)|Moved|0
7664389|NCT00112437|12078485|FG013|Year 2 (12-Month Extension)|Moved|0
7664390|NCT00112437|12078486|FG014|Year 2 (12-Month Extension)|Moved|0
7664391|NCT00112437|12078487|FG015|Year 2 (12-Month Extension)|Moved|0
7664392|NCT00112437|12078488|FG016|Year 2 (12-Month Extension)|Moved|0
7664393|NCT00112437|12078489|FG017|Year 2 (12-Month Extension)|Moved|0
7664394|NCT00112437|12078490|FG018|Year 2 (12-Month Extension)|Moved|0
7664395|NCT00112437|12078491|FG019|Year 2 (12-Month Extension)|Moved|0
7664396|NCT00112437|12078492|FG020|Year 2 (12-Month Extension)|Moved|0
7664397|NCT00112437|12078493|FG021|Year 2 (12-Month Extension)|Moved|0
7664398|NCT00112437|12078494|FG022|Year 2 (12-Month Extension)|Moved|0
7664399|NCT00112437|12078495|FG023|Year 2 (12-Month Extension)|Moved|0
7664400|NCT00112437|12078496|FG024|Year 2 (12-Month Extension)|Moved|0
7664401|NCT00112437|12078497|FG025|Year 2 (12-Month Extension)|Moved|0
7664402|NCT00112437|12078472|FG000|Year 3 (12-Month Extension)|Adverse Event|0
7664403|NCT00112437|12078473|FG001|Year 3 (12-Month Extension)|Adverse Event|0
7664404|NCT00112437|12078474|FG002|Year 3 (12-Month Extension)|Adverse Event|0
7664405|NCT00112437|12078475|FG003|Year 3 (12-Month Extension)|Adverse Event|0
7664406|NCT00112437|12078476|FG004|Year 3 (12-Month Extension)|Adverse Event|0
7664407|NCT00112437|12078477|FG005|Year 3 (12-Month Extension)|Adverse Event|0
7664408|NCT00112437|12078478|FG006|Year 3 (12-Month Extension)|Adverse Event|0
7664409|NCT00112437|12078479|FG007|Year 3 (12-Month Extension)|Adverse Event|0
7664410|NCT00112437|12078480|FG008|Year 3 (12-Month Extension)|Adverse Event|0
7664411|NCT00112437|12078481|FG009|Year 3 (12-Month Extension)|Adverse Event|0
7664412|NCT00112437|12078482|FG010|Year 3 (12-Month Extension)|Adverse Event|1
7664413|NCT00112437|12078483|FG011|Year 3 (12-Month Extension)|Adverse Event|0
7664414|NCT00112437|12078484|FG012|Year 3 (12-Month Extension)|Adverse Event|0
7664415|NCT00112437|12078485|FG013|Year 3 (12-Month Extension)|Adverse Event|0
7664416|NCT00112437|12078486|FG014|Year 3 (12-Month Extension)|Adverse Event|0
7664417|NCT00112437|12078487|FG015|Year 3 (12-Month Extension)|Adverse Event|1
7664418|NCT00112437|12078488|FG016|Year 3 (12-Month Extension)|Adverse Event|3
7664419|NCT00112437|12078489|FG017|Year 3 (12-Month Extension)|Adverse Event|1
7664420|NCT00112437|12078490|FG018|Year 3 (12-Month Extension)|Adverse Event|0
7664421|NCT00112437|12078491|FG019|Year 3 (12-Month Extension)|Adverse Event|1
7664422|NCT00112437|12078492|FG020|Year 3 (12-Month Extension)|Adverse Event|0
7664423|NCT00112437|12078493|FG021|Year 3 (12-Month Extension)|Adverse Event|0
7664424|NCT00112437|12078494|FG022|Year 3 (12-Month Extension)|Adverse Event|0
7664425|NCT00112437|12078495|FG023|Year 3 (12-Month Extension)|Adverse Event|0
7664426|NCT00112437|12078496|FG024|Year 3 (12-Month Extension)|Adverse Event|0
7664427|NCT00112437|12078497|FG025|Year 3 (12-Month Extension)|Adverse Event|0
7664428|NCT00112437|12078472|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664429|NCT00112437|12078473|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664430|NCT00112437|12078474|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664431|NCT00112437|12078475|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664432|NCT00112437|12078476|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664433|NCT00112437|12078477|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664434|NCT00112437|12078478|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664435|NCT00112437|12078479|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664436|NCT00112437|12078480|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664437|NCT00112437|12078481|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664438|NCT00112437|12078482|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664439|NCT00112437|12078483|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1
7664440|NCT00112437|12078484|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664441|NCT00112437|12078485|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1
7664442|NCT00112437|12078486|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664443|NCT00112437|12078487|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1
7664444|NCT00112437|12078488|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664445|NCT00112437|12078489|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664446|NCT00112437|12078490|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2
7664447|NCT00112437|12078491|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664448|NCT00112437|12078492|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664449|NCT00112437|12078493|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664450|NCT00112437|12078494|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664451|NCT00112437|12078495|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664452|NCT00112437|12078496|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664453|NCT00112437|12078497|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0
7664454|NCT00112437|12078472|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664455|NCT00112437|12078473|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664456|NCT00112437|12078474|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664457|NCT00112437|12078475|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664458|NCT00112437|12078476|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664459|NCT00112437|12078477|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664460|NCT00112437|12078478|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664461|NCT00112437|12078479|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664462|NCT00112437|12078480|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664463|NCT00112437|12078481|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664464|NCT00112437|12078482|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664465|NCT00112437|12078483|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664466|NCT00112437|12078484|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664467|NCT00112437|12078485|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664468|NCT00112437|12078486|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664469|NCT00112437|12078487|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1
7664470|NCT00112437|12078488|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664471|NCT00112437|12078489|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664472|NCT00112437|12078490|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664473|NCT00112437|12078491|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664474|NCT00112437|12078492|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664475|NCT00112437|12078493|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664476|NCT00112437|12078494|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664477|NCT00112437|12078495|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664478|NCT00112437|12078496|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664479|NCT00112437|12078497|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0
7664480|NCT00112437|12078472|FG000|Year 3 (12-Month Extension)|Protocol Violation|0
7664481|NCT00112437|12078473|FG001|Year 3 (12-Month Extension)|Protocol Violation|0
7664482|NCT00112437|12078474|FG002|Year 3 (12-Month Extension)|Protocol Violation|0
7664483|NCT00112437|12078475|FG003|Year 3 (12-Month Extension)|Protocol Violation|0
7664484|NCT00112437|12078476|FG004|Year 3 (12-Month Extension)|Protocol Violation|0
7664485|NCT00112437|12078477|FG005|Year 3 (12-Month Extension)|Protocol Violation|0
7664486|NCT00112437|12078478|FG006|Year 3 (12-Month Extension)|Protocol Violation|0
7664487|NCT00112437|12078479|FG007|Year 3 (12-Month Extension)|Protocol Violation|0
7664488|NCT00112437|12078480|FG008|Year 3 (12-Month Extension)|Protocol Violation|0
7664489|NCT00112437|12078481|FG009|Year 3 (12-Month Extension)|Protocol Violation|0
7664490|NCT00112437|12078482|FG010|Year 3 (12-Month Extension)|Protocol Violation|0
7664491|NCT00112437|12078483|FG011|Year 3 (12-Month Extension)|Protocol Violation|0
7664492|NCT00112437|12078484|FG012|Year 3 (12-Month Extension)|Protocol Violation|0
7664493|NCT00112437|12078485|FG013|Year 3 (12-Month Extension)|Protocol Violation|0
7664494|NCT00112437|12078486|FG014|Year 3 (12-Month Extension)|Protocol Violation|0
7664495|NCT00112437|12078487|FG015|Year 3 (12-Month Extension)|Protocol Violation|1
7664496|NCT00112437|12078488|FG016|Year 3 (12-Month Extension)|Protocol Violation|0
7664497|NCT00112437|12078489|FG017|Year 3 (12-Month Extension)|Protocol Violation|0
7664498|NCT00112437|12078490|FG018|Year 3 (12-Month Extension)|Protocol Violation|0
7664499|NCT00112437|12078491|FG019|Year 3 (12-Month Extension)|Protocol Violation|0
7664500|NCT00112437|12078492|FG020|Year 3 (12-Month Extension)|Protocol Violation|0
7664501|NCT00112437|12078493|FG021|Year 3 (12-Month Extension)|Protocol Violation|0
7664502|NCT00112437|12078494|FG022|Year 3 (12-Month Extension)|Protocol Violation|0
7664503|NCT00112437|12078495|FG023|Year 3 (12-Month Extension)|Protocol Violation|0
7664504|NCT00112437|12078496|FG024|Year 3 (12-Month Extension)|Protocol Violation|0
7664505|NCT00112437|12078497|FG025|Year 3 (12-Month Extension)|Protocol Violation|0
7664506|NCT00112437|12078472|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664507|NCT00112437|12078473|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664508|NCT00112437|12078474|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664509|NCT00112437|12078475|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664510|NCT00112437|12078476|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664511|NCT00112437|12078477|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664512|NCT00112437|12078478|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664513|NCT00112437|12078479|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664514|NCT00112437|12078480|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664515|NCT00112437|12078481|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664516|NCT00112437|12078482|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664517|NCT00112437|12078483|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3
7664518|NCT00112437|12078484|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664519|NCT00112437|12078485|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664520|NCT00112437|12078486|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1
7664521|NCT00112437|12078487|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664522|NCT00112437|12078488|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664523|NCT00112437|12078489|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664524|NCT00112437|12078490|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664525|NCT00112437|12078491|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664526|NCT00112437|12078492|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664527|NCT00112437|12078493|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664528|NCT00112437|12078494|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664529|NCT00112437|12078495|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664530|NCT00112437|12078496|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664531|NCT00112437|12078497|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7664532|NCT00112437|12078472|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664533|NCT00112437|12078473|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664534|NCT00112437|12078474|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664535|NCT00112437|12078475|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664536|NCT00112437|12078476|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664537|NCT00112437|12078477|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664538|NCT00112437|12078478|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664539|NCT00112437|12078479|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664540|NCT00112437|12078480|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664541|NCT00112437|12078481|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664542|NCT00112437|12078482|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
7664543|NCT00112437|12078483|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
7664544|NCT00112437|12078484|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664545|NCT00112437|12078485|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664546|NCT00112437|12078486|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664547|NCT00112437|12078487|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664548|NCT00112437|12078488|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664549|NCT00112437|12078489|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664550|NCT00112437|12078490|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664551|NCT00112437|12078491|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664552|NCT00112437|12078492|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664553|NCT00112437|12078493|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664554|NCT00112437|12078494|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664555|NCT00112437|12078495|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664556|NCT00112437|12078496|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664557|NCT00112437|12078497|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7664558|NCT00112437|12078472|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664559|NCT00112437|12078473|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664560|NCT00112437|12078474|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664561|NCT00112437|12078475|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664562|NCT00112437|12078476|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664563|NCT00112437|12078477|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664564|NCT00112437|12078478|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664565|NCT00112437|12078479|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664566|NCT00112437|12078480|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664567|NCT00112437|12078481|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664568|NCT00112437|12078482|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664569|NCT00112437|12078483|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664570|NCT00112437|12078484|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664571|NCT00112437|12078485|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664572|NCT00112437|12078486|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664573|NCT00112437|12078487|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664574|NCT00112437|12078488|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664575|NCT00112437|12078489|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664576|NCT00112437|12078490|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664577|NCT00112437|12078491|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664578|NCT00112437|12078492|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
7664579|NCT00112437|12078493|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
7664580|NCT00112437|12078494|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664581|NCT00112437|12078495|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664582|NCT00112437|12078496|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664583|NCT00112437|12078497|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7664584|NCT00112437|12078472|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664585|NCT00112437|12078473|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664586|NCT00112437|12078474|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664587|NCT00112437|12078475|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664588|NCT00112437|12078476|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664589|NCT00112437|12078477|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664590|NCT00112437|12078478|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664591|NCT00112437|12078479|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664592|NCT00112437|12078480|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664593|NCT00112437|12078481|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664594|NCT00112437|12078482|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664595|NCT00112437|12078483|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664596|NCT00112437|12078484|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664597|NCT00112437|12078485|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664598|NCT00112437|12078486|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664599|NCT00112437|12078487|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664600|NCT00112437|12078488|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664601|NCT00112437|12078489|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664602|NCT00112437|12078490|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664603|NCT00112437|12078491|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664604|NCT00112437|12078492|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
7664605|NCT00112437|12078493|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664606|NCT00112437|12078494|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664607|NCT00112437|12078495|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664608|NCT00112437|12078496|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664609|NCT00112437|12078497|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7664610|NCT00112437|12078472|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0
7664611|NCT00112437|12078473|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0
7664612|NCT00112437|12078474|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0
7664613|NCT00112437|12078475|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0
7664614|NCT00112437|12078476|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0
7664615|NCT00112437|12078477|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0
7664616|NCT00112437|12078478|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0
7664617|NCT00112437|12078479|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0
7664618|NCT00112437|12078480|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0
7664619|NCT00112437|12078481|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0
7664620|NCT00112437|12078482|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0
7664621|NCT00112437|12078483|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0
7664622|NCT00112437|12078484|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0
7664623|NCT00112437|12078485|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0
7664624|NCT00112437|12078486|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0
7664625|NCT00112437|12078487|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0
7664626|NCT00112437|12078488|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0
7664627|NCT00112437|12078489|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0
7664628|NCT00112437|12078490|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0
7664629|NCT00112437|12078491|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0
7664630|NCT00112437|12078492|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0
7664631|NCT00112437|12078493|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4
7664632|NCT00112437|12078494|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0
7664633|NCT00112437|12078495|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0
7664634|NCT00112437|12078496|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0
7664635|NCT00112437|12078497|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0
7664636|NCT00112437|12078472|FG000|Years 4-5 (24-Month Extension)|Participant moved|0
7664637|NCT00112437|12078473|FG001|Years 4-5 (24-Month Extension)|Participant moved|0
7664638|NCT00112437|12078474|FG002|Years 4-5 (24-Month Extension)|Participant moved|0
7664639|NCT00112437|12078475|FG003|Years 4-5 (24-Month Extension)|Participant moved|0
7664640|NCT00112437|12078476|FG004|Years 4-5 (24-Month Extension)|Participant moved|0
7664641|NCT00112437|12078477|FG005|Years 4-5 (24-Month Extension)|Participant moved|0
7664642|NCT00112437|12078478|FG006|Years 4-5 (24-Month Extension)|Participant moved|0
7664643|NCT00112437|12078479|FG007|Years 4-5 (24-Month Extension)|Participant moved|0
7664644|NCT00112437|12078480|FG008|Years 4-5 (24-Month Extension)|Participant moved|0
7664645|NCT00112437|12078481|FG009|Years 4-5 (24-Month Extension)|Participant moved|0
7664646|NCT00112437|12078482|FG010|Years 4-5 (24-Month Extension)|Participant moved|0
7664647|NCT00112437|12078483|FG011|Years 4-5 (24-Month Extension)|Participant moved|0
7664648|NCT00112437|12078484|FG012|Years 4-5 (24-Month Extension)|Participant moved|0
7664649|NCT00112437|12078485|FG013|Years 4-5 (24-Month Extension)|Participant moved|0
7664650|NCT00112437|12078486|FG014|Years 4-5 (24-Month Extension)|Participant moved|0
7664651|NCT00112437|12078487|FG015|Years 4-5 (24-Month Extension)|Participant moved|0
7664652|NCT00112437|12078488|FG016|Years 4-5 (24-Month Extension)|Participant moved|0
7664653|NCT00112437|12078489|FG017|Years 4-5 (24-Month Extension)|Participant moved|0
7664654|NCT00112437|12078490|FG018|Years 4-5 (24-Month Extension)|Participant moved|0
7664655|NCT00112437|12078491|FG019|Years 4-5 (24-Month Extension)|Participant moved|0
7664656|NCT00112437|12078492|FG020|Years 4-5 (24-Month Extension)|Participant moved|0
7664657|NCT00112437|12078493|FG021|Years 4-5 (24-Month Extension)|Participant moved|1
7664658|NCT00112437|12078494|FG022|Years 4-5 (24-Month Extension)|Participant moved|0
7664659|NCT00112437|12078495|FG023|Years 4-5 (24-Month Extension)|Participant moved|0
7664660|NCT00112437|12078496|FG024|Years 4-5 (24-Month Extension)|Participant moved|0
7664661|NCT00112437|12078497|FG025|Years 4-5 (24-Month Extension)|Participant moved|0
7664662|NCT00112437|12078472|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664663|NCT00112437|12078473|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664664|NCT00112437|12078474|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664665|NCT00112437|12078475|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664666|NCT00112437|12078476|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664667|NCT00112437|12078477|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664668|NCT00112437|12078478|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664669|NCT00112437|12078479|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664670|NCT00112437|12078480|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664671|NCT00112437|12078481|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664672|NCT00112437|12078482|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664673|NCT00112437|12078483|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664674|NCT00112437|12078484|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664675|NCT00112437|12078485|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664676|NCT00112437|12078486|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664677|NCT00112437|12078487|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664678|NCT00112437|12078488|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664679|NCT00112437|12078489|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664680|NCT00112437|12078490|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664681|NCT00112437|12078491|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664682|NCT00112437|12078492|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
7664683|NCT00112437|12078493|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
7664684|NCT00112437|12078494|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664685|NCT00112437|12078495|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664686|NCT00112437|12078496|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664687|NCT00112437|12078497|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7664688|NCT00112437|12078472|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0
7664689|NCT00112437|12078473|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0
7664690|NCT00112437|12078474|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0
7664691|NCT00112437|12078475|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0
7664692|NCT00112437|12078476|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0
7664693|NCT00112437|12078477|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0
7664694|NCT00112437|12078478|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0
7664695|NCT00112437|12078479|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0
7664696|NCT00112437|12078480|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0
7664697|NCT00112437|12078481|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0
7664698|NCT00112437|12078482|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0
7664699|NCT00112437|12078483|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0
7664700|NCT00112437|12078484|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0
7664701|NCT00112437|12078485|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0
7664702|NCT00112437|12078486|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0
7664703|NCT00112437|12078487|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0
7664704|NCT00112437|12078488|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0
7664705|NCT00112437|12078489|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0
7664706|NCT00112437|12078490|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0
7664707|NCT00112437|12078491|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0
7664708|NCT00112437|12078492|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0
7664709|NCT00112437|12078493|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0
7664710|NCT00112437|12078494|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1
7664711|NCT00112437|12078495|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2
7664712|NCT00112437|12078496|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0
7664713|NCT00112437|12078497|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1
7664714|NCT00112437|12078472|FG000|Years 6-10 (60-Month Extension)|Death|0
7664715|NCT00112437|12078473|FG001|Years 6-10 (60-Month Extension)|Death|0
7664716|NCT00112437|12078474|FG002|Years 6-10 (60-Month Extension)|Death|0
7664717|NCT00112437|12078475|FG003|Years 6-10 (60-Month Extension)|Death|0
7664718|NCT00112437|12078476|FG004|Years 6-10 (60-Month Extension)|Death|0
7664719|NCT00112437|12078477|FG005|Years 6-10 (60-Month Extension)|Death|0
7664720|NCT00112437|12078478|FG006|Years 6-10 (60-Month Extension)|Death|0
7664721|NCT00112437|12078479|FG007|Years 6-10 (60-Month Extension)|Death|0
7664722|NCT00112437|12078480|FG008|Years 6-10 (60-Month Extension)|Death|0
7664723|NCT00112437|12078481|FG009|Years 6-10 (60-Month Extension)|Death|0
7664724|NCT00112437|12078482|FG010|Years 6-10 (60-Month Extension)|Death|0
7664725|NCT00112437|12078483|FG011|Years 6-10 (60-Month Extension)|Death|0
7664726|NCT00112437|12078484|FG012|Years 6-10 (60-Month Extension)|Death|0
7664727|NCT00112437|12078485|FG013|Years 6-10 (60-Month Extension)|Death|0
7664728|NCT00112437|12078486|FG014|Years 6-10 (60-Month Extension)|Death|0
7664729|NCT00112437|12078487|FG015|Years 6-10 (60-Month Extension)|Death|0
7664730|NCT00112437|12078488|FG016|Years 6-10 (60-Month Extension)|Death|0
7664731|NCT00112437|12078489|FG017|Years 6-10 (60-Month Extension)|Death|0
7664732|NCT00112437|12078490|FG018|Years 6-10 (60-Month Extension)|Death|0
7664733|NCT00112437|12078491|FG019|Years 6-10 (60-Month Extension)|Death|0
7664734|NCT00112437|12078492|FG020|Years 6-10 (60-Month Extension)|Death|0
7664735|NCT00112437|12078493|FG021|Years 6-10 (60-Month Extension)|Death|0
7664736|NCT00112437|12078494|FG022|Years 6-10 (60-Month Extension)|Death|0
7664737|NCT00112437|12078495|FG023|Years 6-10 (60-Month Extension)|Death|2
7664738|NCT00112437|12078496|FG024|Years 6-10 (60-Month Extension)|Death|0
7664739|NCT00112437|12078497|FG025|Years 6-10 (60-Month Extension)|Death|0
7664740|NCT00112437|12078472|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664741|NCT00112437|12078473|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664742|NCT00112437|12078474|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664743|NCT00112437|12078475|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664744|NCT00112437|12078476|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664745|NCT00112437|12078477|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664746|NCT00112437|12078478|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664747|NCT00112437|12078479|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664748|NCT00112437|12078480|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664749|NCT00112437|12078481|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664750|NCT00112437|12078482|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664751|NCT00112437|12078483|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664752|NCT00112437|12078484|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664753|NCT00112437|12078485|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664754|NCT00112437|12078486|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664755|NCT00112437|12078487|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664756|NCT00112437|12078488|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664757|NCT00112437|12078489|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664758|NCT00112437|12078490|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664759|NCT00112437|12078491|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664760|NCT00112437|12078492|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664761|NCT00112437|12078493|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664762|NCT00112437|12078494|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664763|NCT00112437|12078495|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664764|NCT00112437|12078496|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7664765|NCT00112437|12078497|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
7664766|NCT00112437|12078472|FG000|Years 6-10 (60-Month Extension)|Other|0
7664767|NCT00112437|12078473|FG001|Years 6-10 (60-Month Extension)|Other|0
7664768|NCT00112437|12078474|FG002|Years 6-10 (60-Month Extension)|Other|0
7664769|NCT00112437|12078475|FG003|Years 6-10 (60-Month Extension)|Other|0
7664770|NCT00112437|12078476|FG004|Years 6-10 (60-Month Extension)|Other|0
7664771|NCT00112437|12078477|FG005|Years 6-10 (60-Month Extension)|Other|0
7664772|NCT00112437|12078478|FG006|Years 6-10 (60-Month Extension)|Other|0
7664773|NCT00112437|12078479|FG007|Years 6-10 (60-Month Extension)|Other|0
7664774|NCT00112437|12078480|FG008|Years 6-10 (60-Month Extension)|Other|0
7664775|NCT00112437|12078481|FG009|Years 6-10 (60-Month Extension)|Other|0
7664776|NCT00112437|12078482|FG010|Years 6-10 (60-Month Extension)|Other|0
7664777|NCT00112437|12078483|FG011|Years 6-10 (60-Month Extension)|Other|0
7664778|NCT00112437|12078484|FG012|Years 6-10 (60-Month Extension)|Other|0
7664779|NCT00112437|12078485|FG013|Years 6-10 (60-Month Extension)|Other|0
7664780|NCT00112437|12078486|FG014|Years 6-10 (60-Month Extension)|Other|0
7664781|NCT00112437|12078487|FG015|Years 6-10 (60-Month Extension)|Other|0
7664782|NCT00112437|12078488|FG016|Years 6-10 (60-Month Extension)|Other|0
7664783|NCT00112437|12078489|FG017|Years 6-10 (60-Month Extension)|Other|0
7664784|NCT00112437|12078490|FG018|Years 6-10 (60-Month Extension)|Other|0
7664785|NCT00112437|12078491|FG019|Years 6-10 (60-Month Extension)|Other|0
7664786|NCT00112437|12078492|FG020|Years 6-10 (60-Month Extension)|Other|0
7664787|NCT00112437|12078493|FG021|Years 6-10 (60-Month Extension)|Other|0
7664788|NCT00112437|12078494|FG022|Years 6-10 (60-Month Extension)|Other|0
7664789|NCT00112437|12078495|FG023|Years 6-10 (60-Month Extension)|Other|0
7664790|NCT00112437|12078496|FG024|Years 6-10 (60-Month Extension)|Other|1
7664791|NCT00112437|12078497|FG025|Years 6-10 (60-Month Extension)|Other|0
7664792|NCT00112437|12078472|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0
7664793|NCT00112437|12078473|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0
7664794|NCT00112437|12078474|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0
7664795|NCT00112437|12078475|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0
7664796|NCT00112437|12078476|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0
7664797|NCT00112437|12078477|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0
7664798|NCT00112437|12078478|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0
7664799|NCT00112437|12078479|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0
7664800|NCT00112437|12078480|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0
7664801|NCT00112437|12078481|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0
7664802|NCT00112437|12078482|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0
7664803|NCT00112437|12078483|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0
7664804|NCT00112437|12078484|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0
7664805|NCT00112437|12078485|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0
7664806|NCT00112437|12078486|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0
7664807|NCT00112437|12078487|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0
7664808|NCT00112437|12078488|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0
7664809|NCT00112437|12078489|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0
7664810|NCT00112437|12078490|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0
7664811|NCT00112437|12078491|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0
7664812|NCT00112437|12078492|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0
7664813|NCT00112437|12078493|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0
7664814|NCT00112437|12078494|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0
7664815|NCT00112437|12078495|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2
7664816|NCT00112437|12078496|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0
7664817|NCT00112437|12078497|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0
7664818|NCT00112437|12078472|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664819|NCT00112437|12078473|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664820|NCT00112437|12078474|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664821|NCT00112437|12078475|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664822|NCT00112437|12078476|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664823|NCT00112437|12078477|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664824|NCT00112437|12078478|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664825|NCT00112437|12078479|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664826|NCT00112437|12078480|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664827|NCT00112437|12078481|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664828|NCT00112437|12078482|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664829|NCT00112437|12078483|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664830|NCT00112437|12078484|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664831|NCT00112437|12078485|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664832|NCT00112437|12078486|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664833|NCT00112437|12078487|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664834|NCT00112437|12078488|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664835|NCT00112437|12078489|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664836|NCT00112437|12078490|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664837|NCT00112437|12078491|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664838|NCT00112437|12078492|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664839|NCT00112437|12078493|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664840|NCT00112437|12078494|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
7664841|NCT00112437|12078495|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
7664842|NCT00112437|12078496|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7664843|NCT00112437|12078497|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
7664844|NCT00112463|12078551|FG000|Overall Study|Physician Decision|1
7664845|NCT00112463|12078551|FG000|Overall Study|Progression|30
7664846|NCT00112463|12078551|FG000|Overall Study|Second Primary|1
7664847|NCT00112463|12078551|FG000|Overall Study|Toxicity|3
7664848|NCT00112463|12078551|FG000|Overall Study|Withdrawal by Subject|2
7664849|NCT00112463|12078551|FG000|Overall Study|Never started treatment|2
7664850|NCT00112489|12078556|FG000|Overall Study|Refused further treatment|8
7664851|NCT00112489|12078556|FG000|Overall Study|Adverse Event|12
7664852|NCT00112489|12078556|FG000|Overall Study|Death|2
7664853|NCT00112489|12078556|FG000|Overall Study|Other, Not Specified|9
7664854|NCT00112489|12078556|FG000|Overall Study|Patient never treated|2
7664855|NCT00112489|12078556|FG000|Overall Study|Ineligible|7
7664856|NCT00112502|12078574|FG000|Overall Study|Withdrawal by Subject|0
7664857|NCT00112502|12078575|FG001|Overall Study|Withdrawal by Subject|1
7664858|NCT00112502|12078576|FG002|Overall Study|Withdrawal by Subject|1
7664859|NCT00112502|12078577|FG003|Overall Study|Withdrawal by Subject|4
7664860|NCT00112502|12078578|FG004|Overall Study|Withdrawal by Subject|2
7664861|NCT00112502|12078579|FG005|Overall Study|Withdrawal by Subject|5
7664862|NCT00112502|12078580|FG006|Overall Study|Withdrawal by Subject|3
7664863|NCT00112502|12078581|FG007|Overall Study|Withdrawal by Subject|7
7664864|NCT00112580|12078611|FG000|Overall Study|Adverse Event|1
7664865|NCT00112580|12078612|FG001|Overall Study|Adverse Event|2
7664866|NCT00112580|12078611|FG000|Overall Study|Disease progression|5
7664867|NCT00112580|12078612|FG001|Overall Study|Disease progression|16
7664868|NCT00112580|12078611|FG000|Overall Study|Participant withdrew consent|2
7664869|NCT00112580|12078612|FG001|Overall Study|Participant withdrew consent|1
7664870|NCT00112736|12078651|FG000|Overall Study|1 pt never had had RX due rapid decline|1
7664871|NCT00112736|12078652|FG001|Overall Study|1 pt never had had RX due rapid decline|0
7664872|NCT00112866|12078688|FG000|Overall Study|Protocol Violation|1
7664873|NCT00112866|12078689|FG001|Overall Study|Protocol Violation|0
7664874|NCT00112866|12078688|FG000|Overall Study|did not start treatment post-op|1
7664875|NCT00112866|12078689|FG001|Overall Study|did not start treatment post-op|2
7664876|NCT00112905|12078703|FG000|Overall Study|Adverse Event|4
7664877|NCT00112905|12078703|FG000|Overall Study|Death|1
7664878|NCT00112905|12078703|FG000|Overall Study|Ineligibility|5
7664879|NCT00112905|12078703|FG000|Overall Study|Alternative treatment|1
7664880|NCT00112905|12078703|FG000|Overall Study|performance status was deteiorating|1
7664881|NCT00112957|12078720|FG000|Overall Study|Progressive disease|18
7664882|NCT00112957|12078720|FG000|Overall Study|Physician Decision|1
7664883|NCT00113087|12078735|FG000|Overall Study|Death or Transplant|14
7664884|NCT00113087|12078736|FG001|Overall Study|Death or Transplant|16
7664885|NCT00113087|12078735|FG000|Overall Study|Family or MD withdrew subject|10
7664886|NCT00113087|12078736|FG001|Overall Study|Family or MD withdrew subject|5
7664887|NCT00113269|12078754|FG000|Overall Study|Not transplanted, donor issues|4
7664888|NCT00113269|12078755|FG001|Overall Study|Not transplanted, donor issues|0
7664889|NCT00113269|12078756|FG002|Overall Study|Not transplanted, donor issues|2
7664890|NCT00113269|12078757|FG003|Overall Study|Not transplanted, donor issues|2
7664891|NCT00113269|12078754|FG000|Overall Study|Not transplanted, recipient issues|2
7664892|NCT00113269|12078755|FG001|Overall Study|Not transplanted, recipient issues|1
7664893|NCT00113269|12078756|FG002|Overall Study|Not transplanted, recipient issues|7
7664894|NCT00113269|12078757|FG003|Overall Study|Not transplanted, recipient issues|4
7664895|NCT00113269|12078754|FG000|Overall Study|Early graft loss, technical|0
7664896|NCT00113269|12078755|FG001|Overall Study|Early graft loss, technical|0
7664897|NCT00113269|12078756|FG002|Overall Study|Early graft loss, technical|2
7664898|NCT00113269|12078757|FG003|Overall Study|Early graft loss, technical|0
7664899|NCT00113269|12078754|FG000|Overall Study|Death in operating room|0
7664900|NCT00113269|12078755|FG001|Overall Study|Death in operating room|0
7664901|NCT00113269|12078756|FG002|Overall Study|Death in operating room|0
7664902|NCT00113269|12078757|FG003|Overall Study|Death in operating room|1
7664903|NCT00113269|12078754|FG000|Overall Study|Did not meet eligibility - pre-treatment|0
7664904|NCT00113269|12078755|FG001|Overall Study|Did not meet eligibility - pre-treatment|0
7664905|NCT00113269|12078756|FG002|Overall Study|Did not meet eligibility - pre-treatment|0
7664906|NCT00113269|12078757|FG003|Overall Study|Did not meet eligibility - pre-treatment|2
7664907|NCT00113269|12078754|FG000|Overall Study|Adverse Event|2
7664908|NCT00113269|12078755|FG001|Overall Study|Adverse Event|7
7664909|NCT00113269|12078756|FG002|Overall Study|Adverse Event|11
7664910|NCT00113269|12078757|FG003|Overall Study|Adverse Event|7
7664911|NCT00113269|12078754|FG000|Overall Study|Withdrawal by Subject|4
7664912|NCT00113269|12078755|FG001|Overall Study|Withdrawal by Subject|3
7664913|NCT00113269|12078756|FG002|Overall Study|Withdrawal by Subject|4
7664914|NCT00113269|12078757|FG003|Overall Study|Withdrawal by Subject|2
7664915|NCT00113269|12078754|FG000|Overall Study|Graft loss|6
7664916|NCT00113269|12078755|FG001|Overall Study|Graft loss|6
7664917|NCT00113269|12078756|FG002|Overall Study|Graft loss|4
7664918|NCT00113269|12078757|FG003|Overall Study|Graft loss|9
7664919|NCT00113269|12078754|FG000|Overall Study|Protocol Violation|1
7664920|NCT00113269|12078755|FG001|Overall Study|Protocol Violation|0
7664921|NCT00113269|12078756|FG002|Overall Study|Protocol Violation|4
7664922|NCT00113269|12078757|FG003|Overall Study|Protocol Violation|2
7664923|NCT00113269|12078754|FG000|Overall Study|Lost to Follow-up|2
7664924|NCT00113269|12078755|FG001|Overall Study|Lost to Follow-up|3
7664925|NCT00113269|12078756|FG002|Overall Study|Lost to Follow-up|6
7664926|NCT00113269|12078757|FG003|Overall Study|Lost to Follow-up|3
7664927|NCT00113269|12078754|FG000|Overall Study|Sponsor elected to discontinue patient|1
7664928|NCT00113269|12078755|FG001|Overall Study|Sponsor elected to discontinue patient|0
7664929|NCT00113269|12078756|FG002|Overall Study|Sponsor elected to discontinue patient|0
7664930|NCT00113269|12078757|FG003|Overall Study|Sponsor elected to discontinue patient|1
7664931|NCT00113269|12078754|FG000|Overall Study|Discontinued due to rejection|0
7664932|NCT00113269|12078755|FG001|Overall Study|Discontinued due to rejection|0
7664933|NCT00113269|12078756|FG002|Overall Study|Discontinued due to rejection|1
7664934|NCT00113269|12078757|FG003|Overall Study|Discontinued due to rejection|0
7664935|NCT00113269|12078754|FG000|Overall Study|Moved|0
7664936|NCT00113269|12078755|FG001|Overall Study|Moved|1
7664937|NCT00113269|12078756|FG002|Overall Study|Moved|0
7664938|NCT00113269|12078757|FG003|Overall Study|Moved|3
7664939|NCT00113269|12078754|FG000|Overall Study|Received pancreas transplant|0
7664940|NCT00113269|12078755|FG001|Overall Study|Received pancreas transplant|0
7664941|NCT00113269|12078756|FG002|Overall Study|Received pancreas transplant|0
7664942|NCT00113269|12078757|FG003|Overall Study|Received pancreas transplant|2
7664943|NCT00113269|12078754|FG000|Overall Study|Withdrew consent, Prednisone initiated|0
7664944|NCT00113269|12078755|FG001|Overall Study|Withdrew consent, Prednisone initiated|0
7664945|NCT00113269|12078756|FG002|Overall Study|Withdrew consent, Prednisone initiated|0
7664946|NCT00113269|12078757|FG003|Overall Study|Withdrew consent, Prednisone initiated|1
7664947|NCT00113269|12078754|FG000|Overall Study|Did not meet eligibility criteria|1
7664948|NCT00113269|12078755|FG001|Overall Study|Did not meet eligibility criteria|0
7664949|NCT00113269|12078756|FG002|Overall Study|Did not meet eligibility criteria|0
7664950|NCT00113269|12078757|FG003|Overall Study|Did not meet eligibility criteria|1
7664951|NCT00113269|12078754|FG000|Overall Study|Unable to return for follow up|2
7664952|NCT00113269|12078755|FG001|Overall Study|Unable to return for follow up|1
7664953|NCT00113269|12078756|FG002|Overall Study|Unable to return for follow up|0
7664954|NCT00113269|12078757|FG003|Overall Study|Unable to return for follow up|0
7664955|NCT00113295|12078769|FG000|Overall Study|Adverse Event|4
7664956|NCT00113295|12078770|FG001|Overall Study|Adverse Event|1
7664957|NCT00113295|12078769|FG000|Overall Study|Unrelated Medical Illness|1
7664958|NCT00113295|12078770|FG001|Overall Study|Unrelated Medical Illness|0
7664959|NCT00113360|12078786|FG000|Overall Study|Adverse Event|3
7664960|NCT00113360|12078786|FG000|Overall Study|Subject required surgery|1
7664961|NCT00113360|12078786|FG000|Overall Study|Did not meet eligibility criteria|3
7664962|NCT00113373|12078790|FG000|Overall Study|Ineligible: wrong primary|1
7664963|NCT00113373|12078790|FG000|Overall Study|Ineligible: second primary|1
7664964|NCT00113373|12078790|FG000|Overall Study|Never Treated|1
7664965|NCT00113490|12078806|FG000|Overall Study|Withdrawal by Subject|1
7664966|NCT00113490|12078807|FG001|Overall Study|Withdrawal by Subject|3
7664967|NCT00113490|12078806|FG000|Overall Study|Lost to Follow-up|1
7664968|NCT00113490|12078807|FG001|Overall Study|Lost to Follow-up|0
7664969|NCT00113516|12078813|FG000|Part 1|Adverse Event|6
7664970|NCT00113516|12078814|FG001|Part 1|Adverse Event|0
7664971|NCT00113516|12078813|FG000|Part 1|Death|3
7664972|NCT00113516|12078814|FG001|Part 1|Death|0
7664973|NCT00113516|12078813|FG000|Part 1|Other|3
7664974|NCT00113516|12078814|FG001|Part 1|Other|0
7664975|NCT00113516|12078813|FG000|Part 1|Withdrawal by Subject|2
7664976|NCT00113516|12078814|FG001|Part 1|Withdrawal by Subject|0
7664977|NCT00113516|12078813|FG000|Part 1|Lack of Efficacy|2
7664978|NCT00113516|12078814|FG001|Part 1|Lack of Efficacy|0
7664979|NCT00113516|12078813|FG000|Part 1|Did Not Meet Entrance Criteria|1
7664980|NCT00113516|12078814|FG001|Part 1|Did Not Meet Entrance Criteria|0
7664981|NCT00113516|12078813|FG000|Part 1|Laboratory Abnormality|1
7664982|NCT00113516|12078814|FG001|Part 1|Laboratory Abnormality|0
7664983|NCT00113516|12078813|FG000|Part 1|Ongoing|1
7664984|NCT00113516|12078814|FG001|Part 1|Ongoing|0
7664985|NCT00113516|12078813|FG000|Part 1|Missing|65
7664986|NCT00113516|12078814|FG001|Part 1|Missing|0
7664987|NCT00113516|12078813|FG000|Part 2|Adverse Event|0
7664988|NCT00113516|12078814|FG001|Part 2|Adverse Event|16
7664989|NCT00113516|12078813|FG000|Part 2|Death|0
7664990|NCT00113516|12078814|FG001|Part 2|Death|5
7664991|NCT00113516|12078813|FG000|Part 2|Lack of Efficacy|0
7664992|NCT00113516|12078814|FG001|Part 2|Lack of Efficacy|37
7664993|NCT00113516|12078813|FG000|Part 2|Withdrawal by Subject|0
7664994|NCT00113516|12078814|FG001|Part 2|Withdrawal by Subject|3
7664995|NCT00113516|12078813|FG000|Part 2|Other|0
7664996|NCT00113516|12078814|FG001|Part 2|Other|3
7664997|NCT00113516|12078813|FG000|Part 2|Laboratory Abnormality|0
7664998|NCT00113516|12078814|FG001|Part 2|Laboratory Abnormality|1
7664999|NCT00113516|12078813|FG000|Part 2|Ongoing|0
7665000|NCT00113516|12078814|FG001|Part 2|Ongoing|1
7665001|NCT00113529|12078820|FG000|Overall Study|Adverse Event|4
7665002|NCT00113529|12078820|FG000|Overall Study|Lack of Efficacy|20
7665003|NCT00113529|12078820|FG000|Overall Study|Decision of sponsor|6
7665004|NCT00113529|12078820|FG000|Overall Study|Withdrawal by Subject|4
7665005|NCT00113555|12078824|FG000|Overall Study|Baseline Failure|59
7665006|NCT00113555|12078824|FG000|Overall Study|Permanently Explanted|7
7665007|NCT00113555|12078824|FG000|Overall Study|Death|1
7665008|NCT00113555|12078824|FG000|Overall Study|Missed Followup|4
7665009|NCT00113555|12078824|FG000|Overall Study|Lost to Follow-up|8
7665010|NCT00113568|12078829|FG000|Overall Study|Adverse Event|97
7665011|NCT00113568|12078829|FG000|Overall Study|Death|1
7665012|NCT00113568|12078829|FG000|Overall Study|Lack of Efficacy|30
7665013|NCT00113568|12078829|FG000|Overall Study|Lost to Follow-up|156
7665014|NCT00113568|12078829|FG000|Overall Study|Protocol Violation|32
7665015|NCT00113568|12078829|FG000|Overall Study|Withdrawal by Subject|117
7665016|NCT00113568|12078829|FG000|Overall Study|Other|112
7665017|NCT00113607|12078835|FG000|Overall Study|Adverse Event|40
7665018|NCT00113607|12078836|FG001|Overall Study|Adverse Event|71
7665019|NCT00113607|12078835|FG000|Overall Study|Death|8
7665020|NCT00113607|12078836|FG001|Overall Study|Death|8
7665021|NCT00113607|12078835|FG000|Overall Study|Withdrawal by Subject|50
7665022|NCT00113607|12078836|FG001|Overall Study|Withdrawal by Subject|58
7665023|NCT00113607|12078835|FG000|Overall Study|Lost to Follow-up|0
7665024|NCT00113607|12078836|FG001|Overall Study|Lost to Follow-up|2
7665025|NCT00113607|12078835|FG000|Overall Study|Disease Progression|180
7665026|NCT00113607|12078836|FG001|Overall Study|Disease Progression|142
7665027|NCT00113607|12078835|FG000|Overall Study|Complete Response (Confirmed)|14
7665028|NCT00113607|12078836|FG001|Overall Study|Complete Response (Confirmed)|24
7665029|NCT00113607|12078835|FG000|Overall Study|Other|43
7665030|NCT00113607|12078836|FG001|Overall Study|Other|32
7665031|NCT00113841|12078845|FG000|Overall Study|Disease progression|0
7665032|NCT00113841|12078846|FG001|Overall Study|Disease progression|2
7665033|NCT00113841|12078845|FG000|Overall Study|Non-compliant|1
7665034|NCT00113841|12078846|FG001|Overall Study|Non-compliant|0
7665035|NCT00114127|12078901|FG000|Overall Study|Adverse Event|2
7665036|NCT00114127|12078902|FG001|Overall Study|Adverse Event|1
7665037|NCT00114127|12078901|FG000|Overall Study|Lost to Follow-up|1
7665038|NCT00114127|12078902|FG001|Overall Study|Lost to Follow-up|0
7665039|NCT00114127|12078901|FG000|Overall Study|Withdrawal by Subject|1
7665040|NCT00114127|12078902|FG001|Overall Study|Withdrawal by Subject|3
7665041|NCT00114166|12078910|FG000|Overall Study|Wrong primary|0
7665042|NCT00114166|12078911|FG001|Overall Study|Wrong primary|1
7665043|NCT00114218|12078919|FG000|Overall Study|Wrong Cell Type|2
7665044|NCT00114218|12078919|FG000|Overall Study|Wrong Primary|1
7665045|NCT00114218|12078919|FG000|Overall Study|Never Treated|1
7665046|NCT00114231|12078925|FG000|Overall Study|No consent|2
7665047|NCT00114231|12078926|FG001|Overall Study|No consent|0
7665048|NCT00114231|12078925|FG000|Overall Study|QARC requirement not met|1
7665049|NCT00114231|12078926|FG001|Overall Study|QARC requirement not met|0
7665050|NCT00114231|12078925|FG000|Overall Study|Suspected metastatic disease|1
7665051|NCT00114231|12078926|FG001|Overall Study|Suspected metastatic disease|0
7665052|NCT00114231|12078925|FG000|Overall Study|No adenocarcinoma|1
7665053|NCT00114231|12078926|FG001|Overall Study|No adenocarcinoma|0
7665054|NCT00114231|12078925|FG000|Overall Study|Low creatinine clearance|0
7665055|NCT00114231|12078926|FG001|Overall Study|Low creatinine clearance|1
7665056|NCT00114231|12078925|FG000|Overall Study|Tumor size > 4cm|1
7665057|NCT00114231|12078926|FG001|Overall Study|Tumor size > 4cm|0
7665058|NCT00114231|12078925|FG000|Overall Study|Tumor fixed on digital exam|0
7665059|NCT00114231|12078926|FG001|Overall Study|Tumor fixed on digital exam|1
7665060|NCT00114231|12078925|FG000|Overall Study|No Absolute Neutrophil Count|2
7665061|NCT00114231|12078926|FG001|Overall Study|No Absolute Neutrophil Count|0
7665062|NCT00114231|12078925|FG000|Overall Study|Biopsy done after registration|1
7665063|NCT00114231|12078926|FG001|Overall Study|Biopsy done after registration|0
7665064|NCT00114244|12078933|FG000|Overall Study|Adverse Event|2
7665065|NCT00114244|12078934|FG001|Overall Study|Adverse Event|5
7665066|NCT00114244|12078933|FG000|Overall Study|Withdrawal by Subject|0
7665067|NCT00114244|12078934|FG001|Overall Study|Withdrawal by Subject|2
7665068|NCT00114530|12078968|FG000|Overall Study|Death|3
7665069|NCT00114530|12078969|FG001|Overall Study|Death|11
7665070|NCT00114530|12078968|FG000|Overall Study|Lost to Follow-up|1
7665071|NCT00114530|12078969|FG001|Overall Study|Lost to Follow-up|1
7665072|NCT00114530|12078968|FG000|Overall Study|Physician Decision|1
7665073|NCT00114530|12078969|FG001|Overall Study|Physician Decision|1
7665074|NCT00114530|12078968|FG000|Overall Study|Withdrawal by Subject|2
7665075|NCT00114530|12078969|FG001|Overall Study|Withdrawal by Subject|6
7665076|NCT00114530|12078968|FG000|Overall Study|Breast Cancer|1
7665077|NCT00114530|12078969|FG001|Overall Study|Breast Cancer|0
7665078|NCT00114530|12078968|FG000|Overall Study|Subject decision after endpoint failure|0
7665079|NCT00114530|12078969|FG001|Overall Study|Subject decision after endpoint failure|1
7665080|NCT00114530|12078968|FG000|Overall Study|Ineligible|1
7665081|NCT00114530|12078969|FG001|Overall Study|Ineligible|0
7665082|NCT00114634|12078979|FG000|Overall Study|failure to return forms|3
7665083|NCT00114738|12078985|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
7665084|NCT00114738|12078986|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
7665085|NCT00114738|12078987|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
7665086|NCT00114738|12078985|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
7665087|NCT00114738|12078986|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
7665088|NCT00114738|12078987|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
7665089|NCT00114738|12078985|FG000|Screening for Randomization|Neuropathy|17
7665090|NCT00114738|12078986|FG001|Screening for Randomization|Neuropathy|0
7665091|NCT00114738|12078987|FG002|Screening for Randomization|Neuropathy|0
7665092|NCT00114738|12078985|FG000|Screening for Randomization|Progressive disease|2
7665093|NCT00114738|12078986|FG001|Screening for Randomization|Progressive disease|0
7665094|NCT00114738|12078987|FG002|Screening for Randomization|Progressive disease|0
7665095|NCT00114738|12078985|FG000|Screening for Randomization|CNS Hemorrhage|1
7665096|NCT00114738|12078986|FG001|Screening for Randomization|CNS Hemorrhage|0
7665097|NCT00114738|12078987|FG002|Screening for Randomization|CNS Hemorrhage|0
7665098|NCT00114738|12078985|FG000|Screening for Randomization|Other|1
7665099|NCT00114738|12078986|FG001|Screening for Randomization|Other|0
7665100|NCT00114738|12078987|FG002|Screening for Randomization|Other|0
7665101|NCT00114777|12078997|FG000|Randomization to Month 36|Death|10
7665102|NCT00114777|12078998|FG001|Randomization to Month 36|Death|4
7665103|NCT00114777|12078999|FG002|Randomization to Month 36|Death|3
7665104|NCT00114777|12078997|FG000|Randomization to Month 36|No Longer Met Study Criteria|0
7665105|NCT00114777|12078998|FG001|Randomization to Month 36|No Longer Met Study Criteria|0
7665106|NCT00114777|12078999|FG002|Randomization to Month 36|No Longer Met Study Criteria|2
7665107|NCT00114777|12078997|FG000|Randomization to Month 36|Lack of Efficacy|19
7665108|NCT00114777|12078998|FG001|Randomization to Month 36|Lack of Efficacy|15
7665109|NCT00114777|12078999|FG002|Randomization to Month 36|Lack of Efficacy|17
7665110|NCT00114777|12078997|FG000|Randomization to Month 36|Poor or Non-Compliance|0
7665111|NCT00114777|12078998|FG001|Randomization to Month 36|Poor or Non-Compliance|0
7665112|NCT00114777|12078999|FG002|Randomization to Month 36|Poor or Non-Compliance|1
7665113|NCT00114777|12078997|FG000|Randomization to Month 36|Adverse Event|34
7665114|NCT00114777|12078998|FG001|Randomization to Month 36|Adverse Event|35
7665115|NCT00114777|12078999|FG002|Randomization to Month 36|Adverse Event|44
7665116|NCT00114777|12078997|FG000|Randomization to Month 36|Withdrawal by Subject|3
7665117|NCT00114777|12078998|FG001|Randomization to Month 36|Withdrawal by Subject|4
7665118|NCT00114777|12078999|FG002|Randomization to Month 36|Withdrawal by Subject|5
7665119|NCT00114777|12078997|FG000|Randomization to Month 36|Other|9
7665120|NCT00114777|12078998|FG001|Randomization to Month 36|Other|3
7665121|NCT00114777|12078999|FG002|Randomization to Month 36|Other|12
7665122|NCT00114777|12078997|FG000|Long-Term Extension to Month 84|Death|8
7665123|NCT00114777|12078998|FG001|Long-Term Extension to Month 84|Death|13
7665124|NCT00114777|12078999|FG002|Long-Term Extension to Month 84|Death|7
7665125|NCT00114777|12078997|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
7665126|NCT00114777|12078998|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
7665127|NCT00114777|12078999|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
7665128|NCT00114777|12078997|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1
7665129|NCT00114777|12078998|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0
7665130|NCT00114777|12078999|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1
7665131|NCT00114777|12078997|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1
7665132|NCT00114777|12078998|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1
7665133|NCT00114777|12078999|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3
7665134|NCT00114777|12078997|FG000|Long-Term Extension to Month 84|Adverse Event|15
7665135|NCT00114777|12078998|FG001|Long-Term Extension to Month 84|Adverse Event|14
7665136|NCT00114777|12078999|FG002|Long-Term Extension to Month 84|Adverse Event|7
7665137|NCT00114777|12078997|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2
7665138|NCT00114777|12078998|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1
7665139|NCT00114777|12078999|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6
7665140|NCT00114777|12078997|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0
7665141|NCT00114777|12078998|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0
7665142|NCT00114777|12078999|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2
7665143|NCT00114777|12078997|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
7665144|NCT00114777|12078998|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
7665145|NCT00114777|12078999|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
7665146|NCT00114777|12078997|FG000|Long-Term Extension to Month 84|Other|2
7665147|NCT00114777|12078998|FG001|Long-Term Extension to Month 84|Other|0
7665148|NCT00114777|12078999|FG002|Long-Term Extension to Month 84|Other|2
7665149|NCT00114959|12079008|FG000|Overall Study|Lack of Efficacy|6
7665150|NCT00114959|12079008|FG000|Overall Study|Physician Decision|1
7665151|NCT00114959|12079008|FG000|Overall Study|Death|1
7665152|NCT00114972|12079014|FG000|Overall Study|Withdrawal by Subject|40
7665153|NCT00114972|12079015|FG001|Overall Study|Withdrawal by Subject|7
7665154|NCT00114972|12079014|FG000|Overall Study|Lost to Follow-up|8
7665155|NCT00114972|12079015|FG001|Overall Study|Lost to Follow-up|5
7665156|NCT00115037|12079023|FG000|Phase1|Lost to Follow-up|16
7665157|NCT00115037|12079024|FG001|Phase1|Lost to Follow-up|23
7665158|NCT00115037|12079025|FG002|Phase1|Lost to Follow-up|0
7665159|NCT00115037|12079026|FG003|Phase1|Lost to Follow-up|0
7665160|NCT00115037|12079027|FG004|Phase1|Lost to Follow-up|0
7665161|NCT00115037|12079028|FG005|Phase1|Lost to Follow-up|0
7665162|NCT00115037|12079023|FG000|Phase1|Withdrawal by Subject|9
7665163|NCT00115037|12079024|FG001|Phase1|Withdrawal by Subject|4
7665164|NCT00115037|12079025|FG002|Phase1|Withdrawal by Subject|0
7665165|NCT00115037|12079026|FG003|Phase1|Withdrawal by Subject|0
7665166|NCT00115037|12079027|FG004|Phase1|Withdrawal by Subject|0
7665167|NCT00115037|12079028|FG005|Phase1|Withdrawal by Subject|0
7665168|NCT00115037|12079023|FG000|Phase2|Death|0
7665169|NCT00115037|12079024|FG001|Phase2|Death|0
7665170|NCT00115037|12079025|FG002|Phase2|Death|1
7665171|NCT00115037|12079026|FG003|Phase2|Death|0
7665172|NCT00115037|12079027|FG004|Phase2|Death|0
7665173|NCT00115037|12079028|FG005|Phase2|Death|1
7665174|NCT00115037|12079023|FG000|Phase2|Withdrawal by Subject|0
7665175|NCT00115037|12079024|FG001|Phase2|Withdrawal by Subject|0
7665176|NCT00115037|12079025|FG002|Phase2|Withdrawal by Subject|2
7665177|NCT00115037|12079026|FG003|Phase2|Withdrawal by Subject|1
7665178|NCT00115037|12079027|FG004|Phase2|Withdrawal by Subject|2
7665179|NCT00115037|12079028|FG005|Phase2|Withdrawal by Subject|1
7665180|NCT00115037|12079023|FG000|Phase2|Lost to Follow-up|0
7665181|NCT00115037|12079024|FG001|Phase2|Lost to Follow-up|0
7665182|NCT00115037|12079025|FG002|Phase2|Lost to Follow-up|12
7665183|NCT00115037|12079026|FG003|Phase2|Lost to Follow-up|14
7665184|NCT00115037|12079027|FG004|Phase2|Lost to Follow-up|4
7665185|NCT00115037|12079028|FG005|Phase2|Lost to Follow-up|10
7665186|NCT00115063|12079044|FG000|Overall Study|Lost to Follow-up|98
7665187|NCT00115063|12079045|FG001|Overall Study|Lost to Follow-up|104
7665188|NCT00115063|12079044|FG000|Overall Study|Death|1
7665189|NCT00115063|12079045|FG001|Overall Study|Death|0
7665190|NCT00115336|12079069|FG000|Overall Study|Hospital discharge before study drug|0
7665191|NCT00115336|12079070|FG001|Overall Study|Hospital discharge before study drug|1
7665192|NCT00115349|12079080|FG000|Overall Study|Study closed due to low enrollment.|11
7665193|NCT00115349|12079081|FG001|Overall Study|Study closed due to low enrollment.|9
7665194|NCT00115739|12079087|FG000|Overall Study|Lost to Follow-up|3
7665195|NCT00115765|12079097|FG000|Overall Study|Withdrawal by Subject|22
7665196|NCT00115765|12079098|FG001|Overall Study|Withdrawal by Subject|53
7665197|NCT00115765|12079099|FG002|Overall Study|Withdrawal by Subject|76
7665198|NCT00115765|12079100|FG003|Overall Study|Withdrawal by Subject|15
7665199|NCT00115765|12079097|FG000|Overall Study|Physician Decision|4
7665200|NCT00115765|12079098|FG001|Overall Study|Physician Decision|15
7665201|NCT00115765|12079099|FG002|Overall Study|Physician Decision|18
7665202|NCT00115765|12079100|FG003|Overall Study|Physician Decision|13
7665203|NCT00115765|12079097|FG000|Overall Study|Lost to Follow-up|3
7665204|NCT00115765|12079098|FG001|Overall Study|Lost to Follow-up|20
7665205|NCT00115765|12079099|FG002|Overall Study|Lost to Follow-up|18
7665206|NCT00115765|12079100|FG003|Overall Study|Lost to Follow-up|1
7665207|NCT00115765|12079097|FG000|Overall Study|Other|6
7665208|NCT00115765|12079098|FG001|Overall Study|Other|12
7665209|NCT00115765|12079099|FG002|Overall Study|Other|9
7665210|NCT00115765|12079100|FG003|Overall Study|Other|2
7665211|NCT00115778|12079108|FG000|Overall Study|Withdrawal by Subject|0
7665212|NCT00115778|12079109|FG001|Overall Study|Withdrawal by Subject|1
7665213|NCT00115804|12079115|FG000|Overall Study|Adverse Event|2
7665214|NCT00115934|12079134|FG000|Overall Study|Lost to Follow-up|1
7665215|NCT00115934|12079135|FG001|Overall Study|Lost to Follow-up|0
7665216|NCT00115934|12079134|FG000|Overall Study|Did not receive intervention|3
7665217|NCT00115934|12079135|FG001|Overall Study|Did not receive intervention|2
7665218|NCT00116168|12079145|FG000|Overall Study|Lost to Follow-up|6
7665219|NCT00116168|12079146|FG001|Overall Study|Lost to Follow-up|5
7665220|NCT00116168|12079147|FG002|Overall Study|Lost to Follow-up|0
7665221|NCT00116168|12079148|FG003|Overall Study|Lost to Follow-up|0
7665222|NCT00116272|12079169|FG000|Overall Study|Lost to Follow-up|11
7665223|NCT00116272|12079170|FG001|Overall Study|Lost to Follow-up|6
7665224|NCT00116428|12079191|FG000|Overall Study|Withdrawal by Subject|2
7665225|NCT00116428|12079192|FG001|Overall Study|Withdrawal by Subject|5
7665226|NCT00116428|12079191|FG000|Overall Study|Did not meet inclusion criteria|1
7665227|NCT00116428|12079192|FG001|Overall Study|Did not meet inclusion criteria|0
7665228|NCT00116558|12079204|FG000|Overall Study|Death|11
7665229|NCT00116558|12079205|FG001|Overall Study|Death|5
7665230|NCT00116558|12079206|FG002|Overall Study|Death|3
7665231|NCT00116558|12079204|FG000|Overall Study|Withdrawal by Subject|17
7665232|NCT00116558|12079205|FG001|Overall Study|Withdrawal by Subject|3
7665233|NCT00116558|12079206|FG002|Overall Study|Withdrawal by Subject|12
7665234|NCT00116558|12079204|FG000|Overall Study|disease progression|3
7665235|NCT00116558|12079205|FG001|Overall Study|disease progression|7
7665236|NCT00116558|12079206|FG002|Overall Study|disease progression|18
7665237|NCT00116584|12079215|FG000|Overall Study|Withdrawal by Subject|1
7665238|NCT00116584|12079216|FG001|Overall Study|Withdrawal by Subject|0
7665239|NCT00116584|12079215|FG000|Overall Study|Protocol Violation|1
7665240|NCT00116584|12079216|FG001|Overall Study|Protocol Violation|1
7665241|NCT00116649|12079222|FG000|Overall Study|Adverse Event|20
7665242|NCT00116649|12079222|FG000|Overall Study|Lack of Efficacy|1
7665243|NCT00116649|12079222|FG000|Overall Study|Lost to Follow-up|32
7665244|NCT00116649|12079222|FG000|Overall Study|Withdrawal by Subject|68
7665245|NCT00116649|12079222|FG000|Overall Study|Local Skin Reaction|9
7665246|NCT00116649|12079222|FG000|Overall Study|Various Reasons|18
7665247|NCT00116649|12079222|FG000|Overall Study|Protocol Specified|7
7665248|NCT00116688|12079228|FG000|Overall Study|Protocol deviation|1
7665249|NCT00116688|12079229|FG001|Overall Study|Protocol deviation|0
7665250|NCT00116688|12079228|FG000|Overall Study|Noncompliance|3
7665251|NCT00116688|12079229|FG001|Overall Study|Noncompliance|1
7665252|NCT00116688|12079228|FG000|Overall Study|Adverse Event|11
7665253|NCT00116688|12079229|FG001|Overall Study|Adverse Event|0
7665254|NCT00116688|12079228|FG000|Overall Study|Withdrawal by Subject|26
7665255|NCT00116688|12079229|FG001|Overall Study|Withdrawal by Subject|2
7665256|NCT00116688|12079228|FG000|Overall Study|Requirement for alternative therapy|11
7665257|NCT00116688|12079229|FG001|Overall Study|Requirement for alternative therapy|1
7665258|NCT00116688|12079228|FG000|Overall Study|Physician Decision|7
7665259|NCT00116688|12079229|FG001|Overall Study|Physician Decision|0
7665260|NCT00116688|12079228|FG000|Overall Study|Lost to Follow-up|3
7665261|NCT00116688|12079229|FG001|Overall Study|Lost to Follow-up|0
7665262|NCT00116688|12079228|FG000|Overall Study|Death|15
7665263|NCT00116688|12079229|FG001|Overall Study|Death|0
7665264|NCT00116688|12079228|FG000|Overall Study|Protocol-specified criteria|3
7665265|NCT00116688|12079229|FG001|Overall Study|Protocol-specified criteria|0
7665266|NCT00116688|12079228|FG000|Overall Study|Pregnancy|1
7665267|NCT00116688|12079229|FG001|Overall Study|Pregnancy|0
7665268|NCT00116688|12079228|FG000|Overall Study|Other|11
7665269|NCT00116688|12079229|FG001|Overall Study|Other|0
7665270|NCT00116753|12079238|FG000|Overall Study|Adverse Event|16
7665271|NCT00116753|12079239|FG001|Overall Study|Adverse Event|10
7665272|NCT00116753|12079240|FG002|Overall Study|Adverse Event|7
7665273|NCT00116753|12079238|FG000|Overall Study|Withdrawal by Subject|11
7665274|NCT00116753|12079239|FG001|Overall Study|Withdrawal by Subject|12
7665275|NCT00116753|12079240|FG002|Overall Study|Withdrawal by Subject|8
7665276|NCT00116753|12079238|FG000|Overall Study|Lost to Follow-up|0
7665277|NCT00116753|12079239|FG001|Overall Study|Lost to Follow-up|2
7665278|NCT00116753|12079240|FG002|Overall Study|Lost to Follow-up|1
7665279|NCT00116753|12079238|FG000|Overall Study|Protocol Violation|0
7665280|NCT00116753|12079239|FG001|Overall Study|Protocol Violation|0
7665281|NCT00116753|12079240|FG002|Overall Study|Protocol Violation|1
7665282|NCT00116753|12079238|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1
7665283|NCT00116753|12079239|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1
7665284|NCT00116753|12079240|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3
7665285|NCT00116753|12079238|FG000|Overall Study|Disease Progression|3
7665286|NCT00116753|12079239|FG001|Overall Study|Disease Progression|4
7665287|NCT00116753|12079240|FG002|Overall Study|Disease Progression|3
7665288|NCT00116753|12079238|FG000|Overall Study|Abnormal Echocardiogram|0
7665289|NCT00116753|12079239|FG001|Overall Study|Abnormal Echocardiogram|0
7665290|NCT00116753|12079240|FG002|Overall Study|Abnormal Echocardiogram|1
7665291|NCT00116753|12079238|FG000|Overall Study|Progressive Parkinson's Disease|1
7665292|NCT00116753|12079239|FG001|Overall Study|Progressive Parkinson's Disease|0
7665293|NCT00116753|12079240|FG002|Overall Study|Progressive Parkinson's Disease|0
7665294|NCT00116753|12079238|FG000|Overall Study|Dosing Error|0
7665295|NCT00116753|12079239|FG001|Overall Study|Dosing Error|1
7665296|NCT00116753|12079240|FG002|Overall Study|Dosing Error|0
7665297|NCT00116779|12079250|FG000|Overall Study|Adverse Event|4
7665298|NCT00116779|12079251|FG001|Overall Study|Adverse Event|2
7665299|NCT00116779|12079250|FG000|Overall Study|Protocol Violation|1
7665300|NCT00116779|12079251|FG001|Overall Study|Protocol Violation|4
7665301|NCT00116779|12079250|FG000|Overall Study|Withdrawal by Subject|4
7665302|NCT00116779|12079251|FG001|Overall Study|Withdrawal by Subject|1
7665303|NCT00116779|12079250|FG000|Overall Study|Inadequate testosterone suppression|7
7665304|NCT00116779|12079251|FG001|Overall Study|Inadequate testosterone suppression|9
7665305|NCT00116779|12079250|FG000|Overall Study|Physician Decision|3
7665306|NCT00116779|12079251|FG001|Overall Study|Physician Decision|1
7665307|NCT00116779|12079250|FG000|Overall Study|Elevated PSA levels|2
7665308|NCT00116779|12079251|FG001|Overall Study|Elevated PSA levels|2
7665309|NCT00116805|12079259|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6
7665310|NCT00116805|12079260|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2
7665311|NCT00116805|12079259|FG000|Double-blind Period Through Week 48|Protocol Violation|1
7665312|NCT00116805|12079260|FG001|Double-blind Period Through Week 48|Protocol Violation|1
7665313|NCT00116805|12079259|FG000|Double-blind Period Through Week 48|Withdrew Consent|4
7665314|NCT00116805|12079260|FG001|Double-blind Period Through Week 48|Withdrew Consent|2
7665315|NCT00116805|12079259|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
7665316|NCT00116805|12079260|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
7665317|NCT00116805|12079259|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
7665318|NCT00116805|12079260|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
7665319|NCT00116805|12079259|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2
7665320|NCT00116805|12079260|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0
7665321|NCT00116805|12079259|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
7665322|NCT00116805|12079260|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
7665323|NCT00116805|12079259|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2
7665324|NCT00116805|12079260|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0
7665325|NCT00116805|12079259|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2
7665326|NCT00116805|12079260|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1
7665327|NCT00116805|12079259|FG000|Open-label Period Weeks 97 - 144|Completed Study|1
7665328|NCT00116805|12079260|FG001|Open-label Period Weeks 97 - 144|Completed Study|0
7665329|NCT00116805|12079259|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
7665330|NCT00116805|12079260|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
7665331|NCT00116805|12079259|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
7665332|NCT00116805|12079260|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
7665333|NCT00116805|12079259|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0
7665334|NCT00116805|12079260|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1
7665335|NCT00116805|12079259|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2
7665336|NCT00116805|12079260|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3
7665337|NCT00116805|12079259|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1
7665338|NCT00116805|12079260|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3
7665339|NCT00116805|12079259|FG000|Open-label Period Weeks 145 - 192|Completed Study|1
7665340|NCT00116805|12079260|FG001|Open-label Period Weeks 145 - 192|Completed Study|1
7665341|NCT00116805|12079259|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
7665342|NCT00116805|12079260|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
7665343|NCT00116805|12079259|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
7665344|NCT00116805|12079260|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
7665345|NCT00116805|12079259|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1
7665346|NCT00116805|12079260|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0
7665347|NCT00116805|12079259|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
7665348|NCT00116805|12079260|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
7665349|NCT00116805|12079259|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0
7665350|NCT00116805|12079260|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1
7665351|NCT00116805|12079259|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3
7665352|NCT00116805|12079260|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2
7665353|NCT00116805|12079259|FG000|Open-label Period Weeks 193 - 240|Completed Study|0
7665354|NCT00116805|12079260|FG001|Open-label Period Weeks 193 - 240|Completed Study|1
7665355|NCT00116805|12079259|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
7665356|NCT00116805|12079260|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
7665357|NCT00116805|12079259|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
7665358|NCT00116805|12079260|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
7665359|NCT00116805|12079259|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
7665360|NCT00116805|12079260|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
7665361|NCT00116805|12079259|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7
7665362|NCT00116805|12079260|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1
7665363|NCT00116805|12079259|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
7665364|NCT00116805|12079260|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
7665365|NCT00116805|12079259|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4
7665366|NCT00116805|12079260|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0
7665367|NCT00116805|12079259|FG000|Open-label Period Weeks 289 - 336|Completed Study|0
7665368|NCT00116805|12079260|FG001|Open-label Period Weeks 289 - 336|Completed Study|1
7665369|NCT00116805|12079259|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
7665370|NCT00116805|12079260|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
7665371|NCT00116805|12079259|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
7665372|NCT00116805|12079260|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
7665373|NCT00116805|12079259|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0
7665374|NCT00116805|12079260|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1
7665375|NCT00116805|12079259|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
7665450|NCT00117286|12079325|FG000|Overall Study|Lack of Efficacy|2
7665376|NCT00116805|12079260|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
7665377|NCT00116805|12079259|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
7665378|NCT00116805|12079260|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
7665379|NCT00116805|12079259|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2
7665380|NCT00116805|12079260|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0
7665381|NCT00116805|12079259|FG000|Open-label Period Weeks 337 - 384|Completed Study|1
7665382|NCT00116805|12079260|FG001|Open-label Period Weeks 337 - 384|Completed Study|0
7665383|NCT00116805|12079259|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
7665384|NCT00116805|12079260|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
7665385|NCT00116805|12079259|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
7665386|NCT00116805|12079260|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
7665387|NCT00116805|12079259|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1
7665388|NCT00116805|12079260|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0
7665389|NCT00116805|12079259|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3
7665390|NCT00116805|12079260|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1
7665391|NCT00116805|12079259|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1
7665392|NCT00116805|12079260|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0
7665393|NCT00116805|12079259|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1
7665394|NCT00116805|12079260|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0
7665395|NCT00116805|12079259|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1
7665396|NCT00116805|12079260|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0
7665397|NCT00116805|12079259|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3
7665398|NCT00116805|12079260|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0
7665399|NCT00116831|12079277|FG000|Overall Study|Adverse Event|14
7665400|NCT00116831|12079278|FG001|Overall Study|Adverse Event|16
7665401|NCT00116831|12079277|FG000|Overall Study|Baseline IVUS determined unevaluable|12
7665402|NCT00116831|12079278|FG001|Overall Study|Baseline IVUS determined unevaluable|11
7665403|NCT00116831|12079277|FG000|Overall Study|Lost to Follow-up|8
7665404|NCT00116831|12079278|FG001|Overall Study|Lost to Follow-up|6
7665405|NCT00116831|12079277|FG000|Overall Study|Protocol Violation|3
7665406|NCT00116831|12079278|FG001|Overall Study|Protocol Violation|6
7665407|NCT00116831|12079277|FG000|Overall Study|Hypoglycaemic events|1
7665408|NCT00116831|12079278|FG001|Overall Study|Hypoglycaemic events|0
7665409|NCT00116831|12079277|FG000|Overall Study|Low haemoglobin on screening|1
7665410|NCT00116831|12079278|FG001|Overall Study|Low haemoglobin on screening|0
7665411|NCT00116831|12079277|FG000|Overall Study|Withdrawn investigational product|1
7665412|NCT00116831|12079278|FG001|Overall Study|Withdrawn investigational product|0
7665413|NCT00116831|12079277|FG000|Overall Study|Withdrawal by Subject|32
7665414|NCT00116831|12079278|FG001|Overall Study|Withdrawal by Subject|32
7665415|NCT00116831|12079277|FG000|Overall Study|Insufficient therapeutic effect|0
7665416|NCT00116831|12079278|FG001|Overall Study|Insufficient therapeutic effect|1
7665417|NCT00116831|12079277|FG000|Overall Study|Missing data for participant|1
7665418|NCT00116831|12079278|FG001|Overall Study|Missing data for participant|0
7665419|NCT00116844|12079286|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
7665420|NCT00116844|12079287|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
7665421|NCT00116844|12079286|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
7665422|NCT00116844|12079287|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
7665423|NCT00116844|12079286|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
7665424|NCT00116844|12079287|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
7665425|NCT00116844|12079286|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1
7665426|NCT00116844|12079287|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1
7665427|NCT00116844|12079286|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
7665428|NCT00116844|12079287|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
7665429|NCT00116844|12079286|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
7665430|NCT00116844|12079287|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
7665431|NCT00116844|12079286|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0
7665432|NCT00116844|12079287|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2
7665433|NCT00116844|12079286|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
7665434|NCT00116844|12079287|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
7665435|NCT00116844|12079286|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
7665436|NCT00116844|12079287|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
7665437|NCT00117156|12079319|FG000|Overall Study|Adverse Event|9
7665438|NCT00117156|12079319|FG000|Overall Study|Physician Decision|1
7665439|NCT00117156|12079319|FG000|Overall Study|Trt for Pre-Exist Second Primary|1
7665440|NCT00117286|12079325|FG000|Overall Study|Adverse Event|12
7665441|NCT00117286|12079326|FG001|Overall Study|Adverse Event|6
7665442|NCT00117286|12079325|FG000|Overall Study|Lost to Follow-up|2
7665443|NCT00117286|12079326|FG001|Overall Study|Lost to Follow-up|0
7665444|NCT00117286|12079325|FG000|Overall Study|Protocol Violation|3
7665445|NCT00117286|12079326|FG001|Overall Study|Protocol Violation|3
7665446|NCT00117286|12079325|FG000|Overall Study|Withdrawal by Subject|6
7665447|NCT00117286|12079326|FG001|Overall Study|Withdrawal by Subject|2
7665448|NCT00117286|12079325|FG000|Overall Study|Physician Decision|3
7665449|NCT00117286|12079326|FG001|Overall Study|Physician Decision|7
7665451|NCT00117286|12079326|FG001|Overall Study|Lack of Efficacy|1
7665452|NCT00117286|12079325|FG000|Overall Study|Research site closing|0
7665453|NCT00117286|12079326|FG001|Overall Study|Research site closing|2
7665454|NCT00117312|12079336|FG000|Overall Study|Testosterone >1.0 ng/mL|9
7665455|NCT00117312|12079337|FG001|Overall Study|Testosterone >1.0 ng/mL|9
7665456|NCT00117312|12079338|FG002|Overall Study|Testosterone >1.0 ng/mL|5
7665457|NCT00117312|12079339|FG003|Overall Study|Testosterone >1.0 ng/mL|9
7665458|NCT00117312|12079336|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
7665459|NCT00117312|12079337|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
7665460|NCT00117312|12079338|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
7665461|NCT00117312|12079339|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
7665462|NCT00117312|12079336|FG000|Overall Study|Prostate-specific antigen increase >=25%|0
7665463|NCT00117312|12079337|FG001|Overall Study|Prostate-specific antigen increase >=25%|1
7665464|NCT00117312|12079338|FG002|Overall Study|Prostate-specific antigen increase >=25%|5
7665465|NCT00117312|12079339|FG003|Overall Study|Prostate-specific antigen increase >=25%|3
7665466|NCT00117312|12079336|FG000|Overall Study|Other|0
7665467|NCT00117312|12079337|FG001|Overall Study|Other|1
7665468|NCT00117312|12079338|FG002|Overall Study|Other|3
7665469|NCT00117312|12079339|FG003|Overall Study|Other|1
7665470|NCT00117312|12079336|FG000|Overall Study|Patient choice|0
7665471|NCT00117312|12079337|FG001|Overall Study|Patient choice|0
7665472|NCT00117312|12079338|FG002|Overall Study|Patient choice|2
7665473|NCT00117312|12079339|FG003|Overall Study|Patient choice|1
7665474|NCT00117312|12079336|FG000|Overall Study|Adverse Event|0
7665475|NCT00117312|12079337|FG001|Overall Study|Adverse Event|2
7665476|NCT00117312|12079338|FG002|Overall Study|Adverse Event|0
7665477|NCT00117312|12079339|FG003|Overall Study|Adverse Event|0
7665478|NCT00117312|12079336|FG000|Overall Study|Protocol Violation|0
7665479|NCT00117312|12079337|FG001|Overall Study|Protocol Violation|1
7665480|NCT00117312|12079338|FG002|Overall Study|Protocol Violation|3
7665481|NCT00117312|12079339|FG003|Overall Study|Protocol Violation|0
7665482|NCT00117312|12079336|FG000|Overall Study|PSA decrease <=50%|0
7665483|NCT00117312|12079337|FG001|Overall Study|PSA decrease <=50%|2
7665484|NCT00117312|12079338|FG002|Overall Study|PSA decrease <=50%|2
7665485|NCT00117312|12079339|FG003|Overall Study|PSA decrease <=50%|4
7665486|NCT00117312|12079336|FG000|Overall Study|PSA increase >= 10ng/mL|0
7665487|NCT00117312|12079337|FG001|Overall Study|PSA increase >= 10ng/mL|1
7665488|NCT00117312|12079338|FG002|Overall Study|PSA increase >= 10ng/mL|1
7665489|NCT00117312|12079339|FG003|Overall Study|PSA increase >= 10ng/mL|0
7665490|NCT00117312|12079336|FG000|Overall Study|Hepatic abnormality|0
7665491|NCT00117312|12079337|FG001|Overall Study|Hepatic abnormality|1
7665492|NCT00117312|12079338|FG002|Overall Study|Hepatic abnormality|0
7665493|NCT00117312|12079339|FG003|Overall Study|Hepatic abnormality|1
7665494|NCT00117312|12079336|FG000|Overall Study|Withdrawal by Subject|0
7665495|NCT00117312|12079337|FG001|Overall Study|Withdrawal by Subject|2
7665496|NCT00117312|12079338|FG002|Overall Study|Withdrawal by Subject|0
7665497|NCT00117312|12079339|FG003|Overall Study|Withdrawal by Subject|0
7665498|NCT00117325|12079351|FG000|Overall Study|Adverse Event|3
7665499|NCT00117325|12079352|FG001|Overall Study|Adverse Event|3
7665500|NCT00117325|12079351|FG000|Overall Study|Lost to Follow-up|1
7665501|NCT00117325|12079352|FG001|Overall Study|Lost to Follow-up|1
7665502|NCT00117325|12079351|FG000|Overall Study|Protocol Violation|2
7665503|NCT00117325|12079352|FG001|Overall Study|Protocol Violation|3
7665504|NCT00117325|12079351|FG000|Overall Study|Withdrawal by Subject|3
7665505|NCT00117325|12079352|FG001|Overall Study|Withdrawal by Subject|2
7665506|NCT00117325|12079351|FG000|Overall Study|Lack of Efficacy|1
7665507|NCT00117325|12079352|FG001|Overall Study|Lack of Efficacy|0
7665508|NCT00117325|12079351|FG000|Overall Study|Use of prohibited medicine|1
7665509|NCT00117325|12079352|FG001|Overall Study|Use of prohibited medicine|2
7665510|NCT00117325|12079351|FG000|Overall Study|Early termination|1
7665511|NCT00117325|12079352|FG001|Overall Study|Early termination|1
7665512|NCT00117325|12079351|FG000|Overall Study|Admisnitrative|1
7665513|NCT00117325|12079352|FG001|Overall Study|Admisnitrative|0
7665514|NCT00117507|12079359|FG000|Overall Study|Adverse Event|4
7665515|NCT00117507|12079359|FG000|Overall Study|Abnormal laboratory values|3
7665516|NCT00117507|12079359|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7665517|NCT00117507|12079359|FG000|Overall Study|Patient withdrew consent|4
7665518|NCT00117507|12079359|FG000|Overall Study|Death|3
7665519|NCT00117572|12079375|FG000|Overall Study|Site withdrew before starting treatment|2
7665520|NCT00117572|12079376|FG001|Overall Study|Site withdrew before starting treatment|3
7665521|NCT00117572|12079375|FG000|Overall Study|Withdrawal by Subject|3
7665522|NCT00117572|12079376|FG001|Overall Study|Withdrawal by Subject|3
7665523|NCT00117572|12079375|FG000|Overall Study|Protocol Violation|1
7665524|NCT00117572|12079376|FG001|Overall Study|Protocol Violation|0
7665525|NCT00117598|12079389|FG000|Prior to Treatment Cross Over|Death|40
7665526|NCT00117598|12079390|FG001|Prior to Treatment Cross Over|Death|41
7665527|NCT00117598|12079391|FG002|Prior to Treatment Cross Over|Death|37
7665528|NCT00117598|12079392|FG003|Prior to Treatment Cross Over|Death|0
7665529|NCT00117598|12079393|FG004|Prior to Treatment Cross Over|Death|0
7665530|NCT00117598|12079389|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0
7665531|NCT00117598|12079390|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2
7665532|NCT00117598|12079391|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2
7665533|NCT00117598|12079392|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0
7665534|NCT00117598|12079393|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0
7665535|NCT00117598|12079389|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2
7665536|NCT00117598|12079390|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1
7665537|NCT00117598|12079391|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4
7665538|NCT00117598|12079392|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0
7665539|NCT00117598|12079393|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0
7665540|NCT00117598|12079389|FG000|Prior to Treatment Cross Over|Other|15
7665541|NCT00117598|12079390|FG001|Prior to Treatment Cross Over|Other|9
7665542|NCT00117598|12079391|FG002|Prior to Treatment Cross Over|Other|9
7665543|NCT00117598|12079392|FG003|Prior to Treatment Cross Over|Other|0
7665544|NCT00117598|12079393|FG004|Prior to Treatment Cross Over|Other|0
7665545|NCT00117598|12079389|FG000|After Treament Cross Over|Death|0
7665546|NCT00117598|12079390|FG001|After Treament Cross Over|Death|0
7665547|NCT00117598|12079391|FG002|After Treament Cross Over|Death|0
7665548|NCT00117598|12079392|FG003|After Treament Cross Over|Death|1
7665549|NCT00117598|12079393|FG004|After Treament Cross Over|Death|2
7665550|NCT00117598|12079389|FG000|After Treament Cross Over|Withdrawal by Subject|0
7665551|NCT00117598|12079390|FG001|After Treament Cross Over|Withdrawal by Subject|0
7665552|NCT00117598|12079391|FG002|After Treament Cross Over|Withdrawal by Subject|0
7665553|NCT00117598|12079392|FG003|After Treament Cross Over|Withdrawal by Subject|1
7665554|NCT00117598|12079393|FG004|After Treament Cross Over|Withdrawal by Subject|0
7665555|NCT00117598|12079389|FG000|After Treament Cross Over|Other|0
7665556|NCT00117598|12079390|FG001|After Treament Cross Over|Other|0
7665557|NCT00117598|12079391|FG002|After Treament Cross Over|Other|0
7665558|NCT00117598|12079392|FG003|After Treament Cross Over|Other|1
7665559|NCT00117598|12079393|FG004|After Treament Cross Over|Other|2
7665560|NCT00117637|12079405|FG000|First Intervention (Period 1)|Adverse Event|11
7665561|NCT00117637|12079406|FG001|First Intervention (Period 1)|Adverse Event|16
7665562|NCT00117637|12079405|FG000|First Intervention (Period 1)|Lost to Follow-up|0
7665563|NCT00117637|12079406|FG001|First Intervention (Period 1)|Lost to Follow-up|2
7665564|NCT00117637|12079405|FG000|First Intervention (Period 1)|Protocol Violation|1
7665565|NCT00117637|12079406|FG001|First Intervention (Period 1)|Protocol Violation|0
7665566|NCT00117637|12079405|FG000|First Intervention (Period 1)|Withdrawal by Subject|2
7665567|NCT00117637|12079406|FG001|First Intervention (Period 1)|Withdrawal by Subject|4
7665568|NCT00117637|12079405|FG000|First Intervention (Period 1)|study terminated by the sponsor|3
7665569|NCT00117637|12079406|FG001|First Intervention (Period 1)|study terminated by the sponsor|1
7665570|NCT00117637|12079405|FG000|First Intervention (Period 1)|protocol driven decision point|1
7665571|NCT00117637|12079406|FG001|First Intervention (Period 1)|protocol driven decision point|0
7665572|NCT00117637|12079405|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0
7665573|NCT00117637|12079406|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1
7665574|NCT00117637|12079405|FG000|First Intervention (Period 1)|reason not reported|0
7665575|NCT00117637|12079406|FG001|First Intervention (Period 1)|reason not reported|1
7665576|NCT00117637|12079405|FG000|Second Intervention (Period 2)|Adverse Event|0
7665577|NCT00117637|12079406|FG001|Second Intervention (Period 2)|Adverse Event|9
7665578|NCT00117637|12079405|FG000|Second Intervention (Period 2)|Lost to Follow-up|1
7665579|NCT00117637|12079406|FG001|Second Intervention (Period 2)|Lost to Follow-up|0
7665580|NCT00117637|12079405|FG000|Second Intervention (Period 2)|Protocol Violation|1
7665581|NCT00117637|12079406|FG001|Second Intervention (Period 2)|Protocol Violation|0
7665582|NCT00117637|12079405|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4
7665583|NCT00117637|12079406|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3
7665584|NCT00117637|12079405|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2
7665585|NCT00117637|12079406|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9
7665586|NCT00117637|12079405|FG000|Second Intervention (Period 2)|non compliant with study medication|1
7665587|NCT00117637|12079406|FG001|Second Intervention (Period 2)|non compliant with study medication|1
7665588|NCT00117637|12079405|FG000|Second Intervention (Period 2)|reason not reported|1
7665589|NCT00117637|12079406|FG001|Second Intervention (Period 2)|reason not reported|0
7665590|NCT00117676|12079421|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4
7665591|NCT00117676|12079422|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3
7665592|NCT00117676|12079421|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1
7665593|NCT00117676|12079422|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0
7665594|NCT00117676|12079421|FG000|Double-blind Period Through Week 48|Protocol Violation|0
7665595|NCT00117676|12079422|FG001|Double-blind Period Through Week 48|Protocol Violation|1
7665596|NCT00117676|12079421|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
7665597|NCT00117676|12079422|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
7665598|NCT00117676|12079421|FG000|Double-blind Period Through Week 48|Withdrew Consent|0
7665599|NCT00117676|12079422|FG001|Double-blind Period Through Week 48|Withdrew Consent|1
7665600|NCT00117676|12079421|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
7665601|NCT00117676|12079422|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
7665602|NCT00117676|12079421|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
7665603|NCT00117676|12079422|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
7665604|NCT00117676|12079421|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
7665605|NCT00117676|12079422|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
7665674|NCT00117949|12079462|FG000|Overall Study|PSA increase >=10ng/mL|0
7665606|NCT00117676|12079421|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
7665607|NCT00117676|12079422|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
7665608|NCT00117676|12079421|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
7665609|NCT00117676|12079422|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
7665610|NCT00117676|12079421|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
7665611|NCT00117676|12079422|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
7665612|NCT00117676|12079421|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
7665613|NCT00117676|12079422|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
7665614|NCT00117676|12079421|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
7665615|NCT00117676|12079422|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
7665616|NCT00117676|12079421|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
7665617|NCT00117676|12079422|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
7665618|NCT00117676|12079421|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
7665619|NCT00117676|12079422|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
7665620|NCT00117676|12079421|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
7665621|NCT00117676|12079422|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
7665622|NCT00117676|12079421|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
7665623|NCT00117676|12079422|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
7665624|NCT00117676|12079421|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
7665625|NCT00117676|12079422|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
7665626|NCT00117676|12079421|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
7665627|NCT00117676|12079422|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
7665628|NCT00117676|12079421|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
7665629|NCT00117676|12079422|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
7665630|NCT00117676|12079421|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2
7665631|NCT00117676|12079422|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0
7665632|NCT00117676|12079421|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
7665633|NCT00117676|12079422|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
7665634|NCT00117676|12079421|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
7665635|NCT00117676|12079422|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
7665636|NCT00117676|12079421|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
7665637|NCT00117676|12079422|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
7665638|NCT00117676|12079421|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
7665639|NCT00117676|12079422|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
7665640|NCT00117676|12079421|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
7665641|NCT00117676|12079422|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
7665642|NCT00117676|12079421|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
7665643|NCT00117676|12079422|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
7665644|NCT00117676|12079421|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
7665645|NCT00117676|12079422|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
7665646|NCT00117676|12079421|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
7665647|NCT00117676|12079422|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
7665648|NCT00117676|12079421|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
7665649|NCT00117676|12079422|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
7665650|NCT00117676|12079421|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0
7665651|NCT00117676|12079422|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1
7665652|NCT00117676|12079421|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
7665653|NCT00117676|12079422|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
7665654|NCT00117676|12079421|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
7665655|NCT00117676|12079422|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
7665656|NCT00117676|12079421|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
7665657|NCT00117676|12079422|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
7665658|NCT00117676|12079421|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
7665659|NCT00117676|12079422|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
7665660|NCT00117793|12079437|FG000|Overall Study|Withdrawal by Subject|12
7665661|NCT00117845|12079454|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1
7665662|NCT00117949|12079462|FG000|Overall Study|Testosterone >1.0 ng/mL|10
7665663|NCT00117949|12079463|FG001|Overall Study|Testosterone >1.0 ng/mL|18
7665664|NCT00117949|12079464|FG002|Overall Study|Testosterone >1.0 ng/mL|17
7665665|NCT00117949|12079465|FG003|Overall Study|Testosterone >1.0 ng/mL|15
7665666|NCT00117949|12079462|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
7665667|NCT00117949|12079463|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
7665668|NCT00117949|12079464|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
7665669|NCT00117949|12079465|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
7665670|NCT00117949|12079462|FG000|Overall Study|Prostate-specific antigen increase >=25%|0
7665671|NCT00117949|12079463|FG001|Overall Study|Prostate-specific antigen increase >=25%|1
7665672|NCT00117949|12079464|FG002|Overall Study|Prostate-specific antigen increase >=25%|1
7665673|NCT00117949|12079465|FG003|Overall Study|Prostate-specific antigen increase >=25%|2
7665675|NCT00117949|12079463|FG001|Overall Study|PSA increase >=10ng/mL|1
7665676|NCT00117949|12079464|FG002|Overall Study|PSA increase >=10ng/mL|1
7665677|NCT00117949|12079465|FG003|Overall Study|PSA increase >=10ng/mL|0
7665678|NCT00117949|12079462|FG000|Overall Study|PSA reduction <=50%|0
7665679|NCT00117949|12079463|FG001|Overall Study|PSA reduction <=50%|2
7665680|NCT00117949|12079464|FG002|Overall Study|PSA reduction <=50%|2
7665681|NCT00117949|12079465|FG003|Overall Study|PSA reduction <=50%|4
7665682|NCT00117949|12079462|FG000|Overall Study|Hepatic abnormalities|0
7665683|NCT00117949|12079463|FG001|Overall Study|Hepatic abnormalities|1
7665684|NCT00117949|12079464|FG002|Overall Study|Hepatic abnormalities|0
7665685|NCT00117949|12079465|FG003|Overall Study|Hepatic abnormalities|1
7665686|NCT00117988|12079484|FG000|Overall Study|Death|3
7665687|NCT00117988|12079484|FG000|Overall Study|Adverse Event|1
7665688|NCT00118040|12079491|FG000|Overall Study|Adverse Event|0
7665689|NCT00118040|12079492|FG001|Overall Study|Adverse Event|1
7665690|NCT00118040|12079493|FG002|Overall Study|Adverse Event|0
7665691|NCT00118040|12079491|FG000|Overall Study|Withdrawal by Subject|0
7665692|NCT00118040|12079492|FG001|Overall Study|Withdrawal by Subject|0
7665693|NCT00118040|12079493|FG002|Overall Study|Withdrawal by Subject|2
7665694|NCT00118040|12079491|FG000|Overall Study|Medical Contraindication|0
7665695|NCT00118040|12079492|FG001|Overall Study|Medical Contraindication|0
7665696|NCT00118040|12079493|FG002|Overall Study|Medical Contraindication|1
7665697|NCT00118040|12079491|FG000|Overall Study|Non-Compliant Participant|1
7665698|NCT00118040|12079492|FG001|Overall Study|Non-Compliant Participant|1
7665699|NCT00118040|12079493|FG002|Overall Study|Non-Compliant Participant|2
7665700|NCT00118040|12079491|FG000|Overall Study|Other|0
7665701|NCT00118040|12079492|FG001|Overall Study|Other|0
7665702|NCT00118040|12079493|FG002|Overall Study|Other|1
7665703|NCT00118092|12079506|FG000|Overall Study|Withdrawal by Subject|1
7665704|NCT00118092|12079506|FG000|Overall Study|Protocol Violation|1
7665705|NCT00118157|12079520|FG000|Overall Study|Adverse Event|2
7665706|NCT00118157|12079520|FG000|Overall Study|Death|8
7665707|NCT00118157|12079520|FG000|Overall Study|Withdrawal by Subject|2
7665708|NCT00118287|12079559|FG000|Overall Study|Intracranial haemorrhage|1
7665709|NCT00118287|12079559|FG000|Overall Study|Muscle pain|1
7665710|NCT00118417|12079639|FG000|Phase I (Weeks 0 to 6)|Remission|8
7665711|NCT00118417|12079640|FG001|Phase I (Weeks 0 to 6)|Remission|0
7665712|NCT00118417|12079639|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
7665713|NCT00118417|12079640|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
7665714|NCT00118417|12079639|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
7665715|NCT00118417|12079640|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
7665716|NCT00118417|12079639|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
7665717|NCT00118417|12079640|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
7665718|NCT00118417|12079639|FG000|Phase II (Weeks 6 to 12)|Remission|1
7665719|NCT00118417|12079640|FG001|Phase II (Weeks 6 to 12)|Remission|2
7665720|NCT00118430|12079653|FG000|Overall Study|Withdrawal by Subject|6
7665721|NCT00118430|12079654|FG001|Overall Study|Withdrawal by Subject|2
7665722|NCT00118430|12079655|FG002|Overall Study|Withdrawal by Subject|0
7665723|NCT00118430|12079653|FG000|Overall Study|Lost to Follow-up|15
7665724|NCT00118430|12079654|FG001|Overall Study|Lost to Follow-up|22
7665725|NCT00118430|12079655|FG002|Overall Study|Lost to Follow-up|28
7665726|NCT00118482|12079664|FG000|Overall Study|Lost to Follow-up|7
7665727|NCT00118482|12079665|FG001|Overall Study|Lost to Follow-up|7
7665728|NCT00118482|12079664|FG000|Overall Study|Withdrawal by Subject|23
7665729|NCT00118482|12079665|FG001|Overall Study|Withdrawal by Subject|22
7665730|NCT00118703|12079683|FG000|Overall Study|Protocol Violation|1
7665731|NCT00118703|12079684|FG001|Overall Study|Protocol Violation|0
7665732|NCT00118703|12079683|FG000|Overall Study|Adverse Event|1
7665733|NCT00118703|12079684|FG001|Overall Study|Adverse Event|1
7665734|NCT00118703|12079683|FG000|Overall Study|Participant took two different treatment|0
7665735|NCT00118703|12079684|FG001|Overall Study|Participant took two different treatment|1
7665736|NCT00118703|12079683|FG000|Overall Study|Withdrawal by Subject|2
7665737|NCT00118703|12079684|FG001|Overall Study|Withdrawal by Subject|5
7665738|NCT00118703|12079683|FG000|Overall Study|Lost to Follow-up|1
7665739|NCT00118703|12079684|FG001|Overall Study|Lost to Follow-up|2
7665740|NCT00118716|12079692|FG000|Overall Study|Adverse Event|2
7665741|NCT00118716|12079693|FG001|Overall Study|Adverse Event|7
7665742|NCT00118716|12079692|FG000|Overall Study|Protocol Violation|5
7665743|NCT00118716|12079693|FG001|Overall Study|Protocol Violation|4
7665744|NCT00118716|12079692|FG000|Overall Study|Withdrawal by Subject|0
7665745|NCT00118716|12079693|FG001|Overall Study|Withdrawal by Subject|1
7665746|NCT00118716|12079692|FG000|Overall Study|Exacerbation|2
7665747|NCT00118716|12079693|FG001|Overall Study|Exacerbation|2
7665748|NCT00118716|12079692|FG000|Overall Study|Discontinued by sponsor|1
7665749|NCT00118716|12079693|FG001|Overall Study|Discontinued by sponsor|1
7665750|NCT00118716|12079692|FG000|Overall Study|Non-compliance|1
7665751|NCT00118716|12079693|FG001|Overall Study|Non-compliance|3
7665752|NCT00118716|12079692|FG000|Overall Study|misrandomized|1
7665753|NCT00118716|12079693|FG001|Overall Study|misrandomized|1
7665754|NCT00118716|12079692|FG000|Overall Study|Expired drug use|1
7665755|NCT00118716|12079693|FG001|Overall Study|Expired drug use|2
7665756|NCT00118716|12079692|FG000|Overall Study|Investigator discretion|0
7665757|NCT00118716|12079693|FG001|Overall Study|Investigator discretion|1
7665758|NCT00118898|12079721|FG000|Overall Study|Death|6
7665759|NCT00118898|12079722|FG001|Overall Study|Death|11
7665760|NCT00118898|12079723|FG002|Overall Study|Death|6
7665761|NCT00118898|12079724|FG003|Overall Study|Death|8
7665762|NCT00118898|12079721|FG000|Overall Study|Lost to Follow-up|26
7665763|NCT00118898|12079722|FG001|Overall Study|Lost to Follow-up|34
7665764|NCT00118898|12079723|FG002|Overall Study|Lost to Follow-up|33
7665765|NCT00118898|12079724|FG003|Overall Study|Lost to Follow-up|33
7665766|NCT00118898|12079721|FG000|Overall Study|Withdrawal by Subject|10
7665767|NCT00118898|12079722|FG001|Overall Study|Withdrawal by Subject|5
7665768|NCT00118898|12079723|FG002|Overall Study|Withdrawal by Subject|8
7665769|NCT00118898|12079724|FG003|Overall Study|Withdrawal by Subject|8
7665770|NCT00118898|12079721|FG000|Overall Study|Site Closure|33
7665771|NCT00118898|12079722|FG001|Overall Study|Site Closure|31
7665772|NCT00118898|12079723|FG002|Overall Study|Site Closure|28
7665773|NCT00118898|12079724|FG003|Overall Study|Site Closure|37
7665774|NCT00118898|12079721|FG000|Overall Study|Severe debilitation|1
7665775|NCT00118898|12079722|FG001|Overall Study|Severe debilitation|4
7665776|NCT00118898|12079723|FG002|Overall Study|Severe debilitation|6
7665777|NCT00118898|12079724|FG003|Overall Study|Severe debilitation|4
7665778|NCT00118898|12079721|FG000|Overall Study|Not compliant with requirements|11
7665779|NCT00118898|12079722|FG001|Overall Study|Not compliant with requirements|13
7665780|NCT00118898|12079723|FG002|Overall Study|Not compliant with requirements|11
7665781|NCT00118898|12079724|FG003|Overall Study|Not compliant with requirements|11
7665782|NCT00118898|12079721|FG000|Overall Study|Not able to get to clinic|34
7665783|NCT00118898|12079722|FG001|Overall Study|Not able to get to clinic|43
7665784|NCT00118898|12079723|FG002|Overall Study|Not able to get to clinic|31
7665785|NCT00118898|12079724|FG003|Overall Study|Not able to get to clinic|40
7665786|NCT00118911|12079736|FG000|Overall Study|Withdrawal by Subject|2
7665787|NCT00118911|12079737|FG001|Overall Study|Withdrawal by Subject|5
7665788|NCT00119015|12079745|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
7665789|NCT00119015|12079746|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
7665790|NCT00119015|12079747|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
7665791|NCT00119106|12079769|FG000|Overall Study|HIV infected at baseline|179
7665792|NCT00119106|12079770|FG001|Overall Study|HIV infected at baseline|178
7665793|NCT00119262|12079795|FG000|Overall Study|Lack of Efficacy|0
7665794|NCT00119262|12079796|FG001|Overall Study|Lack of Efficacy|3
7665795|NCT00119262|12079795|FG000|Overall Study|Withdrawal by Subject|12
7665796|NCT00119262|12079796|FG001|Overall Study|Withdrawal by Subject|11
7665797|NCT00119262|12079795|FG000|Overall Study|Adverse Event|33
7665798|NCT00119262|12079796|FG001|Overall Study|Adverse Event|35
7665799|NCT00119262|12079795|FG000|Overall Study|other disease|0
7665800|NCT00119262|12079796|FG001|Overall Study|other disease|2
7665801|NCT00119262|12079795|FG000|Overall Study|ineligble|1
7665802|NCT00119262|12079796|FG001|Overall Study|ineligble|2
7665803|NCT00119262|12079795|FG000|Overall Study|others|0
7665804|NCT00119262|12079796|FG001|Overall Study|others|5
7665805|NCT00119379|12079804|FG000|Overall Study|Adverse Event|4
7665806|NCT00119379|12079805|FG001|Overall Study|Adverse Event|1
7665807|NCT00119405|12079815|FG000|Overall Study|Withdrawal by Subject|1
7665808|NCT00119678|12079821|FG000|Double-blind Treatment Period|Death|1
7665809|NCT00119678|12079822|FG001|Double-blind Treatment Period|Death|0
7665810|NCT00119678|12079821|FG000|Double-blind Treatment Period|Adverse Event|7
7665811|NCT00119678|12079822|FG001|Double-blind Treatment Period|Adverse Event|1
7665812|NCT00119678|12079821|FG000|Double-blind Treatment Period|Lack of Efficacy|21
7665813|NCT00119678|12079822|FG001|Double-blind Treatment Period|Lack of Efficacy|12
7665814|NCT00119678|12079821|FG000|Double-blind Treatment Period|Lost to Follow-up|1
7665815|NCT00119678|12079822|FG001|Double-blind Treatment Period|Lost to Follow-up|2
7665816|NCT00119678|12079821|FG000|Double-blind Treatment Period|Participant withdrew consent|4
7665817|NCT00119678|12079822|FG001|Double-blind Treatment Period|Participant withdrew consent|4
7665818|NCT00119678|12079821|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0
7665819|NCT00119678|12079822|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1
7665820|NCT00119678|12079821|FG000|Double-blind Treatment Period|Poor/Non-compliance|3
7665821|NCT00119678|12079822|FG001|Double-blind Treatment Period|Poor/Non-compliance|0
7665822|NCT00119678|12079821|FG000|Double-blind Treatment Period|Pregnancy|0
7665823|NCT00119678|12079822|FG001|Double-blind Treatment Period|Pregnancy|2
7665824|NCT00119678|12079821|FG000|Double-blind Treatment Period|Not treated|1
7665825|NCT00119678|12079822|FG001|Double-blind Treatment Period|Not treated|2
7665826|NCT00119678|12079821|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3
7665827|NCT00119678|12079822|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2
7665828|NCT00119678|12079821|FG000|Open-label Treatment Period|Death|1
7665829|NCT00119678|12079822|FG001|Open-label Treatment Period|Death|0
7665830|NCT00119678|12079821|FG000|Open-label Treatment Period|Adverse Event|3
7665831|NCT00119678|12079822|FG001|Open-label Treatment Period|Adverse Event|0
7665832|NCT00119678|12079821|FG000|Open-label Treatment Period|Lack of Efficacy|9
7665833|NCT00119678|12079822|FG001|Open-label Treatment Period|Lack of Efficacy|0
7665834|NCT00119678|12079821|FG000|Open-label Treatment Period|Lost to Follow-up|3
7665835|NCT00119678|12079822|FG001|Open-label Treatment Period|Lost to Follow-up|0
7665836|NCT00119678|12079821|FG000|Open-label Treatment Period|Participant withdrew consent|4
7665837|NCT00119678|12079822|FG001|Open-label Treatment Period|Participant withdrew consent|0
7665838|NCT00119678|12079821|FG000|Open-label Treatment Period|Participants not meeting study criteria|2
7665839|NCT00119678|12079822|FG001|Open-label Treatment Period|Participants not meeting study criteria|0
7665840|NCT00119678|12079821|FG000|Open-label Treatment Period|Pregnancy|1
7665841|NCT00119678|12079822|FG001|Open-label Treatment Period|Pregnancy|0
7665842|NCT00119678|12079821|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87
7665843|NCT00119678|12079822|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0
7665844|NCT00120250|12079830|FG000|Overall Study|Lost to Follow-up|1
7665845|NCT00120250|12079831|FG001|Overall Study|Lost to Follow-up|1
7665846|NCT00120250|12079830|FG000|Overall Study|Protocol Violation|0
7665847|NCT00120250|12079831|FG001|Overall Study|Protocol Violation|1
7665848|NCT00120289|12079840|FG000|Overall Study|Death|96
7665849|NCT00120289|12079841|FG001|Overall Study|Death|82
7665850|NCT00120289|12079840|FG000|Overall Study|Lost to Follow-up|11
7665851|NCT00120289|12079841|FG001|Overall Study|Lost to Follow-up|14
7665852|NCT00120289|12079840|FG000|Overall Study|Withdrawal by Subject|14
7665853|NCT00120289|12079841|FG001|Overall Study|Withdrawal by Subject|13
7665854|NCT00120406|12079849|FG000|Overall Study|Death|9
7665855|NCT00120406|12079850|FG001|Overall Study|Death|4
7665856|NCT00120406|12079849|FG000|Overall Study|Withdrawal by Subject|5
7665857|NCT00120406|12079850|FG001|Overall Study|Withdrawal by Subject|7
7665858|NCT00120406|12079849|FG000|Overall Study|Lost to Follow-up|5
7665859|NCT00120406|12079850|FG001|Overall Study|Lost to Follow-up|2
7665860|NCT00120406|12079849|FG000|Overall Study|received non-study stent|0
7665861|NCT00120406|12079850|FG001|Overall Study|received non-study stent|2
7665862|NCT00120406|12079849|FG000|Overall Study|patient moved but has not withdrawn|0
7665863|NCT00120406|12079850|FG001|Overall Study|patient moved but has not withdrawn|1
7665864|NCT00120627|12079868|FG000|Overall Study|Withdrawal by Subject|5
7665865|NCT00120627|12079869|FG001|Overall Study|Withdrawal by Subject|5
7665866|NCT00120874|12079886|FG000|Overall Study|Death|0
7665867|NCT00120874|12079887|FG001|Overall Study|Death|1
7665868|NCT00121134|12079897|FG000|Overall Study|Progression of Disease|5
7665869|NCT00121134|12079898|FG001|Overall Study|Progression of Disease|3
7665870|NCT00121134|12079899|FG002|Overall Study|Progression of Disease|4
7665871|NCT00121134|12079900|FG003|Overall Study|Progression of Disease|2
7665872|NCT00121134|12079897|FG000|Overall Study|Toxicity|4
7665873|NCT00121134|12079898|FG001|Overall Study|Toxicity|7
7665874|NCT00121134|12079899|FG002|Overall Study|Toxicity|13
7665875|NCT00121134|12079900|FG003|Overall Study|Toxicity|5
7665876|NCT00121134|12079897|FG000|Overall Study|Physician Decision|6
7665877|NCT00121134|12079898|FG001|Overall Study|Physician Decision|4
7665878|NCT00121134|12079899|FG002|Overall Study|Physician Decision|4
7665879|NCT00121134|12079900|FG003|Overall Study|Physician Decision|1
7665880|NCT00121134|12079897|FG000|Overall Study|Treatment Delay|1
7665881|NCT00121134|12079898|FG001|Overall Study|Treatment Delay|0
7665882|NCT00121134|12079899|FG002|Overall Study|Treatment Delay|0
7665883|NCT00121134|12079900|FG003|Overall Study|Treatment Delay|0
7665884|NCT00121134|12079897|FG000|Overall Study|Intercurrent Illness|0
7665885|NCT00121134|12079898|FG001|Overall Study|Intercurrent Illness|0
7665886|NCT00121134|12079899|FG002|Overall Study|Intercurrent Illness|0
7665887|NCT00121134|12079900|FG003|Overall Study|Intercurrent Illness|1
7665888|NCT00121134|12079897|FG000|Overall Study|Patient Personal Reasons|0
7665889|NCT00121134|12079898|FG001|Overall Study|Patient Personal Reasons|1
7665890|NCT00121134|12079899|FG002|Overall Study|Patient Personal Reasons|0
7665891|NCT00121134|12079900|FG003|Overall Study|Patient Personal Reasons|0
7665892|NCT00121199|12079930|FG000|Overall Study|Adverse Event|11
7665893|NCT00121199|12079930|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
7665894|NCT00121199|12079930|FG000|Overall Study|Progression/Relapse|1
7665895|NCT00121199|12079930|FG000|Overall Study|Death|3
7665896|NCT00121199|12079930|FG000|Overall Study|Other - Not Protocol Specified|3
7665897|NCT00121199|12079930|FG000|Overall Study|Ineligible|9
7665898|NCT00121238|12079939|FG000|Overall Study|disease progression before intervention|1
7665899|NCT00121238|12079939|FG000|Overall Study|Protocol Violation|2
7665900|NCT00121641|12079951|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15
7665901|NCT00121641|12079952|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21
7665902|NCT00121641|12079953|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14
7665903|NCT00121641|12079954|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25
7665904|NCT00121641|12079955|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30
7665905|NCT00121641|12079951|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9
7665906|NCT00121641|12079952|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11
7665907|NCT00121641|12079953|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5
7665908|NCT00121641|12079954|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10
7665909|NCT00121641|12079955|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3
7665910|NCT00121641|12079951|FG000|24-week Short-term Treatment Period|Adverse Event|3
7665911|NCT00121641|12079952|FG001|24-week Short-term Treatment Period|Adverse Event|3
7665912|NCT00121641|12079953|FG002|24-week Short-term Treatment Period|Adverse Event|4
7665913|NCT00121641|12079954|FG003|24-week Short-term Treatment Period|Adverse Event|0
7665914|NCT00121641|12079955|FG004|24-week Short-term Treatment Period|Adverse Event|2
7665915|NCT00121641|12079951|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0
7665916|NCT00121641|12079952|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2
7665917|NCT00121641|12079953|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3
7665918|NCT00121641|12079954|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4
7665919|NCT00121641|12079955|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4
7665920|NCT00121641|12079951|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0
7665921|NCT00121641|12079952|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0
7665922|NCT00121641|12079953|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3
7665923|NCT00121641|12079954|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1
7665924|NCT00121641|12079955|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1
7665925|NCT00121641|12079951|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
7665926|NCT00121641|12079952|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
7665927|NCT00121641|12079953|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
7665928|NCT00121641|12079954|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
7665929|NCT00121641|12079955|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
7665930|NCT00121641|12079951|FG000|24-week Short-term Treatment Period|Other Reason|1
7665931|NCT00121641|12079952|FG001|24-week Short-term Treatment Period|Other Reason|0
7665932|NCT00121641|12079953|FG002|24-week Short-term Treatment Period|Other Reason|0
7665933|NCT00121641|12079954|FG003|24-week Short-term Treatment Period|Other Reason|0
7665934|NCT00121641|12079955|FG004|24-week Short-term Treatment Period|Other Reason|0
7665935|NCT00121641|12079951|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26
7665936|NCT00121641|12079952|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27
7665937|NCT00121641|12079953|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21
7665938|NCT00121641|12079954|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26
7665939|NCT00121641|12079955|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25
7665940|NCT00121641|12079951|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
7665941|NCT00121641|12079952|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
7665942|NCT00121641|12079953|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
7665943|NCT00121641|12079954|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
7665944|NCT00121641|12079955|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
7665945|NCT00121641|12079951|FG000|48-month Short Term + Long Term Period|Adverse Event|9
7665946|NCT00121641|12079952|FG001|48-month Short Term + Long Term Period|Adverse Event|10
7665947|NCT00121641|12079953|FG002|48-month Short Term + Long Term Period|Adverse Event|10
7665948|NCT00121641|12079954|FG003|48-month Short Term + Long Term Period|Adverse Event|5
7665949|NCT00121641|12079955|FG004|48-month Short Term + Long Term Period|Adverse Event|5
7665950|NCT00121641|12079951|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9
7665951|NCT00121641|12079952|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7
7665952|NCT00121641|12079953|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12
7665953|NCT00121641|12079954|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11
7665954|NCT00121641|12079955|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12
7665955|NCT00121641|12079951|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4
7665956|NCT00121641|12079952|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1
7665957|NCT00121641|12079953|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4
7665958|NCT00121641|12079954|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2
7665959|NCT00121641|12079955|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2
7665960|NCT00121641|12079951|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
7665961|NCT00121641|12079952|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
7665962|NCT00121641|12079953|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
7665963|NCT00121641|12079954|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
7665964|NCT00121641|12079955|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
7665965|NCT00121641|12079951|FG000|48-month Short Term + Long Term Period|Pregnancy|0
7665966|NCT00121641|12079952|FG001|48-month Short Term + Long Term Period|Pregnancy|1
7665967|NCT00121641|12079953|FG002|48-month Short Term + Long Term Period|Pregnancy|0
7665968|NCT00121641|12079954|FG003|48-month Short Term + Long Term Period|Pregnancy|1
7665969|NCT00121641|12079955|FG004|48-month Short Term + Long Term Period|Pregnancy|0
7665970|NCT00121641|12079951|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
7665971|NCT00121641|12079952|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
7665972|NCT00121641|12079953|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
7665973|NCT00121641|12079954|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
7665974|NCT00121641|12079955|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
7665975|NCT00121641|12079951|FG000|48-month Short Term + Long Term Period|Death|0
7665976|NCT00121641|12079952|FG001|48-month Short Term + Long Term Period|Death|0
7665977|NCT00121641|12079953|FG002|48-month Short Term + Long Term Period|Death|0
7665978|NCT00121641|12079954|FG003|48-month Short Term + Long Term Period|Death|1
7665979|NCT00121641|12079955|FG004|48-month Short Term + Long Term Period|Death|0
7665980|NCT00121641|12079951|FG000|48-month Short Term + Long Term Period|Missing|0
7665981|NCT00121641|12079952|FG001|48-month Short Term + Long Term Period|Missing|0
7665982|NCT00121641|12079953|FG002|48-month Short Term + Long Term Period|Missing|1
7665983|NCT00121641|12079954|FG003|48-month Short Term + Long Term Period|Missing|0
7665984|NCT00121641|12079955|FG004|48-month Short Term + Long Term Period|Missing|0
7665985|NCT00121641|12079951|FG000|48-month Short Term + Long Term Period|Other Reason|5
7665986|NCT00121641|12079952|FG001|48-month Short Term + Long Term Period|Other Reason|3
7665987|NCT00121641|12079953|FG002|48-month Short Term + Long Term Period|Other Reason|2
7665988|NCT00121641|12079954|FG003|48-month Short Term + Long Term Period|Other Reason|0
7665989|NCT00121641|12079955|FG004|48-month Short Term + Long Term Period|Other Reason|1
7665990|NCT00121667|12079973|FG000|Short Term (ST) Period|Lack of Efficacy|25
7665991|NCT00121667|12079974|FG001|Short Term (ST) Period|Lack of Efficacy|22
7665992|NCT00121667|12079975|FG002|Short Term (ST) Period|Lack of Efficacy|27
7665993|NCT00121667|12079976|FG003|Short Term (ST) Period|Lack of Efficacy|44
7665994|NCT00121667|12079973|FG000|Short Term (ST) Period|Subject Withdrew Consent|8
7665995|NCT00121667|12079974|FG001|Short Term (ST) Period|Subject Withdrew Consent|13
7665996|NCT00121667|12079975|FG002|Short Term (ST) Period|Subject Withdrew Consent|4
7665997|NCT00121667|12079976|FG003|Short Term (ST) Period|Subject Withdrew Consent|11
7665998|NCT00121667|12079973|FG000|Short Term (ST) Period|Adverse Event|5
7665999|NCT00121667|12079974|FG001|Short Term (ST) Period|Adverse Event|6
7666000|NCT00121667|12079975|FG002|Short Term (ST) Period|Adverse Event|5
7666001|NCT00121667|12079976|FG003|Short Term (ST) Period|Adverse Event|3
7666002|NCT00121667|12079973|FG000|Short Term (ST) Period|Lost to Follow-up|3
7666003|NCT00121667|12079974|FG001|Short Term (ST) Period|Lost to Follow-up|4
7666004|NCT00121667|12079975|FG002|Short Term (ST) Period|Lost to Follow-up|4
7666005|NCT00121667|12079976|FG003|Short Term (ST) Period|Lost to Follow-up|3
7666006|NCT00121667|12079973|FG000|Short Term (ST) Period|Poor / Non-compliance|0
7666007|NCT00121667|12079974|FG001|Short Term (ST) Period|Poor / Non-compliance|1
7666008|NCT00121667|12079975|FG002|Short Term (ST) Period|Poor / Non-compliance|1
7666009|NCT00121667|12079976|FG003|Short Term (ST) Period|Poor / Non-compliance|2
7666010|NCT00121667|12079973|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
7666011|NCT00121667|12079974|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
7666012|NCT00121667|12079975|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
7666013|NCT00121667|12079976|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
7666014|NCT00121667|12079973|FG000|Short Term (ST) Period|Other Reason|3
7666015|NCT00121667|12079974|FG001|Short Term (ST) Period|Other Reason|0
7666016|NCT00121667|12079975|FG002|Short Term (ST) Period|Other Reason|0
7666017|NCT00121667|12079976|FG003|Short Term (ST) Period|Other Reason|0
7666018|NCT00121667|12079973|FG000|Short Term (ST) Period|Death|0
7666019|NCT00121667|12079974|FG001|Short Term (ST) Period|Death|0
7666020|NCT00121667|12079975|FG002|Short Term (ST) Period|Death|0
7666021|NCT00121667|12079976|FG003|Short Term (ST) Period|Death|1
7666022|NCT00121667|12079973|FG000|Short Term (ST) Period|Pregnancy|0
7666023|NCT00121667|12079974|FG001|Short Term (ST) Period|Pregnancy|0
7666024|NCT00121667|12079975|FG002|Short Term (ST) Period|Pregnancy|0
7666025|NCT00121667|12079976|FG003|Short Term (ST) Period|Pregnancy|1
7666026|NCT00121667|12079973|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
7666027|NCT00121667|12079974|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
7666028|NCT00121667|12079975|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
7666029|NCT00121667|12079976|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
7666030|NCT00121667|12079973|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
7666031|NCT00121667|12079974|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
7666032|NCT00121667|12079975|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
7666033|NCT00121667|12079976|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
7666034|NCT00121667|12079973|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
7666035|NCT00121667|12079974|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
7666036|NCT00121667|12079975|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
7666037|NCT00121667|12079976|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
7666038|NCT00121667|12079973|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
7666039|NCT00121667|12079974|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
7666040|NCT00121667|12079975|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
7666041|NCT00121667|12079976|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
7666042|NCT00121667|12079973|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5
7666043|NCT00121667|12079974|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7
7666044|NCT00121667|12079975|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6
7666045|NCT00121667|12079976|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3
7666046|NCT00121667|12079973|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
7666047|NCT00121667|12079974|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
7666048|NCT00121667|12079975|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
7666049|NCT00121667|12079976|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
7666050|NCT00121667|12079973|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
7666051|NCT00121667|12079974|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
7666052|NCT00121667|12079975|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
7666053|NCT00121667|12079976|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
7666054|NCT00121667|12079973|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
7666055|NCT00121667|12079974|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
7666056|NCT00121667|12079975|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
7666057|NCT00121667|12079976|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
7666058|NCT00121667|12079973|FG000|Short Term (ST) + Long Term (LT) Period|Death|1
7666059|NCT00121667|12079974|FG001|Short Term (ST) + Long Term (LT) Period|Death|0
7666060|NCT00121667|12079975|FG002|Short Term (ST) + Long Term (LT) Period|Death|0
7666061|NCT00121667|12079976|FG003|Short Term (ST) + Long Term (LT) Period|Death|2
7666062|NCT00121992|12080069|FG000|Overall Study|Treatment not received|2
7666063|NCT00121992|12080070|FG001|Overall Study|Treatment not received|11
7666064|NCT00122109|12080078|FG000|Overall Study|Did not meet criteria|6
7666065|NCT00122109|12080079|FG001|Overall Study|Did not meet criteria|7
7666066|NCT00122135|12080090|FG000|Overall Study|Withdrawal by Subject|3
7666067|NCT00122135|12080091|FG001|Overall Study|Withdrawal by Subject|0
7666068|NCT00122187|12080099|FG000|Overall Study|Withdrew because of resource limitations|2
7666069|NCT00122187|12080100|FG001|Overall Study|Withdrew because of resource limitations|2
7666070|NCT00122278|12080110|FG000|Overall Study|Lost to Follow-up|2
7666071|NCT00122278|12080111|FG001|Overall Study|Lost to Follow-up|0
7666072|NCT00122317|12080117|FG000|Overall Study|Death|3
7666073|NCT00122317|12080117|FG000|Overall Study|Adverse Event|4
7666074|NCT00122317|12080117|FG000|Overall Study|Physician Decision|2
7666075|NCT00122317|12080117|FG000|Overall Study|patient non-compliance|1
7666076|NCT00122317|12080117|FG000|Overall Study|Withdrawal by Subject|1
7666077|NCT00122382|12080139|FG000|Double-Blind Study|Adverse Event|9
7666078|NCT00122382|12080140|FG001|Double-Blind Study|Adverse Event|11
7666079|NCT00122382|12080141|FG002|Double-Blind Study|Adverse Event|0
7666080|NCT00122382|12080139|FG000|Double-Blind Study|Death|2
7666081|NCT00122382|12080140|FG001|Double-Blind Study|Death|2
7666082|NCT00122382|12080141|FG002|Double-Blind Study|Death|0
7666083|NCT00122382|12080139|FG000|Double-Blind Study|Lack of Efficacy|0
7666084|NCT00122382|12080140|FG001|Double-Blind Study|Lack of Efficacy|8
7666085|NCT00122382|12080141|FG002|Double-Blind Study|Lack of Efficacy|0
7666086|NCT00122382|12080139|FG000|Double-Blind Study|Lost to Follow-up|2
7666087|NCT00122382|12080140|FG001|Double-Blind Study|Lost to Follow-up|1
7666088|NCT00122382|12080141|FG002|Double-Blind Study|Lost to Follow-up|0
7666089|NCT00122382|12080139|FG000|Double-Blind Study|Pregnancy|2
7666090|NCT00122382|12080140|FG001|Double-Blind Study|Pregnancy|0
7666091|NCT00122382|12080141|FG002|Double-Blind Study|Pregnancy|0
7666092|NCT00122382|12080139|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1
7666093|NCT00122382|12080140|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0
7666094|NCT00122382|12080141|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0
7666095|NCT00122382|12080139|FG000|Double-Blind Study|Withdrawal of Consent|7
7666096|NCT00122382|12080140|FG001|Double-Blind Study|Withdrawal of Consent|3
7666097|NCT00122382|12080141|FG002|Double-Blind Study|Withdrawal of Consent|0
7666098|NCT00122382|12080139|FG000|Double-Blind Study|Protocol Violation|1
7666099|NCT00122382|12080140|FG001|Double-Blind Study|Protocol Violation|0
7666100|NCT00122382|12080141|FG002|Double-Blind Study|Protocol Violation|0
7666101|NCT00122382|12080139|FG000|Double-Blind Study|Methotrexate Discontinued|0
7666102|NCT00122382|12080140|FG001|Double-Blind Study|Methotrexate Discontinued|1
7666103|NCT00122382|12080141|FG002|Double-Blind Study|Methotrexate Discontinued|0
7666104|NCT00122382|12080139|FG000|Double-Blind Study|Randomized but not treated|0
7666105|NCT00122382|12080140|FG001|Double-Blind Study|Randomized but not treated|2
7666106|NCT00122382|12080141|FG002|Double-Blind Study|Randomized but not treated|0
7666107|NCT00122382|12080139|FG000|Open-Label Study|Adverse Event|0
7666108|NCT00122382|12080140|FG001|Open-Label Study|Adverse Event|0
7666109|NCT00122382|12080141|FG002|Open-Label Study|Adverse Event|11
7666110|NCT00122382|12080139|FG000|Open-Label Study|Death|0
7666111|NCT00122382|12080140|FG001|Open-Label Study|Death|0
7666112|NCT00122382|12080141|FG002|Open-Label Study|Death|2
7666113|NCT00122382|12080139|FG000|Open-Label Study|Lack of Efficacy|0
7666114|NCT00122382|12080140|FG001|Open-Label Study|Lack of Efficacy|0
7666115|NCT00122382|12080141|FG002|Open-Label Study|Lack of Efficacy|3
7666116|NCT00122382|12080139|FG000|Open-Label Study|Lost to Follow-up|0
7666117|NCT00122382|12080140|FG001|Open-Label Study|Lost to Follow-up|0
7666118|NCT00122382|12080141|FG002|Open-Label Study|Lost to Follow-up|3
7666119|NCT00122382|12080139|FG000|Open-Label Study|Pregnancy|0
7666120|NCT00122382|12080140|FG001|Open-Label Study|Pregnancy|0
7666121|NCT00122382|12080141|FG002|Open-Label Study|Pregnancy|2
7666122|NCT00122382|12080139|FG000|Open-Label Study|Poor/Non-Compliance|0
7666123|NCT00122382|12080140|FG001|Open-Label Study|Poor/Non-Compliance|0
7666124|NCT00122382|12080141|FG002|Open-Label Study|Poor/Non-Compliance|1
7666125|NCT00122382|12080139|FG000|Open-Label Study|Withdrawal of Consent|0
7666126|NCT00122382|12080140|FG001|Open-Label Study|Withdrawal of Consent|0
7666127|NCT00122382|12080141|FG002|Open-Label Study|Withdrawal of Consent|4
7666128|NCT00122460|12080182|FG000|Overall Study|investigational study phase ongoing|7
7666129|NCT00122460|12080183|FG001|Overall Study|investigational study phase ongoing|1
7666130|NCT00122681|12080191|FG000|Overall Study|Adverse Event|20
7666131|NCT00122681|12080192|FG001|Overall Study|Adverse Event|16
7666132|NCT00122681|12080191|FG000|Overall Study|Lost to Follow-up|1080
7666133|NCT00122681|12080192|FG001|Overall Study|Lost to Follow-up|1097
7666134|NCT00122681|12080191|FG000|Overall Study|Protocol Violation|7
7666135|NCT00122681|12080192|FG001|Overall Study|Protocol Violation|10
7666136|NCT00122681|12080191|FG000|Overall Study|Withdrawal by Subject|257
7666137|NCT00122681|12080192|FG001|Overall Study|Withdrawal by Subject|251
7666138|NCT00122681|12080191|FG000|Overall Study|Personal reasons|150
7666139|NCT00122681|12080192|FG001|Overall Study|Personal reasons|147
7666140|NCT00122954|12080208|FG000|Overall Study|Withdrawal by Subject|2
7666141|NCT00122954|12080209|FG001|Overall Study|Withdrawal by Subject|2
7666142|NCT00122954|12080208|FG000|Overall Study|Protocol Violation|0
7666143|NCT00122954|12080209|FG001|Overall Study|Protocol Violation|1
7666144|NCT00122980|12080217|FG000|Overall Study|Death|0
7666145|NCT00122980|12080218|FG001|Overall Study|Death|1
7666146|NCT00122980|12080217|FG000|Overall Study|Physician Decision|2
7666147|NCT00122980|12080218|FG001|Overall Study|Physician Decision|0
7666148|NCT00122980|12080217|FG000|Overall Study|Protocol Violation|5
7666149|NCT00122980|12080218|FG001|Overall Study|Protocol Violation|1
7666150|NCT00122980|12080217|FG000|Overall Study|Withdrawal by Subject|2
7666151|NCT00122980|12080218|FG001|Overall Study|Withdrawal by Subject|3
7666152|NCT00122980|12080217|FG000|Overall Study|Adjudicated stroke (study endpoint)|7
7666153|NCT00122980|12080218|FG001|Overall Study|Adjudicated stroke (study endpoint)|0
7666154|NCT00122980|12080217|FG000|Overall Study|Study termination|27
7666155|NCT00122980|12080218|FG001|Overall Study|Study termination|35
7666156|NCT00123422|12080273|FG000|Overall Study|Physician Decision|2
7666157|NCT00123422|12080274|FG001|Overall Study|Physician Decision|2
7666158|NCT00123422|12080275|FG002|Overall Study|Physician Decision|6
7666159|NCT00123422|12080273|FG000|Overall Study|Withdrawal by Subject|1
7666160|NCT00123422|12080274|FG001|Overall Study|Withdrawal by Subject|2
7666161|NCT00123422|12080275|FG002|Overall Study|Withdrawal by Subject|2
7666162|NCT00123422|12080273|FG000|Overall Study|Lost to Follow-up|1
7666163|NCT00123422|12080274|FG001|Overall Study|Lost to Follow-up|2
7666164|NCT00123422|12080275|FG002|Overall Study|Lost to Follow-up|2
7666165|NCT00123474|12080287|FG000|Randomized to Treatment|Randomized, never treated|1
7666166|NCT00123474|12080288|FG001|Randomized to Treatment|Randomized, never treated|4
7666167|NCT00123474|12080289|FG002|Randomized to Treatment|Randomized, never treated|2
7666168|NCT00123474|12080290|FG003|Randomized to Treatment|Randomized, never treated|1
7666169|NCT00123474|12080287|FG000|As Treated at Study Closure|not reported when site closed|1
7666170|NCT00123474|12080288|FG001|As Treated at Study Closure|not reported when site closed|0
7666171|NCT00123474|12080289|FG002|As Treated at Study Closure|not reported when site closed|1
7666172|NCT00123474|12080290|FG003|As Treated at Study Closure|not reported when site closed|0
7666173|NCT00123474|12080287|FG000|As Treated at Study Closure|Adverse Event|10
7666174|NCT00123474|12080288|FG001|As Treated at Study Closure|Adverse Event|4
7666175|NCT00123474|12080289|FG002|As Treated at Study Closure|Adverse Event|10
7666176|NCT00123474|12080290|FG003|As Treated at Study Closure|Adverse Event|8
7666177|NCT00123474|12080287|FG000|As Treated at Study Closure|Disease Progression|35
7666178|NCT00123474|12080288|FG001|As Treated at Study Closure|Disease Progression|42
7666179|NCT00123474|12080289|FG002|As Treated at Study Closure|Disease Progression|29
7666180|NCT00123474|12080290|FG003|As Treated at Study Closure|Disease Progression|27
7666181|NCT00123474|12080287|FG000|As Treated at Study Closure|Investigator Request|12
7666182|NCT00123474|12080288|FG001|As Treated at Study Closure|Investigator Request|6
7666183|NCT00123474|12080289|FG002|As Treated at Study Closure|Investigator Request|7
7666184|NCT00123474|12080290|FG003|As Treated at Study Closure|Investigator Request|5
7666185|NCT00123474|12080287|FG000|As Treated at Study Closure|non-specified|54
7666186|NCT00123474|12080288|FG001|As Treated at Study Closure|non-specified|47
7666187|NCT00123474|12080289|FG002|As Treated at Study Closure|non-specified|57
7666188|NCT00123474|12080290|FG003|As Treated at Study Closure|non-specified|60
7666189|NCT00123474|12080287|FG000|As Treated at Study Closure|Study Drug Toxicity|39
7666190|NCT00123474|12080288|FG001|As Treated at Study Closure|Study Drug Toxicity|45
7666191|NCT00123474|12080289|FG002|As Treated at Study Closure|Study Drug Toxicity|45
7666192|NCT00123474|12080290|FG003|As Treated at Study Closure|Study Drug Toxicity|51
7666193|NCT00123474|12080287|FG000|As Treated at Study Closure|Withdrawal by Subject|14
7666194|NCT00123474|12080288|FG001|As Treated at Study Closure|Withdrawal by Subject|19
7666195|NCT00123474|12080289|FG002|As Treated at Study Closure|Withdrawal by Subject|18
7666196|NCT00123474|12080290|FG003|As Treated at Study Closure|Withdrawal by Subject|16
7666197|NCT00123487|12080323|FG000|Randomized|Death prior to starting treatment|0
7666198|NCT00123487|12080324|FG001|Randomized|Death prior to starting treatment|1
7666199|NCT00123487|12080323|FG000|Randomized|SAE prior to starting treatment|1
7666200|NCT00123487|12080324|FG001|Randomized|SAE prior to starting treatment|0
7666201|NCT00123487|12080323|FG000|Treated With Study Drug|Adverse Event|23
7666202|NCT00123487|12080324|FG001|Treated With Study Drug|Adverse Event|22
7666203|NCT00123487|12080323|FG000|Treated With Study Drug|Disease Progression|141
7666204|NCT00123487|12080324|FG001|Treated With Study Drug|Disease Progression|122
7666205|NCT00123487|12080323|FG000|Treated With Study Drug|Physician Decision|8
7666206|NCT00123487|12080324|FG001|Treated With Study Drug|Physician Decision|9
7666207|NCT00123487|12080323|FG000|Treated With Study Drug|Other|59
7666208|NCT00123487|12080324|FG001|Treated With Study Drug|Other|58
7666209|NCT00123487|12080323|FG000|Treated With Study Drug|Study Drug Toxicity|62
7666210|NCT00123487|12080324|FG001|Treated With Study Drug|Study Drug Toxicity|80
7666211|NCT00123487|12080323|FG000|Treated With Study Drug|Withdrawal by Subject|11
7666212|NCT00123487|12080324|FG001|Treated With Study Drug|Withdrawal by Subject|13
7666213|NCT00123487|12080323|FG000|Treated With Study Drug|Unknown (case report form lost)|0
7666214|NCT00123487|12080324|FG001|Treated With Study Drug|Unknown (case report form lost)|1
7666215|NCT00123734|12080379|FG000|Overall Study|Death|3
7666216|NCT00123734|12080379|FG000|Overall Study|Lost to Follow-up|3
7666217|NCT00123734|12080379|FG000|Overall Study|Dropout|1
7666218|NCT00123734|12080379|FG000|Overall Study|Withdrawal by Subject|1
7666219|NCT00123955|12080388|FG000|Overall Study|Adverse Event|1
7666220|NCT00123955|12080389|FG001|Overall Study|Adverse Event|0
7666221|NCT00123955|12080388|FG000|Overall Study|Withdrawal by Subject|4
7666222|NCT00123955|12080389|FG001|Overall Study|Withdrawal by Subject|3
7666223|NCT00123955|12080388|FG000|Overall Study|Death|0
7666224|NCT00123955|12080389|FG001|Overall Study|Death|1
7666225|NCT00124020|12080397|FG000|Overall Study|Death|67
7666226|NCT00124020|12080398|FG001|Overall Study|Death|71
7666227|NCT00124020|12080397|FG000|Overall Study|Withdrawal by Subject|13
7666228|NCT00124020|12080398|FG001|Overall Study|Withdrawal by Subject|11
7666229|NCT00124020|12080397|FG000|Overall Study|Lost to Follow-up|5
7666230|NCT00124020|12080398|FG001|Overall Study|Lost to Follow-up|8
7666231|NCT00124020|12080397|FG000|Overall Study|Other|1
7666232|NCT00124020|12080398|FG001|Overall Study|Other|1
7666233|NCT00124020|12080397|FG000|Overall Study|Transfer to another hospital|2
7666234|NCT00124020|12080398|FG001|Overall Study|Transfer to another hospital|0
7666235|NCT00124072|12080408|FG000|Overall Study|Lost to Follow-up for Mortality|0
7666236|NCT00124072|12080409|FG001|Overall Study|Lost to Follow-up for Mortality|3
7666237|NCT00124072|12080410|FG002|Overall Study|Lost to Follow-up for Mortality|2
7666238|NCT00124072|12080411|FG003|Overall Study|Lost to Follow-up for Mortality|2
7666239|NCT00124072|12080408|FG000|Overall Study|Lost to Follow-up for Morbidity|15
7666240|NCT00124072|12080409|FG001|Overall Study|Lost to Follow-up for Morbidity|25
7666241|NCT00124072|12080410|FG002|Overall Study|Lost to Follow-up for Morbidity|19
7666242|NCT00124072|12080411|FG003|Overall Study|Lost to Follow-up for Morbidity|18
7666243|NCT00124072|12080408|FG000|Overall Study|Death|499
7666244|NCT00124072|12080409|FG001|Overall Study|Death|484
7666245|NCT00124072|12080410|FG002|Overall Study|Death|471
7666246|NCT00124072|12080411|FG003|Overall Study|Death|480
7666247|NCT00124449|12080432|FG000|6-month Double-Blind Treatment Period|Adverse Event|1
7666248|NCT00124449|12080433|FG001|6-month Double-Blind Treatment Period|Adverse Event|0
7666249|NCT00124449|12080432|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3
7666250|NCT00124449|12080433|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8
7666251|NCT00124449|12080432|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
7666252|NCT00124449|12080433|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
7666253|NCT00124449|12080432|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
7666254|NCT00124449|12080433|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
7666255|NCT00124449|12080432|FG000|6-month Double-Blind Treatment Period|Sponsor request|0
7666256|NCT00124449|12080433|FG001|6-month Double-Blind Treatment Period|Sponsor request|1
7666257|NCT00124449|12080432|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
7666258|NCT00124449|12080433|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
7666259|NCT00124449|12080432|FG000|18-Month Untreated Observation Period|Adverse Event|0
7666260|NCT00124449|12080433|FG001|18-Month Untreated Observation Period|Adverse Event|1
7666261|NCT00124449|12080432|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11
7666262|NCT00124449|12080433|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12
7666263|NCT00124449|12080432|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1
7666264|NCT00124449|12080433|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0
7666265|NCT00124449|12080432|FG000|18-Month Untreated Observation Period|Pregnancy|1
7666266|NCT00124449|12080433|FG001|18-Month Untreated Observation Period|Pregnancy|0
7666267|NCT00124449|12080432|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1
7666268|NCT00124449|12080433|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0
7666269|NCT00124449|12080432|FG000|18-Month Untreated Observation Period|Relocated|1
7666270|NCT00124449|12080433|FG001|18-Month Untreated Observation Period|Relocated|0
7666271|NCT00124462|12080442|FG000|Overall Study|Lost to Follow-up|3
7666272|NCT00124462|12080443|FG001|Overall Study|Lost to Follow-up|3
7666273|NCT00124462|12080442|FG000|Overall Study|Physician Decision|3
7666274|NCT00124462|12080443|FG001|Overall Study|Physician Decision|4
7666275|NCT00124462|12080442|FG000|Overall Study|Withdrawal by Subject|4
7666276|NCT00124462|12080443|FG001|Overall Study|Withdrawal by Subject|5
7666277|NCT00124462|12080442|FG000|Overall Study|Device fitting, n=2, other hlth issues|1
7666278|NCT00124462|12080443|FG001|Overall Study|Device fitting, n=2, other hlth issues|1
7666279|NCT00124618|12080470|FG000|Overall Study|Ineligible|1
7666280|NCT00124657|12080477|FG000|Overall Study|Toxicity|0
7666281|NCT00124657|12080478|FG001|Overall Study|Toxicity|0
7666282|NCT00124657|12080479|FG002|Overall Study|Toxicity|1
7666283|NCT00124657|12080477|FG000|Overall Study|Non-compliance|1
7666284|NCT00124657|12080478|FG001|Overall Study|Non-compliance|0
7666285|NCT00124657|12080479|FG002|Overall Study|Non-compliance|4
7666286|NCT00124657|12080477|FG000|Overall Study|Progressive disease|14
7666287|NCT00124657|12080478|FG001|Overall Study|Progressive disease|5
7666288|NCT00124657|12080479|FG002|Overall Study|Progressive disease|27
7666289|NCT00124657|12080477|FG000|Overall Study|Intercurrent illness|1
7666290|NCT00124657|12080478|FG001|Overall Study|Intercurrent illness|0
7666291|NCT00124657|12080479|FG002|Overall Study|Intercurrent illness|0
7666292|NCT00124709|12080502|FG000|Overall Study|Randomized but did not take medication|3
7666293|NCT00124709|12080503|FG001|Overall Study|Randomized but did not take medication|1
7666294|NCT00124709|12080502|FG000|Overall Study|Adverse Event|3
7666295|NCT00124709|12080503|FG001|Overall Study|Adverse Event|0
7666296|NCT00124709|12080502|FG000|Overall Study|Lack of Efficacy|5
7666297|NCT00124709|12080503|FG001|Overall Study|Lack of Efficacy|10
7666298|NCT00124709|12080502|FG000|Overall Study|Protocol Violation|3
7666299|NCT00124709|12080503|FG001|Overall Study|Protocol Violation|5
7666300|NCT00124709|12080502|FG000|Overall Study|Withdrawal by Subject|127
7666301|NCT00124709|12080503|FG001|Overall Study|Withdrawal by Subject|136
7666302|NCT00124709|12080502|FG000|Overall Study|Lost to Follow-up|114
7666303|NCT00124709|12080503|FG001|Overall Study|Lost to Follow-up|120
7666304|NCT00124748|12080544|FG000|Overall Study|Adverse Event|8
7666305|NCT00124748|12080545|FG001|Overall Study|Adverse Event|39
7666306|NCT00124748|12080544|FG000|Overall Study|Abnormal laboratory Value|2
7666307|NCT00124748|12080545|FG001|Overall Study|Abnormal laboratory Value|2
7666308|NCT00124748|12080544|FG000|Overall Study|Abnormal Procedure|0
7666309|NCT00124748|12080545|FG001|Overall Study|Abnormal Procedure|1
7666310|NCT00124748|12080544|FG000|Overall Study|Lack of Efficacy|20
7666311|NCT00124748|12080545|FG001|Overall Study|Lack of Efficacy|41
7666312|NCT00124748|12080544|FG000|Overall Study|No longer requires study drug|1
7666313|NCT00124748|12080545|FG001|Overall Study|No longer requires study drug|1
7666314|NCT00124748|12080544|FG000|Overall Study|Protocol Violation|3
7666315|NCT00124748|12080545|FG001|Overall Study|Protocol Violation|1
7666316|NCT00124748|12080544|FG000|Overall Study|Withdrawal by Subject|5
7666317|NCT00124748|12080545|FG001|Overall Study|Withdrawal by Subject|15
7666318|NCT00124748|12080544|FG000|Overall Study|Lost to Follow-up|2
7666319|NCT00124748|12080545|FG001|Overall Study|Lost to Follow-up|7
7666320|NCT00124748|12080544|FG000|Overall Study|Administrative Problem(Study Terminated)|101
7666321|NCT00124748|12080545|FG001|Overall Study|Administrative Problem(Study Terminated)|174
7666322|NCT00124748|12080544|FG000|Overall Study|Death|1
7666323|NCT00124748|12080545|FG001|Overall Study|Death|3
7666324|NCT00124917|12080551|FG000|Overall Study|Physician Decision|3
7666325|NCT00124943|12080560|FG000|Phase II|Adverse Event|0
7666326|NCT00124943|12080561|FG001|Phase II|Adverse Event|2
7666327|NCT00124943|12080562|FG002|Phase II|Adverse Event|0
7666328|NCT00124943|12080563|FG003|Phase II|Adverse Event|1
7666329|NCT00124943|12080560|FG000|Phase II|Protocol Violation|0
7666330|NCT00124943|12080561|FG001|Phase II|Protocol Violation|0
7666331|NCT00124943|12080562|FG002|Phase II|Protocol Violation|0
7666332|NCT00124943|12080563|FG003|Phase II|Protocol Violation|1
7666333|NCT00124943|12080560|FG000|Phase II|Lost to Follow-up|0
7666334|NCT00124943|12080561|FG001|Phase II|Lost to Follow-up|0
7666335|NCT00124943|12080562|FG002|Phase II|Lost to Follow-up|0
7666336|NCT00124943|12080563|FG003|Phase II|Lost to Follow-up|1
7666337|NCT00124943|12080560|FG000|Phase II|Withdrawal by Subject|0
7666338|NCT00124943|12080561|FG001|Phase II|Withdrawal by Subject|0
7666339|NCT00124943|12080562|FG002|Phase II|Withdrawal by Subject|0
7666340|NCT00124943|12080563|FG003|Phase II|Withdrawal by Subject|2
7666341|NCT00124982|12080575|FG000|Short-term Period|Death|1
7666342|NCT00124982|12080576|FG001|Short-term Period|Death|1
7666343|NCT00124982|12080577|FG002|Short-term Period|Death|0
7666344|NCT00124982|12080575|FG000|Short-term Period|Adverse Event|17
7666345|NCT00124982|12080576|FG001|Short-term Period|Adverse Event|22
7666346|NCT00124982|12080577|FG002|Short-term Period|Adverse Event|0
7666347|NCT00124982|12080575|FG000|Short-term Period|Lack of Efficacy|32
7666348|NCT00124982|12080576|FG001|Short-term Period|Lack of Efficacy|73
7666349|NCT00124982|12080577|FG002|Short-term Period|Lack of Efficacy|0
7666350|NCT00124982|12080575|FG000|Short-term Period|Lost to Follow-up|8
7666351|NCT00124982|12080576|FG001|Short-term Period|Lost to Follow-up|5
7666352|NCT00124982|12080577|FG002|Short-term Period|Lost to Follow-up|0
7666353|NCT00124982|12080575|FG000|Short-term Period|Withdrawal of Consent|7
7666354|NCT00124982|12080576|FG001|Short-term Period|Withdrawal of Consent|9
7666355|NCT00124982|12080577|FG002|Short-term Period|Withdrawal of Consent|0
7666356|NCT00124982|12080575|FG000|Short-term Period|Poor/Non-compliance|3
7666357|NCT00124982|12080576|FG001|Short-term Period|Poor/Non-compliance|1
7666358|NCT00124982|12080577|FG002|Short-term Period|Poor/Non-compliance|0
7666359|NCT00124982|12080575|FG000|Short-term Period|No Longer Meets Study Criteria|1
7666360|NCT00124982|12080576|FG001|Short-term Period|No Longer Meets Study Criteria|2
7666361|NCT00124982|12080577|FG002|Short-term Period|No Longer Meets Study Criteria|0
7666362|NCT00124982|12080575|FG000|Short-term Period|Participant Decision|1
7666363|NCT00124982|12080576|FG001|Short-term Period|Participant Decision|0
7666364|NCT00124982|12080577|FG002|Short-term Period|Participant Decision|0
7666365|NCT00124982|12080575|FG000|Short-term Period|Participant Chose Own Doctor|0
7666366|NCT00124982|12080576|FG001|Short-term Period|Participant Chose Own Doctor|1
7666367|NCT00124982|12080577|FG002|Short-term Period|Participant Chose Own Doctor|0
7666368|NCT00124982|12080575|FG000|Short-term Period|Investigator Decision-No Specific AE|1
7666369|NCT00124982|12080576|FG001|Short-term Period|Investigator Decision-No Specific AE|0
7666370|NCT00124982|12080577|FG002|Short-term Period|Investigator Decision-No Specific AE|0
7666371|NCT00124982|12080575|FG000|Short-term Period|Participant Had Lymphopenia|1
7666372|NCT00124982|12080576|FG001|Short-term Period|Participant Had Lymphopenia|0
7666373|NCT00124982|12080577|FG002|Short-term Period|Participant Had Lymphopenia|0
7666374|NCT00124982|12080575|FG000|Long-term Period|Death|0
7666375|NCT00124982|12080576|FG001|Long-term Period|Death|0
7666376|NCT00124982|12080577|FG002|Long-term Period|Death|1
7666377|NCT00124982|12080575|FG000|Long-term Period|Adverse Event|0
7666378|NCT00124982|12080576|FG001|Long-term Period|Adverse Event|0
7666379|NCT00124982|12080577|FG002|Long-term Period|Adverse Event|17
7666380|NCT00124982|12080575|FG000|Long-term Period|Lack of Efficacy|0
7666381|NCT00124982|12080576|FG001|Long-term Period|Lack of Efficacy|0
7666382|NCT00124982|12080577|FG002|Long-term Period|Lack of Efficacy|46
7666383|NCT00124982|12080575|FG000|Long-term Period|Lost to Follow-up|0
7666384|NCT00124982|12080576|FG001|Long-term Period|Lost to Follow-up|0
7666385|NCT00124982|12080577|FG002|Long-term Period|Lost to Follow-up|4
7666386|NCT00124982|12080575|FG000|Long-term Period|Withdrawal by Subject|0
7666387|NCT00124982|12080576|FG001|Long-term Period|Withdrawal by Subject|0
7666388|NCT00124982|12080577|FG002|Long-term Period|Withdrawal by Subject|16
7666389|NCT00124982|12080575|FG000|Long-term Period|Pregnancy|0
7666390|NCT00124982|12080576|FG001|Long-term Period|Pregnancy|0
7666391|NCT00124982|12080577|FG002|Long-term Period|Pregnancy|1
7666392|NCT00124982|12080575|FG000|Long-term Period|Poor/Non-compliance|0
7666393|NCT00124982|12080576|FG001|Long-term Period|Poor/Non-compliance|0
7666394|NCT00124982|12080577|FG002|Long-term Period|Poor/Non-compliance|2
7666395|NCT00124982|12080575|FG000|Long-term Period|Administrative Reason by Sponsor|0
7666396|NCT00124982|12080576|FG001|Long-term Period|Administrative Reason by Sponsor|0
7666397|NCT00124982|12080577|FG002|Long-term Period|Administrative Reason by Sponsor|1
7666398|NCT00124982|12080575|FG000|Long-term Period|Neurologist Recommendation|0
7666399|NCT00124982|12080576|FG001|Long-term Period|Neurologist Recommendation|0
7666400|NCT00124982|12080577|FG002|Long-term Period|Neurologist Recommendation|1
7666401|NCT00125138|12080599|FG000|Overall Study|Adverse Event|1
7666402|NCT00125138|12080600|FG001|Overall Study|Adverse Event|0
7666403|NCT00125138|12080601|FG002|Overall Study|Adverse Event|3
7666404|NCT00125138|12080602|FG003|Overall Study|Adverse Event|2
7666405|NCT00125138|12080599|FG000|Overall Study|Withdrawal by Subject|2
7666406|NCT00125138|12080600|FG001|Overall Study|Withdrawal by Subject|3
7666407|NCT00125138|12080601|FG002|Overall Study|Withdrawal by Subject|1
7666408|NCT00125138|12080602|FG003|Overall Study|Withdrawal by Subject|1
7666409|NCT00125138|12080599|FG000|Overall Study|Lack of Efficacy|0
7666410|NCT00125138|12080600|FG001|Overall Study|Lack of Efficacy|0
7666411|NCT00125138|12080601|FG002|Overall Study|Lack of Efficacy|0
7666412|NCT00125138|12080602|FG003|Overall Study|Lack of Efficacy|1
7666413|NCT00125138|12080599|FG000|Overall Study|Sponsor decision-pt moved to assist care|0
7666414|NCT00125138|12080600|FG001|Overall Study|Sponsor decision-pt moved to assist care|0
7666415|NCT00125138|12080601|FG002|Overall Study|Sponsor decision-pt moved to assist care|0
7666416|NCT00125138|12080602|FG003|Overall Study|Sponsor decision-pt moved to assist care|1
7666417|NCT00125164|12080616|FG000|Overall Study|Adverse Event|0
7666418|NCT00125164|12080617|FG001|Overall Study|Adverse Event|0
7666419|NCT00125164|12080618|FG002|Overall Study|Adverse Event|2
7666420|NCT00125164|12080619|FG003|Overall Study|Adverse Event|4
7666421|NCT00125164|12080616|FG000|Overall Study|Lost to Follow-up|0
7666422|NCT00125164|12080617|FG001|Overall Study|Lost to Follow-up|0
7666423|NCT00125164|12080618|FG002|Overall Study|Lost to Follow-up|1
7666424|NCT00125164|12080619|FG003|Overall Study|Lost to Follow-up|1
7666425|NCT00125164|12080616|FG000|Overall Study|Withdrawal by Subject|2
7666426|NCT00125164|12080617|FG001|Overall Study|Withdrawal by Subject|0
7666427|NCT00125164|12080618|FG002|Overall Study|Withdrawal by Subject|1
7666428|NCT00125164|12080619|FG003|Overall Study|Withdrawal by Subject|1
7666429|NCT00125190|12080629|FG000|Overall Study|Subject/Parent Decision|7
7666430|NCT00125190|12080629|FG000|Overall Study|Non-compliance|2
7666431|NCT00125190|12080629|FG000|Overall Study|Adverse Event|1
7666432|NCT00125190|12080629|FG000|Overall Study|Other|1
7666433|NCT00125190|12080629|FG000|Overall Study|Lost to Follow-up|4
7666434|NCT00125242|12080636|FG000|Overall Study|did not qualify|7
7666435|NCT00125242|12080637|FG001|Overall Study|did not qualify|2
7666436|NCT00125359|12080642|FG000|Overall Study|Death|4
7666437|NCT00125359|12080642|FG000|Overall Study|Adverse Event|5
7666438|NCT00125359|12080642|FG000|Overall Study|Physician Decision|14
7666439|NCT00125853|12080715|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3
7666440|NCT00125853|12080716|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7
7666441|NCT00126126|12080746|FG000|Overall Study|Lost to Follow-up|0
7666442|NCT00126126|12080747|FG001|Overall Study|Lost to Follow-up|2
7666443|NCT00126191|12080755|FG000|Overall Study|Physician Decision|0
7666444|NCT00126191|12080756|FG001|Overall Study|Physician Decision|1
7666445|NCT00126191|12080755|FG000|Overall Study|Death|0
7666446|NCT00126191|12080756|FG001|Overall Study|Death|1
7666447|NCT00126425|12080764|FG000|Overall Study|Withdrawal by Subject|17
7666448|NCT00126425|12080765|FG001|Overall Study|Withdrawal by Subject|1
7666449|NCT00126425|12080764|FG000|Overall Study|Lost to Follow-up|8
7666450|NCT00126425|12080765|FG001|Overall Study|Lost to Follow-up|4
7666451|NCT00126425|12080764|FG000|Overall Study|Protocol Violation|9
7666452|NCT00126425|12080765|FG001|Overall Study|Protocol Violation|6
7666453|NCT00126425|12080764|FG000|Overall Study|Adverse Event|1
7666454|NCT00126425|12080765|FG001|Overall Study|Adverse Event|0
7666455|NCT00126425|12080764|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1
7666456|NCT00126425|12080765|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0
7666457|NCT00126425|12080764|FG000|Overall Study|Other|5
7666458|NCT00126425|12080765|FG001|Overall Study|Other|0
7666459|NCT00126438|12080773|FG000|Overall Study|Withdrawal due to adverse event|1
7666460|NCT00126438|12080774|FG001|Overall Study|Withdrawal due to adverse event|0
7666461|NCT00126438|12080773|FG000|Overall Study|Lost to Follow-up|22
7666462|NCT00126438|12080774|FG001|Overall Study|Lost to Follow-up|0
7666463|NCT00126438|12080773|FG000|Overall Study|Protocol Violation|8
7666464|NCT00126438|12080774|FG001|Overall Study|Protocol Violation|8
7666465|NCT00126438|12080773|FG000|Overall Study|Withdrawal by Subject|3
7666466|NCT00126438|12080774|FG001|Overall Study|Withdrawal by Subject|2
7666467|NCT00126490|12080780|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1
7666468|NCT00126503|12080786|FG000|Overall Study|disease progression|23
7666469|NCT00126503|12080787|FG001|Overall Study|disease progression|14
7666470|NCT00126503|12080786|FG000|Overall Study|Withdrawal by Subject|0
7666471|NCT00126503|12080787|FG001|Overall Study|Withdrawal by Subject|1
7666472|NCT00126503|12080786|FG000|Overall Study|alternative therapy|1
7666473|NCT00126503|12080787|FG001|Overall Study|alternative therapy|1
7666474|NCT00126503|12080786|FG000|Overall Study|other complicating disease|4
7666475|NCT00126503|12080787|FG001|Overall Study|other complicating disease|1
7666476|NCT00126503|12080786|FG000|Overall Study|Death|3
7666477|NCT00126503|12080787|FG001|Overall Study|Death|0
7666478|NCT00126503|12080786|FG000|Overall Study|Adverse Event|13
7666479|NCT00126503|12080787|FG001|Overall Study|Adverse Event|3
7666480|NCT00126503|12080786|FG000|Overall Study|non-compliant|1
7666481|NCT00126503|12080787|FG001|Overall Study|non-compliant|0
7666482|NCT00126503|12080786|FG000|Overall Study|Physician Decision|2
7666483|NCT00126503|12080787|FG001|Overall Study|Physician Decision|1
7666484|NCT00126555|12080797|FG000|Overall Study|Withdrawal by Subject|1
7666485|NCT00126555|12080797|FG000|Overall Study|Adverse Event|2
7666486|NCT00126555|12080797|FG000|Overall Study|Progressive Disease|3
7666487|NCT00126568|12080813|FG000|Overall Study|Death|2
7666488|NCT00126581|12080820|FG000|Overall Study|Adverse Event|3
7666489|NCT00126581|12080821|FG001|Overall Study|Adverse Event|7
7666490|NCT00126581|12080820|FG000|Overall Study|Death|3
7666491|NCT00126581|12080821|FG001|Overall Study|Death|2
7666492|NCT00126581|12080820|FG000|Overall Study|Withdrawal by Subject|1
7666493|NCT00126581|12080821|FG001|Overall Study|Withdrawal by Subject|4
7666494|NCT00126581|12080820|FG000|Overall Study|Alternative therapy|3
7666495|NCT00126581|12080821|FG001|Overall Study|Alternative therapy|3
7666496|NCT00126581|12080820|FG000|Overall Study|Other illness/MD discretion|3
7666497|NCT00126581|12080821|FG001|Overall Study|Other illness/MD discretion|4
7666498|NCT00126594|12080831|FG000|Overall Study|Ineligible|2
7666499|NCT00126594|12080832|FG001|Overall Study|Ineligible|0
7666500|NCT00126594|12080831|FG000|Overall Study|Withdrawal by Subject|0
7666501|NCT00126594|12080832|FG001|Overall Study|Withdrawal by Subject|4
7666502|NCT00126594|12080831|FG000|Overall Study|Physician Decision|1
7666503|NCT00126594|12080832|FG001|Overall Study|Physician Decision|3
7666504|NCT00126594|12080831|FG000|Overall Study|Adverse Event|7
7666505|NCT00126594|12080832|FG001|Overall Study|Adverse Event|5
7666506|NCT00126594|12080831|FG000|Overall Study|Non-compliance|0
7666507|NCT00126594|12080832|FG001|Overall Study|Non-compliance|1
7666508|NCT00126594|12080831|FG000|Overall Study|Disease Progression|29
7666509|NCT00126594|12080832|FG001|Overall Study|Disease Progression|24
7666510|NCT00127036|12080870|FG000|Overall Study|Insufficient Data for Analysis|6
7666511|NCT00127036|12080871|FG001|Overall Study|Insufficient Data for Analysis|11
7666512|NCT00127036|12080870|FG000|Overall Study|Screen Failure|2
7666513|NCT00127036|12080871|FG001|Overall Study|Screen Failure|0
7666514|NCT00127101|12080896|FG000|Base Protocol|Adverse Event|0
7666515|NCT00127101|12080897|FG001|Base Protocol|Adverse Event|2
7666516|NCT00127101|12080898|FG002|Base Protocol|Adverse Event|1
7666517|NCT00127101|12080899|FG003|Base Protocol|Adverse Event|0
7666518|NCT00127101|12080900|FG004|Base Protocol|Adverse Event|0
7666519|NCT00127101|12080901|FG005|Base Protocol|Adverse Event|0
7666520|NCT00127101|12080896|FG000|Base Protocol|Lack of Efficacy|1
7666521|NCT00127101|12080897|FG001|Base Protocol|Lack of Efficacy|0
7666522|NCT00127101|12080898|FG002|Base Protocol|Lack of Efficacy|0
7666523|NCT00127101|12080899|FG003|Base Protocol|Lack of Efficacy|0
7666524|NCT00127101|12080900|FG004|Base Protocol|Lack of Efficacy|2
7666525|NCT00127101|12080901|FG005|Base Protocol|Lack of Efficacy|0
7666526|NCT00127101|12080896|FG000|Base Protocol|Withdrawal by Subject|1
7666527|NCT00127101|12080897|FG001|Base Protocol|Withdrawal by Subject|2
7666528|NCT00127101|12080898|FG002|Base Protocol|Withdrawal by Subject|1
7666529|NCT00127101|12080899|FG003|Base Protocol|Withdrawal by Subject|0
7666530|NCT00127101|12080900|FG004|Base Protocol|Withdrawal by Subject|0
7666531|NCT00127101|12080901|FG005|Base Protocol|Withdrawal by Subject|1
7666532|NCT00127101|12080896|FG000|Continuation Phase|Adverse Event|0
7666533|NCT00127101|12080897|FG001|Continuation Phase|Adverse Event|0
7666534|NCT00127101|12080898|FG002|Continuation Phase|Adverse Event|0
7666535|NCT00127101|12080899|FG003|Continuation Phase|Adverse Event|0
7666536|NCT00127101|12080900|FG004|Continuation Phase|Adverse Event|1
7666537|NCT00127101|12080901|FG005|Continuation Phase|Adverse Event|1
7666538|NCT00127101|12080896|FG000|Continuation Phase|Lack of Efficacy|0
7666539|NCT00127101|12080897|FG001|Continuation Phase|Lack of Efficacy|0
7666540|NCT00127101|12080898|FG002|Continuation Phase|Lack of Efficacy|0
7666541|NCT00127101|12080899|FG003|Continuation Phase|Lack of Efficacy|0
7666542|NCT00127101|12080900|FG004|Continuation Phase|Lack of Efficacy|0
7666543|NCT00127101|12080901|FG005|Continuation Phase|Lack of Efficacy|1
7666544|NCT00127101|12080896|FG000|Continuation Phase|Withdrawal by Subject|0
7666545|NCT00127101|12080897|FG001|Continuation Phase|Withdrawal by Subject|0
7666546|NCT00127101|12080898|FG002|Continuation Phase|Withdrawal by Subject|1
7666547|NCT00127101|12080899|FG003|Continuation Phase|Withdrawal by Subject|0
7666548|NCT00127101|12080900|FG004|Continuation Phase|Withdrawal by Subject|2
7666549|NCT00127101|12080901|FG005|Continuation Phase|Withdrawal by Subject|1
7666550|NCT00127166|12080917|FG000|Period I|Protocol Violation|0
7666551|NCT00127166|12080918|FG001|Period I|Protocol Violation|2
7666552|NCT00127166|12080917|FG000|Period I|Withdrawal by Subject|2
7666553|NCT00127166|12080918|FG001|Period I|Withdrawal by Subject|0
7666554|NCT00127166|12080917|FG000|Period I|Patient did not meet inclusion criteria|1
7666555|NCT00127166|12080918|FG001|Period I|Patient did not meet inclusion criteria|0
7666556|NCT00127166|12080917|FG000|Washout Period|Patient did not meet inclusion criteria|0
7666557|NCT00127166|12080918|FG001|Washout Period|Patient did not meet inclusion criteria|1
7666558|NCT00127166|12080917|FG000|Period II|Withdrawal by Subject|2
7666559|NCT00127166|12080918|FG001|Period II|Withdrawal by Subject|0
7666560|NCT00127166|12080917|FG000|Period II|Patient did not perform Visit 6 exercise|1
7666561|NCT00127166|12080918|FG001|Period II|Patient did not perform Visit 6 exercise|0
7666562|NCT00127192|12080929|FG000|Overall Study|Adverse Event|0
7666563|NCT00127192|12080930|FG001|Overall Study|Adverse Event|1
7666564|NCT00127192|12080931|FG002|Overall Study|Adverse Event|1
7666565|NCT00127192|12080932|FG003|Overall Study|Adverse Event|1
7666566|NCT00127192|12080933|FG004|Overall Study|Adverse Event|0
7666567|NCT00127192|12080929|FG000|Overall Study|Lack of Efficacy|2
7666568|NCT00127192|12080930|FG001|Overall Study|Lack of Efficacy|0
7666569|NCT00127192|12080931|FG002|Overall Study|Lack of Efficacy|0
7666570|NCT00127192|12080932|FG003|Overall Study|Lack of Efficacy|0
7666571|NCT00127192|12080933|FG004|Overall Study|Lack of Efficacy|2
7666572|NCT00127192|12080929|FG000|Overall Study|Withdrawal by Subject|0
7666573|NCT00127192|12080930|FG001|Overall Study|Withdrawal by Subject|0
7666574|NCT00127192|12080931|FG002|Overall Study|Withdrawal by Subject|1
7666575|NCT00127192|12080932|FG003|Overall Study|Withdrawal by Subject|0
7666576|NCT00127192|12080933|FG004|Overall Study|Withdrawal by Subject|3
7666577|NCT00127192|12080929|FG000|Overall Study|Adverse event in pre-treatment period|1
7666578|NCT00127192|12080930|FG001|Overall Study|Adverse event in pre-treatment period|0
7666579|NCT00127192|12080931|FG002|Overall Study|Adverse event in pre-treatment period|0
7666580|NCT00127192|12080932|FG003|Overall Study|Adverse event in pre-treatment period|0
7666581|NCT00127192|12080933|FG004|Overall Study|Adverse event in pre-treatment period|0
7666582|NCT00127205|12080948|FG000|Overall Study|Adverse Event|228
7666583|NCT00127205|12080949|FG001|Overall Study|Adverse Event|387
7666584|NCT00127205|12080950|FG002|Overall Study|Adverse Event|273
7666585|NCT00127205|12080948|FG000|Overall Study|Death|8
7666586|NCT00127205|12080949|FG001|Overall Study|Death|6
7666587|NCT00127205|12080950|FG002|Overall Study|Death|5
7666588|NCT00127205|12080948|FG000|Overall Study|Withdrawal by Subject|318
7666589|NCT00127205|12080949|FG001|Overall Study|Withdrawal by Subject|310
7666590|NCT00127205|12080950|FG002|Overall Study|Withdrawal by Subject|172
7666591|NCT00127205|12080948|FG000|Overall Study|Other-non protocol specified|142
7666592|NCT00127205|12080949|FG001|Overall Study|Other-non protocol specified|129
7666593|NCT00127205|12080950|FG002|Overall Study|Other-non protocol specified|77
7666594|NCT00127205|12080948|FG000|Overall Study|Data not reported|6
7666595|NCT00127205|12080949|FG001|Overall Study|Data not reported|10
7666596|NCT00127205|12080950|FG002|Overall Study|Data not reported|1
7666597|NCT00127205|12080948|FG000|Overall Study|Progression|127
7666598|NCT00127205|12080949|FG001|Overall Study|Progression|131
7666599|NCT00127205|12080950|FG002|Overall Study|Progression|84
7666600|NCT00127413|12080984|FG000|Overall Study|Lost to Follow-up|6
7666601|NCT00127413|12080985|FG001|Overall Study|Lost to Follow-up|4
7666602|NCT00127413|12080986|FG002|Overall Study|Lost to Follow-up|8
7666603|NCT00127413|12080987|FG003|Overall Study|Lost to Follow-up|2
7666604|NCT00127608|12081018|FG000|Overall Study|VZV DNA negative|1
7666605|NCT00127660|12081026|FG000|Overall Study|Protocol Violation|3
7666606|NCT00127660|12081027|FG001|Overall Study|Protocol Violation|3
7666607|NCT00127660|12081028|FG002|Overall Study|Protocol Violation|5
7666608|NCT00127660|12081029|FG003|Overall Study|Protocol Violation|0
7666609|NCT00127712|12081041|FG000|Overall Study|Adverse Event|3
7666610|NCT00127712|12081042|FG001|Overall Study|Adverse Event|0
7666611|NCT00127712|12081041|FG000|Overall Study|Lack of GI access to continue|2
7666612|NCT00127712|12081042|FG001|Overall Study|Lack of GI access to continue|0
7666613|NCT00127803|12081069|FG000|Overall Study|Adverse Event|2
7666614|NCT00127803|12081070|FG001|Overall Study|Adverse Event|0
7666615|NCT00127803|12081071|FG002|Overall Study|Adverse Event|0
7666616|NCT00127803|12081072|FG003|Overall Study|Adverse Event|0
7666617|NCT00127803|12081069|FG000|Overall Study|Withdrawal by Subject|1
7666618|NCT00127803|12081070|FG001|Overall Study|Withdrawal by Subject|0
7666619|NCT00127803|12081071|FG002|Overall Study|Withdrawal by Subject|0
7666620|NCT00127803|12081072|FG003|Overall Study|Withdrawal by Subject|0
7666621|NCT00127803|12081069|FG000|Overall Study|Lost to Follow-up|0
7666622|NCT00127803|12081070|FG001|Overall Study|Lost to Follow-up|0
7666623|NCT00127803|12081071|FG002|Overall Study|Lost to Follow-up|0
7666624|NCT00127803|12081072|FG003|Overall Study|Lost to Follow-up|1
7666625|NCT00127842|12081082|FG000|Overall Study|Adverse Event|15
7666626|NCT00127842|12081082|FG000|Overall Study|Withdrawal by Subject|3
7666627|NCT00127842|12081082|FG000|Overall Study|Lost to Follow-up|1
7666628|NCT00127842|12081082|FG000|Overall Study|Lack of Efficacy|12
7666629|NCT00127842|12081082|FG000|Overall Study|Noncompliance|2
7666630|NCT00127842|12081082|FG000|Overall Study|Protocol Violation|1
7666631|NCT00127842|12081082|FG000|Overall Study|Other|5
7666632|NCT00127855|12081091|FG000|Primary Vaccination Course|Adverse Event|0
7666633|NCT00127855|12081092|FG001|Primary Vaccination Course|Adverse Event|0
7666634|NCT00127855|12081093|FG002|Primary Vaccination Course|Adverse Event|1
7666635|NCT00127855|12081094|FG003|Primary Vaccination Course|Adverse Event|0
7666636|NCT00127855|12081095|FG004|Primary Vaccination Course|Adverse Event|0
7666637|NCT00127855|12081091|FG000|Primary Vaccination Course|Withdrawal by Subject|1
7666638|NCT00127855|12081092|FG001|Primary Vaccination Course|Withdrawal by Subject|0
7666639|NCT00127855|12081093|FG002|Primary Vaccination Course|Withdrawal by Subject|0
7666640|NCT00127855|12081094|FG003|Primary Vaccination Course|Withdrawal by Subject|0
7666641|NCT00127855|12081095|FG004|Primary Vaccination Course|Withdrawal by Subject|1
7666642|NCT00127855|12081091|FG000|Primary Vaccination Course|Lost to Follow-up|1
7666643|NCT00127855|12081092|FG001|Primary Vaccination Course|Lost to Follow-up|1
7666644|NCT00127855|12081093|FG002|Primary Vaccination Course|Lost to Follow-up|1
7666645|NCT00127855|12081094|FG003|Primary Vaccination Course|Lost to Follow-up|0
7666646|NCT00127855|12081095|FG004|Primary Vaccination Course|Lost to Follow-up|2
7666647|NCT00127855|12081091|FG000|Primary Vaccination Course|Other|0
7666648|NCT00127855|12081092|FG001|Primary Vaccination Course|Other|0
7666649|NCT00127855|12081093|FG002|Primary Vaccination Course|Other|0
7666650|NCT00127855|12081094|FG003|Primary Vaccination Course|Other|0
7666651|NCT00127855|12081095|FG004|Primary Vaccination Course|Other|1
7666652|NCT00127933|12081109|FG000|Overall Study|Randomized but not dosed|1
7666653|NCT00127933|12081110|FG001|Overall Study|Randomized but not dosed|0
7666654|NCT00128102|12081118|FG000|Overall Study|Site Discontinued|3
7666655|NCT00128102|12081119|FG001|Overall Study|Site Discontinued|6
7666656|NCT00128102|12081118|FG000|Overall Study|Other|0
7666657|NCT00128102|12081119|FG001|Overall Study|Other|1
7666658|NCT00128102|12081118|FG000|Overall Study|Progressive Disease|255
7666659|NCT00128102|12081119|FG001|Overall Study|Progressive Disease|285
7666660|NCT00128102|12081118|FG000|Overall Study|Adverse Event|34
7666661|NCT00128102|12081119|FG001|Overall Study|Adverse Event|11
7666662|NCT00128102|12081118|FG000|Overall Study|Death|12
7666663|NCT00128102|12081119|FG001|Overall Study|Death|13
7666664|NCT00128102|12081118|FG000|Overall Study|Physician Decision|3
7666665|NCT00128102|12081119|FG001|Overall Study|Physician Decision|3
7666666|NCT00128102|12081118|FG000|Overall Study|Withdrawal by Subject|19
7666667|NCT00128102|12081119|FG001|Overall Study|Withdrawal by Subject|11
7666668|NCT00128102|12081118|FG000|Overall Study|Protocol Violation|2
7666669|NCT00128102|12081119|FG001|Overall Study|Protocol Violation|2
7666670|NCT00128206|12081239|FG000|Overall Study|Lost to Follow-up|137
7666671|NCT00128206|12081240|FG001|Overall Study|Lost to Follow-up|118
7666672|NCT00128206|12081239|FG000|Overall Study|Adverse Event|0
7666673|NCT00128206|12081240|FG001|Overall Study|Adverse Event|2
7666674|NCT00128492|12081267|FG000|Overall Study|AE unrelated to study|2
7666675|NCT00128492|12081268|FG001|Overall Study|AE unrelated to study|9
7666676|NCT00128492|12081267|FG000|Overall Study|Study drug intolerance (AE)|2
7666677|NCT00128492|12081268|FG001|Overall Study|Study drug intolerance (AE)|8
7666678|NCT00128492|12081267|FG000|Overall Study|AE related to study|1
7666679|NCT00128492|12081268|FG001|Overall Study|AE related to study|4
7666680|NCT00128492|12081267|FG000|Overall Study|Death|1
7666681|NCT00128492|12081268|FG001|Overall Study|Death|0
7666682|NCT00128492|12081267|FG000|Overall Study|Lost to Follow-up|1
7666683|NCT00128492|12081268|FG001|Overall Study|Lost to Follow-up|5
7666684|NCT00128492|12081267|FG000|Overall Study|Noncompliance|0
7666685|NCT00128492|12081268|FG001|Overall Study|Noncompliance|5
7666686|NCT00128492|12081267|FG000|Overall Study|Personal or administrative|10
7666687|NCT00128492|12081268|FG001|Overall Study|Personal or administrative|22
7666688|NCT00128492|12081267|FG000|Overall Study|Withdrawal by Subject|3
7666689|NCT00128492|12081268|FG001|Overall Study|Withdrawal by Subject|5
7666690|NCT00128492|12081267|FG000|Overall Study|Pregnancy|0
7666691|NCT00128492|12081268|FG001|Overall Study|Pregnancy|1
7666692|NCT00128661|12081276|FG000|Overall Study|Adverse Event|14
7666693|NCT00128661|12081277|FG001|Overall Study|Adverse Event|11
7666694|NCT00128661|12081276|FG000|Overall Study|Lost to Follow-up|10
7666695|NCT00128661|12081277|FG001|Overall Study|Lost to Follow-up|7
7666696|NCT00128661|12081276|FG000|Overall Study|Withdrawal by Subject|243
7666697|NCT00128661|12081277|FG001|Overall Study|Withdrawal by Subject|232
7666698|NCT00128661|12081276|FG000|Overall Study|Other|7
7666699|NCT00128661|12081277|FG001|Overall Study|Other|8
7666700|NCT00128830|12081296|FG000|Overall Study|Adverse Event|10
7666701|NCT00128830|12081296|FG000|Overall Study|Withdrawal by Subject|14
7666702|NCT00128830|12081296|FG000|Overall Study|Lost to Follow-up|4
7666703|NCT00128830|12081296|FG000|Overall Study|Reached a virologic endpoint|29
7666704|NCT00128830|12081296|FG000|Overall Study|Non-compliant|4
7666705|NCT00128830|12081296|FG000|Overall Study|Discontinued or ineligible for study|2
7666706|NCT00128830|12081296|FG000|Overall Study|Other|9
7666707|NCT00129116|12081322|FG000|Primary Phase|Lost to Follow-up|1
7666708|NCT00129116|12081323|FG001|Primary Phase|Lost to Follow-up|1
7666709|NCT00129116|12081324|FG002|Primary Phase|Lost to Follow-up|0
7666710|NCT00129116|12081325|FG003|Primary Phase|Lost to Follow-up|1
7666711|NCT00129116|12081326|FG004|Primary Phase|Lost to Follow-up|1
7666712|NCT00129116|12081322|FG000|Primary Phase|Protocol Violation|0
7666713|NCT00129116|12081323|FG001|Primary Phase|Protocol Violation|1
7666714|NCT00129116|12081324|FG002|Primary Phase|Protocol Violation|0
7666715|NCT00129116|12081325|FG003|Primary Phase|Protocol Violation|0
7666716|NCT00129116|12081326|FG004|Primary Phase|Protocol Violation|0
7666717|NCT00129116|12081322|FG000|Primary Phase|Adverse Event|1
7666718|NCT00129116|12081323|FG001|Primary Phase|Adverse Event|1
7666719|NCT00129116|12081324|FG002|Primary Phase|Adverse Event|0
7666720|NCT00129116|12081325|FG003|Primary Phase|Adverse Event|0
7666721|NCT00129116|12081326|FG004|Primary Phase|Adverse Event|0
7666722|NCT00129116|12081322|FG000|Primary Phase|Withdrawal by Subject|0
7666723|NCT00129116|12081323|FG001|Primary Phase|Withdrawal by Subject|1
7666724|NCT00129116|12081324|FG002|Primary Phase|Withdrawal by Subject|0
7666725|NCT00129116|12081325|FG003|Primary Phase|Withdrawal by Subject|0
7666726|NCT00129116|12081326|FG004|Primary Phase|Withdrawal by Subject|0
7666727|NCT00129116|12081322|FG000|Primary Phase|Other|0
7666728|NCT00129116|12081323|FG001|Primary Phase|Other|0
7666729|NCT00129116|12081324|FG002|Primary Phase|Other|1
7666730|NCT00129116|12081325|FG003|Primary Phase|Other|0
7666731|NCT00129116|12081326|FG004|Primary Phase|Other|0
7666732|NCT00129116|12081322|FG000|Booster Phase|Lost to Follow-up|2
7666733|NCT00129116|12081323|FG001|Booster Phase|Lost to Follow-up|0
7666734|NCT00129116|12081324|FG002|Booster Phase|Lost to Follow-up|0
7666735|NCT00129116|12081325|FG003|Booster Phase|Lost to Follow-up|0
7666736|NCT00129116|12081326|FG004|Booster Phase|Lost to Follow-up|1
7666737|NCT00129129|12081341|FG000|Primary Phase|Adverse Event|2
7666738|NCT00129129|12081342|FG001|Primary Phase|Adverse Event|1
7666739|NCT00129129|12081343|FG002|Primary Phase|Adverse Event|0
7666740|NCT00129129|12081344|FG003|Primary Phase|Adverse Event|0
7666741|NCT00129129|12081345|FG004|Primary Phase|Adverse Event|0
7666742|NCT00129129|12081341|FG000|Primary Phase|Withdrawal by Subject|12
7666743|NCT00129129|12081342|FG001|Primary Phase|Withdrawal by Subject|10
7666744|NCT00129129|12081343|FG002|Primary Phase|Withdrawal by Subject|0
7666745|NCT00129129|12081344|FG003|Primary Phase|Withdrawal by Subject|0
7666746|NCT00129129|12081345|FG004|Primary Phase|Withdrawal by Subject|0
7666747|NCT00129129|12081341|FG000|Primary Phase|Migration from study area|1
7666748|NCT00129129|12081342|FG001|Primary Phase|Migration from study area|3
7666749|NCT00129129|12081343|FG002|Primary Phase|Migration from study area|0
7666750|NCT00129129|12081344|FG003|Primary Phase|Migration from study area|0
7666751|NCT00129129|12081345|FG004|Primary Phase|Migration from study area|0
7666752|NCT00129129|12081341|FG000|Primary Phase|Lost to Follow-up|8
7666753|NCT00129129|12081342|FG001|Primary Phase|Lost to Follow-up|6
7666754|NCT00129129|12081343|FG002|Primary Phase|Lost to Follow-up|0
7666755|NCT00129129|12081344|FG003|Primary Phase|Lost to Follow-up|0
7666756|NCT00129129|12081345|FG004|Primary Phase|Lost to Follow-up|0
7666757|NCT00129129|12081341|FG000|Primary Phase|Other|2
7666758|NCT00129129|12081342|FG001|Primary Phase|Other|5
7666759|NCT00129129|12081343|FG002|Primary Phase|Other|0
7666760|NCT00129129|12081344|FG003|Primary Phase|Other|0
7666761|NCT00129129|12081345|FG004|Primary Phase|Other|0
7666762|NCT00129129|12081341|FG000|Fourth Dose Phase|Lost to Follow-up|4
7666763|NCT00129129|12081342|FG001|Fourth Dose Phase|Lost to Follow-up|0
7666764|NCT00129129|12081343|FG002|Fourth Dose Phase|Lost to Follow-up|0
7666765|NCT00129129|12081344|FG003|Fourth Dose Phase|Lost to Follow-up|2
7666766|NCT00129129|12081345|FG004|Fourth Dose Phase|Lost to Follow-up|2
7666767|NCT00129129|12081341|FG000|Fourth Dose Phase|Withdrawal by Subject|0
7666768|NCT00129129|12081342|FG001|Fourth Dose Phase|Withdrawal by Subject|0
7666769|NCT00129129|12081343|FG002|Fourth Dose Phase|Withdrawal by Subject|0
7666770|NCT00129129|12081344|FG003|Fourth Dose Phase|Withdrawal by Subject|0
7666771|NCT00129129|12081345|FG004|Fourth Dose Phase|Withdrawal by Subject|1
7666772|NCT00129129|12081341|FG000|Fourth Dose Phase|Migration from study area|0
7666773|NCT00129129|12081342|FG001|Fourth Dose Phase|Migration from study area|0
7666774|NCT00129129|12081343|FG002|Fourth Dose Phase|Migration from study area|0
7666775|NCT00129129|12081344|FG003|Fourth Dose Phase|Migration from study area|0
7666776|NCT00129129|12081345|FG004|Fourth Dose Phase|Migration from study area|2
7666777|NCT00129129|12081341|FG000|Fourth Dose Phase|Other|0
7666778|NCT00129129|12081342|FG001|Fourth Dose Phase|Other|0
7666779|NCT00129129|12081343|FG002|Fourth Dose Phase|Other|0
7666780|NCT00129129|12081344|FG003|Fourth Dose Phase|Other|1
7666781|NCT00129129|12081345|FG004|Fourth Dose Phase|Other|1
7666782|NCT00129129|12081341|FG000|Fourth Dose Phase|Protocol Violation|0
7666783|NCT00129129|12081342|FG001|Fourth Dose Phase|Protocol Violation|0
7666784|NCT00129129|12081343|FG002|Fourth Dose Phase|Protocol Violation|0
7666785|NCT00129129|12081344|FG003|Fourth Dose Phase|Protocol Violation|1
7666786|NCT00129129|12081345|FG004|Fourth Dose Phase|Protocol Violation|0
7666787|NCT00129220|12081368|FG000|Study Period II|Adverse Event|9
7666788|NCT00129220|12081369|FG001|Study Period II|Adverse Event|5
7666789|NCT00129220|12081370|FG002|Study Period II|Adverse Event|7
7666790|NCT00129220|12081368|FG000|Study Period II|Lack of Efficacy|15
7666791|NCT00129220|12081369|FG001|Study Period II|Lack of Efficacy|1
7666792|NCT00129220|12081370|FG002|Study Period II|Lack of Efficacy|28
7666793|NCT00129220|12081368|FG000|Study Period II|Entry Criteria Not Met|2
7666794|NCT00129220|12081369|FG001|Study Period II|Entry Criteria Not Met|0
7666795|NCT00129220|12081370|FG002|Study Period II|Entry Criteria Not Met|2
7666796|NCT00129220|12081368|FG000|Study Period II|Protocol Violation|4
7666797|NCT00129220|12081369|FG001|Study Period II|Protocol Violation|2
7666798|NCT00129220|12081370|FG002|Study Period II|Protocol Violation|1
7666799|NCT00129220|12081368|FG000|Study Period II|Physician Decision|0
7666800|NCT00129220|12081369|FG001|Study Period II|Physician Decision|1
7666801|NCT00129220|12081370|FG002|Study Period II|Physician Decision|0
7666802|NCT00129220|12081368|FG000|Study Period II|Withdrawal by Subject|1
7666803|NCT00129220|12081369|FG001|Study Period II|Withdrawal by Subject|3
7666804|NCT00129220|12081370|FG002|Study Period II|Withdrawal by Subject|4
7666805|NCT00129220|12081368|FG000|Study Period II|Reason Not Specified|2
7666806|NCT00129220|12081369|FG001|Study Period II|Reason Not Specified|0
7666807|NCT00129220|12081370|FG002|Study Period II|Reason Not Specified|5
7666808|NCT00129220|12081368|FG000|Study Period III|Adverse Event|1
7666809|NCT00129220|12081369|FG001|Study Period III|Adverse Event|0
7666810|NCT00129220|12081370|FG002|Study Period III|Adverse Event|3
7666811|NCT00129220|12081368|FG000|Study Period III|Protocol Violation|1
7666812|NCT00129220|12081369|FG001|Study Period III|Protocol Violation|1
7666813|NCT00129220|12081370|FG002|Study Period III|Protocol Violation|2
7666814|NCT00129220|12081368|FG000|Study Period III|Withdrawal by Subject|1
7666815|NCT00129220|12081369|FG001|Study Period III|Withdrawal by Subject|0
7666816|NCT00129220|12081370|FG002|Study Period III|Withdrawal by Subject|3
7666817|NCT00129220|12081368|FG000|Study Period III|Sponsor Decision|1
7666818|NCT00129220|12081369|FG001|Study Period III|Sponsor Decision|0
7666819|NCT00129220|12081370|FG002|Study Period III|Sponsor Decision|0
7666820|NCT00129220|12081368|FG000|Study Period III|Reason Not Specified|9
7666821|NCT00129220|12081369|FG001|Study Period III|Reason Not Specified|0
7666822|NCT00129220|12081370|FG002|Study Period III|Reason Not Specified|2
7666823|NCT00129259|12081391|FG000|Overall Study|Lost to Follow-up|1
7666824|NCT00129259|12081392|FG001|Overall Study|Lost to Follow-up|1
7666825|NCT00129259|12081391|FG000|Overall Study|Withdrawal by Subject|2
7666826|NCT00129259|12081392|FG001|Overall Study|Withdrawal by Subject|1
7666827|NCT00129259|12081391|FG000|Overall Study|Only available minimal phone assessments|0
7666828|NCT00129259|12081392|FG001|Overall Study|Only available minimal phone assessments|1
7666829|NCT00129272|12081400|FG000|Overall Study|Lost to Follow-up|12
7666830|NCT00129272|12081401|FG001|Overall Study|Lost to Follow-up|11
7666831|NCT00129272|12081400|FG000|Overall Study|Withdrawal by Subject|5
7666832|NCT00129272|12081401|FG001|Overall Study|Withdrawal by Subject|11
7666833|NCT00129311|12081426|FG000|Overall Study|Withdrawal by Subject|12
7666834|NCT00129311|12081427|FG001|Overall Study|Withdrawal by Subject|19
7666835|NCT00129376|12081433|FG000|Overall Study|Adverse Event|1
7666836|NCT00129376|12081433|FG000|Overall Study|Lack of Efficacy|1
7666837|NCT00129389|12081439|FG000|Overall Study|Adverse Event|19
7666838|NCT00129389|12081440|FG001|Overall Study|Adverse Event|87
7666839|NCT00129389|12081439|FG000|Overall Study|Death|0
7666840|NCT00129389|12081440|FG001|Overall Study|Death|1
7666841|NCT00129389|12081439|FG000|Overall Study|Lost to Follow-up|2
7666842|NCT00129389|12081440|FG001|Overall Study|Lost to Follow-up|1
7666843|NCT00129389|12081439|FG000|Overall Study|Physician Decision|0
7666844|NCT00129389|12081440|FG001|Overall Study|Physician Decision|4
7666845|NCT00129389|12081439|FG000|Overall Study|Protocol Violation|0
7666846|NCT00129389|12081440|FG001|Overall Study|Protocol Violation|6
7666847|NCT00129389|12081439|FG000|Overall Study|Withdrawal by Subject|9
7666848|NCT00129389|12081440|FG001|Overall Study|Withdrawal by Subject|23
7666849|NCT00129389|12081439|FG000|Overall Study|Relapse|1
7666850|NCT00129389|12081440|FG001|Overall Study|Relapse|0
7666851|NCT00129389|12081439|FG000|Overall Study|Not eligible|1
7666852|NCT00129389|12081440|FG001|Overall Study|Not eligible|2
7666853|NCT00129389|12081439|FG000|Overall Study|Crossed to the other arm|1
7666854|NCT00129389|12081440|FG001|Overall Study|Crossed to the other arm|16
7666855|NCT00129467|12081457|FG000|Received Intervention|Death|1
7666856|NCT00129467|12081458|FG001|Received Intervention|Death|1
7666857|NCT00129467|12081457|FG000|Received Intervention|Cardiac SAE (hypertension)|1
7666858|NCT00129467|12081458|FG001|Received Intervention|Cardiac SAE (hypertension)|1
7666859|NCT00129467|12081457|FG000|Received Intervention|Delirium|2
7666860|NCT00129467|12081458|FG001|Received Intervention|Delirium|0
7666861|NCT00129467|12081457|FG000|Received Intervention|Withdrawal by Subject|1
7666862|NCT00129467|12081458|FG001|Received Intervention|Withdrawal by Subject|0
7666863|NCT00129467|12081457|FG000|Received Intervention|Nausea|1
7666864|NCT00129467|12081458|FG001|Received Intervention|Nausea|0
7666865|NCT00129467|12081457|FG000|Received Intervention|Intolerance to citalopram|0
7666866|NCT00129467|12081458|FG001|Received Intervention|Intolerance to citalopram|1
7666867|NCT00129467|12081457|FG000|Received Intervention|Dizzyness, fatigue|0
7666868|NCT00129467|12081458|FG001|Received Intervention|Dizzyness, fatigue|1
7666869|NCT00129467|12081457|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1
7666870|NCT00129467|12081458|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0
7666871|NCT00129467|12081457|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1
7666872|NCT00129467|12081458|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0
7666873|NCT00129545|12081476|FG000|Overall Study|Death|5
7666874|NCT00129545|12081477|FG001|Overall Study|Death|60
7666875|NCT00129545|12081478|FG002|Overall Study|Death|44
7666876|NCT00129545|12081476|FG000|Overall Study|Withdrawal by Subject|3
7666877|NCT00129545|12081477|FG001|Overall Study|Withdrawal by Subject|18
7666878|NCT00129545|12081478|FG002|Overall Study|Withdrawal by Subject|44
7666879|NCT00129545|12081476|FG000|Overall Study|Lost to Follow-up|2
7666880|NCT00129545|12081477|FG001|Overall Study|Lost to Follow-up|22
7666881|NCT00129545|12081478|FG002|Overall Study|Lost to Follow-up|13
7666882|NCT00129545|12081476|FG000|Overall Study|Physician Decision|0
7666883|NCT00129545|12081477|FG001|Overall Study|Physician Decision|3
7666884|NCT00129545|12081478|FG002|Overall Study|Physician Decision|10
7666885|NCT00129545|12081476|FG000|Overall Study|Device not implanted|16
7666886|NCT00129545|12081477|FG001|Overall Study|Device not implanted|61
7666887|NCT00129545|12081478|FG002|Overall Study|Device not implanted|0
7666888|NCT00129623|12081488|FG000|Overall Study|Adverse Event|3
7666889|NCT00129623|12081489|FG001|Overall Study|Adverse Event|7
7666890|NCT00129623|12081488|FG000|Overall Study|Refused Treatment|5
7666891|NCT00129623|12081489|FG001|Overall Study|Refused Treatment|3
7666892|NCT00129623|12081488|FG000|Overall Study|Failure to Return|1
7666893|NCT00129623|12081489|FG001|Overall Study|Failure to Return|1
7666894|NCT00129623|12081488|FG000|Overall Study|Relocated job out of state|1
7666895|NCT00129623|12081489|FG001|Overall Study|Relocated job out of state|0
7666896|NCT00129623|12081488|FG000|Overall Study|Uncertainty to return|0
7666897|NCT00129623|12081489|FG001|Overall Study|Uncertainty to return|1
7666898|NCT00129649|12081499|FG000|Overall Study|Withdrawal by Subject|76
7666899|NCT00129649|12081500|FG001|Overall Study|Withdrawal by Subject|65
7666900|NCT00129701|12081506|FG000|Overall Study|Withdrawal by Subject|33
7666901|NCT00129766|12081523|FG000|Overall Study|Death|3
7666902|NCT00129766|12081524|FG001|Overall Study|Death|8
7666903|NCT00129766|12081523|FG000|Overall Study|Withdrawal of consent|31
7666904|NCT00129766|12081524|FG001|Overall Study|Withdrawal of consent|30
7666905|NCT00129766|12081523|FG000|Overall Study|Lost to Follow-up|26
7666906|NCT00129766|12081524|FG001|Overall Study|Lost to Follow-up|21
7666907|NCT00129935|12081533|FG000|Overall Study|Adverse Event|18
7666908|NCT00129935|12081534|FG001|Overall Study|Adverse Event|56
7666909|NCT00129935|12081533|FG000|Overall Study|Death|1
7666910|NCT00129935|12081534|FG001|Overall Study|Death|1
7666911|NCT00129935|12081533|FG000|Overall Study|Withdrawal by Subject|7
7666912|NCT00129935|12081534|FG001|Overall Study|Withdrawal by Subject|20
7666913|NCT00129935|12081533|FG000|Overall Study|Protocol Violation|0
7666914|NCT00129935|12081534|FG001|Overall Study|Protocol Violation|4
7666915|NCT00129935|12081533|FG000|Overall Study|Physician Decision|3
7666916|NCT00129935|12081534|FG001|Overall Study|Physician Decision|4
7666917|NCT00129935|12081533|FG000|Overall Study|Recurrence|1
7666918|NCT00129935|12081534|FG001|Overall Study|Recurrence|3
7666919|NCT00129935|12081533|FG000|Overall Study|Second primary|0
7666920|NCT00129935|12081534|FG001|Overall Study|Second primary|1
7666921|NCT00129935|12081533|FG000|Overall Study|Other|3
7666922|NCT00129935|12081534|FG001|Overall Study|Other|2
7666923|NCT00129935|12081533|FG000|Overall Study|Crossed to the other arm|2
7666924|NCT00129935|12081534|FG001|Overall Study|Crossed to the other arm|1
7666925|NCT00129935|12081533|FG000|Overall Study|Incorrect study treatment|1
7666926|NCT00129935|12081534|FG001|Overall Study|Incorrect study treatment|0
7666927|NCT00129961|12081542|FG000|Overall Study|Adverse Event|1
7666928|NCT00129961|12081543|FG001|Overall Study|Adverse Event|0
7666929|NCT00129961|12081542|FG000|Overall Study|Death|1
7666930|NCT00129961|12081543|FG001|Overall Study|Death|1
7666931|NCT00129961|12081542|FG000|Overall Study|Withdrawal by Sponsor|14
7666932|NCT00129961|12081543|FG001|Overall Study|Withdrawal by Sponsor|20
7666933|NCT00129961|12081542|FG000|Overall Study|Physician Decision|1
7666934|NCT00129961|12081543|FG001|Overall Study|Physician Decision|0
7666935|NCT00129961|12081542|FG000|Overall Study|Withdrawal by Subject|2
7666936|NCT00129961|12081543|FG001|Overall Study|Withdrawal by Subject|1
7666937|NCT00129961|12081542|FG000|Overall Study|Missing Record|0
7666938|NCT00129961|12081543|FG001|Overall Study|Missing Record|1
7666939|NCT00129987|12081551|FG000|1st Educational Session|Withdrawal by Subject|141
7666940|NCT00129987|12081552|FG001|1st Educational Session|Withdrawal by Subject|109
7666941|NCT00129987|12081551|FG000|1 Year|Withdrawal by Subject|32
7666942|NCT00129987|12081552|FG001|1 Year|Withdrawal by Subject|21
7666943|NCT00130039|12081560|FG000|Overall Study|Withdrawal by Subject|15
7666944|NCT00130039|12081561|FG001|Overall Study|Withdrawal by Subject|11
7666945|NCT00130039|12081560|FG000|Overall Study|Lost to Follow-up|3
7666946|NCT00130039|12081561|FG001|Overall Study|Lost to Follow-up|1
7666947|NCT00130039|12081560|FG000|Overall Study|Adverse Event|4
7666948|NCT00130039|12081561|FG001|Overall Study|Adverse Event|2
7666949|NCT00130039|12081560|FG000|Overall Study|Physician Decision|3
7666950|NCT00130039|12081561|FG001|Overall Study|Physician Decision|0
7666951|NCT00130039|12081560|FG000|Overall Study|clinical events without follow up MRI|5
7666952|NCT00130039|12081561|FG001|Overall Study|clinical events without follow up MRI|4
7666953|NCT00130208|12081579|FG000|Maintenance Period (26 Weeks)|Adverse Event|10
7666954|NCT00130208|12081580|FG001|Maintenance Period (26 Weeks)|Adverse Event|12
7666955|NCT00130208|12081579|FG000|Maintenance Period (26 Weeks)|Physician Decision|0
7666956|NCT00130208|12081580|FG001|Maintenance Period (26 Weeks)|Physician Decision|2
7666957|NCT00130208|12081579|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
7666958|NCT00130208|12081580|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
7666959|NCT00130208|12081579|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5
7666960|NCT00130208|12081580|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4
7666961|NCT00130208|12081579|FG000|Maintenance Period (26 Weeks)|Other|1
7666962|NCT00130208|12081580|FG001|Maintenance Period (26 Weeks)|Other|1
7666963|NCT00130208|12081579|FG000|Washout Period (8 Weeks)|Adverse Event|3
7666964|NCT00130208|12081580|FG001|Washout Period (8 Weeks)|Adverse Event|6
7666965|NCT00130208|12081579|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2
7666966|NCT00130208|12081580|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4
7666967|NCT00130208|12081579|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0
7666968|NCT00130208|12081580|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1
7666969|NCT00130208|12081579|FG000|Washout Period (8 Weeks)|Other|1
7666970|NCT00130208|12081580|FG001|Washout Period (8 Weeks)|Other|1
7666971|NCT00130247|12081588|FG000|Overall Study|Pregnancy|1
7666972|NCT00130247|12081589|FG001|Overall Study|Pregnancy|0
7666973|NCT00130247|12081588|FG000|Overall Study|Post-randomization exclusion|1
7666974|NCT00130247|12081589|FG001|Overall Study|Post-randomization exclusion|2
7666975|NCT00130247|12081588|FG000|Overall Study|Not compliant with DOT|0
7666976|NCT00130247|12081589|FG001|Overall Study|Not compliant with DOT|2
7666977|NCT00130286|12081599|FG000|Overall Study|Withdrawal by Subject|0
7666978|NCT00130286|12081600|FG001|Overall Study|Withdrawal by Subject|1
7666979|NCT00130286|12081601|FG002|Overall Study|Withdrawal by Subject|2
7666980|NCT00130286|12081602|FG003|Overall Study|Withdrawal by Subject|2
7666981|NCT00130286|12081599|FG000|Overall Study|Adverse Event|0
7666982|NCT00130286|12081600|FG001|Overall Study|Adverse Event|0
7666983|NCT00130286|12081601|FG002|Overall Study|Adverse Event|2
7666984|NCT00130286|12081602|FG003|Overall Study|Adverse Event|0
7666985|NCT00130286|12081599|FG000|Overall Study|Missing lab specimens|0
7666986|NCT00130286|12081600|FG001|Overall Study|Missing lab specimens|2
7666987|NCT00130286|12081601|FG002|Overall Study|Missing lab specimens|0
7666988|NCT00130286|12081602|FG003|Overall Study|Missing lab specimens|0
7666989|NCT00130520|12081612|FG000|Overall Study|Adverse Event|11
7666990|NCT00130520|12081612|FG000|Overall Study|Death|1
7666991|NCT00130520|12081612|FG000|Overall Study|Physician Decision|1
7666992|NCT00130520|12081612|FG000|Overall Study|Withdrawal by Subject|1
7666993|NCT00130520|12081612|FG000|Overall Study|Disease Progression|23
7666994|NCT00130520|12081612|FG000|Overall Study|Protocol non-compliance|1
7666995|NCT00130520|12081612|FG000|Overall Study|Did not meet re-treatment criteria|1
7666996|NCT00130533|12081618|FG000|Overall Study|Withdrawal by Subject|33
7666997|NCT00130533|12081619|FG001|Overall Study|Withdrawal by Subject|6
7666998|NCT00130533|12081618|FG000|Overall Study|Adverse Event|34
7666999|NCT00130533|12081619|FG001|Overall Study|Adverse Event|1
7667000|NCT00130533|12081618|FG000|Overall Study|Disease relapse|9
7667001|NCT00130533|12081619|FG001|Overall Study|Disease relapse|13
7667002|NCT00130533|12081618|FG000|Overall Study|Interruption of treatment > 3 weeks|11
7667003|NCT00130533|12081619|FG001|Overall Study|Interruption of treatment > 3 weeks|0
7667004|NCT00130533|12081618|FG000|Overall Study|Death|4
7667005|NCT00130533|12081619|FG001|Overall Study|Death|2
7667006|NCT00130533|12081618|FG000|Overall Study|Protocol Violation|5
7667007|NCT00130533|12081619|FG001|Overall Study|Protocol Violation|1
7667008|NCT00130533|12081618|FG000|Overall Study|Lost to Follow-up|1
7667009|NCT00130533|12081619|FG001|Overall Study|Lost to Follow-up|1
7667010|NCT00130533|12081618|FG000|Overall Study|Sponsor´s decision|2
7667011|NCT00130533|12081619|FG001|Overall Study|Sponsor´s decision|0
7667012|NCT00130533|12081618|FG000|Overall Study|Second Primary Malignancy|0
7667013|NCT00130533|12081619|FG001|Overall Study|Second Primary Malignancy|1
7667014|NCT00130533|12081618|FG000|Overall Study|Other|12
7667015|NCT00130533|12081619|FG001|Overall Study|Other|5
7667016|NCT00130637|12081625|FG000|Overall Study|Adverse Event|2
7667017|NCT00130637|12081625|FG000|Overall Study|Withdrawal by Subject|1
7667018|NCT00130689|12081629|FG000|Overall Study|Progressive Disease|29
7667019|NCT00130689|12081629|FG000|Overall Study|Death|1
7667020|NCT00130689|12081629|FG000|Overall Study|Clinical Deterioration|4
7667021|NCT00130689|12081629|FG000|Overall Study|Withdrawal by Subject|3
7667022|NCT00130689|12081629|FG000|Overall Study|Ineligible|6
7667023|NCT00130728|12081635|FG000|Overall Study|Death|258
7667024|NCT00130728|12081636|FG001|Overall Study|Death|258
7667025|NCT00130728|12081635|FG000|Overall Study|Lost to Follow-up|4
7667026|NCT00130728|12081636|FG001|Overall Study|Lost to Follow-up|0
7667027|NCT00130728|12081635|FG000|Overall Study|Withdrawal by Subject|0
7667028|NCT00130728|12081636|FG001|Overall Study|Withdrawal by Subject|2
7667029|NCT00130793|12081653|FG000|Overall Study|Lost to Follow-up|1
7667030|NCT00130793|12081654|FG001|Overall Study|Lost to Follow-up|4
7667031|NCT00130793|12081653|FG000|Overall Study|Withdrew consent|2
7667032|NCT00130793|12081654|FG001|Overall Study|Withdrew consent|0
7667033|NCT00130832|12081663|FG000|Overall Study|Adverse Event|1
7667034|NCT00130832|12081664|FG001|Overall Study|Adverse Event|1
7667035|NCT00130832|12081663|FG000|Overall Study|Lost to Follow-up|1
7667036|NCT00130832|12081664|FG001|Overall Study|Lost to Follow-up|2
7667037|NCT00130832|12081663|FG000|Overall Study|Protocol Violation|6
7667038|NCT00130832|12081664|FG001|Overall Study|Protocol Violation|8
7667039|NCT00130832|12081663|FG000|Overall Study|Withdrawal by Subject|6
7667040|NCT00130832|12081664|FG001|Overall Study|Withdrawal by Subject|1
7667041|NCT00130832|12081663|FG000|Overall Study|Moved|2
7667042|NCT00130832|12081664|FG001|Overall Study|Moved|2
7667043|NCT00130832|12081663|FG000|Overall Study|Other|0
7667044|NCT00130832|12081664|FG001|Overall Study|Other|3
7667045|NCT00131248|12081680|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1
7667046|NCT00131248|12081681|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0
7667047|NCT00131352|12081689|FG000|Initial Treatment Period|Adverse Event|1
7667048|NCT00131352|12081690|FG001|Initial Treatment Period|Adverse Event|3
7667049|NCT00131352|12081689|FG000|Initial Treatment Period|Non-compliant|1
7667050|NCT00131352|12081690|FG001|Initial Treatment Period|Non-compliant|2
7667051|NCT00131352|12081689|FG000|Initial Treatment Period|Withdrawal by Subject|1
7667052|NCT00131352|12081690|FG001|Initial Treatment Period|Withdrawal by Subject|1
7667053|NCT00131352|12081689|FG000|Initial Treatment Period|Lack of Efficacy|6
7667054|NCT00131352|12081690|FG001|Initial Treatment Period|Lack of Efficacy|4
7667055|NCT00131352|12081689|FG000|Initial Treatment Period|Other|0
7667056|NCT00131352|12081690|FG001|Initial Treatment Period|Other|2
7667057|NCT00131352|12081689|FG000|Repeat Treatment Period|Adverse Event|1
7667058|NCT00131352|12081690|FG001|Repeat Treatment Period|Adverse Event|0
7667059|NCT00131352|12081689|FG000|Repeat Treatment Period|Other|1
7667060|NCT00131352|12081690|FG001|Repeat Treatment Period|Other|0
7667061|NCT00131365|12081698|FG000|Overall Study|Withdrawal by Subject|1
7667062|NCT00131365|12081698|FG000|Overall Study|Alternative treatment|3
7667063|NCT00131469|12081733|FG000|Overall Study|Withdrawal by Subject|3
7667064|NCT00131469|12081734|FG001|Overall Study|Withdrawal by Subject|4
7667065|NCT00131469|12081733|FG000|Overall Study|Protocol Violation|3
7667066|NCT00131469|12081734|FG001|Overall Study|Protocol Violation|1
7667067|NCT00131469|12081733|FG000|Overall Study|Death|0
7667068|NCT00131469|12081734|FG001|Overall Study|Death|1
7667069|NCT00131469|12081733|FG000|Overall Study|Lost to Follow-up|0
7667070|NCT00131469|12081734|FG001|Overall Study|Lost to Follow-up|1
7667071|NCT00131469|12081733|FG000|Overall Study|scan not analyzable|3
7667072|NCT00131469|12081734|FG001|Overall Study|scan not analyzable|6
7667073|NCT00131508|12081742|FG000|Overall Study|Disease progression|0
7667074|NCT00131508|12081743|FG001|Overall Study|Disease progression|2
7667075|NCT00131508|12081742|FG000|Overall Study|Non-Compliance|2
7667076|NCT00131508|12081743|FG001|Overall Study|Non-Compliance|4
7667077|NCT00131508|12081742|FG000|Overall Study|Withdrawal by Subject|1
7667078|NCT00131508|12081743|FG001|Overall Study|Withdrawal by Subject|2
7667079|NCT00131664|12081762|FG000|First Period (First 6 Months)|Lost to Follow-up|7
7667080|NCT00131664|12081763|FG001|First Period (First 6 Months)|Lost to Follow-up|3
7667081|NCT00131664|12081764|FG002|First Period (First 6 Months)|Lost to Follow-up|3
7667082|NCT00131664|12081765|FG003|First Period (First 6 Months)|Lost to Follow-up|0
7667083|NCT00131664|12081766|FG004|First Period (First 6 Months)|Lost to Follow-up|0
7667084|NCT00131664|12081767|FG005|First Period (First 6 Months)|Lost to Follow-up|0
7667085|NCT00131664|12081762|FG000|First Period (First 6 Months)|Death|0
7667086|NCT00131664|12081763|FG001|First Period (First 6 Months)|Death|1
7667087|NCT00131664|12081764|FG002|First Period (First 6 Months)|Death|0
7667088|NCT00131664|12081765|FG003|First Period (First 6 Months)|Death|0
7667089|NCT00131664|12081766|FG004|First Period (First 6 Months)|Death|0
7667090|NCT00131664|12081767|FG005|First Period (First 6 Months)|Death|0
7667091|NCT00131664|12081762|FG000|First Period (First 6 Months)|Protocol Violation|2
7667092|NCT00131664|12081763|FG001|First Period (First 6 Months)|Protocol Violation|2
7667093|NCT00131664|12081764|FG002|First Period (First 6 Months)|Protocol Violation|1
7667094|NCT00131664|12081765|FG003|First Period (First 6 Months)|Protocol Violation|0
7667095|NCT00131664|12081766|FG004|First Period (First 6 Months)|Protocol Violation|0
7667096|NCT00131664|12081767|FG005|First Period (First 6 Months)|Protocol Violation|0
7667097|NCT00131664|12081762|FG000|First Period (First 6 Months)|Withdrawal by Subject|4
7667098|NCT00131664|12081763|FG001|First Period (First 6 Months)|Withdrawal by Subject|6
7667099|NCT00131664|12081764|FG002|First Period (First 6 Months)|Withdrawal by Subject|2
7667100|NCT00131664|12081765|FG003|First Period (First 6 Months)|Withdrawal by Subject|0
7667101|NCT00131664|12081766|FG004|First Period (First 6 Months)|Withdrawal by Subject|0
7667102|NCT00131664|12081767|FG005|First Period (First 6 Months)|Withdrawal by Subject|0
7667103|NCT00131664|12081762|FG000|First Period (First 6 Months)|Adverse Event|9
7667104|NCT00131664|12081763|FG001|First Period (First 6 Months)|Adverse Event|4
7667105|NCT00131664|12081764|FG002|First Period (First 6 Months)|Adverse Event|5
7667106|NCT00131664|12081765|FG003|First Period (First 6 Months)|Adverse Event|0
7667107|NCT00131664|12081766|FG004|First Period (First 6 Months)|Adverse Event|0
7667108|NCT00131664|12081767|FG005|First Period (First 6 Months)|Adverse Event|0
7667109|NCT00131664|12081762|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1
7667110|NCT00131664|12081763|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2
7667111|NCT00131664|12081764|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0
7667112|NCT00131664|12081765|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0
7667113|NCT00131664|12081766|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0
7667114|NCT00131664|12081767|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0
7667115|NCT00131664|12081762|FG000|First Period (First 6 Months)|Administrative reasons|2
7667116|NCT00131664|12081763|FG001|First Period (First 6 Months)|Administrative reasons|0
7667117|NCT00131664|12081764|FG002|First Period (First 6 Months)|Administrative reasons|5
7667118|NCT00131664|12081765|FG003|First Period (First 6 Months)|Administrative reasons|0
7667119|NCT00131664|12081766|FG004|First Period (First 6 Months)|Administrative reasons|0
7667120|NCT00131664|12081767|FG005|First Period (First 6 Months)|Administrative reasons|0
7667121|NCT00131664|12081762|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3
7667122|NCT00131664|12081763|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0
7667123|NCT00131664|12081764|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2
7667124|NCT00131664|12081765|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1
7667125|NCT00131664|12081766|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0
7667126|NCT00131664|12081767|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2
7667127|NCT00131664|12081762|FG000|Second Period (Additional Drug Added)|Protocol Violation|0
7667128|NCT00131664|12081763|FG001|Second Period (Additional Drug Added)|Protocol Violation|1
7667129|NCT00131664|12081764|FG002|Second Period (Additional Drug Added)|Protocol Violation|1
7667130|NCT00131664|12081765|FG003|Second Period (Additional Drug Added)|Protocol Violation|0
7667131|NCT00131664|12081766|FG004|Second Period (Additional Drug Added)|Protocol Violation|0
7667132|NCT00131664|12081767|FG005|Second Period (Additional Drug Added)|Protocol Violation|0
7667133|NCT00131664|12081762|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2
7667134|NCT00131664|12081763|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0
7667135|NCT00131664|12081764|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0
7667136|NCT00131664|12081765|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0
7667137|NCT00131664|12081766|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0
7667138|NCT00131664|12081767|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0
7667139|NCT00131664|12081762|FG000|Second Period (Additional Drug Added)|Adverse Event|0
7667140|NCT00131664|12081763|FG001|Second Period (Additional Drug Added)|Adverse Event|1
7667141|NCT00131664|12081764|FG002|Second Period (Additional Drug Added)|Adverse Event|0
7667142|NCT00131664|12081765|FG003|Second Period (Additional Drug Added)|Adverse Event|0
7667143|NCT00131664|12081766|FG004|Second Period (Additional Drug Added)|Adverse Event|0
7667144|NCT00131664|12081767|FG005|Second Period (Additional Drug Added)|Adverse Event|1
7667145|NCT00131664|12081762|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7667146|NCT00131664|12081763|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7667147|NCT00131664|12081764|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7667148|NCT00131664|12081765|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
7667149|NCT00131664|12081766|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7667150|NCT00131664|12081767|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7667151|NCT00131664|12081762|FG000|Second Period (Additional Drug Added)|Administrative reasons|4
7667152|NCT00131664|12081763|FG001|Second Period (Additional Drug Added)|Administrative reasons|2
7667153|NCT00131664|12081764|FG002|Second Period (Additional Drug Added)|Administrative reasons|0
7667154|NCT00131664|12081765|FG003|Second Period (Additional Drug Added)|Administrative reasons|0
7667155|NCT00131664|12081766|FG004|Second Period (Additional Drug Added)|Administrative reasons|1
7667156|NCT00131664|12081767|FG005|Second Period (Additional Drug Added)|Administrative reasons|0
7667157|NCT00131911|12081811|FG000|Overall Study|Withdrawal by Subject|1
7667158|NCT00131911|12081812|FG001|Overall Study|Withdrawal by Subject|0
7667159|NCT00131937|12081817|FG000|Overall Study|Adverse Event|3
7667160|NCT00131937|12081817|FG000|Overall Study|Withdrawal by Subject|2
7667161|NCT00131937|12081817|FG000|Overall Study|Physician Decision|1
7667162|NCT00131937|12081817|FG000|Overall Study|Disease Progression|7
7667163|NCT00131937|12081817|FG000|Overall Study|Alternative therapy|1
7667164|NCT00132028|12081825|FG000|Overall Study|Adverse Event|7
7667165|NCT00132028|12081825|FG000|Overall Study|Death|2
7667166|NCT00132028|12081825|FG000|Overall Study|Lack of Efficacy|11
7667167|NCT00132028|12081825|FG000|Overall Study|Withdrawal by Subject|2
7667168|NCT00132028|12081825|FG000|Overall Study|not eligible|2
7667169|NCT00132028|12081825|FG000|Overall Study|Physician Decision|3
7667170|NCT00132041|12081829|FG000|Baseline|Ineligible|6
7667171|NCT00132041|12081829|FG000|3 Months Post Ablation|Transplant|1
7667172|NCT00132041|12081829|FG000|3 Months Post Ablation|Non-Protocol Treatment|2
7667173|NCT00132041|12081829|FG000|6 Months Post Ablation|Withdrawal by Subject|2
7667174|NCT00132041|12081829|FG000|6 Months Post Ablation|Death|2
7667175|NCT00132041|12081829|FG000|6 Months Post Ablation|Transplant|6
7667176|NCT00132041|12081829|FG000|9 Months Post Ablation|Death|1
7667177|NCT00132041|12081829|FG000|9 Months Post Ablation|Transplant|1
7667178|NCT00132041|12081829|FG000|12 Months Post Ablation|Withdrawal by Subject|1
7667179|NCT00132041|12081829|FG000|12 Months Post Ablation|Death|1
7667180|NCT00132041|12081829|FG000|12 Months Post Ablation|Transplant|1
7667181|NCT00132041|12081829|FG000|12 Months Post Ablation|non-protocol Treatment|1
7667182|NCT00132041|12081829|FG000|15 Months Post Ablation|Withdrawal by Subject|1
7667183|NCT00132041|12081829|FG000|15 Months Post Ablation|Death|1
7667184|NCT00132041|12081829|FG000|15 Months Post Ablation|Transplant|5
7667185|NCT00132041|12081829|FG000|15 Months Post Ablation|Non-Protocol Treatment|1
7667186|NCT00132041|12081829|FG000|18 Months Post Ablation|Withdrawal by Subject|1
7667187|NCT00132041|12081829|FG000|18 Months Post Ablation|Transplant|1
7667188|NCT00132041|12081829|FG000|18 Months Post Ablation|Non-Protocol Treatment|3
7667189|NCT00132041|12081829|FG000|18 Months Post Ablation|ExtraHepatic tumor|1
7667190|NCT00132132|12081841|FG000|Overall Study|Lost to Follow-up|7
7667191|NCT00132132|12081842|FG001|Overall Study|Lost to Follow-up|2
7667192|NCT00132301|12081850|FG000|Overall Study|Death|7
7667193|NCT00132301|12081851|FG001|Overall Study|Death|6
7667194|NCT00132301|12081850|FG000|Overall Study|Withdrawal by Subject|5
7667195|NCT00132301|12081851|FG001|Overall Study|Withdrawal by Subject|2
7667196|NCT00132301|12081850|FG000|Overall Study|Physician Decision|1
7667197|NCT00132301|12081851|FG001|Overall Study|Physician Decision|1
7667198|NCT00132301|12081850|FG000|Overall Study|Lost to Follow-up|5
7667199|NCT00132301|12081851|FG001|Overall Study|Lost to Follow-up|3
7667200|NCT00132301|12081850|FG000|Overall Study|Other|1
7667201|NCT00132301|12081851|FG001|Overall Study|Other|1
7667202|NCT00132301|12081850|FG000|Overall Study|Excluded by Data Monitoring Committee|1
7667203|NCT00132301|12081851|FG001|Overall Study|Excluded by Data Monitoring Committee|0
7667204|NCT00132314|12081859|FG000|Overall Study|Lost to Follow-up|70
7667205|NCT00132314|12081860|FG001|Overall Study|Lost to Follow-up|62
7667206|NCT00132314|12081859|FG000|Overall Study|Lacked SSN|1
7667207|NCT00132314|12081860|FG001|Overall Study|Lacked SSN|3
7667208|NCT00132314|12081859|FG000|Overall Study|Refused intervention at baseline|2
7667209|NCT00132314|12081860|FG001|Overall Study|Refused intervention at baseline|7
7667210|NCT00132496|12081868|FG000|Overall Study|Withdrawal by Subject|1
7667211|NCT00132496|12081869|FG001|Overall Study|Withdrawal by Subject|2
7667212|NCT00132496|12081868|FG000|Overall Study|Physician Decision|1
7667213|NCT00132496|12081869|FG001|Overall Study|Physician Decision|0
7667214|NCT00132678|12081877|FG000|Period II (Open-Label Oral Risperidone)|Death|0
7667215|NCT00132678|12081878|FG001|Period II (Open-Label Oral Risperidone)|Death|0
7667216|NCT00132678|12081879|FG002|Period II (Open-Label Oral Risperidone)|Death|1
7667217|NCT00132678|12081877|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0
7667218|NCT00132678|12081878|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0
7667219|NCT00132678|12081879|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13
7667220|NCT00132678|12081877|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0
7667221|NCT00132678|12081878|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0
7667222|NCT00132678|12081879|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6
7667223|NCT00132678|12081877|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
7667224|NCT00132678|12081878|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
7667225|NCT00132678|12081879|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
7667226|NCT00132678|12081877|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
7667227|NCT00132678|12081878|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
7667228|NCT00132678|12081879|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
7667229|NCT00132678|12081877|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
7667230|NCT00132678|12081878|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
7667231|NCT00132678|12081879|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
7667232|NCT00132678|12081877|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0
7667233|NCT00132678|12081878|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0
7667234|NCT00132678|12081879|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1
7667235|NCT00132678|12081877|FG000|Period III (Open-Label Stabilization)|Death|2
7667236|NCT00132678|12081878|FG001|Period III (Open-Label Stabilization)|Death|0
7667237|NCT00132678|12081879|FG002|Period III (Open-Label Stabilization)|Death|0
7667238|NCT00132678|12081877|FG000|Period III (Open-Label Stabilization)|Adverse Event|12
7667239|NCT00132678|12081878|FG001|Period III (Open-Label Stabilization)|Adverse Event|0
7667240|NCT00132678|12081879|FG002|Period III (Open-Label Stabilization)|Adverse Event|0
7667241|NCT00132678|12081877|FG000|Period III (Open-Label Stabilization)|Non responder|107
7667242|NCT00132678|12081878|FG001|Period III (Open-Label Stabilization)|Non responder|0
7667243|NCT00132678|12081879|FG002|Period III (Open-Label Stabilization)|Non responder|0
7667244|NCT00132678|12081877|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
7667245|NCT00132678|12081878|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
7667246|NCT00132678|12081879|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
7667247|NCT00132678|12081877|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19
7667248|NCT00132678|12081878|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0
7667249|NCT00132678|12081879|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0
7667250|NCT00132678|12081877|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
7667251|NCT00132678|12081878|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
7667252|NCT00132678|12081879|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
7667253|NCT00132678|12081877|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1
7667254|NCT00132678|12081878|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0
7667255|NCT00132678|12081879|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0
7667256|NCT00132678|12081877|FG000|Period III (Open-Label Stabilization)|Physician Decision|1
7667257|NCT00132678|12081878|FG001|Period III (Open-Label Stabilization)|Physician Decision|0
7667258|NCT00132678|12081879|FG002|Period III (Open-Label Stabilization)|Physician Decision|0
7667259|NCT00132678|12081877|FG000|Period III (Open-Label Stabilization)|Pregnancy|2
7667260|NCT00132678|12081878|FG001|Period III (Open-Label Stabilization)|Pregnancy|0
7667261|NCT00132678|12081879|FG002|Period III (Open-Label Stabilization)|Pregnancy|0
7667262|NCT00132678|12081877|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1
7667263|NCT00132678|12081878|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1
7667264|NCT00132678|12081879|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0
7667265|NCT00132678|12081877|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
7667266|NCT00132678|12081878|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
7667267|NCT00132678|12081879|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
7667268|NCT00132678|12081877|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
7667269|NCT00132678|12081878|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
7667270|NCT00132678|12081879|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
7667271|NCT00132678|12081877|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
7667272|NCT00132678|12081878|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
7667273|NCT00132678|12081879|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
7667274|NCT00132678|12081877|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10
7667275|NCT00132678|12081878|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14
7667276|NCT00132678|12081879|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0
7667277|NCT00132678|12081877|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
7667278|NCT00132678|12081878|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
7667279|NCT00132678|12081879|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
7667280|NCT00132678|12081877|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0
7667281|NCT00132678|12081878|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2
7667282|NCT00132678|12081879|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0
7667283|NCT00132691|12081889|FG000|Overall Study|Lost to Follow-up|5
7667284|NCT00132691|12081890|FG001|Overall Study|Lost to Follow-up|8
7667285|NCT00132691|12081889|FG000|Overall Study|Missed 2-year visit|4
7667286|NCT00132691|12081890|FG001|Overall Study|Missed 2-year visit|4
7667287|NCT00132691|12081889|FG000|Overall Study|Death|2
7667288|NCT00132691|12081890|FG001|Overall Study|Death|0
7667289|NCT00132730|12081905|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
7667290|NCT00132730|12081906|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
7667291|NCT00132730|12081907|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
7667292|NCT00132730|12081908|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
7667293|NCT00132730|12081909|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
7667294|NCT00132730|12081910|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
7667295|NCT00132730|12081905|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
7667296|NCT00132730|12081906|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
7667297|NCT00132730|12081907|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
7667298|NCT00132730|12081908|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
7667299|NCT00132730|12081909|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
7667300|NCT00132730|12081910|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
7667301|NCT00132730|12081905|FG000|Period II - 12-week Treatment (Base)|Other reasons|11
7667302|NCT00132730|12081906|FG001|Period II - 12-week Treatment (Base)|Other reasons|10
7667303|NCT00132730|12081907|FG002|Period II - 12-week Treatment (Base)|Other reasons|9
7667304|NCT00132730|12081908|FG003|Period II - 12-week Treatment (Base)|Other reasons|13
7667305|NCT00132730|12081909|FG004|Period II - 12-week Treatment (Base)|Other reasons|0
7667306|NCT00132730|12081910|FG005|Period II - 12-week Treatment (Base)|Other reasons|0
7667307|NCT00132730|12081905|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0
7667308|NCT00132730|12081906|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0
7667309|NCT00132730|12081907|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57
7667310|NCT00132730|12081908|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20
7667311|NCT00132730|12081909|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0
7667312|NCT00132730|12081910|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0
7667313|NCT00132730|12081905|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
7667314|NCT00132730|12081906|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
7667315|NCT00132730|12081907|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
7667316|NCT00132730|12081908|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
7667317|NCT00132730|12081909|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
7667318|NCT00132730|12081910|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
7667319|NCT00132730|12081905|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
7667320|NCT00132730|12081906|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
7667321|NCT00132730|12081907|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
7667322|NCT00132730|12081908|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
7667323|NCT00132730|12081909|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
7667324|NCT00132730|12081910|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
7667325|NCT00132730|12081905|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0
7667326|NCT00132730|12081906|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0
7667327|NCT00132730|12081907|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14
7667328|NCT00132730|12081908|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3
7667329|NCT00132730|12081909|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0
7667330|NCT00132730|12081910|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0
7667331|NCT00132730|12081905|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0
7667332|NCT00132730|12081906|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0
7667333|NCT00132730|12081907|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0
7667334|NCT00132730|12081908|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0
7667335|NCT00132730|12081909|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169
7667336|NCT00132730|12081910|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68
7667337|NCT00132730|12081905|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
7667338|NCT00132730|12081906|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
7667339|NCT00132730|12081907|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
7667340|NCT00132730|12081908|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
7667341|NCT00132730|12081909|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
7667342|NCT00132730|12081910|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
7667343|NCT00132730|12081905|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
7667344|NCT00132730|12081906|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
7667345|NCT00132730|12081907|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
7667346|NCT00132730|12081908|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
7667347|NCT00132730|12081909|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
7667348|NCT00132730|12081910|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
7667349|NCT00132730|12081905|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0
7667350|NCT00132730|12081906|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0
7667351|NCT00132730|12081907|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0
7667352|NCT00132730|12081908|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0
7667353|NCT00132730|12081909|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6
7667354|NCT00132730|12081910|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0
7667355|NCT00132730|12081905|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0
7667356|NCT00132730|12081906|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0
7667357|NCT00132730|12081907|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0
7667358|NCT00132730|12081908|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0
7667359|NCT00132730|12081909|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7
7667360|NCT00132730|12081910|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2
7667361|NCT00132769|12081926|FG000|Overall Study|Withdrawal by Subject|1
7667362|NCT00132769|12081927|FG001|Overall Study|Withdrawal by Subject|3
7667363|NCT00132769|12081926|FG000|Overall Study|Lack of Efficacy|7
7667364|NCT00132769|12081927|FG001|Overall Study|Lack of Efficacy|6
7667365|NCT00132769|12081926|FG000|Overall Study|Adverse Event|2
7667366|NCT00132769|12081927|FG001|Overall Study|Adverse Event|1
7667367|NCT00132769|12081926|FG000|Overall Study|Protocol Violation|1
7667368|NCT00132769|12081927|FG001|Overall Study|Protocol Violation|1
7667369|NCT00132808|12081936|FG000|Stratum I|Adverse Event|2
7667370|NCT00132808|12081937|FG001|Stratum I|Adverse Event|1
7667371|NCT00132808|12081938|FG002|Stratum I|Adverse Event|0
7667372|NCT00132808|12081936|FG000|Stratum I|Lost to Follow-up|3
7667373|NCT00132808|12081937|FG001|Stratum I|Lost to Follow-up|4
7667374|NCT00132808|12081938|FG002|Stratum I|Lost to Follow-up|1
7667375|NCT00132808|12081936|FG000|Stratum I|Withdrawal by Subject|4
7667376|NCT00132808|12081937|FG001|Stratum I|Withdrawal by Subject|7
7667377|NCT00132808|12081938|FG002|Stratum I|Withdrawal by Subject|3
7667378|NCT00132808|12081936|FG000|Stratum I|Abnormal test procedure result (s)|0
7667379|NCT00132808|12081937|FG001|Stratum I|Abnormal test procedure result (s)|0
7667380|NCT00132808|12081938|FG002|Stratum I|Abnormal test procedure result (s)|1
7667381|NCT00132808|12081936|FG000|Stratum II|Adverse Event|1
7667382|NCT00132808|12081937|FG001|Stratum II|Adverse Event|2
7667383|NCT00132808|12081938|FG002|Stratum II|Adverse Event|1
7667384|NCT00132808|12081936|FG000|Stratum II|Death|1
7667385|NCT00132808|12081937|FG001|Stratum II|Death|0
7667386|NCT00132808|12081938|FG002|Stratum II|Death|0
7667387|NCT00132808|12081936|FG000|Stratum II|Lost to Follow-up|2
7667388|NCT00132808|12081937|FG001|Stratum II|Lost to Follow-up|2
7667389|NCT00132808|12081938|FG002|Stratum II|Lost to Follow-up|1
7667390|NCT00132808|12081936|FG000|Stratum II|Protocol Violation|0
7667391|NCT00132808|12081937|FG001|Stratum II|Protocol Violation|2
7667392|NCT00132808|12081938|FG002|Stratum II|Protocol Violation|1
7667393|NCT00132808|12081936|FG000|Stratum II|Withdrawal by Subject|4
7667394|NCT00132808|12081937|FG001|Stratum II|Withdrawal by Subject|9
7667395|NCT00132808|12081938|FG002|Stratum II|Withdrawal by Subject|6
7667396|NCT00132873|12081946|FG000|Overall Study|Adverse Event|3
7667397|NCT00132873|12081946|FG000|Overall Study|Lost to Follow-up|1
7667398|NCT00132873|12081946|FG000|Overall Study|Lack of Efficacy|1
7667399|NCT00132873|12081946|FG000|Overall Study|Withdrawal by Subject|3
7667400|NCT00132873|12081946|FG000|Overall Study|Planned Pregnancy|1
7667401|NCT00133705|12081990|FG000|Overall Study|Withdrawal by Subject|2
7667402|NCT00133705|12081991|FG001|Overall Study|Withdrawal by Subject|3
7667403|NCT00133952|12082003|FG000|Overall Study|Adverse Event|1
7667404|NCT00133952|12082004|FG001|Overall Study|Adverse Event|2
7667405|NCT00133952|12082003|FG000|Overall Study|Death|3
7667406|NCT00133952|12082004|FG001|Overall Study|Death|2
7667407|NCT00133952|12082003|FG000|Overall Study|Lost to Follow-up|9
7667408|NCT00133952|12082004|FG001|Overall Study|Lost to Follow-up|14
7667409|NCT00133952|12082003|FG000|Overall Study|Protocol Entry Criteria Exclusion|4
7667410|NCT00133952|12082004|FG001|Overall Study|Protocol Entry Criteria Exclusion|1
7667411|NCT00133952|12082003|FG000|Overall Study|Protocol Violation|1
7667412|NCT00133952|12082004|FG001|Overall Study|Protocol Violation|1
7667413|NCT00133952|12082003|FG000|Overall Study|Withdrawal by Subject|20
7667414|NCT00133952|12082004|FG001|Overall Study|Withdrawal by Subject|4
7667415|NCT00133952|12082003|FG000|Overall Study|Physician Decision|4
7667416|NCT00133952|12082004|FG001|Overall Study|Physician Decision|3
7667417|NCT00133952|12082003|FG000|Overall Study|Sponsor Decision|0
7667418|NCT00133952|12082004|FG001|Overall Study|Sponsor Decision|1
7667419|NCT00133991|12082031|FG000|Overall Study|Death|4
7667420|NCT00134056|12082053|FG000|Randomization|Not eligible for assigned treatment|22
7667421|NCT00134056|12082054|FG001|Randomization|Not eligible for assigned treatment|20
7667422|NCT00134056|12082053|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
7667423|NCT00134056|12082054|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
7667424|NCT00134056|12082053|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81
7667425|NCT00134056|12082054|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67
7667426|NCT00134056|12082053|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
7667427|NCT00134056|12082054|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
7667428|NCT00134056|12082053|FG000|Eligible for Protocol Assigned Treatment|Other|55
7667429|NCT00134056|12082054|FG001|Eligible for Protocol Assigned Treatment|Other|56
7667430|NCT00134082|12082063|FG000|Overall Study|Adverse Event|2
7667431|NCT00134082|12082063|FG000|Overall Study|Death|1
7667432|NCT00134563|12082092|FG000|Overall Study|Not treated due to protocol violation|0
7667433|NCT00134563|12082093|FG001|Overall Study|Not treated due to protocol violation|1
7667434|NCT00134563|12082094|FG002|Overall Study|Not treated due to protocol violation|1
7667435|NCT00134563|12082092|FG000|Overall Study|Adverse Event|29
7667436|NCT00134563|12082093|FG001|Overall Study|Adverse Event|37
7667437|NCT00134563|12082094|FG002|Overall Study|Adverse Event|38
7667438|NCT00134563|12082092|FG000|Overall Study|Lack of Efficacy|24
7667439|NCT00134563|12082093|FG001|Overall Study|Lack of Efficacy|14
7667440|NCT00134563|12082094|FG002|Overall Study|Lack of Efficacy|17
7667441|NCT00134563|12082092|FG000|Overall Study|Protocol Violation|3
7667442|NCT00134563|12082093|FG001|Overall Study|Protocol Violation|2
7667443|NCT00134563|12082094|FG002|Overall Study|Protocol Violation|5
7667444|NCT00134563|12082092|FG000|Overall Study|Lost to Follow-up|4
7667445|NCT00134563|12082093|FG001|Overall Study|Lost to Follow-up|0
7667446|NCT00134563|12082094|FG002|Overall Study|Lost to Follow-up|2
7667447|NCT00134563|12082092|FG000|Overall Study|progressive disease|11
7667448|NCT00134563|12082093|FG001|Overall Study|progressive disease|4
7667449|NCT00134563|12082094|FG002|Overall Study|progressive disease|2
7667450|NCT00134563|12082092|FG000|Overall Study|did not wish to continue|33
7667451|NCT00134563|12082093|FG001|Overall Study|did not wish to continue|32
7667452|NCT00134563|12082094|FG002|Overall Study|did not wish to continue|26
7667453|NCT00134563|12082092|FG000|Overall Study|Reason other than above|0
7667454|NCT00134563|12082093|FG001|Overall Study|Reason other than above|2
7667455|NCT00134563|12082094|FG002|Overall Study|Reason other than above|5
7667456|NCT00134719|12082105|FG000|Primary Vaccination Phase|Adverse Event|4
7667457|NCT00134719|12082106|FG001|Primary Vaccination Phase|Adverse Event|0
7667458|NCT00134719|12082107|FG002|Primary Vaccination Phase|Adverse Event|0
7667459|NCT00134719|12082105|FG000|Primary Vaccination Phase|Protocol Violation|1
7667460|NCT00134719|12082106|FG001|Primary Vaccination Phase|Protocol Violation|0
7667461|NCT00134719|12082107|FG002|Primary Vaccination Phase|Protocol Violation|0
7667462|NCT00134719|12082105|FG000|Primary Vaccination Phase|Withdrawal by Subject|2
7667463|NCT00134719|12082106|FG001|Primary Vaccination Phase|Withdrawal by Subject|3
7667464|NCT00134719|12082107|FG002|Primary Vaccination Phase|Withdrawal by Subject|2
7667465|NCT00134719|12082105|FG000|Primary Vaccination Phase|Lost to Follow-up|7
7667466|NCT00134719|12082106|FG001|Primary Vaccination Phase|Lost to Follow-up|3
7667467|NCT00134719|12082107|FG002|Primary Vaccination Phase|Lost to Follow-up|3
7667468|NCT00134719|12082105|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1
7667469|NCT00134719|12082106|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3
7667470|NCT00134719|12082107|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1
7667471|NCT00134719|12082105|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
7667472|NCT00134719|12082106|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
7667473|NCT00134719|12082107|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
7667474|NCT00134784|12082119|FG000|Overall Study|Withdrawal by Subject|2
7667475|NCT00134784|12082120|FG001|Overall Study|Withdrawal by Subject|2
7667476|NCT00134784|12082121|FG002|Overall Study|Withdrawal by Subject|2
7667477|NCT00134784|12082122|FG003|Overall Study|Withdrawal by Subject|1
7667478|NCT00134901|12082131|FG000|Overall Study|Lost to Follow-up|5
7667479|NCT00134901|12082132|FG001|Overall Study|Lost to Follow-up|5
7667480|NCT00134901|12082131|FG000|Overall Study|discontinued intervention|12
7667481|NCT00134901|12082132|FG001|Overall Study|discontinued intervention|10
7667482|NCT00135330|12082162|FG000|Overall Study|Adverse Event|2
7667483|NCT00135330|12082163|FG001|Overall Study|Adverse Event|5
7667484|NCT00135330|12082164|FG002|Overall Study|Adverse Event|1
7667485|NCT00135330|12082162|FG000|Overall Study|Lost to Follow-up|0
7667486|NCT00135330|12082163|FG001|Overall Study|Lost to Follow-up|2
7667487|NCT00135330|12082164|FG002|Overall Study|Lost to Follow-up|3
7667488|NCT00135330|12082162|FG000|Overall Study|Physician Decision|1
7667489|NCT00135330|12082163|FG001|Overall Study|Physician Decision|1
7667490|NCT00135330|12082164|FG002|Overall Study|Physician Decision|0
7667491|NCT00135330|12082162|FG000|Overall Study|Protocol Violation|4
7667492|NCT00135330|12082163|FG001|Overall Study|Protocol Violation|3
7667493|NCT00135330|12082164|FG002|Overall Study|Protocol Violation|3
7667494|NCT00135330|12082162|FG000|Overall Study|Patient Decision|5
7667495|NCT00135330|12082163|FG001|Overall Study|Patient Decision|1
7667496|NCT00135330|12082164|FG002|Overall Study|Patient Decision|4
7667497|NCT00135330|12082162|FG000|Overall Study|Sponsor Decision|0
7667498|NCT00135330|12082163|FG001|Overall Study|Sponsor Decision|1
7667499|NCT00135330|12082164|FG002|Overall Study|Sponsor Decision|0
7667500|NCT00135356|12082174|FG000|Overall Study|Adverse Event|6
7667501|NCT00135356|12082175|FG001|Overall Study|Adverse Event|2
7667502|NCT00135356|12082174|FG000|Overall Study|Lack of Efficacy|2
7667503|NCT00135356|12082175|FG001|Overall Study|Lack of Efficacy|0
7667504|NCT00135356|12082174|FG000|Overall Study|Lost to Follow-up|3
7667505|NCT00135356|12082175|FG001|Overall Study|Lost to Follow-up|1
7667506|NCT00135356|12082174|FG000|Overall Study|Surgery for abdominal fat|1
7667507|NCT00135356|12082175|FG001|Overall Study|Surgery for abdominal fat|0
7667508|NCT00135356|12082174|FG000|Overall Study|Change in antiviral regimen|0
7667509|NCT00135356|12082175|FG001|Overall Study|Change in antiviral regimen|1
7667510|NCT00135356|12082174|FG000|Overall Study|Poor/noncompliance|1
7667511|NCT00135356|12082175|FG001|Overall Study|Poor/noncompliance|1
7667512|NCT00135356|12082174|FG000|Overall Study|No longer meets study criteria|2
7667513|NCT00135356|12082175|FG001|Overall Study|No longer meets study criteria|0
7667514|NCT00135356|12082174|FG000|Overall Study|Withdrawal by Subject|2
7667515|NCT00135356|12082175|FG001|Overall Study|Withdrawal by Subject|4
7667516|NCT00135512|12082181|FG000|Overall Study|Adverse Event|56
7667517|NCT00135512|12082181|FG000|Overall Study|Lack of Efficacy|25
7667518|NCT00135512|12082181|FG000|Overall Study|Other|42
7667519|NCT00135694|12082188|FG000|Overall Study|Adverse Event|17
7667520|NCT00135694|12082189|FG001|Overall Study|Adverse Event|4
7667521|NCT00135694|12082190|FG002|Overall Study|Adverse Event|0
7667522|NCT00135694|12082188|FG000|Overall Study|Death|14
7667523|NCT00135694|12082189|FG001|Overall Study|Death|1
7667524|NCT00135694|12082190|FG002|Overall Study|Death|2
7667525|NCT00135694|12082188|FG000|Overall Study|Lost to Follow-up|8
7667526|NCT00135694|12082189|FG001|Overall Study|Lost to Follow-up|7
7667527|NCT00135694|12082190|FG002|Overall Study|Lost to Follow-up|1
7667528|NCT00135694|12082188|FG000|Overall Study|Withdrawal by Subject|41
7667529|NCT00135694|12082189|FG001|Overall Study|Withdrawal by Subject|7
7667530|NCT00135694|12082190|FG002|Overall Study|Withdrawal by Subject|4
7667531|NCT00135694|12082188|FG000|Overall Study|Protocol Violation|19
7667532|NCT00135694|12082189|FG001|Overall Study|Protocol Violation|1
7667533|NCT00135694|12082190|FG002|Overall Study|Protocol Violation|0
7667534|NCT00135694|12082188|FG000|Overall Study|Hepatitis C related reasons|39
7667535|NCT00135694|12082189|FG001|Overall Study|Hepatitis C related reasons|1
7667536|NCT00135694|12082190|FG002|Overall Study|Hepatitis C related reasons|0
7667537|NCT00135694|12082188|FG000|Overall Study|Ineligible for Random assignment|42
7667538|NCT00135694|12082189|FG001|Overall Study|Ineligible for Random assignment|0
7667539|NCT00135694|12082190|FG002|Overall Study|Ineligible for Random assignment|0
7667540|NCT00135707|12082200|FG000|Overall Study|Lost to Follow-up|94
7667541|NCT00135707|12082201|FG001|Overall Study|Lost to Follow-up|89
7667542|NCT00135707|12082200|FG000|Overall Study|Withdrawal by Subject|0
7667543|NCT00135707|12082201|FG001|Overall Study|Withdrawal by Subject|1
7667544|NCT00135707|12082200|FG000|Overall Study|Institutional review board request|1
7667545|NCT00135707|12082201|FG001|Overall Study|Institutional review board request|0
7667546|NCT00136084|12082225|FG000|Overall Study|Death|12
7667547|NCT00136084|12082226|FG001|Overall Study|Death|5
7667548|NCT00136084|12082225|FG000|Overall Study|Unacceptable toxicity|8
7667549|NCT00136084|12082226|FG001|Overall Study|Unacceptable toxicity|11
7667550|NCT00136084|12082225|FG000|Overall Study|Relapse|20
7667551|NCT00136084|12082226|FG001|Overall Study|Relapse|23
7667552|NCT00136084|12082225|FG000|Overall Study|Lost to Follow-up|2
7667553|NCT00136084|12082226|FG001|Overall Study|Lost to Follow-up|0
7667554|NCT00136084|12082225|FG000|Overall Study|No Response|1
7667555|NCT00136084|12082226|FG001|Overall Study|No Response|2
7667556|NCT00136084|12082225|FG000|Overall Study|Withdrawal by Subject|5
7667557|NCT00136084|12082226|FG001|Overall Study|Withdrawal by Subject|1
7667558|NCT00136318|12082251|FG000|Overall Study|Adverse Event|5
7667559|NCT00136318|12082252|FG001|Overall Study|Adverse Event|5
7667560|NCT00136318|12082251|FG000|Overall Study|Withdrawal by Subject|2
7667561|NCT00136318|12082252|FG001|Overall Study|Withdrawal by Subject|2
7667562|NCT00136357|12082261|FG000|Overall Study|Withdrawal by Subject|3
7667563|NCT00136357|12082262|FG001|Overall Study|Withdrawal by Subject|2
7667564|NCT00136604|12082273|FG000|Overall Study|Lost to Follow-up|1
7667565|NCT00136604|12082274|FG001|Overall Study|Lost to Follow-up|0
7667566|NCT00136604|12082275|FG002|Overall Study|Lost to Follow-up|0
7667567|NCT00136604|12082276|FG003|Overall Study|Lost to Follow-up|0
7667568|NCT00136604|12082277|FG004|Overall Study|Lost to Follow-up|1
7667569|NCT00136604|12082273|FG000|Overall Study|Migrated/moved from study area|0
7667570|NCT00136604|12082274|FG001|Overall Study|Migrated/moved from study area|1
7667571|NCT00136604|12082275|FG002|Overall Study|Migrated/moved from study area|0
7667572|NCT00136604|12082276|FG003|Overall Study|Migrated/moved from study area|0
7667573|NCT00136604|12082277|FG004|Overall Study|Migrated/moved from study area|0
7667574|NCT00136916|12082330|FG000|Overall Study|Never received study treatment|3
7667575|NCT00136916|12082331|FG001|Overall Study|Never received study treatment|5
7667576|NCT00136916|12082330|FG000|Overall Study|Death|1
7667577|NCT00136916|12082331|FG001|Overall Study|Death|3
7667578|NCT00136916|12082330|FG000|Overall Study|Adverse Event|27
7667579|NCT00136916|12082331|FG001|Overall Study|Adverse Event|8
7667580|NCT00136916|12082330|FG000|Overall Study|Laboratory abnormality|0
7667581|NCT00136916|12082331|FG001|Overall Study|Laboratory abnormality|1
7667582|NCT00136916|12082330|FG000|Overall Study|Lack of Efficacy|13
7667583|NCT00136916|12082331|FG001|Overall Study|Lack of Efficacy|3
7667584|NCT00136916|12082330|FG000|Overall Study|Lost to Follow-up|12
7667585|NCT00136916|12082331|FG001|Overall Study|Lost to Follow-up|14
7667586|NCT00136916|12082330|FG000|Overall Study|Withdrawal by Subject|44
7667587|NCT00136916|12082331|FG001|Overall Study|Withdrawal by Subject|46
7667588|NCT00136916|12082330|FG000|Overall Study|Other|22
7667589|NCT00136916|12082331|FG001|Overall Study|Other|24
7667590|NCT00136916|12082330|FG000|Overall Study|Discontinued in follow up period|3
7667591|NCT00136916|12082331|FG001|Overall Study|Discontinued in follow up period|0
7667592|NCT00136955|12082339|FG000|Overall Study|Adverse Event|8
7667593|NCT00136955|12082339|FG000|Overall Study|Lost to Follow-up|1
7667594|NCT00136955|12082339|FG000|Overall Study|Withdrawal by Subject|2
7667595|NCT00136955|12082339|FG000|Overall Study|Incl. prog. disease, protocol violation|12
7667596|NCT00137046|12082345|FG000|Overall Study|Death|2
7667597|NCT00137046|12082346|FG001|Overall Study|Death|1
7667598|NCT00137046|12082345|FG000|Overall Study|Adverse Event|16
7667599|NCT00137046|12082346|FG001|Overall Study|Adverse Event|5
7667600|NCT00137046|12082345|FG000|Overall Study|Laboratory Abnormality|2
7667601|NCT00137046|12082346|FG001|Overall Study|Laboratory Abnormality|0
7667602|NCT00137046|12082345|FG000|Overall Study|Lack of Efficacy|13
7667603|NCT00137046|12082346|FG001|Overall Study|Lack of Efficacy|1
7667604|NCT00137046|12082345|FG000|Overall Study|Lost to Follow-up|8
7667605|NCT00137046|12082346|FG001|Overall Study|Lost to Follow-up|24
7667606|NCT00137046|12082345|FG000|Overall Study|Other|23
7667607|NCT00137046|12082346|FG001|Overall Study|Other|19
7667608|NCT00137046|12082345|FG000|Overall Study|Withdrawal by Subject|33
7667609|NCT00137046|12082346|FG001|Overall Study|Withdrawal by Subject|42
7667610|NCT00137046|12082345|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1
7667611|NCT00137046|12082346|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0
7667612|NCT00137046|12082345|FG000|Overall Study|Withdrew prior to study treatment|1
7667613|NCT00137046|12082346|FG001|Overall Study|Withdrew prior to study treatment|1
7667614|NCT00137111|12082360|FG000|Total Therapy|Death|35
7667615|NCT00137111|12082361|FG001|Total Therapy|Death|0
7667616|NCT00137111|12082362|FG002|Total Therapy|Death|0
7667617|NCT00137111|12082363|FG003|Total Therapy|Death|0
7667618|NCT00137111|12082360|FG000|Total Therapy|Non Compliance|5
7667619|NCT00137111|12082361|FG001|Total Therapy|Non Compliance|0
7667620|NCT00137111|12082362|FG002|Total Therapy|Non Compliance|0
7667621|NCT00137111|12082363|FG003|Total Therapy|Non Compliance|0
7667622|NCT00137267|12082372|FG000|Overall Study|Lost to Follow-up|15
7667623|NCT00137267|12082373|FG001|Overall Study|Lost to Follow-up|21
7667624|NCT00137423|12082390|FG000|Overall Study|Adverse Event|7
7667625|NCT00137423|12082391|FG001|Overall Study|Adverse Event|9
7667626|NCT00137423|12082390|FG000|Overall Study|consent withdrawn|1
7667627|NCT00137423|12082391|FG001|Overall Study|consent withdrawn|1
7667628|NCT00137423|12082390|FG000|Overall Study|Lack of Efficacy|31
7667629|NCT00137423|12082391|FG001|Overall Study|Lack of Efficacy|33
7667630|NCT00137423|12082390|FG000|Overall Study|Death|0
7667631|NCT00137423|12082391|FG001|Overall Study|Death|1
7667632|NCT00137436|12082401|FG000|Overall Study|Adverse Event|13
7667633|NCT00137436|12082401|FG000|Overall Study|Death|2
7667634|NCT00137436|12082401|FG000|Overall Study|Lack of Efficacy|17
7667635|NCT00137436|12082401|FG000|Overall Study|Withdrawal by Subject|6
7667636|NCT00137436|12082401|FG000|Overall Study|Other|5
7667637|NCT00137449|12082407|FG000|Overall Study|Disease Progression|8
7667638|NCT00137449|12082408|FG001|Overall Study|Disease Progression|13
7667639|NCT00137449|12082407|FG000|Overall Study|Death|4
7667640|NCT00137449|12082408|FG001|Overall Study|Death|3
7667641|NCT00137449|12082407|FG000|Overall Study|Adverse Event|3
7667642|NCT00137449|12082408|FG001|Overall Study|Adverse Event|1
7667643|NCT00137449|12082407|FG000|Overall Study|Withdrawal by Subject|1
7667644|NCT00137449|12082408|FG001|Overall Study|Withdrawal by Subject|1
7667645|NCT00137631|12082417|FG000|Overall Study|Lost to Follow-up|37
7667646|NCT00137631|12082418|FG001|Overall Study|Lost to Follow-up|41
7667647|NCT00137839|12082424|FG000|Overall Study|Adverse Event|7
7667648|NCT00137839|12082424|FG000|Overall Study|Physician Decision|7
7667649|NCT00137839|12082424|FG000|Overall Study|Death|8
7667650|NCT00137839|12082424|FG000|Overall Study|Disease Progression|60
7667651|NCT00137839|12082424|FG000|Overall Study|Not Start Treatment|1
7667652|NCT00137839|12082424|FG000|Overall Study|Prolonged Treatment Delay|1
7667653|NCT00138424|12082469|FG000|Overall Study|Physician Decision|0
7667654|NCT00138424|12082470|FG001|Overall Study|Physician Decision|1
7667655|NCT00138424|12082471|FG002|Overall Study|Physician Decision|0
7667656|NCT00138424|12082472|FG003|Overall Study|Physician Decision|0
7667657|NCT00138658|12082493|FG000|Overall Study|Adverse Event|23
7667658|NCT00138658|12082493|FG000|Overall Study|Death|1
7667659|NCT00138658|12082493|FG000|Overall Study|Disease Progression|21
7667660|NCT00138658|12082493|FG000|Overall Study|Physician Decision|11
7667661|NCT00138658|12082493|FG000|Overall Study|Withdrawal by Subject|5
7667662|NCT00138671|12082501|FG000|Overall Study|Death|0
7667663|NCT00138671|12082502|FG001|Overall Study|Death|3
7667664|NCT00138671|12082501|FG000|Overall Study|Adverse Event|6
7667665|NCT00138671|12082502|FG001|Overall Study|Adverse Event|3
7667666|NCT00138671|12082501|FG000|Overall Study|Lost to Follow-up|1
7667667|NCT00138671|12082502|FG001|Overall Study|Lost to Follow-up|2
7667668|NCT00138671|12082501|FG000|Overall Study|Withdrawal by Subject|3
7667669|NCT00138671|12082502|FG001|Overall Study|Withdrawal by Subject|5
7667670|NCT00138671|12082501|FG000|Overall Study|Other|3
7667671|NCT00138671|12082502|FG001|Overall Study|Other|3
7667672|NCT00139477|12082521|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6
7667673|NCT00139477|12082522|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7
7667674|NCT00139477|12082521|FG000|First Intervention -Baseline to 6Months|Relocation|1
7667675|NCT00139477|12082522|FG001|First Intervention -Baseline to 6Months|Relocation|2
7667676|NCT00139477|12082521|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3
7667677|NCT00139477|12082522|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3
7667678|NCT00139477|12082521|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
7667679|NCT00139477|12082522|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
7667680|NCT00139477|12082521|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0
7667681|NCT00139477|12082522|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2
7667682|NCT00139477|12082521|FG000|Second Intervention -6Months to 12Months|Relocation|1
7667683|NCT00139477|12082522|FG001|Second Intervention -6Months to 12Months|Relocation|0
7667684|NCT00139477|12082521|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4
7667685|NCT00139477|12082522|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3
7667686|NCT00139659|12082532|FG000|Overall Study|Adverse Event|12
7667687|NCT00139659|12082533|FG001|Overall Study|Adverse Event|1
7667688|NCT00139659|12082532|FG000|Overall Study|Lack of Efficacy|1
7667689|NCT00139659|12082533|FG001|Overall Study|Lack of Efficacy|1
7667690|NCT00139659|12082532|FG000|Overall Study|Lost to Follow-up|7
7667691|NCT00139659|12082533|FG001|Overall Study|Lost to Follow-up|3
7667692|NCT00139659|12082532|FG000|Overall Study|Reason not Specified|6
7667693|NCT00139659|12082533|FG001|Overall Study|Reason not Specified|3
7667694|NCT00139659|12082532|FG000|Overall Study|Withdrawal by Subject|14
7667695|NCT00139659|12082533|FG001|Overall Study|Withdrawal by Subject|10
7667696|NCT00139737|12082543|FG000|Overall Study|Withdrawal by Subject|190
7667697|NCT00139737|12082543|FG000|Overall Study|Adverse Event|58
7667698|NCT00139737|12082543|FG000|Overall Study|Lack of Efficacy|40
7667699|NCT00139737|12082543|FG000|Overall Study|Lost to Follow-up|8
7667700|NCT00139737|12082543|FG000|Overall Study|Death|3
7667701|NCT00139737|12082543|FG000|Overall Study|Laboratory Abnormality|2
7667702|NCT00139737|12082543|FG000|Overall Study|Protocol Violation|18
7667703|NCT00139737|12082543|FG000|Overall Study|Withdrew During Screening Phase|8
7667704|NCT00139737|12082543|FG000|Overall Study|Did Not Meet Entrance Criteria|1
7667705|NCT00139737|12082543|FG000|Overall Study|Screened, Not Treated|13
7667706|NCT00139776|12082549|FG000|Period I|Did not enter Period II|575
7667707|NCT00139776|12082550|FG001|Period I|Did not enter Period II|0
7667708|NCT00139776|12082551|FG002|Period I|Did not enter Period II|0
7667709|NCT00139776|12082552|FG003|Period I|Did not enter Period II|0
7667710|NCT00139776|12082549|FG000|Period II|Not Randomized into Period III|0
7667711|NCT00139776|12082550|FG001|Period II|Not Randomized into Period III|322
7667712|NCT00139776|12082551|FG002|Period II|Not Randomized into Period III|0
7667713|NCT00139776|12082552|FG003|Period II|Not Randomized into Period III|0
7667714|NCT00139776|12082549|FG000|Period III|Adverse Event|0
7667715|NCT00139776|12082550|FG001|Period III|Adverse Event|0
7667716|NCT00139776|12082551|FG002|Period III|Adverse Event|22
7667717|NCT00139776|12082552|FG003|Period III|Adverse Event|23
7667718|NCT00139776|12082549|FG000|Period III|Other|0
7667719|NCT00139776|12082550|FG001|Period III|Other|0
7667720|NCT00139776|12082551|FG002|Period III|Other|23
7667721|NCT00139776|12082552|FG003|Period III|Other|34
7667722|NCT00139776|12082549|FG000|Period III|Lack of Efficacy|0
7667723|NCT00139776|12082550|FG001|Period III|Lack of Efficacy|0
7667724|NCT00139776|12082551|FG002|Period III|Lack of Efficacy|10
7667725|NCT00139776|12082552|FG003|Period III|Lack of Efficacy|24
7667726|NCT00139776|12082549|FG000|Period III|Lost to Follow-up|0
7667727|NCT00139776|12082550|FG001|Period III|Lost to Follow-up|0
7667728|NCT00139776|12082551|FG002|Period III|Lost to Follow-up|5
7667729|NCT00139776|12082552|FG003|Period III|Lost to Follow-up|4
7667730|NCT00139776|12082549|FG000|Period III|Withdrawal by Subject|0
7667731|NCT00139776|12082550|FG001|Period III|Withdrawal by Subject|0
7667732|NCT00139776|12082551|FG002|Period III|Withdrawal by Subject|16
7667733|NCT00139776|12082552|FG003|Period III|Withdrawal by Subject|21
7667734|NCT00140140|12082571|FG000|Overall Study|Unacceptable toxicity|1
7667735|NCT00140140|12082572|FG001|Overall Study|Unacceptable toxicity|1
7667736|NCT00140140|12082573|FG002|Overall Study|Unacceptable toxicity|2
7667737|NCT00140140|12082571|FG000|Overall Study|Physician Decision|1
7667738|NCT00140140|12082572|FG001|Overall Study|Physician Decision|1
7667739|NCT00140140|12082573|FG002|Overall Study|Physician Decision|0
7667740|NCT00140413|12082634|FG000|Overall Study|Lost to Follow-up|1
7667741|NCT00140413|12082635|FG001|Overall Study|Lost to Follow-up|0
7667742|NCT00140413|12082634|FG000|Overall Study|Withdrawal by Subject|2
7667743|NCT00140413|12082635|FG001|Overall Study|Withdrawal by Subject|0
7667744|NCT00140426|12082644|FG000|Overall Study|Withdrawal by Subject|0
7667745|NCT00140426|12082645|FG001|Overall Study|Withdrawal by Subject|3
7667746|NCT00140855|12082673|FG000|Overall Study|Progressive disease|2
7667747|NCT00141037|12082679|FG000|Overall Study|Physician Decision|1
7667748|NCT00141037|12082680|FG001|Overall Study|Physician Decision|2
7667749|NCT00141037|12082679|FG000|Overall Study|Lost to Follow-up|3
7667750|NCT00141037|12082680|FG001|Overall Study|Lost to Follow-up|1
7667751|NCT00141037|12082679|FG000|Overall Study|Protocol Violation|0
7667752|NCT00141037|12082680|FG001|Overall Study|Protocol Violation|2
7667753|NCT00141037|12082679|FG000|Overall Study|Withdrawal by Subject|2
7667754|NCT00141037|12082680|FG001|Overall Study|Withdrawal by Subject|1
7667755|NCT00141037|12082679|FG000|Overall Study|Other|0
7667756|NCT00141037|12082680|FG001|Overall Study|Other|1
7667757|NCT00141037|12082679|FG000|Overall Study|Moved from area|1
7667758|NCT00141037|12082680|FG001|Overall Study|Moved from area|7
7667759|NCT00141037|12082679|FG000|Overall Study|Graft Failure|3
7667760|NCT00141037|12082680|FG001|Overall Study|Graft Failure|4
7667761|NCT00141102|12082688|FG000|Overall Study|Adverse Event|233
7667762|NCT00141102|12082689|FG001|Overall Study|Adverse Event|305
7667763|NCT00141102|12082688|FG000|Overall Study|Laboratory Abnormality|9
7667764|NCT00141102|12082689|FG001|Overall Study|Laboratory Abnormality|33
7667765|NCT00141102|12082688|FG000|Overall Study|Lack of Efficacy|21
7667766|NCT00141102|12082689|FG001|Overall Study|Lack of Efficacy|26
7667767|NCT00141102|12082688|FG000|Overall Study|Lost to Follow-up|29
7667768|NCT00141102|12082689|FG001|Overall Study|Lost to Follow-up|32
7667769|NCT00141102|12082688|FG000|Overall Study|Other|87
7667770|NCT00141102|12082689|FG001|Overall Study|Other|76
7667771|NCT00141102|12082688|FG000|Overall Study|Withdrawal by Subject|112
7667772|NCT00141102|12082689|FG001|Overall Study|Withdrawal by Subject|142
7667773|NCT00141102|12082688|FG000|Overall Study|Randomized But Did Not Receive Treatment|15
7667774|NCT00141102|12082689|FG001|Overall Study|Randomized But Did Not Receive Treatment|9
7667775|NCT00141102|12082688|FG000|Overall Study|Death|2
7667776|NCT00141102|12082689|FG001|Overall Study|Death|2
7667777|NCT00141219|12082703|FG000|Overall Study|Protocol violations|5
7667778|NCT00141219|12082704|FG001|Overall Study|Protocol violations|4
7667779|NCT00141219|12082703|FG000|Overall Study|Adverse Event|8
7667780|NCT00141219|12082704|FG001|Overall Study|Adverse Event|6
7667781|NCT00141219|12082703|FG000|Overall Study|Lack of Efficacy|5
7667782|NCT00141219|12082704|FG001|Overall Study|Lack of Efficacy|4
7667783|NCT00141219|12082703|FG000|Overall Study|Withdrawal by Subject|6
7667784|NCT00141219|12082704|FG001|Overall Study|Withdrawal by Subject|2
7667785|NCT00141271|12082713|FG000|Overall Study|Adverse Event|31
7667786|NCT00141271|12082714|FG001|Overall Study|Adverse Event|19
7667787|NCT00141271|12082715|FG002|Overall Study|Adverse Event|17
7667788|NCT00141271|12082713|FG000|Overall Study|Laboratory Abnormality|2
7667789|NCT00141271|12082714|FG001|Overall Study|Laboratory Abnormality|1
7667790|NCT00141271|12082715|FG002|Overall Study|Laboratory Abnormality|1
7667791|NCT00141271|12082713|FG000|Overall Study|Lack of Efficacy|7
7667792|NCT00141271|12082714|FG001|Overall Study|Lack of Efficacy|7
7667793|NCT00141271|12082715|FG002|Overall Study|Lack of Efficacy|3
7667794|NCT00141271|12082713|FG000|Overall Study|Lost to Follow-up|15
7667795|NCT00141271|12082714|FG001|Overall Study|Lost to Follow-up|15
7667796|NCT00141271|12082715|FG002|Overall Study|Lost to Follow-up|21
7667797|NCT00141271|12082713|FG000|Overall Study|Withdrawal by Subject|14
7667798|NCT00141271|12082714|FG001|Overall Study|Withdrawal by Subject|9
7667799|NCT00141271|12082715|FG002|Overall Study|Withdrawal by Subject|10
7667800|NCT00141271|12082713|FG000|Overall Study|Other|11
7667801|NCT00141271|12082714|FG001|Overall Study|Other|12
7667802|NCT00141271|12082715|FG002|Overall Study|Other|5
7667803|NCT00141297|12082725|FG000|Overall Study|Adverse Event|0
7667804|NCT00141297|12082726|FG001|Overall Study|Adverse Event|0
7667805|NCT00141297|12082727|FG002|Overall Study|Adverse Event|1
7667806|NCT00141297|12082728|FG003|Overall Study|Adverse Event|0
7667807|NCT00141297|12082729|FG004|Overall Study|Adverse Event|1
7667808|NCT00141297|12082730|FG005|Overall Study|Adverse Event|1
7667809|NCT00141297|12082731|FG006|Overall Study|Adverse Event|0
7667810|NCT00141297|12082732|FG007|Overall Study|Adverse Event|1
7667811|NCT00141297|12082733|FG008|Overall Study|Adverse Event|1
7667812|NCT00141297|12082734|FG009|Overall Study|Adverse Event|0
7667813|NCT00141297|12082725|FG000|Overall Study|Death|1
7667814|NCT00141297|12082726|FG001|Overall Study|Death|0
7667815|NCT00141297|12082727|FG002|Overall Study|Death|0
7667816|NCT00141297|12082728|FG003|Overall Study|Death|0
7667817|NCT00141297|12082729|FG004|Overall Study|Death|0
7667818|NCT00141297|12082730|FG005|Overall Study|Death|0
7667819|NCT00141297|12082731|FG006|Overall Study|Death|0
7667820|NCT00141297|12082732|FG007|Overall Study|Death|0
7667821|NCT00141297|12082733|FG008|Overall Study|Death|1
7667822|NCT00141297|12082734|FG009|Overall Study|Death|0
7667823|NCT00141297|12082725|FG000|Overall Study|Withdrawal by Subject|0
7667824|NCT00141297|12082726|FG001|Overall Study|Withdrawal by Subject|0
7667825|NCT00141297|12082727|FG002|Overall Study|Withdrawal by Subject|0
7667826|NCT00141297|12082728|FG003|Overall Study|Withdrawal by Subject|0
7667827|NCT00141297|12082729|FG004|Overall Study|Withdrawal by Subject|0
7667828|NCT00141297|12082730|FG005|Overall Study|Withdrawal by Subject|0
7667829|NCT00141297|12082731|FG006|Overall Study|Withdrawal by Subject|0
7667830|NCT00141297|12082732|FG007|Overall Study|Withdrawal by Subject|0
7667831|NCT00141297|12082733|FG008|Overall Study|Withdrawal by Subject|1
7667832|NCT00141297|12082734|FG009|Overall Study|Withdrawal by Subject|0
7667833|NCT00141297|12082725|FG000|Overall Study|Other|0
7667834|NCT00141297|12082726|FG001|Overall Study|Other|0
7667835|NCT00141297|12082727|FG002|Overall Study|Other|0
7667836|NCT00141297|12082728|FG003|Overall Study|Other|1
7667837|NCT00141297|12082729|FG004|Overall Study|Other|5
7667838|NCT00141297|12082730|FG005|Overall Study|Other|0
7667839|NCT00141297|12082731|FG006|Overall Study|Other|0
7667840|NCT00141297|12082732|FG007|Overall Study|Other|0
7667841|NCT00141297|12082733|FG008|Overall Study|Other|2
7667842|NCT00141297|12082734|FG009|Overall Study|Other|0
7667843|NCT00141297|12082725|FG000|Overall Study|Progressive Disease|2
7667844|NCT00141297|12082726|FG001|Overall Study|Progressive Disease|3
7667845|NCT00141297|12082727|FG002|Overall Study|Progressive Disease|6
7667846|NCT00141297|12082728|FG003|Overall Study|Progressive Disease|2
7667847|NCT00141297|12082729|FG004|Overall Study|Progressive Disease|15
7667848|NCT00141297|12082730|FG005|Overall Study|Progressive Disease|2
7667849|NCT00141297|12082731|FG006|Overall Study|Progressive Disease|3
7667850|NCT00141297|12082732|FG007|Overall Study|Progressive Disease|3
7667851|NCT00141297|12082733|FG008|Overall Study|Progressive Disease|15
7667852|NCT00141297|12082734|FG009|Overall Study|Progressive Disease|6
7667853|NCT00141297|12082725|FG000|Overall Study|Transitioned|0
7667854|NCT00141297|12082726|FG001|Overall Study|Transitioned|0
7667855|NCT00141297|12082727|FG002|Overall Study|Transitioned|0
7667856|NCT00141297|12082728|FG003|Overall Study|Transitioned|0
7667857|NCT00141297|12082729|FG004|Overall Study|Transitioned|1
7667858|NCT00141297|12082730|FG005|Overall Study|Transitioned|0
7667859|NCT00141297|12082731|FG006|Overall Study|Transitioned|0
7667860|NCT00141297|12082732|FG007|Overall Study|Transitioned|0
7667861|NCT00141297|12082733|FG008|Overall Study|Transitioned|0
7667862|NCT00141297|12082734|FG009|Overall Study|Transitioned|0
7667863|NCT00141453|12082769|FG000|Overall Study|Protocol Violation|6
7667864|NCT00141453|12082770|FG001|Overall Study|Protocol Violation|5
7667865|NCT00141518|12082779|FG000|Overall Study|Withdrew Consent Prior to Treatment|1
7667866|NCT00141518|12082780|FG001|Overall Study|Withdrew Consent Prior to Treatment|0
7667867|NCT00141518|12082781|FG002|Overall Study|Withdrew Consent Prior to Treatment|0
7667868|NCT00141518|12082779|FG000|Overall Study|Adverse Event|7
7667869|NCT00141518|12082780|FG001|Overall Study|Adverse Event|5
7667870|NCT00141518|12082781|FG002|Overall Study|Adverse Event|2
7667871|NCT00141518|12082779|FG000|Overall Study|Withdrawal by Subject|2
7667872|NCT00141518|12082780|FG001|Overall Study|Withdrawal by Subject|0
7667873|NCT00141518|12082781|FG002|Overall Study|Withdrawal by Subject|2
7667874|NCT00141518|12082779|FG000|Overall Study|Protocol Violation|1
7667875|NCT00141518|12082780|FG001|Overall Study|Protocol Violation|1
7667876|NCT00141518|12082781|FG002|Overall Study|Protocol Violation|2
7667877|NCT00141518|12082779|FG000|Overall Study|Lack of Efficacy|5
7667878|NCT00141518|12082780|FG001|Overall Study|Lack of Efficacy|0
7667879|NCT00141518|12082781|FG002|Overall Study|Lack of Efficacy|0
7667880|NCT00141726|12082791|FG000|Overall Study|Completed <50% Scheduled Dosing|3
7667881|NCT00141778|12082808|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5
7667882|NCT00141778|12082809|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2
7667883|NCT00141778|12082810|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6
7667884|NCT00141778|12082808|FG000|Started Study Medication|Met safety criteria for discontinuation|2
7667885|NCT00141778|12082809|FG001|Started Study Medication|Met safety criteria for discontinuation|4
7667886|NCT00141778|12082810|FG002|Started Study Medication|Met safety criteria for discontinuation|3
7667887|NCT00141778|12082808|FG000|Started Study Medication|Withdrawal by Subject|0
7667888|NCT00141778|12082809|FG001|Started Study Medication|Withdrawal by Subject|2
7667889|NCT00141778|12082810|FG002|Started Study Medication|Withdrawal by Subject|0
7667890|NCT00141778|12082808|FG000|Started Study Medication|Difficulty Swallowing|0
7667891|NCT00141778|12082809|FG001|Started Study Medication|Difficulty Swallowing|1
7667892|NCT00141778|12082810|FG002|Started Study Medication|Difficulty Swallowing|0
7667893|NCT00141778|12082808|FG000|Started Study Medication|Chest Discomfort|0
7667894|NCT00141778|12082809|FG001|Started Study Medication|Chest Discomfort|0
7667895|NCT00141778|12082810|FG002|Started Study Medication|Chest Discomfort|1
7667896|NCT00141817|12082822|FG000|Overall Study|Protocol Violation|0
7667897|NCT00141817|12082823|FG001|Overall Study|Protocol Violation|0
7667898|NCT00141817|12082824|FG002|Overall Study|Protocol Violation|1
7667899|NCT00141817|12082825|FG003|Overall Study|Protocol Violation|0
7667900|NCT00141817|12082822|FG000|Overall Study|Parent request|1
7667901|NCT00141817|12082823|FG001|Overall Study|Parent request|0
7667902|NCT00141817|12082824|FG002|Overall Study|Parent request|0
7667903|NCT00141817|12082825|FG003|Overall Study|Parent request|0
7667904|NCT00141921|12082835|FG000|Overall Study|Remain on Study|28
7667905|NCT00141921|12082835|FG000|Overall Study|Withdrawal by Subject|42
7667906|NCT00141921|12082835|FG000|Overall Study|Lost to Follow-up|19
7667907|NCT00141921|12082835|FG000|Overall Study|Noncompliance|17
7667908|NCT00141921|12082835|FG000|Overall Study|Disease Progression|7
7667909|NCT00141921|12082835|FG000|Overall Study|Protocol Deviation|7
7667910|NCT00141921|12082835|FG000|Overall Study|Adverse Event|5
7667911|NCT00141921|12082835|FG000|Overall Study|Administrative Decision|2
7667912|NCT00141921|12082835|FG000|Overall Study|Pregnancy|4
7667913|NCT00141921|12082835|FG000|Overall Study|Ineligibility Determined|2
7667914|NCT00141921|12082835|FG000|Overall Study|Other|8
7667915|NCT00142298|12082858|FG000|Overall Study|Adverse Event|10
7667916|NCT00142298|12082859|FG001|Overall Study|Adverse Event|10
7667917|NCT00142298|12082860|FG002|Overall Study|Adverse Event|1
7667918|NCT00142298|12082861|FG003|Overall Study|Adverse Event|5
7667919|NCT00142298|12082862|FG004|Overall Study|Adverse Event|2
7667920|NCT00142298|12082863|FG005|Overall Study|Adverse Event|2
7667921|NCT00142298|12082864|FG006|Overall Study|Adverse Event|0
7667922|NCT00142298|12082865|FG007|Overall Study|Adverse Event|0
7667923|NCT00142298|12082866|FG008|Overall Study|Adverse Event|0
7667924|NCT00142298|12082867|FG009|Overall Study|Adverse Event|0
7667925|NCT00142298|12082858|FG000|Overall Study|Clinical disease progression|1
7667926|NCT00142298|12082859|FG001|Overall Study|Clinical disease progression|0
7667927|NCT00142298|12082860|FG002|Overall Study|Clinical disease progression|0
7667928|NCT00142298|12082861|FG003|Overall Study|Clinical disease progression|0
7667929|NCT00142298|12082862|FG004|Overall Study|Clinical disease progression|0
7667930|NCT00142298|12082863|FG005|Overall Study|Clinical disease progression|0
7667931|NCT00142298|12082864|FG006|Overall Study|Clinical disease progression|0
7667932|NCT00142298|12082865|FG007|Overall Study|Clinical disease progression|0
7667933|NCT00142298|12082866|FG008|Overall Study|Clinical disease progression|0
7667934|NCT00142298|12082867|FG009|Overall Study|Clinical disease progression|0
7667935|NCT00142298|12082858|FG000|Overall Study|Death|1
7667936|NCT00142298|12082859|FG001|Overall Study|Death|1
7667937|NCT00142298|12082860|FG002|Overall Study|Death|1
7667938|NCT00142298|12082861|FG003|Overall Study|Death|0
7667939|NCT00142298|12082862|FG004|Overall Study|Death|0
7667940|NCT00142298|12082863|FG005|Overall Study|Death|6
7667941|NCT00142298|12082864|FG006|Overall Study|Death|0
7667942|NCT00142298|12082865|FG007|Overall Study|Death|0
7667943|NCT00142298|12082866|FG008|Overall Study|Death|0
7667944|NCT00142298|12082867|FG009|Overall Study|Death|0
7667945|NCT00142298|12082858|FG000|Overall Study|Lack of Efficacy|44
7667946|NCT00142298|12082859|FG001|Overall Study|Lack of Efficacy|62
7667947|NCT00142298|12082860|FG002|Overall Study|Lack of Efficacy|9
7667948|NCT00142298|12082861|FG003|Overall Study|Lack of Efficacy|12
7667949|NCT00142298|12082862|FG004|Overall Study|Lack of Efficacy|1
7667950|NCT00142298|12082863|FG005|Overall Study|Lack of Efficacy|0
7667951|NCT00142298|12082864|FG006|Overall Study|Lack of Efficacy|0
7667952|NCT00142298|12082865|FG007|Overall Study|Lack of Efficacy|1
7667953|NCT00142298|12082866|FG008|Overall Study|Lack of Efficacy|0
7667954|NCT00142298|12082867|FG009|Overall Study|Lack of Efficacy|0
7667955|NCT00142298|12082858|FG000|Overall Study|Non-compliance|15
7667956|NCT00142298|12082859|FG001|Overall Study|Non-compliance|13
7667957|NCT00142298|12082860|FG002|Overall Study|Non-compliance|0
7667958|NCT00142298|12082861|FG003|Overall Study|Non-compliance|6
7667959|NCT00142298|12082862|FG004|Overall Study|Non-compliance|1
7667960|NCT00142298|12082863|FG005|Overall Study|Non-compliance|0
7667961|NCT00142298|12082864|FG006|Overall Study|Non-compliance|0
7667962|NCT00142298|12082865|FG007|Overall Study|Non-compliance|3
7667963|NCT00142298|12082866|FG008|Overall Study|Non-compliance|3
7667964|NCT00142298|12082867|FG009|Overall Study|Non-compliance|0
7667965|NCT00142298|12082858|FG000|Overall Study|Patient, Investigator,or Sponsor request|66
7667966|NCT00142298|12082859|FG001|Overall Study|Patient, Investigator,or Sponsor request|60
7667967|NCT00142298|12082860|FG002|Overall Study|Patient, Investigator,or Sponsor request|11
7667968|NCT00142298|12082861|FG003|Overall Study|Patient, Investigator,or Sponsor request|51
7667969|NCT00142298|12082862|FG004|Overall Study|Patient, Investigator,or Sponsor request|4
7667970|NCT00142298|12082863|FG005|Overall Study|Patient, Investigator,or Sponsor request|3
7667971|NCT00142298|12082864|FG006|Overall Study|Patient, Investigator,or Sponsor request|1
7667972|NCT00142298|12082865|FG007|Overall Study|Patient, Investigator,or Sponsor request|4
7667973|NCT00142298|12082866|FG008|Overall Study|Patient, Investigator,or Sponsor request|1
7667974|NCT00142298|12082867|FG009|Overall Study|Patient, Investigator,or Sponsor request|0
7667975|NCT00142298|12082858|FG000|Overall Study|Pregnancy|4
7667976|NCT00142298|12082859|FG001|Overall Study|Pregnancy|4
7667977|NCT00142298|12082860|FG002|Overall Study|Pregnancy|2
7667978|NCT00142298|12082861|FG003|Overall Study|Pregnancy|3
7667979|NCT00142298|12082862|FG004|Overall Study|Pregnancy|0
7667980|NCT00142298|12082863|FG005|Overall Study|Pregnancy|0
7667981|NCT00142298|12082864|FG006|Overall Study|Pregnancy|0
7667982|NCT00142298|12082865|FG007|Overall Study|Pregnancy|0
7667983|NCT00142298|12082866|FG008|Overall Study|Pregnancy|1
7667984|NCT00142298|12082867|FG009|Overall Study|Pregnancy|0
7667985|NCT00142298|12082858|FG000|Overall Study|Virologic breakthrough|19
7667986|NCT00142298|12082859|FG001|Overall Study|Virologic breakthrough|23
7667987|NCT00142298|12082860|FG002|Overall Study|Virologic breakthrough|9
7667988|NCT00142298|12082861|FG003|Overall Study|Virologic breakthrough|7
7667989|NCT00142298|12082862|FG004|Overall Study|Virologic breakthrough|2
7667990|NCT00142298|12082863|FG005|Overall Study|Virologic breakthrough|3
7667991|NCT00142298|12082864|FG006|Overall Study|Virologic breakthrough|3
7667992|NCT00142298|12082865|FG007|Overall Study|Virologic breakthrough|0
7667993|NCT00142298|12082866|FG008|Overall Study|Virologic breakthrough|0
7667994|NCT00142298|12082867|FG009|Overall Study|Virologic breakthrough|0
7667995|NCT00142298|12082858|FG000|Overall Study|Other- not specified|0
7667996|NCT00142298|12082859|FG001|Overall Study|Other- not specified|3
7667997|NCT00142298|12082860|FG002|Overall Study|Other- not specified|0
7667998|NCT00142298|12082861|FG003|Overall Study|Other- not specified|1
7667999|NCT00142298|12082862|FG004|Overall Study|Other- not specified|0
7668000|NCT00142298|12082863|FG005|Overall Study|Other- not specified|0
7668001|NCT00142298|12082864|FG006|Overall Study|Other- not specified|0
7668002|NCT00142298|12082865|FG007|Overall Study|Other- not specified|0
7668003|NCT00142298|12082866|FG008|Overall Study|Other- not specified|0
7668004|NCT00142298|12082867|FG009|Overall Study|Other- not specified|0
7668005|NCT00142298|12082858|FG000|Overall Study|Lost to Follow-up|0
7668006|NCT00142298|12082859|FG001|Overall Study|Lost to Follow-up|0
7668007|NCT00142298|12082860|FG002|Overall Study|Lost to Follow-up|0
7668008|NCT00142298|12082861|FG003|Overall Study|Lost to Follow-up|0
7668009|NCT00142298|12082862|FG004|Overall Study|Lost to Follow-up|0
7668010|NCT00142298|12082863|FG005|Overall Study|Lost to Follow-up|0
7668011|NCT00142298|12082864|FG006|Overall Study|Lost to Follow-up|2
7668012|NCT00142298|12082865|FG007|Overall Study|Lost to Follow-up|0
7668013|NCT00142298|12082866|FG008|Overall Study|Lost to Follow-up|0
7668014|NCT00142298|12082867|FG009|Overall Study|Lost to Follow-up|0
7668015|NCT00142298|12082858|FG000|Overall Study|Treatment Failure|0
7668016|NCT00142298|12082859|FG001|Overall Study|Treatment Failure|0
7668017|NCT00142298|12082860|FG002|Overall Study|Treatment Failure|0
7668018|NCT00142298|12082861|FG003|Overall Study|Treatment Failure|0
7668019|NCT00142298|12082862|FG004|Overall Study|Treatment Failure|0
7668020|NCT00142298|12082863|FG005|Overall Study|Treatment Failure|2
7668021|NCT00142298|12082864|FG006|Overall Study|Treatment Failure|2
7668022|NCT00142298|12082865|FG007|Overall Study|Treatment Failure|0
7668023|NCT00142298|12082866|FG008|Overall Study|Treatment Failure|0
7668024|NCT00142298|12082867|FG009|Overall Study|Treatment Failure|0
7668025|NCT00142415|12082895|FG000|Overall Study|Physician Decision|0
7668026|NCT00142415|12082896|FG001|Overall Study|Physician Decision|0
7668027|NCT00142415|12082897|FG002|Overall Study|Physician Decision|0
7668028|NCT00142415|12082898|FG003|Overall Study|Physician Decision|0
7668029|NCT00142415|12082899|FG004|Overall Study|Physician Decision|1
7668030|NCT00142415|12082900|FG005|Overall Study|Physician Decision|2
7668031|NCT00142792|12082941|FG000|Overall Study|Death|0
7668032|NCT00142792|12082942|FG001|Overall Study|Death|0
7668033|NCT00142792|12082943|FG002|Overall Study|Death|1
7668034|NCT00142792|12082941|FG000|Overall Study|Withdrawal by Subject|3
7668035|NCT00142792|12082942|FG001|Overall Study|Withdrawal by Subject|2
7668036|NCT00142792|12082943|FG002|Overall Study|Withdrawal by Subject|3
7668037|NCT00142792|12082941|FG000|Overall Study|Lost to Follow-up|8
7668038|NCT00142792|12082942|FG001|Overall Study|Lost to Follow-up|11
7668039|NCT00142792|12082943|FG002|Overall Study|Lost to Follow-up|7
7668040|NCT00142792|12082941|FG000|Overall Study|No category|1
7668041|NCT00142792|12082942|FG001|Overall Study|No category|2
7668042|NCT00142792|12082943|FG002|Overall Study|No category|1
7668043|NCT00142909|12082974|FG000|Randomization|Various Reasons|7
7668044|NCT00142909|12082975|FG001|Randomization|Various Reasons|10
7668045|NCT00142909|12082974|FG000|Medications Begin|Protocol Violation|2
7668046|NCT00142909|12082975|FG001|Medications Begin|Protocol Violation|0
7668047|NCT00142909|12082974|FG000|Medications Begin|Withdrawal by Subject|5
7668048|NCT00142909|12082975|FG001|Medications Begin|Withdrawal by Subject|3
7668049|NCT00142909|12082974|FG000|Medications Begin|Withdrawal by Subject|2
7668050|NCT00142909|12082975|FG001|Medications Begin|Withdrawal by Subject|0
7668051|NCT00142935|12082984|FG000|Overall Study|Other reason|1
7668052|NCT00142935|12082985|FG001|Overall Study|Other reason|1
7668053|NCT00142935|12082986|FG002|Overall Study|Other reason|1
7668054|NCT00142935|12082984|FG000|Overall Study|Lost to Follow-up|2
7668055|NCT00142935|12082985|FG001|Overall Study|Lost to Follow-up|5
7668056|NCT00142935|12082986|FG002|Overall Study|Lost to Follow-up|5
7668057|NCT00142935|12082984|FG000|Overall Study|Death|0
7668058|NCT00142935|12082985|FG001|Overall Study|Death|2
7668059|NCT00142935|12082986|FG002|Overall Study|Death|1
7668060|NCT00143247|12082998|FG000|Overall Study|Death|8
7668061|NCT00143247|12082998|FG000|Overall Study|Adverse Event|19
7668062|NCT00143247|12082998|FG000|Overall Study|Lack of Efficacy|3
7668063|NCT00143247|12082998|FG000|Overall Study|Withdrawal by Subject|55
7668064|NCT00143247|12082998|FG000|Overall Study|Study terminated by sponsor|31
7668065|NCT00143247|12082998|FG000|Overall Study|Protocol Violation|15
7668066|NCT00143247|12082998|FG000|Overall Study|Lost to Follow-up|12
7668067|NCT00143247|12082998|FG000|Overall Study|following inaccurate lab adverse event|1
7668068|NCT00143247|12082998|FG000|Overall Study|Other|12
7668069|NCT00143312|12083002|FG000|Overall Study|Death|11
7668070|NCT00143312|12083002|FG000|Overall Study|Adverse Event|2
7668071|NCT00143312|12083002|FG000|Overall Study|Lost to Follow-up|1
7668072|NCT00143312|12083002|FG000|Overall Study|Other|1
7668073|NCT00143312|12083002|FG000|Overall Study|Withdrawal by Subject|1
7668074|NCT00143390|12083008|FG000|Overall Study|Death|2
7668075|NCT00143390|12083009|FG001|Overall Study|Death|0
7668076|NCT00143390|12083008|FG000|Overall Study|Not meeting entry criteria|2
7668077|NCT00143390|12083009|FG001|Overall Study|Not meeting entry criteria|5
7668078|NCT00143390|12083008|FG000|Overall Study|Withdrawal by Subject|4
7668079|NCT00143390|12083009|FG001|Overall Study|Withdrawal by Subject|4
7668080|NCT00143390|12083008|FG000|Overall Study|Progressive disease|119
7668081|NCT00143390|12083009|FG001|Overall Study|Progressive disease|115
7668082|NCT00143390|12083008|FG000|Overall Study|Protocol Violation|2
7668083|NCT00143390|12083009|FG001|Overall Study|Protocol Violation|0
7668084|NCT00143390|12083008|FG000|Overall Study|Study termination|10
7668085|NCT00143390|12083009|FG001|Overall Study|Study termination|15
7668086|NCT00143390|12083008|FG000|Overall Study|Adverse Event|9
7668087|NCT00143390|12083009|FG001|Overall Study|Adverse Event|8
7668088|NCT00143390|12083008|FG000|Overall Study|Other|1
7668089|NCT00143390|12083009|FG001|Overall Study|Other|2
7668090|NCT00143403|12083017|FG000|Overall Study|Adverse Event|3
7668091|NCT00143403|12083018|FG001|Overall Study|Adverse Event|8
7668092|NCT00143403|12083017|FG000|Overall Study|Death|1
7668093|NCT00143403|12083018|FG001|Overall Study|Death|0
7668094|NCT00143403|12083017|FG000|Overall Study|Withdrawal by Subject|3
7668095|NCT00143403|12083018|FG001|Overall Study|Withdrawal by Subject|12
7668096|NCT00143403|12083017|FG000|Overall Study|Relapse|15
7668097|NCT00143403|12083018|FG001|Overall Study|Relapse|7
7668098|NCT00143403|12083017|FG000|Overall Study|Protocol Violation|2
7668099|NCT00143403|12083018|FG001|Overall Study|Protocol Violation|2
7668100|NCT00143403|12083017|FG000|Overall Study|specified by site|4
7668101|NCT00143403|12083018|FG001|Overall Study|specified by site|9
7668102|NCT00143403|12083017|FG000|Overall Study|Randomized Not Treated|7
7668103|NCT00143403|12083018|FG001|Overall Study|Randomized Not Treated|8
7668104|NCT00143455|12083028|FG000|Cohort 1|Adverse Event|8
7668105|NCT00143455|12083029|FG001|Cohort 1|Adverse Event|4
7668106|NCT00143455|12083030|FG002|Cohort 1|Adverse Event|0
7668107|NCT00143455|12083031|FG003|Cohort 1|Adverse Event|0
7668108|NCT00143455|12083028|FG000|Cohort 1|Death|5
7668109|NCT00143455|12083029|FG001|Cohort 1|Death|2
7668110|NCT00143455|12083030|FG002|Cohort 1|Death|0
7668111|NCT00143455|12083031|FG003|Cohort 1|Death|0
7668112|NCT00143455|12083028|FG000|Cohort 1|Progressive Disease|0
7668113|NCT00143455|12083029|FG001|Cohort 1|Progressive Disease|6
7668114|NCT00143455|12083030|FG002|Cohort 1|Progressive Disease|0
7668115|NCT00143455|12083031|FG003|Cohort 1|Progressive Disease|0
7668116|NCT00143455|12083028|FG000|Cohort 1|Withdrawal by Subject|1
7668117|NCT00143455|12083029|FG001|Cohort 1|Withdrawal by Subject|4
7668118|NCT00143455|12083030|FG002|Cohort 1|Withdrawal by Subject|0
7668119|NCT00143455|12083031|FG003|Cohort 1|Withdrawal by Subject|0
7668120|NCT00143455|12083028|FG000|Cohort 1|Randomized But Not Treated|0
7668121|NCT00143455|12083029|FG001|Cohort 1|Randomized But Not Treated|1
7668122|NCT00143455|12083030|FG002|Cohort 1|Randomized But Not Treated|0
7668123|NCT00143455|12083031|FG003|Cohort 1|Randomized But Not Treated|0
7668124|NCT00143455|12083028|FG000|Cohort 2|Adverse Event|0
7668125|NCT00143455|12083029|FG001|Cohort 2|Adverse Event|0
7668126|NCT00143455|12083030|FG002|Cohort 2|Adverse Event|42
7668127|NCT00143455|12083031|FG003|Cohort 2|Adverse Event|30
7668128|NCT00143455|12083028|FG000|Cohort 2|No Longer Required Study Treatment|0
7668129|NCT00143455|12083029|FG001|Cohort 2|No Longer Required Study Treatment|0
7668130|NCT00143455|12083030|FG002|Cohort 2|No Longer Required Study Treatment|1
7668131|NCT00143455|12083031|FG003|Cohort 2|No Longer Required Study Treatment|0
7668132|NCT00143455|12083028|FG000|Cohort 2|Protocol Violation|0
7668133|NCT00143455|12083029|FG001|Cohort 2|Protocol Violation|0
7668134|NCT00143455|12083030|FG002|Cohort 2|Protocol Violation|1
7668135|NCT00143455|12083031|FG003|Cohort 2|Protocol Violation|1
7668136|NCT00143455|12083028|FG000|Cohort 2|Lost to Follow-up|0
7668137|NCT00143455|12083029|FG001|Cohort 2|Lost to Follow-up|0
7668138|NCT00143455|12083030|FG002|Cohort 2|Lost to Follow-up|1
7668139|NCT00143455|12083031|FG003|Cohort 2|Lost to Follow-up|4
7668140|NCT00143455|12083028|FG000|Cohort 2|Death|0
7668141|NCT00143455|12083029|FG001|Cohort 2|Death|0
7668142|NCT00143455|12083030|FG002|Cohort 2|Death|20
7668143|NCT00143455|12083031|FG003|Cohort 2|Death|12
7668144|NCT00143455|12083028|FG000|Cohort 2|Progressive Disease|0
7668145|NCT00143455|12083029|FG001|Cohort 2|Progressive Disease|0
7668146|NCT00143455|12083030|FG002|Cohort 2|Progressive Disease|20
7668147|NCT00143455|12083031|FG003|Cohort 2|Progressive Disease|27
7668148|NCT00143455|12083028|FG000|Cohort 2|Withdrawal by Subject|0
7668149|NCT00143455|12083029|FG001|Cohort 2|Withdrawal by Subject|0
7668150|NCT00143455|12083030|FG002|Cohort 2|Withdrawal by Subject|13
7668151|NCT00143455|12083031|FG003|Cohort 2|Withdrawal by Subject|12
7668152|NCT00143455|12083028|FG000|Cohort 2|Other|0
7668153|NCT00143455|12083029|FG001|Cohort 2|Other|0
7668154|NCT00143455|12083030|FG002|Cohort 2|Other|7
7668155|NCT00143455|12083031|FG003|Cohort 2|Other|6
7668156|NCT00143455|12083028|FG000|Cohort 2|Randomized But Not Treated|0
7668157|NCT00143455|12083029|FG001|Cohort 2|Randomized But Not Treated|0
7668158|NCT00143455|12083030|FG002|Cohort 2|Randomized But Not Treated|1
7668159|NCT00143455|12083031|FG003|Cohort 2|Randomized But Not Treated|1
7668160|NCT00143507|12083045|FG000|Overall Study|Death|572
7668161|NCT00143507|12083046|FG001|Overall Study|Death|547
7668162|NCT00143507|12083045|FG000|Overall Study|Withdrawal by Subject|114
7668163|NCT00143507|12083046|FG001|Overall Study|Withdrawal by Subject|102
7668164|NCT00143507|12083045|FG000|Overall Study|Lost to Follow-up|1
7668165|NCT00143507|12083046|FG001|Overall Study|Lost to Follow-up|0
7668166|NCT00143507|12083045|FG000|Overall Study|Withdrawn by sponsor's decision|0
7668167|NCT00143507|12083046|FG001|Overall Study|Withdrawn by sponsor's decision|3
7668168|NCT00143598|12083054|FG000|Overall Study|Lost to Follow-up|23
7668169|NCT00143598|12083055|FG001|Overall Study|Lost to Follow-up|21
7668170|NCT00143598|12083054|FG000|Overall Study|Withdrawal by Subject|33
7668171|NCT00143598|12083055|FG001|Overall Study|Withdrawal by Subject|37
7668172|NCT00143598|12083054|FG000|Overall Study|Death|36
7668173|NCT00143598|12083055|FG001|Overall Study|Death|36
7668174|NCT00144027|12083080|FG000|Overall Study|Lost to Follow-up|1
7668175|NCT00144027|12083081|FG001|Overall Study|Lost to Follow-up|3
7668176|NCT00144027|12083080|FG000|Overall Study|Withdrawal by Subject|2
7668177|NCT00144027|12083081|FG001|Overall Study|Withdrawal by Subject|2
7668178|NCT00144027|12083080|FG000|Overall Study|did not complete baseline assessment|0
7668179|NCT00144027|12083081|FG001|Overall Study|did not complete baseline assessment|6
7668180|NCT00144170|12083089|FG000|Overall Study|Adverse Event|84
7668181|NCT00144170|12083090|FG001|Overall Study|Adverse Event|41
7668182|NCT00144170|12083089|FG000|Overall Study|Protocol Violation|23
7668183|NCT00144170|12083090|FG001|Overall Study|Protocol Violation|16
7668184|NCT00144170|12083089|FG000|Overall Study|Lost to Follow-up|5
7668185|NCT00144170|12083090|FG001|Overall Study|Lost to Follow-up|10
7668186|NCT00144170|12083089|FG000|Overall Study|Withdrawal by Subject|29
7668187|NCT00144170|12083090|FG001|Overall Study|Withdrawal by Subject|13
7668188|NCT00144170|12083089|FG000|Overall Study|Other reason not defined above|211
7668189|NCT00144170|12083090|FG001|Overall Study|Other reason not defined above|316
7668190|NCT00144300|12083098|FG000|Overall Study|Adverse Event|18
7668191|NCT00144300|12083099|FG001|Overall Study|Adverse Event|16
7668192|NCT00144300|12083098|FG000|Overall Study|Protocol Violation|1
7668193|NCT00144300|12083099|FG001|Overall Study|Protocol Violation|3
7668194|NCT00144300|12083098|FG000|Overall Study|Lost to Follow-up|3
7668195|NCT00144300|12083099|FG001|Overall Study|Lost to Follow-up|0
7668196|NCT00144300|12083098|FG000|Overall Study|Withdrawal by Subject|6
7668197|NCT00144300|12083099|FG001|Overall Study|Withdrawal by Subject|6
7668198|NCT00144300|12083098|FG000|Overall Study|Other reason (not specified)|1
7668199|NCT00144300|12083099|FG001|Overall Study|Other reason (not specified)|3
7668200|NCT00144339|12083107|FG000|Overall Study|Adverse Event|746
7668201|NCT00144339|12083108|FG001|Overall Study|Adverse Event|627
7668202|NCT00144339|12083107|FG000|Overall Study|Protocol Violation|75
7668203|NCT00144339|12083108|FG001|Overall Study|Protocol Violation|48
7668204|NCT00144339|12083107|FG000|Overall Study|Withdrawal by Subject|403
7668205|NCT00144339|12083108|FG001|Overall Study|Withdrawal by Subject|300
7668206|NCT00144339|12083107|FG000|Overall Study|Lost to Follow-up|76
7668207|NCT00144339|12083108|FG001|Overall Study|Lost to Follow-up|64
7668208|NCT00144339|12083107|FG000|Overall Study|Other|58
7668209|NCT00144339|12083108|FG001|Overall Study|Other|60
7668210|NCT00144781|12083127|FG000|Overall Study|Adverse Event|0
7668211|NCT00144781|12083128|FG001|Overall Study|Adverse Event|1
7668212|NCT00144781|12083129|FG002|Overall Study|Adverse Event|0
7668213|NCT00144781|12083130|FG003|Overall Study|Adverse Event|0
7668214|NCT00144781|12083127|FG000|Overall Study|Non-compliant|0
7668215|NCT00144781|12083128|FG001|Overall Study|Non-compliant|1
7668216|NCT00144781|12083129|FG002|Overall Study|Non-compliant|0
7668217|NCT00144781|12083130|FG003|Overall Study|Non-compliant|0
7668218|NCT00145119|12083148|FG000|Overall Study|Death|45
7668219|NCT00145327|12083172|FG000|Overall Study|Withdrawal by Subject|77
7668220|NCT00145327|12083173|FG001|Overall Study|Withdrawal by Subject|72
7668221|NCT00145327|12083174|FG002|Overall Study|Withdrawal by Subject|164
7668222|NCT00145327|12083172|FG000|Overall Study|Death|26
7668223|NCT00145327|12083173|FG001|Overall Study|Death|18
7668224|NCT00145327|12083174|FG002|Overall Study|Death|30
7668225|NCT00145327|12083172|FG000|Overall Study|Adverse Event|14
7668226|NCT00145327|12083173|FG001|Overall Study|Adverse Event|11
7668227|NCT00145327|12083174|FG002|Overall Study|Adverse Event|22
7668228|NCT00145327|12083172|FG000|Overall Study|Lost to Follow-up|9
7668229|NCT00145327|12083173|FG001|Overall Study|Lost to Follow-up|14
7668230|NCT00145327|12083174|FG002|Overall Study|Lost to Follow-up|14
7668231|NCT00145327|12083172|FG000|Overall Study|Administrative problems|12
7668232|NCT00145327|12083173|FG001|Overall Study|Administrative problems|9
7668233|NCT00145327|12083174|FG002|Overall Study|Administrative problems|13
7668234|NCT00145327|12083172|FG000|Overall Study|Protocol Violation|2
7668235|NCT00145327|12083173|FG001|Overall Study|Protocol Violation|0
7668236|NCT00145327|12083174|FG002|Overall Study|Protocol Violation|2
7668237|NCT00145327|12083172|FG000|Overall Study|Abnormal laboratory value(s)|1
7668238|NCT00145327|12083173|FG001|Overall Study|Abnormal laboratory value(s)|0
7668239|NCT00145327|12083174|FG002|Overall Study|Abnormal laboratory value(s)|2
7668240|NCT00145327|12083172|FG000|Overall Study|Missing - not stated|1
7668241|NCT00145327|12083173|FG001|Overall Study|Missing - not stated|0
7668242|NCT00145327|12083174|FG002|Overall Study|Missing - not stated|1
7668243|NCT00145574|12083189|FG000|Double Blind|Adverse Event|0
7668244|NCT00145574|12083190|FG001|Double Blind|Adverse Event|3
7668245|NCT00145574|12083191|FG002|Double Blind|Adverse Event|1
7668246|NCT00145574|12083189|FG000|Double Blind|Withdrawal by Subject|1
7668247|NCT00145574|12083190|FG001|Double Blind|Withdrawal by Subject|1
7668248|NCT00145574|12083191|FG002|Double Blind|Withdrawal by Subject|1
7668249|NCT00145574|12083189|FG000|Double Blind|required restricted medicine|0
7668250|NCT00145574|12083190|FG001|Double Blind|required restricted medicine|1
7668251|NCT00145574|12083191|FG002|Double Blind|required restricted medicine|0
7668252|NCT00145574|12083189|FG000|Open Label Long-term Extension|Adverse Event|0
7668253|NCT00145574|12083190|FG001|Open Label Long-term Extension|Adverse Event|0
7668254|NCT00145574|12083191|FG002|Open Label Long-term Extension|Adverse Event|5
7668255|NCT00145574|12083189|FG000|Open Label Long-term Extension|Lost to Follow-up|0
7668256|NCT00145574|12083190|FG001|Open Label Long-term Extension|Lost to Follow-up|0
7668257|NCT00145574|12083191|FG002|Open Label Long-term Extension|Lost to Follow-up|1
7668258|NCT00145574|12083189|FG000|Open Label Long-term Extension|Withdrawal by Subject|0
7668259|NCT00145574|12083190|FG001|Open Label Long-term Extension|Withdrawal by Subject|0
7668260|NCT00145574|12083191|FG002|Open Label Long-term Extension|Withdrawal by Subject|4
7668261|NCT00145574|12083189|FG000|Open Label Long-term Extension|required restricted medicine|0
7668262|NCT00145574|12083190|FG001|Open Label Long-term Extension|required restricted medicine|0
7668263|NCT00145574|12083191|FG002|Open Label Long-term Extension|required restricted medicine|1
7668264|NCT00145626|12083215|FG000|Overall Study|Did not have NK infusions|2
7668265|NCT00145626|12083215|FG000|Overall Study|Turned 2 years old before treatment|1
7668266|NCT00145626|12083215|FG000|Overall Study|Death|1
7668267|NCT00145626|12083215|FG000|Overall Study|Withdrawal by Subject|1
7668268|NCT00145977|12083237|FG000|Overall Study|Lack of Efficacy|0
7668269|NCT00145977|12083238|FG001|Overall Study|Lack of Efficacy|4
7668270|NCT00145977|12083237|FG000|Overall Study|Lost to Follow-up|1
7668271|NCT00145977|12083238|FG001|Overall Study|Lost to Follow-up|0
7668272|NCT00145977|12083237|FG000|Overall Study|Withdrawal by Subject|1
7668273|NCT00145977|12083238|FG001|Overall Study|Withdrawal by Subject|0
7668274|NCT00146172|12083252|FG000|Overall Study|Adverse Event|0
7668275|NCT00146172|12083253|FG001|Overall Study|Adverse Event|0
7668276|NCT00146172|12083254|FG002|Overall Study|Adverse Event|1
7668277|NCT00146172|12083255|FG003|Overall Study|Adverse Event|1
7668278|NCT00146172|12083256|FG004|Overall Study|Adverse Event|0
7668279|NCT00146172|12083257|FG005|Overall Study|Adverse Event|2
7668280|NCT00146172|12083258|FG006|Overall Study|Adverse Event|3
7668281|NCT00146172|12083259|FG007|Overall Study|Adverse Event|10
7668282|NCT00146172|12083252|FG000|Overall Study|Lost to Follow-up|0
7668283|NCT00146172|12083253|FG001|Overall Study|Lost to Follow-up|0
7668284|NCT00146172|12083254|FG002|Overall Study|Lost to Follow-up|0
7668285|NCT00146172|12083255|FG003|Overall Study|Lost to Follow-up|0
7668286|NCT00146172|12083256|FG004|Overall Study|Lost to Follow-up|0
7668287|NCT00146172|12083257|FG005|Overall Study|Lost to Follow-up|0
7668288|NCT00146172|12083258|FG006|Overall Study|Lost to Follow-up|0
7668289|NCT00146172|12083259|FG007|Overall Study|Lost to Follow-up|1
7668290|NCT00146172|12083252|FG000|Overall Study|Disease Progression|2
7668291|NCT00146172|12083253|FG001|Overall Study|Disease Progression|4
7668292|NCT00146172|12083254|FG002|Overall Study|Disease Progression|2
7668293|NCT00146172|12083255|FG003|Overall Study|Disease Progression|5
7668294|NCT00146172|12083256|FG004|Overall Study|Disease Progression|2
7668295|NCT00146172|12083257|FG005|Overall Study|Disease Progression|2
7668296|NCT00146172|12083258|FG006|Overall Study|Disease Progression|1
7668297|NCT00146172|12083259|FG007|Overall Study|Disease Progression|22
7668298|NCT00146172|12083252|FG000|Overall Study|Death|0
7668299|NCT00146172|12083253|FG001|Overall Study|Death|0
7668300|NCT00146172|12083254|FG002|Overall Study|Death|0
7668301|NCT00146172|12083255|FG003|Overall Study|Death|0
7668302|NCT00146172|12083256|FG004|Overall Study|Death|0
7668303|NCT00146172|12083257|FG005|Overall Study|Death|0
7668304|NCT00146172|12083258|FG006|Overall Study|Death|1
7668305|NCT00146172|12083259|FG007|Overall Study|Death|0
7668306|NCT00146172|12083252|FG000|Overall Study|Physician Decision|0
7668307|NCT00146172|12083253|FG001|Overall Study|Physician Decision|0
7668308|NCT00146172|12083254|FG002|Overall Study|Physician Decision|0
7668309|NCT00146172|12083255|FG003|Overall Study|Physician Decision|0
7668310|NCT00146172|12083256|FG004|Overall Study|Physician Decision|0
7668311|NCT00146172|12083257|FG005|Overall Study|Physician Decision|0
7668312|NCT00146172|12083258|FG006|Overall Study|Physician Decision|0
7668313|NCT00146172|12083259|FG007|Overall Study|Physician Decision|1
7668314|NCT00146172|12083252|FG000|Overall Study|Withdrawal by Subject|0
7668315|NCT00146172|12083253|FG001|Overall Study|Withdrawal by Subject|0
7668316|NCT00146172|12083254|FG002|Overall Study|Withdrawal by Subject|0
7668317|NCT00146172|12083255|FG003|Overall Study|Withdrawal by Subject|0
7668318|NCT00146172|12083256|FG004|Overall Study|Withdrawal by Subject|0
7668319|NCT00146172|12083257|FG005|Overall Study|Withdrawal by Subject|1
7668320|NCT00146172|12083258|FG006|Overall Study|Withdrawal by Subject|1
7668321|NCT00146172|12083259|FG007|Overall Study|Withdrawal by Subject|4
7668322|NCT00146172|12083252|FG000|Overall Study|Symptomatic Deterioration|1
7668323|NCT00146172|12083253|FG001|Overall Study|Symptomatic Deterioration|0
7668324|NCT00146172|12083254|FG002|Overall Study|Symptomatic Deterioration|1
7668325|NCT00146172|12083255|FG003|Overall Study|Symptomatic Deterioration|0
7668326|NCT00146172|12083256|FG004|Overall Study|Symptomatic Deterioration|1
7668327|NCT00146172|12083257|FG005|Overall Study|Symptomatic Deterioration|2
7668328|NCT00146172|12083258|FG006|Overall Study|Symptomatic Deterioration|0
7668329|NCT00146172|12083259|FG007|Overall Study|Symptomatic Deterioration|2
7668330|NCT00146328|12083288|FG000|Overall Study|Adverse Event|39
7668331|NCT00146328|12083289|FG001|Overall Study|Adverse Event|48
7668332|NCT00146328|12083290|FG002|Overall Study|Adverse Event|79
7668333|NCT00146328|12083288|FG000|Overall Study|Protocol Violation|11
7668334|NCT00146328|12083289|FG001|Overall Study|Protocol Violation|6
7668335|NCT00146328|12083290|FG002|Overall Study|Protocol Violation|12
7668336|NCT00146328|12083288|FG000|Overall Study|Lost to Follow-up|7
7668337|NCT00146328|12083289|FG001|Overall Study|Lost to Follow-up|4
7668338|NCT00146328|12083290|FG002|Overall Study|Lost to Follow-up|7
7668339|NCT00146328|12083288|FG000|Overall Study|Withdrawal by Subject|16
7668340|NCT00146328|12083289|FG001|Overall Study|Withdrawal by Subject|16
7668341|NCT00146328|12083290|FG002|Overall Study|Withdrawal by Subject|22
7668342|NCT00146328|12083288|FG000|Overall Study|Virologic Failure/lack of efficacy|54
7668343|NCT00146328|12083289|FG001|Overall Study|Virologic Failure/lack of efficacy|72
7668344|NCT00146328|12083290|FG002|Overall Study|Virologic Failure/lack of efficacy|142
7668345|NCT00146328|12083288|FG000|Overall Study|Trial ended/site closed|8
7668346|NCT00146328|12083289|FG001|Overall Study|Trial ended/site closed|2
7668347|NCT00146328|12083290|FG002|Overall Study|Trial ended/site closed|19
7668348|NCT00146328|12083288|FG000|Overall Study|Patient decision to end|0
7668349|NCT00146328|12083289|FG001|Overall Study|Patient decision to end|1
7668350|NCT00146328|12083290|FG002|Overall Study|Patient decision to end|6
7668351|NCT00146328|12083288|FG000|Overall Study|Enroll into other trial|2
7668352|NCT00146328|12083289|FG001|Overall Study|Enroll into other trial|4
7668353|NCT00146328|12083290|FG002|Overall Study|Enroll into other trial|2
7668354|NCT00146328|12083288|FG000|Overall Study|Death|0
7668355|NCT00146328|12083289|FG001|Overall Study|Death|1
7668356|NCT00146328|12083290|FG002|Overall Study|Death|1
7668357|NCT00146328|12083288|FG000|Overall Study|Moved|2
7668358|NCT00146328|12083289|FG001|Overall Study|Moved|0
7668359|NCT00146328|12083290|FG002|Overall Study|Moved|0
7668360|NCT00146328|12083288|FG000|Overall Study|Interaction with other medication|2
7668361|NCT00146328|12083289|FG001|Overall Study|Interaction with other medication|0
7668362|NCT00146328|12083290|FG002|Overall Study|Interaction with other medication|1
7668363|NCT00146640|12083300|FG000|Overall Study|Adverse Event|12
7668364|NCT00146640|12083301|FG001|Overall Study|Adverse Event|10
7668365|NCT00146640|12083300|FG000|Overall Study|Medical Reasons|3
7668366|NCT00146640|12083301|FG001|Overall Study|Medical Reasons|0
7668367|NCT00146640|12083300|FG000|Overall Study|Non-Medical Reasons|8
7668368|NCT00146640|12083301|FG001|Overall Study|Non-Medical Reasons|4
7668369|NCT00146757|12083307|FG000|Overall Study|Death|1
7668370|NCT00146757|12083308|FG001|Overall Study|Death|0
7668371|NCT00146757|12083307|FG000|Overall Study|Adverse Event|1
7668372|NCT00146757|12083308|FG001|Overall Study|Adverse Event|0
7668373|NCT00146770|12083316|FG000|Overall Study|Adverse Event|2
7668374|NCT00146770|12083317|FG001|Overall Study|Adverse Event|0
7668375|NCT00146770|12083316|FG000|Overall Study|Pregnancy|1
7668376|NCT00146770|12083317|FG001|Overall Study|Pregnancy|0
7668377|NCT00146770|12083316|FG000|Overall Study|Withdrawal by Subject|2
7668378|NCT00146770|12083317|FG001|Overall Study|Withdrawal by Subject|0
7668379|NCT00146848|12083326|FG000|Pre-randomization|Death|19
7668380|NCT00146848|12083327|FG001|Pre-randomization|Death|0
7668381|NCT00146848|12083328|FG002|Pre-randomization|Death|0
7668382|NCT00146848|12083326|FG000|Pre-randomization|Lost to Follow-up|70
7668383|NCT00146848|12083327|FG001|Pre-randomization|Lost to Follow-up|0
7668384|NCT00146848|12083328|FG002|Pre-randomization|Lost to Follow-up|0
7668385|NCT00146848|12083326|FG000|Pre-randomization|Physician Decision|8
7668386|NCT00146848|12083327|FG001|Pre-randomization|Physician Decision|0
7668387|NCT00146848|12083328|FG002|Pre-randomization|Physician Decision|0
7668388|NCT00146848|12083326|FG000|Pre-randomization|Protocol Violation|172
7668389|NCT00146848|12083327|FG001|Pre-randomization|Protocol Violation|0
7668390|NCT00146848|12083328|FG002|Pre-randomization|Protocol Violation|0
7668391|NCT00146848|12083326|FG000|Pre-randomization|Withdrawal by Subject|40
7668392|NCT00146848|12083327|FG001|Pre-randomization|Withdrawal by Subject|0
7668393|NCT00146848|12083328|FG002|Pre-randomization|Withdrawal by Subject|0
7668394|NCT00146848|12083326|FG000|Post-randomization|Lost to Follow-up|12
7668395|NCT00146848|12083327|FG001|Post-randomization|Lost to Follow-up|15
7668396|NCT00146848|12083328|FG002|Post-randomization|Lost to Follow-up|12
7668397|NCT00146848|12083326|FG000|Post-randomization|Withdrawn|26
7668398|NCT00146848|12083327|FG001|Post-randomization|Withdrawn|32
7668399|NCT00146848|12083328|FG002|Post-randomization|Withdrawn|27
7668400|NCT00147225|12083414|FG000|Overall Study|Withdrawal by Subject|1
7668401|NCT00147225|12083415|FG001|Overall Study|Withdrawal by Subject|0
7668402|NCT00147225|12083416|FG002|Overall Study|Withdrawal by Subject|1
7668403|NCT00147225|12083417|FG003|Overall Study|Withdrawal by Subject|0
7668404|NCT00147225|12083418|FG004|Overall Study|Withdrawal by Subject|0
7668405|NCT00147225|12083419|FG005|Overall Study|Withdrawal by Subject|1
7668406|NCT00147225|12083414|FG000|Overall Study|Adverse Event|0
7668407|NCT00147225|12083415|FG001|Overall Study|Adverse Event|0
7668408|NCT00147225|12083416|FG002|Overall Study|Adverse Event|1
7668409|NCT00147225|12083417|FG003|Overall Study|Adverse Event|1
7668410|NCT00147225|12083418|FG004|Overall Study|Adverse Event|0
7668411|NCT00147225|12083419|FG005|Overall Study|Adverse Event|0
7668412|NCT00147225|12083414|FG000|Overall Study|Screen Failure|0
7668413|NCT00147225|12083415|FG001|Overall Study|Screen Failure|0
7668414|NCT00147225|12083416|FG002|Overall Study|Screen Failure|0
7668415|NCT00147225|12083417|FG003|Overall Study|Screen Failure|0
7668416|NCT00147225|12083418|FG004|Overall Study|Screen Failure|1
7668417|NCT00147225|12083419|FG005|Overall Study|Screen Failure|0
7668418|NCT00147225|12083414|FG000|Overall Study|Chemotherapy Changed|0
7668419|NCT00147225|12083415|FG001|Overall Study|Chemotherapy Changed|0
7668420|NCT00147225|12083416|FG002|Overall Study|Chemotherapy Changed|0
7668421|NCT00147225|12083417|FG003|Overall Study|Chemotherapy Changed|0
7668422|NCT00147225|12083418|FG004|Overall Study|Chemotherapy Changed|0
7668423|NCT00147225|12083419|FG005|Overall Study|Chemotherapy Changed|1
7668424|NCT00147251|12083435|FG000|Recruitment and Enrollment|change in treatment guidelines|24
7668425|NCT00147251|12083436|FG001|Recruitment and Enrollment|change in treatment guidelines|25
7668426|NCT00147498|12083463|FG000|Overall Study|Adverse Event|1
7668427|NCT00147498|12083464|FG001|Overall Study|Adverse Event|6
7668428|NCT00147498|12083465|FG002|Overall Study|Adverse Event|7
7668429|NCT00147498|12083466|FG003|Overall Study|Adverse Event|3
7668430|NCT00147498|12083463|FG000|Overall Study|Lack of Efficacy|1
7668431|NCT00147498|12083464|FG001|Overall Study|Lack of Efficacy|1
7668432|NCT00147498|12083465|FG002|Overall Study|Lack of Efficacy|1
7668433|NCT00147498|12083466|FG003|Overall Study|Lack of Efficacy|8
7668434|NCT00147498|12083463|FG000|Overall Study|Laboratory abnormality|0
7668435|NCT00147498|12083464|FG001|Overall Study|Laboratory abnormality|0
7668436|NCT00147498|12083465|FG002|Overall Study|Laboratory abnormality|2
7668437|NCT00147498|12083466|FG003|Overall Study|Laboratory abnormality|0
7668438|NCT00147498|12083463|FG000|Overall Study|Participant defaulted|0
7668439|NCT00147498|12083464|FG001|Overall Study|Participant defaulted|1
7668440|NCT00147498|12083465|FG002|Overall Study|Participant defaulted|4
7668441|NCT00147498|12083466|FG003|Overall Study|Participant defaulted|3
7668442|NCT00147498|12083463|FG000|Overall Study|Other|1
7668443|NCT00147498|12083464|FG001|Overall Study|Other|1
7668444|NCT00147498|12083465|FG002|Overall Study|Other|3
7668445|NCT00147498|12083466|FG003|Overall Study|Other|3
7668446|NCT00147537|12083480|FG000|Phase 1b|Death|0
7668447|NCT00147537|12083481|FG001|Phase 1b|Death|1
7668448|NCT00147537|12083482|FG002|Phase 1b|Death|2
7668449|NCT00147537|12083483|FG003|Phase 1b|Death|1
7668450|NCT00147537|12083484|FG004|Phase 1b|Death|2
7668451|NCT00147537|12083485|FG005|Phase 1b|Death|2
7668452|NCT00147537|12083486|FG006|Phase 1b|Death|1
7668453|NCT00147537|12083487|FG007|Phase 1b|Death|3
7668454|NCT00147537|12083488|FG008|Phase 1b|Death|9
7668455|NCT00147537|12083489|FG009|Phase 1b|Death|0
7668456|NCT00147537|12083490|FG010|Phase 1b|Death|0
7668457|NCT00147537|12083480|FG000|Phase 1b|Lost to Follow-up|2
7668458|NCT00147537|12083481|FG001|Phase 1b|Lost to Follow-up|1
7668459|NCT00147537|12083482|FG002|Phase 1b|Lost to Follow-up|0
7668460|NCT00147537|12083483|FG003|Phase 1b|Lost to Follow-up|0
7668461|NCT00147537|12083484|FG004|Phase 1b|Lost to Follow-up|0
7668462|NCT00147537|12083485|FG005|Phase 1b|Lost to Follow-up|0
7668463|NCT00147537|12083486|FG006|Phase 1b|Lost to Follow-up|2
7668464|NCT00147537|12083487|FG007|Phase 1b|Lost to Follow-up|0
7668465|NCT00147537|12083488|FG008|Phase 1b|Lost to Follow-up|1
7668466|NCT00147537|12083489|FG009|Phase 1b|Lost to Follow-up|0
7668467|NCT00147537|12083490|FG010|Phase 1b|Lost to Follow-up|0
7668468|NCT00147537|12083480|FG000|Phase 1b|Other|0
7668469|NCT00147537|12083481|FG001|Phase 1b|Other|0
7668470|NCT00147537|12083482|FG002|Phase 1b|Other|2
7668471|NCT00147537|12083483|FG003|Phase 1b|Other|1
7668472|NCT00147537|12083484|FG004|Phase 1b|Other|1
7668473|NCT00147537|12083485|FG005|Phase 1b|Other|1
7668474|NCT00147537|12083486|FG006|Phase 1b|Other|14
7668475|NCT00147537|12083487|FG007|Phase 1b|Other|4
7668476|NCT00147537|12083488|FG008|Phase 1b|Other|4
7668477|NCT00147537|12083489|FG009|Phase 1b|Other|0
7668478|NCT00147537|12083490|FG010|Phase 1b|Other|0
7668479|NCT00147537|12083480|FG000|Phase 1b|Withdrawal by Subject|0
7668480|NCT00147537|12083481|FG001|Phase 1b|Withdrawal by Subject|0
7668481|NCT00147537|12083482|FG002|Phase 1b|Withdrawal by Subject|0
7668482|NCT00147537|12083483|FG003|Phase 1b|Withdrawal by Subject|0
7668483|NCT00147537|12083484|FG004|Phase 1b|Withdrawal by Subject|0
7668484|NCT00147537|12083485|FG005|Phase 1b|Withdrawal by Subject|0
7668485|NCT00147537|12083486|FG006|Phase 1b|Withdrawal by Subject|0
7668486|NCT00147537|12083487|FG007|Phase 1b|Withdrawal by Subject|0
7668487|NCT00147537|12083488|FG008|Phase 1b|Withdrawal by Subject|2
7668488|NCT00147537|12083489|FG009|Phase 1b|Withdrawal by Subject|0
7668489|NCT00147537|12083490|FG010|Phase 1b|Withdrawal by Subject|0
7668490|NCT00147537|12083480|FG000|Phase 1b|Randomized but not treated|0
7668491|NCT00147537|12083481|FG001|Phase 1b|Randomized but not treated|0
7668492|NCT00147537|12083482|FG002|Phase 1b|Randomized but not treated|0
7668493|NCT00147537|12083483|FG003|Phase 1b|Randomized but not treated|0
7668494|NCT00147537|12083484|FG004|Phase 1b|Randomized but not treated|0
7668495|NCT00147537|12083485|FG005|Phase 1b|Randomized but not treated|0
7668496|NCT00147537|12083486|FG006|Phase 1b|Randomized but not treated|1
7668497|NCT00147537|12083487|FG007|Phase 1b|Randomized but not treated|0
7668498|NCT00147537|12083488|FG008|Phase 1b|Randomized but not treated|1
7668499|NCT00147537|12083489|FG009|Phase 1b|Randomized but not treated|0
7668500|NCT00147537|12083490|FG010|Phase 1b|Randomized but not treated|0
7668501|NCT00147537|12083480|FG000|Phase 2|Death|0
7668502|NCT00147537|12083481|FG001|Phase 2|Death|0
7668503|NCT00147537|12083482|FG002|Phase 2|Death|0
7668504|NCT00147537|12083483|FG003|Phase 2|Death|0
7668505|NCT00147537|12083484|FG004|Phase 2|Death|0
7668506|NCT00147537|12083485|FG005|Phase 2|Death|0
7668507|NCT00147537|12083486|FG006|Phase 2|Death|0
7668508|NCT00147537|12083487|FG007|Phase 2|Death|0
7668509|NCT00147537|12083488|FG008|Phase 2|Death|0
7668510|NCT00147537|12083489|FG009|Phase 2|Death|85
7668511|NCT00147537|12083490|FG010|Phase 2|Death|31
7668512|NCT00147537|12083480|FG000|Phase 2|Lost to Follow-up|0
7668513|NCT00147537|12083481|FG001|Phase 2|Lost to Follow-up|0
7668514|NCT00147537|12083482|FG002|Phase 2|Lost to Follow-up|0
7668515|NCT00147537|12083483|FG003|Phase 2|Lost to Follow-up|0
7668516|NCT00147537|12083484|FG004|Phase 2|Lost to Follow-up|0
7668517|NCT00147537|12083485|FG005|Phase 2|Lost to Follow-up|0
7668518|NCT00147537|12083486|FG006|Phase 2|Lost to Follow-up|0
7668519|NCT00147537|12083487|FG007|Phase 2|Lost to Follow-up|0
7668520|NCT00147537|12083488|FG008|Phase 2|Lost to Follow-up|0
7668521|NCT00147537|12083489|FG009|Phase 2|Lost to Follow-up|12
7668522|NCT00147537|12083490|FG010|Phase 2|Lost to Follow-up|4
7668523|NCT00147537|12083480|FG000|Phase 2|Other|0
7668524|NCT00147537|12083481|FG001|Phase 2|Other|0
7668525|NCT00147537|12083482|FG002|Phase 2|Other|0
7668526|NCT00147537|12083483|FG003|Phase 2|Other|0
7668527|NCT00147537|12083484|FG004|Phase 2|Other|0
7668528|NCT00147537|12083485|FG005|Phase 2|Other|0
7668529|NCT00147537|12083486|FG006|Phase 2|Other|0
7668530|NCT00147537|12083487|FG007|Phase 2|Other|0
7668531|NCT00147537|12083488|FG008|Phase 2|Other|0
7668532|NCT00147537|12083489|FG009|Phase 2|Other|47
7668533|NCT00147537|12083490|FG010|Phase 2|Other|12
7668534|NCT00147537|12083480|FG000|Phase 2|Withdrawal by Subject|0
7668535|NCT00147537|12083481|FG001|Phase 2|Withdrawal by Subject|0
7668536|NCT00147537|12083482|FG002|Phase 2|Withdrawal by Subject|0
7668537|NCT00147537|12083483|FG003|Phase 2|Withdrawal by Subject|0
7668538|NCT00147537|12083484|FG004|Phase 2|Withdrawal by Subject|0
7668539|NCT00147537|12083485|FG005|Phase 2|Withdrawal by Subject|0
7668540|NCT00147537|12083486|FG006|Phase 2|Withdrawal by Subject|0
7668541|NCT00147537|12083487|FG007|Phase 2|Withdrawal by Subject|0
7668542|NCT00147537|12083488|FG008|Phase 2|Withdrawal by Subject|0
7668543|NCT00147537|12083489|FG009|Phase 2|Withdrawal by Subject|16
7668544|NCT00147537|12083490|FG010|Phase 2|Withdrawal by Subject|4
7668545|NCT00147537|12083480|FG000|Phase 2|Randomized but not treated|0
7668546|NCT00147537|12083481|FG001|Phase 2|Randomized but not treated|0
7668547|NCT00147537|12083482|FG002|Phase 2|Randomized but not treated|0
7668548|NCT00147537|12083483|FG003|Phase 2|Randomized but not treated|0
7668549|NCT00147537|12083484|FG004|Phase 2|Randomized but not treated|0
7668550|NCT00147537|12083485|FG005|Phase 2|Randomized but not treated|0
7668551|NCT00147537|12083486|FG006|Phase 2|Randomized but not treated|0
7668552|NCT00147537|12083487|FG007|Phase 2|Randomized but not treated|0
7668553|NCT00147537|12083488|FG008|Phase 2|Randomized but not treated|0
7668554|NCT00147537|12083489|FG009|Phase 2|Randomized but not treated|1
7668555|NCT00147537|12083490|FG010|Phase 2|Randomized but not treated|1
7668556|NCT00147745|12083538|FG000|Overall Study|Withdrawal by Subject|1
7668557|NCT00147745|12083539|FG001|Overall Study|Withdrawal by Subject|0
7668558|NCT00147745|12083540|FG002|Overall Study|Withdrawal by Subject|0
7668559|NCT00147823|12083550|FG000|Overall Study|Lost to Follow-up|6
7668560|NCT00147823|12083551|FG001|Overall Study|Lost to Follow-up|12
7668561|NCT00147823|12083550|FG000|Overall Study|Physician Decision|1
7668562|NCT00147823|12083551|FG001|Overall Study|Physician Decision|0
7668563|NCT00147823|12083550|FG000|Overall Study|Withdrawal by Subject|0
7668564|NCT00147823|12083551|FG001|Overall Study|Withdrawal by Subject|1
7668565|NCT00147823|12083550|FG000|Overall Study|Did not receive vitoss due to infection|6
7668566|NCT00147823|12083551|FG001|Overall Study|Did not receive vitoss due to infection|2
7668567|NCT00148109|12083563|FG000|Overall Study|Lack of Efficacy|10
7668568|NCT00148109|12083564|FG001|Overall Study|Lack of Efficacy|18
7668569|NCT00148109|12083563|FG000|Overall Study|Adverse Event|0
7668570|NCT00148109|12083564|FG001|Overall Study|Adverse Event|2
7668571|NCT00148109|12083563|FG000|Overall Study|Withdrawal by Subject|2
7668572|NCT00148109|12083564|FG001|Overall Study|Withdrawal by Subject|0
7668573|NCT00148122|12083570|FG000|Overall Study|Withdrawal by Subject|2
7668574|NCT00148317|12083574|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
7668575|NCT00148317|12083574|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
7668576|NCT00148317|12083574|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
7668577|NCT00148343|12083583|FG000|Overall Study|Withdrawal by Subject|12
7668578|NCT00148343|12083584|FG001|Overall Study|Withdrawal by Subject|7
7668579|NCT00148343|12083583|FG000|Overall Study|Physician Decision|3
7668580|NCT00148343|12083584|FG001|Overall Study|Physician Decision|4
7668581|NCT00148759|12083601|FG000|Overall Study|Withdrawal by Subject|1
7668582|NCT00148759|12083602|FG001|Overall Study|Withdrawal by Subject|1
7668583|NCT00148759|12083601|FG000|Overall Study|Lost to Follow-up|1
7668584|NCT00148759|12083602|FG001|Overall Study|Lost to Follow-up|0
7668585|NCT00148941|12083623|FG000|Overall Study|Lost to Follow-up|17
7668586|NCT00148941|12083624|FG001|Overall Study|Lost to Follow-up|24
7668587|NCT00148941|12083625|FG002|Overall Study|Lost to Follow-up|18
7668588|NCT00148941|12083626|FG003|Overall Study|Lost to Follow-up|22
7668589|NCT00148941|12083623|FG000|Overall Study|Withdrawal by Subject|1
7668590|NCT00148941|12083624|FG001|Overall Study|Withdrawal by Subject|0
7668591|NCT00148941|12083625|FG002|Overall Study|Withdrawal by Subject|1
7668592|NCT00148941|12083626|FG003|Overall Study|Withdrawal by Subject|0
7668593|NCT00148941|12083623|FG000|Overall Study|Other|0
7668594|NCT00148941|12083624|FG001|Overall Study|Other|0
7668595|NCT00148941|12083625|FG002|Overall Study|Other|1
7668596|NCT00148941|12083626|FG003|Overall Study|Other|2
7668597|NCT00149214|12083647|FG000|Overall Study|Adverse Event|12
7668598|NCT00149214|12083648|FG001|Overall Study|Adverse Event|9
7668599|NCT00149214|12083647|FG000|Overall Study|Withdrawal by Subject|4
7668600|NCT00149214|12083648|FG001|Overall Study|Withdrawal by Subject|1
7668601|NCT00149214|12083647|FG000|Overall Study|Physician Decision|3
7668602|NCT00149214|12083648|FG001|Overall Study|Physician Decision|3
7668603|NCT00149214|12083647|FG000|Overall Study|Sponsor Decision|0
7668604|NCT00149214|12083648|FG001|Overall Study|Sponsor Decision|1
7668605|NCT00149214|12083647|FG000|Overall Study|Progressive Disease|7
7668606|NCT00149214|12083648|FG001|Overall Study|Progressive Disease|3
7668607|NCT00149396|12083663|FG000|Overall Study|Death|15
7668608|NCT00149396|12083663|FG000|Overall Study|Withdrawal by Subject|1
7668609|NCT00149396|12083663|FG000|Overall Study|Subject noncompliance|2
7668610|NCT00149396|12083663|FG000|Overall Study|other treatment|5
7668611|NCT00149630|12083676|FG000|Overall Study|Incarceration|2
7668612|NCT00149630|12083677|FG001|Overall Study|Incarceration|0
7668613|NCT00149630|12083676|FG000|Overall Study|Treatment Programs|4
7668614|NCT00149630|12083677|FG001|Overall Study|Treatment Programs|5
7668615|NCT00149630|12083676|FG000|Overall Study|Adverse Event|2
7668616|NCT00149630|12083677|FG001|Overall Study|Adverse Event|0
7668617|NCT00149747|12083716|FG000|Overall Study|Death|1
7668618|NCT00149747|12083717|FG001|Overall Study|Death|0
7668619|NCT00149747|12083716|FG000|Overall Study|Withdrawal by Subject|3
7668620|NCT00149747|12083717|FG001|Overall Study|Withdrawal by Subject|3
7668621|NCT00149825|12083737|FG000|Overall Study|Intolerance to medication side effects|1
7668622|NCT00149825|12083738|FG001|Overall Study|Intolerance to medication side effects|2
7668623|NCT00149825|12083737|FG000|Overall Study|Time commitments|2
7668624|NCT00149825|12083738|FG001|Overall Study|Time commitments|1
7668625|NCT00149825|12083737|FG000|Overall Study|Not liking insomnia therapy|1
7668626|NCT00149825|12083738|FG001|Overall Study|Not liking insomnia therapy|0
7668627|NCT00149825|12083737|FG000|Overall Study|Other|1
7668628|NCT00149825|12083738|FG001|Overall Study|Other|0
7668629|NCT00149890|12083761|FG000|Overall Study|Adverse Event|1
7668630|NCT00149890|12083762|FG001|Overall Study|Adverse Event|8
7668631|NCT00149890|12083761|FG000|Overall Study|Lack of Efficacy|8
7668632|NCT00149890|12083762|FG001|Overall Study|Lack of Efficacy|9
7668633|NCT00149890|12083761|FG000|Overall Study|Protocol Violation|1
7668634|NCT00149890|12083762|FG001|Overall Study|Protocol Violation|0
7668635|NCT00149890|12083761|FG000|Overall Study|Lost to Follow-up|1
7668636|NCT00149890|12083762|FG001|Overall Study|Lost to Follow-up|0
7668637|NCT00149890|12083761|FG000|Overall Study|Graft Loss|2
7668638|NCT00149890|12083762|FG001|Overall Study|Graft Loss|1
7668639|NCT00149994|12083770|FG000|Overall Study|Administrative problems:|1
7668640|NCT00149994|12083771|FG001|Overall Study|Administrative problems:|0
7668641|NCT00149994|12083770|FG000|Overall Study|Protocol Violation|0
7668642|NCT00149994|12083771|FG001|Overall Study|Protocol Violation|1
7668643|NCT00150345|12083779|FG000|Overall Study|Death|5
7668644|NCT00150345|12083780|FG001|Overall Study|Death|2
7668645|NCT00150345|12083779|FG000|Overall Study|Adverse Event|8
7668646|NCT00150345|12083780|FG001|Overall Study|Adverse Event|6
7668647|NCT00150345|12083779|FG000|Overall Study|Lack of Efficacy|5
7668648|NCT00150345|12083780|FG001|Overall Study|Lack of Efficacy|4
7668649|NCT00150345|12083779|FG000|Overall Study|Withdrawal by Subject|3
7668650|NCT00150345|12083780|FG001|Overall Study|Withdrawal by Subject|4
7668651|NCT00150345|12083779|FG000|Overall Study|Laboratory abnormality|1
7668652|NCT00150345|12083780|FG001|Overall Study|Laboratory abnormality|2
7668653|NCT00150345|12083779|FG000|Overall Study|Other|12
7668654|NCT00150345|12083780|FG001|Overall Study|Other|14
7668655|NCT00150462|12083798|FG000|Overall Study|Disease Progression or Relapse|3
7668656|NCT00150462|12083799|FG001|Overall Study|Disease Progression or Relapse|1
7668657|NCT00150462|12083800|FG002|Overall Study|Disease Progression or Relapse|2
7668658|NCT00150462|12083801|FG003|Overall Study|Disease Progression or Relapse|1
7668659|NCT00150462|12083802|FG004|Overall Study|Disease Progression or Relapse|2
7668660|NCT00150462|12083803|FG005|Overall Study|Disease Progression or Relapse|2
7668661|NCT00150462|12083804|FG006|Overall Study|Disease Progression or Relapse|3
7668662|NCT00150462|12083805|FG007|Overall Study|Disease Progression or Relapse|5
7668663|NCT00150462|12083806|FG008|Overall Study|Disease Progression or Relapse|5
7668664|NCT00150462|12083807|FG009|Overall Study|Disease Progression or Relapse|3
7668665|NCT00150462|12083808|FG010|Overall Study|Disease Progression or Relapse|2
7668666|NCT00150462|12083798|FG000|Overall Study|Withdrawal by Subject|0
7668667|NCT00150462|12083799|FG001|Overall Study|Withdrawal by Subject|1
7668668|NCT00150462|12083800|FG002|Overall Study|Withdrawal by Subject|1
7668669|NCT00150462|12083801|FG003|Overall Study|Withdrawal by Subject|0
7668670|NCT00150462|12083802|FG004|Overall Study|Withdrawal by Subject|1
7668671|NCT00150462|12083803|FG005|Overall Study|Withdrawal by Subject|2
7668672|NCT00150462|12083804|FG006|Overall Study|Withdrawal by Subject|0
7668673|NCT00150462|12083805|FG007|Overall Study|Withdrawal by Subject|1
7668674|NCT00150462|12083806|FG008|Overall Study|Withdrawal by Subject|0
7668675|NCT00150462|12083807|FG009|Overall Study|Withdrawal by Subject|1
7668676|NCT00150462|12083808|FG010|Overall Study|Withdrawal by Subject|0
7668677|NCT00150462|12083798|FG000|Overall Study|Death|0
7668678|NCT00150462|12083799|FG001|Overall Study|Death|1
7668679|NCT00150462|12083800|FG002|Overall Study|Death|0
7668680|NCT00150462|12083801|FG003|Overall Study|Death|0
7668681|NCT00150462|12083802|FG004|Overall Study|Death|0
7668682|NCT00150462|12083803|FG005|Overall Study|Death|0
7668683|NCT00150462|12083804|FG006|Overall Study|Death|0
7668684|NCT00150462|12083805|FG007|Overall Study|Death|0
7668685|NCT00150462|12083806|FG008|Overall Study|Death|1
7668686|NCT00150462|12083807|FG009|Overall Study|Death|0
7668687|NCT00150462|12083808|FG010|Overall Study|Death|0
7668688|NCT00150462|12083798|FG000|Overall Study|Adverse Event|0
7668689|NCT00150462|12083799|FG001|Overall Study|Adverse Event|0
7668690|NCT00150462|12083800|FG002|Overall Study|Adverse Event|0
7668691|NCT00150462|12083801|FG003|Overall Study|Adverse Event|1
7668692|NCT00150462|12083802|FG004|Overall Study|Adverse Event|0
7668693|NCT00150462|12083803|FG005|Overall Study|Adverse Event|0
7668694|NCT00150462|12083804|FG006|Overall Study|Adverse Event|0
7668695|NCT00150462|12083805|FG007|Overall Study|Adverse Event|2
7668696|NCT00150462|12083806|FG008|Overall Study|Adverse Event|0
7668697|NCT00150462|12083807|FG009|Overall Study|Adverse Event|1
7668698|NCT00150462|12083808|FG010|Overall Study|Adverse Event|0
7668699|NCT00150462|12083798|FG000|Overall Study|Physician Decision|0
7668700|NCT00150462|12083799|FG001|Overall Study|Physician Decision|0
7668701|NCT00150462|12083800|FG002|Overall Study|Physician Decision|1
7668702|NCT00150462|12083801|FG003|Overall Study|Physician Decision|1
7668703|NCT00150462|12083802|FG004|Overall Study|Physician Decision|0
7668704|NCT00150462|12083803|FG005|Overall Study|Physician Decision|0
7668705|NCT00150462|12083804|FG006|Overall Study|Physician Decision|0
7668706|NCT00150462|12083805|FG007|Overall Study|Physician Decision|0
7668707|NCT00150462|12083806|FG008|Overall Study|Physician Decision|0
7668708|NCT00150462|12083807|FG009|Overall Study|Physician Decision|0
7668709|NCT00150462|12083808|FG010|Overall Study|Physician Decision|0
7668710|NCT00150462|12083798|FG000|Overall Study|Other|0
7668711|NCT00150462|12083799|FG001|Overall Study|Other|0
7668712|NCT00150462|12083800|FG002|Overall Study|Other|0
7668713|NCT00150462|12083801|FG003|Overall Study|Other|0
7668714|NCT00150462|12083802|FG004|Overall Study|Other|0
7668715|NCT00150462|12083803|FG005|Overall Study|Other|0
7668716|NCT00150462|12083804|FG006|Overall Study|Other|0
7668717|NCT00150462|12083805|FG007|Overall Study|Other|0
7668718|NCT00150462|12083806|FG008|Overall Study|Other|0
7668719|NCT00150462|12083807|FG009|Overall Study|Other|1
7668720|NCT00150462|12083808|FG010|Overall Study|Other|1
7668721|NCT00150592|12083837|FG000|Overall Study|Adverse Event|4
7668722|NCT00150592|12083838|FG001|Overall Study|Adverse Event|1
7668723|NCT00150592|12083837|FG000|Overall Study|Protocol Violation|1
7668724|NCT00150592|12083838|FG001|Overall Study|Protocol Violation|0
7668725|NCT00150592|12083837|FG000|Overall Study|Withdrawal by Subject|1
7668726|NCT00150592|12083838|FG001|Overall Study|Withdrawal by Subject|2
7668727|NCT00150592|12083837|FG000|Overall Study|Non-compliance|1
7668728|NCT00150592|12083838|FG001|Overall Study|Non-compliance|0
7668729|NCT00150618|12083849|FG000|Overall Study|Adverse Event|2
7668730|NCT00150618|12083850|FG001|Overall Study|Adverse Event|2
7668731|NCT00150618|12083851|FG002|Overall Study|Adverse Event|6
7668732|NCT00150618|12083852|FG003|Overall Study|Adverse Event|9
7668733|NCT00150618|12083853|FG004|Overall Study|Adverse Event|5
7668734|NCT00150618|12083849|FG000|Overall Study|Withdrawal by Subject|6
7668735|NCT00150618|12083850|FG001|Overall Study|Withdrawal by Subject|8
7668736|NCT00150618|12083851|FG002|Overall Study|Withdrawal by Subject|8
7668737|NCT00150618|12083852|FG003|Overall Study|Withdrawal by Subject|4
7668738|NCT00150618|12083853|FG004|Overall Study|Withdrawal by Subject|5
7668739|NCT00150618|12083849|FG000|Overall Study|Lost to Follow-up|4
7668740|NCT00150618|12083850|FG001|Overall Study|Lost to Follow-up|1
7668741|NCT00150618|12083851|FG002|Overall Study|Lost to Follow-up|5
7668742|NCT00150618|12083852|FG003|Overall Study|Lost to Follow-up|8
7668743|NCT00150618|12083853|FG004|Overall Study|Lost to Follow-up|4
7668744|NCT00150618|12083849|FG000|Overall Study|Protocol Violation|1
7668745|NCT00150618|12083850|FG001|Overall Study|Protocol Violation|0
7668746|NCT00150618|12083851|FG002|Overall Study|Protocol Violation|0
7668747|NCT00150618|12083852|FG003|Overall Study|Protocol Violation|0
7668748|NCT00150618|12083853|FG004|Overall Study|Protocol Violation|1
7668749|NCT00150618|12083849|FG000|Overall Study|Lack of Efficacy|1
7668750|NCT00150618|12083850|FG001|Overall Study|Lack of Efficacy|4
7668751|NCT00150618|12083851|FG002|Overall Study|Lack of Efficacy|7
7668752|NCT00150618|12083852|FG003|Overall Study|Lack of Efficacy|4
7668753|NCT00150618|12083853|FG004|Overall Study|Lack of Efficacy|6
7668754|NCT00150618|12083849|FG000|Overall Study|No study meds|0
7668755|NCT00150618|12083850|FG001|Overall Study|No study meds|0
7668756|NCT00150618|12083851|FG002|Overall Study|No study meds|0
7668757|NCT00150618|12083852|FG003|Overall Study|No study meds|0
7668758|NCT00150618|12083853|FG004|Overall Study|No study meds|2
7668759|NCT00150618|12083849|FG000|Overall Study|Physician Decision|0
7668760|NCT00150618|12083850|FG001|Overall Study|Physician Decision|2
7668761|NCT00150618|12083851|FG002|Overall Study|Physician Decision|0
7668762|NCT00150618|12083852|FG003|Overall Study|Physician Decision|0
7668763|NCT00150618|12083853|FG004|Overall Study|Physician Decision|1
7668764|NCT00150618|12083849|FG000|Overall Study|Lack of compliance|2
7668765|NCT00150618|12083850|FG001|Overall Study|Lack of compliance|1
7668766|NCT00150618|12083851|FG002|Overall Study|Lack of compliance|1
7668767|NCT00150618|12083852|FG003|Overall Study|Lack of compliance|0
7668768|NCT00150618|12083853|FG004|Overall Study|Lack of compliance|1
7668769|NCT00150618|12083849|FG000|Overall Study|Abnormal ECG|1
7668770|NCT00150618|12083850|FG001|Overall Study|Abnormal ECG|0
7668771|NCT00150618|12083851|FG002|Overall Study|Abnormal ECG|0
7668772|NCT00150618|12083852|FG003|Overall Study|Abnormal ECG|0
7668773|NCT00150618|12083853|FG004|Overall Study|Abnormal ECG|0
7668774|NCT00150618|12083849|FG000|Overall Study|Sponsor's decision|0
7668775|NCT00150618|12083850|FG001|Overall Study|Sponsor's decision|0
7668776|NCT00150618|12083851|FG002|Overall Study|Sponsor's decision|0
7668777|NCT00150618|12083852|FG003|Overall Study|Sponsor's decision|1
7668778|NCT00150618|12083853|FG004|Overall Study|Sponsor's decision|0
7668779|NCT00150800|12083865|FG000|Overall Study|Adverse Event|89
7668780|NCT00150800|12083865|FG000|Overall Study|Death|18
7668781|NCT00150800|12083865|FG000|Overall Study|Lack of Efficacy|166
7668782|NCT00150800|12083865|FG000|Overall Study|Lost to Follow-up|58
7668783|NCT00150800|12083865|FG000|Overall Study|Subject's choice|90
7668784|NCT00150800|12083865|FG000|Overall Study|No compliance|18
7668785|NCT00150800|12083865|FG000|Overall Study|IP misshandling|1
7668786|NCT00150800|12083865|FG000|Overall Study|Site closure|24
7668787|NCT00150800|12083865|FG000|Overall Study|Protocol non-adherence|2
7668788|NCT00150800|12083865|FG000|Overall Study|Nobody to accompany patient|1
7668789|NCT00150800|12083865|FG000|Overall Study|Distance too long for patient|1
7668790|NCT00150800|12083865|FG000|Overall Study|Neurosurgery|2
7668791|NCT00150800|12083865|FG000|Overall Study|BRV monotherapy|1
7668792|NCT00150800|12083865|FG000|Overall Study|Visit refusal|3
7668793|NCT00150800|12083865|FG000|Overall Study|Sponsor's request|2
7668794|NCT00150800|12083865|FG000|Overall Study|Generalized Epilepsy|1
7668795|NCT00150800|12083865|FG000|Overall Study|Moved from area/country|8
7668796|NCT00150800|12083865|FG000|Overall Study|PI retiring|2
7668797|NCT00150800|12083865|FG000|Overall Study|PI leaving site|2
7668798|NCT00150800|12083865|FG000|Overall Study|Patient insurance|1
7668799|NCT00150800|12083865|FG000|Overall Study|Surgical intervention|4
7668800|NCT00150800|12083865|FG000|Overall Study|Pregnancy planned|1
7668801|NCT00150800|12083865|FG000|Overall Study|PI discontinuation request|1
7668802|NCT00150813|12083870|FG000|Overall Study|Adverse Event|1
7668803|NCT00150813|12083870|FG000|Overall Study|Lack of Efficacy|1
7668804|NCT00150813|12083870|FG000|Overall Study|Lost to Follow-up|5
7668805|NCT00150813|12083870|FG000|Overall Study|Withdrawal by Subject|5
7668806|NCT00150813|12083870|FG000|Overall Study|Remission|3
7668807|NCT00150813|12083870|FG000|Overall Study|Planned pregancy|1
7668808|NCT00150813|12083870|FG000|Overall Study|Switch to commercially available LEV|2
7668809|NCT00150969|12083876|FG000|24 Month Main Study|Adverse Event|3
7668810|NCT00150969|12083877|FG001|24 Month Main Study|Adverse Event|4
7668811|NCT00150969|12083876|FG000|24 Month Main Study|Death|1
7668812|NCT00150969|12083877|FG001|24 Month Main Study|Death|1
7668813|NCT00150969|12083876|FG000|24 Month Main Study|Lack of Efficacy|1
7668814|NCT00150969|12083877|FG001|24 Month Main Study|Lack of Efficacy|8
7668815|NCT00150969|12083876|FG000|24 Month Main Study|Lost to Follow-up|3
7668816|NCT00150969|12083877|FG001|24 Month Main Study|Lost to Follow-up|2
7668817|NCT00150969|12083876|FG000|24 Month Main Study|Protocol Violation|4
7668818|NCT00150969|12083877|FG001|24 Month Main Study|Protocol Violation|2
7668819|NCT00150969|12083876|FG000|24 Month Main Study|Withdrawal by Subject|7
7668820|NCT00150969|12083877|FG001|24 Month Main Study|Withdrawal by Subject|4
7668821|NCT00150969|12083876|FG000|24-48 Month Extension|Withdrawal by Subject|6
7668822|NCT00150969|12083877|FG001|24-48 Month Extension|Withdrawal by Subject|5
7668823|NCT00150969|12083876|FG000|24-48 Month Extension|Lack of Efficacy|0
7668824|NCT00150969|12083877|FG001|24-48 Month Extension|Lack of Efficacy|1
7668825|NCT00150969|12083876|FG000|24-48 Month Extension|Adverse Event|1
7668826|NCT00150969|12083877|FG001|24-48 Month Extension|Adverse Event|3
7668827|NCT00150969|12083876|FG000|24-48 Month Extension|Other Reason|81
7668828|NCT00150969|12083877|FG001|24-48 Month Extension|Other Reason|91
7668829|NCT00151281|12083884|FG000|Overall Study|Not evaluable|3
7668830|NCT00151372|12083898|FG000|Overall Study|Death|12
7668831|NCT00151372|12083899|FG001|Overall Study|Death|11
7668832|NCT00151372|12083898|FG000|Overall Study|Lost to Follow-up|5
7668833|NCT00151372|12083899|FG001|Overall Study|Lost to Follow-up|5
7668834|NCT00151372|12083898|FG000|Overall Study|Too sick medically to continue|5
7668835|NCT00151372|12083899|FG001|Overall Study|Too sick medically to continue|6
7668836|NCT00151372|12083898|FG000|Overall Study|Withdrawal by Subject|7
7668837|NCT00151372|12083899|FG001|Overall Study|Withdrawal by Subject|7
7668838|NCT00151411|12083907|FG000|Overall Study|Lost to Follow-up|15
7668839|NCT00151411|12083908|FG001|Overall Study|Lost to Follow-up|19
7668840|NCT00151411|12083907|FG000|Overall Study|Withdrawal by Subject|12
7668841|NCT00151411|12083908|FG001|Overall Study|Withdrawal by Subject|20
7668842|NCT00151411|12083907|FG000|Overall Study|Adverse Event|6
7668843|NCT00151411|12083908|FG001|Overall Study|Adverse Event|0
7668844|NCT00151411|12083907|FG000|Overall Study|Pregnancy|0
7668845|NCT00151411|12083908|FG001|Overall Study|Pregnancy|4
7668846|NCT00151476|12083917|FG000|FAP Identified Subjects|Protocol Violation|0
7668847|NCT00151476|12083918|FG001|FAP Identified Subjects|Protocol Violation|1
7668848|NCT00151476|12083917|FG000|FAP Analyzed Subjects|Lost to Follow-up|0
7668849|NCT00151476|12083918|FG001|FAP Analyzed Subjects|Lost to Follow-up|2
7668850|NCT00151476|12083917|FG000|FAP Analyzed Subjects|Other study participation|0
7668851|NCT00151476|12083918|FG001|FAP Analyzed Subjects|Other study participation|1
7668852|NCT00151775|12083930|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1
7668853|NCT00151775|12083931|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2
7668854|NCT00151775|12083932|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0
7668855|NCT00151775|12083933|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0
7668856|NCT00151775|12083934|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0
7668857|NCT00151775|12083935|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0
7668858|NCT00151775|12083936|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0
7668859|NCT00151775|12083937|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0
7668860|NCT00151775|12083938|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0
7668861|NCT00151775|12083939|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0
7668862|NCT00151775|12083940|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0
7668863|NCT00151775|12083941|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0
7668864|NCT00151775|12083930|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
7668865|NCT00151775|12083931|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7668866|NCT00151775|12083932|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7668867|NCT00151775|12083933|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7668868|NCT00151775|12083934|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7668869|NCT00151775|12083935|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7668870|NCT00151775|12083936|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
7668871|NCT00151775|12083937|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7668872|NCT00151775|12083938|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7668873|NCT00151775|12083939|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7668874|NCT00151775|12083940|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
7668875|NCT00151775|12083941|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7668876|NCT00151775|12083930|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7668877|NCT00151775|12083931|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4
7668878|NCT00151775|12083932|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7668879|NCT00151775|12083933|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7668880|NCT00151775|12083934|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7668881|NCT00151775|12083935|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7668882|NCT00151775|12083936|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7668883|NCT00151775|12083937|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7668884|NCT00151775|12083938|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7668885|NCT00151775|12083939|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7668886|NCT00151775|12083940|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7668887|NCT00151775|12083941|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7668888|NCT00151775|12083930|FG000|Period 2 - Double-Blind Dose Response|Other|0
7668889|NCT00151775|12083931|FG001|Period 2 - Double-Blind Dose Response|Other|0
7668890|NCT00151775|12083932|FG002|Period 2 - Double-Blind Dose Response|Other|0
7668891|NCT00151775|12083933|FG003|Period 2 - Double-Blind Dose Response|Other|0
7668892|NCT00151775|12083934|FG004|Period 2 - Double-Blind Dose Response|Other|0
7668893|NCT00151775|12083935|FG005|Period 2 - Double-Blind Dose Response|Other|0
7668894|NCT00151775|12083936|FG006|Period 2 - Double-Blind Dose Response|Other|1
7668895|NCT00151775|12083937|FG007|Period 2 - Double-Blind Dose Response|Other|0
7668896|NCT00151775|12083938|FG008|Period 2 - Double-Blind Dose Response|Other|0
7668897|NCT00151775|12083939|FG009|Period 2 - Double-Blind Dose Response|Other|0
7668898|NCT00151775|12083940|FG010|Period 2 - Double-Blind Dose Response|Other|0
7668899|NCT00151775|12083941|FG011|Period 2 - Double-Blind Dose Response|Other|0
7668900|NCT00151775|12083930|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0
7668901|NCT00151775|12083931|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0
7668902|NCT00151775|12083932|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0
7668903|NCT00151775|12083933|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0
7668904|NCT00151775|12083934|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0
7668905|NCT00151775|12083935|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1
7668906|NCT00151775|12083936|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0
7668907|NCT00151775|12083937|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0
7668908|NCT00151775|12083938|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0
7668909|NCT00151775|12083939|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0
7668910|NCT00151775|12083940|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0
7668911|NCT00151775|12083941|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0
7668912|NCT00151775|12083930|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0
7668913|NCT00151775|12083931|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0
7668914|NCT00151775|12083932|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0
7668915|NCT00151775|12083933|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0
7668916|NCT00151775|12083934|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0
7668917|NCT00151775|12083935|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1
7668918|NCT00151775|12083936|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0
7668919|NCT00151775|12083937|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0
7668920|NCT00151775|12083938|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0
7668921|NCT00151775|12083939|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0
7668922|NCT00151775|12083940|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0
7668923|NCT00151775|12083941|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0
7668924|NCT00151775|12083930|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7668925|NCT00151775|12083931|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7668926|NCT00151775|12083932|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7668927|NCT00151775|12083933|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7668928|NCT00151775|12083934|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7668929|NCT00151775|12083935|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7668930|NCT00151775|12083936|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
7668931|NCT00151775|12083937|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7668932|NCT00151775|12083938|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7668933|NCT00151775|12083939|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7668934|NCT00151775|12083940|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7668935|NCT00151775|12083941|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7668936|NCT00151775|12083930|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7668937|NCT00151775|12083931|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7668938|NCT00151775|12083932|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7668939|NCT00151775|12083933|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7668940|NCT00151775|12083934|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7668941|NCT00151775|12083935|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
7668942|NCT00151775|12083936|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7668943|NCT00151775|12083937|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7668944|NCT00151775|12083938|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7668945|NCT00151775|12083939|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7668946|NCT00151775|12083940|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7668947|NCT00151775|12083941|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7668948|NCT00151775|12083930|FG000|Period 3: Double-blind, Withdrawal|Other|0
7668949|NCT00151775|12083931|FG001|Period 3: Double-blind, Withdrawal|Other|0
7668950|NCT00151775|12083932|FG002|Period 3: Double-blind, Withdrawal|Other|1
7668951|NCT00151775|12083933|FG003|Period 3: Double-blind, Withdrawal|Other|0
7668952|NCT00151775|12083934|FG004|Period 3: Double-blind, Withdrawal|Other|0
7668953|NCT00151775|12083935|FG005|Period 3: Double-blind, Withdrawal|Other|0
7668954|NCT00151775|12083936|FG006|Period 3: Double-blind, Withdrawal|Other|0
7668955|NCT00151775|12083937|FG007|Period 3: Double-blind, Withdrawal|Other|1
7668956|NCT00151775|12083938|FG008|Period 3: Double-blind, Withdrawal|Other|0
7668957|NCT00151775|12083939|FG009|Period 3: Double-blind, Withdrawal|Other|0
7668958|NCT00151775|12083940|FG010|Period 3: Double-blind, Withdrawal|Other|0
7668959|NCT00151775|12083941|FG011|Period 3: Double-blind, Withdrawal|Other|0
7668960|NCT00151775|12083930|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7668961|NCT00151775|12083931|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7668962|NCT00151775|12083932|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7668963|NCT00151775|12083933|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7668964|NCT00151775|12083934|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7668965|NCT00151775|12083935|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7668966|NCT00151775|12083936|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
7668967|NCT00151775|12083937|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7668968|NCT00151775|12083938|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7668969|NCT00151775|12083939|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7668970|NCT00151775|12083940|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7668971|NCT00151775|12083941|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7668972|NCT00151775|12083930|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0
7668973|NCT00151775|12083931|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0
7668974|NCT00151775|12083932|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1
7668975|NCT00151775|12083933|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0
7668976|NCT00151775|12083934|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0
7668977|NCT00151775|12083935|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0
7668978|NCT00151775|12083936|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0
7668979|NCT00151775|12083937|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0
7668980|NCT00151775|12083938|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0
7668981|NCT00151775|12083939|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0
7668982|NCT00151775|12083940|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0
7668983|NCT00151775|12083941|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0
7668984|NCT00151775|12083930|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7668985|NCT00151775|12083931|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7668986|NCT00151775|12083932|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1
7668987|NCT00151775|12083933|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7668988|NCT00151775|12083934|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7668989|NCT00151775|12083935|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7668990|NCT00151775|12083936|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7668991|NCT00151775|12083937|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7668992|NCT00151775|12083938|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7668993|NCT00151775|12083939|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7668994|NCT00151775|12083940|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7668995|NCT00151775|12083941|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7668996|NCT00151775|12083930|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7668997|NCT00151775|12083931|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7668998|NCT00151775|12083932|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7668999|NCT00151775|12083933|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7669000|NCT00151775|12083934|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7669001|NCT00151775|12083935|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7669002|NCT00151775|12083936|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7669003|NCT00151775|12083937|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7669004|NCT00151775|12083938|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7669005|NCT00151775|12083939|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7669006|NCT00151775|12083940|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7669007|NCT00151775|12083941|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
7669008|NCT00151775|12083930|FG000|Period 4: Open Label|Increased blood pressure|0
7669009|NCT00151775|12083931|FG001|Period 4: Open Label|Increased blood pressure|0
7669010|NCT00151775|12083932|FG002|Period 4: Open Label|Increased blood pressure|0
7669011|NCT00151775|12083933|FG003|Period 4: Open Label|Increased blood pressure|0
7669012|NCT00151775|12083934|FG004|Period 4: Open Label|Increased blood pressure|1
7669013|NCT00151775|12083935|FG005|Period 4: Open Label|Increased blood pressure|0
7669014|NCT00151775|12083936|FG006|Period 4: Open Label|Increased blood pressure|0
7669015|NCT00151775|12083937|FG007|Period 4: Open Label|Increased blood pressure|0
7669016|NCT00151775|12083938|FG008|Period 4: Open Label|Increased blood pressure|0
7669017|NCT00151775|12083939|FG009|Period 4: Open Label|Increased blood pressure|1
7669018|NCT00151775|12083940|FG010|Period 4: Open Label|Increased blood pressure|0
7669019|NCT00151775|12083941|FG011|Period 4: Open Label|Increased blood pressure|0
7669020|NCT00151775|12083930|FG000|Period 4: Open Label|Withdrawal by Subject|0
7669021|NCT00151775|12083931|FG001|Period 4: Open Label|Withdrawal by Subject|0
7669022|NCT00151775|12083932|FG002|Period 4: Open Label|Withdrawal by Subject|0
7669023|NCT00151775|12083933|FG003|Period 4: Open Label|Withdrawal by Subject|0
7669024|NCT00151775|12083934|FG004|Period 4: Open Label|Withdrawal by Subject|5
7669025|NCT00151775|12083935|FG005|Period 4: Open Label|Withdrawal by Subject|0
7669026|NCT00151775|12083936|FG006|Period 4: Open Label|Withdrawal by Subject|0
7669027|NCT00151775|12083937|FG007|Period 4: Open Label|Withdrawal by Subject|0
7669028|NCT00151775|12083938|FG008|Period 4: Open Label|Withdrawal by Subject|0
7669029|NCT00151775|12083939|FG009|Period 4: Open Label|Withdrawal by Subject|2
7669030|NCT00151775|12083940|FG010|Period 4: Open Label|Withdrawal by Subject|0
7669031|NCT00151775|12083941|FG011|Period 4: Open Label|Withdrawal by Subject|0
7669032|NCT00151775|12083930|FG000|Period 4: Open Label|Adverse Event|0
7669033|NCT00151775|12083931|FG001|Period 4: Open Label|Adverse Event|0
7669034|NCT00151775|12083932|FG002|Period 4: Open Label|Adverse Event|0
7669035|NCT00151775|12083933|FG003|Period 4: Open Label|Adverse Event|0
7669036|NCT00151775|12083934|FG004|Period 4: Open Label|Adverse Event|1
7669037|NCT00151775|12083935|FG005|Period 4: Open Label|Adverse Event|0
7669038|NCT00151775|12083936|FG006|Period 4: Open Label|Adverse Event|0
7669039|NCT00151775|12083937|FG007|Period 4: Open Label|Adverse Event|0
7669040|NCT00151775|12083938|FG008|Period 4: Open Label|Adverse Event|0
7669041|NCT00151775|12083939|FG009|Period 4: Open Label|Adverse Event|2
7669042|NCT00151775|12083940|FG010|Period 4: Open Label|Adverse Event|0
7669043|NCT00151775|12083941|FG011|Period 4: Open Label|Adverse Event|0
7669044|NCT00151775|12083930|FG000|Period 4: Open Label|Lost to Follow-up|0
7669045|NCT00151775|12083931|FG001|Period 4: Open Label|Lost to Follow-up|0
7669046|NCT00151775|12083932|FG002|Period 4: Open Label|Lost to Follow-up|0
7669047|NCT00151775|12083933|FG003|Period 4: Open Label|Lost to Follow-up|0
7669048|NCT00151775|12083934|FG004|Period 4: Open Label|Lost to Follow-up|17
7669049|NCT00151775|12083935|FG005|Period 4: Open Label|Lost to Follow-up|0
7669050|NCT00151775|12083936|FG006|Period 4: Open Label|Lost to Follow-up|0
7669051|NCT00151775|12083937|FG007|Period 4: Open Label|Lost to Follow-up|0
7669052|NCT00151775|12083938|FG008|Period 4: Open Label|Lost to Follow-up|0
7669053|NCT00151775|12083939|FG009|Period 4: Open Label|Lost to Follow-up|7
7669054|NCT00151775|12083940|FG010|Period 4: Open Label|Lost to Follow-up|0
7669055|NCT00151775|12083941|FG011|Period 4: Open Label|Lost to Follow-up|0
7669056|NCT00151775|12083930|FG000|Period 4: Open Label|Non-compliance with protocol|0
7669057|NCT00151775|12083931|FG001|Period 4: Open Label|Non-compliance with protocol|0
7669058|NCT00151775|12083932|FG002|Period 4: Open Label|Non-compliance with protocol|0
7669059|NCT00151775|12083933|FG003|Period 4: Open Label|Non-compliance with protocol|0
7669060|NCT00151775|12083934|FG004|Period 4: Open Label|Non-compliance with protocol|4
7669061|NCT00151775|12083935|FG005|Period 4: Open Label|Non-compliance with protocol|0
7669062|NCT00151775|12083936|FG006|Period 4: Open Label|Non-compliance with protocol|0
7669063|NCT00151775|12083937|FG007|Period 4: Open Label|Non-compliance with protocol|0
7669064|NCT00151775|12083938|FG008|Period 4: Open Label|Non-compliance with protocol|0
7669065|NCT00151775|12083939|FG009|Period 4: Open Label|Non-compliance with protocol|4
7669066|NCT00151775|12083940|FG010|Period 4: Open Label|Non-compliance with protocol|0
7669067|NCT00151775|12083941|FG011|Period 4: Open Label|Non-compliance with protocol|0
7669068|NCT00151775|12083930|FG000|Period 4: Open Label|Other|0
7669069|NCT00151775|12083931|FG001|Period 4: Open Label|Other|0
7669070|NCT00151775|12083932|FG002|Period 4: Open Label|Other|0
7669071|NCT00151775|12083933|FG003|Period 4: Open Label|Other|0
7669072|NCT00151775|12083934|FG004|Period 4: Open Label|Other|1
7669073|NCT00151775|12083935|FG005|Period 4: Open Label|Other|0
7669074|NCT00151775|12083936|FG006|Period 4: Open Label|Other|0
7669075|NCT00151775|12083937|FG007|Period 4: Open Label|Other|0
7669076|NCT00151775|12083938|FG008|Period 4: Open Label|Other|0
7669077|NCT00151775|12083939|FG009|Period 4: Open Label|Other|3
7669078|NCT00151775|12083940|FG010|Period 4: Open Label|Other|0
7669079|NCT00151775|12083941|FG011|Period 4: Open Label|Other|0
7669080|NCT00151775|12083930|FG000|Period 4: Open Label|Physician Decision|0
7669081|NCT00151775|12083931|FG001|Period 4: Open Label|Physician Decision|0
7669082|NCT00151775|12083932|FG002|Period 4: Open Label|Physician Decision|0
7669083|NCT00151775|12083933|FG003|Period 4: Open Label|Physician Decision|0
7669084|NCT00151775|12083934|FG004|Period 4: Open Label|Physician Decision|0
7669085|NCT00151775|12083935|FG005|Period 4: Open Label|Physician Decision|0
7669086|NCT00151775|12083936|FG006|Period 4: Open Label|Physician Decision|0
7669087|NCT00151775|12083937|FG007|Period 4: Open Label|Physician Decision|0
7669088|NCT00151775|12083938|FG008|Period 4: Open Label|Physician Decision|0
7669089|NCT00151775|12083939|FG009|Period 4: Open Label|Physician Decision|2
7669090|NCT00151775|12083940|FG010|Period 4: Open Label|Physician Decision|0
7669091|NCT00151775|12083941|FG011|Period 4: Open Label|Physician Decision|0
7669092|NCT00151775|12083930|FG000|Period 4: Open Label|Protocol Violation|0
7669093|NCT00151775|12083931|FG001|Period 4: Open Label|Protocol Violation|0
7669094|NCT00151775|12083932|FG002|Period 4: Open Label|Protocol Violation|0
7669095|NCT00151775|12083933|FG003|Period 4: Open Label|Protocol Violation|0
7669096|NCT00151775|12083934|FG004|Period 4: Open Label|Protocol Violation|1
7669097|NCT00151775|12083935|FG005|Period 4: Open Label|Protocol Violation|0
7669098|NCT00151775|12083936|FG006|Period 4: Open Label|Protocol Violation|0
7669099|NCT00151775|12083937|FG007|Period 4: Open Label|Protocol Violation|0
7669100|NCT00151775|12083938|FG008|Period 4: Open Label|Protocol Violation|0
7669101|NCT00151775|12083939|FG009|Period 4: Open Label|Protocol Violation|0
7669102|NCT00151775|12083940|FG010|Period 4: Open Label|Protocol Violation|0
7669103|NCT00151775|12083941|FG011|Period 4: Open Label|Protocol Violation|0
7669104|NCT00151892|12083996|FG000|Overall Study|Lack of Efficacy|50
7669105|NCT00151892|12083997|FG001|Overall Study|Lack of Efficacy|57
7669106|NCT00151892|12083996|FG000|Overall Study|Patient request|10
7669107|NCT00151892|12083997|FG001|Overall Study|Patient request|7
7669108|NCT00151892|12083996|FG000|Overall Study|Lost to Follow-up|5
7669109|NCT00151892|12083997|FG001|Overall Study|Lost to Follow-up|10
7669110|NCT00151892|12083996|FG000|Overall Study|Adverse Event|6
7669111|NCT00151892|12083997|FG001|Overall Study|Adverse Event|3
7669112|NCT00151892|12083996|FG000|Overall Study|Protocol Violation|3
7669113|NCT00151892|12083997|FG001|Overall Study|Protocol Violation|3
7669114|NCT00151892|12083996|FG000|Overall Study|Non-compliance|0
7669115|NCT00151892|12083997|FG001|Overall Study|Non-compliance|1
7669116|NCT00151892|12083996|FG000|Overall Study|Pregnancy|0
7669117|NCT00151892|12083997|FG001|Overall Study|Pregnancy|1
7669118|NCT00151892|12083996|FG000|Overall Study|Did not return for a visit|1
7669119|NCT00151892|12083997|FG001|Overall Study|Did not return for a visit|0
7669120|NCT00151892|12083996|FG000|Overall Study|Used prohibited corticosteroids|1
7669121|NCT00151892|12083997|FG001|Overall Study|Used prohibited corticosteroids|0
7669122|NCT00151892|12083996|FG000|Overall Study|Lack of study medication at center|0
7669123|NCT00151892|12083997|FG001|Overall Study|Lack of study medication at center|1
7669124|NCT00151996|12084005|FG000|Overall Study|Adverse Event|3
7669125|NCT00151996|12084006|FG001|Overall Study|Adverse Event|2
7669126|NCT00151996|12084005|FG000|Overall Study|Withdrawal by Subject|1
7669127|NCT00151996|12084006|FG001|Overall Study|Withdrawal by Subject|1
7669128|NCT00151996|12084005|FG000|Overall Study|Protocol Violation|1
7669129|NCT00151996|12084006|FG001|Overall Study|Protocol Violation|2
7669130|NCT00151996|12084005|FG000|Overall Study|Sponsor's decision|0
7669131|NCT00151996|12084006|FG001|Overall Study|Sponsor's decision|2
7669132|NCT00152009|12084016|FG000|Overall Study|Adverse Event|9
7669133|NCT00152009|12084017|FG001|Overall Study|Adverse Event|13
7669134|NCT00152009|12084018|FG002|Overall Study|Adverse Event|20
7669135|NCT00152009|12084019|FG003|Overall Study|Adverse Event|1
7669136|NCT00152009|12084016|FG000|Overall Study|Protocol Violation|3
7669137|NCT00152009|12084017|FG001|Overall Study|Protocol Violation|0
7669138|NCT00152009|12084018|FG002|Overall Study|Protocol Violation|0
7669139|NCT00152009|12084019|FG003|Overall Study|Protocol Violation|1
7669140|NCT00152009|12084016|FG000|Overall Study|Withdrawal by Subject|2
7669141|NCT00152009|12084017|FG001|Overall Study|Withdrawal by Subject|3
7669142|NCT00152009|12084018|FG002|Overall Study|Withdrawal by Subject|4
7669143|NCT00152009|12084019|FG003|Overall Study|Withdrawal by Subject|9
7669144|NCT00152009|12084016|FG000|Overall Study|Lost to Follow-up|2
7669145|NCT00152009|12084017|FG001|Overall Study|Lost to Follow-up|4
7669146|NCT00152009|12084018|FG002|Overall Study|Lost to Follow-up|3
7669147|NCT00152009|12084019|FG003|Overall Study|Lost to Follow-up|3
7669148|NCT00152009|12084016|FG000|Overall Study|Lack of Efficacy|8
7669149|NCT00152009|12084017|FG001|Overall Study|Lack of Efficacy|6
7669150|NCT00152009|12084018|FG002|Overall Study|Lack of Efficacy|7
7669151|NCT00152009|12084019|FG003|Overall Study|Lack of Efficacy|15
7669152|NCT00152009|12084016|FG000|Overall Study|ECG abnormalities|2
7669153|NCT00152009|12084017|FG001|Overall Study|ECG abnormalities|2
7669154|NCT00152009|12084018|FG002|Overall Study|ECG abnormalities|2
7669155|NCT00152009|12084019|FG003|Overall Study|ECG abnormalities|1
7669156|NCT00152009|12084016|FG000|Overall Study|Sponsor's decision|3
7669157|NCT00152009|12084017|FG001|Overall Study|Sponsor's decision|3
7669158|NCT00152009|12084018|FG002|Overall Study|Sponsor's decision|1
7669159|NCT00152009|12084019|FG003|Overall Study|Sponsor's decision|3
7669160|NCT00152464|12084031|FG000|Overall Study|Adverse Event|3
7669161|NCT00152464|12084032|FG001|Overall Study|Adverse Event|6
7669162|NCT00152464|12084031|FG000|Overall Study|Lost to Follow-up|8
7669163|NCT00152464|12084032|FG001|Overall Study|Lost to Follow-up|4
7669164|NCT00152464|12084031|FG000|Overall Study|Protocol Violation|3
7669165|NCT00152464|12084032|FG001|Overall Study|Protocol Violation|1
7669166|NCT00152464|12084031|FG000|Overall Study|Withdrawal by Subject|21
7669167|NCT00152464|12084032|FG001|Overall Study|Withdrawal by Subject|22
7669168|NCT00152464|12084031|FG000|Overall Study|Atopic dermatitis poorly controlled|0
7669169|NCT00152464|12084032|FG001|Overall Study|Atopic dermatitis poorly controlled|1
7669170|NCT00152464|12084031|FG000|Overall Study|Eczema deterioration|0
7669171|NCT00152464|12084032|FG001|Overall Study|Eczema deterioration|1
7669172|NCT00152464|12084031|FG000|Overall Study|Parent decision|1
7669173|NCT00152464|12084032|FG001|Overall Study|Parent decision|1
7669174|NCT00152464|12084031|FG000|Overall Study|Investigator decision|1
7669175|NCT00152464|12084032|FG001|Overall Study|Investigator decision|0
7669176|NCT00152464|12084031|FG000|Overall Study|Lack of Efficacy|1
7669177|NCT00152464|12084032|FG001|Overall Study|Lack of Efficacy|0
7669178|NCT00152464|12084031|FG000|Overall Study|Eczema poorly controlled|1
7669179|NCT00152464|12084032|FG001|Overall Study|Eczema poorly controlled|0
7669180|NCT00152464|12084031|FG000|Overall Study|Patient relocated|1
7669181|NCT00152464|12084032|FG001|Overall Study|Patient relocated|0
7669182|NCT00152516|12084038|FG000|Overall Study|Adverse Event|18
7669183|NCT00152516|12084038|FG000|Overall Study|Lack and Loss of Efficacy|30
7669184|NCT00152516|12084038|FG000|Overall Study|Lost to Follow-up|5
7669185|NCT00152516|12084038|FG000|Overall Study|Withdrawal by Subject|8
7669186|NCT00152516|12084038|FG000|Overall Study|Protocol Violation|3
7669187|NCT00152516|12084038|FG000|Overall Study|Other: Mother Refused To Cooperate|1
7669188|NCT00152516|12084038|FG000|Overall Study|Other: Given Commercial Drug in Error|2
7669189|NCT00152516|12084038|FG000|Overall Study|Other: Parents Withdrew Consent|2
7669190|NCT00152516|12084038|FG000|Overall Study|Other: Non-Compliance|2
7669191|NCT00152516|12084038|FG000|Overall Study|Other: Primary Care Physician's Decision|1
7669192|NCT00152516|12084038|FG000|Overall Study|Other: Moved Out Of State|1
7669193|NCT00152516|12084038|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1
7669194|NCT00152516|12084038|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
7669195|NCT00152763|12084046|FG000|Overall Study|Death|4
7669196|NCT00152763|12084047|FG001|Overall Study|Death|1
7669197|NCT00152763|12084048|FG002|Overall Study|Death|2
7669198|NCT00152763|12084049|FG003|Overall Study|Death|1
7669199|NCT00152763|12084046|FG000|Overall Study|Lost to Follow-up|6
7669200|NCT00152763|12084047|FG001|Overall Study|Lost to Follow-up|4
7669201|NCT00152763|12084048|FG002|Overall Study|Lost to Follow-up|2
7669202|NCT00152763|12084049|FG003|Overall Study|Lost to Follow-up|13
7669203|NCT00152971|12084064|FG000|Overall Study|Adverse Event|12
7669204|NCT00152971|12084065|FG001|Overall Study|Adverse Event|10
7669205|NCT00152971|12084066|FG002|Overall Study|Adverse Event|9
7669206|NCT00152971|12084064|FG000|Overall Study|Protocol Violation|10
7669207|NCT00152971|12084065|FG001|Overall Study|Protocol Violation|11
7669208|NCT00152971|12084066|FG002|Overall Study|Protocol Violation|8
7669209|NCT00152971|12084064|FG000|Overall Study|Lost to Follow-up|17
7669210|NCT00152971|12084065|FG001|Overall Study|Lost to Follow-up|14
7669211|NCT00152971|12084066|FG002|Overall Study|Lost to Follow-up|13
7669212|NCT00152971|12084064|FG000|Overall Study|Withdrawal by Subject|9
7669213|NCT00152971|12084065|FG001|Overall Study|Withdrawal by Subject|8
7669214|NCT00152971|12084066|FG002|Overall Study|Withdrawal by Subject|14
7669215|NCT00152971|12084064|FG000|Overall Study|Other|3
7669216|NCT00152971|12084065|FG001|Overall Study|Other|5
7669217|NCT00152971|12084066|FG002|Overall Study|Other|5
7669218|NCT00152971|12084064|FG000|Treatment|Adverse Event|49
7669219|NCT00152971|12084065|FG001|Treatment|Adverse Event|40
7669220|NCT00152971|12084066|FG002|Treatment|Adverse Event|54
7669221|NCT00152971|12084064|FG000|Treatment|Protocol Violation|8
7669222|NCT00152971|12084065|FG001|Treatment|Protocol Violation|6
7669223|NCT00152971|12084066|FG002|Treatment|Protocol Violation|10
7669224|NCT00152971|12084064|FG000|Treatment|Lost to Follow-up|1
7669225|NCT00152971|12084065|FG001|Treatment|Lost to Follow-up|2
7669226|NCT00152971|12084066|FG002|Treatment|Lost to Follow-up|1
7669227|NCT00152971|12084064|FG000|Treatment|Withdrawal by Subject|4
7669228|NCT00152971|12084065|FG001|Treatment|Withdrawal by Subject|4
7669229|NCT00152971|12084066|FG002|Treatment|Withdrawal by Subject|5
7669230|NCT00152971|12084064|FG000|Treatment|Other|9
7669231|NCT00152971|12084065|FG001|Treatment|Other|11
7669232|NCT00152971|12084066|FG002|Treatment|Other|10
7669233|NCT00153062|12084078|FG000|Overall Study|Death|360
7669234|NCT00153062|12084079|FG001|Overall Study|Death|352
7669235|NCT00153062|12084080|FG002|Overall Study|Death|369
7669236|NCT00153062|12084081|FG003|Overall Study|Death|365
7669237|NCT00153062|12084078|FG000|Overall Study|Withdrawal by Subject|14
7669238|NCT00153062|12084079|FG001|Overall Study|Withdrawal by Subject|30
7669239|NCT00153062|12084080|FG002|Overall Study|Withdrawal by Subject|27
7669240|NCT00153062|12084081|FG003|Overall Study|Withdrawal by Subject|28
7669241|NCT00153062|12084078|FG000|Overall Study|Lost to Follow-up|12
7669242|NCT00153062|12084079|FG001|Overall Study|Lost to Follow-up|20
7669243|NCT00153062|12084080|FG002|Overall Study|Lost to Follow-up|15
7669244|NCT00153062|12084081|FG003|Overall Study|Lost to Follow-up|16
7669245|NCT00153062|12084078|FG000|Overall Study|Adverse Event|0
7669246|NCT00153062|12084079|FG001|Overall Study|Adverse Event|1
7669247|NCT00153062|12084080|FG002|Overall Study|Adverse Event|1
7669248|NCT00153062|12084081|FG003|Overall Study|Adverse Event|0
7669249|NCT00153062|12084078|FG000|Overall Study|Protocol Violation|0
7669250|NCT00153062|12084079|FG001|Overall Study|Protocol Violation|2
7669251|NCT00153062|12084080|FG002|Overall Study|Protocol Violation|1
7669252|NCT00153062|12084081|FG003|Overall Study|Protocol Violation|1
7669253|NCT00153062|12084078|FG000|Overall Study|No disposition data available|1
7669254|NCT00153062|12084079|FG001|Overall Study|No disposition data available|1
7669255|NCT00153062|12084080|FG002|Overall Study|No disposition data available|1
7669256|NCT00153062|12084081|FG003|Overall Study|No disposition data available|1
7669257|NCT00153062|12084078|FG000|Overall Study|Other|0
7669258|NCT00153062|12084079|FG001|Overall Study|Other|0
7669259|NCT00153062|12084080|FG002|Overall Study|Other|1
7669260|NCT00153062|12084081|FG003|Overall Study|Other|0
7669261|NCT00153101|12084096|FG000|Overall Study|Lost to Follow-up|14
7669262|NCT00153101|12084097|FG001|Overall Study|Lost to Follow-up|14
7669263|NCT00153101|12084098|FG002|Overall Study|Lost to Follow-up|12
7669264|NCT00153101|12084099|FG003|Overall Study|Lost to Follow-up|5
7669265|NCT00153101|12084100|FG004|Overall Study|Lost to Follow-up|5
7669266|NCT00153101|12084096|FG000|Overall Study|Withdrawal by Subject|3
7669267|NCT00153101|12084097|FG001|Overall Study|Withdrawal by Subject|4
7669268|NCT00153101|12084098|FG002|Overall Study|Withdrawal by Subject|3
7669269|NCT00153101|12084099|FG003|Overall Study|Withdrawal by Subject|3
7669270|NCT00153101|12084100|FG004|Overall Study|Withdrawal by Subject|5
7669271|NCT00153179|12084130|FG000|Study Visit Day 2|Withdrawal by Subject|1
7669272|NCT00153179|12084131|FG001|Study Visit Day 2|Withdrawal by Subject|0
7669273|NCT00153179|12084132|FG002|Study Visit Day 2|Withdrawal by Subject|2
7669274|NCT00153179|12084133|FG003|Study Visit Day 2|Withdrawal by Subject|2
7669275|NCT00153816|12084159|FG000|Overall Study|Death|6
7669276|NCT00153816|12084160|FG001|Overall Study|Death|5
7669277|NCT00153816|12084161|FG002|Overall Study|Death|4
7669278|NCT00153816|12084162|FG003|Overall Study|Death|6
7669279|NCT00153816|12084163|FG004|Overall Study|Death|0
7669280|NCT00153816|12084164|FG005|Overall Study|Death|2
7669281|NCT00153816|12084159|FG000|Overall Study|Lost to Follow-up|7
7669282|NCT00153816|12084160|FG001|Overall Study|Lost to Follow-up|8
7669283|NCT00153816|12084161|FG002|Overall Study|Lost to Follow-up|5
7669284|NCT00153816|12084162|FG003|Overall Study|Lost to Follow-up|8
7669285|NCT00153816|12084163|FG004|Overall Study|Lost to Follow-up|7
7669286|NCT00153816|12084164|FG005|Overall Study|Lost to Follow-up|9
7669287|NCT00153816|12084159|FG000|Overall Study|Withdrawal by Subject|9
7669288|NCT00153816|12084160|FG001|Overall Study|Withdrawal by Subject|9
7669289|NCT00153816|12084161|FG002|Overall Study|Withdrawal by Subject|9
7669290|NCT00153816|12084162|FG003|Overall Study|Withdrawal by Subject|4
7669291|NCT00153816|12084163|FG004|Overall Study|Withdrawal by Subject|1
7669292|NCT00153816|12084164|FG005|Overall Study|Withdrawal by Subject|5
7669293|NCT00153816|12084159|FG000|Overall Study|Follow-up exam not done|8
7669294|NCT00153816|12084160|FG001|Overall Study|Follow-up exam not done|7
7669295|NCT00153816|12084161|FG002|Overall Study|Follow-up exam not done|11
7669296|NCT00153816|12084162|FG003|Overall Study|Follow-up exam not done|10
7669297|NCT00153816|12084163|FG004|Overall Study|Follow-up exam not done|8
7669298|NCT00153816|12084164|FG005|Overall Study|Follow-up exam not done|9
7669299|NCT00153816|12084159|FG000|Overall Study|Follow-up exam done, histology missing|2
7669300|NCT00153816|12084160|FG001|Overall Study|Follow-up exam done, histology missing|3
7669301|NCT00153816|12084161|FG002|Overall Study|Follow-up exam done, histology missing|3
7669302|NCT00153816|12084162|FG003|Overall Study|Follow-up exam done, histology missing|3
7669303|NCT00153816|12084163|FG004|Overall Study|Follow-up exam done, histology missing|1
7669304|NCT00153816|12084164|FG005|Overall Study|Follow-up exam done, histology missing|2
7669305|NCT00153920|12084189|FG000|Overall Study|Adverse Event|9
7669306|NCT00153920|12084189|FG000|Overall Study|Progressive Disease|9
7669307|NCT00153920|12084189|FG000|Overall Study|Physician Decision|3
7669308|NCT00153920|12084189|FG000|Overall Study|Lack of Response|3
7669309|NCT00153920|12084189|FG000|Overall Study|Death|2
7669310|NCT00153920|12084189|FG000|Overall Study|Withdrawal by Subject|1
7669311|NCT00153920|12084189|FG000|Overall Study|Non-Protocol Therapy|1
7669312|NCT00153920|12084189|FG000|Overall Study|Withdrawal of Consent before Trt|1
7669313|NCT00153920|12084189|FG000|Overall Study|Progressive Disease before Trt|1
7669314|NCT00154063|12084199|FG000|Overall Study|Adverse Event|4
7669315|NCT00154063|12084200|FG001|Overall Study|Adverse Event|8
7669316|NCT00154063|12084199|FG000|Overall Study|Protocol Violation|1
7669317|NCT00154063|12084200|FG001|Overall Study|Protocol Violation|1
7669318|NCT00154063|12084199|FG000|Overall Study|Investigator or Sponsor Request|0
7669319|NCT00154063|12084200|FG001|Overall Study|Investigator or Sponsor Request|1
7669320|NCT00154063|12084199|FG000|Overall Study|Withdrawal by Subject|4
7669321|NCT00154063|12084200|FG001|Overall Study|Withdrawal by Subject|9
7669322|NCT00154063|12084199|FG000|Overall Study|Other|3
7669323|NCT00154063|12084200|FG001|Overall Study|Other|3
7669324|NCT00154102|12084212|FG000|Overall Study|investigational study phase ongoing|7
7669325|NCT00154102|12084213|FG001|Overall Study|investigational study phase ongoing|2
7669326|NCT00154284|12084221|FG000|Overall Study|Adverse Event|6
7669327|NCT00154284|12084222|FG001|Overall Study|Adverse Event|9
7669328|NCT00154284|12084221|FG000|Overall Study|Abnormal laboratory value(s)|0
7669329|NCT00154284|12084222|FG001|Overall Study|Abnormal laboratory value(s)|1
7669330|NCT00154284|12084221|FG000|Overall Study|Lack of Efficacy|1
7669331|NCT00154284|12084222|FG001|Overall Study|Lack of Efficacy|2
7669332|NCT00154284|12084221|FG000|Overall Study|Protocol Violation|0
7669333|NCT00154284|12084222|FG001|Overall Study|Protocol Violation|1
7669334|NCT00154297|12084232|FG000|Overall Study|Death|5
7669335|NCT00154297|12084233|FG001|Overall Study|Death|2
7669336|NCT00154297|12084232|FG000|Overall Study|Withdrawal by Subject|0
7669337|NCT00154297|12084233|FG001|Overall Study|Withdrawal by Subject|5
7669338|NCT00154297|12084232|FG000|Overall Study|Lost to Follow-up|3
7669339|NCT00154297|12084233|FG001|Overall Study|Lost to Follow-up|0
7669340|NCT00154310|12084241|FG000|Overall Study|Adverse Event|19
7669341|NCT00154310|12084242|FG001|Overall Study|Adverse Event|9
7669342|NCT00154310|12084241|FG000|Overall Study|Lack of Efficacy|5
7669343|NCT00154310|12084242|FG001|Overall Study|Lack of Efficacy|4
7669344|NCT00154310|12084241|FG000|Overall Study|Protocol Violation|4
7669345|NCT00154310|12084242|FG001|Overall Study|Protocol Violation|2
7669346|NCT00154310|12084241|FG000|Overall Study|Withdrawal by Subject|9
7669347|NCT00154310|12084242|FG001|Overall Study|Withdrawal by Subject|3
7669348|NCT00154310|12084241|FG000|Overall Study|Lost to Follow-up|0
7669349|NCT00154310|12084242|FG001|Overall Study|Lost to Follow-up|8
7669350|NCT00154310|12084241|FG000|Overall Study|Administrative problems|0
7669351|NCT00154310|12084242|FG001|Overall Study|Administrative problems|1
7669352|NCT00154310|12084241|FG000|Overall Study|Death|0
7669353|NCT00154310|12084242|FG001|Overall Study|Death|1
7669354|NCT00154375|12084250|FG000|Overall Study|Unsatisfactory therapeutic effect|25
7669355|NCT00154375|12084251|FG001|Overall Study|Unsatisfactory therapeutic effect|26
7669356|NCT00154375|12084250|FG000|Overall Study|Adverse Event|18
7669357|NCT00154375|12084251|FG001|Overall Study|Adverse Event|20
7669358|NCT00154375|12084250|FG000|Overall Study|Withdrawal by Subject|14
7669359|NCT00154375|12084251|FG001|Overall Study|Withdrawal by Subject|10
7669360|NCT00154375|12084250|FG000|Overall Study|Death|5
7669361|NCT00154375|12084251|FG001|Overall Study|Death|13
7669362|NCT00154375|12084250|FG000|Overall Study|Study drug no longer required|5
7669363|NCT00154375|12084251|FG001|Overall Study|Study drug no longer required|3
7669364|NCT00154375|12084250|FG000|Overall Study|Lost to Follow-up|2
7669365|NCT00154375|12084251|FG001|Overall Study|Lost to Follow-up|1
7669366|NCT00154375|12084250|FG000|Overall Study|Abnormal laboratory value(s)|0
7669367|NCT00154375|12084251|FG001|Overall Study|Abnormal laboratory value(s)|2
7669368|NCT00154375|12084250|FG000|Overall Study|Protocol Violation|0
7669369|NCT00154375|12084251|FG001|Overall Study|Protocol Violation|1
7669370|NCT00154375|12084250|FG000|Overall Study|Suspected progression of disease|44
7669371|NCT00154375|12084251|FG001|Overall Study|Suspected progression of disease|30
7669372|NCT00156533|12084297|FG000|Overall Study|Withdrawn - Medication Expiration|0
7669373|NCT00156533|12084298|FG001|Overall Study|Withdrawn - Medication Expiration|2
7669374|NCT00156533|12084299|FG002|Overall Study|Withdrawn - Medication Expiration|1
7669375|NCT00156533|12084300|FG003|Overall Study|Withdrawn - Medication Expiration|0
7669376|NCT00156533|12084297|FG000|Overall Study|Withdrawal by Subject|1
7669377|NCT00156533|12084298|FG001|Overall Study|Withdrawal by Subject|0
7669378|NCT00156533|12084299|FG002|Overall Study|Withdrawal by Subject|0
7669379|NCT00156533|12084300|FG003|Overall Study|Withdrawal by Subject|1
7669380|NCT00156533|12084297|FG000|Overall Study|Failed Screening|1
7669381|NCT00156533|12084298|FG001|Overall Study|Failed Screening|0
7669382|NCT00156533|12084299|FG002|Overall Study|Failed Screening|1
7669383|NCT00156533|12084300|FG003|Overall Study|Failed Screening|1
7669384|NCT00156819|12084319|FG000|Overall Study|Lost to Follow-up|1
7669385|NCT00156819|12084320|FG001|Overall Study|Lost to Follow-up|1
7669386|NCT00156819|12084321|FG002|Overall Study|Lost to Follow-up|3
7669387|NCT00157014|12084360|FG000|Overall Study|Death|4
7669388|NCT00157014|12084361|FG001|Overall Study|Death|2
7669389|NCT00157014|12084362|FG002|Overall Study|Death|1
7669390|NCT00157014|12084363|FG003|Overall Study|Death|1
7669391|NCT00157014|12084360|FG000|Overall Study|Physician Decision|0
7669392|NCT00157014|12084361|FG001|Overall Study|Physician Decision|1
7669393|NCT00157014|12084362|FG002|Overall Study|Physician Decision|0
7669394|NCT00157014|12084363|FG003|Overall Study|Physician Decision|0
7669395|NCT00157014|12084360|FG000|Overall Study|Medications withdrawn on family request|0
7669396|NCT00157014|12084361|FG001|Overall Study|Medications withdrawn on family request|1
7669397|NCT00157014|12084362|FG002|Overall Study|Medications withdrawn on family request|0
7669398|NCT00157014|12084363|FG003|Overall Study|Medications withdrawn on family request|0
7669399|NCT00157014|12084360|FG000|Overall Study|Patient withdrawn by investigator|1
7669400|NCT00157014|12084361|FG001|Overall Study|Patient withdrawn by investigator|0
7669401|NCT00157014|12084362|FG002|Overall Study|Patient withdrawn by investigator|0
7669402|NCT00157014|12084363|FG003|Overall Study|Patient withdrawn by investigator|0
7669403|NCT00157014|12084360|FG000|Overall Study|Patient unable to return in nursing home|1
7669404|NCT00157014|12084361|FG001|Overall Study|Patient unable to return in nursing home|0
7669405|NCT00157014|12084362|FG002|Overall Study|Patient unable to return in nursing home|0
7669406|NCT00157014|12084363|FG003|Overall Study|Patient unable to return in nursing home|0
7669407|NCT00157014|12084360|FG000|Overall Study|Patient would not receive transplant|0
7669408|NCT00157014|12084361|FG001|Overall Study|Patient would not receive transplant|1
7669409|NCT00157014|12084362|FG002|Overall Study|Patient would not receive transplant|0
7669410|NCT00157014|12084363|FG003|Overall Study|Patient would not receive transplant|0
7669411|NCT00157014|12084360|FG000|Overall Study|Withdrawal by Subject|1
7669412|NCT00157014|12084361|FG001|Overall Study|Withdrawal by Subject|0
7669413|NCT00157014|12084362|FG002|Overall Study|Withdrawal by Subject|0
7669414|NCT00157014|12084363|FG003|Overall Study|Withdrawal by Subject|0
7669415|NCT00157157|12084373|FG000|Overall Study|Withdrawal by Subject|6
7669416|NCT00157157|12084373|FG000|Overall Study|Physician Decision|1
7669417|NCT00157157|12084373|FG000|Overall Study|Lost to Follow-up|1
7669418|NCT00157157|12084373|FG000|Overall Study|Enrolled in another study|1
7669419|NCT00157157|12084373|FG000|Overall Study|Met exclusion criteria|1
7669420|NCT00157157|12084373|FG000|Overall Study|Inclusion not met- baseline FVIII value|1
7669421|NCT00157196|12084384|FG000|Overall Study|Ongoing at data cut-off|9
7669422|NCT00157209|12084390|FG000|Overall Study|Ongoing at data cut-off|10
7669423|NCT00157209|12084391|FG001|Overall Study|Ongoing at data cut-off|0
7669424|NCT00157248|12084401|FG000|Overall Study|Adverse Event|36
7669425|NCT00157248|12084402|FG001|Overall Study|Adverse Event|25
7669426|NCT00157248|12084403|FG002|Overall Study|Adverse Event|13
7669427|NCT00157248|12084404|FG003|Overall Study|Adverse Event|33
7669428|NCT00157248|12084401|FG000|Overall Study|Protocol Violation|4
7669429|NCT00157248|12084402|FG001|Overall Study|Protocol Violation|0
7669430|NCT00157248|12084403|FG002|Overall Study|Protocol Violation|2
7669431|NCT00157248|12084404|FG003|Overall Study|Protocol Violation|2
7669432|NCT00157248|12084401|FG000|Overall Study|Lost to Follow-up|0
7669433|NCT00157248|12084402|FG001|Overall Study|Lost to Follow-up|1
7669434|NCT00157248|12084403|FG002|Overall Study|Lost to Follow-up|0
7669435|NCT00157248|12084404|FG003|Overall Study|Lost to Follow-up|0
7669436|NCT00157248|12084401|FG000|Overall Study|Withdrawal by Subject|1
7669437|NCT00157248|12084402|FG001|Overall Study|Withdrawal by Subject|4
7669438|NCT00157248|12084403|FG002|Overall Study|Withdrawal by Subject|3
7669439|NCT00157248|12084404|FG003|Overall Study|Withdrawal by Subject|3
7669440|NCT00157248|12084401|FG000|Overall Study|site closures, subject moving|7
7669441|NCT00157248|12084402|FG001|Overall Study|site closures, subject moving|7
7669442|NCT00157248|12084403|FG002|Overall Study|site closures, subject moving|3
7669443|NCT00157248|12084404|FG003|Overall Study|site closures, subject moving|9
7669444|NCT00157755|12084426|FG000|Overall Study|Death|2
7669445|NCT00157755|12084427|FG001|Overall Study|Death|3
7669446|NCT00157755|12084428|FG002|Overall Study|Death|3
7669447|NCT00157755|12084429|FG003|Overall Study|Death|2
7669448|NCT00157755|12084430|FG004|Overall Study|Death|0
7669449|NCT00157755|12084431|FG005|Overall Study|Death|0
7669450|NCT00157755|12084426|FG000|Overall Study|Lost to Follow-up|0
7669451|NCT00157755|12084427|FG001|Overall Study|Lost to Follow-up|0
7669452|NCT00157755|12084428|FG002|Overall Study|Lost to Follow-up|1
7669453|NCT00157755|12084429|FG003|Overall Study|Lost to Follow-up|0
7669454|NCT00157755|12084430|FG004|Overall Study|Lost to Follow-up|0
7669455|NCT00157755|12084431|FG005|Overall Study|Lost to Follow-up|0
7669456|NCT00157755|12084426|FG000|Overall Study|Withdrawal by Subject|0
7669457|NCT00157755|12084427|FG001|Overall Study|Withdrawal by Subject|0
7669458|NCT00157755|12084428|FG002|Overall Study|Withdrawal by Subject|1
7669459|NCT00157755|12084429|FG003|Overall Study|Withdrawal by Subject|1
7669460|NCT00157755|12084430|FG004|Overall Study|Withdrawal by Subject|1
7669461|NCT00157755|12084431|FG005|Overall Study|Withdrawal by Subject|2
7669462|NCT00157755|12084426|FG000|Overall Study|Explant due to infection|0
7669463|NCT00157755|12084427|FG001|Overall Study|Explant due to infection|0
7669464|NCT00157755|12084428|FG002|Overall Study|Explant due to infection|1
7669465|NCT00157755|12084429|FG003|Overall Study|Explant due to infection|0
7669466|NCT00157755|12084430|FG004|Overall Study|Explant due to infection|0
7669467|NCT00157755|12084431|FG005|Overall Study|Explant due to infection|0
7669468|NCT00157755|12084426|FG000|Overall Study|Medical reason|0
7669469|NCT00157755|12084427|FG001|Overall Study|Medical reason|0
7669470|NCT00157755|12084428|FG002|Overall Study|Medical reason|1
7669471|NCT00157755|12084429|FG003|Overall Study|Medical reason|1
7669472|NCT00157755|12084430|FG004|Overall Study|Medical reason|0
7669473|NCT00157755|12084431|FG005|Overall Study|Medical reason|0
7669474|NCT00157755|12084426|FG000|Overall Study|Study site closure|0
7669475|NCT00157755|12084427|FG001|Overall Study|Study site closure|1
7669476|NCT00157755|12084428|FG002|Overall Study|Study site closure|0
7669477|NCT00157755|12084429|FG003|Overall Study|Study site closure|0
7669478|NCT00157755|12084430|FG004|Overall Study|Study site closure|0
7669479|NCT00157755|12084431|FG005|Overall Study|Study site closure|0
7669480|NCT00157755|12084426|FG000|Overall Study|Subject non-compliance|0
7669481|NCT00157755|12084427|FG001|Overall Study|Subject non-compliance|0
7669482|NCT00157755|12084428|FG002|Overall Study|Subject non-compliance|0
7669483|NCT00157755|12084429|FG003|Overall Study|Subject non-compliance|0
7669484|NCT00157755|12084430|FG004|Overall Study|Subject non-compliance|0
7669485|NCT00157755|12084431|FG005|Overall Study|Subject non-compliance|1
7669486|NCT00157755|12084426|FG000|Overall Study|Study completion|0
7669487|NCT00157755|12084427|FG001|Overall Study|Study completion|0
7669488|NCT00157755|12084428|FG002|Overall Study|Study completion|0
7669489|NCT00157755|12084429|FG003|Overall Study|Study completion|0
7669490|NCT00157755|12084430|FG004|Overall Study|Study completion|1
7669491|NCT00157755|12084431|FG005|Overall Study|Study completion|2
7669492|NCT00157820|12084440|FG000|Randomized|Physician Decision|4
7669493|NCT00157820|12084441|FG001|Randomized|Physician Decision|2
7669494|NCT00157820|12084442|FG002|Randomized|Physician Decision|3
7669495|NCT00157820|12084440|FG000|Randomized|Withdrawal by Subject|1
7669496|NCT00157820|12084441|FG001|Randomized|Withdrawal by Subject|2
7669497|NCT00157820|12084442|FG002|Randomized|Withdrawal by Subject|3
7669498|NCT00157820|12084440|FG000|Randomized|Protocol Violation|2
7669499|NCT00157820|12084441|FG001|Randomized|Protocol Violation|1
7669500|NCT00157820|12084442|FG002|Randomized|Protocol Violation|2
7669501|NCT00157820|12084440|FG000|1st 8 Month|Death|7
7669502|NCT00157820|12084441|FG001|1st 8 Month|Death|8
7669503|NCT00157820|12084442|FG002|1st 8 Month|Death|3
7669504|NCT00157820|12084440|FG000|1st 8 Month|Lost to Follow-up|1
7669505|NCT00157820|12084441|FG001|1st 8 Month|Lost to Follow-up|2
7669506|NCT00157820|12084442|FG002|1st 8 Month|Lost to Follow-up|1
7669507|NCT00157820|12084440|FG000|1st 8 Month|Premature cross-over|0
7669508|NCT00157820|12084441|FG001|1st 8 Month|Premature cross-over|2
7669509|NCT00157820|12084442|FG002|1st 8 Month|Premature cross-over|2
7669510|NCT00157820|12084440|FG000|2nd 8 Months|Death|3
7669511|NCT00157820|12084441|FG001|2nd 8 Months|Death|1
7669512|NCT00157820|12084442|FG002|2nd 8 Months|Death|3
7669513|NCT00157820|12084440|FG000|2nd 8 Months|Lost to Follow-up|1
7669514|NCT00157820|12084441|FG001|2nd 8 Months|Lost to Follow-up|5
7669515|NCT00157820|12084442|FG002|2nd 8 Months|Lost to Follow-up|2
7669516|NCT00157820|12084440|FG000|2nd 8 Months|Premature cross-over|1
7669517|NCT00157820|12084441|FG001|2nd 8 Months|Premature cross-over|7
7669518|NCT00157820|12084442|FG002|2nd 8 Months|Premature cross-over|9
7669519|NCT00157950|12084453|FG000|Overall Study|Death|1
7669520|NCT00157950|12084454|FG001|Overall Study|Death|0
7669521|NCT00158054|12084462|FG000|Overall Study|Refused to continue|3
7669522|NCT00158054|12084463|FG001|Overall Study|Refused to continue|0
7669523|NCT00158054|12084462|FG000|Overall Study|Unavailable for follow up|7
7669524|NCT00158054|12084463|FG001|Overall Study|Unavailable for follow up|3
7669525|NCT00158184|12084471|FG000|Overall Study|personal issues|3
7669526|NCT00158184|12084472|FG001|Overall Study|personal issues|1
7669527|NCT00158184|12084471|FG000|Overall Study|failed for follow unit/study rules|2
7669528|NCT00158184|12084472|FG001|Overall Study|failed for follow unit/study rules|0
7669529|NCT00158184|12084471|FG000|Overall Study|Adverse Event|1
7669530|NCT00158184|12084472|FG001|Overall Study|Adverse Event|1
7669531|NCT00158262|12084517|FG000|Overall Study|Lost to Follow-up|1
7669532|NCT00158262|12084518|FG001|Overall Study|Lost to Follow-up|1
7669533|NCT00158600|12084530|FG000|Overall Study|unable to commit time to study|0
7669534|NCT00158600|12084531|FG001|Overall Study|unable to commit time to study|1
7669535|NCT00158600|12084530|FG000|Overall Study|Adverse Event|2
7669536|NCT00158600|12084531|FG001|Overall Study|Adverse Event|1
7669537|NCT00158600|12084530|FG000|Overall Study|Death|1
7669538|NCT00158600|12084531|FG001|Overall Study|Death|0
7669539|NCT00158600|12084530|FG000|Overall Study|Withdrawal by Subject|2
7669540|NCT00158600|12084531|FG001|Overall Study|Withdrawal by Subject|2
7669541|NCT00158756|12084552|FG000|Overall Study|Withdrawal by Subject|5
7669542|NCT00158756|12084553|FG001|Overall Study|Withdrawal by Subject|0
7669543|NCT00158756|12084554|FG002|Overall Study|Withdrawal by Subject|6
7669544|NCT00158756|12084555|FG003|Overall Study|Withdrawal by Subject|1
7669545|NCT00158756|12084556|FG004|Overall Study|Withdrawal by Subject|3
7669546|NCT00158756|12084552|FG000|Overall Study|Adverse Event|0
7669547|NCT00158756|12084553|FG001|Overall Study|Adverse Event|0
7669548|NCT00158756|12084554|FG002|Overall Study|Adverse Event|1
7669549|NCT00158756|12084555|FG003|Overall Study|Adverse Event|0
7669550|NCT00158756|12084556|FG004|Overall Study|Adverse Event|0
7669551|NCT00158756|12084552|FG000|Overall Study|Serious adverse event|0
7669552|NCT00158756|12084553|FG001|Overall Study|Serious adverse event|0
7669553|NCT00158756|12084554|FG002|Overall Study|Serious adverse event|1
7669554|NCT00158756|12084555|FG003|Overall Study|Serious adverse event|0
7669555|NCT00158756|12084556|FG004|Overall Study|Serious adverse event|0
7669556|NCT00158860|12084570|FG000|Overall Study|Adverse Event|3
7669557|NCT00158860|12084571|FG001|Overall Study|Adverse Event|6
7669558|NCT00158860|12084570|FG000|Overall Study|Lost to Follow-up|11
7669559|NCT00158860|12084571|FG001|Overall Study|Lost to Follow-up|17
7669560|NCT00158860|12084570|FG000|Overall Study|Protocol Violation|8
7669561|NCT00158860|12084571|FG001|Overall Study|Protocol Violation|23
7669562|NCT00158860|12084570|FG000|Overall Study|Withdrawal by Subject|7
7669563|NCT00158860|12084571|FG001|Overall Study|Withdrawal by Subject|17
7669564|NCT00158860|12084570|FG000|Overall Study|MOVING OUT OF STATE|1
7669565|NCT00158860|12084571|FG001|Overall Study|MOVING OUT OF STATE|0
7669566|NCT00158860|12084570|FG000|Overall Study|Pregnancy|3
7669567|NCT00158860|12084571|FG001|Overall Study|Pregnancy|3
7669568|NCT00158860|12084570|FG000|Overall Study|SPONSOR STOPPED STUDY|2
7669569|NCT00158860|12084571|FG001|Overall Study|SPONSOR STOPPED STUDY|2
7669570|NCT00158860|12084570|FG000|Overall Study|SPONSOR REQUEST|0
7669571|NCT00158860|12084571|FG001|Overall Study|SPONSOR REQUEST|1
7669572|NCT00158860|12084570|FG000|Overall Study|Lost to Follow up but returned per GSK|0
7669573|NCT00158860|12084571|FG001|Overall Study|Lost to Follow up but returned per GSK|1
7669574|NCT00158860|12084570|FG000|Overall Study|Closed per sponsor|0
7669575|NCT00158860|12084571|FG001|Overall Study|Closed per sponsor|1
7669576|NCT00159432|12084619|FG000|Overall Study|Adverse Event|1
7669577|NCT00159432|12084619|FG000|Overall Study|Death|1
7669578|NCT00159432|12084619|FG000|Overall Study|Lack of Efficacy|8
7669579|NCT00159822|12084623|FG000|Voriconazole Treatment Period|Lack of Efficacy|3
7669580|NCT00159822|12084623|FG000|Voriconazole Treatment Period|Adverse Event|9
7669581|NCT00159822|12084623|FG000|Voriconazole Treatment Period|Death|4
7669582|NCT00159822|12084623|FG000|Voriconazole Treatment Period|Protocol Violation|2
7669583|NCT00159822|12084623|FG000|Voriconazole Treatment Period|Lost to Follow-up|2
7669584|NCT00159822|12084623|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2
7669585|NCT00159822|12084623|FG000|Post-treatment Follow-up Period|Death|1
7669586|NCT00159822|12084623|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1
7669587|NCT00159822|12084623|FG000|Post-treatment Follow-up Period|Reason unspecified|1
7669588|NCT00159861|12084629|FG000|Core Study - 16 Weeks|Death|3
7669589|NCT00159861|12084630|FG001|Core Study - 16 Weeks|Death|0
7669590|NCT00159861|12084629|FG000|Core Study - 16 Weeks|Adverse Event|12
7669591|NCT00159861|12084630|FG001|Core Study - 16 Weeks|Adverse Event|6
7669592|NCT00159861|12084629|FG000|Core Study - 16 Weeks|Lack of Efficacy|2
7669593|NCT00159861|12084630|FG001|Core Study - 16 Weeks|Lack of Efficacy|3
7669594|NCT00159861|12084629|FG000|Core Study - 16 Weeks|Reason Unspecified|5
7669595|NCT00159861|12084630|FG001|Core Study - 16 Weeks|Reason Unspecified|3
7669596|NCT00159861|12084629|FG000|Core Study - 16 Weeks|Subject Defaulted|1
7669597|NCT00159861|12084630|FG001|Core Study - 16 Weeks|Subject Defaulted|0
7669598|NCT00159861|12084629|FG000|Core Study - 16 Weeks|Randomized but not Treated|2
7669599|NCT00159861|12084630|FG001|Core Study - 16 Weeks|Randomized but not Treated|0
7669600|NCT00159861|12084629|FG000|Extension Study - up to 3 Years|Death|24
7669601|NCT00159861|12084630|FG001|Extension Study - up to 3 Years|Death|28
7669602|NCT00159861|12084629|FG000|Extension Study - up to 3 Years|Adverse Event|14
7669603|NCT00159861|12084630|FG001|Extension Study - up to 3 Years|Adverse Event|14
7669604|NCT00159861|12084629|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5
7669605|NCT00159861|12084630|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1
7669606|NCT00159861|12084629|FG000|Extension Study - up to 3 Years|Reason Unspecified|12
7669607|NCT00159861|12084630|FG001|Extension Study - up to 3 Years|Reason Unspecified|19
7669608|NCT00159861|12084629|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7
7669609|NCT00159861|12084630|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9
7669610|NCT00159874|12084648|FG000|Overall Study|Adverse Event|2
7669611|NCT00159874|12084649|FG001|Overall Study|Adverse Event|2
7669612|NCT00159874|12084650|FG002|Overall Study|Adverse Event|5
7669613|NCT00159874|12084651|FG003|Overall Study|Adverse Event|1
7669614|NCT00159874|12084652|FG004|Overall Study|Adverse Event|1
7669615|NCT00159874|12084653|FG005|Overall Study|Adverse Event|2
7669616|NCT00159874|12084654|FG006|Overall Study|Adverse Event|0
7669617|NCT00159874|12084648|FG000|Overall Study|Does Not Meet Entrance Criteria|1
7669618|NCT00159874|12084649|FG001|Overall Study|Does Not Meet Entrance Criteria|0
7669619|NCT00159874|12084650|FG002|Overall Study|Does Not Meet Entrance Criteria|1
7669620|NCT00159874|12084651|FG003|Overall Study|Does Not Meet Entrance Criteria|0
7669621|NCT00159874|12084652|FG004|Overall Study|Does Not Meet Entrance Criteria|0
7669622|NCT00159874|12084653|FG005|Overall Study|Does Not Meet Entrance Criteria|0
7669623|NCT00159874|12084654|FG006|Overall Study|Does Not Meet Entrance Criteria|0
7669624|NCT00159874|12084648|FG000|Overall Study|Lack of Efficacy|2
7669625|NCT00159874|12084649|FG001|Overall Study|Lack of Efficacy|0
7669626|NCT00159874|12084650|FG002|Overall Study|Lack of Efficacy|1
7669627|NCT00159874|12084651|FG003|Overall Study|Lack of Efficacy|1
7669628|NCT00159874|12084652|FG004|Overall Study|Lack of Efficacy|0
7669629|NCT00159874|12084653|FG005|Overall Study|Lack of Efficacy|3
7669630|NCT00159874|12084654|FG006|Overall Study|Lack of Efficacy|0
7669631|NCT00159874|12084648|FG000|Overall Study|Lost to Follow-up|1
7669632|NCT00159874|12084649|FG001|Overall Study|Lost to Follow-up|0
7669633|NCT00159874|12084650|FG002|Overall Study|Lost to Follow-up|3
7669634|NCT00159874|12084651|FG003|Overall Study|Lost to Follow-up|0
7669635|NCT00159874|12084652|FG004|Overall Study|Lost to Follow-up|1
7669636|NCT00159874|12084653|FG005|Overall Study|Lost to Follow-up|2
7669637|NCT00159874|12084654|FG006|Overall Study|Lost to Follow-up|1
7669638|NCT00159874|12084648|FG000|Overall Study|Other|8
7669639|NCT00159874|12084649|FG001|Overall Study|Other|8
7669640|NCT00159874|12084650|FG002|Overall Study|Other|8
7669641|NCT00159874|12084651|FG003|Overall Study|Other|0
7669642|NCT00159874|12084652|FG004|Overall Study|Other|2
7669643|NCT00159874|12084653|FG005|Overall Study|Other|1
7669644|NCT00159874|12084654|FG006|Overall Study|Other|3
7669645|NCT00159874|12084648|FG000|Overall Study|Protocol Violation|0
7669646|NCT00159874|12084649|FG001|Overall Study|Protocol Violation|5
7669647|NCT00159874|12084650|FG002|Overall Study|Protocol Violation|2
7669648|NCT00159874|12084651|FG003|Overall Study|Protocol Violation|0
7669649|NCT00159874|12084652|FG004|Overall Study|Protocol Violation|0
7669650|NCT00159874|12084653|FG005|Overall Study|Protocol Violation|0
7669651|NCT00159874|12084654|FG006|Overall Study|Protocol Violation|0
7669652|NCT00159874|12084648|FG000|Overall Study|Death|3
7669653|NCT00159874|12084649|FG001|Overall Study|Death|8
7669654|NCT00159874|12084650|FG002|Overall Study|Death|15
7669655|NCT00159874|12084651|FG003|Overall Study|Death|0
7669656|NCT00159874|12084652|FG004|Overall Study|Death|1
7669657|NCT00159874|12084653|FG005|Overall Study|Death|2
7669658|NCT00159874|12084654|FG006|Overall Study|Death|0
7669659|NCT00159874|12084648|FG000|Overall Study|Withdrawal by Subject|2
7669660|NCT00159874|12084649|FG001|Overall Study|Withdrawal by Subject|6
7669661|NCT00159874|12084650|FG002|Overall Study|Withdrawal by Subject|8
7669662|NCT00159874|12084651|FG003|Overall Study|Withdrawal by Subject|4
7669663|NCT00159874|12084652|FG004|Overall Study|Withdrawal by Subject|3
7669664|NCT00159874|12084653|FG005|Overall Study|Withdrawal by Subject|2
7669665|NCT00159874|12084654|FG006|Overall Study|Withdrawal by Subject|1
7669666|NCT00159874|12084648|FG000|Overall Study|Pregnancy|1
7669667|NCT00159874|12084649|FG001|Overall Study|Pregnancy|1
7669668|NCT00159874|12084650|FG002|Overall Study|Pregnancy|0
7669669|NCT00159874|12084651|FG003|Overall Study|Pregnancy|0
7669670|NCT00159874|12084652|FG004|Overall Study|Pregnancy|0
7669671|NCT00159874|12084653|FG005|Overall Study|Pregnancy|0
7669672|NCT00159874|12084654|FG006|Overall Study|Pregnancy|0
7669673|NCT00159913|12084674|FG000|Overall Study|Adverse Event|1
7669674|NCT00159913|12084675|FG001|Overall Study|Adverse Event|0
7669675|NCT00159913|12084676|FG002|Overall Study|Adverse Event|1
7669676|NCT00159913|12084677|FG003|Overall Study|Adverse Event|0
7669677|NCT00159913|12084674|FG000|Overall Study|Withdrawal by Subject|0
7669678|NCT00159913|12084675|FG001|Overall Study|Withdrawal by Subject|0
7669679|NCT00159913|12084676|FG002|Overall Study|Withdrawal by Subject|0
7669680|NCT00159913|12084677|FG003|Overall Study|Withdrawal by Subject|1
7669681|NCT00159913|12084674|FG000|Overall Study|Lost to Follow-up|0
7669682|NCT00159913|12084675|FG001|Overall Study|Lost to Follow-up|0
7669683|NCT00159913|12084676|FG002|Overall Study|Lost to Follow-up|0
7669684|NCT00159913|12084677|FG003|Overall Study|Lost to Follow-up|1
7669685|NCT00159913|12084674|FG000|Overall Study|Protocol Violation|1
7669686|NCT00159913|12084675|FG001|Overall Study|Protocol Violation|0
7669687|NCT00159913|12084676|FG002|Overall Study|Protocol Violation|1
7669688|NCT00159913|12084677|FG003|Overall Study|Protocol Violation|0
7669689|NCT00160199|12084700|FG000|Overall Study|Adverse Event|5
7669690|NCT00160199|12084701|FG001|Overall Study|Adverse Event|14
7669691|NCT00160199|12084700|FG000|Overall Study|Lack of Efficacy|0
7669692|NCT00160199|12084701|FG001|Overall Study|Lack of Efficacy|1
7669693|NCT00160199|12084700|FG000|Overall Study|Lost to Follow-up|7
7669694|NCT00160199|12084701|FG001|Overall Study|Lost to Follow-up|7
7669695|NCT00160199|12084700|FG000|Overall Study|Withdrawal by Subject|4
7669696|NCT00160199|12084701|FG001|Overall Study|Withdrawal by Subject|6
7669697|NCT00160199|12084700|FG000|Overall Study|Administrative|0
7669698|NCT00160199|12084701|FG001|Overall Study|Administrative|1
7669699|NCT00160199|12084700|FG000|Overall Study|Protocol Violation|8
7669700|NCT00160199|12084701|FG001|Overall Study|Protocol Violation|8
7669701|NCT00160251|12084713|FG000|Prior to Amendment 2|Adverse Event|2
7669702|NCT00160251|12084714|FG001|Prior to Amendment 2|Adverse Event|1
7669703|NCT00160251|12084715|FG002|Prior to Amendment 2|Adverse Event|3
7669704|NCT00160251|12084716|FG003|Prior to Amendment 2|Adverse Event|1
7669705|NCT00160251|12084717|FG004|Prior to Amendment 2|Adverse Event|1
7669706|NCT00160251|12084718|FG005|Prior to Amendment 2|Adverse Event|1
7669707|NCT00160251|12084719|FG006|Prior to Amendment 2|Adverse Event|1
7669708|NCT00160251|12084720|FG007|Prior to Amendment 2|Adverse Event|0
7669709|NCT00160251|12084713|FG000|Prior to Amendment 2|Lack of Efficacy|0
7669710|NCT00160251|12084714|FG001|Prior to Amendment 2|Lack of Efficacy|4
7669711|NCT00160251|12084715|FG002|Prior to Amendment 2|Lack of Efficacy|37
7669712|NCT00160251|12084716|FG003|Prior to Amendment 2|Lack of Efficacy|35
7669713|NCT00160251|12084717|FG004|Prior to Amendment 2|Lack of Efficacy|24
7669714|NCT00160251|12084718|FG005|Prior to Amendment 2|Lack of Efficacy|55
7669715|NCT00160251|12084719|FG006|Prior to Amendment 2|Lack of Efficacy|0
7669716|NCT00160251|12084720|FG007|Prior to Amendment 2|Lack of Efficacy|0
7669717|NCT00160251|12084713|FG000|Prior to Amendment 2|Lost to Follow-up|0
7669718|NCT00160251|12084714|FG001|Prior to Amendment 2|Lost to Follow-up|0
7669719|NCT00160251|12084715|FG002|Prior to Amendment 2|Lost to Follow-up|1
7669720|NCT00160251|12084716|FG003|Prior to Amendment 2|Lost to Follow-up|0
7669721|NCT00160251|12084717|FG004|Prior to Amendment 2|Lost to Follow-up|1
7669722|NCT00160251|12084718|FG005|Prior to Amendment 2|Lost to Follow-up|1
7669723|NCT00160251|12084719|FG006|Prior to Amendment 2|Lost to Follow-up|0
7669724|NCT00160251|12084720|FG007|Prior to Amendment 2|Lost to Follow-up|0
7669725|NCT00160251|12084713|FG000|Prior to Amendment 2|Withdrawal by Subject|3
7669726|NCT00160251|12084714|FG001|Prior to Amendment 2|Withdrawal by Subject|1
7669727|NCT00160251|12084715|FG002|Prior to Amendment 2|Withdrawal by Subject|3
7669728|NCT00160251|12084716|FG003|Prior to Amendment 2|Withdrawal by Subject|4
7669729|NCT00160251|12084717|FG004|Prior to Amendment 2|Withdrawal by Subject|2
7669730|NCT00160251|12084718|FG005|Prior to Amendment 2|Withdrawal by Subject|3
7669731|NCT00160251|12084719|FG006|Prior to Amendment 2|Withdrawal by Subject|3
7669732|NCT00160251|12084720|FG007|Prior to Amendment 2|Withdrawal by Subject|0
7669733|NCT00160251|12084713|FG000|Prior to Amendment 2|Noncompliance with protocol|1
7669734|NCT00160251|12084714|FG001|Prior to Amendment 2|Noncompliance with protocol|0
7669735|NCT00160251|12084715|FG002|Prior to Amendment 2|Noncompliance with protocol|0
7669736|NCT00160251|12084716|FG003|Prior to Amendment 2|Noncompliance with protocol|0
7669737|NCT00160251|12084717|FG004|Prior to Amendment 2|Noncompliance with protocol|0
7669738|NCT00160251|12084718|FG005|Prior to Amendment 2|Noncompliance with protocol|0
7669739|NCT00160251|12084719|FG006|Prior to Amendment 2|Noncompliance with protocol|0
7669740|NCT00160251|12084720|FG007|Prior to Amendment 2|Noncompliance with protocol|0
7669741|NCT00160251|12084713|FG000|Prior to Amendment 2|Completed Treatment Phase|3
7669742|NCT00160251|12084714|FG001|Prior to Amendment 2|Completed Treatment Phase|0
7669743|NCT00160251|12084715|FG002|Prior to Amendment 2|Completed Treatment Phase|0
7669744|NCT00160251|12084716|FG003|Prior to Amendment 2|Completed Treatment Phase|0
7669745|NCT00160251|12084717|FG004|Prior to Amendment 2|Completed Treatment Phase|0
7669746|NCT00160251|12084718|FG005|Prior to Amendment 2|Completed Treatment Phase|23
7669747|NCT00160251|12084719|FG006|Prior to Amendment 2|Completed Treatment Phase|0
7669748|NCT00160251|12084720|FG007|Prior to Amendment 2|Completed Treatment Phase|0
7669749|NCT00160251|12084713|FG000|Post-amendment 2|Adverse Event|0
7669750|NCT00160251|12084714|FG001|Post-amendment 2|Adverse Event|0
7669751|NCT00160251|12084715|FG002|Post-amendment 2|Adverse Event|0
7669752|NCT00160251|12084716|FG003|Post-amendment 2|Adverse Event|0
7669753|NCT00160251|12084717|FG004|Post-amendment 2|Adverse Event|0
7669754|NCT00160251|12084718|FG005|Post-amendment 2|Adverse Event|0
7669755|NCT00160251|12084719|FG006|Post-amendment 2|Adverse Event|0
7669756|NCT00160251|12084720|FG007|Post-amendment 2|Adverse Event|20
7669757|NCT00160251|12084713|FG000|Post-amendment 2|Lack of Efficacy|0
7669758|NCT00160251|12084714|FG001|Post-amendment 2|Lack of Efficacy|0
7669759|NCT00160251|12084715|FG002|Post-amendment 2|Lack of Efficacy|0
7669760|NCT00160251|12084716|FG003|Post-amendment 2|Lack of Efficacy|0
7669761|NCT00160251|12084717|FG004|Post-amendment 2|Lack of Efficacy|0
7669762|NCT00160251|12084718|FG005|Post-amendment 2|Lack of Efficacy|0
7669763|NCT00160251|12084719|FG006|Post-amendment 2|Lack of Efficacy|0
7669764|NCT00160251|12084720|FG007|Post-amendment 2|Lack of Efficacy|24
7669765|NCT00160251|12084713|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7669766|NCT00160251|12084714|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7669767|NCT00160251|12084715|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7669768|NCT00160251|12084716|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7669769|NCT00160251|12084717|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7669770|NCT00160251|12084718|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7669771|NCT00160251|12084719|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7669772|NCT00160251|12084720|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
7669773|NCT00160524|12084777|FG000|Overall Study|Adverse Event|119
7669774|NCT00160524|12084777|FG000|Overall Study|Adverse Event and Other|94
7669775|NCT00160524|12084777|FG000|Overall Study|Protocol Violation|16
7669776|NCT00160524|12084777|FG000|Overall Study|Protocol Violation and Other|2
7669777|NCT00160524|12084777|FG000|Overall Study|Withdrawal by Subject|141
7669778|NCT00160524|12084777|FG000|Overall Study|Withdrawal by Subject and Other|17
7669779|NCT00160524|12084777|FG000|Overall Study|Physician Decision|27
7669780|NCT00160524|12084777|FG000|Overall Study|Physician Decision and Other|6
7669781|NCT00160524|12084777|FG000|Overall Study|Lost to Follow-up|13
7669782|NCT00160524|12084777|FG000|Overall Study|Lost to Follow-up and Other|1
7669783|NCT00160524|12084777|FG000|Overall Study|Lack of Efficacy|21
7669784|NCT00160524|12084777|FG000|Overall Study|Lack of Efficacy and Other|1
7669785|NCT00160524|12084777|FG000|Overall Study|Other|20
7669786|NCT00160615|12084783|FG000|Overall Study|Adverse Event|5
7669787|NCT00160615|12084784|FG001|Overall Study|Adverse Event|12
7669788|NCT00160615|12084783|FG000|Overall Study|Withdrawal by Subject|0
7669789|NCT00160615|12084784|FG001|Overall Study|Withdrawal by Subject|2
7669790|NCT00160615|12084783|FG000|Overall Study|Lack of Efficacy|11
7669791|NCT00160615|12084784|FG001|Overall Study|Lack of Efficacy|23
7669792|NCT00160615|12084783|FG000|Overall Study|Patient decision|1
7669793|NCT00160615|12084784|FG001|Overall Study|Patient decision|2
7669794|NCT00160615|12084783|FG000|Overall Study|Investigator decision|1
7669795|NCT00160615|12084784|FG001|Overall Study|Investigator decision|1
7669796|NCT00160615|12084783|FG000|Overall Study|AE agents had to be discontinued (exam.)|0
7669797|NCT00160615|12084784|FG001|Overall Study|AE agents had to be discontinued (exam.)|1
7669798|NCT00160615|12084783|FG000|Overall Study|Switch to surgical treatment|0
7669799|NCT00160615|12084784|FG001|Overall Study|Switch to surgical treatment|2
7669800|NCT00160615|12084783|FG000|Overall Study|Non-compliance was suspected|0
7669801|NCT00160615|12084784|FG001|Overall Study|Non-compliance was suspected|1
7669802|NCT00160615|12084783|FG000|Overall Study|Poor compliance|0
7669803|NCT00160615|12084784|FG001|Overall Study|Poor compliance|1
7669804|NCT00160641|12084792|FG000|Overall Study|Adverse Event|102
7669805|NCT00160641|12084792|FG000|Overall Study|Withdrawal by Subject|87
7669806|NCT00160641|12084792|FG000|Overall Study|Lost to Follow-up|8
7669807|NCT00160641|12084792|FG000|Overall Study|Lack of Efficacy|12
7669808|NCT00160641|12084792|FG000|Overall Study|Protocol Violation|3
7669809|NCT00160641|12084792|FG000|Overall Study|Other|9
7669810|NCT00160654|12084796|FG000|Overall Study|Adverse Event|14
7669811|NCT00160654|12084796|FG000|Overall Study|Lack of Efficacy|4
7669812|NCT00160654|12084796|FG000|Overall Study|Lost to Follow-up|2
7669813|NCT00160654|12084796|FG000|Overall Study|Intake of expired drug|7
7669814|NCT00160654|12084796|FG000|Overall Study|Psychological trauma|1
7669815|NCT00160654|12084796|FG000|Overall Study|Sponsor decision|1
7669816|NCT00160654|12084796|FG000|Overall Study|Patient met exclusion criteria|1
7669817|NCT00160654|12084796|FG000|Overall Study|Patient decision|1
7669818|NCT00160654|12084796|FG000|Overall Study|Poor compliance, dilantin toxicity|1
7669819|NCT00160654|12084796|FG000|Overall Study|Met exclusion criteria|1
7669820|NCT00160667|12084803|FG000|Overall Study|Adverse Event|3
7669821|NCT00160667|12084804|FG001|Overall Study|Adverse Event|1
7669822|NCT00160667|12084805|FG002|Overall Study|Adverse Event|4
7669823|NCT00160667|12084803|FG000|Overall Study|Withdrawal by Subject|2
7669824|NCT00160667|12084804|FG001|Overall Study|Withdrawal by Subject|0
7669825|NCT00160667|12084805|FG002|Overall Study|Withdrawal by Subject|1
7669826|NCT00160667|12084803|FG000|Overall Study|Lack of Efficacy|0
7669827|NCT00160667|12084804|FG001|Overall Study|Lack of Efficacy|1
7669828|NCT00160667|12084805|FG002|Overall Study|Lack of Efficacy|0
7669829|NCT00160667|12084803|FG000|Overall Study|Protocol Violation|0
7669830|NCT00160667|12084804|FG001|Overall Study|Protocol Violation|1
7669831|NCT00160667|12084805|FG002|Overall Study|Protocol Violation|0
7669832|NCT00160667|12084803|FG000|Overall Study|Patient decision|0
7669833|NCT00160667|12084804|FG001|Overall Study|Patient decision|0
7669834|NCT00160667|12084805|FG002|Overall Study|Patient decision|1
7669835|NCT00160680|12084816|FG000|Overall Study|Adverse Event|0
7669836|NCT00160680|12084817|FG001|Overall Study|Adverse Event|1
7669837|NCT00160680|12084816|FG000|Overall Study|Lack of Efficacy|2
7669838|NCT00160680|12084817|FG001|Overall Study|Lack of Efficacy|1
7669839|NCT00160680|12084816|FG000|Overall Study|Lost to Follow-up|3
7669840|NCT00160680|12084817|FG001|Overall Study|Lost to Follow-up|2
7669841|NCT00160680|12084816|FG000|Overall Study|Withdrawal by Subject|4
7669842|NCT00160680|12084817|FG001|Overall Study|Withdrawal by Subject|9
7669843|NCT00160693|12084823|FG000|Overall Study|Adverse Event|97
7669844|NCT00160693|12084823|FG000|Overall Study|Lack of Efficacy|30
7669845|NCT00160693|12084823|FG000|Overall Study|Protocol Violation|24
7669846|NCT00160693|12084823|FG000|Overall Study|Lost to Follow-up|15
7669847|NCT00160693|12084823|FG000|Overall Study|Withdrawal by Subject|54
7669848|NCT00160693|12084823|FG000|Overall Study|Study terminated by sponsor|15
7669849|NCT00160706|12084827|FG000|Overall Study|Adverse Event|53
7669850|NCT00160706|12084827|FG000|Overall Study|Adverse Event and Other Reason|105
7669851|NCT00160706|12084827|FG000|Overall Study|Protocol Violation|3
7669852|NCT00160706|12084827|FG000|Overall Study|Withdrawal by Subject|41
7669853|NCT00160706|12084827|FG000|Overall Study|Withdrawal by Subject and Other|12
7669854|NCT00160706|12084827|FG000|Overall Study|Physician Decision|10
7669855|NCT00160706|12084827|FG000|Overall Study|Physician Decision and Other|3
7669856|NCT00160706|12084827|FG000|Overall Study|Lost to Follow-up|4
7669857|NCT00160706|12084827|FG000|Overall Study|Lost to Follow-up and Other|1
7669858|NCT00160706|12084827|FG000|Overall Study|Lack of Efficacy|42
7669859|NCT00160706|12084827|FG000|Overall Study|Lack of Efficacy and Other|1
7669860|NCT00160706|12084827|FG000|Overall Study|Other Reason|11
7669861|NCT00161213|12084831|FG000|Overall Study|Withdrawal by Subject|1
7669862|NCT00161213|12084831|FG000|Overall Study|Evaluable for toxicity but not response|1
7669863|NCT00161616|12084855|FG000|Overall Study|Withdrawal by Subject|6
7669864|NCT00161616|12084856|FG001|Overall Study|Withdrawal by Subject|5
7669865|NCT00161616|12084855|FG000|Overall Study|Physician Decision|1
7669866|NCT00161616|12084856|FG001|Overall Study|Physician Decision|0
7669867|NCT00161616|12084855|FG000|Overall Study|Death|1
7669868|NCT00161616|12084856|FG001|Overall Study|Death|1
7669869|NCT00161616|12084855|FG000|Overall Study|Lost to Follow-up|17
7669870|NCT00161616|12084856|FG001|Overall Study|Lost to Follow-up|13
7669871|NCT00161616|12084855|FG000|Overall Study|Protocol deviation|1
7669872|NCT00161616|12084856|FG001|Overall Study|Protocol deviation|0
7669873|NCT00162032|12084864|FG000|Overall Study|Lost to Follow-up|4
7669874|NCT00162032|12084865|FG001|Overall Study|Lost to Follow-up|2
7669875|NCT00162032|12084864|FG000|Overall Study|Reason not specified|1
7669876|NCT00162032|12084865|FG001|Overall Study|Reason not specified|0
7669877|NCT00162097|12084880|FG000|Overall Study|Participant no longer met study criteria|0
7669878|NCT00162097|12084881|FG001|Overall Study|Participant no longer met study criteria|0
7669879|NCT00162097|12084882|FG002|Overall Study|Participant no longer met study criteria|0
7669880|NCT00162097|12084883|FG003|Overall Study|Participant no longer met study criteria|1
7669881|NCT00162123|12084907|FG000|Overall Study|Disease progression|27
7669882|NCT00162123|12084908|FG001|Overall Study|Disease progression|19
7669883|NCT00162123|12084909|FG002|Overall Study|Disease progression|10
7669884|NCT00162123|12084910|FG003|Overall Study|Disease progression|4
7669885|NCT00162123|12084911|FG004|Overall Study|Disease progression|8
7669886|NCT00162123|12084912|FG005|Overall Study|Disease progression|3
7669887|NCT00162123|12084913|FG006|Overall Study|Disease progression|1
7669888|NCT00162123|12084914|FG007|Overall Study|Disease progression|0
7669889|NCT00162123|12084907|FG000|Overall Study|Study drug toxicity|6
7669890|NCT00162123|12084908|FG001|Overall Study|Study drug toxicity|1
7669891|NCT00162123|12084909|FG002|Overall Study|Study drug toxicity|5
7669892|NCT00162123|12084910|FG003|Overall Study|Study drug toxicity|0
7669893|NCT00162123|12084911|FG004|Overall Study|Study drug toxicity|4
7669894|NCT00162123|12084912|FG005|Overall Study|Study drug toxicity|1
7669895|NCT00162123|12084913|FG006|Overall Study|Study drug toxicity|1
7669896|NCT00162123|12084914|FG007|Overall Study|Study drug toxicity|0
7669897|NCT00162123|12084907|FG000|Overall Study|Death|3
7669898|NCT00162123|12084908|FG001|Overall Study|Death|3
7669899|NCT00162123|12084909|FG002|Overall Study|Death|1
7669900|NCT00162123|12084910|FG003|Overall Study|Death|1
7669901|NCT00162123|12084911|FG004|Overall Study|Death|1
7669902|NCT00162123|12084912|FG005|Overall Study|Death|1
7669903|NCT00162123|12084913|FG006|Overall Study|Death|0
7669904|NCT00162123|12084914|FG007|Overall Study|Death|0
7669905|NCT00162123|12084907|FG000|Overall Study|Withdrawal by Subject|2
7669906|NCT00162123|12084908|FG001|Overall Study|Withdrawal by Subject|0
7669907|NCT00162123|12084909|FG002|Overall Study|Withdrawal by Subject|2
7669908|NCT00162123|12084910|FG003|Overall Study|Withdrawal by Subject|1
7669909|NCT00162123|12084911|FG004|Overall Study|Withdrawal by Subject|1
7669910|NCT00162123|12084912|FG005|Overall Study|Withdrawal by Subject|2
7669911|NCT00162123|12084913|FG006|Overall Study|Withdrawal by Subject|1
7669912|NCT00162123|12084914|FG007|Overall Study|Withdrawal by Subject|0
7669913|NCT00162123|12084907|FG000|Overall Study|Deterioration without progression|2
7669914|NCT00162123|12084908|FG001|Overall Study|Deterioration without progression|2
7669915|NCT00162123|12084909|FG002|Overall Study|Deterioration without progression|3
7669916|NCT00162123|12084910|FG003|Overall Study|Deterioration without progression|0
7669917|NCT00162123|12084911|FG004|Overall Study|Deterioration without progression|1
7669918|NCT00162123|12084912|FG005|Overall Study|Deterioration without progression|0
7669919|NCT00162123|12084913|FG006|Overall Study|Deterioration without progression|0
7669920|NCT00162123|12084914|FG007|Overall Study|Deterioration without progression|0
7669921|NCT00162123|12084907|FG000|Overall Study|Adverse Event|1
7669922|NCT00162123|12084908|FG001|Overall Study|Adverse Event|2
7669923|NCT00162123|12084909|FG002|Overall Study|Adverse Event|0
7669924|NCT00162123|12084910|FG003|Overall Study|Adverse Event|2
7669925|NCT00162123|12084911|FG004|Overall Study|Adverse Event|1
7669926|NCT00162123|12084912|FG005|Overall Study|Adverse Event|0
7669927|NCT00162123|12084913|FG006|Overall Study|Adverse Event|0
7669928|NCT00162123|12084914|FG007|Overall Study|Adverse Event|0
7669929|NCT00162123|12084907|FG000|Overall Study|Not specified (before treatment)|2
7669930|NCT00162123|12084908|FG001|Overall Study|Not specified (before treatment)|0
7669931|NCT00162123|12084909|FG002|Overall Study|Not specified (before treatment)|0
7669932|NCT00162123|12084910|FG003|Overall Study|Not specified (before treatment)|0
7669933|NCT00162123|12084911|FG004|Overall Study|Not specified (before treatment)|12
7669934|NCT00162123|12084912|FG005|Overall Study|Not specified (before treatment)|1
7669935|NCT00162123|12084913|FG006|Overall Study|Not specified (before treatment)|0
7669936|NCT00162123|12084914|FG007|Overall Study|Not specified (before treatment)|0
7669937|NCT00162123|12084907|FG000|Overall Study|Not specified (after start of treatment)|0
7669938|NCT00162123|12084908|FG001|Overall Study|Not specified (after start of treatment)|0
7669939|NCT00162123|12084909|FG002|Overall Study|Not specified (after start of treatment)|0
7669940|NCT00162123|12084910|FG003|Overall Study|Not specified (after start of treatment)|0
7669941|NCT00162123|12084911|FG004|Overall Study|Not specified (after start of treatment)|3
7669942|NCT00162123|12084912|FG005|Overall Study|Not specified (after start of treatment)|0
7669943|NCT00162123|12084913|FG006|Overall Study|Not specified (after start of treatment)|0
7669944|NCT00162123|12084914|FG007|Overall Study|Not specified (after start of treatment)|0
7669945|NCT00162123|12084907|FG000|Overall Study|Physician Decision|1
7669946|NCT00162123|12084908|FG001|Overall Study|Physician Decision|2
7669947|NCT00162123|12084909|FG002|Overall Study|Physician Decision|0
7669948|NCT00162123|12084910|FG003|Overall Study|Physician Decision|0
7669949|NCT00162123|12084911|FG004|Overall Study|Physician Decision|0
7669950|NCT00162123|12084912|FG005|Overall Study|Physician Decision|1
7669951|NCT00162123|12084913|FG006|Overall Study|Physician Decision|1
7669952|NCT00162123|12084914|FG007|Overall Study|Physician Decision|0
7669953|NCT00162123|12084907|FG000|Overall Study|Tumor assessment only (not treated)|0
7669954|NCT00162123|12084908|FG001|Overall Study|Tumor assessment only (not treated)|0
7669955|NCT00162123|12084909|FG002|Overall Study|Tumor assessment only (not treated)|0
7669956|NCT00162123|12084910|FG003|Overall Study|Tumor assessment only (not treated)|0
7669957|NCT00162123|12084911|FG004|Overall Study|Tumor assessment only (not treated)|0
7669958|NCT00162123|12084912|FG005|Overall Study|Tumor assessment only (not treated)|0
7669959|NCT00162123|12084913|FG006|Overall Study|Tumor assessment only (not treated)|0
7669960|NCT00162123|12084914|FG007|Overall Study|Tumor assessment only (not treated)|1
7669961|NCT00162123|12084907|FG000|Overall Study|Follow-up only (not treated or assessed)|0
7669962|NCT00162123|12084908|FG001|Overall Study|Follow-up only (not treated or assessed)|0
7669963|NCT00162123|12084909|FG002|Overall Study|Follow-up only (not treated or assessed)|0
7669964|NCT00162123|12084910|FG003|Overall Study|Follow-up only (not treated or assessed)|0
7669965|NCT00162123|12084911|FG004|Overall Study|Follow-up only (not treated or assessed)|0
7669966|NCT00162123|12084912|FG005|Overall Study|Follow-up only (not treated or assessed)|0
7669967|NCT00162123|12084913|FG006|Overall Study|Follow-up only (not treated or assessed)|0
7669968|NCT00162123|12084914|FG007|Overall Study|Follow-up only (not treated or assessed)|57
7669969|NCT00162136|12084939|FG000|Overall Study|Adverse Event|1
7669970|NCT00162136|12084939|FG000|Overall Study|Death|1
7669971|NCT00162136|12084939|FG000|Overall Study|Disease Progression/Relapse|23
7669972|NCT00162136|12084939|FG000|Overall Study|Investigator Request|5
7669973|NCT00162136|12084939|FG000|Overall Study|Study Drug Toxicity|4
7669974|NCT00162136|12084939|FG000|Overall Study|Withdrawal by Subject|1
7669975|NCT00162266|12084966|FG000|Double-Blind Period|Adverse Event|5
7669976|NCT00162266|12084967|FG001|Double-Blind Period|Adverse Event|9
7669977|NCT00162266|12084968|FG002|Double-Blind Period|Adverse Event|11
7669978|NCT00162266|12084969|FG003|Double-Blind Period|Adverse Event|0
7669979|NCT00162266|12084966|FG000|Double-Blind Period|Death|0
7669980|NCT00162266|12084967|FG001|Double-Blind Period|Death|1
7669981|NCT00162266|12084968|FG002|Double-Blind Period|Death|0
7669982|NCT00162266|12084969|FG003|Double-Blind Period|Death|0
7669983|NCT00162266|12084966|FG000|Double-Blind Period|Lost to Follow-up|1
7669984|NCT00162266|12084967|FG001|Double-Blind Period|Lost to Follow-up|2
7669985|NCT00162266|12084968|FG002|Double-Blind Period|Lost to Follow-up|0
7669986|NCT00162266|12084969|FG003|Double-Blind Period|Lost to Follow-up|0
7669987|NCT00162266|12084966|FG000|Double-Blind Period|Other Reason|1
7669988|NCT00162266|12084967|FG001|Double-Blind Period|Other Reason|0
7669989|NCT00162266|12084968|FG002|Double-Blind Period|Other Reason|1
7669990|NCT00162266|12084969|FG003|Double-Blind Period|Other Reason|0
7669991|NCT00162266|12084966|FG000|Double-Blind Period|Lack of Efficacy|13
7669992|NCT00162266|12084967|FG001|Double-Blind Period|Lack of Efficacy|17
7669993|NCT00162266|12084968|FG002|Double-Blind Period|Lack of Efficacy|30
7669994|NCT00162266|12084969|FG003|Double-Blind Period|Lack of Efficacy|0
7669995|NCT00162266|12084966|FG000|Double-Blind Period|Withdrawal by Subject|5
7669996|NCT00162266|12084967|FG001|Double-Blind Period|Withdrawal by Subject|2
7669997|NCT00162266|12084968|FG002|Double-Blind Period|Withdrawal by Subject|6
7669998|NCT00162266|12084969|FG003|Double-Blind Period|Withdrawal by Subject|0
7669999|NCT00162266|12084966|FG000|Open-Label Period|Death|0
7670000|NCT00162266|12084967|FG001|Open-Label Period|Death|0
7670001|NCT00162266|12084968|FG002|Open-Label Period|Death|0
7670002|NCT00162266|12084969|FG003|Open-Label Period|Death|7
7670003|NCT00162266|12084966|FG000|Open-Label Period|Adverse Event|0
7670004|NCT00162266|12084967|FG001|Open-Label Period|Adverse Event|0
7670005|NCT00162266|12084968|FG002|Open-Label Period|Adverse Event|0
7670006|NCT00162266|12084969|FG003|Open-Label Period|Adverse Event|46
7670007|NCT00162266|12084966|FG000|Open-Label Period|Lack of Efficacy|0
7670008|NCT00162266|12084967|FG001|Open-Label Period|Lack of Efficacy|0
7670009|NCT00162266|12084968|FG002|Open-Label Period|Lack of Efficacy|0
7670010|NCT00162266|12084969|FG003|Open-Label Period|Lack of Efficacy|26
7670011|NCT00162266|12084966|FG000|Open-Label Period|Lost to Follow-up|0
7670012|NCT00162266|12084967|FG001|Open-Label Period|Lost to Follow-up|0
7670013|NCT00162266|12084968|FG002|Open-Label Period|Lost to Follow-up|0
7670014|NCT00162266|12084969|FG003|Open-Label Period|Lost to Follow-up|3
7670015|NCT00162266|12084966|FG000|Open-Label Period|Withdrawal by Subject|0
7670016|NCT00162266|12084967|FG001|Open-Label Period|Withdrawal by Subject|0
7670017|NCT00162266|12084968|FG002|Open-Label Period|Withdrawal by Subject|0
7670018|NCT00162266|12084969|FG003|Open-Label Period|Withdrawal by Subject|31
7670019|NCT00162266|12084966|FG000|Open-Label Period|Administrative Reason By Sponsor|0
7670020|NCT00162266|12084967|FG001|Open-Label Period|Administrative Reason By Sponsor|0
7670021|NCT00162266|12084968|FG002|Open-Label Period|Administrative Reason By Sponsor|0
7670022|NCT00162266|12084969|FG003|Open-Label Period|Administrative Reason By Sponsor|9
7670023|NCT00162266|12084966|FG000|Open-Label Period|Other Reasons|0
7670024|NCT00162266|12084967|FG001|Open-Label Period|Other Reasons|0
7670025|NCT00162266|12084968|FG002|Open-Label Period|Other Reasons|0
7670026|NCT00162266|12084969|FG003|Open-Label Period|Other Reasons|15
7670027|NCT00162981|12085023|FG000|Overall Study|Adverse Event|2
7670028|NCT00162981|12085024|FG001|Overall Study|Adverse Event|5
7670029|NCT00162981|12085023|FG000|Overall Study|Withdrawal by Subject|1
7670030|NCT00162981|12085024|FG001|Overall Study|Withdrawal by Subject|1
7670031|NCT00162981|12085023|FG000|Overall Study|Physician Decision|1
7670032|NCT00162981|12085024|FG001|Overall Study|Physician Decision|0
7670033|NCT00163020|12085032|FG000|Overall Study|Lost to Follow-up|0
7670034|NCT00163020|12085033|FG001|Overall Study|Lost to Follow-up|2
7670035|NCT00163189|12085041|FG000|Overall Study|Other|6
7670036|NCT00163189|12085041|FG000|Overall Study|Lost to Follow-up|1
7670037|NCT00163189|12085041|FG000|Overall Study|Protocol Violation|2
7670038|NCT00163189|12085041|FG000|Overall Study|Death|3
7670039|NCT00163189|12085041|FG000|Overall Study|Adverse Event|6
7670040|NCT00163189|12085041|FG000|Overall Study|Lack of Efficacy|7
7670041|NCT00163189|12085041|FG000|Overall Study|Study terminated by sponsor|11
7670042|NCT00163189|12085041|FG000|Overall Study|Withdrawal by Subject|11
7670043|NCT00163189|12085041|FG000|Overall Study|Did not meet continuation criterion|16
7670044|NCT00163215|12085045|FG000|Overall Study|Lack of Efficacy|3
7670045|NCT00163215|12085045|FG000|Overall Study|Withdrawal by Subject|5
7670046|NCT00163215|12085045|FG000|Overall Study|Other|7
7670047|NCT00163657|12085065|FG000|Overall Study|Death|12
7670048|NCT00163657|12085066|FG001|Overall Study|Death|14
7670049|NCT00163657|12085067|FG002|Overall Study|Death|19
7670050|NCT00163657|12085065|FG000|Overall Study|graft loss|4
7670051|NCT00163657|12085066|FG001|Overall Study|graft loss|1
7670052|NCT00163657|12085067|FG002|Overall Study|graft loss|2
7670053|NCT00163657|12085065|FG000|Overall Study|Withdrawal by Subject|2
7670054|NCT00163657|12085066|FG001|Overall Study|Withdrawal by Subject|3
7670055|NCT00163657|12085067|FG002|Overall Study|Withdrawal by Subject|2
7670056|NCT00163657|12085065|FG000|Overall Study|Physician Decision|0
7670057|NCT00163657|12085066|FG001|Overall Study|Physician Decision|1
7670058|NCT00163657|12085067|FG002|Overall Study|Physician Decision|1
7670059|NCT00163657|12085065|FG000|Overall Study|Non Compliance|1
7670060|NCT00163657|12085066|FG001|Overall Study|Non Compliance|0
7670061|NCT00163657|12085067|FG002|Overall Study|Non Compliance|0
7670062|NCT00163657|12085065|FG000|Overall Study|Lost to Follow-up|1
7670063|NCT00163657|12085066|FG001|Overall Study|Lost to Follow-up|3
7670064|NCT00163657|12085067|FG002|Overall Study|Lost to Follow-up|10
7670065|NCT00163657|12085065|FG000|Overall Study|Other reason|0
7670066|NCT00163657|12085066|FG001|Overall Study|Other reason|1
7670067|NCT00163657|12085067|FG002|Overall Study|Other reason|3
7670068|NCT00165646|12085078|FG000|Overall Study|Adverse Event|1
7670069|NCT00165646|12085079|FG001|Overall Study|Adverse Event|1
7670070|NCT00165646|12085080|FG002|Overall Study|Adverse Event|1
7670071|NCT00165646|12085078|FG000|Overall Study|Lack of Efficacy|1
7670072|NCT00165646|12085079|FG001|Overall Study|Lack of Efficacy|2
7670073|NCT00165646|12085080|FG002|Overall Study|Lack of Efficacy|0
7670074|NCT00165646|12085078|FG000|Overall Study|Withdrawal by Subject|0
7670075|NCT00165646|12085079|FG001|Overall Study|Withdrawal by Subject|2
7670076|NCT00165646|12085080|FG002|Overall Study|Withdrawal by Subject|1
7670077|NCT00165646|12085078|FG000|Overall Study|Physician Decision|2
7670078|NCT00165646|12085079|FG001|Overall Study|Physician Decision|0
7670079|NCT00165646|12085080|FG002|Overall Study|Physician Decision|2
7670080|NCT00165646|12085078|FG000|Overall Study|Protocol Violation|1
7670081|NCT00165646|12085079|FG001|Overall Study|Protocol Violation|0
7670082|NCT00165646|12085080|FG002|Overall Study|Protocol Violation|0
7670083|NCT00165672|12085090|FG000|Overall Study|Adverse Event|0
7670084|NCT00165672|12085091|FG001|Overall Study|Adverse Event|1
7670085|NCT00165698|12085099|FG000|Overall Study|Adverse Event|2
7670086|NCT00165698|12085100|FG001|Overall Study|Adverse Event|10
7670087|NCT00165698|12085099|FG000|Overall Study|Lost to Follow-up|2
7670088|NCT00165698|12085100|FG001|Overall Study|Lost to Follow-up|2
7670089|NCT00165698|12085099|FG000|Overall Study|Withdrawal by Subject|2
7670090|NCT00165698|12085100|FG001|Overall Study|Withdrawal by Subject|1
7670091|NCT00165698|12085099|FG000|Overall Study|Protocol Violation|1
7670092|NCT00165698|12085100|FG001|Overall Study|Protocol Violation|0
7670093|NCT00165698|12085099|FG000|Overall Study|Not Taken/Lost the medicine|1
7670094|NCT00165698|12085100|FG001|Overall Study|Not Taken/Lost the medicine|2
7670095|NCT00165776|12085110|FG000|Overall Study|Lack of Efficacy|0
7670096|NCT00165776|12085111|FG001|Overall Study|Lack of Efficacy|0
7670097|NCT00165776|12085112|FG002|Overall Study|Lack of Efficacy|0
7670098|NCT00165776|12085113|FG003|Overall Study|Lack of Efficacy|1
7670099|NCT00165776|12085110|FG000|Overall Study|Withdrawal by Subject|4
7670100|NCT00165776|12085111|FG001|Overall Study|Withdrawal by Subject|1
7670101|NCT00165776|12085112|FG002|Overall Study|Withdrawal by Subject|2
7670102|NCT00165776|12085113|FG003|Overall Study|Withdrawal by Subject|0
7670103|NCT00165776|12085110|FG000|Overall Study|Worsening of Cervical Dystonia|0
7670104|NCT00165776|12085111|FG001|Overall Study|Worsening of Cervical Dystonia|0
7670105|NCT00165776|12085112|FG002|Overall Study|Worsening of Cervical Dystonia|0
7670106|NCT00165776|12085113|FG003|Overall Study|Worsening of Cervical Dystonia|1
7670107|NCT00165789|12085127|FG000|Overall Study|Adverse Event|0
7670108|NCT00165789|12085128|FG001|Overall Study|Adverse Event|3
7670109|NCT00165789|12085129|FG002|Overall Study|Adverse Event|0
7670110|NCT00165789|12085130|FG003|Overall Study|Adverse Event|12
7670111|NCT00165789|12085127|FG000|Overall Study|Withdrawal by Subject|0
7670112|NCT00165789|12085128|FG001|Overall Study|Withdrawal by Subject|1
7670113|NCT00165789|12085129|FG002|Overall Study|Withdrawal by Subject|1
7670114|NCT00165789|12085130|FG003|Overall Study|Withdrawal by Subject|2
7670115|NCT00165841|12085142|FG000|Overall Study|Adverse Event|2
7670116|NCT00165841|12085143|FG001|Overall Study|Adverse Event|3
7670117|NCT00165841|12085142|FG000|Overall Study|Lack of Efficacy|6
7670118|NCT00165841|12085143|FG001|Overall Study|Lack of Efficacy|33
7670119|NCT00165841|12085142|FG000|Overall Study|Lost to Follow-up|4
7670120|NCT00165841|12085143|FG001|Overall Study|Lost to Follow-up|4
7670121|NCT00165841|12085142|FG000|Overall Study|Withdrawal by Subject|7
7670122|NCT00165841|12085143|FG001|Overall Study|Withdrawal by Subject|8
7670123|NCT00165841|12085142|FG000|Overall Study|Physician Decision|1
7670124|NCT00165841|12085143|FG001|Overall Study|Physician Decision|0
7670125|NCT00165841|12085142|FG000|Overall Study|Protocol Violation|6
7670126|NCT00165841|12085143|FG001|Overall Study|Protocol Violation|8
7670127|NCT00165841|12085142|FG000|Overall Study|Other|3
7670128|NCT00165841|12085143|FG001|Overall Study|Other|5
7670129|NCT00165841|12085142|FG000|Overall Study|Medication Noncompliance|1
7670130|NCT00165841|12085143|FG001|Overall Study|Medication Noncompliance|1
7670131|NCT00165984|12085158|FG000|Overall Study|Death|15
7670132|NCT00166114|12085177|FG000|Overall Study|Protocol Violation|2
7670133|NCT00166114|12085178|FG001|Overall Study|Protocol Violation|1
7670134|NCT00166114|12085177|FG000|Overall Study|Withdrawal by Subject|10
7670135|NCT00166114|12085178|FG001|Overall Study|Withdrawal by Subject|4
7670136|NCT00166114|12085177|FG000|Overall Study|Adverse Event|2
7670137|NCT00166114|12085178|FG001|Overall Study|Adverse Event|1
7670138|NCT00166296|12085212|FG000|Overall Study|Withdrawal by Subject|1
7670139|NCT00166296|12085213|FG001|Overall Study|Withdrawal by Subject|3
7670140|NCT00166296|12085212|FG000|Overall Study|Adverse Event|2
7670141|NCT00166296|12085213|FG001|Overall Study|Adverse Event|4
7670142|NCT00166296|12085212|FG000|Overall Study|Lost to Follow-up|4
7670143|NCT00166296|12085213|FG001|Overall Study|Lost to Follow-up|2
7670144|NCT00166439|12085228|FG000|Overall Study|Ineligible|5
7670145|NCT00166517|12085234|FG000|Overall Study|Lost to Follow-up|1
7670146|NCT00166517|12085235|FG001|Overall Study|Lost to Follow-up|0
7670147|NCT00166517|12085234|FG000|Overall Study|Protocol Violation|4
7670148|NCT00166517|12085235|FG001|Overall Study|Protocol Violation|1
7670149|NCT00166517|12085234|FG000|Overall Study|Withdrawal by Subject|0
7670150|NCT00166517|12085235|FG001|Overall Study|Withdrawal by Subject|1
7670151|NCT00166712|12085243|FG000|Overall Study|Death|0
7670152|NCT00166712|12085244|FG001|Overall Study|Death|1
7670153|NCT00166712|12085243|FG000|Overall Study|Adverse Event|1
7670154|NCT00166712|12085244|FG001|Overall Study|Adverse Event|0
7670155|NCT00166712|12085243|FG000|Overall Study|Withdrawal by Subject|1
7670156|NCT00166712|12085244|FG001|Overall Study|Withdrawal by Subject|2
7670157|NCT00166712|12085243|FG000|Overall Study|Physician Decision|0
7670158|NCT00166712|12085244|FG001|Overall Study|Physician Decision|2
7670159|NCT00167245|12085280|FG000|Overall Study|Lost to Follow-up|20
7670160|NCT00167245|12085281|FG001|Overall Study|Lost to Follow-up|31
7670161|NCT00167245|12085280|FG000|Overall Study|Withdrawal by Subject|5
7670162|NCT00167245|12085281|FG001|Overall Study|Withdrawal by Subject|8
7670163|NCT00167245|12085280|FG000|Overall Study|Incarcerated|3
7670164|NCT00167245|12085281|FG001|Overall Study|Incarcerated|2
7670165|NCT00167245|12085280|FG000|Overall Study|Drowsy|1
7670166|NCT00167245|12085281|FG001|Overall Study|Drowsy|0
7670167|NCT00167310|12085292|FG000|Overall Study|Protocol Violation|5
7670168|NCT00167310|12085293|FG001|Overall Study|Protocol Violation|3
7670169|NCT00167310|12085292|FG000|Overall Study|Withdrawal by Subject|3
7670170|NCT00167310|12085293|FG001|Overall Study|Withdrawal by Subject|7
7670171|NCT00167414|12085314|FG000|Overall Study|Death|10
7670172|NCT00167778|12085331|FG000|Overall Study|Withdrawal by Subject|1
7670173|NCT00168038|12085345|FG000|Overall Study|Adverse Event|1
7670174|NCT00168038|12085345|FG000|Overall Study|Therapy failure|1
7670175|NCT00168064|12085351|FG000|Overall Study|Adverse Event|26
7670176|NCT00168064|12085352|FG001|Overall Study|Adverse Event|22
7670177|NCT00168064|12085351|FG000|Overall Study|Withdrawal by Subject|3
7670178|NCT00168064|12085352|FG001|Overall Study|Withdrawal by Subject|4
7670179|NCT00168064|12085351|FG000|Overall Study|Lack of Efficacy|4
7670180|NCT00168064|12085352|FG001|Overall Study|Lack of Efficacy|4
7670181|NCT00168064|12085351|FG000|Overall Study|Lost to Follow-up|4
7670182|NCT00168064|12085352|FG001|Overall Study|Lost to Follow-up|3
7670183|NCT00168064|12085351|FG000|Overall Study|Non-compliance|2
7670184|NCT00168064|12085352|FG001|Overall Study|Non-compliance|3
7670185|NCT00168064|12085351|FG000|Overall Study|Concurrent Illness|4
7670186|NCT00168064|12085352|FG001|Overall Study|Concurrent Illness|3
7670187|NCT00168064|12085351|FG000|Overall Study|Subject's Best interest|2
7670188|NCT00168064|12085352|FG001|Overall Study|Subject's Best interest|2
7670189|NCT00168064|12085351|FG000|Overall Study|Various|4
7670190|NCT00168064|12085352|FG001|Overall Study|Various|3
7670191|NCT00168103|12085363|FG000|Overall Study|Withdrawal by Subject|1
7670192|NCT00168103|12085364|FG001|Overall Study|Withdrawal by Subject|2
7670193|NCT00168103|12085365|FG002|Overall Study|Withdrawal by Subject|1
7670194|NCT00168103|12085366|FG003|Overall Study|Withdrawal by Subject|0
7670195|NCT00168103|12085363|FG000|Overall Study|Lost to Follow-up|1
7670196|NCT00168103|12085364|FG001|Overall Study|Lost to Follow-up|3
7670197|NCT00168103|12085365|FG002|Overall Study|Lost to Follow-up|0
7670198|NCT00168103|12085366|FG003|Overall Study|Lost to Follow-up|0
7670199|NCT00168805|12085472|FG000|Overall Study|Adverse Event|7
7670200|NCT00168805|12085473|FG001|Overall Study|Adverse Event|11
7670201|NCT00168805|12085474|FG002|Overall Study|Adverse Event|16
7670202|NCT00168805|12085472|FG000|Overall Study|Protocol Violation|12
7670203|NCT00168805|12085473|FG001|Overall Study|Protocol Violation|11
7670204|NCT00168805|12085474|FG002|Overall Study|Protocol Violation|8
7670205|NCT00168805|12085472|FG000|Overall Study|Lost to Follow-up|12
7670206|NCT00168805|12085473|FG001|Overall Study|Lost to Follow-up|17
7670207|NCT00168805|12085474|FG002|Overall Study|Lost to Follow-up|11
7670208|NCT00168805|12085472|FG000|Overall Study|Withdrawal by Subject|16
7670209|NCT00168805|12085473|FG001|Overall Study|Withdrawal by Subject|18
7670210|NCT00168805|12085474|FG002|Overall Study|Withdrawal by Subject|21
7670211|NCT00168805|12085472|FG000|Overall Study|Other|24
7670212|NCT00168805|12085473|FG001|Overall Study|Other|21
7670213|NCT00168805|12085474|FG002|Overall Study|Other|22
7670214|NCT00168805|12085472|FG000|Treatment|Adverse Event|25
7670215|NCT00168805|12085473|FG001|Treatment|Adverse Event|26
7670216|NCT00168805|12085474|FG002|Treatment|Adverse Event|32
7670217|NCT00168805|12085472|FG000|Treatment|Protocol Violation|3
7670218|NCT00168805|12085473|FG001|Treatment|Protocol Violation|5
7670219|NCT00168805|12085474|FG002|Treatment|Protocol Violation|5
7670220|NCT00168805|12085472|FG000|Treatment|Withdrawal by Subject|3
7670221|NCT00168805|12085473|FG001|Treatment|Withdrawal by Subject|7
7670222|NCT00168805|12085474|FG002|Treatment|Withdrawal by Subject|8
7670223|NCT00168805|12085472|FG000|Treatment|Other|18
7670224|NCT00168805|12085473|FG001|Treatment|Other|18
7670225|NCT00168805|12085474|FG002|Treatment|Other|17
7670226|NCT00168818|12085485|FG000|Overall Study|Adverse Event|23
7670227|NCT00168818|12085486|FG001|Overall Study|Adverse Event|29
7670228|NCT00168818|12085487|FG002|Overall Study|Adverse Event|31
7670229|NCT00168818|12085485|FG000|Overall Study|Protocol Violation|16
7670230|NCT00168818|12085486|FG001|Overall Study|Protocol Violation|11
7670231|NCT00168818|12085487|FG002|Overall Study|Protocol Violation|11
7670232|NCT00168818|12085485|FG000|Overall Study|Lost to Follow-up|13
7670233|NCT00168818|12085486|FG001|Overall Study|Lost to Follow-up|4
7670234|NCT00168818|12085487|FG002|Overall Study|Lost to Follow-up|15
7670235|NCT00168818|12085485|FG000|Overall Study|Withdrawal by Subject|43
7670236|NCT00168818|12085486|FG001|Overall Study|Withdrawal by Subject|41
7670237|NCT00168818|12085487|FG002|Overall Study|Withdrawal by Subject|37
7670238|NCT00168818|12085485|FG000|Overall Study|Other|22
7670239|NCT00168818|12085486|FG001|Overall Study|Other|24
7670240|NCT00168818|12085487|FG002|Overall Study|Other|30
7670241|NCT00168818|12085485|FG000|Treatment|Adverse Event|77
7670242|NCT00168818|12085486|FG001|Treatment|Adverse Event|89
7670243|NCT00168818|12085487|FG002|Treatment|Adverse Event|68
7670244|NCT00168818|12085485|FG000|Treatment|Protocol Violation|8
7670245|NCT00168818|12085486|FG001|Treatment|Protocol Violation|11
7670246|NCT00168818|12085487|FG002|Treatment|Protocol Violation|11
7670247|NCT00168818|12085485|FG000|Treatment|Lost to Follow-up|0
7670248|NCT00168818|12085486|FG001|Treatment|Lost to Follow-up|2
7670249|NCT00168818|12085487|FG002|Treatment|Lost to Follow-up|1
7670250|NCT00168818|12085485|FG000|Treatment|Withdrawal by Subject|25
7670251|NCT00168818|12085486|FG001|Treatment|Withdrawal by Subject|20
7670252|NCT00168818|12085487|FG002|Treatment|Withdrawal by Subject|22
7670253|NCT00168818|12085485|FG000|Treatment|Other|23
7670254|NCT00168818|12085486|FG001|Treatment|Other|29
7670255|NCT00168818|12085487|FG002|Treatment|Other|31
7670256|NCT00168831|12085498|FG000|Overall Study|Adverse Event|36
7670257|NCT00168831|12085499|FG001|Overall Study|Adverse Event|47
7670258|NCT00168831|12085500|FG002|Overall Study|Adverse Event|74
7670259|NCT00168831|12085498|FG000|Overall Study|Lost to Follow-up|5
7670260|NCT00168831|12085499|FG001|Overall Study|Lost to Follow-up|6
7670261|NCT00168831|12085500|FG002|Overall Study|Lost to Follow-up|4
7670262|NCT00168831|12085498|FG000|Overall Study|Withdrawal by Subject|7
7670263|NCT00168831|12085499|FG001|Overall Study|Withdrawal by Subject|14
7670264|NCT00168831|12085500|FG002|Overall Study|Withdrawal by Subject|19
7670265|NCT00168831|12085498|FG000|Overall Study|Protocol Violation|6
7670266|NCT00168831|12085499|FG001|Overall Study|Protocol Violation|11
7670267|NCT00168831|12085500|FG002|Overall Study|Protocol Violation|11
7670268|NCT00168831|12085498|FG000|Overall Study|Other|6
7670269|NCT00168831|12085499|FG001|Overall Study|Other|3
7670270|NCT00168831|12085500|FG002|Overall Study|Other|6
7670271|NCT00168844|12085511|FG000|Overall Study|Adverse Event|31
7670272|NCT00168844|12085512|FG001|Overall Study|Adverse Event|32
7670273|NCT00168844|12085513|FG002|Overall Study|Adverse Event|48
7670274|NCT00168844|12085511|FG000|Overall Study|Lost to Follow-up|4
7670275|NCT00168844|12085512|FG001|Overall Study|Lost to Follow-up|5
7670276|NCT00168844|12085513|FG002|Overall Study|Lost to Follow-up|11
7670277|NCT00168844|12085511|FG000|Overall Study|Withdrawal by Subject|12
7670278|NCT00168844|12085512|FG001|Overall Study|Withdrawal by Subject|9
7670279|NCT00168844|12085513|FG002|Overall Study|Withdrawal by Subject|19
7670280|NCT00168844|12085511|FG000|Overall Study|Protocol Violation|2
7670281|NCT00168844|12085512|FG001|Overall Study|Protocol Violation|2
7670282|NCT00168844|12085513|FG002|Overall Study|Protocol Violation|4
7670283|NCT00168844|12085511|FG000|Overall Study|Other|6
7670284|NCT00168844|12085512|FG001|Overall Study|Other|7
7670285|NCT00168844|12085513|FG002|Overall Study|Other|9
7670286|NCT00169104|12085523|FG000|Overall Study|Withdrawal by Subject|2
7670287|NCT00169104|12085524|FG001|Overall Study|Withdrawal by Subject|0
7670288|NCT00169104|12085523|FG000|Overall Study|Protocol Violation|0
7670289|NCT00169104|12085524|FG001|Overall Study|Protocol Violation|1
7670290|NCT00169104|12085523|FG000|Overall Study|Physician Decision|0
7670291|NCT00169104|12085524|FG001|Overall Study|Physician Decision|1
7670292|NCT00169442|12085537|FG000|Overall Study|Withdrawal by Subject|0
7670293|NCT00169442|12085538|FG001|Overall Study|Withdrawal by Subject|0
7670294|NCT00169442|12085539|FG002|Overall Study|Withdrawal by Subject|1
7670295|NCT00169442|12085540|FG003|Overall Study|Withdrawal by Subject|0
7670296|NCT00169442|12085541|FG004|Overall Study|Withdrawal by Subject|0
7670297|NCT00169442|12085542|FG005|Overall Study|Withdrawal by Subject|0
7670298|NCT00169442|12085537|FG000|Overall Study|Migrated/moved from study area|0
7670299|NCT00169442|12085538|FG001|Overall Study|Migrated/moved from study area|0
7670300|NCT00169442|12085539|FG002|Overall Study|Migrated/moved from study area|0
7670301|NCT00169442|12085540|FG003|Overall Study|Migrated/moved from study area|0
7670302|NCT00169442|12085541|FG004|Overall Study|Migrated/moved from study area|0
7670303|NCT00169442|12085542|FG005|Overall Study|Migrated/moved from study area|2
7670304|NCT00169442|12085537|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0
7670305|NCT00169442|12085538|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0
7670306|NCT00169442|12085539|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0
7670307|NCT00169442|12085540|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0
7670308|NCT00169442|12085541|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1
7670309|NCT00169442|12085542|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0
7670310|NCT00169442|12085537|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0
7670311|NCT00169442|12085538|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1
7670312|NCT00169442|12085539|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0
7670313|NCT00169442|12085540|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0
7670314|NCT00169442|12085541|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0
7670315|NCT00169442|12085542|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0
7670316|NCT00170846|12085572|FG000|Overall Study|Subject withdrew Informed Consent|5
7670317|NCT00170846|12085573|FG001|Overall Study|Subject withdrew Informed Consent|12
7670318|NCT00170846|12085574|FG002|Overall Study|Subject withdrew Informed Consent|8
7670319|NCT00170846|12085572|FG000|Overall Study|Lost to Follow-up|6
7670320|NCT00170846|12085573|FG001|Overall Study|Lost to Follow-up|3
7670321|NCT00170846|12085574|FG002|Overall Study|Lost to Follow-up|2
7670322|NCT00170846|12085572|FG000|Overall Study|Death|0
7670323|NCT00170846|12085573|FG001|Overall Study|Death|3
7670324|NCT00170846|12085574|FG002|Overall Study|Death|3
7670325|NCT00170846|12085572|FG000|Overall Study|Reason Missing|0
7670326|NCT00170846|12085573|FG001|Overall Study|Reason Missing|1
7670327|NCT00170846|12085574|FG002|Overall Study|Reason Missing|0
7670328|NCT00170950|12085584|FG000|Overall Study|Death|236
7670329|NCT00170950|12085585|FG001|Overall Study|Death|274
7670330|NCT00170950|12085584|FG000|Overall Study|Withdrawal by Subject|496
7670331|NCT00170950|12085585|FG001|Overall Study|Withdrawal by Subject|498
7670332|NCT00170950|12085584|FG000|Overall Study|Lost to Follow-up|134
7670333|NCT00170950|12085585|FG001|Overall Study|Lost to Follow-up|115
7670334|NCT00170950|12085584|FG000|Overall Study|Missing|2
7670335|NCT00170950|12085585|FG001|Overall Study|Missing|1
7670336|NCT00170950|12085584|FG000|Overall Study|Termination Data Not Recorded|17
7670337|NCT00170950|12085585|FG001|Overall Study|Termination Data Not Recorded|22
7670338|NCT00171054|12085593|FG000|Overall Study|Protocol Violation|1
7670339|NCT00171054|12085594|FG001|Overall Study|Protocol Violation|2
7670340|NCT00171054|12085593|FG000|Overall Study|Patient withdrew consent|1
7670341|NCT00171054|12085594|FG001|Overall Study|Patient withdrew consent|0
7670342|NCT00171054|12085593|FG000|Overall Study|Lost to Follow-up|0
7670343|NCT00171054|12085594|FG001|Overall Study|Lost to Follow-up|1
7670344|NCT00171054|12085593|FG000|Overall Study|Adverse Event|8
7670345|NCT00171054|12085594|FG001|Overall Study|Adverse Event|8
7670346|NCT00171054|12085593|FG000|Overall Study|Condition no longer required study drug|0
7670347|NCT00171054|12085594|FG001|Overall Study|Condition no longer required study drug|1
7670348|NCT00171158|12085600|FG000|Core Study|Death|27
7670349|NCT00171158|12085600|FG000|Core Study|Unsatisfactory therapeutic effect|163
7670350|NCT00171158|12085600|FG000|Core Study|Protocol Violation|4
7670351|NCT00171158|12085600|FG000|Core Study|Administrative problems|1
7670352|NCT00171158|12085600|FG000|Core Study|Adverse event, non-fatal|21
7670353|NCT00171158|12085600|FG000|Core Study|Consent withdrawn by subject|6
7670354|NCT00171158|12085600|FG000|Core Study|No longer required drug (BMT)|14
7670355|NCT00171158|12085600|FG000|Core Study|Abnormal Laboratory Values|2
7670356|NCT00171158|12085600|FG000|Core Study|Lost to Follow-up|1
7670357|NCT00171158|12085600|FG000|E2 Extension|Other|7
7670358|NCT00171210|12085606|FG000|Overall Study|Adverse Event|16
7670359|NCT00171210|12085607|FG001|Overall Study|Adverse Event|27
7670360|NCT00171210|12085606|FG000|Overall Study|Abnormal laboratory value(s)|6
7670361|NCT00171210|12085607|FG001|Overall Study|Abnormal laboratory value(s)|3
7670362|NCT00171210|12085606|FG000|Overall Study|Abnormal test procedure result(s)|0
7670363|NCT00171210|12085607|FG001|Overall Study|Abnormal test procedure result(s)|1
7670364|NCT00171210|12085606|FG000|Overall Study|Unsatisfactory therapeutic effect|11
7670365|NCT00171210|12085607|FG001|Overall Study|Unsatisfactory therapeutic effect|15
7670366|NCT00171210|12085606|FG000|Overall Study|Protocol Violation|0
7670367|NCT00171210|12085607|FG001|Overall Study|Protocol Violation|2
7670368|NCT00171210|12085606|FG000|Overall Study|Withdrawal by Subject|32
7670369|NCT00171210|12085607|FG001|Overall Study|Withdrawal by Subject|30
7670370|NCT00171210|12085606|FG000|Overall Study|Lost to Follow-up|1
7670371|NCT00171210|12085607|FG001|Overall Study|Lost to Follow-up|0
7670372|NCT00171210|12085606|FG000|Overall Study|Administrative problems|1
7670373|NCT00171210|12085607|FG001|Overall Study|Administrative problems|1
7670374|NCT00171210|12085606|FG000|Overall Study|Death|2
7670375|NCT00171210|12085607|FG001|Overall Study|Death|3
7670376|NCT00171210|12085606|FG000|Overall Study|Stopped at end of core|0
7670377|NCT00171210|12085607|FG001|Overall Study|Stopped at end of core|32
7670378|NCT00171210|12085606|FG000|Overall Study|Stopped at end of extension 1|0
7670379|NCT00171210|12085607|FG001|Overall Study|Stopped at end of extension 1|1
7670380|NCT00171223|12085616|FG000|Overall Study|Adverse Event (Non-fatal)|6
7670381|NCT00171223|12085617|FG001|Overall Study|Adverse Event (Non-fatal)|5
7670382|NCT00171223|12085618|FG002|Overall Study|Adverse Event (Non-fatal)|19
7670383|NCT00171223|12085616|FG000|Overall Study|Abnormal Laboratory Value (s)|4
7670384|NCT00171223|12085617|FG001|Overall Study|Abnormal Laboratory Value (s)|2
7670385|NCT00171223|12085618|FG002|Overall Study|Abnormal Laboratory Value (s)|3
7670386|NCT00171223|12085616|FG000|Overall Study|Abnormal Procedure|1
7670387|NCT00171223|12085617|FG001|Overall Study|Abnormal Procedure|0
7670388|NCT00171223|12085618|FG002|Overall Study|Abnormal Procedure|0
7670389|NCT00171223|12085616|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57
7670390|NCT00171223|12085617|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43
7670391|NCT00171223|12085618|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52
7670392|NCT00171223|12085616|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2
7670393|NCT00171223|12085617|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4
7670394|NCT00171223|12085618|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2
7670395|NCT00171223|12085616|FG000|Overall Study|Protocol Violation|2
7670396|NCT00171223|12085617|FG001|Overall Study|Protocol Violation|2
7670397|NCT00171223|12085618|FG002|Overall Study|Protocol Violation|3
7670398|NCT00171223|12085616|FG000|Overall Study|Participant Withdrew Consent|12
7670399|NCT00171223|12085617|FG001|Overall Study|Participant Withdrew Consent|21
7670400|NCT00171223|12085618|FG002|Overall Study|Participant Withdrew Consent|15
7670401|NCT00171223|12085616|FG000|Overall Study|Lost to Follow-up|5
7670402|NCT00171223|12085617|FG001|Overall Study|Lost to Follow-up|2
7670403|NCT00171223|12085618|FG002|Overall Study|Lost to Follow-up|3
7670404|NCT00171223|12085616|FG000|Overall Study|Administrative Problems|4
7670405|NCT00171223|12085617|FG001|Overall Study|Administrative Problems|7
7670406|NCT00171223|12085618|FG002|Overall Study|Administrative Problems|6
7670407|NCT00171223|12085616|FG000|Overall Study|Adverse Event (Serious Fatal)|6
7670408|NCT00171223|12085617|FG001|Overall Study|Adverse Event (Serious Fatal)|8
7670409|NCT00171223|12085618|FG002|Overall Study|Adverse Event (Serious Fatal)|9
7670410|NCT00171223|12085616|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41
7670411|NCT00171223|12085617|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47
7670412|NCT00171223|12085618|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58
7670413|NCT00171249|12085624|FG000|Overall Study|Withdrawal by Subject|2
7670414|NCT00171249|12085625|FG001|Overall Study|Withdrawal by Subject|0
7670415|NCT00171249|12085626|FG002|Overall Study|Withdrawal by Subject|0
7670416|NCT00171249|12085627|FG003|Overall Study|Withdrawal by Subject|6
7670417|NCT00171249|12085628|FG004|Overall Study|Withdrawal by Subject|0
7670418|NCT00171249|12085629|FG005|Overall Study|Withdrawal by Subject|0
7670419|NCT00171249|12085630|FG006|Overall Study|Withdrawal by Subject|0
7670420|NCT00171249|12085624|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44
7670421|NCT00171249|12085625|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3
7670422|NCT00171249|12085626|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5
7670423|NCT00171249|12085627|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70
7670424|NCT00171249|12085628|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3
7670425|NCT00171249|12085629|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31
7670426|NCT00171249|12085630|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1
7670427|NCT00171249|12085624|FG000|Overall Study|Death|7
7670428|NCT00171249|12085625|FG001|Overall Study|Death|1
7670429|NCT00171249|12085626|FG002|Overall Study|Death|0
7670430|NCT00171249|12085627|FG003|Overall Study|Death|4
7670431|NCT00171249|12085628|FG004|Overall Study|Death|0
7670432|NCT00171249|12085629|FG005|Overall Study|Death|3
7670433|NCT00171249|12085630|FG006|Overall Study|Death|1
7670434|NCT00171249|12085624|FG000|Overall Study|Other|10
7670435|NCT00171249|12085625|FG001|Overall Study|Other|0
7670436|NCT00171249|12085626|FG002|Overall Study|Other|0
7670437|NCT00171249|12085627|FG003|Overall Study|Other|43
7670438|NCT00171249|12085628|FG004|Overall Study|Other|0
7670439|NCT00171249|12085629|FG005|Overall Study|Other|2
7670440|NCT00171249|12085630|FG006|Overall Study|Other|0
7670441|NCT00171249|12085624|FG000|Overall Study|No Longer Requires Study Drug|4
7670442|NCT00171249|12085625|FG001|Overall Study|No Longer Requires Study Drug|0
7670443|NCT00171249|12085626|FG002|Overall Study|No Longer Requires Study Drug|0
7670444|NCT00171249|12085627|FG003|Overall Study|No Longer Requires Study Drug|3
7670445|NCT00171249|12085628|FG004|Overall Study|No Longer Requires Study Drug|0
7670446|NCT00171249|12085629|FG005|Overall Study|No Longer Requires Study Drug|5
7670447|NCT00171249|12085630|FG006|Overall Study|No Longer Requires Study Drug|0
7670448|NCT00171249|12085624|FG000|Overall Study|Administrative Problems|1
7670449|NCT00171249|12085625|FG001|Overall Study|Administrative Problems|0
7670450|NCT00171249|12085626|FG002|Overall Study|Administrative Problems|0
7670451|NCT00171249|12085627|FG003|Overall Study|Administrative Problems|2
7670452|NCT00171249|12085628|FG004|Overall Study|Administrative Problems|0
7670453|NCT00171249|12085629|FG005|Overall Study|Administrative Problems|0
7670454|NCT00171249|12085630|FG006|Overall Study|Administrative Problems|0
7670455|NCT00171249|12085624|FG000|Overall Study|Adverse Event|3
7670456|NCT00171249|12085625|FG001|Overall Study|Adverse Event|1
7670457|NCT00171249|12085626|FG002|Overall Study|Adverse Event|0
7670458|NCT00171249|12085627|FG003|Overall Study|Adverse Event|15
7670459|NCT00171249|12085628|FG004|Overall Study|Adverse Event|0
7670460|NCT00171249|12085629|FG005|Overall Study|Adverse Event|2
7670461|NCT00171249|12085630|FG006|Overall Study|Adverse Event|0
7670462|NCT00171249|12085624|FG000|Overall Study|Lost to Follow-up|5
7670463|NCT00171249|12085625|FG001|Overall Study|Lost to Follow-up|0
7670464|NCT00171249|12085626|FG002|Overall Study|Lost to Follow-up|0
7670465|NCT00171249|12085627|FG003|Overall Study|Lost to Follow-up|9
7670466|NCT00171249|12085628|FG004|Overall Study|Lost to Follow-up|0
7670467|NCT00171249|12085629|FG005|Overall Study|Lost to Follow-up|0
7670468|NCT00171249|12085630|FG006|Overall Study|Lost to Follow-up|0
7670469|NCT00171301|12085641|FG000|Overall Study|Death|1
7670470|NCT00171301|12085642|FG001|Overall Study|Death|2
7670471|NCT00171301|12085641|FG000|Overall Study|Adverse Event|1
7670472|NCT00171301|12085642|FG001|Overall Study|Adverse Event|2
7670473|NCT00171301|12085641|FG000|Overall Study|Lost to Follow-up|6
7670474|NCT00171301|12085642|FG001|Overall Study|Lost to Follow-up|2
7670475|NCT00171301|12085641|FG000|Overall Study|Protocol Violation|0
7670476|NCT00171301|12085642|FG001|Overall Study|Protocol Violation|2
7670477|NCT00171301|12085641|FG000|Overall Study|Withdrawal by Subject|0
7670478|NCT00171301|12085642|FG001|Overall Study|Withdrawal by Subject|1
7670479|NCT00171314|12085651|FG000|Overall Study|Adverse Event|44
7670480|NCT00171314|12085652|FG001|Overall Study|Adverse Event|41
7670481|NCT00171314|12085651|FG000|Overall Study|Lack of Efficacy|19
7670482|NCT00171314|12085652|FG001|Overall Study|Lack of Efficacy|14
7670483|NCT00171314|12085651|FG000|Overall Study|Withdrawal by Subject|9
7670484|NCT00171314|12085652|FG001|Overall Study|Withdrawal by Subject|6
7670485|NCT00171314|12085651|FG000|Overall Study|Abnormal Test Procedure Results|9
7670486|NCT00171314|12085652|FG001|Overall Study|Abnormal Test Procedure Results|3
7670487|NCT00171314|12085651|FG000|Overall Study|Protocol Violation|3
7670488|NCT00171314|12085652|FG001|Overall Study|Protocol Violation|7
7670489|NCT00171314|12085651|FG000|Overall Study|Administrative Problems|4
7670490|NCT00171314|12085652|FG001|Overall Study|Administrative Problems|3
7670491|NCT00171314|12085651|FG000|Overall Study|Lost to Follow-up|1
7670492|NCT00171314|12085652|FG001|Overall Study|Lost to Follow-up|3
7670493|NCT00171314|12085651|FG000|Overall Study|Death|2
7670494|NCT00171314|12085652|FG001|Overall Study|Death|1
7670495|NCT00171340|12085660|FG000|Overall Study|Adverse Event|46
7670496|NCT00171340|12085661|FG001|Overall Study|Adverse Event|42
7670497|NCT00171340|12085660|FG000|Overall Study|Lack of Efficacy|29
7670498|NCT00171340|12085661|FG001|Overall Study|Lack of Efficacy|41
7670499|NCT00171340|12085660|FG000|Overall Study|Protocol Violation|7
7670500|NCT00171340|12085661|FG001|Overall Study|Protocol Violation|8
7670501|NCT00171340|12085660|FG000|Overall Study|Withdrawal by Subject|22
7670502|NCT00171340|12085661|FG001|Overall Study|Withdrawal by Subject|19
7670503|NCT00171340|12085660|FG000|Overall Study|Lost to Follow-up|0
7670504|NCT00171340|12085661|FG001|Overall Study|Lost to Follow-up|5
7670505|NCT00171340|12085660|FG000|Overall Study|Abnormal Laboratory Results|2
7670506|NCT00171340|12085661|FG001|Overall Study|Abnormal Laboratory Results|0
7670507|NCT00171340|12085660|FG000|Overall Study|Abnormal Test Procedure Results|6
7670508|NCT00171340|12085661|FG001|Overall Study|Abnormal Test Procedure Results|11
7670509|NCT00171340|12085660|FG000|Overall Study|No Longer Required Study Drug|1
7670510|NCT00171340|12085661|FG001|Overall Study|No Longer Required Study Drug|1
7670511|NCT00171340|12085660|FG000|Overall Study|Administrative Problems|5
7670512|NCT00171340|12085661|FG001|Overall Study|Administrative Problems|2
7670513|NCT00171340|12085660|FG000|Overall Study|Death|6
7670514|NCT00171340|12085661|FG001|Overall Study|Death|6
7670515|NCT00171704|12085671|FG000|Overall Study|Adverse Event|24
7670516|NCT00171704|12085672|FG001|Overall Study|Adverse Event|33
7670517|NCT00171704|12085671|FG000|Overall Study|Disease Progression|14
7670518|NCT00171704|12085672|FG001|Overall Study|Disease Progression|9
7670519|NCT00171704|12085671|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1
7670520|NCT00171704|12085672|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0
7670521|NCT00171704|12085671|FG000|Overall Study|Administrative Problems|2
7670522|NCT00171704|12085672|FG001|Overall Study|Administrative Problems|1
7670523|NCT00171704|12085671|FG000|Overall Study|Death|2
7670524|NCT00171704|12085672|FG001|Overall Study|Death|2
7670525|NCT00171704|12085671|FG000|Overall Study|Withdrawal by Subject|1
7670526|NCT00171704|12085672|FG001|Overall Study|Withdrawal by Subject|3
7670527|NCT00171704|12085671|FG000|Overall Study|Protocol Violation|0
7670528|NCT00171704|12085672|FG001|Overall Study|Protocol Violation|1
7670529|NCT00171730|12085678|FG000|Overall Study|Adverse Event|3
7670530|NCT00171730|12085678|FG000|Overall Study|Abnormal Laboratory Value(s)|1
7670531|NCT00171730|12085678|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8
7670532|NCT00171730|12085678|FG000|Overall Study|Withdrawal by Subject|3
7670533|NCT00171834|12085695|FG000|Overall Study|Adverse Event|2
7670534|NCT00171834|12085696|FG001|Overall Study|Adverse Event|1
7670535|NCT00171834|12085697|FG002|Overall Study|Adverse Event|3
7670536|NCT00171834|12085698|FG003|Overall Study|Adverse Event|2
7670537|NCT00171834|12085699|FG004|Overall Study|Adverse Event|2
7670538|NCT00171834|12085700|FG005|Overall Study|Adverse Event|15
7670539|NCT00171834|12085701|FG006|Overall Study|Adverse Event|1
7670540|NCT00171834|12085695|FG000|Overall Study|Withdrawal by Subject|0
7670541|NCT00171834|12085696|FG001|Overall Study|Withdrawal by Subject|2
7670542|NCT00171834|12085697|FG002|Overall Study|Withdrawal by Subject|0
7670543|NCT00171834|12085698|FG003|Overall Study|Withdrawal by Subject|1
7670544|NCT00171834|12085699|FG004|Overall Study|Withdrawal by Subject|1
7670545|NCT00171834|12085700|FG005|Overall Study|Withdrawal by Subject|1
7670546|NCT00171834|12085701|FG006|Overall Study|Withdrawal by Subject|0
7670547|NCT00171834|12085695|FG000|Overall Study|Death from study indication|0
7670548|NCT00171834|12085696|FG001|Overall Study|Death from study indication|1
7670549|NCT00171834|12085697|FG002|Overall Study|Death from study indication|0
7670550|NCT00171834|12085698|FG003|Overall Study|Death from study indication|0
7670551|NCT00171834|12085699|FG004|Overall Study|Death from study indication|1
7670552|NCT00171834|12085700|FG005|Overall Study|Death from study indication|0
7670553|NCT00171834|12085701|FG006|Overall Study|Death from study indication|0
7670554|NCT00171834|12085695|FG000|Overall Study|Disease Progression|4
7670555|NCT00171834|12085696|FG001|Overall Study|Disease Progression|8
7670556|NCT00171834|12085697|FG002|Overall Study|Disease Progression|8
7670557|NCT00171834|12085698|FG003|Overall Study|Disease Progression|9
7670558|NCT00171834|12085699|FG004|Overall Study|Disease Progression|2
7670559|NCT00171834|12085700|FG005|Overall Study|Disease Progression|18
7670560|NCT00171834|12085701|FG006|Overall Study|Disease Progression|3
7670561|NCT00171834|12085695|FG000|Overall Study|Treatment Duration Completed|0
7670562|NCT00171834|12085696|FG001|Overall Study|Treatment Duration Completed|0
7670563|NCT00171834|12085697|FG002|Overall Study|Treatment Duration Completed|1
7670564|NCT00171834|12085698|FG003|Overall Study|Treatment Duration Completed|0
7670565|NCT00171834|12085699|FG004|Overall Study|Treatment Duration Completed|2
7670566|NCT00171834|12085700|FG005|Overall Study|Treatment Duration Completed|1
7670567|NCT00171834|12085701|FG006|Overall Study|Treatment Duration Completed|0
7670568|NCT00171873|12085733|FG000|Overall Study|Withdrawal by Subject|4
7670569|NCT00171873|12085734|FG001|Overall Study|Withdrawal by Subject|2
7670570|NCT00171873|12085733|FG000|Overall Study|Adverse Event|5
7670571|NCT00171873|12085734|FG001|Overall Study|Adverse Event|0
7670572|NCT00171873|12085733|FG000|Overall Study|Switched to Octreotide|0
7670573|NCT00171873|12085734|FG001|Overall Study|Switched to Octreotide|1
7670574|NCT00171925|12085742|FG000|Overall Study|Adverse Event|10
7670575|NCT00171925|12085743|FG001|Overall Study|Adverse Event|6
7670576|NCT00171925|12085742|FG000|Overall Study|Protocol Violation|1
7670577|NCT00171925|12085743|FG001|Overall Study|Protocol Violation|1
7670578|NCT00171925|12085742|FG000|Overall Study|Withdrawal by Subject|6
7670579|NCT00171925|12085743|FG001|Overall Study|Withdrawal by Subject|9
7670580|NCT00171925|12085742|FG000|Overall Study|Lost to Follow-up|2
7670581|NCT00171925|12085743|FG001|Overall Study|Lost to Follow-up|2
7670582|NCT00171925|12085742|FG000|Overall Study|Administrative problems|10
7670583|NCT00171925|12085743|FG001|Overall Study|Administrative problems|11
7670584|NCT00171925|12085742|FG000|Overall Study|Death|1
7670585|NCT00171925|12085743|FG001|Overall Study|Death|2
7670586|NCT00171951|12085749|FG000|Overall Study|Adverse Event|1
7670587|NCT00171951|12085749|FG000|Overall Study|Abnormal Laboratory Values|2
7670588|NCT00171951|12085749|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
7670589|NCT00171951|12085749|FG000|Overall Study|Participants Withdrew Consent|3
7670590|NCT00171951|12085749|FG000|Overall Study|New Cancer Therapy|5
7670591|NCT00171951|12085749|FG000|Overall Study|Reason not Specified|2
7670592|NCT00172042|12085758|FG000|Overall Study|Adverse Event|27
7670593|NCT00172042|12085759|FG001|Overall Study|Adverse Event|13
7670594|NCT00172042|12085758|FG000|Overall Study|Abnormal laboratory value(s)|5
7670595|NCT00172042|12085759|FG001|Overall Study|Abnormal laboratory value(s)|1
7670596|NCT00172042|12085758|FG000|Overall Study|Abnormal test procedure(s)|0
7670597|NCT00172042|12085759|FG001|Overall Study|Abnormal test procedure(s)|3
7670598|NCT00172042|12085758|FG000|Overall Study|Unsatisfactory therapeutic effect|13
7670599|NCT00172042|12085759|FG001|Overall Study|Unsatisfactory therapeutic effect|11
7670600|NCT00172042|12085758|FG000|Overall Study|Patient no longer requires study drug|10
7670601|NCT00172042|12085759|FG001|Overall Study|Patient no longer requires study drug|8
7670602|NCT00172042|12085758|FG000|Overall Study|Protocol Violation|8
7670603|NCT00172042|12085759|FG001|Overall Study|Protocol Violation|7
7670604|NCT00172042|12085758|FG000|Overall Study|Withdrawal by Subject|37
7670605|NCT00172042|12085759|FG001|Overall Study|Withdrawal by Subject|25
7670606|NCT00172042|12085758|FG000|Overall Study|Lost to Follow-up|3
7670607|NCT00172042|12085759|FG001|Overall Study|Lost to Follow-up|5
7670608|NCT00172042|12085758|FG000|Overall Study|Administrative problems|13
7670609|NCT00172042|12085759|FG001|Overall Study|Administrative problems|10
7670610|NCT00172042|12085758|FG000|Overall Study|Death|42
7670611|NCT00172042|12085759|FG001|Overall Study|Death|42
7670612|NCT00172185|12085769|FG000|Overall Study|Adverse Event|0
7670613|NCT00172185|12085770|FG001|Overall Study|Adverse Event|1
7670614|NCT00172185|12085771|FG002|Overall Study|Adverse Event|3
7670615|NCT00172185|12085772|FG003|Overall Study|Adverse Event|4
7670616|NCT00172185|12085769|FG000|Overall Study|Physician Decision|0
7670617|NCT00172185|12085770|FG001|Overall Study|Physician Decision|0
7670618|NCT00172185|12085771|FG002|Overall Study|Physician Decision|1
7670619|NCT00172185|12085772|FG003|Overall Study|Physician Decision|0
7670620|NCT00172185|12085769|FG000|Overall Study|SPONSOR Decision|0
7670621|NCT00172185|12085770|FG001|Overall Study|SPONSOR Decision|1
7670622|NCT00172185|12085771|FG002|Overall Study|SPONSOR Decision|0
7670623|NCT00172185|12085772|FG003|Overall Study|SPONSOR Decision|0
7670624|NCT00172185|12085769|FG000|Overall Study|Withdrawal by Subject|0
7670625|NCT00172185|12085770|FG001|Overall Study|Withdrawal by Subject|0
7670626|NCT00172185|12085771|FG002|Overall Study|Withdrawal by Subject|1
7670627|NCT00172185|12085772|FG003|Overall Study|Withdrawal by Subject|0
7670628|NCT00174187|12085788|FG000|Period 1 (up to 3 Years)|Serious adverse event|0
7670629|NCT00174187|12085789|FG001|Period 1 (up to 3 Years)|Serious adverse event|1
7670630|NCT00174187|12085790|FG002|Period 1 (up to 3 Years)|Serious adverse event|0
7670631|NCT00174187|12085788|FG000|Period 1 (up to 3 Years)|Non compliance|0
7670632|NCT00174187|12085789|FG001|Period 1 (up to 3 Years)|Non compliance|1
7670633|NCT00174187|12085790|FG002|Period 1 (up to 3 Years)|Non compliance|0
7670634|NCT00174187|12085788|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0
7670635|NCT00174187|12085789|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1
7670636|NCT00174187|12085790|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0
7670637|NCT00174187|12085788|FG000|Period 1 (up to 3 Years)|Other|0
7670638|NCT00174187|12085789|FG001|Period 1 (up to 3 Years)|Other|1
7670639|NCT00174187|12085790|FG002|Period 1 (up to 3 Years)|Other|0
7670640|NCT00174187|12085788|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0
7670641|NCT00174187|12085789|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0
7670642|NCT00174187|12085790|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2
7670643|NCT00174187|12085788|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0
7670644|NCT00174187|12085789|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0
7670645|NCT00174187|12085790|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3
7670646|NCT00174187|12085788|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0
7670647|NCT00174187|12085789|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0
7670648|NCT00174187|12085790|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2
7670649|NCT00174187|12085788|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0
7670650|NCT00174187|12085789|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0
7670651|NCT00174187|12085790|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1
7670652|NCT00174187|12085788|FG000|Period 2 (After 3 Years)|Other|0
7670653|NCT00174187|12085789|FG001|Period 2 (After 3 Years)|Other|0
7670654|NCT00174187|12085790|FG002|Period 2 (After 3 Years)|Other|5
7670655|NCT00174252|12085798|FG000|Overall Study|Protocol Violation|2
7670656|NCT00174291|12085806|FG000|Overall Study|Lost to Follow-up|1
7670657|NCT00174291|12085807|FG001|Overall Study|Lost to Follow-up|1
7670658|NCT00174291|12085806|FG000|Overall Study|Protocol Violation|0
7670659|NCT00174291|12085807|FG001|Overall Study|Protocol Violation|2
7670660|NCT00174291|12085806|FG000|Overall Study|Study terminated by sponsor|1
7670661|NCT00174291|12085807|FG001|Overall Study|Study terminated by sponsor|0
7670662|NCT00174291|12085806|FG000|Overall Study|Withdrawal by Subject|3
7670663|NCT00174291|12085807|FG001|Overall Study|Withdrawal by Subject|3
7670664|NCT00174382|12085813|FG000|Overall Study|Death|2
7670665|NCT00174382|12085813|FG000|Overall Study|Adverse Event|19
7670666|NCT00174382|12085813|FG000|Overall Study|Withdrawal by Subject|6
7670667|NCT00174382|12085813|FG000|Overall Study|Protocol Violation|3
7670668|NCT00174382|12085813|FG000|Overall Study|Arrived early for last visit in error|1
7670669|NCT00174382|12085813|FG000|Overall Study|Subject felt pill not effective enough|1
7670670|NCT00174382|12085813|FG000|Overall Study|Lost to Follow-up|1
7670671|NCT00174447|12085817|FG000|Overall Study|Adverse Event|19
7670672|NCT00174447|12085817|FG000|Overall Study|Withdrawal by Subject|15
7670673|NCT00174447|12085817|FG000|Overall Study|Protocol Violation|1
7670674|NCT00174447|12085817|FG000|Overall Study|Lack of Efficacy|1
7670675|NCT00174447|12085817|FG000|Overall Study|Administrative reason/Other|2
7670676|NCT00174460|12085823|FG000|Overall Study|Withdrawal by Subject|0
7670677|NCT00174460|12085824|FG001|Overall Study|Withdrawal by Subject|1
7670678|NCT00174785|12085833|FG000|Overall Study|Adverse Event|293
7670679|NCT00174785|12085834|FG001|Overall Study|Adverse Event|191
7670680|NCT00174785|12085833|FG000|Overall Study|Protocol Violation|14
7670681|NCT00174785|12085834|FG001|Overall Study|Protocol Violation|14
7670682|NCT00174785|12085833|FG000|Overall Study|Withdrawal by Subject|173
7670683|NCT00174785|12085834|FG001|Overall Study|Withdrawal by Subject|175
7670684|NCT00174785|12085833|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110
7670685|NCT00174785|12085834|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167
7670686|NCT00174785|12085833|FG000|Overall Study|Prohibited antiarrhythmic medication|39
7670687|NCT00174785|12085834|FG001|Overall Study|Prohibited antiarrhythmic medication|88
7670688|NCT00174785|12085833|FG000|Overall Study|Other prohibited medication|5
7670689|NCT00174785|12085834|FG001|Overall Study|Other prohibited medication|3
7670690|NCT00174785|12085833|FG000|Overall Study|Family request|6
7670691|NCT00174785|12085834|FG001|Overall Study|Family request|8
7670692|NCT00174785|12085833|FG000|Overall Study|Not pre-specified/Not coded|56
7670693|NCT00174785|12085834|FG001|Overall Study|Not pre-specified/Not coded|70
7670694|NCT00174915|12085845|FG000|Overall Study|Lost to Follow-up|19
7670695|NCT00174915|12085846|FG001|Overall Study|Lost to Follow-up|17
7670696|NCT00174915|12085847|FG002|Overall Study|Lost to Follow-up|9
7670697|NCT00174915|12085848|FG003|Overall Study|Lost to Follow-up|17
7670698|NCT00174915|12085849|FG004|Overall Study|Lost to Follow-up|10
7670699|NCT00174915|12085845|FG000|Overall Study|Adverse Event|18
7670700|NCT00174915|12085846|FG001|Overall Study|Adverse Event|16
7670701|NCT00174915|12085847|FG002|Overall Study|Adverse Event|11
7670702|NCT00174915|12085848|FG003|Overall Study|Adverse Event|18
7670703|NCT00174915|12085849|FG004|Overall Study|Adverse Event|5
7670704|NCT00174915|12085845|FG000|Overall Study|Personal Reason(s)|16
7670705|NCT00174915|12085846|FG001|Overall Study|Personal Reason(s)|16
7670706|NCT00174915|12085847|FG002|Overall Study|Personal Reason(s)|9
7670707|NCT00174915|12085848|FG003|Overall Study|Personal Reason(s)|9
7670708|NCT00174915|12085849|FG004|Overall Study|Personal Reason(s)|9
7670709|NCT00174915|12085845|FG000|Overall Study|Other|15
7670710|NCT00174915|12085846|FG001|Overall Study|Other|8
7670711|NCT00174915|12085847|FG002|Overall Study|Other|6
7670712|NCT00174915|12085848|FG003|Overall Study|Other|5
7670713|NCT00174915|12085849|FG004|Overall Study|Other|3
7670714|NCT00174915|12085845|FG000|Overall Study|Gout Flare|13
7670715|NCT00174915|12085846|FG001|Overall Study|Gout Flare|6
7670716|NCT00174915|12085847|FG002|Overall Study|Gout Flare|8
7670717|NCT00174915|12085848|FG003|Overall Study|Gout Flare|1
7670718|NCT00174915|12085849|FG004|Overall Study|Gout Flare|0
7670719|NCT00174915|12085845|FG000|Overall Study|Protocol Violation|6
7670720|NCT00174915|12085846|FG001|Overall Study|Protocol Violation|3
7670721|NCT00174915|12085847|FG002|Overall Study|Protocol Violation|3
7670722|NCT00174915|12085848|FG003|Overall Study|Protocol Violation|6
7670723|NCT00174915|12085849|FG004|Overall Study|Protocol Violation|3
7670724|NCT00174915|12085845|FG000|Overall Study|Therapeutic Failure|6
7670725|NCT00174915|12085846|FG001|Overall Study|Therapeutic Failure|3
7670726|NCT00174915|12085847|FG002|Overall Study|Therapeutic Failure|2
7670727|NCT00174915|12085848|FG003|Overall Study|Therapeutic Failure|1
7670728|NCT00174915|12085849|FG004|Overall Study|Therapeutic Failure|3
7670729|NCT00174941|12085864|FG000|Overall Study|Adverse Event|1
7670730|NCT00174941|12085865|FG001|Overall Study|Adverse Event|10
7670731|NCT00174941|12085866|FG002|Overall Study|Adverse Event|2
7670732|NCT00174941|12085867|FG003|Overall Study|Adverse Event|13
7670733|NCT00174941|12085864|FG000|Overall Study|Protocol Violation|0
7670734|NCT00174941|12085865|FG001|Overall Study|Protocol Violation|1
7670735|NCT00174941|12085866|FG002|Overall Study|Protocol Violation|0
7670736|NCT00174941|12085867|FG003|Overall Study|Protocol Violation|1
7670737|NCT00174941|12085864|FG000|Overall Study|Lost to Follow-up|0
7670738|NCT00174941|12085865|FG001|Overall Study|Lost to Follow-up|3
7670739|NCT00174941|12085866|FG002|Overall Study|Lost to Follow-up|2
7670740|NCT00174941|12085867|FG003|Overall Study|Lost to Follow-up|5
7670741|NCT00174941|12085864|FG000|Overall Study|Personal Reason(s)|0
7670742|NCT00174941|12085865|FG001|Overall Study|Personal Reason(s)|14
7670743|NCT00174941|12085866|FG002|Overall Study|Personal Reason(s)|8
7670744|NCT00174941|12085867|FG003|Overall Study|Personal Reason(s)|22
7670745|NCT00174941|12085864|FG000|Overall Study|Gout Flare|0
7670746|NCT00174941|12085865|FG001|Overall Study|Gout Flare|4
7670747|NCT00174941|12085866|FG002|Overall Study|Gout Flare|4
7670748|NCT00174941|12085867|FG003|Overall Study|Gout Flare|8
7670749|NCT00174941|12085864|FG000|Overall Study|Reason Not Specified|1
7670750|NCT00174941|12085865|FG001|Overall Study|Reason Not Specified|6
7670751|NCT00174941|12085866|FG002|Overall Study|Reason Not Specified|2
7670752|NCT00174941|12085867|FG003|Overall Study|Reason Not Specified|9
7670753|NCT00174954|12085877|FG000|Overall Study|Adverse Event|2
7670754|NCT00174954|12085877|FG000|Overall Study|No tophi found in MRI|1
7670755|NCT00174954|12085877|FG000|Overall Study|Physician Decision|1
7670756|NCT00174967|12085885|FG000|Overall Study|Adverse Event|1
7670757|NCT00174967|12085886|FG001|Overall Study|Adverse Event|2
7670758|NCT00174967|12085887|FG002|Overall Study|Adverse Event|2
7670759|NCT00174967|12085888|FG003|Overall Study|Adverse Event|1
7670760|NCT00174967|12085885|FG000|Overall Study|Gout Flare|0
7670761|NCT00174967|12085886|FG001|Overall Study|Gout Flare|0
7670762|NCT00174967|12085887|FG002|Overall Study|Gout Flare|0
7670763|NCT00174967|12085888|FG003|Overall Study|Gout Flare|1
7670764|NCT00174967|12085885|FG000|Overall Study|Other|0
7670765|NCT00174967|12085886|FG001|Overall Study|Other|1
7670766|NCT00174967|12085887|FG002|Overall Study|Other|0
7670767|NCT00174967|12085888|FG003|Overall Study|Other|0
7670768|NCT00175019|12085905|FG000|Overall Study|Adverse Event|54
7670769|NCT00175019|12085906|FG001|Overall Study|Adverse Event|22
7670770|NCT00175019|12085907|FG002|Overall Study|Adverse Event|2
7670771|NCT00175019|12085905|FG000|Overall Study|Protocol Violation|6
7670772|NCT00175019|12085906|FG001|Overall Study|Protocol Violation|3
7670773|NCT00175019|12085907|FG002|Overall Study|Protocol Violation|3
7670774|NCT00175019|12085905|FG000|Overall Study|Lost to Follow-up|42
7670775|NCT00175019|12085906|FG001|Overall Study|Lost to Follow-up|39
7670776|NCT00175019|12085907|FG002|Overall Study|Lost to Follow-up|9
7670777|NCT00175019|12085905|FG000|Overall Study|Did not continue under Amendment 4|1
7670778|NCT00175019|12085906|FG001|Overall Study|Did not continue under Amendment 4|1
7670779|NCT00175019|12085907|FG002|Overall Study|Did not continue under Amendment 4|2
7670780|NCT00175019|12085905|FG000|Overall Study|Personal Reason(s)|39
7670781|NCT00175019|12085906|FG001|Overall Study|Personal Reason(s)|31
7670782|NCT00175019|12085907|FG002|Overall Study|Personal Reason(s)|8
7670783|NCT00175019|12085905|FG000|Overall Study|Therapeutic Failure|10
7670784|NCT00175019|12085906|FG001|Overall Study|Therapeutic Failure|38
7670785|NCT00175019|12085907|FG002|Overall Study|Therapeutic Failure|22
7670786|NCT00175019|12085905|FG000|Overall Study|Gout Flare|2
7670787|NCT00175019|12085906|FG001|Overall Study|Gout Flare|3
7670788|NCT00175019|12085907|FG002|Overall Study|Gout Flare|0
7670789|NCT00175019|12085905|FG000|Overall Study|Reason Not Specified|40
7670790|NCT00175019|12085906|FG001|Overall Study|Reason Not Specified|34
7670791|NCT00175019|12085907|FG002|Overall Study|Reason Not Specified|11
7670792|NCT00175825|12085919|FG000|Overall Study|Adverse Event|3
7670793|NCT00175825|12085920|FG001|Overall Study|Adverse Event|2
7670794|NCT00175825|12085921|FG002|Overall Study|Adverse Event|1
7670795|NCT00175825|12085922|FG003|Overall Study|Adverse Event|1
7670796|NCT00175825|12085919|FG000|Overall Study|Lost to Follow-up|1
7670797|NCT00175825|12085920|FG001|Overall Study|Lost to Follow-up|2
7670798|NCT00175825|12085921|FG002|Overall Study|Lost to Follow-up|0
7670799|NCT00175825|12085922|FG003|Overall Study|Lost to Follow-up|0
7670800|NCT00175825|12085919|FG000|Overall Study|Withdrawal by Subject|1
7670801|NCT00175825|12085920|FG001|Overall Study|Withdrawal by Subject|0
7670802|NCT00175825|12085921|FG002|Overall Study|Withdrawal by Subject|0
7670803|NCT00175825|12085922|FG003|Overall Study|Withdrawal by Subject|0
7670804|NCT00175877|12085932|FG000|Overall Study|Adverse Event|136
7670805|NCT00175877|12085932|FG000|Overall Study|Withdrawal by Subject|141
7670806|NCT00175877|12085932|FG000|Overall Study|Lost to Follow-up|9
7670807|NCT00175877|12085932|FG000|Overall Study|Lack of Efficacy|26
7670808|NCT00175877|12085932|FG000|Overall Study|Protocol Violation|15
7670809|NCT00175877|12085932|FG000|Overall Study|Other Reason|20
7670810|NCT00175877|12085932|FG000|Overall Study|AE & Other|1
7670811|NCT00175877|12085932|FG000|Overall Study|Withdrawal by subject & Other|1
7670812|NCT00175916|12085936|FG000|Overall Study|Death|19
7670813|NCT00175916|12085936|FG000|Overall Study|Adverse Event|81
7670814|NCT00175916|12085936|FG000|Overall Study|Lack of Efficacy|354
7670815|NCT00175916|12085936|FG000|Overall Study|Lost to Follow-up|17
7670816|NCT00175916|12085936|FG000|Overall Study|Subject Choice|98
7670817|NCT00175916|12085936|FG000|Overall Study|Lack of compliance|8
7670818|NCT00175916|12085936|FG000|Overall Study|Patient cannot record seizures|1
7670819|NCT00175916|12085936|FG000|Overall Study|Sponsor decision|17
7670820|NCT00175916|12085936|FG000|Overall Study|Vigabatrin intake|1
7670821|NCT00175916|12085936|FG000|Overall Study|Suicidal behaviour|1
7670822|NCT00175916|12085936|FG000|Overall Study|Withdrawal by Subject|1
7670823|NCT00175916|12085936|FG000|Overall Study|Seizure - free|4
7670824|NCT00175916|12085936|FG000|Overall Study|Administrative reason|1
7670825|NCT00175916|12085936|FG000|Overall Study|Pregnancy|1
7670826|NCT00175916|12085936|FG000|Overall Study|Patient's request|2
7670827|NCT00175916|12085936|FG000|Overall Study|Treating physiciant's choice|1
7670828|NCT00175916|12085936|FG000|Overall Study|Moved overseas|1
7670829|NCT00175916|12085936|FG000|Overall Study|Loss of job and economic burden|1
7670830|NCT00175916|12085936|FG000|Overall Study|Site was closed|9
7670831|NCT00175916|12085936|FG000|Overall Study|Patient went to prison|1
7670832|NCT00176254|12085957|FG000|Overall Study|Lost to Follow-up|1
7670833|NCT00176462|12085976|FG000|Induction (4 Weeks)|Withdrawal by Subject|0
7670834|NCT00176462|12085977|FG001|Induction (4 Weeks)|Withdrawal by Subject|2
7670835|NCT00176462|12085976|FG000|Induction (4 Weeks)|Death|1
7670836|NCT00176462|12085977|FG001|Induction (4 Weeks)|Death|2
7670837|NCT00176462|12085976|FG000|Induction (4 Weeks)|Lack of Efficacy|0
7670838|NCT00176462|12085977|FG001|Induction (4 Weeks)|Lack of Efficacy|1
7670839|NCT00176462|12085976|FG000|Consolidation (12 Weeks)|Patient moved to another state|0
7670840|NCT00176462|12085977|FG001|Consolidation (12 Weeks)|Patient moved to another state|1
7670841|NCT00176462|12085976|FG000|Consolidation (12 Weeks)|Adverse Event|0
7670842|NCT00176462|12085977|FG001|Consolidation (12 Weeks)|Adverse Event|1
7670843|NCT00176462|12085976|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0
7670844|NCT00176462|12085977|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2
7670845|NCT00176462|12085976|FG000|Consolidation (12 Weeks)|Not documented|0
7670846|NCT00176462|12085977|FG001|Consolidation (12 Weeks)|Not documented|1
7670847|NCT00176462|12085976|FG000|Intensive Continuation (8X8-week Cycles)|Death|1
7670848|NCT00176462|12085977|FG001|Intensive Continuation (8X8-week Cycles)|Death|0
7670849|NCT00176462|12085976|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
7670850|NCT00176462|12085977|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
7670851|NCT00176605|12085993|FG000|Overall Study|Withdrawal by Subject|2
7670852|NCT00176644|12085997|FG000|Overall Study|Withdrawal by Subject|1
7670853|NCT00177164|12086094|FG000|Overall Study|Protocol Violation|0
7670854|NCT00177164|12086095|FG001|Overall Study|Protocol Violation|7
7670855|NCT00177164|12086094|FG000|Overall Study|Lost to Follow-up|4
7670856|NCT00177164|12086095|FG001|Overall Study|Lost to Follow-up|5
7670857|NCT00177164|12086094|FG000|Overall Study|increase in alcohol and drug use|1
7670858|NCT00177164|12086095|FG001|Overall Study|increase in alcohol and drug use|2
7670859|NCT00177164|12086094|FG000|Overall Study|Adverse Event|1
7670860|NCT00177164|12086095|FG001|Overall Study|Adverse Event|0
7670861|NCT00177164|12086094|FG000|Overall Study|discharge from hospital|1
7670862|NCT00177164|12086095|FG001|Overall Study|discharge from hospital|0
7670863|NCT00177164|12086094|FG000|Overall Study|Lack of Efficacy|2
7670864|NCT00177164|12086095|FG001|Overall Study|Lack of Efficacy|1
7670865|NCT00177164|12086094|FG000|Overall Study|Pregnancy|0
7670866|NCT00177164|12086095|FG001|Overall Study|Pregnancy|1
7670867|NCT00177216|12086104|FG000|Overall Study|Withdrawal by Subject|6
7670868|NCT00177216|12086105|FG001|Overall Study|Withdrawal by Subject|3
7670869|NCT00177216|12086106|FG002|Overall Study|Withdrawal by Subject|1
7670870|NCT00177294|12086124|FG000|Overall Study|Withdrawal by Subject|7
7670871|NCT00177294|12086125|FG001|Overall Study|Withdrawal by Subject|5
7670872|NCT00177307|12086131|FG000|Overall Study|Withdrawal by Subject|1
7670873|NCT00177671|12086137|FG000|Overall Study|Withdrawal by Subject|5
7670874|NCT00177671|12086138|FG001|Overall Study|Withdrawal by Subject|6
7670875|NCT00177671|12086137|FG000|Overall Study|medical complications|2
7670876|NCT00177671|12086138|FG001|Overall Study|medical complications|0
7670877|NCT00177671|12086137|FG000|Overall Study|Adverse Event|6
7670878|NCT00177671|12086138|FG001|Overall Study|Adverse Event|0
7670879|NCT00177671|12086137|FG000|Overall Study|Physician Decision|12
7670880|NCT00177671|12086138|FG001|Overall Study|Physician Decision|8
7670881|NCT00178126|12086146|FG000|Overall Study|Lost to Follow-up|21
7670882|NCT00178126|12086147|FG001|Overall Study|Lost to Follow-up|21
7670883|NCT00178126|12086146|FG000|Overall Study|did not receive intervention|4
7670884|NCT00178126|12086147|FG001|Overall Study|did not receive intervention|6
7670885|NCT00178256|12086183|FG000|Overall Study|Adverse Event|2
7670886|NCT00178256|12086184|FG001|Overall Study|Adverse Event|0
7670887|NCT00178256|12086185|FG002|Overall Study|Adverse Event|0
7670888|NCT00178256|12086186|FG003|Overall Study|Adverse Event|0
7670889|NCT00178256|12086183|FG000|Overall Study|Death|0
7670890|NCT00178256|12086184|FG001|Overall Study|Death|1
7670891|NCT00178256|12086185|FG002|Overall Study|Death|0
7670892|NCT00178256|12086186|FG003|Overall Study|Death|1
7670893|NCT00178256|12086183|FG000|Overall Study|Cancer progression|2
7670894|NCT00178256|12086184|FG001|Overall Study|Cancer progression|0
7670895|NCT00178256|12086185|FG002|Overall Study|Cancer progression|0
7670896|NCT00178256|12086186|FG003|Overall Study|Cancer progression|1
7670897|NCT00178399|12086193|FG000|Overall Study|Physician Decision|4
7670898|NCT00178399|12086193|FG000|Overall Study|Withdrawal by Subject|8
7670899|NCT00178399|12086193|FG000|Overall Study|Lost to Follow-up|1
7670900|NCT00178464|12086198|FG000|Overall Study|Withdrawal by Subject|1
7670901|NCT00178464|12086198|FG000|Overall Study|Physician Decision|1
7670902|NCT00178633|12086217|FG000|Overall Study|Lost to Follow-up|6
7670903|NCT00178685|12086241|FG000|Overall Study|Death|3
7670904|NCT00178685|12086242|FG001|Overall Study|Death|3
7670905|NCT00178685|12086243|FG002|Overall Study|Death|6
7670906|NCT00178685|12086241|FG000|Overall Study|Lost to Follow-up|100
7670907|NCT00178685|12086242|FG001|Overall Study|Lost to Follow-up|187
7670908|NCT00178685|12086243|FG002|Overall Study|Lost to Follow-up|183
7670909|NCT00178685|12086241|FG000|Overall Study|Withdrawal by Subject|8
7670910|NCT00178685|12086242|FG001|Overall Study|Withdrawal by Subject|14
7670911|NCT00178685|12086243|FG002|Overall Study|Withdrawal by Subject|7
7670912|NCT00179010|12086278|FG000|Overall Study|Muscle probe defective|1
7670913|NCT00179010|12086279|FG001|Overall Study|Muscle probe defective|1
7670914|NCT00179010|12086278|FG000|Overall Study|Failure to place arterial line|0
7670915|NCT00179010|12086279|FG001|Overall Study|Failure to place arterial line|1
7670916|NCT00179309|12086288|FG000|Treatment|Toxicity|2
7670917|NCT00179309|12086289|FG001|Treatment|Toxicity|3
7670918|NCT00179309|12086288|FG000|Treatment|Withdrawal by Subject|1
7670919|NCT00179309|12086289|FG001|Treatment|Withdrawal by Subject|2
7670920|NCT00179309|12086288|FG000|Treatment|Allergy|1
7670921|NCT00179309|12086289|FG001|Treatment|Allergy|0
7670922|NCT00179413|12086297|FG000|Overall Study|Adverse Event|38
7670923|NCT00179413|12086298|FG001|Overall Study|Adverse Event|20
7670924|NCT00179413|12086297|FG000|Overall Study|Withdrawal by Subject|87
7670925|NCT00179413|12086298|FG001|Overall Study|Withdrawal by Subject|95
7670926|NCT00179517|12086314|FG000|Overall Study|Withdrawal by Subject|2
7670927|NCT00179517|12086315|FG001|Overall Study|Withdrawal by Subject|1
7670928|NCT00179621|12086324|FG000|Double-Blind Period|Lack of Therapeutic Effect|59
7670929|NCT00179621|12086325|FG001|Double-Blind Period|Lack of Therapeutic Effect|35
7670930|NCT00179621|12086326|FG002|Double-Blind Period|Lack of Therapeutic Effect|19
7670931|NCT00179621|12086327|FG003|Double-Blind Period|Lack of Therapeutic Effect|0
7670932|NCT00179621|12086324|FG000|Double-Blind Period|Adverse Event|2
7670933|NCT00179621|12086325|FG001|Double-Blind Period|Adverse Event|7
7670934|NCT00179621|12086326|FG002|Double-Blind Period|Adverse Event|4
7670935|NCT00179621|12086327|FG003|Double-Blind Period|Adverse Event|0
7670936|NCT00179621|12086324|FG000|Double-Blind Period|Withdrawal by Subject|2
7670937|NCT00179621|12086325|FG001|Double-Blind Period|Withdrawal by Subject|1
7670938|NCT00179621|12086326|FG002|Double-Blind Period|Withdrawal by Subject|3
7670939|NCT00179621|12086327|FG003|Double-Blind Period|Withdrawal by Subject|0
7670940|NCT00179621|12086324|FG000|Double-Blind Period|Death|0
7670941|NCT00179621|12086325|FG001|Double-Blind Period|Death|1
7670942|NCT00179621|12086326|FG002|Double-Blind Period|Death|2
7670943|NCT00179621|12086327|FG003|Double-Blind Period|Death|0
7670944|NCT00179621|12086324|FG000|Double-Blind Period|Protocol Violation|1
7670945|NCT00179621|12086325|FG001|Double-Blind Period|Protocol Violation|0
7670946|NCT00179621|12086326|FG002|Double-Blind Period|Protocol Violation|0
7670947|NCT00179621|12086327|FG003|Double-Blind Period|Protocol Violation|0
7670948|NCT00179621|12086324|FG000|Double-Blind Period|Other|0
7670949|NCT00179621|12086325|FG001|Double-Blind Period|Other|2
7670950|NCT00179621|12086326|FG002|Double-Blind Period|Other|2
7670951|NCT00179621|12086327|FG003|Double-Blind Period|Other|0
7670952|NCT00179621|12086324|FG000|Open-Label Period|Lack of Therapeutic Effect|0
7670953|NCT00179621|12086325|FG001|Open-Label Period|Lack of Therapeutic Effect|19
7670954|NCT00179621|12086326|FG002|Open-Label Period|Lack of Therapeutic Effect|19
7670955|NCT00179621|12086327|FG003|Open-Label Period|Lack of Therapeutic Effect|31
7670956|NCT00179621|12086324|FG000|Open-Label Period|Adverse Event|0
7670957|NCT00179621|12086325|FG001|Open-Label Period|Adverse Event|6
7670958|NCT00179621|12086326|FG002|Open-Label Period|Adverse Event|5
7670959|NCT00179621|12086327|FG003|Open-Label Period|Adverse Event|6
7670960|NCT00179621|12086324|FG000|Open-Label Period|Withdrawal by Subject|0
7670961|NCT00179621|12086325|FG001|Open-Label Period|Withdrawal by Subject|2
7670962|NCT00179621|12086326|FG002|Open-Label Period|Withdrawal by Subject|2
7670963|NCT00179621|12086327|FG003|Open-Label Period|Withdrawal by Subject|2
7670964|NCT00179621|12086324|FG000|Open-Label Period|Death|0
7670965|NCT00179621|12086325|FG001|Open-Label Period|Death|0
7670966|NCT00179621|12086326|FG002|Open-Label Period|Death|1
7670967|NCT00179621|12086327|FG003|Open-Label Period|Death|2
7670968|NCT00179621|12086324|FG000|Open-Label Period|Other|0
7670969|NCT00179621|12086325|FG001|Open-Label Period|Other|1
7670970|NCT00179621|12086326|FG002|Open-Label Period|Other|1
7670971|NCT00179621|12086327|FG003|Open-Label Period|Other|2
7670972|NCT00179647|12086336|FG000|Overall Study|Adverse Event|294
7670973|NCT00179647|12086336|FG000|Overall Study|Lack of Efficacy|478
7670974|NCT00179647|12086336|FG000|Overall Study|Withdrawal by Subject|83
7670975|NCT00179647|12086336|FG000|Overall Study|Lost to Follow-up|4
7670976|NCT00179647|12086336|FG000|Overall Study|Death|94
7670977|NCT00179647|12086336|FG000|Overall Study|Other|960
7670978|NCT00179660|12086340|FG000|Overall Study|Adverse Event|7
7670979|NCT00179660|12086340|FG000|Overall Study|Lack of therapeutic effect|28
7670980|NCT00179660|12086340|FG000|Overall Study|Withdrawal by Subject|2
7670981|NCT00179660|12086340|FG000|Overall Study|Lost to Follow-up|1
7670982|NCT00179660|12086340|FG000|Overall Study|Death|3
7670983|NCT00179660|12086340|FG000|Overall Study|Other - Unspecified|9
7670984|NCT00179673|12086344|FG000|Overall Study|Adverse Event|7
7670985|NCT00179673|12086344|FG000|Overall Study|Lack of Efficacy|15
7670986|NCT00179673|12086344|FG000|Overall Study|Withdrawal by Subject|3
7670987|NCT00179673|12086344|FG000|Overall Study|Death|4
7670988|NCT00179673|12086344|FG000|Overall Study|Other Observations and options|14
7670989|NCT00179959|12086361|FG000|Overall Study|Lost to Follow-up|3
7670990|NCT00179959|12086362|FG001|Overall Study|Lost to Follow-up|1
7670991|NCT00179959|12086361|FG000|Overall Study|Withdrawal by Subject|3
7670992|NCT00179959|12086362|FG001|Overall Study|Withdrawal by Subject|2
7670993|NCT00180479|12086409|FG000|Overall Study|Death|4
7670994|NCT00180479|12086410|FG001|Overall Study|Death|2
7670995|NCT00180479|12086409|FG000|Overall Study|Lost to Follow-up|9
7670996|NCT00180479|12086410|FG001|Overall Study|Lost to Follow-up|7
7670997|NCT00180479|12086409|FG000|Overall Study|Withdrawal by Subject|3
7670998|NCT00180479|12086410|FG001|Overall Study|Withdrawal by Subject|3
7670999|NCT00180479|12086409|FG000|Overall Study|Informed consent not signed|0
7671000|NCT00180479|12086410|FG001|Overall Study|Informed consent not signed|1
7671001|NCT00180674|12086425|FG000|Phase 1, Observation Period|Withdrawal by Subject|4
7671002|NCT00180674|12086425|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1
7671003|NCT00180713|12086452|FG000|Overall Study|Withdrawal by Subject|2
7671004|NCT00180713|12086453|FG001|Overall Study|Withdrawal by Subject|0
7671005|NCT00180713|12086452|FG000|Overall Study|Adverse Event|3
7671006|NCT00180713|12086453|FG001|Overall Study|Adverse Event|3
7671007|NCT00181155|12086459|FG000|Overall Study|Physician Decision|1
7671008|NCT00181155|12086460|FG001|Overall Study|Physician Decision|0
7671009|NCT00181155|12086459|FG000|Overall Study|Withdrawal by Subject|1
7671010|NCT00181155|12086460|FG001|Overall Study|Withdrawal by Subject|0
7671011|NCT00181766|12086524|FG000|Overall Study|Lost to Follow-up|6
7671012|NCT00181766|12086524|FG000|Overall Study|Adverse Event|4
7671013|NCT00181766|12086524|FG000|Overall Study|non-compliance|2
7671014|NCT00181844|12086528|FG000|Signed Consent|Withdrawal by Subject|5
7671015|NCT00181844|12086528|FG000|Signed Consent|Did not meet entrance criteria|7
7671016|NCT00181844|12086528|FG000|Exposed to Study Medication|Adverse Event|10
7671017|NCT00181844|12086528|FG000|Exposed to Study Medication|Lack of Efficacy|2
7671018|NCT00181844|12086528|FG000|Exposed to Study Medication|Non-compliance|2
7671019|NCT00181844|12086528|FG000|Exposed to Study Medication|Withdrawal by Subject|1
7671020|NCT00181844|12086528|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2
7671021|NCT00181883|12086532|FG000|Overall Study|Lack of Efficacy|2
7671022|NCT00181883|12086532|FG000|Overall Study|Treatment Limiting AEs|3
7671023|NCT00181883|12086532|FG000|Overall Study|Withdrawal by Subject|4
7671024|NCT00181883|12086532|FG000|Overall Study|Lost to Follow-up|1
7671025|NCT00182078|12086556|FG000|Overall Study|Withdrawal by Subject|1
7671026|NCT00182078|12086557|FG001|Overall Study|Withdrawal by Subject|0
7671027|NCT00182091|12086567|FG000|Overall Study|Withdrawal by Subject|1
7671028|NCT00182091|12086568|FG001|Overall Study|Withdrawal by Subject|0
7671029|NCT00182091|12086569|FG002|Overall Study|Withdrawal by Subject|0
7671030|NCT00182091|12086570|FG003|Overall Study|Withdrawal by Subject|0
7671031|NCT00182325|12086580|FG000|Overall Study|Lost to Follow-up|7
7671032|NCT00182325|12086581|FG001|Overall Study|Lost to Follow-up|7
7671033|NCT00182325|12086580|FG000|Overall Study|Miscarriage|5
7671034|NCT00182325|12086581|FG001|Overall Study|Miscarriage|3
7671035|NCT00182325|12086580|FG000|Overall Study|Did not complete survey|22
7671036|NCT00182325|12086581|FG001|Overall Study|Did not complete survey|43
7671037|NCT00182689|12086589|FG000|Overall Study|Adverse Event|8
7671038|NCT00182689|12086590|FG001|Overall Study|Adverse Event|11
7671039|NCT00182689|12086589|FG000|Overall Study|Withdrawal by Subject|2
7671040|NCT00182689|12086590|FG001|Overall Study|Withdrawal by Subject|2
7671041|NCT00182689|12086589|FG000|Overall Study|Progression|27
7671042|NCT00182689|12086590|FG001|Overall Study|Progression|29
7671043|NCT00182689|12086589|FG000|Overall Study|Death|1
7671044|NCT00182689|12086590|FG001|Overall Study|Death|0
7671045|NCT00182689|12086589|FG000|Overall Study|not protocol specified|0
7671046|NCT00182689|12086590|FG001|Overall Study|not protocol specified|3
7671047|NCT00182689|12086589|FG000|Overall Study|Ineligible|1
7671048|NCT00182689|12086590|FG001|Overall Study|Ineligible|4
7671049|NCT00182689|12086589|FG000|Overall Study|Never received treatment|1
7671050|NCT00182689|12086590|FG001|Overall Study|Never received treatment|0
7671051|NCT00183170|12086645|FG000|First Intervention|Did not complete study|1
7671052|NCT00183170|12086646|FG001|First Intervention|Did not complete study|0
7671053|NCT00183170|12086645|FG000|First Intervention|Did not meet targeted BrAC|1
7671054|NCT00183170|12086646|FG001|First Intervention|Did not meet targeted BrAC|0
7671055|NCT00183170|12086645|FG000|Washout 1 Week|Did not complete study|6
7671056|NCT00183170|12086646|FG001|Washout 1 Week|Did not complete study|8
7671057|NCT00183170|12086645|FG000|Second Intervention|Did not complete study|1
7671058|NCT00183170|12086646|FG001|Second Intervention|Did not complete study|0
7671059|NCT00183170|12086645|FG000|Second Intervention|Did not meet targeted BrAC|0
7671060|NCT00183170|12086646|FG001|Second Intervention|Did not meet targeted BrAC|2
7671061|NCT00183196|12086655|FG000|Overall Study|Withdrawal by Subject|18
7671062|NCT00183196|12086656|FG001|Overall Study|Withdrawal by Subject|11
7671063|NCT00183196|12086657|FG002|Overall Study|Withdrawal by Subject|13
7671064|NCT00183196|12086655|FG000|Overall Study|Adverse Event|1
7671065|NCT00183196|12086656|FG001|Overall Study|Adverse Event|2
7671066|NCT00183196|12086657|FG002|Overall Study|Adverse Event|2
7671067|NCT00183196|12086655|FG000|Overall Study|Legal event|1
7671068|NCT00183196|12086656|FG001|Overall Study|Legal event|1
7671069|NCT00183196|12086657|FG002|Overall Study|Legal event|1
7671070|NCT00183196|12086655|FG000|Overall Study|Required more intensive care|0
7671071|NCT00183196|12086656|FG001|Overall Study|Required more intensive care|1
7671072|NCT00183196|12086657|FG002|Overall Study|Required more intensive care|2
7671073|NCT00183248|12086667|FG000|Overall Study|Lost to Follow-up|0
7671074|NCT00183248|12086668|FG001|Overall Study|Lost to Follow-up|1
7671075|NCT00183248|12086667|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1
7671076|NCT00183248|12086668|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0
7671077|NCT00183274|12086674|FG000|Phase 1: Open-Label|Adverse Event|31
7671078|NCT00183274|12086675|FG001|Phase 1: Open-Label|Adverse Event|0
7671079|NCT00183274|12086676|FG002|Phase 1: Open-Label|Adverse Event|0
7671080|NCT00183274|12086677|FG003|Phase 1: Open-Label|Adverse Event|0
7671081|NCT00183274|12086678|FG004|Phase 1: Open-Label|Adverse Event|0
7671082|NCT00183274|12086679|FG005|Phase 1: Open-Label|Adverse Event|0
7671083|NCT00183274|12086674|FG000|Phase 1: Open-Label|Lack of Efficacy|13
7671084|NCT00183274|12086675|FG001|Phase 1: Open-Label|Lack of Efficacy|0
7671085|NCT00183274|12086676|FG002|Phase 1: Open-Label|Lack of Efficacy|0
7671086|NCT00183274|12086677|FG003|Phase 1: Open-Label|Lack of Efficacy|0
7671087|NCT00183274|12086678|FG004|Phase 1: Open-Label|Lack of Efficacy|0
7671088|NCT00183274|12086679|FG005|Phase 1: Open-Label|Lack of Efficacy|0
7671089|NCT00183274|12086674|FG000|Phase 1: Open-Label|Protocol Violation|11
7671090|NCT00183274|12086675|FG001|Phase 1: Open-Label|Protocol Violation|0
7671091|NCT00183274|12086676|FG002|Phase 1: Open-Label|Protocol Violation|0
7671092|NCT00183274|12086677|FG003|Phase 1: Open-Label|Protocol Violation|0
7671093|NCT00183274|12086678|FG004|Phase 1: Open-Label|Protocol Violation|0
7671094|NCT00183274|12086679|FG005|Phase 1: Open-Label|Protocol Violation|0
7671095|NCT00183274|12086674|FG000|Phase 1: Open-Label|Withdrawal by Subject|13
7671096|NCT00183274|12086675|FG001|Phase 1: Open-Label|Withdrawal by Subject|0
7671097|NCT00183274|12086676|FG002|Phase 1: Open-Label|Withdrawal by Subject|0
7671098|NCT00183274|12086677|FG003|Phase 1: Open-Label|Withdrawal by Subject|0
7671099|NCT00183274|12086678|FG004|Phase 1: Open-Label|Withdrawal by Subject|0
7671100|NCT00183274|12086679|FG005|Phase 1: Open-Label|Withdrawal by Subject|0
7671101|NCT00183274|12086674|FG000|Phase 1: Open-Label|Lost to Follow-up|33
7671102|NCT00183274|12086675|FG001|Phase 1: Open-Label|Lost to Follow-up|0
7671103|NCT00183274|12086676|FG002|Phase 1: Open-Label|Lost to Follow-up|0
7671104|NCT00183274|12086677|FG003|Phase 1: Open-Label|Lost to Follow-up|0
7671105|NCT00183274|12086678|FG004|Phase 1: Open-Label|Lost to Follow-up|0
7671106|NCT00183274|12086679|FG005|Phase 1: Open-Label|Lost to Follow-up|0
7671107|NCT00183274|12086674|FG000|Phase 1: Open-Label|Other|9
7671108|NCT00183274|12086675|FG001|Phase 1: Open-Label|Other|0
7671109|NCT00183274|12086676|FG002|Phase 1: Open-Label|Other|0
7671110|NCT00183274|12086677|FG003|Phase 1: Open-Label|Other|0
7671111|NCT00183274|12086678|FG004|Phase 1: Open-Label|Other|0
7671112|NCT00183274|12086679|FG005|Phase 1: Open-Label|Other|0
7671113|NCT00183274|12086674|FG000|Phase 2: Double-Blind|Relapsed|0
7671114|NCT00183274|12086675|FG001|Phase 2: Double-Blind|Relapsed|8
7671115|NCT00183274|12086676|FG002|Phase 2: Double-Blind|Relapsed|29
7671116|NCT00183274|12086677|FG003|Phase 2: Double-Blind|Relapsed|0
7671117|NCT00183274|12086678|FG004|Phase 2: Double-Blind|Relapsed|0
7671118|NCT00183274|12086679|FG005|Phase 2: Double-Blind|Relapsed|0
7671119|NCT00183274|12086674|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0
7671120|NCT00183274|12086675|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18
7671121|NCT00183274|12086676|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14
7671122|NCT00183274|12086677|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0
7671123|NCT00183274|12086678|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0
7671124|NCT00183274|12086679|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0
7671125|NCT00183274|12086674|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0
7671126|NCT00183274|12086675|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0
7671127|NCT00183274|12086676|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0
7671128|NCT00183274|12086677|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1
7671129|NCT00183274|12086678|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9
7671130|NCT00183274|12086679|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2
7671131|NCT00183274|12086674|FG000|Phase 3: Double-Blind|Relapsed|0
7671132|NCT00183274|12086675|FG001|Phase 3: Double-Blind|Relapsed|0
7671133|NCT00183274|12086676|FG002|Phase 3: Double-Blind|Relapsed|0
7671134|NCT00183274|12086677|FG003|Phase 3: Double-Blind|Relapsed|1
7671135|NCT00183274|12086678|FG004|Phase 3: Double-Blind|Relapsed|11
7671136|NCT00183274|12086679|FG005|Phase 3: Double-Blind|Relapsed|2
7671137|NCT00183391|12086708|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13
7671138|NCT00183391|12086709|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14
7671139|NCT00183391|12086708|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4
7671140|NCT00183391|12086709|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2
7671141|NCT00183430|12086719|FG000|Overall Study|Adverse Event|1
7671142|NCT00183430|12086720|FG001|Overall Study|Adverse Event|0
7671143|NCT00183430|12086719|FG000|Overall Study|Lost to Follow-up|3
7671144|NCT00183430|12086720|FG001|Overall Study|Lost to Follow-up|0
7671145|NCT00183430|12086719|FG000|Overall Study|did not meet inclusion criteria|1
7671146|NCT00183430|12086720|FG001|Overall Study|did not meet inclusion criteria|0
7671147|NCT00183430|12086719|FG000|Overall Study|Withdrawal by Subject|1
7671148|NCT00183430|12086720|FG001|Overall Study|Withdrawal by Subject|0
7671149|NCT00183625|12086767|FG000|Overall Study|Withdrawal by Subject|18
7671150|NCT00183625|12086768|FG001|Overall Study|Withdrawal by Subject|18
7671151|NCT00183625|12086769|FG002|Overall Study|Withdrawal by Subject|19
7671152|NCT00183625|12086770|FG003|Overall Study|Withdrawal by Subject|14
7671153|NCT00183872|12086795|FG000|Overall Study|Death|3
7671154|NCT00183872|12086795|FG000|Overall Study|Adverse Event|9
7671155|NCT00183872|12086795|FG000|Overall Study|Withdrawal by Subject|2
7671156|NCT00183872|12086795|FG000|Overall Study|Drug delayed more than 28 days|2
7671157|NCT00184002|12086799|FG000|Overall Study|Adverse Event|9
7671158|NCT00184002|12086799|FG000|Overall Study|Death|3
7671159|NCT00184002|12086799|FG000|Overall Study|Physician Decision|1
7671160|NCT00184002|12086799|FG000|Overall Study|Withdrawal by Subject|4
7671161|NCT00184028|12086803|FG000|Overall Study|Death|1
7671162|NCT00184028|12086803|FG000|Overall Study|Lack of Efficacy|4
7671163|NCT00184028|12086803|FG000|Overall Study|Adverse Event|2
7671164|NCT00184028|12086803|FG000|Overall Study|Withdrawal by Subject|1
7671165|NCT00184028|12086803|FG000|Overall Study|Non-compliance|2
7671166|NCT00184054|12086808|FG000|Overall Study|Adverse Event|1
7671167|NCT00184093|12086812|FG000|Overall Study|Adverse Event|3
7671168|NCT00184093|12086812|FG000|Overall Study|Lost to Follow-up|3
7671169|NCT00184093|12086812|FG000|Overall Study|Physician Decision|1
7671170|NCT00184093|12086812|FG000|Overall Study|Withdrawal by Subject|2
7671171|NCT00184600|12086836|FG000|Overall Study|Adverse Event|9
7671172|NCT00184600|12086837|FG001|Overall Study|Adverse Event|0
7671173|NCT00184600|12086838|FG002|Overall Study|Adverse Event|5
7671174|NCT00184600|12086836|FG000|Overall Study|Death|3
7671175|NCT00184600|12086837|FG001|Overall Study|Death|9
7671176|NCT00184600|12086838|FG002|Overall Study|Death|7
7671177|NCT00184600|12086836|FG000|Overall Study|Lack of Efficacy|3
7671178|NCT00184600|12086837|FG001|Overall Study|Lack of Efficacy|1
7671179|NCT00184600|12086838|FG002|Overall Study|Lack of Efficacy|3
7671180|NCT00184600|12086836|FG000|Overall Study|Lost to Follow-up|4
7671181|NCT00184600|12086837|FG001|Overall Study|Lost to Follow-up|6
7671182|NCT00184600|12086838|FG002|Overall Study|Lost to Follow-up|1
7671183|NCT00184600|12086836|FG000|Overall Study|Protocol Violation|2
7671184|NCT00184600|12086837|FG001|Overall Study|Protocol Violation|2
7671185|NCT00184600|12086838|FG002|Overall Study|Protocol Violation|3
7671186|NCT00184600|12086836|FG000|Overall Study|Withdrawal by Subject|20
7671187|NCT00184600|12086837|FG001|Overall Study|Withdrawal by Subject|28
7671188|NCT00184600|12086838|FG002|Overall Study|Withdrawal by Subject|12
7671189|NCT00184600|12086836|FG000|Overall Study|Unclassified|4
7671190|NCT00184600|12086837|FG001|Overall Study|Unclassified|5
7671191|NCT00184600|12086838|FG002|Overall Study|Unclassified|3
7671192|NCT00185211|12086865|FG000|Placebo-controlled Study (92012)|Adverse Event|8
7671193|NCT00185211|12086866|FG001|Placebo-controlled Study (92012)|Adverse Event|0
7671194|NCT00185211|12086865|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3
7671195|NCT00185211|12086866|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2
7671196|NCT00185211|12086865|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9
7671197|NCT00185211|12086866|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7
7671198|NCT00185211|12086865|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
7671199|NCT00185211|12086866|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
7671200|NCT00185211|12086865|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
7671201|NCT00185211|12086866|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
7671202|NCT00185211|12086865|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5
7671203|NCT00185211|12086866|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6
7671204|NCT00185211|12086865|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
7671205|NCT00185211|12086866|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
7671206|NCT00185211|12086865|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
7671207|NCT00185211|12086866|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
7671208|NCT00185211|12086865|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1
7671209|NCT00185211|12086866|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0
7671210|NCT00185211|12086865|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0
7671211|NCT00185211|12086866|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1
7671212|NCT00185211|12086865|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
7671213|NCT00185211|12086866|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
7671214|NCT00185211|12086865|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
7671215|NCT00185211|12086866|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
7671216|NCT00185380|12086876|FG000|Overall Study|Adverse Event|41
7671217|NCT00185380|12086877|FG001|Overall Study|Adverse Event|43
7671218|NCT00185380|12086878|FG002|Overall Study|Adverse Event|48
7671219|NCT00185380|12086876|FG000|Overall Study|Lost to Follow-up|0
7671220|NCT00185380|12086877|FG001|Overall Study|Lost to Follow-up|4
7671221|NCT00185380|12086878|FG002|Overall Study|Lost to Follow-up|3
7671222|NCT00185380|12086876|FG000|Overall Study|Pregnancy|1
7671223|NCT00185380|12086877|FG001|Overall Study|Pregnancy|4
7671224|NCT00185380|12086878|FG002|Overall Study|Pregnancy|0
7671225|NCT00185380|12086876|FG000|Overall Study|Protocol Violation|2
7671226|NCT00185380|12086877|FG001|Overall Study|Protocol Violation|2
7671227|NCT00185380|12086878|FG002|Overall Study|Protocol Violation|1
7671228|NCT00185380|12086876|FG000|Overall Study|Withdrawal by Subject|1
7671229|NCT00185380|12086877|FG001|Overall Study|Withdrawal by Subject|2
7671230|NCT00185380|12086878|FG002|Overall Study|Withdrawal by Subject|0
7671231|NCT00185380|12086876|FG000|Overall Study|Failed insertion|1
7671232|NCT00185380|12086877|FG001|Overall Study|Failed insertion|1
7671233|NCT00185380|12086878|FG002|Overall Study|Failed insertion|2
7671234|NCT00185380|12086876|FG000|Overall Study|Planned pregnancy|9
7671235|NCT00185380|12086877|FG001|Overall Study|Planned pregnancy|12
7671236|NCT00185380|12086878|FG002|Overall Study|Planned pregnancy|12
7671237|NCT00185380|12086876|FG000|Overall Study|No need for contraception|3
7671238|NCT00185380|12086877|FG001|Overall Study|No need for contraception|3
7671239|NCT00185380|12086878|FG002|Overall Study|No need for contraception|3
7671240|NCT00185380|12086876|FG000|Overall Study|Could not attend visits|2
7671241|NCT00185380|12086877|FG001|Overall Study|Could not attend visits|0
7671242|NCT00185380|12086878|FG002|Overall Study|Could not attend visits|4
7671243|NCT00185380|12086876|FG000|Overall Study|personal reason|6
7671244|NCT00185380|12086877|FG001|Overall Study|personal reason|1
7671245|NCT00185380|12086878|FG002|Overall Study|personal reason|1
7671246|NCT00185458|12086886|FG000|Contraception Phase|Adverse Event|37
7671247|NCT00185458|12086886|FG000|Contraception Phase|Lost to Follow-up|10
7671248|NCT00185458|12086886|FG000|Contraception Phase|Protocol Violation|2
7671249|NCT00185458|12086886|FG000|Contraception Phase|Physician Decision|2
7671250|NCT00185458|12086886|FG000|Contraception Phase|Withdrawal by Subject|7
7671251|NCT00185458|12086886|FG000|HRT Phase|Adverse Event|18
7671252|NCT00185458|12086886|FG000|HRT Phase|Lost to Follow-up|4
7671253|NCT00185458|12086886|FG000|HRT Phase|Protocol Violation|2
7671254|NCT00185458|12086886|FG000|HRT Phase|Withdrawal by Subject|3
7671255|NCT00185588|12086902|FG000|Overall Study|Adverse Event|3
7671256|NCT00185588|12086903|FG001|Overall Study|Adverse Event|1
7671257|NCT00185588|12086904|FG002|Overall Study|Adverse Event|4
7671258|NCT00185588|12086905|FG003|Overall Study|Adverse Event|2
7671259|NCT00185588|12086902|FG000|Overall Study|Lost to Follow-up|0
7671260|NCT00185588|12086903|FG001|Overall Study|Lost to Follow-up|0
7671261|NCT00185588|12086904|FG002|Overall Study|Lost to Follow-up|1
7671262|NCT00185588|12086905|FG003|Overall Study|Lost to Follow-up|2
7671263|NCT00185588|12086902|FG000|Overall Study|Withdrawal by Subject|0
7671264|NCT00185588|12086903|FG001|Overall Study|Withdrawal by Subject|1
7671265|NCT00185588|12086904|FG002|Overall Study|Withdrawal by Subject|0
7671266|NCT00185588|12086905|FG003|Overall Study|Withdrawal by Subject|0
7671267|NCT00185588|12086902|FG000|Overall Study|Physician Decision|0
7671268|NCT00185588|12086903|FG001|Overall Study|Physician Decision|0
7671269|NCT00185588|12086904|FG002|Overall Study|Physician Decision|1
7671270|NCT00185588|12086905|FG003|Overall Study|Physician Decision|0
7671271|NCT00185614|12086915|FG000|Inter-treatment Period|Physician Decision|1
7671272|NCT00185614|12086915|FG000|Inter-treatment Period|Relapse|2
7671273|NCT00185614|12086915|FG000|Inter-treatment Period|Lack of allogenic donor|1
7671274|NCT00185640|12086919|FG000|Overall Study|Not Eligible|4
7671275|NCT00185640|12086919|FG000|Overall Study|Withdrawal by Subject|3
7671276|NCT00185640|12086919|FG000|Overall Study|Death|138
7671277|NCT00185731|12086931|FG000|Overall Study|Withdrawal by Subject|1
7671278|NCT00185731|12086931|FG000|Overall Study|Not Eligible|1
7671279|NCT00185965|12086948|FG000|Overall Study|Adverse Event|0
7671280|NCT00185965|12086949|FG001|Overall Study|Adverse Event|1
7671281|NCT00186043|12086967|FG000|Overall Study|Lack of Efficacy|1
7671282|NCT00186043|12086968|FG001|Overall Study|Lack of Efficacy|3
7671283|NCT00186043|12086967|FG000|Overall Study|Lost to Follow-up|4
7671284|NCT00186043|12086968|FG001|Overall Study|Lost to Follow-up|6
7671285|NCT00186043|12086967|FG000|Overall Study|Withdrawal by Subject|1
7671286|NCT00186043|12086968|FG001|Overall Study|Withdrawal by Subject|0
7671287|NCT00186043|12086967|FG000|Overall Study|Adverse Event|7
7671288|NCT00186043|12086968|FG001|Overall Study|Adverse Event|3
7671289|NCT00186043|12086967|FG000|Overall Study|Protocol Violation|2
7671290|NCT00186043|12086968|FG001|Overall Study|Protocol Violation|1
7671291|NCT00186121|12086992|FG000|Overall Study|Subject withdrawal (no treatment)|1
7671292|NCT00186121|12086992|FG000|Overall Study|Underwent oophorectomy (no treatment)|1
7671293|NCT00186121|12086992|FG000|Overall Study|Not eligible (no treatment)|1
7671294|NCT00186186|12086996|FG000|Overall Study|Lack of Efficacy|3
7671295|NCT00186186|12086996|FG000|Overall Study|Withdrawal by Subject|3
7671296|NCT00186186|12086996|FG000|Overall Study|Not reported as to reason|2
7671297|NCT00186485|12087007|FG000|Overall Study|Lost to Follow-up|3
7671298|NCT00186537|12087023|FG000|Overall Study|Withdrawal by Subject|4
7671299|NCT00186537|12087024|FG001|Overall Study|Withdrawal by Subject|0
7671300|NCT00186537|12087025|FG002|Overall Study|Withdrawal by Subject|3
7671301|NCT00186537|12087023|FG000|Overall Study|ALT > 1.5 x ULN|3
7671302|NCT00186537|12087024|FG001|Overall Study|ALT > 1.5 x ULN|0
7671303|NCT00186537|12087025|FG002|Overall Study|ALT > 1.5 x ULN|0
7671304|NCT00186628|12087033|FG000|Overall Study|Death|2
7671305|NCT00186628|12087033|FG000|Overall Study|Withdrawal by subject (before treatment)|1
7671306|NCT00186901|12087052|FG000|Overall Study|Pregnancy|6
7671307|NCT00186901|12087053|FG001|Overall Study|Pregnancy|3
7671308|NCT00186901|12087054|FG002|Overall Study|Pregnancy|0
7671309|NCT00186901|12087052|FG000|Overall Study|Lost to Follow-up|6
7671310|NCT00186901|12087053|FG001|Overall Study|Lost to Follow-up|3
7671311|NCT00186901|12087054|FG002|Overall Study|Lost to Follow-up|0
7671312|NCT00186901|12087052|FG000|Overall Study|Bone Mineral Density dropped > 5%|9
7671313|NCT00186901|12087053|FG001|Overall Study|Bone Mineral Density dropped > 5%|7
7671314|NCT00186901|12087054|FG002|Overall Study|Bone Mineral Density dropped > 5%|0
7671315|NCT00186901|12087052|FG000|Overall Study|ALL relapse or second malignancy|1
7671316|NCT00186901|12087053|FG001|Overall Study|ALL relapse or second malignancy|2
7671317|NCT00186901|12087054|FG002|Overall Study|ALL relapse or second malignancy|0
7671318|NCT00186901|12087052|FG000|Overall Study|Withdrawal by Subject|4
7671319|NCT00186901|12087053|FG001|Overall Study|Withdrawal by Subject|5
7671320|NCT00186901|12087054|FG002|Overall Study|Withdrawal by Subject|0
7671321|NCT00186901|12087052|FG000|Overall Study|Open label|3
7671322|NCT00186901|12087053|FG001|Overall Study|Open label|2
7671323|NCT00186901|12087054|FG002|Overall Study|Open label|0
7671324|NCT00186901|12087052|FG000|Overall Study|Limited adherence to study requirements|20
7671325|NCT00186901|12087053|FG001|Overall Study|Limited adherence to study requirements|23
7671326|NCT00186901|12087054|FG002|Overall Study|Limited adherence to study requirements|0
7671327|NCT00186901|12087052|FG000|Overall Study|Bone Mineral Density > 0|0
7671328|NCT00186901|12087053|FG001|Overall Study|Bone Mineral Density > 0|0
7671329|NCT00186901|12087054|FG002|Overall Study|Bone Mineral Density > 0|149
7671330|NCT00187096|12087094|FG000|Overall Study|unacceptable toxicity|0
7671331|NCT00187096|12087095|FG001|Overall Study|unacceptable toxicity|0
7671332|NCT00187096|12087096|FG002|Overall Study|unacceptable toxicity|1
7671333|NCT00187135|12087110|FG000|Visit One|Withdrawal by Subject|1
7671334|NCT00187135|12087111|FG001|Visit One|Withdrawal by Subject|0
7671335|NCT00187135|12087112|FG002|Visit One|Withdrawal by Subject|0
7671336|NCT00187135|12087113|FG003|Visit One|Withdrawal by Subject|0
7671337|NCT00187135|12087114|FG004|Visit One|Withdrawal by Subject|0
7671338|NCT00187135|12087115|FG005|Visit One|Withdrawal by Subject|1
7671339|NCT00187135|12087110|FG000|Visit One|Physician Decision|3
7671340|NCT00187135|12087111|FG001|Visit One|Physician Decision|1
7671341|NCT00187135|12087112|FG002|Visit One|Physician Decision|0
7671342|NCT00187135|12087113|FG003|Visit One|Physician Decision|0
7671343|NCT00187135|12087114|FG004|Visit One|Physician Decision|0
7671344|NCT00187135|12087115|FG005|Visit One|Physician Decision|1
7671345|NCT00187135|12087110|FG000|Visit Two|Death|0
7671346|NCT00187135|12087111|FG001|Visit Two|Death|0
7671347|NCT00187135|12087112|FG002|Visit Two|Death|0
7671348|NCT00187135|12087113|FG003|Visit Two|Death|1
7671349|NCT00187135|12087114|FG004|Visit Two|Death|0
7671350|NCT00187135|12087115|FG005|Visit Two|Death|1
7671351|NCT00187135|12087110|FG000|Visit Two|Physician Decision|1
7671352|NCT00187135|12087111|FG001|Visit Two|Physician Decision|0
7671353|NCT00187135|12087112|FG002|Visit Two|Physician Decision|0
7671354|NCT00187135|12087113|FG003|Visit Two|Physician Decision|0
7671355|NCT00187135|12087114|FG004|Visit Two|Physician Decision|0
7671356|NCT00187135|12087115|FG005|Visit Two|Physician Decision|0
7671357|NCT00187135|12087110|FG000|Visit Two|Withdrawal by Subject|1
7671358|NCT00187135|12087111|FG001|Visit Two|Withdrawal by Subject|1
7671359|NCT00187135|12087112|FG002|Visit Two|Withdrawal by Subject|1
7671360|NCT00187135|12087113|FG003|Visit Two|Withdrawal by Subject|0
7671361|NCT00187135|12087114|FG004|Visit Two|Withdrawal by Subject|1
7671362|NCT00187135|12087115|FG005|Visit Two|Withdrawal by Subject|1
7671363|NCT00187135|12087110|FG000|Visit Two|Study Discontinued|3
7671364|NCT00187135|12087111|FG001|Visit Two|Study Discontinued|2
7671365|NCT00187135|12087112|FG002|Visit Two|Study Discontinued|1
7671366|NCT00187135|12087113|FG003|Visit Two|Study Discontinued|7
7671367|NCT00187135|12087114|FG004|Visit Two|Study Discontinued|5
7671368|NCT00187135|12087115|FG005|Visit Two|Study Discontinued|6
7671369|NCT00187135|12087110|FG000|Visit Three|Death|0
7671370|NCT00187135|12087111|FG001|Visit Three|Death|0
7671371|NCT00187135|12087112|FG002|Visit Three|Death|1
7671372|NCT00187135|12087113|FG003|Visit Three|Death|0
7671373|NCT00187135|12087114|FG004|Visit Three|Death|1
7671374|NCT00187135|12087115|FG005|Visit Three|Death|0
7671375|NCT00187135|12087110|FG000|Visit Three|Withdrawal by Subject|0
7671376|NCT00187135|12087111|FG001|Visit Three|Withdrawal by Subject|1
7671377|NCT00187135|12087112|FG002|Visit Three|Withdrawal by Subject|1
7671378|NCT00187135|12087113|FG003|Visit Three|Withdrawal by Subject|2
7671379|NCT00187135|12087114|FG004|Visit Three|Withdrawal by Subject|0
7671380|NCT00187135|12087115|FG005|Visit Three|Withdrawal by Subject|0
7671381|NCT00187135|12087110|FG000|Visit Three|Study Discontinued|7
7671382|NCT00187135|12087111|FG001|Visit Three|Study Discontinued|6
7671383|NCT00187135|12087112|FG002|Visit Three|Study Discontinued|7
7671384|NCT00187135|12087113|FG003|Visit Three|Study Discontinued|7
7671385|NCT00187135|12087114|FG004|Visit Three|Study Discontinued|7
7671386|NCT00187135|12087115|FG005|Visit Three|Study Discontinued|6
7671387|NCT00187278|12087140|FG000|Overall Study|Protocol Violation|10
7671388|NCT00187278|12087141|FG001|Overall Study|Protocol Violation|13
7671389|NCT00187486|12087164|FG000|Overall Study|Protocol Violation|1
7671390|NCT00187889|12087204|FG000|Overall Study|Withdrawal by Subject|6
7671391|NCT00187889|12087205|FG001|Overall Study|Withdrawal by Subject|4
7671392|NCT00189202|12087232|FG000|Overall Study|Physician Decision|5
7671393|NCT00189306|12087240|FG000|Treatment Period|Withdrawal by Subject|2
7671394|NCT00189306|12087240|FG000|Treatment Period|Adverse Event|2
7671395|NCT00189306|12087240|FG000|Treatment Period|Protocol Violation|1
7671396|NCT00189306|12087240|FG000|Posttreatment Period|Death|1
7671397|NCT00189306|12087240|FG000|Posttreatment Period|Withdrawal by Subject|2
7671398|NCT00189306|12087240|FG000|Posttreatment Period|Noncompliance|1
7671399|NCT00189306|12087240|FG000|Posttreatment Period|Target lesion excised|1
7671400|NCT00189306|12087240|FG000|Posttreatment Period|Protocol Violation|1
7671401|NCT00189306|12087240|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
7671402|NCT00189306|12087240|FG000|Posttreatment Period|Local skin reaction/sign|1
7671403|NCT00189306|12087240|FG000|Long-Term Follow-up|Adverse Event|2
7671404|NCT00189306|12087240|FG000|Long-Term Follow-up|Death|4
7671405|NCT00189306|12087240|FG000|Long-Term Follow-up|Withdrawal by Subject|1
7671406|NCT00189306|12087240|FG000|Long-Term Follow-up|Intercurrent disease|2
7671407|NCT00189306|12087240|FG000|Long-Term Follow-up|Lost to Follow-up|9
7671408|NCT00189306|12087240|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
7671409|NCT00189423|12087246|FG000|Overall Study|Death|746
7671410|NCT00189423|12087247|FG001|Overall Study|Death|747
7671411|NCT00189423|12087246|FG000|Overall Study|Withdrawal by Subject|9
7671412|NCT00189423|12087247|FG001|Overall Study|Withdrawal by Subject|9
7671413|NCT00189423|12087246|FG000|Overall Study|Lost to Follow-up|10
7671414|NCT00189423|12087247|FG001|Overall Study|Lost to Follow-up|10
7671415|NCT00189462|12087264|FG000|Overall Study|Lack of Efficacy|5
7671416|NCT00189462|12087265|FG001|Overall Study|Lack of Efficacy|1
7671417|NCT00189462|12087264|FG000|Overall Study|Lost to Follow-up|18
7671418|NCT00189462|12087265|FG001|Overall Study|Lost to Follow-up|20
7671419|NCT00189488|12087282|FG000|Overall Study|Ineligibility determined|1
7671420|NCT00189488|12087283|FG001|Overall Study|Ineligibility determined|0
7671421|NCT00189488|12087282|FG000|Overall Study|Protocol deviation|2
7671422|NCT00189488|12087283|FG001|Overall Study|Protocol deviation|1
7671423|NCT00189488|12087282|FG000|Overall Study|Adverse Event|2
7671424|NCT00189488|12087283|FG001|Overall Study|Adverse Event|1
7671425|NCT00189488|12087282|FG000|Overall Study|Withdrawal by Subject|2
7671426|NCT00189488|12087283|FG001|Overall Study|Withdrawal by Subject|6
7671427|NCT00189488|12087282|FG000|Overall Study|Disease progression|2
7671428|NCT00189488|12087283|FG001|Overall Study|Disease progression|4
7671429|NCT00189488|12087282|FG000|Overall Study|Administrative Decision|0
7671430|NCT00189488|12087283|FG001|Overall Study|Administrative Decision|2
7671431|NCT00189488|12087282|FG000|Overall Study|Death|5
7671432|NCT00189488|12087283|FG001|Overall Study|Death|8
7671433|NCT00189488|12087282|FG000|Overall Study|Other|1
7671434|NCT00189488|12087283|FG001|Overall Study|Other|0
7671435|NCT00189540|12087292|FG000|Overall Study|Withdrawal by Subject|3
7671436|NCT00189540|12087293|FG001|Overall Study|Withdrawal by Subject|0
7671437|NCT00189540|12087292|FG000|Overall Study|Death|4
7671438|NCT00189540|12087293|FG001|Overall Study|Death|1
7671439|NCT00190671|12087301|FG000|Overall Study|Satisfactory Response|4
7671440|NCT00190671|12087302|FG001|Overall Study|Satisfactory Response|7
7671441|NCT00190671|12087301|FG000|Overall Study|Lack of Efficacy|19
7671442|NCT00190671|12087302|FG001|Overall Study|Lack of Efficacy|24
7671443|NCT00190671|12087301|FG000|Overall Study|Death from Study Disease|1
7671444|NCT00190671|12087302|FG001|Overall Study|Death from Study Disease|1
7671445|NCT00190671|12087301|FG000|Overall Study|Adverse Event|3
7671446|NCT00190671|12087302|FG001|Overall Study|Adverse Event|2
7671447|NCT00190671|12087301|FG000|Overall Study|Clinical Relapse|0
7671448|NCT00190671|12087302|FG001|Overall Study|Clinical Relapse|1
7671449|NCT00190671|12087301|FG000|Overall Study|Death from Study-Drug Toxicity|0
7671450|NCT00190671|12087302|FG001|Overall Study|Death from Study-Drug Toxicity|2
7671451|NCT00190671|12087301|FG000|Overall Study|Death from Other Causes|0
7671452|NCT00190671|12087302|FG001|Overall Study|Death from Other Causes|2
7671453|NCT00190671|12087301|FG000|Overall Study|Protocol Violation|0
7671454|NCT00190671|12087302|FG001|Overall Study|Protocol Violation|1
7671455|NCT00190671|12087301|FG000|Overall Study|Withdrawal by Subject|0
7671456|NCT00190671|12087302|FG001|Overall Study|Withdrawal by Subject|2
7671457|NCT00190684|12087309|FG000|Overall Study|Adverse Event|86
7671458|NCT00190684|12087309|FG000|Overall Study|Satisfactory response|80
7671459|NCT00190684|12087309|FG000|Overall Study|Lack of efficacy|204
7671460|NCT00190684|12087309|FG000|Overall Study|Lost to Follow-up|232
7671461|NCT00190684|12087309|FG000|Overall Study|Patient moved|60
7671462|NCT00190684|12087309|FG000|Overall Study|Patient Decision|432
7671463|NCT00190684|12087309|FG000|Overall Study|Clinical relapse|67
7671464|NCT00190684|12087309|FG000|Overall Study|Sponsor's decision|17
7671465|NCT00190684|12087309|FG000|Overall Study|Physician Decision|84
7671466|NCT00190684|12087309|FG000|Overall Study|Protocol Violation|123
7671467|NCT00190684|12087309|FG000|Overall Study|Study Period III Completed|103
7671468|NCT00190684|12087309|FG000|Overall Study|Study Period V Completed|1
7671469|NCT00190749|12087315|FG000|Overall Study|Lost to Follow-up|8
7671470|NCT00190749|12087316|FG001|Overall Study|Lost to Follow-up|11
7671471|NCT00190749|12087315|FG000|Overall Study|Withdrawal by Subject|10
7671472|NCT00190749|12087316|FG001|Overall Study|Withdrawal by Subject|6
7671473|NCT00190749|12087315|FG000|Overall Study|Protocol Violation|5
7671474|NCT00190749|12087316|FG001|Overall Study|Protocol Violation|4
7671475|NCT00190749|12087315|FG000|Overall Study|Adverse Event|0
7671476|NCT00190749|12087316|FG001|Overall Study|Adverse Event|5
7671477|NCT00190749|12087315|FG000|Overall Study|Lack of Efficacy|2
7671478|NCT00190749|12087316|FG001|Overall Study|Lack of Efficacy|3
7671479|NCT00190749|12087315|FG000|Overall Study|Reason Not Specified|0
7671480|NCT00190749|12087316|FG001|Overall Study|Reason Not Specified|2
7671481|NCT00190749|12087315|FG000|Overall Study|Sponsor Decision|1
7671482|NCT00190749|12087316|FG001|Overall Study|Sponsor Decision|0
7671483|NCT00190775|12087324|FG000|Overall Study|Adverse Event|57
7671484|NCT00190775|12087325|FG001|Overall Study|Adverse Event|22
7671485|NCT00190775|12087324|FG000|Overall Study|Satisfactory Response|1
7671486|NCT00190775|12087325|FG001|Overall Study|Satisfactory Response|0
7671487|NCT00190775|12087324|FG000|Overall Study|Lack of Efficacy|28
7671488|NCT00190775|12087325|FG001|Overall Study|Lack of Efficacy|32
7671489|NCT00190775|12087324|FG000|Overall Study|Lost to Follow-up|31
7671490|NCT00190775|12087325|FG001|Overall Study|Lost to Follow-up|23
7671491|NCT00190775|12087324|FG000|Overall Study|Participant Moved|0
7671492|NCT00190775|12087325|FG001|Overall Study|Participant Moved|1
7671493|NCT00190775|12087324|FG000|Overall Study|Withdrawal by Subject|24
7671494|NCT00190775|12087325|FG001|Overall Study|Withdrawal by Subject|13
7671495|NCT00190775|12087324|FG000|Overall Study|Sponsor Decision|1
7671496|NCT00190775|12087325|FG001|Overall Study|Sponsor Decision|0
7671497|NCT00190775|12087324|FG000|Overall Study|Physician Decision|3
7671498|NCT00190775|12087325|FG001|Overall Study|Physician Decision|0
7671499|NCT00190775|12087324|FG000|Overall Study|Noncompliance|3
7671500|NCT00190775|12087325|FG001|Overall Study|Noncompliance|5
7671501|NCT00190775|12087324|FG000|Overall Study|Protocol Violation|0
7671502|NCT00190775|12087325|FG001|Overall Study|Protocol Violation|1
7671503|NCT00190775|12087324|FG000|Overall Study|Exclusion Criteria Met|1
7671504|NCT00190775|12087325|FG001|Overall Study|Exclusion Criteria Met|3
7671505|NCT00190983|12087338|FG000|Overall Study|Inevaluable (never treated)|2
7671506|NCT00191100|12087344|FG000|Overall Study|Adverse Event|18
7671507|NCT00191100|12087345|FG001|Overall Study|Adverse Event|1
7671508|NCT00191100|12087344|FG000|Overall Study|Lost to Follow-up|2
7671509|NCT00191100|12087345|FG001|Overall Study|Lost to Follow-up|0
7671510|NCT00191100|12087344|FG000|Overall Study|Patient Moved|0
7671511|NCT00191100|12087345|FG001|Overall Study|Patient Moved|1
7671512|NCT00191100|12087344|FG000|Overall Study|Withdrawal by Subject|9
7671513|NCT00191100|12087345|FG001|Overall Study|Withdrawal by Subject|3
7671514|NCT00191100|12087344|FG000|Overall Study|Protocol Entry Criteria Not Met|2
7671515|NCT00191100|12087345|FG001|Overall Study|Protocol Entry Criteria Not Met|1
7671516|NCT00191100|12087344|FG000|Overall Study|Clinical Relapse|2
7671517|NCT00191100|12087345|FG001|Overall Study|Clinical Relapse|1
7671518|NCT00191100|12087344|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1
7671519|NCT00191100|12087345|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2
7671520|NCT00191100|12087344|FG000|Overall Study|Lack of Efficacy, Stable Disease|1
7671521|NCT00191100|12087345|FG001|Overall Study|Lack of Efficacy, Stable Disease|0
7671522|NCT00191100|12087344|FG000|Overall Study|Physician Decision|3
7671523|NCT00191100|12087345|FG001|Overall Study|Physician Decision|1
7671524|NCT00191100|12087344|FG000|Overall Study|Death from Study Drug Toxicity|2
7671525|NCT00191100|12087345|FG001|Overall Study|Death from Study Drug Toxicity|0
7671526|NCT00191100|12087344|FG000|Overall Study|Protocol Violation|1
7671527|NCT00191100|12087345|FG001|Overall Study|Protocol Violation|1
7671528|NCT00191100|12087344|FG000|Overall Study|Death from Other Cause|1
7671529|NCT00191100|12087345|FG001|Overall Study|Death from Other Cause|0
7671530|NCT00191100|12087344|FG000|Overall Study|Reason Not Specified|0
7671531|NCT00191100|12087345|FG001|Overall Study|Reason Not Specified|1
7671532|NCT00191113|12087353|FG000|Core Study|Withdrawal by Subject|25
7671533|NCT00191113|12087354|FG001|Core Study|Withdrawal by Subject|9
7671534|NCT00191113|12087353|FG000|Core Study|Protocol Violation|6
7671535|NCT00191113|12087354|FG001|Core Study|Protocol Violation|2
7671536|NCT00191113|12087353|FG000|Core Study|Lost to Follow-up|3
7671537|NCT00191113|12087354|FG001|Core Study|Lost to Follow-up|0
7671538|NCT00191113|12087353|FG000|Core Study|Adverse Event|0
7671539|NCT00191113|12087354|FG001|Core Study|Adverse Event|2
7671540|NCT00191113|12087353|FG000|Core Study|Lack of Efficacy|0
7671541|NCT00191113|12087354|FG001|Core Study|Lack of Efficacy|2
7671542|NCT00191113|12087353|FG000|Core Study|Death|1
7671543|NCT00191113|12087354|FG001|Core Study|Death|0
7671544|NCT00191139|12087368|FG000|Overall Study|Adverse Event|2
7671545|NCT00191139|12087369|FG001|Overall Study|Adverse Event|6
7671546|NCT00191139|12087368|FG000|Overall Study|Death|2
7671547|NCT00191139|12087369|FG001|Overall Study|Death|0
7671548|NCT00191139|12087368|FG000|Overall Study|Withdrawal by Subject|0
7671549|NCT00191139|12087369|FG001|Overall Study|Withdrawal by Subject|3
7671550|NCT00191139|12087368|FG000|Overall Study|Disease Progression|0
7671551|NCT00191139|12087369|FG001|Overall Study|Disease Progression|1
7671552|NCT00191139|12087368|FG000|Overall Study|Other|1
7671553|NCT00191139|12087369|FG001|Overall Study|Other|2
7671554|NCT00191152|12087377|FG000|Initial Treatment|Adverse Event|43
7671555|NCT00191152|12087378|FG001|Initial Treatment|Adverse Event|67
7671556|NCT00191152|12087377|FG000|Initial Treatment|Physician Decision|40
7671557|NCT00191152|12087378|FG001|Initial Treatment|Physician Decision|31
7671558|NCT00191152|12087377|FG000|Initial Treatment|Withdrawal by Subject|40
7671559|NCT00191152|12087378|FG001|Initial Treatment|Withdrawal by Subject|28
7671560|NCT00191152|12087377|FG000|Initial Treatment|Lost to Follow-up|0
7671561|NCT00191152|12087378|FG001|Initial Treatment|Lost to Follow-up|6
7671562|NCT00191152|12087377|FG000|Initial Treatment|Other|18
7671563|NCT00191152|12087378|FG001|Initial Treatment|Other|21
7671564|NCT00191152|12087377|FG000|Crossover Treatment|Adverse Event|8
7671565|NCT00191152|12087378|FG001|Crossover Treatment|Adverse Event|8
7671566|NCT00191152|12087377|FG000|Crossover Treatment|Physician Decision|7
7671567|NCT00191152|12087378|FG001|Crossover Treatment|Physician Decision|7
7671568|NCT00191152|12087377|FG000|Crossover Treatment|Withdrawal by Subject|6
7671569|NCT00191152|12087378|FG001|Crossover Treatment|Withdrawal by Subject|9
7671570|NCT00191152|12087377|FG000|Crossover Treatment|Lost to Follow-up|2
7671571|NCT00191152|12087378|FG001|Crossover Treatment|Lost to Follow-up|1
7671572|NCT00191152|12087377|FG000|Crossover Treatment|Other|4
7671573|NCT00191152|12087378|FG001|Crossover Treatment|Other|3
7671574|NCT00191165|12087398|FG000|Overall Study|Adverse Event|2
7671575|NCT00191165|12087399|FG001|Overall Study|Adverse Event|0
7671576|NCT00191165|12087398|FG000|Overall Study|Protocol Violation|0
7671577|NCT00191165|12087399|FG001|Overall Study|Protocol Violation|1
7671578|NCT00191165|12087398|FG000|Overall Study|Participant Moved Away|0
7671579|NCT00191165|12087399|FG001|Overall Study|Participant Moved Away|1
7671580|NCT00191191|12087407|FG000|Overall Study|Entry Criteria Exclusion|2
7671581|NCT00191191|12087408|FG001|Overall Study|Entry Criteria Exclusion|0
7671582|NCT00191191|12087407|FG000|Overall Study|Treated with Another Systemic Agent|1
7671583|NCT00191191|12087408|FG001|Overall Study|Treated with Another Systemic Agent|1
7671584|NCT00191191|12087407|FG000|Overall Study|Adverse Event|11
7671585|NCT00191191|12087408|FG001|Overall Study|Adverse Event|21
7671586|NCT00191191|12087407|FG000|Overall Study|Progressive Disease|84
7671587|NCT00191191|12087408|FG001|Overall Study|Progressive Disease|72
7671588|NCT00191191|12087407|FG000|Overall Study|Toxicity After Dose Reduction|7
7671589|NCT00191191|12087408|FG001|Overall Study|Toxicity After Dose Reduction|8
7671590|NCT00191191|12087407|FG000|Overall Study|Family/Caregiver Decision|5
7671591|NCT00191191|12087408|FG001|Overall Study|Family/Caregiver Decision|7
7671592|NCT00191191|12087407|FG000|Overall Study|Lost to Follow-up|1
7671593|NCT00191191|12087408|FG001|Overall Study|Lost to Follow-up|0
7671594|NCT00191191|12087407|FG000|Overall Study|Physician Decision|3
7671595|NCT00191191|12087408|FG001|Overall Study|Physician Decision|2
7671596|NCT00191191|12087407|FG000|Overall Study|Good Clinical Practice Violation|0
7671597|NCT00191191|12087408|FG001|Overall Study|Good Clinical Practice Violation|1
7671598|NCT00191269|12087416|FG000|Overall Study|Protocol Violation|0
7671599|NCT00191269|12087417|FG001|Overall Study|Protocol Violation|2
7671600|NCT00191269|12087416|FG000|Overall Study|Adverse Event|1
7671601|NCT00191269|12087417|FG001|Overall Study|Adverse Event|4
7671602|NCT00191269|12087416|FG000|Overall Study|Progression of Disease|4
7671603|NCT00191269|12087417|FG001|Overall Study|Progression of Disease|42
7671604|NCT00191269|12087416|FG000|Overall Study|Lack of Efficacy|1
7671605|NCT00191269|12087417|FG001|Overall Study|Lack of Efficacy|5
7671606|NCT00191269|12087416|FG000|Overall Study|Withdrawal by Subject|0
7671607|NCT00191269|12087417|FG001|Overall Study|Withdrawal by Subject|1
7671608|NCT00191269|12087416|FG000|Overall Study|Pathologic Aggrevation|0
7671609|NCT00191269|12087417|FG001|Overall Study|Pathologic Aggrevation|1
7671610|NCT00191269|12087416|FG000|Overall Study|Physician Decision|0
7671611|NCT00191269|12087417|FG001|Overall Study|Physician Decision|3
7671612|NCT00191282|12087426|FG000|Overall Study|Adverse Event|5
7671613|NCT00191282|12087427|FG001|Overall Study|Adverse Event|6
7671614|NCT00191282|12087426|FG000|Overall Study|Death|51
7671615|NCT00191282|12087427|FG001|Overall Study|Death|51
7671616|NCT00191282|12087426|FG000|Overall Study|Lack of Efficacy|11
7671617|NCT00191282|12087427|FG001|Overall Study|Lack of Efficacy|6
7671618|NCT00191282|12087426|FG000|Overall Study|Noncompliance|14
7671619|NCT00191282|12087427|FG001|Overall Study|Noncompliance|17
7671620|NCT00191282|12087426|FG000|Overall Study|Patient moved|11
7671621|NCT00191282|12087427|FG001|Overall Study|Patient moved|14
7671622|NCT00191282|12087426|FG000|Overall Study|Withdrawal by Subject|59
7671623|NCT00191282|12087427|FG001|Overall Study|Withdrawal by Subject|44
7671624|NCT00191282|12087426|FG000|Overall Study|Physician Decision|18
7671625|NCT00191282|12087427|FG001|Overall Study|Physician Decision|15
7671626|NCT00191282|12087426|FG000|Overall Study|Protocol entry criteria not met|14
7671627|NCT00191282|12087427|FG001|Overall Study|Protocol entry criteria not met|9
7671628|NCT00191282|12087426|FG000|Overall Study|Protocol Violation|9
7671629|NCT00191282|12087427|FG001|Overall Study|Protocol Violation|12
7671630|NCT00191282|12087426|FG000|Overall Study|Severity of outcome|2
7671631|NCT00191282|12087427|FG001|Overall Study|Severity of outcome|5
7671632|NCT00191282|12087426|FG000|Overall Study|Sponsor's decision|2
7671633|NCT00191282|12087427|FG001|Overall Study|Sponsor's decision|2
7671634|NCT00191282|12087426|FG000|Overall Study|Lost to Follow-up|24
7671635|NCT00191282|12087427|FG001|Overall Study|Lost to Follow-up|31
7671636|NCT00191308|12087433|FG000|Overall Study|Adverse Event|1
7671637|NCT00191334|12087437|FG000|Overall Study|Adverse Event|4
7671638|NCT00191334|12087437|FG000|Overall Study|Disease Progression or Relapse|8
7671639|NCT00191334|12087437|FG000|Overall Study|Physician Decision|1
7671640|NCT00191334|12087437|FG000|Overall Study|Withdrawal by Subject|4
7671641|NCT00191386|12087441|FG000|Overall Study|Adverse Event|16
7671642|NCT00191386|12087441|FG000|Overall Study|Lost to Follow-up|1
7671643|NCT00191386|12087441|FG000|Overall Study|Entry Criteria Exclusion|3
7671644|NCT00191386|12087441|FG000|Overall Study|Protocol Violation|18
7671645|NCT00191386|12087441|FG000|Overall Study|Withdrawal by Subject|96
7671646|NCT00191386|12087441|FG000|Overall Study|Physician Decision|11
7671647|NCT00191386|12087441|FG000|Overall Study|Lack of Efficacy|15
7671648|NCT00191451|12087448|FG000|Overall Study|Withdrawal by Subject|2
7671649|NCT00191451|12087449|FG001|Overall Study|Withdrawal by Subject|3
7671650|NCT00191451|12087450|FG002|Overall Study|Withdrawal by Subject|5
7671651|NCT00191451|12087448|FG000|Overall Study|Physician Decision|2
7671652|NCT00191451|12087449|FG001|Overall Study|Physician Decision|9
7671653|NCT00191451|12087450|FG002|Overall Study|Physician Decision|6
7671654|NCT00191451|12087448|FG000|Overall Study|Sponsor Decision|1
7671655|NCT00191451|12087449|FG001|Overall Study|Sponsor Decision|0
7671656|NCT00191451|12087450|FG002|Overall Study|Sponsor Decision|0
7671657|NCT00191451|12087448|FG000|Overall Study|Ineligible|0
7671658|NCT00191451|12087449|FG001|Overall Study|Ineligible|1
7671659|NCT00191451|12087450|FG002|Overall Study|Ineligible|0
7671660|NCT00191451|12087448|FG000|Overall Study|Reason Not Specified|2
7671661|NCT00191451|12087449|FG001|Overall Study|Reason Not Specified|1
7671662|NCT00191451|12087450|FG002|Overall Study|Reason Not Specified|3
7671663|NCT00191477|12087460|FG000|Overall Study|Tumor Recurrence|49
7671664|NCT00191477|12087461|FG001|Overall Study|Tumor Recurrence|48
7671665|NCT00191477|12087460|FG000|Overall Study|Death, Study Disease|1
7671666|NCT00191477|12087461|FG001|Overall Study|Death, Study Disease|1
7671667|NCT00191477|12087460|FG000|Overall Study|Death, Other Cause|3
7671668|NCT00191477|12087461|FG001|Overall Study|Death, Other Cause|6
7671669|NCT00191477|12087460|FG000|Overall Study|Lost to Follow-up|23
7671670|NCT00191477|12087461|FG001|Overall Study|Lost to Follow-up|21
7671671|NCT00191477|12087460|FG000|Overall Study|Protocol Violation|1
7671672|NCT00191477|12087461|FG001|Overall Study|Protocol Violation|1
7671673|NCT00191477|12087460|FG000|Overall Study|Treatment Change|2
7671674|NCT00191477|12087461|FG001|Overall Study|Treatment Change|0
7671675|NCT00191477|12087460|FG000|Overall Study|Withdrawal by Subject|2
7671676|NCT00191477|12087461|FG001|Overall Study|Withdrawal by Subject|0
7671677|NCT00191477|12087460|FG000|Overall Study|Other|2
7671678|NCT00191477|12087461|FG001|Overall Study|Other|0
7671679|NCT00191477|12087460|FG000|Overall Study|Not Eligible|41
7671680|NCT00191477|12087461|FG001|Overall Study|Not Eligible|38
7671681|NCT00191477|12087460|FG000|Overall Study|Pathological Specimen Lost|1
7671682|NCT00191477|12087461|FG001|Overall Study|Pathological Specimen Lost|0
7671683|NCT00191477|12087460|FG000|Overall Study|Discontinued Prior to Instillation|13
7671684|NCT00191477|12087461|FG001|Overall Study|Discontinued Prior to Instillation|14
7671685|NCT00191646|12087469|FG000|Overall Study|Toxicity|26
7671686|NCT00191646|12087470|FG001|Overall Study|Toxicity|37
7671687|NCT00191646|12087469|FG000|Overall Study|Disease Progression|5
7671688|NCT00191646|12087470|FG001|Overall Study|Disease Progression|6
7671689|NCT00191646|12087469|FG000|Overall Study|Physician Decision|20
7671690|NCT00191646|12087470|FG001|Overall Study|Physician Decision|11
7671691|NCT00191646|12087469|FG000|Overall Study|Withdrawal by Subject|58
7671692|NCT00191646|12087470|FG001|Overall Study|Withdrawal by Subject|39
7671693|NCT00191646|12087469|FG000|Overall Study|Protocol Violation|5
7671694|NCT00191646|12087470|FG001|Overall Study|Protocol Violation|7
7671695|NCT00191646|12087469|FG000|Overall Study|Death|6
7671696|NCT00191646|12087470|FG001|Overall Study|Death|8
7671697|NCT00191646|12087469|FG000|Overall Study|Other|33
7671698|NCT00191646|12087470|FG001|Overall Study|Other|34
7671699|NCT00191646|12087469|FG000|Overall Study|Missing Data|18
7671700|NCT00191646|12087470|FG001|Overall Study|Missing Data|11
7671701|NCT00191724|12087489|FG000|Overall Study|Adverse Event|0
7671702|NCT00191724|12087490|FG001|Overall Study|Adverse Event|0
7671703|NCT00191724|12087491|FG002|Overall Study|Adverse Event|1
7671704|NCT00191724|12087492|FG003|Overall Study|Adverse Event|0
7671705|NCT00191724|12087493|FG004|Overall Study|Adverse Event|0
7671706|NCT00191724|12087489|FG000|Overall Study|Lost to Follow-up|1
7671707|NCT00191724|12087490|FG001|Overall Study|Lost to Follow-up|1
7671708|NCT00191724|12087491|FG002|Overall Study|Lost to Follow-up|0
7671709|NCT00191724|12087492|FG003|Overall Study|Lost to Follow-up|2
7671710|NCT00191724|12087493|FG004|Overall Study|Lost to Follow-up|3
7671711|NCT00191724|12087489|FG000|Overall Study|Withdrawal by Subject|0
7671712|NCT00191724|12087490|FG001|Overall Study|Withdrawal by Subject|0
7671713|NCT00191724|12087491|FG002|Overall Study|Withdrawal by Subject|0
7671714|NCT00191724|12087492|FG003|Overall Study|Withdrawal by Subject|1
7671715|NCT00191724|12087493|FG004|Overall Study|Withdrawal by Subject|0
7671716|NCT00191789|12087505|FG000|Overall Study|Adverse Event|5
7671717|NCT00191789|12087505|FG000|Overall Study|Patient: Satisfactory Response|5
7671718|NCT00191789|12087505|FG000|Overall Study|Patient/Physician: Satisfactory Response|4
7671719|NCT00191789|12087505|FG000|Overall Study|Withdrawal by Subject|4
7671720|NCT00191789|12087505|FG000|Overall Study|Death - Possibly Study Drug Related|4
7671721|NCT00191789|12087505|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2
7671722|NCT00191789|12087505|FG000|Overall Study|Death - Not Study-Drug Related|1
7671723|NCT00191815|12087509|FG000|Overall Study|Adverse Event|2
7671724|NCT00191815|12087509|FG000|Overall Study|Disease progression or relapse|24
7671725|NCT00191815|12087509|FG000|Overall Study|Death|2
7671726|NCT00191815|12087509|FG000|Overall Study|Protocol Violation|3
7671727|NCT00191815|12087509|FG000|Overall Study|Physician Decision|2
7671728|NCT00191815|12087509|FG000|Overall Study|Withdrawal by Subject|7
7671729|NCT00191854|12087516|FG000|Overall Study|Death|26
7671730|NCT00191854|12087517|FG001|Overall Study|Death|23
7671731|NCT00191854|12087518|FG002|Overall Study|Death|29
7671732|NCT00191854|12087516|FG000|Overall Study|Lost to Follow-up|7
7671733|NCT00191854|12087517|FG001|Overall Study|Lost to Follow-up|5
7671734|NCT00191854|12087518|FG002|Overall Study|Lost to Follow-up|5
7671735|NCT00191854|12087516|FG000|Overall Study|Withdrawal by Subject|4
7671736|NCT00191854|12087517|FG001|Overall Study|Withdrawal by Subject|2
7671737|NCT00191854|12087518|FG002|Overall Study|Withdrawal by Subject|3
7671738|NCT00191854|12087516|FG000|Overall Study|Sponsor Decision|0
7671739|NCT00191854|12087517|FG001|Overall Study|Sponsor Decision|0
7671740|NCT00191854|12087518|FG002|Overall Study|Sponsor Decision|1
7671741|NCT00191854|12087516|FG000|Overall Study|Screen Failure|0
7671742|NCT00191854|12087517|FG001|Overall Study|Screen Failure|0
7671743|NCT00191854|12087518|FG002|Overall Study|Screen Failure|1
7671744|NCT00191906|12087530|FG000|Study Period II|Adverse Event|0
7671745|NCT00191906|12087531|FG001|Study Period II|Adverse Event|1
7671746|NCT00191906|12087532|FG002|Study Period II|Adverse Event|0
7671747|NCT00191906|12087533|FG003|Study Period II|Adverse Event|0
7671748|NCT00191906|12087530|FG000|Study Period II|Withdrawal by Subject|0
7671749|NCT00191906|12087531|FG001|Study Period II|Withdrawal by Subject|3
7671750|NCT00191906|12087532|FG002|Study Period II|Withdrawal by Subject|0
7671751|NCT00191906|12087533|FG003|Study Period II|Withdrawal by Subject|0
7671752|NCT00191906|12087530|FG000|Study Period II|Parent/Caregiver Decision|0
7671753|NCT00191906|12087531|FG001|Study Period II|Parent/Caregiver Decision|1
7671754|NCT00191906|12087532|FG002|Study Period II|Parent/Caregiver Decision|0
7671755|NCT00191906|12087533|FG003|Study Period II|Parent/Caregiver Decision|0
7671756|NCT00191906|12087530|FG000|Study Period II|Entry Criteria Exclusion|0
7671757|NCT00191906|12087531|FG001|Study Period II|Entry Criteria Exclusion|0
7671758|NCT00191906|12087532|FG002|Study Period II|Entry Criteria Exclusion|1
7671759|NCT00191906|12087533|FG003|Study Period II|Entry Criteria Exclusion|0
7671760|NCT00191906|12087530|FG000|Study Period III|Adverse Event|1
7671761|NCT00191906|12087531|FG001|Study Period III|Adverse Event|0
7671762|NCT00191906|12087532|FG002|Study Period III|Adverse Event|0
7671763|NCT00191906|12087533|FG003|Study Period III|Adverse Event|0
7671764|NCT00191906|12087530|FG000|Study Period III|Lost to Follow-up|0
7671765|NCT00191906|12087531|FG001|Study Period III|Lost to Follow-up|1
7671766|NCT00191906|12087532|FG002|Study Period III|Lost to Follow-up|0
7671767|NCT00191906|12087533|FG003|Study Period III|Lost to Follow-up|0
7671768|NCT00191906|12087530|FG000|Study Period III|Parent/Caregiver Decision|1
7671769|NCT00191906|12087531|FG001|Study Period III|Parent/Caregiver Decision|0
7671770|NCT00191906|12087532|FG002|Study Period III|Parent/Caregiver Decision|0
7671771|NCT00191906|12087533|FG003|Study Period III|Parent/Caregiver Decision|0
7671772|NCT00191906|12087530|FG000|Study Period III|Lack of Efficacy|3
7671773|NCT00191906|12087531|FG001|Study Period III|Lack of Efficacy|3
7671774|NCT00191906|12087532|FG002|Study Period III|Lack of Efficacy|0
7671775|NCT00191906|12087533|FG003|Study Period III|Lack of Efficacy|0
7671776|NCT00191945|12087551|FG000|Double-Blind Acute Treatment|Parent's Decision|3
7671777|NCT00191945|12087552|FG001|Double-Blind Acute Treatment|Parent's Decision|0
7671778|NCT00191945|12087551|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0
7671779|NCT00191945|12087552|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1
7671780|NCT00191945|12087551|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3
7671781|NCT00191945|12087552|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0
7671782|NCT00191945|12087551|FG000|Double-Blind Acute Treatment|Physician Decision|0
7671783|NCT00191945|12087552|FG001|Double-Blind Acute Treatment|Physician Decision|2
7671784|NCT00191984|12087559|FG000|Overall Study|Disease Progression|21
7671785|NCT00191984|12087559|FG000|Overall Study|Adverse Event|4
7671786|NCT00191984|12087559|FG000|Overall Study|Death|2
7671787|NCT00191984|12087559|FG000|Overall Study|Entry Criteria Exclusion|1
7671788|NCT00191984|12087559|FG000|Overall Study|Withdrawal by Subject|7
7671789|NCT00191984|12087559|FG000|Overall Study|Physician Decision|4
7671790|NCT00192023|12087565|FG000|Period III - Double-Blind|Adverse Event|3
7671791|NCT00192023|12087566|FG001|Period III - Double-Blind|Adverse Event|0
7671792|NCT00192023|12087565|FG000|Period III - Double-Blind|Physician Decision|2
7671793|NCT00192023|12087566|FG001|Period III - Double-Blind|Physician Decision|0
7671794|NCT00192023|12087565|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2
7671795|NCT00192023|12087566|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0
7671796|NCT00192023|12087565|FG000|Period IV - Optional Open-Label|Adverse Event|6
7671797|NCT00192023|12087566|FG001|Period IV - Optional Open-Label|Adverse Event|0
7671798|NCT00192023|12087565|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7
7671799|NCT00192023|12087566|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0
7671800|NCT00192023|12087565|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
7671801|NCT00192023|12087566|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
7671802|NCT00192023|12087565|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2
7671803|NCT00192023|12087566|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0
7671804|NCT00192023|12087565|FG000|Period IV - Optional Open-Label|Protocol Violation|1
7671805|NCT00192023|12087566|FG001|Period IV - Optional Open-Label|Protocol Violation|0
7671806|NCT00192023|12087565|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4
7671807|NCT00192023|12087566|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0
7671808|NCT00192023|12087565|FG000|Period IV - Optional Open-Label|Physician Decision|9
7671809|NCT00192023|12087566|FG001|Period IV - Optional Open-Label|Physician Decision|0
7671810|NCT00192036|12087572|FG000|Overall Study|Protocol Violation|3
7671811|NCT00192036|12087572|FG000|Overall Study|Adverse Event|6
7671812|NCT00192036|12087572|FG000|Overall Study|Patient/Physician Perception|1
7671813|NCT00192036|12087572|FG000|Overall Study|Objective Tumor Progression|4
7671814|NCT00192036|12087572|FG000|Overall Study|Clinical Disease Progression|1
7671815|NCT00192036|12087572|FG000|Overall Study|Death|1
7671816|NCT00192036|12087572|FG000|Overall Study|Unknown or Not Specified|5
7671817|NCT00192075|12087578|FG000|Overall Study|Disease Progression|23
7671818|NCT00192075|12087579|FG001|Overall Study|Disease Progression|6
7671819|NCT00192075|12087578|FG000|Overall Study|Adverse Event|1
7671820|NCT00192075|12087579|FG001|Overall Study|Adverse Event|3
7671821|NCT00192075|12087578|FG000|Overall Study|Death|0
7671822|NCT00192075|12087579|FG001|Overall Study|Death|1
7671823|NCT00192075|12087578|FG000|Overall Study|Lack of Efficacy|0
7671824|NCT00192075|12087579|FG001|Overall Study|Lack of Efficacy|0
7671825|NCT00192075|12087578|FG000|Overall Study|Physician Decision|3
7671826|NCT00192075|12087579|FG001|Overall Study|Physician Decision|0
7671827|NCT00192075|12087578|FG000|Overall Study|Withdrawal by Subject|5
7671828|NCT00192075|12087579|FG001|Overall Study|Withdrawal by Subject|5
7671829|NCT00192075|12087578|FG000|Overall Study|Patient Non-Compliance|0
7671830|NCT00192075|12087579|FG001|Overall Study|Patient Non-Compliance|1
7671831|NCT00192075|12087578|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
7671832|NCT00192075|12087579|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
7671833|NCT00192075|12087578|FG000|Overall Study|Other|5
7671834|NCT00192075|12087579|FG001|Overall Study|Other|2
7671835|NCT00192114|12087590|FG000|Overall Study|Objective Tumor Progression|19
7671836|NCT00192114|12087590|FG000|Overall Study|Adverse Event|2
7671837|NCT00192114|12087590|FG000|Overall Study|Clinical Progression|2
7671838|NCT00192114|12087590|FG000|Overall Study|Death|1
7671839|NCT00192296|12087598|FG000|Overall Study|Withdrawal by Subject|0
7671840|NCT00192296|12087599|FG001|Overall Study|Withdrawal by Subject|1
7671841|NCT00192296|12087600|FG002|Overall Study|Withdrawal by Subject|0
7671842|NCT00192296|12087601|FG003|Overall Study|Withdrawal by Subject|0
7671843|NCT00192504|12087615|FG000|Overall Study|Lost to Follow-up|1
7671844|NCT00192504|12087616|FG001|Overall Study|Lost to Follow-up|0
7671845|NCT00192504|12087617|FG002|Overall Study|Lost to Follow-up|0
7671846|NCT00192504|12087618|FG003|Overall Study|Lost to Follow-up|0
7671847|NCT00192504|12087615|FG000|Overall Study|Dosing window missed|0
7671848|NCT00192504|12087616|FG001|Overall Study|Dosing window missed|0
7671849|NCT00192504|12087617|FG002|Overall Study|Dosing window missed|1
7671850|NCT00192504|12087618|FG003|Overall Study|Dosing window missed|0
7671851|NCT00192647|12087630|FG000|Overall Study|Death|1
7671852|NCT00192647|12087631|FG001|Overall Study|Death|1
7671853|NCT00192647|12087630|FG000|Overall Study|Adverse Event|35
7671854|NCT00192647|12087631|FG001|Overall Study|Adverse Event|29
7671855|NCT00192647|12087630|FG000|Overall Study|Laboratory Test Abnormality|4
7671856|NCT00192647|12087631|FG001|Overall Study|Laboratory Test Abnormality|2
7671857|NCT00192647|12087630|FG000|Overall Study|Insufficient Therapeutic Response|53
7671858|NCT00192647|12087631|FG001|Overall Study|Insufficient Therapeutic Response|83
7671859|NCT00192647|12087630|FG000|Overall Study|Entry Criteria Violation|6
7671860|NCT00192647|12087631|FG001|Overall Study|Entry Criteria Violation|6
7671861|NCT00192647|12087630|FG000|Overall Study|Protocol Violation|3
7671862|NCT00192647|12087631|FG001|Overall Study|Protocol Violation|1
7671863|NCT00192647|12087630|FG000|Overall Study|Refused Treatment/Did not Cooperate|10
7671864|NCT00192647|12087631|FG001|Overall Study|Refused Treatment/Did not Cooperate|8
7671865|NCT00192647|12087630|FG000|Overall Study|Failure to Return|11
7671866|NCT00192647|12087631|FG001|Overall Study|Failure to Return|13
7671867|NCT00192647|12087630|FG000|Overall Study|Other/Administrative|5
7671868|NCT00192647|12087631|FG001|Overall Study|Other/Administrative|3
7671869|NCT00193050|12087646|FG000|Neoadjuvant Treatment|Lack of Efficacy|2
7671870|NCT00193050|12087646|FG000|Neoadjuvant Treatment|Intercurrent Illness|3
7671871|NCT00193050|12087646|FG000|Neoadjuvant Treatment|Physician Decision|2
7671872|NCT00193050|12087646|FG000|Neoadjuvant Treatment|Adverse Event|2
7671873|NCT00193050|12087646|FG000|Adjuvant|Physician Decision|5
7671874|NCT00193050|12087646|FG000|Adjuvant|Intercurrent Hospitalization|3
7671875|NCT00193050|12087646|FG000|Adjuvant|Lack of Efficacy|2
7671876|NCT00193063|12087651|FG000|Overall Study|Lack of Efficacy|3
7671877|NCT00193063|12087651|FG000|Overall Study|Adverse Event|1
7671878|NCT00193180|12087666|FG000|Overall Study|Lack of Efficacy|1
7671879|NCT00193180|12087666|FG000|Overall Study|Adverse Event|8
7671880|NCT00193180|12087666|FG000|Overall Study|Protocol Violation|1
7671881|NCT00193206|12087671|FG000|Preoperative Therapy|Lack of Efficacy|2
7671882|NCT00193206|12087671|FG000|Preoperative Therapy|Adverse Event|2
7671883|NCT00193206|12087671|FG000|Preoperative Therapy|Withdrawal by Subject|2
7671884|NCT00193206|12087671|FG000|Preoperative Therapy|False Positive Pregnancy Test|1
7671885|NCT00193206|12087671|FG000|Postoperative Therapy|Withdrawal by Subject|7
7671886|NCT00193206|12087671|FG000|Postoperative Therapy|Physician Decision|3
7671887|NCT00193206|12087671|FG000|Postoperative Therapy|Intercurrent Illness|2
7671888|NCT00193206|12087671|FG000|Postoperative Therapy|Lack of Efficacy|1
7671889|NCT00193206|12087671|FG000|Postoperative Therapy|Protocol Violation|1
7671890|NCT00193609|12087705|FG000|Overall Study|Lack of Efficacy|2
7671891|NCT00193609|12087705|FG000|Overall Study|Adverse Event|2
7671892|NCT00194012|12087711|FG000|Randomized Phase|Lack of Efficacy|8
7671893|NCT00194012|12087712|FG001|Randomized Phase|Lack of Efficacy|18
7671894|NCT00194012|12087711|FG000|Randomized Phase|Study nonadherence|2
7671895|NCT00194012|12087712|FG001|Randomized Phase|Study nonadherence|1
7671896|NCT00194012|12087711|FG000|Randomized Phase|Withdrawal by Subject|3
7671897|NCT00194012|12087712|FG001|Randomized Phase|Withdrawal by Subject|3
7671898|NCT00194012|12087711|FG000|Randomized Phase|Adverse Event|2
7671899|NCT00194012|12087712|FG001|Randomized Phase|Adverse Event|1
7671900|NCT00194012|12087711|FG000|Randomized Phase|Participant reported having a rash|1
7671901|NCT00194012|12087712|FG001|Randomized Phase|Participant reported having a rash|0
7671902|NCT00194012|12087711|FG000|Randomized Phase|Emesis and enuresis|0
7671903|NCT00194012|12087712|FG001|Randomized Phase|Emesis and enuresis|1
7671904|NCT00194012|12087711|FG000|Randomized Phase|Oral/nasal twitching|0
7671905|NCT00194012|12087712|FG001|Randomized Phase|Oral/nasal twitching|1
7671906|NCT00194012|12087711|FG000|Open Label Extension (OLE)|Weight Gain|1
7671907|NCT00194012|12087712|FG001|Open Label Extension (OLE)|Weight Gain|0
7671908|NCT00194012|12087711|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0
7671909|NCT00194012|12087712|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1
7671910|NCT00194012|12087711|FG000|Open Label Extension (OLE)|Lost to Follow-up|3
7671911|NCT00194012|12087712|FG001|Open Label Extension (OLE)|Lost to Follow-up|5
7671912|NCT00194012|12087711|FG000|Open Label Extension (OLE)|Lack of Efficacy|1
7671913|NCT00194012|12087712|FG001|Open Label Extension (OLE)|Lack of Efficacy|0
7671914|NCT00194025|12087724|FG000|Overall Study|Adverse Event|1
7671915|NCT00194025|12087724|FG000|Overall Study|non-adherence with study medication|4
7671916|NCT00194077|12087730|FG000|Overall Study|Lack of Efficacy|22
7671917|NCT00194077|12087731|FG001|Overall Study|Lack of Efficacy|29
7671918|NCT00194077|12087730|FG000|Overall Study|Study nonadherence|1
7671919|NCT00194077|12087731|FG001|Overall Study|Study nonadherence|0
7671920|NCT00194077|12087730|FG000|Overall Study|Withdrawal by Subject|1
7671921|NCT00194077|12087731|FG001|Overall Study|Withdrawal by Subject|1
7671922|NCT00194675|12087782|FG000|Overall Study|Lost to Follow-up|1
7671923|NCT00194675|12087783|FG001|Overall Study|Lost to Follow-up|1
7671924|NCT00194675|12087782|FG000|Overall Study|lack of interest|1
7671925|NCT00194675|12087783|FG001|Overall Study|lack of interest|1
7671926|NCT00194675|12087782|FG000|Overall Study|"withdrew due to edgy feeling"|1
7671927|NCT00194675|12087783|FG001|Overall Study|"withdrew due to edgy feeling"|0
7671928|NCT00194675|12087782|FG000|Overall Study|Protocol Violation|1
7671929|NCT00194675|12087783|FG001|Overall Study|Protocol Violation|0
7671930|NCT00194675|12087782|FG000|Overall Study|Death|1
7671931|NCT00194675|12087783|FG001|Overall Study|Death|0
7671932|NCT00194792|12087795|FG000|Overall Study|Withdrawal by Subject|1
7671933|NCT00194987|12087818|FG000|Overall Study|Withdrawal by Subject|0
7671934|NCT00194987|12087819|FG001|Overall Study|Withdrawal by Subject|3
7671935|NCT00195260|12087842|FG000|Part 1: Dose Escalation|Adverse Event|0
7671936|NCT00195260|12087843|FG001|Part 1: Dose Escalation|Adverse Event|1
7671937|NCT00195260|12087844|FG002|Part 1: Dose Escalation|Adverse Event|0
7671938|NCT00195260|12087845|FG003|Part 1: Dose Escalation|Adverse Event|1
7671939|NCT00195260|12087846|FG004|Part 1: Dose Escalation|Adverse Event|1
7671940|NCT00195260|12087847|FG005|Part 1: Dose Escalation|Adverse Event|0
7671941|NCT00195260|12087848|FG006|Part 1: Dose Escalation|Adverse Event|3
7671942|NCT00195260|12087849|FG007|Part 1: Dose Escalation|Adverse Event|0
7671943|NCT00195260|12087850|FG008|Part 1: Dose Escalation|Adverse Event|0
7671944|NCT00195260|12087851|FG009|Part 1: Dose Escalation|Adverse Event|0
7671945|NCT00195260|12087852|FG010|Part 1: Dose Escalation|Adverse Event|0
7671946|NCT00195260|12087842|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0
7671947|NCT00195260|12087843|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0
7671948|NCT00195260|12087844|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0
7671949|NCT00195260|12087845|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0
7671950|NCT00195260|12087846|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2
7671951|NCT00195260|12087847|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0
7671952|NCT00195260|12087848|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0
7671953|NCT00195260|12087849|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1
7671954|NCT00195260|12087850|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0
7671955|NCT00195260|12087851|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0
7671956|NCT00195260|12087852|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0
7671957|NCT00195260|12087842|FG000|Part 1: Dose Escalation|Death|0
7671958|NCT00195260|12087843|FG001|Part 1: Dose Escalation|Death|0
7671959|NCT00195260|12087844|FG002|Part 1: Dose Escalation|Death|0
7671960|NCT00195260|12087845|FG003|Part 1: Dose Escalation|Death|0
7671961|NCT00195260|12087846|FG004|Part 1: Dose Escalation|Death|0
7671962|NCT00195260|12087847|FG005|Part 1: Dose Escalation|Death|0
7671963|NCT00195260|12087848|FG006|Part 1: Dose Escalation|Death|0
7671964|NCT00195260|12087849|FG007|Part 1: Dose Escalation|Death|1
7671965|NCT00195260|12087850|FG008|Part 1: Dose Escalation|Death|0
7671966|NCT00195260|12087851|FG009|Part 1: Dose Escalation|Death|0
7671967|NCT00195260|12087852|FG010|Part 1: Dose Escalation|Death|0
7671968|NCT00195260|12087842|FG000|Part 1: Dose Escalation|Disease Progression|3
7671969|NCT00195260|12087843|FG001|Part 1: Dose Escalation|Disease Progression|2
7671970|NCT00195260|12087844|FG002|Part 1: Dose Escalation|Disease Progression|5
7671971|NCT00195260|12087845|FG003|Part 1: Dose Escalation|Disease Progression|6
7671972|NCT00195260|12087846|FG004|Part 1: Dose Escalation|Disease Progression|4
7671973|NCT00195260|12087847|FG005|Part 1: Dose Escalation|Disease Progression|6
7671974|NCT00195260|12087848|FG006|Part 1: Dose Escalation|Disease Progression|7
7671975|NCT00195260|12087849|FG007|Part 1: Dose Escalation|Disease Progression|4
7671976|NCT00195260|12087850|FG008|Part 1: Dose Escalation|Disease Progression|0
7671977|NCT00195260|12087851|FG009|Part 1: Dose Escalation|Disease Progression|0
7671978|NCT00195260|12087852|FG010|Part 1: Dose Escalation|Disease Progression|0
7671979|NCT00195260|12087842|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1
7671980|NCT00195260|12087843|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1
7671981|NCT00195260|12087844|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1
7671982|NCT00195260|12087845|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0
7671983|NCT00195260|12087846|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0
7671984|NCT00195260|12087847|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1
7671985|NCT00195260|12087848|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0
7671986|NCT00195260|12087849|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0
7671987|NCT00195260|12087850|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0
7671988|NCT00195260|12087851|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0
7671989|NCT00195260|12087852|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0
7671990|NCT00195260|12087842|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7671991|NCT00195260|12087843|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7671992|NCT00195260|12087844|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7671993|NCT00195260|12087845|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7671994|NCT00195260|12087846|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7671995|NCT00195260|12087847|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7671996|NCT00195260|12087848|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7671997|NCT00195260|12087849|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7671998|NCT00195260|12087850|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
7671999|NCT00195260|12087851|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
7672000|NCT00195260|12087852|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
7672001|NCT00195260|12087842|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7672002|NCT00195260|12087843|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7672003|NCT00195260|12087844|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7672004|NCT00195260|12087845|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7672005|NCT00195260|12087846|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7672006|NCT00195260|12087847|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7672007|NCT00195260|12087848|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7672008|NCT00195260|12087849|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7672009|NCT00195260|12087850|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
7672010|NCT00195260|12087851|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
7672011|NCT00195260|12087852|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
7672012|NCT00195260|12087842|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7672013|NCT00195260|12087843|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7672014|NCT00195260|12087844|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7672015|NCT00195260|12087845|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7672016|NCT00195260|12087846|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7672017|NCT00195260|12087847|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7672018|NCT00195260|12087848|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7672019|NCT00195260|12087849|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7672020|NCT00195260|12087850|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
7672021|NCT00195260|12087851|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
7672022|NCT00195260|12087852|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
7672023|NCT00195260|12087842|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7672024|NCT00195260|12087843|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7672025|NCT00195260|12087844|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7672026|NCT00195260|12087845|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7672027|NCT00195260|12087846|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7672028|NCT00195260|12087847|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7672029|NCT00195260|12087848|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7672030|NCT00195260|12087849|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7672031|NCT00195260|12087850|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
7672032|NCT00195260|12087851|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
7672033|NCT00195260|12087852|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
7672034|NCT00195273|12087882|FG000|Overall Study|Adverse Event|9
7672035|NCT00195273|12087883|FG001|Overall Study|Adverse Event|9
7672036|NCT00195273|12087882|FG000|Overall Study|Protocol deviation|0
7672037|NCT00195273|12087883|FG001|Overall Study|Protocol deviation|1
7672038|NCT00195273|12087882|FG000|Overall Study|Lack of Efficacy|3
7672039|NCT00195273|12087883|FG001|Overall Study|Lack of Efficacy|1
7672040|NCT00195273|12087882|FG000|Overall Study|Procedural complications|9
7672041|NCT00195273|12087883|FG001|Overall Study|Procedural complications|3
7672042|NCT00195338|12087889|FG000|Overall Study|Lost to Follow-up|2
7672043|NCT00195338|12087889|FG000|Overall Study|Adverse Event|5
7672044|NCT00195338|12087889|FG000|Overall Study|Lack of Efficacy|1
7672045|NCT00195338|12087889|FG000|Overall Study|Early closure of the site|4
7672046|NCT00195351|12087895|FG000|Overall Study|Lost to Follow-up|9
7672047|NCT00195351|12087896|FG001|Overall Study|Lost to Follow-up|9
7672048|NCT00195351|12087895|FG000|Overall Study|Withdrawal by Subject|6
7672049|NCT00195351|12087896|FG001|Overall Study|Withdrawal by Subject|3
7672050|NCT00195351|12087895|FG000|Overall Study|Protocol Deviation|3
7672051|NCT00195351|12087896|FG001|Overall Study|Protocol Deviation|2
7672052|NCT00195351|12087895|FG000|Overall Study|Death|3
7672053|NCT00195351|12087896|FG001|Overall Study|Death|1
7672054|NCT00195351|12087895|FG000|Overall Study|Lack of Efficacy|0
7672055|NCT00195351|12087896|FG001|Overall Study|Lack of Efficacy|1
7672056|NCT00195429|12087908|FG000|Overall Study|Adverse Event|2
7672057|NCT00195429|12087909|FG001|Overall Study|Adverse Event|4
7672058|NCT00195429|12087908|FG000|Overall Study|Lack of Efficacy|2
7672059|NCT00195429|12087909|FG001|Overall Study|Lack of Efficacy|1
7672060|NCT00195429|12087908|FG000|Overall Study|Lost to Follow-up|1
7672061|NCT00195429|12087909|FG001|Overall Study|Lost to Follow-up|0
7672062|NCT00195442|12087915|FG000|Overall Study|Less than expected therapeutic effect|38
7672063|NCT00195442|12087915|FG000|Overall Study|Lost to Follow-up|27
7672064|NCT00195442|12087915|FG000|Overall Study|Switch to other Factor VIII preparation|23
7672065|NCT00195442|12087915|FG000|Overall Study|Intermittent product shortage|21
7672066|NCT00195442|12087915|FG000|Overall Study|Death|7
7672067|NCT00195442|12087915|FG000|Overall Study|No reason specified|4
7672068|NCT00195442|12087915|FG000|Overall Study|Poor cooperation|2
7672069|NCT00195442|12087915|FG000|Overall Study|Other|14
7672070|NCT00195494|12087921|FG000|Year 1|Adverse Event|0
7672071|NCT00195494|12087922|FG001|Year 1|Adverse Event|0
7672072|NCT00195494|12087923|FG002|Year 1|Adverse Event|0
7672073|NCT00195494|12087924|FG003|Year 1|Adverse Event|0
7672074|NCT00195494|12087925|FG004|Year 1|Adverse Event|34
7672075|NCT00195494|12087926|FG005|Year 1|Adverse Event|27
7672076|NCT00195494|12087921|FG000|Year 1|System Toxicity|0
7672077|NCT00195494|12087922|FG001|Year 1|System Toxicity|0
7672078|NCT00195494|12087923|FG002|Year 1|System Toxicity|0
7672079|NCT00195494|12087924|FG003|Year 1|System Toxicity|0
7672080|NCT00195494|12087925|FG004|Year 1|System Toxicity|0
7672081|NCT00195494|12087926|FG005|Year 1|System Toxicity|1
7672082|NCT00195494|12087921|FG000|Year 1|Lack of Efficacy|0
7672083|NCT00195494|12087922|FG001|Year 1|Lack of Efficacy|0
7672084|NCT00195494|12087923|FG002|Year 1|Lack of Efficacy|0
7672085|NCT00195494|12087924|FG003|Year 1|Lack of Efficacy|0
7672086|NCT00195494|12087925|FG004|Year 1|Lack of Efficacy|24
7672087|NCT00195494|12087926|FG005|Year 1|Lack of Efficacy|9
7672088|NCT00195494|12087921|FG000|Year 1|Compliance|0
7672089|NCT00195494|12087922|FG001|Year 1|Compliance|0
7672090|NCT00195494|12087923|FG002|Year 1|Compliance|0
7672091|NCT00195494|12087924|FG003|Year 1|Compliance|0
7672092|NCT00195494|12087925|FG004|Year 1|Compliance|5
7672093|NCT00195494|12087926|FG005|Year 1|Compliance|1
7672094|NCT00195494|12087921|FG000|Year 1|Lost to Follow-up|0
7672095|NCT00195494|12087922|FG001|Year 1|Lost to Follow-up|0
7672096|NCT00195494|12087923|FG002|Year 1|Lost to Follow-up|0
7672097|NCT00195494|12087924|FG003|Year 1|Lost to Follow-up|0
7672098|NCT00195494|12087925|FG004|Year 1|Lost to Follow-up|1
7672099|NCT00195494|12087926|FG005|Year 1|Lost to Follow-up|0
7672100|NCT00195494|12087921|FG000|Year 1|Missed >4 consecutive doses|0
7672101|NCT00195494|12087922|FG001|Year 1|Missed >4 consecutive doses|0
7672102|NCT00195494|12087923|FG002|Year 1|Missed >4 consecutive doses|0
7672103|NCT00195494|12087924|FG003|Year 1|Missed >4 consecutive doses|0
7672104|NCT00195494|12087925|FG004|Year 1|Missed >4 consecutive doses|3
7672105|NCT00195494|12087926|FG005|Year 1|Missed >4 consecutive doses|2
7672106|NCT00195494|12087921|FG000|Year 1|Protocol deviation|0
7672107|NCT00195494|12087922|FG001|Year 1|Protocol deviation|0
7672108|NCT00195494|12087923|FG002|Year 1|Protocol deviation|0
7672109|NCT00195494|12087924|FG003|Year 1|Protocol deviation|0
7672110|NCT00195494|12087925|FG004|Year 1|Protocol deviation|2
7672111|NCT00195494|12087926|FG005|Year 1|Protocol deviation|3
7672112|NCT00195494|12087921|FG000|Year 1|Physician Decision|0
7672113|NCT00195494|12087922|FG001|Year 1|Physician Decision|0
7672114|NCT00195494|12087923|FG002|Year 1|Physician Decision|0
7672115|NCT00195494|12087924|FG003|Year 1|Physician Decision|0
7672116|NCT00195494|12087925|FG004|Year 1|Physician Decision|1
7672117|NCT00195494|12087926|FG005|Year 1|Physician Decision|0
7672118|NCT00195494|12087921|FG000|Year 1|Withdrawal by Subject|0
7672119|NCT00195494|12087922|FG001|Year 1|Withdrawal by Subject|0
7672120|NCT00195494|12087923|FG002|Year 1|Withdrawal by Subject|0
7672121|NCT00195494|12087924|FG003|Year 1|Withdrawal by Subject|0
7672122|NCT00195494|12087925|FG004|Year 1|Withdrawal by Subject|8
7672123|NCT00195494|12087926|FG005|Year 1|Withdrawal by Subject|9
7672124|NCT00195494|12087921|FG000|Year 1|Protocol Violation|0
7672125|NCT00195494|12087922|FG001|Year 1|Protocol Violation|0
7672126|NCT00195494|12087923|FG002|Year 1|Protocol Violation|0
7672127|NCT00195494|12087924|FG003|Year 1|Protocol Violation|0
7672128|NCT00195494|12087925|FG004|Year 1|Protocol Violation|1
7672129|NCT00195494|12087926|FG005|Year 1|Protocol Violation|1
7672130|NCT00195494|12087921|FG000|Year 2|Adverse Event|3
7672131|NCT00195494|12087922|FG001|Year 2|Adverse Event|7
7672132|NCT00195494|12087923|FG002|Year 2|Adverse Event|5
7672133|NCT00195494|12087924|FG003|Year 2|Adverse Event|9
7672134|NCT00195494|12087925|FG004|Year 2|Adverse Event|0
7672135|NCT00195494|12087926|FG005|Year 2|Adverse Event|0
7672136|NCT00195494|12087921|FG000|Year 2|Lack of Efficacy|0
7672137|NCT00195494|12087922|FG001|Year 2|Lack of Efficacy|1
7672138|NCT00195494|12087923|FG002|Year 2|Lack of Efficacy|7
7672139|NCT00195494|12087924|FG003|Year 2|Lack of Efficacy|7
7672140|NCT00195494|12087925|FG004|Year 2|Lack of Efficacy|0
7672141|NCT00195494|12087926|FG005|Year 2|Lack of Efficacy|0
7672142|NCT00195494|12087921|FG000|Year 2|Compliance|1
7672143|NCT00195494|12087922|FG001|Year 2|Compliance|0
7672144|NCT00195494|12087923|FG002|Year 2|Compliance|0
7672145|NCT00195494|12087924|FG003|Year 2|Compliance|2
7672146|NCT00195494|12087925|FG004|Year 2|Compliance|0
7672147|NCT00195494|12087926|FG005|Year 2|Compliance|0
7672148|NCT00195494|12087921|FG000|Year 2|Lost to Follow-up|0
7672149|NCT00195494|12087922|FG001|Year 2|Lost to Follow-up|0
7672150|NCT00195494|12087923|FG002|Year 2|Lost to Follow-up|1
7672151|NCT00195494|12087924|FG003|Year 2|Lost to Follow-up|1
7672152|NCT00195494|12087925|FG004|Year 2|Lost to Follow-up|0
7672153|NCT00195494|12087926|FG005|Year 2|Lost to Follow-up|0
7672154|NCT00195494|12087921|FG000|Year 2|Missed >4 consecutive doses|1
7672155|NCT00195494|12087922|FG001|Year 2|Missed >4 consecutive doses|1
7672156|NCT00195494|12087923|FG002|Year 2|Missed >4 consecutive doses|1
7672157|NCT00195494|12087924|FG003|Year 2|Missed >4 consecutive doses|0
7672158|NCT00195494|12087925|FG004|Year 2|Missed >4 consecutive doses|0
7672159|NCT00195494|12087926|FG005|Year 2|Missed >4 consecutive doses|0
7672160|NCT00195494|12087921|FG000|Year 2|Protocol deviation|0
7672161|NCT00195494|12087922|FG001|Year 2|Protocol deviation|1
7672162|NCT00195494|12087923|FG002|Year 2|Protocol deviation|0
7672163|NCT00195494|12087924|FG003|Year 2|Protocol deviation|0
7672164|NCT00195494|12087925|FG004|Year 2|Protocol deviation|0
7672165|NCT00195494|12087926|FG005|Year 2|Protocol deviation|0
7672166|NCT00195494|12087921|FG000|Year 2|Physician Decision|1
7672167|NCT00195494|12087922|FG001|Year 2|Physician Decision|1
7672168|NCT00195494|12087923|FG002|Year 2|Physician Decision|0
7672169|NCT00195494|12087924|FG003|Year 2|Physician Decision|0
7672170|NCT00195494|12087925|FG004|Year 2|Physician Decision|0
7672171|NCT00195494|12087926|FG005|Year 2|Physician Decision|0
7672172|NCT00195494|12087921|FG000|Year 2|Withdrawal by Subject|1
7672173|NCT00195494|12087922|FG001|Year 2|Withdrawal by Subject|5
7672174|NCT00195494|12087923|FG002|Year 2|Withdrawal by Subject|4
7672175|NCT00195494|12087924|FG003|Year 2|Withdrawal by Subject|3
7672176|NCT00195494|12087925|FG004|Year 2|Withdrawal by Subject|0
7672177|NCT00195494|12087926|FG005|Year 2|Withdrawal by Subject|0
7672178|NCT00195494|12087921|FG000|Year 2|System toxicity|0
7672179|NCT00195494|12087922|FG001|Year 2|System toxicity|0
7672180|NCT00195494|12087923|FG002|Year 2|System toxicity|0
7672181|NCT00195494|12087924|FG003|Year 2|System toxicity|1
7672182|NCT00195494|12087925|FG004|Year 2|System toxicity|0
7672183|NCT00195494|12087926|FG005|Year 2|System toxicity|0
7672184|NCT00195507|12087944|FG000|Overall Study|Adverse Event|24
7672185|NCT00195507|12087945|FG001|Overall Study|Adverse Event|13
7672186|NCT00195507|12087944|FG000|Overall Study|Death|0
7672187|NCT00195507|12087945|FG001|Overall Study|Death|1
7672188|NCT00195507|12087944|FG000|Overall Study|Failed to Return|4
7672189|NCT00195507|12087945|FG001|Overall Study|Failed to Return|3
7672190|NCT00195507|12087944|FG000|Overall Study|Physician Decision|1
7672191|NCT00195507|12087945|FG001|Overall Study|Physician Decision|2
7672192|NCT00195507|12087944|FG000|Overall Study|Lost to Follow-up|3
7672193|NCT00195507|12087945|FG001|Overall Study|Lost to Follow-up|2
7672194|NCT00195507|12087944|FG000|Overall Study|Protocol Violation|5
7672195|NCT00195507|12087945|FG001|Overall Study|Protocol Violation|4
7672196|NCT00195507|12087944|FG000|Overall Study|Lack of Efficacy|40
7672197|NCT00195507|12087945|FG001|Overall Study|Lack of Efficacy|67
7672198|NCT00195507|12087944|FG000|Overall Study|Withdrawal by Subject|16
7672199|NCT00195507|12087945|FG001|Overall Study|Withdrawal by Subject|23
7672200|NCT00195507|12087944|FG000|Overall Study|Protocol Deviation|6
7672201|NCT00195507|12087945|FG001|Overall Study|Protocol Deviation|3
7672202|NCT00195650|12087960|FG000|Overall Study|Adverse Event|194
7672203|NCT00195650|12087960|FG000|Overall Study|Lack of Efficacy|99
7672204|NCT00195650|12087960|FG000|Overall Study|Withdrawal by Subject|67
7672205|NCT00195650|12087960|FG000|Overall Study|Lost to Follow-up|44
7672206|NCT00195650|12087960|FG000|Overall Study|Death|23
7672207|NCT00195650|12087960|FG000|Overall Study|Protocol Violation|15
7672208|NCT00195650|12087960|FG000|Overall Study|Administrative reasons|83
7672209|NCT00195663|12087967|FG000|2-year Double-blind Treatment Period|Adverse Event|21
7672210|NCT00195663|12087968|FG001|2-year Double-blind Treatment Period|Adverse Event|27
7672211|NCT00195663|12087969|FG002|2-year Double-blind Treatment Period|Adverse Event|32
7672212|NCT00195663|12087967|FG000|2-year Double-blind Treatment Period|Death|0
7672213|NCT00195663|12087968|FG001|2-year Double-blind Treatment Period|Death|2
7672214|NCT00195663|12087969|FG002|2-year Double-blind Treatment Period|Death|0
7672215|NCT00195663|12087967|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0
7672216|NCT00195663|12087968|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0
7672217|NCT00195663|12087969|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1
7672218|NCT00195663|12087967|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15
7672219|NCT00195663|12087968|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18
7672220|NCT00195663|12087969|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12
7672221|NCT00195663|12087967|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47
7672222|NCT00195663|12087968|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52
7672223|NCT00195663|12087969|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13
7672224|NCT00195663|12087967|FG000|2-year Double-blind Treatment Period|Protocol Violation|6
7672225|NCT00195663|12087968|FG001|2-year Double-blind Treatment Period|Protocol Violation|6
7672226|NCT00195663|12087969|FG002|2-year Double-blind Treatment Period|Protocol Violation|4
7672227|NCT00195663|12087967|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0
7672228|NCT00195663|12087968|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1
7672229|NCT00195663|12087969|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0
7672230|NCT00195663|12087967|FG000|2-year Double-blind Treatment Period|Recovery|1
7672231|NCT00195663|12087968|FG001|2-year Double-blind Treatment Period|Recovery|0
7672232|NCT00195663|12087969|FG002|2-year Double-blind Treatment Period|Recovery|1
7672233|NCT00195663|12087967|FG000|2-year Double-blind Treatment Period|Administrative reasons|3
7672234|NCT00195663|12087968|FG001|2-year Double-blind Treatment Period|Administrative reasons|2
7672235|NCT00195663|12087969|FG002|2-year Double-blind Treatment Period|Administrative reasons|9
7672236|NCT00195663|12087967|FG000|Open-Label Extension Period|Adverse Event|21
7672237|NCT00195663|12087968|FG001|Open-Label Extension Period|Adverse Event|32
7672238|NCT00195663|12087969|FG002|Open-Label Extension Period|Adverse Event|36
7672239|NCT00195663|12087967|FG000|Open-Label Extension Period|Lost to Follow-up|9
7672240|NCT00195663|12087968|FG001|Open-Label Extension Period|Lost to Follow-up|2
7672241|NCT00195663|12087969|FG002|Open-Label Extension Period|Lost to Follow-up|6
7672242|NCT00195663|12087967|FG000|Open-Label Extension Period|Recovery|0
7672243|NCT00195663|12087968|FG001|Open-Label Extension Period|Recovery|2
7672244|NCT00195663|12087969|FG002|Open-Label Extension Period|Recovery|2
7672245|NCT00195663|12087967|FG000|Open-Label Extension Period|Protocol Violation|3
7672246|NCT00195663|12087968|FG001|Open-Label Extension Period|Protocol Violation|4
7672247|NCT00195663|12087969|FG002|Open-Label Extension Period|Protocol Violation|4
7672248|NCT00195663|12087967|FG000|Open-Label Extension Period|Death|2
7672249|NCT00195663|12087968|FG001|Open-Label Extension Period|Death|2
7672250|NCT00195663|12087969|FG002|Open-Label Extension Period|Death|2
7672251|NCT00195663|12087967|FG000|Open-Label Extension Period|Withdrawal by Subject|16
7672252|NCT00195663|12087968|FG001|Open-Label Extension Period|Withdrawal by Subject|15
7672253|NCT00195663|12087969|FG002|Open-Label Extension Period|Withdrawal by Subject|22
7672254|NCT00195663|12087967|FG000|Open-Label Extension Period|Lack of Efficacy|14
7672255|NCT00195663|12087968|FG001|Open-Label Extension Period|Lack of Efficacy|6
7672256|NCT00195663|12087969|FG002|Open-Label Extension Period|Lack of Efficacy|12
7672257|NCT00195663|12087967|FG000|Open-Label Extension Period|Administrative reasons|11
7672258|NCT00195663|12087968|FG001|Open-Label Extension Period|Administrative reasons|11
7672259|NCT00195663|12087969|FG002|Open-Label Extension Period|Administrative reasons|13
7672260|NCT00195676|12087987|FG000|Period O - Open-label Treatment|Adverse Event|82
7672261|NCT00195676|12087987|FG000|Period O - Open-label Treatment|Death|6
7672262|NCT00195676|12087987|FG000|Period O - Open-label Treatment|Lack of Efficacy|198
7672263|NCT00195676|12087987|FG000|Period O - Open-label Treatment|Lost to Follow-up|91
7672264|NCT00195676|12087987|FG000|Period O - Open-label Treatment|Protocol Violation|12
7672265|NCT00195676|12087987|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147
7672266|NCT00195676|12087987|FG000|Period O - Open-label Treatment|Administrative reasons|2
7672267|NCT00195676|12087987|FG000|Period O - Open-label Treatment|Other reasons|68
7672268|NCT00195676|12087987|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4
7672269|NCT00195676|12087987|FG000|Period W (Withdrawal) - No Treatment|Death|2
7672270|NCT00195676|12087987|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
7672271|NCT00195676|12087987|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
7672272|NCT00195676|12087987|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
7672273|NCT00195676|12087987|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129
7672274|NCT00195676|12087987|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1
7672275|NCT00195676|12087987|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18
7672276|NCT00195676|12087987|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4
7672277|NCT00195676|12087987|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
7672278|NCT00195676|12087987|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
7672279|NCT00195676|12087987|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
7672280|NCT00195676|12087987|FG000|Period R - Retreatment 16 Weeks|Other reasons|6
7672281|NCT00195715|12088016|FG000|Overall Study|Adverse Event|122
7672282|NCT00195715|12088016|FG000|Overall Study|Withdrawal by Subject|58
7672283|NCT00195715|12088016|FG000|Overall Study|Lost to Follow-up|27
7672284|NCT00195715|12088016|FG000|Overall Study|Protocol Violation|13
7672285|NCT00195715|12088016|FG000|Overall Study|Lack of Efficacy|93
7672286|NCT00195715|12088016|FG000|Overall Study|Pregnancy|14
7672287|NCT00195715|12088016|FG000|Overall Study|Investigative site closure|8
7672288|NCT00195715|12088016|FG000|Overall Study|Subject moved/relocated|7
7672289|NCT00195715|12088016|FG000|Overall Study|Subject non-compliance|6
7672290|NCT00195715|12088016|FG000|Overall Study|Subject started commercial Humira|5
7672291|NCT00195715|12088016|FG000|Overall Study|Subject choice|3
7672292|NCT00195715|12088016|FG000|Overall Study|Loss of response/no improvement|3
7672293|NCT00195715|12088016|FG000|Overall Study|Sponsor stopped study|1
7672294|NCT00195715|12088016|FG000|Overall Study|Administrative reasons|2
7672295|NCT00195715|12088016|FG000|Overall Study|Investigator's decision|2
7672296|NCT00195715|12088016|FG000|Overall Study|Subject wants to get pregnant|4
7672297|NCT00195715|12088016|FG000|Overall Study|Use of prohibited medication|2
7672298|NCT00195715|12088016|FG000|Overall Study|Planned surgery|2
7672299|NCT00195715|12088016|FG000|Overall Study|Increased infection rate|1
7672300|NCT00195715|12088016|FG000|Overall Study|Ineligible|1
7672301|NCT00195715|12088016|FG000|Overall Study|Colonic stricture|1
7672302|NCT00195715|12088016|FG000|Overall Study|Sponsor discontinued trial|1
7672303|NCT00195715|12088016|FG000|Overall Study|Sponsor discretion - trial ended early|1
7672304|NCT00195819|12088020|FG000|Double-Blind|Withdrawal by Subject|1
7672305|NCT00195819|12088021|FG001|Double-Blind|Withdrawal by Subject|0
7672306|NCT00195819|12088020|FG000|Double-Blind|Moved|1
7672307|NCT00195819|12088021|FG001|Double-Blind|Moved|0
7672308|NCT00195819|12088020|FG000|Open-label|Adverse Event|0
7672309|NCT00195819|12088021|FG001|Open-label|Adverse Event|9
7672310|NCT00195819|12088020|FG000|Open-label|Lack of Efficacy|0
7672311|NCT00195819|12088021|FG001|Open-label|Lack of Efficacy|2
7672312|NCT00195819|12088020|FG000|Open-label|Pregnancy|0
7672313|NCT00195819|12088021|FG001|Open-label|Pregnancy|1
7672314|NCT00195819|12088020|FG000|Open-label|Protocol Violation|0
7672315|NCT00195819|12088021|FG001|Open-label|Protocol Violation|2
7672316|NCT00195819|12088020|FG000|Open-label|Moved|0
7672317|NCT00195819|12088021|FG001|Open-label|Moved|1
7672318|NCT00195819|12088020|FG000|Open-label|Withdrawal by Subject|0
7672319|NCT00195819|12088021|FG001|Open-label|Withdrawal by Subject|5
7672320|NCT00196105|12088036|FG000|Overall Study|Lost to Follow-up|4
7672321|NCT00196105|12088037|FG001|Overall Study|Lost to Follow-up|5
7672322|NCT00196105|12088038|FG002|Overall Study|Lost to Follow-up|7
7672323|NCT00196196|12088046|FG000|Overall Study|Withdrawal by Subject|2
7672324|NCT00196196|12088046|FG000|Overall Study|Did not have required condition (hydroce|5
7672325|NCT00196313|12088052|FG000|Overall Study|Protocol Violation|2
7672326|NCT00196313|12088053|FG001|Overall Study|Protocol Violation|3
7672327|NCT00196313|12088052|FG000|Overall Study|Withdrawal by Subject|3
7672328|NCT00196313|12088053|FG001|Overall Study|Withdrawal by Subject|1
7672329|NCT00196313|12088052|FG000|Overall Study|Adverse Event|3
7672330|NCT00196313|12088053|FG001|Overall Study|Adverse Event|1
7672331|NCT00196313|12088052|FG000|Overall Study|Subject Pregnant|1
7672332|NCT00196313|12088053|FG001|Overall Study|Subject Pregnant|1
7672333|NCT00196313|12088052|FG000|Overall Study|Lost to Follow-up|2
7672334|NCT00196313|12088053|FG001|Overall Study|Lost to Follow-up|2
7672335|NCT00196326|12088060|FG000|Overall Study|Did not meet protocol requirements|64
7672336|NCT00196326|12088060|FG000|Overall Study|Non-compliance with the protocol|81
7672337|NCT00196326|12088060|FG000|Overall Study|Physician Decision|3
7672338|NCT00196326|12088060|FG000|Overall Study|Withdrawal by Subject|225
7672339|NCT00196326|12088060|FG000|Overall Study|Adverse Event|253
7672340|NCT00196326|12088060|FG000|Overall Study|Pregnancy|34
7672341|NCT00196326|12088060|FG000|Overall Study|Lost to Follow-up|304
7672342|NCT00196326|12088060|FG000|Overall Study|Other|22
7672343|NCT00196937|12088073|FG000|Overall Study|Serious Adverse Event|1
7672344|NCT00196937|12088074|FG001|Overall Study|Serious Adverse Event|0
7672345|NCT00196937|12088075|FG002|Overall Study|Serious Adverse Event|0
7672346|NCT00196937|12088073|FG000|Overall Study|Non-serious adverse event|1
7672347|NCT00196937|12088074|FG001|Overall Study|Non-serious adverse event|1
7672348|NCT00196937|12088075|FG002|Overall Study|Non-serious adverse event|1
7672349|NCT00196937|12088073|FG000|Overall Study|Withdrawal by Subject|0
7672350|NCT00196937|12088074|FG001|Overall Study|Withdrawal by Subject|0
7672351|NCT00196937|12088075|FG002|Overall Study|Withdrawal by Subject|2
7672352|NCT00196937|12088073|FG000|Overall Study|Lost to Follow-up|4
7672353|NCT00196937|12088074|FG001|Overall Study|Lost to Follow-up|3
7672354|NCT00196937|12088075|FG002|Overall Study|Lost to Follow-up|3
7672355|NCT00196937|12088073|FG000|Overall Study|Other|3
7672356|NCT00196937|12088074|FG001|Overall Study|Other|1
7672357|NCT00196937|12088075|FG002|Overall Study|Other|1
7672358|NCT00196976|12088098|FG000|Primary Study|Migrated from study area|0
7672359|NCT00196976|12088099|FG001|Primary Study|Migrated from study area|0
7672360|NCT00196976|12088100|FG002|Primary Study|Migrated from study area|0
7672361|NCT00196976|12088101|FG003|Primary Study|Migrated from study area|0
7672362|NCT00196976|12088102|FG004|Primary Study|Migrated from study area|0
7672363|NCT00196976|12088103|FG005|Primary Study|Migrated from study area|0
7672364|NCT00196976|12088104|FG006|Primary Study|Migrated from study area|0
7672365|NCT00196976|12088105|FG007|Primary Study|Migrated from study area|1
7672366|NCT00196976|12088106|FG008|Primary Study|Migrated from study area|0
7672367|NCT00196976|12088107|FG009|Primary Study|Migrated from study area|0
7672368|NCT00196976|12088108|FG010|Primary Study|Migrated from study area|0
7672369|NCT00196976|12088109|FG011|Primary Study|Migrated from study area|0
7672370|NCT00196976|12088110|FG012|Primary Study|Migrated from study area|0
7672371|NCT00196976|12088111|FG013|Primary Study|Migrated from study area|0
7672372|NCT00196976|12088098|FG000|Primary Study|Protocol Violation|0
7672373|NCT00196976|12088099|FG001|Primary Study|Protocol Violation|1
7672374|NCT00196976|12088100|FG002|Primary Study|Protocol Violation|1
7672375|NCT00196976|12088101|FG003|Primary Study|Protocol Violation|0
7672376|NCT00196976|12088102|FG004|Primary Study|Protocol Violation|0
7672377|NCT00196976|12088103|FG005|Primary Study|Protocol Violation|0
7672378|NCT00196976|12088104|FG006|Primary Study|Protocol Violation|0
7672379|NCT00196976|12088105|FG007|Primary Study|Protocol Violation|0
7672380|NCT00196976|12088106|FG008|Primary Study|Protocol Violation|0
7672381|NCT00196976|12088107|FG009|Primary Study|Protocol Violation|0
7672382|NCT00196976|12088108|FG010|Primary Study|Protocol Violation|0
7672383|NCT00196976|12088109|FG011|Primary Study|Protocol Violation|0
7672384|NCT00196976|12088110|FG012|Primary Study|Protocol Violation|0
7672385|NCT00196976|12088111|FG013|Primary Study|Protocol Violation|0
7672386|NCT00196976|12088098|FG000|Primary Study|Withdrawal by Subject|1
7672387|NCT00196976|12088099|FG001|Primary Study|Withdrawal by Subject|0
7672388|NCT00196976|12088100|FG002|Primary Study|Withdrawal by Subject|1
7672389|NCT00196976|12088101|FG003|Primary Study|Withdrawal by Subject|1
7672390|NCT00196976|12088102|FG004|Primary Study|Withdrawal by Subject|2
7672391|NCT00196976|12088103|FG005|Primary Study|Withdrawal by Subject|1
7672392|NCT00196976|12088104|FG006|Primary Study|Withdrawal by Subject|0
7672393|NCT00196976|12088105|FG007|Primary Study|Withdrawal by Subject|0
7672394|NCT00196976|12088106|FG008|Primary Study|Withdrawal by Subject|0
7672395|NCT00196976|12088107|FG009|Primary Study|Withdrawal by Subject|1
7672396|NCT00196976|12088108|FG010|Primary Study|Withdrawal by Subject|0
7672397|NCT00196976|12088109|FG011|Primary Study|Withdrawal by Subject|0
7672398|NCT00196976|12088110|FG012|Primary Study|Withdrawal by Subject|0
7672399|NCT00196976|12088111|FG013|Primary Study|Withdrawal by Subject|0
7672400|NCT00196976|12088098|FG000|Primary Study|Lost to Follow-up|0
7672401|NCT00196976|12088099|FG001|Primary Study|Lost to Follow-up|0
7672402|NCT00196976|12088100|FG002|Primary Study|Lost to Follow-up|0
7672403|NCT00196976|12088101|FG003|Primary Study|Lost to Follow-up|0
7672404|NCT00196976|12088102|FG004|Primary Study|Lost to Follow-up|1
7672405|NCT00196976|12088103|FG005|Primary Study|Lost to Follow-up|1
7672406|NCT00196976|12088104|FG006|Primary Study|Lost to Follow-up|0
7672407|NCT00196976|12088105|FG007|Primary Study|Lost to Follow-up|2
7672408|NCT00196976|12088106|FG008|Primary Study|Lost to Follow-up|0
7672409|NCT00196976|12088107|FG009|Primary Study|Lost to Follow-up|0
7672410|NCT00196976|12088108|FG010|Primary Study|Lost to Follow-up|0
7672411|NCT00196976|12088109|FG011|Primary Study|Lost to Follow-up|0
7672412|NCT00196976|12088110|FG012|Primary Study|Lost to Follow-up|0
7672413|NCT00196976|12088111|FG013|Primary Study|Lost to Follow-up|0
7672414|NCT00196976|12088098|FG000|Primary Study|Other|0
7672415|NCT00196976|12088099|FG001|Primary Study|Other|0
7672416|NCT00196976|12088100|FG002|Primary Study|Other|2
7672417|NCT00196976|12088101|FG003|Primary Study|Other|0
7672418|NCT00196976|12088102|FG004|Primary Study|Other|0
7672419|NCT00196976|12088103|FG005|Primary Study|Other|0
7672420|NCT00196976|12088104|FG006|Primary Study|Other|0
7672421|NCT00196976|12088105|FG007|Primary Study|Other|0
7672422|NCT00196976|12088106|FG008|Primary Study|Other|0
7672423|NCT00196976|12088107|FG009|Primary Study|Other|0
7672424|NCT00196976|12088108|FG010|Primary Study|Other|0
7672425|NCT00196976|12088109|FG011|Primary Study|Other|0
7672426|NCT00196976|12088110|FG012|Primary Study|Other|0
7672427|NCT00196976|12088111|FG013|Primary Study|Other|0
7672428|NCT00196976|12088098|FG000|Booster Study|Withdrawal by Subject|0
7672429|NCT00196976|12088099|FG001|Booster Study|Withdrawal by Subject|0
7672430|NCT00196976|12088100|FG002|Booster Study|Withdrawal by Subject|0
7672431|NCT00196976|12088101|FG003|Booster Study|Withdrawal by Subject|0
7672432|NCT00196976|12088102|FG004|Booster Study|Withdrawal by Subject|0
7672433|NCT00196976|12088103|FG005|Booster Study|Withdrawal by Subject|0
7672434|NCT00196976|12088104|FG006|Booster Study|Withdrawal by Subject|0
7672435|NCT00196976|12088105|FG007|Booster Study|Withdrawal by Subject|0
7672436|NCT00196976|12088106|FG008|Booster Study|Withdrawal by Subject|0
7672437|NCT00196976|12088107|FG009|Booster Study|Withdrawal by Subject|0
7672438|NCT00196976|12088108|FG010|Booster Study|Withdrawal by Subject|1
7672439|NCT00196976|12088109|FG011|Booster Study|Withdrawal by Subject|0
7672440|NCT00196976|12088110|FG012|Booster Study|Withdrawal by Subject|0
7672441|NCT00196976|12088111|FG013|Booster Study|Withdrawal by Subject|0
7672442|NCT00196976|12088098|FG000|Booster Study|Lost to Follow-up|0
7672443|NCT00196976|12088099|FG001|Booster Study|Lost to Follow-up|0
7672444|NCT00196976|12088100|FG002|Booster Study|Lost to Follow-up|0
7672445|NCT00196976|12088101|FG003|Booster Study|Lost to Follow-up|0
7672446|NCT00196976|12088102|FG004|Booster Study|Lost to Follow-up|0
7672447|NCT00196976|12088103|FG005|Booster Study|Lost to Follow-up|0
7672448|NCT00196976|12088104|FG006|Booster Study|Lost to Follow-up|0
7672449|NCT00196976|12088105|FG007|Booster Study|Lost to Follow-up|0
7672450|NCT00196976|12088106|FG008|Booster Study|Lost to Follow-up|0
7672451|NCT00196976|12088107|FG009|Booster Study|Lost to Follow-up|0
7672452|NCT00196976|12088108|FG010|Booster Study|Lost to Follow-up|1
7672453|NCT00196976|12088109|FG011|Booster Study|Lost to Follow-up|2
7672454|NCT00196976|12088110|FG012|Booster Study|Lost to Follow-up|0
7672455|NCT00196976|12088111|FG013|Booster Study|Lost to Follow-up|0
7672456|NCT00197002|12088154|FG000|Overall Study|Adverse Event|0
7672457|NCT00197002|12088155|FG001|Overall Study|Adverse Event|1
7672458|NCT00197002|12088156|FG002|Overall Study|Adverse Event|0
7672459|NCT00197002|12088154|FG000|Overall Study|Protocol Violation|1
7672460|NCT00197002|12088155|FG001|Overall Study|Protocol Violation|0
7672461|NCT00197002|12088156|FG002|Overall Study|Protocol Violation|2
7672462|NCT00197002|12088154|FG000|Overall Study|Withdrawal by Subject|9
7672463|NCT00197002|12088155|FG001|Overall Study|Withdrawal by Subject|5
7672464|NCT00197002|12088156|FG002|Overall Study|Withdrawal by Subject|7
7672465|NCT00197002|12088154|FG000|Overall Study|Migrated/moved from study area|3
7672466|NCT00197002|12088155|FG001|Overall Study|Migrated/moved from study area|5
7672467|NCT00197002|12088156|FG002|Overall Study|Migrated/moved from study area|1
7672468|NCT00197002|12088154|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4
7672469|NCT00197002|12088155|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4
7672470|NCT00197002|12088156|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5
7672471|NCT00197002|12088154|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2
7672472|NCT00197002|12088155|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2
7672473|NCT00197002|12088156|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1
7672474|NCT00197002|12088154|FG000|Overall Study|Others|3
7672475|NCT00197002|12088155|FG001|Overall Study|Others|1
7672476|NCT00197002|12088156|FG002|Overall Study|Others|1
7672477|NCT00197015|12088170|FG000|Overall Study|Adverse Event|3
7672478|NCT00197015|12088171|FG001|Overall Study|Adverse Event|0
7672479|NCT00197015|12088172|FG002|Overall Study|Adverse Event|1
7672480|NCT00197015|12088170|FG000|Overall Study|Protocol Violation|0
7672481|NCT00197015|12088171|FG001|Overall Study|Protocol Violation|3
7672482|NCT00197015|12088172|FG002|Overall Study|Protocol Violation|3
7672483|NCT00197015|12088170|FG000|Overall Study|Withdrawal by Subject|17
7672484|NCT00197015|12088171|FG001|Overall Study|Withdrawal by Subject|37
7672485|NCT00197015|12088172|FG002|Overall Study|Withdrawal by Subject|34
7672486|NCT00197015|12088170|FG000|Overall Study|Lost to Follow-up|28
7672487|NCT00197015|12088171|FG001|Overall Study|Lost to Follow-up|46
7672488|NCT00197015|12088172|FG002|Overall Study|Lost to Follow-up|37
7672489|NCT00197015|12088170|FG000|Overall Study|Other|2
7672490|NCT00197015|12088171|FG001|Overall Study|Other|3
7672491|NCT00197015|12088172|FG002|Overall Study|Other|2
7672492|NCT00197028|12088182|FG000|Overall Study|Adverse Event|2
7672493|NCT00197028|12088183|FG001|Overall Study|Adverse Event|2
7672494|NCT00197028|12088182|FG000|Overall Study|Protocol Violation|2
7672495|NCT00197028|12088183|FG001|Overall Study|Protocol Violation|1
7672496|NCT00197028|12088182|FG000|Overall Study|Withdrawal by Subject|8
7672497|NCT00197028|12088183|FG001|Overall Study|Withdrawal by Subject|12
7672498|NCT00197028|12088182|FG000|Overall Study|Lost to Follow-up|1
7672499|NCT00197028|12088183|FG001|Overall Study|Lost to Follow-up|0
7672500|NCT00197028|12088182|FG000|Overall Study|Other|3
7672501|NCT00197028|12088183|FG001|Overall Study|Other|6
7672502|NCT00197054|12088192|FG000|Overall Study|Withdrawal by Subject|9
7672503|NCT00197054|12088193|FG001|Overall Study|Withdrawal by Subject|3
7672504|NCT00197054|12088194|FG002|Overall Study|Withdrawal by Subject|3
7672505|NCT00197054|12088192|FG000|Overall Study|Moved from area|7
7672506|NCT00197054|12088193|FG001|Overall Study|Moved from area|14
7672507|NCT00197054|12088194|FG002|Overall Study|Moved from area|9
7672508|NCT00197054|12088192|FG000|Overall Study|Lost to Follow-up|1
7672509|NCT00197054|12088193|FG001|Overall Study|Lost to Follow-up|4
7672510|NCT00197054|12088194|FG002|Overall Study|Lost to Follow-up|0
7672511|NCT00197106|12088214|FG000|4-Week Run-In Period|Did not meet entry criteria|99
7672512|NCT00197106|12088215|FG001|4-Week Run-In Period|Did not meet entry criteria|0
7672513|NCT00197106|12088216|FG002|4-Week Run-In Period|Did not meet entry criteria|0
7672514|NCT00197106|12088214|FG000|Overall Treatment Period|Lack of Efficacy|0
7672515|NCT00197106|12088215|FG001|Overall Treatment Period|Lack of Efficacy|1
7672516|NCT00197106|12088216|FG002|Overall Treatment Period|Lack of Efficacy|0
7672517|NCT00197106|12088214|FG000|Overall Treatment Period|Lost to Follow-up|0
7672518|NCT00197106|12088215|FG001|Overall Treatment Period|Lost to Follow-up|0
7672519|NCT00197106|12088216|FG002|Overall Treatment Period|Lost to Follow-up|2
7672520|NCT00197106|12088214|FG000|Overall Treatment Period|Protocol Violation|0
7672521|NCT00197106|12088215|FG001|Overall Treatment Period|Protocol Violation|0
7672522|NCT00197106|12088216|FG002|Overall Treatment Period|Protocol Violation|2
7672523|NCT00197106|12088214|FG000|Overall Treatment Period|Withdrawal by Subject|0
7672524|NCT00197106|12088215|FG001|Overall Treatment Period|Withdrawal by Subject|0
7672525|NCT00197106|12088216|FG002|Overall Treatment Period|Withdrawal by Subject|2
7672526|NCT00197145|12088233|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
7672527|NCT00197145|12088234|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
7672528|NCT00197145|12088233|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
7672529|NCT00197145|12088234|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
7672530|NCT00197145|12088233|FG000|Period 1: Randomized Treatment Phase|Other|2
7672531|NCT00197145|12088234|FG001|Period 1: Randomized Treatment Phase|Other|2
7672532|NCT00197145|12088233|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1
7672533|NCT00197145|12088234|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0
7672534|NCT00197145|12088233|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3
7672535|NCT00197145|12088234|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0
7672536|NCT00197145|12088233|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2
7672537|NCT00197145|12088234|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0
7672538|NCT00197145|12088233|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3
7672539|NCT00197145|12088234|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0
7672540|NCT00197145|12088233|FG000|Period 2 : Open Label Phase|Other|1
7672541|NCT00197145|12088234|FG001|Period 2 : Open Label Phase|Other|0
7672542|NCT00197236|12088253|FG000|Overall Study|Adverse Event|1
7672543|NCT00197236|12088254|FG001|Overall Study|Adverse Event|0
7672544|NCT00197236|12088255|FG002|Overall Study|Adverse Event|1
7672545|NCT00197236|12088253|FG000|Overall Study|Lost to Follow-up|5
7672546|NCT00197236|12088254|FG001|Overall Study|Lost to Follow-up|14
7672547|NCT00197236|12088255|FG002|Overall Study|Lost to Follow-up|6
7672548|NCT00197236|12088253|FG000|Overall Study|Protocol Violation|0
7672549|NCT00197236|12088254|FG001|Overall Study|Protocol Violation|0
7672550|NCT00197236|12088255|FG002|Overall Study|Protocol Violation|1
7672551|NCT00197236|12088253|FG000|Overall Study|Withdrawal by Subject|7
7672552|NCT00197236|12088254|FG001|Overall Study|Withdrawal by Subject|3
7672553|NCT00197236|12088255|FG002|Overall Study|Withdrawal by Subject|11
7672554|NCT00197236|12088253|FG000|Overall Study|Study drug/medication expiration|1
7672555|NCT00197236|12088254|FG001|Overall Study|Study drug/medication expiration|0
7672556|NCT00197236|12088255|FG002|Overall Study|Study drug/medication expiration|3
7672557|NCT00197236|12088253|FG000|Overall Study|Returned out of specified time window|0
7672558|NCT00197236|12088254|FG001|Overall Study|Returned out of specified time window|0
7672559|NCT00197236|12088255|FG002|Overall Study|Returned out of specified time window|1
7672560|NCT00197496|12088293|FG000|Baseline to Discharge|not interested|1
7672561|NCT00197496|12088294|FG001|Baseline to Discharge|not interested|0
7672562|NCT00197496|12088293|FG000|Baseline to Discharge|MRSA|1
7672563|NCT00197496|12088294|FG001|Baseline to Discharge|MRSA|0
7672564|NCT00197496|12088293|FG000|Baseline to Discharge|Physician Decision|0
7672565|NCT00197496|12088294|FG001|Baseline to Discharge|Physician Decision|1
7672566|NCT00197496|12088293|FG000|Baseline to Discharge|Protocol Violation|0
7672567|NCT00197496|12088294|FG001|Baseline to Discharge|Protocol Violation|1
7672568|NCT00197496|12088293|FG000|Follow-up|Lost to Follow-up|2
7672569|NCT00197496|12088294|FG001|Follow-up|Lost to Follow-up|1
7672570|NCT00198029|12088300|FG000|Overall Study|Withdrawal by Subject|4
7672571|NCT00198107|12088324|FG000|Double-Blind Period|Adverse Event|1
7672572|NCT00198107|12088325|FG001|Double-Blind Period|Adverse Event|1
7672573|NCT00198107|12088326|FG002|Double-Blind Period|Adverse Event|0
7672574|NCT00198107|12088324|FG000|Double-Blind Period|Lack of Efficacy|2
7672575|NCT00198107|12088325|FG001|Double-Blind Period|Lack of Efficacy|0
7672576|NCT00198107|12088326|FG002|Double-Blind Period|Lack of Efficacy|0
7672577|NCT00198107|12088324|FG000|Double-Blind Period|Lost to Follow-up|2
7672578|NCT00198107|12088325|FG001|Double-Blind Period|Lost to Follow-up|1
7672579|NCT00198107|12088326|FG002|Double-Blind Period|Lost to Follow-up|0
7672580|NCT00198107|12088324|FG000|Double-Blind Period|Physician Decision|1
7672581|NCT00198107|12088325|FG001|Double-Blind Period|Physician Decision|0
7672582|NCT00198107|12088326|FG002|Double-Blind Period|Physician Decision|0
7672583|NCT00198107|12088324|FG000|Double-Blind Period|Withdrawal by Subject|0
7672584|NCT00198107|12088325|FG001|Double-Blind Period|Withdrawal by Subject|1
7672585|NCT00198107|12088326|FG002|Double-Blind Period|Withdrawal by Subject|0
7672586|NCT00198107|12088324|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
7672587|NCT00198107|12088325|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
7672588|NCT00198107|12088326|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2
7672589|NCT00198133|12088336|FG000|Overall Study|Disease progression|2
7672590|NCT00198133|12088337|FG001|Overall Study|Disease progression|5
7672591|NCT00198133|12088336|FG000|Overall Study|Adverse Event|1
7672592|NCT00198133|12088337|FG001|Overall Study|Adverse Event|3
7672593|NCT00198133|12088336|FG000|Overall Study|Withdrawal by Subject|1
7672594|NCT00198133|12088337|FG001|Overall Study|Withdrawal by Subject|0
7672595|NCT00198133|12088336|FG000|Overall Study|Physician Decision|1
7672596|NCT00198133|12088337|FG001|Overall Study|Physician Decision|0
7672597|NCT00198822|12088346|FG000|Overall Study|Lost to Follow-up|14
7672598|NCT00198822|12088347|FG001|Overall Study|Lost to Follow-up|20
7672599|NCT00198822|12088348|FG002|Overall Study|Lost to Follow-up|21
7672600|NCT00199381|12088356|FG000|Overall Study|Withdrawal by Subject|38
7672601|NCT00199381|12088356|FG000|Overall Study|Adverse Event|73
7672602|NCT00199381|12088356|FG000|Overall Study|Protocol Violation|6
7672603|NCT00199381|12088356|FG000|Overall Study|Lack of Efficacy|27
7672604|NCT00199381|12088356|FG000|Overall Study|Not including due to early termination|37
7672605|NCT00199381|12088356|FG000|Overall Study|Study termination by Sponsor|323
7672606|NCT00199797|12088360|FG000|Overall Study|Progressive Disease|1
7672607|NCT00199797|12088360|FG000|Overall Study|Adverse Event|1
7672608|NCT00199797|12088360|FG000|Overall Study|Physician Decision|1
7672609|NCT00199836|12088365|FG000|Overall Study|Progressive Disease|5
7672610|NCT00199836|12088365|FG000|Overall Study|Death|1
7672611|NCT00199849|12088373|FG000|Overall Study|Unrelated illness or complication|0
7672612|NCT00199849|12088374|FG001|Overall Study|Unrelated illness or complication|1
7672613|NCT00199849|12088375|FG002|Overall Study|Unrelated illness or complication|0
7672614|NCT00199849|12088373|FG000|Overall Study|Progressive disease requiring intervention|0
7672615|NCT00199849|12088374|FG001|Overall Study|Progressive disease requiring intervention|0
7672616|NCT00199849|12088375|FG002|Overall Study|Progressive disease requiring intervention|1
7672617|NCT00199849|12088373|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0
7672618|NCT00199849|12088374|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0
7672619|NCT00199849|12088375|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1
7672620|NCT00199875|12088388|FG000|Overall Study|Withdrawal by Subject|0
7672621|NCT00199875|12088389|FG001|Overall Study|Withdrawal by Subject|0
7672622|NCT00199875|12088390|FG002|Overall Study|Withdrawal by Subject|0
7672623|NCT00199875|12088391|FG003|Overall Study|Withdrawal by Subject|0
7672624|NCT00199875|12088392|FG004|Overall Study|Withdrawal by Subject|1
7672625|NCT00199888|12088404|FG000|Overall Study|Lost to Follow-up|1
7672626|NCT00199901|12088410|FG000|Overall Study|Protocol Violation|2
7672627|NCT00199901|12088411|FG001|Overall Study|Protocol Violation|0
7672628|NCT00199901|12088410|FG000|Overall Study|Withdrawal by Subject|1
7672629|NCT00199901|12088411|FG001|Overall Study|Withdrawal by Subject|0
7672630|NCT00199901|12088410|FG000|Overall Study|Progressive Disease|24
7672631|NCT00199901|12088411|FG001|Overall Study|Progressive Disease|24
7672632|NCT00200057|12088428|FG000|Overall Study|Lack of Efficacy|3
7672633|NCT00200057|12088428|FG000|Overall Study|Exited due to terminal illness of PI|2
7672634|NCT00200057|12088428|FG000|Overall Study|Withdrawal by Subject|1
7672635|NCT00200057|12088428|FG000|Overall Study|Change in medical condition|1
7672636|NCT00200057|12088428|FG000|Overall Study|Infection|1
7672637|NCT00200057|12088428|FG000|Overall Study|Death|1
7672638|NCT00200356|12088456|FG000|Overall Study|Lack of Efficacy|3
7672639|NCT00200356|12088457|FG001|Overall Study|Lack of Efficacy|3
7672640|NCT00200356|12088456|FG000|Overall Study|Protocol Violation|4
7672641|NCT00200356|12088457|FG001|Overall Study|Protocol Violation|4
7672642|NCT00200356|12088456|FG000|Overall Study|Nontreatment|1
7672643|NCT00200356|12088457|FG001|Overall Study|Nontreatment|0
7672644|NCT00200850|12088475|FG000|Overall Study|relocation|1
7672645|NCT00200850|12088476|FG001|Overall Study|relocation|0
7672646|NCT00200850|12088477|FG002|Overall Study|relocation|1
7672647|NCT00200850|12088475|FG000|Overall Study|too busy|1
7672648|NCT00200850|12088476|FG001|Overall Study|too busy|0
7672649|NCT00200850|12088477|FG002|Overall Study|too busy|0
7672650|NCT00200850|12088475|FG000|Overall Study|Pregnancy|0
7672651|NCT00200850|12088476|FG001|Overall Study|Pregnancy|0
7672652|NCT00200850|12088477|FG002|Overall Study|Pregnancy|1
7672653|NCT00200850|12088475|FG000|Overall Study|Poor adherence|0
7672654|NCT00200850|12088476|FG001|Overall Study|Poor adherence|0
7672655|NCT00200850|12088477|FG002|Overall Study|Poor adherence|1
7672656|NCT00200850|12088475|FG000|Overall Study|optic neuritis|0
7672657|NCT00200850|12088476|FG001|Overall Study|optic neuritis|0
7672658|NCT00200850|12088477|FG002|Overall Study|optic neuritis|1
7672659|NCT00200850|12088475|FG000|Overall Study|Adverse Event|1
7672660|NCT00200850|12088476|FG001|Overall Study|Adverse Event|1
7672661|NCT00200850|12088477|FG002|Overall Study|Adverse Event|2
7672662|NCT00200967|12088506|FG000|First Treatment Period|Withdrawal by Subject|5
7672663|NCT00200967|12088507|FG001|First Treatment Period|Withdrawal by Subject|1
7672664|NCT00200967|12088506|FG000|First Treatment Period|Pregnancy|1
7672665|NCT00200967|12088507|FG001|First Treatment Period|Pregnancy|0
7672666|NCT00200967|12088506|FG000|Wash-out Period|Lost to Follow-up|0
7672667|NCT00200967|12088507|FG001|Wash-out Period|Lost to Follow-up|1
7672668|NCT00200967|12088506|FG000|Second Treatment Period|Withdrawal by Subject|1
7672669|NCT00200967|12088507|FG001|Second Treatment Period|Withdrawal by Subject|2
7672670|NCT00200967|12088506|FG000|Run-out Period|Lost to Follow-up|1
7672671|NCT00200967|12088507|FG001|Run-out Period|Lost to Follow-up|0
7672672|NCT00201006|12088516|FG000|Overall Study|Withdrawal by Subject|7
7672673|NCT00201006|12088517|FG001|Overall Study|Withdrawal by Subject|2
7672674|NCT00201006|12088518|FG002|Overall Study|Withdrawal by Subject|3
7672675|NCT00201006|12088516|FG000|Overall Study|Adverse Event|1
7672676|NCT00201006|12088517|FG001|Overall Study|Adverse Event|0
7672677|NCT00201006|12088518|FG002|Overall Study|Adverse Event|1
7672678|NCT00201201|12088545|FG000|Overall Study|Death|0
7672679|NCT00201201|12088546|FG001|Overall Study|Death|2
7672680|NCT00201201|12088545|FG000|Overall Study|Withdrawal by Subject|5
7672681|NCT00201201|12088546|FG001|Overall Study|Withdrawal by Subject|5
7672682|NCT00201643|12088579|FG000|Overall Study|Withdrawal by Subject|5
7672683|NCT00201643|12088580|FG001|Overall Study|Withdrawal by Subject|4
7672684|NCT00201851|12088634|FG000|Overall Study|Lost to Follow-up|2
7672685|NCT00201851|12088635|FG001|Overall Study|Lost to Follow-up|1
7672686|NCT00201851|12088636|FG002|Overall Study|Lost to Follow-up|0
7672687|NCT00201851|12088634|FG000|Overall Study|Ineligible post enrollment|6
7672688|NCT00201851|12088635|FG001|Overall Study|Ineligible post enrollment|1
7672689|NCT00201851|12088636|FG002|Overall Study|Ineligible post enrollment|1
7672690|NCT00202644|12088670|FG000|Overall Study|Adverse Event|12
7672691|NCT00202644|12088671|FG001|Overall Study|Adverse Event|13
7672692|NCT00202644|12088670|FG000|Overall Study|Withdrawal by Subject|8
7672693|NCT00202644|12088671|FG001|Overall Study|Withdrawal by Subject|6
7672694|NCT00202644|12088670|FG000|Overall Study|Lack of Efficacy|6
7672695|NCT00202644|12088671|FG001|Overall Study|Lack of Efficacy|6
7672696|NCT00202644|12088670|FG000|Overall Study|Lost to Follow-up|0
7672697|NCT00202644|12088671|FG001|Overall Study|Lost to Follow-up|1
7672698|NCT00202644|12088670|FG000|Overall Study|Other|9
7672699|NCT00202644|12088671|FG001|Overall Study|Other|1
7672700|NCT00202839|12088684|FG000|Overall Study|Adverse Event|1
7672701|NCT00202839|12088685|FG001|Overall Study|Adverse Event|5
7672702|NCT00202839|12088684|FG000|Overall Study|Physician Decision|12
7672703|NCT00202839|12088685|FG001|Overall Study|Physician Decision|0
7672704|NCT00202839|12088684|FG000|Overall Study|Withdrawal by Subject|6
7672705|NCT00202839|12088685|FG001|Overall Study|Withdrawal by Subject|2
7672706|NCT00202839|12088684|FG000|Overall Study|Protocol Violation|2
7672707|NCT00202839|12088685|FG001|Overall Study|Protocol Violation|1
7672708|NCT00202839|12088684|FG000|Overall Study|Lost to Follow-up|3
7672709|NCT00202839|12088685|FG001|Overall Study|Lost to Follow-up|2
7672710|NCT00203021|12088697|FG000|Overall Study|Death|4
7672711|NCT00203021|12088698|FG001|Overall Study|Death|1
7672712|NCT00203021|12088697|FG000|Overall Study|Adverse Event|10
7672713|NCT00203021|12088698|FG001|Overall Study|Adverse Event|5
7672714|NCT00203021|12088697|FG000|Overall Study|Withdrawal by Subject|45
7672715|NCT00203021|12088698|FG001|Overall Study|Withdrawal by Subject|48
7672716|NCT00203021|12088697|FG000|Overall Study|Lost to Follow-up|9
7672717|NCT00203021|12088698|FG001|Overall Study|Lost to Follow-up|7
7672718|NCT00203021|12088697|FG000|Overall Study|Other than specified|11
7672719|NCT00203021|12088698|FG001|Overall Study|Other than specified|16
7672720|NCT00203047|12088706|FG000|Overall Study|Ongoing: in database - January 29, 2009|131
7672721|NCT00203047|12088707|FG001|Overall Study|Ongoing: in database - January 29, 2009|109
7672722|NCT00203047|12088706|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5
7672723|NCT00203047|12088707|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1
7672724|NCT00203047|12088706|FG000|Overall Study|Withdrawal by Subject|13
7672725|NCT00203047|12088707|FG001|Overall Study|Withdrawal by Subject|47
7672726|NCT00203047|12088706|FG000|Overall Study|Teva requested participant withdrawal|1
7672727|NCT00203047|12088707|FG001|Overall Study|Teva requested participant withdrawal|1
7672728|NCT00203047|12088706|FG000|Overall Study|Physician Decision|8
7672729|NCT00203047|12088707|FG001|Overall Study|Physician Decision|7
7672730|NCT00203047|12088706|FG000|Overall Study|Non-compliance|4
7672731|NCT00203047|12088707|FG001|Overall Study|Non-compliance|8
7672732|NCT00203047|12088706|FG000|Overall Study|Protocol Violation|1
7672733|NCT00203047|12088707|FG001|Overall Study|Protocol Violation|0
7672734|NCT00203047|12088706|FG000|Overall Study|Lost to Follow-up|11
7672735|NCT00203047|12088707|FG001|Overall Study|Lost to Follow-up|5
7672736|NCT00203047|12088706|FG000|Overall Study|Adverse Event|8
7672737|NCT00203047|12088707|FG001|Overall Study|Adverse Event|18
7672738|NCT00203047|12088706|FG000|Overall Study|Death|1
7672739|NCT00203047|12088707|FG001|Overall Study|Death|2
7672740|NCT00203047|12088706|FG000|Overall Study|Pregnancy|3
7672741|NCT00203047|12088707|FG001|Overall Study|Pregnancy|0
7672742|NCT00203047|12088706|FG000|Overall Study|Other|5
7672743|NCT00203047|12088707|FG001|Overall Study|Other|5
7672744|NCT00203242|12088735|FG000|Overall Study|Lost to Follow-up|1
7672745|NCT00203268|12088739|FG000|Early Treatment|only treated one headache|2
7672746|NCT00203268|12088739|FG000|Early Treatment|Lost to Follow-up|1
7672747|NCT00203268|12088739|FG000|Early Treatment|Withdrawal by Subject|1
7672748|NCT00203294|12088747|FG000|Overall Study|Withdrawal by Subject|8
7672749|NCT00203294|12088748|FG001|Overall Study|Withdrawal by Subject|13
7672750|NCT00203307|12088756|FG000|First Intervention|Adverse Event|2
7672751|NCT00203307|12088757|FG001|First Intervention|Adverse Event|0
7672752|NCT00203411|12088763|FG000|Follow-up|Progressive Disease|4
7672753|NCT00203424|12088768|FG000|Treatment Period|Withdrawal by Subject|4
7672754|NCT00203424|12088768|FG000|Treatment Period|Adverse Event|5
7672755|NCT00203424|12088768|FG000|Treatment Period|progressive disease|2
7672756|NCT00203424|12088768|FG000|Follow-up Period|Withdrawal by Subject|1
7672757|NCT00203424|12088768|FG000|Follow-up Period|progressive disease|4
7672758|NCT00203424|12088768|FG000|Follow-up Period|Lost to Follow-up|1
7672759|NCT00203476|12088775|FG000|Overall Study|Lost to Follow-up|1
7672760|NCT00203476|12088776|FG001|Overall Study|Lost to Follow-up|0
7672761|NCT00203476|12088777|FG002|Overall Study|Lost to Follow-up|0
7672762|NCT00203476|12088775|FG000|Overall Study|Withdrawal by Subject|0
7672763|NCT00203476|12088776|FG001|Overall Study|Withdrawal by Subject|1
7672764|NCT00203476|12088777|FG002|Overall Study|Withdrawal by Subject|0
7672765|NCT00203502|12088785|FG000|Overall Study|Death|1
7672766|NCT00203892|12088792|FG000|Overall Study|Physician Decision|1
7672767|NCT00203892|12088793|FG001|Overall Study|Physician Decision|2
7672768|NCT00203892|12088794|FG002|Overall Study|Physician Decision|0
7672769|NCT00203892|12088792|FG000|Overall Study|Death|1
7672770|NCT00203892|12088793|FG001|Overall Study|Death|0
7672771|NCT00203892|12088794|FG002|Overall Study|Death|0
7672772|NCT00203996|12088821|FG000|Overall Study|Lost to Follow-up|0
7672773|NCT00203996|12088822|FG001|Overall Study|Lost to Follow-up|0
7672774|NCT00203996|12088823|FG002|Overall Study|Lost to Follow-up|0
7672775|NCT00203996|12088824|FG003|Overall Study|Lost to Follow-up|1
7672776|NCT00203996|12088825|FG004|Overall Study|Lost to Follow-up|0
7672777|NCT00203996|12088826|FG005|Overall Study|Lost to Follow-up|0
7672778|NCT00203996|12088827|FG006|Overall Study|Lost to Follow-up|0
7672779|NCT00203996|12088828|FG007|Overall Study|Lost to Follow-up|0
7672780|NCT00203996|12088829|FG008|Overall Study|Lost to Follow-up|0
7672781|NCT00203996|12088830|FG009|Overall Study|Lost to Follow-up|0
7672782|NCT00203996|12088821|FG000|Overall Study|Protocol Violation|0
7672783|NCT00203996|12088822|FG001|Overall Study|Protocol Violation|0
7672784|NCT00203996|12088823|FG002|Overall Study|Protocol Violation|0
7672785|NCT00203996|12088824|FG003|Overall Study|Protocol Violation|6
7672786|NCT00203996|12088825|FG004|Overall Study|Protocol Violation|1
7672787|NCT00203996|12088826|FG005|Overall Study|Protocol Violation|0
7672788|NCT00203996|12088827|FG006|Overall Study|Protocol Violation|0
7672789|NCT00203996|12088828|FG007|Overall Study|Protocol Violation|0
7672790|NCT00203996|12088829|FG008|Overall Study|Protocol Violation|0
7672791|NCT00203996|12088830|FG009|Overall Study|Protocol Violation|0
7672792|NCT00203996|12088821|FG000|Overall Study|Physician Decision|0
7672793|NCT00203996|12088822|FG001|Overall Study|Physician Decision|0
7672794|NCT00203996|12088823|FG002|Overall Study|Physician Decision|0
7672795|NCT00203996|12088824|FG003|Overall Study|Physician Decision|2
7672796|NCT00203996|12088825|FG004|Overall Study|Physician Decision|0
7672797|NCT00203996|12088826|FG005|Overall Study|Physician Decision|0
7672798|NCT00203996|12088827|FG006|Overall Study|Physician Decision|0
7672799|NCT00203996|12088828|FG007|Overall Study|Physician Decision|0
7672800|NCT00203996|12088829|FG008|Overall Study|Physician Decision|0
7672801|NCT00203996|12088830|FG009|Overall Study|Physician Decision|1
7672802|NCT00203996|12088821|FG000|Overall Study|CPAP machine malfunction|0
7672803|NCT00203996|12088822|FG001|Overall Study|CPAP machine malfunction|0
7672804|NCT00203996|12088823|FG002|Overall Study|CPAP machine malfunction|0
7672805|NCT00203996|12088824|FG003|Overall Study|CPAP machine malfunction|1
7672806|NCT00203996|12088825|FG004|Overall Study|CPAP machine malfunction|0
7672807|NCT00203996|12088826|FG005|Overall Study|CPAP machine malfunction|0
7672808|NCT00203996|12088827|FG006|Overall Study|CPAP machine malfunction|0
7672809|NCT00203996|12088828|FG007|Overall Study|CPAP machine malfunction|0
7672810|NCT00203996|12088829|FG008|Overall Study|CPAP machine malfunction|0
7672811|NCT00203996|12088830|FG009|Overall Study|CPAP machine malfunction|0
7672812|NCT00203996|12088821|FG000|Overall Study|Scheduling issue|0
7672813|NCT00203996|12088822|FG001|Overall Study|Scheduling issue|0
7672814|NCT00203996|12088823|FG002|Overall Study|Scheduling issue|0
7672815|NCT00203996|12088824|FG003|Overall Study|Scheduling issue|0
7672816|NCT00203996|12088825|FG004|Overall Study|Scheduling issue|0
7672817|NCT00203996|12088826|FG005|Overall Study|Scheduling issue|0
7672818|NCT00203996|12088827|FG006|Overall Study|Scheduling issue|0
7672819|NCT00203996|12088828|FG007|Overall Study|Scheduling issue|2
7672820|NCT00203996|12088829|FG008|Overall Study|Scheduling issue|0
7672821|NCT00203996|12088830|FG009|Overall Study|Scheduling issue|0
7672822|NCT00205179|12088861|FG000|Overall Study|Death|0
7672823|NCT00205179|12088862|FG001|Overall Study|Death|2
7672824|NCT00205179|12088861|FG000|Overall Study|Physician Decision|1
7672825|NCT00205179|12088862|FG001|Overall Study|Physician Decision|1
7672826|NCT00205179|12088861|FG000|Overall Study|Adverse Event|1
7672827|NCT00205179|12088862|FG001|Overall Study|Adverse Event|1
7672828|NCT00205699|12088908|FG000|Overall Study|Lost to Follow-up|1
7672829|NCT00205699|12088909|FG001|Overall Study|Lost to Follow-up|3
7672830|NCT00205699|12088910|FG002|Overall Study|Lost to Follow-up|5
7672831|NCT00205699|12088908|FG000|Overall Study|Adverse Event|1
7672832|NCT00205699|12088909|FG001|Overall Study|Adverse Event|0
7672833|NCT00205699|12088910|FG002|Overall Study|Adverse Event|0
7672834|NCT00205699|12088908|FG000|Overall Study|Withdrawal by Subject|1
7672835|NCT00205699|12088909|FG001|Overall Study|Withdrawal by Subject|2
7672836|NCT00205699|12088910|FG002|Overall Study|Withdrawal by Subject|1
7672837|NCT00205699|12088908|FG000|Overall Study|Lack of Efficacy|0
7672838|NCT00205699|12088909|FG001|Overall Study|Lack of Efficacy|1
7672839|NCT00205699|12088910|FG002|Overall Study|Lack of Efficacy|0
7672840|NCT00205712|12088923|FG000|Overall Study|Lost to Follow-up|0
7672841|NCT00205712|12088924|FG001|Overall Study|Lost to Follow-up|1
7672842|NCT00205777|12088936|FG000|Core Study (Up to 3 Years)|Adverse Event|260
7672843|NCT00205777|12088937|FG001|Core Study (Up to 3 Years)|Adverse Event|267
7672844|NCT00205777|12088938|FG002|Core Study (Up to 3 Years)|Adverse Event|252
7672845|NCT00205777|12088939|FG003|Core Study (Up to 3 Years)|Adverse Event|232
7672846|NCT00205777|12088940|FG004|Core Study (Up to 3 Years)|Adverse Event|0
7672847|NCT00205777|12088941|FG005|Core Study (Up to 3 Years)|Adverse Event|0
7672848|NCT00205777|12088936|FG000|Core Study (Up to 3 Years)|Death|9
7672849|NCT00205777|12088937|FG001|Core Study (Up to 3 Years)|Death|7
7672850|NCT00205777|12088938|FG002|Core Study (Up to 3 Years)|Death|14
7672851|NCT00205777|12088939|FG003|Core Study (Up to 3 Years)|Death|7
7672852|NCT00205777|12088940|FG004|Core Study (Up to 3 Years)|Death|0
7672853|NCT00205777|12088941|FG005|Core Study (Up to 3 Years)|Death|0
7672854|NCT00205777|12088936|FG000|Core Study (Up to 3 Years)|Failed to return|40
7672855|NCT00205777|12088937|FG001|Core Study (Up to 3 Years)|Failed to return|25
7672856|NCT00205777|12088938|FG002|Core Study (Up to 3 Years)|Failed to return|27
7672857|NCT00205777|12088939|FG003|Core Study (Up to 3 Years)|Failed to return|27
7672858|NCT00205777|12088940|FG004|Core Study (Up to 3 Years)|Failed to return|0
7672859|NCT00205777|12088941|FG005|Core Study (Up to 3 Years)|Failed to return|0
7672860|NCT00205777|12088936|FG000|Core Study (Up to 3 Years)|Other Event|49
7672861|NCT00205777|12088937|FG001|Core Study (Up to 3 Years)|Other Event|52
7672862|NCT00205777|12088938|FG002|Core Study (Up to 3 Years)|Other Event|41
7672863|NCT00205777|12088939|FG003|Core Study (Up to 3 Years)|Other Event|58
7672864|NCT00205777|12088940|FG004|Core Study (Up to 3 Years)|Other Event|0
7672865|NCT00205777|12088941|FG005|Core Study (Up to 3 Years)|Other Event|0
7672866|NCT00205777|12088936|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144
7672867|NCT00205777|12088937|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169
7672868|NCT00205777|12088938|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149
7672869|NCT00205777|12088939|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162
7672870|NCT00205777|12088940|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0
7672871|NCT00205777|12088941|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0
7672872|NCT00205777|12088936|FG000|Core Study (Up to 3 Years)|Protocol Violation|53
7672873|NCT00205777|12088937|FG001|Core Study (Up to 3 Years)|Protocol Violation|55
7672874|NCT00205777|12088938|FG002|Core Study (Up to 3 Years)|Protocol Violation|50
7672875|NCT00205777|12088939|FG003|Core Study (Up to 3 Years)|Protocol Violation|42
7672876|NCT00205777|12088940|FG004|Core Study (Up to 3 Years)|Protocol Violation|0
7672877|NCT00205777|12088941|FG005|Core Study (Up to 3 Years)|Protocol Violation|0
7672878|NCT00205777|12088936|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52
7672879|NCT00205777|12088937|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52
7672880|NCT00205777|12088938|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39
7672881|NCT00205777|12088939|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75
7672882|NCT00205777|12088940|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0
7672883|NCT00205777|12088941|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0
7672884|NCT00205777|12088936|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21
7672885|NCT00205777|12088937|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32
7672886|NCT00205777|12088938|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35
7672887|NCT00205777|12088939|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29
7672888|NCT00205777|12088940|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0
7672889|NCT00205777|12088941|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0
7672890|NCT00205777|12088936|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180
7672891|NCT00205777|12088937|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158
7672892|NCT00205777|12088938|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160
7672893|NCT00205777|12088939|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174
7672894|NCT00205777|12088940|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0
7672895|NCT00205777|12088941|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0
7672896|NCT00205777|12088936|FG000|Completed Core Study, Entered SE I|Other Event|52
7672897|NCT00205777|12088937|FG001|Completed Core Study, Entered SE I|Other Event|46
7672898|NCT00205777|12088938|FG002|Completed Core Study, Entered SE I|Other Event|47
7672899|NCT00205777|12088939|FG003|Completed Core Study, Entered SE I|Other Event|50
7672900|NCT00205777|12088940|FG004|Completed Core Study, Entered SE I|Other Event|0
7672901|NCT00205777|12088941|FG005|Completed Core Study, Entered SE I|Other Event|0
7672902|NCT00205777|12088936|FG000|Study Extension I|Adverse Event|57
7672903|NCT00205777|12088937|FG001|Study Extension I|Adverse Event|0
7672904|NCT00205777|12088938|FG002|Study Extension I|Adverse Event|0
7672905|NCT00205777|12088939|FG003|Study Extension I|Adverse Event|61
7672906|NCT00205777|12088940|FG004|Study Extension I|Adverse Event|58
7672907|NCT00205777|12088941|FG005|Study Extension I|Adverse Event|0
7672908|NCT00205777|12088936|FG000|Study Extension I|Death|5
7672909|NCT00205777|12088937|FG001|Study Extension I|Death|0
7672910|NCT00205777|12088938|FG002|Study Extension I|Death|0
7672911|NCT00205777|12088939|FG003|Study Extension I|Death|1
7672912|NCT00205777|12088940|FG004|Study Extension I|Death|2
7672913|NCT00205777|12088941|FG005|Study Extension I|Death|0
7672914|NCT00205777|12088936|FG000|Study Extension I|Withdrawal by Subject|99
7672915|NCT00205777|12088937|FG001|Study Extension I|Withdrawal by Subject|0
7672916|NCT00205777|12088938|FG002|Study Extension I|Withdrawal by Subject|0
7672917|NCT00205777|12088939|FG003|Study Extension I|Withdrawal by Subject|106
7672918|NCT00205777|12088940|FG004|Study Extension I|Withdrawal by Subject|89
7672919|NCT00205777|12088941|FG005|Study Extension I|Withdrawal by Subject|0
7672920|NCT00205777|12088936|FG000|Study Extension I|Protocol Violation|4
7672921|NCT00205777|12088937|FG001|Study Extension I|Protocol Violation|0
7672922|NCT00205777|12088938|FG002|Study Extension I|Protocol Violation|0
7672923|NCT00205777|12088939|FG003|Study Extension I|Protocol Violation|8
7672924|NCT00205777|12088940|FG004|Study Extension I|Protocol Violation|8
7672925|NCT00205777|12088941|FG005|Study Extension I|Protocol Violation|0
7672926|NCT00205777|12088936|FG000|Study Extension I|Lack of Efficacy|0
7672927|NCT00205777|12088937|FG001|Study Extension I|Lack of Efficacy|0
7672928|NCT00205777|12088938|FG002|Study Extension I|Lack of Efficacy|0
7672929|NCT00205777|12088939|FG003|Study Extension I|Lack of Efficacy|1
7672930|NCT00205777|12088940|FG004|Study Extension I|Lack of Efficacy|2
7672931|NCT00205777|12088941|FG005|Study Extension I|Lack of Efficacy|0
7672932|NCT00205777|12088936|FG000|Study Extension I|Failed to return|15
7672933|NCT00205777|12088937|FG001|Study Extension I|Failed to return|0
7672934|NCT00205777|12088938|FG002|Study Extension I|Failed to return|0
7672935|NCT00205777|12088939|FG003|Study Extension I|Failed to return|17
7672936|NCT00205777|12088940|FG004|Study Extension I|Failed to return|13
7672937|NCT00205777|12088941|FG005|Study Extension I|Failed to return|0
7672938|NCT00205777|12088936|FG000|Study Extension I|Other Event|34
7672939|NCT00205777|12088937|FG001|Study Extension I|Other Event|0
7672940|NCT00205777|12088938|FG002|Study Extension I|Other Event|0
7672941|NCT00205777|12088939|FG003|Study Extension I|Other Event|34
7672942|NCT00205777|12088940|FG004|Study Extension I|Other Event|29
7672943|NCT00205777|12088941|FG005|Study Extension I|Other Event|0
7672944|NCT00205777|12088936|FG000|Study Extension I|Withdrawn as per protocol|0
7672945|NCT00205777|12088937|FG001|Study Extension I|Withdrawn as per protocol|0
7672946|NCT00205777|12088938|FG002|Study Extension I|Withdrawn as per protocol|1070
7672947|NCT00205777|12088939|FG003|Study Extension I|Withdrawn as per protocol|0
7672948|NCT00205777|12088940|FG004|Study Extension I|Withdrawn as per protocol|0
7672949|NCT00205777|12088941|FG005|Study Extension I|Withdrawn as per protocol|0
7672950|NCT00205777|12088936|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
7672951|NCT00205777|12088937|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
7672952|NCT00205777|12088938|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
7672953|NCT00205777|12088939|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
7672954|NCT00205777|12088940|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
7672955|NCT00205777|12088941|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
7672956|NCT00205777|12088936|FG000|Study Extension II|Adverse Event|0
7672957|NCT00205777|12088937|FG001|Study Extension II|Adverse Event|0
7672958|NCT00205777|12088938|FG002|Study Extension II|Adverse Event|0
7672959|NCT00205777|12088939|FG003|Study Extension II|Adverse Event|14
7672960|NCT00205777|12088940|FG004|Study Extension II|Adverse Event|0
7672961|NCT00205777|12088941|FG005|Study Extension II|Adverse Event|30
7672962|NCT00205777|12088936|FG000|Study Extension II|Death|0
7672963|NCT00205777|12088937|FG001|Study Extension II|Death|0
7672964|NCT00205777|12088938|FG002|Study Extension II|Death|0
7672965|NCT00205777|12088939|FG003|Study Extension II|Death|2
7672966|NCT00205777|12088940|FG004|Study Extension II|Death|0
7672967|NCT00205777|12088941|FG005|Study Extension II|Death|5
7672968|NCT00205777|12088936|FG000|Study Extension II|Withdrawal by Subject|0
7672969|NCT00205777|12088937|FG001|Study Extension II|Withdrawal by Subject|0
7672970|NCT00205777|12088938|FG002|Study Extension II|Withdrawal by Subject|0
7672971|NCT00205777|12088939|FG003|Study Extension II|Withdrawal by Subject|35
7672972|NCT00205777|12088940|FG004|Study Extension II|Withdrawal by Subject|0
7672973|NCT00205777|12088941|FG005|Study Extension II|Withdrawal by Subject|59
7672974|NCT00205777|12088936|FG000|Study Extension II|Protocol Violation|0
7672975|NCT00205777|12088937|FG001|Study Extension II|Protocol Violation|0
7672976|NCT00205777|12088938|FG002|Study Extension II|Protocol Violation|0
7672977|NCT00205777|12088939|FG003|Study Extension II|Protocol Violation|1
7672978|NCT00205777|12088940|FG004|Study Extension II|Protocol Violation|0
7672979|NCT00205777|12088941|FG005|Study Extension II|Protocol Violation|10
7672980|NCT00205777|12088936|FG000|Study Extension II|Lack of Efficacy|0
7672981|NCT00205777|12088937|FG001|Study Extension II|Lack of Efficacy|0
7672982|NCT00205777|12088938|FG002|Study Extension II|Lack of Efficacy|0
7672983|NCT00205777|12088939|FG003|Study Extension II|Lack of Efficacy|0
7672984|NCT00205777|12088940|FG004|Study Extension II|Lack of Efficacy|0
7672985|NCT00205777|12088941|FG005|Study Extension II|Lack of Efficacy|1
7672986|NCT00205777|12088936|FG000|Study Extension II|Failed to return|0
7672987|NCT00205777|12088937|FG001|Study Extension II|Failed to return|0
7672988|NCT00205777|12088938|FG002|Study Extension II|Failed to return|0
7672989|NCT00205777|12088939|FG003|Study Extension II|Failed to return|14
7672990|NCT00205777|12088940|FG004|Study Extension II|Failed to return|0
7672991|NCT00205777|12088941|FG005|Study Extension II|Failed to return|26
7672992|NCT00205777|12088936|FG000|Study Extension II|Other Event|0
7672993|NCT00205777|12088937|FG001|Study Extension II|Other Event|0
7672994|NCT00205777|12088938|FG002|Study Extension II|Other Event|0
7672995|NCT00205777|12088939|FG003|Study Extension II|Other Event|12
7672996|NCT00205777|12088940|FG004|Study Extension II|Other Event|0
7672997|NCT00205777|12088941|FG005|Study Extension II|Other Event|20
7672998|NCT00205777|12088936|FG000|Study Extension II|Enrolled but not treated|0
7672999|NCT00205777|12088937|FG001|Study Extension II|Enrolled but not treated|0
7673000|NCT00205777|12088938|FG002|Study Extension II|Enrolled but not treated|0
7673001|NCT00205777|12088939|FG003|Study Extension II|Enrolled but not treated|71
7673002|NCT00205777|12088940|FG004|Study Extension II|Enrolled but not treated|0
7673003|NCT00205777|12088941|FG005|Study Extension II|Enrolled but not treated|131
7673004|NCT00205803|12088958|FG000|Infant Series|Lost to Follow-up|10
7673005|NCT00205803|12088959|FG001|Infant Series|Lost to Follow-up|4
7673006|NCT00205803|12088958|FG000|Infant Series|Withdrawal by Subject|2
7673007|NCT00205803|12088959|FG001|Infant Series|Withdrawal by Subject|5
7673008|NCT00205803|12088958|FG000|Infant Series|Physician Decision|3
7673009|NCT00205803|12088959|FG001|Infant Series|Physician Decision|1
7673010|NCT00205803|12088958|FG000|Infant Series|Protocol Violation|1
7673011|NCT00205803|12088959|FG001|Infant Series|Protocol Violation|0
7673012|NCT00205803|12088958|FG000|Infant Series|Lost Kaiser coverage|0
7673013|NCT00205803|12088959|FG001|Infant Series|Lost Kaiser coverage|1
7673014|NCT00205803|12088958|FG000|Infant Series|Non-compliant|1
7673015|NCT00205803|12088959|FG001|Infant Series|Non-compliant|0
7673016|NCT00205803|12088958|FG000|Infant Series|Sponsor request|1
7673017|NCT00205803|12088959|FG001|Infant Series|Sponsor request|0
7673018|NCT00205803|12088958|FG000|After Infant Series|Adverse Event|1
7673019|NCT00205803|12088959|FG001|After Infant Series|Adverse Event|1
7673020|NCT00205803|12088958|FG000|After Infant Series|Protocol Violation|1
7673021|NCT00205803|12088959|FG001|After Infant Series|Protocol Violation|1
7673022|NCT00205803|12088958|FG000|After Infant Series|Lost to Follow-up|2
7673023|NCT00205803|12088959|FG001|After Infant Series|Lost to Follow-up|1
7673024|NCT00205803|12088958|FG000|After Infant Series|Physician Decision|3
7673025|NCT00205803|12088959|FG001|After Infant Series|Physician Decision|2
7673026|NCT00205803|12088958|FG000|After Infant Series|Withdrawal by Subject|1
7673027|NCT00205803|12088959|FG001|After Infant Series|Withdrawal by Subject|4
7673028|NCT00205803|12088958|FG000|After Infant Series|Other|10
7673029|NCT00205803|12088959|FG001|After Infant Series|Other|4
7673030|NCT00205803|12088958|FG000|Toddler Dose|Lost to Follow-up|2
7673031|NCT00205803|12088959|FG001|Toddler Dose|Lost to Follow-up|3
7673032|NCT00205855|12088983|FG000|Overall Study|Only received temporary implants|16
7673033|NCT00205855|12088983|FG000|Overall Study|Withdrawal by Subject|5
7673034|NCT00205881|12088987|FG000|Overall Study|Withdrawal by Subject|16
7673035|NCT00206076|12088994|FG000|Overall Study|Physician Decision|2
7673036|NCT00206076|12088995|FG001|Overall Study|Physician Decision|0
7673037|NCT00206076|12088994|FG000|Overall Study|Withdrawal by Subject|1
7673038|NCT00206076|12088995|FG001|Overall Study|Withdrawal by Subject|1
7673039|NCT00206102|12089005|FG000|Overall Study|Adverse Event|119
7673040|NCT00206102|12089006|FG001|Overall Study|Adverse Event|82
7673041|NCT00206102|12089005|FG000|Overall Study|Protocol Violation|0
7673042|NCT00206102|12089006|FG001|Overall Study|Protocol Violation|2
7673043|NCT00206102|12089005|FG000|Overall Study|Lack of therapeutic response|16
7673044|NCT00206102|12089006|FG001|Overall Study|Lack of therapeutic response|11
7673045|NCT00206102|12089005|FG000|Overall Study|Lost to Follow-up|95
7673046|NCT00206102|12089006|FG001|Overall Study|Lost to Follow-up|66
7673047|NCT00206102|12089005|FG000|Overall Study|Withdrawal by Subject|118
7673048|NCT00206102|12089006|FG001|Overall Study|Withdrawal by Subject|101
7673049|NCT00206102|12089005|FG000|Overall Study|Study-specific discontinuation criteria|18
7673050|NCT00206102|12089006|FG001|Overall Study|Study-specific discontinuation criteria|17
7673051|NCT00206102|12089005|FG000|Overall Study|None of those categories|42
7673052|NCT00206102|12089006|FG001|Overall Study|None of those categories|36
7673053|NCT00206323|12089014|FG000|Overall Study|Lack of Efficacy|4
7673054|NCT00206323|12089015|FG001|Overall Study|Lack of Efficacy|1
7673055|NCT00206323|12089014|FG000|Overall Study|Adverse Event|1
7673056|NCT00206323|12089015|FG001|Overall Study|Adverse Event|1
7673057|NCT00206323|12089014|FG000|Overall Study|Lost to Follow-up|1
7673058|NCT00206323|12089015|FG001|Overall Study|Lost to Follow-up|1
7673059|NCT00206427|12089025|FG000|Overall Study|Adverse Event|2
7673060|NCT00206440|12089031|FG000|Overall Study|Protocol Violation|1
7673061|NCT00206440|12089032|FG001|Overall Study|Protocol Violation|2
7673062|NCT00206440|12089031|FG000|Overall Study|Adverse Event|4
7673063|NCT00206440|12089032|FG001|Overall Study|Adverse Event|2
7673064|NCT00206518|12089040|FG000|Overall Study|Lack of Efficacy|6
7673065|NCT00206518|12089041|FG001|Overall Study|Lack of Efficacy|4
7673066|NCT00206518|12089040|FG000|Overall Study|Adverse Event|2
7673067|NCT00206518|12089041|FG001|Overall Study|Adverse Event|1
7673068|NCT00206518|12089040|FG000|Overall Study|Physician Decision|1
7673069|NCT00206518|12089041|FG001|Overall Study|Physician Decision|0
7673070|NCT00206518|12089040|FG000|Overall Study|Protocol Violation|1
7673071|NCT00206518|12089041|FG001|Overall Study|Protocol Violation|1
7673072|NCT00206726|12089047|FG000|Overall Study|Delayed recovery of blood counts|1
7673073|NCT00206726|12089047|FG000|Overall Study|Progressive disease or relapsed disease|18
7673074|NCT00206726|12089047|FG000|Overall Study|Placed on new protocol|1
7673075|NCT00206726|12089047|FG000|Overall Study|Bone marrow transplant|1
7673076|NCT00206726|12089047|FG000|Overall Study|Adverse Event|17
7673077|NCT00206726|12089047|FG000|Overall Study|Death|4
7673078|NCT00206726|12089047|FG000|Overall Study|Protocol Violation|1
7673079|NCT00206726|12089047|FG000|Overall Study|Withdrawal by Subject|8
7673080|NCT00207090|12089051|FG000|Overall Study|Study drug toxicity|3
7673081|NCT00207090|12089051|FG000|Overall Study|Chest wall mass larger|1
7673082|NCT00207090|12089051|FG000|Overall Study|Disease progression/relapse|2
7673083|NCT00207090|12089051|FG000|Overall Study|Physician Decision|1
7673084|NCT00207142|12089063|FG000|Induction Phase|Adverse Event|9
7673085|NCT00207142|12089064|FG001|Induction Phase|Adverse Event|0
7673086|NCT00207142|12089065|FG002|Induction Phase|Adverse Event|0
7673087|NCT00207142|12089066|FG003|Induction Phase|Adverse Event|0
7673088|NCT00207142|12089063|FG000|Induction Phase|Death|1
7673089|NCT00207142|12089064|FG001|Induction Phase|Death|0
7673090|NCT00207142|12089065|FG002|Induction Phase|Death|0
7673091|NCT00207142|12089066|FG003|Induction Phase|Death|0
7673092|NCT00207142|12089063|FG000|Induction Phase|Lack of Efficacy|1
7673093|NCT00207142|12089064|FG001|Induction Phase|Lack of Efficacy|0
7673094|NCT00207142|12089065|FG002|Induction Phase|Lack of Efficacy|0
7673095|NCT00207142|12089066|FG003|Induction Phase|Lack of Efficacy|0
7673096|NCT00207142|12089063|FG000|Induction Phase|Lost to Follow-up|5
7673097|NCT00207142|12089064|FG001|Induction Phase|Lost to Follow-up|0
7673098|NCT00207142|12089065|FG002|Induction Phase|Lost to Follow-up|0
7673099|NCT00207142|12089066|FG003|Induction Phase|Lost to Follow-up|0
7673100|NCT00207142|12089063|FG000|Induction Phase|Physician Decision|2
7673101|NCT00207142|12089064|FG001|Induction Phase|Physician Decision|0
7673102|NCT00207142|12089065|FG002|Induction Phase|Physician Decision|0
7673103|NCT00207142|12089066|FG003|Induction Phase|Physician Decision|0
7673104|NCT00207142|12089063|FG000|Induction Phase|Poor/noncompliance|2
7673105|NCT00207142|12089064|FG001|Induction Phase|Poor/noncompliance|0
7673106|NCT00207142|12089065|FG002|Induction Phase|Poor/noncompliance|0
7673107|NCT00207142|12089066|FG003|Induction Phase|Poor/noncompliance|0
7673108|NCT00207142|12089063|FG000|Induction Phase|Pregnancy|1
7673109|NCT00207142|12089064|FG001|Induction Phase|Pregnancy|0
7673110|NCT00207142|12089065|FG002|Induction Phase|Pregnancy|0
7673111|NCT00207142|12089066|FG003|Induction Phase|Pregnancy|0
7673112|NCT00207142|12089063|FG000|Induction Phase|Subject no longer meets study criteria|3
7673113|NCT00207142|12089064|FG001|Induction Phase|Subject no longer meets study criteria|0
7673114|NCT00207142|12089065|FG002|Induction Phase|Subject no longer meets study criteria|0
7673115|NCT00207142|12089066|FG003|Induction Phase|Subject no longer meets study criteria|0
7673116|NCT00207142|12089063|FG000|Induction Phase|Withdrawal by Subject|4
7673117|NCT00207142|12089064|FG001|Induction Phase|Withdrawal by Subject|0
7673118|NCT00207142|12089065|FG002|Induction Phase|Withdrawal by Subject|0
7673119|NCT00207142|12089066|FG003|Induction Phase|Withdrawal by Subject|0
7673120|NCT00207142|12089063|FG000|Induction Phase|Incarceration|1
7673121|NCT00207142|12089064|FG001|Induction Phase|Incarceration|0
7673122|NCT00207142|12089065|FG002|Induction Phase|Incarceration|0
7673123|NCT00207142|12089066|FG003|Induction Phase|Incarceration|0
7673124|NCT00207142|12089063|FG000|Induction Phase|Missing lab data|1
7673125|NCT00207142|12089064|FG001|Induction Phase|Missing lab data|0
7673126|NCT00207142|12089065|FG002|Induction Phase|Missing lab data|0
7673127|NCT00207142|12089066|FG003|Induction Phase|Missing lab data|0
7673128|NCT00207142|12089063|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0
7673129|NCT00207142|12089064|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1
7673130|NCT00207142|12089065|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4
7673131|NCT00207142|12089066|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1
7673132|NCT00207142|12089063|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
7673133|NCT00207142|12089064|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
7673134|NCT00207142|12089065|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
7673135|NCT00207142|12089066|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
7673136|NCT00207142|12089063|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0
7673137|NCT00207142|12089064|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0
7673138|NCT00207142|12089065|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1
7673139|NCT00207142|12089066|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0
7673140|NCT00207142|12089063|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
7673141|NCT00207142|12089064|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
7673142|NCT00207142|12089065|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
7673143|NCT00207142|12089066|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
7673144|NCT00207142|12089063|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0
7673145|NCT00207142|12089064|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2
7673146|NCT00207142|12089065|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2
7673147|NCT00207142|12089066|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0
7673148|NCT00207142|12089063|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
7673149|NCT00207142|12089064|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
7673150|NCT00207142|12089065|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
7673151|NCT00207142|12089066|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
7673152|NCT00207142|12089063|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
7673153|NCT00207142|12089064|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
7673154|NCT00207142|12089065|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
7673155|NCT00207142|12089066|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
7673156|NCT00207142|12089063|FG000|Maintenance Phase/Rescue Phase|Death|0
7673157|NCT00207142|12089064|FG001|Maintenance Phase/Rescue Phase|Death|0
7673158|NCT00207142|12089065|FG002|Maintenance Phase/Rescue Phase|Death|0
7673159|NCT00207142|12089066|FG003|Maintenance Phase/Rescue Phase|Death|1
7673160|NCT00207142|12089063|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
7673161|NCT00207142|12089064|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
7673162|NCT00207142|12089065|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
7673163|NCT00207142|12089066|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
7673164|NCT00207714|12089086|FG000|Overall Study|Adverse Event|6
7673165|NCT00207714|12089087|FG001|Overall Study|Adverse Event|2
7673166|NCT00207714|12089088|FG002|Overall Study|Adverse Event|4
7673167|NCT00207714|12089089|FG003|Overall Study|Adverse Event|3
7673168|NCT00207714|12089090|FG004|Overall Study|Adverse Event|1
7673169|NCT00207714|12089086|FG000|Overall Study|Unsatisfactory therapeutic effect|5
7673170|NCT00207714|12089087|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7673171|NCT00207714|12089088|FG002|Overall Study|Unsatisfactory therapeutic effect|1
7673172|NCT00207714|12089089|FG003|Overall Study|Unsatisfactory therapeutic effect|4
7673173|NCT00207714|12089090|FG004|Overall Study|Unsatisfactory therapeutic effect|4
7673174|NCT00207714|12089086|FG000|Overall Study|Other|3
7673175|NCT00207714|12089087|FG001|Overall Study|Other|2
7673176|NCT00207714|12089088|FG002|Overall Study|Other|5
7673177|NCT00207714|12089089|FG003|Overall Study|Other|1
7673178|NCT00207714|12089090|FG004|Overall Study|Other|0
7673179|NCT00207727|12089114|FG000|Overall Study|Withdrawal by Subject|0
7673180|NCT00207727|12089115|FG001|Overall Study|Withdrawal by Subject|0
7673181|NCT00207727|12089116|FG002|Overall Study|Withdrawal by Subject|0
7673182|NCT00207727|12089117|FG003|Overall Study|Withdrawal by Subject|0
7673183|NCT00207727|12089118|FG004|Overall Study|Withdrawal by Subject|1
7673184|NCT00207727|12089114|FG000|Overall Study|Lost to Follow-up|0
7673185|NCT00207727|12089115|FG001|Overall Study|Lost to Follow-up|1
7673186|NCT00207727|12089116|FG002|Overall Study|Lost to Follow-up|0
7673187|NCT00207727|12089117|FG003|Overall Study|Lost to Follow-up|0
7673188|NCT00207727|12089118|FG004|Overall Study|Lost to Follow-up|0
7673189|NCT00207727|12089114|FG000|Overall Study|Other|38
7673190|NCT00207727|12089115|FG001|Overall Study|Other|41
7673191|NCT00207727|12089116|FG002|Overall Study|Other|41
7673192|NCT00207727|12089117|FG003|Overall Study|Other|37
7673193|NCT00207727|12089118|FG004|Overall Study|Other|33
7673194|NCT00207740|12089134|FG000|Overall Study|Adverse Event|4
7673195|NCT00207740|12089135|FG001|Overall Study|Adverse Event|14
7673196|NCT00207740|12089136|FG002|Overall Study|Adverse Event|14
7673197|NCT00207740|12089137|FG003|Overall Study|Adverse Event|11
7673198|NCT00207740|12089134|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7673199|NCT00207740|12089135|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7673200|NCT00207740|12089136|FG002|Overall Study|Unsatisfactory therapeutic effect|2
7673201|NCT00207740|12089137|FG003|Overall Study|Unsatisfactory therapeutic effect|4
7673202|NCT00207740|12089134|FG000|Overall Study|Lost to Follow-up|0
7673203|NCT00207740|12089135|FG001|Overall Study|Lost to Follow-up|2
7673204|NCT00207740|12089136|FG002|Overall Study|Lost to Follow-up|1
7673205|NCT00207740|12089137|FG003|Overall Study|Lost to Follow-up|1
7673206|NCT00207740|12089134|FG000|Overall Study|Death|0
7673207|NCT00207740|12089135|FG001|Overall Study|Death|0
7673208|NCT00207740|12089136|FG002|Overall Study|Death|0
7673209|NCT00207740|12089137|FG003|Overall Study|Death|1
7673210|NCT00207740|12089134|FG000|Overall Study|Sponsor Directive|22
7673211|NCT00207740|12089135|FG001|Overall Study|Sponsor Directive|15
7673212|NCT00207740|12089136|FG002|Overall Study|Sponsor Directive|16
7673213|NCT00207740|12089137|FG003|Overall Study|Sponsor Directive|21
7673214|NCT00207740|12089134|FG000|Overall Study|Other|2
7673215|NCT00207740|12089135|FG001|Overall Study|Other|10
7673216|NCT00207740|12089136|FG002|Overall Study|Other|7
7673217|NCT00207740|12089137|FG003|Overall Study|Other|5
7673218|NCT00208325|12089178|FG000|Overall Study|Death|18
7673219|NCT00208325|12089179|FG001|Overall Study|Death|19
7673220|NCT00208325|12089180|FG002|Overall Study|Death|7
7673221|NCT00208325|12089181|FG003|Overall Study|Death|5
7673222|NCT00208325|12089178|FG000|Overall Study|Withdrawal by Subject|0
7673223|NCT00208325|12089179|FG001|Overall Study|Withdrawal by Subject|1
7673224|NCT00208325|12089180|FG002|Overall Study|Withdrawal by Subject|0
7673225|NCT00208325|12089181|FG003|Overall Study|Withdrawal by Subject|0
7673226|NCT00208325|12089178|FG000|Overall Study|Revision|4
7673227|NCT00208325|12089179|FG001|Overall Study|Revision|1
7673228|NCT00208325|12089180|FG002|Overall Study|Revision|0
7673229|NCT00208325|12089181|FG003|Overall Study|Revision|4
7673230|NCT00208325|12089178|FG000|Overall Study|Lost to Follow-up|1
7673231|NCT00208325|12089179|FG001|Overall Study|Lost to Follow-up|0
7673232|NCT00208325|12089180|FG002|Overall Study|Lost to Follow-up|2
7673233|NCT00208325|12089181|FG003|Overall Study|Lost to Follow-up|0
7673234|NCT00208325|12089178|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4
7673235|NCT00208325|12089179|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4
7673236|NCT00208325|12089180|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1
7673237|NCT00208325|12089181|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3
7673238|NCT00208325|12089178|FG000|Overall Study|Does not wish to Continue in Study|5
7673239|NCT00208325|12089179|FG001|Overall Study|Does not wish to Continue in Study|8
7673240|NCT00208325|12089180|FG002|Overall Study|Does not wish to Continue in Study|3
7673241|NCT00208325|12089181|FG003|Overall Study|Does not wish to Continue in Study|2
7673242|NCT00208325|12089178|FG000|Overall Study|Other|2
7673243|NCT00208325|12089179|FG001|Overall Study|Other|1
7673244|NCT00208325|12089180|FG002|Overall Study|Other|1
7673245|NCT00208325|12089181|FG003|Overall Study|Other|0
7673246|NCT00208325|12089178|FG000|Overall Study|Mis-Randomized|17
7673247|NCT00208325|12089179|FG001|Overall Study|Mis-Randomized|20
7673248|NCT00208325|12089180|FG002|Overall Study|Mis-Randomized|0
7673249|NCT00208325|12089181|FG003|Overall Study|Mis-Randomized|0
7673250|NCT00208767|12089211|FG000|Overall Study|Adverse Event|9
7673251|NCT00208767|12089212|FG001|Overall Study|Adverse Event|1
7673252|NCT00208767|12089211|FG000|Overall Study|Withdrawal by Subject|14
7673253|NCT00208767|12089212|FG001|Overall Study|Withdrawal by Subject|3
7673254|NCT00208767|12089211|FG000|Overall Study|Death|1
7673255|NCT00208767|12089212|FG001|Overall Study|Death|0
7673256|NCT00208767|12089211|FG000|Overall Study|Lost to Follow-up|3
7673257|NCT00208767|12089212|FG001|Overall Study|Lost to Follow-up|3
7673258|NCT00209092|12089234|FG000|Overall Study|Progression of disease|7
7673259|NCT00209092|12089235|FG001|Overall Study|Progression of disease|1
7673260|NCT00209092|12089234|FG000|Overall Study|Adverse Event|0
7673261|NCT00209092|12089235|FG001|Overall Study|Adverse Event|1
7673262|NCT00209092|12089234|FG000|Overall Study|Withdrawal by Subject|1
7673263|NCT00209092|12089235|FG001|Overall Study|Withdrawal by Subject|0
7673264|NCT00209170|12089243|FG000|Overall Study|Adverse Event|0
7673265|NCT00209170|12089244|FG001|Overall Study|Adverse Event|1
7673266|NCT00209170|12089243|FG000|Overall Study|Withdrawal by Subject|2
7673267|NCT00209170|12089244|FG001|Overall Study|Withdrawal by Subject|1
7673268|NCT00209170|12089243|FG000|Overall Study|Lack of Efficacy|0
7673269|NCT00209170|12089244|FG001|Overall Study|Lack of Efficacy|1
7673270|NCT00209274|12089252|FG000|Overall Study|Missed visit|3
7673271|NCT00209274|12089253|FG001|Overall Study|Missed visit|2
7673272|NCT00209274|12089252|FG000|Overall Study|Death|32
7673273|NCT00209274|12089253|FG001|Overall Study|Death|15
7673274|NCT00209274|12089252|FG000|Overall Study|Withdrawal by Subject|30
7673275|NCT00209274|12089253|FG001|Overall Study|Withdrawal by Subject|15
7673276|NCT00209274|12089252|FG000|Overall Study|Randomized not treated (RNT)|6
7673277|NCT00209274|12089253|FG001|Overall Study|Randomized not treated (RNT)|15
7673278|NCT00209339|12089259|FG000|At 12 Months Follow-up|Withdrawal by Subject|8
7673279|NCT00209339|12089259|FG000|At 12 Months Follow-up|Death|1
7673280|NCT00209339|12089259|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6
7673281|NCT00209339|12089259|FG000|At 24 Months Follow-up|Withdrawal by Subject|4
7673282|NCT00209339|12089259|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6
7673283|NCT00209339|12089259|FG000|At 24 Months Follow-up|Death|1
7673284|NCT00209339|12089259|FG000|At 3 Years Follow-up|Withdrawal by Subject|1
7673285|NCT00209339|12089259|FG000|At 4 Years Follow-up|Withdrawal by Subject|4
7673286|NCT00209339|12089259|FG000|At 4 Years Follow-up|Death|1
7673287|NCT00209339|12089259|FG000|At 5 Years Follow-up|Withdrawal by Subject|2
7673288|NCT00209339|12089259|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5
7673289|NCT00209339|12089259|FG000|At 5 Years Follow-up|Death|1
7673290|NCT00209560|12089274|FG000|Overall Study|Lack of Efficacy|1
7673291|NCT00209560|12089275|FG001|Overall Study|Lack of Efficacy|0
7673292|NCT00210106|12089281|FG000|Overall Study|Death|1
7673293|NCT00210106|12089281|FG000|Overall Study|Protocol Violation|13
7673294|NCT00210119|12089286|FG000|Overall Study|Protocol Violation|1
7673295|NCT00210119|12089286|FG000|Overall Study|Withdrawal by Subject|1
7673296|NCT00210184|12089290|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2
7673297|NCT00210626|12089321|FG000|Overall Study|Adverse Event|1
7673298|NCT00210626|12089322|FG001|Overall Study|Adverse Event|2
7673299|NCT00210626|12089321|FG000|Overall Study|Protocol Violation|1
7673300|NCT00210626|12089322|FG001|Overall Study|Protocol Violation|5
7673301|NCT00210626|12089321|FG000|Overall Study|Lost to Follow-up|11
7673302|NCT00210626|12089322|FG001|Overall Study|Lost to Follow-up|11
7673303|NCT00210626|12089321|FG000|Overall Study|Death|1
7673304|NCT00210626|12089322|FG001|Overall Study|Death|0
7673305|NCT00210626|12089321|FG000|Overall Study|Withdrawal by Subject|29
7673306|NCT00210626|12089322|FG001|Overall Study|Withdrawal by Subject|20
7673307|NCT00210626|12089321|FG000|Overall Study|Physician Decision|0
7673308|NCT00210626|12089322|FG001|Overall Study|Physician Decision|2
7673309|NCT00210626|12089321|FG000|Overall Study|Sponser Request|1
7673310|NCT00210626|12089322|FG001|Overall Study|Sponser Request|0
7673311|NCT00210626|12089321|FG000|Overall Study|Other|4
7673312|NCT00210626|12089322|FG001|Overall Study|Other|5
7673313|NCT00210639|12089330|FG000|Overall Study|Lost to Follow-up|37
7673314|NCT00210639|12089331|FG001|Overall Study|Lost to Follow-up|29
7673315|NCT00210639|12089330|FG000|Overall Study|Withdrawal by Subject|8
7673316|NCT00210639|12089331|FG001|Overall Study|Withdrawal by Subject|1
7673317|NCT00210639|12089330|FG000|Overall Study|Other|18
7673318|NCT00210639|12089331|FG001|Overall Study|Other|12
7673319|NCT00211081|12089337|FG000|Overall Study|Withdrawal by Subject|2
7673320|NCT00211172|12089343|FG000|Overall Study|Died or lost health plan eligibility|39
7673321|NCT00211172|12089344|FG001|Overall Study|Died or lost health plan eligibility|32
7673322|NCT00211185|12089350|FG000|Overall Study|Death|2
7673323|NCT00211185|12089350|FG000|Overall Study|Disease progression|7
7673324|NCT00211185|12089350|FG000|Overall Study|Withdrawal by Subject|6
7673325|NCT00211185|12089350|FG000|Overall Study|Physician Decision|5
7673326|NCT00211237|12089356|FG000|Baseline|Withdrew|1
7673327|NCT00211237|12089357|FG001|Baseline|Withdrew|3
7673328|NCT00211237|12089358|FG002|Baseline|Withdrew|0
7673329|NCT00211237|12089356|FG000|Baseline|Refused random assignment|1
7673330|NCT00211237|12089357|FG001|Baseline|Refused random assignment|0
7673331|NCT00211237|12089358|FG002|Baseline|Refused random assignment|0
7673332|NCT00211237|12089356|FG000|1 Month|Death|2
7673333|NCT00211237|12089357|FG001|1 Month|Death|1
7673334|NCT00211237|12089358|FG002|1 Month|Death|0
7673335|NCT00211237|12089356|FG000|1 Month|Lost to Follow-up|0
7673336|NCT00211237|12089357|FG001|1 Month|Lost to Follow-up|2
7673337|NCT00211237|12089358|FG002|1 Month|Lost to Follow-up|0
7673338|NCT00211237|12089356|FG000|1 Month|Withdrew|0
7673339|NCT00211237|12089357|FG001|1 Month|Withdrew|4
7673340|NCT00211237|12089358|FG002|1 Month|Withdrew|0
7673341|NCT00211237|12089356|FG000|1 Month|Additional surgery needed|1
7673342|NCT00211237|12089357|FG001|1 Month|Additional surgery needed|0
7673343|NCT00211237|12089358|FG002|1 Month|Additional surgery needed|0
7673344|NCT00211237|12089356|FG000|1 Month|Non-medical problem|0
7673345|NCT00211237|12089357|FG001|1 Month|Non-medical problem|2
7673346|NCT00211237|12089358|FG002|1 Month|Non-medical problem|0
7673347|NCT00211237|12089356|FG000|3 Months|Death|7
7673348|NCT00211237|12089357|FG001|3 Months|Death|3
7673349|NCT00211237|12089358|FG002|3 Months|Death|0
7673350|NCT00211237|12089356|FG000|3 Months|Could not comply with protocol|1
7673351|NCT00211237|12089357|FG001|3 Months|Could not comply with protocol|0
7673352|NCT00211237|12089358|FG002|3 Months|Could not comply with protocol|0
7673353|NCT00211237|12089356|FG000|3 Months|Withdrew|0
7673354|NCT00211237|12089357|FG001|3 Months|Withdrew|1
7673355|NCT00211237|12089358|FG002|3 Months|Withdrew|0
7673356|NCT00211237|12089356|FG000|3 Months|Non-medical problem|0
7673357|NCT00211237|12089357|FG001|3 Months|Non-medical problem|0
7673358|NCT00211237|12089358|FG002|3 Months|Non-medical problem|1
7673359|NCT00211237|12089356|FG000|6 Months|Death|6
7673360|NCT00211237|12089357|FG001|6 Months|Death|0
7673361|NCT00211237|12089358|FG002|6 Months|Death|3
7673362|NCT00211237|12089356|FG000|6 Months|Lost to Follow-up|2
7673363|NCT00211237|12089357|FG001|6 Months|Lost to Follow-up|0
7673364|NCT00211237|12089358|FG002|6 Months|Lost to Follow-up|0
7673365|NCT00211237|12089356|FG000|6 Months|Could not comply with protocol|0
7673366|NCT00211237|12089357|FG001|6 Months|Could not comply with protocol|2
7673367|NCT00211237|12089358|FG002|6 Months|Could not comply with protocol|0
7673368|NCT00211237|12089356|FG000|12 Months|Death|8
7673369|NCT00211237|12089357|FG001|12 Months|Death|2
7673370|NCT00211237|12089358|FG002|12 Months|Death|3
7673371|NCT00211237|12089356|FG000|12 Months|Lost to Follow-up|1
7673372|NCT00211237|12089357|FG001|12 Months|Lost to Follow-up|0
7673373|NCT00211237|12089358|FG002|12 Months|Lost to Follow-up|1
7673374|NCT00211237|12089356|FG000|12 Months|Withdrew|0
7673375|NCT00211237|12089357|FG001|12 Months|Withdrew|0
7673376|NCT00211237|12089358|FG002|12 Months|Withdrew|1
7673377|NCT00211237|12089356|FG000|12 Months|unrelated medical problem|0
7673378|NCT00211237|12089357|FG001|12 Months|unrelated medical problem|0
7673379|NCT00211237|12089358|FG002|12 Months|unrelated medical problem|1
7673380|NCT00211510|12089377|FG000|Overall Study|Physician Decision|3
7673381|NCT00211510|12089378|FG001|Overall Study|Physician Decision|1
7673382|NCT00211510|12089377|FG000|Overall Study|Withdrawal by Subject|3
7673383|NCT00211510|12089378|FG001|Overall Study|Withdrawal by Subject|1
7673384|NCT00211536|12089389|FG000|Overall Study|Withdrawal by Subject|2
7673385|NCT00211536|12089390|FG001|Overall Study|Withdrawal by Subject|2
7673386|NCT00211536|12089389|FG000|Overall Study|Physician Decision|0
7673387|NCT00211536|12089390|FG001|Overall Study|Physician Decision|5
7673388|NCT00211536|12089389|FG000|Overall Study|Adverse Event|2
7673389|NCT00211536|12089390|FG001|Overall Study|Adverse Event|0
7673390|NCT00211757|12089407|FG000|Overall Study|Withdrawal by Subject|1
7673391|NCT00211757|12089408|FG001|Overall Study|Withdrawal by Subject|1
7673392|NCT00211757|12089407|FG000|Overall Study|Lack of Efficacy|0
7673393|NCT00211757|12089408|FG001|Overall Study|Lack of Efficacy|1
7673394|NCT00211809|12089416|FG000|Overall Study|Lack of Efficacy|1
7673395|NCT00211809|12089416|FG000|Overall Study|Lost to Follow-up|2
7673396|NCT00211809|12089416|FG000|Overall Study|Pregnancy|1
7673397|NCT00211809|12089416|FG000|Overall Study|side effects|2
7673398|NCT00211887|12089425|FG000|Overall Study|Adverse Event|8
7673399|NCT00211887|12089426|FG001|Overall Study|Adverse Event|4
7673400|NCT00211887|12089427|FG002|Overall Study|Adverse Event|6
7673401|NCT00211887|12089425|FG000|Overall Study|Death|1
7673402|NCT00211887|12089426|FG001|Overall Study|Death|1
7673403|NCT00211887|12089427|FG002|Overall Study|Death|1
7673404|NCT00211887|12089425|FG000|Overall Study|Lost to Follow-up|28
7673405|NCT00211887|12089426|FG001|Overall Study|Lost to Follow-up|13
7673406|NCT00211887|12089427|FG002|Overall Study|Lost to Follow-up|9
7673407|NCT00211887|12089425|FG000|Overall Study|Non-medical reason|31
7673408|NCT00211887|12089426|FG001|Overall Study|Non-medical reason|14
7673409|NCT00211887|12089427|FG002|Overall Study|Non-medical reason|8
7673410|NCT00211887|12089425|FG000|Overall Study|Other medical reason|15
7673411|NCT00211887|12089426|FG001|Overall Study|Other medical reason|11
7673412|NCT00211887|12089427|FG002|Overall Study|Other medical reason|7
7673413|NCT00211887|12089425|FG000|Overall Study|Side effects|19
7673414|NCT00211887|12089426|FG001|Overall Study|Side effects|13
7673415|NCT00211887|12089427|FG002|Overall Study|Side effects|5
7673416|NCT00212355|12089448|FG000|Overall Study|Adverse Event|1
7673417|NCT00212355|12089448|FG000|Overall Study|Withdrawal by Subject|1
7673418|NCT00212355|12089448|FG000|Overall Study|A change of address|1
7673419|NCT00212758|12089456|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1
7673420|NCT00212758|12089457|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0
7673421|NCT00212758|12089456|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
7673422|NCT00212758|12089457|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
7673423|NCT00213135|12089481|FG000|Overall Study|Adverse Event|9
7673424|NCT00213135|12089482|FG001|Overall Study|Adverse Event|5
7673425|NCT00213135|12089483|FG002|Overall Study|Adverse Event|5
7673426|NCT00213135|12089481|FG000|Overall Study|Lost to Follow-up|11
7673427|NCT00213135|12089482|FG001|Overall Study|Lost to Follow-up|8
7673428|NCT00213135|12089483|FG002|Overall Study|Lost to Follow-up|4
7673429|NCT00213135|12089481|FG000|Overall Study|Protocol Violation|4
7673430|NCT00213135|12089482|FG001|Overall Study|Protocol Violation|4
7673431|NCT00213135|12089483|FG002|Overall Study|Protocol Violation|10
7673432|NCT00213135|12089481|FG000|Overall Study|Death|1
7673433|NCT00213135|12089482|FG001|Overall Study|Death|1
7673434|NCT00213135|12089483|FG002|Overall Study|Death|2
7673435|NCT00213135|12089481|FG000|Overall Study|Disease progression|4
7673436|NCT00213135|12089482|FG001|Overall Study|Disease progression|5
7673437|NCT00213135|12089483|FG002|Overall Study|Disease progression|21
7673438|NCT00213135|12089481|FG000|Overall Study|Other|21
7673439|NCT00213135|12089482|FG001|Overall Study|Other|12
7673440|NCT00213135|12089483|FG002|Overall Study|Other|15
7673441|NCT00213148|12089495|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1
7673442|NCT00213148|12089496|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0
7673443|NCT00213148|12089497|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2
7673444|NCT00213148|12089498|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2
7673445|NCT00213148|12089499|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1
7673446|NCT00213148|12089495|FG000|Cycle 1 (1 Month)|Adverse Event|0
7673447|NCT00213148|12089496|FG001|Cycle 1 (1 Month)|Adverse Event|0
7673448|NCT00213148|12089497|FG002|Cycle 1 (1 Month)|Adverse Event|1
7673449|NCT00213148|12089498|FG003|Cycle 1 (1 Month)|Adverse Event|0
7673450|NCT00213148|12089499|FG004|Cycle 1 (1 Month)|Adverse Event|0
7673451|NCT00213148|12089495|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4
7673452|NCT00213148|12089496|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0
7673453|NCT00213148|12089497|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8
7673454|NCT00213148|12089498|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5
7673455|NCT00213148|12089499|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8
7673456|NCT00213148|12089495|FG000|Cycle 1 (1 Month)|Protocol Violation|1
7673457|NCT00213148|12089496|FG001|Cycle 1 (1 Month)|Protocol Violation|0
7673458|NCT00213148|12089497|FG002|Cycle 1 (1 Month)|Protocol Violation|1
7673459|NCT00213148|12089498|FG003|Cycle 1 (1 Month)|Protocol Violation|0
7673460|NCT00213148|12089499|FG004|Cycle 1 (1 Month)|Protocol Violation|0
7673461|NCT00213148|12089495|FG000|Cycle 1 (1 Month)|Other|3
7673462|NCT00213148|12089496|FG001|Cycle 1 (1 Month)|Other|0
7673463|NCT00213148|12089497|FG002|Cycle 1 (1 Month)|Other|2
7673464|NCT00213148|12089498|FG003|Cycle 1 (1 Month)|Other|2
7673465|NCT00213148|12089499|FG004|Cycle 1 (1 Month)|Other|7
7673466|NCT00213148|12089495|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
7673467|NCT00213148|12089496|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
7673468|NCT00213148|12089497|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
7673469|NCT00213148|12089498|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
7673470|NCT00213148|12089499|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
7673471|NCT00213148|12089495|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
7673472|NCT00213148|12089496|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
7673473|NCT00213148|12089497|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
7673474|NCT00213148|12089498|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
7673475|NCT00213148|12089499|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
7673476|NCT00213148|12089495|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
7673477|NCT00213148|12089496|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
7673478|NCT00213148|12089497|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
7673479|NCT00213148|12089498|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
7673480|NCT00213148|12089499|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
7673481|NCT00213148|12089495|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0
7673482|NCT00213148|12089496|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0
7673483|NCT00213148|12089497|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2
7673484|NCT00213148|12089498|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2
7673485|NCT00213148|12089499|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1
7673486|NCT00213148|12089495|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1
7673487|NCT00213148|12089496|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3
7673488|NCT00213148|12089497|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7
7673489|NCT00213148|12089498|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6
7673490|NCT00213148|12089499|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16
7673491|NCT00213148|12089495|FG000|Cycle 2 (1 Month)|Other|2
7673492|NCT00213148|12089496|FG001|Cycle 2 (1 Month)|Other|1
7673493|NCT00213148|12089497|FG002|Cycle 2 (1 Month)|Other|2
7673494|NCT00213148|12089498|FG003|Cycle 2 (1 Month)|Other|8
7673495|NCT00213148|12089499|FG004|Cycle 2 (1 Month)|Other|7
7673496|NCT00213148|12089495|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
7673497|NCT00213148|12089496|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
7673498|NCT00213148|12089497|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
7673499|NCT00213148|12089498|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
7673500|NCT00213148|12089499|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
7673501|NCT00213148|12089495|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
7673502|NCT00213148|12089496|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
7673503|NCT00213148|12089497|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
7673504|NCT00213148|12089498|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
7673505|NCT00213148|12089499|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
7673506|NCT00213148|12089495|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
7673507|NCT00213148|12089496|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
7673508|NCT00213148|12089497|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
7673509|NCT00213148|12089498|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
7673510|NCT00213148|12089499|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
7673511|NCT00213148|12089495|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0
7673512|NCT00213148|12089496|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2
7673513|NCT00213148|12089497|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0
7673514|NCT00213148|12089498|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0
7673515|NCT00213148|12089499|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1
7673516|NCT00213148|12089495|FG000|Cycle 3 (1 Month)|Other|0
7673517|NCT00213148|12089496|FG001|Cycle 3 (1 Month)|Other|0
7673518|NCT00213148|12089497|FG002|Cycle 3 (1 Month)|Other|1
7673519|NCT00213148|12089498|FG003|Cycle 3 (1 Month)|Other|1
7673520|NCT00213148|12089499|FG004|Cycle 3 (1 Month)|Other|0
7673521|NCT00213980|12089530|FG000|Overall Study|Withdrawal by Subject|3
7673522|NCT00213980|12089531|FG001|Overall Study|Withdrawal by Subject|1
7673523|NCT00213980|12089530|FG000|Overall Study|Adverse Event|1
7673524|NCT00213980|12089531|FG001|Overall Study|Adverse Event|1
7673525|NCT00213980|12089530|FG000|Overall Study|Disease progression|0
7673526|NCT00213980|12089531|FG001|Overall Study|Disease progression|2
7673527|NCT00213980|12089530|FG000|Overall Study|Developed ovarian cancer|1
7673528|NCT00213980|12089531|FG001|Overall Study|Developed ovarian cancer|0
7673529|NCT00213980|12089530|FG000|Overall Study|Failed to obtain all 3 DXAs|1
7673530|NCT00213980|12089531|FG001|Overall Study|Failed to obtain all 3 DXAs|3
7673531|NCT00214019|12089537|FG000|Overall Study|Lost to Follow-up|11
7673532|NCT00214019|12089537|FG000|Overall Study|Withdrawal by Subject|2
7673533|NCT00214019|12089537|FG000|Overall Study|Screen Failed prior to randomization|17
7673534|NCT00214136|12089572|FG000|Overall Study|Death|5
7673535|NCT00214201|12089578|FG000|Overall Study|Withdrawal by Subject|2
7673536|NCT00214201|12089579|FG001|Overall Study|Withdrawal by Subject|0
7673537|NCT00214201|12089578|FG000|Overall Study|Death|0
7673538|NCT00214201|12089579|FG001|Overall Study|Death|2
7673539|NCT00214383|12089588|FG000|Overall Study|Lost to Follow-up|16
7673540|NCT00214383|12089589|FG001|Overall Study|Lost to Follow-up|26
7673541|NCT00214422|12089598|FG000|Overall Study|Physician Decision|2
7673542|NCT00214422|12089599|FG001|Overall Study|Physician Decision|0
7673543|NCT00214422|12089600|FG002|Overall Study|Physician Decision|0
7673544|NCT00214422|12089598|FG000|Overall Study|Developed esophageal ca|1
7673545|NCT00214422|12089599|FG001|Overall Study|Developed esophageal ca|0
7673546|NCT00214422|12089600|FG002|Overall Study|Developed esophageal ca|0
7673547|NCT00214422|12089598|FG000|Overall Study|Pt taken off study|1
7673548|NCT00214422|12089599|FG001|Overall Study|Pt taken off study|1
7673549|NCT00214422|12089600|FG002|Overall Study|Pt taken off study|0
7673550|NCT00214422|12089598|FG000|Overall Study|Disease progression on study|1
7673551|NCT00214422|12089599|FG001|Overall Study|Disease progression on study|0
7673552|NCT00214422|12089600|FG002|Overall Study|Disease progression on study|0
7673553|NCT00214422|12089598|FG000|Overall Study|Unable to make a radiation treatment|0
7673554|NCT00214422|12089599|FG001|Overall Study|Unable to make a radiation treatment|0
7673555|NCT00214422|12089600|FG002|Overall Study|Unable to make a radiation treatment|1
7673556|NCT00214461|12089616|FG000|Overall Study|Adverse Event|0
7673557|NCT00214461|12089617|FG001|Overall Study|Adverse Event|0
7673558|NCT00214461|12089618|FG002|Overall Study|Adverse Event|1
7673559|NCT00214461|12089619|FG003|Overall Study|Adverse Event|1
7673560|NCT00214461|12089616|FG000|Overall Study|Withdrawal by Subject|0
7673561|NCT00214461|12089617|FG001|Overall Study|Withdrawal by Subject|0
7673562|NCT00214461|12089618|FG002|Overall Study|Withdrawal by Subject|1
7673563|NCT00214461|12089619|FG003|Overall Study|Withdrawal by Subject|0
7673564|NCT00215137|12089692|FG000|Open Label Escitalopram|Lack of Efficacy|1
7673565|NCT00215137|12089693|FG001|Open Label Escitalopram|Lack of Efficacy|0
7673566|NCT00215137|12089694|FG002|Open Label Escitalopram|Lack of Efficacy|0
7673567|NCT00215137|12089692|FG000|Randomization Period|Lost to Follow-up|0
7673568|NCT00215137|12089693|FG001|Randomization Period|Lost to Follow-up|1
7673569|NCT00215137|12089694|FG002|Randomization Period|Lost to Follow-up|0
7673570|NCT00215137|12089692|FG000|Randomization Period|Withdrawal by Subject|0
7673571|NCT00215137|12089693|FG001|Randomization Period|Withdrawal by Subject|1
7673572|NCT00215137|12089694|FG002|Randomization Period|Withdrawal by Subject|0
7673573|NCT00215150|12089702|FG000|Open Label Phase|Lost to Follow-up|7
7673574|NCT00215150|12089702|FG000|Open Label Phase|Withdrawal by Subject|1
7673575|NCT00215150|12089702|FG000|Open Label Phase|Did not complete a post base visit|13
7673576|NCT00215150|12089702|FG000|Open Label Phase|Did not meet randomization criteria|9
7673577|NCT00215150|12089702|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2
7673578|NCT00215150|12089702|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1
7673579|NCT00215150|12089702|FG000|Randomization Phase Placebo|Withdrawal by Subject|1
7673580|NCT00215540|12089713|FG000|Overall Study|Withdrew from study medication|1
7673581|NCT00215540|12089714|FG001|Overall Study|Withdrew from study medication|0
7673582|NCT00215540|12089715|FG002|Overall Study|Withdrew from study medication|0
7673583|NCT00215553|12089730|FG000|Overall Study|Adverse Event|0
7673584|NCT00215553|12089731|FG001|Overall Study|Adverse Event|1
7673585|NCT00215553|12089732|FG002|Overall Study|Adverse Event|2
7673586|NCT00215553|12089733|FG003|Overall Study|Adverse Event|1
7673587|NCT00215553|12089734|FG004|Overall Study|Adverse Event|2
7673588|NCT00215553|12089735|FG005|Overall Study|Adverse Event|6
7673589|NCT00215553|12089736|FG006|Overall Study|Adverse Event|0
7673590|NCT00215644|12089754|FG000|Overall Study|Disease Progression|28
7673591|NCT00215644|12089755|FG001|Overall Study|Disease Progression|10
7673592|NCT00215644|12089754|FG000|Overall Study|Adverse Event|2
7673593|NCT00215644|12089755|FG001|Overall Study|Adverse Event|9
7673594|NCT00215644|12089754|FG000|Overall Study|Death|1
7673595|NCT00215644|12089755|FG001|Overall Study|Death|2
7673596|NCT00215644|12089754|FG000|Overall Study|Withdrawal by Subject|1
7673597|NCT00215644|12089755|FG001|Overall Study|Withdrawal by Subject|0
7673598|NCT00215644|12089754|FG000|Overall Study|Other|3
7673599|NCT00215644|12089755|FG001|Overall Study|Other|15
7673600|NCT00215644|12089754|FG000|Overall Study|Randomized but Not Treated|1
7673601|NCT00215644|12089755|FG001|Overall Study|Randomized but Not Treated|0
7673602|NCT00215657|12089769|FG000|Overall Study|Adverse Event|5
7673603|NCT00215657|12089770|FG001|Overall Study|Adverse Event|1
7673604|NCT00215657|12089771|FG002|Overall Study|Adverse Event|3
7673605|NCT00215657|12089772|FG003|Overall Study|Adverse Event|0
7673606|NCT00215657|12089773|FG004|Overall Study|Adverse Event|3
7673607|NCT00215657|12089774|FG005|Overall Study|Adverse Event|1
7673608|NCT00215657|12089775|FG006|Overall Study|Adverse Event|0
7673609|NCT00215657|12089776|FG007|Overall Study|Adverse Event|3
7673610|NCT00215657|12089769|FG000|Overall Study|Withdrawal by Subject|6
7673611|NCT00215657|12089770|FG001|Overall Study|Withdrawal by Subject|3
7673612|NCT00215657|12089771|FG002|Overall Study|Withdrawal by Subject|3
7673613|NCT00215657|12089772|FG003|Overall Study|Withdrawal by Subject|1
7673614|NCT00215657|12089773|FG004|Overall Study|Withdrawal by Subject|6
7673615|NCT00215657|12089774|FG005|Overall Study|Withdrawal by Subject|1
7673616|NCT00215657|12089775|FG006|Overall Study|Withdrawal by Subject|10
7673617|NCT00215657|12089776|FG007|Overall Study|Withdrawal by Subject|3
7673618|NCT00215657|12089769|FG000|Overall Study|Insuff prostate specific antigen resp|3
7673619|NCT00215657|12089770|FG001|Overall Study|Insuff prostate specific antigen resp|2
7673620|NCT00215657|12089771|FG002|Overall Study|Insuff prostate specific antigen resp|2
7673621|NCT00215657|12089772|FG003|Overall Study|Insuff prostate specific antigen resp|2
7673622|NCT00215657|12089773|FG004|Overall Study|Insuff prostate specific antigen resp|1
7673623|NCT00215657|12089774|FG005|Overall Study|Insuff prostate specific antigen resp|2
7673624|NCT00215657|12089775|FG006|Overall Study|Insuff prostate specific antigen resp|3
7673625|NCT00215657|12089776|FG007|Overall Study|Insuff prostate specific antigen resp|2
7673626|NCT00215657|12089769|FG000|Overall Study|Insufficient testosterone response|5
7673627|NCT00215657|12089770|FG001|Overall Study|Insufficient testosterone response|4
7673628|NCT00215657|12089771|FG002|Overall Study|Insufficient testosterone response|1
7673629|NCT00215657|12089772|FG003|Overall Study|Insufficient testosterone response|12
7673630|NCT00215657|12089773|FG004|Overall Study|Insufficient testosterone response|8
7673631|NCT00215657|12089774|FG005|Overall Study|Insufficient testosterone response|12
7673632|NCT00215657|12089775|FG006|Overall Study|Insufficient testosterone response|4
7673633|NCT00215657|12089776|FG007|Overall Study|Insufficient testosterone response|7
7673634|NCT00215657|12089769|FG000|Overall Study|Other|3
7673635|NCT00215657|12089770|FG001|Overall Study|Other|1
7673636|NCT00215657|12089771|FG002|Overall Study|Other|2
7673637|NCT00215657|12089772|FG003|Overall Study|Other|3
7673638|NCT00215657|12089773|FG004|Overall Study|Other|5
7673639|NCT00215657|12089774|FG005|Overall Study|Other|4
7673640|NCT00215657|12089775|FG006|Overall Study|Other|6
7673641|NCT00215657|12089776|FG007|Overall Study|Other|1
7673642|NCT00215683|12089797|FG000|Overall Study|Adverse Event|15
7673643|NCT00215683|12089798|FG001|Overall Study|Adverse Event|16
7673644|NCT00215683|12089799|FG002|Overall Study|Adverse Event|15
7673645|NCT00215683|12089797|FG000|Overall Study|Lack of Efficacy|5
7673646|NCT00215683|12089798|FG001|Overall Study|Lack of Efficacy|1
7673647|NCT00215683|12089799|FG002|Overall Study|Lack of Efficacy|2
7673648|NCT00215683|12089797|FG000|Overall Study|Lost to Follow-up|0
7673649|NCT00215683|12089798|FG001|Overall Study|Lost to Follow-up|2
7673650|NCT00215683|12089799|FG002|Overall Study|Lost to Follow-up|1
7673651|NCT00215683|12089797|FG000|Overall Study|Withdrawal by Subject|9
7673652|NCT00215683|12089798|FG001|Overall Study|Withdrawal by Subject|4
7673653|NCT00215683|12089799|FG002|Overall Study|Withdrawal by Subject|13
7673654|NCT00215683|12089797|FG000|Overall Study|Physician Decision|0
7673655|NCT00215683|12089798|FG001|Overall Study|Physician Decision|0
7673656|NCT00215683|12089799|FG002|Overall Study|Physician Decision|1
7673657|NCT00215683|12089797|FG000|Overall Study|Difficult to attend visits|0
7673658|NCT00215683|12089798|FG001|Overall Study|Difficult to attend visits|1
7673659|NCT00215683|12089799|FG002|Overall Study|Difficult to attend visits|0
7673660|NCT00215683|12089797|FG000|Overall Study|No study drug available|0
7673661|NCT00215683|12089798|FG001|Overall Study|No study drug available|1
7673662|NCT00215683|12089799|FG002|Overall Study|No study drug available|0
7673663|NCT00215683|12089797|FG000|Overall Study|Intermittent therapy required|0
7673664|NCT00215683|12089798|FG001|Overall Study|Intermittent therapy required|1
7673665|NCT00215683|12089799|FG002|Overall Study|Intermittent therapy required|0
7673666|NCT00215943|12089818|FG000|Overall Study|Disease Progression|3
7673667|NCT00215943|12089819|FG001|Overall Study|Disease Progression|5
7673668|NCT00215943|12089818|FG000|Overall Study|Alternate therapy|0
7673669|NCT00215943|12089819|FG001|Overall Study|Alternate therapy|1
7673670|NCT00215943|12089818|FG000|Overall Study|Adverse Event|3
7673671|NCT00215943|12089819|FG001|Overall Study|Adverse Event|6
7673672|NCT00215943|12089818|FG000|Overall Study|Other disease|0
7673673|NCT00215943|12089819|FG001|Overall Study|Other disease|1
7673674|NCT00215943|12089818|FG000|Overall Study|Other complications|3
7673675|NCT00215943|12089819|FG001|Overall Study|Other complications|1
7673676|NCT00216086|12089836|FG000|Overall Study|Protocol Violation|1
7673677|NCT00216086|12089836|FG000|Overall Study|Diagnosis of Metastatic Disease|1
7673678|NCT00216086|12089836|FG000|Overall Study|Social Reasons|2
7673679|NCT00216203|12089853|FG000|Overall Study|Withdrawal by Subject|2
7673680|NCT00216476|12089874|FG000|Overall Study|Withdrawal by Subject|59
7673681|NCT00216476|12089875|FG001|Overall Study|Withdrawal by Subject|72
7673682|NCT00216476|12089876|FG002|Overall Study|Withdrawal by Subject|9
7673683|NCT00216476|12089874|FG000|Overall Study|Lost to Follow-up|10
7673684|NCT00216476|12089875|FG001|Overall Study|Lost to Follow-up|9
7673685|NCT00216476|12089876|FG002|Overall Study|Lost to Follow-up|1
7673686|NCT00216476|12089874|FG000|Overall Study|Adverse Event|6
7673687|NCT00216476|12089875|FG001|Overall Study|Adverse Event|10
7673688|NCT00216476|12089876|FG002|Overall Study|Adverse Event|1
7673689|NCT00216476|12089874|FG000|Overall Study|Lack of Efficacy|4
7673690|NCT00216476|12089875|FG001|Overall Study|Lack of Efficacy|3
7673691|NCT00216476|12089876|FG002|Overall Study|Lack of Efficacy|0
7673692|NCT00216476|12089874|FG000|Overall Study|Death|2
7673693|NCT00216476|12089875|FG001|Overall Study|Death|0
7673694|NCT00216476|12089876|FG002|Overall Study|Death|0
7673695|NCT00216476|12089874|FG000|Overall Study|Pregnancy|0
7673696|NCT00216476|12089875|FG001|Overall Study|Pregnancy|1
7673697|NCT00216476|12089876|FG002|Overall Study|Pregnancy|1
7673698|NCT00216476|12089874|FG000|Overall Study|Other|0
7673699|NCT00216476|12089875|FG001|Overall Study|Other|0
7673700|NCT00216476|12089876|FG002|Overall Study|Other|1
7673701|NCT00216476|12089874|FG000|Overall Study|Refuses Injection|11
7673702|NCT00216476|12089875|FG001|Overall Study|Refuses Injection|0
7673703|NCT00216476|12089876|FG002|Overall Study|Refuses Injection|0
7673704|NCT00216476|12089874|FG000|Overall Study|No Further Need for Treatment|3
7673705|NCT00216476|12089875|FG001|Overall Study|No Further Need for Treatment|4
7673706|NCT00216476|12089876|FG002|Overall Study|No Further Need for Treatment|1
7673707|NCT00216476|12089874|FG000|Overall Study|Non-compliance|0
7673708|NCT00216476|12089875|FG001|Overall Study|Non-compliance|4
7673709|NCT00216476|12089876|FG002|Overall Study|Non-compliance|1
7673710|NCT00216476|12089874|FG000|Overall Study|Higher dose/Extra Medication Required|2
7673711|NCT00216476|12089875|FG001|Overall Study|Higher dose/Extra Medication Required|0
7673712|NCT00216476|12089876|FG002|Overall Study|Higher dose/Extra Medication Required|2
7673713|NCT00216476|12089874|FG000|Overall Study|Administrative Reasons|1
7673714|NCT00216476|12089875|FG001|Overall Study|Administrative Reasons|1
7673715|NCT00216476|12089876|FG002|Overall Study|Administrative Reasons|0
7673716|NCT00216476|12089874|FG000|Overall Study|Protocol Deviation|5
7673717|NCT00216476|12089875|FG001|Overall Study|Protocol Deviation|1
7673718|NCT00216476|12089876|FG002|Overall Study|Protocol Deviation|0
7673719|NCT00216476|12089874|FG000|Overall Study|Patient Moved|2
7673720|NCT00216476|12089875|FG001|Overall Study|Patient Moved|2
7673721|NCT00216476|12089876|FG002|Overall Study|Patient Moved|0
7673722|NCT00216671|12089889|FG000|Overall Study|Adverse Event|4
7673723|NCT00216671|12089890|FG001|Overall Study|Adverse Event|9
7673724|NCT00216671|12089889|FG000|Overall Study|Pregnancy|0
7673725|NCT00216671|12089890|FG001|Overall Study|Pregnancy|1
7673726|NCT00216671|12089889|FG000|Overall Study|Withdrawal by Subject|4
7673727|NCT00216671|12089890|FG001|Overall Study|Withdrawal by Subject|2
7673728|NCT00216671|12089889|FG000|Overall Study|Refused Injections|3
7673729|NCT00216671|12089890|FG001|Overall Study|Refused Injections|13
7673730|NCT00216671|12089889|FG000|Overall Study|No Need to Continue Medication|1
7673731|NCT00216671|12089890|FG001|Overall Study|No Need to Continue Medication|1
7673732|NCT00216671|12089889|FG000|Overall Study|Insufficient Response|9
7673733|NCT00216671|12089890|FG001|Overall Study|Insufficient Response|4
7673734|NCT00216671|12089889|FG000|Overall Study|Lost to Follow-up|3
7673735|NCT00216671|12089890|FG001|Overall Study|Lost to Follow-up|5
7673736|NCT00216671|12089889|FG000|Overall Study|Non compliant|2
7673737|NCT00216671|12089890|FG001|Overall Study|Non compliant|2
7673738|NCT00216671|12089889|FG000|Overall Study|Ineligible|0
7673739|NCT00216671|12089890|FG001|Overall Study|Ineligible|2
7673740|NCT00216671|12089889|FG000|Overall Study|Physician Decision|1
7673741|NCT00216671|12089890|FG001|Overall Study|Physician Decision|1
7673742|NCT00216671|12089889|FG000|Overall Study|Protocol Violation|3
7673743|NCT00216671|12089890|FG001|Overall Study|Protocol Violation|5
7673744|NCT00216671|12089889|FG000|Overall Study|Relapse|1
7673745|NCT00216671|12089890|FG001|Overall Study|Relapse|0
7673746|NCT00216671|12089889|FG000|Overall Study|Investigator Illness|0
7673747|NCT00216671|12089890|FG001|Overall Study|Investigator Illness|1
7673748|NCT00216671|12089889|FG000|Overall Study|Patient Moved|0
7673749|NCT00216671|12089890|FG001|Overall Study|Patient Moved|1
7673750|NCT00216671|12089889|FG000|Overall Study|Ineligible, no efficacy data|2
7673751|NCT00216671|12089890|FG001|Overall Study|Ineligible, no efficacy data|2
7673752|NCT00216671|12089889|FG000|Overall Study|Insufficient Response Adverse Event|2
7673753|NCT00216671|12089890|FG001|Overall Study|Insufficient Response Adverse Event|1
7673754|NCT00216736|12089898|FG000|Overall Study|Lost to Follow-up|1
7673755|NCT00216736|12089899|FG001|Overall Study|Lost to Follow-up|1
7673756|NCT00217022|12089907|FG000|Overall Study|Withdrawal by Subject|1
7673757|NCT00217022|12089908|FG001|Overall Study|Withdrawal by Subject|1
7673758|NCT00217087|12089916|FG000|Overall Study|decided to have esophagectomy|1
7673759|NCT00217087|12089917|FG001|Overall Study|decided to have esophagectomy|2
7673760|NCT00217087|12089916|FG000|Overall Study|completed less than 12 months return|10
7673761|NCT00217087|12089917|FG001|Overall Study|completed less than 12 months return|18
7673762|NCT00217425|12089935|FG000|Overall Study|Never started treatment|2
7673763|NCT00217425|12089935|FG000|Overall Study|Patient ineligible|5
7673764|NCT00217425|12089935|FG000|Overall Study|Lack of Efficacy|13
7673765|NCT00217425|12089935|FG000|Overall Study|Adverse Event|8
7673766|NCT00217425|12089935|FG000|Overall Study|Withdrawal by Subject|4
7673767|NCT00217425|12089935|FG000|Overall Study|Other complicating disease|1
7673768|NCT00217425|12089935|FG000|Overall Study|Other|4
7673769|NCT00217464|12089948|FG000|Overall Study|Progression|15
7673770|NCT00217464|12089948|FG000|Overall Study|Other|2
7673771|NCT00217581|12089973|FG000|Overall Study|Withdrawal by Subject|1
7673772|NCT00217620|12089982|FG000|Overall Study|Adverse Event|2
7673773|NCT00217620|12089982|FG000|Overall Study|Progression|31
7673774|NCT00217620|12089982|FG000|Overall Study|Not Protocol Specified|4
7673775|NCT00217620|12089982|FG000|Overall Study|Ineligible|13
7673776|NCT00217620|12089982|FG000|Overall Study|Never received treatment|1
7673777|NCT00217672|12089990|FG000|Allocation|Ineligible|2
7673778|NCT00217672|12089991|FG001|Allocation|Ineligible|0
7673779|NCT00217672|12089990|FG000|Treatment|disease progression|33
7673780|NCT00217672|12089991|FG001|Treatment|disease progression|4
7673781|NCT00217672|12089990|FG000|Treatment|Adverse Event|18
7673782|NCT00217672|12089991|FG001|Treatment|Adverse Event|2
7673783|NCT00217672|12089990|FG000|Treatment|reqd treatment not permitted by protocol|6
7673784|NCT00217672|12089991|FG001|Treatment|reqd treatment not permitted by protocol|0
7673785|NCT00217672|12089990|FG000|Treatment|Physician Decision|6
7673786|NCT00217672|12089991|FG001|Treatment|Physician Decision|0
7673787|NCT00217672|12089990|FG000|Treatment|insurance issues|1
7673788|NCT00217672|12089991|FG001|Treatment|insurance issues|1
7673789|NCT00217672|12089990|FG000|Treatment|Death|2
7673790|NCT00217672|12089991|FG001|Treatment|Death|0
7673791|NCT00217672|12089990|FG000|Treatment|secondary malignancy|1
7673792|NCT00217672|12089991|FG001|Treatment|secondary malignancy|0
7673793|NCT00217672|12089990|FG000|Follow-up|Withdrawal by Subject|4
7673794|NCT00217672|12089991|FG001|Follow-up|Withdrawal by Subject|0
7673795|NCT00217672|12089990|FG000|Follow-up|Lost to Follow-up|1
7673796|NCT00217672|12089991|FG001|Follow-up|Lost to Follow-up|0
7673797|NCT00217971|12090004|FG000|Overall Study|Adverse Event|1
7673798|NCT00217971|12090005|FG001|Overall Study|Adverse Event|1
7673799|NCT00217971|12090004|FG000|Overall Study|Lost to Follow-up|15
7673800|NCT00217971|12090005|FG001|Overall Study|Lost to Follow-up|19
7673801|NCT00217971|12090004|FG000|Overall Study|Physician Decision|0
7673802|NCT00217971|12090005|FG001|Overall Study|Physician Decision|1
7673803|NCT00217971|12090004|FG000|Overall Study|Withdrawal by Subject|7
7673804|NCT00217971|12090005|FG001|Overall Study|Withdrawal by Subject|12
7673805|NCT00217971|12090004|FG000|Overall Study|non compliant|1
7673806|NCT00217971|12090005|FG001|Overall Study|non compliant|0
7673807|NCT00218257|12090045|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4
7673808|NCT00218257|12090046|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3
7673809|NCT00218296|12090057|FG000|Overall Study|Lost to Follow-up|9
7673810|NCT00218296|12090058|FG001|Overall Study|Lost to Follow-up|7
7673811|NCT00218296|12090057|FG000|Overall Study|Withdrawal by Subject|36
7673812|NCT00218296|12090058|FG001|Overall Study|Withdrawal by Subject|47
7673813|NCT00218296|12090057|FG000|Overall Study|Randomized but did not enter treatment|66
7673814|NCT00218296|12090058|FG001|Overall Study|Randomized but did not enter treatment|67
7673815|NCT00218543|12090153|FG000|Overall Study|Lost to Follow-up|8
7673816|NCT00218543|12090153|FG000|Overall Study|relocated|1
7673817|NCT00218543|12090153|FG000|Overall Study|Withdrawal by Subject|1
7673818|NCT00218543|12090153|FG000|Overall Study|Physician Decision|3
7673819|NCT00218543|12090153|FG000|Overall Study|Adverse Event|2
7673820|NCT00218634|12090159|FG000|Overall Study|Lost to Follow-up|8
7673821|NCT00218634|12090160|FG001|Overall Study|Lost to Follow-up|15
7673822|NCT00219141|12090172|FG000|Overall Study|Adverse Event|4
7673823|NCT00219141|12090173|FG001|Overall Study|Adverse Event|10
7673824|NCT00219141|12090174|FG002|Overall Study|Adverse Event|5
7673825|NCT00219141|12090172|FG000|Overall Study|Lack of Efficacy|3
7673826|NCT00219141|12090173|FG001|Overall Study|Lack of Efficacy|2
7673827|NCT00219141|12090174|FG002|Overall Study|Lack of Efficacy|0
7673828|NCT00219141|12090172|FG000|Overall Study|Administrative problems|0
7673829|NCT00219141|12090173|FG001|Overall Study|Administrative problems|1
7673830|NCT00219141|12090174|FG002|Overall Study|Administrative problems|0
7673831|NCT00219141|12090172|FG000|Overall Study|Lost to Follow-up|2
7673832|NCT00219141|12090173|FG001|Overall Study|Lost to Follow-up|4
7673833|NCT00219141|12090174|FG002|Overall Study|Lost to Follow-up|1
7673834|NCT00219141|12090172|FG000|Overall Study|Protocol Violation|3
7673835|NCT00219141|12090173|FG001|Overall Study|Protocol Violation|1
7673836|NCT00219141|12090174|FG002|Overall Study|Protocol Violation|1
7673837|NCT00219141|12090172|FG000|Overall Study|Withdrawal by Subject|1
7673838|NCT00219141|12090173|FG001|Overall Study|Withdrawal by Subject|3
7673839|NCT00219141|12090174|FG002|Overall Study|Withdrawal by Subject|5
7673840|NCT00219141|12090172|FG000|Overall Study|Condition no longer requires study drug|1
7673841|NCT00219141|12090173|FG001|Overall Study|Condition no longer requires study drug|0
7673842|NCT00219141|12090174|FG002|Overall Study|Condition no longer requires study drug|0
7673843|NCT00219284|12090184|FG000|Treatment Phase - 16 Weeks|Adverse Event|26
7673844|NCT00219284|12090185|FG001|Treatment Phase - 16 Weeks|Adverse Event|24
7673845|NCT00219284|12090184|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
7673846|NCT00219284|12090185|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
7673847|NCT00219284|12090184|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3
7673848|NCT00219284|12090185|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10
7673849|NCT00219284|12090184|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9
7673850|NCT00219284|12090185|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5
7673851|NCT00219284|12090184|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
7673852|NCT00219284|12090185|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
7673853|NCT00219284|12090184|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1
7673854|NCT00219284|12090185|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2
7673855|NCT00219284|12090184|FG000|Extension Phase - 8 Weeks|Adverse Event|2
7673856|NCT00219284|12090185|FG001|Extension Phase - 8 Weeks|Adverse Event|3
7673857|NCT00219284|12090184|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0
7673858|NCT00219284|12090185|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2
7673859|NCT00219284|12090184|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0
7673860|NCT00219284|12090185|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2
7673861|NCT00219349|12090191|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
7673862|NCT00219349|12090191|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
7673863|NCT00219349|12090191|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2
7673864|NCT00219349|12090191|FG000|Escitalopram Phase|Withdrawal by Subject|3
7673865|NCT00219544|12090195|FG000|Single Blind Treatment Period|Lack of Efficacy|5
7673866|NCT00219544|12090196|FG001|Single Blind Treatment Period|Lack of Efficacy|0
7673867|NCT00219544|12090195|FG000|Single Blind Treatment Period|Adverse Event|9
7673868|NCT00219544|12090196|FG001|Single Blind Treatment Period|Adverse Event|0
7673869|NCT00219544|12090195|FG000|Single Blind Treatment Period|Protocol Violation|4
7673870|NCT00219544|12090196|FG001|Single Blind Treatment Period|Protocol Violation|0
7673871|NCT00219544|12090195|FG000|Single Blind Treatment Period|Lost to Follow-up|2
7673872|NCT00219544|12090196|FG001|Single Blind Treatment Period|Lost to Follow-up|0
7673873|NCT00219544|12090195|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1
7673874|NCT00219544|12090196|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0
7673875|NCT00219544|12090195|FG000|Single Blind Treatment Period|Withdrawal by Subject|1
7673876|NCT00219544|12090196|FG001|Single Blind Treatment Period|Withdrawal by Subject|0
7673877|NCT00219557|12090207|FG000|Phase 1|Lack of Efficacy|3
7673878|NCT00219557|12090208|FG001|Phase 1|Lack of Efficacy|0
7673879|NCT00219557|12090209|FG002|Phase 1|Lack of Efficacy|0
7673880|NCT00219557|12090207|FG000|Phase 1|Adverse Event|2
7673881|NCT00219557|12090208|FG001|Phase 1|Adverse Event|0
7673882|NCT00219557|12090209|FG002|Phase 1|Adverse Event|0
7673883|NCT00219557|12090207|FG000|Phase 1|Withdrawal by Subject|1
7673884|NCT00219557|12090208|FG001|Phase 1|Withdrawal by Subject|0
7673885|NCT00219557|12090209|FG002|Phase 1|Withdrawal by Subject|0
7673886|NCT00219557|12090207|FG000|Phase 1|Started chemotherapy at other institute|1
7673887|NCT00219557|12090208|FG001|Phase 1|Started chemotherapy at other institute|0
7673888|NCT00219557|12090209|FG002|Phase 1|Started chemotherapy at other institute|0
7673889|NCT00219557|12090207|FG000|Phase 2|Lack of Efficacy|0
7673890|NCT00219557|12090208|FG001|Phase 2|Lack of Efficacy|21
7673891|NCT00219557|12090209|FG002|Phase 2|Lack of Efficacy|15
7673892|NCT00219557|12090207|FG000|Phase 2|Adverse Event|0
7673893|NCT00219557|12090208|FG001|Phase 2|Adverse Event|22
7673894|NCT00219557|12090209|FG002|Phase 2|Adverse Event|2
7673895|NCT00219557|12090207|FG000|Phase 2|Death|0
7673896|NCT00219557|12090208|FG001|Phase 2|Death|8
7673897|NCT00219557|12090209|FG002|Phase 2|Death|2
7673898|NCT00219557|12090207|FG000|Phase 2|Other|0
7673899|NCT00219557|12090208|FG001|Phase 2|Other|8
7673900|NCT00219557|12090209|FG002|Phase 2|Other|6
7673901|NCT00219557|12090207|FG000|Phase 2|Withdrawal by Subject|0
7673902|NCT00219557|12090208|FG001|Phase 2|Withdrawal by Subject|9
7673903|NCT00219557|12090209|FG002|Phase 2|Withdrawal by Subject|5
7673904|NCT00219557|12090207|FG000|Phase 2|Treatment not received|0
7673905|NCT00219557|12090208|FG001|Phase 2|Treatment not received|1
7673906|NCT00219557|12090209|FG002|Phase 2|Treatment not received|3
7673907|NCT00220636|12090218|FG000|Overall Study|Withdrawal by Subject|4
7673908|NCT00220701|12090225|FG000|Overall Study|Lost to Follow-up|5
7673909|NCT00220701|12090226|FG001|Overall Study|Lost to Follow-up|4
7673910|NCT00220727|12090234|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1
7673911|NCT00220727|12090235|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0
7673912|NCT00220740|12090245|FG000|Efficacy Period|Entered rescue treatment with placebo|23
7673913|NCT00220740|12090246|FG001|Efficacy Period|Entered rescue treatment with placebo|0
7673914|NCT00220740|12090245|FG000|Efficacy Period|Adverse Event|1
7673915|NCT00220740|12090246|FG001|Efficacy Period|Adverse Event|1
7673916|NCT00220740|12090245|FG000|Efficacy Period|Withdrawal by Subject|1
7673917|NCT00220740|12090246|FG001|Efficacy Period|Withdrawal by Subject|0
7673918|NCT00220740|12090245|FG000|Efficacy Period|Protocol Violation|1
7673919|NCT00220740|12090246|FG001|Efficacy Period|Protocol Violation|0
7673920|NCT00220740|12090245|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
7673921|NCT00220740|12090246|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
7673922|NCT00220779|12090257|FG000|Overall Study|Adverse Event|1
7673923|NCT00220779|12090258|FG001|Overall Study|Adverse Event|0
7673924|NCT00220779|12090259|FG002|Overall Study|Adverse Event|0
7673925|NCT00220779|12090257|FG000|Overall Study|Withdrawal by Subject|1
7673926|NCT00220779|12090258|FG001|Overall Study|Withdrawal by Subject|4
7673927|NCT00220779|12090259|FG002|Overall Study|Withdrawal by Subject|1
7673928|NCT00220779|12090257|FG000|Overall Study|Non-compliance|1
7673929|NCT00220779|12090258|FG001|Overall Study|Non-compliance|0
7673930|NCT00220779|12090259|FG002|Overall Study|Non-compliance|0
7673931|NCT00220779|12090257|FG000|Overall Study|Too time consuming|1
7673932|NCT00220779|12090258|FG001|Overall Study|Too time consuming|0
7673933|NCT00220779|12090259|FG002|Overall Study|Too time consuming|0
7673934|NCT00220779|12090257|FG000|Overall Study|Pregnancy|0
7673935|NCT00220779|12090258|FG001|Overall Study|Pregnancy|0
7673936|NCT00220779|12090259|FG002|Overall Study|Pregnancy|2
7673937|NCT00220779|12090257|FG000|Overall Study|Lack of Efficacy|3
7673938|NCT00220779|12090258|FG001|Overall Study|Lack of Efficacy|0
7673939|NCT00220779|12090259|FG002|Overall Study|Lack of Efficacy|1
7673940|NCT00220805|12090269|FG000|Overall Study|Adverse Event|1
7673941|NCT00220805|12090270|FG001|Overall Study|Adverse Event|3
7673942|NCT00220805|12090269|FG000|Overall Study|Withdrawal by Subject|3
7673943|NCT00220805|12090270|FG001|Overall Study|Withdrawal by Subject|0
7673944|NCT00220805|12090269|FG000|Overall Study|Lack of Efficacy|1
7673945|NCT00220805|12090270|FG001|Overall Study|Lack of Efficacy|0
7673946|NCT00220805|12090269|FG000|Overall Study|Develop. of choroidal neovascularization|3
7673947|NCT00220805|12090270|FG001|Overall Study|Develop. of choroidal neovascularization|8
7673948|NCT00221104|12090287|FG000|Overall Study|Adverse Event|1
7673949|NCT00221104|12090288|FG001|Overall Study|Adverse Event|0
7673950|NCT00221104|12090287|FG000|Overall Study|Physician Decision|1
7673951|NCT00221104|12090288|FG001|Overall Study|Physician Decision|0
7673952|NCT00221104|12090287|FG000|Overall Study|Protocol Violation|2
7673953|NCT00221104|12090288|FG001|Overall Study|Protocol Violation|0
7673954|NCT00221104|12090287|FG000|Overall Study|Withdrawal by Subject|42
7673955|NCT00221104|12090288|FG001|Overall Study|Withdrawal by Subject|29
7673956|NCT00221104|12090287|FG000|Overall Study|Others|37
7673957|NCT00221104|12090288|FG001|Overall Study|Others|47
7673958|NCT00221195|12090309|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3
7673959|NCT00221195|12090310|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1
7673960|NCT00221195|12090309|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0
7673961|NCT00221195|12090310|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1
7673962|NCT00221195|12090309|FG000|Washout Period (Months 7-9)|Death|0
7673963|NCT00221195|12090310|FG001|Washout Period (Months 7-9)|Death|1
7673964|NCT00221195|12090309|FG000|Therapy 2 (Months 10-15)|Death|1
7673965|NCT00221195|12090310|FG001|Therapy 2 (Months 10-15)|Death|0
7673966|NCT00221195|12090309|FG000|Therapy 2 (Months 10-15)|Adverse Event|1
7673967|NCT00221195|12090310|FG001|Therapy 2 (Months 10-15)|Adverse Event|0
7673968|NCT00221403|12090343|FG000|Overall Study|Protocol Violation|1
7673969|NCT00221403|12090344|FG001|Overall Study|Protocol Violation|0
7673970|NCT00221403|12090345|FG002|Overall Study|Protocol Violation|0
7673971|NCT00221403|12090343|FG000|Overall Study|Physician Decision|1
7673972|NCT00221403|12090344|FG001|Overall Study|Physician Decision|0
7673973|NCT00221403|12090345|FG002|Overall Study|Physician Decision|0
7673974|NCT00221403|12090343|FG000|Overall Study|Withdrawal by Subject|0
7673975|NCT00221403|12090344|FG001|Overall Study|Withdrawal by Subject|3
7673976|NCT00221403|12090345|FG002|Overall Study|Withdrawal by Subject|0
7673977|NCT00221403|12090343|FG000|Overall Study|Lack of Efficacy|0
7673978|NCT00221403|12090344|FG001|Overall Study|Lack of Efficacy|1
7673979|NCT00221403|12090345|FG002|Overall Study|Lack of Efficacy|0
7673980|NCT00221403|12090343|FG000|Overall Study|Adverse Event|0
7673981|NCT00221403|12090344|FG001|Overall Study|Adverse Event|1
7673982|NCT00221403|12090345|FG002|Overall Study|Adverse Event|0
7673983|NCT00222105|12090353|FG000|Overall Study|Removed due to wrong diagnosis|1
7673984|NCT00222105|12090353|FG000|Overall Study|Withdrawal by Subject|1
7673985|NCT00222105|12090353|FG000|Overall Study|Adverse Event|8
7673986|NCT00222105|12090353|FG000|Overall Study|Treatment delays|2
7673987|NCT00222105|12090353|FG000|Overall Study|Death|2
7673988|NCT00222729|12090366|FG000|Overall Study|Adverse Event|3
7673989|NCT00223080|12090372|FG000|Overall Study|Withdrawal by Subject|253
7673990|NCT00223080|12090373|FG001|Overall Study|Withdrawal by Subject|232
7673991|NCT00223080|12090372|FG000|Overall Study|Required contraindicated med|0
7673992|NCT00223080|12090373|FG001|Overall Study|Required contraindicated med|1
7673993|NCT00223080|12090372|FG000|Overall Study|Non-compliant|7
7673994|NCT00223080|12090373|FG001|Overall Study|Non-compliant|7
7673995|NCT00223080|12090372|FG000|Overall Study|Moved from study area|37
7673996|NCT00223080|12090373|FG001|Overall Study|Moved from study area|47
7673997|NCT00223080|12090372|FG000|Overall Study|Lost to Follow-up|259
7673998|NCT00223080|12090373|FG001|Overall Study|Lost to Follow-up|284
7673999|NCT00223080|12090372|FG000|Overall Study|Death|85
7674000|NCT00223080|12090373|FG001|Overall Study|Death|74
7674001|NCT00223080|12090372|FG000|Overall Study|Other|14
7674002|NCT00223080|12090373|FG001|Overall Study|Other|11
7674003|NCT00223080|12090372|FG000|Overall Study|Reason not provided|141
7674004|NCT00223080|12090373|FG001|Overall Study|Reason not provided|140
7674005|NCT00223080|12090372|FG000|Overall Study|Adverse Event|0
7674006|NCT00223080|12090373|FG001|Overall Study|Adverse Event|1
7674007|NCT00223496|12090397|FG000|Overall Study|screen failure|9
7674008|NCT00223496|12090397|FG000|Overall Study|Lost to Follow-up|4
7674009|NCT00223496|12090397|FG000|Overall Study|Lack of Efficacy|6
7674010|NCT00223496|12090397|FG000|Overall Study|Withdrawal by Subject|1
7674011|NCT00223496|12090397|FG000|Overall Study|Physician Decision|2
7674012|NCT00223795|12090438|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7
7674013|NCT00223795|12090439|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9
7674014|NCT00223795|12090438|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
7674015|NCT00223795|12090439|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
7674016|NCT00223808|12090449|FG000|Overall Study|<5 hrs therapy before discharge|3
7674017|NCT00223808|12090450|FG001|Overall Study|<5 hrs therapy before discharge|5
7674018|NCT00223808|12090451|FG002|Overall Study|<5 hrs therapy before discharge|5
7674019|NCT00223977|12090471|FG000|Overall Study|Adverse Event|7
7674020|NCT00223977|12090472|FG001|Overall Study|Adverse Event|10
7674021|NCT00223977|12090473|FG002|Overall Study|Adverse Event|0
7674022|NCT00223977|12090471|FG000|Overall Study|Protocol Violation|0
7674023|NCT00223977|12090472|FG001|Overall Study|Protocol Violation|0
7674024|NCT00223977|12090473|FG002|Overall Study|Protocol Violation|1
7674025|NCT00223977|12090471|FG000|Overall Study|Withdrawal by Subject|1
7674026|NCT00223977|12090472|FG001|Overall Study|Withdrawal by Subject|1
7674027|NCT00223977|12090473|FG002|Overall Study|Withdrawal by Subject|2
7674028|NCT00223977|12090471|FG000|Overall Study|Other|1
7674029|NCT00223977|12090472|FG001|Overall Study|Other|0
7674030|NCT00223977|12090473|FG002|Overall Study|Other|0
7674031|NCT00223990|12090483|FG000|Overall Study|Moved from area|2
7674032|NCT00223990|12090484|FG001|Overall Study|Moved from area|1
7674033|NCT00223990|12090483|FG000|Overall Study|Withdrawal by Subject|4
7674034|NCT00223990|12090484|FG001|Overall Study|Withdrawal by Subject|8
7674035|NCT00223990|12090483|FG000|Overall Study|Lost to Follow-up|1
7674036|NCT00223990|12090484|FG001|Overall Study|Lost to Follow-up|0
7674037|NCT00224016|12090492|FG000|Titration Period|Withdrawal by Subject|0
7674038|NCT00224016|12090493|FG001|Titration Period|Withdrawal by Subject|1
7674039|NCT00224016|12090492|FG000|Titration Period|Lost to Follow-up|1
7674040|NCT00224016|12090493|FG001|Titration Period|Lost to Follow-up|0
7674041|NCT00224016|12090492|FG000|Maintenance Period|Withdrawal by Subject|2
7674042|NCT00224016|12090493|FG001|Maintenance Period|Withdrawal by Subject|0
7674043|NCT00224016|12090492|FG000|Maintenance Period|Lost to Follow-up|0
7674044|NCT00224016|12090493|FG001|Maintenance Period|Lost to Follow-up|1
7674045|NCT00224029|12090499|FG000|Overall Study|Lost to Follow-up|1
7674046|NCT00224029|12090499|FG000|Overall Study|Withdrawal by Subject|4
7674047|NCT00224029|12090499|FG000|Overall Study|Other|1
7674048|NCT00224042|12090505|FG000|Overall Study|Adverse Event|2
7674049|NCT00224042|12090506|FG001|Overall Study|Adverse Event|1
7674050|NCT00224042|12090505|FG000|Overall Study|Protocol Violation|0
7674051|NCT00224042|12090506|FG001|Overall Study|Protocol Violation|1
7674052|NCT00224042|12090505|FG000|Overall Study|Physician Decision|0
7674053|NCT00224042|12090506|FG001|Overall Study|Physician Decision|1
7674054|NCT00224042|12090505|FG000|Overall Study|Did not meet lab incusion criteria|2
7674055|NCT00224042|12090506|FG001|Overall Study|Did not meet lab incusion criteria|3
7674056|NCT00224042|12090505|FG000|Overall Study|Other|2
7674057|NCT00224042|12090506|FG001|Overall Study|Other|0
7674058|NCT00224055|12090514|FG000|Overall Study|Adverse Event|9
7674059|NCT00224055|12090515|FG001|Overall Study|Adverse Event|3
7674060|NCT00224055|12090514|FG000|Overall Study|Lost to Follow-up|1
7674061|NCT00224055|12090515|FG001|Overall Study|Lost to Follow-up|2
7674062|NCT00224055|12090514|FG000|Overall Study|Protocol Violation|1
7674063|NCT00224055|12090515|FG001|Overall Study|Protocol Violation|1
7674064|NCT00224055|12090514|FG000|Overall Study|Inclusion Violation|3
7674065|NCT00224055|12090515|FG001|Overall Study|Inclusion Violation|6
7674066|NCT00224055|12090514|FG000|Overall Study|Withdrawal by Subject|0
7674067|NCT00224055|12090515|FG001|Overall Study|Withdrawal by Subject|2
7674068|NCT00224055|12090514|FG000|Overall Study|Other|1
7674069|NCT00224055|12090515|FG001|Overall Study|Other|0
7674070|NCT00224107|12090523|FG000|Overall Study|Adverse Event|20
7674071|NCT00224107|12090524|FG001|Overall Study|Adverse Event|6
7674072|NCT00224107|12090523|FG000|Overall Study|Protocol Violation|2
7674073|NCT00224107|12090524|FG001|Overall Study|Protocol Violation|3
7674074|NCT00224107|12090523|FG000|Overall Study|Withdrawal by Subject|1
7674075|NCT00224107|12090524|FG001|Overall Study|Withdrawal by Subject|4
7674076|NCT00224107|12090523|FG000|Overall Study|Lack of Efficacy|2
7674077|NCT00224107|12090524|FG001|Overall Study|Lack of Efficacy|0
7674078|NCT00224107|12090523|FG000|Overall Study|Lost to Follow-up|4
7674079|NCT00224107|12090524|FG001|Overall Study|Lost to Follow-up|0
7674080|NCT00224107|12090523|FG000|Overall Study|Physician Decision|1
7674081|NCT00224107|12090524|FG001|Overall Study|Physician Decision|0
7674082|NCT00224107|12090523|FG000|Overall Study|Other|1
7674083|NCT00224107|12090524|FG001|Overall Study|Other|1
7674084|NCT00224120|12090532|FG000|Overall Study|Adverse Event|10
7674085|NCT00224120|12090533|FG001|Overall Study|Adverse Event|4
7674086|NCT00224120|12090532|FG000|Overall Study|Protocol Violation|1
7674087|NCT00224120|12090533|FG001|Overall Study|Protocol Violation|0
7674088|NCT00224120|12090532|FG000|Overall Study|Withdrawal by Subject|5
7674089|NCT00224120|12090533|FG001|Overall Study|Withdrawal by Subject|10
7674090|NCT00224120|12090532|FG000|Overall Study|Lack of Efficacy|0
7674091|NCT00224120|12090533|FG001|Overall Study|Lack of Efficacy|2
7674092|NCT00224120|12090532|FG000|Overall Study|Lost to Follow-up|2
7674093|NCT00224120|12090533|FG001|Overall Study|Lost to Follow-up|3
7674094|NCT00224120|12090532|FG000|Overall Study|Other|4
7674095|NCT00224120|12090533|FG001|Overall Study|Other|5
7674096|NCT00224133|12090539|FG000|Overall Study|Adverse Event|93
7674097|NCT00224133|12090539|FG000|Overall Study|Protocol Violation|6
7674098|NCT00224133|12090539|FG000|Overall Study|Withdrawal by Subject|33
7674099|NCT00224133|12090539|FG000|Overall Study|Lack of Efficacy|58
7674100|NCT00224133|12090539|FG000|Overall Study|Lost to Follow-up|21
7674101|NCT00224133|12090539|FG000|Overall Study|Physician Decision|1
7674102|NCT00224133|12090539|FG000|Overall Study|Other|14
7674103|NCT00224484|12090550|FG000|Overall Study|Serious Adverse Event|1
7674104|NCT00224484|12090551|FG001|Overall Study|Serious Adverse Event|1
7674105|NCT00224484|12090552|FG002|Overall Study|Serious Adverse Event|0
7674106|NCT00224484|12090550|FG000|Overall Study|Non-Serious Adverse Event|5
7674107|NCT00224484|12090551|FG001|Overall Study|Non-Serious Adverse Event|7
7674108|NCT00224484|12090552|FG002|Overall Study|Non-Serious Adverse Event|3
7674109|NCT00224484|12090550|FG000|Overall Study|Protocol Violation|2
7674110|NCT00224484|12090551|FG001|Overall Study|Protocol Violation|2
7674111|NCT00224484|12090552|FG002|Overall Study|Protocol Violation|0
7674112|NCT00224484|12090550|FG000|Overall Study|Withdrawal by Subject|49
7674113|NCT00224484|12090551|FG001|Overall Study|Withdrawal by Subject|18
7674114|NCT00224484|12090552|FG002|Overall Study|Withdrawal by Subject|16
7674115|NCT00224484|12090550|FG000|Overall Study|Migrated/moved from study area|18
7674116|NCT00224484|12090551|FG001|Overall Study|Migrated/moved from study area|5
7674117|NCT00224484|12090552|FG002|Overall Study|Migrated/moved from study area|5
7674118|NCT00224484|12090550|FG000|Overall Study|Lost to Follow-up|66
7674119|NCT00224484|12090551|FG001|Overall Study|Lost to Follow-up|28
7674120|NCT00224484|12090552|FG002|Overall Study|Lost to Follow-up|36
7674121|NCT00224484|12090550|FG000|Overall Study|Reason not specified|5
7674122|NCT00224484|12090551|FG001|Overall Study|Reason not specified|4
7674123|NCT00224484|12090552|FG002|Overall Study|Reason not specified|2
7674124|NCT00224770|12090566|FG000|Overall Study|Lost to Follow-up|4
7674125|NCT00224770|12090567|FG001|Overall Study|Lost to Follow-up|2
7674126|NCT00224770|12090568|FG002|Overall Study|Lost to Follow-up|0
7674127|NCT00224874|12090581|FG000|Overall Study|Withdrawal by Subject|0
7674128|NCT00224874|12090582|FG001|Overall Study|Withdrawal by Subject|0
7674129|NCT00224874|12090583|FG002|Overall Study|Withdrawal by Subject|1
7674130|NCT00224874|12090584|FG003|Overall Study|Withdrawal by Subject|0
7674131|NCT00224887|12090596|FG000|Overall Study|Pregnancy|6
7674132|NCT00224887|12090597|FG001|Overall Study|Pregnancy|6
7674133|NCT00225147|12090630|FG000|Open-label Phase|Lost to Follow-up|0
7674134|NCT00225147|12090631|FG001|Open-label Phase|Lost to Follow-up|0
7674135|NCT00225147|12090632|FG002|Open-label Phase|Lost to Follow-up|0
7674136|NCT00225147|12090633|FG003|Open-label Phase|Lost to Follow-up|4
7674137|NCT00225147|12090630|FG000|Open-label Phase|Withdrawal by Subject|0
7674138|NCT00225147|12090631|FG001|Open-label Phase|Withdrawal by Subject|0
7674139|NCT00225147|12090632|FG002|Open-label Phase|Withdrawal by Subject|0
7674140|NCT00225147|12090633|FG003|Open-label Phase|Withdrawal by Subject|6
7674141|NCT00225212|12090645|FG000|Overall Study|Disease progression|2
7674142|NCT00225212|12090645|FG000|Overall Study|Death|1
7674143|NCT00225212|12090645|FG000|Overall Study|Adverse Event|2
7674144|NCT00225212|12090645|FG000|Overall Study|Intercurrent illness|1
7674145|NCT00225251|12090651|FG000|Overall Study|Withdrawal by Subject|1
7674146|NCT00225251|12090652|FG001|Overall Study|Withdrawal by Subject|1
7674147|NCT00225277|12090660|FG000|Overall Study|Adverse Event|30
7674148|NCT00225277|12090661|FG001|Overall Study|Adverse Event|34
7674149|NCT00225277|12090660|FG000|Overall Study|Lack of Efficacy|4
7674150|NCT00225277|12090661|FG001|Overall Study|Lack of Efficacy|1
7674151|NCT00225277|12090660|FG000|Overall Study|Lost to Follow-up|4
7674152|NCT00225277|12090661|FG001|Overall Study|Lost to Follow-up|6
7674153|NCT00225277|12090660|FG000|Overall Study|Physician Decision|6
7674154|NCT00225277|12090661|FG001|Overall Study|Physician Decision|8
7674155|NCT00225277|12090660|FG000|Overall Study|Protocol Violation|6
7674156|NCT00225277|12090661|FG001|Overall Study|Protocol Violation|3
7674157|NCT00225277|12090660|FG000|Overall Study|Withdrawal by Subject|40
7674158|NCT00225277|12090661|FG001|Overall Study|Withdrawal by Subject|34
7674159|NCT00225277|12090660|FG000|Overall Study|Other|7
7674160|NCT00225277|12090661|FG001|Overall Study|Other|9
7674161|NCT00225758|12090689|FG000|Overall Study|Adverse Event|4
7674162|NCT00226499|12090710|FG000|Overall Study|Adverse Event|10
7674163|NCT00226499|12090711|FG001|Overall Study|Adverse Event|6
7674164|NCT00226499|12090712|FG002|Overall Study|Adverse Event|3
7674165|NCT00226499|12090710|FG000|Overall Study|Others|1064
7674166|NCT00226499|12090711|FG001|Overall Study|Others|1066
7674167|NCT00226499|12090712|FG002|Overall Study|Others|356
7674168|NCT00226655|12090731|FG000|Overall Study|Death|13
7674169|NCT00226655|12090731|FG000|Overall Study|Withdrawal by Subject|15
7674170|NCT00226655|12090731|FG000|Overall Study|Adverse Event|35
7674171|NCT00226655|12090731|FG000|Overall Study|Physician Decision|6
7674172|NCT00226655|12090731|FG000|Overall Study|Clinical deterioration|10
7674173|NCT00226811|12090735|FG000|Overall Study|Death|8
7674174|NCT00226811|12090735|FG000|Overall Study|Adverse Event|11
7674175|NCT00226811|12090735|FG000|Overall Study|Lack of Efficacy|55
7674176|NCT00226811|12090735|FG000|Overall Study|Withdrawal by Subject|2
7674177|NCT00226941|12090743|FG000|Overall Study|Withdrawal by subject - toxicity|0
7674178|NCT00226941|12090744|FG001|Overall Study|Withdrawal by subject - toxicity|0
7674179|NCT00226941|12090745|FG002|Overall Study|Withdrawal by subject - toxicity|0
7674180|NCT00226941|12090746|FG003|Overall Study|Withdrawal by subject - toxicity|1
7674181|NCT00226941|12090743|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0
7674182|NCT00226941|12090744|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0
7674183|NCT00226941|12090745|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0
7674184|NCT00226941|12090746|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1
7674185|NCT00227266|12090770|FG000|Overall Study|Withdrawal by Subject|0
7674186|NCT00227266|12090771|FG001|Overall Study|Withdrawal by Subject|0
7674187|NCT00227266|12090772|FG002|Overall Study|Withdrawal by Subject|1
7674188|NCT00227266|12090770|FG000|Overall Study|Protocol Violation|1
7674189|NCT00227266|12090771|FG001|Overall Study|Protocol Violation|0
7674190|NCT00227266|12090772|FG002|Overall Study|Protocol Violation|1
7674191|NCT00227266|12090770|FG000|Overall Study|Excessive weight gain|0
7674192|NCT00227266|12090771|FG001|Overall Study|Excessive weight gain|0
7674193|NCT00227266|12090772|FG002|Overall Study|Excessive weight gain|2
7674194|NCT00227305|12090783|FG000|Overall Study|Adverse Event|40
7674195|NCT00227305|12090783|FG000|Overall Study|Withdrawal by Subject|42
7674196|NCT00227305|12090783|FG000|Overall Study|Lost to Follow-up|33
7674197|NCT00227305|12090783|FG000|Overall Study|Study specific discontinuation|13
7674198|NCT00227305|12090783|FG000|Overall Study|MOVED OUT OF AREA|3
7674199|NCT00227305|12090783|FG000|Overall Study|Lack of Efficacy|7
7674200|NCT00227305|12090783|FG000|Overall Study|Physician Decision|3
7674201|NCT00227305|12090783|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
7674202|NCT00227305|12090783|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
7674203|NCT00227305|12090783|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
7674204|NCT00227344|12090789|FG000|Overall Study|study terminated early|12
7674205|NCT00227344|12090790|FG001|Overall Study|study terminated early|5
7674206|NCT00227370|12090798|FG000|Overall Study|Withdrawal by Subject|1
7674207|NCT00227370|12090799|FG001|Overall Study|Withdrawal by Subject|2
7674208|NCT00227370|12090798|FG000|Overall Study|Death|3
7674209|NCT00227370|12090799|FG001|Overall Study|Death|4
7674210|NCT00227370|12090798|FG000|Overall Study|Adverse Event|6
7674211|NCT00227370|12090799|FG001|Overall Study|Adverse Event|11
7674212|NCT00227370|12090798|FG000|Overall Study|Physician Decision|9
7674213|NCT00227370|12090799|FG001|Overall Study|Physician Decision|6
7674214|NCT00227370|12090798|FG000|Overall Study|Other reasons|2
7674215|NCT00227370|12090799|FG001|Overall Study|Other reasons|1
7674216|NCT00227539|12090805|FG000|Overall Study|Protocol Violation|1
7674217|NCT00227591|12090809|FG000|Overall Study|Withdrawal by Subject|1
7674218|NCT00227721|12090827|FG000|Overall Study|On study, but never treated.|1
7674219|NCT00227877|12090839|FG000|Pre-visit Assessment|Technical difficulties|7
7674220|NCT00227877|12090840|FG001|Pre-visit Assessment|Technical difficulties|3
7674221|NCT00227877|12090841|FG002|Pre-visit Assessment|Technical difficulties|0
7674222|NCT00227877|12090842|FG003|Pre-visit Assessment|Technical difficulties|0
7674223|NCT00227877|12090839|FG000|Post-visit Checklist|Lost to Follow-up|24
7674224|NCT00227877|12090840|FG001|Post-visit Checklist|Lost to Follow-up|13
7674225|NCT00227877|12090841|FG002|Post-visit Checklist|Lost to Follow-up|1
7674226|NCT00227877|12090842|FG003|Post-visit Checklist|Lost to Follow-up|0
7674227|NCT00227877|12090839|FG000|3-months Follow-up|Completed late|135
7674228|NCT00227877|12090840|FG001|3-months Follow-up|Completed late|128
7674229|NCT00227877|12090841|FG002|3-months Follow-up|Completed late|34
7674230|NCT00227877|12090842|FG003|3-months Follow-up|Completed late|8
7674231|NCT00227877|12090839|FG000|3-months Follow-up|Lost to Follow-up|178
7674232|NCT00227877|12090840|FG001|3-months Follow-up|Lost to Follow-up|139
7674233|NCT00227877|12090841|FG002|3-months Follow-up|Lost to Follow-up|18
7674234|NCT00227877|12090842|FG003|3-months Follow-up|Lost to Follow-up|13
7674235|NCT00227877|12090839|FG000|12-months Follow-up|Completed late|78
7674236|NCT00227877|12090840|FG001|12-months Follow-up|Completed late|74
7674237|NCT00227877|12090841|FG002|12-months Follow-up|Completed late|1
7674238|NCT00227877|12090842|FG003|12-months Follow-up|Completed late|0
7674239|NCT00227877|12090839|FG000|12-months Follow-up|Lost to Follow-up|232
7674240|NCT00227877|12090840|FG001|12-months Follow-up|Lost to Follow-up|189
7674241|NCT00227877|12090841|FG002|12-months Follow-up|Lost to Follow-up|30
7674242|NCT00227877|12090842|FG003|12-months Follow-up|Lost to Follow-up|26
7674243|NCT00227903|12090856|FG000|Overall Study|Withdrawal by Subject|2
7674244|NCT00227903|12090857|FG001|Overall Study|Withdrawal by Subject|5
7674245|NCT00227903|12090856|FG000|Overall Study|Subject moved out of area|1
7674246|NCT00227903|12090857|FG001|Overall Study|Subject moved out of area|2
7674247|NCT00227903|12090856|FG000|Overall Study|Lost to Follow-up|1
7674248|NCT00227903|12090857|FG001|Overall Study|Lost to Follow-up|3
7674249|NCT00227903|12090856|FG000|Overall Study|Miscarriage|1
7674250|NCT00227903|12090857|FG001|Overall Study|Miscarriage|0
7674251|NCT00228384|12090874|FG000|Overall Study|Death|9
7674252|NCT00228384|12090875|FG001|Overall Study|Death|3
7674253|NCT00228384|12090874|FG000|Overall Study|Lost to Follow-up|6
7674254|NCT00228384|12090875|FG001|Overall Study|Lost to Follow-up|10
7674255|NCT00228384|12090874|FG000|Overall Study|Surgical Intervention (bypass)|5
7674256|NCT00228384|12090875|FG001|Overall Study|Surgical Intervention (bypass)|5
7674257|NCT00228384|12090874|FG000|Overall Study|Withdrawal by Subject|9
7674258|NCT00228384|12090875|FG001|Overall Study|Withdrawal by Subject|10
7674259|NCT00228384|12090874|FG000|Overall Study|Physician Decision|0
7674260|NCT00228384|12090875|FG001|Overall Study|Physician Decision|1
7674261|NCT00228423|12090883|FG000|Overall Study|Adverse Event|2
7674262|NCT00228423|12090884|FG001|Overall Study|Adverse Event|5
7674263|NCT00228423|12090883|FG000|Overall Study|Withdrawal by Subject|7
7674264|NCT00228423|12090884|FG001|Overall Study|Withdrawal by Subject|3
7674265|NCT00228423|12090883|FG000|Overall Study|Protocol Violation|1
7674266|NCT00228423|12090884|FG001|Overall Study|Protocol Violation|3
7674267|NCT00228423|12090883|FG000|Overall Study|Physician Decision|0
7674268|NCT00228423|12090884|FG001|Overall Study|Physician Decision|1
7674269|NCT00228553|12090890|FG000|Overall Study|Adverse Event|112
7674270|NCT00228553|12090890|FG000|Overall Study|Lack of Efficacy|34
7674271|NCT00228553|12090890|FG000|Overall Study|Lost to Follow-up|67
7674272|NCT00228553|12090890|FG000|Overall Study|Physician Decision|48
7674273|NCT00228553|12090890|FG000|Overall Study|Protocol Violation|6
7674274|NCT00228553|12090890|FG000|Overall Study|Withdrawal by Subject|115
7674275|NCT00228553|12090890|FG000|Overall Study|Pregnancy|2
7674276|NCT00228553|12090890|FG000|Overall Study|Miscellaneous|46
7674277|NCT00228566|12090894|FG000|Overall Study|Adverse Event|31
7674278|NCT00228566|12090894|FG000|Overall Study|Lack of Efficacy|14
7674279|NCT00228566|12090894|FG000|Overall Study|Lost to Follow-up|16
7674280|NCT00228566|12090894|FG000|Overall Study|Physician Decision|5
7674281|NCT00228566|12090894|FG000|Overall Study|Withdrawal by Subject|4
7674282|NCT00228566|12090894|FG000|Overall Study|Miscellaneous|1
7674283|NCT00228813|12090898|FG000|Overall Study|Death|4
7674284|NCT00228917|12090910|FG000|Overall Study|Migrated/moved from study area|0
7674285|NCT00228917|12090911|FG001|Overall Study|Migrated/moved from study area|0
7674286|NCT00228917|12090912|FG002|Overall Study|Migrated/moved from study area|0
7674287|NCT00228917|12090913|FG003|Overall Study|Migrated/moved from study area|0
7674288|NCT00228917|12090914|FG004|Overall Study|Migrated/moved from study area|0
7674289|NCT00228917|12090915|FG005|Overall Study|Migrated/moved from study area|2
7674290|NCT00228917|12090916|FG006|Overall Study|Migrated/moved from study area|0
7674291|NCT00228917|12090917|FG007|Overall Study|Migrated/moved from study area|0
7674292|NCT00229203|12090939|FG000|Overall Study|Progressive disease|18
7674293|NCT00229203|12090940|FG001|Overall Study|Progressive disease|9
7674294|NCT00229203|12090939|FG000|Overall Study|Toxicity|6
7674295|NCT00229203|12090940|FG001|Overall Study|Toxicity|1
7674296|NCT00229203|12090939|FG000|Overall Study|Death|4
7674297|NCT00229203|12090940|FG001|Overall Study|Death|2
7674298|NCT00229203|12090939|FG000|Overall Study|Other|3
7674299|NCT00229203|12090940|FG001|Overall Study|Other|3
7674300|NCT00229203|12090939|FG000|Overall Study|Withdrawal by Subject|1
7674301|NCT00229203|12090940|FG001|Overall Study|Withdrawal by Subject|4
7674302|NCT00229658|12090954|FG000|Overall Study|Administrative|2
7674303|NCT00229658|12090955|FG001|Overall Study|Administrative|1
7674304|NCT00229658|12090954|FG000|Overall Study|Investigator decision|13
7674305|NCT00229658|12090955|FG001|Overall Study|Investigator decision|10
7674306|NCT00229658|12090954|FG000|Overall Study|Other|80
7674307|NCT00229658|12090955|FG001|Overall Study|Other|60
7674308|NCT00229658|12090954|FG000|Overall Study|Lost to Follow-up|82
7674309|NCT00229658|12090955|FG001|Overall Study|Lost to Follow-up|55
7674310|NCT00229658|12090954|FG000|Overall Study|Serious Adverse Event|2
7674311|NCT00229658|12090955|FG001|Overall Study|Serious Adverse Event|2
7674312|NCT00229658|12090954|FG000|Overall Study|Withdrawal of consent|46
7674313|NCT00229658|12090955|FG001|Overall Study|Withdrawal of consent|39
7674314|NCT00229723|12090968|FG000|Concomitant Phase|Adverse Event|4
7674315|NCT00229723|12090969|FG001|Concomitant Phase|Adverse Event|2
7674316|NCT00229723|12090970|FG002|Concomitant Phase|Adverse Event|5
7674317|NCT00229723|12090971|FG003|Concomitant Phase|Adverse Event|2
7674318|NCT00229723|12090972|FG004|Concomitant Phase|Adverse Event|0
7674319|NCT00229723|12090973|FG005|Concomitant Phase|Adverse Event|1
7674320|NCT00229723|12090974|FG006|Concomitant Phase|Adverse Event|2
7674321|NCT00229723|12090968|FG000|Concomitant Phase|Objective disease progression|0
7674322|NCT00229723|12090969|FG001|Concomitant Phase|Objective disease progression|0
7674323|NCT00229723|12090970|FG002|Concomitant Phase|Objective disease progression|0
7674324|NCT00229723|12090971|FG003|Concomitant Phase|Objective disease progression|0
7674325|NCT00229723|12090972|FG004|Concomitant Phase|Objective disease progression|0
7674326|NCT00229723|12090973|FG005|Concomitant Phase|Objective disease progression|0
7674327|NCT00229723|12090974|FG006|Concomitant Phase|Objective disease progression|0
7674328|NCT00229723|12090968|FG000|Concomitant Phase|Clinical progression|0
7674329|NCT00229723|12090969|FG001|Concomitant Phase|Clinical progression|0
7674330|NCT00229723|12090970|FG002|Concomitant Phase|Clinical progression|0
7674331|NCT00229723|12090971|FG003|Concomitant Phase|Clinical progression|0
7674332|NCT00229723|12090972|FG004|Concomitant Phase|Clinical progression|0
7674333|NCT00229723|12090973|FG005|Concomitant Phase|Clinical progression|0
7674334|NCT00229723|12090974|FG006|Concomitant Phase|Clinical progression|1
7674335|NCT00229723|12090968|FG000|Concomitant Phase|Lost to Follow-up|0
7674336|NCT00229723|12090969|FG001|Concomitant Phase|Lost to Follow-up|0
7674337|NCT00229723|12090970|FG002|Concomitant Phase|Lost to Follow-up|0
7674338|NCT00229723|12090971|FG003|Concomitant Phase|Lost to Follow-up|0
7674339|NCT00229723|12090972|FG004|Concomitant Phase|Lost to Follow-up|1
7674340|NCT00229723|12090973|FG005|Concomitant Phase|Lost to Follow-up|0
7674341|NCT00229723|12090974|FG006|Concomitant Phase|Lost to Follow-up|0
7674342|NCT00229723|12090968|FG000|Concomitant Phase|Informed consent withdrawn|3
7674343|NCT00229723|12090969|FG001|Concomitant Phase|Informed consent withdrawn|2
7674344|NCT00229723|12090970|FG002|Concomitant Phase|Informed consent withdrawn|0
7674345|NCT00229723|12090971|FG003|Concomitant Phase|Informed consent withdrawn|2
7674346|NCT00229723|12090972|FG004|Concomitant Phase|Informed consent withdrawn|0
7674347|NCT00229723|12090973|FG005|Concomitant Phase|Informed consent withdrawn|0
7674348|NCT00229723|12090974|FG006|Concomitant Phase|Informed consent withdrawn|0
7674349|NCT00229723|12090968|FG000|Concomitant Phase|Severe non-compliance|0
7674350|NCT00229723|12090969|FG001|Concomitant Phase|Severe non-compliance|1
7674351|NCT00229723|12090970|FG002|Concomitant Phase|Severe non-compliance|0
7674352|NCT00229723|12090971|FG003|Concomitant Phase|Severe non-compliance|0
7674353|NCT00229723|12090972|FG004|Concomitant Phase|Severe non-compliance|1
7674354|NCT00229723|12090973|FG005|Concomitant Phase|Severe non-compliance|0
7674355|NCT00229723|12090974|FG006|Concomitant Phase|Severe non-compliance|0
7674356|NCT00229723|12090968|FG000|Concomitant Phase|Other|3
7674357|NCT00229723|12090969|FG001|Concomitant Phase|Other|0
7674358|NCT00229723|12090970|FG002|Concomitant Phase|Other|1
7674359|NCT00229723|12090971|FG003|Concomitant Phase|Other|1
7674360|NCT00229723|12090972|FG004|Concomitant Phase|Other|0
7674361|NCT00229723|12090973|FG005|Concomitant Phase|Other|2
7674362|NCT00229723|12090974|FG006|Concomitant Phase|Other|0
7674363|NCT00229723|12090968|FG000|Maintenance Phase|Adverse Event|7
7674364|NCT00229723|12090969|FG001|Maintenance Phase|Adverse Event|2
7674365|NCT00229723|12090970|FG002|Maintenance Phase|Adverse Event|1
7674366|NCT00229723|12090971|FG003|Maintenance Phase|Adverse Event|4
7674367|NCT00229723|12090972|FG004|Maintenance Phase|Adverse Event|7
7674368|NCT00229723|12090973|FG005|Maintenance Phase|Adverse Event|5
7674369|NCT00229723|12090974|FG006|Maintenance Phase|Adverse Event|2
7674370|NCT00229723|12090968|FG000|Maintenance Phase|Objective disease progression|5
7674371|NCT00229723|12090969|FG001|Maintenance Phase|Objective disease progression|5
7674372|NCT00229723|12090970|FG002|Maintenance Phase|Objective disease progression|3
7674373|NCT00229723|12090971|FG003|Maintenance Phase|Objective disease progression|6
7674374|NCT00229723|12090972|FG004|Maintenance Phase|Objective disease progression|2
7674375|NCT00229723|12090973|FG005|Maintenance Phase|Objective disease progression|9
7674376|NCT00229723|12090974|FG006|Maintenance Phase|Objective disease progression|5
7674377|NCT00229723|12090968|FG000|Maintenance Phase|Clinical progression|4
7674378|NCT00229723|12090969|FG001|Maintenance Phase|Clinical progression|1
7674379|NCT00229723|12090970|FG002|Maintenance Phase|Clinical progression|2
7674380|NCT00229723|12090971|FG003|Maintenance Phase|Clinical progression|2
7674381|NCT00229723|12090972|FG004|Maintenance Phase|Clinical progression|1
7674382|NCT00229723|12090973|FG005|Maintenance Phase|Clinical progression|1
7674383|NCT00229723|12090974|FG006|Maintenance Phase|Clinical progression|1
7674384|NCT00229723|12090968|FG000|Maintenance Phase|Lost to Follow-up|0
7674385|NCT00229723|12090969|FG001|Maintenance Phase|Lost to Follow-up|1
7674386|NCT00229723|12090970|FG002|Maintenance Phase|Lost to Follow-up|2
7674387|NCT00229723|12090971|FG003|Maintenance Phase|Lost to Follow-up|2
7674388|NCT00229723|12090972|FG004|Maintenance Phase|Lost to Follow-up|0
7674389|NCT00229723|12090973|FG005|Maintenance Phase|Lost to Follow-up|0
7674390|NCT00229723|12090974|FG006|Maintenance Phase|Lost to Follow-up|1
7674391|NCT00229723|12090968|FG000|Maintenance Phase|Informed consent withdrawn|1
7674392|NCT00229723|12090969|FG001|Maintenance Phase|Informed consent withdrawn|0
7674393|NCT00229723|12090970|FG002|Maintenance Phase|Informed consent withdrawn|0
7674394|NCT00229723|12090971|FG003|Maintenance Phase|Informed consent withdrawn|1
7674395|NCT00229723|12090972|FG004|Maintenance Phase|Informed consent withdrawn|1
7674396|NCT00229723|12090973|FG005|Maintenance Phase|Informed consent withdrawn|1
7674397|NCT00229723|12090974|FG006|Maintenance Phase|Informed consent withdrawn|0
7674398|NCT00229723|12090968|FG000|Maintenance Phase|Severe non-compliance|3
7674399|NCT00229723|12090969|FG001|Maintenance Phase|Severe non-compliance|1
7674400|NCT00229723|12090970|FG002|Maintenance Phase|Severe non-compliance|0
7674401|NCT00229723|12090971|FG003|Maintenance Phase|Severe non-compliance|0
7674402|NCT00229723|12090972|FG004|Maintenance Phase|Severe non-compliance|1
7674403|NCT00229723|12090973|FG005|Maintenance Phase|Severe non-compliance|0
7674404|NCT00229723|12090974|FG006|Maintenance Phase|Severe non-compliance|0
7674405|NCT00229723|12090968|FG000|Maintenance Phase|Other|5
7674406|NCT00229723|12090969|FG001|Maintenance Phase|Other|4
7674407|NCT00229723|12090970|FG002|Maintenance Phase|Other|1
7674408|NCT00229723|12090971|FG003|Maintenance Phase|Other|2
7674409|NCT00229723|12090972|FG004|Maintenance Phase|Other|3
7674410|NCT00229723|12090973|FG005|Maintenance Phase|Other|3
7674411|NCT00229723|12090974|FG006|Maintenance Phase|Other|1
7674412|NCT00230048|12091019|FG000|Overall Study|Lost to Follow-up|13
7674413|NCT00230048|12091020|FG001|Overall Study|Lost to Follow-up|18
7674414|NCT00230178|12091051|FG000|Overall Study|Adverse Event|1
7674415|NCT00230178|12091052|FG001|Overall Study|Adverse Event|5
7674416|NCT00230178|12091053|FG002|Overall Study|Adverse Event|2
7674417|NCT00230178|12091051|FG000|Overall Study|Withdrawal by Subject|0
7674418|NCT00230178|12091052|FG001|Overall Study|Withdrawal by Subject|0
7674419|NCT00230178|12091053|FG002|Overall Study|Withdrawal by Subject|1
7674420|NCT00230178|12091051|FG000|Overall Study|Various other reasons|3
7674421|NCT00230178|12091052|FG001|Overall Study|Various other reasons|2
7674422|NCT00230178|12091053|FG002|Overall Study|Various other reasons|4
7674423|NCT00230282|12091061|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
7674424|NCT00230282|12091061|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
7674425|NCT00230282|12091061|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1
7674426|NCT00230282|12091061|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
7674427|NCT00230971|12091091|FG000|Randomization|No study drug administered|3
7674428|NCT00230971|12091092|FG001|Randomization|No study drug administered|3
7674429|NCT00230971|12091091|FG000|Baseline Participants|Lost to Follow-up|5
7674430|NCT00230971|12091092|FG001|Baseline Participants|Lost to Follow-up|12
7674431|NCT00230971|12091091|FG000|Baseline Participants|Death|6
7674432|NCT00230971|12091092|FG001|Baseline Participants|Death|5
7674433|NCT00230971|12091091|FG000|Baseline Participants|Withdrawal by Subject|7
7674434|NCT00230971|12091092|FG001|Baseline Participants|Withdrawal by Subject|1
7674435|NCT00230971|12091091|FG000|Baseline Participants|Adverse Event|1
7674436|NCT00230971|12091092|FG001|Baseline Participants|Adverse Event|0
7674437|NCT00230971|12091091|FG000|Baseline Participants|No bacteria observed|1
7674438|NCT00230971|12091092|FG001|Baseline Participants|No bacteria observed|0
7674439|NCT00230971|12091091|FG000|Baseline Participants|Failure to return|1
7674440|NCT00230971|12091092|FG001|Baseline Participants|Failure to return|1
7674441|NCT00230971|12091091|FG000|Baseline Participants|Reintervention|1
7674442|NCT00230971|12091092|FG001|Baseline Participants|Reintervention|0
7674443|NCT00231062|12091098|FG000|Overall Study|Physician Decision|6
7674444|NCT00231114|12091104|FG000|Randomized|Withdrawal by Subject|6
7674445|NCT00231114|12091105|FG001|Randomized|Withdrawal by Subject|3
7674446|NCT00231114|12091104|FG000|Treatment Period|Death: Motor Vehicle Accident|1
7674447|NCT00231114|12091105|FG001|Treatment Period|Death: Motor Vehicle Accident|0
7674448|NCT00231114|12091104|FG000|Post-Treatment Period|Lost to Follow-up|6
7674449|NCT00231114|12091105|FG001|Post-Treatment Period|Lost to Follow-up|1
7674450|NCT00231114|12091104|FG000|Post-Treatment Period|Physician Decision|1
7674451|NCT00231114|12091105|FG001|Post-Treatment Period|Physician Decision|0
7674452|NCT00231114|12091104|FG000|Post-Treatment Period|Withdrawal by Subject|1
7674453|NCT00231114|12091105|FG001|Post-Treatment Period|Withdrawal by Subject|0
7674454|NCT00231179|12091115|FG000|Overall Study|Lost to Follow-up|21
7674455|NCT00231179|12091116|FG001|Overall Study|Lost to Follow-up|21
7674456|NCT00231179|12091115|FG000|Overall Study|Withdrawal by Subject|3
7674457|NCT00231179|12091116|FG001|Overall Study|Withdrawal by Subject|3
7674458|NCT00231413|12091138|FG000|Overall Study|Non-serious AE|0
7674459|NCT00231413|12091139|FG001|Overall Study|Non-serious AE|0
7674460|NCT00231413|12091140|FG002|Overall Study|Non-serious AE|1
7674461|NCT00231413|12091141|FG003|Overall Study|Non-serious AE|0
7674462|NCT00231413|12091142|FG004|Overall Study|Non-serious AE|0
7674463|NCT00231413|12091143|FG005|Overall Study|Non-serious AE|0
7674464|NCT00231413|12091144|FG006|Overall Study|Non-serious AE|1
7674465|NCT00231413|12091138|FG000|Overall Study|Withdrawal by Subject|3
7674466|NCT00231413|12091139|FG001|Overall Study|Withdrawal by Subject|1
7674467|NCT00231413|12091140|FG002|Overall Study|Withdrawal by Subject|4
7674468|NCT00231413|12091141|FG003|Overall Study|Withdrawal by Subject|2
7674469|NCT00231413|12091142|FG004|Overall Study|Withdrawal by Subject|2
7674470|NCT00231413|12091143|FG005|Overall Study|Withdrawal by Subject|0
7674471|NCT00231413|12091144|FG006|Overall Study|Withdrawal by Subject|3
7674472|NCT00231413|12091138|FG000|Overall Study|Migrated/moved from study area|0
7674473|NCT00231413|12091139|FG001|Overall Study|Migrated/moved from study area|0
7674474|NCT00231413|12091140|FG002|Overall Study|Migrated/moved from study area|1
7674475|NCT00231413|12091141|FG003|Overall Study|Migrated/moved from study area|0
7674476|NCT00231413|12091142|FG004|Overall Study|Migrated/moved from study area|0
7674477|NCT00231413|12091143|FG005|Overall Study|Migrated/moved from study area|1
7674478|NCT00231413|12091144|FG006|Overall Study|Migrated/moved from study area|0
7674479|NCT00231413|12091138|FG000|Overall Study|Lost to Follow-up|4
7674480|NCT00231413|12091139|FG001|Overall Study|Lost to Follow-up|4
7674481|NCT00231413|12091140|FG002|Overall Study|Lost to Follow-up|1
7674482|NCT00231413|12091141|FG003|Overall Study|Lost to Follow-up|1
7674483|NCT00231413|12091142|FG004|Overall Study|Lost to Follow-up|1
7674484|NCT00231413|12091143|FG005|Overall Study|Lost to Follow-up|4
7674485|NCT00231413|12091144|FG006|Overall Study|Lost to Follow-up|0
7674486|NCT00231413|12091138|FG000|Overall Study|Pregnancy|1
7674487|NCT00231413|12091139|FG001|Overall Study|Pregnancy|0
7674488|NCT00231413|12091140|FG002|Overall Study|Pregnancy|0
7674489|NCT00231413|12091141|FG003|Overall Study|Pregnancy|0
7674490|NCT00231413|12091142|FG004|Overall Study|Pregnancy|0
7674491|NCT00231413|12091143|FG005|Overall Study|Pregnancy|0
7674492|NCT00231413|12091144|FG006|Overall Study|Pregnancy|0
7674493|NCT00231465|12091160|FG000|Overall Study|Completed only one cycle|1
7674494|NCT00231465|12091160|FG000|Overall Study|Did not have follow up CT scans|1
7674495|NCT00231478|12091166|FG000|Overall Study|Protocol Violation|3
7674496|NCT00231478|12091167|FG001|Overall Study|Protocol Violation|2
7674497|NCT00231478|12091166|FG000|Overall Study|Refused Treatment|1
7674498|NCT00231478|12091167|FG001|Overall Study|Refused Treatment|1
7674499|NCT00231478|12091166|FG000|Overall Study|Withdrawal by Subject|1
7674500|NCT00231478|12091167|FG001|Overall Study|Withdrawal by Subject|0
7674501|NCT00231478|12091166|FG000|Overall Study|Adverse Event|0
7674502|NCT00231478|12091167|FG001|Overall Study|Adverse Event|1
7674503|NCT00231478|12091166|FG000|Overall Study|Administrative|3
7674504|NCT00231478|12091167|FG001|Overall Study|Administrative|2
7674505|NCT00231777|12091175|FG000|Overall Study|Lost to Follow-up|3
7674506|NCT00231777|12091176|FG001|Overall Study|Lost to Follow-up|0
7674507|NCT00231777|12091175|FG000|Overall Study|Other|3
7674508|NCT00231777|12091176|FG001|Overall Study|Other|2
7674509|NCT00231816|12091184|FG000|Overall Study|Adverse Event|1
7674510|NCT00231816|12091185|FG001|Overall Study|Adverse Event|0
7674511|NCT00231816|12091184|FG000|Overall Study|Lost to Follow-up|8
7674512|NCT00231816|12091185|FG001|Overall Study|Lost to Follow-up|5
7674513|NCT00231816|12091184|FG000|Overall Study|Protocol Violation|2
7674514|NCT00231816|12091185|FG001|Overall Study|Protocol Violation|3
7674515|NCT00231816|12091184|FG000|Overall Study|Withdrawal by Subject|3
7674516|NCT00231816|12091185|FG001|Overall Study|Withdrawal by Subject|3
7674517|NCT00231816|12091184|FG000|Overall Study|Other|2
7674518|NCT00231816|12091185|FG001|Overall Study|Other|1
7674519|NCT00231842|12091192|FG000|Overall Study|Withdrawal by Subject|3
7674520|NCT00231842|12091192|FG000|Overall Study|Did not complete the last 3 cycle|8
7674521|NCT00231894|12091203|FG000|Overall Study|Withdrawal by Subject|1
7674522|NCT00231894|12091204|FG001|Overall Study|Withdrawal by Subject|1
7674523|NCT00232180|12091218|FG000|Double-blind (DB) Phase|Death|186
7674524|NCT00232180|12091219|FG001|Double-blind (DB) Phase|Death|222
7674525|NCT00232180|12091220|FG002|Double-blind (DB) Phase|Death|0
7674526|NCT00232180|12091218|FG000|Double-blind (DB) Phase|Lost to Follow-up|34
7674527|NCT00232180|12091219|FG001|Double-blind (DB) Phase|Lost to Follow-up|28
7674528|NCT00232180|12091220|FG002|Double-blind (DB) Phase|Lost to Follow-up|0
7674529|NCT00232180|12091218|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131
7674530|NCT00232180|12091219|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148
7674531|NCT00232180|12091220|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0
7674532|NCT00232180|12091218|FG000|Double-blind (DB) Phase|Protocol Violation|28
7674533|NCT00232180|12091219|FG001|Double-blind (DB) Phase|Protocol Violation|21
7674534|NCT00232180|12091220|FG002|Double-blind (DB) Phase|Protocol Violation|0
7674535|NCT00232180|12091218|FG000|Double-blind (DB) Phase|Adverse Event|83
7674536|NCT00232180|12091219|FG001|Double-blind (DB) Phase|Adverse Event|100
7674537|NCT00232180|12091220|FG002|Double-blind (DB) Phase|Adverse Event|0
7674538|NCT00232180|12091218|FG000|Double-blind (DB) Phase|Other|70
7674539|NCT00232180|12091219|FG001|Double-blind (DB) Phase|Other|75
7674540|NCT00232180|12091220|FG002|Double-blind (DB) Phase|Other|0
7674541|NCT00232180|12091218|FG000|Double-blind (DB) Phase|Randomized but not treated|3
7674542|NCT00232180|12091219|FG001|Double-blind (DB) Phase|Randomized but not treated|4
7674543|NCT00232180|12091220|FG002|Double-blind (DB) Phase|Randomized but not treated|0
7674544|NCT00232180|12091218|FG000|Double-blind (DB) Phase|Laboratory abnormality|6
7674545|NCT00232180|12091219|FG001|Double-blind (DB) Phase|Laboratory abnormality|7
7674546|NCT00232180|12091220|FG002|Double-blind (DB) Phase|Laboratory abnormality|0
7674547|NCT00232180|12091218|FG000|Open Label Phase|Death|0
7674548|NCT00232180|12091219|FG001|Open Label Phase|Death|0
7674549|NCT00232180|12091220|FG002|Open Label Phase|Death|48
7674550|NCT00232180|12091218|FG000|Open Label Phase|Lost to Follow-up|0
7674551|NCT00232180|12091219|FG001|Open Label Phase|Lost to Follow-up|0
7674552|NCT00232180|12091220|FG002|Open Label Phase|Lost to Follow-up|5
7674553|NCT00232180|12091218|FG000|Open Label Phase|Protocol Violation|0
7674554|NCT00232180|12091219|FG001|Open Label Phase|Protocol Violation|0
7674555|NCT00232180|12091220|FG002|Open Label Phase|Protocol Violation|3
7674556|NCT00232180|12091218|FG000|Open Label Phase|Study terminated by sponsor|0
7674557|NCT00232180|12091219|FG001|Open Label Phase|Study terminated by sponsor|0
7674558|NCT00232180|12091220|FG002|Open Label Phase|Study terminated by sponsor|3
7674559|NCT00232180|12091218|FG000|Open Label Phase|Withdrawal by Subject|0
7674560|NCT00232180|12091219|FG001|Open Label Phase|Withdrawal by Subject|0
7674561|NCT00232180|12091220|FG002|Open Label Phase|Withdrawal by Subject|37
7674562|NCT00232180|12091218|FG000|Open Label Phase|Other|0
7674563|NCT00232180|12091219|FG001|Open Label Phase|Other|0
7674564|NCT00232180|12091220|FG002|Open Label Phase|Other|16
7674565|NCT00232180|12091218|FG000|Open Label Phase|Adverse Event|0
7674566|NCT00232180|12091219|FG001|Open Label Phase|Adverse Event|0
7674567|NCT00232180|12091220|FG002|Open Label Phase|Adverse Event|25
7674568|NCT00232180|12091218|FG000|Open Label Phase|Laboratory abnormality|0
7674569|NCT00232180|12091219|FG001|Open Label Phase|Laboratory abnormality|0
7674570|NCT00232180|12091220|FG002|Open Label Phase|Laboratory abnormality|10
7674571|NCT00232180|12091218|FG000|Open Label Phase|Randomized but not treated|0
7674572|NCT00232180|12091219|FG001|Open Label Phase|Randomized but not treated|0
7674573|NCT00232180|12091220|FG002|Open Label Phase|Randomized but not treated|1
7674574|NCT00232544|12091249|FG000|Overall Study|Lost to Follow-up|20
7674575|NCT00232544|12091250|FG001|Overall Study|Lost to Follow-up|15
7674576|NCT00232557|12091258|FG000|Overall Study|Lost to Follow-up|3
7674577|NCT00232557|12091259|FG001|Overall Study|Lost to Follow-up|5
7674578|NCT00232596|12091280|FG000|6-Week Titration Phase|Adverse Event|6
7674579|NCT00232596|12091281|FG001|6-Week Titration Phase|Adverse Event|19
7674580|NCT00232596|12091280|FG000|6-Week Titration Phase|Failed to Return|2
7674581|NCT00232596|12091281|FG001|6-Week Titration Phase|Failed to Return|1
7674582|NCT00232596|12091280|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
7674583|NCT00232596|12091281|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
7674584|NCT00232596|12091280|FG000|6-Week Titration Phase|Protocol Violation|1
7674585|NCT00232596|12091281|FG001|6-Week Titration Phase|Protocol Violation|3
7674586|NCT00232596|12091280|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1
7674587|NCT00232596|12091281|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0
7674588|NCT00232596|12091280|FG000|6-Week Titration Phase|Other|3
7674589|NCT00232596|12091281|FG001|6-Week Titration Phase|Other|3
7674590|NCT00232596|12091280|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
7674591|NCT00232596|12091281|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
7674592|NCT00232596|12091280|FG000|12-Week Maintenance Phase|Adverse Event|7
7674593|NCT00232596|12091281|FG001|12-Week Maintenance Phase|Adverse Event|22
7674594|NCT00232596|12091280|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
7674595|NCT00232596|12091281|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
7674596|NCT00232596|12091280|FG000|12-Week Maintenance Phase|Protocol Violation|3
7674597|NCT00232596|12091281|FG001|12-Week Maintenance Phase|Protocol Violation|1
7674598|NCT00232596|12091280|FG000|12-Week Maintenance Phase|Other|1
7674599|NCT00232596|12091281|FG001|12-Week Maintenance Phase|Other|3
7674600|NCT00233064|12091305|FG000|Overall Study|Lost to Follow-up|7
7674601|NCT00233064|12091306|FG001|Overall Study|Lost to Follow-up|7
7674602|NCT00233064|12091305|FG000|Overall Study|Withdrawal by Subject|5
7674603|NCT00233064|12091306|FG001|Overall Study|Withdrawal by Subject|3
7674604|NCT00233064|12091305|FG000|Overall Study|Death|0
7674605|NCT00233064|12091306|FG001|Overall Study|Death|1
7674606|NCT00233064|12091305|FG000|Overall Study|Relocation|0
7674607|NCT00233064|12091306|FG001|Overall Study|Relocation|1
7674608|NCT00233064|12091305|FG000|Overall Study|Protocol Violation|1
7674609|NCT00233064|12091306|FG001|Overall Study|Protocol Violation|0
7674610|NCT00233064|12091305|FG000|Overall Study|Moved to Dom. Republic|1
7674611|NCT00233064|12091306|FG001|Overall Study|Moved to Dom. Republic|0
7674612|NCT00233324|12091326|FG000|Main Study|Death|68
7674613|NCT00233324|12091327|FG001|Main Study|Death|60
7674614|NCT00233324|12091328|FG002|Main Study|Death|62
7674615|NCT00233324|12091329|FG003|Main Study|Death|47
7674616|NCT00233324|12091326|FG000|Follow up at 18-22 Months Corrected Age|Death|5
7674617|NCT00233324|12091327|FG001|Follow up at 18-22 Months Corrected Age|Death|7
7674618|NCT00233324|12091328|FG002|Follow up at 18-22 Months Corrected Age|Death|5
7674619|NCT00233324|12091329|FG003|Follow up at 18-22 Months Corrected Age|Death|4
7674620|NCT00233324|12091326|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
7674621|NCT00233324|12091327|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
7674622|NCT00233324|12091328|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
7674623|NCT00233324|12091329|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
7674624|NCT00233363|12091348|FG000|Overall Study|Adverse Event|1
7674625|NCT00233363|12091349|FG001|Overall Study|Adverse Event|2
7674626|NCT00233363|12091348|FG000|Overall Study|Lack of Efficacy|0
7674627|NCT00233363|12091349|FG001|Overall Study|Lack of Efficacy|2
7674628|NCT00233363|12091348|FG000|Overall Study|Withdrawal by Subject|1
7674629|NCT00233363|12091349|FG001|Overall Study|Withdrawal by Subject|1
7674630|NCT00233363|12091348|FG000|Overall Study|Aggravation of complication|1
7674631|NCT00233363|12091349|FG001|Overall Study|Aggravation of complication|0
7674632|NCT00233389|12091357|FG000|Overall Study|Adverse Event|5
7674633|NCT00233389|12091358|FG001|Overall Study|Adverse Event|5
7674634|NCT00233389|12091357|FG000|Overall Study|Lack of Efficacy|11
7674635|NCT00233389|12091358|FG001|Overall Study|Lack of Efficacy|8
7674636|NCT00233389|12091357|FG000|Overall Study|Lost to Follow-up|1
7674637|NCT00233389|12091358|FG001|Overall Study|Lost to Follow-up|1
7674638|NCT00233389|12091357|FG000|Overall Study|Physician Decision|1
7674639|NCT00233389|12091358|FG001|Overall Study|Physician Decision|0
7674640|NCT00233389|12091357|FG000|Overall Study|Protocol Violation|0
7674641|NCT00233389|12091358|FG001|Overall Study|Protocol Violation|1
7674642|NCT00233389|12091357|FG000|Overall Study|Withdrawal by Subject|0
7674643|NCT00233389|12091358|FG001|Overall Study|Withdrawal by Subject|1
7674644|NCT00233402|12091366|FG000|Overall Study|No pathology data|12
7674645|NCT00233402|12091367|FG001|Overall Study|No pathology data|9
7674646|NCT00233402|12091366|FG000|Overall Study|No Ta/T1|89
7674647|NCT00233402|12091367|FG001|Overall Study|No Ta/T1|94
7674648|NCT00233402|12091366|FG000|Overall Study|Lost to follow up etc|3
7674649|NCT00233402|12091367|FG001|Overall Study|Lost to follow up etc|21
7674650|NCT00233454|12091375|FG000|Overall Study|Death|6
7674651|NCT00233480|12091381|FG000|Overall Study|Underwent status II heart transplant|0
7674735|NCT00235391|12091548|FG004|Overall Study|Withdrawal by Subject|5
7674652|NCT00233480|12091382|FG001|Overall Study|Underwent status II heart transplant|1
7674653|NCT00233948|12091401|FG000|Overall Study|Adverse Event|1
7674654|NCT00233948|12091402|FG001|Overall Study|Adverse Event|0
7674655|NCT00233948|12091403|FG002|Overall Study|Adverse Event|0
7674656|NCT00233948|12091404|FG003|Overall Study|Adverse Event|0
7674657|NCT00233948|12091405|FG004|Overall Study|Adverse Event|0
7674658|NCT00233948|12091406|FG005|Overall Study|Adverse Event|0
7674659|NCT00233987|12091421|FG000|Overall Study|Withdrawal by Subject|1
7674660|NCT00233987|12091421|FG000|Overall Study|Lack of Efficacy|2
7674661|NCT00233987|12091421|FG000|Overall Study|Reason Under Review|1
7674662|NCT00233987|12091421|FG000|Overall Study|Other - Not Protocol Specified|5
7674663|NCT00233987|12091421|FG000|Overall Study|Eligible but No Treatment Received|2
7674664|NCT00233987|12091421|FG000|Overall Study|Ineligible|4
7674665|NCT00234039|12091425|FG000|Overall Study|Adverse Event|2
7674666|NCT00234039|12091425|FG000|Overall Study|Progression/relapse|34
7674667|NCT00234039|12091425|FG000|Overall Study|Other - Not Protocol Specified|3
7674668|NCT00234039|12091425|FG000|Overall Study|Ineligible|9
7674669|NCT00234039|12091425|FG000|Overall Study|No Protocol Treatment Received|2
7674670|NCT00234052|12091429|FG000|Treatment|Withdrawal by Subject|3
7674671|NCT00234052|12091429|FG000|Treatment|Adverse Event|5
7674672|NCT00234052|12091429|FG000|Treatment|Death|2
7674673|NCT00234052|12091429|FG000|Treatment|Progressive Disease|11
7674674|NCT00234052|12091429|FG000|Follow-up for 5 Years|Death|41
7674675|NCT00234052|12091429|FG000|Follow-up for 5 Years|Lost to Follow-up|1
7674676|NCT00234052|12091429|FG000|Follow-up for 5 Years|Other|7
7674677|NCT00234065|12091435|FG000|Overall Study|Adverse Event|268
7674678|NCT00234065|12091436|FG001|Overall Study|Adverse Event|166
7674679|NCT00234065|12091435|FG000|Overall Study|Withdrawal by Subject|73
7674680|NCT00234065|12091436|FG001|Overall Study|Withdrawal by Subject|56
7674681|NCT00234065|12091435|FG000|Overall Study|Physician Decision|23
7674682|NCT00234065|12091436|FG001|Overall Study|Physician Decision|22
7674683|NCT00234065|12091435|FG000|Overall Study|Not Classified|111
7674684|NCT00234065|12091436|FG001|Overall Study|Not Classified|112
7674685|NCT00234104|12091463|FG000|Overall Study|Adverse Event|4
7674686|NCT00234104|12091464|FG001|Overall Study|Adverse Event|0
7674687|NCT00234104|12091465|FG002|Overall Study|Adverse Event|3
7674688|NCT00234104|12091466|FG003|Overall Study|Adverse Event|5
7674689|NCT00234104|12091463|FG000|Overall Study|Protocol Violation|0
7674690|NCT00234104|12091464|FG001|Overall Study|Protocol Violation|0
7674691|NCT00234104|12091465|FG002|Overall Study|Protocol Violation|0
7674692|NCT00234104|12091466|FG003|Overall Study|Protocol Violation|1
7674693|NCT00234104|12091463|FG000|Overall Study|Physician Decision|0
7674694|NCT00234104|12091464|FG001|Overall Study|Physician Decision|1
7674695|NCT00234104|12091465|FG002|Overall Study|Physician Decision|2
7674696|NCT00234104|12091466|FG003|Overall Study|Physician Decision|2
7674697|NCT00234494|12091509|FG000|Overall Study|Protocol Violation|2
7674698|NCT00234533|12091513|FG000|Overall Study|Withdrawal by Subject|6
7674699|NCT00234533|12091513|FG000|Overall Study|Adverse Event|2
7674700|NCT00234533|12091513|FG000|Overall Study|Enrolled but not treated|3
7674701|NCT00235391|12091544|FG000|Overall Study|Adverse Event|4
7674702|NCT00235391|12091545|FG001|Overall Study|Adverse Event|5
7674703|NCT00235391|12091546|FG002|Overall Study|Adverse Event|10
7674704|NCT00235391|12091547|FG003|Overall Study|Adverse Event|72
7674705|NCT00235391|12091548|FG004|Overall Study|Adverse Event|5
7674706|NCT00235391|12091549|FG005|Overall Study|Adverse Event|2
7674707|NCT00235391|12091544|FG000|Overall Study|Abnormal laboratory value(s)|3
7674708|NCT00235391|12091545|FG001|Overall Study|Abnormal laboratory value(s)|5
7674709|NCT00235391|12091546|FG002|Overall Study|Abnormal laboratory value(s)|4
7674710|NCT00235391|12091547|FG003|Overall Study|Abnormal laboratory value(s)|27
7674711|NCT00235391|12091548|FG004|Overall Study|Abnormal laboratory value(s)|1
7674712|NCT00235391|12091549|FG005|Overall Study|Abnormal laboratory value(s)|2
7674713|NCT00235391|12091544|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7674714|NCT00235391|12091545|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7674715|NCT00235391|12091546|FG002|Overall Study|Unsatisfactory therapeutic effect|2
7674716|NCT00235391|12091547|FG003|Overall Study|Unsatisfactory therapeutic effect|17
7674717|NCT00235391|12091548|FG004|Overall Study|Unsatisfactory therapeutic effect|0
7674718|NCT00235391|12091549|FG005|Overall Study|Unsatisfactory therapeutic effect|0
7674719|NCT00235391|12091544|FG000|Overall Study|Condition no longer requires treatment|3
7674720|NCT00235391|12091545|FG001|Overall Study|Condition no longer requires treatment|0
7674721|NCT00235391|12091546|FG002|Overall Study|Condition no longer requires treatment|0
7674722|NCT00235391|12091547|FG003|Overall Study|Condition no longer requires treatment|11
7674723|NCT00235391|12091548|FG004|Overall Study|Condition no longer requires treatment|1
7674724|NCT00235391|12091549|FG005|Overall Study|Condition no longer requires treatment|0
7674725|NCT00235391|12091544|FG000|Overall Study|Protocol deviation|0
7674726|NCT00235391|12091545|FG001|Overall Study|Protocol deviation|0
7674727|NCT00235391|12091546|FG002|Overall Study|Protocol deviation|1
7674728|NCT00235391|12091547|FG003|Overall Study|Protocol deviation|11
7674729|NCT00235391|12091548|FG004|Overall Study|Protocol deviation|0
7674730|NCT00235391|12091549|FG005|Overall Study|Protocol deviation|0
7674731|NCT00235391|12091544|FG000|Overall Study|Withdrawal by Subject|2
7674732|NCT00235391|12091545|FG001|Overall Study|Withdrawal by Subject|3
7674733|NCT00235391|12091546|FG002|Overall Study|Withdrawal by Subject|3
7674734|NCT00235391|12091547|FG003|Overall Study|Withdrawal by Subject|61
7674736|NCT00235391|12091549|FG005|Overall Study|Withdrawal by Subject|0
7674737|NCT00235391|12091544|FG000|Overall Study|Lost to Follow-up|0
7674738|NCT00235391|12091545|FG001|Overall Study|Lost to Follow-up|3
7674739|NCT00235391|12091546|FG002|Overall Study|Lost to Follow-up|3
7674740|NCT00235391|12091547|FG003|Overall Study|Lost to Follow-up|16
7674741|NCT00235391|12091548|FG004|Overall Study|Lost to Follow-up|0
7674742|NCT00235391|12091549|FG005|Overall Study|Lost to Follow-up|0
7674743|NCT00235391|12091544|FG000|Overall Study|Administrative problems|0
7674744|NCT00235391|12091545|FG001|Overall Study|Administrative problems|0
7674745|NCT00235391|12091546|FG002|Overall Study|Administrative problems|0
7674746|NCT00235391|12091547|FG003|Overall Study|Administrative problems|1
7674747|NCT00235391|12091548|FG004|Overall Study|Administrative problems|0
7674748|NCT00235391|12091549|FG005|Overall Study|Administrative problems|0
7674749|NCT00235391|12091544|FG000|Overall Study|Death|0
7674750|NCT00235391|12091545|FG001|Overall Study|Death|0
7674751|NCT00235391|12091546|FG002|Overall Study|Death|1
7674752|NCT00235391|12091547|FG003|Overall Study|Death|4
7674753|NCT00235391|12091548|FG004|Overall Study|Death|0
7674754|NCT00235391|12091549|FG005|Overall Study|Death|0
7674755|NCT00235443|12091564|FG000|Overall Study|Adverse Event|4
7674756|NCT00235443|12091565|FG001|Overall Study|Adverse Event|12
7674757|NCT00235443|12091566|FG002|Overall Study|Adverse Event|17
7674758|NCT00235443|12091567|FG003|Overall Study|Adverse Event|44
7674759|NCT00235443|12091568|FG004|Overall Study|Adverse Event|10
7674760|NCT00235443|12091569|FG005|Overall Study|Adverse Event|15
7674761|NCT00235443|12091564|FG000|Overall Study|Lack of Efficacy|0
7674762|NCT00235443|12091565|FG001|Overall Study|Lack of Efficacy|1
7674763|NCT00235443|12091566|FG002|Overall Study|Lack of Efficacy|5
7674764|NCT00235443|12091567|FG003|Overall Study|Lack of Efficacy|12
7674765|NCT00235443|12091568|FG004|Overall Study|Lack of Efficacy|2
7674766|NCT00235443|12091569|FG005|Overall Study|Lack of Efficacy|9
7674767|NCT00235443|12091564|FG000|Overall Study|Withdrawal by Subject|3
7674768|NCT00235443|12091565|FG001|Overall Study|Withdrawal by Subject|9
7674769|NCT00235443|12091566|FG002|Overall Study|Withdrawal by Subject|25
7674770|NCT00235443|12091567|FG003|Overall Study|Withdrawal by Subject|24
7674771|NCT00235443|12091568|FG004|Overall Study|Withdrawal by Subject|10
7674772|NCT00235443|12091569|FG005|Overall Study|Withdrawal by Subject|12
7674773|NCT00235443|12091564|FG000|Overall Study|Lost to Follow-up|0
7674774|NCT00235443|12091565|FG001|Overall Study|Lost to Follow-up|8
7674775|NCT00235443|12091566|FG002|Overall Study|Lost to Follow-up|6
7674776|NCT00235443|12091567|FG003|Overall Study|Lost to Follow-up|6
7674777|NCT00235443|12091568|FG004|Overall Study|Lost to Follow-up|4
7674778|NCT00235443|12091569|FG005|Overall Study|Lost to Follow-up|3
7674779|NCT00235443|12091564|FG000|Overall Study|Unsatisfactory compliance|0
7674780|NCT00235443|12091565|FG001|Overall Study|Unsatisfactory compliance|2
7674781|NCT00235443|12091566|FG002|Overall Study|Unsatisfactory compliance|3
7674782|NCT00235443|12091567|FG003|Overall Study|Unsatisfactory compliance|4
7674783|NCT00235443|12091568|FG004|Overall Study|Unsatisfactory compliance|1
7674784|NCT00235443|12091569|FG005|Overall Study|Unsatisfactory compliance|0
7674785|NCT00235443|12091564|FG000|Overall Study|Other reasons for premature termination|1
7674786|NCT00235443|12091565|FG001|Overall Study|Other reasons for premature termination|6
7674787|NCT00235443|12091566|FG002|Overall Study|Other reasons for premature termination|6
7674788|NCT00235443|12091567|FG003|Overall Study|Other reasons for premature termination|7
7674789|NCT00235443|12091568|FG004|Overall Study|Other reasons for premature termination|3
7674790|NCT00235443|12091569|FG005|Overall Study|Other reasons for premature termination|6
7674791|NCT00235495|12091596|FG000|Overall Study|Death|52
7674792|NCT00235495|12091597|FG001|Overall Study|Death|42
7674793|NCT00235495|12091596|FG000|Overall Study|Withdrawal by Subject|5
7674794|NCT00235495|12091597|FG001|Overall Study|Withdrawal by Subject|3
7674795|NCT00235495|12091596|FG000|Overall Study|Lost to Follow-up|11
7674796|NCT00235495|12091597|FG001|Overall Study|Lost to Follow-up|13
7674797|NCT00235495|12091596|FG000|Overall Study|Visit/assessmen outside window/missing|0
7674798|NCT00235495|12091597|FG001|Overall Study|Visit/assessmen outside window/missing|10
7674799|NCT00235716|12091620|FG000|Overall Study|Death|26
7674800|NCT00235716|12091621|FG001|Overall Study|Death|39
7674801|NCT00235716|12091622|FG002|Overall Study|Death|32
7674802|NCT00235716|12091623|FG003|Overall Study|Death|31
7674803|NCT00235716|12091620|FG000|Overall Study|Withdrawal by Subject|23
7674804|NCT00235716|12091621|FG001|Overall Study|Withdrawal by Subject|19
7674805|NCT00235716|12091622|FG002|Overall Study|Withdrawal by Subject|17
7674806|NCT00235716|12091623|FG003|Overall Study|Withdrawal by Subject|18
7674807|NCT00235716|12091620|FG000|Overall Study|Lost to Follow-up|12
7674808|NCT00235716|12091621|FG001|Overall Study|Lost to Follow-up|7
7674809|NCT00235716|12091622|FG002|Overall Study|Lost to Follow-up|14
7674810|NCT00235716|12091623|FG003|Overall Study|Lost to Follow-up|10
7674811|NCT00235716|12091620|FG000|Overall Study|Adverse Event|1
7674812|NCT00235716|12091621|FG001|Overall Study|Adverse Event|1
7674813|NCT00235716|12091622|FG002|Overall Study|Adverse Event|1
7674814|NCT00235716|12091623|FG003|Overall Study|Adverse Event|0
7674815|NCT00235716|12091620|FG000|Overall Study|Physician Decision|0
7674816|NCT00235716|12091621|FG001|Overall Study|Physician Decision|1
7674817|NCT00235716|12091622|FG002|Overall Study|Physician Decision|1
7674818|NCT00235716|12091623|FG003|Overall Study|Physician Decision|3
7674819|NCT00235755|12091636|FG000|4-Week Titration Phase|Adverse Event|6
7674820|NCT00235755|12091637|FG001|4-Week Titration Phase|Adverse Event|14
7674821|NCT00235755|12091638|FG002|4-Week Titration Phase|Adverse Event|20
7674822|NCT00235755|12091636|FG000|4-Week Titration Phase|Lost to Follow-up|0
7674823|NCT00235755|12091637|FG001|4-Week Titration Phase|Lost to Follow-up|1
7674824|NCT00235755|12091638|FG002|4-Week Titration Phase|Lost to Follow-up|1
7674825|NCT00235755|12091636|FG000|4-Week Titration Phase|Protocol Violation|2
7674826|NCT00235755|12091637|FG001|4-Week Titration Phase|Protocol Violation|2
7674827|NCT00235755|12091638|FG002|4-Week Titration Phase|Protocol Violation|1
7674828|NCT00235755|12091636|FG000|4-Week Titration Phase|Withdrawal by Subject|1
7674829|NCT00235755|12091637|FG001|4-Week Titration Phase|Withdrawal by Subject|2
7674830|NCT00235755|12091638|FG002|4-Week Titration Phase|Withdrawal by Subject|3
7674831|NCT00235755|12091636|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
7674832|NCT00235755|12091637|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
7674833|NCT00235755|12091638|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
7674834|NCT00235755|12091636|FG000|4-Week Titration Phase|Randomization Occurred in Error|1
7674835|NCT00235755|12091637|FG001|4-Week Titration Phase|Randomization Occurred in Error|0
7674836|NCT00235755|12091638|FG002|4-Week Titration Phase|Randomization Occurred in Error|0
7674837|NCT00235755|12091636|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
7674838|NCT00235755|12091637|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
7674839|NCT00235755|12091638|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
7674840|NCT00235755|12091636|FG000|12-Week Maintenance Phase|Adverse Event|8
7674841|NCT00235755|12091637|FG001|12-Week Maintenance Phase|Adverse Event|12
7674842|NCT00235755|12091638|FG002|12-Week Maintenance Phase|Adverse Event|26
7674843|NCT00235755|12091636|FG000|12-Week Maintenance Phase|Lost to Follow-up|2
7674844|NCT00235755|12091637|FG001|12-Week Maintenance Phase|Lost to Follow-up|3
7674845|NCT00235755|12091638|FG002|12-Week Maintenance Phase|Lost to Follow-up|0
7674846|NCT00235755|12091636|FG000|12-Week Maintenance Phase|Lack of Efficacy|5
7674847|NCT00235755|12091637|FG001|12-Week Maintenance Phase|Lack of Efficacy|0
7674848|NCT00235755|12091638|FG002|12-Week Maintenance Phase|Lack of Efficacy|0
7674849|NCT00235755|12091636|FG000|12-Week Maintenance Phase|Protocol Violation|0
7674850|NCT00235755|12091637|FG001|12-Week Maintenance Phase|Protocol Violation|4
7674851|NCT00235755|12091638|FG002|12-Week Maintenance Phase|Protocol Violation|2
7674852|NCT00235755|12091636|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0
7674853|NCT00235755|12091637|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8
7674854|NCT00235755|12091638|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3
7674855|NCT00235755|12091636|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
7674856|NCT00235755|12091637|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
7674857|NCT00235755|12091638|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
7674858|NCT00235872|12091665|FG000|Overall Study|Adverse Event|34
7674859|NCT00235872|12091665|FG000|Overall Study|Death|1
7674860|NCT00235872|12091665|FG000|Overall Study|Lost to Follow-up|1
7674861|NCT00235872|12091665|FG000|Overall Study|Withdrawal by Subject|50
7674862|NCT00235872|12091665|FG000|Overall Study|Administrative reason|61
7674863|NCT00235989|12091673|FG000|Core Treatment Period (CT)|Lost to Follow-up|0
7674864|NCT00235989|12091674|FG001|Core Treatment Period (CT)|Lost to Follow-up|0
7674865|NCT00235989|12091675|FG002|Core Treatment Period (CT)|Lost to Follow-up|0
7674866|NCT00235989|12091676|FG003|Core Treatment Period (CT)|Lost to Follow-up|0
7674867|NCT00235989|12091677|FG004|Core Treatment Period (CT)|Lost to Follow-up|0
7674868|NCT00235989|12091678|FG005|Core Treatment Period (CT)|Lost to Follow-up|2
7674869|NCT00235989|12091673|FG000|Extension Treatment Period (ET)|Adverse Event|3
7674870|NCT00235989|12091674|FG001|Extension Treatment Period (ET)|Adverse Event|0
7674871|NCT00235989|12091675|FG002|Extension Treatment Period (ET)|Adverse Event|2
7674872|NCT00235989|12091676|FG003|Extension Treatment Period (ET)|Adverse Event|0
7674873|NCT00235989|12091677|FG004|Extension Treatment Period (ET)|Adverse Event|0
7674874|NCT00235989|12091678|FG005|Extension Treatment Period (ET)|Adverse Event|0
7674875|NCT00235989|12091673|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2
7674876|NCT00235989|12091674|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0
7674877|NCT00235989|12091675|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1
7674878|NCT00235989|12091676|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0
7674879|NCT00235989|12091677|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0
7674880|NCT00235989|12091678|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0
7674881|NCT00235989|12091673|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1
7674882|NCT00235989|12091674|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1
7674883|NCT00235989|12091675|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1
7674884|NCT00235989|12091676|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4
7674885|NCT00235989|12091677|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0
7674886|NCT00235989|12091678|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0
7674887|NCT00235989|12091673|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2
7674888|NCT00235989|12091674|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3
7674889|NCT00235989|12091675|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1
7674890|NCT00235989|12091676|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2
7674891|NCT00235989|12091677|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0
7674892|NCT00235989|12091678|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0
7674893|NCT00236080|12091693|FG000|Overall Study|Adverse Event|0
7674894|NCT00236080|12091694|FG001|Overall Study|Adverse Event|0
7674895|NCT00236080|12091695|FG002|Overall Study|Adverse Event|3
7674896|NCT00236080|12091696|FG003|Overall Study|Adverse Event|1
7674897|NCT00236080|12091697|FG004|Overall Study|Adverse Event|0
7674898|NCT00236080|12091693|FG000|Overall Study|Lost to Follow-up|0
7674899|NCT00236080|12091694|FG001|Overall Study|Lost to Follow-up|1
7674900|NCT00236080|12091695|FG002|Overall Study|Lost to Follow-up|0
7674901|NCT00236080|12091696|FG003|Overall Study|Lost to Follow-up|0
7674902|NCT00236080|12091697|FG004|Overall Study|Lost to Follow-up|0
7674903|NCT00236080|12091693|FG000|Overall Study|Physician Decision|1
7674904|NCT00236080|12091694|FG001|Overall Study|Physician Decision|0
7674905|NCT00236080|12091695|FG002|Overall Study|Physician Decision|1
7674906|NCT00236080|12091696|FG003|Overall Study|Physician Decision|1
7674907|NCT00236080|12091697|FG004|Overall Study|Physician Decision|1
7674908|NCT00236080|12091693|FG000|Overall Study|Withdrawal by Subject|1
7674909|NCT00236080|12091694|FG001|Overall Study|Withdrawal by Subject|0
7674910|NCT00236080|12091695|FG002|Overall Study|Withdrawal by Subject|0
7674911|NCT00236080|12091696|FG003|Overall Study|Withdrawal by Subject|0
7674912|NCT00236080|12091697|FG004|Overall Study|Withdrawal by Subject|0
7674913|NCT00236080|12091693|FG000|Overall Study|Miscellaneous|0
7674914|NCT00236080|12091694|FG001|Overall Study|Miscellaneous|0
7674915|NCT00236080|12091695|FG002|Overall Study|Miscellaneous|1
7674916|NCT00236080|12091696|FG003|Overall Study|Miscellaneous|0
7674917|NCT00236080|12091697|FG004|Overall Study|Miscellaneous|0
7674918|NCT00236184|12091711|FG000|Overall Study|Adverse Event|5
7674919|NCT00236184|12091712|FG001|Overall Study|Adverse Event|2
7674920|NCT00236184|12091711|FG000|Overall Study|Lack of Efficacy|0
7674921|NCT00236184|12091712|FG001|Overall Study|Lack of Efficacy|1
7674922|NCT00236184|12091711|FG000|Overall Study|Lost to Follow-up|3
7674923|NCT00236184|12091712|FG001|Overall Study|Lost to Follow-up|4
7674924|NCT00236184|12091711|FG000|Overall Study|Physician Decision|1
7674925|NCT00236184|12091712|FG001|Overall Study|Physician Decision|1
7674926|NCT00236184|12091711|FG000|Overall Study|Withdrawal by Subject|3
7674927|NCT00236184|12091712|FG001|Overall Study|Withdrawal by Subject|0
7674928|NCT00236184|12091711|FG000|Overall Study|Protocol Violation|3
7674929|NCT00236184|12091712|FG001|Overall Study|Protocol Violation|0
7674930|NCT00236184|12091711|FG000|Overall Study|non-compliance with study drug|2
7674931|NCT00236184|12091712|FG001|Overall Study|non-compliance with study drug|1
7674932|NCT00236184|12091711|FG000|Overall Study|other|1
7674933|NCT00236184|12091712|FG001|Overall Study|other|2
7674934|NCT00236197|12091720|FG000|Overall Study|Withdrawal by Subject|3
7674935|NCT00236197|12091721|FG001|Overall Study|Withdrawal by Subject|2
7674936|NCT00236197|12091720|FG000|Overall Study|Lost to Follow-up|1
7674937|NCT00236197|12091721|FG001|Overall Study|Lost to Follow-up|5
7674938|NCT00236197|12091720|FG000|Overall Study|Protocol Violation|0
7674939|NCT00236197|12091721|FG001|Overall Study|Protocol Violation|3
7674940|NCT00236197|12091720|FG000|Overall Study|Medication non-compliance|1
7674941|NCT00236197|12091721|FG001|Overall Study|Medication non-compliance|2
7674942|NCT00236197|12091720|FG000|Overall Study|Other|0
7674943|NCT00236197|12091721|FG001|Overall Study|Other|2
7674944|NCT00236899|12091731|FG000|Overall Study|Adverse Event (Study Related)|1
7674945|NCT00236899|12091732|FG001|Overall Study|Adverse Event (Study Related)|1
7674946|NCT00236899|12091733|FG002|Overall Study|Adverse Event (Study Related)|2
7674947|NCT00236899|12091734|FG003|Overall Study|Adverse Event (Study Related)|1
7674948|NCT00236899|12091731|FG000|Overall Study|Adverse Event (Not Study Related)|3
7674949|NCT00236899|12091732|FG001|Overall Study|Adverse Event (Not Study Related)|3
7674950|NCT00236899|12091733|FG002|Overall Study|Adverse Event (Not Study Related)|4
7674951|NCT00236899|12091734|FG003|Overall Study|Adverse Event (Not Study Related)|7
7674952|NCT00236899|12091731|FG000|Overall Study|Death (Study Disease)|1
7674953|NCT00236899|12091732|FG001|Overall Study|Death (Study Disease)|4
7674954|NCT00236899|12091733|FG002|Overall Study|Death (Study Disease)|0
7674955|NCT00236899|12091734|FG003|Overall Study|Death (Study Disease)|0
7674956|NCT00236899|12091731|FG000|Overall Study|Death (Not Study Related)|2
7674957|NCT00236899|12091732|FG001|Overall Study|Death (Not Study Related)|0
7674958|NCT00236899|12091733|FG002|Overall Study|Death (Not Study Related)|0
7674959|NCT00236899|12091734|FG003|Overall Study|Death (Not Study Related)|0
7674960|NCT00236899|12091731|FG000|Overall Study|Death (Study Drug Toxicity)|1
7674961|NCT00236899|12091732|FG001|Overall Study|Death (Study Drug Toxicity)|0
7674962|NCT00236899|12091733|FG002|Overall Study|Death (Study Drug Toxicity)|0
7674963|NCT00236899|12091734|FG003|Overall Study|Death (Study Drug Toxicity)|0
7674964|NCT00236899|12091731|FG000|Overall Study|Lost to Follow-up|0
7674965|NCT00236899|12091732|FG001|Overall Study|Lost to Follow-up|1
7674966|NCT00236899|12091733|FG002|Overall Study|Lost to Follow-up|0
7674967|NCT00236899|12091734|FG003|Overall Study|Lost to Follow-up|0
7674968|NCT00236899|12091731|FG000|Overall Study|Entry Criteria Exclusion|0
7674969|NCT00236899|12091732|FG001|Overall Study|Entry Criteria Exclusion|1
7674970|NCT00236899|12091733|FG002|Overall Study|Entry Criteria Exclusion|1
7674971|NCT00236899|12091734|FG003|Overall Study|Entry Criteria Exclusion|0
7674972|NCT00236899|12091731|FG000|Overall Study|Protocol Violation|1
7674973|NCT00236899|12091732|FG001|Overall Study|Protocol Violation|0
7674974|NCT00236899|12091733|FG002|Overall Study|Protocol Violation|0
7674975|NCT00236899|12091734|FG003|Overall Study|Protocol Violation|0
7674976|NCT00236899|12091731|FG000|Overall Study|Withdrawal by Subject|6
7674977|NCT00236899|12091732|FG001|Overall Study|Withdrawal by Subject|4
7674978|NCT00236899|12091733|FG002|Overall Study|Withdrawal by Subject|5
7674979|NCT00236899|12091734|FG003|Overall Study|Withdrawal by Subject|2
7674980|NCT00236899|12091731|FG000|Overall Study|Physician Decision|7
7674981|NCT00236899|12091732|FG001|Overall Study|Physician Decision|8
7674982|NCT00236899|12091733|FG002|Overall Study|Physician Decision|7
7674983|NCT00236899|12091734|FG003|Overall Study|Physician Decision|6
7674984|NCT00236899|12091731|FG000|Overall Study|Satisfactory Response|2
7674985|NCT00236899|12091732|FG001|Overall Study|Satisfactory Response|0
7674986|NCT00236899|12091733|FG002|Overall Study|Satisfactory Response|0
7674987|NCT00236899|12091734|FG003|Overall Study|Satisfactory Response|1
7674988|NCT00236899|12091731|FG000|Overall Study|Lack of Efficacy|18
7674989|NCT00236899|12091732|FG001|Overall Study|Lack of Efficacy|18
7674990|NCT00236899|12091733|FG002|Overall Study|Lack of Efficacy|25
7674991|NCT00236899|12091734|FG003|Overall Study|Lack of Efficacy|23
7674992|NCT00237042|12091789|FG000|Treatment|Became ineligible post-randomization|0
7674993|NCT00237042|12091790|FG001|Treatment|Became ineligible post-randomization|1
7674994|NCT00237042|12091791|FG002|Treatment|Became ineligible post-randomization|16
7674995|NCT00237042|12091789|FG000|Treatment|Moved out of state|1
7674996|NCT00237042|12091790|FG001|Treatment|Moved out of state|1
7674997|NCT00237042|12091791|FG002|Treatment|Moved out of state|1
7674998|NCT00237042|12091789|FG000|Treatment|Completed no treatment|5
7674999|NCT00237042|12091790|FG001|Treatment|Completed no treatment|5
7675000|NCT00237042|12091791|FG002|Treatment|Completed no treatment|21
7675001|NCT00237042|12091789|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9
7675002|NCT00237042|12091790|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8
7675003|NCT00237042|12091791|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11
7675004|NCT00237042|12091789|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11
7675005|NCT00237042|12091790|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9
7675006|NCT00237042|12091791|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9
7675007|NCT00237185|12091801|FG000|Core|Adverse Event|3
7675008|NCT00237185|12091802|FG001|Core|Adverse Event|4
7675009|NCT00237185|12091801|FG000|Core|Abnormal laboratory value|0
7675010|NCT00237185|12091802|FG001|Core|Abnormal laboratory value|4
7675011|NCT00237185|12091801|FG000|Core|Abnormal test procedure results|1
7675012|NCT00237185|12091802|FG001|Core|Abnormal test procedure results|0
7675013|NCT00237185|12091801|FG000|Core|Lack of Efficacy|30
7675014|NCT00237185|12091802|FG001|Core|Lack of Efficacy|23
7675015|NCT00237185|12091801|FG000|Core|Protocol Violation|1
7675016|NCT00237185|12091802|FG001|Core|Protocol Violation|1
7675017|NCT00237185|12091801|FG000|Core|Withdrawal by Subject|4
7675018|NCT00237185|12091802|FG001|Core|Withdrawal by Subject|4
7675019|NCT00237185|12091801|FG000|Core|Administrative problems|0
7675020|NCT00237185|12091802|FG001|Core|Administrative problems|1
7675021|NCT00237185|12091801|FG000|Core|Death|4
7675022|NCT00237185|12091802|FG001|Core|Death|0
7675023|NCT00237185|12091801|FG000|Core|Determined ineligible post randomization|1
7675024|NCT00237185|12091802|FG001|Core|Determined ineligible post randomization|0
7675025|NCT00237185|12091801|FG000|Extension|Adverse Event|1
7675026|NCT00237185|12091802|FG001|Extension|Adverse Event|0
7675027|NCT00237185|12091801|FG000|Extension|Abnormal laboratory value|0
7675028|NCT00237185|12091802|FG001|Extension|Abnormal laboratory value|1
7675029|NCT00237185|12091801|FG000|Extension|Lack of Efficacy|9
7675030|NCT00237185|12091802|FG001|Extension|Lack of Efficacy|14
7675031|NCT00237185|12091801|FG000|Extension|Condition no longer required study drug|0
7675032|NCT00237185|12091802|FG001|Extension|Condition no longer required study drug|1
7675033|NCT00237185|12091801|FG000|Extension|Withdrawal by Subject|3
7675034|NCT00237185|12091802|FG001|Extension|Withdrawal by Subject|2
7675035|NCT00237185|12091801|FG000|Extension|Lost to Follow-up|1
7675036|NCT00237185|12091802|FG001|Extension|Lost to Follow-up|0
7675037|NCT00237185|12091801|FG000|Extension|Administrative problems|1
7675038|NCT00237185|12091802|FG001|Extension|Administrative problems|0
7675039|NCT00237185|12091801|FG000|Extension|Death|1
7675040|NCT00237185|12091802|FG001|Extension|Death|1
7675041|NCT00237458|12091808|FG000|Overall Study|Lack of Efficacy|1
7675042|NCT00237458|12091808|FG000|Overall Study|Adverse Event|1
7675043|NCT00237458|12091808|FG000|Overall Study|Withdrawal by Subject|1
7675044|NCT00237692|12091820|FG000|Overall Study|Lost to Follow-up|9
7675045|NCT00237692|12091821|FG001|Overall Study|Lost to Follow-up|3
7675046|NCT00237692|12091822|FG002|Overall Study|Lost to Follow-up|5
7675047|NCT00237692|12091823|FG003|Overall Study|Lost to Follow-up|3
7675048|NCT00237692|12091820|FG000|Overall Study|Death|1
7675049|NCT00237692|12091821|FG001|Overall Study|Death|2
7675050|NCT00237692|12091822|FG002|Overall Study|Death|2
7675051|NCT00237692|12091823|FG003|Overall Study|Death|3
7675052|NCT00237692|12091820|FG000|Overall Study|Excluded - did not meet criteria|4
7675053|NCT00237692|12091821|FG001|Overall Study|Excluded - did not meet criteria|3
7675054|NCT00237692|12091822|FG002|Overall Study|Excluded - did not meet criteria|5
7675055|NCT00237692|12091823|FG003|Overall Study|Excluded - did not meet criteria|9
7675056|NCT00237692|12091820|FG000|Overall Study|Withdrawal by Subject|4
7675057|NCT00237692|12091821|FG001|Overall Study|Withdrawal by Subject|6
7675058|NCT00237692|12091822|FG002|Overall Study|Withdrawal by Subject|10
7675059|NCT00237692|12091823|FG003|Overall Study|Withdrawal by Subject|4
7675060|NCT00237744|12091845|FG000|Overall Study|Withdrawal by Subject|3
7675061|NCT00237744|12091846|FG001|Overall Study|Withdrawal by Subject|1
7675062|NCT00237744|12091847|FG002|Overall Study|Withdrawal by Subject|0
7675063|NCT00237796|12091873|FG000|Overall Study|Baseline and one other ILSS required|10
7675064|NCT00237796|12091874|FG001|Overall Study|Baseline and one other ILSS required|5
7675065|NCT00237809|12091885|FG000|Overall Study|Lost to Follow-up|11
7675066|NCT00237809|12091886|FG001|Overall Study|Lost to Follow-up|10
7675067|NCT00237809|12091887|FG002|Overall Study|Lost to Follow-up|9
7675068|NCT00237809|12091888|FG003|Overall Study|Lost to Follow-up|9
7675069|NCT00238121|12091909|FG000|Overall Study|Withdrawal by Subject|1
7675070|NCT00238121|12091910|FG001|Overall Study|Withdrawal by Subject|1
7675071|NCT00238121|12091909|FG000|Overall Study|Adverse Event|2
7675072|NCT00238121|12091910|FG001|Overall Study|Adverse Event|1
7675073|NCT00238238|12091918|FG000|Overall Study|Withdrawal by Subject|0
7675074|NCT00238238|12091919|FG001|Overall Study|Withdrawal by Subject|3
7675075|NCT00238238|12091920|FG002|Overall Study|Withdrawal by Subject|0
7675076|NCT00238264|12091928|FG000|Overall Study|Death|7
7675077|NCT00238264|12091928|FG000|Overall Study|Lost to Follow-up|18
7675078|NCT00238264|12091928|FG000|Overall Study|Withdrawal by Subject|4
7675079|NCT00238264|12091928|FG000|Overall Study|Ineligible|7
7675080|NCT00238303|12091935|FG000|Overall Study|Withdrawal by Subject|11
7675081|NCT00238303|12091936|FG001|Overall Study|Withdrawal by Subject|1
7675082|NCT00238303|12091937|FG002|Overall Study|Withdrawal by Subject|2
7675083|NCT00238303|12091935|FG000|Overall Study|Death|1
7675084|NCT00238303|12091936|FG001|Overall Study|Death|0
7675085|NCT00238303|12091937|FG002|Overall Study|Death|1
7675086|NCT00238303|12091935|FG000|Overall Study|Other Medical Problems|2
7675087|NCT00238303|12091936|FG001|Overall Study|Other Medical Problems|0
7675088|NCT00238303|12091937|FG002|Overall Study|Other Medical Problems|2
7675089|NCT00238303|12091935|FG000|Overall Study|Poor tolerance of study treatment|1
7675090|NCT00238303|12091936|FG001|Overall Study|Poor tolerance of study treatment|0
7675091|NCT00238303|12091937|FG002|Overall Study|Poor tolerance of study treatment|1
7675092|NCT00238303|12091935|FG000|Overall Study|Adverse Event|0
7675093|NCT00238303|12091936|FG001|Overall Study|Adverse Event|1
7675094|NCT00238303|12091937|FG002|Overall Study|Adverse Event|3
7675095|NCT00238433|12091950|FG000|Overall Study|Screen failure|1
7675096|NCT00238433|12091950|FG000|Overall Study|Lost to Follow-up|1
7675097|NCT00238433|12091950|FG000|Overall Study|Death|1
7675098|NCT00239005|12091963|FG000|Overall Study|Adverse Event|6
7675099|NCT00239005|12091964|FG001|Overall Study|Adverse Event|6
7675100|NCT00239005|12091963|FG000|Overall Study|Withdrawal by Subject|3
7675101|NCT00239005|12091964|FG001|Overall Study|Withdrawal by Subject|4
7675102|NCT00239005|12091963|FG000|Overall Study|Unsatisfactory Therapeutic effect|2
7675103|NCT00239005|12091964|FG001|Overall Study|Unsatisfactory Therapeutic effect|0
7675104|NCT00239005|12091963|FG000|Overall Study|Protocol Violation|1
7675105|NCT00239005|12091964|FG001|Overall Study|Protocol Violation|0
7675106|NCT00239005|12091963|FG000|Overall Study|Subj. cond. no longer needs study drug|0
7675107|NCT00239005|12091964|FG001|Overall Study|Subj. cond. no longer needs study drug|1
7675108|NCT00239005|12091963|FG000|Overall Study|Lost to Follow-up|0
7675109|NCT00239005|12091964|FG001|Overall Study|Lost to Follow-up|1
7675110|NCT00239226|12091974|FG000|Overall Study|permAF during stabilization period|0
7675111|NCT00239226|12091975|FG001|Overall Study|permAF during stabilization period|0
7675112|NCT00239226|12091976|FG002|Overall Study|permAF during stabilization period|0
7675113|NCT00239226|12091977|FG003|Overall Study|permAF during stabilization period|3
7675114|NCT00239226|12091974|FG000|Overall Study|Lost to Follow-up|1
7675115|NCT00239226|12091975|FG001|Overall Study|Lost to Follow-up|0
7675116|NCT00239226|12091976|FG002|Overall Study|Lost to Follow-up|1
7675117|NCT00239226|12091977|FG003|Overall Study|Lost to Follow-up|0
7675118|NCT00239356|12091989|FG000|Overall Study|Lack of Efficacy|1
7675119|NCT00239356|12091990|FG001|Overall Study|Lack of Efficacy|0
7675120|NCT00239356|12091989|FG000|Overall Study|Adverse Event|6
7675121|NCT00239356|12091990|FG001|Overall Study|Adverse Event|0
7675122|NCT00239356|12091989|FG000|Overall Study|Withdrawal by Subject|15
7675123|NCT00239356|12091990|FG001|Overall Study|Withdrawal by Subject|6
7675124|NCT00239356|12091989|FG000|Overall Study|Lost to Follow-up|3
7675125|NCT00239356|12091990|FG001|Overall Study|Lost to Follow-up|0
7675126|NCT00239356|12091989|FG000|Overall Study|poor/non-compliance|2
7675127|NCT00239356|12091990|FG001|Overall Study|poor/non-compliance|0
7675128|NCT00239356|12091989|FG000|Overall Study|Pregnancy|1
7675129|NCT00239356|12091990|FG001|Overall Study|Pregnancy|0
7675130|NCT00239356|12091989|FG000|Overall Study|Administrative reason|0
7675131|NCT00239356|12091990|FG001|Overall Study|Administrative reason|1
7675132|NCT00239356|12091989|FG000|Overall Study|Drug available on market|11
7675133|NCT00239356|12091990|FG001|Overall Study|Drug available on market|2
7675134|NCT00239577|12092000|FG000|Primary Phase|Adverse Event|0
7675135|NCT00239577|12092001|FG001|Primary Phase|Adverse Event|0
7675136|NCT00239577|12092002|FG002|Primary Phase|Adverse Event|1
7675137|NCT00239577|12092003|FG003|Primary Phase|Adverse Event|0
7675138|NCT00239577|12092000|FG000|Primary Phase|Other|5
7675139|NCT00239577|12092001|FG001|Primary Phase|Other|3
7675140|NCT00239577|12092002|FG002|Primary Phase|Other|2
7675141|NCT00239577|12092003|FG003|Primary Phase|Other|0
7675142|NCT00239590|12092015|FG000|Randomized|Lost to Follow-up|0
7675143|NCT00239590|12092016|FG001|Randomized|Lost to Follow-up|1
7675144|NCT00239590|12092015|FG000|Randomized|Withdrawal by Subject|0
7675145|NCT00239590|12092016|FG001|Randomized|Withdrawal by Subject|1
7675146|NCT00239590|12092015|FG000|Completed Study Protocol|Adverse Event|1
7675147|NCT00239590|12092016|FG001|Completed Study Protocol|Adverse Event|1
7675148|NCT00239590|12092015|FG000|Completed Study Protocol|Withdrawal by Subject|0
7675149|NCT00239590|12092016|FG001|Completed Study Protocol|Withdrawal by Subject|1
7675150|NCT00239681|12092039|FG000|Overall Study|Adverse Event|100
7675151|NCT00239681|12092040|FG001|Overall Study|Adverse Event|99
7675152|NCT00239681|12092039|FG000|Overall Study|Withdrawal by Subject|458
7675153|NCT00239681|12092040|FG001|Overall Study|Withdrawal by Subject|489
7675154|NCT00239681|12092039|FG000|Overall Study|Lost to Follow-up|28
7675155|NCT00239681|12092040|FG001|Overall Study|Lost to Follow-up|22
7675156|NCT00239681|12092039|FG000|Overall Study|Protocol Violation|4
7675157|NCT00239681|12092040|FG001|Overall Study|Protocol Violation|4
7675158|NCT00239681|12092039|FG000|Overall Study|Physician Decision|13
7675159|NCT00239681|12092040|FG001|Overall Study|Physician Decision|17
7675160|NCT00239681|12092039|FG000|Overall Study|No information chacked on CaseReportForm|90
7675161|NCT00239681|12092040|FG001|Overall Study|No information chacked on CaseReportForm|84
7675162|NCT00239837|12092052|FG000|Overall Study|Lost to Follow-up|3
7675163|NCT00239837|12092053|FG001|Overall Study|Lost to Follow-up|7
7675164|NCT00239928|12092061|FG000|Overall Study|Lack of Efficacy|1
7675165|NCT00239928|12092061|FG000|Overall Study|Adverse Event|4
7675166|NCT00239928|12092061|FG000|Overall Study|Not need to continue study|3
7675167|NCT00239928|12092061|FG000|Overall Study|Withdrawal by Subject|2
7675168|NCT00240071|12092065|FG000|Overall Study|Withdrawal by Subject|3
7675169|NCT00240097|12092070|FG000|Part I|Adverse Event|1
7675170|NCT00240097|12092070|FG000|Part I|Death|1
7675171|NCT00240097|12092070|FG000|Part I|histology|1
7675172|NCT00240097|12092070|FG000|Part I|unevaluable|1
7675173|NCT00240097|12092070|FG000|Part II|did not continue from Part I|23
7675174|NCT00240110|12092080|FG000|Overall Study|Lost to Follow-up|6
7675175|NCT00240110|12092081|FG001|Overall Study|Lost to Follow-up|7
7675176|NCT00240331|12092095|FG000|Overall Study|Withdrawal by Subject|125
7675177|NCT00240331|12092096|FG001|Overall Study|Withdrawal by Subject|132
7675178|NCT00240331|12092095|FG000|Overall Study|Option selected by investigator|1
7675179|NCT00240331|12092096|FG001|Overall Study|Option selected by investigator|2
7675180|NCT00240994|12092159|FG000|Overall Study|Lost to Follow-up|1
7675181|NCT00240994|12092159|FG000|Overall Study|Protocol Violation|1
7675182|NCT00240994|12092159|FG000|Overall Study|Graft failure|1
7675183|NCT00241280|12092170|FG000|Overall Study|Adverse Event|2
7675184|NCT00241280|12092171|FG001|Overall Study|Adverse Event|6
7675185|NCT00241280|12092170|FG000|Overall Study|Discomfort|11
7675186|NCT00241280|12092171|FG001|Overall Study|Discomfort|16
7675187|NCT00241280|12092170|FG000|Overall Study|Pregnancy|1
7675188|NCT00241280|12092171|FG001|Overall Study|Pregnancy|5
7675189|NCT00241280|12092170|FG000|Overall Study|Lost to Follow-up|5
7675190|NCT00241280|12092171|FG001|Overall Study|Lost to Follow-up|8
7675191|NCT00241280|12092170|FG000|Overall Study|Withdrawal by Subject|7
7675192|NCT00241280|12092171|FG001|Overall Study|Withdrawal by Subject|4
7675193|NCT00241280|12092170|FG000|Overall Study|Protocol Violation|4
7675194|NCT00241280|12092171|FG001|Overall Study|Protocol Violation|10
7675195|NCT00241280|12092170|FG000|Overall Study|Relocation|4
7675196|NCT00241280|12092171|FG001|Overall Study|Relocation|4
7675197|NCT00241280|12092170|FG000|Overall Study|Unsatisfactory Physiological Response|1
7675198|NCT00241280|12092171|FG001|Overall Study|Unsatisfactory Physiological Response|1
7675199|NCT00241280|12092170|FG000|Overall Study|Unsatisfactory Visual Response|1
7675200|NCT00241280|12092171|FG001|Overall Study|Unsatisfactory Visual Response|1
7675201|NCT00241280|12092170|FG000|Overall Study|Diabetic|1
7675202|NCT00241280|12092171|FG001|Overall Study|Diabetic|0
7675203|NCT00241280|12092170|FG000|Overall Study|Subject Ineligible/Dispensed|9
7675204|NCT00241280|12092171|FG001|Overall Study|Subject Ineligible/Dispensed|6
7675205|NCT00241280|12092170|FG000|Overall Study|Dispensed incorrect test article|1
7675206|NCT00241280|12092171|FG001|Overall Study|Dispensed incorrect test article|2
7675207|NCT00241280|12092170|FG000|Overall Study|Unacceptable Fit|0
7675208|NCT00241280|12092171|FG001|Overall Study|Unacceptable Fit|1
7675209|NCT00241280|12092170|FG000|Overall Study|Scheduling Conflict|0
7675210|NCT00241280|12092171|FG001|Overall Study|Scheduling Conflict|2
7675211|NCT00241280|12092170|FG000|Overall Study|History of Ocular Surgery|0
7675212|NCT00241280|12092171|FG001|Overall Study|History of Ocular Surgery|1
7675213|NCT00241280|12092170|FG000|Overall Study|Coating on Lens|1
7675214|NCT00241280|12092171|FG001|Overall Study|Coating on Lens|0
7675215|NCT00241280|12092170|FG000|Overall Study|Excessive Dryness|0
7675216|NCT00241280|12092171|FG001|Overall Study|Excessive Dryness|1
7675217|NCT00241358|12092181|FG000|Overall Study|Determined to be not ineligible|0
7675218|NCT00241358|12092182|FG001|Overall Study|Determined to be not ineligible|1
7675219|NCT00241358|12092183|FG002|Overall Study|Determined to be not ineligible|1
7675220|NCT00241631|12092192|FG000|Run in (2 Weeks)|Physician Decision|3
7675221|NCT00241631|12092193|FG001|Run in (2 Weeks)|Physician Decision|3
7675222|NCT00241631|12092192|FG000|Phase 1 (4 Weeks)|sore throat|1
7675223|NCT00241631|12092193|FG001|Phase 1 (4 Weeks)|sore throat|0
7675224|NCT00241631|12092192|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4
7675225|NCT00241631|12092193|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4
7675226|NCT00241631|12092192|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3
7675227|NCT00241631|12092193|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0
7675228|NCT00241631|12092192|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0
7675229|NCT00241631|12092193|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1
7675230|NCT00241644|12092203|FG000|First Efficacy Period (Year 1)|Adverse Event|46
7675231|NCT00241644|12092204|FG001|First Efficacy Period (Year 1)|Adverse Event|45
7675232|NCT00241644|12092205|FG002|First Efficacy Period (Year 1)|Adverse Event|45
7675233|NCT00241644|12092206|FG003|First Efficacy Period (Year 1)|Adverse Event|91
7675234|NCT00241644|12092203|FG000|First Efficacy Period (Year 1)|Protocol Violation|3
7675235|NCT00241644|12092204|FG001|First Efficacy Period (Year 1)|Protocol Violation|5
7675236|NCT00241644|12092205|FG002|First Efficacy Period (Year 1)|Protocol Violation|4
7675237|NCT00241644|12092206|FG003|First Efficacy Period (Year 1)|Protocol Violation|8
7675238|NCT00241644|12092203|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59
7675239|NCT00241644|12092204|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74
7675240|NCT00241644|12092205|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81
7675241|NCT00241644|12092206|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133
7675242|NCT00241644|12092203|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116
7675243|NCT00241644|12092204|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142
7675244|NCT00241644|12092205|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116
7675245|NCT00241644|12092206|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258
7675246|NCT00241644|12092203|FG000|First Efficacy Period (Year 1)|Non-compliance|2
7675247|NCT00241644|12092204|FG001|First Efficacy Period (Year 1)|Non-compliance|1
7675248|NCT00241644|12092205|FG002|First Efficacy Period (Year 1)|Non-compliance|2
7675249|NCT00241644|12092206|FG003|First Efficacy Period (Year 1)|Non-compliance|3
7675250|NCT00241644|12092203|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1
7675251|NCT00241644|12092204|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0
7675252|NCT00241644|12092205|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0
7675253|NCT00241644|12092206|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1
7675254|NCT00241644|12092203|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
7675255|NCT00241644|12092204|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
7675256|NCT00241644|12092205|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
7675257|NCT00241644|12092206|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
7675258|NCT00241644|12092203|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0
7675259|NCT00241644|12092204|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1
7675260|NCT00241644|12092205|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0
7675261|NCT00241644|12092206|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1
7675262|NCT00241644|12092203|FG000|Second Efficacy Period (Year 2)|Adverse Event|11
7675263|NCT00241644|12092204|FG001|Second Efficacy Period (Year 2)|Adverse Event|9
7675264|NCT00241644|12092205|FG002|Second Efficacy Period (Year 2)|Adverse Event|12
7675265|NCT00241644|12092206|FG003|Second Efficacy Period (Year 2)|Adverse Event|20
7675266|NCT00241644|12092203|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2
7675267|NCT00241644|12092204|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1
7675268|NCT00241644|12092205|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2
7675269|NCT00241644|12092206|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3
7675270|NCT00241644|12092203|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
7675271|NCT00241644|12092204|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
7675272|NCT00241644|12092205|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
7675273|NCT00241644|12092206|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
7675274|NCT00241644|12092203|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43
7675275|NCT00241644|12092204|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43
7675276|NCT00241644|12092205|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46
7675277|NCT00241644|12092206|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86
7675278|NCT00241644|12092203|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1
7675279|NCT00241644|12092204|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1
7675280|NCT00241644|12092205|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2
7675281|NCT00241644|12092206|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2
7675282|NCT00241839|12092218|FG000|Overall Study|Withdrawal by Subject|18
7675283|NCT00241839|12092219|FG001|Overall Study|Withdrawal by Subject|17
7675284|NCT00241839|12092218|FG000|Overall Study|Adverse Event|1
7675285|NCT00241839|12092219|FG001|Overall Study|Adverse Event|1
7675286|NCT00242216|12092246|FG000|Overall Study|Lost to Follow-up|12
7675287|NCT00242216|12092247|FG001|Overall Study|Lost to Follow-up|17
7675288|NCT00242216|12092246|FG000|Overall Study|Death|4
7675289|NCT00242216|12092247|FG001|Overall Study|Death|2
7675290|NCT00242216|12092246|FG000|Overall Study|Lack of Efficacy|1
7675291|NCT00242216|12092247|FG001|Overall Study|Lack of Efficacy|2
7675292|NCT00242216|12092246|FG000|Overall Study|no medicaiton dispensed|1
7675293|NCT00242216|12092247|FG001|Overall Study|no medicaiton dispensed|1
7675294|NCT00242567|12092266|FG000|Overall Study|Adverse Event|70
7675295|NCT00242567|12092267|FG001|Overall Study|Adverse Event|43
7675296|NCT00242567|12092266|FG000|Overall Study|Disease Progression|17
7675297|NCT00242567|12092267|FG001|Overall Study|Disease Progression|22
7675298|NCT00242567|12092266|FG000|Overall Study|Symptomatic deterioration|9
7675299|NCT00242567|12092267|FG001|Overall Study|Symptomatic deterioration|3
7675300|NCT00242567|12092266|FG000|Overall Study|Lack of Efficacy|2
7675301|NCT00242567|12092267|FG001|Overall Study|Lack of Efficacy|2
7675302|NCT00242567|12092266|FG000|Overall Study|Lost to Follow-up|9
7675303|NCT00242567|12092267|FG001|Overall Study|Lost to Follow-up|19
7675304|NCT00242567|12092266|FG000|Overall Study|Withdrawal by Subject|33
7675305|NCT00242567|12092267|FG001|Overall Study|Withdrawal by Subject|28
7675306|NCT00242567|12092266|FG000|Overall Study|Protocol Violation|12
7675307|NCT00242567|12092267|FG001|Overall Study|Protocol Violation|12
7675308|NCT00242567|12092266|FG000|Overall Study|Use of an inhibitor of bone resorption|0
7675309|NCT00242567|12092267|FG001|Overall Study|Use of an inhibitor of bone resorption|2
7675310|NCT00242567|12092266|FG000|Overall Study|Other|14
7675311|NCT00242567|12092267|FG001|Overall Study|Other|9
7675312|NCT00242580|12092278|FG000|Overall Study|Adverse Event|3
7675313|NCT00242580|12092279|FG001|Overall Study|Adverse Event|0
7675314|NCT00242580|12092280|FG002|Overall Study|Adverse Event|2
7675315|NCT00242580|12092278|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7675316|NCT00242580|12092279|FG001|Overall Study|Unsatisfactory therapeutic effect|5
7675317|NCT00242580|12092280|FG002|Overall Study|Unsatisfactory therapeutic effect|5
7675318|NCT00242580|12092278|FG000|Overall Study|Protocol Violation|0
7675319|NCT00242580|12092279|FG001|Overall Study|Protocol Violation|0
7675320|NCT00242580|12092280|FG002|Overall Study|Protocol Violation|1
7675321|NCT00242580|12092278|FG000|Overall Study|Subject withdrew consent|2
7675322|NCT00242580|12092279|FG001|Overall Study|Subject withdrew consent|2
7675323|NCT00242580|12092280|FG002|Overall Study|Subject withdrew consent|5
7675324|NCT00242580|12092278|FG000|Overall Study|Lost to Follow-up|0
7675325|NCT00242580|12092279|FG001|Overall Study|Lost to Follow-up|3
7675326|NCT00242580|12092280|FG002|Overall Study|Lost to Follow-up|0
7675327|NCT00242580|12092278|FG000|Overall Study|Death|1
7675328|NCT00242580|12092279|FG001|Overall Study|Death|2
7675329|NCT00242580|12092280|FG002|Overall Study|Death|1
7675330|NCT00242658|12092309|FG000|Overall Study|Lost to Follow-up|22
7675331|NCT00242658|12092310|FG001|Overall Study|Lost to Follow-up|19
7675332|NCT00242710|12092324|FG000|Core Study (up to Year 1)|Adverse Event|30
7675333|NCT00242710|12092325|FG001|Core Study (up to Year 1)|Adverse Event|25
7675334|NCT00242710|12092326|FG002|Core Study (up to Year 1)|Adverse Event|23
7675335|NCT00242710|12092327|FG003|Core Study (up to Year 1)|Adverse Event|14
7675336|NCT00242710|12092324|FG000|Core Study (up to Year 1)|Death|0
7675337|NCT00242710|12092325|FG001|Core Study (up to Year 1)|Death|0
7675338|NCT00242710|12092326|FG002|Core Study (up to Year 1)|Death|1
7675339|NCT00242710|12092327|FG003|Core Study (up to Year 1)|Death|0
7675340|NCT00242710|12092324|FG000|Core Study (up to Year 1)|Physician Decision|0
7675341|NCT00242710|12092325|FG001|Core Study (up to Year 1)|Physician Decision|1
7675342|NCT00242710|12092326|FG002|Core Study (up to Year 1)|Physician Decision|0
7675343|NCT00242710|12092327|FG003|Core Study (up to Year 1)|Physician Decision|1
7675344|NCT00242710|12092324|FG000|Core Study (up to Year 1)|Lost to Follow-up|8
7675345|NCT00242710|12092325|FG001|Core Study (up to Year 1)|Lost to Follow-up|8
7675346|NCT00242710|12092326|FG002|Core Study (up to Year 1)|Lost to Follow-up|7
7675347|NCT00242710|12092327|FG003|Core Study (up to Year 1)|Lost to Follow-up|3
7675348|NCT00242710|12092324|FG000|Core Study (up to Year 1)|Other|6
7675349|NCT00242710|12092325|FG001|Core Study (up to Year 1)|Other|1
7675350|NCT00242710|12092326|FG002|Core Study (up to Year 1)|Other|0
7675351|NCT00242710|12092327|FG003|Core Study (up to Year 1)|Other|2
7675352|NCT00242710|12092324|FG000|Core Study (up to Year 1)|Protocol Violation|2
7675353|NCT00242710|12092325|FG001|Core Study (up to Year 1)|Protocol Violation|9
7675354|NCT00242710|12092326|FG002|Core Study (up to Year 1)|Protocol Violation|1
7675355|NCT00242710|12092327|FG003|Core Study (up to Year 1)|Protocol Violation|3
7675356|NCT00242710|12092324|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27
7675357|NCT00242710|12092325|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16
7675358|NCT00242710|12092326|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15
7675359|NCT00242710|12092327|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6
7675360|NCT00242710|12092324|FG000|Core Study (up to Year 1)|Lack of Efficacy|1
7675361|NCT00242710|12092325|FG001|Core Study (up to Year 1)|Lack of Efficacy|0
7675362|NCT00242710|12092326|FG002|Core Study (up to Year 1)|Lack of Efficacy|0
7675363|NCT00242710|12092327|FG003|Core Study (up to Year 1)|Lack of Efficacy|0
7675364|NCT00242710|12092324|FG000|Core Study (up to Year 1)|Randomized but not Treated|12
7675365|NCT00242710|12092325|FG001|Core Study (up to Year 1)|Randomized but not Treated|4
7675366|NCT00242710|12092326|FG002|Core Study (up to Year 1)|Randomized but not Treated|4
7675367|NCT00242710|12092327|FG003|Core Study (up to Year 1)|Randomized but not Treated|2
7675368|NCT00242710|12092324|FG000|Period Between Core Study and Extension|Adverse Event|2
7675369|NCT00242710|12092325|FG001|Period Between Core Study and Extension|Adverse Event|3
7675370|NCT00242710|12092326|FG002|Period Between Core Study and Extension|Adverse Event|5
7675371|NCT00242710|12092327|FG003|Period Between Core Study and Extension|Adverse Event|2
7675372|NCT00242710|12092324|FG000|Period Between Core Study and Extension|Physician Decision|1
7675373|NCT00242710|12092325|FG001|Period Between Core Study and Extension|Physician Decision|1
7675374|NCT00242710|12092326|FG002|Period Between Core Study and Extension|Physician Decision|0
7675375|NCT00242710|12092327|FG003|Period Between Core Study and Extension|Physician Decision|0
7675376|NCT00242710|12092324|FG000|Period Between Core Study and Extension|Other|24
7675377|NCT00242710|12092325|FG001|Period Between Core Study and Extension|Other|24
7675378|NCT00242710|12092326|FG002|Period Between Core Study and Extension|Other|9
7675379|NCT00242710|12092327|FG003|Period Between Core Study and Extension|Other|11
7675380|NCT00242710|12092324|FG000|Period Between Core Study and Extension|Extension not Available|17
7675381|NCT00242710|12092325|FG001|Period Between Core Study and Extension|Extension not Available|21
7675382|NCT00242710|12092326|FG002|Period Between Core Study and Extension|Extension not Available|8
7675383|NCT00242710|12092327|FG003|Period Between Core Study and Extension|Extension not Available|7
7675384|NCT00242710|12092324|FG000|Period Between Core Study and Extension|Protocol Violation|0
7675385|NCT00242710|12092325|FG001|Period Between Core Study and Extension|Protocol Violation|0
7675462|NCT00243230|12092373|FG001|Open Label Period|Lost to Follow-up|0
7675386|NCT00242710|12092326|FG002|Period Between Core Study and Extension|Protocol Violation|2
7675387|NCT00242710|12092327|FG003|Period Between Core Study and Extension|Protocol Violation|1
7675388|NCT00242710|12092324|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75
7675389|NCT00242710|12092325|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63
7675390|NCT00242710|12092326|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24
7675391|NCT00242710|12092327|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28
7675392|NCT00242710|12092324|FG000|Study Extension (up to Year 2)|Adverse Event|7
7675393|NCT00242710|12092325|FG001|Study Extension (up to Year 2)|Adverse Event|9
7675394|NCT00242710|12092326|FG002|Study Extension (up to Year 2)|Adverse Event|2
7675395|NCT00242710|12092327|FG003|Study Extension (up to Year 2)|Adverse Event|4
7675396|NCT00242710|12092324|FG000|Study Extension (up to Year 2)|Death|0
7675397|NCT00242710|12092325|FG001|Study Extension (up to Year 2)|Death|0
7675398|NCT00242710|12092326|FG002|Study Extension (up to Year 2)|Death|0
7675399|NCT00242710|12092327|FG003|Study Extension (up to Year 2)|Death|1
7675400|NCT00242710|12092324|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7
7675401|NCT00242710|12092325|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7
7675402|NCT00242710|12092326|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5
7675403|NCT00242710|12092327|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0
7675404|NCT00242710|12092324|FG000|Study Extension (up to Year 2)|Other|3
7675405|NCT00242710|12092325|FG001|Study Extension (up to Year 2)|Other|5
7675406|NCT00242710|12092326|FG002|Study Extension (up to Year 2)|Other|4
7675407|NCT00242710|12092327|FG003|Study Extension (up to Year 2)|Other|3
7675408|NCT00242710|12092324|FG000|Study Extension (up to Year 2)|Protocol Violation|0
7675409|NCT00242710|12092325|FG001|Study Extension (up to Year 2)|Protocol Violation|2
7675410|NCT00242710|12092326|FG002|Study Extension (up to Year 2)|Protocol Violation|0
7675411|NCT00242710|12092327|FG003|Study Extension (up to Year 2)|Protocol Violation|1
7675412|NCT00242710|12092324|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10
7675413|NCT00242710|12092325|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6
7675414|NCT00242710|12092326|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4
7675415|NCT00242710|12092327|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1
7675416|NCT00243022|12092339|FG000|Overall Study|Withdrawal by Subject|1
7675417|NCT00243022|12092340|FG001|Overall Study|Withdrawal by Subject|0
7675418|NCT00243022|12092339|FG000|Overall Study|Death|1
7675419|NCT00243022|12092340|FG001|Overall Study|Death|0
7675420|NCT00243022|12092339|FG000|Overall Study|Difficult Travel Distance|0
7675421|NCT00243022|12092340|FG001|Overall Study|Difficult Travel Distance|1
7675422|NCT00243074|12092352|FG000|Overall Study|Ineligible|6
7675423|NCT00243074|12092352|FG000|Overall Study|Adverse Event|6
7675424|NCT00243074|12092352|FG000|Overall Study|Withdrawal by Subject|2
7675425|NCT00243074|12092352|FG000|Overall Study|Lack of Efficacy|36
7675426|NCT00243074|12092352|FG000|Overall Study|Death|2
7675427|NCT00243074|12092352|FG000|Overall Study|not protocol specified|1
7675428|NCT00243074|12092352|FG000|Overall Study|Did not receive any treatment|1
7675429|NCT00243230|12092372|FG000|Double-Blind Period|Adverse Event|0
7675430|NCT00243230|12092373|FG001|Double-Blind Period|Adverse Event|2
7675431|NCT00243230|12092374|FG002|Double-Blind Period|Adverse Event|2
7675432|NCT00243230|12092375|FG003|Double-Blind Period|Adverse Event|0
7675433|NCT00243230|12092372|FG000|Double-Blind Period|Withdrawal by Subject|1
7675434|NCT00243230|12092373|FG001|Double-Blind Period|Withdrawal by Subject|0
7675435|NCT00243230|12092374|FG002|Double-Blind Period|Withdrawal by Subject|0
7675436|NCT00243230|12092375|FG003|Double-Blind Period|Withdrawal by Subject|0
7675437|NCT00243230|12092372|FG000|Double-Blind Period|Protocol Violation|0
7675438|NCT00243230|12092373|FG001|Double-Blind Period|Protocol Violation|0
7675439|NCT00243230|12092374|FG002|Double-Blind Period|Protocol Violation|1
7675440|NCT00243230|12092375|FG003|Double-Blind Period|Protocol Violation|0
7675441|NCT00243230|12092372|FG000|Double-Blind Period|Randomized but Not Treated|0
7675442|NCT00243230|12092373|FG001|Double-Blind Period|Randomized but Not Treated|0
7675443|NCT00243230|12092374|FG002|Double-Blind Period|Randomized but Not Treated|2
7675444|NCT00243230|12092375|FG003|Double-Blind Period|Randomized but Not Treated|0
7675445|NCT00243230|12092372|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5
7675446|NCT00243230|12092373|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3
7675447|NCT00243230|12092374|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14
7675448|NCT00243230|12092375|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0
7675449|NCT00243230|12092372|FG000|Open Label Period|Adverse Event|0
7675450|NCT00243230|12092373|FG001|Open Label Period|Adverse Event|0
7675451|NCT00243230|12092374|FG002|Open Label Period|Adverse Event|0
7675452|NCT00243230|12092375|FG003|Open Label Period|Adverse Event|2
7675453|NCT00243230|12092372|FG000|Open Label Period|Treatment Failure - Virologic Failure|0
7675454|NCT00243230|12092373|FG001|Open Label Period|Treatment Failure - Virologic Failure|0
7675455|NCT00243230|12092374|FG002|Open Label Period|Treatment Failure - Virologic Failure|0
7675456|NCT00243230|12092375|FG003|Open Label Period|Treatment Failure - Virologic Failure|13
7675457|NCT00243230|12092372|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0
7675458|NCT00243230|12092373|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0
7675459|NCT00243230|12092374|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0
7675460|NCT00243230|12092375|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1
7675461|NCT00243230|12092372|FG000|Open Label Period|Lost to Follow-up|0
7675463|NCT00243230|12092374|FG002|Open Label Period|Lost to Follow-up|0
7675464|NCT00243230|12092375|FG003|Open Label Period|Lost to Follow-up|2
7675465|NCT00243230|12092372|FG000|Open Label Period|Withdrawal by Subject|0
7675466|NCT00243230|12092373|FG001|Open Label Period|Withdrawal by Subject|0
7675467|NCT00243230|12092374|FG002|Open Label Period|Withdrawal by Subject|0
7675468|NCT00243230|12092375|FG003|Open Label Period|Withdrawal by Subject|2
7675469|NCT00243230|12092372|FG000|Open Label Period|Protocol Violation|0
7675470|NCT00243230|12092373|FG001|Open Label Period|Protocol Violation|0
7675471|NCT00243230|12092374|FG002|Open Label Period|Protocol Violation|0
7675472|NCT00243230|12092375|FG003|Open Label Period|Protocol Violation|2
7675473|NCT00243230|12092372|FG000|Open Label Period|Administrative Reason|0
7675474|NCT00243230|12092373|FG001|Open Label Period|Administrative Reason|0
7675475|NCT00243230|12092374|FG002|Open Label Period|Administrative Reason|0
7675476|NCT00243230|12092375|FG003|Open Label Period|Administrative Reason|63
7675477|NCT00243269|12092398|FG000|Overall Study|Protocol Violation|2
7675478|NCT00243269|12092399|FG001|Overall Study|Protocol Violation|1
7675479|NCT00243269|12092400|FG002|Overall Study|Protocol Violation|0
7675480|NCT00243269|12092401|FG003|Overall Study|Protocol Violation|1
7675481|NCT00243269|12092398|FG000|Overall Study|Lost to Follow-up|1
7675482|NCT00243269|12092399|FG001|Overall Study|Lost to Follow-up|0
7675483|NCT00243269|12092400|FG002|Overall Study|Lost to Follow-up|1
7675484|NCT00243269|12092401|FG003|Overall Study|Lost to Follow-up|3
7675485|NCT00243347|12092411|FG000|Overall Study|Lack of Efficacy|4
7675486|NCT00243347|12092411|FG000|Overall Study|Adverse Event|2
7675487|NCT00243347|12092411|FG000|Overall Study|Death|1
7675488|NCT00243347|12092411|FG000|Overall Study|Withdrawal by Subject|5
7675489|NCT00243347|12092411|FG000|Overall Study|Condition worsened|7
7675490|NCT00243386|12092415|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
7675491|NCT00243386|12092416|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
7675492|NCT00243386|12092417|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
7675493|NCT00243386|12092415|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
7675494|NCT00243386|12092416|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
7675495|NCT00243386|12092417|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
7675496|NCT00243386|12092415|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2
7675497|NCT00243386|12092416|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0
7675498|NCT00243386|12092417|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0
7675499|NCT00243386|12092415|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
7675500|NCT00243386|12092416|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
7675501|NCT00243386|12092417|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
7675502|NCT00243386|12092415|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
7675503|NCT00243386|12092416|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
7675504|NCT00243386|12092417|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
7675505|NCT00243386|12092415|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
7675506|NCT00243386|12092416|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
7675507|NCT00243386|12092417|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
7675508|NCT00243386|12092415|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
7675509|NCT00243386|12092416|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
7675510|NCT00243386|12092417|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
7675511|NCT00243386|12092415|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
7675512|NCT00243386|12092416|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
7675513|NCT00243386|12092417|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
7675514|NCT00243412|12092455|FG000|Overall Study|Death|0
7675515|NCT00243412|12092456|FG001|Overall Study|Death|1
7675516|NCT00243412|12092455|FG000|Overall Study|Adverse Event|4
7675517|NCT00243412|12092456|FG001|Overall Study|Adverse Event|2
7675518|NCT00243412|12092455|FG000|Overall Study|Lost to Follow-up|0
7675519|NCT00243412|12092456|FG001|Overall Study|Lost to Follow-up|1
7675520|NCT00243412|12092455|FG000|Overall Study|Physician Decision|1
7675521|NCT00243412|12092456|FG001|Overall Study|Physician Decision|1
7675522|NCT00243412|12092455|FG000|Overall Study|Withdrawal by Subject|4
7675523|NCT00243412|12092456|FG001|Overall Study|Withdrawal by Subject|5
7675524|NCT00243412|12092455|FG000|Overall Study|Other|1
7675525|NCT00243412|12092456|FG001|Overall Study|Other|1
7675526|NCT00243503|12092462|FG000|Overall Study|Adverse Event|11
7675527|NCT00243503|12092462|FG000|Overall Study|Withdrawal by Subject|1
7675528|NCT00243503|12092462|FG000|Overall Study|Lack of Efficacy|44
7675529|NCT00243503|12092462|FG000|Overall Study|Death|1
7675530|NCT00243503|12092462|FG000|Overall Study|Other|1
7675531|NCT00243659|12092469|FG000|Overall Study|Withdrawal by Subject|1
7675532|NCT00243659|12092470|FG001|Overall Study|Withdrawal by Subject|1
7675533|NCT00243659|12092469|FG000|Overall Study|Protocol Violation|1
7675534|NCT00243659|12092470|FG001|Overall Study|Protocol Violation|2
7675535|NCT00243841|12092479|FG000|Overall Study|Physician Decision|0
7675536|NCT00243841|12092480|FG001|Overall Study|Physician Decision|0
7675537|NCT00243841|12092481|FG002|Overall Study|Physician Decision|1
7675538|NCT00243841|12092482|FG003|Overall Study|Physician Decision|0
7675539|NCT00243841|12092483|FG004|Overall Study|Physician Decision|0
7675540|NCT00243841|12092484|FG005|Overall Study|Physician Decision|2
7675541|NCT00243919|12092503|FG000|Overall Study|Death|3
7675542|NCT00243919|12092504|FG001|Overall Study|Death|4
7675543|NCT00243919|12092505|FG002|Overall Study|Death|6
7675544|NCT00243919|12092503|FG000|Overall Study|Withdrawal by Subject|6
7675545|NCT00243919|12092504|FG001|Overall Study|Withdrawal by Subject|6
7675546|NCT00243919|12092505|FG002|Overall Study|Withdrawal by Subject|2
7675547|NCT00243919|12092503|FG000|Overall Study|Lost to Follow-up|6
7675548|NCT00243919|12092504|FG001|Overall Study|Lost to Follow-up|7
7675549|NCT00243919|12092505|FG002|Overall Study|Lost to Follow-up|3
7675550|NCT00243919|12092503|FG000|Overall Study|Administrative Error|1
7675551|NCT00243919|12092504|FG001|Overall Study|Administrative Error|0
7675552|NCT00243919|12092505|FG002|Overall Study|Administrative Error|0
7675553|NCT00243919|12092503|FG000|Overall Study|Physician Decision|1
7675554|NCT00243919|12092504|FG001|Overall Study|Physician Decision|1
7675555|NCT00243919|12092505|FG002|Overall Study|Physician Decision|0
7675556|NCT00243932|12092516|FG000|Stage 1: Dose Selection|Lost to Follow-up|2
7675557|NCT00243932|12092517|FG001|Stage 1: Dose Selection|Lost to Follow-up|0
7675558|NCT00243932|12092518|FG002|Stage 1: Dose Selection|Lost to Follow-up|0
7675559|NCT00244374|12092548|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
7675560|NCT00244374|12092549|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
7675561|NCT00244374|12092550|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
7675562|NCT00244374|12092551|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
7675563|NCT00244374|12092552|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
7675564|NCT00244374|12092548|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
7675565|NCT00244374|12092549|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
7675566|NCT00244374|12092550|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
7675567|NCT00244374|12092551|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
7675568|NCT00244374|12092552|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
7675569|NCT00244374|12092548|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
7675570|NCT00244374|12092549|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
7675571|NCT00244374|12092550|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
7675572|NCT00244374|12092551|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
7675573|NCT00244374|12092552|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
7675574|NCT00244374|12092548|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
7675575|NCT00244374|12092549|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
7675576|NCT00244374|12092550|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
7675577|NCT00244374|12092551|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
7675578|NCT00244374|12092552|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
7675579|NCT00244374|12092548|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
7675580|NCT00244374|12092549|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
7675581|NCT00244374|12092550|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
7675582|NCT00244374|12092551|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
7675583|NCT00244374|12092552|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
7675584|NCT00244374|12092548|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
7675585|NCT00244374|12092549|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
7675586|NCT00244374|12092550|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
7675587|NCT00244374|12092551|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
7675588|NCT00244374|12092552|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
7675589|NCT00244374|12092548|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
7675590|NCT00244374|12092549|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
7675591|NCT00244374|12092550|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
7675592|NCT00244374|12092551|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
7675593|NCT00244374|12092552|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
7675594|NCT00244374|12092548|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
7675595|NCT00244374|12092549|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
7675596|NCT00244374|12092550|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
7675597|NCT00244374|12092551|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
7675598|NCT00244374|12092552|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
7675599|NCT00244374|12092548|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
7675600|NCT00244374|12092549|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
7675601|NCT00244374|12092550|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
7675602|NCT00244374|12092551|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
7675603|NCT00244374|12092552|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
7675604|NCT00244621|12092571|FG000|Double-blind Treatment Period|Lost to Follow-up|0
7675605|NCT00244621|12092572|FG001|Double-blind Treatment Period|Lost to Follow-up|0
7675606|NCT00244621|12092573|FG002|Double-blind Treatment Period|Lost to Follow-up|1
7675607|NCT00244621|12092571|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
7675608|NCT00244621|12092572|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
7675609|NCT00244621|12092573|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7675610|NCT00244621|12092571|FG000|Double-blind Treatment Period|Lack of Efficacy|0
7675611|NCT00244621|12092572|FG001|Double-blind Treatment Period|Lack of Efficacy|1
7675612|NCT00244621|12092573|FG002|Double-blind Treatment Period|Lack of Efficacy|0
7675613|NCT00244621|12092571|FG000|Double-blind Treatment Period|Multiple Reasons|2
7675614|NCT00244621|12092572|FG001|Double-blind Treatment Period|Multiple Reasons|1
7675615|NCT00244621|12092573|FG002|Double-blind Treatment Period|Multiple Reasons|1
7675616|NCT00244621|12092571|FG000|Open-label Treatment Period|Lost to Follow-up|0
7675617|NCT00244621|12092572|FG001|Open-label Treatment Period|Lost to Follow-up|1
7675618|NCT00244621|12092573|FG002|Open-label Treatment Period|Lost to Follow-up|0
7675619|NCT00244621|12092571|FG000|Open-label Treatment Period|Withdrawal by Subject|1
7675620|NCT00244621|12092572|FG001|Open-label Treatment Period|Withdrawal by Subject|0
7675621|NCT00244621|12092573|FG002|Open-label Treatment Period|Withdrawal by Subject|0
7675622|NCT00244621|12092571|FG000|Open-label Treatment Period|Adverse Event|0
7675623|NCT00244621|12092572|FG001|Open-label Treatment Period|Adverse Event|0
7675624|NCT00244621|12092573|FG002|Open-label Treatment Period|Adverse Event|1
7675625|NCT00244621|12092571|FG000|Open-label Treatment Period|Moved abroad|0
7675626|NCT00244621|12092572|FG001|Open-label Treatment Period|Moved abroad|0
7675627|NCT00244621|12092573|FG002|Open-label Treatment Period|Moved abroad|1
7675628|NCT00244712|12092583|FG000|Overall Study|Adverse Event|20
7675629|NCT00244712|12092584|FG001|Overall Study|Adverse Event|21
7675630|NCT00244712|12092583|FG000|Overall Study|Protocol-Defined Virologic Failure|8
7675631|NCT00244712|12092584|FG001|Overall Study|Protocol-Defined Virologic Failure|6
7675632|NCT00244712|12092583|FG000|Overall Study|Lack of Compliance|10
7675633|NCT00244712|12092584|FG001|Overall Study|Lack of Compliance|11
7675634|NCT00244712|12092583|FG000|Overall Study|Lost to Follow-up|45
7675635|NCT00244712|12092584|FG001|Overall Study|Lost to Follow-up|52
7675636|NCT00244712|12092583|FG000|Overall Study|Withdrawal by Subject|13
7675637|NCT00244712|12092584|FG001|Overall Study|Withdrawal by Subject|23
7675638|NCT00244712|12092583|FG000|Overall Study|Protocol Violation, disease progression|13
7675639|NCT00244712|12092584|FG001|Overall Study|Protocol Violation, disease progression|11
7675640|NCT00244725|12092594|FG000|Overall Study|Lost to Follow-up|3
7675641|NCT00244725|12092595|FG001|Overall Study|Lost to Follow-up|4
7675642|NCT00244725|12092596|FG002|Overall Study|Lost to Follow-up|9
7675643|NCT00244725|12092597|FG003|Overall Study|Lost to Follow-up|2
7675644|NCT00244725|12092594|FG000|Overall Study|Withdrawal by Subject|9
7675645|NCT00244725|12092595|FG001|Overall Study|Withdrawal by Subject|7
7675646|NCT00244725|12092596|FG002|Overall Study|Withdrawal by Subject|7
7675647|NCT00244725|12092597|FG003|Overall Study|Withdrawal by Subject|8
7675648|NCT00244725|12092594|FG000|Overall Study|Not meet treatment eligibility criteria|1
7675649|NCT00244725|12092595|FG001|Overall Study|Not meet treatment eligibility criteria|2
7675650|NCT00244725|12092596|FG002|Overall Study|Not meet treatment eligibility criteria|0
7675651|NCT00244725|12092597|FG003|Overall Study|Not meet treatment eligibility criteria|0
7675652|NCT00244725|12092594|FG000|Overall Study|Physician Decision|3
7675653|NCT00244725|12092595|FG001|Overall Study|Physician Decision|0
7675654|NCT00244725|12092596|FG002|Overall Study|Physician Decision|1
7675655|NCT00244725|12092597|FG003|Overall Study|Physician Decision|2
7675656|NCT00244725|12092594|FG000|Overall Study|Adverse Events|3
7675657|NCT00244725|12092595|FG001|Overall Study|Adverse Events|1
7675658|NCT00244725|12092596|FG002|Overall Study|Adverse Events|4
7675659|NCT00244725|12092597|FG003|Overall Study|Adverse Events|4
7675660|NCT00244725|12092594|FG000|Overall Study|Withdrwal by participant|1
7675661|NCT00244725|12092595|FG001|Overall Study|Withdrwal by participant|0
7675662|NCT00244725|12092596|FG002|Overall Study|Withdrwal by participant|0
7675663|NCT00244725|12092597|FG003|Overall Study|Withdrwal by participant|1
7675664|NCT00244725|12092594|FG000|Overall Study|Liver function test abnormality|2
7675665|NCT00244725|12092595|FG001|Overall Study|Liver function test abnormality|0
7675666|NCT00244725|12092596|FG002|Overall Study|Liver function test abnormality|0
7675667|NCT00244725|12092597|FG003|Overall Study|Liver function test abnormality|1
7675668|NCT00244725|12092594|FG000|Overall Study|Sponsor withdrew the participant|1
7675669|NCT00244725|12092595|FG001|Overall Study|Sponsor withdrew the participant|0
7675670|NCT00244725|12092596|FG002|Overall Study|Sponsor withdrew the participant|0
7675671|NCT00244725|12092597|FG003|Overall Study|Sponsor withdrew the participant|1
7675672|NCT00244725|12092594|FG000|Overall Study|Mediciation Error|0
7675673|NCT00244725|12092595|FG001|Overall Study|Mediciation Error|1
7675674|NCT00244725|12092596|FG002|Overall Study|Mediciation Error|0
7675675|NCT00244725|12092597|FG003|Overall Study|Mediciation Error|0
7675676|NCT00244725|12092594|FG000|Overall Study|Rehab Refused to allow participantion|0
7675677|NCT00244725|12092595|FG001|Overall Study|Rehab Refused to allow participantion|1
7675678|NCT00244725|12092596|FG002|Overall Study|Rehab Refused to allow participantion|0
7675679|NCT00244725|12092597|FG003|Overall Study|Rehab Refused to allow participantion|0
7675680|NCT00244725|12092594|FG000|Overall Study|Headache|0
7675681|NCT00244725|12092595|FG001|Overall Study|Headache|1
7675682|NCT00244725|12092596|FG002|Overall Study|Headache|0
7675683|NCT00244725|12092597|FG003|Overall Study|Headache|0
7675684|NCT00244725|12092594|FG000|Overall Study|Received prohibited medication|0
7675685|NCT00244725|12092595|FG001|Overall Study|Received prohibited medication|1
7675686|NCT00244725|12092596|FG002|Overall Study|Received prohibited medication|0
7675687|NCT00244725|12092597|FG003|Overall Study|Received prohibited medication|1
7675688|NCT00244725|12092594|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0
7675689|NCT00244725|12092595|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1
7675690|NCT00244725|12092596|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0
7675691|NCT00244725|12092597|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0
7675692|NCT00244725|12092594|FG000|Overall Study|Administrative reason|0
7675693|NCT00244725|12092595|FG001|Overall Study|Administrative reason|0
7675694|NCT00244725|12092596|FG002|Overall Study|Administrative reason|1
7675695|NCT00244725|12092597|FG003|Overall Study|Administrative reason|0
7675696|NCT00244725|12092594|FG000|Overall Study|Vomit|0
7675697|NCT00244725|12092595|FG001|Overall Study|Vomit|0
7675698|NCT00244725|12092596|FG002|Overall Study|Vomit|1
7675699|NCT00244725|12092597|FG003|Overall Study|Vomit|0
7675700|NCT00244725|12092594|FG000|Overall Study|Failed to follow-up|0
7675701|NCT00244725|12092595|FG001|Overall Study|Failed to follow-up|0
7675702|NCT00244725|12092596|FG002|Overall Study|Failed to follow-up|1
7675703|NCT00244725|12092597|FG003|Overall Study|Failed to follow-up|1
7675704|NCT00244751|12092610|FG000|Overall Study|Adverse Event|7
7675705|NCT00244751|12092611|FG001|Overall Study|Adverse Event|7
7675706|NCT00244751|12092612|FG002|Overall Study|Adverse Event|5
7675707|NCT00244751|12092610|FG000|Overall Study|Lost to Follow-up|0
7675708|NCT00244751|12092611|FG001|Overall Study|Lost to Follow-up|1
7675709|NCT00244751|12092612|FG002|Overall Study|Lost to Follow-up|0
7675710|NCT00244751|12092610|FG000|Overall Study|Protocol Violation|1
7675711|NCT00244751|12092611|FG001|Overall Study|Protocol Violation|0
7675712|NCT00244751|12092612|FG002|Overall Study|Protocol Violation|1
7675713|NCT00244751|12092610|FG000|Overall Study|Withdrawal by Subject|7
7675714|NCT00244751|12092611|FG001|Overall Study|Withdrawal by Subject|5
7675715|NCT00244751|12092612|FG002|Overall Study|Withdrawal by Subject|3
7675716|NCT00244751|12092610|FG000|Overall Study|Elevated liver enzymes|1
7675717|NCT00244751|12092611|FG001|Overall Study|Elevated liver enzymes|0
7675718|NCT00244751|12092612|FG002|Overall Study|Elevated liver enzymes|0
7675719|NCT00244751|12092610|FG000|Overall Study|Lack of compliance with protocol|0
7675720|NCT00244751|12092611|FG001|Overall Study|Lack of compliance with protocol|1
7675721|NCT00244751|12092612|FG002|Overall Study|Lack of compliance with protocol|0
7675722|NCT00244751|12092610|FG000|Overall Study|Safety reasons|0
7675723|NCT00244751|12092611|FG001|Overall Study|Safety reasons|1
7675724|NCT00244751|12092612|FG002|Overall Study|Safety reasons|0
7675725|NCT00244751|12092610|FG000|Overall Study|Participant randomized by mistake|0
7675726|NCT00244751|12092611|FG001|Overall Study|Participant randomized by mistake|0
7675727|NCT00244751|12092612|FG002|Overall Study|Participant randomized by mistake|1
7675728|NCT00244764|12092629|FG000|Overall Study|Adverse Event|37
7675729|NCT00244764|12092629|FG000|Overall Study|Lost to Follow-up|23
7675730|NCT00244764|12092629|FG000|Overall Study|Withdrawal by Subject|12
7675731|NCT00244764|12092629|FG000|Overall Study|Disease Progression|13
7675732|NCT00244764|12092629|FG000|Overall Study|Protocol Violation|2
7675733|NCT00244764|12092629|FG000|Overall Study|Death|1
7675734|NCT00244764|12092629|FG000|Overall Study|Off Study Medication for >21 Days|1
7675735|NCT00244764|12092629|FG000|Overall Study|Declining Performance Status|1
7675736|NCT00244764|12092629|FG000|Overall Study|Participant was Hospitalized until Death|1
7675737|NCT00244764|12092629|FG000|Overall Study|Primary Investigator Discretion|2
7675738|NCT00244764|12092629|FG000|Overall Study|Sponsor Terminated Study|2
7675739|NCT00244764|12092629|FG000|Overall Study|Developed Secondary Malignancy|1
7675740|NCT00244855|12092636|FG000|Overall Study|Withdrawal by Subject|0
7675741|NCT00244855|12092637|FG001|Overall Study|Withdrawal by Subject|1
7675742|NCT00244881|12092645|FG000|Overall Study|Withdrawal by Subject|3
7675743|NCT00244933|12092649|FG000|Overall Study|Not response evaluable|2
7675744|NCT00245011|12092657|FG000|Overall Study|Lack of Efficacy|1
7675745|NCT00245037|12092661|FG000|Overall Study|Death|17
7675746|NCT00245050|12092667|FG000|Overall Study|Adverse Event|3
7675747|NCT00245050|12092668|FG001|Overall Study|Adverse Event|2
7675748|NCT00245063|12092676|FG000|Overall Study|Adverse Event|6
7675749|NCT00245063|12092677|FG001|Overall Study|Adverse Event|5
7675750|NCT00245063|12092676|FG000|Overall Study|Death|1
7675751|NCT00245063|12092677|FG001|Overall Study|Death|0
7675752|NCT00245102|12092689|FG000|Overall Study|Not Treated|1
7675753|NCT00245102|12092690|FG001|Overall Study|Not Treated|0
7675754|NCT00245102|12092691|FG002|Overall Study|Not Treated|1
7675755|NCT00245102|12092692|FG003|Overall Study|Not Treated|0
7675756|NCT00245102|12092693|FG004|Overall Study|Not Treated|0
7675757|NCT00245102|12092694|FG005|Overall Study|Not Treated|0
7675758|NCT00245102|12092689|FG000|Overall Study|Protocol Violation|1
7675759|NCT00245102|12092690|FG001|Overall Study|Protocol Violation|0
7675760|NCT00245102|12092691|FG002|Overall Study|Protocol Violation|0
7675761|NCT00245102|12092692|FG003|Overall Study|Protocol Violation|0
7675762|NCT00245102|12092693|FG004|Overall Study|Protocol Violation|0
7675763|NCT00245102|12092694|FG005|Overall Study|Protocol Violation|0
7675764|NCT00245102|12092689|FG000|Overall Study|Death|0
7675765|NCT00245102|12092690|FG001|Overall Study|Death|0
7675766|NCT00245102|12092691|FG002|Overall Study|Death|0
7675767|NCT00245102|12092692|FG003|Overall Study|Death|1
7675768|NCT00245102|12092693|FG004|Overall Study|Death|0
7675769|NCT00245102|12092694|FG005|Overall Study|Death|0
7675770|NCT00245102|12092689|FG000|Overall Study|Adverse Event|4
7675771|NCT00245102|12092690|FG001|Overall Study|Adverse Event|2
7675772|NCT00245102|12092691|FG002|Overall Study|Adverse Event|5
7675773|NCT00245102|12092692|FG003|Overall Study|Adverse Event|1
7675774|NCT00245102|12092693|FG004|Overall Study|Adverse Event|0
7675775|NCT00245102|12092694|FG005|Overall Study|Adverse Event|2
7675776|NCT00245102|12092689|FG000|Overall Study|Decline in performance|0
7675777|NCT00245102|12092690|FG001|Overall Study|Decline in performance|2
7675778|NCT00245102|12092691|FG002|Overall Study|Decline in performance|0
7675779|NCT00245102|12092692|FG003|Overall Study|Decline in performance|1
7675780|NCT00245102|12092693|FG004|Overall Study|Decline in performance|0
7675781|NCT00245102|12092694|FG005|Overall Study|Decline in performance|2
7675782|NCT00245102|12092689|FG000|Overall Study|Participant needed surgery|0
7675783|NCT00245102|12092690|FG001|Overall Study|Participant needed surgery|0
7675784|NCT00245102|12092691|FG002|Overall Study|Participant needed surgery|1
7675785|NCT00245102|12092692|FG003|Overall Study|Participant needed surgery|0
7675786|NCT00245102|12092693|FG004|Overall Study|Participant needed surgery|0
7675787|NCT00245102|12092694|FG005|Overall Study|Participant needed surgery|0
7675788|NCT00245102|12092689|FG000|Overall Study|Clinical progression|1
7675789|NCT00245102|12092690|FG001|Overall Study|Clinical progression|0
7675790|NCT00245102|12092691|FG002|Overall Study|Clinical progression|0
7675791|NCT00245102|12092692|FG003|Overall Study|Clinical progression|0
7675792|NCT00245102|12092693|FG004|Overall Study|Clinical progression|0
7675793|NCT00245102|12092694|FG005|Overall Study|Clinical progression|0
7675794|NCT00245466|12092724|FG000|Overall Study|Adverse Event|2
7675795|NCT00245466|12092725|FG001|Overall Study|Adverse Event|8
7675796|NCT00245466|12092726|FG002|Overall Study|Adverse Event|4
7675797|NCT00245466|12092724|FG000|Overall Study|Low prostate specific antigen suppr|16
7675798|NCT00245466|12092725|FG001|Overall Study|Low prostate specific antigen suppr|14
7675799|NCT00245466|12092726|FG002|Overall Study|Low prostate specific antigen suppr|5
7675800|NCT00245466|12092724|FG000|Overall Study|Insufficient testosterone suppr|12
7675801|NCT00245466|12092725|FG001|Overall Study|Insufficient testosterone suppr|12
7675802|NCT00245466|12092726|FG002|Overall Study|Insufficient testosterone suppr|21
7675803|NCT00245466|12092724|FG000|Overall Study|Insufficient PSA and testosterone suppr|0
7675804|NCT00245466|12092725|FG001|Overall Study|Insufficient PSA and testosterone suppr|0
7675805|NCT00245466|12092726|FG002|Overall Study|Insufficient PSA and testosterone suppr|3
7675806|NCT00245466|12092724|FG000|Overall Study|Withdrawal by Subject|2
7675807|NCT00245466|12092725|FG001|Overall Study|Withdrawal by Subject|2
7675808|NCT00245466|12092726|FG002|Overall Study|Withdrawal by Subject|1
7675809|NCT00245466|12092724|FG000|Overall Study|Lost to Follow-up|3
7675810|NCT00245466|12092725|FG001|Overall Study|Lost to Follow-up|0
7675811|NCT00245466|12092726|FG002|Overall Study|Lost to Follow-up|0
7675812|NCT00245466|12092724|FG000|Overall Study|Disease progression|0
7675813|NCT00245466|12092725|FG001|Overall Study|Disease progression|3
7675814|NCT00245466|12092726|FG002|Overall Study|Disease progression|1
7675815|NCT00245466|12092724|FG000|Overall Study|Protocol Violation|1
7675816|NCT00245466|12092725|FG001|Overall Study|Protocol Violation|2
7675817|NCT00245466|12092726|FG002|Overall Study|Protocol Violation|2
7675818|NCT00245466|12092724|FG000|Overall Study|Death|0
7675819|NCT00245466|12092725|FG001|Overall Study|Death|2
7675820|NCT00245466|12092726|FG002|Overall Study|Death|0
7675821|NCT00245466|12092724|FG000|Overall Study|Administrative reasons|0
7675822|NCT00245466|12092725|FG001|Overall Study|Administrative reasons|1
7675823|NCT00245466|12092726|FG002|Overall Study|Administrative reasons|0
7675824|NCT00245583|12092755|FG000|Overall Study|Lost to Follow-up|1
7675825|NCT00245583|12092756|FG001|Overall Study|Lost to Follow-up|5
7675826|NCT00245583|12092755|FG000|Overall Study|Adverse Event|2
7675827|NCT00245583|12092756|FG001|Overall Study|Adverse Event|1
7675828|NCT00245583|12092755|FG000|Overall Study|Lack of Efficacy|1
7675829|NCT00245583|12092756|FG001|Overall Study|Lack of Efficacy|0
7675830|NCT00245583|12092755|FG000|Overall Study|Withdrawal by Subject|2
7675831|NCT00245583|12092756|FG001|Overall Study|Withdrawal by Subject|3
7675832|NCT00245765|12092774|FG000|Overall Study|Adverse Event|1
7675833|NCT00245765|12092775|FG001|Overall Study|Adverse Event|1
7675834|NCT00245765|12092776|FG002|Overall Study|Adverse Event|0
7675835|NCT00245765|12092774|FG000|Overall Study|Lack of Efficacy|14
7675836|NCT00245765|12092775|FG001|Overall Study|Lack of Efficacy|7
7675837|NCT00245765|12092776|FG002|Overall Study|Lack of Efficacy|0
7675838|NCT00245765|12092774|FG000|Overall Study|Lost to Follow-up|1
7675839|NCT00245765|12092775|FG001|Overall Study|Lost to Follow-up|2
7675840|NCT00245765|12092776|FG002|Overall Study|Lost to Follow-up|0
7675841|NCT00245765|12092774|FG000|Overall Study|Withdrawal by Subject|1
7675842|NCT00245765|12092775|FG001|Overall Study|Withdrawal by Subject|0
7675843|NCT00245765|12092776|FG002|Overall Study|Withdrawal by Subject|3
7675844|NCT00245765|12092774|FG000|Overall Study|Other reason|2
7675845|NCT00245765|12092775|FG001|Overall Study|Other reason|0
7675846|NCT00245765|12092776|FG002|Overall Study|Other reason|1
7675847|NCT00245765|12092774|FG000|Overall Study|Other|13
7675848|NCT00245765|12092775|FG001|Overall Study|Other|4
7675849|NCT00245765|12092776|FG002|Overall Study|Other|4
7675850|NCT00245856|12092784|FG000|Period Two|Withdrawal by Subject|0
7675851|NCT00245856|12092785|FG001|Period Two|Withdrawal by Subject|1
7675852|NCT00246012|12092801|FG000|Overall Study|Adverse Event|0
7675853|NCT00246012|12092802|FG001|Overall Study|Adverse Event|0
7675854|NCT00246012|12092803|FG002|Overall Study|Adverse Event|0
7675855|NCT00246012|12092804|FG003|Overall Study|Adverse Event|0
7675856|NCT00246012|12092805|FG004|Overall Study|Adverse Event|0
7675857|NCT00246012|12092806|FG005|Overall Study|Adverse Event|1
7675858|NCT00246012|12092807|FG006|Overall Study|Adverse Event|0
7675859|NCT00246012|12092808|FG007|Overall Study|Adverse Event|0
7675860|NCT00246012|12092809|FG008|Overall Study|Adverse Event|2
7675861|NCT00246012|12092801|FG000|Overall Study|Withdrawal by Subject|0
7675862|NCT00246012|12092802|FG001|Overall Study|Withdrawal by Subject|0
7675863|NCT00246012|12092803|FG002|Overall Study|Withdrawal by Subject|0
7675864|NCT00246012|12092804|FG003|Overall Study|Withdrawal by Subject|0
7675865|NCT00246012|12092805|FG004|Overall Study|Withdrawal by Subject|0
7675866|NCT00246012|12092806|FG005|Overall Study|Withdrawal by Subject|1
7675867|NCT00246012|12092807|FG006|Overall Study|Withdrawal by Subject|0
7675868|NCT00246012|12092808|FG007|Overall Study|Withdrawal by Subject|0
7675869|NCT00246012|12092809|FG008|Overall Study|Withdrawal by Subject|0
7675870|NCT00246012|12092801|FG000|Overall Study|Disease progression|3
7675871|NCT00246012|12092802|FG001|Overall Study|Disease progression|1
7675872|NCT00246012|12092803|FG002|Overall Study|Disease progression|2
7675873|NCT00246012|12092804|FG003|Overall Study|Disease progression|3
7675874|NCT00246012|12092805|FG004|Overall Study|Disease progression|3
7675875|NCT00246012|12092806|FG005|Overall Study|Disease progression|25
7675876|NCT00246012|12092807|FG006|Overall Study|Disease progression|30
7675877|NCT00246012|12092808|FG007|Overall Study|Disease progression|27
7675878|NCT00246012|12092809|FG008|Overall Study|Disease progression|26
7675879|NCT00246012|12092801|FG000|Overall Study|Other|0
7675880|NCT00246012|12092802|FG001|Overall Study|Other|0
7675881|NCT00246012|12092803|FG002|Overall Study|Other|0
7675882|NCT00246012|12092804|FG003|Overall Study|Other|0
7675883|NCT00246012|12092805|FG004|Overall Study|Other|0
7675884|NCT00246012|12092806|FG005|Overall Study|Other|0
7675885|NCT00246012|12092807|FG006|Overall Study|Other|0
7675886|NCT00246012|12092808|FG007|Overall Study|Other|1
7675887|NCT00246012|12092809|FG008|Overall Study|Other|0
7675888|NCT00246012|12092801|FG000|Overall Study|Randomly assigned but not treated|0
7675889|NCT00246012|12092802|FG001|Overall Study|Randomly assigned but not treated|0
7675890|NCT00246012|12092803|FG002|Overall Study|Randomly assigned but not treated|0
7675891|NCT00246012|12092804|FG003|Overall Study|Randomly assigned but not treated|0
7675892|NCT00246012|12092805|FG004|Overall Study|Randomly assigned but not treated|0
7675893|NCT00246012|12092806|FG005|Overall Study|Randomly assigned but not treated|1
7675894|NCT00246012|12092807|FG006|Overall Study|Randomly assigned but not treated|1
7675895|NCT00246012|12092808|FG007|Overall Study|Randomly assigned but not treated|0
7675896|NCT00246012|12092809|FG008|Overall Study|Randomly assigned but not treated|0
7675897|NCT00246025|12092835|FG000|Overall Study|Adverse Event|7
7675898|NCT00246025|12092836|FG001|Overall Study|Adverse Event|9
7675899|NCT00246025|12092837|FG002|Overall Study|Adverse Event|9
7675900|NCT00246025|12092838|FG003|Overall Study|Adverse Event|10
7675901|NCT00246025|12092835|FG000|Overall Study|Withdrawal by Subject|3
7675902|NCT00246025|12092836|FG001|Overall Study|Withdrawal by Subject|0
7675903|NCT00246025|12092837|FG002|Overall Study|Withdrawal by Subject|1
7675904|NCT00246025|12092838|FG003|Overall Study|Withdrawal by Subject|2
7675905|NCT00246025|12092835|FG000|Overall Study|unsuitable medical history was found|0
7675906|NCT00246025|12092836|FG001|Overall Study|unsuitable medical history was found|0
7675907|NCT00246025|12092837|FG002|Overall Study|unsuitable medical history was found|0
7675908|NCT00246025|12092838|FG003|Overall Study|unsuitable medical history was found|1
7675909|NCT00246090|12092848|FG000|Overall Study|Adverse Event|25
7675910|NCT00246090|12092848|FG000|Overall Study|Withdrawal by Subject|7
7675911|NCT00246090|12092848|FG000|Overall Study|Progressive Disease|212
7675912|NCT00246090|12092848|FG000|Overall Study|Clinical Progression|30
7675913|NCT00246090|12092848|FG000|Overall Study|Physician Decision|11
7675914|NCT00246090|12092848|FG000|Overall Study|Not Otherwise Specified|10
7675915|NCT00246129|12092854|FG000|Overall Study|Lost to Follow-up|1
7675916|NCT00246129|12092855|FG001|Overall Study|Lost to Follow-up|0
7675917|NCT00246129|12092854|FG000|Overall Study|Death|2
7675918|NCT00246129|12092855|FG001|Overall Study|Death|1
7675919|NCT00246129|12092854|FG000|Overall Study|suffered primary non-function|1
7675920|NCT00246129|12092855|FG001|Overall Study|suffered primary non-function|0
7675921|NCT00246129|12092854|FG000|Overall Study|grafts failed|3
7675922|NCT00246129|12092855|FG001|Overall Study|grafts failed|1
7675923|NCT00246259|12092866|FG000|Overall Study|Other|3
7675924|NCT00246259|12092867|FG001|Overall Study|Other|3
7675925|NCT00246259|12092866|FG000|Overall Study|Not stable by Week 18|2
7675926|NCT00246259|12092867|FG001|Overall Study|Not stable by Week 18|1
7675927|NCT00246259|12092866|FG000|Overall Study|Participant non-compliant|4
7675928|NCT00246259|12092867|FG001|Overall Study|Participant non-compliant|9
7675929|NCT00246259|12092866|FG000|Overall Study|Lack of Efficacy|2
7675930|NCT00246259|12092867|FG001|Overall Study|Lack of Efficacy|2
7675931|NCT00246259|12092866|FG000|Overall Study|Investigator withdrew participant|2
7675932|NCT00246259|12092867|FG001|Overall Study|Investigator withdrew participant|0
7675933|NCT00246259|12092866|FG000|Overall Study|Adverse Event|5
7675934|NCT00246259|12092867|FG001|Overall Study|Adverse Event|0
7675935|NCT00246259|12092866|FG000|Overall Study|Lost to Follow-up|3
7675936|NCT00246259|12092867|FG001|Overall Study|Lost to Follow-up|4
7675937|NCT00246259|12092866|FG000|Overall Study|Withdrawal by Subject|5
7675938|NCT00246259|12092867|FG001|Overall Study|Withdrawal by Subject|1
7675939|NCT00246259|12092866|FG000|Overall Study|randomly assigned, not eligible for ITT|2
7675940|NCT00246259|12092867|FG001|Overall Study|randomly assigned, not eligible for ITT|6
7675941|NCT00246324|12092873|FG000|Overall Study|Withdrawal by Subject|1
7675942|NCT00246337|12092886|FG000|Overall Study|Lost to Follow-up|3
7675943|NCT00246337|12092887|FG001|Overall Study|Lost to Follow-up|0
7675944|NCT00246337|12092888|FG002|Overall Study|Lost to Follow-up|0
7675945|NCT00246337|12092889|FG003|Overall Study|Lost to Follow-up|0
7675946|NCT00246337|12092890|FG004|Overall Study|Lost to Follow-up|2
7675947|NCT00246337|12092891|FG005|Overall Study|Lost to Follow-up|2
7675948|NCT00246337|12092892|FG006|Overall Study|Lost to Follow-up|1
7675949|NCT00246337|12092893|FG007|Overall Study|Lost to Follow-up|2
7675950|NCT00246337|12092894|FG008|Overall Study|Lost to Follow-up|0
7675951|NCT00246337|12092886|FG000|Overall Study|Protocol Violation|1
7675952|NCT00246337|12092887|FG001|Overall Study|Protocol Violation|0
7675953|NCT00246337|12092888|FG002|Overall Study|Protocol Violation|0
7675954|NCT00246337|12092889|FG003|Overall Study|Protocol Violation|0
7675955|NCT00246337|12092890|FG004|Overall Study|Protocol Violation|1
7675956|NCT00246337|12092891|FG005|Overall Study|Protocol Violation|0
7675957|NCT00246337|12092892|FG006|Overall Study|Protocol Violation|1
7675958|NCT00246337|12092893|FG007|Overall Study|Protocol Violation|1
7675959|NCT00246337|12092894|FG008|Overall Study|Protocol Violation|0
7675960|NCT00246337|12092886|FG000|Overall Study|Withdrawal by Subject|2
7675961|NCT00246337|12092887|FG001|Overall Study|Withdrawal by Subject|0
7675962|NCT00246337|12092888|FG002|Overall Study|Withdrawal by Subject|0
7675963|NCT00246337|12092889|FG003|Overall Study|Withdrawal by Subject|0
7675964|NCT00246337|12092890|FG004|Overall Study|Withdrawal by Subject|0
7675965|NCT00246337|12092891|FG005|Overall Study|Withdrawal by Subject|0
7675966|NCT00246337|12092892|FG006|Overall Study|Withdrawal by Subject|1
7675967|NCT00246337|12092893|FG007|Overall Study|Withdrawal by Subject|1
7675968|NCT00246337|12092894|FG008|Overall Study|Withdrawal by Subject|0
7675969|NCT00246337|12092886|FG000|Overall Study|Lack of Qualifying Event|8
7675970|NCT00246337|12092887|FG001|Overall Study|Lack of Qualifying Event|2
7675971|NCT00246337|12092888|FG002|Overall Study|Lack of Qualifying Event|1
7675972|NCT00246337|12092889|FG003|Overall Study|Lack of Qualifying Event|1
7675973|NCT00246337|12092890|FG004|Overall Study|Lack of Qualifying Event|1
7675974|NCT00246337|12092891|FG005|Overall Study|Lack of Qualifying Event|3
7675975|NCT00246337|12092892|FG006|Overall Study|Lack of Qualifying Event|3
7675976|NCT00246337|12092893|FG007|Overall Study|Lack of Qualifying Event|2
7675977|NCT00246337|12092894|FG008|Overall Study|Lack of Qualifying Event|5
7675978|NCT00246337|12092886|FG000|Overall Study|Site Terminated|10
7675979|NCT00246337|12092887|FG001|Overall Study|Site Terminated|0
7675980|NCT00246337|12092888|FG002|Overall Study|Site Terminated|0
7675981|NCT00246337|12092889|FG003|Overall Study|Site Terminated|0
7675982|NCT00246337|12092890|FG004|Overall Study|Site Terminated|0
7675983|NCT00246337|12092891|FG005|Overall Study|Site Terminated|7
7675984|NCT00246337|12092892|FG006|Overall Study|Site Terminated|1
7675985|NCT00246337|12092893|FG007|Overall Study|Site Terminated|6
7675986|NCT00246337|12092894|FG008|Overall Study|Site Terminated|2
7675987|NCT00246337|12092886|FG000|Overall Study|Abnormal baseline lab values|7
7675988|NCT00246337|12092887|FG001|Overall Study|Abnormal baseline lab values|0
7675989|NCT00246337|12092888|FG002|Overall Study|Abnormal baseline lab values|2
7675990|NCT00246337|12092889|FG003|Overall Study|Abnormal baseline lab values|0
7675991|NCT00246337|12092890|FG004|Overall Study|Abnormal baseline lab values|0
7675992|NCT00246337|12092891|FG005|Overall Study|Abnormal baseline lab values|2
7675993|NCT00246337|12092892|FG006|Overall Study|Abnormal baseline lab values|2
7675994|NCT00246337|12092893|FG007|Overall Study|Abnormal baseline lab values|0
7675995|NCT00246337|12092894|FG008|Overall Study|Abnormal baseline lab values|4
7675996|NCT00246337|12092886|FG000|Overall Study|Overwhelmed|0
7675997|NCT00246337|12092887|FG001|Overall Study|Overwhelmed|0
7675998|NCT00246337|12092888|FG002|Overall Study|Overwhelmed|0
7675999|NCT00246337|12092889|FG003|Overall Study|Overwhelmed|0
7676000|NCT00246337|12092890|FG004|Overall Study|Overwhelmed|0
7676001|NCT00246337|12092891|FG005|Overall Study|Overwhelmed|1
7676002|NCT00246337|12092892|FG006|Overall Study|Overwhelmed|0
7676003|NCT00246337|12092893|FG007|Overall Study|Overwhelmed|0
7676004|NCT00246337|12092894|FG008|Overall Study|Overwhelmed|0
7676005|NCT00246337|12092886|FG000|Overall Study|Protocol Violator|1
7676006|NCT00246337|12092887|FG001|Overall Study|Protocol Violator|0
7676007|NCT00246337|12092888|FG002|Overall Study|Protocol Violator|0
7676008|NCT00246337|12092889|FG003|Overall Study|Protocol Violator|0
7676009|NCT00246337|12092890|FG004|Overall Study|Protocol Violator|0
7676010|NCT00246337|12092891|FG005|Overall Study|Protocol Violator|0
7676011|NCT00246337|12092892|FG006|Overall Study|Protocol Violator|0
7676012|NCT00246337|12092893|FG007|Overall Study|Protocol Violator|0
7676013|NCT00246337|12092894|FG008|Overall Study|Protocol Violator|0
7676014|NCT00246337|12092886|FG000|Overall Study|Reported as completing trial in error|0
7676015|NCT00246337|12092887|FG001|Overall Study|Reported as completing trial in error|0
7676016|NCT00246337|12092888|FG002|Overall Study|Reported as completing trial in error|0
7676017|NCT00246337|12092889|FG003|Overall Study|Reported as completing trial in error|0
7676018|NCT00246337|12092890|FG004|Overall Study|Reported as completing trial in error|0
7676019|NCT00246337|12092891|FG005|Overall Study|Reported as completing trial in error|0
7676020|NCT00246337|12092892|FG006|Overall Study|Reported as completing trial in error|0
7676021|NCT00246337|12092893|FG007|Overall Study|Reported as completing trial in error|1
7676022|NCT00246337|12092894|FG008|Overall Study|Reported as completing trial in error|0
7676023|NCT00246376|12092919|FG000|Overall Study|Dropped/withdrew during dietary run-in|11
7676024|NCT00246376|12092920|FG001|Overall Study|Dropped/withdrew during dietary run-in|5
7676025|NCT00246376|12092921|FG002|Overall Study|Dropped/withdrew during dietary run-in|4
7676026|NCT00246376|12092922|FG003|Overall Study|Dropped/withdrew during dietary run-in|7
7676027|NCT00246376|12092923|FG004|Overall Study|Dropped/withdrew during dietary run-in|3
7676028|NCT00246376|12092919|FG000|Overall Study|Adverse Event|2
7676029|NCT00246376|12092920|FG001|Overall Study|Adverse Event|3
7676030|NCT00246376|12092921|FG002|Overall Study|Adverse Event|1
7676031|NCT00246376|12092922|FG003|Overall Study|Adverse Event|3
7676032|NCT00246376|12092923|FG004|Overall Study|Adverse Event|1
7676033|NCT00246376|12092919|FG000|Overall Study|Lost to Follow-up|2
7676034|NCT00246376|12092920|FG001|Overall Study|Lost to Follow-up|11
7676035|NCT00246376|12092921|FG002|Overall Study|Lost to Follow-up|11
7676036|NCT00246376|12092922|FG003|Overall Study|Lost to Follow-up|16
7676037|NCT00246376|12092923|FG004|Overall Study|Lost to Follow-up|13
7676038|NCT00246571|12092961|FG000|Overall Study|Adverse Event|7
7676039|NCT00246571|12092962|FG001|Overall Study|Adverse Event|0
7676040|NCT00246571|12092961|FG000|Overall Study|Protocol Violation|0
7676041|NCT00246571|12092962|FG001|Overall Study|Protocol Violation|1
7676042|NCT00246571|12092961|FG000|Overall Study|Withdrawal by Subject|2
7676043|NCT00246571|12092962|FG001|Overall Study|Withdrawal by Subject|3
7676044|NCT00246571|12092961|FG000|Overall Study|Lack of Efficacy|84
7676045|NCT00246571|12092962|FG001|Overall Study|Lack of Efficacy|21
7676046|NCT00246571|12092961|FG000|Overall Study|Death|17
7676047|NCT00246571|12092962|FG001|Overall Study|Death|3
7676048|NCT00246571|12092961|FG000|Overall Study|Sponsor|0
7676049|NCT00246571|12092962|FG001|Overall Study|Sponsor|1
7676050|NCT00246571|12092961|FG000|Overall Study|Did not meet entrance criteria|2
7676051|NCT00246571|12092962|FG001|Overall Study|Did not meet entrance criteria|1
7676052|NCT00246571|12092961|FG000|Overall Study|Laboratory abnormalities|1
7676053|NCT00246571|12092962|FG001|Overall Study|Laboratory abnormalities|0
7676054|NCT00246571|12092961|FG000|Overall Study|Crossover participants|0
7676055|NCT00246571|12092962|FG001|Overall Study|Crossover participants|74
7676056|NCT00246740|12092970|FG000|Initial Enrollment|Death|1
7676057|NCT00246740|12092971|FG001|Initial Enrollment|Death|0
7676058|NCT00246740|12092970|FG000|Initial Enrollment|Additional surgery scheduled|0
7676059|NCT00246740|12092971|FG001|Initial Enrollment|Additional surgery scheduled|2
7676060|NCT00246740|12092970|FG000|Initial Enrollment|Surgery schedule change|4
7676061|NCT00246740|12092971|FG001|Initial Enrollment|Surgery schedule change|4
7676062|NCT00246740|12092970|FG000|Initial Enrollment|Other|1
7676063|NCT00246740|12092971|FG001|Initial Enrollment|Other|2
7676064|NCT00246753|12092977|FG000|Overall Study|Withdrawal by Subject|2
7676065|NCT00246753|12092977|FG000|Overall Study|Physician Decision|2
7676066|NCT00246753|12092977|FG000|Overall Study|Adverse Event|2
7676067|NCT00246753|12092977|FG000|Overall Study|Unacceptable toxicity|2
7676068|NCT00246805|12092983|FG000|Phase 1|Lost to Follow-up|1
7676069|NCT00246805|12092984|FG001|Phase 1|Lost to Follow-up|0
7676070|NCT00247273|12092992|FG000|Overall Study|Adverse Event|85
7676071|NCT00247273|12092993|FG001|Overall Study|Adverse Event|80
7676072|NCT00247273|12092992|FG000|Overall Study|Physician Decision|6
7676073|NCT00247273|12092993|FG001|Overall Study|Physician Decision|3
7676074|NCT00247273|12092992|FG000|Overall Study|Lost to Follow-up|7
7676075|NCT00247273|12092993|FG001|Overall Study|Lost to Follow-up|7
7676076|NCT00247273|12092992|FG000|Overall Study|Withdrawal by Subject|46
7676077|NCT00247273|12092993|FG001|Overall Study|Withdrawal by Subject|47
7676078|NCT00247273|12092992|FG000|Overall Study|Did not take any study drug|2
7676079|NCT00247273|12092993|FG001|Overall Study|Did not take any study drug|0
7676080|NCT00247416|12093010|FG000|Overall Study|3 patients were found to be ineligible|1
7676081|NCT00247416|12093011|FG001|Overall Study|3 patients were found to be ineligible|2
7676082|NCT00247611|12093021|FG000|Baselined|Completed baseline, never placed on ARVs|8
7676083|NCT00247611|12093022|FG001|Baselined|Completed baseline, never placed on ARVs|5
7676084|NCT00247611|12093021|FG000|Baselined|Completed baseline only|9
7676085|NCT00247611|12093022|FG001|Baselined|Completed baseline only|8
7676086|NCT00247676|12093043|FG000|Overall Study|Death|5
7676087|NCT00247676|12093043|FG000|Overall Study|Adverse Event|11
7676088|NCT00247676|12093043|FG000|Overall Study|Lack of Efficacy|15
7676089|NCT00247676|12093043|FG000|Overall Study|Other|3
7676090|NCT00247676|12093043|FG000|Overall Study|Withdrawal by Subject|2
7676091|NCT00247962|12093049|FG000|Overall Study|Adverse Event|15
7676092|NCT00247962|12093050|FG001|Overall Study|Adverse Event|12
7676093|NCT00247962|12093049|FG000|Overall Study|Lost to Follow-up|3
7676094|NCT00247962|12093050|FG001|Overall Study|Lost to Follow-up|1
7676095|NCT00247962|12093049|FG000|Overall Study|Physician Decision|0
7676096|NCT00247962|12093050|FG001|Overall Study|Physician Decision|1
7676097|NCT00247962|12093049|FG000|Overall Study|Protocol Violation|1
7676098|NCT00247962|12093050|FG001|Overall Study|Protocol Violation|1
7676099|NCT00247962|12093049|FG000|Overall Study|Withdrawal by Subject|3
7676100|NCT00247962|12093050|FG001|Overall Study|Withdrawal by Subject|2
7676101|NCT00247962|12093049|FG000|Overall Study|Lack of Efficacy|4
7676102|NCT00247962|12093050|FG001|Overall Study|Lack of Efficacy|2
7676103|NCT00248040|12093059|FG000|Overall Study|transplantectomy|2
7676104|NCT00248040|12093060|FG001|Overall Study|transplantectomy|1
7676105|NCT00248040|12093061|FG002|Overall Study|transplantectomy|3
7676106|NCT00248040|12093059|FG000|Overall Study|transplant cancelled post treat start|1
7676107|NCT00248040|12093060|FG001|Overall Study|transplant cancelled post treat start|0
7676108|NCT00248040|12093061|FG002|Overall Study|transplant cancelled post treat start|0
7676109|NCT00248040|12093059|FG000|Overall Study|Death|0
7676110|NCT00248040|12093060|FG001|Overall Study|Death|0
7676111|NCT00248040|12093061|FG002|Overall Study|Death|1
7676112|NCT00248170|12093072|FG000|Overall Study|Withdrawal by Subject|71
7676113|NCT00248170|12093073|FG001|Overall Study|Withdrawal by Subject|79
7676114|NCT00248170|12093072|FG000|Overall Study|Protocol Violation|35
7676115|NCT00248170|12093073|FG001|Overall Study|Protocol Violation|30
7676116|NCT00248170|12093072|FG000|Overall Study|Lost to Follow-up|28
7676117|NCT00248170|12093073|FG001|Overall Study|Lost to Follow-up|35
7676118|NCT00248170|12093072|FG000|Overall Study|Disease progression|196
7676119|NCT00248170|12093073|FG001|Overall Study|Disease progression|216
7676120|NCT00248170|12093072|FG000|Overall Study|Death|28
7676121|NCT00248170|12093073|FG001|Overall Study|Death|47
7676122|NCT00248170|12093072|FG000|Overall Study|Adverse Event|311
7676123|NCT00248170|12093073|FG001|Overall Study|Adverse Event|296
7676124|NCT00248170|12093072|FG000|Overall Study|Administrative problems|22
7676125|NCT00248170|12093073|FG001|Overall Study|Administrative problems|25
7676126|NCT00248170|12093072|FG000|Overall Study|Abnormal test procedure(s) result|49
7676127|NCT00248170|12093073|FG001|Overall Study|Abnormal test procedure(s) result|61
7676128|NCT00248170|12093072|FG000|Overall Study|Abnormal laboratory values|4
7676129|NCT00248170|12093073|FG001|Overall Study|Abnormal laboratory values|0
7676130|NCT00248170|12093072|FG000|Overall Study|Protocol deviation|17
7676131|NCT00248170|12093073|FG001|Overall Study|Protocol deviation|19
7676132|NCT00248495|12093079|FG000|Overall Study|Withdrawal by Subject|1
7676133|NCT00248625|12093122|FG000|Overall Study|Withdrawal by Subject|0
7676134|NCT00248625|12093123|FG001|Overall Study|Withdrawal by Subject|2
7676135|NCT00248651|12093143|FG000|Overall Study|Withdrawal by Subject|28
7676136|NCT00248651|12093144|FG001|Overall Study|Withdrawal by Subject|40
7676137|NCT00248651|12093145|FG002|Overall Study|Withdrawal by Subject|32
7676138|NCT00248794|12093165|FG000|Overall Study|Lost to Follow-up|6
7676139|NCT00248794|12093166|FG001|Overall Study|Lost to Follow-up|8
7676140|NCT00248794|12093167|FG002|Overall Study|Lost to Follow-up|3
7676141|NCT00248833|12093199|FG000|Overall Study|Adverse Event|2
7676142|NCT00248833|12093200|FG001|Overall Study|Adverse Event|0
7676143|NCT00248833|12093201|FG002|Overall Study|Adverse Event|0
7676144|NCT00248833|12093199|FG000|Overall Study|Withdrawal by Subject|0
7676145|NCT00248833|12093200|FG001|Overall Study|Withdrawal by Subject|1
7676146|NCT00248833|12093201|FG002|Overall Study|Withdrawal by Subject|1
7676147|NCT00248833|12093199|FG000|Overall Study|Lost to Follow-up|1
7676148|NCT00248833|12093200|FG001|Overall Study|Lost to Follow-up|1
7676149|NCT00248833|12093201|FG002|Overall Study|Lost to Follow-up|1
7676150|NCT00248833|12093199|FG000|Overall Study|Other|0
7676151|NCT00248833|12093200|FG001|Overall Study|Other|1
7676152|NCT00248833|12093201|FG002|Overall Study|Other|0
7676153|NCT00249002|12093211|FG000|Overall Study|Adverse Event|2
7676154|NCT00249002|12093211|FG000|Overall Study|Study cancellation|3
7676155|NCT00249002|12093211|FG000|Overall Study|Other|2
7676156|NCT00249288|12093234|FG000|Overall Study|Lost to Follow-up|3
7676157|NCT00249288|12093235|FG001|Overall Study|Lost to Follow-up|3
7676158|NCT00249288|12093234|FG000|Overall Study|Withdrawal by Subject|2
7676159|NCT00249288|12093235|FG001|Overall Study|Withdrawal by Subject|2
7676160|NCT00249444|12093260|FG000|Overall Study|Lost to Follow-up|2
7676161|NCT00249444|12093261|FG001|Overall Study|Lost to Follow-up|2
7676162|NCT00249444|12093260|FG000|Overall Study|non-compliant|9
7676163|NCT00249444|12093261|FG001|Overall Study|non-compliant|11
7676164|NCT00249444|12093260|FG000|Overall Study|Adverse Event|1
7676165|NCT00249444|12093261|FG001|Overall Study|Adverse Event|1
7676166|NCT00249444|12093260|FG000|Overall Study|life event|0
7676167|NCT00249444|12093261|FG001|Overall Study|life event|1
7676168|NCT00249613|12093289|FG000|12 Month Follow-up|Death|1
7676169|NCT00249613|12093290|FG001|12 Month Follow-up|Death|1
7676170|NCT00249613|12093289|FG000|12 Month Follow-up|Withdrawal by Subject|6
7676171|NCT00249613|12093290|FG001|12 Month Follow-up|Withdrawal by Subject|6
7676172|NCT00249613|12093289|FG000|12 Month Follow-up|Lost to Follow-up|10
7676173|NCT00249613|12093290|FG001|12 Month Follow-up|Lost to Follow-up|8
7676174|NCT00249769|12093302|FG000|Overall Study|Withdrawal by Subject|1
7676175|NCT00249769|12093303|FG001|Overall Study|Withdrawal by Subject|10
7676176|NCT00249769|12093304|FG002|Overall Study|Withdrawal by Subject|6
7676177|NCT00249769|12093302|FG000|Overall Study|Migration from Study Area|1
7676178|NCT00249769|12093303|FG001|Overall Study|Migration from Study Area|3
7676179|NCT00249769|12093304|FG002|Overall Study|Migration from Study Area|14
7676180|NCT00249769|12093302|FG000|Overall Study|Miscellaneous|0
7676181|NCT00249769|12093303|FG001|Overall Study|Miscellaneous|2
7676182|NCT00249769|12093304|FG002|Overall Study|Miscellaneous|2
7676183|NCT00249769|12093302|FG000|Overall Study|Adverse Event|0
7676184|NCT00249769|12093303|FG001|Overall Study|Adverse Event|0
7676185|NCT00249769|12093304|FG002|Overall Study|Adverse Event|1
7676186|NCT00249769|12093302|FG000|Overall Study|Physician Decision|0
7676187|NCT00249769|12093303|FG001|Overall Study|Physician Decision|0
7676188|NCT00249769|12093304|FG002|Overall Study|Physician Decision|2
7676189|NCT00249769|12093302|FG000|Overall Study|Lost to Follow-up|0
7676190|NCT00249769|12093303|FG001|Overall Study|Lost to Follow-up|0
7676191|NCT00249769|12093304|FG002|Overall Study|Lost to Follow-up|3
7676192|NCT00249795|12093314|FG000|Overall Study|Not treated|16
7676193|NCT00249795|12093315|FG001|Overall Study|Not treated|14
7676194|NCT00249795|12093314|FG000|Overall Study|Symptomatic hypotension|127
7676195|NCT00249795|12093315|FG001|Overall Study|Symptomatic hypotension|64
7676196|NCT00249795|12093314|FG000|Overall Study|Other Serious Adverse Event|84
7676197|NCT00249795|12093315|FG001|Overall Study|Other Serious Adverse Event|93
7676198|NCT00249795|12093314|FG000|Overall Study|Qualifying condition not present|26
7676199|NCT00249795|12093315|FG001|Overall Study|Qualifying condition not present|29
7676200|NCT00249795|12093314|FG000|Overall Study|Withdrawal by Subject|678
7676201|NCT00249795|12093315|FG001|Overall Study|Withdrawal by Subject|742
7676202|NCT00249795|12093314|FG000|Overall Study|Thromboembolic / outcome event|39
7676203|NCT00249795|12093315|FG001|Overall Study|Thromboembolic / outcome event|45
7676204|NCT00249795|12093314|FG000|Overall Study|Oral anticoagulant required|2
7676205|NCT00249795|12093315|FG001|Overall Study|Oral anticoagulant required|0
7676206|NCT00249795|12093314|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
7676207|NCT00249795|12093315|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
7676208|NCT00249795|12093314|FG000|Overall Study|Non-compliance|71
7676209|NCT00249795|12093315|FG001|Overall Study|Non-compliance|69
7676210|NCT00249795|12093314|FG000|Overall Study|Study drug intolerance|3
7676211|NCT00249795|12093315|FG001|Overall Study|Study drug intolerance|3
7676212|NCT00249795|12093314|FG000|Overall Study|Other adverse events (non-serious)|188
7676213|NCT00249795|12093315|FG001|Overall Study|Other adverse events (non-serious)|159
7676214|NCT00249795|12093314|FG000|Overall Study|Physician withdrew consent|71
7676215|NCT00249795|12093315|FG001|Overall Study|Physician withdrew consent|63
7676216|NCT00249795|12093314|FG000|Overall Study|Surgery / procedure|4
7676217|NCT00249795|12093315|FG001|Overall Study|Surgery / procedure|5
7676218|NCT00249795|12093314|FG000|Overall Study|Angiotensin II receptor blocker required|35
7676219|NCT00249795|12093315|FG001|Overall Study|Angiotensin II receptor blocker required|58
7676220|NCT00249795|12093314|FG000|Overall Study|Lightheadedness / dizziness|15
7676221|NCT00249795|12093315|FG001|Overall Study|Lightheadedness / dizziness|11
7676222|NCT00249795|12093314|FG000|Overall Study|Hypotension (non-symptomatic)|5
7676223|NCT00249795|12093315|FG001|Overall Study|Hypotension (non-symptomatic)|5
7676224|NCT00249795|12093314|FG000|Overall Study|Other contraindicated medication|1
7676225|NCT00249795|12093315|FG001|Overall Study|Other contraindicated medication|1
7676226|NCT00249795|12093314|FG000|Overall Study|Event related to cardiac condition|17
7676227|NCT00249795|12093315|FG001|Overall Study|Event related to cardiac condition|16
7676228|NCT00249795|12093314|FG000|Overall Study|Patient not wish to continue after May08|4
7676229|NCT00249795|12093315|FG001|Overall Study|Patient not wish to continue after May08|6
7676230|NCT00249795|12093314|FG000|Overall Study|Site not agree to continue after May08|1
7676231|NCT00249795|12093315|FG001|Overall Study|Site not agree to continue after May08|1
7676232|NCT00249795|12093314|FG000|Overall Study|Lost to Follow-up|0
7676233|NCT00249795|12093315|FG001|Overall Study|Lost to Follow-up|2
7676234|NCT00249795|12093314|FG000|Overall Study|Missing|0
7676235|NCT00249795|12093315|FG001|Overall Study|Missing|1
7676236|NCT00249808|12093321|FG000|Overall Study|Other|27
7676237|NCT00249808|12093321|FG000|Overall Study|Protocol Violation|3
7676238|NCT00249808|12093321|FG000|Overall Study|Lost to Follow-up|8
7676239|NCT00249808|12093321|FG000|Overall Study|Adverse Event|81
7676240|NCT00249808|12093321|FG000|Overall Study|Lack of Efficacy|52
7676241|NCT00249808|12093321|FG000|Overall Study|Did Not Provide Post-Baseline Data|11
7676242|NCT00249821|12093327|FG000|Overall Study|Technical problem|0
7676243|NCT00249821|12093328|FG001|Overall Study|Technical problem|1
7676244|NCT00249834|12093342|FG000|Overall Study|Ovarian stimulation failed|1
7676245|NCT00249834|12093343|FG001|Overall Study|Ovarian stimulation failed|0
7676246|NCT00249834|12093344|FG002|Overall Study|Ovarian stimulation failed|0
7676247|NCT00249834|12093345|FG003|Overall Study|Ovarian stimulation failed|0
7676248|NCT00249834|12093346|FG004|Overall Study|Ovarian stimulation failed|0
7676249|NCT00249834|12093347|FG005|Overall Study|Ovarian stimulation failed|0
7676250|NCT00249834|12093348|FG006|Overall Study|Ovarian stimulation failed|0
7676251|NCT00249834|12093349|FG007|Overall Study|Ovarian stimulation failed|0
7676252|NCT00249834|12093342|FG000|Overall Study|Failure of down-regulation|0
7676253|NCT00249834|12093343|FG001|Overall Study|Failure of down-regulation|0
7676254|NCT00249834|12093344|FG002|Overall Study|Failure of down-regulation|0
7676255|NCT00249834|12093345|FG003|Overall Study|Failure of down-regulation|0
7676256|NCT00249834|12093346|FG004|Overall Study|Failure of down-regulation|0
7676257|NCT00249834|12093347|FG005|Overall Study|Failure of down-regulation|0
7676258|NCT00249834|12093348|FG006|Overall Study|Failure of down-regulation|1
7676259|NCT00249834|12093349|FG007|Overall Study|Failure of down-regulation|0
7676260|NCT00249834|12093342|FG000|Overall Study|Protocol Violation|0
7676261|NCT00249834|12093343|FG001|Overall Study|Protocol Violation|19
7676262|NCT00249834|12093344|FG002|Overall Study|Protocol Violation|14
7676263|NCT00249834|12093345|FG003|Overall Study|Protocol Violation|8
7676264|NCT00249834|12093346|FG004|Overall Study|Protocol Violation|5
7676265|NCT00249834|12093347|FG005|Overall Study|Protocol Violation|2
7676266|NCT00249834|12093348|FG006|Overall Study|Protocol Violation|0
7676267|NCT00249834|12093349|FG007|Overall Study|Protocol Violation|0
7676268|NCT00249873|12093363|FG000|Overall Study|Not treated|7
7676269|NCT00249873|12093364|FG001|Overall Study|Not treated|8
7676270|NCT00249873|12093363|FG000|Overall Study|Significant thrombocytopenia|9
7676271|NCT00249873|12093364|FG001|Overall Study|Significant thrombocytopenia|8
7676272|NCT00249873|12093363|FG000|Overall Study|Severe allergic reaction|8
7676273|NCT00249873|12093364|FG001|Overall Study|Severe allergic reaction|1
7676274|NCT00249873|12093363|FG000|Overall Study|Serious haemorrhagic Adverse Event|74
7676275|NCT00249873|12093364|FG001|Overall Study|Serious haemorrhagic Adverse Event|30
7676276|NCT00249873|12093363|FG000|Overall Study|Other Serious Adverse Event|86
7676277|NCT00249873|12093364|FG001|Overall Study|Other Serious Adverse Event|97
7676278|NCT00249873|12093363|FG000|Overall Study|Qualifying condition not present|20
7676279|NCT00249873|12093364|FG001|Overall Study|Qualifying condition not present|23
7676280|NCT00249873|12093363|FG000|Overall Study|Contraindication to oral anticoagulant|4
7676281|NCT00249873|12093364|FG001|Overall Study|Contraindication to oral anticoagulant|8
7676282|NCT00249873|12093363|FG000|Overall Study|Withdrawal by Subject|504
7676283|NCT00249873|12093364|FG001|Overall Study|Withdrawal by Subject|466
7676284|NCT00249873|12093363|FG000|Overall Study|Lost to Follow-up|4
7676285|NCT00249873|12093364|FG001|Overall Study|Lost to Follow-up|7
7676286|NCT00249873|12093363|FG000|Overall Study|Minor bleeding|99
7676287|NCT00249873|12093364|FG001|Overall Study|Minor bleeding|37
7676288|NCT00249873|12093363|FG000|Overall Study|Non-compliance|41
7676289|NCT00249873|12093364|FG001|Overall Study|Non-compliance|46
7676290|NCT00249873|12093363|FG000|Overall Study|Other non serious Adverse Event|112
7676291|NCT00249873|12093364|FG001|Overall Study|Other non serious Adverse Event|108
7676292|NCT00249873|12093363|FG000|Overall Study|Other contraindicated medication|1
7676293|NCT00249873|12093364|FG001|Overall Study|Other contraindicated medication|0
7676294|NCT00249873|12093363|FG000|Overall Study|Patient not wish to continue after May08|3
7676295|NCT00249873|12093364|FG001|Overall Study|Patient not wish to continue after May08|4
7676296|NCT00249873|12093363|FG000|Overall Study|Physician withdrew consent|59
7676297|NCT00249873|12093364|FG001|Overall Study|Physician withdrew consent|60
7676298|NCT00249873|12093363|FG000|Overall Study|Open label clopidogrel required|31
7676299|NCT00249873|12093364|FG001|Overall Study|Open label clopidogrel required|42
7676300|NCT00249873|12093363|FG000|Overall Study|Angiotensin II receptor blocker required|1
7676301|NCT00249873|12093364|FG001|Overall Study|Angiotensin II receptor blocker required|0
7676302|NCT00249873|12093363|FG000|Overall Study|Oral anticoagulant required|159
7676303|NCT00249873|12093364|FG001|Overall Study|Oral anticoagulant required|157
7676304|NCT00249873|12093363|FG000|Overall Study|Study drug intolerance|5
7676305|NCT00249873|12093364|FG001|Overall Study|Study drug intolerance|0
7676306|NCT00249873|12093363|FG000|Overall Study|Surgery/ procedure|9
7676307|NCT00249873|12093364|FG001|Overall Study|Surgery/ procedure|9
7676308|NCT00249873|12093363|FG000|Overall Study|Event related to cardiac condition|12
7676309|NCT00249873|12093364|FG001|Overall Study|Event related to cardiac condition|21
7676310|NCT00249873|12093363|FG000|Overall Study|Thromboembolic/outcome event|82
7676311|NCT00249873|12093364|FG001|Overall Study|Thromboembolic/outcome event|122
7676312|NCT00250276|12093374|FG000|Overall Study|Serious Adverse Event|0
7676313|NCT00250276|12093375|FG001|Overall Study|Serious Adverse Event|0
7676314|NCT00250276|12093376|FG002|Overall Study|Serious Adverse Event|1
7676315|NCT00250276|12093377|FG003|Overall Study|Serious Adverse Event|0
7676316|NCT00250276|12093374|FG000|Overall Study|Non-serious Adverse Event|2
7676317|NCT00250276|12093375|FG001|Overall Study|Non-serious Adverse Event|0
7676318|NCT00250276|12093376|FG002|Overall Study|Non-serious Adverse Event|0
7676319|NCT00250276|12093377|FG003|Overall Study|Non-serious Adverse Event|2
7676320|NCT00250276|12093374|FG000|Overall Study|Protocol Violation|0
7676321|NCT00250276|12093375|FG001|Overall Study|Protocol Violation|1
7676322|NCT00250276|12093376|FG002|Overall Study|Protocol Violation|0
7676323|NCT00250276|12093377|FG003|Overall Study|Protocol Violation|0
7676324|NCT00250276|12093374|FG000|Overall Study|Withdrawal by Subject|1
7676325|NCT00250276|12093375|FG001|Overall Study|Withdrawal by Subject|2
7676326|NCT00250276|12093376|FG002|Overall Study|Withdrawal by Subject|3
7676327|NCT00250276|12093377|FG003|Overall Study|Withdrawal by Subject|2
7676328|NCT00250276|12093374|FG000|Overall Study|Migrated/moved from study area|3
7676329|NCT00250276|12093375|FG001|Overall Study|Migrated/moved from study area|0
7676330|NCT00250276|12093376|FG002|Overall Study|Migrated/moved from study area|2
7676331|NCT00250276|12093377|FG003|Overall Study|Migrated/moved from study area|7
7676332|NCT00250276|12093374|FG000|Overall Study|Lost to Follow-up|11
7676333|NCT00250276|12093375|FG001|Overall Study|Lost to Follow-up|18
7676334|NCT00250276|12093376|FG002|Overall Study|Lost to Follow-up|13
7676335|NCT00250276|12093377|FG003|Overall Study|Lost to Follow-up|8
7676336|NCT00250432|12093394|FG000|Overall Study|Adverse Event|25
7676337|NCT00250432|12093395|FG001|Overall Study|Adverse Event|29
7676338|NCT00250432|12093394|FG000|Overall Study|Lack of Efficacy|2
7676339|NCT00250432|12093395|FG001|Overall Study|Lack of Efficacy|1
7676340|NCT00250432|12093394|FG000|Overall Study|Lost to Follow-up|6
7676341|NCT00250432|12093395|FG001|Overall Study|Lost to Follow-up|5
7676342|NCT00250432|12093394|FG000|Overall Study|Patient Moved|0
7676343|NCT00250432|12093395|FG001|Overall Study|Patient Moved|1
7676344|NCT00250432|12093394|FG000|Overall Study|Protocol Violation|0
7676345|NCT00250432|12093395|FG001|Overall Study|Protocol Violation|3
7676346|NCT00250432|12093394|FG000|Overall Study|Withdrawal by Subject|6
7676347|NCT00250432|12093395|FG001|Overall Study|Withdrawal by Subject|2
7676348|NCT00250432|12093394|FG000|Overall Study|Pt died out of posttherapy report period|6
7676349|NCT00250432|12093395|FG001|Overall Study|Pt died out of posttherapy report period|5
7676350|NCT00250432|12093394|FG000|Overall Study|Pt was considered untreatable|0
7676351|NCT00250432|12093395|FG001|Overall Study|Pt was considered untreatable|1
7676352|NCT00250588|12093422|FG000|Overall Study|Withdrawal by Subject|3
7676353|NCT00250588|12093423|FG001|Overall Study|Withdrawal by Subject|6
7676354|NCT00250588|12093424|FG002|Overall Study|Withdrawal by Subject|0
7676355|NCT00250588|12093422|FG000|Overall Study|Lost to Follow-up|6
7676356|NCT00250588|12093423|FG001|Overall Study|Lost to Follow-up|13
7676357|NCT00250588|12093424|FG002|Overall Study|Lost to Follow-up|13
7676358|NCT00250679|12093435|FG000|Overall Study|Adverse Event|12
7676359|NCT00250679|12093436|FG001|Overall Study|Adverse Event|15
7676360|NCT00250679|12093437|FG002|Overall Study|Adverse Event|16
7676361|NCT00250679|12093435|FG000|Overall Study|Protocol Violation|2
7676362|NCT00250679|12093436|FG001|Overall Study|Protocol Violation|4
7676363|NCT00250679|12093437|FG002|Overall Study|Protocol Violation|3
7676364|NCT00250679|12093435|FG000|Overall Study|Withdrawal by Subject|15
7676365|NCT00250679|12093436|FG001|Overall Study|Withdrawal by Subject|18
7676366|NCT00250679|12093437|FG002|Overall Study|Withdrawal by Subject|15
7676367|NCT00250679|12093435|FG000|Overall Study|Lost to Follow-up|3
7676368|NCT00250679|12093436|FG001|Overall Study|Lost to Follow-up|4
7676369|NCT00250679|12093437|FG002|Overall Study|Lost to Follow-up|2
7676370|NCT00250679|12093435|FG000|Overall Study|Does Not Meet Entry Criteria|1
7676371|NCT00250679|12093436|FG001|Overall Study|Does Not Meet Entry Criteria|4
7676372|NCT00250679|12093437|FG002|Overall Study|Does Not Meet Entry Criteria|2
7676373|NCT00250679|12093435|FG000|Overall Study|Lack of Efficacy|0
7676374|NCT00250679|12093436|FG001|Overall Study|Lack of Efficacy|1
7676375|NCT00250679|12093437|FG002|Overall Study|Lack of Efficacy|3
7676376|NCT00250679|12093435|FG000|Overall Study|Technical Holter issues|1
7676377|NCT00250679|12093436|FG001|Overall Study|Technical Holter issues|0
7676378|NCT00250679|12093437|FG002|Overall Study|Technical Holter issues|2
7676379|NCT00250679|12093435|FG000|Overall Study|Moved|1
7676380|NCT00250679|12093436|FG001|Overall Study|Moved|1
7676381|NCT00250679|12093437|FG002|Overall Study|Moved|0
7676382|NCT00250679|12093435|FG000|Overall Study|Non-compliance|1
7676383|NCT00250679|12093436|FG001|Overall Study|Non-compliance|1
7676384|NCT00250679|12093437|FG002|Overall Study|Non-compliance|0
7676385|NCT00250679|12093435|FG000|Overall Study|various single events: hip surgery,diary|3
7676386|NCT00250679|12093436|FG001|Overall Study|various single events: hip surgery,diary|1
7676387|NCT00250679|12093437|FG002|Overall Study|various single events: hip surgery,diary|1
7676388|NCT00250705|12093445|FG000|Overall Study|Lack of Efficacy|2
7676389|NCT00250835|12093451|FG000|Overall Study|Withdrawal by Subject|1
7676390|NCT00251004|12093463|FG000|Overall Study|Withdrawal by Subject|23
7676391|NCT00251004|12093464|FG001|Overall Study|Withdrawal by Subject|16
7676392|NCT00251004|12093465|FG002|Overall Study|Withdrawal by Subject|14
7676393|NCT00251004|12093463|FG000|Overall Study|Death|9
7676394|NCT00251004|12093464|FG001|Overall Study|Death|10
7676395|NCT00251004|12093465|FG002|Overall Study|Death|8
7676396|NCT00251004|12093463|FG000|Overall Study|Lost to Follow-up|1
7676397|NCT00251004|12093464|FG001|Overall Study|Lost to Follow-up|2
7676398|NCT00251004|12093465|FG002|Overall Study|Lost to Follow-up|1
7676399|NCT00251004|12093463|FG000|Overall Study|Graft Loss|12
7676400|NCT00251004|12093464|FG001|Overall Study|Graft Loss|13
7676401|NCT00251004|12093465|FG002|Overall Study|Graft Loss|8
7676402|NCT00251316|12093499|FG000|Overall Study|Physician Decision|2
7676403|NCT00251316|12093500|FG001|Overall Study|Physician Decision|3
7676404|NCT00251589|12093510|FG000|Overall Study|Adverse Event|5
7676405|NCT00251589|12093511|FG001|Overall Study|Adverse Event|1
7676406|NCT00251589|12093512|FG002|Overall Study|Adverse Event|2
7676407|NCT00251589|12093513|FG003|Overall Study|Adverse Event|1
7676408|NCT00251589|12093510|FG000|Overall Study|Withdrawal by Subject|1
7676409|NCT00251589|12093511|FG001|Overall Study|Withdrawal by Subject|1
7676410|NCT00251589|12093512|FG002|Overall Study|Withdrawal by Subject|0
7676411|NCT00251589|12093513|FG003|Overall Study|Withdrawal by Subject|0
7676412|NCT00251589|12093510|FG000|Overall Study|Discontinued due to progressive disease|9
7676413|NCT00251589|12093511|FG001|Overall Study|Discontinued due to progressive disease|1
7676414|NCT00251589|12093512|FG002|Overall Study|Discontinued due to progressive disease|0
7676415|NCT00251589|12093513|FG003|Overall Study|Discontinued due to progressive disease|1
7676416|NCT00251641|12093525|FG000|Overall Study|Adverse Event|80
7676417|NCT00251641|12093526|FG001|Overall Study|Adverse Event|8
7676418|NCT00251641|12093525|FG000|Overall Study|Lack of Efficacy|2
7676419|NCT00251641|12093526|FG001|Overall Study|Lack of Efficacy|1
7676420|NCT00251641|12093525|FG000|Overall Study|Progression of Disease|0
7676421|NCT00251641|12093526|FG001|Overall Study|Progression of Disease|2
7676422|NCT00251641|12093525|FG000|Overall Study|Lost to Follow-up|3
7676423|NCT00251641|12093526|FG001|Overall Study|Lost to Follow-up|3
7676424|NCT00251641|12093525|FG000|Overall Study|Withdrawal by Subject|6
7676425|NCT00251641|12093526|FG001|Overall Study|Withdrawal by Subject|8
7676426|NCT00251641|12093525|FG000|Overall Study|Protocol Violation|10
7676427|NCT00251641|12093526|FG001|Overall Study|Protocol Violation|2
7676428|NCT00251641|12093525|FG000|Overall Study|Did not Meet protocol Eligibility|2
7676429|NCT00251641|12093526|FG001|Overall Study|Did not Meet protocol Eligibility|1
7676430|NCT00251641|12093525|FG000|Overall Study|Switched Treatment|9
7676431|NCT00251641|12093526|FG001|Overall Study|Switched Treatment|63
7676432|NCT00251693|12093537|FG000|Overall Study|Adverse Event|17
7676433|NCT00251693|12093538|FG001|Overall Study|Adverse Event|9
7676434|NCT00251693|12093539|FG002|Overall Study|Adverse Event|9
7676435|NCT00251693|12093537|FG000|Overall Study|Protocol Violation|2
7676436|NCT00251693|12093538|FG001|Overall Study|Protocol Violation|0
7676437|NCT00251693|12093539|FG002|Overall Study|Protocol Violation|2
7676438|NCT00251693|12093537|FG000|Overall Study|Lost to Follow-up|12
7676439|NCT00251693|12093538|FG001|Overall Study|Lost to Follow-up|7
7676440|NCT00251693|12093539|FG002|Overall Study|Lost to Follow-up|8
7676441|NCT00251693|12093537|FG000|Overall Study|Withdrawal by Subject|11
7676442|NCT00251693|12093538|FG001|Overall Study|Withdrawal by Subject|17
7676443|NCT00251693|12093539|FG002|Overall Study|Withdrawal by Subject|14
7676444|NCT00251693|12093537|FG000|Overall Study|Lack of Efficacy|0
7676445|NCT00251693|12093538|FG001|Overall Study|Lack of Efficacy|1
7676446|NCT00251693|12093539|FG002|Overall Study|Lack of Efficacy|0
7676447|NCT00251693|12093537|FG000|Overall Study|Inclusion/exclusion criteria not met|5
7676448|NCT00251693|12093538|FG001|Overall Study|Inclusion/exclusion criteria not met|3
7676449|NCT00251693|12093539|FG002|Overall Study|Inclusion/exclusion criteria not met|8
7676450|NCT00251693|12093537|FG000|Overall Study|Noncompliant|0
7676451|NCT00251693|12093538|FG001|Overall Study|Noncompliant|0
7676452|NCT00251693|12093539|FG002|Overall Study|Noncompliant|2
7676453|NCT00251693|12093537|FG000|Overall Study|Possible Barrett's esophagus|3
7676454|NCT00251693|12093538|FG001|Overall Study|Possible Barrett's esophagus|5
7676455|NCT00251693|12093539|FG002|Overall Study|Possible Barrett's esophagus|2
7676456|NCT00251693|12093537|FG000|Overall Study|Subject request/subject unavailable|1
7676457|NCT00251693|12093538|FG001|Overall Study|Subject request/subject unavailable|2
7676458|NCT00251693|12093539|FG002|Overall Study|Subject request/subject unavailable|0
7676459|NCT00251693|12093537|FG000|Overall Study|Abnormal laboratory findings|0
7676460|NCT00251693|12093538|FG001|Overall Study|Abnormal laboratory findings|0
7676461|NCT00251693|12093539|FG002|Overall Study|Abnormal laboratory findings|1
7676462|NCT00251719|12093550|FG000|Overall Study|Adverse Event|14
7676463|NCT00251719|12093551|FG001|Overall Study|Adverse Event|8
7676464|NCT00251719|12093552|FG002|Overall Study|Adverse Event|7
7676465|NCT00251719|12093550|FG000|Overall Study|Protocol Violation|1
7676466|NCT00251719|12093551|FG001|Overall Study|Protocol Violation|1
7676467|NCT00251719|12093552|FG002|Overall Study|Protocol Violation|1
7676468|NCT00251719|12093550|FG000|Overall Study|Lost to Follow-up|5
7676469|NCT00251719|12093551|FG001|Overall Study|Lost to Follow-up|11
7676470|NCT00251719|12093552|FG002|Overall Study|Lost to Follow-up|8
7676471|NCT00251719|12093550|FG000|Overall Study|Withdrawal by Subject|14
7676472|NCT00251719|12093551|FG001|Overall Study|Withdrawal by Subject|12
7676473|NCT00251719|12093552|FG002|Overall Study|Withdrawal by Subject|11
7676474|NCT00251719|12093550|FG000|Overall Study|Lack of Efficacy|2
7676475|NCT00251719|12093551|FG001|Overall Study|Lack of Efficacy|1
7676476|NCT00251719|12093552|FG002|Overall Study|Lack of Efficacy|0
7676477|NCT00251719|12093550|FG000|Overall Study|Inclusion/exclusion criteria not met|12
7676478|NCT00251719|12093551|FG001|Overall Study|Inclusion/exclusion criteria not met|6
7676479|NCT00251719|12093552|FG002|Overall Study|Inclusion/exclusion criteria not met|2
7676480|NCT00251719|12093550|FG000|Overall Study|Investigator decision|1
7676481|NCT00251719|12093551|FG001|Overall Study|Investigator decision|1
7676482|NCT00251719|12093552|FG002|Overall Study|Investigator decision|0
7676483|NCT00251719|12093550|FG000|Overall Study|Noncompliance|2
7676484|NCT00251719|12093551|FG001|Overall Study|Noncompliance|3
7676485|NCT00251719|12093552|FG002|Overall Study|Noncompliance|1
7676486|NCT00251719|12093550|FG000|Overall Study|Barrett's esophagus|2
7676487|NCT00251719|12093551|FG001|Overall Study|Barrett's esophagus|2
7676488|NCT00251719|12093552|FG002|Overall Study|Barrett's esophagus|0
7676489|NCT00251745|12093563|FG000|Overall Study|Adverse Event|7
7676490|NCT00251745|12093564|FG001|Overall Study|Adverse Event|9
7676491|NCT00251745|12093565|FG002|Overall Study|Adverse Event|11
7676492|NCT00251745|12093563|FG000|Overall Study|Lost to Follow-up|4
7676493|NCT00251745|12093564|FG001|Overall Study|Lost to Follow-up|2
7676494|NCT00251745|12093565|FG002|Overall Study|Lost to Follow-up|5
7676495|NCT00251745|12093563|FG000|Overall Study|Withdrawal by Subject|13
7676496|NCT00251745|12093564|FG001|Overall Study|Withdrawal by Subject|7
7676497|NCT00251745|12093565|FG002|Overall Study|Withdrawal by Subject|3
7676498|NCT00251745|12093563|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0
7676499|NCT00251745|12093564|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6
7676500|NCT00251745|12093565|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
7676501|NCT00251745|12093563|FG000|Overall Study|Lack of Efficacy|3
7676502|NCT00251745|12093564|FG001|Overall Study|Lack of Efficacy|0
7676503|NCT00251745|12093565|FG002|Overall Study|Lack of Efficacy|0
7676504|NCT00251745|12093563|FG000|Overall Study|Noncompliant|0
7676505|NCT00251745|12093564|FG001|Overall Study|Noncompliant|2
7676506|NCT00251745|12093565|FG002|Overall Study|Noncompliant|2
7676507|NCT00251745|12093563|FG000|Overall Study|Pregnancy|0
7676508|NCT00251745|12093564|FG001|Overall Study|Pregnancy|1
7676509|NCT00251745|12093565|FG002|Overall Study|Pregnancy|0
7676510|NCT00251745|12093563|FG000|Overall Study|Per Subject Request|0
7676511|NCT00251745|12093564|FG001|Overall Study|Per Subject Request|0
7676512|NCT00251745|12093565|FG002|Overall Study|Per Subject Request|1
7676513|NCT00251745|12093563|FG000|Overall Study|Per Investigator Request|1
7676514|NCT00251745|12093564|FG001|Overall Study|Per Investigator Request|0
7676515|NCT00251745|12093565|FG002|Overall Study|Per Investigator Request|0
7676516|NCT00251758|12093576|FG000|Overall Study|Adverse Event|7
7676517|NCT00251758|12093577|FG001|Overall Study|Adverse Event|9
7676518|NCT00251758|12093578|FG002|Overall Study|Adverse Event|11
7676519|NCT00251758|12093576|FG000|Overall Study|Lost to Follow-up|4
7676520|NCT00251758|12093577|FG001|Overall Study|Lost to Follow-up|2
7676521|NCT00251758|12093578|FG002|Overall Study|Lost to Follow-up|5
7676522|NCT00251758|12093576|FG000|Overall Study|Withdrawal by Subject|13
7676523|NCT00251758|12093577|FG001|Overall Study|Withdrawal by Subject|7
7676524|NCT00251758|12093578|FG002|Overall Study|Withdrawal by Subject|3
7676525|NCT00251758|12093576|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0
7676526|NCT00251758|12093577|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6
7676527|NCT00251758|12093578|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
7676528|NCT00251758|12093576|FG000|Overall Study|Lack of Efficacy|3
7676529|NCT00251758|12093577|FG001|Overall Study|Lack of Efficacy|0
7676530|NCT00251758|12093578|FG002|Overall Study|Lack of Efficacy|0
7676531|NCT00251758|12093576|FG000|Overall Study|Noncompliant|0
7676532|NCT00251758|12093577|FG001|Overall Study|Noncompliant|2
7676533|NCT00251758|12093578|FG002|Overall Study|Noncompliant|2
7676534|NCT00251758|12093576|FG000|Overall Study|Pregnancy|0
7676535|NCT00251758|12093577|FG001|Overall Study|Pregnancy|1
7676536|NCT00251758|12093578|FG002|Overall Study|Pregnancy|0
7676537|NCT00251758|12093576|FG000|Overall Study|Per Subject Request|0
7676538|NCT00251758|12093577|FG001|Overall Study|Per Subject Request|0
7676539|NCT00251758|12093578|FG002|Overall Study|Per Subject Request|1
7676540|NCT00251758|12093576|FG000|Overall Study|Per Investigator Request|1
7676541|NCT00251758|12093577|FG001|Overall Study|Per Investigator Request|0
7676542|NCT00251758|12093578|FG002|Overall Study|Per Investigator Request|0
7676543|NCT00251927|12093601|FG000|Overall Study|Adverse Event|3
7676544|NCT00251927|12093602|FG001|Overall Study|Adverse Event|15
7676545|NCT00251927|12093601|FG000|Overall Study|Lack of Efficacy|22
7676546|NCT00251927|12093602|FG001|Overall Study|Lack of Efficacy|16
7676547|NCT00251927|12093601|FG000|Overall Study|Lost to Follow-up|22
7676548|NCT00251927|12093602|FG001|Overall Study|Lost to Follow-up|8
7676549|NCT00251927|12093601|FG000|Overall Study|Protocol Violation|1
7676550|NCT00251927|12093602|FG001|Overall Study|Protocol Violation|2
7676551|NCT00251927|12093601|FG000|Overall Study|Pregnancy|2
7676552|NCT00251927|12093602|FG001|Overall Study|Pregnancy|0
7676553|NCT00251927|12093601|FG000|Overall Study|Withdrawal by Subject|40
7676554|NCT00251927|12093602|FG001|Overall Study|Withdrawal by Subject|25
7676555|NCT00251927|12093601|FG000|Overall Study|Study-specific discont. achieved|13
7676556|NCT00251927|12093602|FG001|Overall Study|Study-specific discont. achieved|2
7676557|NCT00251927|12093601|FG000|Overall Study|Study procedure non-compliance|5
7676558|NCT00251927|12093602|FG001|Overall Study|Study procedure non-compliance|6
7676559|NCT00251979|12093611|FG000|Overall Study|Protocol Violation|3
7676560|NCT00251979|12093612|FG001|Overall Study|Protocol Violation|5
7676561|NCT00251979|12093611|FG000|Overall Study|Adverse Event|11
7676562|NCT00251979|12093612|FG001|Overall Study|Adverse Event|17
7676563|NCT00251979|12093611|FG000|Overall Study|Withdrawal by Subject|13
7676564|NCT00251979|12093612|FG001|Overall Study|Withdrawal by Subject|7
7676565|NCT00251979|12093611|FG000|Overall Study|Lost to Follow-up|8
7676566|NCT00251979|12093612|FG001|Overall Study|Lost to Follow-up|6
7676567|NCT00251979|12093611|FG000|Overall Study|Death|3
7676568|NCT00251979|12093612|FG001|Overall Study|Death|5
7676569|NCT00252057|12093620|FG000|Overall Study|Withdrawal by Subject|2
7676570|NCT00252057|12093621|FG001|Overall Study|Withdrawal by Subject|5
7676571|NCT00252057|12093620|FG000|Overall Study|Death|1
7676572|NCT00252057|12093621|FG001|Overall Study|Death|2
7676573|NCT00252057|12093620|FG000|Overall Study|Participant previously enrolled|0
7676574|NCT00252057|12093621|FG001|Overall Study|Participant previously enrolled|1
7676575|NCT00252187|12093629|FG000|Overall Study|Adverse Event|3
7676576|NCT00252187|12093630|FG001|Overall Study|Adverse Event|1
7676577|NCT00252187|12093629|FG000|Overall Study|Withdrawal by Subject|1
7676578|NCT00252187|12093630|FG001|Overall Study|Withdrawal by Subject|0
7676579|NCT00252239|12093640|FG000|Overall Study|Withdrawal by Subject|1
7676580|NCT00252239|12093641|FG001|Overall Study|Withdrawal by Subject|0
7676581|NCT00252239|12093642|FG002|Overall Study|Withdrawal by Subject|0
7676582|NCT00252239|12093643|FG003|Overall Study|Withdrawal by Subject|1
7676583|NCT00252239|12093640|FG000|Overall Study|Lost to Follow-up|0
7676584|NCT00252239|12093641|FG001|Overall Study|Lost to Follow-up|0
7676585|NCT00252239|12093642|FG002|Overall Study|Lost to Follow-up|2
7676586|NCT00252239|12093643|FG003|Overall Study|Lost to Follow-up|0
7676587|NCT00252499|12093660|FG000|Overall Study|Lost to Follow-up|1
7676588|NCT00252499|12093661|FG001|Overall Study|Lost to Follow-up|0
7676589|NCT00252499|12093662|FG002|Overall Study|Lost to Follow-up|0
7676590|NCT00252564|12093687|FG000|Overall Study|Adverse Event|17
7676591|NCT00252564|12093688|FG001|Overall Study|Adverse Event|13
7676592|NCT00252564|12093687|FG000|Overall Study|Unrelated Complication|2
7676593|NCT00252564|12093688|FG001|Overall Study|Unrelated Complication|1
7676594|NCT00252564|12093687|FG000|Overall Study|Disease Progression|14
7676595|NCT00252564|12093688|FG001|Overall Study|Disease Progression|20
7676596|NCT00252564|12093687|FG000|Overall Study|Death|0
7676597|NCT00252564|12093688|FG001|Overall Study|Death|3
7676598|NCT00252564|12093687|FG000|Overall Study|Physician Decision|1
7676599|NCT00252564|12093688|FG001|Overall Study|Physician Decision|0
7676600|NCT00252564|12093687|FG000|Overall Study|Lost to Follow-up|1
7676601|NCT00252564|12093688|FG001|Overall Study|Lost to Follow-up|0
7676602|NCT00252564|12093687|FG000|Overall Study|Patient Request|4
7676603|NCT00252564|12093688|FG001|Overall Study|Patient Request|5
7676604|NCT00252564|12093687|FG000|Overall Study|Withdrawal by Subject|0
7676605|NCT00252564|12093688|FG001|Overall Study|Withdrawal by Subject|2
7676606|NCT00252577|12093694|FG000|Overall Study|Lost to Follow-up|20
7676607|NCT00252694|12093731|FG000|Overall Study|Withdrawal by Subject|83
7676608|NCT00252694|12093732|FG001|Overall Study|Withdrawal by Subject|91
7676609|NCT00252694|12093731|FG000|Overall Study|Death|36
7676610|NCT00252694|12093732|FG001|Overall Study|Death|34
7676611|NCT00252694|12093731|FG000|Overall Study|Mostly Lost to Follow Up|8
7676612|NCT00252694|12093732|FG001|Overall Study|Mostly Lost to Follow Up|13
7676613|NCT00252694|12093731|FG000|Overall Study|Patient Moving|17
7676614|NCT00252694|12093732|FG001|Overall Study|Patient Moving|16
7676615|NCT00252720|12093740|FG000|Overall Study|Withdrawal by Subject|95
7676616|NCT00252720|12093741|FG001|Overall Study|Withdrawal by Subject|97
7676617|NCT00252720|12093740|FG000|Overall Study|Death|7
7676618|NCT00252720|12093741|FG001|Overall Study|Death|8
7676619|NCT00252720|12093740|FG000|Overall Study|Moving|23
7676620|NCT00252720|12093741|FG001|Overall Study|Moving|42
7676621|NCT00252720|12093740|FG000|Overall Study|Mainly patients lost to follow-up|7
7676622|NCT00252720|12093741|FG001|Overall Study|Mainly patients lost to follow-up|18
7676623|NCT00252733|12093749|FG000|Overall Study|Withdrawal by Subject|73
7676624|NCT00252733|12093750|FG001|Overall Study|Withdrawal by Subject|67
7676625|NCT00252733|12093749|FG000|Overall Study|Death|7
7676626|NCT00252733|12093750|FG001|Overall Study|Death|5
7676627|NCT00252733|12093749|FG000|Overall Study|Lost to Follow-up|12
7676628|NCT00252733|12093750|FG001|Overall Study|Lost to Follow-up|6
7676629|NCT00252733|12093749|FG000|Overall Study|Multiple Reasons|14
7676630|NCT00252733|12093750|FG001|Overall Study|Multiple Reasons|14
7676631|NCT00253370|12093778|FG000|Overall Study|Adverse Event|18
7676632|NCT00253370|12093778|FG000|Overall Study|Disease progression|13
7676633|NCT00253370|12093778|FG000|Overall Study|Death|2
7676634|NCT00253370|12093778|FG000|Overall Study|Withdrawal by Subject|6
7676635|NCT00253370|12093778|FG000|Overall Study|Non-protocol therapy|1
7676636|NCT00253370|12093778|FG000|Overall Study|Physician Decision|1
7676637|NCT00253370|12093778|FG000|Overall Study|Protocol Violation|1
7676638|NCT00253370|12093778|FG000|Overall Study|Abdominal pain due to disease|1
7676639|NCT00253448|12093792|FG000|Overall Study|Withdrawal by Subject|1
7676640|NCT00253630|12093800|FG000|Overall Study|ineligible|2
7676641|NCT00253643|12093808|FG000|Overall Study|Withdrawal by Subject|0
7676642|NCT00253643|12093809|FG001|Overall Study|Withdrawal by Subject|0
7676643|NCT00253643|12093810|FG002|Overall Study|Withdrawal by Subject|1
7676644|NCT00253643|12093811|FG003|Overall Study|Withdrawal by Subject|1
7676645|NCT00253643|12093808|FG000|Overall Study|Non-Compliance|0
7676646|NCT00253643|12093809|FG001|Overall Study|Non-Compliance|0
7676647|NCT00253643|12093810|FG002|Overall Study|Non-Compliance|0
7676648|NCT00253643|12093811|FG003|Overall Study|Non-Compliance|2
7676649|NCT00253747|12093836|FG000|Overall Study|Lost to Follow-up|13
7676650|NCT00253747|12093837|FG001|Overall Study|Lost to Follow-up|14
7676651|NCT00253747|12093836|FG000|Overall Study|Withdrawal by Subject|10
7676652|NCT00253747|12093837|FG001|Overall Study|Withdrawal by Subject|11
7676653|NCT00253747|12093836|FG000|Overall Study|Administrative Discharge (1), Other (2)|1
7676654|NCT00253747|12093837|FG001|Overall Study|Administrative Discharge (1), Other (2)|2
7676655|NCT00254163|12093873|FG000|Overall Study|Adverse Event|29
7676656|NCT00254163|12093874|FG001|Overall Study|Adverse Event|26
7676657|NCT00254163|12093873|FG000|Overall Study|Patient request/withdrew consent|6
7676658|NCT00254163|12093874|FG001|Overall Study|Patient request/withdrew consent|4
7676659|NCT00254163|12093873|FG000|Overall Study|Investigator request|1
7676660|NCT00254163|12093874|FG001|Overall Study|Investigator request|3
7676661|NCT00254163|12093873|FG000|Overall Study|Failed entry|1
7676662|NCT00254163|12093874|FG001|Overall Study|Failed entry|3
7676663|NCT00254163|12093873|FG000|Overall Study|Progressive disease|0
7676664|NCT00254163|12093874|FG001|Overall Study|Progressive disease|1
7676665|NCT00254163|12093873|FG000|Overall Study|Death|0
7676666|NCT00254163|12093874|FG001|Overall Study|Death|1
7676667|NCT00254163|12093873|FG000|Overall Study|Other|8
7676668|NCT00254163|12093874|FG001|Overall Study|Other|8
7676669|NCT00254293|12093886|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7676670|NCT00254293|12093887|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1
7676671|NCT00254293|12093888|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7676672|NCT00254293|12093889|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1
7676673|NCT00254293|12093890|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7676674|NCT00254293|12093891|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7676675|NCT00254293|12093892|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7676676|NCT00254293|12093886|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7676677|NCT00254293|12093887|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7676678|NCT00254293|12093888|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
7676679|NCT00254293|12093889|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7676680|NCT00254293|12093890|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7676681|NCT00254293|12093891|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7676682|NCT00254293|12093892|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7676683|NCT00254293|12093886|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7676684|NCT00254293|12093887|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7676685|NCT00254293|12093888|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
7676686|NCT00254293|12093889|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7676687|NCT00254293|12093890|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7676688|NCT00254293|12093891|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7676689|NCT00254293|12093892|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7676690|NCT00254293|12093886|FG000|LTE Open Label Variable SC Dosing|Death|0
7676691|NCT00254293|12093887|FG001|LTE Open Label Variable SC Dosing|Death|0
7676692|NCT00254293|12093888|FG002|LTE Open Label Variable SC Dosing|Death|1
7676693|NCT00254293|12093889|FG003|LTE Open Label Variable SC Dosing|Death|0
7676694|NCT00254293|12093890|FG004|LTE Open Label Variable SC Dosing|Death|0
7676695|NCT00254293|12093891|FG005|LTE Open Label Variable SC Dosing|Death|0
7676696|NCT00254293|12093892|FG006|LTE Open Label Variable SC Dosing|Death|0
7676697|NCT00254293|12093886|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1
7676698|NCT00254293|12093887|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0
7676699|NCT00254293|12093888|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2
7676700|NCT00254293|12093889|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0
7676701|NCT00254293|12093890|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1
7676702|NCT00254293|12093891|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0
7676703|NCT00254293|12093892|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0
7676704|NCT00254293|12093886|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
7676705|NCT00254293|12093887|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
7676706|NCT00254293|12093888|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
7676707|NCT00254293|12093889|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
7676708|NCT00254293|12093890|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
7676709|NCT00254293|12093891|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
7676710|NCT00254293|12093892|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
7676711|NCT00254293|12093886|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7676712|NCT00254293|12093887|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7676713|NCT00254293|12093888|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
7676714|NCT00254293|12093889|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7676715|NCT00254293|12093890|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7676716|NCT00254293|12093891|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7676717|NCT00254293|12093892|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7676718|NCT00254293|12093886|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7676719|NCT00254293|12093887|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7676720|NCT00254293|12093888|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
7676721|NCT00254293|12093889|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7676722|NCT00254293|12093890|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7676723|NCT00254293|12093891|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7676724|NCT00254293|12093892|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7676725|NCT00254293|12093886|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7676726|NCT00254293|12093887|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7676727|NCT00254293|12093888|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
7676728|NCT00254293|12093889|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7676729|NCT00254293|12093890|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7676730|NCT00254293|12093891|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7676731|NCT00254293|12093892|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7676732|NCT00254293|12093886|FG000|LTE Open Label Variable SC Dosing|Other|0
7676733|NCT00254293|12093887|FG001|LTE Open Label Variable SC Dosing|Other|0
7676734|NCT00254293|12093888|FG002|LTE Open Label Variable SC Dosing|Other|2
7676735|NCT00254293|12093889|FG003|LTE Open Label Variable SC Dosing|Other|0
7676736|NCT00254293|12093890|FG004|LTE Open Label Variable SC Dosing|Other|0
7676737|NCT00254293|12093891|FG005|LTE Open Label Variable SC Dosing|Other|0
7676738|NCT00254293|12093892|FG006|LTE Open Label Variable SC Dosing|Other|0
7676739|NCT00254293|12093886|FG000|LTE Open Label Fixed Dosing|Death|0
7676740|NCT00254293|12093887|FG001|LTE Open Label Fixed Dosing|Death|0
7676741|NCT00254293|12093888|FG002|LTE Open Label Fixed Dosing|Death|0
7676742|NCT00254293|12093889|FG003|LTE Open Label Fixed Dosing|Death|0
7676743|NCT00254293|12093890|FG004|LTE Open Label Fixed Dosing|Death|0
7676744|NCT00254293|12093891|FG005|LTE Open Label Fixed Dosing|Death|0
7676745|NCT00254293|12093892|FG006|LTE Open Label Fixed Dosing|Death|3
7676746|NCT00254293|12093886|FG000|LTE Open Label Fixed Dosing|Adverse Event|0
7676747|NCT00254293|12093887|FG001|LTE Open Label Fixed Dosing|Adverse Event|0
7676748|NCT00254293|12093888|FG002|LTE Open Label Fixed Dosing|Adverse Event|0
7676749|NCT00254293|12093889|FG003|LTE Open Label Fixed Dosing|Adverse Event|0
7676750|NCT00254293|12093890|FG004|LTE Open Label Fixed Dosing|Adverse Event|0
7676751|NCT00254293|12093891|FG005|LTE Open Label Fixed Dosing|Adverse Event|0
7676752|NCT00254293|12093892|FG006|LTE Open Label Fixed Dosing|Adverse Event|1
7676753|NCT00254293|12093886|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7676754|NCT00254293|12093887|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7676755|NCT00254293|12093888|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7676756|NCT00254293|12093889|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7676757|NCT00254293|12093890|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7676758|NCT00254293|12093891|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7676759|NCT00254293|12093892|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3
7676760|NCT00254293|12093886|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7676761|NCT00254293|12093887|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7676762|NCT00254293|12093888|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7676763|NCT00254293|12093889|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7676848|NCT00255008|12094033|FG000|Overall Study|Lost to Follow-up|1
7676764|NCT00254293|12093890|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7676765|NCT00254293|12093891|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7676766|NCT00254293|12093892|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1
7676767|NCT00254293|12093886|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7676768|NCT00254293|12093887|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7676769|NCT00254293|12093888|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7676770|NCT00254293|12093889|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7676771|NCT00254293|12093890|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7676772|NCT00254293|12093891|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7676773|NCT00254293|12093892|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
7676774|NCT00254293|12093886|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7676775|NCT00254293|12093887|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7676776|NCT00254293|12093888|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7676777|NCT00254293|12093889|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7676778|NCT00254293|12093890|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7676779|NCT00254293|12093891|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7676780|NCT00254293|12093892|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1
7676781|NCT00254293|12093886|FG000|LTE Open Label Fixed Dosing|Other|0
7676782|NCT00254293|12093887|FG001|LTE Open Label Fixed Dosing|Other|0
7676783|NCT00254293|12093888|FG002|LTE Open Label Fixed Dosing|Other|0
7676784|NCT00254293|12093889|FG003|LTE Open Label Fixed Dosing|Other|0
7676785|NCT00254293|12093890|FG004|LTE Open Label Fixed Dosing|Other|0
7676786|NCT00254293|12093891|FG005|LTE Open Label Fixed Dosing|Other|0
7676787|NCT00254293|12093892|FG006|LTE Open Label Fixed Dosing|Other|1
7676788|NCT00254397|12093939|FG000|Overall Study|Disease Progression|4
7676789|NCT00254397|12093940|FG001|Overall Study|Disease Progression|1
7676790|NCT00254397|12093941|FG002|Overall Study|Disease Progression|16
7676791|NCT00254397|12093942|FG003|Overall Study|Disease Progression|23
7676792|NCT00254397|12093939|FG000|Overall Study|Non-Compliant|0
7676793|NCT00254397|12093940|FG001|Overall Study|Non-Compliant|0
7676794|NCT00254397|12093941|FG002|Overall Study|Non-Compliant|0
7676795|NCT00254397|12093942|FG003|Overall Study|Non-Compliant|1
7676796|NCT00254397|12093939|FG000|Overall Study|Adverse Event|2
7676797|NCT00254397|12093940|FG001|Overall Study|Adverse Event|0
7676798|NCT00254397|12093941|FG002|Overall Study|Adverse Event|3
7676799|NCT00254397|12093942|FG003|Overall Study|Adverse Event|1
7676800|NCT00254501|12093977|FG000|Overall Study|Lost to Follow-up|1
7676801|NCT00254501|12093978|FG001|Overall Study|Lost to Follow-up|1
7676802|NCT00254540|12093988|FG000|Overall Study|Adverse Event|6
7676803|NCT00254540|12093989|FG001|Overall Study|Adverse Event|7
7676804|NCT00254540|12093988|FG000|Overall Study|Lack of Efficacy|13
7676805|NCT00254540|12093989|FG001|Overall Study|Lack of Efficacy|13
7676806|NCT00254540|12093988|FG000|Overall Study|Death|0
7676807|NCT00254540|12093989|FG001|Overall Study|Death|1
7676808|NCT00254540|12093988|FG000|Overall Study|Laboratory Test Abnormality|0
7676809|NCT00254540|12093989|FG001|Overall Study|Laboratory Test Abnormality|1
7676810|NCT00254566|12093998|FG000|Overall Study|Death|1
7676811|NCT00254566|12093999|FG001|Overall Study|Death|0
7676812|NCT00254566|12093998|FG000|Overall Study|Adverse Event|5
7676813|NCT00254566|12093999|FG001|Overall Study|Adverse Event|4
7676814|NCT00254566|12093998|FG000|Overall Study|Lack of Efficacy|12
7676815|NCT00254566|12093999|FG001|Overall Study|Lack of Efficacy|9
7676816|NCT00254566|12093998|FG000|Overall Study|Other|1
7676817|NCT00254566|12093999|FG001|Overall Study|Other|5
7676818|NCT00254566|12093998|FG000|Overall Study|Withdrawal by Subject|5
7676819|NCT00254566|12093999|FG001|Overall Study|Withdrawal by Subject|6
7676820|NCT00254566|12093998|FG000|Overall Study|Lost to Follow-up|7
7676821|NCT00254566|12093999|FG001|Overall Study|Lost to Follow-up|2
7676822|NCT00254982|12094011|FG000|Overall Study|Other|2
7676823|NCT00254982|12094012|FG001|Overall Study|Other|1
7676824|NCT00254982|12094011|FG000|Overall Study|Lack of Efficacy|5
7676825|NCT00254982|12094012|FG001|Overall Study|Lack of Efficacy|3
7676826|NCT00254982|12094011|FG000|Overall Study|Lost to Follow-up|5
7676827|NCT00254982|12094012|FG001|Overall Study|Lost to Follow-up|3
7676828|NCT00254982|12094011|FG000|Overall Study|Adverse Event|18
7676829|NCT00254982|12094012|FG001|Overall Study|Adverse Event|16
7676830|NCT00254982|12094011|FG000|Overall Study|Withdrawal by Subject|1
7676831|NCT00254982|12094012|FG001|Overall Study|Withdrawal by Subject|1
7676832|NCT00254982|12094011|FG000|Overall Study|Inclusion/exclusion criteria violation|0
7676833|NCT00254982|12094012|FG001|Overall Study|Inclusion/exclusion criteria violation|2
7676834|NCT00254982|12094011|FG000|Overall Study|Protocol deviation|1
7676835|NCT00254982|12094012|FG001|Overall Study|Protocol deviation|1
7676836|NCT00254982|12094011|FG000|Overall Study|Diagnosis of Tuberculosis|1
7676837|NCT00254982|12094012|FG001|Overall Study|Diagnosis of Tuberculosis|1
7676838|NCT00254982|12094011|FG000|Overall Study|Malignancy|0
7676839|NCT00254982|12094012|FG001|Overall Study|Malignancy|2
7676840|NCT00254982|12094011|FG000|Overall Study|Opportunistic infection|1
7676841|NCT00254982|12094012|FG001|Overall Study|Opportunistic infection|0
7676842|NCT00254982|12094011|FG000|Overall Study|Abnormal liver function tests|2
7676843|NCT00254982|12094012|FG001|Overall Study|Abnormal liver function tests|1
7676844|NCT00255008|12094033|FG000|Overall Study|Adverse Event|1
7676845|NCT00255008|12094034|FG001|Overall Study|Adverse Event|1
7676846|NCT00255008|12094035|FG002|Overall Study|Adverse Event|2
7676847|NCT00255008|12094036|FG003|Overall Study|Adverse Event|0
7676849|NCT00255008|12094034|FG001|Overall Study|Lost to Follow-up|0
7676850|NCT00255008|12094035|FG002|Overall Study|Lost to Follow-up|1
7676851|NCT00255008|12094036|FG003|Overall Study|Lost to Follow-up|2
7676852|NCT00255008|12094033|FG000|Overall Study|Did not meet viral reduction criteria|4
7676853|NCT00255008|12094034|FG001|Overall Study|Did not meet viral reduction criteria|5
7676854|NCT00255008|12094035|FG002|Overall Study|Did not meet viral reduction criteria|0
7676855|NCT00255008|12094036|FG003|Overall Study|Did not meet viral reduction criteria|1
7676856|NCT00255008|12094033|FG000|Overall Study|Withdrew consent|0
7676857|NCT00255008|12094034|FG001|Overall Study|Withdrew consent|0
7676858|NCT00255008|12094035|FG002|Overall Study|Withdrew consent|2
7676859|NCT00255008|12094036|FG003|Overall Study|Withdrew consent|0
7676860|NCT00255008|12094033|FG000|Overall Study|Sponsor request|18
7676861|NCT00255008|12094034|FG001|Overall Study|Sponsor request|3
7676862|NCT00255008|12094035|FG002|Overall Study|Sponsor request|8
7676863|NCT00255008|12094036|FG003|Overall Study|Sponsor request|17
7676864|NCT00255008|12094033|FG000|Overall Study|Adverse lab experience|1
7676865|NCT00255008|12094034|FG001|Overall Study|Adverse lab experience|0
7676866|NCT00255008|12094035|FG002|Overall Study|Adverse lab experience|0
7676867|NCT00255008|12094036|FG003|Overall Study|Adverse lab experience|0
7676868|NCT00255008|12094033|FG000|Overall Study|Other|7
7676869|NCT00255008|12094034|FG001|Overall Study|Other|0
7676870|NCT00255008|12094035|FG002|Overall Study|Other|3
7676871|NCT00255008|12094036|FG003|Overall Study|Other|2
7676872|NCT00255034|12094048|FG000|Overall Study|Withdrawal by Subject|15
7676873|NCT00255034|12094049|FG001|Overall Study|Withdrawal by Subject|38
7676874|NCT00255047|12094059|FG000|Overall Study|Serious Adverse Events|2
7676875|NCT00255047|12094060|FG001|Overall Study|Serious Adverse Events|1
7676876|NCT00255047|12094061|FG002|Overall Study|Serious Adverse Events|2
7676877|NCT00255047|12094062|FG003|Overall Study|Serious Adverse Events|1
7676878|NCT00255047|12094059|FG000|Overall Study|Adverse Event|0
7676879|NCT00255047|12094060|FG001|Overall Study|Adverse Event|3
7676880|NCT00255047|12094061|FG002|Overall Study|Adverse Event|2
7676881|NCT00255047|12094062|FG003|Overall Study|Adverse Event|1
7676882|NCT00255047|12094059|FG000|Overall Study|Protocol Violation|13
7676883|NCT00255047|12094060|FG001|Overall Study|Protocol Violation|13
7676884|NCT00255047|12094061|FG002|Overall Study|Protocol Violation|16
7676885|NCT00255047|12094062|FG003|Overall Study|Protocol Violation|20
7676886|NCT00255047|12094059|FG000|Overall Study|Lost to Follow-up|9
7676887|NCT00255047|12094060|FG001|Overall Study|Lost to Follow-up|8
7676888|NCT00255047|12094061|FG002|Overall Study|Lost to Follow-up|5
7676889|NCT00255047|12094062|FG003|Overall Study|Lost to Follow-up|6
7676890|NCT00255047|12094059|FG000|Overall Study|Withdrawal by Subject|24
7676891|NCT00255047|12094060|FG001|Overall Study|Withdrawal by Subject|23
7676892|NCT00255047|12094061|FG002|Overall Study|Withdrawal by Subject|25
7676893|NCT00255047|12094062|FG003|Overall Study|Withdrawal by Subject|18
7676894|NCT00255086|12094074|FG000|Overall Study|Adverse Event|1
7676895|NCT00255086|12094075|FG001|Overall Study|Adverse Event|1
7676896|NCT00255086|12094074|FG000|Overall Study|Protocol Violation|1
7676897|NCT00255086|12094075|FG001|Overall Study|Protocol Violation|1
7676898|NCT00255151|12094096|FG000|Overall Study|Adverse Event|10
7676899|NCT00255151|12094097|FG001|Overall Study|Adverse Event|6
7676900|NCT00255151|12094098|FG002|Overall Study|Adverse Event|9
7676901|NCT00255151|12094096|FG000|Overall Study|Lost to Follow-up|4
7676902|NCT00255151|12094097|FG001|Overall Study|Lost to Follow-up|3
7676903|NCT00255151|12094098|FG002|Overall Study|Lost to Follow-up|4
7676904|NCT00255151|12094096|FG000|Overall Study|Withdrawal by Subject|18
7676905|NCT00255151|12094097|FG001|Overall Study|Withdrawal by Subject|17
7676906|NCT00255151|12094098|FG002|Overall Study|Withdrawal by Subject|8
7676907|NCT00255151|12094096|FG000|Overall Study|Noncompliance|0
7676908|NCT00255151|12094097|FG001|Overall Study|Noncompliance|1
7676909|NCT00255151|12094098|FG002|Overall Study|Noncompliance|2
7676910|NCT00255151|12094096|FG000|Overall Study|Subject Request/Subject Unavailable|1
7676911|NCT00255151|12094097|FG001|Overall Study|Subject Request/Subject Unavailable|1
7676912|NCT00255151|12094098|FG002|Overall Study|Subject Request/Subject Unavailable|2
7676913|NCT00255151|12094096|FG000|Overall Study|Relapse of Erosive Esophagitis|78
7676914|NCT00255151|12094097|FG001|Overall Study|Relapse of Erosive Esophagitis|16
7676915|NCT00255151|12094098|FG002|Overall Study|Relapse of Erosive Esophagitis|12
7676916|NCT00255151|12094096|FG000|Overall Study|Possible Barrett's Esophagus|1
7676917|NCT00255151|12094097|FG001|Overall Study|Possible Barrett's Esophagus|3
7676918|NCT00255151|12094098|FG002|Overall Study|Possible Barrett's Esophagus|8
7676919|NCT00255151|12094096|FG000|Overall Study|Esophageal Stricture|0
7676920|NCT00255151|12094097|FG001|Overall Study|Esophageal Stricture|0
7676921|NCT00255151|12094098|FG002|Overall Study|Esophageal Stricture|1
7676922|NCT00255151|12094096|FG000|Overall Study|Therapeutic Failure|11
7676923|NCT00255151|12094097|FG001|Overall Study|Therapeutic Failure|2
7676924|NCT00255151|12094098|FG002|Overall Study|Therapeutic Failure|3
7676925|NCT00255164|12094109|FG000|Overall Study|Adverse Event|10
7676926|NCT00255164|12094110|FG001|Overall Study|Adverse Event|6
7676927|NCT00255164|12094111|FG002|Overall Study|Adverse Event|9
7676928|NCT00255164|12094109|FG000|Overall Study|Lost to Follow-up|4
7676929|NCT00255164|12094110|FG001|Overall Study|Lost to Follow-up|3
7676930|NCT00255164|12094111|FG002|Overall Study|Lost to Follow-up|4
7676931|NCT00255164|12094109|FG000|Overall Study|Withdrawal by Subject|18
7676932|NCT00255164|12094110|FG001|Overall Study|Withdrawal by Subject|17
7676933|NCT00255164|12094111|FG002|Overall Study|Withdrawal by Subject|8
7676934|NCT00255164|12094109|FG000|Overall Study|Noncompliance|0
7676935|NCT00255164|12094110|FG001|Overall Study|Noncompliance|1
7676936|NCT00255164|12094111|FG002|Overall Study|Noncompliance|2
7676937|NCT00255164|12094109|FG000|Overall Study|Subject Request/Subject Unavailable|1
7676938|NCT00255164|12094110|FG001|Overall Study|Subject Request/Subject Unavailable|1
7676939|NCT00255164|12094111|FG002|Overall Study|Subject Request/Subject Unavailable|2
7676940|NCT00255164|12094109|FG000|Overall Study|Relapse of Erosive Esophagitis|78
7676941|NCT00255164|12094110|FG001|Overall Study|Relapse of Erosive Esophagitis|16
7676942|NCT00255164|12094111|FG002|Overall Study|Relapse of Erosive Esophagitis|12
7676943|NCT00255164|12094109|FG000|Overall Study|Possible Barrett's Esophagus|1
7676944|NCT00255164|12094110|FG001|Overall Study|Possible Barrett's Esophagus|3
7676945|NCT00255164|12094111|FG002|Overall Study|Possible Barrett's Esophagus|8
7676946|NCT00255164|12094109|FG000|Overall Study|Esophageal Stricture|0
7676947|NCT00255164|12094110|FG001|Overall Study|Esophageal Stricture|0
7676948|NCT00255164|12094111|FG002|Overall Study|Esophageal Stricture|1
7676949|NCT00255164|12094109|FG000|Overall Study|Therapeutic Failure|11
7676950|NCT00255164|12094110|FG001|Overall Study|Therapeutic Failure|2
7676951|NCT00255164|12094111|FG002|Overall Study|Therapeutic Failure|3
7676952|NCT00255190|12094138|FG000|Overall Study|Adverse Event|17
7676953|NCT00255190|12094139|FG001|Overall Study|Adverse Event|36
7676954|NCT00255190|12094138|FG000|Overall Study|Protocol Violation|2
7676955|NCT00255190|12094139|FG001|Overall Study|Protocol Violation|2
7676956|NCT00255190|12094138|FG000|Overall Study|Lost to Follow-up|10
7676957|NCT00255190|12094139|FG001|Overall Study|Lost to Follow-up|27
7676958|NCT00255190|12094138|FG000|Overall Study|Withdrew Consent|17
7676959|NCT00255190|12094139|FG001|Overall Study|Withdrew Consent|48
7676960|NCT00255190|12094138|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
7676961|NCT00255190|12094139|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
7676962|NCT00255190|12094138|FG000|Overall Study|Erosive esophagitis not healed|0
7676963|NCT00255190|12094139|FG001|Overall Study|Erosive esophagitis not healed|20
7676964|NCT00255190|12094138|FG000|Overall Study|Various|4
7676965|NCT00255190|12094139|FG001|Overall Study|Various|23
7676966|NCT00255346|12094150|FG000|Overall Study|Adverse Event|1
7676967|NCT00255346|12094151|FG001|Overall Study|Adverse Event|0
7676968|NCT00255346|12094152|FG002|Overall Study|Adverse Event|0
7676969|NCT00255346|12094153|FG003|Overall Study|Adverse Event|0
7676970|NCT00255346|12094154|FG004|Overall Study|Adverse Event|0
7676971|NCT00255723|12094168|FG000|Overall Study|Adverse Event|1
7676972|NCT00255723|12094169|FG001|Overall Study|Adverse Event|1
7676973|NCT00255723|12094168|FG000|Overall Study|Death|0
7676974|NCT00255723|12094169|FG001|Overall Study|Death|1
7676975|NCT00255723|12094168|FG000|Overall Study|Response Data Not Available|1
7676976|NCT00255723|12094169|FG001|Overall Study|Response Data Not Available|0
7676977|NCT00255840|12094181|FG000|Overall Study|Lost to Follow-up|10
7676978|NCT00255840|12094182|FG001|Overall Study|Lost to Follow-up|14
7676979|NCT00255840|12094181|FG000|Overall Study|Discontinued intervention|53
7676980|NCT00255840|12094182|FG001|Overall Study|Discontinued intervention|56
7676981|NCT00255944|12094190|FG000|Overall Study|Lost to Follow-up|797
7676982|NCT00255944|12094191|FG001|Overall Study|Lost to Follow-up|834
7676983|NCT00256126|12094208|FG000|Overall Study|Adverse Event|1
7676984|NCT00256126|12094209|FG001|Overall Study|Adverse Event|0
7676985|NCT00256126|12094208|FG000|Overall Study|Other|1
7676986|NCT00256126|12094209|FG001|Overall Study|Other|2
7676987|NCT00256204|12094219|FG000|Overall Study|Adverse Event|10
7676988|NCT00256204|12094220|FG001|Overall Study|Adverse Event|14
7676989|NCT00256204|12094221|FG002|Overall Study|Adverse Event|16
7676990|NCT00256204|12094222|FG003|Overall Study|Adverse Event|14
7676991|NCT00256204|12094219|FG000|Overall Study|Death|0
7676992|NCT00256204|12094220|FG001|Overall Study|Death|1
7676993|NCT00256204|12094221|FG002|Overall Study|Death|0
7676994|NCT00256204|12094222|FG003|Overall Study|Death|0
7676995|NCT00256204|12094219|FG000|Overall Study|Lost to Follow-up|1
7676996|NCT00256204|12094220|FG001|Overall Study|Lost to Follow-up|1
7676997|NCT00256204|12094221|FG002|Overall Study|Lost to Follow-up|1
7676998|NCT00256204|12094222|FG003|Overall Study|Lost to Follow-up|2
7676999|NCT00256204|12094219|FG000|Overall Study|Protocol Violation|1
7677000|NCT00256204|12094220|FG001|Overall Study|Protocol Violation|0
7677001|NCT00256204|12094221|FG002|Overall Study|Protocol Violation|2
7677002|NCT00256204|12094222|FG003|Overall Study|Protocol Violation|1
7677003|NCT00256204|12094219|FG000|Overall Study|Physician Decision|0
7677004|NCT00256204|12094220|FG001|Overall Study|Physician Decision|0
7677005|NCT00256204|12094221|FG002|Overall Study|Physician Decision|1
7677006|NCT00256204|12094222|FG003|Overall Study|Physician Decision|2
7677007|NCT00256204|12094219|FG000|Overall Study|Withdrawal by Subject|17
7677008|NCT00256204|12094220|FG001|Overall Study|Withdrawal by Subject|6
7677009|NCT00256204|12094221|FG002|Overall Study|Withdrawal by Subject|7
7677010|NCT00256204|12094222|FG003|Overall Study|Withdrawal by Subject|5
7677011|NCT00256204|12094219|FG000|Overall Study|Need for additional prohibited treatment|38
7677012|NCT00256204|12094220|FG001|Overall Study|Need for additional prohibited treatment|28
7677013|NCT00256204|12094221|FG002|Overall Study|Need for additional prohibited treatment|27
7677014|NCT00256204|12094222|FG003|Overall Study|Need for additional prohibited treatment|25
7677015|NCT00256243|12094239|FG000|Overall Study|Lost to Follow-up|2
7677016|NCT00256243|12094239|FG000|Overall Study|Death|7
7677017|NCT00256243|12094239|FG000|Overall Study|Not treated|1
7677018|NCT00256282|12094244|FG000|Overall Study|Disease progression, relapse during acti|12
7677019|NCT00256282|12094244|FG000|Overall Study|Adverse Event|3
7677020|NCT00256282|12094244|FG000|Overall Study|Physician Decision|1
7677021|NCT00256308|12094248|FG000|Overall Study|Death|2
7677022|NCT00256698|12094267|FG000|Overall Study|Withdrawal by Subject|7
7677023|NCT00256698|12094268|FG001|Overall Study|Withdrawal by Subject|7
7677024|NCT00256698|12094267|FG000|Overall Study|Adverse Event|13
7677025|NCT00256698|12094268|FG001|Overall Study|Adverse Event|6
7677026|NCT00256698|12094267|FG000|Overall Study|Protocol Violation|6
7677027|NCT00256698|12094268|FG001|Overall Study|Protocol Violation|5
7677028|NCT00256698|12094267|FG000|Overall Study|Lost to Follow-up|1
7677029|NCT00256698|12094268|FG001|Overall Study|Lost to Follow-up|3
7677030|NCT00256698|12094267|FG000|Overall Study|disease progression|97
7677031|NCT00256698|12094268|FG001|Overall Study|disease progression|105
7677032|NCT00256698|12094267|FG000|Overall Study|still ongoing at data cut-off|41
7677033|NCT00256698|12094268|FG001|Overall Study|still ongoing at data cut-off|46
7677034|NCT00256698|12094267|FG000|Overall Study|withdrawn due to osteoporosis|1
7677035|NCT00256698|12094268|FG001|Overall Study|withdrawn due to osteoporosis|0
7677036|NCT00256698|12094267|FG000|Overall Study|Prematurely Discontinued|1
7677037|NCT00256698|12094268|FG001|Overall Study|Prematurely Discontinued|0
7677038|NCT00256724|12094276|FG000|Overall Study|Physician Decision|2
7677039|NCT00256724|12094277|FG001|Overall Study|Physician Decision|5
7677040|NCT00256724|12094276|FG000|Overall Study|Protocol Violation|3
7677041|NCT00256724|12094277|FG001|Overall Study|Protocol Violation|3
7677042|NCT00256750|12094286|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3
7677043|NCT00256750|12094287|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0
7677044|NCT00256750|12094288|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0
7677045|NCT00256750|12094286|FG000|Transplanted Pre-Treatment|Other|2
7677046|NCT00256750|12094287|FG001|Transplanted Pre-Treatment|Other|0
7677047|NCT00256750|12094288|FG002|Transplanted Pre-Treatment|Other|0
7677048|NCT00256750|12094286|FG000|Transplanted Pre-Treatment|Death|1
7677049|NCT00256750|12094287|FG001|Transplanted Pre-Treatment|Death|0
7677050|NCT00256750|12094288|FG002|Transplanted Pre-Treatment|Death|0
7677051|NCT00256750|12094286|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20
7677052|NCT00256750|12094287|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12
7677053|NCT00256750|12094288|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8
7677054|NCT00256750|12094286|FG000|Post-Transplant Treated (12 Months)|Death|3
7677055|NCT00256750|12094287|FG001|Post-Transplant Treated (12 Months)|Death|2
7677056|NCT00256750|12094288|FG002|Post-Transplant Treated (12 Months)|Death|4
7677057|NCT00256750|12094286|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
7677058|NCT00256750|12094287|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
7677059|NCT00256750|12094288|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
7677060|NCT00256750|12094286|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
7677061|NCT00256750|12094287|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
7677062|NCT00256750|12094288|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
7677063|NCT00256750|12094286|FG000|Post-Transplant Treated (12 Months)|Other|5
7677064|NCT00256750|12094287|FG001|Post-Transplant Treated (12 Months)|Other|4
7677065|NCT00256750|12094288|FG002|Post-Transplant Treated (12 Months)|Other|2
7677066|NCT00256750|12094286|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
7677067|NCT00256750|12094287|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
7677068|NCT00256750|12094288|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
7677069|NCT00256750|12094286|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2
7677070|NCT00256750|12094287|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0
7677071|NCT00256750|12094288|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0
7677072|NCT00256750|12094286|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7
7677073|NCT00256750|12094287|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3
7677074|NCT00256750|12094288|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6
7677075|NCT00256750|12094286|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
7677076|NCT00256750|12094287|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
7677077|NCT00256750|12094288|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
7677078|NCT00256750|12094286|FG000|Post-Transplant Treated (24 Months)|Death|3
7677079|NCT00256750|12094287|FG001|Post-Transplant Treated (24 Months)|Death|0
7677080|NCT00256750|12094288|FG002|Post-Transplant Treated (24 Months)|Death|0
7677081|NCT00256750|12094286|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
7677082|NCT00256750|12094287|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
7677083|NCT00256750|12094288|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
7677084|NCT00256750|12094286|FG000|Post-Transplant Treated (24 Months)|Other|2
7677085|NCT00256750|12094287|FG001|Post-Transplant Treated (24 Months)|Other|0
7677086|NCT00256750|12094288|FG002|Post-Transplant Treated (24 Months)|Other|1
7677087|NCT00256750|12094286|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5
7677088|NCT00256750|12094287|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1
7677089|NCT00256750|12094288|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2
7677090|NCT00256750|12094286|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
7677091|NCT00256750|12094287|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
7677092|NCT00256750|12094288|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
7677093|NCT00256750|12094286|FG000|Post-Transplant Treated (36 Months)|Death|0
7677094|NCT00256750|12094287|FG001|Post-Transplant Treated (36 Months)|Death|2
7677095|NCT00256750|12094288|FG002|Post-Transplant Treated (36 Months)|Death|1
7677096|NCT00256750|12094286|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
7677097|NCT00256750|12094287|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
7677098|NCT00256750|12094288|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
7677099|NCT00256750|12094286|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
7677100|NCT00256750|12094287|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
7677101|NCT00256750|12094288|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
7677102|NCT00256750|12094286|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0
7677103|NCT00256750|12094287|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1
7677104|NCT00256750|12094288|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0
7677105|NCT00256750|12094286|FG000|Post-Transplant Treated (36 Months)|Other|0
7677106|NCT00256750|12094287|FG001|Post-Transplant Treated (36 Months)|Other|1
7677107|NCT00256750|12094288|FG002|Post-Transplant Treated (36 Months)|Other|1
7677108|NCT00256750|12094286|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13
7677109|NCT00256750|12094287|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11
7677110|NCT00256750|12094288|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14
7677111|NCT00256750|12094286|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
7677112|NCT00256750|12094287|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
7677113|NCT00256750|12094288|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
7677114|NCT00256750|12094286|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
7677115|NCT00256750|12094287|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
7677116|NCT00256750|12094288|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
7677117|NCT00256750|12094286|FG000|Long Term Extension (LTE; 84 Months)|Death|9
7677118|NCT00256750|12094287|FG001|Long Term Extension (LTE; 84 Months)|Death|4
7677119|NCT00256750|12094288|FG002|Long Term Extension (LTE; 84 Months)|Death|4
7677120|NCT00256750|12094286|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
7677121|NCT00256750|12094287|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
7677122|NCT00256750|12094288|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
7677123|NCT00256750|12094286|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
7677124|NCT00256750|12094287|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
7677125|NCT00256750|12094288|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
7677126|NCT00256750|12094286|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0
7677127|NCT00256750|12094287|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1
7677128|NCT00256750|12094288|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2
7677129|NCT00256750|12094286|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
7677130|NCT00256750|12094287|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
7677131|NCT00256750|12094288|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
7677132|NCT00256750|12094286|FG000|Long Term Extension (LTE; 84 Months)|Other|5
7677133|NCT00256750|12094287|FG001|Long Term Extension (LTE; 84 Months)|Other|4
7677134|NCT00256750|12094288|FG002|Long Term Extension (LTE; 84 Months)|Other|5
7677135|NCT00256854|12094314|FG000|Overall Study|Withdrawal by Subject|2
7677136|NCT00256854|12094315|FG001|Overall Study|Withdrawal by Subject|3
7677137|NCT00256854|12094316|FG002|Overall Study|Withdrawal by Subject|0
7677138|NCT00256854|12094317|FG003|Overall Study|Withdrawal by Subject|0
7677139|NCT00256854|12094318|FG004|Overall Study|Withdrawal by Subject|0
7677140|NCT00256854|12094319|FG005|Overall Study|Withdrawal by Subject|0
7677141|NCT00256854|12094314|FG000|Overall Study|Lack of Efficacy|1
7677142|NCT00256854|12094315|FG001|Overall Study|Lack of Efficacy|0
7677143|NCT00256854|12094316|FG002|Overall Study|Lack of Efficacy|0
7677144|NCT00256854|12094317|FG003|Overall Study|Lack of Efficacy|0
7677145|NCT00256854|12094318|FG004|Overall Study|Lack of Efficacy|0
7677146|NCT00256854|12094319|FG005|Overall Study|Lack of Efficacy|0
7677147|NCT00256854|12094314|FG000|Overall Study|Protocol Violation|0
7677148|NCT00256854|12094315|FG001|Overall Study|Protocol Violation|1
7677149|NCT00256854|12094316|FG002|Overall Study|Protocol Violation|1
7677150|NCT00256854|12094317|FG003|Overall Study|Protocol Violation|1
7677151|NCT00256854|12094318|FG004|Overall Study|Protocol Violation|0
7677152|NCT00256854|12094319|FG005|Overall Study|Protocol Violation|0
7677153|NCT00256854|12094314|FG000|Overall Study|Adverse Event|0
7677154|NCT00256854|12094315|FG001|Overall Study|Adverse Event|0
7677155|NCT00256854|12094316|FG002|Overall Study|Adverse Event|2
7677156|NCT00256854|12094317|FG003|Overall Study|Adverse Event|2
7677157|NCT00256854|12094318|FG004|Overall Study|Adverse Event|0
7677158|NCT00256854|12094319|FG005|Overall Study|Adverse Event|1
7677159|NCT00256854|12094314|FG000|Overall Study|Not compliant with the study drug|0
7677160|NCT00256854|12094315|FG001|Overall Study|Not compliant with the study drug|0
7677161|NCT00256854|12094316|FG002|Overall Study|Not compliant with the study drug|0
7677162|NCT00256854|12094317|FG003|Overall Study|Not compliant with the study drug|0
7677163|NCT00256854|12094318|FG004|Overall Study|Not compliant with the study drug|1
7677164|NCT00256854|12094319|FG005|Overall Study|Not compliant with the study drug|0
7677165|NCT00256867|12094342|FG000|Overall Study|Adverse Event|0
7677166|NCT00256867|12094343|FG001|Overall Study|Adverse Event|1
7677167|NCT00256867|12094344|FG002|Overall Study|Adverse Event|1
7677168|NCT00256867|12094345|FG003|Overall Study|Adverse Event|1
7677169|NCT00256867|12094346|FG004|Overall Study|Adverse Event|2
7677170|NCT00256867|12094347|FG005|Overall Study|Adverse Event|2
7677171|NCT00256867|12094348|FG006|Overall Study|Adverse Event|1
7677172|NCT00256867|12094349|FG007|Overall Study|Adverse Event|4
7677173|NCT00256867|12094342|FG000|Overall Study|Lost to Follow-up|2
7677174|NCT00256867|12094343|FG001|Overall Study|Lost to Follow-up|2
7677175|NCT00256867|12094344|FG002|Overall Study|Lost to Follow-up|2
7677176|NCT00256867|12094345|FG003|Overall Study|Lost to Follow-up|3
7677177|NCT00256867|12094346|FG004|Overall Study|Lost to Follow-up|2
7677178|NCT00256867|12094347|FG005|Overall Study|Lost to Follow-up|0
7677179|NCT00256867|12094348|FG006|Overall Study|Lost to Follow-up|1
7677180|NCT00256867|12094349|FG007|Overall Study|Lost to Follow-up|2
7677181|NCT00256867|12094342|FG000|Overall Study|Protocol Violation|0
7677182|NCT00256867|12094343|FG001|Overall Study|Protocol Violation|0
7677183|NCT00256867|12094344|FG002|Overall Study|Protocol Violation|0
7677184|NCT00256867|12094345|FG003|Overall Study|Protocol Violation|1
7677185|NCT00256867|12094346|FG004|Overall Study|Protocol Violation|0
7677186|NCT00256867|12094347|FG005|Overall Study|Protocol Violation|1
7677187|NCT00256867|12094348|FG006|Overall Study|Protocol Violation|0
7677188|NCT00256867|12094349|FG007|Overall Study|Protocol Violation|1
7677189|NCT00256867|12094342|FG000|Overall Study|Withdrawal by Subject|0
7677190|NCT00256867|12094343|FG001|Overall Study|Withdrawal by Subject|0
7677191|NCT00256867|12094344|FG002|Overall Study|Withdrawal by Subject|1
7677192|NCT00256867|12094345|FG003|Overall Study|Withdrawal by Subject|1
7677193|NCT00256867|12094346|FG004|Overall Study|Withdrawal by Subject|2
7677194|NCT00256867|12094347|FG005|Overall Study|Withdrawal by Subject|2
7677195|NCT00256867|12094348|FG006|Overall Study|Withdrawal by Subject|3
7677196|NCT00256867|12094349|FG007|Overall Study|Withdrawal by Subject|2
7677197|NCT00256867|12094342|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0
7677198|NCT00256867|12094343|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1
7677199|NCT00256867|12094344|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0
7677200|NCT00256867|12094345|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0
7677201|NCT00256867|12094346|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0
7677202|NCT00256867|12094347|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0
7677203|NCT00256867|12094348|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0
7677204|NCT00256867|12094349|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0
7677205|NCT00256867|12094342|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0
7677206|NCT00256867|12094343|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0
7677207|NCT00256867|12094344|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0
7677208|NCT00256867|12094345|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0
7677209|NCT00256867|12094346|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0
7677210|NCT00256867|12094347|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0
7677211|NCT00256867|12094348|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0
7677212|NCT00256867|12094349|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1
7677213|NCT00256867|12094342|FG000|Overall Study|Investigator's Decision|0
7677214|NCT00256867|12094343|FG001|Overall Study|Investigator's Decision|0
7677215|NCT00256867|12094344|FG002|Overall Study|Investigator's Decision|0
7677216|NCT00256867|12094345|FG003|Overall Study|Investigator's Decision|0
7677217|NCT00256867|12094346|FG004|Overall Study|Investigator's Decision|1
7677218|NCT00256867|12094347|FG005|Overall Study|Investigator's Decision|0
7677219|NCT00256867|12094348|FG006|Overall Study|Investigator's Decision|0
7677220|NCT00256867|12094349|FG007|Overall Study|Investigator's Decision|0
7677221|NCT00256867|12094342|FG000|Overall Study|Non-compliance with study medication|0
7677222|NCT00256867|12094343|FG001|Overall Study|Non-compliance with study medication|0
7677223|NCT00256867|12094344|FG002|Overall Study|Non-compliance with study medication|0
7677224|NCT00256867|12094345|FG003|Overall Study|Non-compliance with study medication|0
7677225|NCT00256867|12094346|FG004|Overall Study|Non-compliance with study medication|0
7677226|NCT00256867|12094347|FG005|Overall Study|Non-compliance with study medication|0
7677227|NCT00256867|12094348|FG006|Overall Study|Non-compliance with study medication|0
7677228|NCT00256867|12094349|FG007|Overall Study|Non-compliance with study medication|1
7677229|NCT00256867|12094342|FG000|Overall Study|Participant travelled Overseas|0
7677230|NCT00256867|12094343|FG001|Overall Study|Participant travelled Overseas|1
7677231|NCT00256867|12094344|FG002|Overall Study|Participant travelled Overseas|0
7677232|NCT00256867|12094345|FG003|Overall Study|Participant travelled Overseas|0
7677233|NCT00256867|12094346|FG004|Overall Study|Participant travelled Overseas|0
7677234|NCT00256867|12094347|FG005|Overall Study|Participant travelled Overseas|0
7677235|NCT00256867|12094348|FG006|Overall Study|Participant travelled Overseas|0
7677236|NCT00256867|12094349|FG007|Overall Study|Participant travelled Overseas|0
7677237|NCT00256867|12094342|FG000|Overall Study|Participant out of assessment window|0
7677238|NCT00256867|12094343|FG001|Overall Study|Participant out of assessment window|0
7677239|NCT00256867|12094344|FG002|Overall Study|Participant out of assessment window|1
7677240|NCT00256867|12094345|FG003|Overall Study|Participant out of assessment window|0
7677241|NCT00256867|12094346|FG004|Overall Study|Participant out of assessment window|0
7677242|NCT00256867|12094347|FG005|Overall Study|Participant out of assessment window|0
7677243|NCT00256867|12094348|FG006|Overall Study|Participant out of assessment window|0
7677244|NCT00256867|12094349|FG007|Overall Study|Participant out of assessment window|0
7677245|NCT00256867|12094342|FG000|Overall Study|Withdrawal by participant|0
7677246|NCT00256867|12094343|FG001|Overall Study|Withdrawal by participant|0
7677247|NCT00256867|12094344|FG002|Overall Study|Withdrawal by participant|0
7677248|NCT00256867|12094345|FG003|Overall Study|Withdrawal by participant|0
7677249|NCT00256867|12094346|FG004|Overall Study|Withdrawal by participant|0
7677250|NCT00256867|12094347|FG005|Overall Study|Withdrawal by participant|1
7677251|NCT00256867|12094348|FG006|Overall Study|Withdrawal by participant|0
7677252|NCT00256867|12094349|FG007|Overall Study|Withdrawal by participant|0
7677253|NCT00256997|12094378|FG000|Overall Study|Protocol Violation|1
7677254|NCT00256997|12094379|FG001|Overall Study|Protocol Violation|4
7677255|NCT00256997|12094378|FG000|Overall Study|Lack of Efficacy|1
7677256|NCT00256997|12094379|FG001|Overall Study|Lack of Efficacy|4
7677257|NCT00256997|12094378|FG000|Overall Study|Death|2
7677258|NCT00256997|12094379|FG001|Overall Study|Death|0
7677259|NCT00256997|12094378|FG000|Overall Study|Adverse Event|4
7677260|NCT00256997|12094379|FG001|Overall Study|Adverse Event|0
7677261|NCT00256997|12094378|FG000|Overall Study|Lost to Follow-up|3
7677262|NCT00256997|12094379|FG001|Overall Study|Lost to Follow-up|5
7677263|NCT00256997|12094378|FG000|Overall Study|Withdrawal by Subject|13
7677264|NCT00256997|12094379|FG001|Overall Study|Withdrawal by Subject|3
7677265|NCT00256997|12094378|FG000|Overall Study|Started but not treated|2
7677266|NCT00256997|12094379|FG001|Overall Study|Started but not treated|0
7677267|NCT00256997|12094378|FG000|Overall Study|Other|5
7677268|NCT00256997|12094379|FG001|Overall Study|Other|8
7677269|NCT00256997|12094378|FG000|Overall Study|End of Study (As Per Sponsor)|12
7677270|NCT00256997|12094379|FG001|Overall Study|End of Study (As Per Sponsor)|24
7677271|NCT00256997|12094378|FG000|Overall Study|Participant Non-compliant|3
7677272|NCT00256997|12094379|FG001|Overall Study|Participant Non-compliant|6
7677273|NCT00256997|12094378|FG000|Overall Study|Investigator Withdrew Participant|2
7677274|NCT00256997|12094379|FG001|Overall Study|Investigator Withdrew Participant|1
7677275|NCT00257010|12094386|FG000|Overall Study|Lack of Efficacy|11
7677276|NCT00257010|12094386|FG000|Overall Study|Lost to Follow-up|53
7677277|NCT00257010|12094386|FG000|Overall Study|Withdrawal by Subject|34
7677278|NCT00257010|12094386|FG000|Overall Study|Adverse Event|10
7677279|NCT00257010|12094386|FG000|Overall Study|various|11
7677280|NCT00257010|12094386|FG000|Overall Study|no headache reported|9
7677281|NCT00257166|12094392|FG000|Overall Study|Adverse Event|18
7677282|NCT00257166|12094393|FG001|Overall Study|Adverse Event|13
7677283|NCT00257166|12094392|FG000|Overall Study|Laboratory abnormality|1
7677284|NCT00257166|12094393|FG001|Overall Study|Laboratory abnormality|0
7677285|NCT00257166|12094392|FG000|Overall Study|Lost to Follow-up|8
7677286|NCT00257166|12094393|FG001|Overall Study|Lost to Follow-up|1
7677287|NCT00257166|12094392|FG000|Overall Study|Withdrawal by Subject|9
7677288|NCT00257166|12094393|FG001|Overall Study|Withdrawal by Subject|2
7677289|NCT00257166|12094392|FG000|Overall Study|Other|16
7677290|NCT00257166|12094393|FG001|Overall Study|Other|21
7677291|NCT00257166|12094392|FG000|Overall Study|Randomized, but not treated|1
7677292|NCT00257166|12094393|FG001|Overall Study|Randomized, but not treated|0
7677293|NCT00257192|12094401|FG000|Overall Study|Adverse Event|21
7677294|NCT00257192|12094402|FG001|Overall Study|Adverse Event|10
7677295|NCT00257192|12094401|FG000|Overall Study|Laboratory abnormality|1
7677296|NCT00257192|12094402|FG001|Overall Study|Laboratory abnormality|1
7677297|NCT00257192|12094401|FG000|Overall Study|Lost to Follow-up|3
7677298|NCT00257192|12094402|FG001|Overall Study|Lost to Follow-up|3
7677299|NCT00257192|12094401|FG000|Overall Study|Insufficient clinical response|18
7677300|NCT00257192|12094402|FG001|Overall Study|Insufficient clinical response|18
7677301|NCT00257192|12094401|FG000|Overall Study|Withdrawal by Subject|14
7677302|NCT00257192|12094402|FG001|Overall Study|Withdrawal by Subject|2
7677303|NCT00257192|12094401|FG000|Overall Study|Randomized but not treated|0
7677304|NCT00257192|12094402|FG001|Overall Study|Randomized but not treated|1
7677305|NCT00257192|12094401|FG000|Overall Study|Study terminated by sponsor|1
7677306|NCT00257192|12094402|FG001|Overall Study|Study terminated by sponsor|0
7677307|NCT00257192|12094401|FG000|Overall Study|Miscellaneous|0
7677308|NCT00257192|12094402|FG001|Overall Study|Miscellaneous|4
7677309|NCT00257556|12094423|FG000|Overall Study|Adverse Event|1
7677310|NCT00257556|12094424|FG001|Overall Study|Adverse Event|4
7677311|NCT00257556|12094423|FG000|Overall Study|Physician Decision|6
7677312|NCT00257556|12094424|FG001|Overall Study|Physician Decision|0
7677313|NCT00257556|12094423|FG000|Overall Study|Did not meet hCG criterion|3
7677314|NCT00257556|12094424|FG001|Overall Study|Did not meet hCG criterion|0
7677315|NCT00257556|12094423|FG000|Overall Study|other reason|4
7677316|NCT00257556|12094424|FG001|Overall Study|other reason|6
7677317|NCT00257608|12094432|FG000|Chemotherapy Phase|Adverse Event|138
7677318|NCT00257608|12094433|FG001|Chemotherapy Phase|Adverse Event|0
7677319|NCT00257608|12094434|FG002|Chemotherapy Phase|Adverse Event|0
7677320|NCT00257608|12094432|FG000|Chemotherapy Phase|Disease progression|139
7677321|NCT00257608|12094433|FG001|Chemotherapy Phase|Disease progression|0
7677322|NCT00257608|12094434|FG002|Chemotherapy Phase|Disease progression|0
7677323|NCT00257608|12094432|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6
7677324|NCT00257608|12094433|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0
7677325|NCT00257608|12094434|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0
7677326|NCT00257608|12094432|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
7677327|NCT00257608|12094433|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
7677328|NCT00257608|12094434|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
7677329|NCT00257608|12094432|FG000|Chemotherapy Phase|Patient's decision to discontinue|35
7677330|NCT00257608|12094433|FG001|Chemotherapy Phase|Patient's decision to discontinue|0
7677331|NCT00257608|12094434|FG002|Chemotherapy Phase|Patient's decision to discontinue|0
7677332|NCT00257608|12094432|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3
7677333|NCT00257608|12094433|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0
7677334|NCT00257608|12094434|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0
7677335|NCT00257608|12094432|FG000|Chemotherapy Phase|Physician Decision|28
7677336|NCT00257608|12094433|FG001|Chemotherapy Phase|Physician Decision|0
7677337|NCT00257608|12094434|FG002|Chemotherapy Phase|Physician Decision|0
7677338|NCT00257608|12094432|FG000|Post Chemotherapy Phase|Adverse Event|0
7677339|NCT00257608|12094433|FG001|Post Chemotherapy Phase|Adverse Event|34
7677340|NCT00257608|12094434|FG002|Post Chemotherapy Phase|Adverse Event|38
7677341|NCT00257608|12094432|FG000|Post Chemotherapy Phase|Disease progression|0
7677342|NCT00257608|12094433|FG001|Post Chemotherapy Phase|Disease progression|204
7677343|NCT00257608|12094434|FG002|Post Chemotherapy Phase|Disease progression|168
7677344|NCT00257608|12094432|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0
7677345|NCT00257608|12094433|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4
7677346|NCT00257608|12094434|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5
7677347|NCT00257608|12094432|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
7677348|NCT00257608|12094433|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
7677349|NCT00257608|12094434|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
7677350|NCT00257608|12094432|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0
7677351|NCT00257608|12094433|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4
7677352|NCT00257608|12094434|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8
7677353|NCT00257608|12094432|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0
7677354|NCT00257608|12094433|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0
7677355|NCT00257608|12094434|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1
7677356|NCT00257608|12094432|FG000|Post Chemotherapy Phase|Lost to Follow-up|0
7677357|NCT00257608|12094433|FG001|Post Chemotherapy Phase|Lost to Follow-up|0
7677358|NCT00257608|12094434|FG002|Post Chemotherapy Phase|Lost to Follow-up|1
7677359|NCT00257608|12094432|FG000|Post Chemotherapy Phase|Physician Decision|0
7677360|NCT00257608|12094433|FG001|Post Chemotherapy Phase|Physician Decision|8
7677361|NCT00257608|12094434|FG002|Post Chemotherapy Phase|Physician Decision|11
7677362|NCT00257608|12094432|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
7677363|NCT00257608|12094433|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
7677364|NCT00257608|12094434|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
7677365|NCT00257608|12094432|FG000|Post Chemotherapy Phase|Not treated|0
7677366|NCT00257608|12094433|FG001|Post Chemotherapy Phase|Not treated|4
7677367|NCT00257608|12094434|FG002|Post Chemotherapy Phase|Not treated|7
7677368|NCT00257725|12094472|FG000|Overall Study|Adverse Event|3
7677369|NCT00257920|12094488|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0
7677370|NCT00257920|12094489|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1
7677371|NCT00257920|12094488|FG000|Period: Second Intervention|Other|2
7677372|NCT00257920|12094489|FG001|Period: Second Intervention|Other|1
7677373|NCT00258154|12094522|FG000|Overall Study|Adverse Event|1
7677374|NCT00258154|12094523|FG001|Overall Study|Adverse Event|0
7677375|NCT00258154|12094522|FG000|Overall Study|Lost to Follow-up|0
7677376|NCT00258154|12094523|FG001|Overall Study|Lost to Follow-up|1
7677377|NCT00258154|12094522|FG000|Overall Study|Protocol Violation|2
7677378|NCT00258154|12094523|FG001|Overall Study|Protocol Violation|1
7677379|NCT00258154|12094522|FG000|Overall Study|Withdrawal by Subject|3
7677380|NCT00258154|12094523|FG001|Overall Study|Withdrawal by Subject|4
7677381|NCT00258154|12094522|FG000|Overall Study|Patient Moved|3
7677382|NCT00258154|12094523|FG001|Overall Study|Patient Moved|1
7677383|NCT00258440|12094556|FG000|Overall Study|Withdrawal by Subject|0
7677384|NCT00258440|12094557|FG001|Overall Study|Withdrawal by Subject|0
7677385|NCT00258440|12094558|FG002|Overall Study|Withdrawal by Subject|1
7677386|NCT00258674|12094569|FG000|Overall Study|Death|32
7677387|NCT00258674|12094570|FG001|Overall Study|Death|53
7677388|NCT00258674|12094571|FG002|Overall Study|Death|34
7677389|NCT00258856|12094601|FG000|Overall Study|Lost to Follow-up|1
7677390|NCT00258856|12094602|FG001|Overall Study|Lost to Follow-up|0
7677391|NCT00258856|12094603|FG002|Overall Study|Lost to Follow-up|2
7677392|NCT00258856|12094604|FG003|Overall Study|Lost to Follow-up|0
7677393|NCT00258856|12094601|FG000|Overall Study|Non-compliance|2
7677394|NCT00258856|12094602|FG001|Overall Study|Non-compliance|0
7677395|NCT00258856|12094603|FG002|Overall Study|Non-compliance|0
7677396|NCT00258856|12094604|FG003|Overall Study|Non-compliance|1
7677397|NCT00258895|12094627|FG000|Overall Study|Lost to Follow-up|3
7677398|NCT00258895|12094628|FG001|Overall Study|Lost to Follow-up|1
7677399|NCT00258895|12094627|FG000|Overall Study|Protocol Violation|6
7677400|NCT00258895|12094628|FG001|Overall Study|Protocol Violation|2
7677401|NCT00258895|12094627|FG000|Overall Study|Withdrawal by Subject|1
7677402|NCT00258895|12094628|FG001|Overall Study|Withdrawal by Subject|0
7677403|NCT00258960|12094638|FG000|Overall Study|Death|2
7677404|NCT00258960|12094638|FG000|Overall Study|Disease Progression|7
7677405|NCT00258960|12094638|FG000|Overall Study|Adverse Event|4
7677406|NCT00258960|12094638|FG000|Overall Study|Physician Decision|1
7677407|NCT00258960|12094638|FG000|Overall Study|Withdrawal by Subject|1
7677408|NCT00258960|12094638|FG000|Overall Study|Mistake|2
7677409|NCT00259012|12094644|FG000|Overall Study|Adverse Event|0
7677410|NCT00259012|12094645|FG001|Overall Study|Adverse Event|1
7677411|NCT00259012|12094644|FG000|Overall Study|Withdrawal by Subject|1
7677412|NCT00259012|12094645|FG001|Overall Study|Withdrawal by Subject|0
7677413|NCT00259012|12094644|FG000|Overall Study|Physician Decision|0
7677414|NCT00259012|12094645|FG001|Overall Study|Physician Decision|1
7677415|NCT00259012|12094644|FG000|Overall Study|Lost to Follow-up|0
7677416|NCT00259012|12094645|FG001|Overall Study|Lost to Follow-up|1
7677417|NCT00259012|12094644|FG000|Overall Study|Protocol Violation|1
7677418|NCT00259012|12094645|FG001|Overall Study|Protocol Violation|1
7677419|NCT00259272|12094668|FG000|Overall Study|Adverse Event|2
7677420|NCT00259272|12094669|FG001|Overall Study|Adverse Event|1
7677421|NCT00259272|12094670|FG002|Overall Study|Adverse Event|0
7677422|NCT00259272|12094671|FG003|Overall Study|Adverse Event|3
7677423|NCT00259272|12094668|FG000|Overall Study|Lack of Efficacy|5
7677424|NCT00259272|12094669|FG001|Overall Study|Lack of Efficacy|1
7677425|NCT00259272|12094670|FG002|Overall Study|Lack of Efficacy|2
7677426|NCT00259272|12094671|FG003|Overall Study|Lack of Efficacy|6
7677427|NCT00259272|12094668|FG000|Overall Study|Physician Decision|1
7677428|NCT00259272|12094669|FG001|Overall Study|Physician Decision|2
7677429|NCT00259272|12094670|FG002|Overall Study|Physician Decision|1
7677430|NCT00259272|12094671|FG003|Overall Study|Physician Decision|3
7677431|NCT00259272|12094668|FG000|Overall Study|Protocol Violation|2
7677432|NCT00259272|12094669|FG001|Overall Study|Protocol Violation|0
7677433|NCT00259272|12094670|FG002|Overall Study|Protocol Violation|0
7677434|NCT00259272|12094671|FG003|Overall Study|Protocol Violation|1
7677435|NCT00259272|12094668|FG000|Overall Study|Sponsor Decision|0
7677436|NCT00259272|12094669|FG001|Overall Study|Sponsor Decision|1
7677437|NCT00259272|12094670|FG002|Overall Study|Sponsor Decision|0
7677438|NCT00259272|12094671|FG003|Overall Study|Sponsor Decision|0
7677439|NCT00259272|12094668|FG000|Overall Study|Withdrawal by Subject|4
7677440|NCT00259272|12094669|FG001|Overall Study|Withdrawal by Subject|2
7677441|NCT00259272|12094670|FG002|Overall Study|Withdrawal by Subject|2
7677442|NCT00259272|12094671|FG003|Overall Study|Withdrawal by Subject|7
7677443|NCT00259272|12094668|FG000|Overall Study|Lost to Follow-up|1
7677444|NCT00259272|12094669|FG001|Overall Study|Lost to Follow-up|0
7677445|NCT00259272|12094670|FG002|Overall Study|Lost to Follow-up|0
7677446|NCT00259272|12094671|FG003|Overall Study|Lost to Follow-up|1
7677447|NCT00259298|12094690|FG000|Overall Study|Withdrawal by Subject|1
7677448|NCT00259298|12094690|FG000|Overall Study|Physician Decision|2
7677449|NCT00259610|12094698|FG000|Overall Study|Withdrawal by Subject|33
7677450|NCT00259610|12094699|FG001|Overall Study|Withdrawal by Subject|25
7677451|NCT00259610|12094700|FG002|Overall Study|Withdrawal by Subject|29
7677452|NCT00259610|12094701|FG003|Overall Study|Withdrawal by Subject|19
7677453|NCT00259610|12094698|FG000|Overall Study|Lost to Follow-up|19
7677454|NCT00259610|12094699|FG001|Overall Study|Lost to Follow-up|8
7677455|NCT00259610|12094700|FG002|Overall Study|Lost to Follow-up|18
7677456|NCT00259610|12094701|FG003|Overall Study|Lost to Follow-up|15
7677457|NCT00259610|12094698|FG000|Overall Study|Physician Decision|6
7677458|NCT00259610|12094699|FG001|Overall Study|Physician Decision|4
7677459|NCT00259610|12094700|FG002|Overall Study|Physician Decision|7
7677460|NCT00259610|12094701|FG003|Overall Study|Physician Decision|2
7677461|NCT00259610|12094698|FG000|Overall Study|Death|1
7677462|NCT00259610|12094699|FG001|Overall Study|Death|1
7677463|NCT00259610|12094700|FG002|Overall Study|Death|2
7677464|NCT00259610|12094701|FG003|Overall Study|Death|0
7677465|NCT00259610|12094698|FG000|Overall Study|non medical reason|6
7677466|NCT00259610|12094699|FG001|Overall Study|non medical reason|2
7677467|NCT00259610|12094700|FG002|Overall Study|non medical reason|10
7677468|NCT00259610|12094701|FG003|Overall Study|non medical reason|3
7677469|NCT00259610|12094698|FG000|Overall Study|Adverse Event|3
7677470|NCT00259610|12094699|FG001|Overall Study|Adverse Event|4
7677471|NCT00259610|12094700|FG002|Overall Study|Adverse Event|5
7677472|NCT00259610|12094701|FG003|Overall Study|Adverse Event|2
7677473|NCT00259610|12094698|FG000|Overall Study|Serious Adverse Event|8
7677474|NCT00259610|12094699|FG001|Overall Study|Serious Adverse Event|2
7677475|NCT00259610|12094700|FG002|Overall Study|Serious Adverse Event|2
7677476|NCT00259610|12094701|FG003|Overall Study|Serious Adverse Event|2
7677477|NCT00259649|12094711|FG000|Overall Study|Lost to Follow-up|7
7677478|NCT00259649|12094711|FG000|Overall Study|irregular menses|3
7677479|NCT00259740|12094717|FG000|Overall Study|Physician Decision|1
7677480|NCT00259740|12094718|FG001|Overall Study|Physician Decision|1
7677481|NCT00259740|12094717|FG000|Overall Study|Adverse Event|0
7677482|NCT00259740|12094718|FG001|Overall Study|Adverse Event|2
7677483|NCT00259740|12094717|FG000|Overall Study|Withdrawal by Subject|2
7677484|NCT00259740|12094718|FG001|Overall Study|Withdrawal by Subject|6
7677485|NCT00259740|12094717|FG000|Overall Study|Death|1
7677486|NCT00259740|12094718|FG001|Overall Study|Death|1
7677487|NCT00259740|12094717|FG000|Overall Study|Disease progression|19
7677488|NCT00259740|12094718|FG001|Overall Study|Disease progression|36
7677489|NCT00259740|12094717|FG000|Overall Study|Ongoing|17
7677490|NCT00259740|12094718|FG001|Overall Study|Ongoing|3
7677491|NCT00259740|12094717|FG000|Overall Study|Other|3
7677492|NCT00259740|12094718|FG001|Overall Study|Other|0
7677493|NCT00259740|12094717|FG000|Overall Study|Requirement for alternative therapy|0
7677494|NCT00259740|12094718|FG001|Overall Study|Requirement for alternative therapy|4
7677495|NCT00259857|12094726|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
7677496|NCT00259857|12094727|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
7677497|NCT00259857|12094726|FG000|24 Months Treatment|Lost to Follow-up|0
7677498|NCT00259857|12094727|FG001|24 Months Treatment|Lost to Follow-up|3
7677499|NCT00260065|12094733|FG000|Overall Study|Progressive Disease|22
7677500|NCT00260065|12094733|FG000|Overall Study|Adverse Event|17
7677501|NCT00260065|12094733|FG000|Overall Study|Death|13
7677502|NCT00260065|12094733|FG000|Overall Study|Withdrawal by Subject|13
7677503|NCT00260065|12094733|FG000|Overall Study|Physician Decision|19
7677504|NCT00260065|12094733|FG000|Overall Study|Not otherwise specified|8
7677505|NCT00260065|12094733|FG000|Overall Study|Medication Noncompliance|1
7677506|NCT00260208|12094749|FG000|Overall Study|Subject withdrew consent|11
7677507|NCT00260208|12094750|FG001|Overall Study|Subject withdrew consent|7
7677508|NCT00260208|12094749|FG000|Overall Study|Lost to Follow-up|6
7677509|NCT00260208|12094750|FG001|Overall Study|Lost to Follow-up|1
7677510|NCT00260208|12094749|FG000|Overall Study|Death|12
7677511|NCT00260208|12094750|FG001|Overall Study|Death|10
7677512|NCT00260208|12094749|FG000|Overall Study|Missing|18
7677513|NCT00260208|12094750|FG001|Overall Study|Missing|16
7677514|NCT00260429|12094758|FG000|Overall Study|failure to follow appointments|1
7677515|NCT00260429|12094759|FG001|Overall Study|failure to follow appointments|0
7677516|NCT00260429|12094758|FG000|Overall Study|scheduled hand surgery|1
7677517|NCT00260429|12094759|FG001|Overall Study|scheduled hand surgery|0
7677518|NCT00260533|12094767|FG000|Overall Study|Other|3
7677519|NCT00260533|12094768|FG001|Overall Study|Other|3
7677520|NCT00260832|12094789|FG000|Overall Study|Adverse Event|26
7677521|NCT00260832|12094790|FG001|Overall Study|Adverse Event|19
7677522|NCT00260832|12094789|FG000|Overall Study|Progression|116
7677523|NCT00260832|12094790|FG001|Overall Study|Progression|96
7677524|NCT00260832|12094789|FG000|Overall Study|Withdrawal by Subject|15
7677525|NCT00260832|12094790|FG001|Overall Study|Withdrawal by Subject|17
7677526|NCT00260832|12094789|FG000|Overall Study|Physician Decision|15
7677527|NCT00260832|12094790|FG001|Overall Study|Physician Decision|9
7677528|NCT00260832|12094789|FG000|Overall Study|Death|43
7677529|NCT00260832|12094790|FG001|Overall Study|Death|62
7677530|NCT00260832|12094789|FG000|Overall Study|Other|10
7677531|NCT00260832|12094790|FG001|Overall Study|Other|7
7677532|NCT00260832|12094789|FG000|Overall Study|Protocol Violation|3
7677533|NCT00260832|12094790|FG001|Overall Study|Protocol Violation|1
7677534|NCT00261443|12094816|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33
7677535|NCT00261443|12094817|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0
7677536|NCT00261443|12094818|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0
7677537|NCT00261443|12094816|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
7677538|NCT00261443|12094817|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
7677539|NCT00261443|12094818|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
7677540|NCT00261443|12094816|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
7677541|NCT00261443|12094817|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
7677542|NCT00261443|12094818|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
7677543|NCT00261443|12094816|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
7677544|NCT00261443|12094817|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
7677545|NCT00261443|12094818|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
7677546|NCT00261443|12094816|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1
7677547|NCT00261443|12094817|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0
7677548|NCT00261443|12094818|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0
7677549|NCT00261443|12094816|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
7677550|NCT00261443|12094817|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
7677551|NCT00261443|12094818|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
7677552|NCT00261443|12094816|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16
7677553|NCT00261443|12094817|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0
7677554|NCT00261443|12094818|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0
7677555|NCT00261443|12094816|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43
7677556|NCT00261443|12094817|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0
7677557|NCT00261443|12094818|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0
7677558|NCT00261443|12094816|FG000|2: Stability & Maintenance of Stability|Adverse Event|93
7677559|NCT00261443|12094817|FG001|2: Stability & Maintenance of Stability|Adverse Event|0
7677560|NCT00261443|12094818|FG002|2: Stability & Maintenance of Stability|Adverse Event|0
7677561|NCT00261443|12094816|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
7677562|NCT00261443|12094817|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
7677563|NCT00261443|12094818|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
7677564|NCT00261443|12094816|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59
7677565|NCT00261443|12094817|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0
7677566|NCT00261443|12094818|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0
7677567|NCT00261443|12094816|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
7677568|NCT00261443|12094817|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
7677569|NCT00261443|12094818|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
7677570|NCT00261443|12094816|FG000|2: Stability & Maintenance of Stability|Pregnancy|1
7677571|NCT00261443|12094817|FG001|2: Stability & Maintenance of Stability|Pregnancy|0
7677572|NCT00261443|12094818|FG002|2: Stability & Maintenance of Stability|Pregnancy|0
7677573|NCT00261443|12094816|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
7677574|NCT00261443|12094817|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
7677575|NCT00261443|12094818|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
7677576|NCT00261443|12094816|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
7677577|NCT00261443|12094817|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
7677578|NCT00261443|12094818|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
7677579|NCT00261443|12094816|FG000|2: Stability & Maintenance of Stability|Other Reasons|13
7677580|NCT00261443|12094817|FG001|2: Stability & Maintenance of Stability|Other Reasons|0
7677581|NCT00261443|12094818|FG002|2: Stability & Maintenance of Stability|Other Reasons|0
7677582|NCT00261443|12094816|FG000|3: Assessment of Relapse|Lack of Efficacy|0
7677583|NCT00261443|12094817|FG001|3: Assessment of Relapse|Lack of Efficacy|31
7677584|NCT00261443|12094818|FG002|3: Assessment of Relapse|Lack of Efficacy|14
7677585|NCT00261443|12094816|FG000|3: Assessment of Relapse|Adverse Event|0
7677586|NCT00261443|12094817|FG001|3: Assessment of Relapse|Adverse Event|15
7677587|NCT00261443|12094818|FG002|3: Assessment of Relapse|Adverse Event|19
7677588|NCT00261443|12094816|FG000|3: Assessment of Relapse|Withdrawal by Subject|0
7677589|NCT00261443|12094817|FG001|3: Assessment of Relapse|Withdrawal by Subject|14
7677590|NCT00261443|12094818|FG002|3: Assessment of Relapse|Withdrawal by Subject|15
7677591|NCT00261443|12094816|FG000|3: Assessment of Relapse|Death|0
7677592|NCT00261443|12094817|FG001|3: Assessment of Relapse|Death|0
7677593|NCT00261443|12094818|FG002|3: Assessment of Relapse|Death|1
7677594|NCT00261443|12094816|FG000|3: Assessment of Relapse|Lost to Follow-up|0
7677595|NCT00261443|12094817|FG001|3: Assessment of Relapse|Lost to Follow-up|7
7677596|NCT00261443|12094818|FG002|3: Assessment of Relapse|Lost to Follow-up|6
7677597|NCT00261443|12094816|FG000|3: Assessment of Relapse|Poor/Noncompliance|0
7677598|NCT00261443|12094817|FG001|3: Assessment of Relapse|Poor/Noncompliance|5
7677599|NCT00261443|12094818|FG002|3: Assessment of Relapse|Poor/Noncompliance|3
7677600|NCT00261443|12094816|FG000|3: Assessment of Relapse|Pregnancy|0
7677601|NCT00261443|12094817|FG001|3: Assessment of Relapse|Pregnancy|2
7677602|NCT00261443|12094818|FG002|3: Assessment of Relapse|Pregnancy|1
7677603|NCT00261443|12094816|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
7677604|NCT00261443|12094817|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
7677605|NCT00261443|12094818|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
7677606|NCT00261443|12094816|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0
7677607|NCT00261443|12094817|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0
7677608|NCT00261443|12094818|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2
7677609|NCT00261443|12094816|FG000|3: Assessment of Relapse|Other Reasons|0
7677610|NCT00261443|12094817|FG001|3: Assessment of Relapse|Other Reasons|4
7677611|NCT00261443|12094818|FG002|3: Assessment of Relapse|Other Reasons|3
7677612|NCT00261443|12094816|FG000|4: Extension Phase|Adverse Event|0
7677613|NCT00261443|12094817|FG001|4: Extension Phase|Adverse Event|1
7677614|NCT00261443|12094818|FG002|4: Extension Phase|Adverse Event|0
7677615|NCT00261443|12094816|FG000|4: Extension Phase|Withdrawal by Subject|0
7677616|NCT00261443|12094817|FG001|4: Extension Phase|Withdrawal by Subject|1
7677617|NCT00261443|12094818|FG002|4: Extension Phase|Withdrawal by Subject|2
7677618|NCT00261443|12094816|FG000|4: Extension Phase|Lost to Follow-up|0
7677619|NCT00261443|12094817|FG001|4: Extension Phase|Lost to Follow-up|1
7677620|NCT00261443|12094818|FG002|4: Extension Phase|Lost to Follow-up|0
7677621|NCT00261495|12094831|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28
7677622|NCT00261495|12094832|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36
7677623|NCT00261495|12094831|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
7677624|NCT00261495|12094832|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
7677625|NCT00261495|12094831|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
7677626|NCT00261495|12094832|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
7677627|NCT00261495|12094831|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3
7677628|NCT00261495|12094832|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1
7677629|NCT00261495|12094831|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2
7677630|NCT00261495|12094832|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5
7677631|NCT00261495|12094831|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
7677632|NCT00261495|12094832|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
7677633|NCT00261495|12094831|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
7677634|NCT00261495|12094832|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
7677635|NCT00261495|12094831|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
7677636|NCT00261495|12094832|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
7677637|NCT00261495|12094831|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
7677638|NCT00261495|12094832|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
7677639|NCT00261495|12094831|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
7677640|NCT00261495|12094832|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
7677641|NCT00261495|12094831|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
7677642|NCT00261495|12094832|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
7677643|NCT00261495|12094831|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6
7677644|NCT00261495|12094832|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5
7677645|NCT00261495|12094831|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
7677646|NCT00261495|12094832|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
7677647|NCT00261495|12094831|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
7677648|NCT00261495|12094832|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
7677807|NCT00262002|12094937|FG006|Overall Study|Protocol Violation|2
7677649|NCT00261495|12094831|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
7677650|NCT00261495|12094832|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
7677651|NCT00261495|12094831|FG000|Extension Phase (Weeks 24 to 52)|Other|4
7677652|NCT00261495|12094832|FG001|Extension Phase (Weeks 24 to 52)|Other|2
7677653|NCT00261495|12094831|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4
7677654|NCT00261495|12094832|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7677655|NCT00261495|12094831|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
7677656|NCT00261495|12094832|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
7677657|NCT00261495|12094831|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7677658|NCT00261495|12094832|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
7677659|NCT00261495|12094831|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1
7677660|NCT00261495|12094832|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0
7677661|NCT00261495|12094831|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
7677662|NCT00261495|12094832|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7677663|NCT00261716|12094840|FG000|Overall Study|Withdrawal by Subject|6
7677664|NCT00261716|12094841|FG001|Overall Study|Withdrawal by Subject|8
7677665|NCT00261716|12094840|FG000|Overall Study|Lost to Follow-up|0
7677666|NCT00261716|12094841|FG001|Overall Study|Lost to Follow-up|2
7677667|NCT00261833|12094853|FG000|Overall Study|Death|1
7677668|NCT00261833|12094854|FG001|Overall Study|Death|3
7677669|NCT00261833|12094853|FG000|Overall Study|Adverse Event|1
7677670|NCT00261833|12094854|FG001|Overall Study|Adverse Event|4
7677671|NCT00261833|12094853|FG000|Overall Study|Withdrawal by Subject|5
7677672|NCT00261833|12094854|FG001|Overall Study|Withdrawal by Subject|7
7677673|NCT00261833|12094853|FG000|Overall Study|Protocol Violation|0
7677674|NCT00261833|12094854|FG001|Overall Study|Protocol Violation|1
7677675|NCT00261833|12094853|FG000|Overall Study|Suspicion of pulmonary cancer|0
7677676|NCT00261833|12094854|FG001|Overall Study|Suspicion of pulmonary cancer|1
7677677|NCT00261833|12094853|FG000|Overall Study|Lung transplantation|1
7677678|NCT00261833|12094854|FG001|Overall Study|Lung transplantation|1
7677679|NCT00261833|12094853|FG000|Overall Study|Missing reason|1
7677680|NCT00261833|12094854|FG001|Overall Study|Missing reason|0
7677681|NCT00261833|12094853|FG000|Overall Study|Not interested in being participant|0
7677682|NCT00261833|12094854|FG001|Overall Study|Not interested in being participant|1
7677683|NCT00261846|12094870|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
7677684|NCT00261846|12094871|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
7677685|NCT00261846|12094872|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
7677686|NCT00261846|12094873|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7677687|NCT00261846|12094874|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7677688|NCT00261846|12094875|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7677689|NCT00261846|12094876|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7677690|NCT00261846|12094877|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7677691|NCT00261846|12094878|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7677692|NCT00261846|12094879|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7677693|NCT00261846|12094880|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7677694|NCT00261846|12094881|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7677695|NCT00261846|12094870|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7677696|NCT00261846|12094871|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7677697|NCT00261846|12094872|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7677698|NCT00261846|12094873|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
7677699|NCT00261846|12094874|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7677700|NCT00261846|12094875|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7677701|NCT00261846|12094876|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7677702|NCT00261846|12094877|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7677703|NCT00261846|12094878|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
7677704|NCT00261846|12094879|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7677705|NCT00261846|12094880|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7677706|NCT00261846|12094881|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7677707|NCT00261846|12094870|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7677708|NCT00261846|12094871|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7677709|NCT00261846|12094872|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7677710|NCT00261846|12094873|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
7677711|NCT00261846|12094874|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
7677712|NCT00261846|12094875|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
7677713|NCT00261846|12094876|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
7677714|NCT00261846|12094877|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
7677715|NCT00261846|12094878|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7677716|NCT00261846|12094879|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
7677717|NCT00261846|12094880|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7677718|NCT00261846|12094881|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7677719|NCT00261846|12094870|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7677720|NCT00261846|12094871|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7677721|NCT00261846|12094872|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7677722|NCT00261846|12094873|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
7677723|NCT00261846|12094874|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
7677724|NCT00261846|12094875|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7677725|NCT00261846|12094876|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
7677726|NCT00261846|12094877|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7677727|NCT00261846|12094878|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
7677728|NCT00261846|12094879|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
7677729|NCT00261846|12094880|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
7677730|NCT00261846|12094881|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7677731|NCT00261846|12094870|FG000|Period 2: Part 2 (Efficacy)|Other|0
7677732|NCT00261846|12094871|FG001|Period 2: Part 2 (Efficacy)|Other|0
7677733|NCT00261846|12094872|FG002|Period 2: Part 2 (Efficacy)|Other|0
7677734|NCT00261846|12094873|FG003|Period 2: Part 2 (Efficacy)|Other|15
7677735|NCT00261846|12094874|FG004|Period 2: Part 2 (Efficacy)|Other|4
7677736|NCT00261846|12094875|FG005|Period 2: Part 2 (Efficacy)|Other|0
7677737|NCT00261846|12094876|FG006|Period 2: Part 2 (Efficacy)|Other|1
7677738|NCT00261846|12094877|FG007|Period 2: Part 2 (Efficacy)|Other|5
7677739|NCT00261846|12094878|FG008|Period 2: Part 2 (Efficacy)|Other|4
7677740|NCT00261846|12094879|FG009|Period 2: Part 2 (Efficacy)|Other|4
7677741|NCT00261846|12094880|FG010|Period 2: Part 2 (Efficacy)|Other|0
7677742|NCT00261846|12094881|FG011|Period 2: Part 2 (Efficacy)|Other|0
7677743|NCT00261846|12094870|FG000|Period 2: Part 2 (Efficacy)|Death|0
7677744|NCT00261846|12094871|FG001|Period 2: Part 2 (Efficacy)|Death|0
7677745|NCT00261846|12094872|FG002|Period 2: Part 2 (Efficacy)|Death|0
7677746|NCT00261846|12094873|FG003|Period 2: Part 2 (Efficacy)|Death|37
7677747|NCT00261846|12094874|FG004|Period 2: Part 2 (Efficacy)|Death|7
7677748|NCT00261846|12094875|FG005|Period 2: Part 2 (Efficacy)|Death|1
7677749|NCT00261846|12094876|FG006|Period 2: Part 2 (Efficacy)|Death|10
7677750|NCT00261846|12094877|FG007|Period 2: Part 2 (Efficacy)|Death|12
7677751|NCT00261846|12094878|FG008|Period 2: Part 2 (Efficacy)|Death|3
7677752|NCT00261846|12094879|FG009|Period 2: Part 2 (Efficacy)|Death|30
7677753|NCT00261846|12094880|FG010|Period 2: Part 2 (Efficacy)|Death|44
7677754|NCT00261846|12094881|FG011|Period 2: Part 2 (Efficacy)|Death|22
7677755|NCT00261846|12094870|FG000|Period 2: Part 2 (Efficacy)|Extension study|0
7677756|NCT00261846|12094871|FG001|Period 2: Part 2 (Efficacy)|Extension study|0
7677757|NCT00261846|12094872|FG002|Period 2: Part 2 (Efficacy)|Extension study|0
7677758|NCT00261846|12094873|FG003|Period 2: Part 2 (Efficacy)|Extension study|61
7677759|NCT00261846|12094874|FG004|Period 2: Part 2 (Efficacy)|Extension study|27
7677760|NCT00261846|12094875|FG005|Period 2: Part 2 (Efficacy)|Extension study|0
7677761|NCT00261846|12094876|FG006|Period 2: Part 2 (Efficacy)|Extension study|4
7677762|NCT00261846|12094877|FG007|Period 2: Part 2 (Efficacy)|Extension study|9
7677763|NCT00261846|12094878|FG008|Period 2: Part 2 (Efficacy)|Extension study|5
7677764|NCT00261846|12094879|FG009|Period 2: Part 2 (Efficacy)|Extension study|9
7677765|NCT00261846|12094880|FG010|Period 2: Part 2 (Efficacy)|Extension study|1
7677766|NCT00261846|12094881|FG011|Period 2: Part 2 (Efficacy)|Extension study|1
7677767|NCT00261950|12094920|FG000|Overall Study|Lost to Follow-up|2
7677768|NCT00261950|12094920|FG000|Overall Study|Death|6
7677769|NCT00261950|12094920|FG000|Overall Study|Withdrawal by Subject|5
7677770|NCT00261950|12094920|FG000|Overall Study|Other|1
7677771|NCT00261950|12094920|FG000|Overall Study|Physician Decision|1
7677772|NCT00261950|12094920|FG000|Overall Study|Protocol specified Criteria|11
7677773|NCT00262002|12094931|FG000|Overall Study|Adverse Event|2
7677774|NCT00262002|12094932|FG001|Overall Study|Adverse Event|1
7677775|NCT00262002|12094933|FG002|Overall Study|Adverse Event|0
7677776|NCT00262002|12094934|FG003|Overall Study|Adverse Event|0
7677777|NCT00262002|12094935|FG004|Overall Study|Adverse Event|0
7677778|NCT00262002|12094936|FG005|Overall Study|Adverse Event|1
7677779|NCT00262002|12094937|FG006|Overall Study|Adverse Event|0
7677780|NCT00262002|12094931|FG000|Overall Study|Withdrawal by Subject|4
7677781|NCT00262002|12094932|FG001|Overall Study|Withdrawal by Subject|2
7677782|NCT00262002|12094933|FG002|Overall Study|Withdrawal by Subject|0
7677783|NCT00262002|12094934|FG003|Overall Study|Withdrawal by Subject|1
7677784|NCT00262002|12094935|FG004|Overall Study|Withdrawal by Subject|2
7677785|NCT00262002|12094936|FG005|Overall Study|Withdrawal by Subject|2
7677786|NCT00262002|12094937|FG006|Overall Study|Withdrawal by Subject|2
7677787|NCT00262002|12094931|FG000|Overall Study|Lost to Follow-up|2
7677788|NCT00262002|12094932|FG001|Overall Study|Lost to Follow-up|0
7677789|NCT00262002|12094933|FG002|Overall Study|Lost to Follow-up|0
7677790|NCT00262002|12094934|FG003|Overall Study|Lost to Follow-up|2
7677791|NCT00262002|12094935|FG004|Overall Study|Lost to Follow-up|0
7677792|NCT00262002|12094936|FG005|Overall Study|Lost to Follow-up|1
7677793|NCT00262002|12094937|FG006|Overall Study|Lost to Follow-up|0
7677794|NCT00262002|12094931|FG000|Overall Study|Inapropriate enrollment|0
7677795|NCT00262002|12094932|FG001|Overall Study|Inapropriate enrollment|1
7677796|NCT00262002|12094933|FG002|Overall Study|Inapropriate enrollment|0
7677797|NCT00262002|12094934|FG003|Overall Study|Inapropriate enrollment|0
7677798|NCT00262002|12094935|FG004|Overall Study|Inapropriate enrollment|0
7677799|NCT00262002|12094936|FG005|Overall Study|Inapropriate enrollment|0
7677800|NCT00262002|12094937|FG006|Overall Study|Inapropriate enrollment|0
7677801|NCT00262002|12094931|FG000|Overall Study|Protocol Violation|3
7677802|NCT00262002|12094932|FG001|Overall Study|Protocol Violation|2
7677803|NCT00262002|12094933|FG002|Overall Study|Protocol Violation|0
7677804|NCT00262002|12094934|FG003|Overall Study|Protocol Violation|2
7677805|NCT00262002|12094935|FG004|Overall Study|Protocol Violation|5
7677806|NCT00262002|12094936|FG005|Overall Study|Protocol Violation|3
7677808|NCT00262002|12094931|FG000|Overall Study|Unable to classify|0
7677809|NCT00262002|12094932|FG001|Overall Study|Unable to classify|0
7677810|NCT00262002|12094933|FG002|Overall Study|Unable to classify|0
7677811|NCT00262002|12094934|FG003|Overall Study|Unable to classify|0
7677812|NCT00262002|12094935|FG004|Overall Study|Unable to classify|0
7677813|NCT00262002|12094936|FG005|Overall Study|Unable to classify|0
7677814|NCT00262002|12094937|FG006|Overall Study|Unable to classify|2
7677815|NCT00262028|12095011|FG000|Overall Study|Withdrawal by Subject|6
7677816|NCT00262028|12095012|FG001|Overall Study|Withdrawal by Subject|3
7677817|NCT00262028|12095013|FG002|Overall Study|Withdrawal by Subject|6
7677818|NCT00262028|12095014|FG003|Overall Study|Withdrawal by Subject|5
7677819|NCT00262028|12095015|FG004|Overall Study|Withdrawal by Subject|2
7677820|NCT00262028|12095016|FG005|Overall Study|Withdrawal by Subject|3
7677821|NCT00262028|12095017|FG006|Overall Study|Withdrawal by Subject|5
7677822|NCT00262028|12095018|FG007|Overall Study|Withdrawal by Subject|7
7677823|NCT00262028|12095019|FG008|Overall Study|Withdrawal by Subject|2
7677824|NCT00262028|12095011|FG000|Overall Study|Lost to Follow-up|7
7677825|NCT00262028|12095012|FG001|Overall Study|Lost to Follow-up|7
7677826|NCT00262028|12095013|FG002|Overall Study|Lost to Follow-up|5
7677827|NCT00262028|12095014|FG003|Overall Study|Lost to Follow-up|5
7677828|NCT00262028|12095015|FG004|Overall Study|Lost to Follow-up|4
7677829|NCT00262028|12095016|FG005|Overall Study|Lost to Follow-up|3
7677830|NCT00262028|12095017|FG006|Overall Study|Lost to Follow-up|3
7677831|NCT00262028|12095018|FG007|Overall Study|Lost to Follow-up|5
7677832|NCT00262028|12095019|FG008|Overall Study|Lost to Follow-up|6
7677833|NCT00262028|12095011|FG000|Overall Study|Administrative Reason|11
7677834|NCT00262028|12095012|FG001|Overall Study|Administrative Reason|14
7677835|NCT00262028|12095013|FG002|Overall Study|Administrative Reason|9
7677836|NCT00262028|12095014|FG003|Overall Study|Administrative Reason|12
7677837|NCT00262028|12095015|FG004|Overall Study|Administrative Reason|6
7677838|NCT00262028|12095016|FG005|Overall Study|Administrative Reason|7
7677839|NCT00262028|12095017|FG006|Overall Study|Administrative Reason|4
7677840|NCT00262028|12095018|FG007|Overall Study|Administrative Reason|6
7677841|NCT00262028|12095019|FG008|Overall Study|Administrative Reason|10
7677842|NCT00262028|12095011|FG000|Overall Study|Protocol Violation|0
7677843|NCT00262028|12095012|FG001|Overall Study|Protocol Violation|0
7677844|NCT00262028|12095013|FG002|Overall Study|Protocol Violation|0
7677845|NCT00262028|12095014|FG003|Overall Study|Protocol Violation|1
7677846|NCT00262028|12095015|FG004|Overall Study|Protocol Violation|0
7677847|NCT00262028|12095016|FG005|Overall Study|Protocol Violation|0
7677848|NCT00262028|12095017|FG006|Overall Study|Protocol Violation|0
7677849|NCT00262028|12095018|FG007|Overall Study|Protocol Violation|0
7677850|NCT00262028|12095019|FG008|Overall Study|Protocol Violation|0
7677851|NCT00262028|12095011|FG000|Overall Study|Unable to classify|0
7677852|NCT00262028|12095012|FG001|Overall Study|Unable to classify|3
7677853|NCT00262028|12095013|FG002|Overall Study|Unable to classify|0
7677854|NCT00262028|12095014|FG003|Overall Study|Unable to classify|0
7677855|NCT00262028|12095015|FG004|Overall Study|Unable to classify|0
7677856|NCT00262028|12095016|FG005|Overall Study|Unable to classify|0
7677857|NCT00262028|12095017|FG006|Overall Study|Unable to classify|0
7677858|NCT00262028|12095018|FG007|Overall Study|Unable to classify|0
7677859|NCT00262028|12095019|FG008|Overall Study|Unable to classify|1
7677860|NCT00262041|12095065|FG000|Overall Study|Withdrawal by Subject|0
7677861|NCT00262041|12095066|FG001|Overall Study|Withdrawal by Subject|3
7677862|NCT00262041|12095067|FG002|Overall Study|Withdrawal by Subject|1
7677863|NCT00262041|12095065|FG000|Overall Study|Lost to Follow-up|1
7677864|NCT00262041|12095066|FG001|Overall Study|Lost to Follow-up|1
7677865|NCT00262041|12095067|FG002|Overall Study|Lost to Follow-up|5
7677866|NCT00262041|12095065|FG000|Overall Study|Unable to classify|1
7677867|NCT00262041|12095066|FG001|Overall Study|Unable to classify|0
7677868|NCT00262041|12095067|FG002|Overall Study|Unable to classify|0
7677869|NCT00262067|12095085|FG000|Overall Study|Death|190
7677870|NCT00262067|12095086|FG001|Overall Study|Death|89
7677871|NCT00262067|12095087|FG002|Overall Study|Death|186
7677872|NCT00262067|12095088|FG003|Overall Study|Death|99
7677873|NCT00262067|12095085|FG000|Overall Study|Lost to Follow-up|5
7677874|NCT00262067|12095086|FG001|Overall Study|Lost to Follow-up|4
7677875|NCT00262067|12095087|FG002|Overall Study|Lost to Follow-up|7
7677876|NCT00262067|12095088|FG003|Overall Study|Lost to Follow-up|5
7677877|NCT00262067|12095085|FG000|Overall Study|Sponsor's Decision to Terminate Study|1
7677878|NCT00262067|12095086|FG001|Overall Study|Sponsor's Decision to Terminate Study|0
7677879|NCT00262067|12095087|FG002|Overall Study|Sponsor's Decision to Terminate Study|0
7677880|NCT00262067|12095088|FG003|Overall Study|Sponsor's Decision to Terminate Study|0
7677881|NCT00262067|12095085|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23
7677882|NCT00262067|12095086|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7
7677883|NCT00262067|12095087|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23
7677884|NCT00262067|12095088|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9
7677885|NCT00262080|12095101|FG000|Double Blind Treatment Period|Lost to Follow-up|1
7677886|NCT00262080|12095102|FG001|Double Blind Treatment Period|Lost to Follow-up|0
7677887|NCT00262080|12095103|FG002|Double Blind Treatment Period|Lost to Follow-up|0
7677888|NCT00262080|12095101|FG000|Repeat Dose Treatment Period|Adverse Event|1
7677889|NCT00262080|12095102|FG001|Repeat Dose Treatment Period|Adverse Event|0
7677890|NCT00262080|12095103|FG002|Repeat Dose Treatment Period|Adverse Event|0
7677969|NCT00262522|12095166|FG002|Study Start Through 48 Weeks|Death|1
7677891|NCT00262080|12095101|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0
7677892|NCT00262080|12095102|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1
7677893|NCT00262080|12095103|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1
7677894|NCT00262080|12095101|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2
7677895|NCT00262080|12095102|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0
7677896|NCT00262080|12095103|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2
7677897|NCT00262080|12095101|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0
7677898|NCT00262080|12095102|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0
7677899|NCT00262080|12095103|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2
7677900|NCT00262080|12095101|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1
7677901|NCT00262080|12095102|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0
7677902|NCT00262080|12095103|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0
7677903|NCT00262119|12095114|FG000|Overall Study|Lost to Follow-up|38
7677904|NCT00262119|12095115|FG001|Overall Study|Lost to Follow-up|51
7677905|NCT00262119|12095116|FG002|Overall Study|Lost to Follow-up|42
7677906|NCT00262119|12095114|FG000|Overall Study|Death|20
7677907|NCT00262119|12095115|FG001|Overall Study|Death|19
7677908|NCT00262119|12095116|FG002|Overall Study|Death|16
7677909|NCT00262223|12095126|FG000|Treatment Phase|Withdrawal by Subject|3
7677910|NCT00262223|12095127|FG001|Treatment Phase|Withdrawal by Subject|6
7677911|NCT00262223|12095126|FG000|Treatment Phase|Adverse Event|1
7677912|NCT00262223|12095127|FG001|Treatment Phase|Adverse Event|2
7677913|NCT00262223|12095126|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4
7677914|NCT00262223|12095127|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4
7677915|NCT00262223|12095126|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6
7677916|NCT00262223|12095127|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1
7677917|NCT00262223|12095126|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7
7677918|NCT00262223|12095127|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7
7677919|NCT00262301|12095137|FG000|Double-blind Phase|Lost to Follow-up|1
7677920|NCT00262301|12095138|FG001|Double-blind Phase|Lost to Follow-up|0
7677921|NCT00262301|12095139|FG002|Double-blind Phase|Lost to Follow-up|0
7677922|NCT00262301|12095137|FG000|Double-blind Phase|"worsening of HAE symptoms"|0
7677923|NCT00262301|12095138|FG001|Double-blind Phase|"worsening of HAE symptoms"|1
7677924|NCT00262301|12095139|FG002|Double-blind Phase|"worsening of HAE symptoms"|0
7677925|NCT00262314|12095147|FG000|Overall Study|Changing physicians|38
7677926|NCT00262314|12095147|FG000|Overall Study|Death|12
7677927|NCT00262314|12095147|FG000|Overall Study|Patient's decision|92
7677928|NCT00262314|12095147|FG000|Overall Study|Other|95
7677929|NCT00262314|12095147|FG000|Overall Study|Lost to Follow-up|70
7677930|NCT00262314|12095147|FG000|Overall Study|Administrative withdrawal|30
7677931|NCT00262522|12095164|FG000|Study Start Through 8 Weeks|Adverse Event|1
7677932|NCT00262522|12095165|FG001|Study Start Through 8 Weeks|Adverse Event|2
7677933|NCT00262522|12095166|FG002|Study Start Through 8 Weeks|Adverse Event|3
7677934|NCT00262522|12095167|FG003|Study Start Through 8 Weeks|Adverse Event|1
7677935|NCT00262522|12095164|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1
7677936|NCT00262522|12095165|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1
7677937|NCT00262522|12095166|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3
7677938|NCT00262522|12095167|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0
7677939|NCT00262522|12095164|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1
7677940|NCT00262522|12095165|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2
7677941|NCT00262522|12095166|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3
7677942|NCT00262522|12095167|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2
7677943|NCT00262522|12095164|FG000|Study Start Through 8 Weeks|Noncompliance|0
7677944|NCT00262522|12095165|FG001|Study Start Through 8 Weeks|Noncompliance|0
7677945|NCT00262522|12095166|FG002|Study Start Through 8 Weeks|Noncompliance|2
7677946|NCT00262522|12095167|FG003|Study Start Through 8 Weeks|Noncompliance|2
7677947|NCT00262522|12095164|FG000|Study Start Through 8 Weeks|Death|1
7677948|NCT00262522|12095165|FG001|Study Start Through 8 Weeks|Death|0
7677949|NCT00262522|12095166|FG002|Study Start Through 8 Weeks|Death|0
7677950|NCT00262522|12095167|FG003|Study Start Through 8 Weeks|Death|0
7677951|NCT00262522|12095164|FG000|Study Start Through 48 Weeks|Adverse Event|16
7677952|NCT00262522|12095165|FG001|Study Start Through 48 Weeks|Adverse Event|0
7677953|NCT00262522|12095166|FG002|Study Start Through 48 Weeks|Adverse Event|10
7677954|NCT00262522|12095167|FG003|Study Start Through 48 Weeks|Adverse Event|0
7677955|NCT00262522|12095164|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10
7677956|NCT00262522|12095165|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0
7677957|NCT00262522|12095166|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11
7677958|NCT00262522|12095167|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0
7677959|NCT00262522|12095164|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8
7677960|NCT00262522|12095165|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0
7677961|NCT00262522|12095166|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14
7677962|NCT00262522|12095167|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0
7677963|NCT00262522|12095164|FG000|Study Start Through 48 Weeks|Noncompliance|3
7677964|NCT00262522|12095165|FG001|Study Start Through 48 Weeks|Noncompliance|0
7677965|NCT00262522|12095166|FG002|Study Start Through 48 Weeks|Noncompliance|8
7677966|NCT00262522|12095167|FG003|Study Start Through 48 Weeks|Noncompliance|0
7677967|NCT00262522|12095164|FG000|Study Start Through 48 Weeks|Death|2
7677968|NCT00262522|12095165|FG001|Study Start Through 48 Weeks|Death|0
7677970|NCT00262522|12095167|FG003|Study Start Through 48 Weeks|Death|0
7677971|NCT00262522|12095164|FG000|Study Start Through 48 Weeks|Virologic failure|2
7677972|NCT00262522|12095165|FG001|Study Start Through 48 Weeks|Virologic failure|0
7677973|NCT00262522|12095166|FG002|Study Start Through 48 Weeks|Virologic failure|4
7677974|NCT00262522|12095167|FG003|Study Start Through 48 Weeks|Virologic failure|0
7677975|NCT00262522|12095164|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
7677976|NCT00262522|12095165|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
7677977|NCT00262522|12095166|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
7677978|NCT00262522|12095167|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
7677979|NCT00262522|12095164|FG000|Study Start Through 96 Weeks|Adverse Event|20
7677980|NCT00262522|12095165|FG001|Study Start Through 96 Weeks|Adverse Event|0
7677981|NCT00262522|12095166|FG002|Study Start Through 96 Weeks|Adverse Event|16
7677982|NCT00262522|12095167|FG003|Study Start Through 96 Weeks|Adverse Event|0
7677983|NCT00262522|12095164|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15
7677984|NCT00262522|12095165|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0
7677985|NCT00262522|12095166|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13
7677986|NCT00262522|12095167|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0
7677987|NCT00262522|12095164|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19
7677988|NCT00262522|12095165|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0
7677989|NCT00262522|12095166|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18
7677990|NCT00262522|12095167|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0
7677991|NCT00262522|12095164|FG000|Study Start Through 96 Weeks|Noncompliance|6
7677992|NCT00262522|12095165|FG001|Study Start Through 96 Weeks|Noncompliance|0
7677993|NCT00262522|12095166|FG002|Study Start Through 96 Weeks|Noncompliance|11
7677994|NCT00262522|12095167|FG003|Study Start Through 96 Weeks|Noncompliance|0
7677995|NCT00262522|12095164|FG000|Study Start Through 96 Weeks|Death|2
7677996|NCT00262522|12095165|FG001|Study Start Through 96 Weeks|Death|0
7677997|NCT00262522|12095166|FG002|Study Start Through 96 Weeks|Death|2
7677998|NCT00262522|12095167|FG003|Study Start Through 96 Weeks|Death|0
7677999|NCT00262522|12095164|FG000|Study Start Through 96 Weeks|Virologic failure|5
7678000|NCT00262522|12095165|FG001|Study Start Through 96 Weeks|Virologic failure|0
7678001|NCT00262522|12095166|FG002|Study Start Through 96 Weeks|Virologic failure|8
7678002|NCT00262522|12095167|FG003|Study Start Through 96 Weeks|Virologic failure|0
7678003|NCT00262522|12095164|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
7678004|NCT00262522|12095165|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
7678005|NCT00262522|12095166|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
7678006|NCT00262522|12095167|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
7678007|NCT00262600|12095178|FG000|Overall Study|Lost to Follow-up|17
7678008|NCT00262600|12095179|FG001|Overall Study|Lost to Follow-up|31
7678009|NCT00262600|12095180|FG002|Overall Study|Lost to Follow-up|41
7678010|NCT00262600|12095178|FG000|Overall Study|Withdrawal by Subject|128
7678011|NCT00262600|12095179|FG001|Overall Study|Withdrawal by Subject|145
7678012|NCT00262600|12095180|FG002|Overall Study|Withdrawal by Subject|139
7678013|NCT00262600|12095178|FG000|Overall Study|Not Treated|32
7678014|NCT00262600|12095179|FG001|Overall Study|Not Treated|17
7678015|NCT00262600|12095180|FG002|Overall Study|Not Treated|24
7678016|NCT00262600|12095178|FG000|Overall Study|Other|58
7678017|NCT00262600|12095179|FG001|Overall Study|Other|59
7678018|NCT00262600|12095180|FG002|Overall Study|Other|62
7678019|NCT00262743|12095211|FG000|Overall Study|Adverse Event|0
7678020|NCT00262743|12095212|FG001|Overall Study|Adverse Event|9
7678021|NCT00262743|12095211|FG000|Overall Study|Disease progression|0
7678022|NCT00262743|12095212|FG001|Overall Study|Disease progression|3
7678023|NCT00262821|12095218|FG000|Overall Study|Ineligible - wrong stage|0
7678024|NCT00262821|12095219|FG001|Overall Study|Ineligible - wrong stage|3
7678025|NCT00262821|12095218|FG000|Overall Study|Ineligible - wrong cell type|2
7678026|NCT00262821|12095219|FG001|Overall Study|Ineligible - wrong cell type|2
7678027|NCT00262821|12095218|FG000|Overall Study|Ineligible - wrong primary|0
7678028|NCT00262821|12095219|FG001|Overall Study|Ineligible - wrong primary|1
7678029|NCT00262821|12095218|FG000|Overall Study|Ineligible - inadequate pathology|1
7678030|NCT00262821|12095219|FG001|Overall Study|Ineligible - inadequate pathology|3
7678031|NCT00262821|12095218|FG000|Overall Study|Ineligible - elevated creatinine|0
7678032|NCT00262821|12095219|FG001|Overall Study|Ineligible - elevated creatinine|2
7678033|NCT00262821|12095218|FG000|Overall Study|Ineligible - required test not done|1
7678034|NCT00262821|12095219|FG001|Overall Study|Ineligible - required test not done|4
7678035|NCT00262821|12095218|FG000|Overall Study|Inevaluable - inadequate data|0
7678036|NCT00262821|12095219|FG001|Overall Study|Inevaluable - inadequate data|4
7678037|NCT00262834|12095227|FG000|Overall Study|Surgery delayed/tissue not collected|1
7678038|NCT00262834|12095228|FG001|Overall Study|Surgery delayed/tissue not collected|4
7678039|NCT00262847|12095237|FG000|Overall Study|Disease Progression|309
7678040|NCT00262847|12095238|FG001|Overall Study|Disease Progression|274
7678041|NCT00262847|12095239|FG002|Overall Study|Disease Progression|195
7678042|NCT00262847|12095237|FG000|Overall Study|Patient Refusal|41
7678043|NCT00262847|12095238|FG001|Overall Study|Patient Refusal|52
7678044|NCT00262847|12095239|FG002|Overall Study|Patient Refusal|47
7678045|NCT00262847|12095237|FG000|Overall Study|Adverse Event|74
7678046|NCT00262847|12095238|FG001|Overall Study|Adverse Event|88
7678047|NCT00262847|12095239|FG002|Overall Study|Adverse Event|108
7678048|NCT00262847|12095237|FG000|Overall Study|Death|8
7678049|NCT00262847|12095238|FG001|Overall Study|Death|8
7678050|NCT00262847|12095239|FG002|Overall Study|Death|11
7678051|NCT00262847|12095237|FG000|Overall Study|Concomitant disease|3
7678052|NCT00262847|12095238|FG001|Overall Study|Concomitant disease|2
7678053|NCT00262847|12095239|FG002|Overall Study|Concomitant disease|4
7678054|NCT00262847|12095237|FG000|Overall Study|Other Reasons|79
7678055|NCT00262847|12095238|FG001|Overall Study|Other Reasons|88
7678056|NCT00262847|12095239|FG002|Overall Study|Other Reasons|27
7678057|NCT00262847|12095237|FG000|Overall Study|Did not receive study treatment|4
7678058|NCT00262847|12095238|FG001|Overall Study|Did not receive study treatment|1
7678059|NCT00262847|12095239|FG002|Overall Study|Did not receive study treatment|4
7678060|NCT00262860|12095250|FG000|Overall Study|Adverse Event|2
7678061|NCT00262873|12095254|FG000|Overall Study|Adverse Event|3
7678062|NCT00262873|12095254|FG000|Overall Study|Withdrawal by Subject|5
7678063|NCT00262925|12095258|FG000|Overall Study|Lack of Efficacy|3
7678064|NCT00262925|12095258|FG000|Overall Study|Adverse Event|4
7678065|NCT00262925|12095258|FG000|Overall Study|Death|2
7678066|NCT00262925|12095258|FG000|Overall Study|alternative therapy|1
7678067|NCT00262925|12095258|FG000|Overall Study|Other|1
7678068|NCT00262951|12095264|FG000|Overall Study|Progressive disease/relapse|3
7678069|NCT00262951|12095264|FG000|Overall Study|Adverse Event|7
7678070|NCT00262951|12095264|FG000|Overall Study|Death|1
7678071|NCT00262951|12095264|FG000|Overall Study|Withdrawal by Subject|1
7678072|NCT00262951|12095264|FG000|Overall Study|Alternative treatment|3
7678073|NCT00262951|12095264|FG000|Overall Study|Off treatment for other disease|1
7678074|NCT00263211|12095297|FG000|Overall Study|Death|1
7678075|NCT00263211|12095298|FG001|Overall Study|Death|0
7678076|NCT00263211|12095297|FG000|Overall Study|Withdrawal by Subject|3
7678077|NCT00263211|12095298|FG001|Overall Study|Withdrawal by Subject|0
7678078|NCT00263211|12095297|FG000|Overall Study|Protocol Violation|1
7678079|NCT00263211|12095298|FG001|Overall Study|Protocol Violation|0
7678080|NCT00263211|12095297|FG000|Overall Study|Disease Progression|0
7678081|NCT00263211|12095298|FG001|Overall Study|Disease Progression|1
7678082|NCT00263328|12095310|FG000|Overall Study|Death|0
7678083|NCT00263328|12095311|FG001|Overall Study|Death|0
7678084|NCT00263328|12095312|FG002|Overall Study|Death|1
7678085|NCT00263328|12095310|FG000|Overall Study|Lost to Follow-up|1
7678086|NCT00263328|12095311|FG001|Overall Study|Lost to Follow-up|1
7678087|NCT00263328|12095312|FG002|Overall Study|Lost to Follow-up|0
7678088|NCT00263328|12095310|FG000|Overall Study|Withdrawal by Subject|3
7678089|NCT00263328|12095311|FG001|Overall Study|Withdrawal by Subject|0
7678090|NCT00263328|12095312|FG002|Overall Study|Withdrawal by Subject|1
7678091|NCT00263328|12095310|FG000|Overall Study|Other|3
7678092|NCT00263328|12095311|FG001|Overall Study|Other|0
7678093|NCT00263328|12095312|FG002|Overall Study|Other|1
7678094|NCT00263328|12095310|FG000|Overall Study|Adverse Event|1
7678095|NCT00263328|12095311|FG001|Overall Study|Adverse Event|1
7678096|NCT00263328|12095312|FG002|Overall Study|Adverse Event|4
7678097|NCT00263562|12095324|FG000|Overall Study|Protocol Violation|3
7678098|NCT00263562|12095325|FG001|Overall Study|Protocol Violation|0
7678099|NCT00263575|12095333|FG000|Titration Period|Adverse Event|14
7678100|NCT00263575|12095333|FG000|Titration Period|Withdrawal by Subject|10
7678101|NCT00263575|12095333|FG000|Titration Period|Protocol Violation|9
7678102|NCT00263575|12095333|FG000|Titration Period|Sponsor Decision|2
7678103|NCT00263575|12095333|FG000|Titration Period|Other|2
7678104|NCT00263575|12095333|FG000|Titration Period|Lack of Efficacy|6
7678105|NCT00263575|12095333|FG000|Maintence Period|Adverse Event|23
7678106|NCT00263575|12095333|FG000|Maintence Period|Withdrawal by Subject|8
7678107|NCT00263575|12095333|FG000|Maintence Period|Protocol Violation|4
7678108|NCT00263575|12095333|FG000|Maintence Period|Lack of Efficacy|4
7678109|NCT00263575|12095333|FG000|Maintence Period|Physician Decision|6
7678110|NCT00263575|12095333|FG000|Maintence Period|Lost to Follow-up|1
7678111|NCT00263575|12095333|FG000|Maintence Period|Sponsor Decision|24
7678112|NCT00263575|12095333|FG000|Maintence Period|Other|7
7678113|NCT00263588|12095341|FG000|Overall Study|Death|54
7678114|NCT00263588|12095342|FG001|Overall Study|Death|90
7678115|NCT00263588|12095341|FG000|Overall Study|disease progression, coma, 1 unknown|10
7678116|NCT00263588|12095342|FG001|Overall Study|disease progression, coma, 1 unknown|11
7678117|NCT00263588|12095341|FG000|Overall Study|Lost to Follow-up|7
7678118|NCT00263588|12095342|FG001|Overall Study|Lost to Follow-up|10
7678119|NCT00263588|12095341|FG000|Overall Study|Withdrawal by Subject|3
7678120|NCT00263588|12095342|FG001|Overall Study|Withdrawal by Subject|4
7678121|NCT00263588|12095341|FG000|Overall Study|Protocol Violation|0
7678122|NCT00263588|12095342|FG001|Overall Study|Protocol Violation|1
7678123|NCT00263588|12095341|FG000|Overall Study|Investigator decision|7
7678124|NCT00263588|12095342|FG001|Overall Study|Investigator decision|15
7678125|NCT00263588|12095341|FG000|Overall Study|Sponsor terminated study|0
7678126|NCT00263588|12095342|FG001|Overall Study|Sponsor terminated study|1
7678127|NCT00263666|12095351|FG000|Overall Study|Adverse Event|6
7678128|NCT00263666|12095352|FG001|Overall Study|Adverse Event|8
7678129|NCT00263666|12095351|FG000|Overall Study|Lost to Follow-up|1
7678130|NCT00263666|12095352|FG001|Overall Study|Lost to Follow-up|2
7678131|NCT00263666|12095351|FG000|Overall Study|Withdrawal by Subject|0
7678132|NCT00263666|12095352|FG001|Overall Study|Withdrawal by Subject|1
7678133|NCT00263757|12095360|FG000|Overall Study|Withdrawal by Subject|5
7678134|NCT00263757|12095361|FG001|Overall Study|Withdrawal by Subject|4
7678135|NCT00263757|12095360|FG000|Overall Study|Screen failure|0
7678136|NCT00263757|12095361|FG001|Overall Study|Screen failure|1
7678137|NCT00263757|12095360|FG000|Overall Study|Adverse Event|3
7678138|NCT00263757|12095361|FG001|Overall Study|Adverse Event|3
7678139|NCT00263887|12095369|FG000|Overall Study|Withdrawal by Subject|1
7678140|NCT00263887|12095370|FG001|Overall Study|Withdrawal by Subject|1
7678141|NCT00263887|12095369|FG000|Overall Study|Lung transplantation|1
7678142|NCT00263887|12095370|FG001|Overall Study|Lung transplantation|2
7678143|NCT00263887|12095369|FG000|Overall Study|Too ill to attend visit|1
7678144|NCT00263887|12095370|FG001|Overall Study|Too ill to attend visit|0
7678145|NCT00263887|12095369|FG000|Overall Study|Adverse Event|0
7678146|NCT00263887|12095370|FG001|Overall Study|Adverse Event|2
7678147|NCT00263887|12095369|FG000|Overall Study|Disease progression|0
7678148|NCT00263887|12095370|FG001|Overall Study|Disease progression|1
7678149|NCT00263887|12095369|FG000|Overall Study|Lack of Efficacy|0
7678150|NCT00263887|12095370|FG001|Overall Study|Lack of Efficacy|1
7678151|NCT00264004|12095380|FG000|Overall Study|Adverse Event|2
7678152|NCT00264004|12095381|FG001|Overall Study|Adverse Event|3
7678153|NCT00264004|12095382|FG002|Overall Study|Adverse Event|6
7678154|NCT00264004|12095383|FG003|Overall Study|Adverse Event|4
7678155|NCT00264004|12095380|FG000|Overall Study|Withdrawal by Subject|0
7678156|NCT00264004|12095381|FG001|Overall Study|Withdrawal by Subject|1
7678157|NCT00264004|12095382|FG002|Overall Study|Withdrawal by Subject|2
7678158|NCT00264004|12095383|FG003|Overall Study|Withdrawal by Subject|2
7678159|NCT00264004|12095380|FG000|Overall Study|Other|2
7678160|NCT00264004|12095381|FG001|Overall Study|Other|2
7678161|NCT00264004|12095382|FG002|Overall Study|Other|0
7678162|NCT00264004|12095383|FG003|Overall Study|Other|3
7678163|NCT00264004|12095380|FG000|Overall Study|Development study specific disc. crit.|1
7678164|NCT00264004|12095381|FG001|Overall Study|Development study specific disc. crit.|0
7678165|NCT00264004|12095382|FG002|Overall Study|Development study specific disc. crit.|1
7678166|NCT00264004|12095383|FG003|Overall Study|Development study specific disc. crit.|0
7678167|NCT00264004|12095380|FG000|Overall Study|Cond. under inv. worsened|9
7678168|NCT00264004|12095381|FG001|Overall Study|Cond. under inv. worsened|5
7678169|NCT00264004|12095382|FG002|Overall Study|Cond. under inv. worsened|3
7678170|NCT00264004|12095383|FG003|Overall Study|Cond. under inv. worsened|4
7678171|NCT00264004|12095380|FG000|Overall Study|Not treated|3
7678172|NCT00264004|12095381|FG001|Overall Study|Not treated|0
7678173|NCT00264004|12095382|FG002|Overall Study|Not treated|2
7678174|NCT00264004|12095383|FG003|Overall Study|Not treated|2
7678175|NCT00264238|12095393|FG000|Overall Study|Protocol Violation|1
7678176|NCT00264290|12095401|FG000|Intervention (8 Weeks)|Adverse Event|1
7678177|NCT00264290|12095402|FG001|Intervention (8 Weeks)|Adverse Event|0
7678178|NCT00264303|12095414|FG000|Overall Study|Adverse Event|4
7678179|NCT00264303|12095415|FG001|Overall Study|Adverse Event|3
7678180|NCT00264303|12095414|FG000|Overall Study|Lack of Efficacy|10
7678181|NCT00264303|12095415|FG001|Overall Study|Lack of Efficacy|13
7678182|NCT00264303|12095414|FG000|Overall Study|Lost to Follow-up|3
7678183|NCT00264303|12095415|FG001|Overall Study|Lost to Follow-up|3
7678184|NCT00264303|12095414|FG000|Overall Study|Withdrawal by Subject|2
7678185|NCT00264303|12095415|FG001|Overall Study|Withdrawal by Subject|3
7678186|NCT00264303|12095414|FG000|Overall Study|Various reasons listed in study report|6
7678187|NCT00264303|12095415|FG001|Overall Study|Various reasons listed in study report|7
7678188|NCT00264498|12095432|FG000|Randomized Treatment|Death|0
7678189|NCT00264498|12095433|FG001|Randomized Treatment|Death|3
7678190|NCT00264498|12095432|FG000|Randomized Treatment|Withdrawal by Subject|0
7678191|NCT00264498|12095433|FG001|Randomized Treatment|Withdrawal by Subject|1
7678192|NCT00264498|12095432|FG000|Randomized Treatment|Objective disease Progression|13
7678193|NCT00264498|12095433|FG001|Randomized Treatment|Objective disease Progression|14
7678194|NCT00264498|12095432|FG000|Randomized Treatment|Physician Decision|1
7678195|NCT00264498|12095433|FG001|Randomized Treatment|Physician Decision|0
7678196|NCT00264498|12095432|FG000|Randomized Treatment|Incorrectly randomized|1
7678197|NCT00264498|12095433|FG001|Randomized Treatment|Incorrectly randomized|0
7678198|NCT00264498|12095432|FG000|Randomized Treatment|Study Closure|1
7678199|NCT00264498|12095433|FG001|Randomized Treatment|Study Closure|0
7678200|NCT00264498|12095432|FG000|Randomized Treatment|Protocol Violation|1
7678201|NCT00264498|12095433|FG001|Randomized Treatment|Protocol Violation|0
7678202|NCT00264498|12095432|FG000|Crossover Treatment|Death|1
7678203|NCT00264498|12095433|FG001|Crossover Treatment|Death|3
7678204|NCT00264498|12095432|FG000|Crossover Treatment|Objective disease progression|4
7678205|NCT00264498|12095433|FG001|Crossover Treatment|Objective disease progression|5
7678206|NCT00264498|12095432|FG000|Crossover Treatment|Study closure|0
7678207|NCT00264498|12095433|FG001|Crossover Treatment|Study closure|1
7678208|NCT00264498|12095432|FG000|Crossover Treatment|Withdrawal by Subject|1
7678209|NCT00264498|12095433|FG001|Crossover Treatment|Withdrawal by Subject|0
7678210|NCT00264537|12095443|FG000|Overall Study|Death|0
7678211|NCT00264537|12095444|FG001|Overall Study|Death|3
7678212|NCT00264537|12095445|FG002|Overall Study|Death|3
7678213|NCT00264537|12095446|FG003|Overall Study|Death|2
7678214|NCT00264537|12095443|FG000|Overall Study|Lost to Follow-up|3
7678215|NCT00264537|12095444|FG001|Overall Study|Lost to Follow-up|4
7678216|NCT00264537|12095445|FG002|Overall Study|Lost to Follow-up|7
7678217|NCT00264537|12095446|FG003|Overall Study|Lost to Follow-up|6
7678218|NCT00264537|12095443|FG000|Overall Study|Adverse Event|21
7678219|NCT00264537|12095444|FG001|Overall Study|Adverse Event|32
7678220|NCT00264537|12095445|FG002|Overall Study|Adverse Event|24
7678221|NCT00264537|12095446|FG003|Overall Study|Adverse Event|34
7678222|NCT00264537|12095443|FG000|Overall Study|Unsatisfactory therapeutic effect|5
7678223|NCT00264537|12095444|FG001|Overall Study|Unsatisfactory therapeutic effect|6
7678224|NCT00264537|12095445|FG002|Overall Study|Unsatisfactory therapeutic effect|5
7678225|NCT00264537|12095446|FG003|Overall Study|Unsatisfactory therapeutic effect|7
7678226|NCT00264537|12095443|FG000|Overall Study|Other|21
7678227|NCT00264537|12095444|FG001|Overall Study|Other|11
7678228|NCT00264537|12095445|FG002|Overall Study|Other|10
7678229|NCT00264537|12095446|FG003|Overall Study|Other|11
7678230|NCT00264537|12095443|FG000|Overall Study|Not treated|0
7678231|NCT00264537|12095444|FG001|Overall Study|Not treated|2
7678232|NCT00264537|12095445|FG002|Overall Study|Not treated|1
7678233|NCT00264537|12095446|FG003|Overall Study|Not treated|0
7678234|NCT00264550|12095462|FG000|Overall Study|Death|0
7678235|NCT00264550|12095463|FG001|Overall Study|Death|3
7678236|NCT00264550|12095464|FG002|Overall Study|Death|0
7678237|NCT00264550|12095465|FG003|Overall Study|Death|0
7678238|NCT00264550|12095462|FG000|Overall Study|Lost to Follow-up|3
7678239|NCT00264550|12095463|FG001|Overall Study|Lost to Follow-up|1
7678240|NCT00264550|12095464|FG002|Overall Study|Lost to Follow-up|1
7678241|NCT00264550|12095465|FG003|Overall Study|Lost to Follow-up|1
7678242|NCT00264550|12095462|FG000|Overall Study|Adverse Event|23
7678243|NCT00264550|12095463|FG001|Overall Study|Adverse Event|18
7678244|NCT00264550|12095464|FG002|Overall Study|Adverse Event|9
7678245|NCT00264550|12095465|FG003|Overall Study|Adverse Event|14
7678246|NCT00264550|12095462|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7678247|NCT00264550|12095463|FG001|Overall Study|Unsatisfactory therapeutic effect|11
7678248|NCT00264550|12095464|FG002|Overall Study|Unsatisfactory therapeutic effect|4
7678249|NCT00264550|12095465|FG003|Overall Study|Unsatisfactory therapeutic effect|6
7678250|NCT00264550|12095462|FG000|Overall Study|Discontinued oral study agent|0
7678251|NCT00264550|12095463|FG001|Overall Study|Discontinued oral study agent|1
7678252|NCT00264550|12095464|FG002|Overall Study|Discontinued oral study agent|0
7678253|NCT00264550|12095465|FG003|Overall Study|Discontinued oral study agent|0
7678254|NCT00264550|12095462|FG000|Overall Study|Other|13
7678255|NCT00264550|12095463|FG001|Overall Study|Other|7
7678256|NCT00264550|12095464|FG002|Overall Study|Other|3
7678257|NCT00264550|12095465|FG003|Overall Study|Other|9
7678258|NCT00264576|12095477|FG000|Overall Study|Lost to Follow-up|1
7678259|NCT00264576|12095478|FG001|Overall Study|Lost to Follow-up|1
7678260|NCT00264797|12095495|FG000|Overall Study|Withdrawal by Subject|11
7678261|NCT00264797|12095496|FG001|Overall Study|Withdrawal by Subject|11
7678262|NCT00264797|12095495|FG000|Overall Study|Lost to Follow-up|9
7678263|NCT00264797|12095496|FG001|Overall Study|Lost to Follow-up|17
7678264|NCT00264797|12095495|FG000|Overall Study|Moved from area|3
7678265|NCT00264797|12095496|FG001|Overall Study|Moved from area|1
7678266|NCT00264797|12095495|FG000|Overall Study|Practical Problems|2
7678267|NCT00264797|12095496|FG001|Overall Study|Practical Problems|3
7678268|NCT00264797|12095495|FG000|Overall Study|Incarceration|4
7678269|NCT00264797|12095496|FG001|Overall Study|Incarceration|5
7678270|NCT00264797|12095495|FG000|Overall Study|Pressure/advice from Outsiders|1
7678271|NCT00264797|12095496|FG001|Overall Study|Pressure/advice from Outsiders|1
7678272|NCT00264797|12095495|FG000|Overall Study|Feels treatment not necessary, not worki|0
7678273|NCT00264797|12095496|FG001|Overall Study|Feels treatment not necessary, not worki|1
7678274|NCT00264797|12095495|FG000|Overall Study|Other|3
7678275|NCT00264797|12095496|FG001|Overall Study|Other|4
7678276|NCT00264810|12095504|FG000|Baseline|Withdrawal by Subject|10
7678277|NCT00264810|12095505|FG001|Baseline|Withdrawal by Subject|10
7678278|NCT00264810|12095504|FG000|Baseline|Physician Decision|7
7678279|NCT00264810|12095505|FG001|Baseline|Physician Decision|8
7678280|NCT00264810|12095504|FG000|Baseline|Subject Compliance Failure|3
7678281|NCT00264810|12095505|FG001|Baseline|Subject Compliance Failure|3
7678282|NCT00264810|12095504|FG000|Baseline|Insufficient Seizure Frequency|2
7678283|NCT00264810|12095505|FG001|Baseline|Insufficient Seizure Frequency|2
7678284|NCT00264810|12095504|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1
7678285|NCT00264810|12095505|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2
7678286|NCT00264810|12095504|FG000|Baseline|Other|0
7678287|NCT00264810|12095505|FG001|Baseline|Other|1
7678288|NCT00264810|12095504|FG000|Stimulation Optimization Period|Withdrawal by Subject|1
7678289|NCT00264810|12095505|FG001|Stimulation Optimization Period|Withdrawal by Subject|0
7678290|NCT00264810|12095504|FG000|Stimulation Optimization Period|Death|0
7678291|NCT00264810|12095505|FG001|Stimulation Optimization Period|Death|1
7678292|NCT00264810|12095504|FG000|Blinded Evaluation Period|Explant due to infection|1
7678293|NCT00264810|12095505|FG001|Blinded Evaluation Period|Explant due to infection|1
7678294|NCT00264810|12095504|FG000|Open Label Evaluation Period|Explant due to infection|1
7678295|NCT00264810|12095505|FG001|Open Label Evaluation Period|Explant due to infection|1
7678296|NCT00264810|12095504|FG000|Open Label Evaluation Period|Death|3
7678297|NCT00264810|12095505|FG001|Open Label Evaluation Period|Death|2
7678298|NCT00264810|12095504|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2
7678299|NCT00264810|12095505|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3
7678300|NCT00264849|12095515|FG000|Overall Study|Adverse Event|7
7678301|NCT00264849|12095516|FG001|Overall Study|Adverse Event|2
7678302|NCT00264849|12095515|FG000|Overall Study|Withdrawal by Subject|7
7678303|NCT00264849|12095516|FG001|Overall Study|Withdrawal by Subject|11
7678304|NCT00264849|12095515|FG000|Overall Study|Protocol Violation|5
7678305|NCT00264849|12095516|FG001|Overall Study|Protocol Violation|3
7678306|NCT00264849|12095515|FG000|Overall Study|Lack of Efficacy|1
7678307|NCT00264849|12095516|FG001|Overall Study|Lack of Efficacy|6
7678308|NCT00264849|12095515|FG000|Overall Study|Lost to Follow-up|0
7678309|NCT00264849|12095516|FG001|Overall Study|Lost to Follow-up|2
7678310|NCT00264849|12095515|FG000|Overall Study|Death|0
7678311|NCT00264849|12095516|FG001|Overall Study|Death|1
7678312|NCT00264849|12095515|FG000|Overall Study|Administrative Problems|2
7678313|NCT00264849|12095516|FG001|Overall Study|Administrative Problems|0
7678314|NCT00264875|12095522|FG000|Overall Study|Adverse Event|6
7678315|NCT00264875|12095522|FG000|Overall Study|Lost to Follow-up|6
7678316|NCT00264875|12095522|FG000|Overall Study|Protocol Violation|11
7678317|NCT00264875|12095522|FG000|Overall Study|Withdrawal by Subject|7
7678318|NCT00265083|12095529|FG000|Overall Study|Adverse Event|5
7678319|NCT00265083|12095530|FG001|Overall Study|Adverse Event|13
7678320|NCT00265083|12095531|FG002|Overall Study|Adverse Event|15
7678321|NCT00265083|12095529|FG000|Overall Study|Lost to Follow-up|3
7678322|NCT00265083|12095530|FG001|Overall Study|Lost to Follow-up|4
7678323|NCT00265083|12095531|FG002|Overall Study|Lost to Follow-up|4
7678324|NCT00265083|12095529|FG000|Overall Study|Unsatisfactory therapeutic effect|8
7678325|NCT00265083|12095530|FG001|Overall Study|Unsatisfactory therapeutic effect|13
7678326|NCT00265083|12095531|FG002|Overall Study|Unsatisfactory therapeutic effect|14
7678327|NCT00265083|12095529|FG000|Overall Study|Other|1
7678328|NCT00265083|12095530|FG001|Overall Study|Other|12
7678329|NCT00265083|12095531|FG002|Overall Study|Other|9
7678330|NCT00265096|12095543|FG000|Overall Study|Adverse Event|14
7678331|NCT00265096|12095544|FG001|Overall Study|Adverse Event|18
7678332|NCT00265096|12095545|FG002|Overall Study|Adverse Event|18
7678333|NCT00265096|12095543|FG000|Overall Study|Lost to Follow-up|2
7678334|NCT00265096|12095544|FG001|Overall Study|Lost to Follow-up|5
7678335|NCT00265096|12095545|FG002|Overall Study|Lost to Follow-up|3
7678336|NCT00265096|12095543|FG000|Overall Study|Death|0
7678337|NCT00265096|12095544|FG001|Overall Study|Death|1
7678338|NCT00265096|12095545|FG002|Overall Study|Death|2
7678339|NCT00265096|12095543|FG000|Overall Study|Unsatisfactory therapeutic effect|9
7678340|NCT00265096|12095544|FG001|Overall Study|Unsatisfactory therapeutic effect|8
7678341|NCT00265096|12095545|FG002|Overall Study|Unsatisfactory therapeutic effect|6
7678342|NCT00265096|12095543|FG000|Overall Study|Other|11
7678343|NCT00265096|12095544|FG001|Overall Study|Other|19
7678344|NCT00265096|12095545|FG002|Overall Study|Other|10
7678345|NCT00265109|12095555|FG000|Overall Study|Withdrawal by Subject|5
7678346|NCT00265109|12095555|FG000|Overall Study|Adverse Event|1
7678347|NCT00265122|12095566|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
7678348|NCT00265122|12095567|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
7678349|NCT00265122|12095568|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
7678350|NCT00265122|12095569|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
7678351|NCT00265122|12095570|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
7678352|NCT00265122|12095571|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
7678353|NCT00265122|12095566|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
7678354|NCT00265122|12095567|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
7678355|NCT00265122|12095568|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
7678356|NCT00265122|12095569|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
7678357|NCT00265122|12095570|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
7678358|NCT00265122|12095571|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
7678359|NCT00265122|12095566|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0
7678360|NCT00265122|12095567|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1
7678361|NCT00265122|12095568|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2
7678362|NCT00265122|12095569|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1
7678363|NCT00265122|12095570|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0
7678364|NCT00265122|12095571|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0
7678365|NCT00265122|12095566|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
7678366|NCT00265122|12095567|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
7678367|NCT00265122|12095568|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
7678368|NCT00265122|12095569|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
7678369|NCT00265122|12095570|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
7678370|NCT00265122|12095571|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
7678371|NCT00265122|12095566|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
7678372|NCT00265122|12095567|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
7678373|NCT00265122|12095568|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
7678374|NCT00265122|12095569|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
7678375|NCT00265122|12095570|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
7678376|NCT00265122|12095571|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
7678377|NCT00265122|12095566|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4
7678378|NCT00265122|12095567|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0
7678379|NCT00265122|12095568|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1
7678380|NCT00265122|12095569|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1
7678381|NCT00265122|12095570|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0
7678382|NCT00265122|12095571|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0
7678383|NCT00265148|12095592|FG000|Overall Study|Adverse Event|2
7678384|NCT00265148|12095593|FG001|Overall Study|Adverse Event|2
7678385|NCT00265148|12095592|FG000|Overall Study|Lack of Efficacy|0
7678386|NCT00265148|12095593|FG001|Overall Study|Lack of Efficacy|2
7678387|NCT00265148|12095592|FG000|Overall Study|Protocol Violation|3
7678388|NCT00265148|12095593|FG001|Overall Study|Protocol Violation|2
7678389|NCT00265148|12095592|FG000|Overall Study|Lost to Follow-up|0
7678390|NCT00265148|12095593|FG001|Overall Study|Lost to Follow-up|1
7678391|NCT00265148|12095592|FG000|Overall Study|Withdrawal by Subject|2
7678392|NCT00265148|12095593|FG001|Overall Study|Withdrawal by Subject|1
7678393|NCT00265148|12095592|FG000|Overall Study|Physician Decision|1
7678394|NCT00265148|12095593|FG001|Overall Study|Physician Decision|0
7678395|NCT00265148|12095592|FG000|Overall Study|Increasing frailty|0
7678396|NCT00265148|12095593|FG001|Overall Study|Increasing frailty|1
7678397|NCT00265148|12095592|FG000|Overall Study|Subject chose to change of the dose|1
7678398|NCT00265148|12095593|FG001|Overall Study|Subject chose to change of the dose|0
7678399|NCT00265239|12095606|FG000|Overall Study|Adverse Event|2
7678400|NCT00265239|12095607|FG001|Overall Study|Adverse Event|1
7678401|NCT00265317|12095617|FG000|Lead-In|Objective progression or relapse|6
7678402|NCT00265317|12095618|FG001|Lead-In|Objective progression or relapse|11
7678403|NCT00265317|12095619|FG002|Lead-In|Objective progression or relapse|0
7678404|NCT00265317|12095620|FG003|Lead-In|Objective progression or relapse|0
7678405|NCT00265317|12095617|FG000|Lead-In|Adverse Event|2
7678406|NCT00265317|12095618|FG001|Lead-In|Adverse Event|1
7678407|NCT00265317|12095619|FG002|Lead-In|Adverse Event|0
7678408|NCT00265317|12095620|FG003|Lead-In|Adverse Event|0
7678409|NCT00265317|12095617|FG000|Lead-In|Death|3
7678410|NCT00265317|12095618|FG001|Lead-In|Death|5
7678411|NCT00265317|12095619|FG002|Lead-In|Death|0
7678412|NCT00265317|12095620|FG003|Lead-In|Death|0
7678413|NCT00265317|12095617|FG000|Lead-In|Withdrawal/other than adverse event|1
7678414|NCT00265317|12095618|FG001|Lead-In|Withdrawal/other than adverse event|0
7678415|NCT00265317|12095619|FG002|Lead-In|Withdrawal/other than adverse event|0
7678416|NCT00265317|12095620|FG003|Lead-In|Withdrawal/other than adverse event|0
7678417|NCT00265317|12095617|FG000|Phase 2|Objective progression or relapse|0
7678418|NCT00265317|12095618|FG001|Phase 2|Objective progression or relapse|0
7678419|NCT00265317|12095619|FG002|Phase 2|Objective progression or relapse|37
7678420|NCT00265317|12095620|FG003|Phase 2|Objective progression or relapse|38
7678421|NCT00265317|12095617|FG000|Phase 2|Global deterioration of health status|0
7678422|NCT00265317|12095618|FG001|Phase 2|Global deterioration of health status|0
7678423|NCT00265317|12095619|FG002|Phase 2|Global deterioration of health status|3
7678424|NCT00265317|12095620|FG003|Phase 2|Global deterioration of health status|0
7678425|NCT00265317|12095617|FG000|Phase 2|Adverse Event|0
7678426|NCT00265317|12095618|FG001|Phase 2|Adverse Event|0
7678427|NCT00265317|12095619|FG002|Phase 2|Adverse Event|7
7678428|NCT00265317|12095620|FG003|Phase 2|Adverse Event|5
7678429|NCT00265317|12095617|FG000|Phase 2|Death|0
7678430|NCT00265317|12095618|FG001|Phase 2|Death|0
7678431|NCT00265317|12095619|FG002|Phase 2|Death|12
7678432|NCT00265317|12095620|FG003|Phase 2|Death|15
7678433|NCT00265317|12095617|FG000|Phase 2|Protocol Violation|0
7678434|NCT00265317|12095618|FG001|Phase 2|Protocol Violation|0
7678435|NCT00265317|12095619|FG002|Phase 2|Protocol Violation|1
7678436|NCT00265317|12095620|FG003|Phase 2|Protocol Violation|4
7678437|NCT00265317|12095617|FG000|Phase 2|Lost to Follow-up|0
7678438|NCT00265317|12095618|FG001|Phase 2|Lost to Follow-up|0
7678439|NCT00265317|12095619|FG002|Phase 2|Lost to Follow-up|0
7678440|NCT00265317|12095620|FG003|Phase 2|Lost to Follow-up|1
7678441|NCT00265317|12095617|FG000|Phase 2|Withdrawal/other than adverse event|0
7678442|NCT00265317|12095618|FG001|Phase 2|Withdrawal/other than adverse event|0
7678443|NCT00265317|12095619|FG002|Phase 2|Withdrawal/other than adverse event|2
7678444|NCT00265317|12095620|FG003|Phase 2|Withdrawal/other than adverse event|1
7678445|NCT00265317|12095617|FG000|Phase 2|Study terminated by sponsor|0
7678446|NCT00265317|12095618|FG001|Phase 2|Study terminated by sponsor|0
7678447|NCT00265317|12095619|FG002|Phase 2|Study terminated by sponsor|1
7678448|NCT00265317|12095620|FG003|Phase 2|Study terminated by sponsor|0
7678449|NCT00265317|12095617|FG000|Phase 2|Other|0
7678450|NCT00265317|12095618|FG001|Phase 2|Other|0
7678451|NCT00265317|12095619|FG002|Phase 2|Other|1
7678452|NCT00265317|12095620|FG003|Phase 2|Other|1
7678453|NCT00265330|12095639|FG000|Overall Study|Adverse Event|41
7678454|NCT00265330|12095639|FG000|Overall Study|Lost to Follow-up|8
7678455|NCT00265330|12095639|FG000|Overall Study|Withdrawal by Subject|34
7678456|NCT00265330|12095639|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1
7678457|NCT00265330|12095639|FG000|Overall Study|Lack of Efficacy|4
7678458|NCT00265330|12095639|FG000|Overall Study|Family Scheduling Conflicts|1
7678459|NCT00265330|12095639|FG000|Overall Study|Began Taking Formulary Geodon|1
7678460|NCT00265330|12095639|FG000|Overall Study|Discharged from Unit for Long Term Care|1
7678461|NCT00265330|12095639|FG000|Overall Study|Site Closed by Sponsor|1
7678462|NCT00265330|12095639|FG000|Overall Study|Principal Investigators Request|1
7678463|NCT00265330|12095639|FG000|Overall Study|Withdrew Consent|1
7678464|NCT00265330|12095639|FG000|Overall Study|Protocol Violation|1
7678465|NCT00265382|12095643|FG000|Overall Study|Adverse Event|21
7678466|NCT00265382|12095643|FG000|Overall Study|Laboratory Abnormality|1
7678467|NCT00265382|12095643|FG000|Overall Study|Lost to Follow-up|3
7678468|NCT00265382|12095643|FG000|Overall Study|Lack of Efficacy|6
7678469|NCT00265382|12095643|FG000|Overall Study|Miscellaneous|6
7678470|NCT00265382|12095643|FG000|Overall Study|Withdrawal by Subject|13
7678471|NCT00265382|12095643|FG000|Overall Study|Study terminated by sponsor|94
7678472|NCT00265382|12095643|FG000|Overall Study|Death|1
7678473|NCT00265395|12095649|FG000|Overall Study|Adverse Event|3
7678474|NCT00265395|12095650|FG001|Overall Study|Adverse Event|6
7678475|NCT00265395|12095649|FG000|Overall Study|Lost to Follow-up|2
7678476|NCT00265395|12095650|FG001|Overall Study|Lost to Follow-up|1
7678477|NCT00265395|12095649|FG000|Overall Study|Withdrawal by Subject|1
7678478|NCT00265395|12095650|FG001|Overall Study|Withdrawal by Subject|6
7678479|NCT00265395|12095649|FG000|Overall Study|Protocol Violation|2
7678480|NCT00265395|12095650|FG001|Overall Study|Protocol Violation|2
7678481|NCT00265395|12095649|FG000|Overall Study|Lack of Efficacy|0
7678482|NCT00265395|12095650|FG001|Overall Study|Lack of Efficacy|1
7678483|NCT00265395|12095649|FG000|Overall Study|Administrative|0
7678484|NCT00265395|12095650|FG001|Overall Study|Administrative|1
7678485|NCT00265564|12095688|FG000|Overall Study|Lost to Follow-up|5
7678486|NCT00265564|12095689|FG001|Overall Study|Lost to Follow-up|7
7678487|NCT00265564|12095688|FG000|Overall Study|met exclusion criteria|5
7678488|NCT00265564|12095689|FG001|Overall Study|met exclusion criteria|2
7678489|NCT00265759|12095710|FG000|Overall Study|Withdrawal by Subject|0
7678490|NCT00265759|12095711|FG001|Overall Study|Withdrawal by Subject|1
7678491|NCT00265759|12095712|FG002|Overall Study|Withdrawal by Subject|2
7678492|NCT00265759|12095713|FG003|Overall Study|Withdrawal by Subject|2
7678493|NCT00265759|12095710|FG000|Overall Study|Cancel|0
7678494|NCT00265759|12095711|FG001|Overall Study|Cancel|0
7678495|NCT00265759|12095712|FG002|Overall Study|Cancel|0
7678496|NCT00265759|12095713|FG003|Overall Study|Cancel|3
7678497|NCT00265759|12095710|FG000|Overall Study|Ineligible|0
7678498|NCT00265759|12095711|FG001|Overall Study|Ineligible|0
7678499|NCT00265759|12095712|FG002|Overall Study|Ineligible|0
7678500|NCT00265759|12095713|FG003|Overall Study|Ineligible|1
7678501|NCT00265759|12095710|FG000|Overall Study|Bilateral disease|0
7678502|NCT00265759|12095711|FG001|Overall Study|Bilateral disease|0
7678503|NCT00265759|12095712|FG002|Overall Study|Bilateral disease|0
7678504|NCT00265759|12095713|FG003|Overall Study|Bilateral disease|2
7678505|NCT00265759|12095710|FG000|Overall Study|Discontinued due to intolerability|0
7678506|NCT00265759|12095711|FG001|Overall Study|Discontinued due to intolerability|0
7678507|NCT00265759|12095712|FG002|Overall Study|Discontinued due to intolerability|0
7678508|NCT00265759|12095713|FG003|Overall Study|Discontinued due to intolerability|1
7678509|NCT00265785|12095724|FG000|Overall Study|Adverse Event|4
7678510|NCT00265785|12095724|FG000|Overall Study|Withdrawal by Subject|3
7678511|NCT00265785|12095724|FG000|Overall Study|Progression/Relapse|15
7678512|NCT00265785|12095724|FG000|Overall Study|Not protocol specified|2
7678513|NCT00265785|12095724|FG000|Overall Study|Ineligible|1
7678514|NCT00265785|12095724|FG000|Overall Study|Did not receive protocol treatment|2
7678515|NCT00265889|12095740|FG000|Overall Study|Physician Decision|1
7678516|NCT00265889|12095740|FG000|Overall Study|Protocol Violation|1
7678517|NCT00265889|12095740|FG000|Overall Study|Insurance denied the request|3
7678518|NCT00266032|12095751|FG000|Treatment|Adverse Event|42
7678519|NCT00266032|12095752|FG001|Treatment|Adverse Event|26
7678520|NCT00266032|12095753|FG002|Treatment|Adverse Event|10
7678521|NCT00266032|12095751|FG000|Treatment|Lost to Follow-up|19
7678522|NCT00266032|12095752|FG001|Treatment|Lost to Follow-up|4
7678523|NCT00266032|12095753|FG002|Treatment|Lost to Follow-up|2
7678524|NCT00266032|12095751|FG000|Treatment|Pregnancy|3
7678525|NCT00266032|12095752|FG001|Treatment|Pregnancy|2
7678526|NCT00266032|12095753|FG002|Treatment|Pregnancy|2
7678527|NCT00266032|12095751|FG000|Treatment|Protocol Violation|6
7678528|NCT00266032|12095752|FG001|Treatment|Protocol Violation|14
7678529|NCT00266032|12095753|FG002|Treatment|Protocol Violation|13
7678530|NCT00266032|12095751|FG000|Treatment|Withdrawal by Subject|28
7678531|NCT00266032|12095752|FG001|Treatment|Withdrawal by Subject|13
7678532|NCT00266032|12095753|FG002|Treatment|Withdrawal by Subject|12
7678533|NCT00266032|12095751|FG000|Treatment|patient moved/wish for pregnancy/no need|13
7678534|NCT00266032|12095752|FG001|Treatment|patient moved/wish for pregnancy/no need|5
7678535|NCT00266032|12095753|FG002|Treatment|patient moved/wish for pregnancy/no need|8
7678536|NCT00266032|12095751|FG000|Open-label Safety Extension|Adverse Event|5
7678537|NCT00266032|12095752|FG001|Open-label Safety Extension|Adverse Event|0
7678538|NCT00266032|12095753|FG002|Open-label Safety Extension|Adverse Event|4
7678539|NCT00266032|12095751|FG000|Open-label Safety Extension|Lost to Follow-up|2
7678540|NCT00266032|12095752|FG001|Open-label Safety Extension|Lost to Follow-up|5
7678541|NCT00266032|12095753|FG002|Open-label Safety Extension|Lost to Follow-up|4
7678542|NCT00266032|12095751|FG000|Open-label Safety Extension|Pregnancy|4
7678543|NCT00266032|12095752|FG001|Open-label Safety Extension|Pregnancy|1
7678544|NCT00266032|12095753|FG002|Open-label Safety Extension|Pregnancy|2
7678545|NCT00266032|12095751|FG000|Open-label Safety Extension|Protocol Violation|1
7678546|NCT00266032|12095752|FG001|Open-label Safety Extension|Protocol Violation|3
7678547|NCT00266032|12095753|FG002|Open-label Safety Extension|Protocol Violation|2
7678548|NCT00266032|12095751|FG000|Open-label Safety Extension|Withdrawal by Subject|19
7678549|NCT00266032|12095752|FG001|Open-label Safety Extension|Withdrawal by Subject|3
7678550|NCT00266032|12095753|FG002|Open-label Safety Extension|Withdrawal by Subject|12
7678630|NCT00266630|12095803|FG000|Overall Study|Entry Criteria not met|1
7678551|NCT00266032|12095751|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
7678552|NCT00266032|12095752|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
7678553|NCT00266032|12095753|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
7678554|NCT00266227|12095768|FG000|Initial Treatment|Adverse Event|0
7678555|NCT00266227|12095769|FG001|Initial Treatment|Adverse Event|0
7678556|NCT00266227|12095770|FG002|Initial Treatment|Adverse Event|13
7678557|NCT00266227|12095768|FG000|Initial Treatment|Lost to Follow-up|0
7678558|NCT00266227|12095769|FG001|Initial Treatment|Lost to Follow-up|0
7678559|NCT00266227|12095770|FG002|Initial Treatment|Lost to Follow-up|6
7678560|NCT00266227|12095768|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0
7678561|NCT00266227|12095769|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0
7678562|NCT00266227|12095770|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45
7678563|NCT00266227|12095768|FG000|Initial Treatment|Physician decision to withdraw|0
7678564|NCT00266227|12095769|FG001|Initial Treatment|Physician decision to withdraw|0
7678565|NCT00266227|12095770|FG002|Initial Treatment|Physician decision to withdraw|12
7678566|NCT00266227|12095768|FG000|Initial Treatment|Pregnancy|0
7678567|NCT00266227|12095769|FG001|Initial Treatment|Pregnancy|0
7678568|NCT00266227|12095770|FG002|Initial Treatment|Pregnancy|1
7678569|NCT00266227|12095768|FG000|Retreatment: Up to Week 48|Death|1
7678570|NCT00266227|12095769|FG001|Retreatment: Up to Week 48|Death|0
7678571|NCT00266227|12095770|FG002|Retreatment: Up to Week 48|Death|0
7678572|NCT00266227|12095768|FG000|Retreatment: Up to Week 48|Adverse Event|7
7678573|NCT00266227|12095769|FG001|Retreatment: Up to Week 48|Adverse Event|7
7678574|NCT00266227|12095770|FG002|Retreatment: Up to Week 48|Adverse Event|0
7678575|NCT00266227|12095768|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3
7678576|NCT00266227|12095769|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0
7678577|NCT00266227|12095770|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0
7678578|NCT00266227|12095768|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
7678579|NCT00266227|12095769|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
7678580|NCT00266227|12095770|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
7678581|NCT00266227|12095768|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
7678582|NCT00266227|12095769|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
7678583|NCT00266227|12095770|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
7678584|NCT00266227|12095768|FG000|Retreatment: Up to Week 48|Pregnancy|1
7678585|NCT00266227|12095769|FG001|Retreatment: Up to Week 48|Pregnancy|0
7678586|NCT00266227|12095770|FG002|Retreatment: Up to Week 48|Pregnancy|0
7678587|NCT00266227|12095768|FG000|Retreatment: Week 48 to Week 72|Death|1
7678588|NCT00266227|12095769|FG001|Retreatment: Week 48 to Week 72|Death|1
7678589|NCT00266227|12095770|FG002|Retreatment: Week 48 to Week 72|Death|0
7678590|NCT00266227|12095768|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6
7678591|NCT00266227|12095769|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2
7678592|NCT00266227|12095770|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0
7678593|NCT00266227|12095768|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
7678594|NCT00266227|12095769|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
7678595|NCT00266227|12095770|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
7678596|NCT00266227|12095768|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
7678597|NCT00266227|12095769|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
7678598|NCT00266227|12095770|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
7678599|NCT00266227|12095768|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
7678600|NCT00266227|12095769|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
7678601|NCT00266227|12095770|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
7678602|NCT00266409|12095788|FG000|Overall Study|Lack of Efficacy|2
7678603|NCT00266409|12095789|FG001|Overall Study|Lack of Efficacy|6
7678604|NCT00266409|12095790|FG002|Overall Study|Lack of Efficacy|1
7678605|NCT00266409|12095791|FG003|Overall Study|Lack of Efficacy|2
7678606|NCT00266409|12095788|FG000|Overall Study|Adverse Event|7
7678607|NCT00266409|12095789|FG001|Overall Study|Adverse Event|2
7678608|NCT00266409|12095790|FG002|Overall Study|Adverse Event|1
7678609|NCT00266409|12095791|FG003|Overall Study|Adverse Event|1
7678610|NCT00266409|12095788|FG000|Overall Study|Lost to Follow-up|18
7678611|NCT00266409|12095789|FG001|Overall Study|Lost to Follow-up|21
7678612|NCT00266409|12095790|FG002|Overall Study|Lost to Follow-up|6
7678613|NCT00266409|12095791|FG003|Overall Study|Lost to Follow-up|8
7678614|NCT00266409|12095788|FG000|Overall Study|Withdrawal by Subject|6
7678615|NCT00266409|12095789|FG001|Overall Study|Withdrawal by Subject|10
7678616|NCT00266409|12095790|FG002|Overall Study|Withdrawal by Subject|3
7678617|NCT00266409|12095791|FG003|Overall Study|Withdrawal by Subject|9
7678618|NCT00266409|12095788|FG000|Overall Study|Protocol Violation|5
7678619|NCT00266409|12095789|FG001|Overall Study|Protocol Violation|3
7678620|NCT00266409|12095790|FG002|Overall Study|Protocol Violation|4
7678621|NCT00266409|12095791|FG003|Overall Study|Protocol Violation|2
7678622|NCT00266409|12095788|FG000|Overall Study|Other|7
7678623|NCT00266409|12095789|FG001|Overall Study|Other|4
7678624|NCT00266409|12095790|FG002|Overall Study|Other|2
7678625|NCT00266409|12095791|FG003|Overall Study|Other|0
7678626|NCT00266630|12095803|FG000|Overall Study|Adverse Event|8
7678627|NCT00266630|12095804|FG001|Overall Study|Adverse Event|6
7678628|NCT00266630|12095803|FG000|Overall Study|Lack of Efficacy|1
7678629|NCT00266630|12095804|FG001|Overall Study|Lack of Efficacy|4
7678631|NCT00266630|12095804|FG001|Overall Study|Entry Criteria not met|0
7678632|NCT00266630|12095803|FG000|Overall Study|Protocol Violation|1
7678633|NCT00266630|12095804|FG001|Overall Study|Protocol Violation|3
7678634|NCT00266630|12095803|FG000|Overall Study|Physician Decision|1
7678635|NCT00266630|12095804|FG001|Overall Study|Physician Decision|2
7678636|NCT00266630|12095803|FG000|Overall Study|Withdrawal by Subject|10
7678637|NCT00266630|12095804|FG001|Overall Study|Withdrawal by Subject|2
7678638|NCT00266630|12095803|FG000|Overall Study|Lost to Follow-up|1
7678639|NCT00266630|12095804|FG001|Overall Study|Lost to Follow-up|0
7678640|NCT00266630|12095803|FG000|Overall Study|Other|19
7678641|NCT00266630|12095804|FG001|Overall Study|Other|11
7678642|NCT00266656|12095814|FG000|Overall Study|Death|1
7678643|NCT00266656|12095815|FG001|Overall Study|Death|0
7678644|NCT00266656|12095814|FG000|Overall Study|Lost to Follow-up|4
7678645|NCT00266656|12095815|FG001|Overall Study|Lost to Follow-up|1
7678646|NCT00266656|12095814|FG000|Overall Study|Withdrawal by Subject|4
7678647|NCT00266656|12095815|FG001|Overall Study|Withdrawal by Subject|2
7678648|NCT00266656|12095814|FG000|Overall Study|Did Not Reach Final Height|4
7678649|NCT00266656|12095815|FG001|Overall Study|Did Not Reach Final Height|8
7678650|NCT00266656|12095814|FG000|Overall Study|Parent/Caregiver Decision|1
7678651|NCT00266656|12095815|FG001|Overall Study|Parent/Caregiver Decision|2
7678652|NCT00266695|12095821|FG000|Overall Study|Adverse Event|1
7678653|NCT00266695|12095821|FG000|Overall Study|Death|9
7678654|NCT00266695|12095821|FG000|Overall Study|Physician Decision|1
7678655|NCT00266695|12095821|FG000|Overall Study|Lost to Follow-up|3
7678656|NCT00266695|12095821|FG000|Overall Study|Withdrawal by Subject|15
7678657|NCT00266708|12095827|FG000|Overall Study|No renal function|1
7678658|NCT00266708|12095828|FG001|Overall Study|No renal function|1
7678659|NCT00266708|12095827|FG000|Overall Study|Refused biopsy|3
7678660|NCT00266708|12095828|FG001|Overall Study|Refused biopsy|6
7678661|NCT00266708|12095827|FG000|Overall Study|Asthma|0
7678662|NCT00266708|12095828|FG001|Overall Study|Asthma|2
7678663|NCT00266812|12095845|FG000|Overall Study|Disease Progression|9
7678664|NCT00266812|12095846|FG001|Overall Study|Disease Progression|3
7678665|NCT00266812|12095845|FG000|Overall Study|Death|5
7678666|NCT00266812|12095846|FG001|Overall Study|Death|4
7678667|NCT00266812|12095845|FG000|Overall Study|Adverse Event|3
7678668|NCT00266812|12095846|FG001|Overall Study|Adverse Event|1
7678669|NCT00266812|12095845|FG000|Overall Study|Protocol Violation|0
7678670|NCT00266812|12095846|FG001|Overall Study|Protocol Violation|1
7678671|NCT00266812|12095845|FG000|Overall Study|Withdrawal by Subject|0
7678672|NCT00266812|12095846|FG001|Overall Study|Withdrawal by Subject|2
7678673|NCT00266812|12095845|FG000|Overall Study|Discontinued before starting study drug|4
7678674|NCT00266812|12095846|FG001|Overall Study|Discontinued before starting study drug|0
7678675|NCT00266825|12095854|FG000|Completed Follow-Up|Lost to Follow-up|14
7678676|NCT00266825|12095855|FG001|Completed Follow-Up|Lost to Follow-up|19
7678677|NCT00266825|12095854|FG000|Completed Follow-Up|Withdrawal by Subject|11
7678678|NCT00266825|12095855|FG001|Completed Follow-Up|Withdrawal by Subject|5
7678679|NCT00266864|12095882|FG000|Overall Study|Lost to Follow-up|4
7678680|NCT00266864|12095883|FG001|Overall Study|Lost to Follow-up|1
7678681|NCT00266864|12095882|FG000|Overall Study|Withdrawal by Subject|1
7678682|NCT00266864|12095883|FG001|Overall Study|Withdrawal by Subject|1
7678683|NCT00266877|12095892|FG000|Overall Study|Death|1
7678684|NCT00266877|12095893|FG001|Overall Study|Death|1
7678685|NCT00266877|12095894|FG002|Overall Study|Death|1
7678686|NCT00266877|12095892|FG000|Overall Study|Adverse Event|6
7678687|NCT00266877|12095893|FG001|Overall Study|Adverse Event|4
7678688|NCT00266877|12095894|FG002|Overall Study|Adverse Event|1
7678689|NCT00266877|12095892|FG000|Overall Study|Physician Decision|2
7678690|NCT00266877|12095893|FG001|Overall Study|Physician Decision|1
7678691|NCT00266877|12095894|FG002|Overall Study|Physician Decision|1
7678692|NCT00266877|12095892|FG000|Overall Study|Withdrawal by Subject|3
7678693|NCT00266877|12095893|FG001|Overall Study|Withdrawal by Subject|1
7678694|NCT00266877|12095894|FG002|Overall Study|Withdrawal by Subject|1
7678695|NCT00266877|12095892|FG000|Overall Study|Disease Progression|72
7678696|NCT00266877|12095893|FG001|Overall Study|Disease Progression|37
7678697|NCT00266877|12095894|FG002|Overall Study|Disease Progression|23
7678698|NCT00266877|12095892|FG000|Overall Study|Symptomatic Deterioration|6
7678699|NCT00266877|12095893|FG001|Overall Study|Symptomatic Deterioration|3
7678700|NCT00266877|12095894|FG002|Overall Study|Symptomatic Deterioration|1
7678701|NCT00266877|12095892|FG000|Overall Study|Hospitalization|1
7678702|NCT00266877|12095893|FG001|Overall Study|Hospitalization|0
7678703|NCT00266877|12095894|FG002|Overall Study|Hospitalization|0
7678704|NCT00266877|12095892|FG000|Overall Study|Concomitant Radiotherapy|0
7678705|NCT00266877|12095893|FG001|Overall Study|Concomitant Radiotherapy|1
7678706|NCT00266877|12095894|FG002|Overall Study|Concomitant Radiotherapy|0
7678707|NCT00267007|12095904|FG000|Overall Study|Withdrawal by Subject|6
7678708|NCT00267007|12095905|FG001|Overall Study|Withdrawal by Subject|0
7678709|NCT00267007|12095904|FG000|Overall Study|Lost to Follow-up|1
7678710|NCT00267007|12095905|FG001|Overall Study|Lost to Follow-up|0
7678711|NCT00267007|12095904|FG000|Overall Study|Non-compliance|0
7678712|NCT00267007|12095905|FG001|Overall Study|Non-compliance|1
7678713|NCT00267007|12095904|FG000|Overall Study|Adverse Event|1
7678714|NCT00267007|12095905|FG001|Overall Study|Adverse Event|0
7678715|NCT00267020|12095913|FG000|Overall Study|Adverse Event|22
7678716|NCT00267020|12095914|FG001|Overall Study|Adverse Event|5
7678717|NCT00267020|12095913|FG000|Overall Study|Death|2
7678718|NCT00267020|12095914|FG001|Overall Study|Death|1
7678719|NCT00267020|12095913|FG000|Overall Study|Withdrawal by Subject|17
7678720|NCT00267020|12095914|FG001|Overall Study|Withdrawal by Subject|7
7678721|NCT00267020|12095913|FG000|Overall Study|Physician Decision|3
7678722|NCT00267020|12095914|FG001|Overall Study|Physician Decision|2
7678723|NCT00267020|12095913|FG000|Overall Study|Disease Progression|39
7678724|NCT00267020|12095914|FG001|Overall Study|Disease Progression|25
7678725|NCT00267020|12095913|FG000|Overall Study|Unrelated Complication|1
7678726|NCT00267020|12095914|FG001|Overall Study|Unrelated Complication|1
7678727|NCT00267020|12095913|FG000|Overall Study|Sponsor Request|1
7678728|NCT00267020|12095914|FG001|Overall Study|Sponsor Request|0
7678729|NCT00267020|12095913|FG000|Overall Study|Other|1
7678730|NCT00267020|12095914|FG001|Overall Study|Other|2
7678731|NCT00267046|12095922|FG000|Overall Study|Disease progression|4
7678732|NCT00267046|12095923|FG001|Overall Study|Disease progression|2
7678733|NCT00267046|12095922|FG000|Overall Study|Chemotoxicity|2
7678734|NCT00267046|12095923|FG001|Overall Study|Chemotoxicity|0
7678735|NCT00267046|12095922|FG000|Overall Study|Open-label palifermin|2
7678736|NCT00267046|12095923|FG001|Overall Study|Open-label palifermin|7
7678737|NCT00267046|12095922|FG000|Overall Study|Surgery|3
7678738|NCT00267046|12095923|FG001|Overall Study|Surgery|1
7678739|NCT00267046|12095922|FG000|Overall Study|Withdrawal by Subject|1
7678740|NCT00267046|12095923|FG001|Overall Study|Withdrawal by Subject|0
7678741|NCT00267046|12095922|FG000|Overall Study|Radiation|0
7678742|NCT00267046|12095923|FG001|Overall Study|Radiation|1
7678743|NCT00267098|12095945|FG000|Overall Study|Death|0
7678744|NCT00267098|12095946|FG001|Overall Study|Death|0
7678745|NCT00267098|12095947|FG002|Overall Study|Death|57
7678746|NCT00267098|12095948|FG003|Overall Study|Death|66
7678747|NCT00267098|12095949|FG004|Overall Study|Death|14
7678748|NCT00267098|12095950|FG005|Overall Study|Death|23
7678749|NCT00267098|12095951|FG006|Overall Study|Death|28
7678750|NCT00267098|12095952|FG007|Overall Study|Death|9
7678751|NCT00267098|12095945|FG000|Overall Study|Lost to Follow-up|0
7678752|NCT00267098|12095946|FG001|Overall Study|Lost to Follow-up|0
7678753|NCT00267098|12095947|FG002|Overall Study|Lost to Follow-up|6
7678754|NCT00267098|12095948|FG003|Overall Study|Lost to Follow-up|5
7678755|NCT00267098|12095949|FG004|Overall Study|Lost to Follow-up|2
7678756|NCT00267098|12095950|FG005|Overall Study|Lost to Follow-up|3
7678757|NCT00267098|12095951|FG006|Overall Study|Lost to Follow-up|1
7678758|NCT00267098|12095952|FG007|Overall Study|Lost to Follow-up|1
7678759|NCT00267098|12095945|FG000|Overall Study|Withdrawal by Subject|8
7678760|NCT00267098|12095946|FG001|Overall Study|Withdrawal by Subject|0
7678761|NCT00267098|12095947|FG002|Overall Study|Withdrawal by Subject|24
7678762|NCT00267098|12095948|FG003|Overall Study|Withdrawal by Subject|21
7678763|NCT00267098|12095949|FG004|Overall Study|Withdrawal by Subject|12
7678764|NCT00267098|12095950|FG005|Overall Study|Withdrawal by Subject|9
7678765|NCT00267098|12095951|FG006|Overall Study|Withdrawal by Subject|12
7678766|NCT00267098|12095952|FG007|Overall Study|Withdrawal by Subject|5
7678767|NCT00267098|12095945|FG000|Overall Study|Physician Decision|5
7678768|NCT00267098|12095946|FG001|Overall Study|Physician Decision|0
7678769|NCT00267098|12095947|FG002|Overall Study|Physician Decision|7
7678770|NCT00267098|12095948|FG003|Overall Study|Physician Decision|11
7678771|NCT00267098|12095949|FG004|Overall Study|Physician Decision|5
7678772|NCT00267098|12095950|FG005|Overall Study|Physician Decision|4
7678773|NCT00267098|12095951|FG006|Overall Study|Physician Decision|3
7678774|NCT00267098|12095952|FG007|Overall Study|Physician Decision|0
7678775|NCT00267098|12095945|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96
7678776|NCT00267098|12095946|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7678777|NCT00267098|12095947|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7678778|NCT00267098|12095948|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7678779|NCT00267098|12095949|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2
7678780|NCT00267098|12095950|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7678781|NCT00267098|12095951|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7678782|NCT00267098|12095952|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7678783|NCT00267098|12095945|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7678784|NCT00267098|12095946|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51
7678785|NCT00267098|12095947|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7678786|NCT00267098|12095948|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7678787|NCT00267098|12095949|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7678788|NCT00267098|12095950|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7678789|NCT00267098|12095951|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7678790|NCT00267098|12095952|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7678791|NCT00267098|12095945|FG000|Overall Study|Site closure|0
7678792|NCT00267098|12095946|FG001|Overall Study|Site closure|0
7678793|NCT00267098|12095947|FG002|Overall Study|Site closure|0
7678794|NCT00267098|12095948|FG003|Overall Study|Site closure|1
7678795|NCT00267098|12095949|FG004|Overall Study|Site closure|0
7678796|NCT00267098|12095950|FG005|Overall Study|Site closure|1
7678797|NCT00267098|12095951|FG006|Overall Study|Site closure|1
7678798|NCT00267098|12095952|FG007|Overall Study|Site closure|0
7678799|NCT00267098|12095945|FG000|Overall Study|Explanted Medtronic device|0
7678800|NCT00267098|12095946|FG001|Overall Study|Explanted Medtronic device|0
7678801|NCT00267098|12095947|FG002|Overall Study|Explanted Medtronic device|0
7678802|NCT00267098|12095948|FG003|Overall Study|Explanted Medtronic device|1
7678803|NCT00267098|12095949|FG004|Overall Study|Explanted Medtronic device|0
7678804|NCT00267098|12095950|FG005|Overall Study|Explanted Medtronic device|0
7678805|NCT00267098|12095951|FG006|Overall Study|Explanted Medtronic device|0
7678806|NCT00267098|12095952|FG007|Overall Study|Explanted Medtronic device|0
7678807|NCT00267098|12095945|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0
7678808|NCT00267098|12095946|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0
7678809|NCT00267098|12095947|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0
7678810|NCT00267098|12095948|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0
7678811|NCT00267098|12095949|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2
7678812|NCT00267098|12095950|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0
7678813|NCT00267098|12095951|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0
7678814|NCT00267098|12095952|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0
7678815|NCT00267098|12095945|FG000|Overall Study|Subject listed for heart transplant|0
7678816|NCT00267098|12095946|FG001|Overall Study|Subject listed for heart transplant|0
7678817|NCT00267098|12095947|FG002|Overall Study|Subject listed for heart transplant|0
7678818|NCT00267098|12095948|FG003|Overall Study|Subject listed for heart transplant|0
7678819|NCT00267098|12095949|FG004|Overall Study|Subject listed for heart transplant|0
7678820|NCT00267098|12095950|FG005|Overall Study|Subject listed for heart transplant|0
7678821|NCT00267098|12095951|FG006|Overall Study|Subject listed for heart transplant|1
7678822|NCT00267098|12095952|FG007|Overall Study|Subject listed for heart transplant|0
7678823|NCT00267098|12095945|FG000|Overall Study|Sponsor withdrew subject|0
7678824|NCT00267098|12095946|FG001|Overall Study|Sponsor withdrew subject|0
7678825|NCT00267098|12095947|FG002|Overall Study|Sponsor withdrew subject|0
7678826|NCT00267098|12095948|FG003|Overall Study|Sponsor withdrew subject|1
7678827|NCT00267098|12095949|FG004|Overall Study|Sponsor withdrew subject|0
7678828|NCT00267098|12095950|FG005|Overall Study|Sponsor withdrew subject|0
7678829|NCT00267098|12095951|FG006|Overall Study|Sponsor withdrew subject|0
7678830|NCT00267098|12095952|FG007|Overall Study|Sponsor withdrew subject|0
7678831|NCT00267150|12095985|FG000|Overall Study|Adverse Event|1
7678832|NCT00267189|12095991|FG000|Overall Study|Patient withdrew consent|1
7678833|NCT00267189|12095992|FG001|Overall Study|Patient withdrew consent|1
7678834|NCT00267189|12095991|FG000|Overall Study|Death|1
7678835|NCT00267189|12095992|FG001|Overall Study|Death|0
7678836|NCT00267189|12095991|FG000|Overall Study|Missing|3
7678837|NCT00267189|12095992|FG001|Overall Study|Missing|0
7678838|NCT00267202|12096000|FG000|Overall Study|Unsatisfactory therapeutic effect|21
7678839|NCT00267202|12096001|FG001|Overall Study|Unsatisfactory therapeutic effect|8
7678840|NCT00267202|12096000|FG000|Overall Study|Withdrawal by Subject|12
7678841|NCT00267202|12096001|FG001|Overall Study|Withdrawal by Subject|15
7678842|NCT00267202|12096000|FG000|Overall Study|Adverse Event|13
7678843|NCT00267202|12096001|FG001|Overall Study|Adverse Event|7
7678844|NCT00267202|12096000|FG000|Overall Study|Protocol Violation|2
7678845|NCT00267202|12096001|FG001|Overall Study|Protocol Violation|3
7678846|NCT00267202|12096000|FG000|Overall Study|Administrative problems|2
7678847|NCT00267202|12096001|FG001|Overall Study|Administrative problems|1
7678848|NCT00267202|12096000|FG000|Overall Study|Lost to Follow-up|3
7678849|NCT00267202|12096001|FG001|Overall Study|Lost to Follow-up|0
7678850|NCT00267488|12096021|FG000|Overall Study|Sponsor Terminated Study|9
7678851|NCT00267488|12096021|FG000|Overall Study|Protocol Violation|1
7678852|NCT00267488|12096021|FG000|Overall Study|Other (Disease Progression)|1
7678853|NCT00267748|12096062|FG000|Non-randomized Period|Progressive disease|10
7678854|NCT00267748|12096063|FG001|Non-randomized Period|Progressive disease|0
7678855|NCT00267748|12096064|FG002|Non-randomized Period|Progressive disease|0
7678856|NCT00267748|12096062|FG000|Non-randomized Period|Adverse Event|8
7678857|NCT00267748|12096063|FG001|Non-randomized Period|Adverse Event|0
7678858|NCT00267748|12096064|FG002|Non-randomized Period|Adverse Event|0
7678859|NCT00267748|12096062|FG000|Non-randomized Period|Death|1
7678860|NCT00267748|12096063|FG001|Non-randomized Period|Death|0
7678861|NCT00267748|12096064|FG002|Non-randomized Period|Death|0
7678862|NCT00267748|12096062|FG000|Non-randomized Period|Participant not willing to participate|1
7678863|NCT00267748|12096063|FG001|Non-randomized Period|Participant not willing to participate|0
7678864|NCT00267748|12096064|FG002|Non-randomized Period|Participant not willing to participate|0
7678865|NCT00267748|12096062|FG000|Non-randomized Period|Other|3
7678866|NCT00267748|12096063|FG001|Non-randomized Period|Other|0
7678867|NCT00267748|12096064|FG002|Non-randomized Period|Other|0
7678868|NCT00267748|12096062|FG000|Randomized Period|Death|0
7678869|NCT00267748|12096063|FG001|Randomized Period|Death|2
7678870|NCT00267748|12096064|FG002|Randomized Period|Death|3
7678871|NCT00267748|12096062|FG000|Randomized Period|Adverse Event|0
7678872|NCT00267748|12096063|FG001|Randomized Period|Adverse Event|23
7678873|NCT00267748|12096064|FG002|Randomized Period|Adverse Event|25
7678874|NCT00267748|12096062|FG000|Randomized Period|Global deterioration of health status|0
7678875|NCT00267748|12096063|FG001|Randomized Period|Global deterioration of health status|6
7678876|NCT00267748|12096064|FG002|Randomized Period|Global deterioration of health status|7
7678877|NCT00267748|12096062|FG000|Randomized Period|Lost to Follow-up|0
7678878|NCT00267748|12096063|FG001|Randomized Period|Lost to Follow-up|1
7678879|NCT00267748|12096064|FG002|Randomized Period|Lost to Follow-up|0
7678880|NCT00267748|12096062|FG000|Randomized Period|Objective progression or relapse|0
7678881|NCT00267748|12096063|FG001|Randomized Period|Objective progression or relapse|77
7678882|NCT00267748|12096064|FG002|Randomized Period|Objective progression or relapse|86
7678883|NCT00267748|12096062|FG000|Randomized Period|Withdrawal by Subject|0
7678884|NCT00267748|12096063|FG001|Randomized Period|Withdrawal by Subject|9
7678885|NCT00267748|12096064|FG002|Randomized Period|Withdrawal by Subject|2
7678886|NCT00267748|12096062|FG000|Randomized Period|Other|0
7678887|NCT00267748|12096063|FG001|Randomized Period|Other|9
7678888|NCT00267748|12096064|FG002|Randomized Period|Other|6
7678889|NCT00267748|12096062|FG000|Randomized Period|randomized but not treated|0
7678890|NCT00267748|12096063|FG001|Randomized Period|randomized but not treated|0
7678891|NCT00267748|12096064|FG002|Randomized Period|randomized but not treated|3
7678892|NCT00267865|12096080|FG000|Induction Treatment|Died before completing.|2
7678893|NCT00267865|12096080|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1
7678894|NCT00267956|12096086|FG000|Controlled Period|Adverse Event|4
7678895|NCT00267956|12096087|FG001|Controlled Period|Adverse Event|1
7678896|NCT00267956|12096088|FG002|Controlled Period|Adverse Event|0
7678897|NCT00267956|12096089|FG003|Controlled Period|Adverse Event|0
7678898|NCT00267956|12096086|FG000|Controlled Period|Lack of Efficacy|4
7678899|NCT00267956|12096087|FG001|Controlled Period|Lack of Efficacy|2
7678900|NCT00267956|12096088|FG002|Controlled Period|Lack of Efficacy|0
7678901|NCT00267956|12096089|FG003|Controlled Period|Lack of Efficacy|0
7678902|NCT00267956|12096086|FG000|Controlled Period|Lost to Follow-up|2
7678903|NCT00267956|12096087|FG001|Controlled Period|Lost to Follow-up|0
7678904|NCT00267956|12096088|FG002|Controlled Period|Lost to Follow-up|0
7678905|NCT00267956|12096089|FG003|Controlled Period|Lost to Follow-up|0
7678906|NCT00267956|12096086|FG000|Controlled Period|Withdrew consent|3
7678907|NCT00267956|12096087|FG001|Controlled Period|Withdrew consent|1
7678908|NCT00267956|12096088|FG002|Controlled Period|Withdrew consent|0
7678909|NCT00267956|12096089|FG003|Controlled Period|Withdrew consent|0
7678910|NCT00267956|12096086|FG000|After Controlled Period|Adverse Event|0
7678911|NCT00267956|12096087|FG001|After Controlled Period|Adverse Event|0
7678912|NCT00267956|12096088|FG002|After Controlled Period|Adverse Event|2
7678913|NCT00267956|12096089|FG003|After Controlled Period|Adverse Event|1
7678914|NCT00267956|12096086|FG000|After Controlled Period|Lack of Efficacy|0
7678915|NCT00267956|12096087|FG001|After Controlled Period|Lack of Efficacy|0
7678916|NCT00267956|12096088|FG002|After Controlled Period|Lack of Efficacy|1
7678917|NCT00267956|12096089|FG003|After Controlled Period|Lack of Efficacy|1
7678918|NCT00267956|12096086|FG000|After Controlled Period|Lost to Follow-up|0
7678919|NCT00267956|12096087|FG001|After Controlled Period|Lost to Follow-up|0
7678920|NCT00267956|12096088|FG002|After Controlled Period|Lost to Follow-up|1
7678921|NCT00267956|12096089|FG003|After Controlled Period|Lost to Follow-up|0
7678922|NCT00267956|12096086|FG000|After Controlled Period|Withdrew consent|0
7678923|NCT00267956|12096087|FG001|After Controlled Period|Withdrew consent|0
7678924|NCT00267956|12096088|FG002|After Controlled Period|Withdrew consent|1
7678925|NCT00267956|12096089|FG003|After Controlled Period|Withdrew consent|0
7678926|NCT00267969|12096100|FG000|Controlled Period|Adverse Event|6
7678927|NCT00267969|12096101|FG001|Controlled Period|Adverse Event|0
7678928|NCT00267969|12096102|FG002|Controlled Period|Adverse Event|2
7678929|NCT00267969|12096103|FG003|Controlled Period|Adverse Event|0
7678930|NCT00267969|12096104|FG004|Controlled Period|Adverse Event|0
7678931|NCT00267969|12096105|FG005|Controlled Period|Adverse Event|0
7678932|NCT00267969|12096106|FG006|Controlled Period|Adverse Event|0
7678933|NCT00267969|12096100|FG000|Controlled Period|Lack of Efficacy|3
7678934|NCT00267969|12096101|FG001|Controlled Period|Lack of Efficacy|0
7678935|NCT00267969|12096102|FG002|Controlled Period|Lack of Efficacy|1
7678936|NCT00267969|12096103|FG003|Controlled Period|Lack of Efficacy|0
7678937|NCT00267969|12096104|FG004|Controlled Period|Lack of Efficacy|0
7678938|NCT00267969|12096105|FG005|Controlled Period|Lack of Efficacy|0
7678939|NCT00267969|12096106|FG006|Controlled Period|Lack of Efficacy|0
7678940|NCT00267969|12096100|FG000|Controlled Period|Lost to Follow-up|1
7678941|NCT00267969|12096101|FG001|Controlled Period|Lost to Follow-up|0
7678942|NCT00267969|12096102|FG002|Controlled Period|Lost to Follow-up|1
7678943|NCT00267969|12096103|FG003|Controlled Period|Lost to Follow-up|0
7678944|NCT00267969|12096104|FG004|Controlled Period|Lost to Follow-up|0
7678945|NCT00267969|12096105|FG005|Controlled Period|Lost to Follow-up|0
7678946|NCT00267969|12096106|FG006|Controlled Period|Lost to Follow-up|0
7678947|NCT00267969|12096100|FG000|Controlled Period|Randomized but not treated|0
7678948|NCT00267969|12096101|FG001|Controlled Period|Randomized but not treated|0
7678949|NCT00267969|12096102|FG002|Controlled Period|Randomized but not treated|1
7678950|NCT00267969|12096103|FG003|Controlled Period|Randomized but not treated|0
7678951|NCT00267969|12096104|FG004|Controlled Period|Randomized but not treated|0
7678952|NCT00267969|12096105|FG005|Controlled Period|Randomized but not treated|0
7678953|NCT00267969|12096106|FG006|Controlled Period|Randomized but not treated|0
7678954|NCT00267969|12096100|FG000|Controlled Period|Other|2
7678955|NCT00267969|12096101|FG001|Controlled Period|Other|1
7678956|NCT00267969|12096102|FG002|Controlled Period|Other|6
7678957|NCT00267969|12096103|FG003|Controlled Period|Other|0
7678958|NCT00267969|12096104|FG004|Controlled Period|Other|0
7678959|NCT00267969|12096105|FG005|Controlled Period|Other|0
7678960|NCT00267969|12096106|FG006|Controlled Period|Other|0
7678961|NCT00267969|12096100|FG000|After Controlled Period|Adverse Event|0
7678962|NCT00267969|12096101|FG001|After Controlled Period|Adverse Event|0
7678963|NCT00267969|12096102|FG002|After Controlled Period|Adverse Event|0
7678964|NCT00267969|12096103|FG003|After Controlled Period|Adverse Event|7
7678965|NCT00267969|12096104|FG004|After Controlled Period|Adverse Event|8
7678966|NCT00267969|12096105|FG005|After Controlled Period|Adverse Event|23
7678967|NCT00267969|12096106|FG006|After Controlled Period|Adverse Event|21
7678968|NCT00267969|12096100|FG000|After Controlled Period|Death|0
7678969|NCT00267969|12096101|FG001|After Controlled Period|Death|0
7678970|NCT00267969|12096102|FG002|After Controlled Period|Death|0
7678971|NCT00267969|12096103|FG003|After Controlled Period|Death|1
7678972|NCT00267969|12096104|FG004|After Controlled Period|Death|2
7678973|NCT00267969|12096105|FG005|After Controlled Period|Death|0
7678974|NCT00267969|12096106|FG006|After Controlled Period|Death|1
7678975|NCT00267969|12096100|FG000|After Controlled Period|Lack of Efficacy|0
7678976|NCT00267969|12096101|FG001|After Controlled Period|Lack of Efficacy|0
7678977|NCT00267969|12096102|FG002|After Controlled Period|Lack of Efficacy|0
7678978|NCT00267969|12096103|FG003|After Controlled Period|Lack of Efficacy|10
7678979|NCT00267969|12096104|FG004|After Controlled Period|Lack of Efficacy|6
7678980|NCT00267969|12096105|FG005|After Controlled Period|Lack of Efficacy|28
7678981|NCT00267969|12096106|FG006|After Controlled Period|Lack of Efficacy|15
7678982|NCT00267969|12096100|FG000|After Controlled Period|Lost to Follow-up|0
7678983|NCT00267969|12096101|FG001|After Controlled Period|Lost to Follow-up|0
7678984|NCT00267969|12096102|FG002|After Controlled Period|Lost to Follow-up|0
7678985|NCT00267969|12096103|FG003|After Controlled Period|Lost to Follow-up|5
7678986|NCT00267969|12096104|FG004|After Controlled Period|Lost to Follow-up|8
7678987|NCT00267969|12096105|FG005|After Controlled Period|Lost to Follow-up|9
7678988|NCT00267969|12096106|FG006|After Controlled Period|Lost to Follow-up|10
7678989|NCT00267969|12096100|FG000|After Controlled Period|Other|0
7678990|NCT00267969|12096101|FG001|After Controlled Period|Other|0
7678991|NCT00267969|12096102|FG002|After Controlled Period|Other|0
7678992|NCT00267969|12096103|FG003|After Controlled Period|Other|13
7678993|NCT00267969|12096104|FG004|After Controlled Period|Other|11
7678994|NCT00267969|12096105|FG005|After Controlled Period|Other|22
7678995|NCT00267969|12096106|FG006|After Controlled Period|Other|25
7678996|NCT00268203|12096124|FG000|Overall Study|Lost to Follow-up|92
7678997|NCT00268203|12096124|FG000|Overall Study|Withdrawal by Subject|9
7678998|NCT00268203|12096124|FG000|Overall Study|Received Other NHL Therapy|7
7678999|NCT00268203|12096124|FG000|Overall Study|Progressive Disease|359
7679000|NCT00268203|12096124|FG000|Overall Study|Death|84
7679001|NCT00268203|12096124|FG000|Overall Study|Reason Not Specified|34
7679002|NCT00268203|12096124|FG000|Overall Study|Completed 2 Years of Follow-up|62
7679003|NCT00268242|12096128|FG000|Overall Study|Death|1
7679004|NCT00268346|12096134|FG000|Overall Study|Adverse Event|0
7679005|NCT00268346|12096135|FG001|Overall Study|Adverse Event|1
7679006|NCT00268346|12096134|FG000|Overall Study|Death|0
7679007|NCT00268346|12096135|FG001|Overall Study|Death|1
7679008|NCT00268346|12096134|FG000|Overall Study|Withdrawal by Subject|0
7679009|NCT00268346|12096135|FG001|Overall Study|Withdrawal by Subject|1
7679010|NCT00268437|12096141|FG000|Overall Study|Ineligible|1
7679011|NCT00268892|12096153|FG000|Overall Study|Adverse Event|14
7679012|NCT00268892|12096154|FG001|Overall Study|Adverse Event|17
7679013|NCT00268892|12096155|FG002|Overall Study|Adverse Event|20
7679014|NCT00268892|12096153|FG000|Overall Study|Lack of Efficacy|1
7679015|NCT00268892|12096154|FG001|Overall Study|Lack of Efficacy|3
7679016|NCT00268892|12096155|FG002|Overall Study|Lack of Efficacy|0
7679017|NCT00268892|12096153|FG000|Overall Study|Withdrawal by Subject|14
7679018|NCT00268892|12096154|FG001|Overall Study|Withdrawal by Subject|15
7679019|NCT00268892|12096155|FG002|Overall Study|Withdrawal by Subject|13
7679020|NCT00268892|12096153|FG000|Overall Study|Physician Decision|0
7679021|NCT00268892|12096154|FG001|Overall Study|Physician Decision|1
7679022|NCT00268892|12096155|FG002|Overall Study|Physician Decision|0
7679023|NCT00268892|12096153|FG000|Overall Study|Lost to Follow-up|5
7679024|NCT00268892|12096154|FG001|Overall Study|Lost to Follow-up|2
7679025|NCT00268892|12096155|FG002|Overall Study|Lost to Follow-up|4
7679026|NCT00268892|12096153|FG000|Overall Study|Protocol Violation|0
7679027|NCT00268892|12096154|FG001|Overall Study|Protocol Violation|1
7679028|NCT00268892|12096155|FG002|Overall Study|Protocol Violation|0
7679029|NCT00268892|12096153|FG000|Overall Study|Disease Progression|1
7679030|NCT00268892|12096154|FG001|Overall Study|Disease Progression|1
7679031|NCT00268892|12096155|FG002|Overall Study|Disease Progression|0
7679032|NCT00268892|12096153|FG000|Overall Study|Trial Site Closed|4
7679033|NCT00268892|12096154|FG001|Overall Study|Trial Site Closed|2
7679034|NCT00268892|12096155|FG002|Overall Study|Trial Site Closed|2
7679035|NCT00268905|12096166|FG000|Overall Study|Adverse Event|3
7679036|NCT00268905|12096167|FG001|Overall Study|Adverse Event|0
7679037|NCT00268905|12096168|FG002|Overall Study|Adverse Event|4
7679038|NCT00268905|12096166|FG000|Overall Study|Lost to Follow-up|0
7679039|NCT00268905|12096167|FG001|Overall Study|Lost to Follow-up|1
7679040|NCT00268905|12096168|FG002|Overall Study|Lost to Follow-up|0
7679041|NCT00268905|12096166|FG000|Overall Study|Withdrawal by Subject|0
7679042|NCT00268905|12096167|FG001|Overall Study|Withdrawal by Subject|0
7679043|NCT00268905|12096168|FG002|Overall Study|Withdrawal by Subject|3
7679044|NCT00268905|12096166|FG000|Overall Study|Progressive Disease|28
7679045|NCT00268905|12096167|FG001|Overall Study|Progressive Disease|4
7679046|NCT00268905|12096168|FG002|Overall Study|Progressive Disease|3
7679047|NCT00268905|12096166|FG000|Overall Study|Physician Decision|3
7679048|NCT00268905|12096167|FG001|Overall Study|Physician Decision|0
7679049|NCT00268905|12096168|FG002|Overall Study|Physician Decision|1
7679050|NCT00268905|12096166|FG000|Overall Study|Clinical Progression|9
7679051|NCT00268905|12096167|FG001|Overall Study|Clinical Progression|4
7679052|NCT00268905|12096168|FG002|Overall Study|Clinical Progression|1
7679053|NCT00268983|12096178|FG000|Overall Study|Death|3
7679054|NCT00268983|12096179|FG001|Overall Study|Death|0
7679055|NCT00268996|12096187|FG000|Overall Study|Adverse Event|11
7679056|NCT00268996|12096188|FG001|Overall Study|Adverse Event|7
7679057|NCT00268996|12096187|FG000|Overall Study|Lost to Follow-up|3
7679058|NCT00268996|12096188|FG001|Overall Study|Lost to Follow-up|1
7679059|NCT00268996|12096187|FG000|Overall Study|Withdrawal by Subject|5
7679060|NCT00268996|12096188|FG001|Overall Study|Withdrawal by Subject|11
7679061|NCT00268996|12096187|FG000|Overall Study|Non-compliance|1
7679062|NCT00268996|12096188|FG001|Overall Study|Non-compliance|0
7679063|NCT00268996|12096187|FG000|Overall Study|Other|1
7679064|NCT00268996|12096188|FG001|Overall Study|Other|1
7679065|NCT00269087|12096196|FG000|Overall Study|Adverse Event|20
7679066|NCT00269087|12096196|FG000|Overall Study|Withdrawal by Subject|1
7679067|NCT00269087|12096196|FG000|Overall Study|Exacerbation of COPD|13
7679068|NCT00269113|12096202|FG000|Overall Study|Adverse Event|14
7679069|NCT00269113|12096203|FG001|Overall Study|Adverse Event|7
7679070|NCT00269113|12096202|FG000|Overall Study|Lack of Efficacy|35
7679071|NCT00269113|12096203|FG001|Overall Study|Lack of Efficacy|18
7679072|NCT00269113|12096202|FG000|Overall Study|Early Improvement|2
7679073|NCT00269113|12096203|FG001|Overall Study|Early Improvement|0
7679074|NCT00269113|12096202|FG000|Overall Study|Withdrawal by Subject|0
7679075|NCT00269113|12096203|FG001|Overall Study|Withdrawal by Subject|2
7679076|NCT00269113|12096202|FG000|Overall Study|Death|6
7679077|NCT00269113|12096203|FG001|Overall Study|Death|2
7679078|NCT00269113|12096202|FG000|Overall Study|Lost to Follow-up|2
7679079|NCT00269113|12096203|FG001|Overall Study|Lost to Follow-up|1
7679080|NCT00269113|12096202|FG000|Overall Study|Protocol Violation|15
7679081|NCT00269113|12096203|FG001|Overall Study|Protocol Violation|5
7679082|NCT00269113|12096202|FG000|Overall Study|Other|0
7679083|NCT00269113|12096203|FG001|Overall Study|Other|2
7679084|NCT00269152|12096211|FG000|Overall Study|Adverse Event|9
7679085|NCT00269152|12096212|FG001|Overall Study|Adverse Event|3
7679086|NCT00269152|12096211|FG000|Overall Study|Withdrawal by Subject|7
7679087|NCT00269152|12096212|FG001|Overall Study|Withdrawal by Subject|3
7679088|NCT00269152|12096211|FG000|Overall Study|Physician Decision|2
7679089|NCT00269152|12096212|FG001|Overall Study|Physician Decision|3
7679090|NCT00269152|12096211|FG000|Overall Study|Protocol Violation|0
7679091|NCT00269152|12096212|FG001|Overall Study|Protocol Violation|1
7679092|NCT00269399|12096220|FG000|Overall Study|Lack of Efficacy|27
7679093|NCT00269399|12096221|FG001|Overall Study|Lack of Efficacy|10
7679094|NCT00269399|12096220|FG000|Overall Study|Adverse Event|10
7679095|NCT00269399|12096221|FG001|Overall Study|Adverse Event|4
7679096|NCT00269399|12096220|FG000|Overall Study|Withdrawal by Subject|2
7679097|NCT00269399|12096221|FG001|Overall Study|Withdrawal by Subject|5
7679098|NCT00269399|12096220|FG000|Overall Study|Negative Lab Result for C. difficile|2
7679099|NCT00269399|12096221|FG001|Overall Study|Negative Lab Result for C. difficile|3
7679100|NCT00269399|12096220|FG000|Overall Study|Other|0
7679101|NCT00269399|12096221|FG001|Overall Study|Other|4
7679102|NCT00269399|12096220|FG000|Overall Study|Development of exclusion criteria|0
7679103|NCT00269399|12096221|FG001|Overall Study|Development of exclusion criteria|1
7679104|NCT00269477|12096231|FG000|Overall Study|Protocol Violation|5
7679105|NCT00269477|12096232|FG001|Overall Study|Protocol Violation|5
7679106|NCT00269477|12096233|FG002|Overall Study|Protocol Violation|1
7679107|NCT00269477|12096234|FG003|Overall Study|Protocol Violation|0
7679108|NCT00269477|12096231|FG000|Overall Study|Missed post-vaccination blood draw|0
7679109|NCT00269477|12096232|FG001|Overall Study|Missed post-vaccination blood draw|1
7679110|NCT00269477|12096233|FG002|Overall Study|Missed post-vaccination blood draw|0
7679111|NCT00269477|12096234|FG003|Overall Study|Missed post-vaccination blood draw|0
7679112|NCT00269633|12096246|FG000|Overall Study|Withdrawal by Subject|1
7679113|NCT00269633|12096247|FG001|Overall Study|Withdrawal by Subject|0
7679114|NCT00269919|12096253|FG000|Overall Study|Other|26
7679115|NCT00269919|12096253|FG000|Overall Study|Started but not treated|1
7679116|NCT00270205|12096262|FG000|Overall Study|Lost to Follow-up|1
7679117|NCT00270205|12096263|FG001|Overall Study|Lost to Follow-up|0
7679118|NCT00270205|12096264|FG002|Overall Study|Lost to Follow-up|0
7679119|NCT00270205|12096265|FG003|Overall Study|Lost to Follow-up|1
7679120|NCT00270231|12096275|FG000|First Intervention|Lost to Follow-up|1
7679121|NCT00270231|12096276|FG001|First Intervention|Lost to Follow-up|1
7679122|NCT00270231|12096275|FG000|Washout Period|Lost to Follow-up|1
7679123|NCT00270231|12096276|FG001|Washout Period|Lost to Follow-up|0
7679124|NCT00270231|12096275|FG000|Second Intervention|Lost to Follow-up|0
7679125|NCT00270231|12096276|FG001|Second Intervention|Lost to Follow-up|1
7679126|NCT00270257|12096284|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
7679127|NCT00270257|12096285|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
7679128|NCT00270855|12096346|FG000|Overall Study|Withdrawal by Subject|8
7679129|NCT00270855|12096347|FG001|Overall Study|Withdrawal by Subject|8
7679130|NCT00270894|12096355|FG000|Overall Study|Adverse Event|1
7679131|NCT00270894|12096355|FG000|Overall Study|Withdrawal by Subject|1
7679132|NCT00270998|12096362|FG000|3 Month Follow-up|Adverse Event|1
7679133|NCT00270998|12096363|FG001|3 Month Follow-up|Adverse Event|0
7679134|NCT00270998|12096364|FG002|3 Month Follow-up|Adverse Event|0
7679135|NCT00270998|12096362|FG000|3 Month Follow-up|Lack of Efficacy|1
7679136|NCT00270998|12096363|FG001|3 Month Follow-up|Lack of Efficacy|2
7679137|NCT00270998|12096364|FG002|3 Month Follow-up|Lack of Efficacy|1
7679138|NCT00270998|12096362|FG000|3 Month Follow-up|Withdrawal by Subject|11
7679139|NCT00270998|12096363|FG001|3 Month Follow-up|Withdrawal by Subject|14
7679140|NCT00270998|12096364|FG002|3 Month Follow-up|Withdrawal by Subject|15
7679141|NCT00270998|12096362|FG000|3 Month Follow-up|Pessary did not fit|12
7679142|NCT00270998|12096363|FG001|3 Month Follow-up|Pessary did not fit|0
7679143|NCT00270998|12096364|FG002|3 Month Follow-up|Pessary did not fit|0
7679144|NCT00270998|12096362|FG000|3 Month Follow-up|Personal/family health|1
7679145|NCT00270998|12096363|FG001|3 Month Follow-up|Personal/family health|1
7679146|NCT00270998|12096364|FG002|3 Month Follow-up|Personal/family health|0
7679147|NCT00270998|12096362|FG000|3 Month Follow-up|Received/desired alternate treatment|13
7679148|NCT00270998|12096363|FG001|3 Month Follow-up|Received/desired alternate treatment|5
7679149|NCT00270998|12096364|FG002|3 Month Follow-up|Received/desired alternate treatment|2
7679150|NCT00270998|12096362|FG000|12 Month Follow-up|Lack of Efficacy|5
7679151|NCT00270998|12096363|FG001|12 Month Follow-up|Lack of Efficacy|4
7679152|NCT00270998|12096364|FG002|12 Month Follow-up|Lack of Efficacy|3
7679153|NCT00270998|12096362|FG000|12 Month Follow-up|Withdrawal by Subject|7
7679154|NCT00270998|12096363|FG001|12 Month Follow-up|Withdrawal by Subject|12
7679155|NCT00270998|12096364|FG002|12 Month Follow-up|Withdrawal by Subject|16
7679156|NCT00270998|12096362|FG000|12 Month Follow-up|Pessary did not fit|1
7679157|NCT00270998|12096363|FG001|12 Month Follow-up|Pessary did not fit|0
7679158|NCT00270998|12096364|FG002|12 Month Follow-up|Pessary did not fit|0
7679159|NCT00270998|12096362|FG000|12 Month Follow-up|Personal/family health|0
7679160|NCT00270998|12096363|FG001|12 Month Follow-up|Personal/family health|5
7679161|NCT00270998|12096364|FG002|12 Month Follow-up|Personal/family health|1
7679162|NCT00270998|12096362|FG000|12 Month Follow-up|Received/desired alternate treatment|1
7679163|NCT00270998|12096363|FG001|12 Month Follow-up|Received/desired alternate treatment|4
7679164|NCT00270998|12096364|FG002|12 Month Follow-up|Received/desired alternate treatment|1
7679165|NCT00271024|12096378|FG000|Overall Study|Lost Interest|3
7679166|NCT00271024|12096379|FG001|Overall Study|Lost Interest|4
7679167|NCT00271024|12096380|FG002|Overall Study|Lost Interest|2
7679168|NCT00271024|12096381|FG003|Overall Study|Lost Interest|3
7679169|NCT00271024|12096378|FG000|Overall Study|Unknown/Unspecified|11
7679170|NCT00271024|12096379|FG001|Overall Study|Unknown/Unspecified|11
7679171|NCT00271024|12096380|FG002|Overall Study|Unknown/Unspecified|8
7679172|NCT00271024|12096381|FG003|Overall Study|Unknown/Unspecified|4
7679173|NCT00271024|12096378|FG000|Overall Study|Protocol Violation|1
7679174|NCT00271024|12096379|FG001|Overall Study|Protocol Violation|6
7679175|NCT00271024|12096380|FG002|Overall Study|Protocol Violation|5
7679176|NCT00271024|12096381|FG003|Overall Study|Protocol Violation|11
7679177|NCT00271024|12096378|FG000|Overall Study|Unpleasant Reaction To Tablet|1
7679178|NCT00271024|12096379|FG001|Overall Study|Unpleasant Reaction To Tablet|3
7679179|NCT00271024|12096380|FG002|Overall Study|Unpleasant Reaction To Tablet|4
7679180|NCT00271024|12096381|FG003|Overall Study|Unpleasant Reaction To Tablet|2
7679181|NCT00271024|12096378|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6
7679182|NCT00271024|12096379|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2
7679183|NCT00271024|12096380|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4
7679184|NCT00271024|12096381|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4
7679185|NCT00271505|12096428|FG000|Overall Study|Screen Failure|3
7679186|NCT00271505|12096428|FG000|Overall Study|Adverse Event|1
7679187|NCT00271505|12096428|FG000|Overall Study|Death|1
7679188|NCT00271596|12096444|FG000|Overall Study|Protocol Violation|1
7679189|NCT00271596|12096445|FG001|Overall Study|Protocol Violation|0
7679190|NCT00271596|12096444|FG000|Overall Study|Withdrawal by Subject|0
7679191|NCT00271596|12096445|FG001|Overall Study|Withdrawal by Subject|1
7679192|NCT00271609|12096453|FG000|Overall Study|Adverse Event|11
7679193|NCT00271609|12096454|FG001|Overall Study|Adverse Event|3
7679194|NCT00271609|12096453|FG000|Overall Study|Withdrawal by Subject|2
7679195|NCT00271609|12096454|FG001|Overall Study|Withdrawal by Subject|0
7679196|NCT00271856|12096471|FG000|Overall Study|Withdrawal by Subject|1
7679197|NCT00271856|12096472|FG001|Overall Study|Withdrawal by Subject|7
7679198|NCT00271856|12096471|FG000|Overall Study|Lost to Follow-up|10
7679199|NCT00271856|12096472|FG001|Overall Study|Lost to Follow-up|11
7679200|NCT00272038|12096478|FG000|Overall Study|withdrew before they received 2 cycles|7
7679201|NCT00272779|12096536|FG000|Baseline Through Week 48|Adverse event before Week 48|10
7679202|NCT00272779|12096537|FG001|Baseline Through Week 48|Adverse event before Week 48|14
7679203|NCT00272779|12096536|FG000|Baseline Through Week 48|Death before Week 48|4
7679204|NCT00272779|12096537|FG001|Baseline Through Week 48|Death before Week 48|4
7679205|NCT00272779|12096536|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5
7679206|NCT00272779|12096537|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8
7679207|NCT00272779|12096536|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6
7679208|NCT00272779|12096537|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6
7679209|NCT00272779|12096536|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1
7679210|NCT00272779|12096537|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0
7679211|NCT00272779|12096536|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6
7679212|NCT00272779|12096537|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9
7679213|NCT00272779|12096536|FG000|Baseline Through Week 48|Pregnancy before Week 48|2
7679214|NCT00272779|12096537|FG001|Baseline Through Week 48|Pregnancy before Week 48|2
7679215|NCT00272779|12096536|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1
7679216|NCT00272779|12096537|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0
7679217|NCT00272779|12096536|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4
7679218|NCT00272779|12096537|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13
7679219|NCT00272779|12096536|FG000|Baseline Through Week 48|Participant's decision before wk 48|0
7679220|NCT00272779|12096537|FG001|Baseline Through Week 48|Participant's decision before wk 48|1
7679221|NCT00272779|12096536|FG000|Baseline Through Week 48|Chose different site before wk 48|0
7679222|NCT00272779|12096537|FG001|Baseline Through Week 48|Chose different site before wk 48|1
7679223|NCT00272779|12096536|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1
7679224|NCT00272779|12096537|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1
7679225|NCT00272779|12096536|FG000|Baseline Through Week 48|Death on/after Week 48|1
7679226|NCT00272779|12096537|FG001|Baseline Through Week 48|Death on/after Week 48|1
7679227|NCT00272779|12096536|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
7679228|NCT00272779|12096537|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
7679229|NCT00272779|12096536|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2
7679230|NCT00272779|12096537|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2
7679231|NCT00272779|12096536|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
7679232|NCT00272779|12096537|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
7679233|NCT00272779|12096536|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1
7679234|NCT00272779|12096537|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2
7679235|NCT00272779|12096536|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0
7679236|NCT00272779|12096537|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2
7679237|NCT00272779|12096536|FG000|Baseline Through Week 48|Continuing treatment|385
7679238|NCT00272779|12096537|FG001|Baseline Through Week 48|Continuing treatment|368
7679239|NCT00272779|12096536|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
7679240|NCT00272779|12096537|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
7679241|NCT00272779|12096536|FG000|Baseline Through Week 48|Never treated|2
7679242|NCT00272779|12096537|FG001|Baseline Through Week 48|Never treated|3
7679243|NCT00272779|12096536|FG000|Baseline Through Week 96|Adverse event before Week 96|13
7679244|NCT00272779|12096537|FG001|Baseline Through Week 96|Adverse event before Week 96|22
7679245|NCT00272779|12096536|FG000|Baseline Through Week 96|Death before Week 96|6
7679246|NCT00272779|12096537|FG001|Baseline Through Week 96|Death before Week 96|5
7679247|NCT00272779|12096536|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16
7679248|NCT00272779|12096537|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10
7679249|NCT00272779|12096536|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10
7679250|NCT00272779|12096537|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13
7679251|NCT00272779|12096536|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1
7679252|NCT00272779|12096537|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0
7679253|NCT00272779|12096536|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12
7679254|NCT00272779|12096537|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16
7679255|NCT00272779|12096536|FG000|Baseline Through Week 96|Pregnancy before Week 96|5
7679256|NCT00272779|12096537|FG001|Baseline Through Week 96|Pregnancy before Week 96|7
7679257|NCT00272779|12096536|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4
7679258|NCT00272779|12096537|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3
7679259|NCT00272779|12096536|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5
7679260|NCT00272779|12096537|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18
7679261|NCT00272779|12096536|FG000|Baseline Through Week 96|Changed address before Week 96|0
7679262|NCT00272779|12096537|FG001|Baseline Through Week 96|Changed address before Week 96|1
7679263|NCT00272779|12096536|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1
7679264|NCT00272779|12096537|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0
7679265|NCT00272779|12096536|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2
7679266|NCT00272779|12096537|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0
7679267|NCT00272779|12096536|FG000|Baseline Through Week 96|Pregnancy at Week 96|1
7679268|NCT00272779|12096537|FG001|Baseline Through Week 96|Pregnancy at Week 96|0
7679269|NCT00272779|12096536|FG000|Baseline Through Week 96|Never treated|2
7679270|NCT00272779|12096537|FG001|Baseline Through Week 96|Never treated|3
7679271|NCT00272779|12096536|FG000|Baseline Through Week 96|Continuing on treatment|61
7679272|NCT00272779|12096537|FG001|Baseline Through Week 96|Continuing on treatment|38
7679273|NCT00272792|12096546|FG000|Part 1: Responsiveness|Lost to Follow-up|1
7679274|NCT00272792|12096547|FG001|Part 1: Responsiveness|Lost to Follow-up|0
7679275|NCT00272792|12096546|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
7679276|NCT00272792|12096547|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
7679277|NCT00272792|12096546|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
7679278|NCT00272792|12096547|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
7679279|NCT00272792|12096546|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
7679280|NCT00272792|12096547|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
7679281|NCT00272844|12096553|FG000|Overall Study|Withdrawal by Subject|5
7679282|NCT00272961|12096562|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
7679283|NCT00272961|12096563|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
7679284|NCT00272961|12096564|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
7679285|NCT00272961|12096565|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
7679286|NCT00272961|12096566|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
7679287|NCT00272961|12096562|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
7679288|NCT00272961|12096563|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
7679289|NCT00272961|12096564|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
7679290|NCT00272961|12096565|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
7679291|NCT00272961|12096566|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
7679292|NCT00272961|12096562|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
7679293|NCT00272961|12096563|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
7679294|NCT00272961|12096564|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
7679295|NCT00272961|12096565|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
7679296|NCT00272961|12096566|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
7679297|NCT00272961|12096562|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
7679298|NCT00272961|12096563|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
7679299|NCT00272961|12096564|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
7679300|NCT00272961|12096565|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
7679301|NCT00272961|12096566|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
7679302|NCT00272961|12096562|FG000|Placebo Run-in Phase: Up to Week 2|Other|2
7679303|NCT00272961|12096563|FG001|Placebo Run-in Phase: Up to Week 2|Other|0
7679304|NCT00272961|12096564|FG002|Placebo Run-in Phase: Up to Week 2|Other|0
7679305|NCT00272961|12096565|FG003|Placebo Run-in Phase: Up to Week 2|Other|0
7679306|NCT00272961|12096566|FG004|Placebo Run-in Phase: Up to Week 2|Other|0
7679307|NCT00272961|12096562|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
7679308|NCT00272961|12096563|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
7679309|NCT00272961|12096564|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
7679310|NCT00272961|12096565|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
7679311|NCT00272961|12096566|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
7679312|NCT00272961|12096562|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
7679313|NCT00272961|12096563|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
7679314|NCT00272961|12096564|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
7679315|NCT00272961|12096565|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
7679316|NCT00272961|12096566|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
7679317|NCT00272961|12096562|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1
7679318|NCT00272961|12096563|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3
7679319|NCT00272961|12096564|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3
7679320|NCT00272961|12096565|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2
7679321|NCT00272961|12096566|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2
7679322|NCT00272987|12096581|FG000|Overall Study|Adverse Event|1
7679323|NCT00272987|12096582|FG001|Overall Study|Adverse Event|0
7679324|NCT00272987|12096583|FG002|Overall Study|Adverse Event|0
7679325|NCT00272987|12096581|FG000|Overall Study|Lost to Follow-up|3
7679326|NCT00272987|12096582|FG001|Overall Study|Lost to Follow-up|1
7679327|NCT00272987|12096583|FG002|Overall Study|Lost to Follow-up|1
7679328|NCT00272987|12096581|FG000|Overall Study|Withdrawal by Subject|1
7679329|NCT00272987|12096582|FG001|Overall Study|Withdrawal by Subject|0
7679330|NCT00272987|12096583|FG002|Overall Study|Withdrawal by Subject|3
7679331|NCT00272987|12096581|FG000|Overall Study|Sponsor Terminated study|0
7679332|NCT00272987|12096582|FG001|Overall Study|Sponsor Terminated study|1
7679333|NCT00272987|12096583|FG002|Overall Study|Sponsor Terminated study|1
7679334|NCT00272987|12096581|FG000|Overall Study|Disease progression|1
7679335|NCT00272987|12096582|FG001|Overall Study|Disease progression|1
7679336|NCT00272987|12096583|FG002|Overall Study|Disease progression|2
7679337|NCT00272987|12096581|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2
7679338|NCT00272987|12096582|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1
7679339|NCT00272987|12096583|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4
7679340|NCT00272987|12096581|FG000|Overall Study|Death|1
7679341|NCT00272987|12096582|FG001|Overall Study|Death|0
7679342|NCT00272987|12096583|FG002|Overall Study|Death|0
7679343|NCT00273052|12096593|FG000|Overall Study|Withdrawal by Subject|16
7679344|NCT00273052|12096594|FG001|Overall Study|Withdrawal by Subject|19
7679345|NCT00273052|12096593|FG000|Overall Study|Adverse Event|21
7679346|NCT00273052|12096594|FG001|Overall Study|Adverse Event|19
7679347|NCT00273052|12096593|FG000|Overall Study|Protocol Violation|14
7679348|NCT00273052|12096594|FG001|Overall Study|Protocol Violation|18
7679349|NCT00273052|12096593|FG000|Overall Study|Lost to Follow-up|7
7679350|NCT00273052|12096594|FG001|Overall Study|Lost to Follow-up|25
7679351|NCT00273052|12096593|FG000|Overall Study|Lack of Efficacy|6
7679352|NCT00273052|12096594|FG001|Overall Study|Lack of Efficacy|4
7679353|NCT00273052|12096593|FG000|Overall Study|Non-Compliance|3
7679354|NCT00273052|12096594|FG001|Overall Study|Non-Compliance|1
7679355|NCT00273052|12096593|FG000|Overall Study|Other|2
7679356|NCT00273052|12096594|FG001|Overall Study|Other|0
7679357|NCT00273052|12096593|FG000|Overall Study|Worsening serum lipid levels|0
7679358|NCT00273052|12096594|FG001|Overall Study|Worsening serum lipid levels|2
7679359|NCT00273182|12096600|FG000|Overall Study|Death|450
7679360|NCT00273182|12096600|FG000|Overall Study|Lost to Follow-up|88
7679361|NCT00273182|12096600|FG000|Overall Study|Withdrawal by Subject|257
7679362|NCT00273182|12096600|FG000|Overall Study|Device/System Explant|154
7679363|NCT00273182|12096600|FG000|Overall Study|Site exit, system change, 36 m FU missed|36
7679364|NCT00273858|12096648|FG000|Overall Study|Not completed 24 month observation time|334
7679365|NCT00273858|12096648|FG000|Overall Study|Lost to Follow-up|101
7679366|NCT00273858|12096648|FG000|Overall Study|Withdrawal by Subject|21
7679367|NCT00273858|12096648|FG000|Overall Study|Adverse Event|81
7679368|NCT00274261|12096679|FG000|Overall Study|Adverse Event|19
7679369|NCT00274261|12096680|FG001|Overall Study|Adverse Event|11
7679370|NCT00274261|12096679|FG000|Overall Study|Pregnancy|114
7679371|NCT00274261|12096680|FG001|Overall Study|Pregnancy|83
7679372|NCT00274261|12096679|FG000|Overall Study|Withdrawal by Subject|179
7679373|NCT00274261|12096680|FG001|Overall Study|Withdrawal by Subject|126
7679374|NCT00274261|12096679|FG000|Overall Study|Protocol Violation|71
7679375|NCT00274261|12096680|FG001|Overall Study|Protocol Violation|42
7679376|NCT00274261|12096679|FG000|Overall Study|Lost to Follow-up|106
7679377|NCT00274261|12096680|FG001|Overall Study|Lost to Follow-up|75
7679378|NCT00274287|12096688|FG000|Overall Study|Withdrawal by Subject|1
7679379|NCT00274287|12096688|FG000|Overall Study|subject non-compliance|1
7679380|NCT00274456|12096697|FG000|Overall Study|Still on treatment|2
7679381|NCT00274456|12096698|FG001|Overall Study|Still on treatment|3
7679382|NCT00274456|12096699|FG002|Overall Study|Still on treatment|5
7679383|NCT00274456|12096700|FG003|Overall Study|Still on treatment|1
7679384|NCT00274456|12096697|FG000|Overall Study|Unacceptable toxicity|10
7679385|NCT00274456|12096698|FG001|Overall Study|Unacceptable toxicity|5
7679386|NCT00274456|12096699|FG002|Overall Study|Unacceptable toxicity|12
7679387|NCT00274456|12096700|FG003|Overall Study|Unacceptable toxicity|16
7679388|NCT00274456|12096697|FG000|Overall Study|Adverse Event|0
7679389|NCT00274456|12096698|FG001|Overall Study|Adverse Event|1
7679390|NCT00274456|12096699|FG002|Overall Study|Adverse Event|2
7679391|NCT00274456|12096700|FG003|Overall Study|Adverse Event|2
7679392|NCT00274456|12096697|FG000|Overall Study|Physician Decision|7
7679393|NCT00274456|12096698|FG001|Overall Study|Physician Decision|5
7679394|NCT00274456|12096699|FG002|Overall Study|Physician Decision|6
7679395|NCT00274456|12096700|FG003|Overall Study|Physician Decision|13
7679396|NCT00274456|12096697|FG000|Overall Study|Lost to Follow-up|0
7679397|NCT00274456|12096698|FG001|Overall Study|Lost to Follow-up|0
7679398|NCT00274456|12096699|FG002|Overall Study|Lost to Follow-up|1
7679399|NCT00274456|12096700|FG003|Overall Study|Lost to Follow-up|0
7679400|NCT00274456|12096697|FG000|Overall Study|Withdrawal by Subject|18
7679401|NCT00274456|12096698|FG001|Overall Study|Withdrawal by Subject|13
7679402|NCT00274456|12096699|FG002|Overall Study|Withdrawal by Subject|9
7679403|NCT00274456|12096700|FG003|Overall Study|Withdrawal by Subject|13
7679404|NCT00274469|12096712|FG000|Overall Study|Death|63
7679405|NCT00274469|12096713|FG001|Overall Study|Death|74
7679406|NCT00274469|12096712|FG000|Overall Study|Did not consent to OS follow-up|16
7679407|NCT00274469|12096713|FG001|Overall Study|Did not consent to OS follow-up|19
7679408|NCT00274625|12096721|FG000|Overall Study|Lost to Follow-up|46
7679409|NCT00274625|12096722|FG001|Overall Study|Lost to Follow-up|54
7679410|NCT00274625|12096721|FG000|Overall Study|Excluded from analysis|14
7679411|NCT00274625|12096722|FG001|Overall Study|Excluded from analysis|8
7679412|NCT00274651|12096730|FG000|Overall Study|Adverse Event|6
7679413|NCT00274651|12096731|FG001|Overall Study|Adverse Event|3
7679414|NCT00274651|12096730|FG000|Overall Study|Lack of Efficacy|13
7679415|NCT00274651|12096731|FG001|Overall Study|Lack of Efficacy|6
7679416|NCT00274651|12096730|FG000|Overall Study|Death|1
7679417|NCT00274651|12096731|FG001|Overall Study|Death|3
7679418|NCT00274651|12096730|FG000|Overall Study|Withdrawal by Subject|0
7679419|NCT00274651|12096731|FG001|Overall Study|Withdrawal by Subject|1
7679420|NCT00274651|12096730|FG000|Overall Study|Physician Decision|8
7679421|NCT00274651|12096731|FG001|Overall Study|Physician Decision|7
7679422|NCT00274716|12096744|FG000|Phase A|Other non-reported reason|4
7679423|NCT00274716|12096745|FG001|Phase A|Other non-reported reason|2
7679424|NCT00274716|12096746|FG002|Phase A|Other non-reported reason|1
7679425|NCT00274716|12096747|FG003|Phase A|Other non-reported reason|2
7679426|NCT00274716|12096748|FG004|Phase A|Other non-reported reason|0
7679427|NCT00274716|12096749|FG005|Phase A|Other non-reported reason|1
7679428|NCT00274716|12096744|FG000|Phase A|Participant moved|0
7679429|NCT00274716|12096745|FG001|Phase A|Participant moved|0
7679430|NCT00274716|12096746|FG002|Phase A|Participant moved|1
7679431|NCT00274716|12096747|FG003|Phase A|Participant moved|0
7679432|NCT00274716|12096748|FG004|Phase A|Participant moved|0
7679433|NCT00274716|12096749|FG005|Phase A|Participant moved|1
7679434|NCT00274716|12096744|FG000|Phase A|Site Terminated|0
7679435|NCT00274716|12096745|FG001|Phase A|Site Terminated|0
7679436|NCT00274716|12096746|FG002|Phase A|Site Terminated|0
7679437|NCT00274716|12096747|FG003|Phase A|Site Terminated|1
7679438|NCT00274716|12096748|FG004|Phase A|Site Terminated|0
7679439|NCT00274716|12096749|FG005|Phase A|Site Terminated|0
7679440|NCT00274716|12096744|FG000|Phase A|Protocol Violation|1
7679441|NCT00274716|12096745|FG001|Phase A|Protocol Violation|0
7679442|NCT00274716|12096746|FG002|Phase A|Protocol Violation|0
7679443|NCT00274716|12096747|FG003|Phase A|Protocol Violation|1
7679444|NCT00274716|12096748|FG004|Phase A|Protocol Violation|0
7679445|NCT00274716|12096749|FG005|Phase A|Protocol Violation|0
7679446|NCT00274716|12096744|FG000|Phase A|Met criteria for discontinuation|1
7679447|NCT00274716|12096745|FG001|Phase A|Met criteria for discontinuation|1
7679448|NCT00274716|12096746|FG002|Phase A|Met criteria for discontinuation|0
7679449|NCT00274716|12096747|FG003|Phase A|Met criteria for discontinuation|0
7679450|NCT00274716|12096748|FG004|Phase A|Met criteria for discontinuation|0
7679451|NCT00274716|12096749|FG005|Phase A|Met criteria for discontinuation|0
7679452|NCT00274716|12096744|FG000|Phase A|Withdrawal by Subject|2
7679453|NCT00274716|12096745|FG001|Phase A|Withdrawal by Subject|2
7679454|NCT00274716|12096746|FG002|Phase A|Withdrawal by Subject|1
7679455|NCT00274716|12096747|FG003|Phase A|Withdrawal by Subject|3
7679456|NCT00274716|12096748|FG004|Phase A|Withdrawal by Subject|0
7679457|NCT00274716|12096749|FG005|Phase A|Withdrawal by Subject|1
7679458|NCT00274716|12096744|FG000|Phase A|Adverse Event|2
7679459|NCT00274716|12096745|FG001|Phase A|Adverse Event|3
7679460|NCT00274716|12096746|FG002|Phase A|Adverse Event|3
7679461|NCT00274716|12096747|FG003|Phase A|Adverse Event|0
7679462|NCT00274716|12096748|FG004|Phase A|Adverse Event|2
7679463|NCT00274716|12096749|FG005|Phase A|Adverse Event|0
7679464|NCT00274716|12096744|FG000|Phase A|Completed but did not enter Phase B|1
7679465|NCT00274716|12096745|FG001|Phase A|Completed but did not enter Phase B|2
7679466|NCT00274716|12096746|FG002|Phase A|Completed but did not enter Phase B|2
7679467|NCT00274716|12096747|FG003|Phase A|Completed but did not enter Phase B|2
7679468|NCT00274716|12096748|FG004|Phase A|Completed but did not enter Phase B|1
7679469|NCT00274716|12096749|FG005|Phase A|Completed but did not enter Phase B|1
7679470|NCT00274716|12096744|FG000|Phase B|Adverse Event|0
7679471|NCT00274716|12096745|FG001|Phase B|Adverse Event|0
7679472|NCT00274716|12096746|FG002|Phase B|Adverse Event|2
7679473|NCT00274716|12096747|FG003|Phase B|Adverse Event|0
7679474|NCT00274716|12096748|FG004|Phase B|Adverse Event|0
7679475|NCT00274716|12096749|FG005|Phase B|Adverse Event|1
7679476|NCT00274716|12096744|FG000|Phase B|Protocol Violation|0
7679477|NCT00274716|12096745|FG001|Phase B|Protocol Violation|2
7679478|NCT00274716|12096746|FG002|Phase B|Protocol Violation|0
7679479|NCT00274716|12096747|FG003|Phase B|Protocol Violation|0
7679480|NCT00274716|12096748|FG004|Phase B|Protocol Violation|0
7679481|NCT00274716|12096749|FG005|Phase B|Protocol Violation|0
7679482|NCT00274716|12096744|FG000|Phase B|Withdrawal by Subject|0
7679483|NCT00274716|12096745|FG001|Phase B|Withdrawal by Subject|1
7679484|NCT00274716|12096746|FG002|Phase B|Withdrawal by Subject|0
7679485|NCT00274716|12096747|FG003|Phase B|Withdrawal by Subject|0
7679486|NCT00274716|12096748|FG004|Phase B|Withdrawal by Subject|0
7679487|NCT00274716|12096749|FG005|Phase B|Withdrawal by Subject|0
7679488|NCT00274716|12096744|FG000|Phase B|Participant moved|1
7679489|NCT00274716|12096745|FG001|Phase B|Participant moved|0
7679490|NCT00274716|12096746|FG002|Phase B|Participant moved|0
7679491|NCT00274716|12096747|FG003|Phase B|Participant moved|0
7679492|NCT00274716|12096748|FG004|Phase B|Participant moved|0
7679493|NCT00274716|12096749|FG005|Phase B|Participant moved|0
7679494|NCT00274716|12096744|FG000|Phase B|Other non-reported reason|0
7679495|NCT00274716|12096745|FG001|Phase B|Other non-reported reason|0
7679496|NCT00274716|12096746|FG002|Phase B|Other non-reported reason|1
7679497|NCT00274716|12096747|FG003|Phase B|Other non-reported reason|1
7679498|NCT00274716|12096748|FG004|Phase B|Other non-reported reason|0
7679499|NCT00274716|12096749|FG005|Phase B|Other non-reported reason|0
7679500|NCT00274716|12096744|FG000|Phase B|Lost to Follow-up|0
7679501|NCT00274716|12096745|FG001|Phase B|Lost to Follow-up|1
7679502|NCT00274716|12096746|FG002|Phase B|Lost to Follow-up|0
7679503|NCT00274716|12096747|FG003|Phase B|Lost to Follow-up|0
7679504|NCT00274716|12096748|FG004|Phase B|Lost to Follow-up|0
7679505|NCT00274716|12096749|FG005|Phase B|Lost to Follow-up|0
7679506|NCT00274742|12096773|FG000|Overall Study|Adverse Event|0
7679507|NCT00274742|12096774|FG001|Overall Study|Adverse Event|4
7679508|NCT00274742|12096775|FG002|Overall Study|Adverse Event|1
7679509|NCT00274742|12096776|FG003|Overall Study|Adverse Event|4
7679510|NCT00274742|12096777|FG004|Overall Study|Adverse Event|12
7679511|NCT00274742|12096778|FG005|Overall Study|Adverse Event|3
7679512|NCT00274742|12096773|FG000|Overall Study|Lost to Follow-up|0
7679513|NCT00274742|12096774|FG001|Overall Study|Lost to Follow-up|0
7679514|NCT00274742|12096775|FG002|Overall Study|Lost to Follow-up|0
7679515|NCT00274742|12096776|FG003|Overall Study|Lost to Follow-up|0
7679516|NCT00274742|12096777|FG004|Overall Study|Lost to Follow-up|1
7679517|NCT00274742|12096778|FG005|Overall Study|Lost to Follow-up|0
7679518|NCT00274742|12096773|FG000|Overall Study|End of Study|0
7679519|NCT00274742|12096774|FG001|Overall Study|End of Study|0
7679520|NCT00274742|12096775|FG002|Overall Study|End of Study|0
7679521|NCT00274742|12096776|FG003|Overall Study|End of Study|1
7679522|NCT00274742|12096777|FG004|Overall Study|End of Study|0
7679523|NCT00274742|12096778|FG005|Overall Study|End of Study|0
7679524|NCT00274742|12096773|FG000|Overall Study|Disease Progression|0
7679525|NCT00274742|12096774|FG001|Overall Study|Disease Progression|1
7679526|NCT00274742|12096775|FG002|Overall Study|Disease Progression|1
7679527|NCT00274742|12096776|FG003|Overall Study|Disease Progression|0
7679528|NCT00274742|12096777|FG004|Overall Study|Disease Progression|1
7679529|NCT00274742|12096778|FG005|Overall Study|Disease Progression|0
7679530|NCT00274742|12096773|FG000|Overall Study|Other|0
7679531|NCT00274742|12096774|FG001|Overall Study|Other|3
7679532|NCT00274742|12096775|FG002|Overall Study|Other|0
7679533|NCT00274742|12096776|FG003|Overall Study|Other|0
7679534|NCT00274742|12096777|FG004|Overall Study|Other|2
7679535|NCT00274742|12096778|FG005|Overall Study|Other|0
7679536|NCT00274846|12096807|FG000|Overall Study|Did not receive adequate NK cells|1
7679537|NCT00274924|12096815|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
7679538|NCT00274924|12096816|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
7679539|NCT00274924|12096817|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
7679540|NCT00274924|12096815|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
7679541|NCT00274924|12096816|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
7679542|NCT00274924|12096817|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
7679543|NCT00274924|12096815|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
7679544|NCT00274924|12096816|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
7679545|NCT00274924|12096817|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
7679546|NCT00274924|12096815|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
7679547|NCT00274924|12096816|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
7679548|NCT00274924|12096817|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
7679549|NCT00274924|12096815|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
7679550|NCT00274924|12096816|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
7679551|NCT00274924|12096817|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
7679552|NCT00274924|12096815|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
7679553|NCT00274924|12096816|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
7679554|NCT00274924|12096817|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
7679555|NCT00274924|12096815|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
7679556|NCT00274924|12096816|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
7679557|NCT00274924|12096817|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
7679558|NCT00274924|12096815|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
7679559|NCT00274924|12096816|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
7679560|NCT00274924|12096817|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
7679561|NCT00274924|12096815|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
7679562|NCT00274924|12096816|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
7679563|NCT00274924|12096817|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
7679564|NCT00274924|12096815|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
7679565|NCT00274924|12096816|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
7679566|NCT00274924|12096817|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
7679567|NCT00274924|12096815|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0
7679568|NCT00274924|12096816|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1
7679569|NCT00274924|12096817|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0
7679570|NCT00274924|12096815|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
7679571|NCT00274924|12096816|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
7679572|NCT00274924|12096817|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
7679573|NCT00274924|12096815|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
7679574|NCT00274924|12096816|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
7679575|NCT00274924|12096817|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
7679576|NCT00275002|12096826|FG000|Overall Study|Death|1
7679577|NCT00275002|12096827|FG001|Overall Study|Death|0
7679578|NCT00275002|12096826|FG000|Overall Study|Disease progression|21
7679579|NCT00275002|12096827|FG001|Overall Study|Disease progression|15
7679580|NCT00275002|12096826|FG000|Overall Study|Adverse Event|0
7679581|NCT00275002|12096827|FG001|Overall Study|Adverse Event|1
7679582|NCT00275028|12096833|FG000|Overall Study|Withdrew consent before treatment began|1
7679583|NCT00275028|12096833|FG000|Overall Study|Withdrawal by Subject|5
7679584|NCT00275028|12096833|FG000|Overall Study|Adverse Event|9
7679585|NCT00275028|12096833|FG000|Overall Study|Progressive Disease|30
7679586|NCT00275028|12096833|FG000|Overall Study|Physician Decision|2
7679587|NCT00275262|12096839|FG000|Overall Study|Adverse Event|2
7679588|NCT00275262|12096840|FG001|Overall Study|Adverse Event|0
7679589|NCT00275262|12096839|FG000|Overall Study|Disease progression|2
7679590|NCT00275262|12096840|FG001|Overall Study|Disease progression|5
7679591|NCT00275262|12096839|FG000|Overall Study|Lost to Follow-up|0
7679592|NCT00275262|12096840|FG001|Overall Study|Lost to Follow-up|2
7679593|NCT00275262|12096839|FG000|Overall Study|Protocol Violation|0
7679594|NCT00275262|12096840|FG001|Overall Study|Protocol Violation|2
7679595|NCT00275262|12096839|FG000|Overall Study|Death|1
7679596|NCT00275262|12096840|FG001|Overall Study|Death|0
7679597|NCT00275262|12096839|FG000|Overall Study|Started Chemotherapy|1
7679598|NCT00275262|12096840|FG001|Overall Study|Started Chemotherapy|0
7679599|NCT00275301|12096859|FG000|Overall Study|Adverse Event|5
7679600|NCT00275509|12096874|FG000|Overall Study|graft thrombosis, post-operative day #8|0
7679601|NCT00275509|12096875|FG001|Overall Study|graft thrombosis, post-operative day #8|1
7679602|NCT00275561|12096883|FG000|Overall Study|Withdrawal by Subject|0
7679603|NCT00275561|12096884|FG001|Overall Study|Withdrawal by Subject|1
7679604|NCT00275561|12096883|FG000|Overall Study|Travel|1
7679605|NCT00275561|12096884|FG001|Overall Study|Travel|1
7679606|NCT00275561|12096883|FG000|Overall Study|Scheduling|1
7679607|NCT00275561|12096884|FG001|Overall Study|Scheduling|2
7679608|NCT00275561|12096883|FG000|Overall Study|Family Issues|0
7679609|NCT00275561|12096884|FG001|Overall Study|Family Issues|2
7679610|NCT00275821|12096893|FG000|Overall Study|Adverse Event|4
7679611|NCT00275821|12096894|FG001|Overall Study|Adverse Event|12
7679612|NCT00275821|12096895|FG002|Overall Study|Adverse Event|5
7679613|NCT00275821|12096893|FG000|Overall Study|Administrative problems|3
7679614|NCT00275821|12096894|FG001|Overall Study|Administrative problems|4
7679615|NCT00275821|12096895|FG002|Overall Study|Administrative problems|4
7679616|NCT00275821|12096893|FG000|Overall Study|Withdrawal by Subject|0
7679617|NCT00275821|12096894|FG001|Overall Study|Withdrawal by Subject|2
7679618|NCT00275821|12096895|FG002|Overall Study|Withdrawal by Subject|1
7679619|NCT00275821|12096893|FG000|Overall Study|Lost to Follow-up|0
7679620|NCT00275821|12096894|FG001|Overall Study|Lost to Follow-up|1
7679621|NCT00275821|12096895|FG002|Overall Study|Lost to Follow-up|1
7679622|NCT00275821|12096893|FG000|Overall Study|Death|0
7679623|NCT00275821|12096894|FG001|Overall Study|Death|2
7679624|NCT00275821|12096895|FG002|Overall Study|Death|1
7679625|NCT00275821|12096893|FG000|Overall Study|Lack of Efficacy|2
7679626|NCT00275821|12096894|FG001|Overall Study|Lack of Efficacy|1
7679627|NCT00275821|12096895|FG002|Overall Study|Lack of Efficacy|0
7679628|NCT00275821|12096893|FG000|Overall Study|Protocol Violation|5
7679629|NCT00275821|12096894|FG001|Overall Study|Protocol Violation|1
7679630|NCT00275821|12096895|FG002|Overall Study|Protocol Violation|0
7679631|NCT00276094|12096921|FG000|Overall Study|Adverse Event|15
7679632|NCT00276094|12096922|FG001|Overall Study|Adverse Event|13
7679633|NCT00276094|12096923|FG002|Overall Study|Adverse Event|11
7679634|NCT00276094|12096921|FG000|Overall Study|Withdrawal by Subject|14
7679635|NCT00276094|12096922|FG001|Overall Study|Withdrawal by Subject|14
7679636|NCT00276094|12096923|FG002|Overall Study|Withdrawal by Subject|12
7679637|NCT00276094|12096921|FG000|Overall Study|Protocol Violation|16
7679638|NCT00276094|12096922|FG001|Overall Study|Protocol Violation|7
7679639|NCT00276094|12096923|FG002|Overall Study|Protocol Violation|10
7679640|NCT00276094|12096921|FG000|Overall Study|Lost to Follow-up|8
7679641|NCT00276094|12096922|FG001|Overall Study|Lost to Follow-up|6
7679642|NCT00276094|12096923|FG002|Overall Study|Lost to Follow-up|4
7679643|NCT00276094|12096921|FG000|Overall Study|Other-Subject moved out of country|1
7679644|NCT00276094|12096922|FG001|Overall Study|Other-Subject moved out of country|0
7679645|NCT00276094|12096923|FG002|Overall Study|Other-Subject moved out of country|0
7679646|NCT00276094|12096921|FG000|Overall Study|Other-Scheduled gastroplasty|1
7679647|NCT00276094|12096922|FG001|Overall Study|Other-Scheduled gastroplasty|0
7679648|NCT00276094|12096923|FG002|Overall Study|Other-Scheduled gastroplasty|0
7679649|NCT00276094|12096921|FG000|Overall Study|Other-Lack of efficacy|1
7679650|NCT00276094|12096922|FG001|Overall Study|Other-Lack of efficacy|0
7679651|NCT00276094|12096923|FG002|Overall Study|Other-Lack of efficacy|0
7679652|NCT00276094|12096921|FG000|Overall Study|Other-Refused follow-up visit|1
7679653|NCT00276094|12096922|FG001|Overall Study|Other-Refused follow-up visit|0
7679654|NCT00276094|12096923|FG002|Overall Study|Other-Refused follow-up visit|0
7679655|NCT00276094|12096921|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0
7679656|NCT00276094|12096922|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1
7679657|NCT00276094|12096923|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0
7679658|NCT00276094|12096921|FG000|Overall Study|Other-Relocation|0
7679659|NCT00276094|12096922|FG001|Overall Study|Other-Relocation|1
7679660|NCT00276094|12096923|FG002|Overall Study|Other-Relocation|0
7679661|NCT00276094|12096921|FG000|Overall Study|Other-Study medication lost|0
7679662|NCT00276094|12096922|FG001|Overall Study|Other-Study medication lost|0
7679663|NCT00276094|12096923|FG002|Overall Study|Other-Study medication lost|1
7679664|NCT00276159|12096931|FG000|Overall Study|Did not receive all 24 doses of 852A|6
7679665|NCT00276380|12096950|FG000|Overall Study|Adverse Event|5
7679666|NCT00276380|12096951|FG001|Overall Study|Adverse Event|3
7679667|NCT00276380|12096950|FG000|Overall Study|Lost to Follow-up|1
7679668|NCT00276380|12096951|FG001|Overall Study|Lost to Follow-up|1
7679669|NCT00276380|12096950|FG000|Overall Study|Withdrawal by Subject|3
7679670|NCT00276380|12096951|FG001|Overall Study|Withdrawal by Subject|6
7679671|NCT00276380|12096950|FG000|Overall Study|Death|5
7679672|NCT00276380|12096951|FG001|Overall Study|Death|3
7679673|NCT00276380|12096950|FG000|Overall Study|Abnormal aPPT Levels|0
7679674|NCT00276380|12096951|FG001|Overall Study|Abnormal aPPT Levels|1
7679675|NCT00276614|12096971|FG000|Overall Study|Progression of disease under study|3
7679676|NCT00276744|12096975|FG000|PART A|Reason unknown|98
7679677|NCT00277095|12096984|FG000|Overall Study|Death|2
7679678|NCT00277095|12096984|FG000|Overall Study|Explanted|7
7679679|NCT00277095|12096984|FG000|Overall Study|Lost to Follow-up|2
7679680|NCT00277095|12096984|FG000|Overall Study|Missed Follow-up|9
7679681|NCT00277095|12096984|FG000|Overall Study|Physician Decision|1
7679682|NCT00277212|12096988|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
7679683|NCT00277212|12096989|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
7679684|NCT00277212|12096990|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
7679685|NCT00277212|12096988|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93
7679686|NCT00277212|12096989|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0
7679687|NCT00277212|12096990|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0
7679688|NCT00277212|12096988|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
7679689|NCT00277212|12096989|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
7679690|NCT00277212|12096990|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
7679691|NCT00277212|12096988|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
7679692|NCT00277212|12096989|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
7679693|NCT00277212|12096990|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
7679694|NCT00277212|12096988|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
7679695|NCT00277212|12096989|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
7679696|NCT00277212|12096990|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
7679697|NCT00277212|12096988|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6
7679698|NCT00277212|12096989|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0
7679699|NCT00277212|12096990|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0
7679700|NCT00277212|12096988|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
7679701|NCT00277212|12096989|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
7679702|NCT00277212|12096990|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
7679703|NCT00277212|12096988|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
7679704|NCT00277212|12096989|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
7679705|NCT00277212|12096990|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
7679706|NCT00277212|12096988|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12
7679707|NCT00277212|12096989|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0
7679708|NCT00277212|12096990|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0
7679709|NCT00277212|12096988|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
7679710|NCT00277212|12096989|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
7679711|NCT00277212|12096990|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
7679712|NCT00277212|12096988|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0
7679713|NCT00277212|12096989|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10
7679714|NCT00277212|12096990|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16
7679715|NCT00277212|12096988|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
7679716|NCT00277212|12096989|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
7679717|NCT00277212|12096990|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
7679718|NCT00277212|12096988|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
7679719|NCT00277212|12096989|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
7679720|NCT00277212|12096990|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
7679721|NCT00277212|12096988|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
7679722|NCT00277212|12096989|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
7679723|NCT00277212|12096990|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
7679724|NCT00277212|12096988|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0
7679725|NCT00277212|12096989|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2
7679726|NCT00277212|12096990|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2
7679727|NCT00277212|12096988|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
7679728|NCT00277212|12096989|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
7679729|NCT00277212|12096990|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
7679730|NCT00277212|12096988|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
7679731|NCT00277212|12096989|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
7679732|NCT00277212|12096990|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
7679733|NCT00277212|12096988|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0
7679734|NCT00277212|12096989|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7
7679735|NCT00277212|12096990|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5
7679736|NCT00277355|12097000|FG000|Overall Study|Withdrawal by Subject|3
7679737|NCT00277355|12097001|FG001|Overall Study|Withdrawal by Subject|3
7679738|NCT00277355|12097000|FG000|Overall Study|Lost to Follow-up|2
7679739|NCT00277355|12097001|FG001|Overall Study|Lost to Follow-up|2
7679740|NCT00277355|12097000|FG000|Overall Study|Adverse Event|5
7679741|NCT00277355|12097001|FG001|Overall Study|Adverse Event|0
7679742|NCT00277355|12097000|FG000|Overall Study|Death|3
7679743|NCT00277355|12097001|FG001|Overall Study|Death|0
7679744|NCT00277355|12097000|FG000|Overall Study|Physician Decision|1
7679745|NCT00277355|12097001|FG001|Overall Study|Physician Decision|0
7679746|NCT00278109|12097042|FG000|Overall Study|Adverse Event|3
7679747|NCT00278109|12097042|FG000|Overall Study|social circumstances|1
7679748|NCT00278148|12097046|FG000|Phase II - Expansion Phase|Disease progression|0
7679749|NCT00278148|12097047|FG001|Phase II - Expansion Phase|Disease progression|0
7679750|NCT00278148|12097048|FG002|Phase II - Expansion Phase|Disease progression|4
7679751|NCT00278148|12097046|FG000|Phase II - Expansion Phase|Adverse Event|0
7679752|NCT00278148|12097047|FG001|Phase II - Expansion Phase|Adverse Event|0
7679753|NCT00278148|12097048|FG002|Phase II - Expansion Phase|Adverse Event|2
7679754|NCT00278161|12097055|FG000|Overall Study|Death|11
7679755|NCT00278200|12097061|FG000|Overall Study|Death|1
7679756|NCT00278200|12097062|FG001|Overall Study|Death|3
7679757|NCT00278200|12097061|FG000|Overall Study|Physician Decision|0
7679758|NCT00278200|12097062|FG001|Overall Study|Physician Decision|1
7679759|NCT00278395|12097068|FG000|Overall Study|Adverse Event|2
7679760|NCT00278395|12097068|FG000|Overall Study|Nonevaluable|1
7679761|NCT00278473|12097077|FG000|Overall Study|drop out|4
7679762|NCT00278473|12097078|FG001|Overall Study|drop out|3
7679763|NCT00278512|12097086|FG000|Overall Study|Death|1
7679764|NCT00278512|12097087|FG001|Overall Study|Death|0
7679765|NCT00278564|12097106|FG000|Overall Study|Lack of Efficacy|4
7679766|NCT00278629|12097110|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14
7679767|NCT00278889|12097136|FG000|Overall Study|Withdrawal by Subject|0
7679768|NCT00278889|12097137|FG001|Overall Study|Withdrawal by Subject|5
7679769|NCT00278889|12097138|FG002|Overall Study|Withdrawal by Subject|3
7679770|NCT00278889|12097136|FG000|Overall Study|Lost to Follow-up|1
7679771|NCT00278889|12097137|FG001|Overall Study|Lost to Follow-up|1
7679772|NCT00278889|12097138|FG002|Overall Study|Lost to Follow-up|0
7679773|NCT00278889|12097136|FG000|Overall Study|Death|24
7679774|NCT00278889|12097137|FG001|Overall Study|Death|21
7679775|NCT00278889|12097138|FG002|Overall Study|Death|17
7679776|NCT00278954|12097146|FG000|Overall Study|Adverse Event|3
7679777|NCT00278954|12097146|FG000|Overall Study|Lost to Follow-up|1
7679778|NCT00278954|12097146|FG000|Overall Study|Withdrawal by Subject|1
7679779|NCT00278993|12097150|FG000|Overall Study|Adverse Event|24
7679780|NCT00278993|12097150|FG000|Overall Study|Withdrawal by Subject|5
7679781|NCT00278993|12097150|FG000|Overall Study|Progressive Disease|65
7679782|NCT00278993|12097150|FG000|Overall Study|Physician Decision|9
7679783|NCT00278993|12097150|FG000|Overall Study|Not Otherwise Specified|4
7679784|NCT00279201|12097156|FG000|Initiation|Death|1
7679785|NCT00279201|12097157|FG001|Initiation|Death|5
7679786|NCT00279201|12097158|FG002|Initiation|Death|0
7679787|NCT00279201|12097159|FG003|Initiation|Death|0
7679788|NCT00279201|12097160|FG004|Initiation|Death|0
7679789|NCT00279201|12097161|FG005|Initiation|Death|0
7679790|NCT00279201|12097156|FG000|Initiation|Adverse Event|6
7679791|NCT00279201|12097157|FG001|Initiation|Adverse Event|15
7679792|NCT00279201|12097158|FG002|Initiation|Adverse Event|0
7679793|NCT00279201|12097159|FG003|Initiation|Adverse Event|0
7679794|NCT00279201|12097160|FG004|Initiation|Adverse Event|0
7679795|NCT00279201|12097161|FG005|Initiation|Adverse Event|0
7679796|NCT00279201|12097156|FG000|Initiation|Lost to Follow-up|42
7679797|NCT00279201|12097157|FG001|Initiation|Lost to Follow-up|41
7679798|NCT00279201|12097158|FG002|Initiation|Lost to Follow-up|0
7679799|NCT00279201|12097159|FG003|Initiation|Lost to Follow-up|0
7679800|NCT00279201|12097160|FG004|Initiation|Lost to Follow-up|0
7679801|NCT00279201|12097161|FG005|Initiation|Lost to Follow-up|0
7679802|NCT00279201|12097156|FG000|Initiation|Entry Criteria Exclusion|7
7679803|NCT00279201|12097157|FG001|Initiation|Entry Criteria Exclusion|9
7679804|NCT00279201|12097158|FG002|Initiation|Entry Criteria Exclusion|0
7679805|NCT00279201|12097159|FG003|Initiation|Entry Criteria Exclusion|0
7679806|NCT00279201|12097160|FG004|Initiation|Entry Criteria Exclusion|0
7679807|NCT00279201|12097161|FG005|Initiation|Entry Criteria Exclusion|0
7679808|NCT00279201|12097156|FG000|Initiation|Protocol Violation|9
7679809|NCT00279201|12097157|FG001|Initiation|Protocol Violation|10
7679810|NCT00279201|12097158|FG002|Initiation|Protocol Violation|0
7679811|NCT00279201|12097159|FG003|Initiation|Protocol Violation|0
7679812|NCT00279201|12097160|FG004|Initiation|Protocol Violation|0
7679813|NCT00279201|12097161|FG005|Initiation|Protocol Violation|0
7679814|NCT00279201|12097156|FG000|Initiation|Withdrawal by Subject|35
7679815|NCT00279201|12097157|FG001|Initiation|Withdrawal by Subject|41
7679816|NCT00279201|12097158|FG002|Initiation|Withdrawal by Subject|0
7679817|NCT00279201|12097159|FG003|Initiation|Withdrawal by Subject|0
7679818|NCT00279201|12097160|FG004|Initiation|Withdrawal by Subject|0
7679819|NCT00279201|12097161|FG005|Initiation|Withdrawal by Subject|0
7679820|NCT00279201|12097156|FG000|Initiation|Physician Decision|15
7679821|NCT00279201|12097157|FG001|Initiation|Physician Decision|18
7679822|NCT00279201|12097158|FG002|Initiation|Physician Decision|0
7679823|NCT00279201|12097159|FG003|Initiation|Physician Decision|0
7679824|NCT00279201|12097160|FG004|Initiation|Physician Decision|0
7679825|NCT00279201|12097161|FG005|Initiation|Physician Decision|0
7679826|NCT00279201|12097156|FG000|Initiation|Sponsor Decision|13
7679827|NCT00279201|12097157|FG001|Initiation|Sponsor Decision|5
7679828|NCT00279201|12097158|FG002|Initiation|Sponsor Decision|0
7679829|NCT00279201|12097159|FG003|Initiation|Sponsor Decision|0
7679830|NCT00279201|12097160|FG004|Initiation|Sponsor Decision|0
7679831|NCT00279201|12097161|FG005|Initiation|Sponsor Decision|0
7679832|NCT00279201|12097156|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0
7679833|NCT00279201|12097157|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1
7679834|NCT00279201|12097158|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0
7679835|NCT00279201|12097159|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0
7679836|NCT00279201|12097160|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0
7679837|NCT00279201|12097161|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0
7679838|NCT00279201|12097156|FG000|Maintenance|Lack of Efficacy|32
7679839|NCT00279201|12097157|FG001|Maintenance|Lack of Efficacy|30
7679840|NCT00279201|12097158|FG002|Maintenance|Lack of Efficacy|0
7679841|NCT00279201|12097159|FG003|Maintenance|Lack of Efficacy|0
7679842|NCT00279201|12097160|FG004|Maintenance|Lack of Efficacy|0
7679843|NCT00279201|12097161|FG005|Maintenance|Lack of Efficacy|0
7679844|NCT00279201|12097156|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3
7679845|NCT00279201|12097157|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2
7679846|NCT00279201|12097158|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0
7679847|NCT00279201|12097159|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0
7679848|NCT00279201|12097160|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0
7679849|NCT00279201|12097161|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0
7679850|NCT00279201|12097156|FG000|Maintenance|Adverse Event|4
7679851|NCT00279201|12097157|FG001|Maintenance|Adverse Event|4
7679852|NCT00279201|12097158|FG002|Maintenance|Adverse Event|0
7679853|NCT00279201|12097159|FG003|Maintenance|Adverse Event|0
7679854|NCT00279201|12097160|FG004|Maintenance|Adverse Event|0
7679855|NCT00279201|12097161|FG005|Maintenance|Adverse Event|0
7679856|NCT00279201|12097156|FG000|Maintenance|Death|4
7679857|NCT00279201|12097157|FG001|Maintenance|Death|4
7679858|NCT00279201|12097158|FG002|Maintenance|Death|0
7679859|NCT00279201|12097159|FG003|Maintenance|Death|0
7679860|NCT00279201|12097160|FG004|Maintenance|Death|0
7679861|NCT00279201|12097161|FG005|Maintenance|Death|0
7679862|NCT00279201|12097156|FG000|Maintenance|Lost to Follow-up|17
7679863|NCT00279201|12097157|FG001|Maintenance|Lost to Follow-up|13
7679864|NCT00279201|12097158|FG002|Maintenance|Lost to Follow-up|0
7679865|NCT00279201|12097159|FG003|Maintenance|Lost to Follow-up|0
7679866|NCT00279201|12097160|FG004|Maintenance|Lost to Follow-up|0
7679867|NCT00279201|12097161|FG005|Maintenance|Lost to Follow-up|0
7679868|NCT00279201|12097156|FG000|Maintenance|Entry Criteria Exclusion|1
7679869|NCT00279201|12097157|FG001|Maintenance|Entry Criteria Exclusion|4
7679870|NCT00279201|12097158|FG002|Maintenance|Entry Criteria Exclusion|0
7679871|NCT00279201|12097159|FG003|Maintenance|Entry Criteria Exclusion|0
7679872|NCT00279201|12097160|FG004|Maintenance|Entry Criteria Exclusion|0
7679873|NCT00279201|12097161|FG005|Maintenance|Entry Criteria Exclusion|0
7679874|NCT00279201|12097156|FG000|Maintenance|Protocol Violation|16
7679875|NCT00279201|12097157|FG001|Maintenance|Protocol Violation|24
7679876|NCT00279201|12097158|FG002|Maintenance|Protocol Violation|0
7679877|NCT00279201|12097159|FG003|Maintenance|Protocol Violation|0
7679878|NCT00279201|12097160|FG004|Maintenance|Protocol Violation|0
7679879|NCT00279201|12097161|FG005|Maintenance|Protocol Violation|0
7679880|NCT00279201|12097156|FG000|Maintenance|Withdrawal by Subject|18
7679881|NCT00279201|12097157|FG001|Maintenance|Withdrawal by Subject|18
7679882|NCT00279201|12097158|FG002|Maintenance|Withdrawal by Subject|0
7679883|NCT00279201|12097159|FG003|Maintenance|Withdrawal by Subject|0
7679884|NCT00279201|12097160|FG004|Maintenance|Withdrawal by Subject|0
7679885|NCT00279201|12097161|FG005|Maintenance|Withdrawal by Subject|0
7679886|NCT00279201|12097156|FG000|Maintenance|Physician Decision|9
7679887|NCT00279201|12097157|FG001|Maintenance|Physician Decision|9
7679888|NCT00279201|12097158|FG002|Maintenance|Physician Decision|0
7679889|NCT00279201|12097159|FG003|Maintenance|Physician Decision|0
7679890|NCT00279201|12097160|FG004|Maintenance|Physician Decision|0
7679891|NCT00279201|12097161|FG005|Maintenance|Physician Decision|0
7679892|NCT00279201|12097156|FG000|Maintenance|Sponsor Decision|4
7679893|NCT00279201|12097157|FG001|Maintenance|Sponsor Decision|0
7679894|NCT00279201|12097158|FG002|Maintenance|Sponsor Decision|0
7679895|NCT00279201|12097159|FG003|Maintenance|Sponsor Decision|0
7679896|NCT00279201|12097160|FG004|Maintenance|Sponsor Decision|0
7679897|NCT00279201|12097161|FG005|Maintenance|Sponsor Decision|0
7679898|NCT00279201|12097156|FG000|Maintenance|HbA1c>7.5%|123
7679899|NCT00279201|12097157|FG001|Maintenance|HbA1c>7.5%|126
7679900|NCT00279201|12097158|FG002|Maintenance|HbA1c>7.5%|0
7679901|NCT00279201|12097159|FG003|Maintenance|HbA1c>7.5%|0
7679902|NCT00279201|12097160|FG004|Maintenance|HbA1c>7.5%|0
7679903|NCT00279201|12097161|FG005|Maintenance|HbA1c>7.5%|0
7679904|NCT00279201|12097156|FG000|Intensification Addendum|Withdrawal by Subject|0
7679905|NCT00279201|12097157|FG001|Intensification Addendum|Withdrawal by Subject|0
7679906|NCT00279201|12097158|FG002|Intensification Addendum|Withdrawal by Subject|12
7679907|NCT00279201|12097159|FG003|Intensification Addendum|Withdrawal by Subject|14
7679908|NCT00279201|12097160|FG004|Intensification Addendum|Withdrawal by Subject|9
7679909|NCT00279201|12097161|FG005|Intensification Addendum|Withdrawal by Subject|18
7679910|NCT00279201|12097156|FG000|Intensification Addendum|Lost to Follow-up|0
7679911|NCT00279201|12097157|FG001|Intensification Addendum|Lost to Follow-up|0
7679912|NCT00279201|12097158|FG002|Intensification Addendum|Lost to Follow-up|4
7679913|NCT00279201|12097159|FG003|Intensification Addendum|Lost to Follow-up|6
7679914|NCT00279201|12097160|FG004|Intensification Addendum|Lost to Follow-up|7
7679915|NCT00279201|12097161|FG005|Intensification Addendum|Lost to Follow-up|7
7679916|NCT00279201|12097156|FG000|Intensification Addendum|Protocol Violation|0
7679917|NCT00279201|12097157|FG001|Intensification Addendum|Protocol Violation|0
7679918|NCT00279201|12097158|FG002|Intensification Addendum|Protocol Violation|2
7679919|NCT00279201|12097159|FG003|Intensification Addendum|Protocol Violation|2
7679920|NCT00279201|12097160|FG004|Intensification Addendum|Protocol Violation|6
7679921|NCT00279201|12097161|FG005|Intensification Addendum|Protocol Violation|6
7679922|NCT00279201|12097156|FG000|Intensification Addendum|Adverse Event|0
7679923|NCT00279201|12097157|FG001|Intensification Addendum|Adverse Event|0
7679924|NCT00279201|12097158|FG002|Intensification Addendum|Adverse Event|0
7679925|NCT00279201|12097159|FG003|Intensification Addendum|Adverse Event|4
7679926|NCT00279201|12097160|FG004|Intensification Addendum|Adverse Event|1
7679927|NCT00279201|12097161|FG005|Intensification Addendum|Adverse Event|3
7679928|NCT00279201|12097156|FG000|Intensification Addendum|Physician Decision|0
7679929|NCT00279201|12097157|FG001|Intensification Addendum|Physician Decision|0
7679930|NCT00279201|12097158|FG002|Intensification Addendum|Physician Decision|4
7679931|NCT00279201|12097159|FG003|Intensification Addendum|Physician Decision|1
7679932|NCT00279201|12097160|FG004|Intensification Addendum|Physician Decision|3
7679933|NCT00279201|12097161|FG005|Intensification Addendum|Physician Decision|2
7679934|NCT00279201|12097156|FG000|Intensification Addendum|Sponsor Decision|0
7679935|NCT00279201|12097157|FG001|Intensification Addendum|Sponsor Decision|0
7679936|NCT00279201|12097158|FG002|Intensification Addendum|Sponsor Decision|0
7679937|NCT00279201|12097159|FG003|Intensification Addendum|Sponsor Decision|0
7679938|NCT00279201|12097160|FG004|Intensification Addendum|Sponsor Decision|1
7679939|NCT00279201|12097161|FG005|Intensification Addendum|Sponsor Decision|1
7679940|NCT00279201|12097156|FG000|Intensification Addendum|Entry Criteria Exclusion|0
7679941|NCT00279201|12097157|FG001|Intensification Addendum|Entry Criteria Exclusion|0
7679942|NCT00279201|12097158|FG002|Intensification Addendum|Entry Criteria Exclusion|1
7679943|NCT00279201|12097159|FG003|Intensification Addendum|Entry Criteria Exclusion|0
7679944|NCT00279201|12097160|FG004|Intensification Addendum|Entry Criteria Exclusion|0
7679945|NCT00279201|12097161|FG005|Intensification Addendum|Entry Criteria Exclusion|0
7679946|NCT00279201|12097156|FG000|Intensification Addendum|Lack of Efficacy|0
7679947|NCT00279201|12097157|FG001|Intensification Addendum|Lack of Efficacy|0
7679948|NCT00279201|12097158|FG002|Intensification Addendum|Lack of Efficacy|0
7679949|NCT00279201|12097159|FG003|Intensification Addendum|Lack of Efficacy|1
7679950|NCT00279201|12097160|FG004|Intensification Addendum|Lack of Efficacy|1
7679951|NCT00279201|12097161|FG005|Intensification Addendum|Lack of Efficacy|0
7679952|NCT00279201|12097156|FG000|Intensification Addendum|Death|0
7679953|NCT00279201|12097157|FG001|Intensification Addendum|Death|0
7679954|NCT00279201|12097158|FG002|Intensification Addendum|Death|0
7679955|NCT00279201|12097159|FG003|Intensification Addendum|Death|0
7679956|NCT00279201|12097160|FG004|Intensification Addendum|Death|1
7679957|NCT00279201|12097161|FG005|Intensification Addendum|Death|0
7679958|NCT00279214|12097196|FG000|Overall Study|Physician Decision|3
7679959|NCT00279214|12097197|FG001|Overall Study|Physician Decision|2
7679960|NCT00279305|12097205|FG000|Overall Study|Pregnancy|1
7679961|NCT00279305|12097206|FG001|Overall Study|Pregnancy|0
7679962|NCT00279305|12097205|FG000|Overall Study|Withdrawal by Subject|2
7679963|NCT00279305|12097206|FG001|Overall Study|Withdrawal by Subject|0
7679964|NCT00279305|12097205|FG000|Overall Study|Dificulting establishing IV|1
7679965|NCT00279305|12097206|FG001|Overall Study|Dificulting establishing IV|0
7679966|NCT00279305|12097205|FG000|Overall Study|FDA Safety Alert|4
7679967|NCT00279305|12097206|FG001|Overall Study|FDA Safety Alert|1
7679968|NCT00279708|12097229|FG000|Overall Study|Withdrawal by Subject|2
7679969|NCT00279708|12097230|FG001|Overall Study|Withdrawal by Subject|3
7679970|NCT00279708|12097229|FG000|Overall Study|Adverse Event|1
7679971|NCT00279708|12097230|FG001|Overall Study|Adverse Event|1
7679972|NCT00279812|12097242|FG000|Overall Study|Protocol Violation|1
7679973|NCT00279812|12097243|FG001|Overall Study|Protocol Violation|1
7679974|NCT00279812|12097244|FG002|Overall Study|Protocol Violation|0
7679975|NCT00279812|12097245|FG003|Overall Study|Protocol Violation|0
7679976|NCT00279812|12097246|FG004|Overall Study|Protocol Violation|1
7679977|NCT00279812|12097247|FG005|Overall Study|Protocol Violation|0
7679978|NCT00279812|12097242|FG000|Overall Study|Withdrawal by Subject|0
7679979|NCT00279812|12097243|FG001|Overall Study|Withdrawal by Subject|4
7679980|NCT00279812|12097244|FG002|Overall Study|Withdrawal by Subject|2
7679981|NCT00279812|12097245|FG003|Overall Study|Withdrawal by Subject|0
7679982|NCT00279812|12097246|FG004|Overall Study|Withdrawal by Subject|0
7679983|NCT00279812|12097247|FG005|Overall Study|Withdrawal by Subject|0
7679984|NCT00279812|12097242|FG000|Overall Study|Adverse Event|0
7679985|NCT00279812|12097243|FG001|Overall Study|Adverse Event|1
7679986|NCT00279812|12097244|FG002|Overall Study|Adverse Event|1
7679987|NCT00279812|12097245|FG003|Overall Study|Adverse Event|0
7679988|NCT00279812|12097246|FG004|Overall Study|Adverse Event|2
7679989|NCT00279812|12097247|FG005|Overall Study|Adverse Event|1
7679990|NCT00279916|12097263|FG000|Overall Study|Withdrawal by Subject|4
7679991|NCT00279916|12097264|FG001|Overall Study|Withdrawal by Subject|3
7679992|NCT00279916|12097263|FG000|Overall Study|Lost to Follow-up|3
7679993|NCT00279916|12097264|FG001|Overall Study|Lost to Follow-up|2
7679994|NCT00280059|12097284|FG000|Efficacy Assessment Phase|Death|2
7679995|NCT00280059|12097285|FG001|Efficacy Assessment Phase|Death|0
7679996|NCT00280059|12097284|FG000|Efficacy Assessment Phase|Adverse Event|33
7679997|NCT00280059|12097285|FG001|Efficacy Assessment Phase|Adverse Event|31
7679998|NCT00280059|12097284|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1
7679999|NCT00280059|12097285|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0
7680000|NCT00280059|12097284|FG000|Efficacy Assessment Phase|Lack of Efficacy|19
7680001|NCT00280059|12097285|FG001|Efficacy Assessment Phase|Lack of Efficacy|3
7680002|NCT00280059|12097284|FG000|Efficacy Assessment Phase|Lost to Follow-up|6
7680003|NCT00280059|12097285|FG001|Efficacy Assessment Phase|Lost to Follow-up|13
7680004|NCT00280059|12097284|FG000|Efficacy Assessment Phase|Other|7
7680005|NCT00280059|12097285|FG001|Efficacy Assessment Phase|Other|8
7680006|NCT00280059|12097284|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26
7680007|NCT00280059|12097285|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25
7680008|NCT00280150|12097303|FG000|Overall Study|Adverse Event|0
7680009|NCT00280150|12097304|FG001|Overall Study|Adverse Event|1
7680010|NCT00280150|12097305|FG002|Overall Study|Adverse Event|2
7680011|NCT00280150|12097306|FG003|Overall Study|Adverse Event|3
7680012|NCT00280150|12097303|FG000|Overall Study|Lack of Efficacy|0
7680013|NCT00280150|12097304|FG001|Overall Study|Lack of Efficacy|0
7680014|NCT00280150|12097305|FG002|Overall Study|Lack of Efficacy|0
7680015|NCT00280150|12097306|FG003|Overall Study|Lack of Efficacy|3
7680016|NCT00280150|12097303|FG000|Overall Study|Physician Decision|0
7680017|NCT00280150|12097304|FG001|Overall Study|Physician Decision|0
7680018|NCT00280150|12097305|FG002|Overall Study|Physician Decision|0
7680019|NCT00280150|12097306|FG003|Overall Study|Physician Decision|1
7680020|NCT00280150|12097303|FG000|Overall Study|Protocol Violation|0
7680021|NCT00280150|12097304|FG001|Overall Study|Protocol Violation|0
7680022|NCT00280150|12097305|FG002|Overall Study|Protocol Violation|0
7680023|NCT00280150|12097306|FG003|Overall Study|Protocol Violation|1
7680024|NCT00280150|12097303|FG000|Overall Study|Withdrawal by Subject|0
7680025|NCT00280150|12097304|FG001|Overall Study|Withdrawal by Subject|0
7680026|NCT00280150|12097305|FG002|Overall Study|Withdrawal by Subject|0
7680027|NCT00280150|12097306|FG003|Overall Study|Withdrawal by Subject|1
7680028|NCT00280150|12097303|FG000|Overall Study|Did not get consolidation therapy|3
7680029|NCT00280150|12097304|FG001|Overall Study|Did not get consolidation therapy|0
7680030|NCT00280150|12097305|FG002|Overall Study|Did not get consolidation therapy|3
7680031|NCT00280150|12097306|FG003|Overall Study|Did not get consolidation therapy|0
7680032|NCT00280150|12097303|FG000|Overall Study|Declining Performance Status|0
7680033|NCT00280150|12097304|FG001|Overall Study|Declining Performance Status|0
7680034|NCT00280150|12097305|FG002|Overall Study|Declining Performance Status|0
7680035|NCT00280150|12097306|FG003|Overall Study|Declining Performance Status|1
7680036|NCT00280293|12097323|FG000|Overall Study|Protocol Violation|3
7680037|NCT00280293|12097324|FG001|Overall Study|Protocol Violation|0
7680038|NCT00280293|12097323|FG000|Overall Study|Physician Decision|5
7680039|NCT00280293|12097324|FG001|Overall Study|Physician Decision|4
7680040|NCT00280293|12097323|FG000|Overall Study|Lost to Follow-up|14
7680041|NCT00280293|12097324|FG001|Overall Study|Lost to Follow-up|12
7680042|NCT00280293|12097323|FG000|Overall Study|Withdrawal by Subject|3
7680043|NCT00280293|12097324|FG001|Overall Study|Withdrawal by Subject|5
7680044|NCT00280293|12097323|FG000|Overall Study|Incarceration/Legal Reasons|1
7680045|NCT00280293|12097324|FG001|Overall Study|Incarceration/Legal Reasons|1
7680046|NCT00280293|12097323|FG000|Overall Study|Adverse Event|0
7680047|NCT00280293|12097324|FG001|Overall Study|Adverse Event|1
7680048|NCT00280397|12097363|FG000|Overall Study|Adverse Event|1
7680049|NCT00280566|12097371|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
7680050|NCT00280566|12097372|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
7680051|NCT00280566|12097373|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
7680052|NCT00280566|12097371|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
7680053|NCT00280566|12097372|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
7680054|NCT00280566|12097373|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
7680055|NCT00280566|12097371|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148
7680056|NCT00280566|12097372|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0
7680057|NCT00280566|12097373|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0
7680058|NCT00280566|12097371|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
7680059|NCT00280566|12097372|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
7680060|NCT00280566|12097373|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
7680061|NCT00280566|12097371|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
7680062|NCT00280566|12097372|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
7680063|NCT00280566|12097373|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
7680064|NCT00280566|12097371|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50
7680065|NCT00280566|12097372|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0
7680066|NCT00280566|12097373|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0
7680067|NCT00280566|12097371|FG000|Period 2 Double Blind|Lack of Efficacy|0
7680068|NCT00280566|12097372|FG001|Period 2 Double Blind|Lack of Efficacy|9
7680069|NCT00280566|12097373|FG002|Period 2 Double Blind|Lack of Efficacy|22
7680070|NCT00280566|12097371|FG000|Period 2 Double Blind|Laboratory Abnormality|0
7680071|NCT00280566|12097372|FG001|Period 2 Double Blind|Laboratory Abnormality|1
7680072|NCT00280566|12097373|FG002|Period 2 Double Blind|Laboratory Abnormality|0
7680073|NCT00280566|12097371|FG000|Period 2 Double Blind|Adverse Event|0
7680074|NCT00280566|12097372|FG001|Period 2 Double Blind|Adverse Event|11
7680075|NCT00280566|12097373|FG002|Period 2 Double Blind|Adverse Event|15
7680076|NCT00280566|12097371|FG000|Period 2 Double Blind|Lost to Follow-up|0
7680077|NCT00280566|12097372|FG001|Period 2 Double Blind|Lost to Follow-up|3
7680078|NCT00280566|12097373|FG002|Period 2 Double Blind|Lost to Follow-up|6
7680079|NCT00280566|12097371|FG000|Period 2 Double Blind|Withdrawal by Subject|0
7680080|NCT00280566|12097372|FG001|Period 2 Double Blind|Withdrawal by Subject|9
7680081|NCT00280566|12097373|FG002|Period 2 Double Blind|Withdrawal by Subject|9
7680082|NCT00280566|12097371|FG000|Period 2 Double Blind|miscellaneous|0
7680083|NCT00280566|12097372|FG001|Period 2 Double Blind|miscellaneous|10
7680084|NCT00280566|12097373|FG002|Period 2 Double Blind|miscellaneous|5
7680085|NCT00280683|12097382|FG000|Overall Study|Withdrawal by Subject|1
7680086|NCT00280683|12097383|FG001|Overall Study|Withdrawal by Subject|2
7680087|NCT00280683|12097382|FG000|Overall Study|Adverse Event|1
7680088|NCT00280683|12097383|FG001|Overall Study|Adverse Event|1
7680089|NCT00280735|12097391|FG000|Overall Study|Adverse Event|5
7680090|NCT00280735|12097391|FG000|Overall Study|Lack of Efficacy|3
7680091|NCT00280735|12097391|FG000|Overall Study|Withdrawal by Subject|8
7680092|NCT00280735|12097391|FG000|Overall Study|Intercurrent Illness|2
7680093|NCT00280748|12097399|FG000|Overall Study|Decline in performance|3
7680094|NCT00280748|12097399|FG000|Overall Study|Extra-cranial disease progression|1
7680095|NCT00280917|12097416|FG000|Overall Study|Adverse Event|1
7680096|NCT00280917|12097417|FG001|Overall Study|Adverse Event|1
7680097|NCT00280917|12097418|FG002|Overall Study|Adverse Event|4
7680098|NCT00280917|12097419|FG003|Overall Study|Adverse Event|1
7680099|NCT00280917|12097416|FG000|Overall Study|Change Therapy|1
7680100|NCT00280917|12097417|FG001|Overall Study|Change Therapy|2
7680101|NCT00280917|12097418|FG002|Overall Study|Change Therapy|0
7680102|NCT00280917|12097419|FG003|Overall Study|Change Therapy|0
7680103|NCT00280917|12097416|FG000|Overall Study|Withdrawal by Subject|0
7680104|NCT00280917|12097417|FG001|Overall Study|Withdrawal by Subject|2
7680105|NCT00280917|12097418|FG002|Overall Study|Withdrawal by Subject|0
7680106|NCT00280917|12097419|FG003|Overall Study|Withdrawal by Subject|1
7680107|NCT00280917|12097416|FG000|Overall Study|Noncompliance|0
7680108|NCT00280917|12097417|FG001|Overall Study|Noncompliance|1
7680109|NCT00280917|12097418|FG002|Overall Study|Noncompliance|2
7680110|NCT00280917|12097419|FG003|Overall Study|Noncompliance|0
7680111|NCT00281099|12097435|FG000|Overall Study|Death|46
7680112|NCT00281099|12097436|FG001|Overall Study|Death|57
7680113|NCT00281099|12097435|FG000|Overall Study|Lost to Follow-up|10
7680114|NCT00281099|12097436|FG001|Overall Study|Lost to Follow-up|19
7680115|NCT00281099|12097435|FG000|Overall Study|Withdrawal by Subject|65
7680116|NCT00281099|12097436|FG001|Overall Study|Withdrawal by Subject|70
7680117|NCT00281099|12097435|FG000|Overall Study|Physician Decision|79
7680118|NCT00281099|12097436|FG001|Overall Study|Physician Decision|72
7680119|NCT00281099|12097435|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5
7680120|NCT00281099|12097436|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4
7680121|NCT00281528|12097450|FG000|Overall Study|Progressive Disease|28
7680122|NCT00281528|12097451|FG001|Overall Study|Progressive Disease|18
7680123|NCT00281528|12097452|FG002|Overall Study|Progressive Disease|27
7680124|NCT00281528|12097450|FG000|Overall Study|Unacceptable Toxicity-related to trt|21
7680125|NCT00281528|12097451|FG001|Overall Study|Unacceptable Toxicity-related to trt|24
7680126|NCT00281528|12097452|FG002|Overall Study|Unacceptable Toxicity-related to trt|32
7680127|NCT00281528|12097450|FG000|Overall Study|Adverse Event-unrelated to treatment|3
7680128|NCT00281528|12097451|FG001|Overall Study|Adverse Event-unrelated to treatment|0
7680129|NCT00281528|12097452|FG002|Overall Study|Adverse Event-unrelated to treatment|2
7680130|NCT00281528|12097450|FG000|Overall Study|Physician Decision|11
7680131|NCT00281528|12097451|FG001|Overall Study|Physician Decision|4
7680132|NCT00281528|12097452|FG002|Overall Study|Physician Decision|5
7680133|NCT00281528|12097450|FG000|Overall Study|Protocol Violation|1
7680134|NCT00281528|12097451|FG001|Overall Study|Protocol Violation|0
7680135|NCT00281528|12097452|FG002|Overall Study|Protocol Violation|1
7680136|NCT00281528|12097450|FG000|Overall Study|Withdrawal by Subject|5
7680137|NCT00281528|12097451|FG001|Overall Study|Withdrawal by Subject|5
7680138|NCT00281528|12097452|FG002|Overall Study|Withdrawal by Subject|7
7680139|NCT00281528|12097450|FG000|Overall Study|Other|6
7680140|NCT00281528|12097451|FG001|Overall Study|Other|3
7680141|NCT00281528|12097452|FG002|Overall Study|Other|5
7680142|NCT00281580|12097476|FG000|Overall Study|Adverse Event|2
7680143|NCT00281580|12097477|FG001|Overall Study|Adverse Event|0
7680144|NCT00281580|12097478|FG002|Overall Study|Adverse Event|2
7680145|NCT00281580|12097479|FG003|Overall Study|Adverse Event|4
7680146|NCT00281580|12097480|FG004|Overall Study|Adverse Event|1
7680147|NCT00281580|12097481|FG005|Overall Study|Adverse Event|0
7680148|NCT00281580|12097482|FG006|Overall Study|Adverse Event|1
7680149|NCT00281580|12097483|FG007|Overall Study|Adverse Event|0
7680150|NCT00281580|12097484|FG008|Overall Study|Adverse Event|1
7680151|NCT00281580|12097485|FG009|Overall Study|Adverse Event|6
7680152|NCT00281580|12097486|FG010|Overall Study|Adverse Event|0
7680153|NCT00281580|12097487|FG011|Overall Study|Adverse Event|5
7680154|NCT00281580|12097488|FG012|Overall Study|Adverse Event|8
7680155|NCT00281580|12097489|FG013|Overall Study|Adverse Event|2
7680156|NCT00281580|12097490|FG014|Overall Study|Adverse Event|3
7680157|NCT00281580|12097491|FG015|Overall Study|Adverse Event|3
7680158|NCT00281580|12097476|FG000|Overall Study|Protocol Violation|0
7680159|NCT00281580|12097477|FG001|Overall Study|Protocol Violation|0
7680160|NCT00281580|12097478|FG002|Overall Study|Protocol Violation|1
7680161|NCT00281580|12097479|FG003|Overall Study|Protocol Violation|1
7680162|NCT00281580|12097480|FG004|Overall Study|Protocol Violation|0
7680163|NCT00281580|12097481|FG005|Overall Study|Protocol Violation|0
7680164|NCT00281580|12097482|FG006|Overall Study|Protocol Violation|1
7680165|NCT00281580|12097483|FG007|Overall Study|Protocol Violation|0
7680166|NCT00281580|12097484|FG008|Overall Study|Protocol Violation|2
7680167|NCT00281580|12097485|FG009|Overall Study|Protocol Violation|0
7680168|NCT00281580|12097486|FG010|Overall Study|Protocol Violation|1
7680169|NCT00281580|12097487|FG011|Overall Study|Protocol Violation|2
7680170|NCT00281580|12097488|FG012|Overall Study|Protocol Violation|0
7680171|NCT00281580|12097489|FG013|Overall Study|Protocol Violation|1
7680172|NCT00281580|12097490|FG014|Overall Study|Protocol Violation|1
7680173|NCT00281580|12097491|FG015|Overall Study|Protocol Violation|3
7680174|NCT00281580|12097476|FG000|Overall Study|Withdrawal by Subject|3
7680175|NCT00281580|12097477|FG001|Overall Study|Withdrawal by Subject|0
7680176|NCT00281580|12097478|FG002|Overall Study|Withdrawal by Subject|1
7680177|NCT00281580|12097479|FG003|Overall Study|Withdrawal by Subject|1
7680178|NCT00281580|12097480|FG004|Overall Study|Withdrawal by Subject|1
7680179|NCT00281580|12097481|FG005|Overall Study|Withdrawal by Subject|2
7680180|NCT00281580|12097482|FG006|Overall Study|Withdrawal by Subject|2
7680181|NCT00281580|12097483|FG007|Overall Study|Withdrawal by Subject|0
7680182|NCT00281580|12097484|FG008|Overall Study|Withdrawal by Subject|1
7680183|NCT00281580|12097485|FG009|Overall Study|Withdrawal by Subject|4
7680184|NCT00281580|12097486|FG010|Overall Study|Withdrawal by Subject|1
7680185|NCT00281580|12097487|FG011|Overall Study|Withdrawal by Subject|1
7680186|NCT00281580|12097488|FG012|Overall Study|Withdrawal by Subject|2
7680187|NCT00281580|12097489|FG013|Overall Study|Withdrawal by Subject|2
7680188|NCT00281580|12097490|FG014|Overall Study|Withdrawal by Subject|1
7680189|NCT00281580|12097491|FG015|Overall Study|Withdrawal by Subject|5
7680190|NCT00281580|12097476|FG000|Overall Study|Lack of Efficacy|2
7680191|NCT00281580|12097477|FG001|Overall Study|Lack of Efficacy|1
7680192|NCT00281580|12097478|FG002|Overall Study|Lack of Efficacy|1
7680193|NCT00281580|12097479|FG003|Overall Study|Lack of Efficacy|6
7680194|NCT00281580|12097480|FG004|Overall Study|Lack of Efficacy|2
7680195|NCT00281580|12097481|FG005|Overall Study|Lack of Efficacy|0
7680196|NCT00281580|12097482|FG006|Overall Study|Lack of Efficacy|0
7680197|NCT00281580|12097483|FG007|Overall Study|Lack of Efficacy|0
7680198|NCT00281580|12097484|FG008|Overall Study|Lack of Efficacy|0
7680199|NCT00281580|12097485|FG009|Overall Study|Lack of Efficacy|0
7680200|NCT00281580|12097486|FG010|Overall Study|Lack of Efficacy|0
7680201|NCT00281580|12097487|FG011|Overall Study|Lack of Efficacy|1
7680202|NCT00281580|12097488|FG012|Overall Study|Lack of Efficacy|0
7680203|NCT00281580|12097489|FG013|Overall Study|Lack of Efficacy|2
7680204|NCT00281580|12097490|FG014|Overall Study|Lack of Efficacy|1
7680205|NCT00281580|12097491|FG015|Overall Study|Lack of Efficacy|0
7680206|NCT00281580|12097476|FG000|Overall Study|Lost to Follow-up|0
7680207|NCT00281580|12097477|FG001|Overall Study|Lost to Follow-up|0
7680208|NCT00281580|12097478|FG002|Overall Study|Lost to Follow-up|0
7680209|NCT00281580|12097479|FG003|Overall Study|Lost to Follow-up|3
7680210|NCT00281580|12097480|FG004|Overall Study|Lost to Follow-up|0
7680211|NCT00281580|12097481|FG005|Overall Study|Lost to Follow-up|1
7680212|NCT00281580|12097482|FG006|Overall Study|Lost to Follow-up|0
7680213|NCT00281580|12097483|FG007|Overall Study|Lost to Follow-up|1
7680214|NCT00281580|12097484|FG008|Overall Study|Lost to Follow-up|2
7680215|NCT00281580|12097485|FG009|Overall Study|Lost to Follow-up|1
7680216|NCT00281580|12097486|FG010|Overall Study|Lost to Follow-up|1
7680217|NCT00281580|12097487|FG011|Overall Study|Lost to Follow-up|0
7680218|NCT00281580|12097488|FG012|Overall Study|Lost to Follow-up|1
7680219|NCT00281580|12097489|FG013|Overall Study|Lost to Follow-up|0
7680220|NCT00281580|12097490|FG014|Overall Study|Lost to Follow-up|0
7680221|NCT00281580|12097491|FG015|Overall Study|Lost to Follow-up|0
7680222|NCT00281580|12097476|FG000|Overall Study|Randomised in error; pregnancy; moving|0
7680223|NCT00281580|12097477|FG001|Overall Study|Randomised in error; pregnancy; moving|0
7680224|NCT00281580|12097478|FG002|Overall Study|Randomised in error; pregnancy; moving|0
7680225|NCT00281580|12097479|FG003|Overall Study|Randomised in error; pregnancy; moving|2
7680226|NCT00281580|12097480|FG004|Overall Study|Randomised in error; pregnancy; moving|0
7680227|NCT00281580|12097481|FG005|Overall Study|Randomised in error; pregnancy; moving|0
7680228|NCT00281580|12097482|FG006|Overall Study|Randomised in error; pregnancy; moving|1
7680229|NCT00281580|12097483|FG007|Overall Study|Randomised in error; pregnancy; moving|0
7680230|NCT00281580|12097484|FG008|Overall Study|Randomised in error; pregnancy; moving|2
7680231|NCT00281580|12097485|FG009|Overall Study|Randomised in error; pregnancy; moving|1
7680232|NCT00281580|12097486|FG010|Overall Study|Randomised in error; pregnancy; moving|1
7680233|NCT00281580|12097487|FG011|Overall Study|Randomised in error; pregnancy; moving|1
7680234|NCT00281580|12097488|FG012|Overall Study|Randomised in error; pregnancy; moving|2
7680235|NCT00281580|12097489|FG013|Overall Study|Randomised in error; pregnancy; moving|0
7680236|NCT00281580|12097490|FG014|Overall Study|Randomised in error; pregnancy; moving|1
7680237|NCT00281580|12097491|FG015|Overall Study|Randomised in error; pregnancy; moving|2
7680238|NCT00281632|12097560|FG000|Overall Study|Adverse Event|7
7680239|NCT00281632|12097560|FG000|Overall Study|Withdrawal by Subject|2
7680240|NCT00281632|12097560|FG000|Overall Study|Disease Progression|22
7680241|NCT00281632|12097560|FG000|Overall Study|Death|1
7680242|NCT00281632|12097560|FG000|Overall Study|Physician Decision|1
7680243|NCT00281632|12097560|FG000|Overall Study|Ongoing|3
7680244|NCT00281684|12097586|FG000|Overall Study|Lost to Follow-up|0
7680245|NCT00281684|12097587|FG001|Overall Study|Lost to Follow-up|0
7680246|NCT00281684|12097588|FG002|Overall Study|Lost to Follow-up|1
7680247|NCT00281684|12097589|FG003|Overall Study|Lost to Follow-up|0
7680248|NCT00281684|12097586|FG000|Overall Study|Withdrawal by Subject|1
7680249|NCT00281684|12097587|FG001|Overall Study|Withdrawal by Subject|0
7680250|NCT00281684|12097588|FG002|Overall Study|Withdrawal by Subject|0
7680251|NCT00281684|12097589|FG003|Overall Study|Withdrawal by Subject|0
7680252|NCT00281697|12097603|FG000|Overall Study|> 60 days since last dose of study drug|4
7680253|NCT00281697|12097604|FG001|Overall Study|> 60 days since last dose of study drug|4
7680254|NCT00281697|12097603|FG000|Overall Study|Adverse Event|54
7680255|NCT00281697|12097604|FG001|Overall Study|Adverse Event|15
7680256|NCT00281697|12097603|FG000|Overall Study|Death|8
7680257|NCT00281697|12097604|FG001|Overall Study|Death|3
7680258|NCT00281697|12097603|FG000|Overall Study|Disease progression|279
7680259|NCT00281697|12097604|FG001|Overall Study|Disease progression|149
7680260|NCT00281697|12097603|FG000|Overall Study|Other|5
7680261|NCT00281697|12097604|FG001|Overall Study|Other|6
7680262|NCT00281697|12097603|FG000|Overall Study|Physician's decision to withdraw|15
7680263|NCT00281697|12097604|FG001|Overall Study|Physician's decision to withdraw|12
7680264|NCT00281697|12097603|FG000|Overall Study|Subject/guardian's decision to withdraw|33
7680265|NCT00281697|12097604|FG001|Overall Study|Subject/guardian's decision to withdraw|6
7680266|NCT00281697|12097603|FG000|Overall Study|Did not receive study drug|3
7680267|NCT00281697|12097604|FG001|Overall Study|Did not receive study drug|2
7680268|NCT00281840|12097616|FG000|Overall Study|Adverse Event|12
7680269|NCT00281840|12097616|FG000|Overall Study|Physician Decision|6
7680270|NCT00281840|12097616|FG000|Overall Study|Withdrawal by Subject|3
7680271|NCT00281840|12097616|FG000|Overall Study|Disease Progression|2
7680272|NCT00281840|12097616|FG000|Overall Study|exceed maximum delay in treatment|1
7680273|NCT00281840|12097616|FG000|Overall Study|Complicating Disease|1
7680274|NCT00281957|12097632|FG000|Overall Study|Adverse Event|7
7680275|NCT00281957|12097633|FG001|Overall Study|Adverse Event|2
7680276|NCT00281957|12097632|FG000|Overall Study|Death|1
7680277|NCT00281957|12097633|FG001|Overall Study|Death|0
7680278|NCT00281957|12097632|FG000|Overall Study|Progression/relapse|47
7680279|NCT00281957|12097633|FG001|Overall Study|Progression/relapse|35
7680280|NCT00281957|12097632|FG000|Overall Study|Not protocol specified|8
7680281|NCT00281957|12097633|FG001|Overall Study|Not protocol specified|1
7680282|NCT00281957|12097632|FG000|Overall Study|Not eligible|1
7680283|NCT00281957|12097633|FG001|Overall Study|Not eligible|2
7680284|NCT00281957|12097632|FG000|Overall Study|Did not start treatment|3
7680285|NCT00281957|12097633|FG001|Overall Study|Did not start treatment|1
7680286|NCT00281957|12097632|FG000|Overall Study|Refusal unrelated to adverse events|0
7680287|NCT00281957|12097633|FG001|Overall Study|Refusal unrelated to adverse events|1
7680288|NCT00282048|12097641|FG000|Overall Study|Lack of Efficacy|30
7680289|NCT00282048|12097641|FG000|Overall Study|Adverse Event|22
7680290|NCT00282048|12097641|FG000|Overall Study|Withdrawal by Subject|1
7680291|NCT00282048|12097641|FG000|Overall Study|Other|8
7680292|NCT00282048|12097641|FG000|Overall Study|Ongoing|1
7680293|NCT00282087|12097645|FG000|Overall Study|Death|1
7680294|NCT00282113|12097653|FG000|Overall Study|Removed at parents request|1
7680295|NCT00282113|12097654|FG001|Overall Study|Removed at parents request|0
7680296|NCT00282113|12097655|FG002|Overall Study|Removed at parents request|0
7680297|NCT00282152|12097665|FG000|Overall Study|Withdrawal by Subject|1
7680298|NCT00282152|12097666|FG001|Overall Study|Withdrawal by Subject|0
7680299|NCT00282243|12097673|FG000|Pharmacokinetic Treatment Period|Adverse Event|3
7680300|NCT00282243|12097673|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
7680301|NCT00282243|12097673|FG000|Extension Treatment Period|Adverse Event|15
7680302|NCT00282243|12097673|FG000|Extension Treatment Period|Withdrawal by Subject|4
7680303|NCT00282243|12097673|FG000|Extension Treatment Period|Non-compliance|2
7680304|NCT00282243|12097673|FG000|Extension Treatment Period|Physician Decision|1
7680305|NCT00282256|12097677|FG000|Pharmacokinetic Treatment Period|Poor venous access|1
7680306|NCT00282256|12097677|FG000|Extension Treatment Period|Adverse Event|2
7680307|NCT00282295|12097689|FG000|Overall Study|Adverse Event|0
7680308|NCT00282295|12097690|FG001|Overall Study|Adverse Event|1
7680309|NCT00282295|12097691|FG002|Overall Study|Adverse Event|0
7680310|NCT00282295|12097689|FG000|Overall Study|Serious Adverse Events|0
7680311|NCT00282295|12097690|FG001|Overall Study|Serious Adverse Events|0
7680312|NCT00282295|12097691|FG002|Overall Study|Serious Adverse Events|1
7680313|NCT00282295|12097689|FG000|Overall Study|Protocol Violation|0
7680314|NCT00282295|12097690|FG001|Overall Study|Protocol Violation|2
7680315|NCT00282295|12097691|FG002|Overall Study|Protocol Violation|1
7680316|NCT00282295|12097689|FG000|Overall Study|Withdrawal by Subject|2
7680317|NCT00282295|12097690|FG001|Overall Study|Withdrawal by Subject|6
7680318|NCT00282295|12097691|FG002|Overall Study|Withdrawal by Subject|4
7680319|NCT00282295|12097689|FG000|Overall Study|Lost to Follow-up|1
7680320|NCT00282295|12097690|FG001|Overall Study|Lost to Follow-up|7
7680321|NCT00282295|12097691|FG002|Overall Study|Lost to Follow-up|2
7680322|NCT00282295|12097689|FG000|Overall Study|Other|0
7680323|NCT00282295|12097690|FG001|Overall Study|Other|1
7680324|NCT00282295|12097691|FG002|Overall Study|Other|0
7680325|NCT00282308|12097706|FG000|Treatment Period|Lost to Follow-up|1
7680326|NCT00282308|12097707|FG001|Treatment Period|Lost to Follow-up|0
7680327|NCT00282308|12097708|FG002|Treatment Period|Lost to Follow-up|0
7680328|NCT00282308|12097706|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2
7680329|NCT00282308|12097707|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4
7680330|NCT00282308|12097708|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0
7680331|NCT00282308|12097706|FG000|Treatment Period|Adverse Event|0
7680332|NCT00282308|12097707|FG001|Treatment Period|Adverse Event|2
7680333|NCT00282308|12097708|FG002|Treatment Period|Adverse Event|0
7680334|NCT00282308|12097706|FG000|Treatment Period|Not Treated with Study Drug|1
7680335|NCT00282308|12097707|FG001|Treatment Period|Not Treated with Study Drug|0
7680336|NCT00282308|12097708|FG002|Treatment Period|Not Treated with Study Drug|0
7680337|NCT00282308|12097706|FG000|Optional Extension Re-treatment Period|Adverse Event|0
7680338|NCT00282308|12097707|FG001|Optional Extension Re-treatment Period|Adverse Event|0
7680339|NCT00282308|12097708|FG002|Optional Extension Re-treatment Period|Adverse Event|4
7680340|NCT00282308|12097706|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
7680341|NCT00282308|12097707|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
7680342|NCT00282308|12097708|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
7680343|NCT00282308|12097706|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
7680344|NCT00282308|12097707|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
7680345|NCT00282308|12097708|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
7680346|NCT00282308|12097706|FG000|Safety Follow-up Period|Adverse Event|0
7680347|NCT00282308|12097707|FG001|Safety Follow-up Period|Adverse Event|0
7680348|NCT00282308|12097708|FG002|Safety Follow-up Period|Adverse Event|1
7680349|NCT00282308|12097706|FG000|Safety Follow-up Period|Lost to Follow-up|0
7680350|NCT00282308|12097707|FG001|Safety Follow-up Period|Lost to Follow-up|0
7680351|NCT00282308|12097708|FG002|Safety Follow-up Period|Lost to Follow-up|5
7680352|NCT00282308|12097706|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0
7680353|NCT00282308|12097707|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0
7680518|NCT00283387|12097940|FG000|First Intervention|Subject non-compliant|1
7680354|NCT00282308|12097708|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1
7680355|NCT00282308|12097706|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
7680356|NCT00282308|12097707|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
7680357|NCT00282308|12097708|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
7680358|NCT00282334|12097720|FG000|Overall Study|Withdrawal by Subject|8
7680359|NCT00282334|12097721|FG001|Overall Study|Withdrawal by Subject|5
7680360|NCT00282347|12097729|FG000|Treatment Period|Death|2
7680361|NCT00282347|12097730|FG001|Treatment Period|Death|0
7680362|NCT00282347|12097729|FG000|Treatment Period|Lost to Follow-up|2
7680363|NCT00282347|12097730|FG001|Treatment Period|Lost to Follow-up|5
7680364|NCT00282347|12097729|FG000|Treatment Period|Withdrawal by Subject|1
7680365|NCT00282347|12097730|FG001|Treatment Period|Withdrawal by Subject|3
7680366|NCT00282347|12097729|FG000|Treatment Period|Physician Decision|0
7680367|NCT00282347|12097730|FG001|Treatment Period|Physician Decision|1
7680368|NCT00282347|12097729|FG000|Safety Follow-up Period|Lost to Follow-up|0
7680369|NCT00282347|12097730|FG001|Safety Follow-up Period|Lost to Follow-up|2
7680370|NCT00282347|12097729|FG000|Safety Follow-up Period|Withdrawal by Subject|2
7680371|NCT00282347|12097730|FG001|Safety Follow-up Period|Withdrawal by Subject|1
7680372|NCT00282347|12097729|FG000|Safety Follow-up Period|Physician Decision|1
7680373|NCT00282347|12097730|FG001|Safety Follow-up Period|Physician Decision|1
7680374|NCT00282347|12097729|FG000|Safety Follow-up Period|Protocol Deviation|0
7680375|NCT00282347|12097730|FG001|Safety Follow-up Period|Protocol Deviation|2
7680376|NCT00282347|12097729|FG000|B Cell Follow-up Period|Withdrawal by Subject|2
7680377|NCT00282347|12097730|FG001|B Cell Follow-up Period|Withdrawal by Subject|0
7680378|NCT00282347|12097729|FG000|B Cell Follow-up Period|Physician Decision|1
7680379|NCT00282347|12097730|FG001|B Cell Follow-up Period|Physician Decision|0
7680380|NCT00282347|12097729|FG000|B Cell Follow-up Period|Reason Not Specified|2
7680381|NCT00282347|12097730|FG001|B Cell Follow-up Period|Reason Not Specified|0
7680382|NCT00282412|12097738|FG000|Overall Study|Death|2
7680383|NCT00282438|12097744|FG000|Overall Study|Lack of Efficacy|1
7680384|NCT00282438|12097745|FG001|Overall Study|Lack of Efficacy|0
7680385|NCT00282438|12097744|FG000|Overall Study|Death|0
7680386|NCT00282438|12097745|FG001|Overall Study|Death|1
7680387|NCT00282464|12097753|FG000|Overall Study|Adverse Event|26
7680388|NCT00282464|12097754|FG001|Overall Study|Adverse Event|20
7680389|NCT00282464|12097753|FG000|Overall Study|Lack of Efficacy|8
7680390|NCT00282464|12097754|FG001|Overall Study|Lack of Efficacy|8
7680391|NCT00282464|12097753|FG000|Overall Study|Lost to Follow-up|10
7680392|NCT00282464|12097754|FG001|Overall Study|Lost to Follow-up|10
7680393|NCT00282464|12097753|FG000|Overall Study|Withdrawal by Subject|24
7680394|NCT00282464|12097754|FG001|Overall Study|Withdrawal by Subject|10
7680395|NCT00282464|12097753|FG000|Overall Study|laboratory abnormality|1
7680396|NCT00282464|12097754|FG001|Overall Study|laboratory abnormality|2
7680397|NCT00282464|12097753|FG000|Overall Study|Protocol Violation|0
7680398|NCT00282464|12097754|FG001|Overall Study|Protocol Violation|7
7680399|NCT00282464|12097753|FG000|Overall Study|Patient moved|1
7680400|NCT00282464|12097754|FG001|Overall Study|Patient moved|0
7680401|NCT00282464|12097753|FG000|Overall Study|patient non-compliant|3
7680402|NCT00282464|12097754|FG001|Overall Study|patient non-compliant|0
7680403|NCT00282464|12097753|FG000|Overall Study|patient no show|0
7680404|NCT00282464|12097754|FG001|Overall Study|patient no show|1
7680405|NCT00282464|12097753|FG000|Overall Study|patient incarcerated|0
7680406|NCT00282464|12097754|FG001|Overall Study|patient incarcerated|1
7680407|NCT00282464|12097753|FG000|Overall Study|family crisis|0
7680408|NCT00282464|12097754|FG001|Overall Study|family crisis|1
7680409|NCT00282464|12097753|FG000|Overall Study|dispensed wrong kit|0
7680410|NCT00282464|12097754|FG001|Overall Study|dispensed wrong kit|1
7680411|NCT00282464|12097753|FG000|Overall Study|dropped due to missed visits|0
7680412|NCT00282464|12097754|FG001|Overall Study|dropped due to missed visits|1
7680413|NCT00282568|12097760|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
7680414|NCT00282568|12097760|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1
7680415|NCT00282568|12097760|FG000|Extended Treatment Period|Adverse Event|17
7680416|NCT00282568|12097760|FG000|Extended Treatment Period|Non-compliance|4
7680417|NCT00282568|12097760|FG000|Extended Treatment Period|Physician Decision|1
7680418|NCT00282568|12097760|FG000|Extended Treatment Period|Lost to Follow-up|2
7680419|NCT00282919|12097835|FG000|Overall Study|Lack of Efficacy|4
7680420|NCT00282919|12097835|FG000|Overall Study|Withdrawal by Subject|1
7680421|NCT00282919|12097835|FG000|Overall Study|Asymptomatic Parasitemia|2
7680422|NCT00282984|12097850|FG000|Overall Study|Death|2
7680423|NCT00282984|12097851|FG001|Overall Study|Death|5
7680424|NCT00282984|12097850|FG000|Overall Study|Adverse Event|8
7680425|NCT00282984|12097851|FG001|Overall Study|Adverse Event|5
7680426|NCT00282984|12097850|FG000|Overall Study|Lack of Efficacy|0
7680427|NCT00282984|12097851|FG001|Overall Study|Lack of Efficacy|2
7680428|NCT00282984|12097850|FG000|Overall Study|Lost to Follow-up|14
7680429|NCT00282984|12097851|FG001|Overall Study|Lost to Follow-up|10
7680430|NCT00282984|12097850|FG000|Overall Study|Withdrawal by Participant|22
7680431|NCT00282984|12097851|FG001|Overall Study|Withdrawal by Participant|34
7680432|NCT00282984|12097850|FG000|Overall Study|Participant stopped study medication|2
7680433|NCT00282984|12097851|FG001|Overall Study|Participant stopped study medication|2
7680434|NCT00282984|12097850|FG000|Overall Study|Participant only allowed phone follow-up|0
7680435|NCT00282984|12097851|FG001|Overall Study|Participant only allowed phone follow-up|1
7680436|NCT00282984|12097850|FG000|Overall Study|Participant used antipsychosis meds|0
7680437|NCT00282984|12097851|FG001|Overall Study|Participant used antipsychosis meds|1
7680438|NCT00282984|12097850|FG000|Overall Study|lack of motivation|1
7680439|NCT00282984|12097851|FG001|Overall Study|lack of motivation|0
7680440|NCT00282984|12097850|FG000|Overall Study|in prison|0
7680441|NCT00282984|12097851|FG001|Overall Study|in prison|1
7680442|NCT00282984|12097850|FG000|Overall Study|Protocol Violation|2
7680443|NCT00282984|12097851|FG001|Overall Study|Protocol Violation|0
7680444|NCT00283049|12097860|FG000|Overall Study|Adverse Event|6
7680445|NCT00283049|12097861|FG001|Overall Study|Adverse Event|1
7680446|NCT00283049|12097862|FG002|Overall Study|Adverse Event|4
7680447|NCT00283049|12097860|FG000|Overall Study|Protocol Violation|3
7680448|NCT00283049|12097861|FG001|Overall Study|Protocol Violation|0
7680449|NCT00283049|12097862|FG002|Overall Study|Protocol Violation|3
7680450|NCT00283049|12097860|FG000|Overall Study|Death|1
7680451|NCT00283049|12097861|FG001|Overall Study|Death|1
7680452|NCT00283049|12097862|FG002|Overall Study|Death|1
7680453|NCT00283049|12097860|FG000|Overall Study|Lack of Efficacy|0
7680454|NCT00283049|12097861|FG001|Overall Study|Lack of Efficacy|1
7680455|NCT00283049|12097862|FG002|Overall Study|Lack of Efficacy|1
7680456|NCT00283049|12097860|FG000|Overall Study|Lost to Follow-up|4
7680457|NCT00283049|12097861|FG001|Overall Study|Lost to Follow-up|2
7680458|NCT00283049|12097862|FG002|Overall Study|Lost to Follow-up|5
7680459|NCT00283049|12097860|FG000|Overall Study|Withdrawal by Subject|26
7680460|NCT00283049|12097861|FG001|Overall Study|Withdrawal by Subject|24
7680461|NCT00283049|12097862|FG002|Overall Study|Withdrawal by Subject|19
7680462|NCT00283049|12097860|FG000|Overall Study|Discontinuation of Study|18
7680463|NCT00283049|12097861|FG001|Overall Study|Discontinuation of Study|16
7680464|NCT00283049|12097862|FG002|Overall Study|Discontinuation of Study|20
7680465|NCT00283049|12097860|FG000|Overall Study|No longer requires study treatment|0
7680466|NCT00283049|12097861|FG001|Overall Study|No longer requires study treatment|0
7680467|NCT00283049|12097862|FG002|Overall Study|No longer requires study treatment|1
7680468|NCT00283062|12097874|FG000|Overall Study|Did not receive any study medication|5
7680469|NCT00283062|12097875|FG001|Overall Study|Did not receive any study medication|4
7680470|NCT00283062|12097876|FG002|Overall Study|Did not receive any study medication|36
7680471|NCT00283062|12097877|FG003|Overall Study|Did not receive any study medication|45
7680472|NCT00283062|12097874|FG000|Overall Study|Adverse Event|2
7680473|NCT00283062|12097875|FG001|Overall Study|Adverse Event|0
7680474|NCT00283062|12097876|FG002|Overall Study|Adverse Event|1
7680475|NCT00283062|12097877|FG003|Overall Study|Adverse Event|0
7680476|NCT00283062|12097874|FG000|Overall Study|Lost to Follow-up|1
7680477|NCT00283062|12097875|FG001|Overall Study|Lost to Follow-up|0
7680478|NCT00283062|12097876|FG002|Overall Study|Lost to Follow-up|1
7680479|NCT00283062|12097877|FG003|Overall Study|Lost to Follow-up|0
7680480|NCT00283062|12097874|FG000|Overall Study|Progressive disease|0
7680481|NCT00283062|12097875|FG001|Overall Study|Progressive disease|0
7680482|NCT00283062|12097876|FG002|Overall Study|Progressive disease|1
7680483|NCT00283062|12097877|FG003|Overall Study|Progressive disease|0
7680484|NCT00283062|12097874|FG000|Overall Study|Participant did not wish to continue|3
7680485|NCT00283062|12097875|FG001|Overall Study|Participant did not wish to continue|2
7680486|NCT00283062|12097876|FG002|Overall Study|Participant did not wish to continue|1
7680487|NCT00283062|12097877|FG003|Overall Study|Participant did not wish to continue|0
7680488|NCT00283062|12097874|FG000|Overall Study|Undefined|0
7680489|NCT00283062|12097875|FG001|Overall Study|Undefined|1
7680490|NCT00283062|12097876|FG002|Overall Study|Undefined|1
7680491|NCT00283062|12097877|FG003|Overall Study|Undefined|4
7680492|NCT00283062|12097874|FG000|Overall Study|chemotherapy not completed (cycle 6)|1
7680493|NCT00283062|12097875|FG001|Overall Study|chemotherapy not completed (cycle 6)|0
7680494|NCT00283062|12097876|FG002|Overall Study|chemotherapy not completed (cycle 6)|0
7680495|NCT00283062|12097877|FG003|Overall Study|chemotherapy not completed (cycle 6)|0
7680496|NCT00283244|12097902|FG000|Overall Study|Adverse Event|0
7680497|NCT00283244|12097903|FG001|Overall Study|Adverse Event|8
7680498|NCT00283244|12097904|FG002|Overall Study|Adverse Event|11
7680499|NCT00283244|12097902|FG000|Overall Study|Death|4
7680500|NCT00283244|12097903|FG001|Overall Study|Death|3
7680501|NCT00283244|12097904|FG002|Overall Study|Death|2
7680502|NCT00283244|12097902|FG000|Overall Study|Lack of Efficacy|8
7680503|NCT00283244|12097903|FG001|Overall Study|Lack of Efficacy|32
7680504|NCT00283244|12097904|FG002|Overall Study|Lack of Efficacy|26
7680505|NCT00283244|12097902|FG000|Overall Study|Withdrawal by Subject|1
7680506|NCT00283244|12097903|FG001|Overall Study|Withdrawal by Subject|2
7680507|NCT00283244|12097904|FG002|Overall Study|Withdrawal by Subject|2
7680508|NCT00283244|12097902|FG000|Overall Study|Physician Decision|0
7680509|NCT00283244|12097903|FG001|Overall Study|Physician Decision|0
7680510|NCT00283244|12097904|FG002|Overall Study|Physician Decision|1
7680511|NCT00283244|12097902|FG000|Overall Study|Medical illness (other complicating dz)|4
7680512|NCT00283244|12097903|FG001|Overall Study|Medical illness (other complicating dz)|3
7680513|NCT00283244|12097904|FG002|Overall Study|Medical illness (other complicating dz)|6
7680514|NCT00283244|12097902|FG000|Overall Study|Clinical deterioration|1
7680515|NCT00283244|12097903|FG001|Overall Study|Clinical deterioration|3
7680516|NCT00283244|12097904|FG002|Overall Study|Clinical deterioration|3
7680517|NCT00283296|12097935|FG000|Overall Study|in-home trial not completed|5
7680519|NCT00283387|12097941|FG001|First Intervention|Subject non-compliant|1
7680520|NCT00283387|12097940|FG000|First Intervention|Withdrawal by Subject|0
7680521|NCT00283387|12097941|FG001|First Intervention|Withdrawal by Subject|1
7680522|NCT00283400|12097951|FG000|Overall Study|Withdrawal by Subject|1
7680523|NCT00283400|12097952|FG001|Overall Study|Withdrawal by Subject|1
7680524|NCT00283400|12097953|FG002|Overall Study|Withdrawal by Subject|0
7680525|NCT00283400|12097954|FG003|Overall Study|Withdrawal by Subject|0
7680526|NCT00283400|12097951|FG000|Overall Study|Death|1
7680527|NCT00283400|12097952|FG001|Overall Study|Death|0
7680528|NCT00283400|12097953|FG002|Overall Study|Death|1
7680529|NCT00283400|12097954|FG003|Overall Study|Death|0
7680530|NCT00283439|12097968|FG000|Overall Study|Adverse Event|0
7680531|NCT00283439|12097969|FG001|Overall Study|Adverse Event|0
7680532|NCT00283439|12097970|FG002|Overall Study|Adverse Event|0
7680533|NCT00283439|12097971|FG003|Overall Study|Adverse Event|1
7680534|NCT00283439|12097968|FG000|Overall Study|Death|0
7680535|NCT00283439|12097969|FG001|Overall Study|Death|0
7680536|NCT00283439|12097970|FG002|Overall Study|Death|1
7680537|NCT00283439|12097971|FG003|Overall Study|Death|0
7680538|NCT00283439|12097968|FG000|Overall Study|Disease progression|0
7680539|NCT00283439|12097969|FG001|Overall Study|Disease progression|1
7680540|NCT00283439|12097970|FG002|Overall Study|Disease progression|0
7680541|NCT00283439|12097971|FG003|Overall Study|Disease progression|0
7680542|NCT00283439|12097968|FG000|Overall Study|Requirement for alternative therapy|1
7680543|NCT00283439|12097969|FG001|Overall Study|Requirement for alternative therapy|2
7680544|NCT00283439|12097970|FG002|Overall Study|Requirement for alternative therapy|5
7680545|NCT00283439|12097971|FG003|Overall Study|Requirement for alternative therapy|2
7680546|NCT00283439|12097968|FG000|Overall Study|Stem cell transplant|6
7680547|NCT00283439|12097969|FG001|Overall Study|Stem cell transplant|6
7680548|NCT00283439|12097970|FG002|Overall Study|Stem cell transplant|4
7680549|NCT00283439|12097971|FG003|Overall Study|Stem cell transplant|3
7680550|NCT00283439|12097968|FG000|Overall Study|Treatment discontinued|0
7680551|NCT00283439|12097969|FG001|Overall Study|Treatment discontinued|2
7680552|NCT00283439|12097970|FG002|Overall Study|Treatment discontinued|1
7680553|NCT00283439|12097971|FG003|Overall Study|Treatment discontinued|3
7680554|NCT00283439|12097968|FG000|Overall Study|Other|1
7680555|NCT00283439|12097969|FG001|Overall Study|Other|0
7680556|NCT00283439|12097970|FG002|Overall Study|Other|0
7680557|NCT00283439|12097971|FG003|Overall Study|Other|0
7680558|NCT00283595|12097994|FG000|Overall Study|Withdrawal by Subject|1
7680559|NCT00283595|12097995|FG001|Overall Study|Withdrawal by Subject|2
7680560|NCT00283686|12098005|FG000|Overall Study|Death|1
7680561|NCT00283686|12098006|FG001|Overall Study|Death|1
7680562|NCT00283686|12098007|FG002|Overall Study|Death|1
7680563|NCT00283686|12098008|FG003|Overall Study|Death|0
7680564|NCT00283686|12098005|FG000|Overall Study|Lost to Follow-up|21
7680565|NCT00283686|12098006|FG001|Overall Study|Lost to Follow-up|31
7680566|NCT00283686|12098007|FG002|Overall Study|Lost to Follow-up|26
7680567|NCT00283686|12098008|FG003|Overall Study|Lost to Follow-up|20
7680568|NCT00283686|12098005|FG000|Overall Study|Less than full participation|7
7680569|NCT00283686|12098006|FG001|Overall Study|Less than full participation|9
7680570|NCT00283686|12098007|FG002|Overall Study|Less than full participation|6
7680571|NCT00283686|12098008|FG003|Overall Study|Less than full participation|12
7680572|NCT00283712|12098020|FG000|Overall Study|Death|0
7680573|NCT00283712|12098021|FG001|Overall Study|Death|1
7680574|NCT00283803|12098027|FG000|Overall Study|Physician Decision|9
7680575|NCT00283803|12098027|FG000|Overall Study|Withdrawal by Subject|4
7680576|NCT00283842|12098047|FG000|Overall Study|Adverse Event|8
7680577|NCT00283842|12098048|FG001|Overall Study|Adverse Event|7
7680578|NCT00283842|12098049|FG002|Overall Study|Adverse Event|21
7680579|NCT00283842|12098050|FG003|Overall Study|Adverse Event|21
7680580|NCT00283842|12098051|FG004|Overall Study|Adverse Event|5
7680581|NCT00283842|12098047|FG000|Overall Study|Protocol Violation|1
7680582|NCT00283842|12098048|FG001|Overall Study|Protocol Violation|5
7680583|NCT00283842|12098049|FG002|Overall Study|Protocol Violation|4
7680584|NCT00283842|12098050|FG003|Overall Study|Protocol Violation|0
7680585|NCT00283842|12098051|FG004|Overall Study|Protocol Violation|0
7680586|NCT00283842|12098047|FG000|Overall Study|Protocol deviation|0
7680587|NCT00283842|12098048|FG001|Overall Study|Protocol deviation|0
7680588|NCT00283842|12098049|FG002|Overall Study|Protocol deviation|0
7680589|NCT00283842|12098050|FG003|Overall Study|Protocol deviation|0
7680590|NCT00283842|12098051|FG004|Overall Study|Protocol deviation|2
7680591|NCT00283842|12098047|FG000|Overall Study|Withdrawal by Subject|2
7680592|NCT00283842|12098048|FG001|Overall Study|Withdrawal by Subject|1
7680593|NCT00283842|12098049|FG002|Overall Study|Withdrawal by Subject|1
7680594|NCT00283842|12098050|FG003|Overall Study|Withdrawal by Subject|5
7680595|NCT00283842|12098051|FG004|Overall Study|Withdrawal by Subject|4
7680596|NCT00283842|12098047|FG000|Overall Study|Lack of Efficacy|1
7680597|NCT00283842|12098048|FG001|Overall Study|Lack of Efficacy|3
7680598|NCT00283842|12098049|FG002|Overall Study|Lack of Efficacy|1
7680599|NCT00283842|12098050|FG003|Overall Study|Lack of Efficacy|0
7680600|NCT00283842|12098051|FG004|Overall Study|Lack of Efficacy|3
7680601|NCT00283842|12098047|FG000|Overall Study|Lost to Follow-up|0
7680602|NCT00283842|12098048|FG001|Overall Study|Lost to Follow-up|2
7680603|NCT00283842|12098049|FG002|Overall Study|Lost to Follow-up|4
7680604|NCT00283842|12098050|FG003|Overall Study|Lost to Follow-up|1
7680605|NCT00283842|12098051|FG004|Overall Study|Lost to Follow-up|1
7680606|NCT00284050|12098070|FG000|Overall Study|Adverse Event|1
7680607|NCT00284050|12098071|FG001|Overall Study|Adverse Event|1
7680608|NCT00284050|12098072|FG002|Overall Study|Adverse Event|1
7680609|NCT00284050|12098070|FG000|Overall Study|Lack of Efficacy|0
7680610|NCT00284050|12098071|FG001|Overall Study|Lack of Efficacy|1
7680611|NCT00284050|12098072|FG002|Overall Study|Lack of Efficacy|3
7680612|NCT00284050|12098070|FG000|Overall Study|Protocol Violation|0
7680613|NCT00284050|12098071|FG001|Overall Study|Protocol Violation|1
7680614|NCT00284050|12098072|FG002|Overall Study|Protocol Violation|2
7680615|NCT00284050|12098070|FG000|Overall Study|Withdrawal by Subject|2
7680616|NCT00284050|12098071|FG001|Overall Study|Withdrawal by Subject|2
7680617|NCT00284050|12098072|FG002|Overall Study|Withdrawal by Subject|2
7680618|NCT00284050|12098070|FG000|Overall Study|Lost to Follow-up|1
7680619|NCT00284050|12098071|FG001|Overall Study|Lost to Follow-up|0
7680620|NCT00284050|12098072|FG002|Overall Study|Lost to Follow-up|1
7680621|NCT00284050|12098070|FG000|Overall Study|Death|1
7680622|NCT00284050|12098071|FG001|Overall Study|Death|0
7680623|NCT00284050|12098072|FG002|Overall Study|Death|0
7680624|NCT00284089|12098084|FG000|Multiple Dose Phase|Adverse Event|1
7680625|NCT00284089|12098085|FG001|Multiple Dose Phase|Adverse Event|0
7680626|NCT00284089|12098086|FG002|Multiple Dose Phase|Adverse Event|1
7680627|NCT00284089|12098087|FG003|Multiple Dose Phase|Adverse Event|1
7680628|NCT00284089|12098084|FG000|Multiple Dose Phase|Protocol Violation|0
7680629|NCT00284089|12098085|FG001|Multiple Dose Phase|Protocol Violation|0
7680630|NCT00284089|12098086|FG002|Multiple Dose Phase|Protocol Violation|1
7680631|NCT00284089|12098087|FG003|Multiple Dose Phase|Protocol Violation|0
7680632|NCT00284089|12098084|FG000|Multiple Dose Phase|Withdrawal by Subject|0
7680633|NCT00284089|12098085|FG001|Multiple Dose Phase|Withdrawal by Subject|0
7680634|NCT00284089|12098086|FG002|Multiple Dose Phase|Withdrawal by Subject|1
7680635|NCT00284089|12098087|FG003|Multiple Dose Phase|Withdrawal by Subject|2
7680636|NCT00284089|12098084|FG000|Multiple Dose Phase|Death|0
7680637|NCT00284089|12098085|FG001|Multiple Dose Phase|Death|0
7680638|NCT00284089|12098086|FG002|Multiple Dose Phase|Death|1
7680639|NCT00284089|12098087|FG003|Multiple Dose Phase|Death|1
7680640|NCT00284089|12098084|FG000|Extension Phase|Adverse Event|0
7680641|NCT00284089|12098085|FG001|Extension Phase|Adverse Event|0
7680642|NCT00284089|12098086|FG002|Extension Phase|Adverse Event|2
7680643|NCT00284089|12098087|FG003|Extension Phase|Adverse Event|2
7680644|NCT00284089|12098084|FG000|Extension Phase|condition no longer requires study drug|2
7680645|NCT00284089|12098085|FG001|Extension Phase|condition no longer requires study drug|0
7680646|NCT00284089|12098086|FG002|Extension Phase|condition no longer requires study drug|2
7680647|NCT00284089|12098087|FG003|Extension Phase|condition no longer requires study drug|7
7680648|NCT00284089|12098084|FG000|Extension Phase|Protocol Violation|0
7680649|NCT00284089|12098085|FG001|Extension Phase|Protocol Violation|0
7680650|NCT00284089|12098086|FG002|Extension Phase|Protocol Violation|1
7680651|NCT00284089|12098087|FG003|Extension Phase|Protocol Violation|0
7680652|NCT00284089|12098084|FG000|Extension Phase|Withdrawal by Subject|0
7680653|NCT00284089|12098085|FG001|Extension Phase|Withdrawal by Subject|0
7680654|NCT00284089|12098086|FG002|Extension Phase|Withdrawal by Subject|1
7680655|NCT00284089|12098087|FG003|Extension Phase|Withdrawal by Subject|3
7680656|NCT00284141|12098097|FG000|Overall Study|Disease Progression / Lack of efficacy|51
7680657|NCT00284141|12098097|FG000|Overall Study|Adverse Event|19
7680658|NCT00284141|12098097|FG000|Overall Study|Participant's request|9
7680659|NCT00284141|12098097|FG000|Overall Study|Symptomatic / Clinical Progression|11
7680660|NCT00284141|12098097|FG000|Overall Study|Clinical deterioration / death|2
7680661|NCT00284141|12098097|FG000|Overall Study|General decline|1
7680662|NCT00284141|12098097|FG000|Overall Study|Pneumonia|1
7680663|NCT00284141|12098097|FG000|Overall Study|Did not take study medication|2
7680664|NCT00284141|12098097|FG000|Overall Study|Ongoing treatment|2
7680665|NCT00284934|12098153|FG000|Overall Study|Adverse Event|1
7680666|NCT00284934|12098154|FG001|Overall Study|Adverse Event|2
7680667|NCT00284934|12098153|FG000|Overall Study|Other reasons|3
7680668|NCT00284934|12098154|FG001|Overall Study|Other reasons|1
7680669|NCT00285012|12098162|FG000|Assigned to Study Treatment (Tx)|Other|2
7680670|NCT00285012|12098163|FG001|Assigned to Study Treatment (Tx)|Other|3
7680671|NCT00285012|12098162|FG000|Received Study Tx|Death|2
7680672|NCT00285012|12098163|FG001|Received Study Tx|Death|1
7680673|NCT00285012|12098162|FG000|Received Study Tx|Adverse Event|5
7680674|NCT00285012|12098163|FG001|Received Study Tx|Adverse Event|11
7680675|NCT00285012|12098162|FG000|Received Study Tx|Lack of Efficacy|0
7680676|NCT00285012|12098163|FG001|Received Study Tx|Lack of Efficacy|3
7680677|NCT00285012|12098162|FG000|Received Study Tx|Lost to Follow-up|29
7680678|NCT00285012|12098163|FG001|Received Study Tx|Lost to Follow-up|31
7680679|NCT00285012|12098162|FG000|Received Study Tx|Withdrawal by Subject|31
7680680|NCT00285012|12098163|FG001|Received Study Tx|Withdrawal by Subject|43
7680681|NCT00285012|12098162|FG000|Received Study Tx|Other|5
7680682|NCT00285012|12098163|FG001|Received Study Tx|Other|5
7680683|NCT00285207|12098171|FG000|Overall Study|Lost to Follow-up|3
7680684|NCT00285207|12098172|FG001|Overall Study|Lost to Follow-up|2
7680685|NCT00285207|12098171|FG000|Overall Study|Withdrawal by Subject|5
7680686|NCT00285207|12098172|FG001|Overall Study|Withdrawal by Subject|2
7680687|NCT00285207|12098171|FG000|Overall Study|Pregnancy|1
7680688|NCT00285207|12098172|FG001|Overall Study|Pregnancy|1
7680689|NCT00285207|12098171|FG000|Overall Study|non-compliance|0
7680690|NCT00285207|12098172|FG001|Overall Study|non-compliance|1
7680691|NCT00285584|12098193|FG000|Month 3|Lost to Follow-up|3
7680692|NCT00285584|12098194|FG001|Month 3|Lost to Follow-up|3
7680693|NCT00285584|12098193|FG000|Month 3|Withdrawal by Subject|1
7680694|NCT00285584|12098194|FG001|Month 3|Withdrawal by Subject|0
7680695|NCT00285584|12098193|FG000|Month 6|Lost to Follow-up|0
7680696|NCT00285584|12098194|FG001|Month 6|Lost to Follow-up|1
7680697|NCT00285649|12098207|FG000|Overall Study|Lost to Follow-up|6
7680698|NCT00285649|12098208|FG001|Overall Study|Lost to Follow-up|4
7680699|NCT00285649|12098209|FG002|Overall Study|Lost to Follow-up|4
7680700|NCT00285649|12098207|FG000|Overall Study|Withdrawal by Subject|3
7680701|NCT00285649|12098208|FG001|Overall Study|Withdrawal by Subject|2
7680702|NCT00285649|12098209|FG002|Overall Study|Withdrawal by Subject|2
7680703|NCT00285818|12098228|FG000|Overall Study|Withdrawal by Subject|3
7680704|NCT00285818|12098229|FG001|Overall Study|Withdrawal by Subject|2
7680705|NCT00285818|12098228|FG000|Overall Study|Lost to Follow-up|1
7680706|NCT00285818|12098229|FG001|Overall Study|Lost to Follow-up|0
7680707|NCT00285857|12098235|FG000|Overall Study|Withdrawal by Subject|2
7680708|NCT00285857|12098235|FG000|Overall Study|Inadequate initial breast cytology|1
7680709|NCT00285857|12098235|FG000|Overall Study|Adverse Event|1
7680710|NCT00286091|12098255|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103
7680711|NCT00286091|12098256|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113
7680712|NCT00286091|12098255|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307
7680713|NCT00286091|12098256|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269
7680714|NCT00286091|12098255|FG000|Double-blind Treatment Phase|Death|58
7680715|NCT00286091|12098256|FG001|Double-blind Treatment Phase|Death|65
7680716|NCT00286091|12098255|FG000|Double-blind Treatment Phase|Adverse Event|28
7680717|NCT00286091|12098256|FG001|Double-blind Treatment Phase|Adverse Event|40
7680718|NCT00286091|12098255|FG000|Double-blind Treatment Phase|Disease Progression|22
7680719|NCT00286091|12098256|FG001|Double-blind Treatment Phase|Disease Progression|35
7680720|NCT00286091|12098255|FG000|Double-blind Treatment Phase|Other|25
7680721|NCT00286091|12098256|FG001|Double-blind Treatment Phase|Other|33
7680722|NCT00286091|12098255|FG000|Double-blind Treatment Phase|Administrative Decision|20
7680723|NCT00286091|12098256|FG001|Double-blind Treatment Phase|Administrative Decision|21
7680724|NCT00286091|12098255|FG000|Double-blind Treatment Phase|Noncompliance|8
7680725|NCT00286091|12098256|FG001|Double-blind Treatment Phase|Noncompliance|8
7680726|NCT00286091|12098255|FG000|Double-blind Treatment Phase|Lost to Follow-up|11
7680727|NCT00286091|12098256|FG001|Double-blind Treatment Phase|Lost to Follow-up|4
7680728|NCT00286091|12098255|FG000|Double-blind Treatment Phase|Protocol Deviation|1
7680729|NCT00286091|12098256|FG001|Double-blind Treatment Phase|Protocol Deviation|3
7680730|NCT00286091|12098255|FG000|Double-blind Treatment Phase|Ineligibility Determined|1
7680731|NCT00286091|12098256|FG001|Double-blind Treatment Phase|Ineligibility Determined|2
7680732|NCT00286091|12098255|FG000|Open-label Treatment Phase|Physician Decision|24
7680733|NCT00286091|12098256|FG001|Open-label Treatment Phase|Physician Decision|21
7680734|NCT00286091|12098255|FG000|Open-label Treatment Phase|Adverse Event|5
7680735|NCT00286091|12098256|FG001|Open-label Treatment Phase|Adverse Event|16
7680736|NCT00286091|12098255|FG000|Open-label Treatment Phase|Other|11
7680737|NCT00286091|12098256|FG001|Open-label Treatment Phase|Other|11
7680738|NCT00286091|12098255|FG000|Open-label Treatment Phase|Withdrawal by Subject|14
7680739|NCT00286091|12098256|FG001|Open-label Treatment Phase|Withdrawal by Subject|10
7680740|NCT00286091|12098255|FG000|Open-label Treatment Phase|Death|10
7680741|NCT00286091|12098256|FG001|Open-label Treatment Phase|Death|7
7680742|NCT00286091|12098255|FG000|Open-label Treatment Phase|Disease Progression|9
7680743|NCT00286091|12098256|FG001|Open-label Treatment Phase|Disease Progression|3
7680744|NCT00286091|12098255|FG000|Open-label Treatment Phase|Noncompliance|3
7680745|NCT00286091|12098256|FG001|Open-label Treatment Phase|Noncompliance|1
7680746|NCT00286091|12098255|FG000|Open-label Treatment Phase|Lost to Follow-up|0
7680747|NCT00286091|12098256|FG001|Open-label Treatment Phase|Lost to Follow-up|1
7680748|NCT00286091|12098255|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1
7680749|NCT00286091|12098256|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0
7680750|NCT00286091|12098255|FG000|Open-label Treatment Phase|Missing End of Study Information|0
7680751|NCT00286091|12098256|FG001|Open-label Treatment Phase|Missing End of Study Information|1
7680752|NCT00286156|12098267|FG000|Overall Study|Missed 12 month visit|0
7680753|NCT00286156|12098268|FG001|Overall Study|Missed 12 month visit|0
7680754|NCT00286156|12098269|FG002|Overall Study|Missed 12 month visit|1
7680755|NCT00286156|12098267|FG000|Overall Study|AE: pulmonary embolus|0
7680756|NCT00286156|12098268|FG001|Overall Study|AE: pulmonary embolus|1
7680757|NCT00286156|12098269|FG002|Overall Study|AE: pulmonary embolus|0
7680758|NCT00286156|12098267|FG000|Overall Study|AE: nephrotic-range proteinuruia|1
7680759|NCT00286156|12098268|FG001|Overall Study|AE: nephrotic-range proteinuruia|0
7680760|NCT00286156|12098269|FG002|Overall Study|AE: nephrotic-range proteinuruia|0
7680761|NCT00286156|12098267|FG000|Overall Study|AE: pneumonia|1
7680762|NCT00286156|12098268|FG001|Overall Study|AE: pneumonia|0
7680763|NCT00286156|12098269|FG002|Overall Study|AE: pneumonia|0
7680764|NCT00286221|12098290|FG000|Overall Study|Protocol Violation|2
7680765|NCT00286221|12098291|FG001|Overall Study|Protocol Violation|1
7680766|NCT00286221|12098292|FG002|Overall Study|Protocol Violation|6
7680767|NCT00286221|12098293|FG003|Overall Study|Protocol Violation|4
7680768|NCT00286221|12098290|FG000|Overall Study|Unanticipated Neurosurgical Complication|6
7680769|NCT00286221|12098291|FG001|Overall Study|Unanticipated Neurosurgical Complication|3
7680770|NCT00286221|12098292|FG002|Overall Study|Unanticipated Neurosurgical Complication|3
7680771|NCT00286221|12098293|FG003|Overall Study|Unanticipated Neurosurgical Complication|2
7680772|NCT00286221|12098290|FG000|Overall Study|Inability to trigger PCA|2
7680773|NCT00286221|12098291|FG001|Overall Study|Inability to trigger PCA|0
7680774|NCT00286221|12098292|FG002|Overall Study|Inability to trigger PCA|0
7680775|NCT00286221|12098293|FG003|Overall Study|Inability to trigger PCA|0
7680776|NCT00286221|12098290|FG000|Overall Study|Unrecognized exclusion criteria met|0
7680777|NCT00286221|12098291|FG001|Overall Study|Unrecognized exclusion criteria met|1
7680778|NCT00286221|12098292|FG002|Overall Study|Unrecognized exclusion criteria met|0
7680779|NCT00286221|12098293|FG003|Overall Study|Unrecognized exclusion criteria met|0
7680780|NCT00286234|12098307|FG000|Overall Study|Protocol Violation|1
7680781|NCT00286234|12098308|FG001|Overall Study|Protocol Violation|2
7680782|NCT00286234|12098309|FG002|Overall Study|Protocol Violation|0
7680783|NCT00286234|12098310|FG003|Overall Study|Protocol Violation|1
7680784|NCT00286234|12098307|FG000|Overall Study|Physician Decision|1
7680785|NCT00286234|12098308|FG001|Overall Study|Physician Decision|0
7680786|NCT00286234|12098309|FG002|Overall Study|Physician Decision|0
7680787|NCT00286234|12098310|FG003|Overall Study|Physician Decision|1
7680788|NCT00286234|12098307|FG000|Overall Study|Adverse Event|0
7680789|NCT00286234|12098308|FG001|Overall Study|Adverse Event|0
7680790|NCT00286234|12098309|FG002|Overall Study|Adverse Event|0
7680791|NCT00286234|12098310|FG003|Overall Study|Adverse Event|1
7680792|NCT00286234|12098307|FG000|Overall Study|Adverse Event|0
7680793|NCT00286234|12098308|FG001|Overall Study|Adverse Event|0
7680794|NCT00286234|12098309|FG002|Overall Study|Adverse Event|0
7680795|NCT00286234|12098310|FG003|Overall Study|Adverse Event|1
7680796|NCT00286429|12098327|FG000|Overall Study|Adverse Event|4
7680797|NCT00286429|12098328|FG001|Overall Study|Adverse Event|1
7680798|NCT00286429|12098329|FG002|Overall Study|Adverse Event|6
7680799|NCT00286429|12098327|FG000|Overall Study|Lack of Efficacy|52
7680800|NCT00286429|12098328|FG001|Overall Study|Lack of Efficacy|27
7680801|NCT00286429|12098329|FG002|Overall Study|Lack of Efficacy|25
7680802|NCT00286429|12098327|FG000|Overall Study|Lost to Follow-up|2
7680803|NCT00286429|12098328|FG001|Overall Study|Lost to Follow-up|4
7680804|NCT00286429|12098329|FG002|Overall Study|Lost to Follow-up|3
7680805|NCT00286429|12098327|FG000|Overall Study|Physician Decision|10
7680806|NCT00286429|12098328|FG001|Overall Study|Physician Decision|7
7680807|NCT00286429|12098329|FG002|Overall Study|Physician Decision|7
7680808|NCT00286429|12098327|FG000|Overall Study|Protocol Violation|3
7680809|NCT00286429|12098328|FG001|Overall Study|Protocol Violation|5
7680810|NCT00286429|12098329|FG002|Overall Study|Protocol Violation|4
7680811|NCT00286429|12098327|FG000|Overall Study|Withdrawal by Subject|3
7680812|NCT00286429|12098328|FG001|Overall Study|Withdrawal by Subject|2
7680813|NCT00286429|12098329|FG002|Overall Study|Withdrawal by Subject|6
7680814|NCT00286429|12098327|FG000|Overall Study|Administrative Error|1
7680815|NCT00286429|12098328|FG001|Overall Study|Administrative Error|1
7680816|NCT00286429|12098329|FG002|Overall Study|Administrative Error|1
7680817|NCT00286429|12098327|FG000|Overall Study|Administrative Decision|0
7680818|NCT00286429|12098328|FG001|Overall Study|Administrative Decision|1
7680819|NCT00286429|12098329|FG002|Overall Study|Administrative Decision|0
7680820|NCT00286442|12098340|FG000|Overall Study|Hyperglycemic Rescue|19
7680821|NCT00286442|12098341|FG001|Overall Study|Hyperglycemic Rescue|17
7680822|NCT00286442|12098342|FG002|Overall Study|Hyperglycemic Rescue|25
7680823|NCT00286442|12098340|FG000|Overall Study|Adverse Event|7
7680824|NCT00286442|12098341|FG001|Overall Study|Adverse Event|6
7680825|NCT00286442|12098342|FG002|Overall Study|Adverse Event|1
7680826|NCT00286442|12098340|FG000|Overall Study|Protocol Violation|2
7680827|NCT00286442|12098341|FG001|Overall Study|Protocol Violation|4
7680828|NCT00286442|12098342|FG002|Overall Study|Protocol Violation|2
7680829|NCT00286442|12098340|FG000|Overall Study|Lost to Follow-up|5
7680830|NCT00286442|12098341|FG001|Overall Study|Lost to Follow-up|2
7680831|NCT00286442|12098342|FG002|Overall Study|Lost to Follow-up|1
7680832|NCT00286442|12098340|FG000|Overall Study|Physician Decision|1
7680833|NCT00286442|12098341|FG001|Overall Study|Physician Decision|1
7680834|NCT00286442|12098342|FG002|Overall Study|Physician Decision|1
7680835|NCT00286442|12098340|FG000|Overall Study|Administrative Error|1
7680836|NCT00286442|12098341|FG001|Overall Study|Administrative Error|1
7680837|NCT00286442|12098342|FG002|Overall Study|Administrative Error|0
7680838|NCT00286442|12098340|FG000|Overall Study|Withdrawal by Subject|2
7680839|NCT00286442|12098341|FG001|Overall Study|Withdrawal by Subject|14
7680840|NCT00286442|12098342|FG002|Overall Study|Withdrawal by Subject|2
7680841|NCT00286455|12098353|FG000|Overall Study|Hyperglycemia rescue|19
7680842|NCT00286455|12098354|FG001|Overall Study|Hyperglycemia rescue|13
7680843|NCT00286455|12098355|FG002|Overall Study|Hyperglycemia rescue|10
7680844|NCT00286455|12098353|FG000|Overall Study|Adverse Event|1
7680845|NCT00286455|12098354|FG001|Overall Study|Adverse Event|3
7680846|NCT00286455|12098355|FG002|Overall Study|Adverse Event|2
7680847|NCT00286455|12098353|FG000|Overall Study|Lost to Follow-up|0
7680848|NCT00286455|12098354|FG001|Overall Study|Lost to Follow-up|3
7680849|NCT00286455|12098355|FG002|Overall Study|Lost to Follow-up|3
7680850|NCT00286455|12098353|FG000|Overall Study|Physician Decision|3
7680851|NCT00286455|12098354|FG001|Overall Study|Physician Decision|0
7680852|NCT00286455|12098355|FG002|Overall Study|Physician Decision|2
7680853|NCT00286455|12098353|FG000|Overall Study|Protocol Violation|1
7680854|NCT00286455|12098354|FG001|Overall Study|Protocol Violation|1
7680855|NCT00286455|12098355|FG002|Overall Study|Protocol Violation|0
7680856|NCT00286455|12098353|FG000|Overall Study|Participant Non-compliance|1
7680857|NCT00286455|12098354|FG001|Overall Study|Participant Non-compliance|0
7680858|NCT00286455|12098355|FG002|Overall Study|Participant Non-compliance|0
7680859|NCT00286455|12098353|FG000|Overall Study|Withdrawal by Subject|0
7680860|NCT00286455|12098354|FG001|Overall Study|Withdrawal by Subject|8
7680861|NCT00286455|12098355|FG002|Overall Study|Withdrawal by Subject|7
7680862|NCT00286468|12098366|FG000|Overall Study|Hyperglycemic Rescue|28
7680863|NCT00286468|12098367|FG001|Overall Study|Hyperglycemic Rescue|30
7680864|NCT00286468|12098368|FG002|Overall Study|Hyperglycemic Rescue|31
7680865|NCT00286468|12098366|FG000|Overall Study|Adverse Event|2
7680866|NCT00286468|12098367|FG001|Overall Study|Adverse Event|6
7680867|NCT00286468|12098368|FG002|Overall Study|Adverse Event|4
7680868|NCT00286468|12098366|FG000|Overall Study|Protocol Violation|0
7680869|NCT00286468|12098367|FG001|Overall Study|Protocol Violation|3
7680870|NCT00286468|12098368|FG002|Overall Study|Protocol Violation|1
7680871|NCT00286468|12098366|FG000|Overall Study|Lost to Follow-up|1
7680872|NCT00286468|12098367|FG001|Overall Study|Lost to Follow-up|1
7680873|NCT00286468|12098368|FG002|Overall Study|Lost to Follow-up|2
7680874|NCT00286468|12098366|FG000|Overall Study|Withdrawal by Subject|3
7680875|NCT00286468|12098367|FG001|Overall Study|Withdrawal by Subject|8
7680876|NCT00286468|12098368|FG002|Overall Study|Withdrawal by Subject|11
7680877|NCT00286468|12098366|FG000|Overall Study|Physician Decision|3
7680878|NCT00286468|12098367|FG001|Overall Study|Physician Decision|2
7680879|NCT00286468|12098368|FG002|Overall Study|Physician Decision|1
7680880|NCT00286494|12098379|FG000|Overall Study|Hyperglycemic rescue|12
7680881|NCT00286494|12098380|FG001|Overall Study|Hyperglycemic rescue|19
7680882|NCT00286494|12098381|FG002|Overall Study|Hyperglycemic rescue|18
7680883|NCT00286494|12098379|FG000|Overall Study|Withdrawal by Subject|2
7680884|NCT00286494|12098380|FG001|Overall Study|Withdrawal by Subject|10
7680885|NCT00286494|12098381|FG002|Overall Study|Withdrawal by Subject|9
7680886|NCT00286494|12098379|FG000|Overall Study|Adverse Event|3
7680887|NCT00286494|12098380|FG001|Overall Study|Adverse Event|8
7680888|NCT00286494|12098381|FG002|Overall Study|Adverse Event|6
7680889|NCT00286494|12098379|FG000|Overall Study|Physician Decision|5
7680890|NCT00286494|12098380|FG001|Overall Study|Physician Decision|5
7680891|NCT00286494|12098381|FG002|Overall Study|Physician Decision|1
7680892|NCT00286494|12098379|FG000|Overall Study|Lost to Follow-up|3
7680893|NCT00286494|12098380|FG001|Overall Study|Lost to Follow-up|1
7680894|NCT00286494|12098381|FG002|Overall Study|Lost to Follow-up|3
7680895|NCT00286494|12098379|FG000|Overall Study|Protocol Violation|1
7680896|NCT00286494|12098380|FG001|Overall Study|Protocol Violation|1
7680897|NCT00286494|12098381|FG002|Overall Study|Protocol Violation|2
7680898|NCT00286754|12098413|FG000|Overall Study|Adverse Event|2
7680899|NCT00286754|12098414|FG001|Overall Study|Adverse Event|2
7680900|NCT00286754|12098415|FG002|Overall Study|Adverse Event|3
7680901|NCT00286754|12098413|FG000|Overall Study|Withdrawal by Subject|6
7680902|NCT00286754|12098414|FG001|Overall Study|Withdrawal by Subject|2
7680903|NCT00286754|12098415|FG002|Overall Study|Withdrawal by Subject|0
7680904|NCT00286754|12098413|FG000|Overall Study|Lost to Follow-up|12
7680905|NCT00286754|12098414|FG001|Overall Study|Lost to Follow-up|14
7680906|NCT00286754|12098415|FG002|Overall Study|Lost to Follow-up|6
7680907|NCT00286754|12098413|FG000|Overall Study|Moved out of state|0
7680908|NCT00286754|12098414|FG001|Overall Study|Moved out of state|0
7680909|NCT00286754|12098415|FG002|Overall Study|Moved out of state|1
7680910|NCT00287079|12098446|FG000|Overall Study|Qualifying relapse|12
7680911|NCT00287079|12098447|FG001|Overall Study|Qualifying relapse|1
7680912|NCT00287079|12098446|FG000|Overall Study|Non-qualifying relapse|1
7680913|NCT00287079|12098447|FG001|Overall Study|Non-qualifying relapse|0
7680914|NCT00287079|12098446|FG000|Overall Study|Adverse Event|5
7680915|NCT00287079|12098447|FG001|Overall Study|Adverse Event|0
7680916|NCT00287079|12098446|FG000|Overall Study|Protocol Violation|1
7680917|NCT00287079|12098447|FG001|Overall Study|Protocol Violation|0
7680918|NCT00287079|12098446|FG000|Overall Study|Other|3
7680919|NCT00287079|12098447|FG001|Overall Study|Other|0
7680920|NCT00287118|12098453|FG000|Overall Study|Adverse Event|30
7680921|NCT00287118|12098453|FG000|Overall Study|Death|1
7680922|NCT00287118|12098453|FG000|Overall Study|Lack of Efficacy|11
7680923|NCT00287118|12098453|FG000|Overall Study|Lost to Follow-up|1
7680924|NCT00287118|12098453|FG000|Overall Study|Protocol Violation|2
7680925|NCT00287118|12098453|FG000|Overall Study|Other|7
7680926|NCT00287365|12098474|FG000|Overall Study|sample not acquired|13
7680927|NCT00287469|12098481|FG000|Overall Study|serious adverse event|1
7680928|NCT00287469|12098482|FG001|Overall Study|serious adverse event|6
7680929|NCT00287469|12098481|FG000|Overall Study|Adverse Event|1
7680930|NCT00287469|12098482|FG001|Overall Study|Adverse Event|1
7680931|NCT00287469|12098481|FG000|Overall Study|moved from area|144
7680932|NCT00287469|12098482|FG001|Overall Study|moved from area|138
7680933|NCT00287469|12098481|FG000|Overall Study|Lost to Follow-up|74
7680934|NCT00287469|12098482|FG001|Overall Study|Lost to Follow-up|69
7680935|NCT00287586|12098492|FG000|Overall Study|Withdrew Consent|19
7680936|NCT00287586|12098493|FG001|Overall Study|Withdrew Consent|30
7680937|NCT00287586|12098492|FG000|Overall Study|Lost to Follow-up|5
7680938|NCT00287586|12098493|FG001|Overall Study|Lost to Follow-up|4
7680939|NCT00287586|12098492|FG000|Overall Study|Death|2
7680940|NCT00287586|12098493|FG001|Overall Study|Death|3
7680941|NCT00287586|12098492|FG000|Overall Study|Elevated Hematocrit|3
7680942|NCT00287586|12098493|FG001|Overall Study|Elevated Hematocrit|0
7680943|NCT00287586|12098492|FG000|Overall Study|Rash|3
7680944|NCT00287586|12098493|FG001|Overall Study|Rash|0
7680945|NCT00287586|12098492|FG000|Overall Study|Elevated Prostate Specific Antigen|2
7680946|NCT00287586|12098493|FG001|Overall Study|Elevated Prostate Specific Antigen|0
7680947|NCT00287586|12098492|FG000|Overall Study|Stroke|2
7680948|NCT00287586|12098493|FG001|Overall Study|Stroke|0
7680949|NCT00287586|12098492|FG000|Overall Study|Myocardial Infarction|1
7680950|NCT00287586|12098493|FG001|Overall Study|Myocardial Infarction|0
7680951|NCT00287586|12098492|FG000|Overall Study|Lower Urinary Tract Symptoms|1
7680952|NCT00287586|12098493|FG001|Overall Study|Lower Urinary Tract Symptoms|0
7680953|NCT00287586|12098492|FG000|Overall Study|Cognitive Impairment|1
7680954|NCT00287586|12098493|FG001|Overall Study|Cognitive Impairment|0
7680955|NCT00287586|12098492|FG000|Overall Study|Pancreatic Cancer|1
7680956|NCT00287586|12098493|FG001|Overall Study|Pancreatic Cancer|3
7680957|NCT00287586|12098492|FG000|Overall Study|Sleep Apnea|1
7680958|NCT00287586|12098493|FG001|Overall Study|Sleep Apnea|0
7680959|NCT00287586|12098492|FG000|Overall Study|Shoulder Pain|1
7680960|NCT00287586|12098493|FG001|Overall Study|Shoulder Pain|0
7680961|NCT00287586|12098492|FG000|Overall Study|Inappropriate Behaviour with Staff|1
7680962|NCT00287586|12098493|FG001|Overall Study|Inappropriate Behaviour with Staff|0
7680963|NCT00287586|12098492|FG000|Overall Study|Nonadherence|1
7680964|NCT00287586|12098493|FG001|Overall Study|Nonadherence|1
7680965|NCT00287586|12098492|FG000|Overall Study|Enrolled in Another Study|1
7680966|NCT00287586|12098493|FG001|Overall Study|Enrolled in Another Study|0
7680967|NCT00287586|12098492|FG000|Overall Study|Major Depression|0
7680968|NCT00287586|12098493|FG001|Overall Study|Major Depression|2
7680969|NCT00287586|12098492|FG000|Overall Study|Lung Cancer|0
7680970|NCT00287586|12098493|FG001|Overall Study|Lung Cancer|2
7680971|NCT00287586|12098492|FG000|Overall Study|Elevated IPSS Score|0
7680972|NCT00287586|12098493|FG001|Overall Study|Elevated IPSS Score|1
7680973|NCT00287586|12098492|FG000|Overall Study|Retroperitoneal Cancer|0
7680974|NCT00287586|12098493|FG001|Overall Study|Retroperitoneal Cancer|1
7680975|NCT00287586|12098492|FG000|Overall Study|Mastodynia and Gynecomastia|0
7680976|NCT00287586|12098493|FG001|Overall Study|Mastodynia and Gynecomastia|1
7680977|NCT00287586|12098492|FG000|Overall Study|Mood Swings and Irritability|0
7680978|NCT00287586|12098493|FG001|Overall Study|Mood Swings and Irritability|1
7680979|NCT00287586|12098492|FG000|Overall Study|Bradycardia|0
7680980|NCT00287586|12098493|FG001|Overall Study|Bradycardia|1
7680981|NCT00287586|12098492|FG000|Overall Study|Itchy Swollen Eyes|0
7680982|NCT00287586|12098493|FG001|Overall Study|Itchy Swollen Eyes|1
7680983|NCT00287586|12098492|FG000|Overall Study|Recurrent Melanoma|0
7680984|NCT00287586|12098493|FG001|Overall Study|Recurrent Melanoma|1
7680985|NCT00287690|12098501|FG000|Overall Study|Protocol Violation|20
7680986|NCT00287690|12098502|FG001|Overall Study|Protocol Violation|26
7680987|NCT00288015|12098548|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
7680988|NCT00288015|12098548|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
7680989|NCT00288015|12098548|FG000|First Response Assessment|Withdrawal by Subject|1
7680990|NCT00288015|12098548|FG000|First Response Assessment|Death|1
7680991|NCT00288015|12098548|FG000|First Response Assessment|Physician Decision|2
7680992|NCT00288015|12098548|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7
7680993|NCT00288015|12098548|FG000|Follow up for Survival x 2 Years|Death|13
7680994|NCT00288015|12098548|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4
7680995|NCT00288015|12098548|FG000|Follow up for Survival x 2 Years|Other|9
7680996|NCT00288054|12098552|FG000|Overall Study|Protocol Violation|2
7680997|NCT00288054|12098552|FG000|Overall Study|Lack of Efficacy|16
7680998|NCT00288054|12098552|FG000|Overall Study|Adverse Event|3
7680999|NCT00288054|12098552|FG000|Overall Study|Withdrawal by Subject|1
7681000|NCT00288054|12098552|FG000|Overall Study|Not protocol specified|2
7681001|NCT00288587|12098587|FG000|Overall Study|Death|4
7681002|NCT00288587|12098588|FG001|Overall Study|Death|4
7681003|NCT00288587|12098587|FG000|Overall Study|Transplant|0
7681004|NCT00288587|12098588|FG001|Overall Study|Transplant|3
7681005|NCT00288587|12098587|FG000|Overall Study|Adverse Event|0
7681006|NCT00288587|12098588|FG001|Overall Study|Adverse Event|1
7681007|NCT00288587|12098587|FG000|Overall Study|Physician Decision|0
7681008|NCT00288587|12098588|FG001|Overall Study|Physician Decision|2
7681009|NCT00288587|12098587|FG000|Overall Study|Severe Aortic Stenosis|1
7681010|NCT00288587|12098588|FG001|Overall Study|Severe Aortic Stenosis|0
7681011|NCT00288626|12098603|FG000|Overall Study|Death|3
7681012|NCT00288626|12098603|FG000|Overall Study|Withdrawal by Subject|4
7681013|NCT00288639|12098609|FG000|Overall Study|Adverse Event|5
7681014|NCT00288639|12098609|FG000|Overall Study|Lack of Efficacy|4
7681015|NCT00288639|12098609|FG000|Overall Study|Withdrawal by Subject|2
7681016|NCT00288639|12098609|FG000|Overall Study|Other|1
7681017|NCT00288704|12098616|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
7681018|NCT00288704|12098617|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
7681019|NCT00288704|12098618|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
7681020|NCT00288704|12098616|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
7681021|NCT00288704|12098617|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
7681022|NCT00288704|12098618|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
7681023|NCT00288704|12098616|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
7681105|NCT00289289|12098736|FG000|Overall Study|Withdrawal by Subject|5
7681024|NCT00288704|12098617|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
7681025|NCT00288704|12098618|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
7681026|NCT00288704|12098616|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
7681027|NCT00288704|12098617|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
7681028|NCT00288704|12098618|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
7681029|NCT00288704|12098616|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0
7681030|NCT00288704|12098617|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0
7681031|NCT00288704|12098618|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2
7681032|NCT00288704|12098616|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
7681033|NCT00288704|12098617|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
7681034|NCT00288704|12098618|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
7681035|NCT00288704|12098616|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
7681036|NCT00288704|12098617|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
7681037|NCT00288704|12098618|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
7681038|NCT00288860|12098627|FG000|Overall Study|Did not complete intake|4
7681039|NCT00288860|12098628|FG001|Overall Study|Did not complete intake|8
7681040|NCT00288860|12098627|FG000|Overall Study|Death|4
7681041|NCT00288860|12098628|FG001|Overall Study|Death|3
7681042|NCT00288860|12098627|FG000|Overall Study|Withdrawal by Subject|20
7681043|NCT00288860|12098628|FG001|Overall Study|Withdrawal by Subject|15
7681044|NCT00288860|12098627|FG000|Overall Study|Lost to Follow-up|74
7681045|NCT00288860|12098628|FG001|Overall Study|Lost to Follow-up|71
7681046|NCT00288912|12098649|FG000|Overall Study|Developed exclusion criterion|4
7681047|NCT00288912|12098650|FG001|Overall Study|Developed exclusion criterion|6
7681048|NCT00288912|12098651|FG002|Overall Study|Developed exclusion criterion|7
7681049|NCT00288912|12098649|FG000|Overall Study|Lost to Follow-up|9
7681050|NCT00288912|12098650|FG001|Overall Study|Lost to Follow-up|6
7681051|NCT00288912|12098651|FG002|Overall Study|Lost to Follow-up|9
7681052|NCT00288912|12098649|FG000|Overall Study|Withdrawal by Subject|4
7681053|NCT00288912|12098650|FG001|Overall Study|Withdrawal by Subject|5
7681054|NCT00288912|12098651|FG002|Overall Study|Withdrawal by Subject|12
7681055|NCT00289016|12098659|FG000|Overall Study|Disease Progression|29
7681056|NCT00289016|12098659|FG000|Overall Study|Death|2
7681057|NCT00289016|12098659|FG000|Overall Study|Unrelated Medical Condition or Accident|2
7681058|NCT00289016|12098659|FG000|Overall Study|Withdrawal by Subject|2
7681059|NCT00289016|12098659|FG000|Overall Study|Adverse Event|1
7681060|NCT00289016|12098659|FG000|Overall Study|Other|1
7681061|NCT00289133|12098682|FG000|Overall Study|Non-study device implanted|12
7681062|NCT00289133|12098683|FG001|Overall Study|Non-study device implanted|0
7681063|NCT00289133|12098682|FG000|Overall Study|Protocol Violation|32
7681064|NCT00289133|12098683|FG001|Overall Study|Protocol Violation|38
7681065|NCT00289133|12098682|FG000|Overall Study|Withdrawal by Subject|9
7681066|NCT00289133|12098683|FG001|Overall Study|Withdrawal by Subject|10
7681067|NCT00289133|12098682|FG000|Overall Study|Death|5
7681068|NCT00289133|12098683|FG001|Overall Study|Death|10
7681069|NCT00289133|12098682|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73
7681070|NCT00289133|12098683|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74
7681071|NCT00289133|12098682|FG000|Overall Study|Physician Decision|41
7681072|NCT00289133|12098683|FG001|Overall Study|Physician Decision|45
7681073|NCT00289133|12098682|FG000|Overall Study|Revision|8
7681074|NCT00289133|12098683|FG001|Overall Study|Revision|6
7681075|NCT00289133|12098682|FG000|Overall Study|Lost to Follow-up|92
7681076|NCT00289133|12098683|FG001|Overall Study|Lost to Follow-up|115
7681077|NCT00289185|12098695|FG000|Overall Study|Withdrawal by Subject|4
7681078|NCT00289185|12098696|FG001|Overall Study|Withdrawal by Subject|8
7681079|NCT00289185|12098695|FG000|Overall Study|Lost to Follow-up|23
7681080|NCT00289185|12098696|FG001|Overall Study|Lost to Follow-up|17
7681081|NCT00289185|12098695|FG000|Overall Study|Death|1
7681082|NCT00289185|12098696|FG001|Overall Study|Death|1
7681083|NCT00289198|12098705|FG000|Overall Study|Adverse Event|0
7681084|NCT00289198|12098706|FG001|Overall Study|Adverse Event|2
7681085|NCT00289198|12098705|FG000|Overall Study|Protocol Violation|2
7681086|NCT00289198|12098706|FG001|Overall Study|Protocol Violation|1
7681087|NCT00289198|12098705|FG000|Overall Study|Withdrawal by Subject|4
7681088|NCT00289198|12098706|FG001|Overall Study|Withdrawal by Subject|1
7681089|NCT00289198|12098705|FG000|Overall Study|Lack of Efficacy|2
7681090|NCT00289198|12098706|FG001|Overall Study|Lack of Efficacy|0
7681091|NCT00289198|12098705|FG000|Overall Study|Other: Low compliance|0
7681092|NCT00289198|12098706|FG001|Overall Study|Other: Low compliance|1
7681093|NCT00289198|12098705|FG000|Overall Study|Other: Physician's decision|0
7681094|NCT00289198|12098706|FG001|Overall Study|Other: Physician's decision|1
7681095|NCT00289198|12098705|FG000|Overall Study|Other: Unable to attend on schedule|2
7681096|NCT00289198|12098706|FG001|Overall Study|Other: Unable to attend on schedule|1
7681097|NCT00289198|12098705|FG000|Overall Study|Other: Miscalculation of the visit date|21
7681098|NCT00289198|12098706|FG001|Overall Study|Other: Miscalculation of the visit date|22
7681099|NCT00289198|12098705|FG000|Overall Study|Other: Impossible to come on visit|0
7681100|NCT00289198|12098706|FG001|Overall Study|Other: Impossible to come on visit|1
7681101|NCT00289276|12098726|FG000|Second Part of FAST Study (Expansion)|Death|0
7681102|NCT00289276|12098727|FG001|Second Part of FAST Study (Expansion)|Death|2
7681103|NCT00289276|12098726|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
7681104|NCT00289276|12098727|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
7681106|NCT00289289|12098737|FG001|Overall Study|Withdrawal by Subject|3
7681107|NCT00289289|12098738|FG002|Overall Study|Withdrawal by Subject|15
7681108|NCT00289289|12098736|FG000|Overall Study|Lost to Follow-up|1
7681109|NCT00289289|12098737|FG001|Overall Study|Lost to Follow-up|0
7681110|NCT00289289|12098738|FG002|Overall Study|Lost to Follow-up|1
7681111|NCT00289289|12098736|FG000|Overall Study|Death|4
7681112|NCT00289289|12098737|FG001|Overall Study|Death|2
7681113|NCT00289289|12098738|FG002|Overall Study|Death|5
7681114|NCT00289289|12098736|FG000|Overall Study|No implant attempted|0
7681115|NCT00289289|12098737|FG001|Overall Study|No implant attempted|0
7681116|NCT00289289|12098738|FG002|Overall Study|No implant attempted|1
7681117|NCT00289289|12098736|FG000|Overall Study|Physician Decision|1
7681118|NCT00289289|12098737|FG001|Overall Study|Physician Decision|0
7681119|NCT00289289|12098738|FG002|Overall Study|Physician Decision|6
7681120|NCT00289289|12098736|FG000|Overall Study|Non-study device implanted|2
7681121|NCT00289289|12098737|FG001|Overall Study|Non-study device implanted|1
7681122|NCT00289289|12098738|FG002|Overall Study|Non-study device implanted|3
7681123|NCT00289289|12098736|FG000|Overall Study|Did not meet inclusion/exclusion|0
7681124|NCT00289289|12098737|FG001|Overall Study|Did not meet inclusion/exclusion|0
7681125|NCT00289289|12098738|FG002|Overall Study|Did not meet inclusion/exclusion|6
7681126|NCT00289289|12098736|FG000|Overall Study|Other Exit Reason|6
7681127|NCT00289289|12098737|FG001|Overall Study|Other Exit Reason|4
7681128|NCT00289289|12098738|FG002|Overall Study|Other Exit Reason|12
7681129|NCT00289458|12098774|FG000|Overall Study|Death|1
7681130|NCT00289458|12098775|FG001|Overall Study|Death|0
7681131|NCT00289458|12098776|FG002|Overall Study|Death|0
7681132|NCT00289458|12098774|FG000|Overall Study|Physician Decision|3
7681133|NCT00289458|12098775|FG001|Overall Study|Physician Decision|4
7681134|NCT00289458|12098776|FG002|Overall Study|Physician Decision|2
7681135|NCT00289458|12098774|FG000|Overall Study|Withdrawal by Subject|2
7681136|NCT00289458|12098775|FG001|Overall Study|Withdrawal by Subject|2
7681137|NCT00289458|12098776|FG002|Overall Study|Withdrawal by Subject|4
7681138|NCT00289536|12098788|FG000|Period 3|Lost to Follow-up|0
7681139|NCT00289536|12098789|FG001|Period 3|Lost to Follow-up|0
7681140|NCT00289536|12098790|FG002|Period 3|Lost to Follow-up|1
7681141|NCT00289731|12098813|FG000|Overall Study|Adverse Event|1
7681142|NCT00289731|12098814|FG001|Overall Study|Adverse Event|2
7681143|NCT00289731|12098815|FG002|Overall Study|Adverse Event|2
7681144|NCT00289731|12098813|FG000|Overall Study|Other|1
7681145|NCT00289731|12098814|FG001|Overall Study|Other|0
7681146|NCT00289731|12098815|FG002|Overall Study|Other|0
7681147|NCT00289770|12098839|FG000|Year 15|Withdrawal by Subject|1
7681148|NCT00289783|12098845|FG000|Primary Phase|Adverse Event|10
7681149|NCT00289783|12098846|FG001|Primary Phase|Adverse Event|1
7681150|NCT00289783|12098845|FG000|Primary Phase|Protocol Violation|27
7681151|NCT00289783|12098846|FG001|Primary Phase|Protocol Violation|6
7681152|NCT00289783|12098845|FG000|Primary Phase|Withdrawal by Subject|93
7681153|NCT00289783|12098846|FG001|Primary Phase|Withdrawal by Subject|40
7681154|NCT00289783|12098845|FG000|Primary Phase|Lost to Follow-up|60
7681155|NCT00289783|12098846|FG001|Primary Phase|Lost to Follow-up|14
7681156|NCT00289783|12098845|FG000|Primary Phase|Migration from the study area|26
7681157|NCT00289783|12098846|FG001|Primary Phase|Migration from the study area|10
7681158|NCT00289783|12098845|FG000|Primary Phase|Other|32
7681159|NCT00289783|12098846|FG001|Primary Phase|Other|12
7681160|NCT00289783|12098845|FG000|Fourth Dose Phase|Adverse Event|1
7681161|NCT00289783|12098846|FG001|Fourth Dose Phase|Adverse Event|0
7681162|NCT00289783|12098845|FG000|Fourth Dose Phase|Withdrawal by Subject|10
7681163|NCT00289783|12098846|FG001|Fourth Dose Phase|Withdrawal by Subject|1
7681164|NCT00289783|12098845|FG000|Fourth Dose Phase|Lost to Follow-up|53
7681165|NCT00289783|12098846|FG001|Fourth Dose Phase|Lost to Follow-up|12
7681166|NCT00289783|12098845|FG000|Fourth Dose Phase|Migration from the study area|1
7681167|NCT00289783|12098846|FG001|Fourth Dose Phase|Migration from the study area|1
7681168|NCT00289783|12098845|FG000|Fourth Dose Phase|Other|22
7681169|NCT00289783|12098846|FG001|Fourth Dose Phase|Other|10
7681170|NCT00289848|12098862|FG000|Overall Study|Adverse Event|6
7681171|NCT00289848|12098863|FG001|Overall Study|Adverse Event|4
7681172|NCT00289848|12098862|FG000|Overall Study|Death|1
7681173|NCT00289848|12098863|FG001|Overall Study|Death|0
7681174|NCT00289848|12098862|FG000|Overall Study|Lack of Efficacy|20
7681175|NCT00289848|12098863|FG001|Overall Study|Lack of Efficacy|24
7681176|NCT00289848|12098862|FG000|Overall Study|Lost to Follow-up|3
7681177|NCT00289848|12098863|FG001|Overall Study|Lost to Follow-up|1
7681178|NCT00289848|12098862|FG000|Overall Study|Protocol Violation|5
7681179|NCT00289848|12098863|FG001|Overall Study|Protocol Violation|2
7681180|NCT00289848|12098862|FG000|Overall Study|Withdrawal by Subject|5
7681181|NCT00289848|12098863|FG001|Overall Study|Withdrawal by Subject|11
7681182|NCT00289848|12098862|FG000|Overall Study|Patient Moved|6
7681183|NCT00289848|12098863|FG001|Overall Study|Patient Moved|2
7681184|NCT00289848|12098862|FG000|Overall Study|Open-Label AHA Treatment Requested|0
7681185|NCT00289848|12098863|FG001|Overall Study|Open-Label AHA Treatment Requested|1
7681186|NCT00289900|12098875|FG000|Overall Study|Adverse Event|28
7681187|NCT00289900|12098876|FG001|Overall Study|Adverse Event|40
7681188|NCT00289900|12098877|FG002|Overall Study|Adverse Event|13
7681189|NCT00289900|12098878|FG003|Overall Study|Adverse Event|19
7681190|NCT00289900|12098879|FG004|Overall Study|Adverse Event|20
7681191|NCT00289900|12098880|FG005|Overall Study|Adverse Event|33
7681192|NCT00289900|12098875|FG000|Overall Study|Lost to Follow-up|7
7681193|NCT00289900|12098876|FG001|Overall Study|Lost to Follow-up|7
7681194|NCT00289900|12098877|FG002|Overall Study|Lost to Follow-up|8
7681195|NCT00289900|12098878|FG003|Overall Study|Lost to Follow-up|8
7681196|NCT00289900|12098879|FG004|Overall Study|Lost to Follow-up|4
7681197|NCT00289900|12098880|FG005|Overall Study|Lost to Follow-up|8
7681198|NCT00289900|12098875|FG000|Overall Study|Participant had flushing|18
7681199|NCT00289900|12098876|FG001|Overall Study|Participant had flushing|42
7681200|NCT00289900|12098877|FG002|Overall Study|Participant had flushing|1
7681201|NCT00289900|12098878|FG003|Overall Study|Participant had flushing|2
7681202|NCT00289900|12098879|FG004|Overall Study|Participant had flushing|0
7681203|NCT00289900|12098880|FG005|Overall Study|Participant had flushing|4
7681204|NCT00289900|12098875|FG000|Overall Study|Other|0
7681205|NCT00289900|12098876|FG001|Overall Study|Other|0
7681206|NCT00289900|12098877|FG002|Overall Study|Other|0
7681207|NCT00289900|12098878|FG003|Overall Study|Other|5
7681208|NCT00289900|12098879|FG004|Overall Study|Other|1
7681209|NCT00289900|12098880|FG005|Overall Study|Other|0
7681210|NCT00289900|12098875|FG000|Overall Study|Participant moved|1
7681211|NCT00289900|12098876|FG001|Overall Study|Participant moved|0
7681212|NCT00289900|12098877|FG002|Overall Study|Participant moved|0
7681213|NCT00289900|12098878|FG003|Overall Study|Participant moved|1
7681214|NCT00289900|12098879|FG004|Overall Study|Participant moved|1
7681215|NCT00289900|12098880|FG005|Overall Study|Participant moved|1
7681216|NCT00289900|12098875|FG000|Overall Study|Withdrawal by Subject|10
7681217|NCT00289900|12098876|FG001|Overall Study|Withdrawal by Subject|21
7681218|NCT00289900|12098877|FG002|Overall Study|Withdrawal by Subject|8
7681219|NCT00289900|12098878|FG003|Overall Study|Withdrawal by Subject|18
7681220|NCT00289900|12098879|FG004|Overall Study|Withdrawal by Subject|12
7681221|NCT00289900|12098880|FG005|Overall Study|Withdrawal by Subject|11
7681222|NCT00289900|12098875|FG000|Overall Study|Protocol Violation|3
7681223|NCT00289900|12098876|FG001|Overall Study|Protocol Violation|9
7681224|NCT00289900|12098877|FG002|Overall Study|Protocol Violation|2
7681225|NCT00289900|12098878|FG003|Overall Study|Protocol Violation|6
7681226|NCT00289900|12098879|FG004|Overall Study|Protocol Violation|7
7681227|NCT00289900|12098880|FG005|Overall Study|Protocol Violation|4
7681228|NCT00289900|12098875|FG000|Overall Study|site terminated|1
7681229|NCT00289900|12098876|FG001|Overall Study|site terminated|0
7681230|NCT00289900|12098877|FG002|Overall Study|site terminated|1
7681231|NCT00289900|12098878|FG003|Overall Study|site terminated|0
7681232|NCT00289900|12098879|FG004|Overall Study|site terminated|0
7681233|NCT00289900|12098880|FG005|Overall Study|site terminated|0
7681234|NCT00289900|12098875|FG000|Overall Study|Not treated|0
7681235|NCT00289900|12098876|FG001|Overall Study|Not treated|1
7681236|NCT00289900|12098877|FG002|Overall Study|Not treated|0
7681237|NCT00289900|12098878|FG003|Overall Study|Not treated|0
7681238|NCT00289900|12098879|FG004|Overall Study|Not treated|0
7681239|NCT00289900|12098880|FG005|Overall Study|Not treated|0
7681240|NCT00289913|12098902|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7681241|NCT00289913|12098903|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
7681242|NCT00289913|12098904|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7681243|NCT00289913|12098905|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7681244|NCT00289913|12098906|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7681245|NCT00289913|12098902|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
7681246|NCT00289913|12098903|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
7681247|NCT00289913|12098904|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
7681248|NCT00289913|12098905|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
7681249|NCT00289913|12098906|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
7681250|NCT00289913|12098902|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
7681251|NCT00289913|12098903|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
7681252|NCT00289913|12098904|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7681253|NCT00289913|12098905|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
7681254|NCT00289913|12098906|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
7681255|NCT00289913|12098902|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
7681256|NCT00289913|12098903|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
7681257|NCT00289913|12098904|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
7681258|NCT00289913|12098905|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
7681259|NCT00289913|12098906|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
7681260|NCT00289913|12098902|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
7681261|NCT00289913|12098903|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
7681262|NCT00289913|12098904|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
7681263|NCT00289913|12098905|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
7681264|NCT00289913|12098906|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
7681265|NCT00289913|12098902|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
7681266|NCT00289913|12098903|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
7681267|NCT00289913|12098904|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
7681268|NCT00289913|12098905|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
7681269|NCT00289913|12098906|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
7681270|NCT00289913|12098902|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
7681271|NCT00289913|12098903|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
7681272|NCT00289913|12098904|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
7681273|NCT00289913|12098905|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
7681274|NCT00289913|12098906|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
7681275|NCT00289913|12098902|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
7681276|NCT00289913|12098903|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
7681277|NCT00289913|12098904|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
7681278|NCT00289913|12098905|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
7681279|NCT00289913|12098906|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
7681280|NCT00289913|12098902|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
7681281|NCT00289913|12098903|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
7681282|NCT00289913|12098904|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
7681283|NCT00289913|12098905|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
7681284|NCT00289913|12098906|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
7681285|NCT00289913|12098902|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7681286|NCT00289913|12098903|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7681287|NCT00289913|12098904|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
7681288|NCT00289913|12098905|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7681289|NCT00289913|12098906|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7681290|NCT00289913|12098902|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
7681291|NCT00289913|12098903|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
7681292|NCT00289913|12098904|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
7681293|NCT00289913|12098905|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
7681294|NCT00289913|12098906|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
7681295|NCT00289913|12098902|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
7681296|NCT00289913|12098903|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
7681297|NCT00289913|12098904|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
7681298|NCT00289913|12098905|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
7681299|NCT00289913|12098906|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
7681300|NCT00289913|12098902|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
7681301|NCT00289913|12098903|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
7681302|NCT00289913|12098904|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
7681303|NCT00289913|12098905|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7681304|NCT00289913|12098906|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7681305|NCT00289913|12098902|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
7681306|NCT00289913|12098903|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
7681307|NCT00289913|12098904|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
7681308|NCT00289913|12098905|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
7681309|NCT00289913|12098906|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
7681310|NCT00289913|12098902|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
7681311|NCT00289913|12098903|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
7681312|NCT00289913|12098904|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
7681313|NCT00289913|12098905|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
7681314|NCT00289913|12098906|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
7681315|NCT00289913|12098902|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
7681316|NCT00289913|12098903|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
7681317|NCT00289913|12098904|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
7681318|NCT00289913|12098905|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
7681319|NCT00289913|12098906|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
7681320|NCT00289913|12098902|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
7681321|NCT00289913|12098903|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
7681322|NCT00289913|12098904|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
7681323|NCT00289913|12098905|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
7681324|NCT00289913|12098906|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
7681325|NCT00289913|12098902|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
7681326|NCT00289913|12098903|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
7681327|NCT00289913|12098904|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
7681328|NCT00289913|12098905|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
7681329|NCT00289913|12098906|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
7681330|NCT00289913|12098902|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
7681331|NCT00289913|12098903|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
7681332|NCT00289913|12098904|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
7681333|NCT00289913|12098905|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
7681334|NCT00289913|12098906|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
7681335|NCT00289913|12098902|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
7681336|NCT00289913|12098903|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
7681337|NCT00289913|12098904|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
7681338|NCT00289913|12098905|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
7681339|NCT00289913|12098906|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
7681340|NCT00289913|12098902|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
7681341|NCT00289913|12098903|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
7681342|NCT00289913|12098904|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
7681343|NCT00289913|12098905|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
7681344|NCT00289913|12098906|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
7681345|NCT00289913|12098902|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
7681346|NCT00289913|12098903|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
7681347|NCT00289913|12098904|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
7681348|NCT00289913|12098905|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
7681349|NCT00289913|12098906|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
7681350|NCT00289913|12098902|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
7681351|NCT00289913|12098903|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
7681352|NCT00289913|12098904|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
7681353|NCT00289913|12098905|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
7681354|NCT00289913|12098906|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
7681355|NCT00289913|12098902|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7681356|NCT00289913|12098903|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
7681357|NCT00289913|12098904|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7681358|NCT00289913|12098905|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7681359|NCT00289913|12098906|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7681360|NCT00289913|12098902|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
7681361|NCT00289913|12098903|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
7681362|NCT00289913|12098904|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
7681363|NCT00289913|12098905|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
7681364|NCT00289913|12098906|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
7681365|NCT00289913|12098902|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7681366|NCT00289913|12098903|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7681367|NCT00289913|12098904|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7681368|NCT00289913|12098905|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
7681369|NCT00289913|12098906|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7681370|NCT00289913|12098902|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
7681371|NCT00289913|12098903|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
7681372|NCT00289913|12098904|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
7681373|NCT00289913|12098905|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
7681374|NCT00289913|12098906|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
7681375|NCT00289913|12098902|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
7681376|NCT00289913|12098903|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
7681377|NCT00289913|12098904|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
7681378|NCT00289913|12098905|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
7681379|NCT00289913|12098906|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
7681380|NCT00289913|12098902|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
7681381|NCT00289913|12098903|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
7681382|NCT00289913|12098904|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
7681383|NCT00289913|12098905|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
7681384|NCT00289913|12098906|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
7681385|NCT00289913|12098902|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
7681386|NCT00289913|12098903|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
7681387|NCT00289913|12098904|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
7681388|NCT00289913|12098905|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
7681389|NCT00289913|12098906|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
7681390|NCT00289913|12098902|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
7681391|NCT00289913|12098903|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
7681392|NCT00289913|12098904|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
7681393|NCT00289913|12098905|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
7681394|NCT00289913|12098906|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
7681395|NCT00289978|12098924|FG000|Overall Study|Withdrawal by Subject|31
7681396|NCT00289978|12098925|FG001|Overall Study|Withdrawal by Subject|17
7681397|NCT00289978|12098926|FG002|Overall Study|Withdrawal by Subject|28
7681398|NCT00289978|12098924|FG000|Overall Study|Adverse Event|22
7681399|NCT00289978|12098925|FG001|Overall Study|Adverse Event|13
7681400|NCT00289978|12098926|FG002|Overall Study|Adverse Event|18
7681401|NCT00289978|12098924|FG000|Overall Study|Lack of Efficacy|13
7681402|NCT00289978|12098925|FG001|Overall Study|Lack of Efficacy|6
7681403|NCT00289978|12098926|FG002|Overall Study|Lack of Efficacy|25
7681404|NCT00289978|12098924|FG000|Overall Study|Abnormal laboratory value(s)|20
7681405|NCT00289978|12098925|FG001|Overall Study|Abnormal laboratory value(s)|9
7681406|NCT00289978|12098926|FG002|Overall Study|Abnormal laboratory value(s)|1
7681407|NCT00289978|12098924|FG000|Overall Study|Lost to Follow-up|3
7681408|NCT00289978|12098925|FG001|Overall Study|Lost to Follow-up|5
7681409|NCT00289978|12098926|FG002|Overall Study|Lost to Follow-up|7
7681410|NCT00289978|12098924|FG000|Overall Study|Protocol Violation|5
7681411|NCT00289978|12098925|FG001|Overall Study|Protocol Violation|5
7681412|NCT00289978|12098926|FG002|Overall Study|Protocol Violation|4
7681413|NCT00289978|12098924|FG000|Overall Study|Abnormal test procedure result(s)|2
7681414|NCT00289978|12098925|FG001|Overall Study|Abnormal test procedure result(s)|1
7681415|NCT00289978|12098926|FG002|Overall Study|Abnormal test procedure result(s)|1
7681416|NCT00289978|12098924|FG000|Overall Study|Death|1
7681417|NCT00289978|12098925|FG001|Overall Study|Death|0
7681418|NCT00289978|12098926|FG002|Overall Study|Death|2
7681419|NCT00289991|12098936|FG000|Overall Study|Death|35
7681420|NCT00289991|12098937|FG001|Overall Study|Death|38
7681421|NCT00289991|12098936|FG000|Overall Study|Adverse Event|15
7681422|NCT00289991|12098937|FG001|Overall Study|Adverse Event|13
7681423|NCT00289991|12098936|FG000|Overall Study|Failure of prophylaxis|1
7681424|NCT00289991|12098937|FG001|Overall Study|Failure of prophylaxis|1
7681425|NCT00289991|12098936|FG000|Overall Study|Fungal breakthrough infection|0
7681426|NCT00289991|12098937|FG001|Overall Study|Fungal breakthrough infection|1
7681427|NCT00289991|12098936|FG000|Overall Study|Lost to Follow-up|0
7681428|NCT00289991|12098937|FG001|Overall Study|Lost to Follow-up|1
7681429|NCT00289991|12098936|FG000|Overall Study|Withdrawal by Subject|2
7681430|NCT00289991|12098937|FG001|Overall Study|Withdrawal by Subject|12
7681431|NCT00289991|12098936|FG000|Overall Study|Other|5
7681432|NCT00289991|12098937|FG001|Overall Study|Other|14
7681433|NCT00290186|12098954|FG000|Overall Study|Adverse Event|1
7681434|NCT00290186|12098955|FG001|Overall Study|Adverse Event|1
7681435|NCT00290186|12098954|FG000|Overall Study|Lost to Follow-up|3
7681436|NCT00290186|12098955|FG001|Overall Study|Lost to Follow-up|2
7681437|NCT00290186|12098954|FG000|Overall Study|Study was terminated prior to 3-month te|1
7681438|NCT00290186|12098955|FG001|Overall Study|Study was terminated prior to 3-month te|1
7681439|NCT00290186|12098954|FG000|Overall Study|Withdrawal by Subject|0
7681440|NCT00290186|12098955|FG001|Overall Study|Withdrawal by Subject|1
7681441|NCT00290238|12098976|FG000|Overall Study|Study terminated|27
7681442|NCT00290238|12098977|FG001|Overall Study|Study terminated|27
7681443|NCT00290238|12098976|FG000|Overall Study|Lost to Follow-up|0
7681444|NCT00290238|12098977|FG001|Overall Study|Lost to Follow-up|1
7681445|NCT00290238|12098976|FG000|Overall Study|Withdrawal by Subject|15
7681446|NCT00290238|12098977|FG001|Overall Study|Withdrawal by Subject|13
7681447|NCT00290290|12098985|FG000|Overall Study|Death|3
7681448|NCT00290290|12098986|FG001|Overall Study|Death|4
7681449|NCT00290290|12098985|FG000|Overall Study|Withdrawal by Subject|2
7681450|NCT00290290|12098986|FG001|Overall Study|Withdrawal by Subject|2
7681451|NCT00290290|12098985|FG000|Overall Study|Underwent clean surgical procedure|13
7681452|NCT00290290|12098986|FG001|Overall Study|Underwent clean surgical procedure|12
7681453|NCT00290342|12099009|FG000|Overall Study|Other|0
7681454|NCT00290342|12099010|FG001|Overall Study|Other|1
7681455|NCT00290342|12099009|FG000|Overall Study|Withdrawal by Subject|6
7681456|NCT00290342|12099010|FG001|Overall Study|Withdrawal by Subject|4
7681457|NCT00290342|12099009|FG000|Overall Study|Lost to Follow-up|1
7681458|NCT00290342|12099010|FG001|Overall Study|Lost to Follow-up|0
7681459|NCT00290355|12099018|FG000|Overall Study|Serious adverse event|7
7681460|NCT00290355|12099019|FG001|Overall Study|Serious adverse event|4
7681461|NCT00290355|12099018|FG000|Overall Study|Study product reactogenicity|1
7681462|NCT00290355|12099019|FG001|Overall Study|Study product reactogenicity|0
7681463|NCT00290355|12099018|FG000|Overall Study|Protocol Violation|1
7681464|NCT00290355|12099019|FG001|Overall Study|Protocol Violation|0
7681465|NCT00290355|12099018|FG000|Overall Study|Withdrawal by Subject|2
7681466|NCT00290355|12099019|FG001|Overall Study|Withdrawal by Subject|0
7681467|NCT00290355|12099018|FG000|Overall Study|Migrated / moved from the study area|1
7681468|NCT00290355|12099019|FG001|Overall Study|Migrated / moved from the study area|0
7681469|NCT00290355|12099018|FG000|Overall Study|Lost to Follow-up|3
7681470|NCT00290355|12099019|FG001|Overall Study|Lost to Follow-up|1
7681471|NCT00290355|12099018|FG000|Overall Study|Other|2
7681472|NCT00290355|12099019|FG001|Overall Study|Other|0
7681473|NCT00290433|12099025|FG000|Overall Study|Disease Progression|13
7681474|NCT00290433|12099025|FG000|Overall Study|Adverse Event|14
7681475|NCT00290433|12099025|FG000|Overall Study|Withdrawal by Subject|1
7681476|NCT00290433|12099025|FG000|Overall Study|Non-Compliance|1
7681477|NCT00290433|12099025|FG000|Overall Study|Congestive Heart Failure|1
7681478|NCT00290433|12099025|FG000|Overall Study|Transplant in CR|5
7681479|NCT00290433|12099025|FG000|Overall Study|Unrelated Infection/Death|1
7681480|NCT00290498|12099042|FG000|Overall Study|Death|2
7681481|NCT00290498|12099043|FG001|Overall Study|Death|0
7681482|NCT00290498|12099042|FG000|Overall Study|Physician Decision|1
7681483|NCT00290498|12099043|FG001|Overall Study|Physician Decision|0
7681484|NCT00290498|12099042|FG000|Overall Study|Withdrawal by Subject|1
7681485|NCT00290498|12099043|FG001|Overall Study|Withdrawal by Subject|0
7681486|NCT00290498|12099042|FG000|Overall Study|Ineligible|3
7681487|NCT00290498|12099043|FG001|Overall Study|Ineligible|0
7681488|NCT00290498|12099042|FG000|Overall Study|Non-Compliance|1
7681489|NCT00290498|12099043|FG001|Overall Study|Non-Compliance|0
7681490|NCT00290589|12099058|FG000|Overall Study|Lost to Follow-up|2
7681491|NCT00290589|12099059|FG001|Overall Study|Lost to Follow-up|2
7681492|NCT00290693|12099073|FG000|Overall Study|Withdrawal by Subject|2
7681493|NCT00290706|12099082|FG000|Overall Study|Withdrawal by Subject|2
7681494|NCT00290706|12099083|FG001|Overall Study|Withdrawal by Subject|0
7681495|NCT00290706|12099084|FG002|Overall Study|Withdrawal by Subject|0
7681496|NCT00290706|12099085|FG003|Overall Study|Withdrawal by Subject|0
7681497|NCT00290706|12099082|FG000|Overall Study|Progressive Disease|3
7681498|NCT00290706|12099083|FG001|Overall Study|Progressive Disease|5
7681499|NCT00290706|12099084|FG002|Overall Study|Progressive Disease|4
7681500|NCT00290706|12099085|FG003|Overall Study|Progressive Disease|10
7681501|NCT00290706|12099082|FG000|Overall Study|Adverse Event|0
7681502|NCT00290706|12099083|FG001|Overall Study|Adverse Event|1
7681503|NCT00290706|12099084|FG002|Overall Study|Adverse Event|2
7681504|NCT00290706|12099085|FG003|Overall Study|Adverse Event|0
7681505|NCT00290706|12099082|FG000|Overall Study|Receive auto transplant or radiation|0
7681506|NCT00290706|12099083|FG001|Overall Study|Receive auto transplant or radiation|0
7681507|NCT00290706|12099084|FG002|Overall Study|Receive auto transplant or radiation|0
7681508|NCT00290706|12099085|FG003|Overall Study|Receive auto transplant or radiation|1
7681509|NCT00290706|12099082|FG000|Overall Study|Physician Decision|0
7681510|NCT00290706|12099083|FG001|Overall Study|Physician Decision|0
7681511|NCT00290706|12099084|FG002|Overall Study|Physician Decision|0
7681512|NCT00290706|12099085|FG003|Overall Study|Physician Decision|1
7681513|NCT00290732|12099098|FG000|Overall Study|Inability to instill drug intraductally.|0
7681514|NCT00290732|12099099|FG001|Overall Study|Inability to instill drug intraductally.|1
7681515|NCT00290732|12099100|FG002|Overall Study|Inability to instill drug intraductally.|1
7681516|NCT00290732|12099101|FG003|Overall Study|Inability to instill drug intraductally.|0
7681517|NCT00290732|12099102|FG004|Overall Study|Inability to instill drug intraductally.|0
7681518|NCT00290745|12099115|FG000|Overall Study|Withdrawal by Subject|4
7681519|NCT00290745|12099115|FG000|Overall Study|Physician Decision|2
7681520|NCT00290745|12099115|FG000|Overall Study|Surgery after 3 months for progression|3
7681521|NCT00290745|12099115|FG000|Overall Study|Baseline MRI not available|3
7681522|NCT00290771|12099121|FG000|Overall Study|Disease progression|95
7681523|NCT00290771|12099122|FG001|Overall Study|Disease progression|73
7681524|NCT00290771|12099121|FG000|Overall Study|Death|11
7681525|NCT00290771|12099122|FG001|Overall Study|Death|10
7681526|NCT00290771|12099121|FG000|Overall Study|Adverse Event|12
7681527|NCT00290771|12099122|FG001|Overall Study|Adverse Event|6
7681528|NCT00290771|12099121|FG000|Overall Study|Withdrawal by Subject|5
7681529|NCT00290771|12099122|FG001|Overall Study|Withdrawal by Subject|6
7681530|NCT00290771|12099121|FG000|Overall Study|Administrative problems|2
7681531|NCT00290771|12099122|FG001|Overall Study|Administrative problems|1
7681532|NCT00290771|12099121|FG000|Overall Study|Protocol Violation|2
7681533|NCT00290771|12099122|FG001|Overall Study|Protocol Violation|0
7681534|NCT00290771|12099121|FG000|Overall Study|Lost to Follow-up|0
7681535|NCT00290771|12099122|FG001|Overall Study|Lost to Follow-up|1
7681536|NCT00290888|12099135|FG000|Overall Study|Physician Decision|3
7681537|NCT00290888|12099136|FG001|Overall Study|Physician Decision|1
7681538|NCT00291018|12099146|FG000|Overall Study|Not Consented or Declined PAS|12
7681539|NCT00291018|12099147|FG001|Overall Study|Not Consented or Declined PAS|15
7681540|NCT00291018|12099148|FG002|Overall Study|Not Consented or Declined PAS|15
7681541|NCT00291018|12099146|FG000|Overall Study|Death|3
7681542|NCT00291018|12099147|FG001|Overall Study|Death|3
7681543|NCT00291018|12099148|FG002|Overall Study|Death|4
7681544|NCT00291018|12099146|FG000|Overall Study|Withdrawal by Subject|2
7681545|NCT00291018|12099147|FG001|Overall Study|Withdrawal by Subject|8
7681546|NCT00291018|12099148|FG002|Overall Study|Withdrawal by Subject|1
7681547|NCT00291018|12099146|FG000|Overall Study|Failures|5
7681548|NCT00291018|12099147|FG001|Overall Study|Failures|12
7681549|NCT00291018|12099148|FG002|Overall Study|Failures|5
7681550|NCT00291018|12099146|FG000|Overall Study|Lost to Follow-up|3
7681551|NCT00291018|12099147|FG001|Overall Study|Lost to Follow-up|4
7681552|NCT00291018|12099148|FG002|Overall Study|Lost to Follow-up|18
7681553|NCT00291187|12099182|FG000|Overall Study|Protocol Violation- No Drug Administered|0
7681554|NCT00291187|12099183|FG001|Overall Study|Protocol Violation- No Drug Administered|0
7681555|NCT00291187|12099184|FG002|Overall Study|Protocol Violation- No Drug Administered|1
7681556|NCT00291187|12099185|FG003|Overall Study|Protocol Violation- No Drug Administered|0
7681557|NCT00291330|12099215|FG000|Overall Study|Adverse Event|47
7681558|NCT00291330|12099216|FG001|Overall Study|Adverse Event|40
7681559|NCT00291330|12099215|FG000|Overall Study|Protocol Violation|13
7681560|NCT00291330|12099216|FG001|Overall Study|Protocol Violation|20
7681561|NCT00291330|12099215|FG000|Overall Study|Lost to Follow-up|16
7681562|NCT00291330|12099216|FG001|Overall Study|Lost to Follow-up|11
7681563|NCT00291330|12099215|FG000|Overall Study|Withdrawal by Subject|22
7681564|NCT00291330|12099216|FG001|Overall Study|Withdrawal by Subject|25
7681565|NCT00291330|12099215|FG000|Overall Study|Other|3
7681566|NCT00291330|12099216|FG001|Overall Study|Other|1
7681567|NCT00291499|12099251|FG000|Overall Study|Adverse Event|3
7681568|NCT00291499|12099252|FG001|Overall Study|Adverse Event|8
7681569|NCT00291499|12099251|FG000|Overall Study|Change to other therapy|2
7681570|NCT00291499|12099252|FG001|Overall Study|Change to other therapy|1
7681571|NCT00291499|12099251|FG000|Overall Study|Intercurrent illness|1
7681572|NCT00291499|12099252|FG001|Overall Study|Intercurrent illness|0
7681573|NCT00291499|12099251|FG000|Overall Study|Protocol Violation|2
7681574|NCT00291499|12099252|FG001|Overall Study|Protocol Violation|2
7681575|NCT00291499|12099251|FG000|Overall Study|Other reasons|1
7681576|NCT00291499|12099252|FG001|Overall Study|Other reasons|4
7681577|NCT00291551|12099258|FG000|Overall Study|Death|7
7681578|NCT00291551|12099258|FG000|Overall Study|Withdrawal by Subject|6
7681579|NCT00291577|12099263|FG000|Overall Study|Adverse Event|1
7681580|NCT00291577|12099263|FG000|Overall Study|Other|4
7681581|NCT00291577|12099263|FG000|Overall Study|Withdrawal by Subject|2
7681582|NCT00291577|12099263|FG000|Overall Study|Lack of Efficacy|14
7681583|NCT00291642|12099272|FG000|Overall Study|Adverse Event|1
7681584|NCT00291642|12099273|FG001|Overall Study|Adverse Event|0
7681585|NCT00291642|12099274|FG002|Overall Study|Adverse Event|1
7681586|NCT00291642|12099275|FG003|Overall Study|Adverse Event|0
7681587|NCT00291642|12099276|FG004|Overall Study|Adverse Event|1
7681588|NCT00291642|12099272|FG000|Overall Study|Patient missed visit|0
7681589|NCT00291642|12099273|FG001|Overall Study|Patient missed visit|0
7681590|NCT00291642|12099274|FG002|Overall Study|Patient missed visit|1
7681591|NCT00291642|12099275|FG003|Overall Study|Patient missed visit|0
7681592|NCT00291642|12099276|FG004|Overall Study|Patient missed visit|0
7681593|NCT00291642|12099272|FG000|Overall Study|Intake of prohibited medication|1
7681594|NCT00291642|12099273|FG001|Overall Study|Intake of prohibited medication|0
7681595|NCT00291642|12099274|FG002|Overall Study|Intake of prohibited medication|0
7681596|NCT00291642|12099275|FG003|Overall Study|Intake of prohibited medication|0
7681597|NCT00291642|12099276|FG004|Overall Study|Intake of prohibited medication|0
7681598|NCT00291668|12099295|FG000|Overall Study|Lack of Efficacy|1
7681599|NCT00291668|12099296|FG001|Overall Study|Lack of Efficacy|0
7681600|NCT00291668|12099297|FG002|Overall Study|Lack of Efficacy|0
7681601|NCT00291668|12099295|FG000|Overall Study|SAE, non-fatal|1
7681602|NCT00291668|12099296|FG001|Overall Study|SAE, non-fatal|1
7681603|NCT00291668|12099297|FG002|Overall Study|SAE, non-fatal|1
7681604|NCT00291668|12099295|FG000|Overall Study|AE, non-serious non-fatal|1
7681605|NCT00291668|12099296|FG001|Overall Study|AE, non-serious non-fatal|0
7681606|NCT00291668|12099297|FG002|Overall Study|AE, non-serious non-fatal|0
7681607|NCT00291668|12099295|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7681608|NCT00291668|12099296|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7681609|NCT00291668|12099297|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7681610|NCT00292045|12099320|FG000|Core Study (Through Week 13)|Adverse Event|1
7681611|NCT00292045|12099320|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1
7681612|NCT00292188|12099335|FG000|Single-Blind|Adverse Event|14
7681613|NCT00292188|12099336|FG001|Single-Blind|Adverse Event|0
7681614|NCT00292188|12099337|FG002|Single-Blind|Adverse Event|0
7681615|NCT00292188|12099335|FG000|Single-Blind|Lack of Efficacy|2
7681616|NCT00292188|12099336|FG001|Single-Blind|Lack of Efficacy|0
7681617|NCT00292188|12099337|FG002|Single-Blind|Lack of Efficacy|0
7681618|NCT00292188|12099335|FG000|Single-Blind|Laboratory Abnormality|5
7681619|NCT00292188|12099336|FG001|Single-Blind|Laboratory Abnormality|0
7681620|NCT00292188|12099337|FG002|Single-Blind|Laboratory Abnormality|0
7681621|NCT00292188|12099335|FG000|Single-Blind|Lost to Follow-up|3
7681622|NCT00292188|12099336|FG001|Single-Blind|Lost to Follow-up|0
7681623|NCT00292188|12099337|FG002|Single-Blind|Lost to Follow-up|0
7681624|NCT00292188|12099335|FG000|Single-Blind|Other|77
7681625|NCT00292188|12099336|FG001|Single-Blind|Other|0
7681626|NCT00292188|12099337|FG002|Single-Blind|Other|0
7681627|NCT00292188|12099335|FG000|Single-Blind|Withdrawal by Subject|12
7681628|NCT00292188|12099336|FG001|Single-Blind|Withdrawal by Subject|0
7681629|NCT00292188|12099337|FG002|Single-Blind|Withdrawal by Subject|0
7681630|NCT00292188|12099335|FG000|Single-Blind|Did not receive treatment|1
7681631|NCT00292188|12099336|FG001|Single-Blind|Did not receive treatment|0
7681632|NCT00292188|12099337|FG002|Single-Blind|Did not receive treatment|0
7681633|NCT00292188|12099335|FG000|Double-Blind|Adverse Event|0
7681634|NCT00292188|12099336|FG001|Double-Blind|Adverse Event|25
7681635|NCT00292188|12099337|FG002|Double-Blind|Adverse Event|9
7681636|NCT00292188|12099335|FG000|Double-Blind|Lack of Efficacy|0
7681637|NCT00292188|12099336|FG001|Double-Blind|Lack of Efficacy|2
7681638|NCT00292188|12099337|FG002|Double-Blind|Lack of Efficacy|12
7681639|NCT00292188|12099335|FG000|Double-Blind|Lost to Follow-up|0
7681640|NCT00292188|12099336|FG001|Double-Blind|Lost to Follow-up|1
7681641|NCT00292188|12099337|FG002|Double-Blind|Lost to Follow-up|0
7681642|NCT00292188|12099335|FG000|Double-Blind|Other|0
7681643|NCT00292188|12099336|FG001|Double-Blind|Other|3
7681644|NCT00292188|12099337|FG002|Double-Blind|Other|4
7681645|NCT00292188|12099335|FG000|Double-Blind|Withdrawal by Subject|0
7681646|NCT00292188|12099336|FG001|Double-Blind|Withdrawal by Subject|0
7681647|NCT00292188|12099337|FG002|Double-Blind|Withdrawal by Subject|3
7681648|NCT00292188|12099335|FG000|Double-Blind|Laboratory Abnormality|0
7681649|NCT00292188|12099336|FG001|Double-Blind|Laboratory Abnormality|0
7681650|NCT00292188|12099337|FG002|Double-Blind|Laboratory Abnormality|1
7681651|NCT00292227|12099346|FG000|Patch Period|Adverse Event|1
7681652|NCT00292227|12099347|FG001|Patch Period|Adverse Event|0
7681653|NCT00292227|12099348|FG002|Patch Period|Adverse Event|2
7681654|NCT00292227|12099346|FG000|Patch Period|Withdrawal by Subject|0
7681655|NCT00292227|12099347|FG001|Patch Period|Withdrawal by Subject|0
7681656|NCT00292227|12099348|FG002|Patch Period|Withdrawal by Subject|1
7681657|NCT00292318|12099358|FG000|Overall Study|Study terminated by officials|2
7681658|NCT00292318|12099359|FG001|Overall Study|Study terminated by officials|1
7681659|NCT00292370|12099368|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
7681660|NCT00292370|12099369|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
7681661|NCT00292370|12099370|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
7681662|NCT00292370|12099368|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
7681663|NCT00292370|12099369|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
7681664|NCT00292370|12099370|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
7681665|NCT00292370|12099368|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
7681666|NCT00292370|12099369|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
7681667|NCT00292370|12099370|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
7681668|NCT00292370|12099368|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
7681669|NCT00292370|12099369|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
7681670|NCT00292370|12099370|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
7681671|NCT00292370|12099368|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
7681672|NCT00292370|12099369|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
7681673|NCT00292370|12099370|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
7681674|NCT00292370|12099368|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
7681675|NCT00292370|12099369|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
7681676|NCT00292370|12099370|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
7681677|NCT00292461|12099379|FG000|Overall Study|Adverse Event|4
7681678|NCT00292461|12099380|FG001|Overall Study|Adverse Event|2
7681679|NCT00292461|12099379|FG000|Overall Study|Lack of Efficacy|1
7681680|NCT00292461|12099380|FG001|Overall Study|Lack of Efficacy|0
7681681|NCT00292461|12099379|FG000|Overall Study|Withdrawal by Subject|0
7681682|NCT00292461|12099380|FG001|Overall Study|Withdrawal by Subject|1
7681683|NCT00292461|12099379|FG000|Overall Study|Protocol Violation|4
7681684|NCT00292461|12099380|FG001|Overall Study|Protocol Violation|3
7681685|NCT00292461|12099379|FG000|Overall Study|Lost to Follow-up|1
7681686|NCT00292461|12099380|FG001|Overall Study|Lost to Follow-up|0
7681687|NCT00292942|12099403|FG000|Overall Study|Withdrawal by Subject|0
7681688|NCT00292942|12099404|FG001|Overall Study|Withdrawal by Subject|0
7681689|NCT00292942|12099405|FG002|Overall Study|Withdrawal by Subject|1
7681690|NCT00292942|12099406|FG003|Overall Study|Withdrawal by Subject|0
7681691|NCT00292942|12099403|FG000|Overall Study|Adverse Event|0
7681692|NCT00292942|12099404|FG001|Overall Study|Adverse Event|0
7681693|NCT00292942|12099405|FG002|Overall Study|Adverse Event|0
7681694|NCT00292942|12099406|FG003|Overall Study|Adverse Event|1
7681695|NCT00292981|12099419|FG000|Overall Study|Adverse Event|1
7681696|NCT00292981|12099419|FG000|Overall Study|Lost to Follow-up|13
7681697|NCT00292981|12099419|FG000|Overall Study|Withdrawal by Subject|22
7681698|NCT00292981|12099419|FG000|Overall Study|Other|3
7681699|NCT00293020|12099423|FG000|Overall Study|Withdrawal by Subject|34
7681700|NCT00293020|12099423|FG000|Overall Study|Adverse Event|30
7681701|NCT00293020|12099423|FG000|Overall Study|Death|32
7681702|NCT00293020|12099423|FG000|Overall Study|Lack of Efficacy|12
7681703|NCT00293020|12099423|FG000|Overall Study|Lost to Follow-up|4
7681704|NCT00293020|12099423|FG000|Overall Study|Protocol Violation|6
7681705|NCT00293020|12099423|FG000|Overall Study|Physician Decision|21
7681706|NCT00293020|12099423|FG000|Overall Study|Other Reason|22
7681707|NCT00293020|12099423|FG000|Overall Study|No dose taken|1
7681708|NCT00293033|12099427|FG000|Open-label Titration Period|Adverse Event|10
7681709|NCT00293033|12099427|FG000|Open-label Titration Period|Death|3
7681710|NCT00293033|12099427|FG000|Open-label Titration Period|Lack of Efficacy|5
7681711|NCT00293033|12099427|FG000|Open-label Titration Period|Protocol Violation|2
7681712|NCT00293033|12099427|FG000|Open-label Titration Period|Withdrawal by Subject|22
7681713|NCT00293033|12099427|FG000|Open-label Titration Period|Noncompliance and other|27
7681714|NCT00293033|12099427|FG000|Double-blind Treatment Period|Adverse Event|3
7681715|NCT00293033|12099427|FG000|Double-blind Treatment Period|Lack of Efficacy|1
7681716|NCT00293033|12099427|FG000|Double-blind Treatment Period|Withdrawal by Subject|4
7681717|NCT00293033|12099427|FG000|Double-blind Treatment Period|Noncompliance|4
7681718|NCT00293059|12099437|FG000|Overall Study|Adverse Event|12
7681719|NCT00293059|12099438|FG001|Overall Study|Adverse Event|4
7681720|NCT00293059|12099437|FG000|Overall Study|Lack of Efficacy|2
7681721|NCT00293059|12099438|FG001|Overall Study|Lack of Efficacy|0
7681722|NCT00293059|12099437|FG000|Overall Study|Lost to Follow-up|2
7681723|NCT00293059|12099438|FG001|Overall Study|Lost to Follow-up|3
7681724|NCT00293059|12099437|FG000|Overall Study|Pregnancy|1
7681725|NCT00293059|12099438|FG001|Overall Study|Pregnancy|1
7681726|NCT00293059|12099437|FG000|Overall Study|Protocol Violation|2
7681727|NCT00293059|12099438|FG001|Overall Study|Protocol Violation|0
7681728|NCT00293059|12099437|FG000|Overall Study|Withdrawal by Subject|11
7681729|NCT00293059|12099438|FG001|Overall Study|Withdrawal by Subject|5
7681730|NCT00293059|12099437|FG000|Overall Study|Participant moved out of state|1
7681731|NCT00293059|12099438|FG001|Overall Study|Participant moved out of state|0
7681732|NCT00293059|12099437|FG000|Overall Study|Participant stopped study drug|1
7681733|NCT00293059|12099438|FG001|Overall Study|Participant stopped study drug|0
7681734|NCT00293059|12099437|FG000|Overall Study|Noncompliant - sanitary pads collection|0
7681735|NCT00293059|12099438|FG001|Overall Study|Noncompliant - sanitary pads collection|1
7681736|NCT00293059|12099437|FG000|Overall Study|missing|3
7681737|NCT00293059|12099438|FG001|Overall Study|missing|5
7681738|NCT00293202|12099446|FG000|Overall Study|Withdrawal by Subject|1
7681739|NCT00293202|12099447|FG001|Overall Study|Withdrawal by Subject|2
7681740|NCT00293202|12099446|FG000|Overall Study|positive ANA (antinuclear antibody)|1
7681741|NCT00293202|12099447|FG001|Overall Study|positive ANA (antinuclear antibody)|0
7681742|NCT00293202|12099446|FG000|Overall Study|on-hold due to fistula maturation time|1
7681743|NCT00293202|12099447|FG001|Overall Study|on-hold due to fistula maturation time|0
7681744|NCT00293215|12099459|FG000|Overall Study|Progressive disease|3
7681745|NCT00293215|12099460|FG001|Overall Study|Progressive disease|1
7681746|NCT00293215|12099459|FG000|Overall Study|Adverse Event|2
7681747|NCT00293215|12099460|FG001|Overall Study|Adverse Event|2
7681748|NCT00293241|12099468|FG000|Overall Study|Lost to Follow-up|9
7681749|NCT00293241|12099469|FG001|Overall Study|Lost to Follow-up|16
7681750|NCT00293241|12099468|FG000|Overall Study|Physician Decision|23
7681751|NCT00293241|12099469|FG001|Overall Study|Physician Decision|17
7681752|NCT00293241|12099468|FG000|Overall Study|Withdrawal by Subject|4
7681753|NCT00293241|12099469|FG001|Overall Study|Withdrawal by Subject|8
7681754|NCT00293254|12099480|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2
7681755|NCT00293254|12099481|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0
7681756|NCT00293254|12099480|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2
7681757|NCT00293254|12099481|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1
7681758|NCT00293254|12099480|FG000|Primary Study - Double-Blind Week 0-48|Death|5
7681759|NCT00293254|12099481|FG001|Primary Study - Double-Blind Week 0-48|Death|2
7681760|NCT00293254|12099480|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
7681761|NCT00293254|12099481|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
7681762|NCT00293254|12099480|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
7681763|NCT00293254|12099481|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
7681764|NCT00293254|12099480|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
7681765|NCT00293254|12099481|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
7681766|NCT00293254|12099480|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
7681767|NCT00293254|12099481|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
7681768|NCT00293254|12099480|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
7681769|NCT00293254|12099481|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
7681770|NCT00293254|12099480|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4
7681771|NCT00293254|12099481|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1
7681772|NCT00293254|12099480|FG000|Extension - Double-Blind Week 49-156|Death|4
7681773|NCT00293254|12099481|FG001|Extension - Double-Blind Week 49-156|Death|1
7681774|NCT00293254|12099480|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
7681775|NCT00293254|12099481|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
7681776|NCT00293254|12099480|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
7681777|NCT00293254|12099481|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
7681778|NCT00293254|12099480|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
7681779|NCT00293254|12099481|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
7681780|NCT00293254|12099480|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
7681781|NCT00293254|12099481|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
7681782|NCT00293254|12099480|FG000|Extension - Double-Blind Week 49-156|Other Reason|10
7681783|NCT00293254|12099481|FG001|Extension - Double-Blind Week 49-156|Other Reason|2
7681784|NCT00293254|12099480|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
7681785|NCT00293254|12099481|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
7681786|NCT00293254|12099480|FG000|Extension - Open-Label Week 157-240|Adverse Event|2
7681787|NCT00293254|12099481|FG001|Extension - Open-Label Week 157-240|Adverse Event|1
7681788|NCT00293254|12099480|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1
7681789|NCT00293254|12099481|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0
7681790|NCT00293254|12099480|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
7681791|NCT00293254|12099481|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
7681792|NCT00293254|12099480|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2
7681793|NCT00293254|12099481|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0
7681794|NCT00293254|12099480|FG000|Extension - Open-Label Week 157-240|Other Reason|4
7681795|NCT00293254|12099481|FG001|Extension - Open-Label Week 157-240|Other Reason|0
7681796|NCT00293254|12099480|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4
7681797|NCT00293254|12099481|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7
7681798|NCT00293254|12099480|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
7681799|NCT00293254|12099481|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
7681800|NCT00293254|12099480|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
7681801|NCT00293254|12099481|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
7681802|NCT00293254|12099480|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
7681803|NCT00293254|12099481|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
7681804|NCT00293254|12099480|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
7681805|NCT00293254|12099481|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
7681806|NCT00293254|12099480|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1
7681807|NCT00293254|12099481|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2
7681808|NCT00293267|12099491|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2
7681809|NCT00293267|12099492|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0
7681810|NCT00293267|12099491|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1
7681811|NCT00293267|12099492|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1
7681812|NCT00293267|12099491|FG000|Primary Study - Double-Blind Week 0-48|Death|3
7681813|NCT00293267|12099492|FG001|Primary Study - Double-Blind Week 0-48|Death|3
7681814|NCT00293267|12099491|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
7681815|NCT00293267|12099492|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
7681816|NCT00293267|12099491|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
7681817|NCT00293267|12099492|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
7681818|NCT00293267|12099491|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
7681819|NCT00293267|12099492|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
7681820|NCT00293267|12099491|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
7681821|NCT00293267|12099492|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
7681822|NCT00293267|12099491|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1
7681823|NCT00293267|12099492|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4
7681824|NCT00293267|12099491|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
7681825|NCT00293267|12099492|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
7681826|NCT00293267|12099491|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
7681827|NCT00293267|12099492|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
7681828|NCT00293267|12099491|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
7681829|NCT00293267|12099492|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
7681830|NCT00293267|12099491|FG000|Extension - Double-Blind Week 49-156|Death|3
7681831|NCT00293267|12099492|FG001|Extension - Double-Blind Week 49-156|Death|0
7681832|NCT00293267|12099491|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
7681833|NCT00293267|12099492|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
7681834|NCT00293267|12099491|FG000|Extension - Double-Blind Week 49-156|Other Reason|7
7681835|NCT00293267|12099492|FG001|Extension - Double-Blind Week 49-156|Other Reason|0
7681836|NCT00293267|12099491|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
7681837|NCT00293267|12099492|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
7681838|NCT00293267|12099491|FG000|Extension - Open-Label Week 157-240|Adverse Event|5
7681839|NCT00293267|12099492|FG001|Extension - Open-Label Week 157-240|Adverse Event|0
7681840|NCT00293267|12099491|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7
7681841|NCT00293267|12099492|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0
7681842|NCT00293267|12099491|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1
7681843|NCT00293267|12099492|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0
7681844|NCT00293267|12099491|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
7681845|NCT00293267|12099492|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
7681846|NCT00293267|12099491|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
7681847|NCT00293267|12099492|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
7681848|NCT00293267|12099491|FG000|Extension - Open-Label Week 157-240|Other Reason|3
7681849|NCT00293267|12099492|FG001|Extension - Open-Label Week 157-240|Other Reason|1
7681850|NCT00293267|12099491|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2
7681851|NCT00293267|12099492|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3
7681852|NCT00293267|12099491|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
7681853|NCT00293267|12099492|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
7681854|NCT00293267|12099491|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
7681855|NCT00293267|12099492|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
7681856|NCT00293267|12099491|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
7681857|NCT00293267|12099492|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
7681858|NCT00293267|12099491|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
7681859|NCT00293267|12099492|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
7681860|NCT00293267|12099491|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
7681861|NCT00293267|12099492|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
7681862|NCT00293267|12099491|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4
7681863|NCT00293267|12099492|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5
7681864|NCT00293293|12099502|FG000|Overall Study|Withdrawal by Subject|1
7681865|NCT00293293|12099503|FG001|Overall Study|Withdrawal by Subject|1
7681866|NCT00293293|12099502|FG000|Overall Study|"Patient too anxious to complete trial"|1
7681867|NCT00293293|12099503|FG001|Overall Study|"Patient too anxious to complete trial"|0
7681868|NCT00293293|12099502|FG000|Overall Study|Patient discontinued chemotherapy|0
7681869|NCT00293293|12099503|FG001|Overall Study|Patient discontinued chemotherapy|1
7681870|NCT00293384|12099510|FG000|Overall Study|Non-compliance|2
7681871|NCT00293384|12099510|FG000|Overall Study|Missed dosage/study drug|1
7681872|NCT00293384|12099510|FG000|Overall Study|Ineligible|2
7681873|NCT00293397|12099514|FG000|Overall Study|Death|2
7681874|NCT00293423|12099521|FG000|Surgical Resection|Less than a 90% extent of resection|0
7681875|NCT00293423|12099522|FG001|Surgical Resection|Less than a 90% extent of resection|1
7681876|NCT00293423|12099521|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0
7681877|NCT00293423|12099522|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4
7681878|NCT00293423|12099521|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9
7681879|NCT00293423|12099522|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13
7681880|NCT00293423|12099521|FG000|Surgical Resection|disease progression prior to initial vaccination|2
7681881|NCT00293423|12099522|FG001|Surgical Resection|disease progression prior to initial vaccination|9
7681882|NCT00293423|12099521|FG000|Surgical Resection|processing error during surgical resection|1
7681883|NCT00293423|12099522|FG001|Surgical Resection|processing error during surgical resection|0
7681884|NCT00293423|12099521|FG000|Surgical Resection|Withdrawal by Subject|4
7681885|NCT00293423|12099522|FG001|Surgical Resection|Withdrawal by Subject|0
7681886|NCT00293423|12099521|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0
7681887|NCT00293423|12099522|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3
7681888|NCT00293462|12099531|FG000|Overall Study|Withdrawal by Subject|4
7681889|NCT00293462|12099532|FG001|Overall Study|Withdrawal by Subject|3
7681890|NCT00293462|12099533|FG002|Overall Study|Withdrawal by Subject|8
7681891|NCT00293462|12099531|FG000|Overall Study|Death|1
7681892|NCT00293462|12099532|FG001|Overall Study|Death|0
7681893|NCT00293462|12099533|FG002|Overall Study|Death|0
7681894|NCT00293462|12099531|FG000|Overall Study|Lost to Follow-up|0
7681895|NCT00293462|12099532|FG001|Overall Study|Lost to Follow-up|1
7681896|NCT00293462|12099533|FG002|Overall Study|Lost to Follow-up|0
7681897|NCT00293462|12099531|FG000|Overall Study|Change Treatment Regimen (ineligible)|1
7681898|NCT00293462|12099532|FG001|Overall Study|Change Treatment Regimen (ineligible)|0
7681899|NCT00293462|12099533|FG002|Overall Study|Change Treatment Regimen (ineligible)|0
7681900|NCT00293462|12099531|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
7681901|NCT00293462|12099532|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
7681902|NCT00293462|12099533|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
7681903|NCT00293462|12099531|FG000|Overall Study|Refuse Radiation Treatment|1
7681904|NCT00293462|12099532|FG001|Overall Study|Refuse Radiation Treatment|0
7681905|NCT00293462|12099533|FG002|Overall Study|Refuse Radiation Treatment|0
7681906|NCT00293462|12099531|FG000|Overall Study|No Show|0
7681907|NCT00293462|12099532|FG001|Overall Study|No Show|0
7681908|NCT00293462|12099533|FG002|Overall Study|No Show|1
7681909|NCT00293462|12099531|FG000|Overall Study|Went back to his home country|0
7681910|NCT00293462|12099532|FG001|Overall Study|Went back to his home country|0
7681911|NCT00293462|12099533|FG002|Overall Study|Went back to his home country|1
7681912|NCT00293462|12099531|FG000|Overall Study|Blood clot after chemotherapy|0
7681913|NCT00293462|12099532|FG001|Overall Study|Blood clot after chemotherapy|0
7681914|NCT00293462|12099533|FG002|Overall Study|Blood clot after chemotherapy|1
7681915|NCT00293462|12099531|FG000|Overall Study|Ischemic stroke after chemotherapy|0
7681916|NCT00293462|12099532|FG001|Overall Study|Ischemic stroke after chemotherapy|0
7681917|NCT00293462|12099533|FG002|Overall Study|Ischemic stroke after chemotherapy|1
7681918|NCT00293462|12099531|FG000|Overall Study|Possible Tracheostomy leakage|0
7681919|NCT00293462|12099532|FG001|Overall Study|Possible Tracheostomy leakage|1
7681920|NCT00293462|12099533|FG002|Overall Study|Possible Tracheostomy leakage|0
7681921|NCT00293462|12099531|FG000|Overall Study|Low radiation dose in oral cavity|0
7681922|NCT00293462|12099532|FG001|Overall Study|Low radiation dose in oral cavity|1
7681923|NCT00293462|12099533|FG002|Overall Study|Low radiation dose in oral cavity|0
7681924|NCT00293462|12099531|FG000|Overall Study|Physician Decision|0
7681925|NCT00293462|12099532|FG001|Overall Study|Physician Decision|1
7681926|NCT00293462|12099533|FG002|Overall Study|Physician Decision|0
7681927|NCT00293579|12099550|FG000|Overall Study|Withdrawal by Subject|1
7681928|NCT00293709|12099555|FG000|Overall Study|Other|47
7681929|NCT00293722|12099559|FG000|Overall Study|Other|427
7681930|NCT00293813|12099566|FG000|Overall Study|Physician Decision|0
7681931|NCT00293813|12099567|FG001|Overall Study|Physician Decision|1
7681932|NCT00293813|12099568|FG002|Overall Study|Physician Decision|0
7681933|NCT00293813|12099566|FG000|Overall Study|Adverse Event|3
7681934|NCT00293813|12099567|FG001|Overall Study|Adverse Event|1
7681935|NCT00293813|12099568|FG002|Overall Study|Adverse Event|1
7681936|NCT00293813|12099566|FG000|Overall Study|Withdrawal by Subject|7
7681937|NCT00293813|12099567|FG001|Overall Study|Withdrawal by Subject|4
7681938|NCT00293813|12099568|FG002|Overall Study|Withdrawal by Subject|4
7681939|NCT00293813|12099566|FG000|Overall Study|Lost to Follow-up|3
7681940|NCT00293813|12099567|FG001|Overall Study|Lost to Follow-up|2
7681941|NCT00293813|12099568|FG002|Overall Study|Lost to Follow-up|3
7681942|NCT00293813|12099566|FG000|Overall Study|Noncompliance|0
7681943|NCT00293813|12099567|FG001|Overall Study|Noncompliance|1
7681944|NCT00293813|12099568|FG002|Overall Study|Noncompliance|0
7681945|NCT00294047|12099578|FG000|Month 48|Adverse Event|28
7681946|NCT00294047|12099579|FG001|Month 48|Adverse Event|13
7681947|NCT00294047|12099578|FG000|Month 48|Protocol Violation|4
7681948|NCT00294047|12099579|FG001|Month 48|Protocol Violation|4
7681949|NCT00294047|12099578|FG000|Month 48|Withdrawal by Subject|111
7681950|NCT00294047|12099579|FG001|Month 48|Withdrawal by Subject|115
7681951|NCT00294047|12099578|FG000|Month 48|Lost to Follow-up|272
7681952|NCT00294047|12099579|FG001|Month 48|Lost to Follow-up|287
7681953|NCT00294047|12099578|FG000|Month 48|Other|10
7681954|NCT00294047|12099579|FG001|Month 48|Other|14
7681955|NCT00294047|12099578|FG000|Month 84|Adverse Event|4
7681956|NCT00294047|12099579|FG001|Month 84|Adverse Event|2
7681957|NCT00294047|12099578|FG000|Month 84|Protocol Violation|1
7681958|NCT00294047|12099579|FG001|Month 84|Protocol Violation|1
7681959|NCT00294047|12099578|FG000|Month 84|Withdrawal by Subject|33
7681960|NCT00294047|12099579|FG001|Month 84|Withdrawal by Subject|31
7681961|NCT00294047|12099578|FG000|Month 84|Lost to Follow-up|187
7681962|NCT00294047|12099579|FG001|Month 84|Lost to Follow-up|190
7681963|NCT00294047|12099578|FG000|Month 84|Absent Cervix|2
7681964|NCT00294047|12099579|FG001|Month 84|Absent Cervix|0
7681965|NCT00294047|12099578|FG000|Month 84|Work related reasons|4
7681966|NCT00294047|12099579|FG001|Month 84|Work related reasons|2
7681967|NCT00294047|12099578|FG000|Month 84|Center closed, subject did not transfer|1
7681968|NCT00294047|12099579|FG001|Month 84|Center closed, subject did not transfer|0
7681969|NCT00294047|12099578|FG000|Month 84|Family problems|2
7681970|NCT00294047|12099579|FG001|Month 84|Family problems|2
7681971|NCT00294047|12099578|FG000|Month 84|Lack of time|3
7681972|NCT00294047|12099579|FG001|Month 84|Lack of time|1
7681973|NCT00294047|12099578|FG000|Month 84|Personal reason|2
7681974|NCT00294047|12099579|FG001|Month 84|Personal reason|4
7681975|NCT00294047|12099578|FG000|Month 84|Subject does not want male physician|1
7681976|NCT00294047|12099579|FG001|Month 84|Subject does not want male physician|0
7681977|NCT00294047|12099578|FG000|Month 84|Transport reimbursement delayed|0
7681978|NCT00294047|12099579|FG001|Month 84|Transport reimbursement delayed|1
7681979|NCT00294047|12099578|FG000|Month 84|Unable to reach study site|1
7681980|NCT00294047|12099579|FG001|Month 84|Unable to reach study site|0
7681981|NCT00294047|12099578|FG000|Month 84|Under investigation locally|1
7681982|NCT00294047|12099579|FG001|Month 84|Under investigation locally|0
7681983|NCT00294047|12099578|FG000|Month 84|Visit missed|0
7681984|NCT00294047|12099579|FG001|Month 84|Visit missed|1
7681985|NCT00294047|12099578|FG000|Month 84|No consent for Month 84 Follow-up|731
7681986|NCT00294047|12099579|FG001|Month 84|No consent for Month 84 Follow-up|754
7681987|NCT00294060|12099586|FG000|Overall Study|Death|225
7681988|NCT00294060|12099586|FG000|Overall Study|Other|59
7681989|NCT00294060|12099586|FG000|Overall Study|Lost to Follow-up|55
7681990|NCT00294060|12099586|FG000|Overall Study|Withdrawal by Subject|11
7681991|NCT00294060|12099586|FG000|Overall Study|Physician Decision|797
7681992|NCT00294060|12099586|FG000|Overall Study|Medical condition|3
7681993|NCT00294060|12099586|FG000|Overall Study|Device explanted/not replaced|23
7681994|NCT00294398|12099592|FG000|Overall Study|Lost to Follow-up|21
7681995|NCT00294398|12099593|FG001|Overall Study|Lost to Follow-up|26
7681996|NCT00294554|12099610|FG000|Overall Study|Lack of Efficacy|0
7681997|NCT00294554|12099611|FG001|Overall Study|Lack of Efficacy|1
7681998|NCT00294554|12099610|FG000|Overall Study|Physician Decision|0
7681999|NCT00294554|12099611|FG001|Overall Study|Physician Decision|1
7682000|NCT00294645|12099629|FG000|Overall Study|Death|10
7682001|NCT00294645|12099630|FG001|Overall Study|Death|18
7682002|NCT00294645|12099629|FG000|Overall Study|Lost to Follow-up|1
7682003|NCT00294645|12099630|FG001|Overall Study|Lost to Follow-up|10
7682004|NCT00294645|12099629|FG000|Overall Study|Withdrawal by Subject|18
7682005|NCT00294645|12099630|FG001|Overall Study|Withdrawal by Subject|34
7682006|NCT00294645|12099629|FG000|Overall Study|Physician Decision|15
7682007|NCT00294645|12099630|FG001|Overall Study|Physician Decision|20
7682008|NCT00294645|12099629|FG000|Overall Study|Other|4
7682009|NCT00294645|12099630|FG001|Overall Study|Other|10
7682010|NCT00294658|12099638|FG000|Overall Study|Death|0
7682011|NCT00294658|12099639|FG001|Overall Study|Death|1
7682012|NCT00294658|12099638|FG000|Overall Study|Lost to Follow-up|4
7682013|NCT00294658|12099639|FG001|Overall Study|Lost to Follow-up|0
7682014|NCT00294658|12099638|FG000|Overall Study|Physician Decision|1
7682015|NCT00294658|12099639|FG001|Overall Study|Physician Decision|2
7682016|NCT00294658|12099638|FG000|Overall Study|Pregnancy|0
7682017|NCT00294658|12099639|FG001|Overall Study|Pregnancy|1
7682018|NCT00294658|12099638|FG000|Overall Study|Withdrawal by Subject|0
7682019|NCT00294658|12099639|FG001|Overall Study|Withdrawal by Subject|4
7682020|NCT00294658|12099638|FG000|Overall Study|Found to have invasive thymoma|1
7682021|NCT00294658|12099639|FG001|Overall Study|Found to have invasive thymoma|0
7682022|NCT00294658|12099638|FG000|Overall Study|Patient and family were not satisfied|0
7682023|NCT00294658|12099639|FG001|Overall Study|Patient and family were not satisfied|1
7682024|NCT00294671|12099647|FG000|Overall Study|Lack of Efficacy|11
7682025|NCT00294671|12099648|FG001|Overall Study|Lack of Efficacy|23
7682026|NCT00294671|12099647|FG000|Overall Study|Liver transplant|7
7682027|NCT00294671|12099648|FG001|Overall Study|Liver transplant|9
7682028|NCT00294671|12099647|FG000|Overall Study|Drug related adverse event (AE)|4
7682029|NCT00294671|12099648|FG001|Overall Study|Drug related adverse event (AE)|2
7682030|NCT00294671|12099647|FG000|Overall Study|Non-drug related AE|3
7682031|NCT00294671|12099648|FG001|Overall Study|Non-drug related AE|2
7682032|NCT00294671|12099647|FG000|Overall Study|Lost to Follow-up|1
7682033|NCT00294671|12099648|FG001|Overall Study|Lost to Follow-up|3
7682034|NCT00294671|12099647|FG000|Overall Study|Non-compliance|1
7682035|NCT00294671|12099648|FG001|Overall Study|Non-compliance|0
7682036|NCT00294671|12099647|FG000|Overall Study|Death|0
7682037|NCT00294671|12099648|FG001|Overall Study|Death|1
7682038|NCT00294684|12099656|FG000|Overall Study|Lost to Follow-up|5
7682039|NCT00294684|12099657|FG001|Overall Study|Lost to Follow-up|8
7682040|NCT00294723|12099666|FG000|Double-Blind Period 52 Weeks|Adverse Event|18
7682041|NCT00294723|12099667|FG001|Double-Blind Period 52 Weeks|Adverse Event|25
7682042|NCT00294723|12099668|FG002|Double-Blind Period 52 Weeks|Adverse Event|15
7682043|NCT00294723|12099666|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9
7682044|NCT00294723|12099667|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15
7682045|NCT00294723|12099668|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25
7682046|NCT00294723|12099666|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11
7682047|NCT00294723|12099667|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11
7682048|NCT00294723|12099668|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5
7682049|NCT00294723|12099666|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36
7682050|NCT00294723|12099667|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38
7682051|NCT00294723|12099668|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51
7682052|NCT00294723|12099666|FG000|Open-Label Extension 52 Weeks|Adverse Event|5
7682053|NCT00294723|12099667|FG001|Open-Label Extension 52 Weeks|Adverse Event|5
7682054|NCT00294723|12099668|FG002|Open-Label Extension 52 Weeks|Adverse Event|2
7682055|NCT00294723|12099666|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12
7682056|NCT00294723|12099667|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15
7682057|NCT00294723|12099668|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21
7682058|NCT00294723|12099666|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4
7682059|NCT00294723|12099667|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3
7682060|NCT00294723|12099668|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3
7682061|NCT00294723|12099666|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19
7682062|NCT00294723|12099667|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16
7682063|NCT00294723|12099668|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14
7682064|NCT00294723|12099666|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1
7682065|NCT00294723|12099667|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1
7682066|NCT00294723|12099668|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0
7682067|NCT00294723|12099666|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
7682068|NCT00294723|12099667|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
7682069|NCT00294723|12099668|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
7682070|NCT00294723|12099666|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
7682071|NCT00294723|12099667|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
7682072|NCT00294723|12099668|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
7682073|NCT00294723|12099666|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
7682074|NCT00294723|12099667|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
7682075|NCT00294723|12099668|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
7682076|NCT00294762|12099681|FG000|Overall Study|Did not receive study treatment|3
7682077|NCT00294762|12099682|FG001|Overall Study|Did not receive study treatment|3
7682078|NCT00295022|12099716|FG000|Overall Study|Adverse Event|1
7682079|NCT00295022|12099717|FG001|Overall Study|Adverse Event|1
7682080|NCT00295022|12099718|FG002|Overall Study|Adverse Event|2
7682081|NCT00295022|12099716|FG000|Overall Study|Lost to Follow-up|0
7682082|NCT00295022|12099717|FG001|Overall Study|Lost to Follow-up|0
7682083|NCT00295022|12099718|FG002|Overall Study|Lost to Follow-up|1
7682084|NCT00295022|12099716|FG000|Overall Study|Withdrawal by Subject|0
7682085|NCT00295022|12099717|FG001|Overall Study|Withdrawal by Subject|0
7682086|NCT00295022|12099718|FG002|Overall Study|Withdrawal by Subject|2
7682087|NCT00295620|12099744|FG000|Overall Study|Lost to Follow-up|9
7682088|NCT00295620|12099745|FG001|Overall Study|Lost to Follow-up|5
7682089|NCT00295620|12099744|FG000|Overall Study|Withdrawal by Subject|37
7682090|NCT00295620|12099745|FG001|Overall Study|Withdrawal by Subject|50
7682091|NCT00295620|12099744|FG000|Overall Study|Death|206
7682092|NCT00295620|12099745|FG001|Overall Study|Death|207
7682093|NCT00295620|12099744|FG000|Overall Study|Other reasons|10
7682094|NCT00295620|12099745|FG001|Overall Study|Other reasons|9
7682095|NCT00295620|12099744|FG000|Overall Study|Discontinuation by sponsor|580
7682096|NCT00295620|12099745|FG001|Overall Study|Discontinuation by sponsor|593
7682097|NCT00295620|12099744|FG000|Overall Study|Protocol Violation|30
7682098|NCT00295620|12099745|FG001|Overall Study|Protocol Violation|32
7682099|NCT00295633|12099754|FG000|Overall Study|Lack of Efficacy|19
7682100|NCT00295633|12099755|FG001|Overall Study|Lack of Efficacy|7
7682101|NCT00295633|12099756|FG002|Overall Study|Lack of Efficacy|16
7682102|NCT00295633|12099754|FG000|Overall Study|Withdrawal of consent by subject|16
7682103|NCT00295633|12099755|FG001|Overall Study|Withdrawal of consent by subject|16
7682104|NCT00295633|12099756|FG002|Overall Study|Withdrawal of consent by subject|26
7682105|NCT00295633|12099754|FG000|Overall Study|Adverse Event|9
7682106|NCT00295633|12099755|FG001|Overall Study|Adverse Event|17
7682107|NCT00295633|12099756|FG002|Overall Study|Adverse Event|9
7682108|NCT00295633|12099754|FG000|Overall Study|Lost to Follow-up|6
7682109|NCT00295633|12099755|FG001|Overall Study|Lost to Follow-up|11
7682110|NCT00295633|12099756|FG002|Overall Study|Lost to Follow-up|7
7682111|NCT00295633|12099754|FG000|Overall Study|Physician Decision|9
7682112|NCT00295633|12099755|FG001|Overall Study|Physician Decision|10
7682113|NCT00295633|12099756|FG002|Overall Study|Physician Decision|8
7682114|NCT00295633|12099754|FG000|Overall Study|Poor/Noncompliance|2
7682115|NCT00295633|12099755|FG001|Overall Study|Poor/Noncompliance|2
7682116|NCT00295633|12099756|FG002|Overall Study|Poor/Noncompliance|6
7682117|NCT00295633|12099754|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
7682118|NCT00295633|12099755|FG001|Overall Study|Subject No Longer Meets Study Criteria|3
7682119|NCT00295633|12099756|FG002|Overall Study|Subject No Longer Meets Study Criteria|3
7682120|NCT00295633|12099754|FG000|Overall Study|Death|1
7682121|NCT00295633|12099755|FG001|Overall Study|Death|1
7682122|NCT00295633|12099756|FG002|Overall Study|Death|0
7682123|NCT00295633|12099754|FG000|Overall Study|Administrative reason by sponsor|0
7682124|NCT00295633|12099755|FG001|Overall Study|Administrative reason by sponsor|0
7682125|NCT00295633|12099756|FG002|Overall Study|Administrative reason by sponsor|1
7682126|NCT00295750|12099767|FG000|Overall Study|Adverse Event|19
7682127|NCT00295750|12099768|FG001|Overall Study|Adverse Event|15
7682128|NCT00295750|12099769|FG002|Overall Study|Adverse Event|12
7682129|NCT00295750|12099767|FG000|Overall Study|Lack of Efficacy|1
7682130|NCT00295750|12099768|FG001|Overall Study|Lack of Efficacy|1
7682131|NCT00295750|12099769|FG002|Overall Study|Lack of Efficacy|0
7682132|NCT00295750|12099767|FG000|Overall Study|Lost to Follow-up|1
7682133|NCT00295750|12099768|FG001|Overall Study|Lost to Follow-up|4
7682134|NCT00295750|12099769|FG002|Overall Study|Lost to Follow-up|1
7682135|NCT00295750|12099767|FG000|Overall Study|Taking prohibited therapy|2
7682136|NCT00295750|12099768|FG001|Overall Study|Taking prohibited therapy|3
7682137|NCT00295750|12099769|FG002|Overall Study|Taking prohibited therapy|2
7682138|NCT00295750|12099767|FG000|Overall Study|Administrative errors|2
7682139|NCT00295750|12099768|FG001|Overall Study|Administrative errors|4
7682140|NCT00295750|12099769|FG002|Overall Study|Administrative errors|5
7682141|NCT00295750|12099767|FG000|Overall Study|Trial drug errors|1
7682142|NCT00295750|12099768|FG001|Overall Study|Trial drug errors|1
7682143|NCT00295750|12099769|FG002|Overall Study|Trial drug errors|0
7682144|NCT00295750|12099767|FG000|Overall Study|Disease progression|2
7682145|NCT00295750|12099768|FG001|Overall Study|Disease progression|1
7682146|NCT00295750|12099769|FG002|Overall Study|Disease progression|0
7682147|NCT00295750|12099767|FG000|Overall Study|Personal reasons|0
7682148|NCT00295750|12099768|FG001|Overall Study|Personal reasons|1
7682149|NCT00295750|12099769|FG002|Overall Study|Personal reasons|0
7682150|NCT00295750|12099767|FG000|Overall Study|Randomized but never received trial drug|4
7682151|NCT00295750|12099768|FG001|Overall Study|Randomized but never received trial drug|3
7682152|NCT00295750|12099769|FG002|Overall Study|Randomized but never received trial drug|3
7682153|NCT00295750|12099767|FG000|Overall Study|Withdrawal by Subject|9
7682154|NCT00295750|12099768|FG001|Overall Study|Withdrawal by Subject|4
7682155|NCT00295750|12099769|FG002|Overall Study|Withdrawal by Subject|7
7682156|NCT00295750|12099767|FG000|Overall Study|Protocol Violation|2
7682157|NCT00295750|12099768|FG001|Overall Study|Protocol Violation|4
7682158|NCT00295750|12099769|FG002|Overall Study|Protocol Violation|2
7682159|NCT00295854|12099780|FG000|Overall Study|Adverse Event|7
7682160|NCT00295854|12099781|FG001|Overall Study|Adverse Event|7
7682161|NCT00295854|12099782|FG002|Overall Study|Adverse Event|6
7682162|NCT00295854|12099780|FG000|Overall Study|Protocol Violation|1
7682163|NCT00295854|12099781|FG001|Overall Study|Protocol Violation|1
7682164|NCT00295854|12099782|FG002|Overall Study|Protocol Violation|1
7682165|NCT00295854|12099780|FG000|Overall Study|Lost to Follow-up|2
7682166|NCT00295854|12099781|FG001|Overall Study|Lost to Follow-up|0
7682167|NCT00295854|12099782|FG002|Overall Study|Lost to Follow-up|1
7682168|NCT00295854|12099780|FG000|Overall Study|Withdrawal by Subject|3
7682169|NCT00295854|12099781|FG001|Overall Study|Withdrawal by Subject|7
7682170|NCT00295854|12099782|FG002|Overall Study|Withdrawal by Subject|4
7682171|NCT00295854|12099780|FG000|Overall Study|did not continue to meet criteria|1
7682172|NCT00295854|12099781|FG001|Overall Study|did not continue to meet criteria|1
7682173|NCT00295854|12099782|FG002|Overall Study|did not continue to meet criteria|2
7682174|NCT00295854|12099780|FG000|Overall Study|required a prohibited medication|1
7682175|NCT00295854|12099781|FG001|Overall Study|required a prohibited medication|0
7682176|NCT00295854|12099782|FG002|Overall Study|required a prohibited medication|0
7682177|NCT00295854|12099780|FG000|Overall Study|Other|3
7682178|NCT00295854|12099781|FG001|Overall Study|Other|5
7682179|NCT00295854|12099782|FG002|Overall Study|Other|1
7682180|NCT00295880|12099794|FG000|Overall Study|IBMI unit could not be volume reduced|1
7682181|NCT00295880|12099794|FG000|Overall Study|Unit randomization did not occur|1
7682182|NCT00295932|12099809|FG000|Overall Study|Not Treated|0
7682183|NCT00295932|12099810|FG001|Overall Study|Not Treated|0
7682184|NCT00295932|12099811|FG002|Overall Study|Not Treated|0
7682185|NCT00295932|12099812|FG003|Overall Study|Not Treated|0
7682186|NCT00295932|12099813|FG004|Overall Study|Not Treated|0
7682187|NCT00295932|12099814|FG005|Overall Study|Not Treated|0
7682188|NCT00295932|12099815|FG006|Overall Study|Not Treated|0
7682189|NCT00295932|12099816|FG007|Overall Study|Not Treated|0
7682190|NCT00295932|12099817|FG008|Overall Study|Not Treated|0
7682191|NCT00295932|12099818|FG009|Overall Study|Not Treated|0
7682192|NCT00295932|12099819|FG010|Overall Study|Not Treated|1
7682193|NCT00296036|12099847|FG000|Overall Study|Withdrawal by Subject|1
7682194|NCT00296036|12099848|FG001|Overall Study|Withdrawal by Subject|0
7682195|NCT00296036|12099849|FG002|Overall Study|Withdrawal by Subject|2
7682196|NCT00296036|12099850|FG003|Overall Study|Withdrawal by Subject|1
7682197|NCT00296036|12099851|FG004|Overall Study|Withdrawal by Subject|2
7682198|NCT00296036|12099852|FG005|Overall Study|Withdrawal by Subject|1
7682199|NCT00296036|12099847|FG000|Overall Study|Protocol Violation|0
7682200|NCT00296036|12099848|FG001|Overall Study|Protocol Violation|0
7682201|NCT00296036|12099849|FG002|Overall Study|Protocol Violation|0
7682202|NCT00296036|12099850|FG003|Overall Study|Protocol Violation|0
7682203|NCT00296036|12099851|FG004|Overall Study|Protocol Violation|0
7682204|NCT00296036|12099852|FG005|Overall Study|Protocol Violation|3
7682205|NCT00296140|12099871|FG000|Overall Study|Lost to Follow-up|1
7682206|NCT00296140|12099872|FG001|Overall Study|Lost to Follow-up|0
7682207|NCT00296140|12099871|FG000|Overall Study|Withdrawal by Subject|1
7682208|NCT00296140|12099872|FG001|Overall Study|Withdrawal by Subject|0
7682209|NCT00296140|12099871|FG000|Overall Study|Discharge to Nursing Home|1
7682210|NCT00296140|12099872|FG001|Overall Study|Discharge to Nursing Home|0
7682211|NCT00296244|12099905|FG000|Overall Study|Underwent retransplant|0
7682212|NCT00296244|12099906|FG001|Overall Study|Underwent retransplant|1
7682213|NCT00296335|12099937|FG000|Overall Study|Recurrence|3
7682214|NCT00296335|12099938|FG001|Overall Study|Recurrence|51
7682215|NCT00296335|12099937|FG000|Overall Study|Adverse Event|17
7682216|NCT00296335|12099938|FG001|Overall Study|Adverse Event|27
7682217|NCT00296335|12099937|FG000|Overall Study|Lost to Follow-up|7
7682218|NCT00296335|12099938|FG001|Overall Study|Lost to Follow-up|33
7682219|NCT00296335|12099937|FG000|Overall Study|Physician Decision|3
7682220|NCT00296335|12099938|FG001|Overall Study|Physician Decision|11
7682221|NCT00296374|12099949|FG000|Overall Study|Adverse Event|14
7682222|NCT00296374|12099950|FG001|Overall Study|Adverse Event|10
7682223|NCT00296374|12099951|FG002|Overall Study|Adverse Event|7
7682224|NCT00296374|12099949|FG000|Overall Study|Withdrawal by Subject|3
7682225|NCT00296374|12099950|FG001|Overall Study|Withdrawal by Subject|5
7682226|NCT00296374|12099951|FG002|Overall Study|Withdrawal by Subject|11
7682227|NCT00296374|12099949|FG000|Overall Study|Incorrect enrollment|3
7682228|NCT00296374|12099950|FG001|Overall Study|Incorrect enrollment|3
7682229|NCT00296374|12099951|FG002|Overall Study|Incorrect enrollment|4
7682230|NCT00296374|12099949|FG000|Overall Study|Protocol Violation|1
7682231|NCT00296374|12099950|FG001|Overall Study|Protocol Violation|2
7682232|NCT00296374|12099951|FG002|Overall Study|Protocol Violation|3
7682233|NCT00296374|12099949|FG000|Overall Study|Lost to Follow-up|3
7682234|NCT00296374|12099950|FG001|Overall Study|Lost to Follow-up|1
7682235|NCT00296374|12099951|FG002|Overall Study|Lost to Follow-up|1
7682236|NCT00296374|12099949|FG000|Overall Study|Relocated to another state|1
7682237|NCT00296374|12099950|FG001|Overall Study|Relocated to another state|0
7682238|NCT00296374|12099951|FG002|Overall Study|Relocated to another state|0
7682239|NCT00296374|12099949|FG000|Overall Study|Stopped drug before end of study visit|0
7682240|NCT00296374|12099950|FG001|Overall Study|Stopped drug before end of study visit|1
7682241|NCT00296374|12099951|FG002|Overall Study|Stopped drug before end of study visit|0
7682242|NCT00296374|12099949|FG000|Overall Study|Nephrologist introduced ACE|0
7682243|NCT00296374|12099950|FG001|Overall Study|Nephrologist introduced ACE|1
7682244|NCT00296374|12099951|FG002|Overall Study|Nephrologist introduced ACE|0
7682245|NCT00296374|12099949|FG000|Overall Study|Pregnancy|0
7682246|NCT00296374|12099950|FG001|Overall Study|Pregnancy|0
7682247|NCT00296374|12099951|FG002|Overall Study|Pregnancy|2
7682248|NCT00296374|12099949|FG000|Overall Study|Other|0
7682249|NCT00296374|12099950|FG001|Overall Study|Other|0
7682250|NCT00296374|12099951|FG002|Overall Study|Other|1
7682251|NCT00296400|12099968|FG000|Overall Study|Adverse Event|7
7682252|NCT00296400|12099969|FG001|Overall Study|Adverse Event|7
7682253|NCT00296400|12099970|FG002|Overall Study|Adverse Event|7
7682254|NCT00296400|12099968|FG000|Overall Study|Withdrawal by Subject|5
7682255|NCT00296400|12099969|FG001|Overall Study|Withdrawal by Subject|6
7682256|NCT00296400|12099970|FG002|Overall Study|Withdrawal by Subject|2
7682257|NCT00296400|12099968|FG000|Overall Study|Incorrect enrollment|2
7682258|NCT00296400|12099969|FG001|Overall Study|Incorrect enrollment|0
7682259|NCT00296400|12099970|FG002|Overall Study|Incorrect enrollment|0
7682260|NCT00296400|12099968|FG000|Overall Study|Protocol Violation|1
7682261|NCT00296400|12099969|FG001|Overall Study|Protocol Violation|1
7682262|NCT00296400|12099970|FG002|Overall Study|Protocol Violation|1
7682263|NCT00296400|12099968|FG000|Overall Study|Lost to Follow-up|1
7682264|NCT00296400|12099969|FG001|Overall Study|Lost to Follow-up|1
7682265|NCT00296400|12099970|FG002|Overall Study|Lost to Follow-up|2
7682266|NCT00296400|12099968|FG000|Overall Study|Study specific discontinuation criteria|0
7682267|NCT00296400|12099969|FG001|Overall Study|Study specific discontinuation criteria|0
7682268|NCT00296400|12099970|FG002|Overall Study|Study specific discontinuation criteria|1
7682269|NCT00296400|12099968|FG000|Overall Study|Visit 10 was performed earlier|0
7682270|NCT00296400|12099969|FG001|Overall Study|Visit 10 was performed earlier|1
7682271|NCT00296400|12099970|FG002|Overall Study|Visit 10 was performed earlier|0
7682272|NCT00296400|12099968|FG000|Overall Study|Pregnancy|1
7682273|NCT00296400|12099969|FG001|Overall Study|Pregnancy|2
7682274|NCT00296400|12099970|FG002|Overall Study|Pregnancy|0
7682275|NCT00296491|12099985|FG000|Overall Study|Low Pollen Counts|18
7682276|NCT00296491|12099986|FG001|Overall Study|Low Pollen Counts|26
7682277|NCT00296491|12099987|FG002|Overall Study|Low Pollen Counts|25
7682278|NCT00296491|12099988|FG003|Overall Study|Low Pollen Counts|16
7682279|NCT00296491|12099985|FG000|Overall Study|Protocol Violation|4
7682280|NCT00296491|12099986|FG001|Overall Study|Protocol Violation|6
7682281|NCT00296491|12099987|FG002|Overall Study|Protocol Violation|2
7682282|NCT00296491|12099988|FG003|Overall Study|Protocol Violation|3
7682283|NCT00296491|12099985|FG000|Overall Study|Adverse Event|1
7682284|NCT00296491|12099986|FG001|Overall Study|Adverse Event|3
7682285|NCT00296491|12099987|FG002|Overall Study|Adverse Event|1
7682286|NCT00296491|12099988|FG003|Overall Study|Adverse Event|4
7682287|NCT00296491|12099985|FG000|Overall Study|Withdrawn due to Asthma|0
7682288|NCT00296491|12099986|FG001|Overall Study|Withdrawn due to Asthma|0
7682289|NCT00296491|12099987|FG002|Overall Study|Withdrawn due to Asthma|0
7682290|NCT00296491|12099988|FG003|Overall Study|Withdrawn due to Asthma|4
7682291|NCT00296491|12099985|FG000|Overall Study|Withdrawal by Subject|7
7682292|NCT00296491|12099986|FG001|Overall Study|Withdrawal by Subject|3
7682293|NCT00296491|12099987|FG002|Overall Study|Withdrawal by Subject|3
7682294|NCT00296491|12099988|FG003|Overall Study|Withdrawal by Subject|2
7682295|NCT00296491|12099985|FG000|Overall Study|Non-Compliance|12
7682296|NCT00296491|12099986|FG001|Overall Study|Non-Compliance|13
7682297|NCT00296491|12099987|FG002|Overall Study|Non-Compliance|10
7682298|NCT00296491|12099988|FG003|Overall Study|Non-Compliance|14
7682299|NCT00296491|12099985|FG000|Overall Study|Lost to Follow-up|0
7682300|NCT00296491|12099986|FG001|Overall Study|Lost to Follow-up|2
7682301|NCT00296491|12099987|FG002|Overall Study|Lost to Follow-up|2
7682302|NCT00296491|12099988|FG003|Overall Study|Lost to Follow-up|0
7682303|NCT00296504|12100013|FG000|Interim Analysis|Withdrawal by Subject|8
7682304|NCT00296504|12100014|FG001|Interim Analysis|Withdrawal by Subject|0
7682305|NCT00296504|12100015|FG002|Interim Analysis|Withdrawal by Subject|12
7682306|NCT00296504|12100016|FG003|Interim Analysis|Withdrawal by Subject|0
7682307|NCT00296504|12100017|FG004|Interim Analysis|Withdrawal by Subject|5
7682308|NCT00296504|12100018|FG005|Interim Analysis|Withdrawal by Subject|5
7682309|NCT00296504|12100019|FG006|Interim Analysis|Withdrawal by Subject|9
7682310|NCT00296504|12100020|FG007|Interim Analysis|Withdrawal by Subject|3
7682311|NCT00296504|12100021|FG008|Interim Analysis|Withdrawal by Subject|0
7682312|NCT00296504|12100013|FG000|Interim Analysis|Lost to Follow-up|13
7682313|NCT00296504|12100014|FG001|Interim Analysis|Lost to Follow-up|3
7682314|NCT00296504|12100015|FG002|Interim Analysis|Lost to Follow-up|26
7682315|NCT00296504|12100016|FG003|Interim Analysis|Lost to Follow-up|8
7682316|NCT00296504|12100017|FG004|Interim Analysis|Lost to Follow-up|14
7682317|NCT00296504|12100018|FG005|Interim Analysis|Lost to Follow-up|4
7682318|NCT00296504|12100019|FG006|Interim Analysis|Lost to Follow-up|11
7682319|NCT00296504|12100020|FG007|Interim Analysis|Lost to Follow-up|4
7682320|NCT00296504|12100021|FG008|Interim Analysis|Lost to Follow-up|0
7682321|NCT00296504|12100013|FG000|Interim Analysis|Clinical Progression|1
7682322|NCT00296504|12100014|FG001|Interim Analysis|Clinical Progression|0
7682323|NCT00296504|12100015|FG002|Interim Analysis|Clinical Progression|1
7682324|NCT00296504|12100016|FG003|Interim Analysis|Clinical Progression|1
7682325|NCT00296504|12100017|FG004|Interim Analysis|Clinical Progression|0
7682326|NCT00296504|12100018|FG005|Interim Analysis|Clinical Progression|2
7682327|NCT00296504|12100019|FG006|Interim Analysis|Clinical Progression|1
7682328|NCT00296504|12100020|FG007|Interim Analysis|Clinical Progression|2
7682329|NCT00296504|12100021|FG008|Interim Analysis|Clinical Progression|0
7682330|NCT00296504|12100013|FG000|Interim Analysis|Insufficient Viral Load Response|5
7682331|NCT00296504|12100014|FG001|Interim Analysis|Insufficient Viral Load Response|1
7682332|NCT00296504|12100015|FG002|Interim Analysis|Insufficient Viral Load Response|12
7682333|NCT00296504|12100016|FG003|Interim Analysis|Insufficient Viral Load Response|2
7682334|NCT00296504|12100017|FG004|Interim Analysis|Insufficient Viral Load Response|7
7682335|NCT00296504|12100018|FG005|Interim Analysis|Insufficient Viral Load Response|9
7682336|NCT00296504|12100019|FG006|Interim Analysis|Insufficient Viral Load Response|2
7682337|NCT00296504|12100020|FG007|Interim Analysis|Insufficient Viral Load Response|24
7682338|NCT00296504|12100021|FG008|Interim Analysis|Insufficient Viral Load Response|0
7682339|NCT00296504|12100013|FG000|Interim Analysis|Adverse Event|0
7682340|NCT00296504|12100014|FG001|Interim Analysis|Adverse Event|0
7682341|NCT00296504|12100015|FG002|Interim Analysis|Adverse Event|13
7682342|NCT00296504|12100016|FG003|Interim Analysis|Adverse Event|4
7682343|NCT00296504|12100017|FG004|Interim Analysis|Adverse Event|6
7682344|NCT00296504|12100018|FG005|Interim Analysis|Adverse Event|3
7682345|NCT00296504|12100019|FG006|Interim Analysis|Adverse Event|4
7682346|NCT00296504|12100020|FG007|Interim Analysis|Adverse Event|5
7682347|NCT00296504|12100021|FG008|Interim Analysis|Adverse Event|0
7682348|NCT00296504|12100013|FG000|Interim Analysis|Protocol Violation|0
7682349|NCT00296504|12100014|FG001|Interim Analysis|Protocol Violation|0
7682350|NCT00296504|12100015|FG002|Interim Analysis|Protocol Violation|2
7682351|NCT00296504|12100016|FG003|Interim Analysis|Protocol Violation|0
7682352|NCT00296504|12100017|FG004|Interim Analysis|Protocol Violation|1
7682353|NCT00296504|12100018|FG005|Interim Analysis|Protocol Violation|0
7682354|NCT00296504|12100019|FG006|Interim Analysis|Protocol Violation|0
7682355|NCT00296504|12100020|FG007|Interim Analysis|Protocol Violation|1
7682356|NCT00296504|12100021|FG008|Interim Analysis|Protocol Violation|0
7682357|NCT00296504|12100013|FG000|Interim Analysis|Insufficient CD4 Response|0
7682358|NCT00296504|12100014|FG001|Interim Analysis|Insufficient CD4 Response|0
7682359|NCT00296504|12100015|FG002|Interim Analysis|Insufficient CD4 Response|0
7682360|NCT00296504|12100016|FG003|Interim Analysis|Insufficient CD4 Response|0
7682361|NCT00296504|12100017|FG004|Interim Analysis|Insufficient CD4 Response|1
7682362|NCT00296504|12100018|FG005|Interim Analysis|Insufficient CD4 Response|1
7682363|NCT00296504|12100019|FG006|Interim Analysis|Insufficient CD4 Response|0
7682364|NCT00296504|12100020|FG007|Interim Analysis|Insufficient CD4 Response|0
7682365|NCT00296504|12100021|FG008|Interim Analysis|Insufficient CD4 Response|0
7682366|NCT00296504|12100013|FG000|Interim Analysis|Switched to Commercially Available Drug|2
7682367|NCT00296504|12100014|FG001|Interim Analysis|Switched to Commercially Available Drug|0
7682368|NCT00296504|12100015|FG002|Interim Analysis|Switched to Commercially Available Drug|4
7682369|NCT00296504|12100016|FG003|Interim Analysis|Switched to Commercially Available Drug|1
7682370|NCT00296504|12100017|FG004|Interim Analysis|Switched to Commercially Available Drug|0
7682371|NCT00296504|12100018|FG005|Interim Analysis|Switched to Commercially Available Drug|5
7682372|NCT00296504|12100019|FG006|Interim Analysis|Switched to Commercially Available Drug|3
7682373|NCT00296504|12100020|FG007|Interim Analysis|Switched to Commercially Available Drug|4
7682374|NCT00296504|12100021|FG008|Interim Analysis|Switched to Commercially Available Drug|0
7682375|NCT00296504|12100013|FG000|Interim Analysis|Pregnancy|4
7682376|NCT00296504|12100014|FG001|Interim Analysis|Pregnancy|1
7682377|NCT00296504|12100015|FG002|Interim Analysis|Pregnancy|4
7682378|NCT00296504|12100016|FG003|Interim Analysis|Pregnancy|2
7682379|NCT00296504|12100017|FG004|Interim Analysis|Pregnancy|0
7682380|NCT00296504|12100018|FG005|Interim Analysis|Pregnancy|1
7682381|NCT00296504|12100019|FG006|Interim Analysis|Pregnancy|1
7682382|NCT00296504|12100020|FG007|Interim Analysis|Pregnancy|1
7682383|NCT00296504|12100021|FG008|Interim Analysis|Pregnancy|0
7682384|NCT00296504|12100013|FG000|Interim Analysis|Death|1
7682385|NCT00296504|12100014|FG001|Interim Analysis|Death|0
7682386|NCT00296504|12100015|FG002|Interim Analysis|Death|3
7682387|NCT00296504|12100016|FG003|Interim Analysis|Death|0
7682388|NCT00296504|12100017|FG004|Interim Analysis|Death|0
7682389|NCT00296504|12100018|FG005|Interim Analysis|Death|0
7682390|NCT00296504|12100019|FG006|Interim Analysis|Death|0
7682391|NCT00296504|12100020|FG007|Interim Analysis|Death|0
7682392|NCT00296504|12100021|FG008|Interim Analysis|Death|0
7682393|NCT00296504|12100013|FG000|Interim Analysis|Participant Non-compliant|0
7682394|NCT00296504|12100014|FG001|Interim Analysis|Participant Non-compliant|1
7682395|NCT00296504|12100015|FG002|Interim Analysis|Participant Non-compliant|2
7682396|NCT00296504|12100016|FG003|Interim Analysis|Participant Non-compliant|1
7682397|NCT00296504|12100017|FG004|Interim Analysis|Participant Non-compliant|1
7682398|NCT00296504|12100018|FG005|Interim Analysis|Participant Non-compliant|3
7682399|NCT00296504|12100019|FG006|Interim Analysis|Participant Non-compliant|6
7682400|NCT00296504|12100020|FG007|Interim Analysis|Participant Non-compliant|2
7682401|NCT00296504|12100021|FG008|Interim Analysis|Participant Non-compliant|0
7682402|NCT00296504|12100013|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0
7682403|NCT00296504|12100014|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0
7682404|NCT00296504|12100015|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2
7682405|NCT00296504|12100016|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0
7682406|NCT00296504|12100017|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0
7682407|NCT00296504|12100018|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1
7682408|NCT00296504|12100019|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0
7682409|NCT00296504|12100020|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0
7682410|NCT00296504|12100021|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0
7682411|NCT00296504|12100013|FG000|Interim Analysis|To Simplify Treatment|0
7682412|NCT00296504|12100014|FG001|Interim Analysis|To Simplify Treatment|0
7682413|NCT00296504|12100015|FG002|Interim Analysis|To Simplify Treatment|1
7682414|NCT00296504|12100016|FG003|Interim Analysis|To Simplify Treatment|0
7682415|NCT00296504|12100017|FG004|Interim Analysis|To Simplify Treatment|0
7682416|NCT00296504|12100018|FG005|Interim Analysis|To Simplify Treatment|0
7682417|NCT00296504|12100019|FG006|Interim Analysis|To Simplify Treatment|2
7682418|NCT00296504|12100020|FG007|Interim Analysis|To Simplify Treatment|0
7682419|NCT00296504|12100021|FG008|Interim Analysis|To Simplify Treatment|0
7682420|NCT00296504|12100013|FG000|Interim Analysis|Participant Had Problems with Alcohol|0
7682421|NCT00296504|12100014|FG001|Interim Analysis|Participant Had Problems with Alcohol|0
7682422|NCT00296504|12100015|FG002|Interim Analysis|Participant Had Problems with Alcohol|1
7682423|NCT00296504|12100016|FG003|Interim Analysis|Participant Had Problems with Alcohol|0
7682424|NCT00296504|12100017|FG004|Interim Analysis|Participant Had Problems with Alcohol|0
7682425|NCT00296504|12100018|FG005|Interim Analysis|Participant Had Problems with Alcohol|0
7682426|NCT00296504|12100019|FG006|Interim Analysis|Participant Had Problems with Alcohol|0
7682427|NCT00296504|12100020|FG007|Interim Analysis|Participant Had Problems with Alcohol|0
7682428|NCT00296504|12100021|FG008|Interim Analysis|Participant Had Problems with Alcohol|0
7682429|NCT00296504|12100013|FG000|Interim Analysis|Participant Moved|1
7682430|NCT00296504|12100014|FG001|Interim Analysis|Participant Moved|0
7682431|NCT00296504|12100015|FG002|Interim Analysis|Participant Moved|1
7682432|NCT00296504|12100016|FG003|Interim Analysis|Participant Moved|0
7682433|NCT00296504|12100017|FG004|Interim Analysis|Participant Moved|0
7682434|NCT00296504|12100018|FG005|Interim Analysis|Participant Moved|1
7682435|NCT00296504|12100019|FG006|Interim Analysis|Participant Moved|1
7682436|NCT00296504|12100020|FG007|Interim Analysis|Participant Moved|0
7682437|NCT00296504|12100021|FG008|Interim Analysis|Participant Moved|0
7682438|NCT00296504|12100013|FG000|Interim Analysis|Participant Was Incarcerated|2
7682439|NCT00296504|12100014|FG001|Interim Analysis|Participant Was Incarcerated|0
7682440|NCT00296504|12100015|FG002|Interim Analysis|Participant Was Incarcerated|1
7682441|NCT00296504|12100016|FG003|Interim Analysis|Participant Was Incarcerated|0
7682442|NCT00296504|12100017|FG004|Interim Analysis|Participant Was Incarcerated|0
7682443|NCT00296504|12100018|FG005|Interim Analysis|Participant Was Incarcerated|0
7682444|NCT00296504|12100019|FG006|Interim Analysis|Participant Was Incarcerated|0
7682445|NCT00296504|12100020|FG007|Interim Analysis|Participant Was Incarcerated|0
7682446|NCT00296504|12100021|FG008|Interim Analysis|Participant Was Incarcerated|0
7682447|NCT00296504|12100013|FG000|Interim Analysis|Resistance to FPV|0
7682448|NCT00296504|12100014|FG001|Interim Analysis|Resistance to FPV|0
7682449|NCT00296504|12100015|FG002|Interim Analysis|Resistance to FPV|1
7682450|NCT00296504|12100016|FG003|Interim Analysis|Resistance to FPV|0
7682451|NCT00296504|12100017|FG004|Interim Analysis|Resistance to FPV|0
7682452|NCT00296504|12100018|FG005|Interim Analysis|Resistance to FPV|0
7682453|NCT00296504|12100019|FG006|Interim Analysis|Resistance to FPV|0
7682454|NCT00296504|12100020|FG007|Interim Analysis|Resistance to FPV|0
7682455|NCT00296504|12100021|FG008|Interim Analysis|Resistance to FPV|0
7682456|NCT00296504|12100013|FG000|Interim Analysis|Physician Decision|0
7682457|NCT00296504|12100014|FG001|Interim Analysis|Physician Decision|0
7682458|NCT00296504|12100015|FG002|Interim Analysis|Physician Decision|1
7682459|NCT00296504|12100016|FG003|Interim Analysis|Physician Decision|0
7682460|NCT00296504|12100017|FG004|Interim Analysis|Physician Decision|0
7682461|NCT00296504|12100018|FG005|Interim Analysis|Physician Decision|0
7682462|NCT00296504|12100019|FG006|Interim Analysis|Physician Decision|0
7682463|NCT00296504|12100020|FG007|Interim Analysis|Physician Decision|0
7682464|NCT00296504|12100021|FG008|Interim Analysis|Physician Decision|0
7682465|NCT00296504|12100013|FG000|Interim Analysis|Principle Investigator Discretion|2
7682466|NCT00296504|12100014|FG001|Interim Analysis|Principle Investigator Discretion|0
7682467|NCT00296504|12100015|FG002|Interim Analysis|Principle Investigator Discretion|1
7682468|NCT00296504|12100016|FG003|Interim Analysis|Principle Investigator Discretion|1
7682469|NCT00296504|12100017|FG004|Interim Analysis|Principle Investigator Discretion|0
7682470|NCT00296504|12100018|FG005|Interim Analysis|Principle Investigator Discretion|0
7682471|NCT00296504|12100019|FG006|Interim Analysis|Principle Investigator Discretion|0
7682472|NCT00296504|12100020|FG007|Interim Analysis|Principle Investigator Discretion|0
7682473|NCT00296504|12100021|FG008|Interim Analysis|Principle Investigator Discretion|0
7682474|NCT00296504|12100013|FG000|Interim Analysis|Principle Investigator Terminated Study|0
7682475|NCT00296504|12100014|FG001|Interim Analysis|Principle Investigator Terminated Study|0
7682476|NCT00296504|12100015|FG002|Interim Analysis|Principle Investigator Terminated Study|1
7682477|NCT00296504|12100016|FG003|Interim Analysis|Principle Investigator Terminated Study|0
7682478|NCT00296504|12100017|FG004|Interim Analysis|Principle Investigator Terminated Study|0
7682479|NCT00296504|12100018|FG005|Interim Analysis|Principle Investigator Terminated Study|0
7682480|NCT00296504|12100019|FG006|Interim Analysis|Principle Investigator Terminated Study|0
7682481|NCT00296504|12100020|FG007|Interim Analysis|Principle Investigator Terminated Study|0
7682482|NCT00296504|12100021|FG008|Interim Analysis|Principle Investigator Terminated Study|0
7682483|NCT00296504|12100013|FG000|Interim Analysis|Non-adherence|2
7682484|NCT00296504|12100014|FG001|Interim Analysis|Non-adherence|0
7682485|NCT00296504|12100015|FG002|Interim Analysis|Non-adherence|0
7682486|NCT00296504|12100016|FG003|Interim Analysis|Non-adherence|0
7682487|NCT00296504|12100017|FG004|Interim Analysis|Non-adherence|1
7682488|NCT00296504|12100018|FG005|Interim Analysis|Non-adherence|0
7682489|NCT00296504|12100019|FG006|Interim Analysis|Non-adherence|0
7682490|NCT00296504|12100020|FG007|Interim Analysis|Non-adherence|1
7682491|NCT00296504|12100021|FG008|Interim Analysis|Non-adherence|0
7682492|NCT00296504|12100013|FG000|Interim Analysis|Site Closing|1
7682493|NCT00296504|12100014|FG001|Interim Analysis|Site Closing|0
7682494|NCT00296504|12100015|FG002|Interim Analysis|Site Closing|0
7682495|NCT00296504|12100016|FG003|Interim Analysis|Site Closing|0
7682496|NCT00296504|12100017|FG004|Interim Analysis|Site Closing|0
7682497|NCT00296504|12100018|FG005|Interim Analysis|Site Closing|1
7682498|NCT00296504|12100019|FG006|Interim Analysis|Site Closing|2
7682499|NCT00296504|12100020|FG007|Interim Analysis|Site Closing|0
7682500|NCT00296504|12100021|FG008|Interim Analysis|Site Closing|0
7682501|NCT00296504|12100013|FG000|Interim Analysis|Lack of Personnel at Site|1
7682502|NCT00296504|12100014|FG001|Interim Analysis|Lack of Personnel at Site|0
7682503|NCT00296504|12100015|FG002|Interim Analysis|Lack of Personnel at Site|0
7682504|NCT00296504|12100016|FG003|Interim Analysis|Lack of Personnel at Site|0
7682505|NCT00296504|12100017|FG004|Interim Analysis|Lack of Personnel at Site|0
7682506|NCT00296504|12100018|FG005|Interim Analysis|Lack of Personnel at Site|0
7682507|NCT00296504|12100019|FG006|Interim Analysis|Lack of Personnel at Site|0
7682508|NCT00296504|12100020|FG007|Interim Analysis|Lack of Personnel at Site|0
7682509|NCT00296504|12100021|FG008|Interim Analysis|Lack of Personnel at Site|0
7682510|NCT00296504|12100013|FG000|Interim Analysis|Missed Schedule Date|1
7682511|NCT00296504|12100014|FG001|Interim Analysis|Missed Schedule Date|0
7682512|NCT00296504|12100015|FG002|Interim Analysis|Missed Schedule Date|0
7682513|NCT00296504|12100016|FG003|Interim Analysis|Missed Schedule Date|0
7682514|NCT00296504|12100017|FG004|Interim Analysis|Missed Schedule Date|0
7682515|NCT00296504|12100018|FG005|Interim Analysis|Missed Schedule Date|0
7682516|NCT00296504|12100019|FG006|Interim Analysis|Missed Schedule Date|0
7682517|NCT00296504|12100020|FG007|Interim Analysis|Missed Schedule Date|0
7682518|NCT00296504|12100021|FG008|Interim Analysis|Missed Schedule Date|0
7682519|NCT00296504|12100013|FG000|Interim Analysis|Inclusion in Other Protocol|0
7682520|NCT00296504|12100014|FG001|Interim Analysis|Inclusion in Other Protocol|0
7682521|NCT00296504|12100015|FG002|Interim Analysis|Inclusion in Other Protocol|0
7682522|NCT00296504|12100016|FG003|Interim Analysis|Inclusion in Other Protocol|1
7682523|NCT00296504|12100017|FG004|Interim Analysis|Inclusion in Other Protocol|0
7682524|NCT00296504|12100018|FG005|Interim Analysis|Inclusion in Other Protocol|0
7682525|NCT00296504|12100019|FG006|Interim Analysis|Inclusion in Other Protocol|0
7682526|NCT00296504|12100020|FG007|Interim Analysis|Inclusion in Other Protocol|0
7682527|NCT00296504|12100021|FG008|Interim Analysis|Inclusion in Other Protocol|0
7682528|NCT00296504|12100013|FG000|Interim Analysis|Participant Stopped|0
7682529|NCT00296504|12100014|FG001|Interim Analysis|Participant Stopped|0
7682530|NCT00296504|12100015|FG002|Interim Analysis|Participant Stopped|0
7682531|NCT00296504|12100016|FG003|Interim Analysis|Participant Stopped|0
7682532|NCT00296504|12100017|FG004|Interim Analysis|Participant Stopped|1
7682533|NCT00296504|12100018|FG005|Interim Analysis|Participant Stopped|0
7682534|NCT00296504|12100019|FG006|Interim Analysis|Participant Stopped|0
7682535|NCT00296504|12100020|FG007|Interim Analysis|Participant Stopped|0
7682536|NCT00296504|12100021|FG008|Interim Analysis|Participant Stopped|0
7682537|NCT00296504|12100013|FG000|Interim Analysis|Physician and Participant Decision|0
7682538|NCT00296504|12100014|FG001|Interim Analysis|Physician and Participant Decision|0
7682539|NCT00296504|12100015|FG002|Interim Analysis|Physician and Participant Decision|0
7682540|NCT00296504|12100016|FG003|Interim Analysis|Physician and Participant Decision|0
7682541|NCT00296504|12100017|FG004|Interim Analysis|Physician and Participant Decision|0
7682542|NCT00296504|12100018|FG005|Interim Analysis|Physician and Participant Decision|1
7682543|NCT00296504|12100019|FG006|Interim Analysis|Physician and Participant Decision|0
7682544|NCT00296504|12100020|FG007|Interim Analysis|Physician and Participant Decision|0
7682545|NCT00296504|12100021|FG008|Interim Analysis|Physician and Participant Decision|0
7682546|NCT00296504|12100013|FG000|Interim Analysis|Participant Stopped HIV Medications|0
7682547|NCT00296504|12100014|FG001|Interim Analysis|Participant Stopped HIV Medications|0
7682548|NCT00296504|12100015|FG002|Interim Analysis|Participant Stopped HIV Medications|0
7682549|NCT00296504|12100016|FG003|Interim Analysis|Participant Stopped HIV Medications|0
7682550|NCT00296504|12100017|FG004|Interim Analysis|Participant Stopped HIV Medications|0
7682551|NCT00296504|12100018|FG005|Interim Analysis|Participant Stopped HIV Medications|0
7682552|NCT00296504|12100019|FG006|Interim Analysis|Participant Stopped HIV Medications|1
7682553|NCT00296504|12100020|FG007|Interim Analysis|Participant Stopped HIV Medications|0
7682554|NCT00296504|12100021|FG008|Interim Analysis|Participant Stopped HIV Medications|0
7682555|NCT00296504|12100013|FG000|Interim Analysis|Study Ended|0
7682556|NCT00296504|12100014|FG001|Interim Analysis|Study Ended|0
7682557|NCT00296504|12100015|FG002|Interim Analysis|Study Ended|0
7682558|NCT00296504|12100016|FG003|Interim Analysis|Study Ended|0
7682559|NCT00296504|12100017|FG004|Interim Analysis|Study Ended|0
7682560|NCT00296504|12100018|FG005|Interim Analysis|Study Ended|0
7682561|NCT00296504|12100019|FG006|Interim Analysis|Study Ended|1
7682562|NCT00296504|12100020|FG007|Interim Analysis|Study Ended|0
7682563|NCT00296504|12100021|FG008|Interim Analysis|Study Ended|0
7682564|NCT00296504|12100013|FG000|Interim Analysis|Participant Needed Interferon|0
7682565|NCT00296504|12100014|FG001|Interim Analysis|Participant Needed Interferon|0
7682566|NCT00296504|12100015|FG002|Interim Analysis|Participant Needed Interferon|0
7682567|NCT00296504|12100016|FG003|Interim Analysis|Participant Needed Interferon|0
7682568|NCT00296504|12100017|FG004|Interim Analysis|Participant Needed Interferon|0
7682569|NCT00296504|12100018|FG005|Interim Analysis|Participant Needed Interferon|0
7682570|NCT00296504|12100019|FG006|Interim Analysis|Participant Needed Interferon|0
7682571|NCT00296504|12100020|FG007|Interim Analysis|Participant Needed Interferon|1
7682572|NCT00296504|12100021|FG008|Interim Analysis|Participant Needed Interferon|0
7682573|NCT00296504|12100013|FG000|Interim Analysis|Ongoing|32
7682574|NCT00296504|12100014|FG001|Interim Analysis|Ongoing|12
7682575|NCT00296504|12100015|FG002|Interim Analysis|Ongoing|16
7682576|NCT00296504|12100016|FG003|Interim Analysis|Ongoing|22
7682577|NCT00296504|12100017|FG004|Interim Analysis|Ongoing|0
7682578|NCT00296504|12100018|FG005|Interim Analysis|Ongoing|0
7682579|NCT00296504|12100019|FG006|Interim Analysis|Ongoing|30
7682580|NCT00296504|12100020|FG007|Interim Analysis|Ongoing|1
7682581|NCT00296504|12100021|FG008|Interim Analysis|Ongoing|0
7682582|NCT00296504|12100013|FG000|Final Analysis|Withdrawal by Subject|0
7682583|NCT00296504|12100014|FG001|Final Analysis|Withdrawal by Subject|0
7682584|NCT00296504|12100015|FG002|Final Analysis|Withdrawal by Subject|0
7682585|NCT00296504|12100016|FG003|Final Analysis|Withdrawal by Subject|0
7682586|NCT00296504|12100017|FG004|Final Analysis|Withdrawal by Subject|0
7682587|NCT00296504|12100018|FG005|Final Analysis|Withdrawal by Subject|0
7682588|NCT00296504|12100019|FG006|Final Analysis|Withdrawal by Subject|0
7682589|NCT00296504|12100020|FG007|Final Analysis|Withdrawal by Subject|0
7682590|NCT00296504|12100021|FG008|Final Analysis|Withdrawal by Subject|1
7682591|NCT00296504|12100013|FG000|Final Analysis|Lost to Follow-up|0
7682592|NCT00296504|12100014|FG001|Final Analysis|Lost to Follow-up|0
7682593|NCT00296504|12100015|FG002|Final Analysis|Lost to Follow-up|0
7682594|NCT00296504|12100016|FG003|Final Analysis|Lost to Follow-up|0
7682595|NCT00296504|12100017|FG004|Final Analysis|Lost to Follow-up|0
7682596|NCT00296504|12100018|FG005|Final Analysis|Lost to Follow-up|0
7682597|NCT00296504|12100019|FG006|Final Analysis|Lost to Follow-up|0
7682598|NCT00296504|12100020|FG007|Final Analysis|Lost to Follow-up|0
7682599|NCT00296504|12100021|FG008|Final Analysis|Lost to Follow-up|5
7682600|NCT00296504|12100013|FG000|Final Analysis|Insufficient Viral Load Response|0
7682601|NCT00296504|12100014|FG001|Final Analysis|Insufficient Viral Load Response|0
7682602|NCT00296504|12100015|FG002|Final Analysis|Insufficient Viral Load Response|0
7682603|NCT00296504|12100016|FG003|Final Analysis|Insufficient Viral Load Response|0
7682604|NCT00296504|12100017|FG004|Final Analysis|Insufficient Viral Load Response|0
7682605|NCT00296504|12100018|FG005|Final Analysis|Insufficient Viral Load Response|0
7682606|NCT00296504|12100019|FG006|Final Analysis|Insufficient Viral Load Response|0
7682607|NCT00296504|12100020|FG007|Final Analysis|Insufficient Viral Load Response|0
7682608|NCT00296504|12100021|FG008|Final Analysis|Insufficient Viral Load Response|6
7682609|NCT00296504|12100013|FG000|Final Analysis|Adverse Event|0
7682610|NCT00296504|12100014|FG001|Final Analysis|Adverse Event|0
7682611|NCT00296504|12100015|FG002|Final Analysis|Adverse Event|0
7682612|NCT00296504|12100016|FG003|Final Analysis|Adverse Event|0
7682613|NCT00296504|12100017|FG004|Final Analysis|Adverse Event|0
7682614|NCT00296504|12100018|FG005|Final Analysis|Adverse Event|0
7682615|NCT00296504|12100019|FG006|Final Analysis|Adverse Event|0
7682616|NCT00296504|12100020|FG007|Final Analysis|Adverse Event|0
7682617|NCT00296504|12100021|FG008|Final Analysis|Adverse Event|2
7682618|NCT00296504|12100013|FG000|Final Analysis|Pregnancy|0
7682619|NCT00296504|12100014|FG001|Final Analysis|Pregnancy|0
7682620|NCT00296504|12100015|FG002|Final Analysis|Pregnancy|0
7682621|NCT00296504|12100016|FG003|Final Analysis|Pregnancy|0
7682622|NCT00296504|12100017|FG004|Final Analysis|Pregnancy|0
7682623|NCT00296504|12100018|FG005|Final Analysis|Pregnancy|0
7682624|NCT00296504|12100019|FG006|Final Analysis|Pregnancy|0
7682625|NCT00296504|12100020|FG007|Final Analysis|Pregnancy|0
7682626|NCT00296504|12100021|FG008|Final Analysis|Pregnancy|4
7682627|NCT00296504|12100013|FG000|Final Analysis|Tuberculosis|0
7682628|NCT00296504|12100014|FG001|Final Analysis|Tuberculosis|0
7682629|NCT00296504|12100015|FG002|Final Analysis|Tuberculosis|0
7682630|NCT00296504|12100016|FG003|Final Analysis|Tuberculosis|0
7682631|NCT00296504|12100017|FG004|Final Analysis|Tuberculosis|0
7682632|NCT00296504|12100018|FG005|Final Analysis|Tuberculosis|0
7682633|NCT00296504|12100019|FG006|Final Analysis|Tuberculosis|0
7682634|NCT00296504|12100020|FG007|Final Analysis|Tuberculosis|0
7682635|NCT00296504|12100021|FG008|Final Analysis|Tuberculosis|1
7682636|NCT00296504|12100013|FG000|Final Analysis|Participant Moved to Another Country|0
7682637|NCT00296504|12100014|FG001|Final Analysis|Participant Moved to Another Country|0
7682638|NCT00296504|12100015|FG002|Final Analysis|Participant Moved to Another Country|0
7682639|NCT00296504|12100016|FG003|Final Analysis|Participant Moved to Another Country|0
7682640|NCT00296504|12100017|FG004|Final Analysis|Participant Moved to Another Country|0
7682641|NCT00296504|12100018|FG005|Final Analysis|Participant Moved to Another Country|0
7682642|NCT00296504|12100019|FG006|Final Analysis|Participant Moved to Another Country|0
7682643|NCT00296504|12100020|FG007|Final Analysis|Participant Moved to Another Country|0
7682644|NCT00296504|12100021|FG008|Final Analysis|Participant Moved to Another Country|1
7682645|NCT00296504|12100013|FG000|Final Analysis|Poor Adherence|0
7682646|NCT00296504|12100014|FG001|Final Analysis|Poor Adherence|0
7682647|NCT00296504|12100015|FG002|Final Analysis|Poor Adherence|0
7682648|NCT00296504|12100016|FG003|Final Analysis|Poor Adherence|0
7682649|NCT00296504|12100017|FG004|Final Analysis|Poor Adherence|0
7682650|NCT00296504|12100018|FG005|Final Analysis|Poor Adherence|0
7682651|NCT00296504|12100019|FG006|Final Analysis|Poor Adherence|0
7682652|NCT00296504|12100020|FG007|Final Analysis|Poor Adherence|0
7682653|NCT00296504|12100021|FG008|Final Analysis|Poor Adherence|1
7682654|NCT00296517|12100048|FG000|Dose Level 2 - Week 2|Adverse Event|1
7682655|NCT00296517|12100049|FG001|Dose Level 2 - Week 2|Adverse Event|5
7682656|NCT00296517|12100048|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1
7682657|NCT00296517|12100049|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0
7682658|NCT00296517|12100048|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30
7682659|NCT00296517|12100049|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34
7682660|NCT00296517|12100048|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
7682661|NCT00296517|12100049|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
7682662|NCT00296517|12100048|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
7682663|NCT00296517|12100049|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
7682664|NCT00296517|12100048|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1
7682665|NCT00296517|12100049|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0
7682666|NCT00296517|12100048|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
7682667|NCT00296517|12100049|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
7682668|NCT00296517|12100048|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1
7682669|NCT00296517|12100049|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0
7682670|NCT00296517|12100048|FG000|Dose Level 3 - Weeks 3-12|Other|0
7682671|NCT00296517|12100049|FG001|Dose Level 3 - Weeks 3-12|Other|2
7682672|NCT00296647|12100060|FG000|Overall Study|Death|4
7682673|NCT00296647|12100061|FG001|Overall Study|Death|1
7682674|NCT00296647|12100062|FG002|Overall Study|Death|2
7682675|NCT00296647|12100063|FG003|Overall Study|Death|1
7682676|NCT00296647|12100064|FG004|Overall Study|Death|1
7682677|NCT00296647|12100060|FG000|Overall Study|Withdrawal by Subject|28
7682678|NCT00296647|12100061|FG001|Overall Study|Withdrawal by Subject|27
7682679|NCT00296647|12100062|FG002|Overall Study|Withdrawal by Subject|32
7682680|NCT00296647|12100063|FG003|Overall Study|Withdrawal by Subject|16
7682681|NCT00296647|12100064|FG004|Overall Study|Withdrawal by Subject|19
7682682|NCT00296725|12100076|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1
7682683|NCT00296725|12100076|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4
7682684|NCT00296725|12100076|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1
7682685|NCT00296816|12100084|FG000|Overall Study|Disease Progression|37
7682686|NCT00296816|12100084|FG000|Overall Study|Adverse Event|18
7682687|NCT00296816|12100084|FG000|Overall Study|Investigator/Participant request|5
7682688|NCT00296816|12100084|FG000|Overall Study|Non-compliance|1
7682689|NCT00296816|12100084|FG000|Overall Study|Missing for end of treatment|4
7682690|NCT00296816|12100084|FG000|Overall Study|Progression based on CA-125 (biomarker)|2
7682691|NCT00296816|12100084|FG000|Overall Study|Poor performance status|1
7682692|NCT00296816|12100084|FG000|Overall Study|Relocation to Florida|1
7682693|NCT00296816|12100084|FG000|Overall Study|Noncompliance/decision to discontinue|1
7682772|NCT00297778|12100191|FG001|Overall Study|Lack of Efficacy|1
7682694|NCT00296816|12100084|FG000|Overall Study|Urine protein/creatinine ratio delay|1
7682695|NCT00296816|12100084|FG000|Overall Study|Neuropathy/patient preference|1
7682696|NCT00296816|12100084|FG000|Overall Study|Proteinuria|1
7682697|NCT00296816|12100084|FG000|Overall Study|ineligibility due to radiation treatment|1
7682698|NCT00297037|12100090|FG000|Overall Study|Withdrawal by Subject|2
7682699|NCT00297037|12100091|FG001|Overall Study|Withdrawal by Subject|0
7682700|NCT00297167|12100117|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
7682701|NCT00297167|12100118|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
7682702|NCT00297167|12100119|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
7682703|NCT00297167|12100117|FG000|Second Double-blind Intervention Period|Protocol Violation|1
7682704|NCT00297167|12100118|FG001|Second Double-blind Intervention Period|Protocol Violation|0
7682705|NCT00297167|12100119|FG002|Second Double-blind Intervention Period|Protocol Violation|0
7682706|NCT00297232|12100126|FG000|Overall Study|Lack of Efficacy|7
7682707|NCT00297232|12100126|FG000|Overall Study|Lost to Follow-up|10
7682708|NCT00297232|12100126|FG000|Overall Study|Adverse Event|63
7682709|NCT00297232|12100126|FG000|Overall Study|Voluntary Withdrawal|120
7682710|NCT00297232|12100126|FG000|Overall Study|Subject was Noncompliant|9
7682711|NCT00297232|12100126|FG000|Overall Study|Death|9
7682712|NCT00297232|12100126|FG000|Overall Study|Anti-natalizumab Positive|8
7682713|NCT00297232|12100126|FG000|Overall Study|Switched to Commercial Tysabri|22
7682714|NCT00297232|12100126|FG000|Overall Study|Disease Progression|8
7682715|NCT00297232|12100126|FG000|Overall Study|Fear of PML|10
7682716|NCT00297232|12100126|FG000|Overall Study|Anti-JCV Antibody Positive|13
7682717|NCT00297232|12100126|FG000|Overall Study|Miscellaneous|5
7682718|NCT00297232|12100126|FG000|Overall Study|Sponsor Decision|34
7682719|NCT00297232|12100126|FG000|Overall Study|Subject Relocated|7
7682720|NCT00297232|12100126|FG000|Overall Study|Subject Withdrew Consent|37
7682721|NCT00297232|12100126|FG000|Overall Study|Persistently Positive Antibodies|11
7682722|NCT00297232|12100126|FG000|Overall Study|Investigator Withdrew From Program|19
7682723|NCT00297232|12100126|FG000|Overall Study|Did Not Enroll to Week 264|34
7682724|NCT00297232|12100126|FG000|Overall Study|Did Not Enroll to Week 480|17
7682725|NCT00297232|12100126|FG000|Overall Study|No data available after Week 264|161
7682726|NCT00297232|12100126|FG000|Overall Study|Other|1
7682727|NCT00297258|12100130|FG000|Overall Study|Disease Progression, Relapse, Death|120
7682728|NCT00297258|12100130|FG000|Overall Study|Toxicity (or Toxic Death)|10
7682729|NCT00297258|12100130|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2
7682730|NCT00297258|12100130|FG000|Overall Study|Intercurrent Illness|3
7682731|NCT00297258|12100130|FG000|Overall Study|Intercurrent Death|2
7682732|NCT00297258|12100130|FG000|Overall Study|Deteriorization of General Condition|1
7682733|NCT00297258|12100130|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1
7682734|NCT00297258|12100130|FG000|Overall Study|Surgery Performed on Target Lesion|1
7682735|NCT00297258|12100130|FG000|Overall Study|Switch to Commercial Treatment|1
7682736|NCT00297258|12100130|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1
7682737|NCT00297427|12100139|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8
7682738|NCT00297427|12100140|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5
7682739|NCT00297427|12100139|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0
7682740|NCT00297427|12100140|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3
7682741|NCT00297427|12100139|FG000|Phase 1: Initial Intervention|Death|0
7682742|NCT00297427|12100140|FG001|Phase 1: Initial Intervention|Death|1
7682743|NCT00297427|12100139|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
7682744|NCT00297427|12100140|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
7682745|NCT00297427|12100139|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
7682746|NCT00297427|12100140|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
7682747|NCT00297427|12100139|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
7682748|NCT00297427|12100140|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
7682749|NCT00297427|12100139|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
7682750|NCT00297427|12100140|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
7682751|NCT00297427|12100139|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
7682752|NCT00297427|12100140|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
7682753|NCT00297479|12100157|FG000|Overall Study|Lost to Follow-up|37
7682754|NCT00297479|12100158|FG001|Overall Study|Lost to Follow-up|54
7682755|NCT00297479|12100159|FG002|Overall Study|Lost to Follow-up|51
7682756|NCT00297492|12100170|FG000|Set Quit Date|Lost to Follow-up|7
7682757|NCT00297492|12100171|FG001|Set Quit Date|Lost to Follow-up|13
7682758|NCT00297492|12100172|FG002|Set Quit Date|Lost to Follow-up|5
7682759|NCT00297492|12100170|FG000|6 Month Follow-up|Lost to Follow-up|63
7682760|NCT00297492|12100171|FG001|6 Month Follow-up|Lost to Follow-up|49
7682761|NCT00297492|12100172|FG002|6 Month Follow-up|Lost to Follow-up|27
7682762|NCT00297648|12100184|FG000|Overall Study|Adverse Event|13
7682763|NCT00297648|12100184|FG000|Overall Study|Lack of Efficacy|18
7682764|NCT00297648|12100184|FG000|Overall Study|Lost to Follow-up|1
7682765|NCT00297648|12100184|FG000|Overall Study|Withdrawal by Subject|3
7682766|NCT00297648|12100184|FG000|Overall Study|Other: Incompliance|1
7682767|NCT00297778|12100190|FG000|Overall Study|Adverse Event|16
7682768|NCT00297778|12100191|FG001|Overall Study|Adverse Event|10
7682769|NCT00297778|12100190|FG000|Overall Study|Withdrawal by Subject|1
7682770|NCT00297778|12100191|FG001|Overall Study|Withdrawal by Subject|5
7682771|NCT00297778|12100190|FG000|Overall Study|Lack of Efficacy|2
7682773|NCT00297778|12100190|FG000|Overall Study|Non-compliant with trial protocol|0
7682774|NCT00297778|12100191|FG001|Overall Study|Non-compliant with trial protocol|3
7682775|NCT00297778|12100190|FG000|Overall Study|Other|0
7682776|NCT00297778|12100191|FG001|Overall Study|Other|1
7682777|NCT00297830|12100200|FG000|6 Month Visit|Death|1
7682778|NCT00297830|12100201|FG001|6 Month Visit|Death|0
7682779|NCT00297830|12100202|FG002|6 Month Visit|Death|2
7682780|NCT00297830|12100200|FG000|6 Month Visit|Withdrawal by Subject|2
7682781|NCT00297830|12100201|FG001|6 Month Visit|Withdrawal by Subject|1
7682782|NCT00297830|12100202|FG002|6 Month Visit|Withdrawal by Subject|1
7682783|NCT00297830|12100200|FG000|6 Month Visit|Adverse Event|0
7682784|NCT00297830|12100201|FG001|6 Month Visit|Adverse Event|1
7682785|NCT00297830|12100202|FG002|6 Month Visit|Adverse Event|0
7682786|NCT00297830|12100200|FG000|12 Month Visit|Lost to Follow-up|1
7682787|NCT00297830|12100201|FG001|12 Month Visit|Lost to Follow-up|0
7682788|NCT00297830|12100202|FG002|12 Month Visit|Lost to Follow-up|0
7682789|NCT00297830|12100200|FG000|12 Month Visit|Adverse Event|0
7682790|NCT00297830|12100201|FG001|12 Month Visit|Adverse Event|3
7682791|NCT00297830|12100202|FG002|12 Month Visit|Adverse Event|0
7682792|NCT00297830|12100200|FG000|12 Month Visit|Withdrawal by Subject|0
7682793|NCT00297830|12100201|FG001|12 Month Visit|Withdrawal by Subject|3
7682794|NCT00297830|12100202|FG002|12 Month Visit|Withdrawal by Subject|0
7682795|NCT00297882|12100212|FG000|Day 14|Lack of Efficacy|12
7682796|NCT00297882|12100213|FG001|Day 14|Lack of Efficacy|49
7682797|NCT00297882|12100212|FG000|Day 28|Lost to Follow-up|13
7682798|NCT00297882|12100213|FG001|Day 28|Lost to Follow-up|23
7682799|NCT00297882|12100212|FG000|Day 28|Lack of Efficacy|3
7682800|NCT00297882|12100213|FG001|Day 28|Lack of Efficacy|0
7682801|NCT00298038|12100223|FG000|Overall Study|Lost to Follow-up|0
7682802|NCT00298038|12100224|FG001|Overall Study|Lost to Follow-up|1
7682803|NCT00298038|12100223|FG000|Overall Study|Liver Transplant|0
7682804|NCT00298038|12100224|FG001|Overall Study|Liver Transplant|1
7682805|NCT00298038|12100223|FG000|Overall Study|Protocol Violation|1
7682806|NCT00298038|12100224|FG001|Overall Study|Protocol Violation|3
7682807|NCT00298038|12100223|FG000|Overall Study|Death|6
7682808|NCT00298038|12100224|FG001|Overall Study|Death|3
7682809|NCT00298038|12100223|FG000|Overall Study|Withdrawal by Subject|6
7682810|NCT00298038|12100224|FG001|Overall Study|Withdrawal by Subject|9
7682811|NCT00298038|12100223|FG000|Overall Study|Adverse Event|8
7682812|NCT00298038|12100224|FG001|Overall Study|Adverse Event|7
7682813|NCT00298038|12100223|FG000|Overall Study|Breakthrough overt HE episode|28
7682814|NCT00298038|12100224|FG001|Overall Study|Breakthrough overt HE episode|69
7682815|NCT00298038|12100223|FG000|Overall Study|Noncompliance|1
7682816|NCT00298038|12100224|FG001|Overall Study|Noncompliance|0
7682817|NCT00298038|12100223|FG000|Overall Study|Cocaine Abuse|1
7682818|NCT00298038|12100224|FG001|Overall Study|Cocaine Abuse|0
7682819|NCT00298038|12100223|FG000|Overall Study|Severe Gastrointestinal Bleed|1
7682820|NCT00298038|12100224|FG001|Overall Study|Severe Gastrointestinal Bleed|0
7682821|NCT00298272|12100260|FG000|Double-blind Phase|Adverse Event|2
7682822|NCT00298272|12100261|FG001|Double-blind Phase|Adverse Event|0
7682823|NCT00298272|12100260|FG000|Double-blind Phase|Failure to Return|2
7682824|NCT00298272|12100261|FG001|Double-blind Phase|Failure to Return|0
7682825|NCT00298272|12100260|FG000|Double-blind Phase|Protocol Violation|2
7682826|NCT00298272|12100261|FG001|Double-blind Phase|Protocol Violation|0
7682827|NCT00298272|12100260|FG000|Double-blind Phase|Withdrawal by Subject|2
7682828|NCT00298272|12100261|FG001|Double-blind Phase|Withdrawal by Subject|0
7682829|NCT00298272|12100260|FG000|Open Label Retreatment Phase|Adverse Event|1
7682830|NCT00298272|12100261|FG001|Open Label Retreatment Phase|Adverse Event|2
7682831|NCT00298272|12100260|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
7682832|NCT00298272|12100261|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
7682833|NCT00298272|12100260|FG000|Open Label Retreatment Phase|Failure to Return|1
7682834|NCT00298272|12100261|FG001|Open Label Retreatment Phase|Failure to Return|0
7682835|NCT00298272|12100260|FG000|Open Label Retreatment Phase|Protocol Violation|2
7682836|NCT00298272|12100261|FG001|Open Label Retreatment Phase|Protocol Violation|1
7682837|NCT00298272|12100260|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1
7682838|NCT00298272|12100261|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0
7682839|NCT00298272|12100260|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2
7682840|NCT00298272|12100261|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0
7682841|NCT00298272|12100260|FG000|Safety Follow-up Phase|Failure to Return|1
7682842|NCT00298272|12100261|FG001|Safety Follow-up Phase|Failure to Return|1
7682843|NCT00298272|12100260|FG000|Safety Follow-up Phase|Withdrawal by Subject|2
7682844|NCT00298272|12100261|FG001|Safety Follow-up Phase|Withdrawal by Subject|2
7682845|NCT00298272|12100260|FG000|Safety Follow-up Phase|Administrative/Other Reason|1
7682846|NCT00298272|12100261|FG001|Safety Follow-up Phase|Administrative/Other Reason|1
7682847|NCT00298363|12100273|FG000|Overall Study|Lost to Follow-up|0
7682848|NCT00298363|12100274|FG001|Overall Study|Lost to Follow-up|0
7682849|NCT00298363|12100275|FG002|Overall Study|Lost to Follow-up|1
7682850|NCT00298363|12100273|FG000|Overall Study|Physician Decision|4
7682851|NCT00298363|12100274|FG001|Overall Study|Physician Decision|1
7682852|NCT00298363|12100275|FG002|Overall Study|Physician Decision|0
7682853|NCT00298363|12100273|FG000|Overall Study|Protocol Violation|1
7682854|NCT00298363|12100274|FG001|Overall Study|Protocol Violation|1
7682855|NCT00298363|12100275|FG002|Overall Study|Protocol Violation|0
7682856|NCT00298363|12100273|FG000|Overall Study|Withdrawal by Subject|5
7682857|NCT00298363|12100274|FG001|Overall Study|Withdrawal by Subject|1
7682858|NCT00298363|12100275|FG002|Overall Study|Withdrawal by Subject|3
7682859|NCT00298363|12100273|FG000|Overall Study|Adverse Event|5
7682860|NCT00298363|12100274|FG001|Overall Study|Adverse Event|2
7682861|NCT00298363|12100275|FG002|Overall Study|Adverse Event|2
7682862|NCT00298363|12100273|FG000|Overall Study|Lack of Efficacy|2
7682863|NCT00298363|12100274|FG001|Overall Study|Lack of Efficacy|3
7682864|NCT00298363|12100275|FG002|Overall Study|Lack of Efficacy|0
7682865|NCT00298766|12100323|FG000|Overall Study|Adverse Event|18
7682866|NCT00298766|12100323|FG000|Overall Study|Death|2
7682867|NCT00298766|12100323|FG000|Overall Study|Withdrawal by Subject|9
7682868|NCT00298766|12100323|FG000|Overall Study|Treatment ongoing|4
7682869|NCT00298766|12100323|FG000|Overall Study|Progression of amyloid markers|4
7682870|NCT00298766|12100323|FG000|Overall Study|Deterioration in KPS and organ function|1
7682871|NCT00298766|12100323|FG000|Overall Study|Subjects overall condition deterioration|4
7682872|NCT00298766|12100323|FG000|Overall Study|Other|4
7682873|NCT00298831|12100327|FG000|Overall Study|Adverse Event|1
7682874|NCT00298831|12100327|FG000|Overall Study|Lost to Follow-up|3
7682875|NCT00298831|12100327|FG000|Overall Study|Withdrawal by Subject|1
7682876|NCT00298831|12100327|FG000|Overall Study|Participants did not receive treatment|27
7682877|NCT00298896|12100331|FG000|Overall Study|Death|3
7682878|NCT00298896|12100331|FG000|Overall Study|Physician Decision|2
7682879|NCT00298896|12100331|FG000|Overall Study|Intercurrent Illness|1
7682880|NCT00298896|12100331|FG000|Overall Study|Disease Progression|41
7682881|NCT00298896|12100331|FG000|Overall Study|Withdrawal by Subject|2
7682882|NCT00298896|12100331|FG000|Overall Study|Assigned to treatment in error|1
7682883|NCT00299104|12100347|FG000|Treatment Period|Adverse Event|14
7682884|NCT00299104|12100348|FG001|Treatment Period|Adverse Event|9
7682885|NCT00299104|12100349|FG002|Treatment Period|Adverse Event|7
7682886|NCT00299104|12100347|FG000|Treatment Period|Death|1
7682887|NCT00299104|12100348|FG001|Treatment Period|Death|1
7682888|NCT00299104|12100349|FG002|Treatment Period|Death|1
7682889|NCT00299104|12100347|FG000|Treatment Period|Insufficient therapeutic response|34
7682890|NCT00299104|12100348|FG001|Treatment Period|Insufficient therapeutic response|13
7682891|NCT00299104|12100349|FG002|Treatment Period|Insufficient therapeutic response|8
7682892|NCT00299104|12100347|FG000|Treatment Period|Failure to return|9
7682893|NCT00299104|12100348|FG001|Treatment Period|Failure to return|8
7682894|NCT00299104|12100349|FG002|Treatment Period|Failure to return|8
7682895|NCT00299104|12100347|FG000|Treatment Period|Violation of selection criteria|1
7682896|NCT00299104|12100348|FG001|Treatment Period|Violation of selection criteria|2
7682897|NCT00299104|12100349|FG002|Treatment Period|Violation of selection criteria|0
7682898|NCT00299104|12100347|FG000|Treatment Period|Protocol Violation|1
7682899|NCT00299104|12100348|FG001|Treatment Period|Protocol Violation|1
7682900|NCT00299104|12100349|FG002|Treatment Period|Protocol Violation|0
7682901|NCT00299104|12100347|FG000|Treatment Period|Refused treatment|9
7682902|NCT00299104|12100348|FG001|Treatment Period|Refused treatment|2
7682903|NCT00299104|12100349|FG002|Treatment Period|Refused treatment|2
7682904|NCT00299104|12100347|FG000|Treatment Period|Withdrew consent|14
7682905|NCT00299104|12100348|FG001|Treatment Period|Withdrew consent|19
7682906|NCT00299104|12100349|FG002|Treatment Period|Withdrew consent|9
7682907|NCT00299104|12100347|FG000|Treatment Period|Administrative reasons|106
7682908|NCT00299104|12100348|FG001|Treatment Period|Administrative reasons|120
7682909|NCT00299104|12100349|FG002|Treatment Period|Administrative reasons|137
7682910|NCT00299104|12100347|FG000|Safety Follow-Up (SFU) Period|Death|3
7682911|NCT00299104|12100348|FG001|Safety Follow-Up (SFU) Period|Death|2
7682912|NCT00299104|12100349|FG002|Safety Follow-Up (SFU) Period|Death|1
7682913|NCT00299104|12100347|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
7682914|NCT00299104|12100348|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
7682915|NCT00299104|12100349|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
7682916|NCT00299104|12100347|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
7682917|NCT00299104|12100348|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
7682918|NCT00299104|12100349|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
7682919|NCT00299104|12100347|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27
7682920|NCT00299104|12100348|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7
7682921|NCT00299104|12100349|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5
7682922|NCT00299104|12100347|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0
7682923|NCT00299104|12100348|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1
7682924|NCT00299104|12100349|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0
7682925|NCT00299104|12100347|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
7682926|NCT00299104|12100348|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
7682927|NCT00299104|12100349|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
7682928|NCT00299104|12100347|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
7682929|NCT00299104|12100348|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
7682930|NCT00299104|12100349|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
7682931|NCT00299104|12100347|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
7682932|NCT00299104|12100348|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
7682933|NCT00299104|12100349|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
7682934|NCT00299130|12100360|FG000|Treatment Period (up to 5 Years)|Adverse Event|13
7682935|NCT00299130|12100361|FG001|Treatment Period (up to 5 Years)|Adverse Event|8
7682936|NCT00299130|12100362|FG002|Treatment Period (up to 5 Years)|Adverse Event|13
7682937|NCT00299130|12100360|FG000|Treatment Period (up to 5 Years)|Death|1
7682938|NCT00299130|12100361|FG001|Treatment Period (up to 5 Years)|Death|3
7682939|NCT00299130|12100362|FG002|Treatment Period (up to 5 Years)|Death|1
7682940|NCT00299130|12100360|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
7682941|NCT00299130|12100361|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
7682942|NCT00299130|12100362|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
7682943|NCT00299130|12100360|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0
7682944|NCT00299130|12100361|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1
7682945|NCT00299130|12100362|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0
7682946|NCT00299130|12100360|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12
7682947|NCT00299130|12100361|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12
7682948|NCT00299130|12100362|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19
7682949|NCT00299130|12100360|FG000|Treatment Period (up to 5 Years)|Failure to Return|4
7682950|NCT00299130|12100361|FG001|Treatment Period (up to 5 Years)|Failure to Return|6
7682951|NCT00299130|12100362|FG002|Treatment Period (up to 5 Years)|Failure to Return|6
7682952|NCT00299130|12100360|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4
7682953|NCT00299130|12100361|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6
7682954|NCT00299130|12100362|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4
7682955|NCT00299130|12100360|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
7682956|NCT00299130|12100361|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
7682957|NCT00299130|12100362|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
7682958|NCT00299130|12100360|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
7682959|NCT00299130|12100361|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
7682960|NCT00299130|12100362|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
7682961|NCT00299130|12100360|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4
7682962|NCT00299130|12100361|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5
7682963|NCT00299130|12100362|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3
7682964|NCT00299130|12100360|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
7682965|NCT00299130|12100361|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
7682966|NCT00299130|12100362|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
7682967|NCT00299130|12100360|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
7682968|NCT00299130|12100361|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
7682969|NCT00299130|12100362|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
7682970|NCT00299130|12100360|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
7682971|NCT00299130|12100361|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
7682972|NCT00299130|12100362|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
7682973|NCT00299130|12100360|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
7682974|NCT00299130|12100361|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
7682975|NCT00299130|12100362|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
7682976|NCT00299130|12100360|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
7682977|NCT00299130|12100361|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
7682978|NCT00299130|12100362|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
7682979|NCT00299130|12100360|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
7682980|NCT00299130|12100361|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
7682981|NCT00299130|12100362|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
7682982|NCT00299130|12100360|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
7682983|NCT00299130|12100361|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
7682984|NCT00299130|12100362|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
7682985|NCT00299156|12100380|FG000|Period 2 (Randomized)|Screen Failure|0
7682986|NCT00299156|12100381|FG001|Period 2 (Randomized)|Screen Failure|1
7682987|NCT00299156|12100382|FG002|Period 2 (Randomized)|Screen Failure|0
7682988|NCT00299182|12100397|FG000|Overall Study|Withdrawal by Subject|0
7682989|NCT00299182|12100398|FG001|Overall Study|Withdrawal by Subject|0
7682990|NCT00299182|12100399|FG002|Overall Study|Withdrawal by Subject|1
7682991|NCT00299182|12100400|FG003|Overall Study|Withdrawal by Subject|0
7682992|NCT00299182|12100401|FG004|Overall Study|Withdrawal by Subject|1
7682993|NCT00299182|12100402|FG005|Overall Study|Withdrawal by Subject|2
7682994|NCT00299182|12100403|FG006|Overall Study|Withdrawal by Subject|0
7682995|NCT00299182|12100397|FG000|Overall Study|Chemotherapy Changed|0
7682996|NCT00299182|12100398|FG001|Overall Study|Chemotherapy Changed|0
7682997|NCT00299182|12100399|FG002|Overall Study|Chemotherapy Changed|1
7682998|NCT00299182|12100400|FG003|Overall Study|Chemotherapy Changed|0
7682999|NCT00299182|12100401|FG004|Overall Study|Chemotherapy Changed|1
7683000|NCT00299182|12100402|FG005|Overall Study|Chemotherapy Changed|0
7683001|NCT00299182|12100403|FG006|Overall Study|Chemotherapy Changed|1
7683002|NCT00299182|12100397|FG000|Overall Study|Adverse Event|0
7683003|NCT00299182|12100398|FG001|Overall Study|Adverse Event|0
7683004|NCT00299182|12100399|FG002|Overall Study|Adverse Event|0
7683005|NCT00299182|12100400|FG003|Overall Study|Adverse Event|0
7683006|NCT00299182|12100401|FG004|Overall Study|Adverse Event|0
7683007|NCT00299182|12100402|FG005|Overall Study|Adverse Event|1
7683008|NCT00299182|12100403|FG006|Overall Study|Adverse Event|0
7683009|NCT00299182|12100397|FG000|Overall Study|Not Eligible|0
7683010|NCT00299182|12100398|FG001|Overall Study|Not Eligible|0
7683011|NCT00299182|12100399|FG002|Overall Study|Not Eligible|0
7683012|NCT00299182|12100400|FG003|Overall Study|Not Eligible|0
7683013|NCT00299182|12100401|FG004|Overall Study|Not Eligible|1
7683014|NCT00299182|12100402|FG005|Overall Study|Not Eligible|0
7683015|NCT00299182|12100403|FG006|Overall Study|Not Eligible|0
7683016|NCT00299494|12100440|FG000|Overall Study|Withdrawal by Subject|0
7683017|NCT00299494|12100441|FG001|Overall Study|Withdrawal by Subject|0
7683018|NCT00299494|12100442|FG002|Overall Study|Withdrawal by Subject|0
7683019|NCT00299494|12100443|FG003|Overall Study|Withdrawal by Subject|3
7683020|NCT00299494|12100444|FG004|Overall Study|Withdrawal by Subject|1
7683021|NCT00299494|12100445|FG005|Overall Study|Withdrawal by Subject|4
7683022|NCT00299494|12100440|FG000|Overall Study|Physician Decision|0
7683023|NCT00299494|12100441|FG001|Overall Study|Physician Decision|0
7683024|NCT00299494|12100442|FG002|Overall Study|Physician Decision|0
7683025|NCT00299494|12100443|FG003|Overall Study|Physician Decision|0
7683026|NCT00299494|12100444|FG004|Overall Study|Physician Decision|1
7683027|NCT00299494|12100445|FG005|Overall Study|Physician Decision|0
7683028|NCT00299494|12100440|FG000|Overall Study|Death|3
7683029|NCT00299494|12100441|FG001|Overall Study|Death|1
7683030|NCT00299494|12100442|FG002|Overall Study|Death|4
7683031|NCT00299494|12100443|FG003|Overall Study|Death|6
7683032|NCT00299494|12100444|FG004|Overall Study|Death|18
7683033|NCT00299494|12100445|FG005|Overall Study|Death|19
7683034|NCT00299494|12100440|FG000|Overall Study|Lost to Follow-up|0
7683035|NCT00299494|12100441|FG001|Overall Study|Lost to Follow-up|0
7683036|NCT00299494|12100442|FG002|Overall Study|Lost to Follow-up|0
7683037|NCT00299494|12100443|FG003|Overall Study|Lost to Follow-up|0
7683038|NCT00299494|12100444|FG004|Overall Study|Lost to Follow-up|3
7683039|NCT00299494|12100445|FG005|Overall Study|Lost to Follow-up|1
7683040|NCT00299494|12100440|FG000|Overall Study|Other - Unspecified|0
7683041|NCT00299494|12100441|FG001|Overall Study|Other - Unspecified|0
7683042|NCT00299494|12100442|FG002|Overall Study|Other - Unspecified|0
7683043|NCT00299494|12100443|FG003|Overall Study|Other - Unspecified|0
7683044|NCT00299494|12100444|FG004|Overall Study|Other - Unspecified|3
7683045|NCT00299494|12100445|FG005|Overall Study|Other - Unspecified|1
7683046|NCT00299494|12100440|FG000|Overall Study|Other - site closure|0
7683047|NCT00299494|12100441|FG001|Overall Study|Other - site closure|0
7683048|NCT00299494|12100442|FG002|Overall Study|Other - site closure|0
7683049|NCT00299494|12100443|FG003|Overall Study|Other - site closure|1
7683050|NCT00299494|12100444|FG004|Overall Study|Other - site closure|1
7683051|NCT00299494|12100445|FG005|Overall Study|Other - site closure|1
7683052|NCT00299546|12100473|FG000|Overall Study|Death|3
7683053|NCT00299546|12100474|FG001|Overall Study|Death|2
7683054|NCT00299546|12100475|FG002|Overall Study|Death|0
7683055|NCT00299546|12100473|FG000|Overall Study|Lost to Follow-up|2
7683056|NCT00299546|12100474|FG001|Overall Study|Lost to Follow-up|2
7683057|NCT00299546|12100475|FG002|Overall Study|Lost to Follow-up|5
7683058|NCT00299546|12100473|FG000|Overall Study|Adverse Event|37
7683059|NCT00299546|12100474|FG001|Overall Study|Adverse Event|22
7683060|NCT00299546|12100475|FG002|Overall Study|Adverse Event|27
7683061|NCT00299546|12100473|FG000|Overall Study|Unsatisfactory therapeutic effect|34
7683062|NCT00299546|12100474|FG001|Overall Study|Unsatisfactory therapeutic effect|39
7683063|NCT00299546|12100475|FG002|Overall Study|Unsatisfactory therapeutic effect|34
7683064|NCT00299546|12100473|FG000|Overall Study|Other|24
7683065|NCT00299546|12100474|FG001|Overall Study|Other|26
7683066|NCT00299546|12100475|FG002|Overall Study|Other|19
7683067|NCT00299546|12100473|FG000|Overall Study|Not treated|0
7683068|NCT00299546|12100474|FG001|Overall Study|Not treated|1
7683069|NCT00299546|12100475|FG002|Overall Study|Not treated|1
7683070|NCT00299702|12100490|FG000|Overall Study|Death|1
7683071|NCT00299702|12100491|FG001|Overall Study|Death|0
7683072|NCT00299702|12100490|FG000|Overall Study|Adverse Event|0
7683073|NCT00299702|12100491|FG001|Overall Study|Adverse Event|4
7683074|NCT00299702|12100490|FG000|Overall Study|Lost to Follow-up|18
7683075|NCT00299702|12100491|FG001|Overall Study|Lost to Follow-up|10
7683076|NCT00299702|12100490|FG000|Overall Study|Withdrawal by Subject|25
7683077|NCT00299702|12100491|FG001|Overall Study|Withdrawal by Subject|23
7683078|NCT00299702|12100490|FG000|Overall Study|Pregnancy|0
7683079|NCT00299702|12100491|FG001|Overall Study|Pregnancy|1
7683080|NCT00299702|12100490|FG000|Overall Study|Insufficient Response|4
7683081|NCT00299702|12100491|FG001|Overall Study|Insufficient Response|3
7683082|NCT00299702|12100490|FG000|Overall Study|Admin issues, sponsor decision, etc.|5
7683083|NCT00299702|12100491|FG001|Overall Study|Admin issues, sponsor decision, etc.|9
7683084|NCT00299975|12100504|FG000|Overall Study|Adverse Event|1
7683085|NCT00299975|12100505|FG001|Overall Study|Adverse Event|0
7683086|NCT00299975|12100506|FG002|Overall Study|Adverse Event|2
7683087|NCT00299975|12100504|FG000|Overall Study|Pregnancy|0
7683088|NCT00299975|12100505|FG001|Overall Study|Pregnancy|0
7683089|NCT00299975|12100506|FG002|Overall Study|Pregnancy|1
7683090|NCT00299975|12100504|FG000|Overall Study|Lack of Efficacy|1
7683091|NCT00299975|12100505|FG001|Overall Study|Lack of Efficacy|0
7683092|NCT00299975|12100506|FG002|Overall Study|Lack of Efficacy|1
7683093|NCT00299975|12100504|FG000|Overall Study|Lost to Follow-up|1
7683094|NCT00299975|12100505|FG001|Overall Study|Lost to Follow-up|0
7683095|NCT00299975|12100506|FG002|Overall Study|Lost to Follow-up|0
7683096|NCT00299975|12100504|FG000|Overall Study|Withdrawal by Subject|0
7683097|NCT00299975|12100505|FG001|Overall Study|Withdrawal by Subject|1
7683098|NCT00299975|12100506|FG002|Overall Study|Withdrawal by Subject|3
7683099|NCT00299975|12100504|FG000|Overall Study|Physician Decision|0
7683100|NCT00299975|12100505|FG001|Overall Study|Physician Decision|0
7683101|NCT00299975|12100506|FG002|Overall Study|Physician Decision|1
7683102|NCT00300053|12100527|FG000|Overall Study|Patient/Caregiver Preference|2
7683103|NCT00300053|12100528|FG001|Overall Study|Patient/Caregiver Preference|2
7683104|NCT00300053|12100529|FG002|Overall Study|Patient/Caregiver Preference|3
7683105|NCT00300053|12100527|FG000|Overall Study|Death|0
7683106|NCT00300053|12100528|FG001|Overall Study|Death|0
7683107|NCT00300053|12100529|FG002|Overall Study|Death|3
7683108|NCT00300053|12100527|FG000|Overall Study|Lost to Follow-up|0
7683109|NCT00300053|12100528|FG001|Overall Study|Lost to Follow-up|1
7683110|NCT00300053|12100529|FG002|Overall Study|Lost to Follow-up|0
7683111|NCT00300274|12100562|FG000|Overall Study|Withdrawal by Subject|12
7683112|NCT00300274|12100563|FG001|Overall Study|Withdrawal by Subject|3
7683113|NCT00300274|12100564|FG002|Overall Study|Withdrawal by Subject|14
7683114|NCT00300274|12100562|FG000|Overall Study|Lost to Follow-up|3
7683115|NCT00300274|12100563|FG001|Overall Study|Lost to Follow-up|4
7683116|NCT00300274|12100564|FG002|Overall Study|Lost to Follow-up|5
7683117|NCT00300274|12100562|FG000|Overall Study|Death|31
7683118|NCT00300274|12100563|FG001|Overall Study|Death|20
7683119|NCT00300274|12100564|FG002|Overall Study|Death|25
7683120|NCT00300274|12100562|FG000|Overall Study|Re-transplant|0
7683121|NCT00300274|12100563|FG001|Overall Study|Re-transplant|0
7683122|NCT00300274|12100564|FG002|Overall Study|Re-transplant|1
7683123|NCT00300365|12100574|FG000|Overall Study|Lost to Follow-up|1
7683124|NCT00300365|12100575|FG001|Overall Study|Lost to Follow-up|0
7683125|NCT00300365|12100574|FG000|Overall Study|Physician Decision|2
7683126|NCT00300365|12100575|FG001|Overall Study|Physician Decision|0
7683127|NCT00300365|12100574|FG000|Overall Study|Withdrawal by Subject|1
7683128|NCT00300365|12100575|FG001|Overall Study|Withdrawal by Subject|0
7683129|NCT00300365|12100574|FG000|Overall Study|Adverse Event|0
7683130|NCT00300365|12100575|FG001|Overall Study|Adverse Event|2
7683131|NCT00300495|12100681|FG000|Overall Study|Protocol Violation|4
7683132|NCT00300495|12100682|FG001|Overall Study|Protocol Violation|1
7683133|NCT00300755|12100700|FG000|Overall Study|Adverse Event|1
7683134|NCT00300755|12100701|FG001|Overall Study|Adverse Event|2
7683135|NCT00300755|12100702|FG002|Overall Study|Adverse Event|1
7683136|NCT00300755|12100700|FG000|Overall Study|Withdrawal by Subject|0
7683137|NCT00300755|12100701|FG001|Overall Study|Withdrawal by Subject|2
7683138|NCT00300755|12100702|FG002|Overall Study|Withdrawal by Subject|0
7683139|NCT00300755|12100700|FG000|Overall Study|Protocol Violation|0
7683140|NCT00300755|12100701|FG001|Overall Study|Protocol Violation|0
7683141|NCT00300755|12100702|FG002|Overall Study|Protocol Violation|1
7683142|NCT00300781|12100712|FG000|Overall Study|Disease Progression|55
7683143|NCT00300781|12100713|FG001|Overall Study|Disease Progression|52
7683144|NCT00300781|12100712|FG000|Overall Study|Adverse Event|5
7683145|NCT00300781|12100713|FG001|Overall Study|Adverse Event|6
7683146|NCT00300781|12100712|FG000|Overall Study|Withdrawal by Subject|1
7683147|NCT00300781|12100713|FG001|Overall Study|Withdrawal by Subject|2
7683148|NCT00300781|12100712|FG000|Overall Study|Physician Decision|1
7683149|NCT00300781|12100713|FG001|Overall Study|Physician Decision|0
7683150|NCT00300781|12100712|FG000|Overall Study|Not Recorded|0
7683151|NCT00300781|12100713|FG001|Overall Study|Not Recorded|1
7683152|NCT00300781|12100712|FG000|Overall Study|Symptomatic Deterioration|1
7683153|NCT00300781|12100713|FG001|Overall Study|Symptomatic Deterioration|0
7683154|NCT00300781|12100712|FG000|Overall Study|Lost to Follow-up|0
7683155|NCT00300781|12100713|FG001|Overall Study|Lost to Follow-up|1
7683156|NCT00300885|12100721|FG000|Treatment|Adverse Event|134
7683157|NCT00300885|12100722|FG001|Treatment|Adverse Event|82
7683158|NCT00300885|12100721|FG000|Treatment|Death|20
7683159|NCT00300885|12100722|FG001|Treatment|Death|7
7683160|NCT00300885|12100721|FG000|Treatment|Lack of Efficacy|1
7683161|NCT00300885|12100722|FG001|Treatment|Lack of Efficacy|1
7683162|NCT00300885|12100721|FG000|Treatment|Lost to Follow-up|3
7683163|NCT00300885|12100722|FG001|Treatment|Lost to Follow-up|2
7683164|NCT00300885|12100721|FG000|Treatment|Physician Decision|4
7683165|NCT00300885|12100722|FG001|Treatment|Physician Decision|5
7683166|NCT00300885|12100721|FG000|Treatment|Protocol Violation|11
7683167|NCT00300885|12100722|FG001|Treatment|Protocol Violation|11
7683168|NCT00300885|12100721|FG000|Treatment|Withdrawal by Subject|26
7683169|NCT00300885|12100722|FG001|Treatment|Withdrawal by Subject|23
7683170|NCT00300885|12100721|FG000|Treatment|Disease progression|171
7683171|NCT00300885|12100722|FG001|Treatment|Disease progression|238
7683172|NCT00300885|12100721|FG000|Treatment|Random code broken (subject died)|0
7683173|NCT00300885|12100722|FG001|Treatment|Random code broken (subject died)|1
7683174|NCT00300885|12100721|FG000|Treatment|Non-compliant with study medication|3
7683175|NCT00300885|12100722|FG001|Treatment|Non-compliant with study medication|4
7683176|NCT00300885|12100721|FG000|Follow-up|Death|141
7683177|NCT00300885|12100722|FG001|Follow-up|Death|163
7683178|NCT00300885|12100721|FG000|Follow-up|Lost to Follow-up|11
7683179|NCT00300885|12100722|FG001|Follow-up|Lost to Follow-up|7
7683180|NCT00300885|12100721|FG000|Follow-up|Withdrawal by Subject|26
7683181|NCT00300885|12100722|FG001|Follow-up|Withdrawal by Subject|25
7683182|NCT00301067|12100732|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1
7683183|NCT00301067|12100733|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0
7683184|NCT00301067|12100734|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0
7683185|NCT00301067|12100735|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1
7683186|NCT00301067|12100732|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2
7683187|NCT00301067|12100733|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1
7683188|NCT00301067|12100734|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1
7683189|NCT00301067|12100735|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2
7683190|NCT00301067|12100732|FG000|Completed 4 Cycles of Treatment|Progressive disease|1
7683191|NCT00301067|12100733|FG001|Completed 4 Cycles of Treatment|Progressive disease|1
7683192|NCT00301067|12100734|FG002|Completed 4 Cycles of Treatment|Progressive disease|2
7683193|NCT00301067|12100735|FG003|Completed 4 Cycles of Treatment|Progressive disease|5
7683194|NCT00301067|12100732|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0
7683195|NCT00301067|12100733|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1
7683196|NCT00301067|12100734|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0
7683197|NCT00301067|12100735|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1
7683198|NCT00301067|12100732|FG000|Completed 12 Cycles of Treatment|Adverse Event|0
7683199|NCT00301067|12100733|FG001|Completed 12 Cycles of Treatment|Adverse Event|0
7683200|NCT00301067|12100734|FG002|Completed 12 Cycles of Treatment|Adverse Event|0
7683201|NCT00301067|12100735|FG003|Completed 12 Cycles of Treatment|Adverse Event|1
7683202|NCT00301067|12100732|FG000|Follow up Until Death|Alive at last data cut point|1
7683203|NCT00301067|12100733|FG001|Follow up Until Death|Alive at last data cut point|0
7683204|NCT00301067|12100734|FG002|Follow up Until Death|Alive at last data cut point|0
7683205|NCT00301067|12100735|FG003|Follow up Until Death|Alive at last data cut point|1
7683206|NCT00301366|12100746|FG000|Overall Study|Adverse Event|1
7683207|NCT00301808|12100760|FG000|Overall Study|Adverse Event|5
7683208|NCT00301808|12100760|FG000|Overall Study|Death|3
7683209|NCT00301808|12100760|FG000|Overall Study|Lack of Efficacy|4
7683210|NCT00301821|12100764|FG000|Overall Study|Ineligible|25
7683211|NCT00301821|12100764|FG000|Overall Study|Cancel|1
7683212|NCT00301834|12100768|FG000|Overall Study|Death|1
7683213|NCT00301964|12100779|FG000|Overall Study|Second primary|2
7683214|NCT00301964|12100779|FG000|Overall Study|Wrong primary|1
7683215|NCT00301964|12100779|FG000|Overall Study|Inadequate pathology|1
7683216|NCT00302003|12100789|FG000|Overall Study|Lack of Efficacy|62
7683217|NCT00302003|12100789|FG000|Overall Study|Lost to Follow-up|1
7683218|NCT00302003|12100789|FG000|Overall Study|Physician Decision|2
7683219|NCT00302003|12100789|FG000|Overall Study|Withdrawal by Subject|5
7683220|NCT00302003|12100789|FG000|Overall Study|Ineligible|9
7683221|NCT00302003|12100789|FG000|Overall Study|Protocol Violation|1
7683222|NCT00302081|12100828|FG000|Overall Study|Adverse Event|6
7683223|NCT00302081|12100829|FG001|Overall Study|Adverse Event|5
7683224|NCT00302081|12100830|FG002|Overall Study|Adverse Event|4
7683225|NCT00302081|12100828|FG000|Overall Study|Lost to Follow-up|21
7683226|NCT00302081|12100829|FG001|Overall Study|Lost to Follow-up|18
7683227|NCT00302081|12100830|FG002|Overall Study|Lost to Follow-up|28
7683228|NCT00302081|12100828|FG000|Overall Study|Withdrawal by Subject|8
7683229|NCT00302081|12100829|FG001|Overall Study|Withdrawal by Subject|12
7683230|NCT00302081|12100830|FG002|Overall Study|Withdrawal by Subject|8
7683231|NCT00302081|12100828|FG000|Overall Study|Protocol Violation|5
7683232|NCT00302081|12100829|FG001|Overall Study|Protocol Violation|1
7683233|NCT00302081|12100830|FG002|Overall Study|Protocol Violation|2
7683234|NCT00302081|12100828|FG000|Overall Study|Lack of Efficacy|1
7683235|NCT00302081|12100829|FG001|Overall Study|Lack of Efficacy|0
7683236|NCT00302081|12100830|FG002|Overall Study|Lack of Efficacy|5
7683237|NCT00302081|12100828|FG000|Overall Study|Death|2
7683238|NCT00302081|12100829|FG001|Overall Study|Death|1
7683239|NCT00302081|12100830|FG002|Overall Study|Death|0
7683240|NCT00302081|12100828|FG000|Overall Study|Other|13
7683241|NCT00302081|12100829|FG001|Overall Study|Other|6
7683242|NCT00302081|12100830|FG002|Overall Study|Other|5
7683243|NCT00302107|12100840|FG000|Overall Study|Lost to Follow-up|6
7683244|NCT00302107|12100841|FG001|Overall Study|Lost to Follow-up|5
7683245|NCT00302107|12100840|FG000|Overall Study|Protocol Violation|1
7683246|NCT00302107|12100841|FG001|Overall Study|Protocol Violation|0
7683247|NCT00302107|12100840|FG000|Overall Study|Relocation|0
7683248|NCT00302107|12100841|FG001|Overall Study|Relocation|1
7683249|NCT00302107|12100840|FG000|Overall Study|Withdrawal by Subject|0
7683250|NCT00302107|12100841|FG001|Overall Study|Withdrawal by Subject|3
7683251|NCT00302107|12100840|FG000|Overall Study|Adverse Event|1
7683252|NCT00302107|12100841|FG001|Overall Study|Adverse Event|0
7683253|NCT00302159|12100856|FG000|Overall Study|pt declined before treatment started|1
7683254|NCT00302159|12100856|FG000|Overall Study|pt started Avastin|1
7683255|NCT00302211|12100864|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2
7683256|NCT00302211|12100865|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1
7683257|NCT00302211|12100866|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0
7683258|NCT00302211|12100867|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0
7683259|NCT00302211|12100868|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0
7683260|NCT00302211|12100864|FG000|Double Blind Period (New Patients)|Adverse Event|0
7683261|NCT00302211|12100865|FG001|Double Blind Period (New Patients)|Adverse Event|0
7683262|NCT00302211|12100866|FG002|Double Blind Period (New Patients)|Adverse Event|3
7683263|NCT00302211|12100867|FG003|Double Blind Period (New Patients)|Adverse Event|0
7683264|NCT00302211|12100868|FG004|Double Blind Period (New Patients)|Adverse Event|0
7683265|NCT00302211|12100864|FG000|Double Blind Period (New Patients)|Investigator's judgement|1
7683266|NCT00302211|12100865|FG001|Double Blind Period (New Patients)|Investigator's judgement|0
7683267|NCT00302211|12100866|FG002|Double Blind Period (New Patients)|Investigator's judgement|0
7683268|NCT00302211|12100867|FG003|Double Blind Period (New Patients)|Investigator's judgement|0
7683269|NCT00302211|12100868|FG004|Double Blind Period (New Patients)|Investigator's judgement|0
7683270|NCT00302211|12100864|FG000|Double Blind Period (New Patients)|Disease progression|0
7683271|NCT00302211|12100865|FG001|Double Blind Period (New Patients)|Disease progression|1
7683272|NCT00302211|12100866|FG002|Double Blind Period (New Patients)|Disease progression|1
7683273|NCT00302211|12100867|FG003|Double Blind Period (New Patients)|Disease progression|0
7683274|NCT00302211|12100868|FG004|Double Blind Period (New Patients)|Disease progression|0
7683275|NCT00302211|12100864|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
7683276|NCT00302211|12100865|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
7683277|NCT00302211|12100866|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
7683278|NCT00302211|12100867|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
7683279|NCT00302211|12100868|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
7683280|NCT00302211|12100864|FG000|Open Label-Patients From Double-Blind|Adverse Event|0
7683281|NCT00302211|12100865|FG001|Open Label-Patients From Double-Blind|Adverse Event|0
7683282|NCT00302211|12100866|FG002|Open Label-Patients From Double-Blind|Adverse Event|0
7683283|NCT00302211|12100867|FG003|Open Label-Patients From Double-Blind|Adverse Event|1
7683284|NCT00302211|12100868|FG004|Open Label-Patients From Double-Blind|Adverse Event|0
7683285|NCT00302211|12100864|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0
7683286|NCT00302211|12100865|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0
7683287|NCT00302211|12100866|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0
7683288|NCT00302211|12100867|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1
7683289|NCT00302211|12100868|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0
7683290|NCT00302211|12100864|FG000|Open Label-Patients From Double-Blind|Disease progression|0
7683291|NCT00302211|12100865|FG001|Open Label-Patients From Double-Blind|Disease progression|0
7683292|NCT00302211|12100866|FG002|Open Label-Patients From Double-Blind|Disease progression|0
7683293|NCT00302211|12100867|FG003|Open Label-Patients From Double-Blind|Disease progression|1
7683294|NCT00302211|12100868|FG004|Open Label-Patients From Double-Blind|Disease progression|2
7683295|NCT00302211|12100864|FG000|Open Label-Patients From Double-Blind|Death|0
7683296|NCT00302211|12100865|FG001|Open Label-Patients From Double-Blind|Death|0
7683297|NCT00302211|12100866|FG002|Open Label-Patients From Double-Blind|Death|0
7683298|NCT00302211|12100867|FG003|Open Label-Patients From Double-Blind|Death|1
7683299|NCT00302211|12100868|FG004|Open Label-Patients From Double-Blind|Death|1
7683300|NCT00302211|12100864|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0
7683301|NCT00302211|12100865|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0
7683302|NCT00302211|12100866|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0
7683303|NCT00302211|12100867|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0
7683304|NCT00302211|12100868|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1
7683305|NCT00302211|12100864|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
7683306|NCT00302211|12100865|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
7683307|NCT00302211|12100866|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
7683308|NCT00302211|12100867|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
7683309|NCT00302211|12100868|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
7683310|NCT00302211|12100864|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
7683311|NCT00302211|12100865|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
7683312|NCT00302211|12100866|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
7683313|NCT00302211|12100867|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
7683314|NCT00302211|12100868|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
7683315|NCT00302328|12100883|FG000|Overall Study|Physician Decision|0
7683316|NCT00302328|12100884|FG001|Overall Study|Physician Decision|1
7683317|NCT00302328|12100885|FG002|Overall Study|Physician Decision|0
7683318|NCT00302458|12100896|FG000|Overall Study|Lost to Follow-up|1
7683319|NCT00302458|12100896|FG000|Overall Study|Ineligible after screening|1
7683320|NCT00302458|12100896|FG000|Overall Study|Withdrawal by Subject|1
7683321|NCT00302718|12100908|FG000|Overall Study|Participant left the hospital|1
7683322|NCT00302718|12100909|FG001|Overall Study|Participant left the hospital|0
7683323|NCT00302718|12100910|FG002|Overall Study|Participant left the hospital|0
7683324|NCT00302718|12100911|FG003|Overall Study|Participant left the hospital|1
7683325|NCT00302718|12100908|FG000|Overall Study|Withdrawal by Subject|0
7683326|NCT00302718|12100909|FG001|Overall Study|Withdrawal by Subject|1
7683327|NCT00302718|12100910|FG002|Overall Study|Withdrawal by Subject|0
7683328|NCT00302718|12100911|FG003|Overall Study|Withdrawal by Subject|0
7683329|NCT00302718|12100908|FG000|Overall Study|Participant left primary care setting|0
7683330|NCT00302718|12100909|FG001|Overall Study|Participant left primary care setting|0
7683331|NCT00302718|12100910|FG002|Overall Study|Participant left primary care setting|2
7683332|NCT00302718|12100911|FG003|Overall Study|Participant left primary care setting|1
7683333|NCT00302731|12100930|FG000|Overall Study|Lost to Follow-up|1
7683334|NCT00302731|12100931|FG001|Overall Study|Lost to Follow-up|2
7683335|NCT00302731|12100932|FG002|Overall Study|Lost to Follow-up|0
7683336|NCT00302731|12100933|FG003|Overall Study|Lost to Follow-up|0
7683337|NCT00302731|12100930|FG000|Overall Study|Adverse Event|0
7683338|NCT00302731|12100931|FG001|Overall Study|Adverse Event|2
7683339|NCT00302731|12100932|FG002|Overall Study|Adverse Event|2
7683340|NCT00302731|12100933|FG003|Overall Study|Adverse Event|0
7683341|NCT00302731|12100930|FG000|Overall Study|Withdrawal by Subject|1
7683342|NCT00302731|12100931|FG001|Overall Study|Withdrawal by Subject|1
7683343|NCT00302731|12100932|FG002|Overall Study|Withdrawal by Subject|0
7683344|NCT00302731|12100933|FG003|Overall Study|Withdrawal by Subject|0
7683345|NCT00302731|12100930|FG000|Overall Study|Protocol Violation|1
7683346|NCT00302731|12100931|FG001|Overall Study|Protocol Violation|0
7683347|NCT00302731|12100932|FG002|Overall Study|Protocol Violation|0
7683348|NCT00302731|12100933|FG003|Overall Study|Protocol Violation|0
7683349|NCT00302731|12100930|FG000|Overall Study|cancer unrelated to study discovered|1
7683350|NCT00302731|12100931|FG001|Overall Study|cancer unrelated to study discovered|0
7683351|NCT00302731|12100932|FG002|Overall Study|cancer unrelated to study discovered|1
7683352|NCT00302731|12100933|FG003|Overall Study|cancer unrelated to study discovered|0
7683353|NCT00303069|12100959|FG000|Overall Study|Lost to Follow-up|1
7683354|NCT00303069|12100960|FG001|Overall Study|Lost to Follow-up|0
7683355|NCT00303069|12100961|FG002|Overall Study|Lost to Follow-up|0
7683356|NCT00303069|12100962|FG003|Overall Study|Lost to Follow-up|2
7683357|NCT00303069|12100959|FG000|Overall Study|subject moved|1
7683358|NCT00303069|12100960|FG001|Overall Study|subject moved|0
7683359|NCT00303069|12100961|FG002|Overall Study|subject moved|0
7683360|NCT00303069|12100962|FG003|Overall Study|subject moved|0
7683361|NCT00303069|12100959|FG000|Overall Study|Recruitment into Army Reserves|0
7683362|NCT00303069|12100960|FG001|Overall Study|Recruitment into Army Reserves|0
7683363|NCT00303069|12100961|FG002|Overall Study|Recruitment into Army Reserves|1
7683364|NCT00303069|12100962|FG003|Overall Study|Recruitment into Army Reserves|0
7683365|NCT00303108|12100975|FG000|Overall Study|Adverse Event|5
7683366|NCT00303108|12100976|FG001|Overall Study|Adverse Event|6
7683367|NCT00303108|12100977|FG002|Overall Study|Adverse Event|7
7683368|NCT00303108|12100975|FG000|Overall Study|Patient Request|4
7683369|NCT00303108|12100976|FG001|Overall Study|Patient Request|2
7683370|NCT00303108|12100977|FG002|Overall Study|Patient Request|8
7683371|NCT00303108|12100975|FG000|Overall Study|Failed Entry|1
7683372|NCT00303108|12100976|FG001|Overall Study|Failed Entry|0
7683373|NCT00303108|12100977|FG002|Overall Study|Failed Entry|1
7683374|NCT00303108|12100975|FG000|Overall Study|ineligible|2
7683375|NCT00303108|12100976|FG001|Overall Study|ineligible|1
7683376|NCT00303108|12100977|FG002|Overall Study|ineligible|0
7683377|NCT00303186|12100984|FG000|Overall Study|Other|52
7683378|NCT00303316|12100990|FG000|Overall Study|Protocol Violation|1
7683379|NCT00303316|12100991|FG001|Overall Study|Protocol Violation|0
7683380|NCT00303316|12100990|FG000|Overall Study|Lost to Follow-up|0
7683381|NCT00303316|12100991|FG001|Overall Study|Lost to Follow-up|1
7683382|NCT00303316|12100990|FG000|Overall Study|Withdrawal by Subject|1
7683383|NCT00303316|12100991|FG001|Overall Study|Withdrawal by Subject|2
7683384|NCT00303329|12100999|FG000|Overall Study|Adverse Event|7
7683385|NCT00303329|12101000|FG001|Overall Study|Adverse Event|14
7683386|NCT00303329|12100999|FG000|Overall Study|Abnormal Laboratory Values|0
7683387|NCT00303329|12101000|FG001|Overall Study|Abnormal Laboratory Values|1
7683388|NCT00303329|12100999|FG000|Overall Study|Unsatisfactory therapeutic effect|9
7683389|NCT00303329|12101000|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7683390|NCT00303329|12100999|FG000|Overall Study|Condition no longer requires study drug|0
7683391|NCT00303329|12101000|FG001|Overall Study|Condition no longer requires study drug|8
7683392|NCT00303329|12100999|FG000|Overall Study|Protocol Violation|3
7683393|NCT00303329|12101000|FG001|Overall Study|Protocol Violation|0
7683394|NCT00303329|12100999|FG000|Overall Study|Withdrawal by Subject|9
7683395|NCT00303329|12101000|FG001|Overall Study|Withdrawal by Subject|15
7683396|NCT00303329|12100999|FG000|Overall Study|Lost to Follow-up|0
7683397|NCT00303329|12101000|FG001|Overall Study|Lost to Follow-up|1
7683398|NCT00303329|12100999|FG000|Overall Study|Administrative problems|1
7683399|NCT00303329|12101000|FG001|Overall Study|Administrative problems|0
7683400|NCT00303329|12100999|FG000|Overall Study|Death|2
7683401|NCT00303329|12101000|FG001|Overall Study|Death|12
7683402|NCT00303329|12100999|FG000|Overall Study|Stopped at end of core|3
7683403|NCT00303329|12101000|FG001|Overall Study|Stopped at end of core|9
7683404|NCT00303329|12100999|FG000|Overall Study|Stopped at end of extension 1|1
7683405|NCT00303329|12101000|FG001|Overall Study|Stopped at end of extension 1|0
7683406|NCT00303446|12101008|FG000|Overall Study|Withdrawal by Subject|2
7683407|NCT00303446|12101009|FG001|Overall Study|Withdrawal by Subject|2
7683408|NCT00303446|12101008|FG000|Overall Study|Death|0
7683409|NCT00303446|12101009|FG001|Overall Study|Death|1
7683410|NCT00303446|12101008|FG000|Overall Study|Physician Decision|0
7683411|NCT00303446|12101009|FG001|Overall Study|Physician Decision|1
7683412|NCT00303459|12101017|FG000|Overall Study|Death|33
7683413|NCT00303459|12101018|FG001|Overall Study|Death|44
7683414|NCT00303459|12101017|FG000|Overall Study|Withdrawal of consent|32
7683415|NCT00303459|12101018|FG001|Overall Study|Withdrawal of consent|26
7683416|NCT00303459|12101017|FG000|Overall Study|Lost to Follow-up|5
7683417|NCT00303459|12101018|FG001|Overall Study|Lost to Follow-up|4
7683418|NCT00303459|12101017|FG000|Overall Study|Administrative reason|7
7683419|NCT00303459|12101018|FG001|Overall Study|Administrative reason|7
7683420|NCT00303459|12101017|FG000|Overall Study|Decision by the investigator|5
7683421|NCT00303459|12101018|FG001|Overall Study|Decision by the investigator|7
7683422|NCT00303459|12101017|FG000|Overall Study|Lung transplantation|1
7683423|NCT00303459|12101018|FG001|Overall Study|Lung transplantation|1
7683424|NCT00303472|12101032|FG000|Treatment Period|Adverse Event|0
7683425|NCT00303472|12101033|FG001|Treatment Period|Adverse Event|0
7683426|NCT00303472|12101034|FG002|Treatment Period|Adverse Event|0
7683427|NCT00303472|12101035|FG003|Treatment Period|Adverse Event|0
7683428|NCT00303472|12101036|FG004|Treatment Period|Adverse Event|1
7683429|NCT00303472|12101037|FG005|Treatment Period|Adverse Event|0
7683430|NCT00303472|12101038|FG006|Treatment Period|Adverse Event|0
7683431|NCT00303472|12101032|FG000|Treatment Period|Death|0
7683432|NCT00303472|12101033|FG001|Treatment Period|Death|0
7683433|NCT00303472|12101034|FG002|Treatment Period|Death|0
7683434|NCT00303472|12101035|FG003|Treatment Period|Death|1
7683435|NCT00303472|12101036|FG004|Treatment Period|Death|0
7683436|NCT00303472|12101037|FG005|Treatment Period|Death|0
7683437|NCT00303472|12101038|FG006|Treatment Period|Death|1
7683438|NCT00303472|12101032|FG000|Treatment Period|Withdrawal by Subject|0
7683439|NCT00303472|12101033|FG001|Treatment Period|Withdrawal by Subject|0
7683440|NCT00303472|12101034|FG002|Treatment Period|Withdrawal by Subject|0
7683441|NCT00303472|12101035|FG003|Treatment Period|Withdrawal by Subject|1
7683442|NCT00303472|12101036|FG004|Treatment Period|Withdrawal by Subject|0
7683443|NCT00303472|12101037|FG005|Treatment Period|Withdrawal by Subject|1
7683444|NCT00303472|12101038|FG006|Treatment Period|Withdrawal by Subject|0
7683445|NCT00303472|12101032|FG000|Treatment Period|Other|0
7683446|NCT00303472|12101033|FG001|Treatment Period|Other|0
7683447|NCT00303472|12101034|FG002|Treatment Period|Other|0
7683448|NCT00303472|12101035|FG003|Treatment Period|Other|0
7683449|NCT00303472|12101036|FG004|Treatment Period|Other|1
7683450|NCT00303472|12101037|FG005|Treatment Period|Other|0
7683451|NCT00303472|12101038|FG006|Treatment Period|Other|1
7683452|NCT00303472|12101032|FG000|Treatment Period|Disease Progression (to AML)|0
7683453|NCT00303472|12101033|FG001|Treatment Period|Disease Progression (to AML)|0
7683454|NCT00303472|12101034|FG002|Treatment Period|Disease Progression (to AML)|0
7683455|NCT00303472|12101035|FG003|Treatment Period|Disease Progression (to AML)|0
7683456|NCT00303472|12101036|FG004|Treatment Period|Disease Progression (to AML)|1
7683457|NCT00303472|12101037|FG005|Treatment Period|Disease Progression (to AML)|0
7683458|NCT00303472|12101038|FG006|Treatment Period|Disease Progression (to AML)|0
7683459|NCT00303472|12101032|FG000|Treatment Extension (Optional)|Adverse Event|1
7683460|NCT00303472|12101033|FG001|Treatment Extension (Optional)|Adverse Event|0
7683461|NCT00303472|12101034|FG002|Treatment Extension (Optional)|Adverse Event|1
7683462|NCT00303472|12101035|FG003|Treatment Extension (Optional)|Adverse Event|0
7683463|NCT00303472|12101036|FG004|Treatment Extension (Optional)|Adverse Event|0
7683464|NCT00303472|12101037|FG005|Treatment Extension (Optional)|Adverse Event|0
7683465|NCT00303472|12101038|FG006|Treatment Extension (Optional)|Adverse Event|0
7683466|NCT00303472|12101032|FG000|Treatment Extension (Optional)|Death|2
7683467|NCT00303472|12101033|FG001|Treatment Extension (Optional)|Death|0
7683468|NCT00303472|12101034|FG002|Treatment Extension (Optional)|Death|1
7683469|NCT00303472|12101035|FG003|Treatment Extension (Optional)|Death|0
7683470|NCT00303472|12101036|FG004|Treatment Extension (Optional)|Death|0
7683471|NCT00303472|12101037|FG005|Treatment Extension (Optional)|Death|0
7683472|NCT00303472|12101038|FG006|Treatment Extension (Optional)|Death|0
7683473|NCT00303472|12101032|FG000|Treatment Extension (Optional)|Lost to Follow-up|0
7683474|NCT00303472|12101033|FG001|Treatment Extension (Optional)|Lost to Follow-up|0
7683475|NCT00303472|12101034|FG002|Treatment Extension (Optional)|Lost to Follow-up|0
7683476|NCT00303472|12101035|FG003|Treatment Extension (Optional)|Lost to Follow-up|1
7683477|NCT00303472|12101036|FG004|Treatment Extension (Optional)|Lost to Follow-up|0
7683478|NCT00303472|12101037|FG005|Treatment Extension (Optional)|Lost to Follow-up|0
7683479|NCT00303472|12101038|FG006|Treatment Extension (Optional)|Lost to Follow-up|0
7683480|NCT00303472|12101032|FG000|Treatment Extension (Optional)|Physician Decision|0
7683481|NCT00303472|12101033|FG001|Treatment Extension (Optional)|Physician Decision|4
7683482|NCT00303472|12101034|FG002|Treatment Extension (Optional)|Physician Decision|2
7683483|NCT00303472|12101035|FG003|Treatment Extension (Optional)|Physician Decision|3
7683484|NCT00303472|12101036|FG004|Treatment Extension (Optional)|Physician Decision|2
7683485|NCT00303472|12101037|FG005|Treatment Extension (Optional)|Physician Decision|0
7683486|NCT00303472|12101038|FG006|Treatment Extension (Optional)|Physician Decision|0
7683487|NCT00303472|12101032|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1
7683488|NCT00303472|12101033|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0
7683489|NCT00303472|12101034|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1
7683490|NCT00303472|12101035|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2
7683491|NCT00303472|12101036|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1
7683492|NCT00303472|12101037|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0
7683493|NCT00303472|12101038|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0
7683494|NCT00303472|12101032|FG000|Treatment Extension (Optional)|Other|0
7683495|NCT00303472|12101033|FG001|Treatment Extension (Optional)|Other|2
7683496|NCT00303472|12101034|FG002|Treatment Extension (Optional)|Other|4
7683497|NCT00303472|12101035|FG003|Treatment Extension (Optional)|Other|2
7683498|NCT00303472|12101036|FG004|Treatment Extension (Optional)|Other|1
7683499|NCT00303472|12101037|FG005|Treatment Extension (Optional)|Other|0
7683500|NCT00303472|12101038|FG006|Treatment Extension (Optional)|Other|0
7683501|NCT00303472|12101032|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1
7683502|NCT00303472|12101033|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0
7683503|NCT00303472|12101034|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0
7683504|NCT00303472|12101035|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0
7683505|NCT00303472|12101036|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0
7683506|NCT00303472|12101037|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1
7683507|NCT00303472|12101038|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0
7683508|NCT00303485|12101056|FG000|Overall Study|Adverse Event/Intercurrent Illness|0
7683509|NCT00303485|12101057|FG001|Overall Study|Adverse Event/Intercurrent Illness|1
7683510|NCT00303485|12101056|FG000|Overall Study|Failure to return|0
7683511|NCT00303485|12101057|FG001|Overall Study|Failure to return|1
7683512|NCT00303485|12101056|FG000|Overall Study|Withdrawal by Subject|1
7683513|NCT00303485|12101057|FG001|Overall Study|Withdrawal by Subject|0
7683514|NCT00303602|12101069|FG000|Overall Study|Adverse Event|2
7683515|NCT00303602|12101070|FG001|Overall Study|Adverse Event|2
7683516|NCT00303602|12101069|FG000|Overall Study|Withdrawal by Subject|5
7683517|NCT00303602|12101070|FG001|Overall Study|Withdrawal by Subject|6
7683518|NCT00303602|12101069|FG000|Overall Study|Lost to Follow-up|5
7683519|NCT00303602|12101070|FG001|Overall Study|Lost to Follow-up|2
7683520|NCT00303602|12101069|FG000|Overall Study|Protocol entry criteria not met|2
7683521|NCT00303602|12101070|FG001|Overall Study|Protocol entry criteria not met|2
7683522|NCT00303602|12101069|FG000|Overall Study|Physician Decision|2
7683523|NCT00303602|12101070|FG001|Overall Study|Physician Decision|1
7683524|NCT00303602|12101069|FG000|Overall Study|Noncompliance|2
7683525|NCT00303602|12101070|FG001|Overall Study|Noncompliance|2
7683526|NCT00303602|12101069|FG000|Overall Study|Protocol Violation|1
7683527|NCT00303602|12101070|FG001|Overall Study|Protocol Violation|0
7683528|NCT00303628|12101078|FG000|Overall Study|Disease progression|0
7683529|NCT00303628|12101079|FG001|Overall Study|Disease progression|1
7683530|NCT00303628|12101078|FG000|Overall Study|Adverse Event|26
7683531|NCT00303628|12101079|FG001|Overall Study|Adverse Event|36
7683532|NCT00303628|12101078|FG000|Overall Study|Death|0
7683533|NCT00303628|12101079|FG001|Overall Study|Death|1
7683534|NCT00303628|12101078|FG000|Overall Study|Withdrawal by Subject|11
7683535|NCT00303628|12101079|FG001|Overall Study|Withdrawal by Subject|20
7683536|NCT00303628|12101078|FG000|Overall Study|Alternative therapy|2
7683537|NCT00303628|12101079|FG001|Overall Study|Alternative therapy|0
7683538|NCT00303628|12101078|FG000|Overall Study|Other complicating disease|0
7683539|NCT00303628|12101079|FG001|Overall Study|Other complicating disease|1
7683540|NCT00303628|12101078|FG000|Overall Study|Not start protocol therapy|3
7683541|NCT00303628|12101079|FG001|Overall Study|Not start protocol therapy|5
7683542|NCT00303628|12101078|FG000|Overall Study|Other|8
7683543|NCT00303628|12101079|FG001|Overall Study|Other|9
7683544|NCT00303667|12101087|FG000|Overall Study|Death|0
7683545|NCT00303667|12101088|FG001|Overall Study|Death|4
7683546|NCT00303719|12101096|FG000|Overall Study|Not evaluable, prior therapies|0
7683547|NCT00303719|12101097|FG001|Overall Study|Not evaluable, prior therapies|30
7683548|NCT00303719|12101096|FG000|Overall Study|Lost to Follow-up|0
7683549|NCT00303719|12101097|FG001|Overall Study|Lost to Follow-up|7
7683550|NCT00303953|12101121|FG000|Overall Study|Ineligible|1
7683551|NCT00303953|12101121|FG000|Overall Study|Death|1
7683552|NCT00303953|12101121|FG000|Overall Study|Adverse Event|4
7683553|NCT00303953|12101121|FG000|Overall Study|Lack of Efficacy|12
7683554|NCT00303953|12101121|FG000|Overall Study|Physician Decision|1
7683555|NCT00304031|12101154|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144
7683556|NCT00304031|12101155|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
7683557|NCT00304031|12101156|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
7683558|NCT00304031|12101154|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48
7683559|NCT00304031|12101155|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
7683560|NCT00304031|12101156|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
7683561|NCT00304031|12101154|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19
7683562|NCT00304031|12101155|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
7683563|NCT00304031|12101156|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
7683564|NCT00304031|12101154|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18
7683565|NCT00304031|12101155|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0
7683566|NCT00304031|12101156|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0
7683567|NCT00304031|12101154|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15
7683568|NCT00304031|12101155|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
7683569|NCT00304031|12101156|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
7683570|NCT00304031|12101154|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10
7683571|NCT00304031|12101155|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
7683572|NCT00304031|12101156|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
7683573|NCT00304031|12101154|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1
7683574|NCT00304031|12101155|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
7683575|NCT00304031|12101156|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
7683576|NCT00304031|12101154|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37
7683577|NCT00304031|12101155|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
7683578|NCT00304031|12101156|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
7683579|NCT00304031|12101154|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
7683580|NCT00304031|12101155|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
7683581|NCT00304031|12101156|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
7683582|NCT00304083|12101173|FG000|Overall Study|Withdrawal by Subject|4
7683583|NCT00304083|12101174|FG001|Overall Study|Withdrawal by Subject|2
7683584|NCT00304083|12101173|FG000|Overall Study|Physician Decision|8
7683585|NCT00304083|12101174|FG001|Overall Study|Physician Decision|3
7683586|NCT00304083|12101173|FG000|Overall Study|Disease Progression|5
7683587|NCT00304083|12101174|FG001|Overall Study|Disease Progression|1
7683588|NCT00304083|12101173|FG000|Overall Study|Other|5
7683589|NCT00304083|12101174|FG001|Overall Study|Other|2
7683590|NCT00304278|12101218|FG000|Overall Study|lack of insurance coverage for chemoRT|1
7683591|NCT00304278|12101218|FG000|Overall Study|PT had medical condition preventing TX|1
7683592|NCT00304356|12101222|FG000|Nitazoxanide|Physician Decision|5
7683593|NCT00304356|12101222|FG000|Nitazoxanide|Physician Decision|1
7683594|NCT00304356|12101222|FG000|Nitazoxanide|number is 0|1
7683595|NCT00304356|12101222|FG000|Nitazoxanide|Physician Decision|1
7683596|NCT00304356|12101222|FG000|Nitazoxanide|Physician Decision|1
7683597|NCT00304356|12101222|FG000|Nitazoxanide|Physician Decision|1
7683598|NCT04493931|12101293|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1
7683599|NCT04493931|12101294|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
7683600|NCT04493931|12101295|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
7683601|NCT04493931|12101296|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
7683602|NCT04493931|12101297|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
7683603|NCT04493931|12101298|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
7683604|NCT04493931|12101299|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
7683605|NCT04493931|12101293|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
7683606|NCT04493931|12101294|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2
7683607|NCT04493931|12101295|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
7683608|NCT04493931|12101296|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
7683609|NCT04493931|12101297|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
7683610|NCT04493931|12101298|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
7683611|NCT04493931|12101299|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
7683612|NCT04493931|12101293|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
7683613|NCT04493931|12101294|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1
7683614|NCT04493931|12101295|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
7683615|NCT04493931|12101296|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
7683616|NCT04493931|12101297|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
7683617|NCT04493931|12101298|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
7683618|NCT04493931|12101299|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
7683619|NCT04493931|12101293|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
7683620|NCT04493931|12101294|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
7683621|NCT04493931|12101295|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1
7683622|NCT04493931|12101296|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
7683623|NCT04493931|12101297|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
7683624|NCT04493931|12101298|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
7683625|NCT04493931|12101299|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
7683626|NCT03999554|12101354|FG000|Overall Study|Lost to Follow-up|4
7683627|NCT03999554|12101355|FG001|Overall Study|Lost to Follow-up|5
7683628|NCT03999554|12101356|FG002|Overall Study|Lost to Follow-up|4
7683629|NCT03999554|12101357|FG003|Overall Study|Lost to Follow-up|5
7683630|NCT03999554|12101358|FG004|Overall Study|Lost to Follow-up|8
7683631|NCT03999554|12101354|FG000|Overall Study|Protocol Violation|0
7683632|NCT03999554|12101355|FG001|Overall Study|Protocol Violation|0
7683633|NCT03999554|12101356|FG002|Overall Study|Protocol Violation|5
7683634|NCT03999554|12101357|FG003|Overall Study|Protocol Violation|0
7683635|NCT03999554|12101358|FG004|Overall Study|Protocol Violation|0
7683636|NCT03999554|12101354|FG000|Overall Study|Pregnancy|0
7683637|NCT03999554|12101355|FG001|Overall Study|Pregnancy|0
7683638|NCT03999554|12101356|FG002|Overall Study|Pregnancy|1
7683639|NCT03999554|12101357|FG003|Overall Study|Pregnancy|0
7683640|NCT03999554|12101358|FG004|Overall Study|Pregnancy|0
7683641|NCT03999554|12101354|FG000|Overall Study|Withdrawal by Subject|2
7683642|NCT03999554|12101355|FG001|Overall Study|Withdrawal by Subject|2
7683643|NCT03999554|12101356|FG002|Overall Study|Withdrawal by Subject|2
7683644|NCT03999554|12101357|FG003|Overall Study|Withdrawal by Subject|1
7683645|NCT03999554|12101358|FG004|Overall Study|Withdrawal by Subject|1
7683646|NCT03999554|12101354|FG000|Overall Study|failure to comply with protocol requirements|0
7683647|NCT03999554|12101355|FG001|Overall Study|failure to comply with protocol requirements|0
7683648|NCT03999554|12101356|FG002|Overall Study|failure to comply with protocol requirements|0
7683649|NCT03999554|12101357|FG003|Overall Study|failure to comply with protocol requirements|1
7683650|NCT03999554|12101358|FG004|Overall Study|failure to comply with protocol requirements|0
7683651|NCT03651622|12101374|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0
7683652|NCT03651622|12101375|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6
7683653|NCT03651622|12101376|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2
7683654|NCT03651622|12101374|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4
7683655|NCT03651622|12101375|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1
7683656|NCT03651622|12101376|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7
7683657|NCT03651622|12101374|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0
7683658|NCT03651622|12101375|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2
7683659|NCT03651622|12101376|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3
7683660|NCT03651622|12101374|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2
7683661|NCT03651622|12101375|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0
7683662|NCT03651622|12101376|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0
7683663|NCT03651622|12101374|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0
7683664|NCT03651622|12101375|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0
7683665|NCT03651622|12101376|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1
7683666|NCT02678351|12101416|FG000|Overall Study|Withdrawal by Subject|1
7683667|NCT01693692|12101440|FG000|Overall Study|Withdrawal by Subject|12
7683668|NCT01693692|12101441|FG001|Overall Study|Withdrawal by Subject|10
7683669|NCT01693692|12101442|FG002|Overall Study|Withdrawal by Subject|11
7683670|NCT01693692|12101440|FG000|Overall Study|Adverse Event|7
7683671|NCT01693692|12101441|FG001|Overall Study|Adverse Event|14
7683672|NCT01693692|12101442|FG002|Overall Study|Adverse Event|9
7683673|NCT01693692|12101440|FG000|Overall Study|Physician Decision|0
7683674|NCT01693692|12101441|FG001|Overall Study|Physician Decision|0
7683675|NCT01693692|12101442|FG002|Overall Study|Physician Decision|1
7683676|NCT01693692|12101440|FG000|Overall Study|Protocol Violation|5
7683677|NCT01693692|12101441|FG001|Overall Study|Protocol Violation|4
7683678|NCT01693692|12101442|FG002|Overall Study|Protocol Violation|6
7683679|NCT01693692|12101440|FG000|Overall Study|Lost to Follow-up|2
7683680|NCT01693692|12101441|FG001|Overall Study|Lost to Follow-up|2
7683681|NCT01693692|12101442|FG002|Overall Study|Lost to Follow-up|3
7683682|NCT01693692|12101440|FG000|Overall Study|Other|4
7683683|NCT01693692|12101441|FG001|Overall Study|Other|4
7683684|NCT01693692|12101442|FG002|Overall Study|Other|6
7683685|NCT01685606|12101450|FG000|Overall Study|Withdrawal by Subject|1
7683686|NCT01650285|12101460|FG000|Overall Study|Adverse Event|1
7683687|NCT01083771|12101464|FG000|Overall Study|non-compliant|2
7683688|NCT01083771|12101464|FG000|Overall Study|Withdrawal by Subject|3
7683689|NCT00743197|12101470|FG000|Overall Study|Study terminated due to departure of PI.|1
7683690|NCT00743197|12101471|FG001|Overall Study|Study terminated due to departure of PI.|2
7683691|NCT00304915|12101479|FG000|Overall Study|Lost to Follow-up|11
7683692|NCT00304915|12101480|FG001|Overall Study|Lost to Follow-up|11
7683693|NCT00304915|12101479|FG000|Overall Study|Death|4
7683694|NCT00304915|12101480|FG001|Overall Study|Death|5
7683695|NCT00304915|12101479|FG000|Overall Study|Withdrawal by Subject|3
7683696|NCT00304915|12101480|FG001|Overall Study|Withdrawal by Subject|0
7683697|NCT00304954|12101490|FG000|Overall Study|Withdrawal by Subject|0
7683698|NCT00304954|12101491|FG001|Overall Study|Withdrawal by Subject|0
7683699|NCT00304954|12101492|FG002|Overall Study|Withdrawal by Subject|1
7683700|NCT00304954|12101493|FG003|Overall Study|Withdrawal by Subject|0
7683701|NCT00304954|12101490|FG000|Overall Study|Adverse Event|1
7683702|NCT00304954|12101491|FG001|Overall Study|Adverse Event|0
7683703|NCT00304954|12101492|FG002|Overall Study|Adverse Event|0
7683704|NCT00304954|12101493|FG003|Overall Study|Adverse Event|0
7683705|NCT00305006|12101513|FG000|Overall Study|Withdrawal by Subject|1
7683706|NCT00305006|12101514|FG001|Overall Study|Withdrawal by Subject|0
7683707|NCT00305006|12101513|FG000|Overall Study|Failure to complete pretest|0
7683708|NCT00305006|12101514|FG001|Overall Study|Failure to complete pretest|1
7683709|NCT00305058|12101522|FG000|Overall Study|Participant too young|1
7683710|NCT00305058|12101523|FG001|Overall Study|Participant too young|0
7683711|NCT00305058|12101522|FG000|Overall Study|Missing data collection instrument|3
7683712|NCT00305058|12101523|FG001|Overall Study|Missing data collection instrument|2
7683713|NCT00305058|12101522|FG000|Overall Study|Missing outcome data|3
7683714|NCT00305058|12101523|FG001|Overall Study|Missing outcome data|2
7683715|NCT00305110|12101578|FG000|Overall Study|Missing data|29
7683716|NCT00305227|12101594|FG000|Overall Study|Lost to Follow-up|7
7683717|NCT00305227|12101595|FG001|Overall Study|Lost to Follow-up|6
7683718|NCT00305253|12101603|FG000|Overall Study|Withdrawal by Subject|0
7683719|NCT00305253|12101604|FG001|Overall Study|Withdrawal by Subject|1
7683720|NCT00305448|12101613|FG000|Overall Study|Protocol Violation|0
7683721|NCT00305448|12101614|FG001|Overall Study|Protocol Violation|1
7683722|NCT00305448|12101615|FG002|Overall Study|Protocol Violation|0
7683723|NCT00305448|12101613|FG000|Overall Study|Withdrawal by Subject|2
7683724|NCT00305448|12101614|FG001|Overall Study|Withdrawal by Subject|0
7683725|NCT00305448|12101615|FG002|Overall Study|Withdrawal by Subject|1
7683726|NCT00305448|12101613|FG000|Overall Study|Adverse Event|1
7683727|NCT00305448|12101614|FG001|Overall Study|Adverse Event|0
7683728|NCT00305448|12101615|FG002|Overall Study|Adverse Event|1
7683729|NCT00305448|12101613|FG000|Overall Study|Disease Progression|27
7683730|NCT00305448|12101614|FG001|Overall Study|Disease Progression|31
7683731|NCT00305448|12101615|FG002|Overall Study|Disease Progression|28
7683732|NCT00305448|12101613|FG000|Overall Study|Subjective Disease Progression|1
7683733|NCT00305448|12101614|FG001|Overall Study|Subjective Disease Progression|2
7683734|NCT00305448|12101615|FG002|Overall Study|Subjective Disease Progression|2
7683735|NCT00305448|12101613|FG000|Overall Study|Tumor Marker Elevation|0
7683736|NCT00305448|12101614|FG001|Overall Study|Tumor Marker Elevation|0
7683737|NCT00305448|12101615|FG002|Overall Study|Tumor Marker Elevation|1
7683738|NCT00305604|12101649|FG000|Overall Study|Adverse Event|6
7683739|NCT00305604|12101650|FG001|Overall Study|Adverse Event|3
7683740|NCT00305604|12101649|FG000|Overall Study|Lack of Efficacy|11
7683741|NCT00305604|12101650|FG001|Overall Study|Lack of Efficacy|18
7683742|NCT00305604|12101649|FG000|Overall Study|Lost to Follow-up|0
7683743|NCT00305604|12101650|FG001|Overall Study|Lost to Follow-up|4
7683744|NCT00305604|12101649|FG000|Overall Study|Protocol Violation|2
7683745|NCT00305604|12101650|FG001|Overall Study|Protocol Violation|1
7683746|NCT00305604|12101649|FG000|Overall Study|Withdrawal by Subject|12
7683747|NCT00305604|12101650|FG001|Overall Study|Withdrawal by Subject|21
7683748|NCT00305604|12101649|FG000|Overall Study|Patient moved|1
7683749|NCT00305604|12101650|FG001|Overall Study|Patient moved|0
7683750|NCT00305695|12101683|FG000|Overall Study|Withdrawal by subject prior to 18 month|40
7683751|NCT00305695|12101684|FG001|Overall Study|Withdrawal by subject prior to 18 month|26
7683752|NCT00305695|12101683|FG000|Overall Study|Did not have baseline scan|1
7683753|NCT00305695|12101684|FG001|Overall Study|Did not have baseline scan|1
7683754|NCT00305773|12101696|FG000|Overall Study|Death|3
7683755|NCT00305773|12101697|FG001|Overall Study|Death|2
7683756|NCT00305773|12101696|FG000|Overall Study|Adverse Event|1
7683757|NCT00305773|12101697|FG001|Overall Study|Adverse Event|2
7683758|NCT00305773|12101696|FG000|Overall Study|Alternative Treatment|4
7683759|NCT00305773|12101697|FG001|Overall Study|Alternative Treatment|4
7683760|NCT00305773|12101696|FG000|Overall Study|Physician Decision|1
7683761|NCT00305773|12101697|FG001|Overall Study|Physician Decision|1
7683762|NCT00305773|12101696|FG000|Overall Study|Withdrawal by Subject|1
7683763|NCT00305773|12101697|FG001|Overall Study|Withdrawal by Subject|4
7683764|NCT00305773|12101696|FG000|Overall Study|Disease Progression|1
7683765|NCT00305773|12101697|FG001|Overall Study|Disease Progression|3
7683766|NCT00305773|12101696|FG000|Overall Study|All other reasons|3
7683767|NCT00305773|12101697|FG001|Overall Study|All other reasons|2
7683768|NCT00305864|12101707|FG000|Overall Study|Ineligible / No protocol treatment|0
7683769|NCT00305864|12101708|FG001|Overall Study|Ineligible / No protocol treatment|1
7683770|NCT00305864|12101709|FG002|Overall Study|Ineligible / No protocol treatment|1
7683771|NCT00305864|12101710|FG003|Overall Study|Ineligible / No protocol treatment|13
7683772|NCT00305877|12101722|FG000|Overall Study|Lack of Efficacy|6
7683773|NCT00305877|12101723|FG001|Overall Study|Lack of Efficacy|9
7683774|NCT00305877|12101722|FG000|Overall Study|Adverse Event|9
7683775|NCT00305877|12101723|FG001|Overall Study|Adverse Event|14
7683776|NCT00305877|12101722|FG000|Overall Study|Death|0
7683777|NCT00305877|12101723|FG001|Overall Study|Death|1
7683778|NCT00305877|12101722|FG000|Overall Study|Withdrawal by Subject|4
7683779|NCT00305877|12101723|FG001|Overall Study|Withdrawal by Subject|2
7683780|NCT00305877|12101722|FG000|Overall Study|Physician Decision|1
7683781|NCT00305877|12101723|FG001|Overall Study|Physician Decision|1
7683782|NCT00305877|12101722|FG000|Overall Study|Never start treatment|2
7683783|NCT00305877|12101723|FG001|Overall Study|Never start treatment|5
7683784|NCT00305877|12101722|FG000|Overall Study|Ineligible|2
7683785|NCT00305877|12101723|FG001|Overall Study|Ineligible|1
7683786|NCT00305877|12101722|FG000|Overall Study|Transportation issue with daily RT|0
7683787|NCT00305877|12101723|FG001|Overall Study|Transportation issue with daily RT|1
7683788|NCT00306189|12101746|FG000|Overall Study|Physician Decision|0
7683789|NCT00306189|12101747|FG001|Overall Study|Physician Decision|0
7683790|NCT00306189|12101748|FG002|Overall Study|Physician Decision|0
7683791|NCT00306189|12101749|FG003|Overall Study|Physician Decision|1
7683792|NCT00306189|12101746|FG000|Overall Study|Adverse Event|3
7683793|NCT00306189|12101747|FG001|Overall Study|Adverse Event|3
7683794|NCT00306189|12101748|FG002|Overall Study|Adverse Event|2
7683795|NCT00306189|12101749|FG003|Overall Study|Adverse Event|2
7683796|NCT00306189|12101746|FG000|Overall Study|Withdrawal by Subject|4
7683797|NCT00306189|12101747|FG001|Overall Study|Withdrawal by Subject|2
7683798|NCT00306189|12101748|FG002|Overall Study|Withdrawal by Subject|8
7683799|NCT00306189|12101749|FG003|Overall Study|Withdrawal by Subject|1
7683800|NCT00306189|12101746|FG000|Overall Study|Ineligibility determined|1
7683801|NCT00306189|12101747|FG001|Overall Study|Ineligibility determined|1
7683802|NCT00306189|12101748|FG002|Overall Study|Ineligibility determined|1
7683803|NCT00306189|12101749|FG003|Overall Study|Ineligibility determined|1
7683804|NCT00306189|12101746|FG000|Overall Study|Other|1
7683805|NCT00306189|12101747|FG001|Overall Study|Other|0
7683806|NCT00306189|12101748|FG002|Overall Study|Other|0
7683807|NCT00306189|12101749|FG003|Overall Study|Other|0
7683808|NCT00306293|12101810|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1
7683809|NCT00306293|12101811|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0
7683810|NCT00306293|12101810|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
7683811|NCT00306293|12101811|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
7683812|NCT00306293|12101810|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
7683813|NCT00306293|12101811|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
7683814|NCT00306293|12101810|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
7683815|NCT00306293|12101811|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
7683816|NCT00306293|12101810|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1
7683817|NCT00306293|12101811|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0
7683818|NCT00306293|12101810|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
7683819|NCT00306293|12101811|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
7683820|NCT00306293|12101810|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
7683821|NCT00306293|12101811|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
7683822|NCT00306293|12101810|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1
7683823|NCT00306293|12101811|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0
7683824|NCT00306384|12101822|FG000|Overall Study|Adverse Event|103
7683825|NCT00306384|12101823|FG001|Overall Study|Adverse Event|87
7683826|NCT00306384|12101824|FG002|Overall Study|Adverse Event|40
7683827|NCT00306384|12101822|FG000|Overall Study|Major protocol deviation|43
7683828|NCT00306384|12101823|FG001|Overall Study|Major protocol deviation|51
7683829|NCT00306384|12101824|FG002|Overall Study|Major protocol deviation|18
7683830|NCT00306384|12101822|FG000|Overall Study|Lost to Follow-up|57
7683831|NCT00306384|12101823|FG001|Overall Study|Lost to Follow-up|41
7683832|NCT00306384|12101824|FG002|Overall Study|Lost to Follow-up|35
7683833|NCT00306384|12101822|FG000|Overall Study|Voluntary withdrawal|199
7683834|NCT00306384|12101823|FG001|Overall Study|Voluntary withdrawal|187
7683835|NCT00306384|12101824|FG002|Overall Study|Voluntary withdrawal|91
7683836|NCT00306384|12101822|FG000|Overall Study|Study termination|1
7683837|NCT00306384|12101823|FG001|Overall Study|Study termination|0
7683838|NCT00306384|12101824|FG002|Overall Study|Study termination|1
7683839|NCT00306384|12101822|FG000|Overall Study|Pregnancy|3
7683840|NCT00306384|12101823|FG001|Overall Study|Pregnancy|1
7683841|NCT00306384|12101824|FG002|Overall Study|Pregnancy|1
7683842|NCT00306384|12101822|FG000|Overall Study|Lack of Efficacy|26
7683843|NCT00306384|12101823|FG001|Overall Study|Lack of Efficacy|40
7683844|NCT00306384|12101824|FG002|Overall Study|Lack of Efficacy|38
7683845|NCT00306384|12101822|FG000|Overall Study|Investigator discretion|28
7683846|NCT00306384|12101823|FG001|Overall Study|Investigator discretion|31
7683847|NCT00306384|12101824|FG002|Overall Study|Investigator discretion|21
7683848|NCT00306384|12101822|FG000|Overall Study|Other|80
7683849|NCT00306384|12101823|FG001|Overall Study|Other|70
7683850|NCT00306384|12101824|FG002|Overall Study|Other|32
7683851|NCT00306384|12101822|FG000|Overall Study|Site closure|2
7683852|NCT00306384|12101823|FG001|Overall Study|Site closure|0
7683853|NCT00306384|12101824|FG002|Overall Study|Site closure|0
7683854|NCT00306527|12101841|FG000|Overall Study|Lost to Follow-up|3
7683855|NCT00306527|12101842|FG001|Overall Study|Lost to Follow-up|4
7683856|NCT00306527|12101843|FG002|Overall Study|Lost to Follow-up|3
7683857|NCT00306527|12101844|FG003|Overall Study|Lost to Follow-up|0
7683858|NCT00306527|12101841|FG000|Overall Study|Withdrawal by Subject|2
7683859|NCT00306527|12101842|FG001|Overall Study|Withdrawal by Subject|3
7683860|NCT00306527|12101843|FG002|Overall Study|Withdrawal by Subject|0
7683861|NCT00306527|12101844|FG003|Overall Study|Withdrawal by Subject|3
7683862|NCT00306527|12101841|FG000|Overall Study|Adverse Event|0
7683863|NCT00306527|12101842|FG001|Overall Study|Adverse Event|0
7683864|NCT00306527|12101843|FG002|Overall Study|Adverse Event|1
7683865|NCT00306527|12101844|FG003|Overall Study|Adverse Event|1
7683866|NCT00306527|12101841|FG000|Overall Study|Death|1
7683867|NCT00306527|12101842|FG001|Overall Study|Death|0
7683868|NCT00306527|12101843|FG002|Overall Study|Death|1
7683869|NCT00306527|12101844|FG003|Overall Study|Death|2
7683870|NCT00306592|12101858|FG000|Overall Study|Adverse Event|8
7683871|NCT00306592|12101859|FG001|Overall Study|Adverse Event|15
7683872|NCT00306592|12101858|FG000|Overall Study|Lost to Follow-up|1
7683873|NCT00306592|12101859|FG001|Overall Study|Lost to Follow-up|0
7683874|NCT00306592|12101858|FG000|Overall Study|Noncompliance|0
7683875|NCT00306592|12101859|FG001|Overall Study|Noncompliance|2
7683876|NCT00306592|12101858|FG000|Overall Study|Persistent Antibodies|6
7683877|NCT00306592|12101859|FG001|Overall Study|Persistent Antibodies|3
7683878|NCT00306592|12101858|FG000|Overall Study|Voluntary|10
7683879|NCT00306592|12101859|FG001|Overall Study|Voluntary|6
7683880|NCT00306592|12101858|FG000|Overall Study|Other|5
7683881|NCT00306592|12101859|FG001|Overall Study|Other|10
7683882|NCT00306592|12101858|FG000|Overall Study|Other|1
7683883|NCT00306592|12101859|FG001|Overall Study|Other|2
7683884|NCT00306592|12101858|FG000|Overall Study|48-week Treatment Period Ongoing|0
7683885|NCT00306592|12101859|FG001|Overall Study|48-week Treatment Period Ongoing|20
7683886|NCT00306670|12101865|FG000|Overall Study|patients recruited; Genentech, the st|0
7683887|NCT00306670|12101866|FG001|Overall Study|patients recruited; Genentech, the st|2
7683888|NCT00306787|12101874|FG000|Overall Study|Discontinued without taking study drug|208
7683889|NCT00306787|12101875|FG001|Overall Study|Discontinued without taking study drug|215
7683890|NCT00306787|12101874|FG000|Overall Study|Adverse Event|1
7683891|NCT00306787|12101875|FG001|Overall Study|Adverse Event|1
7683892|NCT00306787|12101874|FG000|Overall Study|Lack of Efficacy|1
7683893|NCT00306787|12101875|FG001|Overall Study|Lack of Efficacy|0
7683894|NCT00306787|12101874|FG000|Overall Study|Protocol Violation|8
7683895|NCT00306787|12101875|FG001|Overall Study|Protocol Violation|10
7683896|NCT00306787|12101874|FG000|Overall Study|Withdrawal by Subject|2
7683897|NCT00306787|12101875|FG001|Overall Study|Withdrawal by Subject|9
7683898|NCT00306787|12101874|FG000|Overall Study|Lost to Follow-up|9
7683899|NCT00306787|12101875|FG001|Overall Study|Lost to Follow-up|6
7683900|NCT00306787|12101874|FG000|Overall Study|Administrative problems|4
7683901|NCT00306787|12101875|FG001|Overall Study|Administrative problems|0
7683902|NCT00306787|12101874|FG000|Overall Study|Abnormal laboratory value(s)|1
7683903|NCT00306787|12101875|FG001|Overall Study|Abnormal laboratory value(s)|0
7683904|NCT00306852|12101883|FG000|Overall Study|Death|14
7683905|NCT00306852|12101884|FG001|Overall Study|Death|14
7683906|NCT00306852|12101883|FG000|Overall Study|Lost to Follow-up|15
7683907|NCT00306852|12101884|FG001|Overall Study|Lost to Follow-up|24
7683908|NCT00306891|12101894|FG000|Part A|Withdrawal by Subject|1
7683909|NCT00306891|12101895|FG001|Part A|Withdrawal by Subject|1
7683910|NCT00306891|12101896|FG002|Part A|Withdrawal by Subject|0
7683911|NCT00306891|12101897|FG003|Part A|Withdrawal by Subject|0
7683912|NCT00306891|12101894|FG000|Part A|Condition under investigation worsened|2
7683913|NCT00306891|12101895|FG001|Part A|Condition under investigation worsened|2
7683914|NCT00306891|12101896|FG002|Part A|Condition under investigation worsened|0
7683915|NCT00306891|12101897|FG003|Part A|Condition under investigation worsened|0
7683916|NCT00306891|12101894|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0
7683917|NCT00306891|12101895|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1
7683918|NCT00306891|12101896|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0
7683919|NCT00306891|12101897|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0
7683920|NCT00306891|12101894|FG000|Part A|Partial bowel obstruction|1
7683921|NCT00306891|12101895|FG001|Part A|Partial bowel obstruction|0
7683922|NCT00306891|12101896|FG002|Part A|Partial bowel obstruction|0
7683923|NCT00306891|12101897|FG003|Part A|Partial bowel obstruction|0
7683924|NCT00306891|12101894|FG000|Part A|Reaccumul. of ascites following drainage|0
7683925|NCT00306891|12101895|FG001|Part A|Reaccumul. of ascites following drainage|1
7683926|NCT00306891|12101896|FG002|Part A|Reaccumul. of ascites following drainage|0
7683927|NCT00306891|12101897|FG003|Part A|Reaccumul. of ascites following drainage|0
7683928|NCT00306891|12101894|FG000|Part A|Suspicion of second malignancy|0
7683929|NCT00306891|12101895|FG001|Part A|Suspicion of second malignancy|1
7683930|NCT00306891|12101896|FG002|Part A|Suspicion of second malignancy|0
7683931|NCT00306891|12101897|FG003|Part A|Suspicion of second malignancy|0
7683932|NCT00306891|12101894|FG000|Part A|QTC interval outwith elig. criteria|1
7683933|NCT00306891|12101895|FG001|Part A|QTC interval outwith elig. criteria|0
7683934|NCT00306891|12101896|FG002|Part A|QTC interval outwith elig. criteria|0
7683935|NCT00306891|12101897|FG003|Part A|QTC interval outwith elig. criteria|0
7683936|NCT00306891|12101894|FG000|Part B|Death|0
7683937|NCT00306891|12101895|FG001|Part B|Death|0
7683938|NCT00306891|12101896|FG002|Part B|Death|1
7683939|NCT00306891|12101897|FG003|Part B|Death|2
7683940|NCT00306891|12101894|FG000|Part B|Adverse Event|0
7683941|NCT00306891|12101895|FG001|Part B|Adverse Event|0
7683942|NCT00306891|12101896|FG002|Part B|Adverse Event|5
7683943|NCT00306891|12101897|FG003|Part B|Adverse Event|5
7683944|NCT00306891|12101894|FG000|Part B|Withdrawal by Subject|0
7683945|NCT00306891|12101895|FG001|Part B|Withdrawal by Subject|0
7683946|NCT00306891|12101896|FG002|Part B|Withdrawal by Subject|3
7683947|NCT00306891|12101897|FG003|Part B|Withdrawal by Subject|1
7683948|NCT00306891|12101894|FG000|Part B|Condition under investigation worsened|0
7683949|NCT00306891|12101895|FG001|Part B|Condition under investigation worsened|0
7683950|NCT00306891|12101896|FG002|Part B|Condition under investigation worsened|2
7683951|NCT00306891|12101897|FG003|Part B|Condition under investigation worsened|8
7683952|NCT00306891|12101894|FG000|Part B|Development of study specific disc crit.|0
7683953|NCT00306891|12101895|FG001|Part B|Development of study specific disc crit.|0
7683954|NCT00306891|12101896|FG002|Part B|Development of study specific disc crit.|0
7683955|NCT00306891|12101897|FG003|Part B|Development of study specific disc crit.|1
7683956|NCT00306995|12101915|FG000|Study Part I|Withdrawal by Subject|0
7683957|NCT00306995|12101916|FG001|Study Part I|Withdrawal by Subject|0
7683958|NCT00306995|12101917|FG002|Study Part I|Withdrawal by Subject|0
7683959|NCT00306995|12101918|FG003|Study Part I|Withdrawal by Subject|0
7683960|NCT00306995|12101919|FG004|Study Part I|Withdrawal by Subject|0
7683961|NCT00306995|12101920|FG005|Study Part I|Withdrawal by Subject|0
7683962|NCT00306995|12101921|FG006|Study Part I|Withdrawal by Subject|1
7683963|NCT00306995|12101915|FG000|Study Part II for Subset 2|Serious Adverse Event|0
7683964|NCT00306995|12101916|FG001|Study Part II for Subset 2|Serious Adverse Event|1
7683965|NCT00306995|12101917|FG002|Study Part II for Subset 2|Serious Adverse Event|0
7683966|NCT00306995|12101918|FG003|Study Part II for Subset 2|Serious Adverse Event|0
7683967|NCT00306995|12101919|FG004|Study Part II for Subset 2|Serious Adverse Event|0
7683968|NCT00306995|12101920|FG005|Study Part II for Subset 2|Serious Adverse Event|0
7683969|NCT00306995|12101921|FG006|Study Part II for Subset 2|Serious Adverse Event|0
7683970|NCT00307034|12101968|FG000|Overall Study|Adverse Event|1
7683971|NCT00307034|12101969|FG001|Overall Study|Adverse Event|2
7683972|NCT00307034|12101968|FG000|Overall Study|Withdrawal by Subject|1
7683973|NCT00307034|12101969|FG001|Overall Study|Withdrawal by Subject|2
7683974|NCT00307034|12101968|FG000|Overall Study|Lost to Follow-up|0
7683975|NCT00307034|12101969|FG001|Overall Study|Lost to Follow-up|3
7683976|NCT00307047|12101977|FG000|Overall Study|Lost to Follow-up|35
7683977|NCT00307047|12101978|FG001|Overall Study|Lost to Follow-up|24
7683978|NCT00307047|12101977|FG000|Overall Study|Withdrawal by Subject|6
7683979|NCT00307047|12101978|FG001|Overall Study|Withdrawal by Subject|6
7683980|NCT00307047|12101977|FG000|Overall Study|Physician Decision|1
7683981|NCT00307047|12101978|FG001|Overall Study|Physician Decision|2
7683982|NCT00307047|12101977|FG000|Overall Study|Lost to follow-up for other reasons|0
7683983|NCT00307047|12101978|FG001|Overall Study|Lost to follow-up for other reasons|1
7683984|NCT00307047|12101977|FG000|Overall Study|All death, all MI, all Revascularization|27
7683985|NCT00307047|12101978|FG001|Overall Study|All death, all MI, all Revascularization|16
7683986|NCT00307086|12101984|FG000|Overall Study|ineligible|5
7683987|NCT00307125|12101990|FG000|Screening Phase|Adverse Event|1
7683988|NCT00307125|12101991|FG001|Screening Phase|Adverse Event|0
7683989|NCT00307125|12101992|FG002|Screening Phase|Adverse Event|0
7683990|NCT00307125|12101990|FG000|Screening Phase|Protocol Violation|27
7683991|NCT00307125|12101991|FG001|Screening Phase|Protocol Violation|0
7683992|NCT00307125|12101992|FG002|Screening Phase|Protocol Violation|0
7683993|NCT00307125|12101990|FG000|Screening Phase|Lost to Follow-up|87
7683994|NCT00307125|12101991|FG001|Screening Phase|Lost to Follow-up|0
7683995|NCT00307125|12101992|FG002|Screening Phase|Lost to Follow-up|0
7683996|NCT00307125|12101990|FG000|Screening Phase|Death|10
7683997|NCT00307125|12101991|FG001|Screening Phase|Death|0
7683998|NCT00307125|12101992|FG002|Screening Phase|Death|0
7683999|NCT00307125|12101990|FG000|Screening Phase|Withdrawal by Subject|77
7684000|NCT00307125|12101991|FG001|Screening Phase|Withdrawal by Subject|0
7684001|NCT00307125|12101992|FG002|Screening Phase|Withdrawal by Subject|0
7684002|NCT00307125|12101990|FG000|Screening Phase|Physician Decision|26
7684003|NCT00307125|12101991|FG001|Screening Phase|Physician Decision|0
7684004|NCT00307125|12101992|FG002|Screening Phase|Physician Decision|0
7684005|NCT00307125|12101990|FG000|Screening Phase|Sponsor Decision|4
7684006|NCT00307125|12101991|FG001|Screening Phase|Sponsor Decision|0
7684007|NCT00307125|12101992|FG002|Screening Phase|Sponsor Decision|0
7684008|NCT00307125|12101990|FG000|Screening Phase|Study Terminated|17
7684009|NCT00307125|12101991|FG001|Screening Phase|Study Terminated|0
7684010|NCT00307125|12101992|FG002|Screening Phase|Study Terminated|0
7684011|NCT00307125|12101990|FG000|Screening Phase|Graft Loss|3
7684012|NCT00307125|12101991|FG001|Screening Phase|Graft Loss|0
7684013|NCT00307125|12101992|FG002|Screening Phase|Graft Loss|0
7684014|NCT00307125|12101990|FG000|Screening Phase|Graft Failure|8
7684015|NCT00307125|12101991|FG001|Screening Phase|Graft Failure|0
7684016|NCT00307125|12101992|FG002|Screening Phase|Graft Failure|0
7684017|NCT00307125|12101990|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83
7684018|NCT00307125|12101991|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0
7684019|NCT00307125|12101992|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0
7684020|NCT00307125|12101990|FG000|Screening Phase|Scheduling issues/Non-compliance|55
7684021|NCT00307125|12101991|FG001|Screening Phase|Scheduling issues/Non-compliance|0
7684022|NCT00307125|12101992|FG002|Screening Phase|Scheduling issues/Non-compliance|0
7684023|NCT00307125|12101990|FG000|Screening Phase|Moved or transferred facilities|34
7684024|NCT00307125|12101991|FG001|Screening Phase|Moved or transferred facilities|0
7684025|NCT00307125|12101992|FG002|Screening Phase|Moved or transferred facilities|0
7684026|NCT00307125|12101990|FG000|Screening Phase|Received Pancreas Transplant|8
7684027|NCT00307125|12101991|FG001|Screening Phase|Received Pancreas Transplant|0
7684028|NCT00307125|12101992|FG002|Screening Phase|Received Pancreas Transplant|0
7684029|NCT00307125|12101990|FG000|Screening Phase|Ineligible for pilot|4
7684030|NCT00307125|12101991|FG001|Screening Phase|Ineligible for pilot|0
7684031|NCT00307125|12101992|FG002|Screening Phase|Ineligible for pilot|0
7684032|NCT00307125|12101990|FG000|Screening Phase|Try to get pregnant|1
7684033|NCT00307125|12101991|FG001|Screening Phase|Try to get pregnant|0
7684034|NCT00307125|12101992|FG002|Screening Phase|Try to get pregnant|0
7684035|NCT00307125|12101990|FG000|Screening Phase|Developed acute leukemia|1
7684036|NCT00307125|12101991|FG001|Screening Phase|Developed acute leukemia|0
7684037|NCT00307125|12101992|FG002|Screening Phase|Developed acute leukemia|0
7684038|NCT00307125|12101990|FG000|Screening Phase|Metastatic colon cancer|1
7684039|NCT00307125|12101991|FG001|Screening Phase|Metastatic colon cancer|0
7684040|NCT00307125|12101992|FG002|Screening Phase|Metastatic colon cancer|0
7684041|NCT00307125|12101990|FG000|Screening Phase|Malignancy|1
7684042|NCT00307125|12101991|FG001|Screening Phase|Malignancy|0
7684043|NCT00307125|12101992|FG002|Screening Phase|Malignancy|0
7684044|NCT00307125|12101990|FG000|Screening Phase|PAK|1
7684045|NCT00307125|12101991|FG001|Screening Phase|PAK|0
7684046|NCT00307125|12101992|FG002|Screening Phase|PAK|0
7684047|NCT00307125|12101990|FG000|Screening Phase|Ineligible|1
7684048|NCT00307125|12101991|FG001|Screening Phase|Ineligible|0
7684049|NCT00307125|12101992|FG002|Screening Phase|Ineligible|0
7684050|NCT00307125|12101990|FG000|Screening Phase|Screen Error|1
7684051|NCT00307125|12101991|FG001|Screening Phase|Screen Error|0
7684052|NCT00307125|12101992|FG002|Screening Phase|Screen Error|0
7684053|NCT00307125|12101990|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
7684054|NCT00307125|12101991|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
7684055|NCT00307125|12101992|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
7684056|NCT00307125|12101990|FG000|Screening Phase|AMR and treated with rituximab|1
7684057|NCT00307125|12101991|FG001|Screening Phase|AMR and treated with rituximab|0
7684058|NCT00307125|12101992|FG002|Screening Phase|AMR and treated with rituximab|0
7684059|NCT00307125|12101990|FG000|Screening Phase|Coronary artery bypass|1
7684060|NCT00307125|12101991|FG001|Screening Phase|Coronary artery bypass|0
7684061|NCT00307125|12101992|FG002|Screening Phase|Coronary artery bypass|0
7684062|NCT00307125|12101990|FG000|Pilot Phase|Lost to Follow-up|0
7684063|NCT00307125|12101991|FG001|Pilot Phase|Lost to Follow-up|1
7684064|NCT00307125|12101992|FG002|Pilot Phase|Lost to Follow-up|0
7684065|NCT00307125|12101990|FG000|Pilot Phase|Withdrawal by Subject|0
7684066|NCT00307125|12101991|FG001|Pilot Phase|Withdrawal by Subject|1
7684067|NCT00307125|12101992|FG002|Pilot Phase|Withdrawal by Subject|1
7684068|NCT00307151|12102006|FG000|Overall Study|Death|4
7684069|NCT00307151|12102007|FG001|Overall Study|Death|3
7684070|NCT00307151|12102008|FG002|Overall Study|Death|10
7684071|NCT00307151|12102009|FG003|Overall Study|Death|3
7684072|NCT00307151|12102006|FG000|Overall Study|Severe debilitation, unable to continue|1
7684073|NCT00307151|12102007|FG001|Overall Study|Severe debilitation, unable to continue|0
7684074|NCT00307151|12102008|FG002|Overall Study|Severe debilitation, unable to continue|0
7684075|NCT00307151|12102009|FG003|Overall Study|Severe debilitation, unable to continue|0
7684076|NCT00307151|12102006|FG000|Overall Study|Subject unable to get to clinic|1
7684077|NCT00307151|12102007|FG001|Overall Study|Subject unable to get to clinic|0
7684078|NCT00307151|12102008|FG002|Overall Study|Subject unable to get to clinic|6
7684079|NCT00307151|12102009|FG003|Overall Study|Subject unable to get to clinic|2
7684080|NCT00307151|12102006|FG000|Overall Study|Withdrew consent|0
7684081|NCT00307151|12102007|FG001|Overall Study|Withdrew consent|1
7684082|NCT00307151|12102008|FG002|Overall Study|Withdrew consent|1
7684083|NCT00307151|12102009|FG003|Overall Study|Withdrew consent|3
7684084|NCT00307151|12102006|FG000|Overall Study|Not willing to adhere to study reqs|2
7684085|NCT00307151|12102007|FG001|Overall Study|Not willing to adhere to study reqs|0
7684086|NCT00307151|12102008|FG002|Overall Study|Not willing to adhere to study reqs|2
7684087|NCT00307151|12102009|FG003|Overall Study|Not willing to adhere to study reqs|2
7684088|NCT00307151|12102006|FG000|Overall Study|Clinic unable to contact subject|3
7684089|NCT00307151|12102007|FG001|Overall Study|Clinic unable to contact subject|3
7684090|NCT00307151|12102008|FG002|Overall Study|Clinic unable to contact subject|1
7684091|NCT00307151|12102009|FG003|Overall Study|Clinic unable to contact subject|1
7684092|NCT00307164|12102021|FG000|Overall Study|Death|1
7684093|NCT00307164|12102022|FG001|Overall Study|Death|0
7684094|NCT00307164|12102021|FG000|Overall Study|Severe debilitation, unable to continue|1
7684095|NCT00307164|12102022|FG001|Overall Study|Severe debilitation, unable to continue|0
7684096|NCT00307164|12102021|FG000|Overall Study|Subject/parent not able to get to clinic|2
7684097|NCT00307164|12102022|FG001|Overall Study|Subject/parent not able to get to clinic|1
7684098|NCT00307164|12102021|FG000|Overall Study|Withdrawal by Subject|1
7684099|NCT00307164|12102022|FG001|Overall Study|Withdrawal by Subject|8
7684100|NCT00307164|12102021|FG000|Overall Study|Not compliant with requirements|4
7684101|NCT00307164|12102022|FG001|Overall Study|Not compliant with requirements|4
7684102|NCT00307164|12102021|FG000|Overall Study|Lost to Follow-up|6
7684103|NCT00307164|12102022|FG001|Overall Study|Lost to Follow-up|1
7684104|NCT00307294|12102028|FG000|Overall Study|Withdrawal by Subject|1
7684105|NCT00307333|12102035|FG000|Overall Study|Lost to Follow-up|11
7684106|NCT00307333|12102036|FG001|Overall Study|Lost to Follow-up|3
7684107|NCT00307437|12102045|FG000|Controlled Period|Adverse Event|7
7684108|NCT00307437|12102046|FG001|Controlled Period|Adverse Event|2
7684109|NCT00307437|12102047|FG002|Controlled Period|Adverse Event|5
7684110|NCT00307437|12102048|FG003|Controlled Period|Adverse Event|0
7684111|NCT00307437|12102049|FG004|Controlled Period|Adverse Event|0
7684112|NCT00307437|12102050|FG005|Controlled Period|Adverse Event|0
7684113|NCT00307437|12102051|FG006|Controlled Period|Adverse Event|0
7684114|NCT00307437|12102045|FG000|Controlled Period|Death|0
7684115|NCT00307437|12102046|FG001|Controlled Period|Death|0
7684116|NCT00307437|12102047|FG002|Controlled Period|Death|1
7684117|NCT00307437|12102048|FG003|Controlled Period|Death|0
7684118|NCT00307437|12102049|FG004|Controlled Period|Death|0
7684119|NCT00307437|12102050|FG005|Controlled Period|Death|0
7684120|NCT00307437|12102051|FG006|Controlled Period|Death|0
7684121|NCT00307437|12102045|FG000|Controlled Period|Lack of Efficacy|2
7684122|NCT00307437|12102046|FG001|Controlled Period|Lack of Efficacy|0
7684123|NCT00307437|12102047|FG002|Controlled Period|Lack of Efficacy|0
7684124|NCT00307437|12102048|FG003|Controlled Period|Lack of Efficacy|0
7684125|NCT00307437|12102049|FG004|Controlled Period|Lack of Efficacy|0
7684126|NCT00307437|12102050|FG005|Controlled Period|Lack of Efficacy|0
7684127|NCT00307437|12102051|FG006|Controlled Period|Lack of Efficacy|0
7684128|NCT00307437|12102045|FG000|Controlled Period|Lost to Follow-up|2
7684129|NCT00307437|12102046|FG001|Controlled Period|Lost to Follow-up|3
7684130|NCT00307437|12102047|FG002|Controlled Period|Lost to Follow-up|0
7684131|NCT00307437|12102048|FG003|Controlled Period|Lost to Follow-up|0
7684132|NCT00307437|12102049|FG004|Controlled Period|Lost to Follow-up|0
7684133|NCT00307437|12102050|FG005|Controlled Period|Lost to Follow-up|0
7684134|NCT00307437|12102051|FG006|Controlled Period|Lost to Follow-up|0
7684135|NCT00307437|12102045|FG000|Controlled Period|Other|5
7684136|NCT00307437|12102046|FG001|Controlled Period|Other|1
7684137|NCT00307437|12102047|FG002|Controlled Period|Other|3
7684138|NCT00307437|12102048|FG003|Controlled Period|Other|0
7684139|NCT00307437|12102049|FG004|Controlled Period|Other|0
7684140|NCT00307437|12102050|FG005|Controlled Period|Other|0
7684141|NCT00307437|12102051|FG006|Controlled Period|Other|0
7684142|NCT00307437|12102045|FG000|After Controlled Period|Adverse Event|0
7684143|NCT00307437|12102046|FG001|After Controlled Period|Adverse Event|0
7684144|NCT00307437|12102047|FG002|After Controlled Period|Adverse Event|0
7684145|NCT00307437|12102048|FG003|After Controlled Period|Adverse Event|18
7684146|NCT00307437|12102049|FG004|After Controlled Period|Adverse Event|16
7684147|NCT00307437|12102050|FG005|After Controlled Period|Adverse Event|31
7684148|NCT00307437|12102051|FG006|After Controlled Period|Adverse Event|40
7684149|NCT00307437|12102045|FG000|After Controlled Period|Death|0
7684150|NCT00307437|12102046|FG001|After Controlled Period|Death|0
7684151|NCT00307437|12102047|FG002|After Controlled Period|Death|0
7684152|NCT00307437|12102048|FG003|After Controlled Period|Death|3
7684153|NCT00307437|12102049|FG004|After Controlled Period|Death|1
7684154|NCT00307437|12102050|FG005|After Controlled Period|Death|1
7684155|NCT00307437|12102051|FG006|After Controlled Period|Death|3
7684156|NCT00307437|12102045|FG000|After Controlled Period|Lack of Efficacy|0
7684157|NCT00307437|12102046|FG001|After Controlled Period|Lack of Efficacy|0
7684158|NCT00307437|12102047|FG002|After Controlled Period|Lack of Efficacy|0
7684159|NCT00307437|12102048|FG003|After Controlled Period|Lack of Efficacy|15
7684160|NCT00307437|12102049|FG004|After Controlled Period|Lack of Efficacy|17
7684161|NCT00307437|12102050|FG005|After Controlled Period|Lack of Efficacy|37
7684162|NCT00307437|12102051|FG006|After Controlled Period|Lack of Efficacy|24
7684163|NCT00307437|12102045|FG000|After Controlled Period|Lost to Follow-up|0
7684164|NCT00307437|12102046|FG001|After Controlled Period|Lost to Follow-up|0
7684165|NCT00307437|12102047|FG002|After Controlled Period|Lost to Follow-up|0
7684166|NCT00307437|12102048|FG003|After Controlled Period|Lost to Follow-up|7
7684167|NCT00307437|12102049|FG004|After Controlled Period|Lost to Follow-up|12
7684168|NCT00307437|12102050|FG005|After Controlled Period|Lost to Follow-up|13
7684169|NCT00307437|12102051|FG006|After Controlled Period|Lost to Follow-up|18
7684170|NCT00307437|12102045|FG000|After Controlled Period|Other|0
7684171|NCT00307437|12102046|FG001|After Controlled Period|Other|0
7684172|NCT00307437|12102047|FG002|After Controlled Period|Other|0
7684173|NCT00307437|12102048|FG003|After Controlled Period|Other|15
7684174|NCT00307437|12102049|FG004|After Controlled Period|Other|9
7684175|NCT00307437|12102050|FG005|After Controlled Period|Other|40
7684176|NCT00307437|12102051|FG006|After Controlled Period|Other|28
7684177|NCT00307489|12102075|FG000|Baseline Through Week 48|Lost to Follow-up|0
7684178|NCT00307489|12102076|FG001|Baseline Through Week 48|Lost to Follow-up|1
7684179|NCT00307489|12102075|FG000|Baseline Through Week 48|Physician Decision|1
7684180|NCT00307489|12102076|FG001|Baseline Through Week 48|Physician Decision|0
7684181|NCT00307489|12102075|FG000|Baseline Through Week 48|Withdrawal by Subject|0
7684182|NCT00307489|12102076|FG001|Baseline Through Week 48|Withdrawal by Subject|1
7684183|NCT00307489|12102075|FG000|Week 48 Through Week 168|Adverse Event|1
7684184|NCT00307489|12102076|FG001|Week 48 Through Week 168|Adverse Event|0
7684185|NCT00307489|12102075|FG000|Week 48 Through Week 168|Physician Decision|1
7684186|NCT00307489|12102076|FG001|Week 48 Through Week 168|Physician Decision|0
7684187|NCT00307489|12102075|FG000|Week 48 Through Week 168|Withdrawal by Subject|1
7684188|NCT00307489|12102076|FG001|Week 48 Through Week 168|Withdrawal by Subject|2
7684189|NCT00307489|12102075|FG000|Week 48 Through Week 168|Lack of Efficacy|2
7684190|NCT00307489|12102076|FG001|Week 48 Through Week 168|Lack of Efficacy|2
7684191|NCT00307489|12102075|FG000|Week 48 Through Week 168|Death|0
7684192|NCT00307489|12102076|FG001|Week 48 Through Week 168|Death|1
7684193|NCT00307489|12102075|FG000|Week 48 Through Week 168|Lost to Follow-up|0
7684194|NCT00307489|12102076|FG001|Week 48 Through Week 168|Lost to Follow-up|1
7684195|NCT00307489|12102075|FG000|Week 48 Through Week 168|Seroconversion|1
7684196|NCT00307489|12102076|FG001|Week 48 Through Week 168|Seroconversion|0
7684197|NCT00307684|12102082|FG000|Open Label Phase|Lack of Efficacy|0
7684198|NCT00307684|12102083|FG001|Open Label Phase|Lack of Efficacy|0
7684199|NCT00307684|12102084|FG002|Open Label Phase|Lack of Efficacy|3
7684200|NCT00307684|12102082|FG000|Open Label Phase|Adverse Event|0
7684201|NCT00307684|12102083|FG001|Open Label Phase|Adverse Event|0
7684202|NCT00307684|12102084|FG002|Open Label Phase|Adverse Event|16
7684203|NCT00307684|12102082|FG000|Open Label Phase|Withdrawal by Subject|0
7684204|NCT00307684|12102083|FG001|Open Label Phase|Withdrawal by Subject|0
7684205|NCT00307684|12102084|FG002|Open Label Phase|Withdrawal by Subject|15
7684206|NCT00307684|12102082|FG000|Open Label Phase|Lost to Follow-up|0
7684207|NCT00307684|12102083|FG001|Open Label Phase|Lost to Follow-up|0
7684208|NCT00307684|12102084|FG002|Open Label Phase|Lost to Follow-up|11
7684209|NCT00307684|12102082|FG000|Open Label Phase|non compliance|0
7684210|NCT00307684|12102083|FG001|Open Label Phase|non compliance|0
7684211|NCT00307684|12102084|FG002|Open Label Phase|non compliance|5
7684212|NCT00307684|12102082|FG000|Open Label Phase|other|0
7684213|NCT00307684|12102083|FG001|Open Label Phase|other|0
7684214|NCT00307684|12102084|FG002|Open Label Phase|other|6
7684215|NCT00307684|12102082|FG000|Double Blind Phase|Lack of Efficacy|2
7684216|NCT00307684|12102083|FG001|Double Blind Phase|Lack of Efficacy|5
7684217|NCT00307684|12102084|FG002|Double Blind Phase|Lack of Efficacy|0
7684218|NCT00307736|12102092|FG000|Overall Study|Adverse Event|0
7684219|NCT00307736|12102093|FG001|Overall Study|Adverse Event|0
7684220|NCT00307736|12102094|FG002|Overall Study|Adverse Event|1
7684221|NCT00307736|12102095|FG003|Overall Study|Adverse Event|3
7684222|NCT00307736|12102092|FG000|Overall Study|Withdrawal by Subject|0
7684223|NCT00307736|12102093|FG001|Overall Study|Withdrawal by Subject|0
7684224|NCT00307736|12102094|FG002|Overall Study|Withdrawal by Subject|2
7684225|NCT00307736|12102095|FG003|Overall Study|Withdrawal by Subject|0
7684226|NCT00307801|12102108|FG000|Overall Study|Adverse Event|12
7684227|NCT00307801|12102109|FG001|Overall Study|Adverse Event|4
7684228|NCT00307801|12102108|FG000|Overall Study|Withdrawal by Subject|9
7684229|NCT00307801|12102109|FG001|Overall Study|Withdrawal by Subject|4
7684230|NCT00307801|12102108|FG000|Overall Study|Non-compliance, not taken all tablets|1
7684231|NCT00307801|12102109|FG001|Overall Study|Non-compliance, not taken all tablets|2
7684232|NCT00307801|12102108|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2
7684400|NCT00309166|12102302|FG001|Overall Study|Adverse event, non-fatal|0
7684233|NCT00307801|12102109|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0
7684234|NCT00307801|12102108|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0
7684235|NCT00307801|12102109|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1
7684236|NCT00307801|12102108|FG000|Overall Study|Wrong Randomization|1
7684237|NCT00307801|12102109|FG001|Overall Study|Wrong Randomization|0
7684238|NCT00307801|12102108|FG000|Overall Study|Lack of Efficacy|0
7684239|NCT00307801|12102109|FG001|Overall Study|Lack of Efficacy|2
7684240|NCT00307801|12102108|FG000|Overall Study|Lost to Follow-up, moved abroad|1
7684241|NCT00307801|12102109|FG001|Overall Study|Lost to Follow-up, moved abroad|1
7684242|NCT00307801|12102108|FG000|Overall Study|Frustration with e-diary|1
7684243|NCT00307801|12102109|FG001|Overall Study|Frustration with e-diary|0
7684244|NCT00307801|12102108|FG000|Overall Study|Protocol Violation|3
7684245|NCT00307801|12102109|FG001|Overall Study|Protocol Violation|2
7684246|NCT00307801|12102108|FG000|Overall Study|No reason specified|2
7684247|NCT00307801|12102109|FG001|Overall Study|No reason specified|0
7684248|NCT00307801|12102108|FG000|Overall Study|Pregnancy|0
7684249|NCT00307801|12102109|FG001|Overall Study|Pregnancy|1
7684250|NCT00307931|12102116|FG000|Overall Study|Adverse Event|1
7684251|NCT00308074|12102130|FG000|Overall Study|Withdrawal by Subject|1
7684252|NCT00308087|12102136|FG000|Overall Study|Progressive Disease|19
7684253|NCT00308087|12102137|FG001|Overall Study|Progressive Disease|21
7684254|NCT00308087|12102136|FG000|Overall Study|Study Closure|11
7684255|NCT00308087|12102137|FG001|Overall Study|Study Closure|12
7684256|NCT00308087|12102136|FG000|Overall Study|Withdrawal by Subject|2
7684257|NCT00308087|12102137|FG001|Overall Study|Withdrawal by Subject|1
7684258|NCT00308087|12102136|FG000|Overall Study|Other|4
7684259|NCT00308087|12102137|FG001|Overall Study|Other|3
7684260|NCT00308139|12102145|FG000|Overall Study|Adverse Event|20
7684261|NCT00308139|12102146|FG001|Overall Study|Adverse Event|14
7684262|NCT00308139|12102145|FG000|Overall Study|Lost to Follow-up|13
7684263|NCT00308139|12102146|FG001|Overall Study|Lost to Follow-up|8
7684264|NCT00308139|12102145|FG000|Overall Study|Protocol Violation|3
7684265|NCT00308139|12102146|FG001|Overall Study|Protocol Violation|2
7684266|NCT00308139|12102145|FG000|Overall Study|Withdrawal of Consent|40
7684267|NCT00308139|12102146|FG001|Overall Study|Withdrawal of Consent|42
7684268|NCT00308139|12102145|FG000|Overall Study|Investigator Decision|11
7684269|NCT00308139|12102146|FG001|Overall Study|Investigator Decision|10
7684270|NCT00308139|12102145|FG000|Overall Study|Loss of Glucose Control|5
7684271|NCT00308139|12102146|FG001|Overall Study|Loss of Glucose Control|7
7684272|NCT00308139|12102145|FG000|Overall Study|Administrative|1
7684273|NCT00308139|12102146|FG001|Overall Study|Administrative|4
7684274|NCT00308139|12102145|FG000|Overall Study|Other|1
7684275|NCT00308139|12102146|FG001|Overall Study|Other|0
7684276|NCT00308308|12102207|FG000|Overall Study|Adverse Event|17
7684277|NCT00308308|12102208|FG001|Overall Study|Adverse Event|2
7684278|NCT00308308|12102207|FG000|Overall Study|Lost to Follow-up|5
7684279|NCT00308308|12102208|FG001|Overall Study|Lost to Follow-up|5
7684280|NCT00308308|12102207|FG000|Overall Study|Physician Decision|15
7684281|NCT00308308|12102208|FG001|Overall Study|Physician Decision|7
7684282|NCT00308308|12102207|FG000|Overall Study|Protocol Violation|3
7684283|NCT00308308|12102208|FG001|Overall Study|Protocol Violation|14
7684284|NCT00308308|12102207|FG000|Overall Study|Withdrawal by Subject|47
7684285|NCT00308308|12102208|FG001|Overall Study|Withdrawal by Subject|19
7684286|NCT00308308|12102207|FG000|Overall Study|Various|7
7684287|NCT00308308|12102208|FG001|Overall Study|Various|5
7684288|NCT00308308|12102207|FG000|Overall Study|Randomized but not dosed|8
7684289|NCT00308308|12102208|FG001|Overall Study|Randomized but not dosed|16
7684290|NCT00308308|12102207|FG000|Overall Study|Other|1
7684291|NCT00308308|12102208|FG001|Overall Study|Other|0
7684292|NCT00308555|12102216|FG000|Overall Study|Withdrawal by Subject|1
7684293|NCT00308555|12102217|FG001|Overall Study|Withdrawal by Subject|0
7684294|NCT00308555|12102216|FG000|Overall Study|Physician Decision|2
7684295|NCT00308555|12102217|FG001|Overall Study|Physician Decision|0
7684296|NCT00308581|12102223|FG000|Induction Phase|Adverse Event|0
7684297|NCT00308581|12102224|FG001|Induction Phase|Adverse Event|0
7684298|NCT00308581|12102225|FG002|Induction Phase|Adverse Event|37
7684299|NCT00308581|12102223|FG000|Induction Phase|Lack of Efficacy|0
7684300|NCT00308581|12102224|FG001|Induction Phase|Lack of Efficacy|0
7684301|NCT00308581|12102225|FG002|Induction Phase|Lack of Efficacy|121
7684302|NCT00308581|12102223|FG000|Induction Phase|Withdrawal by Subject|0
7684303|NCT00308581|12102224|FG001|Induction Phase|Withdrawal by Subject|0
7684304|NCT00308581|12102225|FG002|Induction Phase|Withdrawal by Subject|5
7684305|NCT00308581|12102223|FG000|Induction Phase|Unknown reason|0
7684306|NCT00308581|12102224|FG001|Induction Phase|Unknown reason|0
7684307|NCT00308581|12102225|FG002|Induction Phase|Unknown reason|3
7684308|NCT00308581|12102223|FG000|Randomized Maintenance Phase|Adverse Event|10
7684309|NCT00308581|12102224|FG001|Randomized Maintenance Phase|Adverse Event|17
7684310|NCT00308581|12102225|FG002|Randomized Maintenance Phase|Adverse Event|0
7684311|NCT00308581|12102223|FG000|Randomized Maintenance Phase|Lack of Efficacy|9
7684312|NCT00308581|12102224|FG001|Randomized Maintenance Phase|Lack of Efficacy|21
7684313|NCT00308581|12102225|FG002|Randomized Maintenance Phase|Lack of Efficacy|0
7684314|NCT00308581|12102223|FG000|Randomized Maintenance Phase|Lost to Follow-up|0
7684315|NCT00308581|12102224|FG001|Randomized Maintenance Phase|Lost to Follow-up|2
7684316|NCT00308581|12102225|FG002|Randomized Maintenance Phase|Lost to Follow-up|0
7684401|NCT00309166|12102301|FG000|Overall Study|Withdrawal by Subject|4
7684317|NCT00308581|12102223|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1
7684318|NCT00308581|12102224|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4
7684319|NCT00308581|12102225|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0
7684320|NCT00308581|12102223|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
7684321|NCT00308581|12102224|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
7684322|NCT00308581|12102225|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
7684323|NCT00308581|12102223|FG000|Randomized Maintenance Phase|Unknown reason|3
7684324|NCT00308581|12102224|FG001|Randomized Maintenance Phase|Unknown reason|0
7684325|NCT00308581|12102225|FG002|Randomized Maintenance Phase|Unknown reason|0
7684326|NCT00308620|12102236|FG000|Overall Study|Death|1
7684327|NCT00308620|12102237|FG001|Overall Study|Death|1
7684328|NCT00308620|12102238|FG002|Overall Study|Death|0
7684329|NCT00308620|12102236|FG000|Overall Study|Lost to Follow-up|0
7684330|NCT00308620|12102237|FG001|Overall Study|Lost to Follow-up|0
7684331|NCT00308620|12102238|FG002|Overall Study|Lost to Follow-up|1
7684332|NCT00308711|12102249|FG000|Overall Study|Withdrawal by Subject|1
7684333|NCT00308711|12102250|FG001|Overall Study|Withdrawal by Subject|0
7684334|NCT00308711|12102251|FG002|Overall Study|Withdrawal by Subject|1
7684335|NCT00308711|12102249|FG000|Overall Study|Protocol Violation|0
7684336|NCT00308711|12102250|FG001|Overall Study|Protocol Violation|1
7684337|NCT00308711|12102251|FG002|Overall Study|Protocol Violation|1
7684338|NCT00308711|12102249|FG000|Overall Study|Lost to Follow-up|0
7684339|NCT00308711|12102250|FG001|Overall Study|Lost to Follow-up|1
7684340|NCT00308711|12102251|FG002|Overall Study|Lost to Follow-up|0
7684341|NCT00308711|12102249|FG000|Overall Study|Baby not born within 7 days of treatment|1
7684342|NCT00308711|12102250|FG001|Overall Study|Baby not born within 7 days of treatment|2
7684343|NCT00308711|12102251|FG002|Overall Study|Baby not born within 7 days of treatment|2
7684344|NCT00308711|12102249|FG000|Overall Study|Subject incarcerated, data not allowed|0
7684345|NCT00308711|12102250|FG001|Overall Study|Subject incarcerated, data not allowed|0
7684346|NCT00308711|12102251|FG002|Overall Study|Subject incarcerated, data not allowed|1
7684347|NCT00308737|12102262|FG000|Overall Study|Adverse Event|104
7684348|NCT00308737|12102263|FG001|Overall Study|Adverse Event|9
7684349|NCT00308737|12102264|FG002|Overall Study|Adverse Event|0
7684350|NCT00308737|12102262|FG000|Overall Study|Death|4
7684351|NCT00308737|12102263|FG001|Overall Study|Death|3
7684352|NCT00308737|12102264|FG002|Overall Study|Death|0
7684353|NCT00308737|12102262|FG000|Overall Study|Lost to Follow-up|56
7684354|NCT00308737|12102263|FG001|Overall Study|Lost to Follow-up|80
7684355|NCT00308737|12102264|FG002|Overall Study|Lost to Follow-up|5
7684356|NCT00308737|12102262|FG000|Overall Study|Physician Decision|15
7684357|NCT00308737|12102263|FG001|Overall Study|Physician Decision|2
7684358|NCT00308737|12102264|FG002|Overall Study|Physician Decision|1
7684359|NCT00308737|12102262|FG000|Overall Study|Protocol Violation|34
7684360|NCT00308737|12102263|FG001|Overall Study|Protocol Violation|9
7684361|NCT00308737|12102264|FG002|Overall Study|Protocol Violation|5
7684362|NCT00308737|12102262|FG000|Overall Study|Withdrawal by Subject|218
7684363|NCT00308737|12102263|FG001|Overall Study|Withdrawal by Subject|166
7684364|NCT00308737|12102264|FG002|Overall Study|Withdrawal by Subject|18
7684365|NCT00308737|12102262|FG000|Overall Study|Various|32
7684366|NCT00308737|12102263|FG001|Overall Study|Various|20
7684367|NCT00308737|12102264|FG002|Overall Study|Various|8
7684368|NCT00308750|12102275|FG000|Overall Study|Adverse Event|9
7684369|NCT00308750|12102276|FG001|Overall Study|Adverse Event|9
7684370|NCT00308750|12102277|FG002|Overall Study|Adverse Event|13
7684371|NCT00308750|12102275|FG000|Overall Study|Withdrawal by Subject|6
7684372|NCT00308750|12102276|FG001|Overall Study|Withdrawal by Subject|2
7684373|NCT00308750|12102277|FG002|Overall Study|Withdrawal by Subject|3
7684374|NCT00308750|12102275|FG000|Overall Study|Physician Decision|3
7684375|NCT00308750|12102276|FG001|Overall Study|Physician Decision|4
7684376|NCT00308750|12102277|FG002|Overall Study|Physician Decision|3
7684377|NCT00308750|12102275|FG000|Overall Study|Sponsor Decision|1
7684378|NCT00308750|12102276|FG001|Overall Study|Sponsor Decision|0
7684379|NCT00308750|12102277|FG002|Overall Study|Sponsor Decision|0
7684380|NCT00308750|12102275|FG000|Overall Study|Disease Progression|47
7684381|NCT00308750|12102276|FG001|Overall Study|Disease Progression|24
7684382|NCT00308750|12102277|FG002|Overall Study|Disease Progression|28
7684383|NCT00308750|12102275|FG000|Overall Study|Unrelated Complication|3
7684384|NCT00308750|12102276|FG001|Overall Study|Unrelated Complication|0
7684385|NCT00308750|12102277|FG002|Overall Study|Unrelated Complication|1
7684386|NCT00308750|12102275|FG000|Overall Study|Death|1
7684387|NCT00308750|12102276|FG001|Overall Study|Death|0
7684388|NCT00308750|12102277|FG002|Overall Study|Death|1
7684389|NCT00308750|12102275|FG000|Overall Study|Protocol Violation|1
7684390|NCT00308750|12102276|FG001|Overall Study|Protocol Violation|0
7684391|NCT00308750|12102277|FG002|Overall Study|Protocol Violation|0
7684392|NCT00308750|12102275|FG000|Overall Study|New Primary Disease Identified|1
7684393|NCT00308750|12102276|FG001|Overall Study|New Primary Disease Identified|1
7684394|NCT00308750|12102277|FG002|Overall Study|New Primary Disease Identified|0
7684395|NCT00308997|12102288|FG000|Overall Study|Subject feigned clinical data|0
7684396|NCT00308997|12102289|FG001|Overall Study|Subject feigned clinical data|1
7684397|NCT00308997|12102288|FG000|Overall Study|Unable to tolerate intervention|1
7684398|NCT00308997|12102289|FG001|Overall Study|Unable to tolerate intervention|0
7684399|NCT00309166|12102301|FG000|Overall Study|Adverse event, non-fatal|1
7684402|NCT00309166|12102302|FG001|Overall Study|Withdrawal by Subject|3
7684403|NCT00309244|12102310|FG000|Overall Study|Adverse Event|29
7684404|NCT00309244|12102311|FG001|Overall Study|Adverse Event|12
7684405|NCT00309244|12102310|FG000|Overall Study|Lost to Follow-up|6
7684406|NCT00309244|12102311|FG001|Overall Study|Lost to Follow-up|22
7684407|NCT00309244|12102310|FG000|Overall Study|Physician Decision|5
7684408|NCT00309244|12102311|FG001|Overall Study|Physician Decision|8
7684409|NCT00309244|12102310|FG000|Overall Study|Protocol Violation|6
7684410|NCT00309244|12102311|FG001|Overall Study|Protocol Violation|3
7684411|NCT00309244|12102310|FG000|Overall Study|Withdrawal by Subject|50
7684412|NCT00309244|12102311|FG001|Overall Study|Withdrawal by Subject|32
7684413|NCT00309244|12102310|FG000|Overall Study|Various|7
7684414|NCT00309244|12102311|FG001|Overall Study|Various|7
7684415|NCT00309244|12102310|FG000|Overall Study|Randomized but not dosed|11
7684416|NCT00309244|12102311|FG001|Overall Study|Randomized but not dosed|12
7684417|NCT00309244|12102310|FG000|Overall Study|Death|4
7684418|NCT00309244|12102311|FG001|Overall Study|Death|1
7684419|NCT00309387|12102319|FG000|Overall Study|Death|72
7684420|NCT00309387|12102320|FG001|Overall Study|Death|73
7684421|NCT00309387|12102319|FG000|Overall Study|Lost to Follow-up|70
7684422|NCT00309387|12102320|FG001|Overall Study|Lost to Follow-up|86
7684423|NCT00309452|12102329|FG000|Overall Study|Withdrawal by Subject|3
7684424|NCT00309452|12102330|FG001|Overall Study|Withdrawal by Subject|0
7684425|NCT00309608|12102366|FG000|Overall Study|Adverse Event|1
7684426|NCT00309608|12102367|FG001|Overall Study|Adverse Event|5
7684427|NCT00309608|12102368|FG002|Overall Study|Adverse Event|3
7684428|NCT00309608|12102369|FG003|Overall Study|Adverse Event|2
7684429|NCT00309608|12102370|FG004|Overall Study|Adverse Event|3
7684430|NCT00309608|12102366|FG000|Overall Study|Protocol Violation|2
7684431|NCT00309608|12102367|FG001|Overall Study|Protocol Violation|0
7684432|NCT00309608|12102368|FG002|Overall Study|Protocol Violation|0
7684433|NCT00309608|12102369|FG003|Overall Study|Protocol Violation|0
7684434|NCT00309608|12102370|FG004|Overall Study|Protocol Violation|0
7684435|NCT00309608|12102366|FG000|Overall Study|Lost to Follow-up|0
7684436|NCT00309608|12102367|FG001|Overall Study|Lost to Follow-up|0
7684437|NCT00309608|12102368|FG002|Overall Study|Lost to Follow-up|2
7684438|NCT00309608|12102369|FG003|Overall Study|Lost to Follow-up|0
7684439|NCT00309608|12102370|FG004|Overall Study|Lost to Follow-up|1
7684440|NCT00309608|12102366|FG000|Overall Study|Withdrawal by Subject|1
7684441|NCT00309608|12102367|FG001|Overall Study|Withdrawal by Subject|4
7684442|NCT00309608|12102368|FG002|Overall Study|Withdrawal by Subject|2
7684443|NCT00309608|12102369|FG003|Overall Study|Withdrawal by Subject|0
7684444|NCT00309608|12102370|FG004|Overall Study|Withdrawal by Subject|0
7684445|NCT00309608|12102366|FG000|Overall Study|Other incl. Lack of efficacy|10
7684446|NCT00309608|12102367|FG001|Overall Study|Other incl. Lack of efficacy|4
7684447|NCT00309608|12102368|FG002|Overall Study|Other incl. Lack of efficacy|3
7684448|NCT00309608|12102369|FG003|Overall Study|Other incl. Lack of efficacy|4
7684449|NCT00309608|12102370|FG004|Overall Study|Other incl. Lack of efficacy|0
7684450|NCT00309777|12102404|FG000|Overall Study|Adverse Event|13
7684451|NCT00309777|12102405|FG001|Overall Study|Adverse Event|2
7684452|NCT00309777|12102406|FG002|Overall Study|Adverse Event|8
7684453|NCT00309777|12102407|FG003|Overall Study|Adverse Event|1
7684454|NCT00309777|12102404|FG000|Overall Study|Protocol Violation|4
7684455|NCT00309777|12102405|FG001|Overall Study|Protocol Violation|1
7684456|NCT00309777|12102406|FG002|Overall Study|Protocol Violation|3
7684457|NCT00309777|12102407|FG003|Overall Study|Protocol Violation|1
7684458|NCT00309777|12102404|FG000|Overall Study|Withdrawal by Subject|6
7684459|NCT00309777|12102405|FG001|Overall Study|Withdrawal by Subject|5
7684460|NCT00309777|12102406|FG002|Overall Study|Withdrawal by Subject|7
7684461|NCT00309777|12102407|FG003|Overall Study|Withdrawal by Subject|2
7684462|NCT00309777|12102404|FG000|Overall Study|Lost to Follow-up|0
7684463|NCT00309777|12102405|FG001|Overall Study|Lost to Follow-up|0
7684464|NCT00309777|12102406|FG002|Overall Study|Lost to Follow-up|1
7684465|NCT00309777|12102407|FG003|Overall Study|Lost to Follow-up|0
7684466|NCT00309777|12102404|FG000|Overall Study|Death|0
7684467|NCT00309777|12102405|FG001|Overall Study|Death|1
7684468|NCT00309777|12102406|FG002|Overall Study|Death|0
7684469|NCT00309777|12102407|FG003|Overall Study|Death|0
7684470|NCT00309842|12102417|FG000|Overall Study|Lost to Follow-up|1
7684471|NCT00309907|12102421|FG000|Overall Study|Death|4
7684472|NCT00309907|12102421|FG000|Overall Study|Physician Decision|1
7684473|NCT00309907|12102421|FG000|Overall Study|Ineligible|11
7684474|NCT00309907|12102421|FG000|Overall Study|Major infectious event|4
7684475|NCT00309946|12102426|FG000|Overall Study|Withdrawal by Subject|1
7684476|NCT00309959|12102430|FG000|Overall Study|Ineligible - no prior chemotherapy|2
7684477|NCT00310037|12102441|FG000|Overall Study|Adverse Event|7
7684478|NCT00310037|12102442|FG001|Overall Study|Adverse Event|14
7684479|NCT00310037|12102441|FG000|Overall Study|Withdrawal by Subject|4
7684480|NCT00310037|12102442|FG001|Overall Study|Withdrawal by Subject|3
7684481|NCT00310037|12102441|FG000|Overall Study|Progression|6
7684482|NCT00310037|12102442|FG001|Overall Study|Progression|0
7684483|NCT00310037|12102441|FG000|Overall Study|Non-protocol treatment|1
7684484|NCT00310037|12102442|FG001|Overall Study|Non-protocol treatment|0
7684485|NCT00310375|12102486|FG000|Primary Reporting Phase|Adverse Event|28
7684486|NCT00310375|12102487|FG001|Primary Reporting Phase|Adverse Event|22
7684487|NCT00310375|12102488|FG002|Primary Reporting Phase|Adverse Event|0
7684488|NCT00310375|12102486|FG000|Primary Reporting Phase|Lack of Efficacy|24
7684489|NCT00310375|12102487|FG001|Primary Reporting Phase|Lack of Efficacy|19
7684490|NCT00310375|12102488|FG002|Primary Reporting Phase|Lack of Efficacy|0
7684491|NCT00310375|12102486|FG000|Primary Reporting Phase|Pregnancy|2
7684492|NCT00310375|12102487|FG001|Primary Reporting Phase|Pregnancy|2
7684493|NCT00310375|12102488|FG002|Primary Reporting Phase|Pregnancy|0
7684494|NCT00310375|12102486|FG000|Primary Reporting Phase|Withdrawal by Subject|10
7684495|NCT00310375|12102487|FG001|Primary Reporting Phase|Withdrawal by Subject|7
7684496|NCT00310375|12102488|FG002|Primary Reporting Phase|Withdrawal by Subject|0
7684497|NCT00310375|12102486|FG000|Primary Reporting Phase|Protocol Violation|8
7684498|NCT00310375|12102487|FG001|Primary Reporting Phase|Protocol Violation|5
7684499|NCT00310375|12102488|FG002|Primary Reporting Phase|Protocol Violation|0
7684500|NCT00310375|12102486|FG000|Primary Reporting Phase|Change in Par medical condition|2
7684501|NCT00310375|12102487|FG001|Primary Reporting Phase|Change in Par medical condition|0
7684502|NCT00310375|12102488|FG002|Primary Reporting Phase|Change in Par medical condition|0
7684503|NCT00310375|12102486|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
7684504|NCT00310375|12102487|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
7684505|NCT00310375|12102488|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
7684506|NCT00310375|12102486|FG000|Primary Reporting Phase|Physician Decision|5
7684507|NCT00310375|12102487|FG001|Primary Reporting Phase|Physician Decision|3
7684508|NCT00310375|12102488|FG002|Primary Reporting Phase|Physician Decision|0
7684509|NCT00310375|12102486|FG000|Primary Reporting Phase|Request of the sponsor|2
7684510|NCT00310375|12102487|FG001|Primary Reporting Phase|Request of the sponsor|2
7684511|NCT00310375|12102488|FG002|Primary Reporting Phase|Request of the sponsor|0
7684512|NCT00310375|12102486|FG000|Primary Reporting Phase|Failed to return|1
7684513|NCT00310375|12102487|FG001|Primary Reporting Phase|Failed to return|3
7684514|NCT00310375|12102488|FG002|Primary Reporting Phase|Failed to return|0
7684515|NCT00310375|12102486|FG000|Primary Reporting Phase|Participant request unrelated to study|1
7684516|NCT00310375|12102487|FG001|Primary Reporting Phase|Participant request unrelated to study|2
7684517|NCT00310375|12102488|FG002|Primary Reporting Phase|Participant request unrelated to study|0
7684518|NCT00310375|12102486|FG000|Primary Reporting Phase|Going for temporal lobectomy|1
7684519|NCT00310375|12102487|FG001|Primary Reporting Phase|Going for temporal lobectomy|0
7684520|NCT00310375|12102488|FG002|Primary Reporting Phase|Going for temporal lobectomy|0
7684521|NCT00310375|12102486|FG000|Primary Reporting Phase|Missed study drug >5 days|1
7684522|NCT00310375|12102487|FG001|Primary Reporting Phase|Missed study drug >5 days|0
7684523|NCT00310375|12102488|FG002|Primary Reporting Phase|Missed study drug >5 days|0
7684524|NCT00310375|12102486|FG000|Primary Reporting Phase|Site closure|3
7684525|NCT00310375|12102487|FG001|Primary Reporting Phase|Site closure|0
7684526|NCT00310375|12102488|FG002|Primary Reporting Phase|Site closure|0
7684527|NCT00310375|12102486|FG000|Primary Reporting Phase|Missed study drug for 2 months|1
7684528|NCT00310375|12102487|FG001|Primary Reporting Phase|Missed study drug for 2 months|0
7684529|NCT00310375|12102488|FG002|Primary Reporting Phase|Missed study drug for 2 months|0
7684530|NCT00310375|12102486|FG000|Primary Reporting Phase|Par. switched to commercial product|0
7684531|NCT00310375|12102487|FG001|Primary Reporting Phase|Par. switched to commercial product|1
7684532|NCT00310375|12102488|FG002|Primary Reporting Phase|Par. switched to commercial product|0
7684533|NCT00310375|12102486|FG000|Primary Reporting Phase|Request of Ethics Committee|0
7684534|NCT00310375|12102487|FG001|Primary Reporting Phase|Request of Ethics Committee|1
7684535|NCT00310375|12102488|FG002|Primary Reporting Phase|Request of Ethics Committee|0
7684536|NCT00310375|12102486|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0
7684537|NCT00310375|12102487|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0
7684538|NCT00310375|12102488|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1
7684539|NCT00310440|12102519|FG000|Overall Study|Lost to Follow-up|17
7684540|NCT00310440|12102520|FG001|Overall Study|Lost to Follow-up|8
7684541|NCT00310440|12102519|FG000|Overall Study|Withdrawal by Subject|2
7684542|NCT00310440|12102520|FG001|Overall Study|Withdrawal by Subject|1
7684543|NCT00310440|12102519|FG000|Overall Study|Missed 12 Month Visit|7
7684544|NCT00310440|12102520|FG001|Overall Study|Missed 12 Month Visit|4
7684545|NCT00310804|12102546|FG000|Overall Study|Lost to Follow-up|2
7684546|NCT00310804|12102547|FG001|Overall Study|Lost to Follow-up|0
7684547|NCT00310804|12102546|FG000|Overall Study|Withdrawal by Subject|3
7684548|NCT00310804|12102547|FG001|Overall Study|Withdrawal by Subject|0
7684549|NCT00310817|12102571|FG000|Overall Study|AE or Death|3
7684550|NCT00310817|12102572|FG001|Overall Study|AE or Death|1
7684551|NCT00310817|12102573|FG002|Overall Study|AE or Death|0
7684552|NCT00310817|12102574|FG003|Overall Study|AE or Death|0
7684553|NCT00310817|12102571|FG000|Overall Study|Withdrawal by Subject|1
7684554|NCT00310817|12102572|FG001|Overall Study|Withdrawal by Subject|4
7684555|NCT00310817|12102573|FG002|Overall Study|Withdrawal by Subject|6
7684556|NCT00310817|12102574|FG003|Overall Study|Withdrawal by Subject|7
7684557|NCT00310817|12102571|FG000|Overall Study|Lost to Follow-up|2
7684558|NCT00310817|12102572|FG001|Overall Study|Lost to Follow-up|1
7684559|NCT00310817|12102573|FG002|Overall Study|Lost to Follow-up|0
7684560|NCT00310817|12102574|FG003|Overall Study|Lost to Follow-up|0
7684561|NCT00310817|12102571|FG000|Overall Study|Inappropriate Enrollment|1
7684562|NCT00310817|12102572|FG001|Overall Study|Inappropriate Enrollment|0
7684563|NCT00310817|12102573|FG002|Overall Study|Inappropriate Enrollment|1
7684564|NCT00310817|12102574|FG003|Overall Study|Inappropriate Enrollment|0
7684565|NCT00310817|12102571|FG000|Overall Study|Protocol Violation|1
7684566|NCT00310817|12102572|FG001|Overall Study|Protocol Violation|1
7684567|NCT00310817|12102573|FG002|Overall Study|Protocol Violation|1
7684568|NCT00310817|12102574|FG003|Overall Study|Protocol Violation|1
7684569|NCT00310817|12102571|FG000|Overall Study|Unable to classify|3
7684570|NCT00310817|12102572|FG001|Overall Study|Unable to classify|1
7684571|NCT00310817|12102573|FG002|Overall Study|Unable to classify|0
7684572|NCT00310817|12102574|FG003|Overall Study|Unable to classify|0
7684573|NCT00310856|12102620|FG000|Overall Study|Withdrawal by Subject|2
7684574|NCT00310856|12102621|FG001|Overall Study|Withdrawal by Subject|2
7684575|NCT00310856|12102622|FG002|Overall Study|Withdrawal by Subject|2
7684576|NCT00310856|12102620|FG000|Overall Study|Lost to Follow-up|1
7684577|NCT00310856|12102621|FG001|Overall Study|Lost to Follow-up|2
7684578|NCT00310856|12102622|FG002|Overall Study|Lost to Follow-up|6
7684579|NCT00310856|12102620|FG000|Overall Study|Inappropriate enrollment|1
7684580|NCT00310856|12102621|FG001|Overall Study|Inappropriate enrollment|1
7684581|NCT00310856|12102622|FG002|Overall Study|Inappropriate enrollment|0
7684582|NCT00310856|12102620|FG000|Overall Study|Unable to classify|1
7684583|NCT00310856|12102621|FG001|Overall Study|Unable to classify|0
7684584|NCT00310856|12102622|FG002|Overall Study|Unable to classify|0
7684585|NCT00311155|12102631|FG000|Overall Study|Adverse Event|21
7684586|NCT00311155|12102631|FG000|Overall Study|Withdrawal by Subject|17
7684587|NCT00311155|12102631|FG000|Overall Study|Did not meet entry criteria|55
7684588|NCT00311168|12102637|FG000|First Intervention|Withdrawal by Subject|2
7684589|NCT00311168|12102638|FG001|First Intervention|Withdrawal by Subject|2
7684590|NCT00311168|12102637|FG000|First Intervention|Lost to Follow-up|1
7684591|NCT00311168|12102638|FG001|First Intervention|Lost to Follow-up|1
7684592|NCT00311168|12102637|FG000|First Intervention|Protocol Violation|1
7684593|NCT00311168|12102638|FG001|First Intervention|Protocol Violation|1
7684594|NCT00311168|12102637|FG000|First Intervention|Adverse Event|1
7684595|NCT00311168|12102638|FG001|First Intervention|Adverse Event|0
7684596|NCT00311168|12102637|FG000|First Intervention|Other|2
7684597|NCT00311168|12102638|FG001|First Intervention|Other|2
7684598|NCT00311168|12102637|FG000|Second Intervention|Lost to Follow-up|9
7684599|NCT00311168|12102638|FG001|Second Intervention|Lost to Follow-up|2
7684600|NCT00311168|12102637|FG000|Second Intervention|Withdrawal by Subject|0
7684601|NCT00311168|12102638|FG001|Second Intervention|Withdrawal by Subject|1
7684602|NCT00311168|12102637|FG000|Second Intervention|Other|1
7684603|NCT00311168|12102638|FG001|Second Intervention|Other|1
7684604|NCT00311181|12102646|FG000|Overall Study|Final DFTs were not obtained|96
7684605|NCT00311311|12102659|FG000|Overall Study|Adverse Event|3
7684606|NCT00311311|12102660|FG001|Overall Study|Adverse Event|2
7684607|NCT00311311|12102659|FG000|Overall Study|Withdrawal by Subject|1
7684608|NCT00311311|12102660|FG001|Overall Study|Withdrawal by Subject|1
7684609|NCT00311311|12102659|FG000|Overall Study|Noncompliance|0
7684610|NCT00311311|12102660|FG001|Overall Study|Noncompliance|1
7684611|NCT00311311|12102659|FG000|Overall Study|Study Termination by Sponsor|3
7684612|NCT00311311|12102660|FG001|Overall Study|Study Termination by Sponsor|4
7684613|NCT00311311|12102659|FG000|Overall Study|Death|1
7684614|NCT00311311|12102660|FG001|Overall Study|Death|0
7684615|NCT00311311|12102659|FG000|Overall Study|Lack of ancillary assistance|0
7684616|NCT00311311|12102660|FG001|Overall Study|Lack of ancillary assistance|1
7684617|NCT00311363|12102669|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42
7684618|NCT00311363|12102670|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0
7684619|NCT00311363|12102671|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0
7684620|NCT00311363|12102669|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
7684621|NCT00311363|12102670|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
7684622|NCT00311363|12102671|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
7684623|NCT00311363|12102669|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
7684624|NCT00311363|12102670|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
7684625|NCT00311363|12102671|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
7684626|NCT00311363|12102669|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
7684627|NCT00311363|12102670|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
7684628|NCT00311363|12102671|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
7684629|NCT00311363|12102669|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8
7684630|NCT00311363|12102670|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0
7684631|NCT00311363|12102671|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0
7684632|NCT00311363|12102669|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1
7684633|NCT00311363|12102670|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0
7684634|NCT00311363|12102671|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0
7684635|NCT00311363|12102669|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
7684636|NCT00311363|12102670|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
7684637|NCT00311363|12102671|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
7684638|NCT00311363|12102669|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1
7684639|NCT00311363|12102670|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0
7684640|NCT00311363|12102671|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0
7684641|NCT00311363|12102669|FG000|24-Week Single-Blind Treatment Period|Death|1
7684642|NCT00311363|12102670|FG001|24-Week Single-Blind Treatment Period|Death|0
7684643|NCT00311363|12102671|FG002|24-Week Single-Blind Treatment Period|Death|0
7684644|NCT00311363|12102669|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0
7684645|NCT00311363|12102670|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3
7684646|NCT00311363|12102671|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0
7684647|NCT00311363|12102669|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
7684648|NCT00311363|12102670|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
7684649|NCT00311363|12102671|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
7684650|NCT00311363|12102669|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
7684651|NCT00311363|12102670|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
7684652|NCT00311363|12102671|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
7684653|NCT00311363|12102669|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
7684654|NCT00311363|12102670|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
7684655|NCT00311363|12102671|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
7684656|NCT00311363|12102669|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0
7684657|NCT00311363|12102670|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1
7684658|NCT00311363|12102671|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2
7684659|NCT00311363|12102669|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
7684660|NCT00311363|12102670|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
7684661|NCT00311363|12102671|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
7684662|NCT00311402|12102696|FG000|Overall Study|Adverse Event|118
7684663|NCT00311402|12102697|FG001|Overall Study|Adverse Event|105
7684664|NCT00311402|12102696|FG000|Overall Study|Lost to Follow-up|0
7684665|NCT00311402|12102697|FG001|Overall Study|Lost to Follow-up|3
7684666|NCT00311402|12102696|FG000|Overall Study|Withdrawal by Subject|17
7684667|NCT00311402|12102697|FG001|Overall Study|Withdrawal by Subject|18
7684668|NCT00311402|12102696|FG000|Overall Study|Lack of Efficacy|58
7684669|NCT00311402|12102697|FG001|Overall Study|Lack of Efficacy|42
7684670|NCT00311402|12102696|FG000|Overall Study|Protocol Violation|7
7684671|NCT00311402|12102697|FG001|Overall Study|Protocol Violation|6
7684672|NCT00311402|12102696|FG000|Overall Study|IRB's rejection etc.|10
7684673|NCT00311402|12102697|FG001|Overall Study|IRB's rejection etc.|3
7684674|NCT00311584|12102705|FG000|Overall Study|Death|1
7684675|NCT00311584|12102706|FG001|Overall Study|Death|0
7684676|NCT00311584|12102705|FG000|Overall Study|Lack of Efficacy|12
7684677|NCT00311584|12102706|FG001|Overall Study|Lack of Efficacy|15
7684678|NCT00311584|12102705|FG000|Overall Study|Physician Decision|4
7684679|NCT00311584|12102706|FG001|Overall Study|Physician Decision|5
7684680|NCT00311584|12102705|FG000|Overall Study|Withdrawal by Subject|1
7684681|NCT00311584|12102706|FG001|Overall Study|Withdrawal by Subject|1
7684682|NCT00311584|12102705|FG000|Overall Study|ineligible|2
7684683|NCT00311584|12102706|FG001|Overall Study|ineligible|2
7684684|NCT00311623|12102715|FG000|Overall Study|Physician Decision|0
7684685|NCT00311623|12102716|FG001|Overall Study|Physician Decision|0
7684686|NCT00311623|12102717|FG002|Overall Study|Physician Decision|2
7684687|NCT00312195|12102737|FG000|Overall Study|Adverse Event|4
7684688|NCT00312195|12102738|FG001|Overall Study|Adverse Event|6
7684689|NCT00312195|12102737|FG000|Overall Study|Lost to Follow-up|1
7684690|NCT00312195|12102738|FG001|Overall Study|Lost to Follow-up|0
7684691|NCT00312195|12102737|FG000|Overall Study|Protocol Violation|1
7684692|NCT00312195|12102738|FG001|Overall Study|Protocol Violation|0
7684693|NCT00312208|12102748|FG000|Overall Study|Adverse Event|97
7684694|NCT00312208|12102749|FG001|Overall Study|Adverse Event|61
7684695|NCT00312208|12102748|FG000|Overall Study|Protocol Violation|5
7684696|NCT00312208|12102749|FG001|Overall Study|Protocol Violation|3
7684697|NCT00312208|12102748|FG000|Overall Study|Death|2
7684698|NCT00312208|12102749|FG001|Overall Study|Death|1
7684699|NCT00312208|12102748|FG000|Overall Study|Lack of Efficacy|7
7684700|NCT00312208|12102749|FG001|Overall Study|Lack of Efficacy|4
7684701|NCT00312208|12102748|FG000|Overall Study|Lost to Follow-up|3
7684702|NCT00312208|12102749|FG001|Overall Study|Lost to Follow-up|5
7684703|NCT00312208|12102748|FG000|Overall Study|Withdrawal by Subject|53
7684704|NCT00312208|12102749|FG001|Overall Study|Withdrawal by Subject|42
7684705|NCT00312208|12102748|FG000|Overall Study|Other|5
7684706|NCT00312208|12102749|FG001|Overall Study|Other|7
7684707|NCT00312221|12102758|FG000|Open-label Run-in Period|Withdrawal by Subject|6
7684708|NCT00312221|12102759|FG001|Open-label Run-in Period|Withdrawal by Subject|0
7684709|NCT00312221|12102760|FG002|Open-label Run-in Period|Withdrawal by Subject|0
7684710|NCT00312221|12102761|FG003|Open-label Run-in Period|Withdrawal by Subject|0
7684711|NCT00312221|12102758|FG000|Open-label Run-in Period|Adverse Event|74
7684712|NCT00312221|12102759|FG001|Open-label Run-in Period|Adverse Event|0
7684713|NCT00312221|12102760|FG002|Open-label Run-in Period|Adverse Event|0
7684714|NCT00312221|12102761|FG003|Open-label Run-in Period|Adverse Event|0
7684715|NCT00312221|12102758|FG000|Open-label Run-in Period|Lost to Follow-up|5
7684716|NCT00312221|12102759|FG001|Open-label Run-in Period|Lost to Follow-up|0
7684717|NCT00312221|12102760|FG002|Open-label Run-in Period|Lost to Follow-up|0
7684718|NCT00312221|12102761|FG003|Open-label Run-in Period|Lost to Follow-up|0
7684719|NCT00312221|12102758|FG000|Open-label Run-in Period|Administrative|42
7684720|NCT00312221|12102759|FG001|Open-label Run-in Period|Administrative|0
7684721|NCT00312221|12102760|FG002|Open-label Run-in Period|Administrative|0
7684722|NCT00312221|12102761|FG003|Open-label Run-in Period|Administrative|0
7684723|NCT00312221|12102758|FG000|Open-label Run-in Period|Lack of Efficacy|102
7684724|NCT00312221|12102759|FG001|Open-label Run-in Period|Lack of Efficacy|0
7684725|NCT00312221|12102760|FG002|Open-label Run-in Period|Lack of Efficacy|0
7684726|NCT00312221|12102761|FG003|Open-label Run-in Period|Lack of Efficacy|0
7684727|NCT00312221|12102758|FG000|Open-label Run-in Period|Did not qualify|5
7684728|NCT00312221|12102759|FG001|Open-label Run-in Period|Did not qualify|0
7684729|NCT00312221|12102760|FG002|Open-label Run-in Period|Did not qualify|0
7684730|NCT00312221|12102761|FG003|Open-label Run-in Period|Did not qualify|0
7684731|NCT00312221|12102758|FG000|Double-blind Phase|Withdrawal by Subject|0
7684732|NCT00312221|12102759|FG001|Double-blind Phase|Withdrawal by Subject|6
7684733|NCT00312221|12102760|FG002|Double-blind Phase|Withdrawal by Subject|8
7684734|NCT00312221|12102761|FG003|Double-blind Phase|Withdrawal by Subject|7
7684735|NCT00312221|12102758|FG000|Double-blind Phase|Adverse Event|0
7684736|NCT00312221|12102759|FG001|Double-blind Phase|Adverse Event|10
7684737|NCT00312221|12102760|FG002|Double-blind Phase|Adverse Event|19
7684738|NCT00312221|12102761|FG003|Double-blind Phase|Adverse Event|18
7684739|NCT00312221|12102758|FG000|Double-blind Phase|Lost to Follow-up|0
7684740|NCT00312221|12102759|FG001|Double-blind Phase|Lost to Follow-up|0
7684741|NCT00312221|12102760|FG002|Double-blind Phase|Lost to Follow-up|2
7684742|NCT00312221|12102761|FG003|Double-blind Phase|Lost to Follow-up|2
7684743|NCT00312221|12102758|FG000|Double-blind Phase|Administrative|0
7684744|NCT00312221|12102759|FG001|Double-blind Phase|Administrative|26
7684745|NCT00312221|12102760|FG002|Double-blind Phase|Administrative|37
7684746|NCT00312221|12102761|FG003|Double-blind Phase|Administrative|33
7684747|NCT00312221|12102758|FG000|Double-blind Phase|Lack of Efficacy|0
7684748|NCT00312221|12102759|FG001|Double-blind Phase|Lack of Efficacy|17
7684749|NCT00312221|12102760|FG002|Double-blind Phase|Lack of Efficacy|6
7684750|NCT00312221|12102761|FG003|Double-blind Phase|Lack of Efficacy|10
7684751|NCT00312338|12102772|FG000|Overall Study|Adverse Event|7
7684752|NCT00312338|12102773|FG001|Overall Study|Adverse Event|2
7684753|NCT00312338|12102772|FG000|Overall Study|Lost to Follow-up|9
7684754|NCT00312338|12102773|FG001|Overall Study|Lost to Follow-up|1
7684755|NCT00312338|12102772|FG000|Overall Study|Withdrawal by Subject|4
7684756|NCT00312338|12102773|FG001|Overall Study|Withdrawal by Subject|0
7684757|NCT00312338|12102772|FG000|Overall Study|Subsequent infection|2
7684758|NCT00312338|12102773|FG001|Overall Study|Subsequent infection|0
7684759|NCT00312377|12102781|FG000|Overall Study|Death|403
7684760|NCT00312377|12102782|FG001|Overall Study|Death|418
7684761|NCT00312377|12102781|FG000|Overall Study|Withdrawal by Subject|23
7684762|NCT00312377|12102782|FG001|Overall Study|Withdrawal by Subject|30
7684763|NCT00312377|12102781|FG000|Overall Study|Lost to Follow-up|9
7684764|NCT00312377|12102782|FG001|Overall Study|Lost to Follow-up|12
7684765|NCT00312377|12102781|FG000|Overall Study|Non-compliance|0
7684766|NCT00312377|12102782|FG001|Overall Study|Non-compliance|2
7684767|NCT00312377|12102781|FG000|Overall Study|Randomised but never received treatment|6
7684768|NCT00312377|12102782|FG001|Overall Study|Randomised but never received treatment|6
7684769|NCT00312377|12102781|FG000|Overall Study|Discontinue treatment survival follow up|202
7684770|NCT00312377|12102782|FG001|Overall Study|Discontinue treatment survival follow up|200
7684771|NCT00312377|12102781|FG000|Overall Study|Site ended participation in study|1
7684772|NCT00312377|12102782|FG001|Overall Study|Site ended participation in study|0
7684773|NCT00312494|12102791|FG000|Overall Study|Randomized; not treated with study drug|9
7684774|NCT00312494|12102792|FG001|Overall Study|Randomized; not treated with study drug|10
7684775|NCT00312494|12102793|FG002|Overall Study|Randomized; not treated with study drug|5
7684776|NCT00312494|12102791|FG000|Overall Study|Adverse Event|33
7684777|NCT00312494|12102792|FG001|Overall Study|Adverse Event|15
7684778|NCT00312494|12102793|FG002|Overall Study|Adverse Event|11
7684779|NCT00312494|12102791|FG000|Overall Study|Lack of Efficacy|4
7684780|NCT00312494|12102792|FG001|Overall Study|Lack of Efficacy|6
7684781|NCT00312494|12102793|FG002|Overall Study|Lack of Efficacy|8
7684782|NCT00312494|12102791|FG000|Overall Study|Laboratory abnormality|1
7684783|NCT00312494|12102792|FG001|Overall Study|Laboratory abnormality|0
7684784|NCT00312494|12102793|FG002|Overall Study|Laboratory abnormality|0
7684785|NCT00312494|12102791|FG000|Overall Study|Lost to Follow-up|8
7684786|NCT00312494|12102792|FG001|Overall Study|Lost to Follow-up|8
7684787|NCT00312494|12102793|FG002|Overall Study|Lost to Follow-up|8
7684788|NCT00312494|12102791|FG000|Overall Study|Withdrawal by Subject|6
7684789|NCT00312494|12102792|FG001|Overall Study|Withdrawal by Subject|9
7684790|NCT00312494|12102793|FG002|Overall Study|Withdrawal by Subject|10
7684791|NCT00312494|12102791|FG000|Overall Study|Other|10
7684792|NCT00312494|12102792|FG001|Overall Study|Other|10
7684793|NCT00312494|12102793|FG002|Overall Study|Other|1
7684794|NCT00312572|12102803|FG000|Overall Study|Adverse Event|10
7684795|NCT00312572|12102804|FG001|Overall Study|Adverse Event|16
7684796|NCT00312572|12102803|FG000|Overall Study|Lost to Follow-up|1
7684797|NCT00312572|12102804|FG001|Overall Study|Lost to Follow-up|1
7684798|NCT00312572|12102803|FG000|Overall Study|Administrative|4
7684799|NCT00312572|12102804|FG001|Overall Study|Administrative|2
7684800|NCT00312572|12102803|FG000|Overall Study|Lack of Efficacy|1
7684801|NCT00312572|12102804|FG001|Overall Study|Lack of Efficacy|2
7684802|NCT00312663|12102815|FG000|Immunization Phase|Adverse Event|0
7684803|NCT00312663|12102816|FG001|Immunization Phase|Adverse Event|1
7684804|NCT00312663|12102817|FG002|Immunization Phase|Adverse Event|0
7684805|NCT00312702|12102829|FG000|Immunization Phase|Lost to Follow-up|0
7684806|NCT00312702|12102830|FG001|Immunization Phase|Lost to Follow-up|1
7684807|NCT00312702|12102831|FG002|Immunization Phase|Lost to Follow-up|0
7684808|NCT00312728|12102839|FG000|Overall Study|Progressive disease|53
7684809|NCT00312728|12102839|FG000|Overall Study|Adverse Event|32
7684810|NCT00312728|12102839|FG000|Overall Study|Withdrawal by Subject|10
7684811|NCT00312728|12102839|FG000|Overall Study|Required non-protocol cancer treatment|2
7684812|NCT00312728|12102839|FG000|Overall Study|Protocol Violation|2
7684813|NCT00312728|12102839|FG000|Overall Study|Other|10
7684814|NCT00312728|12102839|FG000|Overall Study|Other|1
7684815|NCT00312845|12102845|FG000|Overall Study|Adverse Event|19
7684816|NCT00312845|12102846|FG001|Overall Study|Adverse Event|5
7684817|NCT00312845|12102845|FG000|Overall Study|Death|2
7684818|NCT00312845|12102846|FG001|Overall Study|Death|2
7684819|NCT00312845|12102845|FG000|Overall Study|Withdrawal by Subject|14
7684820|NCT00312845|12102846|FG001|Overall Study|Withdrawal by Subject|6
7684821|NCT00312845|12102845|FG000|Overall Study|Disease Progression|56
7684822|NCT00312845|12102846|FG001|Overall Study|Disease Progression|77
7684823|NCT00312845|12102845|FG000|Overall Study|Lost to Follow-up|2
7684824|NCT00312845|12102846|FG001|Overall Study|Lost to Follow-up|0
7684825|NCT00312845|12102845|FG000|Overall Study|Other|6
7684826|NCT00312845|12102846|FG001|Overall Study|Other|5
7684827|NCT00312858|12102854|FG000|Overall Study|Adverse Event|0
7684828|NCT00312858|12102855|FG001|Overall Study|Adverse Event|1
7684829|NCT00312858|12102854|FG000|Overall Study|Lost to Follow-up|25
7684830|NCT00312858|12102855|FG001|Overall Study|Lost to Follow-up|42
7684831|NCT00312858|12102854|FG000|Overall Study|Protocol Violation|3
7684832|NCT00312858|12102855|FG001|Overall Study|Protocol Violation|8
7684833|NCT00312858|12102854|FG000|Overall Study|Withdraw by Participant|20
7684834|NCT00312858|12102855|FG001|Overall Study|Withdraw by Participant|20
7684835|NCT00312858|12102854|FG000|Overall Study|Participant Moved|11
7684836|NCT00312858|12102855|FG001|Overall Study|Participant Moved|10
7684837|NCT00312858|12102854|FG000|Overall Study|Other|9
7684838|NCT00312858|12102855|FG001|Overall Study|Other|12
7684839|NCT00312897|12102872|FG000|Overall Study|Adverse Event|1
7684840|NCT00312897|12102873|FG001|Overall Study|Adverse Event|0
7684841|NCT00312897|12102872|FG000|Overall Study|Lost to Follow-up|2
7684842|NCT00312897|12102873|FG001|Overall Study|Lost to Follow-up|0
7684843|NCT00312897|12102872|FG000|Overall Study|Physician Decision|1
7684844|NCT00312897|12102873|FG001|Overall Study|Physician Decision|0
7684845|NCT00312897|12102872|FG000|Overall Study|Withdrawal by Subject|1
7684846|NCT00312897|12102873|FG001|Overall Study|Withdrawal by Subject|3
7684847|NCT00312897|12102872|FG000|Overall Study|Pregnancy|1
7684848|NCT00312897|12102873|FG001|Overall Study|Pregnancy|0
7684849|NCT00312897|12102872|FG000|Overall Study|discontinued prior to getting treatment|0
7684850|NCT00312897|12102873|FG001|Overall Study|discontinued prior to getting treatment|3
7684851|NCT00313014|12102891|FG000|Overall Study|Withdrawal by Subject|11
7684852|NCT00313014|12102892|FG001|Overall Study|Withdrawal by Subject|7
7684853|NCT00313014|12102893|FG002|Overall Study|Withdrawal by Subject|5
7684854|NCT00313014|12102891|FG000|Overall Study|Adverse Event|14
7684855|NCT00313014|12102892|FG001|Overall Study|Adverse Event|29
7684856|NCT00313014|12102893|FG002|Overall Study|Adverse Event|16
7684857|NCT00313014|12102891|FG000|Overall Study|Lost to Follow-up|7
7684858|NCT00313014|12102892|FG001|Overall Study|Lost to Follow-up|6
7684859|NCT00313014|12102893|FG002|Overall Study|Lost to Follow-up|10
7684860|NCT00313014|12102891|FG000|Overall Study|Administrative|9
7684861|NCT00313014|12102892|FG001|Overall Study|Administrative|6
7684862|NCT00313014|12102893|FG002|Overall Study|Administrative|14
7684863|NCT00313014|12102891|FG000|Overall Study|Lack of Efficacy|52
7684864|NCT00313014|12102892|FG001|Overall Study|Lack of Efficacy|25
7684865|NCT00313014|12102893|FG002|Overall Study|Lack of Efficacy|16
7684866|NCT00313144|12102902|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
7684867|NCT00313144|12102902|FG000|Overall Study|Death|7
7684868|NCT00313144|12102902|FG000|Overall Study|Lost to Follow-up|5
7684869|NCT00313144|12102902|FG000|Overall Study|Withdrawal by Subject|4
7684870|NCT00313144|12102902|FG000|Overall Study|Terminated by sponsor/ homecare provider|4
7684871|NCT00313144|12102902|FG000|Overall Study|Physician Decision|4
7684872|NCT00313144|12102902|FG000|Overall Study|Adverse event - transient|5
7684873|NCT00313144|12102902|FG000|Overall Study|Liver transplant|1
7684874|NCT00313144|12102902|FG000|Overall Study|Insurance (homecare provider) change|1
7684875|NCT00313144|12102902|FG000|Overall Study|Change to different product|1
7684876|NCT00313144|12102902|FG000|Overall Study|Due to termination of the study|66
7684877|NCT00313170|12102918|FG000|Overall Study|Death|2
7684878|NCT00313170|12102919|FG001|Overall Study|Death|4
7684879|NCT00313170|12102920|FG002|Overall Study|Death|2
7684880|NCT00313170|12102918|FG000|Overall Study|Adverse Event|1
7684881|NCT00313170|12102919|FG001|Overall Study|Adverse Event|2
7684882|NCT00313170|12102920|FG002|Overall Study|Adverse Event|0
7684883|NCT00313170|12102918|FG000|Overall Study|Disease progression|31
7684884|NCT00313170|12102919|FG001|Overall Study|Disease progression|26
7684885|NCT00313170|12102920|FG002|Overall Study|Disease progression|27
7684886|NCT00313170|12102918|FG000|Overall Study|Withdrawal by Subject|1
7684887|NCT00313170|12102919|FG001|Overall Study|Withdrawal by Subject|0
7684888|NCT00313170|12102920|FG002|Overall Study|Withdrawal by Subject|1
7684889|NCT00313170|12102918|FG000|Overall Study|Incorrect enrollment|0
7684890|NCT00313170|12102919|FG001|Overall Study|Incorrect enrollment|2
7684891|NCT00313170|12102920|FG002|Overall Study|Incorrect enrollment|1
7684892|NCT00313170|12102918|FG000|Overall Study|Lost to Follow-up|0
7684893|NCT00313170|12102919|FG001|Overall Study|Lost to Follow-up|0
7684894|NCT00313170|12102920|FG002|Overall Study|Lost to Follow-up|1
7684895|NCT00313170|12102918|FG000|Overall Study|Progression (investigators opinion)|1
7684896|NCT00313170|12102919|FG001|Overall Study|Progression (investigators opinion)|0
7684897|NCT00313170|12102920|FG002|Overall Study|Progression (investigators opinion)|0
7684898|NCT00313300|12102943|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19
7684899|NCT00313300|12102944|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14
7684900|NCT00313300|12102945|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17
7684901|NCT00313300|12102946|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0
7684902|NCT00313300|12102947|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0
7684903|NCT00313300|12102943|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
7684904|NCT00313300|12102944|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
7684905|NCT00313300|12102945|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
7684906|NCT00313300|12102946|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
7684907|NCT00313300|12102947|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
7684908|NCT00313300|12102943|FG000|Randomized in Phase A (26 Weeks)|Death|3
7684909|NCT00313300|12102944|FG001|Randomized in Phase A (26 Weeks)|Death|4
7684910|NCT00313300|12102945|FG002|Randomized in Phase A (26 Weeks)|Death|0
7684911|NCT00313300|12102946|FG003|Randomized in Phase A (26 Weeks)|Death|0
7684912|NCT00313300|12102947|FG004|Randomized in Phase A (26 Weeks)|Death|0
7684913|NCT00313300|12102943|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
7684914|NCT00313300|12102944|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
7684915|NCT00313300|12102945|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
7684916|NCT00313300|12102946|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
7684917|NCT00313300|12102947|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
7684918|NCT00313300|12102943|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
7684919|NCT00313300|12102944|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
7684920|NCT00313300|12102945|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
7684921|NCT00313300|12102946|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
7684922|NCT00313300|12102947|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
7684923|NCT00313300|12102943|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
7684924|NCT00313300|12102944|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
7684925|NCT00313300|12102945|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
7684926|NCT00313300|12102946|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
7684927|NCT00313300|12102947|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
7684928|NCT00313300|12102943|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
7684929|NCT00313300|12102944|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
7684930|NCT00313300|12102945|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
7684931|NCT00313300|12102946|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
7684932|NCT00313300|12102947|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
7684933|NCT00313300|12102943|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34
7684934|NCT00313300|12102944|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9
7684935|NCT00313300|12102945|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12
7684936|NCT00313300|12102946|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23
7684937|NCT00313300|12102947|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19
7684938|NCT00313300|12102943|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
7684939|NCT00313300|12102944|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
7684940|NCT00313300|12102945|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
7684941|NCT00313300|12102946|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
7684942|NCT00313300|12102947|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
7684943|NCT00313300|12102943|FG000|Randomized in Phase B (26 Weeks)|Death|5
7684944|NCT00313300|12102944|FG001|Randomized in Phase B (26 Weeks)|Death|3
7684945|NCT00313300|12102945|FG002|Randomized in Phase B (26 Weeks)|Death|1
7684946|NCT00313300|12102946|FG003|Randomized in Phase B (26 Weeks)|Death|0
7684947|NCT00313300|12102947|FG004|Randomized in Phase B (26 Weeks)|Death|1
7684948|NCT00313300|12102943|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
7684949|NCT00313300|12102944|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
7684950|NCT00313300|12102945|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
7684951|NCT00313300|12102946|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
7684952|NCT00313300|12102947|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
7684953|NCT00313300|12102943|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
7684954|NCT00313300|12102944|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
7684955|NCT00313300|12102945|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
7684956|NCT00313300|12102946|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
7684957|NCT00313300|12102947|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
7684958|NCT00313300|12102943|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
7684959|NCT00313300|12102944|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
7684960|NCT00313300|12102945|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
7684961|NCT00313300|12102946|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
7684962|NCT00313300|12102947|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
7684963|NCT00313300|12102943|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
7684964|NCT00313300|12102944|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
7684965|NCT00313300|12102945|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
7684966|NCT00313300|12102946|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
7684967|NCT00313300|12102947|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
7684968|NCT00313300|12102943|FG000|Randomized in Phase B (26 Weeks)|non-specified|1
7684969|NCT00313300|12102944|FG001|Randomized in Phase B (26 Weeks)|non-specified|0
7684970|NCT00313300|12102945|FG002|Randomized in Phase B (26 Weeks)|non-specified|0
7684971|NCT00313300|12102946|FG003|Randomized in Phase B (26 Weeks)|non-specified|0
7684972|NCT00313300|12102947|FG004|Randomized in Phase B (26 Weeks)|non-specified|0
7684973|NCT00313300|12102943|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
7684974|NCT00313300|12102944|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
7684975|NCT00313300|12102945|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
7684976|NCT00313300|12102946|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
7684977|NCT00313300|12102947|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
7684978|NCT00313300|12102943|FG000|Follow-Up(30days)-Randomized Phase A|Death|0
7684979|NCT00313300|12102944|FG001|Follow-Up(30days)-Randomized Phase A|Death|1
7684980|NCT00313300|12102945|FG002|Follow-Up(30days)-Randomized Phase A|Death|0
7684981|NCT00313300|12102946|FG003|Follow-Up(30days)-Randomized Phase A|Death|0
7684982|NCT00313300|12102947|FG004|Follow-Up(30days)-Randomized Phase A|Death|0
7684983|NCT00313300|12102943|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
7684984|NCT00313300|12102944|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
7684985|NCT00313300|12102945|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
7684986|NCT00313300|12102946|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
7684987|NCT00313300|12102947|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
7684988|NCT00313300|12102943|FG000|Follow-Up(30days)-Randomized Phase B|Death|1
7684989|NCT00313300|12102944|FG001|Follow-Up(30days)-Randomized Phase B|Death|0
7684990|NCT00313300|12102945|FG002|Follow-Up(30days)-Randomized Phase B|Death|0
7684991|NCT00313300|12102946|FG003|Follow-Up(30days)-Randomized Phase B|Death|0
7684992|NCT00313300|12102947|FG004|Follow-Up(30days)-Randomized Phase B|Death|0
7684993|NCT00313300|12102943|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
7684994|NCT00313300|12102944|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
7684995|NCT00313300|12102945|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
7684996|NCT00313300|12102946|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
7684997|NCT00313300|12102947|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
7684998|NCT00313300|12102943|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
7684999|NCT00313300|12102944|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
7685000|NCT00313300|12102945|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
7685001|NCT00313300|12102946|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
7685002|NCT00313300|12102947|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
7685003|NCT00313313|12102968|FG000|Overall Study|Lack of Efficacy|14
7685004|NCT00313313|12102969|FG001|Overall Study|Lack of Efficacy|9
7685005|NCT00313313|12102970|FG002|Overall Study|Lack of Efficacy|20
7685006|NCT00313313|12102968|FG000|Overall Study|Withdrawal of consent by subject|18
7685007|NCT00313313|12102969|FG001|Overall Study|Withdrawal of consent by subject|17
7685008|NCT00313313|12102970|FG002|Overall Study|Withdrawal of consent by subject|31
7685009|NCT00313313|12102968|FG000|Overall Study|Lost to Follow-up|10
7685010|NCT00313313|12102969|FG001|Overall Study|Lost to Follow-up|7
7685011|NCT00313313|12102970|FG002|Overall Study|Lost to Follow-up|9
7685012|NCT00313313|12102968|FG000|Overall Study|Adverse Event|15
7685013|NCT00313313|12102969|FG001|Overall Study|Adverse Event|16
7685014|NCT00313313|12102970|FG002|Overall Study|Adverse Event|12
7685015|NCT00313313|12102968|FG000|Overall Study|Physician Decision|2
7685016|NCT00313313|12102969|FG001|Overall Study|Physician Decision|6
7685017|NCT00313313|12102970|FG002|Overall Study|Physician Decision|4
7685018|NCT00313313|12102968|FG000|Overall Study|Poor/Noncompliance|3
7685019|NCT00313313|12102969|FG001|Overall Study|Poor/Noncompliance|6
7685020|NCT00313313|12102970|FG002|Overall Study|Poor/Noncompliance|2
7685021|NCT00313313|12102968|FG000|Overall Study|Pregnancy|1
7685022|NCT00313313|12102969|FG001|Overall Study|Pregnancy|2
7685023|NCT00313313|12102970|FG002|Overall Study|Pregnancy|0
7685024|NCT00313313|12102968|FG000|Overall Study|Death|0
7685025|NCT00313313|12102969|FG001|Overall Study|Death|0
7685026|NCT00313313|12102970|FG002|Overall Study|Death|2
7685027|NCT00313313|12102968|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
7685028|NCT00313313|12102969|FG001|Overall Study|Subject No Longer Meets Study Criteria|3
7685029|NCT00313313|12102970|FG002|Overall Study|Subject No Longer Meets Study Criteria|2
7685030|NCT00313586|12102994|FG000|Overall Study|Disease progression|14
7685031|NCT00313586|12102995|FG001|Overall Study|Disease progression|19
7685032|NCT00313586|12102996|FG002|Overall Study|Disease progression|10
7685033|NCT00313586|12102997|FG003|Overall Study|Disease progression|3
7685034|NCT00313586|12102994|FG000|Overall Study|Adverse Event|12
7685035|NCT00313586|12102995|FG001|Overall Study|Adverse Event|18
7685036|NCT00313586|12102996|FG002|Overall Study|Adverse Event|3
7685037|NCT00313586|12102997|FG003|Overall Study|Adverse Event|10
7685038|NCT00313586|12102994|FG000|Overall Study|Death|11
7685039|NCT00313586|12102995|FG001|Overall Study|Death|8
7685040|NCT00313586|12102996|FG002|Overall Study|Death|1
7685041|NCT00313586|12102997|FG003|Overall Study|Death|7
7685042|NCT00313586|12102994|FG000|Overall Study|Withdrawal by Subject|13
7685043|NCT00313586|12102995|FG001|Overall Study|Withdrawal by Subject|6
7685044|NCT00313586|12102996|FG002|Overall Study|Withdrawal by Subject|6
7685045|NCT00313586|12102997|FG003|Overall Study|Withdrawal by Subject|2
7685046|NCT00313586|12102994|FG000|Overall Study|Alternative therapy|3
7685047|NCT00313586|12102995|FG001|Overall Study|Alternative therapy|6
7685048|NCT00313586|12102996|FG002|Overall Study|Alternative therapy|2
7685049|NCT00313586|12102997|FG003|Overall Study|Alternative therapy|0
7685050|NCT00313586|12102994|FG000|Overall Study|Other complicating disease|2
7685051|NCT00313586|12102995|FG001|Overall Study|Other complicating disease|2
7685052|NCT00313586|12102996|FG002|Overall Study|Other complicating disease|0
7685053|NCT00313586|12102997|FG003|Overall Study|Other complicating disease|0
7685054|NCT00313586|12102994|FG000|Overall Study|Did not achieve HI-major/better response|10
7685055|NCT00313586|12102995|FG001|Overall Study|Did not achieve HI-major/better response|7
7685056|NCT00313586|12102996|FG002|Overall Study|Did not achieve HI-major/better response|2
7685057|NCT00313586|12102997|FG003|Overall Study|Did not achieve HI-major/better response|1
7685058|NCT00313586|12102994|FG000|Overall Study|Physician Decision|2
7685059|NCT00313586|12102995|FG001|Overall Study|Physician Decision|1
7685060|NCT00313586|12102996|FG002|Overall Study|Physician Decision|0
7685061|NCT00313586|12102997|FG003|Overall Study|Physician Decision|0
7685062|NCT00313586|12102994|FG000|Overall Study|Absolute neutrophil count not recovered|2
7685063|NCT00313586|12102995|FG001|Overall Study|Absolute neutrophil count not recovered|1
7685064|NCT00313586|12102996|FG002|Overall Study|Absolute neutrophil count not recovered|0
7685065|NCT00313586|12102997|FG003|Overall Study|Absolute neutrophil count not recovered|0
7685066|NCT00313586|12102994|FG000|Overall Study|Lost insurance|0
7685067|NCT00313586|12102995|FG001|Overall Study|Lost insurance|1
7685068|NCT00313586|12102996|FG002|Overall Study|Lost insurance|0
7685069|NCT00313586|12102997|FG003|Overall Study|Lost insurance|0
7685070|NCT00313586|12102994|FG000|Overall Study|Moved|0
7685071|NCT00313586|12102995|FG001|Overall Study|Moved|1
7685072|NCT00313586|12102996|FG002|Overall Study|Moved|0
7685073|NCT00313586|12102997|FG003|Overall Study|Moved|0
7685074|NCT00313586|12102994|FG000|Overall Study|Death before starting treatment|1
7685075|NCT00313586|12102995|FG001|Overall Study|Death before starting treatment|0
7685076|NCT00313586|12102996|FG002|Overall Study|Death before starting treatment|0
7685077|NCT00313586|12102997|FG003|Overall Study|Death before starting treatment|0
7685078|NCT00313612|12103007|FG000|Overall Study|Patient never received treatment|0
7685079|NCT00313612|12103008|FG001|Overall Study|Patient never received treatment|1
7685080|NCT00313703|12103018|FG000|Overall Study|Lost to Follow-up|11
7685081|NCT00313703|12103019|FG001|Overall Study|Lost to Follow-up|2
7685082|NCT00313703|12103020|FG002|Overall Study|Lost to Follow-up|5
7685083|NCT00313703|12103021|FG003|Overall Study|Lost to Follow-up|12
7685084|NCT00313716|12103037|FG000|Overall Study|Death|3
7685085|NCT00313716|12103038|FG001|Overall Study|Death|2
7685086|NCT00313716|12103039|FG002|Overall Study|Death|9
7685087|NCT00313716|12103040|FG003|Overall Study|Death|3
7685088|NCT00313716|12103041|FG004|Overall Study|Death|5
7685089|NCT00313716|12103042|FG005|Overall Study|Death|9
7685090|NCT00313716|12103037|FG000|Overall Study|Lost to Follow-up|2
7685091|NCT00313716|12103038|FG001|Overall Study|Lost to Follow-up|5
7685092|NCT00313716|12103039|FG002|Overall Study|Lost to Follow-up|2
7685093|NCT00313716|12103040|FG003|Overall Study|Lost to Follow-up|1
7685094|NCT00313716|12103041|FG004|Overall Study|Lost to Follow-up|0
7685095|NCT00313716|12103042|FG005|Overall Study|Lost to Follow-up|4
7685096|NCT00313716|12103037|FG000|Overall Study|Withdrawal by Subject|0
7685097|NCT00313716|12103038|FG001|Overall Study|Withdrawal by Subject|1
7685098|NCT00313716|12103039|FG002|Overall Study|Withdrawal by Subject|1
7685099|NCT00313716|12103040|FG003|Overall Study|Withdrawal by Subject|0
7685100|NCT00313716|12103041|FG004|Overall Study|Withdrawal by Subject|1
7685101|NCT00313716|12103042|FG005|Overall Study|Withdrawal by Subject|0
7685102|NCT00313781|12103066|FG000|Before Crossover|Death|22
7685103|NCT00313781|12103067|FG001|Before Crossover|Death|8
7685104|NCT00313781|12103068|FG002|Before Crossover|Death|0
7685105|NCT00313781|12103066|FG000|Before Crossover|Lost to Follow-up|0
7685106|NCT00313781|12103067|FG001|Before Crossover|Lost to Follow-up|3
7685107|NCT00313781|12103068|FG002|Before Crossover|Lost to Follow-up|0
7685108|NCT00313781|12103066|FG000|Before Crossover|Withdrawal by Subject|3
7685109|NCT00313781|12103067|FG001|Before Crossover|Withdrawal by Subject|1
7685110|NCT00313781|12103068|FG002|Before Crossover|Withdrawal by Subject|0
7685111|NCT00313781|12103066|FG000|Before Crossover|Other|45
7685112|NCT00313781|12103067|FG001|Before Crossover|Other|30
7685113|NCT00313781|12103068|FG002|Before Crossover|Other|0
7685114|NCT00313781|12103066|FG000|Before Crossover|Crossover|0
7685115|NCT00313781|12103067|FG001|Before Crossover|Crossover|37
7685116|NCT00313781|12103068|FG002|Before Crossover|Crossover|0
7685117|NCT00313781|12103066|FG000|Before Crossover|Randomized, not treated|5
7685118|NCT00313781|12103067|FG001|Before Crossover|Randomized, not treated|0
7685119|NCT00313781|12103068|FG002|Before Crossover|Randomized, not treated|0
7685120|NCT00313781|12103066|FG000|After Crossover|Death|0
7685121|NCT00313781|12103067|FG001|After Crossover|Death|0
7685122|NCT00313781|12103068|FG002|After Crossover|Death|6
7685123|NCT00313781|12103066|FG000|After Crossover|Withdrawal by Subject|0
7685124|NCT00313781|12103067|FG001|After Crossover|Withdrawal by Subject|0
7685125|NCT00313781|12103068|FG002|After Crossover|Withdrawal by Subject|3
7685126|NCT00313781|12103066|FG000|After Crossover|Other|0
7685127|NCT00313781|12103067|FG001|After Crossover|Other|0
7685128|NCT00313781|12103068|FG002|After Crossover|Other|18
7685129|NCT00313820|12103079|FG000|Assigned to Treatment|Other|1
7685130|NCT00313820|12103080|FG001|Assigned to Treatment|Other|0
7685131|NCT00313820|12103079|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9
7685132|NCT00313820|12103080|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4
7685133|NCT00313820|12103079|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
7685134|NCT00313820|12103080|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
7685135|NCT00313820|12103079|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
7685136|NCT00313820|12103080|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
7685137|NCT00313820|12103079|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
7685138|NCT00313820|12103080|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
7685139|NCT00313820|12103079|FG000|Pregabalin or Placebo Treatment Period|Other|2
7685140|NCT00313820|12103080|FG001|Pregabalin or Placebo Treatment Period|Other|3
7685141|NCT00313846|12103088|FG000|Overall Study|Withdrawal by Subject|2
7685142|NCT00313846|12103089|FG001|Overall Study|Withdrawal by Subject|0
7685143|NCT00313846|12103088|FG000|Overall Study|Adverse Event|1
7685144|NCT00313846|12103089|FG001|Overall Study|Adverse Event|8
7685145|NCT00313846|12103088|FG000|Overall Study|Administrative|2
7685146|NCT00313846|12103089|FG001|Overall Study|Administrative|3
7685147|NCT00313911|12103098|FG000|Overall Study|Serious adverse event|6
7685148|NCT00313911|12103099|FG001|Overall Study|Serious adverse event|1
7685149|NCT00313911|12103098|FG000|Overall Study|Adverse Event|2
7685150|NCT00313911|12103099|FG001|Overall Study|Adverse Event|3
7685151|NCT00313911|12103098|FG000|Overall Study|Protocol Violation|19
7685152|NCT00313911|12103099|FG001|Overall Study|Protocol Violation|10
7685153|NCT00313911|12103098|FG000|Overall Study|Lost to Follow-up|27
7685154|NCT00313911|12103099|FG001|Overall Study|Lost to Follow-up|14
7685155|NCT00313911|12103098|FG000|Overall Study|Withdrawal by Subject|39
7685156|NCT00313911|12103099|FG001|Overall Study|Withdrawal by Subject|12
7685157|NCT00313911|12103098|FG000|Overall Study|Did not meet age criteria|1
7685158|NCT00313911|12103099|FG001|Overall Study|Did not meet age criteria|1
7685159|NCT00314132|12103116|FG000|Overall Study|Lost to Follow-up|3
7685160|NCT00314132|12103117|FG001|Overall Study|Lost to Follow-up|13
7685161|NCT00314132|12103116|FG000|Overall Study|Withdrawal by Subject|3
7685162|NCT00314132|12103117|FG001|Overall Study|Withdrawal by Subject|5
7685163|NCT00314132|12103116|FG000|Overall Study|Adverse Event|1
7685164|NCT00314132|12103117|FG001|Overall Study|Adverse Event|0
7685165|NCT00314132|12103116|FG000|Overall Study|Physician Decision|1
7685166|NCT00314132|12103117|FG001|Overall Study|Physician Decision|0
7685167|NCT00314145|12103127|FG000|Overall Study|Withdrawal by Subject|8
7685168|NCT00314145|12103128|FG001|Overall Study|Withdrawal by Subject|10
7685169|NCT00314145|12103127|FG000|Overall Study|Lost to Follow-up|5
7685170|NCT00314145|12103128|FG001|Overall Study|Lost to Follow-up|12
7685171|NCT00314145|12103127|FG000|Overall Study|Physician Decision|3
7685172|NCT00314145|12103128|FG001|Overall Study|Physician Decision|4
7685173|NCT00314145|12103127|FG000|Overall Study|Adverse Event|0
7685174|NCT00314145|12103128|FG001|Overall Study|Adverse Event|3
7685175|NCT00314145|12103127|FG000|Overall Study|Protocol Violation|3
7685176|NCT00314145|12103128|FG001|Overall Study|Protocol Violation|0
7685177|NCT00314145|12103127|FG000|Overall Study|Sponsor Decision|2
7685178|NCT00314145|12103128|FG001|Overall Study|Sponsor Decision|0
7685179|NCT00314249|12103146|FG000|Overall Study|Adverse Event|73
7685180|NCT00314249|12103147|FG001|Overall Study|Adverse Event|94
7685181|NCT00314249|12103146|FG000|Overall Study|Lack of Efficacy|33
7685182|NCT00314249|12103147|FG001|Overall Study|Lack of Efficacy|24
7685183|NCT00314249|12103146|FG000|Overall Study|Withdrawal by Subject|21
7685184|NCT00314249|12103147|FG001|Overall Study|Withdrawal by Subject|28
7685185|NCT00314249|12103146|FG000|Overall Study|Lost to Follow-up|15
7685186|NCT00314249|12103147|FG001|Overall Study|Lost to Follow-up|9
7685187|NCT00314249|12103146|FG000|Overall Study|Physician Decision|1
7685188|NCT00314249|12103147|FG001|Overall Study|Physician Decision|1
7685189|NCT00314249|12103146|FG000|Overall Study|Withdrawn for other reasons|4
7685190|NCT00314249|12103147|FG001|Overall Study|Withdrawn for other reasons|1
7685191|NCT00314249|12103146|FG000|Overall Study|Non-Compliant|5
7685192|NCT00314249|12103147|FG001|Overall Study|Non-Compliant|6
7685193|NCT00314262|12103153|FG000|Overall Study|Adverse Event|2
7685194|NCT00314262|12103153|FG000|Overall Study|Withdrawal by Subject|2
7685195|NCT00314262|12103153|FG000|Overall Study|Physician Decision|1
7685196|NCT00314340|12103157|FG000|Overall Study|lost interest|1
7685197|NCT00314574|12103165|FG000|Overall Study|Death|3
7685198|NCT00314574|12103166|FG001|Overall Study|Death|0
7685199|NCT00314574|12103165|FG000|Overall Study|Adverse Event|11
7685200|NCT00314574|12103166|FG001|Overall Study|Adverse Event|16
7685201|NCT00314574|12103165|FG000|Overall Study|Lost to Follow-up|19
7685202|NCT00314574|12103166|FG001|Overall Study|Lost to Follow-up|25
7685203|NCT00314574|12103165|FG000|Overall Study|Withdrawal by Subject|33
7685204|NCT00314574|12103166|FG001|Overall Study|Withdrawal by Subject|22
7685205|NCT00314574|12103165|FG000|Overall Study|Physician Decision|22
7685206|NCT00314574|12103166|FG001|Overall Study|Physician Decision|15
7685207|NCT00314574|12103165|FG000|Overall Study|Pregnancy|6
7685208|NCT00314574|12103166|FG001|Overall Study|Pregnancy|4
7685209|NCT00314574|12103165|FG000|Overall Study|Data unknown at database lock|0
7685210|NCT00314574|12103166|FG001|Overall Study|Data unknown at database lock|1
7685211|NCT00314795|12103172|FG000|Overall Study|Adverse Event|8
7685212|NCT00314795|12103172|FG000|Overall Study|Death|4
7685213|NCT00314795|12103172|FG000|Overall Study|Reason not Specified|3
7685214|NCT00314795|12103172|FG000|Overall Study|Renal Transplant|3
7685215|NCT00314795|12103172|FG000|Overall Study|Participants Withdrew Consent|2
7685216|NCT00314808|12103176|FG000|Overall Study|Disease Progression without AE|4
7685217|NCT00314808|12103176|FG000|Overall Study|Withdrawal by Subject/PI without AE|4
7685218|NCT00314951|12103182|FG000|Treatment|Didn't meet criteria for mITT population|16
7685219|NCT00314951|12103183|FG001|Treatment|Didn't meet criteria for mITT population|11
7685220|NCT00314951|12103182|FG000|Follow-up|mITT failure|44
7685221|NCT00314951|12103183|FG001|Follow-up|mITT failure|34
7685222|NCT00315055|12103191|FG000|Overall Study|Protocol Violation|2
7685223|NCT00315055|12103192|FG001|Overall Study|Protocol Violation|4
7685224|NCT00315055|12103191|FG000|Overall Study|Lost to Follow-up|1
7685225|NCT00315055|12103192|FG001|Overall Study|Lost to Follow-up|1
7685226|NCT00315445|12103287|FG000|Overall Study|Adverse Event|7
7685227|NCT00315445|12103288|FG001|Overall Study|Adverse Event|12
7685228|NCT00315445|12103289|FG002|Overall Study|Adverse Event|15
7685229|NCT00315445|12103287|FG000|Overall Study|Lack of Efficacy|16
7685230|NCT00315445|12103288|FG001|Overall Study|Lack of Efficacy|1
7685231|NCT00315445|12103289|FG002|Overall Study|Lack of Efficacy|7
7685232|NCT00315445|12103287|FG000|Overall Study|Lost to Follow-up|1
7685233|NCT00315445|12103288|FG001|Overall Study|Lost to Follow-up|0
7685234|NCT00315445|12103289|FG002|Overall Study|Lost to Follow-up|1
7685235|NCT00315445|12103287|FG000|Overall Study|Protocol Violation|2
7685236|NCT00315445|12103288|FG001|Overall Study|Protocol Violation|0
7685237|NCT00315445|12103289|FG002|Overall Study|Protocol Violation|1
7685238|NCT00315445|12103287|FG000|Overall Study|Other|1
7685239|NCT00315445|12103288|FG001|Overall Study|Other|3
7685240|NCT00315445|12103289|FG002|Overall Study|Other|0
7685241|NCT00315458|12103299|FG000|Overall Study|Administrative|0
7685242|NCT00315458|12103300|FG001|Overall Study|Administrative|3
7685243|NCT00315458|12103301|FG002|Overall Study|Administrative|8
7685244|NCT00315458|12103302|FG003|Overall Study|Administrative|21
7685245|NCT00315458|12103299|FG000|Overall Study|Adverse Event|2
7685246|NCT00315458|12103300|FG001|Overall Study|Adverse Event|4
7685247|NCT00315458|12103301|FG002|Overall Study|Adverse Event|23
7685248|NCT00315458|12103302|FG003|Overall Study|Adverse Event|3
7685249|NCT00315458|12103299|FG000|Overall Study|Lost to Follow-up|1
7685250|NCT00315458|12103300|FG001|Overall Study|Lost to Follow-up|2
7685251|NCT00315458|12103301|FG002|Overall Study|Lost to Follow-up|0
7685252|NCT00315458|12103302|FG003|Overall Study|Lost to Follow-up|2
7685253|NCT00315458|12103299|FG000|Overall Study|Withdrawal by Subject|0
7685254|NCT00315458|12103300|FG001|Overall Study|Withdrawal by Subject|3
7685255|NCT00315458|12103301|FG002|Overall Study|Withdrawal by Subject|0
7685256|NCT00315458|12103302|FG003|Overall Study|Withdrawal by Subject|2
7685257|NCT00315458|12103299|FG000|Overall Study|Lack of Efficacy|0
7685258|NCT00315458|12103300|FG001|Overall Study|Lack of Efficacy|0
7685259|NCT00315458|12103301|FG002|Overall Study|Lack of Efficacy|20
7685260|NCT00315458|12103302|FG003|Overall Study|Lack of Efficacy|1
7685261|NCT00315458|12103299|FG000|Overall Study|Did not qualify|0
7685262|NCT00315458|12103300|FG001|Overall Study|Did not qualify|0
7685263|NCT00315458|12103301|FG002|Overall Study|Did not qualify|1
7685264|NCT00315458|12103302|FG003|Overall Study|Did not qualify|0
7685265|NCT00315705|12103331|FG000|Phase 1|Refused further treatment|1
7685266|NCT00315705|12103331|FG000|Phase 1|Failure to achieve response|8
7685267|NCT00315705|12103331|FG000|Phase 1|Disease relapse|4
7685268|NCT00315705|12103331|FG000|Phase 1|Scheduled for transplant|9
7685269|NCT00315705|12103331|FG000|Phase 1|Death|3
7685270|NCT00315705|12103331|FG000|Phase 2|Physician Decision|4
7685271|NCT00315705|12103331|FG000|Phase 2|Adverse Event|1
7685272|NCT00315705|12103331|FG000|Phase 2|Failure to achieve response|3
7685273|NCT00315705|12103331|FG000|Phase 2|Disease relapse|1
7685274|NCT00315705|12103331|FG000|Phase 2|Scheduled for transplant|8
7685275|NCT00315705|12103331|FG000|Phase 2|Other|1
7685276|NCT00315705|12103331|FG000|Phase 2|Death|7
7685277|NCT00315731|12103348|FG000|Overall Study|Lost to Follow-up|1
7685278|NCT00315731|12103348|FG000|Overall Study|Death|5
7685279|NCT00316004|12103374|FG000|Overall Study|Subject was not given study fluid.|14
7685280|NCT00316004|12103375|FG001|Overall Study|Subject was not given study fluid.|14
7685281|NCT00316004|12103376|FG002|Overall Study|Subject was not given study fluid.|21
7685282|NCT00316017|12103387|FG000|Overall Study|Protocol Violation|11
7685283|NCT00316017|12103388|FG001|Overall Study|Protocol Violation|13
7685284|NCT00316017|12103389|FG002|Overall Study|Protocol Violation|19
7685285|NCT00316082|12103402|FG000|Overall Study|Lack of Efficacy|2
7685286|NCT00316082|12103403|FG001|Overall Study|Lack of Efficacy|3
7685287|NCT00316082|12103404|FG002|Overall Study|Lack of Efficacy|3
7685288|NCT00316082|12103405|FG003|Overall Study|Lack of Efficacy|4
7685289|NCT00316082|12103406|FG004|Overall Study|Lack of Efficacy|6
7685290|NCT00316082|12103402|FG000|Overall Study|Withdrawal of Consent by Subject|10
7685291|NCT00316082|12103403|FG001|Overall Study|Withdrawal of Consent by Subject|8
7685292|NCT00316082|12103404|FG002|Overall Study|Withdrawal of Consent by Subject|2
7685293|NCT00316082|12103405|FG003|Overall Study|Withdrawal of Consent by Subject|9
7685294|NCT00316082|12103406|FG004|Overall Study|Withdrawal of Consent by Subject|5
7685295|NCT00316082|12103402|FG000|Overall Study|Lost to Follow-up|7
7685296|NCT00316082|12103403|FG001|Overall Study|Lost to Follow-up|6
7685297|NCT00316082|12103404|FG002|Overall Study|Lost to Follow-up|7
7685298|NCT00316082|12103405|FG003|Overall Study|Lost to Follow-up|8
7685299|NCT00316082|12103406|FG004|Overall Study|Lost to Follow-up|6
7685300|NCT00316082|12103402|FG000|Overall Study|Poor/noncompliance|6
7685301|NCT00316082|12103403|FG001|Overall Study|Poor/noncompliance|1
7685302|NCT00316082|12103404|FG002|Overall Study|Poor/noncompliance|4
7685303|NCT00316082|12103405|FG003|Overall Study|Poor/noncompliance|1
7685304|NCT00316082|12103406|FG004|Overall Study|Poor/noncompliance|4
7685305|NCT00316082|12103402|FG000|Overall Study|Adverse Event|4
7685306|NCT00316082|12103403|FG001|Overall Study|Adverse Event|2
7685307|NCT00316082|12103404|FG002|Overall Study|Adverse Event|5
7685308|NCT00316082|12103405|FG003|Overall Study|Adverse Event|1
7685309|NCT00316082|12103406|FG004|Overall Study|Adverse Event|3
7685310|NCT00316082|12103402|FG000|Overall Study|Subject no longer meets study criteria|3
7685311|NCT00316082|12103403|FG001|Overall Study|Subject no longer meets study criteria|1
7685312|NCT00316082|12103404|FG002|Overall Study|Subject no longer meets study criteria|2
7685313|NCT00316082|12103405|FG003|Overall Study|Subject no longer meets study criteria|2
7685314|NCT00316082|12103406|FG004|Overall Study|Subject no longer meets study criteria|1
7685315|NCT00316082|12103402|FG000|Overall Study|Physician Decision|1
7685316|NCT00316082|12103403|FG001|Overall Study|Physician Decision|1
7685317|NCT00316082|12103404|FG002|Overall Study|Physician Decision|2
7685318|NCT00316082|12103405|FG003|Overall Study|Physician Decision|1
7685319|NCT00316082|12103406|FG004|Overall Study|Physician Decision|1
7685320|NCT00316082|12103402|FG000|Overall Study|Death|0
7685321|NCT00316082|12103403|FG001|Overall Study|Death|0
7685322|NCT00316082|12103404|FG002|Overall Study|Death|1
7685323|NCT00316082|12103405|FG003|Overall Study|Death|0
7685324|NCT00316082|12103406|FG004|Overall Study|Death|0
7685325|NCT00316082|12103402|FG000|Overall Study|Administrative reason by sponsor|0
7685326|NCT00316082|12103403|FG001|Overall Study|Administrative reason by sponsor|0
7685327|NCT00316082|12103404|FG002|Overall Study|Administrative reason by sponsor|1
7685328|NCT00316082|12103405|FG003|Overall Study|Administrative reason by sponsor|0
7685329|NCT00316082|12103406|FG004|Overall Study|Administrative reason by sponsor|0
7685330|NCT00316121|12103424|FG000|Overall Study|Death|1
7685331|NCT00316121|12103425|FG001|Overall Study|Death|0
7685332|NCT00316121|12103424|FG000|Overall Study|Lost to Follow-up|14
7685333|NCT00316121|12103425|FG001|Overall Study|Lost to Follow-up|8
7685334|NCT00316121|12103424|FG000|Overall Study|Withdrawal by Subject|2
7685335|NCT00316121|12103425|FG001|Overall Study|Withdrawal by Subject|0
7685336|NCT00316121|12103424|FG000|Overall Study|Reason is missing|1
7685337|NCT00316121|12103425|FG001|Overall Study|Reason is missing|0
7685338|NCT00316121|12103424|FG000|Overall Study|Subject relocated|1
7685339|NCT00316121|12103425|FG001|Overall Study|Subject relocated|1
7685340|NCT00316121|12103424|FG000|Overall Study|Subject refused to return|1
7685341|NCT00316121|12103425|FG001|Overall Study|Subject refused to return|0
7685342|NCT00316121|12103424|FG000|Overall Study|Subject no show for visit x 3|1
7685343|NCT00316121|12103425|FG001|Overall Study|Subject no show for visit x 3|0
7685344|NCT00316121|12103424|FG000|Overall Study|Subject did not have 24 month visit|1
7685345|NCT00316121|12103425|FG001|Overall Study|Subject did not have 24 month visit|0
7685346|NCT00316173|12103433|FG000|Run-in Phase|Adverse Event|1
7685347|NCT00316173|12103434|FG001|Run-in Phase|Adverse Event|0
7685348|NCT00316173|12103433|FG000|Run-in Phase|Protocol Violation|1
7685349|NCT00316173|12103434|FG001|Run-in Phase|Protocol Violation|0
7685350|NCT00316173|12103433|FG000|Run-in Phase|Study Follow-up Stopped|5
7685351|NCT00316173|12103434|FG001|Run-in Phase|Study Follow-up Stopped|0
7685352|NCT00316173|12103433|FG000|Treatment Phase|Adverse Event|0
7685353|NCT00316173|12103434|FG001|Treatment Phase|Adverse Event|1
7685354|NCT00316173|12103433|FG000|Treatment Phase|Lack of Efficacy|0
7685355|NCT00316173|12103434|FG001|Treatment Phase|Lack of Efficacy|3
7685356|NCT00316173|12103433|FG000|Treatment Phase|Lost to Follow-up|0
7685357|NCT00316173|12103434|FG001|Treatment Phase|Lost to Follow-up|3
7685358|NCT00316173|12103433|FG000|Treatment Phase|Withdrawal by Subject|0
7685359|NCT00316173|12103434|FG001|Treatment Phase|Withdrawal by Subject|1
7685360|NCT00316173|12103433|FG000|Treatment Phase|Study Follow-up Stopped|0
7685361|NCT00316173|12103434|FG001|Treatment Phase|Study Follow-up Stopped|34
7685362|NCT00316186|12103439|FG000|Overall Study|Adverse Event|6
7685363|NCT00316186|12103439|FG000|Overall Study|Disease Progression|4
7685364|NCT00316186|12103439|FG000|Overall Study|Lost to Follow-up|1
7685365|NCT00316186|12103439|FG000|Overall Study|Other|1
7685366|NCT00316199|12103443|FG000|Overall Study|Adverse Event|2
7685367|NCT00316199|12103443|FG000|Overall Study|Death|8
7685368|NCT00316199|12103443|FG000|Overall Study|Lost to Follow-up|2
7685369|NCT00316225|12103447|FG000|Overall Study|Adverse Event|2
7685370|NCT00316225|12103447|FG000|Overall Study|Physician Decision|3
7685371|NCT00316225|12103447|FG000|Overall Study|Progressive Disease|15
7685372|NCT00316225|12103447|FG000|Overall Study|Withdrawal by Subject|3
7685373|NCT00316225|12103447|FG000|Overall Study|Death|2
7685374|NCT00316264|12103454|FG000|Overall Study|Lost to Follow-up|0
7685375|NCT00316264|12103455|FG001|Overall Study|Lost to Follow-up|1
7685376|NCT00316264|12103456|FG002|Overall Study|Lost to Follow-up|0
7685377|NCT00316264|12103454|FG000|Overall Study|Withdrawal of Consent|3
7685378|NCT00316264|12103455|FG001|Overall Study|Withdrawal of Consent|5
7685379|NCT00316264|12103456|FG002|Overall Study|Withdrawal of Consent|6
7685380|NCT00316264|12103454|FG000|Overall Study|Death|2
7685381|NCT00316264|12103455|FG001|Overall Study|Death|0
7685382|NCT00316264|12103456|FG002|Overall Study|Death|0
7685383|NCT00316264|12103454|FG000|Overall Study|Other|1
7685384|NCT00316264|12103455|FG001|Overall Study|Other|1
7685385|NCT00316264|12103456|FG002|Overall Study|Other|0
7685386|NCT00316277|12103466|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88
7685387|NCT00316277|12103467|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75
7685388|NCT00316277|12103466|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2
7685389|NCT00316277|12103467|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0
7685390|NCT00316277|12103466|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220
7685391|NCT00316277|12103467|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225
7685392|NCT00316277|12103466|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
7685393|NCT00316277|12103467|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
7685394|NCT00316277|12103466|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
7685395|NCT00316277|12103467|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
7685396|NCT00316303|12103483|FG000|Overall Study|Lost to Follow-up|11
7685397|NCT00316303|12103484|FG001|Overall Study|Lost to Follow-up|16
7685398|NCT00316589|12103527|FG000|Overall Study|Withdrawal by Subject|0
7685399|NCT00316589|12103528|FG001|Overall Study|Withdrawal by Subject|5
7685400|NCT00316589|12103529|FG002|Overall Study|Withdrawal by Subject|0
7685401|NCT00316589|12103530|FG003|Overall Study|Withdrawal by Subject|1
7685402|NCT00316589|12103527|FG000|Overall Study|Subject unwilling/unable to comply|0
7685403|NCT00316589|12103528|FG001|Overall Study|Subject unwilling/unable to comply|6
7685404|NCT00316589|12103529|FG002|Overall Study|Subject unwilling/unable to comply|0
7685405|NCT00316589|12103530|FG003|Overall Study|Subject unwilling/unable to comply|2
7685406|NCT00316589|12103527|FG000|Overall Study|Adverse Event|1
7685407|NCT00316589|12103528|FG001|Overall Study|Adverse Event|0
7685408|NCT00316589|12103529|FG002|Overall Study|Adverse Event|0
7685409|NCT00316589|12103530|FG003|Overall Study|Adverse Event|1
7685410|NCT00316589|12103527|FG000|Overall Study|Physician Decision|0
7685411|NCT00316589|12103528|FG001|Overall Study|Physician Decision|1
7685412|NCT00316589|12103529|FG002|Overall Study|Physician Decision|0
7685413|NCT00316589|12103530|FG003|Overall Study|Physician Decision|0
7685414|NCT00316589|12103527|FG000|Overall Study|Other reason|0
7685415|NCT00316589|12103528|FG001|Overall Study|Other reason|12
7685416|NCT00316589|12103529|FG002|Overall Study|Other reason|1
7685417|NCT00316589|12103530|FG003|Overall Study|Other reason|1
7685418|NCT00316602|12103544|FG000|Overall Study|Withdrawal by Subject|3
7685419|NCT00316602|12103545|FG001|Overall Study|Withdrawal by Subject|2
7685420|NCT00316602|12103544|FG000|Overall Study|Subject unwilling/unable to comply with|3
7685421|NCT00316602|12103545|FG001|Overall Study|Subject unwilling/unable to comply with|17
7685422|NCT00316602|12103544|FG000|Overall Study|Adverse Event|1
7685423|NCT00316602|12103545|FG001|Overall Study|Adverse Event|0
7685424|NCT00316602|12103544|FG000|Overall Study|Other|3
7685425|NCT00316602|12103545|FG001|Overall Study|Other|6
7685426|NCT00316693|12103553|FG000|Overall Study|Adverse Event|6
7685427|NCT00316693|12103554|FG001|Overall Study|Adverse Event|1
7685428|NCT00316693|12103553|FG000|Overall Study|Protocol Violation|1
7685429|NCT00316693|12103554|FG001|Overall Study|Protocol Violation|0
7685430|NCT00316693|12103553|FG000|Overall Study|Withdrawal by Subject|6
7685431|NCT00316693|12103554|FG001|Overall Study|Withdrawal by Subject|6
7685432|NCT00316693|12103553|FG000|Overall Study|Lost to Follow-up|26
7685433|NCT00316693|12103554|FG001|Overall Study|Lost to Follow-up|34
7685434|NCT00316693|12103553|FG000|Overall Study|Other|38
7685435|NCT00316693|12103554|FG001|Overall Study|Other|44
7685436|NCT00316706|12103562|FG000|Overall Study|Lost to Follow-up|38
7685437|NCT00316706|12103563|FG001|Overall Study|Lost to Follow-up|48
7685438|NCT00316719|12103571|FG000|Overall Study|Adverse Event|0
7685439|NCT00316719|12103572|FG001|Overall Study|Adverse Event|6
7685440|NCT00316719|12103571|FG000|Overall Study|Consent withdrawn|2
7685441|NCT00316719|12103572|FG001|Overall Study|Consent withdrawn|0
7685442|NCT00316914|12103584|FG000|Overall Study|Withdrawal by Subject|5
7685443|NCT00316914|12103585|FG001|Overall Study|Withdrawal by Subject|3
7685444|NCT00316914|12103584|FG000|Overall Study|Adverse Event|8
7685445|NCT00316914|12103585|FG001|Overall Study|Adverse Event|7
7685446|NCT00316914|12103584|FG000|Overall Study|Other Problems|6
7685447|NCT00316914|12103585|FG001|Overall Study|Other Problems|11
7685448|NCT00316914|12103584|FG000|Overall Study|Missing end of treatment documentation|14
7685449|NCT00316914|12103585|FG001|Overall Study|Missing end of treatment documentation|15
7685450|NCT00317044|12103594|FG000|Overall Study|Protocol Violation|28
7685451|NCT00317044|12103595|FG001|Overall Study|Protocol Violation|22
7685452|NCT00317044|12103596|FG002|Overall Study|Protocol Violation|20
7685453|NCT00317044|12103594|FG000|Overall Study|Adverse Event|4
7685454|NCT00317044|12103595|FG001|Overall Study|Adverse Event|7
7685455|NCT00317044|12103596|FG002|Overall Study|Adverse Event|4
7685456|NCT00317044|12103594|FG000|Overall Study|Withdrawal by Subject|10
7685457|NCT00317044|12103595|FG001|Overall Study|Withdrawal by Subject|7
7685458|NCT00317044|12103596|FG002|Overall Study|Withdrawal by Subject|12
7685459|NCT00317044|12103594|FG000|Overall Study|Lost to Follow-up|0
7685460|NCT00317044|12103595|FG001|Overall Study|Lost to Follow-up|2
7685461|NCT00317044|12103596|FG002|Overall Study|Lost to Follow-up|3
7685462|NCT00317044|12103594|FG000|Overall Study|Multiple Reasons|6
7685463|NCT00317044|12103595|FG001|Overall Study|Multiple Reasons|2
7685464|NCT00317044|12103596|FG002|Overall Study|Multiple Reasons|6
7685465|NCT00317109|12103606|FG000|Overall Study|Withdrawal by Subject|2
7685466|NCT00317109|12103607|FG001|Overall Study|Withdrawal by Subject|0
7685467|NCT00317109|12103606|FG000|Overall Study|Migated/moved from study area|1
7685468|NCT00317109|12103607|FG001|Overall Study|Migated/moved from study area|0
7685469|NCT00317356|12103630|FG000|Overall Study|Adverse Event|0
7685470|NCT00317356|12103631|FG001|Overall Study|Adverse Event|0
7685471|NCT00317356|12103632|FG002|Overall Study|Adverse Event|1
7685472|NCT00317356|12103633|FG003|Overall Study|Adverse Event|0
7685473|NCT00317356|12103630|FG000|Overall Study|Lack of Efficacy|1
7685474|NCT00317356|12103631|FG001|Overall Study|Lack of Efficacy|1
7685475|NCT00317356|12103632|FG002|Overall Study|Lack of Efficacy|0
7685476|NCT00317356|12103633|FG003|Overall Study|Lack of Efficacy|3
7685477|NCT00317356|12103630|FG000|Overall Study|Physician Decision|0
7685478|NCT00317356|12103631|FG001|Overall Study|Physician Decision|1
7685479|NCT00317356|12103632|FG002|Overall Study|Physician Decision|0
7685480|NCT00317356|12103633|FG003|Overall Study|Physician Decision|0
7685481|NCT00317369|12103646|FG000|Overall Study|Adverse Event|2
7685482|NCT00317369|12103647|FG001|Overall Study|Adverse Event|1
7685483|NCT00317369|12103648|FG002|Overall Study|Adverse Event|0
7685484|NCT00317369|12103646|FG000|Overall Study|Lack of Efficacy|0
7685485|NCT00317369|12103647|FG001|Overall Study|Lack of Efficacy|1
7685486|NCT00317369|12103648|FG002|Overall Study|Lack of Efficacy|1
7685487|NCT00317369|12103646|FG000|Overall Study|Withdrawal by Subject|0
7685488|NCT00317369|12103647|FG001|Overall Study|Withdrawal by Subject|0
7685489|NCT00317369|12103648|FG002|Overall Study|Withdrawal by Subject|1
7685490|NCT00317473|12103662|FG000|Overall Study|Withdrawal by Subject|2
7685491|NCT00317473|12103663|FG001|Overall Study|Withdrawal by Subject|1
7685492|NCT00317473|12103664|FG002|Overall Study|Withdrawal by Subject|2
7685493|NCT00317473|12103665|FG003|Overall Study|Withdrawal by Subject|1
7685494|NCT00317473|12103666|FG004|Overall Study|Withdrawal by Subject|3
7685495|NCT00317473|12103667|FG005|Overall Study|Withdrawal by Subject|1
7685496|NCT00317473|12103662|FG000|Overall Study|Relocation|1
7685497|NCT00317473|12103663|FG001|Overall Study|Relocation|0
7685498|NCT00317473|12103664|FG002|Overall Study|Relocation|1
7685499|NCT00317473|12103665|FG003|Overall Study|Relocation|1
7685500|NCT00317473|12103666|FG004|Overall Study|Relocation|5
7685501|NCT00317473|12103667|FG005|Overall Study|Relocation|2
7685502|NCT00317473|12103662|FG000|Overall Study|Death|1
7685503|NCT00317473|12103663|FG001|Overall Study|Death|0
7685504|NCT00317473|12103664|FG002|Overall Study|Death|0
7685505|NCT00317473|12103665|FG003|Overall Study|Death|0
7685506|NCT00317473|12103666|FG004|Overall Study|Death|0
7685507|NCT00317473|12103667|FG005|Overall Study|Death|0
7685508|NCT00317473|12103662|FG000|Overall Study|Other|0
7685509|NCT00317473|12103663|FG001|Overall Study|Other|2
7685510|NCT00317473|12103664|FG002|Overall Study|Other|0
7685511|NCT00317473|12103665|FG003|Overall Study|Other|0
7685512|NCT00317473|12103666|FG004|Overall Study|Other|0
7685513|NCT00317473|12103667|FG005|Overall Study|Other|0
7685514|NCT00317603|12103691|FG000|Overall Study|Progressive Disease|3
7685515|NCT00317642|12103697|FG000|Overall Study|Not Received Either Study Drug|1
7685516|NCT00317642|12103698|FG001|Overall Study|Not Received Either Study Drug|3
7685517|NCT00317642|12103697|FG000|Overall Study|Physician Decision|15
7685518|NCT00317642|12103698|FG001|Overall Study|Physician Decision|7
7685519|NCT00317642|12103697|FG000|Overall Study|Participant declined treatment|14
7685520|NCT00317642|12103698|FG001|Overall Study|Participant declined treatment|3
7685521|NCT00317642|12103697|FG000|Overall Study|Adverse Event|17
7685522|NCT00317642|12103698|FG001|Overall Study|Adverse Event|5
7685523|NCT00317642|12103697|FG000|Overall Study|Treatment Failure|56
7685524|NCT00317642|12103698|FG001|Overall Study|Treatment Failure|102
7685525|NCT00317642|12103697|FG000|Overall Study|Disease Recurrence|1
7685526|NCT00317642|12103698|FG001|Overall Study|Disease Recurrence|2
7685527|NCT00317642|12103697|FG000|Overall Study|Death|14
7685528|NCT00317642|12103698|FG001|Overall Study|Death|7
7685529|NCT00317642|12103697|FG000|Overall Study|Not Continue to Consolidation|2
7685530|NCT00317642|12103698|FG001|Overall Study|Not Continue to Consolidation|0
7685531|NCT00317642|12103697|FG000|Overall Study|Withdrawal by Subject|0
7685532|NCT00317642|12103698|FG001|Overall Study|Withdrawal by Subject|1
7685533|NCT00317642|12103697|FG000|Overall Study|Referred For Transplantation|1
7685534|NCT00317642|12103698|FG001|Overall Study|Referred For Transplantation|0
7685535|NCT00317642|12103697|FG000|Overall Study|AML Not Centrally Confirmed|1
7685536|NCT00317642|12103698|FG001|Overall Study|AML Not Centrally Confirmed|5
7685537|NCT00318149|12103739|FG000|Overall Study|Adverse Event|0
7685538|NCT00318149|12103740|FG001|Overall Study|Adverse Event|0
7685539|NCT00318149|12103741|FG002|Overall Study|Adverse Event|0
7685540|NCT00318149|12103742|FG003|Overall Study|Adverse Event|0
7685541|NCT00318149|12103743|FG004|Overall Study|Adverse Event|0
7685542|NCT00318149|12103744|FG005|Overall Study|Adverse Event|2
7685543|NCT00318370|12103778|FG000|Period 1|Lack of Efficacy|5
7685544|NCT00318370|12103779|FG001|Period 1|Lack of Efficacy|0
7685545|NCT00318370|12103780|FG002|Period 1|Lack of Efficacy|0
7685546|NCT00318370|12103778|FG000|Period 1|Physician Decision|1
7685547|NCT00318370|12103779|FG001|Period 1|Physician Decision|0
7685548|NCT00318370|12103780|FG002|Period 1|Physician Decision|0
7685549|NCT00318370|12103778|FG000|Period 1|Withdrawal by Subject|1
7685550|NCT00318370|12103779|FG001|Period 1|Withdrawal by Subject|0
7685551|NCT00318370|12103780|FG002|Period 1|Withdrawal by Subject|0
7685552|NCT00318370|12103778|FG000|Period 2|Adverse Event|0
7685553|NCT00318370|12103779|FG001|Period 2|Adverse Event|3
7685554|NCT00318370|12103780|FG002|Period 2|Adverse Event|0
7685555|NCT00318370|12103778|FG000|Period 2|Lack of Efficacy|0
7685556|NCT00318370|12103779|FG001|Period 2|Lack of Efficacy|5
7685557|NCT00318370|12103780|FG002|Period 2|Lack of Efficacy|0
7685558|NCT00318370|12103778|FG000|Period 2|Physician Decision|0
7685559|NCT00318370|12103779|FG001|Period 2|Physician Decision|1
7685560|NCT00318370|12103780|FG002|Period 2|Physician Decision|0
7685561|NCT00318370|12103778|FG000|Period 2|Withdrawal by Subject|0
7685562|NCT00318370|12103779|FG001|Period 2|Withdrawal by Subject|1
7685563|NCT00318370|12103780|FG002|Period 2|Withdrawal by Subject|0
7685564|NCT00318370|12103778|FG000|Period 2|Other|0
7685565|NCT00318370|12103779|FG001|Period 2|Other|1
7685566|NCT00318370|12103780|FG002|Period 2|Other|0
7685567|NCT00318370|12103778|FG000|Period 3|Adverse Event|0
7685568|NCT00318370|12103779|FG001|Period 3|Adverse Event|0
7685569|NCT00318370|12103780|FG002|Period 3|Adverse Event|1
7685570|NCT00318370|12103778|FG000|Period 3|Lack of Efficacy|0
7685571|NCT00318370|12103779|FG001|Period 3|Lack of Efficacy|0
7685572|NCT00318370|12103780|FG002|Period 3|Lack of Efficacy|24
7685573|NCT00318370|12103778|FG000|Period 3|Death|0
7685574|NCT00318370|12103779|FG001|Period 3|Death|0
7685575|NCT00318370|12103780|FG002|Period 3|Death|1
7685576|NCT00318370|12103778|FG000|Period 3|Physician Decision|0
7685577|NCT00318370|12103779|FG001|Period 3|Physician Decision|0
7685578|NCT00318370|12103780|FG002|Period 3|Physician Decision|1
7685579|NCT00318370|12103778|FG000|Period 3|Withdrawal by Subject|0
7685580|NCT00318370|12103779|FG001|Period 3|Withdrawal by Subject|0
7685581|NCT00318370|12103780|FG002|Period 3|Withdrawal by Subject|3
7685582|NCT00318370|12103778|FG000|Period 3|Other|0
7685583|NCT00318370|12103779|FG001|Period 3|Other|0
7685584|NCT00318370|12103780|FG002|Period 3|Other|3
7685585|NCT00318461|12103801|FG000|Double-Blind, 6 Months|Adverse Event|11
7685586|NCT00318461|12103802|FG001|Double-Blind, 6 Months|Adverse Event|23
7685587|NCT00318461|12103803|FG002|Double-Blind, 6 Months|Adverse Event|29
7685588|NCT00318461|12103804|FG003|Double-Blind, 6 Months|Adverse Event|2
7685589|NCT00318461|12103805|FG004|Double-Blind, 6 Months|Adverse Event|8
7685590|NCT00318461|12103801|FG000|Double-Blind, 6 Months|Lack of Efficacy|19
7685591|NCT00318461|12103802|FG001|Double-Blind, 6 Months|Lack of Efficacy|8
7685592|NCT00318461|12103803|FG002|Double-Blind, 6 Months|Lack of Efficacy|13
7685593|NCT00318461|12103804|FG003|Double-Blind, 6 Months|Lack of Efficacy|29
7685594|NCT00318461|12103805|FG004|Double-Blind, 6 Months|Lack of Efficacy|9
7685595|NCT00318461|12103801|FG000|Double-Blind, 6 Months|Protocol Violation|2
7685596|NCT00318461|12103802|FG001|Double-Blind, 6 Months|Protocol Violation|4
7685597|NCT00318461|12103803|FG002|Double-Blind, 6 Months|Protocol Violation|4
7685598|NCT00318461|12103804|FG003|Double-Blind, 6 Months|Protocol Violation|4
7685599|NCT00318461|12103805|FG004|Double-Blind, 6 Months|Protocol Violation|5
7685600|NCT00318461|12103801|FG000|Double-Blind, 6 Months|Lost to follow up|0
7685601|NCT00318461|12103802|FG001|Double-Blind, 6 Months|Lost to follow up|1
7685602|NCT00318461|12103803|FG002|Double-Blind, 6 Months|Lost to follow up|0
7685603|NCT00318461|12103804|FG003|Double-Blind, 6 Months|Lost to follow up|0
7685604|NCT00318461|12103805|FG004|Double-Blind, 6 Months|Lost to follow up|0
7685605|NCT00318461|12103801|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
7685606|NCT00318461|12103802|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
7685607|NCT00318461|12103803|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
7685608|NCT00318461|12103804|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
7685609|NCT00318461|12103805|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
7685610|NCT00318461|12103801|FG000|Double-Blind, 6 Months|Consent withdrawn|0
7685611|NCT00318461|12103802|FG001|Double-Blind, 6 Months|Consent withdrawn|3
7685612|NCT00318461|12103803|FG002|Double-Blind, 6 Months|Consent withdrawn|4
7685613|NCT00318461|12103804|FG003|Double-Blind, 6 Months|Consent withdrawn|10
7685614|NCT00318461|12103805|FG004|Double-Blind, 6 Months|Consent withdrawn|4
7685615|NCT00318461|12103801|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0
7685616|NCT00318461|12103802|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2
7685617|NCT00318461|12103803|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1
7685618|NCT00318461|12103804|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0
7685619|NCT00318461|12103805|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2
7685620|NCT00318461|12103801|FG000|Double-Blind, 6 Months|Move|0
7685621|NCT00318461|12103802|FG001|Double-Blind, 6 Months|Move|1
7685622|NCT00318461|12103803|FG002|Double-Blind, 6 Months|Move|0
7685623|NCT00318461|12103804|FG003|Double-Blind, 6 Months|Move|0
7685624|NCT00318461|12103805|FG004|Double-Blind, 6 Months|Move|0
7685625|NCT00318461|12103801|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
7685626|NCT00318461|12103802|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
7685627|NCT00318461|12103803|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
7685628|NCT00318461|12103804|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
7685629|NCT00318461|12103805|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
7685630|NCT00318461|12103801|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1
7685631|NCT00318461|12103802|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0
7685632|NCT00318461|12103803|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0
7685633|NCT00318461|12103804|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2
7685634|NCT00318461|12103805|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0
7685635|NCT00318461|12103801|FG000|Double-Blind, 6 Months|Work commitment|0
7685636|NCT00318461|12103802|FG001|Double-Blind, 6 Months|Work commitment|0
7685637|NCT00318461|12103803|FG002|Double-Blind, 6 Months|Work commitment|0
7685638|NCT00318461|12103804|FG003|Double-Blind, 6 Months|Work commitment|0
7685639|NCT00318461|12103805|FG004|Double-Blind, 6 Months|Work commitment|1
7685640|NCT00318461|12103801|FG000|Double-Blind, 6 Months|Investigator decision|0
7685641|NCT00318461|12103802|FG001|Double-Blind, 6 Months|Investigator decision|0
7685642|NCT00318461|12103803|FG002|Double-Blind, 6 Months|Investigator decision|0
7685643|NCT00318461|12103804|FG003|Double-Blind, 6 Months|Investigator decision|0
7685644|NCT00318461|12103805|FG004|Double-Blind, 6 Months|Investigator decision|1
7685645|NCT00318461|12103801|FG000|Double-Blind, 6 Months|Lack of time|1
7685646|NCT00318461|12103802|FG001|Double-Blind, 6 Months|Lack of time|0
7685647|NCT00318461|12103803|FG002|Double-Blind, 6 Months|Lack of time|0
7685648|NCT00318461|12103804|FG003|Double-Blind, 6 Months|Lack of time|0
7685649|NCT00318461|12103805|FG004|Double-Blind, 6 Months|Lack of time|0
7685650|NCT00318461|12103801|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
7685651|NCT00318461|12103802|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
7685652|NCT00318461|12103803|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
7685653|NCT00318461|12103804|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
7685654|NCT00318461|12103805|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
7685655|NCT00318461|12103801|FG000|Double-Blind, 6 Months|Hyperglicaemia|0
7685656|NCT00318461|12103802|FG001|Double-Blind, 6 Months|Hyperglicaemia|0
7685657|NCT00318461|12103803|FG002|Double-Blind, 6 Months|Hyperglicaemia|0
7685658|NCT00318461|12103804|FG003|Double-Blind, 6 Months|Hyperglicaemia|1
7685659|NCT00318461|12103805|FG004|Double-Blind, 6 Months|Hyperglicaemia|0
7685660|NCT00318461|12103801|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
7685661|NCT00318461|12103802|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
7685662|NCT00318461|12103803|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
7685663|NCT00318461|12103804|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
7685664|NCT00318461|12103805|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
7685665|NCT00318461|12103801|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0
7685666|NCT00318461|12103802|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1
7685667|NCT00318461|12103803|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0
7685668|NCT00318461|12103804|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0
7685669|NCT00318461|12103805|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0
7685670|NCT00318461|12103801|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
7685671|NCT00318461|12103802|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
7685672|NCT00318461|12103803|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
7685673|NCT00318461|12103804|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
7685674|NCT00318461|12103805|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
7685675|NCT00318461|12103801|FG000|Open-Label Extension, 18 Months|Adverse Event|11
7685676|NCT00318461|12103802|FG001|Open-Label Extension, 18 Months|Adverse Event|8
7685677|NCT00318461|12103803|FG002|Open-Label Extension, 18 Months|Adverse Event|6
7685678|NCT00318461|12103804|FG003|Open-Label Extension, 18 Months|Adverse Event|1
7685679|NCT00318461|12103805|FG004|Open-Label Extension, 18 Months|Adverse Event|6
7685680|NCT00318461|12103801|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41
7685681|NCT00318461|12103802|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33
7685682|NCT00318461|12103803|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37
7685683|NCT00318461|12103804|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27
7685684|NCT00318461|12103805|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63
7685685|NCT00318461|12103801|FG000|Open-Label Extension, 18 Months|Protocol Violation|7
7685686|NCT00318461|12103802|FG001|Open-Label Extension, 18 Months|Protocol Violation|5
7685687|NCT00318461|12103803|FG002|Open-Label Extension, 18 Months|Protocol Violation|3
7685688|NCT00318461|12103804|FG003|Open-Label Extension, 18 Months|Protocol Violation|4
7685689|NCT00318461|12103805|FG004|Open-Label Extension, 18 Months|Protocol Violation|6
7685690|NCT00318474|12103819|FG000|Overall Study|Adverse Event|1
7685691|NCT00318474|12103820|FG001|Overall Study|Adverse Event|1
7685692|NCT00318474|12103819|FG000|Overall Study|Lost to Follow-up|0
7685693|NCT00318474|12103820|FG001|Overall Study|Lost to Follow-up|1
7685694|NCT00318474|12103819|FG000|Overall Study|Pregnancy|0
7685695|NCT00318474|12103820|FG001|Overall Study|Pregnancy|2
7685696|NCT00318474|12103819|FG000|Overall Study|Protocol Violation|1
7685697|NCT00318474|12103820|FG001|Overall Study|Protocol Violation|0
7685698|NCT00318474|12103819|FG000|Overall Study|Withdrawal by Subject|3
7685699|NCT00318474|12103820|FG001|Overall Study|Withdrawal by Subject|2
7685700|NCT00318474|12103819|FG000|Overall Study|Fall in GFR|3
7685701|NCT00318474|12103820|FG001|Overall Study|Fall in GFR|3
7685702|NCT00318474|12103819|FG000|Overall Study|Post-therapy hyperflycemia|0
7685703|NCT00318474|12103820|FG001|Overall Study|Post-therapy hyperflycemia|1
7685704|NCT00318474|12103819|FG000|Overall Study|Trial terminated|10
7685705|NCT00318474|12103820|FG001|Overall Study|Trial terminated|7
7685706|NCT00318565|12103826|FG000|Overall Study|Excluded per protocol|24
7685707|NCT00318643|12103846|FG000|Overall Study|Adverse Event|0
7685708|NCT00318643|12103847|FG001|Overall Study|Adverse Event|0
7685709|NCT00318643|12103848|FG002|Overall Study|Adverse Event|0
7685710|NCT00318643|12103849|FG003|Overall Study|Adverse Event|0
7685711|NCT00318643|12103850|FG004|Overall Study|Adverse Event|1
7685712|NCT00318643|12103846|FG000|Overall Study|Participant's Decision|0
7685713|NCT00318643|12103847|FG001|Overall Study|Participant's Decision|0
7685714|NCT00318643|12103848|FG002|Overall Study|Participant's Decision|0
7685715|NCT00318643|12103849|FG003|Overall Study|Participant's Decision|0
7685716|NCT00318643|12103850|FG004|Overall Study|Participant's Decision|1
7685717|NCT00318643|12103846|FG000|Overall Study|Investigator's Decision|0
7685718|NCT00318643|12103847|FG001|Overall Study|Investigator's Decision|0
7685719|NCT00318643|12103848|FG002|Overall Study|Investigator's Decision|0
7685720|NCT00318643|12103849|FG003|Overall Study|Investigator's Decision|0
7685721|NCT00318643|12103850|FG004|Overall Study|Investigator's Decision|1
7685722|NCT00319020|12103891|FG000|Overall Study|Death|2
7685723|NCT00319020|12103892|FG001|Overall Study|Death|2
7685724|NCT00319020|12103891|FG000|Overall Study|Withdrawal by Subject|4
7685725|NCT00319020|12103892|FG001|Overall Study|Withdrawal by Subject|1
7685726|NCT00319020|12103891|FG000|Overall Study|F-1 completed but not enrolled in F-2|1
7685727|NCT00319020|12103892|FG001|Overall Study|F-1 completed but not enrolled in F-2|0
7685728|NCT00319020|12103891|FG000|Overall Study|Administrative reason|0
7685729|NCT00319020|12103892|FG001|Overall Study|Administrative reason|5
7685730|NCT00319020|12103891|FG000|Overall Study|Disease progression|0
7685731|NCT00319020|12103892|FG001|Overall Study|Disease progression|2
7685732|NCT00319020|12103891|FG000|Overall Study|Transplant|0
7685733|NCT00319020|12103892|FG001|Overall Study|Transplant|1
7685734|NCT00319020|12103891|FG000|Overall Study|Treatment failure|0
7685735|NCT00319020|12103892|FG001|Overall Study|Treatment failure|1
7685736|NCT00319020|12103891|FG000|Overall Study|Adverse Event|0
7685737|NCT00319020|12103892|FG001|Overall Study|Adverse Event|1
7685738|NCT00319046|12103900|FG000|Overall Study|withdrawal of subject's consent|7
7685739|NCT00319046|12103900|FG000|Overall Study|administrative reason|1
7685740|NCT00319098|12103908|FG000|Overall Study|Serious adverse event|3
7685741|NCT00319098|12103909|FG001|Overall Study|Serious adverse event|0
7685742|NCT00319098|12103908|FG000|Overall Study|Adverse Event|20
7685743|NCT00319098|12103909|FG001|Overall Study|Adverse Event|1
7685744|NCT00319098|12103908|FG000|Overall Study|Withdrawal by Subject|37
7685745|NCT00319098|12103909|FG001|Overall Study|Withdrawal by Subject|8
7685746|NCT00319098|12103908|FG000|Overall Study|Migrated/moved from study area|2
7685747|NCT00319098|12103909|FG001|Overall Study|Migrated/moved from study area|1
7685748|NCT00319098|12103908|FG000|Overall Study|Lost to Follow-up|37
7685749|NCT00319098|12103909|FG001|Overall Study|Lost to Follow-up|13
7685750|NCT00319098|12103908|FG000|Overall Study|Others|33
7685751|NCT00319098|12103909|FG001|Overall Study|Others|8
7685752|NCT00319098|12103908|FG000|Overall Study|Protocol Violation|3
7685753|NCT00319098|12103909|FG001|Overall Study|Protocol Violation|1
7685754|NCT00319111|12103919|FG000|Overall Study|Adverse Event|20
7685755|NCT00319111|12103919|FG000|Overall Study|Withdrawal of consent|11
7685756|NCT00319111|12103919|FG000|Overall Study|Death|9
7685757|NCT00319111|12103919|FG000|Overall Study|Lack of clinical improvement|4
7685758|NCT00319111|12103919|FG000|Overall Study|Administrative|2
7685759|NCT00319111|12103919|FG000|Overall Study|Treatment failure|1
7685760|NCT00319254|12103923|FG000|Overall Study|Withdrawal by Subject|4
7685761|NCT00319254|12103923|FG000|Overall Study|Death|46
7685762|NCT00319254|12103923|FG000|Overall Study|Lost to Follow-up|2
7685763|NCT00319254|12103923|FG000|Overall Study|Enrolled, Not Treated|2
7685764|NCT00319436|12103929|FG000|Overall Study|Withdrawal by Subject|6
7685765|NCT00319436|12103930|FG001|Overall Study|Withdrawal by Subject|7
7685766|NCT00319501|12103938|FG000|Double-blind Period|Withdrawal by Subject|0
7685767|NCT00319501|12103939|FG001|Double-blind Period|Withdrawal by Subject|3
7685768|NCT00319501|12103938|FG000|Double-blind Period|Sponsor Request|1
7685769|NCT00319501|12103939|FG001|Double-blind Period|Sponsor Request|0
7685770|NCT00319501|12103938|FG000|Double-blind Period|Did not receive treatment|42
7685771|NCT00319501|12103939|FG001|Double-blind Period|Did not receive treatment|29
7685772|NCT00319501|12103938|FG000|Open-label Period|Adverse Event|5
7685773|NCT00319501|12103939|FG001|Open-label Period|Adverse Event|0
7685774|NCT00319501|12103938|FG000|Open-label Period|Protocol Violation|6
7685775|NCT00319501|12103939|FG001|Open-label Period|Protocol Violation|0
7685776|NCT00319501|12103938|FG000|Open-label Period|Withdrawal by Subject|38
7685777|NCT00319501|12103939|FG001|Open-label Period|Withdrawal by Subject|0
7685778|NCT00319501|12103938|FG000|Open-label Period|Principal Investigator decision|6
7685779|NCT00319501|12103939|FG001|Open-label Period|Principal Investigator decision|0
7685780|NCT00319501|12103938|FG000|Open-label Period|Sponsor request|12
7685781|NCT00319501|12103939|FG001|Open-label Period|Sponsor request|0
7685782|NCT00319501|12103938|FG000|Open-label Period|Lost to Follow-up|5
7685783|NCT00319501|12103939|FG001|Open-label Period|Lost to Follow-up|0
7685784|NCT00319501|12103938|FG000|Open-label Period|Did not receive treatment|33
7685785|NCT00319501|12103939|FG001|Open-label Period|Did not receive treatment|0
7685786|NCT00319501|12103938|FG000|Open-label Period|Other|11
7685787|NCT00319501|12103939|FG001|Open-label Period|Other|0
7685788|NCT00319501|12103938|FG000|Open-label Extension Period|Adverse Event|2
7685789|NCT00319501|12103939|FG001|Open-label Extension Period|Adverse Event|0
7685790|NCT00319501|12103938|FG000|Open-label Extension Period|Did not receive treatment|18
7685791|NCT00319501|12103939|FG001|Open-label Extension Period|Did not receive treatment|0
7685792|NCT00319501|12103938|FG000|Open-label Extension Period|Other|1
7685793|NCT00319501|12103939|FG001|Open-label Extension Period|Other|0
7685794|NCT00319501|12103938|FG000|Open-label Extension Period|Principal investigator decision|2
7685795|NCT00319501|12103939|FG001|Open-label Extension Period|Principal investigator decision|0
7685796|NCT00319501|12103938|FG000|Open-label Extension Period|Sponsor request|26
7685797|NCT00319501|12103939|FG001|Open-label Extension Period|Sponsor request|0
7685798|NCT00319501|12103938|FG000|Open-label Extension Period|Withdrawal by Subject|2
7685799|NCT00319501|12103939|FG001|Open-label Extension Period|Withdrawal by Subject|0
7685800|NCT00319553|12103952|FG000|Overall Study|Protocol Violation|1
7685801|NCT00319553|12103953|FG001|Overall Study|Protocol Violation|2
7685802|NCT00319553|12103952|FG000|Overall Study|Lost to Follow-up|2
7685803|NCT00319553|12103953|FG001|Overall Study|Lost to Follow-up|1
7685804|NCT00319553|12103952|FG000|Overall Study|Withdrawal by Subject|1
7685805|NCT00319553|12103953|FG001|Overall Study|Withdrawal by Subject|1
7685806|NCT00319592|12103961|FG000|Overall Study|Protocol Violation|1
7685807|NCT00319592|12103962|FG001|Overall Study|Protocol Violation|0
7685808|NCT00319592|12103961|FG000|Overall Study|Physician Decision|0
7685809|NCT00319592|12103962|FG001|Overall Study|Physician Decision|1
7685810|NCT00319696|12103977|FG000|Overall Study|Adverse Event|36
7685811|NCT00319696|12103977|FG000|Overall Study|withdrawal of consent|14
7685812|NCT00319696|12103977|FG000|Overall Study|administrative|7
7685813|NCT00319696|12103977|FG000|Overall Study|Lost to Follow-up|3
7685814|NCT00319735|12103987|FG000|Overall Study|Death|2
7685815|NCT00319956|12104004|FG000|Overall Study|Death|20
7685816|NCT00319956|12104005|FG001|Overall Study|Death|24
7685817|NCT00319982|12104013|FG000|Overall Study|Withdrawal by Subject|1
7685818|NCT00319982|12104014|FG001|Overall Study|Withdrawal by Subject|0
7685819|NCT00320112|12104022|FG000|Overall Study|Lost to Follow-up|3
7685820|NCT00320112|12104023|FG001|Overall Study|Lost to Follow-up|4
7685821|NCT00320112|12104022|FG000|Overall Study|Withdrawal by Subject|3
7685822|NCT00320112|12104023|FG001|Overall Study|Withdrawal by Subject|0
7685823|NCT00320112|12104022|FG000|Overall Study|Death|2
7685824|NCT00320112|12104023|FG001|Overall Study|Death|1
7685825|NCT00320190|12104037|FG000|First 12 Months|Completed but did not enter extension|5
7685826|NCT00320190|12104038|FG001|First 12 Months|Completed but did not enter extension|3
7685827|NCT00320190|12104037|FG000|First 12 Months|Sponsor terminated study|2
7685828|NCT00320190|12104038|FG001|First 12 Months|Sponsor terminated study|2
7685829|NCT00320190|12104037|FG000|First 12 Months|Lost to Follow-up|0
7685830|NCT00320190|12104038|FG001|First 12 Months|Lost to Follow-up|1
7685831|NCT00320190|12104037|FG000|First 12 Months|Enrollment failure|0
7685832|NCT00320190|12104038|FG001|First 12 Months|Enrollment failure|1
7685833|NCT00320190|12104037|FG000|First 12 Months|Adverse event unrelated to study drug|1
7685834|NCT00320190|12104038|FG001|First 12 Months|Adverse event unrelated to study drug|0
7685835|NCT00320190|12104037|FG000|First 12 Months|Investigator request|0
7685836|NCT00320190|12104038|FG001|First 12 Months|Investigator request|1
7685837|NCT00320190|12104037|FG000|First 12 Months|Study drug toxicity|0
7685838|NCT00320190|12104038|FG001|First 12 Months|Study drug toxicity|1
7685839|NCT00320190|12104037|FG000|First 12 Months|Withdrawal by Subject|0
7685840|NCT00320190|12104038|FG001|First 12 Months|Withdrawal by Subject|1
7685841|NCT00320190|12104037|FG000|Long-term (12-month) Extension|Sponsor terminated study|7
7685842|NCT00320190|12104038|FG001|Long-term (12-month) Extension|Sponsor terminated study|0
7685843|NCT00320190|12104037|FG000|Long-term (12-month) Extension|Lack of major molecular response|1
7685844|NCT00320190|12104038|FG001|Long-term (12-month) Extension|Lack of major molecular response|2
7685845|NCT00320190|12104037|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1
7685846|NCT00320190|12104038|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0
7685847|NCT00320216|12104049|FG000|Overall Study|Adverse Event|0
7685848|NCT00320216|12104050|FG001|Overall Study|Adverse Event|6
7685849|NCT00320216|12104051|FG002|Overall Study|Adverse Event|0
7685850|NCT00320216|12104052|FG003|Overall Study|Adverse Event|2
7685851|NCT00320216|12104053|FG004|Overall Study|Adverse Event|2
7685852|NCT00320216|12104049|FG000|Overall Study|Lack of Efficacy|6
7685853|NCT00320216|12104050|FG001|Overall Study|Lack of Efficacy|2
7685854|NCT00320216|12104051|FG002|Overall Study|Lack of Efficacy|1
7685855|NCT00320216|12104052|FG003|Overall Study|Lack of Efficacy|0
7685856|NCT00320216|12104053|FG004|Overall Study|Lack of Efficacy|1
7685857|NCT00320216|12104049|FG000|Overall Study|Lost to Follow-up|3
7685858|NCT00320216|12104050|FG001|Overall Study|Lost to Follow-up|0
7685859|NCT00320216|12104051|FG002|Overall Study|Lost to Follow-up|0
7685860|NCT00320216|12104052|FG003|Overall Study|Lost to Follow-up|0
7685861|NCT00320216|12104053|FG004|Overall Study|Lost to Follow-up|0
7685862|NCT00320216|12104049|FG000|Overall Study|Other|7
7685863|NCT00320216|12104050|FG001|Overall Study|Other|2
7685864|NCT00320216|12104051|FG002|Overall Study|Other|5
7685865|NCT00320216|12104052|FG003|Overall Study|Other|1
7685866|NCT00320216|12104053|FG004|Overall Study|Other|3
7685867|NCT00320255|12104084|FG000|Overall Study|Lack of Efficacy|1
7685868|NCT00320255|12104085|FG001|Overall Study|Lack of Efficacy|0
7685869|NCT00320255|12104086|FG002|Overall Study|Lack of Efficacy|0
7685870|NCT00320255|12104087|FG003|Overall Study|Lack of Efficacy|0
7685871|NCT00320255|12104088|FG004|Overall Study|Lack of Efficacy|0
7685872|NCT00320255|12104089|FG005|Overall Study|Lack of Efficacy|0
7685873|NCT00320255|12104084|FG000|Overall Study|Adverse Event|5
7685874|NCT00320255|12104085|FG001|Overall Study|Adverse Event|2
7685875|NCT00320255|12104086|FG002|Overall Study|Adverse Event|3
7685876|NCT00320255|12104087|FG003|Overall Study|Adverse Event|2
7685877|NCT00320255|12104088|FG004|Overall Study|Adverse Event|0
7685878|NCT00320255|12104089|FG005|Overall Study|Adverse Event|0
7685879|NCT00320255|12104084|FG000|Overall Study|Withdrawal by Subject|1
7685880|NCT00320255|12104085|FG001|Overall Study|Withdrawal by Subject|2
7685881|NCT00320255|12104086|FG002|Overall Study|Withdrawal by Subject|2
7685882|NCT00320255|12104087|FG003|Overall Study|Withdrawal by Subject|4
7685883|NCT00320255|12104088|FG004|Overall Study|Withdrawal by Subject|0
7685884|NCT00320255|12104089|FG005|Overall Study|Withdrawal by Subject|0
7685885|NCT00320255|12104084|FG000|Overall Study|Poor compliance/noncompliance|1
7685886|NCT00320255|12104085|FG001|Overall Study|Poor compliance/noncompliance|1
7685887|NCT00320255|12104086|FG002|Overall Study|Poor compliance/noncompliance|0
7685888|NCT00320255|12104087|FG003|Overall Study|Poor compliance/noncompliance|1
7685889|NCT00320255|12104088|FG004|Overall Study|Poor compliance/noncompliance|0
7685890|NCT00320255|12104089|FG005|Overall Study|Poor compliance/noncompliance|0
7685891|NCT00320255|12104084|FG000|Overall Study|No longer meets study criteria|0
7685892|NCT00320255|12104085|FG001|Overall Study|No longer meets study criteria|0
7685893|NCT00320255|12104086|FG002|Overall Study|No longer meets study criteria|0
7685894|NCT00320255|12104087|FG003|Overall Study|No longer meets study criteria|1
7685895|NCT00320255|12104088|FG004|Overall Study|No longer meets study criteria|0
7685896|NCT00320255|12104089|FG005|Overall Study|No longer meets study criteria|0
7685897|NCT00320255|12104084|FG000|Overall Study|Other|3
7685898|NCT00320255|12104085|FG001|Overall Study|Other|2
7685899|NCT00320255|12104086|FG002|Overall Study|Other|1
7685900|NCT00320255|12104087|FG003|Overall Study|Other|0
7685901|NCT00320255|12104088|FG004|Overall Study|Other|0
7685902|NCT00320255|12104089|FG005|Overall Study|Other|0
7685903|NCT00320372|12104118|FG000|Overall Study|Physician Decision|4
7685904|NCT00320372|12104119|FG001|Overall Study|Physician Decision|7
7685905|NCT00320372|12104118|FG000|Overall Study|Death|7
7685906|NCT00320372|12104119|FG001|Overall Study|Death|8
7685907|NCT00320372|12104118|FG000|Overall Study|Withdrawal by Subject|55
7685908|NCT00320372|12104119|FG001|Overall Study|Withdrawal by Subject|37
7685909|NCT00320372|12104118|FG000|Overall Study|Non-Compliance|40
7685910|NCT00320372|12104119|FG001|Overall Study|Non-Compliance|39
7685911|NCT00320372|12104118|FG000|Overall Study|Did not Meet (I/E)|3
7685912|NCT00320372|12104119|FG001|Overall Study|Did not Meet (I/E)|1
7685913|NCT00320372|12104118|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86
7685914|NCT00320372|12104119|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71
7685915|NCT00320385|12104135|FG000|Overall Study|Lost to Follow-up|7
7685916|NCT00320385|12104136|FG001|Overall Study|Lost to Follow-up|10
7685917|NCT00320385|12104135|FG000|Overall Study|Withdrawal by Subject|6
7685918|NCT00320385|12104136|FG001|Overall Study|Withdrawal by Subject|7
7685919|NCT00320385|12104135|FG000|Overall Study|Sponsor Terminated Study|2
7685920|NCT00320385|12104136|FG001|Overall Study|Sponsor Terminated Study|1
7685921|NCT00320385|12104135|FG000|Overall Study|Investigator Decision|0
7685922|NCT00320385|12104136|FG001|Overall Study|Investigator Decision|1
7685923|NCT00320385|12104135|FG000|Overall Study|Death|1
7685924|NCT00320385|12104136|FG001|Overall Study|Death|2
7685925|NCT00320385|12104135|FG000|Overall Study|Serious Adverse Event|1
7685926|NCT00320385|12104136|FG001|Overall Study|Serious Adverse Event|0
7685927|NCT00320385|12104135|FG000|Overall Study|Withdrew Consent|1
7685928|NCT00320385|12104136|FG001|Overall Study|Withdrew Consent|0
7685929|NCT00320385|12104135|FG000|Overall Study|Adverse Event|0
7685930|NCT00320385|12104136|FG001|Overall Study|Adverse Event|1
7685931|NCT00320398|12104144|FG000|Overall Study|Adverse Event|1
7685932|NCT00320398|12104145|FG001|Overall Study|Adverse Event|4
7685933|NCT00320398|12104144|FG000|Overall Study|Other|1
7685934|NCT00320398|12104145|FG001|Overall Study|Other|0
7685935|NCT00320411|12104152|FG000|Overall Study|No investigational product admin.|4
7685936|NCT00320424|12104156|FG000|Overall Study|Adverse Event|3
7685937|NCT00320424|12104156|FG000|Overall Study|Other|3
7685938|NCT00320489|12104162|FG000|Overall Study|Adverse Event|26
7685939|NCT00320489|12104163|FG001|Overall Study|Adverse Event|25
7685940|NCT00320489|12104162|FG000|Overall Study|Clinical Relapse|26
7685941|NCT00320489|12104163|FG001|Overall Study|Clinical Relapse|20
7685942|NCT00320489|12104162|FG000|Overall Study|Death|0
7685943|NCT00320489|12104163|FG001|Overall Study|Death|2
7685944|NCT00320489|12104162|FG000|Overall Study|Entry Criteria Exclusion|2
7685945|NCT00320489|12104163|FG001|Overall Study|Entry Criteria Exclusion|4
7685946|NCT00320489|12104162|FG000|Overall Study|Lack of Efficacy|16
7685947|NCT00320489|12104163|FG001|Overall Study|Lack of Efficacy|7
7685948|NCT00320489|12104162|FG000|Overall Study|Lost to Follow-up|21
7685949|NCT00320489|12104163|FG001|Overall Study|Lost to Follow-up|22
7685950|NCT00320489|12104162|FG000|Overall Study|Physician Decision|8
7685951|NCT00320489|12104163|FG001|Overall Study|Physician Decision|8
7685952|NCT00320489|12104162|FG000|Overall Study|Protocol Violation|4
7685953|NCT00320489|12104163|FG001|Overall Study|Protocol Violation|4
7685954|NCT00320489|12104162|FG000|Overall Study|Sponsor Decision|3
7685955|NCT00320489|12104163|FG001|Overall Study|Sponsor Decision|3
7685956|NCT00320489|12104162|FG000|Overall Study|Withdrawal by Subject|39
7685957|NCT00320489|12104163|FG001|Overall Study|Withdrawal by Subject|41
7685958|NCT00320515|12104169|FG000|Overall Study|Death|33
7685959|NCT00320515|12104169|FG000|Overall Study|Lost to Follow-up|6
7685960|NCT00320515|12104169|FG000|Overall Study|Physician Decision|2
7685961|NCT00320515|12104169|FG000|Overall Study|Withdrawal by Subject|8
7685962|NCT00320528|12104176|FG000|Study Period II|Adverse Event|3
7685963|NCT00320528|12104177|FG001|Study Period II|Adverse Event|4
7685964|NCT00320528|12104178|FG002|Study Period II|Adverse Event|8
7685965|NCT00320528|12104176|FG000|Study Period II|Parent/Caregiver Decision|8
7685966|NCT00320528|12104177|FG001|Study Period II|Parent/Caregiver Decision|3
7685967|NCT00320528|12104178|FG002|Study Period II|Parent/Caregiver Decision|11
7685968|NCT00320528|12104176|FG000|Study Period II|Withdrawal by Subject|0
7685969|NCT00320528|12104177|FG001|Study Period II|Withdrawal by Subject|1
7685970|NCT00320528|12104178|FG002|Study Period II|Withdrawal by Subject|1
7685971|NCT00320528|12104176|FG000|Study Period II|Entry Criteria Exclusion|0
7685972|NCT00320528|12104177|FG001|Study Period II|Entry Criteria Exclusion|2
7685973|NCT00320528|12104178|FG002|Study Period II|Entry Criteria Exclusion|2
7685974|NCT00320528|12104176|FG000|Study Period III|Adverse Event|1
7685975|NCT00320528|12104177|FG001|Study Period III|Adverse Event|0
7685976|NCT00320528|12104178|FG002|Study Period III|Adverse Event|0
7685977|NCT00320528|12104176|FG000|Study Period III|Lost to Follow-up|1
7685978|NCT00320528|12104177|FG001|Study Period III|Lost to Follow-up|0
7685979|NCT00320528|12104178|FG002|Study Period III|Lost to Follow-up|0
7685980|NCT00320528|12104176|FG000|Study Period III|Withdrawal by Subject|1
7685981|NCT00320528|12104177|FG001|Study Period III|Withdrawal by Subject|1
7685982|NCT00320528|12104178|FG002|Study Period III|Withdrawal by Subject|2
7685983|NCT00320528|12104176|FG000|Study Period III|Lack of Efficacy|2
7685984|NCT00320528|12104177|FG001|Study Period III|Lack of Efficacy|0
7685985|NCT00320528|12104178|FG002|Study Period III|Lack of Efficacy|0
7685986|NCT00320528|12104176|FG000|Study Period III|Parent/Caregiver Decision|14
7685987|NCT00320528|12104177|FG001|Study Period III|Parent/Caregiver Decision|3
7685988|NCT00320528|12104178|FG002|Study Period III|Parent/Caregiver Decision|11
7685989|NCT00320528|12104176|FG000|Study Period III|Protocol Violation|0
7685990|NCT00320528|12104177|FG001|Study Period III|Protocol Violation|1
7685991|NCT00320528|12104178|FG002|Study Period III|Protocol Violation|0
7685992|NCT00320528|12104176|FG000|Study Period III|Physician Decision|0
7685993|NCT00320528|12104177|FG001|Study Period III|Physician Decision|1
7685994|NCT00320528|12104178|FG002|Study Period III|Physician Decision|2
7685995|NCT00320528|12104176|FG000|Study Period III|Sponsor Decision|0
7685996|NCT00320528|12104177|FG001|Study Period III|Sponsor Decision|0
7685997|NCT00320528|12104178|FG002|Study Period III|Sponsor Decision|1
7685998|NCT00320528|12104176|FG000|Study Period III|Atomoxetine Commercially Available|68
7685999|NCT00320528|12104177|FG001|Study Period III|Atomoxetine Commercially Available|25
7686000|NCT00320528|12104178|FG002|Study Period III|Atomoxetine Commercially Available|90
7686001|NCT00320541|12104188|FG000|Overall Study|Adverse Event|21
7686002|NCT00320541|12104189|FG001|Overall Study|Adverse Event|19
7686003|NCT00320541|12104188|FG000|Overall Study|Protocol Violation|0
7686004|NCT00320541|12104189|FG001|Overall Study|Protocol Violation|1
7686005|NCT00320541|12104188|FG000|Overall Study|Withdrawal by Subject|12
7686006|NCT00320541|12104189|FG001|Overall Study|Withdrawal by Subject|16
7686007|NCT00320541|12104188|FG000|Overall Study|Physician Decision|9
7686008|NCT00320541|12104189|FG001|Overall Study|Physician Decision|13
7686009|NCT00320541|12104188|FG000|Overall Study|Other|3
7686010|NCT00320541|12104189|FG001|Overall Study|Other|4
7686011|NCT00320541|12104188|FG000|Overall Study|Sponsor Decision|2
7686012|NCT00320541|12104189|FG001|Overall Study|Sponsor Decision|1
7686013|NCT00320541|12104188|FG000|Overall Study|Death due to Study Disease|1
7686014|NCT00320541|12104189|FG001|Overall Study|Death due to Study Disease|3
7686015|NCT00320541|12104188|FG000|Overall Study|Death due to Adverse Event(s)|1
7686016|NCT00320541|12104189|FG001|Overall Study|Death due to Adverse Event(s)|0
7686017|NCT00320541|12104188|FG000|Overall Study|Protocol Entry Criterion Not Met|1
7686018|NCT00320541|12104189|FG001|Overall Study|Protocol Entry Criterion Not Met|0
7686019|NCT00320593|12104197|FG000|Overall Study|Lost to Follow-up|3
7686020|NCT00320593|12104198|FG001|Overall Study|Lost to Follow-up|0
7686021|NCT00320593|12104197|FG000|Overall Study|Moved to another state|1
7686022|NCT00320593|12104198|FG001|Overall Study|Moved to another state|0
7686023|NCT00320593|12104197|FG000|Overall Study|Withdrawal by Subject|2
7686024|NCT00320593|12104198|FG001|Overall Study|Withdrawal by Subject|1
7686025|NCT00320593|12104197|FG000|Overall Study|Withdrawal by clinical center|1
7686026|NCT00320593|12104198|FG001|Overall Study|Withdrawal by clinical center|0
7686027|NCT00320606|12104204|FG000|Overall Study|Adverse Event|1
7686028|NCT00320606|12104204|FG000|Overall Study|Protocol Violation|1
7686029|NCT00320606|12104204|FG000|Overall Study|Withdrawal by Subject|1
7686030|NCT00320710|12104221|FG000|Overall Study|Disease progression|24
7686031|NCT00320710|12104222|FG001|Overall Study|Disease progression|19
7686032|NCT00320710|12104223|FG002|Overall Study|Disease progression|2
7686033|NCT00320710|12104221|FG000|Overall Study|Death|10
7686034|NCT00320710|12104222|FG001|Overall Study|Death|7
7686035|NCT00320710|12104223|FG002|Overall Study|Death|1
7686036|NCT00320710|12104221|FG000|Overall Study|Administrative problems|1
7686037|NCT00320710|12104222|FG001|Overall Study|Administrative problems|2
7686038|NCT00320710|12104223|FG002|Overall Study|Administrative problems|0
7686039|NCT00320710|12104221|FG000|Overall Study|Withdrawal by Subject|20
7686040|NCT00320710|12104222|FG001|Overall Study|Withdrawal by Subject|26
7686041|NCT00320710|12104223|FG002|Overall Study|Withdrawal by Subject|1
7686042|NCT00320710|12104221|FG000|Overall Study|Protocol Violation|6
7686043|NCT00320710|12104222|FG001|Overall Study|Protocol Violation|5
7686044|NCT00320710|12104223|FG002|Overall Study|Protocol Violation|0
7686045|NCT00320710|12104221|FG000|Overall Study|Abnormal test procedure result(s)|2
7686046|NCT00320710|12104222|FG001|Overall Study|Abnormal test procedure result(s)|0
7686047|NCT00320710|12104223|FG002|Overall Study|Abnormal test procedure result(s)|0
7686048|NCT00320710|12104221|FG000|Overall Study|Abnormal laboratory value(s)|12
7686049|NCT00320710|12104222|FG001|Overall Study|Abnormal laboratory value(s)|3
7686050|NCT00320710|12104223|FG002|Overall Study|Abnormal laboratory value(s)|0
7686051|NCT00320710|12104221|FG000|Overall Study|Adverse Event|18
7686052|NCT00320710|12104222|FG001|Overall Study|Adverse Event|14
7686053|NCT00320710|12104223|FG002|Overall Study|Adverse Event|1
7686054|NCT00320710|12104221|FG000|Overall Study|Lost to Follow-up|1
7686055|NCT00320710|12104222|FG001|Overall Study|Lost to Follow-up|0
7686056|NCT00320710|12104223|FG002|Overall Study|Lost to Follow-up|0
7686057|NCT00320788|12104242|FG000|Overall Study|Adverse Event|0
7686058|NCT00320788|12104243|FG001|Overall Study|Adverse Event|0
7686059|NCT00320788|12104244|FG002|Overall Study|Adverse Event|0
7686060|NCT00320788|12104245|FG003|Overall Study|Adverse Event|1
7686061|NCT00320788|12104246|FG004|Overall Study|Adverse Event|0
7686062|NCT00320788|12104242|FG000|Overall Study|Death|0
7686063|NCT00320788|12104243|FG001|Overall Study|Death|0
7686064|NCT00320788|12104244|FG002|Overall Study|Death|1
7686065|NCT00320788|12104245|FG003|Overall Study|Death|0
7686066|NCT00320788|12104246|FG004|Overall Study|Death|1
7686067|NCT00320788|12104242|FG000|Overall Study|Lost to Follow-up|0
7686068|NCT00320788|12104243|FG001|Overall Study|Lost to Follow-up|2
7686069|NCT00320788|12104244|FG002|Overall Study|Lost to Follow-up|1
7686070|NCT00320788|12104245|FG003|Overall Study|Lost to Follow-up|0
7686071|NCT00320788|12104246|FG004|Overall Study|Lost to Follow-up|0
7686072|NCT00320788|12104242|FG000|Overall Study|Decision by the Sponsor|1
7686073|NCT00320788|12104243|FG001|Overall Study|Decision by the Sponsor|1
7686074|NCT00320788|12104244|FG002|Overall Study|Decision by the Sponsor|0
7686075|NCT00320788|12104245|FG003|Overall Study|Decision by the Sponsor|0
7686076|NCT00320788|12104246|FG004|Overall Study|Decision by the Sponsor|1
7686077|NCT00320788|12104242|FG000|Overall Study|Other|1
7686078|NCT00320788|12104243|FG001|Overall Study|Other|2
7686079|NCT00320788|12104244|FG002|Overall Study|Other|1
7686080|NCT00320788|12104245|FG003|Overall Study|Other|1
7686081|NCT00320788|12104246|FG004|Overall Study|Other|1
7686082|NCT00320788|12104242|FG000|Overall Study|Physician Decision|1
7686083|NCT00320788|12104243|FG001|Overall Study|Physician Decision|1
7686084|NCT00320788|12104244|FG002|Overall Study|Physician Decision|0
7686085|NCT00320788|12104245|FG003|Overall Study|Physician Decision|0
7686086|NCT00320788|12104246|FG004|Overall Study|Physician Decision|0
7686087|NCT00320788|12104242|FG000|Overall Study|Protocol Violation|0
7686088|NCT00320788|12104243|FG001|Overall Study|Protocol Violation|0
7686089|NCT00320788|12104244|FG002|Overall Study|Protocol Violation|0
7686090|NCT00320788|12104245|FG003|Overall Study|Protocol Violation|0
7686091|NCT00320788|12104246|FG004|Overall Study|Protocol Violation|1
7686092|NCT00320788|12104242|FG000|Overall Study|Withdrawal by Subject|3
7686093|NCT00320788|12104243|FG001|Overall Study|Withdrawal by Subject|0
7686094|NCT00320788|12104244|FG002|Overall Study|Withdrawal by Subject|0
7686095|NCT00320788|12104245|FG003|Overall Study|Withdrawal by Subject|3
7686096|NCT00320788|12104246|FG004|Overall Study|Withdrawal by Subject|1
7686097|NCT00320801|12104266|FG000|Open-label Run-in Period|Withdrawal by Subject|2
7686098|NCT00320801|12104267|FG001|Open-label Run-in Period|Withdrawal by Subject|0
7686099|NCT00320801|12104268|FG002|Open-label Run-in Period|Withdrawal by Subject|0
7686100|NCT00320801|12104269|FG003|Open-label Run-in Period|Withdrawal by Subject|0
7686101|NCT00320801|12104266|FG000|Open-label Run-in Period|Adverse Event|33
7686102|NCT00320801|12104267|FG001|Open-label Run-in Period|Adverse Event|0
7686103|NCT00320801|12104268|FG002|Open-label Run-in Period|Adverse Event|0
7686104|NCT00320801|12104269|FG003|Open-label Run-in Period|Adverse Event|0
7686105|NCT00320801|12104266|FG000|Open-label Run-in Period|Administrative|10
7686106|NCT00320801|12104267|FG001|Open-label Run-in Period|Administrative|0
7686107|NCT00320801|12104268|FG002|Open-label Run-in Period|Administrative|0
7686108|NCT00320801|12104269|FG003|Open-label Run-in Period|Administrative|0
7686109|NCT00320801|12104266|FG000|Open-label Run-in Period|Lack of Efficacy|44
7686110|NCT00320801|12104267|FG001|Open-label Run-in Period|Lack of Efficacy|0
7686111|NCT00320801|12104268|FG002|Open-label Run-in Period|Lack of Efficacy|0
7686112|NCT00320801|12104269|FG003|Open-label Run-in Period|Lack of Efficacy|0
7686113|NCT00320801|12104266|FG000|Open-label Run-in Period|Lost to Follow-up|2
7686114|NCT00320801|12104267|FG001|Open-label Run-in Period|Lost to Follow-up|0
7686115|NCT00320801|12104268|FG002|Open-label Run-in Period|Lost to Follow-up|0
7686116|NCT00320801|12104269|FG003|Open-label Run-in Period|Lost to Follow-up|0
7686117|NCT00320801|12104266|FG000|Open-label Run-in Period|Did not qualify|1
7686118|NCT00320801|12104267|FG001|Open-label Run-in Period|Did not qualify|0
7686119|NCT00320801|12104268|FG002|Open-label Run-in Period|Did not qualify|0
7686120|NCT00320801|12104269|FG003|Open-label Run-in Period|Did not qualify|0
7686121|NCT00320801|12104266|FG000|Double-blind Phase|Withdrawal by Subject|0
7686122|NCT00320801|12104267|FG001|Double-blind Phase|Withdrawal by Subject|0
7686123|NCT00320801|12104268|FG002|Double-blind Phase|Withdrawal by Subject|1
7686124|NCT00320801|12104269|FG003|Double-blind Phase|Withdrawal by Subject|0
7686125|NCT00320801|12104266|FG000|Double-blind Phase|Adverse Event|0
7686126|NCT00320801|12104267|FG001|Double-blind Phase|Adverse Event|2
7686127|NCT00320801|12104268|FG002|Double-blind Phase|Adverse Event|8
7686128|NCT00320801|12104269|FG003|Double-blind Phase|Adverse Event|0
7686129|NCT00320801|12104266|FG000|Double-blind Phase|Administrative|0
7686130|NCT00320801|12104267|FG001|Double-blind Phase|Administrative|0
7686131|NCT00320801|12104268|FG002|Double-blind Phase|Administrative|4
7686132|NCT00320801|12104269|FG003|Double-blind Phase|Administrative|0
7686133|NCT00320801|12104266|FG000|Double-blind Phase|Lack of Efficacy|0
7686134|NCT00320801|12104267|FG001|Double-blind Phase|Lack of Efficacy|9
7686135|NCT00320801|12104268|FG002|Double-blind Phase|Lack of Efficacy|1
7686136|NCT00320801|12104269|FG003|Double-blind Phase|Lack of Efficacy|0
7686137|NCT00320801|12104266|FG000|Extension Phase|Withdrawal by Subject|0
7686138|NCT00320801|12104267|FG001|Extension Phase|Withdrawal by Subject|0
7686139|NCT00320801|12104268|FG002|Extension Phase|Withdrawal by Subject|0
7686140|NCT00320801|12104269|FG003|Extension Phase|Withdrawal by Subject|6
7686141|NCT00320801|12104266|FG000|Extension Phase|Adverse Event|0
7686142|NCT00320801|12104267|FG001|Extension Phase|Adverse Event|0
7686143|NCT00320801|12104268|FG002|Extension Phase|Adverse Event|0
7686144|NCT00320801|12104269|FG003|Extension Phase|Adverse Event|8
7686145|NCT00320801|12104266|FG000|Extension Phase|Administrative|0
7686146|NCT00320801|12104267|FG001|Extension Phase|Administrative|0
7686147|NCT00320801|12104268|FG002|Extension Phase|Administrative|0
7686148|NCT00320801|12104269|FG003|Extension Phase|Administrative|29
7686149|NCT00320801|12104266|FG000|Extension Phase|Lack of Efficacy|0
7686150|NCT00320801|12104267|FG001|Extension Phase|Lack of Efficacy|0
7686151|NCT00320801|12104268|FG002|Extension Phase|Lack of Efficacy|0
7686152|NCT00320801|12104269|FG003|Extension Phase|Lack of Efficacy|2
7686153|NCT00320801|12104266|FG000|Extension Phase|Lost to Follow-up|0
7686154|NCT00320801|12104267|FG001|Extension Phase|Lost to Follow-up|0
7686155|NCT00320801|12104268|FG002|Extension Phase|Lost to Follow-up|0
7686156|NCT00320801|12104269|FG003|Extension Phase|Lost to Follow-up|3
7686157|NCT00321048|12104281|FG000|Overall Study|Withdrawal by Subject|6
7686158|NCT00321048|12104282|FG001|Overall Study|Withdrawal by Subject|8
7686159|NCT00321373|12104306|FG000|Overall Study|Adverse Event|0
7686160|NCT00321373|12104307|FG001|Overall Study|Adverse Event|0
7686161|NCT00321373|12104308|FG002|Overall Study|Adverse Event|1
7686162|NCT00321373|12104306|FG000|Overall Study|Lost to Follow-up|1
7686163|NCT00321373|12104307|FG001|Overall Study|Lost to Follow-up|0
7686164|NCT00321373|12104308|FG002|Overall Study|Lost to Follow-up|1
7686165|NCT00321373|12104306|FG000|Overall Study|Withdrawal by Subject|1
7686166|NCT00321373|12104307|FG001|Overall Study|Withdrawal by Subject|0
7686167|NCT00321373|12104308|FG002|Overall Study|Withdrawal by Subject|0
7686168|NCT00321373|12104306|FG000|Overall Study|Other|0
7686169|NCT00321373|12104307|FG001|Overall Study|Other|0
7686170|NCT00321373|12104308|FG002|Overall Study|Other|1
7686171|NCT00321464|12104318|FG000|Overall Study|Death|169
7686172|NCT00321464|12104319|FG001|Overall Study|Death|174
7686173|NCT00321464|12104318|FG000|Overall Study|Disease progression|124
7686174|NCT00321464|12104319|FG001|Overall Study|Disease progression|124
7686175|NCT00321464|12104318|FG000|Overall Study|Withdrawal by Subject|117
7686176|NCT00321464|12104319|FG001|Overall Study|Withdrawal by Subject|118
7686177|NCT00321464|12104318|FG000|Overall Study|Participant request|57
7686178|NCT00321464|12104319|FG001|Overall Study|Participant request|61
7686179|NCT00321464|12104318|FG000|Overall Study|Adverse Event|43
7686180|NCT00321464|12104319|FG001|Overall Study|Adverse Event|28
7686181|NCT00321464|12104318|FG000|Overall Study|Physician Decision|15
7686182|NCT00321464|12104319|FG001|Overall Study|Physician Decision|14
7686183|NCT00321464|12104318|FG000|Overall Study|Noncompliance|4
7686184|NCT00321464|12104319|FG001|Overall Study|Noncompliance|10
7686185|NCT00321464|12104318|FG000|Overall Study|Lost to Follow-up|7
7686186|NCT00321464|12104319|FG001|Overall Study|Lost to Follow-up|8
7686187|NCT00321464|12104318|FG000|Overall Study|Protocol deviation|0
7686188|NCT00321464|12104319|FG001|Overall Study|Protocol deviation|2
7686189|NCT00321464|12104318|FG000|Overall Study|Ineligibility determined|2
7686190|NCT00321464|12104319|FG001|Overall Study|Ineligibility determined|1
7686191|NCT00321464|12104318|FG000|Overall Study|Other|21
7686192|NCT00321464|12104319|FG001|Overall Study|Other|18
7686193|NCT00321620|12104345|FG000|Overall Study|Death|269
7686194|NCT00321620|12104346|FG001|Overall Study|Death|294
7686195|NCT00321620|12104345|FG000|Overall Study|Withdrawal by Subject|164
7686196|NCT00321620|12104346|FG001|Overall Study|Withdrawal by Subject|147
7686197|NCT00321620|12104345|FG000|Overall Study|Disease progression|113
7686198|NCT00321620|12104346|FG001|Overall Study|Disease progression|117
7686199|NCT00321620|12104345|FG000|Overall Study|Adverse Event|43
7686200|NCT00321620|12104346|FG001|Overall Study|Adverse Event|56
7686201|NCT00321620|12104345|FG000|Overall Study|Lost to Follow-up|13
7686202|NCT00321620|12104346|FG001|Overall Study|Lost to Follow-up|9
7686203|NCT00321620|12104345|FG000|Overall Study|Physician Decision|4
7686204|NCT00321620|12104346|FG001|Overall Study|Physician Decision|1
7686205|NCT00321620|12104345|FG000|Overall Study|Noncompliance|14
7686206|NCT00321620|12104346|FG001|Overall Study|Noncompliance|7
7686207|NCT00321620|12104345|FG000|Overall Study|Protocol deviation|4
7686208|NCT00321620|12104346|FG001|Overall Study|Protocol deviation|3
7686209|NCT00321620|12104345|FG000|Overall Study|Ineligibility determined|2
7686210|NCT00321620|12104346|FG001|Overall Study|Ineligibility determined|3
7686211|NCT00321620|12104345|FG000|Overall Study|Participant request|75
7686212|NCT00321620|12104346|FG001|Overall Study|Participant request|52
7686213|NCT00321620|12104345|FG000|Overall Study|Other|42
7686214|NCT00321620|12104346|FG001|Overall Study|Other|33
7686215|NCT00321646|12104352|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
7686216|NCT00321646|12104352|FG000|Neoadjuvant Chemotherapy|Adverse Event|2
7686217|NCT00321646|12104352|FG000|Neoadjuvant Chemotherapy|Disease progression|1
7686218|NCT00321672|12104360|FG000|Overall Study|Withdrawal by Subject|5
7686219|NCT00321672|12104361|FG001|Overall Study|Withdrawal by Subject|1
7686220|NCT00321672|12104362|FG002|Overall Study|Withdrawal by Subject|2
7686221|NCT00321672|12104363|FG003|Overall Study|Withdrawal by Subject|0
7686222|NCT00321672|12104360|FG000|Overall Study|Noncompliance|1
7686223|NCT00321672|12104361|FG001|Overall Study|Noncompliance|2
7686224|NCT00321672|12104362|FG002|Overall Study|Noncompliance|1
7686225|NCT00321672|12104363|FG003|Overall Study|Noncompliance|0
7686226|NCT00321672|12104360|FG000|Overall Study|Adverse Event|1
7686227|NCT00321672|12104361|FG001|Overall Study|Adverse Event|1
7686228|NCT00321672|12104362|FG002|Overall Study|Adverse Event|0
7686229|NCT00321672|12104363|FG003|Overall Study|Adverse Event|0
7686230|NCT00321672|12104360|FG000|Overall Study|Lack of Efficacy|1
7686231|NCT00321672|12104361|FG001|Overall Study|Lack of Efficacy|1
7686232|NCT00321672|12104362|FG002|Overall Study|Lack of Efficacy|0
7686233|NCT00321672|12104363|FG003|Overall Study|Lack of Efficacy|0
7686234|NCT00321672|12104360|FG000|Overall Study|Lost to Follow-up|2
7686235|NCT00321672|12104361|FG001|Overall Study|Lost to Follow-up|0
7686236|NCT00321672|12104362|FG002|Overall Study|Lost to Follow-up|4
7686237|NCT00321672|12104363|FG003|Overall Study|Lost to Follow-up|2
7686238|NCT00321672|12104360|FG000|Overall Study|Death|1
7686239|NCT00321672|12104361|FG001|Overall Study|Death|0
7686240|NCT00321672|12104362|FG002|Overall Study|Death|0
7686241|NCT00321672|12104363|FG003|Overall Study|Death|0
7686242|NCT00321672|12104360|FG000|Overall Study|Too far to travel for visits|1
7686243|NCT00321672|12104361|FG001|Overall Study|Too far to travel for visits|0
7686244|NCT00321672|12104362|FG002|Overall Study|Too far to travel for visits|0
7686245|NCT00321672|12104363|FG003|Overall Study|Too far to travel for visits|0
7686246|NCT00321672|12104360|FG000|Overall Study|Incarcerated|0
7686247|NCT00321672|12104361|FG001|Overall Study|Incarcerated|0
7686248|NCT00321672|12104362|FG002|Overall Study|Incarcerated|2
7686249|NCT00321672|12104363|FG003|Overall Study|Incarcerated|0
7686250|NCT00321672|12104360|FG000|Overall Study|Moved out of state|0
7686251|NCT00321672|12104361|FG001|Overall Study|Moved out of state|1
7686252|NCT00321672|12104362|FG002|Overall Study|Moved out of state|1
7686253|NCT00321672|12104363|FG003|Overall Study|Moved out of state|0
7686254|NCT00321672|12104360|FG000|Overall Study|Protocol Violation|0
7686255|NCT00321672|12104361|FG001|Overall Study|Protocol Violation|0
7686256|NCT00321672|12104362|FG002|Overall Study|Protocol Violation|1
7686257|NCT00321672|12104363|FG003|Overall Study|Protocol Violation|0
7686258|NCT00321672|12104360|FG000|Overall Study|Diagnosis of testicular cancer|0
7686259|NCT00321672|12104361|FG001|Overall Study|Diagnosis of testicular cancer|1
7686260|NCT00321672|12104362|FG002|Overall Study|Diagnosis of testicular cancer|0
7686261|NCT00321672|12104363|FG003|Overall Study|Diagnosis of testicular cancer|0
7686262|NCT00321672|12104360|FG000|Overall Study|Extensive travel required for new job|0
7686263|NCT00321672|12104361|FG001|Overall Study|Extensive travel required for new job|1
7686264|NCT00321672|12104362|FG002|Overall Study|Extensive travel required for new job|0
7686265|NCT00321672|12104363|FG003|Overall Study|Extensive travel required for new job|0
7686266|NCT00321685|12104377|FG000|Overall Study|Adverse Event|18
7686267|NCT00321685|12104377|FG000|Overall Study|Death|2
7686268|NCT00321685|12104377|FG000|Overall Study|Withdrawal by Subject|8
7686269|NCT00321685|12104377|FG000|Overall Study|Alternative therapy|1
7686270|NCT00321685|12104377|FG000|Overall Study|Complicating disese|1
7686271|NCT00321685|12104377|FG000|Overall Study|Other|5
7686272|NCT00321685|12104377|FG000|Overall Study|Not start protocol therapy|2
7686273|NCT00321685|12104377|FG000|Overall Study|Ineligible|2
7686274|NCT00321711|12104386|FG000|Part A|Adverse Event|3
7686275|NCT00321711|12104387|FG001|Part A|Adverse Event|3
7686276|NCT00321711|12104388|FG002|Part A|Adverse Event|2
7686277|NCT00321711|12104389|FG003|Part A|Adverse Event|0
7686278|NCT00321711|12104390|FG004|Part A|Adverse Event|0
7686279|NCT00321711|12104386|FG000|Part A|Withdrawal by Subject|1
7686280|NCT00321711|12104387|FG001|Part A|Withdrawal by Subject|1
7686281|NCT00321711|12104388|FG002|Part A|Withdrawal by Subject|1
7686282|NCT00321711|12104389|FG003|Part A|Withdrawal by Subject|0
7686283|NCT00321711|12104390|FG004|Part A|Withdrawal by Subject|0
7686284|NCT00321711|12104386|FG000|Part A|Disease progression|0
7686285|NCT00321711|12104387|FG001|Part A|Disease progression|1
7686286|NCT00321711|12104388|FG002|Part A|Disease progression|0
7686287|NCT00321711|12104389|FG003|Part A|Disease progression|0
7686288|NCT00321711|12104390|FG004|Part A|Disease progression|0
7686289|NCT00321711|12104386|FG000|Part A|Requirement for alternative therapy|0
7686290|NCT00321711|12104387|FG001|Part A|Requirement for alternative therapy|2
7686291|NCT00321711|12104388|FG002|Part A|Requirement for alternative therapy|1
7686292|NCT00321711|12104389|FG003|Part A|Requirement for alternative therapy|0
7686293|NCT00321711|12104390|FG004|Part A|Requirement for alternative therapy|0
7686294|NCT00321711|12104386|FG000|Part A|Physician Decision|0
7686295|NCT00321711|12104387|FG001|Part A|Physician Decision|1
7686296|NCT00321711|12104388|FG002|Part A|Physician Decision|3
7686297|NCT00321711|12104389|FG003|Part A|Physician Decision|0
7686298|NCT00321711|12104390|FG004|Part A|Physician Decision|0
7686299|NCT00321711|12104386|FG000|Part A|Other|1
7686300|NCT00321711|12104387|FG001|Part A|Other|2
7686301|NCT00321711|12104388|FG002|Part A|Other|3
7686302|NCT00321711|12104389|FG003|Part A|Other|0
7686303|NCT00321711|12104390|FG004|Part A|Other|0
7686304|NCT00321711|12104386|FG000|Part A|Protocol deviation|0
7686305|NCT00321711|12104387|FG001|Part A|Protocol deviation|0
7686306|NCT00321711|12104388|FG002|Part A|Protocol deviation|1
7686307|NCT00321711|12104389|FG003|Part A|Protocol deviation|0
7686308|NCT00321711|12104390|FG004|Part A|Protocol deviation|0
7686309|NCT00321711|12104386|FG000|Part B|Noncompliance|0
7686310|NCT00321711|12104387|FG001|Part B|Noncompliance|0
7686311|NCT00321711|12104388|FG002|Part B|Noncompliance|0
7686312|NCT00321711|12104389|FG003|Part B|Noncompliance|0
7686313|NCT00321711|12104390|FG004|Part B|Noncompliance|1
7686314|NCT00321711|12104386|FG000|Part B|Adverse Event|0
7686315|NCT00321711|12104387|FG001|Part B|Adverse Event|0
7686316|NCT00321711|12104388|FG002|Part B|Adverse Event|0
7686317|NCT00321711|12104389|FG003|Part B|Adverse Event|2
7686318|NCT00321711|12104390|FG004|Part B|Adverse Event|1
7686319|NCT00321711|12104386|FG000|Part B|Disease progression|0
7686320|NCT00321711|12104387|FG001|Part B|Disease progression|0
7686321|NCT00321711|12104388|FG002|Part B|Disease progression|0
7686322|NCT00321711|12104389|FG003|Part B|Disease progression|1
7686323|NCT00321711|12104390|FG004|Part B|Disease progression|0
7686324|NCT00321711|12104386|FG000|Part B|Physician Decision|0
7686325|NCT00321711|12104387|FG001|Part B|Physician Decision|0
7686326|NCT00321711|12104388|FG002|Part B|Physician Decision|0
7686327|NCT00321711|12104389|FG003|Part B|Physician Decision|1
7686328|NCT00321711|12104390|FG004|Part B|Physician Decision|2
7686329|NCT00321711|12104386|FG000|Part B|Death|0
7686330|NCT00321711|12104387|FG001|Part B|Death|0
7686331|NCT00321711|12104388|FG002|Part B|Death|0
7686332|NCT00321711|12104389|FG003|Part B|Death|2
7686333|NCT00321711|12104390|FG004|Part B|Death|1
7686334|NCT00321737|12104405|FG000|Overall Study|Relapse of Erosive Esophagitis|76
7686335|NCT00321737|12104406|FG001|Overall Study|Relapse of Erosive Esophagitis|25
7686336|NCT00321737|12104407|FG002|Overall Study|Relapse of Erosive Esophagitis|19
7686337|NCT00321737|12104405|FG000|Overall Study|Adverse Event|11
7686338|NCT00321737|12104406|FG001|Overall Study|Adverse Event|3
7686339|NCT00321737|12104407|FG002|Overall Study|Adverse Event|6
7686340|NCT00321737|12104405|FG000|Overall Study|Lost to Follow-up|5
7686341|NCT00321737|12104406|FG001|Overall Study|Lost to Follow-up|5
7686342|NCT00321737|12104407|FG002|Overall Study|Lost to Follow-up|6
7686343|NCT00321737|12104405|FG000|Overall Study|Withdrawal by Subject|19
7686344|NCT00321737|12104406|FG001|Overall Study|Withdrawal by Subject|12
7686345|NCT00321737|12104407|FG002|Overall Study|Withdrawal by Subject|17
7686346|NCT00321737|12104405|FG000|Overall Study|Protocol Violation|0
7686347|NCT00321737|12104406|FG001|Overall Study|Protocol Violation|0
7686348|NCT00321737|12104407|FG002|Overall Study|Protocol Violation|1
7686349|NCT00321737|12104405|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1
7686350|NCT00321737|12104406|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0
7686351|NCT00321737|12104407|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0
7686352|NCT00321737|12104405|FG000|Overall Study|Possible Barrett's Esophagus|2
7686353|NCT00321737|12104406|FG001|Overall Study|Possible Barrett's Esophagus|1
7686354|NCT00321737|12104407|FG002|Overall Study|Possible Barrett's Esophagus|1
7686355|NCT00321737|12104405|FG000|Overall Study|Therapeutic Failure|6
7686356|NCT00321737|12104406|FG001|Overall Study|Therapeutic Failure|0
7686357|NCT00321737|12104407|FG002|Overall Study|Therapeutic Failure|2
7686358|NCT00321737|12104405|FG000|Overall Study|Pregnancy|0
7686359|NCT00321737|12104406|FG001|Overall Study|Pregnancy|2
7686360|NCT00321737|12104407|FG002|Overall Study|Pregnancy|0
7686361|NCT00321737|12104405|FG000|Overall Study|Noncompliance|2
7686362|NCT00321737|12104406|FG001|Overall Study|Noncompliance|0
7686363|NCT00321737|12104407|FG002|Overall Study|Noncompliance|0
7686364|NCT00321737|12104405|FG000|Overall Study|Subject Request/ Subject Unavailable|0
7686365|NCT00321737|12104406|FG001|Overall Study|Subject Request/ Subject Unavailable|0
7686366|NCT00321737|12104407|FG002|Overall Study|Subject Request/ Subject Unavailable|2
7686367|NCT00321763|12104419|FG000|Overall Study|Adverse Event|1
7686368|NCT00321763|12104420|FG001|Overall Study|Adverse Event|1
7686369|NCT00321763|12104421|FG002|Overall Study|Adverse Event|0
7686370|NCT00321763|12104422|FG003|Overall Study|Adverse Event|1
7686371|NCT00321763|12104419|FG000|Overall Study|Withdrawal by Subject|2
7686372|NCT00321763|12104420|FG001|Overall Study|Withdrawal by Subject|0
7686373|NCT00321763|12104421|FG002|Overall Study|Withdrawal by Subject|1
7686374|NCT00321763|12104422|FG003|Overall Study|Withdrawal by Subject|0
7686375|NCT00321763|12104419|FG000|Overall Study|Lost to Follow-up|3
7686376|NCT00321763|12104420|FG001|Overall Study|Lost to Follow-up|1
7686377|NCT00321763|12104421|FG002|Overall Study|Lost to Follow-up|5
7686378|NCT00321763|12104422|FG003|Overall Study|Lost to Follow-up|4
7686379|NCT00321789|12104436|FG000|Overall Study|Lost to Follow-up|4
7686380|NCT00321789|12104437|FG001|Overall Study|Lost to Follow-up|7
7686381|NCT00321789|12104436|FG000|Overall Study|Withdrawal by Subject|6
7686382|NCT00321789|12104437|FG001|Overall Study|Withdrawal by Subject|6
7686383|NCT00321789|12104436|FG000|Overall Study|Protocol Violation|5
7686384|NCT00321789|12104437|FG001|Overall Study|Protocol Violation|3
7686385|NCT00321828|12104443|FG000|Overall Study|Ineligible|3
7686386|NCT00321828|12104443|FG000|Overall Study|No follow up data|1
7686387|NCT00321854|12104449|FG000|Overall Study|Adverse Event|41
7686388|NCT00321854|12104450|FG001|Overall Study|Adverse Event|43
7686389|NCT00321854|12104449|FG000|Overall Study|Lack of Efficacy|9
7686390|NCT00321854|12104450|FG001|Overall Study|Lack of Efficacy|14
7686391|NCT00321854|12104449|FG000|Overall Study|Protocol Violation|6
7686392|NCT00321854|12104450|FG001|Overall Study|Protocol Violation|5
7686393|NCT00321854|12104449|FG000|Overall Study|Lost to Follow-up|0
7686394|NCT00321854|12104450|FG001|Overall Study|Lost to Follow-up|2
7686395|NCT00321854|12104449|FG000|Overall Study|Withdrawal by Subject|6
7686396|NCT00321854|12104450|FG001|Overall Study|Withdrawal by Subject|17
7686397|NCT00321854|12104449|FG000|Overall Study|Other|1
7686398|NCT00321854|12104450|FG001|Overall Study|Other|1
7686399|NCT00321893|12104460|FG000|Overall Study|Non-Compliance/Refusal|16
7686400|NCT00321893|12104461|FG001|Overall Study|Non-Compliance/Refusal|10
7686401|NCT00321893|12104460|FG000|Overall Study|Lost to Follow-up|2
7686402|NCT00321893|12104461|FG001|Overall Study|Lost to Follow-up|1
7686403|NCT00321893|12104460|FG000|Overall Study|Adverse Event|6
7686404|NCT00321893|12104461|FG001|Overall Study|Adverse Event|3
7686405|NCT00321906|12104469|FG000|Overall Study|Adverse Event|36
7686406|NCT00321906|12104470|FG001|Overall Study|Adverse Event|44
7686407|NCT00321906|12104469|FG000|Overall Study|Death|9
7686408|NCT00321906|12104470|FG001|Overall Study|Death|6
7686409|NCT00321906|12104469|FG000|Overall Study|Lost to Follow-up|1
7686410|NCT00321906|12104470|FG001|Overall Study|Lost to Follow-up|2
7686411|NCT00321906|12104469|FG000|Overall Study|Withdrawal by Subject|0
7686412|NCT00321906|12104470|FG001|Overall Study|Withdrawal by Subject|4
7686413|NCT00321919|12104478|FG000|Overall Study|Adverse Event|17
7686414|NCT00321919|12104479|FG001|Overall Study|Adverse Event|10
7686415|NCT00321919|12104478|FG000|Overall Study|Death|21
7686416|NCT00321919|12104479|FG001|Overall Study|Death|17
7686417|NCT00321919|12104478|FG000|Overall Study|Insufficient Therapeutic Response|1
7686418|NCT00321919|12104479|FG001|Overall Study|Insufficient Therapeutic Response|0
7686419|NCT00321919|12104478|FG000|Overall Study|Violation of Selection Criteria at Entry|1
7686420|NCT00321919|12104479|FG001|Overall Study|Violation of Selection Criteria at Entry|1
7686421|NCT00321919|12104478|FG000|Overall Study|Refused Treatment|23
7686422|NCT00321919|12104479|FG001|Overall Study|Refused Treatment|14
7686423|NCT00321919|12104478|FG000|Overall Study|Other Protocol Violation|2
7686424|NCT00321919|12104479|FG001|Overall Study|Other Protocol Violation|3
7686425|NCT00321919|12104478|FG000|Overall Study|Failure to Return|3
7686426|NCT00321919|12104479|FG001|Overall Study|Failure to Return|1
7686427|NCT00321919|12104478|FG000|Overall Study|Other withdrawal reason|7
7686428|NCT00321919|12104479|FG001|Overall Study|Other withdrawal reason|6
7686429|NCT00321932|12104488|FG000|Overall Study|Death|3
7686430|NCT00321932|12104489|FG001|Overall Study|Death|6
7686431|NCT00321932|12104488|FG000|Overall Study|Withdrawal by Subject|3
7686432|NCT00321932|12104489|FG001|Overall Study|Withdrawal by Subject|6
7686433|NCT00321932|12104488|FG000|Overall Study|Early relapse|2
7686434|NCT00321932|12104489|FG001|Overall Study|Early relapse|8
7686435|NCT00321932|12104488|FG000|Overall Study|Missing data|2
7686436|NCT00321932|12104489|FG001|Overall Study|Missing data|1
7686437|NCT00321984|12104508|FG000|Overall Study|Adverse Event|9
7686438|NCT00321984|12104509|FG001|Overall Study|Adverse Event|6
7686439|NCT00321984|12104510|FG002|Overall Study|Adverse Event|8
7686440|NCT00321984|12104508|FG000|Overall Study|Protocol Violation|0
7686441|NCT00321984|12104509|FG001|Overall Study|Protocol Violation|1
7686442|NCT00321984|12104510|FG002|Overall Study|Protocol Violation|1
7686443|NCT00321984|12104508|FG000|Overall Study|Lost to Follow-up|2
7686444|NCT00321984|12104509|FG001|Overall Study|Lost to Follow-up|4
7686445|NCT00321984|12104510|FG002|Overall Study|Lost to Follow-up|2
7686446|NCT00321984|12104508|FG000|Overall Study|Withdrawal by Subject|8
7686447|NCT00321984|12104509|FG001|Overall Study|Withdrawal by Subject|6
7686448|NCT00321984|12104510|FG002|Overall Study|Withdrawal by Subject|5
7686449|NCT00321984|12104508|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3
7686450|NCT00321984|12104509|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1
7686451|NCT00321984|12104510|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
7686452|NCT00321984|12104508|FG000|Overall Study|Lack of Efficacy|3
7686453|NCT00321984|12104509|FG001|Overall Study|Lack of Efficacy|1
7686454|NCT00321984|12104510|FG002|Overall Study|Lack of Efficacy|3
7686455|NCT00321984|12104508|FG000|Overall Study|Noncompliant|0
7686456|NCT00321984|12104509|FG001|Overall Study|Noncompliant|0
7686457|NCT00321984|12104510|FG002|Overall Study|Noncompliant|2
7686458|NCT00321984|12104508|FG000|Overall Study|Pregnancy|0
7686459|NCT00321984|12104509|FG001|Overall Study|Pregnancy|1
7686460|NCT00321984|12104510|FG002|Overall Study|Pregnancy|0
7686461|NCT00321984|12104508|FG000|Overall Study|Per Subject Request|1
7686462|NCT00321984|12104509|FG001|Overall Study|Per Subject Request|0
7686463|NCT00321984|12104510|FG002|Overall Study|Per Subject Request|0
7686464|NCT00321984|12104508|FG000|Overall Study|Per Investigator Request|1
7686465|NCT00321984|12104509|FG001|Overall Study|Per Investigator Request|0
7686466|NCT00321984|12104510|FG002|Overall Study|Per Investigator Request|0
7686467|NCT00321984|12104508|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
7686468|NCT00321984|12104509|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
7686469|NCT00321984|12104510|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
7686470|NCT00322023|12104521|FG000|Overall Study|various|0
7686471|NCT00322023|12104522|FG001|Overall Study|various|2
7686472|NCT00322023|12104523|FG002|Overall Study|various|6
7686473|NCT00322049|12104535|FG000|Overall Study|Moved out of area|0
7686474|NCT00322049|12104536|FG001|Overall Study|Moved out of area|0
7686475|NCT00322049|12104537|FG002|Overall Study|Moved out of area|0
7686476|NCT00322049|12104538|FG003|Overall Study|Moved out of area|1
7686477|NCT00322049|12104535|FG000|Overall Study|Infected with Dengue during study|0
7686478|NCT00322049|12104536|FG001|Overall Study|Infected with Dengue during study|1
7686479|NCT00322049|12104537|FG002|Overall Study|Infected with Dengue during study|0
7686480|NCT00322049|12104538|FG003|Overall Study|Infected with Dengue during study|0
7686481|NCT00322153|12104568|FG000|Overall Study|Adverse Event|21
7686482|NCT00322153|12104569|FG001|Overall Study|Adverse Event|34
7686483|NCT00322153|12104568|FG000|Overall Study|Protocol Violation|6
7686484|NCT00322153|12104569|FG001|Overall Study|Protocol Violation|14
7686485|NCT00322153|12104568|FG000|Overall Study|Withdrawal by Subject|18
7686486|NCT00322153|12104569|FG001|Overall Study|Withdrawal by Subject|10
7686487|NCT00322153|12104568|FG000|Overall Study|Lack of Efficacy|8
7686488|NCT00322153|12104569|FG001|Overall Study|Lack of Efficacy|3
7686489|NCT00322153|12104568|FG000|Overall Study|Lost to Follow-up|5
7686490|NCT00322153|12104569|FG001|Overall Study|Lost to Follow-up|4
7686491|NCT00322153|12104568|FG000|Overall Study|Withdrawn for other reasons|5
7686492|NCT00322153|12104569|FG001|Overall Study|Withdrawn for other reasons|4
7686493|NCT00322348|12104615|FG000|Overall Study|Adverse Event|0
7686494|NCT00322348|12104616|FG001|Overall Study|Adverse Event|1
7686495|NCT00322348|12104615|FG000|Overall Study|Withdrawal by Subject|1
7686496|NCT00322348|12104616|FG001|Overall Study|Withdrawal by Subject|4
7686497|NCT00322348|12104615|FG000|Overall Study|Lost to Follow-up|1
7686498|NCT00322348|12104616|FG001|Overall Study|Lost to Follow-up|0
7686499|NCT00322348|12104615|FG000|Overall Study|Death|0
7686500|NCT00322348|12104616|FG001|Overall Study|Death|2
7686501|NCT00322348|12104615|FG000|Overall Study|Disease Progression|30
7686502|NCT00322348|12104616|FG001|Overall Study|Disease Progression|25
7686503|NCT00322348|12104615|FG000|Overall Study|Reasons not specified|5
7686504|NCT00322348|12104616|FG001|Overall Study|Reasons not specified|1
7686505|NCT00322374|12104625|FG000|Starting Dose|Physician Decision|2
7686506|NCT00322374|12104626|FG001|Starting Dose|Physician Decision|0
7686507|NCT00322374|12104627|FG002|Starting Dose|Physician Decision|0
7686508|NCT00322374|12104628|FG003|Starting Dose|Physician Decision|0
7686509|NCT00322374|12104625|FG000|Starting Dose|Study Drug Toxicity|4
7686510|NCT00322374|12104626|FG001|Starting Dose|Study Drug Toxicity|0
7686511|NCT00322374|12104627|FG002|Starting Dose|Study Drug Toxicity|0
7686512|NCT00322374|12104628|FG003|Starting Dose|Study Drug Toxicity|0
7686513|NCT00322374|12104625|FG000|First Escalation|Documented Disease Progression|0
7686514|NCT00322374|12104626|FG001|First Escalation|Documented Disease Progression|6
7686515|NCT00322374|12104627|FG002|First Escalation|Documented Disease Progression|0
7686516|NCT00322374|12104628|FG003|First Escalation|Documented Disease Progression|0
7686517|NCT00322374|12104625|FG000|First Escalation|Physician Decision|0
7686518|NCT00322374|12104626|FG001|First Escalation|Physician Decision|12
7686519|NCT00322374|12104627|FG002|First Escalation|Physician Decision|0
7686520|NCT00322374|12104628|FG003|First Escalation|Physician Decision|0
7686521|NCT00322374|12104625|FG000|First Escalation|Study Drug Toxicity|0
7686522|NCT00322374|12104626|FG001|First Escalation|Study Drug Toxicity|11
7686523|NCT00322374|12104627|FG002|First Escalation|Study Drug Toxicity|0
7686524|NCT00322374|12104628|FG003|First Escalation|Study Drug Toxicity|0
7686525|NCT00322374|12104625|FG000|First Escalation|Participant Request|0
7686526|NCT00322374|12104626|FG001|First Escalation|Participant Request|1
7686527|NCT00322374|12104627|FG002|First Escalation|Participant Request|0
7686528|NCT00322374|12104628|FG003|First Escalation|Participant Request|0
7686529|NCT00322374|12104625|FG000|Second Escalation|Physician Decision|0
7686530|NCT00322374|12104626|FG001|Second Escalation|Physician Decision|0
7686531|NCT00322374|12104627|FG002|Second Escalation|Physician Decision|5
7686532|NCT00322374|12104628|FG003|Second Escalation|Physician Decision|0
7686533|NCT00322374|12104625|FG000|Second Escalation|Study Drug Toxicity|0
7686534|NCT00322374|12104626|FG001|Second Escalation|Study Drug Toxicity|0
7686535|NCT00322374|12104627|FG002|Second Escalation|Study Drug Toxicity|1
7686536|NCT00322374|12104628|FG003|Second Escalation|Study Drug Toxicity|0
7686537|NCT00322387|12104643|FG000|Treatment Period|Adverse Event|0
7686538|NCT00322387|12104644|FG001|Treatment Period|Adverse Event|1
7686539|NCT00322387|12104643|FG000|Follow-up Period|Final assessment not done|1
7686540|NCT00322387|12104644|FG001|Follow-up Period|Final assessment not done|3
7686541|NCT00322387|12104643|FG000|Follow-up Period|Death|1
7686542|NCT00322387|12104644|FG001|Follow-up Period|Death|0
7686543|NCT00322452|12104667|FG000|Overall Study|Eligibility criteria not fulfilled|0
7686544|NCT00322452|12104668|FG001|Overall Study|Eligibility criteria not fulfilled|1
7686545|NCT00322452|12104667|FG000|Overall Study|Lost to Follow-up|5
7686546|NCT00322452|12104668|FG001|Overall Study|Lost to Follow-up|2
7686547|NCT00322452|12104667|FG000|Overall Study|Withdrawal by Subject|19
7686548|NCT00322452|12104668|FG001|Overall Study|Withdrawal by Subject|46
7686549|NCT00322452|12104667|FG000|Overall Study|Death|223
7686550|NCT00322452|12104668|FG001|Overall Study|Death|227
7686551|NCT00322491|12104696|FG000|Overall Study|Adverse Event|1
7686552|NCT00322491|12104697|FG001|Overall Study|Adverse Event|0
7686553|NCT00322491|12104696|FG000|Overall Study|Death|1
7686554|NCT00322491|12104697|FG001|Overall Study|Death|2
7686555|NCT00322556|12104704|FG000|Overall Study|Adverse Event|1
7686556|NCT00322556|12104704|FG000|Overall Study|Withdrawal by Subject|1
7686557|NCT00322556|12104704|FG000|Overall Study|Lost to Follow-up|3
7686558|NCT00322556|12104704|FG000|Overall Study|Other Reason|7
7686559|NCT00322621|12104711|FG000|Period II - Acute Therapy Phase|Adverse Event|20
7686560|NCT00322621|12104712|FG001|Period II - Acute Therapy Phase|Adverse Event|0
7686561|NCT00322621|12104713|FG002|Period II - Acute Therapy Phase|Adverse Event|0
7686562|NCT00322621|12104711|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1
7686563|NCT00322621|12104712|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0
7686564|NCT00322621|12104713|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0
7686565|NCT00322621|12104711|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8
7686639|NCT00323297|12104805|FG000|Part B (Open-label)|Lack of Efficacy|3
7686566|NCT00322621|12104712|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0
7686567|NCT00322621|12104713|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0
7686568|NCT00322621|12104711|FG000|Period II - Acute Therapy Phase|Protocol Violation|2
7686569|NCT00322621|12104712|FG001|Period II - Acute Therapy Phase|Protocol Violation|0
7686570|NCT00322621|12104713|FG002|Period II - Acute Therapy Phase|Protocol Violation|0
7686571|NCT00322621|12104711|FG000|Period II - Acute Therapy Phase|Physician Decision|1
7686572|NCT00322621|12104712|FG001|Period II - Acute Therapy Phase|Physician Decision|0
7686573|NCT00322621|12104713|FG002|Period II - Acute Therapy Phase|Physician Decision|0
7686574|NCT00322621|12104711|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0
7686575|NCT00322621|12104712|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14
7686576|NCT00322621|12104713|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5
7686577|NCT00322621|12104711|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
7686578|NCT00322621|12104712|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
7686579|NCT00322621|12104713|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
7686580|NCT00322621|12104711|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
7686581|NCT00322621|12104712|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
7686582|NCT00322621|12104713|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
7686583|NCT00322621|12104711|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0
7686584|NCT00322621|12104712|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2
7686585|NCT00322621|12104713|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5
7686586|NCT00322621|12104711|FG000|Period III - Maintenance / Rescue Phase|Death|0
7686587|NCT00322621|12104712|FG001|Period III - Maintenance / Rescue Phase|Death|1
7686588|NCT00322621|12104713|FG002|Period III - Maintenance / Rescue Phase|Death|0
7686589|NCT00322621|12104711|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
7686590|NCT00322621|12104712|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
7686591|NCT00322621|12104713|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
7686592|NCT00322712|12104726|FG000|Overall Study|treated with bevacizumab not cetuximab|1
7686593|NCT00322842|12104741|FG000|Overall Study|Withdrawal by Subject|0
7686594|NCT00322842|12104742|FG001|Overall Study|Withdrawal by Subject|1
7686595|NCT00322842|12104741|FG000|Overall Study|Lost to Follow-up|0
7686596|NCT00322842|12104742|FG001|Overall Study|Lost to Follow-up|1
7686597|NCT00322842|12104741|FG000|Overall Study|Refused transplant|1
7686598|NCT00322842|12104742|FG001|Overall Study|Refused transplant|0
7686599|NCT00322842|12104741|FG000|Overall Study|Death|1
7686600|NCT00322842|12104742|FG001|Overall Study|Death|0
7686601|NCT00322868|12104749|FG000|Overall Study|disease progression|1
7686602|NCT00322881|12104754|FG000|Overall Study|Death|2
7686603|NCT00322881|12104754|FG000|Overall Study|Adverse Event|1
7686604|NCT00322881|12104754|FG000|Overall Study|Disease Progression|2
7686605|NCT00323115|12104758|FG000|Vaccine Administration|Adverse Event|1
7686606|NCT00323115|12104758|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8
7686607|NCT00323258|12104778|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1
7686608|NCT00323258|12104779|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2
7686609|NCT00323258|12104778|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
7686610|NCT00323258|12104779|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
7686611|NCT00323258|12104778|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
7686612|NCT00323258|12104779|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
7686613|NCT00323258|12104778|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
7686614|NCT00323258|12104779|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
7686615|NCT00323258|12104778|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1
7686616|NCT00323258|12104779|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2
7686617|NCT00323258|12104778|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
7686618|NCT00323258|12104779|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
7686619|NCT00323258|12104778|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
7686620|NCT00323258|12104779|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
7686621|NCT00323297|12104805|FG000|Part A (Double Blind Randomized)|Reason unspecified|0
7686622|NCT00323297|12104806|FG001|Part A (Double Blind Randomized)|Reason unspecified|1
7686623|NCT00323297|12104805|FG000|Part A (Double Blind Randomized)|Death|0
7686624|NCT00323297|12104806|FG001|Part A (Double Blind Randomized)|Death|1
7686625|NCT00323297|12104805|FG000|Part A (Double Blind Randomized)|Protocol Violation|1
7686626|NCT00323297|12104806|FG001|Part A (Double Blind Randomized)|Protocol Violation|3
7686627|NCT00323297|12104805|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1
7686628|NCT00323297|12104806|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0
7686629|NCT00323297|12104805|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
7686630|NCT00323297|12104806|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
7686631|NCT00323297|12104805|FG000|Part A (Double Blind Randomized)|Related adverse event|2
7686632|NCT00323297|12104806|FG001|Part A (Double Blind Randomized)|Related adverse event|2
7686633|NCT00323297|12104805|FG000|Part B (Open-label)|Death|0
7686634|NCT00323297|12104806|FG001|Part B (Open-label)|Death|1
7686635|NCT00323297|12104805|FG000|Part B (Open-label)|Reason unspecified|0
7686636|NCT00323297|12104806|FG001|Part B (Open-label)|Reason unspecified|1
7686637|NCT00323297|12104805|FG000|Part B (Open-label)|Withdrawal by Subject|1
7686638|NCT00323297|12104806|FG001|Part B (Open-label)|Withdrawal by Subject|3
7686640|NCT00323297|12104806|FG001|Part B (Open-label)|Lack of Efficacy|1
7686641|NCT00323297|12104805|FG000|Part B (Open-label)|Adverse Event|5
7686642|NCT00323297|12104806|FG001|Part B (Open-label)|Adverse Event|5
7686643|NCT00323297|12104805|FG000|Part B (Open-label)|Protocol Violation|0
7686644|NCT00323297|12104806|FG001|Part B (Open-label)|Protocol Violation|1
7686645|NCT00323310|12104812|FG000|Overall Study|Withdrawal by Subject|1
7686646|NCT00323310|12104812|FG000|Overall Study|a parent refused blood draw|1
7686647|NCT00323310|12104812|FG000|Overall Study|did not complete the 24-hr f-up visit|1
7686648|NCT00323414|12104822|FG000|Overall Study|Withdrawal by Subject|0
7686649|NCT00323414|12104823|FG001|Overall Study|Withdrawal by Subject|1
7686650|NCT00323479|12104847|FG000|Overall Study|Adverse Event|2
7686651|NCT00323479|12104847|FG000|Overall Study|Withdrawal by Subject|2
7686652|NCT00323479|12104847|FG000|Overall Study|Protocol Violation|3
7686653|NCT00323479|12104847|FG000|Overall Study|house moving|1
7686654|NCT00323492|12104853|FG000|Study Phase 1|Adverse Event|2
7686655|NCT00323492|12104854|FG001|Study Phase 1|Adverse Event|0
7686656|NCT00323492|12104855|FG002|Study Phase 1|Adverse Event|0
7686657|NCT00323492|12104853|FG000|Study Phase 2|Adverse Event|1
7686658|NCT00323492|12104854|FG001|Study Phase 2|Adverse Event|0
7686659|NCT00323492|12104855|FG002|Study Phase 2|Adverse Event|0
7686660|NCT00323492|12104853|FG000|Study Phase 2|Physician Decision|1
7686661|NCT00323492|12104854|FG001|Study Phase 2|Physician Decision|0
7686662|NCT00323492|12104855|FG002|Study Phase 2|Physician Decision|0
7686663|NCT00323492|12104853|FG000|Study Phase 2|Lost to Follow-up|1
7686664|NCT00323492|12104854|FG001|Study Phase 2|Lost to Follow-up|0
7686665|NCT00323492|12104855|FG002|Study Phase 2|Lost to Follow-up|0
7686666|NCT00323492|12104853|FG000|Study Phase 2|Withdrawal by Subject|0
7686667|NCT00323492|12104854|FG001|Study Phase 2|Withdrawal by Subject|1
7686668|NCT00323492|12104855|FG002|Study Phase 2|Withdrawal by Subject|0
7686669|NCT00323492|12104853|FG000|Study Phase 2|Noncompliance with study schedule|0
7686670|NCT00323492|12104854|FG001|Study Phase 2|Noncompliance with study schedule|0
7686671|NCT00323492|12104855|FG002|Study Phase 2|Noncompliance with study schedule|1
7686672|NCT00323492|12104853|FG000|Study Phase 2|Protocol Violation|1
7686673|NCT00323492|12104854|FG001|Study Phase 2|Protocol Violation|0
7686674|NCT00323492|12104855|FG002|Study Phase 2|Protocol Violation|0
7686675|NCT00323557|12104864|FG000|Overall Study|Physician Decision|1
7686676|NCT00323557|12104865|FG001|Overall Study|Physician Decision|0
7686677|NCT00323609|12104874|FG000|Overall Study|Death|16
7686678|NCT00323609|12104875|FG001|Overall Study|Death|21
7686679|NCT00323609|12104876|FG002|Overall Study|Death|0
7686680|NCT00323609|12104877|FG003|Overall Study|Death|0
7686681|NCT00323609|12104874|FG000|Overall Study|Lost to Follow-up|9
7686682|NCT00323609|12104875|FG001|Overall Study|Lost to Follow-up|10
7686683|NCT00323609|12104876|FG002|Overall Study|Lost to Follow-up|0
7686684|NCT00323609|12104877|FG003|Overall Study|Lost to Follow-up|0
7686685|NCT00323609|12104874|FG000|Overall Study|Physician Decision|2
7686686|NCT00323609|12104875|FG001|Overall Study|Physician Decision|0
7686687|NCT00323609|12104876|FG002|Overall Study|Physician Decision|0
7686688|NCT00323609|12104877|FG003|Overall Study|Physician Decision|1
7686689|NCT00323609|12104874|FG000|Overall Study|Withdrawal by Subject|11
7686690|NCT00323609|12104875|FG001|Overall Study|Withdrawal by Subject|23
7686691|NCT00323609|12104876|FG002|Overall Study|Withdrawal by Subject|4
7686692|NCT00323609|12104877|FG003|Overall Study|Withdrawal by Subject|4
7686693|NCT00323609|12104874|FG000|Overall Study|Other non-VCF-related medical condition|3
7686694|NCT00323609|12104875|FG001|Overall Study|Other non-VCF-related medical condition|2
7686695|NCT00323609|12104876|FG002|Overall Study|Other non-VCF-related medical condition|0
7686696|NCT00323609|12104877|FG003|Overall Study|Other non-VCF-related medical condition|0
7686697|NCT00323609|12104874|FG000|Overall Study|Sponsor discontinued trial|29
7686698|NCT00323609|12104875|FG001|Overall Study|Sponsor discontinued trial|29
7686699|NCT00323609|12104876|FG002|Overall Study|Sponsor discontinued trial|0
7686700|NCT00323609|12104877|FG003|Overall Study|Sponsor discontinued trial|0
7686701|NCT00323609|12104874|FG000|Overall Study|Unrelenting or severe back pain|1
7686702|NCT00323609|12104875|FG001|Overall Study|Unrelenting or severe back pain|1
7686703|NCT00323609|12104876|FG002|Overall Study|Unrelenting or severe back pain|0
7686704|NCT00323609|12104877|FG003|Overall Study|Unrelenting or severe back pain|0
7686705|NCT00323609|12104874|FG000|Overall Study|Logistical withdrawal|9
7686706|NCT00323609|12104875|FG001|Overall Study|Logistical withdrawal|5
7686707|NCT00323609|12104876|FG002|Overall Study|Logistical withdrawal|0
7686708|NCT00323609|12104877|FG003|Overall Study|Logistical withdrawal|1
7686709|NCT00323609|12104874|FG000|Overall Study|Other reason|11
7686710|NCT00323609|12104875|FG001|Overall Study|Other reason|8
7686711|NCT00323609|12104876|FG002|Overall Study|Other reason|4
7686712|NCT00323609|12104877|FG003|Overall Study|Other reason|9
7686713|NCT00323622|12104891|FG000|Overall Study|Other|30
7686714|NCT00323622|12104892|FG001|Overall Study|Other|91
7686715|NCT00323622|12104893|FG002|Overall Study|Other|4
7686716|NCT00323622|12104894|FG003|Overall Study|Other|12
7686717|NCT00323622|12104895|FG004|Overall Study|Other|32
7686718|NCT00323622|12104896|FG005|Overall Study|Other|74
7686719|NCT00323622|12104897|FG006|Overall Study|Other|5
7686720|NCT00323622|12104898|FG007|Overall Study|Other|13
7686721|NCT00323622|12104891|FG000|Overall Study|Death|1
7686722|NCT00323622|12104892|FG001|Overall Study|Death|1
7686723|NCT00323622|12104893|FG002|Overall Study|Death|0
7686724|NCT00323622|12104894|FG003|Overall Study|Death|0
7686725|NCT00323622|12104895|FG004|Overall Study|Death|7
7686726|NCT00323622|12104896|FG005|Overall Study|Death|0
7686727|NCT00323622|12104897|FG006|Overall Study|Death|0
7686728|NCT00323622|12104898|FG007|Overall Study|Death|2
7686729|NCT00323869|12104928|FG000|Overall Study|Death|1
7686730|NCT00323882|12104937|FG000|Overall Study|Adverse Event|2
7686731|NCT00323882|12104938|FG001|Overall Study|Adverse Event|1
7686732|NCT00323882|12104939|FG002|Overall Study|Adverse Event|1
7686733|NCT00323882|12104940|FG003|Overall Study|Adverse Event|1
7686734|NCT00323882|12104941|FG004|Overall Study|Adverse Event|3
7686735|NCT00323882|12104937|FG000|Overall Study|Disease Progression|6
7686736|NCT00323882|12104938|FG001|Overall Study|Disease Progression|4
7686737|NCT00323882|12104939|FG002|Overall Study|Disease Progression|10
7686738|NCT00323882|12104940|FG003|Overall Study|Disease Progression|5
7686739|NCT00323882|12104941|FG004|Overall Study|Disease Progression|22
7686740|NCT00323882|12104937|FG000|Overall Study|Death|0
7686741|NCT00323882|12104938|FG001|Overall Study|Death|1
7686742|NCT00323882|12104939|FG002|Overall Study|Death|1
7686743|NCT00323882|12104940|FG003|Overall Study|Death|0
7686744|NCT00323882|12104941|FG004|Overall Study|Death|5
7686745|NCT00323882|12104937|FG000|Overall Study|Lost to Follow-up|0
7686746|NCT00323882|12104938|FG001|Overall Study|Lost to Follow-up|0
7686747|NCT00323882|12104939|FG002|Overall Study|Lost to Follow-up|1
7686748|NCT00323882|12104940|FG003|Overall Study|Lost to Follow-up|0
7686749|NCT00323882|12104941|FG004|Overall Study|Lost to Follow-up|1
7686750|NCT00323882|12104937|FG000|Overall Study|Other|0
7686751|NCT00323882|12104938|FG001|Overall Study|Other|0
7686752|NCT00323882|12104939|FG002|Overall Study|Other|0
7686753|NCT00323882|12104940|FG003|Overall Study|Other|1
7686754|NCT00323882|12104941|FG004|Overall Study|Other|1
7686755|NCT00324038|12104980|FG000|Overall Study|Adverse Event|38
7686756|NCT00324038|12104981|FG001|Overall Study|Adverse Event|23
7686757|NCT00324038|12104980|FG000|Overall Study|Lack of Efficacy|5
7686758|NCT00324038|12104981|FG001|Overall Study|Lack of Efficacy|13
7686759|NCT00324038|12104980|FG000|Overall Study|Lost to Follow-up|0
7686760|NCT00324038|12104981|FG001|Overall Study|Lost to Follow-up|2
7686761|NCT00324038|12104980|FG000|Overall Study|Other|6
7686762|NCT00324038|12104981|FG001|Overall Study|Other|13
7686763|NCT00324116|12104987|FG000|Overall Study|Adverse Event|5
7686764|NCT00324116|12104987|FG000|Overall Study|Lack of Efficacy|17
7686765|NCT00324116|12104987|FG000|Overall Study|Withdrawal by Subject|5
7686766|NCT00324116|12104987|FG000|Overall Study|Other|5
7686767|NCT00324155|12104993|FG000|Enrolled and Randomized|No longer met study criteria|3
7686768|NCT00324155|12104994|FG001|Enrolled and Randomized|No longer met study criteria|0
7686769|NCT00324155|12104993|FG000|Enrolled and Randomized|Lost to Follow-up|0
7686770|NCT00324155|12104994|FG001|Enrolled and Randomized|Lost to Follow-up|1
7686771|NCT00324155|12104993|FG000|Received Treatment in Induction Phase|Disease Progression|88
7686772|NCT00324155|12104994|FG001|Received Treatment in Induction Phase|Disease Progression|152
7686773|NCT00324155|12104993|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83
7686774|NCT00324155|12104994|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10
7686775|NCT00324155|12104993|FG000|Received Treatment in Induction Phase|Death|8
7686776|NCT00324155|12104994|FG001|Received Treatment in Induction Phase|Death|15
7686777|NCT00324155|12104993|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
7686778|NCT00324155|12104994|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
7686779|NCT00324155|12104993|FG000|Received Treatment in Induction Phase|Adverse Event|6
7686780|NCT00324155|12104994|FG001|Received Treatment in Induction Phase|Adverse Event|7
7686781|NCT00324155|12104993|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6
7686782|NCT00324155|12104994|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5
7686783|NCT00324155|12104993|FG000|Received Treatment in Induction Phase|Physician Decision|2
7686784|NCT00324155|12104994|FG001|Received Treatment in Induction Phase|Physician Decision|0
7686785|NCT00324155|12104993|FG000|Received Treatment in Maintenance Phase|Disease Progression|26
7686786|NCT00324155|12104994|FG001|Received Treatment in Maintenance Phase|Disease Progression|41
7686787|NCT00324155|12104993|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
7686788|NCT00324155|12104994|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
7686789|NCT00324155|12104993|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
7686790|NCT00324155|12104994|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
7686791|NCT00324155|12104993|FG000|Received Treatment in Maintenance Phase|Adverse Event|0
7686792|NCT00324155|12104994|FG001|Received Treatment in Maintenance Phase|Adverse Event|3
7686793|NCT00324155|12104993|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
7686794|NCT00324155|12104994|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
7686795|NCT00324155|12104993|FG000|Follow-up Phase|On-going participants still on drug|11
7686796|NCT00324155|12104994|FG001|Follow-up Phase|On-going participants still on drug|6
7686797|NCT00324168|12105015|FG000|Overall Study|Lost to Follow-up|19
7686798|NCT00324168|12105016|FG001|Overall Study|Lost to Follow-up|18
7686799|NCT00324168|12105015|FG000|Overall Study|Death|3
7686800|NCT00324168|12105016|FG001|Overall Study|Death|3
7686801|NCT00324168|12105015|FG000|Overall Study|Patient did not visit in f/u window|6
7686802|NCT00324168|12105016|FG001|Overall Study|Patient did not visit in f/u window|9
7686803|NCT00324233|12105024|FG000|First Period|unable to insert catheter|1
7686804|NCT00324233|12105025|FG001|First Period|unable to insert catheter|0
7686805|NCT00324233|12105024|FG000|Second Period|unable to insert catheter|1
7686806|NCT00324233|12105025|FG001|Second Period|unable to insert catheter|1
7686807|NCT00324233|12105024|FG000|Second Period|Protocol Violation|4
7686808|NCT00324233|12105025|FG001|Second Period|Protocol Violation|6
7686809|NCT00324649|12105075|FG000|Overall Study|Adverse Event|1
7686810|NCT00324649|12105076|FG001|Overall Study|Adverse Event|4
7686811|NCT00324649|12105075|FG000|Overall Study|Withdrawal by Subject|0
7686812|NCT00324649|12105076|FG001|Overall Study|Withdrawal by Subject|1
7686813|NCT00324649|12105075|FG000|Overall Study|Noncompliance|1
7686814|NCT00324649|12105076|FG001|Overall Study|Noncompliance|0
7686815|NCT00324675|12105084|FG000|Overall Study|Adverse Event|1
7686816|NCT00324675|12105085|FG001|Overall Study|Adverse Event|0
7686817|NCT00324740|12105100|FG000|Overall Study|Withdrawal by Subject|1
7686818|NCT00324740|12105101|FG001|Overall Study|Withdrawal by Subject|0
7686819|NCT00324740|12105102|FG002|Overall Study|Withdrawal by Subject|1
7686820|NCT00324961|12105154|FG000|Overall Study|Adverse Event|5
7686821|NCT00324961|12105154|FG000|Overall Study|Consent Withdrawn|11
7686822|NCT00324961|12105154|FG000|Overall Study|Lost to Follow-up|22
7686823|NCT00324961|12105154|FG000|Overall Study|Protocol Violation|3
7686824|NCT00324961|12105154|FG000|Overall Study|Other|2
7686825|NCT00324987|12105162|FG000|Overall Study|Adverse Event|2
7686826|NCT00324987|12105163|FG001|Overall Study|Adverse Event|1
7686827|NCT00324987|12105162|FG000|Overall Study|Withdrawal by Subject|1
7686828|NCT00324987|12105163|FG001|Overall Study|Withdrawal by Subject|1
7686829|NCT00324987|12105162|FG000|Overall Study|Progression|1
7686830|NCT00324987|12105163|FG001|Overall Study|Progression|1
7686831|NCT00324987|12105162|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2
7686832|NCT00324987|12105163|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3
7686833|NCT00325039|12105171|FG000|Overall Study|Lost to Follow-up|18
7686834|NCT00325039|12105172|FG001|Overall Study|Lost to Follow-up|14
7686835|NCT00325130|12105194|FG000|Overall Study|Lost to Follow-up|6
7686836|NCT00325130|12105195|FG001|Overall Study|Lost to Follow-up|14
7686837|NCT00325130|12105194|FG000|Overall Study|Withdrawal by Subject|12
7686838|NCT00325130|12105195|FG001|Overall Study|Withdrawal by Subject|14
7686839|NCT00325130|12105194|FG000|Overall Study|Protocol Deviation|0
7686840|NCT00325130|12105195|FG001|Overall Study|Protocol Deviation|1
7686841|NCT00325130|12105194|FG000|Overall Study|Moved|0
7686842|NCT00325130|12105195|FG001|Overall Study|Moved|1
7686843|NCT00325130|12105194|FG000|Overall Study|Patient Discontinued for Other|1
7686844|NCT00325130|12105195|FG001|Overall Study|Patient Discontinued for Other|0
7686845|NCT00325143|12105201|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13
7686846|NCT00325143|12105201|FG000|Overall Study|Migrated/moved from study area|1
7686847|NCT00325143|12105201|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4
7686848|NCT00325143|12105201|FG000|Overall Study|Withdrawal by Subject|8
7686849|NCT00325156|12105205|FG000|Overall Study|Protocol Violation|8
7686850|NCT00325156|12105205|FG000|Overall Study|Lost to follow-up (complete vaccination)|41
7686851|NCT00325156|12105205|FG000|Overall Study|Migrated/moved from study area|12
7686852|NCT00325156|12105205|FG000|Overall Study|Adverse event, non-fatal|3
7686853|NCT00325156|12105205|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16
7686854|NCT00325156|12105205|FG000|Overall Study|Other|1
7686855|NCT00325156|12105205|FG000|Overall Study|Withdrawal by Subject|31
7686856|NCT00325195|12105212|FG000|Randomized|Not dosed|5
7686857|NCT00325195|12105213|FG001|Randomized|Not dosed|5
7686858|NCT00325195|12105214|FG002|Randomized|Not dosed|3
7686859|NCT00325195|12105212|FG000|Received Intervention: ITT Population|Adverse Event|15
7686860|NCT00325195|12105213|FG001|Received Intervention: ITT Population|Adverse Event|17
7686861|NCT00325195|12105214|FG002|Received Intervention: ITT Population|Adverse Event|1
7686862|NCT00325195|12105212|FG000|Received Intervention: ITT Population|Death|3
7686863|NCT00325195|12105213|FG001|Received Intervention: ITT Population|Death|1
7686864|NCT00325195|12105214|FG002|Received Intervention: ITT Population|Death|0
7686865|NCT00325195|12105212|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7
7686866|NCT00325195|12105213|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6
7686867|NCT00325195|12105214|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1
7686868|NCT00325195|12105212|FG000|Received Intervention: ITT Population|Lost to Follow-up|0
7686869|NCT00325195|12105213|FG001|Received Intervention: ITT Population|Lost to Follow-up|0
7686870|NCT00325195|12105214|FG002|Received Intervention: ITT Population|Lost to Follow-up|2
7686871|NCT00325195|12105212|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1
7686872|NCT00325195|12105213|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1
7686873|NCT00325195|12105214|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0
7686874|NCT00325234|12105224|FG000|Overall Study|Adverse Event|10
7686875|NCT00325234|12105225|FG001|Overall Study|Adverse Event|7
7686876|NCT00325234|12105224|FG000|Overall Study|Death due to Study Disease|1
7686877|NCT00325234|12105225|FG001|Overall Study|Death due to Study Disease|0
7686878|NCT00325234|12105224|FG000|Overall Study|Entry Criteria Not Met|1
7686879|NCT00325234|12105225|FG001|Overall Study|Entry Criteria Not Met|2
7686880|NCT00325234|12105224|FG000|Overall Study|Subject Decision|6
7686881|NCT00325234|12105225|FG001|Overall Study|Subject Decision|8
7686882|NCT00325234|12105224|FG000|Overall Study|Physician Decision|17
7686883|NCT00325234|12105225|FG001|Overall Study|Physician Decision|12
7686884|NCT00325234|12105224|FG000|Overall Study|Progressive Disease|34
7686885|NCT00325234|12105225|FG001|Overall Study|Progressive Disease|37
7686886|NCT00325416|12105246|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8
7686887|NCT00325416|12105247|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9
7686888|NCT00325416|12105246|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7
7686889|NCT00325416|12105247|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4
7686890|NCT00325416|12105246|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7
7686891|NCT00325416|12105247|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2
7686892|NCT00325416|12105246|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
7686893|NCT00325416|12105247|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
7686894|NCT00325416|12105246|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0
7686895|NCT00325416|12105247|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1
7686896|NCT00325416|12105246|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0
7686897|NCT00325416|12105247|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1
7686898|NCT00325468|12105270|FG000|Overall Study|Adverse Event|1
7686899|NCT00325468|12105271|FG001|Overall Study|Adverse Event|1
7686900|NCT00325468|12105272|FG002|Overall Study|Adverse Event|0
7686901|NCT00325468|12105273|FG003|Overall Study|Adverse Event|5
7686902|NCT00325468|12105274|FG004|Overall Study|Adverse Event|1
7686903|NCT00325468|12105270|FG000|Overall Study|Death|2
7686904|NCT00325468|12105271|FG001|Overall Study|Death|0
7686905|NCT00325468|12105272|FG002|Overall Study|Death|2
7686906|NCT00325468|12105273|FG003|Overall Study|Death|4
7686907|NCT00325468|12105274|FG004|Overall Study|Death|0
7686908|NCT00325468|12105270|FG000|Overall Study|Lost to Follow-up|0
7686909|NCT00325468|12105271|FG001|Overall Study|Lost to Follow-up|0
7686910|NCT00325468|12105272|FG002|Overall Study|Lost to Follow-up|1
7686911|NCT00325468|12105273|FG003|Overall Study|Lost to Follow-up|2
7686912|NCT00325468|12105274|FG004|Overall Study|Lost to Follow-up|2
7686913|NCT00325468|12105270|FG000|Overall Study|Physician Decision|1
7686914|NCT00325468|12105271|FG001|Overall Study|Physician Decision|1
7686915|NCT00325468|12105272|FG002|Overall Study|Physician Decision|0
7686916|NCT00325468|12105273|FG003|Overall Study|Physician Decision|1
7686917|NCT00325468|12105274|FG004|Overall Study|Physician Decision|0
7686918|NCT00325468|12105270|FG000|Overall Study|Withdrawal by Subject|3
7686919|NCT00325468|12105271|FG001|Overall Study|Withdrawal by Subject|1
7686920|NCT00325468|12105272|FG002|Overall Study|Withdrawal by Subject|0
7686921|NCT00325468|12105273|FG003|Overall Study|Withdrawal by Subject|14
7686922|NCT00325468|12105274|FG004|Overall Study|Withdrawal by Subject|4
7686923|NCT00325468|12105270|FG000|Overall Study|site closure etc|4
7686924|NCT00325468|12105271|FG001|Overall Study|site closure etc|2
7686925|NCT00325468|12105272|FG002|Overall Study|site closure etc|1
7686926|NCT00325468|12105273|FG003|Overall Study|site closure etc|8
7686927|NCT00325468|12105274|FG004|Overall Study|site closure etc|1
7686928|NCT00325754|12105300|FG000|Overall Study|Adverse Event|4
7686929|NCT00325754|12105301|FG001|Overall Study|Adverse Event|1
7686930|NCT00325819|12105313|FG000|Overall Study|Study product lost in mail|2
7686931|NCT00325819|12105314|FG001|Overall Study|Study product lost in mail|1
7686932|NCT00325819|12105313|FG000|Overall Study|Did not take a dose of study product|4
7686933|NCT00325819|12105314|FG001|Overall Study|Did not take a dose of study product|9
7686934|NCT00325819|12105313|FG000|Overall Study|Lost to Follow-up|3
7686935|NCT00325819|12105314|FG001|Overall Study|Lost to Follow-up|3
7686936|NCT00325897|12105324|FG000|Overall Study|Lost to Follow-up|12
7686937|NCT00325897|12105325|FG001|Overall Study|Lost to Follow-up|13
7686938|NCT00326001|12105336|FG000|Overall Study|Adverse Event|4
7686939|NCT00326001|12105337|FG001|Overall Study|Adverse Event|5
7686940|NCT00326001|12105336|FG000|Overall Study|Physician Decision|3
7686941|NCT00326001|12105337|FG001|Overall Study|Physician Decision|3
7686942|NCT00326118|12105345|FG000|Active Phase|Withdrawal by Subject|4
7686943|NCT00326118|12105346|FG001|Active Phase|Withdrawal by Subject|1
7686944|NCT00326209|12105366|FG000|Overall Study|Adverse Event|28
7686945|NCT00326209|12105366|FG000|Overall Study|Withdrawal by Subject|22
7686946|NCT00326209|12105366|FG000|Overall Study|Lack of Efficacy|31
7686947|NCT00326209|12105366|FG000|Overall Study|Lost to Follow-up|18
7686948|NCT00326209|12105366|FG000|Overall Study|Participant non-compliant|6
7686949|NCT00326209|12105366|FG000|Overall Study|Sponsor closed study|173
7686950|NCT00326209|12105366|FG000|Overall Study|Prohibited medication use|1
7686951|NCT00326209|12105366|FG000|Overall Study|Violation of entry criteria|1
7686952|NCT00326209|12105366|FG000|Overall Study|Withdrawn in error|1
7686953|NCT00326209|12105366|FG000|Overall Study|Pregnancy|1
7686954|NCT00326417|12105372|FG000|Overall Study|Withdrawal by Subject|0
7686955|NCT00326417|12105373|FG001|Overall Study|Withdrawal by Subject|0
7686956|NCT00326417|12105374|FG002|Overall Study|Withdrawal by Subject|1
7686957|NCT00326417|12105375|FG003|Overall Study|Withdrawal by Subject|0
7686958|NCT00326417|12105372|FG000|Overall Study|Arm Closed|7
7686959|NCT00326417|12105373|FG001|Overall Study|Arm Closed|0
7686960|NCT00326417|12105374|FG002|Overall Study|Arm Closed|0
7686961|NCT00326417|12105375|FG003|Overall Study|Arm Closed|3
7686962|NCT00326417|12105372|FG000|Overall Study|Death|7
7686963|NCT00326417|12105373|FG001|Overall Study|Death|0
7686964|NCT00326417|12105374|FG002|Overall Study|Death|0
7686965|NCT00326417|12105375|FG003|Overall Study|Death|0
7686966|NCT00326495|12105383|FG000|Overall Study|Switched to alternative treatment|1
7686967|NCT00326495|12105383|FG000|Overall Study|Disease progression before treatment|1
7686968|NCT00326495|12105383|FG000|Overall Study|Refused further treatment|2
7686969|NCT00326495|12105383|FG000|Overall Study|Subject off study before assessment|1
7686970|NCT00326599|12105391|FG000|Overall Study|Withdrawal by Subject|1
7686971|NCT00326599|12105392|FG001|Overall Study|Withdrawal by Subject|0
7686972|NCT00326599|12105393|FG002|Overall Study|Withdrawal by Subject|5
7686973|NCT00326599|12105394|FG003|Overall Study|Withdrawal by Subject|2
7686974|NCT00326599|12105391|FG000|Overall Study|Adverse Event|1
7686975|NCT00326599|12105392|FG001|Overall Study|Adverse Event|0
7686976|NCT00326599|12105393|FG002|Overall Study|Adverse Event|32
7686977|NCT00326599|12105394|FG003|Overall Study|Adverse Event|3
7686978|NCT00326599|12105391|FG000|Overall Study|Disease Progression|3
7686979|NCT00326599|12105392|FG001|Overall Study|Disease Progression|1
7686980|NCT00326599|12105393|FG002|Overall Study|Disease Progression|13
7686981|NCT00326599|12105394|FG003|Overall Study|Disease Progression|11
7686982|NCT00326599|12105391|FG000|Overall Study|Alternate Treatment|1
7686983|NCT00326599|12105392|FG001|Overall Study|Alternate Treatment|0
7686984|NCT00326599|12105393|FG002|Overall Study|Alternate Treatment|0
7686985|NCT00326599|12105394|FG003|Overall Study|Alternate Treatment|0
7686986|NCT00326599|12105391|FG000|Overall Study|Death|0
7686987|NCT00326599|12105392|FG001|Overall Study|Death|0
7686988|NCT00326599|12105393|FG002|Overall Study|Death|1
7686989|NCT00326599|12105394|FG003|Overall Study|Death|2
7686990|NCT00326599|12105391|FG000|Overall Study|Other Unspecified Reason|0
7686991|NCT00326599|12105392|FG001|Overall Study|Other Unspecified Reason|0
7686992|NCT00326599|12105393|FG002|Overall Study|Other Unspecified Reason|2
7686993|NCT00326599|12105394|FG003|Overall Study|Other Unspecified Reason|1
7686994|NCT00326612|12105405|FG000|Overall Study|They did not have a seizure requiring tx|129
7686995|NCT00326612|12105406|FG001|Overall Study|They did not have a seizure requiring tx|137
7686996|NCT00326716|12105418|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
7686997|NCT00326716|12105419|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
7686998|NCT00326716|12105420|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
7686999|NCT00326716|12105421|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
7687000|NCT00326885|12105464|FG000|Overall Study|Adverse Event|1
7687001|NCT00326885|12105464|FG000|Overall Study|Withdrawal by Subject|3
7687002|NCT00326885|12105464|FG000|Overall Study|Physician Decision|1
7687003|NCT00326885|12105464|FG000|Overall Study|Hospice withdrew consent|2
7687004|NCT00326911|12105471|FG000|Overall Study|Hospitalization prior to treatment|0
7687005|NCT00326911|12105472|FG001|Overall Study|Hospitalization prior to treatment|1
7687006|NCT00326911|12105471|FG000|Overall Study|Physician decision prior to treatment|1
7687007|NCT00326911|12105472|FG001|Overall Study|Physician decision prior to treatment|0
7687008|NCT00326911|12105471|FG000|Overall Study|Withdrawal by subject prior to treatment|0
7687009|NCT00326911|12105472|FG001|Overall Study|Withdrawal by subject prior to treatment|1
7687010|NCT00326950|12105487|FG000|Overall Study|Progressive Disease|1
7687011|NCT00326963|12105491|FG000|Overall Study|Adverse Event|2
7687012|NCT00326963|12105491|FG000|Overall Study|Injection site reaction|1
7687013|NCT00326963|12105491|FG000|Overall Study|Death|1
7687014|NCT00326963|12105491|FG000|Overall Study|Failure to return|10
7687015|NCT00326963|12105491|FG000|Overall Study|Withdrawal by Subject|10
7687016|NCT00326963|12105491|FG000|Overall Study|Refused treatment / did not cooperate|5
7687017|NCT00326963|12105491|FG000|Overall Study|Violation of selection criteria at entry|2
7687018|NCT00326963|12105491|FG000|Overall Study|Other protocol violation|1
7687019|NCT00326963|12105491|FG000|Overall Study|Administrative / other|1
7687020|NCT00327015|12105500|FG000|Overall Study|Lack of Efficacy|18
7687021|NCT00327015|12105501|FG001|Overall Study|Lack of Efficacy|18
7687022|NCT00327015|12105502|FG002|Overall Study|Lack of Efficacy|35
7687023|NCT00327015|12105503|FG003|Overall Study|Lack of Efficacy|29
7687024|NCT00327015|12105500|FG000|Overall Study|Withdrawal of Consent by Subject|20
7687025|NCT00327015|12105501|FG001|Overall Study|Withdrawal of Consent by Subject|24
7687026|NCT00327015|12105502|FG002|Overall Study|Withdrawal of Consent by Subject|28
7687027|NCT00327015|12105503|FG003|Overall Study|Withdrawal of Consent by Subject|25
7687028|NCT00327015|12105500|FG000|Overall Study|Lost to Follow-up|22
7687029|NCT00327015|12105501|FG001|Overall Study|Lost to Follow-up|23
7687030|NCT00327015|12105502|FG002|Overall Study|Lost to Follow-up|29
7687031|NCT00327015|12105503|FG003|Overall Study|Lost to Follow-up|22
7687032|NCT00327015|12105500|FG000|Overall Study|Adverse Event|14
7687033|NCT00327015|12105501|FG001|Overall Study|Adverse Event|10
7687034|NCT00327015|12105502|FG002|Overall Study|Adverse Event|14
7687035|NCT00327015|12105503|FG003|Overall Study|Adverse Event|14
7687036|NCT00327015|12105500|FG000|Overall Study|Subject no longer meets study criteria|4
7687037|NCT00327015|12105501|FG001|Overall Study|Subject no longer meets study criteria|2
7687038|NCT00327015|12105502|FG002|Overall Study|Subject no longer meets study criteria|8
7687039|NCT00327015|12105503|FG003|Overall Study|Subject no longer meets study criteria|7
7687040|NCT00327015|12105500|FG000|Overall Study|Poor/Noncompliance|11
7687041|NCT00327015|12105501|FG001|Overall Study|Poor/Noncompliance|8
7687042|NCT00327015|12105502|FG002|Overall Study|Poor/Noncompliance|4
7687043|NCT00327015|12105503|FG003|Overall Study|Poor/Noncompliance|5
7687044|NCT00327015|12105500|FG000|Overall Study|Physician Decision|0
7687045|NCT00327015|12105501|FG001|Overall Study|Physician Decision|1
7687046|NCT00327015|12105502|FG002|Overall Study|Physician Decision|3
7687047|NCT00327015|12105503|FG003|Overall Study|Physician Decision|2
7687048|NCT00327015|12105500|FG000|Overall Study|Death|1
7687049|NCT00327015|12105501|FG001|Overall Study|Death|2
7687050|NCT00327015|12105502|FG002|Overall Study|Death|2
7687051|NCT00327015|12105503|FG003|Overall Study|Death|3
7687052|NCT00327015|12105500|FG000|Overall Study|Pregnancy|0
7687053|NCT00327015|12105501|FG001|Overall Study|Pregnancy|2
7687054|NCT00327015|12105502|FG002|Overall Study|Pregnancy|1
7687055|NCT00327015|12105503|FG003|Overall Study|Pregnancy|1
7687056|NCT00327015|12105500|FG000|Overall Study|Administrative Reason by Sponsor|1
7687057|NCT00327015|12105501|FG001|Overall Study|Administrative Reason by Sponsor|2
7687058|NCT00327015|12105502|FG002|Overall Study|Administrative Reason by Sponsor|2
7687059|NCT00327015|12105503|FG003|Overall Study|Administrative Reason by Sponsor|1
7687060|NCT00327171|12105515|FG000|Overall Study|Did not receive study medication|3
7687061|NCT00327171|12105516|FG001|Overall Study|Did not receive study medication|0
7687062|NCT00327171|12105515|FG000|Overall Study|Adverse Event|23
7687063|NCT00327171|12105516|FG001|Overall Study|Adverse Event|23
7687064|NCT00327171|12105515|FG000|Overall Study|Disease progression/lack of efficacy|68
7687065|NCT00327171|12105516|FG001|Overall Study|Disease progression/lack of efficacy|69
7687066|NCT00327171|12105515|FG000|Overall Study|Investigator/participant request|1
7687067|NCT00327171|12105516|FG001|Overall Study|Investigator/participant request|8
7687068|NCT00327171|12105515|FG000|Overall Study|Clinical progression|12
7687069|NCT00327171|12105516|FG001|Overall Study|Clinical progression|8
7687070|NCT00327171|12105515|FG000|Overall Study|Undisclosed history of ischemia|0
7687071|NCT00327171|12105516|FG001|Overall Study|Undisclosed history of ischemia|1
7687072|NCT00327171|12105515|FG000|Overall Study|Other|1
7687073|NCT00327171|12105516|FG001|Overall Study|Other|0
7687074|NCT00327340|12105524|FG000|Overall Study|Withdrawal by Subject|1
7687075|NCT00327340|12105525|FG001|Overall Study|Withdrawal by Subject|5
7687076|NCT00327340|12105524|FG000|Overall Study|Physician Decision|1
7687077|NCT00327340|12105525|FG001|Overall Study|Physician Decision|1
7687078|NCT00327340|12105524|FG000|Overall Study|Disease Progression|10
7687079|NCT00327340|12105525|FG001|Overall Study|Disease Progression|19
7687080|NCT00327340|12105524|FG000|Overall Study|Symptomatic Disease|0
7687081|NCT00327340|12105525|FG001|Overall Study|Symptomatic Disease|2
7687082|NCT00327340|12105524|FG000|Overall Study|Adverse Event|3
7687083|NCT00327340|12105525|FG001|Overall Study|Adverse Event|3
7687084|NCT00327444|12105539|FG000|Double Blind Treatment (DB) Period|Disease progression|10
7687085|NCT00327444|12105540|FG001|Double Blind Treatment (DB) Period|Disease progression|13
7687086|NCT00327444|12105539|FG000|Double Blind Treatment (DB) Period|Adverse Event|5
7687087|NCT00327444|12105540|FG001|Double Blind Treatment (DB) Period|Adverse Event|5
7687088|NCT00327444|12105539|FG000|Double Blind Treatment (DB) Period|Subject request|0
7687089|NCT00327444|12105540|FG001|Double Blind Treatment (DB) Period|Subject request|1
7687090|NCT00327444|12105539|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
7687091|NCT00327444|12105540|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
7687092|NCT00327444|12105539|FG000|Open Label Treatment (OL) Period|Disease progression|8
7687093|NCT00327444|12105540|FG001|Open Label Treatment (OL) Period|Disease progression|7
7687094|NCT00327444|12105539|FG000|Open Label Treatment (OL) Period|Adverse Event|2
7687095|NCT00327444|12105540|FG001|Open Label Treatment (OL) Period|Adverse Event|2
7687096|NCT00327444|12105539|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0
7687097|NCT00327444|12105540|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1
7687098|NCT00327444|12105539|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1
7687099|NCT00327444|12105540|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0
7687100|NCT00327470|12105550|FG000|Overall Study|Randomized, but not treated|0
7687101|NCT00327470|12105551|FG001|Overall Study|Randomized, but not treated|2
7687102|NCT00327470|12105550|FG000|Overall Study|Adverse Event|9
7687103|NCT00327470|12105551|FG001|Overall Study|Adverse Event|14
7687104|NCT00327470|12105550|FG000|Overall Study|Lack of Efficacy|7
7687105|NCT00327470|12105551|FG001|Overall Study|Lack of Efficacy|19
7687106|NCT00327470|12105550|FG000|Overall Study|Other|5
7687107|NCT00327470|12105551|FG001|Overall Study|Other|9
7687108|NCT00327470|12105550|FG000|Overall Study|Lost to Follow-up|1
7687109|NCT00327470|12105551|FG001|Overall Study|Lost to Follow-up|3
7687110|NCT00327470|12105550|FG000|Overall Study|Withdrawal by Subject|6
7687111|NCT00327470|12105551|FG001|Overall Study|Withdrawal by Subject|12
7687112|NCT00327470|12105550|FG000|Overall Study|Death|1
7687113|NCT00327470|12105551|FG001|Overall Study|Death|4
7687114|NCT00327717|12105559|FG000|Overall Study|Adverse Event|6
7687115|NCT00327717|12105560|FG001|Overall Study|Adverse Event|6
7687116|NCT00327717|12105559|FG000|Overall Study|Lack of Efficacy|0
7687117|NCT00327717|12105560|FG001|Overall Study|Lack of Efficacy|1
7687118|NCT00327717|12105559|FG000|Overall Study|Withdrawal by Subject|3
7687119|NCT00327717|12105560|FG001|Overall Study|Withdrawal by Subject|7
7687120|NCT00328094|12105589|FG000|Overall Study|Physician Decision|3
7687121|NCT00328094|12105590|FG001|Overall Study|Physician Decision|3
7687122|NCT00328172|12105601|FG000|Overall Study|Adverse Event|3
7687123|NCT00328172|12105602|FG001|Overall Study|Adverse Event|2
7687124|NCT00328172|12105603|FG002|Overall Study|Adverse Event|1
7687125|NCT00328172|12105604|FG003|Overall Study|Adverse Event|2
7687126|NCT00328172|12105605|FG004|Overall Study|Adverse Event|1
7687127|NCT00328172|12105601|FG000|Overall Study|Protocol Violation|0
7687128|NCT00328172|12105602|FG001|Overall Study|Protocol Violation|1
7687129|NCT00328172|12105603|FG002|Overall Study|Protocol Violation|1
7687130|NCT00328172|12105604|FG003|Overall Study|Protocol Violation|0
7687131|NCT00328172|12105605|FG004|Overall Study|Protocol Violation|0
7687132|NCT00328172|12105601|FG000|Overall Study|Lost to Follow-up|1
7687133|NCT00328172|12105602|FG001|Overall Study|Lost to Follow-up|1
7687134|NCT00328172|12105603|FG002|Overall Study|Lost to Follow-up|2
7687135|NCT00328172|12105604|FG003|Overall Study|Lost to Follow-up|1
7687136|NCT00328172|12105605|FG004|Overall Study|Lost to Follow-up|1
7687137|NCT00328172|12105601|FG000|Overall Study|Withdrawal by Subject|1
7687138|NCT00328172|12105602|FG001|Overall Study|Withdrawal by Subject|1
7687139|NCT00328172|12105603|FG002|Overall Study|Withdrawal by Subject|1
7687140|NCT00328172|12105604|FG003|Overall Study|Withdrawal by Subject|6
7687141|NCT00328172|12105605|FG004|Overall Study|Withdrawal by Subject|0
7687142|NCT00328172|12105601|FG000|Overall Study|Lack of Efficacy|14
7687143|NCT00328172|12105602|FG001|Overall Study|Lack of Efficacy|9
7687144|NCT00328172|12105603|FG002|Overall Study|Lack of Efficacy|4
7687145|NCT00328172|12105604|FG003|Overall Study|Lack of Efficacy|4
7687146|NCT00328172|12105605|FG004|Overall Study|Lack of Efficacy|3
7687147|NCT00328172|12105601|FG000|Overall Study|Other reason (not specified)|3
7687148|NCT00328172|12105602|FG001|Overall Study|Other reason (not specified)|0
7687149|NCT00328172|12105603|FG002|Overall Study|Other reason (not specified)|1
7687150|NCT00328172|12105604|FG003|Overall Study|Other reason (not specified)|0
7687151|NCT00328172|12105605|FG004|Overall Study|Other reason (not specified)|0
7687152|NCT00328198|12105617|FG000|Treatment|Adverse Event|21
7687153|NCT00328198|12105617|FG000|Treatment|Death|1
7687154|NCT00328198|12105617|FG000|Treatment|Physician Decision|5
7687155|NCT00328198|12105617|FG000|Treatment|Withdrawal by Subject|5
7687156|NCT00328198|12105617|FG000|Treatment|Evidence of disease progression|2
7687157|NCT00328198|12105617|FG000|Treatment|Non-compliance|1
7687158|NCT00328198|12105617|FG000|Treatment|Confirmed complete response, MRD -|3
7687159|NCT00328198|12105617|FG000|Follow-up|Lost to Follow-up|4
7687160|NCT00328198|12105617|FG000|Follow-up|Death|31
7687161|NCT00328510|12105632|FG000|Overall Study|Gag disorder, could not use frame|4
7687162|NCT00328510|12105633|FG001|Overall Study|Gag disorder, could not use frame|0
7687163|NCT00328510|12105632|FG000|Overall Study|Dentition problems, could not use frame|1
7687164|NCT00328510|12105633|FG001|Overall Study|Dentition problems, could not use frame|0
7687165|NCT00328510|12105632|FG000|Overall Study|Withdrawal by Subject|4
7687166|NCT00328510|12105633|FG001|Overall Study|Withdrawal by Subject|2
7687167|NCT00328510|12105632|FG000|Overall Study|Severe kyphosis, could not use mask|0
7687168|NCT00328510|12105633|FG001|Overall Study|Severe kyphosis, could not use mask|1
7687169|NCT00328510|12105632|FG000|Overall Study|Treatment changed to a single fraction|1
7687170|NCT00328510|12105633|FG001|Overall Study|Treatment changed to a single fraction|1
7687171|NCT00328562|12105639|FG000|Overall Study|Disease progression|1
7687172|NCT00328627|12105675|FG000|Overall Study|Hyperglycemic Rescue|41
7687173|NCT00328627|12105676|FG001|Overall Study|Hyperglycemic Rescue|18
7687174|NCT00328627|12105677|FG002|Overall Study|Hyperglycemic Rescue|16
7687175|NCT00328627|12105678|FG003|Overall Study|Hyperglycemic Rescue|13
7687176|NCT00328627|12105679|FG004|Overall Study|Hyperglycemic Rescue|6
7687177|NCT00328627|12105680|FG005|Overall Study|Hyperglycemic Rescue|5
7687178|NCT00328627|12105681|FG006|Overall Study|Hyperglycemic Rescue|19
7687179|NCT00328627|12105682|FG007|Overall Study|Hyperglycemic Rescue|6
7687180|NCT00328627|12105683|FG008|Overall Study|Hyperglycemic Rescue|6
7687181|NCT00328627|12105684|FG009|Overall Study|Hyperglycemic Rescue|11
7687182|NCT00328627|12105685|FG010|Overall Study|Hyperglycemic Rescue|3
7687183|NCT00328627|12105686|FG011|Overall Study|Hyperglycemic Rescue|2
7687184|NCT00328627|12105675|FG000|Overall Study|Adverse Event|3
7687185|NCT00328627|12105676|FG001|Overall Study|Adverse Event|1
7687186|NCT00328627|12105677|FG002|Overall Study|Adverse Event|2
7687187|NCT00328627|12105678|FG003|Overall Study|Adverse Event|3
7687188|NCT00328627|12105679|FG004|Overall Study|Adverse Event|1
7687189|NCT00328627|12105680|FG005|Overall Study|Adverse Event|2
7687190|NCT00328627|12105681|FG006|Overall Study|Adverse Event|1
7687191|NCT00328627|12105682|FG007|Overall Study|Adverse Event|2
7687192|NCT00328627|12105683|FG008|Overall Study|Adverse Event|0
7687193|NCT00328627|12105684|FG009|Overall Study|Adverse Event|7
7687194|NCT00328627|12105685|FG010|Overall Study|Adverse Event|5
7687195|NCT00328627|12105686|FG011|Overall Study|Adverse Event|4
7687196|NCT00328627|12105675|FG000|Overall Study|Protocol Violation|2
7687197|NCT00328627|12105676|FG001|Overall Study|Protocol Violation|2
7687198|NCT00328627|12105677|FG002|Overall Study|Protocol Violation|2
7687199|NCT00328627|12105678|FG003|Overall Study|Protocol Violation|8
7687200|NCT00328627|12105679|FG004|Overall Study|Protocol Violation|5
7687201|NCT00328627|12105680|FG005|Overall Study|Protocol Violation|5
7687202|NCT00328627|12105681|FG006|Overall Study|Protocol Violation|6
7687203|NCT00328627|12105682|FG007|Overall Study|Protocol Violation|2
7687204|NCT00328627|12105683|FG008|Overall Study|Protocol Violation|1
7687205|NCT00328627|12105684|FG009|Overall Study|Protocol Violation|4
7687206|NCT00328627|12105685|FG010|Overall Study|Protocol Violation|6
7687207|NCT00328627|12105686|FG011|Overall Study|Protocol Violation|2
7687208|NCT00328627|12105675|FG000|Overall Study|Lost to Follow-up|4
7687209|NCT00328627|12105676|FG001|Overall Study|Lost to Follow-up|2
7687210|NCT00328627|12105677|FG002|Overall Study|Lost to Follow-up|2
7687211|NCT00328627|12105678|FG003|Overall Study|Lost to Follow-up|4
7687212|NCT00328627|12105679|FG004|Overall Study|Lost to Follow-up|0
7687213|NCT00328627|12105680|FG005|Overall Study|Lost to Follow-up|2
7687214|NCT00328627|12105681|FG006|Overall Study|Lost to Follow-up|3
7687215|NCT00328627|12105682|FG007|Overall Study|Lost to Follow-up|0
7687216|NCT00328627|12105683|FG008|Overall Study|Lost to Follow-up|3
7687217|NCT00328627|12105684|FG009|Overall Study|Lost to Follow-up|2
7687218|NCT00328627|12105685|FG010|Overall Study|Lost to Follow-up|0
7687219|NCT00328627|12105686|FG011|Overall Study|Lost to Follow-up|1
7687220|NCT00328627|12105675|FG000|Overall Study|Withdrawal by Subject|5
7687221|NCT00328627|12105676|FG001|Overall Study|Withdrawal by Subject|4
7687222|NCT00328627|12105677|FG002|Overall Study|Withdrawal by Subject|5
7687223|NCT00328627|12105678|FG003|Overall Study|Withdrawal by Subject|6
7687224|NCT00328627|12105679|FG004|Overall Study|Withdrawal by Subject|2
7687225|NCT00328627|12105680|FG005|Overall Study|Withdrawal by Subject|5
7687226|NCT00328627|12105681|FG006|Overall Study|Withdrawal by Subject|4
7687227|NCT00328627|12105682|FG007|Overall Study|Withdrawal by Subject|4
7687228|NCT00328627|12105683|FG008|Overall Study|Withdrawal by Subject|4
7687229|NCT00328627|12105684|FG009|Overall Study|Withdrawal by Subject|5
7687230|NCT00328627|12105685|FG010|Overall Study|Withdrawal by Subject|2
7687231|NCT00328627|12105686|FG011|Overall Study|Withdrawal by Subject|7
7687232|NCT00328627|12105675|FG000|Overall Study|Pregnancy|0
7687233|NCT00328627|12105676|FG001|Overall Study|Pregnancy|1
7687234|NCT00328627|12105677|FG002|Overall Study|Pregnancy|0
7687235|NCT00328627|12105678|FG003|Overall Study|Pregnancy|0
7687236|NCT00328627|12105679|FG004|Overall Study|Pregnancy|0
7687237|NCT00328627|12105680|FG005|Overall Study|Pregnancy|0
7687238|NCT00328627|12105681|FG006|Overall Study|Pregnancy|0
7687239|NCT00328627|12105682|FG007|Overall Study|Pregnancy|0
7687240|NCT00328627|12105683|FG008|Overall Study|Pregnancy|0
7687241|NCT00328627|12105684|FG009|Overall Study|Pregnancy|0
7687242|NCT00328627|12105685|FG010|Overall Study|Pregnancy|0
7687243|NCT00328627|12105686|FG011|Overall Study|Pregnancy|0
7687244|NCT00328627|12105675|FG000|Overall Study|Physician Decision|4
7687245|NCT00328627|12105676|FG001|Overall Study|Physician Decision|3
7687246|NCT00328627|12105677|FG002|Overall Study|Physician Decision|1
7687247|NCT00328627|12105678|FG003|Overall Study|Physician Decision|2
7687248|NCT00328627|12105679|FG004|Overall Study|Physician Decision|1
7687249|NCT00328627|12105680|FG005|Overall Study|Physician Decision|1
7687250|NCT00328627|12105681|FG006|Overall Study|Physician Decision|1
7687251|NCT00328627|12105682|FG007|Overall Study|Physician Decision|0
7687252|NCT00328627|12105683|FG008|Overall Study|Physician Decision|3
7687253|NCT00328627|12105684|FG009|Overall Study|Physician Decision|2
7687254|NCT00328627|12105685|FG010|Overall Study|Physician Decision|1
7687255|NCT00328627|12105686|FG011|Overall Study|Physician Decision|0
7687256|NCT00328627|12105675|FG000|Overall Study|Other|0
7687257|NCT00328627|12105676|FG001|Overall Study|Other|0
7687258|NCT00328627|12105677|FG002|Overall Study|Other|0
7687259|NCT00328627|12105678|FG003|Overall Study|Other|1
7687260|NCT00328627|12105679|FG004|Overall Study|Other|0
7687261|NCT00328627|12105680|FG005|Overall Study|Other|0
7687262|NCT00328627|12105681|FG006|Overall Study|Other|1
7687263|NCT00328627|12105682|FG007|Overall Study|Other|0
7687264|NCT00328627|12105683|FG008|Overall Study|Other|0
7687265|NCT00328627|12105684|FG009|Overall Study|Other|1
7687266|NCT00328627|12105685|FG010|Overall Study|Other|1
7687267|NCT00328627|12105686|FG011|Overall Study|Other|0
7687268|NCT00328783|12105725|FG000|Overall Study|Could not tolerate ABC|21
7687269|NCT00328783|12105725|FG000|Overall Study|No heart in RT field|4
7687270|NCT00328783|12105725|FG000|Overall Study|Withdrawal by Subject|1
7687271|NCT00328926|12105743|FG000|Overall Study|Pregnancy|2
7687272|NCT00328926|12105744|FG001|Overall Study|Pregnancy|1
7687273|NCT00328926|12105745|FG002|Overall Study|Pregnancy|0
7687274|NCT00328926|12105743|FG000|Overall Study|Lost to Follow-up|0
7687275|NCT00328926|12105744|FG001|Overall Study|Lost to Follow-up|1
7687276|NCT00328926|12105745|FG002|Overall Study|Lost to Follow-up|0
7687277|NCT00328926|12105743|FG000|Overall Study|Death|0
7687278|NCT00328926|12105744|FG001|Overall Study|Death|0
7687279|NCT00328926|12105745|FG002|Overall Study|Death|1
7687280|NCT00328926|12105743|FG000|Overall Study|In vitro fertilization treatment|0
7687281|NCT00328926|12105744|FG001|Overall Study|In vitro fertilization treatment|0
7687282|NCT00328926|12105745|FG002|Overall Study|In vitro fertilization treatment|1
7687283|NCT00328926|12105743|FG000|Overall Study|Lack of ovarian response|0
7687284|NCT00328926|12105744|FG001|Overall Study|Lack of ovarian response|1
7687285|NCT00328926|12105745|FG002|Overall Study|Lack of ovarian response|0
7687286|NCT00329030|12105755|FG000|Overall Study|Withdrawal by Subject|1
7687287|NCT00329030|12105756|FG001|Overall Study|Withdrawal by Subject|3
7687288|NCT00329030|12105755|FG000|Overall Study|Progressive Disease|6
7687289|NCT00329030|12105756|FG001|Overall Study|Progressive Disease|2
7687290|NCT00329030|12105755|FG000|Overall Study|Ineligible Pathology|1
7687291|NCT00329030|12105756|FG001|Overall Study|Ineligible Pathology|1
7687292|NCT00329160|12105762|FG000|Overall Study|Adverse Event|27
7687293|NCT00329160|12105762|FG000|Overall Study|Withdrawal by Subject|13
7687294|NCT00329160|12105762|FG000|Overall Study|Protocol Violation|2
7687295|NCT00329160|12105762|FG000|Overall Study|Did not Receive Study Drug|1
7687296|NCT00329160|12105762|FG000|Overall Study|Incomplete IVUS|45
7687297|NCT00329238|12105768|FG000|Overall Study|Adverse Event|147
7687298|NCT00329238|12105769|FG001|Overall Study|Adverse Event|129
7687299|NCT00329238|12105768|FG000|Overall Study|Protocol Violation|23
7687300|NCT00329238|12105769|FG001|Overall Study|Protocol Violation|34
7687301|NCT00329238|12105768|FG000|Overall Study|Lost to Follow-up|2
7687302|NCT00329238|12105769|FG001|Overall Study|Lost to Follow-up|6
7687303|NCT00329238|12105768|FG000|Overall Study|Withdrawal by Subject|64
7687304|NCT00329238|12105769|FG001|Overall Study|Withdrawal by Subject|58
7687305|NCT00329238|12105768|FG000|Overall Study|Other reason (not specified)|40
7687306|NCT00329238|12105769|FG001|Overall Study|Other reason (not specified)|54
7687307|NCT00329303|12105779|FG000|Overall Study|Lack of Efficacy|1
7687308|NCT00329303|12105780|FG001|Overall Study|Lack of Efficacy|0
7687309|NCT00329303|12105779|FG000|Overall Study|Decision of the sponsor|0
7687310|NCT00329303|12105780|FG001|Overall Study|Decision of the sponsor|1
7687311|NCT00329303|12105779|FG000|Overall Study|Patient no longer available|1
7687312|NCT00329303|12105780|FG001|Overall Study|Patient no longer available|0
7687313|NCT00329303|12105779|FG000|Overall Study|Patient relocated|0
7687314|NCT00329303|12105780|FG001|Overall Study|Patient relocated|1
7687315|NCT00329407|12105787|FG000|Overall Study|Withdrawal by Subject|1
7687316|NCT00329420|12105794|FG000|Re-induction Phase|Lack of Efficacy|0
7687317|NCT00329420|12105795|FG001|Re-induction Phase|Lack of Efficacy|1
7687318|NCT00329420|12105796|FG002|Re-induction Phase|Lack of Efficacy|0
7687319|NCT00329420|12105794|FG000|Re-induction Phase|Withdrawal of Consent|0
7687320|NCT00329420|12105795|FG001|Re-induction Phase|Withdrawal of Consent|0
7687321|NCT00329420|12105796|FG002|Re-induction Phase|Withdrawal of Consent|1
7687322|NCT00329420|12105794|FG000|Re-induction Phase|Did not respond to re-induction|6
7687323|NCT00329420|12105795|FG001|Re-induction Phase|Did not respond to re-induction|5
7687324|NCT00329420|12105796|FG002|Re-induction Phase|Did not respond to re-induction|7
7687325|NCT00329420|12105794|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
7687326|NCT00329420|12105795|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
7687327|NCT00329420|12105796|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
7687328|NCT00329420|12105794|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
7687329|NCT00329420|12105795|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
7687330|NCT00329420|12105796|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
7687331|NCT00329420|12105794|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
7687332|NCT00329420|12105795|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
7687333|NCT00329420|12105796|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
7687334|NCT00329550|12105822|FG000|Overall Study|Adverse Event|3
7687335|NCT00329550|12105823|FG001|Overall Study|Adverse Event|4
7687336|NCT00329550|12105824|FG002|Overall Study|Adverse Event|2
7687337|NCT00329550|12105822|FG000|Overall Study|Withdrawal of Consent|1
7687338|NCT00329550|12105823|FG001|Overall Study|Withdrawal of Consent|0
7687339|NCT00329550|12105824|FG002|Overall Study|Withdrawal of Consent|1
7687340|NCT00329550|12105822|FG000|Overall Study|Due to Relocation|0
7687341|NCT00329550|12105823|FG001|Overall Study|Due to Relocation|0
7687342|NCT00329550|12105824|FG002|Overall Study|Due to Relocation|1
7687343|NCT00329602|12105836|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
7687344|NCT00329602|12105837|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
7687345|NCT00329602|12105838|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
7687346|NCT00329602|12105836|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0
7687347|NCT00329602|12105837|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0
7687348|NCT00329602|12105838|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20
7687349|NCT00329602|12105836|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
7687350|NCT00329602|12105837|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
7687351|NCT00329602|12105838|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
7687352|NCT00329602|12105836|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0
7687353|NCT00329602|12105837|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0
7687354|NCT00329602|12105838|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2
7687355|NCT00329602|12105836|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
7687356|NCT00329602|12105837|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
7687357|NCT00329602|12105838|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
7687358|NCT00329602|12105836|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0
7687359|NCT00329602|12105837|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0
7687360|NCT00329602|12105838|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4
7687361|NCT00329641|12105854|FG000|Overall Study|Did not start treatment|1
7687362|NCT00329641|12105854|FG000|Overall Study|Not eligible|1
7687363|NCT00329641|12105854|FG000|Overall Study|Adverse Event|3
7687364|NCT00329641|12105854|FG000|Overall Study|Other reason, not protocol specified|1
7687365|NCT00329719|12105863|FG000|Overall Study|Lost to Follow-up|0
7687366|NCT00329719|12105864|FG001|Overall Study|Lost to Follow-up|0
7687367|NCT00329719|12105865|FG002|Overall Study|Lost to Follow-up|0
7687368|NCT00329719|12105866|FG003|Overall Study|Lost to Follow-up|1
7687369|NCT00329745|12105878|FG000|Overall Study|Protocol Violation|1
7687370|NCT00329745|12105879|FG001|Overall Study|Protocol Violation|0
7687371|NCT00329745|12105878|FG000|Overall Study|Withdrawal by Subject|0
7687372|NCT00329745|12105879|FG001|Overall Study|Withdrawal by Subject|1
7687373|NCT00329745|12105878|FG000|Overall Study|Lost to Follow-up|86
7687374|NCT00329745|12105879|FG001|Overall Study|Lost to Follow-up|101
7687375|NCT00329784|12105893|FG000|Overall Study|Lost to Follow-up|0
7687376|NCT00329784|12105894|FG001|Overall Study|Lost to Follow-up|1
7687377|NCT00329784|12105895|FG002|Overall Study|Lost to Follow-up|0
7687378|NCT00329784|12105896|FG003|Overall Study|Lost to Follow-up|0
7687379|NCT00329784|12105893|FG000|Overall Study|Withdrawal by Subject|4
7687380|NCT00329784|12105894|FG001|Overall Study|Withdrawal by Subject|2
7687381|NCT00329784|12105895|FG002|Overall Study|Withdrawal by Subject|0
7687382|NCT00329784|12105896|FG003|Overall Study|Withdrawal by Subject|0
7687383|NCT00329784|12105893|FG000|Overall Study|Other|1
7687384|NCT00329784|12105894|FG001|Overall Study|Other|2
7687385|NCT00329784|12105895|FG002|Overall Study|Other|0
7687386|NCT00329784|12105896|FG003|Overall Study|Other|0
7687387|NCT00329797|12105910|FG000|Overall Study|Protocol Violation|1
7687388|NCT00329797|12105911|FG001|Overall Study|Protocol Violation|0
7687389|NCT00329797|12105910|FG000|Overall Study|Withdrawal by Subject|6
7687390|NCT00329797|12105911|FG001|Overall Study|Withdrawal by Subject|6
7687391|NCT00329849|12105923|FG000|Overall Study|Withdrawal by Subject|6
7687392|NCT00329849|12105924|FG001|Overall Study|Withdrawal by Subject|4
7687393|NCT00329901|12105937|FG000|Overall Study|Withdrawal by Subject|4
7687394|NCT00329901|12105938|FG001|Overall Study|Withdrawal by Subject|3
7687395|NCT00329901|12105939|FG002|Overall Study|Withdrawal by Subject|2
7687396|NCT00329901|12105937|FG000|Overall Study|Lost to Follow-up|2
7687397|NCT00329901|12105938|FG001|Overall Study|Lost to Follow-up|0
7687398|NCT00329901|12105939|FG002|Overall Study|Lost to Follow-up|1
7687399|NCT00329901|12105937|FG000|Overall Study|Protocol Violation|1
7687400|NCT00329901|12105938|FG001|Overall Study|Protocol Violation|0
7687401|NCT00329901|12105939|FG002|Overall Study|Protocol Violation|1
7687402|NCT00329901|12105937|FG000|Overall Study|Unable to classify|2
7687403|NCT00329901|12105938|FG001|Overall Study|Unable to classify|2
7687404|NCT00329901|12105939|FG002|Overall Study|Unable to classify|0
7687405|NCT00330174|12105957|FG000|Overall Study|Withdrawal by Subject|7
7687406|NCT00330174|12105958|FG001|Overall Study|Withdrawal by Subject|7
7687407|NCT00330174|12105957|FG000|Overall Study|Lost to Follow-up|4
7687408|NCT00330174|12105958|FG001|Overall Study|Lost to Follow-up|1
7687409|NCT00330174|12105957|FG000|Overall Study|Clinical deterioration|1
7687410|NCT00330174|12105958|FG001|Overall Study|Clinical deterioration|2
7687411|NCT00330174|12105957|FG000|Overall Study|Excessive missed visits|3
7687412|NCT00330174|12105958|FG001|Overall Study|Excessive missed visits|8
7687413|NCT00330174|12105957|FG000|Overall Study|Miscellaneous reasons|7
7687414|NCT00330174|12105958|FG001|Overall Study|Miscellaneous reasons|1
7687415|NCT00330187|12105968|FG000|Overall Study|Lost to Follow-up|12
7687416|NCT00330187|12105969|FG001|Overall Study|Lost to Follow-up|13
7687417|NCT00330187|12105970|FG002|Overall Study|Lost to Follow-up|14
7687418|NCT00330187|12105971|FG003|Overall Study|Lost to Follow-up|10
7687419|NCT00330187|12105968|FG000|Overall Study|Withdrawal by Subject|8
7687420|NCT00330187|12105969|FG001|Overall Study|Withdrawal by Subject|5
7687421|NCT00330187|12105970|FG002|Overall Study|Withdrawal by Subject|4
7687422|NCT00330187|12105971|FG003|Overall Study|Withdrawal by Subject|4
7687423|NCT00330343|12105981|FG000|Overall Study|Lost to Follow-up|5
7687424|NCT00330460|12106002|FG000|Overall Study|Physician Decision|1
7687425|NCT00330460|12106003|FG001|Overall Study|Physician Decision|0
7687426|NCT00330460|12106002|FG000|Overall Study|Adverse Event|10
7687427|NCT00330460|12106003|FG001|Overall Study|Adverse Event|8
7687428|NCT00330460|12106002|FG000|Overall Study|Withdrawal by Subject|18
7687429|NCT00330460|12106003|FG001|Overall Study|Withdrawal by Subject|17
7687430|NCT00330460|12106002|FG000|Overall Study|Death|1
7687431|NCT00330460|12106003|FG001|Overall Study|Death|1
7687432|NCT00330460|12106002|FG000|Overall Study|Ineligibility determined|1
7687433|NCT00330460|12106003|FG001|Overall Study|Ineligibility determined|3
7687434|NCT00330460|12106002|FG000|Overall Study|Lost to Follow-up|8
7687435|NCT00330460|12106003|FG001|Overall Study|Lost to Follow-up|3
7687436|NCT00330460|12106002|FG000|Overall Study|Noncompliance|2
7687437|NCT00330460|12106003|FG001|Overall Study|Noncompliance|1
7687438|NCT00330460|12106002|FG000|Overall Study|Other|1
7687439|NCT00330460|12106003|FG001|Overall Study|Other|0
7687440|NCT00330616|12106024|FG000|Overall Study|Adverse Event|13
7687441|NCT00330616|12106024|FG000|Overall Study|Lack of Efficacy|1
7687442|NCT00330616|12106024|FG000|Overall Study|Lost to Follow-up|2
7687443|NCT00330616|12106024|FG000|Overall Study|Withdrawal by Subject|4
7687444|NCT00330616|12106024|FG000|Overall Study|Other|1
7687445|NCT00330668|12106028|FG000|BID Dosing Period|Adverse Event|1
7687446|NCT00330668|12106028|FG000|BID Dosing Period|Lost to Follow-up|7
7687447|NCT00330668|12106028|FG000|BID Dosing Period|Non-Compliance|5
7687448|NCT00330668|12106028|FG000|BID Dosing Period|Withdrawal by Subject|19
7687449|NCT00330668|12106028|FG000|BID Dosing Period|Sponsor's decision|1
7687450|NCT00330668|12106028|FG000|BID Dosing Period|Other|3
7687451|NCT00330668|12106028|FG000|QD Dosing Period|Sponsor decision to terminate study|74
7687452|NCT00330668|12106028|FG000|QD Dosing Period|Other|1
7687453|NCT00330668|12106028|FG000|QD Dosing Period|Withdrawal by Subject|1
7687454|NCT00330668|12106028|FG000|QD Dosing Period|Lost to Follow-up|2
7687455|NCT00330681|12106034|FG000|Overall Study|Adverse Event|3
7687456|NCT00330681|12106035|FG001|Overall Study|Adverse Event|6
7687457|NCT00330681|12106034|FG000|Overall Study|Protocol Violation|0
7687458|NCT00330681|12106035|FG001|Overall Study|Protocol Violation|1
7687459|NCT00330681|12106034|FG000|Overall Study|Withdrawal by Subject|5
7687460|NCT00330681|12106035|FG001|Overall Study|Withdrawal by Subject|5
7687461|NCT00330681|12106034|FG000|Overall Study|Tracheotomy due to worsening of ALS|1
7687462|NCT00330681|12106035|FG001|Overall Study|Tracheotomy due to worsening of ALS|2
7687463|NCT00330759|12106052|FG000|Overall Study|Death|316
7687464|NCT00330759|12106053|FG001|Overall Study|Death|310
7687465|NCT00330759|12106052|FG000|Overall Study|Disease progression|104
7687466|NCT00330759|12106053|FG001|Overall Study|Disease progression|126
7687467|NCT00330759|12106052|FG000|Overall Study|Withdrawal by Subject|143
7687468|NCT00330759|12106053|FG001|Overall Study|Withdrawal by Subject|124
7687469|NCT00330759|12106052|FG000|Overall Study|Adverse Event|48
7687470|NCT00330759|12106053|FG001|Overall Study|Adverse Event|36
7687471|NCT00330759|12106052|FG000|Overall Study|Participant request|31
7687472|NCT00330759|12106053|FG001|Overall Study|Participant request|22
7687473|NCT00330759|12106052|FG000|Overall Study|Lost to Follow-up|16
7687474|NCT00330759|12106053|FG001|Overall Study|Lost to Follow-up|22
7687475|NCT00330759|12106052|FG000|Overall Study|Noncompliance|15
7687476|NCT00330759|12106053|FG001|Overall Study|Noncompliance|17
7687477|NCT00330759|12106052|FG000|Overall Study|Physician Decision|1
7687478|NCT00330759|12106053|FG001|Overall Study|Physician Decision|2
7687479|NCT00330759|12106052|FG000|Overall Study|Protocol deviation|0
7687480|NCT00330759|12106053|FG001|Overall Study|Protocol deviation|2
7687481|NCT00330759|12106052|FG000|Overall Study|Ineligibility determined|2
7687482|NCT00330759|12106053|FG001|Overall Study|Ineligibility determined|1
7687483|NCT00330759|12106052|FG000|Overall Study|Other|36
7687484|NCT00330759|12106053|FG001|Overall Study|Other|44
7687485|NCT00330928|12106079|FG000|Overall Study|Lost to Follow-up|6
7687486|NCT00330928|12106079|FG000|Overall Study|Physician Decision|9
7687487|NCT00330928|12106079|FG000|Overall Study|Death|1
7687488|NCT00330928|12106079|FG000|Overall Study|IVUS could not be performed.|1
7687489|NCT00330967|12106085|FG000|Overall Study|Withdrawal by Subject|0
7687490|NCT00330967|12106086|FG001|Overall Study|Withdrawal by Subject|5
7687491|NCT00330967|12106085|FG000|Overall Study|Physician Decision|0
7687492|NCT00330967|12106086|FG001|Overall Study|Physician Decision|9
7687493|NCT00331006|12106092|FG000|Screening Phase|Withdrawal by Subject|1
7687494|NCT00331006|12106092|FG000|Screening Phase|enrollment halted|1
7687495|NCT00331006|12106092|FG000|Screening Phase|Lost to Follow-up|1
7687496|NCT00331006|12106092|FG000|Screening Phase|Ineligible for treatment phase|4
7687497|NCT00331006|12106092|FG000|Treatment Phase|Withdrawal by Subject|1
7687498|NCT00331006|12106092|FG000|Follow-Up Phase I|Lost to Follow-up|1
7687499|NCT00331006|12106092|FG000|Follow-Up Phase II|Lost to Follow-up|3
7687500|NCT00331136|12106100|FG000|Overall Study|Adverse Event|3
7687501|NCT00331136|12106101|FG001|Overall Study|Adverse Event|5
7687502|NCT00331136|12106102|FG002|Overall Study|Adverse Event|0
7687503|NCT00331136|12106103|FG003|Overall Study|Adverse Event|1
7687504|NCT00331136|12106100|FG000|Overall Study|Withdrawal by Subject|0
7687505|NCT00331136|12106101|FG001|Overall Study|Withdrawal by Subject|1
7687506|NCT00331136|12106102|FG002|Overall Study|Withdrawal by Subject|0
7687507|NCT00331136|12106103|FG003|Overall Study|Withdrawal by Subject|0
7687508|NCT00331136|12106100|FG000|Overall Study|Lost to Follow-up|0
7687509|NCT00331136|12106101|FG001|Overall Study|Lost to Follow-up|1
7687510|NCT00331136|12106102|FG002|Overall Study|Lost to Follow-up|0
7687511|NCT00331136|12106103|FG003|Overall Study|Lost to Follow-up|0
7687512|NCT00331136|12106100|FG000|Overall Study|Protocol Violation|1
7687513|NCT00331136|12106101|FG001|Overall Study|Protocol Violation|0
7687514|NCT00331136|12106102|FG002|Overall Study|Protocol Violation|0
7687515|NCT00331136|12106103|FG003|Overall Study|Protocol Violation|0
7687516|NCT00331136|12106100|FG000|Overall Study|Not treated|1
7687517|NCT00331136|12106101|FG001|Overall Study|Not treated|0
7687518|NCT00331136|12106102|FG002|Overall Study|Not treated|0
7687519|NCT00331136|12106103|FG003|Overall Study|Not treated|0
7687520|NCT00331344|12106122|FG000|Phase I|Adverse Event|0
7687521|NCT00331344|12106123|FG001|Phase I|Adverse Event|0
7687522|NCT00331344|12106124|FG002|Phase I|Adverse Event|0
7687523|NCT00331344|12106125|FG003|Phase I|Adverse Event|1
7687524|NCT00331344|12106126|FG004|Phase I|Adverse Event|2
7687525|NCT00331344|12106127|FG005|Phase I|Adverse Event|2
7687526|NCT00331344|12106128|FG006|Phase I|Adverse Event|0
7687527|NCT00331344|12106129|FG007|Phase I|Adverse Event|1
7687528|NCT00331344|12106130|FG008|Phase I|Adverse Event|0
7687529|NCT00331344|12106122|FG000|Phase II|Death|0
7687530|NCT00331344|12106123|FG001|Phase II|Death|0
7687531|NCT00331344|12106124|FG002|Phase II|Death|0
7687532|NCT00331344|12106125|FG003|Phase II|Death|0
7687533|NCT00331344|12106126|FG004|Phase II|Death|0
7687534|NCT00331344|12106127|FG005|Phase II|Death|0
7687535|NCT00331344|12106128|FG006|Phase II|Death|0
7687536|NCT00331344|12106129|FG007|Phase II|Death|0
7687537|NCT00331344|12106130|FG008|Phase II|Death|4
7687538|NCT00331409|12106143|FG000|Overall Study|Lack of Efficacy|4
7687539|NCT00331422|12106147|FG000|Overall Study|Did not receive entire study regimen|5
7687540|NCT00331552|12106154|FG000|Period 3: Phase II|Neurological Symptoms|1
7687541|NCT00331552|12106155|FG001|Period 3: Phase II|Neurological Symptoms|0
7687542|NCT00331552|12106154|FG000|Period 3: Phase II|Severe Nausea|1
7687543|NCT00331552|12106155|FG001|Period 3: Phase II|Severe Nausea|0
7687544|NCT00331630|12106166|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1
7687545|NCT00331630|12106166|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1
7687546|NCT00331630|12106166|FG000|Follow up for 5 Years|Death|5
7687547|NCT00331630|12106166|FG000|Follow up for 5 Years|Data collection was stopped|24
7687548|NCT00331682|12106170|FG000|Overall Study|Adverse Event|1
7687549|NCT00331760|12106176|FG000|Overall Study|Ineligible / no protocol treatment|15
7687550|NCT00331760|12106177|FG001|Overall Study|Ineligible / no protocol treatment|8
7687551|NCT00331799|12106184|FG000|Overall Study|Withdrawal by Subject|2
7687552|NCT00331799|12106184|FG000|Overall Study|Sedation|1
7687553|NCT00331864|12106190|FG000|Overall Study|Adverse Event|30
7687554|NCT00331864|12106191|FG001|Overall Study|Adverse Event|1
7687555|NCT00331864|12106190|FG000|Overall Study|Lack of Efficacy|4
7687556|NCT00331864|12106191|FG001|Overall Study|Lack of Efficacy|0
7687557|NCT00331864|12106190|FG000|Overall Study|Protocol Violation|3
7687558|NCT00331864|12106191|FG001|Overall Study|Protocol Violation|0
7687559|NCT00331864|12106190|FG000|Overall Study|Withdrawal by Subject|10
7687560|NCT00331864|12106191|FG001|Overall Study|Withdrawal by Subject|0
7687561|NCT00331864|12106190|FG000|Overall Study|Lost to Follow-up|4
7687562|NCT00331864|12106191|FG001|Overall Study|Lost to Follow-up|3
7687563|NCT00331864|12106190|FG000|Overall Study|Administrative Problems|1
7687564|NCT00331864|12106191|FG001|Overall Study|Administrative Problems|0
7687565|NCT00331864|12106190|FG000|Overall Study|Death|6
7687566|NCT00331864|12106191|FG001|Overall Study|Death|0
7687567|NCT00332189|12106206|FG000|Overall Study|Adverse Event|3
7687568|NCT00332189|12106206|FG000|Overall Study|Uncooperative/Noncompliant|3
7687569|NCT00332189|12106206|FG000|Overall Study|Withdrawal by Subject|9
7687570|NCT00332189|12106206|FG000|Overall Study|Lack of Efficacy|4
7687571|NCT00332189|12106206|FG000|Overall Study|Moved out of country|2
7687572|NCT00332202|12106213|FG000|Overall Study|Adverse Event|72
7687573|NCT00332202|12106214|FG001|Overall Study|Adverse Event|28
7687574|NCT00332202|12106213|FG000|Overall Study|Lost to Follow-up|2
7687575|NCT00332202|12106214|FG001|Overall Study|Lost to Follow-up|1
7687576|NCT00332202|12106213|FG000|Overall Study|Physician Decision|6
7687577|NCT00332202|12106214|FG001|Overall Study|Physician Decision|8
7687578|NCT00332202|12106213|FG000|Overall Study|Protocol Entry Criteria Not Met|6
7687579|NCT00332202|12106214|FG001|Overall Study|Protocol Entry Criteria Not Met|5
7687580|NCT00332202|12106213|FG000|Overall Study|Protocol Violation|7
7687581|NCT00332202|12106214|FG001|Overall Study|Protocol Violation|2
7687582|NCT00332202|12106213|FG000|Overall Study|Sponsor Decision|1
7687583|NCT00332202|12106214|FG001|Overall Study|Sponsor Decision|2
7687584|NCT00332202|12106213|FG000|Overall Study|Withdrawal by Subject|36
7687585|NCT00332202|12106214|FG001|Overall Study|Withdrawal by Subject|17
7687586|NCT00332202|12106213|FG000|Overall Study|Progressive Disease|106
7687587|NCT00332202|12106214|FG001|Overall Study|Progressive Disease|60
7687588|NCT00332202|12106213|FG000|Overall Study|Death|5
7687589|NCT00332202|12106214|FG001|Overall Study|Death|2
7687590|NCT00332241|12106231|FG000|Overall Study|Lack of Efficacy|6
7687591|NCT00332241|12106232|FG001|Overall Study|Lack of Efficacy|1
7687592|NCT00332241|12106231|FG000|Overall Study|Adverse Event|3
7687593|NCT00332241|12106232|FG001|Overall Study|Adverse Event|5
7687594|NCT00332241|12106231|FG000|Overall Study|Withdrawal by Subject|2
7687595|NCT00332241|12106232|FG001|Overall Study|Withdrawal by Subject|1
7687596|NCT00332241|12106231|FG000|Overall Study|Lost to Follow-up|4
7687597|NCT00332241|12106232|FG001|Overall Study|Lost to Follow-up|1
7687598|NCT00332332|12106238|FG000|Overall Study|Adverse Event|13
7687599|NCT00332332|12106238|FG000|Overall Study|Death|1
7687600|NCT00332332|12106238|FG000|Overall Study|Withdrawal by Subject|8
7687601|NCT00332332|12106238|FG000|Overall Study|Physician Decision|1
7687602|NCT00332332|12106238|FG000|Overall Study|Lost to Follow-up|3
7687603|NCT00332332|12106238|FG000|Overall Study|Protocol deviation|4
7687604|NCT00332332|12106238|FG000|Overall Study|Noncompliance|2
7687605|NCT00332332|12106238|FG000|Overall Study|Disease progression|2
7687606|NCT00332332|12106238|FG000|Overall Study|Other|18
7687607|NCT00332332|12106238|FG000|Overall Study|Did not receive study treatment|16
7687608|NCT00332462|12106242|FG000|Overall Study|Adverse Event|5
7687609|NCT00332462|12106242|FG000|Overall Study|Abnormal Lab Value|1
7687610|NCT00332462|12106242|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7687611|NCT00332462|12106242|FG000|Overall Study|no longer requires study drug|1
7687612|NCT00332462|12106242|FG000|Overall Study|Death|3
7687613|NCT00332462|12106242|FG000|Overall Study|Graft Loss|2
7687614|NCT00332488|12106252|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
7687615|NCT00332488|12106253|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
7687616|NCT00332488|12106254|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
7687617|NCT00332488|12106252|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
7687618|NCT00332488|12106253|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
7687619|NCT00332488|12106254|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
7687620|NCT00332488|12106252|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
7687621|NCT00332488|12106253|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
7687622|NCT00332488|12106254|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
7687623|NCT00332488|12106252|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4
7687624|NCT00332488|12106253|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0
7687625|NCT00332488|12106254|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20
7687626|NCT00332488|12106252|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
7687627|NCT00332488|12106253|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
7687628|NCT00332488|12106254|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
7687629|NCT00332488|12106252|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
7687630|NCT00332488|12106253|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
7687631|NCT00332488|12106254|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
7687632|NCT00332488|12106252|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
7687633|NCT00332488|12106253|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
7687634|NCT00332488|12106254|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3
7687635|NCT00332488|12106252|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
7687636|NCT00332488|12106253|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
7687637|NCT00332488|12106254|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1
7687638|NCT00332488|12106252|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
7687639|NCT00332488|12106253|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
7687640|NCT00332488|12106254|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3
7687641|NCT00332488|12106252|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
7687642|NCT00332488|12106253|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
7687643|NCT00332488|12106254|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1
7687644|NCT00332488|12106252|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
7687645|NCT00332488|12106253|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
7687646|NCT00332488|12106254|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8
7687647|NCT00332488|12106252|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
7687648|NCT00332488|12106253|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
7687649|NCT00332488|12106254|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5
7687650|NCT00332696|12106300|FG000|Overall Study|Death|24
7687651|NCT00332696|12106301|FG001|Overall Study|Death|14
7687652|NCT00332696|12106300|FG000|Overall Study|Insufficient therapeutic effect|4
7687653|NCT00332696|12106301|FG001|Overall Study|Insufficient therapeutic effect|11
7687654|NCT00332696|12106300|FG000|Overall Study|Adverse Event|1
7687655|NCT00332696|12106301|FG001|Overall Study|Adverse Event|2
7687656|NCT00332696|12106300|FG000|Overall Study|Condition does not justify treatment|0
7687657|NCT00332696|12106301|FG001|Overall Study|Condition does not justify treatment|2
7687658|NCT00332696|12106300|FG000|Overall Study|Lost to Follow-up|0
7687659|NCT00332696|12106301|FG001|Overall Study|Lost to Follow-up|1
7687660|NCT00332696|12106300|FG000|Overall Study|Withdrawal by Subject|1
7687661|NCT00332696|12106301|FG001|Overall Study|Withdrawal by Subject|0
7687662|NCT00332709|12106309|FG000|Overall Study|Adverse Event|11
7687663|NCT00332709|12106310|FG001|Overall Study|Adverse Event|14
7687664|NCT00332709|12106309|FG000|Overall Study|Withdrawal by Subject|2
7687665|NCT00332709|12106310|FG001|Overall Study|Withdrawal by Subject|3
7687666|NCT00332709|12106309|FG000|Overall Study|Lost to Follow-up|2
7687667|NCT00332709|12106310|FG001|Overall Study|Lost to Follow-up|0
7687668|NCT00332709|12106309|FG000|Overall Study|Administrative Problems|0
7687669|NCT00332709|12106310|FG001|Overall Study|Administrative Problems|3
7687670|NCT00332709|12106309|FG000|Overall Study|Abnormal test procedure result|1
7687671|NCT00332709|12106310|FG001|Overall Study|Abnormal test procedure result|0
7687672|NCT00332839|12106327|FG000|Core (Months 0 - 12)|Administrative problems|1
7687673|NCT00332839|12106328|FG001|Core (Months 0 - 12)|Administrative problems|1
7687674|NCT00332839|12106327|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3
7687675|NCT00332839|12106328|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1
7687676|NCT00332839|12106327|FG000|Core (Months 0 - 12)|Protocol deviation|1
7687677|NCT00332839|12106328|FG001|Core (Months 0 - 12)|Protocol deviation|1
7687678|NCT00332839|12106327|FG000|Core (Months 0 - 12)|Adverse Event|5
7687679|NCT00332839|12106328|FG001|Core (Months 0 - 12)|Adverse Event|15
7687680|NCT00332839|12106327|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
7687681|NCT00332839|12106328|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
7687682|NCT00332839|12106327|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2
7687683|NCT00332839|12106328|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1
7687684|NCT00332839|12106327|FG000|Follow-up (Months 12 - 60)|Death|1
7687685|NCT00332839|12106328|FG001|Follow-up (Months 12 - 60)|Death|1
7687686|NCT00333138|12106337|FG000|Core Study (6 Months)|Adverse Event|4
7687687|NCT00333138|12106338|FG001|Core Study (6 Months)|Adverse Event|5
7687688|NCT00333138|12106339|FG002|Core Study (6 Months)|Adverse Event|8
7687689|NCT00333138|12106337|FG000|Core Study (6 Months)|Withdrawal by Subject|1
7687690|NCT00333138|12106338|FG001|Core Study (6 Months)|Withdrawal by Subject|1
7687691|NCT00333138|12106339|FG002|Core Study (6 Months)|Withdrawal by Subject|2
7687692|NCT00333138|12106337|FG000|Core Study (6 Months)|Lack of Efficacy|1
7687693|NCT00333138|12106338|FG001|Core Study (6 Months)|Lack of Efficacy|0
7687694|NCT00333138|12106339|FG002|Core Study (6 Months)|Lack of Efficacy|0
7687695|NCT00333138|12106337|FG000|Core Study (6 Months)|Protocol Violation|1
7687696|NCT00333138|12106338|FG001|Core Study (6 Months)|Protocol Violation|0
7687697|NCT00333138|12106339|FG002|Core Study (6 Months)|Protocol Violation|1
7687698|NCT00333138|12106337|FG000|Core Study (6 Months)|Laboratory abnormality|0
7687699|NCT00333138|12106338|FG001|Core Study (6 Months)|Laboratory abnormality|0
7687700|NCT00333138|12106339|FG002|Core Study (6 Months)|Laboratory abnormality|1
7687701|NCT00333138|12106337|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
7687702|NCT00333138|12106338|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
7687703|NCT00333138|12106339|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
7687704|NCT00333138|12106337|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1
7687705|NCT00333138|12106338|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1
7687706|NCT00333138|12106339|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2
7687707|NCT00333138|12106337|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15
7687708|NCT00333138|12106338|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19
7687709|NCT00333138|12106339|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15
7687710|NCT00333138|12106337|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0
7687711|NCT00333138|12106338|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0
7687712|NCT00333138|12106339|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3
7687713|NCT00333138|12106337|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
7687714|NCT00333138|12106338|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
7687715|NCT00333138|12106339|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
7687716|NCT00333138|12106337|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
7687717|NCT00333138|12106338|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
7687718|NCT00333138|12106339|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
7687719|NCT00333138|12106337|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
7687720|NCT00333138|12106338|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
7687721|NCT00333138|12106339|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
7687722|NCT00333138|12106337|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
7687723|NCT00333138|12106338|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
7687724|NCT00333138|12106339|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
7687725|NCT00333138|12106337|FG000|Extension Study (Month6 to End of Study)|Death|0
7687726|NCT00333138|12106338|FG001|Extension Study (Month6 to End of Study)|Death|1
7687727|NCT00333138|12106339|FG002|Extension Study (Month6 to End of Study)|Death|0
7687728|NCT00333359|12106370|FG000|Overall Study|Adverse Event|29
7687729|NCT00333359|12106371|FG001|Overall Study|Adverse Event|35
7687730|NCT00333359|12106370|FG000|Overall Study|Withdrawal by Subject|19
7687731|NCT00333359|12106371|FG001|Overall Study|Withdrawal by Subject|37
7687732|NCT00333359|12106370|FG000|Overall Study|Physician Decision|2
7687733|NCT00333359|12106371|FG001|Overall Study|Physician Decision|2
7687734|NCT00333359|12106370|FG000|Overall Study|Protocol Non-compliance|2
7687735|NCT00333359|12106371|FG001|Overall Study|Protocol Non-compliance|8
7687736|NCT00333359|12106370|FG000|Overall Study|Lost to Follow-up|15
7687737|NCT00333359|12106371|FG001|Overall Study|Lost to Follow-up|25
7687738|NCT00333359|12106370|FG000|Overall Study|Termination or Withdrawal by Sponsor|1
7687739|NCT00333359|12106371|FG001|Overall Study|Termination or Withdrawal by Sponsor|1
7687740|NCT00333359|12106370|FG000|Overall Study|Treatment Failure|3
7687741|NCT00333359|12106371|FG001|Overall Study|Treatment Failure|8
7687742|NCT00333359|12106370|FG000|Overall Study|Withdrew before Receiving One Dose|2
7687743|NCT00333359|12106371|FG001|Overall Study|Withdrew before Receiving One Dose|6
7687744|NCT00333619|12106397|FG000|Overall Study|Death|12
7687745|NCT00333619|12106398|FG001|Overall Study|Death|6
7687746|NCT00333619|12106397|FG000|Overall Study|Withdrawal by Subject|6
7687747|NCT00333619|12106398|FG001|Overall Study|Withdrawal by Subject|1
7687748|NCT00333619|12106397|FG000|Overall Study|Lost to Follow-up|3
7687749|NCT00333619|12106398|FG001|Overall Study|Lost to Follow-up|3
7687750|NCT00333775|12106422|FG000|Overall Study|Death|144
7687751|NCT00333775|12106423|FG001|Overall Study|Death|149
7687752|NCT00333775|12106424|FG002|Overall Study|Death|143
7687753|NCT00333775|12106422|FG000|Overall Study|In Follow-up When Study Stopped|87
7687754|NCT00333775|12106423|FG001|Overall Study|In Follow-up When Study Stopped|92
7687755|NCT00333775|12106424|FG002|Overall Study|In Follow-up When Study Stopped|96
7687756|NCT00333775|12106422|FG000|Overall Study|Lost to Follow-up|10
7687757|NCT00333775|12106423|FG001|Overall Study|Lost to Follow-up|7
7687758|NCT00333775|12106424|FG002|Overall Study|Lost to Follow-up|8
7687759|NCT00333788|12106432|FG000|Overall Study|Adverse Event|44
7687760|NCT00333788|12106432|FG000|Overall Study|Lack of Efficacy|80
7687761|NCT00333788|12106432|FG000|Overall Study|Lost to Follow-up|2
7687762|NCT00333788|12106432|FG000|Overall Study|Withdrawal by Subject|24
7687763|NCT00333788|12106432|FG000|Overall Study|Other: Non-compliance|2
7687764|NCT00333788|12106432|FG000|Overall Study|Other: Moved|2
7687765|NCT00333788|12106432|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1
7687766|NCT00333788|12106432|FG000|Overall Study|Other: Investigator decision|1
7687767|NCT00333788|12106432|FG000|Overall Study|Other: Quality of life concern|1
7687768|NCT00333788|12106432|FG000|Overall Study|Other: Sponsor decision|1
7687769|NCT00333788|12106432|FG000|Overall Study|Other: Subject in need of an Entocort|1
7687770|NCT00333788|12106432|FG000|Overall Study|Other: Medical monitor decision|1
7687771|NCT00333788|12106432|FG000|Overall Study|Other: Physician decision|1
7687772|NCT00333788|12106432|FG000|Overall Study|Other: Signed consent for another study|1
7687773|NCT00333801|12106438|FG000|Overall Study|Moved to another state|5
7687774|NCT00333801|12106439|FG001|Overall Study|Moved to another state|3
7687775|NCT00333801|12106438|FG000|Overall Study|Lost to Follow-up|2
7687776|NCT00333801|12106439|FG001|Overall Study|Lost to Follow-up|0
7687777|NCT00333801|12106438|FG000|Overall Study|Incarcerated|1
7687778|NCT00333801|12106439|FG001|Overall Study|Incarcerated|2
7687779|NCT00333801|12106438|FG000|Overall Study|Withdrawal by Subject|0
7687780|NCT00333801|12106439|FG001|Overall Study|Withdrawal by Subject|1
7687781|NCT00333840|12106460|FG000|First-line Treatment Period|Adverse Event|38
7687782|NCT00333840|12106461|FG001|First-line Treatment Period|Adverse Event|37
7687783|NCT00333840|12106462|FG002|First-line Treatment Period|Adverse Event|0
7687784|NCT00333840|12106463|FG003|First-line Treatment Period|Adverse Event|0
7687785|NCT00333840|12106460|FG000|First-line Treatment Period|Abnormal laboratory values|3
7687786|NCT00333840|12106461|FG001|First-line Treatment Period|Abnormal laboratory values|1
7687787|NCT00333840|12106462|FG002|First-line Treatment Period|Abnormal laboratory values|0
7687788|NCT00333840|12106463|FG003|First-line Treatment Period|Abnormal laboratory values|0
7687789|NCT00333840|12106460|FG000|First-line Treatment Period|Abnormal procedure|2
7687790|NCT00333840|12106461|FG001|First-line Treatment Period|Abnormal procedure|0
7687791|NCT00333840|12106462|FG002|First-line Treatment Period|Abnormal procedure|0
7687792|NCT00333840|12106463|FG003|First-line Treatment Period|Abnormal procedure|0
7687793|NCT00333840|12106460|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88
7687794|NCT00333840|12106461|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29
7687795|NCT00333840|12106462|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0
7687796|NCT00333840|12106463|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0
7687797|NCT00333840|12106460|FG000|First-line Treatment Period|No longer required study drug|21
7687798|NCT00333840|12106461|FG001|First-line Treatment Period|No longer required study drug|8
7687799|NCT00333840|12106462|FG002|First-line Treatment Period|No longer required study drug|0
7687800|NCT00333840|12106463|FG003|First-line Treatment Period|No longer required study drug|0
7687801|NCT00333840|12106460|FG000|First-line Treatment Period|Protocol Violation|17
7687802|NCT00333840|12106461|FG001|First-line Treatment Period|Protocol Violation|17
7687803|NCT00333840|12106462|FG002|First-line Treatment Period|Protocol Violation|0
7687804|NCT00333840|12106463|FG003|First-line Treatment Period|Protocol Violation|0
7687805|NCT00333840|12106460|FG000|First-line Treatment Period|Subject withdrew consent|57
7687806|NCT00333840|12106461|FG001|First-line Treatment Period|Subject withdrew consent|77
7687807|NCT00333840|12106462|FG002|First-line Treatment Period|Subject withdrew consent|0
7687808|NCT00333840|12106463|FG003|First-line Treatment Period|Subject withdrew consent|0
7687809|NCT00333840|12106460|FG000|First-line Treatment Period|Lost to Follow-up|15
7687810|NCT00333840|12106461|FG001|First-line Treatment Period|Lost to Follow-up|6
7687811|NCT00333840|12106462|FG002|First-line Treatment Period|Lost to Follow-up|0
7687812|NCT00333840|12106463|FG003|First-line Treatment Period|Lost to Follow-up|0
7687813|NCT00333840|12106460|FG000|First-line Treatment Period|Administrative problems|12
7687814|NCT00333840|12106461|FG001|First-line Treatment Period|Administrative problems|6
7687815|NCT00333840|12106462|FG002|First-line Treatment Period|Administrative problems|0
7687816|NCT00333840|12106463|FG003|First-line Treatment Period|Administrative problems|0
7687817|NCT00333840|12106460|FG000|First-line Treatment Period|Death|19
7687818|NCT00333840|12106461|FG001|First-line Treatment Period|Death|2
7687819|NCT00333840|12106462|FG002|First-line Treatment Period|Death|0
7687820|NCT00333840|12106463|FG003|First-line Treatment Period|Death|0
7687821|NCT00333840|12106460|FG000|First-line Treatment Period|Crossed over to other treatment arm|14
7687822|NCT00333840|12106461|FG001|First-line Treatment Period|Crossed over to other treatment arm|363
7687823|NCT00333840|12106462|FG002|First-line Treatment Period|Crossed over to other treatment arm|0
7687824|NCT00333840|12106463|FG003|First-line Treatment Period|Crossed over to other treatment arm|0
7687825|NCT00333840|12106460|FG000|Second-line Treatment Period|Adverse Event|0
7687826|NCT00333840|12106461|FG001|Second-line Treatment Period|Adverse Event|0
7687827|NCT00333840|12106462|FG002|Second-line Treatment Period|Adverse Event|3
7687828|NCT00333840|12106463|FG003|Second-line Treatment Period|Adverse Event|34
7687829|NCT00333840|12106460|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0
7687830|NCT00333840|12106461|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0
7687831|NCT00333840|12106462|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0
7687832|NCT00333840|12106463|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3
7687833|NCT00333840|12106460|FG000|Second-line Treatment Period|Abnormal procedure|0
7687834|NCT00333840|12106461|FG001|Second-line Treatment Period|Abnormal procedure|0
7687835|NCT00333840|12106462|FG002|Second-line Treatment Period|Abnormal procedure|0
7687836|NCT00333840|12106463|FG003|Second-line Treatment Period|Abnormal procedure|1
7687837|NCT00333840|12106460|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
7687838|NCT00333840|12106461|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
7687839|NCT00333840|12106462|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
7687840|NCT00333840|12106463|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
7687841|NCT00333840|12106460|FG000|Second-line Treatment Period|No longer required study drug|0
7687842|NCT00333840|12106461|FG001|Second-line Treatment Period|No longer required study drug|0
7687843|NCT00333840|12106462|FG002|Second-line Treatment Period|No longer required study drug|1
7687844|NCT00333840|12106463|FG003|Second-line Treatment Period|No longer required study drug|14
7687845|NCT00333840|12106460|FG000|Second-line Treatment Period|Protocol Violation|0
7687846|NCT00333840|12106461|FG001|Second-line Treatment Period|Protocol Violation|0
7687847|NCT00333840|12106462|FG002|Second-line Treatment Period|Protocol Violation|1
7687848|NCT00333840|12106463|FG003|Second-line Treatment Period|Protocol Violation|10
7687849|NCT00333840|12106460|FG000|Second-line Treatment Period|Subject withdrew consent|0
7687850|NCT00333840|12106461|FG001|Second-line Treatment Period|Subject withdrew consent|0
7687851|NCT00333840|12106462|FG002|Second-line Treatment Period|Subject withdrew consent|0
7687852|NCT00333840|12106463|FG003|Second-line Treatment Period|Subject withdrew consent|34
7687853|NCT00333840|12106460|FG000|Second-line Treatment Period|Lost to Follow-up|0
7687854|NCT00333840|12106461|FG001|Second-line Treatment Period|Lost to Follow-up|0
7687855|NCT00333840|12106462|FG002|Second-line Treatment Period|Lost to Follow-up|0
7687856|NCT00333840|12106463|FG003|Second-line Treatment Period|Lost to Follow-up|6
7687857|NCT00333840|12106460|FG000|Second-line Treatment Period|Administrative problems|0
7687858|NCT00333840|12106461|FG001|Second-line Treatment Period|Administrative problems|0
7687859|NCT00333840|12106462|FG002|Second-line Treatment Period|Administrative problems|0
7687860|NCT00333840|12106463|FG003|Second-line Treatment Period|Administrative problems|7
7687861|NCT00333840|12106460|FG000|Second-line Treatment Period|Death|0
7687862|NCT00333840|12106461|FG001|Second-line Treatment Period|Death|0
7687863|NCT00333840|12106462|FG002|Second-line Treatment Period|Death|0
7687864|NCT00333840|12106463|FG003|Second-line Treatment Period|Death|9
7687865|NCT00333866|12106481|FG000|Overall Study|Adverse Event|23
7687866|NCT00333866|12106482|FG001|Overall Study|Adverse Event|37
7687867|NCT00333866|12106483|FG002|Overall Study|Adverse Event|38
7687868|NCT00333866|12106484|FG003|Overall Study|Adverse Event|47
7687869|NCT00333866|12106481|FG000|Overall Study|Other|3
7687870|NCT00333866|12106482|FG001|Overall Study|Other|2
7687871|NCT00333866|12106483|FG002|Overall Study|Other|2
7687872|NCT00333866|12106484|FG003|Overall Study|Other|2
7687873|NCT00333866|12106481|FG000|Overall Study|Lack of Efficacy|8
7687874|NCT00333866|12106482|FG001|Overall Study|Lack of Efficacy|6
7687875|NCT00333866|12106483|FG002|Overall Study|Lack of Efficacy|3
7687876|NCT00333866|12106484|FG003|Overall Study|Lack of Efficacy|5
7687877|NCT00333866|12106481|FG000|Overall Study|Lost to Follow-up|1
7687878|NCT00333866|12106482|FG001|Overall Study|Lost to Follow-up|2
7687879|NCT00333866|12106483|FG002|Overall Study|Lost to Follow-up|2
7687880|NCT00333866|12106484|FG003|Overall Study|Lost to Follow-up|2
7687881|NCT00333866|12106481|FG000|Overall Study|Withdrawal by Subject|8
7687882|NCT00333866|12106482|FG001|Overall Study|Withdrawal by Subject|14
7687883|NCT00333866|12106483|FG002|Overall Study|Withdrawal by Subject|4
7687884|NCT00333866|12106484|FG003|Overall Study|Withdrawal by Subject|9
7687885|NCT00333866|12106481|FG000|Overall Study|Randomized but not Treated|5
7687886|NCT00333866|12106482|FG001|Overall Study|Randomized but not Treated|3
7687887|NCT00333866|12106483|FG002|Overall Study|Randomized but not Treated|2
7687888|NCT00333866|12106484|FG003|Overall Study|Randomized but not Treated|1
7687889|NCT00333970|12106500|FG000|Overall Study|Withdrawal by Subject|13
7687890|NCT00333970|12106501|FG001|Overall Study|Withdrawal by Subject|7
7687891|NCT00333983|12106510|FG000|Overall Study|Lost to Follow-up|2
7687892|NCT00333983|12106511|FG001|Overall Study|Lost to Follow-up|1
7687893|NCT00333983|12106512|FG002|Overall Study|Lost to Follow-up|0
7687894|NCT00333983|12106510|FG000|Overall Study|Adverse Event|1
7687895|NCT00333983|12106511|FG001|Overall Study|Adverse Event|1
7687896|NCT00333983|12106512|FG002|Overall Study|Adverse Event|1
7687897|NCT00333983|12106510|FG000|Overall Study|Withdrawal by Subject|0
7687898|NCT00333983|12106511|FG001|Overall Study|Withdrawal by Subject|3
7687899|NCT00333983|12106512|FG002|Overall Study|Withdrawal by Subject|1
7687900|NCT00334113|12106531|FG000|Overall Study|Lost to Follow-up|2
7687901|NCT00334113|12106532|FG001|Overall Study|Lost to Follow-up|2
7687902|NCT00334113|12106531|FG000|Overall Study|Withdrawal by Subject|0
7687903|NCT00334113|12106532|FG001|Overall Study|Withdrawal by Subject|1
7687904|NCT00334282|12106545|FG000|Overall Study|Lost to Follow-up|11
7687905|NCT00334282|12106546|FG001|Overall Study|Lost to Follow-up|5
7687906|NCT00334282|12106545|FG000|Overall Study|Withdrawal by Subject|17
7687907|NCT00334282|12106546|FG001|Overall Study|Withdrawal by Subject|3
7687908|NCT00334282|12106545|FG000|Overall Study|Death|194
7687909|NCT00334282|12106546|FG001|Overall Study|Death|100
7687910|NCT00334295|12106556|FG000|Overall Study|Patients received fewer than 3 injection|5
7687911|NCT00334542|12106560|FG000|Overall Study|Adverse Event|3
7687912|NCT00334542|12106560|FG000|Overall Study|Withdrawal by Subject|1
7687913|NCT00334542|12106560|FG000|Overall Study|New cancer diagnosis|1
7687914|NCT00334737|12106584|FG000|Hospital Phase|Death|1
7687915|NCT00334737|12106585|FG001|Hospital Phase|Death|2
7687916|NCT00334737|12106586|FG002|Hospital Phase|Death|3
7687917|NCT00334737|12106584|FG000|Hospital Phase|Withdrawal by Subject|0
7687918|NCT00334737|12106585|FG001|Hospital Phase|Withdrawal by Subject|0
7687919|NCT00334737|12106586|FG002|Hospital Phase|Withdrawal by Subject|1
7687920|NCT00334737|12106584|FG000|Hospital Phase|Did not receive study drug|1
7687921|NCT00334737|12106585|FG001|Hospital Phase|Did not receive study drug|0
7687922|NCT00334737|12106586|FG002|Hospital Phase|Did not receive study drug|0
7687923|NCT00334737|12106584|FG000|Follow up Phase|Lost to Follow-up|5
7687924|NCT00334737|12106585|FG001|Follow up Phase|Lost to Follow-up|3
7687925|NCT00334737|12106586|FG002|Follow up Phase|Lost to Follow-up|6
7687926|NCT00334802|12106596|FG000|Overall Study|Progressive Disease|2
7687927|NCT00334802|12106597|FG001|Overall Study|Progressive Disease|24
7687928|NCT00334802|12106596|FG000|Overall Study|Toxicity|1
7687929|NCT00334802|12106597|FG001|Overall Study|Toxicity|5
7687930|NCT00334802|12106596|FG000|Overall Study|Lack of Efficacy|1
7687931|NCT00334802|12106597|FG001|Overall Study|Lack of Efficacy|3
7687932|NCT00334802|12106596|FG000|Overall Study|Patient Condition Aggrevated|1
7687933|NCT00334802|12106597|FG001|Overall Study|Patient Condition Aggrevated|0
7687934|NCT00334802|12106596|FG000|Overall Study|Physician Decision|1
7687935|NCT00334802|12106597|FG001|Overall Study|Physician Decision|0
7687936|NCT00334802|12106596|FG000|Overall Study|Withdrawal by Subject|0
7687937|NCT00334802|12106597|FG001|Overall Study|Withdrawal by Subject|4
7687938|NCT00334802|12106596|FG000|Overall Study|Adverse Event|0
7687939|NCT00334802|12106597|FG001|Overall Study|Adverse Event|3
7687940|NCT00334802|12106596|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0
7687941|NCT00334802|12106597|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1
7687942|NCT00334893|12106608|FG000|Overall Study|Not Treated|1
7687943|NCT00334893|12106609|FG001|Overall Study|Not Treated|0
7687944|NCT00334958|12106619|FG000|Overall Study|Medication Noncompliance|0
7687945|NCT00334958|12106620|FG001|Overall Study|Medication Noncompliance|3
7687946|NCT00334958|12106619|FG000|Overall Study|Protocol Violation|2
7687947|NCT00334958|12106620|FG001|Overall Study|Protocol Violation|2
7687948|NCT00334958|12106619|FG000|Overall Study|Request of the investigator or sponsor|0
7687949|NCT00334958|12106620|FG001|Overall Study|Request of the investigator or sponsor|1
7687950|NCT00334958|12106619|FG000|Overall Study|Withdrawal by Subject|7
7687951|NCT00334958|12106620|FG001|Overall Study|Withdrawal by Subject|4
7687952|NCT00334958|12106619|FG000|Overall Study|Adverse Event|27
7687953|NCT00334958|12106620|FG001|Overall Study|Adverse Event|12
7687954|NCT00334958|12106619|FG000|Overall Study|Other|1
7687955|NCT00334958|12106620|FG001|Overall Study|Other|2
7687956|NCT00335140|12106626|FG000|Overall Study|Ineligible|1
7687957|NCT00335153|12106630|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5
7687958|NCT00335153|12106630|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
7687959|NCT00335153|12106630|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
7687960|NCT00335153|12106630|FG000|Nasojejunal (NJ) Test Period|Administrative|1
7687961|NCT00335153|12106630|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7
7687962|NCT00335153|12106630|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
7687963|NCT00335153|12106630|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
7687964|NCT00335153|12106630|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
7687965|NCT00335153|12106630|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13
7687966|NCT00335153|12106630|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
7687967|NCT00335322|12106665|FG000|Overall Study|Randomised but withdrew prior to ART sta|1
7687968|NCT00335322|12106666|FG001|Overall Study|Randomised but withdrew prior to ART sta|2
7687969|NCT00335322|12106667|FG002|Overall Study|Randomised but withdrew prior to ART sta|2
7687970|NCT00335452|12106682|FG000|Overall Study|Death|156
7687971|NCT00335452|12106683|FG001|Overall Study|Death|144
7687972|NCT00335452|12106684|FG002|Overall Study|Death|158
7687973|NCT00335452|12106685|FG003|Overall Study|Death|129
7687974|NCT00335452|12106682|FG000|Overall Study|Lost to Follow-up|2
7687975|NCT00335452|12106683|FG001|Overall Study|Lost to Follow-up|3
7687976|NCT00335452|12106684|FG002|Overall Study|Lost to Follow-up|1
7687977|NCT00335452|12106685|FG003|Overall Study|Lost to Follow-up|2
7687978|NCT00335556|12106731|FG000|Overall Study|Death|0
7687979|NCT00335556|12106732|FG001|Overall Study|Death|5
7687980|NCT00335556|12106733|FG002|Overall Study|Death|0
7687981|NCT00335556|12106734|FG003|Overall Study|Death|0
7687982|NCT00335556|12106735|FG004|Overall Study|Death|1
7687983|NCT00335556|12106736|FG005|Overall Study|Death|0
7687984|NCT00335556|12106731|FG000|Overall Study|Lack of Efficacy|0
7687985|NCT00335556|12106732|FG001|Overall Study|Lack of Efficacy|19
7687986|NCT00335556|12106733|FG002|Overall Study|Lack of Efficacy|3
7687987|NCT00335556|12106734|FG003|Overall Study|Lack of Efficacy|3
7687988|NCT00335556|12106735|FG004|Overall Study|Lack of Efficacy|0
7687989|NCT00335556|12106736|FG005|Overall Study|Lack of Efficacy|1
7687990|NCT00335556|12106731|FG000|Overall Study|Physician Decision|0
7687991|NCT00335556|12106732|FG001|Overall Study|Physician Decision|6
7687992|NCT00335556|12106733|FG002|Overall Study|Physician Decision|2
7687993|NCT00335556|12106734|FG003|Overall Study|Physician Decision|1
7687994|NCT00335556|12106735|FG004|Overall Study|Physician Decision|0
7687995|NCT00335556|12106736|FG005|Overall Study|Physician Decision|0
7687996|NCT00335556|12106731|FG000|Overall Study|Ineligible|2
7687997|NCT00335556|12106732|FG001|Overall Study|Ineligible|0
7687998|NCT00335556|12106733|FG002|Overall Study|Ineligible|0
7687999|NCT00335556|12106734|FG003|Overall Study|Ineligible|0
7688000|NCT00335556|12106735|FG004|Overall Study|Ineligible|0
7688001|NCT00335556|12106736|FG005|Overall Study|Ineligible|0
7688002|NCT00335556|12106731|FG000|Overall Study|Refusal of further protocol therapy|0
7688003|NCT00335556|12106732|FG001|Overall Study|Refusal of further protocol therapy|4
7688004|NCT00335556|12106733|FG002|Overall Study|Refusal of further protocol therapy|0
7688005|NCT00335556|12106734|FG003|Overall Study|Refusal of further protocol therapy|1
7688006|NCT00335556|12106735|FG004|Overall Study|Refusal of further protocol therapy|0
7688007|NCT00335556|12106736|FG005|Overall Study|Refusal of further protocol therapy|0
7688008|NCT00335738|12106767|FG000|Overall Study|Physician Decision|6
7688009|NCT00335738|12106768|FG001|Overall Study|Physician Decision|0
7688010|NCT00335738|12106767|FG000|Overall Study|Withdrawal by Subject|2
7688011|NCT00335738|12106768|FG001|Overall Study|Withdrawal by Subject|0
7688012|NCT00335738|12106767|FG000|Overall Study|Ineligible|3
7688013|NCT00335738|12106768|FG001|Overall Study|Ineligible|4
7688014|NCT00335764|12106780|FG000|Overall Study|wrong histology|1
7688015|NCT00335764|12106781|FG001|Overall Study|wrong histology|0
7688016|NCT00335764|12106782|FG002|Overall Study|wrong histology|0
7688017|NCT00335764|12106783|FG003|Overall Study|wrong histology|0
7688018|NCT00335764|12106784|FG004|Overall Study|wrong histology|1
7688019|NCT00335829|12106820|FG000|Overall Study|Withdrawal by Subject|1
7688020|NCT00335829|12106820|FG000|Overall Study|Lost to Follow-up|1
7688021|NCT00335829|12106820|FG000|Overall Study|Adverse Event|1
7688022|NCT00335959|12106824|FG000|Overall Study|Adverse Event|2
7688023|NCT00335959|12106824|FG000|Overall Study|Ineligible|1
7688024|NCT00335972|12106831|FG000|Overall Study|not given treatments|0
7688025|NCT00335972|12106832|FG001|Overall Study|not given treatments|3
7688026|NCT00336284|12106844|FG000|Overall Study|Death|52
7688027|NCT00336284|12106845|FG001|Overall Study|Death|26
7688028|NCT00336284|12106844|FG000|Overall Study|Lost to Follow-up|82
7688029|NCT00336284|12106845|FG001|Overall Study|Lost to Follow-up|61
7688030|NCT00336284|12106844|FG000|Overall Study|Withdrawal by Physician or Subject|102
7688031|NCT00336284|12106845|FG001|Overall Study|Withdrawal by Physician or Subject|64
7688032|NCT00336479|12106880|FG000|Overall Study|Adverse Event|8
7688033|NCT00336479|12106881|FG001|Overall Study|Adverse Event|11
7688034|NCT00336479|12106882|FG002|Overall Study|Adverse Event|18
7688035|NCT00336479|12106883|FG003|Overall Study|Adverse Event|4
7688036|NCT00336479|12106880|FG000|Overall Study|Noncompliant|1
7688037|NCT00336479|12106881|FG001|Overall Study|Noncompliant|7
7688038|NCT00336479|12106882|FG002|Overall Study|Noncompliant|3
7688039|NCT00336479|12106883|FG003|Overall Study|Noncompliant|0
7688040|NCT00336479|12106880|FG000|Overall Study|Physician Decision|2
7688041|NCT00336479|12106881|FG001|Overall Study|Physician Decision|3
7688042|NCT00336479|12106882|FG002|Overall Study|Physician Decision|1
7688043|NCT00336479|12106883|FG003|Overall Study|Physician Decision|0
7688044|NCT00336479|12106880|FG000|Overall Study|Lost to Follow-up|3
7688045|NCT00336479|12106881|FG001|Overall Study|Lost to Follow-up|2
7688046|NCT00336479|12106882|FG002|Overall Study|Lost to Follow-up|0
7688047|NCT00336479|12106883|FG003|Overall Study|Lost to Follow-up|0
7688048|NCT00336479|12106880|FG000|Overall Study|Withdrawal by Subject|3
7688049|NCT00336479|12106881|FG001|Overall Study|Withdrawal by Subject|2
7688050|NCT00336479|12106882|FG002|Overall Study|Withdrawal by Subject|3
7688051|NCT00336479|12106883|FG003|Overall Study|Withdrawal by Subject|0
7688052|NCT00336479|12106880|FG000|Overall Study|Other|0
7688053|NCT00336479|12106881|FG001|Overall Study|Other|0
7688054|NCT00336479|12106882|FG002|Overall Study|Other|1
7688055|NCT00336479|12106883|FG003|Overall Study|Other|0
7688056|NCT00336479|12106880|FG000|Overall Study|Virologic Stopping Rule|20
7688057|NCT00336479|12106881|FG001|Overall Study|Virologic Stopping Rule|0
7688058|NCT00336479|12106882|FG002|Overall Study|Virologic Stopping Rule|0
7688059|NCT00336479|12106883|FG003|Overall Study|Virologic Stopping Rule|0
7688060|NCT00336492|12106897|FG000|Overall Study|Adverse Event|4
7688061|NCT00336492|12106898|FG001|Overall Study|Adverse Event|3
7688062|NCT00336492|12106899|FG002|Overall Study|Adverse Event|6
7688063|NCT00336492|12106897|FG000|Overall Study|Lack of Efficacy|6
7688064|NCT00336492|12106898|FG001|Overall Study|Lack of Efficacy|1
7688065|NCT00336492|12106899|FG002|Overall Study|Lack of Efficacy|4
7688066|NCT00336492|12106897|FG000|Overall Study|Other|5
7688067|NCT00336492|12106898|FG001|Overall Study|Other|0
7688068|NCT00336492|12106899|FG002|Overall Study|Other|1
7688069|NCT00336505|12106909|FG000|Overall Study|Adverse Event|10
7688070|NCT00336505|12106910|FG001|Overall Study|Adverse Event|9
7688071|NCT00336505|12106909|FG000|Overall Study|Lack of Efficacy|8
7688072|NCT00336505|12106910|FG001|Overall Study|Lack of Efficacy|4
7688073|NCT00336505|12106909|FG000|Overall Study|Lost to Follow-up|7
7688074|NCT00336505|12106910|FG001|Overall Study|Lost to Follow-up|4
7688075|NCT00336505|12106909|FG000|Overall Study|Withdrawal by Subject|5
7688076|NCT00336505|12106910|FG001|Overall Study|Withdrawal by Subject|3
7688077|NCT00336505|12106909|FG000|Overall Study|Other|7
7688078|NCT00336505|12106910|FG001|Overall Study|Other|7
7688079|NCT00336544|12106918|FG000|Overall Study|Lack of Efficacy|8
7688080|NCT00336544|12106919|FG001|Overall Study|Lack of Efficacy|5
7688081|NCT00336544|12106918|FG000|Overall Study|Adverse Event|4
7688082|NCT00336544|12106919|FG001|Overall Study|Adverse Event|9
7688083|NCT00336544|12106918|FG000|Overall Study|Withdrawal by Subject|4
7688084|NCT00336544|12106919|FG001|Overall Study|Withdrawal by Subject|3
7688085|NCT00336544|12106918|FG000|Overall Study|Other|3
7688086|NCT00336544|12106919|FG001|Overall Study|Other|5
7688087|NCT00336583|12106925|FG000|Overall Study|Lost to Follow-up|1
7688088|NCT00336583|12106925|FG000|Overall Study|Death|1
7688089|NCT00336856|12106944|FG000|Overall Study|Withdrawal by Subject|3
7688090|NCT00336856|12106944|FG000|Overall Study|Found ineligible at time of analysis|1
7688091|NCT00336895|12106948|FG000|Overall Study|diarrhea|1
7688092|NCT00336895|12106948|FG000|Overall Study|nausea and upset stomach|1
7688093|NCT00336895|12106948|FG000|Overall Study|Physician Decision|1
7688094|NCT00336895|12106948|FG000|Overall Study|screen failed|1
7688095|NCT00337077|12106955|FG000|Overall Study|Progressive disease|25
7688096|NCT00337077|12106956|FG001|Overall Study|Progressive disease|37
7688097|NCT00337077|12106957|FG002|Overall Study|Progressive disease|19
7688098|NCT00337077|12106955|FG000|Overall Study|Adverse Event|7
7688099|NCT00337077|12106956|FG001|Overall Study|Adverse Event|7
7688100|NCT00337077|12106957|FG002|Overall Study|Adverse Event|1
7688101|NCT00337077|12106955|FG000|Overall Study|Death|0
7688102|NCT00337077|12106956|FG001|Overall Study|Death|1
7688103|NCT00337077|12106957|FG002|Overall Study|Death|0
7688104|NCT00337077|12106955|FG000|Overall Study|Withdrawal by Subject|7
7688105|NCT00337077|12106956|FG001|Overall Study|Withdrawal by Subject|2
7688106|NCT00337077|12106957|FG002|Overall Study|Withdrawal by Subject|2
7688107|NCT00337077|12106955|FG000|Overall Study|Alternative therapy|1
7688108|NCT00337077|12106956|FG001|Overall Study|Alternative therapy|0
7688109|NCT00337077|12106957|FG002|Overall Study|Alternative therapy|0
7688110|NCT00337077|12106955|FG000|Overall Study|Physician Decision|1
7688111|NCT00337077|12106956|FG001|Overall Study|Physician Decision|4
7688112|NCT00337077|12106957|FG002|Overall Study|Physician Decision|2
7688113|NCT00337077|12106955|FG000|Overall Study|Never started treatment|1
7688114|NCT00337077|12106956|FG001|Overall Study|Never started treatment|1
7688115|NCT00337077|12106957|FG002|Overall Study|Never started treatment|0
7688116|NCT00337077|12106955|FG000|Overall Study|Ineligible|1
7688117|NCT00337077|12106956|FG001|Overall Study|Ineligible|1
7688118|NCT00337077|12106957|FG002|Overall Study|Ineligible|1
7688119|NCT00337103|12106965|FG000|Overall Study|Progressive Disease|414
7688120|NCT00337103|12106966|FG001|Overall Study|Progressive Disease|410
7688121|NCT00337103|12106965|FG000|Overall Study|Adverse Event|45
7688122|NCT00337103|12106966|FG001|Overall Study|Adverse Event|59
7688123|NCT00337103|12106965|FG000|Overall Study|Subject Choice|34
7688124|NCT00337103|12106966|FG001|Overall Study|Subject Choice|27
7688125|NCT00337103|12106965|FG000|Overall Study|Clinical Progression|27
7688126|NCT00337103|12106966|FG001|Overall Study|Clinical Progression|24
7688127|NCT00337103|12106965|FG000|Overall Study|Physician Decision|15
7688128|NCT00337103|12106966|FG001|Overall Study|Physician Decision|14
7688129|NCT00337103|12106965|FG000|Overall Study|Withdrawal by Subject|8
7688130|NCT00337103|12106966|FG001|Overall Study|Withdrawal by Subject|5
7688131|NCT00337103|12106965|FG000|Overall Study|Other|5
7688132|NCT00337103|12106966|FG001|Overall Study|Other|6
7688133|NCT00337103|12106965|FG000|Overall Study|Entry Criteria Not Met|4
7688134|NCT00337103|12106966|FG001|Overall Study|Entry Criteria Not Met|1
7688135|NCT00337103|12106965|FG000|Overall Study|Lost to Follow-up|1
7688136|NCT00337103|12106966|FG001|Overall Study|Lost to Follow-up|2
7688137|NCT00337103|12106965|FG000|Overall Study|Death|1
7688138|NCT00337103|12106966|FG001|Overall Study|Death|0
7688139|NCT00337129|12106973|FG000|Overall Study|Adverse Event|4
7688140|NCT00337129|12106973|FG000|Overall Study|Withdrawal by Subject|1
7688141|NCT00337129|12106973|FG000|Overall Study|Lack of Efficacy|32
7688142|NCT00337129|12106973|FG000|Overall Study|Death|2
7688143|NCT00337129|12106973|FG000|Overall Study|not protocol specified|1
7688144|NCT00337168|12106977|FG000|Overall Study|Death|5
7688145|NCT00337168|12106977|FG000|Overall Study|Not protocol specified|2
7688146|NCT00337168|12106977|FG000|Overall Study|Did not start therapy|1
7688147|NCT00337194|12106993|FG000|Overall Study|Adverse Event|5
7688148|NCT00337194|12106994|FG001|Overall Study|Adverse Event|1
7688149|NCT00337194|12106993|FG000|Overall Study|Death|2
7688150|NCT00337194|12106994|FG001|Overall Study|Death|0
7688151|NCT00337194|12106993|FG000|Overall Study|Withdrawal by Subject|1
7688152|NCT00337194|12106994|FG001|Overall Study|Withdrawal by Subject|0
7688153|NCT00337194|12106993|FG000|Overall Study|Disease progression|1
7688154|NCT00337194|12106994|FG001|Overall Study|Disease progression|2
7688155|NCT00337194|12106993|FG000|Overall Study|Subsequent non-protocol therapy|3
7688156|NCT00337194|12106994|FG001|Overall Study|Subsequent non-protocol therapy|1
7688157|NCT00337207|12107002|FG000|Overall Study|Withdrawal by Subject|3
7688158|NCT00337272|12107009|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2
7688159|NCT00337272|12107010|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0
7688160|NCT00337272|12107009|FG000|Screening Period (Pre-randomization)|Non-compliance|1
7688161|NCT00337272|12107010|FG001|Screening Period (Pre-randomization)|Non-compliance|0
7688162|NCT00337272|12107009|FG000|Screening Period (Pre-randomization)|Screen failure|3
7688163|NCT00337272|12107010|FG001|Screening Period (Pre-randomization)|Screen failure|0
7688164|NCT00337272|12107009|FG000|Treatment Period|Non-compliance|1
7688165|NCT00337272|12107010|FG001|Treatment Period|Non-compliance|1
7688166|NCT00337272|12107009|FG000|Treatment Period|Withdrawal by Subject|0
7688167|NCT00337272|12107010|FG001|Treatment Period|Withdrawal by Subject|1
7688168|NCT00337272|12107009|FG000|Withdrawal Period|Non-compliance|0
7688169|NCT00337272|12107010|FG001|Withdrawal Period|Non-compliance|1
7688170|NCT00337285|12107016|FG000|Overall Study|Withdrawal by Subject|42
7688171|NCT00337285|12107016|FG000|Overall Study|Lost to Follow-up|41
7688172|NCT00337285|12107016|FG000|Overall Study|Adverse Event|28
7688173|NCT00337285|12107016|FG000|Overall Study|Protocol Violation|27
7688174|NCT00337285|12107016|FG000|Overall Study|Lack of Efficacy|11
7688175|NCT00337285|12107016|FG000|Overall Study|Death|1
7688176|NCT00337285|12107016|FG000|Overall Study|Physician Decision|1
7688177|NCT00337285|12107016|FG000|Overall Study|Lack of protocol compliance|7
7688178|NCT00337428|12107031|FG000|Overall Study|Withdrawal by Subject|1
7688179|NCT00337428|12107032|FG001|Overall Study|Withdrawal by Subject|2
7688180|NCT00337428|12107031|FG000|Overall Study|Lack of Time|1
7688181|NCT00337428|12107032|FG001|Overall Study|Lack of Time|1
7688182|NCT00337428|12107031|FG000|Overall Study|Unwilling to Continue|1
7688183|NCT00337428|12107032|FG001|Overall Study|Unwilling to Continue|0
7688184|NCT00337428|12107031|FG000|Overall Study|Anorexia|1
7688185|NCT00337428|12107032|FG001|Overall Study|Anorexia|0
7688186|NCT00337467|12107038|FG000|Overall Study|Adverse Event|3
7688187|NCT00337467|12107038|FG000|Overall Study|Subject Withdrew Consent|2
7688188|NCT00337467|12107038|FG000|Overall Study|Pregnancy|1
7688189|NCT00337467|12107038|FG000|Overall Study|Lost to Follow-up|2
7688190|NCT00337467|12107038|FG000|Overall Study|Subject No Longer Met Study Criteria|2
7688191|NCT00337571|12107049|FG000|Overall Study|Lack of Efficacy|3
7688192|NCT00337571|12107050|FG001|Overall Study|Lack of Efficacy|0
7688193|NCT00337571|12107051|FG002|Overall Study|Lack of Efficacy|0
7688194|NCT00337571|12107052|FG003|Overall Study|Lack of Efficacy|0
7688195|NCT00337571|12107049|FG000|Overall Study|Adverse Event|4
7688196|NCT00337571|12107050|FG001|Overall Study|Adverse Event|5
7688197|NCT00337571|12107051|FG002|Overall Study|Adverse Event|8
7688198|NCT00337571|12107052|FG003|Overall Study|Adverse Event|4
7688199|NCT00337571|12107049|FG000|Overall Study|Withdrawal by Subject|2
7688200|NCT00337571|12107050|FG001|Overall Study|Withdrawal by Subject|2
7688201|NCT00337571|12107051|FG002|Overall Study|Withdrawal by Subject|1
7688202|NCT00337571|12107052|FG003|Overall Study|Withdrawal by Subject|0
7688203|NCT00337571|12107049|FG000|Overall Study|Lost to Follow-up|3
7688204|NCT00337571|12107050|FG001|Overall Study|Lost to Follow-up|1
7688205|NCT00337571|12107051|FG002|Overall Study|Lost to Follow-up|0
7688206|NCT00337571|12107052|FG003|Overall Study|Lost to Follow-up|1
7688207|NCT00337571|12107049|FG000|Overall Study|Poor/noncompliance|1
7688208|NCT00337571|12107050|FG001|Overall Study|Poor/noncompliance|1
7688209|NCT00337571|12107051|FG002|Overall Study|Poor/noncompliance|1
7688210|NCT00337571|12107052|FG003|Overall Study|Poor/noncompliance|1
7688211|NCT00337571|12107049|FG000|Overall Study|No longer met study criteria|1
7688212|NCT00337571|12107050|FG001|Overall Study|No longer met study criteria|0
7688213|NCT00337571|12107051|FG002|Overall Study|No longer met study criteria|0
7688214|NCT00337571|12107052|FG003|Overall Study|No longer met study criteria|0
7688215|NCT00337571|12107049|FG000|Overall Study|High Potassium level|0
7688216|NCT00337571|12107050|FG001|Overall Study|High Potassium level|0
7688217|NCT00337571|12107051|FG002|Overall Study|High Potassium level|0
7688218|NCT00337571|12107052|FG003|Overall Study|High Potassium level|1
7688219|NCT00337610|12107064|FG000|Overall Study|Adverse Event|2
7688220|NCT00337610|12107065|FG001|Overall Study|Adverse Event|2
7688221|NCT00337610|12107064|FG000|Overall Study|Death|0
7688222|NCT00337610|12107065|FG001|Overall Study|Death|1
7688223|NCT00337610|12107064|FG000|Overall Study|Lack of Efficacy|6
7688224|NCT00337610|12107065|FG001|Overall Study|Lack of Efficacy|3
7688225|NCT00337610|12107064|FG000|Overall Study|Lost to Follow-up|3
7688226|NCT00337610|12107065|FG001|Overall Study|Lost to Follow-up|3
7688227|NCT00337610|12107064|FG000|Overall Study|Withdrawal by Subject|6
7688228|NCT00337610|12107065|FG001|Overall Study|Withdrawal by Subject|5
7688229|NCT00337662|12107074|FG000|Study Period II|Lost to Follow-up|0
7688230|NCT00337662|12107075|FG001|Study Period II|Lost to Follow-up|0
7688231|NCT00337662|12107076|FG002|Study Period II|Lost to Follow-up|0
7688232|NCT00337662|12107077|FG003|Study Period II|Lost to Follow-up|35
7688233|NCT00337662|12107074|FG000|Study Period II|Withdrawal by Subject|0
7688234|NCT00337662|12107075|FG001|Study Period II|Withdrawal by Subject|0
7688235|NCT00337662|12107076|FG002|Study Period II|Withdrawal by Subject|0
7688236|NCT00337662|12107077|FG003|Study Period II|Withdrawal by Subject|20
7688237|NCT00337662|12107074|FG000|Study Period II|Adverse Event|0
7688238|NCT00337662|12107075|FG001|Study Period II|Adverse Event|0
7688239|NCT00337662|12107076|FG002|Study Period II|Adverse Event|0
7688240|NCT00337662|12107077|FG003|Study Period II|Adverse Event|16
7688241|NCT00337662|12107074|FG000|Study Period II|Physician Decision|0
7688242|NCT00337662|12107075|FG001|Study Period II|Physician Decision|0
7688243|NCT00337662|12107076|FG002|Study Period II|Physician Decision|0
7688244|NCT00337662|12107077|FG003|Study Period II|Physician Decision|13
7688245|NCT00337662|12107074|FG000|Study Period II|Entry Criteria Not Met|0
7688246|NCT00337662|12107075|FG001|Study Period II|Entry Criteria Not Met|0
7688247|NCT00337662|12107076|FG002|Study Period II|Entry Criteria Not Met|0
7688248|NCT00337662|12107077|FG003|Study Period II|Entry Criteria Not Met|6
7688249|NCT00337662|12107074|FG000|Study Period II|Protocol Violation|0
7688250|NCT00337662|12107075|FG001|Study Period II|Protocol Violation|0
7688251|NCT00337662|12107076|FG002|Study Period II|Protocol Violation|0
7688252|NCT00337662|12107077|FG003|Study Period II|Protocol Violation|6
7688253|NCT00337662|12107074|FG000|Study Period II|Lack of Efficacy|0
7688254|NCT00337662|12107075|FG001|Study Period II|Lack of Efficacy|0
7688255|NCT00337662|12107076|FG002|Study Period II|Lack of Efficacy|0
7688256|NCT00337662|12107077|FG003|Study Period II|Lack of Efficacy|7
7688257|NCT00337662|12107074|FG000|Study Period II|Sponsor Decision|0
7688258|NCT00337662|12107075|FG001|Study Period II|Sponsor Decision|0
7688259|NCT00337662|12107076|FG002|Study Period II|Sponsor Decision|0
7688260|NCT00337662|12107077|FG003|Study Period II|Sponsor Decision|2
7688261|NCT00337662|12107074|FG000|Study Period II|Parent/Caregiver Decision|0
7688262|NCT00337662|12107075|FG001|Study Period II|Parent/Caregiver Decision|0
7688263|NCT00337662|12107076|FG002|Study Period II|Parent/Caregiver Decision|0
7688264|NCT00337662|12107077|FG003|Study Period II|Parent/Caregiver Decision|1
7688265|NCT00337662|12107074|FG000|Study Period III|Lost to Follow-up|14
7688266|NCT00337662|12107075|FG001|Study Period III|Lost to Follow-up|16
7688267|NCT00337662|12107076|FG002|Study Period III|Lost to Follow-up|14
7688268|NCT00337662|12107077|FG003|Study Period III|Lost to Follow-up|0
7688269|NCT00337662|12107074|FG000|Study Period III|Withdrawal by Subject|18
7688270|NCT00337662|12107075|FG001|Study Period III|Withdrawal by Subject|14
7688271|NCT00337662|12107076|FG002|Study Period III|Withdrawal by Subject|12
7688272|NCT00337662|12107077|FG003|Study Period III|Withdrawal by Subject|0
7688273|NCT00337662|12107074|FG000|Study Period III|Adverse Event|9
7688274|NCT00337662|12107075|FG001|Study Period III|Adverse Event|10
7688275|NCT00337662|12107076|FG002|Study Period III|Adverse Event|8
7688276|NCT00337662|12107077|FG003|Study Period III|Adverse Event|0
7688277|NCT00337662|12107074|FG000|Study Period III|Protocol Violation|3
7688278|NCT00337662|12107075|FG001|Study Period III|Protocol Violation|8
7688279|NCT00337662|12107076|FG002|Study Period III|Protocol Violation|2
7688280|NCT00337662|12107077|FG003|Study Period III|Protocol Violation|0
7688281|NCT00337662|12107074|FG000|Study Period III|Physician Decision|6
7688282|NCT00337662|12107075|FG001|Study Period III|Physician Decision|5
7688283|NCT00337662|12107076|FG002|Study Period III|Physician Decision|0
7688284|NCT00337662|12107077|FG003|Study Period III|Physician Decision|0
7688285|NCT00337662|12107074|FG000|Study Period III|Entry Criteria Not Met|4
7688286|NCT00337662|12107075|FG001|Study Period III|Entry Criteria Not Met|1
7688287|NCT00337662|12107076|FG002|Study Period III|Entry Criteria Not Met|3
7688288|NCT00337662|12107077|FG003|Study Period III|Entry Criteria Not Met|0
7688289|NCT00337662|12107074|FG000|Study Period III|Lack of Efficacy|4
7688290|NCT00337662|12107075|FG001|Study Period III|Lack of Efficacy|4
7688291|NCT00337662|12107076|FG002|Study Period III|Lack of Efficacy|2
7688292|NCT00337662|12107077|FG003|Study Period III|Lack of Efficacy|0
7688293|NCT00337662|12107074|FG000|Study Period III|Parent/Caregiver Decision|0
7688294|NCT00337662|12107075|FG001|Study Period III|Parent/Caregiver Decision|0
7688295|NCT00337662|12107076|FG002|Study Period III|Parent/Caregiver Decision|2
7688296|NCT00337662|12107077|FG003|Study Period III|Parent/Caregiver Decision|0
7688297|NCT00337662|12107074|FG000|Study Period III|Sponsor Decision|1
7688298|NCT00337662|12107075|FG001|Study Period III|Sponsor Decision|0
7688299|NCT00337662|12107076|FG002|Study Period III|Sponsor Decision|1
7688300|NCT00337662|12107077|FG003|Study Period III|Sponsor Decision|0
7688301|NCT00337662|12107074|FG000|Study Period III|Clinical Relapse|1
7688302|NCT00337662|12107075|FG001|Study Period III|Clinical Relapse|0
7688303|NCT00337662|12107076|FG002|Study Period III|Clinical Relapse|0
7688304|NCT00337662|12107077|FG003|Study Period III|Clinical Relapse|0
7688305|NCT00337727|12107090|FG000|Overall Study|Adverse Event|5
7688306|NCT00337727|12107091|FG001|Overall Study|Adverse Event|3
7688307|NCT00337727|12107090|FG000|Overall Study|Lost to Follow-up|5
7688308|NCT00337727|12107091|FG001|Overall Study|Lost to Follow-up|4
7688309|NCT00337727|12107090|FG000|Overall Study|Physician Decision|1
7688310|NCT00337727|12107091|FG001|Overall Study|Physician Decision|0
7688311|NCT00337727|12107090|FG000|Overall Study|Protocol Violation|4
7688312|NCT00337727|12107091|FG001|Overall Study|Protocol Violation|0
7688313|NCT00337727|12107090|FG000|Overall Study|Withdrawal by Subject|3
7688314|NCT00337727|12107091|FG001|Overall Study|Withdrawal by Subject|5
7688315|NCT00337779|12107099|FG000|Overall Study|Withdrawal by Subject|10
7688316|NCT00337779|12107100|FG001|Overall Study|Withdrawal by Subject|12
7688317|NCT00337779|12107099|FG000|Overall Study|Sponsor decision|1
7688318|NCT00337779|12107100|FG001|Overall Study|Sponsor decision|1
7688319|NCT00337779|12107099|FG000|Overall Study|Physician Decision|3
7688320|NCT00337779|12107100|FG001|Overall Study|Physician Decision|6
7688321|NCT00337779|12107099|FG000|Overall Study|Protocol Violation|1
7688322|NCT00337779|12107100|FG001|Overall Study|Protocol Violation|1
7688323|NCT00337779|12107099|FG000|Overall Study|Lost to Follow-up|6
7688324|NCT00337779|12107100|FG001|Overall Study|Lost to Follow-up|5
7688325|NCT00337779|12107099|FG000|Overall Study|Adverse Event|28
7688326|NCT00337779|12107100|FG001|Overall Study|Adverse Event|51
7688327|NCT00337779|12107099|FG000|Overall Study|Pregnancy|3
7688328|NCT00337779|12107100|FG001|Overall Study|Pregnancy|2
7688329|NCT00337779|12107099|FG000|Overall Study|Death|0
7688330|NCT00337779|12107100|FG001|Overall Study|Death|1
7688331|NCT00337818|12107109|FG000|Overall Study|Lost to Follow-up|289
7688332|NCT00337818|12107110|FG001|Overall Study|Lost to Follow-up|91
7688333|NCT00337818|12107111|FG002|Overall Study|Lost to Follow-up|107
7688334|NCT00337935|12107121|FG000|Overall Study|Adverse Event|2
7688335|NCT00337935|12107122|FG001|Overall Study|Adverse Event|5
7688336|NCT00337935|12107121|FG000|Overall Study|Death|2
7688337|NCT00337935|12107122|FG001|Overall Study|Death|8
7688338|NCT00337935|12107121|FG000|Overall Study|Physician Decision|1
7688339|NCT00337935|12107122|FG001|Overall Study|Physician Decision|1
7688340|NCT00337935|12107121|FG000|Overall Study|Lost to Follow-up|0
7688341|NCT00337935|12107122|FG001|Overall Study|Lost to Follow-up|1
7688342|NCT00337935|12107121|FG000|Overall Study|Protocol Violation|4
7688343|NCT00337935|12107122|FG001|Overall Study|Protocol Violation|3
7688344|NCT00337935|12107121|FG000|Overall Study|Withdrawal by Subject|1
7688345|NCT00337935|12107122|FG001|Overall Study|Withdrawal by Subject|7
7688346|NCT00337935|12107121|FG000|Overall Study|Other|0
7688347|NCT00337935|12107122|FG001|Overall Study|Other|1
7688348|NCT00337935|12107121|FG000|Overall Study|Lack of Efficacy|0
7688349|NCT00337935|12107122|FG001|Overall Study|Lack of Efficacy|1
7688350|NCT00338286|12107139|FG000|Overall Study|Withdrawal by Subject|50
7688351|NCT00338286|12107140|FG001|Overall Study|Withdrawal by Subject|54
7688352|NCT00338286|12107139|FG000|Overall Study|Lost to Follow-up|80
7688353|NCT00338286|12107140|FG001|Overall Study|Lost to Follow-up|66
7688354|NCT00338286|12107139|FG000|Overall Study|Other|103
7688355|NCT00338286|12107140|FG001|Overall Study|Other|93
7688356|NCT00338728|12107155|FG000|Overall Study|Screen Failure|14
7688357|NCT00338741|12107161|FG000|Overall Study|Lost to Follow-up|2
7688358|NCT00338741|12107162|FG001|Overall Study|Lost to Follow-up|0
7688359|NCT00338806|12107170|FG000|Acute Phase|Withdrawal by Subject|0
7688360|NCT00338806|12107171|FG001|Acute Phase|Withdrawal by Subject|1
7688361|NCT00338806|12107170|FG000|Follow-up|Lost to Follow-up|1
7688362|NCT00338806|12107171|FG001|Follow-up|Lost to Follow-up|3
7688363|NCT00338884|12107179|FG000|Overall Study|Objective Disease Progression or Relapse|44
7688364|NCT00338884|12107179|FG000|Overall Study|Adverse Event|14
7688365|NCT00338884|12107179|FG000|Overall Study|Death|8
7688366|NCT00338884|12107179|FG000|Overall Study|Other|4
7688367|NCT00338884|12107179|FG000|Overall Study|Global Deterioration of Health Status|3
7688368|NCT00338884|12107179|FG000|Overall Study|Withdrawal by Subject|3
7688369|NCT00338884|12107179|FG000|Overall Study|Lost to Follow-up|1
7688370|NCT00338884|12107179|FG000|Overall Study|Randomized But Did Not Receive Treatment|1
7688371|NCT00338949|12107185|FG000|Subject Screening|Screen failures|11
7688372|NCT00338949|12107186|FG001|Subject Screening|Screen failures|11
7688373|NCT00338949|12107185|FG000|Randomization|Withdrawal by Subject|1
7688374|NCT00338949|12107186|FG001|Randomization|Withdrawal by Subject|0
7688375|NCT00338949|12107185|FG000|Randomization|Adverse Event|0
7688376|NCT00338949|12107186|FG001|Randomization|Adverse Event|5
7688377|NCT00338962|12107196|FG000|Overall Study|Lost to Follow-up|3
7688378|NCT00338962|12107197|FG001|Overall Study|Lost to Follow-up|3
7688379|NCT00338962|12107198|FG002|Overall Study|Lost to Follow-up|2
7688380|NCT00338962|12107199|FG003|Overall Study|Lost to Follow-up|3
7688381|NCT00338962|12107196|FG000|Overall Study|Withdrawal by Subject|1
7688382|NCT00338962|12107197|FG001|Overall Study|Withdrawal by Subject|0
7688383|NCT00338962|12107198|FG002|Overall Study|Withdrawal by Subject|0
7688384|NCT00338962|12107199|FG003|Overall Study|Withdrawal by Subject|0
7688385|NCT00338962|12107196|FG000|Overall Study|No Transportation|2
7688386|NCT00338962|12107197|FG001|Overall Study|No Transportation|0
7688387|NCT00338962|12107198|FG002|Overall Study|No Transportation|0
7688388|NCT00338962|12107199|FG003|Overall Study|No Transportation|0
7688389|NCT00338962|12107196|FG000|Overall Study|Time Constraint|2
7688390|NCT00338962|12107197|FG001|Overall Study|Time Constraint|0
7688391|NCT00338962|12107198|FG002|Overall Study|Time Constraint|0
7688392|NCT00338962|12107199|FG003|Overall Study|Time Constraint|0
7688393|NCT00338962|12107196|FG000|Overall Study|Moved|0
7688394|NCT00338962|12107197|FG001|Overall Study|Moved|1
7688395|NCT00338962|12107198|FG002|Overall Study|Moved|0
7688396|NCT00338962|12107199|FG003|Overall Study|Moved|0
7688397|NCT00338962|12107196|FG000|Overall Study|Adverse Event|0
7688398|NCT00338962|12107197|FG001|Overall Study|Adverse Event|0
7688399|NCT00338962|12107198|FG002|Overall Study|Adverse Event|2
7688400|NCT00338962|12107199|FG003|Overall Study|Adverse Event|0
7688401|NCT00338962|12107196|FG000|Overall Study|Poor Compliance|0
7688402|NCT00338962|12107197|FG001|Overall Study|Poor Compliance|0
7688403|NCT00338962|12107198|FG002|Overall Study|Poor Compliance|2
7688404|NCT00338962|12107199|FG003|Overall Study|Poor Compliance|0
7688405|NCT00339040|12107216|FG000|Stage I|Not able to attend clinic|1
7688406|NCT00339040|12107217|FG001|Stage I|Not able to attend clinic|0
7688407|NCT00339040|12107216|FG000|Stage I|Protocol Violation|1
7688408|NCT00339040|12107217|FG001|Stage I|Protocol Violation|1
7688409|NCT00339040|12107216|FG000|Stage II|Lost to Follow-up|3
7688410|NCT00339040|12107217|FG001|Stage II|Lost to Follow-up|0
7688411|NCT00339040|12107216|FG000|Stage II|Withdrawal by Subject|1
7688412|NCT00339040|12107217|FG001|Stage II|Withdrawal by Subject|2
7688413|NCT00339040|12107216|FG000|Stage II|Protocol Violation|3
7688414|NCT00339040|12107217|FG001|Stage II|Protocol Violation|0
7688415|NCT00339040|12107216|FG000|Stage II|Not able to attend clinic|1
7688416|NCT00339040|12107217|FG001|Stage II|Not able to attend clinic|0
7688417|NCT00339040|12107216|FG000|Stage II|Site closing|2
7688418|NCT00339040|12107217|FG001|Stage II|Site closing|0
7688419|NCT00339144|12107247|FG000|Overall Study|Disease progression|5
7688420|NCT00339144|12107248|FG001|Overall Study|Disease progression|2
7688421|NCT00339144|12107249|FG002|Overall Study|Disease progression|2
7688422|NCT00339144|12107247|FG000|Overall Study|Study drug toxicity|3
7688423|NCT00339144|12107248|FG001|Overall Study|Study drug toxicity|1
7688424|NCT00339144|12107249|FG002|Overall Study|Study drug toxicity|1
7688425|NCT00339144|12107247|FG000|Overall Study|Participant's request to discontinuation|1
7688426|NCT00339144|12107248|FG001|Overall Study|Participant's request to discontinuation|0
7688427|NCT00339144|12107249|FG002|Overall Study|Participant's request to discontinuation|1
7688428|NCT00339833|12107260|FG000|Overall Study|Withdrawal by Subject|1
7688429|NCT00339833|12107261|FG001|Overall Study|Withdrawal by Subject|2
7688430|NCT00339833|12107260|FG000|Overall Study|toothache|0
7688431|NCT00339833|12107261|FG001|Overall Study|toothache|1
7688432|NCT00339833|12107260|FG000|Overall Study|indigestion|0
7688433|NCT00339833|12107261|FG001|Overall Study|indigestion|1
7688434|NCT00339833|12107260|FG000|Overall Study|Chest pain|0
7688435|NCT00339833|12107261|FG001|Overall Study|Chest pain|1
7688436|NCT00339833|12107260|FG000|Overall Study|minor infection|0
7688437|NCT00339833|12107261|FG001|Overall Study|minor infection|1
7688438|NCT00339833|12107260|FG000|Overall Study|Poor venous access|2
7688439|NCT00339833|12107261|FG001|Overall Study|Poor venous access|2
7688440|NCT00339833|12107260|FG000|Overall Study|anaemia or excess drop in glycaemia|2
7688441|NCT00339833|12107261|FG001|Overall Study|anaemia or excess drop in glycaemia|0
7688442|NCT00339833|12107260|FG000|Overall Study|Error in data records|1
7688443|NCT00339833|12107261|FG001|Overall Study|Error in data records|0
7688444|NCT00340678|12107280|FG000|Overall Study|Lost to Follow-up|1
7688445|NCT00340678|12107281|FG001|Overall Study|Lost to Follow-up|0
7688446|NCT00340678|12107282|FG002|Overall Study|Lost to Follow-up|0
7688447|NCT00340678|12107283|FG003|Overall Study|Lost to Follow-up|0
7688448|NCT00340704|12107300|FG000|PK Study|Adverse Event|0
7688449|NCT00340704|12107301|FG001|PK Study|Adverse Event|1
7688450|NCT00340704|12107302|FG002|PK Study|Adverse Event|0
7688451|NCT00340704|12107303|FG003|PK Study|Adverse Event|0
7688452|NCT00340704|12107304|FG004|PK Study|Adverse Event|0
7688453|NCT00340704|12107305|FG005|PK Study|Adverse Event|0
7688454|NCT00340704|12107306|FG006|PK Study|Adverse Event|0
7688455|NCT00340704|12107307|FG007|PK Study|Adverse Event|0
7688456|NCT00340704|12107308|FG008|PK Study|Adverse Event|0
7688457|NCT00340704|12107300|FG000|PK Study|Not treated|0
7688458|NCT00340704|12107301|FG001|PK Study|Not treated|0
7688459|NCT00340704|12107302|FG002|PK Study|Not treated|1
7688460|NCT00340704|12107303|FG003|PK Study|Not treated|0
7688461|NCT00340704|12107304|FG004|PK Study|Not treated|0
7688462|NCT00340704|12107305|FG005|PK Study|Not treated|0
7688463|NCT00340704|12107306|FG006|PK Study|Not treated|0
7688464|NCT00340704|12107307|FG007|PK Study|Not treated|0
7688465|NCT00340704|12107308|FG008|PK Study|Not treated|0
7688466|NCT00340704|12107300|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
7688467|NCT00340704|12107301|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
7688468|NCT00340704|12107302|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
7688469|NCT00340704|12107303|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
7688470|NCT00340704|12107304|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
7688471|NCT00340704|12107305|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
7688472|NCT00340704|12107306|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
7688473|NCT00340704|12107307|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
7688474|NCT00340704|12107308|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
7688475|NCT00340704|12107300|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7688476|NCT00340704|12107301|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7688477|NCT00340704|12107302|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7688478|NCT00340704|12107303|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7688479|NCT00340704|12107304|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7688480|NCT00340704|12107305|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
7688481|NCT00340704|12107306|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7688482|NCT00340704|12107307|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7688483|NCT00340704|12107308|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7688484|NCT00340704|12107300|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7688485|NCT00340704|12107301|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7688486|NCT00340704|12107302|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7688487|NCT00340704|12107303|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7688488|NCT00340704|12107304|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
7688489|NCT00340704|12107305|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
7688490|NCT00340704|12107306|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7688491|NCT00340704|12107307|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7688492|NCT00340704|12107308|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7688493|NCT00340704|12107300|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
7688494|NCT00340704|12107301|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
7688495|NCT00340704|12107302|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
7688496|NCT00340704|12107303|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
7688497|NCT00340704|12107304|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
7688498|NCT00340704|12107305|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
7688499|NCT00340704|12107306|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
7688500|NCT00340704|12107307|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
7688501|NCT00340704|12107308|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
7688502|NCT00340834|12107339|FG000|Core Phase of Study|Adverse Event|26
7688503|NCT00340834|12107340|FG001|Core Phase of Study|Adverse Event|9
7688504|NCT00340834|12107341|FG002|Core Phase of Study|Adverse Event|9
7688505|NCT00340834|12107342|FG003|Core Phase of Study|Adverse Event|0
7688506|NCT00340834|12107343|FG004|Core Phase of Study|Adverse Event|0
7688507|NCT00340834|12107339|FG000|Core Phase of Study|Withdrawal by Subject|11
7688508|NCT00340834|12107340|FG001|Core Phase of Study|Withdrawal by Subject|9
7688509|NCT00340834|12107341|FG002|Core Phase of Study|Withdrawal by Subject|16
7688510|NCT00340834|12107342|FG003|Core Phase of Study|Withdrawal by Subject|0
7688511|NCT00340834|12107343|FG004|Core Phase of Study|Withdrawal by Subject|0
7688512|NCT00340834|12107339|FG000|Core Phase of Study|Administrative Problems|6
7688513|NCT00340834|12107340|FG001|Core Phase of Study|Administrative Problems|2
7688514|NCT00340834|12107341|FG002|Core Phase of Study|Administrative Problems|7
7688515|NCT00340834|12107342|FG003|Core Phase of Study|Administrative Problems|0
7688516|NCT00340834|12107343|FG004|Core Phase of Study|Administrative Problems|0
7688517|NCT00340834|12107339|FG000|Core Phase of Study|Lack of Efficacy|3
7688518|NCT00340834|12107340|FG001|Core Phase of Study|Lack of Efficacy|3
7688519|NCT00340834|12107341|FG002|Core Phase of Study|Lack of Efficacy|7
7688520|NCT00340834|12107342|FG003|Core Phase of Study|Lack of Efficacy|0
7688521|NCT00340834|12107343|FG004|Core Phase of Study|Lack of Efficacy|0
7688522|NCT00340834|12107339|FG000|Core Phase of Study|Abnormal laboratory value(s)|4
7688523|NCT00340834|12107340|FG001|Core Phase of Study|Abnormal laboratory value(s)|6
7688524|NCT00340834|12107341|FG002|Core Phase of Study|Abnormal laboratory value(s)|1
7688525|NCT00340834|12107342|FG003|Core Phase of Study|Abnormal laboratory value(s)|0
7688526|NCT00340834|12107343|FG004|Core Phase of Study|Abnormal laboratory value(s)|0
7688527|NCT00340834|12107339|FG000|Core Phase of Study|Abnormal test procedure result(s)|4
7688528|NCT00340834|12107340|FG001|Core Phase of Study|Abnormal test procedure result(s)|3
7688529|NCT00340834|12107341|FG002|Core Phase of Study|Abnormal test procedure result(s)|3
7688530|NCT00340834|12107342|FG003|Core Phase of Study|Abnormal test procedure result(s)|0
7688531|NCT00340834|12107343|FG004|Core Phase of Study|Abnormal test procedure result(s)|0
7688532|NCT00340834|12107339|FG000|Core Phase of Study|Lost to Follow-up|1
7688533|NCT00340834|12107340|FG001|Core Phase of Study|Lost to Follow-up|1
7688534|NCT00340834|12107341|FG002|Core Phase of Study|Lost to Follow-up|4
7688535|NCT00340834|12107342|FG003|Core Phase of Study|Lost to Follow-up|0
7688536|NCT00340834|12107343|FG004|Core Phase of Study|Lost to Follow-up|0
7688537|NCT00340834|12107339|FG000|Core Phase of Study|Death|2
7688538|NCT00340834|12107340|FG001|Core Phase of Study|Death|0
7688539|NCT00340834|12107341|FG002|Core Phase of Study|Death|0
7688540|NCT00340834|12107342|FG003|Core Phase of Study|Death|0
7688541|NCT00340834|12107343|FG004|Core Phase of Study|Death|0
7688542|NCT00340834|12107339|FG000|Core Phase of Study|Protocol Violation|0
7688543|NCT00340834|12107340|FG001|Core Phase of Study|Protocol Violation|0
7688544|NCT00340834|12107341|FG002|Core Phase of Study|Protocol Violation|2
7688545|NCT00340834|12107342|FG003|Core Phase of Study|Protocol Violation|0
7688546|NCT00340834|12107343|FG004|Core Phase of Study|Protocol Violation|0
7688547|NCT00340834|12107339|FG000|Extension Phase of Study|Subject did not receive study drug|0
7688548|NCT00340834|12107340|FG001|Extension Phase of Study|Subject did not receive study drug|1
7688549|NCT00340834|12107341|FG002|Extension Phase of Study|Subject did not receive study drug|0
7688550|NCT00340834|12107342|FG003|Extension Phase of Study|Subject did not receive study drug|2
7688551|NCT00340834|12107343|FG004|Extension Phase of Study|Subject did not receive study drug|0
7688552|NCT00340834|12107339|FG000|Extension Phase of Study|Subject withdrew consent|26
7688553|NCT00340834|12107340|FG001|Extension Phase of Study|Subject withdrew consent|31
7688554|NCT00340834|12107341|FG002|Extension Phase of Study|Subject withdrew consent|0
7688555|NCT00340834|12107342|FG003|Extension Phase of Study|Subject withdrew consent|12
7688556|NCT00340834|12107343|FG004|Extension Phase of Study|Subject withdrew consent|15
7688557|NCT00340834|12107339|FG000|Extension Phase of Study|Adverse Event|21
7688558|NCT00340834|12107340|FG001|Extension Phase of Study|Adverse Event|22
7688559|NCT00340834|12107341|FG002|Extension Phase of Study|Adverse Event|0
7688560|NCT00340834|12107342|FG003|Extension Phase of Study|Adverse Event|19
7688561|NCT00340834|12107343|FG004|Extension Phase of Study|Adverse Event|7
7688562|NCT00340834|12107339|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14
7688563|NCT00340834|12107340|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13
7688564|NCT00340834|12107341|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0
7688565|NCT00340834|12107342|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13
7688566|NCT00340834|12107343|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4
7688567|NCT00340834|12107339|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13
7688568|NCT00340834|12107340|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7
7688569|NCT00340834|12107341|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0
7688570|NCT00340834|12107342|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4
7688571|NCT00340834|12107343|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9
7688572|NCT00340834|12107339|FG000|Extension Phase of Study|Lost to Follow-up|1
7688573|NCT00340834|12107340|FG001|Extension Phase of Study|Lost to Follow-up|1
7688574|NCT00340834|12107341|FG002|Extension Phase of Study|Lost to Follow-up|0
7688575|NCT00340834|12107342|FG003|Extension Phase of Study|Lost to Follow-up|2
7688576|NCT00340834|12107343|FG004|Extension Phase of Study|Lost to Follow-up|3
7688577|NCT00340834|12107339|FG000|Extension Phase of Study|Subject no longer requires study drug|4
7688578|NCT00340834|12107340|FG001|Extension Phase of Study|Subject no longer requires study drug|0
7688579|NCT00340834|12107341|FG002|Extension Phase of Study|Subject no longer requires study drug|0
7688580|NCT00340834|12107342|FG003|Extension Phase of Study|Subject no longer requires study drug|0
7688581|NCT00340834|12107343|FG004|Extension Phase of Study|Subject no longer requires study drug|2
7688582|NCT00340834|12107339|FG000|Extension Phase of Study|Administrative problems|3
7688583|NCT00340834|12107340|FG001|Extension Phase of Study|Administrative problems|0
7688584|NCT00340834|12107341|FG002|Extension Phase of Study|Administrative problems|0
7688585|NCT00340834|12107342|FG003|Extension Phase of Study|Administrative problems|1
7688586|NCT00340834|12107343|FG004|Extension Phase of Study|Administrative problems|1
7688587|NCT00340834|12107339|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0
7688588|NCT00340834|12107340|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1
7688589|NCT00340834|12107341|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0
7688590|NCT00340834|12107342|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0
7688591|NCT00340834|12107343|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2
7688592|NCT00340834|12107339|FG000|Extension Phase of Study|Protocol Violation|3
7688593|NCT00340834|12107340|FG001|Extension Phase of Study|Protocol Violation|0
7688594|NCT00340834|12107341|FG002|Extension Phase of Study|Protocol Violation|0
7688595|NCT00340834|12107342|FG003|Extension Phase of Study|Protocol Violation|0
7688596|NCT00340834|12107343|FG004|Extension Phase of Study|Protocol Violation|0
7688597|NCT00340834|12107339|FG000|Extension Phase of Study|Death|0
7688598|NCT00340834|12107340|FG001|Extension Phase of Study|Death|0
7688599|NCT00340834|12107341|FG002|Extension Phase of Study|Death|0
7688600|NCT00340834|12107342|FG003|Extension Phase of Study|Death|0
7688601|NCT00340834|12107343|FG004|Extension Phase of Study|Death|1
7688602|NCT00342628|12107392|FG000|Overall Study|Withdrawal by Subject|19
7688603|NCT00342628|12107393|FG001|Overall Study|Withdrawal by Subject|19
7688604|NCT00342628|12107394|FG002|Overall Study|Withdrawal by Subject|18
7688605|NCT00342628|12107392|FG000|Overall Study|Death|1
7688606|NCT00342628|12107393|FG001|Overall Study|Death|1
7688607|NCT00342628|12107394|FG002|Overall Study|Death|0
7688608|NCT00342628|12107392|FG000|Overall Study|moved residence|0
7688609|NCT00342628|12107393|FG001|Overall Study|moved residence|1
7688610|NCT00342628|12107394|FG002|Overall Study|moved residence|1
7688611|NCT00343252|12107413|FG000|6 Months (All Treated Participants)|Adverse Event|17
7688612|NCT00343252|12107414|FG001|6 Months (All Treated Participants)|Adverse Event|11
7688613|NCT00343252|12107413|FG000|6 Months (All Treated Participants)|Death|0
7688614|NCT00343252|12107414|FG001|6 Months (All Treated Participants)|Death|2
7688615|NCT00343252|12107413|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10
7688616|NCT00343252|12107414|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8
7688617|NCT00343252|12107413|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0
7688618|NCT00343252|12107414|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1
7688619|NCT00343252|12107413|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0
7688620|NCT00343252|12107414|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4
7688621|NCT00343252|12107413|FG000|6 Months (All Treated Participants)|Physician Decision|1
7688622|NCT00343252|12107414|FG001|6 Months (All Treated Participants)|Physician Decision|3
7688623|NCT00343252|12107413|FG000|6 Months (All Treated Participants)|Protocol Violation|2
7688624|NCT00343252|12107414|FG001|6 Months (All Treated Participants)|Protocol Violation|2
7688625|NCT00343252|12107413|FG000|6 Months (All Treated Participants)|Sponsor Decision|7
7688626|NCT00343252|12107414|FG001|6 Months (All Treated Participants)|Sponsor Decision|4
7688627|NCT00343252|12107413|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19
7688628|NCT00343252|12107414|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9
7688629|NCT00343252|12107413|FG000|12 Months (All Treated Participants)|Adverse Event|22
7688630|NCT00343252|12107414|FG001|12 Months (All Treated Participants)|Adverse Event|20
7688631|NCT00343252|12107413|FG000|12 Months (All Treated Participants)|Death|3
7688632|NCT00343252|12107414|FG001|12 Months (All Treated Participants)|Death|3
7688633|NCT00343252|12107413|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10
7688634|NCT00343252|12107414|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10
7688635|NCT00343252|12107413|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1
7688636|NCT00343252|12107414|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1
7688637|NCT00343252|12107413|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1
7688638|NCT00343252|12107414|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5
7688639|NCT00343252|12107413|FG000|12 Months (All Treated Participants)|Physician Decision|4
7688640|NCT00343252|12107414|FG001|12 Months (All Treated Participants)|Physician Decision|5
7688641|NCT00343252|12107413|FG000|12 Months (All Treated Participants)|Protocol Violation|3
7688642|NCT00343252|12107414|FG001|12 Months (All Treated Participants)|Protocol Violation|2
7688643|NCT00343252|12107413|FG000|12 Months (All Treated Participants)|Sponsor Decision|9
7688644|NCT00343252|12107414|FG001|12 Months (All Treated Participants)|Sponsor Decision|6
7688645|NCT00343252|12107413|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33
7688646|NCT00343252|12107414|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17
7688647|NCT00343252|12107413|FG000|18 Months (All Treated Participants)|Adverse Event|31
7688648|NCT00343252|12107414|FG001|18 Months (All Treated Participants)|Adverse Event|23
7688649|NCT00343252|12107413|FG000|18 Months (All Treated Participants)|Death|4
7688650|NCT00343252|12107414|FG001|18 Months (All Treated Participants)|Death|5
7688651|NCT00343252|12107413|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11
7688652|NCT00343252|12107414|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10
7688653|NCT00343252|12107413|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1
7688654|NCT00343252|12107414|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1
7688655|NCT00343252|12107413|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3
7688656|NCT00343252|12107414|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7
7688657|NCT00343252|12107413|FG000|18 Months (All Treated Participants)|Physician Decision|4
7688658|NCT00343252|12107414|FG001|18 Months (All Treated Participants)|Physician Decision|7
7688659|NCT00343252|12107413|FG000|18 Months (All Treated Participants)|Protocol Violation|3
7688660|NCT00343252|12107414|FG001|18 Months (All Treated Participants)|Protocol Violation|3
7688661|NCT00343252|12107413|FG000|18 Months (All Treated Participants)|Sponsor Decision|8
7688662|NCT00343252|12107414|FG001|18 Months (All Treated Participants)|Sponsor Decision|5
7688663|NCT00343252|12107413|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36
7688664|NCT00343252|12107414|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20
7688665|NCT00343291|12107422|FG000|Overall Study|Adverse Event|13
7688666|NCT00343291|12107423|FG001|Overall Study|Adverse Event|13
7688667|NCT00343291|12107422|FG000|Overall Study|Death|3
7688668|NCT00343291|12107423|FG001|Overall Study|Death|2
7688669|NCT00343291|12107422|FG000|Overall Study|Progressive disease|33
7688670|NCT00343291|12107423|FG001|Overall Study|Progressive disease|34
7688671|NCT00343291|12107422|FG000|Overall Study|Withdrawal by Subject|0
7688672|NCT00343291|12107423|FG001|Overall Study|Withdrawal by Subject|2
7688673|NCT00343291|12107422|FG000|Overall Study|Other|8
7688674|NCT00343291|12107423|FG001|Overall Study|Other|5
7688675|NCT00343382|12107432|FG000|Overall Study|Adverse Event|2
7688676|NCT00343382|12107433|FG001|Overall Study|Adverse Event|10
7688677|NCT00343382|12107434|FG002|Overall Study|Adverse Event|7
7688678|NCT00343382|12107432|FG000|Overall Study|Withdrawal by Subject|1
7688679|NCT00343382|12107433|FG001|Overall Study|Withdrawal by Subject|2
7688680|NCT00343382|12107434|FG002|Overall Study|Withdrawal by Subject|6
7688681|NCT00343382|12107432|FG000|Overall Study|Other Reason Not Specified|1
7688682|NCT00343382|12107433|FG001|Overall Study|Other Reason Not Specified|2
7688683|NCT00343382|12107434|FG002|Overall Study|Other Reason Not Specified|4
7688684|NCT00343512|12107468|FG000|Overall Study|Withdrawal by Subject|2
7688685|NCT00343642|12107592|FG000|Overall Study|Lost to Follow-up|0
7688686|NCT00343642|12107593|FG001|Overall Study|Lost to Follow-up|1
7688687|NCT00343642|12107594|FG002|Overall Study|Lost to Follow-up|0
7688688|NCT00343642|12107592|FG000|Overall Study|Pregnancy|1
7688689|NCT00343642|12107593|FG001|Overall Study|Pregnancy|0
7688690|NCT00343642|12107594|FG002|Overall Study|Pregnancy|2
7688691|NCT00343642|12107592|FG000|Overall Study|Withdrawal by Subject|2
7688692|NCT00343642|12107593|FG001|Overall Study|Withdrawal by Subject|3
7688693|NCT00343642|12107594|FG002|Overall Study|Withdrawal by Subject|4
7688694|NCT00343642|12107592|FG000|Overall Study|Adverse Event|0
7688695|NCT00343642|12107593|FG001|Overall Study|Adverse Event|0
7688696|NCT00343642|12107594|FG002|Overall Study|Adverse Event|1
7688697|NCT00343642|12107592|FG000|Overall Study|Flare up|6
7688698|NCT00343642|12107593|FG001|Overall Study|Flare up|4
7688699|NCT00343642|12107594|FG002|Overall Study|Flare up|0
7688700|NCT00343889|12107623|FG000|Overall Study|Lost to Follow-up|2
7688701|NCT00343889|12107624|FG001|Overall Study|Lost to Follow-up|0
7688702|NCT00343889|12107623|FG000|Overall Study|Withdrawal by Subject|0
7688703|NCT00343889|12107624|FG001|Overall Study|Withdrawal by Subject|1
7688704|NCT00343889|12107623|FG000|Overall Study|Protocol Violation|1
7688705|NCT00343889|12107624|FG001|Overall Study|Protocol Violation|0
7688706|NCT00343915|12107632|FG000|Primary Study|Withdrawal by Subject|1
7688707|NCT00343915|12107633|FG001|Primary Study|Withdrawal by Subject|0
7688708|NCT00343915|12107632|FG000|Primary Study|Lost to Follow-up|2
7688709|NCT00343915|12107633|FG001|Primary Study|Lost to Follow-up|3
7688710|NCT00343915|12107632|FG000|Primary Study|Other|1
7688711|NCT00343915|12107633|FG001|Primary Study|Other|0
7688712|NCT00344032|12107644|FG000|Overall Study|Adverse Event|0
7688713|NCT00344032|12107645|FG001|Overall Study|Adverse Event|1
7688714|NCT00344032|12107644|FG000|Overall Study|Withdrawal by Subject|6
7688715|NCT00344032|12107645|FG001|Overall Study|Withdrawal by Subject|2
7688716|NCT00344032|12107644|FG000|Overall Study|Lost to Follow-up|4
7688717|NCT00344032|12107645|FG001|Overall Study|Lost to Follow-up|6
7688718|NCT00344032|12107644|FG000|Overall Study|Physician Decision|4
7688719|NCT00344032|12107645|FG001|Overall Study|Physician Decision|1
7688720|NCT00344305|12107662|FG000|Overall Study|Lost to Follow-up|2
7688721|NCT00344305|12107663|FG001|Overall Study|Lost to Follow-up|0
7688722|NCT00344305|12107662|FG000|Overall Study|Participant was not contacted in window|0
7688723|NCT00344305|12107663|FG001|Overall Study|Participant was not contacted in window|1
7688724|NCT00344318|12107674|FG000|Overall Study|Adverse Event|0
7688725|NCT00344318|12107675|FG001|Overall Study|Adverse Event|3
7688726|NCT00344318|12107676|FG002|Overall Study|Adverse Event|0
7688727|NCT00344318|12107677|FG003|Overall Study|Adverse Event|1
7688728|NCT00344318|12107674|FG000|Overall Study|Withdrawal by Subject|2
7688729|NCT00344318|12107675|FG001|Overall Study|Withdrawal by Subject|2
7688730|NCT00344318|12107676|FG002|Overall Study|Withdrawal by Subject|0
7688731|NCT00344318|12107677|FG003|Overall Study|Withdrawal by Subject|2
7688732|NCT00344318|12107674|FG000|Overall Study|Lost to Follow-up|2
7688733|NCT00344318|12107675|FG001|Overall Study|Lost to Follow-up|0
7688734|NCT00344318|12107676|FG002|Overall Study|Lost to Follow-up|1
7688735|NCT00344318|12107677|FG003|Overall Study|Lost to Follow-up|0
7688736|NCT00344448|12107700|FG000|Screening|Withdrawal by Subject|0
7688737|NCT00344448|12107701|FG001|Screening|Withdrawal by Subject|1
7688738|NCT00344448|12107700|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1
7688739|NCT00344448|12107701|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0
7688740|NCT00344448|12107700|FG000|Double Blind, Placebo Controlled|Study terminated|1
7688741|NCT00344448|12107701|FG001|Double Blind, Placebo Controlled|Study terminated|0
7688742|NCT00344448|12107700|FG000|Open Label|Withdrawal by Subject|1
7688743|NCT00344448|12107701|FG001|Open Label|Withdrawal by Subject|1
7688744|NCT00344448|12107700|FG000|Open Label|Study terminated|1
7688745|NCT00344448|12107701|FG001|Open Label|Study terminated|0
7688746|NCT00344461|12107707|FG000|Overall Study|Adverse Event|6
7688747|NCT00344461|12107707|FG000|Overall Study|Death|1
7688748|NCT00344461|12107707|FG000|Overall Study|Lack of Efficacy|2
7688749|NCT00344461|12107707|FG000|Overall Study|Lost to Follow-up|2
7688750|NCT00344461|12107707|FG000|Overall Study|Physician Decision|2
7688751|NCT00344461|12107707|FG000|Overall Study|Protocol Violation|6
7688752|NCT00344461|12107707|FG000|Overall Study|Withdrawal by Subject|2
7688753|NCT00344500|12107714|FG000|Overall Study|Adverse Event|6
7688754|NCT00344500|12107715|FG001|Overall Study|Adverse Event|2
7688755|NCT00344500|12107716|FG002|Overall Study|Adverse Event|0
7688756|NCT00344500|12107714|FG000|Overall Study|Lost to Follow-up|5
7688757|NCT00344500|12107715|FG001|Overall Study|Lost to Follow-up|13
7688758|NCT00344500|12107716|FG002|Overall Study|Lost to Follow-up|1
7688759|NCT00344500|12107714|FG000|Overall Study|Withdrawal by Subject|7
7688760|NCT00344500|12107715|FG001|Overall Study|Withdrawal by Subject|10
7688761|NCT00344500|12107716|FG002|Overall Study|Withdrawal by Subject|0
7688762|NCT00344500|12107714|FG000|Overall Study|Protocol Violation|4
7688763|NCT00344500|12107715|FG001|Overall Study|Protocol Violation|7
7688764|NCT00344500|12107716|FG002|Overall Study|Protocol Violation|1
7688765|NCT00344500|12107714|FG000|Overall Study|Not Noted|1
7688766|NCT00344500|12107715|FG001|Overall Study|Not Noted|3
7688767|NCT00344500|12107716|FG002|Overall Study|Not Noted|0
7688768|NCT00344773|12107732|FG000|Overall Study|Adverse Event|2
7688769|NCT00344773|12107732|FG000|Overall Study|Objective Disease Progression|16
7688770|NCT00344773|12107732|FG000|Overall Study|Withdrawal by Subject|1
7688771|NCT00344773|12107732|FG000|Overall Study|Not Eligible for the study|2
7688772|NCT00344968|12107739|FG000|Overall Study|Adverse Event|5
7688773|NCT00344968|12107740|FG001|Overall Study|Adverse Event|4
7688774|NCT00344968|12107741|FG002|Overall Study|Adverse Event|15
7688775|NCT00344968|12107739|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
7688776|NCT00344968|12107740|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
7688777|NCT00344968|12107741|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1
7688778|NCT00344968|12107739|FG000|Overall Study|Protocol Violation|2
7688779|NCT00344968|12107740|FG001|Overall Study|Protocol Violation|2
7688780|NCT00344968|12107741|FG002|Overall Study|Protocol Violation|5
7688781|NCT00344968|12107739|FG000|Overall Study|Withdrawal by Subject|14
7688782|NCT00344968|12107740|FG001|Overall Study|Withdrawal by Subject|31
7688783|NCT00344968|12107741|FG002|Overall Study|Withdrawal by Subject|27
7688784|NCT00344968|12107739|FG000|Overall Study|Lost to Follow-up|24
7688785|NCT00344968|12107740|FG001|Overall Study|Lost to Follow-up|37
7688786|NCT00344968|12107741|FG002|Overall Study|Lost to Follow-up|37
7688787|NCT00344968|12107739|FG000|Overall Study|Death|11
7688788|NCT00344968|12107740|FG001|Overall Study|Death|27
7688789|NCT00344968|12107741|FG002|Overall Study|Death|31
7688790|NCT00344968|12107739|FG000|Overall Study|Other|0
7688791|NCT00344968|12107740|FG001|Overall Study|Other|1
7688792|NCT00344968|12107741|FG002|Overall Study|Other|0
7688793|NCT00345046|12107762|FG000|Overall Study|Protocol Violation|1
7688794|NCT00345046|12107763|FG001|Overall Study|Protocol Violation|1
7688795|NCT00345046|12107764|FG002|Overall Study|Protocol Violation|2
7688796|NCT00345293|12107800|FG000|Overall Study|Unable to access line for sample|1
7688797|NCT00345293|12107801|FG001|Overall Study|Unable to access line for sample|0
7688798|NCT00345293|12107800|FG000|Overall Study|Withdrawal by Subject|1
7688799|NCT00345293|12107801|FG001|Overall Study|Withdrawal by Subject|0
7688800|NCT00345397|12107836|FG000|Overall Study|Death|1
7688801|NCT00345540|12107841|FG000|Overall Study|Withdrawal by Subject|1
7688802|NCT00345579|12107847|FG000|Overall Study|Adverse Event|9
7688803|NCT00345579|12107848|FG001|Overall Study|Adverse Event|6
7688804|NCT00345579|12107847|FG000|Overall Study|Protocol Violation|14
7688805|NCT00345579|12107848|FG001|Overall Study|Protocol Violation|5
7688806|NCT00345579|12107847|FG000|Overall Study|Withdrawal by Subject|50
7688807|NCT00345579|12107848|FG001|Overall Study|Withdrawal by Subject|17
7688808|NCT00345579|12107847|FG000|Overall Study|Lost to Follow-up|82
7688809|NCT00345579|12107848|FG001|Overall Study|Lost to Follow-up|36
7688810|NCT00345579|12107847|FG000|Overall Study|Other|9
7688811|NCT00345579|12107848|FG001|Overall Study|Other|1
7688812|NCT00345592|12107857|FG000|Overall Study|Death|14
7688813|NCT00345592|12107858|FG001|Overall Study|Death|16
7688814|NCT00345592|12107857|FG000|Overall Study|Withdrawal by Subject|11
7688815|NCT00345592|12107858|FG001|Overall Study|Withdrawal by Subject|8
7688816|NCT00345605|12107864|FG000|Arm 1|Adverse Event|0
7688817|NCT00345605|12107865|FG001|Arm 1|Adverse Event|1
7688818|NCT00345605|12107864|FG000|Arm 2, Opposite Treatment|Adverse Event|1
7688819|NCT00345605|12107865|FG001|Arm 2, Opposite Treatment|Adverse Event|0
7688820|NCT00345631|12107876|FG000|Overall Study|Withdrawal by Subject|1
7688821|NCT00345631|12107877|FG001|Overall Study|Withdrawal by Subject|0
7688822|NCT00345631|12107878|FG002|Overall Study|Withdrawal by Subject|1
7688823|NCT00345631|12107876|FG000|Overall Study|Adverse Event|0
7688824|NCT00345631|12107877|FG001|Overall Study|Adverse Event|1
7688825|NCT00345631|12107878|FG002|Overall Study|Adverse Event|0
7688826|NCT00345631|12107876|FG000|Overall Study|Lost to Follow-up|3
7688827|NCT00345631|12107877|FG001|Overall Study|Lost to Follow-up|7
7688828|NCT00345631|12107878|FG002|Overall Study|Lost to Follow-up|4
7688829|NCT00345631|12107876|FG000|Overall Study|Other reasons|0
7688830|NCT00345631|12107877|FG001|Overall Study|Other reasons|0
7688831|NCT00345631|12107878|FG002|Overall Study|Other reasons|1
7688832|NCT00345683|12107890|FG000|Overall Study|Lost to Follow-up|19
7688833|NCT00345683|12107891|FG001|Overall Study|Lost to Follow-up|7
7688834|NCT00345683|12107890|FG000|Overall Study|Other|6
7688835|NCT00345683|12107891|FG001|Overall Study|Other|2
7688836|NCT00345878|12107920|FG000|Overall Study|Adverse Event|1
7688837|NCT00345878|12107921|FG001|Overall Study|Adverse Event|0
7688838|NCT00345878|12107920|FG000|Overall Study|Lost to Follow-up|2
7688839|NCT00345878|12107921|FG001|Overall Study|Lost to Follow-up|1
7688840|NCT00345878|12107920|FG000|Overall Study|Other|1
7688841|NCT00345878|12107921|FG001|Overall Study|Other|0
7688842|NCT00346034|12107936|FG000|Overall Study|Adverse Event|34
7688843|NCT00346034|12107936|FG000|Overall Study|Lack of Efficacy|8
7688844|NCT00346034|12107936|FG000|Overall Study|Withdrawal by Subject|13
7688845|NCT00346034|12107936|FG000|Overall Study|Patient Stopped Taking Study Drug|1
7688846|NCT00346034|12107936|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1
7688847|NCT00346073|12107942|FG000|Overall Study|Serious Adverse Event|2
7688848|NCT00346073|12107943|FG001|Overall Study|Serious Adverse Event|0
7688849|NCT00346073|12107942|FG000|Overall Study|Lost to Follow-up|39
7688850|NCT00346073|12107943|FG001|Overall Study|Lost to Follow-up|24
7688851|NCT00346151|12107949|FG000|Overall Study|Withdrawal by Subject|3
7688852|NCT00346216|12107956|FG000|Overall Study|Other|181
7688853|NCT00346216|12107957|FG001|Overall Study|Other|231
7688854|NCT00346216|12107958|FG002|Overall Study|Other|205
7688855|NCT00346216|12107956|FG000|Overall Study|No longer willing to participate|600
7688856|NCT00346216|12107957|FG001|Overall Study|No longer willing to participate|606
7688857|NCT00346216|12107958|FG002|Overall Study|No longer willing to participate|585
7688858|NCT00346216|12107956|FG000|Overall Study|Withdrawal by Subject|661
7688859|NCT00346216|12107957|FG001|Overall Study|Withdrawal by Subject|692
7688860|NCT00346216|12107958|FG002|Overall Study|Withdrawal by Subject|651
7688861|NCT00346216|12107956|FG000|Overall Study|Lost to Follow-up|611
7688862|NCT00346216|12107957|FG001|Overall Study|Lost to Follow-up|588
7688863|NCT00346216|12107958|FG002|Overall Study|Lost to Follow-up|542
7688864|NCT00346216|12107956|FG000|Overall Study|Physician Decision|80
7688865|NCT00346216|12107957|FG001|Overall Study|Physician Decision|76
7688866|NCT00346216|12107958|FG002|Overall Study|Physician Decision|59
7688867|NCT00346216|12107956|FG000|Overall Study|Does not meet entrance criteria|13
7688868|NCT00346216|12107957|FG001|Overall Study|Does not meet entrance criteria|10
7688869|NCT00346216|12107958|FG002|Overall Study|Does not meet entrance criteria|8
7688870|NCT00346216|12107956|FG000|Overall Study|Death|189
7688871|NCT00346216|12107957|FG001|Overall Study|Death|192
7688872|NCT00346216|12107958|FG002|Overall Study|Death|228
7688873|NCT00346216|12107956|FG000|Overall Study|Study terminated by sponsor|11
7688874|NCT00346216|12107957|FG001|Overall Study|Study terminated by sponsor|4
7688875|NCT00346216|12107958|FG002|Overall Study|Study terminated by sponsor|8
7688876|NCT00346216|12107956|FG000|Overall Study|Missing Subject Summary Status|62
7688877|NCT00346216|12107957|FG001|Overall Study|Missing Subject Summary Status|61
7688878|NCT00346216|12107958|FG002|Overall Study|Missing Subject Summary Status|62
7688879|NCT00346268|12107968|FG000|Overall Study|Adverse Event|1
7688880|NCT00346268|12107969|FG001|Overall Study|Adverse Event|0
7688881|NCT00346268|12107968|FG000|Overall Study|Protocol Violation|1
7688882|NCT00346268|12107969|FG001|Overall Study|Protocol Violation|0
7688883|NCT00346268|12107968|FG000|Overall Study|Participant refused|0
7688884|NCT00346268|12107969|FG001|Overall Study|Participant refused|3
7688885|NCT00346333|12107977|FG000|Overall Study|Death|1
7688886|NCT00346333|12107978|FG001|Overall Study|Death|0
7688887|NCT00346333|12107977|FG000|Overall Study|unwilling or unable to continue|4
7688888|NCT00346333|12107978|FG001|Overall Study|unwilling or unable to continue|8
7688889|NCT00346398|12107988|FG000|Overall Study|Lost to Follow-up|3
7688890|NCT00346398|12107989|FG001|Overall Study|Lost to Follow-up|0
7688891|NCT00346398|12107988|FG000|Overall Study|Withdrawal by Subject|0
7688892|NCT00346398|12107989|FG001|Overall Study|Withdrawal by Subject|2
7688893|NCT00346632|12108001|FG000|Overall Study|Progressive Disease|2
7688894|NCT00346632|12108002|FG001|Overall Study|Progressive Disease|2
7688895|NCT00346632|12108003|FG002|Overall Study|Progressive Disease|4
7688896|NCT00346632|12108004|FG003|Overall Study|Progressive Disease|3
7688897|NCT00346632|12108005|FG004|Overall Study|Progressive Disease|3
7688898|NCT00346632|12108006|FG005|Overall Study|Progressive Disease|1
7688899|NCT00346632|12108007|FG006|Overall Study|Progressive Disease|2
7688900|NCT00346632|12108008|FG007|Overall Study|Progressive Disease|2
7688901|NCT00346632|12108009|FG008|Overall Study|Progressive Disease|2
7688902|NCT00346632|12108010|FG009|Overall Study|Progressive Disease|2
7688903|NCT00346632|12108001|FG000|Overall Study|Adverse Event|0
7688904|NCT00346632|12108002|FG001|Overall Study|Adverse Event|0
7688905|NCT00346632|12108003|FG002|Overall Study|Adverse Event|0
7688906|NCT00346632|12108004|FG003|Overall Study|Adverse Event|0
7688907|NCT00346632|12108005|FG004|Overall Study|Adverse Event|1
7688908|NCT00346632|12108006|FG005|Overall Study|Adverse Event|1
7688909|NCT00346632|12108007|FG006|Overall Study|Adverse Event|1
7688910|NCT00346632|12108008|FG007|Overall Study|Adverse Event|0
7688911|NCT00346632|12108009|FG008|Overall Study|Adverse Event|0
7688912|NCT00346632|12108010|FG009|Overall Study|Adverse Event|0
7688913|NCT00346632|12108001|FG000|Overall Study|Death|0
7688914|NCT00346632|12108002|FG001|Overall Study|Death|0
7688915|NCT00346632|12108003|FG002|Overall Study|Death|1
7688916|NCT00346632|12108004|FG003|Overall Study|Death|0
7688917|NCT00346632|12108005|FG004|Overall Study|Death|0
7688918|NCT00346632|12108006|FG005|Overall Study|Death|0
7688919|NCT00346632|12108007|FG006|Overall Study|Death|0
7688920|NCT00346632|12108008|FG007|Overall Study|Death|0
7688921|NCT00346632|12108009|FG008|Overall Study|Death|0
7688922|NCT00346632|12108010|FG009|Overall Study|Death|0
7688923|NCT00346632|12108001|FG000|Overall Study|Protocol Violation|0
7688924|NCT00346632|12108002|FG001|Overall Study|Protocol Violation|0
7688925|NCT00346632|12108003|FG002|Overall Study|Protocol Violation|0
7688926|NCT00346632|12108004|FG003|Overall Study|Protocol Violation|0
7688927|NCT00346632|12108005|FG004|Overall Study|Protocol Violation|0
7688928|NCT00346632|12108006|FG005|Overall Study|Protocol Violation|0
7688929|NCT00346632|12108007|FG006|Overall Study|Protocol Violation|1
7688930|NCT00346632|12108008|FG007|Overall Study|Protocol Violation|0
7688931|NCT00346632|12108009|FG008|Overall Study|Protocol Violation|0
7688932|NCT00346632|12108010|FG009|Overall Study|Protocol Violation|0
7688933|NCT00346632|12108001|FG000|Overall Study|Withdrawal by Subject|0
7688934|NCT00346632|12108002|FG001|Overall Study|Withdrawal by Subject|0
7688935|NCT00346632|12108003|FG002|Overall Study|Withdrawal by Subject|0
7688936|NCT00346632|12108004|FG003|Overall Study|Withdrawal by Subject|0
7688937|NCT00346632|12108005|FG004|Overall Study|Withdrawal by Subject|0
7688938|NCT00346632|12108006|FG005|Overall Study|Withdrawal by Subject|0
7688939|NCT00346632|12108007|FG006|Overall Study|Withdrawal by Subject|1
7688940|NCT00346632|12108008|FG007|Overall Study|Withdrawal by Subject|0
7688941|NCT00346632|12108009|FG008|Overall Study|Withdrawal by Subject|0
7688942|NCT00346632|12108010|FG009|Overall Study|Withdrawal by Subject|0
7688943|NCT00346632|12108001|FG000|Overall Study|Switched to alternative treatment|0
7688944|NCT00346632|12108002|FG001|Overall Study|Switched to alternative treatment|0
7688945|NCT00346632|12108003|FG002|Overall Study|Switched to alternative treatment|1
7688946|NCT00346632|12108004|FG003|Overall Study|Switched to alternative treatment|0
7688947|NCT00346632|12108005|FG004|Overall Study|Switched to alternative treatment|0
7688948|NCT00346632|12108006|FG005|Overall Study|Switched to alternative treatment|0
7688949|NCT00346632|12108007|FG006|Overall Study|Switched to alternative treatment|0
7688950|NCT00346632|12108008|FG007|Overall Study|Switched to alternative treatment|0
7688951|NCT00346632|12108009|FG008|Overall Study|Switched to alternative treatment|0
7688952|NCT00346632|12108010|FG009|Overall Study|Switched to alternative treatment|0
7688953|NCT00346632|12108001|FG000|Overall Study|Not Stated|1
7688954|NCT00346632|12108002|FG001|Overall Study|Not Stated|1
7688955|NCT00346632|12108003|FG002|Overall Study|Not Stated|0
7688956|NCT00346632|12108004|FG003|Overall Study|Not Stated|0
7688957|NCT00346632|12108005|FG004|Overall Study|Not Stated|0
7688958|NCT00346632|12108006|FG005|Overall Study|Not Stated|0
7688959|NCT00346632|12108007|FG006|Overall Study|Not Stated|0
7688960|NCT00346632|12108008|FG007|Overall Study|Not Stated|2
7688961|NCT00346632|12108009|FG008|Overall Study|Not Stated|2
7688962|NCT00346632|12108010|FG009|Overall Study|Not Stated|1
7688963|NCT00346697|12108074|FG000|Overall Study|Lost to Follow-up|0
7688964|NCT00346697|12108075|FG001|Overall Study|Lost to Follow-up|1
7688965|NCT00346775|12108083|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1
7688966|NCT00346775|12108084|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1
7688967|NCT00346775|12108083|FG000|Period 1: Intervention Period 1|Protocol Violation|3
7688968|NCT00346775|12108084|FG001|Period 1: Intervention Period 1|Protocol Violation|2
7688969|NCT00346775|12108083|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
7688970|NCT00346775|12108084|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
7688971|NCT00347009|12108098|FG000|Overall Study|Death|1
7688972|NCT00347009|12108098|FG000|Overall Study|Adverse Event|6
7688973|NCT00347009|12108098|FG000|Overall Study|Withdrawal by Subject|3
7688974|NCT00347009|12108098|FG000|Overall Study|Physician Decision|5
7688975|NCT00347009|12108098|FG000|Overall Study|Lost to Follow-up|4
7688976|NCT00347009|12108098|FG000|Overall Study|Protocol Violation|2
7688977|NCT00347009|12108098|FG000|Overall Study|Adverse Laboratory Experience|1
7688978|NCT00347009|12108098|FG000|Overall Study|Insufficient Viral Suppression|3
7688979|NCT00347009|12108098|FG000|Overall Study|Increased ALT/HBV DNA|1
7688980|NCT00347009|12108098|FG000|Overall Study|Serious Adverse Event|1
7688981|NCT00347269|12108113|FG000|Overall Study|Lost to Follow-up|74
7688982|NCT00347269|12108114|FG001|Overall Study|Lost to Follow-up|65
7688983|NCT00347269|12108113|FG000|Overall Study|Withdrawal by Subject|18
7688984|NCT00347269|12108114|FG001|Overall Study|Withdrawal by Subject|38
7688985|NCT00347269|12108113|FG000|Overall Study|Death|2
7688986|NCT00347269|12108114|FG001|Overall Study|Death|3
7688987|NCT00347360|12108139|FG000|Overall Study|Adverse Event|1
7688988|NCT00347360|12108140|FG001|Overall Study|Adverse Event|2
7688989|NCT00347360|12108141|FG002|Overall Study|Adverse Event|0
7688990|NCT00347360|12108142|FG003|Overall Study|Adverse Event|4
7688991|NCT00347360|12108143|FG004|Overall Study|Adverse Event|1
7688992|NCT00347360|12108144|FG005|Overall Study|Adverse Event|2
7688993|NCT00347360|12108145|FG006|Overall Study|Adverse Event|2
7688994|NCT00347360|12108146|FG007|Overall Study|Adverse Event|0
7688995|NCT00347360|12108147|FG008|Overall Study|Adverse Event|2
7688996|NCT00347360|12108148|FG009|Overall Study|Adverse Event|3
7688997|NCT00347360|12108149|FG010|Overall Study|Adverse Event|3
7688998|NCT00347360|12108150|FG011|Overall Study|Adverse Event|1
7688999|NCT00347360|12108151|FG012|Overall Study|Adverse Event|3
7689000|NCT00347360|12108152|FG013|Overall Study|Adverse Event|2
7689001|NCT00347360|12108153|FG014|Overall Study|Adverse Event|2
7689002|NCT00347360|12108139|FG000|Overall Study|Lost to Follow-up|0
7689003|NCT00347360|12108140|FG001|Overall Study|Lost to Follow-up|0
7689004|NCT00347360|12108141|FG002|Overall Study|Lost to Follow-up|0
7689005|NCT00347360|12108142|FG003|Overall Study|Lost to Follow-up|2
7689006|NCT00347360|12108143|FG004|Overall Study|Lost to Follow-up|1
7689007|NCT00347360|12108144|FG005|Overall Study|Lost to Follow-up|1
7689008|NCT00347360|12108145|FG006|Overall Study|Lost to Follow-up|0
7689009|NCT00347360|12108146|FG007|Overall Study|Lost to Follow-up|1
7689010|NCT00347360|12108147|FG008|Overall Study|Lost to Follow-up|1
7689011|NCT00347360|12108148|FG009|Overall Study|Lost to Follow-up|2
7689012|NCT00347360|12108149|FG010|Overall Study|Lost to Follow-up|0
7689013|NCT00347360|12108150|FG011|Overall Study|Lost to Follow-up|0
7689014|NCT00347360|12108151|FG012|Overall Study|Lost to Follow-up|1
7689015|NCT00347360|12108152|FG013|Overall Study|Lost to Follow-up|0
7689016|NCT00347360|12108153|FG014|Overall Study|Lost to Follow-up|0
7689017|NCT00347360|12108139|FG000|Overall Study|Protocol Violation|2
7689018|NCT00347360|12108140|FG001|Overall Study|Protocol Violation|3
7689019|NCT00347360|12108141|FG002|Overall Study|Protocol Violation|1
7689020|NCT00347360|12108142|FG003|Overall Study|Protocol Violation|2
7689021|NCT00347360|12108143|FG004|Overall Study|Protocol Violation|1
7689022|NCT00347360|12108144|FG005|Overall Study|Protocol Violation|2
7689023|NCT00347360|12108145|FG006|Overall Study|Protocol Violation|0
7689024|NCT00347360|12108146|FG007|Overall Study|Protocol Violation|0
7689025|NCT00347360|12108147|FG008|Overall Study|Protocol Violation|1
7689026|NCT00347360|12108148|FG009|Overall Study|Protocol Violation|2
7689027|NCT00347360|12108149|FG010|Overall Study|Protocol Violation|0
7689028|NCT00347360|12108150|FG011|Overall Study|Protocol Violation|0
7689029|NCT00347360|12108151|FG012|Overall Study|Protocol Violation|0
7689030|NCT00347360|12108152|FG013|Overall Study|Protocol Violation|1
7689031|NCT00347360|12108153|FG014|Overall Study|Protocol Violation|0
7689032|NCT00347360|12108139|FG000|Overall Study|Withdrawal by Subject|0
7689033|NCT00347360|12108140|FG001|Overall Study|Withdrawal by Subject|1
7689034|NCT00347360|12108141|FG002|Overall Study|Withdrawal by Subject|2
7689035|NCT00347360|12108142|FG003|Overall Study|Withdrawal by Subject|4
7689036|NCT00347360|12108143|FG004|Overall Study|Withdrawal by Subject|1
7689037|NCT00347360|12108144|FG005|Overall Study|Withdrawal by Subject|2
7689038|NCT00347360|12108145|FG006|Overall Study|Withdrawal by Subject|1
7689039|NCT00347360|12108146|FG007|Overall Study|Withdrawal by Subject|1
7689040|NCT00347360|12108147|FG008|Overall Study|Withdrawal by Subject|1
7689041|NCT00347360|12108148|FG009|Overall Study|Withdrawal by Subject|1
7689042|NCT00347360|12108149|FG010|Overall Study|Withdrawal by Subject|0
7689043|NCT00347360|12108150|FG011|Overall Study|Withdrawal by Subject|3
7689044|NCT00347360|12108151|FG012|Overall Study|Withdrawal by Subject|4
7689045|NCT00347360|12108152|FG013|Overall Study|Withdrawal by Subject|2
7689046|NCT00347360|12108153|FG014|Overall Study|Withdrawal by Subject|1
7689047|NCT00347360|12108139|FG000|Overall Study|Lack of Efficacy|1
7689048|NCT00347360|12108140|FG001|Overall Study|Lack of Efficacy|1
7689049|NCT00347360|12108141|FG002|Overall Study|Lack of Efficacy|3
7689050|NCT00347360|12108142|FG003|Overall Study|Lack of Efficacy|1
7689051|NCT00347360|12108143|FG004|Overall Study|Lack of Efficacy|0
7689052|NCT00347360|12108144|FG005|Overall Study|Lack of Efficacy|1
7689053|NCT00347360|12108145|FG006|Overall Study|Lack of Efficacy|0
7689054|NCT00347360|12108146|FG007|Overall Study|Lack of Efficacy|1
7689055|NCT00347360|12108147|FG008|Overall Study|Lack of Efficacy|1
7689056|NCT00347360|12108148|FG009|Overall Study|Lack of Efficacy|0
7689057|NCT00347360|12108149|FG010|Overall Study|Lack of Efficacy|0
7689058|NCT00347360|12108150|FG011|Overall Study|Lack of Efficacy|0
7689059|NCT00347360|12108151|FG012|Overall Study|Lack of Efficacy|0
7689060|NCT00347360|12108152|FG013|Overall Study|Lack of Efficacy|0
7689061|NCT00347360|12108153|FG014|Overall Study|Lack of Efficacy|0
7689062|NCT00347360|12108139|FG000|Overall Study|Reason not listed/blank|1
7689063|NCT00347360|12108140|FG001|Overall Study|Reason not listed/blank|0
7689064|NCT00347360|12108141|FG002|Overall Study|Reason not listed/blank|0
7689065|NCT00347360|12108142|FG003|Overall Study|Reason not listed/blank|0
7689066|NCT00347360|12108143|FG004|Overall Study|Reason not listed/blank|0
7689067|NCT00347360|12108144|FG005|Overall Study|Reason not listed/blank|0
7689068|NCT00347360|12108145|FG006|Overall Study|Reason not listed/blank|1
7689069|NCT00347360|12108146|FG007|Overall Study|Reason not listed/blank|0
7689070|NCT00347360|12108147|FG008|Overall Study|Reason not listed/blank|0
7689071|NCT00347360|12108148|FG009|Overall Study|Reason not listed/blank|0
7689072|NCT00347360|12108149|FG010|Overall Study|Reason not listed/blank|0
7689073|NCT00347360|12108150|FG011|Overall Study|Reason not listed/blank|0
7689074|NCT00347360|12108151|FG012|Overall Study|Reason not listed/blank|0
7689075|NCT00347360|12108152|FG013|Overall Study|Reason not listed/blank|1
7689076|NCT00347360|12108153|FG014|Overall Study|Reason not listed/blank|0
7689077|NCT00347360|12108139|FG000|Overall Study|Per sponsors instruction|0
7689078|NCT00347360|12108140|FG001|Overall Study|Per sponsors instruction|1
7689079|NCT00347360|12108141|FG002|Overall Study|Per sponsors instruction|0
7689080|NCT00347360|12108142|FG003|Overall Study|Per sponsors instruction|0
7689081|NCT00347360|12108143|FG004|Overall Study|Per sponsors instruction|0
7689082|NCT00347360|12108144|FG005|Overall Study|Per sponsors instruction|0
7689083|NCT00347360|12108145|FG006|Overall Study|Per sponsors instruction|0
7689084|NCT00347360|12108146|FG007|Overall Study|Per sponsors instruction|0
7689085|NCT00347360|12108147|FG008|Overall Study|Per sponsors instruction|0
7689086|NCT00347360|12108148|FG009|Overall Study|Per sponsors instruction|0
7689087|NCT00347360|12108149|FG010|Overall Study|Per sponsors instruction|0
7689088|NCT00347360|12108150|FG011|Overall Study|Per sponsors instruction|0
7689089|NCT00347360|12108151|FG012|Overall Study|Per sponsors instruction|0
7689090|NCT00347360|12108152|FG013|Overall Study|Per sponsors instruction|0
7689091|NCT00347360|12108153|FG014|Overall Study|Per sponsors instruction|0
7689092|NCT00347360|12108139|FG000|Overall Study|P.I. recommended due to blood pressure|0
7689093|NCT00347360|12108140|FG001|Overall Study|P.I. recommended due to blood pressure|0
7689094|NCT00347360|12108141|FG002|Overall Study|P.I. recommended due to blood pressure|0
7689095|NCT00347360|12108142|FG003|Overall Study|P.I. recommended due to blood pressure|0
7689096|NCT00347360|12108143|FG004|Overall Study|P.I. recommended due to blood pressure|1
7689097|NCT00347360|12108144|FG005|Overall Study|P.I. recommended due to blood pressure|0
7689098|NCT00347360|12108145|FG006|Overall Study|P.I. recommended due to blood pressure|0
7689099|NCT00347360|12108146|FG007|Overall Study|P.I. recommended due to blood pressure|0
7689100|NCT00347360|12108147|FG008|Overall Study|P.I. recommended due to blood pressure|0
7689101|NCT00347360|12108148|FG009|Overall Study|P.I. recommended due to blood pressure|0
7689102|NCT00347360|12108149|FG010|Overall Study|P.I. recommended due to blood pressure|0
7689103|NCT00347360|12108150|FG011|Overall Study|P.I. recommended due to blood pressure|0
7689104|NCT00347360|12108151|FG012|Overall Study|P.I. recommended due to blood pressure|0
7689105|NCT00347360|12108152|FG013|Overall Study|P.I. recommended due to blood pressure|0
7689106|NCT00347360|12108153|FG014|Overall Study|P.I. recommended due to blood pressure|0
7689107|NCT00347360|12108139|FG000|Overall Study|Subject did not meet end of study ABPM|0
7689108|NCT00347360|12108140|FG001|Overall Study|Subject did not meet end of study ABPM|0
7689109|NCT00347360|12108141|FG002|Overall Study|Subject did not meet end of study ABPM|0
7689110|NCT00347360|12108142|FG003|Overall Study|Subject did not meet end of study ABPM|0
7689111|NCT00347360|12108143|FG004|Overall Study|Subject did not meet end of study ABPM|0
7689112|NCT00347360|12108144|FG005|Overall Study|Subject did not meet end of study ABPM|0
7689113|NCT00347360|12108145|FG006|Overall Study|Subject did not meet end of study ABPM|1
7689114|NCT00347360|12108146|FG007|Overall Study|Subject did not meet end of study ABPM|0
7689115|NCT00347360|12108147|FG008|Overall Study|Subject did not meet end of study ABPM|0
7689116|NCT00347360|12108148|FG009|Overall Study|Subject did not meet end of study ABPM|0
7689117|NCT00347360|12108149|FG010|Overall Study|Subject did not meet end of study ABPM|1
7689118|NCT00347360|12108150|FG011|Overall Study|Subject did not meet end of study ABPM|0
7689119|NCT00347360|12108151|FG012|Overall Study|Subject did not meet end of study ABPM|1
7689120|NCT00347360|12108152|FG013|Overall Study|Subject did not meet end of study ABPM|1
7689121|NCT00347360|12108153|FG014|Overall Study|Subject did not meet end of study ABPM|0
7689122|NCT00347360|12108139|FG000|Overall Study|Abnormal lab values|0
7689123|NCT00347360|12108140|FG001|Overall Study|Abnormal lab values|0
7689124|NCT00347360|12108141|FG002|Overall Study|Abnormal lab values|0
7689125|NCT00347360|12108142|FG003|Overall Study|Abnormal lab values|0
7689126|NCT00347360|12108143|FG004|Overall Study|Abnormal lab values|0
7689127|NCT00347360|12108144|FG005|Overall Study|Abnormal lab values|0
7689128|NCT00347360|12108145|FG006|Overall Study|Abnormal lab values|1
7689129|NCT00347360|12108146|FG007|Overall Study|Abnormal lab values|0
7689130|NCT00347360|12108147|FG008|Overall Study|Abnormal lab values|0
7689131|NCT00347360|12108148|FG009|Overall Study|Abnormal lab values|0
7689132|NCT00347360|12108149|FG010|Overall Study|Abnormal lab values|0
7689133|NCT00347360|12108150|FG011|Overall Study|Abnormal lab values|0
7689134|NCT00347360|12108151|FG012|Overall Study|Abnormal lab values|0
7689135|NCT00347360|12108152|FG013|Overall Study|Abnormal lab values|0
7689136|NCT00347360|12108153|FG014|Overall Study|Abnormal lab values|0
7689137|NCT00347360|12108139|FG000|Overall Study|PI recommended early withdrawal|0
7689138|NCT00347360|12108140|FG001|Overall Study|PI recommended early withdrawal|0
7689139|NCT00347360|12108141|FG002|Overall Study|PI recommended early withdrawal|0
7689140|NCT00347360|12108142|FG003|Overall Study|PI recommended early withdrawal|0
7689141|NCT00347360|12108143|FG004|Overall Study|PI recommended early withdrawal|0
7689142|NCT00347360|12108144|FG005|Overall Study|PI recommended early withdrawal|0
7689143|NCT00347360|12108145|FG006|Overall Study|PI recommended early withdrawal|0
7689144|NCT00347360|12108146|FG007|Overall Study|PI recommended early withdrawal|0
7689145|NCT00347360|12108147|FG008|Overall Study|PI recommended early withdrawal|0
7689146|NCT00347360|12108148|FG009|Overall Study|PI recommended early withdrawal|1
7689147|NCT00347360|12108149|FG010|Overall Study|PI recommended early withdrawal|0
7689148|NCT00347360|12108150|FG011|Overall Study|PI recommended early withdrawal|0
7689149|NCT00347360|12108151|FG012|Overall Study|PI recommended early withdrawal|0
7689150|NCT00347360|12108152|FG013|Overall Study|PI recommended early withdrawal|0
7689151|NCT00347360|12108153|FG014|Overall Study|PI recommended early withdrawal|0
7689152|NCT00347360|12108139|FG000|Overall Study|Did not meet criteria before ABPM|0
7689153|NCT00347360|12108140|FG001|Overall Study|Did not meet criteria before ABPM|0
7689154|NCT00347360|12108141|FG002|Overall Study|Did not meet criteria before ABPM|0
7689155|NCT00347360|12108142|FG003|Overall Study|Did not meet criteria before ABPM|0
7689156|NCT00347360|12108143|FG004|Overall Study|Did not meet criteria before ABPM|0
7689157|NCT00347360|12108144|FG005|Overall Study|Did not meet criteria before ABPM|0
7689158|NCT00347360|12108145|FG006|Overall Study|Did not meet criteria before ABPM|0
7689159|NCT00347360|12108146|FG007|Overall Study|Did not meet criteria before ABPM|0
7689160|NCT00347360|12108147|FG008|Overall Study|Did not meet criteria before ABPM|0
7689161|NCT00347360|12108148|FG009|Overall Study|Did not meet criteria before ABPM|0
7689162|NCT00347360|12108149|FG010|Overall Study|Did not meet criteria before ABPM|1
7689163|NCT00347360|12108150|FG011|Overall Study|Did not meet criteria before ABPM|0
7689164|NCT00347360|12108151|FG012|Overall Study|Did not meet criteria before ABPM|0
7689165|NCT00347360|12108152|FG013|Overall Study|Did not meet criteria before ABPM|0
7689166|NCT00347360|12108153|FG014|Overall Study|Did not meet criteria before ABPM|0
7689167|NCT00347360|12108139|FG000|Overall Study|Randomized in error|0
7689168|NCT00347360|12108140|FG001|Overall Study|Randomized in error|0
7689169|NCT00347360|12108141|FG002|Overall Study|Randomized in error|0
7689170|NCT00347360|12108142|FG003|Overall Study|Randomized in error|0
7689171|NCT00347360|12108143|FG004|Overall Study|Randomized in error|0
7689172|NCT00347360|12108144|FG005|Overall Study|Randomized in error|0
7689173|NCT00347360|12108145|FG006|Overall Study|Randomized in error|0
7689174|NCT00347360|12108146|FG007|Overall Study|Randomized in error|0
7689175|NCT00347360|12108147|FG008|Overall Study|Randomized in error|0
7689176|NCT00347360|12108148|FG009|Overall Study|Randomized in error|0
7689177|NCT00347360|12108149|FG010|Overall Study|Randomized in error|0
7689178|NCT00347360|12108150|FG011|Overall Study|Randomized in error|1
7689179|NCT00347360|12108151|FG012|Overall Study|Randomized in error|0
7689180|NCT00347360|12108152|FG013|Overall Study|Randomized in error|0
7689181|NCT00347360|12108153|FG014|Overall Study|Randomized in error|0
7689182|NCT00347360|12108139|FG000|Overall Study|Failed inclusion criteria #4|0
7689183|NCT00347360|12108140|FG001|Overall Study|Failed inclusion criteria #4|0
7689184|NCT00347360|12108141|FG002|Overall Study|Failed inclusion criteria #4|0
7689185|NCT00347360|12108142|FG003|Overall Study|Failed inclusion criteria #4|0
7689186|NCT00347360|12108143|FG004|Overall Study|Failed inclusion criteria #4|0
7689187|NCT00347360|12108144|FG005|Overall Study|Failed inclusion criteria #4|0
7689188|NCT00347360|12108145|FG006|Overall Study|Failed inclusion criteria #4|0
7689189|NCT00347360|12108146|FG007|Overall Study|Failed inclusion criteria #4|0
7689190|NCT00347360|12108147|FG008|Overall Study|Failed inclusion criteria #4|0
7689191|NCT00347360|12108148|FG009|Overall Study|Failed inclusion criteria #4|0
7689192|NCT00347360|12108149|FG010|Overall Study|Failed inclusion criteria #4|0
7689193|NCT00347360|12108150|FG011|Overall Study|Failed inclusion criteria #4|1
7689194|NCT00347360|12108151|FG012|Overall Study|Failed inclusion criteria #4|0
7689195|NCT00347360|12108152|FG013|Overall Study|Failed inclusion criteria #4|0
7689196|NCT00347360|12108153|FG014|Overall Study|Failed inclusion criteria #4|0
7689197|NCT00347360|12108139|FG000|Overall Study|Prolonged duration between visits|0
7689198|NCT00347360|12108140|FG001|Overall Study|Prolonged duration between visits|0
7689199|NCT00347360|12108141|FG002|Overall Study|Prolonged duration between visits|0
7689200|NCT00347360|12108142|FG003|Overall Study|Prolonged duration between visits|0
7689201|NCT00347360|12108143|FG004|Overall Study|Prolonged duration between visits|0
7689202|NCT00347360|12108144|FG005|Overall Study|Prolonged duration between visits|0
7689203|NCT00347360|12108145|FG006|Overall Study|Prolonged duration between visits|0
7689204|NCT00347360|12108146|FG007|Overall Study|Prolonged duration between visits|0
7689205|NCT00347360|12108147|FG008|Overall Study|Prolonged duration between visits|0
7689206|NCT00347360|12108148|FG009|Overall Study|Prolonged duration between visits|0
7689207|NCT00347360|12108149|FG010|Overall Study|Prolonged duration between visits|0
7689208|NCT00347360|12108150|FG011|Overall Study|Prolonged duration between visits|0
7689209|NCT00347360|12108151|FG012|Overall Study|Prolonged duration between visits|1
7689210|NCT00347360|12108152|FG013|Overall Study|Prolonged duration between visits|0
7689211|NCT00347360|12108153|FG014|Overall Study|Prolonged duration between visits|0
7689212|NCT00347360|12108139|FG000|Overall Study|Subject left town, ran out of study drug|0
7689213|NCT00347360|12108140|FG001|Overall Study|Subject left town, ran out of study drug|0
7689214|NCT00347360|12108141|FG002|Overall Study|Subject left town, ran out of study drug|0
7689215|NCT00347360|12108142|FG003|Overall Study|Subject left town, ran out of study drug|0
7689216|NCT00347360|12108143|FG004|Overall Study|Subject left town, ran out of study drug|0
7689217|NCT00347360|12108144|FG005|Overall Study|Subject left town, ran out of study drug|0
7689218|NCT00347360|12108145|FG006|Overall Study|Subject left town, ran out of study drug|0
7689219|NCT00347360|12108146|FG007|Overall Study|Subject left town, ran out of study drug|0
7689220|NCT00347360|12108147|FG008|Overall Study|Subject left town, ran out of study drug|0
7689221|NCT00347360|12108148|FG009|Overall Study|Subject left town, ran out of study drug|0
7689222|NCT00347360|12108149|FG010|Overall Study|Subject left town, ran out of study drug|0
7689223|NCT00347360|12108150|FG011|Overall Study|Subject left town, ran out of study drug|0
7689224|NCT00347360|12108151|FG012|Overall Study|Subject left town, ran out of study drug|0
7689225|NCT00347360|12108152|FG013|Overall Study|Subject left town, ran out of study drug|1
7689226|NCT00347360|12108153|FG014|Overall Study|Subject left town, ran out of study drug|0
7689227|NCT00347360|12108139|FG000|Overall Study|Subject refuse to sign updated consent|0
7689228|NCT00347360|12108140|FG001|Overall Study|Subject refuse to sign updated consent|0
7689229|NCT00347360|12108141|FG002|Overall Study|Subject refuse to sign updated consent|0
7689230|NCT00347360|12108142|FG003|Overall Study|Subject refuse to sign updated consent|0
7689231|NCT00347360|12108143|FG004|Overall Study|Subject refuse to sign updated consent|0
7689232|NCT00347360|12108144|FG005|Overall Study|Subject refuse to sign updated consent|0
7689233|NCT00347360|12108145|FG006|Overall Study|Subject refuse to sign updated consent|0
7689234|NCT00347360|12108146|FG007|Overall Study|Subject refuse to sign updated consent|0
7689235|NCT00347360|12108147|FG008|Overall Study|Subject refuse to sign updated consent|0
7689236|NCT00347360|12108148|FG009|Overall Study|Subject refuse to sign updated consent|0
7689237|NCT00347360|12108149|FG010|Overall Study|Subject refuse to sign updated consent|0
7689238|NCT00347360|12108150|FG011|Overall Study|Subject refuse to sign updated consent|0
7689239|NCT00347360|12108151|FG012|Overall Study|Subject refuse to sign updated consent|0
7689240|NCT00347360|12108152|FG013|Overall Study|Subject refuse to sign updated consent|0
7689241|NCT00347360|12108153|FG014|Overall Study|Subject refuse to sign updated consent|1
7689242|NCT00347360|12108139|FG000|Overall Study|Visits conflicted with new job|0
7689243|NCT00347360|12108140|FG001|Overall Study|Visits conflicted with new job|0
7689244|NCT00347360|12108141|FG002|Overall Study|Visits conflicted with new job|0
7689245|NCT00347360|12108142|FG003|Overall Study|Visits conflicted with new job|0
7689246|NCT00347360|12108143|FG004|Overall Study|Visits conflicted with new job|0
7689247|NCT00347360|12108144|FG005|Overall Study|Visits conflicted with new job|0
7689248|NCT00347360|12108145|FG006|Overall Study|Visits conflicted with new job|1
7689249|NCT00347360|12108146|FG007|Overall Study|Visits conflicted with new job|0
7689250|NCT00347360|12108147|FG008|Overall Study|Visits conflicted with new job|0
7689251|NCT00347360|12108148|FG009|Overall Study|Visits conflicted with new job|0
7689252|NCT00347360|12108149|FG010|Overall Study|Visits conflicted with new job|0
7689253|NCT00347360|12108150|FG011|Overall Study|Visits conflicted with new job|0
7689254|NCT00347360|12108151|FG012|Overall Study|Visits conflicted with new job|0
7689255|NCT00347360|12108152|FG013|Overall Study|Visits conflicted with new job|0
7689256|NCT00347360|12108153|FG014|Overall Study|Visits conflicted with new job|0
7689257|NCT00347438|12108185|FG000|Overall Study|Withdrawal by Subject|1
7689258|NCT00347438|12108185|FG000|Overall Study|Physician Decision|1
7689259|NCT00347776|12108192|FG000|1.5 Month Follow-up|Death|2
7689260|NCT00347776|12108193|FG001|1.5 Month Follow-up|Death|0
7689261|NCT00347776|12108194|FG002|1.5 Month Follow-up|Death|0
7689262|NCT00347776|12108192|FG000|1.5 Month Follow-up|reached the endpoint|12
7689263|NCT00347776|12108193|FG001|1.5 Month Follow-up|reached the endpoint|8
7689264|NCT00347776|12108194|FG002|1.5 Month Follow-up|reached the endpoint|12
7689265|NCT00347776|12108192|FG000|6 Month Follow-up|Death|2
7689266|NCT00347776|12108193|FG001|6 Month Follow-up|Death|1
7689267|NCT00347776|12108194|FG002|6 Month Follow-up|Death|3
7689268|NCT00347776|12108192|FG000|6 Month Follow-up|reached endpont|20
7689269|NCT00347776|12108193|FG001|6 Month Follow-up|reached endpont|12
7689270|NCT00347776|12108194|FG002|6 Month Follow-up|reached endpont|15
7689271|NCT00347776|12108192|FG000|12 Month Follow-up|Lost to Follow-up|7
7689272|NCT00347776|12108193|FG001|12 Month Follow-up|Lost to Follow-up|6
7689273|NCT00347776|12108194|FG002|12 Month Follow-up|Lost to Follow-up|6
7689274|NCT00347776|12108192|FG000|12 Month Follow-up|Death|3
7689275|NCT00347776|12108193|FG001|12 Month Follow-up|Death|4
7689276|NCT00347776|12108194|FG002|12 Month Follow-up|Death|4
7689277|NCT00347776|12108192|FG000|12 Month Follow-up|Reached endpoint|13
7689278|NCT00347776|12108193|FG001|12 Month Follow-up|Reached endpoint|6
7689279|NCT00347776|12108194|FG002|12 Month Follow-up|Reached endpoint|9
7689280|NCT00347919|12108205|FG000|Overall Study|Lost to Follow-up|11
7689281|NCT00347919|12108206|FG001|Overall Study|Lost to Follow-up|13
7689282|NCT00347919|12108207|FG002|Overall Study|Lost to Follow-up|0
7689283|NCT00347919|12108205|FG000|Overall Study|Withdrawal by Subject|6
7689284|NCT00347919|12108206|FG001|Overall Study|Withdrawal by Subject|8
7689285|NCT00347919|12108207|FG002|Overall Study|Withdrawal by Subject|0
7689286|NCT00347919|12108205|FG000|Overall Study|Physician Decision|1
7689287|NCT00347919|12108206|FG001|Overall Study|Physician Decision|1
7689288|NCT00347919|12108207|FG002|Overall Study|Physician Decision|0
7689289|NCT00347919|12108205|FG000|Overall Study|Sponsor terminated study|15
7689290|NCT00347919|12108206|FG001|Overall Study|Sponsor terminated study|10
7689291|NCT00347919|12108207|FG002|Overall Study|Sponsor terminated study|16
7689292|NCT00347919|12108205|FG000|Overall Study|Death|35
7689293|NCT00347919|12108206|FG001|Overall Study|Death|42
7689294|NCT00347919|12108207|FG002|Overall Study|Death|19
7689295|NCT00347919|12108205|FG000|Overall Study|Par. Started Other Treatment|1
7689296|NCT00347919|12108206|FG001|Overall Study|Par. Started Other Treatment|1
7689297|NCT00347919|12108207|FG002|Overall Study|Par. Started Other Treatment|1
7689298|NCT00347919|12108205|FG000|Overall Study|Missing|2
7689299|NCT00347919|12108206|FG001|Overall Study|Missing|1
7689300|NCT00347919|12108207|FG002|Overall Study|Missing|2
7689301|NCT00347932|12108219|FG000|Overall Study|Adverse Event|4
7689302|NCT00347932|12108220|FG001|Overall Study|Adverse Event|5
7689303|NCT00347932|12108219|FG000|Overall Study|Lack of Efficacy|3
7689304|NCT00347932|12108220|FG001|Overall Study|Lack of Efficacy|14
7689305|NCT00347932|12108219|FG000|Overall Study|Lost to Follow-up|10
7689306|NCT00347932|12108220|FG001|Overall Study|Lost to Follow-up|9
7689307|NCT00347932|12108219|FG000|Overall Study|Withdrawal by Subject|10
7689308|NCT00347932|12108220|FG001|Overall Study|Withdrawal by Subject|16
7689309|NCT00347932|12108219|FG000|Overall Study|Did not meet inclusion criteria|4
7689310|NCT00347932|12108220|FG001|Overall Study|Did not meet inclusion criteria|8
7689311|NCT00347958|12108226|FG000|Overall Study|Adverse Event|1
7689312|NCT00347958|12108226|FG000|Overall Study|Protocol Violation|2
7689313|NCT00347958|12108226|FG000|Overall Study|Withdrawal by Subject|1
7689314|NCT00348140|12108233|FG000|Overall Study|Adverse Event|46
7689315|NCT00348140|12108234|FG001|Overall Study|Adverse Event|49
7689316|NCT00348140|12108235|FG002|Overall Study|Adverse Event|78
7689317|NCT00348140|12108233|FG000|Overall Study|Lost to Follow-up|4
7689318|NCT00348140|12108234|FG001|Overall Study|Lost to Follow-up|4
7689319|NCT00348140|12108235|FG002|Overall Study|Lost to Follow-up|4
7689320|NCT00348140|12108233|FG000|Overall Study|Protocol Violation|12
7689321|NCT00348140|12108234|FG001|Overall Study|Protocol Violation|13
7689322|NCT00348140|12108235|FG002|Overall Study|Protocol Violation|14
7689323|NCT00348140|12108233|FG000|Overall Study|Withdrawal by Subject|32
7689324|NCT00348140|12108234|FG001|Overall Study|Withdrawal by Subject|40
7689325|NCT00348140|12108235|FG002|Overall Study|Withdrawal by Subject|40
7689326|NCT00348140|12108233|FG000|Overall Study|Non-compliance|8
7689327|NCT00348140|12108234|FG001|Overall Study|Non-compliance|13
7689328|NCT00348140|12108235|FG002|Overall Study|Non-compliance|5
7689329|NCT00348140|12108233|FG000|Overall Study|Participant at risk due to study drug|2
7689330|NCT00348140|12108234|FG001|Overall Study|Participant at risk due to study drug|0
7689331|NCT00348140|12108235|FG002|Overall Study|Participant at risk due to study drug|0
7689332|NCT00348140|12108233|FG000|Overall Study|Conditional medication increased dose|1
7689333|NCT00348140|12108234|FG001|Overall Study|Conditional medication increased dose|0
7689334|NCT00348140|12108235|FG002|Overall Study|Conditional medication increased dose|0
7689335|NCT00348140|12108233|FG000|Overall Study|Caregiver related|4
7689336|NCT00348140|12108234|FG001|Overall Study|Caregiver related|7
7689337|NCT00348140|12108235|FG002|Overall Study|Caregiver related|3
7689338|NCT00348140|12108233|FG000|Overall Study|Participant hospitalised|3
7689339|NCT00348140|12108234|FG001|Overall Study|Participant hospitalised|0
7689340|NCT00348140|12108235|FG002|Overall Study|Participant hospitalised|0
7689341|NCT00348140|12108233|FG000|Overall Study|Efficacy related|1
7689342|NCT00348140|12108234|FG001|Overall Study|Efficacy related|1
7689343|NCT00348140|12108235|FG002|Overall Study|Efficacy related|0
7689344|NCT00348140|12108233|FG000|Overall Study|Administration related|3
7689345|NCT00348140|12108234|FG001|Overall Study|Administration related|1
7689346|NCT00348140|12108235|FG002|Overall Study|Administration related|1
7689347|NCT00348140|12108233|FG000|Overall Study|Unmet inclusion-exclusion criteria|1
7689348|NCT00348140|12108234|FG001|Overall Study|Unmet inclusion-exclusion criteria|0
7689349|NCT00348140|12108235|FG002|Overall Study|Unmet inclusion-exclusion criteria|1
7689350|NCT00348140|12108233|FG000|Overall Study|Participant unwell|1
7689351|NCT00348140|12108234|FG001|Overall Study|Participant unwell|0
7689352|NCT00348140|12108235|FG002|Overall Study|Participant unwell|0
7689353|NCT00348140|12108233|FG000|Overall Study|Screen failure|1
7689354|NCT00348140|12108234|FG001|Overall Study|Screen failure|0
7689355|NCT00348140|12108235|FG002|Overall Study|Screen failure|0
7689356|NCT00348140|12108233|FG000|Overall Study|Investigator decided to discontinue|4
7689357|NCT00348140|12108234|FG001|Overall Study|Investigator decided to discontinue|1
7689358|NCT00348140|12108235|FG002|Overall Study|Investigator decided to discontinue|4
7689359|NCT00348140|12108233|FG000|Overall Study|Decided to discontinue on their own|1
7689360|NCT00348140|12108234|FG001|Overall Study|Decided to discontinue on their own|4
7689361|NCT00348140|12108235|FG002|Overall Study|Decided to discontinue on their own|1
7689362|NCT00348140|12108233|FG000|Overall Study|Use of prohibited drug|1
7689363|NCT00348140|12108234|FG001|Overall Study|Use of prohibited drug|0
7689364|NCT00348140|12108235|FG002|Overall Study|Use of prohibited drug|2
7689365|NCT00348140|12108233|FG000|Overall Study|Disease progression|1
7689366|NCT00348140|12108234|FG001|Overall Study|Disease progression|2
7689367|NCT00348140|12108235|FG002|Overall Study|Disease progression|5
7689368|NCT00348140|12108233|FG000|Overall Study|Increased risk of cardiac infarction|0
7689369|NCT00348140|12108234|FG001|Overall Study|Increased risk of cardiac infarction|1
7689370|NCT00348140|12108235|FG002|Overall Study|Increased risk of cardiac infarction|0
7689371|NCT00348140|12108233|FG000|Overall Study|Serious adverse event|0
7689372|NCT00348140|12108234|FG001|Overall Study|Serious adverse event|1
7689373|NCT00348140|12108235|FG002|Overall Study|Serious adverse event|0
7689374|NCT00348140|12108233|FG000|Overall Study|Abnormal ECG|0
7689375|NCT00348140|12108234|FG001|Overall Study|Abnormal ECG|1
7689376|NCT00348140|12108235|FG002|Overall Study|Abnormal ECG|3
7689377|NCT00348140|12108233|FG000|Overall Study|Participant died|0
7689378|NCT00348140|12108234|FG001|Overall Study|Participant died|1
7689379|NCT00348140|12108235|FG002|Overall Study|Participant died|0
7689380|NCT00348140|12108233|FG000|Overall Study|Exclusion criteria met|0
7689381|NCT00348140|12108234|FG001|Overall Study|Exclusion criteria met|0
7689382|NCT00348140|12108235|FG002|Overall Study|Exclusion criteria met|1
7689383|NCT00348140|12108233|FG000|Overall Study|Memory declined|0
7689384|NCT00348140|12108234|FG001|Overall Study|Memory declined|0
7689385|NCT00348140|12108235|FG002|Overall Study|Memory declined|1
7689386|NCT00348283|12108250|FG000|Induction|Adverse Event|0
7689387|NCT00348283|12108251|FG001|Induction|Adverse Event|2
7689388|NCT00348283|12108250|FG000|Induction|Protocol Violation|0
7689389|NCT00348283|12108251|FG001|Induction|Protocol Violation|4
7689390|NCT00348283|12108250|FG000|Double Blind|Adverse Event|2
7689391|NCT00348283|12108251|FG001|Double Blind|Adverse Event|5
7689392|NCT00348283|12108250|FG000|Double Blind|Withdrawal by Subject|1
7689393|NCT00348283|12108251|FG001|Double Blind|Withdrawal by Subject|1
7689394|NCT00348283|12108250|FG000|Double Blind|Protocol Violation|0
7689395|NCT00348283|12108251|FG001|Double Blind|Protocol Violation|1
7689396|NCT00348283|12108250|FG000|Double Blind|Lack of Efficacy|2
7689397|NCT00348283|12108251|FG001|Double Blind|Lack of Efficacy|2
7689398|NCT00348283|12108250|FG000|Double Blind|Pregnancy|0
7689399|NCT00348283|12108251|FG001|Double Blind|Pregnancy|1
7689400|NCT00348283|12108250|FG000|Open Label|Adverse Event|0
7689401|NCT00348283|12108251|FG001|Open Label|Adverse Event|8
7689402|NCT00348283|12108250|FG000|Open Label|Withdrawal by Subject|0
7689403|NCT00348283|12108251|FG001|Open Label|Withdrawal by Subject|4
7689404|NCT00348283|12108250|FG000|Open Label|Lost to Follow-up|0
7689405|NCT00348283|12108251|FG001|Open Label|Lost to Follow-up|1
7689406|NCT00348283|12108250|FG000|Open Label|Lack of Efficacy|0
7689407|NCT00348283|12108251|FG001|Open Label|Lack of Efficacy|13
7689408|NCT00348283|12108250|FG000|Open Label|Administrative reasons|0
7689409|NCT00348283|12108251|FG001|Open Label|Administrative reasons|5
7689410|NCT00348283|12108250|FG000|Open Label|Subject moved to the United States|0
7689411|NCT00348283|12108251|FG001|Open Label|Subject moved to the United States|1
7689412|NCT00348283|12108250|FG000|Open Label|Pregnancy|0
7689413|NCT00348283|12108251|FG001|Open Label|Pregnancy|1
7689414|NCT00348283|12108250|FG000|Open Label|Sponsor decision|0
7689415|NCT00348283|12108251|FG001|Open Label|Sponsor decision|1
7689416|NCT00348309|12108260|FG000|Overall Study|Adverse Event|56
7689417|NCT00348309|12108261|FG001|Overall Study|Adverse Event|28
7689418|NCT00348309|12108262|FG002|Overall Study|Adverse Event|63
7689419|NCT00348309|12108260|FG000|Overall Study|Lost to Follow-up|6
7689420|NCT00348309|12108261|FG001|Overall Study|Lost to Follow-up|7
7689421|NCT00348309|12108262|FG002|Overall Study|Lost to Follow-up|4
7689422|NCT00348309|12108260|FG000|Overall Study|Protocol Violation|7
7689423|NCT00348309|12108261|FG001|Overall Study|Protocol Violation|12
7689424|NCT00348309|12108262|FG002|Overall Study|Protocol Violation|7
7689425|NCT00348309|12108260|FG000|Overall Study|Withdrawal by Subject|33
7689426|NCT00348309|12108261|FG001|Overall Study|Withdrawal by Subject|37
7689427|NCT00348309|12108262|FG002|Overall Study|Withdrawal by Subject|40
7689428|NCT00348309|12108260|FG000|Overall Study|Non-compliance|8
7689429|NCT00348309|12108261|FG001|Overall Study|Non-compliance|6
7689430|NCT00348309|12108262|FG002|Overall Study|Non-compliance|8
7689431|NCT00348309|12108260|FG000|Overall Study|Death of caregiver|1
7689432|NCT00348309|12108261|FG001|Overall Study|Death of caregiver|0
7689433|NCT00348309|12108262|FG002|Overall Study|Death of caregiver|1
7689434|NCT00348309|12108260|FG000|Overall Study|Lack of insight, dementia|1
7689435|NCT00348309|12108261|FG001|Overall Study|Lack of insight, dementia|0
7689436|NCT00348309|12108262|FG002|Overall Study|Lack of insight, dementia|0
7689437|NCT00348309|12108260|FG000|Overall Study|Wrong bottle allocated|1
7689438|NCT00348309|12108261|FG001|Overall Study|Wrong bottle allocated|0
7689439|NCT00348309|12108262|FG002|Overall Study|Wrong bottle allocated|0
7689440|NCT00348309|12108260|FG000|Overall Study|Caregiver sick|1
7689441|NCT00348309|12108261|FG001|Overall Study|Caregiver sick|0
7689442|NCT00348309|12108262|FG002|Overall Study|Caregiver sick|0
7689443|NCT00348309|12108260|FG000|Overall Study|Use of prohibited medication|5
7689444|NCT00348309|12108261|FG001|Overall Study|Use of prohibited medication|2
7689445|NCT00348309|12108262|FG002|Overall Study|Use of prohibited medication|2
7689446|NCT00348309|12108260|FG000|Overall Study|Caregiver withdrawal|3
7689447|NCT00348309|12108261|FG001|Overall Study|Caregiver withdrawal|0
7689448|NCT00348309|12108262|FG002|Overall Study|Caregiver withdrawal|7
7689449|NCT00348309|12108260|FG000|Overall Study|Unable to complete ET visit|1
7689450|NCT00348309|12108261|FG001|Overall Study|Unable to complete ET visit|0
7689451|NCT00348309|12108262|FG002|Overall Study|Unable to complete ET visit|0
7689452|NCT00348309|12108260|FG000|Overall Study|PI closing medical practice|1
7689453|NCT00348309|12108261|FG001|Overall Study|PI closing medical practice|0
7689454|NCT00348309|12108262|FG002|Overall Study|PI closing medical practice|0
7689455|NCT00348309|12108260|FG000|Overall Study|Principal investigator's decision|1
7689456|NCT00348309|12108261|FG001|Overall Study|Principal investigator's decision|0
7689457|NCT00348309|12108262|FG002|Overall Study|Principal investigator's decision|0
7689458|NCT00348309|12108260|FG000|Overall Study|No disponibility of medication|1
7689459|NCT00348309|12108261|FG001|Overall Study|No disponibility of medication|0
7689460|NCT00348309|12108262|FG002|Overall Study|No disponibility of medication|0
7689461|NCT00348309|12108260|FG000|Overall Study|Worsened neurodegenerative disease|1
7689462|NCT00348309|12108261|FG001|Overall Study|Worsened neurodegenerative disease|0
7689463|NCT00348309|12108262|FG002|Overall Study|Worsened neurodegenerative disease|0
7689464|NCT00348309|12108260|FG000|Overall Study|Cognitive and behaviour worsening|2
7689465|NCT00348309|12108261|FG001|Overall Study|Cognitive and behaviour worsening|0
7689466|NCT00348309|12108262|FG002|Overall Study|Cognitive and behaviour worsening|0
7689467|NCT00348309|12108260|FG000|Overall Study|Worsening of alzheimer|1
7689468|NCT00348309|12108261|FG001|Overall Study|Worsening of alzheimer|0
7689469|NCT00348309|12108262|FG002|Overall Study|Worsening of alzheimer|1
7689470|NCT00348309|12108260|FG000|Overall Study|Did not appear in time for Visit 3|1
7689471|NCT00348309|12108261|FG001|Overall Study|Did not appear in time for Visit 3|0
7689472|NCT00348309|12108262|FG002|Overall Study|Did not appear in time for Visit 3|0
7689473|NCT00348309|12108260|FG000|Overall Study|Participant died|2
7689474|NCT00348309|12108261|FG001|Overall Study|Participant died|1
7689475|NCT00348309|12108262|FG002|Overall Study|Participant died|1
7689476|NCT00348309|12108260|FG000|Overall Study|Decision of sponsor|1
7689477|NCT00348309|12108261|FG001|Overall Study|Decision of sponsor|0
7689478|NCT00348309|12108262|FG002|Overall Study|Decision of sponsor|0
7689479|NCT00348309|12108260|FG000|Overall Study|Ineffectiveness of treatment|0
7689480|NCT00348309|12108261|FG001|Overall Study|Ineffectiveness of treatment|1
7689481|NCT00348309|12108262|FG002|Overall Study|Ineffectiveness of treatment|0
7689482|NCT00348309|12108260|FG000|Overall Study|A foul of exclusion criteria|0
7689483|NCT00348309|12108261|FG001|Overall Study|A foul of exclusion criteria|1
7689484|NCT00348309|12108262|FG002|Overall Study|A foul of exclusion criteria|0
7689485|NCT00348309|12108260|FG000|Overall Study|Participant was hospitalized|0
7689486|NCT00348309|12108261|FG001|Overall Study|Participant was hospitalized|1
7689487|NCT00348309|12108262|FG002|Overall Study|Participant was hospitalized|0
7689488|NCT00348309|12108260|FG000|Overall Study|Sponsor refuseal|0
7689489|NCT00348309|12108261|FG001|Overall Study|Sponsor refuseal|1
7689490|NCT00348309|12108262|FG002|Overall Study|Sponsor refuseal|1
7689491|NCT00348309|12108260|FG000|Overall Study|Forgot often medication|0
7689492|NCT00348309|12108261|FG001|Overall Study|Forgot often medication|1
7689493|NCT00348309|12108262|FG002|Overall Study|Forgot often medication|0
7689494|NCT00348309|12108260|FG000|Overall Study|Medical Monitor decision|0
7689495|NCT00348309|12108261|FG001|Overall Study|Medical Monitor decision|0
7689496|NCT00348309|12108262|FG002|Overall Study|Medical Monitor decision|1
7689497|NCT00348309|12108260|FG000|Overall Study|Increased dose of Aricept|0
7689498|NCT00348309|12108261|FG001|Overall Study|Increased dose of Aricept|0
7689499|NCT00348309|12108262|FG002|Overall Study|Increased dose of Aricept|1
7689500|NCT00348309|12108260|FG000|Overall Study|Site closure|0
7689501|NCT00348309|12108261|FG001|Overall Study|Site closure|0
7689502|NCT00348309|12108262|FG002|Overall Study|Site closure|1
7689503|NCT00348309|12108260|FG000|Overall Study|Adverse event not attended|0
7689504|NCT00348309|12108261|FG001|Overall Study|Adverse event not attended|0
7689505|NCT00348309|12108262|FG002|Overall Study|Adverse event not attended|1
7689506|NCT00348309|12108260|FG000|Overall Study|ECG abnormal|0
7689507|NCT00348309|12108261|FG001|Overall Study|ECG abnormal|0
7689508|NCT00348309|12108262|FG002|Overall Study|ECG abnormal|2
7689509|NCT00348309|12108260|FG000|Overall Study|Cardiologist recommendations|0
7689510|NCT00348309|12108261|FG001|Overall Study|Cardiologist recommendations|0
7689511|NCT00348309|12108262|FG002|Overall Study|Cardiologist recommendations|1
7689512|NCT00348309|12108260|FG000|Overall Study|HCV career|0
7689513|NCT00348309|12108261|FG001|Overall Study|HCV career|0
7689514|NCT00348309|12108262|FG002|Overall Study|HCV career|1
7689515|NCT00348348|12108273|FG000|Overall Study|Adverse event - unrelated to study drug|0
7689516|NCT00348348|12108274|FG001|Overall Study|Adverse event - unrelated to study drug|1
7689517|NCT00348348|12108273|FG000|Overall Study|Lack of Efficacy|1
7689518|NCT00348348|12108274|FG001|Overall Study|Lack of Efficacy|1
7689519|NCT00348348|12108273|FG000|Overall Study|Lost to Follow-up|8
7689520|NCT00348348|12108274|FG001|Overall Study|Lost to Follow-up|10
7689521|NCT00348348|12108273|FG000|Overall Study|Withdrawal by Subject|4
7689522|NCT00348348|12108274|FG001|Overall Study|Withdrawal by Subject|1
7689523|NCT00348348|12108273|FG000|Overall Study|Other|7
7689524|NCT00348348|12108274|FG001|Overall Study|Other|4
7689525|NCT00348348|12108273|FG000|Overall Study|Dissallowed Meds - unrelated to study|1
7689526|NCT00348348|12108274|FG001|Overall Study|Dissallowed Meds - unrelated to study|3
7689527|NCT00348348|12108273|FG000|Overall Study|Dissallowed Meds - unlikley related|1
7689528|NCT00348348|12108274|FG001|Overall Study|Dissallowed Meds - unlikley related|1
7689529|NCT00348348|12108273|FG000|Overall Study|Dissallowed Meds - possibly releated|1
7689530|NCT00348348|12108274|FG001|Overall Study|Dissallowed Meds - possibly releated|1
7689531|NCT00348348|12108273|FG000|Overall Study|Worsening of BC - Unrelated to study|0
7689532|NCT00348348|12108274|FG001|Overall Study|Worsening of BC - Unrelated to study|3
7689533|NCT00348348|12108273|FG000|Overall Study|Worsening of BC - Unlikely related|1
7689534|NCT00348348|12108274|FG001|Overall Study|Worsening of BC - Unlikely related|2
7689535|NCT00348348|12108273|FG000|Overall Study|Adverse event probably related to study|1
7689536|NCT00348348|12108274|FG001|Overall Study|Adverse event probably related to study|0
7689537|NCT00348374|12108282|FG000|Overall Study|Adverse Event|1
7689538|NCT00348374|12108283|FG001|Overall Study|Adverse Event|4
7689539|NCT00348374|12108282|FG000|Overall Study|Lost to Follow-up|1
7689540|NCT00348374|12108283|FG001|Overall Study|Lost to Follow-up|3
7689541|NCT00348374|12108282|FG000|Overall Study|Withdrawal by Subject|5
7689542|NCT00348374|12108283|FG001|Overall Study|Withdrawal by Subject|5
7689543|NCT00348374|12108282|FG000|Overall Study|Other|11
7689544|NCT00348374|12108283|FG001|Overall Study|Other|12
7689545|NCT00348374|12108282|FG000|Overall Study|ongoing at date of cutoff|1
7689546|NCT00348374|12108283|FG001|Overall Study|ongoing at date of cutoff|1
7689547|NCT00348374|12108282|FG000|Overall Study|randomized but did not receive treatment|0
7689548|NCT00348374|12108283|FG001|Overall Study|randomized but did not receive treatment|7
7689549|NCT00348595|12108292|FG000|Overall Study|Adverse Event|5
7689550|NCT00348595|12108293|FG001|Overall Study|Adverse Event|8
7689551|NCT00348673|12108307|FG000|Stage 1|Randomized but not Treated|0
7689552|NCT00348673|12108308|FG001|Stage 1|Randomized but not Treated|0
7689553|NCT00348673|12108309|FG002|Stage 1|Randomized but not Treated|1
7689554|NCT00348673|12108310|FG003|Stage 1|Randomized but not Treated|0
7689555|NCT00348673|12108311|FG004|Stage 1|Randomized but not Treated|0
7689556|NCT00348673|12108312|FG005|Stage 1|Randomized but not Treated|0
7689557|NCT00348673|12108313|FG006|Stage 1|Randomized but not Treated|0
7689558|NCT00348673|12108314|FG007|Stage 1|Randomized but not Treated|0
7689559|NCT00348673|12108315|FG008|Stage 1|Randomized but not Treated|0
7689560|NCT00348686|12108333|FG000|Overall Study|Withdrawal by Subject|45
7689561|NCT00348686|12108333|FG000|Overall Study|Adverse Event|5
7689562|NCT00348686|12108333|FG000|Overall Study|Protocol Violation|6
7689563|NCT00348686|12108333|FG000|Overall Study|Lost to Follow-up|2
7689564|NCT00348686|12108333|FG000|Overall Study|Multiple Reasons|8
7689565|NCT00348790|12108337|FG000|Completed Treatment|Withdrawal by Subject|4
7689566|NCT00348790|12108337|FG000|Completed Treatment|Disease progression|14
7689567|NCT00348790|12108337|FG000|Completed Treatment|Adverse Event|4
7689568|NCT00348790|12108337|FG000|Completed Treatment|Required surgery|2
7689569|NCT00348790|12108337|FG000|Completed Treatment|Unable to travel to study site|1
7689570|NCT00348816|12108342|FG000|Overall Study|Noncompliance with radiation treatment|1
7689571|NCT00348881|12108350|FG000|Overall Study|Lost to Follow-up|12
7689572|NCT00348881|12108351|FG001|Overall Study|Lost to Follow-up|6
7689573|NCT00348881|12108350|FG000|Overall Study|Withdrawal by Subject|3
7689574|NCT00348881|12108351|FG001|Overall Study|Withdrawal by Subject|4
7689575|NCT00348881|12108350|FG000|Overall Study|Adverse Event|2
7689576|NCT00348881|12108351|FG001|Overall Study|Adverse Event|0
7689577|NCT00348881|12108350|FG000|Overall Study|Serious Adverse Event|0
7689578|NCT00348881|12108351|FG001|Overall Study|Serious Adverse Event|2
7689579|NCT00348933|12108361|FG000|Overall Study|Withdrawal by Subject|10
7689580|NCT00348933|12108361|FG000|Overall Study|Lost to Follow-up|6
7689581|NCT00348933|12108361|FG000|Overall Study|Protocol Violation|2
7689582|NCT00348933|12108361|FG000|Overall Study|Adverse Event|7
7689583|NCT00349349|12108389|FG000|Overall Study|Adverse Event|5
7689584|NCT00349349|12108390|FG001|Overall Study|Adverse Event|6
7689585|NCT00349349|12108391|FG002|Overall Study|Adverse Event|2
7689586|NCT00349349|12108389|FG000|Overall Study|Withdrawal by Subject|5
7689587|NCT00349349|12108390|FG001|Overall Study|Withdrawal by Subject|2
7689588|NCT00349349|12108391|FG002|Overall Study|Withdrawal by Subject|1
7689589|NCT00349349|12108389|FG000|Overall Study|Withdrawn due to Disease Progression|27
7689590|NCT00349349|12108390|FG001|Overall Study|Withdrawn due to Disease Progression|37
7689591|NCT00349349|12108391|FG002|Overall Study|Withdrawn due to Disease Progression|1
7689592|NCT00349349|12108389|FG000|Overall Study|Death|13
7689593|NCT00349349|12108390|FG001|Overall Study|Death|10
7689594|NCT00349349|12108391|FG002|Overall Study|Death|1
7689595|NCT00349349|12108389|FG000|Overall Study|Other Treatment Selected|2
7689596|NCT00349349|12108390|FG001|Overall Study|Other Treatment Selected|0
7689597|NCT00349349|12108391|FG002|Overall Study|Other Treatment Selected|0
7689598|NCT00349349|12108389|FG000|Overall Study|Participant Reduced General Condition|0
7689599|NCT00349349|12108390|FG001|Overall Study|Participant Reduced General Condition|1
7689600|NCT00349349|12108391|FG002|Overall Study|Participant Reduced General Condition|0
7689601|NCT00349349|12108389|FG000|Overall Study|Physician Decision|1
7689602|NCT00349349|12108390|FG001|Overall Study|Physician Decision|2
7689603|NCT00349349|12108391|FG002|Overall Study|Physician Decision|1
7689604|NCT00349349|12108389|FG000|Overall Study|No Response|0
7689605|NCT00349349|12108390|FG001|Overall Study|No Response|3
7689606|NCT00349349|12108391|FG002|Overall Study|No Response|0
7689607|NCT00349349|12108389|FG000|Overall Study|New Malignancy (Bladder Cancer)|0
7689608|NCT00349349|12108390|FG001|Overall Study|New Malignancy (Bladder Cancer)|1
7689609|NCT00349349|12108391|FG002|Overall Study|New Malignancy (Bladder Cancer)|0
7689610|NCT00349622|12108412|FG000|Overall Study|Death|168
7689611|NCT00349622|12108413|FG001|Overall Study|Death|86
7689612|NCT00349622|12108412|FG000|Overall Study|Lost to Follow-up|5
7689613|NCT00349622|12108413|FG001|Overall Study|Lost to Follow-up|1
7689614|NCT00349622|12108412|FG000|Overall Study|Withdrawal by Subject|5
7689615|NCT00349622|12108413|FG001|Overall Study|Withdrawal by Subject|9
7689616|NCT00349752|12108434|FG000|Overall Study|Adverse Event|8
7689617|NCT00349752|12108435|FG001|Overall Study|Adverse Event|12
7689618|NCT00349752|12108434|FG000|Overall Study|Lack of Efficacy|37
7689619|NCT00349752|12108435|FG001|Overall Study|Lack of Efficacy|42
7689620|NCT00349752|12108434|FG000|Overall Study|Lost to Follow-up|4
7689621|NCT00349752|12108435|FG001|Overall Study|Lost to Follow-up|2
7689622|NCT00349752|12108434|FG000|Overall Study|Personal reasons|6
7689623|NCT00349752|12108435|FG001|Overall Study|Personal reasons|5
7689624|NCT00349752|12108434|FG000|Overall Study|Other: Required exclusionary medication|0
7689625|NCT00349752|12108435|FG001|Overall Study|Other: Required exclusionary medication|1
7689626|NCT00349752|12108434|FG000|Overall Study|Other: Non compliance|0
7689627|NCT00349752|12108435|FG001|Overall Study|Other: Non compliance|1
7689628|NCT00349752|12108434|FG000|Overall Study|Other: Patient stopped steroids|0
7689629|NCT00349752|12108435|FG001|Overall Study|Other: Patient stopped steroids|1
7689630|NCT00349752|12108434|FG000|Overall Study|Other: Patient's steroid use|1
7689631|NCT00349752|12108435|FG001|Overall Study|Other: Patient's steroid use|0
7689632|NCT00349752|12108434|FG000|Overall Study|Other: Ineligible|1
7689633|NCT00349752|12108435|FG001|Overall Study|Other: Ineligible|0
7689634|NCT00349752|12108434|FG000|Overall Study|Other: Inadvertently unblinded|1
7689635|NCT00349752|12108435|FG001|Overall Study|Other: Inadvertently unblinded|0
7689636|NCT00349752|12108434|FG000|Overall Study|Other:History of squamous cell carcinoma|1
7689637|NCT00349752|12108435|FG001|Overall Study|Other:History of squamous cell carcinoma|0
7689638|NCT00349908|12108447|FG000|Overall Study|Withdrawal by Subject|0
7689639|NCT00349908|12108448|FG001|Overall Study|Withdrawal by Subject|4
7689640|NCT00349921|12108459|FG000|First Spinal Injection|Physician Decision|1
7689641|NCT00349921|12108460|FG001|First Spinal Injection|Physician Decision|0
7689642|NCT00349921|12108461|FG002|First Spinal Injection|Physician Decision|0
7689643|NCT00349921|12108462|FG003|First Spinal Injection|Physician Decision|0
7689644|NCT00349921|12108459|FG000|First Spinal Injection|Adverse Event|0
7689645|NCT00349921|12108460|FG001|First Spinal Injection|Adverse Event|0
7689646|NCT00349921|12108461|FG002|First Spinal Injection|Adverse Event|1
7689647|NCT00349921|12108462|FG003|First Spinal Injection|Adverse Event|0
7689648|NCT00349973|12108473|FG000|Overall Study|Adverse Event|3
7689649|NCT00349973|12108474|FG001|Overall Study|Adverse Event|3
7689650|NCT00349973|12108473|FG000|Overall Study|Withdrawal by Subject|1
7689651|NCT00349973|12108474|FG001|Overall Study|Withdrawal by Subject|0
7689652|NCT00350207|12108497|FG000|Overall Study|Adverse Event|5
7689653|NCT00350207|12108498|FG001|Overall Study|Adverse Event|2
7689654|NCT00350207|12108499|FG002|Overall Study|Adverse Event|2
7689655|NCT00350207|12108497|FG000|Overall Study|Lack of Efficacy|1
7689656|NCT00350207|12108498|FG001|Overall Study|Lack of Efficacy|0
7689657|NCT00350207|12108499|FG002|Overall Study|Lack of Efficacy|2
7689658|NCT00350207|12108497|FG000|Overall Study|Lost to Follow-up|1
7689659|NCT00350207|12108498|FG001|Overall Study|Lost to Follow-up|0
7689660|NCT00350207|12108499|FG002|Overall Study|Lost to Follow-up|1
7689661|NCT00350207|12108497|FG000|Overall Study|Withdrawal by Subject|0
7689662|NCT00350207|12108498|FG001|Overall Study|Withdrawal by Subject|1
7689663|NCT00350207|12108499|FG002|Overall Study|Withdrawal by Subject|1
7689664|NCT00350207|12108497|FG000|Overall Study|Other|1
7689665|NCT00350207|12108498|FG001|Overall Study|Other|3
7689666|NCT00350207|12108499|FG002|Overall Study|Other|1
7689667|NCT00350272|12108518|FG000|Blinded 12 Week Treatment|Adverse Event|1
7689668|NCT00350272|12108519|FG001|Blinded 12 Week Treatment|Adverse Event|0
7689669|NCT00350272|12108518|FG000|Blinded 12 Week Treatment|Death|1
7689670|NCT00350272|12108519|FG001|Blinded 12 Week Treatment|Death|0
7689671|NCT00350272|12108518|FG000|Blinded 12 Week Treatment|Lost to Follow-up|2
7689672|NCT00350272|12108519|FG001|Blinded 12 Week Treatment|Lost to Follow-up|0
7689673|NCT00350272|12108518|FG000|Blinded 12 Week Treatment|Withdrawal by Subject|3
7689674|NCT00350272|12108519|FG001|Blinded 12 Week Treatment|Withdrawal by Subject|0
7689675|NCT00350272|12108518|FG000|Blinded 12 Week Treatment|Physician Decision|2
7689676|NCT00350272|12108519|FG001|Blinded 12 Week Treatment|Physician Decision|1
7689677|NCT00350272|12108518|FG000|Blinded 12 Week Treatment|Sponsor decision|0
7689678|NCT00350272|12108519|FG001|Blinded 12 Week Treatment|Sponsor decision|1
7689679|NCT00350272|12108518|FG000|Open-Label 84 Week Treatment|Adverse Event|2
7689680|NCT00350272|12108519|FG001|Open-Label 84 Week Treatment|Adverse Event|1
7689681|NCT00350272|12108518|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3
7689682|NCT00350272|12108519|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2
7689683|NCT00350272|12108518|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1
7689684|NCT00350272|12108519|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2
7689685|NCT00350272|12108518|FG000|Open-Label 84 Week Treatment|Physician Decision|1
7689686|NCT00350272|12108519|FG001|Open-Label 84 Week Treatment|Physician Decision|2
7689687|NCT00350272|12108518|FG000|Open-Label 84 Week Treatment|Sponsor decision|2
7689688|NCT00350272|12108519|FG001|Open-Label 84 Week Treatment|Sponsor decision|1
7689689|NCT00350298|12108529|FG000|Overall Study|Death|7
7689690|NCT00350298|12108530|FG001|Overall Study|Death|8
7689691|NCT00350298|12108529|FG000|Overall Study|Lost to Follow-up|1
7689692|NCT00350298|12108530|FG001|Overall Study|Lost to Follow-up|2
7689693|NCT00350298|12108529|FG000|Overall Study|Withdrawal by Subject|1
7689694|NCT00350298|12108530|FG001|Overall Study|Withdrawal by Subject|3
7689695|NCT00350402|12108560|FG000|Overall Study|Lost to Follow-up|1
7689696|NCT00350402|12108561|FG001|Overall Study|Lost to Follow-up|1
7689697|NCT00350519|12108575|FG000|Overall Study|Death|0
7689698|NCT00350519|12108576|FG001|Overall Study|Death|1
7689699|NCT00350519|12108575|FG000|Overall Study|Physician Decision|0
7689700|NCT00350519|12108576|FG001|Overall Study|Physician Decision|1
7689701|NCT00350519|12108575|FG000|Overall Study|Protocol Violation|1
7689702|NCT00350519|12108576|FG001|Overall Study|Protocol Violation|2
7689703|NCT00350519|12108575|FG000|Overall Study|Withdrawal by Subject|3
7689704|NCT00350519|12108576|FG001|Overall Study|Withdrawal by Subject|2
7689705|NCT00350545|12108591|FG000|Overall Study|Withdrawal by Subject|2
7689706|NCT00350636|12108597|FG000|Overall Study|Adverse Event|19
7689707|NCT00350636|12108598|FG001|Overall Study|Adverse Event|13
7689708|NCT00350636|12108597|FG000|Overall Study|Protocol Violation|1
7689709|NCT00350636|12108598|FG001|Overall Study|Protocol Violation|3
7689710|NCT00350636|12108597|FG000|Overall Study|Withdrawal by Subject|13
7689711|NCT00350636|12108598|FG001|Overall Study|Withdrawal by Subject|17
7689712|NCT00350636|12108597|FG000|Overall Study|Lost to Follow-up|9
7689713|NCT00350636|12108598|FG001|Overall Study|Lost to Follow-up|8
7689714|NCT00350636|12108597|FG000|Overall Study|Physician Decision|0
7689715|NCT00350636|12108598|FG001|Overall Study|Physician Decision|2
7689716|NCT00350636|12108597|FG000|Overall Study|Other|1
7689717|NCT00350636|12108598|FG001|Overall Study|Other|2
7689718|NCT00350727|12108607|FG000|Phase I: Dose Escalation|Adverse Event|4
7689719|NCT00350727|12108608|FG001|Phase I: Dose Escalation|Adverse Event|0
7689720|NCT00350727|12108609|FG002|Phase I: Dose Escalation|Adverse Event|0
7689721|NCT00350727|12108607|FG000|Phase I: Dose Escalation|Lack of Efficacy|25
7689722|NCT00350727|12108608|FG001|Phase I: Dose Escalation|Lack of Efficacy|0
7689723|NCT00350727|12108609|FG002|Phase I: Dose Escalation|Lack of Efficacy|0
7689724|NCT00350727|12108607|FG000|Phase I: Dose Escalation|Death|1
7689725|NCT00350727|12108608|FG001|Phase I: Dose Escalation|Death|0
7689726|NCT00350727|12108609|FG002|Phase I: Dose Escalation|Death|0
7689727|NCT00350727|12108607|FG000|Phase I: Dose Escalation|Physician Decision|1
7689728|NCT00350727|12108608|FG001|Phase I: Dose Escalation|Physician Decision|0
7689729|NCT00350727|12108609|FG002|Phase I: Dose Escalation|Physician Decision|0
7689730|NCT00350727|12108607|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3
7689731|NCT00350727|12108608|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0
7689732|NCT00350727|12108609|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0
7689733|NCT00350727|12108607|FG000|Phase II|Disease Progression|0
7689734|NCT00350727|12108608|FG001|Phase II|Disease Progression|15
7689735|NCT00350727|12108609|FG002|Phase II|Disease Progression|16
7689736|NCT00350727|12108607|FG000|Phase II|Clinical Deterioration|0
7689737|NCT00350727|12108608|FG001|Phase II|Clinical Deterioration|1
7689738|NCT00350727|12108609|FG002|Phase II|Clinical Deterioration|0
7689739|NCT00350727|12108607|FG000|Phase II|Withdrawal by Subject|0
7689740|NCT00350727|12108608|FG001|Phase II|Withdrawal by Subject|2
7689741|NCT00350727|12108609|FG002|Phase II|Withdrawal by Subject|1
7689742|NCT00350727|12108607|FG000|Phase II|Adverse Event|0
7689743|NCT00350727|12108608|FG001|Phase II|Adverse Event|1
7689744|NCT00350727|12108609|FG002|Phase II|Adverse Event|1
7689745|NCT00350727|12108607|FG000|Phase II|Death|0
7689746|NCT00350727|12108608|FG001|Phase II|Death|0
7689747|NCT00350727|12108609|FG002|Phase II|Death|2
7689748|NCT00350727|12108607|FG000|Phase II|Sponsor Terminated Study|0
7689749|NCT00350727|12108608|FG001|Phase II|Sponsor Terminated Study|0
7689750|NCT00350727|12108609|FG002|Phase II|Sponsor Terminated Study|1
7689751|NCT00350727|12108607|FG000|Phase II|Enrolled in Rollover Study|0
7689752|NCT00350727|12108608|FG001|Phase II|Enrolled in Rollover Study|0
7689753|NCT00350727|12108609|FG002|Phase II|Enrolled in Rollover Study|1
7689754|NCT00350779|12108630|FG000|Overall Study|Adverse Event|4
7689755|NCT00350779|12108631|FG001|Overall Study|Adverse Event|2
7689756|NCT00350779|12108630|FG000|Overall Study|Lack of Efficacy|0
7689757|NCT00350779|12108631|FG001|Overall Study|Lack of Efficacy|4
7689758|NCT00350779|12108630|FG000|Overall Study|Lost to Follow-up|2
7689759|NCT00350779|12108631|FG001|Overall Study|Lost to Follow-up|0
7689760|NCT00350779|12108630|FG000|Overall Study|Physician Decision|2
7689761|NCT00350779|12108631|FG001|Overall Study|Physician Decision|4
7689762|NCT00350779|12108630|FG000|Overall Study|Protocol Violation|3
7689763|NCT00350779|12108631|FG001|Overall Study|Protocol Violation|1
7689764|NCT00350779|12108630|FG000|Overall Study|Withdrawal by Subject|9
7689765|NCT00350779|12108631|FG001|Overall Study|Withdrawal by Subject|8
7689766|NCT00350779|12108630|FG000|Overall Study|Patient Moved|2
7689767|NCT00350779|12108631|FG001|Overall Study|Patient Moved|1
7689768|NCT00350779|12108630|FG000|Overall Study|Non-compliance with study procedures|0
7689769|NCT00350779|12108631|FG001|Overall Study|Non-compliance with study procedures|1
7689770|NCT00350792|12108639|FG000|Overall Study|Adverse Event|11
7689771|NCT00350792|12108639|FG000|Overall Study|Death from Study Disease|1
7689772|NCT00350792|12108639|FG000|Overall Study|Death from Study Drug Toxicity|1
7689773|NCT00350792|12108639|FG000|Overall Study|Death Not Study Drug Related|2
7689774|NCT00350792|12108639|FG000|Overall Study|Protocol Violation|1
7689775|NCT00350792|12108639|FG000|Overall Study|Withdrawal by Subject|4
7689776|NCT00350792|12108639|FG000|Overall Study|Physician Decision|2
7689777|NCT00350792|12108639|FG000|Overall Study|Lack of Efficacy|11
7689778|NCT00350870|12108647|FG000|Overall Study|Withdrawal by Subject|21
7689779|NCT00350870|12108648|FG001|Overall Study|Withdrawal by Subject|17
7689780|NCT00350870|12108649|FG002|Overall Study|Withdrawal by Subject|15
7689781|NCT00350870|12108650|FG003|Overall Study|Withdrawal by Subject|14
7689782|NCT00350870|12108647|FG000|Overall Study|Physician Decision|1
7689783|NCT00350870|12108648|FG001|Overall Study|Physician Decision|0
7689784|NCT00350870|12108649|FG002|Overall Study|Physician Decision|1
7689785|NCT00350870|12108650|FG003|Overall Study|Physician Decision|1
7689786|NCT00351273|12108675|FG000|Overall Study|Lost to Follow-up|1
7689787|NCT00351273|12108676|FG001|Overall Study|Lost to Follow-up|2
7689788|NCT00351273|12108677|FG002|Overall Study|Lost to Follow-up|5
7689789|NCT00351351|12108705|FG000|Overall Study|surgical access pbs; device issues|9
7689790|NCT00351351|12108706|FG001|Overall Study|surgical access pbs; device issues|4
7689791|NCT00351377|12108712|FG000|Overall Study|Adverse Event|5
7689792|NCT00351377|12108712|FG000|Overall Study|Death|1
7689793|NCT00351377|12108712|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7689794|NCT00351468|12108725|FG000|Overall Study|Adverse Event|42
7689795|NCT00351468|12108725|FG000|Overall Study|Withdrawal by Subject|39
7689796|NCT00351468|12108725|FG000|Overall Study|Various -follow up w clinical team|39
7689797|NCT00351468|12108725|FG000|Overall Study|Lack of Efficacy|32
7689798|NCT00351468|12108725|FG000|Overall Study|Non-compliance|8
7689799|NCT00351468|12108725|FG000|Overall Study|Lost to Follow-up|4
7689800|NCT00351468|12108725|FG000|Overall Study|Protocol Violation|3
7689801|NCT00351533|12108732|FG000|Overall Study|Extubated before first BAL|1
7689802|NCT00351533|12108733|FG001|Overall Study|Extubated before first BAL|0
7689803|NCT00351533|12108732|FG000|Overall Study|Lost to Follow-up|1
7689804|NCT00351533|12108733|FG001|Overall Study|Lost to Follow-up|3
7689805|NCT00351533|12108732|FG000|Overall Study|Physician Decision|0
7689806|NCT00351533|12108733|FG001|Overall Study|Physician Decision|1
7689807|NCT00351533|12108732|FG000|Overall Study|Withdrawal by Subject|0
7689808|NCT00351533|12108733|FG001|Overall Study|Withdrawal by Subject|1
7689809|NCT00351611|12108741|FG000|Overall Study|Adverse Event|11
7689810|NCT00351611|12108742|FG001|Overall Study|Adverse Event|3
7689811|NCT00351611|12108741|FG000|Overall Study|Death|1
7689812|NCT00351611|12108742|FG001|Overall Study|Death|0
7689813|NCT00351611|12108741|FG000|Overall Study|Lost to Follow-up|1
7689814|NCT00351611|12108742|FG001|Overall Study|Lost to Follow-up|0
7689815|NCT00351611|12108741|FG000|Overall Study|No Longer Willing to Participate in Study|0
7689816|NCT00351611|12108742|FG001|Overall Study|No Longer Willing to Participate in Study|5
7689817|NCT00351611|12108741|FG000|Overall Study|Other|1
7689818|NCT00351611|12108742|FG001|Overall Study|Other|0
7689819|NCT00351611|12108741|FG000|Overall Study|Protocol Violation|0
7689820|NCT00351611|12108742|FG001|Overall Study|Protocol Violation|2
7689821|NCT00351819|12108759|FG000|Overall Study|Lost to Follow-up|4
7689822|NCT00351819|12108760|FG001|Overall Study|Lost to Follow-up|4
7689823|NCT00351819|12108759|FG000|Overall Study|Withdrawal by Subject|0
7689824|NCT00351819|12108760|FG001|Overall Study|Withdrawal by Subject|4
7689825|NCT00351819|12108759|FG000|Overall Study|Elevated PSA|1
7689826|NCT00351819|12108760|FG001|Overall Study|Elevated PSA|1
7689827|NCT00351819|12108759|FG000|Overall Study|Traumatic ankle fracture|1
7689828|NCT00351819|12108760|FG001|Overall Study|Traumatic ankle fracture|0
7689829|NCT00351819|12108759|FG000|Overall Study|Unprofessional behavior|1
7689830|NCT00351819|12108760|FG001|Overall Study|Unprofessional behavior|0
7689831|NCT00351819|12108759|FG000|Overall Study|Non-compliance|0
7689832|NCT00351819|12108760|FG001|Overall Study|Non-compliance|1
7689833|NCT00351819|12108759|FG000|Overall Study|Incarcerated|0
7689834|NCT00351819|12108760|FG001|Overall Study|Incarcerated|1
7689835|NCT00351819|12108759|FG000|Overall Study|Enrolled in another trial|0
7689836|NCT00351819|12108760|FG001|Overall Study|Enrolled in another trial|1
7689837|NCT00352053|12108777|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14
7689838|NCT00352053|12108778|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10
7689839|NCT00352053|12108777|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2
7689840|NCT00352053|12108778|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2
7689841|NCT00352053|12108777|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1
7689842|NCT00352053|12108778|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0
7689843|NCT00352053|12108777|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
7689844|NCT00352053|12108778|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
7689845|NCT00352053|12108777|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
7689846|NCT00352053|12108778|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
7689847|NCT00352053|12108777|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9
7689848|NCT00352053|12108778|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13
7689849|NCT00352053|12108777|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
7689850|NCT00352053|12108778|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
7689851|NCT00352053|12108777|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1
7689852|NCT00352053|12108778|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0
7689853|NCT00352053|12108777|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
7689854|NCT00352053|12108778|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
7689855|NCT00352053|12108777|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4
7689856|NCT00352053|12108778|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4
7689857|NCT00352053|12108777|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
7689858|NCT00352053|12108778|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
7689859|NCT00352053|12108777|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
7689860|NCT00352053|12108778|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
7689861|NCT00352053|12108777|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
7689862|NCT00352053|12108778|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
7689863|NCT00352105|12108792|FG000|Overall Study|Death|5
7689864|NCT00352105|12108792|FG000|Overall Study|Withdrawal by Subject|5
7689865|NCT00352105|12108792|FG000|Overall Study|Lack of Efficacy|9
7689866|NCT00352105|12108792|FG000|Overall Study|Adverse Event|19
7689867|NCT00352105|12108792|FG000|Overall Study|Protocol Violation|2
7689868|NCT00352365|12108796|FG000|Induction Therapy|Adverse Event|7
7689869|NCT00352365|12108796|FG000|Induction Therapy|Progression/Relapse|8
7689870|NCT00352365|12108796|FG000|Induction Therapy|Death|7
7689871|NCT00352365|12108796|FG000|Induction Therapy|Not protocol specified|1
7689872|NCT00352365|12108796|FG000|Induction Therapy|Not eligible|3
7689873|NCT00352365|12108796|FG000|Induction Therapy|Death before starting protocol therapy|1
7689874|NCT00352365|12108796|FG000|Maintenance Therapy|Progression/Relapse|3
7689875|NCT00352365|12108796|FG000|Maintenance Therapy|Death|2
7689876|NCT00352365|12108796|FG000|Maintenance Therapy|Not protocol specified|3
7689877|NCT00352365|12108796|FG000|Maintenance Therapy|Not eligible|4
7689878|NCT00352417|12108806|FG000|Overall Study|Adverse Event|1
7689879|NCT00352417|12108807|FG001|Overall Study|Adverse Event|0
7689880|NCT00352417|12108806|FG000|Overall Study|Protocol Violation|0
7689881|NCT00352417|12108807|FG001|Overall Study|Protocol Violation|2
7689882|NCT00352417|12108806|FG000|Overall Study|Withdrawal by Subject|1
7689883|NCT00352417|12108807|FG001|Overall Study|Withdrawal by Subject|2
7689884|NCT00352417|12108806|FG000|Overall Study|Lost to Follow-up|1
7689885|NCT00352417|12108807|FG001|Overall Study|Lost to Follow-up|0
7689886|NCT00352417|12108806|FG000|Overall Study|Schedule Change|2
7689887|NCT00352417|12108807|FG001|Overall Study|Schedule Change|1
7689888|NCT00352664|12108824|FG000|Overall Study|Withdrawal by Subject|7
7689889|NCT00352664|12108825|FG001|Overall Study|Withdrawal by Subject|0
7689890|NCT00352690|12108833|FG000|Overall Study|Determined to be ineligible|2
7689891|NCT00352690|12108834|FG001|Overall Study|Determined to be ineligible|0
7689892|NCT00352755|12108840|FG000|Overall Study|Physician Decision|1
7689893|NCT00352755|12108840|FG000|Overall Study|Adverse Event|1
7689894|NCT00352846|12108854|FG000|Overall Study|Disease progression|0
7689895|NCT00352846|12108855|FG001|Overall Study|Disease progression|2
7689896|NCT00352846|12108854|FG000|Overall Study|Withdrawal by Subject|3
7689897|NCT00352846|12108855|FG001|Overall Study|Withdrawal by Subject|8
7689898|NCT00352846|12108854|FG000|Overall Study|Ineligible|3
7689899|NCT00352846|12108855|FG001|Overall Study|Ineligible|2
7689900|NCT00352846|12108854|FG000|Overall Study|Non-compliance|2
7689901|NCT00352846|12108855|FG001|Overall Study|Non-compliance|0
7689902|NCT00352846|12108854|FG000|Overall Study|Death|0
7689903|NCT00352846|12108855|FG001|Overall Study|Death|1
7689904|NCT00352885|12108863|FG000|Overall Study|Withdrawal by Subject|0
7689905|NCT00352885|12108864|FG001|Overall Study|Withdrawal by Subject|3
7689906|NCT00352885|12108863|FG000|Overall Study|Development of major depression|0
7689907|NCT00352885|12108864|FG001|Overall Study|Development of major depression|1
7689908|NCT00352885|12108863|FG000|Overall Study|Progression of metastatic melanoma|5
7689909|NCT00352885|12108864|FG001|Overall Study|Progression of metastatic melanoma|3
7689910|NCT00352885|12108863|FG000|Overall Study|Side effects of IL-2 administration|1
7689911|NCT00352885|12108864|FG001|Overall Study|Side effects of IL-2 administration|0
7689912|NCT00353262|12108896|FG000|Overall Study|Adverse Event|8
7689913|NCT00353262|12108896|FG000|Overall Study|Withdrawal by Subject|2
7689914|NCT00353262|12108896|FG000|Overall Study|Insufficient Therapeutic Response|13
7689915|NCT00353262|12108896|FG000|Overall Study|Progression|1
7689916|NCT00353262|12108896|FG000|Overall Study|Surgery|4
7689917|NCT00353262|12108896|FG000|Overall Study|Break from Chemotherapy|1
7689918|NCT00353366|12108904|FG000|Overall Study|Adverse Event|8
7689919|NCT00353366|12108904|FG000|Overall Study|Protocol Violation|12
7689920|NCT00353366|12108904|FG000|Overall Study|Withdrawal by Subject|12
7689921|NCT00353366|12108904|FG000|Overall Study|Lost to Follow-up|92
7689922|NCT00353366|12108904|FG000|Overall Study|Other|19
7689923|NCT00353496|12108928|FG000|Overall Study|Adverse Event|1
7689924|NCT00353496|12108929|FG001|Overall Study|Adverse Event|0
7689925|NCT00353496|12108928|FG000|Overall Study|Protocol Violation|2
7689926|NCT00353496|12108929|FG001|Overall Study|Protocol Violation|2
7689927|NCT00353496|12108928|FG000|Overall Study|Withdrawal by Subject|3
7689928|NCT00353496|12108929|FG001|Overall Study|Withdrawal by Subject|4
7689929|NCT00353496|12108928|FG000|Overall Study|Physician Decision|6
7689930|NCT00353496|12108929|FG001|Overall Study|Physician Decision|9
7689931|NCT00353496|12108928|FG000|Overall Study|Not otherwise specified|4
7689932|NCT00353496|12108929|FG001|Overall Study|Not otherwise specified|2
7689933|NCT00353704|12108971|FG000|Overall Study|Protocol Violation|3
7689934|NCT00353704|12108972|FG001|Overall Study|Protocol Violation|1
7689935|NCT00353873|12108993|FG000|Overall Study|Protocol Violation|1
7689936|NCT00353873|12108994|FG001|Overall Study|Protocol Violation|2
7689937|NCT00353873|12108993|FG000|Overall Study|Exacerbation|1
7689938|NCT00353873|12108994|FG001|Overall Study|Exacerbation|0
7689939|NCT00353873|12108993|FG000|Overall Study|Adverse Event|1
7689940|NCT00353873|12108994|FG001|Overall Study|Adverse Event|0
7689941|NCT00353873|12108993|FG000|Overall Study|Physician Decision|2
7689942|NCT00353873|12108994|FG001|Overall Study|Physician Decision|0
7689943|NCT00353873|12108993|FG000|Overall Study|Withdrawal by Subject|1
7689944|NCT00353873|12108994|FG001|Overall Study|Withdrawal by Subject|1
7689945|NCT00354029|12109006|FG000|Overall Study|Protocol Violation|4
7689946|NCT00354029|12109007|FG001|Overall Study|Protocol Violation|2
7689947|NCT00354107|12109013|FG000|Overall Study|Adverse Event|2
7689948|NCT00354107|12109013|FG000|Overall Study|Physician Decision|2
7689949|NCT00354107|12109013|FG000|Overall Study|Withdrawal by Subject|1
7689950|NCT00354159|12109019|FG000|Randomized Study Period|Withdrawal by Subject|5
7689951|NCT00354159|12109020|FG001|Randomized Study Period|Withdrawal by Subject|3
7689952|NCT00354159|12109019|FG000|Randomized Study Period|Physician Decision|6
7689953|NCT00354159|12109020|FG001|Randomized Study Period|Physician Decision|10
7689954|NCT00354159|12109019|FG000|Randomized Study Period|Lost to Follow-up|4
7689955|NCT00354159|12109020|FG001|Randomized Study Period|Lost to Follow-up|0
7689956|NCT00354159|12109019|FG000|Randomized Study Period|Death|7
7689957|NCT00354159|12109020|FG001|Randomized Study Period|Death|9
7689958|NCT00354159|12109019|FG000|Long-term Follow-up|Withdrawal by Subject|9
7689959|NCT00354159|12109020|FG001|Long-term Follow-up|Withdrawal by Subject|9
7689960|NCT00354159|12109019|FG000|Long-term Follow-up|Physician Decision|127
7689961|NCT00354159|12109020|FG001|Long-term Follow-up|Physician Decision|122
7689962|NCT00354159|12109019|FG000|Long-term Follow-up|Lost to Follow-up|1
7689963|NCT00354159|12109020|FG001|Long-term Follow-up|Lost to Follow-up|0
7689964|NCT00354159|12109019|FG000|Long-term Follow-up|Death|14
7689965|NCT00354159|12109020|FG001|Long-term Follow-up|Death|11
7689966|NCT00354159|12109019|FG000|Long-term Follow-up|Study Closed|29
7689967|NCT00354159|12109020|FG001|Long-term Follow-up|Study Closed|34
7689968|NCT00354172|12109033|FG000|Overall Study|Did not receive transplant|1
7689969|NCT00354341|12109043|FG000|Overall Study|Adverse Event|1
7689970|NCT00354341|12109044|FG001|Overall Study|Adverse Event|0
7689971|NCT00354341|12109043|FG000|Overall Study|Death|0
7689972|NCT00354341|12109044|FG001|Overall Study|Death|2
7689973|NCT00354341|12109043|FG000|Overall Study|Refused treatment|1
7689974|NCT00354341|12109044|FG001|Overall Study|Refused treatment|2
7689975|NCT00354341|12109043|FG000|Overall Study|Failure to return|0
7689976|NCT00354341|12109044|FG001|Overall Study|Failure to return|1
7689977|NCT00354341|12109043|FG000|Overall Study|Other|1
7689978|NCT00354341|12109044|FG001|Overall Study|Other|2
7689979|NCT00354432|12109054|FG000|Overall Study|Adverse Event|3
7689980|NCT00354432|12109055|FG001|Overall Study|Adverse Event|1
7689981|NCT00354432|12109056|FG002|Overall Study|Adverse Event|5
7689982|NCT00354432|12109057|FG003|Overall Study|Adverse Event|5
7689983|NCT00354432|12109054|FG000|Overall Study|Off/Toxicity|3
7689984|NCT00354432|12109055|FG001|Overall Study|Off/Toxicity|7
7689985|NCT00354432|12109056|FG002|Overall Study|Off/Toxicity|5
7689986|NCT00354432|12109057|FG003|Overall Study|Off/Toxicity|5
7689987|NCT00354601|12109076|FG000|Overall Study|Protocol Violation|1
7689988|NCT00354601|12109076|FG000|Overall Study|progression|1
7689989|NCT00354614|12109080|FG000|Overall Study|Lack of Efficacy|28
7689990|NCT00354679|12109088|FG000|Overall Study|Patient Not Treated|1
7689991|NCT00354744|12109092|FG000|Overall Study|Adverse Event|2
7689992|NCT00354744|12109092|FG000|Overall Study|Death|2
7689993|NCT00354744|12109092|FG000|Overall Study|Lack of Efficacy|11
7689994|NCT00354744|12109092|FG000|Overall Study|Lost to Follow-up|2
7689995|NCT00354744|12109092|FG000|Overall Study|Physician Decision|11
7689996|NCT00354744|12109092|FG000|Overall Study|Withdrawal by Subject|14
7689997|NCT00355030|12109121|FG000|Study Period 1 Treatment|Adverse Event|1
7689998|NCT00355030|12109122|FG001|Study Period 1 Treatment|Adverse Event|1
7689999|NCT00355030|12109121|FG000|Study Period 1 Treatment|Lost to Follow-up|3
7690000|NCT00355030|12109122|FG001|Study Period 1 Treatment|Lost to Follow-up|0
7690001|NCT00355030|12109121|FG000|Study Period 1 Treatment|Withdrawal by Subject|4
7690002|NCT00355030|12109122|FG001|Study Period 1 Treatment|Withdrawal by Subject|1
7690003|NCT00355030|12109121|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1
7690004|NCT00355030|12109122|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2
7690005|NCT00355030|12109121|FG000|Study Period 1 Treatment|Physician Decision|0
7690006|NCT00355030|12109122|FG001|Study Period 1 Treatment|Physician Decision|1
7690007|NCT00355030|12109121|FG000|Study Period 1 Treatment|Sponsor Decision|34
7690008|NCT00355030|12109122|FG001|Study Period 1 Treatment|Sponsor Decision|32
7690009|NCT00355030|12109121|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
7690090|NCT00355134|12109182|FG001|Core Phase|Lost to Follow-up|13
7690010|NCT00355030|12109122|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
7690011|NCT00355030|12109121|FG000|Study Period 1 Treatment|Other|2
7690012|NCT00355030|12109122|FG001|Study Period 1 Treatment|Other|6
7690013|NCT00355030|12109121|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
7690014|NCT00355030|12109122|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
7690015|NCT00355030|12109121|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
7690016|NCT00355030|12109122|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
7690017|NCT00355056|12109130|FG000|Randomization Period|Early Termination|4
7690018|NCT00355056|12109131|FG001|Randomization Period|Early Termination|6
7690019|NCT00355082|12109147|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4
7690020|NCT00355082|12109148|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10
7690021|NCT00355082|12109149|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0
7690022|NCT00355082|12109147|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
7690023|NCT00355082|12109148|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
7690024|NCT00355082|12109149|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
7690025|NCT00355082|12109147|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
7690026|NCT00355082|12109148|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
7690027|NCT00355082|12109149|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
7690028|NCT00355082|12109147|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
7690029|NCT00355082|12109148|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
7690030|NCT00355082|12109149|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
7690031|NCT00355082|12109147|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0
7690032|NCT00355082|12109148|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4
7690033|NCT00355082|12109149|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0
7690034|NCT00355082|12109147|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0
7690035|NCT00355082|12109148|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1
7690036|NCT00355082|12109149|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0
7690037|NCT00355082|12109147|FG000|Continuation Phase|Adverse Event|2
7690038|NCT00355082|12109148|FG001|Continuation Phase|Adverse Event|0
7690039|NCT00355082|12109149|FG002|Continuation Phase|Adverse Event|1
7690040|NCT00355082|12109147|FG000|Continuation Phase|Lost to Follow-up|2
7690041|NCT00355082|12109148|FG001|Continuation Phase|Lost to Follow-up|0
7690042|NCT00355082|12109149|FG002|Continuation Phase|Lost to Follow-up|1
7690043|NCT00355082|12109147|FG000|Continuation Phase|Protocol Violation|1
7690044|NCT00355082|12109148|FG001|Continuation Phase|Protocol Violation|0
7690045|NCT00355082|12109149|FG002|Continuation Phase|Protocol Violation|1
7690046|NCT00355082|12109147|FG000|Continuation Phase|Withdrawal by Subject|4
7690047|NCT00355082|12109148|FG001|Continuation Phase|Withdrawal by Subject|0
7690048|NCT00355082|12109149|FG002|Continuation Phase|Withdrawal by Subject|0
7690049|NCT00355082|12109147|FG000|Continuation Phase|Lack of Efficacy|5
7690050|NCT00355082|12109148|FG001|Continuation Phase|Lack of Efficacy|0
7690051|NCT00355082|12109149|FG002|Continuation Phase|Lack of Efficacy|0
7690052|NCT00355082|12109147|FG000|Continuation Phase|Site Closed by Sponsor|8
7690053|NCT00355082|12109148|FG001|Continuation Phase|Site Closed by Sponsor|0
7690054|NCT00355082|12109149|FG002|Continuation Phase|Site Closed by Sponsor|0
7690055|NCT00355082|12109147|FG000|Continuation Phase|Scheduling Error|1
7690056|NCT00355082|12109148|FG001|Continuation Phase|Scheduling Error|0
7690057|NCT00355082|12109149|FG002|Continuation Phase|Scheduling Error|0
7690058|NCT00355082|12109147|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1
7690059|NCT00355082|12109148|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0
7690060|NCT00355082|12109149|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0
7690061|NCT00355121|12109163|FG000|Overall Study|Did not receive study vaccine|1
7690062|NCT00355121|12109164|FG001|Overall Study|Did not receive study vaccine|0
7690063|NCT00355121|12109165|FG002|Overall Study|Did not receive study vaccine|1
7690064|NCT00355121|12109163|FG000|Overall Study|Adverse Event|0
7690065|NCT00355121|12109164|FG001|Overall Study|Adverse Event|1
7690066|NCT00355121|12109165|FG002|Overall Study|Adverse Event|0
7690067|NCT00355121|12109163|FG000|Overall Study|Protocol Violation|7
7690068|NCT00355121|12109164|FG001|Overall Study|Protocol Violation|9
7690069|NCT00355121|12109165|FG002|Overall Study|Protocol Violation|1
7690070|NCT00355121|12109163|FG000|Overall Study|Lost to Follow-up|4
7690071|NCT00355121|12109164|FG001|Overall Study|Lost to Follow-up|7
7690072|NCT00355121|12109165|FG002|Overall Study|Lost to Follow-up|1
7690073|NCT00355121|12109163|FG000|Overall Study|Withdrawal by Subject|9
7690074|NCT00355121|12109164|FG001|Overall Study|Withdrawal by Subject|10
7690075|NCT00355121|12109165|FG002|Overall Study|Withdrawal by Subject|2
7690076|NCT00355121|12109163|FG000|Overall Study|Serious adverse events|0
7690077|NCT00355121|12109164|FG001|Overall Study|Serious adverse events|2
7690078|NCT00355121|12109165|FG002|Overall Study|Serious adverse events|0
7690079|NCT00355134|12109181|FG000|Core Phase|Withdrawal by Subject|35
7690080|NCT00355134|12109182|FG001|Core Phase|Withdrawal by Subject|24
7690081|NCT00355134|12109183|FG002|Core Phase|Withdrawal by Subject|35
7690082|NCT00355134|12109184|FG003|Core Phase|Withdrawal by Subject|0
7690083|NCT00355134|12109185|FG004|Core Phase|Withdrawal by Subject|0
7690084|NCT00355134|12109181|FG000|Core Phase|Adverse Event|28
7690085|NCT00355134|12109182|FG001|Core Phase|Adverse Event|22
7690086|NCT00355134|12109183|FG002|Core Phase|Adverse Event|16
7690087|NCT00355134|12109184|FG003|Core Phase|Adverse Event|0
7690088|NCT00355134|12109185|FG004|Core Phase|Adverse Event|0
7690089|NCT00355134|12109181|FG000|Core Phase|Lost to Follow-up|17
7690091|NCT00355134|12109183|FG002|Core Phase|Lost to Follow-up|21
7690092|NCT00355134|12109184|FG003|Core Phase|Lost to Follow-up|0
7690093|NCT00355134|12109185|FG004|Core Phase|Lost to Follow-up|0
7690094|NCT00355134|12109181|FG000|Core Phase|Abnormal laboratory value(s)|19
7690095|NCT00355134|12109182|FG001|Core Phase|Abnormal laboratory value(s)|14
7690096|NCT00355134|12109183|FG002|Core Phase|Abnormal laboratory value(s)|2
7690097|NCT00355134|12109184|FG003|Core Phase|Abnormal laboratory value(s)|0
7690098|NCT00355134|12109185|FG004|Core Phase|Abnormal laboratory value(s)|0
7690099|NCT00355134|12109181|FG000|Core Phase|Unsatisfactory therapeutic effect|10
7690100|NCT00355134|12109182|FG001|Core Phase|Unsatisfactory therapeutic effect|6
7690101|NCT00355134|12109183|FG002|Core Phase|Unsatisfactory therapeutic effect|17
7690102|NCT00355134|12109184|FG003|Core Phase|Unsatisfactory therapeutic effect|0
7690103|NCT00355134|12109185|FG004|Core Phase|Unsatisfactory therapeutic effect|0
7690104|NCT00355134|12109181|FG000|Core Phase|Administrative problems|5
7690105|NCT00355134|12109182|FG001|Core Phase|Administrative problems|3
7690106|NCT00355134|12109183|FG002|Core Phase|Administrative problems|5
7690107|NCT00355134|12109184|FG003|Core Phase|Administrative problems|0
7690108|NCT00355134|12109185|FG004|Core Phase|Administrative problems|0
7690109|NCT00355134|12109181|FG000|Core Phase|Protocol Violation|3
7690110|NCT00355134|12109182|FG001|Core Phase|Protocol Violation|2
7690111|NCT00355134|12109183|FG002|Core Phase|Protocol Violation|2
7690112|NCT00355134|12109184|FG003|Core Phase|Protocol Violation|0
7690113|NCT00355134|12109185|FG004|Core Phase|Protocol Violation|0
7690114|NCT00355134|12109181|FG000|Core Phase|Abnormal test procedure result(s)|1
7690115|NCT00355134|12109182|FG001|Core Phase|Abnormal test procedure result(s)|2
7690116|NCT00355134|12109183|FG002|Core Phase|Abnormal test procedure result(s)|1
7690117|NCT00355134|12109184|FG003|Core Phase|Abnormal test procedure result(s)|0
7690118|NCT00355134|12109185|FG004|Core Phase|Abnormal test procedure result(s)|0
7690119|NCT00355134|12109181|FG000|Core Phase|Condition no longer requires study drug|1
7690120|NCT00355134|12109182|FG001|Core Phase|Condition no longer requires study drug|0
7690121|NCT00355134|12109183|FG002|Core Phase|Condition no longer requires study drug|1
7690122|NCT00355134|12109184|FG003|Core Phase|Condition no longer requires study drug|0
7690123|NCT00355134|12109185|FG004|Core Phase|Condition no longer requires study drug|0
7690124|NCT00355134|12109181|FG000|Extension Phase|Withdrawal by Subject|7
7690125|NCT00355134|12109182|FG001|Extension Phase|Withdrawal by Subject|11
7690126|NCT00355134|12109183|FG002|Extension Phase|Withdrawal by Subject|0
7690127|NCT00355134|12109184|FG003|Extension Phase|Withdrawal by Subject|7
7690128|NCT00355134|12109185|FG004|Extension Phase|Withdrawal by Subject|5
7690129|NCT00355134|12109181|FG000|Extension Phase|Adverse Event|13
7690130|NCT00355134|12109182|FG001|Extension Phase|Adverse Event|9
7690131|NCT00355134|12109183|FG002|Extension Phase|Adverse Event|0
7690132|NCT00355134|12109184|FG003|Extension Phase|Adverse Event|3
7690133|NCT00355134|12109185|FG004|Extension Phase|Adverse Event|5
7690134|NCT00355134|12109181|FG000|Extension Phase|Lost to Follow-up|2
7690135|NCT00355134|12109182|FG001|Extension Phase|Lost to Follow-up|6
7690136|NCT00355134|12109183|FG002|Extension Phase|Lost to Follow-up|0
7690137|NCT00355134|12109184|FG003|Extension Phase|Lost to Follow-up|2
7690138|NCT00355134|12109185|FG004|Extension Phase|Lost to Follow-up|4
7690139|NCT00355134|12109181|FG000|Extension Phase|Abnormal laboratory value(s)|4
7690140|NCT00355134|12109182|FG001|Extension Phase|Abnormal laboratory value(s)|2
7690141|NCT00355134|12109183|FG002|Extension Phase|Abnormal laboratory value(s)|0
7690142|NCT00355134|12109184|FG003|Extension Phase|Abnormal laboratory value(s)|2
7690143|NCT00355134|12109185|FG004|Extension Phase|Abnormal laboratory value(s)|2
7690144|NCT00355134|12109181|FG000|Extension Phase|Administrative problems|2
7690145|NCT00355134|12109182|FG001|Extension Phase|Administrative problems|4
7690146|NCT00355134|12109183|FG002|Extension Phase|Administrative problems|0
7690147|NCT00355134|12109184|FG003|Extension Phase|Administrative problems|1
7690148|NCT00355134|12109185|FG004|Extension Phase|Administrative problems|1
7690149|NCT00355134|12109181|FG000|Extension Phase|Unsatisfactory therapeutic effect|3
7690150|NCT00355134|12109182|FG001|Extension Phase|Unsatisfactory therapeutic effect|4
7690151|NCT00355134|12109183|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
7690152|NCT00355134|12109184|FG003|Extension Phase|Unsatisfactory therapeutic effect|0
7690153|NCT00355134|12109185|FG004|Extension Phase|Unsatisfactory therapeutic effect|1
7690154|NCT00355134|12109181|FG000|Extension Phase|Abnormal test procedure result(s)|0
7690155|NCT00355134|12109182|FG001|Extension Phase|Abnormal test procedure result(s)|1
7690156|NCT00355134|12109183|FG002|Extension Phase|Abnormal test procedure result(s)|0
7690157|NCT00355134|12109184|FG003|Extension Phase|Abnormal test procedure result(s)|0
7690158|NCT00355134|12109185|FG004|Extension Phase|Abnormal test procedure result(s)|1
7690159|NCT00355134|12109181|FG000|Extension Phase|Protocol Violation|0
7690160|NCT00355134|12109182|FG001|Extension Phase|Protocol Violation|0
7690161|NCT00355134|12109183|FG002|Extension Phase|Protocol Violation|0
7690162|NCT00355134|12109184|FG003|Extension Phase|Protocol Violation|1
7690163|NCT00355134|12109185|FG004|Extension Phase|Protocol Violation|0
7690164|NCT00355147|12109197|FG000|Overall Study|Lost to Follow-up|10
7690165|NCT00355147|12109198|FG001|Overall Study|Lost to Follow-up|8
7690166|NCT00355147|12109197|FG000|Overall Study|Withdrawal by Subject|8
7690167|NCT00355147|12109198|FG001|Overall Study|Withdrawal by Subject|12
7690168|NCT00355264|12109217|FG000|Extension (Variable Duration)|Adverse Event|1
7690169|NCT00355264|12109217|FG000|Extension (Variable Duration)|Withdrew Consent|1
7690170|NCT00355342|12109228|FG000|Overall Study|Adverse Event|13
7690171|NCT00355342|12109229|FG001|Overall Study|Adverse Event|15
7690172|NCT00355342|12109228|FG000|Overall Study|Lost to Follow-up|4
7690173|NCT00355342|12109229|FG001|Overall Study|Lost to Follow-up|2
7690174|NCT00355342|12109228|FG000|Overall Study|Withdrawal by Subject|14
7690175|NCT00355342|12109229|FG001|Overall Study|Withdrawal by Subject|11
7690176|NCT00355342|12109228|FG000|Overall Study|Sponsor terminated study|2
7690177|NCT00355342|12109229|FG001|Overall Study|Sponsor terminated study|2
7690178|NCT00355342|12109228|FG000|Overall Study|Overcompliant-PI discretion|1
7690179|NCT00355342|12109229|FG001|Overall Study|Overcompliant-PI discretion|0
7690180|NCT00355342|12109228|FG000|Overall Study|Use of prohibited medication|1
7690181|NCT00355342|12109229|FG001|Overall Study|Use of prohibited medication|0
7690182|NCT00355342|12109228|FG000|Overall Study|COPD exacerbation|1
7690183|NCT00355342|12109229|FG001|Overall Study|COPD exacerbation|1
7690184|NCT00355342|12109228|FG000|Overall Study|Dispensed wrong study drug kit|1
7690185|NCT00355342|12109229|FG001|Overall Study|Dispensed wrong study drug kit|0
7690186|NCT00355342|12109228|FG000|Overall Study|Non-compliance with Dexa scans|1
7690187|NCT00355342|12109229|FG001|Overall Study|Non-compliance with Dexa scans|0
7690188|NCT00355342|12109228|FG000|Overall Study|Withdrawal by participant and physician|1
7690189|NCT00355342|12109229|FG001|Overall Study|Withdrawal by participant and physician|0
7690190|NCT00355342|12109228|FG000|Overall Study|Participant relocated|0
7690191|NCT00355342|12109229|FG001|Overall Study|Participant relocated|1
7690192|NCT00355342|12109228|FG000|Overall Study|Participant discontinued study drug|0
7690193|NCT00355342|12109229|FG001|Overall Study|Participant discontinued study drug|1
7690194|NCT00355342|12109228|FG000|Overall Study|Study management|0
7690195|NCT00355342|12109229|FG001|Overall Study|Study management|1
7690196|NCT00355342|12109228|FG000|Overall Study|Protocol Violation|0
7690197|NCT00355342|12109229|FG001|Overall Study|Protocol Violation|1
7690198|NCT00355342|12109228|FG000|Overall Study|Use of protocol excluded medication|0
7690199|NCT00355342|12109229|FG001|Overall Study|Use of protocol excluded medication|1
7690200|NCT00355368|12109237|FG000|Overall Study|Protocol Violation|8
7690201|NCT00355368|12109238|FG001|Overall Study|Protocol Violation|7
7690202|NCT00355368|12109237|FG000|Overall Study|cardiac arrest prior to intubation|2
7690203|NCT00355368|12109238|FG001|Overall Study|cardiac arrest prior to intubation|2
7690204|NCT00355472|12109255|FG000|Overall Study|Physician Decision|1
7690205|NCT00355615|12109271|FG000|Randomized Double Blind Period|Adverse Event|1
7690206|NCT00355615|12109272|FG001|Randomized Double Blind Period|Adverse Event|0
7690207|NCT00355615|12109273|FG002|Randomized Double Blind Period|Adverse Event|0
7690208|NCT00355615|12109274|FG003|Randomized Double Blind Period|Adverse Event|0
7690209|NCT00355615|12109275|FG004|Randomized Double Blind Period|Adverse Event|0
7690210|NCT00355615|12109271|FG000|Randomized Double Blind Period|Protocol Violation|0
7690211|NCT00355615|12109272|FG001|Randomized Double Blind Period|Protocol Violation|0
7690212|NCT00355615|12109273|FG002|Randomized Double Blind Period|Protocol Violation|1
7690213|NCT00355615|12109274|FG003|Randomized Double Blind Period|Protocol Violation|1
7690214|NCT00355615|12109275|FG004|Randomized Double Blind Period|Protocol Violation|0
7690215|NCT00355615|12109271|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0
7690216|NCT00355615|12109272|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0
7690217|NCT00355615|12109273|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0
7690218|NCT00355615|12109274|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0
7690219|NCT00355615|12109275|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4
7690220|NCT00355615|12109271|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0
7690221|NCT00355615|12109272|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0
7690222|NCT00355615|12109273|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0
7690223|NCT00355615|12109274|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0
7690224|NCT00355615|12109275|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1
7690225|NCT00355615|12109271|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
7690226|NCT00355615|12109272|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
7690227|NCT00355615|12109273|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
7690228|NCT00355615|12109274|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
7690229|NCT00355615|12109275|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
7690230|NCT00355615|12109271|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0
7690231|NCT00355615|12109272|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0
7690232|NCT00355615|12109273|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0
7690233|NCT00355615|12109274|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0
7690234|NCT00355615|12109275|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1
7690235|NCT00355784|12109300|FG000|Overall Study|Withdrawal by Subject|0
7690236|NCT00355784|12109301|FG001|Overall Study|Withdrawal by Subject|0
7690237|NCT00355784|12109302|FG002|Overall Study|Withdrawal by Subject|2
7690238|NCT00356122|12109358|FG000|TREATMENT|Lack of Efficacy|26
7690239|NCT00356122|12109358|FG000|TREATMENT|Adverse Event|10
7690240|NCT00356122|12109358|FG000|TREATMENT|Subject's request|4
7690241|NCT00356122|12109358|FG000|TREATMENT|Other|4
7690242|NCT00356122|12109358|FG000|TREATMENT|Did not receive study medication|1
7690243|NCT00356122|12109358|FG000|FOLLOW-UP|Death|37
7690244|NCT00356122|12109358|FG000|FOLLOW-UP|Lost to Follow-up|2
7690245|NCT00356122|12109358|FG000|FOLLOW-UP|Other|2
7690246|NCT00356135|12109365|FG000|Overall Study|Protocol Violation|1
7690247|NCT00356135|12109366|FG001|Overall Study|Protocol Violation|0
7690248|NCT00356135|12109367|FG002|Overall Study|Protocol Violation|0
7690249|NCT00356135|12109365|FG000|Overall Study|Adverse Event|1
7690250|NCT00356135|12109366|FG001|Overall Study|Adverse Event|0
7690251|NCT00356135|12109367|FG002|Overall Study|Adverse Event|0
7690252|NCT00356135|12109365|FG000|Overall Study|Lost to Follow-up|0
7690253|NCT00356135|12109366|FG001|Overall Study|Lost to Follow-up|0
7690254|NCT00356135|12109367|FG002|Overall Study|Lost to Follow-up|1
7690255|NCT00356135|12109365|FG000|Overall Study|Physician Decision|1
7690256|NCT00356135|12109366|FG001|Overall Study|Physician Decision|1
7690257|NCT00356135|12109367|FG002|Overall Study|Physician Decision|1
7690258|NCT00356135|12109365|FG000|Overall Study|Subject non-compliance|1
7690259|NCT00356135|12109366|FG001|Overall Study|Subject non-compliance|1
7690260|NCT00356135|12109367|FG002|Overall Study|Subject non-compliance|3
7690261|NCT00356148|12109379|FG000|Overall Study|Reoperation within 30 days|2
7690262|NCT00356148|12109380|FG001|Overall Study|Reoperation within 30 days|1
7690263|NCT00356200|12109389|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1
7690264|NCT00356200|12109390|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0
7690265|NCT00356200|12109389|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
7690266|NCT00356200|12109390|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
7690267|NCT00356265|12109405|FG000|Overall Study|Withdrawal by Subject|0
7690268|NCT00356265|12109406|FG001|Overall Study|Withdrawal by Subject|0
7690269|NCT00356265|12109407|FG002|Overall Study|Withdrawal by Subject|1
7690270|NCT00356278|12109419|FG000|Overall Study|Withdrawal by Subject|25
7690271|NCT00356278|12109420|FG001|Overall Study|Withdrawal by Subject|15
7690272|NCT00356278|12109421|FG002|Overall Study|Withdrawal by Subject|19
7690273|NCT00356369|12109440|FG000|Active Phase|Withdrawal by Subject|2
7690274|NCT00356369|12109441|FG001|Active Phase|Withdrawal by Subject|1
7690275|NCT00356408|12109451|FG000|Overall Study|Adverse Event|9
7690276|NCT00356408|12109451|FG000|Overall Study|Lack of Efficacy|36
7690277|NCT00356408|12109451|FG000|Overall Study|Lost to Follow-up|2
7690278|NCT00356408|12109451|FG000|Overall Study|Withdrawal by Subject|6
7690279|NCT00356408|12109451|FG000|Overall Study|Other: Principal investigator discretion|3
7690280|NCT00356408|12109451|FG000|Overall Study|Other: Sponsor request|1
7690281|NCT00356408|12109451|FG000|Overall Study|Other: Azathioprine stopped|1
7690282|NCT00356408|12109451|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1
7690283|NCT00356408|12109451|FG000|Overall Study|Other: Subject chose commerical dosing|1
7690284|NCT00356525|12109476|FG000|Overall Study|Progressive Disease|8
7690285|NCT00356525|12109477|FG001|Overall Study|Progressive Disease|5
7690286|NCT00356525|12109478|FG002|Overall Study|Progressive Disease|4
7690287|NCT00356525|12109479|FG003|Overall Study|Progressive Disease|2
7690288|NCT00356525|12109476|FG000|Overall Study|Adverse Event|1
7690289|NCT00356525|12109477|FG001|Overall Study|Adverse Event|3
7690290|NCT00356525|12109478|FG002|Overall Study|Adverse Event|1
7690291|NCT00356525|12109479|FG003|Overall Study|Adverse Event|1
7690292|NCT00356525|12109476|FG000|Overall Study|Lost to Follow-up|1
7690293|NCT00356525|12109477|FG001|Overall Study|Lost to Follow-up|0
7690294|NCT00356525|12109478|FG002|Overall Study|Lost to Follow-up|0
7690295|NCT00356525|12109479|FG003|Overall Study|Lost to Follow-up|0
7690296|NCT00356525|12109476|FG000|Overall Study|Physician Decision|2
7690297|NCT00356525|12109477|FG001|Overall Study|Physician Decision|2
7690298|NCT00356525|12109478|FG002|Overall Study|Physician Decision|2
7690299|NCT00356525|12109479|FG003|Overall Study|Physician Decision|1
7690300|NCT00356525|12109476|FG000|Overall Study|Protocol Entry Criteria Not Met|1
7690301|NCT00356525|12109477|FG001|Overall Study|Protocol Entry Criteria Not Met|0
7690302|NCT00356525|12109478|FG002|Overall Study|Protocol Entry Criteria Not Met|0
7690303|NCT00356525|12109479|FG003|Overall Study|Protocol Entry Criteria Not Met|0
7690304|NCT00356525|12109476|FG000|Overall Study|Withdrawal by Subject|1
7690305|NCT00356525|12109477|FG001|Overall Study|Withdrawal by Subject|1
7690306|NCT00356525|12109478|FG002|Overall Study|Withdrawal by Subject|0
7690307|NCT00356525|12109479|FG003|Overall Study|Withdrawal by Subject|3
7690308|NCT00356525|12109476|FG000|Overall Study|Death|0
7690309|NCT00356525|12109477|FG001|Overall Study|Death|0
7690310|NCT00356525|12109478|FG002|Overall Study|Death|0
7690311|NCT00356525|12109479|FG003|Overall Study|Death|1
7690312|NCT00356525|12109476|FG000|Overall Study|Sponsor Decision|0
7690313|NCT00356525|12109477|FG001|Overall Study|Sponsor Decision|0
7690314|NCT00356525|12109478|FG002|Overall Study|Sponsor Decision|0
7690315|NCT00356525|12109479|FG003|Overall Study|Sponsor Decision|1
7690316|NCT00356590|12109489|FG000|Overall Study|Adverse Event|54
7690317|NCT00356590|12109489|FG000|Overall Study|Death|10
7690318|NCT00356590|12109489|FG000|Overall Study|Lost to Follow-up|35
7690319|NCT00356590|12109489|FG000|Overall Study|Physician Decision|46
7690320|NCT00356590|12109489|FG000|Overall Study|Withdrawal by Subject|41
7690321|NCT00356590|12109489|FG000|Overall Study|Completed month 12 only|2
7690322|NCT00356590|12109489|FG000|Overall Study|Protocol issues|6
7690323|NCT00356590|12109489|FG000|Overall Study|Response status|28
7690324|NCT00356590|12109489|FG000|Overall Study|Other|52
7690325|NCT00356603|12109495|FG000|Overall Study|Other|6
7690326|NCT00356603|12109496|FG001|Overall Study|Other|3
7690327|NCT00356759|12109506|FG000|Overall Study|Death|5
7690328|NCT00356759|12109507|FG001|Overall Study|Death|2
7690329|NCT00356759|12109506|FG000|Overall Study|Withdrawal by Subject|2
7690330|NCT00356759|12109507|FG001|Overall Study|Withdrawal by Subject|2
7690331|NCT00356759|12109506|FG000|Overall Study|Adverse Event|1
7690332|NCT00356759|12109507|FG001|Overall Study|Adverse Event|3
7690333|NCT00356759|12109506|FG000|Overall Study|Lost to Follow-up|1
7690334|NCT00356759|12109507|FG001|Overall Study|Lost to Follow-up|1
7690335|NCT00356759|12109506|FG000|Overall Study|Intercurrent disease or persistent extre|5
7690336|NCT00356759|12109507|FG001|Overall Study|Intercurrent disease or persistent extre|2
7690337|NCT00356811|12109513|FG000|Overall Study|Death|35
7690338|NCT00356811|12109513|FG000|Overall Study|Lost to Follow-up|2
7690339|NCT00356811|12109513|FG000|Overall Study|Withdrawal by Subject|6
7690340|NCT00356811|12109513|FG000|Overall Study|Participant Could Not Make a Checkup|1
7690341|NCT00356811|12109513|FG000|Overall Study|Study Is Terminating|3
7690342|NCT00356811|12109513|FG000|Overall Study|Site Closed during Follow-up|2
7690343|NCT00356863|12109520|FG000|Overall Study|Death|16
7690344|NCT00356863|12109521|FG001|Overall Study|Death|32
7690345|NCT00356863|12109520|FG000|Overall Study|Lost to Follow-up|76
7690346|NCT00356863|12109521|FG001|Overall Study|Lost to Follow-up|43
7690347|NCT00356889|12109531|FG000|Overall Study|Protocol Violation|2
7690348|NCT00356889|12109531|FG000|Overall Study|Adverse Event|1
7690349|NCT00356915|12109539|FG000|Overall Study|Non compliance|1
7690350|NCT00356915|12109540|FG001|Overall Study|Non compliance|2
7690351|NCT00356915|12109541|FG002|Overall Study|Non compliance|1
7690352|NCT00356915|12109539|FG000|Overall Study|Protocol Violation|2
7690353|NCT00356915|12109540|FG001|Overall Study|Protocol Violation|3
7690354|NCT00356915|12109541|FG002|Overall Study|Protocol Violation|2
7690355|NCT00356915|12109539|FG000|Overall Study|Withdrawal by Subject|14
7690356|NCT00356915|12109540|FG001|Overall Study|Withdrawal by Subject|14
7690357|NCT00356915|12109541|FG002|Overall Study|Withdrawal by Subject|10
7690358|NCT00356915|12109539|FG000|Overall Study|Lack of Efficacy|0
7690359|NCT00356915|12109540|FG001|Overall Study|Lack of Efficacy|0
7690360|NCT00356915|12109541|FG002|Overall Study|Lack of Efficacy|3
7690361|NCT00356915|12109539|FG000|Overall Study|Lost to Follow-up|27
7690362|NCT00356915|12109540|FG001|Overall Study|Lost to Follow-up|34
7690363|NCT00356915|12109541|FG002|Overall Study|Lost to Follow-up|14
7690364|NCT00356915|12109539|FG000|Overall Study|Administrative Decision|0
7690365|NCT00356915|12109540|FG001|Overall Study|Administrative Decision|0
7690366|NCT00356915|12109541|FG002|Overall Study|Administrative Decision|1
7690367|NCT00356915|12109539|FG000|Overall Study|Physician Decision|0
7690368|NCT00356915|12109540|FG001|Overall Study|Physician Decision|2
7690369|NCT00356915|12109541|FG002|Overall Study|Physician Decision|0
7690370|NCT00356915|12109539|FG000|Overall Study|Adverse Event|21
7690371|NCT00356915|12109540|FG001|Overall Study|Adverse Event|31
7690372|NCT00356915|12109541|FG002|Overall Study|Adverse Event|8
7690373|NCT00356915|12109539|FG000|Overall Study|Miscellaneous reasons|11
7690374|NCT00356915|12109540|FG001|Overall Study|Miscellaneous reasons|8
7690375|NCT00356915|12109541|FG002|Overall Study|Miscellaneous reasons|3
7690376|NCT00357006|12109562|FG000|Overall Study|Lost to Follow-up|1
7690377|NCT00357006|12109563|FG001|Overall Study|Lost to Follow-up|2
7690378|NCT00357006|12109564|FG002|Overall Study|Lost to Follow-up|1
7690379|NCT00357006|12109562|FG000|Overall Study|Withdrawal by Subject|1
7690380|NCT00357006|12109563|FG001|Overall Study|Withdrawal by Subject|3
7690381|NCT00357006|12109564|FG002|Overall Study|Withdrawal by Subject|2
7690382|NCT00357097|12109578|FG000|Overall Study|Did not meet inclusion criteria|5
7690383|NCT00357097|12109579|FG001|Overall Study|Did not meet inclusion criteria|3
7690384|NCT00357097|12109578|FG000|Overall Study|Adverse Event|34
7690385|NCT00357097|12109579|FG001|Overall Study|Adverse Event|6
7690386|NCT00357097|12109578|FG000|Overall Study|Withdrawal by Subject|8
7690387|NCT00357097|12109579|FG001|Overall Study|Withdrawal by Subject|7
7690388|NCT00357097|12109578|FG000|Overall Study|Non-compliance|1
7690389|NCT00357097|12109579|FG001|Overall Study|Non-compliance|2
7690390|NCT00357097|12109578|FG000|Overall Study|Lack of Efficacy|2
7690391|NCT00357097|12109579|FG001|Overall Study|Lack of Efficacy|8
7690392|NCT00357097|12109578|FG000|Overall Study|Met Exclusion Criteria|3
7690393|NCT00357097|12109579|FG001|Overall Study|Met Exclusion Criteria|1
7690394|NCT00357097|12109578|FG000|Overall Study|Other|1
7690395|NCT00357097|12109579|FG001|Overall Study|Other|1
7690396|NCT00357097|12109578|FG000|Overall Study|Increase of RLS Symptoms|0
7690397|NCT00357097|12109579|FG001|Overall Study|Increase of RLS Symptoms|1
7690398|NCT00357110|12109587|FG000|Overall Study|Early study termination|5
7690399|NCT00357110|12109588|FG001|Overall Study|Early study termination|5
7690400|NCT00357370|12109627|FG000|Cohort 2|Lack of Efficacy|0
7690401|NCT00357370|12109628|FG001|Cohort 2|Lack of Efficacy|2
7690402|NCT00357370|12109629|FG002|Cohort 2|Lack of Efficacy|1
7690403|NCT00357370|12109627|FG000|Cohort 2|Adverse Event|1
7690404|NCT00357370|12109628|FG001|Cohort 2|Adverse Event|1
7690405|NCT00357370|12109629|FG002|Cohort 2|Adverse Event|1
7690406|NCT00357370|12109627|FG000|Cohort 2|Lost to Follow-up|0
7690407|NCT00357370|12109628|FG001|Cohort 2|Lost to Follow-up|1
7690408|NCT00357370|12109629|FG002|Cohort 2|Lost to Follow-up|0
7690409|NCT00357370|12109627|FG000|Cohort 2|non-compliance, not met criteria, etc|1
7690410|NCT00357370|12109628|FG001|Cohort 2|non-compliance, not met criteria, etc|1
7690411|NCT00357370|12109629|FG002|Cohort 2|non-compliance, not met criteria, etc|0
7690412|NCT00357370|12109627|FG000|Cohort 2|Withdrawal by Subject|0
7690413|NCT00357370|12109628|FG001|Cohort 2|Withdrawal by Subject|2
7690414|NCT00357370|12109629|FG002|Cohort 2|Withdrawal by Subject|0
7690415|NCT00357396|12109639|FG000|Overall Study|Adverse Event|1
7690416|NCT00357396|12109640|FG001|Overall Study|Adverse Event|0
7690417|NCT00357500|12109645|FG000|Overall Study|Adverse Event|3
7690418|NCT00357500|12109645|FG000|Overall Study|Withdrawal by Subject|5
7690419|NCT00357500|12109645|FG000|Overall Study|Progressive Disease|65
7690420|NCT00357500|12109645|FG000|Overall Study|Not Started Protocol Therapy|4
7690421|NCT00357552|12109649|FG000|Screening|Did not meet eligibility criteria|84
7690422|NCT00357552|12109649|FG000|Weeks 0 to 24|Death|1
7690423|NCT00357552|12109649|FG000|Weeks 24 to 104|Death|3
7690424|NCT00357552|12109649|FG000|Weeks 24 to 104|Not able to get to clinic|2
7690425|NCT00357656|12109659|FG000|Overall Study|Other, No surgery performed|0
7690426|NCT00357656|12109660|FG001|Overall Study|Other, No surgery performed|3
7690427|NCT00357760|12109684|FG000|Overall Study|Disease progression|44
7690428|NCT00357760|12109685|FG001|Overall Study|Disease progression|17
7690429|NCT00357760|12109684|FG000|Overall Study|Adverse Event|10
7690430|NCT00357760|12109685|FG001|Overall Study|Adverse Event|7
7690431|NCT00357760|12109684|FG000|Overall Study|Death|0
7690432|NCT00357760|12109685|FG001|Overall Study|Death|3
7690433|NCT00357760|12109684|FG000|Overall Study|Alternative therapy|1
7690434|NCT00357760|12109685|FG001|Overall Study|Alternative therapy|0
7690435|NCT00357760|12109684|FG000|Overall Study|Withdrawal by Subject|0
7690436|NCT00357760|12109685|FG001|Overall Study|Withdrawal by Subject|2
7690437|NCT00357760|12109684|FG000|Overall Study|Never started treatment|2
7690438|NCT00357760|12109685|FG001|Overall Study|Never started treatment|1
7690439|NCT00357760|12109684|FG000|Overall Study|Ineligible|0
7690440|NCT00357760|12109685|FG001|Overall Study|Ineligible|2
7690441|NCT00357760|12109684|FG000|Overall Study|Physician Decision|2
7690442|NCT00357760|12109685|FG001|Overall Study|Physician Decision|1
7690443|NCT00357760|12109684|FG000|Overall Study|Protocol Violation|0
7690444|NCT00357760|12109685|FG001|Overall Study|Protocol Violation|1
7690445|NCT00357760|12109684|FG000|Overall Study|To receive hospice care|0
7690446|NCT00357760|12109685|FG001|Overall Study|To receive hospice care|1
7690447|NCT00357877|12109693|FG000|Overall Study|Death|2
7690448|NCT00357877|12109694|FG001|Overall Study|Death|1
7690449|NCT00357877|12109693|FG000|Overall Study|Lost to Follow-up|20
7690450|NCT00357877|12109694|FG001|Overall Study|Lost to Follow-up|23
7690451|NCT00357877|12109693|FG000|Overall Study|Withdrawal by Subject|3
7690452|NCT00357877|12109694|FG001|Overall Study|Withdrawal by Subject|3
7690453|NCT00357877|12109693|FG000|Overall Study|Administrative withdrawal|1
7690454|NCT00357877|12109694|FG001|Overall Study|Administrative withdrawal|1
7690455|NCT00357877|12109693|FG000|Overall Study|Other|0
7690456|NCT00357877|12109694|FG001|Overall Study|Other|2
7690457|NCT00357903|12109704|FG000|Overall Study|Adverse Event|87
7690458|NCT00357903|12109705|FG001|Overall Study|Adverse Event|4
7690459|NCT00357903|12109704|FG000|Overall Study|Death|33
7690460|NCT00357903|12109705|FG001|Overall Study|Death|0
7690461|NCT00357903|12109704|FG000|Overall Study|Lost to Follow-up|23
7690462|NCT00357903|12109705|FG001|Overall Study|Lost to Follow-up|4
7690463|NCT00357903|12109704|FG000|Overall Study|Physician Decision|39
7690464|NCT00357903|12109705|FG001|Overall Study|Physician Decision|5
7690465|NCT00357903|12109704|FG000|Overall Study|Withdrawal by Subject|57
7690466|NCT00357903|12109705|FG001|Overall Study|Withdrawal by Subject|7
7690467|NCT00357903|12109704|FG000|Overall Study|Completed month 12 only|0
7690468|NCT00357903|12109705|FG001|Overall Study|Completed month 12 only|1
7690469|NCT00357903|12109704|FG000|Overall Study|Protocol issues|14
7690470|NCT00357903|12109705|FG001|Overall Study|Protocol issues|3
7690471|NCT00357903|12109704|FG000|Overall Study|Response status|61
7690472|NCT00357903|12109705|FG001|Overall Study|Response status|9
7690473|NCT00357903|12109704|FG000|Overall Study|Other|49
7690474|NCT00357903|12109705|FG001|Overall Study|Other|10
7690475|NCT00357968|12109723|FG000|First Maintenance Dose Phase|Not a PCI patient|47
7690476|NCT00357968|12109724|FG001|First Maintenance Dose Phase|Not a PCI patient|42
7690477|NCT00357968|12109723|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1
7690478|NCT00357968|12109724|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2
7690479|NCT00357994|12109747|FG000|Overall Study|Adverse Event|1
7690480|NCT00357994|12109748|FG001|Overall Study|Adverse Event|2
7690481|NCT00357994|12109747|FG000|Overall Study|Lack of Efficacy|0
7690482|NCT00357994|12109748|FG001|Overall Study|Lack of Efficacy|1
7690483|NCT00357994|12109747|FG000|Overall Study|Protocol Violation|1
7690484|NCT00357994|12109748|FG001|Overall Study|Protocol Violation|0
7690485|NCT00358150|12109758|FG000|Overall Study|Adverse Event|3
7690486|NCT00358150|12109758|FG000|Overall Study|Withdrawal by Subject|1
7690487|NCT00358150|12109758|FG000|Overall Study|Undefined|3
7690488|NCT00358215|12109767|FG000|Overall Study|Ineligibility determined|4
7690489|NCT00358215|12109768|FG001|Overall Study|Ineligibility determined|3
7690490|NCT00358215|12109767|FG000|Overall Study|Adverse Event|83
7690491|NCT00358215|12109768|FG001|Overall Study|Adverse Event|65
7690492|NCT00358215|12109767|FG000|Overall Study|Withdrawal by Subject|111
7690493|NCT00358215|12109768|FG001|Overall Study|Withdrawal by Subject|102
7690494|NCT00358215|12109767|FG000|Overall Study|Participant request|65
7690495|NCT00358215|12109768|FG001|Overall Study|Participant request|64
7690496|NCT00358215|12109767|FG000|Overall Study|Physician Decision|47
7690497|NCT00358215|12109768|FG001|Overall Study|Physician Decision|39
7690498|NCT00358215|12109767|FG000|Overall Study|Lost to Follow-up|16
7690499|NCT00358215|12109768|FG001|Overall Study|Lost to Follow-up|22
7690500|NCT00358215|12109767|FG000|Overall Study|Death|265
7690501|NCT00358215|12109768|FG001|Overall Study|Death|281
7690502|NCT00358215|12109767|FG000|Overall Study|Protocol Violation|64
7690503|NCT00358215|12109768|FG001|Overall Study|Protocol Violation|59
7690504|NCT00358215|12109767|FG000|Overall Study|Pregnancy|1
7690505|NCT00358215|12109768|FG001|Overall Study|Pregnancy|0
7690506|NCT00358215|12109767|FG000|Overall Study|Other|21
7690507|NCT00358215|12109768|FG001|Overall Study|Other|14
7690508|NCT00358215|12109767|FG000|Overall Study|Did not receive investigational product|2
7690509|NCT00358215|12109768|FG001|Overall Study|Did not receive investigational product|3
7690510|NCT00358436|12109793|FG000|Overall Study|Adverse Event|29
7690511|NCT00358436|12109794|FG001|Overall Study|Adverse Event|13
7690512|NCT00358436|12109793|FG000|Overall Study|Lack of Efficacy|34
7690513|NCT00358436|12109794|FG001|Overall Study|Lack of Efficacy|36
7690514|NCT00358436|12109793|FG000|Overall Study|Lost to Follow-up|11
7690515|NCT00358436|12109794|FG001|Overall Study|Lost to Follow-up|6
7690516|NCT00358436|12109793|FG000|Overall Study|Protocol Violation|8
7690517|NCT00358436|12109794|FG001|Overall Study|Protocol Violation|3
7690518|NCT00358436|12109793|FG000|Overall Study|Withdrawal by Subject|40
7690519|NCT00358436|12109794|FG001|Overall Study|Withdrawal by Subject|17
7690520|NCT00358436|12109793|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4
7690521|NCT00358436|12109794|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0
7690522|NCT00358436|12109793|FG000|Overall Study|COPD exacerbation|22
7690523|NCT00358436|12109794|FG001|Overall Study|COPD exacerbation|10
7690524|NCT00358436|12109793|FG000|Overall Study|Other|6
7690525|NCT00358436|12109794|FG001|Overall Study|Other|1
7690526|NCT00358449|12109805|FG000|Overall Study|Adverse Event|1
7690527|NCT00358449|12109806|FG001|Overall Study|Adverse Event|0
7690528|NCT00358449|12109807|FG002|Overall Study|Adverse Event|1
7690529|NCT00358449|12109805|FG000|Overall Study|Lost to Follow-up|1
7690530|NCT00358449|12109806|FG001|Overall Study|Lost to Follow-up|0
7690531|NCT00358449|12109807|FG002|Overall Study|Lost to Follow-up|0
7690532|NCT00358449|12109805|FG000|Overall Study|Withdrawal by Subject|2
7690533|NCT00358449|12109806|FG001|Overall Study|Withdrawal by Subject|0
7690534|NCT00358449|12109807|FG002|Overall Study|Withdrawal by Subject|0
7690535|NCT00358449|12109805|FG000|Overall Study|Lack of Efficacy|0
7690536|NCT00358449|12109806|FG001|Overall Study|Lack of Efficacy|1
7690537|NCT00358449|12109807|FG002|Overall Study|Lack of Efficacy|0
7690538|NCT00358449|12109805|FG000|Overall Study|Steriod Inhaler was Increased|0
7690539|NCT00358449|12109806|FG001|Overall Study|Steriod Inhaler was Increased|0
7690540|NCT00358449|12109807|FG002|Overall Study|Steriod Inhaler was Increased|1
7690541|NCT00358644|12109855|FG000|Overall Study|Progressive Disease|21
7690542|NCT00358644|12109855|FG000|Overall Study|Adverse Event|7
7690543|NCT00358644|12109855|FG000|Overall Study|Death|11
7690544|NCT00358644|12109855|FG000|Overall Study|Withdrawal by Subject|4
7690545|NCT00358644|12109855|FG000|Overall Study|Physician Decision|6
7690546|NCT00358644|12109855|FG000|Overall Study|Patient not eligible for study|1
7690547|NCT00358670|12109865|FG000|Overall Study|Adverse Event|26
7690548|NCT00358670|12109866|FG001|Overall Study|Adverse Event|29
7690549|NCT00358670|12109865|FG000|Overall Study|Lack of Efficacy|20
7690550|NCT00358670|12109866|FG001|Overall Study|Lack of Efficacy|23
7690551|NCT00358670|12109865|FG000|Overall Study|Protocol Violation|6
7690552|NCT00358670|12109866|FG001|Overall Study|Protocol Violation|9
7690553|NCT00358670|12109865|FG000|Overall Study|Lost to Follow-up|4
7690554|NCT00358670|12109866|FG001|Overall Study|Lost to Follow-up|5
7690555|NCT00358670|12109865|FG000|Overall Study|Withdrawal by Subject|13
7690556|NCT00358670|12109866|FG001|Overall Study|Withdrawal by Subject|24
7690557|NCT00358670|12109865|FG000|Overall Study|Protocol Defined Clinical Event|0
7690558|NCT00358670|12109866|FG001|Overall Study|Protocol Defined Clinical Event|1
7690559|NCT00358670|12109865|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
7690560|NCT00358670|12109866|FG001|Overall Study|Did Not Meet Protocol Eligibility|3
7690561|NCT00358670|12109865|FG000|Overall Study|Administrative|153
7690562|NCT00358670|12109866|FG001|Overall Study|Administrative|125
7690563|NCT00358826|12109885|FG000|Core Study|Adverse Event|1
7690564|NCT00358826|12109886|FG001|Core Study|Adverse Event|3
7690565|NCT00358826|12109887|FG002|Core Study|Adverse Event|1
7690566|NCT00358826|12109888|FG003|Core Study|Adverse Event|1
7690567|NCT00358826|12109889|FG004|Core Study|Adverse Event|0
7690568|NCT00358826|12109890|FG005|Core Study|Adverse Event|0
7690569|NCT00358826|12109891|FG006|Core Study|Adverse Event|0
7690570|NCT00358826|12109892|FG007|Core Study|Adverse Event|0
7690571|NCT00358826|12109885|FG000|Core Study|Withdrawal by Subject|2
7690572|NCT00358826|12109886|FG001|Core Study|Withdrawal by Subject|2
7690573|NCT00358826|12109887|FG002|Core Study|Withdrawal by Subject|0
7690574|NCT00358826|12109888|FG003|Core Study|Withdrawal by Subject|0
7690575|NCT00358826|12109889|FG004|Core Study|Withdrawal by Subject|0
7690576|NCT00358826|12109890|FG005|Core Study|Withdrawal by Subject|0
7690577|NCT00358826|12109891|FG006|Core Study|Withdrawal by Subject|0
7690578|NCT00358826|12109892|FG007|Core Study|Withdrawal by Subject|0
7690579|NCT00358826|12109885|FG000|Core Study|Lost to Follow-up|0
7690580|NCT00358826|12109886|FG001|Core Study|Lost to Follow-up|0
7690581|NCT00358826|12109887|FG002|Core Study|Lost to Follow-up|0
7690582|NCT00358826|12109888|FG003|Core Study|Lost to Follow-up|1
7690583|NCT00358826|12109889|FG004|Core Study|Lost to Follow-up|0
7690584|NCT00358826|12109890|FG005|Core Study|Lost to Follow-up|0
7690585|NCT00358826|12109891|FG006|Core Study|Lost to Follow-up|0
7690586|NCT00358826|12109892|FG007|Core Study|Lost to Follow-up|0
7690587|NCT00358826|12109885|FG000|Core Study|Physician Decision|0
7690588|NCT00358826|12109886|FG001|Core Study|Physician Decision|0
7690589|NCT00358826|12109887|FG002|Core Study|Physician Decision|1
7690590|NCT00358826|12109888|FG003|Core Study|Physician Decision|0
7690591|NCT00358826|12109889|FG004|Core Study|Physician Decision|0
7690592|NCT00358826|12109890|FG005|Core Study|Physician Decision|0
7690593|NCT00358826|12109891|FG006|Core Study|Physician Decision|0
7690594|NCT00358826|12109892|FG007|Core Study|Physician Decision|0
7690595|NCT00358826|12109885|FG000|MDCT Substudy|Adverse Event|0
7690596|NCT00358826|12109886|FG001|MDCT Substudy|Adverse Event|0
7690597|NCT00358826|12109887|FG002|MDCT Substudy|Adverse Event|0
7690598|NCT00358826|12109888|FG003|MDCT Substudy|Adverse Event|0
7690599|NCT00358826|12109889|FG004|MDCT Substudy|Adverse Event|1
7690600|NCT00358826|12109890|FG005|MDCT Substudy|Adverse Event|0
7690601|NCT00358826|12109891|FG006|MDCT Substudy|Adverse Event|0
7690602|NCT00358826|12109892|FG007|MDCT Substudy|Adverse Event|0
7690603|NCT00358826|12109885|FG000|MDCT Substudy|Lost to Follow-up|0
7690604|NCT00358826|12109886|FG001|MDCT Substudy|Lost to Follow-up|0
7690605|NCT00358826|12109887|FG002|MDCT Substudy|Lost to Follow-up|0
7690606|NCT00358826|12109888|FG003|MDCT Substudy|Lost to Follow-up|0
7690607|NCT00358826|12109889|FG004|MDCT Substudy|Lost to Follow-up|0
7690608|NCT00358826|12109890|FG005|MDCT Substudy|Lost to Follow-up|1
7690609|NCT00358826|12109891|FG006|MDCT Substudy|Lost to Follow-up|0
7690610|NCT00358826|12109892|FG007|MDCT Substudy|Lost to Follow-up|0
7690611|NCT00358826|12109885|FG000|MDCT Substudy|Withdrawal by Subject|0
7690612|NCT00358826|12109886|FG001|MDCT Substudy|Withdrawal by Subject|0
7690613|NCT00358826|12109887|FG002|MDCT Substudy|Withdrawal by Subject|0
7690614|NCT00358826|12109888|FG003|MDCT Substudy|Withdrawal by Subject|0
7690615|NCT00358826|12109889|FG004|MDCT Substudy|Withdrawal by Subject|0
7690616|NCT00358826|12109890|FG005|MDCT Substudy|Withdrawal by Subject|1
7690617|NCT00358826|12109891|FG006|MDCT Substudy|Withdrawal by Subject|0
7690618|NCT00358826|12109892|FG007|MDCT Substudy|Withdrawal by Subject|0
7690619|NCT00358917|12109908|FG000|Overall Study|Adverse Event|14
7690620|NCT00358917|12109909|FG001|Overall Study|Adverse Event|21
7690621|NCT00358917|12109908|FG000|Overall Study|Withdrawal by Subject|5
7690622|NCT00358917|12109909|FG001|Overall Study|Withdrawal by Subject|7
7690623|NCT00358917|12109908|FG000|Overall Study|Lost to Follow-up|20
7690624|NCT00358917|12109909|FG001|Overall Study|Lost to Follow-up|17
7690625|NCT00358917|12109908|FG000|Overall Study|Noncompliance|12
7690626|NCT00358917|12109909|FG001|Overall Study|Noncompliance|11
7690627|NCT00358917|12109908|FG000|Overall Study|Death|2
7690628|NCT00358917|12109909|FG001|Overall Study|Death|3
7690629|NCT00358917|12109908|FG000|Overall Study|Virologic failure|11
7690630|NCT00358917|12109909|FG001|Overall Study|Virologic failure|8
7690631|NCT00358917|12109908|FG000|Overall Study|Unable to Continue Participation|2
7690632|NCT00358917|12109909|FG001|Overall Study|Unable to Continue Participation|2
7690633|NCT00358956|12109917|FG000|Overall Study|Adverse Event|3
7690634|NCT00358956|12109917|FG000|Overall Study|condition under investigation worsened|4
7690635|NCT00358956|12109917|FG000|Overall Study|Withdrawal by Subject|1
7690636|NCT00359021|12109923|FG000|Overall Study|Adverse Event|26
7690637|NCT00359021|12109924|FG001|Overall Study|Adverse Event|8
7690638|NCT00359021|12109923|FG000|Overall Study|Subject Non-Compliant|1
7690639|NCT00359021|12109924|FG001|Overall Study|Subject Non-Compliant|2
7690640|NCT00359021|12109923|FG000|Overall Study|Subject Ineligible To Continue The Trial|1
7690641|NCT00359021|12109924|FG001|Overall Study|Subject Ineligible To Continue The Trial|0
7690642|NCT00359021|12109923|FG000|Overall Study|Subject Reached A Virologic Endpoint|45
7690643|NCT00359021|12109924|FG001|Overall Study|Subject Reached A Virologic Endpoint|32
7690644|NCT00359021|12109923|FG000|Overall Study|Withdrawal by Subject|2
7690645|NCT00359021|12109924|FG001|Overall Study|Withdrawal by Subject|9
7690646|NCT00359021|12109923|FG000|Overall Study|Lost to Follow-up|1
7690647|NCT00359021|12109924|FG001|Overall Study|Lost to Follow-up|0
7690648|NCT00359021|12109923|FG000|Overall Study|Other|4
7690649|NCT00359021|12109924|FG001|Overall Study|Other|1
7690650|NCT00359021|12109923|FG000|Overall Study|Pregnancy|1
7690651|NCT00359021|12109924|FG001|Overall Study|Pregnancy|0
7690652|NCT00359073|12109934|FG000|Overall Study|Withdrawal by Subject|1
7690653|NCT00359073|12109935|FG001|Overall Study|Withdrawal by Subject|1
7690654|NCT00359073|12109934|FG000|Overall Study|Eligibility criteria no longer met|3
7690655|NCT00359073|12109935|FG001|Overall Study|Eligibility criteria no longer met|0
7690656|NCT00359073|12109934|FG000|Overall Study|developed RV16 antibody|0
7690657|NCT00359073|12109935|FG001|Overall Study|developed RV16 antibody|1
7690658|NCT00359281|12109961|FG000|Overall Study|Adverse Event|1
7690659|NCT00359281|12109962|FG001|Overall Study|Adverse Event|0
7690660|NCT00359281|12109963|FG002|Overall Study|Adverse Event|0
7690661|NCT00359281|12109964|FG003|Overall Study|Adverse Event|0
7690662|NCT00359281|12109965|FG004|Overall Study|Adverse Event|0
7690663|NCT00359281|12109966|FG005|Overall Study|Adverse Event|0
7690664|NCT00359281|12109967|FG006|Overall Study|Adverse Event|1
7690665|NCT00359281|12109968|FG007|Overall Study|Adverse Event|0
7690666|NCT00359281|12109969|FG008|Overall Study|Adverse Event|0
7690667|NCT00359281|12109961|FG000|Overall Study|Withdrawal by Subject|0
7690668|NCT00359281|12109962|FG001|Overall Study|Withdrawal by Subject|0
7690669|NCT00359281|12109963|FG002|Overall Study|Withdrawal by Subject|0
7690670|NCT00359281|12109964|FG003|Overall Study|Withdrawal by Subject|0
7690671|NCT00359281|12109965|FG004|Overall Study|Withdrawal by Subject|0
7690672|NCT00359281|12109966|FG005|Overall Study|Withdrawal by Subject|0
7690673|NCT00359281|12109967|FG006|Overall Study|Withdrawal by Subject|1
7690674|NCT00359281|12109968|FG007|Overall Study|Withdrawal by Subject|0
7690675|NCT00359281|12109969|FG008|Overall Study|Withdrawal by Subject|0
7690676|NCT00359294|12110001|FG000|Overall Study|Progressive disease|1
7690677|NCT00359294|12110002|FG001|Overall Study|Progressive disease|1
7690678|NCT00359294|12110003|FG002|Overall Study|Progressive disease|2
7690679|NCT00359294|12110004|FG003|Overall Study|Progressive disease|3
7690680|NCT00359294|12110005|FG004|Overall Study|Progressive disease|2
7690681|NCT00359294|12110001|FG000|Overall Study|Withdrawal by Subject|0
7690682|NCT00359294|12110002|FG001|Overall Study|Withdrawal by Subject|0
7690683|NCT00359294|12110003|FG002|Overall Study|Withdrawal by Subject|0
7690684|NCT00359294|12110004|FG003|Overall Study|Withdrawal by Subject|0
7690685|NCT00359294|12110005|FG004|Overall Study|Withdrawal by Subject|1
7690686|NCT00359294|12110001|FG000|Overall Study|Not treated|0
7690687|NCT00359294|12110002|FG001|Overall Study|Not treated|0
7690688|NCT00359294|12110003|FG002|Overall Study|Not treated|0
7690689|NCT00359294|12110004|FG003|Overall Study|Not treated|1
7690690|NCT00359294|12110005|FG004|Overall Study|Not treated|0
7690691|NCT00359294|12110001|FG000|Overall Study|Physician Decision|0
7690692|NCT00359294|12110002|FG001|Overall Study|Physician Decision|0
7690693|NCT00359294|12110003|FG002|Overall Study|Physician Decision|1
7690694|NCT00359294|12110004|FG003|Overall Study|Physician Decision|0
7690695|NCT00359294|12110005|FG004|Overall Study|Physician Decision|0
7690696|NCT00359424|12110015|FG000|Overall Study|Death|99
7690697|NCT00359424|12110016|FG001|Overall Study|Death|58
7690698|NCT00359424|12110015|FG000|Overall Study|Lost to Follow-up|19
7690699|NCT00359424|12110016|FG001|Overall Study|Lost to Follow-up|7
7690700|NCT00359424|12110015|FG000|Overall Study|Withdrawal by Subject|10
7690701|NCT00359424|12110016|FG001|Overall Study|Withdrawal by Subject|2
7690702|NCT00359424|12110015|FG000|Overall Study|follow up not conducted|2
7690703|NCT00359424|12110016|FG001|Overall Study|follow up not conducted|0
7690704|NCT00359619|12110029|FG000|Overall Study|Adverse Event|0
7690705|NCT00359619|12110030|FG001|Overall Study|Adverse Event|0
7690706|NCT00359619|12110031|FG002|Overall Study|Adverse Event|1
7690707|NCT00359619|12110032|FG003|Overall Study|Adverse Event|0
7690708|NCT00359619|12110033|FG004|Overall Study|Adverse Event|0
7690709|NCT00359619|12110034|FG005|Overall Study|Adverse Event|0
7690710|NCT00359619|12110035|FG006|Overall Study|Adverse Event|1
7690711|NCT00359619|12110029|FG000|Overall Study|Withdrawal by Subject|3
7690712|NCT00359619|12110030|FG001|Overall Study|Withdrawal by Subject|1
7690713|NCT00359619|12110031|FG002|Overall Study|Withdrawal by Subject|4
7690714|NCT00359619|12110032|FG003|Overall Study|Withdrawal by Subject|2
7690715|NCT00359619|12110033|FG004|Overall Study|Withdrawal by Subject|2
7690716|NCT00359619|12110034|FG005|Overall Study|Withdrawal by Subject|0
7690717|NCT00359619|12110035|FG006|Overall Study|Withdrawal by Subject|3
7690718|NCT00359619|12110029|FG000|Overall Study|Other|1
7690719|NCT00359619|12110030|FG001|Overall Study|Other|0
7690720|NCT00359619|12110031|FG002|Overall Study|Other|0
7690721|NCT00359619|12110032|FG003|Overall Study|Other|0
7690722|NCT00359619|12110033|FG004|Overall Study|Other|0
7690723|NCT00359619|12110034|FG005|Overall Study|Other|0
7690724|NCT00359619|12110035|FG006|Overall Study|Other|0
7690725|NCT00359619|12110029|FG000|Overall Study|Lost to Follow-up|4
7690726|NCT00359619|12110030|FG001|Overall Study|Lost to Follow-up|4
7690727|NCT00359619|12110031|FG002|Overall Study|Lost to Follow-up|2
7690728|NCT00359619|12110032|FG003|Overall Study|Lost to Follow-up|1
7690729|NCT00359619|12110033|FG004|Overall Study|Lost to Follow-up|1
7690730|NCT00359619|12110034|FG005|Overall Study|Lost to Follow-up|5
7690731|NCT00359619|12110035|FG006|Overall Study|Lost to Follow-up|0
7690732|NCT00359632|12110053|FG000|Overall Study|Death|2
7690733|NCT00359632|12110054|FG001|Overall Study|Death|0
7690734|NCT00359632|12110053|FG000|Overall Study|Adverse Event|1
7690735|NCT00359632|12110054|FG001|Overall Study|Adverse Event|0
7690736|NCT00359632|12110053|FG000|Overall Study|Non-compliance with visit schedule|1
7690737|NCT00359632|12110054|FG001|Overall Study|Non-compliance with visit schedule|0
7690738|NCT00359762|12110073|FG000|Period II|Adverse Event|17
7690739|NCT00359762|12110074|FG001|Period II|Adverse Event|0
7690740|NCT00359762|12110075|FG002|Period II|Adverse Event|0
7690741|NCT00359762|12110076|FG003|Period II|Adverse Event|0
7690742|NCT00359762|12110077|FG004|Period II|Adverse Event|49
7690743|NCT00359762|12110073|FG000|Period II|Protocol Violation|18
7690744|NCT00359762|12110074|FG001|Period II|Protocol Violation|0
7690745|NCT00359762|12110075|FG002|Period II|Protocol Violation|0
7690746|NCT00359762|12110076|FG003|Period II|Protocol Violation|0
7690747|NCT00359762|12110077|FG004|Period II|Protocol Violation|11
7690748|NCT00359762|12110073|FG000|Period II|Physician Decision|17
7690749|NCT00359762|12110074|FG001|Period II|Physician Decision|0
7690750|NCT00359762|12110075|FG002|Period II|Physician Decision|0
7690751|NCT00359762|12110076|FG003|Period II|Physician Decision|0
7690752|NCT00359762|12110077|FG004|Period II|Physician Decision|23
7690753|NCT00359762|12110073|FG000|Period II|Death|2
7690754|NCT00359762|12110074|FG001|Period II|Death|0
7690755|NCT00359762|12110075|FG002|Period II|Death|0
7690756|NCT00359762|12110076|FG003|Period II|Death|0
7690757|NCT00359762|12110077|FG004|Period II|Death|4
7690758|NCT00359762|12110073|FG000|Period II|Lack of Efficacy|11
7690759|NCT00359762|12110074|FG001|Period II|Lack of Efficacy|0
7690760|NCT00359762|12110075|FG002|Period II|Lack of Efficacy|0
7690761|NCT00359762|12110076|FG003|Period II|Lack of Efficacy|0
7690762|NCT00359762|12110077|FG004|Period II|Lack of Efficacy|8
7690763|NCT00359762|12110073|FG000|Period II|Lost to follow up|5
7690764|NCT00359762|12110074|FG001|Period II|Lost to follow up|0
7690765|NCT00359762|12110075|FG002|Period II|Lost to follow up|0
7690766|NCT00359762|12110076|FG003|Period II|Lost to follow up|0
7690767|NCT00359762|12110077|FG004|Period II|Lost to follow up|5
7690768|NCT00359762|12110073|FG000|Period II|Entry Criteria Not Met|8
7690769|NCT00359762|12110074|FG001|Period II|Entry Criteria Not Met|0
7690770|NCT00359762|12110075|FG002|Period II|Entry Criteria Not Met|0
7690771|NCT00359762|12110076|FG003|Period II|Entry Criteria Not Met|0
7690772|NCT00359762|12110077|FG004|Period II|Entry Criteria Not Met|4
7690773|NCT00359762|12110073|FG000|Period II|Subject Decision|50
7690774|NCT00359762|12110074|FG001|Period II|Subject Decision|0
7690775|NCT00359762|12110075|FG002|Period II|Subject Decision|0
7690776|NCT00359762|12110076|FG003|Period II|Subject Decision|0
7690777|NCT00359762|12110077|FG004|Period II|Subject Decision|70
7690778|NCT00359762|12110073|FG000|Period III|Protocol Violation|0
7690779|NCT00359762|12110074|FG001|Period III|Protocol Violation|5
7690780|NCT00359762|12110075|FG002|Period III|Protocol Violation|3
7690781|NCT00359762|12110076|FG003|Period III|Protocol Violation|8
7690782|NCT00359762|12110077|FG004|Period III|Protocol Violation|0
7690783|NCT00359762|12110073|FG000|Period III|Adverse Event|0
7690784|NCT00359762|12110074|FG001|Period III|Adverse Event|3
7690785|NCT00359762|12110075|FG002|Period III|Adverse Event|4
7690786|NCT00359762|12110076|FG003|Period III|Adverse Event|10
7690787|NCT00359762|12110077|FG004|Period III|Adverse Event|0
7690788|NCT00359762|12110073|FG000|Period III|Physician Decision|0
7690789|NCT00359762|12110074|FG001|Period III|Physician Decision|5
7690790|NCT00359762|12110075|FG002|Period III|Physician Decision|9
7690791|NCT00359762|12110076|FG003|Period III|Physician Decision|15
7690792|NCT00359762|12110077|FG004|Period III|Physician Decision|0
7690793|NCT00359762|12110073|FG000|Period III|Lack of Efficacy|0
7690794|NCT00359762|12110074|FG001|Period III|Lack of Efficacy|7
7690795|NCT00359762|12110075|FG002|Period III|Lack of Efficacy|5
7690796|NCT00359762|12110076|FG003|Period III|Lack of Efficacy|9
7690797|NCT00359762|12110077|FG004|Period III|Lack of Efficacy|0
7690798|NCT00359762|12110073|FG000|Period III|Lost to follow up|0
7690799|NCT00359762|12110074|FG001|Period III|Lost to follow up|1
7690800|NCT00359762|12110075|FG002|Period III|Lost to follow up|1
7690801|NCT00359762|12110076|FG003|Period III|Lost to follow up|2
7690802|NCT00359762|12110077|FG004|Period III|Lost to follow up|0
7690803|NCT00359762|12110073|FG000|Period III|Entry Criteria Not Met|0
7690804|NCT00359762|12110074|FG001|Period III|Entry Criteria Not Met|1
7690805|NCT00359762|12110075|FG002|Period III|Entry Criteria Not Met|0
7690806|NCT00359762|12110076|FG003|Period III|Entry Criteria Not Met|1
7690807|NCT00359762|12110077|FG004|Period III|Entry Criteria Not Met|0
7690808|NCT00359762|12110073|FG000|Period III|Subject Decision|0
7690809|NCT00359762|12110074|FG001|Period III|Subject Decision|7
7690810|NCT00359762|12110075|FG002|Period III|Subject Decision|8
7690811|NCT00359762|12110076|FG003|Period III|Subject Decision|20
7690812|NCT00359762|12110077|FG004|Period III|Subject Decision|0
7690813|NCT00359788|12110093|FG000|Overall Study|Adverse Event|11
7690814|NCT00359788|12110094|FG001|Overall Study|Adverse Event|10
7690815|NCT00359788|12110093|FG000|Overall Study|Lack of Efficacy|1
7690816|NCT00359788|12110094|FG001|Overall Study|Lack of Efficacy|2
7690817|NCT00359788|12110093|FG000|Overall Study|Lost to Follow-up|3
7690818|NCT00359788|12110094|FG001|Overall Study|Lost to Follow-up|2
7690819|NCT00359788|12110093|FG000|Overall Study|Withdrawal by Subject|4
7690820|NCT00359788|12110094|FG001|Overall Study|Withdrawal by Subject|1
7690821|NCT00359788|12110093|FG000|Overall Study|Protocol Violation|4
7690822|NCT00359788|12110094|FG001|Overall Study|Protocol Violation|2
7690823|NCT00359801|12110102|FG000|Overall Study|Lost to Follow-up|72
7690824|NCT00359801|12110103|FG001|Overall Study|Lost to Follow-up|58
7690825|NCT00359801|12110102|FG000|Overall Study|Withdrawal by Subject|143
7690826|NCT00359801|12110103|FG001|Overall Study|Withdrawal by Subject|96
7690827|NCT00359801|12110102|FG000|Overall Study|Other|66
7690828|NCT00359801|12110103|FG001|Overall Study|Other|46
7690829|NCT00359801|12110102|FG000|Overall Study|Final Status Unknown: missing data|7
7690830|NCT00359801|12110103|FG001|Overall Study|Final Status Unknown: missing data|4
7690831|NCT00359801|12110102|FG000|Overall Study|Sponsor Decision|17
7690832|NCT00359801|12110103|FG001|Overall Study|Sponsor Decision|16
7690833|NCT00360230|12110159|FG000|Overall Study|Withdrawal by Subject|1
7690834|NCT00360230|12110160|FG001|Overall Study|Withdrawal by Subject|1
7690835|NCT00360230|12110161|FG002|Overall Study|Withdrawal by Subject|0
7690836|NCT00360230|12110162|FG003|Overall Study|Withdrawal by Subject|1
7690837|NCT00360230|12110163|FG004|Overall Study|Withdrawal by Subject|1
7690838|NCT00360230|12110164|FG005|Overall Study|Withdrawal by Subject|1
7690839|NCT00360230|12110165|FG006|Overall Study|Withdrawal by Subject|0
7690840|NCT00360230|12110159|FG000|Overall Study|Migrated|4
7690841|NCT00360230|12110160|FG001|Overall Study|Migrated|1
7690842|NCT00360230|12110161|FG002|Overall Study|Migrated|3
7690843|NCT00360230|12110162|FG003|Overall Study|Migrated|1
7690844|NCT00360230|12110163|FG004|Overall Study|Migrated|4
7690845|NCT00360230|12110164|FG005|Overall Study|Migrated|1
7690846|NCT00360230|12110165|FG006|Overall Study|Migrated|1
7690847|NCT00360230|12110159|FG000|Overall Study|Other|1
7690848|NCT00360230|12110160|FG001|Overall Study|Other|0
7690849|NCT00360230|12110161|FG002|Overall Study|Other|0
7690850|NCT00360230|12110162|FG003|Overall Study|Other|0
7690851|NCT00360230|12110163|FG004|Overall Study|Other|0
7690852|NCT00360230|12110164|FG005|Overall Study|Other|0
7690853|NCT00360230|12110165|FG006|Overall Study|Other|0
7690854|NCT00360230|12110159|FG000|Overall Study|Protocol Violation|0
7690855|NCT00360230|12110160|FG001|Overall Study|Protocol Violation|0
7690856|NCT00360230|12110161|FG002|Overall Study|Protocol Violation|0
7690857|NCT00360230|12110162|FG003|Overall Study|Protocol Violation|0
7690858|NCT00360230|12110163|FG004|Overall Study|Protocol Violation|0
7690859|NCT00360230|12110164|FG005|Overall Study|Protocol Violation|1
7690860|NCT00360230|12110165|FG006|Overall Study|Protocol Violation|0
7690861|NCT00360230|12110159|FG000|Overall Study|Death|0
7690862|NCT00360230|12110160|FG001|Overall Study|Death|1
7690863|NCT00360230|12110161|FG002|Overall Study|Death|0
7690864|NCT00360230|12110162|FG003|Overall Study|Death|0
7690865|NCT00360230|12110163|FG004|Overall Study|Death|0
7690866|NCT00360230|12110164|FG005|Overall Study|Death|1
7690867|NCT00360230|12110165|FG006|Overall Study|Death|1
7690868|NCT00360269|12110202|FG000|Overall Study|Lost to Follow-up|7
7690869|NCT00360269|12110203|FG001|Overall Study|Lost to Follow-up|9
7690870|NCT00360269|12110202|FG000|Overall Study|Physician Decision|1
7690871|NCT00360269|12110203|FG001|Overall Study|Physician Decision|2
7690872|NCT00360269|12110202|FG000|Overall Study|Adverse Event|1
7690873|NCT00360269|12110203|FG001|Overall Study|Adverse Event|0
7690874|NCT00360269|12110202|FG000|Overall Study|Withdrawal by Subject|1
7690875|NCT00360269|12110203|FG001|Overall Study|Withdrawal by Subject|1
7690876|NCT00360282|12110209|FG000|Washout 1-3 Weeks|Lost to Follow-up|0
7690877|NCT00360282|12110210|FG001|Washout 1-3 Weeks|Lost to Follow-up|0
7690878|NCT00360282|12110211|FG002|Washout 1-3 Weeks|Lost to Follow-up|1
7690879|NCT00360282|12110212|FG003|Washout 1-3 Weeks|Lost to Follow-up|0
7690880|NCT00360282|12110209|FG000|Second Intervention|Adverse Event|0
7690881|NCT00360282|12110210|FG001|Second Intervention|Adverse Event|1
7690882|NCT00360282|12110211|FG002|Second Intervention|Adverse Event|0
7690883|NCT00360282|12110212|FG003|Second Intervention|Adverse Event|0
7690884|NCT00360308|12110223|FG000|Overall Study|Adverse Event|15
7690885|NCT00360308|12110224|FG001|Overall Study|Adverse Event|14
7690886|NCT00360308|12110225|FG002|Overall Study|Adverse Event|25
7690887|NCT00360308|12110223|FG000|Overall Study|Abnormal Laboratory Value(s)|0
7690888|NCT00360308|12110224|FG001|Overall Study|Abnormal Laboratory Value(s)|1
7690889|NCT00360308|12110225|FG002|Overall Study|Abnormal Laboratory Value(s)|0
7690890|NCT00360308|12110223|FG000|Overall Study|Protocol Violation|2
7690891|NCT00360308|12110224|FG001|Overall Study|Protocol Violation|1
7690892|NCT00360308|12110225|FG002|Overall Study|Protocol Violation|2
7690893|NCT00360308|12110223|FG000|Overall Study|Withdrawal by Subject|11
7690894|NCT00360308|12110224|FG001|Overall Study|Withdrawal by Subject|7
7690895|NCT00360308|12110225|FG002|Overall Study|Withdrawal by Subject|14
7690896|NCT00360308|12110223|FG000|Overall Study|Lack of Efficacy|3
7690897|NCT00360308|12110224|FG001|Overall Study|Lack of Efficacy|0
7690898|NCT00360308|12110225|FG002|Overall Study|Lack of Efficacy|2
7690899|NCT00360308|12110223|FG000|Overall Study|Other|2
7690900|NCT00360308|12110224|FG001|Overall Study|Other|1
7690901|NCT00360308|12110225|FG002|Overall Study|Other|1
7690902|NCT00360308|12110223|FG000|Overall Study|Study termination by sponsor|43
7690903|NCT00360308|12110224|FG001|Overall Study|Study termination by sponsor|55
7690904|NCT00360308|12110225|FG002|Overall Study|Study termination by sponsor|44
7690905|NCT00360334|12110239|FG000|Overall Study|Adverse Event|7
7690906|NCT00360334|12110240|FG001|Overall Study|Adverse Event|4
7690907|NCT00360334|12110239|FG000|Overall Study|Protocol Violation|1
7690908|NCT00360334|12110240|FG001|Overall Study|Protocol Violation|1
7690909|NCT00360334|12110239|FG000|Overall Study|Physician Decision|2
7690910|NCT00360334|12110240|FG001|Overall Study|Physician Decision|3
7690911|NCT00360334|12110239|FG000|Overall Study|Lack of Efficacy|0
7690912|NCT00360334|12110240|FG001|Overall Study|Lack of Efficacy|1
7690913|NCT00360334|12110239|FG000|Overall Study|Entry criterion not met|1
7690914|NCT00360334|12110240|FG001|Overall Study|Entry criterion not met|2
7690915|NCT00360334|12110239|FG000|Overall Study|Subject decision|8
7690916|NCT00360334|12110240|FG001|Overall Study|Subject decision|2
7690917|NCT00360412|12110265|FG000|Overall Study|Adverse Event|37
7690918|NCT00360412|12110266|FG001|Overall Study|Adverse Event|65
7690919|NCT00360412|12110265|FG000|Overall Study|Protocol Violation|2
7690920|NCT00360412|12110266|FG001|Overall Study|Protocol Violation|5
7690921|NCT00360412|12110265|FG000|Overall Study|Patient withdrew consent|27
7690922|NCT00360412|12110266|FG001|Overall Study|Patient withdrew consent|52
7690923|NCT00360412|12110265|FG000|Overall Study|Lack of therapeutic efficacy|46
7690924|NCT00360412|12110266|FG001|Overall Study|Lack of therapeutic efficacy|61
7690925|NCT00360412|12110265|FG000|Overall Study|Physician Decision|2
7690926|NCT00360412|12110266|FG001|Overall Study|Physician Decision|4
7690927|NCT00360412|12110265|FG000|Overall Study|Other|5
7690928|NCT00360412|12110266|FG001|Overall Study|Other|6
7690929|NCT00360412|12110265|FG000|Overall Study|Study termination by Sponsor|214
7690930|NCT00360412|12110266|FG001|Overall Study|Study termination by Sponsor|469
7690931|NCT00360490|12110274|FG000|Overall Study|Adverse Event|4
7690932|NCT00360490|12110275|FG001|Overall Study|Adverse Event|2
7690933|NCT00360490|12110274|FG000|Overall Study|Lost to Follow-up|2
7690934|NCT00360490|12110275|FG001|Overall Study|Lost to Follow-up|1
7690935|NCT00360490|12110274|FG000|Overall Study|Physician Decision|2
7690936|NCT00360490|12110275|FG001|Overall Study|Physician Decision|1
7690937|NCT00360490|12110274|FG000|Overall Study|Protocol Violation|0
7690938|NCT00360490|12110275|FG001|Overall Study|Protocol Violation|4
7690939|NCT00360490|12110274|FG000|Overall Study|Withdrawal by Subject|1
7690940|NCT00360490|12110275|FG001|Overall Study|Withdrawal by Subject|3
7690941|NCT00360529|12110284|FG000|Overall Study|Adverse Event|10
7690942|NCT00360529|12110285|FG001|Overall Study|Adverse Event|23
7690943|NCT00360529|12110286|FG002|Overall Study|Adverse Event|33
7690944|NCT00360529|12110284|FG000|Overall Study|Protocol Violation|3
7690945|NCT00360529|12110285|FG001|Overall Study|Protocol Violation|3
7690946|NCT00360529|12110286|FG002|Overall Study|Protocol Violation|11
7690947|NCT00360529|12110284|FG000|Overall Study|Lost to Follow-up|14
7690948|NCT00360529|12110285|FG001|Overall Study|Lost to Follow-up|10
7690949|NCT00360529|12110286|FG002|Overall Study|Lost to Follow-up|13
7690950|NCT00360529|12110284|FG000|Overall Study|Withdrawal by Subject|22
7690951|NCT00360529|12110285|FG001|Overall Study|Withdrawal by Subject|14
7690952|NCT00360529|12110286|FG002|Overall Study|Withdrawal by Subject|18
7690953|NCT00360529|12110284|FG000|Overall Study|Lack of Efficacy|8
7690954|NCT00360529|12110285|FG001|Overall Study|Lack of Efficacy|6
7690955|NCT00360529|12110286|FG002|Overall Study|Lack of Efficacy|5
7690956|NCT00360529|12110284|FG000|Overall Study|Reason discontinued not explained above|4
7690957|NCT00360529|12110285|FG001|Overall Study|Reason discontinued not explained above|9
7690958|NCT00360529|12110286|FG002|Overall Study|Reason discontinued not explained above|11
7690959|NCT00360568|12110313|FG000|Overall Study|Adverse Event|1
7690960|NCT00360568|12110314|FG001|Overall Study|Adverse Event|2
7690961|NCT00360568|12110313|FG000|Overall Study|Lack of Efficacy|1
7690962|NCT00360568|12110314|FG001|Overall Study|Lack of Efficacy|0
7690963|NCT00360568|12110313|FG000|Overall Study|Withdrawal by Subject|0
7690964|NCT00360568|12110314|FG001|Overall Study|Withdrawal by Subject|3
7690965|NCT00360698|12110338|FG000|Run-In|Physician Decision|0
7690966|NCT00360698|12110339|FG001|Run-In|Physician Decision|1
7690967|NCT00360698|12110338|FG000|Run-In|Withdrawal by Subject|0
7690968|NCT00360698|12110339|FG001|Run-In|Withdrawal by Subject|2
7690969|NCT00360698|12110338|FG000|Run-In|Non compliance with treatment procedure|0
7690970|NCT00360698|12110339|FG001|Run-In|Non compliance with treatment procedure|1
7690971|NCT00360698|12110338|FG000|Run-In|Sponsor request|0
7690972|NCT00360698|12110339|FG001|Run-In|Sponsor request|2
7690973|NCT00360698|12110338|FG000|Run-In|Patient did not meet inclusion criteria|0
7690974|NCT00360698|12110339|FG001|Run-In|Patient did not meet inclusion criteria|1
7690975|NCT00360698|12110338|FG000|Run-In|Patient personal reasons|0
7690976|NCT00360698|12110339|FG001|Run-In|Patient personal reasons|2
7690977|NCT00360698|12110338|FG000|Run-In|Need of insulin with meals|0
7690978|NCT00360698|12110339|FG001|Run-In|Need of insulin with meals|1
7690979|NCT00360698|12110338|FG000|Treatment Period|Non compliance with treatment procedure|1
7690980|NCT00360698|12110339|FG001|Treatment Period|Non compliance with treatment procedure|0
7690981|NCT00360698|12110338|FG000|Treatment Period|Early termination by error|0
7690982|NCT00360698|12110339|FG001|Treatment Period|Early termination by error|1
7690983|NCT00361218|12110383|FG000|Overall Study|Lost to Follow-up|11
7690984|NCT00361218|12110383|FG000|Overall Study|Personal Reasons|7
7690985|NCT00361218|12110383|FG000|Overall Study|terminated / withdrawn due to toxicity /|5
7690986|NCT00361231|12110387|FG000|Overall Study|Physician Decision|3
7690987|NCT00361231|12110387|FG000|Overall Study|Symptomatic deterioration|5
7690988|NCT00361231|12110387|FG000|Overall Study|Radiographic disease progression|16
7690989|NCT00361231|12110387|FG000|Overall Study|Withdrawal by Subject|4
7690990|NCT00361231|12110387|FG000|Overall Study|Adverse Event|6
7690991|NCT00361270|12110406|FG000|Overall Study|Death|0
7690992|NCT00361270|12110407|FG001|Overall Study|Death|0
7690993|NCT00361270|12110408|FG002|Overall Study|Death|0
7690994|NCT00361270|12110409|FG003|Overall Study|Death|2
7690995|NCT00361270|12110406|FG000|Overall Study|Lost to Follow-up|4
7690996|NCT00361270|12110407|FG001|Overall Study|Lost to Follow-up|1
7690997|NCT00361270|12110408|FG002|Overall Study|Lost to Follow-up|0
7690998|NCT00361270|12110409|FG003|Overall Study|Lost to Follow-up|0
7690999|NCT00361270|12110406|FG000|Overall Study|Physician Decision|0
7691000|NCT00361270|12110407|FG001|Overall Study|Physician Decision|0
7691001|NCT00361270|12110408|FG002|Overall Study|Physician Decision|1
7691002|NCT00361270|12110409|FG003|Overall Study|Physician Decision|0
7691003|NCT00361270|12110406|FG000|Overall Study|Protocol Violation|9
7691004|NCT00361270|12110407|FG001|Overall Study|Protocol Violation|4
7691005|NCT00361270|12110408|FG002|Overall Study|Protocol Violation|5
7691006|NCT00361270|12110409|FG003|Overall Study|Protocol Violation|4
7691007|NCT00361270|12110406|FG000|Overall Study|Withdrawal by Subject|6
7691008|NCT00361270|12110407|FG001|Overall Study|Withdrawal by Subject|6
7691009|NCT00361270|12110408|FG002|Overall Study|Withdrawal by Subject|3
7691010|NCT00361270|12110409|FG003|Overall Study|Withdrawal by Subject|7
7691011|NCT00361270|12110406|FG000|Overall Study|Afraid of Hypnosis|1
7691012|NCT00361270|12110407|FG001|Overall Study|Afraid of Hypnosis|2
7691013|NCT00361270|12110408|FG002|Overall Study|Afraid of Hypnosis|0
7691014|NCT00361270|12110409|FG003|Overall Study|Afraid of Hypnosis|0
7691015|NCT00361270|12110406|FG000|Overall Study|Problems with Transportation|4
7691016|NCT00361270|12110407|FG001|Overall Study|Problems with Transportation|0
7691017|NCT00361270|12110408|FG002|Overall Study|Problems with Transportation|0
7691018|NCT00361270|12110409|FG003|Overall Study|Problems with Transportation|0
7691019|NCT00361270|12110406|FG000|Overall Study|Adverse Event|0
7691020|NCT00361270|12110407|FG001|Overall Study|Adverse Event|1
7691021|NCT00361270|12110408|FG002|Overall Study|Adverse Event|1
7691022|NCT00361270|12110409|FG003|Overall Study|Adverse Event|0
7691023|NCT00361283|12110426|FG000|Overall Study|Lost to Follow-up|27
7691024|NCT00361296|12110430|FG000|Overall Study|Physician Decision|1
7691025|NCT00361296|12110430|FG000|Overall Study|Lack of Efficacy|2
7691026|NCT00361335|12110439|FG000|IV Period: Baseline to E0|Adverse Event|9
7691027|NCT00361335|12110440|FG001|IV Period: Baseline to E0|Adverse Event|4
7691028|NCT00361335|12110441|FG002|IV Period: Baseline to E0|Adverse Event|5
7691029|NCT00361335|12110442|FG003|IV Period: Baseline to E0|Adverse Event|9
7691030|NCT00361335|12110443|FG004|IV Period: Baseline to E0|Adverse Event|8
7691031|NCT00361335|12110444|FG005|IV Period: Baseline to E0|Adverse Event|0
7691032|NCT00361335|12110445|FG006|IV Period: Baseline to E0|Adverse Event|0
7691033|NCT00361335|12110439|FG000|IV Period: Baseline to E0|Lost to Follow-up|1
7691034|NCT00361335|12110440|FG001|IV Period: Baseline to E0|Lost to Follow-up|0
7691035|NCT00361335|12110441|FG002|IV Period: Baseline to E0|Lost to Follow-up|0
7691036|NCT00361335|12110442|FG003|IV Period: Baseline to E0|Lost to Follow-up|2
7691037|NCT00361335|12110443|FG004|IV Period: Baseline to E0|Lost to Follow-up|2
7691038|NCT00361335|12110444|FG005|IV Period: Baseline to E0|Lost to Follow-up|0
7691039|NCT00361335|12110445|FG006|IV Period: Baseline to E0|Lost to Follow-up|0
7691040|NCT00361335|12110439|FG000|IV Period: Baseline to E0|Death|1
7691041|NCT00361335|12110440|FG001|IV Period: Baseline to E0|Death|1
7691042|NCT00361335|12110441|FG002|IV Period: Baseline to E0|Death|1
7691043|NCT00361335|12110442|FG003|IV Period: Baseline to E0|Death|1
7691044|NCT00361335|12110443|FG004|IV Period: Baseline to E0|Death|0
7691045|NCT00361335|12110444|FG005|IV Period: Baseline to E0|Death|0
7691046|NCT00361335|12110445|FG006|IV Period: Baseline to E0|Death|0
7691047|NCT00361335|12110439|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2
7691048|NCT00361335|12110440|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1
7691049|NCT00361335|12110441|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1
7691050|NCT00361335|12110442|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1
7691051|NCT00361335|12110443|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2
7691052|NCT00361335|12110444|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0
7691053|NCT00361335|12110445|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0
7691054|NCT00361335|12110439|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0
7691055|NCT00361335|12110440|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0
7691056|NCT00361335|12110441|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1
7691057|NCT00361335|12110442|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0
7691058|NCT00361335|12110443|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0
7691059|NCT00361335|12110444|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0
7691060|NCT00361335|12110445|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0
7691061|NCT00361335|12110439|FG000|IV Period: Baseline to E0|Worsening of RA|0
7691062|NCT00361335|12110440|FG001|IV Period: Baseline to E0|Worsening of RA|5
7691063|NCT00361335|12110441|FG002|IV Period: Baseline to E0|Worsening of RA|1
7691064|NCT00361335|12110442|FG003|IV Period: Baseline to E0|Worsening of RA|4
7691065|NCT00361335|12110443|FG004|IV Period: Baseline to E0|Worsening of RA|2
7691066|NCT00361335|12110444|FG005|IV Period: Baseline to E0|Worsening of RA|0
7691067|NCT00361335|12110445|FG006|IV Period: Baseline to E0|Worsening of RA|0
7691068|NCT00361335|12110439|FG000|IV Period: Baseline to E0|Other|2
7691069|NCT00361335|12110440|FG001|IV Period: Baseline to E0|Other|9
7691070|NCT00361335|12110441|FG002|IV Period: Baseline to E0|Other|9
7691071|NCT00361335|12110442|FG003|IV Period: Baseline to E0|Other|3
7691072|NCT00361335|12110443|FG004|IV Period: Baseline to E0|Other|2
7691073|NCT00361335|12110444|FG005|IV Period: Baseline to E0|Other|0
7691074|NCT00361335|12110445|FG006|IV Period: Baseline to E0|Other|0
7691075|NCT00361335|12110439|FG000|IV Period: Baseline to E0|Lack of Efficacy|5
7691076|NCT00361335|12110440|FG001|IV Period: Baseline to E0|Lack of Efficacy|9
7691077|NCT00361335|12110441|FG002|IV Period: Baseline to E0|Lack of Efficacy|3
7691078|NCT00361335|12110442|FG003|IV Period: Baseline to E0|Lack of Efficacy|7
7691079|NCT00361335|12110443|FG004|IV Period: Baseline to E0|Lack of Efficacy|8
7691080|NCT00361335|12110444|FG005|IV Period: Baseline to E0|Lack of Efficacy|0
7691081|NCT00361335|12110445|FG006|IV Period: Baseline to E0|Lack of Efficacy|0
7691082|NCT00361335|12110439|FG000|SC Period: Week E0 to Week E24|Adverse Event|0
7691083|NCT00361335|12110440|FG001|SC Period: Week E0 to Week E24|Adverse Event|2
7691084|NCT00361335|12110441|FG002|SC Period: Week E0 to Week E24|Adverse Event|1
7691085|NCT00361335|12110442|FG003|SC Period: Week E0 to Week E24|Adverse Event|2
7691086|NCT00361335|12110443|FG004|SC Period: Week E0 to Week E24|Adverse Event|0
7691087|NCT00361335|12110444|FG005|SC Period: Week E0 to Week E24|Adverse Event|0
7691088|NCT00361335|12110445|FG006|SC Period: Week E0 to Week E24|Adverse Event|2
7691089|NCT00361335|12110439|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1
7691090|NCT00361335|12110440|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0
7691091|NCT00361335|12110441|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1
7691092|NCT00361335|12110442|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0
7691093|NCT00361335|12110443|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0
7691094|NCT00361335|12110444|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0
7691095|NCT00361335|12110445|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1
7691096|NCT00361335|12110439|FG000|SC Period: Week E0 to Week E24|Death|0
7691097|NCT00361335|12110440|FG001|SC Period: Week E0 to Week E24|Death|0
7691098|NCT00361335|12110441|FG002|SC Period: Week E0 to Week E24|Death|0
7691099|NCT00361335|12110442|FG003|SC Period: Week E0 to Week E24|Death|0
7691100|NCT00361335|12110443|FG004|SC Period: Week E0 to Week E24|Death|0
7691101|NCT00361335|12110444|FG005|SC Period: Week E0 to Week E24|Death|0
7691102|NCT00361335|12110445|FG006|SC Period: Week E0 to Week E24|Death|1
7691103|NCT00361335|12110439|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0
7691104|NCT00361335|12110440|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1
7691105|NCT00361335|12110441|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1
7691106|NCT00361335|12110442|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1
7691107|NCT00361335|12110443|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0
7691108|NCT00361335|12110444|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0
7691109|NCT00361335|12110445|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0
7691110|NCT00361335|12110439|FG000|SC Period: Week E0 to Week E24|Other|1
7691111|NCT00361335|12110440|FG001|SC Period: Week E0 to Week E24|Other|0
7691112|NCT00361335|12110441|FG002|SC Period: Week E0 to Week E24|Other|0
7691113|NCT00361335|12110442|FG003|SC Period: Week E0 to Week E24|Other|1
7691114|NCT00361335|12110443|FG004|SC Period: Week E0 to Week E24|Other|0
7691115|NCT00361335|12110444|FG005|SC Period: Week E0 to Week E24|Other|1
7691116|NCT00361335|12110445|FG006|SC Period: Week E0 to Week E24|Other|2
7691117|NCT00361335|12110439|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0
7691118|NCT00361335|12110440|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0
7691119|NCT00361335|12110441|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2
7691120|NCT00361335|12110442|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0
7691121|NCT00361335|12110443|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0
7691122|NCT00361335|12110444|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0
7691123|NCT00361335|12110445|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3
7691124|NCT00361504|12110485|FG000|Overall Study|Withdrawal by Subject|94
7691125|NCT00361504|12110486|FG001|Overall Study|Withdrawal by Subject|31
7691126|NCT00361504|12110485|FG000|Overall Study|Lost to Follow-up|40
7691127|NCT00361504|12110486|FG001|Overall Study|Lost to Follow-up|7
7691128|NCT00361504|12110485|FG000|Overall Study|Adverse Event|203
7691129|NCT00361504|12110486|FG001|Overall Study|Adverse Event|82
7691130|NCT00361504|12110485|FG000|Overall Study|Lack of Efficacy|72
7691131|NCT00361504|12110486|FG001|Overall Study|Lack of Efficacy|7
7691132|NCT00361504|12110485|FG000|Overall Study|Resolution of Pain|2
7691133|NCT00361504|12110486|FG001|Overall Study|Resolution of Pain|0
7691134|NCT00361504|12110485|FG000|Overall Study|Study medication non compliant|42
7691135|NCT00361504|12110486|FG001|Overall Study|Study medication non compliant|15
7691136|NCT00361504|12110485|FG000|Overall Study|All other|28
7691137|NCT00361504|12110486|FG001|Overall Study|All other|3
7691138|NCT00361569|12110496|FG000|Overall Study|Protocol Violation|3
7691139|NCT00361569|12110497|FG001|Overall Study|Protocol Violation|2
7691140|NCT00361569|12110498|FG002|Overall Study|Protocol Violation|4
7691141|NCT00361569|12110499|FG003|Overall Study|Protocol Violation|2
7691142|NCT00361569|12110496|FG000|Overall Study|Withdrawal by Subject|2
7691143|NCT00361569|12110497|FG001|Overall Study|Withdrawal by Subject|1
7691144|NCT00361569|12110498|FG002|Overall Study|Withdrawal by Subject|9
7691145|NCT00361569|12110499|FG003|Overall Study|Withdrawal by Subject|14
7691146|NCT00361569|12110496|FG000|Overall Study|Adverse Event|3
7691147|NCT00361569|12110497|FG001|Overall Study|Adverse Event|5
7691148|NCT00361569|12110498|FG002|Overall Study|Adverse Event|2
7691149|NCT00361569|12110499|FG003|Overall Study|Adverse Event|2
7691150|NCT00361569|12110496|FG000|Overall Study|Lost to Follow-up|2
7691151|NCT00361569|12110497|FG001|Overall Study|Lost to Follow-up|3
7691152|NCT00361569|12110498|FG002|Overall Study|Lost to Follow-up|3
7691153|NCT00361569|12110499|FG003|Overall Study|Lost to Follow-up|2
7691154|NCT00361569|12110496|FG000|Overall Study|Not specified by investigator|2
7691155|NCT00361569|12110497|FG001|Overall Study|Not specified by investigator|0
7691156|NCT00361569|12110498|FG002|Overall Study|Not specified by investigator|0
7691157|NCT00361569|12110499|FG003|Overall Study|Not specified by investigator|1
7691158|NCT00361634|12110513|FG000|Overall Study|Lost to Follow-up|1
7691159|NCT00361634|12110513|FG000|Overall Study|Withdrawal by Subject|1
7691160|NCT00361842|12110528|FG000|Overall Study|Withdrawal by Subject|2
7691161|NCT00361842|12110529|FG001|Overall Study|Withdrawal by Subject|3
7691162|NCT00361842|12110528|FG000|Overall Study|Death|2
7691163|NCT00361842|12110529|FG001|Overall Study|Death|1
7691164|NCT00361842|12110528|FG000|Overall Study|Disease progression|19
7691165|NCT00361842|12110529|FG001|Overall Study|Disease progression|20
7691166|NCT00361842|12110528|FG000|Overall Study|Adverse Event|2
7691167|NCT00361842|12110529|FG001|Overall Study|Adverse Event|3
7691168|NCT00361842|12110528|FG000|Overall Study|Occurrence of unacceptable toxicity|1
7691169|NCT00361842|12110529|FG001|Overall Study|Occurrence of unacceptable toxicity|5
7691170|NCT00361842|12110528|FG000|Overall Study|Other|1
7691171|NCT00361842|12110529|FG001|Overall Study|Other|0
7691172|NCT00361842|12110528|FG000|Overall Study|Other|0
7691173|NCT00361842|12110529|FG001|Overall Study|Other|2
7691174|NCT00362115|12110554|FG000|Overall Study|Adverse Event|0
7691175|NCT00362115|12110555|FG001|Overall Study|Adverse Event|1
7691176|NCT00362115|12110556|FG002|Overall Study|Adverse Event|1
7691177|NCT00362115|12110557|FG003|Overall Study|Adverse Event|1
7691178|NCT00362115|12110558|FG004|Overall Study|Adverse Event|2
7691179|NCT00362115|12110559|FG005|Overall Study|Adverse Event|2
7691180|NCT00362115|12110560|FG006|Overall Study|Adverse Event|1
7691181|NCT00362115|12110554|FG000|Overall Study|Protocol Violation|0
7691182|NCT00362115|12110555|FG001|Overall Study|Protocol Violation|0
7691183|NCT00362115|12110556|FG002|Overall Study|Protocol Violation|0
7691184|NCT00362115|12110557|FG003|Overall Study|Protocol Violation|0
7691185|NCT00362115|12110558|FG004|Overall Study|Protocol Violation|0
7691186|NCT00362115|12110559|FG005|Overall Study|Protocol Violation|1
7691187|NCT00362115|12110560|FG006|Overall Study|Protocol Violation|0
7691188|NCT00362115|12110554|FG000|Overall Study|Lost to Follow-up|0
7691189|NCT00362115|12110555|FG001|Overall Study|Lost to Follow-up|1
7691190|NCT00362115|12110556|FG002|Overall Study|Lost to Follow-up|0
7691191|NCT00362115|12110557|FG003|Overall Study|Lost to Follow-up|0
7691192|NCT00362115|12110558|FG004|Overall Study|Lost to Follow-up|2
7691193|NCT00362115|12110559|FG005|Overall Study|Lost to Follow-up|0
7691194|NCT00362115|12110560|FG006|Overall Study|Lost to Follow-up|1
7691195|NCT00362115|12110554|FG000|Overall Study|Withdrawal by Subject|1
7691196|NCT00362115|12110555|FG001|Overall Study|Withdrawal by Subject|3
7691197|NCT00362115|12110556|FG002|Overall Study|Withdrawal by Subject|1
7691198|NCT00362115|12110557|FG003|Overall Study|Withdrawal by Subject|0
7691199|NCT00362115|12110558|FG004|Overall Study|Withdrawal by Subject|1
7691200|NCT00362115|12110559|FG005|Overall Study|Withdrawal by Subject|3
7691201|NCT00362115|12110560|FG006|Overall Study|Withdrawal by Subject|4
7691202|NCT00362115|12110554|FG000|Overall Study|Lack of Efficacy|1
7691203|NCT00362115|12110555|FG001|Overall Study|Lack of Efficacy|0
7691204|NCT00362115|12110556|FG002|Overall Study|Lack of Efficacy|5
7691205|NCT00362115|12110557|FG003|Overall Study|Lack of Efficacy|2
7691206|NCT00362115|12110558|FG004|Overall Study|Lack of Efficacy|2
7691207|NCT00362115|12110559|FG005|Overall Study|Lack of Efficacy|0
7691208|NCT00362115|12110560|FG006|Overall Study|Lack of Efficacy|3
7691209|NCT00362115|12110554|FG000|Overall Study|Physician Decision|0
7691210|NCT00362115|12110555|FG001|Overall Study|Physician Decision|0
7691211|NCT00362115|12110556|FG002|Overall Study|Physician Decision|0
7691212|NCT00362115|12110557|FG003|Overall Study|Physician Decision|0
7691213|NCT00362115|12110558|FG004|Overall Study|Physician Decision|0
7691214|NCT00362115|12110559|FG005|Overall Study|Physician Decision|0
7691215|NCT00362115|12110560|FG006|Overall Study|Physician Decision|3
7691216|NCT00362115|12110554|FG000|Overall Study|Other|0
7691217|NCT00362115|12110555|FG001|Overall Study|Other|1
7691218|NCT00362115|12110556|FG002|Overall Study|Other|0
7691219|NCT00362115|12110557|FG003|Overall Study|Other|1
7691220|NCT00362115|12110558|FG004|Overall Study|Other|0
7691221|NCT00362115|12110559|FG005|Overall Study|Other|1
7691222|NCT00362115|12110560|FG006|Overall Study|Other|0
7691223|NCT00362180|12110589|FG000|Treated Period|Withdrawal by Subject|1
7691224|NCT00362180|12110590|FG001|Treated Period|Withdrawal by Subject|0
7691225|NCT00362180|12110591|FG002|Treated Period|Withdrawal by Subject|0
7691226|NCT00362180|12110592|FG003|Treated Period|Withdrawal by Subject|0
7691227|NCT00362180|12110593|FG004|Treated Period|Withdrawal by Subject|0
7691228|NCT00362180|12110594|FG005|Treated Period|Withdrawal by Subject|0
7691229|NCT00362180|12110595|FG006|Treated Period|Withdrawal by Subject|0
7691230|NCT00362180|12110596|FG007|Treated Period|Withdrawal by Subject|0
7691231|NCT00362180|12110597|FG008|Treated Period|Withdrawal by Subject|0
7691232|NCT00362180|12110589|FG000|Treated Period|Adverse Event|0
7691233|NCT00362180|12110590|FG001|Treated Period|Adverse Event|0
7691234|NCT00362180|12110591|FG002|Treated Period|Adverse Event|0
7691235|NCT00362180|12110592|FG003|Treated Period|Adverse Event|0
7691236|NCT00362180|12110593|FG004|Treated Period|Adverse Event|0
7691237|NCT00362180|12110594|FG005|Treated Period|Adverse Event|1
7691238|NCT00362180|12110595|FG006|Treated Period|Adverse Event|0
7691239|NCT00362180|12110596|FG007|Treated Period|Adverse Event|1
7691240|NCT00362180|12110597|FG008|Treated Period|Adverse Event|0
7691241|NCT00362232|12110617|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62
7691242|NCT00362232|12110618|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56
7691243|NCT00362232|12110617|FG000|Treatment (12 +/- 2 Days)|Death|1
7691244|NCT00362232|12110618|FG001|Treatment (12 +/- 2 Days)|Death|3
7691245|NCT00362232|12110617|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
7691246|NCT00362232|12110618|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
7691247|NCT00362232|12110617|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2
7691248|NCT00362232|12110618|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5
7691249|NCT00362232|12110617|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22
7691250|NCT00362232|12110618|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21
7691251|NCT00362232|12110617|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
7691252|NCT00362232|12110618|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
7691253|NCT00362232|12110617|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
7691254|NCT00362232|12110618|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
7691255|NCT00362232|12110617|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1
7691256|NCT00362232|12110618|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0
7691257|NCT00362232|12110617|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
7691258|NCT00362232|12110618|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
7691259|NCT00362232|12110617|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2
7691260|NCT00362232|12110618|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3
7691261|NCT00362232|12110617|FG000|Follow-up (30 (+ 5) Days)|Death|1
7691262|NCT00362232|12110618|FG001|Follow-up (30 (+ 5) Days)|Death|1
7691263|NCT00362232|12110617|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
7691264|NCT00362232|12110618|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
7691265|NCT00362232|12110617|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
7691266|NCT00362232|12110618|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
7691267|NCT00362297|12110626|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0
7691268|NCT00362297|12110627|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4
7691269|NCT00362336|12110636|FG000|Overall Study|Serious Adverse Event|1
7691270|NCT00362336|12110637|FG001|Overall Study|Serious Adverse Event|0
7691271|NCT00362336|12110638|FG002|Overall Study|Serious Adverse Event|1
7691272|NCT00362336|12110636|FG000|Overall Study|Protocol Violation|0
7691273|NCT00362336|12110637|FG001|Overall Study|Protocol Violation|0
7691274|NCT00362336|12110638|FG002|Overall Study|Protocol Violation|1
7691275|NCT00362336|12110636|FG000|Overall Study|Lost to Follow-up|6
7691276|NCT00362336|12110637|FG001|Overall Study|Lost to Follow-up|4
7691277|NCT00362336|12110638|FG002|Overall Study|Lost to Follow-up|0
7691278|NCT00362336|12110636|FG000|Overall Study|Withdrawal by Subject|3
7691279|NCT00362336|12110637|FG001|Overall Study|Withdrawal by Subject|3
7691280|NCT00362336|12110638|FG002|Overall Study|Withdrawal by Subject|1
7691281|NCT00362375|12110655|FG000|Overall Study|Lost to Follow-up|40
7691282|NCT00362375|12110656|FG001|Overall Study|Lost to Follow-up|35
7691283|NCT00362414|12110662|FG000|Overall Study|Death|2
7691284|NCT00362414|12110662|FG000|Overall Study|Adverse Event|1
7691285|NCT00362609|12110698|FG000|Overall Study|Withdrawal by Subject|0
7691286|NCT00362609|12110699|FG001|Overall Study|Withdrawal by Subject|1
7691287|NCT00362609|12110698|FG000|Overall Study|Protocol Violation|0
7691288|NCT00362609|12110699|FG001|Overall Study|Protocol Violation|1
7691289|NCT00362648|12110709|FG000|Overall Study|Adverse Event|12
7691290|NCT00362648|12110710|FG001|Overall Study|Adverse Event|21
7691291|NCT00362648|12110711|FG002|Overall Study|Adverse Event|1
7691292|NCT00362648|12110712|FG003|Overall Study|Adverse Event|0
7691293|NCT00362648|12110709|FG000|Overall Study|Lost to Follow-up|62
7691294|NCT00362648|12110710|FG001|Overall Study|Lost to Follow-up|69
7691295|NCT00362648|12110711|FG002|Overall Study|Lost to Follow-up|4
7691296|NCT00362648|12110712|FG003|Overall Study|Lost to Follow-up|3
7691297|NCT00362648|12110709|FG000|Overall Study|Protocol Violation|4
7691298|NCT00362648|12110710|FG001|Overall Study|Protocol Violation|2
7691299|NCT00362648|12110711|FG002|Overall Study|Protocol Violation|2
7691300|NCT00362648|12110712|FG003|Overall Study|Protocol Violation|2
7691301|NCT00362648|12110709|FG000|Overall Study|Withdrawal by Subject|48
7691302|NCT00362648|12110710|FG001|Overall Study|Withdrawal by Subject|42
7691303|NCT00362648|12110711|FG002|Overall Study|Withdrawal by Subject|2
7691304|NCT00362648|12110712|FG003|Overall Study|Withdrawal by Subject|6
7691305|NCT00363051|12110742|FG000|Overall Study|Adminstrative problems|1
7691306|NCT00363051|12110743|FG001|Overall Study|Adminstrative problems|1
7691307|NCT00363051|12110742|FG000|Overall Study|Adverse Event|21
7691308|NCT00363051|12110743|FG001|Overall Study|Adverse Event|12
7691309|NCT00363051|12110742|FG000|Overall Study|New Cancer Therapy|2
7691310|NCT00363051|12110743|FG001|Overall Study|New Cancer Therapy|1
7691311|NCT00363051|12110742|FG000|Overall Study|Withdrawal by Subject|11
7691312|NCT00363051|12110743|FG001|Overall Study|Withdrawal by Subject|3
7691313|NCT00363051|12110742|FG000|Overall Study|Lost to Follow-up|0
7691314|NCT00363051|12110743|FG001|Overall Study|Lost to Follow-up|1
7691315|NCT00363051|12110742|FG000|Overall Study|Protocol Violation|0
7691316|NCT00363051|12110743|FG001|Overall Study|Protocol Violation|2
7691317|NCT00363051|12110742|FG000|Overall Study|Death|3
7691318|NCT00363051|12110743|FG001|Overall Study|Death|2
7691319|NCT00363129|12110762|FG000|Overall Study|Withdrawal by Subject|11
7691320|NCT00363129|12110763|FG001|Overall Study|Withdrawal by Subject|18
7691321|NCT00363129|12110762|FG000|Overall Study|Adverse Event|8
7691322|NCT00363129|12110763|FG001|Overall Study|Adverse Event|3
7691323|NCT00363129|12110762|FG000|Overall Study|Alternate Treatment|2
7691324|NCT00363129|12110763|FG001|Overall Study|Alternate Treatment|4
7691325|NCT00363129|12110762|FG000|Overall Study|Other Medical Problems|2
7691326|NCT00363129|12110763|FG001|Overall Study|Other Medical Problems|4
7691327|NCT00363129|12110762|FG000|Overall Study|Death|0
7691328|NCT00363129|12110763|FG001|Overall Study|Death|1
7691329|NCT00363129|12110762|FG000|Overall Study|Other Reasons|6
7691330|NCT00363129|12110763|FG001|Overall Study|Other Reasons|3
7691331|NCT00363142|12110771|FG000|Overall Study|Adverse Event|2
7691332|NCT00363142|12110772|FG001|Overall Study|Adverse Event|0
7691333|NCT00363142|12110771|FG000|Overall Study|Lack of Efficacy|0
7691334|NCT00363142|12110772|FG001|Overall Study|Lack of Efficacy|1
7691335|NCT00363142|12110771|FG000|Overall Study|Lost to Follow-up|1
7691336|NCT00363142|12110772|FG001|Overall Study|Lost to Follow-up|0
7691337|NCT00363142|12110771|FG000|Overall Study|Non-compliance|1
7691338|NCT00363142|12110772|FG001|Overall Study|Non-compliance|1
7691339|NCT00363142|12110771|FG000|Overall Study|Withdrawal by Subject|3
7691340|NCT00363142|12110772|FG001|Overall Study|Withdrawal by Subject|1
7691341|NCT00363246|12110790|FG000|Overall Study|Death|40
7691342|NCT00363246|12110790|FG000|Overall Study|Withdrawal by Subject|19
7691343|NCT00363246|12110790|FG000|Overall Study|Lost to Follow-up|14
7691344|NCT00363246|12110790|FG000|Overall Study|Bad health|6
7691345|NCT00363246|12110790|FG000|Overall Study|Stopped using wheelchair|11
7691346|NCT00363246|12110790|FG000|Overall Study|Subject expressed security concerns|2
7691347|NCT00363246|12110790|FG000|Overall Study|Eligibility changed due to Hospice move|5
7691348|NCT00363298|12110797|FG000|First Study Week|Lack of Efficacy|6
7691349|NCT00363298|12110798|FG001|First Study Week|Lack of Efficacy|5
7691350|NCT00363298|12110797|FG000|4-week Study Continuation Phase|Lack of Efficacy|1
7691351|NCT00363298|12110798|FG001|4-week Study Continuation Phase|Lack of Efficacy|0
7691352|NCT00363311|12110807|FG000|Overall Study|Adverse Event|6
7691353|NCT00363311|12110808|FG001|Overall Study|Adverse Event|4
7691354|NCT00363311|12110807|FG000|Overall Study|Lost to Follow-up|3
7691355|NCT00363311|12110808|FG001|Overall Study|Lost to Follow-up|0
7691356|NCT00363311|12110807|FG000|Overall Study|Protocol Violation|1
7691357|NCT00363311|12110808|FG001|Overall Study|Protocol Violation|2
7691358|NCT00363311|12110807|FG000|Overall Study|Withdrawal by Subject|12
7691359|NCT00363311|12110808|FG001|Overall Study|Withdrawal by Subject|6
7691360|NCT00363311|12110807|FG000|Overall Study|Physician Decision|1
7691361|NCT00363311|12110808|FG001|Overall Study|Physician Decision|1
7691362|NCT00363311|12110807|FG000|Overall Study|Sponsor Terminated Study|2
7691363|NCT00363311|12110808|FG001|Overall Study|Sponsor Terminated Study|2
7691364|NCT00363311|12110807|FG000|Overall Study|Disease Progression|46
7691365|NCT00363311|12110808|FG001|Overall Study|Disease Progression|26
7691366|NCT00363311|12110807|FG000|Overall Study|Non-Compliance|1
7691367|NCT00363311|12110808|FG001|Overall Study|Non-Compliance|1
7691368|NCT00363311|12110807|FG000|Overall Study|Participant Refused Biopsy|1
7691369|NCT00363311|12110808|FG001|Overall Study|Participant Refused Biopsy|0
7691370|NCT00363311|12110807|FG000|Overall Study|Prostate Volume/PSA Doubled|1
7691371|NCT00363311|12110808|FG001|Overall Study|Prostate Volume/PSA Doubled|0
7691372|NCT00363311|12110807|FG000|Overall Study|Participant Opted for Treatment|1
7691373|NCT00363311|12110808|FG001|Overall Study|Participant Opted for Treatment|0
7691374|NCT00363311|12110807|FG000|Overall Study|Participant Moved to Another Country|1
7691375|NCT00363311|12110808|FG001|Overall Study|Participant Moved to Another Country|0
7691376|NCT00363311|12110807|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0
7691377|NCT00363311|12110808|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1
7691378|NCT00363311|12110807|FG000|Overall Study|Withdrawn per Instructions of Monitor|0
7691379|NCT00363311|12110808|FG001|Overall Study|Withdrawn per Instructions of Monitor|1
7691380|NCT00363311|12110807|FG000|Overall Study|Participant Moved to Louisiana|0
7691381|NCT00363311|12110808|FG001|Overall Study|Participant Moved to Louisiana|1
7691382|NCT00363415|12110816|FG000|Overall Study|Progressive Disease|196
7691383|NCT00363415|12110817|FG001|Overall Study|Progressive Disease|107
7691384|NCT00363415|12110816|FG000|Overall Study|Sponsor Decision|67
7691385|NCT00363415|12110817|FG001|Overall Study|Sponsor Decision|31
7691386|NCT00363415|12110816|FG000|Overall Study|Death|32
7691387|NCT00363415|12110817|FG001|Overall Study|Death|29
7691388|NCT00363415|12110816|FG000|Overall Study|Adverse Event|24
7691389|NCT00363415|12110817|FG001|Overall Study|Adverse Event|15
7691390|NCT00363415|12110816|FG000|Overall Study|Physician Decision|18
7691391|NCT00363415|12110817|FG001|Overall Study|Physician Decision|35
7691392|NCT00363415|12110816|FG000|Overall Study|Entry Criteria Not Met|11
7691393|NCT00363415|12110817|FG001|Overall Study|Entry Criteria Not Met|10
7691394|NCT00363415|12110816|FG000|Overall Study|Withdrawal by Subject|9
7691395|NCT00363415|12110817|FG001|Overall Study|Withdrawal by Subject|15
7691396|NCT00363415|12110816|FG000|Overall Study|Lost to Follow-up|3
7691397|NCT00363415|12110817|FG001|Overall Study|Lost to Follow-up|3
7691398|NCT00363415|12110816|FG000|Overall Study|Protocol Violation|1
7691399|NCT00363415|12110817|FG001|Overall Study|Protocol Violation|4
7691400|NCT00363467|12110823|FG000|Overall Study|Physician Decision|1
7691401|NCT00363480|12110827|FG000|Overall Study|Criteria for treatment period not fulfil|1
7691402|NCT00363480|12110827|FG000|Overall Study|Adverse Event|4
7691403|NCT00363480|12110827|FG000|Overall Study|Lost to Follow-up|5
7691404|NCT00363480|12110827|FG000|Overall Study|Withdrawal by Subject|5
7691405|NCT00363480|12110827|FG000|Overall Study|Non-compliance of subject|1
7691406|NCT00363480|12110827|FG000|Overall Study|Participant discontinued on its own|1
7691407|NCT00363545|12110833|FG000|Overall Study|Serious Adverse Event|0
7691408|NCT00363545|12110834|FG001|Overall Study|Serious Adverse Event|1
7691409|NCT00363545|12110833|FG000|Overall Study|Withdrawal by Subject|12
7691410|NCT00363545|12110834|FG001|Overall Study|Withdrawal by Subject|15
7691411|NCT00363545|12110833|FG000|Overall Study|Migrated/moved from study area|3
7691412|NCT00363545|12110834|FG001|Overall Study|Migrated/moved from study area|6
7691413|NCT00363545|12110833|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14
7691414|NCT00363545|12110834|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18
7691415|NCT00363545|12110833|FG000|Overall Study|Lost to follow-up (complete vaccination)|14
7691416|NCT00363545|12110834|FG001|Overall Study|Lost to follow-up (complete vaccination)|17
7691417|NCT00363545|12110833|FG000|Overall Study|Others|1
7691418|NCT00363545|12110834|FG001|Overall Study|Others|0
7691419|NCT00363649|12110842|FG000|Overall Study|Withdrawal by Subject|1
7691420|NCT00363649|12110843|FG001|Overall Study|Withdrawal by Subject|1
7691421|NCT00363649|12110842|FG000|Overall Study|Adverse Event|6
7691422|NCT00363649|12110843|FG001|Overall Study|Adverse Event|0
7691423|NCT00363766|12110856|FG000|Overall Study|Progressive Disease|15
7691424|NCT00363766|12110857|FG001|Overall Study|Progressive Disease|9
7691425|NCT00363766|12110856|FG000|Overall Study|Adverse Event|10
7691426|NCT00363766|12110857|FG001|Overall Study|Adverse Event|2
7691427|NCT00363766|12110856|FG000|Overall Study|Disease Related Death|1
7691428|NCT00363766|12110857|FG001|Overall Study|Disease Related Death|3
7691429|NCT00363766|12110856|FG000|Overall Study|Not Disease Related Death|3
7691430|NCT00363766|12110857|FG001|Overall Study|Not Disease Related Death|4
7691431|NCT00363766|12110856|FG000|Overall Study|Withdrawal by Subject|2
7691432|NCT00363766|12110857|FG001|Overall Study|Withdrawal by Subject|0
7691433|NCT00363766|12110856|FG000|Overall Study|Physician Decision|1
7691434|NCT00363766|12110857|FG001|Overall Study|Physician Decision|2
7691435|NCT00363896|12110887|FG000|Overall Study|Withdrawal by Subject|29
7691436|NCT00363896|12110888|FG001|Overall Study|Withdrawal by Subject|16
7691437|NCT00363896|12110887|FG000|Overall Study|Adverse Event|24
7691438|NCT00363896|12110888|FG001|Overall Study|Adverse Event|13
7691439|NCT00363896|12110887|FG000|Overall Study|COPD exacerbation|13
7691440|NCT00363896|12110888|FG001|Overall Study|COPD exacerbation|7
7691441|NCT00363896|12110887|FG000|Overall Study|Lack of Efficacy|12
7691442|NCT00363896|12110888|FG001|Overall Study|Lack of Efficacy|8
7691443|NCT00363896|12110887|FG000|Overall Study|Protocol Violation|6
7691444|NCT00363896|12110888|FG001|Overall Study|Protocol Violation|1
7691445|NCT00363896|12110887|FG000|Overall Study|Lost to Follow-up|3
7691446|NCT00363896|12110888|FG001|Overall Study|Lost to Follow-up|0
7691447|NCT00363896|12110887|FG000|Overall Study|Non-fulfilment of entry criteria|1
7691448|NCT00363896|12110888|FG001|Overall Study|Non-fulfilment of entry criteria|0
7691449|NCT00363896|12110887|FG000|Overall Study|Other|1
7691450|NCT00363896|12110888|FG001|Overall Study|Other|2
7691451|NCT00364130|12110899|FG000|Intervention Period|Lost to Follow-up|4
7691452|NCT00364130|12110900|FG001|Intervention Period|Lost to Follow-up|3
7691453|NCT00364130|12110899|FG000|Intervention Period|Pregnancy|1
7691454|NCT00364130|12110900|FG001|Intervention Period|Pregnancy|0
7691455|NCT00364130|12110899|FG000|Intervention Period|Withdrawal by Subject|4
7691456|NCT00364130|12110900|FG001|Intervention Period|Withdrawal by Subject|5
7691457|NCT00364130|12110899|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5
7691458|NCT00364130|12110900|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11
7691459|NCT00364156|12110910|FG000|Overall Study|Withdrawal by Subject|73
7691460|NCT00364156|12110911|FG001|Overall Study|Withdrawal by Subject|80
7691461|NCT00364156|12110910|FG000|Overall Study|Protocol Violation|6
7691462|NCT00364156|12110911|FG001|Overall Study|Protocol Violation|1
7691463|NCT00364182|12110920|FG000|First Intervention|Secondary prophylaxis|1
7691464|NCT00364182|12110921|FG001|First Intervention|Secondary prophylaxis|0
7691465|NCT00364182|12110922|FG002|First Intervention|Secondary prophylaxis|0
7691466|NCT00364182|12110920|FG000|First Intervention|Withdrawal by Subject|2
7691467|NCT00364182|12110921|FG001|First Intervention|Withdrawal by Subject|0
7691468|NCT00364182|12110922|FG002|First Intervention|Withdrawal by Subject|0
7691469|NCT00364182|12110920|FG000|Second Intervention|non-compliance|0
7691470|NCT00364182|12110921|FG001|Second Intervention|non-compliance|1
7691471|NCT00364182|12110922|FG002|Second Intervention|non-compliance|1
7691472|NCT00364182|12110920|FG000|Second Intervention|Protocol Violation|0
7691473|NCT00364182|12110921|FG001|Second Intervention|Protocol Violation|1
7691474|NCT00364182|12110922|FG002|Second Intervention|Protocol Violation|0
7691475|NCT00364182|12110920|FG000|Second Intervention|Adverse Event|0
7691476|NCT00364182|12110921|FG001|Second Intervention|Adverse Event|0
7691477|NCT00364182|12110922|FG002|Second Intervention|Adverse Event|1
7691478|NCT00364182|12110920|FG000|Third Intervention|non-compliance|0
7691479|NCT00364182|12110921|FG001|Third Intervention|non-compliance|1
7691480|NCT00364182|12110922|FG002|Third Intervention|non-compliance|0
7691481|NCT00364182|12110920|FG000|Third Intervention|Lost to Follow-up|0
7691482|NCT00364182|12110921|FG001|Third Intervention|Lost to Follow-up|0
7691483|NCT00364182|12110922|FG002|Third Intervention|Lost to Follow-up|1
7691484|NCT00364286|12110932|FG000|Overall Study|Withdrawal by Subject|1
7691485|NCT00364286|12110932|FG000|Overall Study|Adverse Event|2
7691486|NCT00364351|12110938|FG000|Overall Study|Adverse Event|90
7691487|NCT00364351|12110939|FG001|Overall Study|Adverse Event|44
7691488|NCT00364351|12110938|FG000|Overall Study|Condition under investigation worsened|469
7691489|NCT00364351|12110939|FG001|Overall Study|Condition under investigation worsened|497
7691490|NCT00364351|12110938|FG000|Overall Study|Prohibited concomitant medication|0
7691491|NCT00364351|12110939|FG001|Overall Study|Prohibited concomitant medication|2
7691492|NCT00364351|12110938|FG000|Overall Study|Lost to Follow-up|1
7691493|NCT00364351|12110939|FG001|Overall Study|Lost to Follow-up|1
7691494|NCT00364351|12110938|FG000|Overall Study|Withdrawal by Subject|30
7691495|NCT00364351|12110939|FG001|Overall Study|Withdrawal by Subject|29
7691496|NCT00364351|12110938|FG000|Overall Study|Incorrect enrollment|1
7691497|NCT00364351|12110939|FG001|Overall Study|Incorrect enrollment|1
7691498|NCT00364351|12110938|FG000|Overall Study|Sponsor decision|1
7691499|NCT00364351|12110939|FG001|Overall Study|Sponsor decision|0
7691500|NCT00364351|12110938|FG000|Overall Study|Poor treatment compliance|0
7691501|NCT00364351|12110939|FG001|Overall Study|Poor treatment compliance|3
7691502|NCT00364351|12110938|FG000|Overall Study|Investigator error|0
7691503|NCT00364351|12110939|FG001|Overall Study|Investigator error|2
7691504|NCT00364351|12110938|FG000|Overall Study|Patient could not travel to site|0
7691505|NCT00364351|12110939|FG001|Overall Study|Patient could not travel to site|1
7691506|NCT00364351|12110938|FG000|Overall Study|Randomised treatment not started|0
7691507|NCT00364351|12110939|FG001|Overall Study|Randomised treatment not started|3
7691508|NCT00364533|12110959|FG000|Overall Study|Adverse Event|8
7691509|NCT00364533|12110960|FG001|Overall Study|Adverse Event|7
7691510|NCT00364533|12110961|FG002|Overall Study|Adverse Event|15
7691511|NCT00364533|12110962|FG003|Overall Study|Adverse Event|5
7691512|NCT00364533|12110963|FG004|Overall Study|Adverse Event|2
7691513|NCT00364533|12110959|FG000|Overall Study|Withdrawal by Subject|4
7691514|NCT00364533|12110960|FG001|Overall Study|Withdrawal by Subject|8
7691515|NCT00364533|12110961|FG002|Overall Study|Withdrawal by Subject|6
7691516|NCT00364533|12110962|FG003|Overall Study|Withdrawal by Subject|6
7691517|NCT00364533|12110963|FG004|Overall Study|Withdrawal by Subject|6
7691518|NCT00364533|12110959|FG000|Overall Study|Lack of Efficacy|22
7691519|NCT00364533|12110960|FG001|Overall Study|Lack of Efficacy|22
7691520|NCT00364533|12110961|FG002|Overall Study|Lack of Efficacy|21
7691521|NCT00364533|12110962|FG003|Overall Study|Lack of Efficacy|17
7691522|NCT00364533|12110963|FG004|Overall Study|Lack of Efficacy|42
7691523|NCT00364533|12110959|FG000|Overall Study|Subject discharged from hospital|4
7691524|NCT00364533|12110960|FG001|Overall Study|Subject discharged from hospital|1
7691525|NCT00364533|12110961|FG002|Overall Study|Subject discharged from hospital|2
7691526|NCT00364533|12110962|FG003|Overall Study|Subject discharged from hospital|3
7691527|NCT00364533|12110963|FG004|Overall Study|Subject discharged from hospital|1
7691528|NCT00364533|12110959|FG000|Overall Study|Variations in drug compliance|2
7691529|NCT00364533|12110960|FG001|Overall Study|Variations in drug compliance|1
7691530|NCT00364533|12110961|FG002|Overall Study|Variations in drug compliance|1
7691531|NCT00364533|12110962|FG003|Overall Study|Variations in drug compliance|0
7691532|NCT00364533|12110963|FG004|Overall Study|Variations in drug compliance|0
7691533|NCT00364533|12110959|FG000|Overall Study|Non-compliance|1
7691534|NCT00364533|12110960|FG001|Overall Study|Non-compliance|0
7691535|NCT00364533|12110961|FG002|Overall Study|Non-compliance|0
7691536|NCT00364533|12110962|FG003|Overall Study|Non-compliance|0
7691537|NCT00364533|12110963|FG004|Overall Study|Non-compliance|0
7691538|NCT00364533|12110959|FG000|Overall Study|Protocol Violation|1
7691539|NCT00364533|12110960|FG001|Overall Study|Protocol Violation|1
7691540|NCT00364533|12110961|FG002|Overall Study|Protocol Violation|0
7691541|NCT00364533|12110962|FG003|Overall Study|Protocol Violation|0
7691542|NCT00364533|12110963|FG004|Overall Study|Protocol Violation|0
7691543|NCT00364611|12110977|FG000|Overall Study|Did not receive study medication|0
7691544|NCT00364611|12110978|FG001|Overall Study|Did not receive study medication|1
7691545|NCT00364611|12110977|FG000|Overall Study|Adverse Event|7
7691546|NCT00364611|12110978|FG001|Overall Study|Adverse Event|4
7691547|NCT00364611|12110977|FG000|Overall Study|Participant's Request|3
7691548|NCT00364611|12110978|FG001|Overall Study|Participant's Request|4
7691549|NCT00364611|12110977|FG000|Overall Study|Disease Progression|38
7691550|NCT00364611|12110978|FG001|Overall Study|Disease Progression|8
7691551|NCT00364611|12110977|FG000|Overall Study|Investigator decision|2
7691552|NCT00364611|12110978|FG001|Overall Study|Investigator decision|2
7691553|NCT00364611|12110977|FG000|Overall Study|Found Ineligible|1
7691554|NCT00364611|12110978|FG001|Overall Study|Found Ineligible|0
7691555|NCT00364611|12110977|FG000|Overall Study|Presumed CR on Study|0
7691556|NCT00364611|12110978|FG001|Overall Study|Presumed CR on Study|1
7691557|NCT00364611|12110977|FG000|Overall Study|Receiving Liver Ablation|0
7691558|NCT00364611|12110978|FG001|Overall Study|Receiving Liver Ablation|1
7691559|NCT00364793|12110988|FG000|Overall Study|Adverse Event|2
7691560|NCT00364793|12110989|FG001|Overall Study|Adverse Event|0
7691561|NCT00364793|12110990|FG002|Overall Study|Adverse Event|0
7691562|NCT00364793|12110991|FG003|Overall Study|Adverse Event|0
7691563|NCT00364793|12110988|FG000|Overall Study|Death|1
7691564|NCT00364793|12110989|FG001|Overall Study|Death|0
7691565|NCT00364793|12110990|FG002|Overall Study|Death|1
7691566|NCT00364793|12110991|FG003|Overall Study|Death|0
7691567|NCT00364793|12110988|FG000|Overall Study|Lack of Efficacy|3
7691568|NCT00364793|12110989|FG001|Overall Study|Lack of Efficacy|3
7691569|NCT00364793|12110990|FG002|Overall Study|Lack of Efficacy|1
7691570|NCT00364793|12110991|FG003|Overall Study|Lack of Efficacy|1
7691571|NCT00364793|12110988|FG000|Overall Study|Lost to Follow-up|1
7691572|NCT00364793|12110989|FG001|Overall Study|Lost to Follow-up|0
7691573|NCT00364793|12110990|FG002|Overall Study|Lost to Follow-up|2
7691574|NCT00364793|12110991|FG003|Overall Study|Lost to Follow-up|0
7691575|NCT00364793|12110988|FG000|Overall Study|Poor or non-compliance|1
7691576|NCT00364793|12110989|FG001|Overall Study|Poor or non-compliance|1
7691577|NCT00364793|12110990|FG002|Overall Study|Poor or non-compliance|0
7691578|NCT00364793|12110991|FG003|Overall Study|Poor or non-compliance|1
7691579|NCT00364793|12110988|FG000|Overall Study|No longer meets criteria|0
7691580|NCT00364793|12110989|FG001|Overall Study|No longer meets criteria|0
7691581|NCT00364793|12110990|FG002|Overall Study|No longer meets criteria|0
7691582|NCT00364793|12110991|FG003|Overall Study|No longer meets criteria|1
7691583|NCT00364793|12110988|FG000|Overall Study|Withdrawal by Subject|0
7691584|NCT00364793|12110989|FG001|Overall Study|Withdrawal by Subject|1
7691585|NCT00364793|12110990|FG002|Overall Study|Withdrawal by Subject|0
7691586|NCT00364793|12110991|FG003|Overall Study|Withdrawal by Subject|0
7691587|NCT00364832|12111017|FG000|Core Period|Early Withdrawals|2
7691588|NCT00364832|12111018|FG001|Core Period|Early Withdrawals|2
7691589|NCT00364832|12111019|FG002|Core Period|Early Withdrawals|1
7691590|NCT00364832|12111020|FG003|Core Period|Early Withdrawals|1
7691591|NCT00364832|12111021|FG004|Core Period|Early Withdrawals|0
7691592|NCT00364832|12111022|FG005|Core Period|Early Withdrawals|0
7691593|NCT00364832|12111023|FG006|Core Period|Early Withdrawals|4
7691594|NCT00364832|12111024|FG007|Core Period|Early Withdrawals|1
7691595|NCT00364832|12111025|FG008|Core Period|Early Withdrawals|0
7691596|NCT00364832|12111026|FG009|Core Period|Early Withdrawals|0
7691597|NCT00364832|12111027|FG010|Core Period|Early Withdrawals|0
7691598|NCT00364832|12111028|FG011|Core Period|Early Withdrawals|0
7691599|NCT00364832|12111017|FG000|Extension Year 1|Early Withdrawals|0
7691600|NCT00364832|12111018|FG001|Extension Year 1|Early Withdrawals|0
7691601|NCT00364832|12111019|FG002|Extension Year 1|Early Withdrawals|0
7691602|NCT00364832|12111020|FG003|Extension Year 1|Early Withdrawals|0
7691603|NCT00364832|12111021|FG004|Extension Year 1|Early Withdrawals|0
7691604|NCT00364832|12111022|FG005|Extension Year 1|Early Withdrawals|0
7691605|NCT00364832|12111023|FG006|Extension Year 1|Early Withdrawals|0
7691606|NCT00364832|12111024|FG007|Extension Year 1|Early Withdrawals|0
7691607|NCT00364832|12111025|FG008|Extension Year 1|Early Withdrawals|0
7691608|NCT00364832|12111026|FG009|Extension Year 1|Early Withdrawals|4
7691609|NCT00364832|12111027|FG010|Extension Year 1|Early Withdrawals|2
7691610|NCT00364832|12111028|FG011|Extension Year 1|Early Withdrawals|10
7691611|NCT00364832|12111017|FG000|Extension Year 2|Early Withdrawals|0
7691612|NCT00364832|12111018|FG001|Extension Year 2|Early Withdrawals|0
7691613|NCT00364832|12111019|FG002|Extension Year 2|Early Withdrawals|0
7691614|NCT00364832|12111020|FG003|Extension Year 2|Early Withdrawals|0
7691615|NCT00364832|12111021|FG004|Extension Year 2|Early Withdrawals|0
7691616|NCT00364832|12111022|FG005|Extension Year 2|Early Withdrawals|0
7691617|NCT00364832|12111023|FG006|Extension Year 2|Early Withdrawals|0
7691618|NCT00364832|12111024|FG007|Extension Year 2|Early Withdrawals|0
7691619|NCT00364832|12111025|FG008|Extension Year 2|Early Withdrawals|0
7691620|NCT00364832|12111026|FG009|Extension Year 2|Early Withdrawals|5
7691621|NCT00364832|12111027|FG010|Extension Year 2|Early Withdrawals|5
7691622|NCT00364832|12111028|FG011|Extension Year 2|Early Withdrawals|3
7691623|NCT00364845|12111047|FG000|Overall Study|Adverse Event|1
7691624|NCT00364845|12111048|FG001|Overall Study|Adverse Event|0
7691625|NCT00364845|12111047|FG000|Overall Study|Withdrawal by Subject|2
7691626|NCT00364845|12111048|FG001|Overall Study|Withdrawal by Subject|1
7691627|NCT00364845|12111047|FG000|Overall Study|Physician Decision|8
7691628|NCT00364845|12111048|FG001|Overall Study|Physician Decision|8
7691629|NCT00364845|12111047|FG000|Overall Study|Lost to Follow-up|0
7691630|NCT00364845|12111048|FG001|Overall Study|Lost to Follow-up|1
7691631|NCT00364845|12111047|FG000|Overall Study|Death|0
7691632|NCT00364845|12111048|FG001|Overall Study|Death|1
7691633|NCT00364858|12111056|FG000|Overall Study|Adverse Event|1
7691634|NCT00364858|12111057|FG001|Overall Study|Adverse Event|5
7691635|NCT00364858|12111056|FG000|Overall Study|Withdrawal by Subject|1
7691636|NCT00364858|12111057|FG001|Overall Study|Withdrawal by Subject|1
7691637|NCT00364858|12111056|FG000|Overall Study|Pregnancy|1
7691638|NCT00364858|12111057|FG001|Overall Study|Pregnancy|1
7691639|NCT00364858|12111056|FG000|Overall Study|Clinical failure|2
7691640|NCT00364858|12111057|FG001|Overall Study|Clinical failure|13
7691641|NCT00364858|12111056|FG000|Overall Study|Discontinuation at baseline|1
7691642|NCT00364858|12111057|FG001|Overall Study|Discontinuation at baseline|0
7691643|NCT00364858|12111056|FG000|Overall Study|Non-compliant|1
7691644|NCT00364858|12111057|FG001|Overall Study|Non-compliant|0
7691645|NCT00364858|12111056|FG000|Overall Study|Return to Q2 regimen|0
7691646|NCT00364858|12111057|FG001|Overall Study|Return to Q2 regimen|1
7691647|NCT00364858|12111056|FG000|Overall Study|Clinical baseline issue|0
7691648|NCT00364858|12111057|FG001|Overall Study|Clinical baseline issue|1
7691649|NCT00364923|12111064|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
7691650|NCT00364923|12111064|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
7691651|NCT00365105|12111083|FG000|Overall Study|Protocol Violation|5
7691652|NCT00365105|12111084|FG001|Overall Study|Protocol Violation|8
7691653|NCT00365300|12111117|FG000|Open-label Phase|Adverse Event|4
7691654|NCT00365300|12111118|FG001|Open-label Phase|Adverse Event|0
7691655|NCT00365300|12111117|FG000|Open-label Phase|Failed to Return|1
7691656|NCT00365300|12111118|FG001|Open-label Phase|Failed to Return|0
7691657|NCT00365300|12111117|FG000|Open-label Phase|Physician Decision|1
7691658|NCT00365300|12111118|FG001|Open-label Phase|Physician Decision|0
7691659|NCT00365300|12111117|FG000|Open-label Phase|Noncompliance|9
7691660|NCT00365300|12111118|FG001|Open-label Phase|Noncompliance|0
7691661|NCT00365300|12111117|FG000|Open-label Phase|Parent/Legal Guardian Request|4
7691662|NCT00365300|12111118|FG001|Open-label Phase|Parent/Legal Guardian Request|0
7691663|NCT00365300|12111117|FG000|Open-label Phase|Protocol Violation|1
7691664|NCT00365300|12111118|FG001|Open-label Phase|Protocol Violation|0
7691665|NCT00365300|12111117|FG000|Open-label Phase|Lack of Efficacy|1
7691666|NCT00365300|12111118|FG001|Open-label Phase|Lack of Efficacy|0
7691667|NCT00365300|12111117|FG000|Open-label Phase|Patient skipped open label phase|1
7691668|NCT00365300|12111118|FG001|Open-label Phase|Patient skipped open label phase|0
7691669|NCT00365300|12111117|FG000|Double-blind Phase|Failed to return|1
7691670|NCT00365300|12111118|FG001|Double-blind Phase|Failed to return|0
7691671|NCT00365300|12111117|FG000|Double-blind Phase|Noncompliance|1
7691672|NCT00365300|12111118|FG001|Double-blind Phase|Noncompliance|1
7691673|NCT00365300|12111117|FG000|Double-blind Phase|Withdrawal by Subject|0
7691674|NCT00365300|12111118|FG001|Double-blind Phase|Withdrawal by Subject|1
7691675|NCT00365300|12111117|FG000|Double-blind Phase|Protocol Violation|3
7691676|NCT00365300|12111118|FG001|Double-blind Phase|Protocol Violation|1
7691677|NCT00365300|12111117|FG000|Double-blind Phase|Lack of Efficacy|6
7691678|NCT00365300|12111118|FG001|Double-blind Phase|Lack of Efficacy|6
7691679|NCT00365352|12111130|FG000|Overall Study|Adverse Event|6
7691680|NCT00365352|12111131|FG001|Overall Study|Adverse Event|7
7691681|NCT00365352|12111132|FG002|Overall Study|Adverse Event|8
7691682|NCT00365352|12111130|FG000|Overall Study|Participant Withdrew Consent|8
7691683|NCT00365352|12111131|FG001|Overall Study|Participant Withdrew Consent|3
7691684|NCT00365352|12111132|FG002|Overall Study|Participant Withdrew Consent|4
7691685|NCT00365352|12111130|FG000|Overall Study|Lack of Efficacy|3
7691686|NCT00365352|12111131|FG001|Overall Study|Lack of Efficacy|0
7691687|NCT00365352|12111132|FG002|Overall Study|Lack of Efficacy|0
7691688|NCT00365352|12111130|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
7691689|NCT00365352|12111131|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
7691690|NCT00365352|12111132|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
7691691|NCT00365352|12111130|FG000|Overall Study|Non-Compliance (after Randomization)|1
7691692|NCT00365352|12111131|FG001|Overall Study|Non-Compliance (after Randomization)|0
7691693|NCT00365352|12111132|FG002|Overall Study|Non-Compliance (after Randomization)|1
7691694|NCT00365352|12111130|FG000|Overall Study|Lost to Follow-up|1
7691695|NCT00365352|12111131|FG001|Overall Study|Lost to Follow-up|1
7691696|NCT00365352|12111132|FG002|Overall Study|Lost to Follow-up|0
7691697|NCT00365352|12111130|FG000|Overall Study|Withdrawal of Participant by Sponsor|1
7691698|NCT00365352|12111131|FG001|Overall Study|Withdrawal of Participant by Sponsor|0
7691699|NCT00365352|12111132|FG002|Overall Study|Withdrawal of Participant by Sponsor|0
7691700|NCT00365365|12111146|FG000|Overall Study|Randomized but not treated|0
7691701|NCT00365365|12111147|FG001|Overall Study|Randomized but not treated|2
7691702|NCT00365365|12111148|FG002|Overall Study|Randomized but not treated|0
7691703|NCT00365365|12111146|FG000|Overall Study|Poor compliance to protocol|0
7691704|NCT00365365|12111147|FG001|Overall Study|Poor compliance to protocol|1
7691705|NCT00365365|12111148|FG002|Overall Study|Poor compliance to protocol|0
7691706|NCT00365365|12111146|FG000|Overall Study|Lost to Follow-up|3
7691707|NCT00365365|12111147|FG001|Overall Study|Lost to Follow-up|3
7691708|NCT00365365|12111148|FG002|Overall Study|Lost to Follow-up|3
7691709|NCT00365365|12111146|FG000|Overall Study|Death|1
7691710|NCT00365365|12111147|FG001|Overall Study|Death|3
7691711|NCT00365365|12111148|FG002|Overall Study|Death|0
7691712|NCT00365365|12111146|FG000|Overall Study|Subject's request|11
7691713|NCT00365365|12111147|FG001|Overall Study|Subject's request|13
7691714|NCT00365365|12111148|FG002|Overall Study|Subject's request|1
7691715|NCT00365365|12111146|FG000|Overall Study|Disease progression/relapse|9
7691716|NCT00365365|12111147|FG001|Overall Study|Disease progression/relapse|6
7691717|NCT00365365|12111148|FG002|Overall Study|Disease progression/relapse|7
7691718|NCT00365365|12111146|FG000|Overall Study|Adverse Event|6
7691719|NCT00365365|12111147|FG001|Overall Study|Adverse Event|6
7691720|NCT00365365|12111148|FG002|Overall Study|Adverse Event|3
7691721|NCT00365365|12111146|FG000|Overall Study|Moved|2
7691722|NCT00365365|12111147|FG001|Overall Study|Moved|0
7691723|NCT00365365|12111148|FG002|Overall Study|Moved|0
7691724|NCT00365365|12111146|FG000|Overall Study|New cancer|1
7691725|NCT00365365|12111147|FG001|Overall Study|New cancer|0
7691726|NCT00365365|12111148|FG002|Overall Study|New cancer|0
7691727|NCT00365365|12111146|FG000|Overall Study|Withdrew consent|1
7691728|NCT00365365|12111147|FG001|Overall Study|Withdrew consent|1
7691729|NCT00365365|12111148|FG002|Overall Study|Withdrew consent|0
7691730|NCT00365365|12111146|FG000|Overall Study|Second malignancy|0
7691731|NCT00365365|12111147|FG001|Overall Study|Second malignancy|1
7691732|NCT00365365|12111148|FG002|Overall Study|Second malignancy|0
7691733|NCT00365365|12111146|FG000|Overall Study|Patient/physician decision|0
7691734|NCT00365365|12111147|FG001|Overall Study|Patient/physician decision|0
7691735|NCT00365365|12111148|FG002|Overall Study|Patient/physician decision|1
7691736|NCT00365378|12111158|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
7691737|NCT00365378|12111159|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
7691738|NCT00365378|12111160|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
7691739|NCT00365378|12111158|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4
7691740|NCT00365378|12111159|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5
7691741|NCT00365378|12111160|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0
7691742|NCT00365378|12111158|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
7691743|NCT00365378|12111159|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
7691744|NCT00365378|12111160|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
7691745|NCT00365378|12111158|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19
7691746|NCT00365378|12111159|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14
7691747|NCT00365378|12111160|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0
7691748|NCT00365378|12111158|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22
7691749|NCT00365378|12111159|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13
7691750|NCT00365378|12111160|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0
7691751|NCT00365378|12111158|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
7691752|NCT00365378|12111159|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
7691753|NCT00365378|12111160|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
7691754|NCT00365378|12111158|FG000|Vaccination (Day 1 to Month 7)|Other|17
7691755|NCT00365378|12111159|FG001|Vaccination (Day 1 to Month 7)|Other|9
7691756|NCT00365378|12111160|FG002|Vaccination (Day 1 to Month 7)|Other|0
7691757|NCT00365378|12111158|FG000|Follow-up (Month 7 Though Month 48)|Moved|6
7691758|NCT00365378|12111159|FG001|Follow-up (Month 7 Though Month 48)|Moved|5
7691759|NCT00365378|12111160|FG002|Follow-up (Month 7 Though Month 48)|Moved|0
7691760|NCT00365378|12111158|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
7691761|NCT00365378|12111159|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
7691762|NCT00365378|12111160|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
7691763|NCT00365378|12111158|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0
7691764|NCT00365378|12111159|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1
7691765|NCT00365378|12111160|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0
7691766|NCT00365378|12111158|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
7691767|NCT00365378|12111159|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
7691768|NCT00365378|12111160|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
7691769|NCT00365378|12111158|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
7691770|NCT00365378|12111159|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
7691771|NCT00365378|12111160|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
7691772|NCT00365378|12111158|FG000|Follow-up (Month 7 Though Month 48)|Other|11
7691773|NCT00365378|12111159|FG001|Follow-up (Month 7 Though Month 48)|Other|21
7691774|NCT00365378|12111160|FG002|Follow-up (Month 7 Though Month 48)|Other|0
7691775|NCT00365378|12111158|FG000|Extension|Adverse Event|0
7691776|NCT00365378|12111159|FG001|Extension|Adverse Event|0
7691777|NCT00365378|12111160|FG002|Extension|Adverse Event|1
7691778|NCT00365378|12111158|FG000|Extension|Moved|0
7691779|NCT00365378|12111159|FG001|Extension|Moved|0
7691780|NCT00365378|12111160|FG002|Extension|Moved|8
7691781|NCT00365378|12111158|FG000|Extension|Lost to Follow-up|0
7691782|NCT00365378|12111159|FG001|Extension|Lost to Follow-up|0
7691783|NCT00365378|12111160|FG002|Extension|Lost to Follow-up|57
7691784|NCT00365378|12111158|FG000|Extension|Protocol Violation|0
7691785|NCT00365378|12111159|FG001|Extension|Protocol Violation|0
7691786|NCT00365378|12111160|FG002|Extension|Protocol Violation|2
7691787|NCT00365378|12111158|FG000|Extension|Withdrawal by Subject|0
7691788|NCT00365378|12111159|FG001|Extension|Withdrawal by Subject|0
7691789|NCT00365378|12111160|FG002|Extension|Withdrawal by Subject|98
7691790|NCT00365378|12111158|FG000|Extension|Other|0
7691791|NCT00365378|12111159|FG001|Extension|Other|0
7691792|NCT00365378|12111160|FG002|Extension|Other|31
7691793|NCT00365456|12111176|FG000|Trial Period I (12 Months)|Adverse Event|84
7691794|NCT00365456|12111177|FG001|Trial Period I (12 Months)|Adverse Event|0
7691795|NCT00365456|12111176|FG000|Trial Period I (12 Months)|Non-compliance|3
7691796|NCT00365456|12111177|FG001|Trial Period I (12 Months)|Non-compliance|0
7691797|NCT00365456|12111176|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27
7691798|NCT00365456|12111177|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0
7691799|NCT00365456|12111176|FG000|Trial Period I (12 Months)|Other|11
7691800|NCT00365456|12111177|FG001|Trial Period I (12 Months)|Other|0
7691801|NCT00365456|12111176|FG000|Trial Period II (12 Months)|Adverse Event|0
7691802|NCT00365456|12111177|FG001|Trial Period II (12 Months)|Adverse Event|6
7691803|NCT00365456|12111176|FG000|Trial Period II (12 Months)|Non-compliance|0
7691804|NCT00365456|12111177|FG001|Trial Period II (12 Months)|Non-compliance|2
7691805|NCT00365456|12111176|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0
7691806|NCT00365456|12111177|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5
7691807|NCT00365456|12111176|FG000|Trial Period II (12 Months)|Other|0
7691808|NCT00365456|12111177|FG001|Trial Period II (12 Months)|Other|1
7691809|NCT00365456|12111176|FG000|Trial Period III (12 Months)|Adverse Event|13
7691810|NCT00365456|12111177|FG001|Trial Period III (12 Months)|Adverse Event|3
7691811|NCT00365456|12111176|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4
7691812|NCT00365456|12111177|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1
7691813|NCT00365456|12111176|FG000|Trial Period III (12 Months)|Other|1
7691814|NCT00365456|12111177|FG001|Trial Period III (12 Months)|Other|1
7691815|NCT00365508|12111185|FG000|Overall Study|Lost to Follow-up|139
7691816|NCT00365508|12111186|FG001|Overall Study|Lost to Follow-up|154
7691817|NCT00365547|12111192|FG000|Overall Study|Insurance did not cover Avastin|1
7691818|NCT00365547|12111192|FG000|Overall Study|Screen failure|1
7691819|NCT00365547|12111192|FG000|Overall Study|Withdrawal by Subject|1
7691820|NCT00365716|12111208|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
7691821|NCT00365716|12111209|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
7691822|NCT00365716|12111210|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
7691823|NCT00365716|12111211|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
7691824|NCT00365716|12111212|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
7691825|NCT00365716|12111213|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
7691826|NCT00365716|12111214|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
7691827|NCT00365716|12111208|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0
7691828|NCT00365716|12111209|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2
7691829|NCT00365716|12111210|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0
7691830|NCT00365716|12111211|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0
7691831|NCT00365716|12111212|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1
7691832|NCT00365716|12111213|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0
7691833|NCT00365716|12111214|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0
7691834|NCT00365716|12111208|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
7691835|NCT00365716|12111209|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
7691836|NCT00365716|12111210|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
7691837|NCT00365716|12111211|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
7691838|NCT00365716|12111212|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
7691839|NCT00365716|12111213|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
7691840|NCT00365716|12111214|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
7691841|NCT00365716|12111208|FG000|Base Study (Day 1 to Month 7)|Other|0
7691842|NCT00365716|12111209|FG001|Base Study (Day 1 to Month 7)|Other|1
7691843|NCT00365716|12111210|FG002|Base Study (Day 1 to Month 7)|Other|0
7691844|NCT00365716|12111211|FG003|Base Study (Day 1 to Month 7)|Other|0
7691845|NCT00365716|12111212|FG004|Base Study (Day 1 to Month 7)|Other|0
7691846|NCT00365716|12111213|FG005|Base Study (Day 1 to Month 7)|Other|0
7691847|NCT00365716|12111214|FG006|Base Study (Day 1 to Month 7)|Other|0
7691848|NCT00365716|12111208|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3
7691849|NCT00365716|12111209|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2
7691850|NCT00365716|12111210|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3
7691851|NCT00365716|12111211|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1
7691852|NCT00365716|12111212|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1
7691853|NCT00365716|12111213|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0
7691854|NCT00365716|12111214|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0
7691855|NCT00365716|12111208|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1
7691856|NCT00365716|12111209|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2
7691857|NCT00365716|12111210|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0
7691858|NCT00365716|12111211|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1
7691859|NCT00365716|12111212|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2
7691860|NCT00365716|12111213|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0
7691861|NCT00365716|12111214|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0
7691862|NCT00365716|12111208|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
7691863|NCT00365716|12111209|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
7691864|NCT00365716|12111210|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
7691865|NCT00365716|12111211|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
7691866|NCT00365716|12111212|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
7691867|NCT00365716|12111213|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
7691868|NCT00365716|12111214|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
7691869|NCT00365716|12111208|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
7691870|NCT00365716|12111209|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
7691871|NCT00365716|12111210|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
7691872|NCT00365716|12111211|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
7691873|NCT00365716|12111212|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
7691874|NCT00365716|12111213|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
7691875|NCT00365716|12111214|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
7691876|NCT00365716|12111208|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
7691877|NCT00365716|12111209|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
7691878|NCT00365716|12111210|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
7691879|NCT00365716|12111211|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
7691880|NCT00365716|12111212|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
7691881|NCT00365716|12111213|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
7691882|NCT00365716|12111214|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
7691883|NCT00365716|12111208|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
7691884|NCT00365716|12111209|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
7691885|NCT00365716|12111210|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
7691886|NCT00365716|12111211|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
7691887|NCT00365716|12111212|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
7691888|NCT00365716|12111213|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
7691889|NCT00365716|12111214|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
7691890|NCT00365716|12111208|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2
7691891|NCT00365716|12111209|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0
7691892|NCT00365716|12111210|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0
7691893|NCT00365716|12111211|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0
7691894|NCT00365716|12111212|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1
7691895|NCT00365716|12111213|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0
7691896|NCT00365716|12111214|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0
7691897|NCT00365716|12111208|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
7691898|NCT00365716|12111209|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
7691899|NCT00365716|12111210|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
7691900|NCT00365716|12111211|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
7691901|NCT00365716|12111212|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
7691902|NCT00365716|12111213|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
7691903|NCT00365716|12111214|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
7691904|NCT00365716|12111208|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
7691905|NCT00365716|12111209|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
7691906|NCT00365716|12111210|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
7691907|NCT00365716|12111211|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
7691908|NCT00365716|12111212|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
7691909|NCT00365716|12111213|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
7691910|NCT00365716|12111214|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
7691911|NCT00365716|12111208|FG000|Extension 1|Lost to Follow-up|0
7691912|NCT00365716|12111209|FG001|Extension 1|Lost to Follow-up|0
7691913|NCT00365716|12111210|FG002|Extension 1|Lost to Follow-up|0
7691914|NCT00365716|12111211|FG003|Extension 1|Lost to Follow-up|0
7691915|NCT00365716|12111212|FG004|Extension 1|Lost to Follow-up|0
7691916|NCT00365716|12111213|FG005|Extension 1|Lost to Follow-up|1
7691917|NCT00365716|12111214|FG006|Extension 1|Lost to Follow-up|0
7691918|NCT00365716|12111208|FG000|Extension 1|Other|0
7691919|NCT00365716|12111209|FG001|Extension 1|Other|0
7691920|NCT00365716|12111210|FG002|Extension 1|Other|0
7691921|NCT00365716|12111211|FG003|Extension 1|Other|0
7691922|NCT00365716|12111212|FG004|Extension 1|Other|0
7691923|NCT00365716|12111213|FG005|Extension 1|Other|9
7691924|NCT00365716|12111214|FG006|Extension 1|Other|0
7691925|NCT00365716|12111208|FG000|Extension 1|Moved|0
7691926|NCT00365716|12111209|FG001|Extension 1|Moved|0
7691927|NCT00365716|12111210|FG002|Extension 1|Moved|0
7691928|NCT00365716|12111211|FG003|Extension 1|Moved|0
7691929|NCT00365716|12111212|FG004|Extension 1|Moved|0
7691930|NCT00365716|12111213|FG005|Extension 1|Moved|4
7691931|NCT00365716|12111214|FG006|Extension 1|Moved|0
7691932|NCT00365716|12111208|FG000|Extension 1|Withdrawal by Subject|0
7691933|NCT00365716|12111209|FG001|Extension 1|Withdrawal by Subject|0
7691934|NCT00365716|12111210|FG002|Extension 1|Withdrawal by Subject|0
7691935|NCT00365716|12111211|FG003|Extension 1|Withdrawal by Subject|0
7691936|NCT00365716|12111212|FG004|Extension 1|Withdrawal by Subject|0
7691937|NCT00365716|12111213|FG005|Extension 1|Withdrawal by Subject|3
7691938|NCT00365716|12111214|FG006|Extension 1|Withdrawal by Subject|0
7691939|NCT00365716|12111208|FG000|Extension 1|Pregnancy|0
7691940|NCT00365716|12111209|FG001|Extension 1|Pregnancy|0
7691941|NCT00365716|12111210|FG002|Extension 1|Pregnancy|0
7691942|NCT00365716|12111211|FG003|Extension 1|Pregnancy|0
7691943|NCT00365716|12111212|FG004|Extension 1|Pregnancy|0
7691944|NCT00365716|12111213|FG005|Extension 1|Pregnancy|4
7691945|NCT00365716|12111214|FG006|Extension 1|Pregnancy|0
7691946|NCT00365716|12111208|FG000|Extension 1|Protocol Violation|0
7691947|NCT00365716|12111209|FG001|Extension 1|Protocol Violation|0
7691948|NCT00365716|12111210|FG002|Extension 1|Protocol Violation|0
7691949|NCT00365716|12111211|FG003|Extension 1|Protocol Violation|0
7691950|NCT00365716|12111212|FG004|Extension 1|Protocol Violation|0
7691951|NCT00365716|12111213|FG005|Extension 1|Protocol Violation|1
7691952|NCT00365716|12111214|FG006|Extension 1|Protocol Violation|0
7691953|NCT00365716|12111208|FG000|Extension 2|Lost to Follow-up|0
7691954|NCT00365716|12111209|FG001|Extension 2|Lost to Follow-up|0
7691955|NCT00365716|12111210|FG002|Extension 2|Lost to Follow-up|0
7691956|NCT00365716|12111211|FG003|Extension 2|Lost to Follow-up|0
7691957|NCT00365716|12111212|FG004|Extension 2|Lost to Follow-up|0
7691958|NCT00365716|12111213|FG005|Extension 2|Lost to Follow-up|0
7691959|NCT00365716|12111214|FG006|Extension 2|Lost to Follow-up|2
7691960|NCT00365716|12111208|FG000|Extension 2|Other|0
7691961|NCT00365716|12111209|FG001|Extension 2|Other|0
7691962|NCT00365716|12111210|FG002|Extension 2|Other|0
7691963|NCT00365716|12111211|FG003|Extension 2|Other|0
7691964|NCT00365716|12111212|FG004|Extension 2|Other|0
7691965|NCT00365716|12111213|FG005|Extension 2|Other|0
7691966|NCT00365716|12111214|FG006|Extension 2|Other|3
7691967|NCT00365716|12111208|FG000|Extension 2|Withdrawal by Subject|0
7691968|NCT00365716|12111209|FG001|Extension 2|Withdrawal by Subject|0
7691969|NCT00365716|12111210|FG002|Extension 2|Withdrawal by Subject|0
7691970|NCT00365716|12111211|FG003|Extension 2|Withdrawal by Subject|0
7691971|NCT00365716|12111212|FG004|Extension 2|Withdrawal by Subject|0
7691972|NCT00365716|12111213|FG005|Extension 2|Withdrawal by Subject|0
7691973|NCT00365716|12111214|FG006|Extension 2|Withdrawal by Subject|5
7691974|NCT00365794|12111237|FG000|Overall Study|Withdrawal by Subject|2
7691975|NCT00365846|12111242|FG000|Overall Study|Lost to Follow-up|1
7691976|NCT00365976|12111277|FG000|Overall Study|Withdrawal by Subject|1
7691977|NCT00365976|12111278|FG001|Overall Study|Withdrawal by Subject|5
7691978|NCT00365989|12111284|FG000|Overall Study|Withdrawal by Subject|1
7691979|NCT00365989|12111284|FG000|Overall Study|Non-compliance|1
7691980|NCT00366249|12111306|FG000|Overall Study|Adverse Event|53
7691981|NCT00366249|12111307|FG001|Overall Study|Adverse Event|28
7691982|NCT00366249|12111306|FG000|Overall Study|Death|0
7691983|NCT00366249|12111307|FG001|Overall Study|Death|1
7691984|NCT00366249|12111306|FG000|Overall Study|Physician Decision|5
7691985|NCT00366249|12111307|FG001|Overall Study|Physician Decision|2
7691986|NCT00366249|12111306|FG000|Overall Study|Lost to Follow-up|2
7691987|NCT00366249|12111307|FG001|Overall Study|Lost to Follow-up|0
7691988|NCT00366249|12111306|FG000|Overall Study|Protocol Violation|1
7691989|NCT00366249|12111307|FG001|Overall Study|Protocol Violation|2
7691990|NCT00366249|12111306|FG000|Overall Study|Withdrawal by Subject|18
7691991|NCT00366249|12111307|FG001|Overall Study|Withdrawal by Subject|4
7691992|NCT00366249|12111306|FG000|Overall Study|Lack of Efficacy|21
7691993|NCT00366249|12111307|FG001|Overall Study|Lack of Efficacy|21
7691994|NCT00366249|12111306|FG000|Overall Study|Most due to osteomylitis status|31
7691995|NCT00366249|12111307|FG001|Overall Study|Most due to osteomylitis status|20
7691996|NCT00366301|12111321|FG000|Overall Study|Lost to Follow-up|4
7691997|NCT00366301|12111322|FG001|Overall Study|Lost to Follow-up|4
7691998|NCT00366301|12111323|FG002|Overall Study|Lost to Follow-up|3
7691999|NCT00366301|12111324|FG003|Overall Study|Lost to Follow-up|7
7692000|NCT00366301|12111321|FG000|Overall Study|Withdrawal by Subject|4
7692001|NCT00366301|12111322|FG001|Overall Study|Withdrawal by Subject|2
7692002|NCT00366301|12111323|FG002|Overall Study|Withdrawal by Subject|1
7692003|NCT00366301|12111324|FG003|Overall Study|Withdrawal by Subject|1
7692004|NCT00366340|12111336|FG000|Infant Series|Protocol Violation|3
7692005|NCT00366340|12111337|FG001|Infant Series|Protocol Violation|4
7692006|NCT00366340|12111336|FG000|Infant Series|Withdrawal by Subject|3
7692007|NCT00366340|12111337|FG001|Infant Series|Withdrawal by Subject|3
7692008|NCT00366340|12111336|FG000|Infant Series|Adverse Event|0
7692009|NCT00366340|12111337|FG001|Infant Series|Adverse Event|2
7692010|NCT00366340|12111336|FG000|Infant Series|Lost to Follow-up|1
7692011|NCT00366340|12111337|FG001|Infant Series|Lost to Follow-up|1
7692012|NCT00366340|12111336|FG000|Infant Series|Failure to return|1
7692013|NCT00366340|12111337|FG001|Infant Series|Failure to return|0
7692014|NCT00366340|12111336|FG000|After the Infant Series|Parent/legal guardian request|1
7692015|NCT00366340|12111337|FG001|After the Infant Series|Parent/legal guardian request|1
7692016|NCT00366340|12111336|FG000|After the Infant Series|Failed to return|0
7692017|NCT00366340|12111337|FG001|After the Infant Series|Failed to return|1
7692018|NCT00366340|12111336|FG000|After the Infant Series|Protocol Violation|2
7692019|NCT00366340|12111337|FG001|After the Infant Series|Protocol Violation|2
7692020|NCT00366340|12111336|FG000|After the Infant Series|Adverse Event|0
7692021|NCT00366340|12111337|FG001|After the Infant Series|Adverse Event|1
7692022|NCT00366340|12111336|FG000|After the Infant Series|Lost to Follow-up|0
7692023|NCT00366340|12111337|FG001|After the Infant Series|Lost to Follow-up|1
7692024|NCT00366340|12111336|FG000|Toddler Dose|Failed to return|1
7692025|NCT00366340|12111337|FG001|Toddler Dose|Failed to return|0
7692026|NCT00366340|12111336|FG000|Toddler Dose|Parent/legal guardian request|0
7692027|NCT00366340|12111337|FG001|Toddler Dose|Parent/legal guardian request|1
7692028|NCT00366444|12111369|FG000|Overall Study|Withdrawal by Subject|1
7692029|NCT00366444|12111370|FG001|Overall Study|Withdrawal by Subject|1
7692030|NCT00366444|12111369|FG000|Overall Study|Lack of Efficacy|0
7692031|NCT00366444|12111370|FG001|Overall Study|Lack of Efficacy|1
7692032|NCT00366457|12111376|FG000|Overall Study|never began study therapy|2
7692033|NCT00366535|12111382|FG000|First Phase: 12 Weeks|Adverse Event|1
7692034|NCT00366535|12111383|FG001|First Phase: 12 Weeks|Adverse Event|3
7692035|NCT00366535|12111382|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2
7692036|NCT00366535|12111383|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5
7692037|NCT00366535|12111382|FG000|Second Phase: 12 Weeks|Adverse Event|1
7692038|NCT00366535|12111383|FG001|Second Phase: 12 Weeks|Adverse Event|1
7692039|NCT00366535|12111382|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2
7692040|NCT00366535|12111383|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2
7692041|NCT00366548|12111399|FG000|Infant Series|Adverse Event|1
7692042|NCT00366548|12111400|FG001|Infant Series|Adverse Event|3
7692043|NCT00366548|12111399|FG000|Infant Series|Protocol Violation|0
7692044|NCT00366548|12111400|FG001|Infant Series|Protocol Violation|1
7692045|NCT00366548|12111399|FG000|Infant Series|Withdrawal by Subject|3
7692046|NCT00366548|12111400|FG001|Infant Series|Withdrawal by Subject|1
7692047|NCT00366548|12111399|FG000|After Infant Series|Withdrawal by Subject|3
7692048|NCT00366548|12111400|FG001|After Infant Series|Withdrawal by Subject|1
7692049|NCT00366548|12111399|FG000|After Infant Series|Adverse Event|2
7692050|NCT00366548|12111400|FG001|After Infant Series|Adverse Event|0
7692051|NCT00366548|12111399|FG000|After Infant Series|Lost to Follow-up|1
7692052|NCT00366548|12111400|FG001|After Infant Series|Lost to Follow-up|0
7692053|NCT00366678|12111437|FG000|Infant Series|Withdrawal by Subject|8
7692054|NCT00366678|12111438|FG001|Infant Series|Withdrawal by Subject|6
7692055|NCT00366678|12111439|FG002|Infant Series|Withdrawal by Subject|0
7692056|NCT00366678|12111437|FG000|Infant Series|Protocol Violation|4
7692057|NCT00366678|12111438|FG001|Infant Series|Protocol Violation|3
7692058|NCT00366678|12111439|FG002|Infant Series|Protocol Violation|0
7692059|NCT00366678|12111437|FG000|Infant Series|Failed to return|1
7692060|NCT00366678|12111438|FG001|Infant Series|Failed to return|1
7692061|NCT00366678|12111439|FG002|Infant Series|Failed to return|0
7692062|NCT00366678|12111437|FG000|Infant Series|Adverse Event|1
7692063|NCT00366678|12111438|FG001|Infant Series|Adverse Event|0
7692064|NCT00366678|12111439|FG002|Infant Series|Adverse Event|0
7692065|NCT00366678|12111437|FG000|After Infant|Withdrawal by Subject|8
7692066|NCT00366678|12111438|FG001|After Infant|Withdrawal by Subject|4
7692067|NCT00366678|12111439|FG002|After Infant|Withdrawal by Subject|0
7692068|NCT00366678|12111437|FG000|After Infant|Lost to Follow-up|2
7692069|NCT00366678|12111438|FG001|After Infant|Lost to Follow-up|1
7692070|NCT00366678|12111439|FG002|After Infant|Lost to Follow-up|0
7692071|NCT00366678|12111437|FG000|After Infant|Failed to return|5
7692072|NCT00366678|12111438|FG001|After Infant|Failed to return|5
7692073|NCT00366678|12111439|FG002|After Infant|Failed to return|0
7692074|NCT00366678|12111437|FG000|After Infant|Adverse Event|1
7692075|NCT00366678|12111438|FG001|After Infant|Adverse Event|0
7692076|NCT00366678|12111439|FG002|After Infant|Adverse Event|0
7692077|NCT00366678|12111437|FG000|After Infant|Protocol Violation|1
7692078|NCT00366678|12111438|FG001|After Infant|Protocol Violation|0
7692079|NCT00366678|12111439|FG002|After Infant|Protocol Violation|0
7692080|NCT00366678|12111437|FG000|Toddler Dose|Protocol Violation|2
7692081|NCT00366678|12111438|FG001|Toddler Dose|Protocol Violation|1
7692082|NCT00366678|12111439|FG002|Toddler Dose|Protocol Violation|0
7692083|NCT00366678|12111437|FG000|Toddler Dose|Failed to return|1
7692084|NCT00366678|12111438|FG001|Toddler Dose|Failed to return|0
7692085|NCT00366678|12111439|FG002|Toddler Dose|Failed to return|0
7692086|NCT00366678|12111437|FG000|Toddler Dose|Withdrawal by Subject|1
7692087|NCT00366678|12111438|FG001|Toddler Dose|Withdrawal by Subject|0
7692088|NCT00366678|12111439|FG002|Toddler Dose|Withdrawal by Subject|0
7692089|NCT00366678|12111437|FG000|Toddler Dose|protocol deviation|1
7692090|NCT00366678|12111438|FG001|Toddler Dose|protocol deviation|0
7692091|NCT00366678|12111439|FG002|Toddler Dose|protocol deviation|0
7692092|NCT00366899|12111486|FG000|Infant Series|Withdrawal by Subject|4
7692093|NCT00366899|12111487|FG001|Infant Series|Withdrawal by Subject|7
7692094|NCT00366899|12111486|FG000|Infant Series|Protocol Violation|2
7692095|NCT00366899|12111487|FG001|Infant Series|Protocol Violation|1
7692096|NCT00366899|12111486|FG000|Infant Series|Failed to return|1
7692097|NCT00366899|12111487|FG001|Infant Series|Failed to return|1
7692098|NCT00366899|12111486|FG000|Infant Series|Lost to Follow-up|0
7692099|NCT00366899|12111487|FG001|Infant Series|Lost to Follow-up|2
7692100|NCT00366899|12111486|FG000|Infant Series|Adverse Event|0
7692101|NCT00366899|12111487|FG001|Infant Series|Adverse Event|1
7692102|NCT00366899|12111486|FG000|Infant Series|Physician Decision|1
7692103|NCT00366899|12111487|FG001|Infant Series|Physician Decision|0
7692104|NCT00366899|12111486|FG000|Infant Series|Randomized but not consented|1
7692105|NCT00366899|12111487|FG001|Infant Series|Randomized but not consented|0
7692106|NCT00366899|12111486|FG000|After Infant Series|Lost to Follow-up|4
7692107|NCT00366899|12111487|FG001|After Infant Series|Lost to Follow-up|3
7692108|NCT00366899|12111486|FG000|After Infant Series|Withdrawal by Subject|1
7692109|NCT00366899|12111487|FG001|After Infant Series|Withdrawal by Subject|4
7692110|NCT00366899|12111486|FG000|After Infant Series|Adverse Event|1
7692111|NCT00366899|12111487|FG001|After Infant Series|Adverse Event|2
7692112|NCT00366899|12111486|FG000|After Infant Series|Protocol Violation|1
7692113|NCT00366899|12111487|FG001|After Infant Series|Protocol Violation|0
7692114|NCT00366899|12111486|FG000|Toddler Dose|Withdrawal by Subject|1
7692115|NCT00366899|12111487|FG001|Toddler Dose|Withdrawal by Subject|1
7692116|NCT00366899|12111486|FG000|Toddler Dose|Protocol Violation|1
7692117|NCT00366899|12111487|FG001|Toddler Dose|Protocol Violation|0
7692118|NCT00367055|12111532|FG000|Overall Study|Adverse Event|6
7692119|NCT00367055|12111533|FG001|Overall Study|Adverse Event|3
7692120|NCT00367055|12111532|FG000|Overall Study|Patient's Willing|3
7692121|NCT00367055|12111533|FG001|Overall Study|Patient's Willing|2
7692122|NCT00367055|12111532|FG000|Overall Study|Lack of Efficacy|1
7692123|NCT00367055|12111533|FG001|Overall Study|Lack of Efficacy|2
7692124|NCT00367055|12111532|FG000|Overall Study|Lost to Follow-up|1
7692125|NCT00367055|12111533|FG001|Overall Study|Lost to Follow-up|1
7692126|NCT00367055|12111532|FG000|Overall Study|Protocol Violation|0
7692127|NCT00367055|12111533|FG001|Overall Study|Protocol Violation|1
7692128|NCT00367055|12111532|FG000|Overall Study|Stopping Criterion Met|0
7692129|NCT00367055|12111533|FG001|Overall Study|Stopping Criterion Met|1
7692130|NCT00367055|12111532|FG000|Overall Study|Participant Living too Far from Hospital|0
7692131|NCT00367055|12111533|FG001|Overall Study|Participant Living too Far from Hospital|1
7692132|NCT00367133|12111542|FG000|2 Years|Death|20
7692133|NCT00367133|12111543|FG001|2 Years|Death|12
7692134|NCT00367133|12111544|FG002|2 Years|Death|12
7692135|NCT00367133|12111542|FG000|2 Years|Dropped|34
7692136|NCT00367133|12111543|FG001|2 Years|Dropped|19
7692137|NCT00367133|12111544|FG002|2 Years|Dropped|33
7692138|NCT00367133|12111542|FG000|2 Years|Missed visit|4
7692139|NCT00367133|12111543|FG001|2 Years|Missed visit|5
7692140|NCT00367133|12111544|FG002|2 Years|Missed visit|4
7692141|NCT00367237|12111554|FG000|Overall Study|Adverse Event|7
7692142|NCT00367237|12111555|FG001|Overall Study|Adverse Event|2
7692143|NCT00367237|12111554|FG000|Overall Study|Lost to Follow-up|1
7692144|NCT00367237|12111555|FG001|Overall Study|Lost to Follow-up|0
7692145|NCT00367237|12111554|FG000|Overall Study|Withdrawal by Subject|0
7692146|NCT00367237|12111555|FG001|Overall Study|Withdrawal by Subject|4
7692147|NCT00367237|12111554|FG000|Overall Study|Protocol Violation|2
7692148|NCT00367237|12111555|FG001|Overall Study|Protocol Violation|5
7692149|NCT00367341|12111563|FG000|Overall Study|Physician Decision|1
7692150|NCT00367341|12111564|FG001|Overall Study|Physician Decision|0
7692151|NCT00367341|12111563|FG000|Overall Study|Protocol Violation|1
7692152|NCT00367341|12111564|FG001|Overall Study|Protocol Violation|0
7692153|NCT00367432|12111583|FG000|First Period (16 Weeks)|Adverse Event|6
7692154|NCT00367432|12111584|FG001|First Period (16 Weeks)|Adverse Event|0
7692155|NCT00367432|12111583|FG000|First Period (16 Weeks)|Lack of Efficacy|24
7692156|NCT00367432|12111584|FG001|First Period (16 Weeks)|Lack of Efficacy|0
7692157|NCT00367432|12111583|FG000|First Period (16 Weeks)|Withdrawal by Subject|6
7692158|NCT00367432|12111584|FG001|First Period (16 Weeks)|Withdrawal by Subject|0
7692159|NCT00367432|12111583|FG000|First Period (16 Weeks)|Other Reason|2
7692160|NCT00367432|12111584|FG001|First Period (16 Weeks)|Other Reason|0
7692161|NCT00367432|12111583|FG000|Second Period (up to 54 Months)|Adverse Event|14
7692162|NCT00367432|12111584|FG001|Second Period (up to 54 Months)|Adverse Event|3
7692163|NCT00367432|12111583|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59
7692164|NCT00367432|12111584|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5
7692165|NCT00367432|12111583|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0
7692166|NCT00367432|12111584|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1
7692167|NCT00367432|12111583|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8
7692168|NCT00367432|12111584|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5
7692169|NCT00367432|12111583|FG000|Second Period (up to 54 Months)|Other Reason|6
7692170|NCT00367432|12111584|FG001|Second Period (up to 54 Months)|Other Reason|2
7692171|NCT00367458|12111590|FG000|First Intervention - 8 Weeks|Adverse Event|2
7692172|NCT00367458|12111591|FG001|First Intervention - 8 Weeks|Adverse Event|0
7692173|NCT00367484|12111597|FG000|Overall Study|Adverse Event|7
7692174|NCT00367484|12111597|FG000|Overall Study|Withdrew informed consent|5
7692175|NCT00367484|12111597|FG000|Overall Study|Travel to USA|1
7692176|NCT00367484|12111597|FG000|Overall Study|Lost to Follow-up|1
7692177|NCT00367484|12111597|FG000|Overall Study|Protocol Violation|1
7692178|NCT00367484|12111597|FG000|Overall Study|The choice of the patient|1
7692179|NCT00367484|12111597|FG000|Overall Study|Lack of Efficacy|1
7692180|NCT00367640|12111610|FG000|Overall Study|Adverse Event|3
7692181|NCT00367640|12111611|FG001|Overall Study|Adverse Event|6
7692182|NCT00367640|12111612|FG002|Overall Study|Adverse Event|8
7692183|NCT00367640|12111613|FG003|Overall Study|Adverse Event|0
7692184|NCT00367640|12111610|FG000|Overall Study|Withdrawal by Subject|8
7692185|NCT00367640|12111611|FG001|Overall Study|Withdrawal by Subject|11
7692186|NCT00367640|12111612|FG002|Overall Study|Withdrawal by Subject|8
7692187|NCT00367640|12111613|FG003|Overall Study|Withdrawal by Subject|6
7692188|NCT00367640|12111610|FG000|Overall Study|Any other reason not above-mentioned|7
7692189|NCT00367640|12111611|FG001|Overall Study|Any other reason not above-mentioned|5
7692190|NCT00367640|12111612|FG002|Overall Study|Any other reason not above-mentioned|3
7692191|NCT00367640|12111613|FG003|Overall Study|Any other reason not above-mentioned|4
7692192|NCT00367744|12111631|FG000|Overall Study|Lost to Follow-up|4
7692193|NCT00367744|12111632|FG001|Overall Study|Lost to Follow-up|5
7692194|NCT00367770|12111639|FG000|Overall Study|Adverse Event|1
7692195|NCT00367770|12111639|FG000|Overall Study|Withdrawal by Subject|1
7692196|NCT00367835|12111645|FG000|Overall Study|Adverse Event|14
7692197|NCT00367835|12111646|FG001|Overall Study|Adverse Event|1
7692198|NCT00367835|12111645|FG000|Overall Study|Protocol Violation|1
7692199|NCT00367835|12111646|FG001|Overall Study|Protocol Violation|7
7692200|NCT00367835|12111645|FG000|Overall Study|Withdrawal by Subject|7
7692201|NCT00367835|12111646|FG001|Overall Study|Withdrawal by Subject|6
7692202|NCT00367835|12111645|FG000|Overall Study|Lost to Follow-up|1
7692203|NCT00367835|12111646|FG001|Overall Study|Lost to Follow-up|4
7692204|NCT00367835|12111645|FG000|Overall Study|Lack of Efficacy|3
7692205|NCT00367835|12111646|FG001|Overall Study|Lack of Efficacy|12
7692206|NCT00367835|12111645|FG000|Overall Study|Subject in juvenile detention center|1
7692207|NCT00367835|12111646|FG001|Overall Study|Subject in juvenile detention center|0
7692208|NCT00367835|12111645|FG000|Overall Study|refused blood collection|1
7692209|NCT00367835|12111646|FG001|Overall Study|refused blood collection|0
7692210|NCT00367835|12111645|FG000|Overall Study|Did not respond to calls|1
7692211|NCT00367835|12111646|FG001|Overall Study|Did not respond to calls|0
7692212|NCT00367835|12111645|FG000|Overall Study|History of lead poisoning|0
7692213|NCT00367835|12111646|FG001|Overall Study|History of lead poisoning|1
7692214|NCT00367991|12111654|FG000|Overall Study|Withdrawal by Subject|1
7692215|NCT00367991|12111655|FG001|Overall Study|Withdrawal by Subject|1
7692216|NCT00367991|12111654|FG000|Overall Study|Adverse Event|1
7692217|NCT00367991|12111655|FG001|Overall Study|Adverse Event|1
7692218|NCT00368069|12111663|FG000|Overall Study|Adverse Event|5
7692219|NCT00368069|12111664|FG001|Overall Study|Adverse Event|2
7692220|NCT00368069|12111663|FG000|Overall Study|Lack of Efficacy|0
7692221|NCT00368069|12111664|FG001|Overall Study|Lack of Efficacy|1
7692222|NCT00368069|12111663|FG000|Overall Study|Lost to Follow-up|1
7692223|NCT00368069|12111664|FG001|Overall Study|Lost to Follow-up|0
7692224|NCT00368069|12111663|FG000|Overall Study|Protocol Violation|0
7692225|NCT00368069|12111664|FG001|Overall Study|Protocol Violation|2
7692226|NCT00368069|12111663|FG000|Overall Study|Withdrawal of Consent|2
7692227|NCT00368069|12111664|FG001|Overall Study|Withdrawal of Consent|1
7692228|NCT00368069|12111663|FG000|Overall Study|no blood sampling possible|0
7692229|NCT00368069|12111664|FG001|Overall Study|no blood sampling possible|1
7692230|NCT00368108|12111673|FG000|Overall Study|Adverse Event|38
7692231|NCT00368108|12111674|FG001|Overall Study|Adverse Event|26
7692232|NCT00368108|12111675|FG002|Overall Study|Adverse Event|44
7692233|NCT00368108|12111673|FG000|Overall Study|Abnormal Laboratory Value|0
7692234|NCT00368108|12111674|FG001|Overall Study|Abnormal Laboratory Value|0
7692235|NCT00368108|12111675|FG002|Overall Study|Abnormal Laboratory Value|3
7692236|NCT00368108|12111673|FG000|Overall Study|Protocol Violation|5
7692237|NCT00368108|12111674|FG001|Overall Study|Protocol Violation|9
7692238|NCT00368108|12111675|FG002|Overall Study|Protocol Violation|9
7692239|NCT00368108|12111673|FG000|Overall Study|Withdrawal by Subject|9
7692240|NCT00368108|12111674|FG001|Overall Study|Withdrawal by Subject|3
7692241|NCT00368108|12111675|FG002|Overall Study|Withdrawal by Subject|5
7692242|NCT00368108|12111673|FG000|Overall Study|Lack of Efficacy|7
7692243|NCT00368108|12111674|FG001|Overall Study|Lack of Efficacy|8
7692244|NCT00368108|12111675|FG002|Overall Study|Lack of Efficacy|5
7692245|NCT00368108|12111673|FG000|Overall Study|Physician Decision|2
7692246|NCT00368108|12111674|FG001|Overall Study|Physician Decision|0
7692247|NCT00368108|12111675|FG002|Overall Study|Physician Decision|1
7692248|NCT00368108|12111673|FG000|Overall Study|Other|3
7692249|NCT00368108|12111674|FG001|Overall Study|Other|7
7692250|NCT00368108|12111675|FG002|Overall Study|Other|1
7692251|NCT00368251|12111686|FG000|Overall Study|SAE, non-fatal|1
7692252|NCT00368251|12111687|FG001|Overall Study|SAE, non-fatal|0
7692253|NCT00368251|12111688|FG002|Overall Study|SAE, non-fatal|0
7692254|NCT00368251|12111686|FG000|Overall Study|AE, non-serious non-fatal|0
7692255|NCT00368251|12111687|FG001|Overall Study|AE, non-serious non-fatal|0
7692256|NCT00368251|12111688|FG002|Overall Study|AE, non-serious non-fatal|1
7692257|NCT00368277|12111698|FG000|Overall Study|Adverse Event|33
7692258|NCT00368277|12111699|FG001|Overall Study|Adverse Event|49
7692259|NCT00368277|12111698|FG000|Overall Study|Death|2
7692260|NCT00368277|12111699|FG001|Overall Study|Death|1
7692344|NCT00368927|12111799|FG001|Overall Study|Physician Decision|0
7692261|NCT00368277|12111698|FG000|Overall Study|Unsatisfactory therapeutic effect|31
7692262|NCT00368277|12111699|FG001|Overall Study|Unsatisfactory therapeutic effect|24
7692263|NCT00368277|12111698|FG000|Overall Study|Protocol deviation|7
7692264|NCT00368277|12111699|FG001|Overall Study|Protocol deviation|0
7692265|NCT00368277|12111698|FG000|Overall Study|Patient withdrew consent|32
7692266|NCT00368277|12111699|FG001|Overall Study|Patient withdrew consent|28
7692267|NCT00368277|12111698|FG000|Overall Study|Lost to Follow-up|8
7692268|NCT00368277|12111699|FG001|Overall Study|Lost to Follow-up|6
7692269|NCT00368355|12111725|FG000|Overall Study|Adverse Event|1
7692270|NCT00368355|12111726|FG001|Overall Study|Adverse Event|0
7692271|NCT00368355|12111725|FG000|Overall Study|Death|2
7692272|NCT00368355|12111726|FG001|Overall Study|Death|4
7692273|NCT00368355|12111725|FG000|Overall Study|Relapse|6
7692274|NCT00368355|12111726|FG001|Overall Study|Relapse|10
7692275|NCT00368355|12111725|FG000|Overall Study|Subsequent transplant|0
7692276|NCT00368355|12111726|FG001|Overall Study|Subsequent transplant|3
7692277|NCT00368355|12111725|FG000|Overall Study|Treatment - hematopoietic cell product|2
7692278|NCT00368355|12111726|FG001|Overall Study|Treatment - hematopoietic cell product|0
7692279|NCT00368472|12111741|FG000|Overall Study|Adverse Event|22
7692280|NCT00368472|12111741|FG000|Overall Study|Medication non-compliance|4
7692281|NCT00368472|12111741|FG000|Overall Study|Protocol Violation|2
7692282|NCT00368472|12111741|FG000|Overall Study|Request of Investigator or Sponsor|3
7692283|NCT00368472|12111741|FG000|Overall Study|Withdrawal by Subject|40
7692284|NCT00368472|12111741|FG000|Overall Study|Diary non-compliance|1
7692285|NCT00368472|12111741|FG000|Overall Study|Other|32
7692286|NCT00368472|12111741|FG000|Overall Study|Missing Final Disposition Date|1
7692287|NCT00368537|12111747|FG000|Randomization|No study drug dosed|13
7692288|NCT00368537|12111748|FG001|Randomization|No study drug dosed|6
7692289|NCT00368537|12111747|FG000|Baseline Participants|Lost to Follow-up|16
7692290|NCT00368537|12111748|FG001|Baseline Participants|Lost to Follow-up|17
7692291|NCT00368537|12111747|FG000|Baseline Participants|Withdrawal by Subject|6
7692292|NCT00368537|12111748|FG001|Baseline Participants|Withdrawal by Subject|4
7692293|NCT00368537|12111747|FG000|Baseline Participants|Death|1
7692294|NCT00368537|12111748|FG001|Baseline Participants|Death|2
7692295|NCT00368537|12111747|FG000|Baseline Participants|No susceptibility|1
7692296|NCT00368537|12111748|FG001|Baseline Participants|No susceptibility|0
7692297|NCT00368537|12111747|FG000|Baseline Participants|Patient uncompliant|0
7692298|NCT00368537|12111748|FG001|Baseline Participants|Patient uncompliant|1
7692299|NCT00368550|12111756|FG000|Overall Study|Adverse Event|7
7692300|NCT00368550|12111757|FG001|Overall Study|Adverse Event|4
7692301|NCT00368550|12111756|FG000|Overall Study|Lack of Efficacy|4
7692302|NCT00368550|12111757|FG001|Overall Study|Lack of Efficacy|9
7692303|NCT00368550|12111756|FG000|Overall Study|Withdrawal by Subject|17
7692304|NCT00368550|12111757|FG001|Overall Study|Withdrawal by Subject|10
7692305|NCT00368641|12111765|FG000|Overall Study|Adverse Event|2
7692306|NCT00368641|12111766|FG001|Overall Study|Adverse Event|1
7692307|NCT00368641|12111765|FG000|Overall Study|Death|1
7692308|NCT00368641|12111766|FG001|Overall Study|Death|0
7692309|NCT00368641|12111765|FG000|Overall Study|Withdrawal by Subject|1
7692310|NCT00368641|12111766|FG001|Overall Study|Withdrawal by Subject|0
7692311|NCT00368641|12111765|FG000|Overall Study|Sponsor decision to terminate study|2
7692312|NCT00368641|12111766|FG001|Overall Study|Sponsor decision to terminate study|5
7692313|NCT00368745|12111774|FG000|Double-blind Treatment Period|Adverse Event|6
7692314|NCT00368745|12111775|FG001|Double-blind Treatment Period|Adverse Event|6
7692315|NCT00368745|12111774|FG000|Double-blind Treatment Period|Lack of Efficacy|7
7692316|NCT00368745|12111775|FG001|Double-blind Treatment Period|Lack of Efficacy|16
7692317|NCT00368745|12111774|FG000|Double-blind Treatment Period|Lost to Follow-up|1
7692318|NCT00368745|12111775|FG001|Double-blind Treatment Period|Lost to Follow-up|0
7692319|NCT00368745|12111774|FG000|Double-blind Treatment Period|Withdrawal by Subject|5
7692320|NCT00368745|12111775|FG001|Double-blind Treatment Period|Withdrawal by Subject|3
7692321|NCT00368745|12111774|FG000|Double-blind Treatment Period|Other|7
7692322|NCT00368745|12111775|FG001|Double-blind Treatment Period|Other|6
7692323|NCT00368849|12111781|FG000|Overall Study|Withdrawal by Subject|0
7692324|NCT00368849|12111782|FG001|Overall Study|Withdrawal by Subject|1
7692325|NCT00368849|12111781|FG000|Overall Study|Physician Decision|0
7692326|NCT00368849|12111782|FG001|Overall Study|Physician Decision|1
7692327|NCT00368875|12111789|FG000|Overall Study|Adverse Event|0
7692328|NCT00368875|12111790|FG001|Overall Study|Adverse Event|12
7692329|NCT00368875|12111789|FG000|Overall Study|Progressive disease|3
7692330|NCT00368875|12111790|FG001|Overall Study|Progressive disease|27
7692331|NCT00368875|12111789|FG000|Overall Study|Withdrawal by Subject|2
7692332|NCT00368875|12111790|FG001|Overall Study|Withdrawal by Subject|6
7692333|NCT00368875|12111789|FG000|Overall Study|Other Reason|0
7692334|NCT00368875|12111790|FG001|Overall Study|Other Reason|2
7692335|NCT00368875|12111789|FG000|Overall Study|Alternative Therapy|1
7692336|NCT00368875|12111790|FG001|Overall Study|Alternative Therapy|1
7692337|NCT00368927|12111798|FG000|Overall Study|Lost to Follow-up|2
7692338|NCT00368927|12111799|FG001|Overall Study|Lost to Follow-up|0
7692339|NCT00368927|12111798|FG000|Overall Study|Adverse Event|1
7692340|NCT00368927|12111799|FG001|Overall Study|Adverse Event|1
7692341|NCT00368927|12111798|FG000|Overall Study|Withdrawal by Subject|1
7692342|NCT00368927|12111799|FG001|Overall Study|Withdrawal by Subject|2
7692343|NCT00368927|12111798|FG000|Overall Study|Physician Decision|1
7692345|NCT00368966|12111817|FG000|Infant Series|Withdrawal by Subject|11
7692346|NCT00368966|12111818|FG001|Infant Series|Withdrawal by Subject|6
7692347|NCT00368966|12111817|FG000|Infant Series|Protocol Violation|2
7692348|NCT00368966|12111818|FG001|Infant Series|Protocol Violation|1
7692349|NCT00368966|12111817|FG000|Infant Series|Lost to Follow-up|2
7692350|NCT00368966|12111818|FG001|Infant Series|Lost to Follow-up|0
7692351|NCT00368966|12111817|FG000|Infant Series|Randomization error|0
7692352|NCT00368966|12111818|FG001|Infant Series|Randomization error|1
7692353|NCT00368966|12111817|FG000|Infant Series|Failed to meet eligibility criteria|0
7692354|NCT00368966|12111818|FG001|Infant Series|Failed to meet eligibility criteria|1
7692355|NCT00368966|12111817|FG000|Infant Series|Adverse Event|0
7692356|NCT00368966|12111818|FG001|Infant Series|Adverse Event|1
7692357|NCT00368966|12111817|FG000|Infant Series|Failed to return|1
7692358|NCT00368966|12111818|FG001|Infant Series|Failed to return|0
7692359|NCT00368966|12111817|FG000|After Infant|Failed to return|3
7692360|NCT00368966|12111818|FG001|After Infant|Failed to return|1
7692361|NCT00368966|12111817|FG000|After Infant|Adverse Event|1
7692362|NCT00368966|12111818|FG001|After Infant|Adverse Event|2
7692363|NCT00368966|12111817|FG000|After Infant|Withdrawal by Subject|1
7692364|NCT00368966|12111818|FG001|After Infant|Withdrawal by Subject|1
7692365|NCT00368966|12111817|FG000|After Infant|Death|1
7692366|NCT00368966|12111818|FG001|After Infant|Death|0
7692367|NCT00368966|12111817|FG000|After Infant|Lost to Follow-up|0
7692368|NCT00368966|12111818|FG001|After Infant|Lost to Follow-up|1
7692369|NCT00368966|12111817|FG000|Toddler Dose|Withdrawal by Subject|1
7692370|NCT00368966|12111818|FG001|Toddler Dose|Withdrawal by Subject|1
7692371|NCT00368966|12111817|FG000|Toddler Dose|Lost to Follow-up|0
7692372|NCT00368966|12111818|FG001|Toddler Dose|Lost to Follow-up|2
7692373|NCT00368979|12111851|FG000|Overall Study|Adverse Event|9
7692374|NCT00368979|12111852|FG001|Overall Study|Adverse Event|16
7692375|NCT00368979|12111851|FG000|Overall Study|Lack of Efficacy|5
7692376|NCT00368979|12111852|FG001|Overall Study|Lack of Efficacy|3
7692377|NCT00368979|12111851|FG000|Overall Study|Other|3
7692378|NCT00368979|12111852|FG001|Overall Study|Other|1
7692379|NCT00368979|12111851|FG000|Overall Study|Lost to Follow-up|1
7692380|NCT00368979|12111852|FG001|Overall Study|Lost to Follow-up|0
7692381|NCT00368979|12111851|FG000|Overall Study|Protocol Violation|2
7692382|NCT00368979|12111852|FG001|Overall Study|Protocol Violation|1
7692383|NCT00368979|12111851|FG000|Overall Study|Withdrawal by Subject|5
7692384|NCT00368979|12111852|FG001|Overall Study|Withdrawal by Subject|9
7692385|NCT00368992|12111858|FG000|Overall Study|Ineligible|5
7692386|NCT00368992|12111858|FG000|Overall Study|Refused treatment|3
7692387|NCT00368992|12111858|FG000|Overall Study|Lack of Efficacy|63
7692388|NCT00368992|12111858|FG000|Overall Study|Adverse Event|26
7692389|NCT00368992|12111858|FG000|Overall Study|Death|4
7692390|NCT00368992|12111858|FG000|Overall Study|Other|9
7692391|NCT00369122|12111863|FG000|Overall Study|Ineligible|10
7692392|NCT00369122|12111863|FG000|Overall Study|No protocol treatment|1
7692393|NCT00369161|12111869|FG000|Overall Study|Adverse Event|15
7692394|NCT00369161|12111870|FG001|Overall Study|Adverse Event|13
7692395|NCT00369161|12111869|FG000|Overall Study|Abnormal laboratory value|0
7692396|NCT00369161|12111870|FG001|Overall Study|Abnormal laboratory value|1
7692397|NCT00369161|12111869|FG000|Overall Study|Lack of Efficacy|3
7692398|NCT00369161|12111870|FG001|Overall Study|Lack of Efficacy|1
7692399|NCT00369161|12111869|FG000|Overall Study|Protocol Violation|0
7692400|NCT00369161|12111870|FG001|Overall Study|Protocol Violation|2
7692401|NCT00369161|12111869|FG000|Overall Study|Withdrawal by Subject|2
7692402|NCT00369161|12111870|FG001|Overall Study|Withdrawal by Subject|3
7692403|NCT00369161|12111869|FG000|Overall Study|Death|1
7692404|NCT00369161|12111870|FG001|Overall Study|Death|2
7692405|NCT00369161|12111869|FG000|Overall Study|Graft loss|4
7692406|NCT00369161|12111870|FG001|Overall Study|Graft loss|0
7692407|NCT00369161|12111869|FG000|Overall Study|Administrative Problem|2
7692408|NCT00369161|12111870|FG001|Overall Study|Administrative Problem|2
7692409|NCT00369278|12111890|FG000|Overall Study|Adverse Event|14
7692410|NCT00369278|12111891|FG001|Overall Study|Adverse Event|11
7692411|NCT00369278|12111890|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7692412|NCT00369278|12111891|FG001|Overall Study|Unsatisfactory therapeutic effect|5
7692413|NCT00369278|12111890|FG000|Overall Study|Protocol Violation|2
7692414|NCT00369278|12111891|FG001|Overall Study|Protocol Violation|1
7692415|NCT00369278|12111890|FG000|Overall Study|Withdrawal by Subject|2
7692416|NCT00369278|12111891|FG001|Overall Study|Withdrawal by Subject|2
7692417|NCT00369278|12111890|FG000|Overall Study|Lost to Follow-up|1
7692418|NCT00369278|12111891|FG001|Overall Study|Lost to Follow-up|0
7692419|NCT00369278|12111890|FG000|Overall Study|Graft loss|1
7692420|NCT00369278|12111891|FG001|Overall Study|Graft loss|2
7692421|NCT00369343|12111899|FG000|Double-blind Phase|Adverse Event|19
7692422|NCT00369343|12111900|FG001|Double-blind Phase|Adverse Event|4
7692423|NCT00369343|12111899|FG000|Double-blind Phase|Failed to return|2
7692424|NCT00369343|12111900|FG001|Double-blind Phase|Failed to return|0
7692425|NCT00369343|12111899|FG000|Double-blind Phase|Lost to Follow-up|9
7692426|NCT00369343|12111900|FG001|Double-blind Phase|Lost to Follow-up|2
7692427|NCT00369343|12111899|FG000|Double-blind Phase|Protocol Violation|2
7692428|NCT00369343|12111900|FG001|Double-blind Phase|Protocol Violation|0
7692429|NCT00369343|12111899|FG000|Double-blind Phase|Withdrawal by Subject|8
7692430|NCT00369343|12111900|FG001|Double-blind Phase|Withdrawal by Subject|6
7692431|NCT00369343|12111899|FG000|Double-blind Phase|Lack of Efficacy|0
7692432|NCT00369343|12111900|FG001|Double-blind Phase|Lack of Efficacy|4
7692433|NCT00369343|12111899|FG000|Double-blind Phase|Protocol deviation|4
7692434|NCT00369343|12111900|FG001|Double-blind Phase|Protocol deviation|0
7692435|NCT00369343|12111899|FG000|Open-label Phase|Adverse Event|19
7692436|NCT00369343|12111900|FG001|Open-label Phase|Adverse Event|7
7692437|NCT00369343|12111899|FG000|Open-label Phase|Failed to return|4
7692438|NCT00369343|12111900|FG001|Open-label Phase|Failed to return|0
7692439|NCT00369343|12111899|FG000|Open-label Phase|Physician Decision|2
7692440|NCT00369343|12111900|FG001|Open-label Phase|Physician Decision|0
7692441|NCT00369343|12111899|FG000|Open-label Phase|Lost to Follow-up|5
7692442|NCT00369343|12111900|FG001|Open-label Phase|Lost to Follow-up|3
7692443|NCT00369343|12111899|FG000|Open-label Phase|inadvertently reported study completers|3
7692444|NCT00369343|12111900|FG001|Open-label Phase|inadvertently reported study completers|2
7692445|NCT00369343|12111899|FG000|Open-label Phase|Protocol Violation|1
7692446|NCT00369343|12111900|FG001|Open-label Phase|Protocol Violation|3
7692447|NCT00369343|12111899|FG000|Open-label Phase|Withdrawal by Subject|15
7692448|NCT00369343|12111900|FG001|Open-label Phase|Withdrawal by Subject|6
7692449|NCT00369343|12111899|FG000|Open-label Phase|Lack of Efficacy|4
7692450|NCT00369343|12111900|FG001|Open-label Phase|Lack of Efficacy|3
7692451|NCT00369343|12111899|FG000|Open-label Phase|Lack of continuance tolerability|3
7692452|NCT00369343|12111900|FG001|Open-label Phase|Lack of continuance tolerability|4
7692453|NCT00369343|12111899|FG000|Open-label Phase|did not take study drug|1
7692454|NCT00369343|12111900|FG001|Open-label Phase|did not take study drug|2
7692455|NCT00369382|12111915|FG000|Overall Study|Death|0
7692456|NCT00369382|12111916|FG001|Overall Study|Death|2
7692457|NCT00369382|12111915|FG000|Overall Study|Physician Decision|2
7692458|NCT00369382|12111916|FG001|Overall Study|Physician Decision|1
7692459|NCT00369382|12111915|FG000|Overall Study|Withdrawal by Subject|5
7692460|NCT00369382|12111916|FG001|Overall Study|Withdrawal by Subject|0
7692461|NCT00369382|12111915|FG000|Overall Study|Randomized, not treated|2
7692462|NCT00369382|12111916|FG001|Overall Study|Randomized, not treated|0
7692463|NCT00369382|12111915|FG000|Overall Study|Other|1
7692464|NCT00369382|12111916|FG001|Overall Study|Other|0
7692465|NCT00369486|12111928|FG000|4-Week Visit|Missed visit|2
7692466|NCT00369486|12111929|FG001|4-Week Visit|Missed visit|2
7692467|NCT00369486|12111930|FG002|4-Week Visit|Missed visit|0
7692468|NCT00369486|12111931|FG003|4-Week Visit|Missed visit|2
7692469|NCT00369486|12111932|FG004|4-Week Visit|Missed visit|1
7692470|NCT00369486|12111928|FG000|4-Week Visit|Dropped|0
7692471|NCT00369486|12111929|FG001|4-Week Visit|Dropped|0
7692472|NCT00369486|12111930|FG002|4-Week Visit|Dropped|1
7692473|NCT00369486|12111931|FG003|4-Week Visit|Dropped|0
7692474|NCT00369486|12111932|FG004|4-Week Visit|Dropped|0
7692475|NCT00369486|12111928|FG000|8-Week Visit|Missed visit|0
7692476|NCT00369486|12111929|FG001|8-Week Visit|Missed visit|1
7692477|NCT00369486|12111930|FG002|8-Week Visit|Missed visit|0
7692478|NCT00369486|12111931|FG003|8-Week Visit|Missed visit|0
7692479|NCT00369486|12111932|FG004|8-Week Visit|Missed visit|1
7692480|NCT00369486|12111928|FG000|8-Week Visit|Dropped|0
7692481|NCT00369486|12111929|FG001|8-Week Visit|Dropped|0
7692482|NCT00369486|12111930|FG002|8-Week Visit|Dropped|0
7692483|NCT00369486|12111931|FG003|8-Week Visit|Dropped|1
7692484|NCT00369486|12111932|FG004|8-Week Visit|Dropped|0
7692485|NCT00369486|12111928|FG000|17-Week Visit|Missed visit|0
7692486|NCT00369486|12111929|FG001|17-Week Visit|Missed visit|0
7692487|NCT00369486|12111930|FG002|17-Week Visit|Missed visit|1
7692488|NCT00369486|12111931|FG003|17-Week Visit|Missed visit|1
7692489|NCT00369486|12111932|FG004|17-Week Visit|Missed visit|1
7692490|NCT00369486|12111928|FG000|34-Week Visit|Dropped|0
7692491|NCT00369486|12111929|FG001|34-Week Visit|Dropped|1
7692492|NCT00369486|12111930|FG002|34-Week Visit|Dropped|1
7692493|NCT00369486|12111931|FG003|34-Week Visit|Dropped|3
7692494|NCT00369486|12111932|FG004|34-Week Visit|Dropped|3
7692495|NCT00369577|12111964|FG000|Overall Study|Withdrawal by Subject|0
7692496|NCT00369577|12111965|FG001|Overall Study|Withdrawal by Subject|0
7692497|NCT00369577|12111966|FG002|Overall Study|Withdrawal by Subject|1
7692498|NCT00369629|12111982|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0
7692499|NCT00369629|12111983|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1
7692500|NCT00369629|12111984|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1
7692501|NCT00369629|12111985|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0
7692502|NCT00369629|12111982|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0
7692503|NCT00369629|12111983|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0
7692504|NCT00369629|12111984|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1
7692505|NCT00369629|12111985|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0
7692506|NCT00369629|12111982|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2
7692507|NCT00369629|12111983|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0
7692508|NCT00369629|12111984|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0
7692509|NCT00369629|12111985|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0
7692510|NCT00369629|12111982|FG000|Moved on to 4 More Cycles|Progressive Disease|0
7692511|NCT00369629|12111983|FG001|Moved on to 4 More Cycles|Progressive Disease|0
7692512|NCT00369629|12111984|FG002|Moved on to 4 More Cycles|Progressive Disease|1
7692513|NCT00369629|12111985|FG003|Moved on to 4 More Cycles|Progressive Disease|0
7692514|NCT00369629|12111982|FG000|Completed 4 More Cycles|Withdrawal by Subject|2
7692515|NCT00369629|12111983|FG001|Completed 4 More Cycles|Withdrawal by Subject|1
7692516|NCT00369629|12111984|FG002|Completed 4 More Cycles|Withdrawal by Subject|0
7692517|NCT00369629|12111985|FG003|Completed 4 More Cycles|Withdrawal by Subject|0
7692518|NCT00369629|12111982|FG000|Completed 4 More Cycles|Progressive disease|2
7692519|NCT00369629|12111983|FG001|Completed 4 More Cycles|Progressive disease|1
7692520|NCT00369629|12111984|FG002|Completed 4 More Cycles|Progressive disease|2
7692521|NCT00369629|12111985|FG003|Completed 4 More Cycles|Progressive disease|0
7692522|NCT00369629|12111982|FG000|Follow up for 1 Year|Death|2
7692523|NCT00369629|12111983|FG001|Follow up for 1 Year|Death|1
7692524|NCT00369629|12111984|FG002|Follow up for 1 Year|Death|1
7692525|NCT00369629|12111985|FG003|Follow up for 1 Year|Death|0
7692526|NCT00369629|12111982|FG000|Follow up for 1 Year|Lost to Follow-up|0
7692527|NCT00369629|12111983|FG001|Follow up for 1 Year|Lost to Follow-up|1
7692528|NCT00369629|12111984|FG002|Follow up for 1 Year|Lost to Follow-up|0
7692529|NCT00369629|12111985|FG003|Follow up for 1 Year|Lost to Follow-up|0
7692530|NCT00369629|12111982|FG000|Follow up for 1 Year|stopped being followed as study closed|0
7692531|NCT00369629|12111983|FG001|Follow up for 1 Year|stopped being followed as study closed|0
7692532|NCT00369629|12111984|FG002|Follow up for 1 Year|stopped being followed as study closed|2
7692533|NCT00369629|12111985|FG003|Follow up for 1 Year|stopped being followed as study closed|0
7692534|NCT00369655|12111995|FG000|Overall Study|Refusal of further treatment|2
7692535|NCT00369668|12112002|FG000|Overall Study|Lack of Efficacy|4
7692536|NCT00369668|12112003|FG001|Overall Study|Lack of Efficacy|5
7692537|NCT00369668|12112004|FG002|Overall Study|Lack of Efficacy|7
7692538|NCT00369681|12112015|FG000|Overall Study|Death|1
7692539|NCT00369707|12112019|FG000|Induction Part B (2 Cycles)|Adverse Event|3
7692540|NCT00369707|12112019|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2
7692541|NCT00369707|12112019|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
7692542|NCT00369707|12112019|FG000|Induction Part B (2 Cycles)|Progressive disease|1
7692543|NCT00369707|12112019|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
7692544|NCT00369707|12112019|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
7692545|NCT00369707|12112019|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4
7692546|NCT00369707|12112019|FG000|Follow up for 2 Years After Treatment|Death|1
7692547|NCT00369707|12112019|FG000|Follow up for 2 Years After Treatment|Other|2
7692548|NCT00369785|12112034|FG000|Overall Study|Physician Decision|3
7692549|NCT00369785|12112035|FG001|Overall Study|Physician Decision|2
7692550|NCT00369785|12112034|FG000|Overall Study|Death|1
7692551|NCT00369785|12112035|FG001|Overall Study|Death|2
7692552|NCT00369785|12112034|FG000|Overall Study|Withdrawal by Subject|7
7692553|NCT00369785|12112035|FG001|Overall Study|Withdrawal by Subject|6
7692554|NCT00369785|12112034|FG000|Overall Study|Toxicity|6
7692555|NCT00369785|12112035|FG001|Overall Study|Toxicity|4
7692556|NCT00369785|12112034|FG000|Overall Study|Never started|0
7692557|NCT00369785|12112035|FG001|Overall Study|Never started|2
7692558|NCT00369785|12112034|FG000|Overall Study|Progression|4
7692559|NCT00369785|12112035|FG001|Overall Study|Progression|4
7692560|NCT00369785|12112034|FG000|Overall Study|Multiple reasons|6
7692561|NCT00369785|12112035|FG001|Overall Study|Multiple reasons|5
7692562|NCT00369824|12112047|FG000|Overall Study|Adverse Event|0
7692563|NCT00369824|12112048|FG001|Overall Study|Adverse Event|2
7692564|NCT00369824|12112049|FG002|Overall Study|Adverse Event|0
7692565|NCT00369824|12112050|FG003|Overall Study|Adverse Event|0
7692566|NCT00369824|12112051|FG004|Overall Study|Adverse Event|1
7692567|NCT00369824|12112052|FG005|Overall Study|Adverse Event|0
7692568|NCT00369824|12112047|FG000|Overall Study|Protocol Violation|0
7692569|NCT00369824|12112048|FG001|Overall Study|Protocol Violation|1
7692570|NCT00369824|12112049|FG002|Overall Study|Protocol Violation|0
7692571|NCT00369824|12112050|FG003|Overall Study|Protocol Violation|1
7692572|NCT00369824|12112051|FG004|Overall Study|Protocol Violation|1
7692573|NCT00369824|12112052|FG005|Overall Study|Protocol Violation|0
7692574|NCT00369824|12112047|FG000|Overall Study|Withdrawal by Subject|9
7692575|NCT00369824|12112048|FG001|Overall Study|Withdrawal by Subject|5
7692576|NCT00369824|12112049|FG002|Overall Study|Withdrawal by Subject|5
7692577|NCT00369824|12112050|FG003|Overall Study|Withdrawal by Subject|4
7692578|NCT00369824|12112051|FG004|Overall Study|Withdrawal by Subject|6
7692579|NCT00369824|12112052|FG005|Overall Study|Withdrawal by Subject|2
7692580|NCT00369824|12112047|FG000|Overall Study|Lost to Follow-up|6
7692581|NCT00369824|12112048|FG001|Overall Study|Lost to Follow-up|11
7692582|NCT00369824|12112049|FG002|Overall Study|Lost to Follow-up|7
7692583|NCT00369824|12112050|FG003|Overall Study|Lost to Follow-up|8
7692584|NCT00369824|12112051|FG004|Overall Study|Lost to Follow-up|9
7692585|NCT00369824|12112052|FG005|Overall Study|Lost to Follow-up|6
7692586|NCT00369824|12112047|FG000|Overall Study|Other|0
7692587|NCT00369824|12112048|FG001|Overall Study|Other|0
7692588|NCT00369824|12112049|FG002|Overall Study|Other|0
7692589|NCT00369824|12112050|FG003|Overall Study|Other|2
7692590|NCT00369824|12112051|FG004|Overall Study|Other|1
7692591|NCT00369824|12112052|FG005|Overall Study|Other|3
7692592|NCT00369915|12112068|FG000|Overall Study|expected side effects|2
7692593|NCT00369915|12112069|FG001|Overall Study|expected side effects|1
7692594|NCT00369915|12112068|FG000|Overall Study|Withdrawal by Subject|4
7692595|NCT00369915|12112069|FG001|Overall Study|Withdrawal by Subject|1
7692596|NCT00369915|12112068|FG000|Overall Study|W/drawl by investigators|0
7692597|NCT00369915|12112069|FG001|Overall Study|W/drawl by investigators|1
7692598|NCT00369941|12112090|FG000|Overall Study|Never Treated|1
7692599|NCT00369941|12112091|FG001|Overall Study|Never Treated|2
7692600|NCT00369941|12112090|FG000|Overall Study|Adverse Event|14
7692601|NCT00369941|12112091|FG001|Overall Study|Adverse Event|28
7692602|NCT00369941|12112090|FG000|Overall Study|Lack of Efficacy|6
7692603|NCT00369941|12112091|FG001|Overall Study|Lack of Efficacy|10
7692604|NCT00369941|12112090|FG000|Overall Study|Lost to Follow-up|12
7692605|NCT00369941|12112091|FG001|Overall Study|Lost to Follow-up|22
7692606|NCT00369941|12112090|FG000|Overall Study|Protocol Violation|5
7692607|NCT00369941|12112091|FG001|Overall Study|Protocol Violation|3
7692608|NCT00369941|12112090|FG000|Overall Study|Withdrawal by Subject|5
7692609|NCT00369941|12112091|FG001|Overall Study|Withdrawal by Subject|18
7692610|NCT00369941|12112090|FG000|Overall Study|Pregnancy|4
7692611|NCT00369941|12112091|FG001|Overall Study|Pregnancy|2
7692612|NCT00369941|12112090|FG000|Overall Study|Completed, Did Not Enter Extension|5
7692613|NCT00369941|12112091|FG001|Overall Study|Completed, Did Not Enter Extension|6
7692614|NCT00369941|12112090|FG000|Overall Study|Moved|11
7692615|NCT00369941|12112091|FG001|Overall Study|Moved|5
7692616|NCT00369941|12112090|FG000|Overall Study|Treatment with Prohibited Medication|3
7692617|NCT00369941|12112091|FG001|Overall Study|Treatment with Prohibited Medication|1
7692618|NCT00369941|12112090|FG000|Overall Study|Employment Interfered with Study Visits|1
7692619|NCT00369941|12112091|FG001|Overall Study|Employment Interfered with Study Visits|0
7692620|NCT00369941|12112090|FG000|Overall Study|Study Site Terminated|2
7692621|NCT00369941|12112091|FG001|Overall Study|Study Site Terminated|0
7692622|NCT00369941|12112090|FG000|Overall Study|Miscellaneous|3
7692623|NCT00369941|12112091|FG001|Overall Study|Miscellaneous|3
7692624|NCT00369967|12112100|FG000|Overall Study|Lost to Follow-up|23
7692625|NCT00369967|12112101|FG001|Overall Study|Lost to Follow-up|12
7692626|NCT00370032|12112113|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
7692627|NCT00370032|12112114|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
7692628|NCT00370032|12112113|FG000|Washout Period|Withdrawal by Subject|0
7692629|NCT00370032|12112114|FG001|Washout Period|Withdrawal by Subject|1
7692630|NCT00370032|12112113|FG000|Washout Period|Lost to Follow-up|0
7692631|NCT00370032|12112114|FG001|Washout Period|Lost to Follow-up|1
7692632|NCT00370032|12112113|FG000|Washout Period|Adverse Event|1
7692633|NCT00370032|12112114|FG001|Washout Period|Adverse Event|0
7692634|NCT00370032|12112113|FG000|Follow-up Period|Withdrawal by Subject|1
7692635|NCT00370032|12112114|FG001|Follow-up Period|Withdrawal by Subject|0
7692636|NCT00370071|12112129|FG000|Overall Study|Withdrawal by Subject|2
7692637|NCT00370149|12112135|FG000|Overall Study|Physician Decision|16
7692638|NCT00370149|12112136|FG001|Overall Study|Physician Decision|16
7692639|NCT00370149|12112135|FG000|Overall Study|Protocol Violation|1
7692640|NCT00370149|12112136|FG001|Overall Study|Protocol Violation|0
7692641|NCT00370149|12112135|FG000|Overall Study|Catheter inserted in wrong vessel-|2
7692642|NCT00370149|12112136|FG001|Overall Study|Catheter inserted in wrong vessel-|1
7692643|NCT00370149|12112135|FG000|Overall Study|Pre-existing infection|0
7692644|NCT00370149|12112136|FG001|Overall Study|Pre-existing infection|1
7692645|NCT00370149|12112135|FG000|Overall Study|Antibiotic coated dressing placed|0
7692646|NCT00370149|12112136|FG001|Overall Study|Antibiotic coated dressing placed|1
7692647|NCT00370292|12112147|FG000|Overall Study|Disease Progression|4
7692648|NCT00370292|12112147|FG000|Overall Study|Adverse Event|7
7692649|NCT00370292|12112147|FG000|Overall Study|Physician Decision|2
7692650|NCT04876274|12112160|FG000|Overall Study|Lost to Follow-up|9
7692651|NCT04876274|12112161|FG001|Overall Study|Lost to Follow-up|12
7692652|NCT04656691|12112167|FG000|Overall Study|Adverse Event|1
7692653|NCT04555096|12112182|FG000|Overall Study|Death|4
7692654|NCT04555096|12112183|FG001|Overall Study|Death|4
7692655|NCT04555096|12112182|FG000|Overall Study|Withdrawal by Subject|1
7692656|NCT04555096|12112183|FG001|Overall Study|Withdrawal by Subject|0
7692657|NCT04555096|12112182|FG000|Overall Study|Other|0
7692658|NCT04555096|12112183|FG001|Overall Study|Other|1
7692659|NCT04150341|12112189|FG000|Overall Study|Physician Decision|0
7692660|NCT04150341|12112190|FG001|Overall Study|Physician Decision|0
7692661|NCT04150341|12112191|FG002|Overall Study|Physician Decision|1
7692662|NCT04150341|12112192|FG003|Overall Study|Physician Decision|0
7692663|NCT04150341|12112193|FG004|Overall Study|Physician Decision|0
7692664|NCT04150341|12112194|FG005|Overall Study|Physician Decision|0
7692665|NCT04150341|12112189|FG000|Overall Study|Adverse Event|0
7692666|NCT04150341|12112190|FG001|Overall Study|Adverse Event|0
7692667|NCT04150341|12112191|FG002|Overall Study|Adverse Event|0
7692668|NCT04150341|12112192|FG003|Overall Study|Adverse Event|0
7692669|NCT04150341|12112193|FG004|Overall Study|Adverse Event|1
7692670|NCT04150341|12112194|FG005|Overall Study|Adverse Event|0
7692671|NCT04115839|12112207|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14
7692672|NCT04115839|12112208|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13
7692673|NCT04115839|12112209|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14
7692674|NCT04115839|12112210|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
7692675|NCT04115839|12112211|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
7692676|NCT04115839|12112212|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
7692677|NCT04115839|12112213|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
7692678|NCT04115839|12112207|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2
7692679|NCT04115839|12112208|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1
7692680|NCT04115839|12112209|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3
7692681|NCT04115839|12112210|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0
7692682|NCT04115839|12112211|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0
7692683|NCT04115839|12112212|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0
7692684|NCT04115839|12112213|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0
7692685|NCT04115839|12112207|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2
7692686|NCT04115839|12112208|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0
7692687|NCT04115839|12112209|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0
7692688|NCT04115839|12112210|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0
7692689|NCT04115839|12112211|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0
7692690|NCT04115839|12112212|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0
7692691|NCT04115839|12112213|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0
7692692|NCT04115839|12112207|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
7692693|NCT04115839|12112208|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
7692694|NCT04115839|12112209|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1
7692695|NCT04115839|12112210|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
7692696|NCT04115839|12112211|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
7692697|NCT04115839|12112212|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
7692698|NCT04115839|12112213|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
7692699|NCT04115839|12112207|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0
7692700|NCT04115839|12112208|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0
7692701|NCT04115839|12112209|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0
7692702|NCT04115839|12112210|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17
7692703|NCT04115839|12112211|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19
7692704|NCT04115839|12112212|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10
7692705|NCT04115839|12112213|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8
7692706|NCT04115839|12112207|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
7692707|NCT04115839|12112208|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
7692708|NCT04115839|12112209|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
7692709|NCT04115839|12112210|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1
7692710|NCT04115839|12112211|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1
7692711|NCT04115839|12112212|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
7692712|NCT04115839|12112213|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
7692713|NCT04078126|12112238|FG000|Washout|Study put on hold due to COVID-19|0
7692714|NCT04078126|12112239|FG001|Washout|Study put on hold due to COVID-19|2
7692715|NCT04078126|12112238|FG000|Period 2|Study put on hold due to COVID-19|1
7692716|NCT04078126|12112239|FG001|Period 2|Study put on hold due to COVID-19|1
7692717|NCT03825341|12112247|FG000|Overall Study|Withdrawal by Subject|0
7692718|NCT03825341|12112248|FG001|Overall Study|Withdrawal by Subject|1
7692719|NCT03751631|12112256|FG000|Overall Study|Withdrawal by Subject|0
7692720|NCT03751631|12112257|FG001|Overall Study|Withdrawal by Subject|0
7692721|NCT03751631|12112258|FG002|Overall Study|Withdrawal by Subject|1
7692722|NCT03751631|12112259|FG003|Overall Study|Withdrawal by Subject|1
7692723|NCT03751631|12112260|FG004|Overall Study|Withdrawal by Subject|0
7692724|NCT03751631|12112261|FG005|Overall Study|Withdrawal by Subject|0
7692725|NCT03751098|12112272|FG000|Overall Study|Withdrawal by Subject|0
7692726|NCT03751098|12112273|FG001|Overall Study|Withdrawal by Subject|1
7692727|NCT03673345|12112289|FG000|Overall Study|Lost to Follow-up|1
7692728|NCT03673345|12112290|FG001|Overall Study|Lost to Follow-up|0
7692729|NCT03673345|12112291|FG002|Overall Study|Lost to Follow-up|3
7692730|NCT03673345|12112292|FG003|Overall Study|Lost to Follow-up|3
7692731|NCT03673345|12112293|FG004|Overall Study|Lost to Follow-up|2
7692732|NCT03673345|12112294|FG005|Overall Study|Lost to Follow-up|1
7692733|NCT03673345|12112295|FG006|Overall Study|Lost to Follow-up|0
7692734|NCT03673345|12112296|FG007|Overall Study|Lost to Follow-up|0
7692735|NCT03673345|12112289|FG000|Overall Study|Withdrawal by Subject|1
7692736|NCT03673345|12112290|FG001|Overall Study|Withdrawal by Subject|0
7692737|NCT03673345|12112291|FG002|Overall Study|Withdrawal by Subject|4
7692738|NCT03673345|12112292|FG003|Overall Study|Withdrawal by Subject|2
7692739|NCT03673345|12112293|FG004|Overall Study|Withdrawal by Subject|0
7692740|NCT03673345|12112294|FG005|Overall Study|Withdrawal by Subject|0
7692741|NCT03673345|12112295|FG006|Overall Study|Withdrawal by Subject|0
7692742|NCT03673345|12112296|FG007|Overall Study|Withdrawal by Subject|0
7692743|NCT03673345|12112289|FG000|Overall Study|Physician Decision|0
7692744|NCT03673345|12112290|FG001|Overall Study|Physician Decision|0
7692745|NCT03673345|12112291|FG002|Overall Study|Physician Decision|2
7692746|NCT03673345|12112292|FG003|Overall Study|Physician Decision|0
7692747|NCT03673345|12112293|FG004|Overall Study|Physician Decision|0
7692748|NCT03673345|12112294|FG005|Overall Study|Physician Decision|0
7692749|NCT03673345|12112295|FG006|Overall Study|Physician Decision|0
7692750|NCT03673345|12112296|FG007|Overall Study|Physician Decision|0
7692751|NCT03418675|12112316|FG000|Overall Study|Lost to Follow-up|13
7692752|NCT03418675|12112317|FG001|Overall Study|Lost to Follow-up|10
7692753|NCT03418675|12112316|FG000|Overall Study|Adverse Event|2
7692754|NCT03418675|12112317|FG001|Overall Study|Adverse Event|0
7692755|NCT03329690|12112332|FG000|Overall Study|Progressive disease per RECIST|85
7692756|NCT03329690|12112333|FG001|Overall Study|Progressive disease per RECIST|44
7692757|NCT03329690|12112334|FG002|Overall Study|Progressive disease per RECIST|6
7692758|NCT03329690|12112335|FG003|Overall Study|Progressive disease per RECIST|16
7692759|NCT03329690|12112336|FG004|Overall Study|Progressive disease per RECIST|20
7692760|NCT03329690|12112332|FG000|Overall Study|Clinical progression|7
7692761|NCT03329690|12112333|FG001|Overall Study|Clinical progression|4
7692762|NCT03329690|12112334|FG002|Overall Study|Clinical progression|1
7692763|NCT03329690|12112335|FG003|Overall Study|Clinical progression|1
7692764|NCT03329690|12112336|FG004|Overall Study|Clinical progression|1
7692765|NCT03329690|12112332|FG000|Overall Study|Adverse Event|22
7692766|NCT03329690|12112333|FG001|Overall Study|Adverse Event|4
7692767|NCT03329690|12112334|FG002|Overall Study|Adverse Event|0
7692768|NCT03329690|12112335|FG003|Overall Study|Adverse Event|1
7692769|NCT03329690|12112336|FG004|Overall Study|Adverse Event|2
7692770|NCT03329690|12112332|FG000|Overall Study|Death|2
7692771|NCT03329690|12112333|FG001|Overall Study|Death|0
7692772|NCT03329690|12112334|FG002|Overall Study|Death|0
7692773|NCT03329690|12112335|FG003|Overall Study|Death|1
7692774|NCT03329690|12112336|FG004|Overall Study|Death|0
7692775|NCT03329690|12112332|FG000|Overall Study|Withdrawal by Subject|2
7692776|NCT03329690|12112333|FG001|Overall Study|Withdrawal by Subject|3
7692777|NCT03329690|12112334|FG002|Overall Study|Withdrawal by Subject|0
7692778|NCT03329690|12112335|FG003|Overall Study|Withdrawal by Subject|1
7692779|NCT03329690|12112336|FG004|Overall Study|Withdrawal by Subject|0
7692780|NCT03329690|12112332|FG000|Overall Study|Physician Decision|1
7692781|NCT03329690|12112333|FG001|Overall Study|Physician Decision|0
7692782|NCT03329690|12112334|FG002|Overall Study|Physician Decision|0
7692783|NCT03329690|12112335|FG003|Overall Study|Physician Decision|0
7692784|NCT03329690|12112336|FG004|Overall Study|Physician Decision|1
7692785|NCT03329690|12112332|FG000|Overall Study|Miscellaneous|6
7692786|NCT03329690|12112333|FG001|Overall Study|Miscellaneous|0
7692787|NCT03329690|12112334|FG002|Overall Study|Miscellaneous|0
7692788|NCT03329690|12112335|FG003|Overall Study|Miscellaneous|0
7692789|NCT03329690|12112336|FG004|Overall Study|Miscellaneous|0
7692790|NCT03329690|12112332|FG000|Overall Study|Did not receive treatment|1
7692791|NCT03329690|12112333|FG001|Overall Study|Did not receive treatment|0
7692792|NCT03329690|12112334|FG002|Overall Study|Did not receive treatment|0
7692793|NCT03329690|12112335|FG003|Overall Study|Did not receive treatment|1
7692794|NCT03329690|12112336|FG004|Overall Study|Did not receive treatment|0
7692795|NCT03320564|12112354|FG000|Overall Study|Protocol Violation|1
7692796|NCT03165955|12112372|FG000|Treatment|Withdrawal by Subject|3
7692797|NCT03165955|12112372|FG000|Treatment|Death|1
7692798|NCT03165955|12112372|FG000|Treatment|Adverse Event|1
7692799|NCT03165955|12112372|FG000|Treatment|Progressive disease|3
7692800|NCT03133793|12112380|FG000|Overall Study|Withdrawal by Subject|0
7692801|NCT03133793|12112381|FG001|Overall Study|Withdrawal by Subject|4
7692802|NCT03133793|12112382|FG002|Overall Study|Withdrawal by Subject|2
7692803|NCT03133793|12112383|FG003|Overall Study|Withdrawal by Subject|4
7692804|NCT03133793|12112380|FG000|Overall Study|Lost to Follow-up|1
7692805|NCT03133793|12112381|FG001|Overall Study|Lost to Follow-up|0
7692806|NCT03133793|12112382|FG002|Overall Study|Lost to Follow-up|2
7692807|NCT03133793|12112383|FG003|Overall Study|Lost to Follow-up|0
7692808|NCT03133793|12112380|FG000|Overall Study|Death|0
7692809|NCT03133793|12112381|FG001|Overall Study|Death|0
7692810|NCT03133793|12112382|FG002|Overall Study|Death|0
7692811|NCT03133793|12112383|FG003|Overall Study|Death|1
7692812|NCT03103542|12112397|FG000|Overall Study|Physician Decision|2
7692813|NCT03103542|12112397|FG000|Overall Study|Adverse Event|2
7692814|NCT03103542|12112397|FG000|Overall Study|Other|2
7692815|NCT03103542|12112397|FG000|Overall Study|Withdrawal by Subject|1
7692816|NCT02676765|12112413|FG000|Overall Study|Lost to Follow-up|0
7692817|NCT02676765|12112414|FG001|Overall Study|Lost to Follow-up|1
7692818|NCT02362451|12112440|FG000|Overall Study|Withdrawal by Subject|0
7692819|NCT02362451|12112441|FG001|Overall Study|Withdrawal by Subject|1
7692820|NCT02362451|12112440|FG000|Overall Study|Lack of Efficacy|2
7692821|NCT02362451|12112441|FG001|Overall Study|Lack of Efficacy|0
7692822|NCT02362451|12112440|FG000|Overall Study|Progression|1
7692823|NCT02362451|12112441|FG001|Overall Study|Progression|0
7692824|NCT02362451|12112440|FG000|Overall Study|Participant chose other therapy.|1
7692825|NCT02362451|12112441|FG001|Overall Study|Participant chose other therapy.|0
7692826|NCT02180724|12112466|FG000|Overall Study|Death|12
7692827|NCT02180724|12112467|FG001|Overall Study|Death|1
7692828|NCT02180724|12112466|FG000|Overall Study|Lost to Follow-up|1
7692829|NCT02180724|12112467|FG001|Overall Study|Lost to Follow-up|0
7692830|NCT02180724|12112466|FG000|Overall Study|Withdrawal by Subject|1
7692831|NCT02180724|12112467|FG001|Overall Study|Withdrawal by Subject|2
7692832|NCT02180724|12112466|FG000|Overall Study|Ongoing Study|78
7692833|NCT02180724|12112467|FG001|Overall Study|Ongoing Study|11
7692834|NCT02038777|12112481|FG000|Overall Study|Death|0
7692835|NCT02038777|12112482|FG001|Overall Study|Death|2
7692836|NCT02038777|12112483|FG002|Overall Study|Death|0
7692837|NCT02038777|12112484|FG003|Overall Study|Death|1
7692838|NCT02038777|12112485|FG004|Overall Study|Death|2
7692839|NCT02038777|12112486|FG005|Overall Study|Death|4
7692840|NCT02038777|12112487|FG006|Overall Study|Death|0
7692841|NCT02038777|12112488|FG007|Overall Study|Death|10
7692842|NCT02038777|12112481|FG000|Overall Study|Lost to Follow-up|0
7692843|NCT02038777|12112482|FG001|Overall Study|Lost to Follow-up|0
7692844|NCT02038777|12112483|FG002|Overall Study|Lost to Follow-up|0
7692845|NCT02038777|12112484|FG003|Overall Study|Lost to Follow-up|1
7692846|NCT02038777|12112485|FG004|Overall Study|Lost to Follow-up|0
7692847|NCT02038777|12112486|FG005|Overall Study|Lost to Follow-up|0
7692848|NCT02038777|12112487|FG006|Overall Study|Lost to Follow-up|0
7692849|NCT02038777|12112488|FG007|Overall Study|Lost to Follow-up|0
7692850|NCT02038777|12112481|FG000|Overall Study|Other|0
7692851|NCT02038777|12112482|FG001|Overall Study|Other|1
7692852|NCT02038777|12112483|FG002|Overall Study|Other|0
7692853|NCT02038777|12112484|FG003|Overall Study|Other|2
7692854|NCT02038777|12112485|FG004|Overall Study|Other|1
7692855|NCT02038777|12112486|FG005|Overall Study|Other|0
7692856|NCT02038777|12112487|FG006|Overall Study|Other|0
7692857|NCT02038777|12112488|FG007|Overall Study|Other|0
7692858|NCT02038777|12112481|FG000|Overall Study|Randomized but not treated|0
7692859|NCT02038777|12112482|FG001|Overall Study|Randomized but not treated|1
7692860|NCT02038777|12112483|FG002|Overall Study|Randomized but not treated|0
7692861|NCT02038777|12112484|FG003|Overall Study|Randomized but not treated|0
7692862|NCT02038777|12112485|FG004|Overall Study|Randomized but not treated|0
7692863|NCT02038777|12112486|FG005|Overall Study|Randomized but not treated|0
7692864|NCT02038777|12112487|FG006|Overall Study|Randomized but not treated|0
7692865|NCT02038777|12112488|FG007|Overall Study|Randomized but not treated|0
7692866|NCT02038777|12112481|FG000|Overall Study|Started Chemotherapy|1
7692867|NCT02038777|12112482|FG001|Overall Study|Started Chemotherapy|0
7692868|NCT02038777|12112483|FG002|Overall Study|Started Chemotherapy|3
7692869|NCT02038777|12112484|FG003|Overall Study|Started Chemotherapy|0
7692870|NCT02038777|12112485|FG004|Overall Study|Started Chemotherapy|0
7692871|NCT02038777|12112486|FG005|Overall Study|Started Chemotherapy|0
7692872|NCT02038777|12112487|FG006|Overall Study|Started Chemotherapy|0
7692873|NCT02038777|12112488|FG007|Overall Study|Started Chemotherapy|0
7692874|NCT01927419|12112518|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0
7692875|NCT01927419|12112519|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1
7692876|NCT01927419|12112518|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1
7692877|NCT01927419|12112519|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0
7692878|NCT01927419|12112518|FG000|Treatment Period|Disease progression|17
7692879|NCT01927419|12112519|FG001|Treatment Period|Disease progression|20
7692880|NCT01927419|12112518|FG000|Treatment Period|Study drug toxicity|48
7692881|NCT01927419|12112519|FG001|Treatment Period|Study drug toxicity|10
7692882|NCT01927419|12112518|FG000|Treatment Period|Death|0
7692883|NCT01927419|12112519|FG001|Treatment Period|Death|1
7692884|NCT01927419|12112518|FG000|Treatment Period|Adverse event unrelated to study drug|6
7692885|NCT01927419|12112519|FG001|Treatment Period|Adverse event unrelated to study drug|3
7692886|NCT01927419|12112518|FG000|Treatment Period|Participant request to discontinue|12
7692887|NCT01927419|12112519|FG001|Treatment Period|Participant request to discontinue|4
7692888|NCT01927419|12112518|FG000|Treatment Period|Withdrawal by Subject|1
7692889|NCT01927419|12112519|FG001|Treatment Period|Withdrawal by Subject|1
7692890|NCT01927419|12112518|FG000|Treatment Period|Maximum Clinical Benefit|6
7692891|NCT01927419|12112519|FG001|Treatment Period|Maximum Clinical Benefit|2
7692892|NCT01927419|12112518|FG000|Treatment Period|Other reasons|3
7692893|NCT01927419|12112519|FG001|Treatment Period|Other reasons|4
7692894|NCT01927419|12112518|FG000|Treatment Period|Not Reported|1
7692895|NCT01927419|12112519|FG001|Treatment Period|Not Reported|1
7692896|NCT01711879|12112536|FG000|Overall Study|Death|1
7692897|NCT01711879|12112537|FG001|Overall Study|Death|0
7692898|NCT01697267|12112547|FG000|Overall Study|Death|3
7692899|NCT01697267|12112548|FG001|Overall Study|Death|1
7692900|NCT01697267|12112547|FG000|Overall Study|Withdrawal by Subject|5
7692901|NCT01697267|12112548|FG001|Overall Study|Withdrawal by Subject|5
7692902|NCT01697267|12112547|FG000|Overall Study|Adverse Event|2
7692903|NCT01697267|12112548|FG001|Overall Study|Adverse Event|1
7692904|NCT01697267|12112547|FG000|Overall Study|Lost to Follow-up|2
7692905|NCT01697267|12112548|FG001|Overall Study|Lost to Follow-up|4
7692906|NCT01697267|12112547|FG000|Overall Study|Physician Decision|2
7692907|NCT01697267|12112548|FG001|Overall Study|Physician Decision|4
7692908|NCT01527149|12112554|FG000|Overall Study|Death|2
7692909|NCT00554840|12112584|FG000|Overall Study|Physician Decision|0
7692910|NCT00554840|12112585|FG001|Overall Study|Physician Decision|1
7692911|NCT00003656|12112595|FG000|Overall Study|Adverse Event|0
7692912|NCT00003656|12112596|FG001|Overall Study|Adverse Event|1
7692913|NCT00370331|12112605|FG000|Overall Study|Adverse Event|4
7692914|NCT00370331|12112606|FG001|Overall Study|Adverse Event|13
7692915|NCT00370331|12112605|FG000|Overall Study|Withdrawal by Subject|2
7692916|NCT00370331|12112606|FG001|Overall Study|Withdrawal by Subject|4
7692917|NCT00370331|12112605|FG000|Overall Study|Lost to Follow-up|0
7692918|NCT00370331|12112606|FG001|Overall Study|Lost to Follow-up|3
7692919|NCT00370331|12112605|FG000|Overall Study|Lack of Efficacy|0
7692920|NCT00370331|12112606|FG001|Overall Study|Lack of Efficacy|1
7692921|NCT00370331|12112605|FG000|Overall Study|Non-compliance|0
7692922|NCT00370331|12112606|FG001|Overall Study|Non-compliance|1
7692923|NCT00370331|12112605|FG000|Overall Study|Protocol Violation|1
7692924|NCT00370331|12112606|FG001|Overall Study|Protocol Violation|1
7692925|NCT00370396|12112615|FG000|Overall Study|Withdrawal by Subject|0
7692926|NCT00370396|12112616|FG001|Overall Study|Withdrawal by Subject|0
7692927|NCT00370396|12112617|FG002|Overall Study|Withdrawal by Subject|1
7692928|NCT00370396|12112615|FG000|Overall Study|Lost to Follow-up|11
7692929|NCT00370396|12112616|FG001|Overall Study|Lost to Follow-up|1
7692930|NCT00370396|12112617|FG002|Overall Study|Lost to Follow-up|0
7692931|NCT00370552|12112628|FG000|Overall Study|Adverse Event|2
7692932|NCT00370552|12112629|FG001|Overall Study|Adverse Event|2
7692933|NCT00370552|12112630|FG002|Overall Study|Adverse Event|2
7692934|NCT00370552|12112628|FG000|Overall Study|Disease progression|23
7692935|NCT00370552|12112629|FG001|Overall Study|Disease progression|23
7692936|NCT00370552|12112630|FG002|Overall Study|Disease progression|15
7692937|NCT00370552|12112628|FG000|Overall Study|Maximum clinical benefit|3
7692938|NCT00370552|12112629|FG001|Overall Study|Maximum clinical benefit|5
7692939|NCT00370552|12112630|FG002|Overall Study|Maximum clinical benefit|5
7692940|NCT00370552|12112628|FG000|Overall Study|Poor or noncompliance|0
7692941|NCT00370552|12112629|FG001|Overall Study|Poor or noncompliance|0
7692942|NCT00370552|12112630|FG002|Overall Study|Poor or noncompliance|1
7692943|NCT00370552|12112628|FG000|Overall Study|Study drug toxicity|11
7692944|NCT00370552|12112629|FG001|Overall Study|Study drug toxicity|8
7692945|NCT00370552|12112630|FG002|Overall Study|Study drug toxicity|6
7692946|NCT00370552|12112628|FG000|Overall Study|Withdrawal by Subject|2
7692947|NCT00370552|12112629|FG001|Overall Study|Withdrawal by Subject|0
7692948|NCT00370552|12112630|FG002|Overall Study|Withdrawal by Subject|1
7692949|NCT00370552|12112628|FG000|Overall Study|Still on treatment|1
7692950|NCT00370552|12112629|FG001|Overall Study|Still on treatment|3
7692951|NCT00370552|12112630|FG002|Overall Study|Still on treatment|2
7692952|NCT00370552|12112628|FG000|Overall Study|Never treated|1
7692953|NCT00370552|12112629|FG001|Overall Study|Never treated|0
7692954|NCT00370552|12112630|FG002|Overall Study|Never treated|0
7692955|NCT00370552|12112628|FG000|Overall Study|Physician Decision|1
7692956|NCT00370552|12112629|FG001|Overall Study|Physician Decision|1
7692957|NCT00370552|12112630|FG002|Overall Study|Physician Decision|0
7692958|NCT00370552|12112628|FG000|Overall Study|Investigator decision|2
7692959|NCT00370552|12112629|FG001|Overall Study|Investigator decision|1
7692960|NCT00370552|12112630|FG002|Overall Study|Investigator decision|0
7692961|NCT00370552|12112628|FG000|Overall Study|High risk of allergic reaction|0
7692962|NCT00370552|12112629|FG001|Overall Study|High risk of allergic reaction|1
7692963|NCT00370552|12112630|FG002|Overall Study|High risk of allergic reaction|0
7692964|NCT00370552|12112628|FG000|Overall Study|Planned radiation for palliation|0
7692965|NCT00370552|12112629|FG001|Overall Study|Planned radiation for palliation|1
7692966|NCT00370552|12112630|FG002|Overall Study|Planned radiation for palliation|0
7692967|NCT00370682|12112641|FG000|Overall Study|Moved from area|0
7692968|NCT00370682|12112642|FG001|Overall Study|Moved from area|2
7692969|NCT00370682|12112643|FG002|Overall Study|Moved from area|0
7692970|NCT00370682|12112641|FG000|Overall Study|Lost to Follow-up|0
7692971|NCT00370682|12112642|FG001|Overall Study|Lost to Follow-up|1
7692972|NCT00370682|12112643|FG002|Overall Study|Lost to Follow-up|1
7692973|NCT00371137|12112676|FG000|Overall Study|Adverse Event|20
7692974|NCT00371137|12112677|FG001|Overall Study|Adverse Event|35
7692975|NCT00371137|12112678|FG002|Overall Study|Adverse Event|42
7692976|NCT00371137|12112676|FG000|Overall Study|Withdrawal by Subject|11
7692977|NCT00371137|12112677|FG001|Overall Study|Withdrawal by Subject|10
7692978|NCT00371137|12112678|FG002|Overall Study|Withdrawal by Subject|15
7692979|NCT00371137|12112676|FG000|Overall Study|Lost to Follow-up|6
7692980|NCT00371137|12112677|FG001|Overall Study|Lost to Follow-up|3
7692981|NCT00371137|12112678|FG002|Overall Study|Lost to Follow-up|5
7692982|NCT00371137|12112676|FG000|Overall Study|Lack of Efficacy|30
7692983|NCT00371137|12112677|FG001|Overall Study|Lack of Efficacy|12
7692984|NCT00371137|12112678|FG002|Overall Study|Lack of Efficacy|13
7692985|NCT00371137|12112676|FG000|Overall Study|Sponsor Decision|2
7692986|NCT00371137|12112677|FG001|Overall Study|Sponsor Decision|1
7692987|NCT00371137|12112678|FG002|Overall Study|Sponsor Decision|2
7692988|NCT00371137|12112676|FG000|Overall Study|Physician Decision|1
7692989|NCT00371137|12112677|FG001|Overall Study|Physician Decision|1
7692990|NCT00371137|12112678|FG002|Overall Study|Physician Decision|1
7692991|NCT00371137|12112676|FG000|Overall Study|Protocol Violation|2
7692992|NCT00371137|12112677|FG001|Overall Study|Protocol Violation|1
7692993|NCT00371137|12112678|FG002|Overall Study|Protocol Violation|1
7692994|NCT00371150|12112688|FG000|Overall Study|Lost to Follow-up|3
7692995|NCT00371150|12112689|FG001|Overall Study|Lost to Follow-up|2
7692996|NCT00371254|12112710|FG000|Overall Study|Disease progression|13
7692997|NCT00371254|12112711|FG001|Overall Study|Disease progression|13
7692998|NCT00371254|12112710|FG000|Overall Study|Study drug toxicity|3
7692999|NCT00371254|12112711|FG001|Overall Study|Study drug toxicity|5
7693000|NCT00371254|12112710|FG000|Overall Study|Subject request|5
7693001|NCT00371254|12112711|FG001|Overall Study|Subject request|0
7693002|NCT00371254|12112710|FG000|Overall Study|Investigator Decision|2
7693003|NCT00371254|12112711|FG001|Overall Study|Investigator Decision|0
7693004|NCT00371254|12112710|FG000|Overall Study|Adverse event unrelated to study drug|0
7693005|NCT00371254|12112711|FG001|Overall Study|Adverse event unrelated to study drug|1
7693006|NCT00371254|12112710|FG000|Overall Study|Lost to Follow-up|0
7693007|NCT00371254|12112711|FG001|Overall Study|Lost to Follow-up|1
7693008|NCT00371254|12112710|FG000|Overall Study|Withdrawal by Subject|0
7693009|NCT00371254|12112711|FG001|Overall Study|Withdrawal by Subject|1
7693010|NCT00371345|12112742|FG000|Overall Study|Disease Progression|21
7693011|NCT00371345|12112743|FG001|Overall Study|Disease Progression|35
7693012|NCT00371345|12112742|FG000|Overall Study|Study Drug Toxicity|1
7693013|NCT00371345|12112743|FG001|Overall Study|Study Drug Toxicity|7
7693014|NCT00371345|12112742|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1
7693015|NCT00371345|12112743|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2
7693016|NCT00371345|12112742|FG000|Overall Study|Participant Request|1
7693017|NCT00371345|12112743|FG001|Overall Study|Participant Request|1
7693018|NCT00371345|12112742|FG000|Overall Study|Participant Withdrew Consent|0
7693019|NCT00371345|12112743|FG001|Overall Study|Participant Withdrew Consent|1
7693020|NCT00371397|12112763|FG000|Session 1|Withdrawal by Subject|1
7693021|NCT00371397|12112764|FG001|Session 1|Withdrawal by Subject|0
7693022|NCT00371397|12112765|FG002|Session 1|Withdrawal by Subject|0
7693023|NCT00371397|12112766|FG003|Session 1|Withdrawal by Subject|0
7693024|NCT00371397|12112767|FG004|Session 1|Withdrawal by Subject|0
7693025|NCT00371397|12112768|FG005|Session 1|Withdrawal by Subject|0
7693026|NCT00371397|12112769|FG006|Session 1|Withdrawal by Subject|0
7693027|NCT00371397|12112770|FG007|Session 1|Withdrawal by Subject|1
7693028|NCT00371397|12112771|FG008|Session 1|Withdrawal by Subject|0
7693029|NCT00371397|12112772|FG009|Session 1|Withdrawal by Subject|0
7693030|NCT00371397|12112773|FG010|Session 1|Withdrawal by Subject|0
7693031|NCT00371397|12112774|FG011|Session 1|Withdrawal by Subject|0
7693032|NCT00371566|12112806|FG000|Treatment Phase|Withdrawal by Subject|0
7693033|NCT00371566|12112807|FG001|Treatment Phase|Withdrawal by Subject|1
7693034|NCT00371566|12112806|FG000|Treatment Phase|Adverse Event|0
7693035|NCT00371566|12112807|FG001|Treatment Phase|Adverse Event|1
7693036|NCT00371566|12112806|FG000|Treatment Phase|Protocol Violation|0
7693037|NCT00371566|12112807|FG001|Treatment Phase|Protocol Violation|1
7693038|NCT00371566|12112806|FG000|Chemoradiation Phase|Physician Decision|2
7693039|NCT00371566|12112807|FG001|Chemoradiation Phase|Physician Decision|0
7693040|NCT00371566|12112806|FG000|Chemoradiation Phase|Withdrawal by Subject|0
7693041|NCT00371566|12112807|FG001|Chemoradiation Phase|Withdrawal by Subject|1
7693042|NCT00371566|12112806|FG000|Chemoradiation Phase|Non compliant|0
7693043|NCT00371566|12112807|FG001|Chemoradiation Phase|Non compliant|1
7693044|NCT00371566|12112806|FG000|Chemoradiation Phase|Progressive Disease|1
7693045|NCT00371566|12112807|FG001|Chemoradiation Phase|Progressive Disease|1
7693046|NCT00371566|12112806|FG000|Chemoradiation Phase|Death|2
7693047|NCT00371566|12112807|FG001|Chemoradiation Phase|Death|0
7693048|NCT00371566|12112806|FG000|Follow Up Phase|Death|0
7693049|NCT00371566|12112807|FG001|Follow Up Phase|Death|5
7693050|NCT00371566|12112806|FG000|Follow Up Phase|Disease progression|1
7693051|NCT00371566|12112807|FG001|Follow Up Phase|Disease progression|0
7693052|NCT00371566|12112806|FG000|Follow Up Phase|Withdrawal by Subject|0
7693053|NCT00371566|12112807|FG001|Follow Up Phase|Withdrawal by Subject|1
7693054|NCT00371566|12112806|FG000|Follow Up Phase|Physician Decision|1
7693055|NCT00371566|12112807|FG001|Follow Up Phase|Physician Decision|1
7693056|NCT00371566|12112806|FG000|Follow Up Phase|Lost to Follow-up|1
7693057|NCT00371566|12112807|FG001|Follow Up Phase|Lost to Follow-up|0
7693058|NCT00371683|12112828|FG000|DB Treatment Period-Randomized Patients|Death|1
7693059|NCT00371683|12112829|FG001|DB Treatment Period-Randomized Patients|Death|1
7693060|NCT00371683|12112828|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60
7693061|NCT00371683|12112829|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58
7693062|NCT00371683|12112828|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
7693063|NCT00371683|12112829|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
7693064|NCT00371683|12112828|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
7693065|NCT00371683|12112829|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
7693066|NCT00371683|12112828|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
7693067|NCT00371683|12112829|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
7693068|NCT00371683|12112828|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
7693069|NCT00371683|12112829|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
7693070|NCT00371683|12112828|FG000|DB Treatment Period-Randomized Patients|non-specified|9
7693071|NCT00371683|12112829|FG001|DB Treatment Period-Randomized Patients|non-specified|8
7693072|NCT00371683|12112828|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
7693073|NCT00371683|12112829|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
7693074|NCT00371683|12112828|FG000|Follow-Up Period - Randomized Patients|Death|0
7693075|NCT00371683|12112829|FG001|Follow-Up Period - Randomized Patients|Death|2
7693076|NCT00371683|12112828|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
7693077|NCT00371683|12112829|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
7693078|NCT00371683|12112828|FG000|Follow-Up Period - Randomized Patients|non-specified|6
7693079|NCT00371683|12112829|FG001|Follow-Up Period - Randomized Patients|non-specified|12
7693080|NCT00371761|12112847|FG000|Overall Study|Adverse Event|1
7693081|NCT00371761|12112848|FG001|Overall Study|Adverse Event|1
7693082|NCT00371761|12112847|FG000|Overall Study|Withdrawal by Subject|1
7693083|NCT00371761|12112848|FG001|Overall Study|Withdrawal by Subject|3
7693084|NCT00371761|12112847|FG000|Overall Study|Investigator Judgment|2
7693085|NCT00371761|12112848|FG001|Overall Study|Investigator Judgment|3
7693086|NCT00371761|12112847|FG000|Overall Study|Study termination|4
7693087|NCT00371761|12112848|FG001|Overall Study|Study termination|3
7693088|NCT00371787|12112856|FG000|Overall Study|Withdrawal by Subject|3
7693089|NCT00371787|12112857|FG001|Overall Study|Withdrawal by Subject|1
7693090|NCT00371826|12112866|FG000|Core Phase (12 Months)|Adverse Event|15
7693091|NCT00371826|12112867|FG001|Core Phase (12 Months)|Adverse Event|4
7693092|NCT00371826|12112868|FG002|Core Phase (12 Months)|Adverse Event|9
7693093|NCT00371826|12112866|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1
7693094|NCT00371826|12112867|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0
7693095|NCT00371826|12112868|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1
7693096|NCT00371826|12112866|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
7693097|NCT00371826|12112867|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
7693098|NCT00371826|12112868|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
7693099|NCT00371826|12112866|FG000|Core Phase (12 Months)|Protocol Violation|1
7693100|NCT00371826|12112867|FG001|Core Phase (12 Months)|Protocol Violation|0
7693101|NCT00371826|12112868|FG002|Core Phase (12 Months)|Protocol Violation|1
7693102|NCT00371826|12112866|FG000|Core Phase (12 Months)|Subject withdrew consent|0
7693103|NCT00371826|12112867|FG001|Core Phase (12 Months)|Subject withdrew consent|0
7693104|NCT00371826|12112868|FG002|Core Phase (12 Months)|Subject withdrew consent|3
7693105|NCT00371826|12112866|FG000|Core Phase (12 Months)|Administrative problems|1
7693106|NCT00371826|12112867|FG001|Core Phase (12 Months)|Administrative problems|0
7693107|NCT00371826|12112868|FG002|Core Phase (12 Months)|Administrative problems|8
7693108|NCT00371826|12112866|FG000|Core Phase (12 Months)|Graft Loss|0
7693109|NCT00371826|12112867|FG001|Core Phase (12 Months)|Graft Loss|1
7693110|NCT00371826|12112868|FG002|Core Phase (12 Months)|Graft Loss|0
7693111|NCT00371826|12112866|FG000|Extension Phase (24 Months)|Adverse Event|4
7693112|NCT00371826|12112867|FG001|Extension Phase (24 Months)|Adverse Event|5
7693113|NCT00371826|12112868|FG002|Extension Phase (24 Months)|Adverse Event|0
7693114|NCT00371826|12112866|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
7693115|NCT00371826|12112867|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
7693116|NCT00371826|12112868|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
7693117|NCT00371826|12112866|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
7693118|NCT00371826|12112867|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
7693119|NCT00371826|12112868|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
7693120|NCT00371826|12112866|FG000|Extension Phase (24 Months)|Subject withdrew consent|1
7693121|NCT00371826|12112867|FG001|Extension Phase (24 Months)|Subject withdrew consent|2
7693122|NCT00371826|12112868|FG002|Extension Phase (24 Months)|Subject withdrew consent|0
7693123|NCT00371826|12112866|FG000|Extension Phase (24 Months)|Administrative problems|0
7693124|NCT00371826|12112867|FG001|Extension Phase (24 Months)|Administrative problems|0
7693125|NCT00371826|12112868|FG002|Extension Phase (24 Months)|Administrative problems|2
7693126|NCT00371839|12112879|FG000|Overall Study|Death|4
7693127|NCT00371839|12112880|FG001|Overall Study|Death|0
7693128|NCT00371839|12112881|FG002|Overall Study|Death|0
7693129|NCT00371839|12112879|FG000|Overall Study|Withdrawal by Subject|7
7693130|NCT00371839|12112880|FG001|Overall Study|Withdrawal by Subject|4
7693131|NCT00371839|12112881|FG002|Overall Study|Withdrawal by Subject|0
7693132|NCT00371839|12112879|FG000|Overall Study|Lost to Follow-up|6
7693133|NCT00371839|12112880|FG001|Overall Study|Lost to Follow-up|3
7693134|NCT00371839|12112881|FG002|Overall Study|Lost to Follow-up|2
7693135|NCT00371865|12112889|FG000|Overall Study|Lack of Efficacy|0
7693136|NCT00371865|12112890|FG001|Overall Study|Lack of Efficacy|2
7693137|NCT00371865|12112889|FG000|Overall Study|Protocol Violation|3
7693138|NCT00371865|12112890|FG001|Overall Study|Protocol Violation|2
7693139|NCT00371865|12112889|FG000|Overall Study|Withdrawal by Subject|12
7693140|NCT00371865|12112890|FG001|Overall Study|Withdrawal by Subject|10
7693141|NCT00372060|12112898|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
7693142|NCT00372060|12112899|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
7693143|NCT00372060|12112898|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
7693144|NCT00372060|12112899|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
7693145|NCT00372060|12112898|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
7693146|NCT00372060|12112899|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
7693147|NCT00372060|12112898|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3
7693148|NCT00372060|12112899|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0
7693149|NCT00372060|12112898|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
7693150|NCT00372060|12112899|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
7693151|NCT00372060|12112898|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
7693152|NCT00372060|12112899|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
7693153|NCT00372112|12112912|FG000|Overall Study|Adverse Event|0
7693154|NCT00372112|12112913|FG001|Overall Study|Adverse Event|1
7693155|NCT00372112|12112914|FG002|Overall Study|Adverse Event|1
7693156|NCT00372112|12112915|FG003|Overall Study|Adverse Event|1
7693157|NCT00372112|12112912|FG000|Overall Study|Withdrawal by Subject|0
7693158|NCT00372112|12112913|FG001|Overall Study|Withdrawal by Subject|0
7693159|NCT00372112|12112914|FG002|Overall Study|Withdrawal by Subject|2
7693160|NCT00372112|12112915|FG003|Overall Study|Withdrawal by Subject|1
7693161|NCT00372112|12112912|FG000|Overall Study|Exacerbation|0
7693162|NCT00372112|12112913|FG001|Overall Study|Exacerbation|0
7693163|NCT00372112|12112914|FG002|Overall Study|Exacerbation|0
7693164|NCT00372112|12112915|FG003|Overall Study|Exacerbation|1
7693165|NCT00372112|12112912|FG000|Overall Study|PR >240 at Visit 3|0
7693166|NCT00372112|12112913|FG001|Overall Study|PR >240 at Visit 3|0
7693167|NCT00372112|12112914|FG002|Overall Study|PR >240 at Visit 3|0
7693168|NCT00372112|12112915|FG003|Overall Study|PR >240 at Visit 3|1
7693169|NCT00372112|12112912|FG000|Overall Study|Hepatitis B|1
7693170|NCT00372112|12112913|FG001|Overall Study|Hepatitis B|0
7693171|NCT00372112|12112914|FG002|Overall Study|Hepatitis B|0
7693172|NCT00372112|12112915|FG003|Overall Study|Hepatitis B|0
7693173|NCT00372112|12112912|FG000|Overall Study|Other-protocol violation|0
7693174|NCT00372112|12112913|FG001|Overall Study|Other-protocol violation|0
7693175|NCT00372112|12112914|FG002|Overall Study|Other-protocol violation|1
7693176|NCT00372112|12112915|FG003|Overall Study|Other-protocol violation|0
7693177|NCT00372190|12112930|FG000|Overall Study|Lost to Follow-up|3
7693178|NCT00372190|12112931|FG001|Overall Study|Lost to Follow-up|1
7693179|NCT00372255|12112941|FG000|Overall Study|Withdrawn for other reasons|2
7693180|NCT00372255|12112942|FG001|Overall Study|Withdrawn for other reasons|1
7693181|NCT00372385|12112953|FG000|Overall Study|Adverse Event|6
7693182|NCT00372385|12112954|FG001|Overall Study|Adverse Event|11
7693183|NCT00372385|12112955|FG002|Overall Study|Adverse Event|9
7693184|NCT00372385|12112956|FG003|Overall Study|Adverse Event|7
7693185|NCT00372385|12112953|FG000|Overall Study|Noncompliance|0
7693186|NCT00372385|12112954|FG001|Overall Study|Noncompliance|1
7693187|NCT00372385|12112955|FG002|Overall Study|Noncompliance|1
7693188|NCT00372385|12112956|FG003|Overall Study|Noncompliance|1
7693189|NCT00372385|12112953|FG000|Overall Study|Physician Decision|1
7693190|NCT00372385|12112954|FG001|Overall Study|Physician Decision|0
7693191|NCT00372385|12112955|FG002|Overall Study|Physician Decision|0
7693192|NCT00372385|12112956|FG003|Overall Study|Physician Decision|0
7693193|NCT00372385|12112953|FG000|Overall Study|Lost to Follow-up|2
7693194|NCT00372385|12112954|FG001|Overall Study|Lost to Follow-up|0
7693195|NCT00372385|12112955|FG002|Overall Study|Lost to Follow-up|0
7693196|NCT00372385|12112956|FG003|Overall Study|Lost to Follow-up|0
7693197|NCT00372385|12112953|FG000|Overall Study|Withdrawal by Subject|2
7693198|NCT00372385|12112954|FG001|Overall Study|Withdrawal by Subject|1
7693199|NCT00372385|12112955|FG002|Overall Study|Withdrawal by Subject|0
7693200|NCT00372385|12112956|FG003|Overall Study|Withdrawal by Subject|0
7693201|NCT00372385|12112953|FG000|Overall Study|Refusal of Treatment|3
7693202|NCT00372385|12112954|FG001|Overall Study|Refusal of Treatment|6
7693203|NCT00372385|12112955|FG002|Overall Study|Refusal of Treatment|0
7693204|NCT00372385|12112956|FG003|Overall Study|Refusal of Treatment|0
7693205|NCT00372385|12112953|FG000|Overall Study|No Response|1
7693206|NCT00372385|12112954|FG001|Overall Study|No Response|1
7693207|NCT00372385|12112955|FG002|Overall Study|No Response|0
7693208|NCT00372385|12112956|FG003|Overall Study|No Response|0
7693209|NCT00372385|12112953|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1
7693210|NCT00372385|12112954|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0
7693211|NCT00372385|12112955|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0
7693212|NCT00372385|12112956|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0
7693213|NCT00372385|12112953|FG000|Overall Study|Virologic Stopping Rule|17
7693214|NCT00372385|12112954|FG001|Overall Study|Virologic Stopping Rule|0
7693215|NCT00372385|12112955|FG002|Overall Study|Virologic Stopping Rule|0
7693216|NCT00372385|12112956|FG003|Overall Study|Virologic Stopping Rule|0
7693217|NCT00372411|12112970|FG000|Overall Study|Withdrawal by Subject|3
7693218|NCT00372411|12112971|FG001|Overall Study|Withdrawal by Subject|4
7693219|NCT00372411|12112972|FG002|Overall Study|Withdrawal by Subject|1
7693220|NCT00372411|12112970|FG000|Overall Study|Death|0
7693221|NCT00372411|12112971|FG001|Overall Study|Death|2
7693222|NCT00372411|12112972|FG002|Overall Study|Death|1
7693223|NCT00372411|12112970|FG000|Overall Study|Lost to Follow-up|1
7693224|NCT00372411|12112971|FG001|Overall Study|Lost to Follow-up|1
7693225|NCT00372411|12112972|FG002|Overall Study|Lost to Follow-up|1
7693226|NCT00372411|12112970|FG000|Overall Study|Adverse Event|1
7693227|NCT00372411|12112971|FG001|Overall Study|Adverse Event|1
7693228|NCT00372411|12112972|FG002|Overall Study|Adverse Event|0
7693229|NCT00372424|12112980|FG000|Overall Study|Adverse Event|2
7693230|NCT00372424|12112980|FG000|Overall Study|Withdrawal by Subject|1
7693231|NCT00372424|12112980|FG000|Overall Study|Death|1
7693232|NCT00372424|12112980|FG000|Overall Study|Objective Progression or Relapse|14
7693233|NCT00372424|12112980|FG000|Overall Study|Other|7
7693234|NCT00372424|12112980|FG000|Overall Study|Enrolled, Not Treated|1
7693235|NCT00372489|12112984|FG000|Overall Study|Adverse Event|18
7693236|NCT00372489|12112984|FG000|Overall Study|Lack of Efficacy|1
7693237|NCT00372489|12112984|FG000|Overall Study|Lost to Follow-up|3
7693238|NCT00372489|12112984|FG000|Overall Study|Physician Decision|3
7693239|NCT00372489|12112984|FG000|Overall Study|Withdrawal by Subject|5
7693240|NCT00372489|12112984|FG000|Overall Study|Patient Relocation|2
7693241|NCT00372489|12112984|FG000|Overall Study|Renal transplant|6
7693242|NCT00372489|12112984|FG000|Overall Study|Sponsor Decision to Terminate Study|41
7693243|NCT00372528|12112988|FG000|Overall Study|Lack of Efficacy|1
7693244|NCT00372528|12112988|FG000|Overall Study|Adverse Event|1
7693245|NCT00372528|12112988|FG000|Overall Study|Study Terminated by Sponsor|18
7693246|NCT00372528|12112988|FG000|Overall Study|Other|1
7693247|NCT00372567|12112995|FG000|Phase 3 Study|Adverse Event|5
7693248|NCT00372567|12112996|FG001|Phase 3 Study|Adverse Event|1
7693249|NCT00372567|12112997|FG002|Phase 3 Study|Adverse Event|1
7693250|NCT00372567|12112995|FG000|Phase 3 Study|Death|1
7693251|NCT00372567|12112996|FG001|Phase 3 Study|Death|1
7693252|NCT00372567|12112997|FG002|Phase 3 Study|Death|0
7693253|NCT00372567|12112995|FG000|Phase 3 Study|Protocol Violation|0
7693254|NCT00372567|12112996|FG001|Phase 3 Study|Protocol Violation|0
7693255|NCT00372567|12112997|FG002|Phase 3 Study|Protocol Violation|1
7693256|NCT00372567|12112995|FG000|Phase 3 Study|Objective progression or relapse|10
7693257|NCT00372567|12112996|FG001|Phase 3 Study|Objective progression or relapse|13
7693258|NCT00372567|12112997|FG002|Phase 3 Study|Objective progression or relapse|4
7693259|NCT00372567|12112995|FG000|Phase 3 Study|Global deterioration of health status|0
7693260|NCT00372567|12112996|FG001|Phase 3 Study|Global deterioration of health status|1
7693261|NCT00372567|12112997|FG002|Phase 3 Study|Global deterioration of health status|0
7693262|NCT00372567|12112995|FG000|Phase 3 Study|Other|2
7693263|NCT00372567|12112996|FG001|Phase 3 Study|Other|2
7693264|NCT00372567|12112997|FG002|Phase 3 Study|Other|1
7693265|NCT00372567|12112995|FG000|Phase 3 Study|study terminated by sponsor|13
7693266|NCT00372567|12112996|FG001|Phase 3 Study|study terminated by sponsor|8
7693267|NCT00372567|12112997|FG002|Phase 3 Study|study terminated by sponsor|5
7693268|NCT00372593|12113008|FG000|Overall Study|Adverse Event|43
7693269|NCT00372593|12113009|FG001|Overall Study|Adverse Event|45
7693270|NCT00372593|12113010|FG002|Overall Study|Adverse Event|0
7693271|NCT00372593|12113008|FG000|Overall Study|Death|16
7693272|NCT00372593|12113009|FG001|Overall Study|Death|20
7693273|NCT00372593|12113010|FG002|Overall Study|Death|1
7693274|NCT00372593|12113008|FG000|Overall Study|Lack of Efficacy|82
7693275|NCT00372593|12113009|FG001|Overall Study|Lack of Efficacy|71
7693276|NCT00372593|12113010|FG002|Overall Study|Lack of Efficacy|2
7693277|NCT00372593|12113008|FG000|Overall Study|Lost to Follow-up|1
7693278|NCT00372593|12113009|FG001|Overall Study|Lost to Follow-up|0
7693279|NCT00372593|12113010|FG002|Overall Study|Lost to Follow-up|0
7693280|NCT00372593|12113008|FG000|Overall Study|Physician Decision|42
7693281|NCT00372593|12113009|FG001|Overall Study|Physician Decision|41
7693282|NCT00372593|12113010|FG002|Overall Study|Physician Decision|0
7693283|NCT00372593|12113008|FG000|Overall Study|Ineligible|20
7693284|NCT00372593|12113009|FG001|Overall Study|Ineligible|21
7693285|NCT00372593|12113010|FG002|Overall Study|Ineligible|1
7693286|NCT00372619|12113026|FG000|Overall Study|Ineligible|0
7693287|NCT00372619|12113027|FG001|Overall Study|Ineligible|0
7693288|NCT00372619|12113028|FG002|Overall Study|Ineligible|0
7693289|NCT00372619|12113029|FG003|Overall Study|Ineligible|0
7693290|NCT00372619|12113030|FG004|Overall Study|Ineligible|0
7693291|NCT00372619|12113031|FG005|Overall Study|Ineligible|2
7693292|NCT00372619|12113032|FG006|Overall Study|Ineligible|0
7693293|NCT00372619|12113026|FG000|Overall Study|Inevaluable|0
7693294|NCT00372619|12113027|FG001|Overall Study|Inevaluable|0
7693295|NCT00372619|12113028|FG002|Overall Study|Inevaluable|0
7693296|NCT00372619|12113029|FG003|Overall Study|Inevaluable|0
7693297|NCT00372619|12113030|FG004|Overall Study|Inevaluable|0
7693298|NCT00372619|12113031|FG005|Overall Study|Inevaluable|1
7693299|NCT00372619|12113032|FG006|Overall Study|Inevaluable|0
7693300|NCT00372697|12113050|FG000|Overall Study|Protocol Violation|1
7693301|NCT00372697|12113051|FG001|Overall Study|Protocol Violation|1
7693302|NCT00372775|12113057|FG000|Overall Study|Adverse Event|8
7693303|NCT00372775|12113057|FG000|Overall Study|Death|15
7693304|NCT00372775|12113057|FG000|Overall Study|Objective progression or relapse|30
7693305|NCT00372775|12113057|FG000|Overall Study|Global deterioration of health status|6
7693306|NCT00372775|12113057|FG000|Overall Study|Withdrawal by Subject|1
7693307|NCT00372775|12113057|FG000|Overall Study|Other|1
7693308|NCT00372775|12113057|FG000|Overall Study|Not Treated|2
7693309|NCT00372905|12113061|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
7693310|NCT00372905|12113062|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
7693311|NCT00372905|12113063|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
7693312|NCT00372905|12113064|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
7693313|NCT00372905|12113061|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
7693314|NCT00372905|12113062|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
7693315|NCT00372905|12113063|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
7693316|NCT00372905|12113064|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
7693317|NCT00372905|12113061|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
7693318|NCT00372905|12113062|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
7693319|NCT00372905|12113063|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
7693320|NCT00372905|12113064|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
7693321|NCT00372905|12113061|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
7693322|NCT00372905|12113062|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
7693323|NCT00372905|12113063|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
7693324|NCT00372905|12113064|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
7693325|NCT00372905|12113061|FG000|Follow up Until Relapse or Progression|Study closed|0
7693326|NCT00372905|12113062|FG001|Follow up Until Relapse or Progression|Study closed|0
7693327|NCT00372905|12113063|FG002|Follow up Until Relapse or Progression|Study closed|0
7693328|NCT00372905|12113064|FG003|Follow up Until Relapse or Progression|Study closed|3
7693329|NCT00372905|12113061|FG000|Follow up Until Relapse or Progression|Other|0
7693330|NCT00372905|12113062|FG001|Follow up Until Relapse or Progression|Other|1
7693331|NCT00372905|12113063|FG002|Follow up Until Relapse or Progression|Other|0
7693332|NCT00372905|12113064|FG003|Follow up Until Relapse or Progression|Other|0
7693333|NCT00372996|12113100|FG000|Overall Study|Death|11
7693334|NCT00372996|12113101|FG001|Overall Study|Death|4
7693335|NCT00372996|12113102|FG002|Overall Study|Death|8
7693336|NCT00372996|12113103|FG003|Overall Study|Death|7
7693337|NCT00372996|12113100|FG000|Overall Study|Lost to Follow-up|0
7693338|NCT00372996|12113101|FG001|Overall Study|Lost to Follow-up|2
7693339|NCT00372996|12113102|FG002|Overall Study|Lost to Follow-up|0
7693340|NCT00372996|12113103|FG003|Overall Study|Lost to Follow-up|1
7693341|NCT00372996|12113100|FG000|Overall Study|Withdrawal by Subject|12
7693342|NCT00372996|12113101|FG001|Overall Study|Withdrawal by Subject|6
7693343|NCT00372996|12113102|FG002|Overall Study|Withdrawal by Subject|9
7693344|NCT00372996|12113103|FG003|Overall Study|Withdrawal by Subject|5
7693345|NCT00372996|12113100|FG000|Overall Study|Study Terminated by Sponsor|4
7693346|NCT00372996|12113101|FG001|Overall Study|Study Terminated by Sponsor|0
7693347|NCT00372996|12113102|FG002|Overall Study|Study Terminated by Sponsor|4
7693348|NCT00372996|12113103|FG003|Overall Study|Study Terminated by Sponsor|0
7693349|NCT00372996|12113100|FG000|Overall Study|Other|10
7693350|NCT00372996|12113101|FG001|Overall Study|Other|2
7693351|NCT00372996|12113102|FG002|Overall Study|Other|7
7693352|NCT00372996|12113103|FG003|Overall Study|Other|7
7693353|NCT00373113|12113115|FG000|Overall Study|Death|1
7693354|NCT00373113|12113116|FG001|Overall Study|Death|7
7693355|NCT00373113|12113115|FG000|Overall Study|Adverse Event|38
7693356|NCT00373113|12113116|FG001|Overall Study|Adverse Event|24
7693357|NCT00373113|12113115|FG000|Overall Study|Study terminated by sponsor|9
7693358|NCT00373113|12113116|FG001|Overall Study|Study terminated by sponsor|1
7693359|NCT00373113|12113115|FG000|Overall Study|Global deterioration of health status|10
7693360|NCT00373113|12113116|FG001|Overall Study|Global deterioration of health status|7
7693361|NCT00373113|12113115|FG000|Overall Study|Lost to Follow-up|1
7693362|NCT00373113|12113116|FG001|Overall Study|Lost to Follow-up|3
7693363|NCT00373113|12113115|FG000|Overall Study|Objective progression or relapse|150
7693364|NCT00373113|12113116|FG001|Overall Study|Objective progression or relapse|169
7693365|NCT00373113|12113115|FG000|Overall Study|Other|14
7693366|NCT00373113|12113116|FG001|Overall Study|Other|17
7693367|NCT00373113|12113115|FG000|Overall Study|Protocol Violation|5
7693368|NCT00373113|12113116|FG001|Overall Study|Protocol Violation|1
7693369|NCT00373113|12113115|FG000|Overall Study|Withdrawal by Subject|10
7693370|NCT00373113|12113116|FG001|Overall Study|Withdrawal by Subject|15
7693371|NCT00373256|12113124|FG000|Overall Study|Adverse Event (AE)|1
7693372|NCT00373256|12113125|FG001|Overall Study|Adverse Event (AE)|5
7693373|NCT00373256|12113124|FG000|Overall Study|Lost to Follow-up|2
7693374|NCT00373256|12113125|FG001|Overall Study|Lost to Follow-up|1
7693375|NCT00373256|12113124|FG000|Overall Study|Death|9
7693376|NCT00373256|12113125|FG001|Overall Study|Death|8
7693377|NCT00373256|12113124|FG000|Overall Study|Objective Progression or Relapse|111
7693378|NCT00373256|12113125|FG001|Overall Study|Objective Progression or Relapse|104
7693379|NCT00373256|12113124|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4
7693380|NCT00373256|12113125|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7
7693381|NCT00373256|12113124|FG000|Overall Study|Other|73
7693382|NCT00373256|12113125|FG001|Overall Study|Other|107
7693383|NCT00373256|12113124|FG000|Overall Study|Protocol Violation|0
7693384|NCT00373256|12113125|FG001|Overall Study|Protocol Violation|2
7693385|NCT00373256|12113124|FG000|Overall Study|Study Terminated by Sponsor|41
7693386|NCT00373256|12113125|FG001|Overall Study|Study Terminated by Sponsor|13
7693387|NCT00373295|12113140|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0
7693388|NCT00373295|12113141|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2
7693389|NCT00373295|12113142|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0
7693390|NCT00373295|12113143|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0
7693391|NCT00373295|12113144|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1
7693392|NCT00373295|12113145|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0
7693393|NCT00373425|12113194|FG000|Overall Study|Relapse of NSCLC|116
7693394|NCT00373425|12113195|FG001|Overall Study|Relapse of NSCLC|104
7693395|NCT00373425|12113196|FG002|Overall Study|Relapse of NSCLC|19
7693396|NCT00373425|12113197|FG003|Overall Study|Relapse of NSCLC|2
7693397|NCT00373425|12113198|FG004|Overall Study|Relapse of NSCLC|26
7693398|NCT00373425|12113194|FG000|Overall Study|Adverse Event|191
7693399|NCT00373425|12113195|FG001|Overall Study|Adverse Event|22
7693400|NCT00373425|12113196|FG002|Overall Study|Adverse Event|59
7693401|NCT00373425|12113197|FG003|Overall Study|Adverse Event|0
7693402|NCT00373425|12113198|FG004|Overall Study|Adverse Event|34
7693403|NCT00373425|12113194|FG000|Overall Study|Patient request|35
7693404|NCT00373425|12113195|FG001|Overall Study|Patient request|18
7693405|NCT00373425|12113196|FG002|Overall Study|Patient request|43
7693406|NCT00373425|12113197|FG003|Overall Study|Patient request|6
7693407|NCT00373425|12113198|FG004|Overall Study|Patient request|7
7693408|NCT00373425|12113194|FG000|Overall Study|Medical/ethical/noncompliance reason|21
7693409|NCT00373425|12113195|FG001|Overall Study|Medical/ethical/noncompliance reason|9
7693410|NCT00373425|12113196|FG002|Overall Study|Medical/ethical/noncompliance reason|10
7693411|NCT00373425|12113197|FG003|Overall Study|Medical/ethical/noncompliance reason|2
7693412|NCT00373425|12113198|FG004|Overall Study|Medical/ethical/noncompliance reason|5
7693413|NCT00373425|12113194|FG000|Overall Study|Death|7
7693414|NCT00373425|12113195|FG001|Overall Study|Death|0
7693415|NCT00373425|12113196|FG002|Overall Study|Death|3
7693416|NCT00373425|12113197|FG003|Overall Study|Death|1
7693417|NCT00373425|12113198|FG004|Overall Study|Death|0
7693418|NCT00373490|12113209|FG000|Overall Study|Adverse Event|0
7693419|NCT00373490|12113210|FG001|Overall Study|Adverse Event|1
7693420|NCT00373490|12113209|FG000|Overall Study|Lack of Efficacy|9
7693421|NCT00373490|12113210|FG001|Overall Study|Lack of Efficacy|4
7693422|NCT00373490|12113209|FG000|Overall Study|Withdrawal by Subject|0
7693423|NCT00373490|12113210|FG001|Overall Study|Withdrawal by Subject|1
7693424|NCT00373529|12113216|FG000|Overall Study|Physician Decision|19
7693425|NCT00373529|12113216|FG000|Overall Study|Withdrawal by Subject|7
7693426|NCT00373529|12113216|FG000|Overall Study|Adverse Event|7
7693427|NCT00373529|12113216|FG000|Overall Study|Treatment failure|36
7693428|NCT00373529|12113216|FG000|Overall Study|Disease recurrence|10
7693429|NCT00373529|12113216|FG000|Overall Study|Death|16
7693430|NCT00373529|12113216|FG000|Overall Study|Need for treatment prohibited by study|1
7693431|NCT00373529|12113216|FG000|Overall Study|Other|8
7693432|NCT00373529|12113216|FG000|Overall Study|Failed independent confirmation of AML|3
7693433|NCT00373529|12113216|FG000|Overall Study|Consent violation|1
7693434|NCT00373685|12113222|FG000|Overall Study|Death|2
7693435|NCT00373685|12113223|FG001|Overall Study|Death|1
7693436|NCT00373685|12113222|FG000|Overall Study|Adverse Event|278
7693437|NCT00373685|12113223|FG001|Overall Study|Adverse Event|253
7693438|NCT00373685|12113222|FG000|Overall Study|Insufficient clinical response|169
7693439|NCT00373685|12113223|FG001|Overall Study|Insufficient clinical response|119
7693440|NCT00373685|12113222|FG000|Overall Study|Did not meet entrance criteria|167
7693441|NCT00373685|12113223|FG001|Overall Study|Did not meet entrance criteria|184
7693442|NCT00373685|12113222|FG000|Overall Study|Lost to follow up|83
7693443|NCT00373685|12113223|FG001|Overall Study|Lost to follow up|103
7693444|NCT00373685|12113222|FG000|Overall Study|No longer willing to participate|337
7693445|NCT00373685|12113223|FG001|Overall Study|No longer willing to participate|352
7693446|NCT00373685|12113222|FG000|Overall Study|Other|149
7693447|NCT00373685|12113223|FG001|Overall Study|Other|146
7693448|NCT00373685|12113222|FG000|Overall Study|Protocol Violation|191
7693449|NCT00373685|12113223|FG001|Overall Study|Protocol Violation|182
7693450|NCT00373685|12113222|FG000|Overall Study|Final Status Unknown|12
7693451|NCT00373685|12113223|FG001|Overall Study|Final Status Unknown|4
7693452|NCT00373685|12113222|FG000|Overall Study|Randomized, not treated|51
7693453|NCT00373685|12113223|FG001|Overall Study|Randomized, not treated|77
7693454|NCT00373880|12113240|FG000|Overall Study|Physician Decision|3
7693455|NCT00373880|12113240|FG000|Overall Study|Arrested|1
7693456|NCT00373880|12113240|FG000|Overall Study|Protocol Violation|14
7693457|NCT00373958|12113254|FG000|Infant Series|Withdrawal by Subject|13
7693458|NCT00373958|12113255|FG001|Infant Series|Withdrawal by Subject|15
7693459|NCT00373958|12113254|FG000|Infant Series|Failed to return|8
7693460|NCT00373958|12113255|FG001|Infant Series|Failed to return|13
7693461|NCT00373958|12113254|FG000|Infant Series|Lost to Follow-up|6
7693462|NCT00373958|12113255|FG001|Infant Series|Lost to Follow-up|5
7693463|NCT00373958|12113254|FG000|Infant Series|Protocol Violation|3
7693464|NCT00373958|12113255|FG001|Infant Series|Protocol Violation|7
7693465|NCT00373958|12113254|FG000|Infant Series|Lost Kaiser coverage|4
7693466|NCT00373958|12113255|FG001|Infant Series|Lost Kaiser coverage|0
7693467|NCT00373958|12113254|FG000|Infant Series|Child relocated|1
7693468|NCT00373958|12113255|FG001|Infant Series|Child relocated|0
7693469|NCT00373958|12113254|FG000|Infant Series|Consent was not received|1
7693470|NCT00373958|12113255|FG001|Infant Series|Consent was not received|0
7693471|NCT00373958|12113254|FG000|Infant Series|Adverse Event|3
7693472|NCT00373958|12113255|FG001|Infant Series|Adverse Event|1
7693473|NCT00373958|12113254|FG000|Infant Series|Physician Decision|1
7693474|NCT00373958|12113255|FG001|Infant Series|Physician Decision|1
7693475|NCT00373958|12113254|FG000|Toddler Dose|Lost to Follow-up|5
7693476|NCT00373958|12113255|FG001|Toddler Dose|Lost to Follow-up|8
7693477|NCT00373958|12113254|FG000|Toddler Dose|Withdrawal by Subject|2
7693478|NCT00373958|12113255|FG001|Toddler Dose|Withdrawal by Subject|2
7693479|NCT00373958|12113254|FG000|Toddler Dose|Failed to return|1
7693480|NCT00373958|12113255|FG001|Toddler Dose|Failed to return|2
7693481|NCT00373958|12113254|FG000|Toddler Dose|Protocol Violation|0
7693482|NCT00373958|12113255|FG001|Toddler Dose|Protocol Violation|1
7693483|NCT00373958|12113254|FG000|Toddler Dose|Withdrawn after infant series|22
7693484|NCT00373958|12113255|FG001|Toddler Dose|Withdrawn after infant series|25
7693485|NCT00374127|12113293|FG000|Overall Study|Did not inhale during smoking procedure.|3
7693486|NCT00374127|12113293|FG000|Overall Study|Blood could not be drawn.|2
7693487|NCT00374127|12113293|FG000|Overall Study|Protocol Violation|5
7693488|NCT00374127|12113293|FG000|Overall Study|Pregnancy|1
7693489|NCT00374140|12113303|FG000|Overall Study|Lost to Follow-up|1
7693490|NCT00374140|12113303|FG000|Overall Study|Protocol Violation|1
7693491|NCT00374322|12113323|FG000|Overall Study|Lost to Follow-up|92
7693492|NCT00374322|12113324|FG001|Overall Study|Lost to Follow-up|90
7693493|NCT00374322|12113323|FG000|Overall Study|Protocol Violation|8
7693494|NCT00374322|12113324|FG001|Overall Study|Protocol Violation|3
7693495|NCT00374322|12113323|FG000|Overall Study|Withdrawal by Subject|235
7693496|NCT00374322|12113324|FG001|Overall Study|Withdrawal by Subject|167
7693497|NCT00374322|12113323|FG000|Overall Study|Sponsor Terminated Study|866
7693498|NCT00374322|12113324|FG001|Overall Study|Sponsor Terminated Study|990
7693499|NCT00374322|12113323|FG000|Overall Study|Physician Decision|36
7693500|NCT00374322|12113324|FG001|Overall Study|Physician Decision|32
7693501|NCT00374322|12113323|FG000|Overall Study|Par. Consented to Survival FU Only|3
7693502|NCT00374322|12113324|FG001|Overall Study|Par. Consented to Survival FU Only|1
7693503|NCT00374322|12113323|FG000|Overall Study|Sponsor Decision|2
7693504|NCT00374322|12113324|FG001|Overall Study|Sponsor Decision|3
7693505|NCT00374322|12113323|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2
7693506|NCT00374322|12113324|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3
7693507|NCT00374322|12113323|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1
7693508|NCT00374322|12113324|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0
7693509|NCT00374322|12113323|FG000|Overall Study|Severe Toxicity|1
7693510|NCT00374322|12113324|FG001|Overall Study|Severe Toxicity|0
7693511|NCT00374322|12113323|FG000|Overall Study|Site Closed|2
7693512|NCT00374322|12113324|FG001|Overall Study|Site Closed|2
7693513|NCT00374322|12113323|FG000|Overall Study|Participant Changed Physician|1
7693514|NCT00374322|12113324|FG001|Overall Study|Participant Changed Physician|0
7693515|NCT00374322|12113323|FG000|Overall Study|Started Another Chemotherapy Regimen|0
7693516|NCT00374322|12113324|FG001|Overall Study|Started Another Chemotherapy Regimen|1
7693517|NCT00374322|12113323|FG000|Overall Study|Noncompliance with Study Requirements|0
7693518|NCT00374322|12113324|FG001|Overall Study|Noncompliance with Study Requirements|1
7693519|NCT00374322|12113323|FG000|Overall Study|Withdrew Consent During Follow-up|0
7693520|NCT00374322|12113324|FG001|Overall Study|Withdrew Consent During Follow-up|5
7693521|NCT00374322|12113323|FG000|Overall Study|Did Not Receive Study Medication|8
7693522|NCT00374322|12113324|FG001|Overall Study|Did Not Receive Study Medication|6
7693523|NCT00374452|12113337|FG000|Overall Study|Left clinic before intervention started|4
7693524|NCT00374452|12113338|FG001|Overall Study|Left clinic before intervention started|1
7693525|NCT00374452|12113337|FG000|Overall Study|Change in job role before intervention|0
7693526|NCT00374452|12113338|FG001|Overall Study|Change in job role before intervention|1
7693527|NCT00374452|12113337|FG000|Overall Study|Left clinic after intervention started|1
7693528|NCT00374452|12113338|FG001|Overall Study|Left clinic after intervention started|1
7693529|NCT00374452|12113337|FG000|Overall Study|Withdrawal by Subject|0
7693530|NCT00374452|12113338|FG001|Overall Study|Withdrawal by Subject|2
7693531|NCT00374556|12113346|FG000|Overall Study|Lost to Follow-up|1
7693532|NCT00374556|12113347|FG001|Overall Study|Lost to Follow-up|0
7693533|NCT00374556|12113346|FG000|Overall Study|Removed at baseline due to medical cond|0
7693534|NCT00374556|12113347|FG001|Overall Study|Removed at baseline due to medical cond|1
7693535|NCT00374868|12113379|FG000|Overall Study|Adverse Event|12
7693536|NCT00374868|12113379|FG000|Overall Study|Progressive Disease|7
7693537|NCT00374868|12113379|FG000|Overall Study|Physician Decision|13
7693538|NCT00374868|12113379|FG000|Overall Study|Lost to Follow-up|1
7693539|NCT00374868|12113379|FG000|Overall Study|Death|2
7693540|NCT00374868|12113379|FG000|Overall Study|Other - Not Specified|1
7693541|NCT00374907|12113385|FG000|12-Week Short-term Period|Subject Withdrew Consent|3
7693542|NCT00374907|12113386|FG001|12-Week Short-term Period|Subject Withdrew Consent|1
7693543|NCT00374907|12113385|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
7693544|NCT00374907|12113386|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
7693545|NCT00374907|12113385|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4
7693546|NCT00374907|12113386|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2
7693547|NCT00374907|12113385|FG000|116-Week Short-term + Long-term Period|Adverse Event|0
7693548|NCT00374907|12113386|FG001|116-Week Short-term + Long-term Period|Adverse Event|2
7693549|NCT00374907|12113385|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1
7693550|NCT00374907|12113386|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1
7693551|NCT00375219|12113408|FG000|Overall Study|Failure to achieve a response|16
7693552|NCT00375219|12113409|FG001|Overall Study|Failure to achieve a response|2
7693553|NCT00375219|12113410|FG002|Overall Study|Failure to achieve a response|0
7693554|NCT00375219|12113408|FG000|Overall Study|Adverse Event|8
7693555|NCT00375219|12113409|FG001|Overall Study|Adverse Event|2
7693556|NCT00375219|12113410|FG002|Overall Study|Adverse Event|1
7693557|NCT00375219|12113408|FG000|Overall Study|Protocol Violation|1
7693558|NCT00375219|12113409|FG001|Overall Study|Protocol Violation|0
7693559|NCT00375219|12113410|FG002|Overall Study|Protocol Violation|1
7693560|NCT00375219|12113408|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5
7693561|NCT00375219|12113409|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3
7693562|NCT00375219|12113410|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0
7693563|NCT00375219|12113408|FG000|Overall Study|Lost to Follow-up|1
7693564|NCT00375219|12113409|FG001|Overall Study|Lost to Follow-up|1
7693565|NCT00375219|12113410|FG002|Overall Study|Lost to Follow-up|0
7693566|NCT00375219|12113408|FG000|Overall Study|Disease progression|18
7693567|NCT00375219|12113409|FG001|Overall Study|Disease progression|9
7693568|NCT00375219|12113410|FG002|Overall Study|Disease progression|12
7693569|NCT00375219|12113408|FG000|Overall Study|Death|4
7693570|NCT00375219|12113409|FG001|Overall Study|Death|3
7693571|NCT00375219|12113410|FG002|Overall Study|Death|7
7693572|NCT00375219|12113408|FG000|Overall Study|Hematologic resistance|1
7693573|NCT00375219|12113409|FG001|Overall Study|Hematologic resistance|0
7693574|NCT00375219|12113410|FG002|Overall Study|Hematologic resistance|0
7693575|NCT00375219|12113408|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1
7693576|NCT00375219|12113409|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0
7693577|NCT00375219|12113410|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0
7693578|NCT00375219|12113408|FG000|Overall Study|Allograft|2
7693579|NCT00375219|12113409|FG001|Overall Study|Allograft|0
7693580|NCT00375219|12113410|FG002|Overall Study|Allograft|0
7693581|NCT00375219|12113408|FG000|Overall Study|Cord blood transplantation|1
7693582|NCT00375219|12113409|FG001|Overall Study|Cord blood transplantation|0
7693583|NCT00375219|12113410|FG002|Overall Study|Cord blood transplantation|0
7693584|NCT00375219|12113408|FG000|Overall Study|Withdrawal by Subject|1
7693585|NCT00375219|12113409|FG001|Overall Study|Withdrawal by Subject|0
7693586|NCT00375219|12113410|FG002|Overall Study|Withdrawal by Subject|0
7693587|NCT00375427|12113419|FG000|Overall Study|Adverse Event|21
7693588|NCT00375427|12113420|FG001|Overall Study|Adverse Event|27
7693589|NCT00375427|12113419|FG000|Overall Study|Abnormal test procedure result(s)|0
7693590|NCT00375427|12113420|FG001|Overall Study|Abnormal test procedure result(s)|1
7693591|NCT00375427|12113419|FG000|Overall Study|Abnormal laboratory value(s)|1
7693592|NCT00375427|12113420|FG001|Overall Study|Abnormal laboratory value(s)|2
7693593|NCT00375427|12113419|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7693594|NCT00375427|12113420|FG001|Overall Study|Unsatisfactory therapeutic effect|4
7693595|NCT00375427|12113419|FG000|Overall Study|Patient no longer requires study drug|3
7693596|NCT00375427|12113420|FG001|Overall Study|Patient no longer requires study drug|7
7693597|NCT00375427|12113419|FG000|Overall Study|Protocol Violation|10
7693598|NCT00375427|12113420|FG001|Overall Study|Protocol Violation|8
7693599|NCT00375427|12113419|FG000|Overall Study|Withdrawal by Subject|9
7693600|NCT00375427|12113420|FG001|Overall Study|Withdrawal by Subject|13
7693601|NCT00375427|12113419|FG000|Overall Study|Lost to Follow-up|1
7693602|NCT00375427|12113420|FG001|Overall Study|Lost to Follow-up|1
7693603|NCT00375427|12113419|FG000|Overall Study|Administrative reasons|0
7693604|NCT00375427|12113420|FG001|Overall Study|Administrative reasons|1
7693605|NCT00375427|12113419|FG000|Overall Study|Death|11
7693606|NCT00375427|12113420|FG001|Overall Study|Death|10
7693607|NCT00375492|12113428|FG000|Overall Study|Adverse Event|4
7693608|NCT00375492|12113429|FG001|Overall Study|Adverse Event|5
7693609|NCT00375492|12113428|FG000|Overall Study|Entry Criteria Not Met|0
7693610|NCT00375492|12113429|FG001|Overall Study|Entry Criteria Not Met|1
7693611|NCT00375492|12113428|FG000|Overall Study|Loss of Glucose Control|0
7693612|NCT00375492|12113429|FG001|Overall Study|Loss of Glucose Control|1
7693613|NCT00375492|12113428|FG000|Overall Study|Lost to Follow-up|10
7693614|NCT00375492|12113429|FG001|Overall Study|Lost to Follow-up|5
7693615|NCT00375492|12113428|FG000|Overall Study|Physician Decision|0
7693616|NCT00375492|12113429|FG001|Overall Study|Physician Decision|4
7693617|NCT00375492|12113428|FG000|Overall Study|Protocol Violation|6
7693618|NCT00375492|12113429|FG001|Overall Study|Protocol Violation|3
7693619|NCT00375492|12113428|FG000|Overall Study|Sponsor Decision|0
7693620|NCT00375492|12113429|FG001|Overall Study|Sponsor Decision|1
7693621|NCT00375492|12113428|FG000|Overall Study|Withdrawal by Subject|6
7693622|NCT00375492|12113429|FG001|Overall Study|Withdrawal by Subject|6
7693623|NCT00375505|12113437|FG000|Overall Study|Adverse Event|1
7693624|NCT00375505|12113438|FG001|Overall Study|Adverse Event|2
7693625|NCT00375518|12113446|FG000|Overall Study|Withdrawal by Subject|2
7693626|NCT00375518|12113447|FG001|Overall Study|Withdrawal by Subject|10
7693627|NCT00375518|12113446|FG000|Overall Study|Patient Not Treated|6
7693628|NCT00375518|12113447|FG001|Overall Study|Patient Not Treated|6
7693629|NCT00375518|12113446|FG000|Overall Study|Death|0
7693630|NCT00375518|12113447|FG001|Overall Study|Death|1
7693631|NCT00375609|12113456|FG000|Overall Study|Did not receive treatment|1
7693632|NCT00375609|12113457|FG001|Overall Study|Did not receive treatment|0
7693633|NCT00375609|12113458|FG002|Overall Study|Did not receive treatment|0
7693634|NCT00375609|12113456|FG000|Overall Study|Adverse Event|0
7693635|NCT00375609|12113457|FG001|Overall Study|Adverse Event|3
7693636|NCT00375609|12113458|FG002|Overall Study|Adverse Event|0
7693637|NCT00375609|12113456|FG000|Overall Study|Lost to Follow-up|1
7693638|NCT00375609|12113457|FG001|Overall Study|Lost to Follow-up|0
7693639|NCT00375609|12113458|FG002|Overall Study|Lost to Follow-up|0
7693640|NCT00375609|12113456|FG000|Overall Study|Physician Decision|0
7693641|NCT00375609|12113457|FG001|Overall Study|Physician Decision|0
7693642|NCT00375609|12113458|FG002|Overall Study|Physician Decision|1
7693643|NCT00375609|12113456|FG000|Overall Study|Withdrawal by Subject|1
7693644|NCT00375609|12113457|FG001|Overall Study|Withdrawal by Subject|4
7693645|NCT00375609|12113458|FG002|Overall Study|Withdrawal by Subject|0
7693646|NCT00375609|12113456|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1
7693647|NCT00375609|12113457|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0
7693648|NCT00375609|12113458|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0
7693649|NCT00375674|12113468|FG000|Overall Study|Other|26
7693650|NCT00375674|12113469|FG001|Overall Study|Other|18
7693651|NCT00375674|12113468|FG000|Overall Study|Death|67
7693652|NCT00375674|12113469|FG001|Overall Study|Death|76
7693653|NCT00375674|12113468|FG000|Overall Study|Participants refused further follow-up|31
7693654|NCT00375674|12113469|FG001|Overall Study|Participants refused further follow-up|30
7693655|NCT00375674|12113468|FG000|Overall Study|Lost to Follow-up|17
7693656|NCT00375674|12113469|FG001|Overall Study|Lost to Follow-up|15
7693657|NCT00375674|12113468|FG000|Overall Study|Enrolled but not treated|3
7693658|NCT00375674|12113469|FG001|Overall Study|Enrolled but not treated|2
7693659|NCT00375752|12113486|FG000|Overall Study|Lack of Efficacy|4
7693660|NCT00375752|12113487|FG001|Overall Study|Lack of Efficacy|4
7693661|NCT00375752|12113486|FG000|Overall Study|Adverse Event|1
7693662|NCT00375752|12113487|FG001|Overall Study|Adverse Event|6
7693663|NCT00375752|12113486|FG000|Overall Study|Withdrawal by Subject|6
7693664|NCT00375752|12113487|FG001|Overall Study|Withdrawal by Subject|1
7693665|NCT00375752|12113486|FG000|Overall Study|Abnormal Laboratory Value(s)|1
7693666|NCT00375752|12113487|FG001|Overall Study|Abnormal Laboratory Value(s)|1
7693667|NCT00375752|12113486|FG000|Overall Study|Protocol Violation|0
7693668|NCT00375752|12113487|FG001|Overall Study|Protocol Violation|2
7693669|NCT00375752|12113486|FG000|Overall Study|Administrative Problems|0
7693670|NCT00375752|12113487|FG001|Overall Study|Administrative Problems|1
7693671|NCT00375934|12113520|FG000|Overall Study|Adverse Event|1
7693672|NCT00375934|12113521|FG001|Overall Study|Adverse Event|1
7693673|NCT00375934|12113520|FG000|Overall Study|Withdrawal by Subject|2
7693674|NCT00375934|12113521|FG001|Overall Study|Withdrawal by Subject|2
7693675|NCT00375934|12113520|FG000|Overall Study|Lack of Efficacy|0
7693676|NCT00375934|12113521|FG001|Overall Study|Lack of Efficacy|2
7693677|NCT00375934|12113520|FG000|Overall Study|Physician Decision|0
7693678|NCT00375934|12113521|FG001|Overall Study|Physician Decision|1
7693679|NCT00376168|12113542|FG000|Overall Study|Adverse Event|1
7693680|NCT00376168|12113543|FG001|Overall Study|Adverse Event|1
7693681|NCT00376168|12113542|FG000|Overall Study|Pregnancy|1
7693682|NCT00376168|12113543|FG001|Overall Study|Pregnancy|0
7693683|NCT00376220|12113551|FG000|Overall Study|Lost to Follow-up|7
7693684|NCT00376220|12113552|FG001|Overall Study|Lost to Follow-up|10
7693685|NCT00376220|12113551|FG000|Overall Study|Withdrawal by Subject|3
7693686|NCT00376220|12113552|FG001|Overall Study|Withdrawal by Subject|2
7693687|NCT00376246|12113558|FG000|First Intervention (2 Weeks)|Adverse Event|2
7693688|NCT00376246|12113559|FG001|First Intervention (2 Weeks)|Adverse Event|0
7693689|NCT00376246|12113558|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1
7693690|NCT00376246|12113559|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2
7693691|NCT00376246|12113558|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1
7693692|NCT00376246|12113559|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0
7693693|NCT00376259|12113569|FG000|Overall Study|Sponsor request - study termination|21
7693694|NCT00376259|12113570|FG001|Overall Study|Sponsor request - study termination|21
7693695|NCT00376259|12113569|FG000|Overall Study|Patient request|1
7693696|NCT00376259|12113570|FG001|Overall Study|Patient request|0
7693697|NCT00376506|12113587|FG000|Overall Study|Death|0
7693698|NCT00376506|12113588|FG001|Overall Study|Death|2
7693699|NCT00376532|12113599|FG000|Overall Study|Lack sufficient blood sample|6
7693700|NCT00376532|12113600|FG001|Overall Study|Lack sufficient blood sample|6
7693701|NCT00376675|12113629|FG000|Overall Study|Withdrawal by Subject|9
7693702|NCT00376675|12113630|FG001|Overall Study|Withdrawal by Subject|2
7693703|NCT00376675|12113629|FG000|Overall Study|Adverse Event|10
7693704|NCT00376675|12113630|FG001|Overall Study|Adverse Event|5
7693705|NCT00376675|12113629|FG000|Overall Study|Other Reason|1
7693706|NCT00376675|12113630|FG001|Overall Study|Other Reason|7
7693707|NCT00376688|12113636|FG000|Overall Study|Adverse Event|3
7693708|NCT00376688|12113636|FG000|Overall Study|Death|1
7693709|NCT00376961|12113665|FG000|Initial Registration|Adverse Event|1
7693710|NCT00376961|12113666|FG001|Initial Registration|Adverse Event|0
7693711|NCT00376961|12113665|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2
7693712|NCT00376961|12113666|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0
7693713|NCT00376961|12113665|FG000|Initial Registration|Progression/relapse|1
7693714|NCT00376961|12113666|FG001|Initial Registration|Progression/relapse|0
7693715|NCT00376961|12113665|FG000|Initial Registration|Ineligible|3
7693716|NCT00376961|12113666|FG001|Initial Registration|Ineligible|0
7693717|NCT00376961|12113665|FG000|Maintenance|Adverse Event|0
7693718|NCT00376961|12113666|FG001|Maintenance|Adverse Event|1
7693719|NCT00376961|12113665|FG000|Maintenance|Refusal Unrelated to Adverse Event|0
7693720|NCT00376961|12113666|FG001|Maintenance|Refusal Unrelated to Adverse Event|1
7693721|NCT00376961|12113665|FG000|Maintenance|Progression/relapse|0
7693722|NCT00376961|12113666|FG001|Maintenance|Progression/relapse|18
7693723|NCT00376961|12113665|FG000|Maintenance|Ineligible|0
7693724|NCT00376961|12113666|FG001|Maintenance|Ineligible|3
7693725|NCT00377234|12113676|FG000|Overall Study|Adverse Event|14
7693726|NCT00377234|12113677|FG001|Overall Study|Adverse Event|17
7693727|NCT00377234|12113676|FG000|Overall Study|Withdrawal by Subject|11
7693728|NCT00377234|12113677|FG001|Overall Study|Withdrawal by Subject|9
7693729|NCT00377234|12113676|FG000|Overall Study|Lost to Follow-up|4
7693730|NCT00377234|12113677|FG001|Overall Study|Lost to Follow-up|2
7693731|NCT00377234|12113676|FG000|Overall Study|Administrative|2
7693732|NCT00377234|12113677|FG001|Overall Study|Administrative|1
7693733|NCT00377234|12113676|FG000|Overall Study|Not assigned|3
7693734|NCT00377234|12113677|FG001|Overall Study|Not assigned|2
7693735|NCT00377260|12113691|FG000|Overall Study|Lost to Follow-up|0
7693736|NCT00377260|12113692|FG001|Overall Study|Lost to Follow-up|1
7693737|NCT00377260|12113691|FG000|Overall Study|Withdrawal by Subject|2
7693738|NCT00377260|12113692|FG001|Overall Study|Withdrawal by Subject|4
7693739|NCT00377299|12113700|FG000|Overall Study|Lost to Follow-up|14
7693740|NCT00377299|12113701|FG001|Overall Study|Lost to Follow-up|19
7693741|NCT00377299|12113700|FG000|Overall Study|Adverse Event|0
7693742|NCT00377299|12113701|FG001|Overall Study|Adverse Event|1
7693743|NCT00377299|12113700|FG000|Overall Study|Withdrawal by Subject|5
7693744|NCT00377299|12113701|FG001|Overall Study|Withdrawal by Subject|4
7693745|NCT00377312|12113710|FG000|Overall Study|Adverse Event|1
7693746|NCT00377312|12113711|FG001|Overall Study|Adverse Event|1
7693747|NCT00377364|12113719|FG000|Overall Study|Lost to Follow-up|1
7693748|NCT00377364|12113720|FG001|Overall Study|Lost to Follow-up|0
7693749|NCT00377364|12113719|FG000|Overall Study|Withdrawal by Subject|1
7693750|NCT00377364|12113720|FG001|Overall Study|Withdrawal by Subject|0
7693751|NCT00377403|12113730|FG000|Overall Study|Unable to contact for telephone intervie|4
7693752|NCT00377403|12113731|FG001|Overall Study|Unable to contact for telephone intervie|7
7693753|NCT00377429|12113737|FG000|Overall Study|Withdrawal by Subject|5
7693754|NCT00377429|12113737|FG000|Overall Study|Adverse Event|8
7693755|NCT00377429|12113737|FG000|Overall Study|Physician Decision|1
7693756|NCT00377429|12113737|FG000|Overall Study|Patient non-compliance|1
7693757|NCT00377520|12113741|FG000|Overall Study|Ineligible (Prior radiation)|1
7693758|NCT00377611|12113756|FG000|Overall Study|Adverse Event|2
7693759|NCT00377611|12113757|FG001|Overall Study|Adverse Event|9
7693760|NCT00377611|12113756|FG000|Overall Study|Protocol Violation|2
7693761|NCT00377611|12113757|FG001|Overall Study|Protocol Violation|0
7693762|NCT00377611|12113756|FG000|Overall Study|Withdrawal by Subject|0
7693763|NCT00377611|12113757|FG001|Overall Study|Withdrawal by Subject|5
7693764|NCT00377611|12113756|FG000|Overall Study|Lost to Follow-up|18
7693765|NCT00377611|12113757|FG001|Overall Study|Lost to Follow-up|16
7693766|NCT00377611|12113756|FG000|Overall Study|Other|0
7693767|NCT00377611|12113757|FG001|Overall Study|Other|3
7693768|NCT00377637|12113768|FG000|Induction Phase|Adverse Event|12
7693769|NCT00377637|12113769|FG001|Induction Phase|Adverse Event|21
7693770|NCT00377637|12113770|FG002|Induction Phase|Adverse Event|0
7693771|NCT00377637|12113771|FG003|Induction Phase|Adverse Event|0
7693772|NCT00377637|12113768|FG000|Induction Phase|Deterioration/serum creatinine|2
7693773|NCT00377637|12113769|FG001|Induction Phase|Deterioration/serum creatinine|0
7693774|NCT00377637|12113770|FG002|Induction Phase|Deterioration/serum creatinine|0
7693775|NCT00377637|12113771|FG003|Induction Phase|Deterioration/serum creatinine|0
7693776|NCT00377637|12113768|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
7693777|NCT00377637|12113769|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
7693778|NCT00377637|12113770|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
7693779|NCT00377637|12113771|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
7693780|NCT00377637|12113768|FG000|Induction Phase|Lost to Follow-up|2
7693781|NCT00377637|12113769|FG001|Induction Phase|Lost to Follow-up|1
7693782|NCT00377637|12113770|FG002|Induction Phase|Lost to Follow-up|0
7693783|NCT00377637|12113771|FG003|Induction Phase|Lost to Follow-up|0
7693784|NCT00377637|12113768|FG000|Induction Phase|Death|1
7693785|NCT00377637|12113769|FG001|Induction Phase|Death|3
7693786|NCT00377637|12113770|FG002|Induction Phase|Death|0
7693787|NCT00377637|12113771|FG003|Induction Phase|Death|0
7693788|NCT00377637|12113768|FG000|Induction Phase|Withdrawal by Subject|5
7693789|NCT00377637|12113769|FG001|Induction Phase|Withdrawal by Subject|6
7693790|NCT00377637|12113770|FG002|Induction Phase|Withdrawal by Subject|0
7693791|NCT00377637|12113771|FG003|Induction Phase|Withdrawal by Subject|0
7693792|NCT00377637|12113768|FG000|Induction Phase|Physician Decision|3
7693793|NCT00377637|12113769|FG001|Induction Phase|Physician Decision|1
7693794|NCT00377637|12113770|FG002|Induction Phase|Physician Decision|0
7693795|NCT00377637|12113771|FG003|Induction Phase|Physician Decision|0
7693796|NCT00377637|12113768|FG000|Induction Phase|Sponsor decision|1
7693797|NCT00377637|12113769|FG001|Induction Phase|Sponsor decision|2
7693798|NCT00377637|12113770|FG002|Induction Phase|Sponsor decision|0
7693799|NCT00377637|12113771|FG003|Induction Phase|Sponsor decision|0
7693800|NCT00377637|12113768|FG000|Induction Phase|Non-Compliance|1
7693801|NCT00377637|12113769|FG001|Induction Phase|Non-Compliance|0
7693802|NCT00377637|12113770|FG002|Induction Phase|Non-Compliance|0
7693803|NCT00377637|12113771|FG003|Induction Phase|Non-Compliance|0
7693804|NCT00377637|12113768|FG000|Induction Phase|Reason for withdrawal is not noted|2
7693805|NCT00377637|12113769|FG001|Induction Phase|Reason for withdrawal is not noted|0
7693806|NCT00377637|12113770|FG002|Induction Phase|Reason for withdrawal is not noted|0
7693807|NCT00377637|12113771|FG003|Induction Phase|Reason for withdrawal is not noted|0
7693808|NCT00377637|12113768|FG000|Maintenance Phase|Adverse Event|0
7693809|NCT00377637|12113769|FG001|Maintenance Phase|Adverse Event|0
7693810|NCT00377637|12113770|FG002|Maintenance Phase|Adverse Event|29
7693811|NCT00377637|12113771|FG003|Maintenance Phase|Adverse Event|43
7693812|NCT00377637|12113768|FG000|Maintenance Phase|Physician Decision|0
7693813|NCT00377637|12113769|FG001|Maintenance Phase|Physician Decision|0
7693814|NCT00377637|12113770|FG002|Maintenance Phase|Physician Decision|5
7693815|NCT00377637|12113771|FG003|Maintenance Phase|Physician Decision|4
7693816|NCT00377637|12113768|FG000|Maintenance Phase|Lost to Follow-up|0
7693817|NCT00377637|12113769|FG001|Maintenance Phase|Lost to Follow-up|0
7693818|NCT00377637|12113770|FG002|Maintenance Phase|Lost to Follow-up|3
7693819|NCT00377637|12113771|FG003|Maintenance Phase|Lost to Follow-up|1
7693820|NCT00377637|12113768|FG000|Maintenance Phase|Withdrawal by Subject|0
7693821|NCT00377637|12113769|FG001|Maintenance Phase|Withdrawal by Subject|0
7693822|NCT00377637|12113770|FG002|Maintenance Phase|Withdrawal by Subject|3
7693823|NCT00377637|12113771|FG003|Maintenance Phase|Withdrawal by Subject|3
7693824|NCT00377637|12113768|FG000|Maintenance Phase|Sponsor decision|0
7693825|NCT00377637|12113769|FG001|Maintenance Phase|Sponsor decision|0
7693826|NCT00377637|12113770|FG002|Maintenance Phase|Sponsor decision|2
7693827|NCT00377637|12113771|FG003|Maintenance Phase|Sponsor decision|3
7693828|NCT00377637|12113768|FG000|Maintenance Phase|Non-compliance|0
7693829|NCT00377637|12113769|FG001|Maintenance Phase|Non-compliance|0
7693830|NCT00377637|12113770|FG002|Maintenance Phase|Non-compliance|1
7693831|NCT00377637|12113771|FG003|Maintenance Phase|Non-compliance|1
7693832|NCT00377637|12113768|FG000|Maintenance Phase|Study medication stopped > 14 days|0
7693833|NCT00377637|12113769|FG001|Maintenance Phase|Study medication stopped > 14 days|0
7693834|NCT00377637|12113770|FG002|Maintenance Phase|Study medication stopped > 14 days|0
7693835|NCT00377637|12113771|FG003|Maintenance Phase|Study medication stopped > 14 days|1
7693836|NCT00377637|12113768|FG000|Maintenance Phase|Death|0
7693837|NCT00377637|12113769|FG001|Maintenance Phase|Death|0
7693838|NCT00377637|12113770|FG002|Maintenance Phase|Death|0
7693839|NCT00377637|12113771|FG003|Maintenance Phase|Death|1
7693840|NCT00377676|12113787|FG000|Overall Study|Adverse Event|498
7693841|NCT00377676|12113788|FG001|Overall Study|Adverse Event|107
7693842|NCT00377676|12113787|FG000|Overall Study|Protocol Violation|33
7693843|NCT00377676|12113788|FG001|Overall Study|Protocol Violation|27
7693844|NCT00377676|12113787|FG000|Overall Study|Death|5
7693845|NCT00377676|12113788|FG001|Overall Study|Death|2
7693846|NCT00377676|12113787|FG000|Overall Study|Withdrawal by Subject|187
7693847|NCT00377676|12113788|FG001|Overall Study|Withdrawal by Subject|72
7693848|NCT00377676|12113787|FG000|Overall Study|Lost to Follow-up|120
7693849|NCT00377676|12113788|FG001|Overall Study|Lost to Follow-up|56
7693850|NCT00377676|12113787|FG000|Overall Study|Other|118
7693851|NCT00377676|12113788|FG001|Overall Study|Other|58
7693852|NCT00377819|12113805|FG000|Overall Study|Adverse Event|2
7693853|NCT00377819|12113806|FG001|Overall Study|Adverse Event|3
7693854|NCT00377819|12113805|FG000|Overall Study|Withdrawal by Subject|10
7693855|NCT00377819|12113806|FG001|Overall Study|Withdrawal by Subject|4
7693856|NCT00377819|12113805|FG000|Overall Study|Death|0
7693857|NCT00377819|12113806|FG001|Overall Study|Death|1
7693858|NCT00377819|12113805|FG000|Overall Study|Lost to Follow-up|0
7693859|NCT00377819|12113806|FG001|Overall Study|Lost to Follow-up|1
7693860|NCT00377819|12113805|FG000|Overall Study|Protocol Violation|1
7693861|NCT00377819|12113806|FG001|Overall Study|Protocol Violation|1
7693862|NCT00377858|12113826|FG000|Overall Study|Withdrawal by Subject|12
7693863|NCT00377858|12113827|FG001|Overall Study|Withdrawal by Subject|11
7693864|NCT00377858|12113826|FG000|Overall Study|Lost to Follow-up|6
7693865|NCT00377858|12113827|FG001|Overall Study|Lost to Follow-up|1
7693866|NCT00377858|12113826|FG000|Overall Study|Physician Decision|5
7693867|NCT00377858|12113827|FG001|Overall Study|Physician Decision|5
7693868|NCT00377858|12113826|FG000|Overall Study|Protocol Violation|3
7693869|NCT00377858|12113827|FG001|Overall Study|Protocol Violation|4
7693870|NCT00377858|12113826|FG000|Overall Study|Adverse Event|2
7693871|NCT00377858|12113827|FG001|Overall Study|Adverse Event|1
7693872|NCT00377858|12113826|FG000|Overall Study|Entry Criteria Not Met|2
7693873|NCT00377858|12113827|FG001|Overall Study|Entry Criteria Not Met|0
7693874|NCT00377858|12113826|FG000|Overall Study|Sponsor Decision|1
7693875|NCT00377858|12113827|FG001|Overall Study|Sponsor Decision|2
7693876|NCT00377858|12113826|FG000|Overall Study|Death|0
7693877|NCT00377858|12113827|FG001|Overall Study|Death|3
7693878|NCT00377962|12113835|FG000|Core Study: 0-12 Months|Adverse Event|18
7693879|NCT00377962|12113836|FG001|Core Study: 0-12 Months|Adverse Event|2
7693880|NCT00377962|12113835|FG000|Core Study: 0-12 Months|Death|3
7693881|NCT00377962|12113836|FG001|Core Study: 0-12 Months|Death|0
7693882|NCT00377962|12113835|FG000|Core Study: 0-12 Months|Withdrew Consent|5
7693883|NCT00377962|12113836|FG001|Core Study: 0-12 Months|Withdrew Consent|2
7693884|NCT00377962|12113835|FG000|Core Study: 0-12 Months|Administrative Reason|1
7693885|NCT00377962|12113836|FG001|Core Study: 0-12 Months|Administrative Reason|1
7693886|NCT00377962|12113835|FG000|Core Study: 0-12 Months|Unspecified reasons|1
7693887|NCT00377962|12113836|FG001|Core Study: 0-12 Months|Unspecified reasons|4
7693888|NCT00377962|12113835|FG000|Extension Study: 12-24 Months|Death|1
7693889|NCT00377962|12113836|FG001|Extension Study: 12-24 Months|Death|1
7693890|NCT00377962|12113835|FG000|Extension Study: 12-24 Months|Adverse Event|8
7693891|NCT00377962|12113836|FG001|Extension Study: 12-24 Months|Adverse Event|0
7693892|NCT00377962|12113835|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1
7693893|NCT00377962|12113836|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0
7693894|NCT00377962|12113835|FG000|Extension Study: 12-24 Months|Unspecified reason|0
7693895|NCT00377962|12113836|FG001|Extension Study: 12-24 Months|Unspecified reason|3
7693896|NCT00378014|12113850|FG000|Core (Randomization to Month 11)|Adverse Event|1
7693897|NCT00378014|12113851|FG001|Core (Randomization to Month 11)|Adverse Event|0
7693898|NCT00378014|12113850|FG000|Core (Randomization to Month 11)|Graft loss|1
7693899|NCT00378014|12113851|FG001|Core (Randomization to Month 11)|Graft loss|2
7693900|NCT00378014|12113850|FG000|Core (Randomization to Month 11)|Death|5
7693901|NCT00378014|12113851|FG001|Core (Randomization to Month 11)|Death|3
7693902|NCT00378014|12113850|FG000|Core (Randomization to Month 11)|Administrative Problems|2
7693903|NCT00378014|12113851|FG001|Core (Randomization to Month 11)|Administrative Problems|2
7693904|NCT00378014|12113850|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0
7693905|NCT00378014|12113851|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1
7693906|NCT00378014|12113850|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5
7693907|NCT00378014|12113851|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2
7693908|NCT00378014|12113850|FG000|Core (Randomization to Month 11)|Protocol deviation|0
7693909|NCT00378014|12113851|FG001|Core (Randomization to Month 11)|Protocol deviation|1
7693910|NCT00378014|12113850|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0
7693911|NCT00378014|12113851|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1
7693912|NCT00378014|12113850|FG000|Extension (Month 12 to Month 59)|Adverse Event|8
7693913|NCT00378014|12113851|FG001|Extension (Month 12 to Month 59)|Adverse Event|7
7693914|NCT00378014|12113850|FG000|Extension (Month 12 to Month 59)|Death|1
7693915|NCT00378014|12113851|FG001|Extension (Month 12 to Month 59)|Death|2
7693916|NCT00378014|12113850|FG000|Extension (Month 12 to Month 59)|Administrative problems|1
7693917|NCT00378014|12113851|FG001|Extension (Month 12 to Month 59)|Administrative problems|0
7693918|NCT00378014|12113850|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1
7693919|NCT00378014|12113851|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1
7693920|NCT00378014|12113850|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
7693921|NCT00378014|12113851|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
7693922|NCT00378014|12113850|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3
7693923|NCT00378014|12113851|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1
7693924|NCT00378079|12113862|FG000|Overall Study|Lost to Follow-up|6
7693925|NCT00378079|12113863|FG001|Overall Study|Lost to Follow-up|1
7693926|NCT00378079|12113864|FG002|Overall Study|Lost to Follow-up|0
7693927|NCT00378105|12113874|FG000|Overall Study|Adverse Event|3
7693928|NCT00378105|12113875|FG001|Overall Study|Adverse Event|1
7693929|NCT00378105|12113874|FG000|Overall Study|Withdrawal by Subject|3
7693930|NCT00378105|12113875|FG001|Overall Study|Withdrawal by Subject|3
7693931|NCT00378105|12113874|FG000|Overall Study|Death|1
7693932|NCT00378105|12113875|FG001|Overall Study|Death|0
7693933|NCT00378105|12113874|FG000|Overall Study|Going to transplant|7
7693934|NCT00378105|12113875|FG001|Overall Study|Going to transplant|8
7693935|NCT00378105|12113874|FG000|Overall Study|Progressive disease|3
7693936|NCT00378105|12113875|FG001|Overall Study|Progressive disease|3
7693937|NCT00378105|12113874|FG000|Overall Study|remain on study|3
7693938|NCT00378105|12113875|FG001|Overall Study|remain on study|11
7693939|NCT00378105|12113874|FG000|Overall Study|Physician Decision|0
7693940|NCT00378105|12113875|FG001|Overall Study|Physician Decision|2
7693941|NCT00378105|12113874|FG000|Overall Study|Going non-protocol therapy|0
7693942|NCT00378105|12113875|FG001|Overall Study|Going non-protocol therapy|1
7693943|NCT00378105|12113874|FG000|Overall Study|necessity to increase lenalidomide dose|0
7693944|NCT00378105|12113875|FG001|Overall Study|necessity to increase lenalidomide dose|1
7693945|NCT00378209|12113882|FG000|Overall Study|Progressive disease|11
7693946|NCT00378209|12113882|FG000|Overall Study|Adverse Event|3
7693947|NCT00378209|12113882|FG000|Overall Study|Initiation of non-protocol therapy|3
7693948|NCT00378209|12113882|FG000|Overall Study|Physician Decision|3
7693949|NCT00378209|12113882|FG000|Overall Study|Death|1
7693950|NCT00378209|12113882|FG000|Overall Study|Treatment delay|1
7693951|NCT00378508|12113910|FG000|Overall Study|Withdrawal by Subject|1
7693952|NCT00378508|12113911|FG001|Overall Study|Withdrawal by Subject|3
7693953|NCT00378508|12113910|FG000|Overall Study|Lost to Follow-up|1
7693954|NCT00378508|12113911|FG001|Overall Study|Lost to Follow-up|0
7693955|NCT00378534|12113920|FG000|Overall Study|Participants did not receive transplant|3
7693956|NCT00378534|12113921|FG001|Overall Study|Participants did not receive transplant|0
7693957|NCT00378560|12113928|FG000|Overall Study|Adverse Event|1
7693958|NCT00378560|12113929|FG001|Overall Study|Adverse Event|0
7693959|NCT00378560|12113928|FG000|Overall Study|Lost to Follow-up|24
7693960|NCT00378560|12113929|FG001|Overall Study|Lost to Follow-up|29
7693961|NCT00378560|12113928|FG000|Overall Study|Protocol Violation|2
7693962|NCT00378560|12113929|FG001|Overall Study|Protocol Violation|0
7693963|NCT00378560|12113928|FG000|Overall Study|Withdrawal by Subject|17
7693964|NCT00378560|12113929|FG001|Overall Study|Withdrawal by Subject|21
7693965|NCT00378560|12113928|FG000|Overall Study|Moved|4
7693966|NCT00378560|12113929|FG001|Overall Study|Moved|3
7693967|NCT00378560|12113928|FG000|Overall Study|Pregnancy|7
7693968|NCT00378560|12113929|FG001|Overall Study|Pregnancy|5
7693969|NCT00378560|12113928|FG000|Overall Study|Laboratory test values abnormal|1
7693970|NCT00378560|12113929|FG001|Overall Study|Laboratory test values abnormal|0
7693971|NCT00378573|12113935|FG000|Treatment Period|Adverse Event|9
7693972|NCT00378573|12113935|FG000|Treatment Period|Physician Decision|1
7693973|NCT00378573|12113935|FG000|Treatment Period|Withdrawal by Subject|2
7693974|NCT00378573|12113935|FG000|Treatment Period|Disease Progression|4
7693975|NCT00378573|12113935|FG000|Treatment Period|Sponsor decision to close study|1
7693976|NCT00378573|12113935|FG000|Follow-up|Death|12
7693977|NCT00378573|12113935|FG000|Follow-up|Lost to Follow-up|1
7693978|NCT00378573|12113935|FG000|Follow-up|Withdrawal by Subject|1
7693979|NCT00378599|12113939|FG000|Overall Study|Adverse Event|38
7693980|NCT00378599|12113939|FG000|Overall Study|Protocol Violation|2
7693981|NCT00378599|12113939|FG000|Overall Study|Treatment failure|7
7693982|NCT00378599|12113939|FG000|Overall Study|Withdrawal by Subject|5
7693983|NCT00378703|12113947|FG000|Overall Study|Disease progression|59
7693984|NCT00378703|12113948|FG001|Overall Study|Disease progression|43
7693985|NCT00378703|12113949|FG002|Overall Study|Disease progression|48
7693986|NCT00378703|12113950|FG003|Overall Study|Disease progression|49
7693987|NCT00378703|12113947|FG000|Overall Study|Adverse Event|11
7693988|NCT00378703|12113948|FG001|Overall Study|Adverse Event|17
7693989|NCT00378703|12113949|FG002|Overall Study|Adverse Event|20
7693990|NCT00378703|12113950|FG003|Overall Study|Adverse Event|18
7693991|NCT00378703|12113947|FG000|Overall Study|Death|2
7693992|NCT00378703|12113948|FG001|Overall Study|Death|2
7693993|NCT00378703|12113949|FG002|Overall Study|Death|4
7693994|NCT00378703|12113950|FG003|Overall Study|Death|3
7693995|NCT00378703|12113947|FG000|Overall Study|Withdrawal by Subject|4
7693996|NCT00378703|12113948|FG001|Overall Study|Withdrawal by Subject|8
7693997|NCT00378703|12113949|FG002|Overall Study|Withdrawal by Subject|5
7693998|NCT00378703|12113950|FG003|Overall Study|Withdrawal by Subject|7
7693999|NCT00378703|12113947|FG000|Overall Study|Physician Decision|1
7694000|NCT00378703|12113948|FG001|Overall Study|Physician Decision|4
7694001|NCT00378703|12113949|FG002|Overall Study|Physician Decision|1
7694002|NCT00378703|12113950|FG003|Overall Study|Physician Decision|0
7694003|NCT00378703|12113947|FG000|Overall Study|Alternative therapy|4
7694004|NCT00378703|12113948|FG001|Overall Study|Alternative therapy|2
7694005|NCT00378703|12113949|FG002|Overall Study|Alternative therapy|0
7694006|NCT00378703|12113950|FG003|Overall Study|Alternative therapy|0
7694007|NCT00378703|12113947|FG000|Overall Study|Other complicated disease|0
7694008|NCT00378703|12113948|FG001|Overall Study|Other complicated disease|2
7694009|NCT00378703|12113949|FG002|Overall Study|Other complicated disease|2
7694010|NCT00378703|12113950|FG003|Overall Study|Other complicated disease|0
7694011|NCT00378703|12113947|FG000|Overall Study|Symptomatic deterioration|0
7694012|NCT00378703|12113948|FG001|Overall Study|Symptomatic deterioration|1
7694013|NCT00378703|12113949|FG002|Overall Study|Symptomatic deterioration|0
7694014|NCT00378703|12113950|FG003|Overall Study|Symptomatic deterioration|2
7694015|NCT00378703|12113947|FG000|Overall Study|Surgery|1
7694016|NCT00378703|12113948|FG001|Overall Study|Surgery|0
7694017|NCT00378703|12113949|FG002|Overall Study|Surgery|0
7694018|NCT00378703|12113950|FG003|Overall Study|Surgery|1
7694019|NCT00378703|12113947|FG000|Overall Study|Joint decision of physician and patient|1
7694020|NCT00378703|12113948|FG001|Overall Study|Joint decision of physician and patient|0
7694021|NCT00378703|12113949|FG002|Overall Study|Joint decision of physician and patient|0
7694022|NCT00378703|12113950|FG003|Overall Study|Joint decision of physician and patient|0
7694023|NCT00378703|12113947|FG000|Overall Study|Adverse events and progressive disease|0
7694024|NCT00378703|12113948|FG001|Overall Study|Adverse events and progressive disease|0
7694025|NCT00378703|12113949|FG002|Overall Study|Adverse events and progressive disease|0
7694026|NCT00378703|12113950|FG003|Overall Study|Adverse events and progressive disease|1
7694027|NCT00378703|12113947|FG000|Overall Study|Relocation|0
7694028|NCT00378703|12113948|FG001|Overall Study|Relocation|0
7694029|NCT00378703|12113949|FG002|Overall Study|Relocation|1
7694030|NCT00378703|12113950|FG003|Overall Study|Relocation|0
7694031|NCT00378703|12113947|FG000|Overall Study|Ineligible|4
7694032|NCT00378703|12113948|FG001|Overall Study|Ineligible|7
7694033|NCT00378703|12113949|FG002|Overall Study|Ineligible|7
7694034|NCT00378703|12113950|FG003|Overall Study|Ineligible|7
7694035|NCT00378703|12113947|FG000|Overall Study|Never started treatment|1
7694036|NCT00378703|12113948|FG001|Overall Study|Never started treatment|4
7694037|NCT00378703|12113949|FG002|Overall Study|Never started treatment|0
7694038|NCT00378703|12113950|FG003|Overall Study|Never started treatment|0
7694039|NCT00378703|12113947|FG000|Overall Study|Other|1
7694040|NCT00378703|12113948|FG001|Overall Study|Other|1
7694041|NCT00378703|12113949|FG002|Overall Study|Other|2
7694042|NCT00378703|12113950|FG003|Overall Study|Other|3
7694043|NCT00378898|12113962|FG000|Overall Study|Withdrawal by Subject|10
7694044|NCT00378898|12113963|FG001|Overall Study|Withdrawal by Subject|5
7694045|NCT00378898|12113962|FG000|Overall Study|Protocol Violation|1
7694046|NCT00378898|12113963|FG001|Overall Study|Protocol Violation|1
7694047|NCT00379080|12113974|FG000|Overall Study|Withdrawal by Subject|0
7694048|NCT00379080|12113975|FG001|Overall Study|Withdrawal by Subject|4
7694049|NCT00379080|12113976|FG002|Overall Study|Withdrawal by Subject|0
7694050|NCT00379210|12114015|FG000|Overall Study|Withdrawal by Subject|10
7694051|NCT00379210|12114016|FG001|Overall Study|Withdrawal by Subject|7
7694052|NCT00379236|12114024|FG000|Double-blind|Adverse Event|11
7694053|NCT00379236|12114025|FG001|Double-blind|Adverse Event|6
7694054|NCT00379236|12114026|FG002|Double-blind|Adverse Event|0
7694055|NCT00379236|12114024|FG000|Double-blind|Protocol Violation|3
7694056|NCT00379236|12114025|FG001|Double-blind|Protocol Violation|3
7694057|NCT00379236|12114026|FG002|Double-blind|Protocol Violation|0
7694058|NCT00379236|12114024|FG000|Double-blind|Withdrawal by Subject|12
7694059|NCT00379236|12114025|FG001|Double-blind|Withdrawal by Subject|13
7694060|NCT00379236|12114026|FG002|Double-blind|Withdrawal by Subject|0
7694061|NCT00379236|12114024|FG000|Double-blind|Lost to Follow-up|4
7694062|NCT00379236|12114025|FG001|Double-blind|Lost to Follow-up|3
7694063|NCT00379236|12114026|FG002|Double-blind|Lost to Follow-up|0
7694064|NCT00379236|12114024|FG000|Double-blind|Use of exclusionary medication|1
7694065|NCT00379236|12114025|FG001|Double-blind|Use of exclusionary medication|2
7694066|NCT00379236|12114026|FG002|Double-blind|Use of exclusionary medication|0
7694067|NCT00379236|12114024|FG000|Double-blind|Other|3
7694068|NCT00379236|12114025|FG001|Double-blind|Other|7
7694069|NCT00379236|12114026|FG002|Double-blind|Other|0
7694070|NCT00379236|12114024|FG000|Double-blind|Data could not be retrieved|2
7694071|NCT00379236|12114025|FG001|Double-blind|Data could not be retrieved|2
7694072|NCT00379236|12114026|FG002|Double-blind|Data could not be retrieved|0
7694073|NCT00379236|12114024|FG000|Open-label Extension|Adverse Event|0
7694074|NCT00379236|12114025|FG001|Open-label Extension|Adverse Event|0
7694075|NCT00379236|12114026|FG002|Open-label Extension|Adverse Event|13
7694076|NCT00379236|12114024|FG000|Open-label Extension|Protocol Violation|0
7694077|NCT00379236|12114025|FG001|Open-label Extension|Protocol Violation|0
7694078|NCT00379236|12114026|FG002|Open-label Extension|Protocol Violation|7
7694079|NCT00379236|12114024|FG000|Open-label Extension|Withdrawal by Subject|0
7694080|NCT00379236|12114025|FG001|Open-label Extension|Withdrawal by Subject|0
7694081|NCT00379236|12114026|FG002|Open-label Extension|Withdrawal by Subject|13
7694082|NCT00379236|12114024|FG000|Open-label Extension|Lost to Follow-up|0
7694083|NCT00379236|12114025|FG001|Open-label Extension|Lost to Follow-up|0
7694084|NCT00379236|12114026|FG002|Open-label Extension|Lost to Follow-up|12
7694085|NCT00379236|12114024|FG000|Open-label Extension|Use of exclusionary medication|0
7694086|NCT00379236|12114025|FG001|Open-label Extension|Use of exclusionary medication|0
7694087|NCT00379236|12114026|FG002|Open-label Extension|Use of exclusionary medication|3
7694088|NCT00379236|12114024|FG000|Open-label Extension|Other|0
7694089|NCT00379236|12114025|FG001|Open-label Extension|Other|0
7694090|NCT00379236|12114026|FG002|Open-label Extension|Other|7
7694091|NCT00379353|12114040|FG000|Overall Study|Hospitalization|3
7694092|NCT00379353|12114041|FG001|Overall Study|Hospitalization|3
7694093|NCT00379353|12114040|FG000|Overall Study|Withdrawal by Subject|5
7694094|NCT00379353|12114041|FG001|Overall Study|Withdrawal by Subject|2
7694095|NCT00379353|12114040|FG000|Overall Study|Death|1
7694096|NCT00379353|12114041|FG001|Overall Study|Death|0
7694097|NCT00379353|12114040|FG000|Overall Study|Cardiac Tamponade|1
7694098|NCT00379353|12114041|FG001|Overall Study|Cardiac Tamponade|0
7694099|NCT00379353|12114040|FG000|Overall Study|Non-compliance|1
7694100|NCT00379353|12114041|FG001|Overall Study|Non-compliance|0
7694101|NCT00379353|12114040|FG000|Overall Study|Conflicting drug treatment|0
7694102|NCT00379353|12114041|FG001|Overall Study|Conflicting drug treatment|1
7694103|NCT00379587|12114061|FG000|Overall Study|Lost to Follow-up|2
7694104|NCT00379639|12114070|FG000|Overall Study|Disease Progression|3
7694105|NCT00379639|12114071|FG001|Overall Study|Disease Progression|3
7694106|NCT00379639|12114072|FG002|Overall Study|Disease Progression|3
7694107|NCT00379639|12114073|FG003|Overall Study|Disease Progression|4
7694108|NCT00379639|12114074|FG004|Overall Study|Disease Progression|4
7694109|NCT00379639|12114070|FG000|Overall Study|Physician Decision|0
7694110|NCT00379639|12114071|FG001|Overall Study|Physician Decision|2
7694111|NCT00379639|12114072|FG002|Overall Study|Physician Decision|1
7694112|NCT00379639|12114073|FG003|Overall Study|Physician Decision|1
7694113|NCT00379639|12114074|FG004|Overall Study|Physician Decision|0
7694114|NCT00379639|12114070|FG000|Overall Study|Symptomatic Deterioration|0
7694115|NCT00379639|12114071|FG001|Overall Study|Symptomatic Deterioration|0
7694116|NCT00379639|12114072|FG002|Overall Study|Symptomatic Deterioration|1
7694117|NCT00379639|12114073|FG003|Overall Study|Symptomatic Deterioration|0
7694118|NCT00379639|12114074|FG004|Overall Study|Symptomatic Deterioration|1
7694119|NCT00379639|12114070|FG000|Overall Study|Adverse Event|0
7694120|NCT00379639|12114071|FG001|Overall Study|Adverse Event|0
7694121|NCT00379639|12114072|FG002|Overall Study|Adverse Event|1
7694122|NCT00379639|12114073|FG003|Overall Study|Adverse Event|0
7694123|NCT00379639|12114074|FG004|Overall Study|Adverse Event|1
7694124|NCT00379639|12114070|FG000|Overall Study|Lost to Follow-up|0
7694125|NCT00379639|12114071|FG001|Overall Study|Lost to Follow-up|0
7694126|NCT00379639|12114072|FG002|Overall Study|Lost to Follow-up|0
7694127|NCT00379639|12114073|FG003|Overall Study|Lost to Follow-up|1
7694128|NCT00379639|12114074|FG004|Overall Study|Lost to Follow-up|0
7694129|NCT00379639|12114070|FG000|Overall Study|Other|0
7694130|NCT00379639|12114071|FG001|Overall Study|Other|0
7694131|NCT00379639|12114072|FG002|Overall Study|Other|3
7694132|NCT00379639|12114073|FG003|Overall Study|Other|0
7694133|NCT00379639|12114074|FG004|Overall Study|Other|0
7694134|NCT00379769|12114090|FG000|Main Study|Death|57
7694135|NCT00379769|12114091|FG001|Main Study|Death|67
7694136|NCT00379769|12114092|FG002|Main Study|Death|54
7694137|NCT00379769|12114093|FG003|Main Study|Death|72
7694138|NCT00379769|12114094|FG004|Main Study|Death|0
7694139|NCT00379769|12114095|FG005|Main Study|Death|0
7694140|NCT00379769|12114090|FG000|Main Study|Adverse Event|5
7694141|NCT00379769|12114091|FG001|Main Study|Adverse Event|8
7694142|NCT00379769|12114092|FG002|Main Study|Adverse Event|10
7694143|NCT00379769|12114093|FG003|Main Study|Adverse Event|11
7694144|NCT00379769|12114094|FG004|Main Study|Adverse Event|0
7694145|NCT00379769|12114095|FG005|Main Study|Adverse Event|0
7694146|NCT00379769|12114090|FG000|Main Study|Lost to Follow-up|29
7694147|NCT00379769|12114091|FG001|Main Study|Lost to Follow-up|29
7694148|NCT00379769|12114092|FG002|Main Study|Lost to Follow-up|25
7694149|NCT00379769|12114093|FG003|Main Study|Lost to Follow-up|26
7694150|NCT00379769|12114094|FG004|Main Study|Lost to Follow-up|0
7694151|NCT00379769|12114095|FG005|Main Study|Lost to Follow-up|0
7694152|NCT00379769|12114090|FG000|Main Study|Withdrawal by Subject|46
7694153|NCT00379769|12114091|FG001|Main Study|Withdrawal by Subject|56
7694154|NCT00379769|12114092|FG002|Main Study|Withdrawal by Subject|72
7694155|NCT00379769|12114093|FG003|Main Study|Withdrawal by Subject|70
7694156|NCT00379769|12114094|FG004|Main Study|Withdrawal by Subject|0
7694157|NCT00379769|12114095|FG005|Main Study|Withdrawal by Subject|0
7694158|NCT00379769|12114090|FG000|Main Study|Moved to survival status follow-up only|27
7694159|NCT00379769|12114091|FG001|Main Study|Moved to survival status follow-up only|25
7694160|NCT00379769|12114092|FG002|Main Study|Moved to survival status follow-up only|32
7694161|NCT00379769|12114093|FG003|Main Study|Moved to survival status follow-up only|36
7694162|NCT00379769|12114094|FG004|Main Study|Moved to survival status follow-up only|0
7694163|NCT00379769|12114095|FG005|Main Study|Moved to survival status follow-up only|0
7694164|NCT00379769|12114090|FG000|Main Study|Participant moved|3
7694165|NCT00379769|12114091|FG001|Main Study|Participant moved|2
7694166|NCT00379769|12114092|FG002|Main Study|Participant moved|3
7694167|NCT00379769|12114093|FG003|Main Study|Participant moved|3
7694168|NCT00379769|12114094|FG004|Main Study|Participant moved|0
7694169|NCT00379769|12114095|FG005|Main Study|Participant moved|0
7694170|NCT00379769|12114090|FG000|Main Study|Poor compliance|3
7694171|NCT00379769|12114091|FG001|Main Study|Poor compliance|2
7694172|NCT00379769|12114092|FG002|Main Study|Poor compliance|2
7694173|NCT00379769|12114093|FG003|Main Study|Poor compliance|1
7694174|NCT00379769|12114094|FG004|Main Study|Poor compliance|0
7694175|NCT00379769|12114095|FG005|Main Study|Poor compliance|0
7694176|NCT00379769|12114090|FG000|Main Study|Prohibited glucose lowering medication|0
7694177|NCT00379769|12114091|FG001|Main Study|Prohibited glucose lowering medication|3
7694178|NCT00379769|12114092|FG002|Main Study|Prohibited glucose lowering medication|0
7694179|NCT00379769|12114093|FG003|Main Study|Prohibited glucose lowering medication|1
7694180|NCT00379769|12114094|FG004|Main Study|Prohibited glucose lowering medication|0
7694181|NCT00379769|12114095|FG005|Main Study|Prohibited glucose lowering medication|0
7694182|NCT00379769|12114090|FG000|Main Study|Site closed|4
7694183|NCT00379769|12114091|FG001|Main Study|Site closed|4
7694184|NCT00379769|12114092|FG002|Main Study|Site closed|4
7694185|NCT00379769|12114093|FG003|Main Study|Site closed|8
7694186|NCT00379769|12114094|FG004|Main Study|Site closed|0
7694187|NCT00379769|12114095|FG005|Main Study|Site closed|0
7694188|NCT00379769|12114090|FG000|Main Study|Entry criteria violation|0
7694189|NCT00379769|12114091|FG001|Main Study|Entry criteria violation|0
7694190|NCT00379769|12114092|FG002|Main Study|Entry criteria violation|1
7694191|NCT00379769|12114093|FG003|Main Study|Entry criteria violation|1
7694192|NCT00379769|12114094|FG004|Main Study|Entry criteria violation|0
7694193|NCT00379769|12114095|FG005|Main Study|Entry criteria violation|0
7694194|NCT00379769|12114090|FG000|Main Study|Participant did not take study drug|0
7694195|NCT00379769|12114091|FG001|Main Study|Participant did not take study drug|0
7694196|NCT00379769|12114092|FG002|Main Study|Participant did not take study drug|1
7694197|NCT00379769|12114093|FG003|Main Study|Participant did not take study drug|0
7694198|NCT00379769|12114094|FG004|Main Study|Participant did not take study drug|0
7694199|NCT00379769|12114095|FG005|Main Study|Participant did not take study drug|0
7694200|NCT00379769|12114090|FG000|Main Study|Physician Decision|2
7694201|NCT00379769|12114091|FG001|Main Study|Physician Decision|2
7694202|NCT00379769|12114092|FG002|Main Study|Physician Decision|1
7694203|NCT00379769|12114093|FG003|Main Study|Physician Decision|1
7694204|NCT00379769|12114094|FG004|Main Study|Physician Decision|0
7694205|NCT00379769|12114095|FG005|Main Study|Physician Decision|0
7694206|NCT00379769|12114090|FG000|Main Study|Participant completed study at visit 27|1
7694207|NCT00379769|12114091|FG001|Main Study|Participant completed study at visit 27|0
7694208|NCT00379769|12114092|FG002|Main Study|Participant completed study at visit 27|0
7694209|NCT00379769|12114093|FG003|Main Study|Participant completed study at visit 27|0
7694210|NCT00379769|12114094|FG004|Main Study|Participant completed study at visit 27|0
7694211|NCT00379769|12114095|FG005|Main Study|Participant completed study at visit 27|0
7694212|NCT00379769|12114090|FG000|Main Study|Personal reasons|1
7694213|NCT00379769|12114091|FG001|Main Study|Personal reasons|0
7694214|NCT00379769|12114092|FG002|Main Study|Personal reasons|0
7694215|NCT00379769|12114093|FG003|Main Study|Personal reasons|0
7694216|NCT00379769|12114094|FG004|Main Study|Personal reasons|0
7694217|NCT00379769|12114095|FG005|Main Study|Personal reasons|0
7694218|NCT00379769|12114090|FG000|Main Study|Risk of heart failure|0
7694219|NCT00379769|12114091|FG001|Main Study|Risk of heart failure|1
7694220|NCT00379769|12114092|FG002|Main Study|Risk of heart failure|0
7694221|NCT00379769|12114093|FG003|Main Study|Risk of heart failure|0
7694222|NCT00379769|12114094|FG004|Main Study|Risk of heart failure|0
7694223|NCT00379769|12114095|FG005|Main Study|Risk of heart failure|0
7694224|NCT00379769|12114090|FG000|Main Study|Investigator refused to log temperature|0
7694225|NCT00379769|12114091|FG001|Main Study|Investigator refused to log temperature|0
7694226|NCT00379769|12114092|FG002|Main Study|Investigator refused to log temperature|1
7694227|NCT00379769|12114093|FG003|Main Study|Investigator refused to log temperature|0
7694228|NCT00379769|12114094|FG004|Main Study|Investigator refused to log temperature|0
7694229|NCT00379769|12114095|FG005|Main Study|Investigator refused to log temperature|0
7694230|NCT00379769|12114090|FG000|Main Study|Reason unspecified|0
7694231|NCT00379769|12114091|FG001|Main Study|Reason unspecified|0
7694232|NCT00379769|12114092|FG002|Main Study|Reason unspecified|1
7694233|NCT00379769|12114093|FG003|Main Study|Reason unspecified|0
7694234|NCT00379769|12114094|FG004|Main Study|Reason unspecified|0
7694235|NCT00379769|12114095|FG005|Main Study|Reason unspecified|0
7694236|NCT00379769|12114090|FG000|Observational Follow-up|Death|0
7694237|NCT00379769|12114091|FG001|Observational Follow-up|Death|0
7694238|NCT00379769|12114092|FG002|Observational Follow-up|Death|0
7694239|NCT00379769|12114093|FG003|Observational Follow-up|Death|0
7694240|NCT00379769|12114094|FG004|Observational Follow-up|Death|78
7694241|NCT00379769|12114095|FG005|Observational Follow-up|Death|70
7694242|NCT00379769|12114090|FG000|Observational Follow-up|Adverse Event|0
7694243|NCT00379769|12114091|FG001|Observational Follow-up|Adverse Event|0
7694244|NCT00379769|12114092|FG002|Observational Follow-up|Adverse Event|0
7694245|NCT00379769|12114093|FG003|Observational Follow-up|Adverse Event|0
7694246|NCT00379769|12114094|FG004|Observational Follow-up|Adverse Event|1
7694247|NCT00379769|12114095|FG005|Observational Follow-up|Adverse Event|0
7694248|NCT00379769|12114090|FG000|Observational Follow-up|Lost to Follow-up|0
7694249|NCT00379769|12114091|FG001|Observational Follow-up|Lost to Follow-up|0
7694250|NCT00379769|12114092|FG002|Observational Follow-up|Lost to Follow-up|0
7694251|NCT00379769|12114093|FG003|Observational Follow-up|Lost to Follow-up|0
7694252|NCT00379769|12114094|FG004|Observational Follow-up|Lost to Follow-up|25
7694253|NCT00379769|12114095|FG005|Observational Follow-up|Lost to Follow-up|27
7694254|NCT00379769|12114090|FG000|Observational Follow-up|Withdrawal by Subject|0
7694255|NCT00379769|12114091|FG001|Observational Follow-up|Withdrawal by Subject|0
7694256|NCT00379769|12114092|FG002|Observational Follow-up|Withdrawal by Subject|0
7694257|NCT00379769|12114093|FG003|Observational Follow-up|Withdrawal by Subject|0
7694258|NCT00379769|12114094|FG004|Observational Follow-up|Withdrawal by Subject|12
7694259|NCT00379769|12114095|FG005|Observational Follow-up|Withdrawal by Subject|12
7694260|NCT00379769|12114090|FG000|Observational Follow-up|Entered into Another Clinical Trial|0
7694261|NCT00379769|12114091|FG001|Observational Follow-up|Entered into Another Clinical Trial|0
7694262|NCT00379769|12114092|FG002|Observational Follow-up|Entered into Another Clinical Trial|0
7694263|NCT00379769|12114093|FG003|Observational Follow-up|Entered into Another Clinical Trial|0
7694264|NCT00379769|12114094|FG004|Observational Follow-up|Entered into Another Clinical Trial|18
7694265|NCT00379769|12114095|FG005|Observational Follow-up|Entered into Another Clinical Trial|22
7694266|NCT00379769|12114090|FG000|Observational Follow-up|Physician Decision|0
7694267|NCT00379769|12114091|FG001|Observational Follow-up|Physician Decision|0
7694268|NCT00379769|12114092|FG002|Observational Follow-up|Physician Decision|0
7694269|NCT00379769|12114093|FG003|Observational Follow-up|Physician Decision|0
7694270|NCT00379769|12114094|FG004|Observational Follow-up|Physician Decision|8
7694271|NCT00379769|12114095|FG005|Observational Follow-up|Physician Decision|8
7694272|NCT00379769|12114090|FG000|Observational Follow-up|Site Closed Early|0
7694273|NCT00379769|12114091|FG001|Observational Follow-up|Site Closed Early|0
7694274|NCT00379769|12114092|FG002|Observational Follow-up|Site Closed Early|0
7694275|NCT00379769|12114093|FG003|Observational Follow-up|Site Closed Early|0
7694276|NCT00379769|12114094|FG004|Observational Follow-up|Site Closed Early|6
7694277|NCT00379769|12114095|FG005|Observational Follow-up|Site Closed Early|7
7694278|NCT00379769|12114090|FG000|Observational Follow-up|Participant Moved|0
7694279|NCT00379769|12114091|FG001|Observational Follow-up|Participant Moved|0
7694280|NCT00379769|12114092|FG002|Observational Follow-up|Participant Moved|0
7694281|NCT00379769|12114093|FG003|Observational Follow-up|Participant Moved|0
7694282|NCT00379769|12114094|FG004|Observational Follow-up|Participant Moved|0
7694283|NCT00379769|12114095|FG005|Observational Follow-up|Participant Moved|1
7694284|NCT00379769|12114090|FG000|Observational Follow-up|Unknown; Reason Not Provided|0
7694285|NCT00379769|12114091|FG001|Observational Follow-up|Unknown; Reason Not Provided|0
7694286|NCT00379769|12114092|FG002|Observational Follow-up|Unknown; Reason Not Provided|0
7694287|NCT00379769|12114093|FG003|Observational Follow-up|Unknown; Reason Not Provided|0
7694288|NCT00379769|12114094|FG004|Observational Follow-up|Unknown; Reason Not Provided|1
7694289|NCT00379769|12114095|FG005|Observational Follow-up|Unknown; Reason Not Provided|1
7694290|NCT00379795|12114127|FG000|Overall Study|Death|31
7694291|NCT00379795|12114128|FG001|Overall Study|Death|8
7694292|NCT00379795|12114129|FG002|Overall Study|Death|6
7694293|NCT00379795|12114130|FG003|Overall Study|Death|4
7694294|NCT00379795|12114131|FG004|Overall Study|Death|7
7694295|NCT00379795|12114127|FG000|Overall Study|Adverse Event|17
7694296|NCT00379795|12114128|FG001|Overall Study|Adverse Event|3
7694297|NCT00379795|12114129|FG002|Overall Study|Adverse Event|3
7694298|NCT00379795|12114130|FG003|Overall Study|Adverse Event|1
7694299|NCT00379795|12114131|FG004|Overall Study|Adverse Event|4
7694300|NCT00379795|12114127|FG000|Overall Study|Lost to Follow-up|8
7694301|NCT00379795|12114128|FG001|Overall Study|Lost to Follow-up|1
7694302|NCT00379795|12114129|FG002|Overall Study|Lost to Follow-up|2
7694303|NCT00379795|12114130|FG003|Overall Study|Lost to Follow-up|1
7694304|NCT00379795|12114131|FG004|Overall Study|Lost to Follow-up|4
7694305|NCT00379795|12114127|FG000|Overall Study|Physician Decision|25
7694306|NCT00379795|12114128|FG001|Overall Study|Physician Decision|0
7694307|NCT00379795|12114129|FG002|Overall Study|Physician Decision|2
7694308|NCT00379795|12114130|FG003|Overall Study|Physician Decision|2
7694309|NCT00379795|12114131|FG004|Overall Study|Physician Decision|2
7694310|NCT00379795|12114127|FG000|Overall Study|Withdrawal by Subject|94
7694311|NCT00379795|12114128|FG001|Overall Study|Withdrawal by Subject|11
7694312|NCT00379795|12114129|FG002|Overall Study|Withdrawal by Subject|19
7694313|NCT00379795|12114130|FG003|Overall Study|Withdrawal by Subject|7
7694314|NCT00379795|12114131|FG004|Overall Study|Withdrawal by Subject|14
7694315|NCT00379795|12114127|FG000|Overall Study|Subject non-compliance|7
7694316|NCT00379795|12114128|FG001|Overall Study|Subject non-compliance|2
7694317|NCT00379795|12114129|FG002|Overall Study|Subject non-compliance|0
7694318|NCT00379795|12114130|FG003|Overall Study|Subject non-compliance|0
7694319|NCT00379795|12114131|FG004|Overall Study|Subject non-compliance|1
7694320|NCT00379795|12114127|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3
7694321|NCT00379795|12114128|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0
7694322|NCT00379795|12114129|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0
7694323|NCT00379795|12114130|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1
7694324|NCT00379795|12114131|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0
7694325|NCT00379795|12114127|FG000|Overall Study|Subjects condition mandated intervention|34
7694326|NCT00379795|12114128|FG001|Overall Study|Subjects condition mandated intervention|9
7694327|NCT00379795|12114129|FG002|Overall Study|Subjects condition mandated intervention|7
7694328|NCT00379795|12114130|FG003|Overall Study|Subjects condition mandated intervention|5
7694329|NCT00379795|12114131|FG004|Overall Study|Subjects condition mandated intervention|7
7694330|NCT00379795|12114127|FG000|Overall Study|Sponsor's decision|257
7694331|NCT00379795|12114128|FG001|Overall Study|Sponsor's decision|17
7694332|NCT00379795|12114129|FG002|Overall Study|Sponsor's decision|54
7694333|NCT00379795|12114130|FG003|Overall Study|Sponsor's decision|47
7694334|NCT00379795|12114131|FG004|Overall Study|Sponsor's decision|10
7694335|NCT00379808|12114146|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
7694336|NCT00379808|12114147|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
7694337|NCT00379834|12114177|FG000|Overall Study|Time constraints|2
7694338|NCT00379899|12114183|FG000|Overall Study|Adverse Event|7
7694339|NCT00379899|12114184|FG001|Overall Study|Adverse Event|3
7694340|NCT00379899|12114183|FG000|Overall Study|Death|10
7694341|NCT00379899|12114184|FG001|Overall Study|Death|10
7694342|NCT00379899|12114183|FG000|Overall Study|Lost to Follow-up|2
7694343|NCT00379899|12114184|FG001|Overall Study|Lost to Follow-up|4
7694344|NCT00379899|12114183|FG000|Overall Study|Physician Decision|3
7694345|NCT00379899|12114184|FG001|Overall Study|Physician Decision|4
7694346|NCT00379899|12114183|FG000|Overall Study|Withdrawal by Subject|5
7694347|NCT00379899|12114184|FG001|Overall Study|Withdrawal by Subject|5
7694348|NCT00379899|12114183|FG000|Overall Study|Ineligibility determined|0
7694349|NCT00379899|12114184|FG001|Overall Study|Ineligibility determined|1
7694350|NCT00379899|12114183|FG000|Overall Study|Noncompliance|1
7694351|NCT00379899|12114184|FG001|Overall Study|Noncompliance|1
7694352|NCT00379899|12114183|FG000|Overall Study|Parathyroidectomy|0
7694353|NCT00379899|12114184|FG001|Overall Study|Parathyroidectomy|2
7694354|NCT00379899|12114183|FG000|Overall Study|Renal transplantation|5
7694355|NCT00379899|12114184|FG001|Overall Study|Renal transplantation|4
7694356|NCT00379899|12114183|FG000|Overall Study|Coronary artery bypass graft|1
7694357|NCT00379899|12114184|FG001|Overall Study|Coronary artery bypass graft|1
7694358|NCT00379899|12114183|FG000|Overall Study|Other protocol-specified criteria|3
7694359|NCT00379899|12114184|FG001|Overall Study|Other protocol-specified criteria|4
7694360|NCT00379899|12114183|FG000|Overall Study|Other|3
7694361|NCT00379899|12114184|FG001|Overall Study|Other|1
7694362|NCT00379912|12114192|FG000|Overall Study|Lack of Efficacy|1
7694363|NCT00379912|12114193|FG001|Overall Study|Lack of Efficacy|0
7694364|NCT00380068|12114213|FG000|Overall Study|Adverse Event|40
7694365|NCT00380068|12114213|FG000|Overall Study|Withdrawal by Subject|10
7694366|NCT00380068|12114213|FG000|Overall Study|Not compliant|6
7694367|NCT00380068|12114213|FG000|Overall Study|Lost to Follow-up|1
7694368|NCT00380068|12114213|FG000|Overall Study|Addition of other PAH therapeutic agent|1
7694369|NCT00380068|12114213|FG000|Overall Study|Lung transplant|3
7694370|NCT00380068|12114213|FG000|Overall Study|Physician Decision|2
7694371|NCT00380068|12114213|FG000|Overall Study|Partipant moved away|1
7694372|NCT00380068|12114213|FG000|Overall Study|Lack of Efficacy|5
7694373|NCT00380081|12114223|FG000|Overall Study|Withdrawal by Subject|0
7694374|NCT00380081|12114224|FG001|Overall Study|Withdrawal by Subject|0
7694375|NCT00380081|12114225|FG002|Overall Study|Withdrawal by Subject|0
7694376|NCT00380081|12114226|FG003|Overall Study|Withdrawal by Subject|0
7694377|NCT00380081|12114227|FG004|Overall Study|Withdrawal by Subject|1
7694378|NCT00380081|12114228|FG005|Overall Study|Withdrawal by Subject|0
7694379|NCT00380081|12114223|FG000|Overall Study|Family Emergency|0
7694380|NCT00380081|12114224|FG001|Overall Study|Family Emergency|0
7694381|NCT00380081|12114225|FG002|Overall Study|Family Emergency|0
7694382|NCT00380081|12114226|FG003|Overall Study|Family Emergency|0
7694383|NCT00380081|12114227|FG004|Overall Study|Family Emergency|0
7694384|NCT00380081|12114228|FG005|Overall Study|Family Emergency|1
7694385|NCT00380250|12114238|FG000|Overall Study|Withdrawal by Subject|39
7694386|NCT00380250|12114239|FG001|Overall Study|Withdrawal by Subject|28
7694387|NCT00380250|12114238|FG000|Overall Study|Adverse Event|20
7694388|NCT00380250|12114239|FG001|Overall Study|Adverse Event|9
7694389|NCT00380250|12114238|FG000|Overall Study|Lack of Efficacy|10
7694390|NCT00380250|12114239|FG001|Overall Study|Lack of Efficacy|8
7694391|NCT00380250|12114238|FG000|Overall Study|Protocol Violation|15
7694392|NCT00380250|12114239|FG001|Overall Study|Protocol Violation|5
7694393|NCT00380250|12114238|FG000|Overall Study|Lost to Follow-up|14
7694394|NCT00380250|12114239|FG001|Overall Study|Lost to Follow-up|5
7694395|NCT00380250|12114238|FG000|Overall Study|Physician Decision|1
7694396|NCT00380250|12114239|FG001|Overall Study|Physician Decision|0
7694397|NCT00380367|12114245|FG000|Overall Study|Lost to Follow-up|1
7694398|NCT00380367|12114245|FG000|Overall Study|Withdrawal by Subject|1
7694399|NCT00380393|12114251|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
7694400|NCT00380393|12114252|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
7694401|NCT00380393|12114251|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
7694402|NCT00380393|12114252|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
7694403|NCT00380393|12114251|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
7694404|NCT00380393|12114252|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
7694405|NCT00380393|12114251|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
7694406|NCT00380393|12114252|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
7694407|NCT00380393|12114251|FG000|Month 8 (Cross-sectional Visit)|Others|5
7694408|NCT00380393|12114252|FG001|Month 8 (Cross-sectional Visit)|Others|4
7694409|NCT00380393|12114251|FG000|Month 14|Withdrawal by Subject|9
7694410|NCT00380393|12114252|FG001|Month 14|Withdrawal by Subject|7
7694411|NCT00380393|12114251|FG000|Month 14|Death|1
7694412|NCT00380393|12114252|FG001|Month 14|Death|0
7694413|NCT00380393|12114251|FG000|Month 14|Lost to Follow-up|0
7694414|NCT00380393|12114252|FG001|Month 14|Lost to Follow-up|1
7694415|NCT00380393|12114251|FG000|Month 14|Migrated/moved from study area|39
7694416|NCT00380393|12114252|FG001|Month 14|Migrated/moved from study area|42
7694417|NCT00380393|12114251|FG000|Month 14|Protocol Violation|2
7694418|NCT00380393|12114252|FG001|Month 14|Protocol Violation|0
7694419|NCT00380393|12114251|FG000|Month 14|Others|6
7694420|NCT00380393|12114252|FG001|Month 14|Others|6
7694421|NCT00380588|12114260|FG000|Overall Study|Unequivocal Disease Progression|25
7694422|NCT00380588|12114261|FG001|Overall Study|Unequivocal Disease Progression|34
7694423|NCT00380588|12114260|FG000|Overall Study|Next Cycle Not Started|4
7694424|NCT00380588|12114261|FG001|Overall Study|Next Cycle Not Started|0
7694425|NCT00380588|12114260|FG000|Overall Study|Adverse Event|7
7694426|NCT00380588|12114261|FG001|Overall Study|Adverse Event|3
7694427|NCT00380588|12114260|FG000|Overall Study|Withdrawal by Subject|1
7694428|NCT00380588|12114261|FG001|Overall Study|Withdrawal by Subject|3
7694429|NCT00380588|12114260|FG000|Overall Study|Physician Decision|2
7694430|NCT00380588|12114261|FG001|Overall Study|Physician Decision|0
7694431|NCT00380692|12114269|FG000|Study Period II - Double Blind|Adverse Event|1
7694432|NCT00380692|12114270|FG001|Study Period II - Double Blind|Adverse Event|0
7694433|NCT00380692|12114269|FG000|Study Period II - Double Blind|Protocol Violation|2
7694434|NCT00380692|12114270|FG001|Study Period II - Double Blind|Protocol Violation|2
7694435|NCT00380692|12114269|FG000|Study Period II - Double Blind|Withdrawal by Subject|0
7694436|NCT00380692|12114270|FG001|Study Period II - Double Blind|Withdrawal by Subject|0
7694437|NCT00380692|12114269|FG000|Study Period II - Double Blind|Physician Decision|0
7694438|NCT00380692|12114270|FG001|Study Period II - Double Blind|Physician Decision|1
7694439|NCT00380692|12114269|FG000|Study Period II - Double Blind|Lack of Efficacy|1
7694440|NCT00380692|12114270|FG001|Study Period II - Double Blind|Lack of Efficacy|0
7694441|NCT00380692|12114269|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1
7694442|NCT00380692|12114270|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0
7694443|NCT00380692|12114269|FG000|Study Period III - Open Label|Adverse Event|5
7694444|NCT00380692|12114270|FG001|Study Period III - Open Label|Adverse Event|3
7694445|NCT00380692|12114269|FG000|Study Period III - Open Label|Protocol Violation|0
7694446|NCT00380692|12114270|FG001|Study Period III - Open Label|Protocol Violation|0
7694447|NCT00380692|12114269|FG000|Study Period III - Open Label|Withdrawal by Subject|0
7694448|NCT00380692|12114270|FG001|Study Period III - Open Label|Withdrawal by Subject|1
7694449|NCT00380692|12114269|FG000|Study Period III - Open Label|Physician Decision|0
7694450|NCT00380692|12114270|FG001|Study Period III - Open Label|Physician Decision|3
7694451|NCT00380692|12114269|FG000|Study Period III - Open Label|Lack of Efficacy|0
7694452|NCT00380692|12114270|FG001|Study Period III - Open Label|Lack of Efficacy|4
7694453|NCT00380692|12114269|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1
7694454|NCT00380692|12114270|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1
7694455|NCT00380718|12114276|FG000|Overall Study|Adverse Event|1
7694456|NCT00380718|12114276|FG000|Overall Study|Death after 30-day post-therapy followup|17
7694457|NCT00380744|12114287|FG000|Overall Study|Death|0
7694458|NCT00380744|12114288|FG001|Overall Study|Death|0
7694459|NCT00380744|12114289|FG002|Overall Study|Death|0
7694460|NCT00380744|12114290|FG003|Overall Study|Death|0
7694461|NCT00380744|12114291|FG004|Overall Study|Death|0
7694462|NCT00380744|12114292|FG005|Overall Study|Death|0
7694463|NCT00380744|12114293|FG006|Overall Study|Death|1
7694464|NCT00380744|12114287|FG000|Overall Study|Withdrawal by Subject|1
7694465|NCT00380744|12114288|FG001|Overall Study|Withdrawal by Subject|0
7694466|NCT00380744|12114289|FG002|Overall Study|Withdrawal by Subject|0
7694467|NCT00380744|12114290|FG003|Overall Study|Withdrawal by Subject|0
7694468|NCT00380744|12114291|FG004|Overall Study|Withdrawal by Subject|0
7694469|NCT00380744|12114292|FG005|Overall Study|Withdrawal by Subject|0
7694470|NCT00380744|12114293|FG006|Overall Study|Withdrawal by Subject|0
7694471|NCT00380874|12114321|FG000|Overall Study|Adverse Event|7
7694472|NCT00380874|12114322|FG001|Overall Study|Adverse Event|7
7694473|NCT00380874|12114321|FG000|Overall Study|Death|1
7694474|NCT00380874|12114322|FG001|Overall Study|Death|0
7694475|NCT00380874|12114321|FG000|Overall Study|Withdrawal by Subject|2
7694476|NCT00380874|12114322|FG001|Overall Study|Withdrawal by Subject|1
7694477|NCT00380874|12114321|FG000|Overall Study|Not related to study drug|3
7694478|NCT00380874|12114322|FG001|Overall Study|Not related to study drug|2
7694479|NCT00380978|12114330|FG000|Overall Study|Refused allocated intervention|0
7694480|NCT00380978|12114331|FG001|Overall Study|Refused allocated intervention|6
7694481|NCT00380978|12114330|FG000|Overall Study|Wrong study envelope|0
7694482|NCT00380978|12114331|FG001|Overall Study|Wrong study envelope|2
7694483|NCT00380978|12114330|FG000|Overall Study|Allocation prior to analgesia request|1
7694484|NCT00380978|12114331|FG001|Overall Study|Allocation prior to analgesia request|2
7694485|NCT00380978|12114330|FG000|Overall Study|Parous patient|1
7694486|NCT00380978|12114331|FG001|Overall Study|Parous patient|0
7694487|NCT00381043|12114343|FG000|Overall Study|Lost to Follow-up|8
7694488|NCT00381043|12114344|FG001|Overall Study|Lost to Follow-up|6
7694489|NCT00381043|12114343|FG000|Overall Study|Withdrawal by Subject|3
7694490|NCT00381043|12114344|FG001|Overall Study|Withdrawal by Subject|1
7694491|NCT00381043|12114343|FG000|Overall Study|wanted more care|0
7694492|NCT00381043|12114344|FG001|Overall Study|wanted more care|1
7694493|NCT00381043|12114343|FG000|Overall Study|incarcerated|1
7694494|NCT00381043|12114344|FG001|Overall Study|incarcerated|0
7694495|NCT00381095|12114352|FG000|Overall Study|Death|3
7694496|NCT00381095|12114353|FG001|Overall Study|Death|4
7694497|NCT00381095|12114352|FG000|Overall Study|Lack of Efficacy|2
7694498|NCT00381095|12114353|FG001|Overall Study|Lack of Efficacy|4
7694499|NCT00381095|12114352|FG000|Overall Study|Other|2
7694500|NCT00381095|12114353|FG001|Overall Study|Other|2
7694501|NCT00381095|12114352|FG000|Overall Study|Protocol Violation|1
7694502|NCT00381095|12114353|FG001|Overall Study|Protocol Violation|1
7694503|NCT00381095|12114352|FG000|Overall Study|Withdrawal by Subject|3
7694504|NCT00381095|12114353|FG001|Overall Study|Withdrawal by Subject|3
7694505|NCT00381095|12114352|FG000|Overall Study|Adverse Event|2
7694506|NCT00381095|12114353|FG001|Overall Study|Adverse Event|7
7694507|NCT00381238|12114359|FG000|Overall Study|Adverse Event|3
7694508|NCT00381238|12114359|FG000|Overall Study|Protocol Violation|1
7694509|NCT00381238|12114359|FG000|Overall Study|Withdrawal by Subject|4
7694510|NCT00381238|12114359|FG000|Overall Study|Lack of Efficacy|2
7694511|NCT00381238|12114359|FG000|Overall Study|Withdrew by physician|1
7694512|NCT00381238|12114359|FG000|Overall Study|Disease progression|1
7694513|NCT00381303|12114365|FG000|Overall Study|Lost to Follow-up|25
7694514|NCT00381303|12114366|FG001|Overall Study|Lost to Follow-up|9
7694515|NCT00381303|12114365|FG000|Overall Study|AE/HIV-related event|22
7694516|NCT00381303|12114366|FG001|Overall Study|AE/HIV-related event|6
7694517|NCT00381303|12114365|FG000|Overall Study|Non-Adherence|13
7694518|NCT00381303|12114366|FG001|Overall Study|Non-Adherence|6
7694519|NCT00381303|12114365|FG000|Overall Study|Withdrawal by Subject|13
7694520|NCT00381303|12114366|FG001|Overall Study|Withdrawal by Subject|6
7694521|NCT00381303|12114365|FG000|Overall Study|Virologic failure|6
7694522|NCT00381303|12114366|FG001|Overall Study|Virologic failure|4
7694523|NCT00381303|12114365|FG000|Overall Study|Ineligible to continue the trial|2
7694524|NCT00381303|12114366|FG001|Overall Study|Ineligible to continue the trial|1
7694525|NCT00381303|12114365|FG000|Overall Study|Pregnancy|2
7694526|NCT00381303|12114366|FG001|Overall Study|Pregnancy|0
7694527|NCT00381303|12114365|FG000|Overall Study|Physician Decision|1
7694528|NCT00381303|12114366|FG001|Overall Study|Physician Decision|0
7694529|NCT00381303|12114365|FG000|Overall Study|Physician's decision to close the site|3
7694530|NCT00381303|12114366|FG001|Overall Study|Physician's decision to close the site|1
7694531|NCT00381303|12114365|FG000|Overall Study|Subject moved out of state|2
7694532|NCT00381303|12114366|FG001|Overall Study|Subject moved out of state|0
7694533|NCT00381303|12114365|FG000|Overall Study|Subject taking too many different meds|1
7694534|NCT00381303|12114366|FG001|Overall Study|Subject taking too many different meds|0
7694535|NCT00381303|12114365|FG000|Overall Study|No virologic response by week 12|1
7694536|NCT00381303|12114366|FG001|Overall Study|No virologic response by week 12|0
7694537|NCT00381303|12114365|FG000|Overall Study|Subject was too busy for appointments|1
7694538|NCT00381303|12114366|FG001|Overall Study|Subject was too busy for appointments|0
7694539|NCT00381303|12114365|FG000|Overall Study|Subject did not continue visits|1
7694540|NCT00381303|12114366|FG001|Overall Study|Subject did not continue visits|0
7694541|NCT00381303|12114365|FG000|Overall Study|Subject primary physician's decision|1
7694542|NCT00381303|12114366|FG001|Overall Study|Subject primary physician's decision|0
7694543|NCT00381563|12114390|FG000|Overall Study|Withdrawal by Subject|5
7694544|NCT00381563|12114391|FG001|Overall Study|Withdrawal by Subject|5
7694545|NCT00381563|12114390|FG000|Overall Study|Lost to Follow-up|2
7694546|NCT00381563|12114391|FG001|Overall Study|Lost to Follow-up|0
7694547|NCT00381563|12114390|FG000|Overall Study|Protocol Violation|0
7694548|NCT00381563|12114391|FG001|Overall Study|Protocol Violation|1
7694549|NCT00381615|12114400|FG000|Overall Study|Withdrawal by Subject|1
7694550|NCT00381615|12114401|FG001|Overall Study|Withdrawal by Subject|3
7694551|NCT00381615|12114402|FG002|Overall Study|Withdrawal by Subject|0
7694552|NCT00381615|12114403|FG003|Overall Study|Withdrawal by Subject|1
7694553|NCT00381615|12114400|FG000|Overall Study|Lost to Follow-up|3
7694554|NCT00381615|12114401|FG001|Overall Study|Lost to Follow-up|2
7694555|NCT00381615|12114402|FG002|Overall Study|Lost to Follow-up|0
7694556|NCT00381615|12114403|FG003|Overall Study|Lost to Follow-up|1
7694557|NCT00381615|12114400|FG000|Overall Study|Protocol Violation|0
7694558|NCT00381615|12114401|FG001|Overall Study|Protocol Violation|0
7694559|NCT00381615|12114402|FG002|Overall Study|Protocol Violation|1
7694560|NCT00381615|12114403|FG003|Overall Study|Protocol Violation|0
7694561|NCT00381680|12114434|FG000|Overall Study|Adverse Event|9
7694562|NCT00381680|12114435|FG001|Overall Study|Adverse Event|3
7694563|NCT00381680|12114434|FG000|Overall Study|Death|10
7694564|NCT00381680|12114435|FG001|Overall Study|Death|7
7694565|NCT00381680|12114434|FG000|Overall Study|Lost to Follow-up|3
7694566|NCT00381680|12114435|FG001|Overall Study|Lost to Follow-up|2
7694567|NCT00381680|12114434|FG000|Overall Study|Physician Decision|25
7694568|NCT00381680|12114435|FG001|Overall Study|Physician Decision|6
7694569|NCT00381680|12114434|FG000|Overall Study|Withdrawal by Subject|3
7694570|NCT00381680|12114435|FG001|Overall Study|Withdrawal by Subject|1
7694571|NCT00381680|12114434|FG000|Overall Study|Entry onto another COG Trial|1
7694572|NCT00381680|12114435|FG001|Overall Study|Entry onto another COG Trial|2
7694573|NCT00381680|12114434|FG000|Overall Study|Alternative Therapy|11
7694574|NCT00381680|12114435|FG001|Overall Study|Alternative Therapy|5
7694575|NCT00381680|12114434|FG000|Overall Study|Secondary Malignancy|3
7694576|NCT00381680|12114435|FG001|Overall Study|Secondary Malignancy|0
7694577|NCT00381680|12114434|FG000|Overall Study|Delay initiation|1
7694578|NCT00381680|12114435|FG001|Overall Study|Delay initiation|0
7694579|NCT00381680|12114434|FG000|Overall Study|Stem Cell Transplant|26
7694580|NCT00381680|12114435|FG001|Overall Study|Stem Cell Transplant|10
7694581|NCT00381680|12114434|FG000|Overall Study|Relapse|18
7694582|NCT00381680|12114435|FG001|Overall Study|Relapse|9
7694583|NCT00381680|12114434|FG000|Overall Study|Induction Failure|4
7694584|NCT00381680|12114435|FG001|Overall Study|Induction Failure|1
7694585|NCT00381680|12114434|FG000|Overall Study|Progression|1
7694586|NCT00381680|12114435|FG001|Overall Study|Progression|1
7694587|NCT00381680|12114434|FG000|Overall Study|Other not otherwise specified|7
7694588|NCT00381680|12114435|FG001|Overall Study|Other not otherwise specified|2
7694589|NCT00381680|12114434|FG000|Overall Study|Ineligible|3
7694590|NCT00381680|12114435|FG001|Overall Study|Ineligible|1
7694591|NCT00381693|12114445|FG000|Overall Study|Death|1
7694592|NCT00381693|12114445|FG000|Overall Study|Adverse Event|4
7694593|NCT00381693|12114445|FG000|Overall Study|Patient Choice|1
7694594|NCT00381693|12114445|FG000|Overall Study|Progression|2
7694595|NCT00381706|12114455|FG000|Overall Study|Never treated|7
7694596|NCT00381706|12114456|FG001|Overall Study|Never treated|2
7694597|NCT00381706|12114457|FG002|Overall Study|Never treated|1
7694598|NCT00381797|12114476|FG000|Overall Study|Withdrawal by Subject|1
7694599|NCT00381797|12114477|FG001|Overall Study|Withdrawal by Subject|1
7694600|NCT00381797|12114478|FG002|Overall Study|Withdrawal by Subject|0
7694601|NCT00381797|12114479|FG003|Overall Study|Withdrawal by Subject|0
7694602|NCT00381797|12114480|FG004|Overall Study|Withdrawal by Subject|2
7694603|NCT00381797|12114476|FG000|Overall Study|Ineligible|0
7694604|NCT00381797|12114477|FG001|Overall Study|Ineligible|0
7694605|NCT00381797|12114478|FG002|Overall Study|Ineligible|0
7694606|NCT00381797|12114479|FG003|Overall Study|Ineligible|1
7694607|NCT00381797|12114480|FG004|Overall Study|Ineligible|0
7694608|NCT00381849|12114519|FG000|Wash Out|Withdrawal by Subject|0
7694609|NCT00381849|12114520|FG001|Wash Out|Withdrawal by Subject|1
7694610|NCT00381888|12114530|FG000|Overall Study|Death|1
7694611|NCT00381888|12114530|FG000|Overall Study|Withdrawal by Subject|1
7694612|NCT00381888|12114530|FG000|Overall Study|Physician Decision|1
7694613|NCT00381888|12114530|FG000|Overall Study|Protocol Violation|9
7694614|NCT00381888|12114530|FG000|Overall Study|Had laparoscopic surgery|2
7694615|NCT00381888|12114530|FG000|Overall Study|Surgery was cancelled|2
7694616|NCT00381888|12114530|FG000|Overall Study|Adverse Event|1
7694617|NCT00381940|12114534|FG000|Overall Study|Lack of Efficacy|3
7694618|NCT00381940|12114534|FG000|Overall Study|Protocol Violation|1
7694619|NCT00381940|12114534|FG000|Overall Study|Ineligible|1
7694620|NCT00382018|12114546|FG000|Overall Study|Progression|0
7694621|NCT00382018|12114547|FG001|Overall Study|Progression|136
7694622|NCT00382018|12114548|FG002|Overall Study|Progression|51
7694623|NCT00382018|12114549|FG003|Overall Study|Progression|43
7694624|NCT00382018|12114546|FG000|Overall Study|Death|0
7694625|NCT00382018|12114547|FG001|Overall Study|Death|9
7694626|NCT00382018|12114548|FG002|Overall Study|Death|7
7694627|NCT00382018|12114549|FG003|Overall Study|Death|11
7694628|NCT00382018|12114546|FG000|Overall Study|Withdrawal by Subject|0
7694629|NCT00382018|12114547|FG001|Overall Study|Withdrawal by Subject|4
7694630|NCT00382018|12114548|FG002|Overall Study|Withdrawal by Subject|3
7694631|NCT00382018|12114549|FG003|Overall Study|Withdrawal by Subject|4
7694632|NCT00382018|12114546|FG000|Overall Study|Other, not protocol specified|0
7694633|NCT00382018|12114547|FG001|Overall Study|Other, not protocol specified|16
7694634|NCT00382018|12114548|FG002|Overall Study|Other, not protocol specified|3
7694635|NCT00382018|12114549|FG003|Overall Study|Other, not protocol specified|1
7694636|NCT00382070|12114573|FG000|Overall Study|No follow up data mapped to Other|17
7694637|NCT00382070|12114574|FG001|Overall Study|No follow up data mapped to Other|19
7694638|NCT00382070|12114573|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7
7694639|NCT00382070|12114574|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0
7694640|NCT00382070|12114573|FG000|Overall Study|No clinical assessment|9
7694641|NCT00382070|12114574|FG001|Overall Study|No clinical assessment|11
7694642|NCT00382109|12114582|FG000|Overall Study|Adverse Event|3
7694643|NCT00382109|12114583|FG001|Overall Study|Adverse Event|0
7694644|NCT00382109|12114582|FG000|Overall Study|Physician Decision|6
7694645|NCT00382109|12114583|FG001|Overall Study|Physician Decision|1
7694646|NCT00382109|12114582|FG000|Overall Study|Withdrawal by Subject|1
7694647|NCT00382109|12114583|FG001|Overall Study|Withdrawal by Subject|0
7694648|NCT00382109|12114582|FG000|Overall Study|ineligible|2
7694649|NCT00382109|12114583|FG001|Overall Study|ineligible|0
7694650|NCT00382109|12114582|FG000|Overall Study|Other|0
7694651|NCT00382109|12114583|FG001|Overall Study|Other|2
7694652|NCT00382109|12114582|FG000|Overall Study|consent withdrawal|0
7694653|NCT00382109|12114583|FG001|Overall Study|consent withdrawal|1
7694654|NCT00382174|12114603|FG000|Overall Study|Lost to Follow-up|1
7694655|NCT00382174|12114604|FG001|Overall Study|Lost to Follow-up|4
7694656|NCT00382174|12114605|FG002|Overall Study|Lost to Follow-up|5
7694657|NCT00382174|12114603|FG000|Overall Study|Adverse Event|1
7694658|NCT00382174|12114604|FG001|Overall Study|Adverse Event|4
7694659|NCT00382174|12114605|FG002|Overall Study|Adverse Event|5
7694660|NCT00382174|12114603|FG000|Overall Study|Withdrawal by Subject|1
7694661|NCT00382174|12114604|FG001|Overall Study|Withdrawal by Subject|4
7694662|NCT00382174|12114605|FG002|Overall Study|Withdrawal by Subject|5
7694663|NCT00382174|12114603|FG000|Overall Study|Non compliance|1
7694664|NCT00382174|12114604|FG001|Overall Study|Non compliance|0
7694665|NCT00382174|12114605|FG002|Overall Study|Non compliance|1
7694666|NCT00382174|12114603|FG000|Overall Study|Physician Decision|0
7694667|NCT00382174|12114604|FG001|Overall Study|Physician Decision|2
7694668|NCT00382174|12114605|FG002|Overall Study|Physician Decision|2
7694669|NCT00382174|12114603|FG000|Overall Study|Failed to meet criteria|0
7694670|NCT00382174|12114604|FG001|Overall Study|Failed to meet criteria|1
7694671|NCT00382174|12114605|FG002|Overall Study|Failed to meet criteria|1
7694672|NCT00382174|12114603|FG000|Overall Study|Wounds merged|0
7694673|NCT00382174|12114604|FG001|Overall Study|Wounds merged|2
7694674|NCT00382174|12114605|FG002|Overall Study|Wounds merged|2
7694675|NCT00382291|12114629|FG000|Overall Study|Adverse Event|1
7694676|NCT00382291|12114630|FG001|Overall Study|Adverse Event|2
7694677|NCT00382291|12114631|FG002|Overall Study|Adverse Event|2
7694678|NCT00382291|12114629|FG000|Overall Study|Protocol Violation|1
7694679|NCT00382291|12114630|FG001|Overall Study|Protocol Violation|0
7694680|NCT00382291|12114631|FG002|Overall Study|Protocol Violation|0
7694681|NCT00382291|12114629|FG000|Overall Study|Temporary study suspension|2
7694682|NCT00382291|12114630|FG001|Overall Study|Temporary study suspension|2
7694683|NCT00382291|12114631|FG002|Overall Study|Temporary study suspension|5
7694684|NCT00382291|12114629|FG000|Overall Study|Withdrawal by Subject|0
7694685|NCT00382291|12114630|FG001|Overall Study|Withdrawal by Subject|2
7694686|NCT00382291|12114631|FG002|Overall Study|Withdrawal by Subject|0
7694687|NCT00382291|12114629|FG000|Overall Study|Physician Decision|0
7694688|NCT00382291|12114630|FG001|Overall Study|Physician Decision|1
7694689|NCT00382291|12114631|FG002|Overall Study|Physician Decision|0
7694690|NCT00382291|12114629|FG000|Overall Study|Lack of Efficacy|0
7694691|NCT00382291|12114630|FG001|Overall Study|Lack of Efficacy|0
7694692|NCT00382291|12114631|FG002|Overall Study|Lack of Efficacy|1
7694693|NCT00382408|12114643|FG000|Overall Study|Did not meet protocol requirement|3
7694694|NCT00382408|12114644|FG001|Overall Study|Did not meet protocol requirement|3
7694695|NCT00382408|12114643|FG000|Overall Study|Protocol Violation|2
7694696|NCT00382408|12114644|FG001|Overall Study|Protocol Violation|2
7694697|NCT00382408|12114643|FG000|Overall Study|Physician Decision|1
7694698|NCT00382408|12114644|FG001|Overall Study|Physician Decision|0
7694699|NCT00382408|12114643|FG000|Overall Study|Withdrawal by Subject|17
7694700|NCT00382408|12114644|FG001|Overall Study|Withdrawal by Subject|6
7694701|NCT00382408|12114643|FG000|Overall Study|Pregnancy|2
7694702|NCT00382408|12114644|FG001|Overall Study|Pregnancy|0
7694703|NCT00382408|12114643|FG000|Overall Study|Lost to Follow-up|19
7694704|NCT00382408|12114644|FG001|Overall Study|Lost to Follow-up|8
7694705|NCT00382408|12114643|FG000|Overall Study|Other|100
7694706|NCT00382408|12114644|FG001|Overall Study|Other|35
7694707|NCT00382720|12114662|FG000|Overall Study|Adverse Event|21
7694708|NCT00382720|12114663|FG001|Overall Study|Adverse Event|23
7694709|NCT00382720|12114664|FG002|Overall Study|Adverse Event|15
7694710|NCT00382720|12114662|FG000|Overall Study|Protocol Violation|2
7694711|NCT00382720|12114663|FG001|Overall Study|Protocol Violation|5
7694712|NCT00382720|12114664|FG002|Overall Study|Protocol Violation|1
7694713|NCT00382720|12114662|FG000|Overall Study|Death|0
7694714|NCT00382720|12114663|FG001|Overall Study|Death|1
7694715|NCT00382720|12114664|FG002|Overall Study|Death|2
7694716|NCT00382720|12114662|FG000|Overall Study|Progressive disease|37
7694717|NCT00382720|12114663|FG001|Overall Study|Progressive disease|28
7694718|NCT00382720|12114664|FG002|Overall Study|Progressive disease|38
7694719|NCT00382720|12114662|FG000|Overall Study|Withdrew consent|1
7694720|NCT00382720|12114663|FG001|Overall Study|Withdrew consent|1
7694721|NCT00382720|12114664|FG002|Overall Study|Withdrew consent|2
7694722|NCT00382720|12114662|FG000|Overall Study|Withdrawal by Subject|11
7694723|NCT00382720|12114663|FG001|Overall Study|Withdrawal by Subject|20
7694724|NCT00382720|12114664|FG002|Overall Study|Withdrawal by Subject|12
7694725|NCT00382720|12114662|FG000|Overall Study|Surgery|1
7694726|NCT00382720|12114663|FG001|Overall Study|Surgery|1
7694727|NCT00382720|12114664|FG002|Overall Study|Surgery|4
7694728|NCT00382720|12114662|FG000|Overall Study|Patient did not receive study medication|1
7694729|NCT00382720|12114663|FG001|Overall Study|Patient did not receive study medication|1
7694730|NCT00382720|12114664|FG002|Overall Study|Patient did not receive study medication|4
7694731|NCT00382720|12114662|FG000|Overall Study|Clinically progressive disease|0
7694732|NCT00382720|12114663|FG001|Overall Study|Clinically progressive disease|1
7694733|NCT00382720|12114664|FG002|Overall Study|Clinically progressive disease|0
7694734|NCT00382720|12114662|FG000|Overall Study|Good prognosis|0
7694735|NCT00382720|12114663|FG001|Overall Study|Good prognosis|1
7694736|NCT00382720|12114664|FG002|Overall Study|Good prognosis|0
7694737|NCT00382720|12114662|FG000|Overall Study|Investigator/Clinical decision|5
7694738|NCT00382720|12114663|FG001|Overall Study|Investigator/Clinical decision|6
7694739|NCT00382720|12114664|FG002|Overall Study|Investigator/Clinical decision|6
7694740|NCT00382720|12114662|FG000|Overall Study|Discontinued at end of study|0
7694741|NCT00382720|12114663|FG001|Overall Study|Discontinued at end of study|1
7694742|NCT00382720|12114664|FG002|Overall Study|Discontinued at end of study|2
7694743|NCT00382733|12114672|FG000|Overall Study|Withdrawal by Subject|0
7694744|NCT00382733|12114673|FG001|Overall Study|Withdrawal by Subject|1
7694745|NCT00382733|12114674|FG002|Overall Study|Withdrawal by Subject|0
7694746|NCT00382733|12114675|FG003|Overall Study|Withdrawal by Subject|0
7694747|NCT00382733|12114676|FG004|Overall Study|Withdrawal by Subject|0
7694748|NCT00382863|12114709|FG000|Overall Study|Death|9
7694749|NCT00382863|12114710|FG001|Overall Study|Death|9
7694750|NCT00382863|12114709|FG000|Overall Study|Lost to Follow-up|1
7694751|NCT00382863|12114710|FG001|Overall Study|Lost to Follow-up|2
7694752|NCT00382863|12114709|FG000|Overall Study|Withdrawal by Subject|5
7694753|NCT00382863|12114710|FG001|Overall Study|Withdrawal by Subject|25
7694754|NCT00382967|12114732|FG000|Overall Study|Protocol Violation|1
7694755|NCT00382967|12114733|FG001|Overall Study|Protocol Violation|1
7694756|NCT00382993|12114739|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
7694757|NCT00382993|12114740|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
7694922|NCT00384059|12114959|FG000|After Infant Series|Failed to Return|0
7694758|NCT00382993|12114739|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
7694759|NCT00382993|12114740|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
7694760|NCT00382993|12114739|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
7694761|NCT00382993|12114740|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
7694762|NCT00382993|12114739|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
7694763|NCT00382993|12114740|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
7694764|NCT00382993|12114739|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
7694765|NCT00382993|12114740|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
7694766|NCT00382993|12114739|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
7694767|NCT00382993|12114740|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
7694768|NCT00382993|12114739|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
7694769|NCT00382993|12114740|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
7694770|NCT00382993|12114739|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
7694771|NCT00382993|12114740|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
7694772|NCT00382993|12114739|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0
7694773|NCT00382993|12114740|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1
7694774|NCT00382993|12114739|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
7694775|NCT00382993|12114740|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
7694776|NCT00383019|12114748|FG000|Overall Study|Adverse Event|5
7694777|NCT00383019|12114749|FG001|Overall Study|Adverse Event|1
7694778|NCT00383019|12114748|FG000|Overall Study|Withdrawal by Subject|0
7694779|NCT00383019|12114749|FG001|Overall Study|Withdrawal by Subject|1
7694780|NCT00383084|12114774|FG000|Overall Study|Withdrawal by Subject|12
7694781|NCT00383084|12114775|FG001|Overall Study|Withdrawal by Subject|10
7694782|NCT00383123|12114793|FG000|Overall Study|Adverse Event|1
7694783|NCT00383123|12114794|FG001|Overall Study|Adverse Event|0
7694784|NCT00383123|12114793|FG000|Overall Study|Lost to Follow-up|68
7694785|NCT00383123|12114794|FG001|Overall Study|Lost to Follow-up|61
7694786|NCT00383123|12114793|FG000|Overall Study|Protocol Violation|5
7694787|NCT00383123|12114794|FG001|Overall Study|Protocol Violation|1
7694788|NCT00383123|12114793|FG000|Overall Study|Withdrawal by Subject|27
7694789|NCT00383123|12114794|FG001|Overall Study|Withdrawal by Subject|18
7694790|NCT00383123|12114793|FG000|Overall Study|Other reason|10
7694791|NCT00383123|12114794|FG001|Overall Study|Other reason|6
7694792|NCT00383149|12114800|FG000|Overall Study|Adverse Event not Related to Study Drug|3
7694793|NCT00383149|12114800|FG000|Overall Study|Death|2
7694794|NCT00383149|12114800|FG000|Overall Study|Disease Progression|38
7694795|NCT00383149|12114800|FG000|Overall Study|Lost to Follow-up|1
7694796|NCT00383149|12114800|FG000|Overall Study|Other|1
7694797|NCT00383149|12114800|FG000|Overall Study|Study Drug Toxicity|4
7694798|NCT00383149|12114800|FG000|Overall Study|Request to Discontinue Treatment|4
7694799|NCT00383149|12114800|FG000|Overall Study|Participant Withdrew Consent|1
7694800|NCT00383162|12114806|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
7694801|NCT00383162|12114807|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
7694802|NCT00383162|12114806|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
7694803|NCT00383162|12114807|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
7694804|NCT00383162|12114806|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
7694805|NCT00383162|12114807|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
7694806|NCT00383162|12114806|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
7694807|NCT00383162|12114807|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
7694808|NCT00383162|12114806|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3
7694809|NCT00383162|12114807|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0
7694810|NCT00383162|12114806|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
7694811|NCT00383162|12114807|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
7694812|NCT00383162|12114806|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
7694813|NCT00383162|12114807|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
7694814|NCT00383162|12114806|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1
7694815|NCT00383162|12114807|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0
7694816|NCT00383162|12114806|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0
7694817|NCT00383162|12114807|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3
7694818|NCT00383188|12114818|FG000|Overall Study|Adverse Event|4
7694819|NCT00383188|12114819|FG001|Overall Study|Adverse Event|7
7694820|NCT00383188|12114820|FG002|Overall Study|Adverse Event|9
7694821|NCT00383188|12114821|FG003|Overall Study|Adverse Event|8
7694822|NCT00383188|12114822|FG004|Overall Study|Adverse Event|8
7694823|NCT00383188|12114818|FG000|Overall Study|Lack of Efficacy|9
7694824|NCT00383188|12114819|FG001|Overall Study|Lack of Efficacy|3
7694825|NCT00383188|12114820|FG002|Overall Study|Lack of Efficacy|3
7694826|NCT00383188|12114821|FG003|Overall Study|Lack of Efficacy|2
7694827|NCT00383188|12114822|FG004|Overall Study|Lack of Efficacy|6
7694828|NCT00383188|12114818|FG000|Overall Study|Other|3
7694829|NCT00383188|12114819|FG001|Overall Study|Other|1
7694830|NCT00383188|12114820|FG002|Overall Study|Other|0
7694831|NCT00383188|12114821|FG003|Overall Study|Other|2
7694832|NCT00383188|12114822|FG004|Overall Study|Other|6
7694833|NCT00383188|12114818|FG000|Overall Study|No longer willing to participate|1
7694834|NCT00383188|12114819|FG001|Overall Study|No longer willing to participate|0
7694835|NCT00383188|12114820|FG002|Overall Study|No longer willing to participate|1
7694836|NCT00383188|12114821|FG003|Overall Study|No longer willing to participate|0
7694837|NCT00383188|12114822|FG004|Overall Study|No longer willing to participate|2
7694838|NCT00383188|12114818|FG000|Overall Study|Lost to Follow-up|0
7694839|NCT00383188|12114819|FG001|Overall Study|Lost to Follow-up|0
7694840|NCT00383188|12114820|FG002|Overall Study|Lost to Follow-up|0
7694841|NCT00383188|12114821|FG003|Overall Study|Lost to Follow-up|0
7694842|NCT00383188|12114822|FG004|Overall Study|Lost to Follow-up|1
7694843|NCT00383292|12114843|FG000|Overall Study|Adverse Event|4
7694844|NCT00383292|12114844|FG001|Overall Study|Adverse Event|1
7694845|NCT00383292|12114845|FG002|Overall Study|Adverse Event|2
7694846|NCT00383292|12114843|FG000|Overall Study|Death|3
7694847|NCT00383292|12114844|FG001|Overall Study|Death|3
7694848|NCT00383292|12114845|FG002|Overall Study|Death|3
7694849|NCT00383292|12114843|FG000|Overall Study|Physician Decision|4
7694850|NCT00383292|12114844|FG001|Overall Study|Physician Decision|0
7694851|NCT00383292|12114845|FG002|Overall Study|Physician Decision|1
7694852|NCT00383292|12114843|FG000|Overall Study|Withdrawal by Subject|3
7694853|NCT00383292|12114844|FG001|Overall Study|Withdrawal by Subject|2
7694854|NCT00383292|12114845|FG002|Overall Study|Withdrawal by Subject|2
7694855|NCT00383292|12114843|FG000|Overall Study|Other|1
7694856|NCT00383292|12114844|FG001|Overall Study|Other|0
7694857|NCT00383292|12114845|FG002|Overall Study|Other|0
7694858|NCT00383331|12114856|FG000|Overall Study|Protocol Violation|0
7694859|NCT00383331|12114857|FG001|Overall Study|Protocol Violation|1
7694860|NCT00383500|12114871|FG000|Overall Study|Withdrawal by Subject|8
7694861|NCT00383500|12114872|FG001|Overall Study|Withdrawal by Subject|3
7694862|NCT00383500|12114873|FG002|Overall Study|Withdrawal by Subject|0
7694863|NCT00383500|12114871|FG000|Overall Study|Lost to Follow-up|0
7694864|NCT00383500|12114872|FG001|Overall Study|Lost to Follow-up|0
7694865|NCT00383500|12114873|FG002|Overall Study|Lost to Follow-up|2
7694866|NCT00383786|12114924|FG000|Overall Study|Protocol Violation|2
7694867|NCT00383786|12114925|FG001|Overall Study|Protocol Violation|6
7694868|NCT00383786|12114924|FG000|Overall Study|Withdrawal by Subject|2
7694869|NCT00383786|12114925|FG001|Overall Study|Withdrawal by Subject|5
7694870|NCT00383786|12114924|FG000|Overall Study|Physician Decision|0
7694871|NCT00383786|12114925|FG001|Overall Study|Physician Decision|1
7694872|NCT00384033|12114944|FG000|Overall Study|Adverse Event|10
7694873|NCT00384033|12114945|FG001|Overall Study|Adverse Event|8
7694874|NCT00384033|12114946|FG002|Overall Study|Adverse Event|11
7694875|NCT00384033|12114947|FG003|Overall Study|Adverse Event|20
7694876|NCT00384033|12114944|FG000|Overall Study|Failed to return|1
7694877|NCT00384033|12114945|FG001|Overall Study|Failed to return|3
7694878|NCT00384033|12114946|FG002|Overall Study|Failed to return|2
7694879|NCT00384033|12114947|FG003|Overall Study|Failed to return|2
7694880|NCT00384033|12114944|FG000|Overall Study|Physician Decision|1
7694881|NCT00384033|12114945|FG001|Overall Study|Physician Decision|0
7694882|NCT00384033|12114946|FG002|Overall Study|Physician Decision|0
7694883|NCT00384033|12114947|FG003|Overall Study|Physician Decision|0
7694884|NCT00384033|12114944|FG000|Overall Study|Lost to Follow-up|6
7694885|NCT00384033|12114945|FG001|Overall Study|Lost to Follow-up|12
7694886|NCT00384033|12114946|FG002|Overall Study|Lost to Follow-up|7
7694887|NCT00384033|12114947|FG003|Overall Study|Lost to Follow-up|7
7694888|NCT00384033|12114944|FG000|Overall Study|Other|2
7694889|NCT00384033|12114945|FG001|Overall Study|Other|0
7694890|NCT00384033|12114946|FG002|Overall Study|Other|0
7694891|NCT00384033|12114947|FG003|Overall Study|Other|0
7694892|NCT00384033|12114944|FG000|Overall Study|Protocol Violation|5
7694893|NCT00384033|12114945|FG001|Overall Study|Protocol Violation|0
7694894|NCT00384033|12114946|FG002|Overall Study|Protocol Violation|5
7694895|NCT00384033|12114947|FG003|Overall Study|Protocol Violation|6
7694896|NCT00384033|12114944|FG000|Overall Study|Withdrawal by Subject|6
7694897|NCT00384033|12114945|FG001|Overall Study|Withdrawal by Subject|2
7694898|NCT00384033|12114946|FG002|Overall Study|Withdrawal by Subject|5
7694899|NCT00384033|12114947|FG003|Overall Study|Withdrawal by Subject|2
7694900|NCT00384033|12114944|FG000|Overall Study|Lack of Efficacy|7
7694901|NCT00384033|12114945|FG001|Overall Study|Lack of Efficacy|3
7694902|NCT00384033|12114946|FG002|Overall Study|Lack of Efficacy|3
7694903|NCT00384033|12114947|FG003|Overall Study|Lack of Efficacy|1
7694904|NCT00384033|12114944|FG000|Overall Study|Randomized but not treated|3
7694905|NCT00384033|12114945|FG001|Overall Study|Randomized but not treated|7
7694906|NCT00384033|12114946|FG002|Overall Study|Randomized but not treated|10
7694907|NCT00384033|12114947|FG003|Overall Study|Randomized but not treated|2
7694908|NCT00384059|12114959|FG000|Infant Series|Not consented|2
7694909|NCT00384059|12114960|FG001|Infant Series|Not consented|6
7694910|NCT00384059|12114959|FG000|Infant Series|Withdrawal by Subject|2
7694911|NCT00384059|12114960|FG001|Infant Series|Withdrawal by Subject|2
7694912|NCT00384059|12114959|FG000|Infant Series|Adverse Event|1
7694913|NCT00384059|12114960|FG001|Infant Series|Adverse Event|2
7694914|NCT00384059|12114959|FG000|Infant Series|Protocol Violation|1
7694915|NCT00384059|12114960|FG001|Infant Series|Protocol Violation|2
7694916|NCT00384059|12114959|FG000|Infant Series|Lost to Follow-up|0
7694917|NCT00384059|12114960|FG001|Infant Series|Lost to Follow-up|1
7694918|NCT00384059|12114959|FG000|After Infant Series|Protocol Violation|2
7694919|NCT00384059|12114960|FG001|After Infant Series|Protocol Violation|3
7694920|NCT00384059|12114959|FG000|After Infant Series|Withdrawal by Subject|2
7694921|NCT00384059|12114960|FG001|After Infant Series|Withdrawal by Subject|2
7694923|NCT00384059|12114960|FG001|After Infant Series|Failed to Return|2
7694924|NCT00384059|12114959|FG000|After Infant Series|Adverse Event|0
7694925|NCT00384059|12114960|FG001|After Infant Series|Adverse Event|1
7694926|NCT00384059|12114959|FG000|After Infant Series|Physician Decision|0
7694927|NCT00384059|12114960|FG001|After Infant Series|Physician Decision|1
7694928|NCT00384059|12114959|FG000|After Infant Series|Lost to Follow-up|0
7694929|NCT00384059|12114960|FG001|After Infant Series|Lost to Follow-up|1
7694930|NCT00384059|12114959|FG000|Toddler Dose|Lost to Follow-up|1
7694931|NCT00384059|12114960|FG001|Toddler Dose|Lost to Follow-up|1
7694932|NCT00384059|12114959|FG000|Toddler Dose|Failed to return|0
7694933|NCT00384059|12114960|FG001|Toddler Dose|Failed to return|1
7694934|NCT00384085|12114990|FG000|Overall Study|Adverse Event|5
7694935|NCT00384085|12114991|FG001|Overall Study|Adverse Event|5
7694936|NCT00384085|12114992|FG002|Overall Study|Adverse Event|4
7694937|NCT00384085|12114990|FG000|Overall Study|Lack of Efficacy|0
7694938|NCT00384085|12114991|FG001|Overall Study|Lack of Efficacy|3
7694939|NCT00384085|12114992|FG002|Overall Study|Lack of Efficacy|2
7694940|NCT00384085|12114990|FG000|Overall Study|No longer Requires Study Treatment|1
7694941|NCT00384085|12114991|FG001|Overall Study|No longer Requires Study Treatment|0
7694942|NCT00384085|12114992|FG002|Overall Study|No longer Requires Study Treatment|1
7694943|NCT00384085|12114990|FG000|Overall Study|Protocol Violation|2
7694944|NCT00384085|12114991|FG001|Overall Study|Protocol Violation|2
7694945|NCT00384085|12114992|FG002|Overall Study|Protocol Violation|2
7694946|NCT00384085|12114990|FG000|Overall Study|Lost to Follow-up|9
7694947|NCT00384085|12114991|FG001|Overall Study|Lost to Follow-up|9
7694948|NCT00384085|12114992|FG002|Overall Study|Lost to Follow-up|10
7694949|NCT00384085|12114990|FG000|Overall Study|Progressive Disease|0
7694950|NCT00384085|12114991|FG001|Overall Study|Progressive Disease|1
7694951|NCT00384085|12114992|FG002|Overall Study|Progressive Disease|0
7694952|NCT00384085|12114990|FG000|Overall Study|Withdrawal by Subject|14
7694953|NCT00384085|12114991|FG001|Overall Study|Withdrawal by Subject|19
7694954|NCT00384085|12114992|FG002|Overall Study|Withdrawal by Subject|29
7694955|NCT00384085|12114990|FG000|Overall Study|Patient non-compliant|4
7694956|NCT00384085|12114991|FG001|Overall Study|Patient non-compliant|4
7694957|NCT00384085|12114992|FG002|Overall Study|Patient non-compliant|5
7694958|NCT00384085|12114990|FG000|Overall Study|Physician Decision|1
7694959|NCT00384085|12114991|FG001|Overall Study|Physician Decision|0
7694960|NCT00384085|12114992|FG002|Overall Study|Physician Decision|0
7694961|NCT00384085|12114990|FG000|Overall Study|Loss of site personnel|1
7694962|NCT00384085|12114991|FG001|Overall Study|Loss of site personnel|0
7694963|NCT00384085|12114992|FG002|Overall Study|Loss of site personnel|1
7694964|NCT00384085|12114990|FG000|Overall Study|Sponsor decision|1
7694965|NCT00384085|12114991|FG001|Overall Study|Sponsor decision|2
7694966|NCT00384085|12114992|FG002|Overall Study|Sponsor decision|1
7694967|NCT00384085|12114990|FG000|Overall Study|Patient moved|1
7694968|NCT00384085|12114991|FG001|Overall Study|Patient moved|0
7694969|NCT00384085|12114992|FG002|Overall Study|Patient moved|1
7694970|NCT00384085|12114990|FG000|Overall Study|Patient required surgery|0
7694971|NCT00384085|12114991|FG001|Overall Study|Patient required surgery|1
7694972|NCT00384085|12114992|FG002|Overall Study|Patient required surgery|0
7694973|NCT00384176|12115005|FG000|Overall Study|Death|239
7694974|NCT00384176|12115006|FG001|Overall Study|Death|247
7694975|NCT00384176|12115007|FG002|Overall Study|Death|105
7694976|NCT00384176|12115005|FG000|Overall Study|Withdrawal by Subject|52
7694977|NCT00384176|12115006|FG001|Overall Study|Withdrawal by Subject|48
7694978|NCT00384176|12115007|FG002|Overall Study|Withdrawal by Subject|22
7694979|NCT00384176|12115005|FG000|Overall Study|Lost to Follow-up|16
7694980|NCT00384176|12115006|FG001|Overall Study|Lost to Follow-up|18
7694981|NCT00384176|12115007|FG002|Overall Study|Lost to Follow-up|4
7694982|NCT00384176|12115005|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2
7694983|NCT00384176|12115006|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3
7694984|NCT00384176|12115007|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0
7694985|NCT00384176|12115005|FG000|Overall Study|Longer QTC as Visit 1|1
7694986|NCT00384176|12115006|FG001|Overall Study|Longer QTC as Visit 1|0
7694987|NCT00384176|12115007|FG002|Overall Study|Longer QTC as Visit 1|0
7694988|NCT00384176|12115005|FG000|Overall Study|Toxicity of treatment|1
7694989|NCT00384176|12115006|FG001|Overall Study|Toxicity of treatment|0
7694990|NCT00384176|12115007|FG002|Overall Study|Toxicity of treatment|0
7694991|NCT00384176|12115005|FG000|Overall Study|Did not receive study treatment|0
7694992|NCT00384176|12115006|FG001|Overall Study|Did not receive study treatment|1
7694993|NCT00384176|12115007|FG002|Overall Study|Did not receive study treatment|1
7694994|NCT00384176|12115005|FG000|Overall Study|Physician Decision|0
7694995|NCT00384176|12115006|FG001|Overall Study|Physician Decision|2
7694996|NCT00384176|12115007|FG002|Overall Study|Physician Decision|0
7694997|NCT00384176|12115005|FG000|Overall Study|Liver metastases, colon resec. planned|1
7694998|NCT00384176|12115006|FG001|Overall Study|Liver metastases, colon resec. planned|0
7694999|NCT00384176|12115007|FG002|Overall Study|Liver metastases, colon resec. planned|0
7695000|NCT00384189|12115019|FG000|Overall Study|Reason Not Specified|50
7695001|NCT00384189|12115020|FG001|Overall Study|Reason Not Specified|57
7695002|NCT00384189|12115021|FG002|Overall Study|Reason Not Specified|58
7695003|NCT00384189|12115022|FG003|Overall Study|Reason Not Specified|40
7695004|NCT00384332|12115042|FG000|Overall Study|Lost to Follow-up|4
7695005|NCT00384332|12115043|FG001|Overall Study|Lost to Follow-up|0
7695006|NCT00384397|12115054|FG000|Overall Study|Adverse Event|0
7695007|NCT00384397|12115055|FG001|Overall Study|Adverse Event|1
7695008|NCT00384397|12115056|FG002|Overall Study|Adverse Event|2
7695009|NCT00384397|12115054|FG000|Overall Study|Protocol Violation|7
7695010|NCT00384397|12115055|FG001|Overall Study|Protocol Violation|15
7695011|NCT00384397|12115056|FG002|Overall Study|Protocol Violation|13
7695012|NCT00384397|12115054|FG000|Overall Study|Lost to Follow-up|11
7695013|NCT00384397|12115055|FG001|Overall Study|Lost to Follow-up|13
7695014|NCT00384397|12115056|FG002|Overall Study|Lost to Follow-up|3
7695015|NCT00384397|12115054|FG000|Overall Study|Withdrawal by Subject|14
7695016|NCT00384397|12115055|FG001|Overall Study|Withdrawal by Subject|17
7695017|NCT00384397|12115056|FG002|Overall Study|Withdrawal by Subject|15
7695018|NCT00384839|12115119|FG000|Overall Study|Adverse Event|4
7695019|NCT00384839|12115119|FG000|Overall Study|Investigator Request|1
7695020|NCT00384839|12115119|FG000|Overall Study|Patient Request|1
7695021|NCT00384839|12115119|FG000|Overall Study|Ineligible|2
7695022|NCT00384930|12115145|FG000|Overall Study|Adverse Event|5
7695023|NCT00384930|12115146|FG001|Overall Study|Adverse Event|4
7695024|NCT00384930|12115147|FG002|Overall Study|Adverse Event|12
7695025|NCT00384930|12115148|FG003|Overall Study|Adverse Event|11
7695026|NCT00384930|12115149|FG004|Overall Study|Adverse Event|14
7695027|NCT00384930|12115145|FG000|Overall Study|Entry Criteria Not Met|2
7695028|NCT00384930|12115146|FG001|Overall Study|Entry Criteria Not Met|6
7695029|NCT00384930|12115147|FG002|Overall Study|Entry Criteria Not Met|7
7695030|NCT00384930|12115148|FG003|Overall Study|Entry Criteria Not Met|8
7695031|NCT00384930|12115149|FG004|Overall Study|Entry Criteria Not Met|4
7695032|NCT00384930|12115145|FG000|Overall Study|Lack of Efficacy|1
7695033|NCT00384930|12115146|FG001|Overall Study|Lack of Efficacy|1
7695034|NCT00384930|12115147|FG002|Overall Study|Lack of Efficacy|2
7695035|NCT00384930|12115148|FG003|Overall Study|Lack of Efficacy|1
7695036|NCT00384930|12115149|FG004|Overall Study|Lack of Efficacy|2
7695037|NCT00384930|12115145|FG000|Overall Study|Lost to Follow-up|5
7695038|NCT00384930|12115146|FG001|Overall Study|Lost to Follow-up|3
7695039|NCT00384930|12115147|FG002|Overall Study|Lost to Follow-up|0
7695040|NCT00384930|12115148|FG003|Overall Study|Lost to Follow-up|4
7695041|NCT00384930|12115149|FG004|Overall Study|Lost to Follow-up|6
7695042|NCT00384930|12115145|FG000|Overall Study|Physician Decision|0
7695043|NCT00384930|12115146|FG001|Overall Study|Physician Decision|1
7695044|NCT00384930|12115147|FG002|Overall Study|Physician Decision|1
7695045|NCT00384930|12115148|FG003|Overall Study|Physician Decision|0
7695046|NCT00384930|12115149|FG004|Overall Study|Physician Decision|1
7695047|NCT00384930|12115145|FG000|Overall Study|Protocol Violation|1
7695048|NCT00384930|12115146|FG001|Overall Study|Protocol Violation|0
7695049|NCT00384930|12115147|FG002|Overall Study|Protocol Violation|1
7695050|NCT00384930|12115148|FG003|Overall Study|Protocol Violation|6
7695051|NCT00384930|12115149|FG004|Overall Study|Protocol Violation|4
7695052|NCT00384930|12115145|FG000|Overall Study|Sponsor Decision|3
7695053|NCT00384930|12115146|FG001|Overall Study|Sponsor Decision|4
7695054|NCT00384930|12115147|FG002|Overall Study|Sponsor Decision|0
7695055|NCT00384930|12115148|FG003|Overall Study|Sponsor Decision|5
7695056|NCT00384930|12115149|FG004|Overall Study|Sponsor Decision|0
7695057|NCT00384930|12115145|FG000|Overall Study|Withdrawal by Subject|9
7695058|NCT00384930|12115146|FG001|Overall Study|Withdrawal by Subject|7
7695059|NCT00384930|12115147|FG002|Overall Study|Withdrawal by Subject|7
7695060|NCT00384930|12115148|FG003|Overall Study|Withdrawal by Subject|6
7695061|NCT00384930|12115149|FG004|Overall Study|Withdrawal by Subject|16
7695062|NCT00384930|12115145|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1
7695063|NCT00384930|12115146|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1
7695064|NCT00384930|12115147|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0
7695065|NCT00384930|12115148|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0
7695066|NCT00384930|12115149|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0
7695067|NCT00384956|12115164|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3
7695068|NCT00385203|12115189|FG000|Overall Study|Adverse Event|5
7695069|NCT00385203|12115190|FG001|Overall Study|Adverse Event|4
7695070|NCT00385203|12115189|FG000|Overall Study|Death|1
7695071|NCT00385203|12115190|FG001|Overall Study|Death|0
7695072|NCT00385203|12115189|FG000|Overall Study|Condition under investigation worsened|18
7695073|NCT00385203|12115190|FG001|Overall Study|Condition under investigation worsened|3
7695074|NCT00385203|12115189|FG000|Overall Study|Incorrect enrollment|2
7695075|NCT00385203|12115190|FG001|Overall Study|Incorrect enrollment|0
7695076|NCT00385255|12115206|FG000|Overall Study|Serious Adverse Event|1
7695077|NCT00385255|12115207|FG001|Overall Study|Serious Adverse Event|2
7695078|NCT00385255|12115206|FG000|Overall Study|Protocol Violation|0
7695079|NCT00385255|12115207|FG001|Overall Study|Protocol Violation|4
7695080|NCT00385255|12115206|FG000|Overall Study|Withdrawal by Subject|0
7695081|NCT00385255|12115207|FG001|Overall Study|Withdrawal by Subject|8
7695082|NCT00385255|12115206|FG000|Overall Study|Migrated/moved from study area|0
7695083|NCT00385255|12115207|FG001|Overall Study|Migrated/moved from study area|1
7695084|NCT00385255|12115206|FG000|Overall Study|Lost to Follow-up|20
7695085|NCT00385255|12115207|FG001|Overall Study|Lost to Follow-up|58
7695086|NCT00385541|12115228|FG000|Overall Study|severe pain, clinician requested unblind|0
7695087|NCT00385541|12115229|FG001|Overall Study|severe pain, clinician requested unblind|1
7695088|NCT00385593|12115256|FG000|Overall Study|Adverse Event|3
7695089|NCT00385593|12115257|FG001|Overall Study|Adverse Event|2
7695090|NCT00385593|12115256|FG000|Overall Study|Withdrawal by Subject|17
7695091|NCT00385593|12115257|FG001|Overall Study|Withdrawal by Subject|7
7695092|NCT00385593|12115256|FG000|Overall Study|Lost to Follow-up|12
7695093|NCT00385593|12115257|FG001|Overall Study|Lost to Follow-up|8
7695094|NCT00385593|12115256|FG000|Overall Study|Protocol Violation|7
7695095|NCT00385593|12115257|FG001|Overall Study|Protocol Violation|4
7695096|NCT00385593|12115256|FG000|Overall Study|Several reasons|17
7695097|NCT00385593|12115257|FG001|Overall Study|Several reasons|15
7695098|NCT00385593|12115256|FG000|Overall Study|Incorrect inclusion|2
7695099|NCT00385593|12115257|FG001|Overall Study|Incorrect inclusion|0
7695100|NCT00385593|12115256|FG000|Overall Study|Incorrect randomization|0
7695101|NCT00385593|12115257|FG001|Overall Study|Incorrect randomization|1
7695102|NCT00385671|12115266|FG000|Overall Study|Adverse Event|14
7695103|NCT00385671|12115267|FG001|Overall Study|Adverse Event|27
7695104|NCT00385671|12115268|FG002|Overall Study|Adverse Event|18
7695105|NCT00385671|12115266|FG000|Overall Study|Lack of Efficacy|5
7695106|NCT00385671|12115267|FG001|Overall Study|Lack of Efficacy|9
7695107|NCT00385671|12115268|FG002|Overall Study|Lack of Efficacy|5
7695108|NCT00385671|12115266|FG000|Overall Study|Lost to Follow-up|6
7695109|NCT00385671|12115267|FG001|Overall Study|Lost to Follow-up|6
7695110|NCT00385671|12115268|FG002|Overall Study|Lost to Follow-up|5
7695111|NCT00385671|12115266|FG000|Overall Study|Physician Decision|2
7695112|NCT00385671|12115267|FG001|Overall Study|Physician Decision|1
7695113|NCT00385671|12115268|FG002|Overall Study|Physician Decision|2
7695114|NCT00385671|12115266|FG000|Overall Study|Protocol Violation|5
7695115|NCT00385671|12115267|FG001|Overall Study|Protocol Violation|2
7695116|NCT00385671|12115268|FG002|Overall Study|Protocol Violation|1
7695117|NCT00385671|12115266|FG000|Overall Study|Sponsor Decision|2
7695118|NCT00385671|12115267|FG001|Overall Study|Sponsor Decision|2
7695119|NCT00385671|12115268|FG002|Overall Study|Sponsor Decision|1
7695120|NCT00385671|12115266|FG000|Overall Study|Withdrawal by Subject|4
7695121|NCT00385671|12115267|FG001|Overall Study|Withdrawal by Subject|4
7695122|NCT00385671|12115268|FG002|Overall Study|Withdrawal by Subject|4
7695123|NCT00385684|12115278|FG000|FIRST INTERVENTION OF PHASE A|Death|1
7695124|NCT00385684|12115279|FG001|FIRST INTERVENTION OF PHASE A|Death|0
7695125|NCT00385684|12115278|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0
7695126|NCT00385684|12115279|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1
7695127|NCT00385684|12115278|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0
7695128|NCT00385684|12115279|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1
7695129|NCT00385723|12115288|FG000|Overall Study|Lost to Follow-up|1
7695130|NCT00385723|12115289|FG001|Overall Study|Lost to Follow-up|1
7695131|NCT00385723|12115290|FG002|Overall Study|Lost to Follow-up|0
7695132|NCT00385723|12115288|FG000|Overall Study|Withdrawal by Subject|1
7695133|NCT00385723|12115289|FG001|Overall Study|Withdrawal by Subject|0
7695134|NCT00385723|12115290|FG002|Overall Study|Withdrawal by Subject|2
7695135|NCT00385736|12115301|FG000|Efficacy Analysis Set - Induction|Adverse Event|5
7695136|NCT00385736|12115302|FG001|Efficacy Analysis Set - Induction|Adverse Event|6
7695137|NCT00385736|12115303|FG002|Efficacy Analysis Set - Induction|Adverse Event|4
7695138|NCT00385736|12115301|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
7695139|NCT00385736|12115302|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
7695140|NCT00385736|12115303|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
7695141|NCT00385736|12115301|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0
7695142|NCT00385736|12115302|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2
7695143|NCT00385736|12115303|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0
7695144|NCT00385736|12115301|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4
7695145|NCT00385736|12115302|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2
7695146|NCT00385736|12115303|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1
7695147|NCT00385736|12115301|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0
7695148|NCT00385736|12115302|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0
7695149|NCT00385736|12115303|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2
7695150|NCT00385736|12115301|FG000|Efficacy Analysis Set - Induction|Other|0
7695151|NCT00385736|12115302|FG001|Efficacy Analysis Set - Induction|Other|0
7695152|NCT00385736|12115303|FG002|Efficacy Analysis Set - Induction|Other|1
7695153|NCT00385736|12115301|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23
7695154|NCT00385736|12115302|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15
7695155|NCT00385736|12115303|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23
7695156|NCT00385736|12115301|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
7695157|NCT00385736|12115302|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
7695158|NCT00385736|12115303|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
7695159|NCT00385736|12115301|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
7695160|NCT00385736|12115302|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
7695161|NCT00385736|12115303|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
7695162|NCT00385736|12115301|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
7695163|NCT00385736|12115302|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
7695164|NCT00385736|12115303|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
7695165|NCT00385736|12115301|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2
7695166|NCT00385736|12115302|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1
7695167|NCT00385736|12115303|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6
7695168|NCT00385736|12115301|FG000|Efficacy Analysis Set - Maintenance|Other|0
7695169|NCT00385736|12115302|FG001|Efficacy Analysis Set - Maintenance|Other|4
7695170|NCT00385736|12115303|FG002|Efficacy Analysis Set - Maintenance|Other|4
7695171|NCT00385736|12115301|FG000|Safety Analysis Set|Adverse Event|23
7695172|NCT00385736|12115302|FG001|Safety Analysis Set|Adverse Event|15
7695173|NCT00385736|12115303|FG002|Safety Analysis Set|Adverse Event|23
7695174|NCT00385736|12115301|FG000|Safety Analysis Set|Withdrawal by Subject|6
7695175|NCT00385736|12115302|FG001|Safety Analysis Set|Withdrawal by Subject|6
7695176|NCT00385736|12115303|FG002|Safety Analysis Set|Withdrawal by Subject|14
7695177|NCT00385736|12115301|FG000|Safety Analysis Set|Lost to Follow-up|0
7695178|NCT00385736|12115302|FG001|Safety Analysis Set|Lost to Follow-up|2
7695179|NCT00385736|12115303|FG002|Safety Analysis Set|Lost to Follow-up|2
7695180|NCT00385736|12115301|FG000|Safety Analysis Set|Lack of Efficacy|38
7695181|NCT00385736|12115302|FG001|Safety Analysis Set|Lack of Efficacy|16
7695182|NCT00385736|12115303|FG002|Safety Analysis Set|Lack of Efficacy|31
7695183|NCT00385736|12115301|FG000|Safety Analysis Set|Protocol Violation|2
7695184|NCT00385736|12115302|FG001|Safety Analysis Set|Protocol Violation|1
7695185|NCT00385736|12115303|FG002|Safety Analysis Set|Protocol Violation|6
7695186|NCT00385736|12115301|FG000|Safety Analysis Set|Other|1
7695187|NCT00385736|12115302|FG001|Safety Analysis Set|Other|4
7695188|NCT00385736|12115303|FG002|Safety Analysis Set|Other|4
7695189|NCT00385762|12115314|FG000|Overall Study|Adverse Event|1
7695190|NCT00385762|12115314|FG000|Overall Study|Lost to Follow-up|1
7695191|NCT00385827|12115340|FG000|Part 1|Adverse Event|1
7695192|NCT00385827|12115341|FG001|Part 1|Adverse Event|0
7695193|NCT00385827|12115342|FG002|Part 1|Adverse Event|0
7695194|NCT00385827|12115340|FG000|Part 1|Death|2
7695195|NCT00385827|12115341|FG001|Part 1|Death|0
7695196|NCT00385827|12115342|FG002|Part 1|Death|0
7695197|NCT00385827|12115340|FG000|Part 1|Lack of Efficacy|5
7695198|NCT00385827|12115341|FG001|Part 1|Lack of Efficacy|0
7695199|NCT00385827|12115342|FG002|Part 1|Lack of Efficacy|0
7695200|NCT00385827|12115340|FG000|Part 1|Other|1
7695201|NCT00385827|12115341|FG001|Part 1|Other|0
7695202|NCT00385827|12115342|FG002|Part 1|Other|0
7695203|NCT00385827|12115340|FG000|Part 2|Adverse Event|0
7695204|NCT00385827|12115341|FG001|Part 2|Adverse Event|6
7695205|NCT00385827|12115342|FG002|Part 2|Adverse Event|10
7695206|NCT00385827|12115340|FG000|Part 2|Death|0
7695207|NCT00385827|12115341|FG001|Part 2|Death|0
7695208|NCT00385827|12115342|FG002|Part 2|Death|2
7695209|NCT00385827|12115340|FG000|Part 2|Lack of Efficacy|0
7695210|NCT00385827|12115341|FG001|Part 2|Lack of Efficacy|14
7695211|NCT00385827|12115342|FG002|Part 2|Lack of Efficacy|13
7695212|NCT00385827|12115340|FG000|Part 2|Randomized but not treated|0
7695213|NCT00385827|12115341|FG001|Part 2|Randomized but not treated|2
7695214|NCT00385827|12115342|FG002|Part 2|Randomized but not treated|2
7695215|NCT00385827|12115340|FG000|Part 2|Other|0
7695216|NCT00385827|12115341|FG001|Part 2|Other|11
7695217|NCT00385827|12115342|FG002|Part 2|Other|21
7695218|NCT00385840|12115354|FG000|Overall Study|Adverse Event|1
7695219|NCT00385840|12115355|FG001|Overall Study|Adverse Event|1
7695220|NCT00385840|12115354|FG000|Overall Study|Lost to Follow-up|3
7695221|NCT00385840|12115355|FG001|Overall Study|Lost to Follow-up|13
7695222|NCT00385918|12115363|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
7695223|NCT00385918|12115364|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
7695224|NCT00385918|12115365|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
7695225|NCT00385918|12115363|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
7695226|NCT00385918|12115364|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
7695227|NCT00385918|12115365|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
7695228|NCT00385918|12115363|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0
7695229|NCT00385918|12115364|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0
7695230|NCT00385918|12115365|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1
7695231|NCT00385918|12115363|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1
7695232|NCT00385918|12115364|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0
7695233|NCT00385918|12115365|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0
7695234|NCT00385918|12115363|FG000|Intervention Phase After Randomization|Physician Decision|1
7695235|NCT00385918|12115364|FG001|Intervention Phase After Randomization|Physician Decision|0
7695236|NCT00385918|12115365|FG002|Intervention Phase After Randomization|Physician Decision|0
7695237|NCT00385918|12115363|FG000|Intervention Phase After Randomization|Lost to Follow-up|1
7695238|NCT00385918|12115364|FG001|Intervention Phase After Randomization|Lost to Follow-up|0
7695239|NCT00385918|12115365|FG002|Intervention Phase After Randomization|Lost to Follow-up|0
7695240|NCT00385944|12115374|FG000|1st Maintenance Dose Period|Physician Decision|1
7695241|NCT00385944|12115375|FG001|1st Maintenance Dose Period|Physician Decision|0
7695242|NCT00385944|12115376|FG002|1st Maintenance Dose Period|Physician Decision|0
7695243|NCT00385944|12115374|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0
7695244|NCT00385944|12115375|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1
7695245|NCT00385944|12115376|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0
7695246|NCT00385944|12115374|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
7695247|NCT00385944|12115375|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
7695248|NCT00385944|12115376|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
7695249|NCT00385944|12115374|FG000|2nd Maintenance Dose Period|Invalid PD Data|2
7695250|NCT00385944|12115375|FG001|2nd Maintenance Dose Period|Invalid PD Data|3
7695251|NCT00385944|12115376|FG002|2nd Maintenance Dose Period|Invalid PD Data|0
7695252|NCT00386009|12115398|FG000|Overall Study|Adverse Event|0
7695253|NCT00386009|12115399|FG001|Overall Study|Adverse Event|2
7695254|NCT00386009|12115398|FG000|Overall Study|Death|1
7695255|NCT00386009|12115399|FG001|Overall Study|Death|0
7695256|NCT00386009|12115398|FG000|Overall Study|Entry Criteria Not Met|0
7695257|NCT00386009|12115399|FG001|Overall Study|Entry Criteria Not Met|2
7695258|NCT00386009|12115398|FG000|Overall Study|Lost to Follow-up|1
7695259|NCT00386009|12115399|FG001|Overall Study|Lost to Follow-up|1
7695260|NCT00386009|12115398|FG000|Overall Study|Protocol Violation|1
7695261|NCT00386009|12115399|FG001|Overall Study|Protocol Violation|0
7695262|NCT00386009|12115398|FG000|Overall Study|Sponsor Decision|1
7695263|NCT00386009|12115399|FG001|Overall Study|Sponsor Decision|1
7695264|NCT00386009|12115398|FG000|Overall Study|Withdrawal by Subject|5
7695265|NCT00386009|12115399|FG001|Overall Study|Withdrawal by Subject|4
7695266|NCT00386022|12115407|FG000|Plus Estrogen|Lost to Follow-up|2
7695267|NCT00386022|12115408|FG001|Plus Estrogen|Lost to Follow-up|0
7695268|NCT00386022|12115407|FG000|Plus Estrogen|Adverse Event|0
7695269|NCT00386022|12115408|FG001|Plus Estrogen|Adverse Event|1
7695270|NCT00386100|12115418|FG000|Overall Study|Did not receive study medication|6
7695271|NCT00386100|12115419|FG001|Overall Study|Did not receive study medication|4
7695272|NCT00386100|12115418|FG000|Overall Study|Adverse Event|15
7695273|NCT00386100|12115419|FG001|Overall Study|Adverse Event|25
7695274|NCT00386100|12115418|FG000|Overall Study|Death|0
7695275|NCT00386100|12115419|FG001|Overall Study|Death|1
7695276|NCT00386100|12115418|FG000|Overall Study|Insufficient therapeutic effect|30
7695277|NCT00386100|12115419|FG001|Overall Study|Insufficient therapeutic effect|6
7695278|NCT00386100|12115418|FG000|Overall Study|Lost to Follow-up|29
7695279|NCT00386100|12115419|FG001|Overall Study|Lost to Follow-up|29
7695280|NCT00386100|12115418|FG000|Overall Study|Non-compliance|18
7695281|NCT00386100|12115419|FG001|Overall Study|Non-compliance|19
7695282|NCT00386100|12115418|FG000|Overall Study|Protocol Violation|5
7695283|NCT00386100|12115419|FG001|Overall Study|Protocol Violation|3
7695284|NCT00386100|12115418|FG000|Overall Study|Withdrawal by Subject|32
7695285|NCT00386100|12115419|FG001|Overall Study|Withdrawal by Subject|31
7695286|NCT00386100|12115418|FG000|Overall Study|Bone mass density (BMD) loss >6%|4
7695287|NCT00386100|12115419|FG001|Overall Study|Bone mass density (BMD) loss >6%|4
7695288|NCT00386100|12115418|FG000|Overall Study|BMD <2.5|1
7695289|NCT00386100|12115419|FG001|Overall Study|BMD <2.5|0
7695290|NCT00386100|12115418|FG000|Overall Study|Consecutive elevated Hba1C|1
7695291|NCT00386100|12115419|FG001|Overall Study|Consecutive elevated Hba1C|0
7695292|NCT00386100|12115418|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0
7695293|NCT00386100|12115419|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1
7695294|NCT00386100|12115418|FG000|Overall Study|Laboratory findings|1
7695295|NCT00386100|12115419|FG001|Overall Study|Laboratory findings|0
7695296|NCT00386100|12115418|FG000|Overall Study|Participant's concern due to CPK levels|1
7695297|NCT00386100|12115419|FG001|Overall Study|Participant's concern due to CPK levels|0
7695298|NCT00386100|12115418|FG000|Overall Study|Participant moving out of state|2
7695299|NCT00386100|12115419|FG001|Overall Study|Participant moving out of state|0
7695300|NCT00386100|12115418|FG000|Overall Study|Excessive bone loss vs. baseline value|0
7695301|NCT00386100|12115419|FG001|Overall Study|Excessive bone loss vs. baseline value|1
7695302|NCT00386100|12115418|FG000|Overall Study|Didn't meet entry criteria|1
7695303|NCT00386100|12115419|FG001|Overall Study|Didn't meet entry criteria|1
7695304|NCT00386100|12115418|FG000|Overall Study|Participant's PCP wanted to stop drug|1
7695305|NCT00386100|12115419|FG001|Overall Study|Participant's PCP wanted to stop drug|0
7695306|NCT00386100|12115418|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0
7695307|NCT00386100|12115419|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1
7695308|NCT00386100|12115418|FG000|Overall Study|Bad metabolic control & patient security|1
7695309|NCT00386100|12115419|FG001|Overall Study|Bad metabolic control & patient security|0
7695310|NCT00386100|12115418|FG000|Overall Study|Bone loss by DXA bone scan|1
7695311|NCT00386100|12115419|FG001|Overall Study|Bone loss by DXA bone scan|0
7695312|NCT00386100|12115418|FG000|Overall Study|DBP 93 mmHg at randomization|1
7695313|NCT00386100|12115419|FG001|Overall Study|DBP 93 mmHg at randomization|0
7695314|NCT00386100|12115418|FG000|Overall Study|7.6% bone loss|1
7695315|NCT00386100|12115419|FG001|Overall Study|7.6% bone loss|0
7695316|NCT00386100|12115418|FG000|Overall Study|Osteoporosis|0
7695317|NCT00386100|12115419|FG001|Overall Study|Osteoporosis|1
7695318|NCT00386100|12115418|FG000|Overall Study|Positive pregnancy test|1
7695319|NCT00386100|12115419|FG001|Overall Study|Positive pregnancy test|3
7695320|NCT00386100|12115418|FG000|Overall Study|Out of country for 5 months|1
7695321|NCT00386100|12115419|FG001|Overall Study|Out of country for 5 months|0
7695322|NCT00386100|12115418|FG000|Overall Study|Hb1Ac >8%|0
7695323|NCT00386100|12115419|FG001|Overall Study|Hb1Ac >8%|1
7695324|NCT00386100|12115418|FG000|Overall Study|Participant randomized in error|1
7695325|NCT00386100|12115419|FG001|Overall Study|Participant randomized in error|0
7695326|NCT00386152|12115428|FG000|Overall Study|Adverse Event|6
7695327|NCT00386152|12115429|FG001|Overall Study|Adverse Event|5
7695328|NCT00386152|12115430|FG002|Overall Study|Adverse Event|4
7695329|NCT00386152|12115428|FG000|Overall Study|Chang from original chemo stratification|4
7695330|NCT00386152|12115429|FG001|Overall Study|Chang from original chemo stratification|5
7695331|NCT00386152|12115430|FG002|Overall Study|Chang from original chemo stratification|6
7695332|NCT00386152|12115428|FG000|Overall Study|Death|3
7695333|NCT00386152|12115429|FG001|Overall Study|Death|0
7695334|NCT00386152|12115430|FG002|Overall Study|Death|1
7695335|NCT00386152|12115428|FG000|Overall Study|Disease progression|7
7695336|NCT00386152|12115429|FG001|Overall Study|Disease progression|4
7695337|NCT00386152|12115430|FG002|Overall Study|Disease progression|5
7695338|NCT00386152|12115428|FG000|Overall Study|Physician Decision|13
7695339|NCT00386152|12115429|FG001|Overall Study|Physician Decision|10
7695340|NCT00386152|12115430|FG002|Overall Study|Physician Decision|4
7695341|NCT00386152|12115428|FG000|Overall Study|Lost to Follow-up|1
7695342|NCT00386152|12115429|FG001|Overall Study|Lost to Follow-up|0
7695343|NCT00386152|12115430|FG002|Overall Study|Lost to Follow-up|0
7695344|NCT00386152|12115428|FG000|Overall Study|Completed chemotherapy|4
7695345|NCT00386152|12115429|FG001|Overall Study|Completed chemotherapy|5
7695346|NCT00386152|12115430|FG002|Overall Study|Completed chemotherapy|1
7695347|NCT00386152|12115428|FG000|Overall Study|Protocol Violation|3
7695348|NCT00386152|12115429|FG001|Overall Study|Protocol Violation|5
7695349|NCT00386152|12115430|FG002|Overall Study|Protocol Violation|2
7695350|NCT00386152|12115428|FG000|Overall Study|Withdrawal by Subject|3
7695351|NCT00386152|12115429|FG001|Overall Study|Withdrawal by Subject|6
7695352|NCT00386152|12115430|FG002|Overall Study|Withdrawal by Subject|10
7695353|NCT00386308|12115466|FG000|Overall Study|Adverse Event|3
7695354|NCT00386308|12115467|FG001|Overall Study|Adverse Event|3
7695355|NCT00386308|12115466|FG000|Overall Study|Protocol Violation|2
7695356|NCT00386308|12115467|FG001|Overall Study|Protocol Violation|5
7695357|NCT00386308|12115466|FG000|Overall Study|Lack of Efficacy|0
7695358|NCT00386308|12115467|FG001|Overall Study|Lack of Efficacy|2
7695359|NCT00386308|12115466|FG000|Overall Study|Lost to Follow-up|10
7695360|NCT00386308|12115467|FG001|Overall Study|Lost to Follow-up|6
7695361|NCT00386308|12115466|FG000|Overall Study|Withdrawal by Subject|6
7695362|NCT00386308|12115467|FG001|Overall Study|Withdrawal by Subject|2
7695363|NCT00386308|12115466|FG000|Overall Study|Other Event|8
7695364|NCT00386308|12115467|FG001|Overall Study|Other Event|1
7695365|NCT00386334|12115475|FG000|Double Blind Period|Adverse Event|9
7695366|NCT00386334|12115476|FG001|Double Blind Period|Adverse Event|14
7695367|NCT00386334|12115475|FG000|Double Blind Period|Protocol Violation|1
7695368|NCT00386334|12115476|FG001|Double Blind Period|Protocol Violation|1
7695369|NCT00386334|12115475|FG000|Double Blind Period|Withdrawal by Subject|9
7695370|NCT00386334|12115476|FG001|Double Blind Period|Withdrawal by Subject|13
7695371|NCT00386334|12115475|FG000|Double Blind Period|Lack of Efficacy|20
7695372|NCT00386334|12115476|FG001|Double Blind Period|Lack of Efficacy|11
7695373|NCT00386334|12115475|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
7695374|NCT00386334|12115476|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
7695375|NCT00386334|12115475|FG000|Double Blind Period|Other|3
7695376|NCT00386334|12115476|FG001|Double Blind Period|Other|3
7695377|NCT00386334|12115475|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
7695378|NCT00386334|12115476|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
7695379|NCT00386360|12115484|FG000|Overall Study|Adverse Event|4
7695380|NCT00386360|12115485|FG001|Overall Study|Adverse Event|2
7695381|NCT00386360|12115484|FG000|Overall Study|Physician Decision|2
7695382|NCT00386360|12115485|FG001|Overall Study|Physician Decision|2
7695383|NCT00386360|12115484|FG000|Overall Study|Lost to Follow-up|0
7695384|NCT00386360|12115485|FG001|Overall Study|Lost to Follow-up|2
7695385|NCT00386360|12115484|FG000|Overall Study|Protocol Violation|0
7695386|NCT00386360|12115485|FG001|Overall Study|Protocol Violation|3
7695387|NCT00386360|12115484|FG000|Overall Study|Withdrawal by Subject|3
7695388|NCT00386360|12115485|FG001|Overall Study|Withdrawal by Subject|6
7695389|NCT00386360|12115484|FG000|Overall Study|Did not take any study medication|0
7695390|NCT00386360|12115485|FG001|Overall Study|Did not take any study medication|2
7695391|NCT00386425|12115494|FG000|Overall Study|Physician Decision|3
7695392|NCT00386425|12115495|FG001|Overall Study|Physician Decision|0
7695393|NCT00386425|12115496|FG002|Overall Study|Physician Decision|0
7695394|NCT00386425|12115494|FG000|Overall Study|Withdrawal by Subject|0
7695395|NCT00386425|12115495|FG001|Overall Study|Withdrawal by Subject|1
7695396|NCT00386425|12115496|FG002|Overall Study|Withdrawal by Subject|0
7695397|NCT00386607|12115517|FG000|Core|Adverse Event|40
7695398|NCT00386607|12115518|FG001|Core|Adverse Event|0
7695399|NCT00386607|12115517|FG000|Core|Abnormal laboratory value(s)|3
7695400|NCT00386607|12115518|FG001|Core|Abnormal laboratory value(s)|0
7695401|NCT00386607|12115517|FG000|Core|Unsatisfactory therapeutic effect|23
7695402|NCT00386607|12115518|FG001|Core|Unsatisfactory therapeutic effect|0
7695403|NCT00386607|12115517|FG000|Core|Condition no longer requires study drug|4
7695404|NCT00386607|12115518|FG001|Core|Condition no longer requires study drug|0
7695405|NCT00386607|12115517|FG000|Core|Patient withdrew consent|15
7695406|NCT00386607|12115518|FG001|Core|Patient withdrew consent|0
7695407|NCT00386607|12115517|FG000|Core|Lost to Follow-up|23
7695408|NCT00386607|12115518|FG001|Core|Lost to Follow-up|0
7695409|NCT00386607|12115517|FG000|Core|Administrative problems|1
7695410|NCT00386607|12115518|FG001|Core|Administrative problems|0
7695411|NCT00386607|12115517|FG000|Core|Protocol Deviation|6
7695412|NCT00386607|12115518|FG001|Core|Protocol Deviation|0
7695413|NCT00386607|12115517|FG000|Extension|Adverse Event|0
7695414|NCT00386607|12115518|FG001|Extension|Adverse Event|6
7695415|NCT00386607|12115517|FG000|Extension|Abnormal laboratory value(s)|0
7695416|NCT00386607|12115518|FG001|Extension|Abnormal laboratory value(s)|1
7695417|NCT00386607|12115517|FG000|Extension|Administrative problems|0
7695418|NCT00386607|12115518|FG001|Extension|Administrative problems|1
7695419|NCT00386607|12115517|FG000|Extension|Lost to Follow-up|0
7695420|NCT00386607|12115518|FG001|Extension|Lost to Follow-up|3
7695421|NCT00386607|12115517|FG000|Extension|Patient withdrew consent|0
7695422|NCT00386607|12115518|FG001|Extension|Patient withdrew consent|5
7695423|NCT00386607|12115517|FG000|Extension|Unsatisfactory therapeutic effect|0
7695424|NCT00386607|12115518|FG001|Extension|Unsatisfactory therapeutic effect|1
7695425|NCT00386776|12115530|FG000|Overall Study|Withdrawal by Subject|8
7695426|NCT00387010|12115542|FG000|Dose Titration Period|Adverse Event|12
7695427|NCT00387010|12115542|FG000|Dose Titration Period|Lack of Efficacy|5
7695428|NCT00387010|12115542|FG000|Dose Titration Period|Withdrawal by Subject|3
7695429|NCT00387010|12115542|FG000|Dose Titration Period|Protocol Violation|1
7695430|NCT00387010|12115542|FG000|Dose Titration Period|Lost to Follow-up|2
7695431|NCT00387010|12115542|FG000|Dose Titration Period|Noncompliance with study medication|8
7695432|NCT00387010|12115542|FG000|Dose Titration Period|Noncompliance with study procedures|7
7695433|NCT00387010|12115542|FG000|Treatment Period|Adverse Event|4
7695434|NCT00387010|12115542|FG000|Treatment Period|Withdrawal by Subject|1
7695435|NCT00387010|12115542|FG000|Treatment Period|Noncompliance with study medication|2
7695436|NCT00387010|12115542|FG000|Treatment Period|Noncompliance with study procedures|3
7695437|NCT00387010|12115542|FG000|Treatment Period|Participant reported study drug stolen|1
7695438|NCT00387088|12115559|FG000|Overall Study|Adverse Event|143
7695439|NCT00387088|12115560|FG001|Overall Study|Adverse Event|156
7695440|NCT00387088|12115559|FG000|Overall Study|Protocol Violation|47
7695441|NCT00387088|12115560|FG001|Overall Study|Protocol Violation|35
7695442|NCT00387088|12115559|FG000|Overall Study|Withdrawal by Subject|20
7695443|NCT00387088|12115560|FG001|Overall Study|Withdrawal by Subject|35
7695444|NCT00387088|12115559|FG000|Overall Study|Lack of Efficacy|28
7695445|NCT00387088|12115560|FG001|Overall Study|Lack of Efficacy|67
7695446|NCT00387088|12115559|FG000|Overall Study|Lost to Follow-up|22
7695447|NCT00387088|12115560|FG001|Overall Study|Lost to Follow-up|28
7695448|NCT00387088|12115559|FG000|Overall Study|Other|58
7695449|NCT00387088|12115560|FG001|Overall Study|Other|52
7695450|NCT00387127|12115568|FG000|Overall Study|Lost to Follow-up|0
7695451|NCT00387127|12115569|FG001|Overall Study|Lost to Follow-up|4
7695452|NCT00387127|12115568|FG000|Overall Study|Death|16
7695453|NCT00387127|12115569|FG001|Overall Study|Death|16
7695454|NCT00387127|12115568|FG000|Overall Study|Physician Decision|0
7695455|NCT00387127|12115569|FG001|Overall Study|Physician Decision|1
7695456|NCT00387127|12115568|FG000|Overall Study|Withdrawal by Subject|3
7695457|NCT00387127|12115569|FG001|Overall Study|Withdrawal by Subject|2
7695458|NCT00387127|12115568|FG000|Overall Study|Required by Protocol Amendment #4|12
7695459|NCT00387127|12115569|FG001|Overall Study|Required by Protocol Amendment #4|10
7695460|NCT00387127|12115568|FG000|Overall Study|Serious Adverse Event|1
7695461|NCT00387127|12115569|FG001|Overall Study|Serious Adverse Event|1
7695462|NCT00387127|12115568|FG000|Overall Study|Sponsor Unblinded|1
7695463|NCT00387127|12115569|FG001|Overall Study|Sponsor Unblinded|0
7695464|NCT00387153|12115577|FG000|Overall Study|Adverse Event|1
7695465|NCT00387153|12115577|FG000|Overall Study|Disease Progression|3
7695466|NCT00387153|12115577|FG000|Overall Study|Lack of Response|4
7695467|NCT00387348|12115593|FG000|Overall Study|Death|1
7695468|NCT00387348|12115594|FG001|Overall Study|Death|1
7695469|NCT00387348|12115595|FG002|Overall Study|Death|0
7695470|NCT00387348|12115593|FG000|Overall Study|Physician Decision|1
7695471|NCT00387348|12115594|FG001|Overall Study|Physician Decision|0
7695472|NCT00387348|12115595|FG002|Overall Study|Physician Decision|1
7695473|NCT00387348|12115593|FG000|Overall Study|Withdrawal by Subject|0
7695474|NCT00387348|12115594|FG001|Overall Study|Withdrawal by Subject|2
7695475|NCT00387348|12115595|FG002|Overall Study|Withdrawal by Subject|2
7695476|NCT00387348|12115593|FG000|Overall Study|Adverse Event|1
7695477|NCT00387348|12115594|FG001|Overall Study|Adverse Event|0
7695478|NCT00387348|12115595|FG002|Overall Study|Adverse Event|1
7695479|NCT00387426|12115608|FG000|Overall Study|Lack of Response|7
7695480|NCT00387426|12115608|FG000|Overall Study|Toxicities|4
7695481|NCT00387426|12115608|FG000|Overall Study|Disease Progression|3
7695482|NCT00387465|12115615|FG000|Overall Study|Withdrawal by Subject|0
7695483|NCT00387465|12115616|FG001|Overall Study|Withdrawal by Subject|1
7695484|NCT00387465|12115617|FG002|Overall Study|Withdrawal by Subject|0
7695485|NCT00387647|12115641|FG000|Overall Study|Death|18
7695486|NCT00387712|12115656|FG000|Overall Study|Physician Decision|6
7695487|NCT00387712|12115657|FG001|Overall Study|Physician Decision|4
7695488|NCT00387712|12115656|FG000|Overall Study|Lost to Follow-up|17
7695489|NCT00387712|12115657|FG001|Overall Study|Lost to Follow-up|20
7695490|NCT00387712|12115656|FG000|Overall Study|Withdrawal by Subject|6
7695491|NCT00387712|12115657|FG001|Overall Study|Withdrawal by Subject|12
7695492|NCT00387725|12115667|FG000|Overall Study|Adverse Event|0
7695493|NCT00387725|12115668|FG001|Overall Study|Adverse Event|0
7695494|NCT00387725|12115669|FG002|Overall Study|Adverse Event|0
7695495|NCT00387725|12115670|FG003|Overall Study|Adverse Event|1
7695496|NCT00387725|12115667|FG000|Overall Study|Protocol Violation|0
7695497|NCT00387725|12115668|FG001|Overall Study|Protocol Violation|1
7695498|NCT00387725|12115669|FG002|Overall Study|Protocol Violation|0
7695499|NCT00387725|12115670|FG003|Overall Study|Protocol Violation|0
7695500|NCT00387725|12115667|FG000|Overall Study|Withdrawal by Subject|1
7695501|NCT00387725|12115668|FG001|Overall Study|Withdrawal by Subject|0
7695502|NCT00387725|12115669|FG002|Overall Study|Withdrawal by Subject|1
7695503|NCT00387725|12115670|FG003|Overall Study|Withdrawal by Subject|0
7695504|NCT00387725|12115667|FG000|Overall Study|Parent/legal guardian request|0
7695505|NCT00387725|12115668|FG001|Overall Study|Parent/legal guardian request|0
7695506|NCT00387725|12115669|FG002|Overall Study|Parent/legal guardian request|1
7695507|NCT00387725|12115670|FG003|Overall Study|Parent/legal guardian request|1
7695508|NCT00387764|12115686|FG000|Overall Study|Adverse Event|12
7695509|NCT00387764|12115686|FG000|Overall Study|Withdrawal by Subject|8
7695510|NCT00387764|12115686|FG000|Overall Study|Sponsor Terminated Study|1
7695511|NCT00387764|12115686|FG000|Overall Study|Physician Decision|1
7695512|NCT00387764|12115686|FG000|Overall Study|Other|2
7695513|NCT00387764|12115686|FG000|Overall Study|Death|7
7695514|NCT00387790|12115690|FG000|Overall Study|Adverse Event|5
7695515|NCT00387790|12115690|FG000|Overall Study|Lack of Efficacy|2
7695516|NCT00387790|12115690|FG000|Overall Study|Physician Decision|2
7695517|NCT00387790|12115690|FG000|Overall Study|Withdrawal by Subject|3
7695518|NCT00387790|12115690|FG000|Overall Study|Ineligible for study|2
7695519|NCT00387881|12115705|FG000|Overall Study|Lost to Follow-up|23
7695520|NCT00387881|12115706|FG001|Overall Study|Lost to Follow-up|23
7695521|NCT00387881|12115705|FG000|Overall Study|Protocol Violation|2
7695522|NCT00387881|12115706|FG001|Overall Study|Protocol Violation|12
7695523|NCT00387881|12115705|FG000|Overall Study|Withdrawal by Subject|15
7695524|NCT00387881|12115706|FG001|Overall Study|Withdrawal by Subject|18
7695525|NCT00387881|12115705|FG000|Overall Study|Sponsor terminated Study|0
7695526|NCT00387881|12115706|FG001|Overall Study|Sponsor terminated Study|1
7695527|NCT00387881|12115705|FG000|Overall Study|Not eligible|6
7695528|NCT00387881|12115706|FG001|Overall Study|Not eligible|7
7695529|NCT00387881|12115705|FG000|Overall Study|No opportunity to treat headache|32
7695530|NCT00387881|12115706|FG001|Overall Study|No opportunity to treat headache|34
7695531|NCT00387881|12115705|FG000|Overall Study|Not otherwise specified|11
7695532|NCT00387881|12115706|FG001|Overall Study|Not otherwise specified|7
7695533|NCT00387894|12115712|FG000|Overall Study|Withdrawal by Subject|1
7695534|NCT00388037|12115720|FG000|Overall Study|Protocol Violation|1
7695535|NCT00388154|12115724|FG000|Overall Study|Withdrawal by Subject|1
7695536|NCT00388297|12115732|FG000|Overall Study|Lost to Follow-up|16
7695537|NCT00388297|12115733|FG001|Overall Study|Lost to Follow-up|12
7695538|NCT00388297|12115734|FG002|Overall Study|Lost to Follow-up|11
7695539|NCT00388297|12115735|FG003|Overall Study|Lost to Follow-up|8
7695540|NCT00388349|12115745|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0
7695541|NCT00388349|12115746|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3
7695542|NCT00388362|12115754|FG000|Enrolled|Ineligible|1
7695543|NCT00388362|12115754|FG000|Enrolled|Adverse Event|9
7695544|NCT00388362|12115754|FG000|Enrolled|Death|1
7695545|NCT00388362|12115754|FG000|Enrolled|Loss insurance|1
7695546|NCT00388362|12115754|FG000|Enrolled|Withdrawal by Subject|1
7695547|NCT00388362|12115754|FG000|Remained on Study Median of 514 Days|Death|2
7695548|NCT00388505|12115784|FG000|Overall Study|Adverse Event or Death|43
7695549|NCT00388505|12115785|FG001|Overall Study|Adverse Event or Death|17
7695550|NCT00388505|12115784|FG000|Overall Study|Withdrawal by Subject|24
7695551|NCT00388505|12115785|FG001|Overall Study|Withdrawal by Subject|9
7695552|NCT00388505|12115784|FG000|Overall Study|Lost to Follow-up|5
7695553|NCT00388505|12115785|FG001|Overall Study|Lost to Follow-up|3
7695554|NCT00388505|12115784|FG000|Overall Study|Inappropriate Enrollment|0
7695555|NCT00388505|12115785|FG001|Overall Study|Inappropriate Enrollment|1
7695556|NCT00388505|12115784|FG000|Overall Study|Administrative Reason|1
7695557|NCT00388505|12115785|FG001|Overall Study|Administrative Reason|0
7695558|NCT00388505|12115784|FG000|Overall Study|Protocol Violation|6
7695559|NCT00388505|12115785|FG001|Overall Study|Protocol Violation|5
7695560|NCT00388505|12115784|FG000|Overall Study|Unable to classify|4
7695561|NCT00388505|12115785|FG001|Overall Study|Unable to classify|3
7695562|NCT00388583|12115793|FG000|Overall Study|Protocol Violation|1
7695563|NCT00388583|12115794|FG001|Overall Study|Protocol Violation|0
7695564|NCT00388583|12115793|FG000|Overall Study|Withdrawal by Subject|3
7695565|NCT00388583|12115794|FG001|Overall Study|Withdrawal by Subject|3
7695566|NCT00388583|12115793|FG000|Overall Study|Serious Adverse Event|2
7695567|NCT00388583|12115794|FG001|Overall Study|Serious Adverse Event|0
7695568|NCT00388583|12115793|FG000|Overall Study|Did not receive vaccine|0
7695569|NCT00388583|12115794|FG001|Overall Study|Did not receive vaccine|1
7695570|NCT00388674|12115802|FG000|Initial Treatment|Administrative Reason by Sponsor|241
7695571|NCT00388674|12115803|FG001|Initial Treatment|Administrative Reason by Sponsor|158
7695572|NCT00388674|12115802|FG000|Initial Treatment|Adverse Event|22
7695573|NCT00388674|12115803|FG001|Initial Treatment|Adverse Event|87
7695574|NCT00388674|12115802|FG000|Initial Treatment|Death|215
7695575|NCT00388674|12115803|FG001|Initial Treatment|Death|216
7695576|NCT00388674|12115802|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11
7695577|NCT00388674|12115803|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17
7695578|NCT00388674|12115802|FG000|Initial Treatment|HCC|12
7695579|NCT00388674|12115803|FG001|Initial Treatment|HCC|20
7695580|NCT00388674|12115802|FG000|Initial Treatment|Lost to Follow-up|526
7695581|NCT00388674|12115803|FG001|Initial Treatment|Lost to Follow-up|624
7695582|NCT00388674|12115802|FG000|Initial Treatment|Malignancy (Non-HCC)|7
7695583|NCT00388674|12115803|FG001|Initial Treatment|Malignancy (Non-HCC)|3
7695584|NCT00388674|12115802|FG000|Initial Treatment|Never Treated with Study Medication|1
7695585|NCT00388674|12115803|FG001|Initial Treatment|Never Treated with Study Medication|7
7695670|NCT00389207|12115862|FG001|Overall Study|Adverse Event|32
7695586|NCT00388674|12115802|FG000|Initial Treatment|Non-Study related Comorbidities|3
7695587|NCT00388674|12115803|FG001|Initial Treatment|Non-Study related Comorbidities|4
7695588|NCT00388674|12115802|FG000|Initial Treatment|Not Defined|125
7695589|NCT00388674|12115803|FG001|Initial Treatment|Not Defined|172
7695590|NCT00388674|12115802|FG000|Initial Treatment|Partial or inadequate Treatment|112
7695591|NCT00388674|12115803|FG001|Initial Treatment|Partial or inadequate Treatment|472
7695592|NCT00388674|12115802|FG000|Initial Treatment|Pregnancy|26
7695593|NCT00388674|12115803|FG001|Initial Treatment|Pregnancy|16
7695594|NCT00388674|12115802|FG000|Initial Treatment|Study Drug Toxicity|5
7695595|NCT00388674|12115803|FG001|Initial Treatment|Study Drug Toxicity|92
7695596|NCT00388674|12115802|FG000|Initial Treatment|Participant Request|501
7695597|NCT00388674|12115803|FG001|Initial Treatment|Participant Request|673
7695598|NCT00388674|12115802|FG000|Initial Treatment|No Off-Treatment Status Data|11
7695599|NCT00388674|12115803|FG001|Initial Treatment|No Off-Treatment Status Data|13
7695600|NCT00388674|12115802|FG000|Initial Treatment|Not Reported|10
7695601|NCT00388674|12115803|FG001|Initial Treatment|Not Reported|12
7695602|NCT00388674|12115802|FG000|End of Study|Administrative Reason By Sponsor|299
7695603|NCT00388674|12115803|FG001|End of Study|Administrative Reason By Sponsor|253
7695604|NCT00388674|12115802|FG000|End of Study|Death|239
7695605|NCT00388674|12115803|FG001|End of Study|Death|262
7695606|NCT00388674|12115802|FG000|End of Study|HBV Disease Progression (Non-HCC)|3
7695607|NCT00388674|12115803|FG001|End of Study|HBV Disease Progression (Non-HCC)|9
7695608|NCT00388674|12115802|FG000|End of Study|HCC|8
7695609|NCT00388674|12115803|FG001|End of Study|HCC|7
7695610|NCT00388674|12115802|FG000|End of Study|Lost to Follow-up|587
7695611|NCT00388674|12115803|FG001|End of Study|Lost to Follow-up|715
7695612|NCT00388674|12115802|FG000|End of Study|Malignancy (Non-HCC)|1
7695613|NCT00388674|12115803|FG001|End of Study|Malignancy (Non-HCC)|1
7695614|NCT00388674|12115802|FG000|End of Study|Non-Study Related Comorbidities|3
7695615|NCT00388674|12115803|FG001|End of Study|Non-Study Related Comorbidities|4
7695616|NCT00388674|12115802|FG000|End of Study|Not Defined|135
7695617|NCT00388674|12115803|FG001|End of Study|Not Defined|214
7695618|NCT00388674|12115802|FG000|End of Study|Participant Withdrew Consent|437
7695619|NCT00388674|12115803|FG001|End of Study|Participant Withdrew Consent|673
7695620|NCT00388674|12115802|FG000|End of Study|No Off-Treatment Status Data|22
7695621|NCT00388674|12115803|FG001|End of Study|No Off-Treatment Status Data|30
7695622|NCT00388674|12115802|FG000|End of Study|Not Reported|0
7695623|NCT00388674|12115803|FG001|End of Study|Not Reported|1
7695624|NCT00388726|12115811|FG000|Overall Study|Adverse Event|50
7695625|NCT00388726|12115812|FG001|Overall Study|Adverse Event|24
7695626|NCT00388726|12115811|FG000|Overall Study|Progressive Disease|336
7695627|NCT00388726|12115812|FG001|Overall Study|Progressive Disease|153
7695628|NCT00388726|12115811|FG000|Overall Study|Clinical Progression|61
7695629|NCT00388726|12115812|FG001|Overall Study|Clinical Progression|36
7695630|NCT00388726|12115811|FG000|Overall Study|Withdrawal by Subject|10
7695631|NCT00388726|12115812|FG001|Overall Study|Withdrawal by Subject|7
7695632|NCT00388726|12115811|FG000|Overall Study|Administrative|6
7695633|NCT00388726|12115812|FG001|Overall Study|Administrative|9
7695634|NCT00388726|12115811|FG000|Overall Study|Physician Decision|18
7695635|NCT00388726|12115812|FG001|Overall Study|Physician Decision|13
7695636|NCT00388726|12115811|FG000|Overall Study|Death|3
7695637|NCT00388726|12115812|FG001|Overall Study|Death|2
7695638|NCT00388947|12115827|FG000|Overall Study|Protocol Violation|47
7695639|NCT00388973|12115833|FG000|Overall Study|Adverse Event|16
7695640|NCT00388973|12115834|FG001|Overall Study|Adverse Event|6
7695641|NCT00388973|12115833|FG000|Overall Study|Lack of Efficacy|1
7695642|NCT00388973|12115834|FG001|Overall Study|Lack of Efficacy|12
7695643|NCT00388973|12115833|FG000|Overall Study|Protocol Violation|3
7695644|NCT00388973|12115834|FG001|Overall Study|Protocol Violation|0
7695645|NCT00388973|12115833|FG000|Overall Study|Withdrawal by Subject|14
7695646|NCT00388973|12115834|FG001|Overall Study|Withdrawal by Subject|17
7695647|NCT00388973|12115833|FG000|Overall Study|Study specific Discontinuation Criteria|0
7695648|NCT00388973|12115834|FG001|Overall Study|Study specific Discontinuation Criteria|1
7695649|NCT00388973|12115833|FG000|Overall Study|Did not complete 61 days of treatment|5
7695650|NCT00388973|12115834|FG001|Overall Study|Did not complete 61 days of treatment|4
7695651|NCT00388973|12115833|FG000|Overall Study|Left region|0
7695652|NCT00388973|12115834|FG001|Overall Study|Left region|1
7695653|NCT00388973|12115833|FG000|Overall Study|Did not complete 2-week follow-up visit|17
7695654|NCT00388973|12115834|FG001|Overall Study|Did not complete 2-week follow-up visit|17
7695655|NCT00389064|12115842|FG000|Overall Study|Adverse Event|11
7695656|NCT00389064|12115843|FG001|Overall Study|Adverse Event|3
7695657|NCT00389064|12115842|FG000|Overall Study|Lack of Efficacy|3
7695658|NCT00389064|12115843|FG001|Overall Study|Lack of Efficacy|14
7695659|NCT00389064|12115842|FG000|Overall Study|Withdrawal by Subject|17
7695660|NCT00389064|12115843|FG001|Overall Study|Withdrawal by Subject|27
7695661|NCT00389064|12115842|FG000|Overall Study|Physician Decision|2
7695662|NCT00389064|12115843|FG001|Overall Study|Physician Decision|2
7695663|NCT00389064|12115842|FG000|Overall Study|Lost to Follow-up|1
7695664|NCT00389064|12115843|FG001|Overall Study|Lost to Follow-up|2
7695665|NCT00389064|12115842|FG000|Overall Study|Protocol Violation|2
7695666|NCT00389064|12115843|FG001|Overall Study|Protocol Violation|0
7695667|NCT00389064|12115842|FG000|Overall Study|Multiple Reasons|9
7695668|NCT00389064|12115843|FG001|Overall Study|Multiple Reasons|11
7695669|NCT00389207|12115861|FG000|Overall Study|Adverse Event|26
7695671|NCT00389207|12115863|FG002|Overall Study|Adverse Event|10
7695672|NCT00389207|12115861|FG000|Overall Study|Protocol Violation|3
7695673|NCT00389207|12115862|FG001|Overall Study|Protocol Violation|1
7695674|NCT00389207|12115863|FG002|Overall Study|Protocol Violation|4
7695675|NCT00389207|12115861|FG000|Overall Study|Lost to Follow-up|12
7695676|NCT00389207|12115862|FG001|Overall Study|Lost to Follow-up|9
7695677|NCT00389207|12115863|FG002|Overall Study|Lost to Follow-up|7
7695678|NCT00389207|12115861|FG000|Overall Study|Withdrawal by Subject|5
7695679|NCT00389207|12115862|FG001|Overall Study|Withdrawal by Subject|7
7695680|NCT00389207|12115863|FG002|Overall Study|Withdrawal by Subject|11
7695681|NCT00389207|12115861|FG000|Overall Study|Other|17
7695682|NCT00389207|12115862|FG001|Overall Study|Other|23
7695683|NCT00389207|12115863|FG002|Overall Study|Other|9
7695684|NCT00389324|12115876|FG000|Run-In Phase|Adverse Event|1
7695685|NCT00389324|12115876|FG000|Run-In Phase|Lost to Follow-up|1
7695686|NCT00389324|12115876|FG000|Run-In Phase|Withdrawal by Subject|1
7695687|NCT00389324|12115876|FG000|Subcutaneous Phase|Adverse Event|2
7695688|NCT00389324|12115876|FG000|Subcutaneous Phase|Non-compliance with study medication|2
7695689|NCT00389324|12115876|FG000|Subcutaneous Phase|Withdrawal by Subject|2
7695690|NCT00389324|12115876|FG000|Subcutaneous Phase|Lost to Follow-up|1
7695691|NCT00389441|12115883|FG000|Overall Study|Adverse Event|7
7695692|NCT00389441|12115883|FG000|Overall Study|Death|4
7695693|NCT00389441|12115883|FG000|Overall Study|Lost to Follow-up|2
7695694|NCT00389441|12115883|FG000|Overall Study|Withdrawal by Subject|4
7695695|NCT00389441|12115883|FG000|Overall Study|Physician Decision|1
7695696|NCT00389441|12115883|FG000|Overall Study|Protocol Violation|1
7695697|NCT00389441|12115883|FG000|Overall Study|Global deterioration of health status|4
7695698|NCT00389441|12115883|FG000|Overall Study|Objective progression or relapse|26
7695699|NCT00389441|12115883|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
7695700|NCT00389441|12115883|FG000|Overall Study|Clinical progression|1
7695701|NCT00389519|12115925|FG000|Placebo Run-In|Did not meet blood pressure criteria|119
7695702|NCT00389519|12115926|FG001|Placebo Run-In|Did not meet blood pressure criteria|0
7695703|NCT00389519|12115927|FG002|Placebo Run-In|Did not meet blood pressure criteria|0
7695704|NCT00389519|12115928|FG003|Placebo Run-In|Did not meet blood pressure criteria|0
7695705|NCT00389519|12115925|FG000|Placebo Run-In|Withdrawal by Subject|19
7695706|NCT00389519|12115926|FG001|Placebo Run-In|Withdrawal by Subject|0
7695707|NCT00389519|12115927|FG002|Placebo Run-In|Withdrawal by Subject|0
7695708|NCT00389519|12115928|FG003|Placebo Run-In|Withdrawal by Subject|0
7695709|NCT00389519|12115925|FG000|Placebo Run-In|Reason not specified|40
7695710|NCT00389519|12115926|FG001|Placebo Run-In|Reason not specified|0
7695711|NCT00389519|12115927|FG002|Placebo Run-In|Reason not specified|0
7695712|NCT00389519|12115928|FG003|Placebo Run-In|Reason not specified|0
7695713|NCT00389519|12115925|FG000|Randomized|Did not receive study drug|2
7695714|NCT00389519|12115926|FG001|Randomized|Did not receive study drug|0
7695715|NCT00389519|12115927|FG002|Randomized|Did not receive study drug|0
7695716|NCT00389519|12115928|FG003|Randomized|Did not receive study drug|0
7695717|NCT00389519|12115925|FG000|Treated|Adverse Event|1
7695718|NCT00389519|12115926|FG001|Treated|Adverse Event|0
7695719|NCT00389519|12115927|FG002|Treated|Adverse Event|0
7695720|NCT00389519|12115928|FG003|Treated|Adverse Event|2
7695721|NCT00389519|12115925|FG000|Treated|Reason not specified|1
7695722|NCT00389519|12115926|FG001|Treated|Reason not specified|1
7695723|NCT00389519|12115927|FG002|Treated|Reason not specified|0
7695724|NCT00389519|12115928|FG003|Treated|Reason not specified|2
7695725|NCT00389597|12115951|FG000|Overall Study|Lost to Follow-up|8
7695726|NCT00389597|12115952|FG001|Overall Study|Lost to Follow-up|6
7695727|NCT00389597|12115953|FG002|Overall Study|Lost to Follow-up|4
7695728|NCT00389597|12115954|FG003|Overall Study|Lost to Follow-up|6
7695729|NCT00389831|12115979|FG000|Overall Study|Lack of Efficacy|0
7695730|NCT00389831|12115980|FG001|Overall Study|Lack of Efficacy|2
7695731|NCT00389831|12115979|FG000|Overall Study|Did not receive treatment.|0
7695732|NCT00389831|12115980|FG001|Overall Study|Did not receive treatment.|2
7695733|NCT00389831|12115979|FG000|Overall Study|Other reasons|0
7695734|NCT00389831|12115980|FG001|Overall Study|Other reasons|2
7695735|NCT00389831|12115979|FG000|Overall Study|Lost to Follow-up|0
7695736|NCT00389831|12115980|FG001|Overall Study|Lost to Follow-up|1
7695737|NCT00390013|12116014|FG000|Phase 1|tired|0
7695738|NCT00390013|12116015|FG001|Phase 1|tired|0
7695739|NCT00390013|12116016|FG002|Phase 1|tired|0
7695740|NCT00390013|12116017|FG003|Phase 1|tired|1
7695741|NCT00390013|12116014|FG000|Phase 2 First Treatment|tired|1
7695742|NCT00390013|12116015|FG001|Phase 2 First Treatment|tired|0
7695743|NCT00390013|12116016|FG002|Phase 2 First Treatment|tired|0
7695744|NCT00390013|12116017|FG003|Phase 2 First Treatment|tired|0
7695745|NCT00390013|12116014|FG000|Phase 2 First Treatment|Withdrawal by Subject|0
7695746|NCT00390013|12116015|FG001|Phase 2 First Treatment|Withdrawal by Subject|1
7695747|NCT00390013|12116016|FG002|Phase 2 First Treatment|Withdrawal by Subject|0
7695748|NCT00390013|12116017|FG003|Phase 2 First Treatment|Withdrawal by Subject|0
7695749|NCT00390221|12116030|FG000|Overall Study|Lost to Follow-up|0
7695750|NCT00390221|12116031|FG001|Overall Study|Lost to Follow-up|3
7695751|NCT00390221|12116032|FG002|Overall Study|Lost to Follow-up|0
7695752|NCT00390221|12116030|FG000|Overall Study|Adverse Event|1
7695753|NCT00390221|12116031|FG001|Overall Study|Adverse Event|4
7695754|NCT00390221|12116032|FG002|Overall Study|Adverse Event|3
7695755|NCT00390221|12116030|FG000|Overall Study|Investigator Decision|0
7695756|NCT00390221|12116031|FG001|Overall Study|Investigator Decision|0
7695757|NCT00390221|12116032|FG002|Overall Study|Investigator Decision|1
7695758|NCT00390221|12116030|FG000|Overall Study|Withdrawal by Subject|13
7695759|NCT00390221|12116031|FG001|Overall Study|Withdrawal by Subject|9
7695760|NCT00390221|12116032|FG002|Overall Study|Withdrawal by Subject|7
7695761|NCT00390221|12116030|FG000|Overall Study|Subject Non-compliance|1
7695762|NCT00390221|12116031|FG001|Overall Study|Subject Non-compliance|0
7695763|NCT00390221|12116032|FG002|Overall Study|Subject Non-compliance|2
7695764|NCT00390221|12116030|FG000|Overall Study|Other|3
7695765|NCT00390221|12116031|FG001|Overall Study|Other|4
7695766|NCT00390221|12116032|FG002|Overall Study|Other|2
7695767|NCT00390299|12116051|FG000|Overall Study|Cancellation|1
7695768|NCT00390299|12116052|FG001|Overall Study|Cancellation|0
7695769|NCT00390299|12116053|FG002|Overall Study|Cancellation|0
7695770|NCT00390299|12116054|FG003|Overall Study|Cancellation|0
7695771|NCT00390299|12116055|FG004|Overall Study|Cancellation|0
7695772|NCT00390416|12116073|FG000|Overall Study|Withdrawal by Subject|1
7695773|NCT00390416|12116073|FG000|Overall Study|Not treated|3
7695774|NCT00390455|12116096|FG000|Overall Study|Adverse Event|17
7695775|NCT00390455|12116097|FG001|Overall Study|Adverse Event|3
7695776|NCT00390455|12116096|FG000|Overall Study|Withdrawal by Subject|8
7695777|NCT00390455|12116097|FG001|Overall Study|Withdrawal by Subject|8
7695778|NCT00390455|12116096|FG000|Overall Study|Alternate Treatment|0
7695779|NCT00390455|12116097|FG001|Overall Study|Alternate Treatment|1
7695780|NCT00390455|12116096|FG000|Overall Study|Other Medical Reasons|7
7695781|NCT00390455|12116097|FG001|Overall Study|Other Medical Reasons|11
7695782|NCT00390468|12116103|FG000|Overall Study|Protocol Violation|2
7695783|NCT00390468|12116103|FG000|Overall Study|Lack of Efficacy|1
7695784|NCT00390546|12116109|FG000|Overall Study|Renal impairment|1
7695785|NCT00390546|12116110|FG001|Overall Study|Renal impairment|0
7695786|NCT00390546|12116109|FG000|Overall Study|Physician Decision|5
7695787|NCT00390546|12116110|FG001|Overall Study|Physician Decision|5
7695788|NCT00390572|12116129|FG000|Overall Study|Lost to Follow-up|8
7695789|NCT00390572|12116130|FG001|Overall Study|Lost to Follow-up|4
7695790|NCT00390572|12116129|FG000|Overall Study|health condition|0
7695791|NCT00390572|12116130|FG001|Overall Study|health condition|1
7695792|NCT00390689|12116150|FG000|Overall Study|Adverse Event|2
7695793|NCT00390689|12116151|FG001|Overall Study|Adverse Event|5
7695794|NCT00390689|12116152|FG002|Overall Study|Adverse Event|2
7695795|NCT00390689|12116150|FG000|Overall Study|Lack of Efficacy|0
7695796|NCT00390689|12116151|FG001|Overall Study|Lack of Efficacy|0
7695797|NCT00390689|12116152|FG002|Overall Study|Lack of Efficacy|1
7695798|NCT00390689|12116150|FG000|Overall Study|Protocol Violation|1
7695799|NCT00390689|12116151|FG001|Overall Study|Protocol Violation|0
7695800|NCT00390689|12116152|FG002|Overall Study|Protocol Violation|0
7695801|NCT00390689|12116150|FG000|Overall Study|Investigator's judgement|2
7695802|NCT00390689|12116151|FG001|Overall Study|Investigator's judgement|0
7695803|NCT00390689|12116152|FG002|Overall Study|Investigator's judgement|0
7695804|NCT00390780|12116171|FG000|Overall Study|Not completed|10
7695805|NCT00390780|12116172|FG001|Overall Study|Not completed|4
7695806|NCT00390780|12116171|FG000|Overall Study|Protocol Violation|6
7695807|NCT00390780|12116172|FG001|Overall Study|Protocol Violation|4
7695808|NCT00390780|12116171|FG000|Overall Study|Lost to Follow-up|3
7695809|NCT00390780|12116172|FG001|Overall Study|Lost to Follow-up|6
7695810|NCT00390780|12116171|FG000|Overall Study|Adverse Event|2
7695811|NCT00390780|12116172|FG001|Overall Study|Adverse Event|3
7695812|NCT00390780|12116171|FG000|Overall Study|Death|1
7695813|NCT00390780|12116172|FG001|Overall Study|Death|3
7695814|NCT00390780|12116171|FG000|Overall Study|Withdrawal by Subject|1
7695815|NCT00390780|12116172|FG001|Overall Study|Withdrawal by Subject|2
7695816|NCT00390780|12116171|FG000|Overall Study|Inclusion criteria not satisfied|0
7695817|NCT00390780|12116172|FG001|Overall Study|Inclusion criteria not satisfied|2
7695818|NCT00390780|12116171|FG000|Overall Study|Lost to follow up and other reasons|0
7695819|NCT00390780|12116172|FG001|Overall Study|Lost to follow up and other reasons|1
7695820|NCT00390780|12116171|FG000|Overall Study|Investigator decision, SAE, other reason|0
7695821|NCT00390780|12116172|FG001|Overall Study|Investigator decision, SAE, other reason|1
7695822|NCT00390780|12116171|FG000|Overall Study|SAE, death|0
7695823|NCT00390780|12116172|FG001|Overall Study|SAE, death|1
7695824|NCT00390806|12116180|FG000|Overall Study|Lost to Follow-up|7
7695825|NCT00390806|12116181|FG001|Overall Study|Lost to Follow-up|6
7695826|NCT00390806|12116180|FG000|Overall Study|Protocol Violation|2
7695827|NCT00390806|12116181|FG001|Overall Study|Protocol Violation|2
7695828|NCT00390806|12116180|FG000|Overall Study|Withdrawal by Subject|12
7695829|NCT00390806|12116181|FG001|Overall Study|Withdrawal by Subject|15
7695830|NCT00390806|12116180|FG000|Overall Study|Investigator Decision|4
7695831|NCT00390806|12116181|FG001|Overall Study|Investigator Decision|6
7695832|NCT00390806|12116180|FG000|Overall Study|Death|1
7695833|NCT00390806|12116181|FG001|Overall Study|Death|0
7695834|NCT00390806|12116180|FG000|Overall Study|Physician Decision|0
7695835|NCT00390806|12116181|FG001|Overall Study|Physician Decision|1
7695836|NCT00390806|12116180|FG000|Overall Study|Ongoing|4
7695837|NCT00390806|12116181|FG001|Overall Study|Ongoing|2
7695838|NCT00390858|12116189|FG000|Overall Study|Adverse Event|6
7695839|NCT00390858|12116190|FG001|Overall Study|Adverse Event|2
7695840|NCT00390858|12116189|FG000|Overall Study|Lack of Efficacy|0
7695841|NCT00390858|12116190|FG001|Overall Study|Lack of Efficacy|1
7695842|NCT00390858|12116189|FG000|Overall Study|Withdrawal by Subject|3
7695843|NCT00390858|12116190|FG001|Overall Study|Withdrawal by Subject|4
7695844|NCT00390884|12116198|FG000|Overall Study|Withdrawal by Subject|2
7695845|NCT00390884|12116199|FG001|Overall Study|Withdrawal by Subject|2
7695846|NCT00390910|12116208|FG000|Overall Study|Adverse Event|1
7695847|NCT00390910|12116209|FG001|Overall Study|Adverse Event|0
7695848|NCT00390910|12116210|FG002|Overall Study|Adverse Event|0
7695849|NCT00390910|12116208|FG000|Overall Study|Lost to Follow-up|0
7695850|NCT00390910|12116209|FG001|Overall Study|Lost to Follow-up|1
7695851|NCT00390910|12116210|FG002|Overall Study|Lost to Follow-up|5
7695852|NCT00390910|12116208|FG000|Overall Study|Withdrawal by Subject|1
7695853|NCT00390910|12116209|FG001|Overall Study|Withdrawal by Subject|3
7695854|NCT00390910|12116210|FG002|Overall Study|Withdrawal by Subject|2
7695855|NCT00390910|12116208|FG000|Overall Study|Migrated/moved from study area|0
7695856|NCT00390910|12116209|FG001|Overall Study|Migrated/moved from study area|0
7695857|NCT00390910|12116210|FG002|Overall Study|Migrated/moved from study area|3
7695858|NCT00391027|12116231|FG000|Overall Study|Adverse Event|8
7695859|NCT00391027|12116232|FG001|Overall Study|Adverse Event|8
7695860|NCT00391027|12116231|FG000|Overall Study|Lack of Efficacy|3
7695861|NCT00391027|12116232|FG001|Overall Study|Lack of Efficacy|0
7695862|NCT00391027|12116231|FG000|Overall Study|Withdrawal by Subject|10
7695863|NCT00391027|12116232|FG001|Overall Study|Withdrawal by Subject|1
7695864|NCT00391027|12116231|FG000|Overall Study|Other|4
7695865|NCT00391027|12116232|FG001|Overall Study|Other|3
7695866|NCT00391053|12116242|FG000|Overall Study|Serious Adverse Events|1
7695867|NCT00391053|12116243|FG001|Overall Study|Serious Adverse Events|0
7695868|NCT00391053|12116244|FG002|Overall Study|Serious Adverse Events|1
7695869|NCT00391053|12116245|FG003|Overall Study|Serious Adverse Events|4
7695870|NCT00391053|12116242|FG000|Overall Study|Protocol Violation|2
7695871|NCT00391053|12116243|FG001|Overall Study|Protocol Violation|0
7695872|NCT00391053|12116244|FG002|Overall Study|Protocol Violation|0
7695873|NCT00391053|12116245|FG003|Overall Study|Protocol Violation|0
7695874|NCT00391053|12116242|FG000|Overall Study|Lost to Follow-up|1
7695875|NCT00391053|12116243|FG001|Overall Study|Lost to Follow-up|0
7695876|NCT00391053|12116244|FG002|Overall Study|Lost to Follow-up|0
7695877|NCT00391053|12116245|FG003|Overall Study|Lost to Follow-up|5
7695878|NCT00391053|12116242|FG000|Overall Study|Withdrawal by Subject|5
7695879|NCT00391053|12116243|FG001|Overall Study|Withdrawal by Subject|1
7695880|NCT00391053|12116244|FG002|Overall Study|Withdrawal by Subject|1
7695881|NCT00391053|12116245|FG003|Overall Study|Withdrawal by Subject|1
7695882|NCT00391092|12116266|FG000|Overall Study|Death|78
7695883|NCT00391092|12116267|FG001|Overall Study|Death|81
7695884|NCT00391092|12116266|FG000|Overall Study|Lost to Follow-up|13
7695885|NCT00391092|12116267|FG001|Overall Study|Lost to Follow-up|18
7695886|NCT00391092|12116266|FG000|Overall Study|Alive on treatment|29
7695887|NCT00391092|12116267|FG001|Overall Study|Alive on treatment|33
7695888|NCT00391092|12116266|FG000|Overall Study|Alive in follow-up|88
7695889|NCT00391092|12116267|FG001|Overall Study|Alive in follow-up|84
7695890|NCT00391118|12116276|FG000|Overall Study|Adverse Event|3
7695891|NCT00391118|12116277|FG001|Overall Study|Adverse Event|10
7695892|NCT00391118|12116278|FG002|Overall Study|Adverse Event|7
7695893|NCT00391118|12116276|FG000|Overall Study|Lost to Follow-up|0
7695894|NCT00391118|12116277|FG001|Overall Study|Lost to Follow-up|2
7695895|NCT00391118|12116278|FG002|Overall Study|Lost to Follow-up|3
7695896|NCT00391118|12116276|FG000|Overall Study|Withdrawal by Subject|0
7695897|NCT00391118|12116277|FG001|Overall Study|Withdrawal by Subject|9
7695898|NCT00391118|12116278|FG002|Overall Study|Withdrawal by Subject|1
7695899|NCT00391118|12116276|FG000|Overall Study|Death|0
7695900|NCT00391118|12116277|FG001|Overall Study|Death|1
7695901|NCT00391118|12116278|FG002|Overall Study|Death|0
7695902|NCT00391118|12116276|FG000|Overall Study|Physician Decision|0
7695903|NCT00391118|12116277|FG001|Overall Study|Physician Decision|3
7695904|NCT00391118|12116278|FG002|Overall Study|Physician Decision|0
7695905|NCT00391118|12116276|FG000|Overall Study|Protocol Entry Criteria Not Met|0
7695906|NCT00391118|12116277|FG001|Overall Study|Protocol Entry Criteria Not Met|3
7695907|NCT00391118|12116278|FG002|Overall Study|Protocol Entry Criteria Not Met|1
7695908|NCT00391118|12116276|FG000|Overall Study|Progressive Disease|7
7695909|NCT00391118|12116277|FG001|Overall Study|Progressive Disease|26
7695910|NCT00391118|12116278|FG002|Overall Study|Progressive Disease|43
7695911|NCT00391118|12116276|FG000|Overall Study|Sponsor Decision|0
7695912|NCT00391118|12116277|FG001|Overall Study|Sponsor Decision|1
7695913|NCT00391118|12116278|FG002|Overall Study|Sponsor Decision|3
7695914|NCT00391118|12116276|FG000|Overall Study|Protocol Violation|1
7695915|NCT00391118|12116277|FG001|Overall Study|Protocol Violation|0
7695916|NCT00391118|12116278|FG002|Overall Study|Protocol Violation|0
7695917|NCT00391222|12116292|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
7695918|NCT00391222|12116293|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
7695919|NCT00391222|12116294|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
7695920|NCT00391222|12116295|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
7695921|NCT00391222|12116292|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
7695922|NCT00391222|12116293|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
7695923|NCT00391222|12116294|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
7695924|NCT00391222|12116295|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
7696003|NCT00391768|12116421|FG006|Overall Study|Withdrawal by Subject|1
7695925|NCT00391222|12116292|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0
7695926|NCT00391222|12116293|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0
7695927|NCT00391222|12116294|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0
7695928|NCT00391222|12116295|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10
7695929|NCT00391222|12116292|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0
7695930|NCT00391222|12116293|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0
7695931|NCT00391222|12116294|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0
7695932|NCT00391222|12116295|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97
7695933|NCT00391222|12116292|FG000|Period II (Open-label Risperidone LAI)|Other|0
7695934|NCT00391222|12116293|FG001|Period II (Open-label Risperidone LAI)|Other|0
7695935|NCT00391222|12116294|FG002|Period II (Open-label Risperidone LAI)|Other|0
7695936|NCT00391222|12116295|FG003|Period II (Open-label Risperidone LAI)|Other|24
7695937|NCT00391222|12116292|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
7695938|NCT00391222|12116293|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
7695939|NCT00391222|12116294|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
7695940|NCT00391222|12116295|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
7695941|NCT00391222|12116292|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2
7695942|NCT00391222|12116293|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4
7695943|NCT00391222|12116294|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4
7695944|NCT00391222|12116295|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0
7695945|NCT00391222|12116292|FG000|Period III (Double-Blind Treatment)|Adverse Event|5
7695946|NCT00391222|12116293|FG001|Period III (Double-Blind Treatment)|Adverse Event|2
7695947|NCT00391222|12116294|FG002|Period III (Double-Blind Treatment)|Adverse Event|4
7695948|NCT00391222|12116295|FG003|Period III (Double-Blind Treatment)|Adverse Event|0
7695949|NCT00391222|12116292|FG000|Period III (Double-Blind Treatment)|Pregnancy|0
7695950|NCT00391222|12116293|FG001|Period III (Double-Blind Treatment)|Pregnancy|2
7695951|NCT00391222|12116294|FG002|Period III (Double-Blind Treatment)|Pregnancy|0
7695952|NCT00391222|12116295|FG003|Period III (Double-Blind Treatment)|Pregnancy|0
7695953|NCT00391222|12116292|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
7695954|NCT00391222|12116293|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
7695955|NCT00391222|12116294|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
7695956|NCT00391222|12116295|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
7695957|NCT00391222|12116292|FG000|Period III (Double-Blind Treatment)|Other|6
7695958|NCT00391222|12116293|FG001|Period III (Double-Blind Treatment)|Other|1
7695959|NCT00391222|12116294|FG002|Period III (Double-Blind Treatment)|Other|6
7695960|NCT00391222|12116295|FG003|Period III (Double-Blind Treatment)|Other|0
7695961|NCT00391274|12116307|FG000|Overall Study|Death Due to Study Disease|55
7695962|NCT00391274|12116308|FG001|Overall Study|Death Due to Study Disease|45
7695963|NCT00391274|12116307|FG000|Overall Study|Lost to Follow-up|0
7695964|NCT00391274|12116308|FG001|Overall Study|Lost to Follow-up|3
7695965|NCT00391274|12116307|FG000|Overall Study|Physician Decision|4
7695966|NCT00391274|12116308|FG001|Overall Study|Physician Decision|2
7695967|NCT00391274|12116307|FG000|Overall Study|Withdrawal by Subject|0
7695968|NCT00391274|12116308|FG001|Overall Study|Withdrawal by Subject|3
7695969|NCT00391274|12116307|FG000|Overall Study|Death Due to Adverse Event|1
7695970|NCT00391274|12116308|FG001|Overall Study|Death Due to Adverse Event|3
7695971|NCT00391274|12116307|FG000|Overall Study|Death Due to Indeterminate Cause|1
7695972|NCT00391274|12116308|FG001|Overall Study|Death Due to Indeterminate Cause|0
7695973|NCT00391274|12116307|FG000|Overall Study|Death Not Study Related|0
7695974|NCT00391274|12116308|FG001|Overall Study|Death Not Study Related|1
7695975|NCT00391391|12116318|FG000|Overall Study|Adverse Event|0
7695976|NCT00391391|12116319|FG001|Overall Study|Adverse Event|0
7695977|NCT00391391|12116320|FG002|Overall Study|Adverse Event|0
7695978|NCT00391391|12116321|FG003|Overall Study|Adverse Event|1
7695979|NCT00391391|12116318|FG000|Overall Study|Lost to Follow-up|1
7695980|NCT00391391|12116319|FG001|Overall Study|Lost to Follow-up|3
7695981|NCT00391391|12116320|FG002|Overall Study|Lost to Follow-up|7
7695982|NCT00391391|12116321|FG003|Overall Study|Lost to Follow-up|4
7695983|NCT00391391|12116318|FG000|Overall Study|Protocol Violation|2
7695984|NCT00391391|12116319|FG001|Overall Study|Protocol Violation|3
7695985|NCT00391391|12116320|FG002|Overall Study|Protocol Violation|6
7695986|NCT00391391|12116321|FG003|Overall Study|Protocol Violation|7
7695987|NCT00391391|12116318|FG000|Overall Study|Withdrawal by Subject|6
7695988|NCT00391391|12116319|FG001|Overall Study|Withdrawal by Subject|4
7695989|NCT00391391|12116320|FG002|Overall Study|Withdrawal by Subject|10
7695990|NCT00391391|12116321|FG003|Overall Study|Withdrawal by Subject|7
7695991|NCT00391586|12116353|FG000|Overall Study|Progressive disease|13
7695992|NCT00391586|12116353|FG000|Overall Study|Adverse Event|5
7695993|NCT00391586|12116353|FG000|Overall Study|Physician Decision|2
7695994|NCT00391586|12116353|FG000|Overall Study|Death|4
7695995|NCT00391625|12116368|FG000|Month 14|Withdrawal by Subject|1
7695996|NCT00391625|12116368|FG000|Month 50|Physician Decision|1
7695997|NCT00391768|12116415|FG000|Overall Study|Withdrawal by Subject|0
7695998|NCT00391768|12116416|FG001|Overall Study|Withdrawal by Subject|0
7695999|NCT00391768|12116417|FG002|Overall Study|Withdrawal by Subject|1
7696000|NCT00391768|12116418|FG003|Overall Study|Withdrawal by Subject|0
7696001|NCT00391768|12116419|FG004|Overall Study|Withdrawal by Subject|0
7696002|NCT00391768|12116420|FG005|Overall Study|Withdrawal by Subject|1
7696004|NCT00391768|12116415|FG000|Overall Study|Lost to Follow-up|0
7696005|NCT00391768|12116416|FG001|Overall Study|Lost to Follow-up|0
7696006|NCT00391768|12116417|FG002|Overall Study|Lost to Follow-up|0
7696007|NCT00391768|12116418|FG003|Overall Study|Lost to Follow-up|1
7696008|NCT00391768|12116419|FG004|Overall Study|Lost to Follow-up|2
7696009|NCT00391768|12116420|FG005|Overall Study|Lost to Follow-up|2
7696010|NCT00391768|12116421|FG006|Overall Study|Lost to Follow-up|3
7696011|NCT00391807|12116455|FG000|Overall Study|Did not receive study medication|23
7696012|NCT00391807|12116455|FG000|Overall Study|Adverse Event|177
7696013|NCT00391807|12116455|FG000|Overall Study|Pregnancy|25
7696014|NCT00391807|12116455|FG000|Overall Study|Lost to Follow-up|227
7696015|NCT00391807|12116455|FG000|Overall Study|Withdrawal by Subject|147
7696016|NCT00391807|12116455|FG000|Overall Study|Protocol Violation|20
7696017|NCT00391807|12116455|FG000|Overall Study|Various|96
7696018|NCT00391846|12116461|FG000|Overall Study|Adverse Event|4
7696019|NCT00391846|12116462|FG001|Overall Study|Adverse Event|1
7696020|NCT00391846|12116461|FG000|Overall Study|Did not meet the required elig. crit|2
7696021|NCT00391846|12116462|FG001|Overall Study|Did not meet the required elig. crit|2
7696022|NCT00391846|12116461|FG000|Overall Study|Withdrawal by Subject|2
7696023|NCT00391846|12116462|FG001|Overall Study|Withdrawal by Subject|3
7696024|NCT00391846|12116461|FG000|Overall Study|Developed study specific DC criteria|0
7696025|NCT00391846|12116462|FG001|Overall Study|Developed study specific DC criteria|1
7696026|NCT00391872|12116470|FG000|Overall Study|Protocol Violation|7
7696027|NCT00391872|12116471|FG001|Overall Study|Protocol Violation|2
7696028|NCT00391872|12116470|FG000|Overall Study|Withdrawal by Subject|296
7696029|NCT00391872|12116471|FG001|Overall Study|Withdrawal by Subject|249
7696030|NCT00391872|12116470|FG000|Overall Study|Reason unknown|2
7696031|NCT00391872|12116471|FG001|Overall Study|Reason unknown|4
7696032|NCT00391872|12116470|FG000|Overall Study|Lost to Follow-up|2
7696033|NCT00391872|12116471|FG001|Overall Study|Lost to Follow-up|0
7696034|NCT00391898|12116479|FG000|Overall Study|Adverse Event|3
7696035|NCT00391898|12116480|FG001|Overall Study|Adverse Event|0
7696036|NCT00391898|12116479|FG000|Overall Study|Other|8
7696037|NCT00391898|12116480|FG001|Overall Study|Other|10
7696038|NCT00391976|12116489|FG000|Overall Study|Adverse Event|0
7696039|NCT00391976|12116490|FG001|Overall Study|Adverse Event|0
7696040|NCT00391976|12116491|FG002|Overall Study|Adverse Event|1
7696041|NCT00391976|12116489|FG000|Overall Study|Withdrawal of consent|0
7696042|NCT00391976|12116490|FG001|Overall Study|Withdrawal of consent|1
7696043|NCT00391976|12116491|FG002|Overall Study|Withdrawal of consent|1
7696044|NCT00391976|12116489|FG000|Overall Study|Lost to Follow-up|1
7696045|NCT00391976|12116490|FG001|Overall Study|Lost to Follow-up|2
7696046|NCT00391976|12116491|FG002|Overall Study|Lost to Follow-up|0
7696047|NCT00391976|12116489|FG000|Overall Study|Inappropriate enrollment|1
7696048|NCT00391976|12116490|FG001|Overall Study|Inappropriate enrollment|1
7696049|NCT00391976|12116491|FG002|Overall Study|Inappropriate enrollment|0
7696050|NCT00391976|12116489|FG000|Overall Study|Protocol deviation/violation|4
7696051|NCT00391976|12116490|FG001|Overall Study|Protocol deviation/violation|2
7696052|NCT00391976|12116491|FG002|Overall Study|Protocol deviation/violation|1
7696053|NCT00391976|12116489|FG000|Overall Study|Recurrence/no eradication of infection|21
7696054|NCT00391976|12116490|FG001|Overall Study|Recurrence/no eradication of infection|19
7696055|NCT00391976|12116491|FG002|Overall Study|Recurrence/no eradication of infection|0
7696056|NCT00391976|12116489|FG000|Overall Study|Unable to classify|0
7696057|NCT00391976|12116490|FG001|Overall Study|Unable to classify|0
7696058|NCT00391976|12116491|FG002|Overall Study|Unable to classify|1
7696059|NCT00391976|12116489|FG000|Overall Study|Positive P. aeruginosa antibody test|0
7696060|NCT00391976|12116490|FG001|Overall Study|Positive P. aeruginosa antibody test|0
7696061|NCT00391976|12116491|FG002|Overall Study|Positive P. aeruginosa antibody test|31
7696062|NCT00392015|12116511|FG000|Overall Study|Lost to Follow-up|2
7696063|NCT00392015|12116512|FG001|Overall Study|Lost to Follow-up|0
7696064|NCT00392015|12116513|FG002|Overall Study|Lost to Follow-up|2
7696065|NCT00392015|12116514|FG003|Overall Study|Lost to Follow-up|1
7696066|NCT00392015|12116515|FG004|Overall Study|Lost to Follow-up|1
7696067|NCT00392015|12116516|FG005|Overall Study|Lost to Follow-up|0
7696068|NCT00392015|12116511|FG000|Overall Study|Withdrawal by Subject|0
7696069|NCT00392015|12116512|FG001|Overall Study|Withdrawal by Subject|0
7696070|NCT00392015|12116513|FG002|Overall Study|Withdrawal by Subject|2
7696071|NCT00392015|12116514|FG003|Overall Study|Withdrawal by Subject|0
7696072|NCT00392015|12116515|FG004|Overall Study|Withdrawal by Subject|0
7696073|NCT00392015|12116516|FG005|Overall Study|Withdrawal by Subject|0
7696074|NCT00392015|12116511|FG000|Overall Study|Adverse Event|0
7696075|NCT00392015|12116512|FG001|Overall Study|Adverse Event|0
7696076|NCT00392015|12116513|FG002|Overall Study|Adverse Event|0
7696077|NCT00392015|12116514|FG003|Overall Study|Adverse Event|0
7696078|NCT00392015|12116515|FG004|Overall Study|Adverse Event|1
7696079|NCT00392015|12116516|FG005|Overall Study|Adverse Event|0
7696080|NCT00392015|12116511|FG000|Overall Study|Previous trial recipient|0
7696081|NCT00392015|12116512|FG001|Overall Study|Previous trial recipient|0
7696082|NCT00392015|12116513|FG002|Overall Study|Previous trial recipient|0
7696083|NCT00392015|12116514|FG003|Overall Study|Previous trial recipient|0
7696084|NCT00392015|12116515|FG004|Overall Study|Previous trial recipient|1
7696085|NCT00392015|12116516|FG005|Overall Study|Previous trial recipient|0
7696086|NCT00392171|12116557|FG000|Overall Study|Did not meet inclusion criteria|4
7696087|NCT00392171|12116557|FG000|Overall Study|Disease progression|101
7696088|NCT00392197|12116563|FG000|Overall Study|Adverse Event|4
7696089|NCT00392197|12116564|FG001|Overall Study|Adverse Event|12
7696090|NCT00392197|12116563|FG000|Overall Study|Lack of Efficacy|3
7696091|NCT00392197|12116564|FG001|Overall Study|Lack of Efficacy|4
7696092|NCT00392197|12116563|FG000|Overall Study|Lost to Follow-up|0
7696093|NCT00392197|12116564|FG001|Overall Study|Lost to Follow-up|1
7696094|NCT00392197|12116563|FG000|Overall Study|Physician Decision|3
7696095|NCT00392197|12116564|FG001|Overall Study|Physician Decision|2
7696096|NCT00392197|12116563|FG000|Overall Study|Protocol Violation|7
7696097|NCT00392197|12116564|FG001|Overall Study|Protocol Violation|5
7696098|NCT00392197|12116563|FG000|Overall Study|Withdrawal by Subject|4
7696099|NCT00392197|12116564|FG001|Overall Study|Withdrawal by Subject|6
7696100|NCT00392210|12116572|FG000|First Voiding Trial|Physician Decision|2
7696101|NCT00392210|12116573|FG001|First Voiding Trial|Physician Decision|2
7696102|NCT00392223|12116581|FG000|Overall Study|Adverse Event|5
7696103|NCT00392223|12116582|FG001|Overall Study|Adverse Event|4
7696104|NCT00392223|12116581|FG000|Overall Study|Lost to Follow-up|1
7696105|NCT00392223|12116582|FG001|Overall Study|Lost to Follow-up|4
7696106|NCT00392223|12116581|FG000|Overall Study|Protocol Violation|0
7696107|NCT00392223|12116582|FG001|Overall Study|Protocol Violation|3
7696108|NCT00392223|12116581|FG000|Overall Study|Withdrawal by Subject|3
7696109|NCT00392223|12116582|FG001|Overall Study|Withdrawal by Subject|2
7696110|NCT00392288|12116600|FG000|Overall Study|Adverse Event|17
7696111|NCT00392288|12116601|FG001|Overall Study|Adverse Event|7
7696112|NCT00392288|12116602|FG002|Overall Study|Adverse Event|8
7696113|NCT00392288|12116600|FG000|Overall Study|Lack of Efficacy|8
7696114|NCT00392288|12116601|FG001|Overall Study|Lack of Efficacy|5
7696115|NCT00392288|12116602|FG002|Overall Study|Lack of Efficacy|3
7696116|NCT00392288|12116600|FG000|Overall Study|Protocol Violation|1
7696117|NCT00392288|12116601|FG001|Overall Study|Protocol Violation|3
7696118|NCT00392288|12116602|FG002|Overall Study|Protocol Violation|1
7696119|NCT00392288|12116600|FG000|Overall Study|Lost to Follow-up|1
7696120|NCT00392288|12116601|FG001|Overall Study|Lost to Follow-up|1
7696121|NCT00392288|12116602|FG002|Overall Study|Lost to Follow-up|1
7696122|NCT00392288|12116600|FG000|Overall Study|Withdrawal by Subject|1
7696123|NCT00392288|12116601|FG001|Overall Study|Withdrawal by Subject|0
7696124|NCT00392288|12116602|FG002|Overall Study|Withdrawal by Subject|2
7696125|NCT00392288|12116600|FG000|Overall Study|Parent/legal guardian withdrawal|1
7696126|NCT00392288|12116601|FG001|Overall Study|Parent/legal guardian withdrawal|2
7696127|NCT00392288|12116602|FG002|Overall Study|Parent/legal guardian withdrawal|1
7696128|NCT00392288|12116600|FG000|Overall Study|Other|3
7696129|NCT00392288|12116601|FG001|Overall Study|Other|4
7696130|NCT00392288|12116602|FG002|Overall Study|Other|1
7696131|NCT00392379|12116612|FG000|Overall Study|Withdrawal by Subject|17
7696132|NCT00392379|12116613|FG001|Overall Study|Withdrawal by Subject|28
7696133|NCT00392379|12116612|FG000|Overall Study|Lost to Follow-up|4
7696134|NCT00392379|12116613|FG001|Overall Study|Lost to Follow-up|9
7696135|NCT00392379|12116612|FG000|Overall Study|Adverse Event|1
7696136|NCT00392379|12116613|FG001|Overall Study|Adverse Event|1
7696137|NCT00392665|12116633|FG000|Overall Study|Death|16
7696138|NCT00392665|12116634|FG001|Overall Study|Death|14
7696139|NCT00392665|12116633|FG000|Overall Study|Lost to Follow-up|1
7696140|NCT00392665|12116634|FG001|Overall Study|Lost to Follow-up|1
7696141|NCT00392769|12116670|FG000|Overall Study|Clinical Deterioration|9
7696142|NCT00392769|12116670|FG000|Overall Study|Adverse Event|1
7696143|NCT00392808|12116682|FG000|Overall Study|Lost to Follow-up|3
7696144|NCT00392808|12116683|FG001|Overall Study|Lost to Follow-up|2
7696145|NCT00392808|12116684|FG002|Overall Study|Lost to Follow-up|1
7696146|NCT00392808|12116685|FG003|Overall Study|Lost to Follow-up|2
7696147|NCT00392808|12116682|FG000|Overall Study|Unable to withdraw blood|3
7696148|NCT00392808|12116683|FG001|Overall Study|Unable to withdraw blood|1
7696149|NCT00392808|12116684|FG002|Overall Study|Unable to withdraw blood|1
7696150|NCT00392808|12116685|FG003|Overall Study|Unable to withdraw blood|2
7696151|NCT00392925|12116708|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
7696152|NCT00392925|12116709|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
7696153|NCT00392925|12116710|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
7696154|NCT00392925|12116711|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
7696155|NCT00392925|12116708|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
7696156|NCT00392925|12116709|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
7696157|NCT00392925|12116710|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
7696158|NCT00392925|12116711|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
7696159|NCT00392925|12116708|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
7696160|NCT00392925|12116709|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
7696161|NCT00392925|12116710|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
7696162|NCT00392925|12116711|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
7696163|NCT00392925|12116708|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
7696164|NCT00392925|12116709|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
7696165|NCT00392925|12116710|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
7696166|NCT00392925|12116711|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
7696167|NCT00392925|12116708|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
7696246|NCT00393458|12116831|FG001|Overall Study|Death|1
7696168|NCT00392925|12116709|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
7696169|NCT00392925|12116710|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
7696170|NCT00392925|12116711|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
7696171|NCT00392925|12116708|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0
7696172|NCT00392925|12116709|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2
7696173|NCT00392925|12116710|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6
7696174|NCT00392925|12116711|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8
7696175|NCT00392925|12116708|FG000|Randomization to Treatment Group Period|Adverse Event|0
7696176|NCT00392925|12116709|FG001|Randomization to Treatment Group Period|Adverse Event|3
7696177|NCT00392925|12116710|FG002|Randomization to Treatment Group Period|Adverse Event|3
7696178|NCT00392925|12116711|FG003|Randomization to Treatment Group Period|Adverse Event|5
7696179|NCT00392925|12116708|FG000|Randomization to Treatment Group Period|Protocol Violation|0
7696180|NCT00392925|12116709|FG001|Randomization to Treatment Group Period|Protocol Violation|0
7696181|NCT00392925|12116710|FG002|Randomization to Treatment Group Period|Protocol Violation|2
7696182|NCT00392925|12116711|FG003|Randomization to Treatment Group Period|Protocol Violation|1
7696183|NCT00392925|12116708|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0
7696184|NCT00392925|12116709|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3
7696185|NCT00392925|12116710|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8
7696186|NCT00392925|12116711|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4
7696187|NCT00392990|12116733|FG000|Treatment on Study|Adverse Event|3
7696188|NCT00392990|12116734|FG001|Treatment on Study|Adverse Event|1
7696189|NCT00392990|12116733|FG000|Follow up for 2 Years|Death|4
7696190|NCT00392990|12116734|FG001|Follow up for 2 Years|Death|0
7696191|NCT00393029|12116742|FG000|Overall Study|Not treated|0
7696192|NCT00393029|12116743|FG001|Overall Study|Not treated|1
7696193|NCT00393042|12116750|FG000|First Intervention|Withdrawal by Subject|1
7696194|NCT00393042|12116751|FG001|First Intervention|Withdrawal by Subject|2
7696195|NCT00393042|12116750|FG000|First Intervention|Lost to Follow-up|3
7696196|NCT00393042|12116751|FG001|First Intervention|Lost to Follow-up|3
7696197|NCT00393042|12116750|FG000|First Intervention|Protocol Violation|1
7696198|NCT00393042|12116751|FG001|First Intervention|Protocol Violation|0
7696199|NCT00393042|12116750|FG000|First Intervention|Adverse Event|0
7696200|NCT00393042|12116751|FG001|First Intervention|Adverse Event|1
7696201|NCT00393042|12116750|FG000|Second Intervetion|Adverse Event|0
7696202|NCT00393042|12116751|FG001|Second Intervetion|Adverse Event|3
7696203|NCT00393042|12116750|FG000|Second Intervetion|Withdrawal by Subject|0
7696204|NCT00393042|12116751|FG001|Second Intervetion|Withdrawal by Subject|2
7696205|NCT00393042|12116750|FG000|Second Intervetion|Lack of Efficacy|1
7696206|NCT00393042|12116751|FG001|Second Intervetion|Lack of Efficacy|0
7696207|NCT00393042|12116750|FG000|Second Intervetion|Lost to Follow-up|0
7696208|NCT00393042|12116751|FG001|Second Intervetion|Lost to Follow-up|2
7696209|NCT00393042|12116750|FG000|Second Intervetion|Protocol Violation|1
7696210|NCT00393042|12116751|FG001|Second Intervetion|Protocol Violation|1
7696211|NCT00393094|12116805|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
7696212|NCT00393094|12116805|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
7696213|NCT00393367|12116813|FG000|Overall Study|Protocol Violation|2
7696214|NCT00393367|12116814|FG001|Overall Study|Protocol Violation|5
7696215|NCT00393367|12116813|FG000|Overall Study|Withdrawal by Subject|0
7696216|NCT00393367|12116814|FG001|Overall Study|Withdrawal by Subject|2
7696217|NCT00393458|12116830|FG000|Overall Study|Adverse Event|35
7696218|NCT00393458|12116831|FG001|Overall Study|Adverse Event|24
7696219|NCT00393458|12116832|FG002|Overall Study|Adverse Event|40
7696220|NCT00393458|12116833|FG003|Overall Study|Adverse Event|35
7696221|NCT00393458|12116830|FG000|Overall Study|Subject withdrew consent|27
7696222|NCT00393458|12116831|FG001|Overall Study|Subject withdrew consent|40
7696223|NCT00393458|12116832|FG002|Overall Study|Subject withdrew consent|33
7696224|NCT00393458|12116833|FG003|Overall Study|Subject withdrew consent|50
7696225|NCT00393458|12116830|FG000|Overall Study|Unsatisfactory therapeutic effect|12
7696226|NCT00393458|12116831|FG001|Overall Study|Unsatisfactory therapeutic effect|9
7696227|NCT00393458|12116832|FG002|Overall Study|Unsatisfactory therapeutic effect|12
7696228|NCT00393458|12116833|FG003|Overall Study|Unsatisfactory therapeutic effect|30
7696229|NCT00393458|12116830|FG000|Overall Study|Protocol deviation|11
7696230|NCT00393458|12116831|FG001|Overall Study|Protocol deviation|11
7696231|NCT00393458|12116832|FG002|Overall Study|Protocol deviation|11
7696232|NCT00393458|12116833|FG003|Overall Study|Protocol deviation|10
7696233|NCT00393458|12116830|FG000|Overall Study|Administrative problems|7
7696234|NCT00393458|12116831|FG001|Overall Study|Administrative problems|8
7696235|NCT00393458|12116832|FG002|Overall Study|Administrative problems|5
7696236|NCT00393458|12116833|FG003|Overall Study|Administrative problems|2
7696237|NCT00393458|12116830|FG000|Overall Study|Lost to Follow-up|5
7696238|NCT00393458|12116831|FG001|Overall Study|Lost to Follow-up|6
7696239|NCT00393458|12116832|FG002|Overall Study|Lost to Follow-up|5
7696240|NCT00393458|12116833|FG003|Overall Study|Lost to Follow-up|3
7696241|NCT00393458|12116830|FG000|Overall Study|Abnormal laboratory value(s)|1
7696242|NCT00393458|12116831|FG001|Overall Study|Abnormal laboratory value(s)|1
7696243|NCT00393458|12116832|FG002|Overall Study|Abnormal laboratory value(s)|0
7696244|NCT00393458|12116833|FG003|Overall Study|Abnormal laboratory value(s)|0
7696245|NCT00393458|12116830|FG000|Overall Study|Death|1
7696247|NCT00393458|12116832|FG002|Overall Study|Death|5
7696248|NCT00393458|12116833|FG003|Overall Study|Death|5
7696249|NCT00393458|12116830|FG000|Overall Study|Abnormal test procedure result(s)|0
7696250|NCT00393458|12116831|FG001|Overall Study|Abnormal test procedure result(s)|1
7696251|NCT00393458|12116832|FG002|Overall Study|Abnormal test procedure result(s)|1
7696252|NCT00393458|12116833|FG003|Overall Study|Abnormal test procedure result(s)|2
7696253|NCT00393458|12116830|FG000|Overall Study|Subject no longer requires study drug|0
7696254|NCT00393458|12116831|FG001|Overall Study|Subject no longer requires study drug|1
7696255|NCT00393458|12116832|FG002|Overall Study|Subject no longer requires study drug|0
7696256|NCT00393458|12116833|FG003|Overall Study|Subject no longer requires study drug|0
7696257|NCT00393484|12116845|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
7696258|NCT00393484|12116846|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
7696259|NCT00393484|12116845|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
7696260|NCT00393484|12116846|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
7696261|NCT00393484|12116845|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
7696262|NCT00393484|12116846|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
7696263|NCT00393484|12116845|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
7696264|NCT00393484|12116846|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
7696265|NCT00393484|12116845|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
7696266|NCT00393484|12116846|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
7696267|NCT00393484|12116845|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
7696268|NCT00393484|12116846|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
7696269|NCT00393484|12116845|FG000|Open-label Period (Weeks 96 to 240)|Death|1
7696270|NCT00393484|12116846|FG001|Open-label Period (Weeks 96 to 240)|Death|0
7696271|NCT00393484|12116845|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
7696272|NCT00393484|12116846|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
7696273|NCT00393484|12116845|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2
7696274|NCT00393484|12116846|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2
7696275|NCT00393484|12116845|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
7696276|NCT00393484|12116846|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
7696277|NCT00393510|12116856|FG000|Overall Study|Physician Decision|3
7696278|NCT00393510|12116857|FG001|Overall Study|Physician Decision|9
7696279|NCT00393523|12116868|FG000|Overall Study|Lost to Follow-up|0
7696280|NCT00393523|12116869|FG001|Overall Study|Lost to Follow-up|0
7696281|NCT00393523|12116870|FG002|Overall Study|Lost to Follow-up|0
7696282|NCT00393523|12116871|FG003|Overall Study|Lost to Follow-up|2
7696283|NCT00393523|12116872|FG004|Overall Study|Lost to Follow-up|1
7696284|NCT00393523|12116868|FG000|Overall Study|Protocol Violation|6
7696285|NCT00393523|12116869|FG001|Overall Study|Protocol Violation|2
7696286|NCT00393523|12116870|FG002|Overall Study|Protocol Violation|0
7696287|NCT00393523|12116871|FG003|Overall Study|Protocol Violation|1
7696288|NCT00393523|12116872|FG004|Overall Study|Protocol Violation|0
7696289|NCT00393523|12116868|FG000|Overall Study|Withdrawal by Subject|6
7696290|NCT00393523|12116869|FG001|Overall Study|Withdrawal by Subject|7
7696291|NCT00393523|12116870|FG002|Overall Study|Withdrawal by Subject|2
7696292|NCT00393523|12116871|FG003|Overall Study|Withdrawal by Subject|3
7696293|NCT00393523|12116872|FG004|Overall Study|Withdrawal by Subject|0
7696294|NCT00393523|12116868|FG000|Overall Study|Difficulties in specimen collection|0
7696295|NCT00393523|12116869|FG001|Overall Study|Difficulties in specimen collection|0
7696296|NCT00393523|12116870|FG002|Overall Study|Difficulties in specimen collection|1
7696297|NCT00393523|12116871|FG003|Overall Study|Difficulties in specimen collection|0
7696298|NCT00393523|12116872|FG004|Overall Study|Difficulties in specimen collection|0
7696299|NCT00393523|12116868|FG000|Overall Study|Vaccine supply issue|0
7696300|NCT00393523|12116869|FG001|Overall Study|Vaccine supply issue|0
7696301|NCT00393523|12116870|FG002|Overall Study|Vaccine supply issue|1
7696302|NCT00393523|12116871|FG003|Overall Study|Vaccine supply issue|0
7696303|NCT00393523|12116872|FG004|Overall Study|Vaccine supply issue|0
7696304|NCT00393705|12116885|FG000|Overall Study|Adverse Event|0
7696305|NCT00393705|12116886|FG001|Overall Study|Adverse Event|2
7696306|NCT00393705|12116885|FG000|Overall Study|Death|0
7696307|NCT00393705|12116886|FG001|Overall Study|Death|1
7696308|NCT00393705|12116885|FG000|Overall Study|Lost to Follow-up|2
7696309|NCT00393705|12116886|FG001|Overall Study|Lost to Follow-up|2
7696310|NCT00393705|12116885|FG000|Overall Study|Entry Criteria Not Met|10
7696311|NCT00393705|12116886|FG001|Overall Study|Entry Criteria Not Met|10
7696312|NCT00393705|12116885|FG000|Overall Study|Protocol Violation|4
7696313|NCT00393705|12116886|FG001|Overall Study|Protocol Violation|3
7696314|NCT00393705|12116885|FG000|Overall Study|Withdrawal by Subject|5
7696315|NCT00393705|12116886|FG001|Overall Study|Withdrawal by Subject|3
7696316|NCT00393705|12116885|FG000|Overall Study|Physician Decision|2
7696317|NCT00393705|12116886|FG001|Overall Study|Physician Decision|2
7696318|NCT00393718|12116894|FG000|Overall Study|Adverse Event|20
7696319|NCT00393718|12116895|FG001|Overall Study|Adverse Event|8
7696320|NCT00393718|12116894|FG000|Overall Study|Protocol Violation|1
7696321|NCT00393718|12116895|FG001|Overall Study|Protocol Violation|2
7696322|NCT00393718|12116894|FG000|Overall Study|Lack of Efficacy|10
7696323|NCT00393718|12116895|FG001|Overall Study|Lack of Efficacy|9
7696324|NCT00393718|12116894|FG000|Overall Study|Hypoglycaemia|3
7696325|NCT00393718|12116895|FG001|Overall Study|Hypoglycaemia|2
7696326|NCT00393718|12116894|FG000|Overall Study|Subject decision|5
7696327|NCT00393718|12116895|FG001|Overall Study|Subject decision|0
7696328|NCT00393718|12116894|FG000|Overall Study|Withdrawal of consent|2
7696329|NCT00393718|12116895|FG001|Overall Study|Withdrawal of consent|1
7696330|NCT00393718|12116894|FG000|Overall Study|Missed measurement|1
7696331|NCT00393718|12116895|FG001|Overall Study|Missed measurement|0
7696332|NCT00393718|12116894|FG000|Overall Study|Move|1
7696333|NCT00393718|12116895|FG001|Overall Study|Move|0
7696334|NCT00393848|12116914|FG000|Overall Study|Surgical schedule|0
7696335|NCT00393848|12116915|FG001|Overall Study|Surgical schedule|0
7696336|NCT00393848|12116916|FG002|Overall Study|Surgical schedule|0
7696337|NCT00393848|12116917|FG003|Overall Study|Surgical schedule|1
7696338|NCT00393848|12116914|FG000|Overall Study|Personal reasons|0
7696339|NCT00393848|12116915|FG001|Overall Study|Personal reasons|0
7696340|NCT00393848|12116916|FG002|Overall Study|Personal reasons|2
7696341|NCT00393848|12116917|FG003|Overall Study|Personal reasons|0
7696342|NCT00393861|12116928|FG000|Overall Study|Adverse Event|2
7696343|NCT00393861|12116928|FG000|Overall Study|Disease Progression|24
7696344|NCT00393887|12116950|FG000|Overall Study|Physician Decision|5
7696345|NCT00393887|12116951|FG001|Overall Study|Physician Decision|0
7696346|NCT00393887|12116950|FG000|Overall Study|Lost to Follow-up|11
7696347|NCT00393887|12116951|FG001|Overall Study|Lost to Follow-up|9
7696348|NCT00393913|12116957|FG000|Initial Assessment|diagnosed with other sleep disorder|21
7696349|NCT00393913|12116957|FG000|Initial Assessment|Withdrawal by Subject|16
7696350|NCT00393913|12116957|FG000|CPAP|Withdrawal by Subject|3
7696351|NCT00393913|12116957|FG000|CPAP|Physician Decision|1
7696352|NCT00393913|12116957|FG000|CPAP|TEchnical problem with CPAP|3
7696353|NCT00393939|12116964|FG000|Overall Study|Protocol Violation|1
7696354|NCT00393939|12116965|FG001|Overall Study|Protocol Violation|1
7696355|NCT00393939|12116964|FG000|Overall Study|Lost to Follow-up|2
7696356|NCT00393939|12116965|FG001|Overall Study|Lost to Follow-up|4
7696357|NCT00393939|12116964|FG000|Overall Study|Death|10
7696358|NCT00393939|12116965|FG001|Overall Study|Death|4
7696359|NCT00393939|12116964|FG000|Overall Study|Sponsor|5
7696360|NCT00393939|12116965|FG001|Overall Study|Sponsor|13
7696361|NCT00393939|12116964|FG000|Overall Study|Objective progression or relapse|239
7696362|NCT00393939|12116965|FG001|Overall Study|Objective progression or relapse|223
7696363|NCT00393939|12116964|FG000|Overall Study|Withdrawal by Subject|2
7696364|NCT00393939|12116965|FG001|Overall Study|Withdrawal by Subject|7
7696365|NCT00393939|12116964|FG000|Overall Study|Other|37
7696366|NCT00393939|12116965|FG001|Overall Study|Other|45
7696367|NCT00394082|12116980|FG000|Overall Study|Unacceptable toxicity|15
7696368|NCT00394082|12116980|FG000|Overall Study|Adverse Event|4
7696369|NCT00394082|12116980|FG000|Overall Study|Physician Decision|4
7696370|NCT00394082|12116980|FG000|Overall Study|Withdrawal by Subject|2
7696371|NCT00394082|12116980|FG000|Overall Study|Other|1
7696372|NCT00394095|12116986|FG000|Overall Study|Adverse Event|1
7696373|NCT00394095|12116987|FG001|Overall Study|Adverse Event|0
7696374|NCT00394212|12116996|FG000|Overall Study|Lost to Follow-up|3
7696375|NCT00394212|12116997|FG001|Overall Study|Lost to Follow-up|0
7696376|NCT00394212|12116996|FG000|Overall Study|Withdrawal by Subject|4
7696377|NCT00394212|12116997|FG001|Overall Study|Withdrawal by Subject|1
7696378|NCT00394251|12117005|FG000|Overall Study|Adverse Event|7
7696379|NCT00394251|12117006|FG001|Overall Study|Adverse Event|5
7696380|NCT00394251|12117005|FG000|Overall Study|Unacceptable Toxicity|20
7696381|NCT00394251|12117006|FG001|Overall Study|Unacceptable Toxicity|18
7696382|NCT00394251|12117005|FG000|Overall Study|Physician Decision|1
7696383|NCT00394251|12117006|FG001|Overall Study|Physician Decision|1
7696384|NCT00394251|12117005|FG000|Overall Study|Protocol Violation|0
7696385|NCT00394251|12117006|FG001|Overall Study|Protocol Violation|1
7696386|NCT00394251|12117005|FG000|Overall Study|Withdrawal by Subject|7
7696387|NCT00394251|12117006|FG001|Overall Study|Withdrawal by Subject|11
7696388|NCT00394251|12117005|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2
7696389|NCT00394251|12117006|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2
7696390|NCT00394433|12117056|FG000|Overall Study|Adverse Event|2
7696391|NCT00394433|12117056|FG000|Overall Study|Alternative Therapy|1
7696392|NCT00394472|12117062|FG000|Overall Study|Protocol Violation|1
7696393|NCT00394472|12117063|FG001|Overall Study|Protocol Violation|3
7696394|NCT00394472|12117062|FG000|Overall Study|incorrect enrolment|4
7696395|NCT00394472|12117063|FG001|Overall Study|incorrect enrolment|2
7696396|NCT00394472|12117062|FG000|Overall Study|Adverse Event|4
7696397|NCT00394472|12117063|FG001|Overall Study|Adverse Event|2
7696398|NCT00394472|12117062|FG000|Overall Study|Withdrawal by Subject|0
7696399|NCT00394472|12117063|FG001|Overall Study|Withdrawal by Subject|2
7696400|NCT00394472|12117062|FG000|Overall Study|Physician Decision|0
7696401|NCT00394472|12117063|FG001|Overall Study|Physician Decision|1
7696402|NCT00394472|12117062|FG000|Overall Study|Lost to Follow-up|0
7696403|NCT00394472|12117063|FG001|Overall Study|Lost to Follow-up|1
7696404|NCT00394524|12117071|FG000|Overall Study|Protocol Violation|2
7696405|NCT00394524|12117072|FG001|Overall Study|Protocol Violation|3
7696406|NCT00394524|12117071|FG000|Overall Study|Death|1
7696407|NCT00394524|12117072|FG001|Overall Study|Death|0
7696408|NCT00394524|12117071|FG000|Overall Study|Withdrawal by Subject|0
7696409|NCT00394524|12117072|FG001|Overall Study|Withdrawal by Subject|1
7696410|NCT00394589|12117083|FG000|Overall Study|Adverse Event|2
7696411|NCT00394589|12117084|FG001|Overall Study|Adverse Event|1
7696412|NCT00394589|12117085|FG002|Overall Study|Adverse Event|2
7696413|NCT00394589|12117083|FG000|Overall Study|Lack of Efficacy|2
7696414|NCT00394589|12117084|FG001|Overall Study|Lack of Efficacy|2
7696415|NCT00394589|12117085|FG002|Overall Study|Lack of Efficacy|3
7696416|NCT00394589|12117083|FG000|Overall Study|Protocol Violation|4
7696417|NCT00394589|12117084|FG001|Overall Study|Protocol Violation|0
7696418|NCT00394589|12117085|FG002|Overall Study|Protocol Violation|2
7696419|NCT00394654|12117095|FG000|Overall Study|Lost to Follow-up|1
7696420|NCT00394654|12117096|FG001|Overall Study|Lost to Follow-up|0
7696421|NCT00394654|12117095|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1
7696422|NCT00394654|12117096|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0
7696423|NCT00394706|12117110|FG000|Overall Study|Withdrawal by Subject|2
7696424|NCT00394706|12117111|FG001|Overall Study|Withdrawal by Subject|0
7696425|NCT00394706|12117112|FG002|Overall Study|Withdrawal by Subject|1
7696426|NCT00394706|12117113|FG003|Overall Study|Withdrawal by Subject|0
7696427|NCT00394706|12117114|FG004|Overall Study|Withdrawal by Subject|0
7696428|NCT00394706|12117115|FG005|Overall Study|Withdrawal by Subject|2
7696429|NCT00394706|12117116|FG006|Overall Study|Withdrawal by Subject|1
7696430|NCT00394706|12117117|FG007|Overall Study|Withdrawal by Subject|0
7696431|NCT00394706|12117110|FG000|Overall Study|Lost to Follow-up|2
7696432|NCT00394706|12117111|FG001|Overall Study|Lost to Follow-up|2
7696433|NCT00394706|12117112|FG002|Overall Study|Lost to Follow-up|8
7696434|NCT00394706|12117113|FG003|Overall Study|Lost to Follow-up|1
7696435|NCT00394706|12117114|FG004|Overall Study|Lost to Follow-up|2
7696436|NCT00394706|12117115|FG005|Overall Study|Lost to Follow-up|5
7696437|NCT00394706|12117116|FG006|Overall Study|Lost to Follow-up|2
7696438|NCT00394706|12117117|FG007|Overall Study|Lost to Follow-up|0
7696439|NCT00394771|12117135|FG000|Overall Study|Did not meet protocol requirements|1
7696440|NCT00394771|12117136|FG001|Overall Study|Did not meet protocol requirements|0
7696441|NCT00394771|12117137|FG002|Overall Study|Did not meet protocol requirements|2
7696442|NCT00394771|12117138|FG003|Overall Study|Did not meet protocol requirements|0
7696443|NCT00394771|12117135|FG000|Overall Study|Protocol Violation|2
7696444|NCT00394771|12117136|FG001|Overall Study|Protocol Violation|4
7696445|NCT00394771|12117137|FG002|Overall Study|Protocol Violation|9
7696446|NCT00394771|12117138|FG003|Overall Study|Protocol Violation|7
7696447|NCT00394771|12117135|FG000|Overall Study|Withdrawal by Subject|10
7696448|NCT00394771|12117136|FG001|Overall Study|Withdrawal by Subject|6
7696449|NCT00394771|12117137|FG002|Overall Study|Withdrawal by Subject|8
7696450|NCT00394771|12117138|FG003|Overall Study|Withdrawal by Subject|12
7696451|NCT00394771|12117135|FG000|Overall Study|Adverse Event|10
7696452|NCT00394771|12117136|FG001|Overall Study|Adverse Event|5
7696453|NCT00394771|12117137|FG002|Overall Study|Adverse Event|12
7696454|NCT00394771|12117138|FG003|Overall Study|Adverse Event|8
7696455|NCT00394771|12117135|FG000|Overall Study|Participant pregnant|0
7696456|NCT00394771|12117136|FG001|Overall Study|Participant pregnant|1
7696457|NCT00394771|12117137|FG002|Overall Study|Participant pregnant|2
7696458|NCT00394771|12117138|FG003|Overall Study|Participant pregnant|2
7696459|NCT00394771|12117135|FG000|Overall Study|Lost to Follow-up|15
7696460|NCT00394771|12117136|FG001|Overall Study|Lost to Follow-up|15
7696461|NCT00394771|12117137|FG002|Overall Study|Lost to Follow-up|13
7696462|NCT00394771|12117138|FG003|Overall Study|Lost to Follow-up|10
7696463|NCT00394771|12117135|FG000|Overall Study|Other|3
7696464|NCT00394771|12117136|FG001|Overall Study|Other|3
7696465|NCT00394771|12117137|FG002|Overall Study|Other|1
7696466|NCT00394771|12117138|FG003|Overall Study|Other|0
7696467|NCT00394836|12117150|FG000|Teatment or Follow-up Phase|Adverse Event|0
7696468|NCT00394836|12117151|FG001|Teatment or Follow-up Phase|Adverse Event|2
7696469|NCT00394836|12117150|FG000|Teatment or Follow-up Phase|Protocol Violation|0
7696470|NCT00394836|12117151|FG001|Teatment or Follow-up Phase|Protocol Violation|2
7696471|NCT00394836|12117150|FG000|Teatment or Follow-up Phase|Disease Progression|27
7696472|NCT00394836|12117151|FG001|Teatment or Follow-up Phase|Disease Progression|60
7696473|NCT00394836|12117150|FG000|Teatment or Follow-up Phase|Patient Refusal|1
7696474|NCT00394836|12117151|FG001|Teatment or Follow-up Phase|Patient Refusal|2
7696475|NCT00394836|12117150|FG000|Teatment or Follow-up Phase|Death|0
7696476|NCT00394836|12117151|FG001|Teatment or Follow-up Phase|Death|1
7696477|NCT00394836|12117150|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
7696478|NCT00394836|12117151|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
7696479|NCT00394836|12117150|FG000|Teatment or Follow-up Phase|Started alternative treatment|0
7696480|NCT00394836|12117151|FG001|Teatment or Follow-up Phase|Started alternative treatment|6
7696481|NCT00394836|12117150|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
7696482|NCT00394836|12117151|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
7696483|NCT00394836|12117150|FG000|Teatment or Follow-up Phase|Physician Decision|0
7696484|NCT00394836|12117151|FG001|Teatment or Follow-up Phase|Physician Decision|1
7696485|NCT00394836|12117150|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
7696486|NCT00394836|12117151|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
7696487|NCT00394836|12117150|FG000|Teatment or Follow-up Phase|Non compliance|0
7696488|NCT00394836|12117151|FG001|Teatment or Follow-up Phase|Non compliance|1
7696489|NCT00394836|12117150|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
7696490|NCT00394836|12117151|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
7696491|NCT00394836|12117150|FG000|Extended Follow-up Phase (2-5 Years)|Death|0
7696492|NCT00394836|12117151|FG001|Extended Follow-up Phase (2-5 Years)|Death|1
7696493|NCT00394836|12117150|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
7696494|NCT00394836|12117151|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
7696495|NCT00394836|12117150|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
7696496|NCT00394836|12117151|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
7696497|NCT00394901|12117174|FG000|Baseline Phase|Protocol Violation|0
7696498|NCT00394901|12117175|FG001|Baseline Phase|Protocol Violation|0
7696499|NCT00394901|12117176|FG002|Baseline Phase|Protocol Violation|1
7696500|NCT00394901|12117177|FG003|Baseline Phase|Protocol Violation|0
7696501|NCT00394901|12117174|FG000|Double-blind Phase|Adverse Event|5
7696502|NCT00394901|12117175|FG001|Double-blind Phase|Adverse Event|7
7696503|NCT00394901|12117176|FG002|Double-blind Phase|Adverse Event|16
7696504|NCT00394901|12117177|FG003|Double-blind Phase|Adverse Event|20
7696505|NCT00394901|12117174|FG000|Double-blind Phase|Lack of Efficacy|6
7696506|NCT00394901|12117175|FG001|Double-blind Phase|Lack of Efficacy|4
7696507|NCT00394901|12117176|FG002|Double-blind Phase|Lack of Efficacy|1
7696508|NCT00394901|12117177|FG003|Double-blind Phase|Lack of Efficacy|3
7696509|NCT00394901|12117174|FG000|Double-blind Phase|Withdrawal by Subject|2
7696510|NCT00394901|12117175|FG001|Double-blind Phase|Withdrawal by Subject|0
7696511|NCT00394901|12117176|FG002|Double-blind Phase|Withdrawal by Subject|0
7696512|NCT00394901|12117177|FG003|Double-blind Phase|Withdrawal by Subject|0
7696513|NCT00394901|12117174|FG000|Double-blind Phase|Lost to Follow-up|0
7696514|NCT00394901|12117175|FG001|Double-blind Phase|Lost to Follow-up|0
7696515|NCT00394901|12117176|FG002|Double-blind Phase|Lost to Follow-up|0
7696516|NCT00394901|12117177|FG003|Double-blind Phase|Lost to Follow-up|1
7696517|NCT00394901|12117174|FG000|Double-blind Phase|Protocol Violation|0
7696518|NCT00394901|12117175|FG001|Double-blind Phase|Protocol Violation|0
7696519|NCT00394901|12117176|FG002|Double-blind Phase|Protocol Violation|0
7696520|NCT00394901|12117177|FG003|Double-blind Phase|Protocol Violation|1
7696521|NCT00394901|12117174|FG000|Double-blind Phase|Death|1
7696522|NCT00394901|12117175|FG001|Double-blind Phase|Death|0
7696523|NCT00394901|12117176|FG002|Double-blind Phase|Death|0
7696524|NCT00394901|12117177|FG003|Double-blind Phase|Death|0
7696525|NCT00394901|12117174|FG000|Double-blind Phase|Subject's Personal Reason|1
7696526|NCT00394901|12117175|FG001|Double-blind Phase|Subject's Personal Reason|0
7696527|NCT00394901|12117176|FG002|Double-blind Phase|Subject's Personal Reason|0
7696528|NCT00394901|12117177|FG003|Double-blind Phase|Subject's Personal Reason|1
7696529|NCT00394901|12117174|FG000|Double-blind Phase|Lack of Compliance|0
7696530|NCT00394901|12117175|FG001|Double-blind Phase|Lack of Compliance|3
7696531|NCT00394901|12117176|FG002|Double-blind Phase|Lack of Compliance|0
7696532|NCT00394901|12117177|FG003|Double-blind Phase|Lack of Compliance|0
7696533|NCT00394901|12117174|FG000|Double-blind Phase|Entry into another study was found|0
7696534|NCT00394901|12117175|FG001|Double-blind Phase|Entry into another study was found|0
7696535|NCT00394901|12117176|FG002|Double-blind Phase|Entry into another study was found|1
7696536|NCT00394901|12117177|FG003|Double-blind Phase|Entry into another study was found|0
7696537|NCT00394901|12117174|FG000|Double-blind Phase|Found not to meet entrance criteria|0
7696538|NCT00394901|12117175|FG001|Double-blind Phase|Found not to meet entrance criteria|0
7696539|NCT00394901|12117176|FG002|Double-blind Phase|Found not to meet entrance criteria|0
7696540|NCT00394901|12117177|FG003|Double-blind Phase|Found not to meet entrance criteria|1
7696541|NCT00394914|12117192|FG000|Treatment Period|Adverse Event|0
7696542|NCT00394914|12117193|FG001|Treatment Period|Adverse Event|3
7696543|NCT00394914|12117194|FG002|Treatment Period|Adverse Event|1
7696544|NCT00394914|12117192|FG000|Treatment Period|Lost to Follow-up|0
7696545|NCT00394914|12117193|FG001|Treatment Period|Lost to Follow-up|1
7696546|NCT00394914|12117194|FG002|Treatment Period|Lost to Follow-up|0
7696547|NCT00394914|12117192|FG000|Treatment Period|Withdrawal by Subject|0
7696548|NCT00394914|12117193|FG001|Treatment Period|Withdrawal by Subject|2
7696549|NCT00394914|12117194|FG002|Treatment Period|Withdrawal by Subject|2
7696550|NCT00394914|12117192|FG000|Treatment Period|Noncompliance with protocol|0
7696551|NCT00394914|12117193|FG001|Treatment Period|Noncompliance with protocol|3
7696552|NCT00394914|12117194|FG002|Treatment Period|Noncompliance with protocol|2
7696553|NCT00394914|12117192|FG000|Treatment Period|Did not meet protocol eligibility|0
7696554|NCT00394914|12117193|FG001|Treatment Period|Did not meet protocol eligibility|1
7696555|NCT00394914|12117194|FG002|Treatment Period|Did not meet protocol eligibility|1
7696556|NCT00394953|12117202|FG000|First Treatment Period|Adverse Event|1
7696557|NCT00394953|12117203|FG001|First Treatment Period|Adverse Event|2
7696558|NCT00394953|12117202|FG000|First Treatment Period|Death|6
7696559|NCT00394953|12117203|FG001|First Treatment Period|Death|7
7696560|NCT00394953|12117202|FG000|First Treatment Period|Lack of Efficacy|1
7696561|NCT00394953|12117203|FG001|First Treatment Period|Lack of Efficacy|1
7696562|NCT00394953|12117202|FG000|First Treatment Period|Withdrawal by Subject|6
7696563|NCT00394953|12117203|FG001|First Treatment Period|Withdrawal by Subject|3
7696564|NCT00394953|12117202|FG000|First Treatment Period|Lost to Follow-up|0
7696565|NCT00394953|12117203|FG001|First Treatment Period|Lost to Follow-up|1
7696566|NCT00394953|12117202|FG000|First Treatment Period|Renal transplant|11
7696567|NCT00394953|12117203|FG001|First Treatment Period|Renal transplant|7
7696568|NCT00394953|12117202|FG000|First Treatment Period|Not defined|4
7696569|NCT00394953|12117203|FG001|First Treatment Period|Not defined|1
7696570|NCT00394953|12117202|FG000|Second Treatment Period|Adverse Event|2
7696571|NCT00394953|12117203|FG001|Second Treatment Period|Adverse Event|5
7696572|NCT00394953|12117202|FG000|Second Treatment Period|Death|8
7696573|NCT00394953|12117203|FG001|Second Treatment Period|Death|4
7696574|NCT00394953|12117202|FG000|Second Treatment Period|Lack of Efficacy|9
7696575|NCT00394953|12117203|FG001|Second Treatment Period|Lack of Efficacy|47
7696576|NCT00394953|12117202|FG000|Second Treatment Period|Withdrawal by Subject|3
7696577|NCT00394953|12117203|FG001|Second Treatment Period|Withdrawal by Subject|3
7696578|NCT00394953|12117202|FG000|Second Treatment Period|Lost to Follow-up|0
7696579|NCT00394953|12117203|FG001|Second Treatment Period|Lost to Follow-up|1
7696580|NCT00394953|12117202|FG000|Second Treatment Period|Renal transplant|4
7696581|NCT00394953|12117203|FG001|Second Treatment Period|Renal transplant|6
7696582|NCT00394953|12117202|FG000|Second Treatment Period|Not defined|3
7696583|NCT00394953|12117203|FG001|Second Treatment Period|Not defined|8
7696584|NCT00395018|12117209|FG000|On-Treatment|Death|4
7696585|NCT00395018|12117209|FG000|On-Treatment|Other Reason|2
7696586|NCT00395018|12117209|FG000|On-Treatment|Poor/non-compliance|2
7696587|NCT00395018|12117209|FG000|On-Treatment|Subject no longer meets study criteria|2
7696588|NCT00395018|12117209|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1
7696589|NCT00395018|12117209|FG000|Off-Treatment Follow-up|Lost to Follow-up|2
7696590|NCT00395018|12117209|FG000|Off-Treatment Follow-up|Poor/non-compliance|1
7696591|NCT00395083|12117241|FG000|Overall Study|Withdrawal by Subject|6
7696592|NCT00395083|12117242|FG001|Overall Study|Withdrawal by Subject|5
7696593|NCT00395083|12117241|FG000|Overall Study|Developed another disease|4
7696594|NCT00395083|12117242|FG001|Overall Study|Developed another disease|3
7696595|NCT00395226|12117281|FG000|Overall Study|Adverse Event|4
7696596|NCT00395226|12117282|FG001|Overall Study|Adverse Event|3
7696597|NCT00395226|12117281|FG000|Overall Study|Withdrawal by Subject|0
7696598|NCT00395226|12117282|FG001|Overall Study|Withdrawal by Subject|1
7696599|NCT00395226|12117281|FG000|Overall Study|Lost to Follow-up|0
7696600|NCT00395226|12117282|FG001|Overall Study|Lost to Follow-up|1
7696601|NCT00395304|12117295|FG000|Treatment Period 1|Withdrawal by Subject|0
7696602|NCT00395304|12117296|FG001|Treatment Period 1|Withdrawal by Subject|3
7696603|NCT00395304|12117297|FG002|Treatment Period 1|Withdrawal by Subject|0
7696604|NCT00395304|12117298|FG003|Treatment Period 1|Withdrawal by Subject|2
7696605|NCT00395304|12117299|FG004|Treatment Period 1|Withdrawal by Subject|1
7696606|NCT00395304|12117300|FG005|Treatment Period 1|Withdrawal by Subject|1
7696607|NCT00395304|12117295|FG000|Treatment Period 1|Lost to Follow-up|1
7696608|NCT00395304|12117296|FG001|Treatment Period 1|Lost to Follow-up|0
7696609|NCT00395304|12117297|FG002|Treatment Period 1|Lost to Follow-up|0
7696610|NCT00395304|12117298|FG003|Treatment Period 1|Lost to Follow-up|1
7696611|NCT00395304|12117299|FG004|Treatment Period 1|Lost to Follow-up|0
7696612|NCT00395304|12117300|FG005|Treatment Period 1|Lost to Follow-up|1
7696613|NCT00395304|12117295|FG000|Treatment Period 1|Physician Decision|0
7696614|NCT00395304|12117296|FG001|Treatment Period 1|Physician Decision|1
7696615|NCT00395304|12117297|FG002|Treatment Period 1|Physician Decision|0
7696616|NCT00395304|12117298|FG003|Treatment Period 1|Physician Decision|0
7696617|NCT00395304|12117299|FG004|Treatment Period 1|Physician Decision|0
7696618|NCT00395304|12117300|FG005|Treatment Period 1|Physician Decision|0
7696619|NCT00395304|12117295|FG000|Treatment Period 2|Withdrawal by Subject|0
7696620|NCT00395304|12117296|FG001|Treatment Period 2|Withdrawal by Subject|0
7696621|NCT00395304|12117297|FG002|Treatment Period 2|Withdrawal by Subject|0
7696622|NCT00395304|12117298|FG003|Treatment Period 2|Withdrawal by Subject|1
7696623|NCT00395304|12117299|FG004|Treatment Period 2|Withdrawal by Subject|0
7696624|NCT00395304|12117300|FG005|Treatment Period 2|Withdrawal by Subject|2
7696625|NCT00395304|12117295|FG000|Treatment Period 2|Lost to Follow-up|0
7696626|NCT00395304|12117296|FG001|Treatment Period 2|Lost to Follow-up|3
7696627|NCT00395304|12117297|FG002|Treatment Period 2|Lost to Follow-up|0
7696628|NCT00395304|12117298|FG003|Treatment Period 2|Lost to Follow-up|0
7696629|NCT00395304|12117299|FG004|Treatment Period 2|Lost to Follow-up|0
7696630|NCT00395304|12117300|FG005|Treatment Period 2|Lost to Follow-up|0
7696631|NCT00395304|12117295|FG000|Treatment Period 2|Physician Decision|0
7696632|NCT00395304|12117296|FG001|Treatment Period 2|Physician Decision|0
7696633|NCT00395304|12117297|FG002|Treatment Period 2|Physician Decision|1
7696634|NCT00395304|12117298|FG003|Treatment Period 2|Physician Decision|0
7696635|NCT00395304|12117299|FG004|Treatment Period 2|Physician Decision|0
7696636|NCT00395304|12117300|FG005|Treatment Period 2|Physician Decision|0
7696637|NCT00395304|12117295|FG000|Treatment Period 2|Other|0
7696638|NCT00395304|12117296|FG001|Treatment Period 2|Other|1
7696639|NCT00395304|12117297|FG002|Treatment Period 2|Other|0
7696640|NCT00395304|12117298|FG003|Treatment Period 2|Other|0
7696641|NCT00395304|12117299|FG004|Treatment Period 2|Other|0
7696642|NCT00395304|12117300|FG005|Treatment Period 2|Other|0
7696643|NCT00395304|12117295|FG000|Treatment Period 3|Withdrawal by Subject|0
7696644|NCT00395304|12117296|FG001|Treatment Period 3|Withdrawal by Subject|0
7696645|NCT00395304|12117297|FG002|Treatment Period 3|Withdrawal by Subject|0
7696646|NCT00395304|12117298|FG003|Treatment Period 3|Withdrawal by Subject|1
7696647|NCT00395304|12117299|FG004|Treatment Period 3|Withdrawal by Subject|0
7696648|NCT00395304|12117300|FG005|Treatment Period 3|Withdrawal by Subject|1
7696649|NCT00395304|12117295|FG000|Treatment Period 3|Lost to Follow-up|1
7696650|NCT00395304|12117296|FG001|Treatment Period 3|Lost to Follow-up|1
7696651|NCT00395304|12117297|FG002|Treatment Period 3|Lost to Follow-up|0
7696652|NCT00395304|12117298|FG003|Treatment Period 3|Lost to Follow-up|0
7696653|NCT00395304|12117299|FG004|Treatment Period 3|Lost to Follow-up|0
7696654|NCT00395304|12117300|FG005|Treatment Period 3|Lost to Follow-up|0
7696655|NCT00395304|12117295|FG000|Treatment Period 3|Physician Decision|0
7696656|NCT00395304|12117296|FG001|Treatment Period 3|Physician Decision|1
7696657|NCT00395304|12117297|FG002|Treatment Period 3|Physician Decision|0
7696658|NCT00395304|12117298|FG003|Treatment Period 3|Physician Decision|0
7696659|NCT00395304|12117299|FG004|Treatment Period 3|Physician Decision|0
7696660|NCT00395304|12117300|FG005|Treatment Period 3|Physician Decision|0
7696661|NCT00395304|12117295|FG000|Treatment Period 3|Other|0
7696662|NCT00395304|12117296|FG001|Treatment Period 3|Other|0
7696663|NCT00395304|12117297|FG002|Treatment Period 3|Other|0
7696664|NCT00395304|12117298|FG003|Treatment Period 3|Other|1
7696665|NCT00395304|12117299|FG004|Treatment Period 3|Other|0
7696666|NCT00395304|12117300|FG005|Treatment Period 3|Other|0
7696667|NCT00395343|12117309|FG000|Overall Study|Adverse Event|13
7696668|NCT00395343|12117310|FG001|Overall Study|Adverse Event|5
7696669|NCT00395343|12117309|FG000|Overall Study|Lack of Efficacy|0
7696670|NCT00395343|12117310|FG001|Overall Study|Lack of Efficacy|1
7696671|NCT00395343|12117309|FG000|Overall Study|Lost to Follow-up|4
7696672|NCT00395343|12117310|FG001|Overall Study|Lost to Follow-up|4
7696673|NCT00395343|12117309|FG000|Overall Study|Physician Decision|2
7696674|NCT00395343|12117310|FG001|Overall Study|Physician Decision|4
7696675|NCT00395343|12117309|FG000|Overall Study|Protocol Violation|6
7696676|NCT00395343|12117310|FG001|Overall Study|Protocol Violation|8
7696677|NCT00395343|12117309|FG000|Overall Study|Withdrawal by Subject|11
7696678|NCT00395343|12117310|FG001|Overall Study|Withdrawal by Subject|12
7696679|NCT00395343|12117309|FG000|Overall Study|Other|5
7696680|NCT00395343|12117310|FG001|Overall Study|Other|2
7696681|NCT00395447|12117318|FG000|Overall Study|Death|37
7696682|NCT00395447|12117319|FG001|Overall Study|Death|32
7696683|NCT00395447|12117318|FG000|Overall Study|Lost to Follow-up|52
7696684|NCT00395447|12117319|FG001|Overall Study|Lost to Follow-up|43
7696685|NCT00395447|12117318|FG000|Overall Study|Withdrawal by Subject|24
7696686|NCT00395447|12117319|FG001|Overall Study|Withdrawal by Subject|19
7696687|NCT00395447|12117318|FG000|Overall Study|Withdrawl - Other (not subject)|8
7696688|NCT00395447|12117319|FG001|Overall Study|Withdrawl - Other (not subject)|17
7696689|NCT00395460|12117327|FG000|Overall Study|Withdrawal by Subject|1
7696690|NCT00395460|12117328|FG001|Overall Study|Withdrawal by Subject|0
7696691|NCT00395486|12117336|FG000|Overall Study|Adverse Event|1
7696692|NCT00395486|12117337|FG001|Overall Study|Adverse Event|2
7696693|NCT00395486|12117336|FG000|Overall Study|Withdrawal by Subject|5
7696694|NCT00395486|12117337|FG001|Overall Study|Withdrawal by Subject|2
7696695|NCT00395486|12117336|FG000|Overall Study|Lost to Follow-up|0
7696696|NCT00395486|12117337|FG001|Overall Study|Lost to Follow-up|1
7696697|NCT00395512|12117347|FG000|Overall Study|Adverse Event|3
7696698|NCT00395512|12117348|FG001|Overall Study|Adverse Event|8
7696699|NCT00395512|12117349|FG002|Overall Study|Adverse Event|6
7696700|NCT00395512|12117350|FG003|Overall Study|Adverse Event|6
7696701|NCT00395512|12117347|FG000|Overall Study|Protocol Violation|2
7696702|NCT00395512|12117348|FG001|Overall Study|Protocol Violation|3
7696703|NCT00395512|12117349|FG002|Overall Study|Protocol Violation|6
7696704|NCT00395512|12117350|FG003|Overall Study|Protocol Violation|7
7696705|NCT00395512|12117347|FG000|Overall Study|Lost to Follow-up|2
7696706|NCT00395512|12117348|FG001|Overall Study|Lost to Follow-up|6
7696707|NCT00395512|12117349|FG002|Overall Study|Lost to Follow-up|5
7696708|NCT00395512|12117350|FG003|Overall Study|Lost to Follow-up|5
7696709|NCT00395512|12117347|FG000|Overall Study|Withdrawal by Subject|6
7696710|NCT00395512|12117348|FG001|Overall Study|Withdrawal by Subject|5
7696711|NCT00395512|12117349|FG002|Overall Study|Withdrawal by Subject|5
7696712|NCT00395512|12117350|FG003|Overall Study|Withdrawal by Subject|12
7696713|NCT00395512|12117347|FG000|Overall Study|Physician Decision|6
7696714|NCT00395512|12117348|FG001|Overall Study|Physician Decision|4
7696715|NCT00395512|12117349|FG002|Overall Study|Physician Decision|2
7696716|NCT00395512|12117350|FG003|Overall Study|Physician Decision|2
7696717|NCT00395512|12117347|FG000|Overall Study|Other|1
7696718|NCT00395512|12117348|FG001|Overall Study|Other|1
7696719|NCT00395512|12117349|FG002|Overall Study|Other|0
7696720|NCT00395512|12117350|FG003|Overall Study|Other|0
7696721|NCT00395512|12117347|FG000|Overall Study|Hyperglycemic Rescue|18
7696722|NCT00395512|12117348|FG001|Overall Study|Hyperglycemic Rescue|10
7696723|NCT00395512|12117349|FG002|Overall Study|Hyperglycemic Rescue|4
7696724|NCT00395512|12117350|FG003|Overall Study|Hyperglycemic Rescue|6
7696725|NCT00395538|12117363|FG000|Overall Study|Did not re-consent to revised protocol|1
7696726|NCT00395538|12117364|FG001|Overall Study|Did not re-consent to revised protocol|10
7696727|NCT00395538|12117365|FG002|Overall Study|Did not re-consent to revised protocol|0
7696728|NCT00395538|12117363|FG000|Overall Study|FDA partial hold on PTH|0
7696729|NCT00395538|12117364|FG001|Overall Study|FDA partial hold on PTH|0
7696730|NCT00395538|12117365|FG002|Overall Study|FDA partial hold on PTH|11
7696731|NCT00395538|12117363|FG000|Overall Study|Failed screening|0
7696732|NCT00395538|12117364|FG001|Overall Study|Failed screening|0
7696733|NCT00395538|12117365|FG002|Overall Study|Failed screening|4
7696734|NCT00395538|12117363|FG000|Overall Study|Switch to Natpara|0
7696735|NCT00395538|12117364|FG001|Overall Study|Switch to Natpara|0
7696736|NCT00395538|12117365|FG002|Overall Study|Switch to Natpara|3
7696737|NCT00395538|12117363|FG000|Overall Study|Adverse Event|1
7696738|NCT00395538|12117364|FG001|Overall Study|Adverse Event|0
7696739|NCT00395538|12117365|FG002|Overall Study|Adverse Event|2
7696740|NCT00395538|12117363|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0
7696741|NCT00395538|12117364|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2
7696742|NCT00395538|12117365|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0
7696743|NCT00395538|12117363|FG000|Overall Study|Non-compliance with study protocol|0
7696744|NCT00395538|12117364|FG001|Overall Study|Non-compliance with study protocol|1
7696745|NCT00395538|12117365|FG002|Overall Study|Non-compliance with study protocol|0
7696746|NCT00395538|12117363|FG000|Overall Study|PTH resistance|0
7696747|NCT00395538|12117364|FG001|Overall Study|PTH resistance|0
7696748|NCT00395538|12117365|FG002|Overall Study|PTH resistance|1
7696749|NCT00395538|12117363|FG000|Overall Study|Pregnancy|1
7696750|NCT00395538|12117364|FG001|Overall Study|Pregnancy|0
7696751|NCT00395538|12117365|FG002|Overall Study|Pregnancy|0
7696752|NCT00395538|12117363|FG000|Overall Study|Partial recovery of parathyroid function|0
7696753|NCT00395538|12117364|FG001|Overall Study|Partial recovery of parathyroid function|0
7696754|NCT00395538|12117365|FG002|Overall Study|Partial recovery of parathyroid function|1
7696755|NCT00395538|12117363|FG000|Overall Study|Participant elected to discontinue|0
7696756|NCT00395538|12117364|FG001|Overall Study|Participant elected to discontinue|0
7696757|NCT00395538|12117365|FG002|Overall Study|Participant elected to discontinue|1
7696758|NCT00395629|12117376|FG000|Core Study|Adverse Event|0
7696759|NCT00395629|12117377|FG001|Core Study|Adverse Event|3
7696760|NCT00395629|12117378|FG002|Core Study|Adverse Event|4
7696761|NCT00395629|12117376|FG000|Core Study|Abnormal laboratory value(s)|0
7696762|NCT00395629|12117377|FG001|Core Study|Abnormal laboratory value(s)|0
7696763|NCT00395629|12117378|FG002|Core Study|Abnormal laboratory value(s)|1
7696764|NCT00395629|12117376|FG000|Core Study|Protocol Violation|1
7696765|NCT00395629|12117377|FG001|Core Study|Protocol Violation|0
7696766|NCT00395629|12117378|FG002|Core Study|Protocol Violation|0
7696767|NCT00395629|12117376|FG000|Core Study|Withdrawal by Subject|0
7696768|NCT00395629|12117377|FG001|Core Study|Withdrawal by Subject|1
7696769|NCT00395629|12117378|FG002|Core Study|Withdrawal by Subject|1
7696770|NCT00395629|12117376|FG000|Core Study|Lost to Follow-up|0
7696771|NCT00395629|12117377|FG001|Core Study|Lost to Follow-up|0
7696772|NCT00395629|12117378|FG002|Core Study|Lost to Follow-up|1
7696773|NCT00395629|12117376|FG000|Extension Study|Adverse Event|0
7696774|NCT00395629|12117377|FG001|Extension Study|Adverse Event|0
7696775|NCT00395629|12117378|FG002|Extension Study|Adverse Event|2
7696776|NCT00395629|12117376|FG000|Extension Study|Administrative problems|0
7696777|NCT00395629|12117377|FG001|Extension Study|Administrative problems|0
7696778|NCT00395629|12117378|FG002|Extension Study|Administrative problems|1
7696779|NCT00395642|12117389|FG000|Overall Study|Death|4
7696780|NCT00395642|12117389|FG000|Overall Study|Lost to Follow-up|1
7696781|NCT00395642|12117389|FG000|Overall Study|Physician Decision|7
7696782|NCT00395642|12117389|FG000|Overall Study|Withdrawal by Subject|1
7696783|NCT00395694|12117395|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1
7696784|NCT00395694|12117396|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2
7696785|NCT00395694|12117395|FG000|Continuation Phase|Adverse Event|1
7696786|NCT00395694|12117396|FG001|Continuation Phase|Adverse Event|0
7696787|NCT00395694|12117395|FG000|Continuation Phase|Lack of Efficacy|12
7696788|NCT00395694|12117396|FG001|Continuation Phase|Lack of Efficacy|11
7696789|NCT00395694|12117395|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1
7696790|NCT00395694|12117396|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0
7696791|NCT00395694|12117395|FG000|Continuation Phase|Poor Compliance|1
7696792|NCT00395694|12117396|FG001|Continuation Phase|Poor Compliance|0
7696793|NCT00395694|12117395|FG000|Continuation Phase|Withdrawal by Subject|0
7696794|NCT00395694|12117396|FG001|Continuation Phase|Withdrawal by Subject|2
7696795|NCT00395733|12117407|FG000|Period 2|Withdrawal by Subject|1
7696796|NCT00395733|12117408|FG001|Period 2|Withdrawal by Subject|2
7696797|NCT00395733|12117407|FG000|Period 2|Protocol Violation|0
7696798|NCT00395733|12117408|FG001|Period 2|Protocol Violation|1
7696799|NCT00395733|12117407|FG000|Period 2|Adverse Event|0
7696800|NCT00395733|12117408|FG001|Period 2|Adverse Event|2
7696801|NCT00395733|12117407|FG000|Period 2|Technical problems|1
7696802|NCT00395733|12117408|FG001|Period 2|Technical problems|0
7696803|NCT00395746|12117417|FG000|Overall Study|Adverse Event|5
7696804|NCT00395746|12117418|FG001|Overall Study|Adverse Event|2
7696805|NCT00395746|12117419|FG002|Overall Study|Adverse Event|2
7696806|NCT00395746|12117417|FG000|Overall Study|Protocol Violation|0
7696807|NCT00395746|12117418|FG001|Overall Study|Protocol Violation|1
7696808|NCT00395746|12117419|FG002|Overall Study|Protocol Violation|0
7696809|NCT00395746|12117417|FG000|Overall Study|Lack of Efficacy|2
7696810|NCT00395746|12117418|FG001|Overall Study|Lack of Efficacy|0
7696811|NCT00395746|12117419|FG002|Overall Study|Lack of Efficacy|17
7696812|NCT00395746|12117417|FG000|Overall Study|Hypoglycaemia|2
7696813|NCT00395746|12117418|FG001|Overall Study|Hypoglycaemia|1
7696814|NCT00395746|12117419|FG002|Overall Study|Hypoglycaemia|0
7696815|NCT00395746|12117417|FG000|Overall Study|Subject decision|0
7696816|NCT00395746|12117418|FG001|Overall Study|Subject decision|0
7696817|NCT00395746|12117419|FG002|Overall Study|Subject decision|1
7696818|NCT00395746|12117417|FG000|Overall Study|Withdrawal of consent|0
7696819|NCT00395746|12117418|FG001|Overall Study|Withdrawal of consent|0
7696820|NCT00395746|12117419|FG002|Overall Study|Withdrawal of consent|1
7696821|NCT00395746|12117417|FG000|Overall Study|Difficultulty in use of device|0
7696822|NCT00395746|12117418|FG001|Overall Study|Difficultulty in use of device|0
7696823|NCT00395746|12117419|FG002|Overall Study|Difficultulty in use of device|1
7696824|NCT00395746|12117417|FG000|Overall Study|Unable to visit site on schedule|1
7696825|NCT00395746|12117418|FG001|Overall Study|Unable to visit site on schedule|0
7696826|NCT00395746|12117419|FG002|Overall Study|Unable to visit site on schedule|0
7696827|NCT00395850|12117431|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
7696828|NCT00395850|12117432|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
7696829|NCT00395850|12117433|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
7696830|NCT00395850|12117434|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
7696831|NCT00395850|12117431|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
7696832|NCT00395850|12117432|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
7696833|NCT00395850|12117433|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
7696834|NCT00395850|12117434|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
7696835|NCT00395850|12117431|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1
7696836|NCT00395850|12117432|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0
7696837|NCT00395850|12117433|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0
7696838|NCT00395850|12117434|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0
7696839|NCT00395850|12117431|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
7696840|NCT00395850|12117432|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
7696841|NCT00395850|12117433|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
7696842|NCT00395850|12117434|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
7696843|NCT00395850|12117431|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
7696844|NCT00395850|12117432|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
7696845|NCT00395850|12117433|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
7696846|NCT00395850|12117434|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
7696847|NCT00395850|12117431|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
7696848|NCT00395850|12117432|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
7696849|NCT00395850|12117433|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
7696850|NCT00395850|12117434|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
7696851|NCT00395850|12117431|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
7696852|NCT00395850|12117432|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
7696853|NCT00395850|12117433|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
7696854|NCT00395850|12117434|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
7696855|NCT00395863|12117446|FG000|Overall Study|Patients did not complete both exams|2
7696856|NCT00395863|12117447|FG001|Overall Study|Patients did not complete both exams|3
7696857|NCT00395967|12117465|FG000|Treatment Period|Failed Mobilization|1
7696858|NCT00395967|12117465|FG000|Follow-up Period|Death|1
7696859|NCT00395967|12117465|FG000|Follow-up Period|Lost to Follow-up|1
7696860|NCT00396084|12117512|FG000|Overall Study|Adverse Event|0
7696861|NCT00396084|12117513|FG001|Overall Study|Adverse Event|0
7696862|NCT00396084|12117514|FG002|Overall Study|Adverse Event|0
7696863|NCT00396084|12117515|FG003|Overall Study|Adverse Event|0
7696864|NCT00396084|12117516|FG004|Overall Study|Adverse Event|1
7696865|NCT00396084|12117517|FG005|Overall Study|Adverse Event|2
7696866|NCT00396084|12117512|FG000|Overall Study|Withdrawal by Subject|0
7696867|NCT00396084|12117513|FG001|Overall Study|Withdrawal by Subject|0
7696868|NCT00396084|12117514|FG002|Overall Study|Withdrawal by Subject|0
7696869|NCT00396084|12117515|FG003|Overall Study|Withdrawal by Subject|1
7696870|NCT00396084|12117516|FG004|Overall Study|Withdrawal by Subject|0
7696871|NCT00396084|12117517|FG005|Overall Study|Withdrawal by Subject|0
7696872|NCT00396097|12117537|FG000|Overall Study|Withdrawal by Subject|17
7696873|NCT00396097|12117538|FG001|Overall Study|Withdrawal by Subject|17
7696874|NCT00396097|12117537|FG000|Overall Study|Lost to Follow-up|4
7696875|NCT00396097|12117538|FG001|Overall Study|Lost to Follow-up|9
7696876|NCT00396097|12117537|FG000|Overall Study|Other|3
7696877|NCT00396097|12117538|FG001|Overall Study|Other|5
7696878|NCT00396097|12117537|FG000|Overall Study|Protocol Violation|0
7696879|NCT00396097|12117538|FG001|Overall Study|Protocol Violation|6
7696880|NCT00396097|12117537|FG000|Overall Study|Adverse Event|1
7696881|NCT00396097|12117538|FG001|Overall Study|Adverse Event|5
7696882|NCT00396097|12117537|FG000|Overall Study|Insufficient Clinical Response|1
7696883|NCT00396097|12117538|FG001|Overall Study|Insufficient Clinical Response|4
7696884|NCT00396136|12117548|FG000|Overall Study|Death|43
7696885|NCT00396136|12117548|FG000|Overall Study|Withdrawal by Subject|59
7696886|NCT00396136|12117548|FG000|Overall Study|Lost to Follow-up|15
7696887|NCT00396136|12117548|FG000|Overall Study|Study device explanted|8
7696888|NCT00396162|12117554|FG000|Overall Study|Withdrawal by Subject|2
7696889|NCT00396162|12117555|FG001|Overall Study|Withdrawal by Subject|3
7696890|NCT00396253|12117570|FG000|Overall Study|Protocol Violation|1
7696891|NCT00396253|12117570|FG000|Overall Study|Withdrawal by Subject|7
7696892|NCT00396253|12117570|FG000|Overall Study|Death|3
7696893|NCT00396253|12117570|FG000|Overall Study|Physician Decision|1
7696894|NCT00396253|12117570|FG000|Overall Study|Change in eligibility status|1
7696895|NCT00396279|12117587|FG000|Overall Study|Ongoing in study|26
7696896|NCT00396279|12117587|FG000|Overall Study|Disease progression|2
7696897|NCT00396279|12117587|FG000|Overall Study|Withdrawal by Subject|1
7696898|NCT00396279|12117587|FG000|Overall Study|Physician Decision|1
7696899|NCT00396318|12117600|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
7696900|NCT00396331|12117608|FG000|Overall Study|Failed to mobilize - no transplant|8
7696901|NCT00396331|12117608|FG000|Overall Study|Did not go on to transplant|5
7696902|NCT00396331|12117608|FG000|Overall Study|Lost to Follow-up|3
7696903|NCT00396331|12117608|FG000|Overall Study|Death|16
7696904|NCT00396383|12117620|FG000|Overall Study|Death|2
7696905|NCT00396383|12117620|FG000|Overall Study|Lost to Follow-up|1
7696906|NCT00396409|12117626|FG000|Period 1 - 2007|Adverse Event|0
7696907|NCT00396409|12117627|FG001|Period 1 - 2007|Adverse Event|1
7696908|NCT00396409|12117626|FG000|Period 1 - 2007|Lack of Efficacy|0
7696909|NCT00396409|12117627|FG001|Period 1 - 2007|Lack of Efficacy|1
7696910|NCT00396409|12117626|FG000|Period 1 - 2007|Withdrawal by Subject|1
7696911|NCT00396409|12117627|FG001|Period 1 - 2007|Withdrawal by Subject|1
7696912|NCT00396409|12117626|FG000|Period 1 - 2007|Lost to Follow-up|2
7696913|NCT00396409|12117627|FG001|Period 1 - 2007|Lost to Follow-up|3
7696914|NCT00396409|12117626|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3
7696915|NCT00396409|12117627|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2
7696916|NCT00396409|12117626|FG000|Period 2 - 2008|Protocol Violation|1
7696917|NCT00396409|12117627|FG001|Period 2 - 2008|Protocol Violation|0
7696918|NCT00396409|12117626|FG000|Period 2 - 2008|Withdrawal by Subject|3
7696919|NCT00396409|12117627|FG001|Period 2 - 2008|Withdrawal by Subject|1
7696920|NCT00396409|12117626|FG000|Period 2 - 2008|Lost to Follow-up|3
7696921|NCT00396409|12117627|FG001|Period 2 - 2008|Lost to Follow-up|1
7696922|NCT00396565|12117638|FG000|Overall Study|Physician Decision|3
7696923|NCT00396565|12117639|FG001|Overall Study|Physician Decision|1
7696924|NCT00396565|12117640|FG002|Overall Study|Physician Decision|2
7696925|NCT00396565|12117638|FG000|Overall Study|Adverse Event|5
7696926|NCT00396565|12117639|FG001|Overall Study|Adverse Event|13
7696927|NCT00396565|12117640|FG002|Overall Study|Adverse Event|3
7696928|NCT00396565|12117638|FG000|Overall Study|Withdrawal by Subject|8
7696929|NCT00396565|12117639|FG001|Overall Study|Withdrawal by Subject|13
7696930|NCT00396565|12117640|FG002|Overall Study|Withdrawal by Subject|1
7696931|NCT00396565|12117638|FG000|Overall Study|Lack of Efficacy|32
7696932|NCT00396565|12117639|FG001|Overall Study|Lack of Efficacy|64
7696933|NCT00396565|12117640|FG002|Overall Study|Lack of Efficacy|11
7696934|NCT00396591|12117648|FG000|Overall Study|Disease Progression|13
7696935|NCT00396591|12117648|FG000|Overall Study|Adverse Event|2
7696936|NCT00396591|12117648|FG000|Overall Study|Participant request|1
7696937|NCT00396630|12117654|FG000|Overall Study|Lost to Follow-up|1
7696938|NCT00396630|12117655|FG001|Overall Study|Lost to Follow-up|1
7696939|NCT00396630|12117654|FG000|Overall Study|Withdrawal by Subject|1
7696940|NCT00396630|12117655|FG001|Overall Study|Withdrawal by Subject|1
7696941|NCT00396630|12117654|FG000|Overall Study|Not vaccinated at Visit 3|3
7696942|NCT00396630|12117655|FG001|Overall Study|Not vaccinated at Visit 3|3
7696943|NCT00396656|12117662|FG000|First Treatment Period|Withdrawal by Subject|0
7696944|NCT00396656|12117663|FG001|First Treatment Period|Withdrawal by Subject|2
7696945|NCT00396656|12117662|FG000|Second Treatment Period|Adverse Event|0
7696946|NCT00396656|12117663|FG001|Second Treatment Period|Adverse Event|1
7696947|NCT00396812|12117669|FG000|Overall Study|Physician Decision|1
7696948|NCT00396877|12117675|FG000|Overall Study|Lost to Follow-up|2
7696949|NCT00396877|12117676|FG001|Overall Study|Lost to Follow-up|1
7696950|NCT00396877|12117675|FG000|Overall Study|Parent(s)/guardian(s)'s request|4
7696951|NCT00396877|12117676|FG001|Overall Study|Parent(s)/guardian(s)'s request|7
7696952|NCT00397033|12117703|FG000|Overall Study|Adverse Event|7
7696953|NCT00397033|12117704|FG001|Overall Study|Adverse Event|10
7696954|NCT00397033|12117705|FG002|Overall Study|Adverse Event|4
7696955|NCT00397033|12117703|FG000|Overall Study|Lack of Efficacy|22
7696956|NCT00397033|12117704|FG001|Overall Study|Lack of Efficacy|12
7696957|NCT00397033|12117705|FG002|Overall Study|Lack of Efficacy|9
7696958|NCT00397033|12117703|FG000|Overall Study|Lost to Follow-up|3
7696959|NCT00397033|12117704|FG001|Overall Study|Lost to Follow-up|3
7696960|NCT00397033|12117705|FG002|Overall Study|Lost to Follow-up|3
7696961|NCT00397033|12117703|FG000|Overall Study|Withdrawal by Subject|12
7696962|NCT00397033|12117704|FG001|Overall Study|Withdrawal by Subject|7
7696963|NCT00397033|12117705|FG002|Overall Study|Withdrawal by Subject|5
7696964|NCT00397033|12117703|FG000|Overall Study|Other|0
7696965|NCT00397033|12117704|FG001|Overall Study|Other|5
7696966|NCT00397033|12117705|FG002|Overall Study|Other|2
7696967|NCT00397046|12117717|FG000|Overall Study|Disease Progression|3
7696968|NCT00397046|12117718|FG001|Overall Study|Disease Progression|3
7696969|NCT00397046|12117719|FG002|Overall Study|Disease Progression|10
7696970|NCT00397046|12117720|FG003|Overall Study|Disease Progression|5
7696971|NCT00397189|12117742|FG000|3 Weeks Period|Lost to Follow-up|5
7696972|NCT00397189|12117743|FG001|3 Weeks Period|Lost to Follow-up|4
7696973|NCT00397189|12117742|FG000|3 Weeks Period|Adverse Event|3
7696974|NCT00397189|12117743|FG001|3 Weeks Period|Adverse Event|2
7696975|NCT00397189|12117742|FG000|3 Weeks Period|Withdrawal by Subject|13
7696976|NCT00397189|12117743|FG001|3 Weeks Period|Withdrawal by Subject|9
7696977|NCT00397189|12117742|FG000|3 Weeks Period|Physician Decision|0
7696978|NCT00397189|12117743|FG001|3 Weeks Period|Physician Decision|2
7696979|NCT00397189|12117742|FG000|3 Weeks Period|Protocol Violation|0
7696980|NCT00397189|12117743|FG001|3 Weeks Period|Protocol Violation|3
7696981|NCT00397189|12117742|FG000|3 Weeks Period|Other|0
7696982|NCT00397189|12117743|FG001|3 Weeks Period|Other|2
7696983|NCT00397215|12117755|FG000|Month 0 (Day 0)|Adverse Event|0
7696984|NCT00397215|12117756|FG001|Month 0 (Day 0)|Adverse Event|1
7696985|NCT00397215|12117757|FG002|Month 0 (Day 0)|Adverse Event|0
7696986|NCT00397215|12117758|FG003|Month 0 (Day 0)|Adverse Event|0
7696987|NCT00397215|12117755|FG000|Month 0 (Day 0)|Withdrawal by Subject|3
7696988|NCT00397215|12117756|FG001|Month 0 (Day 0)|Withdrawal by Subject|3
7696989|NCT00397215|12117757|FG002|Month 0 (Day 0)|Withdrawal by Subject|3
7696990|NCT00397215|12117758|FG003|Month 0 (Day 0)|Withdrawal by Subject|1
7696991|NCT00397215|12117755|FG000|Month 0 (Day 0)|Other|4
7696992|NCT00397215|12117756|FG001|Month 0 (Day 0)|Other|1
7696993|NCT00397215|12117757|FG002|Month 0 (Day 0)|Other|3
7696994|NCT00397215|12117758|FG003|Month 0 (Day 0)|Other|3
7696995|NCT00397215|12117755|FG000|Month 6 (Day 180)|Adverse Event|0
7696996|NCT00397215|12117756|FG001|Month 6 (Day 180)|Adverse Event|3
7696997|NCT00397215|12117757|FG002|Month 6 (Day 180)|Adverse Event|2
7696998|NCT00397215|12117758|FG003|Month 6 (Day 180)|Adverse Event|0
7696999|NCT00397215|12117755|FG000|Month 6 (Day 180)|Other|2
7697000|NCT00397215|12117756|FG001|Month 6 (Day 180)|Other|0
7697001|NCT00397215|12117757|FG002|Month 6 (Day 180)|Other|3
7697002|NCT00397215|12117758|FG003|Month 6 (Day 180)|Other|0
7697003|NCT00397488|12117784|FG000|Overall Study|Withdrawal by Subject|3
7697004|NCT00397488|12117784|FG000|Overall Study|Adverse Event|3
7697005|NCT00397488|12117784|FG000|Overall Study|Death|1
7697006|NCT00397514|12117788|FG000|Overall Study|Withdrawal by Subject|1
7697007|NCT00397514|12117788|FG000|Overall Study|Pacing wire malfunction|1
7697008|NCT00397514|12117788|FG000|Overall Study|Not able to capture & pace LV intraoper.|4
7697009|NCT00397514|12117788|FG000|Overall Study|early extubation|2
7697010|NCT00397514|12117788|FG000|Overall Study|poor echocardiographic windows|1
7697011|NCT00397540|12117800|FG000|Overall Study|short follow-up duration < 12 months|1
7697012|NCT00397540|12117801|FG001|Overall Study|short follow-up duration < 12 months|0
7697013|NCT00397631|12117814|FG000|Overall Study|Adverse Event|5
7697014|NCT00397631|12117815|FG001|Overall Study|Adverse Event|6
7697015|NCT00397631|12117814|FG000|Overall Study|Lack of Efficacy|7
7697016|NCT00397631|12117815|FG001|Overall Study|Lack of Efficacy|10
7697017|NCT00397631|12117814|FG000|Overall Study|Lost to Follow-up|8
7697018|NCT00397631|12117815|FG001|Overall Study|Lost to Follow-up|9
7697019|NCT00397631|12117814|FG000|Overall Study|Physician Decision|2
7697020|NCT00397631|12117815|FG001|Overall Study|Physician Decision|0
7697021|NCT00397631|12117814|FG000|Overall Study|Protocol Violation|0
7697022|NCT00397631|12117815|FG001|Overall Study|Protocol Violation|1
7697023|NCT00397631|12117814|FG000|Overall Study|Withdrawal by Subject|7
7697024|NCT00397631|12117815|FG001|Overall Study|Withdrawal by Subject|14
7697025|NCT00397631|12117814|FG000|Overall Study|protocol discontinuation criteria|1
7697026|NCT00397631|12117815|FG001|Overall Study|protocol discontinuation criteria|4
7697027|NCT00397891|12117864|FG000|Overall Study|Withdrawal by Subject|1
7697028|NCT00397891|12117865|FG001|Overall Study|Withdrawal by Subject|0
7697029|NCT00397891|12117866|FG002|Overall Study|Withdrawal by Subject|0
7697030|NCT00397891|12117867|FG003|Overall Study|Withdrawal by Subject|0
7697031|NCT00397891|12117868|FG004|Overall Study|Withdrawal by Subject|1
7697032|NCT00397930|12117886|FG000|Overall Study|Personal reasons|14
7697033|NCT00397930|12117887|FG001|Overall Study|Personal reasons|8
7697034|NCT00397930|12117886|FG000|Overall Study|Other medical|9
7697035|NCT00397930|12117887|FG001|Overall Study|Other medical|4
7697036|NCT00397930|12117886|FG000|Overall Study|Unknown reasons|9
7697037|NCT00397930|12117887|FG001|Overall Study|Unknown reasons|14
7697038|NCT00397930|12117886|FG000|Overall Study|Noncompliant|3
7697039|NCT00397930|12117887|FG001|Overall Study|Noncompliant|2
7697040|NCT00397930|12117886|FG000|Overall Study|Too time-consuming|2
7697041|NCT00397930|12117887|FG001|Overall Study|Too time-consuming|9
7697042|NCT00397930|12117886|FG000|Overall Study|Started own yoga program|1
7697043|NCT00397930|12117887|FG001|Overall Study|Started own yoga program|1
7697044|NCT00397930|12117886|FG000|Overall Study|Did not want to be in control group|0
7697045|NCT00397930|12117887|FG001|Overall Study|Did not want to be in control group|1
7697046|NCT00397930|12117886|FG000|Overall Study|Withdrawal by Subject|0
7697047|NCT00397930|12117887|FG001|Overall Study|Withdrawal by Subject|8
7697048|NCT00397930|12117886|FG000|Overall Study|Missing data|0
7697049|NCT00397930|12117887|FG001|Overall Study|Missing data|4
7697050|NCT00397943|12117898|FG000|Overall Study|Unspecified reasons|12
7697051|NCT00397943|12117899|FG001|Overall Study|Unspecified reasons|9
7697052|NCT00397943|12117900|FG002|Overall Study|Unspecified reasons|0
7697053|NCT00397943|12117901|FG003|Overall Study|Unspecified reasons|0
7697054|NCT00397943|12117902|FG004|Overall Study|Unspecified reasons|0
7697055|NCT00397982|12117914|FG000|Overall Study|Withdrawal by Subject|1
7697056|NCT00397982|12117914|FG000|Overall Study|Adverse Event|1
7697057|NCT00397982|12117914|FG000|Overall Study|noncompliance|1
7697058|NCT00397982|12117914|FG000|Overall Study|Unrelated health issues|1
7697059|NCT00398047|12117919|FG000|Overall Study|all patient progressed before completion|3
7697060|NCT00398073|12117926|FG000|Overall Study|Withdrawal by Subject|1
7697061|NCT00398073|12117927|FG001|Overall Study|Withdrawal by Subject|0
7697062|NCT00398086|12117936|FG000|Overall Study|Unacceptable Toxicity|2
7697063|NCT00398086|12117937|FG001|Overall Study|Unacceptable Toxicity|8
7697064|NCT00398086|12117938|FG002|Overall Study|Unacceptable Toxicity|2
7697065|NCT00398086|12117936|FG000|Overall Study|Adverse Event|1
7697066|NCT00398086|12117937|FG001|Overall Study|Adverse Event|4
7697067|NCT00398086|12117938|FG002|Overall Study|Adverse Event|0
7697068|NCT00398086|12117936|FG000|Overall Study|Physician Decision|1
7697069|NCT00398086|12117937|FG001|Overall Study|Physician Decision|4
7697070|NCT00398086|12117938|FG002|Overall Study|Physician Decision|0
7697071|NCT00398086|12117936|FG000|Overall Study|Withdrawal by Subject|5
7697072|NCT00398086|12117937|FG001|Overall Study|Withdrawal by Subject|7
7697073|NCT00398086|12117938|FG002|Overall Study|Withdrawal by Subject|0
7697074|NCT00398112|12117946|FG000|Overall Study|Adverse Event|4
7697075|NCT00398112|12117946|FG000|Overall Study|Disease progression|9
7697076|NCT00398112|12117946|FG000|Overall Study|Alternative treatment|1
7697077|NCT00398112|12117946|FG000|Overall Study|Withdrawal by Subject|3
7697078|NCT00398112|12117946|FG000|Overall Study|Death|1
7697079|NCT00398138|12117950|FG000|Overall Study|Adverse Event|2
7697080|NCT00398216|12117959|FG000|Overall Study|Adverse Event|4
7697081|NCT00398216|12117960|FG001|Overall Study|Adverse Event|2
7697082|NCT00398216|12117961|FG002|Overall Study|Adverse Event|5
7697083|NCT00398216|12117962|FG003|Overall Study|Adverse Event|7
7697084|NCT00398216|12117963|FG004|Overall Study|Adverse Event|2
7697085|NCT00398216|12117959|FG000|Overall Study|Protocol Violation|2
7697086|NCT00398216|12117960|FG001|Overall Study|Protocol Violation|4
7697087|NCT00398216|12117961|FG002|Overall Study|Protocol Violation|5
7697088|NCT00398216|12117962|FG003|Overall Study|Protocol Violation|7
7697089|NCT00398216|12117963|FG004|Overall Study|Protocol Violation|5
7697090|NCT00398216|12117959|FG000|Overall Study|Lost to Follow-up|1
7697091|NCT00398216|12117960|FG001|Overall Study|Lost to Follow-up|6
7697092|NCT00398216|12117961|FG002|Overall Study|Lost to Follow-up|4
7697093|NCT00398216|12117962|FG003|Overall Study|Lost to Follow-up|4
7697094|NCT00398216|12117963|FG004|Overall Study|Lost to Follow-up|1
7697095|NCT00398216|12117959|FG000|Overall Study|Death|0
7697096|NCT00398216|12117960|FG001|Overall Study|Death|3
7697097|NCT00398216|12117961|FG002|Overall Study|Death|0
7697098|NCT00398216|12117962|FG003|Overall Study|Death|0
7697099|NCT00398216|12117963|FG004|Overall Study|Death|0
7697100|NCT00398216|12117959|FG000|Overall Study|Withdrawal by Subject|1
7697101|NCT00398216|12117960|FG001|Overall Study|Withdrawal by Subject|0
7697102|NCT00398216|12117961|FG002|Overall Study|Withdrawal by Subject|3
7697103|NCT00398216|12117962|FG003|Overall Study|Withdrawal by Subject|1
7697104|NCT00398216|12117963|FG004|Overall Study|Withdrawal by Subject|2
7697105|NCT00398216|12117959|FG000|Overall Study|administrative reasons|3
7697106|NCT00398216|12117960|FG001|Overall Study|administrative reasons|4
7697107|NCT00398216|12117961|FG002|Overall Study|administrative reasons|4
7697108|NCT00398216|12117962|FG003|Overall Study|administrative reasons|3
7697109|NCT00398216|12117963|FG004|Overall Study|administrative reasons|3
7697110|NCT00398216|12117959|FG000|Overall Study|entrance criteria|0
7697111|NCT00398216|12117960|FG001|Overall Study|entrance criteria|0
7697112|NCT00398216|12117961|FG002|Overall Study|entrance criteria|0
7697113|NCT00398216|12117962|FG003|Overall Study|entrance criteria|0
7697114|NCT00398216|12117963|FG004|Overall Study|entrance criteria|2
7697115|NCT00398320|12117975|FG000|Overall Study|Death|1
7697116|NCT00398320|12117975|FG000|Overall Study|Adverse Event|4
7697117|NCT00398320|12117975|FG000|Overall Study|Physician Decision|1
7697118|NCT00398411|12117985|FG000|Overall Study|Death|0
7697119|NCT00398411|12117986|FG001|Overall Study|Death|1
7697120|NCT00398567|12118004|FG000|Overall Study|Disease Progression|3
7697121|NCT00398567|12118005|FG001|Overall Study|Disease Progression|4
7697122|NCT00398567|12118006|FG002|Overall Study|Disease Progression|27
7697123|NCT00398567|12118004|FG000|Overall Study|Withdrawal by Subject|1
7697124|NCT00398567|12118005|FG001|Overall Study|Withdrawal by Subject|0
7697125|NCT00398567|12118006|FG002|Overall Study|Withdrawal by Subject|4
7697126|NCT00398567|12118004|FG000|Overall Study|Adverse Event|0
7697127|NCT00398567|12118005|FG001|Overall Study|Adverse Event|0
7697128|NCT00398567|12118006|FG002|Overall Study|Adverse Event|2
7697129|NCT00398567|12118004|FG000|Overall Study|Protocol Violation|0
7697130|NCT00398567|12118005|FG001|Overall Study|Protocol Violation|0
7697131|NCT00398567|12118006|FG002|Overall Study|Protocol Violation|1
7697132|NCT00398632|12118012|FG000|Overall Study|Withdrawal by Subject|1
7697133|NCT00398632|12118012|FG000|Overall Study|Lack of Efficacy|1
7697134|NCT00398866|12118020|FG000|Overall Study|Adverse Event|1
7697135|NCT00398866|12118021|FG001|Overall Study|Adverse Event|0
7697136|NCT00398866|12118022|FG002|Overall Study|Adverse Event|0
7697137|NCT00398866|12118020|FG000|Overall Study|Lack of Efficacy|0
7697138|NCT00398866|12118021|FG001|Overall Study|Lack of Efficacy|0
7697139|NCT00398866|12118022|FG002|Overall Study|Lack of Efficacy|1
7697140|NCT00398866|12118020|FG000|Overall Study|Lost to Follow-up|7
7697141|NCT00398866|12118021|FG001|Overall Study|Lost to Follow-up|6
7697142|NCT00398866|12118022|FG002|Overall Study|Lost to Follow-up|4
7697143|NCT00398866|12118020|FG000|Overall Study|Withdrawal by Subject|5
7697144|NCT00398866|12118021|FG001|Overall Study|Withdrawal by Subject|1
7697145|NCT00398866|12118022|FG002|Overall Study|Withdrawal by Subject|2
7697146|NCT00398866|12118020|FG000|Overall Study|Unable to complete requirements of study|1
7697147|NCT00398866|12118021|FG001|Overall Study|Unable to complete requirements of study|1
7697148|NCT00398866|12118022|FG002|Overall Study|Unable to complete requirements of study|1
7697149|NCT00399035|12118047|FG000|Overall Study|Death|289
7697150|NCT00399035|12118048|FG001|Overall Study|Death|141
7697151|NCT00399035|12118049|FG002|Overall Study|Death|234
7697152|NCT00399035|12118047|FG000|Overall Study|Lost to Follow-up|2
7697153|NCT00399035|12118048|FG001|Overall Study|Lost to Follow-up|1
7697154|NCT00399035|12118049|FG002|Overall Study|Lost to Follow-up|5
7697155|NCT00399035|12118047|FG000|Overall Study|Withdrawal by Subject|19
7697156|NCT00399035|12118048|FG001|Overall Study|Withdrawal by Subject|15
7697157|NCT00399035|12118049|FG002|Overall Study|Withdrawal by Subject|12
7697158|NCT00399035|12118047|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1
7697159|NCT00399035|12118048|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0
7697160|NCT00399035|12118049|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1
7697161|NCT00399035|12118047|FG000|Overall Study|Severe non-compliance with protocol|2
7697162|NCT00399035|12118048|FG001|Overall Study|Severe non-compliance with protocol|1
7697163|NCT00399035|12118049|FG002|Overall Study|Severe non-compliance with protocol|0
7697164|NCT00399360|12118073|FG000|Overall Study|Lost to Follow-up|2
7697165|NCT00399360|12118074|FG001|Overall Study|Lost to Follow-up|1
7697166|NCT00399360|12118075|FG002|Overall Study|Lost to Follow-up|2
7697167|NCT00399360|12118076|FG003|Overall Study|Lost to Follow-up|4
7697168|NCT00399360|12118073|FG000|Overall Study|Adverse Event|0
7697169|NCT00399360|12118074|FG001|Overall Study|Adverse Event|0
7697170|NCT00399360|12118075|FG002|Overall Study|Adverse Event|1
7697171|NCT00399360|12118076|FG003|Overall Study|Adverse Event|0
7697172|NCT00399360|12118073|FG000|Overall Study|Withdrawal by Subject|0
7697173|NCT00399360|12118074|FG001|Overall Study|Withdrawal by Subject|2
7697174|NCT00399360|12118075|FG002|Overall Study|Withdrawal by Subject|0
7697175|NCT00399360|12118076|FG003|Overall Study|Withdrawal by Subject|2
7697176|NCT00399490|12118091|FG000|Overall Study|Adverse Event|19
7697177|NCT00399490|12118091|FG000|Overall Study|Lack of Efficacy|31
7697178|NCT00399490|12118091|FG000|Overall Study|Lost to Follow-up|5
7697179|NCT00399490|12118091|FG000|Overall Study|Withdrawal by Subject|18
7697180|NCT00399490|12118091|FG000|Overall Study|Other|25
7697181|NCT00399516|12118097|FG000|Overall Study|Lost to Follow-up|2
7697182|NCT00399529|12118101|FG000|Overall Study|Off Study Prior to Treatment|2
7697183|NCT00399542|12118108|FG000|Overall Study|Adverse Event|18
7697184|NCT00399542|12118109|FG001|Overall Study|Adverse Event|15
7697185|NCT00399542|12118108|FG000|Overall Study|Protocol Violation|13
7697186|NCT00399542|12118109|FG001|Overall Study|Protocol Violation|3
7697187|NCT00399542|12118108|FG000|Overall Study|Withdrawal by Subject|28
7697188|NCT00399542|12118109|FG001|Overall Study|Withdrawal by Subject|10
7697189|NCT00399542|12118108|FG000|Overall Study|Lack of Efficacy|18
7697190|NCT00399542|12118109|FG001|Overall Study|Lack of Efficacy|8
7697191|NCT00399542|12118108|FG000|Overall Study|Lost to Follow-up|6
7697192|NCT00399542|12118109|FG001|Overall Study|Lost to Follow-up|6
7697193|NCT00399542|12118108|FG000|Overall Study|Other|1
7697194|NCT00399542|12118109|FG001|Overall Study|Other|0
7697195|NCT00399542|12118108|FG000|Overall Study|Physician Decision|0
7697196|NCT00399542|12118109|FG001|Overall Study|Physician Decision|1
7697197|NCT00399568|12118117|FG000|Overall Study|Adverse Event|1
7697198|NCT00399568|12118118|FG001|Overall Study|Adverse Event|2
7697199|NCT00399568|12118117|FG000|Overall Study|Withdrawal by Subject|7
7697200|NCT00399568|12118118|FG001|Overall Study|Withdrawal by Subject|3
7697201|NCT00399568|12118117|FG000|Overall Study|Protocol non-compliance|2
7697202|NCT00399568|12118118|FG001|Overall Study|Protocol non-compliance|2
7697203|NCT00399568|12118117|FG000|Overall Study|Lost to Follow-up|2
7697204|NCT00399568|12118118|FG001|Overall Study|Lost to Follow-up|2
7697205|NCT00399763|12118128|FG000|Overall Study|Lost to Follow-up|2
7697206|NCT00399763|12118129|FG001|Overall Study|Lost to Follow-up|3
7697207|NCT00399802|12118137|FG000|Overall Study|Adverse Event|0
7697208|NCT00399802|12118138|FG001|Overall Study|Adverse Event|2
7697209|NCT00399802|12118137|FG000|Overall Study|Participant discontinued by mistake|0
7697210|NCT00399802|12118138|FG001|Overall Study|Participant discontinued by mistake|1
7697211|NCT00399893|12118155|FG000|Overall Study|Withdrawal by Subject|1
7697212|NCT00399893|12118156|FG001|Overall Study|Withdrawal by Subject|0
7697213|NCT00400153|12118165|FG000|Overall Study|AE due to study disease worsening|14
7697214|NCT00400153|12118166|FG001|Overall Study|AE due to study disease worsening|19
7697215|NCT00400153|12118167|FG002|Overall Study|AE due to study disease worsening|20
7697216|NCT00400153|12118165|FG000|Overall Study|AE due to other disease worsening|2
7697217|NCT00400153|12118166|FG001|Overall Study|AE due to other disease worsening|1
7697218|NCT00400153|12118167|FG002|Overall Study|AE due to other disease worsening|0
7697219|NCT00400153|12118165|FG000|Overall Study|AE due to other condition|3
7697220|NCT00400153|12118166|FG001|Overall Study|AE due to other condition|14
7697221|NCT00400153|12118167|FG002|Overall Study|AE due to other condition|15
7697222|NCT00400153|12118165|FG000|Overall Study|Protocol Violation|7
7697223|NCT00400153|12118166|FG001|Overall Study|Protocol Violation|4
7697224|NCT00400153|12118167|FG002|Overall Study|Protocol Violation|9
7697225|NCT00400153|12118165|FG000|Overall Study|Lost to Follow-up|2
7697226|NCT00400153|12118166|FG001|Overall Study|Lost to Follow-up|1
7697227|NCT00400153|12118167|FG002|Overall Study|Lost to Follow-up|4
7697228|NCT00400153|12118165|FG000|Overall Study|Withdrawal by Subject|12
7697229|NCT00400153|12118166|FG001|Overall Study|Withdrawal by Subject|11
7697230|NCT00400153|12118167|FG002|Overall Study|Withdrawal by Subject|10
7697231|NCT00400153|12118165|FG000|Overall Study|Other reasons - not mentioned above|8
7697232|NCT00400153|12118166|FG001|Overall Study|Other reasons - not mentioned above|5
7697233|NCT00400153|12118167|FG002|Overall Study|Other reasons - not mentioned above|3
7697234|NCT00400179|12118182|FG000|Overall Study|Adverse Event|2
7697235|NCT00400179|12118183|FG001|Overall Study|Adverse Event|2
7697236|NCT00400179|12118182|FG000|Overall Study|Death|1
7697237|NCT00400179|12118183|FG001|Overall Study|Death|2
7697238|NCT00400179|12118182|FG000|Overall Study|Withdrew Consent|1
7697239|NCT00400179|12118183|FG001|Overall Study|Withdrew Consent|5
7697240|NCT00400179|12118182|FG000|Overall Study|Disease progression|1
7697241|NCT00400179|12118183|FG001|Overall Study|Disease progression|1
7697242|NCT00400179|12118182|FG000|Overall Study|Intercurrent illness|0
7697243|NCT00400179|12118183|FG001|Overall Study|Intercurrent illness|1
7697244|NCT00400179|12118182|FG000|Overall Study|Investigator judgment|0
7697245|NCT00400179|12118183|FG001|Overall Study|Investigator judgment|1
7697246|NCT00400179|12118182|FG000|Overall Study|Randomization error/patient ineligible|1
7697247|NCT00400179|12118183|FG001|Overall Study|Randomization error/patient ineligible|6
7697248|NCT00400400|12118196|FG000|Overall Study|Adverse Event|9
7697249|NCT00400400|12118197|FG001|Overall Study|Adverse Event|8
7697250|NCT00400400|12118196|FG000|Overall Study|Protocol Violation|2
7697251|NCT00400400|12118197|FG001|Overall Study|Protocol Violation|0
7697252|NCT00400400|12118196|FG000|Overall Study|Withdrawal by Subject|1
7697253|NCT00400400|12118197|FG001|Overall Study|Withdrawal by Subject|3
7697254|NCT00400400|12118196|FG000|Overall Study|Administrative Problem|1
7697255|NCT00400400|12118197|FG001|Overall Study|Administrative Problem|0
7697256|NCT00400400|12118196|FG000|Overall Study|Lost to Follow-up|0
7697257|NCT00400400|12118197|FG001|Overall Study|Lost to Follow-up|1
7697258|NCT00400400|12118196|FG000|Overall Study|Did not receive study drug|1
7697259|NCT00400400|12118197|FG001|Overall Study|Did not receive study drug|3
7697260|NCT00400517|12118212|FG000|Overall Study|Withdrawal by Subject|1
7697261|NCT00400517|12118212|FG000|Overall Study|Physician Decision|1
7697262|NCT00400569|12118216|FG000|Overall Study|Death|1
7697263|NCT00400712|12118238|FG000|Overall Study|Death|1
7697264|NCT00400712|12118239|FG001|Overall Study|Death|0
7697265|NCT00400712|12118238|FG000|Overall Study|Withdrawal by Subject|11
7697266|NCT00400712|12118239|FG001|Overall Study|Withdrawal by Subject|12
7697267|NCT00400712|12118238|FG000|Overall Study|Physician Decision|5
7697268|NCT00400712|12118239|FG001|Overall Study|Physician Decision|4
7697269|NCT00400764|12118252|FG000|Phase Ib|Adverse Event|1
7697270|NCT00400764|12118253|FG001|Phase Ib|Adverse Event|0
7697271|NCT00400764|12118254|FG002|Phase Ib|Adverse Event|0
7697272|NCT00400764|12118255|FG003|Phase Ib|Adverse Event|0
7697273|NCT00400764|12118256|FG004|Phase Ib|Adverse Event|0
7697274|NCT00400764|12118252|FG000|Phase Ib|Death|1
7697275|NCT00400764|12118253|FG001|Phase Ib|Death|0
7697276|NCT00400764|12118254|FG002|Phase Ib|Death|0
7697277|NCT00400764|12118255|FG003|Phase Ib|Death|0
7697278|NCT00400764|12118256|FG004|Phase Ib|Death|0
7697279|NCT00400764|12118252|FG000|Phase Ib|Disease Progression|4
7697280|NCT00400764|12118253|FG001|Phase Ib|Disease Progression|4
7697281|NCT00400764|12118254|FG002|Phase Ib|Disease Progression|0
7697282|NCT00400764|12118255|FG003|Phase Ib|Disease Progression|0
7697283|NCT00400764|12118256|FG004|Phase Ib|Disease Progression|0
7697284|NCT00400764|12118252|FG000|Phase II|Death|0
7697285|NCT00400764|12118253|FG001|Phase II|Death|0
7697286|NCT00400764|12118254|FG002|Phase II|Death|1
7697287|NCT00400764|12118255|FG003|Phase II|Death|2
7697288|NCT00400764|12118256|FG004|Phase II|Death|0
7697289|NCT00400764|12118252|FG000|Phase II|Lost to Follow-up|0
7697290|NCT00400764|12118253|FG001|Phase II|Lost to Follow-up|0
7697291|NCT00400764|12118254|FG002|Phase II|Lost to Follow-up|1
7697292|NCT00400764|12118255|FG003|Phase II|Lost to Follow-up|0
7697293|NCT00400764|12118256|FG004|Phase II|Lost to Follow-up|0
7697294|NCT00400764|12118252|FG000|Phase II|Physician Decision|0
7697295|NCT00400764|12118253|FG001|Phase II|Physician Decision|0
7697296|NCT00400764|12118254|FG002|Phase II|Physician Decision|1
7697297|NCT00400764|12118255|FG003|Phase II|Physician Decision|1
7697298|NCT00400764|12118256|FG004|Phase II|Physician Decision|0
7697299|NCT00400764|12118252|FG000|Phase II|Sponsor's decision to terminate|0
7697300|NCT00400764|12118253|FG001|Phase II|Sponsor's decision to terminate|0
7697301|NCT00400764|12118254|FG002|Phase II|Sponsor's decision to terminate|18
7697302|NCT00400764|12118255|FG003|Phase II|Sponsor's decision to terminate|22
7697303|NCT00400764|12118256|FG004|Phase II|Sponsor's decision to terminate|11
7697304|NCT00400764|12118252|FG000|Phase II|Patient began new, non-protocol, therapy|0
7697305|NCT00400764|12118253|FG001|Phase II|Patient began new, non-protocol, therapy|0
7697306|NCT00400764|12118254|FG002|Phase II|Patient began new, non-protocol, therapy|1
7697307|NCT00400764|12118255|FG003|Phase II|Patient began new, non-protocol, therapy|0
7697308|NCT00400764|12118256|FG004|Phase II|Patient began new, non-protocol, therapy|0
7697309|NCT00400764|12118252|FG000|Phase II|Withdrawal by Subject|0
7697310|NCT00400764|12118253|FG001|Phase II|Withdrawal by Subject|0
7697311|NCT00400764|12118254|FG002|Phase II|Withdrawal by Subject|1
7697312|NCT00400764|12118255|FG003|Phase II|Withdrawal by Subject|1
7697313|NCT00400764|12118256|FG004|Phase II|Withdrawal by Subject|0
7697314|NCT00400985|12118295|FG000|Overall Study|Withdrawal by Subject|5
7697315|NCT00400985|12118295|FG000|Overall Study|system modification|8
7697316|NCT00400985|12118295|FG000|Overall Study|Death|30
7697317|NCT00400985|12118295|FG000|Overall Study|Lost to Follow-up|9
7697318|NCT00401193|12118306|FG000|Overall Study|Adverse Event|1
7697319|NCT00401193|12118307|FG001|Overall Study|Adverse Event|3
7697320|NCT00401193|12118308|FG002|Overall Study|Adverse Event|1
7697321|NCT00401193|12118306|FG000|Overall Study|Protocol Violation|3
7697322|NCT00401193|12118307|FG001|Overall Study|Protocol Violation|1
7697323|NCT00401193|12118308|FG002|Overall Study|Protocol Violation|1
7697324|NCT00401193|12118306|FG000|Overall Study|Lost to Follow-up|6
7697325|NCT00401193|12118307|FG001|Overall Study|Lost to Follow-up|5
7697326|NCT00401193|12118308|FG002|Overall Study|Lost to Follow-up|1
7697327|NCT00401193|12118306|FG000|Overall Study|Withdrawal by Subject|2
7697328|NCT00401193|12118307|FG001|Overall Study|Withdrawal by Subject|0
7697329|NCT00401193|12118308|FG002|Overall Study|Withdrawal by Subject|1
7697330|NCT00401193|12118306|FG000|Overall Study|Other Event|3
7697331|NCT00401193|12118307|FG001|Overall Study|Other Event|2
7697332|NCT00401193|12118308|FG002|Overall Study|Other Event|2
7697333|NCT00401245|12118321|FG000|Double Blind Titration Phase|Adverse Event|3
7697334|NCT00401245|12118322|FG001|Double Blind Titration Phase|Adverse Event|2
7697335|NCT00401245|12118323|FG002|Double Blind Titration Phase|Adverse Event|5
7697336|NCT00401245|12118324|FG003|Double Blind Titration Phase|Adverse Event|12
7697337|NCT00401245|12118325|FG004|Double Blind Titration Phase|Adverse Event|0
7697338|NCT00401245|12118326|FG005|Double Blind Titration Phase|Adverse Event|0
7697339|NCT00401245|12118327|FG006|Double Blind Titration Phase|Adverse Event|0
7697340|NCT00401245|12118328|FG007|Double Blind Titration Phase|Adverse Event|0
7697341|NCT00401245|12118321|FG000|Double Blind Titration Phase|Other|0
7697342|NCT00401245|12118322|FG001|Double Blind Titration Phase|Other|0
7697343|NCT00401245|12118323|FG002|Double Blind Titration Phase|Other|1
7697344|NCT00401245|12118324|FG003|Double Blind Titration Phase|Other|0
7697345|NCT00401245|12118325|FG004|Double Blind Titration Phase|Other|0
7697346|NCT00401245|12118326|FG005|Double Blind Titration Phase|Other|0
7697347|NCT00401245|12118327|FG006|Double Blind Titration Phase|Other|0
7697348|NCT00401245|12118328|FG007|Double Blind Titration Phase|Other|0
7697349|NCT00401245|12118321|FG000|Double Blind Titration Phase|Protocol Violation|0
7697350|NCT00401245|12118322|FG001|Double Blind Titration Phase|Protocol Violation|0
7697351|NCT00401245|12118323|FG002|Double Blind Titration Phase|Protocol Violation|0
7697352|NCT00401245|12118324|FG003|Double Blind Titration Phase|Protocol Violation|1
7697353|NCT00401245|12118325|FG004|Double Blind Titration Phase|Protocol Violation|0
7697354|NCT00401245|12118326|FG005|Double Blind Titration Phase|Protocol Violation|0
7697355|NCT00401245|12118327|FG006|Double Blind Titration Phase|Protocol Violation|0
7697356|NCT00401245|12118328|FG007|Double Blind Titration Phase|Protocol Violation|0
7697357|NCT00401245|12118321|FG000|Double Blind Titration Phase|Withdrawal by Subject|1
7697358|NCT00401245|12118322|FG001|Double Blind Titration Phase|Withdrawal by Subject|1
7697359|NCT00401245|12118323|FG002|Double Blind Titration Phase|Withdrawal by Subject|0
7697360|NCT00401245|12118324|FG003|Double Blind Titration Phase|Withdrawal by Subject|2
7697361|NCT00401245|12118325|FG004|Double Blind Titration Phase|Withdrawal by Subject|0
7697362|NCT00401245|12118326|FG005|Double Blind Titration Phase|Withdrawal by Subject|0
7697363|NCT00401245|12118327|FG006|Double Blind Titration Phase|Withdrawal by Subject|0
7697364|NCT00401245|12118328|FG007|Double Blind Titration Phase|Withdrawal by Subject|0
7697365|NCT00401245|12118321|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0
7697366|NCT00401245|12118322|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2
7697367|NCT00401245|12118323|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0
7697368|NCT00401245|12118324|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2
7697369|NCT00401245|12118325|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0
7697370|NCT00401245|12118326|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0
7697371|NCT00401245|12118327|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0
7697372|NCT00401245|12118328|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0
7697373|NCT00401245|12118321|FG000|Open Label Phase|Adverse Event|5
7697374|NCT00401245|12118322|FG001|Open Label Phase|Adverse Event|14
7697375|NCT00401245|12118323|FG002|Open Label Phase|Adverse Event|6
7697376|NCT00401245|12118324|FG003|Open Label Phase|Adverse Event|7
7697377|NCT00401245|12118325|FG004|Open Label Phase|Adverse Event|0
7697378|NCT00401245|12118326|FG005|Open Label Phase|Adverse Event|0
7697379|NCT00401245|12118327|FG006|Open Label Phase|Adverse Event|0
7697380|NCT00401245|12118328|FG007|Open Label Phase|Adverse Event|0
7697381|NCT00401245|12118321|FG000|Open Label Phase|Lost to Follow-up|5
7697382|NCT00401245|12118322|FG001|Open Label Phase|Lost to Follow-up|7
7697383|NCT00401245|12118323|FG002|Open Label Phase|Lost to Follow-up|5
7697384|NCT00401245|12118324|FG003|Open Label Phase|Lost to Follow-up|4
7697385|NCT00401245|12118325|FG004|Open Label Phase|Lost to Follow-up|0
7697386|NCT00401245|12118326|FG005|Open Label Phase|Lost to Follow-up|0
7697387|NCT00401245|12118327|FG006|Open Label Phase|Lost to Follow-up|0
7697388|NCT00401245|12118328|FG007|Open Label Phase|Lost to Follow-up|0
7697389|NCT00401245|12118321|FG000|Open Label Phase|Other|4
7697390|NCT00401245|12118322|FG001|Open Label Phase|Other|8
7697391|NCT00401245|12118323|FG002|Open Label Phase|Other|7
7697392|NCT00401245|12118324|FG003|Open Label Phase|Other|8
7697393|NCT00401245|12118325|FG004|Open Label Phase|Other|0
7697394|NCT00401245|12118326|FG005|Open Label Phase|Other|0
7697395|NCT00401245|12118327|FG006|Open Label Phase|Other|0
7697396|NCT00401245|12118328|FG007|Open Label Phase|Other|0
7697397|NCT00401245|12118321|FG000|Open Label Phase|Protocol Violation|0
7697398|NCT00401245|12118322|FG001|Open Label Phase|Protocol Violation|1
7697399|NCT00401245|12118323|FG002|Open Label Phase|Protocol Violation|0
7697400|NCT00401245|12118324|FG003|Open Label Phase|Protocol Violation|1
7697401|NCT00401245|12118325|FG004|Open Label Phase|Protocol Violation|0
7697402|NCT00401245|12118326|FG005|Open Label Phase|Protocol Violation|0
7697403|NCT00401245|12118327|FG006|Open Label Phase|Protocol Violation|0
7697404|NCT00401245|12118328|FG007|Open Label Phase|Protocol Violation|0
7697405|NCT00401245|12118321|FG000|Open Label Phase|Withdrawal by Subject|3
7697406|NCT00401245|12118322|FG001|Open Label Phase|Withdrawal by Subject|3
7697407|NCT00401245|12118323|FG002|Open Label Phase|Withdrawal by Subject|2
7697408|NCT00401245|12118324|FG003|Open Label Phase|Withdrawal by Subject|1
7697409|NCT00401245|12118325|FG004|Open Label Phase|Withdrawal by Subject|0
7697410|NCT00401245|12118326|FG005|Open Label Phase|Withdrawal by Subject|0
7697411|NCT00401245|12118327|FG006|Open Label Phase|Withdrawal by Subject|0
7697412|NCT00401245|12118328|FG007|Open Label Phase|Withdrawal by Subject|0
7697413|NCT00401245|12118321|FG000|Open Label Phase|Lack of Efficacy|4
7697414|NCT00401245|12118322|FG001|Open Label Phase|Lack of Efficacy|2
7697415|NCT00401245|12118323|FG002|Open Label Phase|Lack of Efficacy|3
7697416|NCT00401245|12118324|FG003|Open Label Phase|Lack of Efficacy|0
7697417|NCT00401245|12118325|FG004|Open Label Phase|Lack of Efficacy|0
7697418|NCT00401245|12118326|FG005|Open Label Phase|Lack of Efficacy|0
7697419|NCT00401245|12118327|FG006|Open Label Phase|Lack of Efficacy|0
7697420|NCT00401245|12118328|FG007|Open Label Phase|Lack of Efficacy|0
7697421|NCT00401245|12118321|FG000|Double Blind Tapering Phase|Adverse Event|0
7697422|NCT00401245|12118322|FG001|Double Blind Tapering Phase|Adverse Event|0
7697423|NCT00401245|12118323|FG002|Double Blind Tapering Phase|Adverse Event|0
7697424|NCT00401245|12118324|FG003|Double Blind Tapering Phase|Adverse Event|0
7697425|NCT00401245|12118325|FG004|Double Blind Tapering Phase|Adverse Event|1
7697426|NCT00401245|12118326|FG005|Double Blind Tapering Phase|Adverse Event|1
7697427|NCT00401245|12118327|FG006|Double Blind Tapering Phase|Adverse Event|2
7697428|NCT00401245|12118328|FG007|Double Blind Tapering Phase|Adverse Event|4
7697429|NCT00401245|12118321|FG000|Double Blind Tapering Phase|Investigator request|0
7697430|NCT00401245|12118322|FG001|Double Blind Tapering Phase|Investigator request|0
7697431|NCT00401245|12118323|FG002|Double Blind Tapering Phase|Investigator request|0
7697432|NCT00401245|12118324|FG003|Double Blind Tapering Phase|Investigator request|0
7697433|NCT00401245|12118325|FG004|Double Blind Tapering Phase|Investigator request|0
7697434|NCT00401245|12118326|FG005|Double Blind Tapering Phase|Investigator request|0
7697435|NCT00401245|12118327|FG006|Double Blind Tapering Phase|Investigator request|0
7697436|NCT00401245|12118328|FG007|Double Blind Tapering Phase|Investigator request|1
7697437|NCT00401245|12118321|FG000|Double Blind Tapering Phase|Other|0
7697438|NCT00401245|12118322|FG001|Double Blind Tapering Phase|Other|0
7697439|NCT00401245|12118323|FG002|Double Blind Tapering Phase|Other|0
7697440|NCT00401245|12118324|FG003|Double Blind Tapering Phase|Other|0
7697441|NCT00401245|12118325|FG004|Double Blind Tapering Phase|Other|1
7697442|NCT00401245|12118326|FG005|Double Blind Tapering Phase|Other|0
7697443|NCT00401245|12118327|FG006|Double Blind Tapering Phase|Other|2
7697444|NCT00401245|12118328|FG007|Double Blind Tapering Phase|Other|2
7697445|NCT00401245|12118321|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0
7697446|NCT00401245|12118322|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0
7697447|NCT00401245|12118323|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0
7697448|NCT00401245|12118324|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0
7697449|NCT00401245|12118325|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2
7697450|NCT00401245|12118326|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2
7697451|NCT00401245|12118327|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3
7697452|NCT00401245|12118328|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0
7697453|NCT00401245|12118321|FG000|Double Blind Tapering Phase|Lack of Efficacy|0
7697454|NCT00401245|12118322|FG001|Double Blind Tapering Phase|Lack of Efficacy|0
7697455|NCT00401245|12118323|FG002|Double Blind Tapering Phase|Lack of Efficacy|0
7697456|NCT00401245|12118324|FG003|Double Blind Tapering Phase|Lack of Efficacy|0
7697457|NCT00401245|12118325|FG004|Double Blind Tapering Phase|Lack of Efficacy|0
7697458|NCT00401245|12118326|FG005|Double Blind Tapering Phase|Lack of Efficacy|1
7697459|NCT00401245|12118327|FG006|Double Blind Tapering Phase|Lack of Efficacy|0
7697460|NCT00401245|12118328|FG007|Double Blind Tapering Phase|Lack of Efficacy|0
7697461|NCT00401258|12118348|FG000|Overall Study|Adverse Event|7
7697462|NCT00401375|12118355|FG000|Overall Study|Protocol Violation|2
7697463|NCT00401375|12118356|FG001|Overall Study|Protocol Violation|2
7697464|NCT00401375|12118357|FG002|Overall Study|Protocol Violation|1
7697465|NCT00401375|12118355|FG000|Overall Study|Adverse Event|6
7697466|NCT00401375|12118356|FG001|Overall Study|Adverse Event|11
7697467|NCT00401375|12118357|FG002|Overall Study|Adverse Event|10
7697468|NCT00401375|12118355|FG000|Overall Study|Withdrawal by Subject|9
7697469|NCT00401375|12118356|FG001|Overall Study|Withdrawal by Subject|7
7697470|NCT00401375|12118357|FG002|Overall Study|Withdrawal by Subject|7
7697471|NCT00401375|12118355|FG000|Overall Study|Lost to Follow-up|0
7697472|NCT00401375|12118356|FG001|Overall Study|Lost to Follow-up|1
7697473|NCT00401375|12118357|FG002|Overall Study|Lost to Follow-up|1
7697474|NCT00401375|12118355|FG000|Overall Study|Other than specified|2
7697475|NCT00401375|12118356|FG001|Overall Study|Other than specified|1
7697476|NCT00401375|12118357|FG002|Overall Study|Other than specified|3
7697477|NCT00401375|12118355|FG000|Overall Study|Randomized but not treated|3
7697478|NCT00401375|12118356|FG001|Overall Study|Randomized but not treated|3
7697479|NCT00401375|12118357|FG002|Overall Study|Randomized but not treated|3
7697480|NCT00401531|12118416|FG000|Overall Study|Adverse Event|2
7697481|NCT00401531|12118417|FG001|Overall Study|Adverse Event|0
7697482|NCT00401531|12118416|FG000|Overall Study|Protocol Violation|3
7697483|NCT00401531|12118417|FG001|Overall Study|Protocol Violation|7
7697484|NCT00401531|12118416|FG000|Overall Study|Lost to Follow-up|1
7697485|NCT00401531|12118417|FG001|Overall Study|Lost to Follow-up|1
7697486|NCT00401531|12118416|FG000|Overall Study|Withdrawal by Subject|3
7697487|NCT00401531|12118417|FG001|Overall Study|Withdrawal by Subject|2
7697488|NCT00401544|12118427|FG000|Overall Study|Adverse Event|5
7697489|NCT00401544|12118428|FG001|Overall Study|Adverse Event|1
7697490|NCT00401544|12118429|FG002|Overall Study|Adverse Event|1
7697491|NCT00401544|12118430|FG003|Overall Study|Adverse Event|1
7697492|NCT00401544|12118427|FG000|Overall Study|Death|3
7697493|NCT00401544|12118428|FG001|Overall Study|Death|6
7697494|NCT00401544|12118429|FG002|Overall Study|Death|2
7697495|NCT00401544|12118430|FG003|Overall Study|Death|5
7697496|NCT00401544|12118427|FG000|Overall Study|Lost to Follow-up|2
7697497|NCT00401544|12118428|FG001|Overall Study|Lost to Follow-up|0
7697498|NCT00401544|12118429|FG002|Overall Study|Lost to Follow-up|1
7697499|NCT00401544|12118430|FG003|Overall Study|Lost to Follow-up|1
7697500|NCT00401544|12118427|FG000|Overall Study|Withdrawal by Subject|7
7697501|NCT00401544|12118428|FG001|Overall Study|Withdrawal by Subject|6
7697502|NCT00401544|12118429|FG002|Overall Study|Withdrawal by Subject|6
7697503|NCT00401544|12118430|FG003|Overall Study|Withdrawal by Subject|5
7697504|NCT00401544|12118427|FG000|Overall Study|Physician Decision|1
7697505|NCT00401544|12118428|FG001|Overall Study|Physician Decision|3
7697506|NCT00401544|12118429|FG002|Overall Study|Physician Decision|0
7697507|NCT00401544|12118430|FG003|Overall Study|Physician Decision|0
7697508|NCT00401544|12118427|FG000|Overall Study|Ineligibility determined|0
7697509|NCT00401544|12118428|FG001|Overall Study|Ineligibility determined|1
7697510|NCT00401544|12118429|FG002|Overall Study|Ineligibility determined|0
7697511|NCT00401544|12118430|FG003|Overall Study|Ineligibility determined|2
7697512|NCT00401544|12118427|FG000|Overall Study|Disease progression|0
7697513|NCT00401544|12118428|FG001|Overall Study|Disease progression|1
7697514|NCT00401544|12118429|FG002|Overall Study|Disease progression|0
7697515|NCT00401544|12118430|FG003|Overall Study|Disease progression|0
7697516|NCT00401544|12118427|FG000|Overall Study|Other|0
7697517|NCT00401544|12118428|FG001|Overall Study|Other|0
7697518|NCT00401544|12118429|FG002|Overall Study|Other|2
7697519|NCT00401544|12118430|FG003|Overall Study|Other|2
7697520|NCT00401726|12118456|FG000|Overall Study|Adverse Event|34
7697521|NCT00401726|12118457|FG001|Overall Study|Adverse Event|45
7697522|NCT00401726|12118456|FG000|Overall Study|Death|0
7697523|NCT00401726|12118457|FG001|Overall Study|Death|3
7697524|NCT00401726|12118456|FG000|Overall Study|Sponsor Request|0
7697525|NCT00401726|12118457|FG001|Overall Study|Sponsor Request|1
7697526|NCT00401726|12118456|FG000|Overall Study|Physician Decision|3
7697527|NCT00401726|12118457|FG001|Overall Study|Physician Decision|6
7697528|NCT00401726|12118456|FG000|Overall Study|Lost to Follow-up|23
7697529|NCT00401726|12118457|FG001|Overall Study|Lost to Follow-up|20
7697530|NCT00401726|12118456|FG000|Overall Study|Protocol Violation|6
7697531|NCT00401726|12118457|FG001|Overall Study|Protocol Violation|3
7697532|NCT00401726|12118456|FG000|Overall Study|Withdrawal by Subject|18
7697533|NCT00401726|12118457|FG001|Overall Study|Withdrawal by Subject|24
7697534|NCT00401726|12118456|FG000|Overall Study|Lack of Efficacy|4
7697535|NCT00401726|12118457|FG001|Overall Study|Lack of Efficacy|6
7697536|NCT00401726|12118456|FG000|Overall Study|Protocol Deviation|9
7697537|NCT00401726|12118457|FG001|Overall Study|Protocol Deviation|4
7697538|NCT00401752|12118465|FG000|Overall Study|Adverse Event|2
7697539|NCT00401752|12118466|FG001|Overall Study|Adverse Event|5
7697540|NCT00401752|12118465|FG000|Overall Study|Withdrawal by Subject|2
7697541|NCT00401752|12118466|FG001|Overall Study|Withdrawal by Subject|6
7697542|NCT00401752|12118465|FG000|Overall Study|Lost to Follow-up|1
7697543|NCT00401752|12118466|FG001|Overall Study|Lost to Follow-up|4
7697544|NCT00401752|12118465|FG000|Overall Study|Development of any exclusion criteria|4
7697545|NCT00401752|12118466|FG001|Overall Study|Development of any exclusion criteria|2
7697546|NCT00401752|12118465|FG000|Overall Study|Physician Decision|1
7697547|NCT00401752|12118466|FG001|Overall Study|Physician Decision|1
7697548|NCT00401830|12118492|FG000|Overall Study|Adverse Event|10
7697549|NCT00401830|12118493|FG001|Overall Study|Adverse Event|18
7697550|NCT00401830|12118492|FG000|Overall Study|Lack of Efficacy|11
7697551|NCT00401830|12118493|FG001|Overall Study|Lack of Efficacy|5
7697552|NCT00401830|12118492|FG000|Overall Study|Withdrawal by Subject|4
7697553|NCT00401830|12118493|FG001|Overall Study|Withdrawal by Subject|3
7697554|NCT00401830|12118492|FG000|Overall Study|Protocol Violation|3
7697555|NCT00401830|12118493|FG001|Overall Study|Protocol Violation|3
7697556|NCT00401830|12118492|FG000|Overall Study|Non-compliance with drug study|1
7697557|NCT00401830|12118493|FG001|Overall Study|Non-compliance with drug study|0
7697558|NCT00401830|12118492|FG000|Overall Study|Lost to Follow-up|1
7697559|NCT00401830|12118493|FG001|Overall Study|Lost to Follow-up|3
7697560|NCT00401830|12118492|FG000|Overall Study|Other: Personal / Family problems|1
7697561|NCT00401830|12118493|FG001|Overall Study|Other: Personal / Family problems|0
7697562|NCT00401843|12118502|FG000|Overall Study|Achieved Complete Response|1
7697563|NCT00401843|12118503|FG001|Overall Study|Achieved Complete Response|5
7697564|NCT00401843|12118504|FG002|Overall Study|Achieved Complete Response|11
7697565|NCT00401843|12118502|FG000|Overall Study|Adverse Event|7
7697566|NCT00401843|12118503|FG001|Overall Study|Adverse Event|26
7697567|NCT00401843|12118504|FG002|Overall Study|Adverse Event|27
7697568|NCT00401843|12118502|FG000|Overall Study|Death|0
7697569|NCT00401843|12118503|FG001|Overall Study|Death|8
7697570|NCT00401843|12118504|FG002|Overall Study|Death|10
7697571|NCT00401843|12118502|FG000|Overall Study|Disease progression|10
7697572|NCT00401843|12118503|FG001|Overall Study|Disease progression|60
7697573|NCT00401843|12118504|FG002|Overall Study|Disease progression|49
7697574|NCT00401843|12118502|FG000|Overall Study|End of Study|1
7697575|NCT00401843|12118503|FG001|Overall Study|End of Study|1
7697576|NCT00401843|12118504|FG002|Overall Study|End of Study|2
7697577|NCT00401843|12118502|FG000|Overall Study|Lost to Follow-up|0
7697578|NCT00401843|12118503|FG001|Overall Study|Lost to Follow-up|0
7697579|NCT00401843|12118504|FG002|Overall Study|Lost to Follow-up|2
7697580|NCT00401843|12118502|FG000|Overall Study|Other Unspecified|0
7697581|NCT00401843|12118503|FG001|Overall Study|Other Unspecified|3
7697582|NCT00401843|12118504|FG002|Overall Study|Other Unspecified|5
7697583|NCT00401843|12118502|FG000|Overall Study|Physician Decision|0
7697584|NCT00401843|12118503|FG001|Overall Study|Physician Decision|16
7697585|NCT00401843|12118504|FG002|Overall Study|Physician Decision|10
7697586|NCT00401843|12118502|FG000|Overall Study|Protocol Violation|0
7697587|NCT00401843|12118503|FG001|Overall Study|Protocol Violation|0
7697588|NCT00401843|12118504|FG002|Overall Study|Protocol Violation|1
7697589|NCT00401843|12118502|FG000|Overall Study|Withdrawal by Subject|1
7697590|NCT00401843|12118503|FG001|Overall Study|Withdrawal by Subject|5
7697591|NCT00401843|12118504|FG002|Overall Study|Withdrawal by Subject|5
7697592|NCT00401843|12118502|FG000|Overall Study|Withdrawal of consent to study agent|1
7697593|NCT00401843|12118503|FG001|Overall Study|Withdrawal of consent to study agent|15
7697594|NCT00401843|12118504|FG002|Overall Study|Withdrawal of consent to study agent|17
7697595|NCT00401843|12118502|FG000|Overall Study|Randomized but not Treated|0
7697596|NCT00401843|12118503|FG001|Overall Study|Randomized but not Treated|2
7697597|NCT00401843|12118504|FG002|Overall Study|Randomized but not Treated|3
7697598|NCT00401843|12118502|FG000|Overall Study|Received incorrect treatment|0
7697599|NCT00401843|12118503|FG001|Overall Study|Received incorrect treatment|3
7697600|NCT00401843|12118504|FG002|Overall Study|Received incorrect treatment|0
7697601|NCT00401960|12118531|FG000|Overall Study|Lost to Follow-up|3
7697602|NCT00401960|12118532|FG001|Overall Study|Lost to Follow-up|0
7697603|NCT00401960|12118531|FG000|Overall Study|Death|2
7697604|NCT00401960|12118532|FG001|Overall Study|Death|0
7697605|NCT00401973|12118543|FG000|Overall Study|Adverse Event|2
7697606|NCT00401973|12118544|FG001|Overall Study|Adverse Event|8
7697607|NCT00401973|12118545|FG002|Overall Study|Adverse Event|4
7697608|NCT00401973|12118543|FG000|Overall Study|Clinical Relapse|0
7697609|NCT00401973|12118544|FG001|Overall Study|Clinical Relapse|1
7697610|NCT00401973|12118545|FG002|Overall Study|Clinical Relapse|1
7697611|NCT00401973|12118543|FG000|Overall Study|Lack of Efficacy|0
7697612|NCT00401973|12118544|FG001|Overall Study|Lack of Efficacy|0
7697613|NCT00401973|12118545|FG002|Overall Study|Lack of Efficacy|3
7697614|NCT00401973|12118543|FG000|Overall Study|Lost to Follow-up|2
7697615|NCT00401973|12118544|FG001|Overall Study|Lost to Follow-up|2
7697616|NCT00401973|12118545|FG002|Overall Study|Lost to Follow-up|2
7697617|NCT00401973|12118543|FG000|Overall Study|Physician Decision|2
7697618|NCT00401973|12118544|FG001|Overall Study|Physician Decision|0
7697619|NCT00401973|12118545|FG002|Overall Study|Physician Decision|1
7697620|NCT00401973|12118543|FG000|Overall Study|Protocol Violation|1
7697621|NCT00401973|12118544|FG001|Overall Study|Protocol Violation|2
7697622|NCT00401973|12118545|FG002|Overall Study|Protocol Violation|3
7697623|NCT00401973|12118543|FG000|Overall Study|Sponsor Decision|0
7697624|NCT00401973|12118544|FG001|Overall Study|Sponsor Decision|1
7697625|NCT00401973|12118545|FG002|Overall Study|Sponsor Decision|0
7697626|NCT00401973|12118543|FG000|Overall Study|Withdrawal by Subject|4
7697627|NCT00401973|12118544|FG001|Overall Study|Withdrawal by Subject|12
7697628|NCT00401973|12118545|FG002|Overall Study|Withdrawal by Subject|9
7697629|NCT00402025|12118567|FG000|Overall Study|Adverse Event|0
7697630|NCT00402025|12118568|FG001|Overall Study|Adverse Event|0
7697631|NCT00402025|12118569|FG002|Overall Study|Adverse Event|2
7697632|NCT00402025|12118567|FG000|Overall Study|Death|0
7697633|NCT00402025|12118568|FG001|Overall Study|Death|1
7697634|NCT00402025|12118569|FG002|Overall Study|Death|5
7697635|NCT00402025|12118567|FG000|Overall Study|Disease Progression|1
7697636|NCT00402025|12118568|FG001|Overall Study|Disease Progression|1
7697637|NCT00402025|12118569|FG002|Overall Study|Disease Progression|2
7697638|NCT00402025|12118567|FG000|Overall Study|Physician Decision|1
7697639|NCT00402025|12118568|FG001|Overall Study|Physician Decision|1
7697640|NCT00402025|12118569|FG002|Overall Study|Physician Decision|0
7697641|NCT00402025|12118567|FG000|Overall Study|Participant Decision|0
7697642|NCT00402025|12118568|FG001|Overall Study|Participant Decision|0
7697643|NCT00402025|12118569|FG002|Overall Study|Participant Decision|1
7697644|NCT00402051|12118579|FG000|Overall Study|Progressive Disease|13
7697645|NCT00402051|12118580|FG001|Overall Study|Progressive Disease|20
7697646|NCT00402051|12118579|FG000|Overall Study|Adverse Event|11
7697647|NCT00402051|12118580|FG001|Overall Study|Adverse Event|4
7697648|NCT00402051|12118579|FG000|Overall Study|Physician Decision|7
7697649|NCT00402051|12118580|FG001|Overall Study|Physician Decision|3
7697650|NCT00402051|12118579|FG000|Overall Study|Withdrawal by Subject|3
7697651|NCT00402051|12118580|FG001|Overall Study|Withdrawal by Subject|3
7697652|NCT00402051|12118579|FG000|Overall Study|Death - Related to Study Drug|1
7697653|NCT00402051|12118580|FG001|Overall Study|Death - Related to Study Drug|2
7697654|NCT00402051|12118579|FG000|Overall Study|Death Due to Study Disease|2
7697655|NCT00402051|12118580|FG001|Overall Study|Death Due to Study Disease|1
7697656|NCT00402051|12118579|FG000|Overall Study|Death Due to Adverse Event|0
7697657|NCT00402051|12118580|FG001|Overall Study|Death Due to Adverse Event|2
7697658|NCT00402051|12118579|FG000|Overall Study|Lost to Follow-up|1
7697659|NCT00402051|12118580|FG001|Overall Study|Lost to Follow-up|0
7697660|NCT00402103|12118588|FG000|Overall Study|Adverse Event|60
7697661|NCT00402103|12118589|FG001|Overall Study|Adverse Event|7
7697662|NCT00402103|12118588|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7697663|NCT00402103|12118589|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7697664|NCT00402103|12118588|FG000|Overall Study|Condition no longer requires study drug|2
7697665|NCT00402103|12118589|FG001|Overall Study|Condition no longer requires study drug|0
7697666|NCT00402103|12118588|FG000|Overall Study|Protocol Deviation|8
7697667|NCT00402103|12118589|FG001|Overall Study|Protocol Deviation|0
7697668|NCT00402103|12118588|FG000|Overall Study|Patient withdrew consent|12
7697669|NCT00402103|12118589|FG001|Overall Study|Patient withdrew consent|1
7697670|NCT00402103|12118588|FG000|Overall Study|Lost to Follow-up|6
7697671|NCT00402103|12118589|FG001|Overall Study|Lost to Follow-up|3
7697672|NCT00402103|12118588|FG000|Overall Study|Administrative problems|2
7697673|NCT00402103|12118589|FG001|Overall Study|Administrative problems|0
7697674|NCT00402116|12118602|FG000|Overall Study|Jaw infection after surgery-other|1
7697675|NCT00402116|12118603|FG001|Overall Study|Jaw infection after surgery-other|0
7697676|NCT00402116|12118604|FG002|Overall Study|Jaw infection after surgery-other|0
7697677|NCT00402116|12118602|FG000|Overall Study|Withdrawal by Subject|1
7697678|NCT00402116|12118603|FG001|Overall Study|Withdrawal by Subject|0
7697679|NCT00402116|12118604|FG002|Overall Study|Withdrawal by Subject|5
7697680|NCT00402116|12118602|FG000|Overall Study|Treatment completed per protocol|1
7697681|NCT00402116|12118603|FG001|Overall Study|Treatment completed per protocol|1
7697682|NCT00402116|12118604|FG002|Overall Study|Treatment completed per protocol|2
7697683|NCT00402116|12118602|FG000|Overall Study|other complicating disease|0
7697684|NCT00402116|12118603|FG001|Overall Study|other complicating disease|0
7697685|NCT00402116|12118604|FG002|Overall Study|other complicating disease|2
7697686|NCT00402116|12118602|FG000|Overall Study|Disease Progression|0
7697687|NCT00402116|12118603|FG001|Overall Study|Disease Progression|4
7697688|NCT00402116|12118604|FG002|Overall Study|Disease Progression|38
7697689|NCT00402116|12118602|FG000|Overall Study|mistaken thrombocytopenia|0
7697690|NCT00402116|12118603|FG001|Overall Study|mistaken thrombocytopenia|0
7697691|NCT00402116|12118604|FG002|Overall Study|mistaken thrombocytopenia|1
7697692|NCT00402116|12118602|FG000|Overall Study|decline related hyponatremia/tumor|0
7697693|NCT00402116|12118603|FG001|Overall Study|decline related hyponatremia/tumor|0
7697694|NCT00402116|12118604|FG002|Overall Study|decline related hyponatremia/tumor|1
7697695|NCT00402116|12118602|FG000|Overall Study|Adverse Event|0
7697696|NCT00402116|12118603|FG001|Overall Study|Adverse Event|1
7697697|NCT00402116|12118604|FG002|Overall Study|Adverse Event|6
7697698|NCT00402168|12118634|FG000|Randomized|Lost to Follow-up|1
7697699|NCT00402168|12118635|FG001|Randomized|Lost to Follow-up|0
7697700|NCT00402168|12118634|FG000|Randomized|Withdrawal by Subject|0
7697701|NCT00402168|12118635|FG001|Randomized|Withdrawal by Subject|1
7697702|NCT00402168|12118634|FG000|Treatment (up to 12 Months)|Death|0
7697703|NCT00402168|12118635|FG001|Treatment (up to 12 Months)|Death|1
7697704|NCT00402168|12118634|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2
7697705|NCT00402168|12118635|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0
7697706|NCT00402168|12118634|FG000|Treatment (up to 12 Months)|non-specified|0
7697707|NCT00402168|12118635|FG001|Treatment (up to 12 Months)|non-specified|1
7697708|NCT00402168|12118634|FG000|Long Term (LT)|Adverse Event|1
7697709|NCT00402168|12118635|FG001|Long Term (LT)|Adverse Event|5
7697710|NCT00402168|12118634|FG000|Long Term (LT)|Withdrawal by Subject|4
7697711|NCT00402168|12118635|FG001|Long Term (LT)|Withdrawal by Subject|7
7697712|NCT00402168|12118634|FG000|Long Term (LT)|Pregnancy|0
7697713|NCT00402168|12118635|FG001|Long Term (LT)|Pregnancy|1
7697714|NCT00402168|12118634|FG000|Long Term (LT)|Lost to Follow-up|1
7697715|NCT00402168|12118635|FG001|Long Term (LT)|Lost to Follow-up|0
7697716|NCT00402168|12118634|FG000|Long Term (LT)|Death|4
7697717|NCT00402168|12118635|FG001|Long Term (LT)|Death|0
7697718|NCT00402168|12118634|FG000|Long Term (LT)|Lack of Efficacy|0
7697719|NCT00402168|12118635|FG001|Long Term (LT)|Lack of Efficacy|2
7697720|NCT00402168|12118634|FG000|Long Term (LT)|non-specified|1
7697721|NCT00402168|12118635|FG001|Long Term (LT)|non-specified|2
7697722|NCT00402168|12118634|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
7697723|NCT00402168|12118635|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
7697724|NCT00402168|12118634|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4
7697725|NCT00402168|12118635|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0
7697726|NCT00402233|12118662|FG000|Overall Study|Adverse Event|1
7697727|NCT00402233|12118663|FG001|Overall Study|Adverse Event|7
7697728|NCT00402233|12118664|FG002|Overall Study|Adverse Event|9
7697729|NCT00402233|12118665|FG003|Overall Study|Adverse Event|9
7697730|NCT00402233|12118662|FG000|Overall Study|Protocol Violation|0
7697731|NCT00402233|12118663|FG001|Overall Study|Protocol Violation|1
7697732|NCT00402233|12118664|FG002|Overall Study|Protocol Violation|0
7697733|NCT00402233|12118665|FG003|Overall Study|Protocol Violation|0
7697734|NCT00402233|12118662|FG000|Overall Study|Withdrawal by Subject|2
7697735|NCT00402233|12118663|FG001|Overall Study|Withdrawal by Subject|1
7697736|NCT00402233|12118664|FG002|Overall Study|Withdrawal by Subject|2
7697737|NCT00402233|12118665|FG003|Overall Study|Withdrawal by Subject|2
7697738|NCT00402233|12118662|FG000|Overall Study|Worsening of disease under study|2
7697739|NCT00402233|12118663|FG001|Overall Study|Worsening of disease under study|0
7697740|NCT00402233|12118664|FG002|Overall Study|Worsening of disease under study|0
7697741|NCT00402233|12118665|FG003|Overall Study|Worsening of disease under study|0
7697742|NCT00402233|12118662|FG000|Overall Study|Worsening of other pre-existing disease|0
7697743|NCT00402233|12118663|FG001|Overall Study|Worsening of other pre-existing disease|1
7697744|NCT00402233|12118664|FG002|Overall Study|Worsening of other pre-existing disease|0
7697745|NCT00402233|12118665|FG003|Overall Study|Worsening of other pre-existing disease|0
7697746|NCT00402246|12118677|FG000|Overall Study|Death|62
7697747|NCT00402246|12118678|FG001|Overall Study|Death|58
7697748|NCT00402246|12118677|FG000|Overall Study|Lost to Follow-up|20
7697749|NCT00402246|12118678|FG001|Overall Study|Lost to Follow-up|28
7697750|NCT00402246|12118677|FG000|Overall Study|Withdrawal by Subject|72
7697751|NCT00402246|12118678|FG001|Overall Study|Withdrawal by Subject|87
7697752|NCT00402246|12118677|FG000|Overall Study|Physician Decision|24
7697753|NCT00402246|12118678|FG001|Overall Study|Physician Decision|26
7697754|NCT00402246|12118677|FG000|Overall Study|Protocol Violation|25
7697755|NCT00402246|12118678|FG001|Overall Study|Protocol Violation|24
7697756|NCT00402246|12118677|FG000|Overall Study|Missed Final Visit|1
7697757|NCT00402246|12118678|FG001|Overall Study|Missed Final Visit|2
7697758|NCT00402246|12118677|FG000|Overall Study|Insurance Issues|2
7697759|NCT00402246|12118678|FG001|Overall Study|Insurance Issues|1
7697760|NCT00402246|12118677|FG000|Overall Study|Heart Transplant|0
7697761|NCT00402246|12118678|FG001|Overall Study|Heart Transplant|1
7697762|NCT00402246|12118677|FG000|Overall Study|Patient's device explanted|6
7697763|NCT00402246|12118678|FG001|Overall Study|Patient's device explanted|2
7697764|NCT00402246|12118677|FG000|Overall Study|Center Closure|5
7697765|NCT00402246|12118678|FG001|Overall Study|Center Closure|3
7697766|NCT00402246|12118677|FG000|Overall Study|Deterioriating Condition|3
7697767|NCT00402246|12118678|FG001|Overall Study|Deterioriating Condition|2
7697768|NCT00402285|12118689|FG000|Overall Study|insufficient RNA quality|7
7697769|NCT00402285|12118690|FG001|Overall Study|insufficient RNA quality|6
7697770|NCT00402285|12118691|FG002|Overall Study|insufficient RNA quality|2
7697771|NCT00402324|12118699|FG000|Overall Study|Lost to Follow-up|11
7697772|NCT00402324|12118700|FG001|Overall Study|Lost to Follow-up|11
7697773|NCT00402324|12118699|FG000|Overall Study|Protocol Entry Criteria Not Met|5
7697774|NCT00402324|12118700|FG001|Overall Study|Protocol Entry Criteria Not Met|4
7697775|NCT00402324|12118699|FG000|Overall Study|Protocol Violation|8
7697776|NCT00402324|12118700|FG001|Overall Study|Protocol Violation|7
7697777|NCT00402324|12118699|FG000|Overall Study|Withdrawal by Subject|5
7697778|NCT00402324|12118700|FG001|Overall Study|Withdrawal by Subject|2
7697779|NCT00402324|12118699|FG000|Overall Study|Physician Decision|2
7697780|NCT00402324|12118700|FG001|Overall Study|Physician Decision|4
7697781|NCT00402324|12118699|FG000|Overall Study|Sponsor Decision|4
7697782|NCT00402324|12118700|FG001|Overall Study|Sponsor Decision|5
7697783|NCT00402324|12118699|FG000|Overall Study|Lack of Efficacy|1
7697784|NCT00402324|12118700|FG001|Overall Study|Lack of Efficacy|4
7697785|NCT00402324|12118699|FG000|Overall Study|Adverse Event|6
7697786|NCT00402324|12118700|FG001|Overall Study|Adverse Event|4
7697787|NCT00402324|12118699|FG000|Overall Study|Death|1
7697788|NCT00402324|12118700|FG001|Overall Study|Death|0
7697789|NCT00402337|12118711|FG000|Overall Study|Adverse Event|0
7697790|NCT00402337|12118712|FG001|Overall Study|Adverse Event|2
7697791|NCT00402337|12118713|FG002|Overall Study|Adverse Event|2
7697792|NCT00402337|12118714|FG003|Overall Study|Adverse Event|3
7697793|NCT00402337|12118715|FG004|Overall Study|Adverse Event|2
7697794|NCT00402337|12118711|FG000|Overall Study|Noncompliance|0
7697795|NCT00402337|12118712|FG001|Overall Study|Noncompliance|0
7697796|NCT00402337|12118713|FG002|Overall Study|Noncompliance|0
7697797|NCT00402337|12118714|FG003|Overall Study|Noncompliance|0
7697798|NCT00402337|12118715|FG004|Overall Study|Noncompliance|2
7697799|NCT00402337|12118711|FG000|Overall Study|Withdrawal by Subject|5
7697800|NCT00402337|12118712|FG001|Overall Study|Withdrawal by Subject|3
7697801|NCT00402337|12118713|FG002|Overall Study|Withdrawal by Subject|1
7697802|NCT00402337|12118714|FG003|Overall Study|Withdrawal by Subject|6
7697803|NCT00402337|12118715|FG004|Overall Study|Withdrawal by Subject|4
7697804|NCT00402337|12118711|FG000|Overall Study|Lost to Follow-up|0
7697805|NCT00402337|12118712|FG001|Overall Study|Lost to Follow-up|0
7697806|NCT00402337|12118713|FG002|Overall Study|Lost to Follow-up|1
7697807|NCT00402337|12118714|FG003|Overall Study|Lost to Follow-up|2
7697808|NCT00402337|12118715|FG004|Overall Study|Lost to Follow-up|0
7697809|NCT00402337|12118711|FG000|Overall Study|Physician Decision|0
7697810|NCT00402337|12118712|FG001|Overall Study|Physician Decision|0
7697811|NCT00402337|12118713|FG002|Overall Study|Physician Decision|0
7697812|NCT00402337|12118714|FG003|Overall Study|Physician Decision|1
7697813|NCT00402337|12118715|FG004|Overall Study|Physician Decision|0
7697814|NCT00402337|12118711|FG000|Overall Study|Other Reason|0
7697815|NCT00402337|12118712|FG001|Overall Study|Other Reason|1
7697816|NCT00402337|12118713|FG002|Overall Study|Other Reason|0
7697817|NCT00402337|12118714|FG003|Overall Study|Other Reason|0
7697818|NCT00402337|12118715|FG004|Overall Study|Other Reason|0
7697819|NCT00402363|12118731|FG000|Overall Study|Adverse Event|9
7697820|NCT00402363|12118732|FG001|Overall Study|Adverse Event|14
7697821|NCT00402363|12118733|FG002|Overall Study|Adverse Event|2
7697822|NCT00402363|12118734|FG003|Overall Study|Adverse Event|2
7697823|NCT00402363|12118731|FG000|Overall Study|Withdrew Consent|10
7697824|NCT00402363|12118732|FG001|Overall Study|Withdrew Consent|5
7697825|NCT00402363|12118733|FG002|Overall Study|Withdrew Consent|2
7697826|NCT00402363|12118734|FG003|Overall Study|Withdrew Consent|1
7697827|NCT00402363|12118731|FG000|Overall Study|Protocol Violation|3
7697828|NCT00402363|12118732|FG001|Overall Study|Protocol Violation|5
7697829|NCT00402363|12118733|FG002|Overall Study|Protocol Violation|0
7697830|NCT00402363|12118734|FG003|Overall Study|Protocol Violation|3
7697831|NCT00402363|12118731|FG000|Overall Study|Lost to Follow-up|5
7697832|NCT00402363|12118732|FG001|Overall Study|Lost to Follow-up|4
7697833|NCT00402363|12118733|FG002|Overall Study|Lost to Follow-up|0
7697834|NCT00402363|12118734|FG003|Overall Study|Lost to Follow-up|2
7697835|NCT00402363|12118731|FG000|Overall Study|"Captured as Other"|6
7697836|NCT00402363|12118732|FG001|Overall Study|"Captured as Other"|2
7697837|NCT00402363|12118733|FG002|Overall Study|"Captured as Other"|2
7697838|NCT00402363|12118734|FG003|Overall Study|"Captured as Other"|2
7697839|NCT00402597|12118755|FG000|Overall Study|Death|15
7697840|NCT00402597|12118756|FG001|Overall Study|Death|7
7697841|NCT00402597|12118757|FG002|Overall Study|Death|6
7697842|NCT00402597|12118758|FG003|Overall Study|Death|4
7697843|NCT00402597|12118759|FG004|Overall Study|Death|6
7697844|NCT00402597|12118755|FG000|Overall Study|Adverse Event|81
7697845|NCT00402597|12118756|FG001|Overall Study|Adverse Event|18
7697846|NCT00402597|12118757|FG002|Overall Study|Adverse Event|106
7697847|NCT00402597|12118758|FG003|Overall Study|Adverse Event|39
7697848|NCT00402597|12118759|FG004|Overall Study|Adverse Event|71
7697849|NCT00402597|12118755|FG000|Overall Study|Lost to Follow-up|8
7697850|NCT00402597|12118756|FG001|Overall Study|Lost to Follow-up|1
7697851|NCT00402597|12118757|FG002|Overall Study|Lost to Follow-up|8
7697852|NCT00402597|12118758|FG003|Overall Study|Lost to Follow-up|2
7697853|NCT00402597|12118759|FG004|Overall Study|Lost to Follow-up|3
7697854|NCT00402597|12118755|FG000|Overall Study|Withdrawal by Subject|57
7697855|NCT00402597|12118756|FG001|Overall Study|Withdrawal by Subject|16
7697856|NCT00402597|12118757|FG002|Overall Study|Withdrawal by Subject|65
7697857|NCT00402597|12118758|FG003|Overall Study|Withdrawal by Subject|15
7697858|NCT00402597|12118759|FG004|Overall Study|Withdrawal by Subject|24
7697859|NCT00402597|12118755|FG000|Overall Study|reason not specified|30
7697860|NCT00402597|12118756|FG001|Overall Study|reason not specified|4
7697861|NCT00402597|12118757|FG002|Overall Study|reason not specified|27
7697862|NCT00402597|12118758|FG003|Overall Study|reason not specified|14
7697863|NCT00402597|12118759|FG004|Overall Study|reason not specified|20
7697864|NCT00402649|12118771|FG000|Overall Study|Lost to Follow-up|1
7697865|NCT00402649|12118771|FG000|Overall Study|Withdrawal by Subject|1
7697866|NCT00402688|12118778|FG000|Overall Study|Adverse Event|12
7697867|NCT00402688|12118779|FG001|Overall Study|Adverse Event|9
7697868|NCT00402688|12118780|FG002|Overall Study|Adverse Event|3
7697869|NCT00402688|12118778|FG000|Overall Study|Withdrawal by Subject|3
7697870|NCT00402688|12118779|FG001|Overall Study|Withdrawal by Subject|1
7697871|NCT00402688|12118780|FG002|Overall Study|Withdrawal by Subject|1
7697872|NCT00402688|12118778|FG000|Overall Study|Physician Decision|0
7697873|NCT00402688|12118779|FG001|Overall Study|Physician Decision|0
7697874|NCT00402688|12118780|FG002|Overall Study|Physician Decision|1
7697875|NCT00402688|12118778|FG000|Overall Study|Lack of Efficacy|4
7697876|NCT00402688|12118779|FG001|Overall Study|Lack of Efficacy|4
7697877|NCT00402688|12118780|FG002|Overall Study|Lack of Efficacy|5
7697878|NCT00402688|12118778|FG000|Overall Study|Protocol Violation|1
7697879|NCT00402688|12118779|FG001|Overall Study|Protocol Violation|1
7697880|NCT00402688|12118780|FG002|Overall Study|Protocol Violation|1
7697881|NCT00402688|12118778|FG000|Overall Study|Lost to Follow-up|1
7697882|NCT00402688|12118779|FG001|Overall Study|Lost to Follow-up|0
7697883|NCT00402688|12118780|FG002|Overall Study|Lost to Follow-up|2
7697884|NCT00402688|12118778|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0
7697885|NCT00402688|12118779|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1
7697886|NCT00402688|12118780|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0
7697887|NCT00402688|12118778|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
7697888|NCT00402688|12118779|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
7697889|NCT00402688|12118780|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
7697890|NCT00402688|12118778|FG000|Overall Study|Patient Left Town and Forgot Medication|0
7697891|NCT00402688|12118779|FG001|Overall Study|Patient Left Town and Forgot Medication|0
7697892|NCT00402688|12118780|FG002|Overall Study|Patient Left Town and Forgot Medication|1
7697893|NCT00402727|12118801|FG000|Overall Study|Adverse Event|10
7697894|NCT00402727|12118802|FG001|Overall Study|Adverse Event|6
7697895|NCT00402727|12118801|FG000|Overall Study|Death|1
7697896|NCT00402727|12118802|FG001|Overall Study|Death|0
7697897|NCT00402727|12118801|FG000|Overall Study|Lack of Efficacy|1
7697898|NCT00402727|12118802|FG001|Overall Study|Lack of Efficacy|3
7697899|NCT00402727|12118801|FG000|Overall Study|Lost to Follow-up|24
7697900|NCT00402727|12118802|FG001|Overall Study|Lost to Follow-up|11
7697901|NCT00402727|12118801|FG000|Overall Study|Physician Decision|1
7697902|NCT00402727|12118802|FG001|Overall Study|Physician Decision|1
7697903|NCT00402727|12118801|FG000|Overall Study|Protocol Violation|0
7697904|NCT00402727|12118802|FG001|Overall Study|Protocol Violation|4
7697905|NCT00402727|12118801|FG000|Overall Study|Withdrawal by Subject|3
7697906|NCT00402727|12118802|FG001|Overall Study|Withdrawal by Subject|7
7697907|NCT00402727|12118801|FG000|Overall Study|supply problems|2
7697908|NCT00402727|12118802|FG001|Overall Study|supply problems|1
7697909|NCT00402727|12118801|FG000|Overall Study|non-compliance|0
7697910|NCT00402727|12118802|FG001|Overall Study|non-compliance|1
7697911|NCT00402740|12118808|FG000|Overall Study|Withdrawal by Subject|18
7697912|NCT00402740|12118808|FG000|Overall Study|Death|50
7697913|NCT00402740|12118808|FG000|Overall Study|Lost to Follow-up|6
7697914|NCT00402740|12118808|FG000|Overall Study|No stent. Completed FU at 30 days.|5
7697915|NCT00402740|12118808|FG000|Overall Study|Subject disposition unknown.|1
7697916|NCT00402779|12118818|FG000|Overall Study|Screen Failure|77
7697917|NCT00402779|12118819|FG001|Overall Study|Screen Failure|76
7697918|NCT00402831|12118827|FG000|Overall Study|Lost to Follow-up|1
7697919|NCT00402831|12118828|FG001|Overall Study|Lost to Follow-up|2
7697920|NCT00402831|12118827|FG000|Overall Study|Non-compliance with protocol|0
7697921|NCT00402831|12118828|FG001|Overall Study|Non-compliance with protocol|1
7697922|NCT00402987|12118844|FG000|Overall Study|Lack of Efficacy|0
7697923|NCT00402987|12118845|FG001|Overall Study|Lack of Efficacy|0
7697924|NCT00402987|12118846|FG002|Overall Study|Lack of Efficacy|1
7697925|NCT00402987|12118847|FG003|Overall Study|Lack of Efficacy|0
7697926|NCT00403130|12118902|FG000|2 Years From Start of Treatment|Not Eligible|3
7697927|NCT00403130|12118902|FG000|2 Years From Start of Treatment|Lost to Follow up|1
7697928|NCT00403130|12118902|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1
7697929|NCT00403130|12118902|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10
7697930|NCT00403234|12118910|FG000|Overall Study|Withdrawal by Subject|0
7697931|NCT00403234|12118911|FG001|Overall Study|Withdrawal by Subject|1
7697932|NCT00403234|12118912|FG002|Overall Study|Withdrawal by Subject|0
7697933|NCT00403234|12118913|FG003|Overall Study|Withdrawal by Subject|0
7697934|NCT00403234|12118910|FG000|Overall Study|Adverse Event|1
7697935|NCT00403234|12118911|FG001|Overall Study|Adverse Event|0
7697936|NCT00403234|12118912|FG002|Overall Study|Adverse Event|1
7697937|NCT00403234|12118913|FG003|Overall Study|Adverse Event|0
7697938|NCT00403260|12118925|FG000|Overall Study|Adverse Event|5
7697939|NCT00403260|12118926|FG001|Overall Study|Adverse Event|4
7697940|NCT00403260|12118925|FG000|Overall Study|Withdrawal by Subject|5
7697941|NCT00403260|12118926|FG001|Overall Study|Withdrawal by Subject|6
7697942|NCT00403260|12118925|FG000|Overall Study|Lost to Follow-up|49
7697943|NCT00403260|12118926|FG001|Overall Study|Lost to Follow-up|25
7697944|NCT00403260|12118925|FG000|Overall Study|Re-appearance of P. falciparum|34
7697945|NCT00403260|12118926|FG001|Overall Study|Re-appearance of P. falciparum|25
7697946|NCT00403260|12118925|FG000|Overall Study|P. vivax infection|26
7697947|NCT00403260|12118926|FG001|Overall Study|P. vivax infection|4
7697948|NCT00403260|12118925|FG000|Overall Study|Mixed infection with P. vivax|2
7697949|NCT00403260|12118926|FG001|Overall Study|Mixed infection with P. vivax|0
7697950|NCT00403260|12118925|FG000|Overall Study|Mixed infection with P. falciparum|1
7697951|NCT00403260|12118926|FG001|Overall Study|Mixed infection with P. falciparum|0
7697952|NCT00403260|12118925|FG000|Overall Study|P. vivax infection at screening|1
7697953|NCT00403260|12118926|FG001|Overall Study|P. vivax infection at screening|0
7697954|NCT00403260|12118925|FG000|Overall Study|P. ovale infection|1
7697955|NCT00403260|12118926|FG001|Overall Study|P. ovale infection|0
7697956|NCT00403260|12118925|FG000|Overall Study|Gametocyte re-appearance|1
7697957|NCT00403260|12118926|FG001|Overall Study|Gametocyte re-appearance|1
7697958|NCT00403260|12118925|FG000|Overall Study|Withdrawn from study accidentally|0
7697959|NCT00403260|12118926|FG001|Overall Study|Withdrawn from study accidentally|1
7697960|NCT00403273|12118934|FG000|Overall Study|Lost to Follow-up|3
7697961|NCT00403273|12118935|FG001|Overall Study|Lost to Follow-up|2
7697962|NCT00403273|12118934|FG000|Overall Study|Physician Decision|0
7697963|NCT00403273|12118935|FG001|Overall Study|Physician Decision|1
7697964|NCT00403273|12118934|FG000|Overall Study|pt. wanted to have a surgical procedure|0
7697965|NCT00403273|12118935|FG001|Overall Study|pt. wanted to have a surgical procedure|1
7697966|NCT00403390|12118945|FG000|Overall Study|Withdrawal by Subject|1
7697967|NCT00403390|12118946|FG001|Overall Study|Withdrawal by Subject|0
7697968|NCT00403390|12118945|FG000|Overall Study|samples lost|1
7697969|NCT00403390|12118946|FG001|Overall Study|samples lost|0
7697970|NCT00403390|12118945|FG000|Overall Study|non-compliant|1
7697971|NCT00403390|12118946|FG001|Overall Study|non-compliant|0
7697972|NCT00403455|12118961|FG000|Overall Study|Withdrawal by Subject|1
7697973|NCT00403481|12118965|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
7697974|NCT00403481|12118965|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
7697975|NCT00403481|12118965|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
7697976|NCT00403481|12118965|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
7697977|NCT00403481|12118965|FG000|Olm 40 mg|Adverse Event|2
7697978|NCT00403481|12118965|FG000|Olm 40 mg|Protocol Violation|1
7697979|NCT00403481|12118965|FG000|Olm 40 mg|Withdrawal by Subject|1
7697980|NCT00403481|12118965|FG000|Olm 40 mg|Other|1
7697981|NCT00403481|12118965|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
7697982|NCT00403481|12118965|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
7697983|NCT00403481|12118965|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
7697984|NCT00403481|12118965|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
7697985|NCT00403481|12118965|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
7697986|NCT00403481|12118965|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
7697987|NCT00403494|12118974|FG000|Overall Study|Adverse Event|10
7697988|NCT00403494|12118975|FG001|Overall Study|Adverse Event|8
7697989|NCT00403494|12118974|FG000|Overall Study|Withdrew Consent|3
7697990|NCT00403494|12118975|FG001|Overall Study|Withdrew Consent|2
7697991|NCT00403494|12118974|FG000|Overall Study|Inappropriately enrolled|0
7697992|NCT00403494|12118975|FG001|Overall Study|Inappropriately enrolled|1
7697993|NCT00403494|12118974|FG000|Overall Study|Lost to Follow-up|0
7697994|NCT00403494|12118975|FG001|Overall Study|Lost to Follow-up|2
7697995|NCT00403494|12118974|FG000|Overall Study|Protocol noncompliance|0
7697996|NCT00403494|12118975|FG001|Overall Study|Protocol noncompliance|1
7697997|NCT00403494|12118974|FG000|Overall Study|Death|1
7697998|NCT00403494|12118975|FG001|Overall Study|Death|0
7697999|NCT00403494|12118974|FG000|Overall Study|Sponsor Request|1
7698000|NCT00403494|12118975|FG001|Overall Study|Sponsor Request|0
7698001|NCT00403546|12118985|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6
7698002|NCT00403546|12118986|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0
7698003|NCT00403546|12118987|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0
7698004|NCT00403546|12118985|FG000|Signed Informed Consent/Open-Label|Early Termination|8
7698005|NCT00403546|12118986|FG001|Signed Informed Consent/Open-Label|Early Termination|0
7698006|NCT00403546|12118987|FG002|Signed Informed Consent/Open-Label|Early Termination|0
7698007|NCT00403546|12118985|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9
7698008|NCT00403546|12118986|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0
7698009|NCT00403546|12118987|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0
7698010|NCT00403546|12118985|FG000|Signed Informed Consent/Open-Label|Adverse Event|5
7698011|NCT00403546|12118986|FG001|Signed Informed Consent/Open-Label|Adverse Event|0
7698012|NCT00403546|12118987|FG002|Signed Informed Consent/Open-Label|Adverse Event|0
7698013|NCT00403546|12118985|FG000|Screening Phase|Screening Failure|22
7698014|NCT00403546|12118986|FG001|Screening Phase|Screening Failure|0
7698015|NCT00403546|12118987|FG002|Screening Phase|Screening Failure|0
7698016|NCT00403546|12118985|FG000|Screening Phase|Adverse Event|1
7698017|NCT00403546|12118986|FG001|Screening Phase|Adverse Event|0
7698018|NCT00403546|12118987|FG002|Screening Phase|Adverse Event|0
7698019|NCT00403546|12118985|FG000|Screening Phase|Terminated Prior to Randomization|5
7698020|NCT00403546|12118986|FG001|Screening Phase|Terminated Prior to Randomization|0
7698021|NCT00403546|12118987|FG002|Screening Phase|Terminated Prior to Randomization|0
7698022|NCT00403546|12118985|FG000|Randomized Trial|Early Terminations|0
7698023|NCT00403546|12118986|FG001|Randomized Trial|Early Terminations|17
7698024|NCT00403546|12118987|FG002|Randomized Trial|Early Terminations|16
7698025|NCT00403585|12118996|FG000|Initial Treatment Phase|Lost to Follow-up|2
7698026|NCT00403585|12118996|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2
7698027|NCT00403585|12118996|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
7698028|NCT00403754|12119000|FG000|Core Treatment Period 1|Withdrawal by Subject|0
7698029|NCT00403754|12119001|FG001|Core Treatment Period 1|Withdrawal by Subject|1
7698030|NCT00403754|12119002|FG002|Core Treatment Period 1|Withdrawal by Subject|0
7698031|NCT00403754|12119003|FG003|Core Treatment Period 1|Withdrawal by Subject|0
7698032|NCT00403754|12119000|FG000|Core Treatment Period 2|Lack of Efficacy|0
7698033|NCT00403754|12119001|FG001|Core Treatment Period 2|Lack of Efficacy|0
7698034|NCT00403754|12119002|FG002|Core Treatment Period 2|Lack of Efficacy|1
7698035|NCT00403754|12119003|FG003|Core Treatment Period 2|Lack of Efficacy|0
7698036|NCT00403767|12119017|FG000|Overall Study|Adverse Event|993
7698037|NCT00403767|12119018|FG001|Overall Study|Adverse Event|919
7698038|NCT00403767|12119017|FG000|Overall Study|Non-compliant with study medication|134
7698039|NCT00403767|12119018|FG001|Overall Study|Non-compliant with study medication|164
7698040|NCT00403767|12119017|FG000|Overall Study|Consent withdrawn|671
7698041|NCT00403767|12119018|FG001|Overall Study|Consent withdrawn|673
7698042|NCT00403767|12119017|FG000|Overall Study|Investigator dec./not protocol-related|191
7698043|NCT00403767|12119018|FG001|Overall Study|Investigator dec./not protocol-related|178
7698044|NCT00403767|12119017|FG000|Overall Study|Lost to Follow-up|6
7698045|NCT00403767|12119018|FG001|Overall Study|Lost to Follow-up|8
7698046|NCT00403767|12119017|FG000|Overall Study|Protocol Violation|142
7698047|NCT00403767|12119018|FG001|Overall Study|Protocol Violation|124
7698048|NCT00403767|12119017|FG000|Overall Study|Clinical efficacy endpoint reached|300
7698049|NCT00403767|12119018|FG001|Overall Study|Clinical efficacy endpoint reached|332
7698050|NCT00403767|12119017|FG000|Overall Study|Study terminated by sponsor|82
7698051|NCT00403767|12119018|FG001|Overall Study|Study terminated by sponsor|69
7698052|NCT00403767|12119017|FG000|Overall Study|Missing/incomplete data|1
7698053|NCT00403767|12119018|FG001|Overall Study|Missing/incomplete data|1
7698054|NCT00403845|12119024|FG000|Treatment Period 1|Subject withdrew consent|1
7698055|NCT00403845|12119025|FG001|Treatment Period 1|Subject withdrew consent|0
7698056|NCT00403845|12119026|FG002|Treatment Period 1|Subject withdrew consent|0
7698057|NCT00403845|12119027|FG003|Treatment Period 1|Subject withdrew consent|0
7698058|NCT00403845|12119024|FG000|Treatment Period 1|Subject no longer needs study drug|0
7698059|NCT00403845|12119025|FG001|Treatment Period 1|Subject no longer needs study drug|0
7698060|NCT00403845|12119026|FG002|Treatment Period 1|Subject no longer needs study drug|0
7698061|NCT00403845|12119027|FG003|Treatment Period 1|Subject no longer needs study drug|1
7698062|NCT00403845|12119024|FG000|Treatment Period 2|Subject withdrew consent|1
7698063|NCT00403845|12119025|FG001|Treatment Period 2|Subject withdrew consent|0
7698064|NCT00403845|12119026|FG002|Treatment Period 2|Subject withdrew consent|0
7698065|NCT00403845|12119027|FG003|Treatment Period 2|Subject withdrew consent|0
7698066|NCT00403845|12119024|FG000|Treatment Period 3|Subject withdrew consent|0
7698067|NCT00403845|12119025|FG001|Treatment Period 3|Subject withdrew consent|0
7698068|NCT00403845|12119026|FG002|Treatment Period 3|Subject withdrew consent|0
7698069|NCT00403845|12119027|FG003|Treatment Period 3|Subject withdrew consent|1
7698070|NCT00403845|12119024|FG000|Treatment Period 3|Adverse Event|0
7698071|NCT00403845|12119025|FG001|Treatment Period 3|Adverse Event|0
7698072|NCT00403845|12119026|FG002|Treatment Period 3|Adverse Event|0
7698073|NCT00403845|12119027|FG003|Treatment Period 3|Adverse Event|1
7698074|NCT00404066|12119037|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1
7698075|NCT00404066|12119037|FG000|Overall Study|Withdrawal by Subject - Adverse event|2
7698076|NCT00404079|12119043|FG000|Overall Study|Lost to follow up, adverse event etc|22
7698077|NCT00404079|12119044|FG001|Overall Study|Lost to follow up, adverse event etc|20
7698078|NCT00404092|12119054|FG000|Overall Study|Death|1
7698079|NCT00404092|12119055|FG001|Overall Study|Death|0
7698080|NCT00404092|12119056|FG002|Overall Study|Death|0
7698081|NCT00404092|12119057|FG003|Overall Study|Death|0
7698082|NCT00404092|12119054|FG000|Overall Study|Adverse Event|0
7698083|NCT00404092|12119055|FG001|Overall Study|Adverse Event|0
7698084|NCT00404092|12119056|FG002|Overall Study|Adverse Event|1
7698085|NCT00404092|12119057|FG003|Overall Study|Adverse Event|0
7698086|NCT00404235|12119069|FG000|Overall Study|Withdrawal by Subject|1
7698087|NCT00404235|12119070|FG001|Overall Study|Withdrawal by Subject|2
7698088|NCT00404248|12119079|FG000|Overall Study|pts declining status|0
7698089|NCT00404248|12119080|FG001|Overall Study|pts declining status|1
7698090|NCT00404248|12119081|FG002|Overall Study|pts declining status|0
7698091|NCT00404248|12119082|FG003|Overall Study|pts declining status|0
7698092|NCT00404248|12119083|FG004|Overall Study|pts declining status|0
7698093|NCT00404248|12119084|FG005|Overall Study|pts declining status|0
7698094|NCT00404248|12119085|FG006|Overall Study|pts declining status|0
7698095|NCT00404248|12119086|FG007|Overall Study|pts declining status|0
7698096|NCT00404248|12119087|FG008|Overall Study|pts declining status|0
7698097|NCT00404352|12119116|FG000|Double Blind (up to 24 Month)|Adverse Event|5
7698098|NCT00404352|12119117|FG001|Double Blind (up to 24 Month)|Adverse Event|4
7698099|NCT00404352|12119118|FG002|Double Blind (up to 24 Month)|Adverse Event|6
7698100|NCT00404352|12119119|FG003|Double Blind (up to 24 Month)|Adverse Event|0
7698101|NCT00404352|12119120|FG004|Double Blind (up to 24 Month)|Adverse Event|0
7698102|NCT00404352|12119121|FG005|Double Blind (up to 24 Month)|Adverse Event|0
7698103|NCT00404352|12119122|FG006|Double Blind (up to 24 Month)|Adverse Event|0
7698104|NCT00404352|12119123|FG007|Double Blind (up to 24 Month)|Adverse Event|0
7698105|NCT00404352|12119124|FG008|Double Blind (up to 24 Month)|Adverse Event|0
7698106|NCT00404352|12119116|FG000|Double Blind (up to 24 Month)|Pregnancy|0
7698107|NCT00404352|12119117|FG001|Double Blind (up to 24 Month)|Pregnancy|0
7698108|NCT00404352|12119118|FG002|Double Blind (up to 24 Month)|Pregnancy|2
7698109|NCT00404352|12119119|FG003|Double Blind (up to 24 Month)|Pregnancy|0
7698110|NCT00404352|12119120|FG004|Double Blind (up to 24 Month)|Pregnancy|0
7698111|NCT00404352|12119121|FG005|Double Blind (up to 24 Month)|Pregnancy|0
7698112|NCT00404352|12119122|FG006|Double Blind (up to 24 Month)|Pregnancy|0
7698113|NCT00404352|12119123|FG007|Double Blind (up to 24 Month)|Pregnancy|0
7698114|NCT00404352|12119124|FG008|Double Blind (up to 24 Month)|Pregnancy|0
7698115|NCT00404352|12119116|FG000|Double Blind (up to 24 Month)|Death|0
7698116|NCT00404352|12119117|FG001|Double Blind (up to 24 Month)|Death|0
7698117|NCT00404352|12119118|FG002|Double Blind (up to 24 Month)|Death|1
7698118|NCT00404352|12119119|FG003|Double Blind (up to 24 Month)|Death|0
7698119|NCT00404352|12119120|FG004|Double Blind (up to 24 Month)|Death|0
7698120|NCT00404352|12119121|FG005|Double Blind (up to 24 Month)|Death|0
7698121|NCT00404352|12119122|FG006|Double Blind (up to 24 Month)|Death|0
7698122|NCT00404352|12119123|FG007|Double Blind (up to 24 Month)|Death|0
7698123|NCT00404352|12119124|FG008|Double Blind (up to 24 Month)|Death|0
7698124|NCT00404352|12119116|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1
7698125|NCT00404352|12119117|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2
7698126|NCT00404352|12119118|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1
7698127|NCT00404352|12119119|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0
7698128|NCT00404352|12119120|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0
7698129|NCT00404352|12119121|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0
7698130|NCT00404352|12119122|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0
7698131|NCT00404352|12119123|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0
7698132|NCT00404352|12119124|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0
7698133|NCT00404352|12119116|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11
7698134|NCT00404352|12119117|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8
7698135|NCT00404352|12119118|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7
7698136|NCT00404352|12119119|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7698137|NCT00404352|12119120|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7698138|NCT00404352|12119121|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7698139|NCT00404352|12119122|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7698140|NCT00404352|12119123|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7698141|NCT00404352|12119124|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7698142|NCT00404352|12119116|FG000|Double Blind (up to 24 Month)|Disease progression|3
7698143|NCT00404352|12119117|FG001|Double Blind (up to 24 Month)|Disease progression|0
7698144|NCT00404352|12119118|FG002|Double Blind (up to 24 Month)|Disease progression|2
7698145|NCT00404352|12119119|FG003|Double Blind (up to 24 Month)|Disease progression|0
7698146|NCT00404352|12119120|FG004|Double Blind (up to 24 Month)|Disease progression|0
7698147|NCT00404352|12119121|FG005|Double Blind (up to 24 Month)|Disease progression|0
7698148|NCT00404352|12119122|FG006|Double Blind (up to 24 Month)|Disease progression|0
7698149|NCT00404352|12119123|FG007|Double Blind (up to 24 Month)|Disease progression|0
7698150|NCT00404352|12119124|FG008|Double Blind (up to 24 Month)|Disease progression|0
7698151|NCT00404352|12119116|FG000|Double Blind (up to 24 Month)|Poor compliance|1
7698152|NCT00404352|12119117|FG001|Double Blind (up to 24 Month)|Poor compliance|0
7698153|NCT00404352|12119118|FG002|Double Blind (up to 24 Month)|Poor compliance|0
7698154|NCT00404352|12119119|FG003|Double Blind (up to 24 Month)|Poor compliance|0
7698155|NCT00404352|12119120|FG004|Double Blind (up to 24 Month)|Poor compliance|0
7698156|NCT00404352|12119121|FG005|Double Blind (up to 24 Month)|Poor compliance|0
7698157|NCT00404352|12119122|FG006|Double Blind (up to 24 Month)|Poor compliance|0
7698158|NCT00404352|12119123|FG007|Double Blind (up to 24 Month)|Poor compliance|0
7698159|NCT00404352|12119124|FG008|Double Blind (up to 24 Month)|Poor compliance|0
7698160|NCT00404352|12119116|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31
7698161|NCT00404352|12119117|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30
7698162|NCT00404352|12119118|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59
7698163|NCT00404352|12119119|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0
7698164|NCT00404352|12119120|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0
7698165|NCT00404352|12119121|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0
7698166|NCT00404352|12119122|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0
7698167|NCT00404352|12119123|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0
7698168|NCT00404352|12119124|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0
7698169|NCT00404352|12119116|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0
7698170|NCT00404352|12119117|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2
7698171|NCT00404352|12119118|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0
7698172|NCT00404352|12119119|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0
7698173|NCT00404352|12119120|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0
7698174|NCT00404352|12119121|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0
7698175|NCT00404352|12119122|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0
7698176|NCT00404352|12119123|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0
7698177|NCT00404352|12119124|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0
7698178|NCT00404352|12119116|FG000|Double Blind (up to 24 Month)|Physician Decision|0
7698179|NCT00404352|12119117|FG001|Double Blind (up to 24 Month)|Physician Decision|0
7698180|NCT00404352|12119118|FG002|Double Blind (up to 24 Month)|Physician Decision|1
7698181|NCT00404352|12119119|FG003|Double Blind (up to 24 Month)|Physician Decision|0
7698182|NCT00404352|12119120|FG004|Double Blind (up to 24 Month)|Physician Decision|0
7698183|NCT00404352|12119121|FG005|Double Blind (up to 24 Month)|Physician Decision|0
7698184|NCT00404352|12119122|FG006|Double Blind (up to 24 Month)|Physician Decision|0
7698185|NCT00404352|12119123|FG007|Double Blind (up to 24 Month)|Physician Decision|0
7698186|NCT00404352|12119124|FG008|Double Blind (up to 24 Month)|Physician Decision|0
7698187|NCT00404352|12119116|FG000|Double Blind (up to 24 Month)|Other|0
7698188|NCT00404352|12119117|FG001|Double Blind (up to 24 Month)|Other|1
7698189|NCT00404352|12119118|FG002|Double Blind (up to 24 Month)|Other|0
7698190|NCT00404352|12119119|FG003|Double Blind (up to 24 Month)|Other|0
7698191|NCT00404352|12119120|FG004|Double Blind (up to 24 Month)|Other|0
7698192|NCT00404352|12119121|FG005|Double Blind (up to 24 Month)|Other|0
7698193|NCT00404352|12119122|FG006|Double Blind (up to 24 Month)|Other|0
7698194|NCT00404352|12119123|FG007|Double Blind (up to 24 Month)|Other|0
7698195|NCT00404352|12119124|FG008|Double Blind (up to 24 Month)|Other|0
7698196|NCT00404352|12119116|FG000|Open Label (up to 24 Month)|Adverse Event|0
7698197|NCT00404352|12119117|FG001|Open Label (up to 24 Month)|Adverse Event|0
7698198|NCT00404352|12119118|FG002|Open Label (up to 24 Month)|Adverse Event|0
7698199|NCT00404352|12119119|FG003|Open Label (up to 24 Month)|Adverse Event|2
7698200|NCT00404352|12119120|FG004|Open Label (up to 24 Month)|Adverse Event|1
7698201|NCT00404352|12119121|FG005|Open Label (up to 24 Month)|Adverse Event|1
7698202|NCT00404352|12119122|FG006|Open Label (up to 24 Month)|Adverse Event|0
7698203|NCT00404352|12119123|FG007|Open Label (up to 24 Month)|Adverse Event|0
7698204|NCT00404352|12119124|FG008|Open Label (up to 24 Month)|Adverse Event|0
7698205|NCT00404352|12119116|FG000|Open Label (up to 24 Month)|Pregnancy|0
7698206|NCT00404352|12119117|FG001|Open Label (up to 24 Month)|Pregnancy|0
7698207|NCT00404352|12119118|FG002|Open Label (up to 24 Month)|Pregnancy|0
7698208|NCT00404352|12119119|FG003|Open Label (up to 24 Month)|Pregnancy|0
7698209|NCT00404352|12119120|FG004|Open Label (up to 24 Month)|Pregnancy|0
7698210|NCT00404352|12119121|FG005|Open Label (up to 24 Month)|Pregnancy|1
7698211|NCT00404352|12119122|FG006|Open Label (up to 24 Month)|Pregnancy|0
7698212|NCT00404352|12119123|FG007|Open Label (up to 24 Month)|Pregnancy|0
7698213|NCT00404352|12119124|FG008|Open Label (up to 24 Month)|Pregnancy|0
7698214|NCT00404352|12119116|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0
7698215|NCT00404352|12119117|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0
7698216|NCT00404352|12119118|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0
7698217|NCT00404352|12119119|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0
7698218|NCT00404352|12119120|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1
7698219|NCT00404352|12119121|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0
7698220|NCT00404352|12119122|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0
7698221|NCT00404352|12119123|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0
7698222|NCT00404352|12119124|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0
7698223|NCT00404352|12119116|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0
7698224|NCT00404352|12119117|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0
7698225|NCT00404352|12119118|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0
7698226|NCT00404352|12119119|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0
7698227|NCT00404352|12119120|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0
7698228|NCT00404352|12119121|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5
7698229|NCT00404352|12119122|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0
7698230|NCT00404352|12119123|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0
7698231|NCT00404352|12119124|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0
7698232|NCT00404352|12119116|FG000|Open Label (up to 24 Month)|Disease progression|0
7698233|NCT00404352|12119117|FG001|Open Label (up to 24 Month)|Disease progression|0
7698234|NCT00404352|12119118|FG002|Open Label (up to 24 Month)|Disease progression|0
7698235|NCT00404352|12119119|FG003|Open Label (up to 24 Month)|Disease progression|1
7698236|NCT00404352|12119120|FG004|Open Label (up to 24 Month)|Disease progression|0
7698237|NCT00404352|12119121|FG005|Open Label (up to 24 Month)|Disease progression|0
7698238|NCT00404352|12119122|FG006|Open Label (up to 24 Month)|Disease progression|0
7698239|NCT00404352|12119123|FG007|Open Label (up to 24 Month)|Disease progression|0
7698240|NCT00404352|12119124|FG008|Open Label (up to 24 Month)|Disease progression|0
7698241|NCT00404352|12119116|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0
7698242|NCT00404352|12119117|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0
7698243|NCT00404352|12119118|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0
7698244|NCT00404352|12119119|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0
7698245|NCT00404352|12119120|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0
7698246|NCT00404352|12119121|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0
7698247|NCT00404352|12119122|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1
7698248|NCT00404352|12119123|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1
7698249|NCT00404352|12119124|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0
7698250|NCT00404352|12119116|FG000|Open Label Extension (up to 36 Months)|Other|0
7698251|NCT00404352|12119117|FG001|Open Label Extension (up to 36 Months)|Other|0
7698252|NCT00404352|12119118|FG002|Open Label Extension (up to 36 Months)|Other|0
7698253|NCT00404352|12119119|FG003|Open Label Extension (up to 36 Months)|Other|0
7698254|NCT00404352|12119120|FG004|Open Label Extension (up to 36 Months)|Other|0
7698255|NCT00404352|12119121|FG005|Open Label Extension (up to 36 Months)|Other|0
7698256|NCT00404352|12119122|FG006|Open Label Extension (up to 36 Months)|Other|0
7698257|NCT00404352|12119123|FG007|Open Label Extension (up to 36 Months)|Other|0
7698258|NCT00404352|12119124|FG008|Open Label Extension (up to 36 Months)|Other|2
7698259|NCT00404495|12119143|FG000|Overall Study|Death|37
7698260|NCT00404495|12119144|FG001|Overall Study|Death|11
7698261|NCT00404495|12119143|FG000|Overall Study|Lost to Follow-up|5
7698262|NCT00404495|12119144|FG001|Overall Study|Lost to Follow-up|0
7698263|NCT00404495|12119143|FG000|Overall Study|Other|1
7698264|NCT00404495|12119144|FG001|Overall Study|Other|0
7698265|NCT00404495|12119143|FG000|Overall Study|Withdrawal by Subject|1
7698266|NCT00404495|12119144|FG001|Overall Study|Withdrawal by Subject|0
7698267|NCT00404547|12119152|FG000|Overall Study|Adverse Event|39
7698268|NCT00404547|12119153|FG001|Overall Study|Adverse Event|6
7698269|NCT00404547|12119152|FG000|Overall Study|Withdrawal by Subject|19
7698270|NCT00404547|12119153|FG001|Overall Study|Withdrawal by Subject|2
7698271|NCT00404547|12119152|FG000|Overall Study|Protocol Violation|0
7698272|NCT00404547|12119153|FG001|Overall Study|Protocol Violation|1
7698273|NCT00404547|12119152|FG000|Overall Study|Lost to Follow-up|20
7698274|NCT00404547|12119153|FG001|Overall Study|Lost to Follow-up|9
7698275|NCT00404547|12119152|FG000|Overall Study|Lack of compliance|5
7698276|NCT00404547|12119153|FG001|Overall Study|Lack of compliance|1
7698277|NCT00404547|12119152|FG000|Overall Study|Other|4
7698278|NCT00404547|12119153|FG001|Overall Study|Other|0
7698279|NCT00404547|12119152|FG000|Overall Study|Reason not stated|3
7698280|NCT00404547|12119153|FG001|Overall Study|Reason not stated|6
7698281|NCT00404651|12119163|FG000|Overall Study|Serious Adverse Event|0
7698282|NCT00404651|12119164|FG001|Overall Study|Serious Adverse Event|0
7698283|NCT00404651|12119165|FG002|Overall Study|Serious Adverse Event|2
7698284|NCT00404651|12119166|FG003|Overall Study|Serious Adverse Event|0
7698285|NCT00404651|12119163|FG000|Overall Study|Protocol Violation|10
7698286|NCT00404651|12119164|FG001|Overall Study|Protocol Violation|5
7698287|NCT00404651|12119165|FG002|Overall Study|Protocol Violation|14
7698288|NCT00404651|12119166|FG003|Overall Study|Protocol Violation|5
7698289|NCT00404651|12119163|FG000|Overall Study|Lost to Follow-up|15
7698290|NCT00404651|12119164|FG001|Overall Study|Lost to Follow-up|11
7698291|NCT00404651|12119165|FG002|Overall Study|Lost to Follow-up|13
7698292|NCT00404651|12119166|FG003|Overall Study|Lost to Follow-up|10
7698293|NCT00404651|12119163|FG000|Overall Study|Withdrawal by Subject|14
7698294|NCT00404651|12119164|FG001|Overall Study|Withdrawal by Subject|12
7698295|NCT00404651|12119165|FG002|Overall Study|Withdrawal by Subject|16
7698296|NCT00404651|12119166|FG003|Overall Study|Withdrawal by Subject|6
7698297|NCT00404755|12119176|FG000|Phase I (Bupropion)|Adverse Event|3
7698298|NCT00404755|12119176|FG000|Phase I (Bupropion)|Other|1
7698299|NCT00404755|12119176|FG000|Phase II (Escitalopram)|Lost to Follow-up|2
7698300|NCT00404768|12119188|FG000|Part A and B|Withdrawn due to labor progression|1
7698301|NCT00404768|12119189|FG001|Part A and B|Withdrawn due to labor progression|0
7698302|NCT00404768|12119190|FG002|Part A and B|Withdrawn due to labor progression|0
7698303|NCT00404768|12119191|FG003|Part A and B|Withdrawn due to labor progression|0
7698304|NCT00404768|12119188|FG000|Part A and B|Withdrawn as delivery imminemnt|0
7698305|NCT00404768|12119189|FG001|Part A and B|Withdrawn as delivery imminemnt|1
7698306|NCT00404768|12119190|FG002|Part A and B|Withdrawn as delivery imminemnt|0
7698307|NCT00404768|12119191|FG003|Part A and B|Withdrawn as delivery imminemnt|0
7698308|NCT00404768|12119188|FG000|Part C|Adverse Event|0
7698309|NCT00404768|12119189|FG001|Part C|Adverse Event|0
7698310|NCT00404768|12119190|FG002|Part C|Adverse Event|0
7698311|NCT00404768|12119191|FG003|Part C|Adverse Event|3
7698312|NCT00404768|12119188|FG000|Part C|Lost to Follow-up|0
7698313|NCT00404768|12119189|FG001|Part C|Lost to Follow-up|0
7698314|NCT00404768|12119190|FG002|Part C|Lost to Follow-up|3
7698315|NCT00404768|12119191|FG003|Part C|Lost to Follow-up|1
7698316|NCT00404768|12119188|FG000|Part C|Withdrawal by Subject|0
7698317|NCT00404768|12119189|FG001|Part C|Withdrawal by Subject|0
7698318|NCT00404768|12119190|FG002|Part C|Withdrawal by Subject|2
7698319|NCT00404768|12119191|FG003|Part C|Withdrawal by Subject|1
7698320|NCT00404768|12119188|FG000|Part C|Early withdrawal from study medication|0
7698321|NCT00404768|12119189|FG001|Part C|Early withdrawal from study medication|0
7698322|NCT00404768|12119190|FG002|Part C|Early withdrawal from study medication|1
7698323|NCT00404768|12119191|FG003|Part C|Early withdrawal from study medication|0
7698324|NCT00404768|12119188|FG000|Part C|Participant did not respond to therapy|0
7698325|NCT00404768|12119189|FG001|Part C|Participant did not respond to therapy|0
7698326|NCT00404768|12119190|FG002|Part C|Participant did not respond to therapy|1
7698327|NCT00404768|12119191|FG003|Part C|Participant did not respond to therapy|1
7698328|NCT00404768|12119188|FG000|Part C|Physician withdrew the study medication|0
7698329|NCT00404768|12119189|FG001|Part C|Physician withdrew the study medication|0
7698330|NCT00404768|12119190|FG002|Part C|Physician withdrew the study medication|1
7698331|NCT00404768|12119191|FG003|Part C|Physician withdrew the study medication|0
7698332|NCT00404768|12119188|FG000|Part C|Participant delivered baby|0
7698333|NCT00404768|12119189|FG001|Part C|Participant delivered baby|0
7698334|NCT00404768|12119190|FG002|Part C|Participant delivered baby|0
7698335|NCT00404768|12119191|FG003|Part C|Participant delivered baby|1
7698336|NCT00404768|12119188|FG000|Part C|Unsatisfactory uterine response to IP|0
7698337|NCT00404768|12119189|FG001|Part C|Unsatisfactory uterine response to IP|0
7698338|NCT00404768|12119190|FG002|Part C|Unsatisfactory uterine response to IP|0
7698339|NCT00404768|12119191|FG003|Part C|Unsatisfactory uterine response to IP|1
7698340|NCT00404768|12119188|FG000|Part C|Active labor|0
7698341|NCT00404768|12119189|FG001|Part C|Active labor|0
7698342|NCT00404768|12119190|FG002|Part C|Active labor|0
7698343|NCT00404768|12119191|FG003|Part C|Active labor|1
7698344|NCT00404768|12119188|FG000|Part C|Lack of Efficacy|0
7698345|NCT00404768|12119189|FG001|Part C|Lack of Efficacy|0
7698346|NCT00404768|12119190|FG002|Part C|Lack of Efficacy|0
7698347|NCT00404768|12119191|FG003|Part C|Lack of Efficacy|2
7698348|NCT00404768|12119188|FG000|Part C|Treatment failure|0
7698349|NCT00404768|12119189|FG001|Part C|Treatment failure|0
7698350|NCT00404768|12119190|FG002|Part C|Treatment failure|0
7698351|NCT00404768|12119191|FG003|Part C|Treatment failure|1
7698352|NCT00404768|12119188|FG000|Part C|Investigator discretion|0
7698353|NCT00404768|12119189|FG001|Part C|Investigator discretion|0
7698354|NCT00404768|12119190|FG002|Part C|Investigator discretion|0
7698355|NCT00404768|12119191|FG003|Part C|Investigator discretion|1
7698356|NCT00404768|12119188|FG000|Part C|Researcher suspended study medication|0
7698357|NCT00404768|12119189|FG001|Part C|Researcher suspended study medication|0
7698358|NCT00404768|12119190|FG002|Part C|Researcher suspended study medication|0
7698359|NCT00404768|12119191|FG003|Part C|Researcher suspended study medication|1
7698360|NCT00404820|12119208|FG000|Overall Study|Adverse Event|4
7698361|NCT00404820|12119209|FG001|Overall Study|Adverse Event|16
7698362|NCT00404820|12119208|FG000|Overall Study|Withdrawal by Subject|5
7698363|NCT00404820|12119209|FG001|Overall Study|Withdrawal by Subject|3
7698364|NCT00404820|12119208|FG000|Overall Study|Lost to Follow-up|7
7698365|NCT00404820|12119209|FG001|Overall Study|Lost to Follow-up|3
7698366|NCT00404820|12119208|FG000|Overall Study|Administrative problems|2
7698367|NCT00404820|12119209|FG001|Overall Study|Administrative problems|0
7698368|NCT00404820|12119208|FG000|Overall Study|Death|1
7698369|NCT00404820|12119209|FG001|Overall Study|Death|0
7698370|NCT00404820|12119208|FG000|Overall Study|Other|0
7698371|NCT00404820|12119209|FG001|Overall Study|Other|2
7698372|NCT00404924|12119217|FG000|Overall Study|Adverse Event|75
7698373|NCT00404924|12119218|FG001|Overall Study|Adverse Event|16
7698374|NCT00404924|12119217|FG000|Overall Study|Condition under investigation worsened|475
7698375|NCT00404924|12119218|FG001|Overall Study|Condition under investigation worsened|264
7698376|NCT00404924|12119217|FG000|Overall Study|Lost to Follow-up|1
7698377|NCT00404924|12119218|FG001|Overall Study|Lost to Follow-up|1
7698378|NCT00404924|12119217|FG000|Overall Study|Withdrawal by Subject|26
7698379|NCT00404924|12119218|FG001|Overall Study|Withdrawal by Subject|13
7698380|NCT00404924|12119217|FG000|Overall Study|Other|25
7698381|NCT00404924|12119218|FG001|Overall Study|Other|11
7698382|NCT00404924|12119217|FG000|Overall Study|Randomised but not received treatment|1
7698383|NCT00404924|12119218|FG001|Overall Study|Randomised but not received treatment|1
7698384|NCT00405067|12119227|FG000|Overall Study|Adverse Event|4
7698385|NCT00405067|12119228|FG001|Overall Study|Adverse Event|9
7698386|NCT00405067|12119229|FG002|Overall Study|Adverse Event|4
7698387|NCT00405067|12119227|FG000|Overall Study|Lost to Follow-up|0
7698388|NCT00405067|12119228|FG001|Overall Study|Lost to Follow-up|0
7698389|NCT00405067|12119229|FG002|Overall Study|Lost to Follow-up|1
7698390|NCT00405275|12119239|FG000|Overall Study|Death|1
7698391|NCT00405275|12119240|FG001|Overall Study|Death|0
7698392|NCT00405275|12119239|FG000|Overall Study|Lost to Follow-up|5
7698393|NCT00405275|12119240|FG001|Overall Study|Lost to Follow-up|1
7698394|NCT00405275|12119239|FG000|Overall Study|Withdrawal by Subject|7
7698395|NCT00405275|12119240|FG001|Overall Study|Withdrawal by Subject|9
7698396|NCT00405275|12119239|FG000|Overall Study|Unwilling to continue|10
7698397|NCT00405275|12119240|FG001|Overall Study|Unwilling to continue|9
7698398|NCT00405392|12119261|FG000|Overall Study|Adverse Event|15
7698399|NCT00405392|12119262|FG001|Overall Study|Adverse Event|14
7698400|NCT00405392|12119261|FG000|Overall Study|Did not meet Eligibility criteria|7
7698401|NCT00405392|12119262|FG001|Overall Study|Did not meet Eligibility criteria|2
7698402|NCT00405392|12119261|FG000|Overall Study|Withdrawal by Subject|4
7698403|NCT00405392|12119262|FG001|Overall Study|Withdrawal by Subject|3
7698404|NCT00405392|12119261|FG000|Overall Study|Lost to Follow-up|1
7698405|NCT00405392|12119262|FG001|Overall Study|Lost to Follow-up|2
7698406|NCT00405392|12119261|FG000|Overall Study|Data missing|2
7698407|NCT00405392|12119262|FG001|Overall Study|Data missing|0
7698408|NCT00405392|12119261|FG000|Overall Study|Non-compliance|0
7698409|NCT00405392|12119262|FG001|Overall Study|Non-compliance|1
7698410|NCT00405392|12119261|FG000|Overall Study|Other|1
7698411|NCT00405392|12119262|FG001|Overall Study|Other|5
7698412|NCT00405548|12119288|FG000|Overall Study|Cognitive Memory problems on study day|1
7698413|NCT00405548|12119289|FG001|Overall Study|Cognitive Memory problems on study day|0
7698414|NCT00405548|12119288|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0
7698415|NCT00405548|12119289|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1
7698416|NCT00405548|12119288|FG000|Overall Study|Unable to self-administer shots|1
7698417|NCT00405548|12119289|FG001|Overall Study|Unable to self-administer shots|0
7698418|NCT00405548|12119288|FG000|Overall Study|Venous access failed during study day|1
7698419|NCT00405548|12119289|FG001|Overall Study|Venous access failed during study day|0
7698420|NCT00405548|12119288|FG000|Overall Study|Withdrawal by Subject|1
7698421|NCT00405548|12119289|FG001|Overall Study|Withdrawal by Subject|0
7698422|NCT00405587|12119299|FG000|Overall Study|Death|0
7698423|NCT00405587|12119300|FG001|Overall Study|Death|0
7698424|NCT00405587|12119301|FG002|Overall Study|Death|0
7698425|NCT00405587|12119302|FG003|Overall Study|Death|1
7698426|NCT00405587|12119299|FG000|Overall Study|Disease Progression|22
7698427|NCT00405587|12119300|FG001|Overall Study|Disease Progression|23
7698428|NCT00405587|12119301|FG002|Overall Study|Disease Progression|21
7698429|NCT00405587|12119302|FG003|Overall Study|Disease Progression|17
7698430|NCT00405587|12119299|FG000|Overall Study|Physician Decision|3
7698431|NCT00405587|12119300|FG001|Overall Study|Physician Decision|2
7698432|NCT00405587|12119301|FG002|Overall Study|Physician Decision|0
7698433|NCT00405587|12119302|FG003|Overall Study|Physician Decision|0
7698434|NCT00405587|12119299|FG000|Overall Study|Adverse Event|1
7698435|NCT00405587|12119300|FG001|Overall Study|Adverse Event|0
7698436|NCT00405587|12119301|FG002|Overall Study|Adverse Event|0
7698437|NCT00405587|12119302|FG003|Overall Study|Adverse Event|0
7698438|NCT00405587|12119299|FG000|Overall Study|Lost to Follow-up|0
7698439|NCT00405587|12119300|FG001|Overall Study|Lost to Follow-up|1
7698440|NCT00405587|12119301|FG002|Overall Study|Lost to Follow-up|1
7698441|NCT00405587|12119302|FG003|Overall Study|Lost to Follow-up|0
7698442|NCT00405587|12119299|FG000|Overall Study|Radiation induced necrosis|0
7698443|NCT00405587|12119300|FG001|Overall Study|Radiation induced necrosis|1
7698444|NCT00405587|12119301|FG002|Overall Study|Radiation induced necrosis|0
7698445|NCT00405587|12119302|FG003|Overall Study|Radiation induced necrosis|0
7698446|NCT00405587|12119299|FG000|Overall Study|Withdrawal by Subject|0
7698447|NCT00405587|12119300|FG001|Overall Study|Withdrawal by Subject|0
7698448|NCT00405587|12119301|FG002|Overall Study|Withdrawal by Subject|0
7698449|NCT00405587|12119302|FG003|Overall Study|Withdrawal by Subject|2
7698450|NCT00405587|12119299|FG000|Overall Study|Participant not dosed|0
7698451|NCT00405587|12119300|FG001|Overall Study|Participant not dosed|1
7698452|NCT00405587|12119301|FG002|Overall Study|Participant not dosed|0
7698453|NCT00405587|12119302|FG003|Overall Study|Participant not dosed|0
7698454|NCT00405639|12119340|FG000|Overall Study|Withdrawal by Subject|1
7698455|NCT00405639|12119341|FG001|Overall Study|Withdrawal by Subject|0
7698456|NCT00405639|12119340|FG000|Overall Study|Adverse Event|1
7698457|NCT00405639|12119341|FG001|Overall Study|Adverse Event|0
7698458|NCT00405639|12119340|FG000|Overall Study|Seizure prior to receiving BNP|1
7698459|NCT00405639|12119341|FG001|Overall Study|Seizure prior to receiving BNP|0
7698460|NCT00405652|12119347|FG000|Overall Study|Adverse Event|4
7698461|NCT00405756|12119364|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45
7698462|NCT00405756|12119365|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24
7698463|NCT00405756|12119366|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18
7698464|NCT00405756|12119364|FG000|Double-blind Treatment|Adverse Event|31
7698465|NCT00405756|12119365|FG001|Double-blind Treatment|Adverse Event|27
7698466|NCT00405756|12119366|FG002|Double-blind Treatment|Adverse Event|12
7698467|NCT00405756|12119364|FG000|Double-blind Treatment|Disease Progression|47
7698468|NCT00405756|12119365|FG001|Double-blind Treatment|Disease Progression|81
7698469|NCT00405756|12119366|FG002|Double-blind Treatment|Disease Progression|102
7698470|NCT00405756|12119364|FG000|Double-blind Treatment|Lack of Efficacy|1
7698471|NCT00405756|12119365|FG001|Double-blind Treatment|Lack of Efficacy|4
7698472|NCT00405756|12119366|FG002|Double-blind Treatment|Lack of Efficacy|2
7698473|NCT00405756|12119364|FG000|Double-blind Treatment|Withdrawal by Subject|15
7698474|NCT00405756|12119365|FG001|Double-blind Treatment|Withdrawal by Subject|9
7698475|NCT00405756|12119366|FG002|Double-blind Treatment|Withdrawal by Subject|10
7698476|NCT00405756|12119364|FG000|Double-blind Treatment|Lost to Follow-up|1
7698477|NCT00405756|12119365|FG001|Double-blind Treatment|Lost to Follow-up|0
7698478|NCT00405756|12119366|FG002|Double-blind Treatment|Lost to Follow-up|0
7698479|NCT00405756|12119364|FG000|Double-blind Treatment|Death|4
7698480|NCT00405756|12119365|FG001|Double-blind Treatment|Death|4
7698481|NCT00405756|12119366|FG002|Double-blind Treatment|Death|4
7698482|NCT00405756|12119364|FG000|Double-blind Treatment|Protocol Violation|1
7698483|NCT00405756|12119365|FG001|Double-blind Treatment|Protocol Violation|0
7698484|NCT00405756|12119366|FG002|Double-blind Treatment|Protocol Violation|2
7698485|NCT00405756|12119364|FG000|Double-blind Treatment|Other|7
7698486|NCT00405756|12119365|FG001|Double-blind Treatment|Other|4
7698487|NCT00405756|12119366|FG002|Double-blind Treatment|Other|4
7698488|NCT00405756|12119364|FG000|Open-label Extension|Ongoing in Open Label Period|7
7698489|NCT00405756|12119365|FG001|Open-label Extension|Ongoing in Open Label Period|15
7698490|NCT00405756|12119366|FG002|Open-label Extension|Ongoing in Open Label Period|25
7698491|NCT00405756|12119364|FG000|Open-label Extension|Adverse Event|1
7698492|NCT00405756|12119365|FG001|Open-label Extension|Adverse Event|3
7698493|NCT00405756|12119366|FG002|Open-label Extension|Adverse Event|7
7698494|NCT00405756|12119364|FG000|Open-label Extension|Disease Progression|8
7698495|NCT00405756|12119365|FG001|Open-label Extension|Disease Progression|23
7698496|NCT00405756|12119366|FG002|Open-label Extension|Disease Progression|26
7698497|NCT00405756|12119364|FG000|Open-label Extension|Withdrawal by Subject|2
7698498|NCT00405756|12119365|FG001|Open-label Extension|Withdrawal by Subject|3
7698499|NCT00405756|12119366|FG002|Open-label Extension|Withdrawal by Subject|3
7698500|NCT00405756|12119364|FG000|Open-label Extension|Death|1
7698501|NCT00405756|12119365|FG001|Open-label Extension|Death|2
7698502|NCT00405756|12119366|FG002|Open-label Extension|Death|4
7698503|NCT00405756|12119364|FG000|Open-label Extension|Other|0
7698504|NCT00405756|12119365|FG001|Open-label Extension|Other|1
7698505|NCT00405756|12119366|FG002|Open-label Extension|Other|7
7698506|NCT00405756|12119364|FG000|Follow-up|Ongoing in Follow-up Period|52
7698507|NCT00405756|12119365|FG001|Follow-up|Ongoing in Follow-up Period|51
7698508|NCT00405756|12119366|FG002|Follow-up|Ongoing in Follow-up Period|60
7698509|NCT00405756|12119364|FG000|Follow-up|Death|21
7698510|NCT00405756|12119365|FG001|Follow-up|Death|31
7698511|NCT00405756|12119366|FG002|Follow-up|Death|24
7698512|NCT00405756|12119364|FG000|Follow-up|Lost to Follow-up|2
7698513|NCT00405756|12119365|FG001|Follow-up|Lost to Follow-up|8
7698514|NCT00405756|12119366|FG002|Follow-up|Lost to Follow-up|4
7698515|NCT00405821|12119376|FG000|Overall Study|Death|5
7698516|NCT00405821|12119377|FG001|Overall Study|Death|7
7698517|NCT00405821|12119376|FG000|Overall Study|Lost to Follow-up|7
7698518|NCT00405821|12119377|FG001|Overall Study|Lost to Follow-up|7
7698519|NCT00405821|12119376|FG000|Overall Study|Protocol Violation|1
7698520|NCT00405821|12119377|FG001|Overall Study|Protocol Violation|0
7698521|NCT00405821|12119376|FG000|Overall Study|initiated ART|9
7698522|NCT00405821|12119377|FG001|Overall Study|initiated ART|8
7698523|NCT00405912|12119386|FG000|Overall Study|Withdrawal by Subject|12
7698524|NCT00405912|12119387|FG001|Overall Study|Withdrawal by Subject|11
7698525|NCT00405912|12119388|FG002|Overall Study|Withdrawal by Subject|12
7698526|NCT00405912|12119386|FG000|Overall Study|Lost to Follow-up|4
7698527|NCT00405912|12119387|FG001|Overall Study|Lost to Follow-up|8
7698528|NCT00405912|12119388|FG002|Overall Study|Lost to Follow-up|4
7698529|NCT00406029|12119410|FG000|Overall Study|Adverse Event|12
7698530|NCT00406029|12119411|FG001|Overall Study|Adverse Event|2
7698531|NCT00406029|12119412|FG002|Overall Study|Adverse Event|5
7698532|NCT00406029|12119413|FG003|Overall Study|Adverse Event|10
7698533|NCT00406029|12119414|FG004|Overall Study|Adverse Event|7
7698534|NCT00406029|12119410|FG000|Overall Study|Withdrawal by Subject|3
7698535|NCT00406029|12119411|FG001|Overall Study|Withdrawal by Subject|4
7698536|NCT00406029|12119412|FG002|Overall Study|Withdrawal by Subject|2
7698537|NCT00406029|12119413|FG003|Overall Study|Withdrawal by Subject|2
7698538|NCT00406029|12119414|FG004|Overall Study|Withdrawal by Subject|0
7698539|NCT00406029|12119410|FG000|Overall Study|Protocol Violation|1
7698540|NCT00406029|12119411|FG001|Overall Study|Protocol Violation|2
7698541|NCT00406029|12119412|FG002|Overall Study|Protocol Violation|0
7698542|NCT00406029|12119413|FG003|Overall Study|Protocol Violation|2
7698543|NCT00406029|12119414|FG004|Overall Study|Protocol Violation|0
7698544|NCT00406029|12119410|FG000|Overall Study|Did Not Meet Eligibility Criteria|0
7698545|NCT00406029|12119411|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
7698546|NCT00406029|12119412|FG002|Overall Study|Did Not Meet Eligibility Criteria|1
7698547|NCT00406029|12119413|FG003|Overall Study|Did Not Meet Eligibility Criteria|0
7698548|NCT00406029|12119414|FG004|Overall Study|Did Not Meet Eligibility Criteria|0
7698549|NCT00406029|12119410|FG000|Overall Study|Randomized in Error|0
7698550|NCT00406029|12119411|FG001|Overall Study|Randomized in Error|0
7698551|NCT00406029|12119412|FG002|Overall Study|Randomized in Error|2
7698552|NCT00406029|12119413|FG003|Overall Study|Randomized in Error|3
7698553|NCT00406029|12119414|FG004|Overall Study|Randomized in Error|1
7698554|NCT00406315|12119463|FG000|Overall Study|Death|1
7698555|NCT00406315|12119463|FG000|Overall Study|Adverse Event|39
7698556|NCT00406315|12119463|FG000|Overall Study|Laboratory Abnormality|4
7698557|NCT00406315|12119463|FG000|Overall Study|Lack of Efficacy|13
7698558|NCT00406315|12119463|FG000|Overall Study|Other|33
7698559|NCT00406315|12119463|FG000|Overall Study|Lost to Follow-up|21
7698560|NCT00406315|12119463|FG000|Overall Study|Withdrawal by Subject|30
7698561|NCT00406354|12119470|FG000|All Randomized Patients|Protocol Violation|0
7698562|NCT00406354|12119471|FG001|All Randomized Patients|Protocol Violation|0
7698563|NCT00406354|12119472|FG002|All Randomized Patients|Protocol Violation|1
7698564|NCT00406354|12119470|FG000|All Randomized and Treated Patients|Lack of Efficacy|7
7698565|NCT00406354|12119471|FG001|All Randomized and Treated Patients|Lack of Efficacy|4
7698566|NCT00406354|12119472|FG002|All Randomized and Treated Patients|Lack of Efficacy|17
7698567|NCT00406354|12119470|FG000|All Randomized and Treated Patients|Adverse Event|6
7698568|NCT00406354|12119471|FG001|All Randomized and Treated Patients|Adverse Event|2
7698569|NCT00406354|12119472|FG002|All Randomized and Treated Patients|Adverse Event|1
7698570|NCT00406354|12119470|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2
7698571|NCT00406354|12119471|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6
7698572|NCT00406354|12119472|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1
7698573|NCT00406354|12119470|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1
7698574|NCT00406354|12119471|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1
7698575|NCT00406354|12119472|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2
7698576|NCT00406354|12119470|FG000|All Randomized and Treated Patients|Physician Decision|0
7698577|NCT00406354|12119471|FG001|All Randomized and Treated Patients|Physician Decision|0
7698578|NCT00406354|12119472|FG002|All Randomized and Treated Patients|Physician Decision|1
7698579|NCT00406367|12119482|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
7698580|NCT00406367|12119483|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
7698581|NCT00406367|12119482|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
7698582|NCT00406367|12119483|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
7698583|NCT00406367|12119482|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
7698584|NCT00406367|12119483|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
7698585|NCT00406367|12119482|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
7698586|NCT00406367|12119483|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
7698587|NCT00406367|12119482|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
7698588|NCT00406367|12119483|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
7698589|NCT00406367|12119482|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
7698590|NCT00406367|12119483|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
7698591|NCT00406367|12119482|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
7698592|NCT00406367|12119483|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
7698593|NCT00406367|12119482|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
7698594|NCT00406367|12119483|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
7698595|NCT00406367|12119482|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
7698596|NCT00406367|12119483|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
7698597|NCT00406367|12119482|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
7698598|NCT00406367|12119483|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
7698599|NCT00406367|12119482|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
7698600|NCT00406367|12119483|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
7698601|NCT00406367|12119482|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
7698602|NCT00406367|12119483|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
7698603|NCT00406393|12119491|FG000|Overall Study|Did not undergo transplantation|2
7698604|NCT00406393|12119492|FG001|Overall Study|Did not undergo transplantation|1
7698605|NCT00406419|12119501|FG000|Overall Study|Death|3
7698606|NCT00406419|12119502|FG001|Overall Study|Death|1
7698607|NCT00406419|12119503|FG002|Overall Study|Death|4
7698608|NCT00406419|12119501|FG000|Overall Study|Protocol Violation|6
7698609|NCT00406419|12119502|FG001|Overall Study|Protocol Violation|2
7698610|NCT00406419|12119503|FG002|Overall Study|Protocol Violation|5
7698611|NCT00406419|12119501|FG000|Overall Study|Study Terminated by Sponsor|260
7698612|NCT00406419|12119502|FG001|Overall Study|Study Terminated by Sponsor|288
7698613|NCT00406419|12119503|FG002|Overall Study|Study Terminated by Sponsor|282
7698614|NCT00406419|12119501|FG000|Overall Study|Withdrawal by Subject|17
7698615|NCT00406419|12119502|FG001|Overall Study|Withdrawal by Subject|24
7698616|NCT00406419|12119503|FG002|Overall Study|Withdrawal by Subject|26
7698617|NCT00406419|12119501|FG000|Overall Study|Lack of Efficacy|12
7698618|NCT00406419|12119502|FG001|Overall Study|Lack of Efficacy|1
7698619|NCT00406419|12119503|FG002|Overall Study|Lack of Efficacy|6
7698620|NCT00406419|12119501|FG000|Overall Study|Non-Compliance with Study Drug|5
7698621|NCT00406419|12119502|FG001|Overall Study|Non-Compliance with Study Drug|6
7698622|NCT00406419|12119503|FG002|Overall Study|Non-Compliance with Study Drug|3
7698623|NCT00406419|12119501|FG000|Overall Study|Adverse Event|10
7698624|NCT00406419|12119502|FG001|Overall Study|Adverse Event|12
7698625|NCT00406419|12119503|FG002|Overall Study|Adverse Event|16
7698626|NCT00406419|12119501|FG000|Overall Study|Lost to Follow-up|11
7698627|NCT00406419|12119502|FG001|Overall Study|Lost to Follow-up|10
7698628|NCT00406419|12119503|FG002|Overall Study|Lost to Follow-up|5
7698629|NCT00406640|12119513|FG000|Acute Phase|Adverse Event|18
7698630|NCT00406640|12119514|FG001|Acute Phase|Adverse Event|13
7698631|NCT00406640|12119513|FG000|Acute Phase|Failed to Return|5
7698632|NCT00406640|12119514|FG001|Acute Phase|Failed to Return|1
7698633|NCT00406640|12119513|FG000|Acute Phase|Physician Decision|0
7698634|NCT00406640|12119514|FG001|Acute Phase|Physician Decision|1
7698635|NCT00406640|12119513|FG000|Acute Phase|Lost to Follow-up|7
7698636|NCT00406640|12119514|FG001|Acute Phase|Lost to Follow-up|4
7698637|NCT00406640|12119513|FG000|Acute Phase|Protocol deviation|4
7698638|NCT00406640|12119514|FG001|Acute Phase|Protocol deviation|10
7698639|NCT00406640|12119513|FG000|Acute Phase|Protocol Violation|3
7698640|NCT00406640|12119514|FG001|Acute Phase|Protocol Violation|2
7698641|NCT00406640|12119513|FG000|Acute Phase|Withdrawal by Subject|11
7698642|NCT00406640|12119514|FG001|Acute Phase|Withdrawal by Subject|9
7698643|NCT00406640|12119513|FG000|Acute Phase|Lack of Efficacy|3
7698644|NCT00406640|12119514|FG001|Acute Phase|Lack of Efficacy|3
7698645|NCT00406640|12119513|FG000|DB Continuation Phase for Responders|Adverse Event|11
7698646|NCT00406640|12119514|FG001|DB Continuation Phase for Responders|Adverse Event|11
7698647|NCT00406640|12119513|FG000|DB Continuation Phase for Responders|Death|1
7698648|NCT00406640|12119514|FG001|DB Continuation Phase for Responders|Death|0
7698649|NCT00406640|12119513|FG000|DB Continuation Phase for Responders|Failed to Return|0
7698650|NCT00406640|12119514|FG001|DB Continuation Phase for Responders|Failed to Return|2
7698651|NCT00406640|12119513|FG000|DB Continuation Phase for Responders|Physician Decision|2
7698652|NCT00406640|12119514|FG001|DB Continuation Phase for Responders|Physician Decision|3
7698653|NCT00406640|12119513|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1
7698654|NCT00406640|12119514|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7
7698655|NCT00406640|12119513|FG000|DB Continuation Phase for Responders|non-compliance|7
7698656|NCT00406640|12119514|FG001|DB Continuation Phase for Responders|non-compliance|5
7698657|NCT00406640|12119513|FG000|DB Continuation Phase for Responders|Protocol Violation|2
7698658|NCT00406640|12119514|FG001|DB Continuation Phase for Responders|Protocol Violation|2
7698659|NCT00406640|12119513|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8
7698660|NCT00406640|12119514|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6
7698661|NCT00406640|12119513|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1
7698662|NCT00406640|12119514|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1
7698663|NCT00406640|12119513|FG000|OL Extension Phase for Non-Responders|Adverse Event|6
7698664|NCT00406640|12119514|FG001|OL Extension Phase for Non-Responders|Adverse Event|6
7698665|NCT00406640|12119513|FG000|OL Extension Phase for Non-Responders|Failed to Return|1
7698666|NCT00406640|12119514|FG001|OL Extension Phase for Non-Responders|Failed to Return|0
7698667|NCT00406640|12119513|FG000|OL Extension Phase for Non-Responders|Physician Decision|1
7698668|NCT00406640|12119514|FG001|OL Extension Phase for Non-Responders|Physician Decision|0
7698669|NCT00406640|12119513|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2
7698670|NCT00406640|12119514|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3
7698671|NCT00406640|12119513|FG000|OL Extension Phase for Non-Responders|non-compliance|3
7698672|NCT00406640|12119514|FG001|OL Extension Phase for Non-Responders|non-compliance|2
7698673|NCT00406640|12119513|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
7698674|NCT00406640|12119514|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
7698675|NCT00406640|12119513|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6
7698676|NCT00406640|12119514|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7
7698677|NCT00406653|12119530|FG000|Induction Period|Adverse Event|1
7698678|NCT00406653|12119531|FG001|Induction Period|Adverse Event|10
7698679|NCT00406653|12119532|FG002|Induction Period|Adverse Event|4
7698680|NCT00406653|12119533|FG003|Induction Period|Adverse Event|11
7698681|NCT00406653|12119534|FG004|Induction Period|Adverse Event|0
7698682|NCT00406653|12119535|FG005|Induction Period|Adverse Event|0
7698683|NCT00406653|12119536|FG006|Induction Period|Adverse Event|0
7698684|NCT00406653|12119530|FG000|Induction Period|Lack of Efficacy|11
7698685|NCT00406653|12119531|FG001|Induction Period|Lack of Efficacy|14
7698686|NCT00406653|12119532|FG002|Induction Period|Lack of Efficacy|8
7698687|NCT00406653|12119533|FG003|Induction Period|Lack of Efficacy|10
7698688|NCT00406653|12119534|FG004|Induction Period|Lack of Efficacy|0
7698689|NCT00406653|12119535|FG005|Induction Period|Lack of Efficacy|0
7698690|NCT00406653|12119536|FG006|Induction Period|Lack of Efficacy|0
7698691|NCT00406653|12119530|FG000|Induction Period|Lost to Follow-up|0
7698692|NCT00406653|12119531|FG001|Induction Period|Lost to Follow-up|2
7698693|NCT00406653|12119532|FG002|Induction Period|Lost to Follow-up|0
7698694|NCT00406653|12119533|FG003|Induction Period|Lost to Follow-up|0
7698695|NCT00406653|12119534|FG004|Induction Period|Lost to Follow-up|0
7698696|NCT00406653|12119535|FG005|Induction Period|Lost to Follow-up|0
7698697|NCT00406653|12119536|FG006|Induction Period|Lost to Follow-up|0
7698698|NCT00406653|12119530|FG000|Induction Period|Withdrawal of Consent|2
7698699|NCT00406653|12119531|FG001|Induction Period|Withdrawal of Consent|5
7698700|NCT00406653|12119532|FG002|Induction Period|Withdrawal of Consent|1
7698701|NCT00406653|12119533|FG003|Induction Period|Withdrawal of Consent|2
7698702|NCT00406653|12119534|FG004|Induction Period|Withdrawal of Consent|0
7698703|NCT00406653|12119535|FG005|Induction Period|Withdrawal of Consent|0
7698704|NCT00406653|12119536|FG006|Induction Period|Withdrawal of Consent|0
7698705|NCT00406653|12119530|FG000|Induction Period|Subject No Longer Meets Study Criteria|0
7698706|NCT00406653|12119531|FG001|Induction Period|Subject No Longer Meets Study Criteria|0
7698707|NCT00406653|12119532|FG002|Induction Period|Subject No Longer Meets Study Criteria|0
7698708|NCT00406653|12119533|FG003|Induction Period|Subject No Longer Meets Study Criteria|2
7698709|NCT00406653|12119534|FG004|Induction Period|Subject No Longer Meets Study Criteria|0
7698710|NCT00406653|12119535|FG005|Induction Period|Subject No Longer Meets Study Criteria|0
7698711|NCT00406653|12119536|FG006|Induction Period|Subject No Longer Meets Study Criteria|0
7698712|NCT00406653|12119530|FG000|Induction Period|Pregnancy|1
7698713|NCT00406653|12119531|FG001|Induction Period|Pregnancy|0
7698714|NCT00406653|12119532|FG002|Induction Period|Pregnancy|0
7698715|NCT00406653|12119533|FG003|Induction Period|Pregnancy|0
7698716|NCT00406653|12119534|FG004|Induction Period|Pregnancy|0
7698717|NCT00406653|12119535|FG005|Induction Period|Pregnancy|0
7698718|NCT00406653|12119536|FG006|Induction Period|Pregnancy|0
7698719|NCT00406653|12119530|FG000|Induction Period|Declined participation but followup done|0
7698720|NCT00406653|12119531|FG001|Induction Period|Declined participation but followup done|2
7698721|NCT00406653|12119532|FG002|Induction Period|Declined participation but followup done|1
7698722|NCT00406653|12119533|FG003|Induction Period|Declined participation but followup done|1
7698723|NCT00406653|12119534|FG004|Induction Period|Declined participation but followup done|0
7698724|NCT00406653|12119535|FG005|Induction Period|Declined participation but followup done|0
7698725|NCT00406653|12119536|FG006|Induction Period|Declined participation but followup done|0
7698726|NCT00406653|12119530|FG000|Induction Period|Given prohibited drug|0
7698727|NCT00406653|12119531|FG001|Induction Period|Given prohibited drug|1
7698728|NCT00406653|12119532|FG002|Induction Period|Given prohibited drug|2
7698729|NCT00406653|12119533|FG003|Induction Period|Given prohibited drug|0
7698730|NCT00406653|12119534|FG004|Induction Period|Given prohibited drug|0
7698731|NCT00406653|12119535|FG005|Induction Period|Given prohibited drug|0
7698732|NCT00406653|12119536|FG006|Induction Period|Given prohibited drug|0
7698733|NCT00406653|12119530|FG000|Induction Period|Incarcerated|0
7698734|NCT00406653|12119531|FG001|Induction Period|Incarcerated|0
7698735|NCT00406653|12119532|FG002|Induction Period|Incarcerated|1
7698736|NCT00406653|12119533|FG003|Induction Period|Incarcerated|0
7698737|NCT00406653|12119534|FG004|Induction Period|Incarcerated|0
7698738|NCT00406653|12119535|FG005|Induction Period|Incarcerated|0
7698739|NCT00406653|12119536|FG006|Induction Period|Incarcerated|0
7698740|NCT00406653|12119530|FG000|Induction Period|Patient relocated|0
7698741|NCT00406653|12119531|FG001|Induction Period|Patient relocated|0
7698742|NCT00406653|12119532|FG002|Induction Period|Patient relocated|1
7698743|NCT00406653|12119533|FG003|Induction Period|Patient relocated|0
7698744|NCT00406653|12119534|FG004|Induction Period|Patient relocated|0
7698745|NCT00406653|12119535|FG005|Induction Period|Patient relocated|0
7698746|NCT00406653|12119536|FG006|Induction Period|Patient relocated|0
7698747|NCT00406653|12119530|FG000|Maintenance Period|Adverse Event|0
7698748|NCT00406653|12119531|FG001|Maintenance Period|Adverse Event|0
7698749|NCT00406653|12119532|FG002|Maintenance Period|Adverse Event|0
7698750|NCT00406653|12119533|FG003|Maintenance Period|Adverse Event|0
7698751|NCT00406653|12119534|FG004|Maintenance Period|Adverse Event|1
7698752|NCT00406653|12119535|FG005|Maintenance Period|Adverse Event|1
7698753|NCT00406653|12119536|FG006|Maintenance Period|Adverse Event|0
7698754|NCT00406653|12119530|FG000|Maintenance Period|Lack of Efficacy|0
7698755|NCT00406653|12119531|FG001|Maintenance Period|Lack of Efficacy|0
7698756|NCT00406653|12119532|FG002|Maintenance Period|Lack of Efficacy|0
7698757|NCT00406653|12119533|FG003|Maintenance Period|Lack of Efficacy|0
7698758|NCT00406653|12119534|FG004|Maintenance Period|Lack of Efficacy|20
7698759|NCT00406653|12119535|FG005|Maintenance Period|Lack of Efficacy|26
7698760|NCT00406653|12119536|FG006|Maintenance Period|Lack of Efficacy|0
7698761|NCT00406653|12119530|FG000|Maintenance Period|Lost to Follow-up|0
7698762|NCT00406653|12119531|FG001|Maintenance Period|Lost to Follow-up|0
7698763|NCT00406653|12119532|FG002|Maintenance Period|Lost to Follow-up|0
7698764|NCT00406653|12119533|FG003|Maintenance Period|Lost to Follow-up|0
7698765|NCT00406653|12119534|FG004|Maintenance Period|Lost to Follow-up|2
7698766|NCT00406653|12119535|FG005|Maintenance Period|Lost to Follow-up|1
7698767|NCT00406653|12119536|FG006|Maintenance Period|Lost to Follow-up|0
7698768|NCT00406653|12119530|FG000|Maintenance Period|Withdrawal of Consent|0
7698769|NCT00406653|12119531|FG001|Maintenance Period|Withdrawal of Consent|0
7698770|NCT00406653|12119532|FG002|Maintenance Period|Withdrawal of Consent|0
7698771|NCT00406653|12119533|FG003|Maintenance Period|Withdrawal of Consent|0
7698772|NCT00406653|12119534|FG004|Maintenance Period|Withdrawal of Consent|2
7698773|NCT00406653|12119535|FG005|Maintenance Period|Withdrawal of Consent|0
7698774|NCT00406653|12119536|FG006|Maintenance Period|Withdrawal of Consent|0
7698775|NCT00406653|12119530|FG000|Maintenance Period|Pregnancy|0
7698776|NCT00406653|12119531|FG001|Maintenance Period|Pregnancy|0
7698777|NCT00406653|12119532|FG002|Maintenance Period|Pregnancy|0
7698778|NCT00406653|12119533|FG003|Maintenance Period|Pregnancy|0
7698779|NCT00406653|12119534|FG004|Maintenance Period|Pregnancy|0
7698780|NCT00406653|12119535|FG005|Maintenance Period|Pregnancy|1
7698781|NCT00406653|12119536|FG006|Maintenance Period|Pregnancy|0
7698782|NCT00406653|12119530|FG000|Maintenance Period|Administrative Reason By Sponsor|0
7698783|NCT00406653|12119531|FG001|Maintenance Period|Administrative Reason By Sponsor|0
7698784|NCT00406653|12119532|FG002|Maintenance Period|Administrative Reason By Sponsor|0
7698785|NCT00406653|12119533|FG003|Maintenance Period|Administrative Reason By Sponsor|0
7698786|NCT00406653|12119534|FG004|Maintenance Period|Administrative Reason By Sponsor|4
7698787|NCT00406653|12119535|FG005|Maintenance Period|Administrative Reason By Sponsor|7
7698788|NCT00406653|12119536|FG006|Maintenance Period|Administrative Reason By Sponsor|0
7698789|NCT00406653|12119530|FG000|Maintenance Period|Error in disease score evaluation|0
7698790|NCT00406653|12119531|FG001|Maintenance Period|Error in disease score evaluation|0
7698791|NCT00406653|12119532|FG002|Maintenance Period|Error in disease score evaluation|0
7698792|NCT00406653|12119533|FG003|Maintenance Period|Error in disease score evaluation|0
7698793|NCT00406653|12119534|FG004|Maintenance Period|Error in disease score evaluation|1
7698794|NCT00406653|12119535|FG005|Maintenance Period|Error in disease score evaluation|0
7698795|NCT00406653|12119536|FG006|Maintenance Period|Error in disease score evaluation|0
7698796|NCT00406653|12119530|FG000|Open-Label Period|Death|0
7698797|NCT00406653|12119531|FG001|Open-Label Period|Death|0
7698798|NCT00406653|12119532|FG002|Open-Label Period|Death|0
7698799|NCT00406653|12119533|FG003|Open-Label Period|Death|0
7698800|NCT00406653|12119534|FG004|Open-Label Period|Death|0
7698801|NCT00406653|12119535|FG005|Open-Label Period|Death|0
7698802|NCT00406653|12119536|FG006|Open-Label Period|Death|1
7698803|NCT00406653|12119530|FG000|Open-Label Period|Adverse Event|0
7698804|NCT00406653|12119531|FG001|Open-Label Period|Adverse Event|0
7698805|NCT00406653|12119532|FG002|Open-Label Period|Adverse Event|0
7698806|NCT00406653|12119533|FG003|Open-Label Period|Adverse Event|0
7698807|NCT00406653|12119534|FG004|Open-Label Period|Adverse Event|0
7698808|NCT00406653|12119535|FG005|Open-Label Period|Adverse Event|0
7698809|NCT00406653|12119536|FG006|Open-Label Period|Adverse Event|18
7698810|NCT00406653|12119530|FG000|Open-Label Period|Lack of Efficacy|0
7698811|NCT00406653|12119531|FG001|Open-Label Period|Lack of Efficacy|0
7698812|NCT00406653|12119532|FG002|Open-Label Period|Lack of Efficacy|0
7698813|NCT00406653|12119533|FG003|Open-Label Period|Lack of Efficacy|0
7698814|NCT00406653|12119534|FG004|Open-Label Period|Lack of Efficacy|0
7698815|NCT00406653|12119535|FG005|Open-Label Period|Lack of Efficacy|0
7698816|NCT00406653|12119536|FG006|Open-Label Period|Lack of Efficacy|160
7698817|NCT00406653|12119530|FG000|Open-Label Period|Lost to Follow-up|0
7698818|NCT00406653|12119531|FG001|Open-Label Period|Lost to Follow-up|0
7698819|NCT00406653|12119532|FG002|Open-Label Period|Lost to Follow-up|0
7698820|NCT00406653|12119533|FG003|Open-Label Period|Lost to Follow-up|0
7698821|NCT00406653|12119534|FG004|Open-Label Period|Lost to Follow-up|0
7698822|NCT00406653|12119535|FG005|Open-Label Period|Lost to Follow-up|0
7698823|NCT00406653|12119536|FG006|Open-Label Period|Lost to Follow-up|6
7698824|NCT00406653|12119530|FG000|Open-Label Period|Withdrawal of Consent|0
7698825|NCT00406653|12119531|FG001|Open-Label Period|Withdrawal of Consent|0
7698826|NCT00406653|12119532|FG002|Open-Label Period|Withdrawal of Consent|0
7698827|NCT00406653|12119533|FG003|Open-Label Period|Withdrawal of Consent|0
7698828|NCT00406653|12119534|FG004|Open-Label Period|Withdrawal of Consent|0
7698829|NCT00406653|12119535|FG005|Open-Label Period|Withdrawal of Consent|0
7698830|NCT00406653|12119536|FG006|Open-Label Period|Withdrawal of Consent|11
7698831|NCT00406653|12119530|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0
7698832|NCT00406653|12119531|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0
7698833|NCT00406653|12119532|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0
7698834|NCT00406653|12119533|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0
7698835|NCT00406653|12119534|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0
7698836|NCT00406653|12119535|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0
7698837|NCT00406653|12119536|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1
7698838|NCT00406653|12119530|FG000|Open-Label Period|Pregnancy|0
7698839|NCT00406653|12119531|FG001|Open-Label Period|Pregnancy|0
7698840|NCT00406653|12119532|FG002|Open-Label Period|Pregnancy|0
7698841|NCT00406653|12119533|FG003|Open-Label Period|Pregnancy|0
7698842|NCT00406653|12119534|FG004|Open-Label Period|Pregnancy|0
7698843|NCT00406653|12119535|FG005|Open-Label Period|Pregnancy|0
7698844|NCT00406653|12119536|FG006|Open-Label Period|Pregnancy|2
7698845|NCT00406653|12119530|FG000|Open-Label Period|Administrative Reason By Sponsor|0
7698846|NCT00406653|12119531|FG001|Open-Label Period|Administrative Reason By Sponsor|0
7698847|NCT00406653|12119532|FG002|Open-Label Period|Administrative Reason By Sponsor|0
7698848|NCT00406653|12119533|FG003|Open-Label Period|Administrative Reason By Sponsor|0
7698849|NCT00406653|12119534|FG004|Open-Label Period|Administrative Reason By Sponsor|0
7698850|NCT00406653|12119535|FG005|Open-Label Period|Administrative Reason By Sponsor|0
7698851|NCT00406653|12119536|FG006|Open-Label Period|Administrative Reason By Sponsor|115
7698852|NCT00406653|12119530|FG000|Open-Label Period|Declined participation but followup done|0
7698853|NCT00406653|12119531|FG001|Open-Label Period|Declined participation but followup done|0
7698854|NCT00406653|12119532|FG002|Open-Label Period|Declined participation but followup done|0
7698855|NCT00406653|12119533|FG003|Open-Label Period|Declined participation but followup done|0
7698856|NCT00406653|12119534|FG004|Open-Label Period|Declined participation but followup done|0
7698857|NCT00406653|12119535|FG005|Open-Label Period|Declined participation but followup done|0
7698858|NCT00406653|12119536|FG006|Open-Label Period|Declined participation but followup done|8
7698859|NCT00406653|12119530|FG000|Open-Label Period|Discontinued by Sponsor|0
7698860|NCT00406653|12119531|FG001|Open-Label Period|Discontinued by Sponsor|0
7698861|NCT00406653|12119532|FG002|Open-Label Period|Discontinued by Sponsor|0
7698862|NCT00406653|12119533|FG003|Open-Label Period|Discontinued by Sponsor|0
7698863|NCT00406653|12119534|FG004|Open-Label Period|Discontinued by Sponsor|0
7698864|NCT00406653|12119535|FG005|Open-Label Period|Discontinued by Sponsor|0
7698865|NCT00406653|12119536|FG006|Open-Label Period|Discontinued by Sponsor|1
7698866|NCT00406653|12119530|FG000|Open-Label Period|Refused followup|0
7698867|NCT00406653|12119531|FG001|Open-Label Period|Refused followup|0
7698868|NCT00406653|12119532|FG002|Open-Label Period|Refused followup|0
7698869|NCT00406653|12119533|FG003|Open-Label Period|Refused followup|0
7698870|NCT00406653|12119534|FG004|Open-Label Period|Refused followup|0
7698871|NCT00406653|12119535|FG005|Open-Label Period|Refused followup|0
7698872|NCT00406653|12119536|FG006|Open-Label Period|Refused followup|1
7698873|NCT00406692|12119556|FG000|Overall Study|Withdrawal by Subject|4
7698874|NCT00406692|12119556|FG000|Overall Study|Physician Decision|1
7698875|NCT00406692|12119556|FG000|Overall Study|Adverse Event|1
7698876|NCT00406692|12119556|FG000|Overall Study|Lack of Efficacy|1
7698877|NCT00406718|12119563|FG000|Overall Study|Withdrawal by Subject|2
7698878|NCT00406718|12119564|FG001|Overall Study|Withdrawal by Subject|9
7698879|NCT00406718|12119565|FG002|Overall Study|Withdrawal by Subject|4
7698880|NCT00406718|12119563|FG000|Overall Study|Lost to Follow-up|2
7698881|NCT00406718|12119564|FG001|Overall Study|Lost to Follow-up|5
7698882|NCT00406718|12119565|FG002|Overall Study|Lost to Follow-up|4
7698883|NCT00406848|12119577|FG000|Overall Study|Withdrawal by Subject|27
7698884|NCT00406848|12119578|FG001|Overall Study|Withdrawal by Subject|22
7698885|NCT00406848|12119577|FG000|Overall Study|Adverse Event|38
7698886|NCT00406848|12119578|FG001|Overall Study|Adverse Event|7
7698887|NCT00406848|12119577|FG000|Overall Study|Lack of Efficacy|9
7698888|NCT00406848|12119578|FG001|Overall Study|Lack of Efficacy|14
7698889|NCT00406848|12119577|FG000|Overall Study|Protocol Violation|10
7698890|NCT00406848|12119578|FG001|Overall Study|Protocol Violation|6
7698891|NCT00406848|12119577|FG000|Overall Study|Lost to Follow-up|6
7698892|NCT00406848|12119578|FG001|Overall Study|Lost to Follow-up|2
7698893|NCT00406848|12119577|FG000|Overall Study|Physician Decision|2
7698894|NCT00406848|12119578|FG001|Overall Study|Physician Decision|2
7698895|NCT00406848|12119577|FG000|Overall Study|Sponsor Decision|1
7698896|NCT00406848|12119578|FG001|Overall Study|Sponsor Decision|1
7698897|NCT00407030|12119590|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2
7698898|NCT00407030|12119591|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1
7698899|NCT00407030|12119592|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0
7698900|NCT00407030|12119590|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
7698901|NCT00407030|12119591|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
7698902|NCT00407030|12119592|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
7698903|NCT00407030|12119590|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
7698904|NCT00407030|12119591|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
7698905|NCT00407030|12119592|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
7698906|NCT00407030|12119590|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
7698907|NCT00407030|12119591|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
7698908|NCT00407030|12119592|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
7698909|NCT00407030|12119590|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
7698910|NCT00407030|12119591|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
7698911|NCT00407030|12119592|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
7698912|NCT00407030|12119590|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1
7698913|NCT00407030|12119591|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0
7698914|NCT00407030|12119592|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0
7698915|NCT00407030|12119590|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
7698916|NCT00407030|12119591|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
7698917|NCT00407030|12119592|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
7698918|NCT00407030|12119590|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11
7698919|NCT00407030|12119591|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11
7698920|NCT00407030|12119592|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0
7698921|NCT00407030|12119590|FG000|Extension Period - up to 68 Weeks|Adverse Event|1
7698922|NCT00407030|12119591|FG001|Extension Period - up to 68 Weeks|Adverse Event|0
7698923|NCT00407030|12119592|FG002|Extension Period - up to 68 Weeks|Adverse Event|0
7698924|NCT00407030|12119590|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4
7698925|NCT00407030|12119591|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4
7698926|NCT00407030|12119592|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0
7698927|NCT00407030|12119590|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5
7698928|NCT00407030|12119591|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5
7698929|NCT00407030|12119592|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0
7698930|NCT00407030|12119590|FG000|Extension Period - up to 68 Weeks|Patient Decision|1
7698931|NCT00407030|12119591|FG001|Extension Period - up to 68 Weeks|Patient Decision|2
7698932|NCT00407030|12119592|FG002|Extension Period - up to 68 Weeks|Patient Decision|0
7698933|NCT00407030|12119590|FG000|Extension Period - up to 68 Weeks|Physician Decision|1
7698934|NCT00407030|12119591|FG001|Extension Period - up to 68 Weeks|Physician Decision|2
7698935|NCT00407030|12119592|FG002|Extension Period - up to 68 Weeks|Physician Decision|0
7698936|NCT00407511|12119640|FG000|Overall Study|Adverse Event|9
7698937|NCT00407511|12119640|FG000|Overall Study|Lost to Follow-up|4
7698938|NCT00407511|12119640|FG000|Overall Study|Other|5
7698939|NCT00407511|12119640|FG000|Overall Study|Withdrawal by Subject|4
7698940|NCT00407537|12119646|FG000|Overall Study|Death|5
7698941|NCT00407537|12119647|FG001|Overall Study|Death|2
7698942|NCT00407537|12119646|FG000|Overall Study|Adverse Event|36
7698943|NCT00407537|12119647|FG001|Overall Study|Adverse Event|0
7698944|NCT00407537|12119646|FG000|Overall Study|Lost to Follow-up|12
7698945|NCT00407537|12119647|FG001|Overall Study|Lost to Follow-up|19
7698946|NCT00407537|12119646|FG000|Overall Study|Other|6
7698947|NCT00407537|12119647|FG001|Overall Study|Other|7
7698948|NCT00407537|12119646|FG000|Overall Study|Withdrawal by Subject|34
7698949|NCT00407537|12119647|FG001|Overall Study|Withdrawal by Subject|16
7698950|NCT00407550|12119655|FG000|Overall Study|Adverse Event|0
7698951|NCT00407550|12119656|FG001|Overall Study|Adverse Event|1
7698952|NCT00407550|12119655|FG000|Overall Study|Withdrawal by Subject|0
7698953|NCT00407550|12119656|FG001|Overall Study|Withdrawal by Subject|2
7698954|NCT00407550|12119655|FG000|Overall Study|Death|1
7698955|NCT00407550|12119656|FG001|Overall Study|Death|0
7698956|NCT00407550|12119655|FG000|Overall Study|Insurance or Other medical condition|2
7698957|NCT00407550|12119656|FG001|Overall Study|Insurance or Other medical condition|1
7698958|NCT00407563|12119662|FG000|Overall Study|Patient continues on treatment|1
7698959|NCT00407745|12119673|FG000|Overall Study|Lack of Efficacy|1
7698960|NCT00407745|12119674|FG001|Overall Study|Lack of Efficacy|2
7698961|NCT00407745|12119673|FG000|Overall Study|Withdrawal by Subject|3
7698962|NCT00407745|12119674|FG001|Overall Study|Withdrawal by Subject|3
7698963|NCT00407745|12119673|FG000|Overall Study|Protocol Violation|5
7698964|NCT00407745|12119674|FG001|Overall Study|Protocol Violation|3
7698965|NCT00407745|12119673|FG000|Overall Study|Adverse Event|8
7698966|NCT00407745|12119674|FG001|Overall Study|Adverse Event|8
7698967|NCT00407745|12119673|FG000|Overall Study|Other|2
7698968|NCT00407745|12119674|FG001|Overall Study|Other|0
7698969|NCT00407745|12119673|FG000|Overall Study|Randomized, unknown if treated|0
7698970|NCT00407745|12119674|FG001|Overall Study|Randomized, unknown if treated|1
7698971|NCT00407758|12119680|FG000|Overall Study|ineligible -improper prior treatment|1
7698972|NCT00407797|12119684|FG000|Overall Study|Lost to Follow-up|2
7698973|NCT00407797|12119684|FG000|Overall Study|Adverse Event|6
7698974|NCT00407797|12119684|FG000|Overall Study|Other|7
7698975|NCT00407797|12119684|FG000|Overall Study|Withdrawal by Subject|3
7698976|NCT00408317|12119709|FG000|First Intervention Period|Adverse Event|0
7698977|NCT00408317|12119710|FG001|First Intervention Period|Adverse Event|1
7698978|NCT00408317|12119709|FG000|Second Intervention Period|Adverse Event|2
7698979|NCT00408317|12119710|FG001|Second Intervention Period|Adverse Event|0
7698980|NCT00408317|12119709|FG000|Second Intervention Period|Protocol Violation|0
7698981|NCT00408317|12119710|FG001|Second Intervention Period|Protocol Violation|1
7698982|NCT00408317|12119709|FG000|Second Intervention Period|Withdrawal of consent|0
7698983|NCT00408317|12119710|FG001|Second Intervention Period|Withdrawal of consent|1
7698984|NCT00408408|12119722|FG000|Overall Study|No follow up data|2
7698985|NCT00408408|12119723|FG001|Overall Study|No follow up data|3
7698986|NCT00408408|12119724|FG002|Overall Study|No follow up data|0
7698987|NCT00408408|12119725|FG003|Overall Study|No follow up data|7
7698988|NCT00408408|12119726|FG004|Overall Study|No follow up data|5
7698989|NCT00408408|12119727|FG005|Overall Study|No follow up data|3
7698990|NCT00408421|12119743|FG000|Treatment Initial Randomization|Adverse Event|5
7698991|NCT00408421|12119744|FG001|Treatment Initial Randomization|Adverse Event|9
7698992|NCT00408421|12119745|FG002|Treatment Initial Randomization|Adverse Event|0
7698993|NCT00408421|12119743|FG000|Treatment Initial Randomization|Lack of Efficacy|2
7698994|NCT00408421|12119744|FG001|Treatment Initial Randomization|Lack of Efficacy|2
7698995|NCT00408421|12119745|FG002|Treatment Initial Randomization|Lack of Efficacy|0
7698996|NCT00408421|12119743|FG000|Treatment Initial Randomization|Lost to Follow-up|0
7698997|NCT00408421|12119744|FG001|Treatment Initial Randomization|Lost to Follow-up|3
7698998|NCT00408421|12119745|FG002|Treatment Initial Randomization|Lost to Follow-up|0
7698999|NCT00408421|12119743|FG000|Treatment Initial Randomization|Physician Decision|1
7699000|NCT00408421|12119744|FG001|Treatment Initial Randomization|Physician Decision|0
7699001|NCT00408421|12119745|FG002|Treatment Initial Randomization|Physician Decision|0
7699002|NCT00408421|12119743|FG000|Treatment Initial Randomization|Protocol Violation|0
7699003|NCT00408421|12119744|FG001|Treatment Initial Randomization|Protocol Violation|1
7699004|NCT00408421|12119745|FG002|Treatment Initial Randomization|Protocol Violation|0
7699005|NCT00408421|12119743|FG000|Treatment Initial Randomization|Withdrawal by Subject|7
7699006|NCT00408421|12119744|FG001|Treatment Initial Randomization|Withdrawal by Subject|7
7699007|NCT00408421|12119745|FG002|Treatment Initial Randomization|Withdrawal by Subject|0
7699008|NCT00408421|12119743|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1
7699009|NCT00408421|12119744|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0
7699010|NCT00408421|12119745|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0
7699011|NCT00408421|12119743|FG000|Treatment Initial Randomization|Sponsor Decision|1
7699012|NCT00408421|12119744|FG001|Treatment Initial Randomization|Sponsor Decision|0
7699013|NCT00408421|12119745|FG002|Treatment Initial Randomization|Sponsor Decision|0
7699014|NCT00408421|12119743|FG000|Treatment Re-Randomization|Adverse Event|2
7699015|NCT00408421|12119744|FG001|Treatment Re-Randomization|Adverse Event|2
7699016|NCT00408421|12119745|FG002|Treatment Re-Randomization|Adverse Event|4
7699017|NCT00408421|12119743|FG000|Treatment Re-Randomization|Lack of Efficacy|1
7699018|NCT00408421|12119744|FG001|Treatment Re-Randomization|Lack of Efficacy|0
7699019|NCT00408421|12119745|FG002|Treatment Re-Randomization|Lack of Efficacy|0
7699020|NCT00408421|12119743|FG000|Treatment Re-Randomization|Lost to Follow-up|0
7699021|NCT00408421|12119744|FG001|Treatment Re-Randomization|Lost to Follow-up|0
7699022|NCT00408421|12119745|FG002|Treatment Re-Randomization|Lost to Follow-up|1
7699023|NCT00408421|12119743|FG000|Treatment Re-Randomization|Physician Decision|1
7699024|NCT00408421|12119744|FG001|Treatment Re-Randomization|Physician Decision|3
7699025|NCT00408421|12119745|FG002|Treatment Re-Randomization|Physician Decision|0
7699026|NCT00408421|12119743|FG000|Treatment Re-Randomization|Protocol Violation|1
7699027|NCT00408421|12119744|FG001|Treatment Re-Randomization|Protocol Violation|1
7699028|NCT00408421|12119745|FG002|Treatment Re-Randomization|Protocol Violation|0
7699029|NCT00408421|12119743|FG000|Treatment Re-Randomization|Withdrawal by Subject|2
7699030|NCT00408421|12119744|FG001|Treatment Re-Randomization|Withdrawal by Subject|1
7699031|NCT00408421|12119745|FG002|Treatment Re-Randomization|Withdrawal by Subject|0
7699032|NCT00408434|12119760|FG000|Overall Study|Adverse Event|0
7699033|NCT00408434|12119761|FG001|Overall Study|Adverse Event|0
7699034|NCT00408434|12119762|FG002|Overall Study|Adverse Event|1
7699035|NCT00408434|12119763|FG003|Overall Study|Adverse Event|0
7699036|NCT00408434|12119764|FG004|Overall Study|Adverse Event|0
7699037|NCT00408434|12119765|FG005|Overall Study|Adverse Event|0
7699038|NCT00408434|12119766|FG006|Overall Study|Adverse Event|0
7699039|NCT00408434|12119760|FG000|Overall Study|Progressive disease|6
7699040|NCT00408434|12119761|FG001|Overall Study|Progressive disease|3
7699041|NCT00408434|12119762|FG002|Overall Study|Progressive disease|4
7699042|NCT00408434|12119763|FG003|Overall Study|Progressive disease|3
7699043|NCT00408434|12119764|FG004|Overall Study|Progressive disease|3
7699044|NCT00408434|12119765|FG005|Overall Study|Progressive disease|1
7699045|NCT00408434|12119766|FG006|Overall Study|Progressive disease|4
7699046|NCT00408434|12119760|FG000|Overall Study|Other|0
7699047|NCT00408434|12119761|FG001|Overall Study|Other|0
7699048|NCT00408434|12119762|FG002|Overall Study|Other|1
7699049|NCT00408434|12119763|FG003|Overall Study|Other|0
7699050|NCT00408434|12119764|FG004|Overall Study|Other|2
7699051|NCT00408434|12119765|FG005|Overall Study|Other|1
7699052|NCT00408434|12119766|FG006|Overall Study|Other|0
7699053|NCT00408434|12119760|FG000|Overall Study|Terminated by Investigator|0
7699054|NCT00408434|12119761|FG001|Overall Study|Terminated by Investigator|0
7699055|NCT00408434|12119762|FG002|Overall Study|Terminated by Investigator|0
7699056|NCT00408434|12119763|FG003|Overall Study|Terminated by Investigator|0
7699057|NCT00408434|12119764|FG004|Overall Study|Terminated by Investigator|1
7699058|NCT00408434|12119765|FG005|Overall Study|Terminated by Investigator|1
7699059|NCT00408434|12119766|FG006|Overall Study|Terminated by Investigator|0
7699060|NCT00408499|12119787|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0
7699061|NCT00408499|12119788|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0
7699062|NCT00408499|12119789|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1
7699063|NCT00408499|12119790|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0
7699064|NCT00408499|12119791|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0
7699065|NCT00408499|12119787|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
7699066|NCT00408499|12119788|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
7699067|NCT00408499|12119789|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
7699068|NCT00408499|12119790|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
7699069|NCT00408499|12119791|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
7699070|NCT00408499|12119787|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1
7699071|NCT00408499|12119788|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1
7699072|NCT00408499|12119789|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0
7699073|NCT00408499|12119790|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0
7699074|NCT00408499|12119791|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0
7699075|NCT00408499|12119787|FG000|Phase II- MTD Expansion|Adverse Event|0
7699076|NCT00408499|12119788|FG001|Phase II- MTD Expansion|Adverse Event|0
7699077|NCT00408499|12119789|FG002|Phase II- MTD Expansion|Adverse Event|0
7699078|NCT00408499|12119790|FG003|Phase II- MTD Expansion|Adverse Event|0
7699079|NCT00408499|12119791|FG004|Phase II- MTD Expansion|Adverse Event|9
7699080|NCT00408499|12119787|FG000|Phase II- MTD Expansion|Death|0
7699081|NCT00408499|12119788|FG001|Phase II- MTD Expansion|Death|0
7699082|NCT00408499|12119789|FG002|Phase II- MTD Expansion|Death|0
7699083|NCT00408499|12119790|FG003|Phase II- MTD Expansion|Death|0
7699084|NCT00408499|12119791|FG004|Phase II- MTD Expansion|Death|2
7699085|NCT00408499|12119787|FG000|Phase II- MTD Expansion|Physician Decision|0
7699086|NCT00408499|12119788|FG001|Phase II- MTD Expansion|Physician Decision|0
7699087|NCT00408499|12119789|FG002|Phase II- MTD Expansion|Physician Decision|0
7699088|NCT00408499|12119790|FG003|Phase II- MTD Expansion|Physician Decision|0
7699089|NCT00408499|12119791|FG004|Phase II- MTD Expansion|Physician Decision|1
7699090|NCT00408499|12119787|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0
7699091|NCT00408499|12119788|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0
7699092|NCT00408499|12119789|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0
7699093|NCT00408499|12119790|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0
7699094|NCT00408499|12119791|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5
7699095|NCT00408499|12119787|FG000|Phase II- MTD Expansion|treatment delay|0
7699096|NCT00408499|12119788|FG001|Phase II- MTD Expansion|treatment delay|0
7699097|NCT00408499|12119789|FG002|Phase II- MTD Expansion|treatment delay|0
7699098|NCT00408499|12119790|FG003|Phase II- MTD Expansion|treatment delay|0
7699099|NCT00408499|12119791|FG004|Phase II- MTD Expansion|treatment delay|3
7699100|NCT00408629|12119847|FG000|Overall Study|Adverse Event|13
7699101|NCT00408629|12119848|FG001|Overall Study|Adverse Event|27
7699102|NCT00408629|12119847|FG000|Overall Study|Withdrawal by Subject|8
7699103|NCT00408629|12119848|FG001|Overall Study|Withdrawal by Subject|4
7699104|NCT00408629|12119847|FG000|Overall Study|Lost to Follow-up|1
7699105|NCT00408629|12119848|FG001|Overall Study|Lost to Follow-up|1
7699106|NCT00408629|12119847|FG000|Overall Study|Lack of Efficacy|63
7699107|NCT00408629|12119848|FG001|Overall Study|Lack of Efficacy|73
7699108|NCT00408629|12119847|FG000|Overall Study|Protocol Violation|1
7699109|NCT00408629|12119848|FG001|Overall Study|Protocol Violation|5
7699110|NCT00408629|12119847|FG000|Overall Study|Miscellaneous|11
7699111|NCT00408629|12119848|FG001|Overall Study|Miscellaneous|15
7699112|NCT00408681|12119855|FG000|Overall Study|Lack of Efficacy|2
7699113|NCT00408681|12119855|FG000|Overall Study|Adverse Event|7
7699114|NCT00408694|12119860|FG000|Overall Study|Ineligible|1
7699115|NCT00408694|12119860|FG000|Overall Study|No protocol treatment|1
7699116|NCT00408876|12119868|FG000|Overall Study|Adverse Event|9
7699117|NCT00408876|12119869|FG001|Overall Study|Adverse Event|17
7699118|NCT00408876|12119870|FG002|Overall Study|Adverse Event|27
7699119|NCT00408876|12119871|FG003|Overall Study|Adverse Event|10
7699120|NCT00408876|12119868|FG000|Overall Study|Withdrawal by Subject|3
7699121|NCT00408876|12119869|FG001|Overall Study|Withdrawal by Subject|6
7699122|NCT00408876|12119870|FG002|Overall Study|Withdrawal by Subject|6
7699123|NCT00408876|12119871|FG003|Overall Study|Withdrawal by Subject|14
7699124|NCT00408876|12119868|FG000|Overall Study|Lack of Efficacy|2
7699125|NCT00408876|12119869|FG001|Overall Study|Lack of Efficacy|4
7699126|NCT00408876|12119870|FG002|Overall Study|Lack of Efficacy|5
7699127|NCT00408876|12119871|FG003|Overall Study|Lack of Efficacy|6
7699128|NCT00408876|12119868|FG000|Overall Study|Lost to Follow-up|1
7699129|NCT00408876|12119869|FG001|Overall Study|Lost to Follow-up|6
7699130|NCT00408876|12119870|FG002|Overall Study|Lost to Follow-up|5
7699131|NCT00408876|12119871|FG003|Overall Study|Lost to Follow-up|2
7699132|NCT00408876|12119868|FG000|Overall Study|Protocol Violation|0
7699133|NCT00408876|12119869|FG001|Overall Study|Protocol Violation|3
7699134|NCT00408876|12119870|FG002|Overall Study|Protocol Violation|4
7699135|NCT00408876|12119871|FG003|Overall Study|Protocol Violation|3
7699136|NCT00408876|12119868|FG000|Overall Study|Physician Decision|1
7699137|NCT00408876|12119869|FG001|Overall Study|Physician Decision|0
7699138|NCT00408876|12119870|FG002|Overall Study|Physician Decision|3
7699139|NCT00408876|12119871|FG003|Overall Study|Physician Decision|0
7699140|NCT00408902|12119881|FG000|Overall Study|Lack of Efficacy|7
7699141|NCT00408902|12119881|FG000|Overall Study|Adverse Event|3
7699142|NCT00408928|12119886|FG000|Overall Study|Withdrawal by Subject|1
7699143|NCT00408928|12119886|FG000|Overall Study|Death|1
7699144|NCT00408928|12119886|FG000|Overall Study|Infection indistinguishable from GVHD|1
7699145|NCT00408993|12119892|FG000|Overall Study|Adverse Event|15
7699146|NCT00408993|12119893|FG001|Overall Study|Adverse Event|4
7699147|NCT00408993|12119892|FG000|Overall Study|Protocol Violation|1
7699148|NCT00408993|12119893|FG001|Overall Study|Protocol Violation|6
7699149|NCT00408993|12119892|FG000|Overall Study|Lack of Efficacy|1
7699150|NCT00408993|12119893|FG001|Overall Study|Lack of Efficacy|4
7699151|NCT00408993|12119892|FG000|Overall Study|Withdrawal by Subject|2
7699152|NCT00408993|12119893|FG001|Overall Study|Withdrawal by Subject|3
7699153|NCT00409006|12119905|FG000|Overall Study|Death|15
7699154|NCT00409006|12119906|FG001|Overall Study|Death|6
7699155|NCT00409006|12119905|FG000|Overall Study|Lost to Follow-up|1
7699156|NCT00409006|12119906|FG001|Overall Study|Lost to Follow-up|2
7699157|NCT00409006|12119905|FG000|Overall Study|Withdrawal by Subject|3
7699158|NCT00409006|12119906|FG001|Overall Study|Withdrawal by Subject|2
7699159|NCT00409006|12119905|FG000|Overall Study|Physician Decision|1
7699160|NCT00409006|12119906|FG001|Overall Study|Physician Decision|2
7699161|NCT00409175|12119914|FG000|Overall Study|Adverse Event|4
7699162|NCT00409175|12119915|FG001|Overall Study|Adverse Event|3
7699163|NCT00409175|12119914|FG000|Overall Study|Withdrawal by Subject|1
7699164|NCT00409175|12119915|FG001|Overall Study|Withdrawal by Subject|2
7699165|NCT00409175|12119914|FG000|Overall Study|Negative genotype|0
7699166|NCT00409175|12119915|FG001|Overall Study|Negative genotype|1
7699167|NCT00409175|12119914|FG000|Overall Study|Liver transplantation|13
7699168|NCT00409175|12119915|FG001|Overall Study|Liver transplantation|13
7699169|NCT00409188|12119923|FG000|Overall Study|Ongoing at data cut-off|383
7699170|NCT00409188|12119924|FG001|Overall Study|Ongoing at data cut-off|175
7699171|NCT00409409|12119947|FG000|Overall Study|Adverse Event|7
7699172|NCT00409409|12119948|FG001|Overall Study|Adverse Event|2
7699173|NCT00409409|12119947|FG000|Overall Study|Withdrawal by Subject|1
7699174|NCT00409409|12119948|FG001|Overall Study|Withdrawal by Subject|1
7699175|NCT00409409|12119947|FG000|Overall Study|Any other reason not above-mentioned|0
7699176|NCT00409409|12119948|FG001|Overall Study|Any other reason not above-mentioned|1
7699177|NCT00409578|12119983|FG000|Overall Study|Adverse Event|27
7699178|NCT00409578|12119984|FG001|Overall Study|Adverse Event|37
7699179|NCT00409578|12119985|FG002|Overall Study|Adverse Event|25
7699180|NCT00409578|12119986|FG003|Overall Study|Adverse Event|33
7699181|NCT00409578|12119983|FG000|Overall Study|Abnormal laboratory value(s)|2
7699182|NCT00409578|12119984|FG001|Overall Study|Abnormal laboratory value(s)|2
7699183|NCT00409578|12119985|FG002|Overall Study|Abnormal laboratory value(s)|2
7699184|NCT00409578|12119986|FG003|Overall Study|Abnormal laboratory value(s)|4
7699185|NCT00409578|12119983|FG000|Overall Study|Lack of Efficacy|0
7699186|NCT00409578|12119984|FG001|Overall Study|Lack of Efficacy|0
7699187|NCT00409578|12119985|FG002|Overall Study|Lack of Efficacy|0
7699188|NCT00409578|12119986|FG003|Overall Study|Lack of Efficacy|2
7699189|NCT00409578|12119983|FG000|Overall Study|Subject no longer requires study drug|0
7699190|NCT00409578|12119984|FG001|Overall Study|Subject no longer requires study drug|0
7699191|NCT00409578|12119985|FG002|Overall Study|Subject no longer requires study drug|0
7699192|NCT00409578|12119986|FG003|Overall Study|Subject no longer requires study drug|1
7699193|NCT00409578|12119983|FG000|Overall Study|Withdrawal by Subject|8
7699194|NCT00409578|12119984|FG001|Overall Study|Withdrawal by Subject|15
7699195|NCT00409578|12119985|FG002|Overall Study|Withdrawal by Subject|16
7699196|NCT00409578|12119986|FG003|Overall Study|Withdrawal by Subject|17
7699197|NCT00409578|12119983|FG000|Overall Study|Lost to Follow-up|2
7699198|NCT00409578|12119984|FG001|Overall Study|Lost to Follow-up|0
7699199|NCT00409578|12119985|FG002|Overall Study|Lost to Follow-up|2
7699200|NCT00409578|12119986|FG003|Overall Study|Lost to Follow-up|2
7699201|NCT00409578|12119983|FG000|Overall Study|Administrative problems|8
7699202|NCT00409578|12119984|FG001|Overall Study|Administrative problems|9
7699203|NCT00409578|12119985|FG002|Overall Study|Administrative problems|2
7699204|NCT00409578|12119986|FG003|Overall Study|Administrative problems|4
7699205|NCT00409578|12119983|FG000|Overall Study|Death|2
7699206|NCT00409578|12119984|FG001|Overall Study|Death|4
7699207|NCT00409578|12119985|FG002|Overall Study|Death|4
7699208|NCT00409578|12119986|FG003|Overall Study|Death|2
7699209|NCT00409578|12119983|FG000|Overall Study|Protocol Violation|3
7699210|NCT00409578|12119984|FG001|Overall Study|Protocol Violation|2
7699211|NCT00409578|12119985|FG002|Overall Study|Protocol Violation|3
7699212|NCT00409578|12119986|FG003|Overall Study|Protocol Violation|1
7699213|NCT00409578|12119983|FG000|Overall Study|Missing|0
7699214|NCT00409578|12119984|FG001|Overall Study|Missing|1
7699215|NCT00409578|12119985|FG002|Overall Study|Missing|0
7699216|NCT00409578|12119986|FG003|Overall Study|Missing|1
7699217|NCT00409617|12119996|FG000|Overall Study|Adverse Event|57
7699218|NCT00409617|12119996|FG000|Overall Study|Lack of Efficacy|54
7699219|NCT00409617|12119996|FG000|Overall Study|Lost to Follow-up|2
7699220|NCT00409617|12119996|FG000|Overall Study|Protocol Violation|24
7699221|NCT00409617|12119996|FG000|Overall Study|Withdrawal by Subject|8
7699222|NCT00409617|12119996|FG000|Overall Study|Administrative reasons|1
7699223|NCT00409617|12119996|FG000|Overall Study|Not described|14
7699224|NCT00409682|12120003|FG000|Open-label Induction Period|Adverse Event|1
7699225|NCT00409682|12120004|FG001|Open-label Induction Period|Adverse Event|0
7699226|NCT00409682|12120005|FG002|Open-label Induction Period|Adverse Event|0
7699227|NCT00409682|12120003|FG000|Open-label Induction Period|Lack of Efficacy|1
7699228|NCT00409682|12120004|FG001|Open-label Induction Period|Lack of Efficacy|0
7699229|NCT00409682|12120005|FG002|Open-label Induction Period|Lack of Efficacy|0
7699230|NCT00409682|12120003|FG000|Open-label Induction Period|Protocol Violation|1
7699231|NCT00409682|12120004|FG001|Open-label Induction Period|Protocol Violation|0
7699232|NCT00409682|12120005|FG002|Open-label Induction Period|Protocol Violation|0
7699233|NCT00409682|12120003|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1
7699234|NCT00409682|12120004|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0
7699235|NCT00409682|12120005|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0
7699236|NCT00409682|12120003|FG000|EOW Double-blind Maintenance Period|Adverse Event|0
7699237|NCT00409682|12120004|FG001|EOW Double-blind Maintenance Period|Adverse Event|10
7699238|NCT00409682|12120005|FG002|EOW Double-blind Maintenance Period|Adverse Event|12
7699239|NCT00409682|12120003|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0
7699240|NCT00409682|12120004|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18
7699241|NCT00409682|12120005|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11
7699242|NCT00409682|12120003|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0
7699243|NCT00409682|12120004|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1
7699244|NCT00409682|12120005|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0
7699245|NCT00409682|12120003|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
7699246|NCT00409682|12120004|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
7699247|NCT00409682|12120005|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
7699248|NCT00409682|12120003|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0
7699249|NCT00409682|12120004|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4
7699250|NCT00409682|12120005|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1
7699251|NCT00409682|12120003|FG000|EOW Double-blind Maintenance Period|Non-compliance|0
7699252|NCT00409682|12120004|FG001|EOW Double-blind Maintenance Period|Non-compliance|0
7699253|NCT00409682|12120005|FG002|EOW Double-blind Maintenance Period|Non-compliance|1
7699254|NCT00409708|12120014|FG000|Treatment|Abnormal test procedure result(s)|1
7699255|NCT00409708|12120015|FG001|Treatment|Abnormal test procedure result(s)|0
7699256|NCT00409708|12120014|FG000|Treatment|Lack of Efficacy|0
7699257|NCT00409708|12120015|FG001|Treatment|Lack of Efficacy|1
7699258|NCT00409708|12120014|FG000|Treatment|Protocol Violation|6
7699259|NCT00409708|12120015|FG001|Treatment|Protocol Violation|2
7699260|NCT00409708|12120014|FG000|Treatment|Withdrawal by Subject|3
7699261|NCT00409708|12120015|FG001|Treatment|Withdrawal by Subject|8
7699262|NCT00409708|12120014|FG000|Treatment|Lost to Follow-up|0
7699263|NCT00409708|12120015|FG001|Treatment|Lost to Follow-up|6
7699264|NCT00409708|12120014|FG000|Treatment|Administrative problems|5
7699265|NCT00409708|12120015|FG001|Treatment|Administrative problems|0
7699266|NCT00409708|12120014|FG000|Washout|Lack of Efficacy|9
7699267|NCT00409708|12120015|FG001|Washout|Lack of Efficacy|1
7699268|NCT00409708|12120014|FG000|Washout|Protocol Violation|0
7699269|NCT00409708|12120015|FG001|Washout|Protocol Violation|1
7699270|NCT00409708|12120014|FG000|Washout|Withdrawal by Subject|11
7699271|NCT00409708|12120015|FG001|Washout|Withdrawal by Subject|5
7699272|NCT00409708|12120014|FG000|Washout|Lost to Follow-up|1
7699273|NCT00409708|12120015|FG001|Washout|Lost to Follow-up|3
7699274|NCT00409747|12120021|FG000|Overall Study|Withdrawal by Subject|1
7699275|NCT00409786|12120025|FG000|Overall Study|Withdrawal by Subject|3
7699276|NCT00409838|12120035|FG000|Short-term Period|Adverse Event|0
7699277|NCT00409838|12120036|FG001|Short-term Period|Adverse Event|1
7699278|NCT00409838|12120035|FG000|Short-term Period|Lost to Follow-up|0
7699279|NCT00409838|12120036|FG001|Short-term Period|Lost to Follow-up|1
7699280|NCT00409838|12120035|FG000|Short-term Period|Withdrawal by Subject|2
7699281|NCT00409838|12120036|FG001|Short-term Period|Withdrawal by Subject|3
7699282|NCT00409838|12120035|FG000|Short-term Period|Never Treated|1
7699283|NCT00409838|12120036|FG001|Short-term Period|Never Treated|0
7699284|NCT00409838|12120035|FG000|Long-term Extension Period|Adverse Event|10
7699285|NCT00409838|12120036|FG001|Long-term Extension Period|Adverse Event|0
7699286|NCT00409838|12120035|FG000|Long-term Extension Period|Death|1
7699287|NCT00409838|12120036|FG001|Long-term Extension Period|Death|0
7699288|NCT00409838|12120035|FG000|Long-term Extension Period|Lack of Efficacy|2
7699289|NCT00409838|12120036|FG001|Long-term Extension Period|Lack of Efficacy|0
7699290|NCT00409838|12120035|FG000|Long-term Extension Period|Withdrawal by Subject|3
7699291|NCT00409838|12120036|FG001|Long-term Extension Period|Withdrawal by Subject|0
7699292|NCT00409838|12120035|FG000|Long-term Extension Period|Poor compliance/noncompliance|1
7699293|NCT00409838|12120036|FG001|Long-term Extension Period|Poor compliance/noncompliance|0
7699294|NCT00409838|12120035|FG000|Long-term Extension Period|Pregnancy|1
7699295|NCT00409838|12120036|FG001|Long-term Extension Period|Pregnancy|0
7699296|NCT00410046|12120059|FG000|Overall Study|Adverse Event|3
7699297|NCT00410046|12120059|FG000|Overall Study|Withdrawal by Subject|1
7699298|NCT00410046|12120059|FG000|Overall Study|Lost to Follow-up|1
7699299|NCT00410072|12120070|FG000|Day 1 to Week 48|Adverse Event|1
7699300|NCT00410072|12120071|FG001|Day 1 to Week 48|Adverse Event|2
7699301|NCT00410072|12120070|FG000|Day 1 to Week 48|Lost to Follow-up|5
7699302|NCT00410072|12120071|FG001|Day 1 to Week 48|Lost to Follow-up|2
7699303|NCT00410072|12120070|FG000|Day 1 to Week 48|Other|0
7699304|NCT00410072|12120071|FG001|Day 1 to Week 48|Other|1
7699305|NCT00410072|12120070|FG000|Day 1 to Week 48|poor compliance/noncompliance|0
7699306|NCT00410072|12120071|FG001|Day 1 to Week 48|poor compliance/noncompliance|3
7699307|NCT00410072|12120070|FG000|Day 1 to Week 48|Pregnancy|0
7699308|NCT00410072|12120071|FG001|Day 1 to Week 48|Pregnancy|2
7699309|NCT00410072|12120070|FG000|Day 1 to Week 48|Withdrawal by Subject|0
7699310|NCT00410072|12120071|FG001|Day 1 to Week 48|Withdrawal by Subject|2
7699311|NCT00410072|12120070|FG000|After Week 48 to Week 96|Adverse Event|1
7699312|NCT00410072|12120071|FG001|After Week 48 to Week 96|Adverse Event|2
7699313|NCT00410072|12120070|FG000|After Week 48 to Week 96|Death|0
7699314|NCT00410072|12120071|FG001|After Week 48 to Week 96|Death|1
7699315|NCT00410072|12120070|FG000|After Week 48 to Week 96|Lack of Efficacy|1
7699316|NCT00410072|12120071|FG001|After Week 48 to Week 96|Lack of Efficacy|0
7699317|NCT00410072|12120070|FG000|After Week 48 to Week 96|Lost to Follow-up|2
7699318|NCT00410072|12120071|FG001|After Week 48 to Week 96|Lost to Follow-up|4
7699319|NCT00410072|12120070|FG000|After Week 48 to Week 96|Other|2
7699320|NCT00410072|12120071|FG001|After Week 48 to Week 96|Other|0
7699321|NCT00410072|12120070|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0
7699322|NCT00410072|12120071|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1
7699323|NCT00410072|12120070|FG000|After Week 48 to Week 96|Pregnancy|0
7699324|NCT00410072|12120071|FG001|After Week 48 to Week 96|Pregnancy|2
7699325|NCT00410072|12120070|FG000|After Week 48 to Week 96|Withdrawal by Subject|0
7699326|NCT00410072|12120071|FG001|After Week 48 to Week 96|Withdrawal by Subject|1
7699327|NCT00410124|12120079|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36
7699328|NCT00410124|12120080|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2
7699329|NCT00410124|12120079|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
7699330|NCT00410124|12120080|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
7699331|NCT00410124|12120079|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2
7699332|NCT00410124|12120080|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1
7699333|NCT00410124|12120079|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
7699334|NCT00410124|12120080|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
7699335|NCT00410124|12120079|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
7699336|NCT00410124|12120080|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
7699337|NCT00410124|12120079|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2
7699338|NCT00410124|12120080|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0
7699339|NCT00410124|12120079|FG000|Core Phase Double Blind (15 Months)|Death|7
7699340|NCT00410124|12120080|FG001|Core Phase Double Blind (15 Months)|Death|4
7699341|NCT00410124|12120079|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137
7699342|NCT00410124|12120080|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124
7699343|NCT00410124|12120079|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7
7699344|NCT00410124|12120080|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19
7699345|NCT00410124|12120079|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
7699346|NCT00410124|12120080|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
7699347|NCT00410124|12120079|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
7699348|NCT00410124|12120080|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
7699349|NCT00410124|12120079|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
7699350|NCT00410124|12120080|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
7699351|NCT00410124|12120079|FG000|Extension Phase - Open Label (45 Months)|Death|2
7699352|NCT00410124|12120080|FG001|Extension Phase - Open Label (45 Months)|Death|10
7699353|NCT00410124|12120079|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56
7699354|NCT00410124|12120080|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78
7699355|NCT00410124|12120079|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
7699356|NCT00410124|12120080|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
7699357|NCT00410124|12120079|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
7699358|NCT00410124|12120080|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
7699359|NCT00410163|12120101|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
7699360|NCT00410163|12120102|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
7699361|NCT00410163|12120101|FG000|Treatment and Follow-up Phase (2 Years)|Death|1
7699362|NCT00410163|12120102|FG001|Treatment and Follow-up Phase (2 Years)|Death|1
7699363|NCT00410163|12120101|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
7699364|NCT00410163|12120102|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
7699365|NCT00410163|12120101|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
7699366|NCT00410163|12120102|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
7699367|NCT00410163|12120101|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
7699368|NCT00410163|12120102|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
7699369|NCT00410163|12120101|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
7699370|NCT00410163|12120102|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
7699371|NCT00410163|12120101|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
7699372|NCT00410163|12120102|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
7699373|NCT00410163|12120101|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
7699374|NCT00410163|12120102|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
7699375|NCT00410163|12120101|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
7699376|NCT00410163|12120102|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
7699377|NCT00410163|12120101|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
7699378|NCT00410163|12120102|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
7699379|NCT00410163|12120101|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1
7699380|NCT00410163|12120102|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1
7699381|NCT00410163|12120101|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
7699382|NCT00410163|12120102|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
7699383|NCT00410163|12120101|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
7699384|NCT00410163|12120102|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
7699385|NCT00410163|12120101|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
7699386|NCT00410163|12120102|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
7699387|NCT00410202|12120119|FG000|On-Treatment|Continuing treatment|69
7699388|NCT00410202|12120120|FG001|On-Treatment|Continuing treatment|71
7699389|NCT00410202|12120121|FG002|On-Treatment|Continuing treatment|66
7699390|NCT00410202|12120119|FG000|On-Treatment|Adverse Event|1
7699391|NCT00410202|12120120|FG001|On-Treatment|Adverse Event|3
7699392|NCT00410202|12120121|FG002|On-Treatment|Adverse Event|2
7699393|NCT00410202|12120119|FG000|On-Treatment|Death|1
7699394|NCT00410202|12120120|FG001|On-Treatment|Death|0
7699395|NCT00410202|12120121|FG002|On-Treatment|Death|0
7699396|NCT00410202|12120119|FG000|On-Treatment|Lost to Follow-up|1
7699397|NCT00410202|12120120|FG001|On-Treatment|Lost to Follow-up|0
7699398|NCT00410202|12120121|FG002|On-Treatment|Lost to Follow-up|1
7699399|NCT00410202|12120119|FG000|On-Treatment|Lack of Efficacy|1
7699400|NCT00410202|12120120|FG001|On-Treatment|Lack of Efficacy|4
7699401|NCT00410202|12120121|FG002|On-Treatment|Lack of Efficacy|0
7699402|NCT00410202|12120119|FG000|On-Treatment|Withdrawal by Subject|2
7699403|NCT00410202|12120120|FG001|On-Treatment|Withdrawal by Subject|1
7699404|NCT00410202|12120121|FG002|On-Treatment|Withdrawal by Subject|1
7699405|NCT00410202|12120119|FG000|On-Treatment|Other Reason|0
7699406|NCT00410202|12120120|FG001|On-Treatment|Other Reason|0
7699407|NCT00410202|12120121|FG002|On-Treatment|Other Reason|1
7699408|NCT00410202|12120119|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10
7699409|NCT00410202|12120120|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8
7699410|NCT00410202|12120121|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11
7699411|NCT00410202|12120119|FG000|Off-treatment Follow up|Follow up not required per protocol|3
7699412|NCT00410202|12120120|FG001|Off-treatment Follow up|Follow up not required per protocol|0
7699413|NCT00410202|12120121|FG002|Off-treatment Follow up|Follow up not required per protocol|1
7699414|NCT00410202|12120119|FG000|Off-treatment Follow up|Lost to Follow-up|1
7699415|NCT00410202|12120120|FG001|Off-treatment Follow up|Lost to Follow-up|0
7699416|NCT00410202|12120121|FG002|Off-treatment Follow up|Lost to Follow-up|0
7699417|NCT00410384|12120142|FG000|Overall Study|Withdrawal by Subject|28
7699418|NCT00410384|12120143|FG001|Overall Study|Withdrawal by Subject|17
7699419|NCT00410384|12120144|FG002|Overall Study|Withdrawal by Subject|20
7699420|NCT00410384|12120142|FG000|Overall Study|Adverse Event|23
7699421|NCT00410384|12120143|FG001|Overall Study|Adverse Event|18
7699422|NCT00410384|12120144|FG002|Overall Study|Adverse Event|23
7699423|NCT00410384|12120142|FG000|Overall Study|Lack of Efficacy|20
7699424|NCT00410384|12120143|FG001|Overall Study|Lack of Efficacy|12
7699425|NCT00410384|12120144|FG002|Overall Study|Lack of Efficacy|17
7699426|NCT00410384|12120142|FG000|Overall Study|Lack of Compliance|2
7699427|NCT00410384|12120143|FG001|Overall Study|Lack of Compliance|2
7699428|NCT00410384|12120144|FG002|Overall Study|Lack of Compliance|2
7699429|NCT00410384|12120142|FG000|Overall Study|Lost to Follow-up|4
7699430|NCT00410384|12120143|FG001|Overall Study|Lost to Follow-up|6
7699431|NCT00410384|12120144|FG002|Overall Study|Lost to Follow-up|6
7699432|NCT00410384|12120142|FG000|Overall Study|Protocol Violation|6
7699433|NCT00410384|12120143|FG001|Overall Study|Protocol Violation|6
7699434|NCT00410384|12120144|FG002|Overall Study|Protocol Violation|6
7699435|NCT00410384|12120142|FG000|Overall Study|Physician Decision|3
7699436|NCT00410384|12120143|FG001|Overall Study|Physician Decision|3
7699437|NCT00410384|12120144|FG002|Overall Study|Physician Decision|4
7699438|NCT00410384|12120142|FG000|Overall Study|Other|3
7699439|NCT00410384|12120143|FG001|Overall Study|Other|8
7699440|NCT00410384|12120144|FG002|Overall Study|Other|4
7699441|NCT00410410|12120158|FG000|Induction Period (IP)|Death|1
7699442|NCT00410410|12120159|FG001|Induction Period (IP)|Death|0
7699443|NCT00410410|12120160|FG002|Induction Period (IP)|Death|0
7699444|NCT00410410|12120161|FG003|Induction Period (IP)|Death|0
7699445|NCT00410410|12120162|FG004|Induction Period (IP)|Death|0
7699446|NCT00410410|12120163|FG005|Induction Period (IP)|Death|0
7699447|NCT00410410|12120164|FG006|Induction Period (IP)|Death|0
7699448|NCT00410410|12120165|FG007|Induction Period (IP)|Death|0
7699449|NCT00410410|12120166|FG008|Induction Period (IP)|Death|0
7699450|NCT00410410|12120158|FG000|Induction Period (IP)|Adverse Event|3
7699451|NCT00410410|12120159|FG001|Induction Period (IP)|Adverse Event|4
7699452|NCT00410410|12120160|FG002|Induction Period (IP)|Adverse Event|2
7699453|NCT00410410|12120161|FG003|Induction Period (IP)|Adverse Event|4
7699454|NCT00410410|12120162|FG004|Induction Period (IP)|Adverse Event|1
7699455|NCT00410410|12120163|FG005|Induction Period (IP)|Adverse Event|0
7699456|NCT00410410|12120164|FG006|Induction Period (IP)|Adverse Event|0
7699457|NCT00410410|12120165|FG007|Induction Period (IP)|Adverse Event|0
7699458|NCT00410410|12120166|FG008|Induction Period (IP)|Adverse Event|0
7699459|NCT00410410|12120158|FG000|Induction Period (IP)|Lack of Efficacy|26
7699460|NCT00410410|12120159|FG001|Induction Period (IP)|Lack of Efficacy|24
7699461|NCT00410410|12120160|FG002|Induction Period (IP)|Lack of Efficacy|8
7699462|NCT00410410|12120161|FG003|Induction Period (IP)|Lack of Efficacy|8
7699463|NCT00410410|12120162|FG004|Induction Period (IP)|Lack of Efficacy|7
7699464|NCT00410410|12120163|FG005|Induction Period (IP)|Lack of Efficacy|7
7699465|NCT00410410|12120164|FG006|Induction Period (IP)|Lack of Efficacy|0
7699466|NCT00410410|12120165|FG007|Induction Period (IP)|Lack of Efficacy|0
7699467|NCT00410410|12120166|FG008|Induction Period (IP)|Lack of Efficacy|0
7699468|NCT00410410|12120158|FG000|Induction Period (IP)|Lost to Follow-up|2
7699469|NCT00410410|12120159|FG001|Induction Period (IP)|Lost to Follow-up|2
7699470|NCT00410410|12120160|FG002|Induction Period (IP)|Lost to Follow-up|2
7699471|NCT00410410|12120161|FG003|Induction Period (IP)|Lost to Follow-up|3
7699472|NCT00410410|12120162|FG004|Induction Period (IP)|Lost to Follow-up|0
7699473|NCT00410410|12120163|FG005|Induction Period (IP)|Lost to Follow-up|1
7699474|NCT00410410|12120164|FG006|Induction Period (IP)|Lost to Follow-up|0
7699475|NCT00410410|12120165|FG007|Induction Period (IP)|Lost to Follow-up|0
7699476|NCT00410410|12120166|FG008|Induction Period (IP)|Lost to Follow-up|0
7699477|NCT00410410|12120158|FG000|Induction Period (IP)|Withdrawal by Subject|3
7699478|NCT00410410|12120159|FG001|Induction Period (IP)|Withdrawal by Subject|5
7699479|NCT00410410|12120160|FG002|Induction Period (IP)|Withdrawal by Subject|3
7699480|NCT00410410|12120161|FG003|Induction Period (IP)|Withdrawal by Subject|5
7699481|NCT00410410|12120162|FG004|Induction Period (IP)|Withdrawal by Subject|2
7699482|NCT00410410|12120163|FG005|Induction Period (IP)|Withdrawal by Subject|0
7699483|NCT00410410|12120164|FG006|Induction Period (IP)|Withdrawal by Subject|0
7699484|NCT00410410|12120165|FG007|Induction Period (IP)|Withdrawal by Subject|0
7699485|NCT00410410|12120166|FG008|Induction Period (IP)|Withdrawal by Subject|0
7699486|NCT00410410|12120158|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7699487|NCT00410410|12120159|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7699488|NCT00410410|12120160|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
7699489|NCT00410410|12120161|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7699490|NCT00410410|12120162|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7699491|NCT00410410|12120163|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7699492|NCT00410410|12120164|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7699493|NCT00410410|12120165|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7699494|NCT00410410|12120166|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7699495|NCT00410410|12120158|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0
7699496|NCT00410410|12120159|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0
7699497|NCT00410410|12120160|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0
7699498|NCT00410410|12120161|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0
7699499|NCT00410410|12120162|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22
7699500|NCT00410410|12120163|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21
7699501|NCT00410410|12120164|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0
7699502|NCT00410410|12120165|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0
7699503|NCT00410410|12120166|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0
7699504|NCT00410410|12120158|FG000|Induction Period (IP)|Other|0
7699505|NCT00410410|12120159|FG001|Induction Period (IP)|Other|0
7699506|NCT00410410|12120160|FG002|Induction Period (IP)|Other|1
7699507|NCT00410410|12120161|FG003|Induction Period (IP)|Other|0
7699508|NCT00410410|12120162|FG004|Induction Period (IP)|Other|0
7699509|NCT00410410|12120163|FG005|Induction Period (IP)|Other|0
7699510|NCT00410410|12120164|FG006|Induction Period (IP)|Other|0
7699511|NCT00410410|12120165|FG007|Induction Period (IP)|Other|0
7699512|NCT00410410|12120166|FG008|Induction Period (IP)|Other|0
7699513|NCT00410410|12120158|FG000|Maintenance Period (MP)|Death|0
7699514|NCT00410410|12120159|FG001|Maintenance Period (MP)|Death|0
7699515|NCT00410410|12120160|FG002|Maintenance Period (MP)|Death|0
7699516|NCT00410410|12120161|FG003|Maintenance Period (MP)|Death|0
7699517|NCT00410410|12120162|FG004|Maintenance Period (MP)|Death|0
7699518|NCT00410410|12120163|FG005|Maintenance Period (MP)|Death|0
7699519|NCT00410410|12120164|FG006|Maintenance Period (MP)|Death|1
7699520|NCT00410410|12120165|FG007|Maintenance Period (MP)|Death|0
7699521|NCT00410410|12120166|FG008|Maintenance Period (MP)|Death|0
7699522|NCT00410410|12120158|FG000|Maintenance Period (MP)|Adverse Event|0
7699523|NCT00410410|12120159|FG001|Maintenance Period (MP)|Adverse Event|0
7699524|NCT00410410|12120160|FG002|Maintenance Period (MP)|Adverse Event|0
7699525|NCT00410410|12120161|FG003|Maintenance Period (MP)|Adverse Event|0
7699526|NCT00410410|12120162|FG004|Maintenance Period (MP)|Adverse Event|0
7699527|NCT00410410|12120163|FG005|Maintenance Period (MP)|Adverse Event|0
7699528|NCT00410410|12120164|FG006|Maintenance Period (MP)|Adverse Event|1
7699529|NCT00410410|12120165|FG007|Maintenance Period (MP)|Adverse Event|3
7699530|NCT00410410|12120166|FG008|Maintenance Period (MP)|Adverse Event|0
7699531|NCT00410410|12120158|FG000|Maintenance Period (MP)|Lack of Efficacy|0
7699532|NCT00410410|12120159|FG001|Maintenance Period (MP)|Lack of Efficacy|0
7699533|NCT00410410|12120160|FG002|Maintenance Period (MP)|Lack of Efficacy|0
7699534|NCT00410410|12120161|FG003|Maintenance Period (MP)|Lack of Efficacy|0
7699535|NCT00410410|12120162|FG004|Maintenance Period (MP)|Lack of Efficacy|0
7699536|NCT00410410|12120163|FG005|Maintenance Period (MP)|Lack of Efficacy|0
7699537|NCT00410410|12120164|FG006|Maintenance Period (MP)|Lack of Efficacy|25
7699538|NCT00410410|12120165|FG007|Maintenance Period (MP)|Lack of Efficacy|24
7699539|NCT00410410|12120166|FG008|Maintenance Period (MP)|Lack of Efficacy|0
7699540|NCT00410410|12120158|FG000|Maintenance Period (MP)|Lost to Follow-up|0
7699541|NCT00410410|12120159|FG001|Maintenance Period (MP)|Lost to Follow-up|0
7699542|NCT00410410|12120160|FG002|Maintenance Period (MP)|Lost to Follow-up|0
7699543|NCT00410410|12120161|FG003|Maintenance Period (MP)|Lost to Follow-up|0
7699544|NCT00410410|12120162|FG004|Maintenance Period (MP)|Lost to Follow-up|0
7699545|NCT00410410|12120163|FG005|Maintenance Period (MP)|Lost to Follow-up|0
7699546|NCT00410410|12120164|FG006|Maintenance Period (MP)|Lost to Follow-up|1
7699547|NCT00410410|12120165|FG007|Maintenance Period (MP)|Lost to Follow-up|2
7699548|NCT00410410|12120166|FG008|Maintenance Period (MP)|Lost to Follow-up|0
7699549|NCT00410410|12120158|FG000|Maintenance Period (MP)|Withdrawal by Subject|0
7699550|NCT00410410|12120159|FG001|Maintenance Period (MP)|Withdrawal by Subject|0
7699551|NCT00410410|12120160|FG002|Maintenance Period (MP)|Withdrawal by Subject|0
7699552|NCT00410410|12120161|FG003|Maintenance Period (MP)|Withdrawal by Subject|0
7699553|NCT00410410|12120162|FG004|Maintenance Period (MP)|Withdrawal by Subject|0
7699554|NCT00410410|12120163|FG005|Maintenance Period (MP)|Withdrawal by Subject|0
7699555|NCT00410410|12120164|FG006|Maintenance Period (MP)|Withdrawal by Subject|1
7699556|NCT00410410|12120165|FG007|Maintenance Period (MP)|Withdrawal by Subject|1
7699557|NCT00410410|12120166|FG008|Maintenance Period (MP)|Withdrawal by Subject|0
7699558|NCT00410410|12120158|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7699559|NCT00410410|12120159|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7699560|NCT00410410|12120160|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7699561|NCT00410410|12120161|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7699562|NCT00410410|12120162|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7699563|NCT00410410|12120163|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7699564|NCT00410410|12120164|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21
7699565|NCT00410410|12120165|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25
7699566|NCT00410410|12120166|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7699567|NCT00410410|12120158|FG000|Open-Label Period (OL)|Death|0
7699568|NCT00410410|12120159|FG001|Open-Label Period (OL)|Death|0
7699569|NCT00410410|12120160|FG002|Open-Label Period (OL)|Death|0
7699570|NCT00410410|12120161|FG003|Open-Label Period (OL)|Death|0
7699571|NCT00410410|12120162|FG004|Open-Label Period (OL)|Death|0
7699572|NCT00410410|12120163|FG005|Open-Label Period (OL)|Death|0
7699573|NCT00410410|12120164|FG006|Open-Label Period (OL)|Death|0
7699574|NCT00410410|12120165|FG007|Open-Label Period (OL)|Death|0
7699575|NCT00410410|12120166|FG008|Open-Label Period (OL)|Death|1
7699576|NCT00410410|12120158|FG000|Open-Label Period (OL)|Adverse Event|0
7699577|NCT00410410|12120159|FG001|Open-Label Period (OL)|Adverse Event|0
7699578|NCT00410410|12120160|FG002|Open-Label Period (OL)|Adverse Event|0
7699579|NCT00410410|12120161|FG003|Open-Label Period (OL)|Adverse Event|0
7699580|NCT00410410|12120162|FG004|Open-Label Period (OL)|Adverse Event|0
7699581|NCT00410410|12120163|FG005|Open-Label Period (OL)|Adverse Event|0
7699582|NCT00410410|12120164|FG006|Open-Label Period (OL)|Adverse Event|0
7699583|NCT00410410|12120165|FG007|Open-Label Period (OL)|Adverse Event|0
7699584|NCT00410410|12120166|FG008|Open-Label Period (OL)|Adverse Event|10
7699585|NCT00410410|12120158|FG000|Open-Label Period (OL)|Lack of Efficacy|0
7699586|NCT00410410|12120159|FG001|Open-Label Period (OL)|Lack of Efficacy|0
7699587|NCT00410410|12120160|FG002|Open-Label Period (OL)|Lack of Efficacy|0
7699588|NCT00410410|12120161|FG003|Open-Label Period (OL)|Lack of Efficacy|0
7699589|NCT00410410|12120162|FG004|Open-Label Period (OL)|Lack of Efficacy|0
7699590|NCT00410410|12120163|FG005|Open-Label Period (OL)|Lack of Efficacy|0
7699591|NCT00410410|12120164|FG006|Open-Label Period (OL)|Lack of Efficacy|0
7699592|NCT00410410|12120165|FG007|Open-Label Period (OL)|Lack of Efficacy|0
7699593|NCT00410410|12120166|FG008|Open-Label Period (OL)|Lack of Efficacy|161
7699594|NCT00410410|12120158|FG000|Open-Label Period (OL)|Lost to Follow-up|0
7699595|NCT00410410|12120159|FG001|Open-Label Period (OL)|Lost to Follow-up|0
7699596|NCT00410410|12120160|FG002|Open-Label Period (OL)|Lost to Follow-up|0
7699597|NCT00410410|12120161|FG003|Open-Label Period (OL)|Lost to Follow-up|0
7699598|NCT00410410|12120162|FG004|Open-Label Period (OL)|Lost to Follow-up|0
7699599|NCT00410410|12120163|FG005|Open-Label Period (OL)|Lost to Follow-up|0
7699600|NCT00410410|12120164|FG006|Open-Label Period (OL)|Lost to Follow-up|0
7699601|NCT00410410|12120165|FG007|Open-Label Period (OL)|Lost to Follow-up|0
7699602|NCT00410410|12120166|FG008|Open-Label Period (OL)|Lost to Follow-up|4
7699603|NCT00410410|12120158|FG000|Open-Label Period (OL)|Withdrawal by Subject|0
7699604|NCT00410410|12120159|FG001|Open-Label Period (OL)|Withdrawal by Subject|0
7699605|NCT00410410|12120160|FG002|Open-Label Period (OL)|Withdrawal by Subject|0
7699606|NCT00410410|12120161|FG003|Open-Label Period (OL)|Withdrawal by Subject|0
7699607|NCT00410410|12120162|FG004|Open-Label Period (OL)|Withdrawal by Subject|0
7699608|NCT00410410|12120163|FG005|Open-Label Period (OL)|Withdrawal by Subject|0
7699609|NCT00410410|12120164|FG006|Open-Label Period (OL)|Withdrawal by Subject|0
7699610|NCT00410410|12120165|FG007|Open-Label Period (OL)|Withdrawal by Subject|0
7699611|NCT00410410|12120166|FG008|Open-Label Period (OL)|Withdrawal by Subject|20
7699612|NCT00410410|12120158|FG000|Open-Label Period (OL)|Pregnancy|0
7699613|NCT00410410|12120159|FG001|Open-Label Period (OL)|Pregnancy|0
7699614|NCT00410410|12120160|FG002|Open-Label Period (OL)|Pregnancy|0
7699615|NCT00410410|12120161|FG003|Open-Label Period (OL)|Pregnancy|0
7699616|NCT00410410|12120162|FG004|Open-Label Period (OL)|Pregnancy|0
7699617|NCT00410410|12120163|FG005|Open-Label Period (OL)|Pregnancy|0
7699618|NCT00410410|12120164|FG006|Open-Label Period (OL)|Pregnancy|0
7699619|NCT00410410|12120165|FG007|Open-Label Period (OL)|Pregnancy|0
7699620|NCT00410410|12120166|FG008|Open-Label Period (OL)|Pregnancy|1
7699621|NCT00410410|12120158|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7699622|NCT00410410|12120159|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7699623|NCT00410410|12120160|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7699624|NCT00410410|12120161|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7699625|NCT00410410|12120162|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7699626|NCT00410410|12120163|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7699627|NCT00410410|12120164|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7699628|NCT00410410|12120165|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7699629|NCT00410410|12120166|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145
7699630|NCT00410410|12120158|FG000|Open-Label Period (OL)|Other|0
7699631|NCT00410410|12120159|FG001|Open-Label Period (OL)|Other|0
7699632|NCT00410410|12120160|FG002|Open-Label Period (OL)|Other|0
7699633|NCT00410410|12120161|FG003|Open-Label Period (OL)|Other|0
7699634|NCT00410410|12120162|FG004|Open-Label Period (OL)|Other|0
7699635|NCT00410410|12120163|FG005|Open-Label Period (OL)|Other|0
7699636|NCT00410410|12120164|FG006|Open-Label Period (OL)|Other|0
7699637|NCT00410410|12120165|FG007|Open-Label Period (OL)|Other|0
7699638|NCT00410410|12120166|FG008|Open-Label Period (OL)|Other|7
7699639|NCT00410514|12120222|FG000|Overall Study|Adverse Event|2
7699640|NCT00410514|12120223|FG001|Overall Study|Adverse Event|2
7699641|NCT00410514|12120224|FG002|Overall Study|Adverse Event|2
7699642|NCT00410514|12120222|FG000|Overall Study|Protocol Violation|0
7699643|NCT00410514|12120223|FG001|Overall Study|Protocol Violation|1
7699644|NCT00410514|12120224|FG002|Overall Study|Protocol Violation|1
7699645|NCT00410514|12120222|FG000|Overall Study|Lost to Follow-up|0
7699646|NCT00410514|12120223|FG001|Overall Study|Lost to Follow-up|0
7699647|NCT00410514|12120224|FG002|Overall Study|Lost to Follow-up|2
7699648|NCT00410514|12120222|FG000|Overall Study|Non-compliant with study procedures|0
7699649|NCT00410514|12120223|FG001|Overall Study|Non-compliant with study procedures|0
7699650|NCT00410514|12120224|FG002|Overall Study|Non-compliant with study procedures|2
7699651|NCT00410605|12120232|FG000|Overall Study|Adverse Event|12
7699652|NCT00410605|12120232|FG000|Overall Study|Physician Decision|3
7699653|NCT00410605|12120232|FG000|Overall Study|Withdrawal by Subject|5
7699654|NCT00410605|12120232|FG000|Overall Study|Started Non-Protocol Therapy|3
7699655|NCT00410605|12120232|FG000|Overall Study|Stopped treatmen to collect stem cells|1
7699656|NCT00410605|12120232|FG000|Overall Study|Transferred to another Institution|1
7699657|NCT00410761|12120238|FG000|Overall Study|Adverse Event|29
7699658|NCT00410761|12120239|FG001|Overall Study|Adverse Event|3
7699659|NCT00410761|12120238|FG000|Overall Study|objective disease progression|71
7699660|NCT00410761|12120239|FG001|Overall Study|objective disease progression|55
7699661|NCT00410761|12120238|FG000|Overall Study|Withdrawal by Subject|8
7699662|NCT00410761|12120239|FG001|Overall Study|Withdrawal by Subject|4
7699663|NCT00410761|12120238|FG000|Overall Study|Other|12
7699664|NCT00410761|12120239|FG001|Overall Study|Other|9
7699665|NCT00410761|12120238|FG000|Overall Study|Never received randomised treatment|0
7699666|NCT00410761|12120239|FG001|Overall Study|Never received randomised treatment|1
7699667|NCT00410813|12120247|FG000|Overall Study|Adverse Event|6
7699668|NCT00410813|12120248|FG001|Overall Study|Adverse Event|11
7699669|NCT00410813|12120247|FG000|Overall Study|Progression|32
7699670|NCT00410813|12120248|FG001|Overall Study|Progression|21
7699671|NCT00410813|12120247|FG000|Overall Study|Not protocol specified|3
7699672|NCT00410813|12120248|FG001|Overall Study|Not protocol specified|4
7699673|NCT00410813|12120247|FG000|Overall Study|Ineligible|2
7699674|NCT00410813|12120248|FG001|Overall Study|Ineligible|4
7699675|NCT00410813|12120247|FG000|Overall Study|Death|0
7699676|NCT00410813|12120248|FG001|Overall Study|Death|2
7699677|NCT00411151|12120304|FG000|Overall Study|Death|38
7699678|NCT00411151|12120304|FG000|Overall Study|Withdrawal by Subject|2
7699679|NCT00411151|12120304|FG000|Overall Study|Lost to Follow-up|2
7699680|NCT00411151|12120304|FG000|Overall Study|Protocol Violation|1
7699681|NCT00411151|12120304|FG000|Overall Study|Trial prematurely closed|4
7699682|NCT00411216|12120310|FG000|Overall Study|Ten participants were entered into the c|0
7699683|NCT00411216|12120311|FG001|Overall Study|Ten participants were entered into the c|2
7699684|NCT00411450|12120331|FG000|Overall Study|Ongoing at time of data cut-off.|3
7699685|NCT00411554|12120351|FG000|Overall Study|Adverse Event|2
7699686|NCT00411554|12120352|FG001|Overall Study|Adverse Event|4
7699687|NCT00411554|12120351|FG000|Overall Study|Lack of Efficacy|2
7699688|NCT00411554|12120352|FG001|Overall Study|Lack of Efficacy|5
7699689|NCT00411554|12120351|FG000|Overall Study|Withdrawal by Subject|3
7699690|NCT00411554|12120352|FG001|Overall Study|Withdrawal by Subject|0
7699691|NCT00411554|12120351|FG000|Overall Study|Patient Moved|1
7699692|NCT00411554|12120352|FG001|Overall Study|Patient Moved|0
7699693|NCT00411632|12120363|FG000|Overall Study|Death|1
7699694|NCT00411645|12120369|FG000|Overall Study|Consent Withdrawn|13
7699695|NCT00411645|12120370|FG001|Overall Study|Consent Withdrawn|22
7699696|NCT00411645|12120369|FG000|Overall Study|Death|56
7699697|NCT00411645|12120370|FG001|Overall Study|Death|135
7699698|NCT00411645|12120369|FG000|Overall Study|Investigator/Sponsor Decision|10
7699699|NCT00411645|12120370|FG001|Overall Study|Investigator/Sponsor Decision|7
7699700|NCT00411645|12120369|FG000|Overall Study|Lost to Follow-up|2
7699701|NCT00411645|12120370|FG001|Overall Study|Lost to Follow-up|0
7699702|NCT00411671|12120377|FG000|Overall Study|Adverse Event|15
7699703|NCT00411671|12120377|FG000|Overall Study|Death|2
7699704|NCT00411671|12120377|FG000|Overall Study|Lost to Follow-up|3
7699705|NCT00411762|12120398|FG000|Overall Study|Withdrawal by Subject|5
7699706|NCT00411788|12120402|FG000|Overall Study|Protocol Violation|1
7699707|NCT00411788|12120402|FG000|Overall Study|Adverse Event|1
7699708|NCT00412061|12120408|FG000|Double Blind Phase|Disease Progression|101
7699709|NCT00412061|12120409|FG001|Double Blind Phase|Disease Progression|154
7699710|NCT00412061|12120408|FG000|Double Blind Phase|Adverse Event|61
7699711|NCT00412061|12120409|FG001|Double Blind Phase|Adverse Event|16
7699712|NCT00412061|12120408|FG000|Double Blind Phase|Final Primary Analysis|26
7699713|NCT00412061|12120409|FG001|Double Blind Phase|Final Primary Analysis|14
7699714|NCT00412061|12120408|FG000|Double Blind Phase|Withdrawal by Subject|18
7699715|NCT00412061|12120409|FG001|Double Blind Phase|Withdrawal by Subject|20
7699716|NCT00412061|12120408|FG000|Double Blind Phase|Death|6
7699717|NCT00412061|12120409|FG001|Double Blind Phase|Death|3
7699718|NCT00412061|12120408|FG000|Double Blind Phase|Protocol Violation|3
7699719|NCT00412061|12120409|FG001|Double Blind Phase|Protocol Violation|4
7699720|NCT00412061|12120408|FG000|Double Blind Phase|New Cander Therapy|1
7699721|NCT00412061|12120409|FG001|Double Blind Phase|New Cander Therapy|1
7699722|NCT00412061|12120408|FG000|Double Blind Phase|Lost to Follow-up|0
7699723|NCT00412061|12120409|FG001|Double Blind Phase|Lost to Follow-up|1
7699724|NCT00412061|12120408|FG000|Open Label Phase|Disease Progression|0
7699725|NCT00412061|12120409|FG001|Open Label Phase|Disease Progression|86
7699726|NCT00412061|12120408|FG000|Open Label Phase|Adverse Event|0
7699727|NCT00412061|12120409|FG001|Open Label Phase|Adverse Event|46
7699728|NCT00412061|12120408|FG000|Open Label Phase|Withdrawal by Subject|0
7699729|NCT00412061|12120409|FG001|Open Label Phase|Withdrawal by Subject|15
7699730|NCT00412061|12120408|FG000|Open Label Phase|Administrative Problems|0
7699731|NCT00412061|12120409|FG001|Open Label Phase|Administrative Problems|13
7699732|NCT00412061|12120408|FG000|Open Label Phase|Death|0
7699733|NCT00412061|12120409|FG001|Open Label Phase|Death|7
7699734|NCT00412061|12120408|FG000|Open Label Phase|Lost to Follow-up|0
7699735|NCT00412061|12120409|FG001|Open Label Phase|Lost to Follow-up|2
7699736|NCT00412061|12120408|FG000|Open Label Phase|New Cancer Therapy|0
7699737|NCT00412061|12120409|FG001|Open Label Phase|New Cancer Therapy|1
7699738|NCT00412113|12120445|FG000|Overall Study|Adverse Event|11
7699739|NCT00412113|12120446|FG001|Overall Study|Adverse Event|15
7699740|NCT00412113|12120445|FG000|Overall Study|did not receive treatment|1
7699741|NCT00412113|12120446|FG001|Overall Study|did not receive treatment|0
7699742|NCT00412217|12120454|FG000|Overall Study|Insufficient Data Available|8
7699743|NCT00412217|12120455|FG001|Overall Study|Insufficient Data Available|3
7699744|NCT00412217|12120454|FG000|Overall Study|Death|5
7699745|NCT00412217|12120455|FG001|Overall Study|Death|4
7699746|NCT00412217|12120454|FG000|Overall Study|Disease Progression|2
7699747|NCT00412217|12120455|FG001|Overall Study|Disease Progression|3
7699748|NCT00412217|12120454|FG000|Overall Study|Investigator Decision|1
7699749|NCT00412217|12120455|FG001|Overall Study|Investigator Decision|0
7699750|NCT00412217|12120454|FG000|Overall Study|Withdrawal by Subject|2
7699751|NCT00412217|12120455|FG001|Overall Study|Withdrawal by Subject|0
7699752|NCT00412217|12120454|FG000|Overall Study|Lost to Follow-up|1
7699753|NCT00412217|12120455|FG001|Overall Study|Lost to Follow-up|4
7699754|NCT00412217|12120454|FG000|Overall Study|Study Terminated by Sponsor|26
7699755|NCT00412217|12120455|FG001|Overall Study|Study Terminated by Sponsor|33
7699756|NCT00412217|12120454|FG000|Overall Study|Other|1
7699757|NCT00412217|12120455|FG001|Overall Study|Other|1
7699758|NCT00412360|12120467|FG000|Overall Study|Lost to Follow-up|0
7699759|NCT00412360|12120468|FG001|Overall Study|Lost to Follow-up|1
7699760|NCT00412360|12120467|FG000|Overall Study|Not Transplanted|1
7699761|NCT00412360|12120468|FG001|Overall Study|Not Transplanted|2
7699762|NCT00412373|12120476|FG000|Overall Study|Adverse Event|8
7699763|NCT00412373|12120477|FG001|Overall Study|Adverse Event|13
7699764|NCT00412373|12120476|FG000|Overall Study|Lack of Efficacy|16
7699765|NCT00412373|12120477|FG001|Overall Study|Lack of Efficacy|22
7699766|NCT00412373|12120476|FG000|Overall Study|Lost to Follow-up|7
7699767|NCT00412373|12120477|FG001|Overall Study|Lost to Follow-up|13
7699768|NCT00412373|12120476|FG000|Overall Study|Withdrawal by Subject|8
7699769|NCT00412373|12120477|FG001|Overall Study|Withdrawal by Subject|27
7699770|NCT00412373|12120476|FG000|Overall Study|Other|2
7699771|NCT00412373|12120477|FG001|Overall Study|Other|2
7699772|NCT00412542|12120537|FG000|Overall Study|Withdrawal by Subject|0
7699773|NCT00412542|12120538|FG001|Overall Study|Withdrawal by Subject|2
7699774|NCT00412542|12120537|FG000|Overall Study|Not Eligible|0
7699775|NCT00412542|12120538|FG001|Overall Study|Not Eligible|1
7699776|NCT00412607|12120542|FG000|Overall Study|Withdrawal by Subject|9
7699777|NCT00412607|12120542|FG000|Overall Study|Lost to Follow-up|19
7699778|NCT00412607|12120542|FG000|Overall Study|Death|61
7699779|NCT00412607|12120542|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15
7699780|NCT00412737|12120551|FG000|Overall Study|Death|1
7699781|NCT00412737|12120552|FG001|Overall Study|Death|0
7699782|NCT00412737|12120551|FG000|Overall Study|Adverse Event|3
7699783|NCT00412737|12120552|FG001|Overall Study|Adverse Event|2
7699784|NCT00412737|12120551|FG000|Overall Study|Refused Treatment|6
7699785|NCT00412737|12120552|FG001|Overall Study|Refused Treatment|2
7699786|NCT00412737|12120551|FG000|Overall Study|Failure to Return|6
7699787|NCT00412737|12120552|FG001|Overall Study|Failure to Return|2
7699788|NCT00412750|12120561|FG000|Overall Study|Abnormal laboratory value(s)|1
7699789|NCT00412750|12120562|FG001|Overall Study|Abnormal laboratory value(s)|0
7699790|NCT00412750|12120563|FG002|Overall Study|Abnormal laboratory value(s)|0
7699791|NCT00412750|12120561|FG000|Overall Study|Administrative problems|21
7699792|NCT00412750|12120562|FG001|Overall Study|Administrative problems|17
7699793|NCT00412750|12120563|FG002|Overall Study|Administrative problems|14
7699794|NCT00412750|12120561|FG000|Overall Study|Adverse Event|8
7699795|NCT00412750|12120562|FG001|Overall Study|Adverse Event|3
7699796|NCT00412750|12120563|FG002|Overall Study|Adverse Event|3
7699797|NCT00412750|12120561|FG000|Overall Study|Lost to Follow-up|1
7699798|NCT00412750|12120562|FG001|Overall Study|Lost to Follow-up|0
7699799|NCT00412750|12120563|FG002|Overall Study|Lost to Follow-up|1
7699800|NCT00412750|12120561|FG000|Overall Study|Withdrawal by Subject|0
7699801|NCT00412750|12120562|FG001|Overall Study|Withdrawal by Subject|1
7699802|NCT00412750|12120563|FG002|Overall Study|Withdrawal by Subject|2
7699803|NCT00412750|12120561|FG000|Overall Study|Lack of Efficacy|0
7699804|NCT00412750|12120562|FG001|Overall Study|Lack of Efficacy|0
7699805|NCT00412750|12120563|FG002|Overall Study|Lack of Efficacy|3
7699806|NCT00412854|12120585|FG000|Overall Study|Withdrawn due to adverse events|1
7699807|NCT00412854|12120586|FG001|Overall Study|Withdrawn due to adverse events|5
7699808|NCT00412854|12120585|FG000|Overall Study|Withdrawn for other reasons|13
7699809|NCT00412854|12120586|FG001|Overall Study|Withdrawn for other reasons|11
7699810|NCT00412893|12120599|FG000|Overall Study|Adverse Event|31
7699811|NCT00412893|12120600|FG001|Overall Study|Adverse Event|53
7699812|NCT00412893|12120599|FG000|Overall Study|Death|17
7699813|NCT00412893|12120600|FG001|Overall Study|Death|21
7699814|NCT00412893|12120599|FG000|Overall Study|Insufficient Therapeutic Response|39
7699815|NCT00412893|12120600|FG001|Overall Study|Insufficient Therapeutic Response|23
7699816|NCT00412893|12120599|FG000|Overall Study|Lost to Follow-up|2
7699817|NCT00412893|12120600|FG001|Overall Study|Lost to Follow-up|1
7699818|NCT00412893|12120599|FG000|Overall Study|Violation of Selection at Entry|17
7699819|NCT00412893|12120600|FG001|Overall Study|Violation of Selection at Entry|10
7699820|NCT00412893|12120599|FG000|Overall Study|Other Protocol Violation|10
7699821|NCT00412893|12120600|FG001|Overall Study|Other Protocol Violation|6
7699822|NCT00412893|12120599|FG000|Overall Study|Did Not Cooperate|12
7699823|NCT00412893|12120600|FG001|Overall Study|Did Not Cooperate|9
7699824|NCT00412893|12120599|FG000|Overall Study|Administrative Reason|12
7699825|NCT00412893|12120600|FG001|Overall Study|Administrative Reason|15
7699826|NCT00412893|12120599|FG000|Overall Study|Randomized but Never Received Study Drug|5
7699827|NCT00412893|12120600|FG001|Overall Study|Randomized but Never Received Study Drug|6
7699828|NCT00412958|12120610|FG000|Overall Study|Withdrawal by Subject|3
7699829|NCT00412958|12120611|FG001|Overall Study|Withdrawal by Subject|0
7699830|NCT00412958|12120612|FG002|Overall Study|Withdrawal by Subject|0
7699831|NCT00412958|12120613|FG003|Overall Study|Withdrawal by Subject|1
7699832|NCT00412958|12120610|FG000|Overall Study|Adverse Event|0
7699833|NCT00412958|12120611|FG001|Overall Study|Adverse Event|1
7699834|NCT00412958|12120612|FG002|Overall Study|Adverse Event|0
7699835|NCT00412958|12120613|FG003|Overall Study|Adverse Event|0
7699836|NCT00412958|12120610|FG000|Overall Study|Lost to Follow-up|0
7699837|NCT00412958|12120611|FG001|Overall Study|Lost to Follow-up|1
7699838|NCT00412958|12120612|FG002|Overall Study|Lost to Follow-up|0
7699839|NCT00412958|12120613|FG003|Overall Study|Lost to Follow-up|0
7699840|NCT00412958|12120610|FG000|Overall Study|Death|0
7699841|NCT00412958|12120611|FG001|Overall Study|Death|1
7699842|NCT00412958|12120612|FG002|Overall Study|Death|0
7699843|NCT00412958|12120613|FG003|Overall Study|Death|0
7699844|NCT00412958|12120610|FG000|Overall Study|Transport issue|0
7699845|NCT00412958|12120611|FG001|Overall Study|Transport issue|1
7699846|NCT00412958|12120612|FG002|Overall Study|Transport issue|0
7699847|NCT00412958|12120613|FG003|Overall Study|Transport issue|0
7699848|NCT00412971|12120625|FG000|Overall Study|Lost to Follow-up|17
7699849|NCT00412971|12120626|FG001|Overall Study|Lost to Follow-up|9
7699850|NCT00412971|12120625|FG000|Overall Study|Protocol Violation|13
7699851|NCT00412971|12120626|FG001|Overall Study|Protocol Violation|1
7699852|NCT00412984|12120634|FG000|Overall Study|Death|331
7699853|NCT00412984|12120635|FG001|Overall Study|Death|349
7699854|NCT00412984|12120634|FG000|Overall Study|Adverse Event|679
7699855|NCT00412984|12120635|FG001|Overall Study|Adverse Event|738
7699856|NCT00412984|12120634|FG000|Overall Study|Withdrawal by Subject|921
7699857|NCT00412984|12120635|FG001|Overall Study|Withdrawal by Subject|989
7699858|NCT00412984|12120634|FG000|Overall Study|Lost to Follow-up|51
7699859|NCT00412984|12120635|FG001|Overall Study|Lost to Follow-up|39
7699860|NCT00412984|12120634|FG000|Overall Study|Poor/Noncompliance|57
7699861|NCT00412984|12120635|FG001|Overall Study|Poor/Noncompliance|77
7699862|NCT00412984|12120634|FG000|Overall Study|Pregnancy|1
7699863|NCT00412984|12120635|FG001|Overall Study|Pregnancy|0
7699864|NCT00412984|12120634|FG000|Overall Study|Subject No Longer Meets Study Criteria|87
7699865|NCT00412984|12120635|FG001|Overall Study|Subject No Longer Meets Study Criteria|100
7699866|NCT00412984|12120634|FG000|Overall Study|Administrative Reason by Sponsor|11
7699867|NCT00412984|12120635|FG001|Overall Study|Administrative Reason by Sponsor|8
7699868|NCT00412984|12120634|FG000|Overall Study|Physician Refused to Continue Treatment|81
7699869|NCT00412984|12120635|FG001|Overall Study|Physician Refused to Continue Treatment|89
7699870|NCT00412984|12120634|FG000|Overall Study|Other Reason|80
7699871|NCT00412984|12120635|FG001|Overall Study|Other Reason|92
7699872|NCT00412984|12120634|FG000|Overall Study|Not Reported|11
7699873|NCT00412984|12120635|FG001|Overall Study|Not Reported|12
7699874|NCT00413010|12120643|FG000|Overall Study|Adverse Event|8
7699875|NCT00413010|12120644|FG001|Overall Study|Adverse Event|4
7699876|NCT00413010|12120643|FG000|Overall Study|Laboratory abnormality|0
7699877|NCT00413010|12120644|FG001|Overall Study|Laboratory abnormality|2
7699878|NCT00413010|12120643|FG000|Overall Study|Lack of Efficacy|0
7699879|NCT00413010|12120644|FG001|Overall Study|Lack of Efficacy|3
7699880|NCT00413010|12120643|FG000|Overall Study|Lost to Follow-up|3
7699881|NCT00413010|12120644|FG001|Overall Study|Lost to Follow-up|0
7699882|NCT00413010|12120643|FG000|Overall Study|Withdrawal by Subject|7
7699883|NCT00413010|12120644|FG001|Overall Study|Withdrawal by Subject|2
7699884|NCT00413010|12120643|FG000|Overall Study|Due to termination of the study|54
7699885|NCT00413010|12120644|FG001|Overall Study|Due to termination of the study|52
7699886|NCT00413036|12120650|FG000|Overall Study|Adverse Event|44
7699887|NCT00413036|12120650|FG000|Overall Study|Lack of Efficacy|129
7699888|NCT00413036|12120650|FG000|Overall Study|Withdrawal by Subject|7
7699889|NCT00413036|12120650|FG000|Overall Study|Death|9
7699890|NCT00413036|12120650|FG000|Overall Study|Other|26
7699891|NCT00413036|12120650|FG000|Overall Study|Missing|2
7699892|NCT00413049|12120656|FG000|Overall Study|Adverse Event|10
7699893|NCT00413049|12120657|FG001|Overall Study|Adverse Event|8
7699894|NCT00413049|12120656|FG000|Overall Study|Withdrawal by Subject|7
7699895|NCT00413049|12120657|FG001|Overall Study|Withdrawal by Subject|5
7699896|NCT00413049|12120656|FG000|Overall Study|Lost to Follow-up|2
7699897|NCT00413049|12120657|FG001|Overall Study|Lost to Follow-up|3
7699898|NCT00413049|12120656|FG000|Overall Study|Protocol Violation|3
7699899|NCT00413049|12120657|FG001|Overall Study|Protocol Violation|1
7699900|NCT00413049|12120656|FG000|Overall Study|Subject no longer requires study drug|0
7699901|NCT00413049|12120657|FG001|Overall Study|Subject no longer requires study drug|1
7699902|NCT00413049|12120656|FG000|Overall Study|Abnormal laboratory value(s)|1
7699903|NCT00413049|12120657|FG001|Overall Study|Abnormal laboratory value(s)|0
7699904|NCT00413049|12120656|FG000|Overall Study|Lack of Efficacy|1
7699905|NCT00413049|12120657|FG001|Overall Study|Lack of Efficacy|0
7699906|NCT00413153|12120665|FG000|Overall Study|Withdrawal by Subject|1
7699907|NCT00413153|12120666|FG001|Overall Study|Withdrawal by Subject|1
7699908|NCT00413153|12120665|FG000|Overall Study|Adverse Event|1
7699909|NCT00413153|12120666|FG001|Overall Study|Adverse Event|0
7699910|NCT00413192|12120689|FG000|Overall Study|Disease progression|26
7699911|NCT00413192|12120690|FG001|Overall Study|Disease progression|31
7699912|NCT00413192|12120691|FG002|Overall Study|Disease progression|16
7699913|NCT00413192|12120692|FG003|Overall Study|Disease progression|25
7699914|NCT00413192|12120689|FG000|Overall Study|Toxicity|3
7699915|NCT00413192|12120690|FG001|Overall Study|Toxicity|2
7699916|NCT00413192|12120691|FG002|Overall Study|Toxicity|2
7699917|NCT00413192|12120692|FG003|Overall Study|Toxicity|2
7699918|NCT00413192|12120689|FG000|Overall Study|Withdrawal by Subject|3
7699919|NCT00413192|12120690|FG001|Overall Study|Withdrawal by Subject|5
7699920|NCT00413192|12120691|FG002|Overall Study|Withdrawal by Subject|0
7699921|NCT00413192|12120692|FG003|Overall Study|Withdrawal by Subject|1
7699922|NCT00413192|12120689|FG000|Overall Study|Intercurrent illness|0
7699923|NCT00413192|12120690|FG001|Overall Study|Intercurrent illness|0
7699924|NCT00413192|12120691|FG002|Overall Study|Intercurrent illness|0
7699925|NCT00413192|12120692|FG003|Overall Study|Intercurrent illness|1
7699926|NCT00413192|12120689|FG000|Overall Study|Intercurrent death|0
7699927|NCT00413192|12120690|FG001|Overall Study|Intercurrent death|1
7699928|NCT00413192|12120691|FG002|Overall Study|Intercurrent death|0
7699929|NCT00413192|12120692|FG003|Overall Study|Intercurrent death|0
7699930|NCT00413192|12120689|FG000|Overall Study|Other|5
7699931|NCT00413192|12120690|FG001|Overall Study|Other|1
7699932|NCT00413192|12120691|FG002|Overall Study|Other|1
7699933|NCT00413192|12120692|FG003|Overall Study|Other|2
7699934|NCT00413192|12120689|FG000|Overall Study|Not treated|0
7699935|NCT00413192|12120690|FG001|Overall Study|Not treated|0
7699936|NCT00413192|12120691|FG002|Overall Study|Not treated|0
7699937|NCT00413192|12120692|FG003|Overall Study|Not treated|1
7699938|NCT00413218|12120704|FG000|Overall Study|Randomized but didn't receive study drug|2
7699939|NCT00413218|12120705|FG001|Overall Study|Randomized but didn't receive study drug|8
7699940|NCT00413218|12120704|FG000|Overall Study|Death|57
7699941|NCT00413218|12120705|FG001|Overall Study|Death|56
7699942|NCT00413218|12120704|FG000|Overall Study|Lost to Follow-up|14
7699943|NCT00413218|12120705|FG001|Overall Study|Lost to Follow-up|17
7699944|NCT00413218|12120704|FG000|Overall Study|Admin|20
7699945|NCT00413218|12120705|FG001|Overall Study|Admin|14
7699946|NCT00413218|12120704|FG000|Overall Study|Missing|1
7699947|NCT00413218|12120705|FG001|Overall Study|Missing|0
7699948|NCT00413218|12120704|FG000|Overall Study|Withdrawal by Subject|9
7699949|NCT00413218|12120705|FG001|Overall Study|Withdrawal by Subject|1
7699950|NCT00413231|12120712|FG000|0 to 30-day Post Treatment|Death|5
7699951|NCT00413231|12120712|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
7699952|NCT00413231|12120712|FG000|30-day to 365-day Post Treatment|Death|13
7699953|NCT00413231|12120712|FG000|365-day to 60-month Post Treatment|Death|36
7699954|NCT00413231|12120712|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5
7699955|NCT00413231|12120712|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4
7699956|NCT00413231|12120712|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1
7699957|NCT00413244|12120719|FG000|Overall Study|Withdrawal by Subject|10
7699958|NCT00413244|12120720|FG001|Overall Study|Withdrawal by Subject|1
7699959|NCT00413283|12120730|FG000|Overall Study|Withdrawal by Subject|1
7699960|NCT00413283|12120731|FG001|Overall Study|Withdrawal by Subject|0
7699961|NCT00413283|12120732|FG002|Overall Study|Withdrawal by Subject|0
7699962|NCT00413283|12120733|FG003|Overall Study|Withdrawal by Subject|1
7699963|NCT00413283|12120730|FG000|Overall Study|Death|0
7699964|NCT00413283|12120731|FG001|Overall Study|Death|0
7699965|NCT00413283|12120732|FG002|Overall Study|Death|1
7699966|NCT00413283|12120733|FG003|Overall Study|Death|1
7699967|NCT00413283|12120730|FG000|Overall Study|Adverse Event|0
7699968|NCT00413283|12120731|FG001|Overall Study|Adverse Event|0
7699969|NCT00413283|12120732|FG002|Overall Study|Adverse Event|0
7699970|NCT00413283|12120733|FG003|Overall Study|Adverse Event|1
7699971|NCT00413283|12120730|FG000|Overall Study|Ineligibility determined|0
7699972|NCT00413283|12120731|FG001|Overall Study|Ineligibility determined|0
7699973|NCT00413283|12120732|FG002|Overall Study|Ineligibility determined|0
7699974|NCT00413283|12120733|FG003|Overall Study|Ineligibility determined|1
7699975|NCT00413283|12120730|FG000|Overall Study|Protocol deviation|0
7699976|NCT00413283|12120731|FG001|Overall Study|Protocol deviation|1
7699977|NCT00413283|12120732|FG002|Overall Study|Protocol deviation|0
7699978|NCT00413283|12120733|FG003|Overall Study|Protocol deviation|0
7699979|NCT00413283|12120730|FG000|Overall Study|Requirement for alternative therapy|0
7699980|NCT00413283|12120731|FG001|Overall Study|Requirement for alternative therapy|2
7699981|NCT00413283|12120732|FG002|Overall Study|Requirement for alternative therapy|0
7699982|NCT00413283|12120733|FG003|Overall Study|Requirement for alternative therapy|0
7699983|NCT00413283|12120730|FG000|Overall Study|Other|0
7699984|NCT00413283|12120731|FG001|Overall Study|Other|0
7699985|NCT00413283|12120732|FG002|Overall Study|Other|1
7699986|NCT00413283|12120733|FG003|Overall Study|Other|0
7699987|NCT00413374|12120754|FG000|Overall Study|Ineligible due to screening criteria.|3
7699988|NCT00413374|12120755|FG001|Overall Study|Ineligible due to screening criteria.|0
7699989|NCT00413374|12120754|FG000|Overall Study|Adverse Event|1
7699990|NCT00413374|12120755|FG001|Overall Study|Adverse Event|0
7699991|NCT00413374|12120754|FG000|Overall Study|Lost to Follow-up|1
7699992|NCT00413374|12120755|FG001|Overall Study|Lost to Follow-up|0
7699993|NCT00413374|12120754|FG000|Overall Study|Surgery|1
7699994|NCT00413374|12120755|FG001|Overall Study|Surgery|0
7699995|NCT00413413|12120776|FG000|Single-Blind|Adverse Event|0
7699996|NCT00413413|12120777|FG001|Single-Blind|Adverse Event|9
7699997|NCT00413413|12120778|FG002|Single-Blind|Adverse Event|0
7699998|NCT00413413|12120776|FG000|Single-Blind|Lack of Efficacy|0
7699999|NCT00413413|12120777|FG001|Single-Blind|Lack of Efficacy|5
7700000|NCT00413413|12120778|FG002|Single-Blind|Lack of Efficacy|0
7700001|NCT00413413|12120776|FG000|Single-Blind|Subject no longer requires study drug|0
7700002|NCT00413413|12120777|FG001|Single-Blind|Subject no longer requires study drug|151
7700003|NCT00413413|12120778|FG002|Single-Blind|Subject no longer requires study drug|0
7700004|NCT00413413|12120776|FG000|Single-Blind|Protocol Violation|0
7700005|NCT00413413|12120777|FG001|Single-Blind|Protocol Violation|16
7700006|NCT00413413|12120778|FG002|Single-Blind|Protocol Violation|0
7700007|NCT00413413|12120776|FG000|Single-Blind|Withdrawal by Subject|0
7700008|NCT00413413|12120777|FG001|Single-Blind|Withdrawal by Subject|27
7700009|NCT00413413|12120778|FG002|Single-Blind|Withdrawal by Subject|0
7700010|NCT00413413|12120776|FG000|Single-Blind|Lost to Follow-up|0
7700011|NCT00413413|12120777|FG001|Single-Blind|Lost to Follow-up|8
7700012|NCT00413413|12120778|FG002|Single-Blind|Lost to Follow-up|0
7700013|NCT00413413|12120776|FG000|Double-Blind|Adverse Event|6
7700014|NCT00413413|12120777|FG001|Double-Blind|Adverse Event|0
7700015|NCT00413413|12120778|FG002|Double-Blind|Adverse Event|5
7700016|NCT00413413|12120776|FG000|Double-Blind|Unsatisfactory therapeutic effect|1
7700017|NCT00413413|12120777|FG001|Double-Blind|Unsatisfactory therapeutic effect|2
7700018|NCT00413413|12120778|FG002|Double-Blind|Unsatisfactory therapeutic effect|1
7700019|NCT00413413|12120776|FG000|Double-Blind|Protocol deviation|1
7700020|NCT00413413|12120777|FG001|Double-Blind|Protocol deviation|2
7700021|NCT00413413|12120778|FG002|Double-Blind|Protocol deviation|1
7700022|NCT00413413|12120776|FG000|Double-Blind|Subject withdrew consent|4
7700023|NCT00413413|12120777|FG001|Double-Blind|Subject withdrew consent|6
7700024|NCT00413413|12120778|FG002|Double-Blind|Subject withdrew consent|9
7700025|NCT00413413|12120776|FG000|Double-Blind|Lost to Follow-up|3
7700026|NCT00413413|12120777|FG001|Double-Blind|Lost to Follow-up|4
7700027|NCT00413413|12120778|FG002|Double-Blind|Lost to Follow-up|2
7700028|NCT00413660|12120817|FG000|Up To Week 12|Adverse Event|1
7700029|NCT00413660|12120818|FG001|Up To Week 12|Adverse Event|3
7700030|NCT00413660|12120819|FG002|Up To Week 12|Adverse Event|1
7700031|NCT00413660|12120820|FG003|Up To Week 12|Adverse Event|4
7700032|NCT00413660|12120821|FG004|Up To Week 12|Adverse Event|6
7700033|NCT00413660|12120822|FG005|Up To Week 12|Adverse Event|4
7700034|NCT00413660|12120823|FG006|Up To Week 12|Adverse Event|1
7700035|NCT00413660|12120824|FG007|Up To Week 12|Adverse Event|0
7700036|NCT00413660|12120825|FG008|Up To Week 12|Adverse Event|0
7700037|NCT00413660|12120826|FG009|Up To Week 12|Adverse Event|0
7700038|NCT00413660|12120827|FG010|Up To Week 12|Adverse Event|0
7700039|NCT00413660|12120817|FG000|Up To Week 12|Lack of Efficacy|2
7700040|NCT00413660|12120818|FG001|Up To Week 12|Lack of Efficacy|0
7700041|NCT00413660|12120819|FG002|Up To Week 12|Lack of Efficacy|0
7700042|NCT00413660|12120820|FG003|Up To Week 12|Lack of Efficacy|0
7700043|NCT00413660|12120821|FG004|Up To Week 12|Lack of Efficacy|0
7700044|NCT00413660|12120822|FG005|Up To Week 12|Lack of Efficacy|0
7700045|NCT00413660|12120823|FG006|Up To Week 12|Lack of Efficacy|5
7700046|NCT00413660|12120824|FG007|Up To Week 12|Lack of Efficacy|0
7700047|NCT00413660|12120825|FG008|Up To Week 12|Lack of Efficacy|0
7700048|NCT00413660|12120826|FG009|Up To Week 12|Lack of Efficacy|0
7700049|NCT00413660|12120827|FG010|Up To Week 12|Lack of Efficacy|0
7700050|NCT00413660|12120817|FG000|Up To Week 12|Lost to Follow-up|0
7700051|NCT00413660|12120818|FG001|Up To Week 12|Lost to Follow-up|1
7700052|NCT00413660|12120819|FG002|Up To Week 12|Lost to Follow-up|0
7700053|NCT00413660|12120820|FG003|Up To Week 12|Lost to Follow-up|0
7700054|NCT00413660|12120821|FG004|Up To Week 12|Lost to Follow-up|1
7700055|NCT00413660|12120822|FG005|Up To Week 12|Lost to Follow-up|0
7700056|NCT00413660|12120823|FG006|Up To Week 12|Lost to Follow-up|0
7700057|NCT00413660|12120824|FG007|Up To Week 12|Lost to Follow-up|0
7700058|NCT00413660|12120825|FG008|Up To Week 12|Lost to Follow-up|0
7700059|NCT00413660|12120826|FG009|Up To Week 12|Lost to Follow-up|0
7700060|NCT00413660|12120827|FG010|Up To Week 12|Lost to Follow-up|0
7700061|NCT00413660|12120817|FG000|Up To Week 12|Withdrawal by Subject|0
7700062|NCT00413660|12120818|FG001|Up To Week 12|Withdrawal by Subject|2
7700063|NCT00413660|12120819|FG002|Up To Week 12|Withdrawal by Subject|0
7700064|NCT00413660|12120820|FG003|Up To Week 12|Withdrawal by Subject|2
7700065|NCT00413660|12120821|FG004|Up To Week 12|Withdrawal by Subject|0
7700066|NCT00413660|12120822|FG005|Up To Week 12|Withdrawal by Subject|2
7700067|NCT00413660|12120823|FG006|Up To Week 12|Withdrawal by Subject|2
7700068|NCT00413660|12120824|FG007|Up To Week 12|Withdrawal by Subject|0
7700069|NCT00413660|12120825|FG008|Up To Week 12|Withdrawal by Subject|0
7700070|NCT00413660|12120826|FG009|Up To Week 12|Withdrawal by Subject|0
7700071|NCT00413660|12120827|FG010|Up To Week 12|Withdrawal by Subject|0
7700072|NCT00413660|12120817|FG000|Up To Week 12|Randomized, Not Treated|1
7700073|NCT00413660|12120818|FG001|Up To Week 12|Randomized, Not Treated|0
7700074|NCT00413660|12120819|FG002|Up To Week 12|Randomized, Not Treated|0
7700075|NCT00413660|12120820|FG003|Up To Week 12|Randomized, Not Treated|1
7700076|NCT00413660|12120821|FG004|Up To Week 12|Randomized, Not Treated|0
7700077|NCT00413660|12120822|FG005|Up To Week 12|Randomized, Not Treated|0
7700078|NCT00413660|12120823|FG006|Up To Week 12|Randomized, Not Treated|0
7700079|NCT00413660|12120824|FG007|Up To Week 12|Randomized, Not Treated|0
7700080|NCT00413660|12120825|FG008|Up To Week 12|Randomized, Not Treated|0
7700081|NCT00413660|12120826|FG009|Up To Week 12|Randomized, Not Treated|0
7700082|NCT00413660|12120827|FG010|Up To Week 12|Randomized, Not Treated|0
7700083|NCT00413660|12120817|FG000|Up To Week 12|Other|3
7700084|NCT00413660|12120818|FG001|Up To Week 12|Other|1
7700085|NCT00413660|12120819|FG002|Up To Week 12|Other|6
7700086|NCT00413660|12120820|FG003|Up To Week 12|Other|1
7700087|NCT00413660|12120821|FG004|Up To Week 12|Other|2
7700088|NCT00413660|12120822|FG005|Up To Week 12|Other|4
7700089|NCT00413660|12120823|FG006|Up To Week 12|Other|3
7700090|NCT00413660|12120824|FG007|Up To Week 12|Other|0
7700091|NCT00413660|12120825|FG008|Up To Week 12|Other|0
7700092|NCT00413660|12120826|FG009|Up To Week 12|Other|0
7700093|NCT00413660|12120827|FG010|Up To Week 12|Other|0
7700094|NCT00413660|12120817|FG000|Post Week 12|Adverse Event|2
7700095|NCT00413660|12120818|FG001|Post Week 12|Adverse Event|0
7700096|NCT00413660|12120819|FG002|Post Week 12|Adverse Event|2
7700097|NCT00413660|12120820|FG003|Post Week 12|Adverse Event|1
7700098|NCT00413660|12120821|FG004|Post Week 12|Adverse Event|4
7700099|NCT00413660|12120822|FG005|Post Week 12|Adverse Event|2
7700100|NCT00413660|12120823|FG006|Post Week 12|Adverse Event|2
7700101|NCT00413660|12120824|FG007|Post Week 12|Adverse Event|0
7700102|NCT00413660|12120825|FG008|Post Week 12|Adverse Event|0
7700103|NCT00413660|12120826|FG009|Post Week 12|Adverse Event|0
7700104|NCT00413660|12120827|FG010|Post Week 12|Adverse Event|0
7700105|NCT00413660|12120817|FG000|Post Week 12|Lack of Efficacy|0
7700106|NCT00413660|12120818|FG001|Post Week 12|Lack of Efficacy|0
7700107|NCT00413660|12120819|FG002|Post Week 12|Lack of Efficacy|1
7700108|NCT00413660|12120820|FG003|Post Week 12|Lack of Efficacy|0
7700109|NCT00413660|12120821|FG004|Post Week 12|Lack of Efficacy|0
7700110|NCT00413660|12120822|FG005|Post Week 12|Lack of Efficacy|0
7700111|NCT00413660|12120823|FG006|Post Week 12|Lack of Efficacy|0
7700112|NCT00413660|12120824|FG007|Post Week 12|Lack of Efficacy|0
7700113|NCT00413660|12120825|FG008|Post Week 12|Lack of Efficacy|0
7700114|NCT00413660|12120826|FG009|Post Week 12|Lack of Efficacy|1
7700115|NCT00413660|12120827|FG010|Post Week 12|Lack of Efficacy|0
7700116|NCT00413660|12120817|FG000|Post Week 12|Lost to Follow-up|0
7700117|NCT00413660|12120818|FG001|Post Week 12|Lost to Follow-up|1
7700118|NCT00413660|12120819|FG002|Post Week 12|Lost to Follow-up|1
7700119|NCT00413660|12120820|FG003|Post Week 12|Lost to Follow-up|0
7700120|NCT00413660|12120821|FG004|Post Week 12|Lost to Follow-up|0
7700121|NCT00413660|12120822|FG005|Post Week 12|Lost to Follow-up|0
7700122|NCT00413660|12120823|FG006|Post Week 12|Lost to Follow-up|0
7700123|NCT00413660|12120824|FG007|Post Week 12|Lost to Follow-up|0
7700124|NCT00413660|12120825|FG008|Post Week 12|Lost to Follow-up|0
7700125|NCT00413660|12120826|FG009|Post Week 12|Lost to Follow-up|0
7700126|NCT00413660|12120827|FG010|Post Week 12|Lost to Follow-up|0
7700127|NCT00413660|12120817|FG000|Post Week 12|Withdrawal by Subject|0
7700128|NCT00413660|12120818|FG001|Post Week 12|Withdrawal by Subject|1
7700129|NCT00413660|12120819|FG002|Post Week 12|Withdrawal by Subject|1
7700130|NCT00413660|12120820|FG003|Post Week 12|Withdrawal by Subject|0
7700131|NCT00413660|12120821|FG004|Post Week 12|Withdrawal by Subject|1
7700132|NCT00413660|12120822|FG005|Post Week 12|Withdrawal by Subject|0
7700133|NCT00413660|12120823|FG006|Post Week 12|Withdrawal by Subject|0
7700134|NCT00413660|12120824|FG007|Post Week 12|Withdrawal by Subject|0
7700135|NCT00413660|12120825|FG008|Post Week 12|Withdrawal by Subject|0
7700136|NCT00413660|12120826|FG009|Post Week 12|Withdrawal by Subject|0
7700137|NCT00413660|12120827|FG010|Post Week 12|Withdrawal by Subject|1
7700138|NCT00413660|12120817|FG000|Post Week 12|Other|1
7700139|NCT00413660|12120818|FG001|Post Week 12|Other|2
7700140|NCT00413660|12120819|FG002|Post Week 12|Other|3
7700141|NCT00413660|12120820|FG003|Post Week 12|Other|0
7700142|NCT00413660|12120821|FG004|Post Week 12|Other|1
7700143|NCT00413660|12120822|FG005|Post Week 12|Other|1
7700144|NCT00413660|12120823|FG006|Post Week 12|Other|1
7700145|NCT00413660|12120824|FG007|Post Week 12|Other|0
7700146|NCT00413660|12120825|FG008|Post Week 12|Other|0
7700147|NCT00413660|12120826|FG009|Post Week 12|Other|0
7700148|NCT00413660|12120827|FG010|Post Week 12|Other|0
7700149|NCT00413777|12120859|FG000|Fixed-dose Period|Lost to Follow-up|1
7700150|NCT00413777|12120860|FG001|Fixed-dose Period|Lost to Follow-up|1
7700151|NCT00413777|12120859|FG000|Fixed-dose Period|Adverse Event|2
7700152|NCT00413777|12120860|FG001|Fixed-dose Period|Adverse Event|1
7700153|NCT00413777|12120859|FG000|Fixed-dose Period|Met Withdrawal Criteria|1
7700154|NCT00413777|12120860|FG001|Fixed-dose Period|Met Withdrawal Criteria|0
7700155|NCT00413777|12120859|FG000|Fixed-dose Period|Withdrew Consent|0
7700156|NCT00413777|12120860|FG001|Fixed-dose Period|Withdrew Consent|1
7700157|NCT00413894|12120866|FG000|Overall Study|Withdrawal by Subject|10
7700158|NCT00413894|12120866|FG000|Overall Study|Administrative Reasons|1
7700159|NCT00413894|12120866|FG000|Overall Study|Hb <10 grams/deciliter|12
7700160|NCT00413894|12120866|FG000|Overall Study|Adverse Event|28
7700161|NCT00413894|12120866|FG000|Overall Study|Protocol Violation|11
7700162|NCT00413894|12120866|FG000|Overall Study|Other|18
7700163|NCT00413920|12120875|FG000|Overall Study|Adverse Event|9
7700164|NCT00413920|12120876|FG001|Overall Study|Adverse Event|11
7700165|NCT00413920|12120875|FG000|Overall Study|Lack of Efficacy|11
7700166|NCT00413920|12120876|FG001|Overall Study|Lack of Efficacy|9
7700167|NCT00413920|12120875|FG000|Overall Study|Death|3
7700168|NCT00413920|12120876|FG001|Overall Study|Death|5
7700169|NCT00413920|12120875|FG000|Overall Study|Graft Loss|5
7700170|NCT00413920|12120876|FG001|Overall Study|Graft Loss|3
7700171|NCT00413959|12120882|FG000|Overall Study|Pt had only one cycle.|1
7700172|NCT00414011|12120886|FG000|Overall Study|Physician Decision|3
7700173|NCT00414011|12120886|FG000|Overall Study|Withdrawal by Subject|2
7700174|NCT00414050|12120895|FG000|Overall Study|Adverse Event|1
7700175|NCT00414050|12120896|FG001|Overall Study|Adverse Event|1
7700176|NCT00414050|12120897|FG002|Overall Study|Adverse Event|1
7700177|NCT00414050|12120898|FG003|Overall Study|Adverse Event|1
7700178|NCT00414050|12120895|FG000|Overall Study|Lost to Follow-up|2
7700179|NCT00414050|12120896|FG001|Overall Study|Lost to Follow-up|2
7700180|NCT00414050|12120897|FG002|Overall Study|Lost to Follow-up|1
7700181|NCT00414050|12120898|FG003|Overall Study|Lost to Follow-up|1
7700182|NCT00414050|12120895|FG000|Overall Study|Withdrawal by Subject|5
7700183|NCT00414050|12120896|FG001|Overall Study|Withdrawal by Subject|3
7700184|NCT00414050|12120897|FG002|Overall Study|Withdrawal by Subject|2
7700185|NCT00414050|12120898|FG003|Overall Study|Withdrawal by Subject|4
7700186|NCT00414050|12120895|FG000|Overall Study|Subject discontinued for other reason|1
7700187|NCT00414050|12120896|FG001|Overall Study|Subject discontinued for other reason|2
7700188|NCT00414050|12120897|FG002|Overall Study|Subject discontinued for other reason|2
7700189|NCT00414050|12120898|FG003|Overall Study|Subject discontinued for other reason|1
7700190|NCT00414050|12120895|FG000|Overall Study|Subject Moved|0
7700191|NCT00414050|12120896|FG001|Overall Study|Subject Moved|0
7700192|NCT00414050|12120897|FG002|Overall Study|Subject Moved|0
7700193|NCT00414050|12120898|FG003|Overall Study|Subject Moved|1
7700194|NCT00414076|12120910|FG000|Overall Study|Progression|1
7700195|NCT00414076|12120911|FG001|Overall Study|Progression|2
7700196|NCT00414076|12120910|FG000|Overall Study|Withdrawal by Subject|1
7700197|NCT00414076|12120911|FG001|Overall Study|Withdrawal by Subject|3
7700198|NCT00414076|12120910|FG000|Overall Study|Adverse Event|1
7700199|NCT00414076|12120911|FG001|Overall Study|Adverse Event|0
7700200|NCT00414310|12120947|FG000|Overall Study|Not treated|1
7700201|NCT00414310|12120948|FG001|Overall Study|Not treated|0
7700202|NCT00414388|12120956|FG000|Overall Study|Adverse Event|1
7700203|NCT00414440|12120963|FG000|Core Period|Withdrawal by Subject|70
7700204|NCT00414440|12120964|FG001|Core Period|Withdrawal by Subject|32
7700205|NCT00414440|12120963|FG000|Extension Period|Lost to Follow-up|44
7700206|NCT00414440|12120964|FG001|Extension Period|Lost to Follow-up|52
7700207|NCT00414440|12120963|FG000|Extension Period|Did not consent to continue follow up|61
7700208|NCT00414440|12120964|FG001|Extension Period|Did not consent to continue follow up|54
7700209|NCT00414440|12120963|FG000|Extension Period|Other|1
7700210|NCT00414440|12120964|FG001|Extension Period|Other|1
7700211|NCT00414440|12120963|FG000|Extension Period|Administrative|16
7700212|NCT00414440|12120964|FG001|Extension Period|Administrative|16
7700213|NCT00414440|12120963|FG000|Extension Period|Death|1
7700214|NCT00414440|12120964|FG001|Extension Period|Death|2
7700215|NCT00414440|12120963|FG000|Extension Period|Withdrawal by Subject|9
7700216|NCT00414440|12120964|FG001|Extension Period|Withdrawal by Subject|7
7700217|NCT00414440|12120963|FG000|Extension Period|Not included in follow up period|18
7700218|NCT00414440|12120964|FG001|Extension Period|Not included in follow up period|8
7700219|NCT00414466|12120974|FG000|Overall Study|Adverse Event|0
7700220|NCT00414466|12120975|FG001|Overall Study|Adverse Event|0
7700221|NCT00414466|12120976|FG002|Overall Study|Adverse Event|1
7700222|NCT00414466|12120977|FG003|Overall Study|Adverse Event|1
7700223|NCT00414466|12120974|FG000|Overall Study|Lack of Efficacy|1
7700224|NCT00414466|12120975|FG001|Overall Study|Lack of Efficacy|0
7700225|NCT00414466|12120976|FG002|Overall Study|Lack of Efficacy|0
7700226|NCT00414466|12120977|FG003|Overall Study|Lack of Efficacy|0
7700227|NCT00414466|12120974|FG000|Overall Study|Withdrawn by Sponsor|1
7700228|NCT00414466|12120975|FG001|Overall Study|Withdrawn by Sponsor|0
7700229|NCT00414466|12120976|FG002|Overall Study|Withdrawn by Sponsor|0
7700230|NCT00414466|12120977|FG003|Overall Study|Withdrawn by Sponsor|0
7700231|NCT00414544|12121003|FG000|Overall Study|Lost to Follow-up|14
7700232|NCT00414596|12121009|FG000|Overall Study|Protocol Violation|2
7700233|NCT00414609|12121015|FG000|Core Study|Adverse Event|9
7700234|NCT00414609|12121016|FG001|Core Study|Adverse Event|11
7700235|NCT00414609|12121017|FG002|Core Study|Adverse Event|0
7700236|NCT00414609|12121015|FG000|Core Study|Abnormal laboratory values|0
7700237|NCT00414609|12121016|FG001|Core Study|Abnormal laboratory values|1
7700238|NCT00414609|12121017|FG002|Core Study|Abnormal laboratory values|0
7700239|NCT00414609|12121015|FG000|Core Study|Abnormal test procedure results|1
7700240|NCT00414609|12121016|FG001|Core Study|Abnormal test procedure results|1
7700241|NCT00414609|12121017|FG002|Core Study|Abnormal test procedure results|0
7700242|NCT00414609|12121015|FG000|Core Study|Protocol deviation|0
7700243|NCT00414609|12121016|FG001|Core Study|Protocol deviation|1
7700244|NCT00414609|12121017|FG002|Core Study|Protocol deviation|0
7700245|NCT00414609|12121015|FG000|Core Study|Patient withdrew consent|10
7700246|NCT00414609|12121016|FG001|Core Study|Patient withdrew consent|11
7700247|NCT00414609|12121017|FG002|Core Study|Patient withdrew consent|0
7700248|NCT00414609|12121015|FG000|Core Study|Lost to Follow-up|7
7700249|NCT00414609|12121016|FG001|Core Study|Lost to Follow-up|4
7700250|NCT00414609|12121017|FG002|Core Study|Lost to Follow-up|0
7700251|NCT00414609|12121015|FG000|Core Study|Administrative problems|0
7700252|NCT00414609|12121016|FG001|Core Study|Administrative problems|2
7700253|NCT00414609|12121017|FG002|Core Study|Administrative problems|0
7700254|NCT00414609|12121015|FG000|Core Study|Death|7
7700255|NCT00414609|12121016|FG001|Core Study|Death|14
7700256|NCT00414609|12121017|FG002|Core Study|Death|0
7700257|NCT00414609|12121015|FG000|Extension Study|Adverse Event|0
7700258|NCT00414609|12121016|FG001|Extension Study|Adverse Event|0
7700259|NCT00414609|12121017|FG002|Extension Study|Adverse Event|14
7700260|NCT00414609|12121015|FG000|Extension Study|Unsatisfactory therapeutic effect|0
7700261|NCT00414609|12121016|FG001|Extension Study|Unsatisfactory therapeutic effect|0
7700262|NCT00414609|12121017|FG002|Extension Study|Unsatisfactory therapeutic effect|2
7700263|NCT00414609|12121015|FG000|Extension Study|Withdrawal by Subject|0
7700264|NCT00414609|12121016|FG001|Extension Study|Withdrawal by Subject|0
7700265|NCT00414609|12121017|FG002|Extension Study|Withdrawal by Subject|13
7700266|NCT00414609|12121015|FG000|Extension Study|Lost to Follow-up|0
7700267|NCT00414609|12121016|FG001|Extension Study|Lost to Follow-up|0
7700268|NCT00414609|12121017|FG002|Extension Study|Lost to Follow-up|10
7700269|NCT00414609|12121015|FG000|Extension Study|Administrative problems|0
7700270|NCT00414609|12121016|FG001|Extension Study|Administrative problems|0
7700271|NCT00414609|12121017|FG002|Extension Study|Administrative problems|1
7700272|NCT00414609|12121015|FG000|Extension Study|Death|0
7700273|NCT00414609|12121016|FG001|Extension Study|Death|0
7700274|NCT00414609|12121017|FG002|Extension Study|Death|17
7700275|NCT00414661|12121039|FG000|Overall Study|Death|2
7700276|NCT00414661|12121040|FG001|Overall Study|Death|5
7700277|NCT00414661|12121041|FG002|Overall Study|Death|0
7700278|NCT00414661|12121042|FG003|Overall Study|Death|0
7700279|NCT00414661|12121039|FG000|Overall Study|Lost to Follow-up|1
7700280|NCT00414661|12121040|FG001|Overall Study|Lost to Follow-up|4
7700281|NCT00414661|12121041|FG002|Overall Study|Lost to Follow-up|0
7700282|NCT00414661|12121042|FG003|Overall Study|Lost to Follow-up|1
7700283|NCT00414661|12121039|FG000|Overall Study|Withdrawal by Subject|5
7700284|NCT00414661|12121040|FG001|Overall Study|Withdrawal by Subject|2
7700285|NCT00414661|12121041|FG002|Overall Study|Withdrawal by Subject|2
7700286|NCT00414661|12121042|FG003|Overall Study|Withdrawal by Subject|2
7700287|NCT00414661|12121039|FG000|Overall Study|Other|6
7700288|NCT00414661|12121040|FG001|Overall Study|Other|3
7700289|NCT00414661|12121041|FG002|Overall Study|Other|0
7700290|NCT00414661|12121042|FG003|Overall Study|Other|0
7700291|NCT00414726|12121063|FG000|Overall Study|Withdrawal by Subject|0
7700292|NCT00414726|12121064|FG001|Overall Study|Withdrawal by Subject|1
7700293|NCT00414765|12121072|FG000|Overall Study|Adverse Event|5
7700294|NCT00414765|12121073|FG001|Overall Study|Adverse Event|9
7700295|NCT00414765|12121072|FG000|Overall Study|Withdrawal by Subject|1
7700296|NCT00414765|12121073|FG001|Overall Study|Withdrawal by Subject|1
7700297|NCT00414765|12121072|FG000|Overall Study|Disease Progression|0
7700298|NCT00414765|12121073|FG001|Overall Study|Disease Progression|1
7700299|NCT00414908|12121090|FG000|Overall Study|Protocol Violation|1
7700300|NCT00414908|12121091|FG001|Overall Study|Protocol Violation|1
7700301|NCT00414960|12121101|FG000|Overall Study|Adverse Event|4
7700302|NCT00414960|12121102|FG001|Overall Study|Adverse Event|0
7700303|NCT00414960|12121101|FG000|Overall Study|Withdrawal by Subject|3
7700304|NCT00414960|12121102|FG001|Overall Study|Withdrawal by Subject|0
7700305|NCT00414960|12121101|FG000|Overall Study|Physician Decision|0
7700306|NCT00414960|12121102|FG001|Overall Study|Physician Decision|1
7700307|NCT00414973|12121112|FG000|Overall Study|Withdrawal by Subject|14
7700308|NCT00414973|12121113|FG001|Overall Study|Withdrawal by Subject|4
7700309|NCT00414973|12121114|FG002|Overall Study|Withdrawal by Subject|1
7700310|NCT00414973|12121115|FG003|Overall Study|Withdrawal by Subject|0
7700311|NCT00414973|12121112|FG000|Overall Study|Adverse Event|10
7700312|NCT00414973|12121113|FG001|Overall Study|Adverse Event|0
7700313|NCT00414973|12121114|FG002|Overall Study|Adverse Event|1
7700314|NCT00414973|12121115|FG003|Overall Study|Adverse Event|0
7700315|NCT00414973|12121112|FG000|Overall Study|Protocol Violation|3
7700316|NCT00414973|12121113|FG001|Overall Study|Protocol Violation|4
7700317|NCT00414973|12121114|FG002|Overall Study|Protocol Violation|0
7700318|NCT00414973|12121115|FG003|Overall Study|Protocol Violation|0
7700319|NCT00414973|12121112|FG000|Overall Study|Lost to Follow-up|0
7700320|NCT00414973|12121113|FG001|Overall Study|Lost to Follow-up|2
7700321|NCT00414973|12121114|FG002|Overall Study|Lost to Follow-up|0
7700322|NCT00414973|12121115|FG003|Overall Study|Lost to Follow-up|0
7700323|NCT00414973|12121112|FG000|Overall Study|Sponsor Decision|1
7700324|NCT00414973|12121113|FG001|Overall Study|Sponsor Decision|0
7700325|NCT00414973|12121114|FG002|Overall Study|Sponsor Decision|0
7700326|NCT00414973|12121115|FG003|Overall Study|Sponsor Decision|0
7700327|NCT00414973|12121112|FG000|Overall Study|Death|0
7700328|NCT00414973|12121113|FG001|Overall Study|Death|0
7700329|NCT00414973|12121114|FG002|Overall Study|Death|1
7700330|NCT00414973|12121115|FG003|Overall Study|Death|0
7700331|NCT00415051|12121125|FG000|Overall Study|Protocol Violation|1
7700332|NCT00415168|12121129|FG000|Overall Study|Death|26
7700333|NCT00415168|12121129|FG000|Overall Study|Lost to Follow-up|3
7700334|NCT00415168|12121129|FG000|Overall Study|Physician Decision|13
7700335|NCT00415168|12121129|FG000|Overall Study|Sponsor Decision|4
7700336|NCT00415168|12121129|FG000|Overall Study|Withdrawal by Subject|6
7700337|NCT00415194|12121135|FG000|Overall Study|Adverse Event|37
7700338|NCT00415194|12121136|FG001|Overall Study|Adverse Event|32
7700339|NCT00415194|12121135|FG000|Overall Study|Entry Criteria Not Met|4
7700340|NCT00415194|12121136|FG001|Overall Study|Entry Criteria Not Met|8
7700341|NCT00415194|12121135|FG000|Overall Study|Lost to Follow-up|1
7700342|NCT00415194|12121136|FG001|Overall Study|Lost to Follow-up|0
7700343|NCT00415194|12121135|FG000|Overall Study|Physician Decision|10
7700344|NCT00415194|12121136|FG001|Overall Study|Physician Decision|16
7700345|NCT00415194|12121135|FG000|Overall Study|Progressive Disease|180
7700346|NCT00415194|12121136|FG001|Overall Study|Progressive Disease|217
7700347|NCT00415194|12121135|FG000|Overall Study|Protocol Violation|4
7700348|NCT00415194|12121136|FG001|Overall Study|Protocol Violation|2
7700349|NCT00415194|12121135|FG000|Overall Study|Withdrawal by Subject|28
7700350|NCT00415194|12121136|FG001|Overall Study|Withdrawal by Subject|21
7700351|NCT00415194|12121135|FG000|Overall Study|Death Due to Study Disease|26
7700352|NCT00415194|12121136|FG001|Overall Study|Death Due to Study Disease|29
7700353|NCT00415194|12121135|FG000|Overall Study|Death Due to Study Drug Related AE|11
7700354|NCT00415194|12121136|FG001|Overall Study|Death Due to Study Drug Related AE|1
7700355|NCT00415194|12121135|FG000|Overall Study|Death Due to Procedural Related AE|0
7700356|NCT00415194|12121136|FG001|Overall Study|Death Due to Procedural Related AE|1
7700357|NCT00415194|12121135|FG000|Overall Study|Death Due to AE (Other Causes)|27
7700358|NCT00415194|12121136|FG001|Overall Study|Death Due to AE (Other Causes)|15
7700359|NCT00415363|12121144|FG000|Overall Study|Withdrawal by Subject|4
7700360|NCT00415363|12121145|FG001|Overall Study|Withdrawal by Subject|4
7700361|NCT00415363|12121144|FG000|Overall Study|Adverse Event|4
7700362|NCT00415363|12121145|FG001|Overall Study|Adverse Event|4
7700363|NCT00415363|12121144|FG000|Overall Study|Lost to Follow-up|2
7700364|NCT00415363|12121145|FG001|Overall Study|Lost to Follow-up|1
7700365|NCT00415363|12121144|FG000|Overall Study|Physician Decision|3
7700366|NCT00415363|12121145|FG001|Overall Study|Physician Decision|1
7700367|NCT00415363|12121144|FG000|Overall Study|Death|16
7700368|NCT00415363|12121145|FG001|Overall Study|Death|12
7700369|NCT00415363|12121144|FG000|Overall Study|Progressive disease|26
7700370|NCT00415363|12121145|FG001|Overall Study|Progressive disease|32
7700371|NCT00415519|12121172|FG000|Overall Study|Adverse Event|1
7700372|NCT00415519|12121173|FG001|Overall Study|Adverse Event|0
7700373|NCT00415519|12121172|FG000|Overall Study|Withdrawal by Subject|2
7700374|NCT00415519|12121173|FG001|Overall Study|Withdrawal by Subject|0
7700375|NCT00415519|12121172|FG000|Overall Study|Patient's convenience|1
7700376|NCT00415519|12121173|FG001|Overall Study|Patient's convenience|0
7700377|NCT00415597|12121179|FG000|Enrollment|Withdrawal by Subject|1
7700378|NCT00415597|12121179|FG000|Enrollment|Protocol Violation|1
7700379|NCT00415597|12121179|FG000|Treatment|Adverse Event|110
7700380|NCT00415597|12121179|FG000|Treatment|Lack of Efficacy|39
7700381|NCT00415597|12121179|FG000|Treatment|Protocol Violation|67
7700382|NCT00415597|12121179|FG000|Treatment|Physician Decision|3
7700383|NCT00415597|12121179|FG000|Treatment|Withdrawal by Subject|51
7700384|NCT00415597|12121179|FG000|Treatment|Lost to Follow-up|28
7700385|NCT00415597|12121179|FG000|Treatment|Drug Screen|2
7700386|NCT00415597|12121179|FG000|Treatment|Administrative|3
7700387|NCT00415597|12121179|FG000|Treatment|Sponsor Decision|1
7700388|NCT00415597|12121179|FG000|Treatment|Multiple Reasons|1
7700389|NCT00415610|12121186|FG000|Overall Study|Death|3
7700390|NCT00415610|12121187|FG001|Overall Study|Death|2
7700391|NCT00415610|12121188|FG002|Overall Study|Death|5
7700392|NCT00415636|12121202|FG000|Overall Study|Symptomatic deterioration|1
7700393|NCT00415636|12121203|FG001|Overall Study|Symptomatic deterioration|0
7700394|NCT00415636|12121204|FG002|Overall Study|Symptomatic deterioration|1
7700395|NCT00415636|12121205|FG003|Overall Study|Symptomatic deterioration|2
7700396|NCT00415636|12121206|FG004|Overall Study|Symptomatic deterioration|0
7700397|NCT00415636|12121207|FG005|Overall Study|Symptomatic deterioration|1
7700398|NCT00415636|12121202|FG000|Overall Study|Adverse Event|0
7700399|NCT00415636|12121203|FG001|Overall Study|Adverse Event|0
7700400|NCT00415636|12121204|FG002|Overall Study|Adverse Event|0
7700401|NCT00415636|12121205|FG003|Overall Study|Adverse Event|1
7700402|NCT00415636|12121206|FG004|Overall Study|Adverse Event|1
7700403|NCT00415636|12121207|FG005|Overall Study|Adverse Event|0
7700404|NCT00415636|12121202|FG000|Overall Study|Withdrawal by Subject|0
7700405|NCT00415636|12121203|FG001|Overall Study|Withdrawal by Subject|0
7700406|NCT00415636|12121204|FG002|Overall Study|Withdrawal by Subject|0
7700407|NCT00415636|12121205|FG003|Overall Study|Withdrawal by Subject|0
7700408|NCT00415636|12121206|FG004|Overall Study|Withdrawal by Subject|1
7700409|NCT00415636|12121207|FG005|Overall Study|Withdrawal by Subject|0
7700410|NCT00415636|12121202|FG000|Overall Study|Disease progression|0
7700411|NCT00415636|12121203|FG001|Overall Study|Disease progression|0
7700412|NCT00415636|12121204|FG002|Overall Study|Disease progression|0
7700413|NCT00415636|12121205|FG003|Overall Study|Disease progression|3
7700414|NCT00415636|12121206|FG004|Overall Study|Disease progression|0
7700415|NCT00415636|12121207|FG005|Overall Study|Disease progression|1
7700416|NCT00415909|12121247|FG000|Overall Study|Withdrawal by Subject|2
7700417|NCT00415909|12121247|FG000|Overall Study|Death|1
7700418|NCT00416078|12121253|FG000|Overall Study|Death|3
7700419|NCT00416078|12121254|FG001|Overall Study|Death|4
7700420|NCT00416078|12121253|FG000|Overall Study|Withdrawal by Subject|3
7700421|NCT00416078|12121254|FG001|Overall Study|Withdrawal by Subject|2
7700422|NCT00416078|12121253|FG000|Overall Study|Physician Decision|1
7700423|NCT00416078|12121254|FG001|Overall Study|Physician Decision|0
7700424|NCT00416078|12121253|FG000|Overall Study|Lost to Follow-up|4
7700425|NCT00416078|12121254|FG001|Overall Study|Lost to Follow-up|2
7700426|NCT00416195|12121277|FG000|Overall Study|Adverse Event|1
7700427|NCT00416195|12121278|FG001|Overall Study|Adverse Event|2
7700428|NCT00416195|12121277|FG000|Overall Study|Protocol Violation|1
7700429|NCT00416195|12121278|FG001|Overall Study|Protocol Violation|1
7700430|NCT00416195|12121277|FG000|Overall Study|Other|0
7700431|NCT00416195|12121278|FG001|Overall Study|Other|1
7700432|NCT00416312|12121284|FG000|Overall Study|tumors not visible on imaging|2
7700433|NCT00416455|12121290|FG000|Overall Study|PET / CT not done|3
7700434|NCT00416455|12121291|FG001|Overall Study|PET / CT not done|5
7700435|NCT00416455|12121290|FG000|Overall Study|PET / CT poor quality|2
7700436|NCT00416455|12121291|FG001|Overall Study|PET / CT poor quality|1
7700437|NCT00416455|12121290|FG000|Overall Study|Inadequate pathology|11
7700438|NCT00416455|12121291|FG001|Overall Study|Inadequate pathology|2
7700439|NCT00416520|12121319|FG000|Open-label Period|Adverse Event|28
7700440|NCT00416520|12121320|FG001|Open-label Period|Adverse Event|10
7700441|NCT00416520|12121321|FG002|Open-label Period|Adverse Event|0
7700442|NCT00416520|12121322|FG003|Open-label Period|Adverse Event|0
7700443|NCT00416520|12121319|FG000|Open-label Period|Death|2
7700444|NCT00416520|12121320|FG001|Open-label Period|Death|1
7700445|NCT00416520|12121321|FG002|Open-label Period|Death|0
7700446|NCT00416520|12121322|FG003|Open-label Period|Death|0
7700447|NCT00416520|12121319|FG000|Open-label Period|Lack of Efficacy|8
7700448|NCT00416520|12121320|FG001|Open-label Period|Lack of Efficacy|1
7700449|NCT00416520|12121321|FG002|Open-label Period|Lack of Efficacy|0
7700450|NCT00416520|12121322|FG003|Open-label Period|Lack of Efficacy|0
7700451|NCT00416520|12121319|FG000|Open-label Period|Protocol Violation|3
7700452|NCT00416520|12121320|FG001|Open-label Period|Protocol Violation|3
7700453|NCT00416520|12121321|FG002|Open-label Period|Protocol Violation|0
7700454|NCT00416520|12121322|FG003|Open-label Period|Protocol Violation|0
7700455|NCT00416520|12121319|FG000|Open-label Period|Withdrawal by Subject|16
7700456|NCT00416520|12121320|FG001|Open-label Period|Withdrawal by Subject|5
7700457|NCT00416520|12121321|FG002|Open-label Period|Withdrawal by Subject|0
7700458|NCT00416520|12121322|FG003|Open-label Period|Withdrawal by Subject|0
7700459|NCT00416520|12121319|FG000|Open-label Period|Other Reasons|3
7700460|NCT00416520|12121320|FG001|Open-label Period|Other Reasons|12
7700461|NCT00416520|12121321|FG002|Open-label Period|Other Reasons|0
7700462|NCT00416520|12121322|FG003|Open-label Period|Other Reasons|0
7700463|NCT00416520|12121319|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0
7700464|NCT00416520|12121320|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0
7700465|NCT00416520|12121321|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0
7700466|NCT00416520|12121322|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1
7700467|NCT00416520|12121319|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
7700468|NCT00416520|12121320|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
7700469|NCT00416520|12121321|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
7700470|NCT00416520|12121322|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
7700471|NCT00416520|12121319|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0
7700472|NCT00416520|12121320|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0
7700473|NCT00416520|12121321|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1
7700474|NCT00416520|12121322|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1
7700475|NCT00416598|12121345|FG000|Induction & Intensification|Adverse Event|38
7700476|NCT00416598|12121345|FG000|Induction & Intensification|Death|32
7700477|NCT00416598|12121345|FG000|Induction & Intensification|Withdrawal by Subject|46
7700478|NCT00416598|12121345|FG000|Induction & Intensification|Alternative Treatment|135
7700479|NCT00416598|12121345|FG000|Induction & Intensification|Physician discretion/other medical issue|45
7700480|NCT00416598|12121345|FG000|Induction & Intensification|Relapse/progression|29
7700481|NCT00416598|12121345|FG000|Induction & Intensification|Failed induction|87
7700482|NCT00416598|12121345|FG000|Decitabine Maintenance|Adverse Event|5
7700483|NCT00416598|12121345|FG000|Decitabine Maintenance|Withdrawal by Subject|18
7700484|NCT00416598|12121345|FG000|Decitabine Maintenance|Progression/relapse|38
7700485|NCT00416598|12121345|FG000|Decitabine Maintenance|Alternative treatment|2
7700486|NCT00416598|12121345|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9
7700487|NCT00416624|12121353|FG000|Overall Study|Withdrawal by Subject|1
7700488|NCT00416624|12121354|FG001|Overall Study|Withdrawal by Subject|6
7700489|NCT00416624|12121355|FG002|Overall Study|Withdrawal by Subject|4
7700490|NCT00416624|12121356|FG003|Overall Study|Withdrawal by Subject|9
7700491|NCT00416624|12121353|FG000|Overall Study|Death|4
7700492|NCT00416624|12121354|FG001|Overall Study|Death|7
7700493|NCT00416624|12121355|FG002|Overall Study|Death|7
7700494|NCT00416624|12121356|FG003|Overall Study|Death|1
7700495|NCT00416624|12121353|FG000|Overall Study|Adverse Event|8
7700496|NCT00416624|12121354|FG001|Overall Study|Adverse Event|3
7700497|NCT00416624|12121355|FG002|Overall Study|Adverse Event|2
7700498|NCT00416624|12121356|FG003|Overall Study|Adverse Event|2
7700499|NCT00416624|12121353|FG000|Overall Study|Other|8
7700500|NCT00416624|12121354|FG001|Overall Study|Other|11
7700501|NCT00416624|12121355|FG002|Overall Study|Other|5
7700502|NCT00416624|12121356|FG003|Overall Study|Other|5
7700503|NCT00416624|12121353|FG000|Overall Study|Cancel|1
7700504|NCT00416624|12121354|FG001|Overall Study|Cancel|0
7700505|NCT00416624|12121355|FG002|Overall Study|Cancel|0
7700506|NCT00416624|12121356|FG003|Overall Study|Cancel|0
7700507|NCT00416715|12121366|FG000|Overall Study|Not evaluable for joint aches|7
7700508|NCT00416715|12121366|FG000|Overall Study|Vitamin D levels not evaluable|8
7700509|NCT00416884|12121377|FG000|Overall Study|Study terminated due to low accrual|1
7700510|NCT00416949|12121381|FG000|Overall Study|Patients refused to participate|5
7700511|NCT00417027|12121388|FG000|Overall Study|Protocol Violation|0
7700512|NCT00417027|12121389|FG001|Overall Study|Protocol Violation|5
7700513|NCT00417027|12121390|FG002|Overall Study|Protocol Violation|5
7700514|NCT00417079|12121400|FG000|Overall Study|Disease progression|267
7700515|NCT00417079|12121401|FG001|Overall Study|Disease progression|180
7700516|NCT00417079|12121400|FG000|Overall Study|Adverse Event|32
7700517|NCT00417079|12121401|FG001|Overall Study|Adverse Event|67
7700518|NCT00417079|12121400|FG000|Overall Study|Non-compliance to protocol|0
7700519|NCT00417079|12121401|FG001|Overall Study|Non-compliance to protocol|1
7700520|NCT00417079|12121400|FG000|Overall Study|Lost to Follow-up|2
7700521|NCT00417079|12121401|FG001|Overall Study|Lost to Follow-up|0
7700522|NCT00417079|12121400|FG000|Overall Study|Withdrawal by Subject|17
7700523|NCT00417079|12121401|FG001|Overall Study|Withdrawal by Subject|8
7700524|NCT00417079|12121400|FG000|Overall Study|Not treated|6
7700525|NCT00417079|12121401|FG001|Overall Study|Not treated|7
7700526|NCT00417079|12121400|FG000|Overall Study|Screened failure|2
7700527|NCT00417079|12121401|FG001|Overall Study|Screened failure|1
7700528|NCT00417079|12121400|FG000|Overall Study|Investigator's decision|1
7700529|NCT00417079|12121401|FG001|Overall Study|Investigator's decision|4
7700530|NCT00417079|12121400|FG000|Overall Study|Non-confirmed Disease progression|1
7700531|NCT00417079|12121401|FG001|Overall Study|Non-confirmed Disease progression|1
7700532|NCT00417079|12121400|FG000|Overall Study|Clinical deterioration|1
7700533|NCT00417079|12121401|FG001|Overall Study|Clinical deterioration|0
7700534|NCT00417079|12121400|FG000|Overall Study|Screening error|2
7700535|NCT00417079|12121401|FG001|Overall Study|Screening error|1
7700536|NCT00417079|12121400|FG000|Overall Study|Withdrawal by subject's family|0
7700537|NCT00417079|12121401|FG001|Overall Study|Withdrawal by subject's family|1
7700538|NCT00417079|12121400|FG000|Overall Study|Patient unable to come to the clinic|0
7700539|NCT00417079|12121401|FG001|Overall Study|Patient unable to come to the clinic|1
7700540|NCT00417079|12121400|FG000|Overall Study|abnormal liver function tests|0
7700541|NCT00417079|12121401|FG001|Overall Study|abnormal liver function tests|1
7700542|NCT00417170|12121409|FG000|Overall Study|Adverse Event|1
7700543|NCT00417170|12121410|FG001|Overall Study|Adverse Event|1
7700544|NCT00417170|12121409|FG000|Overall Study|Withdrawal by Subject|1
7700545|NCT00417170|12121410|FG001|Overall Study|Withdrawal by Subject|1
7700546|NCT00417170|12121409|FG000|Overall Study|Lost to Follow-up|0
7700547|NCT00417170|12121410|FG001|Overall Study|Lost to Follow-up|1
7700548|NCT00417482|12121434|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14
7700549|NCT00417482|12121435|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8
7700550|NCT00417482|12121436|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24
7700551|NCT00417482|12121434|FG000|Phase B 1st 16 Weeks|Adverse Event|2
7700552|NCT00417482|12121435|FG001|Phase B 1st 16 Weeks|Adverse Event|0
7700553|NCT00417482|12121436|FG002|Phase B 1st 16 Weeks|Adverse Event|1
7700554|NCT00417482|12121434|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
7700555|NCT00417482|12121435|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
7700556|NCT00417482|12121436|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
7700557|NCT00417482|12121434|FG000|Phase B 1st 16 Weeks|Death|1
7700558|NCT00417482|12121435|FG001|Phase B 1st 16 Weeks|Death|0
7700559|NCT00417482|12121436|FG002|Phase B 1st 16 Weeks|Death|0
7700560|NCT00417482|12121434|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1
7700561|NCT00417482|12121435|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12
7700562|NCT00417482|12121436|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2
7700563|NCT00417482|12121434|FG000|Phase B 2nd 16 Weeks|Adverse Event|0
7700564|NCT00417482|12121435|FG001|Phase B 2nd 16 Weeks|Adverse Event|0
7700565|NCT00417482|12121436|FG002|Phase B 2nd 16 Weeks|Adverse Event|1
7700566|NCT00417482|12121434|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1
7700567|NCT00417482|12121435|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0
7700568|NCT00417482|12121436|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0
7700569|NCT00417482|12121434|FG000|Phase B 2nd 16 Weeks|Death|1
7700570|NCT00417482|12121435|FG001|Phase B 2nd 16 Weeks|Death|1
7700571|NCT00417482|12121436|FG002|Phase B 2nd 16 Weeks|Death|0
7700572|NCT00417612|12121452|FG000|Overall Study|Errant diagnosis|0
7700573|NCT00417612|12121453|FG001|Overall Study|Errant diagnosis|1
7700574|NCT00417612|12121452|FG000|Overall Study|Adverse Event|2
7700575|NCT00417612|12121453|FG001|Overall Study|Adverse Event|0
7700576|NCT00417612|12121452|FG000|Overall Study|Protocol Violation|0
7700577|NCT00417612|12121453|FG001|Overall Study|Protocol Violation|2
7700578|NCT00417612|12121452|FG000|Overall Study|Lost to Follow-up|1
7700579|NCT00417612|12121453|FG001|Overall Study|Lost to Follow-up|0
7700580|NCT00417885|12121472|FG000|Overall Study|Adverse Event|1
7700581|NCT00417885|12121472|FG000|Overall Study|Objective Progression or Relapse|3
7700582|NCT00417885|12121472|FG000|Overall Study|Transferred to Another Sunitinib Study|2
7700583|NCT00417963|12121476|FG000|Overall Study|Lost to Follow-up|3
7700584|NCT00417963|12121476|FG000|Overall Study|Withdrawal by Subject|18
7700585|NCT00417963|12121476|FG000|Overall Study|Death|17
7700586|NCT00417963|12121476|FG000|Overall Study|Study device could not be deployed|3
7700587|NCT00417976|12121485|FG000|Overall Study|Non compliance unrelated to toxicity|1
7700588|NCT00417976|12121485|FG000|Overall Study|Treatment -related toxicity|2
7700589|NCT00417989|12121492|FG000|Overall Study|Withdrawal by Subject|13
7700590|NCT00417989|12121493|FG001|Overall Study|Withdrawal by Subject|13
7700591|NCT00417989|12121492|FG000|Overall Study|Lost to Follow-up|1
7700592|NCT00417989|12121493|FG001|Overall Study|Lost to Follow-up|6
7700593|NCT00417989|12121492|FG000|Overall Study|Protocol Violation|1
7700594|NCT00417989|12121493|FG001|Overall Study|Protocol Violation|0
7700595|NCT00417989|12121492|FG000|Overall Study|Death|0
7700596|NCT00417989|12121493|FG001|Overall Study|Death|1
7700597|NCT00417989|12121492|FG000|Overall Study|Physician Decision|5
7700598|NCT00417989|12121493|FG001|Overall Study|Physician Decision|2
7700599|NCT00418184|12121533|FG000|Double-blind Phase|Withdrawal by Subject|22
7700600|NCT00418184|12121534|FG001|Double-blind Phase|Withdrawal by Subject|9
7700601|NCT00418184|12121533|FG000|Double-blind Phase|Adverse Event|2
7700602|NCT00418184|12121534|FG001|Double-blind Phase|Adverse Event|1
7700603|NCT00418184|12121533|FG000|Double-blind Phase|Poor compliance|3
7700604|NCT00418184|12121534|FG001|Double-blind Phase|Poor compliance|1
7700605|NCT00418314|12121550|FG000|Overall Study|Withdrawal by Subject|1
7700606|NCT00418314|12121551|FG001|Overall Study|Withdrawal by Subject|2
7700607|NCT00418379|12121560|FG000|Year 1|Adverse Event|9
7700608|NCT00418379|12121561|FG001|Year 1|Adverse Event|15
7700609|NCT00418379|12121562|FG002|Year 1|Adverse Event|3
7700610|NCT00418379|12121560|FG000|Year 1|Withdrawal by Subject|7
7700611|NCT00418379|12121561|FG001|Year 1|Withdrawal by Subject|8
7700612|NCT00418379|12121562|FG002|Year 1|Withdrawal by Subject|5
7700613|NCT00418379|12121560|FG000|Year 1|Any other reason not above-mentioned|2
7700614|NCT00418379|12121561|FG001|Year 1|Any other reason not above-mentioned|5
7700615|NCT00418379|12121562|FG002|Year 1|Any other reason not above-mentioned|7
7700616|NCT00418379|12121560|FG000|Year 2|Adverse Event|5
7700617|NCT00418379|12121561|FG001|Year 2|Adverse Event|2
7700618|NCT00418379|12121562|FG002|Year 2|Adverse Event|1
7700619|NCT00418379|12121560|FG000|Year 2|Withdrawal by Subject|1
7700620|NCT00418379|12121561|FG001|Year 2|Withdrawal by Subject|1
7700621|NCT00418379|12121562|FG002|Year 2|Withdrawal by Subject|3
7700622|NCT00418379|12121560|FG000|Year 2|Any other reason not above-mentioned|2
7700623|NCT00418379|12121561|FG001|Year 2|Any other reason not above-mentioned|1
7700624|NCT00418379|12121562|FG002|Year 2|Any other reason not above-mentioned|6
7700625|NCT00418379|12121560|FG000|Year 3|Withdrawal by Subject|1
7700626|NCT00418379|12121561|FG001|Year 3|Withdrawal by Subject|1
7700627|NCT00418379|12121562|FG002|Year 3|Withdrawal by Subject|2
7700628|NCT00418379|12121560|FG000|Year 3|Any other reason not above-mentioned|2
7700629|NCT00418379|12121561|FG001|Year 3|Any other reason not above-mentioned|1
7700630|NCT00418379|12121562|FG002|Year 3|Any other reason not above-mentioned|1
7700631|NCT00418379|12121560|FG000|Year 4|Adverse Event|0
7700632|NCT00418379|12121561|FG001|Year 4|Adverse Event|1
7700633|NCT00418379|12121562|FG002|Year 4|Adverse Event|0
7700634|NCT00418379|12121560|FG000|Year 4|Withdrawal by Subject|2
7700635|NCT00418379|12121561|FG001|Year 4|Withdrawal by Subject|3
7700636|NCT00418379|12121562|FG002|Year 4|Withdrawal by Subject|2
7700637|NCT00418379|12121560|FG000|Year 4|Any other reason not above-mentioned|1
7700638|NCT00418379|12121561|FG001|Year 4|Any other reason not above-mentioned|1
7700639|NCT00418379|12121562|FG002|Year 4|Any other reason not above-mentioned|0
7700640|NCT00418379|12121560|FG000|Year 5|Adverse Event|0
7700641|NCT00418379|12121561|FG001|Year 5|Adverse Event|1
7700642|NCT00418379|12121562|FG002|Year 5|Adverse Event|0
7700643|NCT00418379|12121560|FG000|Year 5|Any other reason not above-mentioned|2
7700644|NCT00418379|12121561|FG001|Year 5|Any other reason not above-mentioned|4
7700645|NCT00418379|12121562|FG002|Year 5|Any other reason not above-mentioned|3
7700646|NCT00418522|12121581|FG000|Overall Study|Adverse Event|7
7700647|NCT00418522|12121582|FG001|Overall Study|Adverse Event|1
7700648|NCT00418522|12121581|FG000|Overall Study|Lack of Efficacy|1
7700649|NCT00418522|12121582|FG001|Overall Study|Lack of Efficacy|3
7700650|NCT00418522|12121581|FG000|Overall Study|Lost to Follow-up|10
7700651|NCT00418522|12121582|FG001|Overall Study|Lost to Follow-up|4
7700652|NCT00418522|12121581|FG000|Overall Study|Withdrawal by Subject|31
7700653|NCT00418522|12121582|FG001|Overall Study|Withdrawal by Subject|7
7700654|NCT00418522|12121581|FG000|Overall Study|Other|27
7700655|NCT00418522|12121582|FG001|Overall Study|Other|23
7700656|NCT00418522|12121581|FG000|Overall Study|Randomized but did not receive treatment|7
7700657|NCT00418522|12121582|FG001|Overall Study|Randomized but did not receive treatment|4
7700658|NCT00418561|12121591|FG000|Overall Study|Participant's (guardian's) decision|0
7700659|NCT00418561|12121592|FG001|Overall Study|Participant's (guardian's) decision|1
7700660|NCT00418561|12121593|FG002|Overall Study|Participant's (guardian's) decision|0
7700661|NCT00418665|12121613|FG000|Treatment Period|Ineligibility determined|1
7700662|NCT00418665|12121614|FG001|Treatment Period|Ineligibility determined|1
7700663|NCT00418665|12121615|FG002|Treatment Period|Ineligibility determined|0
7700664|NCT00418665|12121613|FG000|Treatment Period|Adverse Event|2
7700665|NCT00418665|12121614|FG001|Treatment Period|Adverse Event|2
7700666|NCT00418665|12121615|FG002|Treatment Period|Adverse Event|0
7700667|NCT00418665|12121613|FG000|Treatment Period|Withdrawal by Subject|0
7700668|NCT00418665|12121614|FG001|Treatment Period|Withdrawal by Subject|3
7700669|NCT00418665|12121615|FG002|Treatment Period|Withdrawal by Subject|1
7700670|NCT00418665|12121613|FG000|Treatment Period|Requirement for alternative therapy|1
7700671|NCT00418665|12121614|FG001|Treatment Period|Requirement for alternative therapy|0
7700672|NCT00418665|12121615|FG002|Treatment Period|Requirement for alternative therapy|0
7700673|NCT00418665|12121613|FG000|Treatment Period|Physician Decision|1
7700674|NCT00418665|12121614|FG001|Treatment Period|Physician Decision|0
7700675|NCT00418665|12121615|FG002|Treatment Period|Physician Decision|3
7700676|NCT00418665|12121613|FG000|Treatment Extension|Adverse Event|1
7700677|NCT00418665|12121614|FG001|Treatment Extension|Adverse Event|0
7700678|NCT00418665|12121615|FG002|Treatment Extension|Adverse Event|0
7700679|NCT00418665|12121613|FG000|Treatment Extension|Withdrawal by Subject|1
7700680|NCT00418665|12121614|FG001|Treatment Extension|Withdrawal by Subject|0
7700681|NCT00418665|12121615|FG002|Treatment Extension|Withdrawal by Subject|0
7700682|NCT00418665|12121613|FG000|Treatment Extension|Requirement for alternative therapy|2
7700683|NCT00418665|12121614|FG001|Treatment Extension|Requirement for alternative therapy|2
7700684|NCT00418665|12121615|FG002|Treatment Extension|Requirement for alternative therapy|0
7700685|NCT00418665|12121613|FG000|Treatment Extension|Physician Decision|2
7700686|NCT00418665|12121614|FG001|Treatment Extension|Physician Decision|2
7700687|NCT00418665|12121615|FG002|Treatment Extension|Physician Decision|1
7700688|NCT00418665|12121613|FG000|Treatment Extension|Death|0
7700689|NCT00418665|12121614|FG001|Treatment Extension|Death|0
7700690|NCT00418665|12121615|FG002|Treatment Extension|Death|1
7700691|NCT00418691|12121626|FG000|Overall Study|Lost to Follow-up|1
7700692|NCT00418691|12121627|FG001|Overall Study|Lost to Follow-up|2
7700693|NCT00418691|12121628|FG002|Overall Study|Lost to Follow-up|3
7700694|NCT00418691|12121626|FG000|Overall Study|Started new medication voiding entry|0
7700695|NCT00418691|12121627|FG001|Overall Study|Started new medication voiding entry|0
7700696|NCT00418691|12121628|FG002|Overall Study|Started new medication voiding entry|1
7700697|NCT00418691|12121626|FG000|Overall Study|Progressive Disease|1
7700698|NCT00418691|12121627|FG001|Overall Study|Progressive Disease|0
7700699|NCT00418691|12121628|FG002|Overall Study|Progressive Disease|1
7700700|NCT00418717|12121636|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1
7700701|NCT00418717|12121636|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2
7700702|NCT00418886|12121642|FG000|Overall Study|discontinue treatment survival follow up|90
7700703|NCT00418886|12121643|FG001|Overall Study|discontinue treatment survival follow up|91
7700704|NCT00418886|12121642|FG000|Overall Study|Death|122
7700705|NCT00418886|12121643|FG001|Overall Study|Death|147
7700706|NCT00418886|12121642|FG000|Overall Study|Withdrawal by Subject|9
7700707|NCT00418886|12121643|FG001|Overall Study|Withdrawal by Subject|10
7700708|NCT00418886|12121642|FG000|Overall Study|Lost to Follow-up|4
7700709|NCT00418886|12121643|FG001|Overall Study|Lost to Follow-up|6
7700710|NCT00418886|12121642|FG000|Overall Study|withdrawn due to other reason|1
7700711|NCT00418886|12121643|FG001|Overall Study|withdrawn due to other reason|0
7700712|NCT00418886|12121642|FG000|Overall Study|randomised but no treatment received|0
7700713|NCT00418886|12121643|FG001|Overall Study|randomised but no treatment received|1
7700714|NCT00418938|12121651|FG000|Overall Study|Reimbursement|1
7700715|NCT00418938|12121652|FG001|Overall Study|Reimbursement|0
7700716|NCT00418938|12121651|FG000|Overall Study|Administrative decision|3
7700717|NCT00418938|12121652|FG001|Overall Study|Administrative decision|3
7700718|NCT00418938|12121651|FG000|Overall Study|Withdrawal by Subject|16
7700719|NCT00418938|12121652|FG001|Overall Study|Withdrawal by Subject|15
7700720|NCT00418938|12121651|FG000|Overall Study|Lost to Follow-up|1
7700721|NCT00418938|12121652|FG001|Overall Study|Lost to Follow-up|3
7700722|NCT00418938|12121651|FG000|Overall Study|Adverse Event|1
7700723|NCT00418938|12121652|FG001|Overall Study|Adverse Event|1
7700724|NCT00418938|12121651|FG000|Overall Study|On-going|1
7700725|NCT00418938|12121652|FG001|Overall Study|On-going|1
7700726|NCT00418938|12121651|FG000|Overall Study|Ineligibility Determined|1
7700727|NCT00418938|12121652|FG001|Overall Study|Ineligibility Determined|0
7700728|NCT00419003|12121695|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6
7700729|NCT00419003|12121696|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6
7700730|NCT00419003|12121695|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
7700731|NCT00419003|12121696|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
7700732|NCT00419094|12121707|FG000|Overall Study|Adverse Event|3
7700733|NCT00419094|12121708|FG001|Overall Study|Adverse Event|7
7700734|NCT00419094|12121707|FG000|Overall Study|Lack of Efficacy|1
7700735|NCT00419094|12121708|FG001|Overall Study|Lack of Efficacy|0
7700736|NCT00419094|12121707|FG000|Overall Study|Lost to Follow-up|0
7700737|NCT00419094|12121708|FG001|Overall Study|Lost to Follow-up|2
7700738|NCT00419094|12121707|FG000|Overall Study|Protocol Violation|1
7700739|NCT00419094|12121708|FG001|Overall Study|Protocol Violation|14
7700740|NCT00419094|12121707|FG000|Overall Study|Withdrawal of consent|1
7700741|NCT00419094|12121708|FG001|Overall Study|Withdrawal of consent|5
7700742|NCT00419094|12121707|FG000|Overall Study|Other: Error determining exit criteria|1
7700743|NCT00419094|12121708|FG001|Overall Study|Other: Error determining exit criteria|0
7700744|NCT00419094|12121707|FG000|Overall Study|Other: Patient non-compliant|0
7700745|NCT00419094|12121708|FG001|Overall Study|Other: Patient non-compliant|1
7700746|NCT00419094|12121707|FG000|Overall Study|Other: No contact for extended period|0
7700747|NCT00419094|12121708|FG001|Overall Study|Other: No contact for extended period|1
7700748|NCT00419120|12121714|FG000|Long Term Follow up Period|study ongoing|10
7700749|NCT00419159|12121720|FG000|Overall Study|Adverse Event|7
7700750|NCT00419159|12121721|FG001|Overall Study|Adverse Event|15
7700751|NCT00419159|12121720|FG000|Overall Study|Abnormal laboratory value(s)|0
7700752|NCT00419159|12121721|FG001|Overall Study|Abnormal laboratory value(s)|2
7700753|NCT00419159|12121720|FG000|Overall Study|Subject's no longer requires study drug|0
7700754|NCT00419159|12121721|FG001|Overall Study|Subject's no longer requires study drug|1
7700755|NCT00419159|12121720|FG000|Overall Study|Protocol Violation|1
7700756|NCT00419159|12121721|FG001|Overall Study|Protocol Violation|0
7700757|NCT00419159|12121720|FG000|Overall Study|Withdrawal by Subject|10
7700758|NCT00419159|12121721|FG001|Overall Study|Withdrawal by Subject|3
7700759|NCT00419159|12121720|FG000|Overall Study|Lost to Follow-up|0
7700760|NCT00419159|12121721|FG001|Overall Study|Lost to Follow-up|1
7700761|NCT00419159|12121720|FG000|Overall Study|Death|2
7700762|NCT00419159|12121721|FG001|Overall Study|Death|2
7700763|NCT00419159|12121720|FG000|Overall Study|Disease progression|79
7700764|NCT00419159|12121721|FG001|Overall Study|Disease progression|76
7700765|NCT00419263|12121738|FG000|Overall Study|Lost to Follow-up|2
7700766|NCT00419263|12121739|FG001|Overall Study|Lost to Follow-up|1
7700767|NCT00419263|12121740|FG002|Overall Study|Lost to Follow-up|1
7700768|NCT00419263|12121738|FG000|Overall Study|Randomized in Error, Not Treated|1
7700769|NCT00419263|12121739|FG001|Overall Study|Randomized in Error, Not Treated|1
7700770|NCT00419263|12121740|FG002|Overall Study|Randomized in Error, Not Treated|0
7700771|NCT00419263|12121738|FG000|Overall Study|Adverse Event|0
7700772|NCT00419263|12121739|FG001|Overall Study|Adverse Event|0
7700773|NCT00419263|12121740|FG002|Overall Study|Adverse Event|1
7700774|NCT00419263|12121738|FG000|Overall Study|Withdrawal by Subject|0
7700775|NCT00419263|12121739|FG001|Overall Study|Withdrawal by Subject|0
7700776|NCT00419263|12121740|FG002|Overall Study|Withdrawal by Subject|1
7700777|NCT00419341|12121758|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8
7700778|NCT00419341|12121758|FG000|Wash in/Wash Out Period|Adverse Event|2
7700779|NCT00419341|12121758|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1
7700780|NCT00419341|12121758|FG000|Efficacy Period|Withdrawal by Subject|6
7700781|NCT00419341|12121758|FG000|Efficacy Period|Protocol Violation|1
7700782|NCT00419341|12121758|FG000|Efficacy Period|Lost to Follow-up|1
7700783|NCT00419341|12121758|FG000|Efficacy Period|Non-compliance|1
7700784|NCT00419341|12121758|FG000|Efficacy Period|Termination of study site|1
7700785|NCT00419380|12121766|FG000|Overall Study|Lack of Efficacy|1
7700786|NCT00419380|12121767|FG001|Overall Study|Lack of Efficacy|7
7700787|NCT00419380|12121766|FG000|Overall Study|Physician Decision|0
7700788|NCT00419380|12121767|FG001|Overall Study|Physician Decision|1
7700789|NCT00419380|12121766|FG000|Overall Study|Lost to Follow-up|0
7700790|NCT00419380|12121767|FG001|Overall Study|Lost to Follow-up|1
7700791|NCT00419380|12121766|FG000|Overall Study|Withdrawal by Subject|0
7700792|NCT00419380|12121767|FG001|Overall Study|Withdrawal by Subject|1
7700793|NCT00419393|12121773|FG000|Overall Study|Adverse Event|5
7700794|NCT00419393|12121773|FG000|Overall Study|Protocol Violation|5
7700795|NCT00419393|12121773|FG000|Overall Study|Withdrawal by Subject|7
7700796|NCT00419393|12121773|FG000|Overall Study|Other: Sponsor request|3
7700797|NCT00419393|12121773|FG000|Overall Study|Other: Subject had temporal lobectomy|1
7700798|NCT00419393|12121773|FG000|Overall Study|Other: Site closure|1
7700799|NCT00419393|12121773|FG000|Overall Study|Other: Other health problems|1
7700800|NCT00419393|12121773|FG000|Overall Study|Other: Investigator decision|1
7700801|NCT00419562|12121792|FG000|Overall Study|Lost to Follow-up|12
7700802|NCT00419562|12121793|FG001|Overall Study|Lost to Follow-up|13
7700803|NCT00419562|12121792|FG000|Overall Study|Withdrawal by Subject|20
7700804|NCT00419562|12121793|FG001|Overall Study|Withdrawal by Subject|18
7700805|NCT00419562|12121792|FG000|Overall Study|Participant Institutionalized|1
7700806|NCT00419562|12121793|FG001|Overall Study|Participant Institutionalized|0
7700807|NCT00419744|12121806|FG000|Overall Study|Adverse Event|39
7700808|NCT00419744|12121807|FG001|Overall Study|Adverse Event|40
7700809|NCT00419744|12121808|FG002|Overall Study|Adverse Event|50
7700810|NCT00419744|12121806|FG000|Overall Study|Withdrawal by Subject|45
7700811|NCT00419744|12121807|FG001|Overall Study|Withdrawal by Subject|49
7700812|NCT00419744|12121808|FG002|Overall Study|Withdrawal by Subject|52
7700813|NCT00419744|12121806|FG000|Overall Study|Lost to Follow-up|8
7700814|NCT00419744|12121807|FG001|Overall Study|Lost to Follow-up|10
7700815|NCT00419744|12121808|FG002|Overall Study|Lost to Follow-up|6
7700816|NCT00419744|12121806|FG000|Overall Study|Protocol Violation|4
7700817|NCT00419744|12121807|FG001|Overall Study|Protocol Violation|7
7700818|NCT00419744|12121808|FG002|Overall Study|Protocol Violation|8
7700819|NCT00419744|12121806|FG000|Overall Study|Randomized in error|9
7700820|NCT00419744|12121807|FG001|Overall Study|Randomized in error|6
7700821|NCT00419744|12121808|FG002|Overall Study|Randomized in error|7
7700822|NCT00419744|12121806|FG000|Overall Study|Moving out of state|2
7700823|NCT00419744|12121807|FG001|Overall Study|Moving out of state|0
7700824|NCT00419744|12121808|FG002|Overall Study|Moving out of state|1
7700825|NCT00419744|12121806|FG000|Overall Study|Physician Decision|10
7700826|NCT00419744|12121807|FG001|Overall Study|Physician Decision|5
7700827|NCT00419744|12121808|FG002|Overall Study|Physician Decision|6
7700828|NCT00419744|12121806|FG000|Overall Study|Spirometry mouthpiece issues|0
7700829|NCT00419744|12121807|FG001|Overall Study|Spirometry mouthpiece issues|1
7700830|NCT00419744|12121808|FG002|Overall Study|Spirometry mouthpiece issues|2
7700831|NCT00419744|12121806|FG000|Overall Study|Incorrect medication kit dispensed|0
7700832|NCT00419744|12121807|FG001|Overall Study|Incorrect medication kit dispensed|0
7700833|NCT00419744|12121808|FG002|Overall Study|Incorrect medication kit dispensed|1
7700834|NCT00419757|12121818|FG000|Overall Study|Adverse Event|1
7700835|NCT00419757|12121819|FG001|Overall Study|Adverse Event|4
7700836|NCT00419757|12121818|FG000|Overall Study|Lost to Follow-up|1
7700837|NCT00419757|12121819|FG001|Overall Study|Lost to Follow-up|4
7700838|NCT00419757|12121818|FG000|Overall Study|Withdrawal by Subject|7
7700839|NCT00419757|12121819|FG001|Overall Study|Withdrawal by Subject|1
7700840|NCT00419757|12121818|FG000|Overall Study|Protocol Violation|2
7700841|NCT00419757|12121819|FG001|Overall Study|Protocol Violation|3
7700842|NCT00419757|12121818|FG000|Overall Study|Study specific discontinuation criteria|4
7700843|NCT00419757|12121819|FG001|Overall Study|Study specific discontinuation criteria|8
7700844|NCT00419757|12121818|FG000|Overall Study|Multiple reasons|3
7700845|NCT00419757|12121819|FG001|Overall Study|Multiple reasons|1
7700846|NCT00419770|12121829|FG000|Overall Study|Withdrawal by Subject|5
7700847|NCT00419770|12121830|FG001|Overall Study|Withdrawal by Subject|1
7700848|NCT00419926|12121838|FG000|Overall Study|Withdrawal by Subject|7
7700849|NCT00419926|12121839|FG001|Overall Study|Withdrawal by Subject|3
7700850|NCT00419926|12121838|FG000|Overall Study|Administrative Problem|4
7700851|NCT00419926|12121839|FG001|Overall Study|Administrative Problem|4
7700852|NCT00419926|12121838|FG000|Overall Study|Lost to Follow-up|1
7700853|NCT00419926|12121839|FG001|Overall Study|Lost to Follow-up|2
7700854|NCT00419926|12121838|FG000|Overall Study|Death|2
7700855|NCT00419926|12121839|FG001|Overall Study|Death|1
7700856|NCT00419952|12121847|FG000|Overall Study|Adverse Event|8
7700857|NCT00419952|12121848|FG001|Overall Study|Adverse Event|10
7700858|NCT00419952|12121847|FG000|Overall Study|Withdrawal by Subject|44
7700859|NCT00419952|12121848|FG001|Overall Study|Withdrawal by Subject|43
7700860|NCT00419952|12121847|FG000|Overall Study|Lost to Follow-up|43
7700861|NCT00419952|12121848|FG001|Overall Study|Lost to Follow-up|34
7700862|NCT00419952|12121847|FG000|Overall Study|Protocol Violation|32
7700863|NCT00419952|12121848|FG001|Overall Study|Protocol Violation|24
7700864|NCT00419952|12121847|FG000|Overall Study|Pregnancy|4
7700865|NCT00419952|12121848|FG001|Overall Study|Pregnancy|2
7700866|NCT00419952|12121847|FG000|Overall Study|Physician Decision|1
7700867|NCT00419952|12121848|FG001|Overall Study|Physician Decision|3
7700868|NCT00419952|12121847|FG000|Overall Study|Incorrectly enrolled|10
7700869|NCT00419952|12121848|FG001|Overall Study|Incorrectly enrolled|3
7700870|NCT00419952|12121847|FG000|Overall Study|Intake of prohibited medication|2
7700871|NCT00419952|12121848|FG001|Overall Study|Intake of prohibited medication|2
7700872|NCT00419952|12121847|FG000|Overall Study|Occurence of 2 or more exacerbations|2
7700873|NCT00419952|12121848|FG001|Overall Study|Occurence of 2 or more exacerbations|0
7700874|NCT00419952|12121847|FG000|Overall Study|Diary or medication non-compliance|2
7700875|NCT00419952|12121848|FG001|Overall Study|Diary or medication non-compliance|4
7700876|NCT00419952|12121847|FG000|Overall Study|Abnormal ECG|1
7700877|NCT00419952|12121848|FG001|Overall Study|Abnormal ECG|0
7700878|NCT00420004|12121857|FG000|Overall Study|Adverse Event|4
7700879|NCT00420004|12121858|FG001|Overall Study|Adverse Event|1
7700880|NCT00420004|12121859|FG002|Overall Study|Adverse Event|1
7700881|NCT00420004|12121857|FG000|Overall Study|Lack of Efficacy|5
7700882|NCT00420004|12121858|FG001|Overall Study|Lack of Efficacy|4
7700883|NCT00420004|12121859|FG002|Overall Study|Lack of Efficacy|1
7700884|NCT00420004|12121857|FG000|Overall Study|Lost to Follow-up|31
7700885|NCT00420004|12121858|FG001|Overall Study|Lost to Follow-up|12
7700886|NCT00420004|12121859|FG002|Overall Study|Lost to Follow-up|10
7700887|NCT00420004|12121857|FG000|Overall Study|Entry Criteria Not Met|0
7700888|NCT00420004|12121858|FG001|Overall Study|Entry Criteria Not Met|1
7700889|NCT00420004|12121859|FG002|Overall Study|Entry Criteria Not Met|0
7700890|NCT00420004|12121857|FG000|Overall Study|Physician Decision|14
7700891|NCT00420004|12121858|FG001|Overall Study|Physician Decision|4
7700892|NCT00420004|12121859|FG002|Overall Study|Physician Decision|2
7700893|NCT00420004|12121857|FG000|Overall Study|Protocol Violation|5
7700894|NCT00420004|12121858|FG001|Overall Study|Protocol Violation|4
7700895|NCT00420004|12121859|FG002|Overall Study|Protocol Violation|3
7700896|NCT00420004|12121857|FG000|Overall Study|Withdrawal by Subject|67
7700897|NCT00420004|12121858|FG001|Overall Study|Withdrawal by Subject|42
7700898|NCT00420004|12121859|FG002|Overall Study|Withdrawal by Subject|14
7700899|NCT00420004|12121857|FG000|Overall Study|Sponsor Decision|3
7700900|NCT00420004|12121858|FG001|Overall Study|Sponsor Decision|3
7700901|NCT00420004|12121859|FG002|Overall Study|Sponsor Decision|1
7700902|NCT00420056|12121880|FG000|Overall Study|Objective progression or relapse|17
7700903|NCT00420095|12121886|FG000|Overall Study|Adverse Event|1
7700904|NCT00420095|12121887|FG001|Overall Study|Adverse Event|0
7700905|NCT00420095|12121886|FG000|Overall Study|Protocol Violation|1
7700906|NCT00420095|12121887|FG001|Overall Study|Protocol Violation|1
7700907|NCT00420095|12121886|FG000|Overall Study|Lost to Follow-up|1
7700908|NCT00420095|12121887|FG001|Overall Study|Lost to Follow-up|0
7700909|NCT00420199|12121904|FG000|Overall Study|Participant no longer met study criteria|1
7700910|NCT00420199|12121905|FG001|Overall Study|Participant no longer met study criteria|0
7700911|NCT00420212|12121919|FG000|Overall Study|Adverse Event|22
7700912|NCT00420212|12121920|FG001|Overall Study|Adverse Event|40
7700913|NCT00420212|12121921|FG002|Overall Study|Adverse Event|36
7700914|NCT00420212|12121919|FG000|Overall Study|Lost to Follow-up|9
7700915|NCT00420212|12121920|FG001|Overall Study|Lost to Follow-up|11
7700916|NCT00420212|12121921|FG002|Overall Study|Lost to Follow-up|11
7700917|NCT00420212|12121919|FG000|Overall Study|Withdrawal by Subject|31
7700918|NCT00420212|12121920|FG001|Overall Study|Withdrawal by Subject|22
7700919|NCT00420212|12121921|FG002|Overall Study|Withdrawal by Subject|19
7700920|NCT00420212|12121919|FG000|Overall Study|Physician Decision|4
7700921|NCT00420212|12121920|FG001|Overall Study|Physician Decision|4
7700922|NCT00420212|12121921|FG002|Overall Study|Physician Decision|3
7700923|NCT00420212|12121919|FG000|Overall Study|Protocol Violation|4
7700924|NCT00420212|12121920|FG001|Overall Study|Protocol Violation|4
7700925|NCT00420212|12121921|FG002|Overall Study|Protocol Violation|8
7700926|NCT00420212|12121919|FG000|Overall Study|Death|0
7700927|NCT00420212|12121920|FG001|Overall Study|Death|0
7700928|NCT00420212|12121921|FG002|Overall Study|Death|1
7700929|NCT00420212|12121919|FG000|Overall Study|Other-Unspecified|21
7700930|NCT00420212|12121920|FG001|Overall Study|Other-Unspecified|14
7700931|NCT00420212|12121921|FG002|Overall Study|Other-Unspecified|18
7700932|NCT00420238|12121934|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1
7700933|NCT00420238|12121935|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0
7700934|NCT00420238|12121934|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
7700935|NCT00420238|12121935|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
7700936|NCT00420238|12121934|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
7700937|NCT00420238|12121935|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
7700938|NCT00420238|12121934|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
7700939|NCT00420238|12121935|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
7700940|NCT00420238|12121934|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
7700941|NCT00420238|12121935|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
7700942|NCT00420238|12121934|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
7700943|NCT00420238|12121935|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
7700944|NCT00420290|12121949|FG000|Overall Study|Adverse Event|3
7700945|NCT00420290|12121950|FG001|Overall Study|Adverse Event|1
7700946|NCT00420290|12121949|FG000|Overall Study|Withdrawal by Subject|0
7700947|NCT00420290|12121950|FG001|Overall Study|Withdrawal by Subject|2
7700948|NCT00420290|12121949|FG000|Overall Study|did not meet inclusion/exclusion|1
7700949|NCT00420290|12121950|FG001|Overall Study|did not meet inclusion/exclusion|1
7700950|NCT00420303|12121958|FG000|Overall Study|Serious Adverse Event|1
7700951|NCT00420303|12121959|FG001|Overall Study|Serious Adverse Event|0
7700952|NCT00420303|12121958|FG000|Overall Study|Lack of Efficacy|0
7700953|NCT00420303|12121959|FG001|Overall Study|Lack of Efficacy|3
7700954|NCT00420303|12121958|FG000|Overall Study|Physician Decision|0
7700955|NCT00420303|12121959|FG001|Overall Study|Physician Decision|1
7700956|NCT00420316|12121967|FG000|Overall Study|Withdrawal by Subject|0
7700957|NCT00420316|12121968|FG001|Overall Study|Withdrawal by Subject|1
7700958|NCT00420316|12121967|FG000|Overall Study|Lost to Follow-up|12
7700959|NCT00420316|12121968|FG001|Overall Study|Lost to Follow-up|8
7700960|NCT00420342|12121977|FG000|Overall Study|Lost to Follow-up|1
7700961|NCT00420342|12121978|FG001|Overall Study|Lost to Follow-up|0
7700962|NCT00420342|12121979|FG002|Overall Study|Lost to Follow-up|1
7700963|NCT00420342|12121977|FG000|Overall Study|Withdrawal by Subject|0
7700964|NCT00420342|12121978|FG001|Overall Study|Withdrawal by Subject|2
7700965|NCT00420342|12121979|FG002|Overall Study|Withdrawal by Subject|0
7700966|NCT00420381|12121987|FG000|Overall Study|Protocol Violation|1
7700967|NCT00420407|12121993|FG000|Overall Study|Lost to Follow-up|0
7700968|NCT00420407|12121994|FG001|Overall Study|Lost to Follow-up|3
7700969|NCT00420407|12121993|FG000|Overall Study|Physician Decision|2
7700970|NCT00420407|12121994|FG001|Overall Study|Physician Decision|1
7700971|NCT00420407|12121993|FG000|Overall Study|subject identified as detainee|1
7700972|NCT00420407|12121994|FG001|Overall Study|subject identified as detainee|0
7700973|NCT00420407|12121993|FG000|Overall Study|subject identified as Jehovah's witness|1
7700974|NCT00420407|12121994|FG001|Overall Study|subject identified as Jehovah's witness|0
7700975|NCT00420407|12121993|FG000|Overall Study|Withdrawal by Subject|0
7700976|NCT00420407|12121994|FG001|Overall Study|Withdrawal by Subject|2
7700977|NCT00420420|12122003|FG000|Overall Study|Adverse Event|5
7700978|NCT00420420|12122004|FG001|Overall Study|Adverse Event|3
7700979|NCT00420420|12122003|FG000|Overall Study|Protocol Violation|1
7700980|NCT00420420|12122004|FG001|Overall Study|Protocol Violation|1
7700981|NCT00420420|12122003|FG000|Overall Study|Withdrawal by Subject|1
7700982|NCT00420420|12122004|FG001|Overall Study|Withdrawal by Subject|0
7700983|NCT00420420|12122003|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1
7700984|NCT00420420|12122004|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0
7700985|NCT00420511|12122018|FG000|Overall Study|Adverse Event|1
7700986|NCT00420511|12122019|FG001|Overall Study|Adverse Event|1
7700987|NCT00420511|12122018|FG000|Overall Study|Lost to Follow-up|1
7700988|NCT00420511|12122019|FG001|Overall Study|Lost to Follow-up|0
7700989|NCT00420628|12122029|FG000|Overall Study|Withdrawn by parent or gaurdian|5
7700990|NCT00420628|12122030|FG001|Overall Study|Withdrawn by parent or gaurdian|2
7700991|NCT00420628|12122029|FG000|Overall Study|Lost to Follow-up|3
7700992|NCT00420628|12122030|FG001|Overall Study|Lost to Follow-up|2
7700993|NCT00420628|12122029|FG000|Overall Study|Adverse Event|1
7700994|NCT00420628|12122030|FG001|Overall Study|Adverse Event|0
7700995|NCT00420641|12122039|FG000|Overall Study|Adverse Event|3
7700996|NCT00420641|12122040|FG001|Overall Study|Adverse Event|25
7700997|NCT00420641|12122041|FG002|Overall Study|Adverse Event|10
7700998|NCT00420641|12122039|FG000|Overall Study|Lost to Follow-up|2
7700999|NCT00420641|12122040|FG001|Overall Study|Lost to Follow-up|4
7701000|NCT00420641|12122041|FG002|Overall Study|Lost to Follow-up|2
7701001|NCT00420641|12122039|FG000|Overall Study|Protocol Violation|8
7701002|NCT00420641|12122040|FG001|Overall Study|Protocol Violation|8
7701003|NCT00420641|12122041|FG002|Overall Study|Protocol Violation|7
7701004|NCT00420641|12122039|FG000|Overall Study|Withdrawal by Subject|15
7701005|NCT00420641|12122040|FG001|Overall Study|Withdrawal by Subject|21
7701006|NCT00420641|12122041|FG002|Overall Study|Withdrawal by Subject|14
7701007|NCT00420641|12122039|FG000|Overall Study|Lack of Efficacy|6
7701008|NCT00420641|12122040|FG001|Overall Study|Lack of Efficacy|5
7701009|NCT00420641|12122041|FG002|Overall Study|Lack of Efficacy|4
7701010|NCT00420641|12122039|FG000|Overall Study|Non-compliance|7
7701011|NCT00420641|12122040|FG001|Overall Study|Non-compliance|5
7701012|NCT00420641|12122041|FG002|Overall Study|Non-compliance|4
7701013|NCT00420641|12122039|FG000|Overall Study|Other|4
7701014|NCT00420641|12122040|FG001|Overall Study|Other|4
7701015|NCT00420641|12122041|FG002|Overall Study|Other|3
7701016|NCT00420745|12122051|FG000|Overall Study|Adverse Event|2
7701017|NCT00420745|12122052|FG001|Overall Study|Adverse Event|2
7701018|NCT00420745|12122051|FG000|Overall Study|Lost to Follow-up|10
7701019|NCT00420745|12122052|FG001|Overall Study|Lost to Follow-up|2
7701020|NCT00420745|12122051|FG000|Overall Study|Protocol Violation|1
7701021|NCT00420745|12122052|FG001|Overall Study|Protocol Violation|0
7701022|NCT00420745|12122051|FG000|Overall Study|Physician Decision|1
7701023|NCT00420745|12122052|FG001|Overall Study|Physician Decision|1
7701024|NCT00420745|12122051|FG000|Overall Study|Recurrent pneumonia & bronchitis|0
7701025|NCT00420745|12122052|FG001|Overall Study|Recurrent pneumonia & bronchitis|1
7701026|NCT00420745|12122051|FG000|Overall Study|Age limit exceeded for Dose 2|1
7701027|NCT00420745|12122052|FG001|Overall Study|Age limit exceeded for Dose 2|0
7701028|NCT00420784|12122071|FG000|Overall Study|Adverse Event|11
7701029|NCT00420784|12122072|FG001|Overall Study|Adverse Event|29
7701030|NCT00420784|12122073|FG002|Overall Study|Adverse Event|10
7701031|NCT00420784|12122074|FG003|Overall Study|Adverse Event|5
7701032|NCT00420784|12122071|FG000|Overall Study|Withdrawal by Subject|0
7701033|NCT00420784|12122072|FG001|Overall Study|Withdrawal by Subject|1
7701034|NCT00420784|12122073|FG002|Overall Study|Withdrawal by Subject|0
7701035|NCT00420784|12122074|FG003|Overall Study|Withdrawal by Subject|0
7701036|NCT00420784|12122071|FG000|Overall Study|Lost to Follow-up|0
7701037|NCT00420784|12122072|FG001|Overall Study|Lost to Follow-up|0
7701038|NCT00420784|12122073|FG002|Overall Study|Lost to Follow-up|2
7701039|NCT00420784|12122074|FG003|Overall Study|Lost to Follow-up|1
7701040|NCT00420784|12122071|FG000|Overall Study|Virologic Stopping Rule|17
7701041|NCT00420784|12122072|FG001|Overall Study|Virologic Stopping Rule|26
7701042|NCT00420784|12122073|FG002|Overall Study|Virologic Stopping Rule|41
7701043|NCT00420784|12122074|FG003|Overall Study|Virologic Stopping Rule|67
7701044|NCT00420784|12122071|FG000|Overall Study|Other|1
7701045|NCT00420784|12122072|FG001|Overall Study|Other|2
7701046|NCT00420784|12122073|FG002|Overall Study|Other|0
7701047|NCT00420784|12122074|FG003|Overall Study|Other|5
7701048|NCT00420849|12122085|FG000|Overall Study|Lack of Efficacy|154
7701049|NCT00420849|12122085|FG000|Overall Study|Adverse Event|107
7701050|NCT00420849|12122085|FG000|Overall Study|Withdrawal by Subject|28
7701051|NCT00420849|12122085|FG000|Overall Study|Death|18
7701052|NCT00420849|12122085|FG000|Overall Study|Other|14
7701053|NCT00420849|12122085|FG000|Overall Study|Transplant|8
7701054|NCT00420849|12122085|FG000|Overall Study|Protocol Violation|1
7701055|NCT00420849|12122085|FG000|Overall Study|Lost to Follow-up|1
7701056|NCT00420927|12122099|FG000|Period 1|Adverse Event|19
7701057|NCT00420927|12122100|FG001|Period 1|Adverse Event|15
7701058|NCT00420927|12122101|FG002|Period 1|Adverse Event|0
7701059|NCT00420927|12122102|FG003|Period 1|Adverse Event|0
7701060|NCT00420927|12122103|FG004|Period 1|Adverse Event|0
7701061|NCT00420927|12122104|FG005|Period 1|Adverse Event|0
7701062|NCT00420927|12122105|FG006|Period 1|Adverse Event|0
7701063|NCT00420927|12122099|FG000|Period 1|Withdrawal by Subject|7
7701064|NCT00420927|12122100|FG001|Period 1|Withdrawal by Subject|12
7701065|NCT00420927|12122101|FG002|Period 1|Withdrawal by Subject|0
7701066|NCT00420927|12122102|FG003|Period 1|Withdrawal by Subject|0
7701067|NCT00420927|12122103|FG004|Period 1|Withdrawal by Subject|0
7701068|NCT00420927|12122104|FG005|Period 1|Withdrawal by Subject|0
7701069|NCT00420927|12122105|FG006|Period 1|Withdrawal by Subject|0
7701070|NCT00420927|12122099|FG000|Period 1|Lost to Follow-up|8
7701071|NCT00420927|12122100|FG001|Period 1|Lost to Follow-up|6
7701072|NCT00420927|12122101|FG002|Period 1|Lost to Follow-up|0
7701073|NCT00420927|12122102|FG003|Period 1|Lost to Follow-up|0
7701074|NCT00420927|12122103|FG004|Period 1|Lost to Follow-up|0
7701075|NCT00420927|12122104|FG005|Period 1|Lost to Follow-up|0
7701076|NCT00420927|12122105|FG006|Period 1|Lost to Follow-up|0
7701077|NCT00420927|12122099|FG000|Period 1|Lack of efficacy/Loss of efficacy|1
7701078|NCT00420927|12122100|FG001|Period 1|Lack of efficacy/Loss of efficacy|6
7701079|NCT00420927|12122101|FG002|Period 1|Lack of efficacy/Loss of efficacy|0
7701080|NCT00420927|12122102|FG003|Period 1|Lack of efficacy/Loss of efficacy|0
7701081|NCT00420927|12122103|FG004|Period 1|Lack of efficacy/Loss of efficacy|0
7701082|NCT00420927|12122104|FG005|Period 1|Lack of efficacy/Loss of efficacy|0
7701083|NCT00420927|12122105|FG006|Period 1|Lack of efficacy/Loss of efficacy|0
7701084|NCT00420927|12122099|FG000|Period 1|Death|2
7701085|NCT00420927|12122100|FG001|Period 1|Death|0
7701086|NCT00420927|12122101|FG002|Period 1|Death|0
7701087|NCT00420927|12122102|FG003|Period 1|Death|0
7701088|NCT00420927|12122103|FG004|Period 1|Death|0
7701089|NCT00420927|12122104|FG005|Period 1|Death|0
7701090|NCT00420927|12122105|FG006|Period 1|Death|0
7701091|NCT00420927|12122099|FG000|Period 1|Subject moved/relocated|0
7701092|NCT00420927|12122100|FG001|Period 1|Subject moved/relocated|2
7701093|NCT00420927|12122101|FG002|Period 1|Subject moved/relocated|0
7701094|NCT00420927|12122102|FG003|Period 1|Subject moved/relocated|0
7701095|NCT00420927|12122103|FG004|Period 1|Subject moved/relocated|0
7701096|NCT00420927|12122104|FG005|Period 1|Subject moved/relocated|0
7701097|NCT00420927|12122105|FG006|Period 1|Subject moved/relocated|0
7701098|NCT00420927|12122099|FG000|Period 1|Noncompliant with study drug|1
7701099|NCT00420927|12122100|FG001|Period 1|Noncompliant with study drug|1
7701100|NCT00420927|12122101|FG002|Period 1|Noncompliant with study drug|0
7701101|NCT00420927|12122102|FG003|Period 1|Noncompliant with study drug|0
7701102|NCT00420927|12122103|FG004|Period 1|Noncompliant with study drug|0
7701103|NCT00420927|12122104|FG005|Period 1|Noncompliant with study drug|0
7701104|NCT00420927|12122105|FG006|Period 1|Noncompliant with study drug|0
7701105|NCT00420927|12122099|FG000|Period 1|Randomization error|1
7701106|NCT00420927|12122100|FG001|Period 1|Randomization error|0
7701107|NCT00420927|12122101|FG002|Period 1|Randomization error|0
7701108|NCT00420927|12122102|FG003|Period 1|Randomization error|0
7701109|NCT00420927|12122103|FG004|Period 1|Randomization error|0
7701110|NCT00420927|12122104|FG005|Period 1|Randomization error|0
7701111|NCT00420927|12122105|FG006|Period 1|Randomization error|0
7701112|NCT00420927|12122099|FG000|Period 1|Suspected tuberculosis/positive test|1
7701113|NCT00420927|12122100|FG001|Period 1|Suspected tuberculosis/positive test|1
7701114|NCT00420927|12122101|FG002|Period 1|Suspected tuberculosis/positive test|0
7701115|NCT00420927|12122102|FG003|Period 1|Suspected tuberculosis/positive test|0
7701116|NCT00420927|12122103|FG004|Period 1|Suspected tuberculosis/positive test|0
7701117|NCT00420927|12122104|FG005|Period 1|Suspected tuberculosis/positive test|0
7701118|NCT00420927|12122105|FG006|Period 1|Suspected tuberculosis/positive test|0
7701119|NCT00420927|12122099|FG000|Period 1|Study site closure|0
7701120|NCT00420927|12122100|FG001|Period 1|Study site closure|1
7701121|NCT00420927|12122101|FG002|Period 1|Study site closure|0
7701122|NCT00420927|12122102|FG003|Period 1|Study site closure|0
7701123|NCT00420927|12122103|FG004|Period 1|Study site closure|0
7701124|NCT00420927|12122104|FG005|Period 1|Study site closure|0
7701125|NCT00420927|12122105|FG006|Period 1|Study site closure|0
7701126|NCT00420927|12122099|FG000|Period 1|Subject received new diagnosis|0
7701127|NCT00420927|12122100|FG001|Period 1|Subject received new diagnosis|2
7701128|NCT00420927|12122101|FG002|Period 1|Subject received new diagnosis|0
7701129|NCT00420927|12122102|FG003|Period 1|Subject received new diagnosis|0
7701130|NCT00420927|12122103|FG004|Period 1|Subject received new diagnosis|0
7701131|NCT00420927|12122104|FG005|Period 1|Subject received new diagnosis|0
7701132|NCT00420927|12122105|FG006|Period 1|Subject received new diagnosis|0
7701133|NCT00420927|12122099|FG000|Period 1|Received wrong treatment/incorrect dose|0
7701134|NCT00420927|12122100|FG001|Period 1|Received wrong treatment/incorrect dose|1
7701135|NCT00420927|12122101|FG002|Period 1|Received wrong treatment/incorrect dose|0
7701136|NCT00420927|12122102|FG003|Period 1|Received wrong treatment/incorrect dose|0
7701137|NCT00420927|12122103|FG004|Period 1|Received wrong treatment/incorrect dose|0
7701138|NCT00420927|12122104|FG005|Period 1|Received wrong treatment/incorrect dose|0
7701139|NCT00420927|12122105|FG006|Period 1|Received wrong treatment/incorrect dose|0
7701140|NCT00420927|12122099|FG000|Period 1|Failed to meet entry criteria|8
7701141|NCT00420927|12122100|FG001|Period 1|Failed to meet entry criteria|7
7701142|NCT00420927|12122101|FG002|Period 1|Failed to meet entry criteria|0
7701143|NCT00420927|12122102|FG003|Period 1|Failed to meet entry criteria|0
7701144|NCT00420927|12122103|FG004|Period 1|Failed to meet entry criteria|0
7701145|NCT00420927|12122104|FG005|Period 1|Failed to meet entry criteria|0
7701146|NCT00420927|12122105|FG006|Period 1|Failed to meet entry criteria|0
7701147|NCT00420927|12122099|FG000|Period 1|Took prohibited medication|1
7701148|NCT00420927|12122100|FG001|Period 1|Took prohibited medication|3
7701149|NCT00420927|12122101|FG002|Period 1|Took prohibited medication|0
7701150|NCT00420927|12122102|FG003|Period 1|Took prohibited medication|0
7701151|NCT00420927|12122103|FG004|Period 1|Took prohibited medication|0
7701152|NCT00420927|12122104|FG005|Period 1|Took prohibited medication|0
7701153|NCT00420927|12122105|FG006|Period 1|Took prohibited medication|0
7701154|NCT00420927|12122099|FG000|Period 2|Adverse Event|0
7701155|NCT00420927|12122100|FG001|Period 2|Adverse Event|0
7701156|NCT00420927|12122101|FG002|Period 2|Adverse Event|7
7701157|NCT00420927|12122102|FG003|Period 2|Adverse Event|3
7701158|NCT00420927|12122103|FG004|Period 2|Adverse Event|17
7701159|NCT00420927|12122104|FG005|Period 2|Adverse Event|6
7701160|NCT00420927|12122105|FG006|Period 2|Adverse Event|20
7701161|NCT00420927|12122099|FG000|Period 2|Withdrawal by Subject|0
7701162|NCT00420927|12122100|FG001|Period 2|Withdrawal by Subject|0
7701163|NCT00420927|12122101|FG002|Period 2|Withdrawal by Subject|1
7701164|NCT00420927|12122102|FG003|Period 2|Withdrawal by Subject|3
7701165|NCT00420927|12122103|FG004|Period 2|Withdrawal by Subject|11
7701166|NCT00420927|12122104|FG005|Period 2|Withdrawal by Subject|2
7701167|NCT00420927|12122105|FG006|Period 2|Withdrawal by Subject|12
7701168|NCT00420927|12122099|FG000|Period 2|Lost to Follow-up|0
7701169|NCT00420927|12122100|FG001|Period 2|Lost to Follow-up|0
7701170|NCT00420927|12122101|FG002|Period 2|Lost to Follow-up|2
7701171|NCT00420927|12122102|FG003|Period 2|Lost to Follow-up|2
7701172|NCT00420927|12122103|FG004|Period 2|Lost to Follow-up|6
7701173|NCT00420927|12122104|FG005|Period 2|Lost to Follow-up|3
7701174|NCT00420927|12122105|FG006|Period 2|Lost to Follow-up|9
7701175|NCT00420927|12122099|FG000|Period 2|Lack of efficacy/Loss of efficacy|0
7701176|NCT00420927|12122100|FG001|Period 2|Lack of efficacy/Loss of efficacy|0
7701177|NCT00420927|12122101|FG002|Period 2|Lack of efficacy/Loss of efficacy|2
7701178|NCT00420927|12122102|FG003|Period 2|Lack of efficacy/Loss of efficacy|1
7701179|NCT00420927|12122103|FG004|Period 2|Lack of efficacy/Loss of efficacy|6
7701180|NCT00420927|12122104|FG005|Period 2|Lack of efficacy/Loss of efficacy|2
7701181|NCT00420927|12122105|FG006|Period 2|Lack of efficacy/Loss of efficacy|6
7701182|NCT00420927|12122099|FG000|Period 2|Received wrong treatment/incorrect dose|0
7701183|NCT00420927|12122100|FG001|Period 2|Received wrong treatment/incorrect dose|0
7701184|NCT00420927|12122101|FG002|Period 2|Received wrong treatment/incorrect dose|0
7701185|NCT00420927|12122102|FG003|Period 2|Received wrong treatment/incorrect dose|0
7701186|NCT00420927|12122103|FG004|Period 2|Received wrong treatment/incorrect dose|0
7701187|NCT00420927|12122104|FG005|Period 2|Received wrong treatment/incorrect dose|0
7701188|NCT00420927|12122105|FG006|Period 2|Received wrong treatment/incorrect dose|1
7701189|NCT00420927|12122099|FG000|Period 2|Subject unable to find transportation|0
7701190|NCT00420927|12122100|FG001|Period 2|Subject unable to find transportation|0
7701191|NCT00420927|12122101|FG002|Period 2|Subject unable to find transportation|0
7701192|NCT00420927|12122102|FG003|Period 2|Subject unable to find transportation|0
7701193|NCT00420927|12122103|FG004|Period 2|Subject unable to find transportation|0
7701194|NCT00420927|12122104|FG005|Period 2|Subject unable to find transportation|0
7701195|NCT00420927|12122105|FG006|Period 2|Subject unable to find transportation|1
7701196|NCT00420927|12122099|FG000|Period 2|Physician Decision|0
7701197|NCT00420927|12122100|FG001|Period 2|Physician Decision|0
7701198|NCT00420927|12122101|FG002|Period 2|Physician Decision|0
7701199|NCT00420927|12122102|FG003|Period 2|Physician Decision|0
7701200|NCT00420927|12122103|FG004|Period 2|Physician Decision|1
7701201|NCT00420927|12122104|FG005|Period 2|Physician Decision|1
7701202|NCT00420927|12122105|FG006|Period 2|Physician Decision|0
7701203|NCT00420927|12122099|FG000|Period 2|Sponsor decision|0
7701204|NCT00420927|12122100|FG001|Period 2|Sponsor decision|0
7701205|NCT00420927|12122101|FG002|Period 2|Sponsor decision|1
7701206|NCT00420927|12122102|FG003|Period 2|Sponsor decision|0
7701207|NCT00420927|12122103|FG004|Period 2|Sponsor decision|0
7701208|NCT00420927|12122104|FG005|Period 2|Sponsor decision|0
7701209|NCT00420927|12122105|FG006|Period 2|Sponsor decision|1
7701210|NCT00420927|12122099|FG000|Period 2|Randomization error|0
7701211|NCT00420927|12122100|FG001|Period 2|Randomization error|0
7701212|NCT00420927|12122101|FG002|Period 2|Randomization error|0
7701213|NCT00420927|12122102|FG003|Period 2|Randomization error|0
7701214|NCT00420927|12122103|FG004|Period 2|Randomization error|1
7701215|NCT00420927|12122104|FG005|Period 2|Randomization error|1
7701216|NCT00420927|12122105|FG006|Period 2|Randomization error|0
7701217|NCT00420927|12122099|FG000|Period 2|Noncompliant with study drug|0
7701218|NCT00420927|12122100|FG001|Period 2|Noncompliant with study drug|0
7701219|NCT00420927|12122101|FG002|Period 2|Noncompliant with study drug|0
7701220|NCT00420927|12122102|FG003|Period 2|Noncompliant with study drug|1
7701221|NCT00420927|12122103|FG004|Period 2|Noncompliant with study drug|0
7701222|NCT00420927|12122104|FG005|Period 2|Noncompliant with study drug|0
7701223|NCT00420927|12122105|FG006|Period 2|Noncompliant with study drug|2
7701224|NCT00420927|12122099|FG000|Period 2|Methotrexate intolerance|0
7701225|NCT00420927|12122100|FG001|Period 2|Methotrexate intolerance|0
7701226|NCT00420927|12122101|FG002|Period 2|Methotrexate intolerance|0
7701227|NCT00420927|12122102|FG003|Period 2|Methotrexate intolerance|0
7701228|NCT00420927|12122103|FG004|Period 2|Methotrexate intolerance|0
7701229|NCT00420927|12122104|FG005|Period 2|Methotrexate intolerance|0
7701230|NCT00420927|12122105|FG006|Period 2|Methotrexate intolerance|1
7701231|NCT00420927|12122099|FG000|Period 2|Took prohibited medication|0
7701232|NCT00420927|12122100|FG001|Period 2|Took prohibited medication|0
7701233|NCT00420927|12122101|FG002|Period 2|Took prohibited medication|0
7701234|NCT00420927|12122102|FG003|Period 2|Took prohibited medication|0
7701235|NCT00420927|12122103|FG004|Period 2|Took prohibited medication|1
7701236|NCT00420927|12122104|FG005|Period 2|Took prohibited medication|0
7701237|NCT00420927|12122105|FG006|Period 2|Took prohibited medication|0
7701238|NCT00421148|12122149|FG000|Overall Study|Lost to Follow-up|0
7701239|NCT00421148|12122150|FG001|Overall Study|Lost to Follow-up|0
7701240|NCT00421148|12122151|FG002|Overall Study|Lost to Follow-up|0
7701241|NCT00421148|12122152|FG003|Overall Study|Lost to Follow-up|0
7701242|NCT00421148|12122153|FG004|Overall Study|Lost to Follow-up|0
7701243|NCT00421148|12122154|FG005|Overall Study|Lost to Follow-up|0
7701244|NCT00421148|12122155|FG006|Overall Study|Lost to Follow-up|0
7701245|NCT00421148|12122156|FG007|Overall Study|Lost to Follow-up|0
7701246|NCT00421148|12122157|FG008|Overall Study|Lost to Follow-up|0
7701247|NCT00421148|12122158|FG009|Overall Study|Lost to Follow-up|0
7701248|NCT00421148|12122159|FG010|Overall Study|Lost to Follow-up|0
7701249|NCT00421148|12122160|FG011|Overall Study|Lost to Follow-up|0
7701250|NCT00421148|12122161|FG012|Overall Study|Lost to Follow-up|0
7701251|NCT00421148|12122162|FG013|Overall Study|Lost to Follow-up|0
7701252|NCT00421148|12122163|FG014|Overall Study|Lost to Follow-up|0
7701253|NCT00421148|12122164|FG015|Overall Study|Lost to Follow-up|0
7701254|NCT00421148|12122165|FG016|Overall Study|Lost to Follow-up|0
7701255|NCT00421148|12122166|FG017|Overall Study|Lost to Follow-up|1
7701256|NCT00421148|12122167|FG018|Overall Study|Lost to Follow-up|0
7701257|NCT00421148|12122168|FG019|Overall Study|Lost to Follow-up|0
7701258|NCT00421148|12122149|FG000|Overall Study|Withdrawal by Subject|0
7701259|NCT00421148|12122150|FG001|Overall Study|Withdrawal by Subject|0
7701260|NCT00421148|12122151|FG002|Overall Study|Withdrawal by Subject|0
7701261|NCT00421148|12122152|FG003|Overall Study|Withdrawal by Subject|0
7701262|NCT00421148|12122153|FG004|Overall Study|Withdrawal by Subject|0
7701263|NCT00421148|12122154|FG005|Overall Study|Withdrawal by Subject|0
7701264|NCT00421148|12122155|FG006|Overall Study|Withdrawal by Subject|0
7701265|NCT00421148|12122156|FG007|Overall Study|Withdrawal by Subject|0
7701266|NCT00421148|12122157|FG008|Overall Study|Withdrawal by Subject|0
7701267|NCT00421148|12122158|FG009|Overall Study|Withdrawal by Subject|0
7701268|NCT00421148|12122159|FG010|Overall Study|Withdrawal by Subject|0
7701269|NCT00421148|12122160|FG011|Overall Study|Withdrawal by Subject|0
7701270|NCT00421148|12122161|FG012|Overall Study|Withdrawal by Subject|0
7701271|NCT00421148|12122162|FG013|Overall Study|Withdrawal by Subject|0
7701272|NCT00421148|12122163|FG014|Overall Study|Withdrawal by Subject|0
7701273|NCT00421148|12122164|FG015|Overall Study|Withdrawal by Subject|0
7701274|NCT00421148|12122165|FG016|Overall Study|Withdrawal by Subject|0
7701275|NCT00421148|12122166|FG017|Overall Study|Withdrawal by Subject|1
7701276|NCT00421148|12122167|FG018|Overall Study|Withdrawal by Subject|0
7701277|NCT00421148|12122168|FG019|Overall Study|Withdrawal by Subject|0
7701278|NCT00421148|12122149|FG000|Overall Study|Protocol Violation|0
7701279|NCT00421148|12122150|FG001|Overall Study|Protocol Violation|0
7701280|NCT00421148|12122151|FG002|Overall Study|Protocol Violation|0
7701281|NCT00421148|12122152|FG003|Overall Study|Protocol Violation|0
7701282|NCT00421148|12122153|FG004|Overall Study|Protocol Violation|0
7701283|NCT00421148|12122154|FG005|Overall Study|Protocol Violation|1
7701284|NCT00421148|12122155|FG006|Overall Study|Protocol Violation|0
7701285|NCT00421148|12122156|FG007|Overall Study|Protocol Violation|0
7701286|NCT00421148|12122157|FG008|Overall Study|Protocol Violation|0
7701287|NCT00421148|12122158|FG009|Overall Study|Protocol Violation|0
7701288|NCT00421148|12122159|FG010|Overall Study|Protocol Violation|0
7701289|NCT00421148|12122160|FG011|Overall Study|Protocol Violation|0
7701290|NCT00421148|12122161|FG012|Overall Study|Protocol Violation|0
7701291|NCT00421148|12122162|FG013|Overall Study|Protocol Violation|0
7701292|NCT00421148|12122163|FG014|Overall Study|Protocol Violation|0
7701293|NCT00421148|12122164|FG015|Overall Study|Protocol Violation|0
7701294|NCT00421148|12122165|FG016|Overall Study|Protocol Violation|0
7701295|NCT00421148|12122166|FG017|Overall Study|Protocol Violation|0
7701296|NCT00421148|12122167|FG018|Overall Study|Protocol Violation|1
7701297|NCT00421148|12122168|FG019|Overall Study|Protocol Violation|0
7701298|NCT00421174|12122212|FG000|Overall Study|Withdrawal by Subject|0
7701299|NCT00421174|12122213|FG001|Overall Study|Withdrawal by Subject|1
7701300|NCT00421174|12122212|FG000|Overall Study|Ineligible due to infection|2
7701301|NCT00421174|12122213|FG001|Overall Study|Ineligible due to infection|0
7701302|NCT00421304|12122222|FG000|Overall Study|Lost to Follow-up|5
7701303|NCT00421304|12122223|FG001|Overall Study|Lost to Follow-up|2
7701304|NCT00421304|12122224|FG002|Overall Study|Lost to Follow-up|5
7701305|NCT00421304|12122222|FG000|Overall Study|Withdrawal by Subject|2
7701306|NCT00421304|12122223|FG001|Overall Study|Withdrawal by Subject|2
7701307|NCT00421304|12122224|FG002|Overall Study|Withdrawal by Subject|2
7701308|NCT00421304|12122222|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1
7701309|NCT00421304|12122223|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0
7701310|NCT00421304|12122224|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0
7701311|NCT00421304|12122222|FG000|Overall Study|Did not attend Day 360 visit|0
7701312|NCT00421304|12122223|FG001|Overall Study|Did not attend Day 360 visit|0
7701313|NCT00421304|12122224|FG002|Overall Study|Did not attend Day 360 visit|1
7701314|NCT00421343|12122234|FG000|Overall Study|Death|1
7701315|NCT00421343|12122234|FG000|Overall Study|Withdrawal by Subject|2
7701316|NCT00421343|12122234|FG000|Overall Study|Lost to Follow-up|3
7701317|NCT00421408|12122240|FG000|Overall Study|Lost to Follow-up|30
7701318|NCT00421408|12122241|FG001|Overall Study|Lost to Follow-up|20
7701319|NCT00421408|12122240|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12
7701320|NCT00421408|12122241|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25
7701321|NCT00421707|12122258|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1
7701322|NCT00421707|12122259|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5
7701323|NCT00421707|12122258|FG000|Period 1: Treatment Period 1|Adverse Event|7
7701324|NCT00421707|12122259|FG001|Period 1: Treatment Period 1|Adverse Event|2
7701325|NCT00421707|12122258|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2
7701326|NCT00421707|12122259|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2
7701327|NCT00421707|12122258|FG000|Period 1: Treatment Period 1|Protocol Violation|1
7701328|NCT00421707|12122259|FG001|Period 1: Treatment Period 1|Protocol Violation|0
7701329|NCT00421707|12122258|FG000|Period 2: Washout|Adverse Event|1
7701330|NCT00421707|12122259|FG001|Period 2: Washout|Adverse Event|1
7701331|NCT00421707|12122258|FG000|Period 2: Washout|Withdrawal by Subject|0
7701332|NCT00421707|12122259|FG001|Period 2: Washout|Withdrawal by Subject|1
7701333|NCT00421707|12122258|FG000|Period 2: Washout|Lost to Follow-up|0
7701334|NCT00421707|12122259|FG001|Period 2: Washout|Lost to Follow-up|1
7701335|NCT00421707|12122258|FG000|Period 2: Washout|Other: Pregnancy|0
7701336|NCT00421707|12122259|FG001|Period 2: Washout|Other: Pregnancy|1
7701337|NCT00421707|12122258|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1
7701338|NCT00421707|12122259|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1
7701339|NCT00421707|12122258|FG000|Period 3:Treatment Period 2|Protocol Violation|1
7701340|NCT00421707|12122259|FG001|Period 3:Treatment Period 2|Protocol Violation|0
7701341|NCT00421707|12122258|FG000|Period 3:Treatment Period 2|Adverse Event|0
7701342|NCT00421707|12122259|FG001|Period 3:Treatment Period 2|Adverse Event|2
7701343|NCT00421733|12122271|FG000|Overall Study|Adverse Event|4
7701344|NCT00421733|12122272|FG001|Overall Study|Adverse Event|9
7701345|NCT00421733|12122273|FG002|Overall Study|Adverse Event|2
7701346|NCT00421733|12122271|FG000|Overall Study|Lost to Follow-up|1
7701347|NCT00421733|12122272|FG001|Overall Study|Lost to Follow-up|2
7701348|NCT00421733|12122273|FG002|Overall Study|Lost to Follow-up|4
7701349|NCT00421733|12122271|FG000|Overall Study|Withdrawal by Subject|1
7701350|NCT00421733|12122272|FG001|Overall Study|Withdrawal by Subject|2
7701351|NCT00421733|12122273|FG002|Overall Study|Withdrawal by Subject|7
7701352|NCT00421733|12122271|FG000|Overall Study|Death|0
7701353|NCT00421733|12122272|FG001|Overall Study|Death|3
7701354|NCT00421733|12122273|FG002|Overall Study|Death|0
7701355|NCT00421733|12122271|FG000|Overall Study|Required dialysis|1
7701356|NCT00421733|12122272|FG001|Overall Study|Required dialysis|0
7701357|NCT00421733|12122273|FG002|Overall Study|Required dialysis|0
7701358|NCT00421733|12122271|FG000|Overall Study|Administrative|2
7701359|NCT00421733|12122272|FG001|Overall Study|Administrative|0
7701360|NCT00421733|12122273|FG002|Overall Study|Administrative|0
7701361|NCT00421733|12122271|FG000|Overall Study|Did not satisfy entry criteria|1
7701362|NCT00421733|12122272|FG001|Overall Study|Did not satisfy entry criteria|3
7701363|NCT00421733|12122273|FG002|Overall Study|Did not satisfy entry criteria|2
7701364|NCT00421733|12122271|FG000|Overall Study|Sponsor request|1
7701365|NCT00421733|12122272|FG001|Overall Study|Sponsor request|0
7701366|NCT00421733|12122273|FG002|Overall Study|Sponsor request|3
7701367|NCT00421733|12122271|FG000|Overall Study|Protocol deviation|4
7701368|NCT00421733|12122272|FG001|Overall Study|Protocol deviation|7
7701369|NCT00421733|12122273|FG002|Overall Study|Protocol deviation|2
7701370|NCT00421889|12122294|FG000|Overall Study|Adverse Event|1
7701371|NCT00421889|12122295|FG001|Overall Study|Adverse Event|0
7701372|NCT00421889|12122296|FG002|Overall Study|Adverse Event|1
7701373|NCT00421889|12122297|FG003|Overall Study|Adverse Event|1
7701374|NCT00421889|12122298|FG004|Overall Study|Adverse Event|1
7701375|NCT00421889|12122299|FG005|Overall Study|Adverse Event|4
7701376|NCT00421889|12122300|FG006|Overall Study|Adverse Event|1
7701377|NCT00421889|12122301|FG007|Overall Study|Adverse Event|0
7701378|NCT00421889|12122302|FG008|Overall Study|Adverse Event|2
7701379|NCT00421889|12122294|FG000|Overall Study|Withdrawal by Subject|1
7701380|NCT00421889|12122295|FG001|Overall Study|Withdrawal by Subject|3
7701381|NCT00421889|12122296|FG002|Overall Study|Withdrawal by Subject|0
7701382|NCT00421889|12122297|FG003|Overall Study|Withdrawal by Subject|0
7701383|NCT00421889|12122298|FG004|Overall Study|Withdrawal by Subject|2
7701384|NCT00421889|12122299|FG005|Overall Study|Withdrawal by Subject|0
7701385|NCT00421889|12122300|FG006|Overall Study|Withdrawal by Subject|0
7701386|NCT00421889|12122301|FG007|Overall Study|Withdrawal by Subject|0
7701387|NCT00421889|12122302|FG008|Overall Study|Withdrawal by Subject|0
7701388|NCT00421889|12122294|FG000|Overall Study|Death|0
7701389|NCT00421889|12122295|FG001|Overall Study|Death|0
7701390|NCT00421889|12122296|FG002|Overall Study|Death|0
7701391|NCT00421889|12122297|FG003|Overall Study|Death|0
7701392|NCT00421889|12122298|FG004|Overall Study|Death|1
7701393|NCT00421889|12122299|FG005|Overall Study|Death|1
7701394|NCT00421889|12122300|FG006|Overall Study|Death|0
7701395|NCT00421889|12122301|FG007|Overall Study|Death|0
7701396|NCT00421889|12122302|FG008|Overall Study|Death|0
7701397|NCT00421889|12122294|FG000|Overall Study|Progressive disease|3
7701398|NCT00421889|12122295|FG001|Overall Study|Progressive disease|2
7701399|NCT00421889|12122296|FG002|Overall Study|Progressive disease|2
7701400|NCT00421889|12122297|FG003|Overall Study|Progressive disease|3
7701401|NCT00421889|12122298|FG004|Overall Study|Progressive disease|2
7701402|NCT00421889|12122299|FG005|Overall Study|Progressive disease|21
7701403|NCT00421889|12122300|FG006|Overall Study|Progressive disease|3
7701404|NCT00421889|12122301|FG007|Overall Study|Progressive disease|1
7701405|NCT00421889|12122302|FG008|Overall Study|Progressive disease|5
7701406|NCT00421889|12122294|FG000|Overall Study|Patient/Investigator request|0
7701407|NCT00421889|12122295|FG001|Overall Study|Patient/Investigator request|0
7701408|NCT00421889|12122296|FG002|Overall Study|Patient/Investigator request|0
7701409|NCT00421889|12122297|FG003|Overall Study|Patient/Investigator request|0
7701410|NCT00421889|12122298|FG004|Overall Study|Patient/Investigator request|0
7701411|NCT00421889|12122299|FG005|Overall Study|Patient/Investigator request|9
7701412|NCT00421889|12122300|FG006|Overall Study|Patient/Investigator request|0
7701413|NCT00421889|12122301|FG007|Overall Study|Patient/Investigator request|1
7701414|NCT00421889|12122302|FG008|Overall Study|Patient/Investigator request|3
7701415|NCT00421889|12122294|FG000|Overall Study|Lost to Follow-up|0
7701416|NCT00421889|12122295|FG001|Overall Study|Lost to Follow-up|0
7701417|NCT00421889|12122296|FG002|Overall Study|Lost to Follow-up|0
7701418|NCT00421889|12122297|FG003|Overall Study|Lost to Follow-up|0
7701419|NCT00421889|12122298|FG004|Overall Study|Lost to Follow-up|0
7701420|NCT00421889|12122299|FG005|Overall Study|Lost to Follow-up|0
7701421|NCT00421889|12122300|FG006|Overall Study|Lost to Follow-up|0
7701422|NCT00421889|12122301|FG007|Overall Study|Lost to Follow-up|0
7701423|NCT00421889|12122302|FG008|Overall Study|Lost to Follow-up|1
7701424|NCT00421928|12122329|FG000|Overall Study|Adverse Event|61
7701425|NCT00421928|12122330|FG001|Overall Study|Adverse Event|140
7701426|NCT00421928|12122331|FG002|Overall Study|Adverse Event|22
7701427|NCT00421928|12122329|FG000|Overall Study|Lost to Follow-up|5
7701428|NCT00421928|12122330|FG001|Overall Study|Lost to Follow-up|0
7701429|NCT00421928|12122331|FG002|Overall Study|Lost to Follow-up|3
7701430|NCT00421928|12122329|FG000|Overall Study|Withdrawal by Subject|50
7701431|NCT00421928|12122330|FG001|Overall Study|Withdrawal by Subject|48
7701432|NCT00421928|12122331|FG002|Overall Study|Withdrawal by Subject|43
7701433|NCT00421928|12122329|FG000|Overall Study|Lack of Efficacy|15
7701434|NCT00421928|12122330|FG001|Overall Study|Lack of Efficacy|7
7701435|NCT00421928|12122331|FG002|Overall Study|Lack of Efficacy|35
7701436|NCT00421928|12122329|FG000|Overall Study|Study drug non-compliant|6
7701437|NCT00421928|12122330|FG001|Overall Study|Study drug non-compliant|7
7701438|NCT00421928|12122331|FG002|Overall Study|Study drug non-compliant|4
7701439|NCT00421928|12122329|FG000|Overall Study|All other|26
7701440|NCT00421928|12122330|FG001|Overall Study|All other|21
7701441|NCT00421928|12122331|FG002|Overall Study|All other|27
7701442|NCT00421928|12122329|FG000|Overall Study|Death|0
7701443|NCT00421928|12122330|FG001|Overall Study|Death|1
7701444|NCT00421928|12122331|FG002|Overall Study|Death|0
7701445|NCT00421993|12122343|FG000|Overall Study|Withdrawal by Subject|22
7701446|NCT00421993|12122344|FG001|Overall Study|Withdrawal by Subject|23
7701447|NCT00421993|12122345|FG002|Overall Study|Withdrawal by Subject|23
7701448|NCT00421993|12122346|FG003|Overall Study|Withdrawal by Subject|24
7701449|NCT00421993|12122343|FG000|Overall Study|Lost to Follow-up|18
7701450|NCT00421993|12122344|FG001|Overall Study|Lost to Follow-up|19
7701451|NCT00421993|12122345|FG002|Overall Study|Lost to Follow-up|22
7701452|NCT00421993|12122346|FG003|Overall Study|Lost to Follow-up|20
7701453|NCT00421993|12122343|FG000|Overall Study|Adverse Event|11
7701454|NCT00421993|12122344|FG001|Overall Study|Adverse Event|1
7701455|NCT00421993|12122345|FG002|Overall Study|Adverse Event|6
7701456|NCT00421993|12122346|FG003|Overall Study|Adverse Event|4
7701457|NCT00421993|12122343|FG000|Overall Study|Protocol Violation|2
7701458|NCT00421993|12122344|FG001|Overall Study|Protocol Violation|2
7701459|NCT00421993|12122345|FG002|Overall Study|Protocol Violation|0
7701460|NCT00421993|12122346|FG003|Overall Study|Protocol Violation|1
7701461|NCT00421993|12122343|FG000|Overall Study|Lack of Efficacy|0
7701462|NCT00421993|12122344|FG001|Overall Study|Lack of Efficacy|3
7701463|NCT00421993|12122345|FG002|Overall Study|Lack of Efficacy|0
7701464|NCT00421993|12122346|FG003|Overall Study|Lack of Efficacy|5
7701465|NCT00421993|12122343|FG000|Overall Study|Pregnancy|0
7701466|NCT00421993|12122344|FG001|Overall Study|Pregnancy|1
7701467|NCT00421993|12122345|FG002|Overall Study|Pregnancy|1
7701468|NCT00421993|12122346|FG003|Overall Study|Pregnancy|2
7701469|NCT00421993|12122343|FG000|Overall Study|Subject transportation issues|0
7701470|NCT00421993|12122344|FG001|Overall Study|Subject transportation issues|0
7701471|NCT00421993|12122345|FG002|Overall Study|Subject transportation issues|0
7701472|NCT00421993|12122346|FG003|Overall Study|Subject transportation issues|1
7701473|NCT00422058|12122371|FG000|Double-Blind, Week 0-20|Adverse Event|3
7701474|NCT00422058|12122372|FG001|Double-Blind, Week 0-20|Adverse Event|4
7701475|NCT00422058|12122373|FG002|Double-Blind, Week 0-20|Adverse Event|5
7701476|NCT00422058|12122374|FG003|Double-Blind, Week 0-20|Adverse Event|9
7701477|NCT00422058|12122375|FG004|Double-Blind, Week 0-20|Adverse Event|5
7701478|NCT00422058|12122376|FG005|Double-Blind, Week 0-20|Adverse Event|3
7701479|NCT00422058|12122371|FG000|Double-Blind, Week 0-20|Protocol Violation|3
7701480|NCT00422058|12122372|FG001|Double-Blind, Week 0-20|Protocol Violation|2
7701481|NCT00422058|12122373|FG002|Double-Blind, Week 0-20|Protocol Violation|2
7701482|NCT00422058|12122374|FG003|Double-Blind, Week 0-20|Protocol Violation|3
7701483|NCT00422058|12122375|FG004|Double-Blind, Week 0-20|Protocol Violation|2
7701484|NCT00422058|12122376|FG005|Double-Blind, Week 0-20|Protocol Violation|2
7701485|NCT00422058|12122371|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2
7701486|NCT00422058|12122372|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1
7701487|NCT00422058|12122373|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1
7701488|NCT00422058|12122374|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0
7701489|NCT00422058|12122375|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0
7701490|NCT00422058|12122376|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1
7701491|NCT00422058|12122371|FG000|Double-Blind, Week 0-20|Other|11
7701492|NCT00422058|12122372|FG001|Double-Blind, Week 0-20|Other|3
7701493|NCT00422058|12122373|FG002|Double-Blind, Week 0-20|Other|8
7701494|NCT00422058|12122374|FG003|Double-Blind, Week 0-20|Other|8
7701495|NCT00422058|12122375|FG004|Double-Blind, Week 0-20|Other|4
7701496|NCT00422058|12122376|FG005|Double-Blind, Week 0-20|Other|10
7701497|NCT00422058|12122371|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12
7701498|NCT00422058|12122372|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17
7701499|NCT00422058|12122373|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15
7701500|NCT00422058|12122374|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8
7701501|NCT00422058|12122375|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10
7701502|NCT00422058|12122376|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12
7701503|NCT00422058|12122371|FG000|Open-Label Extension, Week 20-104|Adverse Event|3
7701504|NCT00422058|12122372|FG001|Open-Label Extension, Week 20-104|Adverse Event|4
7701505|NCT00422058|12122373|FG002|Open-Label Extension, Week 20-104|Adverse Event|7
7701506|NCT00422058|12122374|FG003|Open-Label Extension, Week 20-104|Adverse Event|4
7701507|NCT00422058|12122375|FG004|Open-Label Extension, Week 20-104|Adverse Event|4
7701508|NCT00422058|12122376|FG005|Open-Label Extension, Week 20-104|Adverse Event|0
7701509|NCT00422058|12122371|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1
7701510|NCT00422058|12122372|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2
7701511|NCT00422058|12122373|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3
7701512|NCT00422058|12122374|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1
7701513|NCT00422058|12122375|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5
7701514|NCT00422058|12122376|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3
7701515|NCT00422058|12122371|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3
7701516|NCT00422058|12122372|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2
7701517|NCT00422058|12122373|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5
7701518|NCT00422058|12122374|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2
7701519|NCT00422058|12122375|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0
7701520|NCT00422058|12122376|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1
7701521|NCT00422058|12122371|FG000|Open-Label Extension, Week 20-104|Other|13
7701522|NCT00422058|12122372|FG001|Open-Label Extension, Week 20-104|Other|14
7701523|NCT00422058|12122373|FG002|Open-Label Extension, Week 20-104|Other|6
7701524|NCT00422058|12122374|FG003|Open-Label Extension, Week 20-104|Other|13
7701525|NCT00422058|12122375|FG004|Open-Label Extension, Week 20-104|Other|16
7701526|NCT00422058|12122376|FG005|Open-Label Extension, Week 20-104|Other|18
7701527|NCT00422084|12122392|FG000|Overall Study|Adverse Event|21
7701528|NCT00422084|12122393|FG001|Overall Study|Adverse Event|7
7701529|NCT00422084|12122392|FG000|Overall Study|Withdrawal by Subject|12
7701530|NCT00422084|12122393|FG001|Overall Study|Withdrawal by Subject|9
7701531|NCT00422084|12122392|FG000|Overall Study|Lost to Follow-up|14
7701532|NCT00422084|12122393|FG001|Overall Study|Lost to Follow-up|9
7701533|NCT00422084|12122392|FG000|Overall Study|Protocol Violation|4
7701534|NCT00422084|12122393|FG001|Overall Study|Protocol Violation|1
7701535|NCT00422084|12122392|FG000|Overall Study|Lack of Efficacy|40
7701536|NCT00422084|12122393|FG001|Overall Study|Lack of Efficacy|42
7701537|NCT00422084|12122392|FG000|Overall Study|P. vivax infection|3
7701538|NCT00422084|12122393|FG001|Overall Study|P. vivax infection|6
7701539|NCT00422084|12122392|FG000|Overall Study|Cyesis|1
7701540|NCT00422084|12122393|FG001|Overall Study|Cyesis|0
7701541|NCT00422084|12122392|FG000|Overall Study|Withdrawn from study accidentally|1
7701542|NCT00422084|12122393|FG001|Overall Study|Withdrawn from study accidentally|0
7701543|NCT00422084|12122392|FG000|Overall Study|Non-compliance|1
7701544|NCT00422084|12122393|FG001|Overall Study|Non-compliance|0
7701545|NCT00422084|12122392|FG000|Overall Study|Re-location|0
7701546|NCT00422084|12122393|FG001|Overall Study|Re-location|1
7701547|NCT00422084|12122392|FG000|Overall Study|Not defined|1
7701548|NCT00422084|12122393|FG001|Overall Study|Not defined|1
7701549|NCT00422097|12122405|FG000|Dose Level 2|Still on treatment|0
7701550|NCT00422097|12122406|FG001|Dose Level 2|Still on treatment|1
7701551|NCT00422097|12122407|FG002|Dose Level 2|Still on treatment|0
7701552|NCT00422097|12122408|FG003|Dose Level 2|Still on treatment|0
7701553|NCT00422097|12122409|FG004|Dose Level 2|Still on treatment|0
7701554|NCT00422097|12122410|FG005|Dose Level 2|Still on treatment|0
7701555|NCT00422097|12122411|FG006|Dose Level 2|Still on treatment|0
7701556|NCT00422097|12122412|FG007|Dose Level 2|Still on treatment|0
7701557|NCT00422162|12122438|FG000|Overall Study|Adverse Event|11
7701558|NCT00422162|12122439|FG001|Overall Study|Adverse Event|9
7701559|NCT00422162|12122438|FG000|Overall Study|Lack of Efficacy|4
7701560|NCT00422162|12122439|FG001|Overall Study|Lack of Efficacy|10
7701561|NCT00422162|12122438|FG000|Overall Study|Withdrawal by Subject|7
7701562|NCT00422162|12122439|FG001|Overall Study|Withdrawal by Subject|6
7701563|NCT00422162|12122438|FG000|Overall Study|Lost to Follow-up|1
7701564|NCT00422162|12122439|FG001|Overall Study|Lost to Follow-up|2
7701565|NCT00422162|12122438|FG000|Overall Study|Non-Compliant with Protocol|1
7701566|NCT00422162|12122439|FG001|Overall Study|Non-Compliant with Protocol|1
7701567|NCT00422162|12122438|FG000|Overall Study|Other|0
7701568|NCT00422162|12122439|FG001|Overall Study|Other|1
7701569|NCT00422162|12122438|FG000|Overall Study|Didn't Receive Treatment|0
7701570|NCT00422162|12122439|FG001|Overall Study|Didn't Receive Treatment|1
7701571|NCT00422227|12122462|FG000|Overall Study|Adverse Event|3
7701572|NCT00422227|12122463|FG001|Overall Study|Adverse Event|8
7701573|NCT00422227|12122462|FG000|Overall Study|Lost to Follow-up|1
7701574|NCT00422227|12122463|FG001|Overall Study|Lost to Follow-up|3
7701575|NCT00422227|12122462|FG000|Overall Study|Withdrawal by Subject|0
7701576|NCT00422227|12122463|FG001|Overall Study|Withdrawal by Subject|4
7701577|NCT00422292|12122484|FG000|Overall Study|Serious adverse events|1
7701578|NCT00422292|12122485|FG001|Overall Study|Serious adverse events|4
7701579|NCT00422292|12122486|FG002|Overall Study|Serious adverse events|0
7701580|NCT00422292|12122487|FG003|Overall Study|Serious adverse events|0
7701581|NCT00422292|12122484|FG000|Overall Study|Adverse Event|1
7701582|NCT00422292|12122485|FG001|Overall Study|Adverse Event|0
7701583|NCT00422292|12122486|FG002|Overall Study|Adverse Event|1
7701584|NCT00422292|12122487|FG003|Overall Study|Adverse Event|0
7701585|NCT00422292|12122484|FG000|Overall Study|Protocol Violation|4
7701586|NCT00422292|12122485|FG001|Overall Study|Protocol Violation|25
7701587|NCT00422292|12122486|FG002|Overall Study|Protocol Violation|8
7701588|NCT00422292|12122487|FG003|Overall Study|Protocol Violation|5
7701589|NCT00422292|12122484|FG000|Overall Study|Lost to Follow-up|6
7701590|NCT00422292|12122485|FG001|Overall Study|Lost to Follow-up|12
7701591|NCT00422292|12122486|FG002|Overall Study|Lost to Follow-up|6
7701592|NCT00422292|12122487|FG003|Overall Study|Lost to Follow-up|6
7701593|NCT00422292|12122484|FG000|Overall Study|Withdrawal by Subject|6
7701594|NCT00422292|12122485|FG001|Overall Study|Withdrawal by Subject|25
7701595|NCT00422292|12122486|FG002|Overall Study|Withdrawal by Subject|7
7701596|NCT00422292|12122487|FG003|Overall Study|Withdrawal by Subject|13
7701597|NCT00422383|12122502|FG000|Overall Study|Adverse Event|5
7701598|NCT00422383|12122503|FG001|Overall Study|Adverse Event|3
7701599|NCT00422383|12122504|FG002|Overall Study|Adverse Event|1
7701600|NCT00422383|12122505|FG003|Overall Study|Adverse Event|1
7701601|NCT00422383|12122506|FG004|Overall Study|Adverse Event|0
7701602|NCT00422383|12122502|FG000|Overall Study|Lack of Efficacy|4
7701603|NCT00422383|12122503|FG001|Overall Study|Lack of Efficacy|4
7701604|NCT00422383|12122504|FG002|Overall Study|Lack of Efficacy|2
7701605|NCT00422383|12122505|FG003|Overall Study|Lack of Efficacy|1
7701606|NCT00422383|12122506|FG004|Overall Study|Lack of Efficacy|1
7701607|NCT00422383|12122502|FG000|Overall Study|Lost to Follow-up|0
7701608|NCT00422383|12122503|FG001|Overall Study|Lost to Follow-up|1
7701609|NCT00422383|12122504|FG002|Overall Study|Lost to Follow-up|0
7701610|NCT00422383|12122505|FG003|Overall Study|Lost to Follow-up|0
7701611|NCT00422383|12122506|FG004|Overall Study|Lost to Follow-up|1
7701612|NCT00422383|12122502|FG000|Overall Study|Protocol Violation|1
7701613|NCT00422383|12122503|FG001|Overall Study|Protocol Violation|1
7701614|NCT00422383|12122504|FG002|Overall Study|Protocol Violation|1
7701615|NCT00422383|12122505|FG003|Overall Study|Protocol Violation|0
7701616|NCT00422383|12122506|FG004|Overall Study|Protocol Violation|0
7701617|NCT00422383|12122502|FG000|Overall Study|Withdrawal by Subject|5
7701618|NCT00422383|12122503|FG001|Overall Study|Withdrawal by Subject|5
7701619|NCT00422383|12122504|FG002|Overall Study|Withdrawal by Subject|0
7701620|NCT00422383|12122505|FG003|Overall Study|Withdrawal by Subject|0
7701621|NCT00422383|12122506|FG004|Overall Study|Withdrawal by Subject|1
7701622|NCT00422422|12122524|FG000|Overall Study|Lack of Efficacy|1
7701623|NCT00422422|12122524|FG000|Overall Study|Protocol Violation|1
7701624|NCT00422422|12122524|FG000|Overall Study|Withdrawal by Subject|2
7701625|NCT00422422|12122524|FG000|Overall Study|SAE, non-fatal|1
7701626|NCT00422422|12122524|FG000|Overall Study|AE, non-serious non-fatal|5
7701627|NCT00422461|12122538|FG000|Overall Study|Adverse Event|1
7701628|NCT00422461|12122539|FG001|Overall Study|Adverse Event|2
7701629|NCT00422461|12122540|FG002|Overall Study|Adverse Event|1
7701630|NCT00422461|12122541|FG003|Overall Study|Adverse Event|1
7701631|NCT00422461|12122538|FG000|Overall Study|Other|0
7701632|NCT00422461|12122539|FG001|Overall Study|Other|0
7701633|NCT00422461|12122540|FG002|Overall Study|Other|0
7701634|NCT00422461|12122541|FG003|Overall Study|Other|2
7701635|NCT00422461|12122538|FG000|Overall Study|Participants no longer willing to participate in study|1
7701636|NCT00422461|12122539|FG001|Overall Study|Participants no longer willing to participate in study|0
7701637|NCT00422461|12122540|FG002|Overall Study|Participants no longer willing to participate in study|0
7701638|NCT00422461|12122541|FG003|Overall Study|Participants no longer willing to participate in study|0
7701639|NCT00422461|12122538|FG000|Overall Study|Randomized but not treated|1
7701640|NCT00422461|12122539|FG001|Overall Study|Randomized but not treated|1
7701641|NCT00422461|12122540|FG002|Overall Study|Randomized but not treated|0
7701642|NCT00422461|12122541|FG003|Overall Study|Randomized but not treated|0
7701643|NCT00422513|12122553|FG000|Overall Study|Lack of Efficacy|4
7701644|NCT00422513|12122554|FG001|Overall Study|Lack of Efficacy|5
7701645|NCT00422513|12122553|FG000|Overall Study|Protocol Violation|23
7701646|NCT00422513|12122554|FG001|Overall Study|Protocol Violation|7
7701647|NCT00422513|12122553|FG000|Overall Study|Refused Treatment|4
7701648|NCT00422513|12122554|FG001|Overall Study|Refused Treatment|2
7701649|NCT00422513|12122553|FG000|Overall Study|Withdrawal by Subject|2
7701650|NCT00422513|12122554|FG001|Overall Study|Withdrawal by Subject|1
7701651|NCT00422513|12122553|FG000|Overall Study|early termination of the study|67
7701652|NCT00422513|12122554|FG001|Overall Study|early termination of the study|80
7701653|NCT00422513|12122553|FG000|Overall Study|Adverse Event|4
7701654|NCT00422513|12122554|FG001|Overall Study|Adverse Event|4
7701655|NCT00422513|12122553|FG000|Overall Study|Death|3
7701656|NCT00422513|12122554|FG001|Overall Study|Death|7
7701657|NCT00422591|12122560|FG000|Overall Study|Physician Decision|4
7701658|NCT00422591|12122560|FG000|Overall Study|Withdrawal by Subject|2
7701659|NCT00422734|12122579|FG000|Overall Study|Physician Decision|1
7701660|NCT00422734|12122580|FG001|Overall Study|Physician Decision|1
7701661|NCT00422734|12122579|FG000|Overall Study|Protocol Violation|1
7701662|NCT00422734|12122580|FG001|Overall Study|Protocol Violation|6
7701663|NCT00422734|12122579|FG000|Overall Study|Withdrawal by Subject|12
7701664|NCT00422734|12122580|FG001|Overall Study|Withdrawal by Subject|8
7701665|NCT00422734|12122579|FG000|Overall Study|Adverse Event|0
7701666|NCT00422734|12122580|FG001|Overall Study|Adverse Event|3
7701667|NCT00422734|12122579|FG000|Overall Study|Partner Decision|0
7701668|NCT00422734|12122580|FG001|Overall Study|Partner Decision|3
7701669|NCT00422799|12122586|FG000|Overall Study|Withdrawal by Subject|6
7701670|NCT00422799|12122586|FG000|Overall Study|Adverse Event|7
7701671|NCT00422903|12122609|FG000|Overall Study|Disease Progression|3
7701672|NCT00422903|12122610|FG001|Overall Study|Disease Progression|1
7701673|NCT00422903|12122609|FG000|Overall Study|Adverse Event|0
7701674|NCT00422903|12122610|FG001|Overall Study|Adverse Event|2
7701675|NCT00422903|12122609|FG000|Overall Study|Informed Consent Withdrawn|1
7701676|NCT00422903|12122610|FG001|Overall Study|Informed Consent Withdrawn|2
7701677|NCT00423046|12122618|FG000|Overall Study|Other|340
7701678|NCT00423046|12122619|FG001|Overall Study|Other|345
7701679|NCT00423085|12122630|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21
7701680|NCT00423085|12122631|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38
7701681|NCT00423085|12122632|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34
7701682|NCT00423085|12122633|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0
7701683|NCT00423085|12122630|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
7701684|NCT00423085|12122631|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
7701685|NCT00423085|12122632|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
7701686|NCT00423085|12122633|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
7701687|NCT00423085|12122630|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
7701688|NCT00423085|12122631|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
7701689|NCT00423085|12122632|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
7701690|NCT00423085|12122633|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
7701691|NCT00423085|12122630|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8
7701692|NCT00423085|12122631|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3
7701693|NCT00423085|12122632|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7
7701694|NCT00423085|12122633|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0
7701695|NCT00423085|12122630|FG000|24-Week Double-Blind Treatment Phase|Death|1
7701696|NCT00423085|12122631|FG001|24-Week Double-Blind Treatment Phase|Death|1
7701697|NCT00423085|12122632|FG002|24-Week Double-Blind Treatment Phase|Death|0
7701698|NCT00423085|12122633|FG003|24-Week Double-Blind Treatment Phase|Death|0
7701699|NCT00423085|12122630|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
7701700|NCT00423085|12122631|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
7701701|NCT00423085|12122632|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
7701702|NCT00423085|12122633|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
7701703|NCT00423085|12122630|FG000|52-Week Open-Label Extension Phase|Adverse Event|0
7701704|NCT00423085|12122631|FG001|52-Week Open-Label Extension Phase|Adverse Event|0
7701705|NCT00423085|12122632|FG002|52-Week Open-Label Extension Phase|Adverse Event|0
7701706|NCT00423085|12122633|FG003|52-Week Open-Label Extension Phase|Adverse Event|97
7701707|NCT00423085|12122630|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
7701708|NCT00423085|12122631|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
7701709|NCT00423085|12122632|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
7701710|NCT00423085|12122633|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
7701711|NCT00423085|12122630|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
7701712|NCT00423085|12122631|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
7701713|NCT00423085|12122632|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
7701714|NCT00423085|12122633|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
7701715|NCT00423085|12122630|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0
7701716|NCT00423085|12122631|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0
7701717|NCT00423085|12122632|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0
7701718|NCT00423085|12122633|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9
7701719|NCT00423085|12122630|FG000|52-Week Open-Label Extension Phase|Death|0
7701720|NCT00423085|12122631|FG001|52-Week Open-Label Extension Phase|Death|0
7701721|NCT00423085|12122632|FG002|52-Week Open-Label Extension Phase|Death|0
7701722|NCT00423085|12122633|FG003|52-Week Open-Label Extension Phase|Death|2
7701723|NCT00423098|12122645|FG000|Overall Study|Adverse Event|1
7701724|NCT00423098|12122646|FG001|Overall Study|Adverse Event|2
7701725|NCT00423098|12122645|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7701726|NCT00423098|12122646|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7701727|NCT00423098|12122645|FG000|Overall Study|Administrative problems|0
7701728|NCT00423098|12122646|FG001|Overall Study|Administrative problems|1
7701729|NCT00423098|12122645|FG000|Overall Study|Death|2
7701730|NCT00423098|12122646|FG001|Overall Study|Death|0
7701731|NCT00423137|12122656|FG000|Overall Study|Lost to Follow-up|0
7701732|NCT00423137|12122657|FG001|Overall Study|Lost to Follow-up|0
7701733|NCT00423137|12122658|FG002|Overall Study|Lost to Follow-up|1
7701734|NCT00423137|12122659|FG003|Overall Study|Lost to Follow-up|0
7701735|NCT00423137|12122656|FG000|Overall Study|Protocol Violation|0
7701736|NCT00423137|12122657|FG001|Overall Study|Protocol Violation|0
7701737|NCT00423137|12122658|FG002|Overall Study|Protocol Violation|0
7701738|NCT00423137|12122659|FG003|Overall Study|Protocol Violation|1
7701739|NCT00423137|12122656|FG000|Overall Study|Adverse Event Study disease worse|1
7701740|NCT00423137|12122657|FG001|Overall Study|Adverse Event Study disease worse|0
7701741|NCT00423137|12122658|FG002|Overall Study|Adverse Event Study disease worse|3
7701742|NCT00423137|12122659|FG003|Overall Study|Adverse Event Study disease worse|1
7701743|NCT00423137|12122656|FG000|Overall Study|Adverse Event Other|0
7701744|NCT00423137|12122657|FG001|Overall Study|Adverse Event Other|0
7701745|NCT00423137|12122658|FG002|Overall Study|Adverse Event Other|2
7701746|NCT00423137|12122659|FG003|Overall Study|Adverse Event Other|0
7701747|NCT00423150|12122672|FG000|Overall Study|Adverse Event|11
7701748|NCT00423150|12122672|FG000|Overall Study|Progression of disease being studied|69
7701749|NCT00423150|12122672|FG000|Overall Study|Withdrawal by Subject|1
7701750|NCT00423150|12122672|FG000|Overall Study|Non-compliance with protocol|1
7701751|NCT00423150|12122672|FG000|Overall Study|Administrative|4
7701752|NCT00423189|12122679|FG000|Overall Study|Death|0
7701753|NCT00423189|12122680|FG001|Overall Study|Death|1
7701754|NCT00423189|12122681|FG002|Overall Study|Death|0
7701755|NCT00423267|12122696|FG000|Period A|Withdrawal by Subject|0
7701756|NCT00423267|12122697|FG001|Period A|Withdrawal by Subject|1
7701757|NCT00423267|12122696|FG000|Period A|Non-compliance with protocol|1
7701758|NCT00423267|12122697|FG001|Period A|Non-compliance with protocol|0
7701759|NCT00423267|12122696|FG000|Period A|Administrative|1
7701760|NCT00423267|12122697|FG001|Period A|Administrative|0
7701761|NCT00423293|12122705|FG000|Overall Study|Ineligible / No protocol treatment|11
7701762|NCT00423319|12122711|FG000|Overall Study|Death|2
7701763|NCT00423319|12122712|FG001|Overall Study|Death|0
7701764|NCT00423319|12122711|FG000|Overall Study|Adverse Event|93
7701765|NCT00423319|12122712|FG001|Overall Study|Adverse Event|112
7701766|NCT00423319|12122711|FG000|Overall Study|Withdrawal by Subject|86
7701767|NCT00423319|12122712|FG001|Overall Study|Withdrawal by Subject|99
7701768|NCT00423319|12122711|FG000|Overall Study|Lost to Follow-up|4
7701769|NCT00423319|12122712|FG001|Overall Study|Lost to Follow-up|3
7701770|NCT00423319|12122711|FG000|Overall Study|Poor compliance or noncompliance|1
7701771|NCT00423319|12122712|FG001|Overall Study|Poor compliance or noncompliance|1
7701772|NCT00423319|12122711|FG000|Overall Study|No longer meets study criteria|15
7701773|NCT00423319|12122712|FG001|Overall Study|No longer meets study criteria|15
7701774|NCT00423319|12122711|FG000|Overall Study|Other|23
7701775|NCT00423319|12122712|FG001|Overall Study|Other|22
7701776|NCT00423332|12122721|FG000|Overall Study|Adverse Event|6
7701777|NCT00423332|12122722|FG001|Overall Study|Adverse Event|2
7701778|NCT00423332|12122721|FG000|Overall Study|Withdrawal by Subject|1
7701779|NCT00423332|12122722|FG001|Overall Study|Withdrawal by Subject|0
7701780|NCT00423332|12122721|FG000|Overall Study|Condition under investigation worsened|1
7701781|NCT00423332|12122722|FG001|Overall Study|Condition under investigation worsened|1
7701782|NCT00423332|12122721|FG000|Overall Study|Progressive at Week 6|0
7701783|NCT00423332|12122722|FG001|Overall Study|Progressive at Week 6|1
7701784|NCT00423332|12122721|FG000|Overall Study|Unblinded before 12 weeks|1
7701785|NCT00423332|12122722|FG001|Overall Study|Unblinded before 12 weeks|3
7701786|NCT00423449|12122747|FG000|Overall Study|Clinical Adverse Event|1
7701787|NCT00423449|12122748|FG001|Overall Study|Clinical Adverse Event|0
7701788|NCT00423449|12122749|FG002|Overall Study|Clinical Adverse Event|1
7701789|NCT00423449|12122750|FG003|Overall Study|Clinical Adverse Event|8
7701790|NCT00423449|12122751|FG004|Overall Study|Clinical Adverse Event|2
7701791|NCT00423449|12122747|FG000|Overall Study|Death|1
7701792|NCT00423449|12122748|FG001|Overall Study|Death|0
7701793|NCT00423449|12122749|FG002|Overall Study|Death|2
7701794|NCT00423449|12122750|FG003|Overall Study|Death|1
7701795|NCT00423449|12122751|FG004|Overall Study|Death|1
7701796|NCT00423449|12122747|FG000|Overall Study|Progressive Disease|1
7701797|NCT00423449|12122748|FG001|Overall Study|Progressive Disease|3
7701798|NCT00423449|12122749|FG002|Overall Study|Progressive Disease|8
7701799|NCT00423449|12122750|FG003|Overall Study|Progressive Disease|11
7701800|NCT00423449|12122751|FG004|Overall Study|Progressive Disease|4
7701801|NCT00423449|12122747|FG000|Overall Study|Laboratory Adverse Event|0
7701802|NCT00423449|12122748|FG001|Overall Study|Laboratory Adverse Event|1
7701803|NCT00423449|12122749|FG002|Overall Study|Laboratory Adverse Event|2
7701804|NCT00423449|12122750|FG003|Overall Study|Laboratory Adverse Event|0
7701805|NCT00423449|12122751|FG004|Overall Study|Laboratory Adverse Event|0
7701806|NCT00423449|12122747|FG000|Overall Study|Other|0
7701807|NCT00423449|12122748|FG001|Overall Study|Other|0
7701808|NCT00423449|12122749|FG002|Overall Study|Other|0
7701809|NCT00423449|12122750|FG003|Overall Study|Other|1
7701810|NCT00423449|12122751|FG004|Overall Study|Other|0
7701811|NCT00423449|12122747|FG000|Overall Study|Protocol Violation|0
7701812|NCT00423449|12122748|FG001|Overall Study|Protocol Violation|0
7701813|NCT00423449|12122749|FG002|Overall Study|Protocol Violation|2
7701814|NCT00423449|12122750|FG003|Overall Study|Protocol Violation|1
7701815|NCT00423449|12122751|FG004|Overall Study|Protocol Violation|0
7701816|NCT00423592|12122764|FG000|Overall Study|Adverse Event (through Week 12)|2
7701817|NCT00423592|12122764|FG000|Overall Study|Adverse Event (post Week 12)|5
7701818|NCT00423605|12122768|FG000|Overall Study|Adverse Event|129
7701819|NCT00423605|12122768|FG000|Overall Study|Withdrawal by Subject|36
7701820|NCT00423605|12122768|FG000|Overall Study|Lost to Follow-up|15
7701821|NCT00423605|12122768|FG000|Overall Study|Lack of Efficacy|38
7701822|NCT00423605|12122768|FG000|Overall Study|Sponsor Decision|3
7701823|NCT00423605|12122768|FG000|Overall Study|Physician Decision|8
7701824|NCT00423605|12122768|FG000|Overall Study|Protocol Violation|7
7701825|NCT00423605|12122768|FG000|Overall Study|Not one of the pre-specified options|5
7701826|NCT00423657|12122774|FG000|Overall Study|Withdrew consent|10
7701827|NCT00423657|12122775|FG001|Overall Study|Withdrew consent|8
7701828|NCT00423657|12122774|FG000|Overall Study|Non-compliance|0
7701829|NCT00423657|12122775|FG001|Overall Study|Non-compliance|1
7701830|NCT00423657|12122774|FG000|Overall Study|Other|15
7701831|NCT00423657|12122775|FG001|Overall Study|Other|16
7701832|NCT00423657|12122774|FG000|Overall Study|Request of sponsor/investigator|1
7701833|NCT00423657|12122775|FG001|Overall Study|Request of sponsor/investigator|0
7701834|NCT00423670|12122788|FG000|Treatment Period|Switched to Arm 8 at TW 24|36
7701835|NCT00423670|12122789|FG001|Treatment Period|Switched to Arm 8 at TW 24|0
7701836|NCT00423670|12122790|FG002|Treatment Period|Switched to Arm 8 at TW 24|0
7701837|NCT00423670|12122791|FG003|Treatment Period|Switched to Arm 8 at TW 24|0
7701838|NCT00423670|12122792|FG004|Treatment Period|Switched to Arm 8 at TW 24|0
7701839|NCT00423670|12122793|FG005|Treatment Period|Switched to Arm 8 at TW 24|0
7701840|NCT00423670|12122794|FG006|Treatment Period|Switched to Arm 8 at TW 24|0
7701841|NCT00423670|12122795|FG007|Treatment Period|Switched to Arm 8 at TW 24|0
7701842|NCT00423670|12122788|FG000|Treatment Period|Adverse Event|8
7701843|NCT00423670|12122789|FG001|Treatment Period|Adverse Event|12
7701844|NCT00423670|12122790|FG002|Treatment Period|Adverse Event|15
7701845|NCT00423670|12122791|FG003|Treatment Period|Adverse Event|20
7701846|NCT00423670|12122792|FG004|Treatment Period|Adverse Event|9
7701847|NCT00423670|12122793|FG005|Treatment Period|Adverse Event|4
7701848|NCT00423670|12122794|FG006|Treatment Period|Adverse Event|7
7701849|NCT00423670|12122795|FG007|Treatment Period|Adverse Event|2
7701850|NCT00423670|12122788|FG000|Treatment Period|Protocol-defined clinical event|0
7701851|NCT00423670|12122789|FG001|Treatment Period|Protocol-defined clinical event|7
7701852|NCT00423670|12122790|FG002|Treatment Period|Protocol-defined clinical event|4
7701853|NCT00423670|12122791|FG003|Treatment Period|Protocol-defined clinical event|12
7701854|NCT00423670|12122792|FG004|Treatment Period|Protocol-defined clinical event|5
7701855|NCT00423670|12122793|FG005|Treatment Period|Protocol-defined clinical event|4
7701856|NCT00423670|12122794|FG006|Treatment Period|Protocol-defined clinical event|16
7701857|NCT00423670|12122795|FG007|Treatment Period|Protocol-defined clinical event|15
7701858|NCT00423670|12122788|FG000|Treatment Period|Lost to Follow-up|2
7701859|NCT00423670|12122789|FG001|Treatment Period|Lost to Follow-up|1
7701860|NCT00423670|12122790|FG002|Treatment Period|Lost to Follow-up|3
7701861|NCT00423670|12122791|FG003|Treatment Period|Lost to Follow-up|1
7701862|NCT00423670|12122792|FG004|Treatment Period|Lost to Follow-up|6
7701863|NCT00423670|12122793|FG005|Treatment Period|Lost to Follow-up|0
7701864|NCT00423670|12122794|FG006|Treatment Period|Lost to Follow-up|3
7701865|NCT00423670|12122795|FG007|Treatment Period|Lost to Follow-up|1
7701866|NCT00423670|12122788|FG000|Treatment Period|Subject withdrew (not treatment related)|3
7701867|NCT00423670|12122789|FG001|Treatment Period|Subject withdrew (not treatment related)|9
7701868|NCT00423670|12122790|FG002|Treatment Period|Subject withdrew (not treatment related)|4
7701869|NCT00423670|12122791|FG003|Treatment Period|Subject withdrew (not treatment related)|4
7701870|NCT00423670|12122792|FG004|Treatment Period|Subject withdrew (not treatment related)|5
7701871|NCT00423670|12122793|FG005|Treatment Period|Subject withdrew (not treatment related)|0
7701872|NCT00423670|12122794|FG006|Treatment Period|Subject withdrew (not treatment related)|3
7701873|NCT00423670|12122795|FG007|Treatment Period|Subject withdrew (not treatment related)|0
7701874|NCT00423670|12122788|FG000|Treatment Period|Investigator decision|0
7701875|NCT00423670|12122789|FG001|Treatment Period|Investigator decision|0
7701876|NCT00423670|12122790|FG002|Treatment Period|Investigator decision|0
7701877|NCT00423670|12122791|FG003|Treatment Period|Investigator decision|0
7701878|NCT00423670|12122792|FG004|Treatment Period|Investigator decision|0
7701879|NCT00423670|12122793|FG005|Treatment Period|Investigator decision|0
7701880|NCT00423670|12122794|FG006|Treatment Period|Investigator decision|0
7701881|NCT00423670|12122795|FG007|Treatment Period|Investigator decision|1
7701882|NCT00423670|12122788|FG000|Treatment Period|Non-compliance with protocol|3
7701883|NCT00423670|12122789|FG001|Treatment Period|Non-compliance with protocol|1
7701884|NCT00423670|12122790|FG002|Treatment Period|Non-compliance with protocol|1
7701885|NCT00423670|12122791|FG003|Treatment Period|Non-compliance with protocol|3
7701886|NCT00423670|12122792|FG004|Treatment Period|Non-compliance with protocol|2
7701887|NCT00423670|12122793|FG005|Treatment Period|Non-compliance with protocol|0
7701888|NCT00423670|12122794|FG006|Treatment Period|Non-compliance with protocol|2
7701889|NCT00423670|12122795|FG007|Treatment Period|Non-compliance with protocol|2
7701890|NCT00423670|12122788|FG000|Follow-up Period|Lost to Follow-up|0
7701891|NCT00423670|12122789|FG001|Follow-up Period|Lost to Follow-up|12
7701892|NCT00423670|12122790|FG002|Follow-up Period|Lost to Follow-up|8
7701893|NCT00423670|12122791|FG003|Follow-up Period|Lost to Follow-up|3
7701894|NCT00423670|12122792|FG004|Follow-up Period|Lost to Follow-up|1
7701895|NCT00423670|12122793|FG005|Follow-up Period|Lost to Follow-up|0
7701896|NCT00423670|12122794|FG006|Follow-up Period|Lost to Follow-up|5
7701897|NCT00423670|12122795|FG007|Follow-up Period|Lost to Follow-up|0
7701898|NCT00423670|12122788|FG000|Follow-up Period|Subject withdrew (not treatment related)|1
7701899|NCT00423670|12122789|FG001|Follow-up Period|Subject withdrew (not treatment related)|4
7701900|NCT00423670|12122790|FG002|Follow-up Period|Subject withdrew (not treatment related)|2
7701901|NCT00423670|12122791|FG003|Follow-up Period|Subject withdrew (not treatment related)|1
7701902|NCT00423670|12122792|FG004|Follow-up Period|Subject withdrew (not treatment related)|1
7701903|NCT00423670|12122793|FG005|Follow-up Period|Subject withdrew (not treatment related)|0
7701904|NCT00423670|12122794|FG006|Follow-up Period|Subject withdrew (not treatment related)|1
7701905|NCT00423670|12122795|FG007|Follow-up Period|Subject withdrew (not treatment related)|1
7701906|NCT00423670|12122788|FG000|Follow-up Period|Non-compliance with protocol|2
7701907|NCT00423670|12122789|FG001|Follow-up Period|Non-compliance with protocol|0
7701908|NCT00423670|12122790|FG002|Follow-up Period|Non-compliance with protocol|1
7701909|NCT00423670|12122791|FG003|Follow-up Period|Non-compliance with protocol|1
7701910|NCT00423670|12122792|FG004|Follow-up Period|Non-compliance with protocol|0
7701911|NCT00423670|12122793|FG005|Follow-up Period|Non-compliance with protocol|0
7701912|NCT00423670|12122794|FG006|Follow-up Period|Non-compliance with protocol|3
7701913|NCT00423670|12122795|FG007|Follow-up Period|Non-compliance with protocol|2
7701914|NCT00423722|12122829|FG000|Overall Study|Death|4
7701915|NCT00423722|12122830|FG001|Overall Study|Death|4
7701916|NCT00423722|12122829|FG000|Overall Study|Declined to participate|2
7701917|NCT00423722|12122830|FG001|Overall Study|Declined to participate|3
7701918|NCT00423722|12122829|FG000|Overall Study|Unable to complete questionnaires|4
7701919|NCT00423722|12122830|FG001|Overall Study|Unable to complete questionnaires|4
7701920|NCT00423722|12122829|FG000|Overall Study|Withdrawal by Subject|4
7701921|NCT00423722|12122830|FG001|Overall Study|Withdrawal by Subject|2
7701922|NCT00423735|12122845|FG000|Overall Study|Ineligible / No protocol treatment|8
7701923|NCT00423735|12122846|FG001|Overall Study|Ineligible / No protocol treatment|6
7701924|NCT00423735|12122847|FG002|Overall Study|Ineligible / No protocol treatment|0
7701925|NCT00423800|12122859|FG000|Overall Study|Protocol Violation|0
7701926|NCT00423800|12122860|FG001|Overall Study|Protocol Violation|1
7701927|NCT00423813|12122870|FG000|Overall Study|Adverse Event|11
7701928|NCT00423813|12122871|FG001|Overall Study|Adverse Event|30
7701929|NCT00423813|12122872|FG002|Overall Study|Adverse Event|40
7701930|NCT00423813|12122870|FG000|Overall Study|Withdrawal by Subject|6
7701931|NCT00423813|12122871|FG001|Overall Study|Withdrawal by Subject|8
7701932|NCT00423813|12122872|FG002|Overall Study|Withdrawal by Subject|5
7701933|NCT00423813|12122870|FG000|Overall Study|Lost to Follow-up|5
7701934|NCT00423813|12122871|FG001|Overall Study|Lost to Follow-up|4
7701935|NCT00423813|12122872|FG002|Overall Study|Lost to Follow-up|4
7701936|NCT00423813|12122870|FG000|Overall Study|Lack of Efficacy|23
7701937|NCT00423813|12122871|FG001|Overall Study|Lack of Efficacy|18
7701938|NCT00423813|12122872|FG002|Overall Study|Lack of Efficacy|19
7701939|NCT00423813|12122870|FG000|Overall Study|Physician Decision|2
7701940|NCT00423813|12122871|FG001|Overall Study|Physician Decision|0
7701941|NCT00423813|12122872|FG002|Overall Study|Physician Decision|0
7701942|NCT00423813|12122870|FG000|Overall Study|Sponsor Decision|0
7701943|NCT00423813|12122871|FG001|Overall Study|Sponsor Decision|1
7701944|NCT00423813|12122872|FG002|Overall Study|Sponsor Decision|0
7701945|NCT00423813|12122870|FG000|Overall Study|Protocol Violation|9
7701946|NCT00423813|12122871|FG001|Overall Study|Protocol Violation|4
7701947|NCT00423813|12122872|FG002|Overall Study|Protocol Violation|4
7701948|NCT00423813|12122870|FG000|Overall Study|Pregnancy|0
7701949|NCT00423813|12122871|FG001|Overall Study|Pregnancy|0
7701950|NCT00423813|12122872|FG002|Overall Study|Pregnancy|1
7701951|NCT00423813|12122870|FG000|Overall Study|Subject started night shift work|1
7701952|NCT00423813|12122871|FG001|Overall Study|Subject started night shift work|0
7701953|NCT00423813|12122872|FG002|Overall Study|Subject started night shift work|0
7701954|NCT00423813|12122870|FG000|Overall Study|Will start exclusionary medications|0
7701955|NCT00423813|12122871|FG001|Overall Study|Will start exclusionary medications|1
7701956|NCT00423813|12122872|FG002|Overall Study|Will start exclusionary medications|0
7701957|NCT00423813|12122870|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0
7701958|NCT00423813|12122871|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0
7701959|NCT00423813|12122872|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1
7701960|NCT00423852|12122880|FG000|Overall Study|Removed pior to the high-dose portion|3
7701961|NCT00423891|12122896|FG000|Enrolled|Withdrawal by Subject|0
7701962|NCT00423891|12122897|FG001|Enrolled|Withdrawal by Subject|0
7701963|NCT00423891|12122898|FG002|Enrolled|Withdrawal by Subject|1
7701964|NCT00423891|12122896|FG000|Enrolled|Lost to Follow-up|0
7701965|NCT00423891|12122897|FG001|Enrolled|Lost to Follow-up|0
7701966|NCT00423891|12122898|FG002|Enrolled|Lost to Follow-up|1
7701967|NCT00423891|12122896|FG000|Enrolled|No longer met criteria|11
7701968|NCT00423891|12122897|FG001|Enrolled|No longer met criteria|2
7701969|NCT00423891|12122898|FG002|Enrolled|No longer met criteria|1
7701970|NCT00423891|12122896|FG000|Treatment|Withdrawal by Subject|1
7701971|NCT00423891|12122897|FG001|Treatment|Withdrawal by Subject|0
7701972|NCT00423891|12122898|FG002|Treatment|Withdrawal by Subject|0
7701973|NCT00423891|12122896|FG000|Treatment|Lost to Follow-up|1
7701974|NCT00423891|12122897|FG001|Treatment|Lost to Follow-up|0
7701975|NCT00423891|12122898|FG002|Treatment|Lost to Follow-up|0
7701976|NCT00423891|12122896|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0
7701977|NCT00423891|12122897|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3
7701978|NCT00423891|12122898|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2
7701979|NCT00423891|12122896|FG000|Post-Dosing Follow Up|Lost to Follow-up|2
7701980|NCT00423891|12122897|FG001|Post-Dosing Follow Up|Lost to Follow-up|0
7701981|NCT00423891|12122898|FG002|Post-Dosing Follow Up|Lost to Follow-up|0
7701982|NCT00423917|12122908|FG000|Overall Study|Cancel|2
7701983|NCT00423917|12122908|FG000|Overall Study|Ineligible|1
7701984|NCT00423930|12122912|FG000|Overall Study|Withdrawal by Subject|2
7701985|NCT00423943|12122918|FG000|Overall Study|Withdrawal by Subject|3
7701986|NCT00423943|12122919|FG001|Overall Study|Withdrawal by Subject|1
7701987|NCT00424021|12122929|FG000|NCT00046319 Study Period|Adverse Event|1
7701988|NCT00424021|12122930|FG001|NCT00046319 Study Period|Adverse Event|0
7701989|NCT00424021|12122931|FG002|NCT00046319 Study Period|Adverse Event|1
7701990|NCT00424021|12122932|FG003|NCT00046319 Study Period|Adverse Event|1
7701991|NCT00424021|12122929|FG000|NCT00046319 Study Period|Withdrawal by Subject|0
7701992|NCT00424021|12122930|FG001|NCT00046319 Study Period|Withdrawal by Subject|1
7701993|NCT00424021|12122931|FG002|NCT00046319 Study Period|Withdrawal by Subject|0
7701994|NCT00424021|12122932|FG003|NCT00046319 Study Period|Withdrawal by Subject|0
7701995|NCT00424021|12122929|FG000|NCT00046319 Study Period|Sponsor discretion|0
7701996|NCT00424021|12122930|FG001|NCT00046319 Study Period|Sponsor discretion|1
7701997|NCT00424021|12122931|FG002|NCT00046319 Study Period|Sponsor discretion|0
7701998|NCT00424021|12122932|FG003|NCT00046319 Study Period|Sponsor discretion|0
7701999|NCT00424021|12122929|FG000|NCT00046319 Study Period|Lost to Follow-up|0
7702000|NCT00424021|12122930|FG001|NCT00046319 Study Period|Lost to Follow-up|1
7702001|NCT00424021|12122931|FG002|NCT00046319 Study Period|Lost to Follow-up|0
7702002|NCT00424021|12122932|FG003|NCT00046319 Study Period|Lost to Follow-up|0
7702003|NCT00424021|12122929|FG000|AMB-220-E Study Period|Adverse Event|1
7702004|NCT00424021|12122930|FG001|AMB-220-E Study Period|Adverse Event|1
7702005|NCT00424021|12122931|FG002|AMB-220-E Study Period|Adverse Event|3
7702006|NCT00424021|12122932|FG003|AMB-220-E Study Period|Adverse Event|7
7702007|NCT00424021|12122929|FG000|AMB-220-E Study Period|Death|0
7702008|NCT00424021|12122930|FG001|AMB-220-E Study Period|Death|0
7702009|NCT00424021|12122931|FG002|AMB-220-E Study Period|Death|1
7702010|NCT00424021|12122932|FG003|AMB-220-E Study Period|Death|1
7702011|NCT00424021|12122929|FG000|AMB-220-E Study Period|Lost to Follow-up|0
7702012|NCT00424021|12122930|FG001|AMB-220-E Study Period|Lost to Follow-up|1
7702013|NCT00424021|12122931|FG002|AMB-220-E Study Period|Lost to Follow-up|1
7702014|NCT00424021|12122932|FG003|AMB-220-E Study Period|Lost to Follow-up|1
7702015|NCT00424021|12122929|FG000|AMB-220-E Study Period|Physician Decision|0
7702016|NCT00424021|12122930|FG001|AMB-220-E Study Period|Physician Decision|0
7702017|NCT00424021|12122931|FG002|AMB-220-E Study Period|Physician Decision|0
7702018|NCT00424021|12122932|FG003|AMB-220-E Study Period|Physician Decision|1
7702019|NCT00424047|12122951|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
7702020|NCT00424047|12122952|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
7702021|NCT00424047|12122951|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
7702022|NCT00424047|12122952|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
7702023|NCT00424047|12122951|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
7702024|NCT00424047|12122952|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
7702025|NCT00424047|12122951|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
7702026|NCT00424047|12122952|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
7702027|NCT00424047|12122951|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11
7702028|NCT00424047|12122952|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10
7702029|NCT00424047|12122951|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2
7702030|NCT00424047|12122952|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1
7702031|NCT00424047|12122951|FG000|On Study at Time of Unblinding|Adverse Event|22
7702032|NCT00424047|12122952|FG001|On Study at Time of Unblinding|Adverse Event|12
7702033|NCT00424047|12122951|FG000|On Study at Time of Unblinding|Progression of disease|92
7702034|NCT00424047|12122952|FG001|On Study at Time of Unblinding|Progression of disease|128
7702035|NCT00424047|12122951|FG000|On Study at Time of Unblinding|Lack of Efficacy|1
7702036|NCT00424047|12122952|FG001|On Study at Time of Unblinding|Lack of Efficacy|3
7702037|NCT00424047|12122951|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24
7702038|NCT00424047|12122952|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9
7702039|NCT00424047|12122951|FG000|On Study at Time of Unblinding|Death|11
7702040|NCT00424047|12122952|FG001|On Study at Time of Unblinding|Death|11
7702041|NCT00424047|12122951|FG000|On Study at Time of Unblinding|Other|5
7702042|NCT00424047|12122952|FG001|On Study at Time of Unblinding|Other|4
7702043|NCT00424047|12122951|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
7702044|NCT00424047|12122952|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
7702045|NCT00424047|12122951|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0
7702046|NCT00424047|12122952|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1
7702047|NCT00424047|12122951|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12
7702048|NCT00424047|12122952|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4
7702049|NCT00424047|12122951|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
7702050|NCT00424047|12122952|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
7702051|NCT00424047|12122951|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
7702052|NCT00424047|12122952|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
7702053|NCT00424177|12122963|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
7702054|NCT00424177|12122963|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
7702055|NCT00424177|12122963|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
7702056|NCT00424177|12122963|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
7702057|NCT00424177|12122963|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
7702058|NCT00424177|12122963|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
7702059|NCT00424177|12122963|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
7702060|NCT00424177|12122963|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
7702061|NCT00424177|12122963|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
7702062|NCT00424177|12122963|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
7702063|NCT00424190|12122977|FG000|Overall Study|Withdrew consent|3
7702064|NCT00424190|12122978|FG001|Overall Study|Withdrew consent|4
7702065|NCT00424190|12122977|FG000|Overall Study|Death|3
7702066|NCT00424190|12122978|FG001|Overall Study|Death|0
7702067|NCT00424190|12122977|FG000|Overall Study|Noncompliance|1
7702068|NCT00424190|12122978|FG001|Overall Study|Noncompliance|2
7702069|NCT00424190|12122977|FG000|Overall Study|Request of sponsor or investigator|0
7702070|NCT00424190|12122978|FG001|Overall Study|Request of sponsor or investigator|2
7702071|NCT00424190|12122977|FG000|Overall Study|Diagnosis of osteomyelitis|0
7702072|NCT00424190|12122978|FG001|Overall Study|Diagnosis of osteomyelitis|1
7702073|NCT00424190|12122977|FG000|Overall Study|Other|15
7702074|NCT00424190|12122978|FG001|Overall Study|Other|21
7702075|NCT00424255|12122986|FG000|Overall Study|Death|115
7702076|NCT00424255|12122987|FG001|Overall Study|Death|111
7702077|NCT00424255|12122986|FG000|Overall Study|Lost to Follow-up|26
7702078|NCT00424255|12122987|FG001|Overall Study|Lost to Follow-up|20
7702079|NCT00424255|12122986|FG000|Overall Study|Protocol Violation|0
7702080|NCT00424255|12122987|FG001|Overall Study|Protocol Violation|1
7702081|NCT00424255|12122986|FG000|Overall Study|Withdrawal by Subject|34
7702082|NCT00424255|12122987|FG001|Overall Study|Withdrawal by Subject|38
7702083|NCT00424255|12122986|FG000|Overall Study|Physician Decision|3
7702084|NCT00424255|12122987|FG001|Overall Study|Physician Decision|7
7702085|NCT00424255|12122986|FG000|Overall Study|Cognitive Disturbance|1
7702086|NCT00424255|12122987|FG001|Overall Study|Cognitive Disturbance|0
7702087|NCT00424255|12122986|FG000|Overall Study|Non-compliance by Participants|1
7702342|NCT00425061|12123222|FG001|Overall Study|Withdrawal by Subject|1
7702088|NCT00424255|12122987|FG001|Overall Study|Non-compliance by Participants|0
7702089|NCT00424255|12122986|FG000|Overall Study|Fatigue|1
7702090|NCT00424255|12122987|FG001|Overall Study|Fatigue|0
7702091|NCT00424255|12122986|FG000|Overall Study|Disease Progression|0
7702092|NCT00424255|12122987|FG001|Overall Study|Disease Progression|2
7702093|NCT00424255|12122986|FG000|Overall Study|Sponsor Terminated Study|161
7702094|NCT00424255|12122987|FG001|Overall Study|Sponsor Terminated Study|167
7702095|NCT00424294|12123004|FG000|Overall Study|Adverse Event|4
7702096|NCT00424294|12123005|FG001|Overall Study|Adverse Event|10
7702097|NCT00424294|12123004|FG000|Overall Study|Lack of Efficacy|2
7702098|NCT00424294|12123005|FG001|Overall Study|Lack of Efficacy|1
7702099|NCT00424294|12123004|FG000|Overall Study|Withdrawal by Subject|1
7702100|NCT00424294|12123005|FG001|Overall Study|Withdrawal by Subject|2
7702101|NCT00424294|12123004|FG000|Overall Study|Other|0
7702102|NCT00424294|12123005|FG001|Overall Study|Other|2
7702103|NCT00424294|12123004|FG000|Overall Study|Randomized but not Treated|1
7702104|NCT00424294|12123005|FG001|Overall Study|Randomized but not Treated|0
7702105|NCT00424346|12123015|FG000|Core Study|Adverse Event|5
7702106|NCT00424346|12123016|FG001|Core Study|Adverse Event|3
7702107|NCT00424346|12123017|FG002|Core Study|Adverse Event|1
7702108|NCT00424346|12123018|FG003|Core Study|Adverse Event|1
7702109|NCT00424346|12123015|FG000|Core Study|Abnormal Laboratory Values|0
7702110|NCT00424346|12123016|FG001|Core Study|Abnormal Laboratory Values|1
7702111|NCT00424346|12123017|FG002|Core Study|Abnormal Laboratory Values|0
7702112|NCT00424346|12123018|FG003|Core Study|Abnormal Laboratory Values|0
7702113|NCT00424346|12123015|FG000|Core Study|Lack of Efficacy|1
7702114|NCT00424346|12123016|FG001|Core Study|Lack of Efficacy|3
7702115|NCT00424346|12123017|FG002|Core Study|Lack of Efficacy|0
7702116|NCT00424346|12123018|FG003|Core Study|Lack of Efficacy|4
7702117|NCT00424346|12123015|FG000|Core Study|Withdrawal by Subject|1
7702118|NCT00424346|12123016|FG001|Core Study|Withdrawal by Subject|0
7702119|NCT00424346|12123017|FG002|Core Study|Withdrawal by Subject|0
7702120|NCT00424346|12123018|FG003|Core Study|Withdrawal by Subject|2
7702121|NCT00424346|12123015|FG000|Core Study|Lost to Follow-up|1
7702122|NCT00424346|12123016|FG001|Core Study|Lost to Follow-up|1
7702123|NCT00424346|12123017|FG002|Core Study|Lost to Follow-up|0
7702124|NCT00424346|12123018|FG003|Core Study|Lost to Follow-up|0
7702125|NCT00424346|12123015|FG000|Core Study|Administrative Problems|1
7702126|NCT00424346|12123016|FG001|Core Study|Administrative Problems|0
7702127|NCT00424346|12123017|FG002|Core Study|Administrative Problems|1
7702128|NCT00424346|12123018|FG003|Core Study|Administrative Problems|0
7702129|NCT00424346|12123015|FG000|Core Study|Protocol Violation|0
7702130|NCT00424346|12123016|FG001|Core Study|Protocol Violation|0
7702131|NCT00424346|12123017|FG002|Core Study|Protocol Violation|2
7702132|NCT00424346|12123018|FG003|Core Study|Protocol Violation|0
7702133|NCT00424346|12123015|FG000|Extension Phase|Adverse Event|0
7702134|NCT00424346|12123016|FG001|Extension Phase|Adverse Event|9
7702135|NCT00424346|12123017|FG002|Extension Phase|Adverse Event|5
7702136|NCT00424346|12123018|FG003|Extension Phase|Adverse Event|4
7702137|NCT00424346|12123015|FG000|Extension Phase|Lack of Efficacy|0
7702138|NCT00424346|12123016|FG001|Extension Phase|Lack of Efficacy|16
7702139|NCT00424346|12123017|FG002|Extension Phase|Lack of Efficacy|14
7702140|NCT00424346|12123018|FG003|Extension Phase|Lack of Efficacy|11
7702141|NCT00424346|12123015|FG000|Extension Phase|Withdrawal by Subject|0
7702142|NCT00424346|12123016|FG001|Extension Phase|Withdrawal by Subject|5
7702143|NCT00424346|12123017|FG002|Extension Phase|Withdrawal by Subject|3
7702144|NCT00424346|12123018|FG003|Extension Phase|Withdrawal by Subject|4
7702145|NCT00424346|12123015|FG000|Extension Phase|Lost to Follow-up|0
7702146|NCT00424346|12123016|FG001|Extension Phase|Lost to Follow-up|2
7702147|NCT00424346|12123017|FG002|Extension Phase|Lost to Follow-up|0
7702148|NCT00424346|12123018|FG003|Extension Phase|Lost to Follow-up|0
7702149|NCT00424346|12123015|FG000|Extension Phase|Administrative Problems|0
7702150|NCT00424346|12123016|FG001|Extension Phase|Administrative Problems|69
7702151|NCT00424346|12123017|FG002|Extension Phase|Administrative Problems|32
7702152|NCT00424346|12123018|FG003|Extension Phase|Administrative Problems|35
7702153|NCT00424346|12123015|FG000|Extension Phase|Death|0
7702154|NCT00424346|12123016|FG001|Extension Phase|Death|0
7702155|NCT00424346|12123017|FG002|Extension Phase|Death|0
7702156|NCT00424346|12123018|FG003|Extension Phase|Death|1
7702157|NCT00424346|12123015|FG000|Extension Phase|Protocol Violation|0
7702158|NCT00424346|12123016|FG001|Extension Phase|Protocol Violation|1
7702159|NCT00424346|12123017|FG002|Extension Phase|Protocol Violation|1
7702160|NCT00424346|12123018|FG003|Extension Phase|Protocol Violation|0
7702161|NCT00424372|12123031|FG000|Overall Study|Death|1
7702162|NCT00424372|12123031|FG000|Overall Study|Adverse Event|18
7702163|NCT00424372|12123031|FG000|Overall Study|Lack of Efficacy|6
7702164|NCT00424372|12123031|FG000|Overall Study|Withdrawal by Subject|4
7702165|NCT00424372|12123031|FG000|Overall Study|Protocol Violation|1
7702166|NCT00424372|12123031|FG000|Overall Study|Health deterioration|1
7702167|NCT00424385|12123035|FG000|Cohort 0|Withdrawal by Subject|5
7702168|NCT00424385|12123035|FG000|Cohort 0|Physician Decision|1
7702169|NCT00424385|12123035|FG000|Cohort 1|Withdrawal by Subject|1
7702170|NCT00424398|12123044|FG000|Overall Study|Withdrawal by Subject|2
7702171|NCT00424398|12123045|FG001|Overall Study|Withdrawal by Subject|1
7702172|NCT00424398|12123046|FG002|Overall Study|Withdrawal by Subject|0
7702173|NCT00424398|12123044|FG000|Overall Study|Subject met exclusion criteria|1
7702174|NCT00424398|12123045|FG001|Overall Study|Subject met exclusion criteria|0
7702175|NCT00424398|12123046|FG002|Overall Study|Subject met exclusion criteria|0
7702176|NCT00424463|12123057|FG000|Overall Study|Adverse Event|2
7702177|NCT00424463|12123058|FG001|Overall Study|Adverse Event|3
7702178|NCT00424463|12123059|FG002|Overall Study|Adverse Event|2
7702179|NCT00424463|12123057|FG000|Overall Study|Physician Decision|0
7702180|NCT00424463|12123058|FG001|Overall Study|Physician Decision|2
7702181|NCT00424463|12123059|FG002|Overall Study|Physician Decision|2
7702182|NCT00424463|12123057|FG000|Overall Study|Withdrawal by Subject|4
7702183|NCT00424463|12123058|FG001|Overall Study|Withdrawal by Subject|2
7702184|NCT00424463|12123059|FG002|Overall Study|Withdrawal by Subject|5
7702185|NCT00424463|12123057|FG000|Overall Study|Tracheotomy due to worsening of ALS|1
7702186|NCT00424463|12123058|FG001|Overall Study|Tracheotomy due to worsening of ALS|7
7702187|NCT00424463|12123059|FG002|Overall Study|Tracheotomy due to worsening of ALS|6
7702188|NCT00424463|12123057|FG000|Overall Study|Patient's convenience|0
7702189|NCT00424463|12123058|FG001|Overall Study|Patient's convenience|0
7702190|NCT00424463|12123059|FG002|Overall Study|Patient's convenience|1
7702191|NCT00424476|12123070|FG000|Overall Study|Withdrawal by Subject|7
7702192|NCT00424476|12123071|FG001|Overall Study|Withdrawal by Subject|6
7702193|NCT00424476|12123072|FG002|Overall Study|Withdrawal by Subject|3
7702194|NCT00424476|12123070|FG000|Overall Study|Adverse Event|19
7702195|NCT00424476|12123071|FG001|Overall Study|Adverse Event|16
7702196|NCT00424476|12123072|FG002|Overall Study|Adverse Event|15
7702197|NCT00424476|12123070|FG000|Overall Study|Lack of Efficacy|16
7702198|NCT00424476|12123071|FG001|Overall Study|Lack of Efficacy|12
7702199|NCT00424476|12123072|FG002|Overall Study|Lack of Efficacy|12
7702200|NCT00424476|12123070|FG000|Overall Study|Lack of Compliance|1
7702201|NCT00424476|12123071|FG001|Overall Study|Lack of Compliance|1
7702202|NCT00424476|12123072|FG002|Overall Study|Lack of Compliance|1
7702203|NCT00424476|12123070|FG000|Overall Study|Lost to Follow-up|4
7702204|NCT00424476|12123071|FG001|Overall Study|Lost to Follow-up|6
7702205|NCT00424476|12123072|FG002|Overall Study|Lost to Follow-up|3
7702206|NCT00424476|12123070|FG000|Overall Study|Protocol Violation|7
7702207|NCT00424476|12123071|FG001|Overall Study|Protocol Violation|2
7702208|NCT00424476|12123072|FG002|Overall Study|Protocol Violation|3
7702209|NCT00424476|12123070|FG000|Overall Study|Physician Decision|3
7702210|NCT00424476|12123071|FG001|Overall Study|Physician Decision|2
7702211|NCT00424476|12123072|FG002|Overall Study|Physician Decision|3
7702212|NCT00424476|12123070|FG000|Overall Study|Other|4
7702213|NCT00424476|12123071|FG001|Overall Study|Other|3
7702214|NCT00424476|12123072|FG002|Overall Study|Other|9
7702215|NCT00424489|12123080|FG000|Overall Study|Death|3
7702216|NCT00424515|12123090|FG000|Overall Study|Progressive Disease|10
7702217|NCT00424515|12123091|FG001|Overall Study|Progressive Disease|11
7702218|NCT00424515|12123090|FG000|Overall Study|Adverse Event|0
7702219|NCT00424515|12123091|FG001|Overall Study|Adverse Event|1
7702220|NCT00424515|12123090|FG000|Overall Study|Intercurrent Illness|0
7702221|NCT00424515|12123091|FG001|Overall Study|Intercurrent Illness|1
7702222|NCT00424515|12123090|FG000|Overall Study|Withdrawal by Subject|1
7702223|NCT00424515|12123091|FG001|Overall Study|Withdrawal by Subject|0
7702224|NCT00424528|12123100|FG000|Overall Study|Adverse Event|2
7702225|NCT00424528|12123101|FG001|Overall Study|Adverse Event|1
7702226|NCT00424528|12123102|FG002|Overall Study|Adverse Event|2
7702227|NCT00424528|12123100|FG000|Overall Study|Protocol Violation|1
7702228|NCT00424528|12123101|FG001|Overall Study|Protocol Violation|1
7702229|NCT00424528|12123102|FG002|Overall Study|Protocol Violation|0
7702230|NCT00424528|12123100|FG000|Overall Study|Lost to Follow-up|0
7702231|NCT00424528|12123101|FG001|Overall Study|Lost to Follow-up|1
7702232|NCT00424528|12123102|FG002|Overall Study|Lost to Follow-up|0
7702233|NCT00424528|12123100|FG000|Overall Study|noncompliance with study requirements|2
7702234|NCT00424528|12123101|FG001|Overall Study|noncompliance with study requirements|1
7702235|NCT00424528|12123102|FG002|Overall Study|noncompliance with study requirements|2
7702236|NCT00424593|12123121|FG000|Acute Double-Blind Period|Adverse Event|16
7702237|NCT00424593|12123122|FG001|Acute Double-Blind Period|Adverse Event|7
7702238|NCT00424593|12123121|FG000|Acute Double-Blind Period|Withdrawal by Subject|11
7702239|NCT00424593|12123122|FG001|Acute Double-Blind Period|Withdrawal by Subject|10
7702240|NCT00424593|12123121|FG000|Acute Double-Blind Period|Protocol Violation|2
7702241|NCT00424593|12123122|FG001|Acute Double-Blind Period|Protocol Violation|2
7702242|NCT00424593|12123121|FG000|Acute Double-Blind Period|Physician Decision|1
7702243|NCT00424593|12123122|FG001|Acute Double-Blind Period|Physician Decision|2
7702244|NCT00424593|12123121|FG000|Acute Double-Blind Period|Lost to Follow-up|1
7702245|NCT00424593|12123122|FG001|Acute Double-Blind Period|Lost to Follow-up|1
7702246|NCT00424593|12123121|FG000|Acute Double-Blind Period|Lack of Efficacy|0
7702247|NCT00424593|12123122|FG001|Acute Double-Blind Period|Lack of Efficacy|1
7702248|NCT00424593|12123121|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19
7702249|NCT00424593|12123122|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0
7702250|NCT00424593|12123121|FG000|Dose-Blind Extension Period|Adverse Event|18
7702251|NCT00424593|12123122|FG001|Dose-Blind Extension Period|Adverse Event|0
7702252|NCT00424593|12123121|FG000|Dose-Blind Extension Period|Lack of Efficacy|9
7702253|NCT00424593|12123122|FG001|Dose-Blind Extension Period|Lack of Efficacy|0
7702254|NCT00424593|12123121|FG000|Dose-Blind Extension Period|Protocol Violation|9
7702255|NCT00424593|12123122|FG001|Dose-Blind Extension Period|Protocol Violation|0
7702256|NCT00424593|12123121|FG000|Dose-Blind Extension Period|Lost to Follow-up|6
7702257|NCT00424593|12123122|FG001|Dose-Blind Extension Period|Lost to Follow-up|0
7702258|NCT00424593|12123121|FG000|Dose-Blind Extension Period|Physician Decision|3
7702259|NCT00424593|12123122|FG001|Dose-Blind Extension Period|Physician Decision|0
7702260|NCT00424632|12123143|FG000|Overall Study|Death|0
7702261|NCT00424632|12123144|FG001|Overall Study|Death|0
7702262|NCT00424632|12123145|FG002|Overall Study|Death|0
7702263|NCT00424632|12123146|FG003|Overall Study|Death|0
7702264|NCT00424632|12123147|FG004|Overall Study|Death|0
7702265|NCT00424632|12123148|FG005|Overall Study|Death|2
7702266|NCT00424632|12123149|FG006|Overall Study|Death|0
7702267|NCT00424632|12123150|FG007|Overall Study|Death|0
7702268|NCT00424632|12123151|FG008|Overall Study|Death|0
7702269|NCT00424632|12123152|FG009|Overall Study|Death|0
7702270|NCT00424632|12123143|FG000|Overall Study|Adverse Event|0
7702271|NCT00424632|12123144|FG001|Overall Study|Adverse Event|0
7702272|NCT00424632|12123145|FG002|Overall Study|Adverse Event|0
7702273|NCT00424632|12123146|FG003|Overall Study|Adverse Event|0
7702274|NCT00424632|12123147|FG004|Overall Study|Adverse Event|0
7702275|NCT00424632|12123148|FG005|Overall Study|Adverse Event|0
7702276|NCT00424632|12123149|FG006|Overall Study|Adverse Event|0
7702277|NCT00424632|12123150|FG007|Overall Study|Adverse Event|0
7702278|NCT00424632|12123151|FG008|Overall Study|Adverse Event|3
7702279|NCT00424632|12123152|FG009|Overall Study|Adverse Event|2
7702280|NCT00424632|12123143|FG000|Overall Study|Global deterioration of health status|0
7702281|NCT00424632|12123144|FG001|Overall Study|Global deterioration of health status|0
7702282|NCT00424632|12123145|FG002|Overall Study|Global deterioration of health status|0
7702283|NCT00424632|12123146|FG003|Overall Study|Global deterioration of health status|1
7702284|NCT00424632|12123147|FG004|Overall Study|Global deterioration of health status|1
7702285|NCT00424632|12123148|FG005|Overall Study|Global deterioration of health status|0
7702286|NCT00424632|12123149|FG006|Overall Study|Global deterioration of health status|0
7702287|NCT00424632|12123150|FG007|Overall Study|Global deterioration of health status|0
7702288|NCT00424632|12123151|FG008|Overall Study|Global deterioration of health status|0
7702289|NCT00424632|12123152|FG009|Overall Study|Global deterioration of health status|0
7702290|NCT00424632|12123143|FG000|Overall Study|Objective progression or relapse|1
7702291|NCT00424632|12123144|FG001|Overall Study|Objective progression or relapse|1
7702292|NCT00424632|12123145|FG002|Overall Study|Objective progression or relapse|1
7702293|NCT00424632|12123146|FG003|Overall Study|Objective progression or relapse|2
7702294|NCT00424632|12123147|FG004|Overall Study|Objective progression or relapse|2
7702295|NCT00424632|12123148|FG005|Overall Study|Objective progression or relapse|13
7702296|NCT00424632|12123149|FG006|Overall Study|Objective progression or relapse|7
7702297|NCT00424632|12123150|FG007|Overall Study|Objective progression or relapse|3
7702298|NCT00424632|12123151|FG008|Overall Study|Objective progression or relapse|12
7702299|NCT00424632|12123152|FG009|Overall Study|Objective progression or relapse|4
7702300|NCT00424632|12123143|FG000|Overall Study|Other|0
7702301|NCT00424632|12123144|FG001|Overall Study|Other|0
7702302|NCT00424632|12123145|FG002|Overall Study|Other|0
7702303|NCT00424632|12123146|FG003|Overall Study|Other|1
7702304|NCT00424632|12123147|FG004|Overall Study|Other|0
7702305|NCT00424632|12123148|FG005|Overall Study|Other|0
7702306|NCT00424632|12123149|FG006|Overall Study|Other|0
7702307|NCT00424632|12123150|FG007|Overall Study|Other|0
7702308|NCT00424632|12123151|FG008|Overall Study|Other|1
7702309|NCT00424632|12123152|FG009|Overall Study|Other|0
7702310|NCT00424749|12123183|FG000|Overall Study|Withdrawal by Subject|1
7702311|NCT00424762|12123189|FG000|Overall Study|Withdrawal by Subject|18
7702312|NCT00424762|12123190|FG001|Overall Study|Withdrawal by Subject|19
7702313|NCT00424762|12123189|FG000|Overall Study|Lost to Follow-up|2
7702314|NCT00424762|12123190|FG001|Overall Study|Lost to Follow-up|3
7702315|NCT00424775|12123196|FG000|Overall Study|Adverse Event|2
7702316|NCT00424775|12123197|FG001|Overall Study|Adverse Event|0
7702317|NCT00424775|12123196|FG000|Overall Study|Lack of Efficacy|1
7702318|NCT00424775|12123197|FG001|Overall Study|Lack of Efficacy|0
7702319|NCT00424827|12123201|FG000|Overall Study|Adverse Event|1
7702320|NCT00425061|12123221|FG000|Overall Study|Adverse Event|1
7702321|NCT00425061|12123222|FG001|Overall Study|Adverse Event|0
7702322|NCT00425061|12123223|FG002|Overall Study|Adverse Event|0
7702323|NCT00425061|12123224|FG003|Overall Study|Adverse Event|2
7702324|NCT00425061|12123225|FG004|Overall Study|Adverse Event|2
7702325|NCT00425061|12123226|FG005|Overall Study|Adverse Event|0
7702326|NCT00425061|12123227|FG006|Overall Study|Adverse Event|0
7702327|NCT00425061|12123221|FG000|Overall Study|Lost to Follow-up|0
7702328|NCT00425061|12123222|FG001|Overall Study|Lost to Follow-up|1
7702329|NCT00425061|12123223|FG002|Overall Study|Lost to Follow-up|0
7702330|NCT00425061|12123224|FG003|Overall Study|Lost to Follow-up|0
7702331|NCT00425061|12123225|FG004|Overall Study|Lost to Follow-up|0
7702332|NCT00425061|12123226|FG005|Overall Study|Lost to Follow-up|0
7702333|NCT00425061|12123227|FG006|Overall Study|Lost to Follow-up|0
7702334|NCT00425061|12123221|FG000|Overall Study|Protocol Violation|1
7702335|NCT00425061|12123222|FG001|Overall Study|Protocol Violation|0
7702336|NCT00425061|12123223|FG002|Overall Study|Protocol Violation|0
7702337|NCT00425061|12123224|FG003|Overall Study|Protocol Violation|0
7702338|NCT00425061|12123225|FG004|Overall Study|Protocol Violation|0
7702339|NCT00425061|12123226|FG005|Overall Study|Protocol Violation|0
7702340|NCT00425061|12123227|FG006|Overall Study|Protocol Violation|0
7702341|NCT00425061|12123221|FG000|Overall Study|Withdrawal by Subject|0
7702343|NCT00425061|12123223|FG002|Overall Study|Withdrawal by Subject|0
7702344|NCT00425061|12123224|FG003|Overall Study|Withdrawal by Subject|0
7702345|NCT00425061|12123225|FG004|Overall Study|Withdrawal by Subject|1
7702346|NCT00425061|12123226|FG005|Overall Study|Withdrawal by Subject|0
7702347|NCT00425061|12123227|FG006|Overall Study|Withdrawal by Subject|3
7702348|NCT00425061|12123221|FG000|Overall Study|Sponsor's request|0
7702349|NCT00425061|12123222|FG001|Overall Study|Sponsor's request|0
7702350|NCT00425061|12123223|FG002|Overall Study|Sponsor's request|0
7702351|NCT00425061|12123224|FG003|Overall Study|Sponsor's request|0
7702352|NCT00425061|12123225|FG004|Overall Study|Sponsor's request|19
7702353|NCT00425061|12123226|FG005|Overall Study|Sponsor's request|4
7702354|NCT00425061|12123227|FG006|Overall Study|Sponsor's request|15
7702355|NCT00425061|12123221|FG000|Overall Study|Physician Decision|0
7702356|NCT00425061|12123222|FG001|Overall Study|Physician Decision|0
7702357|NCT00425061|12123223|FG002|Overall Study|Physician Decision|0
7702358|NCT00425061|12123224|FG003|Overall Study|Physician Decision|0
7702359|NCT00425061|12123225|FG004|Overall Study|Physician Decision|1
7702360|NCT00425061|12123226|FG005|Overall Study|Physician Decision|0
7702361|NCT00425061|12123227|FG006|Overall Study|Physician Decision|0
7702362|NCT00425061|12123221|FG000|Overall Study|Other|0
7702363|NCT00425061|12123222|FG001|Overall Study|Other|0
7702364|NCT00425061|12123223|FG002|Overall Study|Other|0
7702365|NCT00425061|12123224|FG003|Overall Study|Other|0
7702366|NCT00425061|12123225|FG004|Overall Study|Other|3
7702367|NCT00425061|12123226|FG005|Overall Study|Other|0
7702368|NCT00425061|12123227|FG006|Overall Study|Other|1
7702369|NCT00425113|12123247|FG000|Overall Study|uncontrolled diabetes mellitus|1
7702370|NCT00425113|12123248|FG001|Overall Study|uncontrolled diabetes mellitus|0
7702371|NCT00425113|12123247|FG000|Overall Study|diagnosis of abdominal TB|0
7702372|NCT00425113|12123248|FG001|Overall Study|diagnosis of abdominal TB|1
7702373|NCT00425113|12123247|FG000|Overall Study|missing study drug more than 14 days|0
7702374|NCT00425113|12123248|FG001|Overall Study|missing study drug more than 14 days|1
7702375|NCT00425113|12123247|FG000|Overall Study|Withdrawal by Subject|1
7702376|NCT00425113|12123248|FG001|Overall Study|Withdrawal by Subject|0
7702377|NCT00425269|12123257|FG000|Overall Study|Pregnancy|5
7702378|NCT00425269|12123258|FG001|Overall Study|Pregnancy|7
7702379|NCT00425269|12123257|FG000|Overall Study|Lost to Follow-up|9
7702380|NCT00425269|12123258|FG001|Overall Study|Lost to Follow-up|9
7702381|NCT00425269|12123257|FG000|Overall Study|moved or medical reason|5
7702382|NCT00425269|12123258|FG001|Overall Study|moved or medical reason|4
7702383|NCT00425308|12123266|FG000|Overall Study|Adverse Event|2
7702384|NCT00425308|12123267|FG001|Overall Study|Adverse Event|1
7702385|NCT00425308|12123266|FG000|Overall Study|Withdrawal by Subject|1
7702386|NCT00425308|12123267|FG001|Overall Study|Withdrawal by Subject|0
7702387|NCT00425308|12123266|FG000|Overall Study|Death|1
7702388|NCT00425308|12123267|FG001|Overall Study|Death|0
7702389|NCT00425373|12123282|FG000|Overall Study|Adverse Event|2
7702390|NCT00425373|12123283|FG001|Overall Study|Adverse Event|2
7702391|NCT00425373|12123284|FG002|Overall Study|Adverse Event|0
7702392|NCT00425373|12123285|FG003|Overall Study|Adverse Event|1
7702393|NCT00425373|12123286|FG004|Overall Study|Adverse Event|4
7702394|NCT00425373|12123287|FG005|Overall Study|Adverse Event|6
7702395|NCT00425373|12123288|FG006|Overall Study|Adverse Event|2
7702396|NCT00425373|12123289|FG007|Overall Study|Adverse Event|3
7702397|NCT00425373|12123290|FG008|Overall Study|Adverse Event|8
7702398|NCT00425373|12123282|FG000|Overall Study|Lost to Follow-up|0
7702399|NCT00425373|12123283|FG001|Overall Study|Lost to Follow-up|1
7702400|NCT00425373|12123284|FG002|Overall Study|Lost to Follow-up|0
7702401|NCT00425373|12123285|FG003|Overall Study|Lost to Follow-up|0
7702402|NCT00425373|12123286|FG004|Overall Study|Lost to Follow-up|1
7702403|NCT00425373|12123287|FG005|Overall Study|Lost to Follow-up|0
7702404|NCT00425373|12123288|FG006|Overall Study|Lost to Follow-up|0
7702405|NCT00425373|12123289|FG007|Overall Study|Lost to Follow-up|0
7702406|NCT00425373|12123290|FG008|Overall Study|Lost to Follow-up|0
7702407|NCT00425373|12123282|FG000|Overall Study|Protocol Violation|1
7702408|NCT00425373|12123283|FG001|Overall Study|Protocol Violation|0
7702409|NCT00425373|12123284|FG002|Overall Study|Protocol Violation|1
7702410|NCT00425373|12123285|FG003|Overall Study|Protocol Violation|0
7702411|NCT00425373|12123286|FG004|Overall Study|Protocol Violation|0
7702412|NCT00425373|12123287|FG005|Overall Study|Protocol Violation|0
7702413|NCT00425373|12123288|FG006|Overall Study|Protocol Violation|0
7702414|NCT00425373|12123289|FG007|Overall Study|Protocol Violation|5
7702415|NCT00425373|12123290|FG008|Overall Study|Protocol Violation|3
7702416|NCT00425373|12123282|FG000|Overall Study|Withdrawal by Subject|2
7702417|NCT00425373|12123283|FG001|Overall Study|Withdrawal by Subject|0
7702418|NCT00425373|12123284|FG002|Overall Study|Withdrawal by Subject|2
7702419|NCT00425373|12123285|FG003|Overall Study|Withdrawal by Subject|1
7702420|NCT00425373|12123286|FG004|Overall Study|Withdrawal by Subject|4
7702421|NCT00425373|12123287|FG005|Overall Study|Withdrawal by Subject|0
7702422|NCT00425373|12123288|FG006|Overall Study|Withdrawal by Subject|2
7702423|NCT00425373|12123289|FG007|Overall Study|Withdrawal by Subject|2
7702424|NCT00425373|12123290|FG008|Overall Study|Withdrawal by Subject|2
7702425|NCT00425373|12123282|FG000|Overall Study|Lack of Efficacy|0
7702426|NCT00425373|12123283|FG001|Overall Study|Lack of Efficacy|0
7702427|NCT00425373|12123284|FG002|Overall Study|Lack of Efficacy|0
7702428|NCT00425373|12123285|FG003|Overall Study|Lack of Efficacy|0
7702429|NCT00425373|12123286|FG004|Overall Study|Lack of Efficacy|1
7702430|NCT00425373|12123287|FG005|Overall Study|Lack of Efficacy|3
7702431|NCT00425373|12123288|FG006|Overall Study|Lack of Efficacy|3
7702432|NCT00425373|12123289|FG007|Overall Study|Lack of Efficacy|0
7702433|NCT00425373|12123290|FG008|Overall Study|Lack of Efficacy|5
7702434|NCT00425503|12123318|FG000|Overall Study|Adverse Event|2
7702435|NCT00425503|12123318|FG000|Overall Study|Protocol Violation|1
7702436|NCT00425555|12123324|FG000|Overall Study|Withdrawal by Subject|11
7702437|NCT00425555|12123325|FG001|Overall Study|Withdrawal by Subject|8
7702438|NCT00425555|12123324|FG000|Overall Study|Lost to Follow-up|0
7702439|NCT00425555|12123325|FG001|Overall Study|Lost to Follow-up|1
7702440|NCT00425555|12123324|FG000|Overall Study|Administrative problems|3
7702441|NCT00425555|12123325|FG001|Overall Study|Administrative problems|0
7702442|NCT00425555|12123324|FG000|Overall Study|Death|1
7702443|NCT00425555|12123325|FG001|Overall Study|Death|2
7702444|NCT00425555|12123324|FG000|Overall Study|New cancer therapy|2
7702445|NCT00425555|12123325|FG001|Overall Study|New cancer therapy|1
7702446|NCT00425555|12123324|FG000|Overall Study|Disease progression|36
7702447|NCT00425555|12123325|FG001|Overall Study|Disease progression|33
7702448|NCT00425555|12123324|FG000|Overall Study|Adverse Event|25
7702449|NCT00425555|12123325|FG001|Overall Study|Adverse Event|15
7702450|NCT00425555|12123324|FG000|Overall Study|Protocol Violation|1
7702451|NCT00425555|12123325|FG001|Overall Study|Protocol Violation|0
7702452|NCT00425607|12123334|FG000|Overall Study|Death|1
7702453|NCT00425607|12123334|FG000|Overall Study|Withdrawal by Subject|1
7702454|NCT00425698|12123344|FG000|Overall Study|Adverse Event|3
7702455|NCT00425698|12123345|FG001|Overall Study|Adverse Event|1
7702456|NCT00425698|12123344|FG000|Overall Study|Withdrawal by Subject|0
7702457|NCT00425698|12123345|FG001|Overall Study|Withdrawal by Subject|1
7702458|NCT00425750|12123351|FG000|Overall Study|Death|1
7702459|NCT00425750|12123351|FG000|Overall Study|Withdrawal by Subject|3
7702460|NCT00425750|12123351|FG000|Overall Study|Adverse Event|3
7702461|NCT00425750|12123351|FG000|Overall Study|Progression of disease|18
7702462|NCT00425854|12123361|FG000|Overall Study|Progressive Disease|19
7702463|NCT00425854|12123362|FG001|Overall Study|Progressive Disease|12
7702464|NCT00425854|12123361|FG000|Overall Study|Dose reduction toxicity AE|8
7702465|NCT00425854|12123362|FG001|Overall Study|Dose reduction toxicity AE|7
7702466|NCT00425854|12123361|FG000|Overall Study|Other Adverse Event|2
7702467|NCT00425854|12123362|FG001|Overall Study|Other Adverse Event|2
7702468|NCT00425945|12123371|FG000|Overall Study|Concern about Supplement|2
7702469|NCT00425945|12123372|FG001|Overall Study|Concern about Supplement|0
7702470|NCT00425945|12123371|FG000|Overall Study|Inconvenience|0
7702471|NCT00425945|12123372|FG001|Overall Study|Inconvenience|2
7702472|NCT00425945|12123371|FG000|Overall Study|Lost to Follow-up|0
7702473|NCT00425945|12123372|FG001|Overall Study|Lost to Follow-up|2
7702474|NCT00425945|12123371|FG000|Overall Study|Began hypertension medication|1
7702475|NCT00425945|12123372|FG001|Overall Study|Began hypertension medication|0
7702476|NCT00425945|12123371|FG000|Overall Study|Began cancer treatments|1
7702477|NCT00425945|12123372|FG001|Overall Study|Began cancer treatments|0
7702478|NCT00425945|12123371|FG000|Overall Study|Moved from area|0
7702479|NCT00425945|12123372|FG001|Overall Study|Moved from area|1
7702480|NCT00426127|12123380|FG000|Overall Study|Adverse Event|1
7702481|NCT00426127|12123380|FG000|Overall Study|Removed due to disease progression|1
7702482|NCT00426231|12123395|FG000|Overall Study|Withdrawal by Subject|9
7702483|NCT00426231|12123396|FG001|Overall Study|Withdrawal by Subject|12
7702484|NCT00426270|12123402|FG000|Overall Study|Incorrectly Enrolled in the Study|1
7702485|NCT00426270|12123402|FG000|Overall Study|Adverse Event|5
7702486|NCT00426361|12123422|FG000|Overall Study|Lost to Follow-up|3
7702487|NCT00426361|12123423|FG001|Overall Study|Lost to Follow-up|2
7702488|NCT00426361|12123424|FG002|Overall Study|Lost to Follow-up|5
7702489|NCT00426361|12123422|FG000|Overall Study|Withdrawal by Subject|1
7702490|NCT00426361|12123423|FG001|Overall Study|Withdrawal by Subject|3
7702491|NCT00426361|12123424|FG002|Overall Study|Withdrawal by Subject|0
7702492|NCT00426556|12123453|FG000|Phase I - Core Phase|Disease Progression|0
7702493|NCT00426556|12123454|FG001|Phase I - Core Phase|Disease Progression|6
7702494|NCT00426556|12123455|FG002|Phase I - Core Phase|Disease Progression|2
7702495|NCT00426556|12123456|FG003|Phase I - Core Phase|Disease Progression|0
7702496|NCT00426556|12123453|FG000|Phase I - Core Phase|Adverse Event|1
7702497|NCT00426556|12123454|FG001|Phase I - Core Phase|Adverse Event|3
7702498|NCT00426556|12123455|FG002|Phase I - Core Phase|Adverse Event|1
7702499|NCT00426556|12123456|FG003|Phase I - Core Phase|Adverse Event|0
7702500|NCT00426556|12123453|FG000|Phase I - Core Phase|Death|0
7702501|NCT00426556|12123454|FG001|Phase I - Core Phase|Death|1
7702502|NCT00426556|12123455|FG002|Phase I - Core Phase|Death|0
7702503|NCT00426556|12123456|FG003|Phase I - Core Phase|Death|0
7702504|NCT00426556|12123453|FG000|Phase I - Extension Phase|Adverse Event|0
7702505|NCT00426556|12123454|FG001|Phase I - Extension Phase|Adverse Event|1
7702506|NCT00426556|12123455|FG002|Phase I - Extension Phase|Adverse Event|1
7702507|NCT00426556|12123456|FG003|Phase I - Extension Phase|Adverse Event|0
7702508|NCT00426556|12123453|FG000|Phase I - Extension Phase|Disease Progression|5
7702509|NCT00426556|12123454|FG001|Phase I - Extension Phase|Disease Progression|5
7702510|NCT00426556|12123455|FG002|Phase I - Extension Phase|Disease Progression|6
7702511|NCT00426556|12123456|FG003|Phase I - Extension Phase|Disease Progression|0
7702512|NCT00426556|12123453|FG000|Phase II - Core Phase|Withdrawal by Subject|0
7702513|NCT00426556|12123454|FG001|Phase II - Core Phase|Withdrawal by Subject|0
7702514|NCT00426556|12123455|FG002|Phase II - Core Phase|Withdrawal by Subject|0
7702515|NCT00426556|12123456|FG003|Phase II - Core Phase|Withdrawal by Subject|3
7702516|NCT00426556|12123453|FG000|Phase II - Core Phase|Disease Progression|0
7702517|NCT00426556|12123454|FG001|Phase II - Core Phase|Disease Progression|0
7702518|NCT00426556|12123455|FG002|Phase II - Core Phase|Disease Progression|0
7702519|NCT00426556|12123456|FG003|Phase II - Core Phase|Disease Progression|16
7702520|NCT00426556|12123453|FG000|Phase II - Core Phase|Adverse Event|0
7702521|NCT00426556|12123454|FG001|Phase II - Core Phase|Adverse Event|0
7702522|NCT00426556|12123455|FG002|Phase II - Core Phase|Adverse Event|0
7702523|NCT00426556|12123456|FG003|Phase II - Core Phase|Adverse Event|8
7702524|NCT00426556|12123453|FG000|Phase II - Extension Phase|Disease Progression|0
7702525|NCT00426556|12123454|FG001|Phase II - Extension Phase|Disease Progression|0
7702526|NCT00426556|12123455|FG002|Phase II - Extension Phase|Disease Progression|0
7702527|NCT00426556|12123456|FG003|Phase II - Extension Phase|Disease Progression|21
7702528|NCT00426556|12123453|FG000|Phase II - Extension Phase|Adverse Event|0
7702529|NCT00426556|12123454|FG001|Phase II - Extension Phase|Adverse Event|0
7702530|NCT00426556|12123455|FG002|Phase II - Extension Phase|Adverse Event|0
7702531|NCT00426556|12123456|FG003|Phase II - Extension Phase|Adverse Event|2
7702532|NCT00426660|12123466|FG000|Overall Study|Death|14
7702533|NCT00426660|12123466|FG000|Overall Study|Adverse Event|23
7702534|NCT00426660|12123466|FG000|Overall Study|Insufficient Clinical Response|22
7702535|NCT00426660|12123466|FG000|Overall Study|Lost to Follow-up|15
7702536|NCT00426660|12123466|FG000|Overall Study|Other|23
7702537|NCT00426660|12123466|FG000|Overall Study|Withdrawal by Subject|18
7702538|NCT00426660|12123466|FG000|Overall Study|Protocol Violation|1
7702539|NCT00426660|12123466|FG000|Overall Study|Enrolled Not Treated|15
7702540|NCT00426751|12123472|FG000|Overall Study|Adverse Event|8
7702541|NCT00426751|12123473|FG001|Overall Study|Adverse Event|1
7702542|NCT00426751|12123472|FG000|Overall Study|Lost to Follow-up|7
7702543|NCT00426751|12123473|FG001|Overall Study|Lost to Follow-up|6
7702544|NCT00426751|12123472|FG000|Overall Study|Consent Withdrawn|0
7702545|NCT00426751|12123473|FG001|Overall Study|Consent Withdrawn|1
7702546|NCT00426751|12123472|FG000|Overall Study|Other Reasons|7
7702547|NCT00426751|12123473|FG001|Overall Study|Other Reasons|12
7702548|NCT00426764|12123479|FG000|Overall Study|Protocol Violation|1
7702549|NCT00426764|12123479|FG000|Overall Study|Withdrawal by Subject|4
7702550|NCT00426764|12123479|FG000|Overall Study|Physician Decision|6
7702551|NCT00426764|12123479|FG000|Overall Study|Compassionate Use|1
7702552|NCT00426764|12123479|FG000|Overall Study|Progressive Disease|83
7702553|NCT00426764|12123479|FG000|Overall Study|Adverse Event|24
7702554|NCT00426764|12123479|FG000|Overall Study|Other|1
7702555|NCT00426764|12123479|FG000|Overall Study|Death|1
7702556|NCT00426764|12123479|FG000|Overall Study|Other Reasons (Miscellaneous)|10
7702557|NCT00426842|12123489|FG000|Overall Study|Lost to Follow-up|1
7702558|NCT00427011|12123499|FG000|Overall Study|Adverse Event|10
7702559|NCT00427011|12123499|FG000|Overall Study|Withdrawal by Subject|1
7702560|NCT00427011|12123499|FG000|Overall Study|Lack of Efficacy|2
7702561|NCT00427011|12123499|FG000|Overall Study|Other|12
7702562|NCT00427349|12123528|FG000|Overall Study|Lack of Efficacy|23
7702563|NCT00427349|12123528|FG000|Overall Study|Adverse Event|14
7702564|NCT00427349|12123528|FG000|Overall Study|Death|1
7702565|NCT00427349|12123528|FG000|Overall Study|Withdrawal by Subject|3
7702566|NCT00427349|12123528|FG000|Overall Study|Alternative therapy|1
7702567|NCT00427349|12123528|FG000|Overall Study|Other|2
7702568|NCT00427349|12123528|FG000|Overall Study|Ineligible|1
7702569|NCT00427349|12123528|FG000|Overall Study|Never started therapy|1
7702570|NCT00427635|12123538|FG000|Treatment Phase|Withdrawal by Subject|1
7702571|NCT00427635|12123539|FG001|Treatment Phase|Withdrawal by Subject|0
7702572|NCT00427635|12123538|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0
7702573|NCT00427635|12123539|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1
7702574|NCT00427648|12123547|FG000|Overall Study|Protocol Violation|1
7702575|NCT00427648|12123548|FG001|Overall Study|Protocol Violation|2
7702576|NCT00427648|12123547|FG000|Overall Study|Adverse Event|0
7702577|NCT00427648|12123548|FG001|Overall Study|Adverse Event|1
7702578|NCT00427700|12123563|FG000|Overall Study|Lost to Follow-up|2
7702579|NCT00427700|12123564|FG001|Overall Study|Lost to Follow-up|5
7702580|NCT00427700|12123563|FG000|Overall Study|no induction of menses|1
7702581|NCT00427700|12123564|FG001|Overall Study|no induction of menses|4
7702582|NCT00427700|12123563|FG000|Overall Study|Pregnancy|0
7702583|NCT00427700|12123564|FG001|Overall Study|Pregnancy|2
7702584|NCT00427778|12123575|FG000|First Intervention (4 Weeks)|no longer interested|1
7702585|NCT00427778|12123576|FG001|First Intervention (4 Weeks)|no longer interested|0
7702586|NCT00427778|12123575|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2
7702587|NCT00427778|12123576|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0
7702588|NCT00427778|12123575|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
7702589|NCT00427778|12123576|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
7702590|NCT00427778|12123575|FG000|First Intervention (4 Weeks)|anxious about using ring|1
7702591|NCT00427778|12123576|FG001|First Intervention (4 Weeks)|anxious about using ring|0
7702592|NCT00427895|12123617|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7702593|NCT00427895|12123618|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7702594|NCT00427895|12123619|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7702595|NCT00427895|12123620|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
7702596|NCT00427895|12123621|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7702597|NCT00427895|12123622|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7702598|NCT00427895|12123623|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7702599|NCT00427895|12123624|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7702600|NCT00427895|12123617|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0
7702601|NCT00427895|12123618|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0
7702602|NCT00427895|12123619|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0
7702603|NCT00427895|12123620|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0
7702604|NCT00427895|12123621|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0
7702605|NCT00427895|12123622|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0
7702606|NCT00427895|12123623|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0
7702607|NCT00427895|12123624|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1
7702608|NCT00427895|12123617|FG000|Vax 2/Year 3 to 4|Protocol Violation|0
7702609|NCT00427895|12123618|FG001|Vax 2/Year 3 to 4|Protocol Violation|0
7702610|NCT00427895|12123619|FG002|Vax 2/Year 3 to 4|Protocol Violation|0
7702611|NCT00427895|12123620|FG003|Vax 2/Year 3 to 4|Protocol Violation|0
7702612|NCT00427895|12123621|FG004|Vax 2/Year 3 to 4|Protocol Violation|0
7702613|NCT00427895|12123622|FG005|Vax 2/Year 3 to 4|Protocol Violation|0
7702614|NCT00427895|12123623|FG006|Vax 2/Year 3 to 4|Protocol Violation|0
7702615|NCT00427895|12123624|FG007|Vax 2/Year 3 to 4|Protocol Violation|1
7702616|NCT00427895|12123617|FG000|Vax 2/Year 3 to 4|Failed to Return|0
7702617|NCT00427895|12123618|FG001|Vax 2/Year 3 to 4|Failed to Return|0
7702618|NCT00427895|12123619|FG002|Vax 2/Year 3 to 4|Failed to Return|0
7702619|NCT00427895|12123620|FG003|Vax 2/Year 3 to 4|Failed to Return|0
7702620|NCT00427895|12123621|FG004|Vax 2/Year 3 to 4|Failed to Return|1
7702621|NCT00427895|12123622|FG005|Vax 2/Year 3 to 4|Failed to Return|0
7702622|NCT00427895|12123623|FG006|Vax 2/Year 3 to 4|Failed to Return|0
7702623|NCT00427895|12123624|FG007|Vax 2/Year 3 to 4|Failed to Return|0
7702624|NCT00427895|12123617|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
7702625|NCT00427895|12123618|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
7702626|NCT00427895|12123619|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
7702627|NCT00427895|12123620|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
7702628|NCT00427895|12123621|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
7702629|NCT00427895|12123622|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
7702630|NCT00427895|12123623|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
7702631|NCT00427895|12123624|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
7702632|NCT00427895|12123617|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
7702633|NCT00427895|12123618|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
7702634|NCT00427895|12123619|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
7702635|NCT00427895|12123620|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
7702636|NCT00427895|12123621|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
7702637|NCT00427895|12123622|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
7702638|NCT00427895|12123623|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
7702639|NCT00427895|12123624|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
7702640|NCT00427895|12123617|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
7702641|NCT00427895|12123618|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
7702642|NCT00427895|12123619|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7702643|NCT00427895|12123620|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7702644|NCT00427895|12123621|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7702645|NCT00427895|12123622|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7702646|NCT00427895|12123623|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7702647|NCT00427895|12123624|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7702648|NCT00427895|12123617|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
7702649|NCT00427895|12123618|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
7702650|NCT00427895|12123619|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
7702651|NCT00427895|12123620|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
7702652|NCT00427895|12123621|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
7702653|NCT00427895|12123622|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
7702654|NCT00427895|12123623|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
7702655|NCT00427895|12123624|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
7702656|NCT00427895|12123617|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7702657|NCT00427895|12123618|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7702658|NCT00427895|12123619|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7702659|NCT00427895|12123620|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
7702660|NCT00427895|12123621|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7702661|NCT00427895|12123622|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7702662|NCT00427895|12123623|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7702663|NCT00427895|12123624|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7702664|NCT00427895|12123617|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
7702665|NCT00427895|12123618|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
7702666|NCT00427895|12123619|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
7702667|NCT00427895|12123620|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
7702668|NCT00427895|12123621|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
7702669|NCT00427895|12123622|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
7702670|NCT00427895|12123623|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
7702671|NCT00427895|12123624|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
7702672|NCT00427895|12123617|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0
7702673|NCT00427895|12123618|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0
7702674|NCT00427895|12123619|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1
7702675|NCT00427895|12123620|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2
7702676|NCT00427895|12123621|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0
7702677|NCT00427895|12123622|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0
7702678|NCT00427895|12123623|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0
7702679|NCT00427895|12123624|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0
7702680|NCT00427895|12123617|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
7702681|NCT00427895|12123618|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
7702682|NCT00427895|12123619|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
7702683|NCT00427895|12123620|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
7702684|NCT00427895|12123621|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
7702685|NCT00427895|12123622|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
7702686|NCT00427895|12123623|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
7702687|NCT00427895|12123624|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
7702688|NCT00427895|12123617|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3
7702689|NCT00427895|12123618|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3
7702690|NCT00427895|12123619|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0
7702691|NCT00427895|12123620|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1
7702692|NCT00427895|12123621|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0
7702693|NCT00427895|12123622|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0
7702694|NCT00427895|12123623|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0
7702695|NCT00427895|12123624|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0
7702696|NCT00427895|12123617|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
7702697|NCT00427895|12123618|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
7702698|NCT00427895|12123619|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
7702699|NCT00427895|12123620|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
7702700|NCT00427895|12123621|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
7702701|NCT00427895|12123622|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
7702702|NCT00427895|12123623|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
7702703|NCT00427895|12123624|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
7702704|NCT00427895|12123617|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0
7702705|NCT00427895|12123618|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1
7702706|NCT00427895|12123619|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0
7702707|NCT00427895|12123620|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0
7702708|NCT00427895|12123621|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0
7702709|NCT00427895|12123622|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0
7702710|NCT00427895|12123623|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0
7702711|NCT00427895|12123624|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0
7702712|NCT00427895|12123617|FG000|Vax 1/Year 1 Follow-up|Death|1
7702713|NCT00427895|12123618|FG001|Vax 1/Year 1 Follow-up|Death|0
7702714|NCT00427895|12123619|FG002|Vax 1/Year 1 Follow-up|Death|0
7702715|NCT00427895|12123620|FG003|Vax 1/Year 1 Follow-up|Death|0
7702716|NCT00427895|12123621|FG004|Vax 1/Year 1 Follow-up|Death|0
7702717|NCT00427895|12123622|FG005|Vax 1/Year 1 Follow-up|Death|0
7702718|NCT00427895|12123623|FG006|Vax 1/Year 1 Follow-up|Death|0
7702719|NCT00427895|12123624|FG007|Vax 1/Year 1 Follow-up|Death|0
7702720|NCT00427895|12123617|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0
7702721|NCT00427895|12123618|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0
7702722|NCT00427895|12123619|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12
7702723|NCT00427895|12123620|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5
7702724|NCT00427895|12123621|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0
7702725|NCT00427895|12123622|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0
7702726|NCT00427895|12123623|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0
7702727|NCT00427895|12123624|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0
7702728|NCT00427895|12123617|FG000|Vax 1/Year 1 Follow-up|Other|0
7702729|NCT00427895|12123618|FG001|Vax 1/Year 1 Follow-up|Other|0
7702730|NCT00427895|12123619|FG002|Vax 1/Year 1 Follow-up|Other|0
7702731|NCT00427895|12123620|FG003|Vax 1/Year 1 Follow-up|Other|2
7702732|NCT00427895|12123621|FG004|Vax 1/Year 1 Follow-up|Other|0
7702733|NCT00427895|12123622|FG005|Vax 1/Year 1 Follow-up|Other|0
7702734|NCT00427895|12123623|FG006|Vax 1/Year 1 Follow-up|Other|0
7702735|NCT00427895|12123624|FG007|Vax 1/Year 1 Follow-up|Other|0
7702736|NCT00427895|12123617|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
7702737|NCT00427895|12123618|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
7702738|NCT00427895|12123619|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
7702739|NCT00427895|12123620|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
7702740|NCT00427895|12123621|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
7702741|NCT00427895|12123622|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
7702742|NCT00427895|12123623|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
7702743|NCT00427895|12123624|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
7702744|NCT00427908|12123667|FG000|Primary Phase|Lost to Follow-up|4
7702745|NCT00427908|12123668|FG001|Primary Phase|Lost to Follow-up|0
7702746|NCT00427908|12123669|FG002|Primary Phase|Lost to Follow-up|2
7702747|NCT00427908|12123670|FG003|Primary Phase|Lost to Follow-up|0
7702748|NCT00427908|12123667|FG000|Primary Phase|Withdrawal by Subject|1
7702749|NCT00427908|12123668|FG001|Primary Phase|Withdrawal by Subject|2
7702750|NCT00427908|12123669|FG002|Primary Phase|Withdrawal by Subject|1
7702751|NCT00427908|12123670|FG003|Primary Phase|Withdrawal by Subject|0
7702752|NCT00427908|12123667|FG000|Primary Phase|Adverse Event|0
7702753|NCT00427908|12123668|FG001|Primary Phase|Adverse Event|1
7702754|NCT00427908|12123669|FG002|Primary Phase|Adverse Event|0
7702755|NCT00427908|12123670|FG003|Primary Phase|Adverse Event|0
7702756|NCT00427921|12123705|FG000|Overall Study|Adverse Event|26
7702757|NCT00427921|12123705|FG000|Overall Study|Withdrawal by Subject|4
7702758|NCT00427921|12123705|FG000|Overall Study|Lost to Follow-up|2
7702759|NCT00427921|12123705|FG000|Overall Study|Other reason not specified|10
7702760|NCT00427921|12123705|FG000|Overall Study|Adverse Event + Hospitalization|1
7702761|NCT00427921|12123705|FG000|Overall Study|Adverse Event + Withdrew Consent|1
7702762|NCT00427921|12123705|FG000|Overall Study|Adverse Event + No Response|1
7702763|NCT00427921|12123705|FG000|Overall Study|Adverse Event + Worsening of CD|1
7702764|NCT00427921|12123705|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1
7702765|NCT00427921|12123705|FG000|Overall Study|Adverse Event + Lost Response|1
7702766|NCT00427921|12123705|FG000|Overall Study|Adverse Event + Withdrawn from Study|1
7702767|NCT00427921|12123705|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1
7702768|NCT00427934|12123713|FG000|Overall Study|Adverse Event|1
7702769|NCT00427934|12123714|FG001|Overall Study|Adverse Event|0
7702770|NCT00427934|12123715|FG002|Overall Study|Adverse Event|5
7702771|NCT00427934|12123716|FG003|Overall Study|Adverse Event|4
7702772|NCT00427934|12123713|FG000|Overall Study|Lack of Efficacy|0
7702773|NCT00427934|12123714|FG001|Overall Study|Lack of Efficacy|0
7702774|NCT00427934|12123715|FG002|Overall Study|Lack of Efficacy|5
7702775|NCT00427934|12123716|FG003|Overall Study|Lack of Efficacy|2
7702776|NCT00427934|12123713|FG000|Overall Study|Randomized But Did Not Receive Treatment|0
7702777|NCT00427934|12123714|FG001|Overall Study|Randomized But Did Not Receive Treatment|0
7702778|NCT00427934|12123715|FG002|Overall Study|Randomized But Did Not Receive Treatment|1
7702779|NCT00427934|12123716|FG003|Overall Study|Randomized But Did Not Receive Treatment|1
7702780|NCT00427934|12123713|FG000|Overall Study|Other|0
7702781|NCT00427934|12123714|FG001|Overall Study|Other|0
7702782|NCT00427934|12123715|FG002|Overall Study|Other|11
7702783|NCT00427934|12123716|FG003|Overall Study|Other|5
7702784|NCT00427934|12123713|FG000|Overall Study|Withdrawal by Subject|0
7702785|NCT00427934|12123714|FG001|Overall Study|Withdrawal by Subject|0
7702786|NCT00427934|12123715|FG002|Overall Study|Withdrawal by Subject|1
7702787|NCT00427934|12123716|FG003|Overall Study|Withdrawal by Subject|3
7702788|NCT00427960|12123730|FG000|Overall Study|Adverse Event|2
7702789|NCT00427960|12123731|FG001|Overall Study|Adverse Event|0
7702790|NCT00427960|12123730|FG000|Overall Study|Withdrawal by Subject|0
7702791|NCT00427960|12123731|FG001|Overall Study|Withdrawal by Subject|3
7702792|NCT00427960|12123730|FG000|Overall Study|Other|0
7702793|NCT00427960|12123731|FG001|Overall Study|Other|1
7702794|NCT00427999|12123741|FG000|Overall Study|Adverse Event|6
7702795|NCT00427999|12123741|FG000|Overall Study|Abnormal laboratory values|1
7702796|NCT00427999|12123741|FG000|Overall Study|Unsatisfactory therapeutic effect|13
7702797|NCT00427999|12123741|FG000|Overall Study|Protocol Violation|2
7702798|NCT00427999|12123741|FG000|Overall Study|Withdrawal by Subject|9
7702799|NCT00427999|12123741|FG000|Overall Study|Death|1
7702800|NCT00428090|12123754|FG000|Overall Study|Adverse Event|10
7702801|NCT00428090|12123755|FG001|Overall Study|Adverse Event|8
7702802|NCT00428090|12123756|FG002|Overall Study|Adverse Event|10
7702803|NCT00428090|12123757|FG003|Overall Study|Adverse Event|11
7702804|NCT00428090|12123754|FG000|Overall Study|Lost to Follow-up|3
7702805|NCT00428090|12123755|FG001|Overall Study|Lost to Follow-up|6
7702806|NCT00428090|12123756|FG002|Overall Study|Lost to Follow-up|1
7702807|NCT00428090|12123757|FG003|Overall Study|Lost to Follow-up|4
7702808|NCT00428090|12123754|FG000|Overall Study|Protocol Violation|3
7702809|NCT00428090|12123755|FG001|Overall Study|Protocol Violation|1
7702810|NCT00428090|12123756|FG002|Overall Study|Protocol Violation|3
7702811|NCT00428090|12123757|FG003|Overall Study|Protocol Violation|3
7702812|NCT00428090|12123754|FG000|Overall Study|Withdrawal by Subject|10
7702813|NCT00428090|12123755|FG001|Overall Study|Withdrawal by Subject|12
7702814|NCT00428090|12123756|FG002|Overall Study|Withdrawal by Subject|15
7702815|NCT00428090|12123757|FG003|Overall Study|Withdrawal by Subject|5
7702816|NCT00428090|12123754|FG000|Overall Study|Sponsor terminated study|0
7702817|NCT00428090|12123755|FG001|Overall Study|Sponsor terminated study|1
7702818|NCT00428090|12123756|FG002|Overall Study|Sponsor terminated study|0
7702819|NCT00428090|12123757|FG003|Overall Study|Sponsor terminated study|0
7702820|NCT00428090|12123754|FG000|Overall Study|Non-compliance|4
7702821|NCT00428090|12123755|FG001|Overall Study|Non-compliance|0
7702822|NCT00428090|12123756|FG002|Overall Study|Non-compliance|1
7702823|NCT00428090|12123757|FG003|Overall Study|Non-compliance|3
7702824|NCT00428090|12123754|FG000|Overall Study|Par. did not returned to visit|1
7702825|NCT00428090|12123755|FG001|Overall Study|Par. did not returned to visit|0
7702826|NCT00428090|12123756|FG002|Overall Study|Par. did not returned to visit|0
7702827|NCT00428090|12123757|FG003|Overall Study|Par. did not returned to visit|1
7702828|NCT00428090|12123754|FG000|Overall Study|Follow-Up visit not possible|1
7702829|NCT00428090|12123755|FG001|Overall Study|Follow-Up visit not possible|0
7702830|NCT00428090|12123756|FG002|Overall Study|Follow-Up visit not possible|0
7702831|NCT00428090|12123757|FG003|Overall Study|Follow-Up visit not possible|0
7702832|NCT00428090|12123754|FG000|Overall Study|Prohibited medication used for SAE|1
7702833|NCT00428090|12123755|FG001|Overall Study|Prohibited medication used for SAE|0
7702834|NCT00428090|12123756|FG002|Overall Study|Prohibited medication used for SAE|0
7702835|NCT00428090|12123757|FG003|Overall Study|Prohibited medication used for SAE|0
7702836|NCT00428090|12123754|FG000|Overall Study|Death of par.|1
7702837|NCT00428090|12123755|FG001|Overall Study|Death of par.|0
7702838|NCT00428090|12123756|FG002|Overall Study|Death of par.|1
7702839|NCT00428090|12123757|FG003|Overall Study|Death of par.|0
7702840|NCT00428090|12123754|FG000|Overall Study|Visit 7 exceed the visit window|0
7702841|NCT00428090|12123755|FG001|Overall Study|Visit 7 exceed the visit window|1
7702842|NCT00428090|12123756|FG002|Overall Study|Visit 7 exceed the visit window|0
7702843|NCT00428090|12123757|FG003|Overall Study|Visit 7 exceed the visit window|0
7702844|NCT00428090|12123754|FG000|Overall Study|Medical monitor terminated par.|0
7702845|NCT00428090|12123755|FG001|Overall Study|Medical monitor terminated par.|1
7702846|NCT00428090|12123756|FG002|Overall Study|Medical monitor terminated par.|0
7702847|NCT00428090|12123757|FG003|Overall Study|Medical monitor terminated par.|0
7702848|NCT00428090|12123754|FG000|Overall Study|Mental status of par. was|0
7702849|NCT00428090|12123755|FG001|Overall Study|Mental status of par. was|1
7702850|NCT00428090|12123756|FG002|Overall Study|Mental status of par. was|0
7702851|NCT00428090|12123757|FG003|Overall Study|Mental status of par. was|0
7702852|NCT00428090|12123754|FG000|Overall Study|Worsening of AD|0
7702853|NCT00428090|12123755|FG001|Overall Study|Worsening of AD|0
7702854|NCT00428090|12123756|FG002|Overall Study|Worsening of AD|1
7702855|NCT00428090|12123757|FG003|Overall Study|Worsening of AD|0
7702856|NCT00428090|12123754|FG000|Overall Study|Excluded for concerning QTc value|0
7702857|NCT00428090|12123755|FG001|Overall Study|Excluded for concerning QTc value|0
7702858|NCT00428090|12123756|FG002|Overall Study|Excluded for concerning QTc value|1
7702859|NCT00428090|12123757|FG003|Overall Study|Excluded for concerning QTc value|0
7702860|NCT00428090|12123754|FG000|Overall Study|Insufficient AD documentation|0
7702861|NCT00428090|12123755|FG001|Overall Study|Insufficient AD documentation|0
7702862|NCT00428090|12123756|FG002|Overall Study|Insufficient AD documentation|1
7702863|NCT00428090|12123757|FG003|Overall Study|Insufficient AD documentation|0
7702864|NCT00428090|12123754|FG000|Overall Study|High MMSE scores|0
7702865|NCT00428090|12123755|FG001|Overall Study|High MMSE scores|0
7702866|NCT00428090|12123756|FG002|Overall Study|High MMSE scores|1
7702867|NCT00428090|12123757|FG003|Overall Study|High MMSE scores|0
7702868|NCT00428090|12123754|FG000|Overall Study|Deterioration of cognitive status|0
7702869|NCT00428090|12123755|FG001|Overall Study|Deterioration of cognitive status|0
7702870|NCT00428090|12123756|FG002|Overall Study|Deterioration of cognitive status|1
7702871|NCT00428090|12123757|FG003|Overall Study|Deterioration of cognitive status|0
7702872|NCT00428090|12123754|FG000|Overall Study|Serious adverse event|0
7702873|NCT00428090|12123755|FG001|Overall Study|Serious adverse event|0
7702874|NCT00428090|12123756|FG002|Overall Study|Serious adverse event|1
7702875|NCT00428090|12123757|FG003|Overall Study|Serious adverse event|0
7702876|NCT00428090|12123754|FG000|Overall Study|Excluded for heart insufficiency|0
7702877|NCT00428090|12123755|FG001|Overall Study|Excluded for heart insufficiency|0
7702878|NCT00428090|12123756|FG002|Overall Study|Excluded for heart insufficiency|1
7702879|NCT00428090|12123757|FG003|Overall Study|Excluded for heart insufficiency|0
7702880|NCT00428090|12123754|FG000|Overall Study|Raised Creatinine Value|0
7702881|NCT00428090|12123755|FG001|Overall Study|Raised Creatinine Value|0
7702882|NCT00428090|12123756|FG002|Overall Study|Raised Creatinine Value|0
7702883|NCT00428090|12123757|FG003|Overall Study|Raised Creatinine Value|1
7702884|NCT00428116|12123777|FG000|Overall Study|Death|1
7702885|NCT00428116|12123778|FG001|Overall Study|Death|0
7702886|NCT00428116|12123777|FG000|Overall Study|Withdrawal by Subject|1
7702887|NCT00428116|12123778|FG001|Overall Study|Withdrawal by Subject|0
7702888|NCT00428116|12123777|FG000|Overall Study|Lost to Follow-up|1
7702889|NCT00428116|12123778|FG001|Overall Study|Lost to Follow-up|0
7702890|NCT00428220|12123785|FG000|Overall Study|Participant died|8
7702891|NCT00428220|12123785|FG000|Overall Study|Global deterioration of health status|7
7702892|NCT00428220|12123785|FG000|Overall Study|Lost to Follow-up|4
7702893|NCT00428220|12123785|FG000|Overall Study|Objective progression or relapse|123
7702894|NCT00428220|12123785|FG000|Overall Study|Participant refused continued treatment|7
7702895|NCT00428220|12123785|FG000|Overall Study|Adverse Event|51
7702896|NCT00428220|12123785|FG000|Overall Study|Other|23
7702897|NCT00428246|12123803|FG000|Overall Study|Withdrawal by Subject|0
7702898|NCT00428246|12123804|FG001|Overall Study|Withdrawal by Subject|0
7702899|NCT00428246|12123805|FG002|Overall Study|Withdrawal by Subject|1
7702900|NCT00428246|12123803|FG000|Overall Study|Adverse Event|1
7702901|NCT00428246|12123804|FG001|Overall Study|Adverse Event|0
7702902|NCT00428246|12123805|FG002|Overall Study|Adverse Event|0
7702903|NCT00428389|12123826|FG000|Core Phase|Adverse Event|6
7702904|NCT00428389|12123827|FG001|Core Phase|Adverse Event|4
7702905|NCT00428389|12123826|FG000|Core Phase|Lack of Efficacy|2
7702906|NCT00428389|12123827|FG001|Core Phase|Lack of Efficacy|0
7702907|NCT00428389|12123826|FG000|Core Phase|Abnormal test procedure result(s)|0
7702908|NCT00428389|12123827|FG001|Core Phase|Abnormal test procedure result(s)|1
7702909|NCT00428389|12123826|FG000|Core Phase|Withdrawal by Subject|3
7702910|NCT00428389|12123827|FG001|Core Phase|Withdrawal by Subject|4
7702911|NCT00428389|12123826|FG000|Core Phase|Protocol deviation|0
7702912|NCT00428389|12123827|FG001|Core Phase|Protocol deviation|2
7702913|NCT00428389|12123826|FG000|Extension Phase|Adverse Event|17
7702914|NCT00428389|12123827|FG001|Extension Phase|Adverse Event|11
7702915|NCT00428389|12123826|FG000|Extension Phase|Lack of Efficacy|4
7702916|NCT00428389|12123827|FG001|Extension Phase|Lack of Efficacy|3
7702917|NCT00428389|12123826|FG000|Extension Phase|Withdrawal by Subject|6
7702918|NCT00428389|12123827|FG001|Extension Phase|Withdrawal by Subject|6
7702919|NCT00428389|12123826|FG000|Extension Phase|Lost to Follow-up|0
7702920|NCT00428389|12123827|FG001|Extension Phase|Lost to Follow-up|3
7702921|NCT00428389|12123826|FG000|Extension Phase|Death|1
7702922|NCT00428389|12123827|FG001|Extension Phase|Death|0
7702923|NCT00428389|12123826|FG000|Extension Phase|Protocol Violation|3
7702924|NCT00428389|12123827|FG001|Extension Phase|Protocol Violation|2
7702925|NCT00428389|12123826|FG000|Extension Phase|Administrative problems|1
7702926|NCT00428389|12123827|FG001|Extension Phase|Administrative problems|1
7702927|NCT00428441|12123833|FG000|Overall Study|Lost to Follow-up|1
7702928|NCT00428597|12123852|FG000|Overall Study|Randomized but not treated|3
7702929|NCT00428597|12123853|FG001|Overall Study|Randomized but not treated|3
7702930|NCT00428597|12123852|FG000|Overall Study|Objective Progression or Relapse|19
7702931|NCT00428597|12123853|FG001|Overall Study|Objective Progression or Relapse|47
7702932|NCT00428597|12123852|FG000|Overall Study|Study Terminated by Sponsor|41
7702933|NCT00428597|12123853|FG001|Overall Study|Study Terminated by Sponsor|16
7702934|NCT00428597|12123852|FG000|Overall Study|Adverse Event|15
7702935|NCT00428597|12123853|FG001|Overall Study|Adverse Event|7
7702936|NCT00428597|12123852|FG000|Overall Study|Global Deterioration of Health Status|1
7702937|NCT00428597|12123853|FG001|Overall Study|Global Deterioration of Health Status|5
7702938|NCT00428597|12123852|FG000|Overall Study|Protocol Violation|2
7702939|NCT00428597|12123853|FG001|Overall Study|Protocol Violation|1
7702940|NCT00428597|12123852|FG000|Overall Study|Withdrawal by Subject|2
7702941|NCT00428597|12123853|FG001|Overall Study|Withdrawal by Subject|1
7702942|NCT00428597|12123852|FG000|Overall Study|Other|1
7702943|NCT00428597|12123853|FG001|Overall Study|Other|1
7702944|NCT00428597|12123852|FG000|Overall Study|Lost to Follow-up|0
7702945|NCT00428597|12123853|FG001|Overall Study|Lost to Follow-up|1
7702946|NCT00428597|12123852|FG000|Overall Study|Pregnancy|1
7702947|NCT00428597|12123853|FG001|Overall Study|Pregnancy|0
7702948|NCT00428597|12123852|FG000|Overall Study|Death|1
7702949|NCT00428597|12123853|FG001|Overall Study|Death|3
7702950|NCT00428610|12123862|FG000|Overall Study|Death Due to Adverse Event|3
7702951|NCT00428610|12123863|FG001|Overall Study|Death Due to Adverse Event|0
7702952|NCT00428610|12123864|FG002|Overall Study|Death Due to Adverse Event|5
7702953|NCT00428610|12123862|FG000|Overall Study|Death Due to Progressive Disease|0
7702954|NCT00428610|12123863|FG001|Overall Study|Death Due to Progressive Disease|0
7702955|NCT00428610|12123864|FG002|Overall Study|Death Due to Progressive Disease|2
7702956|NCT00428610|12123862|FG000|Overall Study|Adverse Event|2
7702957|NCT00428610|12123863|FG001|Overall Study|Adverse Event|3
7702958|NCT00428610|12123864|FG002|Overall Study|Adverse Event|2
7702959|NCT00428610|12123862|FG000|Overall Study|Investigator Decision|2
7702960|NCT00428610|12123863|FG001|Overall Study|Investigator Decision|1
7702961|NCT00428610|12123864|FG002|Overall Study|Investigator Decision|1
7702962|NCT00428610|12123862|FG000|Overall Study|Progressive Disease|42
7702963|NCT00428610|12123863|FG001|Overall Study|Progressive Disease|14
7702964|NCT00428610|12123864|FG002|Overall Study|Progressive Disease|22
7702965|NCT00428610|12123862|FG000|Overall Study|Withdrawal by Subject|4
7702966|NCT00428610|12123863|FG001|Overall Study|Withdrawal by Subject|0
7702967|NCT00428610|12123864|FG002|Overall Study|Withdrawal by Subject|0
7702968|NCT00428714|12123874|FG000|Overall Study|Progressive Disease|28
7702969|NCT00428714|12123875|FG001|Overall Study|Progressive Disease|36
7702970|NCT00428714|12123874|FG000|Overall Study|Withdrawal by Subject|0
7702971|NCT00428714|12123875|FG001|Overall Study|Withdrawal by Subject|3
7702972|NCT00428714|12123874|FG000|Overall Study|Adverse Event|0
7702973|NCT00428714|12123875|FG001|Overall Study|Adverse Event|2
7702974|NCT00428714|12123874|FG000|Overall Study|Physician Decision|1
7702975|NCT00428714|12123875|FG001|Overall Study|Physician Decision|1
7702976|NCT00428714|12123874|FG000|Overall Study|Death due to Progressive Disease (PD)|1
7702977|NCT00428714|12123875|FG001|Overall Study|Death due to Progressive Disease (PD)|0
7702978|NCT00428714|12123874|FG000|Overall Study|Death due to other then PD|1
7702979|NCT00428714|12123875|FG001|Overall Study|Death due to other then PD|0
7702980|NCT00428792|12123884|FG000|Overall Study|Lack of Efficacy|1
7702981|NCT00428792|12123885|FG001|Overall Study|Lack of Efficacy|3
7702982|NCT00428792|12123884|FG000|Overall Study|Lost to Follow-up|0
7702983|NCT00428792|12123885|FG001|Overall Study|Lost to Follow-up|1
7702984|NCT00428844|12123894|FG000|Completed Study Drug Treatment|Adverse Event|2
7702985|NCT00428844|12123895|FG001|Completed Study Drug Treatment|Adverse Event|4
7702986|NCT00428844|12123896|FG002|Completed Study Drug Treatment|Adverse Event|4
7702987|NCT00428844|12123894|FG000|Completed Study Drug Treatment|Protocol Violation|0
7702988|NCT00428844|12123895|FG001|Completed Study Drug Treatment|Protocol Violation|1
7702989|NCT00428844|12123896|FG002|Completed Study Drug Treatment|Protocol Violation|1
7702990|NCT00428844|12123894|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0
7702991|NCT00428844|12123895|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1
7702992|NCT00428844|12123896|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1
7702993|NCT00428844|12123894|FG000|Completed Study Drug Treatment|Randomized Not Treated|0
7702994|NCT00428844|12123895|FG001|Completed Study Drug Treatment|Randomized Not Treated|0
7702995|NCT00428844|12123896|FG002|Completed Study Drug Treatment|Randomized Not Treated|1
7702996|NCT00428844|12123894|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0
7702997|NCT00428844|12123895|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1
7702998|NCT00428844|12123896|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1
7702999|NCT00428844|12123894|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0
7703000|NCT00428844|12123895|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0
7703001|NCT00428844|12123896|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1
7703002|NCT00428844|12123894|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
7703003|NCT00428844|12123895|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
7703004|NCT00428844|12123896|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
7703005|NCT00428844|12123894|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
7703006|NCT00428844|12123895|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
7703007|NCT00428844|12123896|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
7703008|NCT00428844|12123894|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
7703009|NCT00428844|12123895|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
7703010|NCT00428844|12123896|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
7703011|NCT00428948|12123910|FG000|Overall Study|Lost to Follow-up|15
7703012|NCT00428948|12123911|FG001|Overall Study|Lost to Follow-up|8
7703013|NCT00428948|12123910|FG000|Overall Study|Adverse Event|148
7703014|NCT00428948|12123911|FG001|Overall Study|Adverse Event|24
7703015|NCT00428948|12123910|FG000|Overall Study|Subject Met Withdrawal Criteria|4
7703016|NCT00428948|12123911|FG001|Overall Study|Subject Met Withdrawal Criteria|0
7703017|NCT00428948|12123910|FG000|Overall Study|Investigator Withdrew Subject|3
7703018|NCT00428948|12123911|FG001|Overall Study|Investigator Withdrew Subject|4
7703019|NCT00428948|12123910|FG000|Overall Study|Subject Withdrew Consent|50
7703020|NCT00428948|12123911|FG001|Overall Study|Subject Withdrew Consent|30
7703021|NCT00428948|12123910|FG000|Overall Study|Protocol Deviation|1
7703022|NCT00428948|12123911|FG001|Overall Study|Protocol Deviation|1
7703023|NCT00429104|12123935|FG000|Overall Study|Protocol Violation|1
7703024|NCT00429169|12123945|FG000|Overall Study|Lost to Follow-up|0
7703025|NCT00429169|12123946|FG001|Overall Study|Lost to Follow-up|1
7703026|NCT00429169|12123945|FG000|Overall Study|Ineligibility discovered after entry|2
7703027|NCT00429169|12123946|FG001|Overall Study|Ineligibility discovered after entry|1
7703028|NCT00429182|12123954|FG000|Overall Study|Not evaluable, Disease Progression|2
7703029|NCT00429182|12123954|FG000|Overall Study|Not eligible|5
7703030|NCT00429273|12123961|FG000|Overall Study|Lost to Follow-up|1
7703031|NCT00429273|12123962|FG001|Overall Study|Lost to Follow-up|2
7703032|NCT00429273|12123963|FG002|Overall Study|Lost to Follow-up|2
7703033|NCT00429273|12123961|FG000|Overall Study|Physician Decision|6
7703034|NCT00429273|12123962|FG001|Overall Study|Physician Decision|5
7703035|NCT00429273|12123963|FG002|Overall Study|Physician Decision|5
7703036|NCT00429273|12123961|FG000|Overall Study|Adverse Event|1
7703037|NCT00429273|12123962|FG001|Overall Study|Adverse Event|1
7703038|NCT00429273|12123963|FG002|Overall Study|Adverse Event|2
7703039|NCT00429299|12123974|FG000|Overall Study|Disease Progression|1
7703040|NCT00429299|12123975|FG001|Overall Study|Disease Progression|1
7703041|NCT00429299|12123976|FG002|Overall Study|Disease Progression|0
7703042|NCT00429299|12123974|FG000|Overall Study|Adverse Event|2
7703043|NCT00429299|12123975|FG001|Overall Study|Adverse Event|5
7703044|NCT00429299|12123976|FG002|Overall Study|Adverse Event|1
7703045|NCT00429299|12123974|FG000|Overall Study|Protocol Violation|1
7703046|NCT00429299|12123975|FG001|Overall Study|Protocol Violation|0
7703047|NCT00429299|12123976|FG002|Overall Study|Protocol Violation|0
7703048|NCT00429299|12123974|FG000|Overall Study|Withdrawal by Subject|0
7703049|NCT00429299|12123975|FG001|Overall Study|Withdrawal by Subject|1
7703050|NCT00429299|12123976|FG002|Overall Study|Withdrawal by Subject|3
7703051|NCT00429364|12123986|FG000|Overall Study|Withdrawal by Subject|11
7703052|NCT00429364|12123987|FG001|Overall Study|Withdrawal by Subject|5
7703053|NCT00429364|12123986|FG000|Overall Study|Physician Decision|4
7703054|NCT00429364|12123987|FG001|Overall Study|Physician Decision|2
7703055|NCT00429364|12123986|FG000|Overall Study|Lost to Follow-up|7
7703056|NCT00429364|12123987|FG001|Overall Study|Lost to Follow-up|6
7703057|NCT00429364|12123986|FG000|Overall Study|Death|0
7703058|NCT00429364|12123987|FG001|Overall Study|Death|1
7703059|NCT00429364|12123986|FG000|Overall Study|Underwent aortic root surgery|10
7703060|NCT00429364|12123987|FG001|Overall Study|Underwent aortic root surgery|18
7703061|NCT00429364|12123986|FG000|Overall Study|Pregnancy|0
7703062|NCT00429364|12123987|FG001|Overall Study|Pregnancy|1
7703063|NCT00429416|12124002|FG000|Overall Study|Death|1
7703064|NCT00429494|12124006|FG000|Overall Study|Withdrawal by Subject|9
7703065|NCT00429494|12124006|FG000|Overall Study|Death|6
7703066|NCT00429572|12124014|FG000|Overall Study|Disease progression|1
7703067|NCT00429585|12124020|FG000|Overall Study|Death|1
7703068|NCT00429585|12124021|FG001|Overall Study|Death|0
7703069|NCT00429585|12124020|FG000|Overall Study|Lost to Follow-up|27
7703070|NCT00429585|12124021|FG001|Overall Study|Lost to Follow-up|20
7703071|NCT00429585|12124020|FG000|Overall Study|Physician Decision|2
7703072|NCT00429585|12124021|FG001|Overall Study|Physician Decision|0
7703073|NCT00429663|12124029|FG000|Overall Study|Lost to Follow-up|24
7703074|NCT00429663|12124030|FG001|Overall Study|Lost to Follow-up|31
7703075|NCT00429663|12124029|FG000|Overall Study|Physician Decision|6
7703076|NCT00429663|12124030|FG001|Overall Study|Physician Decision|3
7703077|NCT00429663|12124029|FG000|Overall Study|Withdrawal by Subject|2
7703078|NCT00429663|12124030|FG001|Overall Study|Withdrawal by Subject|5
7703079|NCT00429663|12124029|FG000|Overall Study|Death|4
7703080|NCT00429663|12124030|FG001|Overall Study|Death|0
7703081|NCT00429793|12124045|FG000|Overall Study|Improper pre-protocol treatment|3
7703082|NCT00429793|12124045|FG000|Overall Study|Required test not done|1
7703083|NCT00429793|12124045|FG000|Overall Study|Never treated|1
7703084|NCT00429793|12124045|FG000|Overall Study|Non-measurable|1
7703085|NCT00430248|12124072|FG000|Overall Study|Adverse Event|49
7703086|NCT00430248|12124073|FG001|Overall Study|Adverse Event|61
7703087|NCT00430248|12124074|FG002|Overall Study|Adverse Event|64
7703088|NCT00430248|12124072|FG000|Overall Study|Protocol Violation|10
7703089|NCT00430248|12124073|FG001|Overall Study|Protocol Violation|2
7703090|NCT00430248|12124074|FG002|Overall Study|Protocol Violation|4
7703091|NCT00430248|12124072|FG000|Overall Study|Personal Reasons|12
7703092|NCT00430248|12124073|FG001|Overall Study|Personal Reasons|24
7703093|NCT00430248|12124074|FG002|Overall Study|Personal Reasons|9
7703094|NCT00430248|12124072|FG000|Overall Study|Lost to Follow-up|28
7703095|NCT00430248|12124073|FG001|Overall Study|Lost to Follow-up|33
7703096|NCT00430248|12124074|FG002|Overall Study|Lost to Follow-up|28
7703097|NCT00430248|12124072|FG000|Overall Study|Therapeutic Failure|1
7703098|NCT00430248|12124073|FG001|Overall Study|Therapeutic Failure|1
7703099|NCT00430248|12124074|FG002|Overall Study|Therapeutic Failure|1
7703100|NCT00430248|12124072|FG000|Overall Study|Withdrawal by Subject|14
7703101|NCT00430248|12124073|FG001|Overall Study|Withdrawal by Subject|20
7703102|NCT00430248|12124074|FG002|Overall Study|Withdrawal by Subject|16
7703103|NCT00430248|12124072|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7703104|NCT00430248|12124073|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2
7703105|NCT00430248|12124074|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7703106|NCT00430248|12124072|FG000|Overall Study|Gout Flare|3
7703107|NCT00430248|12124073|FG001|Overall Study|Gout Flare|7
7703108|NCT00430248|12124074|FG002|Overall Study|Gout Flare|2
7703109|NCT00430248|12124072|FG000|Overall Study|Reason Not Specified|8
7703110|NCT00430248|12124073|FG001|Overall Study|Reason Not Specified|8
7703111|NCT00430248|12124074|FG002|Overall Study|Reason Not Specified|11
7703112|NCT00430300|12124086|FG000|Overall Study|Adverse Event|0
7703113|NCT00430300|12124087|FG001|Overall Study|Adverse Event|2
7703114|NCT00430300|12124088|FG002|Overall Study|Adverse Event|1
7703115|NCT00430300|12124089|FG003|Overall Study|Adverse Event|1
7703116|NCT00430300|12124086|FG000|Overall Study|Withdrawal by Subject|1
7703117|NCT00430300|12124087|FG001|Overall Study|Withdrawal by Subject|0
7703118|NCT00430300|12124088|FG002|Overall Study|Withdrawal by Subject|5
7703119|NCT00430300|12124089|FG003|Overall Study|Withdrawal by Subject|0
7703120|NCT00430300|12124086|FG000|Overall Study|Laboratory abnormality|1
7703121|NCT00430300|12124087|FG001|Overall Study|Laboratory abnormality|0
7703122|NCT00430300|12124088|FG002|Overall Study|Laboratory abnormality|0
7703123|NCT00430300|12124089|FG003|Overall Study|Laboratory abnormality|0
7703124|NCT00430300|12124086|FG000|Overall Study|Other|0
7703125|NCT00430300|12124087|FG001|Overall Study|Other|0
7703126|NCT00430300|12124088|FG002|Overall Study|Other|0
7703127|NCT00430300|12124089|FG003|Overall Study|Other|1
7703128|NCT00430352|12124099|FG000|Overall Study|Disease progression|58
7703129|NCT00430352|12124099|FG000|Overall Study|Withdrawal by Subject|11
7703130|NCT00430352|12124099|FG000|Overall Study|Adverse Event|16
7703131|NCT00430352|12124099|FG000|Overall Study|Death|5
7703132|NCT00430352|12124099|FG000|Overall Study|Other|48
7703133|NCT00430482|12124105|FG000|Completed Treatment|Insufficient Treatment|7
7703134|NCT00430482|12124106|FG001|Completed Treatment|Insufficient Treatment|11
7703135|NCT00430495|12124116|FG000|Overall Study|Adverse Event|2
7703136|NCT00430495|12124117|FG001|Overall Study|Adverse Event|3
7703137|NCT00430495|12124118|FG002|Overall Study|Adverse Event|2
7703138|NCT00430495|12124119|FG003|Overall Study|Adverse Event|0
7703139|NCT00430495|12124116|FG000|Overall Study|Death|0
7703140|NCT00430495|12124117|FG001|Overall Study|Death|0
7703141|NCT00430495|12124118|FG002|Overall Study|Death|1
7703142|NCT00430495|12124119|FG003|Overall Study|Death|0
7703143|NCT00430495|12124116|FG000|Overall Study|Lost to Follow-up|0
7703144|NCT00430495|12124117|FG001|Overall Study|Lost to Follow-up|1
7703145|NCT00430495|12124118|FG002|Overall Study|Lost to Follow-up|4
7703146|NCT00430495|12124119|FG003|Overall Study|Lost to Follow-up|0
7703147|NCT00430495|12124116|FG000|Overall Study|Protocol Violation|1
7703148|NCT00430495|12124117|FG001|Overall Study|Protocol Violation|0
7703149|NCT00430495|12124118|FG002|Overall Study|Protocol Violation|1
7703150|NCT00430495|12124119|FG003|Overall Study|Protocol Violation|0
7703151|NCT00430495|12124116|FG000|Overall Study|Disease Progression|1
7703152|NCT00430495|12124117|FG001|Overall Study|Disease Progression|1
7703153|NCT00430495|12124118|FG002|Overall Study|Disease Progression|0
7703154|NCT00430495|12124119|FG003|Overall Study|Disease Progression|0
7703155|NCT00430495|12124116|FG000|Overall Study|Other|8
7703156|NCT00430495|12124117|FG001|Overall Study|Other|2
7703157|NCT00430495|12124118|FG002|Overall Study|Other|5
7703158|NCT00430495|12124119|FG003|Overall Study|Other|4
7703159|NCT00430495|12124116|FG000|Overall Study|Randomized but not Treated|2
7703160|NCT00430495|12124117|FG001|Overall Study|Randomized but not Treated|0
7703161|NCT00430495|12124118|FG002|Overall Study|Randomized but not Treated|0
7703162|NCT00430495|12124119|FG003|Overall Study|Randomized but not Treated|0
7703163|NCT00430521|12124137|FG000|Overall Study|Adverse Event|0
7703164|NCT00430521|12124138|FG001|Overall Study|Adverse Event|0
7703165|NCT00430521|12124139|FG002|Overall Study|Adverse Event|0
7703166|NCT00430521|12124140|FG003|Overall Study|Adverse Event|0
7703167|NCT00430521|12124141|FG004|Overall Study|Adverse Event|0
7703168|NCT00430521|12124142|FG005|Overall Study|Adverse Event|2
7703169|NCT00430521|12124143|FG006|Overall Study|Adverse Event|1
7703170|NCT00430521|12124144|FG007|Overall Study|Adverse Event|0
7703171|NCT00430521|12124137|FG000|Overall Study|Lost to Follow-up|7
7703172|NCT00430521|12124138|FG001|Overall Study|Lost to Follow-up|8
7703173|NCT00430521|12124139|FG002|Overall Study|Lost to Follow-up|3
7703174|NCT00430521|12124140|FG003|Overall Study|Lost to Follow-up|5
7703175|NCT00430521|12124141|FG004|Overall Study|Lost to Follow-up|5
7703176|NCT00430521|12124142|FG005|Overall Study|Lost to Follow-up|2
7703177|NCT00430521|12124143|FG006|Overall Study|Lost to Follow-up|8
7703178|NCT00430521|12124144|FG007|Overall Study|Lost to Follow-up|10
7703179|NCT00430521|12124137|FG000|Overall Study|Pregnancy|0
7703180|NCT00430521|12124138|FG001|Overall Study|Pregnancy|0
7703181|NCT00430521|12124139|FG002|Overall Study|Pregnancy|0
7703182|NCT00430521|12124140|FG003|Overall Study|Pregnancy|0
7703183|NCT00430521|12124141|FG004|Overall Study|Pregnancy|0
7703184|NCT00430521|12124142|FG005|Overall Study|Pregnancy|0
7703185|NCT00430521|12124143|FG006|Overall Study|Pregnancy|1
7703186|NCT00430521|12124144|FG007|Overall Study|Pregnancy|0
7703187|NCT00430521|12124137|FG000|Overall Study|Vaccine Expired|0
7703188|NCT00430521|12124138|FG001|Overall Study|Vaccine Expired|0
7703189|NCT00430521|12124139|FG002|Overall Study|Vaccine Expired|0
7703190|NCT00430521|12124140|FG003|Overall Study|Vaccine Expired|0
7703191|NCT00430521|12124141|FG004|Overall Study|Vaccine Expired|0
7703192|NCT00430521|12124142|FG005|Overall Study|Vaccine Expired|1
7703193|NCT00430521|12124143|FG006|Overall Study|Vaccine Expired|0
7703194|NCT00430521|12124144|FG007|Overall Study|Vaccine Expired|0
7703195|NCT00430521|12124137|FG000|Overall Study|Protocol Violation|1
7703196|NCT00430521|12124138|FG001|Overall Study|Protocol Violation|0
7703197|NCT00430521|12124139|FG002|Overall Study|Protocol Violation|0
7703198|NCT00430521|12124140|FG003|Overall Study|Protocol Violation|0
7703199|NCT00430521|12124141|FG004|Overall Study|Protocol Violation|0
7703200|NCT00430521|12124142|FG005|Overall Study|Protocol Violation|0
7703201|NCT00430521|12124143|FG006|Overall Study|Protocol Violation|0
7703202|NCT00430521|12124144|FG007|Overall Study|Protocol Violation|0
7703203|NCT00430521|12124137|FG000|Overall Study|Withdrawal by Subject|3
7703204|NCT00430521|12124138|FG001|Overall Study|Withdrawal by Subject|1
7703205|NCT00430521|12124139|FG002|Overall Study|Withdrawal by Subject|0
7703206|NCT00430521|12124140|FG003|Overall Study|Withdrawal by Subject|3
7703207|NCT00430521|12124141|FG004|Overall Study|Withdrawal by Subject|0
7703208|NCT00430521|12124142|FG005|Overall Study|Withdrawal by Subject|0
7703209|NCT00430521|12124143|FG006|Overall Study|Withdrawal by Subject|0
7703210|NCT00430521|12124144|FG007|Overall Study|Withdrawal by Subject|2
7703211|NCT00430573|12124175|FG000|Overall Study|Withdrawal by Subject|5
7703212|NCT00430638|12124192|FG000|Overall Study|Adverse Event|15
7703213|NCT00430638|12124193|FG001|Overall Study|Adverse Event|15
7703214|NCT00430638|12124192|FG000|Overall Study|Uncontrolled blood pressure|48
7703215|NCT00430638|12124193|FG001|Overall Study|Uncontrolled blood pressure|13
7703216|NCT00430638|12124192|FG000|Overall Study|Lost to Follow-up|1
7703217|NCT00430638|12124193|FG001|Overall Study|Lost to Follow-up|7
7703218|NCT00430638|12124192|FG000|Overall Study|Protocol Violation|6
7703219|NCT00430638|12124193|FG001|Overall Study|Protocol Violation|4
7703220|NCT00430638|12124192|FG000|Overall Study|Withdrawal by Subject|4
7703221|NCT00430638|12124193|FG001|Overall Study|Withdrawal by Subject|6
7703222|NCT00430638|12124192|FG000|Overall Study|Non-compliant|2
7703223|NCT00430638|12124193|FG001|Overall Study|Non-compliant|1
7703224|NCT00430638|12124192|FG000|Overall Study|Other|2
7703225|NCT00430638|12124193|FG001|Overall Study|Other|2
7703226|NCT00430677|12124206|FG000|Short-term Period|Death|1
7703227|NCT00430677|12124207|FG001|Short-term Period|Death|1
7703228|NCT00430677|12124208|FG002|Short-term Period|Death|5
7703229|NCT00430677|12124206|FG000|Short-term Period|Adverse Event|15
7703230|NCT00430677|12124207|FG001|Short-term Period|Adverse Event|13
7703231|NCT00430677|12124208|FG002|Short-term Period|Adverse Event|9
7703232|NCT00430677|12124206|FG000|Short-term Period|Lack of Efficacy|5
7703233|NCT00430677|12124207|FG001|Short-term Period|Lack of Efficacy|6
7703234|NCT00430677|12124208|FG002|Short-term Period|Lack of Efficacy|4
7703235|NCT00430677|12124206|FG000|Short-term Period|Withdrawal by Subject|1
7703236|NCT00430677|12124207|FG001|Short-term Period|Withdrawal by Subject|1
7703237|NCT00430677|12124208|FG002|Short-term Period|Withdrawal by Subject|2
7703238|NCT00430677|12124206|FG000|Short-term Period|Participant no longer met study criteria|1
7703239|NCT00430677|12124207|FG001|Short-term Period|Participant no longer met study criteria|1
7703240|NCT00430677|12124208|FG002|Short-term Period|Participant no longer met study criteria|2
7703241|NCT00430677|12124206|FG000|Short-term Period|Poor compliance/ noncompliance|0
7703242|NCT00430677|12124207|FG001|Short-term Period|Poor compliance/ noncompliance|1
7703243|NCT00430677|12124208|FG002|Short-term Period|Poor compliance/ noncompliance|0
7703244|NCT00430677|12124206|FG000|Short-term Period|Pregnancy|0
7703245|NCT00430677|12124207|FG001|Short-term Period|Pregnancy|2
7703246|NCT00430677|12124208|FG002|Short-term Period|Pregnancy|0
7703247|NCT00430677|12124206|FG000|Long-term Extension Period|Death|1
7703248|NCT00430677|12124207|FG001|Long-term Extension Period|Death|0
7703249|NCT00430677|12124208|FG002|Long-term Extension Period|Death|0
7703250|NCT00430677|12124206|FG000|Long-term Extension Period|Adverse Event|3
7703251|NCT00430677|12124207|FG001|Long-term Extension Period|Adverse Event|2
7703252|NCT00430677|12124208|FG002|Long-term Extension Period|Adverse Event|5
7703253|NCT00430677|12124206|FG000|Long-term Extension Period|Lack of Efficacy|5
7703254|NCT00430677|12124207|FG001|Long-term Extension Period|Lack of Efficacy|3
7703255|NCT00430677|12124208|FG002|Long-term Extension Period|Lack of Efficacy|8
7703256|NCT00430677|12124206|FG000|Long-term Extension Period|Lost to Follow-up|1
7703257|NCT00430677|12124207|FG001|Long-term Extension Period|Lost to Follow-up|1
7703258|NCT00430677|12124208|FG002|Long-term Extension Period|Lost to Follow-up|1
7703259|NCT00430677|12124206|FG000|Long-term Extension Period|Withdrawal by Subject|5
7703260|NCT00430677|12124207|FG001|Long-term Extension Period|Withdrawal by Subject|1
7703261|NCT00430677|12124208|FG002|Long-term Extension Period|Withdrawal by Subject|2
7703262|NCT00430677|12124206|FG000|Long-term Extension Period|Pregnancy|1
7703263|NCT00430677|12124207|FG001|Long-term Extension Period|Pregnancy|1
7703264|NCT00430677|12124208|FG002|Long-term Extension Period|Pregnancy|0
7703265|NCT00430677|12124206|FG000|Long-term Extension Period|Administrative reason by sponsor|41
7703266|NCT00430677|12124207|FG001|Long-term Extension Period|Administrative reason by sponsor|49
7703267|NCT00430677|12124208|FG002|Long-term Extension Period|Administrative reason by sponsor|46
7703268|NCT00430677|12124206|FG000|Long-term Extension Period|Other|2
7703269|NCT00430677|12124207|FG001|Long-term Extension Period|Other|1
7703270|NCT00430677|12124208|FG002|Long-term Extension Period|Other|1
7703271|NCT00430677|12124206|FG000|Long-term Extension Period|Poor compliance/noncompliance|1
7703272|NCT00430677|12124207|FG001|Long-term Extension Period|Poor compliance/noncompliance|0
7703273|NCT00430677|12124208|FG002|Long-term Extension Period|Poor compliance/noncompliance|0
7703274|NCT00430716|12124237|FG000|Double Blind Phase|Death|1
7703275|NCT00430716|12124238|FG001|Double Blind Phase|Death|0
7703276|NCT00430716|12124239|FG002|Double Blind Phase|Death|0
7703277|NCT00430716|12124237|FG000|Double Blind Phase|No longer willing to participate|2
7703278|NCT00430716|12124238|FG001|Double Blind Phase|No longer willing to participate|1
7703279|NCT00430716|12124239|FG002|Double Blind Phase|No longer willing to participate|1
7703280|NCT00430716|12124237|FG000|Double Blind Phase|Other|0
7703281|NCT00430716|12124238|FG001|Double Blind Phase|Other|2
7703282|NCT00430716|12124239|FG002|Double Blind Phase|Other|0
7703283|NCT00430716|12124237|FG000|Double Blind Phase|Study terminated by sponsor|1
7703284|NCT00430716|12124238|FG001|Double Blind Phase|Study terminated by sponsor|1
7703285|NCT00430716|12124239|FG002|Double Blind Phase|Study terminated by sponsor|2
7703286|NCT00430716|12124237|FG000|Double Blind Phase|Adverse Event|1
7703287|NCT00430716|12124238|FG001|Double Blind Phase|Adverse Event|1
7703288|NCT00430716|12124239|FG002|Double Blind Phase|Adverse Event|3
7703289|NCT00430716|12124237|FG000|Double Blind Phase|Not treated|1
7703290|NCT00430716|12124238|FG001|Double Blind Phase|Not treated|0
7703291|NCT00430716|12124239|FG002|Double Blind Phase|Not treated|0
7703292|NCT00430716|12124237|FG000|Open Label Phase|Lost to Follow-up|1
7703293|NCT00430716|12124238|FG001|Open Label Phase|Lost to Follow-up|0
7703294|NCT00430716|12124239|FG002|Open Label Phase|Lost to Follow-up|1
7703295|NCT00430716|12124237|FG000|Open Label Phase|No longer willing to participate|0
7703296|NCT00430716|12124238|FG001|Open Label Phase|No longer willing to participate|1
7703297|NCT00430716|12124239|FG002|Open Label Phase|No longer willing to participate|1
7703298|NCT00430716|12124237|FG000|Open Label Phase|Other|3
7703299|NCT00430716|12124238|FG001|Open Label Phase|Other|1
7703300|NCT00430716|12124239|FG002|Open Label Phase|Other|1
7703301|NCT00430716|12124237|FG000|Open Label Phase|Protocol Violation|1
7703302|NCT00430716|12124238|FG001|Open Label Phase|Protocol Violation|0
7703303|NCT00430716|12124239|FG002|Open Label Phase|Protocol Violation|0
7703304|NCT00430716|12124237|FG000|Open Label Phase|Study terminated by sponsor|4
7703305|NCT00430716|12124238|FG001|Open Label Phase|Study terminated by sponsor|5
7703306|NCT00430716|12124239|FG002|Open Label Phase|Study terminated by sponsor|4
7703307|NCT00430755|12124247|FG000|Overall Study|Withdrawal by Subject|53
7703308|NCT00430781|12124273|FG000|Interim Analysis; 11 February 2008|Adverse Event|10
7703309|NCT00430781|12124274|FG001|Interim Analysis; 11 February 2008|Adverse Event|3
7703310|NCT00430781|12124275|FG002|Interim Analysis; 11 February 2008|Adverse Event|7
7703311|NCT00430781|12124273|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1
7703312|NCT00430781|12124274|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0
7703313|NCT00430781|12124275|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1
7703314|NCT00430781|12124273|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0
7703315|NCT00430781|12124274|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1
7703316|NCT00430781|12124275|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0
7703317|NCT00430781|12124273|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
7703318|NCT00430781|12124274|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
7703319|NCT00430781|12124275|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
7703320|NCT00430781|12124273|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
7703321|NCT00430781|12124274|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
7703322|NCT00430781|12124275|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
7703323|NCT00430781|12124273|FG000|Interim Analysis; 11 February 2008|Disease Progression|16
7703324|NCT00430781|12124274|FG001|Interim Analysis; 11 February 2008|Disease Progression|30
7703325|NCT00430781|12124275|FG002|Interim Analysis; 11 February 2008|Disease Progression|22
7703326|NCT00430781|12124273|FG000|Interim Analysis; 11 February 2008|Death|0
7703327|NCT00430781|12124274|FG001|Interim Analysis; 11 February 2008|Death|1
7703328|NCT00430781|12124275|FG002|Interim Analysis; 11 February 2008|Death|0
7703329|NCT00430781|12124273|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
7703330|NCT00430781|12124274|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
7703331|NCT00430781|12124275|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
7703332|NCT00430781|12124273|FG000|Interim Analysis; 11 February 2008|Physician Decision|2
7703333|NCT00430781|12124274|FG001|Interim Analysis; 11 February 2008|Physician Decision|3
7703334|NCT00430781|12124275|FG002|Interim Analysis; 11 February 2008|Physician Decision|3
7703335|NCT00430781|12124273|FG000|Interim Analysis; 11 February 2008|Ongoing|23
7703336|NCT00430781|12124274|FG001|Interim Analysis; 11 February 2008|Ongoing|20
7703337|NCT00430781|12124275|FG002|Interim Analysis; 11 February 2008|Ongoing|25
7703338|NCT00430781|12124273|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0
7703339|NCT00430781|12124274|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0
7703340|NCT00430781|12124275|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3
7703341|NCT00430781|12124273|FG000|Final Analysis; 31 July 2008|Protocol Violation|0
7703342|NCT00430781|12124274|FG001|Final Analysis; 31 July 2008|Protocol Violation|1
7703343|NCT00430781|12124275|FG002|Final Analysis; 31 July 2008|Protocol Violation|0
7703344|NCT00430781|12124273|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0
7703345|NCT00430781|12124274|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2
7703346|NCT00430781|12124275|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7
7703347|NCT00430781|12124273|FG000|Final Analysis; 31 July 2008|Physician Decision|0
7703348|NCT00430781|12124274|FG001|Final Analysis; 31 July 2008|Physician Decision|6
7703349|NCT00430781|12124275|FG002|Final Analysis; 31 July 2008|Physician Decision|6
7703350|NCT00430781|12124273|FG000|Final Analysis; 31 July 2008|Other|0
7703351|NCT00430781|12124274|FG001|Final Analysis; 31 July 2008|Other|1
7703352|NCT00430781|12124275|FG002|Final Analysis; 31 July 2008|Other|0
7703353|NCT00430781|12124273|FG000|Final Analysis; 31 July 2008|Ongoing|0
7703354|NCT00430781|12124274|FG001|Final Analysis; 31 July 2008|Ongoing|29
7703355|NCT00430781|12124275|FG002|Final Analysis; 31 July 2008|Ongoing|32
7703356|NCT00430781|12124273|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
7703357|NCT00430781|12124274|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
7703358|NCT00430781|12124275|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
7703359|NCT00430781|12124273|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
7703360|NCT00430781|12124274|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
7703361|NCT00430781|12124275|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
7703362|NCT00430781|12124273|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
7703363|NCT00430781|12124274|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
7703364|NCT00430781|12124275|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
7703365|NCT00430781|12124273|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
7703366|NCT00430781|12124274|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
7703367|NCT00430781|12124275|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
7703368|NCT00430781|12124273|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4
7703369|NCT00430781|12124274|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6
7703370|NCT00430781|12124275|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6
7703371|NCT00430781|12124273|FG000|End-of-Study Analysis; 28 July 2011|Other|4
7703372|NCT00430781|12124274|FG001|End-of-Study Analysis; 28 July 2011|Other|1
7703373|NCT00430781|12124275|FG002|End-of-Study Analysis; 28 July 2011|Other|0
7703374|NCT00430937|12124288|FG000|Overall Study|Adverse Event|3
7703375|NCT00430937|12124289|FG001|Overall Study|Adverse Event|8
7703376|NCT00430937|12124288|FG000|Overall Study|Death|0
7703377|NCT00430937|12124289|FG001|Overall Study|Death|1
7703378|NCT00430937|12124288|FG000|Overall Study|Lost to Follow-up|6
7703379|NCT00430937|12124289|FG001|Overall Study|Lost to Follow-up|6
7703380|NCT00430937|12124288|FG000|Overall Study|Withdrawal by Subject|5
7703381|NCT00430937|12124289|FG001|Overall Study|Withdrawal by Subject|2
7703382|NCT00430937|12124288|FG000|Overall Study|Protocol Violation|3
7703383|NCT00430937|12124289|FG001|Overall Study|Protocol Violation|2
7703384|NCT00430937|12124288|FG000|Overall Study|Lack of Efficacy|6
7703385|NCT00430937|12124289|FG001|Overall Study|Lack of Efficacy|5
7703386|NCT00430937|12124288|FG000|Overall Study|Inappropriate enrollment|2
7703387|NCT00430937|12124289|FG001|Overall Study|Inappropriate enrollment|1
7703388|NCT00430937|12124288|FG000|Overall Study|Administrative reasons|1
7703389|NCT00430937|12124289|FG001|Overall Study|Administrative reasons|0
7703390|NCT00430937|12124288|FG000|Overall Study|Protocol discontinuation criteria met|1
7703391|NCT00430937|12124289|FG001|Overall Study|Protocol discontinuation criteria met|2
7703392|NCT00430937|12124288|FG000|Overall Study|Unable to classify|0
7703393|NCT00430937|12124289|FG001|Overall Study|Unable to classify|1
7703394|NCT00430989|12124297|FG000|Overall Study|Lost to Follow-up|2
7703395|NCT00430989|12124298|FG001|Overall Study|Lost to Follow-up|3
7703396|NCT00430989|12124297|FG000|Overall Study|Withdrawal by Subject|15
7703397|NCT00430989|12124298|FG001|Overall Study|Withdrawal by Subject|14
7703398|NCT00430989|12124297|FG000|Overall Study|Protocol Violation|30
7703399|NCT00430989|12124298|FG001|Overall Study|Protocol Violation|37
7703400|NCT00430989|12124297|FG000|Overall Study|Not eligible|13
7703401|NCT00430989|12124298|FG001|Overall Study|Not eligible|6
7703402|NCT00431067|12124315|FG000|Overall Study|Other Adverse Event|9
7703403|NCT00431067|12124315|FG000|Overall Study|Progressive disease|30
7703404|NCT00431067|12124315|FG000|Overall Study|Non-compliance,lost to follow-up|2
7703405|NCT00431444|12124336|FG000|Overall Study|Protocol Violation|1
7703406|NCT00431444|12124337|FG001|Overall Study|Protocol Violation|4
7703407|NCT00431444|12124336|FG000|Overall Study|Adverse Event|2
7703408|NCT00431444|12124337|FG001|Overall Study|Adverse Event|1
7703409|NCT00431444|12124336|FG000|Overall Study|Withdrawal by Subject|1
7703410|NCT00431444|12124337|FG001|Overall Study|Withdrawal by Subject|1
7703411|NCT00431444|12124336|FG000|Overall Study|Lost to Follow-up|1
7703412|NCT00431444|12124337|FG001|Overall Study|Lost to Follow-up|0
7703413|NCT00431444|12124336|FG000|Overall Study|Administrative Problems|0
7703414|NCT00431444|12124337|FG001|Overall Study|Administrative Problems|1
7703415|NCT00431496|12124343|FG000|Overall Study|Adverse Event|3
7703416|NCT00431496|12124343|FG000|Overall Study|Lost to Follow-up|1
7703417|NCT00431496|12124343|FG000|Overall Study|Withdrawal by Subject|2
7703418|NCT00431496|12124343|FG000|Overall Study|Protocol-specified criteria|5
7703419|NCT00431834|12124356|FG000|Overall Study|Withdrawal by Subject|7
7703420|NCT00431834|12124356|FG000|Overall Study|Death|3
7703421|NCT00431834|12124356|FG000|Overall Study|Missed Endpoint Visit|2
7703422|NCT00431834|12124356|FG000|Overall Study|Lost to Follow-up|1
7703423|NCT00431847|12124367|FG000|Overall Study|completion of less than two study visits|6
7703424|NCT00431847|12124368|FG001|Overall Study|completion of less than two study visits|3
7703425|NCT00431847|12124369|FG002|Overall Study|completion of less than two study visits|4
7703426|NCT00431847|12124370|FG003|Overall Study|completion of less than two study visits|14
7703427|NCT00431847|12124371|FG004|Overall Study|completion of less than two study visits|0
7703428|NCT00431847|12124367|FG000|Overall Study|Protocol Violation|0
7703429|NCT00431847|12124368|FG001|Overall Study|Protocol Violation|0
7703430|NCT00431847|12124369|FG002|Overall Study|Protocol Violation|0
7703431|NCT00431847|12124370|FG003|Overall Study|Protocol Violation|0
7703432|NCT00431847|12124371|FG004|Overall Study|Protocol Violation|1
7703433|NCT00431951|12124385|FG000|Overall Study|Inability to follow study procedures|1
7703434|NCT00431951|12124386|FG001|Overall Study|Inability to follow study procedures|0
7703435|NCT00431951|12124387|FG002|Overall Study|Inability to follow study procedures|1
7703436|NCT00431951|12124388|FG003|Overall Study|Inability to follow study procedures|2
7703437|NCT00431951|12124385|FG000|Overall Study|Lost to Follow-up|0
7703438|NCT00431951|12124386|FG001|Overall Study|Lost to Follow-up|1
7703439|NCT00431951|12124387|FG002|Overall Study|Lost to Follow-up|0
7703440|NCT00431951|12124388|FG003|Overall Study|Lost to Follow-up|0
7703441|NCT00431951|12124385|FG000|Overall Study|Withdrawal by Subject|0
7703442|NCT00431951|12124386|FG001|Overall Study|Withdrawal by Subject|1
7703443|NCT00431951|12124387|FG002|Overall Study|Withdrawal by Subject|0
7703444|NCT00431951|12124388|FG003|Overall Study|Withdrawal by Subject|0
7703445|NCT00431951|12124385|FG000|Overall Study|Adverse Event|0
7703446|NCT00431951|12124386|FG001|Overall Study|Adverse Event|0
7703447|NCT00431951|12124387|FG002|Overall Study|Adverse Event|1
7703448|NCT00431951|12124388|FG003|Overall Study|Adverse Event|0
7703449|NCT00431964|12124404|FG000|Overall Study|Adverse Event|1
7703450|NCT00431964|12124405|FG001|Overall Study|Adverse Event|0
7703451|NCT00431964|12124404|FG000|Overall Study|Lost to Follow-up|1
7703452|NCT00431964|12124405|FG001|Overall Study|Lost to Follow-up|2
7703453|NCT00431964|12124404|FG000|Overall Study|Physician Decision|2
7703454|NCT00431964|12124405|FG001|Overall Study|Physician Decision|2
7703455|NCT00431964|12124404|FG000|Overall Study|Withdrawal by Subject|2
7703456|NCT00431964|12124405|FG001|Overall Study|Withdrawal by Subject|1
7703457|NCT00431964|12124404|FG000|Overall Study|Parental Consent Withdrawn|0
7703458|NCT00431964|12124405|FG001|Overall Study|Parental Consent Withdrawn|2
7703459|NCT00431964|12124404|FG000|Overall Study|Due to Unstable Health|0
7703460|NCT00431964|12124405|FG001|Overall Study|Due to Unstable Health|1
7703461|NCT00432042|12124414|FG000|Overall Study|Protocol Violation|2
7703462|NCT00432042|12124415|FG001|Overall Study|Protocol Violation|0
7703463|NCT00432042|12124416|FG002|Overall Study|Protocol Violation|0
7703464|NCT00432042|12124414|FG000|Overall Study|Withdrawal by Subject|0
7703465|NCT00432042|12124415|FG001|Overall Study|Withdrawal by Subject|0
7703466|NCT00432042|12124416|FG002|Overall Study|Withdrawal by Subject|2
7703467|NCT00432042|12124414|FG000|Overall Study|Lost to Follow-up|5
7703468|NCT00432042|12124415|FG001|Overall Study|Lost to Follow-up|1
7703469|NCT00432042|12124416|FG002|Overall Study|Lost to Follow-up|0
7703470|NCT00432159|12124429|FG000|Overall Study|Death|0
7703471|NCT00432159|12124430|FG001|Overall Study|Death|1
7703472|NCT00432159|12124431|FG002|Overall Study|Death|0
7703473|NCT00432159|12124432|FG003|Overall Study|Death|0
7703474|NCT00432159|12124433|FG004|Overall Study|Death|0
7703475|NCT00432159|12124429|FG000|Overall Study|Failure|9
7703476|NCT00432159|12124430|FG001|Overall Study|Failure|5
7703477|NCT00432159|12124431|FG002|Overall Study|Failure|3
7703478|NCT00432159|12124432|FG003|Overall Study|Failure|2
7703479|NCT00432159|12124433|FG004|Overall Study|Failure|3
7703480|NCT00432159|12124429|FG000|Overall Study|Missing NDI and/or neuro. assessment|13
7703481|NCT00432159|12124430|FG001|Overall Study|Missing NDI and/or neuro. assessment|24
7703482|NCT00432159|12124431|FG002|Overall Study|Missing NDI and/or neuro. assessment|1
7703483|NCT00432159|12124432|FG003|Overall Study|Missing NDI and/or neuro. assessment|3
7703484|NCT00432159|12124433|FG004|Overall Study|Missing NDI and/or neuro. assessment|7
7703485|NCT00432172|12124449|FG000|Overall Study|Physician Decision|0
7703486|NCT00432172|12124450|FG001|Overall Study|Physician Decision|0
7703487|NCT00432172|12124451|FG002|Overall Study|Physician Decision|2
7703488|NCT00432172|12124452|FG003|Overall Study|Physician Decision|0
7703489|NCT00432172|12124449|FG000|Overall Study|Adverse Event|4
7703490|NCT00432172|12124450|FG001|Overall Study|Adverse Event|2
7703491|NCT00432172|12124451|FG002|Overall Study|Adverse Event|4
7703492|NCT00432172|12124452|FG003|Overall Study|Adverse Event|3
7703493|NCT00432172|12124449|FG000|Overall Study|Disease progression|0
7703494|NCT00432172|12124450|FG001|Overall Study|Disease progression|2
7703495|NCT00432172|12124451|FG002|Overall Study|Disease progression|5
7703496|NCT00432172|12124452|FG003|Overall Study|Disease progression|1
7703497|NCT00432172|12124449|FG000|Overall Study|Withdrawal by Subject|0
7703498|NCT00432172|12124450|FG001|Overall Study|Withdrawal by Subject|1
7703499|NCT00432172|12124451|FG002|Overall Study|Withdrawal by Subject|0
7703500|NCT00432172|12124452|FG003|Overall Study|Withdrawal by Subject|2
7703501|NCT00432172|12124449|FG000|Overall Study|No treatment received|2
7703502|NCT00432172|12124450|FG001|Overall Study|No treatment received|2
7703503|NCT00432172|12124451|FG002|Overall Study|No treatment received|0
7703504|NCT00432172|12124452|FG003|Overall Study|No treatment received|1
7703505|NCT00432237|12124468|FG000|Overall Study|Adverse Event|0
7703506|NCT00432237|12124469|FG001|Overall Study|Adverse Event|0
7703507|NCT00432237|12124470|FG002|Overall Study|Adverse Event|0
7703508|NCT00432237|12124471|FG003|Overall Study|Adverse Event|1
7703509|NCT00432237|12124468|FG000|Overall Study|Lack of Efficacy|0
7703510|NCT00432237|12124469|FG001|Overall Study|Lack of Efficacy|0
7703511|NCT00432237|12124470|FG002|Overall Study|Lack of Efficacy|0
7703512|NCT00432237|12124471|FG003|Overall Study|Lack of Efficacy|1
7703513|NCT00432237|12124468|FG000|Overall Study|Lost to Follow-up|10
7703514|NCT00432237|12124469|FG001|Overall Study|Lost to Follow-up|10
7703515|NCT00432237|12124470|FG002|Overall Study|Lost to Follow-up|18
7703516|NCT00432237|12124471|FG003|Overall Study|Lost to Follow-up|18
7703517|NCT00432237|12124468|FG000|Overall Study|Physician Decision|1
7703518|NCT00432237|12124469|FG001|Overall Study|Physician Decision|3
7703519|NCT00432237|12124470|FG002|Overall Study|Physician Decision|2
7703520|NCT00432237|12124471|FG003|Overall Study|Physician Decision|1
7703521|NCT00432237|12124468|FG000|Overall Study|Pregnancy|0
7703522|NCT00432237|12124469|FG001|Overall Study|Pregnancy|1
7703523|NCT00432237|12124470|FG002|Overall Study|Pregnancy|0
7703524|NCT00432237|12124471|FG003|Overall Study|Pregnancy|0
7703525|NCT00432237|12124468|FG000|Overall Study|Protocol Violation|13
7703526|NCT00432237|12124469|FG001|Overall Study|Protocol Violation|10
7703527|NCT00432237|12124470|FG002|Overall Study|Protocol Violation|11
7703528|NCT00432237|12124471|FG003|Overall Study|Protocol Violation|8
7703529|NCT00432237|12124468|FG000|Overall Study|Withdrawal by Subject|5
7703530|NCT00432237|12124469|FG001|Overall Study|Withdrawal by Subject|6
7703531|NCT00432237|12124470|FG002|Overall Study|Withdrawal by Subject|9
7703532|NCT00432237|12124471|FG003|Overall Study|Withdrawal by Subject|11
7703533|NCT00432237|12124468|FG000|Overall Study|Lack of Qualifying Event|38
7703534|NCT00432237|12124469|FG001|Overall Study|Lack of Qualifying Event|71
7703535|NCT00432237|12124470|FG002|Overall Study|Lack of Qualifying Event|69
7703536|NCT00432237|12124471|FG003|Overall Study|Lack of Qualifying Event|84
7703537|NCT00432276|12124483|FG000|Overall Study|Hyperglycemic Rescue|44
7703538|NCT00432276|12124484|FG001|Overall Study|Hyperglycemic Rescue|87
7703539|NCT00432276|12124483|FG000|Overall Study|Adverse Event|13
7703540|NCT00432276|12124484|FG001|Overall Study|Adverse Event|16
7703541|NCT00432276|12124483|FG000|Overall Study|Protocol Violation|25
7703542|NCT00432276|12124484|FG001|Overall Study|Protocol Violation|20
7703543|NCT00432276|12124483|FG000|Overall Study|Lost to Follow-up|6
7703544|NCT00432276|12124484|FG001|Overall Study|Lost to Follow-up|2
7703545|NCT00432276|12124483|FG000|Overall Study|Withdrawal by Subject|25
7703546|NCT00432276|12124484|FG001|Overall Study|Withdrawal by Subject|20
7703547|NCT00432276|12124483|FG000|Overall Study|Physician Decision|6
7703548|NCT00432276|12124484|FG001|Overall Study|Physician Decision|8
7703549|NCT00432276|12124483|FG000|Overall Study|Other|2
7703550|NCT00432276|12124484|FG001|Overall Study|Other|3
7703551|NCT00432380|12124502|FG000|Overall Study|Migrated/moved from study area|3
7703552|NCT00432380|12124503|FG001|Overall Study|Migrated/moved from study area|4
7703553|NCT00432380|12124504|FG002|Overall Study|Migrated/moved from study area|1
7703554|NCT00432380|12124502|FG000|Overall Study|Adverse Event|1
7703555|NCT00432380|12124503|FG001|Overall Study|Adverse Event|0
7703556|NCT00432380|12124504|FG002|Overall Study|Adverse Event|0
7703557|NCT00432562|12124524|FG000|Overall Study|Death|3
7703558|NCT00432562|12124525|FG001|Overall Study|Death|0
7703559|NCT00432666|12124542|FG000|Main Period|Adverse Event|1
7703560|NCT00432666|12124543|FG001|Main Period|Adverse Event|1
7703561|NCT00432666|12124542|FG000|Main Period|Consent Withdrawn|1
7703562|NCT00432666|12124543|FG001|Main Period|Consent Withdrawn|0
7703563|NCT00432666|12124542|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1
7703564|NCT00432666|12124543|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0
7703565|NCT00432666|12124542|FG000|Open-Label Extension Period|Lack of Efficacy|6
7703566|NCT00432666|12124543|FG001|Open-Label Extension Period|Lack of Efficacy|0
7703567|NCT00432666|12124542|FG000|Open-Label Extension Period|Adverse Event|5
7703568|NCT00432666|12124543|FG001|Open-Label Extension Period|Adverse Event|0
7703569|NCT00432666|12124542|FG000|Open-Label Extension Period|Consent withdrawn|10
7703570|NCT00432666|12124543|FG001|Open-Label Extension Period|Consent withdrawn|0
7703571|NCT00432666|12124542|FG000|Open-Label Extension Period|Physician Decision|3
7703572|NCT00432666|12124543|FG001|Open-Label Extension Period|Physician Decision|0
7703573|NCT00432679|12124551|FG000|Overall Study|Adverse Event|2
7703574|NCT00432679|12124552|FG001|Overall Study|Adverse Event|1
7703575|NCT00432679|12124551|FG000|Overall Study|Withdrawal by Subject|3
7703576|NCT00432679|12124552|FG001|Overall Study|Withdrawal by Subject|2
7703577|NCT00432744|12124560|FG000|Months 0-6|Withdrawal by Subject|4
7703578|NCT00432744|12124561|FG001|Months 0-6|Withdrawal by Subject|4
7703579|NCT00432744|12124560|FG000|Months 0-6|Too disabled to score|1
7703580|NCT00432744|12124561|FG001|Months 0-6|Too disabled to score|0
7703581|NCT00432744|12124560|FG000|Months 7 - 12|Withdrawal by Subject|1
7703582|NCT00432744|12124561|FG001|Months 7 - 12|Withdrawal by Subject|0
7703583|NCT00432744|12124560|FG000|Months 7 - 12|Too disabled to score|0
7703584|NCT00432744|12124561|FG001|Months 7 - 12|Too disabled to score|1
7703585|NCT00432809|12124570|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2
7703586|NCT00432809|12124571|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0
7703587|NCT00432809|12124572|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0
7703588|NCT00432809|12124570|FG000|1 Year Follow-up|Withdrawal by Subject|7
7703589|NCT00432809|12124571|FG001|1 Year Follow-up|Withdrawal by Subject|0
7703590|NCT00432809|12124572|FG002|1 Year Follow-up|Withdrawal by Subject|1
7703591|NCT00432835|12124582|FG000|Overall Study|Adverse event: lead dislodgement.|6
7703592|NCT00432835|12124583|FG001|Overall Study|Adverse event: lead dislodgement.|7
7703593|NCT00432991|12124591|FG000|Overall Study|Protocol Violation|7
7703594|NCT00432991|12124592|FG001|Overall Study|Protocol Violation|12
7703595|NCT00433004|12124600|FG000|Overall Study|Lost to Follow-up|5
7703596|NCT00433004|12124601|FG001|Overall Study|Lost to Follow-up|7
7703597|NCT00433017|12124609|FG000|Overall Study|Adverse Event|5
7703598|NCT00433017|12124610|FG001|Overall Study|Adverse Event|3
7703599|NCT00433017|12124609|FG000|Overall Study|Withdrawal by Subject|4
7703600|NCT00433017|12124610|FG001|Overall Study|Withdrawal by Subject|5
7703601|NCT00433017|12124609|FG000|Overall Study|Lost to Follow-up|3
7703602|NCT00433017|12124610|FG001|Overall Study|Lost to Follow-up|4
7703603|NCT00433017|12124609|FG000|Overall Study|Administrative problems|80
7703604|NCT00433017|12124610|FG001|Overall Study|Administrative problems|86
7703605|NCT00433017|12124609|FG000|Overall Study|Protocol Violation|1
7703606|NCT00433017|12124610|FG001|Overall Study|Protocol Violation|0
7703607|NCT00433017|12124609|FG000|Overall Study|Death|2
7703608|NCT00433017|12124610|FG001|Overall Study|Death|2
7703609|NCT00433017|12124609|FG000|Overall Study|Subject no longer requires study drug|1
7703610|NCT00433017|12124610|FG001|Overall Study|Subject no longer requires study drug|1
7703611|NCT00433147|12124620|FG000|Overall Study|Adverse Event|0
7703612|NCT00433147|12124621|FG001|Overall Study|Adverse Event|1
7703613|NCT00433147|12124622|FG002|Overall Study|Adverse Event|0
7703614|NCT00433147|12124623|FG003|Overall Study|Adverse Event|0
7703615|NCT00433160|12124635|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6
7703616|NCT00433160|12124636|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2
7703617|NCT00433160|12124635|FG000|52-Week Double-Blind (DB) Period|Death|0
7703618|NCT00433160|12124636|FG001|52-Week Double-Blind (DB) Period|Death|0
7703619|NCT00433160|12124635|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
7703620|NCT00433160|12124636|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
7703621|NCT00433160|12124635|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
7703622|NCT00433160|12124636|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
7703623|NCT00433160|12124635|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0
7703624|NCT00433160|12124636|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2
7703625|NCT00433160|12124635|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
7703626|NCT00433160|12124636|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
7703627|NCT00433160|12124635|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4
7703628|NCT00433160|12124636|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2
7703629|NCT00433160|12124635|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0
7703630|NCT00433160|12124636|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0
7703631|NCT00433160|12124635|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
7703632|NCT00433160|12124636|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
7703633|NCT00433160|12124635|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
7703634|NCT00433160|12124636|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
7703635|NCT00433160|12124635|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
7703636|NCT00433160|12124636|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
7703637|NCT00433160|12124635|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
7703638|NCT00433160|12124636|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
7703639|NCT00433160|12124635|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
7703640|NCT00433160|12124636|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
7703641|NCT00433160|12124635|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2
7703642|NCT00433160|12124636|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0
7703643|NCT00433160|12124635|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
7703644|NCT00433160|12124636|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
7703645|NCT00433160|12124635|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0
7703646|NCT00433160|12124636|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1
7703647|NCT00433199|12124648|FG000|Double-Blind Period|Adverse Event|0
7703648|NCT00433199|12124649|FG001|Double-Blind Period|Adverse Event|25
7703649|NCT00433199|12124648|FG000|Double-Blind Period|Lack of Efficacy|0
7703650|NCT00433199|12124649|FG001|Double-Blind Period|Lack of Efficacy|2
7703651|NCT00433199|12124648|FG000|Double-Blind Period|Lost to Follow-up|2
7703652|NCT00433199|12124649|FG001|Double-Blind Period|Lost to Follow-up|5
7703653|NCT00433199|12124648|FG000|Double-Blind Period|Withdrawal by Subject|8
7703654|NCT00433199|12124649|FG001|Double-Blind Period|Withdrawal by Subject|19
7703655|NCT00433199|12124648|FG000|Double-Blind Period|Protocol Violation|1
7703656|NCT00433199|12124649|FG001|Double-Blind Period|Protocol Violation|10
7703657|NCT00433199|12124648|FG000|Double-Blind Period|Administrative|1
7703658|NCT00433199|12124649|FG001|Double-Blind Period|Administrative|5
7703659|NCT00433199|12124648|FG000|Open-Label Period|Adverse Event|0
7703660|NCT00433199|12124649|FG001|Open-Label Period|Adverse Event|19
7703661|NCT00433199|12124648|FG000|Open-Label Period|Lack of Efficacy|0
7703662|NCT00433199|12124649|FG001|Open-Label Period|Lack of Efficacy|2
7703663|NCT00433199|12124648|FG000|Open-Label Period|Lost to Follow-up|0
7703664|NCT00433199|12124649|FG001|Open-Label Period|Lost to Follow-up|3
7703665|NCT00433199|12124648|FG000|Open-Label Period|Withdrawal by Subject|0
7703666|NCT00433199|12124649|FG001|Open-Label Period|Withdrawal by Subject|7
7703667|NCT00433199|12124648|FG000|Open-Label Period|Protocol Violation|0
7703668|NCT00433199|12124649|FG001|Open-Label Period|Protocol Violation|2
7703669|NCT00433199|12124648|FG000|Open-Label Period|Administrative|0
7703670|NCT00433199|12124649|FG001|Open-Label Period|Administrative|1
7703671|NCT00433290|12124662|FG000|Overall Study|Adverse Event|24
7703672|NCT00433290|12124663|FG001|Overall Study|Adverse Event|7
7703673|NCT00433290|12124662|FG000|Overall Study|Lack of Efficacy|1
7703674|NCT00433290|12124663|FG001|Overall Study|Lack of Efficacy|5
7703675|NCT00433290|12124662|FG000|Overall Study|Withdrawal by Subject|4
7703676|NCT00433290|12124663|FG001|Overall Study|Withdrawal by Subject|2
7703677|NCT00433290|12124662|FG000|Overall Study|Protocol Violation|3
7703678|NCT00433290|12124663|FG001|Overall Study|Protocol Violation|2
7703679|NCT00433290|12124662|FG000|Overall Study|Physician Decision|2
7703680|NCT00433290|12124663|FG001|Overall Study|Physician Decision|0
7703681|NCT00433290|12124662|FG000|Overall Study|Entry Criteria Not Met|0
7703682|NCT00433290|12124663|FG001|Overall Study|Entry Criteria Not Met|1
7703683|NCT00433290|12124662|FG000|Overall Study|Lost to Follow-up|1
7703684|NCT00433290|12124663|FG001|Overall Study|Lost to Follow-up|0
7703685|NCT00433329|12124669|FG000|Overall Study|Adverse Event|9
7703686|NCT00433329|12124669|FG000|Overall Study|Death|4
7703687|NCT00433329|12124669|FG000|Overall Study|Withdrew consent|3
7703688|NCT00433329|12124669|FG000|Overall Study|Discontinued sildenafil|2
7703689|NCT00433329|12124669|FG000|Overall Study|Moved out of state|1
7703690|NCT00433329|12124669|FG000|Overall Study|Lost to Follow-up|1
7703691|NCT00433329|12124669|FG000|Overall Study|Physician Decision|1
7703692|NCT00433381|12124675|FG000|Overall Study|Ineligible / no protocol treatment|3
7703693|NCT00433381|12124676|FG001|Overall Study|Ineligible / no protocol treatment|3
7703694|NCT00433446|12124690|FG000|Overall Study|Adverse Event|4
7703695|NCT00433446|12124690|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
7703696|NCT00433446|12124690|FG000|Overall Study|Progression|44
7703697|NCT00433446|12124690|FG000|Overall Study|Other - Not Protocol specified|3
7703698|NCT00433446|12124690|FG000|Overall Study|Ineligible|9
7703699|NCT00433537|12124694|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
7703700|NCT00433537|12124695|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
7703701|NCT00433537|12124696|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
7703702|NCT00433537|12124694|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
7703703|NCT00433537|12124695|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
7703704|NCT00433537|12124696|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
7703705|NCT00433537|12124694|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0
7703706|NCT00433537|12124695|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0
7703707|NCT00433537|12124696|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4
7703708|NCT00433537|12124694|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
7703709|NCT00433537|12124695|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
7703710|NCT00433537|12124696|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
7703711|NCT00433537|12124694|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
7703712|NCT00433537|12124695|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
7703713|NCT00433537|12124696|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
7703714|NCT00433537|12124694|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
7703715|NCT00433537|12124695|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
7703716|NCT00433537|12124696|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
7703717|NCT00433537|12124694|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
7703718|NCT00433537|12124695|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
7703719|NCT00433537|12124696|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
7703720|NCT00433537|12124694|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
7703721|NCT00433537|12124695|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
7703722|NCT00433537|12124696|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
7703723|NCT00433537|12124694|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1
7703724|NCT00433537|12124695|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0
7703725|NCT00433537|12124696|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0
7703726|NCT00433654|12124718|FG000|Overall Study|Death|4
7703727|NCT00433654|12124719|FG001|Overall Study|Death|0
7703728|NCT00433654|12124718|FG000|Overall Study|Missed visit|6
7703729|NCT00433654|12124719|FG001|Overall Study|Missed visit|3
7703730|NCT00433654|12124718|FG000|Overall Study|Subject not yet due for visit|4
7703731|NCT00433654|12124719|FG001|Overall Study|Subject not yet due for visit|0
7703732|NCT00433654|12124718|FG000|Overall Study|Withdrawal by Subject|1
7703733|NCT00433654|12124719|FG001|Overall Study|Withdrawal by Subject|2
7703734|NCT00433771|12124736|FG000|Overall Study|screen fail|14
7703735|NCT00433771|12124736|FG000|Overall Study|Treated and later found to be ineligible|2
7703736|NCT00433771|12124736|FG000|Overall Study|Death|2
7703737|NCT00433771|12124736|FG000|Overall Study|Failure to deploy stent|1
7703738|NCT00433836|12124742|FG000|Overall Study|Adverse Event|7
7703739|NCT00433836|12124743|FG001|Overall Study|Adverse Event|0
7703740|NCT00433836|12124742|FG000|Overall Study|Lost to Follow-up|3
7703741|NCT00433836|12124743|FG001|Overall Study|Lost to Follow-up|0
7703742|NCT00433836|12124742|FG000|Overall Study|Withdrawal by Subject|2
7703743|NCT00433836|12124743|FG001|Overall Study|Withdrawal by Subject|1
7703744|NCT00433836|12124742|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7703745|NCT00433836|12124743|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7703746|NCT00433836|12124742|FG000|Overall Study|Protocol Violation|0
7703747|NCT00433836|12124743|FG001|Overall Study|Protocol Violation|2
7703748|NCT00433836|12124742|FG000|Overall Study|Condition no longer requires study drug|0
7703749|NCT00433836|12124743|FG001|Overall Study|Condition no longer requires study drug|1
7703750|NCT00433836|12124742|FG000|Overall Study|Abnormal laboratory values|0
7703751|NCT00433836|12124743|FG001|Overall Study|Abnormal laboratory values|1
7703752|NCT00433914|12124751|FG000|Overall Study|Withdrawal by Subject|0
7703753|NCT00433914|12124752|FG001|Overall Study|Withdrawal by Subject|2
7703754|NCT00433914|12124751|FG000|Overall Study|Lost to Follow-up|0
7703755|NCT00433914|12124752|FG001|Overall Study|Lost to Follow-up|1
7703756|NCT00433966|12124760|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
7703757|NCT00433966|12124761|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
7703758|NCT00433966|12124762|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
7703759|NCT00433966|12124763|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
7703760|NCT00433966|12124760|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97
7703761|NCT00433966|12124761|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103
7703762|NCT00433966|12124762|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0
7703763|NCT00433966|12124763|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0
7703764|NCT00433966|12124760|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
7703765|NCT00433966|12124761|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
7703766|NCT00433966|12124762|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
7703767|NCT00433966|12124763|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
7703768|NCT00433966|12124760|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0
7703769|NCT00433966|12124761|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0
7703770|NCT00433966|12124762|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41
7703771|NCT00433966|12124763|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15
7703772|NCT00433966|12124760|FG000|Stent Intervention/Randomization|Lost to Follow-up|0
7703773|NCT00433966|12124761|FG001|Stent Intervention/Randomization|Lost to Follow-up|0
7703774|NCT00433966|12124762|FG002|Stent Intervention/Randomization|Lost to Follow-up|113
7703775|NCT00433966|12124763|FG003|Stent Intervention/Randomization|Lost to Follow-up|47
7703776|NCT00434057|12124796|FG000|Overall Study|Withdrawal by Subject|1
7703777|NCT00434109|12124800|FG000|Overall Study|Physician Decision|9
7703778|NCT00434109|12124800|FG000|Overall Study|Adverse Event|5
7703779|NCT00434109|12124800|FG000|Overall Study|Protocol Violation|1
7703780|NCT00434109|12124800|FG000|Overall Study|had embolism, did not receive sunitinib|3
7703781|NCT00434122|12124806|FG000|Overall Study|Non-compliance with protocol|0
7703782|NCT00434122|12124807|FG001|Overall Study|Non-compliance with protocol|1
7703783|NCT00434122|12124806|FG000|Overall Study|loss of subject contact|1
7703784|NCT00434122|12124807|FG001|Overall Study|loss of subject contact|1
7703785|NCT00434122|12124806|FG000|Overall Study|Personal reasons|1
7703786|NCT00434122|12124807|FG001|Overall Study|Personal reasons|1
7703787|NCT00434122|12124806|FG000|Overall Study|Large follicle size|2
7703788|NCT00434122|12124807|FG001|Overall Study|Large follicle size|2
7703789|NCT00434122|12124806|FG000|Overall Study|Low follicular response.|1
7703790|NCT00434122|12124807|FG001|Overall Study|Low follicular response.|2
7703791|NCT00434122|12124806|FG000|Overall Study|Travelling of subject.|1
7703792|NCT00434122|12124807|FG001|Overall Study|Travelling of subject.|0
7703793|NCT00434148|12124817|FG000|Overall Study|Adverse Event|18
7703794|NCT00434148|12124818|FG001|Overall Study|Adverse Event|18
7703795|NCT00434148|12124817|FG000|Overall Study|Lack of Efficacy|25
7703796|NCT00434148|12124818|FG001|Overall Study|Lack of Efficacy|28
7703797|NCT00434148|12124817|FG000|Overall Study|Withdrawal by Subject|15
7703798|NCT00434148|12124818|FG001|Overall Study|Withdrawal by Subject|15
7703799|NCT00434148|12124817|FG000|Overall Study|Protocol Violation|4
7703800|NCT00434148|12124818|FG001|Overall Study|Protocol Violation|0
7703801|NCT00434148|12124817|FG000|Overall Study|Administrative problems|6
7703802|NCT00434148|12124818|FG001|Overall Study|Administrative problems|10
7703803|NCT00434148|12124817|FG000|Overall Study|Lost to Follow-up|0
7703804|NCT00434148|12124818|FG001|Overall Study|Lost to Follow-up|1
7703805|NCT00434148|12124817|FG000|Overall Study|Condition no longer requires study drug|1
7703806|NCT00434148|12124818|FG001|Overall Study|Condition no longer requires study drug|0
7703807|NCT00434148|12124817|FG000|Overall Study|Abnormal test procedure result|0
7703808|NCT00434148|12124818|FG001|Overall Study|Abnormal test procedure result|1
7703809|NCT00434161|12124827|FG000|Overall Study|Adverse Event|5
7703810|NCT00434161|12124828|FG001|Overall Study|Adverse Event|1
7703811|NCT00434161|12124829|FG002|Overall Study|Adverse Event|4
7703812|NCT00434161|12124827|FG000|Overall Study|Lost to Follow-up|0
7703813|NCT00434161|12124828|FG001|Overall Study|Lost to Follow-up|1
7703814|NCT00434161|12124829|FG002|Overall Study|Lost to Follow-up|0
7703815|NCT00434161|12124827|FG000|Overall Study|Death|1
7703816|NCT00434161|12124828|FG001|Overall Study|Death|0
7703817|NCT00434161|12124829|FG002|Overall Study|Death|1
7703818|NCT00434161|12124827|FG000|Overall Study|Non-Compliance|1
7703819|NCT00434161|12124828|FG001|Overall Study|Non-Compliance|1
7703820|NCT00434161|12124829|FG002|Overall Study|Non-Compliance|0
7703821|NCT00434161|12124827|FG000|Overall Study|Withdrawal by Subject|2
7703822|NCT00434161|12124828|FG001|Overall Study|Withdrawal by Subject|0
7703823|NCT00434161|12124829|FG002|Overall Study|Withdrawal by Subject|3
7703824|NCT00434161|12124827|FG000|Overall Study|Logistical error study assessments|1
7703825|NCT00434161|12124828|FG001|Overall Study|Logistical error study assessments|0
7703826|NCT00434161|12124829|FG002|Overall Study|Logistical error study assessments|3
7703827|NCT00434213|12124844|FG000|Overall Study|Adverse Event|12
7703828|NCT00434213|12124844|FG000|Overall Study|Lack of Efficacy|9
7703829|NCT00434213|12124844|FG000|Overall Study|Lost to Follow-up|14
7703830|NCT00434213|12124844|FG000|Overall Study|Withdrawal by Subject|7
7703831|NCT00434213|12124844|FG000|Overall Study|Protocol Violation|3
7703832|NCT00434213|12124844|FG000|Overall Study|Unable to comply with study visit window|2
7703833|NCT00434213|12124844|FG000|Overall Study|Application site reaction|1
7703834|NCT00434213|12124844|FG000|Overall Study|Non-compliant to study schedule|1
7703835|NCT00434252|12124850|FG000|Overall Study|Lack of Efficacy|50
7703836|NCT00434252|12124851|FG001|Overall Study|Lack of Efficacy|100
7703837|NCT00434252|12124850|FG000|Overall Study|Adverse Event|6
7703838|NCT00434252|12124851|FG001|Overall Study|Adverse Event|13
7703839|NCT00434252|12124850|FG000|Overall Study|Death|1
7703840|NCT00434252|12124851|FG001|Overall Study|Death|2
7703841|NCT00434252|12124850|FG000|Overall Study|Lost to Follow-up|0
7703842|NCT00434252|12124851|FG001|Overall Study|Lost to Follow-up|1
7703843|NCT00434252|12124850|FG000|Overall Study|Physician Decision|4
7703844|NCT00434252|12124851|FG001|Overall Study|Physician Decision|8
7703845|NCT00434252|12124850|FG000|Overall Study|Withdrawal by Subject|3
7703846|NCT00434252|12124851|FG001|Overall Study|Withdrawal by Subject|7
7703847|NCT00434304|12124866|FG000|Overall Study|Adverse Event|14
7703848|NCT00434304|12124866|FG000|Overall Study|Lack of Efficacy|2
7703849|NCT00434304|12124866|FG000|Overall Study|Withdrawal by Subject|4
7703850|NCT00434330|12124877|FG000|Overall Study|Adverse Event|0
7703851|NCT00434330|12124878|FG001|Overall Study|Adverse Event|0
7703852|NCT00434330|12124879|FG002|Overall Study|Adverse Event|1
7703853|NCT00434330|12124880|FG003|Overall Study|Adverse Event|0
7703854|NCT00434330|12124881|FG004|Overall Study|Adverse Event|0
7703855|NCT00434330|12124882|FG005|Overall Study|Adverse Event|0
7703856|NCT00434330|12124877|FG000|Overall Study|Death|1
7703857|NCT00434330|12124878|FG001|Overall Study|Death|0
7703858|NCT00434330|12124879|FG002|Overall Study|Death|0
7703859|NCT00434330|12124880|FG003|Overall Study|Death|0
7703860|NCT00434330|12124881|FG004|Overall Study|Death|1
7703861|NCT00434330|12124882|FG005|Overall Study|Death|1
7703862|NCT00434330|12124877|FG000|Overall Study|Withdrawal by Subject|0
7703863|NCT00434330|12124878|FG001|Overall Study|Withdrawal by Subject|0
7703864|NCT00434330|12124879|FG002|Overall Study|Withdrawal by Subject|1
7703865|NCT00434330|12124880|FG003|Overall Study|Withdrawal by Subject|1
7703866|NCT00434330|12124881|FG004|Overall Study|Withdrawal by Subject|0
7703867|NCT00434330|12124882|FG005|Overall Study|Withdrawal by Subject|0
7703868|NCT00434330|12124877|FG000|Overall Study|Renal transplant|0
7703869|NCT00434330|12124878|FG001|Overall Study|Renal transplant|0
7703870|NCT00434330|12124879|FG002|Overall Study|Renal transplant|0
7703871|NCT00434330|12124880|FG003|Overall Study|Renal transplant|1
7703872|NCT00434330|12124881|FG004|Overall Study|Renal transplant|0
7703873|NCT00434330|12124882|FG005|Overall Study|Renal transplant|0
7703874|NCT00434330|12124877|FG000|Overall Study|Subject Not Compliant With Study|0
7703875|NCT00434330|12124878|FG001|Overall Study|Subject Not Compliant With Study|0
7703876|NCT00434330|12124879|FG002|Overall Study|Subject Not Compliant With Study|1
7703877|NCT00434330|12124880|FG003|Overall Study|Subject Not Compliant With Study|0
7703878|NCT00434330|12124881|FG004|Overall Study|Subject Not Compliant With Study|0
7703879|NCT00434330|12124882|FG005|Overall Study|Subject Not Compliant With Study|0
7703880|NCT00434421|12124905|FG000|Overall Study|Withdrawal by Subject|1
7703881|NCT00434421|12124905|FG000|Overall Study|Non-compliance with study treatment|1
7703882|NCT00434512|12124928|FG000|Overall Study|Migrated/moved from study area|0
7703883|NCT00434512|12124929|FG001|Overall Study|Migrated/moved from study area|0
7703884|NCT00434512|12124930|FG002|Overall Study|Migrated/moved from study area|0
7703885|NCT00434512|12124931|FG003|Overall Study|Migrated/moved from study area|1
7703886|NCT00434512|12124932|FG004|Overall Study|Migrated/moved from study area|1
7703887|NCT00434512|12124933|FG005|Overall Study|Migrated/moved from study area|1
7703888|NCT00434512|12124928|FG000|Overall Study|Other|0
7703889|NCT00434512|12124929|FG001|Overall Study|Other|1
7703890|NCT00434512|12124930|FG002|Overall Study|Other|0
7703891|NCT00434512|12124931|FG003|Overall Study|Other|0
7703892|NCT00434512|12124932|FG004|Overall Study|Other|0
7703893|NCT00434512|12124933|FG005|Overall Study|Other|0
7703894|NCT00434577|12124956|FG000|Months 0-3|Serious Adverse Event|0
7703895|NCT00434577|12124957|FG001|Months 0-3|Serious Adverse Event|0
7703896|NCT00434577|12124958|FG002|Months 0-3|Serious Adverse Event|1
7703897|NCT00434577|12124959|FG003|Months 0-3|Serious Adverse Event|0
7703898|NCT00434577|12124960|FG004|Months 0-3|Serious Adverse Event|0
7703899|NCT00434577|12124956|FG000|Months 0-3|Adverse Event|0
7703900|NCT00434577|12124957|FG001|Months 0-3|Adverse Event|1
7703901|NCT00434577|12124958|FG002|Months 0-3|Adverse Event|1
7703902|NCT00434577|12124959|FG003|Months 0-3|Adverse Event|0
7703903|NCT00434577|12124960|FG004|Months 0-3|Adverse Event|0
7703904|NCT00434577|12124956|FG000|Months 0-3|Lost to Follow-up|0
7703905|NCT00434577|12124957|FG001|Months 0-3|Lost to Follow-up|0
7703906|NCT00434577|12124958|FG002|Months 0-3|Lost to Follow-up|0
7703907|NCT00434577|12124959|FG003|Months 0-3|Lost to Follow-up|0
7703908|NCT00434577|12124960|FG004|Months 0-3|Lost to Follow-up|2
7703909|NCT00434577|12124956|FG000|Months 0-3|Protocol Violation|1
7703910|NCT00434577|12124957|FG001|Months 0-3|Protocol Violation|0
7703911|NCT00434577|12124958|FG002|Months 0-3|Protocol Violation|1
7703912|NCT00434577|12124959|FG003|Months 0-3|Protocol Violation|0
7703913|NCT00434577|12124960|FG004|Months 0-3|Protocol Violation|0
7703914|NCT00434577|12124956|FG000|Months 0-3|Withdrawal by Subject|2
7703915|NCT00434577|12124957|FG001|Months 0-3|Withdrawal by Subject|1
7703916|NCT00434577|12124958|FG002|Months 0-3|Withdrawal by Subject|1
7703917|NCT00434577|12124959|FG003|Months 0-3|Withdrawal by Subject|1
7703918|NCT00434577|12124960|FG004|Months 0-3|Withdrawal by Subject|1
7703919|NCT00434642|12124974|FG000|Blinded Treatment Phase|Adverse Event|12
7703920|NCT00434642|12124975|FG001|Blinded Treatment Phase|Adverse Event|58
7703921|NCT00434642|12124974|FG000|Blinded Treatment Phase|Clinical Disease Progression|4
7703922|NCT00434642|12124975|FG001|Blinded Treatment Phase|Clinical Disease Progression|5
7703923|NCT00434642|12124974|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168
7703924|NCT00434642|12124975|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109
7703925|NCT00434642|12124974|FG000|Blinded Treatment Phase|Physician Decision|19
7703926|NCT00434642|12124975|FG001|Blinded Treatment Phase|Physician Decision|27
7703927|NCT00434642|12124974|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
7703928|NCT00434642|12124975|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
7703929|NCT00434642|12124974|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
7703930|NCT00434642|12124975|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
7703931|NCT00434642|12124974|FG000|Blinded Treatment Phase|Did not Receive Treatment|4
7703932|NCT00434642|12124975|FG001|Blinded Treatment Phase|Did not Receive Treatment|1
7703933|NCT00434642|12124974|FG000|Open-label Treatment Phase|Adverse Event|0
7703934|NCT00434642|12124975|FG001|Open-label Treatment Phase|Adverse Event|5
7703935|NCT00434642|12124974|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0
7703936|NCT00434642|12124975|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6
7703937|NCT00434759|12124983|FG000|Overall Study|Lack of Efficacy|5
7703938|NCT00434759|12124984|FG001|Overall Study|Lack of Efficacy|4
7703939|NCT00434759|12124983|FG000|Overall Study|Withdrawal by Subject|17
7703940|NCT00434759|12124984|FG001|Overall Study|Withdrawal by Subject|1
7703941|NCT00434759|12124983|FG000|Overall Study|family affairs|2
7703942|NCT00434759|12124984|FG001|Overall Study|family affairs|0
7703943|NCT00434876|12124994|FG000|Overall Study|Lost to Follow-up|1
7703944|NCT00434876|12124995|FG001|Overall Study|Lost to Follow-up|1
7703945|NCT00434954|12125003|FG000|Overall Study|Adverse Event|17
7703946|NCT00434954|12125004|FG001|Overall Study|Adverse Event|2
7703947|NCT00434954|12125003|FG000|Overall Study|Entry criteria not met|14
7703948|NCT00434954|12125004|FG001|Overall Study|Entry criteria not met|16
7703949|NCT00434954|12125003|FG000|Overall Study|Lost to Follow-up|0
7703950|NCT00434954|12125004|FG001|Overall Study|Lost to Follow-up|1
7703951|NCT00434954|12125003|FG000|Overall Study|Physician Decision|6
7703952|NCT00434954|12125004|FG001|Overall Study|Physician Decision|3
7703953|NCT00434954|12125003|FG000|Overall Study|Protocol Violation|36
7703954|NCT00434954|12125004|FG001|Overall Study|Protocol Violation|27
7703955|NCT00434954|12125003|FG000|Overall Study|Sponsor decision|1
7703956|NCT00434954|12125004|FG001|Overall Study|Sponsor decision|0
7703957|NCT00434954|12125003|FG000|Overall Study|Subject decision|8
7703958|NCT00434954|12125004|FG001|Overall Study|Subject decision|22
7703959|NCT00434967|12125014|FG000|Overall Study|Adverse Event|2
7703960|NCT00434967|12125015|FG001|Overall Study|Adverse Event|4
7703961|NCT00434967|12125016|FG002|Overall Study|Adverse Event|3
7703962|NCT00434967|12125017|FG003|Overall Study|Adverse Event|3
7703963|NCT00434967|12125014|FG000|Overall Study|Lost to Follow-up|0
7703964|NCT00434967|12125015|FG001|Overall Study|Lost to Follow-up|0
7703965|NCT00434967|12125016|FG002|Overall Study|Lost to Follow-up|1
7703966|NCT00434967|12125017|FG003|Overall Study|Lost to Follow-up|0
7703967|NCT00434967|12125014|FG000|Overall Study|Withdrawal by Subject|2
7703968|NCT00434967|12125015|FG001|Overall Study|Withdrawal by Subject|2
7703969|NCT00434967|12125016|FG002|Overall Study|Withdrawal by Subject|4
7703970|NCT00434967|12125017|FG003|Overall Study|Withdrawal by Subject|6
7703971|NCT00434967|12125014|FG000|Overall Study|Randomized in error|0
7703972|NCT00434967|12125015|FG001|Overall Study|Randomized in error|0
7703973|NCT00434967|12125016|FG002|Overall Study|Randomized in error|0
7703974|NCT00434967|12125017|FG003|Overall Study|Randomized in error|1
7703975|NCT00434967|12125014|FG000|Overall Study|Protocol Violation|0
7703976|NCT00434967|12125015|FG001|Overall Study|Protocol Violation|1
7703977|NCT00434967|12125016|FG002|Overall Study|Protocol Violation|0
7703978|NCT00434967|12125017|FG003|Overall Study|Protocol Violation|1
7703979|NCT00434967|12125014|FG000|Overall Study|Physician Decision|1
7703980|NCT00434967|12125015|FG001|Overall Study|Physician Decision|1
7703981|NCT00434967|12125016|FG002|Overall Study|Physician Decision|1
7703982|NCT00434967|12125017|FG003|Overall Study|Physician Decision|0
7703983|NCT00434967|12125014|FG000|Overall Study|Patient Disposition Challenges|2
7703984|NCT00434967|12125015|FG001|Overall Study|Patient Disposition Challenges|0
7703985|NCT00434967|12125016|FG002|Overall Study|Patient Disposition Challenges|0
7703986|NCT00434967|12125017|FG003|Overall Study|Patient Disposition Challenges|3
7703987|NCT00435019|12125038|FG000|Overall Study|Adverse Event|1
7703988|NCT00435019|12125039|FG001|Overall Study|Adverse Event|0
7703989|NCT00435019|12125038|FG000|Overall Study|Lack of Efficacy|1
7703990|NCT00435019|12125039|FG001|Overall Study|Lack of Efficacy|2
7703991|NCT00435019|12125038|FG000|Overall Study|Protocol Violation|3
7703992|NCT00435019|12125039|FG001|Overall Study|Protocol Violation|1
7703993|NCT00435019|12125038|FG000|Overall Study|Personal reasons for withdrawal|8
7703994|NCT00435019|12125039|FG001|Overall Study|Personal reasons for withdrawal|7
7703995|NCT00435045|12125047|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
7703996|NCT00435045|12125048|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
7703997|NCT00435045|12125047|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
7703998|NCT00435045|12125048|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
7703999|NCT00435045|12125047|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
7704000|NCT00435045|12125048|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
7704001|NCT00435045|12125047|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
7704002|NCT00435045|12125048|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
7704003|NCT00435045|12125047|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
7704004|NCT00435045|12125048|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
7704005|NCT00435045|12125047|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
7704006|NCT00435045|12125048|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
7704007|NCT00435045|12125047|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
7704008|NCT00435045|12125048|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
7704009|NCT00435045|12125047|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
7704010|NCT00435045|12125048|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
7704011|NCT00435045|12125047|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
7704012|NCT00435045|12125048|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
7704013|NCT00435045|12125047|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
7704014|NCT00435045|12125048|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
7704015|NCT00435045|12125047|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
7704016|NCT00435045|12125048|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
7704017|NCT00435162|12125057|FG000|Period 2 (2 Weeks)|Adverse Event|0
7704018|NCT00435162|12125058|FG001|Period 2 (2 Weeks)|Adverse Event|1
7704019|NCT00435162|12125059|FG002|Period 2 (2 Weeks)|Adverse Event|0
7704020|NCT00435162|12125060|FG003|Period 2 (2 Weeks)|Adverse Event|0
7704021|NCT00435162|12125061|FG004|Period 2 (2 Weeks)|Adverse Event|0
7704022|NCT00435162|12125062|FG005|Period 2 (2 Weeks)|Adverse Event|0
7704023|NCT00435188|12125077|FG000|Overall Study|Death|1
7704024|NCT00435188|12125078|FG001|Overall Study|Death|6
7704025|NCT00435188|12125077|FG000|Overall Study|Withdrawal by Subject|16
7704026|NCT00435188|12125078|FG001|Overall Study|Withdrawal by Subject|11
7704027|NCT00435188|12125077|FG000|Overall Study|Lost to Follow-up|5
7704028|NCT00435188|12125078|FG001|Overall Study|Lost to Follow-up|6
7704029|NCT00435370|12125088|FG000|Overall Study|Adverse Event|8
7704030|NCT00435370|12125089|FG001|Overall Study|Adverse Event|8
7704031|NCT00435370|12125088|FG000|Overall Study|Withdrawal by Subject|10
7704032|NCT00435370|12125089|FG001|Overall Study|Withdrawal by Subject|10
7704033|NCT00435370|12125088|FG000|Overall Study|Antipsychotic medication changed|4
7704034|NCT00435370|12125089|FG001|Overall Study|Antipsychotic medication changed|2
7704035|NCT00435409|12125097|FG000|Overall Study|Protocol Violation|1
7704036|NCT00435409|12125098|FG001|Overall Study|Protocol Violation|2
7704037|NCT00435409|12125099|FG002|Overall Study|Protocol Violation|0
7704038|NCT00435409|12125097|FG000|Overall Study|Lost to Follow-up|1
7704039|NCT00435409|12125098|FG001|Overall Study|Lost to Follow-up|2
7704040|NCT00435409|12125099|FG002|Overall Study|Lost to Follow-up|0
7704041|NCT00435409|12125097|FG000|Overall Study|Death|8
7704042|NCT00435409|12125098|FG001|Overall Study|Death|6
7704043|NCT00435409|12125099|FG002|Overall Study|Death|6
7704044|NCT00435409|12125097|FG000|Overall Study|Objective progression or relapse|158
7704045|NCT00435409|12125098|FG001|Overall Study|Objective progression or relapse|93
7704046|NCT00435409|12125099|FG002|Overall Study|Objective progression or relapse|58
7704047|NCT00435409|12125097|FG000|Overall Study|Global deterioration of health status|0
7704048|NCT00435409|12125098|FG001|Overall Study|Global deterioration of health status|0
7704049|NCT00435409|12125099|FG002|Overall Study|Global deterioration of health status|4
7704050|NCT00435409|12125097|FG000|Overall Study|Withdrawal by Subject|8
7704051|NCT00435409|12125098|FG001|Overall Study|Withdrawal by Subject|7
7704052|NCT00435409|12125099|FG002|Overall Study|Withdrawal by Subject|1
7704053|NCT00435409|12125097|FG000|Overall Study|Other|45
7704054|NCT00435409|12125098|FG001|Overall Study|Other|30
7704055|NCT00435409|12125099|FG002|Overall Study|Other|1
7704056|NCT00435409|12125097|FG000|Overall Study|Adverse Event|0
7704057|NCT00435409|12125098|FG001|Overall Study|Adverse Event|0
7704058|NCT00435409|12125099|FG002|Overall Study|Adverse Event|8
7704059|NCT00435409|12125097|FG000|Overall Study|Sponsor decision|0
7704060|NCT00435409|12125098|FG001|Overall Study|Sponsor decision|3
7704061|NCT00435409|12125099|FG002|Overall Study|Sponsor decision|0
7704062|NCT00435461|12125108|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1
7704063|NCT00435461|12125109|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0
7704064|NCT00435461|12125110|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0
7704065|NCT00435461|12125108|FG000|Overall Study|Protocol Violation|6
7704066|NCT00435461|12125109|FG001|Overall Study|Protocol Violation|9
7704067|NCT00435461|12125110|FG002|Overall Study|Protocol Violation|10
7704068|NCT00435461|12125108|FG000|Overall Study|Participant randomized(inadequate score)|1
7704069|NCT00435461|12125109|FG001|Overall Study|Participant randomized(inadequate score)|0
7704070|NCT00435461|12125110|FG002|Overall Study|Participant randomized(inadequate score)|0
7704071|NCT00435461|12125108|FG000|Overall Study|Compliance less than 80 percent|1
7704072|NCT00435461|12125109|FG001|Overall Study|Compliance less than 80 percent|0
7704073|NCT00435461|12125110|FG002|Overall Study|Compliance less than 80 percent|0
7704074|NCT00435461|12125108|FG000|Overall Study|In error, two study medications switched|1
7704075|NCT00435461|12125109|FG001|Overall Study|In error, two study medications switched|0
7704076|NCT00435461|12125110|FG002|Overall Study|In error, two study medications switched|0
7704077|NCT00435461|12125108|FG000|Overall Study|Lack of Efficacy|2
7704078|NCT00435461|12125109|FG001|Overall Study|Lack of Efficacy|1
7704079|NCT00435461|12125110|FG002|Overall Study|Lack of Efficacy|0
7704080|NCT00435461|12125108|FG000|Overall Study|Withdrawal by Subject|1
7704081|NCT00435461|12125109|FG001|Overall Study|Withdrawal by Subject|0
7704082|NCT00435461|12125110|FG002|Overall Study|Withdrawal by Subject|2
7704083|NCT00435461|12125108|FG000|Overall Study|Randomized in error|1
7704084|NCT00435461|12125109|FG001|Overall Study|Randomized in error|0
7704085|NCT00435461|12125110|FG002|Overall Study|Randomized in error|0
7704086|NCT00435461|12125108|FG000|Overall Study|Participant could not tolerate symptoms|0
7704087|NCT00435461|12125109|FG001|Overall Study|Participant could not tolerate symptoms|0
7704088|NCT00435461|12125110|FG002|Overall Study|Participant could not tolerate symptoms|1
7704089|NCT00435461|12125108|FG000|Overall Study|Participant could not swallow capsule|0
7704090|NCT00435461|12125109|FG001|Overall Study|Participant could not swallow capsule|0
7704091|NCT00435461|12125110|FG002|Overall Study|Participant could not swallow capsule|1
7704092|NCT00435461|12125108|FG000|Overall Study|Pregnancy|2
7704093|NCT00435461|12125109|FG001|Overall Study|Pregnancy|0
7704094|NCT00435461|12125110|FG002|Overall Study|Pregnancy|0
7704095|NCT00435461|12125108|FG000|Overall Study|Participant moved eDiary,studymedication|1
7704096|NCT00435461|12125109|FG001|Overall Study|Participant moved eDiary,studymedication|0
7704097|NCT00435461|12125110|FG002|Overall Study|Participant moved eDiary,studymedication|0
7704098|NCT00435461|12125108|FG000|Overall Study|Participant ended study one day early|1
7704099|NCT00435461|12125109|FG001|Overall Study|Participant ended study one day early|0
7704100|NCT00435461|12125110|FG002|Overall Study|Participant ended study one day early|0
7704101|NCT00435461|12125108|FG000|Overall Study|Noncompliance with study requirements|1
7704102|NCT00435461|12125109|FG001|Overall Study|Noncompliance with study requirements|1
7704103|NCT00435461|12125110|FG002|Overall Study|Noncompliance with study requirements|1
7704104|NCT00435461|12125108|FG000|Overall Study|Adverse Event|1
7704105|NCT00435461|12125109|FG001|Overall Study|Adverse Event|2
7704106|NCT00435461|12125110|FG002|Overall Study|Adverse Event|6
7704107|NCT00435461|12125108|FG000|Overall Study|Non-Compliance of diary|2
7704108|NCT00435461|12125109|FG001|Overall Study|Non-Compliance of diary|0
7704109|NCT00435461|12125110|FG002|Overall Study|Non-Compliance of diary|1
7704110|NCT00435461|12125108|FG000|Overall Study|Lost to Follow-up|1
7704111|NCT00435461|12125109|FG001|Overall Study|Lost to Follow-up|1
7704112|NCT00435461|12125110|FG002|Overall Study|Lost to Follow-up|2
7704113|NCT00435487|12125120|FG000|Overall Study|Death|3
7704114|NCT00435487|12125121|FG001|Overall Study|Death|4
7704115|NCT00435487|12125120|FG000|Overall Study|Adverse Event|0
7704116|NCT00435487|12125121|FG001|Overall Study|Adverse Event|3
7704117|NCT00435487|12125120|FG000|Overall Study|Lost to Follow-up|2
7704118|NCT00435487|12125121|FG001|Overall Study|Lost to Follow-up|2
7704119|NCT00435487|12125120|FG000|Overall Study|Other|5
7704120|NCT00435487|12125121|FG001|Overall Study|Other|2
7704121|NCT00435487|12125120|FG000|Overall Study|Withdrawal by Subject|2
7704122|NCT00435487|12125121|FG001|Overall Study|Withdrawal by Subject|1
7704123|NCT00435487|12125120|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0
7704124|NCT00435487|12125121|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2
7704125|NCT00435487|12125120|FG000|Overall Study|Received Drug in Other Treatment Group|0
7704126|NCT00435487|12125121|FG001|Overall Study|Received Drug in Other Treatment Group|1
7704127|NCT00435825|12125180|FG000|Overall Study|Abnormality of Laboratory Test|0
7704128|NCT00435825|12125181|FG001|Overall Study|Abnormality of Laboratory Test|1
7704129|NCT00435825|12125182|FG002|Overall Study|Abnormality of Laboratory Test|0
7704130|NCT00435825|12125183|FG003|Overall Study|Abnormality of Laboratory Test|0
7704131|NCT00435825|12125180|FG000|Overall Study|Insufficient Therapeutic Response|3
7704132|NCT00435825|12125181|FG001|Overall Study|Insufficient Therapeutic Response|1
7704133|NCT00435825|12125182|FG002|Overall Study|Insufficient Therapeutic Response|0
7704134|NCT00435825|12125183|FG003|Overall Study|Insufficient Therapeutic Response|3
7704135|NCT00435825|12125180|FG000|Overall Study|Other Protocol Violation|1
7704136|NCT00435825|12125181|FG001|Overall Study|Other Protocol Violation|0
7704137|NCT00435825|12125182|FG002|Overall Study|Other Protocol Violation|0
7704138|NCT00435825|12125183|FG003|Overall Study|Other Protocol Violation|0
7704139|NCT00435825|12125180|FG000|Overall Study|Refused treatment|2
7704140|NCT00435825|12125181|FG001|Overall Study|Refused treatment|0
7704141|NCT00435825|12125182|FG002|Overall Study|Refused treatment|0
7704142|NCT00435825|12125183|FG003|Overall Study|Refused treatment|5
7704143|NCT00435825|12125180|FG000|Overall Study|Failure to return|5
7704144|NCT00435825|12125181|FG001|Overall Study|Failure to return|0
7704145|NCT00435825|12125182|FG002|Overall Study|Failure to return|4
7704146|NCT00435825|12125183|FG003|Overall Study|Failure to return|0
7704147|NCT00435825|12125180|FG000|Overall Study|Did not receive study drug|1
7704148|NCT00435825|12125181|FG001|Overall Study|Did not receive study drug|0
7704149|NCT00435825|12125182|FG002|Overall Study|Did not receive study drug|2
7704150|NCT00435825|12125183|FG003|Overall Study|Did not receive study drug|0
7704151|NCT00435825|12125180|FG000|Overall Study|Did not enter follow-up|0
7704152|NCT00435825|12125181|FG001|Overall Study|Did not enter follow-up|4
7704153|NCT00435825|12125182|FG002|Overall Study|Did not enter follow-up|1
7704154|NCT00435825|12125183|FG003|Overall Study|Did not enter follow-up|3
7704155|NCT00435825|12125180|FG000|Overall Study|Did not complete full follow-up period|6
7704156|NCT00435825|12125181|FG001|Overall Study|Did not complete full follow-up period|6
7704157|NCT00435825|12125182|FG002|Overall Study|Did not complete full follow-up period|4
7704158|NCT00435825|12125183|FG003|Overall Study|Did not complete full follow-up period|5
7704159|NCT00435942|12125204|FG000|Overall Study|Death|17
7704160|NCT00435942|12125205|FG001|Overall Study|Death|10
7704161|NCT00435942|12125204|FG000|Overall Study|Withdrawal by Subject|2
7704162|NCT00435942|12125205|FG001|Overall Study|Withdrawal by Subject|0
7704163|NCT00435942|12125204|FG000|Overall Study|Lost to Follow-up|0
7704164|NCT00435942|12125205|FG001|Overall Study|Lost to Follow-up|16
7704165|NCT00435942|12125204|FG000|Overall Study|Conversion to Open Repair|1
7704166|NCT00435942|12125205|FG001|Overall Study|Conversion to Open Repair|0
7704167|NCT00435942|12125204|FG000|Overall Study|Technical Failure|3
7704168|NCT00435942|12125205|FG001|Overall Study|Technical Failure|0
7704169|NCT00435942|12125204|FG000|Overall Study|Other|0
7704170|NCT00435942|12125205|FG001|Overall Study|Other|1
7704171|NCT00435994|12125214|FG000|Overall Study|Lost to Follow-up|7
7704172|NCT00435994|12125215|FG001|Overall Study|Lost to Follow-up|0
7704173|NCT00435994|12125216|FG002|Overall Study|Lost to Follow-up|0
7704174|NCT00436007|12125228|FG000|Overall Study|Withdrawal by Subject|5
7704175|NCT00436007|12125229|FG001|Overall Study|Withdrawal by Subject|3
7704176|NCT00436007|12125230|FG002|Overall Study|Withdrawal by Subject|4
7704177|NCT00436007|12125228|FG000|Overall Study|Lost to Follow-up|14
7704178|NCT00436007|12125229|FG001|Overall Study|Lost to Follow-up|10
7704179|NCT00436007|12125230|FG002|Overall Study|Lost to Follow-up|13
7704180|NCT00436007|12125228|FG000|Overall Study|Physician Decision|0
7704181|NCT00436007|12125229|FG001|Overall Study|Physician Decision|0
7704182|NCT00436007|12125230|FG002|Overall Study|Physician Decision|2
7704183|NCT00436007|12125228|FG000|Overall Study|Death|0
7704184|NCT00436007|12125229|FG001|Overall Study|Death|1
7704185|NCT00436007|12125230|FG002|Overall Study|Death|3
7704186|NCT00436007|12125228|FG000|Overall Study|Other|0
7704187|NCT00436007|12125229|FG001|Overall Study|Other|0
7704188|NCT00436007|12125230|FG002|Overall Study|Other|1
7704189|NCT00436163|12125256|FG000|Overall Study|Lost to Follow-up|2
7704190|NCT00436163|12125256|FG000|Overall Study|Adverse Event|1
7704191|NCT00436215|12125261|FG000|Overall Study|Refused further treatment|3
7704192|NCT00436215|12125261|FG000|Overall Study|Small bowel obstruction|1
7704193|NCT00436280|12125265|FG000|Period 1: Induction|Adverse Event|8
7704194|NCT00436280|12125265|FG000|Period 1: Induction|Progressive Disease|12
7704195|NCT00436280|12125265|FG000|Period 1: Induction|Stable Disease|6
7704196|NCT00436280|12125265|FG000|Period 1: Induction|Withdrawal by Subject|1
7704197|NCT00436280|12125265|FG000|Period 1: Induction|Death|1
7704198|NCT00436280|12125265|FG000|Period 2: Consolidation|Adverse Event|1
7704199|NCT00436280|12125265|FG000|Period 2: Consolidation|Progressive Disease|10
7704200|NCT00436280|12125265|FG000|Period 2: Consolidation|Stable Disease|1
7704201|NCT00436280|12125265|FG000|Period 2: Consolidation|Physician Decision|2
7704202|NCT00436280|12125265|FG000|Period 2: Consolidation|Withdrawal by Subject|2
7704203|NCT00436280|12125265|FG000|Period 2: Consolidation|Death|1
7704204|NCT00436280|12125265|FG000|Period 3: Maintenance|Adverse Event|6
7704205|NCT00436280|12125265|FG000|Period 3: Maintenance|Progressive Disease|12
7704206|NCT00436332|12125269|FG000|Overall Study|Adverse Event|9
7704207|NCT00436332|12125269|FG000|Overall Study|Withdrawal by Subject|2
7704208|NCT00436332|12125269|FG000|Overall Study|Progression|59
7704209|NCT00436332|12125269|FG000|Overall Study|Death|2
7704210|NCT00436332|12125269|FG000|Overall Study|Not Protocol Specified|6
7704211|NCT00436332|12125269|FG000|Overall Study|Ineligible|2
7704212|NCT00436332|12125269|FG000|Overall Study|Never Received Treatment|3
7704213|NCT00436345|12125275|FG000|Overall Study|ICU resident beyond follow-up period|3
7704214|NCT00436345|12125276|FG001|Overall Study|ICU resident beyond follow-up period|0
7704215|NCT00436436|12125283|FG000|Overall Study|Progression|4
7704216|NCT00436436|12125283|FG000|Overall Study|Adverse Event|2
7704217|NCT00436436|12125283|FG000|Overall Study|Death|6
7704218|NCT00436501|12125306|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
7704304|NCT00437073|12125414|FG001|Overall Study|Physician Decision|1
7704219|NCT00436501|12125307|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
7704220|NCT00436501|12125306|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
7704221|NCT00436501|12125307|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
7704222|NCT00436553|12125317|FG000|Overall Study|Adverse Event|4
7704223|NCT00436553|12125318|FG001|Overall Study|Adverse Event|3
7704224|NCT00436553|12125319|FG002|Overall Study|Adverse Event|4
7704225|NCT00436553|12125317|FG000|Overall Study|Death|3
7704226|NCT00436553|12125318|FG001|Overall Study|Death|1
7704227|NCT00436553|12125319|FG002|Overall Study|Death|3
7704228|NCT00436553|12125317|FG000|Overall Study|Lost to Follow-up|0
7704229|NCT00436553|12125318|FG001|Overall Study|Lost to Follow-up|2
7704230|NCT00436553|12125319|FG002|Overall Study|Lost to Follow-up|0
7704231|NCT00436553|12125317|FG000|Overall Study|Protocol Violation|1
7704232|NCT00436553|12125318|FG001|Overall Study|Protocol Violation|0
7704233|NCT00436553|12125319|FG002|Overall Study|Protocol Violation|0
7704234|NCT00436553|12125317|FG000|Overall Study|Withdrawal by Subject|5
7704235|NCT00436553|12125318|FG001|Overall Study|Withdrawal by Subject|6
7704236|NCT00436553|12125319|FG002|Overall Study|Withdrawal by Subject|3
7704237|NCT00436605|12125327|FG000|Overall Study|Protocol Violation|3
7704238|NCT00436618|12125334|FG000|Overall Study|Withdrawal by Subject|5
7704239|NCT00436618|12125335|FG001|Overall Study|Withdrawal by Subject|8
7704240|NCT00436618|12125336|FG002|Overall Study|Withdrawal by Subject|11
7704241|NCT00436618|12125334|FG000|Overall Study|Adverse Event|8
7704242|NCT00436618|12125335|FG001|Overall Study|Adverse Event|8
7704243|NCT00436618|12125336|FG002|Overall Study|Adverse Event|9
7704244|NCT00436618|12125334|FG000|Overall Study|Alternate Treatment|3
7704245|NCT00436618|12125335|FG001|Overall Study|Alternate Treatment|4
7704246|NCT00436618|12125336|FG002|Overall Study|Alternate Treatment|12
7704247|NCT00436618|12125334|FG000|Overall Study|Other Medical Problems|3
7704248|NCT00436618|12125335|FG001|Overall Study|Other Medical Problems|1
7704249|NCT00436618|12125336|FG002|Overall Study|Other Medical Problems|7
7704250|NCT00436618|12125334|FG000|Overall Study|Death|4
7704251|NCT00436618|12125335|FG001|Overall Study|Death|2
7704252|NCT00436618|12125336|FG002|Overall Study|Death|3
7704253|NCT00436618|12125334|FG000|Overall Study|New Primary or Other Reasons|6
7704254|NCT00436618|12125335|FG001|Overall Study|New Primary or Other Reasons|2
7704255|NCT00436618|12125336|FG002|Overall Study|New Primary or Other Reasons|12
7704256|NCT00436618|12125334|FG000|Overall Study|Still on treatment|1
7704257|NCT00436618|12125335|FG001|Overall Study|Still on treatment|2
7704258|NCT00436618|12125336|FG002|Overall Study|Still on treatment|7
7704259|NCT00436644|12125344|FG000|Overall Study|Adverse Event|2
7704260|NCT00436644|12125344|FG000|Overall Study|Death|1
7704261|NCT00436748|12125350|FG000|Overall Study|Ineligibility Determined|1
7704262|NCT00436748|12125351|FG001|Overall Study|Ineligibility Determined|1
7704263|NCT00436748|12125350|FG000|Overall Study|Adverse Event|0
7704264|NCT00436748|12125351|FG001|Overall Study|Adverse Event|2
7704265|NCT00436748|12125350|FG000|Overall Study|Consent Withdrawn|1
7704266|NCT00436748|12125351|FG001|Overall Study|Consent Withdrawn|4
7704267|NCT00436748|12125350|FG000|Overall Study|Administrative Decision|1
7704268|NCT00436748|12125351|FG001|Overall Study|Administrative Decision|0
7704269|NCT00436748|12125350|FG000|Overall Study|Lost to Follow-up|0
7704270|NCT00436748|12125351|FG001|Overall Study|Lost to Follow-up|1
7704271|NCT00436748|12125350|FG000|Overall Study|Protocol-specified Criteria|5
7704272|NCT00436748|12125351|FG001|Overall Study|Protocol-specified Criteria|4
7704273|NCT00436748|12125350|FG000|Overall Study|Other|3
7704274|NCT00436748|12125351|FG001|Overall Study|Other|0
7704275|NCT00436852|12125359|FG000|Overall Study|Death|23
7704276|NCT00436852|12125360|FG001|Overall Study|Death|34
7704277|NCT00436852|12125359|FG000|Overall Study|Lack of Efficacy|9
7704278|NCT00436852|12125360|FG001|Overall Study|Lack of Efficacy|7
7704279|NCT00436852|12125359|FG000|Overall Study|Withdrawal by Subject|2
7704280|NCT00436852|12125360|FG001|Overall Study|Withdrawal by Subject|4
7704281|NCT00436852|12125359|FG000|Overall Study|Ineligible|1
7704282|NCT00436852|12125360|FG001|Overall Study|Ineligible|0
7704283|NCT00436917|12125373|FG000|Overall Study|Withdrawal by Subject|13
7704284|NCT00436917|12125373|FG000|Overall Study|Adverse Event|2
7704285|NCT00436917|12125373|FG000|Overall Study|Physician Decision|1
7704286|NCT00436917|12125373|FG000|Overall Study|Death|1
7704287|NCT00436917|12125373|FG000|Overall Study|Lost to Follow-up|1
7704288|NCT00436917|12125373|FG000|Overall Study|Treatment for polymyalgia rheumatic|1
7704289|NCT00436917|12125373|FG000|Overall Study|Increased creatinine|1
7704290|NCT00436917|12125373|FG000|Overall Study|Personal conflicts of patient|1
7704291|NCT00436956|12125377|FG000|Overall Study|Not evaluable|1
7704292|NCT00436956|12125378|FG001|Overall Study|Not evaluable|0
7704293|NCT00436982|12125396|FG000|Overall Study|Withdrawal by Subject|3
7704294|NCT00436982|12125397|FG001|Overall Study|Withdrawal by Subject|1
7704295|NCT00436982|12125396|FG000|Overall Study|Did not receive allocated intervention|0
7704296|NCT00436982|12125397|FG001|Overall Study|Did not receive allocated intervention|1
7704297|NCT00436982|12125396|FG000|Overall Study|no RSA data|1
7704298|NCT00436982|12125397|FG001|Overall Study|no RSA data|2
7704299|NCT00437034|12125407|FG000|Overall Study|Adverse Event|1
7704300|NCT00437034|12125407|FG000|Overall Study|Disease progression during treatment|5
7704301|NCT00437073|12125413|FG000|Overall Study|Sponsor Terminated Study|1
7704302|NCT00437073|12125414|FG001|Overall Study|Sponsor Terminated Study|0
7704303|NCT00437073|12125413|FG000|Overall Study|Physician Decision|0
7704305|NCT00437125|12125420|FG000|Overall Study|Adverse Event|12
7704306|NCT00437125|12125420|FG000|Overall Study|Death|1
7704307|NCT00437125|12125420|FG000|Overall Study|Clinical Relapse|1
7704308|NCT00437125|12125420|FG000|Overall Study|Lack of Efficacy|1
7704309|NCT00437125|12125420|FG000|Overall Study|Lost to Follow-up|1
7704310|NCT00437125|12125420|FG000|Overall Study|Withdrawal by Subject|13
7704311|NCT00437125|12125420|FG000|Overall Study|Withdrawal by Caregiver|2
7704312|NCT00437125|12125420|FG000|Overall Study|Physician Decision|1
7704313|NCT00437203|12125434|FG000|Overall Study|Death|0
7704314|NCT00437203|12125435|FG001|Overall Study|Death|0
7704315|NCT00437203|12125436|FG002|Overall Study|Death|1
7704316|NCT00437203|12125437|FG003|Overall Study|Death|0
7704317|NCT00437203|12125438|FG004|Overall Study|Death|0
7704318|NCT00437203|12125439|FG005|Overall Study|Death|0
7704319|NCT00437203|12125440|FG006|Overall Study|Death|0
7704320|NCT00437203|12125441|FG007|Overall Study|Death|1
7704321|NCT00437203|12125442|FG008|Overall Study|Death|0
7704322|NCT00437203|12125443|FG009|Overall Study|Death|1
7704323|NCT00437203|12125434|FG000|Overall Study|Adverse Event|1
7704324|NCT00437203|12125435|FG001|Overall Study|Adverse Event|1
7704325|NCT00437203|12125436|FG002|Overall Study|Adverse Event|0
7704326|NCT00437203|12125437|FG003|Overall Study|Adverse Event|0
7704327|NCT00437203|12125438|FG004|Overall Study|Adverse Event|0
7704328|NCT00437203|12125439|FG005|Overall Study|Adverse Event|0
7704329|NCT00437203|12125440|FG006|Overall Study|Adverse Event|0
7704330|NCT00437203|12125441|FG007|Overall Study|Adverse Event|1
7704331|NCT00437203|12125442|FG008|Overall Study|Adverse Event|0
7704332|NCT00437203|12125443|FG009|Overall Study|Adverse Event|1
7704333|NCT00437203|12125434|FG000|Overall Study|Study terminated by sponsor|0
7704334|NCT00437203|12125435|FG001|Overall Study|Study terminated by sponsor|0
7704335|NCT00437203|12125436|FG002|Overall Study|Study terminated by sponsor|0
7704336|NCT00437203|12125437|FG003|Overall Study|Study terminated by sponsor|0
7704337|NCT00437203|12125438|FG004|Overall Study|Study terminated by sponsor|0
7704338|NCT00437203|12125439|FG005|Overall Study|Study terminated by sponsor|0
7704339|NCT00437203|12125440|FG006|Overall Study|Study terminated by sponsor|0
7704340|NCT00437203|12125441|FG007|Overall Study|Study terminated by sponsor|0
7704341|NCT00437203|12125442|FG008|Overall Study|Study terminated by sponsor|1
7704342|NCT00437203|12125443|FG009|Overall Study|Study terminated by sponsor|0
7704343|NCT00437203|12125434|FG000|Overall Study|Objective progression or relapse|5
7704344|NCT00437203|12125435|FG001|Overall Study|Objective progression or relapse|6
7704345|NCT00437203|12125436|FG002|Overall Study|Objective progression or relapse|2
7704346|NCT00437203|12125437|FG003|Overall Study|Objective progression or relapse|3
7704347|NCT00437203|12125438|FG004|Overall Study|Objective progression or relapse|3
7704348|NCT00437203|12125439|FG005|Overall Study|Objective progression or relapse|3
7704349|NCT00437203|12125440|FG006|Overall Study|Objective progression or relapse|6
7704350|NCT00437203|12125441|FG007|Overall Study|Objective progression or relapse|1
7704351|NCT00437203|12125442|FG008|Overall Study|Objective progression or relapse|2
7704352|NCT00437203|12125443|FG009|Overall Study|Objective progression or relapse|2
7704353|NCT00437203|12125434|FG000|Overall Study|Other|0
7704354|NCT00437203|12125435|FG001|Overall Study|Other|1
7704355|NCT00437203|12125436|FG002|Overall Study|Other|0
7704356|NCT00437203|12125437|FG003|Overall Study|Other|0
7704357|NCT00437203|12125438|FG004|Overall Study|Other|0
7704358|NCT00437203|12125439|FG005|Overall Study|Other|0
7704359|NCT00437203|12125440|FG006|Overall Study|Other|1
7704360|NCT00437203|12125441|FG007|Overall Study|Other|0
7704361|NCT00437203|12125442|FG008|Overall Study|Other|0
7704362|NCT00437203|12125443|FG009|Overall Study|Other|0
7704363|NCT00437268|12125476|FG000|Overall Study|Adverse Event|1
7704364|NCT00437268|12125477|FG001|Overall Study|Adverse Event|1
7704365|NCT00437268|12125476|FG000|Overall Study|Withdrawal by Subject|2
7704366|NCT00437268|12125477|FG001|Overall Study|Withdrawal by Subject|2
7704367|NCT00437268|12125476|FG000|Overall Study|Progressive disease|9
7704368|NCT00437268|12125477|FG001|Overall Study|Progressive disease|9
7704369|NCT00437268|12125476|FG000|Overall Study|Physician Decision|1
7704370|NCT00437268|12125477|FG001|Overall Study|Physician Decision|0
7704371|NCT00437268|12125476|FG000|Overall Study|Death|0
7704372|NCT00437268|12125477|FG001|Overall Study|Death|1
7704373|NCT00437281|12125505|FG000|Overall Study|Adverse Event|0
7704374|NCT00437281|12125506|FG001|Overall Study|Adverse Event|0
7704375|NCT00437281|12125507|FG002|Overall Study|Adverse Event|0
7704376|NCT00437281|12125508|FG003|Overall Study|Adverse Event|1
7704377|NCT00437281|12125509|FG004|Overall Study|Adverse Event|0
7704378|NCT00437281|12125510|FG005|Overall Study|Adverse Event|1
7704379|NCT00437281|12125511|FG006|Overall Study|Adverse Event|0
7704380|NCT00437281|12125512|FG007|Overall Study|Adverse Event|0
7704381|NCT00437281|12125513|FG008|Overall Study|Adverse Event|0
7704382|NCT00437281|12125514|FG009|Overall Study|Adverse Event|1
7704383|NCT00437281|12125515|FG010|Overall Study|Adverse Event|0
7704384|NCT00437281|12125516|FG011|Overall Study|Adverse Event|0
7704385|NCT00437281|12125517|FG012|Overall Study|Adverse Event|0
7704386|NCT00437281|12125518|FG013|Overall Study|Adverse Event|1
7704387|NCT00437281|12125519|FG014|Overall Study|Adverse Event|1
7704388|NCT00437281|12125520|FG015|Overall Study|Adverse Event|0
7704389|NCT00437281|12125521|FG016|Overall Study|Adverse Event|0
7704390|NCT00437281|12125522|FG017|Overall Study|Adverse Event|0
7704391|NCT00437281|12125523|FG018|Overall Study|Adverse Event|1
7704392|NCT00437281|12125524|FG019|Overall Study|Adverse Event|0
7704393|NCT00437281|12125505|FG000|Overall Study|Lost to Follow-up|0
7704394|NCT00437281|12125506|FG001|Overall Study|Lost to Follow-up|0
7704395|NCT00437281|12125507|FG002|Overall Study|Lost to Follow-up|0
7704396|NCT00437281|12125508|FG003|Overall Study|Lost to Follow-up|0
7704397|NCT00437281|12125509|FG004|Overall Study|Lost to Follow-up|0
7704398|NCT00437281|12125510|FG005|Overall Study|Lost to Follow-up|0
7704399|NCT00437281|12125511|FG006|Overall Study|Lost to Follow-up|0
7704400|NCT00437281|12125512|FG007|Overall Study|Lost to Follow-up|0
7704401|NCT00437281|12125513|FG008|Overall Study|Lost to Follow-up|0
7704402|NCT00437281|12125514|FG009|Overall Study|Lost to Follow-up|0
7704403|NCT00437281|12125515|FG010|Overall Study|Lost to Follow-up|0
7704404|NCT00437281|12125516|FG011|Overall Study|Lost to Follow-up|0
7704405|NCT00437281|12125517|FG012|Overall Study|Lost to Follow-up|0
7704406|NCT00437281|12125518|FG013|Overall Study|Lost to Follow-up|0
7704407|NCT00437281|12125519|FG014|Overall Study|Lost to Follow-up|0
7704408|NCT00437281|12125520|FG015|Overall Study|Lost to Follow-up|0
7704409|NCT00437281|12125521|FG016|Overall Study|Lost to Follow-up|0
7704410|NCT00437281|12125522|FG017|Overall Study|Lost to Follow-up|0
7704411|NCT00437281|12125523|FG018|Overall Study|Lost to Follow-up|0
7704412|NCT00437281|12125524|FG019|Overall Study|Lost to Follow-up|1
7704413|NCT00437294|12125598|FG000|Overall Study|Adverse Event|5
7704414|NCT00437294|12125599|FG001|Overall Study|Adverse Event|4
7704415|NCT00437294|12125598|FG000|Overall Study|Death|5
7704416|NCT00437294|12125599|FG001|Overall Study|Death|2
7704417|NCT00437294|12125598|FG000|Overall Study|Physician Decision|0
7704418|NCT00437294|12125599|FG001|Overall Study|Physician Decision|3
7704419|NCT00437294|12125598|FG000|Overall Study|Withdrawal by Subject|5
7704420|NCT00437294|12125599|FG001|Overall Study|Withdrawal by Subject|0
7704421|NCT00437294|12125598|FG000|Overall Study|Progressive Disease|19
7704422|NCT00437294|12125599|FG001|Overall Study|Progressive Disease|23
7704423|NCT00437294|12125598|FG000|Overall Study|Sponsor Decision|8
7704424|NCT00437294|12125599|FG001|Overall Study|Sponsor Decision|9
7704425|NCT00437294|12125598|FG000|Overall Study|Protocol Violation|0
7704426|NCT00437294|12125599|FG001|Overall Study|Protocol Violation|1
7704427|NCT00437294|12125598|FG000|Overall Study|Entry criteria not met|1
7704428|NCT00437294|12125599|FG001|Overall Study|Entry criteria not met|1
7704429|NCT00437489|12125613|FG000|Overall Study|Study terminated by sponsor|23
7704430|NCT00437489|12125614|FG001|Overall Study|Study terminated by sponsor|21
7704431|NCT00437489|12125613|FG000|Overall Study|Lost to Follow-up|0
7704432|NCT00437489|12125614|FG001|Overall Study|Lost to Follow-up|1
7704433|NCT00437645|12125622|FG000|Overall Study|Adverse Event|15
7704434|NCT00437645|12125623|FG001|Overall Study|Adverse Event|84
7704435|NCT00437645|12125622|FG000|Overall Study|Withdrawal by Subject|10
7704436|NCT00437645|12125623|FG001|Overall Study|Withdrawal by Subject|22
7704437|NCT00437645|12125622|FG000|Overall Study|Protocol Violation|3
7704438|NCT00437645|12125623|FG001|Overall Study|Protocol Violation|3
7704439|NCT00437645|12125622|FG000|Overall Study|Lost to Follow-up|2
7704440|NCT00437645|12125623|FG001|Overall Study|Lost to Follow-up|3
7704441|NCT00437645|12125622|FG000|Overall Study|Administrative problems|2
7704442|NCT00437645|12125623|FG001|Overall Study|Administrative problems|1
7704443|NCT00437645|12125622|FG000|Overall Study|Lack of Efficacy|2
7704444|NCT00437645|12125623|FG001|Overall Study|Lack of Efficacy|1
7704445|NCT00437645|12125622|FG000|Overall Study|Condition no longer requires study drug|1
7704446|NCT00437645|12125623|FG001|Overall Study|Condition no longer requires study drug|1
7704447|NCT00437658|12125632|FG000|Treatment Period (24 Weeks)|Adverse Event|4
7704448|NCT00437658|12125633|FG001|Treatment Period (24 Weeks)|Adverse Event|7
7704449|NCT00437658|12125634|FG002|Treatment Period (24 Weeks)|Adverse Event|14
7704450|NCT00437658|12125632|FG000|Treatment Period (24 Weeks)|Non-compliance|1
7704451|NCT00437658|12125633|FG001|Treatment Period (24 Weeks)|Non-compliance|1
7704452|NCT00437658|12125634|FG002|Treatment Period (24 Weeks)|Non-compliance|4
7704453|NCT00437658|12125632|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9
7704454|NCT00437658|12125633|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7
7704455|NCT00437658|12125634|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7
7704456|NCT00437658|12125632|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4
7704457|NCT00437658|12125633|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2
7704458|NCT00437658|12125634|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3
7704459|NCT00437658|12125632|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5
7704460|NCT00437658|12125633|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4
7704461|NCT00437658|12125634|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5
7704462|NCT00437658|12125632|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
7704463|NCT00437658|12125633|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
7704464|NCT00437658|12125634|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
7704465|NCT00437658|12125632|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1
7704466|NCT00437658|12125633|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0
7704467|NCT00437658|12125634|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1
7704468|NCT00437658|12125632|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3
7704469|NCT00437658|12125633|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0
7704470|NCT00437658|12125634|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1
7704471|NCT00437658|12125632|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
7704472|NCT00437658|12125633|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
7704473|NCT00437658|12125634|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
7704474|NCT00437658|12125632|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
7704475|NCT00437658|12125633|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
7704476|NCT00437658|12125634|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
7704477|NCT00437658|12125632|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
7704478|NCT00437658|12125633|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
7704479|NCT00437658|12125634|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
7704480|NCT00437658|12125632|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
7704481|NCT00437658|12125633|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
7704482|NCT00437658|12125634|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
7704483|NCT00437983|12125644|FG000|Overall Study|Adverse Event|6
7704484|NCT00437983|12125645|FG001|Overall Study|Adverse Event|6
7704485|NCT00437983|12125644|FG000|Overall Study|Protocol Violation|2
7704486|NCT00437983|12125645|FG001|Overall Study|Protocol Violation|1
7704487|NCT00437983|12125644|FG000|Overall Study|Withdrawal by Subject|5
7704488|NCT00437983|12125645|FG001|Overall Study|Withdrawal by Subject|6
7704489|NCT00438256|12125674|FG000|Overall Study|Ineligible for Resection|2
7704490|NCT00438256|12125675|FG001|Overall Study|Ineligible for Resection|1
7704491|NCT00438256|12125676|FG002|Overall Study|Ineligible for Resection|1
7704492|NCT00438256|12125677|FG003|Overall Study|Ineligible for Resection|7
7704493|NCT00438256|12125674|FG000|Overall Study|Excluded final Diagnosis|0
7704494|NCT00438256|12125675|FG001|Overall Study|Excluded final Diagnosis|0
7704495|NCT00438256|12125676|FG002|Overall Study|Excluded final Diagnosis|0
7704496|NCT00438256|12125677|FG003|Overall Study|Excluded final Diagnosis|2
7704497|NCT00438360|12125692|FG000|Overall Study|Adverse Event|6
7704498|NCT00438360|12125693|FG001|Overall Study|Adverse Event|1
7704499|NCT00438360|12125692|FG000|Overall Study|Lack of Efficacy|42
7704500|NCT00438360|12125693|FG001|Overall Study|Lack of Efficacy|27
7704501|NCT00438360|12125692|FG000|Overall Study|Other|24
7704502|NCT00438360|12125693|FG001|Overall Study|Other|15
7704503|NCT00438399|12125702|FG000|Overall Study|Lost to Follow-up|2
7704504|NCT00438399|12125703|FG001|Overall Study|Lost to Follow-up|2
7704505|NCT00438399|12125704|FG002|Overall Study|Lost to Follow-up|1
7704506|NCT00438399|12125705|FG003|Overall Study|Lost to Follow-up|1
7704507|NCT00438399|12125706|FG004|Overall Study|Lost to Follow-up|1
7704508|NCT00438399|12125707|FG005|Overall Study|Lost to Follow-up|1
7704509|NCT00438399|12125702|FG000|Overall Study|Adverse Event|0
7704510|NCT00438399|12125703|FG001|Overall Study|Adverse Event|0
7704511|NCT00438399|12125704|FG002|Overall Study|Adverse Event|1
7704512|NCT00438399|12125705|FG003|Overall Study|Adverse Event|1
7704513|NCT00438399|12125706|FG004|Overall Study|Adverse Event|0
7704514|NCT00438399|12125707|FG005|Overall Study|Adverse Event|1
7704515|NCT00438399|12125702|FG000|Overall Study|Withdrawal by Subject|5
7704516|NCT00438399|12125703|FG001|Overall Study|Withdrawal by Subject|6
7704517|NCT00438399|12125704|FG002|Overall Study|Withdrawal by Subject|3
7704518|NCT00438399|12125705|FG003|Overall Study|Withdrawal by Subject|2
7704519|NCT00438399|12125706|FG004|Overall Study|Withdrawal by Subject|2
7704520|NCT00438399|12125707|FG005|Overall Study|Withdrawal by Subject|2
7704521|NCT00438399|12125702|FG000|Overall Study|Protocol Violation|0
7704522|NCT00438399|12125703|FG001|Overall Study|Protocol Violation|0
7704523|NCT00438399|12125704|FG002|Overall Study|Protocol Violation|1
7704524|NCT00438399|12125705|FG003|Overall Study|Protocol Violation|0
7704525|NCT00438399|12125706|FG004|Overall Study|Protocol Violation|0
7704526|NCT00438399|12125707|FG005|Overall Study|Protocol Violation|1
7704527|NCT00438399|12125702|FG000|Overall Study|Subje stopped study|0
7704528|NCT00438399|12125703|FG001|Overall Study|Subje stopped study|0
7704529|NCT00438399|12125704|FG002|Overall Study|Subje stopped study|1
7704530|NCT00438399|12125705|FG003|Overall Study|Subje stopped study|0
7704531|NCT00438399|12125706|FG004|Overall Study|Subje stopped study|0
7704532|NCT00438399|12125707|FG005|Overall Study|Subje stopped study|0
7704533|NCT00438399|12125702|FG000|Overall Study|Pregnancy|0
7704534|NCT00438399|12125703|FG001|Overall Study|Pregnancy|0
7704535|NCT00438399|12125704|FG002|Overall Study|Pregnancy|0
7704536|NCT00438399|12125705|FG003|Overall Study|Pregnancy|0
7704537|NCT00438399|12125706|FG004|Overall Study|Pregnancy|0
7704538|NCT00438399|12125707|FG005|Overall Study|Pregnancy|1
7704539|NCT00438399|12125702|FG000|Overall Study|Patien stopped study at visit 4 by error|1
7704540|NCT00438399|12125703|FG001|Overall Study|Patien stopped study at visit 4 by error|0
7704541|NCT00438399|12125704|FG002|Overall Study|Patien stopped study at visit 4 by error|0
7704542|NCT00438399|12125705|FG003|Overall Study|Patien stopped study at visit 4 by error|0
7704543|NCT00438399|12125706|FG004|Overall Study|Patien stopped study at visit 4 by error|0
7704544|NCT00438399|12125707|FG005|Overall Study|Patien stopped study at visit 4 by error|0
7704545|NCT00438464|12125731|FG000|Overall Study|Terminated Early|14
7704546|NCT00438464|12125732|FG001|Overall Study|Terminated Early|5
7704547|NCT00438464|12125731|FG000|Overall Study|Incomplete data submission|0
7704548|NCT00438464|12125732|FG001|Overall Study|Incomplete data submission|2
7704549|NCT00438633|12125765|FG000|Overall Study|Withdrawal by Subject|1
7704550|NCT00438633|12125766|FG001|Overall Study|Withdrawal by Subject|0
7704551|NCT00438633|12125765|FG000|Overall Study|Lost to Follow-up|15
7704552|NCT00438633|12125766|FG001|Overall Study|Lost to Follow-up|17
7704553|NCT00438659|12125774|FG000|Overall Study|Discontinued Mometasone/Placebo|1
7704554|NCT00438659|12125775|FG001|Overall Study|Discontinued Mometasone/Placebo|2
7704555|NCT00438659|12125774|FG000|Overall Study|Cancel|5
7704556|NCT00438659|12125775|FG001|Overall Study|Cancel|2
7704557|NCT00438672|12125784|FG000|Overall Study|Lost to Follow-up|7
7704558|NCT00438672|12125785|FG001|Overall Study|Lost to Follow-up|9
7704559|NCT00438815|12125815|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
7704560|NCT00438815|12125815|FG000|Overall Study|3-month follow-up no longer required|12
7704561|NCT00438815|12125815|FG000|Overall Study|Noncompliance with protocol requirements|9
7704562|NCT00438815|12125815|FG000|Overall Study|Transitioned to commercial C1INH-nf|6
7704563|NCT00438815|12125815|FG000|Overall Study|Lost to Follow-up|6
7704564|NCT00438815|12125815|FG000|Overall Study|Withdrawal by Subject|6
7704565|NCT00438815|12125815|FG000|Overall Study|Death|1
7704566|NCT00439140|12125857|FG000|Treatment Cycle 1|Lost to Follow-up|1
7704567|NCT00439140|12125858|FG001|Treatment Cycle 1|Lost to Follow-up|1
7704568|NCT00439140|12125859|FG002|Treatment Cycle 1|Lost to Follow-up|1
7704569|NCT00439140|12125857|FG000|Treatment Cycle 1|Personal reasons|0
7704570|NCT00439140|12125858|FG001|Treatment Cycle 1|Personal reasons|2
7704571|NCT00439140|12125859|FG002|Treatment Cycle 1|Personal reasons|0
7704572|NCT00439140|12125857|FG000|Treatment Cycle 1|Withdrawal by Subject|0
7704573|NCT00439140|12125858|FG001|Treatment Cycle 1|Withdrawal by Subject|1
7704574|NCT00439140|12125859|FG002|Treatment Cycle 1|Withdrawal by Subject|0
7704575|NCT00439140|12125857|FG000|Treatment Cycle 2|Withdrawal by Subject|1
7704576|NCT00439140|12125858|FG001|Treatment Cycle 2|Withdrawal by Subject|0
7704577|NCT00439140|12125859|FG002|Treatment Cycle 2|Withdrawal by Subject|0
7704578|NCT00439140|12125857|FG000|Treatment Cycle 2|Lost to Follow-up|1
7704579|NCT00439140|12125858|FG001|Treatment Cycle 2|Lost to Follow-up|1
7704580|NCT00439140|12125859|FG002|Treatment Cycle 2|Lost to Follow-up|0
7704581|NCT00439179|12125871|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0
7704582|NCT00439179|12125872|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2
7704583|NCT00439179|12125873|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0
7704584|NCT00439179|12125874|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0
7704585|NCT00439218|12125887|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
7704586|NCT00439231|12125891|FG000|Overall Study|Lack of Efficacy|28
7704587|NCT00439244|12125898|FG000|Overall Study|Adverse Event|5
7704588|NCT00439244|12125899|FG001|Overall Study|Adverse Event|2
7704589|NCT00439244|12125900|FG002|Overall Study|Adverse Event|3
7704590|NCT00439244|12125898|FG000|Overall Study|Withdrawal by Subject|3
7704591|NCT00439244|12125899|FG001|Overall Study|Withdrawal by Subject|1
7704592|NCT00439244|12125900|FG002|Overall Study|Withdrawal by Subject|2
7704593|NCT00439244|12125898|FG000|Overall Study|Lost to Follow-up|2
7704594|NCT00439244|12125899|FG001|Overall Study|Lost to Follow-up|1
7704595|NCT00439244|12125900|FG002|Overall Study|Lost to Follow-up|2
7704596|NCT00439244|12125898|FG000|Overall Study|Death|0
7704597|NCT00439244|12125899|FG001|Overall Study|Death|1
7704598|NCT00439244|12125900|FG002|Overall Study|Death|0
7704599|NCT00439244|12125898|FG000|Overall Study|Protocol Violation|0
7704600|NCT00439244|12125899|FG001|Overall Study|Protocol Violation|1
7704601|NCT00439244|12125900|FG002|Overall Study|Protocol Violation|0
7704602|NCT00439244|12125898|FG000|Overall Study|Administrative problems|1
7704603|NCT00439244|12125899|FG001|Overall Study|Administrative problems|0
7704604|NCT00439244|12125900|FG002|Overall Study|Administrative problems|0
7704605|NCT00439270|12125913|FG000|Phase 1 (18.1 Months)|Disease progression|3
7704606|NCT00439270|12125914|FG001|Phase 1 (18.1 Months)|Disease progression|2
7704607|NCT00439270|12125915|FG002|Phase 1 (18.1 Months)|Disease progression|3
7704608|NCT00439270|12125916|FG003|Phase 1 (18.1 Months)|Disease progression|0
7704609|NCT00439270|12125917|FG004|Phase 1 (18.1 Months)|Disease progression|3
7704610|NCT00439270|12125913|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0
7704611|NCT00439270|12125914|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1
7704612|NCT00439270|12125915|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0
7704613|NCT00439270|12125916|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0
7704614|NCT00439270|12125917|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0
7704615|NCT00439270|12125913|FG000|Phase 2 (51.6 Months)|Disease progression|0
7704616|NCT00439270|12125914|FG001|Phase 2 (51.6 Months)|Disease progression|0
7704617|NCT00439270|12125915|FG002|Phase 2 (51.6 Months)|Disease progression|0
7704618|NCT00439270|12125916|FG003|Phase 2 (51.6 Months)|Disease progression|18
7704619|NCT00439270|12125917|FG004|Phase 2 (51.6 Months)|Disease progression|0
7704620|NCT00439270|12125913|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
7704621|NCT00439270|12125914|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
7704622|NCT00439270|12125915|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
7704623|NCT00439270|12125916|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
7704624|NCT00439270|12125917|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
7704625|NCT00439270|12125913|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0
7704626|NCT00439270|12125914|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0
7704627|NCT00439270|12125915|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0
7704628|NCT00439270|12125916|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6
7704629|NCT00439270|12125917|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0
7704630|NCT00439270|12125913|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0
7704631|NCT00439270|12125914|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0
7704632|NCT00439270|12125915|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0
7704633|NCT00439270|12125916|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3
7704634|NCT00439270|12125917|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0
7704635|NCT00439270|12125913|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0
7704636|NCT00439270|12125914|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0
7704637|NCT00439270|12125915|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0
7704638|NCT00439270|12125916|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1
7704639|NCT00439270|12125917|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0
7704640|NCT00439270|12125913|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0
7704641|NCT00439270|12125914|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0
7704642|NCT00439270|12125915|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0
7704643|NCT00439270|12125916|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2
7704644|NCT00439270|12125917|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0
7704645|NCT00439270|12125913|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
7704646|NCT00439270|12125914|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
7704647|NCT00439270|12125915|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
7704648|NCT00439270|12125916|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
7704649|NCT00439270|12125917|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
7704650|NCT00439270|12125913|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
7704651|NCT00439270|12125914|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
7704652|NCT00439270|12125915|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
7704653|NCT00439270|12125916|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
7704654|NCT00439270|12125917|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
7704655|NCT00439309|12125947|FG000|Follow-Up|Death|1
7704656|NCT00439309|12125948|FG001|Follow-Up|Death|0
7704657|NCT00439309|12125947|FG000|Follow-Up|Lost to Follow-up|2
7704658|NCT00439309|12125948|FG001|Follow-Up|Lost to Follow-up|0
7704659|NCT00439309|12125947|FG000|Follow-Up|Withdrawal by Subject|0
7704660|NCT00439309|12125948|FG001|Follow-Up|Withdrawal by Subject|1
7704661|NCT00439309|12125947|FG000|Follow-Up|Late response by subject|0
7704662|NCT00439309|12125948|FG001|Follow-Up|Late response by subject|1
7704663|NCT00439517|12125992|FG000|Overall Study|Subject on treatment|1
7704664|NCT00439517|12125993|FG001|Overall Study|Subject on treatment|0
7704665|NCT00439517|12125992|FG000|Overall Study|Subject in survival follow-up|1
7704666|NCT00439517|12125993|FG001|Overall Study|Subject in survival follow-up|0
7704667|NCT00439556|12126002|FG000|Overall Study|Patient was taken off study for non-comp|0
7704668|NCT00439556|12126003|FG001|Overall Study|Patient was taken off study for non-comp|1
7704669|NCT00439556|12126004|FG002|Overall Study|Patient was taken off study for non-comp|0
7704670|NCT00439647|12126019|FG000|Overall Study|Withdrawal by Subject|25
7704671|NCT00439647|12126020|FG001|Overall Study|Withdrawal by Subject|22
7704672|NCT00439647|12126019|FG000|Overall Study|Death|15
7704673|NCT00439647|12126020|FG001|Overall Study|Death|18
7704674|NCT00439647|12126019|FG000|Overall Study|Adverse Event|11
7704675|NCT00439647|12126020|FG001|Overall Study|Adverse Event|11
7704676|NCT00439647|12126019|FG000|Overall Study|Lost to Follow-up|4
7704677|NCT00439647|12126020|FG001|Overall Study|Lost to Follow-up|12
7704678|NCT00439647|12126019|FG000|Overall Study|Protocol Violation|3
7704679|NCT00439647|12126020|FG001|Overall Study|Protocol Violation|4
7704680|NCT00439647|12126019|FG000|Overall Study|Lack of Efficacy|0
7704681|NCT00439647|12126020|FG001|Overall Study|Lack of Efficacy|4
7704682|NCT00439725|12126032|FG000|Treatment Period|Withdrawal by Subject|22
7704683|NCT00439725|12126033|FG001|Treatment Period|Withdrawal by Subject|19
7704684|NCT00439725|12126032|FG000|Treatment Period|Study terminated by sponsor|156
7704685|NCT00439725|12126033|FG001|Treatment Period|Study terminated by sponsor|148
7704686|NCT00439725|12126032|FG000|Treatment Period|Site closed by investigator|1
7704687|NCT00439725|12126033|FG001|Treatment Period|Site closed by investigator|2
7704688|NCT00439725|12126032|FG000|Treatment Period|Adverse Event|39
7704689|NCT00439725|12126033|FG001|Treatment Period|Adverse Event|18
7704690|NCT00439725|12126032|FG000|Treatment Period|Physician Decision|1
7704691|NCT00439725|12126033|FG001|Treatment Period|Physician Decision|1
7704692|NCT00439725|12126032|FG000|Treatment Period|Protocol Violation|2
7704693|NCT00439725|12126033|FG001|Treatment Period|Protocol Violation|1
7704694|NCT00439725|12126032|FG000|Treatment Period|Clinical endpoint reached|6
7704695|NCT00439725|12126033|FG001|Treatment Period|Clinical endpoint reached|50
7704696|NCT00439725|12126032|FG000|Treatment Period|Technical problems|1
7704697|NCT00439725|12126033|FG001|Treatment Period|Technical problems|0
7704698|NCT00439725|12126032|FG000|Treatment Period|Lost to Follow-up|1
7704699|NCT00439725|12126033|FG001|Treatment Period|Lost to Follow-up|1
7704700|NCT00439725|12126032|FG000|Treatment Period|Participant convenience|1
7704701|NCT00439725|12126033|FG001|Treatment Period|Participant convenience|0
7704702|NCT00439725|12126032|FG000|Treatment Period|Protocol driven decision point|1
7704703|NCT00439725|12126033|FG001|Treatment Period|Protocol driven decision point|1
7704704|NCT00439725|12126032|FG000|Treatment Period|Death|1
7704705|NCT00439725|12126033|FG001|Treatment Period|Death|1
7704706|NCT00439725|12126032|FG000|Treatment Period|Participant did not receive treatment|4
7704707|NCT00439725|12126033|FG001|Treatment Period|Participant did not receive treatment|4
7704708|NCT00439725|12126032|FG000|Observational Period|Withdrawal by Subject|2
7704709|NCT00439725|12126033|FG001|Observational Period|Withdrawal by Subject|2
7704710|NCT00439725|12126032|FG000|Observational Period|Lost to Follow-up|0
7704711|NCT00439725|12126033|FG001|Observational Period|Lost to Follow-up|1
7704712|NCT00439725|12126032|FG000|Observational Period|Death|0
7704713|NCT00439725|12126033|FG001|Observational Period|Death|2
7704714|NCT00439725|12126032|FG000|Observational Period|Study termination by sponsor|1
7704715|NCT00439725|12126033|FG001|Observational Period|Study termination by sponsor|1
7704716|NCT00439725|12126032|FG000|Observational Period|Clinical endpoint reached|3
7704717|NCT00439725|12126033|FG001|Observational Period|Clinical endpoint reached|1
7704718|NCT00439725|12126032|FG000|Observational Period|Technical problems|1
7704719|NCT00439725|12126033|FG001|Observational Period|Technical problems|0
7704720|NCT00439725|12126032|FG000|Observational Period|Participant convenience|1
7704721|NCT00439725|12126033|FG001|Observational Period|Participant convenience|0
7704722|NCT00439777|12126041|FG000|Treatment Period|Death|29
7704723|NCT00439777|12126042|FG001|Treatment Period|Death|21
7704724|NCT00439777|12126041|FG000|Treatment Period|Study terminated by sponsor|125
7704725|NCT00439777|12126042|FG001|Treatment Period|Study terminated by sponsor|132
7704726|NCT00439777|12126041|FG000|Treatment Period|Site closed by investigator|0
7704727|NCT00439777|12126042|FG001|Treatment Period|Site closed by investigator|1
7704728|NCT00439777|12126041|FG000|Treatment Period|Did not take study treatment|7
7704729|NCT00439777|12126042|FG001|Treatment Period|Did not take study treatment|8
7704730|NCT00439777|12126041|FG000|Treatment Period|Adverse Event|111
7704731|NCT00439777|12126042|FG001|Treatment Period|Adverse Event|92
7704732|NCT00439777|12126041|FG000|Treatment Period|Protocol Violation|23
7704733|NCT00439777|12126042|FG001|Treatment Period|Protocol Violation|30
7704734|NCT00439777|12126041|FG000|Treatment Period|Withdrawal by Subject|66
7704735|NCT00439777|12126042|FG001|Treatment Period|Withdrawal by Subject|118
7704736|NCT00439777|12126041|FG000|Treatment Period|Lack of Efficacy|1
7704737|NCT00439777|12126042|FG001|Treatment Period|Lack of Efficacy|4
7704738|NCT00439777|12126041|FG000|Treatment Period|Lost to Follow-up|8
7704739|NCT00439777|12126042|FG001|Treatment Period|Lost to Follow-up|10
7704740|NCT00439777|12126041|FG000|Treatment Period|Protocol driven decision point|1
7704741|NCT00439777|12126042|FG001|Treatment Period|Protocol driven decision point|3
7704742|NCT00439777|12126041|FG000|Treatment Period|Physician Decision|7
7704743|NCT00439777|12126042|FG001|Treatment Period|Physician Decision|18
7704744|NCT00439777|12126041|FG000|Treatment Period|Clinical endpoint reached|26
7704745|NCT00439777|12126042|FG001|Treatment Period|Clinical endpoint reached|13
7704746|NCT00439777|12126041|FG000|Treatment Period|Technical problems|3
7704747|NCT00439777|12126042|FG001|Treatment Period|Technical problems|1
7704748|NCT00439777|12126041|FG000|Treatment Period|Participant convenience|12
7704749|NCT00439777|12126042|FG001|Treatment Period|Participant convenience|8
7704750|NCT00439777|12126041|FG000|Observational Period|Protocol Violation|0
7704751|NCT00439777|12126042|FG001|Observational Period|Protocol Violation|2
7704752|NCT00439777|12126041|FG000|Observational Period|Withdrawal by Subject|9
7704753|NCT00439777|12126042|FG001|Observational Period|Withdrawal by Subject|5
7704754|NCT00439777|12126041|FG000|Observational Period|Lost to Follow-up|1
7704755|NCT00439777|12126042|FG001|Observational Period|Lost to Follow-up|11
7704756|NCT00439777|12126041|FG000|Observational Period|Death|27
7704757|NCT00439777|12126042|FG001|Observational Period|Death|20
7704758|NCT00439777|12126041|FG000|Observational Period|Study terminated by sponsor|3
7704759|NCT00439777|12126042|FG001|Observational Period|Study terminated by sponsor|1
7704760|NCT00439777|12126041|FG000|Observational Period|Protocol driven decision point|0
7704761|NCT00439777|12126042|FG001|Observational Period|Protocol driven decision point|1
7704762|NCT00439777|12126041|FG000|Observational Period|Lack of Efficacy|1
7704763|NCT00439777|12126042|FG001|Observational Period|Lack of Efficacy|0
7704764|NCT00439777|12126041|FG000|Observational Period|Technical problems|0
7704765|NCT00439777|12126042|FG001|Observational Period|Technical problems|1
7704766|NCT00440011|12126054|FG000|Overall Study|Adverse Event|2
7704767|NCT00440011|12126055|FG001|Overall Study|Adverse Event|0
7704768|NCT00440011|12126054|FG000|Overall Study|Lost to Follow-up|0
7704769|NCT00440011|12126055|FG001|Overall Study|Lost to Follow-up|2
7704770|NCT00440011|12126054|FG000|Overall Study|Protocol Violation|1
7704771|NCT00440011|12126055|FG001|Overall Study|Protocol Violation|1
7704772|NCT00440011|12126054|FG000|Overall Study|Withdrawal by Subject|1
7704773|NCT00440011|12126055|FG001|Overall Study|Withdrawal by Subject|0
7704774|NCT00440037|12126061|FG000|Overall Study|Withdrawal by Subject|6
7704775|NCT00440037|12126061|FG000|Overall Study|Administrative decision|3
7704776|NCT00440115|12126077|FG000|Overall Study|Death|7
7704777|NCT00440115|12126078|FG001|Overall Study|Death|9
7704778|NCT00440115|12126079|FG002|Overall Study|Death|5
7704779|NCT00440115|12126077|FG000|Overall Study|Incarceration|0
7704780|NCT00440115|12126078|FG001|Overall Study|Incarceration|2
7704781|NCT00440115|12126079|FG002|Overall Study|Incarceration|1
7704782|NCT00440193|12126098|FG000|Treatment Period|Adverse Event|74
7704783|NCT00440193|12126099|FG001|Treatment Period|Adverse Event|67
7704784|NCT00440193|12126098|FG000|Treatment Period|Death|19
7704785|NCT00440193|12126099|FG001|Treatment Period|Death|22
7704786|NCT00440193|12126098|FG000|Treatment Period|Lack of Efficacy|0
7704787|NCT00440193|12126099|FG001|Treatment Period|Lack of Efficacy|1
7704788|NCT00440193|12126098|FG000|Treatment Period|Lost to Follow-up|12
7704789|NCT00440193|12126099|FG001|Treatment Period|Lost to Follow-up|18
7704790|NCT00440193|12126098|FG000|Treatment Period|Physician Decision|3
7704791|NCT00440193|12126099|FG001|Treatment Period|Physician Decision|6
7704792|NCT00440193|12126098|FG000|Treatment Period|Protocol Violation|16
7704793|NCT00440193|12126099|FG001|Treatment Period|Protocol Violation|19
7704794|NCT00440193|12126098|FG000|Treatment Period|Withdrawal by Subject|36
7704795|NCT00440193|12126099|FG001|Treatment Period|Withdrawal by Subject|77
7704796|NCT00440193|12126098|FG000|Treatment Period|Clinical endpoint reached|28
7704797|NCT00440193|12126099|FG001|Treatment Period|Clinical endpoint reached|25
7704798|NCT00440193|12126098|FG000|Treatment Period|Study terminated by sponsor|102
7704799|NCT00440193|12126099|FG001|Treatment Period|Study terminated by sponsor|94
7704800|NCT00440193|12126098|FG000|Treatment Period|Protocol driven decision point|2
7704801|NCT00440193|12126099|FG001|Treatment Period|Protocol driven decision point|2
7704802|NCT00440193|12126098|FG000|Treatment Period|Switch to commercial drug|0
7704803|NCT00440193|12126099|FG001|Treatment Period|Switch to commercial drug|2
7704804|NCT00440193|12126098|FG000|Treatment Period|Technical problems|1
7704805|NCT00440193|12126099|FG001|Treatment Period|Technical problems|1
7704806|NCT00440193|12126098|FG000|Treatment Period|Participant convenience|5
7704807|NCT00440193|12126099|FG001|Treatment Period|Participant convenience|2
7704808|NCT00440193|12126098|FG000|Treatment Period|Participant did not receive treatment|7
7704809|NCT00440193|12126099|FG001|Treatment Period|Participant did not receive treatment|13
7704810|NCT00440193|12126098|FG000|Treatment Period|Site closed by investigator|0
7704811|NCT00440193|12126099|FG001|Treatment Period|Site closed by investigator|2
7704812|NCT00440193|12126098|FG000|Observational Period|Adverse Event|2
7704813|NCT00440193|12126099|FG001|Observational Period|Adverse Event|2
7704814|NCT00440193|12126098|FG000|Observational Period|Death|15
7704815|NCT00440193|12126099|FG001|Observational Period|Death|20
7704816|NCT00440193|12126098|FG000|Observational Period|Lost to Follow-up|12
7704817|NCT00440193|12126099|FG001|Observational Period|Lost to Follow-up|8
7704818|NCT00440193|12126098|FG000|Observational Period|Protocol Violation|1
7704819|NCT00440193|12126099|FG001|Observational Period|Protocol Violation|0
7704820|NCT00440193|12126098|FG000|Observational Period|Withdrawal by Subject|11
7704821|NCT00440193|12126099|FG001|Observational Period|Withdrawal by Subject|8
7704822|NCT00440193|12126098|FG000|Observational Period|Physician Decision|1
7704823|NCT00440193|12126099|FG001|Observational Period|Physician Decision|0
7704824|NCT00440193|12126098|FG000|Observational Period|Clinical endpoint reached|1
7704825|NCT00440193|12126099|FG001|Observational Period|Clinical endpoint reached|0
7704826|NCT00440193|12126098|FG000|Observational Period|Participant convenience|2
7704827|NCT00440193|12126099|FG001|Observational Period|Participant convenience|0
7704828|NCT00440232|12126107|FG000|Overall Study|Lost to Follow-up|1
7704829|NCT00440232|12126108|FG001|Overall Study|Lost to Follow-up|1
7704830|NCT00440232|12126107|FG000|Overall Study|Unable to treat within allowed time|0
7704831|NCT00440232|12126108|FG001|Overall Study|Unable to treat within allowed time|1
7704832|NCT00440232|12126107|FG000|Overall Study|Onset of headache within 4 hours of fast|2
7704833|NCT00440232|12126108|FG001|Overall Study|Onset of headache within 4 hours of fast|2
7704834|NCT00440297|12126116|FG000|Overall Study|Adverse Event|8
7704835|NCT00440297|12126117|FG001|Overall Study|Adverse Event|5
7704836|NCT00440297|12126116|FG000|Overall Study|Lost to Follow-up|1
7704837|NCT00440297|12126117|FG001|Overall Study|Lost to Follow-up|0
7704838|NCT00440297|12126116|FG000|Overall Study|Physician Decision|1
7704839|NCT00440297|12126117|FG001|Overall Study|Physician Decision|0
7704840|NCT00440297|12126116|FG000|Overall Study|Protocol Violation|11
7704841|NCT00440297|12126117|FG001|Overall Study|Protocol Violation|7
7704842|NCT00440297|12126116|FG000|Overall Study|Withdrawal by Subject|1
7704843|NCT00440297|12126117|FG001|Overall Study|Withdrawal by Subject|6
7704844|NCT00440297|12126116|FG000|Overall Study|Randomized by mistake|1
7704845|NCT00440297|12126117|FG001|Overall Study|Randomized by mistake|0
7704846|NCT00440310|12126125|FG000|Overall Study|Lost to Follow-up|4
7704847|NCT00440310|12126126|FG001|Overall Study|Lost to Follow-up|5
7704848|NCT00440310|12126125|FG000|Overall Study|Protocol Violation|0
7704849|NCT00440310|12126126|FG001|Overall Study|Protocol Violation|1
7704850|NCT00440310|12126125|FG000|Overall Study|Withdrawal by Subject|15
7704851|NCT00440310|12126126|FG001|Overall Study|Withdrawal by Subject|14
7704852|NCT00440310|12126125|FG000|Overall Study|No Reply at EOS|7
7704853|NCT00440310|12126126|FG001|Overall Study|No Reply at EOS|7
7704854|NCT00440310|12126125|FG000|Overall Study|Other|1
7704855|NCT00440310|12126126|FG001|Overall Study|Other|0
7704856|NCT00440310|12126125|FG000|Overall Study|Status Unknown|1
7704857|NCT00440310|12126126|FG001|Overall Study|Status Unknown|3
7704858|NCT00440401|12126134|FG000|Overall Study|Adverse Event|2
7704859|NCT00440401|12126135|FG001|Overall Study|Adverse Event|1
7704860|NCT00440401|12126134|FG000|Overall Study|Other|2
7704861|NCT00440401|12126135|FG001|Overall Study|Other|5
7704862|NCT00440466|12126144|FG000|Overall Study|Death|3
7704863|NCT00440466|12126145|FG001|Overall Study|Death|2
7704864|NCT00440466|12126146|FG002|Overall Study|Death|9
7704865|NCT00440466|12126144|FG000|Overall Study|Adverse Event|3
7704866|NCT00440466|12126145|FG001|Overall Study|Adverse Event|4
7704867|NCT00440466|12126146|FG002|Overall Study|Adverse Event|11
7704868|NCT00440466|12126144|FG000|Overall Study|Lost to Follow-up|1
7704869|NCT00440466|12126145|FG001|Overall Study|Lost to Follow-up|0
7704870|NCT00440466|12126146|FG002|Overall Study|Lost to Follow-up|2
7704871|NCT00440466|12126144|FG000|Overall Study|Physician Decision|2
7704872|NCT00440466|12126145|FG001|Overall Study|Physician Decision|0
7704873|NCT00440466|12126146|FG002|Overall Study|Physician Decision|1
7704874|NCT00440466|12126144|FG000|Overall Study|Protocol Violation|2
7704875|NCT00440466|12126145|FG001|Overall Study|Protocol Violation|0
7704876|NCT00440466|12126146|FG002|Overall Study|Protocol Violation|4
7704877|NCT00440466|12126144|FG000|Overall Study|Withdrawal by Subject|2
7704878|NCT00440466|12126145|FG001|Overall Study|Withdrawal by Subject|5
7704879|NCT00440466|12126146|FG002|Overall Study|Withdrawal by Subject|9
7704880|NCT00440466|12126144|FG000|Overall Study|Began Dialysis|0
7704881|NCT00440466|12126145|FG001|Overall Study|Began Dialysis|0
7704882|NCT00440466|12126146|FG002|Overall Study|Began Dialysis|1
7704883|NCT00440466|12126144|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0
7704884|NCT00440466|12126145|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4
7704885|NCT00440466|12126146|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4
7704886|NCT00440518|12126170|FG000|Randomized /Titration Period|Lack of Efficacy|1
7704887|NCT00440518|12126171|FG001|Randomized /Titration Period|Lack of Efficacy|0
7704888|NCT00440518|12126172|FG002|Randomized /Titration Period|Lack of Efficacy|1
7704889|NCT00440518|12126170|FG000|Randomized /Titration Period|Subject Withdrew Consent|4
7704890|NCT00440518|12126171|FG001|Randomized /Titration Period|Subject Withdrew Consent|1
7704891|NCT00440518|12126172|FG002|Randomized /Titration Period|Subject Withdrew Consent|0
7704892|NCT00440518|12126170|FG000|Randomized /Titration Period|Protocol Deviation|1
7704893|NCT00440518|12126171|FG001|Randomized /Titration Period|Protocol Deviation|0
7704894|NCT00440518|12126172|FG002|Randomized /Titration Period|Protocol Deviation|0
7704895|NCT00440518|12126170|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2
7704896|NCT00440518|12126171|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3
7704897|NCT00440518|12126172|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2
7704898|NCT00440518|12126170|FG000|Randomized /Titration Period|Other|1
7704899|NCT00440518|12126171|FG001|Randomized /Titration Period|Other|0
7704900|NCT00440518|12126172|FG002|Randomized /Titration Period|Other|0
7704901|NCT00440518|12126170|FG000|Randomized /Titration Period|Lost to Follow-up|2
7704902|NCT00440518|12126171|FG001|Randomized /Titration Period|Lost to Follow-up|2
7704903|NCT00440518|12126172|FG002|Randomized /Titration Period|Lost to Follow-up|1
7704904|NCT00440518|12126170|FG000|Randomized /Titration Period|Adverse Event|2
7704905|NCT00440518|12126171|FG001|Randomized /Titration Period|Adverse Event|3
7704906|NCT00440518|12126172|FG002|Randomized /Titration Period|Adverse Event|0
7704907|NCT00440518|12126170|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3
7704908|NCT00440518|12126171|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4
7704909|NCT00440518|12126172|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2
7704910|NCT00440518|12126170|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
7704911|NCT00440518|12126171|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
7704912|NCT00440518|12126172|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
7704913|NCT00440518|12126170|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
7704914|NCT00440518|12126171|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
7704915|NCT00440518|12126172|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
7704916|NCT00440518|12126170|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
7704917|NCT00440518|12126171|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
7704918|NCT00440518|12126172|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
7704919|NCT00440518|12126170|FG000|Maintenance and Safety Follow-up Periods|Other|0
7704920|NCT00440518|12126171|FG001|Maintenance and Safety Follow-up Periods|Other|0
7704921|NCT00440518|12126172|FG002|Maintenance and Safety Follow-up Periods|Other|2
7704922|NCT00440518|12126170|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
7704923|NCT00440518|12126171|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
7704924|NCT00440518|12126172|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
7704925|NCT00440557|12126183|FG000|Overall Study|Withdrawal by Subject|10
7704926|NCT00440557|12126184|FG001|Overall Study|Withdrawal by Subject|5
7704927|NCT00440557|12126185|FG002|Overall Study|Withdrawal by Subject|11
7704928|NCT00440557|12126183|FG000|Overall Study|Lost to Follow-up|1
7704929|NCT00440557|12126184|FG001|Overall Study|Lost to Follow-up|2
7704930|NCT00440557|12126185|FG002|Overall Study|Lost to Follow-up|6
7704931|NCT00440557|12126183|FG000|Overall Study|Adverse Event|3
7704932|NCT00440557|12126184|FG001|Overall Study|Adverse Event|3
7704933|NCT00440557|12126185|FG002|Overall Study|Adverse Event|5
7704934|NCT00440557|12126183|FG000|Overall Study|Death|2
7704935|NCT00440557|12126184|FG001|Overall Study|Death|6
7704936|NCT00440557|12126185|FG002|Overall Study|Death|3
7704937|NCT00440557|12126183|FG000|Overall Study|Began Dialysis|4
7704938|NCT00440557|12126184|FG001|Overall Study|Began Dialysis|1
7704939|NCT00440557|12126185|FG002|Overall Study|Began Dialysis|4
7704940|NCT00440557|12126183|FG000|Overall Study|Principal Investigator decision|0
7704941|NCT00440557|12126184|FG001|Overall Study|Principal Investigator decision|3
7704942|NCT00440557|12126185|FG002|Overall Study|Principal Investigator decision|1
7704943|NCT00440557|12126183|FG000|Overall Study|Patient moved|1
7704944|NCT00440557|12126184|FG001|Overall Study|Patient moved|2
7704945|NCT00440557|12126185|FG002|Overall Study|Patient moved|1
7704946|NCT00440557|12126183|FG000|Overall Study|Principal Investigator's office closed|3
7704947|NCT00440557|12126184|FG001|Overall Study|Principal Investigator's office closed|6
7704948|NCT00440557|12126185|FG002|Overall Study|Principal Investigator's office closed|4
7704949|NCT00440557|12126183|FG000|Overall Study|Patient transferred to nursing home|0
7704950|NCT00440557|12126184|FG001|Overall Study|Patient transferred to nursing home|1
7704951|NCT00440557|12126185|FG002|Overall Study|Patient transferred to nursing home|0
7704952|NCT00440557|12126183|FG000|Overall Study|Patient had surgery|1
7704953|NCT00440557|12126184|FG001|Overall Study|Patient had surgery|0
7704954|NCT00440557|12126185|FG002|Overall Study|Patient had surgery|0
7704955|NCT00440700|12126207|FG000|Overall Study|Withdrawal by Subject|8
7704956|NCT00440700|12126208|FG001|Overall Study|Withdrawal by Subject|8
7704957|NCT00440700|12126209|FG002|Overall Study|Withdrawal by Subject|4
7704958|NCT00440726|12126220|FG000|Phase 1|Dose-Limiting Toxicity|0
7704959|NCT00440726|12126221|FG001|Phase 1|Dose-Limiting Toxicity|1
7704960|NCT00440726|12126222|FG002|Phase 1|Dose-Limiting Toxicity|0
7704961|NCT00440726|12126220|FG000|Phase 1|Physician Decision|1
7704962|NCT00440726|12126221|FG001|Phase 1|Physician Decision|0
7704963|NCT00440726|12126222|FG002|Phase 1|Physician Decision|0
7704964|NCT00440726|12126220|FG000|Phase 2|Death|0
7704965|NCT00440726|12126221|FG001|Phase 2|Death|0
7704966|NCT00440726|12126222|FG002|Phase 2|Death|1
7704967|NCT00440726|12126220|FG000|Phase 2|Adverse Event|0
7704968|NCT00440726|12126221|FG001|Phase 2|Adverse Event|0
7704969|NCT00440726|12126222|FG002|Phase 2|Adverse Event|1
7704970|NCT00440947|12126254|FG000|36-Week Induction Phase|Adverse Event|16
7704971|NCT00440947|12126255|FG001|36-Week Induction Phase|Adverse Event|0
7704972|NCT00440947|12126256|FG002|36-Week Induction Phase|Adverse Event|0
7704973|NCT00440947|12126257|FG003|36-Week Induction Phase|Adverse Event|0
7704974|NCT00440947|12126258|FG004|36-Week Induction Phase|Adverse Event|0
7704975|NCT00440947|12126254|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11
7704976|NCT00440947|12126255|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0
7704977|NCT00440947|12126256|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0
7704978|NCT00440947|12126257|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0
7704979|NCT00440947|12126258|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0
7704980|NCT00440947|12126254|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5
7704981|NCT00440947|12126255|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0
7704982|NCT00440947|12126256|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0
7704983|NCT00440947|12126257|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0
7704984|NCT00440947|12126258|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0
7704985|NCT00440947|12126254|FG000|36-Week Induction Phase|Non-compliance|10
7704986|NCT00440947|12126255|FG001|36-Week Induction Phase|Non-compliance|0
7704987|NCT00440947|12126256|FG002|36-Week Induction Phase|Non-compliance|0
7704988|NCT00440947|12126257|FG003|36-Week Induction Phase|Non-compliance|0
7704989|NCT00440947|12126258|FG004|36-Week Induction Phase|Non-compliance|0
7704990|NCT00440947|12126254|FG000|36-Week Induction Phase|Lost to Follow-up|16
7704991|NCT00440947|12126255|FG001|36-Week Induction Phase|Lost to Follow-up|0
7704992|NCT00440947|12126256|FG002|36-Week Induction Phase|Lost to Follow-up|0
7704993|NCT00440947|12126257|FG003|36-Week Induction Phase|Lost to Follow-up|0
7704994|NCT00440947|12126258|FG004|36-Week Induction Phase|Lost to Follow-up|0
7704995|NCT00440947|12126254|FG000|36-Week Induction Phase|Withdrawal by Subject|7
7704996|NCT00440947|12126255|FG001|36-Week Induction Phase|Withdrawal by Subject|0
7704997|NCT00440947|12126256|FG002|36-Week Induction Phase|Withdrawal by Subject|0
7704998|NCT00440947|12126257|FG003|36-Week Induction Phase|Withdrawal by Subject|0
7704999|NCT00440947|12126258|FG004|36-Week Induction Phase|Withdrawal by Subject|0
7705000|NCT00440947|12126254|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
7705001|NCT00440947|12126255|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
7705002|NCT00440947|12126256|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
7705003|NCT00440947|12126257|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
7705004|NCT00440947|12126258|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
7705005|NCT00440947|12126254|FG000|36-Week Induction Phase|Took Exclusionary Medications|1
7705006|NCT00440947|12126255|FG001|36-Week Induction Phase|Took Exclusionary Medications|0
7705007|NCT00440947|12126256|FG002|36-Week Induction Phase|Took Exclusionary Medications|0
7705008|NCT00440947|12126257|FG003|36-Week Induction Phase|Took Exclusionary Medications|0
7705009|NCT00440947|12126258|FG004|36-Week Induction Phase|Took Exclusionary Medications|0
7705010|NCT00440947|12126254|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
7705011|NCT00440947|12126255|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
7705012|NCT00440947|12126256|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
7705013|NCT00440947|12126257|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
7705014|NCT00440947|12126258|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
7705015|NCT00440947|12126254|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
7705016|NCT00440947|12126255|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
7705017|NCT00440947|12126256|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
7705018|NCT00440947|12126257|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
7705019|NCT00440947|12126258|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
7705020|NCT00440947|12126254|FG000|36-Week Induction Phase|Incarceration|3
7705021|NCT00440947|12126255|FG001|36-Week Induction Phase|Incarceration|0
7705022|NCT00440947|12126256|FG002|36-Week Induction Phase|Incarceration|0
7705023|NCT00440947|12126257|FG003|36-Week Induction Phase|Incarceration|0
7705024|NCT00440947|12126258|FG004|36-Week Induction Phase|Incarceration|0
7705025|NCT00440947|12126254|FG000|36-Week Induction Phase|Pregnancy|1
7705026|NCT00440947|12126255|FG001|36-Week Induction Phase|Pregnancy|0
7705027|NCT00440947|12126256|FG002|36-Week Induction Phase|Pregnancy|0
7705028|NCT00440947|12126257|FG003|36-Week Induction Phase|Pregnancy|0
7705029|NCT00440947|12126258|FG004|36-Week Induction Phase|Pregnancy|0
7705030|NCT00440947|12126254|FG000|48-Week Randomization Phase|Adverse Event|0
7705031|NCT00440947|12126255|FG001|48-Week Randomization Phase|Adverse Event|2
7705032|NCT00440947|12126256|FG002|48-Week Randomization Phase|Adverse Event|5
7705033|NCT00440947|12126257|FG003|48-Week Randomization Phase|Adverse Event|0
7705034|NCT00440947|12126258|FG004|48-Week Randomization Phase|Adverse Event|0
7705035|NCT00440947|12126254|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
7705036|NCT00440947|12126255|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
7705037|NCT00440947|12126256|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
7705038|NCT00440947|12126257|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
7705039|NCT00440947|12126258|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
7705040|NCT00440947|12126254|FG000|48-Week Randomization Phase|Non-compliance|0
7705041|NCT00440947|12126255|FG001|48-Week Randomization Phase|Non-compliance|3
7705042|NCT00440947|12126256|FG002|48-Week Randomization Phase|Non-compliance|4
7705043|NCT00440947|12126257|FG003|48-Week Randomization Phase|Non-compliance|0
7705044|NCT00440947|12126258|FG004|48-Week Randomization Phase|Non-compliance|0
7705045|NCT00440947|12126254|FG000|48-Week Randomization Phase|Lost to Follow-up|0
7705046|NCT00440947|12126255|FG001|48-Week Randomization Phase|Lost to Follow-up|2
7705047|NCT00440947|12126256|FG002|48-Week Randomization Phase|Lost to Follow-up|8
7705048|NCT00440947|12126257|FG003|48-Week Randomization Phase|Lost to Follow-up|0
7705049|NCT00440947|12126258|FG004|48-Week Randomization Phase|Lost to Follow-up|0
7705050|NCT00440947|12126254|FG000|48-Week Randomization Phase|Protocol Violation|0
7705051|NCT00440947|12126255|FG001|48-Week Randomization Phase|Protocol Violation|0
7705052|NCT00440947|12126256|FG002|48-Week Randomization Phase|Protocol Violation|1
7705053|NCT00440947|12126257|FG003|48-Week Randomization Phase|Protocol Violation|0
7705054|NCT00440947|12126258|FG004|48-Week Randomization Phase|Protocol Violation|0
7705055|NCT00440947|12126254|FG000|48-Week Randomization Phase|Withdrawal by Subject|0
7705056|NCT00440947|12126255|FG001|48-Week Randomization Phase|Withdrawal by Subject|2
7705057|NCT00440947|12126256|FG002|48-Week Randomization Phase|Withdrawal by Subject|4
7705058|NCT00440947|12126257|FG003|48-Week Randomization Phase|Withdrawal by Subject|0
7705059|NCT00440947|12126258|FG004|48-Week Randomization Phase|Withdrawal by Subject|0
7705060|NCT00440947|12126254|FG000|48-Week Randomization Phase|Pregnancy|0
7705061|NCT00440947|12126255|FG001|48-Week Randomization Phase|Pregnancy|0
7705062|NCT00440947|12126256|FG002|48-Week Randomization Phase|Pregnancy|1
7705063|NCT00440947|12126257|FG003|48-Week Randomization Phase|Pregnancy|0
7705064|NCT00440947|12126258|FG004|48-Week Randomization Phase|Pregnancy|0
7705065|NCT00440947|12126254|FG000|48-Week Randomization Phase|Incarceration|0
7705066|NCT00440947|12126255|FG001|48-Week Randomization Phase|Incarceration|3
7705067|NCT00440947|12126256|FG002|48-Week Randomization Phase|Incarceration|0
7705068|NCT00440947|12126257|FG003|48-Week Randomization Phase|Incarceration|0
7705069|NCT00440947|12126258|FG004|48-Week Randomization Phase|Incarceration|0
7705070|NCT00440947|12126254|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0
7705071|NCT00440947|12126255|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1
7705072|NCT00440947|12126256|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0
7705073|NCT00440947|12126257|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0
7705074|NCT00440947|12126258|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0
7705075|NCT00440947|12126254|FG000|48-Week Randomization Phase|Physician Decision|0
7705076|NCT00440947|12126255|FG001|48-Week Randomization Phase|Physician Decision|2
7705077|NCT00440947|12126256|FG002|48-Week Randomization Phase|Physician Decision|0
7705078|NCT00440947|12126257|FG003|48-Week Randomization Phase|Physician Decision|0
7705079|NCT00440947|12126258|FG004|48-Week Randomization Phase|Physician Decision|0
7705080|NCT00440947|12126254|FG000|Optional 60-Week Extension Phase|Adverse Event|0
7705081|NCT00440947|12126255|FG001|Optional 60-Week Extension Phase|Adverse Event|0
7705082|NCT00440947|12126256|FG002|Optional 60-Week Extension Phase|Adverse Event|0
7705083|NCT00440947|12126257|FG003|Optional 60-Week Extension Phase|Adverse Event|1
7705084|NCT00440947|12126258|FG004|Optional 60-Week Extension Phase|Adverse Event|3
7705085|NCT00440947|12126254|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
7705086|NCT00440947|12126255|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
7705087|NCT00440947|12126256|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
7705088|NCT00440947|12126257|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
7705089|NCT00440947|12126258|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
7705090|NCT00440947|12126254|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
7705091|NCT00440947|12126255|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
7705092|NCT00440947|12126256|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
7705093|NCT00440947|12126257|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
7705094|NCT00440947|12126258|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
7705095|NCT00440947|12126254|FG000|Optional 60-Week Extension Phase|Non-compliance|0
7705096|NCT00440947|12126255|FG001|Optional 60-Week Extension Phase|Non-compliance|0
7705097|NCT00440947|12126256|FG002|Optional 60-Week Extension Phase|Non-compliance|0
7705098|NCT00440947|12126257|FG003|Optional 60-Week Extension Phase|Non-compliance|1
7705099|NCT00440947|12126258|FG004|Optional 60-Week Extension Phase|Non-compliance|1
7705100|NCT00440947|12126254|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0
7705101|NCT00440947|12126255|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0
7705102|NCT00440947|12126256|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0
7705103|NCT00440947|12126257|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9
7705104|NCT00440947|12126258|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9
7705105|NCT00440947|12126254|FG000|Optional 60-Week Extension Phase|Protocol Violation|0
7705106|NCT00440947|12126255|FG001|Optional 60-Week Extension Phase|Protocol Violation|0
7705107|NCT00440947|12126256|FG002|Optional 60-Week Extension Phase|Protocol Violation|0
7705108|NCT00440947|12126257|FG003|Optional 60-Week Extension Phase|Protocol Violation|1
7705109|NCT00440947|12126258|FG004|Optional 60-Week Extension Phase|Protocol Violation|0
7705110|NCT00440947|12126254|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0
7705111|NCT00440947|12126255|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0
7705112|NCT00440947|12126256|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0
7705113|NCT00440947|12126257|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4
7705114|NCT00440947|12126258|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3
7705115|NCT00440947|12126254|FG000|Optional 60-Week Extension Phase|Pregnancy|0
7705116|NCT00440947|12126255|FG001|Optional 60-Week Extension Phase|Pregnancy|0
7705117|NCT00440947|12126256|FG002|Optional 60-Week Extension Phase|Pregnancy|0
7705118|NCT00440947|12126257|FG003|Optional 60-Week Extension Phase|Pregnancy|3
7705119|NCT00440947|12126258|FG004|Optional 60-Week Extension Phase|Pregnancy|0
7705120|NCT00440947|12126254|FG000|Optional 60-Week Extension Phase|Participant Moved|0
7705121|NCT00440947|12126255|FG001|Optional 60-Week Extension Phase|Participant Moved|0
7705122|NCT00440947|12126256|FG002|Optional 60-Week Extension Phase|Participant Moved|0
7705123|NCT00440947|12126257|FG003|Optional 60-Week Extension Phase|Participant Moved|1
7705124|NCT00440947|12126258|FG004|Optional 60-Week Extension Phase|Participant Moved|1
7705125|NCT00440947|12126254|FG000|Optional 60-Week Extension Phase|Sponsor Request|0
7705126|NCT00440947|12126255|FG001|Optional 60-Week Extension Phase|Sponsor Request|0
7705127|NCT00440947|12126256|FG002|Optional 60-Week Extension Phase|Sponsor Request|0
7705128|NCT00440947|12126257|FG003|Optional 60-Week Extension Phase|Sponsor Request|1
7705129|NCT00440947|12126258|FG004|Optional 60-Week Extension Phase|Sponsor Request|1
7705130|NCT00440947|12126254|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
7705131|NCT00440947|12126255|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
7705132|NCT00440947|12126256|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
7705133|NCT00440947|12126257|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
7705134|NCT00440947|12126258|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
7705135|NCT00440947|12126254|FG000|Optional 60-Week Extension Phase|Other|0
7705136|NCT00440947|12126255|FG001|Optional 60-Week Extension Phase|Other|0
7705137|NCT00440947|12126256|FG002|Optional 60-Week Extension Phase|Other|0
7705138|NCT00440947|12126257|FG003|Optional 60-Week Extension Phase|Other|1
7705139|NCT00440947|12126258|FG004|Optional 60-Week Extension Phase|Other|0
7705140|NCT00440947|12126254|FG000|Optional 60-Week Extension Phase|Physician Decision|0
7705141|NCT00440947|12126255|FG001|Optional 60-Week Extension Phase|Physician Decision|0
7705142|NCT00440947|12126256|FG002|Optional 60-Week Extension Phase|Physician Decision|0
7705143|NCT00440947|12126257|FG003|Optional 60-Week Extension Phase|Physician Decision|0
7705144|NCT00440947|12126258|FG004|Optional 60-Week Extension Phase|Physician Decision|1
7705145|NCT00440947|12126254|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
7705146|NCT00440947|12126255|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
7705147|NCT00440947|12126256|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
7705148|NCT00440947|12126257|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
7705149|NCT00440947|12126258|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
7705150|NCT00440999|12126272|FG000|Overall Study|Adverse Event|0
7705151|NCT00440999|12126273|FG001|Overall Study|Adverse Event|2
7705152|NCT00440999|12126272|FG000|Overall Study|Lack of Efficacy|6
7705153|NCT00440999|12126273|FG001|Overall Study|Lack of Efficacy|7
7705154|NCT00440999|12126272|FG000|Overall Study|Lost to Follow-up|19
7705155|NCT00440999|12126273|FG001|Overall Study|Lost to Follow-up|12
7705156|NCT00440999|12126272|FG000|Overall Study|Protocol Violation|1
7705157|NCT00440999|12126273|FG001|Overall Study|Protocol Violation|0
7705158|NCT00440999|12126272|FG000|Overall Study|Withdrawal by Subject|2
7705159|NCT00440999|12126273|FG001|Overall Study|Withdrawal by Subject|5
7705160|NCT00440999|12126272|FG000|Overall Study|Subjets missed the visit|1
7705161|NCT00440999|12126273|FG001|Overall Study|Subjets missed the visit|0
7705162|NCT00440999|12126272|FG000|Overall Study|Mixed infection at entry|1
7705163|NCT00440999|12126273|FG001|Overall Study|Mixed infection at entry|0
7705164|NCT00440999|12126272|FG000|Overall Study|P. falciparum malaria|5
7705165|NCT00440999|12126273|FG001|Overall Study|P. falciparum malaria|14
7705166|NCT00440999|12126272|FG000|Overall Study|Subj left hosp without inform staff|0
7705167|NCT00440999|12126273|FG001|Overall Study|Subj left hosp without inform staff|1
7705168|NCT00441012|12126283|FG000|Overall Study|Adverse Event|0
7705169|NCT00441012|12126284|FG001|Overall Study|Adverse Event|1
7705170|NCT00441012|12126283|FG000|Overall Study|Lost to Follow-up|3
7705171|NCT00441012|12126284|FG001|Overall Study|Lost to Follow-up|3
7705172|NCT00441012|12126283|FG000|Overall Study|Protocol Violation|10
7705173|NCT00441012|12126284|FG001|Overall Study|Protocol Violation|9
7705174|NCT00441012|12126283|FG000|Overall Study|Withdrawal by Subject|4
7705175|NCT00441012|12126284|FG001|Overall Study|Withdrawal by Subject|0
7705176|NCT00441012|12126283|FG000|Overall Study|Subject Randomized but Not Vaccinated|1
7705177|NCT00441012|12126284|FG001|Overall Study|Subject Randomized but Not Vaccinated|0
7705178|NCT00441064|12126292|FG000|Overall Study|Adverse Event|1
7705179|NCT00441064|12126293|FG001|Overall Study|Adverse Event|0
7705180|NCT00441064|12126292|FG000|Overall Study|Abnormal laboratory values|0
7705181|NCT00441064|12126293|FG001|Overall Study|Abnormal laboratory values|2
7705182|NCT00441064|12126292|FG000|Overall Study|Abnormal test procedure results|0
7705183|NCT00441064|12126293|FG001|Overall Study|Abnormal test procedure results|1
7705184|NCT00441064|12126292|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7705185|NCT00441064|12126293|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7705186|NCT00441064|12126292|FG000|Overall Study|Protocol Deviation|3
7705187|NCT00441064|12126293|FG001|Overall Study|Protocol Deviation|2
7705188|NCT00441064|12126292|FG000|Overall Study|Patient withdrew consent|5
7705189|NCT00441064|12126293|FG001|Overall Study|Patient withdrew consent|2
7705190|NCT00441090|12126304|FG000|Overall Study|Adverse Event|0
7705191|NCT00441090|12126305|FG001|Overall Study|Adverse Event|1
7705192|NCT00441090|12126306|FG002|Overall Study|Adverse Event|1
7705193|NCT00441090|12126307|FG003|Overall Study|Adverse Event|0
7705194|NCT00441090|12126308|FG004|Overall Study|Adverse Event|0
7705195|NCT00441090|12126304|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0
7705196|NCT00441090|12126305|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0
7705197|NCT00441090|12126306|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0
7705198|NCT00441090|12126307|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2
7705199|NCT00441090|12126308|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0
7705200|NCT00441090|12126304|FG000|Overall Study|Withdrawal by Subject|1
7705201|NCT00441090|12126305|FG001|Overall Study|Withdrawal by Subject|0
7705202|NCT00441090|12126306|FG002|Overall Study|Withdrawal by Subject|1
7705203|NCT00441090|12126307|FG003|Overall Study|Withdrawal by Subject|0
7705204|NCT00441090|12126308|FG004|Overall Study|Withdrawal by Subject|0
7705205|NCT00441090|12126304|FG000|Overall Study|Lack of Efficacy|1
7705206|NCT00441090|12126305|FG001|Overall Study|Lack of Efficacy|0
7705207|NCT00441090|12126306|FG002|Overall Study|Lack of Efficacy|0
7705208|NCT00441090|12126307|FG003|Overall Study|Lack of Efficacy|0
7705209|NCT00441090|12126308|FG004|Overall Study|Lack of Efficacy|0
7705210|NCT00441103|12126322|FG000|Overall Study|Adverse Event|2
7705211|NCT00441103|12126323|FG001|Overall Study|Adverse Event|1
7705212|NCT00441103|12126322|FG000|Overall Study|Death|1
7705213|NCT00441103|12126323|FG001|Overall Study|Death|0
7705214|NCT00441103|12126322|FG000|Overall Study|Disease Progression|2
7705215|NCT00441103|12126323|FG001|Overall Study|Disease Progression|0
7705216|NCT00441103|12126322|FG000|Overall Study|Lost to Follow-up|1
7705217|NCT00441103|12126323|FG001|Overall Study|Lost to Follow-up|0
7705218|NCT00441103|12126322|FG000|Overall Study|Protocol Violation|1
7705219|NCT00441103|12126323|FG001|Overall Study|Protocol Violation|0
7705220|NCT00441103|12126322|FG000|Overall Study|Participant unable to use Rebiject II|1
7705221|NCT00441103|12126323|FG001|Overall Study|Participant unable to use Rebiject II|0
7705222|NCT00441103|12126322|FG000|Overall Study|Participant refused MRI|1
7705223|NCT00441103|12126323|FG001|Overall Study|Participant refused MRI|0
7705224|NCT00441103|12126322|FG000|Overall Study|Inclusion criteria absent|1
7705225|NCT00441103|12126323|FG001|Overall Study|Inclusion criteria absent|0
7705226|NCT00441103|12126322|FG000|Overall Study|Non-compliant|0
7705227|NCT00441103|12126323|FG001|Overall Study|Non-compliant|1
7705228|NCT00441103|12126322|FG000|Overall Study|Participant decided to withdraw|1
7705229|NCT00441103|12126323|FG001|Overall Study|Participant decided to withdraw|0
7705230|NCT00441103|12126322|FG000|Overall Study|Participant's reason|0
7705231|NCT00441103|12126323|FG001|Overall Study|Participant's reason|1
7705232|NCT00441103|12126322|FG000|Overall Study|Participant decided to stop|0
7705233|NCT00441103|12126323|FG001|Overall Study|Participant decided to stop|1
7705234|NCT00441116|12126332|FG000|Overall Study|Adverse Event|1
7705235|NCT00441116|12126333|FG001|Overall Study|Adverse Event|1
7705236|NCT00441116|12126332|FG000|Overall Study|Withdrawal by Subject|1
7705237|NCT00441116|12126333|FG001|Overall Study|Withdrawal by Subject|0
7705238|NCT00441116|12126332|FG000|Overall Study|Did not meet Eligibility Criteria|1
7705239|NCT00441116|12126333|FG001|Overall Study|Did not meet Eligibility Criteria|1
7705240|NCT00441129|12126341|FG000|Overall Study|Withdrawal by Subject|6
7705241|NCT00441129|12126342|FG001|Overall Study|Withdrawal by Subject|14
7705242|NCT00441142|12126352|FG000|Overall Study|Adverse Event|2
7705243|NCT00441142|12126353|FG001|Overall Study|Adverse Event|3
7705244|NCT00441142|12126354|FG002|Overall Study|Adverse Event|3
7705245|NCT00441142|12126355|FG003|Overall Study|Adverse Event|22
7705246|NCT00441142|12126352|FG000|Overall Study|Lack of Efficacy|3
7705247|NCT00441142|12126353|FG001|Overall Study|Lack of Efficacy|3
7705248|NCT00441142|12126354|FG002|Overall Study|Lack of Efficacy|17
7705249|NCT00441142|12126355|FG003|Overall Study|Lack of Efficacy|32
7705250|NCT00441142|12126352|FG000|Overall Study|Withdrawal by Subject|0
7705251|NCT00441142|12126353|FG001|Overall Study|Withdrawal by Subject|0
7705252|NCT00441142|12126354|FG002|Overall Study|Withdrawal by Subject|2
7705253|NCT00441142|12126355|FG003|Overall Study|Withdrawal by Subject|10
7705254|NCT00441142|12126352|FG000|Overall Study|Patient still receiving active study tx|1
7705255|NCT00441142|12126353|FG001|Overall Study|Patient still receiving active study tx|0
7705256|NCT00441142|12126354|FG002|Overall Study|Patient still receiving active study tx|0
7705257|NCT00441142|12126355|FG003|Overall Study|Patient still receiving active study tx|2
7705258|NCT00441142|12126352|FG000|Overall Study|Physician Decision|0
7705259|NCT00441142|12126353|FG001|Overall Study|Physician Decision|1
7705260|NCT00441142|12126354|FG002|Overall Study|Physician Decision|0
7705261|NCT00441142|12126355|FG003|Overall Study|Physician Decision|1
7705262|NCT00441142|12126352|FG000|Overall Study|Death|0
7705263|NCT00441142|12126353|FG001|Overall Study|Death|0
7705264|NCT00441142|12126354|FG002|Overall Study|Death|0
7705265|NCT00441142|12126355|FG003|Overall Study|Death|1
7705266|NCT00441168|12126369|FG000|Treatment Period|Death|3
7705267|NCT00441168|12126370|FG001|Treatment Period|Death|0
7705268|NCT00441168|12126369|FG000|Treatment Period|Adverse Event|1
7705269|NCT00441168|12126370|FG001|Treatment Period|Adverse Event|2
7705270|NCT00441168|12126369|FG000|Treatment Period|Progressive Disease|0
7705271|NCT00441168|12126370|FG001|Treatment Period|Progressive Disease|2
7705272|NCT00441168|12126369|FG000|Treatment Period|Protocol Violation|0
7705273|NCT00441168|12126370|FG001|Treatment Period|Protocol Violation|1
7705274|NCT00441168|12126369|FG000|Treatment Period|Lost to Follow-up|0
7705275|NCT00441168|12126370|FG001|Treatment Period|Lost to Follow-up|1
7705276|NCT00441168|12126369|FG000|Treatment Period|Withdrawal by Subject|3
7705277|NCT00441168|12126370|FG001|Treatment Period|Withdrawal by Subject|0
7705278|NCT00441168|12126369|FG000|Treatment Period|qualified for stem-cell transplantation|3
7705279|NCT00441168|12126370|FG001|Treatment Period|qualified for stem-cell transplantation|0
7705280|NCT00441168|12126369|FG000|Treatment Period|refractory disease|1
7705281|NCT00441168|12126370|FG001|Treatment Period|refractory disease|0
7705282|NCT00441168|12126369|FG000|Follow-up Period|Death|3
7705283|NCT00441168|12126370|FG001|Follow-up Period|Death|0
7705284|NCT00441168|12126369|FG000|Follow-up Period|Lost to Follow-up|5
7705285|NCT00441168|12126370|FG001|Follow-up Period|Lost to Follow-up|6
7705286|NCT00441168|12126369|FG000|Follow-up Period|Withdrawal by Subject|3
7705287|NCT00441168|12126370|FG001|Follow-up Period|Withdrawal by Subject|0
7705288|NCT00441168|12126369|FG000|Follow-up Period|Other|1
7705289|NCT00441168|12126370|FG001|Follow-up Period|Other|3
7705290|NCT00441337|12126410|FG000|Overall Study|Disease Progression|6
7705291|NCT00441337|12126411|FG001|Overall Study|Disease Progression|6
7705292|NCT00441337|12126412|FG002|Overall Study|Disease Progression|4
7705293|NCT00441337|12126413|FG003|Overall Study|Disease Progression|18
7705294|NCT00441337|12126410|FG000|Overall Study|Lost to Follow-up|0
7705295|NCT00441337|12126411|FG001|Overall Study|Lost to Follow-up|0
7705296|NCT00441337|12126412|FG002|Overall Study|Lost to Follow-up|0
7705297|NCT00441337|12126413|FG003|Overall Study|Lost to Follow-up|1
7705298|NCT00441337|12126410|FG000|Overall Study|Sponsor Decision|0
7705299|NCT00441337|12126411|FG001|Overall Study|Sponsor Decision|0
7705300|NCT00441337|12126412|FG002|Overall Study|Sponsor Decision|1
7705301|NCT00441337|12126413|FG003|Overall Study|Sponsor Decision|2
7705302|NCT00441337|12126410|FG000|Overall Study|Did not meet inclusion criteria|0
7705303|NCT00441337|12126411|FG001|Overall Study|Did not meet inclusion criteria|0
7705304|NCT00441337|12126412|FG002|Overall Study|Did not meet inclusion criteria|1
7705305|NCT00441337|12126413|FG003|Overall Study|Did not meet inclusion criteria|0
7705306|NCT00441363|12126454|FG000|Overall Study|Adverse Event|4
7705307|NCT00441363|12126455|FG001|Overall Study|Adverse Event|2
7705308|NCT00441363|12126454|FG000|Overall Study|Withdrawal by Subject|3
7705309|NCT00441363|12126455|FG001|Overall Study|Withdrawal by Subject|4
7705310|NCT00441363|12126454|FG000|Overall Study|Physician Decision|6
7705311|NCT00441363|12126455|FG001|Overall Study|Physician Decision|7
7705312|NCT00441363|12126454|FG000|Overall Study|Lost to Follow-up|2
7705313|NCT00441363|12126455|FG001|Overall Study|Lost to Follow-up|2
7705314|NCT00441363|12126454|FG000|Overall Study|Other|2
7705315|NCT00441363|12126455|FG001|Overall Study|Other|0
7705316|NCT00441441|12126463|FG000|Overall Study|Adverse Event|2
7705317|NCT00441441|12126464|FG001|Overall Study|Adverse Event|1
7705318|NCT00441441|12126463|FG000|Overall Study|Protocol Violation|4
7705319|NCT00441441|12126464|FG001|Overall Study|Protocol Violation|6
7705320|NCT00441441|12126463|FG000|Overall Study|Exacerbation of asthma|1
7705321|NCT00441441|12126464|FG001|Overall Study|Exacerbation of asthma|2
7705322|NCT00441441|12126463|FG000|Overall Study|Withdrawal by Subject|1
7705323|NCT00441441|12126464|FG001|Overall Study|Withdrawal by Subject|2
7705324|NCT00441441|12126463|FG000|Overall Study|Other|3
7705325|NCT00441441|12126464|FG001|Overall Study|Other|3
7705326|NCT00441467|12126484|FG000|Overall Study|Adverse Event|6
7705327|NCT00441467|12126484|FG000|Overall Study|Withdrawal by Subject|3
7705328|NCT00441467|12126484|FG000|Overall Study|Progressive disease|9
7705329|NCT00441480|12126490|FG000|Overall Study|Protocol Violation|1
7705330|NCT00441480|12126491|FG001|Overall Study|Protocol Violation|1
7705331|NCT00441480|12126490|FG000|Overall Study|Withdrawal by Subject|2
7705332|NCT00441480|12126491|FG001|Overall Study|Withdrawal by Subject|3
7705333|NCT00441545|12126497|FG000|First Intervention|Adverse Event|6
7705334|NCT00441545|12126498|FG001|First Intervention|Adverse Event|5
7705335|NCT00441545|12126497|FG000|First Intervention|Protocol Violation|2
7705336|NCT00441545|12126498|FG001|First Intervention|Protocol Violation|2
7705337|NCT00441545|12126497|FG000|First Intervention|Withdrawal by Subject|3
7705338|NCT00441545|12126498|FG001|First Intervention|Withdrawal by Subject|3
7705339|NCT00441545|12126497|FG000|First Intervention|Kidney transplant|1
7705340|NCT00441545|12126498|FG001|First Intervention|Kidney transplant|1
7705341|NCT00441545|12126497|FG000|First Intervention|Lack of Efficacy|2
7705342|NCT00441545|12126498|FG001|First Intervention|Lack of Efficacy|0
7705343|NCT00441545|12126497|FG000|First Intervention|Subject exceeded safety criteria|0
7705344|NCT00441545|12126498|FG001|First Intervention|Subject exceeded safety criteria|1
7705345|NCT00441545|12126497|FG000|First Intervention|Subject met an exclusionary criteria|1
7705346|NCT00441545|12126498|FG001|First Intervention|Subject met an exclusionary criteria|0
7705347|NCT00441545|12126497|FG000|First Intervention|Extended hospitalization|1
7705348|NCT00441545|12126498|FG001|First Intervention|Extended hospitalization|0
7705349|NCT00441545|12126497|FG000|First Intervention|Site error|1
7705350|NCT00441545|12126498|FG001|First Intervention|Site error|0
7705351|NCT00441545|12126497|FG000|First Intervention|Sponsor's request|1
7705352|NCT00441545|12126498|FG001|First Intervention|Sponsor's request|0
7705353|NCT00441545|12126497|FG000|Second Intervention|Adverse Event|5
7705354|NCT00441545|12126498|FG001|Second Intervention|Adverse Event|2
7705355|NCT00441545|12126497|FG000|Second Intervention|Protocol Violation|4
7705356|NCT00441545|12126498|FG001|Second Intervention|Protocol Violation|1
7705357|NCT00441545|12126497|FG000|Second Intervention|Withdrawal by Subject|1
7705358|NCT00441545|12126498|FG001|Second Intervention|Withdrawal by Subject|1
7705359|NCT00441545|12126497|FG000|Second Intervention|Kidney Transplant|1
7705360|NCT00441545|12126498|FG001|Second Intervention|Kidney Transplant|1
7705361|NCT00441545|12126497|FG000|Second Intervention|Lack of Efficacy|0
7705362|NCT00441545|12126498|FG001|Second Intervention|Lack of Efficacy|1
7705363|NCT00441545|12126497|FG000|Second Intervention|Subject exceeded safety criteria|1
7705364|NCT00441545|12126498|FG001|Second Intervention|Subject exceeded safety criteria|0
7705365|NCT00441545|12126497|FG000|Second Intervention|Subject moved|0
7705366|NCT00441545|12126498|FG001|Second Intervention|Subject moved|1
7705367|NCT00441584|12126508|FG000|Overall Study|Lack of Efficacy|79
7705368|NCT00441584|12126508|FG000|Overall Study|Withdrawal by Subject|8
7705369|NCT00441584|12126508|FG000|Overall Study|Adverse Event|6
7705370|NCT00441584|12126508|FG000|Overall Study|Protocol Violation|5
7705371|NCT00441584|12126508|FG000|Overall Study|Lost to Follow-up|4
7705372|NCT00441584|12126508|FG000|Overall Study|Failure to meet eligibility criteria|3
7705373|NCT00441701|12126522|FG000|Overall Study|Adverse Event|3
7705374|NCT00441701|12126523|FG001|Overall Study|Adverse Event|2
7705375|NCT00441701|12126524|FG002|Overall Study|Adverse Event|1
7705376|NCT00441701|12126525|FG003|Overall Study|Adverse Event|0
7705377|NCT00441701|12126526|FG004|Overall Study|Adverse Event|2
7705378|NCT00441701|12126527|FG005|Overall Study|Adverse Event|2
7705379|NCT00441701|12126528|FG006|Overall Study|Adverse Event|0
7705380|NCT00441701|12126529|FG007|Overall Study|Adverse Event|0
7705381|NCT00441701|12126530|FG008|Overall Study|Adverse Event|0
7705382|NCT00441701|12126531|FG009|Overall Study|Adverse Event|0
7705383|NCT00441701|12126522|FG000|Overall Study|Lack of Efficacy|2
7705384|NCT00441701|12126523|FG001|Overall Study|Lack of Efficacy|0
7705385|NCT00441701|12126524|FG002|Overall Study|Lack of Efficacy|2
7705386|NCT00441701|12126525|FG003|Overall Study|Lack of Efficacy|2
7705387|NCT00441701|12126526|FG004|Overall Study|Lack of Efficacy|0
7705388|NCT00441701|12126527|FG005|Overall Study|Lack of Efficacy|1
7705389|NCT00441701|12126528|FG006|Overall Study|Lack of Efficacy|0
7705390|NCT00441701|12126529|FG007|Overall Study|Lack of Efficacy|0
7705391|NCT00441701|12126530|FG008|Overall Study|Lack of Efficacy|0
7705392|NCT00441701|12126531|FG009|Overall Study|Lack of Efficacy|0
7705393|NCT00441701|12126522|FG000|Overall Study|Withdrawal by Subject|0
7705394|NCT00441701|12126523|FG001|Overall Study|Withdrawal by Subject|2
7705395|NCT00441701|12126524|FG002|Overall Study|Withdrawal by Subject|1
7705396|NCT00441701|12126525|FG003|Overall Study|Withdrawal by Subject|1
7705397|NCT00441701|12126526|FG004|Overall Study|Withdrawal by Subject|0
7705398|NCT00441701|12126527|FG005|Overall Study|Withdrawal by Subject|0
7705399|NCT00441701|12126528|FG006|Overall Study|Withdrawal by Subject|0
7705400|NCT00441701|12126529|FG007|Overall Study|Withdrawal by Subject|0
7705401|NCT00441701|12126530|FG008|Overall Study|Withdrawal by Subject|0
7705402|NCT00441701|12126531|FG009|Overall Study|Withdrawal by Subject|0
7705403|NCT00441727|12126552|FG000|Overall Study|Protocol Violation|19
7705404|NCT00441727|12126553|FG001|Overall Study|Protocol Violation|28
7705405|NCT00441727|12126554|FG002|Overall Study|Protocol Violation|32
7705406|NCT00441727|12126552|FG000|Overall Study|Adverse Event|26
7705407|NCT00441727|12126553|FG001|Overall Study|Adverse Event|33
7705408|NCT00441727|12126554|FG002|Overall Study|Adverse Event|28
7705409|NCT00441727|12126552|FG000|Overall Study|Lack of Efficacy|7
7705410|NCT00441727|12126553|FG001|Overall Study|Lack of Efficacy|8
7705411|NCT00441727|12126554|FG002|Overall Study|Lack of Efficacy|48
7705412|NCT00441727|12126552|FG000|Overall Study|Withdrawal by Subject|40
7705413|NCT00441727|12126553|FG001|Overall Study|Withdrawal by Subject|34
7705414|NCT00441727|12126554|FG002|Overall Study|Withdrawal by Subject|47
7705415|NCT00441727|12126552|FG000|Overall Study|Lost to Follow-up|5
7705416|NCT00441727|12126553|FG001|Overall Study|Lost to Follow-up|6
7705417|NCT00441727|12126554|FG002|Overall Study|Lost to Follow-up|5
7705418|NCT00441727|12126552|FG000|Overall Study|Safety Reasons|3
7705419|NCT00441727|12126553|FG001|Overall Study|Safety Reasons|1
7705420|NCT00441727|12126554|FG002|Overall Study|Safety Reasons|3
7705421|NCT00441727|12126552|FG000|Overall Study|Various reason specified|6
7705422|NCT00441727|12126553|FG001|Overall Study|Various reason specified|8
7705423|NCT00441727|12126554|FG002|Overall Study|Various reason specified|5
7705424|NCT00441792|12126586|FG000|Overall Study|Lost to Follow-up|0
7705425|NCT00441792|12126587|FG001|Overall Study|Lost to Follow-up|2
7705426|NCT00441974|12126614|FG000|Overall Study|Adverse Event|6
7705427|NCT00441974|12126614|FG000|Overall Study|Consent Withdrawn|35
7705428|NCT00441974|12126614|FG000|Overall Study|Lost to Follow-up|80
7705429|NCT00441974|12126614|FG000|Overall Study|Protocol Violation|7
7705430|NCT00442286|12126659|FG000|Overall Study|Death|2
7705431|NCT00442286|12126660|FG001|Overall Study|Death|2
7705432|NCT00442286|12126659|FG000|Overall Study|Lost to Follow-up|1
7705433|NCT00442286|12126660|FG001|Overall Study|Lost to Follow-up|0
7705434|NCT00442286|12126659|FG000|Overall Study|Withdrawal by Subject|2
7705435|NCT00442286|12126660|FG001|Overall Study|Withdrawal by Subject|0
7705436|NCT00442286|12126659|FG000|Overall Study|System explanted|1
7705437|NCT00442286|12126660|FG001|Overall Study|System explanted|0
7705438|NCT00442286|12126659|FG000|Overall Study|Patient Injury|1
7705439|NCT00442286|12126660|FG001|Overall Study|Patient Injury|0
7705440|NCT00442416|12126674|FG000|Overall Study|Adverse Event|4
7705441|NCT00442416|12126675|FG001|Overall Study|Adverse Event|1
7705442|NCT00442416|12126674|FG000|Overall Study|Death|1
7705443|NCT00442416|12126675|FG001|Overall Study|Death|0
7705444|NCT00442416|12126674|FG000|Overall Study|Lack of Efficacy|2
7705445|NCT00442416|12126675|FG001|Overall Study|Lack of Efficacy|0
7705446|NCT00442416|12126674|FG000|Overall Study|Protocol Violation|2
7705447|NCT00442416|12126675|FG001|Overall Study|Protocol Violation|3
7705448|NCT00442416|12126674|FG000|Overall Study|Withdrew consent|1
7705449|NCT00442416|12126675|FG001|Overall Study|Withdrew consent|2
7705450|NCT00442416|12126674|FG000|Overall Study|Administrative/Other|27
7705451|NCT00442416|12126675|FG001|Overall Study|Administrative/Other|33
7705452|NCT00442468|12126681|FG000|Overall Study|Adverse Event|4
7705453|NCT00442468|12126681|FG000|Overall Study|Withdrawal by Subject|91
7705454|NCT00442468|12126681|FG000|Overall Study|Did not complete all study procedures|88
7705455|NCT00442572|12126691|FG000|Overall Study|Relapse|8
7705456|NCT00442572|12126692|FG001|Overall Study|Relapse|1
7705457|NCT00442572|12126691|FG000|Overall Study|Lost to Follow-up|0
7705458|NCT00442572|12126692|FG001|Overall Study|Lost to Follow-up|1
7705459|NCT00442572|12126691|FG000|Overall Study|Withdrawal by Subject|0
7705460|NCT00442572|12126692|FG001|Overall Study|Withdrawal by Subject|1
7705461|NCT00442598|12126702|FG000|Overall Study|Adverse Event|1
7705462|NCT00442598|12126703|FG001|Overall Study|Adverse Event|0
7705463|NCT00442598|12126704|FG002|Overall Study|Adverse Event|0
7705464|NCT00442598|12126702|FG000|Overall Study|Tumor progression|3
7705465|NCT00442598|12126703|FG001|Overall Study|Tumor progression|4
7705466|NCT00442598|12126704|FG002|Overall Study|Tumor progression|0
7705467|NCT00442598|12126702|FG000|Overall Study|Clinical deterioration|1
7705468|NCT00442598|12126703|FG001|Overall Study|Clinical deterioration|2
7705469|NCT00442598|12126704|FG002|Overall Study|Clinical deterioration|0
7705470|NCT00442598|12126702|FG000|Overall Study|CA125 progression|0
7705471|NCT00442598|12126703|FG001|Overall Study|CA125 progression|1
7705472|NCT00442598|12126704|FG002|Overall Study|CA125 progression|0
7705473|NCT00442598|12126702|FG000|Overall Study|Reduced creatinine clearance|1
7705474|NCT00442598|12126703|FG001|Overall Study|Reduced creatinine clearance|0
7705475|NCT00442598|12126704|FG002|Overall Study|Reduced creatinine clearance|0
7705476|NCT00442598|12126702|FG000|Overall Study|Death|0
7705477|NCT00442598|12126703|FG001|Overall Study|Death|1
7705478|NCT00442598|12126704|FG002|Overall Study|Death|0
7705479|NCT00442702|12126735|FG000|Titration Period|Adverse Event|2
7705480|NCT00442702|12126736|FG001|Titration Period|Adverse Event|0
7705481|NCT00442702|12126735|FG000|Titration Period|Death|3
7705482|NCT00442702|12126736|FG001|Titration Period|Death|2
7705483|NCT00442702|12126735|FG000|Titration Period|Insufficient Therapeutic Response|1
7705484|NCT00442702|12126736|FG001|Titration Period|Insufficient Therapeutic Response|0
7705485|NCT00442702|12126735|FG000|Titration Period|Refused Treatment|4
7705486|NCT00442702|12126736|FG001|Titration Period|Refused Treatment|1
7705487|NCT00442702|12126735|FG000|Titration Period|Failure to return|1
7705488|NCT00442702|12126736|FG001|Titration Period|Failure to return|0
7705489|NCT00442702|12126735|FG000|Titration Period|Hospitalized in another hospital|1
7705490|NCT00442702|12126736|FG001|Titration Period|Hospitalized in another hospital|0
7705491|NCT00442702|12126735|FG000|Evaluation Period|Adverse Event|1
7705492|NCT00442702|12126736|FG001|Evaluation Period|Adverse Event|0
7705493|NCT00442702|12126735|FG000|Evaluation Period|Death|1
7705494|NCT00442702|12126736|FG001|Evaluation Period|Death|1
7705495|NCT00442702|12126735|FG000|Evaluation Period|Insufficient Therapeutic Response|1
7705496|NCT00442702|12126736|FG001|Evaluation Period|Insufficient Therapeutic Response|0
7705497|NCT00442702|12126735|FG000|Evaluation Period|Refused treatment|1
7705498|NCT00442702|12126736|FG001|Evaluation Period|Refused treatment|1
7705499|NCT00442702|12126735|FG000|Evaluation Period|Renal transplant|0
7705500|NCT00442702|12126736|FG001|Evaluation Period|Renal transplant|1
7705501|NCT00442702|12126735|FG000|Evaluation Period|Failure to return|1
7705502|NCT00442702|12126736|FG001|Evaluation Period|Failure to return|0
7705503|NCT00442702|12126735|FG000|Evaluation Period|Site closure|0
7705504|NCT00442702|12126736|FG001|Evaluation Period|Site closure|1
7705505|NCT00442936|12126752|FG000|Overall Study|Protocol Violation|1
7705506|NCT00442936|12126753|FG001|Overall Study|Protocol Violation|0
7705507|NCT00442936|12126754|FG002|Overall Study|Protocol Violation|1
7705508|NCT00442936|12126755|FG003|Overall Study|Protocol Violation|1
7705509|NCT00442962|12126765|FG000|Overall Study|Pregnancy|1
7705510|NCT00442962|12126765|FG000|Overall Study|Lost to Follow-up|7
7705511|NCT00443053|12126771|FG000|Overall Study|Adverse Event|2
7705512|NCT00443053|12126772|FG001|Overall Study|Adverse Event|1
7705513|NCT00443053|12126771|FG000|Overall Study|Withdrawal by Subject|9
7705514|NCT00443053|12126772|FG001|Overall Study|Withdrawal by Subject|18
7705515|NCT00443053|12126771|FG000|Overall Study|Lost to Follow-up|4
7705516|NCT00443053|12126772|FG001|Overall Study|Lost to Follow-up|5
7705517|NCT00443053|12126771|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
7705518|NCT00443053|12126772|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
7705519|NCT00443053|12126771|FG000|Overall Study|Noncompliance|2
7705520|NCT00443053|12126772|FG001|Overall Study|Noncompliance|1
7705521|NCT00443053|12126771|FG000|Overall Study|Other|3
7705522|NCT00443053|12126772|FG001|Overall Study|Other|4
7705523|NCT00443053|12126771|FG000|Overall Study|Physician Decision|0
7705524|NCT00443053|12126772|FG001|Overall Study|Physician Decision|4
7705525|NCT00443079|12126780|FG000|Overall Study|Lost to Follow-up|0
7705526|NCT00443079|12126781|FG001|Overall Study|Lost to Follow-up|1
7705527|NCT00443118|12126792|FG000|Overall Study|unknown primary outcome|3
7705528|NCT00443118|12126793|FG001|Overall Study|unknown primary outcome|1
7705529|NCT00443118|12126794|FG002|Overall Study|unknown primary outcome|0
7705530|NCT00443118|12126792|FG000|Overall Study|Withdrawal by Subject|1
7705531|NCT00443118|12126793|FG001|Overall Study|Withdrawal by Subject|0
7705532|NCT00443118|12126794|FG002|Overall Study|Withdrawal by Subject|0
7705533|NCT00443209|12126822|FG000|Months 1 to 12 Treatment Period|Adverse Event|22
7705534|NCT00443209|12126823|FG001|Months 1 to 12 Treatment Period|Adverse Event|11
7705535|NCT00443209|12126822|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14
7705536|NCT00443209|12126823|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7
7705537|NCT00443209|12126822|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50
7705538|NCT00443209|12126823|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11
7705539|NCT00443209|12126822|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
7705540|NCT00443209|12126823|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
7705541|NCT00443209|12126822|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36
7705542|NCT00443209|12126823|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15
7705543|NCT00443209|12126822|FG000|Months 1 to 12 Treatment Period|Physician Decision|8
7705544|NCT00443209|12126823|FG001|Months 1 to 12 Treatment Period|Physician Decision|4
7705545|NCT00443209|12126822|FG000|Months 1 to 12 Treatment Period|Pregnancy|3
7705546|NCT00443209|12126823|FG001|Months 1 to 12 Treatment Period|Pregnancy|4
7705547|NCT00443209|12126822|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43
7705548|NCT00443209|12126823|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23
7705549|NCT00443209|12126822|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
7705550|NCT00443209|12126823|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
7705551|NCT00443209|12126822|FG000|Months 1 to 12 Treatment Period|Missing|2
7705552|NCT00443209|12126823|FG001|Months 1 to 12 Treatment Period|Missing|1
7705553|NCT00443209|12126822|FG000|Months 1 to 12 Treatment Period|Not Treated|71
7705554|NCT00443209|12126823|FG001|Months 1 to 12 Treatment Period|Not Treated|43
7705555|NCT00443209|12126822|FG000|Months 13 to 18 Treatment Period|Adverse Event|1
7705556|NCT00443209|12126823|FG001|Months 13 to 18 Treatment Period|Adverse Event|0
7705557|NCT00443209|12126822|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1
7705558|NCT00443209|12126823|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0
7705559|NCT00443209|12126822|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1
7705560|NCT00443209|12126823|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0
7705561|NCT00443209|12126822|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2
7705562|NCT00443209|12126823|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2
7705563|NCT00443209|12126822|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87
7705564|NCT00443209|12126823|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43
7705565|NCT00443209|12126822|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
7705566|NCT00443209|12126823|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
7705567|NCT00443261|12126829|FG000|Overall Study|Death|1
7705568|NCT00443430|12126839|FG000|Overall Study|Lack of Efficacy|3
7705569|NCT00443430|12126840|FG001|Overall Study|Lack of Efficacy|3
7705570|NCT00443430|12126839|FG000|Overall Study|Adverse Event|1
7705571|NCT00443430|12126840|FG001|Overall Study|Adverse Event|1
7705572|NCT00443456|12126846|FG000|Overall Study|Adverse Event|16
7705573|NCT00443456|12126846|FG000|Overall Study|Move|1
7705574|NCT00443456|12126846|FG000|Overall Study|Withdrawal by Subject|1
7705575|NCT00443534|12126854|FG000|Overall Study|Lack of Efficacy|67
7705576|NCT00443534|12126854|FG000|Overall Study|Adverse Event|16
7705577|NCT00443534|12126854|FG000|Overall Study|Death|9
7705578|NCT00443534|12126854|FG000|Overall Study|Withdrawal by Subject|8
7705579|NCT00443534|12126854|FG000|Overall Study|Study Terminated by Sponsor|12
7705580|NCT00443534|12126854|FG000|Overall Study|Other|10
7705581|NCT00443534|12126854|FG000|Overall Study|Enrolled, Not Treated|1
7705582|NCT00443560|12126877|FG000|Overall Study|No intrathecal dose|58
7705583|NCT00443560|12126878|FG001|Overall Study|No intrathecal dose|26
7705584|NCT00443560|12126877|FG000|Overall Study|Multiple pregnancies or fetal demise|2
7705585|NCT00443560|12126878|FG001|Overall Study|Multiple pregnancies or fetal demise|4
7705586|NCT00443651|12126886|FG000|Overall Study|Death|1
7705587|NCT00443651|12126887|FG001|Overall Study|Death|5
7705588|NCT00443651|12126886|FG000|Overall Study|Adverse Event|5
7705589|NCT00443651|12126887|FG001|Overall Study|Adverse Event|6
7705590|NCT00443651|12126886|FG000|Overall Study|Lost to Follow-up|18
7705591|NCT00443651|12126887|FG001|Overall Study|Lost to Follow-up|12
7705592|NCT00443651|12126886|FG000|Overall Study|Patient's/Guardian's Decision|58
7705593|NCT00443651|12126887|FG001|Overall Study|Patient's/Guardian's Decision|30
7705594|NCT00443651|12126886|FG000|Overall Study|Physician Decision|13
7705595|NCT00443651|12126887|FG001|Overall Study|Physician Decision|4
7705596|NCT00443651|12126886|FG000|Overall Study|Pregnancy|0
7705597|NCT00443651|12126887|FG001|Overall Study|Pregnancy|1
7705598|NCT00443703|12126895|FG000|Overall Study|Never Treated|3
7705599|NCT00443703|12126896|FG001|Overall Study|Never Treated|1
7705600|NCT00443703|12126895|FG000|Overall Study|Adverse Event|7
7705601|NCT00443703|12126896|FG001|Overall Study|Adverse Event|3
7705602|NCT00443703|12126895|FG000|Overall Study|Lack of Efficacy|3
7705603|NCT00443703|12126896|FG001|Overall Study|Lack of Efficacy|1
7705604|NCT00443703|12126895|FG000|Overall Study|Lost to Follow-up|0
7705605|NCT00443703|12126896|FG001|Overall Study|Lost to Follow-up|4
7705606|NCT00443703|12126895|FG000|Overall Study|Physician Decision|4
7705607|NCT00443703|12126896|FG001|Overall Study|Physician Decision|2
7705608|NCT00443703|12126895|FG000|Overall Study|Protocol Violation|1
7705609|NCT00443703|12126896|FG001|Overall Study|Protocol Violation|1
7705610|NCT00443703|12126895|FG000|Overall Study|Withdrawal by Subject|9
7705611|NCT00443703|12126896|FG001|Overall Study|Withdrawal by Subject|6
7705612|NCT00443703|12126895|FG000|Overall Study|Progressive Disease|1
7705613|NCT00443703|12126896|FG001|Overall Study|Progressive Disease|0
7705614|NCT00443729|12126904|FG000|Overall Study|Never Treated|0
7705615|NCT00443729|12126905|FG001|Overall Study|Never Treated|1
7705616|NCT00443729|12126904|FG000|Overall Study|Lack of Efficacy|4
7705617|NCT00443729|12126905|FG001|Overall Study|Lack of Efficacy|2
7705618|NCT00443729|12126904|FG000|Overall Study|Lost to Follow-up|0
7705619|NCT00443729|12126905|FG001|Overall Study|Lost to Follow-up|1
7705620|NCT00443729|12126904|FG000|Overall Study|Physician Decision|2
7705621|NCT00443729|12126905|FG001|Overall Study|Physician Decision|1
7705622|NCT00443729|12126904|FG000|Overall Study|Protocol Violation|1
7705623|NCT00443729|12126905|FG001|Overall Study|Protocol Violation|1
7705624|NCT00443729|12126904|FG000|Overall Study|Withdrawal by Subject|3
7705625|NCT00443729|12126905|FG001|Overall Study|Withdrawal by Subject|1
7705626|NCT00443755|12126913|FG000|Overall Study|Withdrawal by Subject|2
7705627|NCT00443755|12126914|FG001|Overall Study|Withdrawal by Subject|1
7705628|NCT00443781|12126920|FG000|Overall Study|Lost to Follow-up|10
7705629|NCT00443781|12126920|FG000|Overall Study|Physician Decision|2
7705630|NCT00443781|12126920|FG000|Overall Study|Protocol Violation|1
7705631|NCT00443781|12126920|FG000|Overall Study|Withdrawal by Subject|6
7705632|NCT00443781|12126920|FG000|Overall Study|Unable to comply with study follow up|2
7705633|NCT00443781|12126920|FG000|Overall Study|Investigator terminated participation|1
7705634|NCT00443781|12126920|FG000|Overall Study|Insurance not covered|2
7705635|NCT00443781|12126920|FG000|Overall Study|PD/FAD not done|1
7705636|NCT00443820|12126928|FG000|Overall Study|Adverse Event|1
7705637|NCT00443820|12126929|FG001|Overall Study|Adverse Event|1
7705638|NCT00443820|12126930|FG002|Overall Study|Adverse Event|0
7705639|NCT00443820|12126931|FG003|Overall Study|Adverse Event|0
7705640|NCT00443820|12126928|FG000|Overall Study|Lack of Efficacy|3
7705641|NCT00443820|12126929|FG001|Overall Study|Lack of Efficacy|2
7705642|NCT00443820|12126930|FG002|Overall Study|Lack of Efficacy|1
7705643|NCT00443820|12126931|FG003|Overall Study|Lack of Efficacy|1
7705644|NCT00443820|12126928|FG000|Overall Study|Protocol Violation|2
7705645|NCT00443820|12126929|FG001|Overall Study|Protocol Violation|1
7705646|NCT00443820|12126930|FG002|Overall Study|Protocol Violation|2
7705647|NCT00443820|12126931|FG003|Overall Study|Protocol Violation|1
7705648|NCT00443820|12126928|FG000|Overall Study|Withdrawal by Subject|6
7705649|NCT00443820|12126929|FG001|Overall Study|Withdrawal by Subject|7
7705650|NCT00443820|12126930|FG002|Overall Study|Withdrawal by Subject|8
7705651|NCT00443820|12126931|FG003|Overall Study|Withdrawal by Subject|9
7705652|NCT00443820|12126928|FG000|Overall Study|Lost to Follow-up|9
7705653|NCT00443820|12126929|FG001|Overall Study|Lost to Follow-up|8
7705654|NCT00443820|12126930|FG002|Overall Study|Lost to Follow-up|6
7705655|NCT00443820|12126931|FG003|Overall Study|Lost to Follow-up|5
7705656|NCT00443820|12126928|FG000|Overall Study|Administrative problems|0
7705657|NCT00443820|12126929|FG001|Overall Study|Administrative problems|0
7705658|NCT00443820|12126930|FG002|Overall Study|Administrative problems|0
7705659|NCT00443820|12126931|FG003|Overall Study|Administrative problems|1
7705660|NCT00443820|12126928|FG000|Overall Study|Death|0
7705661|NCT00443820|12126929|FG001|Overall Study|Death|0
7705662|NCT00443820|12126930|FG002|Overall Study|Death|1
7705663|NCT00443820|12126931|FG003|Overall Study|Death|0
7705664|NCT00443846|12126943|FG000|Overall Study|Withdrawn due to intercurrent disease|1
7705665|NCT00443846|12126944|FG001|Overall Study|Withdrawn due to intercurrent disease|0
7705666|NCT00443846|12126943|FG000|Overall Study|Not vaccinated, no blood sample drawn|1
7705667|NCT00443846|12126944|FG001|Overall Study|Not vaccinated, no blood sample drawn|0
7705668|NCT00443846|12126943|FG000|Overall Study|Adverse Event|0
7705669|NCT00443846|12126944|FG001|Overall Study|Adverse Event|1
7705670|NCT00443846|12126943|FG000|Overall Study|Personal reason|8
7705671|NCT00443846|12126944|FG001|Overall Study|Personal reason|3
7705672|NCT00443846|12126943|FG000|Overall Study|Lost to Follow-up|1
7705673|NCT00443846|12126944|FG001|Overall Study|Lost to Follow-up|2
7705674|NCT00443872|12126950|FG000|Overall Study|Protocol Violation|7
7705675|NCT00443872|12126950|FG000|Overall Study|Lost to Follow-up|2
7705676|NCT00443872|12126950|FG000|Overall Study|Adverse Event|8
7705677|NCT00443898|12126967|FG000|Overall Study|Adverse Event|0
7705678|NCT00443898|12126968|FG001|Overall Study|Adverse Event|0
7705679|NCT00443898|12126969|FG002|Overall Study|Adverse Event|1
7705680|NCT00443898|12126970|FG003|Overall Study|Adverse Event|1
7705681|NCT00443898|12126967|FG000|Overall Study|Lack of Efficacy|2
7705682|NCT00443898|12126968|FG001|Overall Study|Lack of Efficacy|3
7705683|NCT00443898|12126969|FG002|Overall Study|Lack of Efficacy|3
7705684|NCT00443898|12126970|FG003|Overall Study|Lack of Efficacy|1
7705685|NCT00443898|12126967|FG000|Overall Study|Protocol Violation|1
7705686|NCT00443898|12126968|FG001|Overall Study|Protocol Violation|1
7705687|NCT00443898|12126969|FG002|Overall Study|Protocol Violation|1
7705688|NCT00443898|12126970|FG003|Overall Study|Protocol Violation|0
7705689|NCT00443898|12126967|FG000|Overall Study|Withdrawal by Subject|11
7705690|NCT00443898|12126968|FG001|Overall Study|Withdrawal by Subject|10
7705691|NCT00443898|12126969|FG002|Overall Study|Withdrawal by Subject|10
7705692|NCT00443898|12126970|FG003|Overall Study|Withdrawal by Subject|6
7705693|NCT00443898|12126967|FG000|Overall Study|Lost to Follow-up|10
7705694|NCT00443898|12126968|FG001|Overall Study|Lost to Follow-up|10
7705695|NCT00443898|12126969|FG002|Overall Study|Lost to Follow-up|14
7705696|NCT00443898|12126970|FG003|Overall Study|Lost to Follow-up|10
7705697|NCT00443898|12126967|FG000|Overall Study|Death|0
7705698|NCT00443898|12126968|FG001|Overall Study|Death|1
7705699|NCT00443898|12126969|FG002|Overall Study|Death|0
7705700|NCT00443898|12126970|FG003|Overall Study|Death|0
7705701|NCT00444067|12127006|FG000|Overall Study|Lost to Follow-up|0
7705702|NCT00444067|12127007|FG001|Overall Study|Lost to Follow-up|1
7705703|NCT00444106|12127028|FG000|Overall Study|Lost to Follow-up|2
7705704|NCT00444106|12127029|FG001|Overall Study|Lost to Follow-up|1
7705705|NCT00444106|12127030|FG002|Overall Study|Lost to Follow-up|0
7705706|NCT00444106|12127028|FG000|Overall Study|Abnormal Test Procedure Results|0
7705707|NCT00444106|12127029|FG001|Overall Study|Abnormal Test Procedure Results|0
7705708|NCT00444106|12127030|FG002|Overall Study|Abnormal Test Procedure Results|1
7705709|NCT00444145|12127041|FG000|Overall Study|Withdrawal by Subject|2
7705710|NCT00444145|12127041|FG000|Overall Study|Lost to Follow-up|1
7705711|NCT00444145|12127041|FG000|Overall Study|non-compliant|11
7705712|NCT00444145|12127041|FG000|Overall Study|Screen Failures|5
7705713|NCT00444275|12127048|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0
7705714|NCT00444275|12127049|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0
7705715|NCT00444275|12127050|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22
7705716|NCT00444275|12127051|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17
7705717|NCT00444275|12127052|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29
7705718|NCT00444275|12127048|FG000|Maintenance Treatment Phase|Lost to Follow-up|0
7705719|NCT00444275|12127049|FG001|Maintenance Treatment Phase|Lost to Follow-up|0
7705720|NCT00444275|12127050|FG002|Maintenance Treatment Phase|Lost to Follow-up|8
7705721|NCT00444275|12127051|FG003|Maintenance Treatment Phase|Lost to Follow-up|14
7705722|NCT00444275|12127052|FG004|Maintenance Treatment Phase|Lost to Follow-up|10
7705723|NCT00444275|12127048|FG000|Maintenance Treatment Phase|Adverse Event|0
7705724|NCT00444275|12127049|FG001|Maintenance Treatment Phase|Adverse Event|0
7705725|NCT00444275|12127050|FG002|Maintenance Treatment Phase|Adverse Event|3
7705726|NCT00444275|12127051|FG003|Maintenance Treatment Phase|Adverse Event|2
7705727|NCT00444275|12127052|FG004|Maintenance Treatment Phase|Adverse Event|13
7705728|NCT00444275|12127048|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0
7705729|NCT00444275|12127049|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0
7705730|NCT00444275|12127050|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1
7705731|NCT00444275|12127051|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0
7705732|NCT00444275|12127052|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6
7705733|NCT00444275|12127048|FG000|Maintenance Treatment Phase|Patient's wish|0
7705734|NCT00444275|12127049|FG001|Maintenance Treatment Phase|Patient's wish|0
7705735|NCT00444275|12127050|FG002|Maintenance Treatment Phase|Patient's wish|19
7705736|NCT00444275|12127051|FG003|Maintenance Treatment Phase|Patient's wish|9
7705737|NCT00444275|12127052|FG004|Maintenance Treatment Phase|Patient's wish|20
7705738|NCT00444275|12127048|FG000|Maintenance Treatment Phase|Protocol Violation|0
7705739|NCT00444275|12127049|FG001|Maintenance Treatment Phase|Protocol Violation|0
7705740|NCT00444275|12127050|FG002|Maintenance Treatment Phase|Protocol Violation|103
7705741|NCT00444275|12127051|FG003|Maintenance Treatment Phase|Protocol Violation|88
7705742|NCT00444275|12127052|FG004|Maintenance Treatment Phase|Protocol Violation|87
7705743|NCT00444275|12127048|FG000|Maintenance Treatment Phase|Ineffectiveness|0
7705744|NCT00444275|12127049|FG001|Maintenance Treatment Phase|Ineffectiveness|0
7705745|NCT00444275|12127050|FG002|Maintenance Treatment Phase|Ineffectiveness|5
7705746|NCT00444275|12127051|FG003|Maintenance Treatment Phase|Ineffectiveness|3
7705747|NCT00444275|12127052|FG004|Maintenance Treatment Phase|Ineffectiveness|14
7705748|NCT00444457|12127071|FG000|Infant Series|Other|0
7705749|NCT00444457|12127072|FG001|Infant Series|Other|1
7705750|NCT00444457|12127073|FG002|Infant Series|Other|0
7705751|NCT00444457|12127074|FG003|Infant Series|Other|0
7705752|NCT00444457|12127071|FG000|Infant Series|Parent or legal guardian request|18
7705753|NCT00444457|12127072|FG001|Infant Series|Parent or legal guardian request|29
7705754|NCT00444457|12127073|FG002|Infant Series|Parent or legal guardian request|34
7705755|NCT00444457|12127074|FG003|Infant Series|Parent or legal guardian request|14
7705756|NCT00444457|12127071|FG000|Infant Series|Lost to Follow-up|10
7705757|NCT00444457|12127072|FG001|Infant Series|Lost to Follow-up|11
7705758|NCT00444457|12127073|FG002|Infant Series|Lost to Follow-up|7
7705759|NCT00444457|12127074|FG003|Infant Series|Lost to Follow-up|6
7705760|NCT00444457|12127071|FG000|Infant Series|Protocol Violation|16
7705761|NCT00444457|12127072|FG001|Infant Series|Protocol Violation|8
7705762|NCT00444457|12127073|FG002|Infant Series|Protocol Violation|6
7705763|NCT00444457|12127074|FG003|Infant Series|Protocol Violation|3
7705764|NCT00444457|12127071|FG000|Infant Series|Failed to return|5
7705765|NCT00444457|12127072|FG001|Infant Series|Failed to return|4
7705766|NCT00444457|12127073|FG002|Infant Series|Failed to return|4
7705767|NCT00444457|12127074|FG003|Infant Series|Failed to return|2
7705768|NCT00444457|12127071|FG000|Infant Series|Investigator request|4
7705769|NCT00444457|12127072|FG001|Infant Series|Investigator request|3
7705770|NCT00444457|12127073|FG002|Infant Series|Investigator request|3
7705771|NCT00444457|12127074|FG003|Infant Series|Investigator request|2
7705772|NCT00444457|12127071|FG000|Infant Series|Other|0
7705773|NCT00444457|12127072|FG001|Infant Series|Other|2
7705774|NCT00444457|12127073|FG002|Infant Series|Other|4
7705775|NCT00444457|12127074|FG003|Infant Series|Other|0
7705776|NCT00444457|12127071|FG000|Infant Series|Adverse Event|1
7705777|NCT00444457|12127072|FG001|Infant Series|Adverse Event|2
7705778|NCT00444457|12127073|FG002|Infant Series|Adverse Event|2
7705779|NCT00444457|12127074|FG003|Infant Series|Adverse Event|0
7705780|NCT00444457|12127071|FG000|Infant Series|Death|0
7705781|NCT00444457|12127072|FG001|Infant Series|Death|1
7705782|NCT00444457|12127073|FG002|Infant Series|Death|1
7705783|NCT00444457|12127074|FG003|Infant Series|Death|1
7705784|NCT00444457|12127071|FG000|After Infant Series|Other|0
7705785|NCT00444457|12127072|FG001|After Infant Series|Other|1
7705786|NCT00444457|12127073|FG002|After Infant Series|Other|1
7705787|NCT00444457|12127074|FG003|After Infant Series|Other|1
7705788|NCT00444457|12127071|FG000|After Infant Series|Parent or legal guardian request|4
7705789|NCT00444457|12127072|FG001|After Infant Series|Parent or legal guardian request|11
7705790|NCT00444457|12127073|FG002|After Infant Series|Parent or legal guardian request|6
7705791|NCT00444457|12127074|FG003|After Infant Series|Parent or legal guardian request|3
7705792|NCT00444457|12127071|FG000|After Infant Series|Failed to return|7
7705793|NCT00444457|12127072|FG001|After Infant Series|Failed to return|6
7705794|NCT00444457|12127073|FG002|After Infant Series|Failed to return|5
7705795|NCT00444457|12127074|FG003|After Infant Series|Failed to return|1
7705796|NCT00444457|12127071|FG000|After Infant Series|Lost to Follow-up|5
7705797|NCT00444457|12127072|FG001|After Infant Series|Lost to Follow-up|5
7705798|NCT00444457|12127073|FG002|After Infant Series|Lost to Follow-up|5
7705799|NCT00444457|12127074|FG003|After Infant Series|Lost to Follow-up|2
7705800|NCT00444457|12127071|FG000|After Infant Series|Protocol Violation|2
7705801|NCT00444457|12127072|FG001|After Infant Series|Protocol Violation|4
7705802|NCT00444457|12127073|FG002|After Infant Series|Protocol Violation|2
7705803|NCT00444457|12127074|FG003|After Infant Series|Protocol Violation|2
7705804|NCT00444457|12127071|FG000|After Infant Series|Adverse Event|2
7705805|NCT00444457|12127072|FG001|After Infant Series|Adverse Event|2
7705806|NCT00444457|12127073|FG002|After Infant Series|Adverse Event|0
7705807|NCT00444457|12127074|FG003|After Infant Series|Adverse Event|0
7705808|NCT00444457|12127071|FG000|After Infant Series|Investigator request|0
7705809|NCT00444457|12127072|FG001|After Infant Series|Investigator request|0
7705810|NCT00444457|12127073|FG002|After Infant Series|Investigator request|0
7705811|NCT00444457|12127074|FG003|After Infant Series|Investigator request|1
7705812|NCT00444457|12127071|FG000|After Infant Series|Other|0
7705813|NCT00444457|12127072|FG001|After Infant Series|Other|1
7705814|NCT00444457|12127073|FG002|After Infant Series|Other|0
7705815|NCT00444457|12127074|FG003|After Infant Series|Other|0
7705816|NCT00444457|12127071|FG000|Toddler Dose|Lost to Follow-up|4
7705817|NCT00444457|12127072|FG001|Toddler Dose|Lost to Follow-up|1
7705818|NCT00444457|12127073|FG002|Toddler Dose|Lost to Follow-up|1
7705819|NCT00444457|12127074|FG003|Toddler Dose|Lost to Follow-up|3
7705820|NCT00444457|12127071|FG000|Toddler Dose|Failed to return|2
7705821|NCT00444457|12127072|FG001|Toddler Dose|Failed to return|2
7705822|NCT00444457|12127073|FG002|Toddler Dose|Failed to return|1
7705823|NCT00444457|12127074|FG003|Toddler Dose|Failed to return|3
7705824|NCT00444457|12127071|FG000|Toddler Dose|Parent or legal guardian request|0
7705825|NCT00444457|12127072|FG001|Toddler Dose|Parent or legal guardian request|3
7705826|NCT00444457|12127073|FG002|Toddler Dose|Parent or legal guardian request|2
7705827|NCT00444457|12127074|FG003|Toddler Dose|Parent or legal guardian request|1
7705828|NCT00444457|12127071|FG000|Toddler Dose|Protocol Violation|1
7705829|NCT00444457|12127072|FG001|Toddler Dose|Protocol Violation|0
7705830|NCT00444457|12127073|FG002|Toddler Dose|Protocol Violation|0
7705831|NCT00444457|12127074|FG003|Toddler Dose|Protocol Violation|1
7705832|NCT00444535|12127095|FG000|Overall Study|Withdrawal by Subject|5
7705833|NCT00444535|12127095|FG000|Overall Study|Physician Decision|5
7705834|NCT00444535|12127095|FG000|Overall Study|progressive disease|1
7705835|NCT00444535|12127095|FG000|Overall Study|Adverse Event|2
7705836|NCT00444587|12127101|FG000|Overall Study|Death|2
7705837|NCT00444587|12127102|FG001|Overall Study|Death|1
7705838|NCT00444587|12127101|FG000|Overall Study|Progression of the disease|73
7705839|NCT00444587|12127102|FG001|Overall Study|Progression of the disease|8
7705840|NCT00444587|12127101|FG000|Overall Study|Refused treatment/did not cooperate|4
7705841|NCT00444587|12127102|FG001|Overall Study|Refused treatment/did not cooperate|1
7705842|NCT00444587|12127101|FG000|Overall Study|Investigator decision|3
7705843|NCT00444587|12127102|FG001|Overall Study|Investigator decision|0
7705844|NCT00444587|12127101|FG000|Overall Study|Protocol Violation|1
7705845|NCT00444587|12127102|FG001|Overall Study|Protocol Violation|0
7705846|NCT00444587|12127101|FG000|Overall Study|Missing|0
7705847|NCT00444587|12127102|FG001|Overall Study|Missing|5
7705848|NCT00444600|12127114|FG000|Overall Study|Death|7
7705849|NCT00444600|12127115|FG001|Overall Study|Death|5
7705850|NCT00444600|12127116|FG002|Overall Study|Death|3
7705851|NCT00444600|12127117|FG003|Overall Study|Death|2
7705852|NCT00444600|12127114|FG000|Overall Study|Dropped|11
7705853|NCT00444600|12127115|FG001|Overall Study|Dropped|11
7705854|NCT00444600|12127116|FG002|Overall Study|Dropped|7
7705855|NCT00444600|12127117|FG003|Overall Study|Dropped|7
7705856|NCT00444600|12127114|FG000|Overall Study|Missed visit|1
7705857|NCT00444600|12127115|FG001|Overall Study|Missed visit|0
7705858|NCT00444600|12127116|FG002|Overall Study|Missed visit|0
7705859|NCT00444600|12127117|FG003|Overall Study|Missed visit|1
7705860|NCT00444626|12127133|FG000|Initial Treatment Period|Withdrawal by Subject|2
7705861|NCT00444626|12127133|FG000|Initial Treatment Period|Adverse Event|1
7705862|NCT00444626|12127133|FG000|Initial Treatment Period|Lost to Follow-up|9
7705863|NCT00444678|12127146|FG000|Overall Study|Toxicity|11
7705864|NCT00444678|12127146|FG000|Overall Study|Disease Progression|12
7705865|NCT00444678|12127146|FG000|Overall Study|Death|3
7705866|NCT00444678|12127146|FG000|Overall Study|Physician Decision|3
7705867|NCT00444678|12127146|FG000|Overall Study|Withdrawal by Subject|2
7705868|NCT00444795|12127150|FG000|Overall Study|Not Treated|1
7705869|NCT00444795|12127150|FG000|Overall Study|Treated Prior to the Contract Date|2
7705870|NCT00444912|12127165|FG000|Overall Study|Death|1
7705871|NCT00444912|12127166|FG001|Overall Study|Death|2
7705872|NCT00444912|12127165|FG000|Overall Study|Lost to Follow-up|1
7705873|NCT00444912|12127166|FG001|Overall Study|Lost to Follow-up|0
7705874|NCT00444912|12127165|FG000|Overall Study|Participant Failed Mobilization|1
7705875|NCT00444912|12127166|FG001|Overall Study|Participant Failed Mobilization|0
7705876|NCT00444925|12127175|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3
7705877|NCT00444925|12127176|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6
7705878|NCT00444925|12127177|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6
7705879|NCT00444925|12127175|FG000|Double-blind Treatment Period|Death|2
7705880|NCT00444925|12127176|FG001|Double-blind Treatment Period|Death|0
7705881|NCT00444925|12127177|FG002|Double-blind Treatment Period|Death|0
7705882|NCT00444925|12127175|FG000|Double-blind Treatment Period|Adverse Event|6
7705883|NCT00444925|12127176|FG001|Double-blind Treatment Period|Adverse Event|28
7705884|NCT00444925|12127177|FG002|Double-blind Treatment Period|Adverse Event|44
7705885|NCT00444925|12127175|FG000|Double-blind Treatment Period|Lack of Efficacy|5
7705886|NCT00444925|12127176|FG001|Double-blind Treatment Period|Lack of Efficacy|5
7705887|NCT00444925|12127177|FG002|Double-blind Treatment Period|Lack of Efficacy|13
7705888|NCT00444925|12127175|FG000|Double-blind Treatment Period|Lost to Follow-up|4
7705889|NCT00444925|12127176|FG001|Double-blind Treatment Period|Lost to Follow-up|8
7705890|NCT00444925|12127177|FG002|Double-blind Treatment Period|Lost to Follow-up|5
7705891|NCT00444925|12127175|FG000|Double-blind Treatment Period|Withdrawal by Subject|6
7705892|NCT00444925|12127176|FG001|Double-blind Treatment Period|Withdrawal by Subject|8
7705893|NCT00444925|12127177|FG002|Double-blind Treatment Period|Withdrawal by Subject|7
7705894|NCT00444925|12127175|FG000|Double-blind Treatment Period|Other|7
7705895|NCT00444925|12127176|FG001|Double-blind Treatment Period|Other|7
7705896|NCT00444925|12127177|FG002|Double-blind Treatment Period|Other|12
7705897|NCT00444951|12127188|FG000|Overall Study|Lost to Follow-up|1
7705898|NCT00444951|12127189|FG001|Overall Study|Lost to Follow-up|1
7705899|NCT00444951|12127190|FG002|Overall Study|Lost to Follow-up|0
7705900|NCT00444951|12127188|FG000|Overall Study|Withdrawal by Subject|4
7705901|NCT00444951|12127189|FG001|Overall Study|Withdrawal by Subject|5
7705902|NCT00444951|12127190|FG002|Overall Study|Withdrawal by Subject|3
7705903|NCT00445003|12127205|FG000|Overall Study|Death|1
7705904|NCT00445003|12127206|FG001|Overall Study|Death|2
7705905|NCT00445003|12127207|FG002|Overall Study|Death|1
7705906|NCT00445003|12127205|FG000|Overall Study|Missed Visit|3
7705907|NCT00445003|12127206|FG001|Overall Study|Missed Visit|5
7705908|NCT00445003|12127207|FG002|Overall Study|Missed Visit|1
7705909|NCT00445003|12127205|FG000|Overall Study|Dropped|1
7705910|NCT00445003|12127206|FG001|Overall Study|Dropped|3
7705911|NCT00445003|12127207|FG002|Overall Study|Dropped|2
7705912|NCT00445068|12127215|FG000|Overall Study|Disease progression|26
7705913|NCT00445068|12127215|FG000|Overall Study|Adverse Event|5
7705914|NCT00445068|12127215|FG000|Overall Study|Abnormal laboratory value|2
7705915|NCT00445068|12127215|FG000|Overall Study|Withdrawal by Subject|2
7705916|NCT00445068|12127215|FG000|Overall Study|Death|1
7705917|NCT00445146|12127219|FG000|Overall Study|Withdrew Consent|29
7705918|NCT00445146|12127219|FG000|Overall Study|Lack of Efficacy|28
7705919|NCT00445146|12127219|FG000|Overall Study|Investigator's Discretion|22
7705920|NCT00445146|12127219|FG000|Overall Study|Adverse Event|13
7705921|NCT00445146|12127219|FG000|Overall Study|Lost to Follow-up|13
7705922|NCT00445146|12127219|FG000|Overall Study|Death|9
7705923|NCT00445146|12127219|FG000|Overall Study|Protocol Violation|4
7705924|NCT00445146|12127219|FG000|Overall Study|Pregnancy|1
7705925|NCT00445224|12127234|FG000|Specific Exercises|Withdrawal by Subject|3
7705926|NCT00445224|12127235|FG001|Specific Exercises|Withdrawal by Subject|3
7705927|NCT00445224|12127234|FG000|Specific Exercises|Withdrawal by Subject|1
7705928|NCT00445224|12127235|FG001|Specific Exercises|Withdrawal by Subject|0
7705929|NCT00445328|12127291|FG000|Overall Study|Death|0
7705930|NCT00445328|12127292|FG001|Overall Study|Death|1
7705931|NCT00445328|12127291|FG000|Overall Study|Adverse Event|0
7705932|NCT00445328|12127292|FG001|Overall Study|Adverse Event|3
7705933|NCT00445328|12127291|FG000|Overall Study|Other|0
7705934|NCT00445328|12127292|FG001|Overall Study|Other|2
7705935|NCT00445328|12127291|FG000|Overall Study|Withdrawal by Subject|2
7705936|NCT00445328|12127292|FG001|Overall Study|Withdrawal by Subject|0
7705937|NCT00445328|12127291|FG000|Overall Study|Protocol Violation|1
7705938|NCT00445328|12127292|FG001|Overall Study|Protocol Violation|0
7705939|NCT00445341|12127298|FG000|Overall Study|refused further treatment|1
7705940|NCT00445341|12127298|FG000|Overall Study|taken off treatment too early|1
7705941|NCT00445432|12127305|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
7705942|NCT00445432|12127306|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
7705943|NCT00445432|12127307|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
7705944|NCT00445432|12127308|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
7705945|NCT00445432|12127305|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
7705946|NCT00445432|12127306|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
7705947|NCT00445432|12127307|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
7705948|NCT00445432|12127308|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
7705949|NCT00445432|12127305|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
7705950|NCT00445432|12127306|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
7705951|NCT00445432|12127307|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
7705952|NCT00445432|12127308|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
7705953|NCT00445432|12127305|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0
7705954|NCT00445432|12127306|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1
7705955|NCT00445432|12127307|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2
7705956|NCT00445432|12127308|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0
7705957|NCT00445432|12127305|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0
7705958|NCT00445432|12127306|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0
7705959|NCT00445432|12127307|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0
7705960|NCT00445432|12127308|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32
7705961|NCT00445432|12127305|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
7705962|NCT00445432|12127306|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
7705963|NCT00445432|12127307|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
7705964|NCT00445432|12127308|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
7705965|NCT00445432|12127305|FG000|148 Weeks of Adalimumab Treatment|Other|0
7705966|NCT00445432|12127306|FG001|148 Weeks of Adalimumab Treatment|Other|0
7705967|NCT00445432|12127307|FG002|148 Weeks of Adalimumab Treatment|Other|0
7705968|NCT00445432|12127308|FG003|148 Weeks of Adalimumab Treatment|Other|9
7705969|NCT00445458|12127323|FG000|Overall Study|Disease Progression|3
7705970|NCT00445458|12127324|FG001|Overall Study|Disease Progression|4
7705971|NCT00445458|12127325|FG002|Overall Study|Disease Progression|54
7705972|NCT00445458|12127326|FG003|Overall Study|Disease Progression|27
7705973|NCT00445458|12127323|FG000|Overall Study|Withdrawal by Subject|0
7705974|NCT00445458|12127324|FG001|Overall Study|Withdrawal by Subject|0
7705975|NCT00445458|12127325|FG002|Overall Study|Withdrawal by Subject|7
7705976|NCT00445458|12127326|FG003|Overall Study|Withdrawal by Subject|0
7705977|NCT00445458|12127323|FG000|Overall Study|Adverse Event|0
7705978|NCT00445458|12127324|FG001|Overall Study|Adverse Event|0
7705979|NCT00445458|12127325|FG002|Overall Study|Adverse Event|3
7705980|NCT00445458|12127326|FG003|Overall Study|Adverse Event|0
7705981|NCT00445458|12127323|FG000|Overall Study|Death|0
7705982|NCT00445458|12127324|FG001|Overall Study|Death|1
7705983|NCT00445458|12127325|FG002|Overall Study|Death|2
7705984|NCT00445458|12127326|FG003|Overall Study|Death|0
7705985|NCT00445458|12127323|FG000|Overall Study|Physician Decision|0
7705986|NCT00445458|12127324|FG001|Overall Study|Physician Decision|0
7705987|NCT00445458|12127325|FG002|Overall Study|Physician Decision|1
7705988|NCT00445458|12127326|FG003|Overall Study|Physician Decision|1
7705989|NCT00445458|12127323|FG000|Overall Study|Surgery|0
7705990|NCT00445458|12127324|FG001|Overall Study|Surgery|0
7705991|NCT00445458|12127325|FG002|Overall Study|Surgery|1
7705992|NCT00445458|12127326|FG003|Overall Study|Surgery|0
7705993|NCT00445549|12127348|FG000|Overall Study|progressive disease|12
7705994|NCT00445601|12127359|FG000|Overall Study|Withdrawal by Subject|11
7705995|NCT00445601|12127360|FG001|Overall Study|Withdrawal by Subject|11
7705996|NCT00445601|12127359|FG000|Overall Study|TURBT Complication|12
7705997|NCT00445601|12127360|FG001|Overall Study|TURBT Complication|8
7705998|NCT00445601|12127359|FG000|Overall Study|Incorrect Disease Status|6
7705999|NCT00445601|12127360|FG001|Overall Study|Incorrect Disease Status|6
7706000|NCT00445601|12127359|FG000|Overall Study|Drug Delivery Issue|2
7706001|NCT00445601|12127360|FG001|Overall Study|Drug Delivery Issue|2
7706002|NCT00445601|12127359|FG000|Overall Study|Adverse Event|2
7706003|NCT00445601|12127360|FG001|Overall Study|Adverse Event|0
7706004|NCT00445601|12127359|FG000|Overall Study|Death prior to TURBT|0
7706005|NCT00445601|12127360|FG001|Overall Study|Death prior to TURBT|1
7706006|NCT00445679|12127374|FG000|Overall Study|Adverse Event|22
7706007|NCT00445679|12127375|FG001|Overall Study|Adverse Event|12
7706008|NCT00445679|12127376|FG002|Overall Study|Adverse Event|30
7706009|NCT00445679|12127377|FG003|Overall Study|Adverse Event|19
7706010|NCT00445679|12127374|FG000|Overall Study|Failed to return|1
7706011|NCT00445679|12127375|FG001|Overall Study|Failed to return|3
7706012|NCT00445679|12127376|FG002|Overall Study|Failed to return|2
7706013|NCT00445679|12127377|FG003|Overall Study|Failed to return|2
7706014|NCT00445679|12127374|FG000|Overall Study|Physician Decision|0
7706015|NCT00445679|12127375|FG001|Overall Study|Physician Decision|0
7706016|NCT00445679|12127376|FG002|Overall Study|Physician Decision|1
7706017|NCT00445679|12127377|FG003|Overall Study|Physician Decision|0
7706018|NCT00445679|12127374|FG000|Overall Study|Lost to Follow-up|10
7706019|NCT00445679|12127375|FG001|Overall Study|Lost to Follow-up|6
7706020|NCT00445679|12127376|FG002|Overall Study|Lost to Follow-up|6
7706021|NCT00445679|12127377|FG003|Overall Study|Lost to Follow-up|5
7706022|NCT00445679|12127374|FG000|Overall Study|Compliance|3
7706023|NCT00445679|12127375|FG001|Overall Study|Compliance|2
7706024|NCT00445679|12127376|FG002|Overall Study|Compliance|1
7706025|NCT00445679|12127377|FG003|Overall Study|Compliance|2
7706026|NCT00445679|12127374|FG000|Overall Study|Withdrawal of Informed Consent|0
7706027|NCT00445679|12127375|FG001|Overall Study|Withdrawal of Informed Consent|0
7706028|NCT00445679|12127376|FG002|Overall Study|Withdrawal of Informed Consent|1
7706029|NCT00445679|12127377|FG003|Overall Study|Withdrawal of Informed Consent|0
7706030|NCT00445679|12127374|FG000|Overall Study|Protocol Violation|2
7706031|NCT00445679|12127375|FG001|Overall Study|Protocol Violation|3
7706032|NCT00445679|12127376|FG002|Overall Study|Protocol Violation|3
7706033|NCT00445679|12127377|FG003|Overall Study|Protocol Violation|1
7706034|NCT00445679|12127374|FG000|Overall Study|Withdrawal by Subject|8
7706035|NCT00445679|12127375|FG001|Overall Study|Withdrawal by Subject|14
7706036|NCT00445679|12127376|FG002|Overall Study|Withdrawal by Subject|20
7706037|NCT00445679|12127377|FG003|Overall Study|Withdrawal by Subject|18
7706038|NCT00445679|12127374|FG000|Overall Study|Lack of Efficacy|2
7706039|NCT00445679|12127375|FG001|Overall Study|Lack of Efficacy|6
7706040|NCT00445679|12127376|FG002|Overall Study|Lack of Efficacy|2
7706041|NCT00445679|12127377|FG003|Overall Study|Lack of Efficacy|0
7706042|NCT00445692|12127387|FG000|Overall Study|Adverse Event|11
7706043|NCT00445692|12127387|FG000|Overall Study|Lack of Efficacy|5
7706044|NCT00445770|12127417|FG000|Overall Study|Adverse Event|9
7706045|NCT00445770|12127418|FG001|Overall Study|Adverse Event|15
7706046|NCT00445770|12127419|FG002|Overall Study|Adverse Event|19
7706047|NCT00445770|12127417|FG000|Overall Study|Lack of Efficacy|38
7706048|NCT00445770|12127418|FG001|Overall Study|Lack of Efficacy|13
7706049|NCT00445770|12127419|FG002|Overall Study|Lack of Efficacy|6
7706050|NCT00445770|12127417|FG000|Overall Study|Lost to Follow-up|0
7706051|NCT00445770|12127418|FG001|Overall Study|Lost to Follow-up|2
7706052|NCT00445770|12127419|FG002|Overall Study|Lost to Follow-up|0
7706053|NCT00445770|12127417|FG000|Overall Study|Other|6
7706054|NCT00445770|12127418|FG001|Overall Study|Other|5
7706055|NCT00445770|12127419|FG002|Overall Study|Other|6
7706056|NCT00445848|12127429|FG000|Overall Study|Adverse Event|14
7706057|NCT00445848|12127429|FG000|Overall Study|Withdrawal by Subject|4
7706058|NCT00445848|12127429|FG000|Overall Study|Progression|62
7706059|NCT00445848|12127429|FG000|Overall Study|Other-Not protocol specified|5
7706060|NCT00445939|12127455|FG000|Period A - Week 0 - Week 4|Adverse Event|1
7706061|NCT00445939|12127456|FG001|Period A - Week 0 - Week 4|Adverse Event|2
7706062|NCT00445939|12127457|FG002|Period A - Week 0 - Week 4|Adverse Event|0
7706063|NCT00445939|12127458|FG003|Period A - Week 0 - Week 4|Adverse Event|0
7706064|NCT00445939|12127455|FG000|Period B - Week 4 - Week 8|Adverse Event|2
7706065|NCT00445939|12127456|FG001|Period B - Week 4 - Week 8|Adverse Event|0
7706066|NCT00445939|12127457|FG002|Period B - Week 4 - Week 8|Adverse Event|0
7706067|NCT00445939|12127458|FG003|Period B - Week 4 - Week 8|Adverse Event|1
7706068|NCT00445978|12127478|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1
7706069|NCT00445978|12127478|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1
7706070|NCT00445978|12127478|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1
7706071|NCT00445978|12127478|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1
7706072|NCT00445978|12127478|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1
7706073|NCT00445978|12127478|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1
7706074|NCT00445978|12127478|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1
7706075|NCT00445978|12127478|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1
7706076|NCT00445978|12127478|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1
7706077|NCT00446030|12127491|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29
7706078|NCT00446030|12127492|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8
7706079|NCT00446030|12127491|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9
7706080|NCT00446030|12127492|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1
7706081|NCT00446030|12127491|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1
7706082|NCT00446030|12127492|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0
7706083|NCT00446030|12127491|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
7706084|NCT00446030|12127492|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
7706085|NCT00446030|12127491|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1
7706086|NCT00446030|12127492|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0
7706087|NCT00446030|12127491|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1
7706088|NCT00446030|12127492|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0
7706089|NCT00446030|12127491|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1
7706090|NCT00446030|12127492|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0
7706091|NCT00446030|12127491|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
7706092|NCT00446030|12127492|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
7706093|NCT00446030|12127491|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9
7706094|NCT00446030|12127492|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4
7706095|NCT00446030|12127491|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
7706096|NCT00446030|12127492|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
7706097|NCT00446030|12127491|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
7706098|NCT00446030|12127492|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
7706099|NCT00446030|12127491|FG000|FOLLOW-UP (up to 2-years)|Death|2
7706100|NCT00446030|12127492|FG001|FOLLOW-UP (up to 2-years)|Death|2
7706101|NCT00446030|12127491|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
7706102|NCT00446030|12127492|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
7706103|NCT00446030|12127491|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
7706104|NCT00446030|12127492|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
7706105|NCT00446030|12127491|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2
7706106|NCT00446030|12127492|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0
7706107|NCT00446030|12127491|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1
7706108|NCT00446030|12127492|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0
7706109|NCT00446030|12127491|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1
7706110|NCT00446030|12127492|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0
7706111|NCT00446030|12127491|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1
7706112|NCT00446030|12127492|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0
7706113|NCT00446030|12127491|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
7706114|NCT00446030|12127492|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
7706115|NCT00446095|12127503|FG000|Phase II (8 Weeks)|Lost to Follow-up|1
7706116|NCT00446095|12127504|FG001|Phase II (8 Weeks)|Lost to Follow-up|0
7706117|NCT00446095|12127505|FG002|Phase II (8 Weeks)|Lost to Follow-up|0
7706118|NCT00446095|12127506|FG003|Phase II (8 Weeks)|Lost to Follow-up|0
7706119|NCT00446095|12127507|FG004|Phase II (8 Weeks)|Lost to Follow-up|0
7706120|NCT00446095|12127503|FG000|Phase II (8 Weeks)|Adverse Event|0
7706121|NCT00446095|12127504|FG001|Phase II (8 Weeks)|Adverse Event|1
7706122|NCT00446095|12127505|FG002|Phase II (8 Weeks)|Adverse Event|1
7706123|NCT00446095|12127506|FG003|Phase II (8 Weeks)|Adverse Event|0
7706124|NCT00446095|12127507|FG004|Phase II (8 Weeks)|Adverse Event|0
7706125|NCT00446095|12127503|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1
7706126|NCT00446095|12127504|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0
7706127|NCT00446095|12127505|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0
7706128|NCT00446095|12127506|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0
7706129|NCT00446095|12127507|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0
7706130|NCT00446095|12127503|FG000|Phase II (8 Weeks)|Physician Decision|1
7706131|NCT00446095|12127504|FG001|Phase II (8 Weeks)|Physician Decision|0
7706132|NCT00446095|12127505|FG002|Phase II (8 Weeks)|Physician Decision|0
7706133|NCT00446095|12127506|FG003|Phase II (8 Weeks)|Physician Decision|0
7706134|NCT00446095|12127507|FG004|Phase II (8 Weeks)|Physician Decision|0
7706135|NCT00446095|12127503|FG000|Phase II (8 Weeks)|Lack of Efficacy|9
7706136|NCT00446095|12127504|FG001|Phase II (8 Weeks)|Lack of Efficacy|2
7706137|NCT00446095|12127505|FG002|Phase II (8 Weeks)|Lack of Efficacy|1
7706138|NCT00446095|12127506|FG003|Phase II (8 Weeks)|Lack of Efficacy|0
7706139|NCT00446095|12127507|FG004|Phase II (8 Weeks)|Lack of Efficacy|0
7706140|NCT00446095|12127503|FG000|Phase II (8 Weeks)|Ongoing|0
7706141|NCT00446095|12127504|FG001|Phase II (8 Weeks)|Ongoing|0
7706142|NCT00446095|12127505|FG002|Phase II (8 Weeks)|Ongoing|1
7706143|NCT00446095|12127506|FG003|Phase II (8 Weeks)|Ongoing|0
7706144|NCT00446095|12127507|FG004|Phase II (8 Weeks)|Ongoing|0
7706145|NCT00446095|12127503|FG000|Phase I (28 Days)|Adverse Event|0
7706146|NCT00446095|12127504|FG001|Phase I (28 Days)|Adverse Event|0
7706147|NCT00446095|12127505|FG002|Phase I (28 Days)|Adverse Event|0
7706148|NCT00446095|12127506|FG003|Phase I (28 Days)|Adverse Event|1
7706149|NCT00446095|12127507|FG004|Phase I (28 Days)|Adverse Event|0
7706150|NCT00446095|12127503|FG000|Phase I (28 Days)|Lack of Efficacy|0
7706151|NCT00446095|12127504|FG001|Phase I (28 Days)|Lack of Efficacy|0
7706152|NCT00446095|12127505|FG002|Phase I (28 Days)|Lack of Efficacy|0
7706153|NCT00446095|12127506|FG003|Phase I (28 Days)|Lack of Efficacy|0
7706154|NCT00446095|12127507|FG004|Phase I (28 Days)|Lack of Efficacy|3
7706155|NCT00446134|12127522|FG000|Overall Study|Adverse Event|7
7706156|NCT00446134|12127523|FG001|Overall Study|Adverse Event|17
7706157|NCT00446134|12127524|FG002|Overall Study|Adverse Event|13
7706158|NCT00446134|12127525|FG003|Overall Study|Adverse Event|18
7706159|NCT00446134|12127522|FG000|Overall Study|Lack of Efficacy|19
7706160|NCT00446134|12127523|FG001|Overall Study|Lack of Efficacy|19
7706161|NCT00446134|12127524|FG002|Overall Study|Lack of Efficacy|24
7706162|NCT00446134|12127525|FG003|Overall Study|Lack of Efficacy|19
7706163|NCT00446134|12127522|FG000|Overall Study|Protocol Violation|0
7706164|NCT00446134|12127523|FG001|Overall Study|Protocol Violation|2
7706165|NCT00446134|12127524|FG002|Overall Study|Protocol Violation|1
7706166|NCT00446134|12127525|FG003|Overall Study|Protocol Violation|0
7706167|NCT00446134|12127522|FG000|Overall Study|Lost to Follow-up|1
7706168|NCT00446134|12127523|FG001|Overall Study|Lost to Follow-up|3
7706169|NCT00446134|12127524|FG002|Overall Study|Lost to Follow-up|1
7706170|NCT00446134|12127525|FG003|Overall Study|Lost to Follow-up|1
7706171|NCT00446134|12127522|FG000|Overall Study|Withdrawal by Subject|3
7706172|NCT00446134|12127523|FG001|Overall Study|Withdrawal by Subject|3
7706173|NCT00446134|12127524|FG002|Overall Study|Withdrawal by Subject|1
7706174|NCT00446134|12127525|FG003|Overall Study|Withdrawal by Subject|3
7706175|NCT00446134|12127522|FG000|Overall Study|Physician Decision|0
7706176|NCT00446134|12127523|FG001|Overall Study|Physician Decision|0
7706177|NCT00446134|12127524|FG002|Overall Study|Physician Decision|0
7706178|NCT00446134|12127525|FG003|Overall Study|Physician Decision|2
7706179|NCT00446134|12127522|FG000|Overall Study|Adverse Event-Diarrhea|1
7706180|NCT00446134|12127523|FG001|Overall Study|Adverse Event-Diarrhea|1
7706181|NCT00446134|12127524|FG002|Overall Study|Adverse Event-Diarrhea|2
7706182|NCT00446134|12127525|FG003|Overall Study|Adverse Event-Diarrhea|0
7706183|NCT00446134|12127522|FG000|Overall Study|Reason Not Completed|3
7706184|NCT00446134|12127523|FG001|Overall Study|Reason Not Completed|0
7706185|NCT00446134|12127524|FG002|Overall Study|Reason Not Completed|1
7706186|NCT00446134|12127525|FG003|Overall Study|Reason Not Completed|2
7706187|NCT00446199|12127548|FG000|Overall Study|Adverse Event|7
7706188|NCT00446199|12127549|FG001|Overall Study|Adverse Event|4
7706189|NCT00446199|12127550|FG002|Overall Study|Adverse Event|6
7706190|NCT00446199|12127551|FG003|Overall Study|Adverse Event|4
7706191|NCT00446199|12127548|FG000|Overall Study|Lost to Follow-up|4
7706192|NCT00446199|12127549|FG001|Overall Study|Lost to Follow-up|5
7706193|NCT00446199|12127550|FG002|Overall Study|Lost to Follow-up|2
7706194|NCT00446199|12127551|FG003|Overall Study|Lost to Follow-up|6
7706195|NCT00446199|12127548|FG000|Overall Study|Protocol Violation|1
7706196|NCT00446199|12127549|FG001|Overall Study|Protocol Violation|2
7706197|NCT00446199|12127550|FG002|Overall Study|Protocol Violation|1
7706198|NCT00446199|12127551|FG003|Overall Study|Protocol Violation|3
7706199|NCT00446199|12127548|FG000|Overall Study|Withdrawal by Subject|2
7706200|NCT00446199|12127549|FG001|Overall Study|Withdrawal by Subject|5
7706201|NCT00446199|12127550|FG002|Overall Study|Withdrawal by Subject|9
7706202|NCT00446199|12127551|FG003|Overall Study|Withdrawal by Subject|10
7706203|NCT00446199|12127548|FG000|Overall Study|Site termination|2
7706204|NCT00446199|12127549|FG001|Overall Study|Site termination|0
7706205|NCT00446199|12127550|FG002|Overall Study|Site termination|0
7706206|NCT00446199|12127551|FG003|Overall Study|Site termination|1
7706207|NCT00446199|12127548|FG000|Overall Study|Randomization in Error|2
7706208|NCT00446199|12127549|FG001|Overall Study|Randomization in Error|0
7706209|NCT00446199|12127550|FG002|Overall Study|Randomization in Error|1
7706210|NCT00446199|12127551|FG003|Overall Study|Randomization in Error|1
7706211|NCT00446199|12127548|FG000|Overall Study|Lack of Efficacy|1
7706212|NCT00446199|12127549|FG001|Overall Study|Lack of Efficacy|0
7706213|NCT00446199|12127550|FG002|Overall Study|Lack of Efficacy|0
7706214|NCT00446199|12127551|FG003|Overall Study|Lack of Efficacy|1
7706215|NCT00446199|12127548|FG000|Overall Study|Non-compliant with study drug|1
7706216|NCT00446199|12127549|FG001|Overall Study|Non-compliant with study drug|0
7706217|NCT00446199|12127550|FG002|Overall Study|Non-compliant with study drug|5
7706218|NCT00446199|12127551|FG003|Overall Study|Non-compliant with study drug|0
7706219|NCT00446199|12127548|FG000|Overall Study|Non-compliant with visit schedule|1
7706220|NCT00446199|12127549|FG001|Overall Study|Non-compliant with visit schedule|1
7706221|NCT00446199|12127550|FG002|Overall Study|Non-compliant with visit schedule|1
7706222|NCT00446199|12127551|FG003|Overall Study|Non-compliant with visit schedule|2
7706223|NCT00446199|12127548|FG000|Overall Study|Hormone fear|0
7706224|NCT00446199|12127549|FG001|Overall Study|Hormone fear|0
7706225|NCT00446199|12127550|FG002|Overall Study|Hormone fear|0
7706226|NCT00446199|12127551|FG003|Overall Study|Hormone fear|1
7706227|NCT00446199|12127548|FG000|Overall Study|Lost interest in study participation|0
7706228|NCT00446199|12127549|FG001|Overall Study|Lost interest in study participation|1
7706229|NCT00446199|12127550|FG002|Overall Study|Lost interest in study participation|0
7706230|NCT00446199|12127551|FG003|Overall Study|Lost interest in study participation|0
7706231|NCT00446199|12127548|FG000|Overall Study|In-/Exclusion criterion violated|2
7706232|NCT00446199|12127549|FG001|Overall Study|In-/Exclusion criterion violated|1
7706233|NCT00446199|12127550|FG002|Overall Study|In-/Exclusion criterion violated|2
7706234|NCT00446199|12127551|FG003|Overall Study|In-/Exclusion criterion violated|1
7706235|NCT00446199|12127548|FG000|Overall Study|Move|0
7706236|NCT00446199|12127549|FG001|Overall Study|Move|1
7706237|NCT00446199|12127550|FG002|Overall Study|Move|0
7706238|NCT00446199|12127551|FG003|Overall Study|Move|0
7706239|NCT00446251|12127561|FG000|Overall Study|On-study Transplants|2
7706240|NCT00446251|12127561|FG000|Overall Study|Rituximab Infusion Reaction|2
7706241|NCT00446251|12127561|FG000|Overall Study|Lost to Follow-up|1
7706242|NCT00446446|12127573|FG000|Overall Study|Death|10
7706243|NCT00446446|12127573|FG000|Overall Study|Withdrawal by Subject|6
7706244|NCT00446446|12127573|FG000|Overall Study|Other|4
7706245|NCT00446446|12127573|FG000|Overall Study|Disease Progession|2
7706246|NCT00446446|12127573|FG000|Overall Study|Adverse Event|1
7706247|NCT00446446|12127573|FG000|Overall Study|On Treatment at Time of Data Cut-off|1
7706248|NCT00446459|12127577|FG000|8 Months|Protocol Violation|12
7706249|NCT00446459|12127577|FG000|12 Months|Protocol Violation|4
7706250|NCT00446459|12127577|FG000|12 Months|14 subjects to MMF + Rituximab Study|14
7706251|NCT00446511|12127585|FG000|Overall Study|Adverse Event|7
7706252|NCT00446511|12127586|FG001|Overall Study|Adverse Event|2
7706253|NCT00446511|12127587|FG002|Overall Study|Adverse Event|3
7706254|NCT00446511|12127588|FG003|Overall Study|Adverse Event|1
7706255|NCT00446511|12127585|FG000|Overall Study|Protocol Violation|0
7706256|NCT00446511|12127586|FG001|Overall Study|Protocol Violation|0
7706257|NCT00446511|12127587|FG002|Overall Study|Protocol Violation|0
7706258|NCT00446511|12127588|FG003|Overall Study|Protocol Violation|1
7706259|NCT00446511|12127585|FG000|Overall Study|Withdrawal by Subject|0
7706260|NCT00446511|12127586|FG001|Overall Study|Withdrawal by Subject|0
7706261|NCT00446511|12127587|FG002|Overall Study|Withdrawal by Subject|0
7706262|NCT00446511|12127588|FG003|Overall Study|Withdrawal by Subject|3
7706263|NCT00446511|12127585|FG000|Overall Study|Administrative Problems|3
7706264|NCT00446511|12127586|FG001|Overall Study|Administrative Problems|0
7706265|NCT00446511|12127587|FG002|Overall Study|Administrative Problems|4
7706266|NCT00446511|12127588|FG003|Overall Study|Administrative Problems|1
7706267|NCT00446550|12127602|FG000|Overall Study|Adverse Event|1
7706268|NCT00446550|12127603|FG001|Overall Study|Adverse Event|0
7706269|NCT00446563|12127612|FG000|Overall Study|Adverse Event|4
7706270|NCT00446563|12127613|FG001|Overall Study|Adverse Event|3
7706271|NCT00446563|12127612|FG000|Overall Study|Abnormal laboratory value(s)|0
7706272|NCT00446563|12127613|FG001|Overall Study|Abnormal laboratory value(s)|1
7706273|NCT00446563|12127612|FG000|Overall Study|Abnormal test procedure result(s)|1
7706274|NCT00446563|12127613|FG001|Overall Study|Abnormal test procedure result(s)|0
7706275|NCT00446563|12127612|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7706276|NCT00446563|12127613|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7706277|NCT00446563|12127612|FG000|Overall Study|Withdrawal by Subject|2
7706278|NCT00446563|12127613|FG001|Overall Study|Withdrawal by Subject|1
7706279|NCT00446563|12127612|FG000|Overall Study|Administrative problems|0
7706280|NCT00446563|12127613|FG001|Overall Study|Administrative problems|1
7706281|NCT00446641|12127621|FG000|Overall Study|Withdrawal by Subject|8
7706282|NCT00446641|12127622|FG001|Overall Study|Withdrawal by Subject|3
7706283|NCT00446641|12127621|FG000|Overall Study|poor compliance|8
7706284|NCT00446641|12127622|FG001|Overall Study|poor compliance|6
7706285|NCT00446641|12127621|FG000|Overall Study|Lost to Follow-up|1
7706286|NCT00446641|12127622|FG001|Overall Study|Lost to Follow-up|1
7706287|NCT00446654|12127630|FG000|Overall Study|Withdrawal by Subject|1
7706288|NCT00446654|12127631|FG001|Overall Study|Withdrawal by Subject|0
7706289|NCT00446654|12127630|FG000|Overall Study|Adverse Event|1
7706290|NCT00446654|12127631|FG001|Overall Study|Adverse Event|0
7706291|NCT00446797|12127639|FG000|Overall Study|Lack of Efficacy|0
7706292|NCT00446797|12127640|FG001|Overall Study|Lack of Efficacy|2
7706293|NCT00446797|12127639|FG000|Overall Study|Lost to Follow-up|5
7706294|NCT00446797|12127640|FG001|Overall Study|Lost to Follow-up|3
7706295|NCT00446797|12127639|FG000|Overall Study|Withdrawal by Subject|2
7706296|NCT00446797|12127640|FG001|Overall Study|Withdrawal by Subject|2
7706297|NCT00446797|12127639|FG000|Overall Study|Protocol Violation|1
7706298|NCT00446797|12127640|FG001|Overall Study|Protocol Violation|3
7706299|NCT00446797|12127639|FG000|Overall Study|subject entered at another site|0
7706300|NCT00446797|12127640|FG001|Overall Study|subject entered at another site|1
7706301|NCT00446797|12127639|FG000|Overall Study|did not meet entrance criteria|0
7706302|NCT00446797|12127640|FG001|Overall Study|did not meet entrance criteria|1
7706303|NCT00446849|12127646|FG000|Acute Phase|Lack of Efficacy|64
7706304|NCT00446849|12127646|FG000|Acute Phase|Protocol Violation|10
7706305|NCT00446849|12127646|FG000|Acute Phase|Consent withdrawn|4
7706306|NCT00446849|12127646|FG000|Acute Phase|Lost to Follow-up|2
7706307|NCT00446849|12127646|FG000|Acute Phase|Physician Decision|1
7706308|NCT00446849|12127646|FG000|Acute Phase|noncompliance|1
7706309|NCT00446849|12127646|FG000|Maintenance Phase|Lack of Efficacy|40
7706310|NCT00446849|12127646|FG000|Maintenance Phase|Protocol Violation|7
7706311|NCT00446849|12127646|FG000|Maintenance Phase|Adverse Event|6
7706312|NCT00446849|12127646|FG000|Maintenance Phase|Consent withdrawn|5
7706313|NCT00446849|12127646|FG000|Maintenance Phase|Lost to Follow-up|3
7706314|NCT00446849|12127646|FG000|Maintenance Phase|Pregnancy|1
7706315|NCT00446849|12127646|FG000|Maintenance Phase|noncompliance|2
7706316|NCT00446849|12127646|FG000|Maintenance Phase|prohibited medication use|2
7706317|NCT00446849|12127646|FG000|Maintenance Phase|antibiotic use|1
7706318|NCT00446849|12127646|FG000|Maintenance Phase|study closure|1
7706319|NCT00446849|12127646|FG000|Maintenance Phase|hydrocodone use|1
7706320|NCT00446849|12127646|FG000|Maintenance Phase|concomitant medication use|1
7706321|NCT00446966|12127653|FG000|Overall Study|Lost to Follow-up|10
7706322|NCT00446966|12127654|FG001|Overall Study|Lost to Follow-up|7
7706323|NCT00446992|12127660|FG000|Overall Study|Adverse Event|11
7706324|NCT00446992|12127660|FG000|Overall Study|Lost to Follow-up|5
7706325|NCT00447005|12127664|FG000|Overall Study|Adverse Event|1
7706326|NCT00447005|12127664|FG000|Overall Study|Lack of Efficacy|11
7706327|NCT00447057|12127672|FG000|Overall Study|Adverse Event|4
7706328|NCT00447057|12127673|FG001|Overall Study|Adverse Event|10
7706329|NCT00447057|12127674|FG002|Overall Study|Adverse Event|0
7706330|NCT00447057|12127675|FG003|Overall Study|Adverse Event|3
7706331|NCT00447057|12127672|FG000|Overall Study|Death due to study disease|6
7706332|NCT00447057|12127673|FG001|Overall Study|Death due to study disease|4
7706333|NCT00447057|12127674|FG002|Overall Study|Death due to study disease|1
7706334|NCT00447057|12127675|FG003|Overall Study|Death due to study disease|1
7706335|NCT00447057|12127672|FG000|Overall Study|Lost to Follow-up|0
7706336|NCT00447057|12127673|FG001|Overall Study|Lost to Follow-up|1
7706337|NCT00447057|12127674|FG002|Overall Study|Lost to Follow-up|0
7706338|NCT00447057|12127675|FG003|Overall Study|Lost to Follow-up|0
7706339|NCT00447057|12127672|FG000|Overall Study|Entry criteria not met|1
7706340|NCT00447057|12127673|FG001|Overall Study|Entry criteria not met|1
7706341|NCT00447057|12127674|FG002|Overall Study|Entry criteria not met|0
7706342|NCT00447057|12127675|FG003|Overall Study|Entry criteria not met|0
7706343|NCT00447057|12127672|FG000|Overall Study|Protocol Violation|0
7706344|NCT00447057|12127673|FG001|Overall Study|Protocol Violation|1
7706345|NCT00447057|12127674|FG002|Overall Study|Protocol Violation|0
7706346|NCT00447057|12127675|FG003|Overall Study|Protocol Violation|0
7706347|NCT00447057|12127672|FG000|Overall Study|Withdrawal by Subject|4
7706348|NCT00447057|12127673|FG001|Overall Study|Withdrawal by Subject|5
7706349|NCT00447057|12127674|FG002|Overall Study|Withdrawal by Subject|1
7706350|NCT00447057|12127675|FG003|Overall Study|Withdrawal by Subject|1
7706351|NCT00447057|12127672|FG000|Overall Study|Physician Decision|9
7706352|NCT00447057|12127673|FG001|Overall Study|Physician Decision|6
7706353|NCT00447057|12127674|FG002|Overall Study|Physician Decision|3
7706354|NCT00447057|12127675|FG003|Overall Study|Physician Decision|1
7706355|NCT00447057|12127672|FG000|Overall Study|Sponsor decision|1
7706356|NCT00447057|12127673|FG001|Overall Study|Sponsor decision|1
7706357|NCT00447057|12127674|FG002|Overall Study|Sponsor decision|0
7706358|NCT00447057|12127675|FG003|Overall Study|Sponsor decision|0
7706359|NCT00447057|12127672|FG000|Overall Study|Progressive disease|58
7706360|NCT00447057|12127673|FG001|Overall Study|Progressive disease|43
7706361|NCT00447057|12127674|FG002|Overall Study|Progressive disease|13
7706362|NCT00447057|12127675|FG003|Overall Study|Progressive disease|18
7706363|NCT00447057|12127672|FG000|Overall Study|Death due to adverse event|0
7706364|NCT00447057|12127673|FG001|Overall Study|Death due to adverse event|0
7706365|NCT00447057|12127674|FG002|Overall Study|Death due to adverse event|1
7706366|NCT00447057|12127675|FG003|Overall Study|Death due to adverse event|2
7706367|NCT00447057|12127672|FG000|Overall Study|Death, study drug related|0
7706368|NCT00447057|12127673|FG001|Overall Study|Death, study drug related|1
7706369|NCT00447057|12127674|FG002|Overall Study|Death, study drug related|0
7706370|NCT00447057|12127675|FG003|Overall Study|Death, study drug related|0
7706371|NCT00447226|12127696|FG000|12-Week Open-label Phase|Adverse Event|0
7706372|NCT00447226|12127697|FG001|12-Week Open-label Phase|Adverse Event|3
7706373|NCT00447226|12127696|FG000|12-Week Open-label Phase|Protocol Violation|0
7706374|NCT00447226|12127697|FG001|12-Week Open-label Phase|Protocol Violation|1
7706375|NCT00447226|12127696|FG000|12-Week Open-label Phase|Disease Progression|0
7706376|NCT00447226|12127697|FG001|12-Week Open-label Phase|Disease Progression|20
7706377|NCT00447226|12127696|FG000|12-Week Open-label Phase|Physician Decision|0
7706378|NCT00447226|12127697|FG001|12-Week Open-label Phase|Physician Decision|1
7706379|NCT00447226|12127696|FG000|Double-blind Phase|Disease Progression|4
7706380|NCT00447226|12127697|FG001|Double-blind Phase|Disease Progression|3
7706381|NCT00447265|12127712|FG000|Overall Study|Physician Decision|1
7706382|NCT00447265|12127713|FG001|Overall Study|Physician Decision|0
7706383|NCT00447278|12127719|FG000|Period II (6 Month Open-Label)|Adverse Event|7
7706384|NCT00447278|12127720|FG001|Period II (6 Month Open-Label)|Adverse Event|3
7706385|NCT00447278|12127719|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0
7706386|NCT00447278|12127720|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4
7706387|NCT00447278|12127719|FG000|Period II (6 Month Open-Label)|Protocol Violation|10
7706388|NCT00447278|12127720|FG001|Period II (6 Month Open-Label)|Protocol Violation|7
7706389|NCT00447278|12127719|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1
7706390|NCT00447278|12127720|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3
7706391|NCT00447278|12127719|FG000|Period II (6 Month Open-Label)|Physician Decision|4
7706392|NCT00447278|12127720|FG001|Period II (6 Month Open-Label)|Physician Decision|1
7706393|NCT00447278|12127719|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11
7706394|NCT00447278|12127720|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1
7706395|NCT00447278|12127719|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
7706396|NCT00447278|12127720|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
7706397|NCT00447278|12127719|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2
7706398|NCT00447278|12127720|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2
7706399|NCT00447278|12127719|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
7706400|NCT00447278|12127720|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
7706401|NCT00447278|12127719|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6
7706402|NCT00447278|12127720|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1
7706403|NCT00447278|12127719|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
7706404|NCT00447278|12127720|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
7706405|NCT00447278|12127719|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1
7706406|NCT00447278|12127720|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1
7706407|NCT00447278|12127719|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
7706408|NCT00447278|12127720|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
7706409|NCT00447278|12127719|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
7706410|NCT00447278|12127720|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
7706411|NCT00447382|12127734|FG000|Overall Study|Adverse Event|1
7706412|NCT00447382|12127735|FG001|Overall Study|Adverse Event|1
7706413|NCT00447382|12127734|FG000|Overall Study|Lack of Efficacy|1
7706414|NCT00447382|12127735|FG001|Overall Study|Lack of Efficacy|0
7706415|NCT00447382|12127734|FG000|Overall Study|Protocol Violation|2
7706416|NCT00447382|12127735|FG001|Overall Study|Protocol Violation|0
7706417|NCT00447382|12127734|FG000|Overall Study|Unclassified|2
7706418|NCT00447382|12127735|FG001|Overall Study|Unclassified|5
7706419|NCT00447499|12127741|FG000|Overall Study|Adverse Event|1
7706420|NCT00447499|12127741|FG000|Overall Study|Patient Decision|4
7706421|NCT00447499|12127741|FG000|Overall Study|Sponsor Decision|1
7706422|NCT00447499|12127741|FG000|Overall Study|Physician Decision|1
7706423|NCT00447590|12127747|FG000|Overall Study|Withdrawal by Subject|26
7706424|NCT00447590|12127747|FG000|Overall Study|Lost to Follow-up|24
7706425|NCT00447590|12127747|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
7706426|NCT00447694|12127751|FG000|Overall Study|Adverse Event|2
7706427|NCT00447694|12127751|FG000|Overall Study|Abnormal laboratory value|1
7706428|NCT00447694|12127751|FG000|Overall Study|Abnormal test procedure result|1
7706429|NCT00447694|12127751|FG000|Overall Study|Withdrawal by Subject|2
7706430|NCT00447772|12127755|FG000|Overall Study|Lack of Efficacy|3
7706431|NCT00447772|12127755|FG000|Overall Study|Insufficient compliance|6
7706432|NCT00447772|12127755|FG000|Overall Study|Discontinuation of drug therapy|1
7706433|NCT00447772|12127755|FG000|Overall Study|Lost to Follow-up|9
7706434|NCT00447772|12127755|FG000|Overall Study|Withdrawal by Subject|1
7706435|NCT00447772|12127755|FG000|Overall Study|Unable to attend all study visits|2
7706436|NCT00447772|12127755|FG000|Overall Study|Adverse Event|1
7706437|NCT00447772|12127755|FG000|Overall Study|Patient relocated|1
7706438|NCT00447772|12127755|FG000|Overall Study|Incomplete documentation at visit 1|1
7706439|NCT00447772|12127755|FG000|Overall Study|Chemotherapy for lung cancer|1
7706440|NCT00447772|12127755|FG000|Overall Study|Premature re-injection required|1
7706441|NCT00447876|12127764|FG000|Overall Study|Withdrawal by Subject|1
7706442|NCT00447876|12127765|FG001|Overall Study|Withdrawal by Subject|4
7706443|NCT00447876|12127764|FG000|Overall Study|Lost to Follow-up|1
7706444|NCT00447876|12127765|FG001|Overall Study|Lost to Follow-up|0
7706445|NCT00447876|12127764|FG000|Overall Study|Deterioration of symptomology|1
7706446|NCT00447876|12127765|FG001|Overall Study|Deterioration of symptomology|0
7706447|NCT00447902|12127773|FG000|Overall Study|Adverse Event|0
7706448|NCT00447902|12127774|FG001|Overall Study|Adverse Event|3
7706449|NCT00447902|12127773|FG000|Overall Study|Protocol Violation|1
7706450|NCT00447902|12127774|FG001|Overall Study|Protocol Violation|0
7706451|NCT00447902|12127773|FG000|Overall Study|Withdrawal by Subject|0
7706452|NCT00447902|12127774|FG001|Overall Study|Withdrawal by Subject|1
7706453|NCT00447902|12127773|FG000|Overall Study|included patients who discontinued|1
7706454|NCT00447902|12127774|FG001|Overall Study|included patients who discontinued|1
7706455|NCT00447902|12127773|FG000|Overall Study|Lack of Efficacy|2
7706456|NCT00447902|12127774|FG001|Overall Study|Lack of Efficacy|1
7706457|NCT00448019|12127780|FG000|Overall Study|Withdrawal by Subject|3
7706458|NCT00448019|12127780|FG000|Overall Study|Disease progression|1
7706459|NCT00448019|12127780|FG000|Overall Study|Death|2
7706460|NCT00448019|12127780|FG000|Overall Study|Insurance Issues|1
7706461|NCT00448123|12127786|FG000|Overall Study|Lost to Follow-up|9
7706462|NCT00448123|12127787|FG001|Overall Study|Lost to Follow-up|6
7706463|NCT00448123|12127786|FG000|Overall Study|Physician Decision|6
7706464|NCT00448123|12127787|FG001|Overall Study|Physician Decision|6
7706465|NCT00448136|12127798|FG000|Overall Study|Death|3
7706466|NCT00448136|12127799|FG001|Overall Study|Death|8
7706467|NCT00448136|12127798|FG000|Overall Study|Investigator's decision (progression)|1
7706468|NCT00448136|12127799|FG001|Overall Study|Investigator's decision (progression)|0
7706469|NCT00448279|12127829|FG000|Overall Study|Lost to Follow-up|2
7706470|NCT00448279|12127830|FG001|Overall Study|Lost to Follow-up|2
7706471|NCT00448279|12127829|FG000|Overall Study|Adverse Event|1
7706472|NCT00448279|12127830|FG001|Overall Study|Adverse Event|1
7706473|NCT00448279|12127829|FG000|Overall Study|Disease progression|16
7706474|NCT00448279|12127830|FG001|Overall Study|Disease progression|18
7706475|NCT00448279|12127829|FG000|Overall Study|Withdrawal by Subject|4
7706476|NCT00448279|12127830|FG001|Overall Study|Withdrawal by Subject|3
7706477|NCT00448279|12127829|FG000|Overall Study|Other|6
7706478|NCT00448279|12127830|FG001|Overall Study|Other|4
7706479|NCT00448279|12127829|FG000|Overall Study|Protocol Violation|0
7706480|NCT00448279|12127830|FG001|Overall Study|Protocol Violation|1
7706481|NCT00448344|12127838|FG000|Overall Study|Lost to Follow-up|20
7706482|NCT00448344|12127839|FG001|Overall Study|Lost to Follow-up|22
7706483|NCT00448344|12127838|FG000|Overall Study|Withdrawal by Subject|6
7706484|NCT00448344|12127839|FG001|Overall Study|Withdrawal by Subject|8
7706485|NCT00448344|12127838|FG000|Overall Study|Death|3
7706486|NCT00448344|12127839|FG001|Overall Study|Death|4
7706487|NCT00448344|12127838|FG000|Overall Study|Physician Decision|1
7706488|NCT00448344|12127839|FG001|Overall Study|Physician Decision|2
7706489|NCT00448435|12127861|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1
7706490|NCT00448435|12127862|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0
7706491|NCT00448448|12127873|FG000|Overall Study|Withdrawal by Subject|13
7706492|NCT00448448|12127874|FG001|Overall Study|Withdrawal by Subject|2
7706493|NCT00448448|12127873|FG000|Overall Study|On protocol when study ended|83
7706494|NCT00448448|12127874|FG001|Overall Study|On protocol when study ended|36
7706495|NCT00448448|12127873|FG000|Overall Study|Lost to Follow-up|2
7706496|NCT00448448|12127874|FG001|Overall Study|Lost to Follow-up|1
7706497|NCT00448448|12127873|FG000|Overall Study|Wrong diagnosis (n=3) or other|2
7706498|NCT00448448|12127874|FG001|Overall Study|Wrong diagnosis (n=3) or other|1
7706499|NCT00448448|12127873|FG000|Overall Study|Signed consent lost|0
7706500|NCT00448448|12127874|FG001|Overall Study|Signed consent lost|1
7706501|NCT00448539|12127882|FG000|Overall Study|Medication non-compliance|4
7706502|NCT00448539|12127883|FG001|Overall Study|Medication non-compliance|1
7706503|NCT00448539|12127882|FG000|Overall Study|Protocol Violation|1
7706504|NCT00448539|12127883|FG001|Overall Study|Protocol Violation|0
7706505|NCT00448539|12127882|FG000|Overall Study|Request of the investigator or sponsor|67
7706506|NCT00448539|12127883|FG001|Overall Study|Request of the investigator or sponsor|54
7706507|NCT00448539|12127882|FG000|Overall Study|Withdrawal by Subject|20
7706508|NCT00448539|12127883|FG001|Overall Study|Withdrawal by Subject|24
7706509|NCT00448539|12127882|FG000|Overall Study|Diary non-compliance|1
7706510|NCT00448539|12127883|FG001|Overall Study|Diary non-compliance|0
7706511|NCT00448539|12127882|FG000|Overall Study|Adverse Event|9
7706512|NCT00448539|12127883|FG001|Overall Study|Adverse Event|26
7706513|NCT00448539|12127882|FG000|Overall Study|Lack of Efficacy|27
7706514|NCT00448539|12127883|FG001|Overall Study|Lack of Efficacy|40
7706515|NCT00448539|12127882|FG000|Overall Study|Miscellaneous|2
7706516|NCT00448539|12127883|FG001|Overall Study|Miscellaneous|1
7706517|NCT00448539|12127882|FG000|Overall Study|Change of meds|2
7706518|NCT00448539|12127883|FG001|Overall Study|Change of meds|3
7706519|NCT00448539|12127882|FG000|Overall Study|Lost to Follow-up|1
7706520|NCT00448539|12127883|FG001|Overall Study|Lost to Follow-up|3
7706521|NCT00448591|12127889|FG000|Overall Study|Withdrawal by Subject|178
7706522|NCT00448591|12127889|FG000|Overall Study|Progressive Disease|1382
7706523|NCT00448591|12127889|FG000|Overall Study|Adverse Event|382
7706524|NCT00448591|12127889|FG000|Overall Study|Protocol Violation|41
7706525|NCT00448591|12127889|FG000|Overall Study|Lost to Follow-up|19
7706526|NCT00448591|12127889|FG000|Overall Study|Treatment Regimen Completed|70
7706527|NCT00448591|12127889|FG000|Overall Study|Other|154
7706528|NCT00448591|12127889|FG000|Overall Study|Termination of Study|70
7706529|NCT00448669|12127897|FG000|Overall Study|Lost to Follow-up|52
7706530|NCT00448669|12127898|FG001|Overall Study|Lost to Follow-up|63
7706531|NCT00448669|12127897|FG000|Overall Study|Withdrawal by Subject|90
7706532|NCT00448669|12127898|FG001|Overall Study|Withdrawal by Subject|74
7706533|NCT00448669|12127897|FG000|Overall Study|Relocated|49
7706534|NCT00448669|12127898|FG001|Overall Study|Relocated|36
7706535|NCT00448669|12127897|FG000|Overall Study|Were withdrawn by investigator|10
7706536|NCT00448669|12127898|FG001|Overall Study|Were withdrawn by investigator|6
7706537|NCT00448669|12127897|FG000|Overall Study|Death|2
7706538|NCT00448669|12127898|FG001|Overall Study|Death|4
7706539|NCT00448669|12127897|FG000|Overall Study|Had other reasons|5
7706540|NCT00448669|12127898|FG001|Overall Study|Had other reasons|6
7706541|NCT00448669|12127897|FG000|Overall Study|HIV-infected at enrollment|1
7706542|NCT00448669|12127898|FG001|Overall Study|HIV-infected at enrollment|2
7706543|NCT00448669|12127897|FG000|Overall Study|Never started drug|9
7706544|NCT00448669|12127898|FG001|Overall Study|Never started drug|7
7706545|NCT00448708|12127908|FG000|Overall Study|Death|21
7706546|NCT00448708|12127909|FG001|Overall Study|Death|17
7706547|NCT00448708|12127908|FG000|Overall Study|Withdrawal by Subject|8
7706548|NCT00448708|12127909|FG001|Overall Study|Withdrawal by Subject|4
7706549|NCT00448708|12127908|FG000|Overall Study|Lost to Follow-up|6
7706550|NCT00448708|12127909|FG001|Overall Study|Lost to Follow-up|8
7706551|NCT00448708|12127908|FG000|Overall Study|not listed|0
7706552|NCT00448708|12127909|FG001|Overall Study|not listed|2
7706553|NCT00448747|12127917|FG000|Overall Study|collapsed veins|1
7706554|NCT00448747|12127918|FG001|Overall Study|collapsed veins|0
7706555|NCT00448760|12127934|FG000|Overall Study|Death|3
7706556|NCT00448812|12127940|FG000|Year 2|Missed visit but remained in study|4
7706557|NCT00448812|12127941|FG001|Year 2|Missed visit but remained in study|1
7706558|NCT00448812|12127940|FG000|Year 3|Withdrawal by Subject|1
7706559|NCT00448812|12127941|FG001|Year 3|Withdrawal by Subject|3
7706560|NCT00448812|12127940|FG000|Year 3|Lost to Follow-up|1
7706561|NCT00448812|12127941|FG001|Year 3|Lost to Follow-up|0
7706562|NCT00448812|12127940|FG000|Year 3|Missed visit but remained in study|2
7706563|NCT00448812|12127941|FG001|Year 3|Missed visit but remained in study|0
7706564|NCT00448812|12127940|FG000|Year 5|Missed visit but remained in study|1
7706565|NCT00448812|12127941|FG001|Year 5|Missed visit but remained in study|0
7706566|NCT00448864|12127962|FG000|Overall Study|Death|1
7706567|NCT00448864|12127963|FG001|Overall Study|Death|0
7706568|NCT00448864|12127964|FG002|Overall Study|Death|0
7706569|NCT00448864|12127962|FG000|Overall Study|Lost to Follow-up|3
7706570|NCT00448864|12127963|FG001|Overall Study|Lost to Follow-up|1
7706571|NCT00448864|12127964|FG002|Overall Study|Lost to Follow-up|0
7706572|NCT00448864|12127962|FG000|Overall Study|Physician Decision|1
7706573|NCT00448864|12127963|FG001|Overall Study|Physician Decision|0
7706574|NCT00448864|12127964|FG002|Overall Study|Physician Decision|1
7706575|NCT00448864|12127962|FG000|Overall Study|Withdrawal by Subject|0
7706576|NCT00448864|12127963|FG001|Overall Study|Withdrawal by Subject|2
7706577|NCT00448864|12127964|FG002|Overall Study|Withdrawal by Subject|0
7706578|NCT00448864|12127962|FG000|Overall Study|Protocol Violation|0
7706579|NCT00448864|12127963|FG001|Overall Study|Protocol Violation|2
7706580|NCT00448864|12127964|FG002|Overall Study|Protocol Violation|0
7706581|NCT00448916|12127978|FG000|Overall Study|Adverse Event|2
7706582|NCT00448916|12127979|FG001|Overall Study|Adverse Event|2
7706583|NCT00448916|12127980|FG002|Overall Study|Adverse Event|3
7706584|NCT00448916|12127981|FG003|Overall Study|Adverse Event|2
7706585|NCT00448916|12127978|FG000|Overall Study|Lack of Efficacy|1
7706586|NCT00448916|12127979|FG001|Overall Study|Lack of Efficacy|0
7706587|NCT00448916|12127980|FG002|Overall Study|Lack of Efficacy|2
7706588|NCT00448916|12127981|FG003|Overall Study|Lack of Efficacy|1
7706589|NCT00448916|12127978|FG000|Overall Study|Withdrawal by Subject|3
7706590|NCT00448916|12127979|FG001|Overall Study|Withdrawal by Subject|3
7706591|NCT00448916|12127980|FG002|Overall Study|Withdrawal by Subject|1
7706592|NCT00448916|12127981|FG003|Overall Study|Withdrawal by Subject|1
7706593|NCT00448916|12127978|FG000|Overall Study|Other|1
7706594|NCT00448916|12127979|FG001|Overall Study|Other|0
7706595|NCT00448916|12127980|FG002|Overall Study|Other|0
7706596|NCT00448916|12127981|FG003|Overall Study|Other|0
7706597|NCT00448916|12127978|FG000|Overall Study|Lost to Follow-up|0
7706598|NCT00448916|12127979|FG001|Overall Study|Lost to Follow-up|1
7706599|NCT00448916|12127980|FG002|Overall Study|Lost to Follow-up|0
7706600|NCT00448916|12127981|FG003|Overall Study|Lost to Follow-up|1
7706601|NCT00448916|12127978|FG000|Overall Study|Protocol Violation|0
7706602|NCT00448916|12127979|FG001|Overall Study|Protocol Violation|0
7706603|NCT00448916|12127980|FG002|Overall Study|Protocol Violation|0
7706604|NCT00448916|12127981|FG003|Overall Study|Protocol Violation|1
7706605|NCT00449033|12128006|FG000|Treatment Period|Adverse Event|117
7706606|NCT00449033|12128007|FG001|Treatment Period|Adverse Event|83
7706607|NCT00449033|12128006|FG000|Treatment Period|Death|21
7706608|NCT00449033|12128007|FG001|Treatment Period|Death|12
7706609|NCT00449033|12128006|FG000|Treatment Period|Lost to Follow-up|0
7706610|NCT00449033|12128007|FG001|Treatment Period|Lost to Follow-up|2
7706611|NCT00449033|12128006|FG000|Treatment Period|Physician Decision|4
7706612|NCT00449033|12128007|FG001|Treatment Period|Physician Decision|5
7706613|NCT00449033|12128006|FG000|Treatment Period|Protocol Violation|8
7706614|NCT00449033|12128007|FG001|Treatment Period|Protocol Violation|7
7706615|NCT00449033|12128006|FG000|Treatment Period|Disease Progression|231
7706616|NCT00449033|12128007|FG001|Treatment Period|Disease Progression|288
7706617|NCT00449033|12128006|FG000|Treatment Period|Consent Withdrawn|36
7706618|NCT00449033|12128007|FG001|Treatment Period|Consent Withdrawn|20
7706619|NCT00449033|12128006|FG000|Treatment Period|Amended Protocol Criteria|22
7706620|NCT00449033|12128007|FG001|Treatment Period|Amended Protocol Criteria|18
7706621|NCT00449033|12128006|FG000|Treatment Period|Non-compliance|7
7706622|NCT00449033|12128007|FG001|Treatment Period|Non-compliance|8
7706623|NCT00449033|12128006|FG000|Treatment Period|Second Malignancy|0
7706624|NCT00449033|12128007|FG001|Treatment Period|Second Malignancy|1
7706625|NCT00449033|12128006|FG000|Treatment Period|Reason Missing|0
7706626|NCT00449033|12128007|FG001|Treatment Period|Reason Missing|4
7706627|NCT00449033|12128006|FG000|Treatment Period|Treatment Ongoing|6
7706628|NCT00449033|12128007|FG001|Treatment Period|Treatment Ongoing|4
7706629|NCT00449033|12128006|FG000|Follow-up Period|Death|299
7706630|NCT00449033|12128007|FG001|Follow-up Period|Death|311
7706631|NCT00449033|12128006|FG000|Follow-up Period|Lost to Follow-up|6
7706632|NCT00449033|12128007|FG001|Follow-up Period|Lost to Follow-up|10
7706633|NCT00449033|12128006|FG000|Follow-up Period|Reason Missing|120
7706634|NCT00449033|12128007|FG001|Follow-up Period|Reason Missing|113
7706635|NCT00449072|12128019|FG000|Overall Study|Adverse Event|3
7706636|NCT00449072|12128020|FG001|Overall Study|Adverse Event|1
7706637|NCT00449072|12128019|FG000|Overall Study|Protocol Violation|14
7706638|NCT00449072|12128020|FG001|Overall Study|Protocol Violation|12
7706639|NCT00449072|12128019|FG000|Overall Study|Lost to Follow-up|5
7706640|NCT00449072|12128020|FG001|Overall Study|Lost to Follow-up|7
7706641|NCT00449072|12128019|FG000|Overall Study|Withdrawal by Subject|11
7706642|NCT00449072|12128020|FG001|Overall Study|Withdrawal by Subject|8
7706643|NCT00449072|12128019|FG000|Overall Study|Lack of Efficacy|1
7706644|NCT00449072|12128020|FG001|Overall Study|Lack of Efficacy|1
7706645|NCT00449072|12128019|FG000|Overall Study|Physician Decision|1
7706646|NCT00449072|12128020|FG001|Overall Study|Physician Decision|0
7706647|NCT00449072|12128019|FG000|Overall Study|Not treated|0
7706648|NCT00449072|12128020|FG001|Overall Study|Not treated|1
7706649|NCT00449072|12128019|FG000|Overall Study|Excluded medication|0
7706650|NCT00449072|12128020|FG001|Overall Study|Excluded medication|2
7706651|NCT00449072|12128019|FG000|Overall Study|Non-compliance|2
7706652|NCT00449072|12128020|FG001|Overall Study|Non-compliance|5
7706653|NCT00449072|12128019|FG000|Overall Study|Sponsor decision|1
7706654|NCT00449072|12128020|FG001|Overall Study|Sponsor decision|3
7706655|NCT00449072|12128019|FG000|Overall Study|Relocation|3
7706656|NCT00449072|12128020|FG001|Overall Study|Relocation|2
7706657|NCT00449150|12128029|FG000|Overall Study|Adverse Event|11
7706658|NCT00449150|12128030|FG001|Overall Study|Adverse Event|18
7706659|NCT00449150|12128031|FG002|Overall Study|Adverse Event|9
7706660|NCT00449150|12128029|FG000|Overall Study|Lack of Efficacy|1
7706661|NCT00449150|12128030|FG001|Overall Study|Lack of Efficacy|2
7706662|NCT00449150|12128031|FG002|Overall Study|Lack of Efficacy|2
7706663|NCT00449150|12128029|FG000|Overall Study|Other|16
7706664|NCT00449150|12128030|FG001|Overall Study|Other|13
7706665|NCT00449150|12128031|FG002|Overall Study|Other|14
7706666|NCT00449150|12128029|FG000|Overall Study|Withdrawal by Subject|17
7706667|NCT00449150|12128030|FG001|Overall Study|Withdrawal by Subject|18
7706668|NCT00449150|12128031|FG002|Overall Study|Withdrawal by Subject|21
7706669|NCT00449150|12128029|FG000|Overall Study|Protocol Violation|1
7706670|NCT00449150|12128030|FG001|Overall Study|Protocol Violation|2
7706671|NCT00449150|12128031|FG002|Overall Study|Protocol Violation|1
7706672|NCT00449163|12128042|FG000|Overall Study|Physician Decision|3
7706673|NCT00449176|12128049|FG000|Overall Study|Withdrawal by Subject|39
7706674|NCT00449176|12128050|FG001|Overall Study|Withdrawal by Subject|43
7706675|NCT00449176|12128051|FG002|Overall Study|Withdrawal by Subject|59
7706676|NCT00449176|12128049|FG000|Overall Study|Lost to Follow-up|13
7706677|NCT00449176|12128050|FG001|Overall Study|Lost to Follow-up|8
7706678|NCT00449176|12128051|FG002|Overall Study|Lost to Follow-up|12
7706679|NCT00449176|12128049|FG000|Overall Study|Adverse Event|51
7706680|NCT00449176|12128050|FG001|Overall Study|Adverse Event|107
7706681|NCT00449176|12128051|FG002|Overall Study|Adverse Event|15
7706682|NCT00449176|12128049|FG000|Overall Study|Lack of Efficacy|13
7706683|NCT00449176|12128050|FG001|Overall Study|Lack of Efficacy|7
7706684|NCT00449176|12128051|FG002|Overall Study|Lack of Efficacy|50
7706685|NCT00449176|12128049|FG000|Overall Study|Study drug non-compliant|14
7706686|NCT00449176|12128050|FG001|Overall Study|Study drug non-compliant|11
7706687|NCT00449176|12128051|FG002|Overall Study|Study drug non-compliant|11
7706688|NCT00449176|12128049|FG000|Overall Study|all other|22
7706689|NCT00449176|12128050|FG001|Overall Study|all other|19
7706690|NCT00449176|12128051|FG002|Overall Study|all other|20
7706691|NCT00449540|12128061|FG000|Pretreatment Phase|No migraine experienced|66
7706692|NCT00449540|12128062|FG001|Pretreatment Phase|No migraine experienced|0
7706693|NCT00449540|12128063|FG002|Pretreatment Phase|No migraine experienced|0
7706694|NCT00449540|12128061|FG000|Treatment Phase|did not experience or treat migraine|0
7706695|NCT00449540|12128062|FG001|Treatment Phase|did not experience or treat migraine|20
7706696|NCT00449540|12128063|FG002|Treatment Phase|did not experience or treat migraine|17
7706697|NCT00449644|12128075|FG000|Overall Study|Adverse Event|0
7706698|NCT00449644|12128076|FG001|Overall Study|Adverse Event|0
7706699|NCT00449644|12128077|FG002|Overall Study|Adverse Event|3
7706700|NCT00449644|12128078|FG003|Overall Study|Adverse Event|5
7706701|NCT00449644|12128075|FG000|Overall Study|Death|1
7706702|NCT00449644|12128076|FG001|Overall Study|Death|0
7706703|NCT00449644|12128077|FG002|Overall Study|Death|6
7706704|NCT00449644|12128078|FG003|Overall Study|Death|1
7706705|NCT00449644|12128075|FG000|Overall Study|Lost to Follow-up|1
7706706|NCT00449644|12128076|FG001|Overall Study|Lost to Follow-up|1
7706707|NCT00449644|12128077|FG002|Overall Study|Lost to Follow-up|5
7706708|NCT00449644|12128078|FG003|Overall Study|Lost to Follow-up|3
7706709|NCT00449644|12128075|FG000|Overall Study|Pregnancy|0
7706710|NCT00449644|12128076|FG001|Overall Study|Pregnancy|0
7706711|NCT00449644|12128077|FG002|Overall Study|Pregnancy|3
7706712|NCT00449644|12128078|FG003|Overall Study|Pregnancy|2
7706713|NCT00449644|12128075|FG000|Overall Study|Protocol Violation|4
7706714|NCT00449644|12128076|FG001|Overall Study|Protocol Violation|4
7706715|NCT00449644|12128077|FG002|Overall Study|Protocol Violation|3
7706716|NCT00449644|12128078|FG003|Overall Study|Protocol Violation|7
7706717|NCT00449644|12128075|FG000|Overall Study|Withdrawal by Subject|3
7706718|NCT00449644|12128076|FG001|Overall Study|Withdrawal by Subject|4
7706719|NCT00449644|12128077|FG002|Overall Study|Withdrawal by Subject|6
7706720|NCT00449644|12128078|FG003|Overall Study|Withdrawal by Subject|7
7706721|NCT00449644|12128075|FG000|Overall Study|Inclusion/exclusion criteria not met|0
7706722|NCT00449644|12128076|FG001|Overall Study|Inclusion/exclusion criteria not met|0
7706723|NCT00449644|12128077|FG002|Overall Study|Inclusion/exclusion criteria not met|2
7706724|NCT00449644|12128078|FG003|Overall Study|Inclusion/exclusion criteria not met|6
7706725|NCT00449644|12128075|FG000|Overall Study|Other|1
7706726|NCT00449644|12128076|FG001|Overall Study|Other|4
7706727|NCT00449644|12128077|FG002|Overall Study|Other|1
7706728|NCT00449644|12128078|FG003|Overall Study|Other|0
7706729|NCT00449644|12128075|FG000|Overall Study|Rolled-over to treatment with TMC207|0
7706730|NCT00449644|12128076|FG001|Overall Study|Rolled-over to treatment with TMC207|0
7706731|NCT00449644|12128077|FG002|Overall Study|Rolled-over to treatment with TMC207|0
7706732|NCT00449644|12128078|FG003|Overall Study|Rolled-over to treatment with TMC207|1
7706733|NCT00449670|12128093|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1
7706734|NCT00449670|12128094|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0
7706735|NCT00449670|12128093|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4
7706736|NCT00449670|12128094|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0
7706737|NCT00449670|12128093|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4
7706738|NCT00449670|12128094|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1
7706739|NCT00449670|12128093|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5
7706740|NCT00449670|12128094|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1
7706741|NCT00449670|12128093|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0
7706742|NCT00449670|12128094|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1
7706743|NCT00449670|12128093|FG000|Booster Phase (Study no.109873)|Other|0
7706744|NCT00449670|12128094|FG001|Booster Phase (Study no.109873)|Other|2
7706745|NCT00449696|12128109|FG000|Overall Study|Other Treatment Required|6
7706746|NCT00449696|12128110|FG001|Overall Study|Other Treatment Required|1
7706747|NCT00449696|12128109|FG000|Overall Study|Withdrawal by Subject|5
7706748|NCT00449696|12128110|FG001|Overall Study|Withdrawal by Subject|5
7706749|NCT00449696|12128109|FG000|Overall Study|Lost to Follow-up|2
7706750|NCT00449696|12128110|FG001|Overall Study|Lost to Follow-up|3
7706751|NCT00449696|12128109|FG000|Overall Study|Others|7
7706752|NCT00449696|12128110|FG001|Overall Study|Others|0
7706753|NCT00449761|12128120|FG000|Overall Study|Disease progression|12
7706754|NCT00449761|12128120|FG000|Overall Study|Death|5
7706755|NCT00449761|12128120|FG000|Overall Study|New cancer therapy|1
7706756|NCT00449787|12128127|FG000|Overall Study|Lost to Follow-up|10
7706757|NCT00449787|12128128|FG001|Overall Study|Lost to Follow-up|8
7706758|NCT00449787|12128127|FG000|Overall Study|Did not require medication|95
7706759|NCT00449787|12128128|FG001|Overall Study|Did not require medication|92
7706760|NCT00449865|12128138|FG000|Overall Study|Withdrawal by Subject|110
7706761|NCT00449865|12128139|FG001|Overall Study|Withdrawal by Subject|110
7706762|NCT00449865|12128138|FG000|Overall Study|Lost to Follow-up|36
7706763|NCT00449865|12128139|FG001|Overall Study|Lost to Follow-up|37
7706764|NCT00449865|12128138|FG000|Overall Study|Physician Decision|13
7706765|NCT00449865|12128139|FG001|Overall Study|Physician Decision|12
7706766|NCT00449865|12128138|FG000|Overall Study|Death|31
7706767|NCT00449865|12128139|FG001|Overall Study|Death|40
7706768|NCT00449865|12128138|FG000|Overall Study|Protocol Violation|8
7706769|NCT00449865|12128139|FG001|Overall Study|Protocol Violation|7
7706770|NCT00449865|12128138|FG000|Overall Study|Study was stopped|324
7706771|NCT00449865|12128139|FG001|Overall Study|Study was stopped|328
7706772|NCT00449930|12128147|FG000|Overall Study|Adverse Event|9
7706773|NCT00449930|12128148|FG001|Overall Study|Adverse Event|19
7706774|NCT00449930|12128147|FG000|Overall Study|Trial Terminated ( Site Closed)|1
7706775|NCT00449930|12128148|FG001|Overall Study|Trial Terminated ( Site Closed)|0
7706776|NCT00449930|12128147|FG000|Overall Study|Lack of Efficacy|10
7706777|NCT00449930|12128148|FG001|Overall Study|Lack of Efficacy|1
7706778|NCT00449930|12128147|FG000|Overall Study|Lost to Follow-up|9
7706779|NCT00449930|12128148|FG001|Overall Study|Lost to Follow-up|14
7706780|NCT00449930|12128147|FG000|Overall Study|Physician Decision|1
7706781|NCT00449930|12128148|FG001|Overall Study|Physician Decision|2
7706782|NCT00449930|12128147|FG000|Overall Study|Protocol Violation|14
7706783|NCT00449930|12128148|FG001|Overall Study|Protocol Violation|15
7706784|NCT00449930|12128147|FG000|Overall Study|Withdrawal by Subject|16
7706785|NCT00449930|12128148|FG001|Overall Study|Withdrawal by Subject|23
7706786|NCT00449930|12128147|FG000|Overall Study|Glycemic discontinuation criteria|1
7706787|NCT00449930|12128148|FG001|Overall Study|Glycemic discontinuation criteria|1
7706788|NCT00449956|12128157|FG000|Overall Study|Adverse Event|7
7706789|NCT00449956|12128158|FG001|Overall Study|Adverse Event|1
7706790|NCT00449956|12128159|FG002|Overall Study|Adverse Event|6
7706791|NCT00449956|12128157|FG000|Overall Study|Lack of Efficacy|0
7706792|NCT00449956|12128158|FG001|Overall Study|Lack of Efficacy|0
7706793|NCT00449956|12128159|FG002|Overall Study|Lack of Efficacy|1
7706794|NCT00449956|12128157|FG000|Overall Study|Protocol Violation|1
7706795|NCT00449956|12128158|FG001|Overall Study|Protocol Violation|1
7706796|NCT00449956|12128159|FG002|Overall Study|Protocol Violation|1
7706797|NCT00449956|12128157|FG000|Overall Study|Withdrawal by Subject|0
7706798|NCT00449956|12128158|FG001|Overall Study|Withdrawal by Subject|1
7706799|NCT00449956|12128159|FG002|Overall Study|Withdrawal by Subject|0
7706800|NCT00449956|12128157|FG000|Overall Study|Physician Decision|2
7706801|NCT00449956|12128158|FG001|Overall Study|Physician Decision|1
7706802|NCT00449956|12128159|FG002|Overall Study|Physician Decision|1
7706803|NCT00450112|12128182|FG000|Overall Study|Other Treatment Required|5
7706804|NCT00450112|12128183|FG001|Overall Study|Other Treatment Required|1
7706805|NCT00450112|12128182|FG000|Overall Study|Withdrawal by Subject|4
7706806|NCT00450112|12128183|FG001|Overall Study|Withdrawal by Subject|1
7706807|NCT00450112|12128182|FG000|Overall Study|Lost to Follow-up|2
7706808|NCT00450112|12128183|FG001|Overall Study|Lost to Follow-up|1
7706809|NCT00450112|12128182|FG000|Overall Study|Others|2
7706810|NCT00450112|12128183|FG001|Overall Study|Others|3
7706811|NCT00450177|12128191|FG000|Overall Study|Adverse Event|7
7706812|NCT00450177|12128192|FG001|Overall Study|Adverse Event|4
7706813|NCT00450177|12128191|FG000|Overall Study|Withdrawal by Subject|1
7706814|NCT00450177|12128192|FG001|Overall Study|Withdrawal by Subject|6
7706815|NCT00450177|12128191|FG000|Overall Study|Withdrawal by Primary Team|1
7706816|NCT00450177|12128192|FG001|Overall Study|Withdrawal by Primary Team|1
7706817|NCT00450190|12128198|FG000|Overall Study|Withdrawal by Subject|2
7706818|NCT00450216|12128204|FG000|Overall Study|Adverse Event|38
7706819|NCT00450216|12128205|FG001|Overall Study|Adverse Event|23
7706820|NCT00450216|12128204|FG000|Overall Study|Withdrawal by Subject|48
7706821|NCT00450216|12128205|FG001|Overall Study|Withdrawal by Subject|26
7706822|NCT00450216|12128204|FG000|Overall Study|Lost to Follow-up|16
7706823|NCT00450216|12128205|FG001|Overall Study|Lost to Follow-up|9
7706824|NCT00450216|12128204|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51
7706825|NCT00450216|12128205|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51
7706826|NCT00450216|12128204|FG000|Overall Study|misc|21
7706827|NCT00450216|12128205|FG001|Overall Study|misc|20
7706828|NCT00450255|12128222|FG000|Overall Study|Prior RFA ablation of liver|1
7706829|NCT00450372|12128232|FG000|Overall Study|Physician Decision|1
7706830|NCT00450385|12128239|FG000|Overall Study|Death|3
7706831|NCT00450385|12128239|FG000|Overall Study|Protocol Violation|1
7706832|NCT00450385|12128239|FG000|Overall Study|Withdrawal by Subject|2
7706833|NCT00450385|12128239|FG000|Overall Study|Lack of Efficacy|2
7706834|NCT00450385|12128239|FG000|Overall Study|Adverse Event|1
7706835|NCT00450385|12128239|FG000|Overall Study|Physician Decision|1
7706836|NCT00450385|12128239|FG000|Overall Study|Other|3
7706837|NCT00450437|12128255|FG000|Overall Study|Withdrawal by Subject|10
7706838|NCT00450437|12128256|FG001|Overall Study|Withdrawal by Subject|2
7706839|NCT00450437|12128257|FG002|Overall Study|Withdrawal by Subject|0
7706840|NCT00450437|12128258|FG003|Overall Study|Withdrawal by Subject|1
7706841|NCT00450437|12128255|FG000|Overall Study|Lost to Follow-up|31
7706842|NCT00450437|12128256|FG001|Overall Study|Lost to Follow-up|12
7706843|NCT00450437|12128257|FG002|Overall Study|Lost to Follow-up|19
7706844|NCT00450437|12128258|FG003|Overall Study|Lost to Follow-up|9
7706845|NCT00450437|12128255|FG000|Overall Study|Protocol Violation|0
7706846|NCT00450437|12128256|FG001|Overall Study|Protocol Violation|1
7706847|NCT00450437|12128257|FG002|Overall Study|Protocol Violation|0
7706848|NCT00450437|12128258|FG003|Overall Study|Protocol Violation|1
7706849|NCT00450437|12128255|FG000|Overall Study|Inappropriate enrollment|4
7706850|NCT00450437|12128256|FG001|Overall Study|Inappropriate enrollment|1
7706851|NCT00450437|12128257|FG002|Overall Study|Inappropriate enrollment|3
7706852|NCT00450437|12128258|FG003|Overall Study|Inappropriate enrollment|0
7706853|NCT00450437|12128255|FG000|Overall Study|Administrative reason|0
7706854|NCT00450437|12128256|FG001|Overall Study|Administrative reason|0
7706855|NCT00450437|12128257|FG002|Overall Study|Administrative reason|1
7706856|NCT00450437|12128258|FG003|Overall Study|Administrative reason|0
7706857|NCT00450437|12128255|FG000|Overall Study|Unable to Classify|1
7706858|NCT00450437|12128256|FG001|Overall Study|Unable to Classify|0
7706859|NCT00450437|12128257|FG002|Overall Study|Unable to Classify|1
7706860|NCT00450437|12128258|FG003|Overall Study|Unable to Classify|0
7706861|NCT00450580|12128286|FG000|Overall Study|Adverse Event|5
7706862|NCT00450580|12128287|FG001|Overall Study|Adverse Event|7
7706863|NCT00450580|12128286|FG000|Overall Study|Lost to Follow-up|4
7706864|NCT00450580|12128287|FG001|Overall Study|Lost to Follow-up|5
7706865|NCT00450580|12128286|FG000|Overall Study|Withdrawal by Subject|2
7706866|NCT00450580|12128287|FG001|Overall Study|Withdrawal by Subject|2
7706867|NCT00450580|12128286|FG000|Overall Study|Protocol Violation|1
7706868|NCT00450580|12128287|FG001|Overall Study|Protocol Violation|1
7706869|NCT00450580|12128286|FG000|Overall Study|Protocol-defined virologic failure|1
7706870|NCT00450580|12128287|FG001|Overall Study|Protocol-defined virologic failure|0
7706871|NCT00450580|12128286|FG000|Overall Study|Could not comply with scheduled visits|1
7706872|NCT00450580|12128287|FG001|Overall Study|Could not comply with scheduled visits|0
7706873|NCT00450580|12128286|FG000|Overall Study|Patient went to Brazil|1
7706874|NCT00450580|12128287|FG001|Overall Study|Patient went to Brazil|0
7706875|NCT00450580|12128286|FG000|Overall Study|Patient could not swallow Norvir|1
7706876|NCT00450580|12128287|FG001|Overall Study|Patient could not swallow Norvir|0
7706877|NCT00450580|12128286|FG000|Overall Study|Withdrawal due to pregnancy|0
7706878|NCT00450580|12128287|FG001|Overall Study|Withdrawal due to pregnancy|1
7706879|NCT00450619|12128295|FG000|Overall Study|refused treatment after randomization|2
7706880|NCT00450619|12128296|FG001|Overall Study|refused treatment after randomization|0
7706881|NCT00450619|12128295|FG000|Overall Study|did not progress; refused further trmt|1
7706882|NCT00450619|12128296|FG001|Overall Study|did not progress; refused further trmt|1
7706883|NCT00450619|12128295|FG000|Overall Study|Adverse Event|1
7706884|NCT00450619|12128296|FG001|Overall Study|Adverse Event|0
7706885|NCT00450658|12128305|FG000|Overall Study|Adverse Event|24
7706886|NCT00450658|12128306|FG001|Overall Study|Adverse Event|15
7706887|NCT00450658|12128305|FG000|Overall Study|Withdrawal by Subject|43
7706888|NCT00450658|12128306|FG001|Overall Study|Withdrawal by Subject|26
7706889|NCT00450658|12128305|FG000|Overall Study|Lost to Follow-up|22
7706890|NCT00450658|12128306|FG001|Overall Study|Lost to Follow-up|5
7706891|NCT00450658|12128305|FG000|Overall Study|UGI ulcer|33
7706892|NCT00450658|12128306|FG001|Overall Study|UGI ulcer|34
7706893|NCT00450658|12128305|FG000|Overall Study|misc|21
7706894|NCT00450658|12128306|FG001|Overall Study|misc|10
7706895|NCT00450723|12128312|FG000|Overall Study|Physician Decision|5
7706896|NCT00450749|12128320|FG000|Overall Study|Withdrawal by Subject|0
7706897|NCT00450749|12128321|FG001|Overall Study|Withdrawal by Subject|0
7706898|NCT00450749|12128322|FG002|Overall Study|Withdrawal by Subject|2
7706899|NCT00450749|12128320|FG000|Overall Study|Noncompliant|0
7706900|NCT00450749|12128321|FG001|Overall Study|Noncompliant|1
7706901|NCT00450749|12128322|FG002|Overall Study|Noncompliant|0
7706902|NCT00450801|12128330|FG000|Overall Study|Death|1
7706903|NCT00450814|12128349|FG000|Overall Study|Failed to complete the initial therapy|0
7706904|NCT00450814|12128350|FG001|Overall Study|Failed to complete the initial therapy|0
7706905|NCT00450814|12128351|FG002|Overall Study|Failed to complete the initial therapy|0
7706906|NCT00450814|12128352|FG003|Overall Study|Failed to complete the initial therapy|1
7706907|NCT00450814|12128353|FG004|Overall Study|Failed to complete the initial therapy|1
7706908|NCT00450814|12128354|FG005|Overall Study|Failed to complete the initial therapy|1
7706909|NCT00450814|12128355|FG006|Overall Study|Failed to complete the initial therapy|0
7706910|NCT00450814|12128356|FG007|Overall Study|Failed to complete the initial therapy|0
7706911|NCT00450814|12128357|FG008|Overall Study|Failed to complete the initial therapy|0
7706912|NCT00450814|12128358|FG009|Overall Study|Failed to complete the initial therapy|0
7706913|NCT00450814|12128359|FG010|Overall Study|Failed to complete the initial therapy|0
7706914|NCT00450814|12128349|FG000|Overall Study|Patient withdrawal prior to treatment|0
7706915|NCT00450814|12128350|FG001|Overall Study|Patient withdrawal prior to treatment|0
7706916|NCT00450814|12128351|FG002|Overall Study|Patient withdrawal prior to treatment|0
7706917|NCT00450814|12128352|FG003|Overall Study|Patient withdrawal prior to treatment|0
7706918|NCT00450814|12128353|FG004|Overall Study|Patient withdrawal prior to treatment|0
7706919|NCT00450814|12128354|FG005|Overall Study|Patient withdrawal prior to treatment|0
7706920|NCT00450814|12128355|FG006|Overall Study|Patient withdrawal prior to treatment|0
7706921|NCT00450814|12128356|FG007|Overall Study|Patient withdrawal prior to treatment|0
7706922|NCT00450814|12128357|FG008|Overall Study|Patient withdrawal prior to treatment|0
7706923|NCT00450814|12128358|FG009|Overall Study|Patient withdrawal prior to treatment|1
7706924|NCT00450814|12128359|FG010|Overall Study|Patient withdrawal prior to treatment|0
7706925|NCT00450866|12128384|FG000|Overall Study|Adverse Event|0
7706926|NCT00450866|12128385|FG001|Overall Study|Adverse Event|1
7706927|NCT00450866|12128384|FG000|Overall Study|Withdrawal by Subject|5
7706928|NCT00450866|12128385|FG001|Overall Study|Withdrawal by Subject|2
7706929|NCT00450866|12128384|FG000|Overall Study|Death|1
7706930|NCT00450866|12128385|FG001|Overall Study|Death|0
7706931|NCT00450866|12128384|FG000|Overall Study|Physician Decision|1
7706932|NCT00450866|12128385|FG001|Overall Study|Physician Decision|0
7706933|NCT00451035|12128395|FG000|Overall Study|Disease progression|11
7706934|NCT00451035|12128395|FG000|Overall Study|Death|3
7706935|NCT00451035|12128395|FG000|Overall Study|New anti-neoplastic therapy|3
7706936|NCT00451178|12128406|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
7706937|NCT00451178|12128407|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
7706938|NCT00451178|12128406|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4
7706939|NCT00451178|12128407|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3
7706940|NCT00451178|12128406|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2
7706941|NCT00451178|12128407|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1
7706942|NCT00451178|12128406|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1
7706943|NCT00451178|12128407|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2
7706944|NCT00451178|12128406|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4
7706945|NCT00451178|12128407|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3
7706946|NCT00451178|12128406|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1
7706947|NCT00451178|12128407|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2
7706948|NCT00451178|12128406|FG000|Prior to Maintenance Therapy|Physician Decision|2
7706949|NCT00451178|12128407|FG001|Prior to Maintenance Therapy|Physician Decision|0
7706950|NCT00451178|12128406|FG000|Prior to Maintenance Therapy|PD|2
7706951|NCT00451178|12128407|FG001|Prior to Maintenance Therapy|PD|0
7706952|NCT00451178|12128406|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4
7706953|NCT00451178|12128407|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0
7706954|NCT00451178|12128406|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5
7706955|NCT00451178|12128407|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0
7706956|NCT00451178|12128406|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1
7706957|NCT00451178|12128407|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0
7706958|NCT00451178|12128406|FG000|Maintenance Therapy (up to 3 Years)|Death|1
7706959|NCT00451178|12128407|FG001|Maintenance Therapy (up to 3 Years)|Death|0
7706960|NCT00451178|12128406|FG000|Maintenance Therapy (up to 3 Years)|PD|10
7706961|NCT00451178|12128407|FG001|Maintenance Therapy (up to 3 Years)|PD|0
7706962|NCT00451178|12128406|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9
7706963|NCT00451178|12128407|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0
7706964|NCT00451178|12128406|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6
7706965|NCT00451178|12128407|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26
7706966|NCT00451191|12128419|FG000|Overall Study|withdrawal or received alternate tx|15
7706967|NCT00451191|12128420|FG001|Overall Study|withdrawal or received alternate tx|11
7706968|NCT00451204|12128428|FG000|Overall Study|Adverse Event|4
7706969|NCT00451204|12128429|FG001|Overall Study|Adverse Event|6
7706970|NCT00451204|12128428|FG000|Overall Study|Lack of Efficacy|4
7706971|NCT00451204|12128429|FG001|Overall Study|Lack of Efficacy|4
7706972|NCT00451204|12128428|FG000|Overall Study|Lost to Follow-up|4
7706973|NCT00451204|12128429|FG001|Overall Study|Lost to Follow-up|4
7706974|NCT00451204|12128428|FG000|Overall Study|Protocol Violation|1
7706975|NCT00451204|12128429|FG001|Overall Study|Protocol Violation|0
7706976|NCT00451204|12128428|FG000|Overall Study|Patient refusal|8
7706977|NCT00451204|12128429|FG001|Overall Study|Patient refusal|4
7706978|NCT00451204|12128428|FG000|Overall Study|Other|1
7706979|NCT00451204|12128429|FG001|Overall Study|Other|2
7706980|NCT00451217|12128442|FG000|Overall Study|Lost to Follow-up|0
7706981|NCT00451217|12128443|FG001|Overall Study|Lost to Follow-up|1
7706982|NCT00451217|12128444|FG002|Overall Study|Lost to Follow-up|1
7706983|NCT00451217|12128445|FG003|Overall Study|Lost to Follow-up|1
7706984|NCT00451217|12128442|FG000|Overall Study|Withdrawal by Subject|1
7706985|NCT00451217|12128443|FG001|Overall Study|Withdrawal by Subject|0
7706986|NCT00451217|12128444|FG002|Overall Study|Withdrawal by Subject|0
7706987|NCT00451217|12128445|FG003|Overall Study|Withdrawal by Subject|0
7706988|NCT00451217|12128442|FG000|Overall Study|Not Treated|1
7706989|NCT00451217|12128443|FG001|Overall Study|Not Treated|1
7706990|NCT00451217|12128444|FG002|Overall Study|Not Treated|3
7706991|NCT00451217|12128445|FG003|Overall Study|Not Treated|4
7706992|NCT00451282|12128457|FG000|Overall Study|Lost to Follow-up|6
7706993|NCT00451282|12128458|FG001|Overall Study|Lost to Follow-up|5
7706994|NCT00451321|12128472|FG000|Overall Study|Lost to Follow-up|3
7706995|NCT00451321|12128473|FG001|Overall Study|Lost to Follow-up|3
7706996|NCT00451321|12128474|FG002|Overall Study|Lost to Follow-up|1
7706997|NCT00451321|12128475|FG003|Overall Study|Lost to Follow-up|3
7706998|NCT00451321|12128476|FG004|Overall Study|Lost to Follow-up|0
7706999|NCT00451321|12128477|FG005|Overall Study|Lost to Follow-up|1
7707000|NCT00451321|12128478|FG006|Overall Study|Lost to Follow-up|0
7707001|NCT00451321|12128479|FG007|Overall Study|Lost to Follow-up|0
7707002|NCT00451321|12128472|FG000|Overall Study|Withdrawal by Subject|3
7707003|NCT00451321|12128473|FG001|Overall Study|Withdrawal by Subject|1
7707004|NCT00451321|12128474|FG002|Overall Study|Withdrawal by Subject|0
7707005|NCT00451321|12128475|FG003|Overall Study|Withdrawal by Subject|4
7707006|NCT00451321|12128476|FG004|Overall Study|Withdrawal by Subject|0
7707007|NCT00451321|12128477|FG005|Overall Study|Withdrawal by Subject|0
7707008|NCT00451321|12128478|FG006|Overall Study|Withdrawal by Subject|0
7707009|NCT00451321|12128479|FG007|Overall Study|Withdrawal by Subject|0
7707010|NCT00451321|12128472|FG000|Overall Study|Study closed/terminated|1
7707011|NCT00451321|12128473|FG001|Overall Study|Study closed/terminated|1
7707012|NCT00451321|12128474|FG002|Overall Study|Study closed/terminated|17
7707013|NCT00451321|12128475|FG003|Overall Study|Study closed/terminated|5
7707014|NCT00451321|12128476|FG004|Overall Study|Study closed/terminated|7
7707015|NCT00451321|12128477|FG005|Overall Study|Study closed/terminated|7
7707016|NCT00451321|12128478|FG006|Overall Study|Study closed/terminated|5
7707017|NCT00451321|12128479|FG007|Overall Study|Study closed/terminated|3
7707018|NCT00451321|12128472|FG000|Overall Study|Sponsor decision to amend protocol|0
7707019|NCT00451321|12128473|FG001|Overall Study|Sponsor decision to amend protocol|0
7707020|NCT00451321|12128474|FG002|Overall Study|Sponsor decision to amend protocol|0
7707021|NCT00451321|12128475|FG003|Overall Study|Sponsor decision to amend protocol|0
7707022|NCT00451321|12128476|FG004|Overall Study|Sponsor decision to amend protocol|0
7707023|NCT00451321|12128477|FG005|Overall Study|Sponsor decision to amend protocol|1
7707024|NCT00451321|12128478|FG006|Overall Study|Sponsor decision to amend protocol|1
7707025|NCT00451321|12128479|FG007|Overall Study|Sponsor decision to amend protocol|3
7707026|NCT00451451|12128501|FG000|Overall Study|Adverse Event|11
7707027|NCT00451451|12128502|FG001|Overall Study|Adverse Event|21
7707028|NCT00451451|12128503|FG002|Overall Study|Adverse Event|26
7707029|NCT00451451|12128504|FG003|Overall Study|Adverse Event|10
7707030|NCT00451451|12128501|FG000|Overall Study|Lost to Follow-up|11
7707031|NCT00451451|12128502|FG001|Overall Study|Lost to Follow-up|9
7707032|NCT00451451|12128503|FG002|Overall Study|Lost to Follow-up|8
7707033|NCT00451451|12128504|FG003|Overall Study|Lost to Follow-up|11
7707034|NCT00451451|12128501|FG000|Overall Study|Consent Withdrawn|14
7707035|NCT00451451|12128502|FG001|Overall Study|Consent Withdrawn|9
7707036|NCT00451451|12128503|FG002|Overall Study|Consent Withdrawn|17
7707037|NCT00451451|12128504|FG003|Overall Study|Consent Withdrawn|17
7707038|NCT00451451|12128501|FG000|Overall Study|Investigator Decision|6
7707039|NCT00451451|12128502|FG001|Overall Study|Investigator Decision|2
7707040|NCT00451451|12128503|FG002|Overall Study|Investigator Decision|1
7707041|NCT00451451|12128504|FG003|Overall Study|Investigator Decision|2
7707042|NCT00451451|12128501|FG000|Overall Study|Subject Non-Compliance|8
7707043|NCT00451451|12128502|FG001|Overall Study|Subject Non-Compliance|4
7707044|NCT00451451|12128503|FG002|Overall Study|Subject Non-Compliance|3
7707045|NCT00451451|12128504|FG003|Overall Study|Subject Non-Compliance|3
7707046|NCT00451451|12128501|FG000|Overall Study|Death|1
7707047|NCT00451451|12128502|FG001|Overall Study|Death|0
7707048|NCT00451451|12128503|FG002|Overall Study|Death|0
7707049|NCT00451451|12128504|FG003|Overall Study|Death|1
7707050|NCT00451451|12128501|FG000|Overall Study|Other Reasons for Not Completing Study|34
7707051|NCT00451451|12128502|FG001|Overall Study|Other Reasons for Not Completing Study|30
7707052|NCT00451451|12128503|FG002|Overall Study|Other Reasons for Not Completing Study|17
7707053|NCT00451451|12128504|FG003|Overall Study|Other Reasons for Not Completing Study|14
7707054|NCT00451555|12128519|FG000|Overall Study|Protocol Violation|2
7707055|NCT00451555|12128520|FG001|Overall Study|Protocol Violation|2
7707056|NCT00451555|12128519|FG000|Overall Study|Adverse Event|3
7707057|NCT00451555|12128520|FG001|Overall Study|Adverse Event|1
7707058|NCT00451555|12128519|FG000|Overall Study|Withdrawal by Subject|6
7707059|NCT00451555|12128520|FG001|Overall Study|Withdrawal by Subject|0
7707060|NCT00451555|12128519|FG000|Overall Study|Physician Decision|2
7707061|NCT00451555|12128520|FG001|Overall Study|Physician Decision|1
7707062|NCT00451906|12128546|FG000|Overall Study|Adverse Event|515
7707063|NCT00451906|12128546|FG000|Overall Study|Lost to Follow-up|31
7707064|NCT00451906|12128546|FG000|Overall Study|Withdrawal by Subject|111
7707065|NCT00451906|12128546|FG000|Overall Study|Protocol Violation|21
7707066|NCT00451906|12128546|FG000|Overall Study|Progressive disease|1328
7707067|NCT00451906|12128546|FG000|Overall Study|Termination of the study|108
7707068|NCT00451906|12128546|FG000|Overall Study|Other Reasons|121
7707069|NCT00451906|12128546|FG000|Overall Study|Did not complete final visit|4
7707070|NCT00451958|12128554|FG000|CS21A (NCT00451958)|Adverse Event|21
7707071|NCT00451958|12128555|FG001|CS21A (NCT00451958)|Adverse Event|34
7707072|NCT00451958|12128556|FG002|CS21A (NCT00451958)|Adverse Event|14
7707073|NCT00451958|12128557|FG003|CS21A (NCT00451958)|Adverse Event|17
7707074|NCT00451958|12128558|FG004|CS21A (NCT00451958)|Adverse Event|0
7707075|NCT00451958|12128554|FG000|CS21A (NCT00451958)|Lost to Follow-up|6
7707076|NCT00451958|12128555|FG001|CS21A (NCT00451958)|Lost to Follow-up|5
7707077|NCT00451958|12128556|FG002|CS21A (NCT00451958)|Lost to Follow-up|1
7707078|NCT00451958|12128557|FG003|CS21A (NCT00451958)|Lost to Follow-up|1
7707079|NCT00451958|12128558|FG004|CS21A (NCT00451958)|Lost to Follow-up|0
7707080|NCT00451958|12128554|FG000|CS21A (NCT00451958)|Protocol Violation|1
7707081|NCT00451958|12128555|FG001|CS21A (NCT00451958)|Protocol Violation|3
7707082|NCT00451958|12128556|FG002|CS21A (NCT00451958)|Protocol Violation|2
7707083|NCT00451958|12128557|FG003|CS21A (NCT00451958)|Protocol Violation|0
7707084|NCT00451958|12128558|FG004|CS21A (NCT00451958)|Protocol Violation|0
7707085|NCT00451958|12128554|FG000|CS21A (NCT00451958)|Physician Decision|2
7707086|NCT00451958|12128555|FG001|CS21A (NCT00451958)|Physician Decision|4
7707087|NCT00451958|12128556|FG002|CS21A (NCT00451958)|Physician Decision|4
7707088|NCT00451958|12128557|FG003|CS21A (NCT00451958)|Physician Decision|4
7707089|NCT00451958|12128558|FG004|CS21A (NCT00451958)|Physician Decision|0
7707090|NCT00451958|12128554|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7
7707091|NCT00451958|12128555|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4
7707092|NCT00451958|12128556|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4
7707093|NCT00451958|12128557|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3
7707094|NCT00451958|12128558|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0
7707095|NCT00451958|12128554|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28
7707096|NCT00451958|12128555|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27
7707097|NCT00451958|12128556|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17
7707098|NCT00451958|12128557|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14
7707099|NCT00451958|12128558|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0
7707100|NCT00452114|12128574|FG000|Overall Study|Physician Decision|3
7707101|NCT00452114|12128575|FG001|Overall Study|Physician Decision|3
7707102|NCT00452348|12128599|FG000|Overall Study|Adverse Event|6
7707103|NCT00452348|12128600|FG001|Overall Study|Adverse Event|9
7707104|NCT00452348|12128599|FG000|Overall Study|Lack of Efficacy|10
7707105|NCT00452348|12128600|FG001|Overall Study|Lack of Efficacy|9
7707106|NCT00452348|12128599|FG000|Overall Study|Lost to Follow-up|14
7707107|NCT00452348|12128600|FG001|Overall Study|Lost to Follow-up|8
7707108|NCT00452348|12128599|FG000|Overall Study|Protocol Violation|22
7707109|NCT00452348|12128600|FG001|Overall Study|Protocol Violation|28
7707110|NCT00452348|12128599|FG000|Overall Study|Withdrawal by Subject|18
7707111|NCT00452348|12128600|FG001|Overall Study|Withdrawal by Subject|21
7707112|NCT00452348|12128599|FG000|Overall Study|Other|9
7707113|NCT00452348|12128600|FG001|Overall Study|Other|9
7707114|NCT00452400|12128621|FG000|Overall Study|Adverse Event|1
7707115|NCT00452400|12128622|FG001|Overall Study|Adverse Event|1
7707116|NCT00452400|12128623|FG002|Overall Study|Adverse Event|5
7707117|NCT00452400|12128624|FG003|Overall Study|Adverse Event|0
7707118|NCT00452400|12128625|FG004|Overall Study|Adverse Event|2
7707119|NCT00452400|12128621|FG000|Overall Study|Protocol Violation|0
7707120|NCT00452400|12128622|FG001|Overall Study|Protocol Violation|0
7707121|NCT00452400|12128623|FG002|Overall Study|Protocol Violation|1
7707122|NCT00452400|12128624|FG003|Overall Study|Protocol Violation|0
7707123|NCT00452400|12128625|FG004|Overall Study|Protocol Violation|0
7707124|NCT00452400|12128621|FG000|Overall Study|Lost to Follow-up|1
7707125|NCT00452400|12128622|FG001|Overall Study|Lost to Follow-up|0
7707126|NCT00452400|12128623|FG002|Overall Study|Lost to Follow-up|0
7707127|NCT00452400|12128624|FG003|Overall Study|Lost to Follow-up|0
7707128|NCT00452400|12128625|FG004|Overall Study|Lost to Follow-up|0
7707129|NCT00452400|12128621|FG000|Overall Study|Withdrawal by Subject|1
7707130|NCT00452400|12128622|FG001|Overall Study|Withdrawal by Subject|0
7707131|NCT00452400|12128623|FG002|Overall Study|Withdrawal by Subject|1
7707132|NCT00452400|12128624|FG003|Overall Study|Withdrawal by Subject|0
7707133|NCT00452400|12128625|FG004|Overall Study|Withdrawal by Subject|0
7707134|NCT00452400|12128621|FG000|Overall Study|Lack of Efficacy|2
7707135|NCT00452400|12128622|FG001|Overall Study|Lack of Efficacy|0
7707136|NCT00452400|12128623|FG002|Overall Study|Lack of Efficacy|0
7707137|NCT00452400|12128624|FG003|Overall Study|Lack of Efficacy|0
7707138|NCT00452400|12128625|FG004|Overall Study|Lack of Efficacy|0
7707139|NCT00452400|12128621|FG000|Overall Study|Other reasons not listed above|0
7707140|NCT00452400|12128622|FG001|Overall Study|Other reasons not listed above|0
7707141|NCT00452400|12128623|FG002|Overall Study|Other reasons not listed above|0
7707142|NCT00452400|12128624|FG003|Overall Study|Other reasons not listed above|1
7707143|NCT00452400|12128625|FG004|Overall Study|Other reasons not listed above|1
7707144|NCT00452413|12128640|FG000|Overall Study|Progressive Disease|4
7707145|NCT00452413|12128641|FG001|Overall Study|Progressive Disease|11
7707146|NCT00452413|12128642|FG002|Overall Study|Progressive Disease|30
7707147|NCT00452413|12128640|FG000|Overall Study|Withdrawal by Subject|0
7707148|NCT00452413|12128641|FG001|Overall Study|Withdrawal by Subject|1
7707149|NCT00452413|12128642|FG002|Overall Study|Withdrawal by Subject|4
7707150|NCT00452413|12128640|FG000|Overall Study|Adverse Event|0
7707151|NCT00452413|12128641|FG001|Overall Study|Adverse Event|0
7707152|NCT00452413|12128642|FG002|Overall Study|Adverse Event|5
7707153|NCT00452413|12128640|FG000|Overall Study|Physician Decision|0
7707154|NCT00452413|12128641|FG001|Overall Study|Physician Decision|0
7707155|NCT00452413|12128642|FG002|Overall Study|Physician Decision|4
7707156|NCT00452413|12128640|FG000|Overall Study|Death due to study disease|0
7707157|NCT00452413|12128641|FG001|Overall Study|Death due to study disease|0
7707158|NCT00452413|12128642|FG002|Overall Study|Death due to study disease|2
7707159|NCT00452413|12128640|FG000|Overall Study|Death due to adverse event (AE)|0
7707160|NCT00452413|12128641|FG001|Overall Study|Death due to adverse event (AE)|0
7707161|NCT00452413|12128642|FG002|Overall Study|Death due to adverse event (AE)|1
7707162|NCT00452413|12128640|FG000|Overall Study|On treatment|0
7707163|NCT00452413|12128641|FG001|Overall Study|On treatment|0
7707164|NCT00452413|12128642|FG002|Overall Study|On treatment|3
7707165|NCT00452439|12128662|FG000|Overall Study|Lost to Follow-up|1
7707166|NCT00452439|12128663|FG001|Overall Study|Lost to Follow-up|1
7707167|NCT00452439|12128662|FG000|Overall Study|Refused Treatment|4
7707168|NCT00452439|12128663|FG001|Overall Study|Refused Treatment|3
7707169|NCT00452439|12128662|FG000|Overall Study|Death|3
7707170|NCT00452439|12128663|FG001|Overall Study|Death|1
7707171|NCT00452439|12128662|FG000|Overall Study|Bone Marrow Transplant|0
7707172|NCT00452439|12128663|FG001|Overall Study|Bone Marrow Transplant|1
7707173|NCT00452439|12128662|FG000|Overall Study|Too Ill to Continue|0
7707174|NCT00452439|12128663|FG001|Overall Study|Too Ill to Continue|1
7707175|NCT00452439|12128662|FG000|Overall Study|Failed to achieve complete response|2
7707176|NCT00452439|12128663|FG001|Overall Study|Failed to achieve complete response|0
7707177|NCT00452439|12128662|FG000|Overall Study|Relapse|3
7707178|NCT00452439|12128663|FG001|Overall Study|Relapse|0
7707179|NCT00452439|12128662|FG000|Overall Study|Fracture|1
7707180|NCT00452439|12128663|FG001|Overall Study|Fracture|0
7707181|NCT00452452|12128672|FG000|Overall Study|Protocol Violation|0
7707182|NCT00452452|12128673|FG001|Overall Study|Protocol Violation|0
7707183|NCT00452452|12128674|FG002|Overall Study|Protocol Violation|1
7707184|NCT00452452|12128672|FG000|Overall Study|Withdrawal by Subject|1
7707185|NCT00452452|12128673|FG001|Overall Study|Withdrawal by Subject|0
7707186|NCT00452452|12128674|FG002|Overall Study|Withdrawal by Subject|0
7707187|NCT00452452|12128672|FG000|Overall Study|Lost to Follow-up|1
7707188|NCT00452452|12128673|FG001|Overall Study|Lost to Follow-up|0
7707189|NCT00452452|12128674|FG002|Overall Study|Lost to Follow-up|0
7707190|NCT00452530|12128690|FG000|Overall Study|Death|1
7707191|NCT00452530|12128691|FG001|Overall Study|Death|0
7707192|NCT00452530|12128690|FG000|Overall Study|Adverse Event|40
7707193|NCT00452530|12128691|FG001|Overall Study|Adverse Event|44
7707194|NCT00452530|12128690|FG000|Overall Study|Withdrawal by Subject|68
7707195|NCT00452530|12128691|FG001|Overall Study|Withdrawal by Subject|57
7707196|NCT00452530|12128690|FG000|Overall Study|Lost to Follow-up|1
7707197|NCT00452530|12128691|FG001|Overall Study|Lost to Follow-up|0
7707198|NCT00452530|12128690|FG000|Overall Study|Poor compliance/noncompliance|1
7707199|NCT00452530|12128691|FG001|Overall Study|Poor compliance/noncompliance|2
7707200|NCT00452530|12128690|FG000|Overall Study|No longer met study criteria|18
7707201|NCT00452530|12128691|FG001|Overall Study|No longer met study criteria|22
7707202|NCT00452530|12128690|FG000|Overall Study|Other|7
7707203|NCT00452530|12128691|FG001|Overall Study|Other|11
7707204|NCT00452673|12128714|FG000|Dose Escalation Period|Disease Progression|6
7707205|NCT00452673|12128715|FG001|Dose Escalation Period|Disease Progression|6
7707206|NCT00452673|12128716|FG002|Dose Escalation Period|Disease Progression|2
7707207|NCT00452673|12128717|FG003|Dose Escalation Period|Disease Progression|6
7707208|NCT00452673|12128718|FG004|Dose Escalation Period|Disease Progression|0
7707209|NCT00452673|12128714|FG000|Dose Escalation Period|study drug toxicity|1
7707210|NCT00452673|12128715|FG001|Dose Escalation Period|study drug toxicity|3
7707211|NCT00452673|12128716|FG002|Dose Escalation Period|study drug toxicity|3
7707212|NCT00452673|12128717|FG003|Dose Escalation Period|study drug toxicity|1
7707213|NCT00452673|12128718|FG004|Dose Escalation Period|study drug toxicity|0
7707214|NCT00452673|12128714|FG000|Dose Escalation Period|Other|0
7707215|NCT00452673|12128715|FG001|Dose Escalation Period|Other|0
7707216|NCT00452673|12128716|FG002|Dose Escalation Period|Other|1
7707217|NCT00452673|12128717|FG003|Dose Escalation Period|Other|0
7707218|NCT00452673|12128718|FG004|Dose Escalation Period|Other|0
7707219|NCT00452673|12128714|FG000|Dose Escalation Period|Adverse Event|0
7707220|NCT00452673|12128715|FG001|Dose Escalation Period|Adverse Event|0
7707221|NCT00452673|12128716|FG002|Dose Escalation Period|Adverse Event|0
7707222|NCT00452673|12128717|FG003|Dose Escalation Period|Adverse Event|1
7707223|NCT00452673|12128718|FG004|Dose Escalation Period|Adverse Event|0
7707224|NCT00452673|12128714|FG000|Dose Escalation Period|Withdrawal by Subject|0
7707225|NCT00452673|12128715|FG001|Dose Escalation Period|Withdrawal by Subject|0
7707226|NCT00452673|12128716|FG002|Dose Escalation Period|Withdrawal by Subject|0
7707227|NCT00452673|12128717|FG003|Dose Escalation Period|Withdrawal by Subject|1
7707228|NCT00452673|12128718|FG004|Dose Escalation Period|Withdrawal by Subject|0
7707229|NCT00452673|12128714|FG000|Dose Expansion Period|Disease Progression|0
7707230|NCT00452673|12128715|FG001|Dose Expansion Period|Disease Progression|0
7707231|NCT00452673|12128716|FG002|Dose Expansion Period|Disease Progression|0
7707232|NCT00452673|12128717|FG003|Dose Expansion Period|Disease Progression|0
7707233|NCT00452673|12128718|FG004|Dose Expansion Period|Disease Progression|19
7707234|NCT00452673|12128714|FG000|Dose Expansion Period|Other|0
7707235|NCT00452673|12128715|FG001|Dose Expansion Period|Other|0
7707236|NCT00452673|12128716|FG002|Dose Expansion Period|Other|0
7707237|NCT00452673|12128717|FG003|Dose Expansion Period|Other|0
7707238|NCT00452673|12128718|FG004|Dose Expansion Period|Other|2
7707239|NCT00452699|12128731|FG000|Overall Study|Adverse Event|10
7707240|NCT00452699|12128732|FG001|Overall Study|Adverse Event|3
7707241|NCT00452699|12128731|FG000|Overall Study|Lack of Efficacy|6
7707242|NCT00452699|12128732|FG001|Overall Study|Lack of Efficacy|4
7707243|NCT00452699|12128731|FG000|Overall Study|Lost to Follow-up|6
7707244|NCT00452699|12128732|FG001|Overall Study|Lost to Follow-up|9
7707245|NCT00452699|12128731|FG000|Overall Study|Protocol Violation|21
7707246|NCT00452699|12128732|FG001|Overall Study|Protocol Violation|25
7707247|NCT00452699|12128731|FG000|Overall Study|Withdrawal by Subject|26
7707248|NCT00452699|12128732|FG001|Overall Study|Withdrawal by Subject|25
7707249|NCT00452699|12128731|FG000|Overall Study|Other|12
7707250|NCT00452699|12128732|FG001|Overall Study|Other|7
7707251|NCT00452790|12128740|FG000|Infant Series|Clinical hold - consent withdrawn|118
7707252|NCT00452790|12128741|FG001|Infant Series|Clinical hold - consent withdrawn|123
7707253|NCT00452790|12128740|FG000|Infant Series|Parent/legal guardian request|8
7707254|NCT00452790|12128741|FG001|Infant Series|Parent/legal guardian request|6
7707255|NCT00452790|12128740|FG000|Infant Series|Failed to return|4
7707256|NCT00452790|12128741|FG001|Infant Series|Failed to return|1
7707257|NCT00452790|12128740|FG000|Infant Series|Protocol Violation|1
7707258|NCT00452790|12128741|FG001|Infant Series|Protocol Violation|3
7707259|NCT00452790|12128740|FG000|Infant Series|Lost to Follow-up|2
7707260|NCT00452790|12128741|FG001|Infant Series|Lost to Follow-up|2
7707261|NCT00452790|12128740|FG000|Infant Series|Adverse Event|1
7707262|NCT00452790|12128741|FG001|Infant Series|Adverse Event|2
7707263|NCT00452790|12128740|FG000|Infant Series|Other reasons|1
7707264|NCT00452790|12128741|FG001|Infant Series|Other reasons|2
7707265|NCT00452790|12128740|FG000|Infant Series|Investigator request|0
7707266|NCT00452790|12128741|FG001|Infant Series|Investigator request|1
7707267|NCT00452790|12128740|FG000|Infant Series|Death|0
7707268|NCT00452790|12128741|FG001|Infant Series|Death|1
7707269|NCT00452790|12128740|FG000|After Infant Series|Investigator request|10
7707270|NCT00452790|12128741|FG001|After Infant Series|Investigator request|10
7707271|NCT00452790|12128740|FG000|After Infant Series|Adverse Event|4
7707272|NCT00452790|12128741|FG001|After Infant Series|Adverse Event|1
7707273|NCT00452790|12128740|FG000|After Infant Series|Parent/legal guardian request|1
7707274|NCT00452790|12128741|FG001|After Infant Series|Parent/legal guardian request|3
7707275|NCT00452790|12128740|FG000|After Infant Series|Lost to Follow-up|4
7707276|NCT00452790|12128741|FG001|After Infant Series|Lost to Follow-up|0
7707277|NCT00452790|12128740|FG000|After Infant Series|Failed to return|1
7707278|NCT00452790|12128741|FG001|After Infant Series|Failed to return|0
7707279|NCT00452790|12128740|FG000|After Infant Series|Other reasons|1
7707280|NCT00452790|12128741|FG001|After Infant Series|Other reasons|0
7707281|NCT00452790|12128740|FG000|Toddler Dose|Failed to return|0
7707282|NCT00452790|12128741|FG001|Toddler Dose|Failed to return|1
7707283|NCT00452790|12128740|FG000|Toddler Dose|Parent/legal guardian request|0
7707284|NCT00452790|12128741|FG001|Toddler Dose|Parent/legal guardian request|1
7707285|NCT00453102|12128755|FG000|Overall Study|Withdrawal by Subject|2
7707286|NCT00453154|12128762|FG000|Double BIind Maintenance|Adverse Event|0
7707287|NCT00453154|12128763|FG001|Double BIind Maintenance|Adverse Event|0
7707288|NCT00453154|12128764|FG002|Double BIind Maintenance|Adverse Event|3
7707289|NCT00453154|12128765|FG003|Double BIind Maintenance|Adverse Event|12
7707290|NCT00453154|12128762|FG000|Double BIind Maintenance|Death|0
7707291|NCT00453154|12128763|FG001|Double BIind Maintenance|Death|0
7707292|NCT00453154|12128764|FG002|Double BIind Maintenance|Death|2
7707293|NCT00453154|12128765|FG003|Double BIind Maintenance|Death|1
7707294|NCT00453154|12128762|FG000|Double BIind Maintenance|Withdrawal by Subject|0
7707295|NCT00453154|12128763|FG001|Double BIind Maintenance|Withdrawal by Subject|0
7707296|NCT00453154|12128764|FG002|Double BIind Maintenance|Withdrawal by Subject|4
7707297|NCT00453154|12128765|FG003|Double BIind Maintenance|Withdrawal by Subject|4
7707298|NCT00453154|12128762|FG000|Double BIind Maintenance|Progression|0
7707299|NCT00453154|12128763|FG001|Double BIind Maintenance|Progression|0
7707300|NCT00453154|12128764|FG002|Double BIind Maintenance|Progression|29
7707301|NCT00453154|12128765|FG003|Double BIind Maintenance|Progression|26
7707302|NCT00453154|12128762|FG000|Double BIind Maintenance|Medical Issues|0
7707303|NCT00453154|12128763|FG001|Double BIind Maintenance|Medical Issues|0
7707304|NCT00453154|12128764|FG002|Double BIind Maintenance|Medical Issues|3
7707305|NCT00453154|12128765|FG003|Double BIind Maintenance|Medical Issues|1
7707306|NCT00453154|12128762|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0
7707307|NCT00453154|12128763|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0
7707308|NCT00453154|12128764|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5
7707309|NCT00453154|12128765|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5
7707310|NCT00453180|12128776|FG000|Overall Study|Lost to Follow-up|2
7707311|NCT00453180|12128777|FG001|Overall Study|Lost to Follow-up|1
7707312|NCT00453180|12128776|FG000|Overall Study|Adverse Event|1
7707313|NCT00453180|12128777|FG001|Overall Study|Adverse Event|2
7707314|NCT00453206|12128787|FG000|Overall Study|Death|1
7707315|NCT00453310|12128791|FG000|Overall Study|Progression of Disease|10
7707316|NCT00453349|12128801|FG000|Randomized|Adverse Event|12
7707317|NCT00453349|12128802|FG001|Randomized|Adverse Event|11
7707318|NCT00453349|12128801|FG000|Randomized|Lack of Efficacy|2
7707319|NCT00453349|12128802|FG001|Randomized|Lack of Efficacy|1
7707320|NCT00453349|12128801|FG000|Randomized|Lost to Follow-up|7
7707321|NCT00453349|12128802|FG001|Randomized|Lost to Follow-up|5
7707322|NCT00453349|12128801|FG000|Randomized|Protocol Violation|1
7707323|NCT00453349|12128802|FG001|Randomized|Protocol Violation|1
7707324|NCT00453349|12128801|FG000|Randomized|Withdrawal by Subject|3
7707325|NCT00453349|12128802|FG001|Randomized|Withdrawal by Subject|5
7707326|NCT00453349|12128801|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10
7707327|NCT00453349|12128802|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11
7707328|NCT00453349|12128801|FG000|Completed Study|Adverse Event|12
7707329|NCT00453349|12128802|FG001|Completed Study|Adverse Event|11
7707330|NCT00453349|12128801|FG000|Completed Study|Lack of Efficacy|2
7707331|NCT00453349|12128802|FG001|Completed Study|Lack of Efficacy|1
7707332|NCT00453349|12128801|FG000|Completed Study|Lost to Follow-up|7
7707333|NCT00453349|12128802|FG001|Completed Study|Lost to Follow-up|5
7707334|NCT00453349|12128801|FG000|Completed Study|Protocol Violation|1
7707335|NCT00453349|12128802|FG001|Completed Study|Protocol Violation|1
7707336|NCT00453349|12128801|FG000|Completed Study|Withdrawal by Subject|3
7707337|NCT00453349|12128802|FG001|Completed Study|Withdrawal by Subject|5
7707338|NCT00453349|12128801|FG000|Completed Study|Lost to follow up after study treatment|2
7707339|NCT00453349|12128802|FG001|Completed Study|Lost to follow up after study treatment|11
7707340|NCT00453362|12128808|FG000|Overall Study|Adverse Event|5
7707341|NCT00453362|12128808|FG000|Overall Study|Death|7
7707342|NCT00453362|12128808|FG000|Overall Study|Physician Decision|2
7707343|NCT00453362|12128808|FG000|Overall Study|Withdrawal by Subject|3
7707344|NCT00453362|12128808|FG000|Overall Study|Progression of disease|56
7707345|NCT00453362|12128808|FG000|Overall Study|Screening Failure|14
7707346|NCT00453921|12128864|FG000|Overall Study|Withdrawal by Subject|1
7707347|NCT00453921|12128865|FG001|Overall Study|Withdrawal by Subject|1
7707348|NCT00453921|12128866|FG002|Overall Study|Withdrawal by Subject|1
7707349|NCT00453921|12128867|FG003|Overall Study|Withdrawal by Subject|1
7707350|NCT00453921|12128864|FG000|Overall Study|Lost to Follow-up|0
7707351|NCT00453921|12128865|FG001|Overall Study|Lost to Follow-up|0
7707352|NCT00453921|12128866|FG002|Overall Study|Lost to Follow-up|1
7707353|NCT00453921|12128867|FG003|Overall Study|Lost to Follow-up|0
7707354|NCT00453973|12128883|FG000|Overall Study|Adverse Event|4
7707355|NCT00453973|12128884|FG001|Overall Study|Adverse Event|9
7707356|NCT00453973|12128883|FG000|Overall Study|Withdrawal by Subject|7
7707357|NCT00453973|12128884|FG001|Overall Study|Withdrawal by Subject|6
7707358|NCT00453973|12128883|FG000|Overall Study|PI Decision|0
7707359|NCT00453973|12128884|FG001|Overall Study|PI Decision|2
7707360|NCT00453973|12128883|FG000|Overall Study|Relocation|1
7707361|NCT00453973|12128884|FG001|Overall Study|Relocation|0
7707362|NCT00453973|12128883|FG000|Overall Study|Renal transplant|1
7707363|NCT00453973|12128884|FG001|Overall Study|Renal transplant|1
7707364|NCT00453973|12128883|FG000|Overall Study|Site closed by sponsor|3
7707365|NCT00453973|12128884|FG001|Overall Study|Site closed by sponsor|0
7707366|NCT00453973|12128883|FG000|Overall Study|Sponsor Decision to Terminate Study|35
7707367|NCT00453973|12128884|FG001|Overall Study|Sponsor Decision to Terminate Study|30
7707368|NCT00453986|12128895|FG000|Overall Study|Lost to Follow-up|6
7707369|NCT00453986|12128896|FG001|Overall Study|Lost to Follow-up|5
7707370|NCT00453986|12128897|FG002|Overall Study|Lost to Follow-up|6
7707371|NCT00453986|12128898|FG003|Overall Study|Lost to Follow-up|2
7707372|NCT00453986|12128899|FG004|Overall Study|Lost to Follow-up|0
7707373|NCT00453999|12128918|FG000|Overall Study|Adverse Event|1
7707374|NCT00453999|12128919|FG001|Overall Study|Adverse Event|2
7707375|NCT00453999|12128920|FG002|Overall Study|Adverse Event|1
7707376|NCT00453999|12128918|FG000|Overall Study|Lost to Follow-up|0
7707377|NCT00453999|12128919|FG001|Overall Study|Lost to Follow-up|1
7707378|NCT00453999|12128920|FG002|Overall Study|Lost to Follow-up|1
7707379|NCT00453999|12128918|FG000|Overall Study|Withdrawal by Subject|2
7707380|NCT00453999|12128919|FG001|Overall Study|Withdrawal by Subject|1
7707381|NCT00453999|12128920|FG002|Overall Study|Withdrawal by Subject|1
7707382|NCT00453999|12128918|FG000|Overall Study|Subject Request|2
7707383|NCT00453999|12128919|FG001|Overall Study|Subject Request|1
7707384|NCT00453999|12128920|FG002|Overall Study|Subject Request|0
7707385|NCT00454051|12128931|FG000|Overall Study|Adverse Event|1
7707386|NCT00454051|12128932|FG001|Overall Study|Adverse Event|2
7707387|NCT00454051|12128931|FG000|Overall Study|Withdrawal by Subject|1
7707388|NCT00454051|12128932|FG001|Overall Study|Withdrawal by Subject|0
7707389|NCT00454051|12128931|FG000|Overall Study|Protocol Violation|1
7707390|NCT00454051|12128932|FG001|Overall Study|Protocol Violation|1
7707391|NCT00454116|12128941|FG000|Overall Study|Adverse Event|5
7707392|NCT00454116|12128942|FG001|Overall Study|Adverse Event|11
7707393|NCT00454116|12128943|FG002|Overall Study|Adverse Event|9
7707394|NCT00454116|12128941|FG000|Overall Study|Condition under investigation worsened|17
7707395|NCT00454116|12128942|FG001|Overall Study|Condition under investigation worsened|13
7707396|NCT00454116|12128943|FG002|Overall Study|Condition under investigation worsened|18
7707397|NCT00454116|12128941|FG000|Overall Study|Withdrawal by Subject|3
7707398|NCT00454116|12128942|FG001|Overall Study|Withdrawal by Subject|3
7707399|NCT00454116|12128943|FG002|Overall Study|Withdrawal by Subject|1
7707400|NCT00454116|12128941|FG000|Overall Study|Other|2
7707401|NCT00454116|12128942|FG001|Overall Study|Other|2
7707402|NCT00454116|12128943|FG002|Overall Study|Other|0
7707403|NCT00454142|12128951|FG000|Overall Study|Withdrawal by Subject|1
7707404|NCT00454181|12128959|FG000|Overall Study|Adverse Event|1
7707405|NCT00454181|12128960|FG001|Overall Study|Adverse Event|1
7707406|NCT00454181|12128959|FG000|Overall Study|Lost to Follow-up|11
7707407|NCT00454181|12128960|FG001|Overall Study|Lost to Follow-up|1
7707408|NCT00454181|12128959|FG000|Overall Study|Protocol Violation|1
7707409|NCT00454181|12128960|FG001|Overall Study|Protocol Violation|1
7707410|NCT00454181|12128959|FG000|Overall Study|Withdrawal by Subject|2
7707411|NCT00454181|12128960|FG001|Overall Study|Withdrawal by Subject|0
7707412|NCT00454194|12128968|FG000|Overall Study|Adverse Event|7
7707413|NCT00454194|12128969|FG001|Overall Study|Adverse Event|2
7707414|NCT00454194|12128968|FG000|Overall Study|Withdrawal by Subject|12
7707415|NCT00454194|12128969|FG001|Overall Study|Withdrawal by Subject|8
7707416|NCT00454194|12128968|FG000|Overall Study|Other Medical Problems|1
7707417|NCT00454194|12128969|FG001|Overall Study|Other Medical Problems|2
7707418|NCT00454194|12128968|FG000|Overall Study|Other Unspecified Reason|2
7707419|NCT00454194|12128969|FG001|Overall Study|Other Unspecified Reason|2
7707420|NCT00454207|12128977|FG000|Overall Study|Adverse Event|3
7707421|NCT00454207|12128978|FG001|Overall Study|Adverse Event|1
7707422|NCT00454207|12128977|FG000|Overall Study|Lack of Efficacy|1
7707423|NCT00454207|12128978|FG001|Overall Study|Lack of Efficacy|0
7707424|NCT00454207|12128977|FG000|Overall Study|Protocol Violation|0
7707425|NCT00454207|12128978|FG001|Overall Study|Protocol Violation|1
7707426|NCT00454246|12128999|FG000|Overall Study|Adverse Event|2
7707427|NCT00454246|12129000|FG001|Overall Study|Adverse Event|2
7707428|NCT00454246|12129001|FG002|Overall Study|Adverse Event|0
7707429|NCT00454246|12128999|FG000|Overall Study|Violation of selection criteria at entry|6
7707430|NCT00454246|12129000|FG001|Overall Study|Violation of selection criteria at entry|0
7707431|NCT00454246|12129001|FG002|Overall Study|Violation of selection criteria at entry|0
7707432|NCT00454246|12128999|FG000|Overall Study|Protocol Violation|1
7707433|NCT00454246|12129000|FG001|Overall Study|Protocol Violation|0
7707434|NCT00454246|12129001|FG002|Overall Study|Protocol Violation|0
7707435|NCT00454246|12128999|FG000|Overall Study|Refused Treatment|1
7707436|NCT00454246|12129000|FG001|Overall Study|Refused Treatment|1
7707437|NCT00454246|12129001|FG002|Overall Study|Refused Treatment|0
7707438|NCT00454246|12128999|FG000|Overall Study|Failure to return|1
7707439|NCT00454246|12129000|FG001|Overall Study|Failure to return|0
7707440|NCT00454246|12129001|FG002|Overall Study|Failure to return|0
7707441|NCT00454246|12128999|FG000|Overall Study|Early termination of study|62
7707442|NCT00454246|12129000|FG001|Overall Study|Early termination of study|26
7707443|NCT00454246|12129001|FG002|Overall Study|Early termination of study|9
7707444|NCT00454363|12129020|FG000|Overall Study|Adverse Event|1
7707445|NCT00454363|12129021|FG001|Overall Study|Adverse Event|2
7707446|NCT00454363|12129020|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4
7707447|NCT00454363|12129021|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0
7707448|NCT00454584|12129046|FG000|Controlled Period|Adverse Event|5
7707449|NCT00454584|12129047|FG001|Controlled Period|Adverse Event|2
7707450|NCT00454584|12129048|FG002|Controlled Period|Adverse Event|1
7707451|NCT00454584|12129049|FG003|Controlled Period|Adverse Event|0
7707452|NCT00454584|12129050|FG004|Controlled Period|Adverse Event|0
7707453|NCT00454584|12129051|FG005|Controlled Period|Adverse Event|0
7707454|NCT00454584|12129046|FG000|Controlled Period|Lost to Follow-up|1
7707455|NCT00454584|12129047|FG001|Controlled Period|Lost to Follow-up|2
7707456|NCT00454584|12129048|FG002|Controlled Period|Lost to Follow-up|2
7707457|NCT00454584|12129049|FG003|Controlled Period|Lost to Follow-up|0
7707458|NCT00454584|12129050|FG004|Controlled Period|Lost to Follow-up|0
7707459|NCT00454584|12129051|FG005|Controlled Period|Lost to Follow-up|0
7707460|NCT00454584|12129046|FG000|Controlled Period|Other|5
7707461|NCT00454584|12129047|FG001|Controlled Period|Other|4
7707462|NCT00454584|12129048|FG002|Controlled Period|Other|2
7707463|NCT00454584|12129049|FG003|Controlled Period|Other|0
7707464|NCT00454584|12129050|FG004|Controlled Period|Other|0
7707465|NCT00454584|12129051|FG005|Controlled Period|Other|0
7707466|NCT00454584|12129046|FG000|After Controlled Period|Adverse Event|0
7707467|NCT00454584|12129047|FG001|After Controlled Period|Adverse Event|0
7707468|NCT00454584|12129048|FG002|After Controlled Period|Adverse Event|0
7707469|NCT00454584|12129049|FG003|After Controlled Period|Adverse Event|9
7707470|NCT00454584|12129050|FG004|After Controlled Period|Adverse Event|3
7707471|NCT00454584|12129051|FG005|After Controlled Period|Adverse Event|9
7707472|NCT00454584|12129046|FG000|After Controlled Period|Lack of Efficacy|0
7707473|NCT00454584|12129047|FG001|After Controlled Period|Lack of Efficacy|0
7707474|NCT00454584|12129048|FG002|After Controlled Period|Lack of Efficacy|0
7707475|NCT00454584|12129049|FG003|After Controlled Period|Lack of Efficacy|1
7707476|NCT00454584|12129050|FG004|After Controlled Period|Lack of Efficacy|0
7707477|NCT00454584|12129051|FG005|After Controlled Period|Lack of Efficacy|0
7707478|NCT00454584|12129046|FG000|After Controlled Period|Lost to Follow-up|0
7707479|NCT00454584|12129047|FG001|After Controlled Period|Lost to Follow-up|0
7707480|NCT00454584|12129048|FG002|After Controlled Period|Lost to Follow-up|0
7707481|NCT00454584|12129049|FG003|After Controlled Period|Lost to Follow-up|2
7707482|NCT00454584|12129050|FG004|After Controlled Period|Lost to Follow-up|4
7707483|NCT00454584|12129051|FG005|After Controlled Period|Lost to Follow-up|6
7707484|NCT00454584|12129046|FG000|After Controlled Period|Other|0
7707485|NCT00454584|12129047|FG001|After Controlled Period|Other|0
7707486|NCT00454584|12129048|FG002|After Controlled Period|Other|0
7707487|NCT00454584|12129049|FG003|After Controlled Period|Other|1
7707488|NCT00454584|12129050|FG004|After Controlled Period|Other|0
7707489|NCT00454584|12129051|FG005|After Controlled Period|Other|0
7707490|NCT00454584|12129046|FG000|After Controlled Period|Other|0
7707491|NCT00454584|12129047|FG001|After Controlled Period|Other|0
7707492|NCT00454584|12129048|FG002|After Controlled Period|Other|0
7707493|NCT00454584|12129049|FG003|After Controlled Period|Other|13
7707494|NCT00454584|12129050|FG004|After Controlled Period|Other|5
7707495|NCT00454584|12129051|FG005|After Controlled Period|Other|17
7707496|NCT00454636|12129069|FG000|Overall Study|Adverse Event|10
7707497|NCT00454636|12129070|FG001|Overall Study|Adverse Event|6
7707498|NCT00454636|12129071|FG002|Overall Study|Adverse Event|9
7707499|NCT00454636|12129072|FG003|Overall Study|Adverse Event|15
7707500|NCT00454636|12129069|FG000|Overall Study|Disease Progression|11
7707501|NCT00454636|12129070|FG001|Overall Study|Disease Progression|12
7707502|NCT00454636|12129071|FG002|Overall Study|Disease Progression|4
7707503|NCT00454636|12129072|FG003|Overall Study|Disease Progression|11
7707504|NCT00454636|12129069|FG000|Overall Study|Protocol Violation|3
7707505|NCT00454636|12129070|FG001|Overall Study|Protocol Violation|2
7707506|NCT00454636|12129071|FG002|Overall Study|Protocol Violation|3
7707507|NCT00454636|12129072|FG003|Overall Study|Protocol Violation|3
7707508|NCT00454636|12129069|FG000|Overall Study|Death|6
7707509|NCT00454636|12129070|FG001|Overall Study|Death|1
7707510|NCT00454636|12129071|FG002|Overall Study|Death|1
7707511|NCT00454636|12129072|FG003|Overall Study|Death|1
7707512|NCT00454636|12129069|FG000|Overall Study|Patient refusal|1
7707513|NCT00454636|12129070|FG001|Overall Study|Patient refusal|1
7707514|NCT00454636|12129071|FG002|Overall Study|Patient refusal|3
7707515|NCT00454636|12129072|FG003|Overall Study|Patient refusal|2
7707516|NCT00454636|12129069|FG000|Overall Study|Lost to Follow-up|0
7707517|NCT00454636|12129070|FG001|Overall Study|Lost to Follow-up|1
7707518|NCT00454636|12129071|FG002|Overall Study|Lost to Follow-up|0
7707519|NCT00454636|12129072|FG003|Overall Study|Lost to Follow-up|0
7707520|NCT00454649|12129092|FG000|Overall Study|Lack of Efficacy|2
7707521|NCT00454649|12129093|FG001|Overall Study|Lack of Efficacy|2
7707522|NCT00454649|12129094|FG002|Overall Study|Lack of Efficacy|10
7707523|NCT00454649|12129095|FG003|Overall Study|Lack of Efficacy|3
7707524|NCT00454649|12129096|FG004|Overall Study|Lack of Efficacy|0
7707525|NCT00454649|12129097|FG005|Overall Study|Lack of Efficacy|4
7707526|NCT00454649|12129098|FG006|Overall Study|Lack of Efficacy|5
7707527|NCT00454649|12129099|FG007|Overall Study|Lack of Efficacy|13
7707528|NCT00454649|12129100|FG008|Overall Study|Lack of Efficacy|10
7707529|NCT00454649|12129101|FG009|Overall Study|Lack of Efficacy|2
7707530|NCT00454649|12129092|FG000|Overall Study|Adverse Event|0
7707531|NCT00454649|12129093|FG001|Overall Study|Adverse Event|1
7707532|NCT00454649|12129094|FG002|Overall Study|Adverse Event|3
7707533|NCT00454649|12129095|FG003|Overall Study|Adverse Event|0
7707534|NCT00454649|12129096|FG004|Overall Study|Adverse Event|1
7707535|NCT00454649|12129097|FG005|Overall Study|Adverse Event|2
7707536|NCT00454649|12129098|FG006|Overall Study|Adverse Event|3
7707537|NCT00454649|12129099|FG007|Overall Study|Adverse Event|4
7707538|NCT00454649|12129100|FG008|Overall Study|Adverse Event|6
7707539|NCT00454649|12129101|FG009|Overall Study|Adverse Event|2
7707540|NCT00454649|12129092|FG000|Overall Study|Lost to Follow-up|0
7707541|NCT00454649|12129093|FG001|Overall Study|Lost to Follow-up|0
7707542|NCT00454649|12129094|FG002|Overall Study|Lost to Follow-up|1
7707543|NCT00454649|12129095|FG003|Overall Study|Lost to Follow-up|0
7707544|NCT00454649|12129096|FG004|Overall Study|Lost to Follow-up|0
7707545|NCT00454649|12129097|FG005|Overall Study|Lost to Follow-up|0
7707546|NCT00454649|12129098|FG006|Overall Study|Lost to Follow-up|1
7707547|NCT00454649|12129099|FG007|Overall Study|Lost to Follow-up|0
7707548|NCT00454649|12129100|FG008|Overall Study|Lost to Follow-up|0
7707549|NCT00454649|12129101|FG009|Overall Study|Lost to Follow-up|0
7707550|NCT00454649|12129092|FG000|Overall Study|Other|1
7707551|NCT00454649|12129093|FG001|Overall Study|Other|1
7707552|NCT00454649|12129094|FG002|Overall Study|Other|5
7707553|NCT00454649|12129095|FG003|Overall Study|Other|3
7707554|NCT00454649|12129096|FG004|Overall Study|Other|0
7707555|NCT00454649|12129097|FG005|Overall Study|Other|0
7707556|NCT00454649|12129098|FG006|Overall Study|Other|0
7707557|NCT00454649|12129099|FG007|Overall Study|Other|0
7707558|NCT00454649|12129100|FG008|Overall Study|Other|3
7707559|NCT00454649|12129101|FG009|Overall Study|Other|1
7707560|NCT00454649|12129092|FG000|Overall Study|Withdrawal by Subject|0
7707561|NCT00454649|12129093|FG001|Overall Study|Withdrawal by Subject|0
7707562|NCT00454649|12129094|FG002|Overall Study|Withdrawal by Subject|0
7707563|NCT00454649|12129095|FG003|Overall Study|Withdrawal by Subject|0
7707564|NCT00454649|12129096|FG004|Overall Study|Withdrawal by Subject|0
7707565|NCT00454649|12129097|FG005|Overall Study|Withdrawal by Subject|1
7707566|NCT00454649|12129098|FG006|Overall Study|Withdrawal by Subject|0
7707567|NCT00454649|12129099|FG007|Overall Study|Withdrawal by Subject|2
7707568|NCT00454649|12129100|FG008|Overall Study|Withdrawal by Subject|1
7707569|NCT00454649|12129101|FG009|Overall Study|Withdrawal by Subject|0
7707570|NCT00454779|12129144|FG000|First-line Treatment Phase|Lack of Efficacy|0
7707571|NCT00454779|12129145|FG001|First-line Treatment Phase|Lack of Efficacy|2
7707572|NCT00454779|12129144|FG000|First-line Treatment Phase|Withdrawal by Subject|2
7707573|NCT00454779|12129145|FG001|First-line Treatment Phase|Withdrawal by Subject|4
7707574|NCT00454779|12129144|FG000|First-line Treatment Phase|Lost to Follow-up|1
7707575|NCT00454779|12129145|FG001|First-line Treatment Phase|Lost to Follow-up|0
7707576|NCT00454779|12129144|FG000|First-line Treatment Phase|Protocol Violation|0
7707577|NCT00454779|12129145|FG001|First-line Treatment Phase|Protocol Violation|1
7707578|NCT00454779|12129144|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1
7707579|NCT00454779|12129145|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1
7707580|NCT00454779|12129144|FG000|First-line Treatment Phase|Ongoing|1
7707581|NCT00454779|12129145|FG001|First-line Treatment Phase|Ongoing|0
7707582|NCT00454779|12129144|FG000|Second-line Treatment Phase|Withdrawal by Subject|0
7707583|NCT00454779|12129145|FG001|Second-line Treatment Phase|Withdrawal by Subject|1
7707584|NCT00454779|12129144|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0
7707585|NCT00454779|12129145|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1
7707586|NCT00454779|12129144|FG000|Second-line Treatment Phase|Ongoing|0
7707587|NCT00454779|12129145|FG001|Second-line Treatment Phase|Ongoing|1
7707588|NCT00454805|12129153|FG000|Overall Study|Withdrawal by Subject|9
7707589|NCT00454805|12129154|FG001|Overall Study|Withdrawal by Subject|2
7707590|NCT00454805|12129153|FG000|Overall Study|Death|0
7707591|NCT00454805|12129154|FG001|Overall Study|Death|2
7707592|NCT00454805|12129153|FG000|Overall Study|Disease progression|16
7707593|NCT00454805|12129154|FG001|Overall Study|Disease progression|19
7707594|NCT00454805|12129153|FG000|Overall Study|In order to begin radiotherapy|1
7707595|NCT00454805|12129154|FG001|Overall Study|In order to begin radiotherapy|0
7707596|NCT00454818|12129168|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1
7707597|NCT00454818|12129169|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0
7707598|NCT00454818|12129170|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0
7707599|NCT00454818|12129171|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0
7707600|NCT00454818|12129172|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0
7707601|NCT00454818|12129168|FG000|Phase I: Open-label Dose-escalation|Death|0
7707602|NCT00454818|12129169|FG001|Phase I: Open-label Dose-escalation|Death|1
7707603|NCT00454818|12129170|FG002|Phase I: Open-label Dose-escalation|Death|0
7707604|NCT00454818|12129171|FG003|Phase I: Open-label Dose-escalation|Death|0
7707605|NCT00454818|12129172|FG004|Phase I: Open-label Dose-escalation|Death|0
7707606|NCT00454818|12129168|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
7707607|NCT00454818|12129169|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
7707608|NCT00454818|12129170|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
7707609|NCT00454818|12129171|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
7707610|NCT00454818|12129172|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
7707611|NCT00454818|12129168|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
7707612|NCT00454818|12129169|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
7707613|NCT00454818|12129170|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
7707614|NCT00454818|12129171|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
7707615|NCT00454818|12129172|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
7707616|NCT00454818|12129168|FG000|Phase 2: Randomized Double-blind|Death|0
7707617|NCT00454818|12129169|FG001|Phase 2: Randomized Double-blind|Death|1
7707618|NCT00454818|12129170|FG002|Phase 2: Randomized Double-blind|Death|0
7707619|NCT00454818|12129171|FG003|Phase 2: Randomized Double-blind|Death|0
7707620|NCT00454818|12129172|FG004|Phase 2: Randomized Double-blind|Death|1
7707621|NCT00454818|12129168|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0
7707622|NCT00454818|12129169|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0
7707623|NCT00454818|12129170|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2
7707624|NCT00454818|12129171|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0
7707625|NCT00454818|12129172|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1
7707626|NCT00454818|12129168|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
7707627|NCT00454818|12129169|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
7707628|NCT00454818|12129170|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
7707629|NCT00454818|12129171|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
7707630|NCT00454818|12129172|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
7707631|NCT00454857|12129189|FG000|Overall Study|Withdrawal by Subject|15
7707632|NCT00454857|12129189|FG000|Overall Study|Lost to Follow-up|16
7707633|NCT00454857|12129189|FG000|Overall Study|Noncompliance|6
7707634|NCT00454857|12129189|FG000|Overall Study|Death|5
7707635|NCT00454857|12129189|FG000|Overall Study|Other|11
7707636|NCT00454857|12129189|FG000|Overall Study|Reason unknown|1
7707637|NCT00454909|12129196|FG000|Overall Study|Withdrawal by Subject|1
7707638|NCT00454909|12129197|FG001|Overall Study|Withdrawal by Subject|0
7707639|NCT00454909|12129198|FG002|Overall Study|Withdrawal by Subject|0
7707640|NCT00454909|12129196|FG000|Overall Study|Migrated/moved from study area|0
7707641|NCT00454909|12129197|FG001|Overall Study|Migrated/moved from study area|0
7707642|NCT00454909|12129198|FG002|Overall Study|Migrated/moved from study area|1
7707643|NCT00454909|12129196|FG000|Overall Study|Lost to follow-up (complete vaccination)|5
7707644|NCT00454909|12129197|FG001|Overall Study|Lost to follow-up (complete vaccination)|3
7707645|NCT00454909|12129198|FG002|Overall Study|Lost to follow-up (complete vaccination)|1
7707646|NCT00454909|12129196|FG000|Overall Study|Others|1
7707647|NCT00454909|12129197|FG001|Overall Study|Others|0
7707648|NCT00454909|12129198|FG002|Overall Study|Others|0
7707649|NCT00454987|12129210|FG000|Booster Period (NCT00258700)|Adverse Event|1
7707650|NCT00454987|12129211|FG001|Booster Period (NCT00258700)|Adverse Event|0
7707651|NCT00454987|12129212|FG002|Booster Period (NCT00258700)|Adverse Event|0
7707652|NCT00454987|12129210|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0
7707653|NCT00454987|12129211|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1
7707654|NCT00454987|12129212|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0
7707655|NCT00454987|12129210|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1
7707656|NCT00454987|12129211|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0
7707657|NCT00454987|12129212|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0
7707658|NCT00455013|12129224|FG000|Short Term Period|Adverse Event|2
7707659|NCT00455013|12129225|FG001|Short Term Period|Adverse Event|5
7707660|NCT00455013|12129226|FG002|Short Term Period|Adverse Event|0
7707661|NCT00455013|12129224|FG000|Short Term Period|Withdrawal by Subject|0
7707662|NCT00455013|12129225|FG001|Short Term Period|Withdrawal by Subject|0
7707663|NCT00455013|12129226|FG002|Short Term Period|Withdrawal by Subject|1
7707664|NCT00455013|12129224|FG000|Short Term Period|Lack of Efficacy|4
7707665|NCT00455013|12129225|FG001|Short Term Period|Lack of Efficacy|0
7707666|NCT00455013|12129226|FG002|Short Term Period|Lack of Efficacy|0
7707667|NCT00455013|12129224|FG000|Short Term Period|Other|0
7707668|NCT00455013|12129225|FG001|Short Term Period|Other|0
7707669|NCT00455013|12129226|FG002|Short Term Period|Other|1
7707670|NCT00455013|12129224|FG000|Long Term Extension (LTE)|Adverse Event|0
7707671|NCT00455013|12129225|FG001|Long Term Extension (LTE)|Adverse Event|1
7707672|NCT00455013|12129226|FG002|Long Term Extension (LTE)|Adverse Event|1
7707673|NCT00455013|12129224|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1
7707674|NCT00455013|12129225|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0
7707675|NCT00455013|12129226|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1
7707676|NCT00455013|12129224|FG000|Long Term Extension (LTE)|Death|1
7707677|NCT00455013|12129225|FG001|Long Term Extension (LTE)|Death|1
7707678|NCT00455013|12129226|FG002|Long Term Extension (LTE)|Death|0
7707679|NCT00455013|12129224|FG000|Long Term Extension (LTE)|No longer met criteria|0
7707680|NCT00455013|12129225|FG001|Long Term Extension (LTE)|No longer met criteria|0
7707681|NCT00455013|12129226|FG002|Long Term Extension (LTE)|No longer met criteria|1
7707682|NCT00455013|12129224|FG000|Long Term Extension (LTE)|Subject Request or refused|0
7707683|NCT00455013|12129225|FG001|Long Term Extension (LTE)|Subject Request or refused|0
7707684|NCT00455013|12129226|FG002|Long Term Extension (LTE)|Subject Request or refused|3
7707685|NCT00455013|12129224|FG000|Long Term Extension (LTE)|Poor non-compliance|0
7707686|NCT00455013|12129225|FG001|Long Term Extension (LTE)|Poor non-compliance|1
7707687|NCT00455013|12129226|FG002|Long Term Extension (LTE)|Poor non-compliance|0
7707688|NCT00455013|12129224|FG000|Long Term Extension (LTE)|non-specified|0
7707689|NCT00455013|12129225|FG001|Long Term Extension (LTE)|non-specified|0
7707690|NCT00455013|12129226|FG002|Long Term Extension (LTE)|non-specified|1
7707691|NCT00455195|12129236|FG000|Double-blind Study AGLU02704|Adverse Event|2
7707692|NCT00455195|12129237|FG001|Double-blind Study AGLU02704|Adverse Event|1
7707693|NCT00455195|12129236|FG000|Double-blind Study AGLU02704|Death|1
7707694|NCT00455195|12129237|FG001|Double-blind Study AGLU02704|Death|0
7707695|NCT00455195|12129236|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2
7707696|NCT00455195|12129237|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2
7707697|NCT00455195|12129236|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0
7707698|NCT00455195|12129237|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1
7707699|NCT00455312|12129245|FG000|Overall Study|Death|0
7707700|NCT00455312|12129246|FG001|Overall Study|Death|1
7707701|NCT00455429|12129256|FG000|Overall Study|Study Terminated by Sponsor|0
7707702|NCT00455429|12129257|FG001|Overall Study|Study Terminated by Sponsor|0
7707703|NCT00455429|12129258|FG002|Overall Study|Study Terminated by Sponsor|0
7707704|NCT00455429|12129259|FG003|Overall Study|Study Terminated by Sponsor|3
7707705|NCT00455429|12129256|FG000|Overall Study|Lost to Follow-up|1
7707706|NCT00455429|12129257|FG001|Overall Study|Lost to Follow-up|0
7707707|NCT00455429|12129258|FG002|Overall Study|Lost to Follow-up|0
7707708|NCT00455429|12129259|FG003|Overall Study|Lost to Follow-up|3
7707709|NCT00455429|12129256|FG000|Overall Study|Withdrawal by Subject|0
7707710|NCT00455429|12129257|FG001|Overall Study|Withdrawal by Subject|1
7707711|NCT00455429|12129258|FG002|Overall Study|Withdrawal by Subject|1
7707712|NCT00455429|12129259|FG003|Overall Study|Withdrawal by Subject|0
7707713|NCT00455429|12129256|FG000|Overall Study|Lack of Efficacy|0
7707714|NCT00455429|12129257|FG001|Overall Study|Lack of Efficacy|1
7707715|NCT00455429|12129258|FG002|Overall Study|Lack of Efficacy|0
7707716|NCT00455429|12129259|FG003|Overall Study|Lack of Efficacy|1
7707717|NCT00455429|12129256|FG000|Overall Study|Adverse Event|0
7707718|NCT00455429|12129257|FG001|Overall Study|Adverse Event|1
7707719|NCT00455429|12129258|FG002|Overall Study|Adverse Event|0
7707720|NCT00455429|12129259|FG003|Overall Study|Adverse Event|3
7707721|NCT00455429|12129256|FG000|Overall Study|Randomly assigned but not treated|0
7707722|NCT00455429|12129257|FG001|Overall Study|Randomly assigned but not treated|0
7707723|NCT00455429|12129258|FG002|Overall Study|Randomly assigned but not treated|0
7707724|NCT00455429|12129259|FG003|Overall Study|Randomly assigned but not treated|2
7707725|NCT00455429|12129256|FG000|Overall Study|Personal Reason|1
7707726|NCT00455429|12129257|FG001|Overall Study|Personal Reason|0
7707727|NCT00455429|12129258|FG002|Overall Study|Personal Reason|0
7707728|NCT00455429|12129259|FG003|Overall Study|Personal Reason|0
7707729|NCT00455429|12129256|FG000|Overall Study|Non-compliance|0
7707730|NCT00455429|12129257|FG001|Overall Study|Non-compliance|0
7707731|NCT00455429|12129258|FG002|Overall Study|Non-compliance|0
7707732|NCT00455429|12129259|FG003|Overall Study|Non-compliance|1
7707733|NCT00455429|12129256|FG000|Overall Study|Other|0
7707734|NCT00455429|12129257|FG001|Overall Study|Other|2
7707735|NCT00455429|12129258|FG002|Overall Study|Other|0
7707736|NCT00455429|12129259|FG003|Overall Study|Other|1
7707737|NCT00455455|12129272|FG000|Washout|Withdrawal by Subject|0
7707738|NCT00455455|12129273|FG001|Washout|Withdrawal by Subject|1
7707739|NCT00455455|12129272|FG000|Washout|Withdrawal by Subject|1
7707740|NCT00455455|12129273|FG001|Washout|Withdrawal by Subject|0
7707741|NCT00455520|12129284|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
7707742|NCT00455520|12129285|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
7707743|NCT00455520|12129284|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3
7707744|NCT00455520|12129285|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0
7707745|NCT00455520|12129284|FG000|Open Label Tapentadol Extended Release|Adverse Event|100
7707746|NCT00455520|12129285|FG001|Open Label Tapentadol Extended Release|Adverse Event|0
7707747|NCT00455520|12129284|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23
7707748|NCT00455520|12129285|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0
7707749|NCT00455520|12129284|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13
7707750|NCT00455520|12129285|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0
7707751|NCT00455520|12129284|FG000|Open Label Tapentadol Extended Release|All other|33
7707752|NCT00455520|12129285|FG001|Open Label Tapentadol Extended Release|All other|0
7707753|NCT00455520|12129284|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
7707754|NCT00455520|12129285|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
7707755|NCT00455520|12129284|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
7707756|NCT00455520|12129285|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
7707757|NCT00455520|12129284|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
7707758|NCT00455520|12129285|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
7707759|NCT00455520|12129284|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
7707760|NCT00455520|12129285|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
7707761|NCT00455520|12129284|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
7707762|NCT00455520|12129285|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
7707763|NCT00455520|12129284|FG000|Double Blind Tapentadol ER vs Placebo|All other|4
7707764|NCT00455520|12129285|FG001|Double Blind Tapentadol ER vs Placebo|All other|6
7707765|NCT00455533|12129293|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
7707766|NCT00455533|12129294|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
7707767|NCT00455533|12129295|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
7707768|NCT00455533|12129293|FG000|Period One: Initial Chemotherapy|Disease Progression|5
7707769|NCT00455533|12129294|FG001|Period One: Initial Chemotherapy|Disease Progression|0
7707770|NCT00455533|12129295|FG002|Period One: Initial Chemotherapy|Disease Progression|0
7707771|NCT00455533|12129293|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2
7707772|NCT00455533|12129294|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0
7707773|NCT00455533|12129295|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0
7707774|NCT00455533|12129293|FG000|Period One: Initial Chemotherapy|Not Reported|1
7707775|NCT00455533|12129294|FG001|Period One: Initial Chemotherapy|Not Reported|0
7707776|NCT00455533|12129295|FG002|Period One: Initial Chemotherapy|Not Reported|0
7707777|NCT00455533|12129293|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2
7707778|NCT00455533|12129294|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0
7707779|NCT00455533|12129295|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0
7707780|NCT00455533|12129293|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2
7707781|NCT00455533|12129294|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0
7707782|NCT00455533|12129295|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0
7707783|NCT00455533|12129293|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
7707784|NCT00455533|12129294|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
7707785|NCT00455533|12129295|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
7707786|NCT00455533|12129293|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
7707787|NCT00455533|12129294|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
7707788|NCT00455533|12129295|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
7707789|NCT00455533|12129293|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
7707790|NCT00455533|12129294|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
7707791|NCT00455533|12129295|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
7707792|NCT00455533|12129293|FG000|Period Two: Randomized Period|Death|0
7707793|NCT00455533|12129294|FG001|Period Two: Randomized Period|Death|0
7707794|NCT00455533|12129295|FG002|Period Two: Randomized Period|Death|3
7707795|NCT00455533|12129293|FG000|Period Two: Randomized Period|Disease Progression|0
7707796|NCT00455533|12129294|FG001|Period Two: Randomized Period|Disease Progression|1
7707797|NCT00455533|12129295|FG002|Period Two: Randomized Period|Disease Progression|1
7707798|NCT00455533|12129293|FG000|Period Two: Randomized Period|Lost to Follow-up|0
7707799|NCT00455533|12129294|FG001|Period Two: Randomized Period|Lost to Follow-up|0
7707800|NCT00455533|12129295|FG002|Period Two: Randomized Period|Lost to Follow-up|1
7707801|NCT00455533|12129293|FG000|Period Two: Randomized Period|Other - need reasons|0
7707802|NCT00455533|12129294|FG001|Period Two: Randomized Period|Other - need reasons|1
7707803|NCT00455533|12129295|FG002|Period Two: Randomized Period|Other - need reasons|0
7707804|NCT00455533|12129293|FG000|Period Two: Randomized Period|Study Drug Toxicity|0
7707805|NCT00455533|12129294|FG001|Period Two: Randomized Period|Study Drug Toxicity|2
7707806|NCT00455533|12129295|FG002|Period Two: Randomized Period|Study Drug Toxicity|0
7707807|NCT00455533|12129293|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0
7707808|NCT00455533|12129294|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2
7707809|NCT00455533|12129295|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1
7707810|NCT00455741|12129358|FG000|Overall Study|Physician Decision|0
7707811|NCT00455741|12129359|FG001|Overall Study|Physician Decision|1
7707812|NCT00455858|12129375|FG000|Overall Study|Lost to Follow-up|2
7707813|NCT00455858|12129375|FG000|Overall Study|Protocol Violation|1
7707814|NCT00455858|12129375|FG000|Overall Study|Lack of Efficacy|1
7707815|NCT00455858|12129375|FG000|Overall Study|Well controlled FPG without insulin|1
7707816|NCT00455858|12129375|FG000|Overall Study|Withdrawal|1
7707817|NCT00455923|12129381|FG000|Overall Study|Pregnancy|0
7707818|NCT00455923|12129382|FG001|Overall Study|Pregnancy|2
7707819|NCT00455923|12129381|FG000|Overall Study|Other|3
7707820|NCT00455923|12129382|FG001|Overall Study|Other|1
7707821|NCT00456092|12129415|FG000|Extension Phase|Grade 2 or Greater AE|2
7707822|NCT00456092|12129416|FG001|Extension Phase|Grade 2 or Greater AE|2
7707823|NCT00456092|12129417|FG002|Extension Phase|Grade 2 or Greater AE|0
7707824|NCT00456092|12129418|FG003|Extension Phase|Grade 2 or Greater AE|0
7707825|NCT00456092|12129419|FG004|Extension Phase|Grade 2 or Greater AE|2
7707826|NCT00456092|12129415|FG000|Extension Phase|Flare of Psoriatic Arthritis|1
7707827|NCT00456092|12129416|FG001|Extension Phase|Flare of Psoriatic Arthritis|0
7707828|NCT00456092|12129417|FG002|Extension Phase|Flare of Psoriatic Arthritis|0
7707829|NCT00456092|12129418|FG003|Extension Phase|Flare of Psoriatic Arthritis|0
7707830|NCT00456092|12129419|FG004|Extension Phase|Flare of Psoriatic Arthritis|1
7707831|NCT00456092|12129415|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3
7707832|NCT00456092|12129416|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1
7707833|NCT00456092|12129417|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0
7707834|NCT00456092|12129418|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0
7707835|NCT00456092|12129419|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2
7707836|NCT00456092|12129415|FG000|Extension Phase|Withdrew Consent|2
7707837|NCT00456092|12129416|FG001|Extension Phase|Withdrew Consent|0
7707838|NCT00456092|12129417|FG002|Extension Phase|Withdrew Consent|0
7707839|NCT00456092|12129418|FG003|Extension Phase|Withdrew Consent|0
7707840|NCT00456092|12129419|FG004|Extension Phase|Withdrew Consent|0
7707841|NCT00456092|12129415|FG000|Extension Phase|Lost to Follow-up|1
7707842|NCT00456092|12129416|FG001|Extension Phase|Lost to Follow-up|1
7707843|NCT00456092|12129417|FG002|Extension Phase|Lost to Follow-up|0
7707844|NCT00456092|12129418|FG003|Extension Phase|Lost to Follow-up|0
7707845|NCT00456092|12129419|FG004|Extension Phase|Lost to Follow-up|1
7707846|NCT00456092|12129415|FG000|Extension Phase|Other|2
7707847|NCT00456092|12129416|FG001|Extension Phase|Other|0
7707848|NCT00456092|12129417|FG002|Extension Phase|Other|0
7707849|NCT00456092|12129418|FG003|Extension Phase|Other|1
7707850|NCT00456092|12129419|FG004|Extension Phase|Other|1
7707851|NCT00456092|12129415|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3
7707852|NCT00456092|12129416|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4
7707853|NCT00456092|12129417|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2
7707854|NCT00456092|12129418|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
7707855|NCT00456092|12129419|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
7707856|NCT00456092|12129415|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1
7707857|NCT00456092|12129416|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2
7707858|NCT00456092|12129417|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
7707859|NCT00456092|12129418|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
7707860|NCT00456092|12129419|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
7707861|NCT00456092|12129415|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2
7707862|NCT00456092|12129416|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
7707863|NCT00456092|12129417|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
7707864|NCT00456092|12129418|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
7707865|NCT00456092|12129419|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
7707866|NCT00456092|12129415|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
7707867|NCT00456092|12129416|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1
7707868|NCT00456092|12129417|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2
7707869|NCT00456092|12129418|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
7707870|NCT00456092|12129419|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
7707871|NCT00456092|12129415|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
7707872|NCT00456092|12129416|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
7707873|NCT00456092|12129417|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
7707874|NCT00456092|12129418|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
7707875|NCT00456092|12129419|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
7707876|NCT00456092|12129415|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
7707877|NCT00456092|12129416|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2
7707878|NCT00456092|12129417|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7
7707879|NCT00456092|12129418|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
7707880|NCT00456092|12129419|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
7707881|NCT00456092|12129415|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0
7707882|NCT00456092|12129416|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1
7707883|NCT00456092|12129417|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2
7707884|NCT00456092|12129418|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0
7707885|NCT00456092|12129419|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0
7707886|NCT00456092|12129415|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0
7707887|NCT00456092|12129416|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1
7707888|NCT00456092|12129417|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1
7707889|NCT00456092|12129418|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0
7707890|NCT00456092|12129419|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0
7707891|NCT00456092|12129415|FG000|Treatment Phase (12 Weeks)|Other|1
7707892|NCT00456092|12129416|FG001|Treatment Phase (12 Weeks)|Other|0
7707893|NCT00456092|12129417|FG002|Treatment Phase (12 Weeks)|Other|1
7707894|NCT00456092|12129418|FG003|Treatment Phase (12 Weeks)|Other|0
7707895|NCT00456092|12129419|FG004|Treatment Phase (12 Weeks)|Other|0
7707896|NCT00456300|12129433|FG000|Overall Study|Adverse Event|1
7707897|NCT00456300|12129434|FG001|Overall Study|Adverse Event|0
7707898|NCT00456365|12129444|FG000|Overall Study|Lost to Follow-up|1
7707899|NCT00456365|12129445|FG001|Overall Study|Lost to Follow-up|3
7707900|NCT00456365|12129444|FG000|Overall Study|Withdrawal by Subject|4
7707901|NCT00456365|12129445|FG001|Overall Study|Withdrawal by Subject|7
7707902|NCT00456365|12129444|FG000|Overall Study|Pregnancy|1
7707903|NCT00456365|12129445|FG001|Overall Study|Pregnancy|1
7707904|NCT00456365|12129444|FG000|Overall Study|oncologic diagnosis|1
7707905|NCT00456365|12129445|FG001|Overall Study|oncologic diagnosis|1
7707906|NCT00456495|12129453|FG000|Overall Study|Physician Decision|2
7707907|NCT00456521|12129464|FG000|Overall Study|Adverse Event|150
7707908|NCT00456521|12129465|FG001|Overall Study|Adverse Event|25
7707909|NCT00456521|12129464|FG000|Overall Study|Withdrawal by Subject|43
7707910|NCT00456521|12129465|FG001|Overall Study|Withdrawal by Subject|24
7707911|NCT00456521|12129464|FG000|Overall Study|Lost to Follow-up|22
7707912|NCT00456521|12129465|FG001|Overall Study|Lost to Follow-up|17
7707913|NCT00456521|12129464|FG000|Overall Study|Lack of Efficacy|3
7707914|NCT00456521|12129465|FG001|Overall Study|Lack of Efficacy|6
7707915|NCT00456521|12129464|FG000|Overall Study|Protocol Violation|4
7707916|NCT00456521|12129465|FG001|Overall Study|Protocol Violation|0
7707917|NCT00456521|12129464|FG000|Overall Study|Pregnancy|1
7707918|NCT00456521|12129465|FG001|Overall Study|Pregnancy|1
7707919|NCT00456521|12129464|FG000|Overall Study|Drug non-compliance, moved, other|26
7707920|NCT00456521|12129465|FG001|Overall Study|Drug non-compliance, moved, other|11
7707921|NCT00456599|12129481|FG000|Overall Study|Non-compliance|1
7707922|NCT00456599|12129481|FG000|Overall Study|Withdrawal by Subject|2
7707923|NCT00456755|12129491|FG000|Overall Study|Lost to Follow-up|2
7707924|NCT00456755|12129492|FG001|Overall Study|Lost to Follow-up|1
7707925|NCT00456846|12129509|FG000|Overall Study|Adverse Event|2
7707926|NCT00456846|12129510|FG001|Overall Study|Adverse Event|15
7707927|NCT00456846|12129509|FG000|Overall Study|Physician Decision|11
7707928|NCT00456846|12129510|FG001|Overall Study|Physician Decision|6
7707929|NCT00456846|12129509|FG000|Overall Study|Protocol Deviation|2
7707930|NCT00456846|12129510|FG001|Overall Study|Protocol Deviation|0
7707931|NCT00456846|12129509|FG000|Overall Study|Participant Discretion|1
7707932|NCT00456846|12129510|FG001|Overall Study|Participant Discretion|5
7707933|NCT00456846|12129509|FG000|Overall Study|Other|0
7707934|NCT00456846|12129510|FG001|Overall Study|Other|2
7707935|NCT00457002|12129524|FG000|Overall Study|Death|40
7707936|NCT00457002|12129525|FG001|Overall Study|Death|47
7707937|NCT00457002|12129524|FG000|Overall Study|Adverse Event|284
7707938|NCT00457002|12129525|FG001|Overall Study|Adverse Event|260
7707939|NCT00457002|12129524|FG000|Overall Study|Withdrawal by Subject|299
7707940|NCT00457002|12129525|FG001|Overall Study|Withdrawal by Subject|271
7707941|NCT00457002|12129524|FG000|Overall Study|Lost to Follow-up|72
7707942|NCT00457002|12129525|FG001|Overall Study|Lost to Follow-up|71
7707943|NCT00457002|12129524|FG000|Overall Study|Poor/Non-compliance|46
7707944|NCT00457002|12129525|FG001|Overall Study|Poor/Non-compliance|33
7707945|NCT00457002|12129524|FG000|Overall Study|No longer met criteria|41
7707946|NCT00457002|12129525|FG001|Overall Study|No longer met criteria|37
7707947|NCT00457002|12129524|FG000|Overall Study|Administrative reason by Sponsor|1
7707948|NCT00457002|12129525|FG001|Overall Study|Administrative reason by Sponsor|0
7707949|NCT00457002|12129524|FG000|Overall Study|non-specified|29
7707950|NCT00457002|12129525|FG001|Overall Study|non-specified|38
7707951|NCT00457002|12129524|FG000|Overall Study|treated for 1 day; missing status/reason|1
7707952|NCT00457002|12129525|FG001|Overall Study|treated for 1 day; missing status/reason|0
7707953|NCT00457015|12129533|FG000|Overall Study|Left study site against medical advice|0
7707954|NCT00457015|12129534|FG001|Overall Study|Left study site against medical advice|1
7707955|NCT00457249|12129551|FG000|Overall Study|Lost to Follow-up|3
7707956|NCT00457249|12129552|FG001|Overall Study|Lost to Follow-up|0
7707957|NCT00457249|12129551|FG000|Overall Study|Protocol Violation|4
7707958|NCT00457249|12129552|FG001|Overall Study|Protocol Violation|1
7707959|NCT00457249|12129551|FG000|Overall Study|Withdrawal by Subject|3
7707960|NCT00457249|12129552|FG001|Overall Study|Withdrawal by Subject|1
7707961|NCT00457249|12129551|FG000|Overall Study|Serious Adverse Events|2
7707962|NCT00457249|12129552|FG001|Overall Study|Serious Adverse Events|0
7707963|NCT00457301|12129562|FG000|Overall Study|Withdrawal by Subject|3
7707964|NCT00457301|12129563|FG001|Overall Study|Withdrawal by Subject|3
7707965|NCT00457301|12129562|FG000|Overall Study|Censored out of the study|15
7707966|NCT00457301|12129563|FG001|Overall Study|Censored out of the study|14
7707967|NCT00457301|12129562|FG000|Overall Study|Death|5
7707968|NCT00457301|12129563|FG001|Overall Study|Death|7
7707969|NCT00457392|12129580|FG000|Overall Study|Objective Progression or Relapse|229
7707970|NCT00457392|12129581|FG001|Overall Study|Objective Progression or Relapse|296
7707971|NCT00457392|12129580|FG000|Overall Study|Death|106
7707972|NCT00457392|12129581|FG001|Overall Study|Death|106
7707973|NCT00457392|12129580|FG000|Overall Study|Adverse Event|84
7707974|NCT00457392|12129581|FG001|Overall Study|Adverse Event|41
7707975|NCT00457392|12129580|FG000|Overall Study|Global Deterioration of Health Status|22
7707976|NCT00457392|12129581|FG001|Overall Study|Global Deterioration of Health Status|8
7707977|NCT00457392|12129580|FG000|Overall Study|Withdrawal by Subject|14
7707978|NCT00457392|12129581|FG001|Overall Study|Withdrawal by Subject|8
7707979|NCT00457392|12129580|FG000|Overall Study|Lost to Follow-up|6
7707980|NCT00457392|12129581|FG001|Overall Study|Lost to Follow-up|7
7707981|NCT00457392|12129580|FG000|Overall Study|Protocol Violation|4
7707982|NCT00457392|12129581|FG001|Overall Study|Protocol Violation|3
7707983|NCT00457392|12129580|FG000|Overall Study|Other|7
7707984|NCT00457392|12129581|FG001|Overall Study|Other|4
7707985|NCT00457392|12129580|FG000|Overall Study|Study Terminated by Sponsor|1
7707986|NCT00457392|12129581|FG001|Overall Study|Study Terminated by Sponsor|4
7707987|NCT00457392|12129580|FG000|Overall Study|Randomized, Not Treated|7
7707988|NCT00457392|12129581|FG001|Overall Study|Randomized, Not Treated|3
7707989|NCT00457418|12129587|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
7707990|NCT00457418|12129587|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
7707991|NCT00457418|12129587|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
7707992|NCT00457418|12129587|FG000|Post PK Maintenance|Adverse Event|10
7707993|NCT00457418|12129587|FG000|Post PK Maintenance|Progression of Disease|6
7707994|NCT00457418|12129587|FG000|Post PK Maintenance|Withdrawal by Subject|11
7707995|NCT00457418|12129587|FG000|Post PK Maintenance|Lost to Follow-up|1
7707996|NCT00457626|12129591|FG000|Overall Study|Adverse Event|3
7707997|NCT00457626|12129591|FG000|Overall Study|Administrative Problems|2
7707998|NCT00457626|12129591|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1
7707999|NCT00457639|12129595|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3
7708000|NCT00457639|12129596|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0
7708001|NCT00457639|12129595|FG000|Intervention 1 (6 Months)|unrelated illness|0
7708002|NCT00457639|12129596|FG001|Intervention 1 (6 Months)|unrelated illness|2
7708003|NCT00457639|12129595|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0
7708004|NCT00457639|12129596|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1
7708005|NCT00457665|12129604|FG000|12 Months|Drug allergy|1
7708006|NCT00457665|12129605|FG001|12 Months|Drug allergy|1
7708007|NCT00457665|12129604|FG000|12 Months|High HIV viral load|5
7708008|NCT00457665|12129605|FG001|12 Months|High HIV viral load|1
7708009|NCT00457665|12129604|FG000|12 Months|Lipodystrophy|2
7708010|NCT00457665|12129605|FG001|12 Months|Lipodystrophy|0
7708011|NCT00457665|12129604|FG000|12 Months|Withdrawal by Subject|0
7708012|NCT00457665|12129605|FG001|12 Months|Withdrawal by Subject|2
7708013|NCT00457665|12129604|FG000|12 Months|Abnormal Liver function tests|0
7708014|NCT00457665|12129605|FG001|12 Months|Abnormal Liver function tests|5
7708015|NCT00457665|12129604|FG000|24 Months|Withdrawal by Subject|3
7708016|NCT00457665|12129605|FG001|24 Months|Withdrawal by Subject|2
7708017|NCT00457665|12129604|FG000|24 Months|Lipodystrophy|1
7708018|NCT00457665|12129605|FG001|24 Months|Lipodystrophy|1
7708019|NCT00457665|12129604|FG000|24 Months|Abnormal liver function tests|1
7708020|NCT00457665|12129605|FG001|24 Months|Abnormal liver function tests|5
7708021|NCT00457691|12129613|FG000|Overall Study|Adverse Event|4
7708022|NCT00457691|12129614|FG001|Overall Study|Adverse Event|1
7708023|NCT00457691|12129613|FG000|Overall Study|Death|163
7708024|NCT00457691|12129614|FG001|Overall Study|Death|148
7708025|NCT00457691|12129613|FG000|Overall Study|Protocol Violation|1
7708026|NCT00457691|12129614|FG001|Overall Study|Protocol Violation|3
7708027|NCT00457691|12129613|FG000|Overall Study|Lost to Follow-up|23
7708028|NCT00457691|12129614|FG001|Overall Study|Lost to Follow-up|14
7708029|NCT00457691|12129613|FG000|Overall Study|Study terminated by Sponsor|1
7708030|NCT00457691|12129614|FG001|Overall Study|Study terminated by Sponsor|1
7708031|NCT00457691|12129613|FG000|Overall Study|Subject refused (reason other than AE)|14
7708032|NCT00457691|12129614|FG001|Overall Study|Subject refused (reason other than AE)|19
7708033|NCT00457691|12129613|FG000|Overall Study|Disease progression, study terminated|180
7708034|NCT00457691|12129614|FG001|Overall Study|Disease progression, study terminated|196
7708035|NCT00457743|12129636|FG000|Overall Study|Adverse Event|0
7708036|NCT00457743|12129637|FG001|Overall Study|Adverse Event|4
7708037|NCT00457743|12129638|FG002|Overall Study|Adverse Event|0
7708038|NCT00457743|12129636|FG000|Overall Study|Lack of Efficacy|3
7708039|NCT00457743|12129637|FG001|Overall Study|Lack of Efficacy|23
7708040|NCT00457743|12129638|FG002|Overall Study|Lack of Efficacy|3
7708041|NCT00457821|12129659|FG000|Part 2|Withdrawal by Subject|0
7708042|NCT00457821|12129660|FG001|Part 2|Withdrawal by Subject|0
7708043|NCT00457821|12129661|FG002|Part 2|Withdrawal by Subject|0
7708044|NCT00457821|12129662|FG003|Part 2|Withdrawal by Subject|0
7708045|NCT00457821|12129663|FG004|Part 2|Withdrawal by Subject|0
7708046|NCT00457821|12129664|FG005|Part 2|Withdrawal by Subject|0
7708047|NCT00457821|12129665|FG006|Part 2|Withdrawal by Subject|0
7708048|NCT00457821|12129666|FG007|Part 2|Withdrawal by Subject|1
7708049|NCT00458211|12129692|FG000|Overall Study|Lack of Efficacy|12
7708050|NCT00458211|12129692|FG000|Overall Study|Withdrawal by Subject|2
7708051|NCT00458211|12129692|FG000|Overall Study|Protocol Violation|2
7708052|NCT00458302|12129716|FG000|Overall Study|Adverse Event|4
7708053|NCT00458302|12129717|FG001|Overall Study|Adverse Event|14
7708054|NCT00458302|12129716|FG000|Overall Study|Pregnancy|2
7708055|NCT00458302|12129717|FG001|Overall Study|Pregnancy|1
7708056|NCT00458302|12129716|FG000|Overall Study|Protocol Violation|0
7708057|NCT00458302|12129717|FG001|Overall Study|Protocol Violation|2
7708058|NCT00458302|12129716|FG000|Overall Study|Withdrawal by Subject|6
7708059|NCT00458302|12129717|FG001|Overall Study|Withdrawal by Subject|4
7708060|NCT00458302|12129716|FG000|Overall Study|Inc/Exc Criteria Not Met|1
7708061|NCT00458302|12129717|FG001|Overall Study|Inc/Exc Criteria Not Met|1
7708062|NCT00458302|12129716|FG000|Overall Study|Study Termination By Sponsor|1
7708063|NCT00458302|12129717|FG001|Overall Study|Study Termination By Sponsor|0
7708064|NCT00458302|12129716|FG000|Overall Study|Lost to Follow-up|2
7708065|NCT00458302|12129717|FG001|Overall Study|Lost to Follow-up|0
7708066|NCT00458302|12129716|FG000|Overall Study|Other|4
7708067|NCT00458302|12129717|FG001|Overall Study|Other|2
7708068|NCT00458341|12129726|FG000|Cycle 1|Adverse Event|1
7708069|NCT00458341|12129727|FG001|Cycle 1|Adverse Event|0
7708070|NCT00458393|12129735|FG000|Overall Study|Withdrawal by Subject|67
7708071|NCT00458393|12129736|FG001|Overall Study|Withdrawal by Subject|80
7708072|NCT00458393|12129735|FG000|Overall Study|Physician Decision|31
7708073|NCT00458393|12129736|FG001|Overall Study|Physician Decision|22
7708074|NCT00458393|12129735|FG000|Overall Study|Relocated|77
7708075|NCT00458393|12129736|FG001|Overall Study|Relocated|81
7708076|NCT00458393|12129735|FG000|Overall Study|Lost to Follow-up|115
7708077|NCT00458393|12129736|FG001|Overall Study|Lost to Follow-up|92
7708078|NCT00458393|12129735|FG000|Overall Study|Sites marked other on the form.|19
7708079|NCT00458393|12129736|FG001|Overall Study|Sites marked other on the form.|20
7708080|NCT00458484|12129767|FG000|Overall Study|Not eligible b/c prior radiation history|0
7708081|NCT00458484|12129768|FG001|Overall Study|Not eligible b/c prior radiation history|0
7708082|NCT00458484|12129769|FG002|Overall Study|Not eligible b/c prior radiation history|0
7708083|NCT00458484|12129770|FG003|Overall Study|Not eligible b/c prior radiation history|0
7708084|NCT00458484|12129771|FG004|Overall Study|Not eligible b/c prior radiation history|0
7708085|NCT00458484|12129772|FG005|Overall Study|Not eligible b/c prior radiation history|1
7708086|NCT00458484|12129773|FG006|Overall Study|Not eligible b/c prior radiation history|0
7708087|NCT00458705|12129798|FG000|Overall Study|Adverse Event|4
7708088|NCT00458705|12129798|FG000|Overall Study|Not Treated|1
7708089|NCT00458783|12129804|FG000|Overall Study|Protocol Violation|1228
7708090|NCT00458783|12129805|FG001|Overall Study|Protocol Violation|1220
7708091|NCT00459043|12129828|FG000|Overall Study|Withdrawal by Subject|1
7708092|NCT00459043|12129829|FG001|Overall Study|Withdrawal by Subject|0
7708093|NCT00459056|12129837|FG000|First Intervention (First Three Months)|Lost to Follow-up|1
7708094|NCT00459056|12129838|FG001|First Intervention (First Three Months)|Lost to Follow-up|1
7708095|NCT00459108|12129844|FG000|Overall Study|Withdrawal by Subject|5
7708096|NCT00459108|12129844|FG000|Overall Study|Adverse Event|3
7708097|NCT00459108|12129844|FG000|Overall Study|Death|2
7708098|NCT00459108|12129844|FG000|Overall Study|Progression|1
7708099|NCT00459134|12129851|FG000|Overall Study|Physician Decision|1
7708100|NCT00459134|12129852|FG001|Overall Study|Physician Decision|1
7708101|NCT00459134|12129851|FG000|Overall Study|Withdrawal by Subject|8
7708102|NCT00459134|12129852|FG001|Overall Study|Withdrawal by Subject|7
7708103|NCT00459134|12129851|FG000|Overall Study|Lost to Follow-up|6
7708104|NCT00459134|12129852|FG001|Overall Study|Lost to Follow-up|7
7708105|NCT00459134|12129851|FG000|Overall Study|Surgery|1
7708106|NCT00459134|12129852|FG001|Overall Study|Surgery|2
7708107|NCT00459134|12129851|FG000|Overall Study|Toxicity|4
7708108|NCT00459134|12129852|FG001|Overall Study|Toxicity|5
7708109|NCT00459134|12129851|FG000|Overall Study|Progression|1
7708110|NCT00459134|12129852|FG001|Overall Study|Progression|0
7708111|NCT00459134|12129851|FG000|Overall Study|Multiple Reasons|2
7708112|NCT00459134|12129852|FG001|Overall Study|Multiple Reasons|3
7708113|NCT00459186|12129858|FG000|Single Agent RAD001|Withdrawal by Subject|1
7708114|NCT00459186|12129858|FG000|PET Imaging and Assessment|Adverse Event|3
7708115|NCT00459290|12129862|FG000|Overall Study|Adverse Event|3
7708116|NCT00459290|12129862|FG000|Overall Study|Ineligible|2
7708117|NCT00459316|12129885|FG000|Steps 1 & 2|Other eligibility failure|1
7708118|NCT00459316|12129886|FG001|Steps 1 & 2|Other eligibility failure|1
7708119|NCT00459316|12129887|FG002|Steps 1 & 2|Other eligibility failure|0
7708120|NCT00459316|12129885|FG000|Steps 1 & 2|Death|1
7708121|NCT00459316|12129886|FG001|Steps 1 & 2|Death|1
7708122|NCT00459316|12129887|FG002|Steps 1 & 2|Death|0
7708123|NCT00459316|12129885|FG000|Steps 1 & 2|Not able to get to clinic|7
7708124|NCT00459316|12129886|FG001|Steps 1 & 2|Not able to get to clinic|4
7708125|NCT00459316|12129887|FG002|Steps 1 & 2|Not able to get to clinic|0
7708126|NCT00459316|12129885|FG000|Steps 1 & 2|Withdrawal by Subject|6
7708127|NCT00459316|12129886|FG001|Steps 1 & 2|Withdrawal by Subject|1
7708128|NCT00459316|12129887|FG002|Steps 1 & 2|Withdrawal by Subject|0
7708129|NCT00459316|12129885|FG000|Steps 1 & 2|Not willing to adhere to regulations|1
7708130|NCT00459316|12129886|FG001|Steps 1 & 2|Not willing to adhere to regulations|0
7708131|NCT00459316|12129887|FG002|Steps 1 & 2|Not willing to adhere to regulations|0
7708132|NCT00459316|12129885|FG000|Steps 1 & 2|Lost to Follow-up|5
7708133|NCT00459316|12129886|FG001|Steps 1 & 2|Lost to Follow-up|0
7708134|NCT00459316|12129887|FG002|Steps 1 & 2|Lost to Follow-up|2
7708135|NCT00459316|12129885|FG000|Step 3|Withdrawal by Subject|3
7708136|NCT00459316|12129886|FG001|Step 3|Withdrawal by Subject|0
7708137|NCT00459316|12129887|FG002|Step 3|Withdrawal by Subject|1
7708138|NCT00459342|12129910|FG000|Overall Study|Not eligible|1
7708139|NCT00459355|12129916|FG000|Overall Study|Subject no longer met inc criteria|20
7708140|NCT00459355|12129917|FG001|Overall Study|Subject no longer met inc criteria|18
7708141|NCT00459537|12129942|FG000|Overall Study|Adverse Event|1
7708142|NCT00459537|12129943|FG001|Overall Study|Adverse Event|6
7708143|NCT00459537|12129942|FG000|Overall Study|Lack of Efficacy|10
7708144|NCT00459537|12129943|FG001|Overall Study|Lack of Efficacy|11
7708145|NCT00459537|12129942|FG000|Overall Study|Withdrawal by Subject|20
7708146|NCT00459537|12129943|FG001|Overall Study|Withdrawal by Subject|26
7708147|NCT00459537|12129942|FG000|Overall Study|Lost to Follow-up|27
7708148|NCT00459537|12129943|FG001|Overall Study|Lost to Follow-up|30
7708149|NCT00459537|12129942|FG000|Overall Study|Administrative problems|3
7708150|NCT00459537|12129943|FG001|Overall Study|Administrative problems|0
7708151|NCT00459537|12129942|FG000|Overall Study|Protocol Violation|4
7708152|NCT00459537|12129943|FG001|Overall Study|Protocol Violation|3
7708153|NCT00459537|12129942|FG000|Overall Study|Missing|1
7708154|NCT00459537|12129943|FG001|Overall Study|Missing|0
7708155|NCT00459667|12129952|FG000|Overall Study|Adverse Event|9
7708156|NCT00459667|12129953|FG001|Overall Study|Adverse Event|12
7708157|NCT00459667|12129954|FG002|Overall Study|Adverse Event|8
7708158|NCT00459667|12129952|FG000|Overall Study|Lost to Follow-up|5
7708159|NCT00459667|12129953|FG001|Overall Study|Lost to Follow-up|9
7708160|NCT00459667|12129954|FG002|Overall Study|Lost to Follow-up|3
7708161|NCT00459667|12129952|FG000|Overall Study|Pregnancy|1
7708162|NCT00459667|12129953|FG001|Overall Study|Pregnancy|1
7708163|NCT00459667|12129954|FG002|Overall Study|Pregnancy|1
7708164|NCT00459667|12129952|FG000|Overall Study|Protocol Violation|1
7708165|NCT00459667|12129953|FG001|Overall Study|Protocol Violation|0
7708166|NCT00459667|12129954|FG002|Overall Study|Protocol Violation|0
7708167|NCT00459667|12129952|FG000|Overall Study|Withdrawal by Subject|3
7708168|NCT00459667|12129953|FG001|Overall Study|Withdrawal by Subject|5
7708169|NCT00459667|12129954|FG002|Overall Study|Withdrawal by Subject|5
7708170|NCT00459667|12129952|FG000|Overall Study|Other disease modifying treatment|1
7708171|NCT00459667|12129953|FG001|Overall Study|Other disease modifying treatment|2
7708172|NCT00459667|12129954|FG002|Overall Study|Other disease modifying treatment|1
7708173|NCT00459667|12129952|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12
7708174|NCT00459667|12129953|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15
7708175|NCT00459667|12129954|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1
7708176|NCT00459667|12129952|FG000|Overall Study|No treatment administered|6
7708177|NCT00459667|12129953|FG001|Overall Study|No treatment administered|3
7708178|NCT00459667|12129954|FG002|Overall Study|No treatment administered|1
7708179|NCT00459706|12129964|FG000|Overall Study|Adverse Event|19
7708180|NCT00459706|12129965|FG001|Overall Study|Adverse Event|13
7708181|NCT00459706|12129964|FG000|Overall Study|Withdrawal by Subject|1
7708182|NCT00459706|12129965|FG001|Overall Study|Withdrawal by Subject|6
7708183|NCT00459706|12129964|FG000|Overall Study|Physician Decision|2
7708184|NCT00459706|12129965|FG001|Overall Study|Physician Decision|0
7708185|NCT00459706|12129964|FG000|Overall Study|Discontinuation of Study by Sponsor|1
7708186|NCT00459706|12129965|FG001|Overall Study|Discontinuation of Study by Sponsor|0
7708187|NCT00459706|12129964|FG000|Overall Study|Protocol Violation|2
7708188|NCT00459706|12129965|FG001|Overall Study|Protocol Violation|1
7708189|NCT00459706|12129964|FG000|Overall Study|Failed to Return|1
7708190|NCT00459706|12129965|FG001|Overall Study|Failed to Return|0
7708191|NCT00459706|12129964|FG000|Overall Study|Other|0
7708192|NCT00459706|12129965|FG001|Overall Study|Other|1
7708193|NCT00459875|12129988|FG000|Overall Study|Ineligible participant|1
7708194|NCT00459875|12129988|FG000|Overall Study|Adverse Event|2
7708195|NCT00459953|12129994|FG000|Overall Study|not analyzed-household member in study|1
7708196|NCT00459953|12129995|FG001|Overall Study|not analyzed-household member in study|1
7708197|NCT00459979|12130001|FG000|Overall Study|Withdrawal by Subject|1
7708198|NCT00459979|12130001|FG000|Overall Study|Protocol Violation|1
7708199|NCT00460031|12130005|FG000|Overall Study|Adverse Event|5
7708200|NCT00460031|12130005|FG000|Overall Study|Withdrawal by Subject|5
7708201|NCT00460031|12130005|FG000|Overall Study|Death|1
7708202|NCT00460109|12130009|FG000|Overall Study|Death|1
7708203|NCT00460239|12130013|FG000|Overall Study|Physician Decision|0
7708204|NCT00460239|12130014|FG001|Overall Study|Physician Decision|1
7708205|NCT00460239|12130015|FG002|Overall Study|Physician Decision|0
7708206|NCT00460239|12130016|FG003|Overall Study|Physician Decision|0
7708207|NCT00460239|12130017|FG004|Overall Study|Physician Decision|0
7708208|NCT00460239|12130018|FG005|Overall Study|Physician Decision|2
7708209|NCT00460239|12130019|FG006|Overall Study|Physician Decision|0
7708210|NCT00460239|12130020|FG007|Overall Study|Physician Decision|0
7708211|NCT00460239|12130021|FG008|Overall Study|Physician Decision|0
7708212|NCT00460239|12130013|FG000|Overall Study|Withdrawal by Subject|0
7708213|NCT00460239|12130014|FG001|Overall Study|Withdrawal by Subject|0
7708214|NCT00460239|12130015|FG002|Overall Study|Withdrawal by Subject|0
7708215|NCT00460239|12130016|FG003|Overall Study|Withdrawal by Subject|0
7708216|NCT00460239|12130017|FG004|Overall Study|Withdrawal by Subject|0
7708217|NCT00460239|12130018|FG005|Overall Study|Withdrawal by Subject|1
7708218|NCT00460239|12130019|FG006|Overall Study|Withdrawal by Subject|0
7708219|NCT00460239|12130020|FG007|Overall Study|Withdrawal by Subject|0
7708220|NCT00460239|12130021|FG008|Overall Study|Withdrawal by Subject|0
7708221|NCT00460265|12130036|FG000|Overall Study|Lost to Follow-up|14
7708222|NCT00460265|12130037|FG001|Overall Study|Lost to Follow-up|15
7708223|NCT00460265|12130036|FG000|Overall Study|Physician Decision|1
7708224|NCT00460265|12130037|FG001|Overall Study|Physician Decision|2
7708225|NCT00460265|12130036|FG000|Overall Study|Withdrawal by Subject|10
7708226|NCT00460265|12130037|FG001|Overall Study|Withdrawal by Subject|25
7708227|NCT00460265|12130036|FG000|Overall Study|Ongoing|60
7708228|NCT00460265|12130037|FG001|Overall Study|Ongoing|47
7708229|NCT00460408|12130047|FG000|Overall Study|Adverse Event|1
7708230|NCT00460408|12130048|FG001|Overall Study|Adverse Event|0
7708231|NCT00460408|12130049|FG002|Overall Study|Adverse Event|0
7708232|NCT00460408|12130050|FG003|Overall Study|Adverse Event|0
7708233|NCT00460408|12130047|FG000|Overall Study|Death|7
7708234|NCT00460408|12130048|FG001|Overall Study|Death|0
7708235|NCT00460408|12130049|FG002|Overall Study|Death|0
7708236|NCT00460408|12130050|FG003|Overall Study|Death|0
7708237|NCT00460408|12130047|FG000|Overall Study|Lost to Follow-up|11
7708238|NCT00460408|12130048|FG001|Overall Study|Lost to Follow-up|0
7708239|NCT00460408|12130049|FG002|Overall Study|Lost to Follow-up|1
7708240|NCT00460408|12130050|FG003|Overall Study|Lost to Follow-up|0
7708241|NCT00460408|12130047|FG000|Overall Study|Withdrawal by Subject|31
7708242|NCT00460408|12130048|FG001|Overall Study|Withdrawal by Subject|0
7708243|NCT00460408|12130049|FG002|Overall Study|Withdrawal by Subject|0
7708244|NCT00460408|12130050|FG003|Overall Study|Withdrawal by Subject|0
7708245|NCT00460408|12130047|FG000|Overall Study|Insufficient clinical response|5
7708246|NCT00460408|12130048|FG001|Overall Study|Insufficient clinical response|1
7708247|NCT00460408|12130049|FG002|Overall Study|Insufficient clinical response|5
7708248|NCT00460408|12130050|FG003|Overall Study|Insufficient clinical response|0
7708249|NCT00460408|12130047|FG000|Overall Study|Other|12
7708250|NCT00460408|12130048|FG001|Overall Study|Other|2
7708251|NCT00460408|12130049|FG002|Overall Study|Other|0
7708252|NCT00460408|12130050|FG003|Overall Study|Other|0
7708253|NCT00460434|12130074|FG000|Overall Study|Lost to Follow-up|3
7708254|NCT00460434|12130075|FG001|Overall Study|Lost to Follow-up|7
7708255|NCT00460564|12130098|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3
7708256|NCT00460564|12130099|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1
7708257|NCT00460564|12130100|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0
7708258|NCT00460564|12130101|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0
7708259|NCT00460564|12130102|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0
7708260|NCT00460564|12130103|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0
7708261|NCT00460564|12130104|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0
7708262|NCT00460564|12130105|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0
7708263|NCT00460564|12130098|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
7708264|NCT00460564|12130099|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7708265|NCT00460564|12130100|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7708266|NCT00460564|12130101|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7708267|NCT00460564|12130102|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7708268|NCT00460564|12130103|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7708269|NCT00460564|12130104|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7708270|NCT00460564|12130105|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7708271|NCT00460564|12130098|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0
7708272|NCT00460564|12130099|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0
7708273|NCT00460564|12130100|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0
7708274|NCT00460564|12130101|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0
7708275|NCT00460564|12130102|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3
7708276|NCT00460564|12130103|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5
7708277|NCT00460564|12130104|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2
7708278|NCT00460564|12130105|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0
7708279|NCT00460564|12130098|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7708280|NCT00460564|12130099|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7708281|NCT00460564|12130100|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7708282|NCT00460564|12130101|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7708283|NCT00460564|12130102|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
7708284|NCT00460564|12130103|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
7708285|NCT00460564|12130104|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7708286|NCT00460564|12130105|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7708287|NCT00460564|12130098|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7708288|NCT00460564|12130099|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7708289|NCT00460564|12130100|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7708290|NCT00460564|12130101|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7708291|NCT00460564|12130102|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
7708292|NCT00460564|12130103|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7708293|NCT00460564|12130104|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7708294|NCT00460564|12130105|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7708295|NCT00460577|12130127|FG000|Overall Study|Protocol Violation|2
7708296|NCT00460577|12130128|FG001|Overall Study|Protocol Violation|6
7708297|NCT00460603|12130146|FG000|Phase 1|Death|1
7708298|NCT00460603|12130147|FG001|Phase 1|Death|0
7708299|NCT00460603|12130148|FG002|Phase 1|Death|0
7708300|NCT00460603|12130149|FG003|Phase 1|Death|2
7708301|NCT00460603|12130150|FG004|Phase 1|Death|0
7708302|NCT00460603|12130151|FG005|Phase 1|Death|0
7708303|NCT00460603|12130152|FG006|Phase 1|Death|0
7708304|NCT00460603|12130153|FG007|Phase 1|Death|0
7708305|NCT00460603|12130154|FG008|Phase 1|Death|1
7708306|NCT00460603|12130155|FG009|Phase 1|Death|0
7708307|NCT00460603|12130156|FG010|Phase 1|Death|0
7708308|NCT00460603|12130157|FG011|Phase 1|Death|0
7708309|NCT00460603|12130146|FG000|Phase 1|Adverse Event|3
7708310|NCT00460603|12130147|FG001|Phase 1|Adverse Event|1
7708311|NCT00460603|12130148|FG002|Phase 1|Adverse Event|1
7708312|NCT00460603|12130149|FG003|Phase 1|Adverse Event|2
7708313|NCT00460603|12130150|FG004|Phase 1|Adverse Event|0
7708314|NCT00460603|12130151|FG005|Phase 1|Adverse Event|0
7708315|NCT00460603|12130152|FG006|Phase 1|Adverse Event|3
7708316|NCT00460603|12130153|FG007|Phase 1|Adverse Event|0
7708317|NCT00460603|12130154|FG008|Phase 1|Adverse Event|4
7708318|NCT00460603|12130155|FG009|Phase 1|Adverse Event|0
7708319|NCT00460603|12130156|FG010|Phase 1|Adverse Event|0
7708320|NCT00460603|12130157|FG011|Phase 1|Adverse Event|0
7708321|NCT00460603|12130146|FG000|Phase 1|Lack of Efficacy|1
7708322|NCT00460603|12130147|FG001|Phase 1|Lack of Efficacy|0
7708323|NCT00460603|12130148|FG002|Phase 1|Lack of Efficacy|1
7708324|NCT00460603|12130149|FG003|Phase 1|Lack of Efficacy|2
7708325|NCT00460603|12130150|FG004|Phase 1|Lack of Efficacy|2
7708326|NCT00460603|12130151|FG005|Phase 1|Lack of Efficacy|2
7708327|NCT00460603|12130152|FG006|Phase 1|Lack of Efficacy|2
7708328|NCT00460603|12130153|FG007|Phase 1|Lack of Efficacy|2
7708329|NCT00460603|12130154|FG008|Phase 1|Lack of Efficacy|11
7708330|NCT00460603|12130155|FG009|Phase 1|Lack of Efficacy|0
7708331|NCT00460603|12130156|FG010|Phase 1|Lack of Efficacy|0
7708332|NCT00460603|12130157|FG011|Phase 1|Lack of Efficacy|0
7708333|NCT00460603|12130146|FG000|Phase 1|Withdrawal by Subject|1
7708334|NCT00460603|12130147|FG001|Phase 1|Withdrawal by Subject|2
7708335|NCT00460603|12130148|FG002|Phase 1|Withdrawal by Subject|1
7708336|NCT00460603|12130149|FG003|Phase 1|Withdrawal by Subject|1
7708337|NCT00460603|12130150|FG004|Phase 1|Withdrawal by Subject|3
7708338|NCT00460603|12130151|FG005|Phase 1|Withdrawal by Subject|0
7708339|NCT00460603|12130152|FG006|Phase 1|Withdrawal by Subject|1
7708340|NCT00460603|12130153|FG007|Phase 1|Withdrawal by Subject|0
7708341|NCT00460603|12130154|FG008|Phase 1|Withdrawal by Subject|2
7708342|NCT00460603|12130155|FG009|Phase 1|Withdrawal by Subject|0
7708343|NCT00460603|12130156|FG010|Phase 1|Withdrawal by Subject|0
7708344|NCT00460603|12130157|FG011|Phase 1|Withdrawal by Subject|0
7708345|NCT00460603|12130146|FG000|Phase 1|Other|0
7708346|NCT00460603|12130147|FG001|Phase 1|Other|3
7708347|NCT00460603|12130148|FG002|Phase 1|Other|1
7708348|NCT00460603|12130149|FG003|Phase 1|Other|1
7708349|NCT00460603|12130150|FG004|Phase 1|Other|1
7708350|NCT00460603|12130151|FG005|Phase 1|Other|2
7708351|NCT00460603|12130152|FG006|Phase 1|Other|0
7708352|NCT00460603|12130153|FG007|Phase 1|Other|1
7708353|NCT00460603|12130154|FG008|Phase 1|Other|0
7708354|NCT00460603|12130155|FG009|Phase 1|Other|0
7708355|NCT00460603|12130156|FG010|Phase 1|Other|0
7708356|NCT00460603|12130157|FG011|Phase 1|Other|0
7708357|NCT00460603|12130146|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7708358|NCT00460603|12130147|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7708359|NCT00460603|12130148|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7708360|NCT00460603|12130149|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7708361|NCT00460603|12130150|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7708362|NCT00460603|12130151|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7708363|NCT00460603|12130152|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7708364|NCT00460603|12130153|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7708365|NCT00460603|12130154|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7708366|NCT00460603|12130155|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
7708367|NCT00460603|12130156|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7708368|NCT00460603|12130157|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7708369|NCT00460603|12130146|FG000|Phase 2|Adverse Event|0
7708370|NCT00460603|12130147|FG001|Phase 2|Adverse Event|0
7708371|NCT00460603|12130148|FG002|Phase 2|Adverse Event|0
7708372|NCT00460603|12130149|FG003|Phase 2|Adverse Event|0
7708373|NCT00460603|12130150|FG004|Phase 2|Adverse Event|0
7708374|NCT00460603|12130151|FG005|Phase 2|Adverse Event|0
7708375|NCT00460603|12130152|FG006|Phase 2|Adverse Event|0
7708376|NCT00460603|12130153|FG007|Phase 2|Adverse Event|0
7708377|NCT00460603|12130154|FG008|Phase 2|Adverse Event|0
7708378|NCT00460603|12130155|FG009|Phase 2|Adverse Event|12
7708379|NCT00460603|12130156|FG010|Phase 2|Adverse Event|9
7708380|NCT00460603|12130157|FG011|Phase 2|Adverse Event|10
7708381|NCT00460603|12130146|FG000|Phase 2|Death|0
7708382|NCT00460603|12130147|FG001|Phase 2|Death|0
7708383|NCT00460603|12130148|FG002|Phase 2|Death|0
7708384|NCT00460603|12130149|FG003|Phase 2|Death|0
7708385|NCT00460603|12130150|FG004|Phase 2|Death|0
7708386|NCT00460603|12130151|FG005|Phase 2|Death|0
7708387|NCT00460603|12130152|FG006|Phase 2|Death|0
7708388|NCT00460603|12130153|FG007|Phase 2|Death|0
7708389|NCT00460603|12130154|FG008|Phase 2|Death|0
7708390|NCT00460603|12130155|FG009|Phase 2|Death|4
7708391|NCT00460603|12130156|FG010|Phase 2|Death|2
7708392|NCT00460603|12130157|FG011|Phase 2|Death|2
7708393|NCT00460603|12130146|FG000|Phase 2|Protocol Violation|0
7708394|NCT00460603|12130147|FG001|Phase 2|Protocol Violation|0
7708395|NCT00460603|12130148|FG002|Phase 2|Protocol Violation|0
7708396|NCT00460603|12130149|FG003|Phase 2|Protocol Violation|0
7708397|NCT00460603|12130150|FG004|Phase 2|Protocol Violation|0
7708398|NCT00460603|12130151|FG005|Phase 2|Protocol Violation|0
7708399|NCT00460603|12130152|FG006|Phase 2|Protocol Violation|0
7708400|NCT00460603|12130153|FG007|Phase 2|Protocol Violation|0
7708401|NCT00460603|12130154|FG008|Phase 2|Protocol Violation|0
7708402|NCT00460603|12130155|FG009|Phase 2|Protocol Violation|1
7708403|NCT00460603|12130156|FG010|Phase 2|Protocol Violation|1
7708404|NCT00460603|12130157|FG011|Phase 2|Protocol Violation|0
7708405|NCT00460603|12130146|FG000|Phase 2|Lost to Follow-up|0
7708406|NCT00460603|12130147|FG001|Phase 2|Lost to Follow-up|0
7708407|NCT00460603|12130148|FG002|Phase 2|Lost to Follow-up|0
7708408|NCT00460603|12130149|FG003|Phase 2|Lost to Follow-up|0
7708409|NCT00460603|12130150|FG004|Phase 2|Lost to Follow-up|0
7708410|NCT00460603|12130151|FG005|Phase 2|Lost to Follow-up|0
7708411|NCT00460603|12130152|FG006|Phase 2|Lost to Follow-up|0
7708412|NCT00460603|12130153|FG007|Phase 2|Lost to Follow-up|0
7708413|NCT00460603|12130154|FG008|Phase 2|Lost to Follow-up|0
7708414|NCT00460603|12130155|FG009|Phase 2|Lost to Follow-up|1
7708415|NCT00460603|12130156|FG010|Phase 2|Lost to Follow-up|0
7708416|NCT00460603|12130157|FG011|Phase 2|Lost to Follow-up|0
7708417|NCT00460603|12130146|FG000|Phase 2|Other|0
7708418|NCT00460603|12130147|FG001|Phase 2|Other|0
7708419|NCT00460603|12130148|FG002|Phase 2|Other|0
7708420|NCT00460603|12130149|FG003|Phase 2|Other|0
7708421|NCT00460603|12130150|FG004|Phase 2|Other|0
7708422|NCT00460603|12130151|FG005|Phase 2|Other|0
7708423|NCT00460603|12130152|FG006|Phase 2|Other|0
7708424|NCT00460603|12130153|FG007|Phase 2|Other|0
7708425|NCT00460603|12130154|FG008|Phase 2|Other|0
7708426|NCT00460603|12130155|FG009|Phase 2|Other|6
7708427|NCT00460603|12130156|FG010|Phase 2|Other|16
7708428|NCT00460603|12130157|FG011|Phase 2|Other|7
7708429|NCT00460603|12130146|FG000|Phase 2|Objective Progression or Relapse|0
7708430|NCT00460603|12130147|FG001|Phase 2|Objective Progression or Relapse|0
7708431|NCT00460603|12130148|FG002|Phase 2|Objective Progression or Relapse|0
7708432|NCT00460603|12130149|FG003|Phase 2|Objective Progression or Relapse|0
7708433|NCT00460603|12130150|FG004|Phase 2|Objective Progression or Relapse|0
7708434|NCT00460603|12130151|FG005|Phase 2|Objective Progression or Relapse|0
7708435|NCT00460603|12130152|FG006|Phase 2|Objective Progression or Relapse|0
7708436|NCT00460603|12130153|FG007|Phase 2|Objective Progression or Relapse|0
7708437|NCT00460603|12130154|FG008|Phase 2|Objective Progression or Relapse|0
7708438|NCT00460603|12130155|FG009|Phase 2|Objective Progression or Relapse|9
7708439|NCT00460603|12130156|FG010|Phase 2|Objective Progression or Relapse|10
7708440|NCT00460603|12130157|FG011|Phase 2|Objective Progression or Relapse|17
7708441|NCT00460603|12130146|FG000|Phase 2|Global Deterioration of Health Status|0
7708442|NCT00460603|12130147|FG001|Phase 2|Global Deterioration of Health Status|0
7708443|NCT00460603|12130148|FG002|Phase 2|Global Deterioration of Health Status|0
7708444|NCT00460603|12130149|FG003|Phase 2|Global Deterioration of Health Status|0
7708445|NCT00460603|12130150|FG004|Phase 2|Global Deterioration of Health Status|0
7708446|NCT00460603|12130151|FG005|Phase 2|Global Deterioration of Health Status|0
7708447|NCT00460603|12130152|FG006|Phase 2|Global Deterioration of Health Status|0
7708448|NCT00460603|12130153|FG007|Phase 2|Global Deterioration of Health Status|0
7708449|NCT00460603|12130154|FG008|Phase 2|Global Deterioration of Health Status|0
7708450|NCT00460603|12130155|FG009|Phase 2|Global Deterioration of Health Status|0
7708451|NCT00460603|12130156|FG010|Phase 2|Global Deterioration of Health Status|1
7708452|NCT00460603|12130157|FG011|Phase 2|Global Deterioration of Health Status|0
7708453|NCT00460603|12130146|FG000|Phase 2|Withdrawal by Subject|0
7708454|NCT00460603|12130147|FG001|Phase 2|Withdrawal by Subject|0
7708455|NCT00460603|12130148|FG002|Phase 2|Withdrawal by Subject|0
7708456|NCT00460603|12130149|FG003|Phase 2|Withdrawal by Subject|0
7708457|NCT00460603|12130150|FG004|Phase 2|Withdrawal by Subject|0
7708458|NCT00460603|12130151|FG005|Phase 2|Withdrawal by Subject|0
7708459|NCT00460603|12130152|FG006|Phase 2|Withdrawal by Subject|0
7708460|NCT00460603|12130153|FG007|Phase 2|Withdrawal by Subject|0
7708461|NCT00460603|12130154|FG008|Phase 2|Withdrawal by Subject|0
7708462|NCT00460603|12130155|FG009|Phase 2|Withdrawal by Subject|5
7708463|NCT00460603|12130156|FG010|Phase 2|Withdrawal by Subject|4
7708464|NCT00460603|12130157|FG011|Phase 2|Withdrawal by Subject|5
7708465|NCT00460603|12130146|FG000|Phase 2|Randomized, but not treated|0
7708466|NCT00460603|12130147|FG001|Phase 2|Randomized, but not treated|0
7708467|NCT00460603|12130148|FG002|Phase 2|Randomized, but not treated|0
7708468|NCT00460603|12130149|FG003|Phase 2|Randomized, but not treated|0
7708469|NCT00460603|12130150|FG004|Phase 2|Randomized, but not treated|0
7708470|NCT00460603|12130151|FG005|Phase 2|Randomized, but not treated|0
7708471|NCT00460603|12130152|FG006|Phase 2|Randomized, but not treated|0
7708472|NCT00460603|12130153|FG007|Phase 2|Randomized, but not treated|0
7708473|NCT00460603|12130154|FG008|Phase 2|Randomized, but not treated|0
7708474|NCT00460603|12130155|FG009|Phase 2|Randomized, but not treated|3
7708475|NCT00460603|12130156|FG010|Phase 2|Randomized, but not treated|0
7708476|NCT00460603|12130157|FG011|Phase 2|Randomized, but not treated|0
7708477|NCT00460655|12130185|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3
7708478|NCT00460655|12130186|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0
7708479|NCT00460655|12130187|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0
7708480|NCT00460655|12130188|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0
7708481|NCT00460655|12130185|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
7708482|NCT00460655|12130186|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7708483|NCT00460655|12130187|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7708484|NCT00460655|12130188|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7708485|NCT00460655|12130185|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0
7708486|NCT00460655|12130186|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1
7708487|NCT00460655|12130187|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0
7708488|NCT00460655|12130188|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0
7708489|NCT00460655|12130185|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0
7708490|NCT00460655|12130186|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0
7708491|NCT00460655|12130187|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1
7708492|NCT00460655|12130188|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6
7708493|NCT00460655|12130185|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7708494|NCT00460655|12130186|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7708495|NCT00460655|12130187|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
7708496|NCT00460655|12130188|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
7708497|NCT00460655|12130185|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
7708498|NCT00460655|12130186|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
7708499|NCT00460655|12130187|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
7708500|NCT00460655|12130188|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
7708501|NCT00460746|12130198|FG000|Overall Study|Adverse Event|1
7708502|NCT00460746|12130198|FG000|Overall Study|Lost to Follow-up|1
7708503|NCT00460798|12130202|FG000|Overall Study|Death|59
7708504|NCT00460798|12130202|FG000|Overall Study|Adverse Event|27
7708505|NCT00460798|12130202|FG000|Overall Study|Lost to Follow-up|19
7708506|NCT00460798|12130202|FG000|Overall Study|Progressive Disease|99
7708507|NCT00460798|12130202|FG000|Overall Study|Other|27
7708508|NCT00460798|12130202|FG000|Overall Study|Ongoing at Date of Cut-Off|82
7708509|NCT00460798|12130202|FG000|Overall Study|Missing/Incomplete Dosing Information|27
7708510|NCT00460811|12130211|FG000|Overall Study|Adverse Event|4
7708511|NCT00460811|12130212|FG001|Overall Study|Adverse Event|6
7708512|NCT00460811|12130213|FG002|Overall Study|Adverse Event|3
7708513|NCT00460811|12130214|FG003|Overall Study|Adverse Event|10
7708514|NCT00460811|12130215|FG004|Overall Study|Adverse Event|2
7708515|NCT00460811|12130211|FG000|Overall Study|Noncompliance|1
7708516|NCT00460811|12130212|FG001|Overall Study|Noncompliance|0
7708517|NCT00460811|12130213|FG002|Overall Study|Noncompliance|0
7708518|NCT00460811|12130214|FG003|Overall Study|Noncompliance|2
7708519|NCT00460811|12130215|FG004|Overall Study|Noncompliance|1
7708520|NCT00460811|12130211|FG000|Overall Study|Withdrawal by Subject|7
7708521|NCT00460811|12130212|FG001|Overall Study|Withdrawal by Subject|7
7708522|NCT00460811|12130213|FG002|Overall Study|Withdrawal by Subject|6
7708523|NCT00460811|12130214|FG003|Overall Study|Withdrawal by Subject|3
7708524|NCT00460811|12130215|FG004|Overall Study|Withdrawal by Subject|11
7708525|NCT00460811|12130211|FG000|Overall Study|Physician Decision|1
7708526|NCT00460811|12130212|FG001|Overall Study|Physician Decision|0
7708527|NCT00460811|12130213|FG002|Overall Study|Physician Decision|0
7708528|NCT00460811|12130214|FG003|Overall Study|Physician Decision|0
7708529|NCT00460811|12130215|FG004|Overall Study|Physician Decision|0
7708530|NCT00460811|12130211|FG000|Overall Study|Lost to Follow-up|3
7708531|NCT00460811|12130212|FG001|Overall Study|Lost to Follow-up|2
7708532|NCT00460811|12130213|FG002|Overall Study|Lost to Follow-up|5
7708533|NCT00460811|12130214|FG003|Overall Study|Lost to Follow-up|3
7708534|NCT00460811|12130215|FG004|Overall Study|Lost to Follow-up|6
7708535|NCT00461123|12130257|FG000|Overall Study|Adverse Event|1
7708536|NCT00461123|12130258|FG001|Overall Study|Adverse Event|0
7708537|NCT00461123|12130257|FG000|Overall Study|Lost to Follow-up|1
7708538|NCT00461123|12130258|FG001|Overall Study|Lost to Follow-up|1
7708539|NCT00461123|12130257|FG000|Overall Study|Protocol Violation|3
7708540|NCT00461123|12130258|FG001|Overall Study|Protocol Violation|2
7708541|NCT00461123|12130257|FG000|Overall Study|Withdrawal by Subject|1
7708542|NCT00461123|12130258|FG001|Overall Study|Withdrawal by Subject|3
7708543|NCT00461175|12130266|FG000|Overall Study|Protocol Violation|522
7708544|NCT00461175|12130267|FG001|Overall Study|Protocol Violation|365
7708545|NCT00461253|12130275|FG000|Overall Study|Death|985
7708546|NCT00461253|12130276|FG001|Overall Study|Death|0
7708547|NCT00461253|12130275|FG000|Overall Study|Protocol Violation|613
7708548|NCT00461253|12130276|FG001|Overall Study|Protocol Violation|236
7708549|NCT00461253|12130275|FG000|Overall Study|no response|2609
7708550|NCT00461253|12130276|FG001|Overall Study|no response|11789
7708551|NCT00461253|12130275|FG000|Overall Study|administrative|773
7708552|NCT00461253|12130276|FG001|Overall Study|administrative|7773
7708553|NCT00461305|12130297|FG000|Treatment|Adverse Event|26
7708554|NCT00461305|12130298|FG001|Treatment|Adverse Event|3
7708555|NCT00461305|12130297|FG000|Treatment|Lost to Follow-up|4
7708556|NCT00461305|12130298|FG001|Treatment|Lost to Follow-up|2
7708557|NCT00461305|12130297|FG000|Treatment|Protocol Violation|13
7708558|NCT00461305|12130298|FG001|Treatment|Protocol Violation|2
7708559|NCT00461305|12130297|FG000|Treatment|Withdrawal by Subject|48
7708560|NCT00461305|12130298|FG001|Treatment|Withdrawal by Subject|2
7708561|NCT00461305|12130297|FG000|Treatment|Never dispensed|5
7708562|NCT00461305|12130298|FG001|Treatment|Never dispensed|0
7708563|NCT00461305|12130297|FG000|Treatment|Study drug not taken|1
7708564|NCT00461305|12130298|FG001|Treatment|Study drug not taken|0
7708565|NCT00461305|12130297|FG000|Treatment|Partially missing diary|2
7708566|NCT00461305|12130298|FG001|Treatment|Partially missing diary|0
7708567|NCT00461305|12130297|FG000|Treatment|Other (missing drug etc)|2
7708568|NCT00461305|12130298|FG001|Treatment|Other (missing drug etc)|0
7708569|NCT00461305|12130297|FG000|Continued Treatment|Adverse Event|26
7708570|NCT00461305|12130298|FG001|Continued Treatment|Adverse Event|0
7708571|NCT00461305|12130297|FG000|Continued Treatment|Lost to Follow-up|4
7708572|NCT00461305|12130298|FG001|Continued Treatment|Lost to Follow-up|0
7708573|NCT00461305|12130297|FG000|Continued Treatment|Protocol Violation|13
7708574|NCT00461305|12130298|FG001|Continued Treatment|Protocol Violation|0
7708575|NCT00461305|12130297|FG000|Continued Treatment|Withdrawal by Subject|48
7708576|NCT00461305|12130298|FG001|Continued Treatment|Withdrawal by Subject|0
7708577|NCT00461305|12130297|FG000|Continued Treatment|Partially missing diary|2
7708578|NCT00461305|12130298|FG001|Continued Treatment|Partially missing diary|0
7708579|NCT00461305|12130297|FG000|Continued Treatment|Other (missing drug etc)|2
7708580|NCT00461305|12130298|FG001|Continued Treatment|Other (missing drug etc)|0
7708581|NCT00461500|12130315|FG000|Overall Study|Adverse Event|1
7708582|NCT00461500|12130316|FG001|Overall Study|Adverse Event|0
7708583|NCT00461500|12130315|FG000|Overall Study|Lack of Efficacy|0
7708584|NCT00461500|12130316|FG001|Overall Study|Lack of Efficacy|1
7708585|NCT00461500|12130315|FG000|Overall Study|Expired Drug Treatment|1
7708586|NCT00461500|12130316|FG001|Overall Study|Expired Drug Treatment|1
7708587|NCT00461500|12130315|FG000|Overall Study|Study Stopped|1
7708588|NCT00461500|12130316|FG001|Overall Study|Study Stopped|2
7708589|NCT00461500|12130315|FG000|Overall Study|Drug Treatment Misuse|1
7708590|NCT00461500|12130316|FG001|Overall Study|Drug Treatment Misuse|0
7708591|NCT00461500|12130315|FG000|Overall Study|No Longer Willing to Take Part in Study|1
7708592|NCT00461500|12130316|FG001|Overall Study|No Longer Willing to Take Part in Study|0
7708593|NCT00461500|12130315|FG000|Overall Study|Lost to Follow-up|2
7708594|NCT00461500|12130316|FG001|Overall Study|Lost to Follow-up|2
7708595|NCT00461552|12130337|FG000|Overall Study|Drug Dispensing error|0
7708596|NCT00461552|12130338|FG001|Overall Study|Drug Dispensing error|2
7708597|NCT00461630|12130355|FG000|Overall Study|Death|798
7708598|NCT00461630|12130356|FG001|Overall Study|Death|732
7708599|NCT00461630|12130355|FG000|Overall Study|Lost to Follow-up|108
7708600|NCT00461630|12130356|FG001|Overall Study|Lost to Follow-up|95
7708601|NCT00461708|12130364|FG000|Overall Study|Adverse Event|17
7708602|NCT00461708|12130365|FG001|Overall Study|Adverse Event|7
7708603|NCT00461708|12130364|FG000|Overall Study|Lack of Efficacy|68
7708604|NCT00461708|12130365|FG001|Overall Study|Lack of Efficacy|20
7708605|NCT00461708|12130364|FG000|Overall Study|Physician Decision|10
7708606|NCT00461708|12130365|FG001|Overall Study|Physician Decision|4
7708607|NCT00461708|12130364|FG000|Overall Study|Withdrawal by Subject|8
7708608|NCT00461708|12130365|FG001|Overall Study|Withdrawal by Subject|2
7708609|NCT00461708|12130364|FG000|Overall Study|Other|4
7708610|NCT00461708|12130365|FG001|Overall Study|Other|4
7708611|NCT00461708|12130364|FG000|Overall Study|Death|8
7708612|NCT00461708|12130365|FG001|Overall Study|Death|1
7708613|NCT00461786|12130397|FG000|Overall Study|Entry Criteria Not Met|2
7708614|NCT00461786|12130397|FG000|Overall Study|Inevaluable (Never Treated)|1
7708615|NCT00461981|12130407|FG000|Overall Study|Lost to Follow-up|9
7708616|NCT00461981|12130408|FG001|Overall Study|Lost to Follow-up|6
7708617|NCT00461981|12130407|FG000|Overall Study|Withdrawal by Subject|2
7708618|NCT00461981|12130408|FG001|Overall Study|Withdrawal by Subject|3
7708619|NCT00462306|12130473|FG000|Overall Study|insufficient data|0
7708620|NCT00462306|12130474|FG001|Overall Study|insufficient data|13
7708621|NCT00462345|12130493|FG000|Overall Study|Withdrawal by Subject|2
7708622|NCT00462345|12130493|FG000|Overall Study|Did not complete second course|1
7708623|NCT00462384|12130497|FG000|Overall Study|Adverse Event|2
7708624|NCT00462384|12130497|FG000|Overall Study|Death|2
7708625|NCT00462384|12130497|FG000|Overall Study|Withdrawal by Subject|1
7708626|NCT00462384|12130497|FG000|Overall Study|Other|4
7708627|NCT00462462|12130517|FG000|Overall Study|Physician Decision|0
7708628|NCT00462462|12130518|FG001|Overall Study|Physician Decision|1
7708629|NCT00462488|12130528|FG000|Overall Study|Protocol Violation|1
7708630|NCT00462488|12130529|FG001|Overall Study|Protocol Violation|0
7708631|NCT00462488|12130528|FG000|Overall Study|Lack of Efficacy|19
7708632|NCT00462488|12130529|FG001|Overall Study|Lack of Efficacy|17
7708633|NCT00462501|12130535|FG000|Overall Study|Not treated|3
7708634|NCT00462501|12130535|FG000|Overall Study|Adverse Event|2
7708635|NCT00462670|12130554|FG000|Overall Study|Adverse Event|3
7708636|NCT00462670|12130555|FG001|Overall Study|Adverse Event|5
7708637|NCT00462670|12130554|FG000|Overall Study|Lack of Efficacy|1
7708638|NCT00462670|12130555|FG001|Overall Study|Lack of Efficacy|0
7708639|NCT00462670|12130554|FG000|Overall Study|Protocol Violation|1
7708640|NCT00462670|12130555|FG001|Overall Study|Protocol Violation|0
7708641|NCT00462670|12130554|FG000|Overall Study|Resolution of signs and symptoms|0
7708642|NCT00462670|12130555|FG001|Overall Study|Resolution of signs and symptoms|2
7708643|NCT00462709|12130561|FG000|Overall Study|Transitioned to commercial C1INH-nf|40
7708644|NCT00462709|12130561|FG000|Overall Study|Lost to Follow-up|10
7708645|NCT00462709|12130561|FG000|Overall Study|Withdrawal by Subject|8
7708646|NCT00462709|12130561|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
7708647|NCT00462709|12130561|FG000|Overall Study|Death|2
7708648|NCT00462709|12130561|FG000|Overall Study|Logistical reasons|2
7708649|NCT00462709|12130561|FG000|Overall Study|Physician Decision|1
7708650|NCT00462709|12130561|FG000|Overall Study|Withdrew to start treatment with Cetor|1
7708651|NCT00462761|12130583|FG000|Overall Study|Adverse Event|6
7708652|NCT00462761|12130583|FG000|Overall Study|Withdrawal by Subject|9
7708653|NCT00462761|12130583|FG000|Overall Study|Physician Decision|5
7708654|NCT00462761|12130583|FG000|Overall Study|Disease progression|43
7708655|NCT00462761|12130583|FG000|Overall Study|Death|12
7708656|NCT00462761|12130583|FG000|Overall Study|Other|1
7708657|NCT00462826|12130615|FG000|Overall Study|Ineligible - second primary|1
7708658|NCT00462826|12130615|FG000|Overall Study|Ineligible - wrong cell type|1
7708659|NCT00462826|12130615|FG000|Overall Study|Ineligible - wrong primary|2
7708660|NCT00462826|12130615|FG000|Overall Study|Never treated|1
7708661|NCT00462865|12130634|FG000|Overall Study|Adverse Event|1
7708662|NCT00462982|12130655|FG000|Overall Study|Adverse Event|1
7708663|NCT00462982|12130655|FG000|Overall Study|Patient Not Treated|2
7708664|NCT00463047|12130659|FG000|Titration Period 1|Adverse Event|10
7708665|NCT00463047|12130660|FG001|Titration Period 1|Adverse Event|8
7708666|NCT00463047|12130659|FG000|Titration Period 1|Lack of Efficacy|10
7708667|NCT00463047|12130660|FG001|Titration Period 1|Lack of Efficacy|4
7708668|NCT00463047|12130659|FG000|Titration Period 1|Lost to Follow-up|2
7708669|NCT00463047|12130660|FG001|Titration Period 1|Lost to Follow-up|0
7708670|NCT00463047|12130659|FG000|Titration Period 1|Non-compliance with study medication|3
7708671|NCT00463047|12130660|FG001|Titration Period 1|Non-compliance with study medication|5
7708672|NCT00463047|12130659|FG000|Titration Period 1|Protocol Violation|5
7708673|NCT00463047|12130660|FG001|Titration Period 1|Protocol Violation|5
7708674|NCT00463047|12130659|FG000|Titration Period 1|Withdrawal by Subject|3
7708675|NCT00463047|12130660|FG001|Titration Period 1|Withdrawal by Subject|5
7708676|NCT00463047|12130659|FG000|Titration Period 1|Non-compliance procedures|4
7708677|NCT00463047|12130660|FG001|Titration Period 1|Non-compliance procedures|10
7708678|NCT00463047|12130659|FG000|Titration Period 1|Other|0
7708679|NCT00463047|12130660|FG001|Titration Period 1|Other|2
7708680|NCT00463047|12130659|FG000|Titration Period 2|Adverse Event|9
7708681|NCT00463047|12130660|FG001|Titration Period 2|Adverse Event|9
7708682|NCT00463047|12130659|FG000|Titration Period 2|Lack of Efficacy|6
7708683|NCT00463047|12130660|FG001|Titration Period 2|Lack of Efficacy|4
7708684|NCT00463047|12130659|FG000|Titration Period 2|Withdrawal by Subject|1
7708685|NCT00463047|12130660|FG001|Titration Period 2|Withdrawal by Subject|0
7708686|NCT00463047|12130659|FG000|Titration Period 2|Protocol Violation|2
7708687|NCT00463047|12130660|FG001|Titration Period 2|Protocol Violation|3
7708688|NCT00463047|12130659|FG000|Titration Period 2|Lost to Follow-up|1
7708689|NCT00463047|12130660|FG001|Titration Period 2|Lost to Follow-up|2
7708690|NCT00463047|12130659|FG000|Titration Period 2|Non-compliance study medication|4
7708691|NCT00463047|12130660|FG001|Titration Period 2|Non-compliance study medication|2
7708692|NCT00463047|12130659|FG000|Titration Period 2|Non-compliance procedures|4
7708693|NCT00463047|12130660|FG001|Titration Period 2|Non-compliance procedures|1
7708694|NCT00463047|12130659|FG000|Titration Period 2|Other|3
7708695|NCT00463047|12130660|FG001|Titration Period 2|Other|2
7708696|NCT00463047|12130659|FG000|Double-Blind Treatment Period 1|Adverse Event|0
7708697|NCT00463047|12130660|FG001|Double-Blind Treatment Period 1|Adverse Event|2
7708698|NCT00463047|12130659|FG000|Double-Blind Treatment Period 1|Protocol Violation|1
7708699|NCT00463047|12130660|FG001|Double-Blind Treatment Period 1|Protocol Violation|2
7708700|NCT00463047|12130659|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1
7708701|NCT00463047|12130660|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0
7708702|NCT00463047|12130659|FG000|Double-Blind Treatment Period 1|Other|1
7708703|NCT00463047|12130660|FG001|Double-Blind Treatment Period 1|Other|0
7708704|NCT00463047|12130659|FG000|Double-Blind Treatment Period 2|Adverse Event|0
7708705|NCT00463047|12130660|FG001|Double-Blind Treatment Period 2|Adverse Event|1
7708706|NCT00463047|12130659|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0
7708707|NCT00463047|12130660|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1
7708708|NCT00463047|12130659|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1
7708709|NCT00463047|12130660|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0
7708710|NCT00463060|12130669|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
7708711|NCT00463060|12130669|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
7708712|NCT00463151|12130682|FG000|Overall Study|Adverse Event|0
7708713|NCT00463151|12130683|FG001|Overall Study|Adverse Event|0
7708714|NCT00463151|12130684|FG002|Overall Study|Adverse Event|1
7708715|NCT00463151|12130685|FG003|Overall Study|Adverse Event|0
7708716|NCT00463151|12130682|FG000|Overall Study|Lack of Efficacy|2
7708717|NCT00463151|12130683|FG001|Overall Study|Lack of Efficacy|5
7708718|NCT00463151|12130684|FG002|Overall Study|Lack of Efficacy|2
7708719|NCT00463151|12130685|FG003|Overall Study|Lack of Efficacy|5
7708720|NCT00463151|12130682|FG000|Overall Study|Protocol Violation|0
7708721|NCT00463151|12130683|FG001|Overall Study|Protocol Violation|0
7708722|NCT00463151|12130684|FG002|Overall Study|Protocol Violation|0
7708723|NCT00463151|12130685|FG003|Overall Study|Protocol Violation|1
7708724|NCT00463151|12130682|FG000|Overall Study|Withdrawal by Subject|0
7708725|NCT00463151|12130683|FG001|Overall Study|Withdrawal by Subject|0
7708726|NCT00463151|12130684|FG002|Overall Study|Withdrawal by Subject|0
7708727|NCT00463151|12130685|FG003|Overall Study|Withdrawal by Subject|1
7708728|NCT00463229|12130697|FG000|Overall Study|Lost to Follow-up|5
7708729|NCT00463229|12130698|FG001|Overall Study|Lost to Follow-up|7
7708730|NCT00463229|12130697|FG000|Overall Study|Death|4
7708731|NCT00463229|12130698|FG001|Overall Study|Death|3
7708732|NCT00463346|12130707|FG000|Overall Study|Withdrawal by Subject|3
7708733|NCT00463346|12130708|FG001|Overall Study|Withdrawal by Subject|3
7708734|NCT00463385|12130720|FG000|Overall Study|Other|4
7708735|NCT00463385|12130721|FG001|Overall Study|Other|3
7708736|NCT00463385|12130722|FG002|Overall Study|Other|6
7708737|NCT00463385|12130723|FG003|Overall Study|Other|4
7708738|NCT00463385|12130720|FG000|Overall Study|Adverse Event|5
7708739|NCT00463385|12130721|FG001|Overall Study|Adverse Event|8
7708740|NCT00463385|12130722|FG002|Overall Study|Adverse Event|4
7708741|NCT00463385|12130723|FG003|Overall Study|Adverse Event|2
7708742|NCT00463385|12130720|FG000|Overall Study|Lack of Efficacy|6
7708743|NCT00463385|12130721|FG001|Overall Study|Lack of Efficacy|6
7708744|NCT00463385|12130722|FG002|Overall Study|Lack of Efficacy|7
7708745|NCT00463385|12130723|FG003|Overall Study|Lack of Efficacy|9
7708746|NCT00463385|12130720|FG000|Overall Study|Withdrawal by Subject|3
7708747|NCT00463385|12130721|FG001|Overall Study|Withdrawal by Subject|3
7708748|NCT00463385|12130722|FG002|Overall Study|Withdrawal by Subject|3
7708749|NCT00463385|12130723|FG003|Overall Study|Withdrawal by Subject|4
7708750|NCT00463385|12130720|FG000|Overall Study|Lost to Follow-up|0
7708751|NCT00463385|12130721|FG001|Overall Study|Lost to Follow-up|0
7708752|NCT00463385|12130722|FG002|Overall Study|Lost to Follow-up|0
7708753|NCT00463385|12130723|FG003|Overall Study|Lost to Follow-up|1
7708754|NCT00463385|12130720|FG000|Overall Study|Death|2
7708755|NCT00463385|12130721|FG001|Overall Study|Death|1
7708756|NCT00463385|12130722|FG002|Overall Study|Death|2
7708757|NCT00463385|12130723|FG003|Overall Study|Death|0
7708758|NCT00463385|12130720|FG000|Overall Study|Missing|2
7708759|NCT00463385|12130721|FG001|Overall Study|Missing|0
7708760|NCT00463385|12130722|FG002|Overall Study|Missing|0
7708761|NCT00463385|12130723|FG003|Overall Study|Missing|2
7708762|NCT00463385|12130720|FG000|Overall Study|1 participant received commercial drug|0
7708763|NCT00463385|12130721|FG001|Overall Study|1 participant received commercial drug|1
7708764|NCT00463385|12130722|FG002|Overall Study|1 participant received commercial drug|0
7708765|NCT00463385|12130723|FG003|Overall Study|1 participant received commercial drug|0
7708766|NCT00463476|12130760|FG000|Overall Study|Withdrawal by Subject|1
7708767|NCT00463476|12130761|FG001|Overall Study|Withdrawal by Subject|2
7708768|NCT00463476|12130760|FG000|Overall Study|Lost to Follow-up|1
7708769|NCT00463476|12130761|FG001|Overall Study|Lost to Follow-up|1
7708770|NCT00463567|12130774|FG000|Overall Study|Adverse Event|29
7708771|NCT00463567|12130775|FG001|Overall Study|Adverse Event|26
7708772|NCT00463567|12130776|FG002|Overall Study|Adverse Event|17
7708773|NCT00463567|12130777|FG003|Overall Study|Adverse Event|46
7708774|NCT00463567|12130778|FG004|Overall Study|Adverse Event|10
7708775|NCT00463567|12130779|FG005|Overall Study|Adverse Event|10
7708776|NCT00463567|12130780|FG006|Overall Study|Adverse Event|4
7708777|NCT00463567|12130774|FG000|Overall Study|Withdrawal by Subject|29
7708778|NCT00463567|12130775|FG001|Overall Study|Withdrawal by Subject|22
7708779|NCT00463567|12130776|FG002|Overall Study|Withdrawal by Subject|20
7708780|NCT00463567|12130777|FG003|Overall Study|Withdrawal by Subject|37
7708781|NCT00463567|12130778|FG004|Overall Study|Withdrawal by Subject|6
7708782|NCT00463567|12130779|FG005|Overall Study|Withdrawal by Subject|5
7708783|NCT00463567|12130780|FG006|Overall Study|Withdrawal by Subject|1
7708784|NCT00463567|12130774|FG000|Overall Study|Protocol Deviation|13
7708785|NCT00463567|12130775|FG001|Overall Study|Protocol Deviation|9
7708786|NCT00463567|12130776|FG002|Overall Study|Protocol Deviation|14
7708787|NCT00463567|12130777|FG003|Overall Study|Protocol Deviation|11
7708788|NCT00463567|12130778|FG004|Overall Study|Protocol Deviation|1
7708789|NCT00463567|12130779|FG005|Overall Study|Protocol Deviation|1
7708790|NCT00463567|12130780|FG006|Overall Study|Protocol Deviation|2
7708791|NCT00463567|12130774|FG000|Overall Study|Lost to Follow-up|12
7708792|NCT00463567|12130775|FG001|Overall Study|Lost to Follow-up|6
7708793|NCT00463567|12130776|FG002|Overall Study|Lost to Follow-up|13
7708794|NCT00463567|12130777|FG003|Overall Study|Lost to Follow-up|8
7708795|NCT00463567|12130778|FG004|Overall Study|Lost to Follow-up|1
7708796|NCT00463567|12130779|FG005|Overall Study|Lost to Follow-up|1
7708797|NCT00463567|12130780|FG006|Overall Study|Lost to Follow-up|1
7708798|NCT00463567|12130774|FG000|Overall Study|Administrative problems|5
7708799|NCT00463567|12130775|FG001|Overall Study|Administrative problems|3
7708800|NCT00463567|12130776|FG002|Overall Study|Administrative problems|6
7708801|NCT00463567|12130777|FG003|Overall Study|Administrative problems|9
7708802|NCT00463567|12130778|FG004|Overall Study|Administrative problems|3
7708803|NCT00463567|12130779|FG005|Overall Study|Administrative problems|2
7708804|NCT00463567|12130780|FG006|Overall Study|Administrative problems|2
7708805|NCT00463567|12130774|FG000|Overall Study|Lack of Efficacy|4
7708806|NCT00463567|12130775|FG001|Overall Study|Lack of Efficacy|9
7708807|NCT00463567|12130776|FG002|Overall Study|Lack of Efficacy|9
7708808|NCT00463567|12130777|FG003|Overall Study|Lack of Efficacy|17
7708809|NCT00463567|12130778|FG004|Overall Study|Lack of Efficacy|1
7708810|NCT00463567|12130779|FG005|Overall Study|Lack of Efficacy|0
7708811|NCT00463567|12130780|FG006|Overall Study|Lack of Efficacy|1
7708812|NCT00463567|12130774|FG000|Overall Study|Abnormal lab value(s)|1
7708813|NCT00463567|12130775|FG001|Overall Study|Abnormal lab value(s)|1
7708814|NCT00463567|12130776|FG002|Overall Study|Abnormal lab value(s)|2
7708815|NCT00463567|12130777|FG003|Overall Study|Abnormal lab value(s)|1
7708816|NCT00463567|12130778|FG004|Overall Study|Abnormal lab value(s)|1
7708817|NCT00463567|12130779|FG005|Overall Study|Abnormal lab value(s)|0
7708818|NCT00463567|12130780|FG006|Overall Study|Abnormal lab value(s)|0
7708819|NCT00463567|12130774|FG000|Overall Study|Abnormal test procedure result(s)|1
7708820|NCT00463567|12130775|FG001|Overall Study|Abnormal test procedure result(s)|1
7708821|NCT00463567|12130776|FG002|Overall Study|Abnormal test procedure result(s)|6
7708822|NCT00463567|12130777|FG003|Overall Study|Abnormal test procedure result(s)|2
7708823|NCT00463567|12130778|FG004|Overall Study|Abnormal test procedure result(s)|0
7708824|NCT00463567|12130779|FG005|Overall Study|Abnormal test procedure result(s)|2
7708825|NCT00463567|12130780|FG006|Overall Study|Abnormal test procedure result(s)|0
7708826|NCT00463567|12130774|FG000|Overall Study|Death|1
7708827|NCT00463567|12130775|FG001|Overall Study|Death|0
7708828|NCT00463567|12130776|FG002|Overall Study|Death|2
7708829|NCT00463567|12130777|FG003|Overall Study|Death|0
7708830|NCT00463567|12130778|FG004|Overall Study|Death|0
7708831|NCT00463567|12130779|FG005|Overall Study|Death|0
7708832|NCT00463567|12130780|FG006|Overall Study|Death|0
7708833|NCT00463580|12130804|FG000|Overall Study|Lost to Follow-up|1
7708834|NCT00463580|12130805|FG001|Overall Study|Lost to Follow-up|0
7708835|NCT00463580|12130804|FG000|Overall Study|Schedule conflict|2
7708836|NCT00463580|12130805|FG001|Overall Study|Schedule conflict|0
7708837|NCT00463580|12130804|FG000|Overall Study|Medical/psychiatric complications|0
7708838|NCT00463580|12130805|FG001|Overall Study|Medical/psychiatric complications|2
7708839|NCT00463606|12130820|FG000|Overall Study|Adverse Event|21
7708840|NCT00463606|12130821|FG001|Overall Study|Adverse Event|18
7708841|NCT00463606|12130822|FG002|Overall Study|Adverse Event|11
7708842|NCT00463606|12130820|FG000|Overall Study|Withdrawal by Subject|11
7708843|NCT00463606|12130821|FG001|Overall Study|Withdrawal by Subject|11
7708844|NCT00463606|12130822|FG002|Overall Study|Withdrawal by Subject|5
7708845|NCT00463606|12130820|FG000|Overall Study|Lost to Follow-up|2
7708846|NCT00463606|12130821|FG001|Overall Study|Lost to Follow-up|2
7708847|NCT00463606|12130822|FG002|Overall Study|Lost to Follow-up|3
7708848|NCT00463606|12130820|FG000|Overall Study|Subject noncompliance|1
7708849|NCT00463606|12130821|FG001|Overall Study|Subject noncompliance|1
7708850|NCT00463606|12130822|FG002|Overall Study|Subject noncompliance|0
7708851|NCT00463606|12130820|FG000|Overall Study|Subject moved out of town|1
7708852|NCT00463606|12130821|FG001|Overall Study|Subject moved out of town|0
7708853|NCT00463606|12130822|FG002|Overall Study|Subject moved out of town|0
7708854|NCT00463606|12130820|FG000|Overall Study|Physician Decision|0
7708855|NCT00463606|12130821|FG001|Overall Study|Physician Decision|1
7708856|NCT00463606|12130822|FG002|Overall Study|Physician Decision|0
7708857|NCT00463606|12130820|FG000|Overall Study|Sponsor request|0
7708858|NCT00463606|12130821|FG001|Overall Study|Sponsor request|1
7708859|NCT00463606|12130822|FG002|Overall Study|Sponsor request|0
7708860|NCT00463606|12130820|FG000|Overall Study|Exclusion criteria violation|2
7708861|NCT00463606|12130821|FG001|Overall Study|Exclusion criteria violation|0
7708862|NCT00463606|12130822|FG002|Overall Study|Exclusion criteria violation|0
7708863|NCT00463606|12130820|FG000|Overall Study|Coordinator error|1
7708864|NCT00463606|12130821|FG001|Overall Study|Coordinator error|0
7708865|NCT00463606|12130822|FG002|Overall Study|Coordinator error|0
7708866|NCT00463606|12130820|FG000|Overall Study|Patient randomized in error|1
7708867|NCT00463606|12130821|FG001|Overall Study|Patient randomized in error|0
7708868|NCT00463606|12130822|FG002|Overall Study|Patient randomized in error|0
7708869|NCT00463606|12130820|FG000|Overall Study|Participation in another ABT-335 trial|1
7708870|NCT00463606|12130821|FG001|Overall Study|Participation in another ABT-335 trial|0
7708871|NCT00463606|12130822|FG002|Overall Study|Participation in another ABT-335 trial|0
7708872|NCT00463606|12130820|FG000|Overall Study|Protocol Violation|0
7708873|NCT00463606|12130821|FG001|Overall Study|Protocol Violation|0
7708874|NCT00463606|12130822|FG002|Overall Study|Protocol Violation|1
7708875|NCT00463684|12130830|FG000|Overall Study|Withdrawal by Subject|1
7708876|NCT00463684|12130830|FG000|Overall Study|Lost to Follow-up|3
7708877|NCT00463788|12130836|FG000|Overall Study|Progressive Disease|86
7708878|NCT00463788|12130837|FG001|Overall Study|Progressive Disease|42
7708879|NCT00463788|12130836|FG000|Overall Study|Adverse Event|6
7708880|NCT00463788|12130837|FG001|Overall Study|Adverse Event|2
7708881|NCT00463788|12130836|FG000|Overall Study|Withdrawal by Subject|6
7708882|NCT00463788|12130837|FG001|Overall Study|Withdrawal by Subject|2
7708883|NCT00463788|12130836|FG000|Overall Study|Death|4
7708884|NCT00463788|12130837|FG001|Overall Study|Death|3
7708885|NCT00463788|12130836|FG000|Overall Study|Symptomatic Deterioration|2
7708886|NCT00463788|12130837|FG001|Overall Study|Symptomatic Deterioration|3
7708887|NCT00463788|12130836|FG000|Overall Study|Lost to Follow-up|1
7708888|NCT00463788|12130837|FG001|Overall Study|Lost to Follow-up|0
7708889|NCT00463788|12130836|FG000|Overall Study|Protocol Violation|0
7708890|NCT00463788|12130837|FG001|Overall Study|Protocol Violation|1
7708891|NCT00463788|12130836|FG000|Overall Study|Other|3
7708892|NCT00463788|12130837|FG001|Overall Study|Other|0
7708893|NCT00463788|12130836|FG000|Overall Study|Randomized but not treated|1
7708894|NCT00463788|12130837|FG001|Overall Study|Randomized but not treated|1
7708895|NCT00463801|12130844|FG000|Overall Study|Protocol Violation|1
7708896|NCT00463801|12130844|FG000|Overall Study|Lack of Efficacy|2
7708897|NCT00463801|12130844|FG000|Overall Study|Adverse Event|4
7708898|NCT00463801|12130844|FG000|Overall Study|Lost to Follow-up|5
7708899|NCT00463801|12130844|FG000|Overall Study|No longer require therapy|1
7708900|NCT00463840|12130848|FG000|Overall Study|Disease progression|7
7708901|NCT00463840|12130848|FG000|Overall Study|Withdrawal by Subject|2
7708902|NCT00463840|12130848|FG000|Overall Study|Adverse Event|3
7708903|NCT00463866|12130854|FG000|Overall Study|Adverse Event|70
7708904|NCT00463866|12130855|FG001|Overall Study|Adverse Event|93
7708905|NCT00463866|12130854|FG000|Overall Study|Withdrawal by Subject|81
7708906|NCT00463866|12130855|FG001|Overall Study|Withdrawal by Subject|79
7708907|NCT00463866|12130854|FG000|Overall Study|Lost to Follow-up|46
7708908|NCT00463866|12130855|FG001|Overall Study|Lost to Follow-up|55
7708909|NCT00463866|12130854|FG000|Overall Study|Incorrect Enrolment|64
7708910|NCT00463866|12130855|FG001|Overall Study|Incorrect Enrolment|66
7708911|NCT00463866|12130854|FG000|Overall Study|Severe Non-Compliance to Protocol|25
7708912|NCT00463866|12130855|FG001|Overall Study|Severe Non-Compliance to Protocol|21
7708913|NCT00463866|12130854|FG000|Overall Study|Safety Reason|1
7708914|NCT00463866|12130855|FG001|Overall Study|Safety Reason|3
7708915|NCT00463866|12130854|FG000|Overall Study|Mis-Randomization of subject|0
7708916|NCT00463866|12130855|FG001|Overall Study|Mis-Randomization of subject|1
7708917|NCT00463866|12130854|FG000|Overall Study|Other|22
7708918|NCT00463866|12130855|FG001|Overall Study|Other|22
7708919|NCT00464087|12130864|FG000|Overall Study|No PCI per inclusion criteria|0
7708920|NCT00464087|12130865|FG001|Overall Study|No PCI per inclusion criteria|0
7708921|NCT00464087|12130866|FG002|Overall Study|No PCI per inclusion criteria|29
7708922|NCT00464308|12130888|FG000|Overall Study|Adverse Event|22
7708923|NCT00464308|12130889|FG001|Overall Study|Adverse Event|27
7708924|NCT00464308|12130890|FG002|Overall Study|Adverse Event|16
7708925|NCT00464308|12130888|FG000|Overall Study|Lost to Follow-up|29
7708926|NCT00464308|12130889|FG001|Overall Study|Lost to Follow-up|19
7708927|NCT00464308|12130890|FG002|Overall Study|Lost to Follow-up|20
7708928|NCT00464308|12130888|FG000|Overall Study|Patient discontinued and other reasons|17
7708929|NCT00464308|12130889|FG001|Overall Study|Patient discontinued and other reasons|17
7708930|NCT00464308|12130890|FG002|Overall Study|Patient discontinued and other reasons|23
7708931|NCT00464308|12130888|FG000|Overall Study|Physician Decision|1
7708932|NCT00464308|12130889|FG001|Overall Study|Physician Decision|0
7708933|NCT00464308|12130890|FG002|Overall Study|Physician Decision|0
7708934|NCT00464334|12130909|FG000|Overall Study|Adverse Event|0
7708935|NCT00464334|12130910|FG001|Overall Study|Adverse Event|0
7708936|NCT00464334|12130911|FG002|Overall Study|Adverse Event|0
7708937|NCT00464334|12130912|FG003|Overall Study|Adverse Event|1
7708938|NCT00464334|12130913|FG004|Overall Study|Adverse Event|1
7708939|NCT00464334|12130914|FG005|Overall Study|Adverse Event|1
7708940|NCT00464334|12130915|FG006|Overall Study|Adverse Event|0
7708941|NCT00464334|12130916|FG007|Overall Study|Adverse Event|0
7708942|NCT00464334|12130917|FG008|Overall Study|Adverse Event|2
7708943|NCT00464334|12130918|FG009|Overall Study|Adverse Event|1
7708944|NCT00464334|12130919|FG010|Overall Study|Adverse Event|2
7708945|NCT00464334|12130909|FG000|Overall Study|Lack of Efficacy|0
7708946|NCT00464334|12130910|FG001|Overall Study|Lack of Efficacy|1
7708947|NCT00464334|12130911|FG002|Overall Study|Lack of Efficacy|0
7708948|NCT00464334|12130912|FG003|Overall Study|Lack of Efficacy|0
7708949|NCT00464334|12130913|FG004|Overall Study|Lack of Efficacy|0
7708950|NCT00464334|12130914|FG005|Overall Study|Lack of Efficacy|0
7708951|NCT00464334|12130915|FG006|Overall Study|Lack of Efficacy|0
7708952|NCT00464334|12130916|FG007|Overall Study|Lack of Efficacy|0
7708953|NCT00464334|12130917|FG008|Overall Study|Lack of Efficacy|0
7708954|NCT00464334|12130918|FG009|Overall Study|Lack of Efficacy|0
7708955|NCT00464334|12130919|FG010|Overall Study|Lack of Efficacy|0
7708956|NCT00464334|12130909|FG000|Overall Study|Lost to Follow-up|0
7708957|NCT00464334|12130910|FG001|Overall Study|Lost to Follow-up|0
7708958|NCT00464334|12130911|FG002|Overall Study|Lost to Follow-up|1
7708959|NCT00464334|12130912|FG003|Overall Study|Lost to Follow-up|0
7708960|NCT00464334|12130913|FG004|Overall Study|Lost to Follow-up|1
7708961|NCT00464334|12130914|FG005|Overall Study|Lost to Follow-up|0
7708962|NCT00464334|12130915|FG006|Overall Study|Lost to Follow-up|1
7708963|NCT00464334|12130916|FG007|Overall Study|Lost to Follow-up|0
7708964|NCT00464334|12130917|FG008|Overall Study|Lost to Follow-up|0
7708965|NCT00464334|12130918|FG009|Overall Study|Lost to Follow-up|0
7708966|NCT00464334|12130919|FG010|Overall Study|Lost to Follow-up|2
7708967|NCT00464334|12130909|FG000|Overall Study|Progressive Disease|0
7708968|NCT00464334|12130910|FG001|Overall Study|Progressive Disease|0
7708969|NCT00464334|12130911|FG002|Overall Study|Progressive Disease|0
7708970|NCT00464334|12130912|FG003|Overall Study|Progressive Disease|0
7708971|NCT00464334|12130913|FG004|Overall Study|Progressive Disease|0
7708972|NCT00464334|12130914|FG005|Overall Study|Progressive Disease|1
7708973|NCT00464334|12130915|FG006|Overall Study|Progressive Disease|0
7708974|NCT00464334|12130916|FG007|Overall Study|Progressive Disease|0
7708975|NCT00464334|12130917|FG008|Overall Study|Progressive Disease|1
7708976|NCT00464334|12130918|FG009|Overall Study|Progressive Disease|0
7708977|NCT00464334|12130919|FG010|Overall Study|Progressive Disease|0
7708978|NCT00464334|12130909|FG000|Overall Study|Study Terminated by Sponsor|0
7708979|NCT00464334|12130910|FG001|Overall Study|Study Terminated by Sponsor|0
7708980|NCT00464334|12130911|FG002|Overall Study|Study Terminated by Sponsor|0
7708981|NCT00464334|12130912|FG003|Overall Study|Study Terminated by Sponsor|1
7708982|NCT00464334|12130913|FG004|Overall Study|Study Terminated by Sponsor|0
7708983|NCT00464334|12130914|FG005|Overall Study|Study Terminated by Sponsor|0
7708984|NCT00464334|12130915|FG006|Overall Study|Study Terminated by Sponsor|0
7708985|NCT00464334|12130916|FG007|Overall Study|Study Terminated by Sponsor|0
7708986|NCT00464334|12130917|FG008|Overall Study|Study Terminated by Sponsor|0
7708987|NCT00464334|12130918|FG009|Overall Study|Study Terminated by Sponsor|0
7708988|NCT00464334|12130919|FG010|Overall Study|Study Terminated by Sponsor|0
7708989|NCT00464334|12130909|FG000|Overall Study|Withdrawal by Subject|1
7708990|NCT00464334|12130910|FG001|Overall Study|Withdrawal by Subject|7
7708991|NCT00464334|12130911|FG002|Overall Study|Withdrawal by Subject|4
7708992|NCT00464334|12130912|FG003|Overall Study|Withdrawal by Subject|2
7708993|NCT00464334|12130913|FG004|Overall Study|Withdrawal by Subject|2
7708994|NCT00464334|12130914|FG005|Overall Study|Withdrawal by Subject|2
7708995|NCT00464334|12130915|FG006|Overall Study|Withdrawal by Subject|2
7708996|NCT00464334|12130916|FG007|Overall Study|Withdrawal by Subject|1
7708997|NCT00464334|12130917|FG008|Overall Study|Withdrawal by Subject|3
7708998|NCT00464334|12130918|FG009|Overall Study|Withdrawal by Subject|0
7708999|NCT00464334|12130919|FG010|Overall Study|Withdrawal by Subject|0
7709000|NCT00464490|12130974|FG000|Overall Study|Physician Decision|11
7709001|NCT00464490|12130975|FG001|Overall Study|Physician Decision|11
7709002|NCT00464542|12130981|FG000|Pre-treatment|Withdrawal by Subject|2
7709003|NCT00464568|12130985|FG000|Overall Study|Adverse Event|2
7709004|NCT00464620|12131002|FG000|Overall Study|Physician Decision|1
7709005|NCT00464620|12131003|FG001|Overall Study|Physician Decision|0
7709006|NCT00464620|12131004|FG002|Overall Study|Physician Decision|0
7709007|NCT00464620|12131002|FG000|Overall Study|Withdrawal by Subject|1
7709008|NCT00464620|12131003|FG001|Overall Study|Withdrawal by Subject|0
7709009|NCT00464620|12131004|FG002|Overall Study|Withdrawal by Subject|3
7709010|NCT00464620|12131002|FG000|Overall Study|Ineligible sarcoma subtype|0
7709011|NCT00464620|12131003|FG001|Overall Study|Ineligible sarcoma subtype|2
7709012|NCT00464620|12131004|FG002|Overall Study|Ineligible sarcoma subtype|2
7709013|NCT00464620|12131002|FG000|Overall Study|Use of prohibited concomitant medication|0
7709014|NCT00464620|12131003|FG001|Overall Study|Use of prohibited concomitant medication|0
7709015|NCT00464620|12131004|FG002|Overall Study|Use of prohibited concomitant medication|2
7709016|NCT00464672|12131029|FG000|Overall Study|withdrawal of consent|0
7709017|NCT00464672|12131030|FG001|Overall Study|withdrawal of consent|0
7709018|NCT00464672|12131031|FG002|Overall Study|withdrawal of consent|0
7709019|NCT00464672|12131032|FG003|Overall Study|withdrawal of consent|1
7709020|NCT00464672|12131033|FG004|Overall Study|withdrawal of consent|9
7709021|NCT00464672|12131034|FG005|Overall Study|withdrawal of consent|4
7709022|NCT00464672|12131029|FG000|Overall Study|Lost to Follow-up|25
7709023|NCT00464672|12131030|FG001|Overall Study|Lost to Follow-up|10
7709024|NCT00464672|12131031|FG002|Overall Study|Lost to Follow-up|0
7709025|NCT00464672|12131032|FG003|Overall Study|Lost to Follow-up|0
7709026|NCT00464672|12131033|FG004|Overall Study|Lost to Follow-up|1
7709027|NCT00464672|12131034|FG005|Overall Study|Lost to Follow-up|0
7709028|NCT00464737|12131084|FG000|Overall Study|Adverse Event|12
7709029|NCT00464737|12131085|FG001|Overall Study|Adverse Event|17
7709030|NCT00464737|12131086|FG002|Overall Study|Adverse Event|33
7709031|NCT00464737|12131084|FG000|Overall Study|Lack of Efficacy|7
7709032|NCT00464737|12131085|FG001|Overall Study|Lack of Efficacy|7
7709033|NCT00464737|12131086|FG002|Overall Study|Lack of Efficacy|4
7709034|NCT00464737|12131084|FG000|Overall Study|Withdrawal by Subject|5
7709035|NCT00464737|12131085|FG001|Overall Study|Withdrawal by Subject|3
7709036|NCT00464737|12131086|FG002|Overall Study|Withdrawal by Subject|5
7709037|NCT00464737|12131084|FG000|Overall Study|Protocol Violation|1
7709038|NCT00464737|12131085|FG001|Overall Study|Protocol Violation|1
7709039|NCT00464737|12131086|FG002|Overall Study|Protocol Violation|5
7709040|NCT00464737|12131084|FG000|Overall Study|Non-compliance|0
7709041|NCT00464737|12131085|FG001|Overall Study|Non-compliance|1
7709042|NCT00464737|12131086|FG002|Overall Study|Non-compliance|1
7709043|NCT00464737|12131084|FG000|Overall Study|Lost to Follow-up|5
7709044|NCT00464737|12131085|FG001|Overall Study|Lost to Follow-up|2
7709045|NCT00464737|12131086|FG002|Overall Study|Lost to Follow-up|5
7709046|NCT00464737|12131084|FG000|Overall Study|Other: Subject's schedule doesn't permit|1
7709047|NCT00464737|12131085|FG001|Overall Study|Other: Subject's schedule doesn't permit|0
7709048|NCT00464737|12131086|FG002|Overall Study|Other: Subject's schedule doesn't permit|0
7709049|NCT00464737|12131084|FG000|Overall Study|Other: Subject left town; family illness|1
7709050|NCT00464737|12131085|FG001|Overall Study|Other: Subject left town; family illness|0
7709051|NCT00464737|12131086|FG002|Overall Study|Other: Subject left town; family illness|0
7709052|NCT00464737|12131084|FG000|Overall Study|Other: Study demands too great|0
7709053|NCT00464737|12131085|FG001|Overall Study|Other: Study demands too great|1
7709054|NCT00464737|12131086|FG002|Overall Study|Other: Study demands too great|0
7709055|NCT00464737|12131084|FG000|Overall Study|Other: Personal family reasons|0
7709056|NCT00464737|12131085|FG001|Overall Study|Other: Personal family reasons|0
7709057|NCT00464737|12131086|FG002|Overall Study|Other: Personal family reasons|1
7709058|NCT00464737|12131084|FG000|Overall Study|Other: Subject's disability per sponsor|0
7709059|NCT00464737|12131085|FG001|Overall Study|Other: Subject's disability per sponsor|0
7709060|NCT00464737|12131086|FG002|Overall Study|Other: Subject's disability per sponsor|1
7709061|NCT00464815|12131096|FG000|Overall Study|Withdrawal by Subject|6
7709062|NCT00464815|12131097|FG001|Overall Study|Withdrawal by Subject|3
7709063|NCT00464945|12131105|FG000|Infant Series|Withdrawal by parent/guardian request|2
7709064|NCT00464945|12131106|FG001|Infant Series|Withdrawal by parent/guardian request|1
7709065|NCT00464945|12131105|FG000|Infant Series|Protocol Violation|1
7709066|NCT00464945|12131106|FG001|Infant Series|Protocol Violation|0
7709067|NCT00464945|12131105|FG000|Infant Series|Lost to Follow-up|1
7709068|NCT00464945|12131106|FG001|Infant Series|Lost to Follow-up|0
7709069|NCT00464945|12131105|FG000|After Infant Series|Withdrawal by Subject|0
7709070|NCT00464945|12131106|FG001|After Infant Series|Withdrawal by Subject|2
7709071|NCT00464945|12131105|FG000|Toddler Dose|Lost to Follow-up|0
7709072|NCT00464945|12131106|FG001|Toddler Dose|Lost to Follow-up|1
7709073|NCT00465101|12131137|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3
7709074|NCT00465101|12131137|FG000|Overall Study|Change in health precluded follow up|4
7709075|NCT00465101|12131137|FG000|Overall Study|Did not meet study criteria|4
7709076|NCT00465101|12131137|FG000|Overall Study|Lost to Follow-up|5
7709077|NCT00465101|12131137|FG000|Overall Study|Other|6
7709078|NCT00465101|12131137|FG000|Overall Study|Pt. Insurance not accepted at center|2
7709079|NCT00465101|12131137|FG000|Overall Study|Patient postponed procedure|1
7709080|NCT00465101|12131137|FG000|Overall Study|Site closed due to IRB expiration|1
7709081|NCT00465101|12131137|FG000|Overall Study|Unable to obtain IRB approval|1
7709082|NCT00465101|12131137|FG000|Overall Study|Death|3
7709083|NCT00465101|12131137|FG000|Overall Study|Withdrawal by Subject|25
7709084|NCT00465101|12131137|FG000|Overall Study|Physician Decision|1
7709085|NCT00465101|12131137|FG000|Overall Study|Withdrew consent prior to procedure|3
7709086|NCT00465179|12131163|FG000|Overall Study|Adverse Event|4
7709087|NCT00465179|12131163|FG000|Overall Study|Withdrawal by Subject|2
7709088|NCT00465179|12131163|FG000|Overall Study|Progression of Disease|47
7709089|NCT00465270|12131169|FG000|Overall Study|Death|7
7709090|NCT00465270|12131170|FG001|Overall Study|Death|11
7709091|NCT00465270|12131169|FG000|Overall Study|Withdrawal by Subject|34
7709092|NCT00465270|12131170|FG001|Overall Study|Withdrawal by Subject|78
7709093|NCT00465270|12131169|FG000|Overall Study|Lost to Follow-up|60
7709094|NCT00465270|12131170|FG001|Overall Study|Lost to Follow-up|67
7709095|NCT00465270|12131169|FG000|Overall Study|Investigator request|3
7709096|NCT00465270|12131170|FG001|Overall Study|Investigator request|4
7709097|NCT00465361|12131176|FG000|Baseline Assessment|Personal Issues/Scheduling|4
7709098|NCT00465569|12131191|FG000|Overall Study|persistent eczema during dose escalation|1
7709099|NCT00465569|12131192|FG001|Overall Study|persistent eczema during dose escalation|0
7709100|NCT00465647|12131217|FG000|Overall Study|Administrative|2
7709101|NCT00465647|12131218|FG001|Overall Study|Administrative|2
7709102|NCT00465647|12131219|FG002|Overall Study|Administrative|3
7709103|NCT00465647|12131220|FG003|Overall Study|Administrative|2
7709104|NCT00465647|12131217|FG000|Overall Study|Adverse Event|2
7709105|NCT00465647|12131218|FG001|Overall Study|Adverse Event|0
7709106|NCT00465647|12131219|FG002|Overall Study|Adverse Event|3
7709107|NCT00465647|12131220|FG003|Overall Study|Adverse Event|2
7709108|NCT00465647|12131217|FG000|Overall Study|Withdrawal by Subject|1
7709109|NCT00465647|12131218|FG001|Overall Study|Withdrawal by Subject|2
7709110|NCT00465647|12131219|FG002|Overall Study|Withdrawal by Subject|2
7709111|NCT00465647|12131220|FG003|Overall Study|Withdrawal by Subject|7
7709112|NCT00465647|12131217|FG000|Overall Study|"The other reasons included loss of IV"|8
7709113|NCT00465647|12131218|FG001|Overall Study|"The other reasons included loss of IV"|4
7709114|NCT00465647|12131219|FG002|Overall Study|"The other reasons included loss of IV"|3
7709115|NCT00465647|12131220|FG003|Overall Study|"The other reasons included loss of IV"|2
7709116|NCT00465738|12131242|FG000|Overall Study|Lost to Follow-up|2
7709117|NCT00465738|12131243|FG001|Overall Study|Lost to Follow-up|0
7709118|NCT00465738|12131242|FG000|Overall Study|Adverse Event|0
7709119|NCT00465738|12131243|FG001|Overall Study|Adverse Event|1
7709120|NCT00465738|12131242|FG000|Overall Study|Withdrawal by Subject|2
7709121|NCT00465738|12131243|FG001|Overall Study|Withdrawal by Subject|0
7709122|NCT00465738|12131242|FG000|Overall Study|Other|2
7709123|NCT00465738|12131243|FG001|Overall Study|Other|5
7709124|NCT00465816|12131252|FG000|Overall Study|Lost to Follow-up|0
7709125|NCT00465816|12131253|FG001|Overall Study|Lost to Follow-up|0
7709126|NCT00465816|12131254|FG002|Overall Study|Lost to Follow-up|2
7709127|NCT00465894|12131265|FG000|Treatment For 12 Weeks|Lost to Follow-up|4
7709128|NCT00465894|12131266|FG001|Treatment For 12 Weeks|Lost to Follow-up|1
7709129|NCT00465894|12131265|FG000|Treatment For 12 Weeks|Family Issues|1
7709130|NCT00465894|12131266|FG001|Treatment For 12 Weeks|Family Issues|1
7709131|NCT00465894|12131265|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0
7709132|NCT00465894|12131266|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1
7709133|NCT00465972|12131290|FG000|Overall Study|Withdrawal by Subject|2
7709134|NCT00465972|12131291|FG001|Overall Study|Withdrawal by Subject|1
7709135|NCT00465985|12131299|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
7709136|NCT00465985|12131300|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
7709137|NCT00465985|12131299|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
7709138|NCT00465985|12131300|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
7709139|NCT00465985|12131299|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
7709140|NCT00465985|12131300|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
7709141|NCT00465985|12131299|FG000|Part III - Open-label Treatment Period|Adverse Event|1
7709142|NCT00465985|12131300|FG001|Part III - Open-label Treatment Period|Adverse Event|0
7709143|NCT00466167|12131317|FG000|Overall Study|Adverse Event|8
7709144|NCT00466167|12131318|FG001|Overall Study|Adverse Event|8
7709145|NCT00466167|12131319|FG002|Overall Study|Adverse Event|7
7709146|NCT00466167|12131317|FG000|Overall Study|Lack of Efficacy|2
7709147|NCT00466167|12131318|FG001|Overall Study|Lack of Efficacy|0
7709148|NCT00466167|12131319|FG002|Overall Study|Lack of Efficacy|3
7709149|NCT00466167|12131317|FG000|Overall Study|Protocol Violation|1
7709150|NCT00466167|12131318|FG001|Overall Study|Protocol Violation|1
7709151|NCT00466167|12131319|FG002|Overall Study|Protocol Violation|2
7709152|NCT00466167|12131317|FG000|Overall Study|Lost to Follow-up|3
7709153|NCT00466167|12131318|FG001|Overall Study|Lost to Follow-up|2
7709154|NCT00466167|12131319|FG002|Overall Study|Lost to Follow-up|2
7709155|NCT00466167|12131317|FG000|Overall Study|Withdrawal by Subject|4
7709156|NCT00466167|12131318|FG001|Overall Study|Withdrawal by Subject|1
7709157|NCT00466167|12131319|FG002|Overall Study|Withdrawal by Subject|6
7709158|NCT00466167|12131317|FG000|Overall Study|patient did not meet inclusion criteria|1
7709159|NCT00466167|12131318|FG001|Overall Study|patient did not meet inclusion criteria|0
7709160|NCT00466167|12131319|FG002|Overall Study|patient did not meet inclusion criteria|1
7709161|NCT00466167|12131317|FG000|Overall Study|Not treated|1
7709162|NCT00466167|12131318|FG001|Overall Study|Not treated|0
7709163|NCT00466167|12131319|FG002|Overall Study|Not treated|0
7709164|NCT00466193|12131329|FG000|Overall Study|Adverse Event|0
7709165|NCT00466193|12131330|FG001|Overall Study|Adverse Event|1
7709166|NCT00466193|12131329|FG000|Overall Study|Lost to Follow-up|2
7709167|NCT00466193|12131330|FG001|Overall Study|Lost to Follow-up|4
7709168|NCT00466193|12131329|FG000|Overall Study|Physician Decision|1
7709169|NCT00466193|12131330|FG001|Overall Study|Physician Decision|0
7709170|NCT00466193|12131329|FG000|Overall Study|Protocol Violation|1
7709171|NCT00466193|12131330|FG001|Overall Study|Protocol Violation|1
7709172|NCT00466193|12131329|FG000|Overall Study|Withdrawal by Subject|7
7709173|NCT00466193|12131330|FG001|Overall Study|Withdrawal by Subject|2
7709174|NCT00466193|12131329|FG000|Overall Study|Patient refused Visit 4 procedures|1
7709175|NCT00466193|12131330|FG001|Overall Study|Patient refused Visit 4 procedures|0
7709176|NCT00466440|12131368|FG000|Overall Study|Adverse Event|0
7709177|NCT00466440|12131369|FG001|Overall Study|Adverse Event|3
7709178|NCT00466440|12131370|FG002|Overall Study|Adverse Event|1
7709179|NCT00466440|12131368|FG000|Overall Study|Death|1
7709180|NCT00466440|12131369|FG001|Overall Study|Death|1
7709181|NCT00466440|12131370|FG002|Overall Study|Death|0
7709182|NCT00466440|12131368|FG000|Overall Study|Progressive disease|13
7709183|NCT00466440|12131369|FG001|Overall Study|Progressive disease|5
7709184|NCT00466440|12131370|FG002|Overall Study|Progressive disease|4
7709185|NCT00466440|12131368|FG000|Overall Study|Lost to Follow-up|0
7709186|NCT00466440|12131369|FG001|Overall Study|Lost to Follow-up|1
7709187|NCT00466440|12131370|FG002|Overall Study|Lost to Follow-up|0
7709188|NCT00466440|12131368|FG000|Overall Study|Physician Decision|0
7709189|NCT00466440|12131369|FG001|Overall Study|Physician Decision|1
7709190|NCT00466440|12131370|FG002|Overall Study|Physician Decision|2
7709191|NCT00466440|12131368|FG000|Overall Study|Protocol entry criteria not met|0
7709192|NCT00466440|12131369|FG001|Overall Study|Protocol entry criteria not met|0
7709193|NCT00466440|12131370|FG002|Overall Study|Protocol entry criteria not met|4
7709194|NCT00466440|12131368|FG000|Overall Study|Withdrawal by Subject|0
7709195|NCT00466440|12131369|FG001|Overall Study|Withdrawal by Subject|1
7709196|NCT00466440|12131370|FG002|Overall Study|Withdrawal by Subject|0
7709197|NCT00466440|12131368|FG000|Overall Study|Sponsor decision|0
7709198|NCT00466440|12131369|FG001|Overall Study|Sponsor decision|0
7709199|NCT00466440|12131370|FG002|Overall Study|Sponsor decision|1
7709200|NCT00466505|12131387|FG000|Overall Study|disease progression|13
7709201|NCT00466505|12131387|FG000|Overall Study|Adverse Event|4
7709202|NCT00466687|12131400|FG000|Overall Study|Adverse Event|1
7709203|NCT00466687|12131400|FG000|Overall Study|Other complicating illness|3
7709204|NCT00466687|12131400|FG000|Overall Study|Withdrawal by Subject|1
7709205|NCT00466687|12131400|FG000|Overall Study|Disease progression|29
7709206|NCT00466726|12131406|FG000|Overall Study|Not evaluable for response|14
7709207|NCT00466921|12131437|FG000|First 3 Cycles of Treatment|Adverse Event|2
7709208|NCT00466921|12131437|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5
7709209|NCT00466921|12131437|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2
7709210|NCT00466921|12131437|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2
7709211|NCT00466921|12131437|FG000|Completed 4 Cycles/Reached 1st Response|Other|1
7709212|NCT00466921|12131437|FG000|Follow up for a Minimum of 1 Year|Death|6
7709213|NCT00466947|12131443|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875
7709214|NCT00466947|12131444|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863
7709215|NCT00466947|12131443|FG000|Study End Analysis Period|Adverse Event|35
7709216|NCT00466947|12131444|FG001|Study End Analysis Period|Adverse Event|43
7709217|NCT00466947|12131443|FG000|Study End Analysis Period|Lost to Follow-up|1137
7709218|NCT00466947|12131444|FG001|Study End Analysis Period|Lost to Follow-up|1167
7709219|NCT00466947|12131443|FG000|Study End Analysis Period|Physician Decision|29
7709220|NCT00466947|12131444|FG001|Study End Analysis Period|Physician Decision|29
7709221|NCT00466947|12131443|FG000|Study End Analysis Period|Protocol Violation|9
7709222|NCT00466947|12131444|FG001|Study End Analysis Period|Protocol Violation|17
7709223|NCT00466947|12131443|FG000|Study End Analysis Period|Withdrawal by Subject|1264
7709224|NCT00466947|12131444|FG001|Study End Analysis Period|Withdrawal by Subject|1267
7709225|NCT00466947|12131443|FG000|Study End Analysis Period|Other - Forbidden vaccination|21
7709226|NCT00466947|12131444|FG001|Study End Analysis Period|Other - Forbidden vaccination|10
7709227|NCT00466947|12131443|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1
7709228|NCT00466947|12131444|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0
7709229|NCT00466947|12131443|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0
7709230|NCT00466947|12131444|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1
7709231|NCT00467051|12131465|FG000|Overall Study|Adverse Event|2
7709232|NCT00467259|12131476|FG000|Overall Study|Adverse Event|24
7709233|NCT00467259|12131477|FG001|Overall Study|Adverse Event|90
7709234|NCT00467259|12131476|FG000|Overall Study|Protocol Violation|1
7709235|NCT00467259|12131477|FG001|Overall Study|Protocol Violation|7
7709236|NCT00467259|12131476|FG000|Overall Study|Withdrawal by Subject|34
7709237|NCT00467259|12131477|FG001|Overall Study|Withdrawal by Subject|108
7709238|NCT00467259|12131476|FG000|Overall Study|Physician Decision|0
7709239|NCT00467259|12131477|FG001|Overall Study|Physician Decision|2
7709240|NCT00467259|12131476|FG000|Overall Study|Lost to Follow-up|14
7709241|NCT00467259|12131477|FG001|Overall Study|Lost to Follow-up|34
7709242|NCT00467259|12131476|FG000|Overall Study|Site Closed|2
7709243|NCT00467259|12131477|FG001|Overall Study|Site Closed|1
7709244|NCT00467272|12131483|FG000|Overall Study|Pneumonia|2
7709245|NCT00467272|12131483|FG000|Overall Study|Thrombophlebitis|1
7709246|NCT00467285|12131489|FG000|Overall Study|Lost to Follow-up|4
7709247|NCT00467285|12131490|FG001|Overall Study|Lost to Follow-up|4
7709248|NCT00467363|12131518|FG000|Overall Study|Lost to Follow-up|80
7709249|NCT00467363|12131519|FG001|Overall Study|Lost to Follow-up|70
7709250|NCT00467519|12131534|FG000|Overall Study|Protocol Violation|8
7709251|NCT00467519|12131535|FG001|Overall Study|Protocol Violation|4
7709252|NCT00467519|12131534|FG000|Overall Study|Lost to Follow-up|2
7709253|NCT00467519|12131535|FG001|Overall Study|Lost to Follow-up|9
7709254|NCT00467519|12131534|FG000|Overall Study|Withdrawal by Subject|4
7709255|NCT00467519|12131535|FG001|Overall Study|Withdrawal by Subject|10
7709256|NCT00467558|12131543|FG000|Overall Study|Lost to Follow-up|2
7709257|NCT00467558|12131544|FG001|Overall Study|Lost to Follow-up|0
7709258|NCT00467584|12131553|FG000|Overall Study|Withdrawal by Subject|4
7709259|NCT00467584|12131554|FG001|Overall Study|Withdrawal by Subject|5
7709260|NCT00467584|12131555|FG002|Overall Study|Withdrawal by Subject|1
7709261|NCT00467597|12131567|FG000|Overall Study|Withdrawal by Subject|2
7709262|NCT00467597|12131568|FG001|Overall Study|Withdrawal by Subject|0
7709263|NCT00467610|12131578|FG000|Overall Study|Withdrawal by Subject|1
7709264|NCT00467649|12131584|FG000|Phase 1 (Randomized Population)|Adverse Event|2
7709265|NCT00467649|12131585|FG001|Phase 1 (Randomized Population)|Adverse Event|0
7709266|NCT00467649|12131586|FG002|Phase 1 (Randomized Population)|Adverse Event|0
7709267|NCT00467649|12131587|FG003|Phase 1 (Randomized Population)|Adverse Event|0
7709268|NCT00467649|12131588|FG004|Phase 1 (Randomized Population)|Adverse Event|0
7709269|NCT00467649|12131589|FG005|Phase 1 (Randomized Population)|Adverse Event|0
7709270|NCT00467649|12131584|FG000|Phase 1 (Randomized Population)|Investigator Decision|1
7709271|NCT00467649|12131585|FG001|Phase 1 (Randomized Population)|Investigator Decision|0
7709272|NCT00467649|12131586|FG002|Phase 1 (Randomized Population)|Investigator Decision|0
7709273|NCT00467649|12131587|FG003|Phase 1 (Randomized Population)|Investigator Decision|0
7709274|NCT00467649|12131588|FG004|Phase 1 (Randomized Population)|Investigator Decision|0
7709275|NCT00467649|12131589|FG005|Phase 1 (Randomized Population)|Investigator Decision|0
7709276|NCT00467649|12131584|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2
7709277|NCT00467649|12131585|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4
7709278|NCT00467649|12131586|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0
7709279|NCT00467649|12131587|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0
7709280|NCT00467649|12131588|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0
7709281|NCT00467649|12131589|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0
7709282|NCT00467649|12131584|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4
7709283|NCT00467649|12131585|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2
7709284|NCT00467649|12131586|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0
7709285|NCT00467649|12131587|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0
7709286|NCT00467649|12131588|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0
7709287|NCT00467649|12131589|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0
7709288|NCT00467649|12131584|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
7709289|NCT00467649|12131585|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
7709290|NCT00467649|12131586|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
7709291|NCT00467649|12131587|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
7709292|NCT00467649|12131588|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
7709293|NCT00467649|12131589|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
7709294|NCT00467649|12131584|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
7709295|NCT00467649|12131585|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
7709296|NCT00467649|12131586|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
7709297|NCT00467649|12131587|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
7709298|NCT00467649|12131588|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
7709299|NCT00467649|12131589|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
7709300|NCT00467649|12131584|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
7709301|NCT00467649|12131585|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
7709302|NCT00467649|12131586|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
7709303|NCT00467649|12131587|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
7709304|NCT00467649|12131588|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
7709305|NCT00467649|12131589|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
7709306|NCT00467740|12131612|FG000|Overall Study|Adverse Event|0
7709307|NCT00467740|12131613|FG001|Overall Study|Adverse Event|0
7709308|NCT00467740|12131614|FG002|Overall Study|Adverse Event|1
7709309|NCT00467740|12131615|FG003|Overall Study|Adverse Event|0
7709310|NCT00467740|12131616|FG004|Overall Study|Adverse Event|0
7709311|NCT00467740|12131612|FG000|Overall Study|Protocol Violation|0
7709312|NCT00467740|12131613|FG001|Overall Study|Protocol Violation|0
7709313|NCT00467740|12131614|FG002|Overall Study|Protocol Violation|1
7709314|NCT00467740|12131615|FG003|Overall Study|Protocol Violation|0
7709315|NCT00467740|12131616|FG004|Overall Study|Protocol Violation|0
7709316|NCT00467740|12131612|FG000|Overall Study|Lost to Follow-up|0
7709317|NCT00467740|12131613|FG001|Overall Study|Lost to Follow-up|1
7709318|NCT00467740|12131614|FG002|Overall Study|Lost to Follow-up|0
7709319|NCT00467740|12131615|FG003|Overall Study|Lost to Follow-up|0
7709320|NCT00467740|12131616|FG004|Overall Study|Lost to Follow-up|0
7709321|NCT00467740|12131612|FG000|Overall Study|Withdrawal by Subject|1
7709322|NCT00467740|12131613|FG001|Overall Study|Withdrawal by Subject|1
7709323|NCT00467740|12131614|FG002|Overall Study|Withdrawal by Subject|0
7709324|NCT00467740|12131615|FG003|Overall Study|Withdrawal by Subject|1
7709325|NCT00467740|12131616|FG004|Overall Study|Withdrawal by Subject|0
7709326|NCT00467740|12131612|FG000|Overall Study|Lack of Efficacy|0
7709327|NCT00467740|12131613|FG001|Overall Study|Lack of Efficacy|1
7709328|NCT00467740|12131614|FG002|Overall Study|Lack of Efficacy|0
7709329|NCT00467740|12131615|FG003|Overall Study|Lack of Efficacy|0
7709330|NCT00467740|12131616|FG004|Overall Study|Lack of Efficacy|0
7709331|NCT00467779|12131643|FG000|Stage 1|Adverse Event|1
7709332|NCT00467779|12131644|FG001|Stage 1|Adverse Event|0
7709333|NCT00467779|12131645|FG002|Stage 1|Adverse Event|0
7709334|NCT00467779|12131646|FG003|Stage 1|Adverse Event|0
7709335|NCT00467779|12131647|FG004|Stage 1|Adverse Event|0
7709336|NCT00467779|12131648|FG005|Stage 1|Adverse Event|1
7709337|NCT00467779|12131649|FG006|Stage 1|Adverse Event|2
7709338|NCT00467779|12131650|FG007|Stage 1|Adverse Event|1
7709339|NCT00467779|12131651|FG008|Stage 1|Adverse Event|0
7709340|NCT00467779|12131652|FG009|Stage 1|Adverse Event|0
7709341|NCT00467779|12131653|FG010|Stage 1|Adverse Event|0
7709342|NCT00467779|12131654|FG011|Stage 1|Adverse Event|0
7709343|NCT00467779|12131655|FG012|Stage 1|Adverse Event|0
7709344|NCT00467779|12131656|FG013|Stage 1|Adverse Event|0
7709345|NCT00467779|12131657|FG014|Stage 1|Adverse Event|0
7709346|NCT00467779|12131643|FG000|Stage 1|Disease Progression|2
7709347|NCT00467779|12131644|FG001|Stage 1|Disease Progression|2
7709348|NCT00467779|12131645|FG002|Stage 1|Disease Progression|2
7709349|NCT00467779|12131646|FG003|Stage 1|Disease Progression|3
7709350|NCT00467779|12131647|FG004|Stage 1|Disease Progression|2
7709351|NCT00467779|12131648|FG005|Stage 1|Disease Progression|2
7709352|NCT00467779|12131649|FG006|Stage 1|Disease Progression|4
7709353|NCT00467779|12131650|FG007|Stage 1|Disease Progression|5
7709354|NCT00467779|12131651|FG008|Stage 1|Disease Progression|0
7709355|NCT00467779|12131652|FG009|Stage 1|Disease Progression|0
7709356|NCT00467779|12131653|FG010|Stage 1|Disease Progression|0
7709357|NCT00467779|12131654|FG011|Stage 1|Disease Progression|0
7709358|NCT00467779|12131655|FG012|Stage 1|Disease Progression|0
7709359|NCT00467779|12131656|FG013|Stage 1|Disease Progression|0
7709360|NCT00467779|12131657|FG014|Stage 1|Disease Progression|0
7709361|NCT00467779|12131643|FG000|Stage 1|Unspecified Reason|1
7709362|NCT00467779|12131644|FG001|Stage 1|Unspecified Reason|0
7709363|NCT00467779|12131645|FG002|Stage 1|Unspecified Reason|1
7709364|NCT00467779|12131646|FG003|Stage 1|Unspecified Reason|0
7709365|NCT00467779|12131647|FG004|Stage 1|Unspecified Reason|1
7709366|NCT00467779|12131648|FG005|Stage 1|Unspecified Reason|2
7709367|NCT00467779|12131649|FG006|Stage 1|Unspecified Reason|0
7709368|NCT00467779|12131650|FG007|Stage 1|Unspecified Reason|0
7709369|NCT00467779|12131651|FG008|Stage 1|Unspecified Reason|0
7709370|NCT00467779|12131652|FG009|Stage 1|Unspecified Reason|0
7709371|NCT00467779|12131653|FG010|Stage 1|Unspecified Reason|0
7709372|NCT00467779|12131654|FG011|Stage 1|Unspecified Reason|0
7709373|NCT00467779|12131655|FG012|Stage 1|Unspecified Reason|0
7709374|NCT00467779|12131656|FG013|Stage 1|Unspecified Reason|0
7709375|NCT00467779|12131657|FG014|Stage 1|Unspecified Reason|0
7709376|NCT00467779|12131643|FG000|Stage 1|Physician Decision|0
7709377|NCT00467779|12131644|FG001|Stage 1|Physician Decision|1
7709378|NCT00467779|12131645|FG002|Stage 1|Physician Decision|0
7709379|NCT00467779|12131646|FG003|Stage 1|Physician Decision|0
7709380|NCT00467779|12131647|FG004|Stage 1|Physician Decision|0
7709381|NCT00467779|12131648|FG005|Stage 1|Physician Decision|0
7709382|NCT00467779|12131649|FG006|Stage 1|Physician Decision|0
7709383|NCT00467779|12131650|FG007|Stage 1|Physician Decision|0
7709384|NCT00467779|12131651|FG008|Stage 1|Physician Decision|0
7709385|NCT00467779|12131652|FG009|Stage 1|Physician Decision|0
7709386|NCT00467779|12131653|FG010|Stage 1|Physician Decision|0
7709387|NCT00467779|12131654|FG011|Stage 1|Physician Decision|0
7709388|NCT00467779|12131655|FG012|Stage 1|Physician Decision|0
7709389|NCT00467779|12131656|FG013|Stage 1|Physician Decision|0
7709390|NCT00467779|12131657|FG014|Stage 1|Physician Decision|0
7709391|NCT00467779|12131643|FG000|Stage 1|Withdrawal by Subject|0
7709392|NCT00467779|12131644|FG001|Stage 1|Withdrawal by Subject|0
7709393|NCT00467779|12131645|FG002|Stage 1|Withdrawal by Subject|0
7709394|NCT00467779|12131646|FG003|Stage 1|Withdrawal by Subject|0
7709395|NCT00467779|12131647|FG004|Stage 1|Withdrawal by Subject|0
7709396|NCT00467779|12131648|FG005|Stage 1|Withdrawal by Subject|0
7709397|NCT00467779|12131649|FG006|Stage 1|Withdrawal by Subject|1
7709398|NCT00467779|12131650|FG007|Stage 1|Withdrawal by Subject|1
7709399|NCT00467779|12131651|FG008|Stage 1|Withdrawal by Subject|0
7709400|NCT00467779|12131652|FG009|Stage 1|Withdrawal by Subject|0
7709401|NCT00467779|12131653|FG010|Stage 1|Withdrawal by Subject|0
7709402|NCT00467779|12131654|FG011|Stage 1|Withdrawal by Subject|0
7709403|NCT00467779|12131655|FG012|Stage 1|Withdrawal by Subject|0
7709404|NCT00467779|12131656|FG013|Stage 1|Withdrawal by Subject|0
7709405|NCT00467779|12131657|FG014|Stage 1|Withdrawal by Subject|0
7709406|NCT00467779|12131643|FG000|Stage 1A|Adverse Event|0
7709407|NCT00467779|12131644|FG001|Stage 1A|Adverse Event|0
7709408|NCT00467779|12131645|FG002|Stage 1A|Adverse Event|0
7709409|NCT00467779|12131646|FG003|Stage 1A|Adverse Event|0
7709410|NCT00467779|12131647|FG004|Stage 1A|Adverse Event|0
7709411|NCT00467779|12131648|FG005|Stage 1A|Adverse Event|0
7709412|NCT00467779|12131649|FG006|Stage 1A|Adverse Event|0
7709413|NCT00467779|12131650|FG007|Stage 1A|Adverse Event|0
7709414|NCT00467779|12131651|FG008|Stage 1A|Adverse Event|0
7709415|NCT00467779|12131652|FG009|Stage 1A|Adverse Event|0
7709416|NCT00467779|12131653|FG010|Stage 1A|Adverse Event|0
7709417|NCT00467779|12131654|FG011|Stage 1A|Adverse Event|0
7709418|NCT00467779|12131655|FG012|Stage 1A|Adverse Event|1
7709419|NCT00467779|12131656|FG013|Stage 1A|Adverse Event|0
7709420|NCT00467779|12131657|FG014|Stage 1A|Adverse Event|0
7709421|NCT00467779|12131643|FG000|Stage 1A|Death|0
7709422|NCT00467779|12131644|FG001|Stage 1A|Death|0
7709423|NCT00467779|12131645|FG002|Stage 1A|Death|0
7709424|NCT00467779|12131646|FG003|Stage 1A|Death|0
7709425|NCT00467779|12131647|FG004|Stage 1A|Death|0
7709426|NCT00467779|12131648|FG005|Stage 1A|Death|0
7709427|NCT00467779|12131649|FG006|Stage 1A|Death|0
7709428|NCT00467779|12131650|FG007|Stage 1A|Death|0
7709429|NCT00467779|12131651|FG008|Stage 1A|Death|0
7709430|NCT00467779|12131652|FG009|Stage 1A|Death|0
7709431|NCT00467779|12131653|FG010|Stage 1A|Death|0
7709432|NCT00467779|12131654|FG011|Stage 1A|Death|1
7709433|NCT00467779|12131655|FG012|Stage 1A|Death|1
7709434|NCT00467779|12131656|FG013|Stage 1A|Death|0
7709435|NCT00467779|12131657|FG014|Stage 1A|Death|0
7709436|NCT00467779|12131643|FG000|Stage 1A|Disease Progression|0
7709437|NCT00467779|12131644|FG001|Stage 1A|Disease Progression|0
7709438|NCT00467779|12131645|FG002|Stage 1A|Disease Progression|0
7709439|NCT00467779|12131646|FG003|Stage 1A|Disease Progression|0
7709440|NCT00467779|12131647|FG004|Stage 1A|Disease Progression|0
7709441|NCT00467779|12131648|FG005|Stage 1A|Disease Progression|0
7709442|NCT00467779|12131649|FG006|Stage 1A|Disease Progression|0
7709443|NCT00467779|12131650|FG007|Stage 1A|Disease Progression|0
7709444|NCT00467779|12131651|FG008|Stage 1A|Disease Progression|0
7709445|NCT00467779|12131652|FG009|Stage 1A|Disease Progression|2
7709446|NCT00467779|12131653|FG010|Stage 1A|Disease Progression|2
7709447|NCT00467779|12131654|FG011|Stage 1A|Disease Progression|5
7709448|NCT00467779|12131655|FG012|Stage 1A|Disease Progression|2
7709449|NCT00467779|12131656|FG013|Stage 1A|Disease Progression|0
7709450|NCT00467779|12131657|FG014|Stage 1A|Disease Progression|0
7709451|NCT00467779|12131643|FG000|Stage 1A|Physician Decision|0
7709452|NCT00467779|12131644|FG001|Stage 1A|Physician Decision|0
7709453|NCT00467779|12131645|FG002|Stage 1A|Physician Decision|0
7709454|NCT00467779|12131646|FG003|Stage 1A|Physician Decision|0
7709455|NCT00467779|12131647|FG004|Stage 1A|Physician Decision|0
7709456|NCT00467779|12131648|FG005|Stage 1A|Physician Decision|0
7709457|NCT00467779|12131649|FG006|Stage 1A|Physician Decision|0
7709458|NCT00467779|12131650|FG007|Stage 1A|Physician Decision|0
7709459|NCT00467779|12131651|FG008|Stage 1A|Physician Decision|0
7709460|NCT00467779|12131652|FG009|Stage 1A|Physician Decision|1
7709461|NCT00467779|12131653|FG010|Stage 1A|Physician Decision|0
7709462|NCT00467779|12131654|FG011|Stage 1A|Physician Decision|0
7709463|NCT00467779|12131655|FG012|Stage 1A|Physician Decision|0
7709464|NCT00467779|12131656|FG013|Stage 1A|Physician Decision|0
7709465|NCT00467779|12131657|FG014|Stage 1A|Physician Decision|0
7709466|NCT00467779|12131643|FG000|Stage 1A|Withdrawal by Subject|0
7709467|NCT00467779|12131644|FG001|Stage 1A|Withdrawal by Subject|0
7709468|NCT00467779|12131645|FG002|Stage 1A|Withdrawal by Subject|0
7709469|NCT00467779|12131646|FG003|Stage 1A|Withdrawal by Subject|0
7709470|NCT00467779|12131647|FG004|Stage 1A|Withdrawal by Subject|0
7709471|NCT00467779|12131648|FG005|Stage 1A|Withdrawal by Subject|0
7709472|NCT00467779|12131649|FG006|Stage 1A|Withdrawal by Subject|0
7709473|NCT00467779|12131650|FG007|Stage 1A|Withdrawal by Subject|0
7709474|NCT00467779|12131651|FG008|Stage 1A|Withdrawal by Subject|0
7709475|NCT00467779|12131652|FG009|Stage 1A|Withdrawal by Subject|0
7709476|NCT00467779|12131653|FG010|Stage 1A|Withdrawal by Subject|1
7709477|NCT00467779|12131654|FG011|Stage 1A|Withdrawal by Subject|1
7709478|NCT00467779|12131655|FG012|Stage 1A|Withdrawal by Subject|1
7709479|NCT00467779|12131656|FG013|Stage 1A|Withdrawal by Subject|0
7709480|NCT00467779|12131657|FG014|Stage 1A|Withdrawal by Subject|0
7709481|NCT00467779|12131643|FG000|Stage 1A|Unspecified Reason|0
7709482|NCT00467779|12131644|FG001|Stage 1A|Unspecified Reason|0
7709483|NCT00467779|12131645|FG002|Stage 1A|Unspecified Reason|0
7709484|NCT00467779|12131646|FG003|Stage 1A|Unspecified Reason|0
7709485|NCT00467779|12131647|FG004|Stage 1A|Unspecified Reason|0
7709486|NCT00467779|12131648|FG005|Stage 1A|Unspecified Reason|0
7709487|NCT00467779|12131649|FG006|Stage 1A|Unspecified Reason|0
7709488|NCT00467779|12131650|FG007|Stage 1A|Unspecified Reason|0
7709489|NCT00467779|12131651|FG008|Stage 1A|Unspecified Reason|0
7709490|NCT00467779|12131652|FG009|Stage 1A|Unspecified Reason|0
7709491|NCT00467779|12131653|FG010|Stage 1A|Unspecified Reason|0
7709492|NCT00467779|12131654|FG011|Stage 1A|Unspecified Reason|1
7709493|NCT00467779|12131655|FG012|Stage 1A|Unspecified Reason|1
7709494|NCT00467779|12131656|FG013|Stage 1A|Unspecified Reason|0
7709495|NCT00467779|12131657|FG014|Stage 1A|Unspecified Reason|0
7709496|NCT00467779|12131643|FG000|Stage 2|Adverse Event|0
7709497|NCT00467779|12131644|FG001|Stage 2|Adverse Event|0
7709498|NCT00467779|12131645|FG002|Stage 2|Adverse Event|0
7709499|NCT00467779|12131646|FG003|Stage 2|Adverse Event|0
7709500|NCT00467779|12131647|FG004|Stage 2|Adverse Event|0
7709501|NCT00467779|12131648|FG005|Stage 2|Adverse Event|0
7709502|NCT00467779|12131649|FG006|Stage 2|Adverse Event|0
7709503|NCT00467779|12131650|FG007|Stage 2|Adverse Event|0
7709504|NCT00467779|12131651|FG008|Stage 2|Adverse Event|1
7709505|NCT00467779|12131652|FG009|Stage 2|Adverse Event|0
7709506|NCT00467779|12131653|FG010|Stage 2|Adverse Event|0
7709507|NCT00467779|12131654|FG011|Stage 2|Adverse Event|0
7709508|NCT00467779|12131655|FG012|Stage 2|Adverse Event|0
7709509|NCT00467779|12131656|FG013|Stage 2|Adverse Event|0
7709510|NCT00467779|12131657|FG014|Stage 2|Adverse Event|0
7709511|NCT00467779|12131643|FG000|Stage 2|Death|0
7709512|NCT00467779|12131644|FG001|Stage 2|Death|0
7709513|NCT00467779|12131645|FG002|Stage 2|Death|0
7709514|NCT00467779|12131646|FG003|Stage 2|Death|0
7709515|NCT00467779|12131647|FG004|Stage 2|Death|0
7709516|NCT00467779|12131648|FG005|Stage 2|Death|0
7709517|NCT00467779|12131649|FG006|Stage 2|Death|0
7709518|NCT00467779|12131650|FG007|Stage 2|Death|0
7709519|NCT00467779|12131651|FG008|Stage 2|Death|1
7709520|NCT00467779|12131652|FG009|Stage 2|Death|0
7709521|NCT00467779|12131653|FG010|Stage 2|Death|0
7709522|NCT00467779|12131654|FG011|Stage 2|Death|0
7709523|NCT00467779|12131655|FG012|Stage 2|Death|0
7709524|NCT00467779|12131656|FG013|Stage 2|Death|0
7709525|NCT00467779|12131657|FG014|Stage 2|Death|0
7709526|NCT00467779|12131643|FG000|Stage 2|Disease Progression|0
7709527|NCT00467779|12131644|FG001|Stage 2|Disease Progression|0
7709528|NCT00467779|12131645|FG002|Stage 2|Disease Progression|0
7709529|NCT00467779|12131646|FG003|Stage 2|Disease Progression|0
7709530|NCT00467779|12131647|FG004|Stage 2|Disease Progression|0
7709531|NCT00467779|12131648|FG005|Stage 2|Disease Progression|0
7709532|NCT00467779|12131649|FG006|Stage 2|Disease Progression|0
7709533|NCT00467779|12131650|FG007|Stage 2|Disease Progression|0
7709534|NCT00467779|12131651|FG008|Stage 2|Disease Progression|16
7709535|NCT00467779|12131652|FG009|Stage 2|Disease Progression|0
7709536|NCT00467779|12131653|FG010|Stage 2|Disease Progression|0
7709537|NCT00467779|12131654|FG011|Stage 2|Disease Progression|0
7709538|NCT00467779|12131655|FG012|Stage 2|Disease Progression|0
7709539|NCT00467779|12131656|FG013|Stage 2|Disease Progression|0
7709540|NCT00467779|12131657|FG014|Stage 2|Disease Progression|0
7709541|NCT00467779|12131643|FG000|Stage 2|Unspecified Reason|0
7709542|NCT00467779|12131644|FG001|Stage 2|Unspecified Reason|0
7709543|NCT00467779|12131645|FG002|Stage 2|Unspecified Reason|0
7709544|NCT00467779|12131646|FG003|Stage 2|Unspecified Reason|0
7709545|NCT00467779|12131647|FG004|Stage 2|Unspecified Reason|0
7709546|NCT00467779|12131648|FG005|Stage 2|Unspecified Reason|0
7709547|NCT00467779|12131649|FG006|Stage 2|Unspecified Reason|0
7709548|NCT00467779|12131650|FG007|Stage 2|Unspecified Reason|0
7709549|NCT00467779|12131651|FG008|Stage 2|Unspecified Reason|3
7709550|NCT00467779|12131652|FG009|Stage 2|Unspecified Reason|0
7709551|NCT00467779|12131653|FG010|Stage 2|Unspecified Reason|0
7709552|NCT00467779|12131654|FG011|Stage 2|Unspecified Reason|0
7709553|NCT00467779|12131655|FG012|Stage 2|Unspecified Reason|0
7709554|NCT00467779|12131656|FG013|Stage 2|Unspecified Reason|0
7709555|NCT00467779|12131657|FG014|Stage 2|Unspecified Reason|0
7709556|NCT00467779|12131643|FG000|Stage 2A|Adverse Event|0
7709557|NCT00467779|12131644|FG001|Stage 2A|Adverse Event|0
7709558|NCT00467779|12131645|FG002|Stage 2A|Adverse Event|0
7709559|NCT00467779|12131646|FG003|Stage 2A|Adverse Event|0
7709560|NCT00467779|12131647|FG004|Stage 2A|Adverse Event|0
7709561|NCT00467779|12131648|FG005|Stage 2A|Adverse Event|0
7709562|NCT00467779|12131649|FG006|Stage 2A|Adverse Event|0
7709563|NCT00467779|12131650|FG007|Stage 2A|Adverse Event|0
7709564|NCT00467779|12131651|FG008|Stage 2A|Adverse Event|0
7709565|NCT00467779|12131652|FG009|Stage 2A|Adverse Event|0
7709566|NCT00467779|12131653|FG010|Stage 2A|Adverse Event|0
7709567|NCT00467779|12131654|FG011|Stage 2A|Adverse Event|0
7709568|NCT00467779|12131655|FG012|Stage 2A|Adverse Event|0
7709569|NCT00467779|12131656|FG013|Stage 2A|Adverse Event|2
7709570|NCT00467779|12131657|FG014|Stage 2A|Adverse Event|0
7709571|NCT00467779|12131643|FG000|Stage 2A|Death|0
7709572|NCT00467779|12131644|FG001|Stage 2A|Death|0
7709573|NCT00467779|12131645|FG002|Stage 2A|Death|0
7709574|NCT00467779|12131646|FG003|Stage 2A|Death|0
7709575|NCT00467779|12131647|FG004|Stage 2A|Death|0
7709576|NCT00467779|12131648|FG005|Stage 2A|Death|0
7709577|NCT00467779|12131649|FG006|Stage 2A|Death|0
7709578|NCT00467779|12131650|FG007|Stage 2A|Death|0
7709579|NCT00467779|12131651|FG008|Stage 2A|Death|0
7709580|NCT00467779|12131652|FG009|Stage 2A|Death|0
7709581|NCT00467779|12131653|FG010|Stage 2A|Death|0
7709582|NCT00467779|12131654|FG011|Stage 2A|Death|0
7709583|NCT00467779|12131655|FG012|Stage 2A|Death|0
7709584|NCT00467779|12131656|FG013|Stage 2A|Death|1
7709585|NCT00467779|12131657|FG014|Stage 2A|Death|0
7709586|NCT00467779|12131643|FG000|Stage 2A|Disease Progression|0
7709587|NCT00467779|12131644|FG001|Stage 2A|Disease Progression|0
7709588|NCT00467779|12131645|FG002|Stage 2A|Disease Progression|0
7709589|NCT00467779|12131646|FG003|Stage 2A|Disease Progression|0
7709590|NCT00467779|12131647|FG004|Stage 2A|Disease Progression|0
7709591|NCT00467779|12131648|FG005|Stage 2A|Disease Progression|0
7709592|NCT00467779|12131649|FG006|Stage 2A|Disease Progression|0
7709593|NCT00467779|12131650|FG007|Stage 2A|Disease Progression|0
7709594|NCT00467779|12131651|FG008|Stage 2A|Disease Progression|0
7709595|NCT00467779|12131652|FG009|Stage 2A|Disease Progression|0
7709596|NCT00467779|12131653|FG010|Stage 2A|Disease Progression|0
7709597|NCT00467779|12131654|FG011|Stage 2A|Disease Progression|0
7709598|NCT00467779|12131655|FG012|Stage 2A|Disease Progression|0
7709599|NCT00467779|12131656|FG013|Stage 2A|Disease Progression|10
7709600|NCT00467779|12131657|FG014|Stage 2A|Disease Progression|0
7709601|NCT00467779|12131643|FG000|Stage 2A|Unspecified Reason|0
7709602|NCT00467779|12131644|FG001|Stage 2A|Unspecified Reason|0
7709603|NCT00467779|12131645|FG002|Stage 2A|Unspecified Reason|0
7709604|NCT00467779|12131646|FG003|Stage 2A|Unspecified Reason|0
7709605|NCT00467779|12131647|FG004|Stage 2A|Unspecified Reason|0
7709606|NCT00467779|12131648|FG005|Stage 2A|Unspecified Reason|0
7709607|NCT00467779|12131649|FG006|Stage 2A|Unspecified Reason|0
7709608|NCT00467779|12131650|FG007|Stage 2A|Unspecified Reason|0
7709609|NCT00467779|12131651|FG008|Stage 2A|Unspecified Reason|0
7709610|NCT00467779|12131652|FG009|Stage 2A|Unspecified Reason|0
7709611|NCT00467779|12131653|FG010|Stage 2A|Unspecified Reason|0
7709612|NCT00467779|12131654|FG011|Stage 2A|Unspecified Reason|0
7709613|NCT00467779|12131655|FG012|Stage 2A|Unspecified Reason|0
7709614|NCT00467779|12131656|FG013|Stage 2A|Unspecified Reason|7
7709615|NCT00467779|12131657|FG014|Stage 2A|Unspecified Reason|0
7709616|NCT00467779|12131643|FG000|Stage 2A|Withdrawal by Subject|0
7709617|NCT00467779|12131644|FG001|Stage 2A|Withdrawal by Subject|0
7709618|NCT00467779|12131645|FG002|Stage 2A|Withdrawal by Subject|0
7709619|NCT00467779|12131646|FG003|Stage 2A|Withdrawal by Subject|0
7709620|NCT00467779|12131647|FG004|Stage 2A|Withdrawal by Subject|0
7709621|NCT00467779|12131648|FG005|Stage 2A|Withdrawal by Subject|0
7709622|NCT00467779|12131649|FG006|Stage 2A|Withdrawal by Subject|0
7709623|NCT00467779|12131650|FG007|Stage 2A|Withdrawal by Subject|0
7709624|NCT00467779|12131651|FG008|Stage 2A|Withdrawal by Subject|0
7709625|NCT00467779|12131652|FG009|Stage 2A|Withdrawal by Subject|0
7709626|NCT00467779|12131653|FG010|Stage 2A|Withdrawal by Subject|0
7709627|NCT00467779|12131654|FG011|Stage 2A|Withdrawal by Subject|0
7709628|NCT00467779|12131655|FG012|Stage 2A|Withdrawal by Subject|0
7709629|NCT00467779|12131656|FG013|Stage 2A|Withdrawal by Subject|1
7709630|NCT00467779|12131657|FG014|Stage 2A|Withdrawal by Subject|0
7709631|NCT00467779|12131643|FG000|Stage 3|Adverse Event|0
7709632|NCT00467779|12131644|FG001|Stage 3|Adverse Event|0
7709633|NCT00467779|12131645|FG002|Stage 3|Adverse Event|0
7709634|NCT00467779|12131646|FG003|Stage 3|Adverse Event|0
7709635|NCT00467779|12131647|FG004|Stage 3|Adverse Event|0
7709636|NCT00467779|12131648|FG005|Stage 3|Adverse Event|0
7709637|NCT00467779|12131649|FG006|Stage 3|Adverse Event|0
7709638|NCT00467779|12131650|FG007|Stage 3|Adverse Event|0
7709639|NCT00467779|12131651|FG008|Stage 3|Adverse Event|0
7709640|NCT00467779|12131652|FG009|Stage 3|Adverse Event|0
7709641|NCT00467779|12131653|FG010|Stage 3|Adverse Event|0
7709642|NCT00467779|12131654|FG011|Stage 3|Adverse Event|0
7709643|NCT00467779|12131655|FG012|Stage 3|Adverse Event|0
7709644|NCT00467779|12131656|FG013|Stage 3|Adverse Event|0
7709645|NCT00467779|12131657|FG014|Stage 3|Adverse Event|2
7709646|NCT00467779|12131643|FG000|Stage 3|Death|0
7709647|NCT00467779|12131644|FG001|Stage 3|Death|0
7709648|NCT00467779|12131645|FG002|Stage 3|Death|0
7709649|NCT00467779|12131646|FG003|Stage 3|Death|0
7709650|NCT00467779|12131647|FG004|Stage 3|Death|0
7709651|NCT00467779|12131648|FG005|Stage 3|Death|0
7709652|NCT00467779|12131649|FG006|Stage 3|Death|0
7709653|NCT00467779|12131650|FG007|Stage 3|Death|0
7709654|NCT00467779|12131651|FG008|Stage 3|Death|0
7709655|NCT00467779|12131652|FG009|Stage 3|Death|0
7709656|NCT00467779|12131653|FG010|Stage 3|Death|0
7709657|NCT00467779|12131654|FG011|Stage 3|Death|0
7709658|NCT00467779|12131655|FG012|Stage 3|Death|0
7709659|NCT00467779|12131656|FG013|Stage 3|Death|0
7709660|NCT00467779|12131657|FG014|Stage 3|Death|1
7709661|NCT00467779|12131643|FG000|Stage 3|Disease Progression|0
7709662|NCT00467779|12131644|FG001|Stage 3|Disease Progression|0
7709663|NCT00467779|12131645|FG002|Stage 3|Disease Progression|0
7709664|NCT00467779|12131646|FG003|Stage 3|Disease Progression|0
7709665|NCT00467779|12131647|FG004|Stage 3|Disease Progression|0
7709666|NCT00467779|12131648|FG005|Stage 3|Disease Progression|0
7709667|NCT00467779|12131649|FG006|Stage 3|Disease Progression|0
7709668|NCT00467779|12131650|FG007|Stage 3|Disease Progression|0
7709669|NCT00467779|12131651|FG008|Stage 3|Disease Progression|0
7709670|NCT00467779|12131652|FG009|Stage 3|Disease Progression|0
7709671|NCT00467779|12131653|FG010|Stage 3|Disease Progression|0
7709672|NCT00467779|12131654|FG011|Stage 3|Disease Progression|0
7709673|NCT00467779|12131655|FG012|Stage 3|Disease Progression|0
7709674|NCT00467779|12131656|FG013|Stage 3|Disease Progression|0
7709675|NCT00467779|12131657|FG014|Stage 3|Disease Progression|9
7709676|NCT00467779|12131643|FG000|Stage 3|Unspecified Reason|0
7709677|NCT00467779|12131644|FG001|Stage 3|Unspecified Reason|0
7709678|NCT00467779|12131645|FG002|Stage 3|Unspecified Reason|0
7709679|NCT00467779|12131646|FG003|Stage 3|Unspecified Reason|0
7709680|NCT00467779|12131647|FG004|Stage 3|Unspecified Reason|0
7709681|NCT00467779|12131648|FG005|Stage 3|Unspecified Reason|0
7709682|NCT00467779|12131649|FG006|Stage 3|Unspecified Reason|0
7709683|NCT00467779|12131650|FG007|Stage 3|Unspecified Reason|0
7709684|NCT00467779|12131651|FG008|Stage 3|Unspecified Reason|0
7709685|NCT00467779|12131652|FG009|Stage 3|Unspecified Reason|0
7709686|NCT00467779|12131653|FG010|Stage 3|Unspecified Reason|0
7709687|NCT00467779|12131654|FG011|Stage 3|Unspecified Reason|0
7709688|NCT00467779|12131655|FG012|Stage 3|Unspecified Reason|0
7709689|NCT00467779|12131656|FG013|Stage 3|Unspecified Reason|0
7709690|NCT00467779|12131657|FG014|Stage 3|Unspecified Reason|5
7709691|NCT00467818|12131697|FG000|Overall Study|Adverse Event|1
7709692|NCT00467818|12131698|FG001|Overall Study|Adverse Event|0
7709693|NCT00467818|12131697|FG000|Overall Study|Lost to Follow-up|2
7709694|NCT00467818|12131698|FG001|Overall Study|Lost to Follow-up|2
7709695|NCT00467831|12131706|FG000|Overall Study|Death|2
7709696|NCT00467831|12131706|FG000|Overall Study|Withdrawal by Subject|1
7709697|NCT00467857|12131728|FG000|Overall Study|Adverse Event|1
7709698|NCT00467857|12131729|FG001|Overall Study|Adverse Event|0
7709699|NCT00467857|12131728|FG000|Overall Study|Withdrew consent|2
7709700|NCT00467857|12131729|FG001|Overall Study|Withdrew consent|0
7709701|NCT00467857|12131728|FG000|Overall Study|Death|0
7709702|NCT00467857|12131729|FG001|Overall Study|Death|1
7709703|NCT00467857|12131728|FG000|Overall Study|Discharged from court service|0
7709704|NCT00467857|12131729|FG001|Overall Study|Discharged from court service|1
7709705|NCT00467857|12131728|FG000|Overall Study|Emergency care required|0
7709706|NCT00467857|12131729|FG001|Overall Study|Emergency care required|1
7709707|NCT00467857|12131728|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0
7709708|NCT00467857|12131729|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2
7709709|NCT00467857|12131728|FG000|Overall Study|Discontinuation reason missing|0
7709710|NCT00467857|12131729|FG001|Overall Study|Discontinuation reason missing|3
7709711|NCT00467870|12131741|FG000|Overall Study|Adverse Event|13
7709712|NCT00467870|12131742|FG001|Overall Study|Adverse Event|9
7709713|NCT00467870|12131743|FG002|Overall Study|Adverse Event|1
7709714|NCT00467870|12131744|FG003|Overall Study|Adverse Event|15
7709715|NCT00467870|12131745|FG004|Overall Study|Adverse Event|15
7709716|NCT00467870|12131746|FG005|Overall Study|Adverse Event|1
7709717|NCT00467870|12131741|FG000|Overall Study|Protocol Violation|2
7709718|NCT00467870|12131742|FG001|Overall Study|Protocol Violation|1
7709719|NCT00467870|12131743|FG002|Overall Study|Protocol Violation|1
7709720|NCT00467870|12131744|FG003|Overall Study|Protocol Violation|2
7709721|NCT00467870|12131745|FG004|Overall Study|Protocol Violation|0
7709722|NCT00467870|12131746|FG005|Overall Study|Protocol Violation|0
7709723|NCT00467870|12131741|FG000|Overall Study|Withdrawal by Subject|14
7709724|NCT00467870|12131742|FG001|Overall Study|Withdrawal by Subject|21
7709725|NCT00467870|12131743|FG002|Overall Study|Withdrawal by Subject|0
7709726|NCT00467870|12131744|FG003|Overall Study|Withdrawal by Subject|9
7709727|NCT00467870|12131745|FG004|Overall Study|Withdrawal by Subject|10
7709728|NCT00467870|12131746|FG005|Overall Study|Withdrawal by Subject|1
7709729|NCT00467870|12131741|FG000|Overall Study|Lost to Follow-up|5
7709730|NCT00467870|12131742|FG001|Overall Study|Lost to Follow-up|3
7709731|NCT00467870|12131743|FG002|Overall Study|Lost to Follow-up|1
7709732|NCT00467870|12131744|FG003|Overall Study|Lost to Follow-up|1
7709733|NCT00467870|12131745|FG004|Overall Study|Lost to Follow-up|3
7709734|NCT00467870|12131746|FG005|Overall Study|Lost to Follow-up|0
7709735|NCT00467870|12131741|FG000|Overall Study|Subject Non-compliance|3
7709736|NCT00467870|12131742|FG001|Overall Study|Subject Non-compliance|4
7709737|NCT00467870|12131743|FG002|Overall Study|Subject Non-compliance|0
7709738|NCT00467870|12131744|FG003|Overall Study|Subject Non-compliance|1
7709739|NCT00467870|12131745|FG004|Overall Study|Subject Non-compliance|5
7709740|NCT00467870|12131746|FG005|Overall Study|Subject Non-compliance|0
7709741|NCT00467870|12131741|FG000|Overall Study|Other/Unknown|8
7709742|NCT00467870|12131742|FG001|Overall Study|Other/Unknown|5
7709743|NCT00467870|12131743|FG002|Overall Study|Other/Unknown|1
7709744|NCT00467870|12131744|FG003|Overall Study|Other/Unknown|5
7709745|NCT00467870|12131745|FG004|Overall Study|Other/Unknown|4
7709746|NCT00467870|12131746|FG005|Overall Study|Other/Unknown|0
7709747|NCT00467896|12131756|FG000|Overall Study|Consent Withdrawal|18
7709748|NCT00467896|12131756|FG000|Overall Study|Adverse Event|7
7709749|NCT00467896|12131756|FG000|Overall Study|Serious Adverse Event|13
7709750|NCT00467896|12131756|FG000|Overall Study|Non-compliance|3
7709751|NCT00467896|12131756|FG000|Overall Study|Changed therapy|2
7709752|NCT00467896|12131756|FG000|Overall Study|Patient received transplant|2
7709753|NCT00467896|12131756|FG000|Overall Study|Patient had atrial septostomy|1
7709754|NCT00467896|12131756|FG000|Overall Study|Patient weaned off iloprost|1
7709755|NCT00467896|12131756|FG000|Overall Study|Mainly used Prodose not I-neb® device|1
7709756|NCT00467896|12131756|FG000|Overall Study|Started intravenous prostacyclin|1
7709757|NCT00467896|12131756|FG000|Overall Study|Started inhaled Remodulin|1
7709758|NCT00467896|12131756|FG000|Overall Study|Patient had no improvement|1
7709759|NCT00467961|12131762|FG000|Overall Study|Technical Failures|5
7709760|NCT00467961|12131762|FG000|Overall Study|Disease Progression|2
7709761|NCT00468052|12131768|FG000|Overall Study|Protocol Violation|7
7709762|NCT00468052|12131769|FG001|Overall Study|Protocol Violation|8
7709763|NCT00468104|12131777|FG000|First Intervention|Protocol Violation|2
7709764|NCT00468104|12131778|FG001|First Intervention|Protocol Violation|1
7709765|NCT00468104|12131777|FG000|First Intervention|bleeding at chest tube site--first dose|1
7709766|NCT00468104|12131778|FG001|First Intervention|bleeding at chest tube site--first dose|0
7709767|NCT00468104|12131777|FG000|First Intervention|died within 3 weeks|1
7709768|NCT00468104|12131778|FG001|First Intervention|died within 3 weeks|0
7709769|NCT00468104|12131777|FG000|First Intervention|malposition/blocked chest tube tube|2
7709770|NCT00468104|12131778|FG001|First Intervention|malposition/blocked chest tube tube|0
7709771|NCT00468104|12131777|FG000|First Intervention|large lung mass with minimal effusion|1
7709772|NCT00468104|12131778|FG001|First Intervention|large lung mass with minimal effusion|0
7709773|NCT00468104|12131777|FG000|First Intervention|associated prolonged pneumothorax|1
7709774|NCT00468104|12131778|FG001|First Intervention|associated prolonged pneumothorax|0
7709775|NCT00468104|12131777|FG000|First Intervention|trapped lung|1
7709776|NCT00468104|12131778|FG001|First Intervention|trapped lung|0
7709777|NCT00468104|12131777|FG000|Second Intervention|Withdrawal by Subject|5
7709778|NCT00468104|12131778|FG001|Second Intervention|Withdrawal by Subject|2
7709779|NCT00468104|12131777|FG000|Second Intervention|discarded for malposition of chest tube|0
7709780|NCT00468104|12131778|FG001|Second Intervention|discarded for malposition of chest tube|2
7709781|NCT00468143|12131787|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3
7709782|NCT00468143|12131788|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4
7709783|NCT00468143|12131787|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3
7709784|NCT00468143|12131788|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3
7709785|NCT00468169|12131796|FG000|Overall Study|Withdrawal by Subject|1
7709786|NCT00468169|12131797|FG001|Overall Study|Withdrawal by Subject|0
7709787|NCT00468286|12131811|FG000|Overall Study|Adverse Event|1
7709788|NCT00468286|12131812|FG001|Overall Study|Adverse Event|6
7709789|NCT00468286|12131811|FG000|Overall Study|Protocol Violation|2
7709790|NCT00468286|12131812|FG001|Overall Study|Protocol Violation|2
7709791|NCT00468286|12131811|FG000|Overall Study|Withdrawal by Subject|4
7709792|NCT00468286|12131812|FG001|Overall Study|Withdrawal by Subject|3
7709793|NCT00468286|12131811|FG000|Overall Study|Physician Decision|0
7709794|NCT00468286|12131812|FG001|Overall Study|Physician Decision|1
7709795|NCT00468299|12131820|FG000|Overall Study|Withdrawal by Subject|0
7709796|NCT00468299|12131821|FG001|Overall Study|Withdrawal by Subject|1
7709797|NCT00468481|12131831|FG000|Overall Study|Adverse Event|13
7709798|NCT00468481|12131832|FG001|Overall Study|Adverse Event|3
7709799|NCT00468481|12131831|FG000|Overall Study|Lost to Follow-up|25
7709800|NCT00468481|12131832|FG001|Overall Study|Lost to Follow-up|8
7709801|NCT00468481|12131831|FG000|Overall Study|Pregnancy|2
7709802|NCT00468481|12131832|FG001|Overall Study|Pregnancy|0
7709803|NCT00468481|12131831|FG000|Overall Study|Protocol Violation|18
7709804|NCT00468481|12131832|FG001|Overall Study|Protocol Violation|8
7709805|NCT00468481|12131831|FG000|Overall Study|Withdrawal by Subject|12
7709806|NCT00468481|12131832|FG001|Overall Study|Withdrawal by Subject|3
7709807|NCT00468481|12131831|FG000|Overall Study|susp/diag malignant/premalignant disease|1
7709808|NCT00468481|12131832|FG001|Overall Study|susp/diag malignant/premalignant disease|0
7709809|NCT00468481|12131831|FG000|Overall Study|Prohibited Medication|1
7709810|NCT00468481|12131832|FG001|Overall Study|Prohibited Medication|1
7709811|NCT00468481|12131831|FG000|Overall Study|Egg Donor|1
7709812|NCT00468481|12131832|FG001|Overall Study|Egg Donor|0
7709813|NCT00468481|12131831|FG000|Overall Study|Moved out of area|4
7709814|NCT00468481|12131832|FG001|Overall Study|Moved out of area|1
7709815|NCT00468481|12131831|FG000|Overall Study|Non-Compliance|5
7709816|NCT00468481|12131832|FG001|Overall Study|Non-Compliance|0
7709817|NCT00468481|12131831|FG000|Overall Study|Other|6
7709818|NCT00468481|12131832|FG001|Overall Study|Other|0
7709819|NCT00468546|12131840|FG000|Week 24 Analysis|Lack of Efficacy|83
7709820|NCT00468546|12131841|FG001|Week 24 Analysis|Lack of Efficacy|37
7709821|NCT00468546|12131840|FG000|Week 24 Analysis|Refused treatment|5
7709822|NCT00468546|12131841|FG001|Week 24 Analysis|Refused treatment|5
7709823|NCT00468546|12131840|FG000|Week 24 Analysis|Adverse Event|1
7709824|NCT00468546|12131841|FG001|Week 24 Analysis|Adverse Event|8
7709825|NCT00468546|12131840|FG000|Week 24 Analysis|Failure to return|3
7709826|NCT00468546|12131841|FG001|Week 24 Analysis|Failure to return|4
7709827|NCT00468546|12131840|FG000|Week 24 Analysis|Rescue therapy|2
7709828|NCT00468546|12131841|FG001|Week 24 Analysis|Rescue therapy|0
7709829|NCT00468546|12131840|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0
7709830|NCT00468546|12131841|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1
7709831|NCT00468546|12131840|FG000|Week 24 Analysis|Due to clinical hold|1
7709832|NCT00468546|12131841|FG001|Week 24 Analysis|Due to clinical hold|0
7709833|NCT00468546|12131840|FG000|Week 24 Analysis|Went onto rescue therapy|1
7709834|NCT00468546|12131841|FG001|Week 24 Analysis|Went onto rescue therapy|0
7709835|NCT00468546|12131840|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1
7709836|NCT00468546|12131841|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0
7709837|NCT00468546|12131840|FG000|Week 24 to Week 104 Analysis|Adverse Event|2
7709838|NCT00468546|12131841|FG001|Week 24 to Week 104 Analysis|Adverse Event|5
7709839|NCT00468546|12131840|FG000|Week 24 to Week 104 Analysis|Death|1
7709840|NCT00468546|12131841|FG001|Week 24 to Week 104 Analysis|Death|0
7709841|NCT00468546|12131840|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3
7709842|NCT00468546|12131841|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12
7709843|NCT00468546|12131840|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0
7709844|NCT00468546|12131841|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2
7709845|NCT00468546|12131840|FG000|Week 24 to Week 104 Analysis|Refused treatment|4
7709846|NCT00468546|12131841|FG001|Week 24 to Week 104 Analysis|Refused treatment|7
7709847|NCT00468546|12131840|FG000|Week 24 to Week 104 Analysis|Failure to return|1
7709848|NCT00468546|12131841|FG001|Week 24 to Week 104 Analysis|Failure to return|2
7709849|NCT00468546|12131840|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
7709850|NCT00468546|12131841|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
7709851|NCT00468546|12131840|FG000|Week 24 to Week 104 Analysis|Other|17
7709852|NCT00468546|12131841|FG001|Week 24 to Week 104 Analysis|Other|14
7709853|NCT00468559|12131849|FG000|Open-label Treatment Phase|Adverse Event|5
7709854|NCT00468559|12131850|FG001|Open-label Treatment Phase|Adverse Event|0
7709855|NCT00468559|12131851|FG002|Open-label Treatment Phase|Adverse Event|0
7709856|NCT00468559|12131849|FG000|Open-label Treatment Phase|Lack of Efficacy|9
7709857|NCT00468559|12131850|FG001|Open-label Treatment Phase|Lack of Efficacy|0
7709858|NCT00468559|12131851|FG002|Open-label Treatment Phase|Lack of Efficacy|0
7709859|NCT00468559|12131849|FG000|Open-label Treatment Phase|Withdrawal by Subject|4
7709860|NCT00468559|12131850|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
7709861|NCT00468559|12131851|FG002|Open-label Treatment Phase|Withdrawal by Subject|0
7709862|NCT00468559|12131849|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
7709863|NCT00468559|12131850|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
7709864|NCT00468559|12131851|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
7709865|NCT00468559|12131849|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
7709866|NCT00468559|12131850|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
7709867|NCT00468559|12131851|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
7709868|NCT00468585|12131863|FG000|Overall Study|Patient not treated|1
7709869|NCT00468585|12131864|FG001|Overall Study|Patient not treated|0
7709870|NCT00468585|12131865|FG002|Overall Study|Patient not treated|1
7709871|NCT00468585|12131866|FG003|Overall Study|Patient not treated|0
7709872|NCT00468585|12131863|FG000|Overall Study|Patient found to be ineligible|0
7709873|NCT00468585|12131864|FG001|Overall Study|Patient found to be ineligible|0
7709874|NCT00468585|12131865|FG002|Overall Study|Patient found to be ineligible|1
7709875|NCT00468585|12131866|FG003|Overall Study|Patient found to be ineligible|0
7709876|NCT00468585|12131863|FG000|Overall Study|Adverse Event|0
7709877|NCT00468585|12131864|FG001|Overall Study|Adverse Event|0
7709878|NCT00468585|12131865|FG002|Overall Study|Adverse Event|1
7709879|NCT00468585|12131866|FG003|Overall Study|Adverse Event|0
7709880|NCT00468585|12131863|FG000|Overall Study|Withdrawal by Subject|0
7709881|NCT00468585|12131864|FG001|Overall Study|Withdrawal by Subject|0
7709882|NCT00468585|12131865|FG002|Overall Study|Withdrawal by Subject|2
7709883|NCT00468585|12131866|FG003|Overall Study|Withdrawal by Subject|1
7709884|NCT00468650|12131876|FG000|Overall Study|Lost to Follow-up|4
7709885|NCT00468650|12131876|FG000|Overall Study|Withdrawal by Subject|2
7709886|NCT00468650|12131876|FG000|Overall Study|Protocol Violation|1
7709887|NCT00468676|12131883|FG000|Overall Study|Lost to Follow-up|14
7709888|NCT00468676|12131884|FG001|Overall Study|Lost to Follow-up|11
7709889|NCT00468676|12131883|FG000|Overall Study|Death|2
7709890|NCT00468676|12131884|FG001|Overall Study|Death|1
7709891|NCT00468728|12131894|FG000|Treatment|criteria for mITT population|4
7709892|NCT00468728|12131895|FG001|Treatment|criteria for mITT population|11
7709893|NCT00468728|12131894|FG000|Follow-up|mITT failure|34
7709894|NCT00468728|12131895|FG001|Follow-up|mITT failure|31
7709895|NCT00468819|12131906|FG000|Overall Study|Withdrawal by Subject|4
7709896|NCT00468819|12131907|FG001|Overall Study|Withdrawal by Subject|0
7709897|NCT00468819|12131908|FG002|Overall Study|Withdrawal by Subject|1
7709898|NCT00468819|12131906|FG000|Overall Study|Lost to Follow-up|0
7709899|NCT00468819|12131907|FG001|Overall Study|Lost to Follow-up|0
7709900|NCT00468819|12131908|FG002|Overall Study|Lost to Follow-up|1
7709901|NCT00468819|12131906|FG000|Overall Study|Drop-outs (Treatment never received)|2
7709902|NCT00468819|12131907|FG001|Overall Study|Drop-outs (Treatment never received)|0
7709903|NCT00468819|12131908|FG002|Overall Study|Drop-outs (Treatment never received)|0
7709904|NCT00468845|12131921|FG000|Overall Study|Adverse Event|9
7709905|NCT00468845|12131922|FG001|Overall Study|Adverse Event|14
7709906|NCT00468845|12131923|FG002|Overall Study|Adverse Event|11
7709907|NCT00468845|12131921|FG000|Overall Study|Lost to Follow-up|2
7709908|NCT00468845|12131922|FG001|Overall Study|Lost to Follow-up|1
7709909|NCT00468845|12131923|FG002|Overall Study|Lost to Follow-up|2
7709910|NCT00468845|12131921|FG000|Overall Study|Other|4
7709911|NCT00468845|12131922|FG001|Overall Study|Other|9
7709912|NCT00468845|12131923|FG002|Overall Study|Other|5
7709913|NCT00468845|12131921|FG000|Overall Study|No longer willing to participate|5
7709914|NCT00468845|12131922|FG001|Overall Study|No longer willing to participate|6
7709915|NCT00468845|12131923|FG002|Overall Study|No longer willing to participate|10
7709916|NCT00468845|12131921|FG000|Overall Study|Randomized, not treated|1
7709917|NCT00468845|12131922|FG001|Overall Study|Randomized, not treated|4
7709918|NCT00468845|12131923|FG002|Overall Study|Randomized, not treated|2
7709919|NCT00468858|12131934|FG000|Overall Study|Adverse Event|0
7709920|NCT00468858|12131935|FG001|Overall Study|Adverse Event|1
7709921|NCT00468858|12131936|FG002|Overall Study|Adverse Event|0
7709922|NCT00468858|12131934|FG000|Overall Study|Withdrawal by Subject|7
7709923|NCT00468858|12131935|FG001|Overall Study|Withdrawal by Subject|4
7709924|NCT00468858|12131936|FG002|Overall Study|Withdrawal by Subject|5
7709925|NCT00468858|12131934|FG000|Overall Study|Relocation|1
7709926|NCT00468858|12131935|FG001|Overall Study|Relocation|3
7709927|NCT00468858|12131936|FG002|Overall Study|Relocation|3
7709928|NCT00468858|12131934|FG000|Overall Study|Lost to Follow-up|1
7709929|NCT00468858|12131935|FG001|Overall Study|Lost to Follow-up|2
7709930|NCT00468858|12131936|FG002|Overall Study|Lost to Follow-up|5
7709931|NCT00468858|12131934|FG000|Overall Study|Other|0
7709932|NCT00468858|12131935|FG001|Overall Study|Other|0
7709933|NCT00468858|12131936|FG002|Overall Study|Other|1
7709934|NCT00468910|12132000|FG000|Overall Study|Lost to Follow-up|2
7709935|NCT00468910|12132001|FG001|Overall Study|Lost to Follow-up|1
7709936|NCT00468910|12132000|FG000|Overall Study|Withdrawal by Subject|2
7709937|NCT00468910|12132001|FG001|Overall Study|Withdrawal by Subject|1
7709938|NCT00468910|12132000|FG000|Overall Study|Medical Contraindication|0
7709939|NCT00468910|12132001|FG001|Overall Study|Medical Contraindication|1
7709940|NCT00469014|12132012|FG000|Initial Phase Randomization|Disease Progression|0
7709941|NCT00469014|12132013|FG001|Initial Phase Randomization|Disease Progression|1
7709942|NCT00469014|12132014|FG002|Initial Phase Randomization|Disease Progression|1
7709943|NCT00469014|12132015|FG003|Initial Phase Randomization|Disease Progression|0
7709944|NCT00469014|12132012|FG000|Initial Phase Randomization|No Response|1
7709945|NCT00469014|12132013|FG001|Initial Phase Randomization|No Response|0
7709946|NCT00469014|12132014|FG002|Initial Phase Randomization|No Response|0
7709947|NCT00469014|12132015|FG003|Initial Phase Randomization|No Response|1
7709948|NCT00469014|12132012|FG000|Adaptive Randomization|Not Evaluable|1
7709949|NCT00469014|12132013|FG001|Adaptive Randomization|Not Evaluable|0
7709950|NCT00469014|12132014|FG002|Adaptive Randomization|Not Evaluable|0
7709951|NCT00469014|12132015|FG003|Adaptive Randomization|Not Evaluable|1
7709952|NCT00469014|12132012|FG000|Adaptive Randomization|No Response|0
7709953|NCT00469014|12132013|FG001|Adaptive Randomization|No Response|1
7709954|NCT00469014|12132014|FG002|Adaptive Randomization|No Response|0
7709955|NCT00469014|12132015|FG003|Adaptive Randomization|No Response|0
7709956|NCT00469014|12132012|FG000|Adaptive Randomization|Death|0
7709957|NCT00469014|12132013|FG001|Adaptive Randomization|Death|0
7709958|NCT00469014|12132014|FG002|Adaptive Randomization|Death|1
7709959|NCT00469014|12132015|FG003|Adaptive Randomization|Death|0
7709960|NCT00469079|12132028|FG000|Overall Study|Lack of Efficacy|3
7709961|NCT00469079|12132029|FG001|Overall Study|Lack of Efficacy|8
7709962|NCT00469079|12132030|FG002|Overall Study|Lack of Efficacy|5
7709963|NCT00469079|12132028|FG000|Overall Study|Adverse Event|1
7709964|NCT00469079|12132029|FG001|Overall Study|Adverse Event|3
7709965|NCT00469079|12132030|FG002|Overall Study|Adverse Event|2
7709966|NCT00469079|12132028|FG000|Overall Study|Lost to Follow-up|4
7709967|NCT00469079|12132029|FG001|Overall Study|Lost to Follow-up|8
7709968|NCT00469079|12132030|FG002|Overall Study|Lost to Follow-up|10
7709969|NCT00469079|12132028|FG000|Overall Study|Withdrawal by Subject|1
7709970|NCT00469079|12132029|FG001|Overall Study|Withdrawal by Subject|2
7709971|NCT00469079|12132030|FG002|Overall Study|Withdrawal by Subject|2
7709972|NCT00469079|12132028|FG000|Overall Study|Ineligible|0
7709973|NCT00469079|12132029|FG001|Overall Study|Ineligible|1
7709974|NCT00469079|12132030|FG002|Overall Study|Ineligible|0
7709975|NCT00469092|12132046|FG000|Overall Study|Adverse Event|5
7709976|NCT00469092|12132047|FG001|Overall Study|Adverse Event|4
7709977|NCT00469092|12132046|FG000|Overall Study|Lack of Efficacy|1
7709978|NCT00469092|12132047|FG001|Overall Study|Lack of Efficacy|0
7709979|NCT00469092|12132046|FG000|Overall Study|Lost to Follow-up|1
7709980|NCT00469092|12132047|FG001|Overall Study|Lost to Follow-up|2
7709981|NCT00469092|12132046|FG000|Overall Study|Protocol Violation|3
7709982|NCT00469092|12132047|FG001|Overall Study|Protocol Violation|3
7709983|NCT00469092|12132046|FG000|Overall Study|Withdrawal by Subject|4
7709984|NCT00469092|12132047|FG001|Overall Study|Withdrawal by Subject|4
7709985|NCT00469092|12132046|FG000|Overall Study|Withdrawal Criteria|3
7709986|NCT00469092|12132047|FG001|Overall Study|Withdrawal Criteria|4
7709987|NCT00469092|12132046|FG000|Overall Study|Incorrectly Randomised|4
7709988|NCT00469092|12132047|FG001|Overall Study|Incorrectly Randomised|3
7709989|NCT00469092|12132046|FG000|Overall Study|Contraindication metformin/glimepiride|1
7709990|NCT00469092|12132047|FG001|Overall Study|Contraindication metformin/glimepiride|0
7709991|NCT00469092|12132046|FG000|Overall Study|Use of lipid lowering drug|1
7709992|NCT00469092|12132047|FG001|Overall Study|Use of lipid lowering drug|0
7709993|NCT00469092|12132046|FG000|Overall Study|Hypoglycaemic Episodes|1
7709994|NCT00469092|12132047|FG001|Overall Study|Hypoglycaemic Episodes|1
7709995|NCT00469092|12132046|FG000|Overall Study|Abnormal lab value|1
7709996|NCT00469092|12132047|FG001|Overall Study|Abnormal lab value|0
7709997|NCT00469092|12132046|FG000|Overall Study|Use of Corticosteroid|1
7709998|NCT00469092|12132047|FG001|Overall Study|Use of Corticosteroid|0
7709999|NCT00469144|12132055|FG000|Overall Study|Death|0
7710000|NCT00469144|12132056|FG001|Overall Study|Death|1
7710001|NCT00469144|12132055|FG000|Overall Study|No Response|5
7710002|NCT00469144|12132056|FG001|Overall Study|No Response|5
7710003|NCT00469144|12132055|FG000|Overall Study|Progressive Disease|1
7710004|NCT00469144|12132056|FG001|Overall Study|Progressive Disease|0
7710005|NCT00469209|12132069|FG000|Overall Study|Adverse Event|1
7710006|NCT00469209|12132070|FG001|Overall Study|Adverse Event|0
7710007|NCT00469209|12132071|FG002|Overall Study|Adverse Event|1
7710008|NCT00469456|12132099|FG000|Overall Study|Adverse Event|4
7710009|NCT00469456|12132100|FG001|Overall Study|Adverse Event|3
7710010|NCT00469456|12132099|FG000|Overall Study|Protocol Violation|1
7710011|NCT00469456|12132100|FG001|Overall Study|Protocol Violation|0
7710012|NCT00469456|12132099|FG000|Overall Study|Withdrawal by Subject|4
7710013|NCT00469456|12132100|FG001|Overall Study|Withdrawal by Subject|1
7710014|NCT00469833|12132115|FG000|Overall Study|No IV access|2
7710015|NCT00469859|12132127|FG000|Overall Study|Inevaluable|0
7710016|NCT00469859|12132128|FG001|Overall Study|Inevaluable|2
7710017|NCT00469898|12132134|FG000|Overall Study|Adverse Event|7
7710018|NCT00469898|12132134|FG000|Overall Study|Withdrawal by Subject|4
7710019|NCT00469898|12132134|FG000|Overall Study|Death|4
7710020|NCT00469898|12132134|FG000|Overall Study|Disease progression|9
7710021|NCT00469898|12132134|FG000|Overall Study|Decreased performance status|1
7710022|NCT00470054|12132146|FG000|Overall Study|Ineligible|1
7710023|NCT00470093|12132150|FG000|Overall Study|Adverse Event|2
7710024|NCT00470158|12132180|FG000|Overall Study|Death|0
7710025|NCT00470158|12132181|FG001|Overall Study|Death|0
7710026|NCT00470158|12132182|FG002|Overall Study|Death|0
7710027|NCT00470158|12132183|FG003|Overall Study|Death|0
7710028|NCT00470158|12132184|FG004|Overall Study|Death|2
7710029|NCT00470158|12132180|FG000|Overall Study|Lost to Follow-up|7
7710030|NCT00470158|12132181|FG001|Overall Study|Lost to Follow-up|8
7710031|NCT00470158|12132182|FG002|Overall Study|Lost to Follow-up|8
7710032|NCT00470158|12132183|FG003|Overall Study|Lost to Follow-up|5
7710033|NCT00470158|12132184|FG004|Overall Study|Lost to Follow-up|4
7710034|NCT00470158|12132180|FG000|Overall Study|Protocol Violation|1
7710035|NCT00470158|12132181|FG001|Overall Study|Protocol Violation|0
7710036|NCT00470158|12132182|FG002|Overall Study|Protocol Violation|0
7710037|NCT00470158|12132183|FG003|Overall Study|Protocol Violation|0
7710038|NCT00470158|12132184|FG004|Overall Study|Protocol Violation|0
7710039|NCT00470184|12132196|FG000|Overall Study|Not Treated(became ineligible)|4
7710040|NCT00470184|12132196|FG000|Overall Study|Not treated (other)|1
7710041|NCT00470184|12132196|FG000|Overall Study|disease Progression|4
7710042|NCT00470184|12132196|FG000|Overall Study|Adverse Event|3
7710043|NCT00470184|12132196|FG000|Overall Study|Withdrawal by Subject|4
7710044|NCT00470184|12132196|FG000|Overall Study|other|5
7710045|NCT00470184|12132196|FG000|Overall Study|recurrence|1
7710046|NCT00470262|12132203|FG000|Overall Study|Withdrawal by Subject|2
7710047|NCT00470262|12132204|FG001|Overall Study|Withdrawal by Subject|0
7710048|NCT00470275|12132211|FG000|Overall Study|Death|1
7710049|NCT00470275|12132211|FG000|Overall Study|Lack of Efficacy|7
7710050|NCT00470275|12132211|FG000|Overall Study|Withdrawal by Subject|2
7710051|NCT00470366|12132220|FG000|Overall Study|Adverse Event|3
7710052|NCT00470366|12132220|FG000|Overall Study|Poor compliance|1
7710053|NCT00470418|12132236|FG000|Overall Study|Withdrawal by Subject|1
7710054|NCT00470418|12132237|FG001|Overall Study|Withdrawal by Subject|0
7710055|NCT00470470|12132243|FG000|Overall Study|Adverse Event|2
7710056|NCT00470470|12132243|FG000|Overall Study|Death|2
7710057|NCT00470470|12132243|FG000|Overall Study|Not treated|1
7710058|NCT00470535|12132247|FG000|Overall Study|Disease Progression|13
7710059|NCT00470535|12132247|FG000|Overall Study|Withdrawal by Subject|1
7710060|NCT00470535|12132247|FG000|Overall Study|Adverse Event|1
7710061|NCT00470535|12132247|FG000|Overall Study|Death|1
7710062|NCT00470535|12132247|FG000|Overall Study|Other|2
7710063|NCT00470626|12132275|FG000|Overall Study|Lost to Follow-up|10
7710064|NCT00470626|12132275|FG000|Overall Study|Withdrawal by Subject|7
7710065|NCT00470834|12132285|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
7710066|NCT00470834|12132286|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
7710067|NCT00470834|12132285|FG000|Treatment Period (18 Months)|Adverse Event|7
7710068|NCT00470834|12132286|FG001|Treatment Period (18 Months)|Adverse Event|6
7710069|NCT00470834|12132285|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4
7710070|NCT00470834|12132286|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5
7710071|NCT00470834|12132285|FG000|Treatment Period (18 Months)|Physician Decision|4
7710072|NCT00470834|12132286|FG001|Treatment Period (18 Months)|Physician Decision|4
7710073|NCT00470834|12132285|FG000|Treatment Period (18 Months)|Protocol Violation|3
7710074|NCT00470834|12132286|FG001|Treatment Period (18 Months)|Protocol Violation|1
7710075|NCT00470834|12132285|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1
7710076|NCT00470834|12132286|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1
7710077|NCT00470834|12132285|FG000|Treatment Period (18 Months)|Lost to Follow-up|1
7710078|NCT00470834|12132286|FG001|Treatment Period (18 Months)|Lost to Follow-up|0
7710079|NCT00470834|12132285|FG000|Treatment Period (18 Months)|Non-compliance|1
7710080|NCT00470834|12132286|FG001|Treatment Period (18 Months)|Non-compliance|0
7710081|NCT00470834|12132285|FG000|Treatment Period (18 Months)|Lack of Efficacy|1
7710082|NCT00470834|12132286|FG001|Treatment Period (18 Months)|Lack of Efficacy|0
7710083|NCT00470834|12132285|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
7710084|NCT00470834|12132286|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
7710085|NCT00470834|12132285|FG000|Extension Period (24 Months)|Adverse Event|3
7710086|NCT00470834|12132286|FG001|Extension Period (24 Months)|Adverse Event|4
7710087|NCT00470834|12132285|FG000|Extension Period (24 Months)|Withdrawal by Subject|2
7710088|NCT00470834|12132286|FG001|Extension Period (24 Months)|Withdrawal by Subject|5
7710089|NCT00470834|12132285|FG000|Extension Period (24 Months)|Physician Decision|4
7710090|NCT00470834|12132286|FG001|Extension Period (24 Months)|Physician Decision|3
7710091|NCT00470834|12132285|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0
7710092|NCT00470834|12132286|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1
7710093|NCT00470834|12132285|FG000|Extension Period (24 Months)|Lost to Follow-up|0
7710094|NCT00470834|12132286|FG001|Extension Period (24 Months)|Lost to Follow-up|1
7710095|NCT00470834|12132285|FG000|Extension Period (24 Months)|Non-compliance|0
7710096|NCT00470834|12132286|FG001|Extension Period (24 Months)|Non-compliance|1
7710097|NCT00470834|12132285|FG000|Extension Period (24 Months)|Disease Progression|0
7710098|NCT00470834|12132286|FG001|Extension Period (24 Months)|Disease Progression|1
7710099|NCT00470847|12132292|FG000|Overall Study|Pt still receiving treatment|1
7710100|NCT00471081|12132309|FG000|Active Phase|Protocol Violation|1
7710101|NCT00471081|12132310|FG001|Active Phase|Protocol Violation|1
7710102|NCT00471081|12132309|FG000|Active Phase|Withdrawal by Subject|0
7710103|NCT00471081|12132310|FG001|Active Phase|Withdrawal by Subject|3
7710104|NCT00471081|12132309|FG000|Active Phase|Lost to Follow-up|0
7710105|NCT00471081|12132310|FG001|Active Phase|Lost to Follow-up|1
7710106|NCT00471081|12132309|FG000|Active Phase|Lost health plan/insurance|1
7710107|NCT00471081|12132310|FG001|Active Phase|Lost health plan/insurance|8
7710108|NCT00471081|12132309|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1
7710109|NCT00471081|12132310|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4
7710110|NCT00471081|12132309|FG000|Extended Safety Follow-Up|Lost to Follow-up|1
7710111|NCT00471081|12132310|FG001|Extended Safety Follow-Up|Lost to Follow-up|8
7710112|NCT00471081|12132309|FG000|Extended Safety Follow-Up|Missing confirmed|0
7710113|NCT00471081|12132310|FG001|Extended Safety Follow-Up|Missing confirmed|1
7710114|NCT00471107|12132320|FG000|Overall Study|Technical problems/data loss|3
7710115|NCT00471107|12132321|FG001|Overall Study|Technical problems/data loss|1
7710116|NCT00471107|12132322|FG002|Overall Study|Technical problems/data loss|3
7710117|NCT00471146|12132332|FG000|Overall Study|Adverse Event|32
7710118|NCT00471146|12132333|FG001|Overall Study|Adverse Event|33
7710119|NCT00471146|12132332|FG000|Overall Study|Withdrawal by Subject|14
7710120|NCT00471146|12132333|FG001|Overall Study|Withdrawal by Subject|11
7710121|NCT00471146|12132332|FG000|Overall Study|Death|11
7710122|NCT00471146|12132333|FG001|Overall Study|Death|12
7710123|NCT00471146|12132332|FG000|Overall Study|Lost to Follow-up|4
7710124|NCT00471146|12132333|FG001|Overall Study|Lost to Follow-up|2
7710125|NCT00471146|12132332|FG000|Overall Study|Protocol Violation|2
7710126|NCT00471146|12132333|FG001|Overall Study|Protocol Violation|2
7710127|NCT00471146|12132332|FG000|Overall Study|Objective progression or relapse|84
7710128|NCT00471146|12132333|FG001|Overall Study|Objective progression or relapse|87
7710129|NCT00471146|12132332|FG000|Overall Study|Global deterioration of health status|12
7710130|NCT00471146|12132333|FG001|Overall Study|Global deterioration of health status|14
7710131|NCT00471146|12132332|FG000|Overall Study|Randomized but not treated|9
7710132|NCT00471146|12132333|FG001|Overall Study|Randomized but not treated|8
7710133|NCT00471146|12132332|FG000|Overall Study|Other|4
7710134|NCT00471146|12132333|FG001|Overall Study|Other|5
7710135|NCT00471237|12132346|FG000|Overall Study|Adverse Event|6
7710136|NCT00471237|12132347|FG001|Overall Study|Adverse Event|5
7710137|NCT00471237|12132348|FG002|Overall Study|Adverse Event|4
7710138|NCT00471237|12132349|FG003|Overall Study|Adverse Event|8
7710139|NCT00471237|12132350|FG004|Overall Study|Adverse Event|7
7710140|NCT00471237|12132351|FG005|Overall Study|Adverse Event|5
7710141|NCT00471237|12132352|FG006|Overall Study|Adverse Event|0
7710142|NCT00471237|12132346|FG000|Overall Study|Lost to Follow-up|1
7710143|NCT00471237|12132347|FG001|Overall Study|Lost to Follow-up|1
7710144|NCT00471237|12132348|FG002|Overall Study|Lost to Follow-up|0
7710145|NCT00471237|12132349|FG003|Overall Study|Lost to Follow-up|2
7710146|NCT00471237|12132350|FG004|Overall Study|Lost to Follow-up|3
7710147|NCT00471237|12132351|FG005|Overall Study|Lost to Follow-up|0
7710148|NCT00471237|12132352|FG006|Overall Study|Lost to Follow-up|0
7710149|NCT00471237|12132346|FG000|Overall Study|Protocol Violation|3
7710150|NCT00471237|12132347|FG001|Overall Study|Protocol Violation|6
7710151|NCT00471237|12132348|FG002|Overall Study|Protocol Violation|3
7710152|NCT00471237|12132349|FG003|Overall Study|Protocol Violation|2
7710153|NCT00471237|12132350|FG004|Overall Study|Protocol Violation|2
7710154|NCT00471237|12132351|FG005|Overall Study|Protocol Violation|4
7710155|NCT00471237|12132352|FG006|Overall Study|Protocol Violation|1
7710156|NCT00471237|12132346|FG000|Overall Study|Withdrawal by Subject|8
7710157|NCT00471237|12132347|FG001|Overall Study|Withdrawal by Subject|6
7710158|NCT00471237|12132348|FG002|Overall Study|Withdrawal by Subject|5
7710159|NCT00471237|12132349|FG003|Overall Study|Withdrawal by Subject|8
7710160|NCT00471237|12132350|FG004|Overall Study|Withdrawal by Subject|7
7710161|NCT00471237|12132351|FG005|Overall Study|Withdrawal by Subject|4
7710162|NCT00471237|12132352|FG006|Overall Study|Withdrawal by Subject|2
7710163|NCT00471237|12132346|FG000|Overall Study|Sponsor terminated study|20
7710164|NCT00471237|12132347|FG001|Overall Study|Sponsor terminated study|23
7710165|NCT00471237|12132348|FG002|Overall Study|Sponsor terminated study|19
7710166|NCT00471237|12132349|FG003|Overall Study|Sponsor terminated study|22
7710167|NCT00471237|12132350|FG004|Overall Study|Sponsor terminated study|18
7710168|NCT00471237|12132351|FG005|Overall Study|Sponsor terminated study|24
7710169|NCT00471237|12132352|FG006|Overall Study|Sponsor terminated study|0
7710170|NCT00471237|12132346|FG000|Overall Study|Non-compliance|0
7710171|NCT00471237|12132347|FG001|Overall Study|Non-compliance|1
7710172|NCT00471237|12132348|FG002|Overall Study|Non-compliance|0
7710173|NCT00471237|12132349|FG003|Overall Study|Non-compliance|1
7710174|NCT00471237|12132350|FG004|Overall Study|Non-compliance|0
7710175|NCT00471237|12132351|FG005|Overall Study|Non-compliance|0
7710176|NCT00471237|12132352|FG006|Overall Study|Non-compliance|0
7710177|NCT00471237|12132346|FG000|Overall Study|Met serum creatinine withdrawal criteria|1
7710178|NCT00471237|12132347|FG001|Overall Study|Met serum creatinine withdrawal criteria|0
7710179|NCT00471237|12132348|FG002|Overall Study|Met serum creatinine withdrawal criteria|2
7710180|NCT00471237|12132349|FG003|Overall Study|Met serum creatinine withdrawal criteria|2
7710181|NCT00471237|12132350|FG004|Overall Study|Met serum creatinine withdrawal criteria|0
7710182|NCT00471237|12132351|FG005|Overall Study|Met serum creatinine withdrawal criteria|0
7710183|NCT00471237|12132352|FG006|Overall Study|Met serum creatinine withdrawal criteria|0
7710184|NCT00471237|12132346|FG000|Overall Study|Early stopping due to non-efficacy|1
7710185|NCT00471237|12132347|FG001|Overall Study|Early stopping due to non-efficacy|0
7710186|NCT00471237|12132348|FG002|Overall Study|Early stopping due to non-efficacy|0
7710187|NCT00471237|12132349|FG003|Overall Study|Early stopping due to non-efficacy|0
7710188|NCT00471237|12132350|FG004|Overall Study|Early stopping due to non-efficacy|1
7710189|NCT00471237|12132351|FG005|Overall Study|Early stopping due to non-efficacy|0
7710190|NCT00471237|12132352|FG006|Overall Study|Early stopping due to non-efficacy|0
7710191|NCT00471237|12132346|FG000|Overall Study|Participant planned to travel to abraod|1
7710192|NCT00471237|12132347|FG001|Overall Study|Participant planned to travel to abraod|0
7710193|NCT00471237|12132348|FG002|Overall Study|Participant planned to travel to abraod|0
7710194|NCT00471237|12132349|FG003|Overall Study|Participant planned to travel to abraod|0
7710195|NCT00471237|12132350|FG004|Overall Study|Participant planned to travel to abraod|0
7710196|NCT00471237|12132351|FG005|Overall Study|Participant planned to travel to abraod|1
7710197|NCT00471237|12132352|FG006|Overall Study|Participant planned to travel to abraod|0
7710198|NCT00471237|12132346|FG000|Overall Study|High parathyroid hormone|0
7710199|NCT00471237|12132347|FG001|Overall Study|High parathyroid hormone|0
7710200|NCT00471237|12132348|FG002|Overall Study|High parathyroid hormone|1
7710201|NCT00471237|12132349|FG003|Overall Study|High parathyroid hormone|0
7710202|NCT00471237|12132350|FG004|Overall Study|High parathyroid hormone|0
7710203|NCT00471237|12132351|FG005|Overall Study|High parathyroid hormone|0
7710204|NCT00471237|12132352|FG006|Overall Study|High parathyroid hormone|0
7710205|NCT00471237|12132346|FG000|Overall Study|Participant lost medication|0
7710206|NCT00471237|12132347|FG001|Overall Study|Participant lost medication|0
7710207|NCT00471237|12132348|FG002|Overall Study|Participant lost medication|0
7710208|NCT00471237|12132349|FG003|Overall Study|Participant lost medication|0
7710209|NCT00471237|12132350|FG004|Overall Study|Participant lost medication|1
7710210|NCT00471237|12132351|FG005|Overall Study|Participant lost medication|0
7710211|NCT00471237|12132352|FG006|Overall Study|Participant lost medication|0
7710212|NCT00471237|12132346|FG000|Overall Study|Administration of prohibited medicine|0
7710213|NCT00471237|12132347|FG001|Overall Study|Administration of prohibited medicine|0
7710214|NCT00471237|12132348|FG002|Overall Study|Administration of prohibited medicine|0
7710215|NCT00471237|12132349|FG003|Overall Study|Administration of prohibited medicine|0
7710216|NCT00471237|12132350|FG004|Overall Study|Administration of prohibited medicine|1
7710217|NCT00471237|12132351|FG005|Overall Study|Administration of prohibited medicine|0
7710218|NCT00471237|12132352|FG006|Overall Study|Administration of prohibited medicine|0
7710219|NCT00471237|12132346|FG000|Overall Study|Participant shifted residence|0
7710220|NCT00471237|12132347|FG001|Overall Study|Participant shifted residence|0
7710221|NCT00471237|12132348|FG002|Overall Study|Participant shifted residence|0
7710222|NCT00471237|12132349|FG003|Overall Study|Participant shifted residence|0
7710223|NCT00471237|12132350|FG004|Overall Study|Participant shifted residence|1
7710224|NCT00471237|12132351|FG005|Overall Study|Participant shifted residence|0
7710225|NCT00471237|12132352|FG006|Overall Study|Participant shifted residence|0
7710226|NCT00471237|12132346|FG000|Overall Study|Participant's decision|0
7710227|NCT00471237|12132347|FG001|Overall Study|Participant's decision|0
7710228|NCT00471237|12132348|FG002|Overall Study|Participant's decision|0
7710229|NCT00471237|12132349|FG003|Overall Study|Participant's decision|0
7710230|NCT00471237|12132350|FG004|Overall Study|Participant's decision|0
7710231|NCT00471237|12132351|FG005|Overall Study|Participant's decision|1
7710232|NCT00471237|12132352|FG006|Overall Study|Participant's decision|0
7710233|NCT00471276|12132372|FG000|Overall Study|Death|2
7710234|NCT00471276|12132372|FG000|Overall Study|Adverse Event|16
7710235|NCT00471276|12132372|FG000|Overall Study|Protocol Violation|1
7710236|NCT00471276|12132372|FG000|Overall Study|Objective progression or relapse|54
7710237|NCT00471276|12132372|FG000|Overall Study|Global deterioration of health status|1
7710238|NCT00471276|12132372|FG000|Overall Study|Other|3
7710239|NCT00471276|12132372|FG000|Overall Study|Refused treatment|6
7710240|NCT00471315|12132376|FG000|Overall Study|Adverse Event|7
7710241|NCT00471315|12132376|FG000|Overall Study|Withdrawal by Subject|1
7710242|NCT00471328|12132382|FG000|Core Phase|Adverse Event|18
7710243|NCT00471328|12132383|FG001|Core Phase|Adverse Event|6
7710244|NCT00471328|12132382|FG000|Core Phase|Death|8
7710245|NCT00471328|12132383|FG001|Core Phase|Death|4
7710246|NCT00471328|12132382|FG000|Core Phase|Withdrawal by Subject|2
7710247|NCT00471328|12132383|FG001|Core Phase|Withdrawal by Subject|2
7710248|NCT00471328|12132382|FG000|Core Phase|Abnormal laboratory value|1
7710249|NCT00471328|12132383|FG001|Core Phase|Abnormal laboratory value|0
7710250|NCT00471328|12132382|FG000|Core Phase|Disease Progression|78
7710251|NCT00471328|12132383|FG001|Core Phase|Disease Progression|53
7710252|NCT00471328|12132382|FG000|Core Phase|Administrative Problem|0
7710253|NCT00471328|12132383|FG001|Core Phase|Administrative Problem|1
7710254|NCT00471328|12132382|FG000|Core Phase|Protocol Deviation|0
7710255|NCT00471328|12132383|FG001|Core Phase|Protocol Deviation|1
7710256|NCT00471328|12132382|FG000|Extension Phase|Adverse Event|3
7710257|NCT00471328|12132383|FG001|Extension Phase|Adverse Event|12
7710258|NCT00471328|12132382|FG000|Extension Phase|Withdrawal by Subject|0
7710259|NCT00471328|12132383|FG001|Extension Phase|Withdrawal by Subject|2
7710260|NCT00471328|12132382|FG000|Extension Phase|Death|1
7710261|NCT00471328|12132383|FG001|Extension Phase|Death|7
7710262|NCT00471328|12132382|FG000|Extension Phase|Protocol Deviation|3
7710263|NCT00471328|12132383|FG001|Extension Phase|Protocol Deviation|1
7710264|NCT00471328|12132382|FG000|Extension Phase|Treatment duration as per protocol|0
7710265|NCT00471328|12132383|FG001|Extension Phase|Treatment duration as per protocol|1
7710266|NCT00471328|12132382|FG000|Extension Phase|Disease Progression|32
7710267|NCT00471328|12132383|FG001|Extension Phase|Disease Progression|44
7710268|NCT00471328|12132382|FG000|Extension Phase|New cancer Therapy|1
7710269|NCT00471328|12132383|FG001|Extension Phase|New cancer Therapy|0
7710270|NCT00471328|12132382|FG000|Extension Phase|Administrative Problem|1
7710271|NCT00471328|12132383|FG001|Extension Phase|Administrative Problem|0
7710272|NCT00471354|12132391|FG000|Overall Study|Protocol Entry Criteria Not Met|1
7710273|NCT00471354|12132391|FG000|Overall Study|Adverse Event|13
7710274|NCT00471354|12132391|FG000|Overall Study|Protocol Violation|12
7710275|NCT00471354|12132391|FG000|Overall Study|Withdrawal by Subject|1
7710276|NCT00471354|12132391|FG000|Overall Study|Physician Decision|4
7710277|NCT00471354|12132391|FG000|Overall Study|Sponsor Decision|1
7710278|NCT00471354|12132391|FG000|Overall Study|Lost to Follow-up|3
7710279|NCT00471354|12132391|FG000|Overall Study|Lack of Efficacy|5
7710280|NCT00471354|12132391|FG000|Overall Study|Patient/Caregiver Decision|12
7710281|NCT00471445|12132404|FG000|Overall Study|Withdrawal by Subject|1
7710282|NCT00471445|12132405|FG001|Overall Study|Withdrawal by Subject|1
7710283|NCT00471445|12132404|FG000|Overall Study|Ineligible|1
7710284|NCT00471445|12132405|FG001|Overall Study|Ineligible|0
7710285|NCT00471445|12132404|FG000|Overall Study|Protocol Violation|0
7710286|NCT00471445|12132405|FG001|Overall Study|Protocol Violation|1
7710287|NCT00471497|12132414|FG000|Core Treatment Phase|Abnormal Laboratory Values|3
7710288|NCT00471497|12132415|FG001|Core Treatment Phase|Abnormal Laboratory Values|9
7710289|NCT00471497|12132416|FG002|Core Treatment Phase|Abnormal Laboratory Values|9
7710290|NCT00471497|12132414|FG000|Core Treatment Phase|Abnormal Test Procedures|1
7710291|NCT00471497|12132415|FG001|Core Treatment Phase|Abnormal Test Procedures|0
7710292|NCT00471497|12132416|FG002|Core Treatment Phase|Abnormal Test Procedures|1
7710293|NCT00471497|12132414|FG000|Core Treatment Phase|Condition no longer requires study drug|0
7710294|NCT00471497|12132415|FG001|Core Treatment Phase|Condition no longer requires study drug|1
7710295|NCT00471497|12132416|FG002|Core Treatment Phase|Condition no longer requires study drug|0
7710296|NCT00471497|12132414|FG000|Core Treatment Phase|Withdrawal by Subject|31
7710297|NCT00471497|12132415|FG001|Core Treatment Phase|Withdrawal by Subject|29
7710298|NCT00471497|12132416|FG002|Core Treatment Phase|Withdrawal by Subject|34
7710299|NCT00471497|12132414|FG000|Core Treatment Phase|Lost to Follow-up|6
7710300|NCT00471497|12132415|FG001|Core Treatment Phase|Lost to Follow-up|6
7710301|NCT00471497|12132416|FG002|Core Treatment Phase|Lost to Follow-up|3
7710302|NCT00471497|12132414|FG000|Core Treatment Phase|Death|3
7710303|NCT00471497|12132415|FG001|Core Treatment Phase|Death|9
7710304|NCT00471497|12132416|FG002|Core Treatment Phase|Death|3
7710305|NCT00471497|12132414|FG000|Core Treatment Phase|Disease Progression|10
7710306|NCT00471497|12132415|FG001|Core Treatment Phase|Disease Progression|2
7710307|NCT00471497|12132416|FG002|Core Treatment Phase|Disease Progression|4
7710308|NCT00471497|12132414|FG000|Core Treatment Phase|Protocol Violation|6
7710309|NCT00471497|12132415|FG001|Core Treatment Phase|Protocol Violation|15
7710310|NCT00471497|12132416|FG002|Core Treatment Phase|Protocol Violation|11
7710311|NCT00471497|12132414|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19
7710312|NCT00471497|12132415|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11
7710313|NCT00471497|12132416|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13
7710314|NCT00471497|12132414|FG000|Core Treatment Phase|Administrative problems|14
7710315|NCT00471497|12132415|FG001|Core Treatment Phase|Administrative problems|14
7710316|NCT00471497|12132416|FG002|Core Treatment Phase|Administrative problems|12
7710317|NCT00471497|12132414|FG000|Core Treatment Phase|Adverse Event|43
7710318|NCT00471497|12132415|FG001|Core Treatment Phase|Adverse Event|53
7710319|NCT00471497|12132416|FG002|Core Treatment Phase|Adverse Event|89
7710320|NCT00471497|12132414|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2
7710321|NCT00471497|12132415|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
7710322|NCT00471497|12132416|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
7710323|NCT00471497|12132414|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46
7710324|NCT00471497|12132415|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26
7710325|NCT00471497|12132416|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3
7710326|NCT00471497|12132414|FG000|Extension Phase|Adverse Event|9
7710327|NCT00471497|12132415|FG001|Extension Phase|Adverse Event|5
7710328|NCT00471497|12132416|FG002|Extension Phase|Adverse Event|1
7710329|NCT00471497|12132414|FG000|Extension Phase|Unsatisfactory therapeutic effect|8
7710330|NCT00471497|12132415|FG001|Extension Phase|Unsatisfactory therapeutic effect|6
7710331|NCT00471497|12132416|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
7710332|NCT00471497|12132414|FG000|Extension Phase|Withdrawal by Subject|3
7710333|NCT00471497|12132415|FG001|Extension Phase|Withdrawal by Subject|1
7710334|NCT00471497|12132416|FG002|Extension Phase|Withdrawal by Subject|0
7710335|NCT00471497|12132414|FG000|Extension Phase|Lost to Follow-up|2
7710336|NCT00471497|12132415|FG001|Extension Phase|Lost to Follow-up|0
7710337|NCT00471497|12132416|FG002|Extension Phase|Lost to Follow-up|0
7710338|NCT00471497|12132414|FG000|Extension Phase|Death|1
7710339|NCT00471497|12132415|FG001|Extension Phase|Death|0
7710340|NCT00471497|12132416|FG002|Extension Phase|Death|0
7710341|NCT00471497|12132414|FG000|Extension Phase|Disease progression|2
7710342|NCT00471497|12132415|FG001|Extension Phase|Disease progression|0
7710343|NCT00471497|12132416|FG002|Extension Phase|Disease progression|0
7710344|NCT00471497|12132414|FG000|Extension Phase|Protocol Violation|2
7710345|NCT00471497|12132415|FG001|Extension Phase|Protocol Violation|2
7710346|NCT00471497|12132416|FG002|Extension Phase|Protocol Violation|0
7710347|NCT00471536|12132427|FG000|Overall Study|Withdrawal by Subject|1
7710348|NCT00471718|12132444|FG000|Overall Study|Adverse Event|3
7710349|NCT00471718|12132444|FG000|Overall Study|other complicating disease|1
7710350|NCT00471718|12132444|FG000|Overall Study|disease progression|22
7710351|NCT00471718|12132444|FG000|Overall Study|Withdrawal by Subject|1
7710352|NCT00471822|12132452|FG000|Overall Study|Protocol Violation|2
7710353|NCT00471887|12132460|FG000|Overall Study|Adverse Event|9
7710354|NCT00472030|12132466|FG000|Overall Study|Physician Decision|1
7710355|NCT00472030|12132467|FG001|Overall Study|Physician Decision|0
7710356|NCT00472199|12132494|FG000|Overall Study|Adverse Event|19
7710357|NCT00472199|12132495|FG001|Overall Study|Adverse Event|23
7710358|NCT00472199|12132494|FG000|Overall Study|Lack of Efficacy|4
7710359|NCT00472199|12132495|FG001|Overall Study|Lack of Efficacy|25
7710360|NCT00472199|12132494|FG000|Overall Study|Lost to Follow-up|2
7710361|NCT00472199|12132495|FG001|Overall Study|Lost to Follow-up|4
7710362|NCT00472199|12132494|FG000|Overall Study|Protocol Violation|3
7710363|NCT00472199|12132495|FG001|Overall Study|Protocol Violation|2
7710364|NCT00472199|12132494|FG000|Overall Study|Withdrawal by Subject|6
7710365|NCT00472199|12132495|FG001|Overall Study|Withdrawal by Subject|5
7710366|NCT00472199|12132494|FG000|Overall Study|personal reason|0
7710367|NCT00472199|12132495|FG001|Overall Study|personal reason|1
7710368|NCT00472199|12132494|FG000|Overall Study|patient was asymptomatic|1
7710369|NCT00472199|12132495|FG001|Overall Study|patient was asymptomatic|0
7710370|NCT00472290|12132501|FG000|Overall Study|Progression of Therapy-Related MDS|1
7710371|NCT00472290|12132501|FG000|Overall Study|Protocol Specified Criteria|7
7710372|NCT00472290|12132501|FG000|Overall Study|Administrative Decision|37
7710373|NCT00472290|12132501|FG000|Overall Study|Death|3
7710374|NCT00472290|12132501|FG000|Overall Study|Lost to Follow-up|1
7710375|NCT00472290|12132501|FG000|Overall Study|Lack of Efficacy|1
7710376|NCT00472290|12132501|FG000|Overall Study|Disease Progression|4
7710377|NCT00472290|12132501|FG000|Overall Study|Withdrawal by Subject|5
7710378|NCT00472290|12132501|FG000|Overall Study|Adverse Event|6
7710379|NCT00472290|12132501|FG000|Overall Study|Requirement for alternative therapy|7
7710380|NCT00472303|12132507|FG000|Titration Phase|Adverse Event|22
7710381|NCT00472303|12132508|FG001|Titration Phase|Adverse Event|12
7710382|NCT00472303|12132509|FG002|Titration Phase|Adverse Event|0
7710383|NCT00472303|12132507|FG000|Titration Phase|Death|4
7710384|NCT00472303|12132508|FG001|Titration Phase|Death|2
7710385|NCT00472303|12132509|FG002|Titration Phase|Death|0
7710386|NCT00472303|12132507|FG000|Titration Phase|Lack of Efficacy|10
7710387|NCT00472303|12132508|FG001|Titration Phase|Lack of Efficacy|0
7710388|NCT00472303|12132509|FG002|Titration Phase|Lack of Efficacy|0
7710389|NCT00472303|12132507|FG000|Titration Phase|Withdrawal by Subject|16
7710390|NCT00472303|12132508|FG001|Titration Phase|Withdrawal by Subject|13
7710391|NCT00472303|12132509|FG002|Titration Phase|Withdrawal by Subject|0
7710392|NCT00472303|12132507|FG000|Titration Phase|Trial Medication non-compliant|4
7710393|NCT00472303|12132508|FG001|Titration Phase|Trial Medication non-compliant|1
7710394|NCT00472303|12132509|FG002|Titration Phase|Trial Medication non-compliant|0
7710395|NCT00472303|12132507|FG000|Titration Phase|Other|3
7710396|NCT00472303|12132508|FG001|Titration Phase|Other|1
7710397|NCT00472303|12132509|FG002|Titration Phase|Other|0
7710398|NCT00472303|12132507|FG000|Discontinuations After Titration Phase|Adverse Event|6
7710399|NCT00472303|12132508|FG001|Discontinuations After Titration Phase|Adverse Event|0
7710400|NCT00472303|12132509|FG002|Discontinuations After Titration Phase|Adverse Event|0
7710401|NCT00472303|12132507|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48
7710402|NCT00472303|12132508|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17
7710403|NCT00472303|12132509|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0
7710404|NCT00472303|12132507|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2
7710405|NCT00472303|12132508|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2
7710406|NCT00472303|12132509|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0
7710407|NCT00472303|12132507|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0
7710408|NCT00472303|12132508|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1
7710409|NCT00472303|12132509|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0
7710410|NCT00472303|12132507|FG000|Discontinuations After Titration Phase|Other|5
7710411|NCT00472303|12132508|FG001|Discontinuations After Titration Phase|Other|0
7710412|NCT00472303|12132509|FG002|Discontinuations After Titration Phase|Other|0
7710413|NCT00472303|12132507|FG000|Maintenance Phase|Adverse Event|5
7710414|NCT00472303|12132508|FG001|Maintenance Phase|Adverse Event|6
7710415|NCT00472303|12132509|FG002|Maintenance Phase|Adverse Event|6
7710416|NCT00472303|12132507|FG000|Maintenance Phase|Death|3
7710417|NCT00472303|12132508|FG001|Maintenance Phase|Death|0
7710418|NCT00472303|12132509|FG002|Maintenance Phase|Death|2
7710419|NCT00472303|12132507|FG000|Maintenance Phase|Lack of Efficacy|2
7710420|NCT00472303|12132508|FG001|Maintenance Phase|Lack of Efficacy|2
7710421|NCT00472303|12132509|FG002|Maintenance Phase|Lack of Efficacy|4
7710422|NCT00472303|12132507|FG000|Maintenance Phase|Withdrawal by Subject|6
7710423|NCT00472303|12132508|FG001|Maintenance Phase|Withdrawal by Subject|7
7710424|NCT00472303|12132509|FG002|Maintenance Phase|Withdrawal by Subject|3
7710425|NCT00472303|12132507|FG000|Maintenance Phase|Trial medication non-compliant|0
7710426|NCT00472303|12132508|FG001|Maintenance Phase|Trial medication non-compliant|0
7710427|NCT00472303|12132509|FG002|Maintenance Phase|Trial medication non-compliant|1
7710428|NCT00472303|12132507|FG000|Maintenance Phase|Resolution of pain|0
7710429|NCT00472303|12132508|FG001|Maintenance Phase|Resolution of pain|0
7710430|NCT00472303|12132509|FG002|Maintenance Phase|Resolution of pain|1
7710431|NCT00472303|12132507|FG000|Maintenance Phase|Other|1
7710432|NCT00472303|12132508|FG001|Maintenance Phase|Other|1
7710433|NCT00472303|12132509|FG002|Maintenance Phase|Other|0
7710434|NCT00472420|12132537|FG000|Induction Treatment Period|Physician Decision|9
7710435|NCT00472420|12132537|FG000|Induction Treatment Period|Adverse Event|3
7710436|NCT00472420|12132537|FG000|Induction Treatment Period|Non-compliance|1
7710437|NCT00472420|12132537|FG000|Induction Treatment Period|Death|3
7710438|NCT00472420|12132537|FG000|Follow-up Period|Death|5
7710439|NCT00472420|12132537|FG000|Follow-up Period|Physician Decision|9
7710440|NCT00472420|12132537|FG000|Follow-up Period|Lost to Follow-up|2
7710441|NCT00472420|12132537|FG000|Follow-up Period|Protocol Violation|1
7710442|NCT00472446|12132545|FG000|Overall Study|Protocol Violation|0
7710443|NCT00472446|12132546|FG001|Overall Study|Protocol Violation|0
7710444|NCT00472446|12132547|FG002|Overall Study|Protocol Violation|0
7710445|NCT00472446|12132548|FG003|Overall Study|Protocol Violation|1
7710446|NCT00472446|12132545|FG000|Overall Study|Reintervention|0
7710447|NCT00472446|12132546|FG001|Overall Study|Reintervention|0
7710448|NCT00472446|12132547|FG002|Overall Study|Reintervention|1
7710449|NCT00472446|12132548|FG003|Overall Study|Reintervention|1
7710450|NCT00472446|12132545|FG000|Overall Study|Questionnaires not returned|5
7710451|NCT00472446|12132546|FG001|Overall Study|Questionnaires not returned|6
7710452|NCT00472446|12132547|FG002|Overall Study|Questionnaires not returned|6
7710453|NCT00472446|12132548|FG003|Overall Study|Questionnaires not returned|4
7710454|NCT00472641|12132567|FG000|Overall Study|Lack of Efficacy|3
7710455|NCT00472641|12132567|FG000|Overall Study|Adverse Event|3
7710456|NCT00472641|12132567|FG000|Overall Study|Lost to Follow-up|1
7710457|NCT00473083|12132604|FG000|Overall Study|Adverse Event|1
7710458|NCT00473083|12132605|FG001|Overall Study|Adverse Event|0
7710459|NCT00473083|12132606|FG002|Overall Study|Adverse Event|0
7710460|NCT00473265|12132617|FG000|Overall Study|Unrelated adverse event|5
7710461|NCT00473265|12132617|FG000|Overall Study|Off treatment early|15
7710462|NCT00473330|12132624|FG000|Core Study|Adverse Event|4
7710463|NCT00473330|12132625|FG001|Core Study|Adverse Event|4
7710464|NCT00473330|12132626|FG002|Core Study|Adverse Event|1
7710465|NCT00473330|12132624|FG000|Core Study|Death|6
7710466|NCT00473330|12132625|FG001|Core Study|Death|4
7710467|NCT00473330|12132626|FG002|Core Study|Death|4
7710468|NCT00473330|12132624|FG000|Core Study|Lost to Follow-up|5
7710469|NCT00473330|12132625|FG001|Core Study|Lost to Follow-up|5
7710470|NCT00473330|12132626|FG002|Core Study|Lost to Follow-up|10
7710471|NCT00473330|12132624|FG000|Core Study|Physician Decision|2
7710472|NCT00473330|12132625|FG001|Core Study|Physician Decision|1
7710473|NCT00473330|12132626|FG002|Core Study|Physician Decision|3
7710474|NCT00473330|12132624|FG000|Core Study|Subject Non-compliance|1
7710475|NCT00473330|12132625|FG001|Core Study|Subject Non-compliance|2
7710476|NCT00473330|12132626|FG002|Core Study|Subject Non-compliance|1
7710477|NCT00473330|12132624|FG000|Core Study|Subject Required Other Therapy|0
7710478|NCT00473330|12132625|FG001|Core Study|Subject Required Other Therapy|1
7710479|NCT00473330|12132626|FG002|Core Study|Subject Required Other Therapy|3
7710480|NCT00473330|12132624|FG000|Core Study|Subject's Decision|9
7710481|NCT00473330|12132625|FG001|Core Study|Subject's Decision|8
7710482|NCT00473330|12132626|FG002|Core Study|Subject's Decision|19
7710483|NCT00473330|12132624|FG000|Open-label Extension Through Month 48|Adverse Event|0
7710484|NCT00473330|12132625|FG001|Open-label Extension Through Month 48|Adverse Event|0
7710485|NCT00473330|12132626|FG002|Open-label Extension Through Month 48|Adverse Event|2
7710486|NCT00473330|12132624|FG000|Open-label Extension Through Month 48|Death|2
7710487|NCT00473330|12132625|FG001|Open-label Extension Through Month 48|Death|0
7710488|NCT00473330|12132626|FG002|Open-label Extension Through Month 48|Death|0
7710489|NCT00473330|12132624|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1
7710490|NCT00473330|12132625|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0
7710491|NCT00473330|12132626|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2
7710492|NCT00473330|12132624|FG000|Open-label Extension Through Month 48|Physician's Decision|2
7710493|NCT00473330|12132625|FG001|Open-label Extension Through Month 48|Physician's Decision|1
7710494|NCT00473330|12132626|FG002|Open-label Extension Through Month 48|Physician's Decision|3
7710495|NCT00473330|12132624|FG000|Open-label Extension Through Month 48|Subject's Decision|1
7710496|NCT00473330|12132625|FG001|Open-label Extension Through Month 48|Subject's Decision|3
7710497|NCT00473330|12132626|FG002|Open-label Extension Through Month 48|Subject's Decision|3
7710498|NCT00473330|12132624|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18
7710499|NCT00473330|12132625|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15
7710500|NCT00473330|12132626|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16
7710501|NCT00473330|12132624|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2
7710502|NCT00473330|12132625|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1
7710503|NCT00473330|12132626|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0
7710504|NCT00473330|12132624|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0
7710505|NCT00473330|12132625|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0
7710506|NCT00473330|12132626|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1
7710507|NCT00473330|12132624|FG000|Open-label Extension Through Month 60|Adverse Event|0
7710508|NCT00473330|12132625|FG001|Open-label Extension Through Month 60|Adverse Event|0
7710509|NCT00473330|12132626|FG002|Open-label Extension Through Month 60|Adverse Event|2
7710510|NCT00473330|12132624|FG000|Open-label Extension Through Month 60|Death|2
7710511|NCT00473330|12132625|FG001|Open-label Extension Through Month 60|Death|2
7710512|NCT00473330|12132626|FG002|Open-label Extension Through Month 60|Death|1
7710513|NCT00473330|12132624|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3
7710514|NCT00473330|12132625|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0
7710515|NCT00473330|12132626|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4
7710516|NCT00473330|12132624|FG000|Open-label Extension Through Month 60|Physician's Decision|2
7710517|NCT00473330|12132625|FG001|Open-label Extension Through Month 60|Physician's Decision|1
7710518|NCT00473330|12132626|FG002|Open-label Extension Through Month 60|Physician's Decision|3
7710519|NCT00473330|12132624|FG000|Open-label Extension Through Month 60|Subject's Decision|1
7710520|NCT00473330|12132625|FG001|Open-label Extension Through Month 60|Subject's Decision|3
7710521|NCT00473330|12132626|FG002|Open-label Extension Through Month 60|Subject's Decision|4
7710522|NCT00473330|12132624|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77
7710523|NCT00473330|12132625|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71
7710524|NCT00473330|12132626|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62
7710525|NCT00473330|12132624|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2
7710526|NCT00473330|12132625|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1
7710527|NCT00473330|12132626|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0
7710528|NCT00473330|12132624|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1
7710529|NCT00473330|12132625|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0
7710530|NCT00473330|12132626|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1
7710531|NCT00473382|12132657|FG000|Core Study|Adverse Event|3
7710532|NCT00473382|12132658|FG001|Core Study|Adverse Event|1
7710533|NCT00473382|12132659|FG002|Core Study|Adverse Event|1
7710534|NCT00473382|12132657|FG000|Core Study|Death|3
7710535|NCT00473382|12132658|FG001|Core Study|Death|5
7710536|NCT00473382|12132659|FG002|Core Study|Death|10
7710537|NCT00473382|12132657|FG000|Core Study|Lost to Follow-up|3
7710538|NCT00473382|12132658|FG001|Core Study|Lost to Follow-up|3
7710539|NCT00473382|12132659|FG002|Core Study|Lost to Follow-up|3
7710540|NCT00473382|12132657|FG000|Core Study|Physician Decision|1
7710541|NCT00473382|12132658|FG001|Core Study|Physician Decision|2
7710542|NCT00473382|12132659|FG002|Core Study|Physician Decision|2
7710543|NCT00473382|12132657|FG000|Core Study|Subject non-compliance|5
7710544|NCT00473382|12132658|FG001|Core Study|Subject non-compliance|2
7710545|NCT00473382|12132659|FG002|Core Study|Subject non-compliance|1
7710546|NCT00473382|12132657|FG000|Core Study|Subject needed other treatment|1
7710547|NCT00473382|12132658|FG001|Core Study|Subject needed other treatment|3
7710548|NCT00473382|12132659|FG002|Core Study|Subject needed other treatment|2
7710549|NCT00473382|12132657|FG000|Core Study|Subject's decision|12
7710550|NCT00473382|12132658|FG001|Core Study|Subject's decision|11
7710551|NCT00473382|12132659|FG002|Core Study|Subject's decision|10
7710552|NCT00473382|12132657|FG000|Open-label Extension Through Month 48|Adverse Event|0
7710553|NCT00473382|12132658|FG001|Open-label Extension Through Month 48|Adverse Event|0
7710554|NCT00473382|12132659|FG002|Open-label Extension Through Month 48|Adverse Event|1
7710555|NCT00473382|12132657|FG000|Open-label Extension Through Month 48|Death|1
7710556|NCT00473382|12132658|FG001|Open-label Extension Through Month 48|Death|3
7710557|NCT00473382|12132659|FG002|Open-label Extension Through Month 48|Death|3
7710558|NCT00473382|12132657|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1
7710559|NCT00473382|12132658|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2
7710560|NCT00473382|12132659|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1
7710561|NCT00473382|12132657|FG000|Open-label Extension Through Month 48|Subject's Decision|5
7710562|NCT00473382|12132658|FG001|Open-label Extension Through Month 48|Subject's Decision|1
7710563|NCT00473382|12132659|FG002|Open-label Extension Through Month 48|Subject's Decision|6
7710564|NCT00473382|12132657|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41
7710565|NCT00473382|12132658|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34
7710566|NCT00473382|12132659|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36
7710567|NCT00473382|12132657|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2
7710568|NCT00473382|12132658|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1
7710569|NCT00473382|12132659|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0
7710570|NCT00473382|12132657|FG000|Open-label Extension Through Month 60|Adverse Event|0
7710571|NCT00473382|12132658|FG001|Open-label Extension Through Month 60|Adverse Event|0
7710572|NCT00473382|12132659|FG002|Open-label Extension Through Month 60|Adverse Event|2
7710573|NCT00473382|12132657|FG000|Open-label Extension Through Month 60|Death|1
7710574|NCT00473382|12132658|FG001|Open-label Extension Through Month 60|Death|7
7710575|NCT00473382|12132659|FG002|Open-label Extension Through Month 60|Death|4
7710576|NCT00473382|12132657|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1
7710577|NCT00473382|12132658|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3
7710578|NCT00473382|12132659|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1
7710579|NCT00473382|12132657|FG000|Open-label Extension Through Month 60|Subject's Decision|7
7710580|NCT00473382|12132658|FG001|Open-label Extension Through Month 60|Subject's Decision|1
7710581|NCT00473382|12132659|FG002|Open-label Extension Through Month 60|Subject's Decision|6
7710582|NCT00473382|12132657|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75
7710583|NCT00473382|12132658|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70
7710584|NCT00473382|12132659|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69
7710585|NCT00473382|12132657|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2
7710586|NCT00473382|12132658|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1
7710587|NCT00473382|12132659|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0
7710588|NCT00473434|12132685|FG000|Overall Study|Physician Decision|3
7710589|NCT00473434|12132685|FG000|Overall Study|Withdrawal by Subject|9
7710590|NCT00473434|12132685|FG000|Overall Study|Compliance|3
7710591|NCT00473434|12132685|FG000|Overall Study|Lack of Efficacy|3
7710592|NCT00473434|12132685|FG000|Overall Study|Adverse Event|3
7710593|NCT00473434|12132685|FG000|Overall Study|Patient was selling medication to others|1
7710594|NCT00473434|12132685|FG000|Overall Study|Safety evaluation|1
7710595|NCT00473434|12132685|FG000|Overall Study|Reason not specified|6
7710596|NCT00473434|12132685|FG000|Overall Study|Ceased in favor of Paliperidone|1
7710597|NCT00473434|12132685|FG000|Overall Study|Switching to trial medication|1
7710598|NCT00473434|12132685|FG000|Overall Study|No longer required|1
7710599|NCT00473512|12132707|FG000|Period 1 (Phase 1)|Adverse Event|0
7710600|NCT00473512|12132708|FG001|Period 1 (Phase 1)|Adverse Event|0
7710601|NCT00473512|12132709|FG002|Period 1 (Phase 1)|Adverse Event|0
7710602|NCT00473512|12132710|FG003|Period 1 (Phase 1)|Adverse Event|5
7710603|NCT00473512|12132711|FG004|Period 1 (Phase 1)|Adverse Event|0
7710604|NCT00473512|12132707|FG000|Period 1 (Phase 1)|Death|0
7710605|NCT00473512|12132708|FG001|Period 1 (Phase 1)|Death|0
7710606|NCT00473512|12132709|FG002|Period 1 (Phase 1)|Death|0
7710607|NCT00473512|12132710|FG003|Period 1 (Phase 1)|Death|1
7710608|NCT00473512|12132711|FG004|Period 1 (Phase 1)|Death|0
7710609|NCT00473512|12132707|FG000|Period 1 (Phase 1)|Disease Progression|1
7710610|NCT00473512|12132708|FG001|Period 1 (Phase 1)|Disease Progression|1
7710611|NCT00473512|12132709|FG002|Period 1 (Phase 1)|Disease Progression|0
7710612|NCT00473512|12132710|FG003|Period 1 (Phase 1)|Disease Progression|10
7710613|NCT00473512|12132711|FG004|Period 1 (Phase 1)|Disease Progression|1
7710614|NCT00473512|12132707|FG000|Period 1 (Phase 1)|Other|0
7710615|NCT00473512|12132708|FG001|Period 1 (Phase 1)|Other|0
7710616|NCT00473512|12132709|FG002|Period 1 (Phase 1)|Other|0
7710617|NCT00473512|12132710|FG003|Period 1 (Phase 1)|Other|1
7710618|NCT00473512|12132711|FG004|Period 1 (Phase 1)|Other|0
7710619|NCT00473512|12132707|FG000|Period 2 (Phase 2)|Adverse Event|0
7710620|NCT00473512|12132708|FG001|Period 2 (Phase 2)|Adverse Event|0
7710621|NCT00473512|12132709|FG002|Period 2 (Phase 2)|Adverse Event|0
7710622|NCT00473512|12132710|FG003|Period 2 (Phase 2)|Adverse Event|1
7710623|NCT00473512|12132711|FG004|Period 2 (Phase 2)|Adverse Event|0
7710624|NCT00473512|12132707|FG000|Period 2 (Phase 2)|Death|0
7710625|NCT00473512|12132708|FG001|Period 2 (Phase 2)|Death|0
7710626|NCT00473512|12132709|FG002|Period 2 (Phase 2)|Death|0
7710627|NCT00473512|12132710|FG003|Period 2 (Phase 2)|Death|1
7710628|NCT00473512|12132711|FG004|Period 2 (Phase 2)|Death|1
7710629|NCT00473512|12132707|FG000|Period 2 (Phase 2)|Disease Progression|0
7710630|NCT00473512|12132708|FG001|Period 2 (Phase 2)|Disease Progression|2
7710631|NCT00473512|12132709|FG002|Period 2 (Phase 2)|Disease Progression|2
7710632|NCT00473512|12132710|FG003|Period 2 (Phase 2)|Disease Progression|17
7710633|NCT00473512|12132711|FG004|Period 2 (Phase 2)|Disease Progression|1
7710634|NCT00473512|12132707|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0
7710635|NCT00473512|12132708|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0
7710636|NCT00473512|12132709|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0
7710637|NCT00473512|12132710|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1
7710638|NCT00473512|12132711|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0
7710639|NCT00473512|12132707|FG000|Period 2 (Phase 2)|Other|1
7710640|NCT00473512|12132708|FG001|Period 2 (Phase 2)|Other|0
7710641|NCT00473512|12132709|FG002|Period 2 (Phase 2)|Other|0
7710642|NCT00473512|12132710|FG003|Period 2 (Phase 2)|Other|3
7710643|NCT00473512|12132711|FG004|Period 2 (Phase 2)|Other|0
7710644|NCT00473564|12132731|FG000|Overall Study|robot surgery aborted in OR|23
7710645|NCT00473590|12132737|FG000|Overall Study|Adverse Event|3
7710646|NCT00473590|12132738|FG001|Overall Study|Adverse Event|3
7710647|NCT00473590|12132737|FG000|Overall Study|Death|4
7710648|NCT00473590|12132738|FG001|Overall Study|Death|2
7710649|NCT00473590|12132737|FG000|Overall Study|Progression not resulting in death|24
7710650|NCT00473590|12132738|FG001|Overall Study|Progression not resulting in death|20
7710651|NCT00473590|12132737|FG000|Overall Study|Non-protocol-specified therapy|7
7710652|NCT00473590|12132738|FG001|Overall Study|Non-protocol-specified therapy|5
7710653|NCT00473590|12132737|FG000|Overall Study|Physician Decision|2
7710654|NCT00473590|12132738|FG001|Overall Study|Physician Decision|4
7710655|NCT00473590|12132737|FG000|Overall Study|Withdrawal by Subject|5
7710656|NCT00473590|12132738|FG001|Overall Study|Withdrawal by Subject|3
7710657|NCT00473590|12132737|FG000|Overall Study|Other|0
7710658|NCT00473590|12132738|FG001|Overall Study|Other|1
7710659|NCT00473655|12132763|FG000|Overall Study|Lost to Follow-up|9
7710660|NCT00473655|12132764|FG001|Overall Study|Lost to Follow-up|5
7710661|NCT00473655|12132765|FG002|Overall Study|Lost to Follow-up|8
7710662|NCT00473668|12132776|FG000|Overall Study|Withdrawal by Subject|0
7710663|NCT00473668|12132777|FG001|Overall Study|Withdrawal by Subject|2
7710664|NCT00473668|12132778|FG002|Overall Study|Withdrawal by Subject|0
7710665|NCT00473668|12132776|FG000|Overall Study|Migrated/moved from study area|3
7710666|NCT00473668|12132777|FG001|Overall Study|Migrated/moved from study area|2
7710667|NCT00473668|12132778|FG002|Overall Study|Migrated/moved from study area|0
7710668|NCT00473668|12132776|FG000|Overall Study|Lost to Follow-up|0
7710669|NCT00473668|12132777|FG001|Overall Study|Lost to Follow-up|4
7710670|NCT00473668|12132778|FG002|Overall Study|Lost to Follow-up|6
7710671|NCT00473668|12132776|FG000|Overall Study|Other|2
7710672|NCT00473668|12132777|FG001|Overall Study|Other|3
7710673|NCT00473668|12132778|FG002|Overall Study|Other|4
7710674|NCT00473694|12132790|FG000|Overall Study|Adverse Event|0
7710675|NCT00473694|12132791|FG001|Overall Study|Adverse Event|1
7710676|NCT00473694|12132792|FG002|Overall Study|Adverse Event|0
7710677|NCT00473694|12132793|FG003|Overall Study|Adverse Event|0
7710678|NCT00473694|12132790|FG000|Overall Study|Participants did not receive treatment|11
7710679|NCT00473694|12132791|FG001|Overall Study|Participants did not receive treatment|3
7710680|NCT00473694|12132792|FG002|Overall Study|Participants did not receive treatment|5
7710681|NCT00473694|12132793|FG003|Overall Study|Participants did not receive treatment|6
7710682|NCT00473694|12132790|FG000|Overall Study|Lost to Follow-up|0
7710683|NCT00473694|12132791|FG001|Overall Study|Lost to Follow-up|0
7710684|NCT00473694|12132792|FG002|Overall Study|Lost to Follow-up|0
7710685|NCT00473694|12132793|FG003|Overall Study|Lost to Follow-up|1
7710686|NCT00473746|12132811|FG000|Period 1 (Phase 1)|Adverse Event|1
7710687|NCT00473746|12132812|FG001|Period 1 (Phase 1)|Adverse Event|0
7710688|NCT00473746|12132813|FG002|Period 1 (Phase 1)|Adverse Event|0
7710689|NCT00473746|12132814|FG003|Period 1 (Phase 1)|Adverse Event|0
7710690|NCT00473746|12132815|FG004|Period 1 (Phase 1)|Adverse Event|0
7710691|NCT00473746|12132811|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0
7710692|NCT00473746|12132812|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1
7710693|NCT00473746|12132813|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0
7710694|NCT00473746|12132814|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0
7710695|NCT00473746|12132815|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0
7710696|NCT00473746|12132811|FG000|Period 1 (Phase 1)|Progressive Disease|5
7710697|NCT00473746|12132812|FG001|Period 1 (Phase 1)|Progressive Disease|6
7710698|NCT00473746|12132813|FG002|Period 1 (Phase 1)|Progressive Disease|6
7710699|NCT00473746|12132814|FG003|Period 1 (Phase 1)|Progressive Disease|10
7710700|NCT00473746|12132815|FG004|Period 1 (Phase 1)|Progressive Disease|0
7710701|NCT00473746|12132811|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0
7710702|NCT00473746|12132812|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1
7710703|NCT00473746|12132813|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0
7710704|NCT00473746|12132814|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0
7710705|NCT00473746|12132815|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0
7710706|NCT00473746|12132811|FG000|Period 1 (Phase 1)|Reason not specified|0
7710707|NCT00473746|12132812|FG001|Period 1 (Phase 1)|Reason not specified|1
7710708|NCT00473746|12132813|FG002|Period 1 (Phase 1)|Reason not specified|0
7710709|NCT00473746|12132814|FG003|Period 1 (Phase 1)|Reason not specified|0
7710710|NCT00473746|12132815|FG004|Period 1 (Phase 1)|Reason not specified|0
7710711|NCT00473746|12132811|FG000|Period 2 (Phase 2)|Adverse Event|0
7710712|NCT00473746|12132812|FG001|Period 2 (Phase 2)|Adverse Event|0
7710713|NCT00473746|12132813|FG002|Period 2 (Phase 2)|Adverse Event|0
7710714|NCT00473746|12132814|FG003|Period 2 (Phase 2)|Adverse Event|0
7710715|NCT00473746|12132815|FG004|Period 2 (Phase 2)|Adverse Event|3
7710716|NCT00473746|12132811|FG000|Period 2 (Phase 2)|Death|0
7710717|NCT00473746|12132812|FG001|Period 2 (Phase 2)|Death|0
7710718|NCT00473746|12132813|FG002|Period 2 (Phase 2)|Death|0
7710719|NCT00473746|12132814|FG003|Period 2 (Phase 2)|Death|0
7710720|NCT00473746|12132815|FG004|Period 2 (Phase 2)|Death|1
7710721|NCT00473746|12132811|FG000|Period 2 (Phase 2)|Progressive Disease|0
7710722|NCT00473746|12132812|FG001|Period 2 (Phase 2)|Progressive Disease|0
7710723|NCT00473746|12132813|FG002|Period 2 (Phase 2)|Progressive Disease|0
7710724|NCT00473746|12132814|FG003|Period 2 (Phase 2)|Progressive Disease|0
7710725|NCT00473746|12132815|FG004|Period 2 (Phase 2)|Progressive Disease|20
7710726|NCT00473746|12132811|FG000|Period 2 (Phase 2)|Reason not specified|0
7710727|NCT00473746|12132812|FG001|Period 2 (Phase 2)|Reason not specified|0
7710728|NCT00473746|12132813|FG002|Period 2 (Phase 2)|Reason not specified|0
7710729|NCT00473746|12132814|FG003|Period 2 (Phase 2)|Reason not specified|0
7710730|NCT00473746|12132815|FG004|Period 2 (Phase 2)|Reason not specified|3
7710731|NCT00473824|12132831|FG000|Overall Study|Virologic Breakthrough|1
7710732|NCT00473824|12132832|FG001|Overall Study|Virologic Breakthrough|0
7710733|NCT00473824|12132831|FG000|Overall Study|Adverse Event|1
7710734|NCT00473824|12132832|FG001|Overall Study|Adverse Event|0
7710735|NCT00473824|12132831|FG000|Overall Study|Death|1
7710736|NCT00473824|12132832|FG001|Overall Study|Death|0
7710737|NCT00473824|12132831|FG000|Overall Study|Lost to Follow-up|1
7710738|NCT00473824|12132832|FG001|Overall Study|Lost to Follow-up|0
7710739|NCT00473824|12132831|FG000|Overall Study|Withdrawal by physician|1
7710740|NCT00473824|12132832|FG001|Overall Study|Withdrawal by physician|0
7710741|NCT00473876|12132849|FG000|Overall Study|Lost to Follow-up|3
7710742|NCT00473876|12132850|FG001|Overall Study|Lost to Follow-up|1
7710743|NCT00473889|12132860|FG000|Overall Study|Did not receive study medication|1
7710744|NCT00473889|12132861|FG001|Overall Study|Did not receive study medication|4
7710745|NCT00473889|12132860|FG000|Overall Study|Adverse Event|30
7710746|NCT00473889|12132861|FG001|Overall Study|Adverse Event|17
7710747|NCT00473889|12132860|FG000|Overall Study|Protocol Violation|4
7710748|NCT00473889|12132861|FG001|Overall Study|Protocol Violation|2
7710749|NCT00473889|12132860|FG000|Overall Study|Lack of Efficacy|28
7710750|NCT00473889|12132861|FG001|Overall Study|Lack of Efficacy|29
7710751|NCT00473889|12132860|FG000|Overall Study|Lost to Follow-up|2
7710752|NCT00473889|12132861|FG001|Overall Study|Lost to Follow-up|1
7710753|NCT00473889|12132860|FG000|Overall Study|Physician Decision|10
7710754|NCT00473889|12132861|FG001|Overall Study|Physician Decision|5
7710755|NCT00473889|12132860|FG000|Overall Study|Trial Terminated|3
7710756|NCT00473889|12132861|FG001|Overall Study|Trial Terminated|6
7710757|NCT00473889|12132860|FG000|Overall Study|Withdrawal by Subject|5
7710758|NCT00473889|12132861|FG001|Overall Study|Withdrawal by Subject|0
7710759|NCT00474045|12132869|FG000|Overall Study|Adverse Event|18
7710760|NCT00474045|12132870|FG001|Overall Study|Adverse Event|8
7710761|NCT00474045|12132869|FG000|Overall Study|Unclassified|1
7710762|NCT00474045|12132870|FG001|Overall Study|Unclassified|3
7710763|NCT00474045|12132869|FG000|Overall Study|Lack of Efficacy|0
7710764|NCT00474045|12132870|FG001|Overall Study|Lack of Efficacy|9
7710765|NCT00474045|12132869|FG000|Overall Study|Lost to Follow-up|1
7710766|NCT00474045|12132870|FG001|Overall Study|Lost to Follow-up|1
7710767|NCT00474045|12132869|FG000|Overall Study|Protocol Violation|10
7710768|NCT00474045|12132870|FG001|Overall Study|Protocol Violation|12
7710769|NCT00474045|12132869|FG000|Overall Study|Withdrawal by Subject|16
7710770|NCT00474045|12132870|FG001|Overall Study|Withdrawal by Subject|18
7710771|NCT00474045|12132869|FG000|Overall Study|Withdrawal criteria|60
7710772|NCT00474045|12132870|FG001|Overall Study|Withdrawal criteria|50
7710773|NCT00474058|12132878|FG000|Overall Study|Adverse Event|11
7710774|NCT00474058|12132879|FG001|Overall Study|Adverse Event|6
7710775|NCT00474058|12132878|FG000|Overall Study|Lack of Efficacy|0
7710776|NCT00474058|12132879|FG001|Overall Study|Lack of Efficacy|4
7710777|NCT00474058|12132878|FG000|Overall Study|Withdrawal by Subject|11
7710778|NCT00474058|12132879|FG001|Overall Study|Withdrawal by Subject|7
7710779|NCT00474058|12132878|FG000|Overall Study|Other|2
7710780|NCT00474058|12132879|FG001|Overall Study|Other|0
7710781|NCT00474175|12132897|FG000|Overall Study|Lack of Efficacy|0
7710782|NCT00474175|12132898|FG001|Overall Study|Lack of Efficacy|0
7710783|NCT00474175|12132899|FG002|Overall Study|Lack of Efficacy|1
7710784|NCT00474175|12132897|FG000|Overall Study|Withdrawal by Subject|0
7710785|NCT00474175|12132898|FG001|Overall Study|Withdrawal by Subject|1
7710786|NCT00474175|12132899|FG002|Overall Study|Withdrawal by Subject|1
7710787|NCT00474175|12132897|FG000|Overall Study|Ineligible|1
7710788|NCT00474175|12132898|FG001|Overall Study|Ineligible|3
7710789|NCT00474175|12132899|FG002|Overall Study|Ineligible|1
7710790|NCT00474175|12132897|FG000|Overall Study|Protocol Violation|0
7710791|NCT00474175|12132898|FG001|Overall Study|Protocol Violation|2
7710792|NCT00474175|12132899|FG002|Overall Study|Protocol Violation|1
7710793|NCT00474175|12132897|FG000|Overall Study|Administrative|0
7710794|NCT00474175|12132898|FG001|Overall Study|Administrative|1
7710795|NCT00474175|12132899|FG002|Overall Study|Administrative|0
7710796|NCT00474240|12132918|FG000|Overall Study|Withdrawal by Subject|1
7710797|NCT00474240|12132919|FG001|Overall Study|Withdrawal by Subject|1
7710798|NCT00474240|12132920|FG002|Overall Study|Withdrawal by Subject|0
7710799|NCT00474240|12132921|FG003|Overall Study|Withdrawal by Subject|2
7710800|NCT00474240|12132922|FG004|Overall Study|Withdrawal by Subject|3
7710801|NCT00474240|12132923|FG005|Overall Study|Withdrawal by Subject|1
7710802|NCT00474240|12132918|FG000|Overall Study|Adverse Event|0
7710803|NCT00474240|12132919|FG001|Overall Study|Adverse Event|0
7710804|NCT00474240|12132920|FG002|Overall Study|Adverse Event|9
7710805|NCT00474240|12132921|FG003|Overall Study|Adverse Event|14
7710806|NCT00474240|12132922|FG004|Overall Study|Adverse Event|5
7710807|NCT00474240|12132923|FG005|Overall Study|Adverse Event|16
7710808|NCT00474240|12132918|FG000|Overall Study|Removed due to lab value|0
7710809|NCT00474240|12132919|FG001|Overall Study|Removed due to lab value|0
7710810|NCT00474240|12132920|FG002|Overall Study|Removed due to lab value|0
7710811|NCT00474240|12132921|FG003|Overall Study|Removed due to lab value|0
7710812|NCT00474240|12132922|FG004|Overall Study|Removed due to lab value|0
7710813|NCT00474240|12132923|FG005|Overall Study|Removed due to lab value|1
7710814|NCT00474253|12132939|FG000|Overall Study|Withdrew consent|2
7710815|NCT00474253|12132940|FG001|Overall Study|Withdrew consent|0
7710816|NCT00474253|12132939|FG000|Overall Study|Withdrew due to surgery-related issues|0
7710817|NCT00474253|12132940|FG001|Overall Study|Withdrew due to surgery-related issues|3
7710818|NCT00474253|12132939|FG000|Overall Study|Lost to Follow-up|1
7710819|NCT00474253|12132940|FG001|Overall Study|Lost to Follow-up|0
7710820|NCT00474253|12132939|FG000|Overall Study|Discharged prior to study completion|0
7710821|NCT00474253|12132940|FG001|Overall Study|Discharged prior to study completion|1
7710822|NCT00474266|12132950|FG000|Overall Study|Withdrawal by Subject|7
7710823|NCT00474266|12132951|FG001|Overall Study|Withdrawal by Subject|20
7710824|NCT00474266|12132952|FG002|Overall Study|Withdrawal by Subject|4
7710825|NCT00474266|12132953|FG003|Overall Study|Withdrawal by Subject|7
7710826|NCT00474383|12132966|FG000|Main Study|Adverse Event|11
7710827|NCT00474383|12132967|FG001|Main Study|Adverse Event|0
7710828|NCT00474383|12132966|FG000|Main Study|Symptomatic Deterioration|1
7710829|NCT00474383|12132967|FG001|Main Study|Symptomatic Deterioration|0
7710830|NCT00474383|12132966|FG000|Main Study|Progressive Disease|23
7710831|NCT00474383|12132967|FG001|Main Study|Progressive Disease|0
7710832|NCT00474383|12132966|FG000|Main Study|Other|1
7710833|NCT00474383|12132967|FG001|Main Study|Other|0
7710834|NCT00474383|12132966|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6
7710835|NCT00474383|12132967|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0
7710836|NCT00474383|12132966|FG000|Extension|Progressive Disease|0
7710837|NCT00474383|12132967|FG001|Extension|Progressive Disease|5
7710838|NCT00474487|12132975|FG000|Overall Study|Withdrawal by Subject|6
7710839|NCT00474487|12132976|FG001|Overall Study|Withdrawal by Subject|0
7710840|NCT00474487|12132977|FG002|Overall Study|Withdrawal by Subject|0
7710841|NCT00474487|12132978|FG003|Overall Study|Withdrawal by Subject|0
7710842|NCT00474487|12132975|FG000|Overall Study|Lost to Follow-up|20
7710843|NCT00474487|12132976|FG001|Overall Study|Lost to Follow-up|1
7710844|NCT00474487|12132977|FG002|Overall Study|Lost to Follow-up|7
7710845|NCT00474487|12132978|FG003|Overall Study|Lost to Follow-up|0
7710846|NCT00474487|12132975|FG000|Overall Study|Inappropriate enrollment|4
7710847|NCT00474487|12132976|FG001|Overall Study|Inappropriate enrollment|0
7710848|NCT00474487|12132977|FG002|Overall Study|Inappropriate enrollment|7
7710849|NCT00474487|12132978|FG003|Overall Study|Inappropriate enrollment|0
7710850|NCT00474487|12132975|FG000|Overall Study|Death|0
7710851|NCT00474487|12132976|FG001|Overall Study|Death|1
7710852|NCT00474487|12132977|FG002|Overall Study|Death|0
7710853|NCT00474487|12132978|FG003|Overall Study|Death|0
7710854|NCT00474526|12133005|FG000|Overall Study|ADMINISTRATIVE REASON|11
7710855|NCT00474526|12133006|FG001|Overall Study|ADMINISTRATIVE REASON|9
7710856|NCT00474526|12133007|FG002|Overall Study|ADMINISTRATIVE REASON|9
7710857|NCT00474526|12133008|FG003|Overall Study|ADMINISTRATIVE REASON|20
7710858|NCT00474526|12133009|FG004|Overall Study|ADMINISTRATIVE REASON|9
7710859|NCT00474526|12133010|FG005|Overall Study|ADMINISTRATIVE REASON|1
7710860|NCT00474526|12133011|FG006|Overall Study|ADMINISTRATIVE REASON|1
7710861|NCT00474526|12133012|FG007|Overall Study|ADMINISTRATIVE REASON|0
7710862|NCT00474526|12133013|FG008|Overall Study|ADMINISTRATIVE REASON|2
7710863|NCT00474526|12133014|FG009|Overall Study|ADMINISTRATIVE REASON|1
7710864|NCT00474526|12133015|FG010|Overall Study|ADMINISTRATIVE REASON|1
7710865|NCT00474526|12133016|FG011|Overall Study|ADMINISTRATIVE REASON|1
7710866|NCT00474526|12133017|FG012|Overall Study|ADMINISTRATIVE REASON|1
7710867|NCT00474526|12133018|FG013|Overall Study|ADMINISTRATIVE REASON|1
7710868|NCT00474526|12133019|FG014|Overall Study|ADMINISTRATIVE REASON|2
7710869|NCT00474526|12133020|FG015|Overall Study|ADMINISTRATIVE REASON|0
7710870|NCT00474526|12133021|FG016|Overall Study|ADMINISTRATIVE REASON|0
7710871|NCT00474526|12133005|FG000|Overall Study|Adverse Event|2
7710872|NCT00474526|12133006|FG001|Overall Study|Adverse Event|0
7710873|NCT00474526|12133007|FG002|Overall Study|Adverse Event|2
7710874|NCT00474526|12133008|FG003|Overall Study|Adverse Event|4
7710875|NCT00474526|12133009|FG004|Overall Study|Adverse Event|2
7710876|NCT00474526|12133010|FG005|Overall Study|Adverse Event|1
7710877|NCT00474526|12133011|FG006|Overall Study|Adverse Event|1
7710878|NCT00474526|12133012|FG007|Overall Study|Adverse Event|0
7710879|NCT00474526|12133013|FG008|Overall Study|Adverse Event|0
7710880|NCT00474526|12133014|FG009|Overall Study|Adverse Event|0
7710881|NCT00474526|12133015|FG010|Overall Study|Adverse Event|0
7710882|NCT00474526|12133016|FG011|Overall Study|Adverse Event|0
7710883|NCT00474526|12133017|FG012|Overall Study|Adverse Event|0
7710884|NCT00474526|12133018|FG013|Overall Study|Adverse Event|0
7710885|NCT00474526|12133019|FG014|Overall Study|Adverse Event|1
7710886|NCT00474526|12133020|FG015|Overall Study|Adverse Event|1
7710887|NCT00474526|12133021|FG016|Overall Study|Adverse Event|0
7710888|NCT00474526|12133005|FG000|Overall Study|Death|0
7710889|NCT00474526|12133006|FG001|Overall Study|Death|0
7710890|NCT00474526|12133007|FG002|Overall Study|Death|0
7710891|NCT00474526|12133008|FG003|Overall Study|Death|0
7710892|NCT00474526|12133009|FG004|Overall Study|Death|0
7710893|NCT00474526|12133010|FG005|Overall Study|Death|0
7710894|NCT00474526|12133011|FG006|Overall Study|Death|0
7710895|NCT00474526|12133012|FG007|Overall Study|Death|0
7710896|NCT00474526|12133013|FG008|Overall Study|Death|0
7710897|NCT00474526|12133014|FG009|Overall Study|Death|0
7710898|NCT00474526|12133015|FG010|Overall Study|Death|0
7710899|NCT00474526|12133016|FG011|Overall Study|Death|0
7710900|NCT00474526|12133017|FG012|Overall Study|Death|0
7710901|NCT00474526|12133018|FG013|Overall Study|Death|3
7710902|NCT00474526|12133019|FG014|Overall Study|Death|0
7710903|NCT00474526|12133020|FG015|Overall Study|Death|0
7710904|NCT00474526|12133021|FG016|Overall Study|Death|0
7710905|NCT00474526|12133005|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0
7710906|NCT00474526|12133006|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1
7710907|NCT00474526|12133007|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0
7710908|NCT00474526|12133008|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1
7710909|NCT00474526|12133009|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2
7710910|NCT00474526|12133010|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0
7710911|NCT00474526|12133011|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0
7710912|NCT00474526|12133012|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0
7710913|NCT00474526|12133013|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0
7710914|NCT00474526|12133014|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0
7710915|NCT00474526|12133015|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0
7710916|NCT00474526|12133016|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0
7710917|NCT00474526|12133017|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0
7710918|NCT00474526|12133018|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2
7710919|NCT00474526|12133019|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2
7710920|NCT00474526|12133020|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0
7710921|NCT00474526|12133021|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0
7710922|NCT00474526|12133005|FG000|Overall Study|Lost to Follow-up|8
7710923|NCT00474526|12133006|FG001|Overall Study|Lost to Follow-up|6
7710924|NCT00474526|12133007|FG002|Overall Study|Lost to Follow-up|13
7710925|NCT00474526|12133008|FG003|Overall Study|Lost to Follow-up|29
7710926|NCT00474526|12133009|FG004|Overall Study|Lost to Follow-up|11
7710927|NCT00474526|12133010|FG005|Overall Study|Lost to Follow-up|5
7710928|NCT00474526|12133011|FG006|Overall Study|Lost to Follow-up|8
7710929|NCT00474526|12133012|FG007|Overall Study|Lost to Follow-up|1
7710930|NCT00474526|12133013|FG008|Overall Study|Lost to Follow-up|0
7710931|NCT00474526|12133014|FG009|Overall Study|Lost to Follow-up|6
7710932|NCT00474526|12133015|FG010|Overall Study|Lost to Follow-up|2
7710933|NCT00474526|12133016|FG011|Overall Study|Lost to Follow-up|4
7710934|NCT00474526|12133017|FG012|Overall Study|Lost to Follow-up|6
7710935|NCT00474526|12133018|FG013|Overall Study|Lost to Follow-up|74
7710936|NCT00474526|12133019|FG014|Overall Study|Lost to Follow-up|29
7710937|NCT00474526|12133020|FG015|Overall Study|Lost to Follow-up|4
7710938|NCT00474526|12133021|FG016|Overall Study|Lost to Follow-up|5
7710939|NCT00474526|12133005|FG000|Overall Study|Protocol Violation|2
7710940|NCT00474526|12133006|FG001|Overall Study|Protocol Violation|6
7710941|NCT00474526|12133007|FG002|Overall Study|Protocol Violation|4
7710942|NCT00474526|12133008|FG003|Overall Study|Protocol Violation|12
7710943|NCT00474526|12133009|FG004|Overall Study|Protocol Violation|3
7710944|NCT00474526|12133010|FG005|Overall Study|Protocol Violation|1
7710945|NCT00474526|12133011|FG006|Overall Study|Protocol Violation|3
7710946|NCT00474526|12133012|FG007|Overall Study|Protocol Violation|0
7710947|NCT00474526|12133013|FG008|Overall Study|Protocol Violation|0
7710948|NCT00474526|12133014|FG009|Overall Study|Protocol Violation|4
7710949|NCT00474526|12133015|FG010|Overall Study|Protocol Violation|2
7710950|NCT00474526|12133016|FG011|Overall Study|Protocol Violation|2
7710951|NCT00474526|12133017|FG012|Overall Study|Protocol Violation|4
7710952|NCT00474526|12133018|FG013|Overall Study|Protocol Violation|19
7710953|NCT00474526|12133019|FG014|Overall Study|Protocol Violation|9
7710954|NCT00474526|12133020|FG015|Overall Study|Protocol Violation|6
7710955|NCT00474526|12133021|FG016|Overall Study|Protocol Violation|2
7710956|NCT00474526|12133005|FG000|Overall Study|UNABLE TO CLASSIFY|1
7710957|NCT00474526|12133006|FG001|Overall Study|UNABLE TO CLASSIFY|0
7710958|NCT00474526|12133007|FG002|Overall Study|UNABLE TO CLASSIFY|0
7710959|NCT00474526|12133008|FG003|Overall Study|UNABLE TO CLASSIFY|1
7710960|NCT00474526|12133009|FG004|Overall Study|UNABLE TO CLASSIFY|3
7710961|NCT00474526|12133010|FG005|Overall Study|UNABLE TO CLASSIFY|2
7710962|NCT00474526|12133011|FG006|Overall Study|UNABLE TO CLASSIFY|0
7710963|NCT00474526|12133012|FG007|Overall Study|UNABLE TO CLASSIFY|1
7710964|NCT00474526|12133013|FG008|Overall Study|UNABLE TO CLASSIFY|0
7710965|NCT00474526|12133014|FG009|Overall Study|UNABLE TO CLASSIFY|3
7710966|NCT00474526|12133015|FG010|Overall Study|UNABLE TO CLASSIFY|0
7710967|NCT00474526|12133016|FG011|Overall Study|UNABLE TO CLASSIFY|0
7710968|NCT00474526|12133017|FG012|Overall Study|UNABLE TO CLASSIFY|0
7710969|NCT00474526|12133018|FG013|Overall Study|UNABLE TO CLASSIFY|20
7710970|NCT00474526|12133019|FG014|Overall Study|UNABLE TO CLASSIFY|12
7710971|NCT00474526|12133020|FG015|Overall Study|UNABLE TO CLASSIFY|6
7710972|NCT00474526|12133021|FG016|Overall Study|UNABLE TO CLASSIFY|1
7710973|NCT00474526|12133005|FG000|Overall Study|Withdrawal by Subject|9
7710974|NCT00474526|12133006|FG001|Overall Study|Withdrawal by Subject|24
7710975|NCT00474526|12133007|FG002|Overall Study|Withdrawal by Subject|21
7710976|NCT00474526|12133008|FG003|Overall Study|Withdrawal by Subject|52
7710977|NCT00474526|12133009|FG004|Overall Study|Withdrawal by Subject|38
7710978|NCT00474526|12133010|FG005|Overall Study|Withdrawal by Subject|6
7710979|NCT00474526|12133011|FG006|Overall Study|Withdrawal by Subject|12
7710980|NCT00474526|12133012|FG007|Overall Study|Withdrawal by Subject|4
7710981|NCT00474526|12133013|FG008|Overall Study|Withdrawal by Subject|4
7710982|NCT00474526|12133014|FG009|Overall Study|Withdrawal by Subject|13
7710983|NCT00474526|12133015|FG010|Overall Study|Withdrawal by Subject|5
7710984|NCT00474526|12133016|FG011|Overall Study|Withdrawal by Subject|4
7710985|NCT00474526|12133017|FG012|Overall Study|Withdrawal by Subject|4
7710986|NCT00474526|12133018|FG013|Overall Study|Withdrawal by Subject|37
7710987|NCT00474526|12133019|FG014|Overall Study|Withdrawal by Subject|22
7710988|NCT00474526|12133020|FG015|Overall Study|Withdrawal by Subject|1
7710989|NCT00474526|12133021|FG016|Overall Study|Withdrawal by Subject|1
7710990|NCT00474539|12133109|FG000|Infant Series|Withdrawal by Subject|3
7710991|NCT00474539|12133110|FG001|Infant Series|Withdrawal by Subject|4
7710992|NCT00474539|12133109|FG000|Infant Series|Randomization error|5
7710993|NCT00474539|12133110|FG001|Infant Series|Randomization error|0
7710994|NCT00474539|12133109|FG000|Infant Series|Lost to Follow-up|2
7710995|NCT00474539|12133110|FG001|Infant Series|Lost to Follow-up|1
7710996|NCT00474539|12133109|FG000|Infant Series|Protocol Violation|0
7710997|NCT00474539|12133110|FG001|Infant Series|Protocol Violation|1
7710998|NCT00474539|12133109|FG000|After Infant Series|Lost to Follow-up|3
7710999|NCT00474539|12133110|FG001|After Infant Series|Lost to Follow-up|0
7711000|NCT00474539|12133109|FG000|After Infant Series|Withdrawal by Subject|1
7711001|NCT00474539|12133110|FG001|After Infant Series|Withdrawal by Subject|0
7711002|NCT00474539|12133109|FG000|Toddler Dose|Protocol Violation|1
7711003|NCT00474539|12133110|FG001|Toddler Dose|Protocol Violation|0
7711004|NCT00474630|12133156|FG000|Overall Study|Adverse Event|98
7711005|NCT00474630|12133157|FG001|Overall Study|Adverse Event|26
7711006|NCT00474630|12133156|FG000|Overall Study|Lost to Follow-up|22
7711007|NCT00474630|12133157|FG001|Overall Study|Lost to Follow-up|15
7711008|NCT00474630|12133156|FG000|Overall Study|Withdrawal by Subject|21
7711009|NCT00474630|12133157|FG001|Overall Study|Withdrawal by Subject|15
7711010|NCT00474630|12133156|FG000|Overall Study|Protocol Violation|3
7711011|NCT00474630|12133157|FG001|Overall Study|Protocol Violation|4
7711012|NCT00474630|12133156|FG000|Overall Study|Lack of Efficacy|5
7711013|NCT00474630|12133157|FG001|Overall Study|Lack of Efficacy|6
7711014|NCT00474630|12133156|FG000|Overall Study|Drug noncompliance, other|11
7711015|NCT00474630|12133157|FG001|Overall Study|Drug noncompliance, other|4
7711016|NCT00474708|12133166|FG000|Overall Study|Lack of Efficacy|11
7711017|NCT00474708|12133167|FG001|Overall Study|Lack of Efficacy|5
7711018|NCT00474708|12133166|FG000|Overall Study|Suicide ideation/behavior|0
7711019|NCT00474708|12133167|FG001|Overall Study|Suicide ideation/behavior|1
7711020|NCT00474708|12133166|FG000|Overall Study|Withdrawal by Subject|7
7711021|NCT00474708|12133167|FG001|Overall Study|Withdrawal by Subject|0
7711022|NCT00474708|12133166|FG000|Overall Study|Lack of compliance|12
7711023|NCT00474708|12133167|FG001|Overall Study|Lack of compliance|4
7711024|NCT00474708|12133166|FG000|Overall Study|Lost to Follow-up|18
7711025|NCT00474708|12133167|FG001|Overall Study|Lost to Follow-up|9
7711026|NCT00474708|12133166|FG000|Overall Study|Physician Decision|9
7711027|NCT00474708|12133167|FG001|Overall Study|Physician Decision|6
7711028|NCT00474760|12133180|FG000|Overall Study|Death|0
7711029|NCT00474760|12133181|FG001|Overall Study|Death|0
7711030|NCT00474760|12133182|FG002|Overall Study|Death|0
7711031|NCT00474760|12133183|FG003|Overall Study|Death|0
7711032|NCT00474760|12133184|FG004|Overall Study|Death|2
7711033|NCT00474760|12133185|FG005|Overall Study|Death|0
7711034|NCT00474760|12133186|FG006|Overall Study|Death|0
7711035|NCT00474760|12133180|FG000|Overall Study|Adverse Event|0
7711036|NCT00474760|12133181|FG001|Overall Study|Adverse Event|0
7711037|NCT00474760|12133182|FG002|Overall Study|Adverse Event|0
7711038|NCT00474760|12133183|FG003|Overall Study|Adverse Event|0
7711039|NCT00474760|12133184|FG004|Overall Study|Adverse Event|1
7711040|NCT00474760|12133185|FG005|Overall Study|Adverse Event|7
7711041|NCT00474760|12133186|FG006|Overall Study|Adverse Event|0
7711042|NCT00474760|12133180|FG000|Overall Study|Laboratory abnormality|0
7711043|NCT00474760|12133181|FG001|Overall Study|Laboratory abnormality|0
7711044|NCT00474760|12133182|FG002|Overall Study|Laboratory abnormality|0
7711045|NCT00474760|12133183|FG003|Overall Study|Laboratory abnormality|0
7711046|NCT00474760|12133184|FG004|Overall Study|Laboratory abnormality|0
7711047|NCT00474760|12133185|FG005|Overall Study|Laboratory abnormality|1
7711048|NCT00474760|12133186|FG006|Overall Study|Laboratory abnormality|0
7711049|NCT00474760|12133180|FG000|Overall Study|Withdrawal by Subject|0
7711050|NCT00474760|12133181|FG001|Overall Study|Withdrawal by Subject|0
7711051|NCT00474760|12133182|FG002|Overall Study|Withdrawal by Subject|0
7711052|NCT00474760|12133183|FG003|Overall Study|Withdrawal by Subject|1
7711053|NCT00474760|12133184|FG004|Overall Study|Withdrawal by Subject|0
7711054|NCT00474760|12133185|FG005|Overall Study|Withdrawal by Subject|1
7711055|NCT00474760|12133186|FG006|Overall Study|Withdrawal by Subject|1
7711056|NCT00474760|12133180|FG000|Overall Study|Other|0
7711057|NCT00474760|12133181|FG001|Overall Study|Other|1
7711058|NCT00474760|12133182|FG002|Overall Study|Other|0
7711059|NCT00474760|12133183|FG003|Overall Study|Other|0
7711060|NCT00474760|12133184|FG004|Overall Study|Other|1
7711061|NCT00474760|12133185|FG005|Overall Study|Other|0
7711062|NCT00474760|12133186|FG006|Overall Study|Other|0
7711063|NCT00474760|12133180|FG000|Overall Study|Progressive disease|3
7711064|NCT00474760|12133181|FG001|Overall Study|Progressive disease|2
7711065|NCT00474760|12133182|FG002|Overall Study|Progressive disease|3
7711066|NCT00474760|12133183|FG003|Overall Study|Progressive disease|2
7711067|NCT00474760|12133184|FG004|Overall Study|Progressive disease|8
7711068|NCT00474760|12133185|FG005|Overall Study|Progressive disease|20
7711069|NCT00474760|12133186|FG006|Overall Study|Progressive disease|7
7711070|NCT00474760|12133180|FG000|Overall Study|Terminated by sponsor|0
7711071|NCT00474760|12133181|FG001|Overall Study|Terminated by sponsor|0
7711072|NCT00474760|12133182|FG002|Overall Study|Terminated by sponsor|0
7711073|NCT00474760|12133183|FG003|Overall Study|Terminated by sponsor|0
7711074|NCT00474760|12133184|FG004|Overall Study|Terminated by sponsor|0
7711075|NCT00474760|12133185|FG005|Overall Study|Terminated by sponsor|0
7711076|NCT00474760|12133186|FG006|Overall Study|Terminated by sponsor|2
7711077|NCT00474786|12133211|FG000|Overall Study|Not Meeting Study Criteria|0
7711078|NCT00474786|12133212|FG001|Overall Study|Not Meeting Study Criteria|1
7711079|NCT00474786|12133211|FG000|Overall Study|Investigator Request|2
7711080|NCT00474786|12133212|FG001|Overall Study|Investigator Request|1
7711081|NCT00474786|12133211|FG000|Overall Study|Death|189
7711082|NCT00474786|12133212|FG001|Overall Study|Death|170
7711083|NCT00474786|12133211|FG000|Overall Study|Discontinuation of Study by Sponsor|42
7711084|NCT00474786|12133212|FG001|Overall Study|Discontinuation of Study by Sponsor|59
7711085|NCT00474786|12133211|FG000|Overall Study|Lost to Follow-up|4
7711086|NCT00474786|12133212|FG001|Overall Study|Lost to Follow-up|7
7711087|NCT00474786|12133211|FG000|Overall Study|Protocol Violation|2
7711088|NCT00474786|12133212|FG001|Overall Study|Protocol Violation|0
7711089|NCT00474786|12133211|FG000|Overall Study|Withdrawal by Subject|15
7711090|NCT00474786|12133212|FG001|Overall Study|Withdrawal by Subject|15
7711091|NCT00474786|12133211|FG000|Overall Study|Other|5
7711092|NCT00474786|12133212|FG001|Overall Study|Other|0
7711093|NCT00474812|12133218|FG000|Overall Study|Withdrawal by Subject|5
7711094|NCT00474812|12133218|FG000|Overall Study|No Initiation of treatment|2
7711095|NCT00474903|12133235|FG000|Overall Study|Protocol Violation|1
7711096|NCT00474903|12133236|FG001|Overall Study|Protocol Violation|5
7711097|NCT00474903|12133237|FG002|Overall Study|Protocol Violation|2
7711098|NCT00474929|12133250|FG000|Overall Study|Withdrawal by Subject|0
7711099|NCT00474929|12133251|FG001|Overall Study|Withdrawal by Subject|1
7711100|NCT00474929|12133252|FG002|Overall Study|Withdrawal by Subject|0
7711101|NCT00474929|12133253|FG003|Overall Study|Withdrawal by Subject|0
7711102|NCT00474929|12133254|FG004|Overall Study|Withdrawal by Subject|0
7711103|NCT00474929|12133250|FG000|Overall Study|Unrelated medical condition|0
7711104|NCT00474929|12133251|FG001|Overall Study|Unrelated medical condition|0
7711105|NCT00474929|12133252|FG002|Overall Study|Unrelated medical condition|1
7711106|NCT00474929|12133253|FG003|Overall Study|Unrelated medical condition|0
7711107|NCT00474929|12133254|FG004|Overall Study|Unrelated medical condition|0
7711108|NCT00474929|12133250|FG000|Overall Study|Physician Decision|0
7711109|NCT00474929|12133251|FG001|Overall Study|Physician Decision|0
7711110|NCT00474929|12133252|FG002|Overall Study|Physician Decision|1
7711111|NCT00474929|12133253|FG003|Overall Study|Physician Decision|2
7711112|NCT00474929|12133254|FG004|Overall Study|Physician Decision|0
7711113|NCT00474955|12133267|FG000|Overall Study|Adverse Event|2
7711114|NCT00474955|12133267|FG000|Overall Study|Drug unavailability|1
7711115|NCT00474955|12133267|FG000|Overall Study|Personal reasons|5
7711116|NCT00474968|12133273|FG000|Overall Study|Withdrawal by Subject|8
7711117|NCT00474968|12133274|FG001|Overall Study|Withdrawal by Subject|7
7711118|NCT00474968|12133273|FG000|Overall Study|Protocol Violation|9
7711119|NCT00474968|12133274|FG001|Overall Study|Protocol Violation|8
7711120|NCT00474968|12133273|FG000|Overall Study|Sample not collected|1
7711121|NCT00474968|12133274|FG001|Overall Study|Sample not collected|1
7711122|NCT00474994|12133280|FG000|Overall Study|Patient Not treated|1
7711123|NCT00474994|12133280|FG000|Overall Study|Patient evaluable for toxicity only|3
7711124|NCT00474994|12133280|FG000|Overall Study|Patient found to be ineligible|1
7711125|NCT00475020|12133284|FG000|Overall Study|Physician Decision|3
7711126|NCT00475020|12133284|FG000|Overall Study|Insurance Denial|1
7711127|NCT00475020|12133284|FG000|Overall Study|Donor not able to donate the last minute|1
7711128|NCT00475033|12133290|FG000|Infant Series|Failed to return|3
7711129|NCT00475033|12133291|FG001|Infant Series|Failed to return|4
7711130|NCT00475033|12133290|FG000|Infant Series|Parent or legal guardian request|1
7711131|NCT00475033|12133291|FG001|Infant Series|Parent or legal guardian request|5
7711132|NCT00475033|12133290|FG000|Infant Series|Protocol Violation|1
7711133|NCT00475033|12133291|FG001|Infant Series|Protocol Violation|2
7711134|NCT00475033|12133290|FG000|Infant Series|Lost to Follow-up|2
7711135|NCT00475033|12133291|FG001|Infant Series|Lost to Follow-up|0
7711136|NCT00475033|12133290|FG000|Infant Series|Adverse Event|0
7711137|NCT00475033|12133291|FG001|Infant Series|Adverse Event|2
7711138|NCT00475033|12133290|FG000|After the Infant Series|Adverse Event|0
7711139|NCT00475033|12133291|FG001|After the Infant Series|Adverse Event|4
7711140|NCT00475033|12133290|FG000|After the Infant Series|Parent or legal guardian request|2
7711141|NCT00475033|12133291|FG001|After the Infant Series|Parent or legal guardian request|2
7711142|NCT00475033|12133290|FG000|After the Infant Series|Failed to return|2
7711143|NCT00475033|12133291|FG001|After the Infant Series|Failed to return|1
7711144|NCT00475033|12133290|FG000|After the Infant Series|Protocol Violation|1
7711145|NCT00475033|12133291|FG001|After the Infant Series|Protocol Violation|0
7711146|NCT00475033|12133290|FG000|After the Infant Series|Lost to Follow-up|1
7711147|NCT00475033|12133291|FG001|After the Infant Series|Lost to Follow-up|0
7711148|NCT00475033|12133290|FG000|After the Infant Series|Other|0
7711149|NCT00475033|12133291|FG001|After the Infant Series|Other|1
7711150|NCT00475033|12133290|FG000|Toddler Dose|Parent or legal guardian request|2
7711151|NCT00475033|12133291|FG001|Toddler Dose|Parent or legal guardian request|0
7711152|NCT00475033|12133290|FG000|Toddler Dose|Failed to return|1
7711153|NCT00475033|12133291|FG001|Toddler Dose|Failed to return|0
7711154|NCT00475033|12133290|FG000|Toddler Dose|Lost to Follow-up|1
7711155|NCT00475033|12133291|FG001|Toddler Dose|Lost to Follow-up|0
7711156|NCT00475176|12133329|FG000|Overall Study|Adverse Event|2
7711157|NCT00475176|12133329|FG000|Overall Study|Withdrawal by Subject|1
7711158|NCT00475176|12133329|FG000|Overall Study|Protocol Violation|1
7711159|NCT00475228|12133344|FG000|Overall Study|Lost to Follow-up|17
7711160|NCT00475228|12133345|FG001|Overall Study|Lost to Follow-up|17
7711161|NCT00475306|12133369|FG000|Overall Study|Protocol Violation|1
7711162|NCT00475306|12133370|FG001|Overall Study|Protocol Violation|1
7711163|NCT00475306|12133371|FG002|Overall Study|Protocol Violation|0
7711164|NCT00475306|12133372|FG003|Overall Study|Protocol Violation|1
7711165|NCT00475423|12133398|FG000|Overall Study|Protocol Violation|5
7711166|NCT00475423|12133398|FG000|Overall Study|Adverse Event|4
7711167|NCT00475423|12133398|FG000|Overall Study|Withdrawal by Subject|6
7711168|NCT00475423|12133398|FG000|Overall Study|Lack of Efficacy|8
7711169|NCT00475423|12133398|FG000|Overall Study|Death|1
7711170|NCT00475423|12133398|FG000|Overall Study|Reason not specified|1
7711171|NCT00475423|12133398|FG000|Overall Study|Lost to Follow-up|7
7711172|NCT00475644|12133451|FG000|Overall Study|Protocol Violation|13
7711173|NCT00475670|12133457|FG000|Overall Study|Death|0
7711174|NCT00475670|12133458|FG001|Overall Study|Death|1
7711175|NCT00475670|12133457|FG000|Overall Study|Lack of Efficacy|3
7711176|NCT00475670|12133458|FG001|Overall Study|Lack of Efficacy|34
7711177|NCT00475670|12133457|FG000|Overall Study|Refused treatment|0
7711178|NCT00475670|12133458|FG001|Overall Study|Refused treatment|2
7711179|NCT00475670|12133457|FG000|Overall Study|Failure to Return|0
7711180|NCT00475670|12133458|FG001|Overall Study|Failure to Return|1
7711181|NCT00475670|12133457|FG000|Overall Study|Other|0
7711182|NCT00475670|12133458|FG001|Overall Study|Other|3
7711183|NCT00475709|12133464|FG000|Overall Study|Did not meet eligibility criteria|8
7711184|NCT00475709|12133464|FG000|Overall Study|Death|41
7711185|NCT00475709|12133464|FG000|Overall Study|Device Explant|6
7711186|NCT00475709|12133464|FG000|Overall Study|Lost to Follow-up|21
7711187|NCT00475722|12133470|FG000|Overall Study|Withdrawal by Subject|12
7711188|NCT00475722|12133471|FG001|Overall Study|Withdrawal by Subject|12
7711189|NCT00475722|12133470|FG000|Overall Study|Protocol Violation|3
7711190|NCT00475722|12133471|FG001|Overall Study|Protocol Violation|0
7711191|NCT00475735|12133483|FG000|Treatment Period 1|Adverse Event|2
7711192|NCT00475735|12133484|FG001|Treatment Period 1|Adverse Event|0
7711193|NCT00475735|12133485|FG002|Treatment Period 1|Adverse Event|0
7711194|NCT00475735|12133486|FG003|Treatment Period 1|Adverse Event|0
7711195|NCT00475735|12133487|FG004|Treatment Period 1|Adverse Event|0
7711196|NCT00475735|12133488|FG005|Treatment Period 1|Adverse Event|0
7711197|NCT00475735|12133483|FG000|Treatment Period 1|Lack of Efficacy|1
7711198|NCT00475735|12133484|FG001|Treatment Period 1|Lack of Efficacy|0
7711199|NCT00475735|12133485|FG002|Treatment Period 1|Lack of Efficacy|0
7711200|NCT00475735|12133486|FG003|Treatment Period 1|Lack of Efficacy|0
7711201|NCT00475735|12133487|FG004|Treatment Period 1|Lack of Efficacy|0
7711202|NCT00475735|12133488|FG005|Treatment Period 1|Lack of Efficacy|0
7711203|NCT00475735|12133483|FG000|Treatment Period 1|Lost to Follow-up|0
7711204|NCT00475735|12133484|FG001|Treatment Period 1|Lost to Follow-up|0
7711205|NCT00475735|12133485|FG002|Treatment Period 1|Lost to Follow-up|0
7711206|NCT00475735|12133486|FG003|Treatment Period 1|Lost to Follow-up|0
7711207|NCT00475735|12133487|FG004|Treatment Period 1|Lost to Follow-up|0
7711208|NCT00475735|12133488|FG005|Treatment Period 1|Lost to Follow-up|1
7711209|NCT00475735|12133483|FG000|Treatment Period 1|Protocol Violation|0
7711210|NCT00475735|12133484|FG001|Treatment Period 1|Protocol Violation|0
7711211|NCT00475735|12133485|FG002|Treatment Period 1|Protocol Violation|0
7711212|NCT00475735|12133486|FG003|Treatment Period 1|Protocol Violation|1
7711213|NCT00475735|12133487|FG004|Treatment Period 1|Protocol Violation|0
7711214|NCT00475735|12133488|FG005|Treatment Period 1|Protocol Violation|0
7711215|NCT00475735|12133483|FG000|Treatment Period 1|Withdrawal by Subject|1
7711216|NCT00475735|12133484|FG001|Treatment Period 1|Withdrawal by Subject|1
7711217|NCT00475735|12133485|FG002|Treatment Period 1|Withdrawal by Subject|0
7711218|NCT00475735|12133486|FG003|Treatment Period 1|Withdrawal by Subject|0
7711219|NCT00475735|12133487|FG004|Treatment Period 1|Withdrawal by Subject|0
7711220|NCT00475735|12133488|FG005|Treatment Period 1|Withdrawal by Subject|0
7711221|NCT00475735|12133483|FG000|Treatment Period 1|DC due to AE but continuing|0
7711222|NCT00475735|12133484|FG001|Treatment Period 1|DC due to AE but continuing|0
7711223|NCT00475735|12133485|FG002|Treatment Period 1|DC due to AE but continuing|0
7711224|NCT00475735|12133486|FG003|Treatment Period 1|DC due to AE but continuing|1
7711225|NCT00475735|12133487|FG004|Treatment Period 1|DC due to AE but continuing|2
7711226|NCT00475735|12133488|FG005|Treatment Period 1|DC due to AE but continuing|2
7711227|NCT00475735|12133483|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0
7711228|NCT00475735|12133484|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1
7711229|NCT00475735|12133485|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0
7711230|NCT00475735|12133486|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0
7711231|NCT00475735|12133487|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0
7711232|NCT00475735|12133488|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0
7711233|NCT00475735|12133483|FG000|Treatment Washout|Lost to Follow-up|0
7711234|NCT00475735|12133484|FG001|Treatment Washout|Lost to Follow-up|1
7711235|NCT00475735|12133485|FG002|Treatment Washout|Lost to Follow-up|0
7711236|NCT00475735|12133486|FG003|Treatment Washout|Lost to Follow-up|0
7711237|NCT00475735|12133487|FG004|Treatment Washout|Lost to Follow-up|0
7711238|NCT00475735|12133488|FG005|Treatment Washout|Lost to Follow-up|0
7711239|NCT00475735|12133483|FG000|Treatment Washout|Protocol Violation|0
7711240|NCT00475735|12133484|FG001|Treatment Washout|Protocol Violation|1
7711241|NCT00475735|12133485|FG002|Treatment Washout|Protocol Violation|0
7711242|NCT00475735|12133486|FG003|Treatment Washout|Protocol Violation|0
7711243|NCT00475735|12133487|FG004|Treatment Washout|Protocol Violation|0
7711244|NCT00475735|12133488|FG005|Treatment Washout|Protocol Violation|0
7711245|NCT00475735|12133483|FG000|Treatment Period 2|Adverse Event|0
7711246|NCT00475735|12133484|FG001|Treatment Period 2|Adverse Event|1
7711247|NCT00475735|12133485|FG002|Treatment Period 2|Adverse Event|0
7711248|NCT00475735|12133486|FG003|Treatment Period 2|Adverse Event|2
7711249|NCT00475735|12133487|FG004|Treatment Period 2|Adverse Event|0
7711250|NCT00475735|12133488|FG005|Treatment Period 2|Adverse Event|0
7711251|NCT00475735|12133483|FG000|Treatment Period 2|Lack of Efficacy|0
7711252|NCT00475735|12133484|FG001|Treatment Period 2|Lack of Efficacy|0
7711253|NCT00475735|12133485|FG002|Treatment Period 2|Lack of Efficacy|0
7711254|NCT00475735|12133486|FG003|Treatment Period 2|Lack of Efficacy|0
7711255|NCT00475735|12133487|FG004|Treatment Period 2|Lack of Efficacy|0
7711256|NCT00475735|12133488|FG005|Treatment Period 2|Lack of Efficacy|1
7711257|NCT00475735|12133483|FG000|Treatment Period 2|Withdrawal by Subject|0
7711258|NCT00475735|12133484|FG001|Treatment Period 2|Withdrawal by Subject|0
7711259|NCT00475735|12133485|FG002|Treatment Period 2|Withdrawal by Subject|0
7711260|NCT00475735|12133486|FG003|Treatment Period 2|Withdrawal by Subject|0
7711261|NCT00475735|12133487|FG004|Treatment Period 2|Withdrawal by Subject|1
7711262|NCT00475735|12133488|FG005|Treatment Period 2|Withdrawal by Subject|0
7711263|NCT00475852|12133509|FG000|Overall Study|Death|444
7711264|NCT00475852|12133510|FG001|Overall Study|Death|456
7711265|NCT00475852|12133509|FG000|Overall Study|Withdrawal by Subject|19
7711266|NCT00475852|12133510|FG001|Overall Study|Withdrawal by Subject|24
7711267|NCT00475852|12133509|FG000|Overall Study|Lost to Follow-up|54
7711268|NCT00475852|12133510|FG001|Overall Study|Lost to Follow-up|68
7711269|NCT00475865|12133519|FG000|Overall Study|Adverse Event|0
7711270|NCT00475865|12133520|FG001|Overall Study|Adverse Event|3
7711271|NCT00475865|12133521|FG002|Overall Study|Adverse Event|4
7711272|NCT00475865|12133519|FG000|Overall Study|Lack of Efficacy|1
7711273|NCT00475865|12133520|FG001|Overall Study|Lack of Efficacy|0
7711274|NCT00475865|12133521|FG002|Overall Study|Lack of Efficacy|0
7711275|NCT00475865|12133519|FG000|Overall Study|Progressive disease|0
7711276|NCT00475865|12133520|FG001|Overall Study|Progressive disease|1
7711277|NCT00475865|12133521|FG002|Overall Study|Progressive disease|2
7711278|NCT00475865|12133519|FG000|Overall Study|Participant did not wish to continue|1
7711279|NCT00475865|12133520|FG001|Overall Study|Participant did not wish to continue|0
7711280|NCT00475865|12133521|FG002|Overall Study|Participant did not wish to continue|0
7711281|NCT00475865|12133519|FG000|Overall Study|Other than above|0
7711282|NCT00475865|12133520|FG001|Overall Study|Other than above|1
7711283|NCT00475865|12133521|FG002|Overall Study|Other than above|0
7711284|NCT00475982|12133557|FG000|Overall Study|surgery rescheduled|7
7711285|NCT00475982|12133558|FG001|Overall Study|surgery rescheduled|3
7711286|NCT00476008|12133566|FG000|Overall Study|Adverse Event|4
7711287|NCT00476008|12133567|FG001|Overall Study|Adverse Event|4
7711288|NCT00476008|12133566|FG000|Overall Study|Placebo concerns|2
7711289|NCT00476008|12133567|FG001|Overall Study|Placebo concerns|2
7711290|NCT00476008|12133566|FG000|Overall Study|Physician Decision: Medication Noncompli|2
7711291|NCT00476008|12133567|FG001|Overall Study|Physician Decision: Medication Noncompli|1
7711292|NCT00476008|12133566|FG000|Overall Study|Withdrawal by Subject|0
7711293|NCT00476008|12133567|FG001|Overall Study|Withdrawal by Subject|1
7711294|NCT00476008|12133566|FG000|Overall Study|Death|1
7711295|NCT00476008|12133567|FG001|Overall Study|Death|0
7711296|NCT00476047|12133592|FG000|Overall Study|Lost to Follow-up|1
7711297|NCT00476086|12133598|FG000|Overall Study|Alternative therapy|1
7711298|NCT00476086|12133598|FG000|Overall Study|Progressive Disease|4
7711299|NCT00476151|12133606|FG000|Overall Study|Adverse Event|0
7711300|NCT00476151|12133607|FG001|Overall Study|Adverse Event|2
7711301|NCT00476151|12133606|FG000|Overall Study|Protocol Violation|1
7711302|NCT00476151|12133607|FG001|Overall Study|Protocol Violation|3
7711303|NCT00476151|12133606|FG000|Overall Study|Withdrawal by Subject|2
7711304|NCT00476151|12133607|FG001|Overall Study|Withdrawal by Subject|0
7711305|NCT00476151|12133606|FG000|Overall Study|Physician Decision|0
7711306|NCT00476151|12133607|FG001|Overall Study|Physician Decision|2
7711307|NCT00476229|12133613|FG000|Overall Study|Progressive shortness of breath|1
7711308|NCT00476476|12133630|FG000|Overall Study|Adverse Event|2
7711309|NCT00476476|12133631|FG001|Overall Study|Adverse Event|7
7711310|NCT00476476|12133630|FG000|Overall Study|Progressive Disease|0
7711311|NCT00476476|12133631|FG001|Overall Study|Progressive Disease|17
7711312|NCT00476593|12133640|FG000|Overall Study|Lost to Follow-up|10
7711313|NCT00476593|12133641|FG001|Overall Study|Lost to Follow-up|2
7711314|NCT00476593|12133642|FG002|Overall Study|Lost to Follow-up|8
7711315|NCT00476593|12133643|FG003|Overall Study|Lost to Follow-up|22
7711316|NCT00476957|12133663|FG000|Overall Study|Lost to Follow-up|176
7711317|NCT00476957|12133664|FG001|Overall Study|Lost to Follow-up|193
7711318|NCT00476996|12133673|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12
7711319|NCT00476996|12133674|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
7711320|NCT00476996|12133675|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
7711321|NCT00476996|12133676|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0
7711322|NCT00476996|12133673|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1
7711323|NCT00476996|12133674|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3
7711324|NCT00476996|12133675|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
7711325|NCT00476996|12133676|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
7711326|NCT00476996|12133673|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24
7711327|NCT00476996|12133674|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20
7711328|NCT00476996|12133675|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21
7711329|NCT00476996|12133676|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0
7711330|NCT00476996|12133673|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
7711331|NCT00476996|12133674|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2
7711332|NCT00476996|12133675|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
7711333|NCT00476996|12133676|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
7711334|NCT00476996|12133673|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
7711335|NCT00476996|12133674|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4
7711336|NCT00476996|12133675|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3
7711337|NCT00476996|12133676|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
7711338|NCT00476996|12133673|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22
7711339|NCT00476996|12133674|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5
7711340|NCT00476996|12133675|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6
7711341|NCT00476996|12133676|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0
7711342|NCT00476996|12133673|FG000|Blinded Treatment Phase (up to Week 48)|Death|2
7711343|NCT00476996|12133674|FG001|Blinded Treatment Phase (up to Week 48)|Death|1
7711344|NCT00476996|12133675|FG002|Blinded Treatment Phase (up to Week 48)|Death|1
7711345|NCT00476996|12133676|FG003|Blinded Treatment Phase (up to Week 48)|Death|0
7711346|NCT00476996|12133673|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11
7711347|NCT00476996|12133674|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13
7711348|NCT00476996|12133675|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7
7711349|NCT00476996|12133676|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0
7711350|NCT00476996|12133673|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0
7711351|NCT00476996|12133674|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0
7711352|NCT00476996|12133675|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0
7711353|NCT00476996|12133676|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50
7711354|NCT00476996|12133673|FG000|OLE Phase (From Week 48)|Adverse Event|0
7711355|NCT00476996|12133674|FG001|OLE Phase (From Week 48)|Adverse Event|0
7711356|NCT00476996|12133675|FG002|OLE Phase (From Week 48)|Adverse Event|0
7711357|NCT00476996|12133676|FG003|OLE Phase (From Week 48)|Adverse Event|8
7711358|NCT00476996|12133673|FG000|OLE Phase (From Week 48)|Death|0
7711359|NCT00476996|12133674|FG001|OLE Phase (From Week 48)|Death|0
7711360|NCT00476996|12133675|FG002|OLE Phase (From Week 48)|Death|0
7711361|NCT00476996|12133676|FG003|OLE Phase (From Week 48)|Death|7
7711362|NCT00476996|12133673|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0
7711363|NCT00476996|12133674|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0
7711364|NCT00476996|12133675|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0
7711365|NCT00476996|12133676|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13
7711366|NCT00476996|12133673|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0
7711367|NCT00476996|12133674|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0
7711368|NCT00476996|12133675|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0
7711369|NCT00476996|12133676|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4
7711370|NCT00476996|12133673|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
7711371|NCT00476996|12133674|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
7711372|NCT00476996|12133675|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
7711373|NCT00476996|12133676|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4
7711374|NCT00476996|12133673|FG000|OLE Phase (From Week 48)|Early termination of the study|0
7711375|NCT00476996|12133674|FG001|OLE Phase (From Week 48)|Early termination of the study|0
7711376|NCT00476996|12133675|FG002|OLE Phase (From Week 48)|Early termination of the study|0
7711377|NCT00476996|12133676|FG003|OLE Phase (From Week 48)|Early termination of the study|578
7711378|NCT00477152|12133689|FG000|Overall Study|Parent withdrew consent|2
7711379|NCT00477152|12133689|FG000|Overall Study|Adverse Event|1
7711380|NCT00477165|12133695|FG000|Overall Study|Adverse Event|7
7711381|NCT00477165|12133696|FG001|Overall Study|Adverse Event|2
7711382|NCT00477269|12133717|FG000|Core Study|Adverse Event|6
7711383|NCT00477269|12133718|FG001|Core Study|Adverse Event|4
7711384|NCT00477269|12133719|FG002|Core Study|Adverse Event|0
7711385|NCT00477269|12133717|FG000|Core Study|Death|3
7711386|NCT00477269|12133718|FG001|Core Study|Death|3
7711387|NCT00477269|12133719|FG002|Core Study|Death|0
7711388|NCT00477269|12133717|FG000|Core Study|Withdrawn Consent|0
7711389|NCT00477269|12133718|FG001|Core Study|Withdrawn Consent|1
7711390|NCT00477269|12133719|FG002|Core Study|Withdrawn Consent|0
7711391|NCT00477269|12133717|FG000|Open Label Extension|Adverse Event|0
7711392|NCT00477269|12133718|FG001|Open Label Extension|Adverse Event|0
7711393|NCT00477269|12133719|FG002|Open Label Extension|Adverse Event|4
7711394|NCT00477269|12133717|FG000|Open Label Extension|Abnormal laboratory values|0
7711395|NCT00477269|12133718|FG001|Open Label Extension|Abnormal laboratory values|0
7711396|NCT00477269|12133719|FG002|Open Label Extension|Abnormal laboratory values|1
7711397|NCT00477269|12133717|FG000|Open Label Extension|unsatisfactory therapeutic effects|0
7711398|NCT00477269|12133718|FG001|Open Label Extension|unsatisfactory therapeutic effects|0
7711399|NCT00477269|12133719|FG002|Open Label Extension|unsatisfactory therapeutic effects|2
7711400|NCT00477269|12133717|FG000|Open Label Extension|Adminiatrative problems|0
7711401|NCT00477269|12133718|FG001|Open Label Extension|Adminiatrative problems|0
7711402|NCT00477269|12133719|FG002|Open Label Extension|Adminiatrative problems|2
7711403|NCT00477269|12133717|FG000|Open Label Extension|Death|0
7711404|NCT00477269|12133718|FG001|Open Label Extension|Death|0
7711405|NCT00477269|12133719|FG002|Open Label Extension|Death|4
7711406|NCT00477295|12133729|FG000|Overall Study|Adverse Event|31
7711407|NCT00477295|12133730|FG001|Overall Study|Adverse Event|35
7711408|NCT00477295|12133729|FG000|Overall Study|Withdrawal by Subject|35
7711409|NCT00477295|12133730|FG001|Overall Study|Withdrawal by Subject|24
7711410|NCT00477295|12133729|FG000|Overall Study|Lack of Efficacy|23
7711411|NCT00477295|12133730|FG001|Overall Study|Lack of Efficacy|23
7711412|NCT00477295|12133729|FG000|Overall Study|Protocol Violation|3
7711413|NCT00477295|12133730|FG001|Overall Study|Protocol Violation|8
7711414|NCT00477295|12133729|FG000|Overall Study|Physician Decision|4
7711415|NCT00477295|12133730|FG001|Overall Study|Physician Decision|5
7711416|NCT00477295|12133729|FG000|Overall Study|Lost to Follow-up|21
7711417|NCT00477295|12133730|FG001|Overall Study|Lost to Follow-up|11
7711418|NCT00477295|12133729|FG000|Overall Study|Other|4
7711419|NCT00477295|12133730|FG001|Overall Study|Other|3
7711420|NCT00477334|12133740|FG000|Overall Study|Discontinued prior to taking study drug|106
7711421|NCT00477334|12133741|FG001|Overall Study|Discontinued prior to taking study drug|53
7711422|NCT00477334|12133740|FG000|Overall Study|Adverse Event|1
7711423|NCT00477334|12133741|FG001|Overall Study|Adverse Event|2
7711424|NCT00477334|12133740|FG000|Overall Study|Withdrawal by Subject|2
7711425|NCT00477334|12133741|FG001|Overall Study|Withdrawal by Subject|1
7711426|NCT00477334|12133740|FG000|Overall Study|Lost to Follow-up|15
7711427|NCT00477334|12133741|FG001|Overall Study|Lost to Follow-up|4
7711428|NCT00477334|12133740|FG000|Overall Study|Administrative Problems|39
7711429|NCT00477334|12133741|FG001|Overall Study|Administrative Problems|15
7711430|NCT00477334|12133740|FG000|Overall Study|Protocol Violation|7
7711431|NCT00477334|12133741|FG001|Overall Study|Protocol Violation|1
7711432|NCT00477386|12133753|FG000|Overall Study|Adverse Event|4
7711433|NCT00477386|12133754|FG001|Overall Study|Adverse Event|8
7711434|NCT00477386|12133753|FG000|Overall Study|Disease progression, relapse|3
7711435|NCT00477386|12133754|FG001|Overall Study|Disease progression, relapse|4
7711436|NCT00477386|12133753|FG000|Overall Study|Disease progression, refractory|1
7711437|NCT00477386|12133754|FG001|Overall Study|Disease progression, refractory|3
7711438|NCT00477386|12133753|FG000|Overall Study|Other|1
7711439|NCT00477386|12133754|FG001|Overall Study|Other|2
7711440|NCT00477386|12133753|FG000|Overall Study|Physician Decision|1
7711441|NCT00477386|12133754|FG001|Overall Study|Physician Decision|0
7711442|NCT00477386|12133753|FG000|Overall Study|Withdrawal by Subject|1
7711443|NCT00477386|12133754|FG001|Overall Study|Withdrawal by Subject|0
7711444|NCT00477464|12133775|FG000|Overall Study|Lost to Follow-up|1
7711445|NCT00477464|12133775|FG000|Overall Study|Death|36
7711446|NCT00477464|12133775|FG000|Overall Study|Completion of protocol-defined follow-up|14
7711447|NCT00477490|12133786|FG000|Part I: 4 Week Efficacy|Adverse Event|1
7711448|NCT00477490|12133787|FG001|Part I: 4 Week Efficacy|Adverse Event|4
7711449|NCT00477490|12133788|FG002|Part I: 4 Week Efficacy|Adverse Event|0
7711450|NCT00477490|12133789|FG003|Part I: 4 Week Efficacy|Adverse Event|5
7711451|NCT00477490|12133790|FG004|Part I: 4 Week Efficacy|Adverse Event|6
7711452|NCT00477490|12133791|FG005|Part I: 4 Week Efficacy|Adverse Event|0
7711453|NCT00477490|12133792|FG006|Part I: 4 Week Efficacy|Adverse Event|0
7711454|NCT00477490|12133793|FG007|Part I: 4 Week Efficacy|Adverse Event|0
7711455|NCT00477490|12133794|FG008|Part I: 4 Week Efficacy|Adverse Event|0
7711456|NCT00477490|12133786|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
7711457|NCT00477490|12133787|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7711458|NCT00477490|12133788|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7711459|NCT00477490|12133789|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
7711460|NCT00477490|12133790|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
7711461|NCT00477490|12133791|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7711462|NCT00477490|12133792|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7711463|NCT00477490|12133793|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7711464|NCT00477490|12133794|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7711465|NCT00477490|12133786|FG000|Part I: 4 Week Efficacy|Protocol Violation|2
7711466|NCT00477490|12133787|FG001|Part I: 4 Week Efficacy|Protocol Violation|0
7711467|NCT00477490|12133788|FG002|Part I: 4 Week Efficacy|Protocol Violation|0
7711468|NCT00477490|12133789|FG003|Part I: 4 Week Efficacy|Protocol Violation|0
7711469|NCT00477490|12133790|FG004|Part I: 4 Week Efficacy|Protocol Violation|1
7711470|NCT00477490|12133791|FG005|Part I: 4 Week Efficacy|Protocol Violation|0
7711471|NCT00477490|12133792|FG006|Part I: 4 Week Efficacy|Protocol Violation|0
7711472|NCT00477490|12133793|FG007|Part I: 4 Week Efficacy|Protocol Violation|0
7711473|NCT00477490|12133794|FG008|Part I: 4 Week Efficacy|Protocol Violation|0
7711474|NCT00477490|12133786|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6
7711475|NCT00477490|12133787|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5
7711476|NCT00477490|12133788|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6
7711477|NCT00477490|12133789|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4
7711478|NCT00477490|12133790|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9
7711479|NCT00477490|12133791|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0
7711480|NCT00477490|12133792|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0
7711481|NCT00477490|12133793|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0
7711482|NCT00477490|12133794|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0
7711483|NCT00477490|12133786|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2
7711484|NCT00477490|12133787|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4
7711485|NCT00477490|12133788|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1
7711486|NCT00477490|12133789|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5
7711487|NCT00477490|12133790|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3
7711488|NCT00477490|12133791|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0
7711489|NCT00477490|12133792|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0
7711490|NCT00477490|12133793|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0
7711491|NCT00477490|12133794|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0
7711492|NCT00477490|12133786|FG000|Part I: 4 Week Efficacy|Other, not specified|2
7711493|NCT00477490|12133787|FG001|Part I: 4 Week Efficacy|Other, not specified|4
7711494|NCT00477490|12133788|FG002|Part I: 4 Week Efficacy|Other, not specified|0
7711495|NCT00477490|12133789|FG003|Part I: 4 Week Efficacy|Other, not specified|1
7711496|NCT00477490|12133790|FG004|Part I: 4 Week Efficacy|Other, not specified|1
7711497|NCT00477490|12133791|FG005|Part I: 4 Week Efficacy|Other, not specified|0
7711498|NCT00477490|12133792|FG006|Part I: 4 Week Efficacy|Other, not specified|0
7711499|NCT00477490|12133793|FG007|Part I: 4 Week Efficacy|Other, not specified|0
7711500|NCT00477490|12133794|FG008|Part I: 4 Week Efficacy|Other, not specified|0
7711501|NCT00477490|12133786|FG000|Part I: 4 Week Efficacy|Not Reported|1
7711502|NCT00477490|12133787|FG001|Part I: 4 Week Efficacy|Not Reported|2
7711503|NCT00477490|12133788|FG002|Part I: 4 Week Efficacy|Not Reported|3
7711504|NCT00477490|12133789|FG003|Part I: 4 Week Efficacy|Not Reported|0
7711505|NCT00477490|12133790|FG004|Part I: 4 Week Efficacy|Not Reported|1
7711506|NCT00477490|12133791|FG005|Part I: 4 Week Efficacy|Not Reported|0
7711507|NCT00477490|12133792|FG006|Part I: 4 Week Efficacy|Not Reported|0
7711508|NCT00477490|12133793|FG007|Part I: 4 Week Efficacy|Not Reported|0
7711509|NCT00477490|12133794|FG008|Part I: 4 Week Efficacy|Not Reported|0
7711510|NCT00477490|12133786|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
7711511|NCT00477490|12133787|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
7711512|NCT00477490|12133788|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
7711513|NCT00477490|12133789|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
7711514|NCT00477490|12133790|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
7711515|NCT00477490|12133791|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
7711516|NCT00477490|12133792|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
7711517|NCT00477490|12133793|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
7711518|NCT00477490|12133794|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
7711519|NCT00477490|12133786|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0
7711520|NCT00477490|12133787|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2
7711521|NCT00477490|12133788|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3
7711522|NCT00477490|12133789|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1
7711523|NCT00477490|12133790|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1
7711524|NCT00477490|12133791|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1
7711525|NCT00477490|12133792|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1
7711526|NCT00477490|12133793|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1
7711527|NCT00477490|12133794|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4
7711528|NCT00477490|12133786|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
7711529|NCT00477490|12133787|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
7711530|NCT00477490|12133788|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
7711531|NCT00477490|12133789|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
7711532|NCT00477490|12133790|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
7711533|NCT00477490|12133791|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
7711534|NCT00477490|12133792|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
7711535|NCT00477490|12133793|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
7711536|NCT00477490|12133794|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
7711537|NCT00477490|12133786|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7711538|NCT00477490|12133787|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7711539|NCT00477490|12133788|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7711540|NCT00477490|12133789|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7711541|NCT00477490|12133790|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
7711542|NCT00477490|12133791|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7711543|NCT00477490|12133792|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7711544|NCT00477490|12133793|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
7711545|NCT00477490|12133794|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
7711546|NCT00477490|12133786|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7711547|NCT00477490|12133787|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1
7711548|NCT00477490|12133788|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7711549|NCT00477490|12133789|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7711550|NCT00477490|12133790|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7711551|NCT00477490|12133791|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7711552|NCT00477490|12133792|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7711553|NCT00477490|12133793|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7711554|NCT00477490|12133794|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7711555|NCT00477490|12133786|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0
7711556|NCT00477490|12133787|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4
7711557|NCT00477490|12133788|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2
7711558|NCT00477490|12133789|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4
7711559|NCT00477490|12133790|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2
7711560|NCT00477490|12133791|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1
7711561|NCT00477490|12133792|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1
7711562|NCT00477490|12133793|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0
7711563|NCT00477490|12133794|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1
7711564|NCT00477490|12133786|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0
7711565|NCT00477490|12133787|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3
7711566|NCT00477490|12133788|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1
7711567|NCT00477490|12133789|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0
7711568|NCT00477490|12133790|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1
7711569|NCT00477490|12133791|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0
7711570|NCT00477490|12133792|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0
7711571|NCT00477490|12133793|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0
7711572|NCT00477490|12133794|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0
7711573|NCT00477594|12133824|FG000|Year 1 and Year 2|Adverse Event|4
7711574|NCT00477594|12133825|FG001|Year 1 and Year 2|Adverse Event|2
7711575|NCT00477594|12133824|FG000|Year 1 and Year 2|Physician Decision|2
7711576|NCT00477594|12133825|FG001|Year 1 and Year 2|Physician Decision|1
7711577|NCT00477594|12133824|FG000|Year 1 and Year 2|Withdrawal by Subject|2
7711578|NCT00477594|12133825|FG001|Year 1 and Year 2|Withdrawal by Subject|1
7711579|NCT00477594|12133824|FG000|Year 1 and Year 2|Other|1
7711580|NCT00477594|12133825|FG001|Year 1 and Year 2|Other|0
7711581|NCT00477594|12133824|FG000|Year 3|Adverse Event|1
7711582|NCT00477594|12133825|FG001|Year 3|Adverse Event|0
7711583|NCT00477594|12133824|FG000|Year 3|Withdrawal by Subject|1
7711584|NCT00477594|12133825|FG001|Year 3|Withdrawal by Subject|0
7711585|NCT00477594|12133824|FG000|Follow-up Period|Withdrawal by Subject|2
7711586|NCT00477594|12133825|FG001|Follow-up Period|Withdrawal by Subject|1
7711587|NCT00477594|12133824|FG000|Follow-up Period|Other|1
7711588|NCT00477594|12133825|FG001|Follow-up Period|Other|0
7711589|NCT00477607|12133833|FG000|Overall Study|Lost to Follow-up|7
7711590|NCT00477607|12133834|FG001|Overall Study|Lost to Follow-up|7
7711591|NCT00477633|12133840|FG000|Overall Study|Did not receive treatment|23
7711592|NCT00477633|12133840|FG000|Overall Study|Adverse Event|143
7711593|NCT00477633|12133840|FG000|Overall Study|Pregnancy|23
7711594|NCT00477633|12133840|FG000|Overall Study|Lost to Follow-up|271
7711595|NCT00477633|12133840|FG000|Overall Study|Withdrawal by Subject|149
7711596|NCT00477633|12133840|FG000|Overall Study|Protocol Violation|25
7711597|NCT00477633|12133840|FG000|Overall Study|Various (Moving, Enrollment closed)|75
7711598|NCT00477672|12133851|FG000|Overall Study|Adverse Event|3
7711599|NCT00477672|12133852|FG001|Overall Study|Adverse Event|5
7711600|NCT00477672|12133853|FG002|Overall Study|Adverse Event|6
7711601|NCT00477672|12133851|FG000|Overall Study|Death|0
7711602|NCT00477672|12133852|FG001|Overall Study|Death|1
7711603|NCT00477672|12133853|FG002|Overall Study|Death|0
7711604|NCT00477672|12133851|FG000|Overall Study|Disease progression|0
7711605|NCT00477672|12133852|FG001|Overall Study|Disease progression|1
7711606|NCT00477672|12133853|FG002|Overall Study|Disease progression|0
7711607|NCT00477672|12133851|FG000|Overall Study|Physician Decision|1
7711608|NCT00477672|12133852|FG001|Overall Study|Physician Decision|0
7711609|NCT00477672|12133853|FG002|Overall Study|Physician Decision|0
7711610|NCT00477672|12133851|FG000|Overall Study|Protocol noncompliance|0
7711611|NCT00477672|12133852|FG001|Overall Study|Protocol noncompliance|2
7711612|NCT00477672|12133853|FG002|Overall Study|Protocol noncompliance|0
7711613|NCT00477672|12133851|FG000|Overall Study|Consent withdrawn|2
7711614|NCT00477672|12133852|FG001|Overall Study|Consent withdrawn|5
7711615|NCT00477672|12133853|FG002|Overall Study|Consent withdrawn|10
7711616|NCT00477672|12133851|FG000|Overall Study|Discretion of Sponsor|1
7711617|NCT00477672|12133852|FG001|Overall Study|Discretion of Sponsor|2
7711618|NCT00477672|12133853|FG002|Overall Study|Discretion of Sponsor|0
7711619|NCT00477750|12133865|FG000|Overall Study|Currently Receiving Treatment|11
7711620|NCT00477971|12133873|FG000|Overall Study|Disease progression|6
7711621|NCT00477971|12133874|FG001|Overall Study|Disease progression|0
7711622|NCT00477971|12133873|FG000|Overall Study|Withdrawal by Subject|3
7711623|NCT00477971|12133874|FG001|Overall Study|Withdrawal by Subject|1
7711624|NCT00477971|12133873|FG000|Overall Study|Adverse Event|3
7711625|NCT00477971|12133874|FG001|Overall Study|Adverse Event|0
7711626|NCT00477971|12133873|FG000|Overall Study|Death|2
7711627|NCT00477971|12133874|FG001|Overall Study|Death|4
7711628|NCT00477971|12133873|FG000|Overall Study|Alternative treatment|3
7711629|NCT00477971|12133874|FG001|Overall Study|Alternative treatment|1
7711630|NCT00478023|12133885|FG000|Overall Study|Adverse Event|11
7711631|NCT00478023|12133886|FG001|Overall Study|Adverse Event|7
7711632|NCT00478023|12133887|FG002|Overall Study|Adverse Event|8
7711633|NCT00478023|12133888|FG003|Overall Study|Adverse Event|14
7711634|NCT00478023|12133889|FG004|Overall Study|Adverse Event|6
7711635|NCT00478023|12133885|FG000|Overall Study|Death|1
7711636|NCT00478023|12133886|FG001|Overall Study|Death|0
7711637|NCT00478023|12133887|FG002|Overall Study|Death|0
7711638|NCT00478023|12133888|FG003|Overall Study|Death|0
7711639|NCT00478023|12133889|FG004|Overall Study|Death|0
7711640|NCT00478023|12133885|FG000|Overall Study|Lack of Efficacy|11
7711641|NCT00478023|12133886|FG001|Overall Study|Lack of Efficacy|10
7711642|NCT00478023|12133887|FG002|Overall Study|Lack of Efficacy|4
7711643|NCT00478023|12133888|FG003|Overall Study|Lack of Efficacy|5
7711644|NCT00478023|12133889|FG004|Overall Study|Lack of Efficacy|41
7711645|NCT00478023|12133885|FG000|Overall Study|Lost to Follow-up|3
7711646|NCT00478023|12133886|FG001|Overall Study|Lost to Follow-up|1
7711647|NCT00478023|12133887|FG002|Overall Study|Lost to Follow-up|1
7711648|NCT00478023|12133888|FG003|Overall Study|Lost to Follow-up|1
7711649|NCT00478023|12133889|FG004|Overall Study|Lost to Follow-up|0
7711650|NCT00478023|12133885|FG000|Overall Study|Withdrawal by Subject|2
7711651|NCT00478023|12133886|FG001|Overall Study|Withdrawal by Subject|3
7711652|NCT00478023|12133887|FG002|Overall Study|Withdrawal by Subject|2
7711653|NCT00478023|12133888|FG003|Overall Study|Withdrawal by Subject|4
7711654|NCT00478023|12133889|FG004|Overall Study|Withdrawal by Subject|5
7711655|NCT00478023|12133885|FG000|Overall Study|Lack of pain, Technical difficulties|7
7711656|NCT00478023|12133886|FG001|Overall Study|Lack of pain, Technical difficulties|3
7711657|NCT00478023|12133887|FG002|Overall Study|Lack of pain, Technical difficulties|5
7711658|NCT00478023|12133888|FG003|Overall Study|Lack of pain, Technical difficulties|6
7711659|NCT00478023|12133889|FG004|Overall Study|Lack of pain, Technical difficulties|3
7711660|NCT00478140|12133914|FG000|Overall Study|Clinical Disease Progression|1
7711661|NCT00478205|12133934|FG000|Overall Study|Adverse Event|182
7711662|NCT00478205|12133935|FG001|Overall Study|Adverse Event|39
7711663|NCT00478205|12133934|FG000|Overall Study|Medication Non-compliance|9
7711664|NCT00478205|12133935|FG001|Overall Study|Medication Non-compliance|4
7711665|NCT00478205|12133934|FG000|Overall Study|Protocol Violation|15
7711666|NCT00478205|12133935|FG001|Overall Study|Protocol Violation|5
7711667|NCT00478205|12133934|FG000|Overall Study|Request of Investigator or Sponsor|4
7711668|NCT00478205|12133935|FG001|Overall Study|Request of Investigator or Sponsor|5
7711669|NCT00478205|12133934|FG000|Overall Study|Withdrawal by Subject|61
7711670|NCT00478205|12133935|FG001|Overall Study|Withdrawal by Subject|22
7711671|NCT00478205|12133934|FG000|Overall Study|Lack of Efficacy|1
7711672|NCT00478205|12133935|FG001|Overall Study|Lack of Efficacy|0
7711673|NCT00478205|12133934|FG000|Overall Study|Other|24
7711674|NCT00478205|12133935|FG001|Overall Study|Other|12
7711675|NCT00478231|12133950|FG000|Overall Study|Death|7
7711676|NCT00478231|12133950|FG000|Overall Study|Lack of Efficacy|47
7711677|NCT00478231|12133950|FG000|Overall Study|Lost to Follow-up|7
7711678|NCT00478231|12133950|FG000|Overall Study|Withdrawal by Subject|6
7711679|NCT00478231|12133950|FG000|Overall Study|Other|9
7711680|NCT00478231|12133950|FG000|Overall Study|Adverse Event|5
7711681|NCT00478231|12133950|FG000|Overall Study|Randomized, not treated|3
7711682|NCT00478244|12133954|FG000|Overall Study|Did not receive transplant|1
7711683|NCT00478257|12133960|FG000|Overall Study|Withdrawal by Subject|8
7711684|NCT00478257|12133961|FG001|Overall Study|Withdrawal by Subject|3
7711685|NCT00478426|12133980|FG000|Overall Study|Withdrawal by Subject|1
7711686|NCT00478608|12134005|FG000|Overall Study|Adverse Event|1
7711687|NCT00478608|12134005|FG000|Overall Study|Serious Adverse Event|14
7711688|NCT00478608|12134005|FG000|Overall Study|Withdrawal by Subject|2
7711689|NCT00478608|12134005|FG000|Overall Study|Protocol Violation|3
7711690|NCT00478647|12134009|FG000|Overall Study|Adverse Event|1
7711691|NCT00478647|12134009|FG000|Overall Study|Withdrawal by Subject|1
7711692|NCT00478673|12134013|FG000|30-Days Post-Procedure|Death|2
7711693|NCT00478673|12134013|FG000|30-Days Post-Procedure|Withdrawal by Subject|1
7711694|NCT00478673|12134013|FG000|30-Days Post-Procedure|Missed Visit|7
7711695|NCT00478673|12134013|FG000|12-Months Post-Procedure|Death|23
7711696|NCT00478673|12134013|FG000|12-Months Post-Procedure|Lost to Follow-up|4
7711697|NCT00478673|12134013|FG000|12-Months Post-Procedure|Withdrawal by Subject|6
7711698|NCT00478673|12134013|FG000|12-Months Post-Procedure|Missed Visit|25
7711699|NCT00478673|12134013|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6
7711700|NCT00478777|12134017|FG000|Overall Study|Adverse Event|29
7711701|NCT00478777|12134017|FG000|Overall Study|Lack of Efficacy|23
7711702|NCT00478777|12134017|FG000|Overall Study|Withdrawal by Subject|4
7711703|NCT00478777|12134017|FG000|Overall Study|Death|3
7711704|NCT00478777|12134017|FG000|Overall Study|Protocol Violation|3
7711705|NCT00478777|12134017|FG000|Overall Study|Lost to Follow-up|3
7711706|NCT00478777|12134017|FG000|Overall Study|Physician Decision|1
7711707|NCT00478777|12134017|FG000|Overall Study|Intolerance of therapy|1
7711708|NCT00478777|12134017|FG000|Overall Study|Lack of compliance|1
7711709|NCT00478777|12134017|FG000|Overall Study|Lymphocytes infusion|1
7711710|NCT00478777|12134017|FG000|Overall Study|End of therapy|2
7711711|NCT00478777|12134017|FG000|Overall Study|Not treated with lenalidomide|6
7711712|NCT00478881|12134023|FG000|Overall Study|Adverse Event|31
7711713|NCT00478881|12134024|FG001|Overall Study|Adverse Event|12
7711714|NCT00478881|12134023|FG000|Overall Study|Lack of Efficacy|0
7711715|NCT00478881|12134024|FG001|Overall Study|Lack of Efficacy|3
7711716|NCT00478881|12134023|FG000|Overall Study|Lost to Follow-up|0
7711717|NCT00478881|12134024|FG001|Overall Study|Lost to Follow-up|1
7711718|NCT00478881|12134023|FG000|Overall Study|Protocol Violation|2
7711719|NCT00478881|12134024|FG001|Overall Study|Protocol Violation|2
7711720|NCT00478881|12134023|FG000|Overall Study|Withdrawal by Subject|6
7711721|NCT00478881|12134024|FG001|Overall Study|Withdrawal by Subject|2
7711722|NCT00478881|12134023|FG000|Overall Study|Non-Compliance with Study Medication|0
7711723|NCT00478881|12134024|FG001|Overall Study|Non-Compliance with Study Medication|2
7711724|NCT00478933|12134030|FG000|Overall Study|Protocol Violation|22
7711725|NCT00478933|12134030|FG000|Overall Study|Informed consent not verified|3
7711726|NCT00478933|12134030|FG000|Overall Study|Inadequate data available|53
7711727|NCT00479232|12134087|FG000|Overall Study|Adverse Event|0
7711728|NCT00479232|12134088|FG001|Overall Study|Adverse Event|0
7711729|NCT00479232|12134089|FG002|Overall Study|Adverse Event|5
7711730|NCT00479232|12134090|FG003|Overall Study|Adverse Event|0
7711731|NCT00479232|12134091|FG004|Overall Study|Adverse Event|0
7711732|NCT00479232|12134092|FG005|Overall Study|Adverse Event|10
7711733|NCT00479232|12134087|FG000|Overall Study|Deviation from Protocol|0
7711734|NCT00479232|12134088|FG001|Overall Study|Deviation from Protocol|0
7711735|NCT00479232|12134089|FG002|Overall Study|Deviation from Protocol|1
7711736|NCT00479232|12134090|FG003|Overall Study|Deviation from Protocol|0
7711737|NCT00479232|12134091|FG004|Overall Study|Deviation from Protocol|0
7711738|NCT00479232|12134092|FG005|Overall Study|Deviation from Protocol|0
7711739|NCT00479232|12134087|FG000|Overall Study|Lack of Efficacy|0
7711740|NCT00479232|12134088|FG001|Overall Study|Lack of Efficacy|0
7711741|NCT00479232|12134089|FG002|Overall Study|Lack of Efficacy|2
7711742|NCT00479232|12134090|FG003|Overall Study|Lack of Efficacy|0
7711743|NCT00479232|12134091|FG004|Overall Study|Lack of Efficacy|0
7711744|NCT00479232|12134092|FG005|Overall Study|Lack of Efficacy|4
7711745|NCT00479232|12134087|FG000|Overall Study|Physician Decision|0
7711746|NCT00479232|12134088|FG001|Overall Study|Physician Decision|0
7711747|NCT00479232|12134089|FG002|Overall Study|Physician Decision|2
7711748|NCT00479232|12134090|FG003|Overall Study|Physician Decision|0
7711749|NCT00479232|12134091|FG004|Overall Study|Physician Decision|0
7711750|NCT00479232|12134092|FG005|Overall Study|Physician Decision|1
7711751|NCT00479232|12134087|FG000|Overall Study|Progressive Disease|3
7711752|NCT00479232|12134088|FG001|Overall Study|Progressive Disease|1
7711753|NCT00479232|12134089|FG002|Overall Study|Progressive Disease|12
7711754|NCT00479232|12134090|FG003|Overall Study|Progressive Disease|3
7711755|NCT00479232|12134091|FG004|Overall Study|Progressive Disease|3
7711756|NCT00479232|12134092|FG005|Overall Study|Progressive Disease|12
7711757|NCT00479232|12134087|FG000|Overall Study|Withdrew Consent|0
7711758|NCT00479232|12134088|FG001|Overall Study|Withdrew Consent|2
7711759|NCT00479232|12134089|FG002|Overall Study|Withdrew Consent|6
7711760|NCT00479232|12134090|FG003|Overall Study|Withdrew Consent|0
7711761|NCT00479232|12134091|FG004|Overall Study|Withdrew Consent|1
7711762|NCT00479232|12134092|FG005|Overall Study|Withdrew Consent|3
7711763|NCT00479336|12134114|FG000|Overall Study|Adverse Event|1
7711764|NCT00479336|12134115|FG001|Overall Study|Adverse Event|1
7711765|NCT00479336|12134116|FG002|Overall Study|Adverse Event|1
7711766|NCT00479336|12134117|FG003|Overall Study|Adverse Event|3
7711767|NCT00479336|12134114|FG000|Overall Study|Lack of Efficacy|1
7711768|NCT00479336|12134115|FG001|Overall Study|Lack of Efficacy|0
7711769|NCT00479336|12134116|FG002|Overall Study|Lack of Efficacy|0
7711770|NCT00479336|12134117|FG003|Overall Study|Lack of Efficacy|0
7711771|NCT00479336|12134114|FG000|Overall Study|Protocol Violation|0
7711772|NCT00479336|12134115|FG001|Overall Study|Protocol Violation|1
7711773|NCT00479336|12134116|FG002|Overall Study|Protocol Violation|0
7711774|NCT00479336|12134117|FG003|Overall Study|Protocol Violation|0
7711775|NCT00479336|12134114|FG000|Overall Study|Withdrawal by Subject|1
7711776|NCT00479336|12134115|FG001|Overall Study|Withdrawal by Subject|2
7711777|NCT00479336|12134116|FG002|Overall Study|Withdrawal by Subject|0
7711778|NCT00479336|12134117|FG003|Overall Study|Withdrawal by Subject|0
7711779|NCT00479336|12134114|FG000|Overall Study|Physician Decision|0
7711780|NCT00479336|12134115|FG001|Overall Study|Physician Decision|1
7711781|NCT00479336|12134116|FG002|Overall Study|Physician Decision|0
7711782|NCT00479336|12134117|FG003|Overall Study|Physician Decision|2
7711783|NCT00479336|12134114|FG000|Overall Study|Resolution of all hepatic edema findings|1
7711784|NCT00479336|12134115|FG001|Overall Study|Resolution of all hepatic edema findings|1
7711785|NCT00479336|12134116|FG002|Overall Study|Resolution of all hepatic edema findings|0
7711786|NCT00479336|12134117|FG003|Overall Study|Resolution of all hepatic edema findings|0
7711787|NCT00479388|12134129|FG000|Overall Study|Adverse Event|90
7711788|NCT00479388|12134130|FG001|Overall Study|Adverse Event|45
7711789|NCT00479388|12134129|FG000|Overall Study|Lost to Follow-up|0
7711790|NCT00479388|12134130|FG001|Overall Study|Lost to Follow-up|2
7711791|NCT00479388|12134129|FG000|Overall Study|Protocol Violation|10
7711792|NCT00479388|12134130|FG001|Overall Study|Protocol Violation|9
7711793|NCT00479388|12134129|FG000|Overall Study|Withdrawal by Subject|32
7711794|NCT00479388|12134130|FG001|Overall Study|Withdrawal by Subject|17
7711795|NCT00479401|12134139|FG000|Overall Study|Adverse Event|24
7711796|NCT00479401|12134140|FG001|Overall Study|Adverse Event|20
7711797|NCT00479401|12134141|FG002|Overall Study|Adverse Event|4
7711798|NCT00479401|12134139|FG000|Overall Study|Lack of Efficacy|2
7711799|NCT00479401|12134140|FG001|Overall Study|Lack of Efficacy|2
7711800|NCT00479401|12134141|FG002|Overall Study|Lack of Efficacy|4
7711801|NCT00479401|12134139|FG000|Overall Study|Protocol Violation|2
7711802|NCT00479401|12134140|FG001|Overall Study|Protocol Violation|1
7711803|NCT00479401|12134141|FG002|Overall Study|Protocol Violation|1
7711804|NCT00479401|12134139|FG000|Overall Study|Lost to Follow-up|1
7711805|NCT00479401|12134140|FG001|Overall Study|Lost to Follow-up|1
7711806|NCT00479401|12134141|FG002|Overall Study|Lost to Follow-up|1
7711807|NCT00479401|12134139|FG000|Overall Study|Withdrawal by Subject|16
7711808|NCT00479401|12134140|FG001|Overall Study|Withdrawal by Subject|10
7711809|NCT00479401|12134141|FG002|Overall Study|Withdrawal by Subject|2
7711810|NCT00479401|12134139|FG000|Overall Study|Exclusion criteria, relocation|4
7711811|NCT00479401|12134140|FG001|Overall Study|Exclusion criteria, relocation|3
7711812|NCT00479401|12134141|FG002|Overall Study|Exclusion criteria, relocation|0
7711813|NCT00479466|12134155|FG000|Overall Study|Adverse Event|5
7711814|NCT00479466|12134156|FG001|Overall Study|Adverse Event|1
7711815|NCT00479466|12134157|FG002|Overall Study|Adverse Event|0
7711816|NCT00479466|12134158|FG003|Overall Study|Adverse Event|1
7711817|NCT00479466|12134159|FG004|Overall Study|Adverse Event|2
7711818|NCT00479466|12134160|FG005|Overall Study|Adverse Event|0
7711819|NCT00479466|12134155|FG000|Overall Study|Hyperglycemia|0
7711820|NCT00479466|12134156|FG001|Overall Study|Hyperglycemia|0
7711821|NCT00479466|12134157|FG002|Overall Study|Hyperglycemia|0
7711822|NCT00479466|12134158|FG003|Overall Study|Hyperglycemia|0
7711823|NCT00479466|12134159|FG004|Overall Study|Hyperglycemia|0
7711824|NCT00479466|12134160|FG005|Overall Study|Hyperglycemia|1
7711825|NCT00479466|12134155|FG000|Overall Study|Lack of Efficacy|2
7711826|NCT00479466|12134156|FG001|Overall Study|Lack of Efficacy|0
7711827|NCT00479466|12134157|FG002|Overall Study|Lack of Efficacy|1
7711828|NCT00479466|12134158|FG003|Overall Study|Lack of Efficacy|0
7711829|NCT00479466|12134159|FG004|Overall Study|Lack of Efficacy|0
7711830|NCT00479466|12134160|FG005|Overall Study|Lack of Efficacy|0
7711831|NCT00479466|12134155|FG000|Overall Study|Lost to Follow-up|0
7711832|NCT00479466|12134156|FG001|Overall Study|Lost to Follow-up|1
7711833|NCT00479466|12134157|FG002|Overall Study|Lost to Follow-up|1
7711834|NCT00479466|12134158|FG003|Overall Study|Lost to Follow-up|0
7711835|NCT00479466|12134159|FG004|Overall Study|Lost to Follow-up|2
7711836|NCT00479466|12134160|FG005|Overall Study|Lost to Follow-up|2
7711837|NCT00479466|12134155|FG000|Overall Study|Physician Decision|2
7711838|NCT00479466|12134156|FG001|Overall Study|Physician Decision|1
7711839|NCT00479466|12134157|FG002|Overall Study|Physician Decision|1
7711840|NCT00479466|12134158|FG003|Overall Study|Physician Decision|0
7711841|NCT00479466|12134159|FG004|Overall Study|Physician Decision|0
7711842|NCT00479466|12134160|FG005|Overall Study|Physician Decision|0
7711843|NCT00479466|12134155|FG000|Overall Study|Pregnancy|0
7711844|NCT00479466|12134156|FG001|Overall Study|Pregnancy|0
7711845|NCT00479466|12134157|FG002|Overall Study|Pregnancy|0
7711846|NCT00479466|12134158|FG003|Overall Study|Pregnancy|0
7711847|NCT00479466|12134159|FG004|Overall Study|Pregnancy|1
7711848|NCT00479466|12134160|FG005|Overall Study|Pregnancy|0
7711849|NCT00479466|12134155|FG000|Overall Study|Protocol Violation|1
7711850|NCT00479466|12134156|FG001|Overall Study|Protocol Violation|0
7711851|NCT00479466|12134157|FG002|Overall Study|Protocol Violation|0
7711852|NCT00479466|12134158|FG003|Overall Study|Protocol Violation|0
7711853|NCT00479466|12134159|FG004|Overall Study|Protocol Violation|0
7711854|NCT00479466|12134160|FG005|Overall Study|Protocol Violation|0
7711855|NCT00479466|12134155|FG000|Overall Study|Withdrawal by Subject|3
7711856|NCT00479466|12134156|FG001|Overall Study|Withdrawal by Subject|5
7711857|NCT00479466|12134157|FG002|Overall Study|Withdrawal by Subject|0
7711858|NCT00479466|12134158|FG003|Overall Study|Withdrawal by Subject|2
7711859|NCT00479466|12134159|FG004|Overall Study|Withdrawal by Subject|3
7711860|NCT00479466|12134160|FG005|Overall Study|Withdrawal by Subject|1
7711861|NCT00479557|12134181|FG000|Overall Study|Death|0
7711862|NCT00479557|12134182|FG001|Overall Study|Death|0
7711863|NCT00479557|12134183|FG002|Overall Study|Death|0
7711864|NCT00479557|12134184|FG003|Overall Study|Death|0
7711865|NCT00479557|12134185|FG004|Overall Study|Death|0
7711866|NCT00479557|12134186|FG005|Overall Study|Death|1
7711867|NCT00479557|12134187|FG006|Overall Study|Death|0
7711868|NCT00479557|12134181|FG000|Overall Study|Lack of Efficacy|1
7711869|NCT00479557|12134182|FG001|Overall Study|Lack of Efficacy|0
7711870|NCT00479557|12134183|FG002|Overall Study|Lack of Efficacy|0
7711871|NCT00479557|12134184|FG003|Overall Study|Lack of Efficacy|0
7711872|NCT00479557|12134185|FG004|Overall Study|Lack of Efficacy|0
7711873|NCT00479557|12134186|FG005|Overall Study|Lack of Efficacy|0
7711874|NCT00479557|12134187|FG006|Overall Study|Lack of Efficacy|0
7711875|NCT00479557|12134181|FG000|Overall Study|Lost to Follow-up|0
7711876|NCT00479557|12134182|FG001|Overall Study|Lost to Follow-up|2
7711877|NCT00479557|12134183|FG002|Overall Study|Lost to Follow-up|0
7711878|NCT00479557|12134184|FG003|Overall Study|Lost to Follow-up|2
7711879|NCT00479557|12134185|FG004|Overall Study|Lost to Follow-up|0
7711880|NCT00479557|12134186|FG005|Overall Study|Lost to Follow-up|0
7711881|NCT00479557|12134187|FG006|Overall Study|Lost to Follow-up|0
7711882|NCT00479557|12134181|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1
7711883|NCT00479557|12134182|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0
7711884|NCT00479557|12134183|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3
7711885|NCT00479557|12134184|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2
7711886|NCT00479557|12134185|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0
7711887|NCT00479557|12134186|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1
7711888|NCT00479557|12134187|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0
7711889|NCT00479557|12134181|FG000|Overall Study|AE not related to Study Drug|1
7711890|NCT00479557|12134182|FG001|Overall Study|AE not related to Study Drug|3
7711891|NCT00479557|12134183|FG002|Overall Study|AE not related to Study Drug|0
7711892|NCT00479557|12134184|FG003|Overall Study|AE not related to Study Drug|0
7711893|NCT00479557|12134185|FG004|Overall Study|AE not related to Study Drug|2
7711894|NCT00479557|12134186|FG005|Overall Study|AE not related to Study Drug|2
7711895|NCT00479557|12134187|FG006|Overall Study|AE not related to Study Drug|1
7711896|NCT00479557|12134181|FG000|Overall Study|Caregiver Request|2
7711897|NCT00479557|12134182|FG001|Overall Study|Caregiver Request|2
7711898|NCT00479557|12134183|FG002|Overall Study|Caregiver Request|2
7711899|NCT00479557|12134184|FG003|Overall Study|Caregiver Request|0
7711900|NCT00479557|12134185|FG004|Overall Study|Caregiver Request|1
7711901|NCT00479557|12134186|FG005|Overall Study|Caregiver Request|2
7711902|NCT00479557|12134187|FG006|Overall Study|Caregiver Request|0
7711903|NCT00479557|12134181|FG000|Overall Study|Investigator Request|0
7711904|NCT00479557|12134182|FG001|Overall Study|Investigator Request|0
7711905|NCT00479557|12134183|FG002|Overall Study|Investigator Request|1
7711906|NCT00479557|12134184|FG003|Overall Study|Investigator Request|0
7711907|NCT00479557|12134185|FG004|Overall Study|Investigator Request|0
7711908|NCT00479557|12134186|FG005|Overall Study|Investigator Request|0
7711909|NCT00479557|12134187|FG006|Overall Study|Investigator Request|0
7711910|NCT00479557|12134181|FG000|Overall Study|Subject Request|3
7711911|NCT00479557|12134182|FG001|Overall Study|Subject Request|0
7711912|NCT00479557|12134183|FG002|Overall Study|Subject Request|1
7711913|NCT00479557|12134184|FG003|Overall Study|Subject Request|1
7711914|NCT00479557|12134185|FG004|Overall Study|Subject Request|1
7711915|NCT00479557|12134186|FG005|Overall Study|Subject Request|4
7711916|NCT00479557|12134187|FG006|Overall Study|Subject Request|1
7711917|NCT00479557|12134181|FG000|Overall Study|Other|2
7711918|NCT00479557|12134182|FG001|Overall Study|Other|3
7711919|NCT00479557|12134183|FG002|Overall Study|Other|1
7711920|NCT00479557|12134184|FG003|Overall Study|Other|0
7711921|NCT00479557|12134185|FG004|Overall Study|Other|0
7711922|NCT00479557|12134186|FG005|Overall Study|Other|3
7711923|NCT00479557|12134187|FG006|Overall Study|Other|0
7711924|NCT00479674|12134209|FG000|Overall Study|Adverse Event|18
7711925|NCT00479674|12134209|FG000|Overall Study|Withdrawal by Subject|6
7711926|NCT00479674|12134209|FG000|Overall Study|Physician Decision|14
7711927|NCT00479674|12134209|FG000|Overall Study|none provided|3
7711928|NCT00479687|12134215|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0
7711929|NCT00479687|12134216|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2
7711930|NCT00479687|12134217|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0
7711931|NCT00479687|12134215|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0
7711932|NCT00479687|12134216|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1
7711933|NCT00479687|12134217|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0
7711934|NCT00479687|12134215|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4
7711935|NCT00479687|12134216|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5
7711936|NCT00479687|12134217|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0
7711937|NCT00479687|12134215|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2
7711938|NCT00479687|12134216|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0
7711939|NCT00479687|12134217|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0
7711940|NCT00479687|12134215|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19
7711941|NCT00479687|12134216|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11
7711942|NCT00479687|12134217|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0
7711943|NCT00479687|12134215|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0
7711944|NCT00479687|12134216|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0
7711945|NCT00479687|12134217|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4
7711946|NCT00479687|12134215|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0
7711947|NCT00479687|12134216|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0
7711948|NCT00479687|12134217|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3
7711949|NCT00479687|12134215|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0
7711950|NCT00479687|12134216|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0
7711951|NCT00479687|12134217|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1
7711952|NCT00479687|12134215|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0
7711953|NCT00479687|12134216|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0
7711954|NCT00479687|12134217|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1
7711955|NCT00479856|12134224|FG000|Overall Study|Adverse Event|1
7711956|NCT00479856|12134224|FG000|Overall Study|Withdrawal by Subject|1
7711957|NCT00479856|12134224|FG000|Overall Study|Physician Decision|1
7711958|NCT00479882|12134232|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
7711959|NCT00479882|12134233|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
7711960|NCT00479882|12134234|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
7711961|NCT00479882|12134235|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
7711962|NCT00479882|12134232|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
7711963|NCT00479882|12134233|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
7711964|NCT00479882|12134234|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
7711965|NCT00479882|12134235|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
7711966|NCT00479882|12134232|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
7711967|NCT00479882|12134233|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
7711968|NCT00479882|12134234|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
7711969|NCT00479882|12134235|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
7711970|NCT00479882|12134232|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4
7711971|NCT00479882|12134233|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6
7711972|NCT00479882|12134234|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9
7711973|NCT00479882|12134235|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5
7711974|NCT00479882|12134232|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
7711975|NCT00479882|12134233|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
7711976|NCT00479882|12134234|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
7711977|NCT00479882|12134235|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
7711978|NCT00479882|12134232|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
7711979|NCT00479882|12134233|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
7711980|NCT00479882|12134234|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
7711981|NCT00479882|12134235|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
7711982|NCT00479882|12134232|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
7711983|NCT00479882|12134233|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
7711984|NCT00479882|12134234|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
7711985|NCT00479882|12134235|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
7711986|NCT00479882|12134232|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
7711987|NCT00479882|12134233|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
7711988|NCT00479882|12134234|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
7711989|NCT00479882|12134235|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
7711990|NCT00479882|12134232|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
7711991|NCT00479882|12134233|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
7711992|NCT00479882|12134234|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
7711993|NCT00479882|12134235|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
7711994|NCT00479882|12134232|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
7711995|NCT00479882|12134233|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
7711996|NCT00479882|12134234|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
7711997|NCT00479882|12134235|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
7711998|NCT00479882|12134232|FG000|Crossover: Period III (Weeks 13-20)|Other|5
7711999|NCT00479882|12134233|FG001|Crossover: Period III (Weeks 13-20)|Other|0
7712000|NCT00479882|12134234|FG002|Crossover: Period III (Weeks 13-20)|Other|2
7712001|NCT00479882|12134235|FG003|Crossover: Period III (Weeks 13-20)|Other|2
7712002|NCT00479882|12134232|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1
7712003|NCT00479882|12134233|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2
7712004|NCT00479882|12134234|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1
7712005|NCT00479882|12134235|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0
7712006|NCT00479882|12134232|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
7712007|NCT00479882|12134233|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
7712008|NCT00479882|12134234|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
7712009|NCT00479882|12134235|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
7712010|NCT00479882|12134232|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
7712011|NCT00479882|12134233|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
7712012|NCT00479882|12134234|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
7712013|NCT00479882|12134235|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
7712014|NCT00480025|12134263|FG000|Overall Study|Protocol Violation|12
7712015|NCT00480025|12134264|FG001|Overall Study|Protocol Violation|7
7712016|NCT00480025|12134263|FG000|Overall Study|Patients remaining ongoing at Data Lock|101
7712017|NCT00480025|12134264|FG001|Overall Study|Patients remaining ongoing at Data Lock|55
7712018|NCT00480025|12134263|FG000|Overall Study|Disease Progression / Recurrence|449
7712019|NCT00480025|12134264|FG001|Overall Study|Disease Progression / Recurrence|224
7712020|NCT00480025|12134263|FG000|Overall Study|Adverse Event|44
7712021|NCT00480025|12134264|FG001|Overall Study|Adverse Event|12
7712022|NCT00480025|12134263|FG000|Overall Study|Other|70
7712023|NCT00480025|12134264|FG001|Overall Study|Other|29
7712024|NCT00480025|12134263|FG000|Overall Study|SAE including intercurrent illness|76
7712025|NCT00480025|12134264|FG001|Overall Study|SAE including intercurrent illness|42
7712026|NCT00480077|12134278|FG000|Overall Study|Death|19
7712027|NCT00480077|12134279|FG001|Overall Study|Death|15
7712028|NCT00480077|12134278|FG000|Overall Study|early exit|12
7712029|NCT00480077|12134279|FG001|Overall Study|early exit|11
7712030|NCT00480324|12134287|FG000|Overall Study|Adverse Event|1
7712031|NCT00480324|12134288|FG001|Overall Study|Adverse Event|1
7712032|NCT00480324|12134287|FG000|Overall Study|Protocol Violation|0
7712033|NCT00480324|12134288|FG001|Overall Study|Protocol Violation|1
7712034|NCT00480324|12134287|FG000|Overall Study|Withdrawal by Subject|14
7712035|NCT00480324|12134288|FG001|Overall Study|Withdrawal by Subject|5
7712036|NCT00480324|12134287|FG000|Overall Study|Lost to Follow-up|17
7712037|NCT00480324|12134288|FG001|Overall Study|Lost to Follow-up|8
7712038|NCT00480324|12134287|FG000|Overall Study|Subject's mother pregnant|0
7712039|NCT00480324|12134288|FG001|Overall Study|Subject's mother pregnant|1
7712040|NCT00480441|12134296|FG000|Screening|Not Eligible|37
7712041|NCT00480441|12134297|FG001|Screening|Not Eligible|0
7712042|NCT00480441|12134298|FG002|Screening|Not Eligible|0
7712043|NCT00480441|12134296|FG000|Baseline Functional MRI|Functional MRI data not usable|4
7712044|NCT00480441|12134297|FG001|Baseline Functional MRI|Functional MRI data not usable|0
7712045|NCT00480441|12134298|FG002|Baseline Functional MRI|Functional MRI data not usable|0
7712046|NCT00480441|12134296|FG000|Baseline Functional MRI|Lost to Follow-up|4
7712047|NCT00480441|12134297|FG001|Baseline Functional MRI|Lost to Follow-up|0
7712048|NCT00480441|12134298|FG002|Baseline Functional MRI|Lost to Follow-up|0
7712049|NCT00480441|12134296|FG000|Baseline Functional MRI|physical contraindication|4
7712050|NCT00480441|12134297|FG001|Baseline Functional MRI|physical contraindication|0
7712051|NCT00480441|12134298|FG002|Baseline Functional MRI|physical contraindication|0
7712052|NCT00480441|12134296|FG000|Randomization|Lost to Follow-up|0
7712053|NCT00480441|12134297|FG001|Randomization|Lost to Follow-up|7
7712054|NCT00480441|12134298|FG002|Randomization|Lost to Follow-up|2
7712055|NCT00480493|12134307|FG000|Overall Study|moved|2
7712056|NCT00480493|12134308|FG001|Overall Study|moved|7
7712057|NCT00480532|12134320|FG000|Overall Study|Withdrawal by Subject|2
7712058|NCT00480532|12134321|FG001|Overall Study|Withdrawal by Subject|4
7712059|NCT00480532|12134322|FG002|Overall Study|Withdrawal by Subject|3
7712060|NCT00480532|12134323|FG003|Overall Study|Withdrawal by Subject|1
7712061|NCT00480532|12134320|FG000|Overall Study|Protocol Violation|0
7712062|NCT00480532|12134321|FG001|Overall Study|Protocol Violation|0
7712063|NCT00480532|12134322|FG002|Overall Study|Protocol Violation|1
7712064|NCT00480532|12134323|FG003|Overall Study|Protocol Violation|0
7712065|NCT00480636|12134333|FG000|Overall Study|Death|12
7712066|NCT00480636|12134333|FG000|Overall Study|Lost to Follow-up|4
7712067|NCT00480636|12134333|FG000|Overall Study|Other|2
7712068|NCT00480636|12134333|FG000|Overall Study|Lost to follow-up; subsequently died|1
7712069|NCT00480779|12134352|FG000|Overall Study|Other|2
7712070|NCT00480779|12134353|FG001|Overall Study|Other|0
7712071|NCT00480779|12134352|FG000|Overall Study|Job and Health-related|0
7712072|NCT00480779|12134353|FG001|Overall Study|Job and Health-related|3
7712073|NCT00480857|12134359|FG000|Overall Study|Lack of Efficacy|2
7712074|NCT00481065|12134375|FG000|Overall Study|Adverse event or death|1
7712075|NCT00481065|12134376|FG001|Overall Study|Adverse event or death|1
7712076|NCT00481065|12134377|FG002|Overall Study|Adverse event or death|3
7712077|NCT00481065|12134378|FG003|Overall Study|Adverse event or death|0
7712078|NCT00481065|12134379|FG004|Overall Study|Adverse event or death|2
7712079|NCT00481065|12134380|FG005|Overall Study|Adverse event or death|0
7712080|NCT00481065|12134381|FG006|Overall Study|Adverse event or death|1
7712081|NCT00481065|12134382|FG007|Overall Study|Adverse event or death|1
7712082|NCT00481065|12134375|FG000|Overall Study|Withdrawal by Subject|11
7712083|NCT00481065|12134376|FG001|Overall Study|Withdrawal by Subject|12
7712084|NCT00481065|12134377|FG002|Overall Study|Withdrawal by Subject|7
7712085|NCT00481065|12134378|FG003|Overall Study|Withdrawal by Subject|11
7712086|NCT00481065|12134379|FG004|Overall Study|Withdrawal by Subject|13
7712087|NCT00481065|12134380|FG005|Overall Study|Withdrawal by Subject|12
7712088|NCT00481065|12134381|FG006|Overall Study|Withdrawal by Subject|9
7712089|NCT00481065|12134382|FG007|Overall Study|Withdrawal by Subject|10
7712090|NCT00481065|12134375|FG000|Overall Study|Lost to Follow-up|4
7712091|NCT00481065|12134376|FG001|Overall Study|Lost to Follow-up|2
7712092|NCT00481065|12134377|FG002|Overall Study|Lost to Follow-up|4
7712093|NCT00481065|12134378|FG003|Overall Study|Lost to Follow-up|3
7712094|NCT00481065|12134379|FG004|Overall Study|Lost to Follow-up|3
7712095|NCT00481065|12134380|FG005|Overall Study|Lost to Follow-up|3
7712096|NCT00481065|12134381|FG006|Overall Study|Lost to Follow-up|2
7712097|NCT00481065|12134382|FG007|Overall Study|Lost to Follow-up|5
7712098|NCT00481065|12134375|FG000|Overall Study|Inappropriate enrollment|4
7712099|NCT00481065|12134376|FG001|Overall Study|Inappropriate enrollment|0
7712100|NCT00481065|12134377|FG002|Overall Study|Inappropriate enrollment|2
7712101|NCT00481065|12134378|FG003|Overall Study|Inappropriate enrollment|0
7712102|NCT00481065|12134379|FG004|Overall Study|Inappropriate enrollment|2
7712103|NCT00481065|12134380|FG005|Overall Study|Inappropriate enrollment|1
7712104|NCT00481065|12134381|FG006|Overall Study|Inappropriate enrollment|0
7712105|NCT00481065|12134382|FG007|Overall Study|Inappropriate enrollment|1
7712106|NCT00481065|12134375|FG000|Overall Study|Administrative reason|0
7712107|NCT00481065|12134376|FG001|Overall Study|Administrative reason|0
7712108|NCT00481065|12134377|FG002|Overall Study|Administrative reason|0
7712109|NCT00481065|12134378|FG003|Overall Study|Administrative reason|0
7712110|NCT00481065|12134379|FG004|Overall Study|Administrative reason|0
7712111|NCT00481065|12134380|FG005|Overall Study|Administrative reason|2
7712112|NCT00481065|12134381|FG006|Overall Study|Administrative reason|1
7712113|NCT00481065|12134382|FG007|Overall Study|Administrative reason|0
7712114|NCT00481065|12134375|FG000|Overall Study|Protocol Violation|2
7712115|NCT00481065|12134376|FG001|Overall Study|Protocol Violation|1
7712116|NCT00481065|12134377|FG002|Overall Study|Protocol Violation|1
7712117|NCT00481065|12134378|FG003|Overall Study|Protocol Violation|1
7712118|NCT00481065|12134379|FG004|Overall Study|Protocol Violation|2
7712119|NCT00481065|12134380|FG005|Overall Study|Protocol Violation|6
7712120|NCT00481065|12134381|FG006|Overall Study|Protocol Violation|3
7712121|NCT00481065|12134382|FG007|Overall Study|Protocol Violation|2
7712122|NCT00481065|12134375|FG000|Overall Study|Unable to classify|0
7712123|NCT00481065|12134376|FG001|Overall Study|Unable to classify|1
7712124|NCT00481065|12134377|FG002|Overall Study|Unable to classify|2
7712125|NCT00481065|12134378|FG003|Overall Study|Unable to classify|0
7712126|NCT00481065|12134379|FG004|Overall Study|Unable to classify|1
7712127|NCT00481065|12134380|FG005|Overall Study|Unable to classify|0
7712128|NCT00481065|12134381|FG006|Overall Study|Unable to classify|0
7712129|NCT00481065|12134382|FG007|Overall Study|Unable to classify|0
7712130|NCT00481078|12134404|FG000|Overall Study|Progression of disease|11
7712131|NCT00481078|12134405|FG001|Overall Study|Progression of disease|11
7712132|NCT00481078|12134404|FG000|Overall Study|Adverse Event|15
7712133|NCT00481078|12134405|FG001|Overall Study|Adverse Event|3
7712134|NCT00481078|12134404|FG000|Overall Study|Death|5
7712135|NCT00481078|12134405|FG001|Overall Study|Death|3
7712136|NCT00481078|12134404|FG000|Overall Study|Intercurrent illness|1
7712137|NCT00481078|12134405|FG001|Overall Study|Intercurrent illness|0
7712138|NCT00481078|12134404|FG000|Overall Study|Withdrawal by Subject|7
7712139|NCT00481078|12134405|FG001|Overall Study|Withdrawal by Subject|1
7712140|NCT00481078|12134404|FG000|Overall Study|Information not available|1
7712141|NCT00481078|12134405|FG001|Overall Study|Information not available|0
7712142|NCT00481078|12134404|FG000|Overall Study|Received other treatment|2
7712143|NCT00481078|12134405|FG001|Overall Study|Received other treatment|1
7712144|NCT00481078|12134404|FG000|Overall Study|Brain metastasis|0
7712145|NCT00481078|12134405|FG001|Overall Study|Brain metastasis|1
7712146|NCT00481195|12134413|FG000|Overall Study|Adverse Event|16
7712147|NCT00481195|12134414|FG001|Overall Study|Adverse Event|11
7712148|NCT00481195|12134413|FG000|Overall Study|Lack of Efficacy|1
7712149|NCT00481195|12134414|FG001|Overall Study|Lack of Efficacy|3
7712150|NCT00481195|12134413|FG000|Overall Study|Lost to Follow-up|4
7712151|NCT00481195|12134414|FG001|Overall Study|Lost to Follow-up|6
7712152|NCT00481195|12134413|FG000|Overall Study|Physician Decision|3
7712153|NCT00481195|12134414|FG001|Overall Study|Physician Decision|1
7712154|NCT00481195|12134413|FG000|Overall Study|Protocol Violation|10
7712155|NCT00481195|12134414|FG001|Overall Study|Protocol Violation|7
7712156|NCT00481195|12134413|FG000|Overall Study|Withdrawal by Subject|3
7712157|NCT00481195|12134414|FG001|Overall Study|Withdrawal by Subject|9
7712158|NCT00481195|12134413|FG000|Overall Study|Miscellaneous|2
7712159|NCT00481195|12134414|FG001|Overall Study|Miscellaneous|2
7712160|NCT00481247|12134422|FG000|Overall Study|Death|0
7712161|NCT00481247|12134423|FG001|Overall Study|Death|1
7712162|NCT00481247|12134422|FG000|Overall Study|Disease progression|18
7712163|NCT00481247|12134423|FG001|Overall Study|Disease progression|22
7712164|NCT00481247|12134422|FG000|Overall Study|Intolerance|42
7712165|NCT00481247|12134423|FG001|Overall Study|Intolerance|17
7712166|NCT00481247|12134422|FG000|Overall Study|Treatment failure|10
7712167|NCT00481247|12134423|FG001|Overall Study|Treatment failure|14
7712168|NCT00481247|12134422|FG000|Overall Study|AE unrelated to study drug|13
7712169|NCT00481247|12134423|FG001|Overall Study|AE unrelated to study drug|4
7712170|NCT00481247|12134422|FG000|Overall Study|Withdrawal by Subject|8
7712171|NCT00481247|12134423|FG001|Overall Study|Withdrawal by Subject|13
7712172|NCT00481247|12134422|FG000|Overall Study|Pregnancy|2
7712173|NCT00481247|12134423|FG001|Overall Study|Pregnancy|1
7712174|NCT00481247|12134422|FG000|Overall Study|Lost to Follow-up|1
7712175|NCT00481247|12134423|FG001|Overall Study|Lost to Follow-up|2
7712176|NCT00481247|12134422|FG000|Overall Study|Poor compliance/noncompliance|1
7712177|NCT00481247|12134423|FG001|Overall Study|Poor compliance/noncompliance|7
7712178|NCT00481247|12134422|FG000|Overall Study|Administrative reason by sponsor|157
7712179|NCT00481247|12134423|FG001|Overall Study|Administrative reason by sponsor|162
7712180|NCT00481247|12134422|FG000|Overall Study|Varied|6
7712181|NCT00481247|12134423|FG001|Overall Study|Varied|15
7712182|NCT00481247|12134422|FG000|Overall Study|Did not receive treatment|1
7712183|NCT00481247|12134423|FG001|Overall Study|Did not receive treatment|2
7712184|NCT00481676|12134449|FG000|Overall Study|Adverse Event|0
7712185|NCT00481676|12134450|FG001|Overall Study|Adverse Event|1
7712186|NCT00481676|12134449|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7712187|NCT00481676|12134450|FG001|Overall Study|Unsatisfactory therapeutic effect|4
7712188|NCT00481676|12134449|FG000|Overall Study|Administrative problem|1
7712189|NCT00481676|12134450|FG001|Overall Study|Administrative problem|0
7712190|NCT00481767|12134458|FG000|Overall Study|Withdrawal by Subject|16
7712191|NCT00481767|12134459|FG001|Overall Study|Withdrawal by Subject|11
7712192|NCT00481767|12134458|FG000|Overall Study|Lost to Follow-up|16
7712193|NCT00481767|12134459|FG001|Overall Study|Lost to Follow-up|10
7712194|NCT00481832|12134465|FG000|Enrollment|Physician Decision|8
7712195|NCT00481832|12134465|FG000|Enrollment|Unable to collect enough stem cells|2
7712196|NCT00481832|12134465|FG000|Inter-transplant Period|Adverse Event|4
7712197|NCT00481832|12134465|FG000|Inter-transplant Period|Death|3
7712198|NCT00481832|12134465|FG000|Inter-transplant Period|Physician Decision|4
7712199|NCT00481832|12134465|FG000|Inter-transplant Period|Disease relapse|11
7712200|NCT00481832|12134465|FG000|Inter-transplant Period|Lack of allogeneic donor|5
7712201|NCT00481871|12134483|FG000|Overall Study|Progressive Disease - pt withdrew|0
7712202|NCT00481871|12134484|FG001|Overall Study|Progressive Disease - pt withdrew|0
7712203|NCT00481871|12134485|FG002|Overall Study|Progressive Disease - pt withdrew|1
7712204|NCT00481871|12134486|FG003|Overall Study|Progressive Disease - pt withdrew|0
7712205|NCT00481871|12134487|FG004|Overall Study|Progressive Disease - pt withdrew|0
7712206|NCT00481988|12134497|FG000|Overall Study|Withdrawal by Subject|1
7712207|NCT00481988|12134498|FG001|Overall Study|Withdrawal by Subject|1
7712208|NCT00482001|12134506|FG000|Overall Study|Protocol Violation|1
7712209|NCT00482001|12134507|FG001|Overall Study|Protocol Violation|1
7712210|NCT00482014|12134519|FG000|Overall Study|Withdrawal by Subject|1
7712211|NCT00482014|12134520|FG001|Overall Study|Withdrawal by Subject|2
7712212|NCT00482014|12134521|FG002|Overall Study|Withdrawal by Subject|3
7712213|NCT00482014|12134522|FG003|Overall Study|Withdrawal by Subject|4
7712214|NCT00482014|12134519|FG000|Overall Study|Adverse Event|3
7712215|NCT00482014|12134520|FG001|Overall Study|Adverse Event|0
7712216|NCT00482014|12134521|FG002|Overall Study|Adverse Event|2
7712217|NCT00482014|12134522|FG003|Overall Study|Adverse Event|8
7712218|NCT00482014|12134519|FG000|Overall Study|Death|1
7712219|NCT00482014|12134520|FG001|Overall Study|Death|2
7712220|NCT00482014|12134521|FG002|Overall Study|Death|1
7712221|NCT00482014|12134522|FG003|Overall Study|Death|4
7712222|NCT00482014|12134519|FG000|Overall Study|Lack of Efficacy|1
7712223|NCT00482014|12134520|FG001|Overall Study|Lack of Efficacy|0
7712224|NCT00482014|12134521|FG002|Overall Study|Lack of Efficacy|4
7712225|NCT00482014|12134522|FG003|Overall Study|Lack of Efficacy|6
7712226|NCT00482014|12134519|FG000|Overall Study|Sponsor Decision|1
7712227|NCT00482014|12134520|FG001|Overall Study|Sponsor Decision|2
7712228|NCT00482014|12134521|FG002|Overall Study|Sponsor Decision|1
7712229|NCT00482014|12134522|FG003|Overall Study|Sponsor Decision|1
7712230|NCT00482053|12134534|FG000|Inter-treatment Period|Disease progression|1
7712231|NCT00482170|12134540|FG000|Overall Study|Adverse Event|5
7712232|NCT00482170|12134541|FG001|Overall Study|Adverse Event|14
7712233|NCT00482170|12134540|FG000|Overall Study|Withdrawal by Subject|6
7712234|NCT00482170|12134541|FG001|Overall Study|Withdrawal by Subject|1
7712235|NCT00482170|12134540|FG000|Overall Study|Protocol Violation|2
7712236|NCT00482170|12134541|FG001|Overall Study|Protocol Violation|3
7712237|NCT00482170|12134540|FG000|Overall Study|Lost to Follow-up|2
7712238|NCT00482170|12134541|FG001|Overall Study|Lost to Follow-up|0
7712239|NCT00482170|12134540|FG000|Overall Study|Unspecified reason|0
7712240|NCT00482170|12134541|FG001|Overall Study|Unspecified reason|2
7712241|NCT00482274|12134547|FG000|Overall Study|Adverse Event|1
7712242|NCT00482391|12134551|FG000|Overall Study|Withdrawal by Subject|1
7712243|NCT00482391|12134551|FG000|Overall Study|Adverse Event|1
7712244|NCT00482391|12134551|FG000|Overall Study|Death|1
7712245|NCT00482612|12134569|FG000|In-treatment Period|No study medication administered|0
7712246|NCT00482612|12134570|FG001|In-treatment Period|No study medication administered|0
7712247|NCT00482612|12134571|FG002|In-treatment Period|No study medication administered|1
7712248|NCT00482612|12134572|FG003|In-treatment Period|No study medication administered|0
7712249|NCT00482612|12134569|FG000|Follow-up Period|Other|4
7712250|NCT00482612|12134570|FG001|Follow-up Period|Other|2
7712251|NCT00482612|12134571|FG002|Follow-up Period|Other|1
7712252|NCT00482612|12134572|FG003|Follow-up Period|Other|2
7712253|NCT00482612|12134569|FG000|Follow-up Period|Lack of compliance|0
7712254|NCT00482612|12134570|FG001|Follow-up Period|Lack of compliance|0
7712255|NCT00482612|12134571|FG002|Follow-up Period|Lack of compliance|1
7712256|NCT00482612|12134572|FG003|Follow-up Period|Lack of compliance|0
7712257|NCT00482612|12134569|FG000|Follow-up Period|Lost to Follow-up|0
7712258|NCT00482612|12134570|FG001|Follow-up Period|Lost to Follow-up|4
7712259|NCT00482612|12134571|FG002|Follow-up Period|Lost to Follow-up|2
7712260|NCT00482612|12134572|FG003|Follow-up Period|Lost to Follow-up|1
7712261|NCT00482612|12134569|FG000|Follow-up Period|Adverse Event|4
7712262|NCT00482612|12134570|FG001|Follow-up Period|Adverse Event|7
7712263|NCT00482612|12134571|FG002|Follow-up Period|Adverse Event|9
7712264|NCT00482612|12134572|FG003|Follow-up Period|Adverse Event|0
7712265|NCT00482612|12134569|FG000|Follow-up Period|Lack of Efficacy|2
7712266|NCT00482612|12134570|FG001|Follow-up Period|Lack of Efficacy|0
7712267|NCT00482612|12134571|FG002|Follow-up Period|Lack of Efficacy|1
7712268|NCT00482612|12134572|FG003|Follow-up Period|Lack of Efficacy|0
7712269|NCT00482612|12134569|FG000|Follow-up Period|Withdrawal by Subject|3
7712270|NCT00482612|12134570|FG001|Follow-up Period|Withdrawal by Subject|5
7712271|NCT00482612|12134571|FG002|Follow-up Period|Withdrawal by Subject|7
7712272|NCT00482612|12134572|FG003|Follow-up Period|Withdrawal by Subject|2
7712273|NCT00482612|12134569|FG000|Follow-up Period|Reasons not related to trial|1
7712274|NCT00482612|12134570|FG001|Follow-up Period|Reasons not related to trial|0
7712275|NCT00482612|12134571|FG002|Follow-up Period|Reasons not related to trial|1
7712276|NCT00482612|12134572|FG003|Follow-up Period|Reasons not related to trial|3
7712277|NCT00482703|12134601|FG000|Overall Study|Poor compliance|1
7712278|NCT00482703|12134602|FG001|Overall Study|Poor compliance|0
7712279|NCT00482729|12134617|FG000|Overall Study|Adverse Event|29
7712280|NCT00482729|12134618|FG001|Overall Study|Adverse Event|33
7712281|NCT00482729|12134617|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0
7712282|NCT00482729|12134618|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2
7712283|NCT00482729|12134617|FG000|Overall Study|Hyperglycemia Criteria|7
7712284|NCT00482729|12134618|FG001|Overall Study|Hyperglycemia Criteria|5
7712285|NCT00482729|12134617|FG000|Overall Study|Lack of Efficacy|4
7712286|NCT00482729|12134618|FG001|Overall Study|Lack of Efficacy|16
7712287|NCT00482729|12134617|FG000|Overall Study|Lost to Follow-up|86
7712288|NCT00482729|12134618|FG001|Overall Study|Lost to Follow-up|66
7712289|NCT00482729|12134617|FG000|Overall Study|Physician Decision|10
7712290|NCT00482729|12134618|FG001|Overall Study|Physician Decision|7
7712291|NCT00482729|12134617|FG000|Overall Study|Pregnancy|4
7712292|NCT00482729|12134618|FG001|Overall Study|Pregnancy|2
7712293|NCT00482729|12134617|FG000|Overall Study|Protocol Violation|10
7712294|NCT00482729|12134618|FG001|Overall Study|Protocol Violation|18
7712295|NCT00482729|12134617|FG000|Overall Study|Withdrawal by Subject|67
7712296|NCT00482729|12134618|FG001|Overall Study|Withdrawal by Subject|69
7712297|NCT00483002|12134633|FG000|Overall Study|Adverse Event|68
7712298|NCT00483002|12134633|FG000|Overall Study|Lack of Efficacy|555
7712299|NCT00483002|12134633|FG000|Overall Study|Lost to Follow-up|962
7712300|NCT00483002|12134633|FG000|Overall Study|Other|2
7712301|NCT00483002|12134633|FG000|Overall Study|Other|967
7712302|NCT00483041|12134639|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
7712303|NCT00483041|12134640|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
7712304|NCT00483184|12134649|FG000|Overall Study|Withdrawal by Subject|2
7712305|NCT00483184|12134650|FG001|Overall Study|Withdrawal by Subject|2
7712306|NCT00483184|12134651|FG002|Overall Study|Withdrawal by Subject|0
7712307|NCT00483184|12134649|FG000|Overall Study|Lost to Follow-up|1
7712308|NCT00483184|12134650|FG001|Overall Study|Lost to Follow-up|0
7712309|NCT00483184|12134651|FG002|Overall Study|Lost to Follow-up|0
7712310|NCT00483184|12134649|FG000|Overall Study|Adverse Event|1
7712311|NCT00483184|12134650|FG001|Overall Study|Adverse Event|2
7712312|NCT00483184|12134651|FG002|Overall Study|Adverse Event|2
7712313|NCT00483184|12134649|FG000|Overall Study|Protocol Violation|1
7712314|NCT00483184|12134650|FG001|Overall Study|Protocol Violation|0
7712315|NCT00483184|12134651|FG002|Overall Study|Protocol Violation|1
7712316|NCT00483327|12134676|FG000|Overall Study|Adverse Event|1
7712317|NCT00483327|12134676|FG000|Overall Study|Withdrawal by Subject|3
7712318|NCT00483327|12134676|FG000|Overall Study|Lost to Follow-up|4
7712319|NCT00483327|12134676|FG000|Overall Study|Patient Non Compliance|2
7712320|NCT00483379|12134684|FG000|Treatment Period|Adverse Event|1
7712321|NCT00483379|12134685|FG001|Treatment Period|Adverse Event|0
7712322|NCT00483379|12134684|FG000|Treatment Period|Withdrawal by Subject|1
7712323|NCT00483379|12134685|FG001|Treatment Period|Withdrawal by Subject|0
7712324|NCT00483405|12134693|FG000|Overall Study|Adverse Event|8
7712325|NCT00483405|12134693|FG000|Overall Study|Lack of Efficacy|14
7712326|NCT00483405|12134693|FG000|Overall Study|Death|3
7712327|NCT00483405|12134693|FG000|Overall Study|Withdrawal by Subject|2
7712328|NCT00483405|12134693|FG000|Overall Study|Other complicating disease|1
7712329|NCT00483548|12134715|FG000|Overall Study|Randomized; not treated with study drug|1
7712330|NCT00483548|12134716|FG001|Overall Study|Randomized; not treated with study drug|3
7712331|NCT00483548|12134715|FG000|Overall Study|Adverse Event|25
7712332|NCT00483548|12134716|FG001|Overall Study|Adverse Event|14
7712333|NCT00483548|12134715|FG000|Overall Study|Laboratory abnormality|1
7712334|NCT00483548|12134716|FG001|Overall Study|Laboratory abnormality|2
7712335|NCT00483548|12134715|FG000|Overall Study|Lack of Efficacy|4
7712336|NCT00483548|12134716|FG001|Overall Study|Lack of Efficacy|8
7712337|NCT00483548|12134715|FG000|Overall Study|Protocol Violation|11
7712338|NCT00483548|12134716|FG001|Overall Study|Protocol Violation|7
7712339|NCT00483548|12134715|FG000|Overall Study|Pregnancy|1
7712340|NCT00483548|12134716|FG001|Overall Study|Pregnancy|0
7712341|NCT00483548|12134715|FG000|Overall Study|Protocol required discontinuation|6
7712342|NCT00483548|12134716|FG001|Overall Study|Protocol required discontinuation|6
7712343|NCT00483548|12134715|FG000|Overall Study|Unable to comply with protocol schedule|1
7712344|NCT00483548|12134716|FG001|Overall Study|Unable to comply with protocol schedule|0
7712345|NCT00483548|12134715|FG000|Overall Study|Non-compliance with medication|2
7712346|NCT00483548|12134716|FG001|Overall Study|Non-compliance with medication|0
7712347|NCT00483548|12134715|FG000|Overall Study|Lost to Follow-up|3
7712348|NCT00483548|12134716|FG001|Overall Study|Lost to Follow-up|4
7712349|NCT00483548|12134715|FG000|Overall Study|Withdrawal by Subject|5
7712350|NCT00483548|12134716|FG001|Overall Study|Withdrawal by Subject|2
7712351|NCT00483574|12134728|FG000|Overall Study|Adverse Event|6
7712352|NCT00483574|12134729|FG001|Overall Study|Adverse Event|0
7712353|NCT00483574|12134728|FG000|Overall Study|Protocol Violation|28
7712354|NCT00483574|12134729|FG001|Overall Study|Protocol Violation|9
7712355|NCT00483574|12134728|FG000|Overall Study|Lost to Follow-up|16
7712356|NCT00483574|12134729|FG001|Overall Study|Lost to Follow-up|4
7712357|NCT00483574|12134728|FG000|Overall Study|Withdrawal by Subject|52
7712358|NCT00483574|12134729|FG001|Overall Study|Withdrawal by Subject|0
7712359|NCT00483652|12134739|FG000|Double-blind Treatment Period|Protocol Violation|2
7712360|NCT00483652|12134740|FG001|Double-blind Treatment Period|Protocol Violation|1
7712361|NCT00483652|12134739|FG000|Double-blind Treatment Period|Adverse Event|3
7712362|NCT00483652|12134740|FG001|Double-blind Treatment Period|Adverse Event|4
7712363|NCT00483652|12134739|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1
7712364|NCT00483652|12134740|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0
7712365|NCT00483652|12134739|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1
7712366|NCT00483652|12134740|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0
7712367|NCT00483704|12134749|FG000|Randomization|Withdrawal by Subject|19
7712368|NCT00483704|12134750|FG001|Randomization|Withdrawal by Subject|28
7712369|NCT00483704|12134751|FG002|Randomization|Withdrawal by Subject|18
7712370|NCT00483704|12134749|FG000|Randomization|Protocol Violation|14
7712371|NCT00483704|12134750|FG001|Randomization|Protocol Violation|25
7712372|NCT00483704|12134751|FG002|Randomization|Protocol Violation|22
7712373|NCT00483704|12134749|FG000|Randomization|Lost to Follow-up|14
7712374|NCT00483704|12134750|FG001|Randomization|Lost to Follow-up|14
7712375|NCT00483704|12134751|FG002|Randomization|Lost to Follow-up|19
7712376|NCT00483704|12134749|FG000|Randomization|Pregnancy|1
7712377|NCT00483704|12134750|FG001|Randomization|Pregnancy|0
7712378|NCT00483704|12134751|FG002|Randomization|Pregnancy|0
7712379|NCT00483704|12134749|FG000|Randomization|Physician Decision|2
7712380|NCT00483704|12134750|FG001|Randomization|Physician Decision|4
7712381|NCT00483704|12134751|FG002|Randomization|Physician Decision|0
7712382|NCT00483704|12134749|FG000|Randomization|Progressive disease|0
7712383|NCT00483704|12134750|FG001|Randomization|Progressive disease|0
7712384|NCT00483704|12134751|FG002|Randomization|Progressive disease|1
7712385|NCT00483704|12134749|FG000|Randomization|Lack of qualifying migraines|21
7712386|NCT00483704|12134750|FG001|Randomization|Lack of qualifying migraines|25
7712387|NCT00483704|12134751|FG002|Randomization|Lack of qualifying migraines|31
7712388|NCT00483704|12134749|FG000|Treatment|Lack of qualifying migraines|101
7712389|NCT00483704|12134750|FG001|Treatment|Lack of qualifying migraines|99
7712390|NCT00483704|12134751|FG002|Treatment|Lack of qualifying migraines|116
7712391|NCT00483704|12134749|FG000|Treatment|Adverse Event|3
7712392|NCT00483704|12134750|FG001|Treatment|Adverse Event|5
7712393|NCT00483704|12134751|FG002|Treatment|Adverse Event|4
7712394|NCT00483704|12134749|FG000|Treatment|Withdrawal by Subject|16
7712395|NCT00483704|12134750|FG001|Treatment|Withdrawal by Subject|12
7712396|NCT00483704|12134751|FG002|Treatment|Withdrawal by Subject|21
7712397|NCT00483704|12134749|FG000|Treatment|Protocol Violation|6
7712398|NCT00483704|12134750|FG001|Treatment|Protocol Violation|3
7712399|NCT00483704|12134751|FG002|Treatment|Protocol Violation|5
7712400|NCT00483704|12134749|FG000|Treatment|Lost to Follow-up|2
7712401|NCT00483704|12134750|FG001|Treatment|Lost to Follow-up|7
7712402|NCT00483704|12134751|FG002|Treatment|Lost to Follow-up|5
7712403|NCT00483704|12134749|FG000|Treatment|Lack of Efficacy|1
7712404|NCT00483704|12134750|FG001|Treatment|Lack of Efficacy|1
7712405|NCT00483704|12134751|FG002|Treatment|Lack of Efficacy|1
7712406|NCT00483704|12134749|FG000|Treatment|Pregnancy|0
7712407|NCT00483704|12134750|FG001|Treatment|Pregnancy|1
7712408|NCT00483704|12134751|FG002|Treatment|Pregnancy|0
7712409|NCT00483704|12134749|FG000|Treatment|Physician Decision|0
7712410|NCT00483704|12134750|FG001|Treatment|Physician Decision|1
7712411|NCT00483704|12134751|FG002|Treatment|Physician Decision|4
7712412|NCT00483717|12134764|FG000|Overall Study|Protocol Violation|5
7712413|NCT00483717|12134765|FG001|Overall Study|Protocol Violation|7
7712414|NCT00483717|12134764|FG000|Overall Study|Time of dosing missing|1
7712415|NCT00483717|12134765|FG001|Overall Study|Time of dosing missing|1
7712416|NCT00483717|12134764|FG000|Overall Study|No treatment for migraine|16
7712417|NCT00483717|12134765|FG001|Overall Study|No treatment for migraine|13
7712418|NCT00483717|12134764|FG000|Overall Study|Lost to Follow-up|1
7712419|NCT00483717|12134765|FG001|Overall Study|Lost to Follow-up|0
7712420|NCT00483717|12134764|FG000|Overall Study|Withdrawal by Subject|1
7712421|NCT00483717|12134765|FG001|Overall Study|Withdrawal by Subject|0
7712422|NCT00483756|12134774|FG000|Overall Study|Death|2
7712423|NCT00483756|12134775|FG001|Overall Study|Death|0
7712424|NCT00483756|12134776|FG002|Overall Study|Death|1
7712425|NCT00483756|12134774|FG000|Overall Study|Adverse Event|19
7712426|NCT00483756|12134775|FG001|Overall Study|Adverse Event|38
7712427|NCT00483756|12134776|FG002|Overall Study|Adverse Event|40
7712428|NCT00483756|12134774|FG000|Overall Study|Lack of Efficacy|1
7712429|NCT00483756|12134775|FG001|Overall Study|Lack of Efficacy|0
7712430|NCT00483756|12134776|FG002|Overall Study|Lack of Efficacy|0
7712431|NCT00483756|12134774|FG000|Overall Study|Lost to Follow-up|3
7712432|NCT00483756|12134775|FG001|Overall Study|Lost to Follow-up|1
7712433|NCT00483756|12134776|FG002|Overall Study|Lost to Follow-up|0
7712434|NCT00483756|12134774|FG000|Overall Study|Withdrawal by Subject|5
7712435|NCT00483756|12134775|FG001|Overall Study|Withdrawal by Subject|3
7712436|NCT00483756|12134776|FG002|Overall Study|Withdrawal by Subject|4
7712437|NCT00483756|12134774|FG000|Overall Study|Other|2
7712438|NCT00483756|12134775|FG001|Overall Study|Other|4
7712439|NCT00483756|12134776|FG002|Overall Study|Other|3
7712440|NCT00483756|12134774|FG000|Overall Study|Randomized, Not Treated|1
7712441|NCT00483756|12134775|FG001|Overall Study|Randomized, Not Treated|4
7712442|NCT00483756|12134776|FG002|Overall Study|Randomized, Not Treated|4
7712443|NCT00483938|12134791|FG000|Overall Study|Protocol Violation|0
7712444|NCT00483938|12134792|FG001|Overall Study|Protocol Violation|0
7712445|NCT00483938|12134793|FG002|Overall Study|Protocol Violation|0
7712446|NCT00483938|12134794|FG003|Overall Study|Protocol Violation|0
7712447|NCT00483938|12134795|FG004|Overall Study|Protocol Violation|0
7712448|NCT00483938|12134796|FG005|Overall Study|Protocol Violation|0
7712449|NCT00483938|12134797|FG006|Overall Study|Protocol Violation|3
7712450|NCT00483938|12134791|FG000|Overall Study|Withdrawal by Subject|1
7712451|NCT00483938|12134792|FG001|Overall Study|Withdrawal by Subject|6
7712452|NCT00483938|12134793|FG002|Overall Study|Withdrawal by Subject|0
7712453|NCT00483938|12134794|FG003|Overall Study|Withdrawal by Subject|0
7712454|NCT00483938|12134795|FG004|Overall Study|Withdrawal by Subject|1
7712455|NCT00483938|12134796|FG005|Overall Study|Withdrawal by Subject|3
7712456|NCT00483938|12134797|FG006|Overall Study|Withdrawal by Subject|2
7712457|NCT00483938|12134791|FG000|Overall Study|Lost to Follow-up|1
7712458|NCT00483938|12134792|FG001|Overall Study|Lost to Follow-up|2
7712459|NCT00483938|12134793|FG002|Overall Study|Lost to Follow-up|0
7712460|NCT00483938|12134794|FG003|Overall Study|Lost to Follow-up|2
7712461|NCT00483938|12134795|FG004|Overall Study|Lost to Follow-up|1
7712462|NCT00483938|12134796|FG005|Overall Study|Lost to Follow-up|1
7712463|NCT00483938|12134797|FG006|Overall Study|Lost to Follow-up|3
7712464|NCT00483938|12134791|FG000|Overall Study|Death|0
7712465|NCT00483938|12134792|FG001|Overall Study|Death|2
7712466|NCT00483938|12134793|FG002|Overall Study|Death|0
7712467|NCT00483938|12134794|FG003|Overall Study|Death|0
7712468|NCT00483938|12134795|FG004|Overall Study|Death|0
7712469|NCT00483938|12134796|FG005|Overall Study|Death|0
7712470|NCT00483938|12134797|FG006|Overall Study|Death|0
7712471|NCT00483938|12134791|FG000|Overall Study|Other|3
7712472|NCT00483938|12134792|FG001|Overall Study|Other|9
7712473|NCT00483938|12134793|FG002|Overall Study|Other|0
7712474|NCT00483938|12134794|FG003|Overall Study|Other|4
7712475|NCT00483938|12134795|FG004|Overall Study|Other|0
7712476|NCT00483938|12134796|FG005|Overall Study|Other|4
7712477|NCT00483938|12134797|FG006|Overall Study|Other|32
7712478|NCT00484094|12134816|FG000|Overall Study|Discontinued|39
7712479|NCT00484094|12134816|FG000|Overall Study|Other|3
7712480|NCT00484159|12134823|FG000|Overall Study|Lost to Follow-up|1
7712481|NCT00484159|12134824|FG001|Overall Study|Lost to Follow-up|1
7712482|NCT00484159|12134825|FG002|Overall Study|Lost to Follow-up|0
7712483|NCT00484185|12134833|FG000|Overall Study|Lost to Follow-up|44
7712484|NCT00484185|12134833|FG000|Overall Study|Other|20
7712485|NCT00484185|12134833|FG000|Overall Study|Randomized but not treated|5
7712486|NCT00484185|12134833|FG000|Overall Study|Death|2
7712487|NCT00484198|12134841|FG000|Overall Study|Participant Withdrew Consent|12
7712488|NCT00484198|12134842|FG001|Overall Study|Participant Withdrew Consent|21
7712489|NCT00484198|12134843|FG002|Overall Study|Participant Withdrew Consent|47
7712490|NCT00484198|12134844|FG003|Overall Study|Participant Withdrew Consent|59
7712491|NCT00484198|12134841|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16
7712492|NCT00484198|12134842|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17
7712493|NCT00484198|12134843|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29
7712494|NCT00484198|12134844|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38
7712495|NCT00484198|12134841|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3
7712496|NCT00484198|12134842|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2
7712497|NCT00484198|12134843|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6
7712498|NCT00484198|12134844|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8
7712499|NCT00484198|12134841|FG000|Overall Study|Adverse Event|3
7712500|NCT00484198|12134842|FG001|Overall Study|Adverse Event|11
7712501|NCT00484198|12134843|FG002|Overall Study|Adverse Event|32
7712502|NCT00484198|12134844|FG003|Overall Study|Adverse Event|31
7712503|NCT00484198|12134841|FG000|Overall Study|Protocol Violation|0
7712504|NCT00484198|12134842|FG001|Overall Study|Protocol Violation|5
7712505|NCT00484198|12134843|FG002|Overall Study|Protocol Violation|6
7712506|NCT00484198|12134844|FG003|Overall Study|Protocol Violation|8
7712507|NCT00484198|12134841|FG000|Overall Study|Other|7
7712508|NCT00484198|12134842|FG001|Overall Study|Other|10
7712509|NCT00484198|12134843|FG002|Overall Study|Other|31
7712510|NCT00484198|12134844|FG003|Overall Study|Other|28
7712511|NCT00484289|12134862|FG000|Long Term Phase|Adverse Event|1
7712512|NCT00484289|12134863|FG001|Long Term Phase|Adverse Event|17
7712513|NCT00484289|12134864|FG002|Long Term Phase|Adverse Event|5
7712514|NCT00484289|12134862|FG000|Long Term Phase|Withdrawal by Subject|0
7712515|NCT00484289|12134863|FG001|Long Term Phase|Withdrawal by Subject|7
7712516|NCT00484289|12134864|FG002|Long Term Phase|Withdrawal by Subject|6
7712517|NCT00484289|12134862|FG000|Long Term Phase|Inadequate response|2
7712518|NCT00484289|12134863|FG001|Long Term Phase|Inadequate response|7
7712519|NCT00484289|12134864|FG002|Long Term Phase|Inadequate response|4
7712520|NCT00484289|12134862|FG000|Long Term Phase|Other Reason|0
7712521|NCT00484289|12134863|FG001|Long Term Phase|Other Reason|5
7712522|NCT00484289|12134864|FG002|Long Term Phase|Other Reason|1
7712523|NCT00484289|12134862|FG000|Post Marketing Phase|Adverse Event|0
7712524|NCT00484289|12134863|FG001|Post Marketing Phase|Adverse Event|1
7712525|NCT00484289|12134864|FG002|Post Marketing Phase|Adverse Event|0
7712526|NCT00484315|12134875|FG000|12-Month Clinical Follow-up|Death|6
7712527|NCT00484315|12134876|FG001|12-Month Clinical Follow-up|Death|2
7712528|NCT00484315|12134875|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4
7712529|NCT00484315|12134876|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0
7712530|NCT00484315|12134875|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2
7712531|NCT00484315|12134876|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1
7712532|NCT00484315|12134875|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13
7712533|NCT00484315|12134876|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4
7712534|NCT00484315|12134875|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
7712535|NCT00484315|12134876|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
7712536|NCT00484315|12134875|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
7712537|NCT00484315|12134876|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
7712538|NCT00484315|12134875|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
7712539|NCT00484315|12134876|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
7712540|NCT00484679|12134900|FG000|Overall Study|Withdrawal by Subject|3
7712541|NCT00484939|12134913|FG000|Overall Study|Death|9
7712542|NCT00484939|12134914|FG001|Overall Study|Death|13
7712543|NCT00484939|12134913|FG000|Overall Study|Adverse Event|22
7712544|NCT00484939|12134914|FG001|Overall Study|Adverse Event|12
7712545|NCT00484939|12134913|FG000|Overall Study|Patient Withdrew Consent|19
7712546|NCT00484939|12134914|FG001|Overall Study|Patient Withdrew Consent|10
7712547|NCT00484939|12134913|FG000|Overall Study|Protocol Violation|3
7712548|NCT00484939|12134914|FG001|Overall Study|Protocol Violation|3
7712549|NCT00484939|12134913|FG000|Overall Study|Lost to Follow-up|0
7712550|NCT00484939|12134914|FG001|Overall Study|Lost to Follow-up|3
7712551|NCT00484939|12134913|FG000|Overall Study|Discretion of Investigator or Sponsor|7
7712552|NCT00484939|12134914|FG001|Overall Study|Discretion of Investigator or Sponsor|3
7712553|NCT00484939|12134913|FG000|Overall Study|Disease progression|67
7712554|NCT00484939|12134914|FG001|Overall Study|Disease progression|88
7712555|NCT00484939|12134913|FG000|Overall Study|Screen Failure|2
7712556|NCT00484939|12134914|FG001|Overall Study|Screen Failure|2
7712557|NCT00484939|12134913|FG000|Overall Study|Reason Not Specified|11
7712558|NCT00484939|12134914|FG001|Overall Study|Reason Not Specified|6
7712559|NCT00485069|12134922|FG000|Overall Study|Adverse Event|10
7712560|NCT00485069|12134923|FG001|Overall Study|Adverse Event|4
7712561|NCT00485069|12134922|FG000|Overall Study|Lack of Efficacy|2
7712562|NCT00485069|12134923|FG001|Overall Study|Lack of Efficacy|1
7712563|NCT00485069|12134922|FG000|Overall Study|Protocol Violation|0
7712564|NCT00485069|12134923|FG001|Overall Study|Protocol Violation|1
7712565|NCT00485069|12134922|FG000|Overall Study|Withdrawal by Subject|6
7712566|NCT00485069|12134923|FG001|Overall Study|Withdrawal by Subject|6
7712567|NCT00485134|12134944|FG000|Overall Study|Lost to Follow-up|1
7712568|NCT00485134|12134945|FG001|Overall Study|Lost to Follow-up|0
7712569|NCT00485134|12134946|FG002|Overall Study|Lost to Follow-up|0
7712570|NCT00485134|12134947|FG003|Overall Study|Lost to Follow-up|0
7712571|NCT00485134|12134948|FG004|Overall Study|Lost to Follow-up|0
7712572|NCT00485134|12134949|FG005|Overall Study|Lost to Follow-up|0
7712573|NCT00485134|12134950|FG006|Overall Study|Lost to Follow-up|0
7712574|NCT00485134|12134951|FG007|Overall Study|Lost to Follow-up|0
7712575|NCT00485134|12134944|FG000|Overall Study|Withdrawal by Subject|0
7712576|NCT00485134|12134945|FG001|Overall Study|Withdrawal by Subject|1
7712577|NCT00485134|12134946|FG002|Overall Study|Withdrawal by Subject|0
7712578|NCT00485134|12134947|FG003|Overall Study|Withdrawal by Subject|0
7712579|NCT00485134|12134948|FG004|Overall Study|Withdrawal by Subject|0
7712580|NCT00485134|12134949|FG005|Overall Study|Withdrawal by Subject|0
7712581|NCT00485134|12134950|FG006|Overall Study|Withdrawal by Subject|0
7712582|NCT00485134|12134951|FG007|Overall Study|Withdrawal by Subject|0
7712583|NCT00485134|12134944|FG000|Overall Study|Change in health status|0
7712584|NCT00485134|12134945|FG001|Overall Study|Change in health status|1
7712585|NCT00485134|12134946|FG002|Overall Study|Change in health status|2
7712586|NCT00485134|12134947|FG003|Overall Study|Change in health status|1
7712587|NCT00485134|12134948|FG004|Overall Study|Change in health status|0
7712588|NCT00485134|12134949|FG005|Overall Study|Change in health status|1
7712589|NCT00485134|12134950|FG006|Overall Study|Change in health status|0
7712590|NCT00485134|12134951|FG007|Overall Study|Change in health status|0
7712591|NCT00485134|12134944|FG000|Overall Study|Withdrew for adverse event|0
7712592|NCT00485134|12134945|FG001|Overall Study|Withdrew for adverse event|0
7712593|NCT00485134|12134946|FG002|Overall Study|Withdrew for adverse event|1
7712594|NCT00485134|12134947|FG003|Overall Study|Withdrew for adverse event|0
7712595|NCT00485134|12134948|FG004|Overall Study|Withdrew for adverse event|0
7712596|NCT00485134|12134949|FG005|Overall Study|Withdrew for adverse event|0
7712597|NCT00485134|12134950|FG006|Overall Study|Withdrew for adverse event|0
7712598|NCT00485134|12134951|FG007|Overall Study|Withdrew for adverse event|0
7712599|NCT00485134|12134944|FG000|Overall Study|Positive drug test|0
7712600|NCT00485134|12134945|FG001|Overall Study|Positive drug test|0
7712601|NCT00485134|12134946|FG002|Overall Study|Positive drug test|0
7712602|NCT00485134|12134947|FG003|Overall Study|Positive drug test|0
7712603|NCT00485134|12134948|FG004|Overall Study|Positive drug test|2
7712604|NCT00485134|12134949|FG005|Overall Study|Positive drug test|1
7712605|NCT00485134|12134950|FG006|Overall Study|Positive drug test|0
7712606|NCT00485134|12134951|FG007|Overall Study|Positive drug test|0
7712607|NCT00485134|12134944|FG000|Overall Study|Non-compliance|0
7712608|NCT00485134|12134945|FG001|Overall Study|Non-compliance|0
7712609|NCT00485134|12134946|FG002|Overall Study|Non-compliance|0
7712610|NCT00485134|12134947|FG003|Overall Study|Non-compliance|0
7712611|NCT00485134|12134948|FG004|Overall Study|Non-compliance|1
7712612|NCT00485134|12134949|FG005|Overall Study|Non-compliance|2
7712613|NCT00485134|12134950|FG006|Overall Study|Non-compliance|2
7712614|NCT00485134|12134951|FG007|Overall Study|Non-compliance|0
7712615|NCT00485134|12134944|FG000|Overall Study|Unable to comply with study schedule|0
7712616|NCT00485134|12134945|FG001|Overall Study|Unable to comply with study schedule|0
7712617|NCT00485134|12134946|FG002|Overall Study|Unable to comply with study schedule|0
7712618|NCT00485134|12134947|FG003|Overall Study|Unable to comply with study schedule|0
7712619|NCT00485134|12134948|FG004|Overall Study|Unable to comply with study schedule|0
7712620|NCT00485134|12134949|FG005|Overall Study|Unable to comply with study schedule|0
7712621|NCT00485134|12134950|FG006|Overall Study|Unable to comply with study schedule|0
7712622|NCT00485134|12134951|FG007|Overall Study|Unable to comply with study schedule|1
7712623|NCT00485134|12134944|FG000|Overall Study|Pregnancy|0
7712624|NCT00485134|12134945|FG001|Overall Study|Pregnancy|0
7712625|NCT00485134|12134946|FG002|Overall Study|Pregnancy|0
7712626|NCT00485134|12134947|FG003|Overall Study|Pregnancy|0
7712627|NCT00485134|12134948|FG004|Overall Study|Pregnancy|0
7712628|NCT00485134|12134949|FG005|Overall Study|Pregnancy|0
7712629|NCT00485134|12134950|FG006|Overall Study|Pregnancy|1
7712630|NCT00485134|12134951|FG007|Overall Study|Pregnancy|0
7712631|NCT00485173|12134965|FG000|Overall Study|Death|4
7712632|NCT00485173|12134966|FG001|Overall Study|Death|3
7712633|NCT00485173|12134965|FG000|Overall Study|Lost to Follow-up|32
7712634|NCT00485173|12134966|FG001|Overall Study|Lost to Follow-up|61
7712635|NCT00485264|12134978|FG000|Overall Study|Enrolled But Not Given Treatment|0
7712636|NCT00485264|12134979|FG001|Overall Study|Enrolled But Not Given Treatment|0
7712637|NCT00485264|12134980|FG002|Overall Study|Enrolled But Not Given Treatment|0
7712638|NCT00485264|12134981|FG003|Overall Study|Enrolled But Not Given Treatment|0
7712639|NCT00485264|12134982|FG004|Overall Study|Enrolled But Not Given Treatment|1
7712640|NCT00485264|12134983|FG005|Overall Study|Enrolled But Not Given Treatment|0
7712641|NCT00485264|12134978|FG000|Overall Study|Death|1
7712642|NCT00485264|12134979|FG001|Overall Study|Death|0
7712643|NCT00485264|12134980|FG002|Overall Study|Death|0
7712644|NCT00485264|12134981|FG003|Overall Study|Death|0
7712645|NCT00485264|12134982|FG004|Overall Study|Death|1
7712646|NCT00485264|12134983|FG005|Overall Study|Death|0
7712647|NCT00485264|12134978|FG000|Overall Study|Adverse Event|1
7712648|NCT00485264|12134979|FG001|Overall Study|Adverse Event|0
7712649|NCT00485264|12134980|FG002|Overall Study|Adverse Event|2
7712650|NCT00485264|12134981|FG003|Overall Study|Adverse Event|3
7712651|NCT00485264|12134982|FG004|Overall Study|Adverse Event|1
7712652|NCT00485264|12134983|FG005|Overall Study|Adverse Event|3
7712653|NCT00485264|12134978|FG000|Overall Study|Pregnancy|4
7712654|NCT00485264|12134979|FG001|Overall Study|Pregnancy|0
7712655|NCT00485264|12134980|FG002|Overall Study|Pregnancy|0
7712656|NCT00485264|12134981|FG003|Overall Study|Pregnancy|0
7712657|NCT00485264|12134982|FG004|Overall Study|Pregnancy|0
7712658|NCT00485264|12134983|FG005|Overall Study|Pregnancy|0
7712659|NCT00485264|12134978|FG000|Overall Study|Disallowed Medication|0
7712660|NCT00485264|12134979|FG001|Overall Study|Disallowed Medication|0
7712661|NCT00485264|12134980|FG002|Overall Study|Disallowed Medication|0
7712662|NCT00485264|12134981|FG003|Overall Study|Disallowed Medication|0
7712663|NCT00485264|12134982|FG004|Overall Study|Disallowed Medication|0
7712664|NCT00485264|12134983|FG005|Overall Study|Disallowed Medication|1
7712665|NCT00485264|12134978|FG000|Overall Study|Number/Volume/Timing of Study Meds|2
7712666|NCT00485264|12134979|FG001|Overall Study|Number/Volume/Timing of Study Meds|1
7712667|NCT00485264|12134980|FG002|Overall Study|Number/Volume/Timing of Study Meds|1
7712668|NCT00485264|12134981|FG003|Overall Study|Number/Volume/Timing of Study Meds|0
7712669|NCT00485264|12134982|FG004|Overall Study|Number/Volume/Timing of Study Meds|0
7712670|NCT00485264|12134983|FG005|Overall Study|Number/Volume/Timing of Study Meds|0
7712671|NCT00485264|12134978|FG000|Overall Study|Lack of Efficacy|0
7712672|NCT00485264|12134979|FG001|Overall Study|Lack of Efficacy|1
7712673|NCT00485264|12134980|FG002|Overall Study|Lack of Efficacy|0
7712674|NCT00485264|12134981|FG003|Overall Study|Lack of Efficacy|0
7712675|NCT00485264|12134982|FG004|Overall Study|Lack of Efficacy|0
7712676|NCT00485264|12134983|FG005|Overall Study|Lack of Efficacy|0
7712677|NCT00485264|12134978|FG000|Overall Study|Guardian Consent Withdrawn|1
7712678|NCT00485264|12134979|FG001|Overall Study|Guardian Consent Withdrawn|0
7712679|NCT00485264|12134980|FG002|Overall Study|Guardian Consent Withdrawn|0
7712680|NCT00485264|12134981|FG003|Overall Study|Guardian Consent Withdrawn|0
7712681|NCT00485264|12134982|FG004|Overall Study|Guardian Consent Withdrawn|1
7712682|NCT00485264|12134983|FG005|Overall Study|Guardian Consent Withdrawn|0
7712683|NCT00485264|12134978|FG000|Overall Study|Physician Decision|0
7712684|NCT00485264|12134979|FG001|Overall Study|Physician Decision|2
7712685|NCT00485264|12134980|FG002|Overall Study|Physician Decision|0
7712686|NCT00485264|12134981|FG003|Overall Study|Physician Decision|0
7712687|NCT00485264|12134982|FG004|Overall Study|Physician Decision|0
7712688|NCT00485264|12134983|FG005|Overall Study|Physician Decision|0
7712689|NCT00485264|12134978|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0
7712690|NCT00485264|12134979|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0
7712691|NCT00485264|12134980|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1
7712692|NCT00485264|12134981|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0
7712693|NCT00485264|12134982|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0
7712694|NCT00485264|12134983|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0
7712695|NCT00485264|12134978|FG000|Overall Study|Not Able to Attend Clinic|5
7712696|NCT00485264|12134979|FG001|Overall Study|Not Able to Attend Clinic|0
7712697|NCT00485264|12134980|FG002|Overall Study|Not Able to Attend Clinic|0
7712698|NCT00485264|12134981|FG003|Overall Study|Not Able to Attend Clinic|1
7712699|NCT00485264|12134982|FG004|Overall Study|Not Able to Attend Clinic|1
7712700|NCT00485264|12134983|FG005|Overall Study|Not Able to Attend Clinic|2
7712701|NCT00485264|12134978|FG000|Overall Study|Non-Compliant|17
7712702|NCT00485264|12134979|FG001|Overall Study|Non-Compliant|2
7712703|NCT00485264|12134980|FG002|Overall Study|Non-Compliant|1
7712704|NCT00485264|12134981|FG003|Overall Study|Non-Compliant|0
7712705|NCT00485264|12134982|FG004|Overall Study|Non-Compliant|1
7712706|NCT00485264|12134983|FG005|Overall Study|Non-Compliant|0
7712707|NCT00485264|12134978|FG000|Overall Study|Lost to Follow-up|2
7712708|NCT00485264|12134979|FG001|Overall Study|Lost to Follow-up|1
7712709|NCT00485264|12134980|FG002|Overall Study|Lost to Follow-up|1
7712710|NCT00485264|12134981|FG003|Overall Study|Lost to Follow-up|0
7712711|NCT00485264|12134982|FG004|Overall Study|Lost to Follow-up|0
7712712|NCT00485264|12134983|FG005|Overall Study|Lost to Follow-up|1
7712713|NCT00485264|12134978|FG000|Overall Study|Other Reason|3
7712714|NCT00485264|12134979|FG001|Overall Study|Other Reason|0
7712715|NCT00485264|12134980|FG002|Overall Study|Other Reason|0
7712716|NCT00485264|12134981|FG003|Overall Study|Other Reason|0
7712717|NCT00485264|12134982|FG004|Overall Study|Other Reason|0
7712718|NCT00485264|12134983|FG005|Overall Study|Other Reason|0
7712719|NCT00485303|12135002|FG000|Overall Study|Adverse Event|5
7712720|NCT00485303|12135002|FG000|Overall Study|Progressive Disease|44
7712721|NCT00485303|12135002|FG000|Overall Study|Other|3
7712722|NCT00485303|12135002|FG000|Overall Study|Initiation of new anti-cancer treatment|2
7712723|NCT00485303|12135002|FG000|Overall Study|Treatment ongoing at cutoff date|2
7712724|NCT00485472|12135023|FG000|Overall Study|Adverse Event|8
7712725|NCT00485472|12135024|FG001|Overall Study|Adverse Event|5
7712726|NCT00485472|12135023|FG000|Overall Study|Lack of Efficacy|5
7712727|NCT00485472|12135024|FG001|Overall Study|Lack of Efficacy|4
7712728|NCT00485472|12135023|FG000|Overall Study|Withdrawal by Subject|1
7712729|NCT00485472|12135024|FG001|Overall Study|Withdrawal by Subject|0
7712730|NCT00485472|12135023|FG000|Overall Study|Protocol Violation|0
7712731|NCT00485472|12135024|FG001|Overall Study|Protocol Violation|1
7712732|NCT00485472|12135023|FG000|Overall Study|Other|2
7712733|NCT00485472|12135024|FG001|Overall Study|Other|1
7712734|NCT00485472|12135023|FG000|Overall Study|Lost to Follow-up|0
7712735|NCT00485472|12135024|FG001|Overall Study|Lost to Follow-up|1
7712736|NCT00485589|12135037|FG000|Overall Study|Death|2
7712737|NCT00485589|12135038|FG001|Overall Study|Death|2
7712738|NCT00485589|12135039|FG002|Overall Study|Death|0
7712739|NCT00485589|12135037|FG000|Overall Study|Failure to return|6
7712740|NCT00485589|12135038|FG001|Overall Study|Failure to return|5
7712741|NCT00485589|12135039|FG002|Overall Study|Failure to return|1
7712742|NCT00485589|12135037|FG000|Overall Study|Protocol Violation|1
7712743|NCT00485589|12135038|FG001|Overall Study|Protocol Violation|0
7712744|NCT00485589|12135039|FG002|Overall Study|Protocol Violation|0
7712745|NCT00485589|12135037|FG000|Overall Study|Violation of selection criteria at entry|0
7712746|NCT00485589|12135038|FG001|Overall Study|Violation of selection criteria at entry|3
7712747|NCT00485589|12135039|FG002|Overall Study|Violation of selection criteria at entry|1
7712748|NCT00485589|12135037|FG000|Overall Study|Administrative/Other|1
7712749|NCT00485589|12135038|FG001|Overall Study|Administrative/Other|2
7712750|NCT00485589|12135039|FG002|Overall Study|Administrative/Other|1
7712751|NCT00485589|12135037|FG000|Overall Study|Insufficient therapeutic response|10
7712752|NCT00485589|12135038|FG001|Overall Study|Insufficient therapeutic response|3
7712753|NCT00485589|12135039|FG002|Overall Study|Insufficient therapeutic response|1
7712754|NCT00485589|12135037|FG000|Overall Study|Refused treatment/did not cooperate|1
7712755|NCT00485589|12135038|FG001|Overall Study|Refused treatment/did not cooperate|0
7712756|NCT00485589|12135039|FG002|Overall Study|Refused treatment/did not cooperate|2
7712757|NCT00485589|12135037|FG000|Overall Study|Withdrawal by Subject|3
7712758|NCT00485589|12135038|FG001|Overall Study|Withdrawal by Subject|2
7712759|NCT00485589|12135039|FG002|Overall Study|Withdrawal by Subject|2
7712760|NCT00485589|12135037|FG000|Overall Study|Adverse Event|3
7712761|NCT00485589|12135038|FG001|Overall Study|Adverse Event|3
7712762|NCT00485589|12135039|FG002|Overall Study|Adverse Event|10
7712763|NCT00485732|12135058|FG000|Overall Study|Protocol Violation|1
7712764|NCT00485732|12135059|FG001|Overall Study|Protocol Violation|3
7712765|NCT00485732|12135058|FG000|Overall Study|Withdrawal by Subject|5
7712766|NCT00485732|12135059|FG001|Overall Study|Withdrawal by Subject|4
7712767|NCT00485732|12135058|FG000|Overall Study|Lost to Follow-up|2
7712768|NCT00485732|12135059|FG001|Overall Study|Lost to Follow-up|2
7712769|NCT00485758|12135067|FG000|Overall Study|Adverse Event|102
7712770|NCT00485758|12135068|FG001|Overall Study|Adverse Event|31
7712771|NCT00485758|12135067|FG000|Overall Study|Death|0
7712772|NCT00485758|12135068|FG001|Overall Study|Death|1
7712773|NCT00485758|12135067|FG000|Overall Study|Lost to Follow-up|5
7712774|NCT00485758|12135068|FG001|Overall Study|Lost to Follow-up|1
7712775|NCT00485758|12135067|FG000|Overall Study|Physician Decision|3
7712776|NCT00485758|12135068|FG001|Overall Study|Physician Decision|3
7712777|NCT00485758|12135067|FG000|Overall Study|Protocol Violation|11
7712778|NCT00485758|12135068|FG001|Overall Study|Protocol Violation|2
7712779|NCT00485758|12135067|FG000|Overall Study|Withdrawal by Subject|32
7712780|NCT00485758|12135068|FG001|Overall Study|Withdrawal by Subject|27
7712781|NCT00485758|12135067|FG000|Overall Study|Study Terminated by Sponsor|3
7712782|NCT00485758|12135068|FG001|Overall Study|Study Terminated by Sponsor|0
7712783|NCT00486044|12135118|FG000|Overall Study|Withdrawal by Subject|2
7712784|NCT00486044|12135119|FG001|Overall Study|Withdrawal by Subject|1
7712785|NCT00486044|12135118|FG000|Overall Study|Adverse Event|0
7712786|NCT00486044|12135119|FG001|Overall Study|Adverse Event|1
7712787|NCT00486044|12135118|FG000|Overall Study|Lost to Follow-up|0
7712788|NCT00486044|12135119|FG001|Overall Study|Lost to Follow-up|1
7712789|NCT00486226|12135125|FG000|Overall Study|Death|3
7712790|NCT00486226|12135125|FG000|Overall Study|Adverse Event|1
7712791|NCT00486226|12135125|FG000|Overall Study|Withdrawal by Subject|1
7712792|NCT00486226|12135125|FG000|Overall Study|Lost to Follow-up|8
7712793|NCT00486252|12135132|FG000|Overall Study|Adverse Event|7
7712794|NCT00486252|12135132|FG000|Overall Study|Lack of Efficacy|9
7712795|NCT00486252|12135132|FG000|Overall Study|Lost to Follow-up|24
7712796|NCT00486252|12135132|FG000|Overall Study|Other|18
7712797|NCT00486265|12135138|FG000|Overall Study|Adverse Event|1
7712798|NCT00486265|12135138|FG000|Overall Study|Lack of Efficacy|8
7712799|NCT00486278|12135142|FG000|Overall Study|Adverse Event|5
7712800|NCT00486278|12135142|FG000|Overall Study|Withdrawal by Subject|2
7712801|NCT00486278|12135142|FG000|Overall Study|Physician Decision|2
7712802|NCT00486291|12135158|FG000|Overall Study|Adverse Event|3
7712803|NCT00486291|12135159|FG001|Overall Study|Adverse Event|4
7712804|NCT00486291|12135158|FG000|Overall Study|Lost to Follow-up|3
7712805|NCT00486291|12135159|FG001|Overall Study|Lost to Follow-up|7
7712806|NCT00486291|12135158|FG000|Overall Study|protocol non-compliance|10
7712807|NCT00486291|12135159|FG001|Overall Study|protocol non-compliance|15
7712808|NCT00486291|12135158|FG000|Overall Study|requirement for restricted medication|0
7712809|NCT00486291|12135159|FG001|Overall Study|requirement for restricted medication|3
7712810|NCT00486330|12135165|FG000|Overall Study|Adverse Event|2
7712811|NCT00486434|12135171|FG000|Overall Study|Withdrawal by Subject|34
7712812|NCT00486434|12135172|FG001|Overall Study|Withdrawal by Subject|39
7712813|NCT00486434|12135171|FG000|Overall Study|Adverse Event|118
7712814|NCT00486434|12135172|FG001|Overall Study|Adverse Event|44
7712815|NCT00486434|12135171|FG000|Overall Study|Protocol Violation|22
7712816|NCT00486434|12135172|FG001|Overall Study|Protocol Violation|21
7712817|NCT00486434|12135171|FG000|Overall Study|Lack of Efficacy|12
7712818|NCT00486434|12135172|FG001|Overall Study|Lack of Efficacy|19
7712819|NCT00486434|12135171|FG000|Overall Study|Lost to Follow-up|2
7712820|NCT00486434|12135172|FG001|Overall Study|Lost to Follow-up|3
7712821|NCT00486434|12135171|FG000|Overall Study|Death|1
7712822|NCT00486434|12135172|FG001|Overall Study|Death|2
7712823|NCT00486434|12135171|FG000|Overall Study|Personal reasons|5
7712824|NCT00486434|12135172|FG001|Overall Study|Personal reasons|6
7712825|NCT00486603|12135195|FG000|Overall Study|Withdrawal by Subject|1
7712826|NCT00486603|12135196|FG001|Overall Study|Withdrawal by Subject|0
7712827|NCT00486603|12135197|FG002|Overall Study|Withdrawal by Subject|0
7712828|NCT00486603|12135198|FG003|Overall Study|Withdrawal by Subject|0
7712829|NCT00486603|12135199|FG004|Overall Study|Withdrawal by Subject|0
7712830|NCT00486603|12135195|FG000|Overall Study|Physician Decision|0
7712831|NCT00486603|12135196|FG001|Overall Study|Physician Decision|1
7712832|NCT00486603|12135197|FG002|Overall Study|Physician Decision|0
7712833|NCT00486603|12135198|FG003|Overall Study|Physician Decision|0
7712834|NCT00486603|12135199|FG004|Overall Study|Physician Decision|0
7712835|NCT00486720|12135227|FG000|Overall Study|Adverse Event|1
7712836|NCT00486720|12135228|FG001|Overall Study|Adverse Event|2
7712837|NCT00486720|12135227|FG000|Overall Study|Lack of Efficacy|4
7712838|NCT00486720|12135228|FG001|Overall Study|Lack of Efficacy|6
7712839|NCT00486720|12135227|FG000|Overall Study|Physician Decision|1
7712840|NCT00486720|12135228|FG001|Overall Study|Physician Decision|2
7712841|NCT00486720|12135227|FG000|Overall Study|Protocol Violation|1
7712842|NCT00486720|12135228|FG001|Overall Study|Protocol Violation|0
7712843|NCT00486720|12135227|FG000|Overall Study|Withdrawal by Subject|3
7712844|NCT00486720|12135228|FG001|Overall Study|Withdrawal by Subject|1
7712845|NCT00486720|12135227|FG000|Overall Study|Progressive Disease|0
7712846|NCT00486720|12135228|FG001|Overall Study|Progressive Disease|1
7712847|NCT00486759|12135236|FG000|Treatment|Adverse event/intercurrent illness|86
7712848|NCT00486759|12135237|FG001|Treatment|Adverse event/intercurrent illness|39
7712849|NCT00486759|12135236|FG000|Treatment|Insufficient therapeutic response|37
7712850|NCT00486759|12135237|FG001|Treatment|Insufficient therapeutic response|39
7712851|NCT00486759|12135236|FG000|Treatment|Death|17
7712852|NCT00486759|12135237|FG001|Treatment|Death|10
7712853|NCT00486759|12135236|FG000|Treatment|Withdrew consent|15
7712854|NCT00486759|12135237|FG001|Treatment|Withdrew consent|12
7712855|NCT00486759|12135236|FG000|Treatment|Administrative/reason not specified|17
7712856|NCT00486759|12135237|FG001|Treatment|Administrative/reason not specified|21
7712857|NCT00486759|12135236|FG000|Treatment|Refused treatment|10
7712858|NCT00486759|12135237|FG001|Treatment|Refused treatment|7
7712859|NCT00486759|12135236|FG000|Treatment|Violation of selection criteria at entry|3
7712860|NCT00486759|12135237|FG001|Treatment|Violation of selection criteria at entry|3
7712861|NCT00486759|12135236|FG000|Treatment|Other protocol violation|1
7712862|NCT00486759|12135237|FG001|Treatment|Other protocol violation|5
7712863|NCT00486759|12135236|FG000|Treatment|Failure to return|1
7712864|NCT00486759|12135237|FG001|Treatment|Failure to return|1
7712865|NCT00486759|12135236|FG000|Safety Follow-up|Insufficient therapeutic response|40
7712866|NCT00486759|12135237|FG001|Safety Follow-up|Insufficient therapeutic response|50
7712867|NCT00486759|12135236|FG000|Safety Follow-up|Death|40
7712868|NCT00486759|12135237|FG001|Safety Follow-up|Death|29
7712869|NCT00486759|12135236|FG000|Safety Follow-up|Withdrew consent|32
7712870|NCT00486759|12135237|FG001|Safety Follow-up|Withdrew consent|23
7712871|NCT00486759|12135236|FG000|Safety Follow-up|Failure to return|9
7712872|NCT00486759|12135237|FG001|Safety Follow-up|Failure to return|6
7712873|NCT00486759|12135236|FG000|Safety Follow-up|Administrative/not specified|8
7712874|NCT00486759|12135237|FG001|Safety Follow-up|Administrative/not specified|6
7712875|NCT00486759|12135236|FG000|Safety Follow-up|Refused treatment/did not cooperate|6
7712876|NCT00486759|12135237|FG001|Safety Follow-up|Refused treatment/did not cooperate|4
7712877|NCT00486759|12135236|FG000|Safety Follow-up|Adverse event/intercurrent illness|4
7712878|NCT00486759|12135237|FG001|Safety Follow-up|Adverse event/intercurrent illness|0
7712879|NCT00486811|12135246|FG000|Overall Study|Adverse Event|28
7712880|NCT00486811|12135247|FG001|Overall Study|Adverse Event|60
7712881|NCT00486811|12135248|FG002|Overall Study|Adverse Event|135
7712882|NCT00486811|12135246|FG000|Overall Study|Lack of Efficacy|34
7712883|NCT00486811|12135247|FG001|Overall Study|Lack of Efficacy|14
7712884|NCT00486811|12135248|FG002|Overall Study|Lack of Efficacy|7
7712885|NCT00486811|12135246|FG000|Overall Study|Lost to Follow-up|4
7712886|NCT00486811|12135247|FG001|Overall Study|Lost to Follow-up|6
7712887|NCT00486811|12135248|FG002|Overall Study|Lost to Follow-up|4
7712888|NCT00486811|12135246|FG000|Overall Study|Withdrawal by Subject|33
7712889|NCT00486811|12135247|FG001|Overall Study|Withdrawal by Subject|44
7712890|NCT00486811|12135248|FG002|Overall Study|Withdrawal by Subject|58
7712891|NCT00486811|12135246|FG000|Overall Study|Study drug non-compliant|5
7712892|NCT00486811|12135247|FG001|Overall Study|Study drug non-compliant|6
7712893|NCT00486811|12135248|FG002|Overall Study|Study drug non-compliant|3
7712894|NCT00486811|12135246|FG000|Overall Study|All other|18
7712895|NCT00486811|12135247|FG001|Overall Study|All other|11
7712896|NCT00486811|12135248|FG002|Overall Study|All other|7
7712897|NCT00486837|12135267|FG000|Overall Study|Withdrawal by Subject|1
7712898|NCT00486837|12135268|FG001|Overall Study|Withdrawal by Subject|0
7712899|NCT00486837|12135267|FG000|Overall Study|Adverse Event|1
7712900|NCT00486837|12135268|FG001|Overall Study|Adverse Event|1
7712901|NCT00486837|12135267|FG000|Overall Study|Protocol Violation|4
7712902|NCT00486837|12135268|FG001|Overall Study|Protocol Violation|2
7712903|NCT00486837|12135267|FG000|Overall Study|No sputum, devise issues, exacerbation|3
7712904|NCT00486837|12135268|FG001|Overall Study|No sputum, devise issues, exacerbation|4
7712905|NCT00486902|12135288|FG000|Overall Study|Withdrawal by Subject|1
7712906|NCT00486902|12135289|FG001|Overall Study|Withdrawal by Subject|2
7712907|NCT00486902|12135288|FG000|Overall Study|decision for postpartum tubal ligation|3
7712908|NCT00486902|12135289|FG001|Overall Study|decision for postpartum tubal ligation|1
7712909|NCT00486902|12135288|FG000|Overall Study|spinal anesthetic protocal violation|1
7712910|NCT00486902|12135289|FG001|Overall Study|spinal anesthetic protocal violation|1
7712911|NCT00486902|12135288|FG000|Overall Study|Did not meet inclusion criteria|1
7712912|NCT00486902|12135289|FG001|Overall Study|Did not meet inclusion criteria|0
7712913|NCT00486902|12135288|FG000|Overall Study|No toradol due to hemmorhage or allergy|3
7712914|NCT00486902|12135289|FG001|Overall Study|No toradol due to hemmorhage or allergy|1
7712915|NCT00486954|12135299|FG000|Pilot Part|Adverse Event|4
7712916|NCT00486954|12135300|FG001|Pilot Part|Adverse Event|0
7712917|NCT00486954|12135301|FG002|Pilot Part|Adverse Event|5
7712918|NCT00486954|12135302|FG003|Pilot Part|Adverse Event|0
7712919|NCT00486954|12135303|FG004|Pilot Part|Adverse Event|0
7712920|NCT00486954|12135299|FG000|Pilot Part|Disease Progression|2
7712921|NCT00486954|12135300|FG001|Pilot Part|Disease Progression|0
7712922|NCT00486954|12135301|FG002|Pilot Part|Disease Progression|1
7712923|NCT00486954|12135302|FG003|Pilot Part|Disease Progression|0
7712924|NCT00486954|12135303|FG004|Pilot Part|Disease Progression|0
7712925|NCT00486954|12135299|FG000|Randomized Part|Lost to Follow-up|0
7712926|NCT00486954|12135300|FG001|Randomized Part|Lost to Follow-up|0
7712927|NCT00486954|12135301|FG002|Randomized Part|Lost to Follow-up|0
7712928|NCT00486954|12135302|FG003|Randomized Part|Lost to Follow-up|0
7712929|NCT00486954|12135303|FG004|Randomized Part|Lost to Follow-up|1
7712930|NCT00486954|12135299|FG000|Randomized Part|Withdrawal by Subject|0
7712931|NCT00486954|12135300|FG001|Randomized Part|Withdrawal by Subject|0
7712932|NCT00486954|12135301|FG002|Randomized Part|Withdrawal by Subject|0
7712933|NCT00486954|12135302|FG003|Randomized Part|Withdrawal by Subject|1
7712934|NCT00486954|12135303|FG004|Randomized Part|Withdrawal by Subject|0
7712935|NCT00486954|12135299|FG000|Randomized Part|Sponsor Terminated Study|0
7712936|NCT00486954|12135300|FG001|Randomized Part|Sponsor Terminated Study|0
7712937|NCT00486954|12135301|FG002|Randomized Part|Sponsor Terminated Study|0
7712938|NCT00486954|12135302|FG003|Randomized Part|Sponsor Terminated Study|19
7712939|NCT00486954|12135303|FG004|Randomized Part|Sponsor Terminated Study|13
7712940|NCT00487084|12135316|FG000|Overall Study|Did not receive intervention|4
7712941|NCT00487084|12135317|FG001|Overall Study|Did not receive intervention|3
7712942|NCT00487084|12135318|FG002|Overall Study|Did not receive intervention|5
7712943|NCT00487188|12135328|FG000|Induction Phase|Abnormality of Laboratory Test|0
7712944|NCT00487188|12135329|FG001|Induction Phase|Abnormality of Laboratory Test|1
7712945|NCT00487188|12135330|FG002|Induction Phase|Abnormality of Laboratory Test|0
7712946|NCT00487188|12135328|FG000|Induction Phase|Adverse Event|5
7712947|NCT00487188|12135329|FG001|Induction Phase|Adverse Event|0
7712948|NCT00487188|12135330|FG002|Induction Phase|Adverse Event|0
7712949|NCT00487188|12135328|FG000|Induction Phase|Lack of Efficacy|0
7712950|NCT00487188|12135329|FG001|Induction Phase|Lack of Efficacy|1
7712951|NCT00487188|12135330|FG002|Induction Phase|Lack of Efficacy|0
7712952|NCT00487188|12135328|FG000|Induction Phase|Protocol Violation|1
7712953|NCT00487188|12135329|FG001|Induction Phase|Protocol Violation|0
7712954|NCT00487188|12135330|FG002|Induction Phase|Protocol Violation|0
7712955|NCT00487188|12135328|FG000|Induction Phase|Refused Treatment|1
7712956|NCT00487188|12135329|FG001|Induction Phase|Refused Treatment|2
7712957|NCT00487188|12135330|FG002|Induction Phase|Refused Treatment|0
7712958|NCT00487188|12135328|FG000|Induction Phase|Lost to Follow-up|2
7712959|NCT00487188|12135329|FG001|Induction Phase|Lost to Follow-up|2
7712960|NCT00487188|12135330|FG002|Induction Phase|Lost to Follow-up|0
7712961|NCT00487188|12135328|FG000|Induction Phase|Administrative|0
7712962|NCT00487188|12135329|FG001|Induction Phase|Administrative|1
7712963|NCT00487188|12135330|FG002|Induction Phase|Administrative|0
7712964|NCT00487188|12135328|FG000|Maintenance Phase|Adverse Event|1
7712965|NCT00487188|12135329|FG001|Maintenance Phase|Adverse Event|0
7712966|NCT00487188|12135330|FG002|Maintenance Phase|Adverse Event|0
7712967|NCT00487188|12135328|FG000|Maintenance Phase|Death|1
7712968|NCT00487188|12135329|FG001|Maintenance Phase|Death|0
7712969|NCT00487188|12135330|FG002|Maintenance Phase|Death|0
7712970|NCT00487188|12135328|FG000|Maintenance Phase|Lost to Follow-up|1
7712971|NCT00487188|12135329|FG001|Maintenance Phase|Lost to Follow-up|0
7712972|NCT00487188|12135330|FG002|Maintenance Phase|Lost to Follow-up|0
7712973|NCT00487188|12135328|FG000|Maintenance Phase|Administrative|0
7712974|NCT00487188|12135329|FG001|Maintenance Phase|Administrative|0
7712975|NCT00487188|12135330|FG002|Maintenance Phase|Administrative|1
7712976|NCT00487240|12135348|FG000|Overall Study|Withdrawal by Subject|12
7712977|NCT00487240|12135349|FG001|Overall Study|Withdrawal by Subject|6
7712978|NCT00487240|12135348|FG000|Overall Study|Lost to Follow-up|7
7712979|NCT00487240|12135349|FG001|Overall Study|Lost to Follow-up|6
7712980|NCT00487240|12135348|FG000|Overall Study|Adverse Event|0
7712981|NCT00487240|12135349|FG001|Overall Study|Adverse Event|4
7712982|NCT00487240|12135348|FG000|Overall Study|Protocol Violation|5
7712983|NCT00487240|12135349|FG001|Overall Study|Protocol Violation|5
7712984|NCT00487240|12135348|FG000|Overall Study|Entry Criteria Not Met|3
7712985|NCT00487240|12135349|FG001|Overall Study|Entry Criteria Not Met|4
7712986|NCT00487240|12135348|FG000|Overall Study|Sponsor Decision|2
7712987|NCT00487240|12135349|FG001|Overall Study|Sponsor Decision|1
7712988|NCT00487240|12135348|FG000|Overall Study|Physician Decision|2
7712989|NCT00487240|12135349|FG001|Overall Study|Physician Decision|0
7712990|NCT00487279|12135357|FG000|Overall Study|Death|1
7712991|NCT00487279|12135358|FG001|Overall Study|Death|0
7712992|NCT00487279|12135357|FG000|Overall Study|Withdrawal by Subject|0
7712993|NCT00487279|12135358|FG001|Overall Study|Withdrawal by Subject|2
7712994|NCT00487435|12135373|FG000|Overall Study|Adverse Event|146
7712995|NCT00487435|12135373|FG000|Overall Study|Death|2
7712996|NCT00487435|12135373|FG000|Overall Study|Lack of Efficacy|33
7712997|NCT00487435|12135373|FG000|Overall Study|Lost to Follow-up|54
7712998|NCT00487435|12135373|FG000|Overall Study|Pregnancy|2
7712999|NCT00487435|12135373|FG000|Overall Study|Withdrawal by Subject|132
7713000|NCT00487435|12135373|FG000|Overall Study|Resolution Of Pain|1
7713001|NCT00487435|12135373|FG000|Overall Study|Study Medication Non-Compliant|32
7713002|NCT00487435|12135373|FG000|Overall Study|Other|83
7713003|NCT00487539|12135381|FG000|Overall Study|Adverse Event|3
7713004|NCT00487539|12135382|FG001|Overall Study|Adverse Event|2
7713005|NCT00487539|12135383|FG002|Overall Study|Adverse Event|1
7713006|NCT00487539|12135384|FG003|Overall Study|Adverse Event|1
7713007|NCT00487539|12135381|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7713008|NCT00487539|12135382|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7713009|NCT00487539|12135383|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7713010|NCT00487539|12135384|FG003|Overall Study|Unsatisfactory therapeutic effect|1
7713011|NCT00487539|12135381|FG000|Overall Study|Other|3
7713012|NCT00487539|12135382|FG001|Overall Study|Other|1
7713013|NCT00487539|12135383|FG002|Overall Study|Other|2
7713014|NCT00487539|12135384|FG003|Overall Study|Other|2
7713015|NCT00487552|12135393|FG000|Overall Study|Unsuccessful magnet placements|3
7713016|NCT00487552|12135393|FG000|Overall Study|Death due to progressive malignancy|2
7713017|NCT00487552|12135393|FG000|Overall Study|Stent not placed|1
7713018|NCT00487695|12135408|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1
7713019|NCT00487695|12135409|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0
7713020|NCT00487695|12135408|FG000|First Procedure|active wheezing (did not have procedure)|1
7713021|NCT00487695|12135409|FG001|First Procedure|active wheezing (did not have procedure)|0
7713022|NCT00487695|12135408|FG000|First Procedure|esophageal stricture found (excl crit)|1
7713023|NCT00487695|12135409|FG001|First Procedure|esophageal stricture found (excl crit)|0
7713024|NCT00487695|12135408|FG000|Second Procedure|active wheezing|0
7713025|NCT00487695|12135409|FG001|Second Procedure|active wheezing|1
7713026|NCT00487695|12135408|FG000|Second Procedure|Withdrawal by Subject|1
7713027|NCT00487695|12135409|FG001|Second Procedure|Withdrawal by Subject|2
7713028|NCT00487747|12135423|FG000|Overall Study|Adverse Event|1
7713029|NCT00487747|12135423|FG000|Overall Study|Lost to Follow-up|9
7713030|NCT00487747|12135423|FG000|Overall Study|Lack of Efficacy|1
7713031|NCT00487825|12135429|FG000|Overall Study|Adverse Event|2
7713032|NCT00487825|12135430|FG001|Overall Study|Adverse Event|2
7713033|NCT00487825|12135429|FG000|Overall Study|Lack of Efficacy|1
7713034|NCT00487825|12135430|FG001|Overall Study|Lack of Efficacy|1
7713035|NCT00487825|12135429|FG000|Overall Study|Other|3
7713036|NCT00487825|12135430|FG001|Overall Study|Other|2
7713037|NCT00487942|12135440|FG000|Overall Study|Adverse Event|1
7713038|NCT00487942|12135441|FG001|Overall Study|Adverse Event|1
7713039|NCT00487942|12135442|FG002|Overall Study|Adverse Event|1
7713040|NCT00487942|12135443|FG003|Overall Study|Adverse Event|1
7713041|NCT00487942|12135440|FG000|Overall Study|Lost to Follow-up|1
7713042|NCT00487942|12135441|FG001|Overall Study|Lost to Follow-up|0
7713043|NCT00487942|12135442|FG002|Overall Study|Lost to Follow-up|0
7713044|NCT00487942|12135443|FG003|Overall Study|Lost to Follow-up|1
7713045|NCT00487942|12135440|FG000|Overall Study|Protocol Violation|1
7713046|NCT00487942|12135441|FG001|Overall Study|Protocol Violation|1
7713047|NCT00487942|12135442|FG002|Overall Study|Protocol Violation|0
7713048|NCT00487942|12135443|FG003|Overall Study|Protocol Violation|0
7713049|NCT00487942|12135440|FG000|Overall Study|Withdrawal by Subject|0
7713050|NCT00487942|12135441|FG001|Overall Study|Withdrawal by Subject|1
7713051|NCT00487942|12135442|FG002|Overall Study|Withdrawal by Subject|2
7713052|NCT00487942|12135443|FG003|Overall Study|Withdrawal by Subject|0
7713053|NCT00488033|12135455|FG000|Overall Study|Withdrawal by Subject|1
7713054|NCT00488033|12135456|FG001|Overall Study|Withdrawal by Subject|0
7713055|NCT00488293|12135479|FG000|Overall Study|Lost to Follow-up|28
7713056|NCT00488293|12135480|FG001|Overall Study|Lost to Follow-up|25
7713057|NCT00488293|12135479|FG000|Overall Study|Withdrawal by Subject|5
7713058|NCT00488293|12135480|FG001|Overall Study|Withdrawal by Subject|3
7713059|NCT00488293|12135479|FG000|Overall Study|Death|2
7713060|NCT00488293|12135480|FG001|Overall Study|Death|1
7713061|NCT00488293|12135479|FG000|Overall Study|Misrandomization/Other Unspecified|1
7713062|NCT00488293|12135480|FG001|Overall Study|Misrandomization/Other Unspecified|1
7713063|NCT00488319|12135489|FG000|Overall Study|Adverse Event|1
7713064|NCT00488319|12135490|FG001|Overall Study|Adverse Event|2
7713065|NCT00488319|12135491|FG002|Overall Study|Adverse Event|23
7713066|NCT00488319|12135489|FG000|Overall Study|Lack of Efficacy|6
7713067|NCT00488319|12135490|FG001|Overall Study|Lack of Efficacy|12
7713068|NCT00488319|12135491|FG002|Overall Study|Lack of Efficacy|27
7713069|NCT00488319|12135489|FG000|Overall Study|Lost to Follow-up|3
7713070|NCT00488319|12135490|FG001|Overall Study|Lost to Follow-up|5
7713071|NCT00488319|12135491|FG002|Overall Study|Lost to Follow-up|16
7713072|NCT00488319|12135489|FG000|Overall Study|Withdrawal by Subject|5
7713073|NCT00488319|12135490|FG001|Overall Study|Withdrawal by Subject|20
7713074|NCT00488319|12135491|FG002|Overall Study|Withdrawal by Subject|44
7713075|NCT00488319|12135489|FG000|Overall Study|Other reasons for withdrawal|0
7713076|NCT00488319|12135490|FG001|Overall Study|Other reasons for withdrawal|4
7713077|NCT00488319|12135491|FG002|Overall Study|Other reasons for withdrawal|12
7713078|NCT00488345|12135503|FG000|Overall Study|Adverse Event|0
7713079|NCT00488345|12135504|FG001|Overall Study|Adverse Event|1
7713080|NCT00488345|12135505|FG002|Overall Study|Adverse Event|1
7713081|NCT00488345|12135503|FG000|Overall Study|Unable to administer antibiotics at home|0
7713082|NCT00488345|12135504|FG001|Overall Study|Unable to administer antibiotics at home|1
7713083|NCT00488345|12135505|FG002|Overall Study|Unable to administer antibiotics at home|0
7713084|NCT00488345|12135503|FG000|Overall Study|Institutional Review Board review|0
7713085|NCT00488345|12135504|FG001|Overall Study|Institutional Review Board review|0
7713086|NCT00488345|12135505|FG002|Overall Study|Institutional Review Board review|1
7713087|NCT00488345|12135503|FG000|Overall Study|Surgical team recommendation|0
7713088|NCT00488345|12135504|FG001|Overall Study|Surgical team recommendation|1
7713089|NCT00488345|12135505|FG002|Overall Study|Surgical team recommendation|0
7713090|NCT00488345|12135503|FG000|Overall Study|Parent/legal guardian request|0
7713091|NCT00488345|12135504|FG001|Overall Study|Parent/legal guardian request|1
7713092|NCT00488345|12135505|FG002|Overall Study|Parent/legal guardian request|1
7713093|NCT00488475|12135514|FG000|Overall Study|Other|1754
7713094|NCT00488514|12135522|FG000|Overall Study|Adverse Event|41
7713095|NCT00488514|12135522|FG000|Overall Study|Lost to Follow-up|44
7713096|NCT00488514|12135522|FG000|Overall Study|Protocol Violation|32
7713097|NCT00488514|12135522|FG000|Overall Study|Withdrawal by Subject|106
7713098|NCT00488514|12135522|FG000|Overall Study|Lack of Efficacy|28
7713099|NCT00488514|12135522|FG000|Overall Study|Did not meet criteria for treatment|30
7713100|NCT00488514|12135522|FG000|Overall Study|Postive drug screen|1
7713101|NCT00488514|12135522|FG000|Overall Study|Withdrawn per medical monitor decision|2
7713102|NCT00488514|12135522|FG000|Overall Study|Investigator decision|1
7713103|NCT00488514|12135522|FG000|Overall Study|Participant had too few migraines|5
7713104|NCT00488514|12135522|FG000|Overall Study|Increase in number of migraines|2
7713105|NCT00488514|12135522|FG000|Overall Study|Increased use of concomitant medication|1
7713106|NCT00488592|12135543|FG000|Overall Study|Withdrawal by Subject|1
7713107|NCT00488592|12135543|FG000|Overall Study|Disease progression|1
7713108|NCT00488592|12135543|FG000|Overall Study|Enrolled but not treated|1
7713109|NCT00488618|12135549|FG000|Overall Study|Adverse Event|13
7713110|NCT00488618|12135550|FG001|Overall Study|Adverse Event|17
7713111|NCT00488618|12135549|FG000|Overall Study|Insufficient Therapeutic Response|18
7713112|NCT00488618|12135550|FG001|Overall Study|Insufficient Therapeutic Response|11
7713113|NCT00488618|12135549|FG000|Overall Study|Protocol Violation|0
7713114|NCT00488618|12135550|FG001|Overall Study|Protocol Violation|2
7713115|NCT00488618|12135549|FG000|Overall Study|Withdrawal of Consent|15
7713116|NCT00488618|12135550|FG001|Overall Study|Withdrawal of Consent|13
7713117|NCT00488618|12135549|FG000|Overall Study|Lost to Follow-up|1
7713118|NCT00488618|12135550|FG001|Overall Study|Lost to Follow-up|0
7713119|NCT00488631|12135562|FG000|Double Blind Period (Week 0-54)|Adverse Event|17
7713120|NCT00488631|12135563|FG001|Double Blind Period (Week 0-54)|Adverse Event|12
7713121|NCT00488631|12135564|FG002|Double Blind Period (Week 0-54)|Adverse Event|12
7713122|NCT00488631|12135565|FG003|Double Blind Period (Week 0-54)|Adverse Event|12
7713123|NCT00488631|12135566|FG004|Double Blind Period (Week 0-54)|Adverse Event|30
7713124|NCT00488631|12135567|FG005|Double Blind Period (Week 0-54)|Adverse Event|50
7713125|NCT00488631|12135568|FG006|Double Blind Period (Week 0-54)|Adverse Event|0
7713126|NCT00488631|12135569|FG007|Double Blind Period (Week 0-54)|Adverse Event|0
7713127|NCT00488631|12135570|FG008|Double Blind Period (Week 0-54)|Adverse Event|0
7713128|NCT00488631|12135571|FG009|Double Blind Period (Week 0-54)|Adverse Event|0
7713129|NCT00488631|12135562|FG000|Double Blind Period (Week 0-54)|Death|0
7713130|NCT00488631|12135563|FG001|Double Blind Period (Week 0-54)|Death|0
7713131|NCT00488631|12135564|FG002|Double Blind Period (Week 0-54)|Death|0
7713132|NCT00488631|12135565|FG003|Double Blind Period (Week 0-54)|Death|0
7713133|NCT00488631|12135566|FG004|Double Blind Period (Week 0-54)|Death|0
7713134|NCT00488631|12135567|FG005|Double Blind Period (Week 0-54)|Death|1
7713135|NCT00488631|12135568|FG006|Double Blind Period (Week 0-54)|Death|0
7713136|NCT00488631|12135569|FG007|Double Blind Period (Week 0-54)|Death|0
7713137|NCT00488631|12135570|FG008|Double Blind Period (Week 0-54)|Death|0
7713138|NCT00488631|12135571|FG009|Double Blind Period (Week 0-54)|Death|0
7713139|NCT00488631|12135562|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
7713140|NCT00488631|12135563|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
7713141|NCT00488631|12135564|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
7713142|NCT00488631|12135565|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
7713143|NCT00488631|12135566|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
7713144|NCT00488631|12135567|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
7713145|NCT00488631|12135568|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
7713146|NCT00488631|12135569|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
7713147|NCT00488631|12135570|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
7713148|NCT00488631|12135571|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
7713149|NCT00488631|12135562|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1
7713150|NCT00488631|12135563|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2
7713151|NCT00488631|12135564|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1
7713152|NCT00488631|12135565|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0
7713153|NCT00488631|12135566|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3
7713154|NCT00488631|12135567|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7
7713155|NCT00488631|12135568|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0
7713156|NCT00488631|12135569|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0
7713157|NCT00488631|12135570|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0
7713158|NCT00488631|12135571|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0
7713159|NCT00488631|12135562|FG000|Double Blind Period (Week 0-54)|Other|6
7713160|NCT00488631|12135563|FG001|Double Blind Period (Week 0-54)|Other|12
7713161|NCT00488631|12135564|FG002|Double Blind Period (Week 0-54)|Other|10
7713162|NCT00488631|12135565|FG003|Double Blind Period (Week 0-54)|Other|11
7713163|NCT00488631|12135566|FG004|Double Blind Period (Week 0-54)|Other|14
7713164|NCT00488631|12135567|FG005|Double Blind Period (Week 0-54)|Other|34
7713165|NCT00488631|12135568|FG006|Double Blind Period (Week 0-54)|Other|0
7713166|NCT00488631|12135569|FG007|Double Blind Period (Week 0-54)|Other|0
7713167|NCT00488631|12135570|FG008|Double Blind Period (Week 0-54)|Other|0
7713168|NCT00488631|12135571|FG009|Double Blind Period (Week 0-54)|Other|0
7713169|NCT00488631|12135562|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0
7713170|NCT00488631|12135563|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0
7713171|NCT00488631|12135564|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0
7713172|NCT00488631|12135565|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0
7713173|NCT00488631|12135566|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0
7713174|NCT00488631|12135567|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0
7713175|NCT00488631|12135568|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10
7713176|NCT00488631|12135569|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8
7713177|NCT00488631|12135570|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54
7713178|NCT00488631|12135571|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0
7713179|NCT00488631|12135562|FG000|Open Label Study Extension (Week 54-228)|Death|0
7713180|NCT00488631|12135563|FG001|Open Label Study Extension (Week 54-228)|Death|0
7713181|NCT00488631|12135564|FG002|Open Label Study Extension (Week 54-228)|Death|0
7713182|NCT00488631|12135565|FG003|Open Label Study Extension (Week 54-228)|Death|0
7713183|NCT00488631|12135566|FG004|Open Label Study Extension (Week 54-228)|Death|0
7713184|NCT00488631|12135567|FG005|Open Label Study Extension (Week 54-228)|Death|0
7713185|NCT00488631|12135568|FG006|Open Label Study Extension (Week 54-228)|Death|0
7713186|NCT00488631|12135569|FG007|Open Label Study Extension (Week 54-228)|Death|0
7713187|NCT00488631|12135570|FG008|Open Label Study Extension (Week 54-228)|Death|1
7713188|NCT00488631|12135571|FG009|Open Label Study Extension (Week 54-228)|Death|0
7713189|NCT00488631|12135562|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7713190|NCT00488631|12135563|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7713191|NCT00488631|12135564|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7713192|NCT00488631|12135565|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7713193|NCT00488631|12135566|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7713194|NCT00488631|12135567|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7713195|NCT00488631|12135568|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
7713196|NCT00488631|12135569|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
7713197|NCT00488631|12135570|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
7713198|NCT00488631|12135571|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
7713199|NCT00488631|12135562|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7713200|NCT00488631|12135563|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7713201|NCT00488631|12135564|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7713202|NCT00488631|12135565|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7713203|NCT00488631|12135566|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7713204|NCT00488631|12135567|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7713205|NCT00488631|12135568|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
7713206|NCT00488631|12135569|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7713207|NCT00488631|12135570|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
7713208|NCT00488631|12135571|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7713209|NCT00488631|12135562|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7713210|NCT00488631|12135563|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7713211|NCT00488631|12135564|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7713212|NCT00488631|12135565|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7713213|NCT00488631|12135566|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7713214|NCT00488631|12135567|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7713215|NCT00488631|12135568|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
7713216|NCT00488631|12135569|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
7713217|NCT00488631|12135570|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
7713218|NCT00488631|12135571|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7713219|NCT00488644|12135594|FG000|Overall Study|Not Eligible|1
7713220|NCT00488644|12135594|FG000|Overall Study|Not Evaluable|1
7713221|NCT00488683|12135601|FG000|Overall Study|Withdrawal by Subject|1
7713222|NCT00488683|12135602|FG001|Overall Study|Withdrawal by Subject|2
7713223|NCT00488683|12135603|FG002|Overall Study|Withdrawal by Subject|2
7713224|NCT00488683|12135601|FG000|Overall Study|Lost to Follow-up|5
7713225|NCT00488683|12135602|FG001|Overall Study|Lost to Follow-up|3
7713226|NCT00488683|12135603|FG002|Overall Study|Lost to Follow-up|0
7713227|NCT00488683|12135601|FG000|Overall Study|Protocol Violation|5
7713228|NCT00488683|12135602|FG001|Overall Study|Protocol Violation|1
7713229|NCT00488683|12135603|FG002|Overall Study|Protocol Violation|0
7713230|NCT00488683|12135601|FG000|Overall Study|Unable to Classify|1
7713231|NCT00488683|12135602|FG001|Overall Study|Unable to Classify|0
7713232|NCT00488683|12135603|FG002|Overall Study|Unable to Classify|0
7713233|NCT00488774|12135619|FG000|Overall Study|Withdrawal of consent|2
7713234|NCT00488774|12135620|FG001|Overall Study|Withdrawal of consent|2
7713235|NCT00488774|12135621|FG002|Overall Study|Withdrawal of consent|2
7713236|NCT00488774|12135622|FG003|Overall Study|Withdrawal of consent|0
7713237|NCT00488774|12135619|FG000|Overall Study|Other|6
7713238|NCT00488774|12135620|FG001|Overall Study|Other|3
7713239|NCT00488774|12135621|FG002|Overall Study|Other|2
7713240|NCT00488774|12135622|FG003|Overall Study|Other|2
7713241|NCT00488774|12135619|FG000|Overall Study|Lost to Follow-up|0
7713242|NCT00488774|12135620|FG001|Overall Study|Lost to Follow-up|0
7713243|NCT00488774|12135621|FG002|Overall Study|Lost to Follow-up|1
7713244|NCT00488774|12135622|FG003|Overall Study|Lost to Follow-up|1
7713245|NCT00488826|12135636|FG000|Overall Study|Withdrawal by Subject|40
7713246|NCT00488826|12135637|FG001|Overall Study|Withdrawal by Subject|35
7713247|NCT00488826|12135638|FG002|Overall Study|Withdrawal by Subject|19
7713248|NCT00488826|12135636|FG000|Overall Study|Protocol Violation|0
7713249|NCT00488826|12135637|FG001|Overall Study|Protocol Violation|0
7713250|NCT00488826|12135638|FG002|Overall Study|Protocol Violation|2
7713251|NCT00488826|12135636|FG000|Overall Study|Adverse Event|9
7713252|NCT00488826|12135637|FG001|Overall Study|Adverse Event|15
7713253|NCT00488826|12135638|FG002|Overall Study|Adverse Event|4
7713254|NCT00488826|12135636|FG000|Overall Study|Lost to Follow-up|5
7713255|NCT00488826|12135637|FG001|Overall Study|Lost to Follow-up|1
7713256|NCT00488826|12135638|FG002|Overall Study|Lost to Follow-up|0
7713257|NCT00488826|12135636|FG000|Overall Study|Protocol Deviations|2
7713258|NCT00488826|12135637|FG001|Overall Study|Protocol Deviations|1
7713259|NCT00488826|12135638|FG002|Overall Study|Protocol Deviations|1
7713260|NCT00488982|12135650|FG000|Course 1|Physician Decision|0
7713261|NCT00488982|12135651|FG001|Course 1|Physician Decision|2
7713262|NCT00488982|12135652|FG002|Course 1|Physician Decision|4
7713263|NCT00488982|12135650|FG000|Course 1|Withdrawal by Subject|0
7713264|NCT00488982|12135651|FG001|Course 1|Withdrawal by Subject|8
7713265|NCT00488982|12135652|FG002|Course 1|Withdrawal by Subject|2
7713266|NCT00488982|12135650|FG000|Course 1|nonprotocol therapy|0
7713267|NCT00488982|12135651|FG001|Course 1|nonprotocol therapy|2
7713268|NCT00488982|12135652|FG002|Course 1|nonprotocol therapy|2
7713269|NCT00488982|12135650|FG000|Course 1|Adverse Event|0
7713270|NCT00488982|12135651|FG001|Course 1|Adverse Event|0
7713271|NCT00488982|12135652|FG002|Course 1|Adverse Event|6
7713272|NCT00489216|12135670|FG000|Overall Study|Adverse Event|1
7713273|NCT00489255|12135676|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9
7713274|NCT00489255|12135677|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3
7713275|NCT00489255|12135676|FG000|Period 1: Days 1 to 28|Adverse Event|21
7713276|NCT00489255|12135677|FG001|Period 1: Days 1 to 28|Adverse Event|8
7713277|NCT00489255|12135676|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5
7713278|NCT00489255|12135677|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0
7713279|NCT00489255|12135676|FG000|Period 1: Days 1 to 28|Physician Decision|1
7713280|NCT00489255|12135677|FG001|Period 1: Days 1 to 28|Physician Decision|4
7713281|NCT00489255|12135676|FG000|Period 1: Days 1 to 28|Noncompliance|2
7713282|NCT00489255|12135677|FG001|Period 1: Days 1 to 28|Noncompliance|0
7713283|NCT00489255|12135676|FG000|Period 2: Days 29 to 56|Adverse Event|3
7713284|NCT00489255|12135677|FG001|Period 2: Days 29 to 56|Adverse Event|1
7713285|NCT00489255|12135676|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0
7713286|NCT00489255|12135677|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3
7713287|NCT00489255|12135676|FG000|Period 3: Days 57 to 84|Adverse Event|3
7713288|NCT00489255|12135677|FG001|Period 3: Days 57 to 84|Adverse Event|3
7713289|NCT00489255|12135676|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1
7713290|NCT00489255|12135677|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0
7713291|NCT00489255|12135676|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0
7713292|NCT00489255|12135677|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1
7713293|NCT00489359|12135715|FG000|Overall Study|Death|0
7713294|NCT00489359|12135716|FG001|Overall Study|Death|2
7713295|NCT00489359|12135715|FG000|Overall Study|Progressive Disease|5
7713296|NCT00489359|12135716|FG001|Overall Study|Progressive Disease|6
7713297|NCT00489359|12135715|FG000|Overall Study|Lost to Follow-up|1
7713298|NCT00489359|12135716|FG001|Overall Study|Lost to Follow-up|0
7713299|NCT00489359|12135715|FG000|Overall Study|Withdrawal by Subject|1
7713300|NCT00489359|12135716|FG001|Overall Study|Withdrawal by Subject|5
7713301|NCT00489359|12135715|FG000|Overall Study|Adverse Event|0
7713302|NCT00489359|12135716|FG001|Overall Study|Adverse Event|16
7713303|NCT00489411|12135729|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
7713304|NCT00489411|12135730|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
7713305|NCT00489411|12135729|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
7713306|NCT00489411|12135730|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
7713307|NCT00489411|12135729|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
7713308|NCT00489411|12135730|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
7713309|NCT00489411|12135729|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
7713310|NCT00489411|12135730|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
7713311|NCT00489411|12135729|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
7713312|NCT00489411|12135730|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
7713313|NCT00489424|12135739|FG000|Overall Study|Adverse Event|3
7713314|NCT00489424|12135740|FG001|Overall Study|Adverse Event|3
7713315|NCT00489424|12135741|FG002|Overall Study|Adverse Event|4
7713316|NCT00489424|12135739|FG000|Overall Study|Lack of Efficacy|1
7713317|NCT00489424|12135740|FG001|Overall Study|Lack of Efficacy|0
7713318|NCT00489424|12135741|FG002|Overall Study|Lack of Efficacy|0
7713319|NCT00489424|12135739|FG000|Overall Study|Administrative problems|0
7713320|NCT00489424|12135740|FG001|Overall Study|Administrative problems|2
7713321|NCT00489424|12135741|FG002|Overall Study|Administrative problems|1
7713322|NCT00489476|12135753|FG000|Overall Study|Lost to Follow-up|0
7713323|NCT00489476|12135754|FG001|Overall Study|Lost to Follow-up|1
7713324|NCT00489476|12135755|FG002|Overall Study|Lost to Follow-up|0
7713325|NCT00489476|12135756|FG003|Overall Study|Lost to Follow-up|0
7713326|NCT00489489|12135769|FG000|Overall Study|Not treated due to protocol violation|0
7713327|NCT00489489|12135770|FG001|Overall Study|Not treated due to protocol violation|1
7713328|NCT00489489|12135771|FG002|Overall Study|Not treated due to protocol violation|1
7713329|NCT00489489|12135769|FG000|Overall Study|Adverse Event|1
7713330|NCT00489489|12135770|FG001|Overall Study|Adverse Event|1
7713331|NCT00489489|12135771|FG002|Overall Study|Adverse Event|1
7713332|NCT00489489|12135769|FG000|Overall Study|Protocol Violation|1
7713333|NCT00489489|12135770|FG001|Overall Study|Protocol Violation|0
7713334|NCT00489489|12135771|FG002|Overall Study|Protocol Violation|1
7713335|NCT00489489|12135769|FG000|Overall Study|Progressive disease|0
7713336|NCT00489489|12135770|FG001|Overall Study|Progressive disease|1
7713337|NCT00489489|12135771|FG002|Overall Study|Progressive disease|0
7713338|NCT00489489|12135769|FG000|Overall Study|Participant did not wish to continue|1
7713339|NCT00489489|12135770|FG001|Overall Study|Participant did not wish to continue|1
7713340|NCT00489489|12135771|FG002|Overall Study|Participant did not wish to continue|0
7713341|NCT00489489|12135769|FG000|Overall Study|Other than above|0
7713342|NCT00489489|12135770|FG001|Overall Study|Other than above|1
7713343|NCT00489489|12135771|FG002|Overall Study|Other than above|0
7713344|NCT00489541|12135783|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2
7713345|NCT00489541|12135784|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3
7713346|NCT00489541|12135783|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2
7713347|NCT00489541|12135784|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0
7713348|NCT00489541|12135783|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2
7713349|NCT00489541|12135784|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0
7713350|NCT00489541|12135783|FG000|12-Month Clinical Follow-up|Death|3
7713351|NCT00489541|12135784|FG001|12-Month Clinical Follow-up|Death|2
7713352|NCT00489541|12135783|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
7713353|NCT00489541|12135784|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
7713354|NCT00489541|12135783|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
7713355|NCT00489541|12135784|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
7713356|NCT00489554|12135790|FG000|Overall Study|Adverse Event|2
7713357|NCT00489554|12135790|FG000|Overall Study|Withdrawal by Subject|1
7713358|NCT00489554|12135790|FG000|Overall Study|Lost to Follow-up|1
7713359|NCT00489736|12135796|FG000|Overall Study|Lack of Efficacy|53
7713360|NCT00489736|12135797|FG001|Overall Study|Lack of Efficacy|14
7713361|NCT00489736|12135796|FG000|Overall Study|Adverse Event|32
7713362|NCT00489736|12135797|FG001|Overall Study|Adverse Event|45
7713363|NCT00489736|12135796|FG000|Overall Study|Poor compliance|6
7713364|NCT00489736|12135797|FG001|Overall Study|Poor compliance|2
7713365|NCT00489736|12135796|FG000|Overall Study|Not coded/ Not pre-specified|5
7713366|NCT00489736|12135797|FG001|Overall Study|Not coded/ Not pre-specified|8
7713367|NCT00489853|12135803|FG000|Wash-out Period 1|Withdrawal by Subject|1
7713368|NCT00489853|12135804|FG001|Wash-out Period 1|Withdrawal by Subject|0
7713369|NCT00489853|12135805|FG002|Wash-out Period 1|Withdrawal by Subject|0
7713370|NCT00489853|12135803|FG000|Wash-out Period 1|Adverse Event|0
7713371|NCT00489853|12135804|FG001|Wash-out Period 1|Adverse Event|1
7713372|NCT00489853|12135805|FG002|Wash-out Period 1|Adverse Event|1
7713373|NCT00489853|12135803|FG000|Wash-out Period 1|Protocol Violation|0
7713374|NCT00489853|12135804|FG001|Wash-out Period 1|Protocol Violation|1
7713375|NCT00489853|12135805|FG002|Wash-out Period 1|Protocol Violation|1
7713376|NCT00489853|12135803|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0
7713377|NCT00489853|12135804|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1
7713378|NCT00489853|12135805|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4
7713379|NCT00489853|12135803|FG000|Wash-out Period 2|Adverse Event|1
7713380|NCT00489853|12135804|FG001|Wash-out Period 2|Adverse Event|1
7713381|NCT00489853|12135805|FG002|Wash-out Period 2|Adverse Event|0
7713382|NCT00489853|12135803|FG000|Wash-out Period 2|Study specific discontinuation criteria|3
7713383|NCT00489853|12135804|FG001|Wash-out Period 2|Study specific discontinuation criteria|2
7713384|NCT00489853|12135805|FG002|Wash-out Period 2|Study specific discontinuation criteria|2
7713385|NCT00489853|12135803|FG000|Treatment Period 3|Study specific discontinuation criteria|0
7713386|NCT00489853|12135804|FG001|Treatment Period 3|Study specific discontinuation criteria|1
7713387|NCT00489853|12135805|FG002|Treatment Period 3|Study specific discontinuation criteria|0
7713388|NCT00489918|12135835|FG000|Overall Study|Withdrawal by Subject|2
7713389|NCT00489918|12135836|FG001|Overall Study|Withdrawal by Subject|1
7713390|NCT00489918|12135837|FG002|Overall Study|Withdrawal by Subject|1
7713391|NCT00489918|12135838|FG003|Overall Study|Withdrawal by Subject|0
7713392|NCT00489918|12135839|FG004|Overall Study|Withdrawal by Subject|1
7713393|NCT00489918|12135835|FG000|Overall Study|Adverse Event|0
7713394|NCT00489918|12135836|FG001|Overall Study|Adverse Event|1
7713395|NCT00489918|12135837|FG002|Overall Study|Adverse Event|1
7713396|NCT00489918|12135838|FG003|Overall Study|Adverse Event|0
7713397|NCT00489918|12135839|FG004|Overall Study|Adverse Event|0
7713398|NCT00489918|12135835|FG000|Overall Study|Lost to Follow-up|0
7713399|NCT00489918|12135836|FG001|Overall Study|Lost to Follow-up|0
7713400|NCT00489918|12135837|FG002|Overall Study|Lost to Follow-up|1
7713401|NCT00489918|12135838|FG003|Overall Study|Lost to Follow-up|1
7713402|NCT00489918|12135839|FG004|Overall Study|Lost to Follow-up|0
7713403|NCT00489918|12135835|FG000|Overall Study|Physician Decision|0
7713404|NCT00489918|12135836|FG001|Overall Study|Physician Decision|0
7713405|NCT00489918|12135837|FG002|Overall Study|Physician Decision|1
7713406|NCT00489918|12135838|FG003|Overall Study|Physician Decision|0
7713407|NCT00489918|12135839|FG004|Overall Study|Physician Decision|0
7713408|NCT00489970|12135854|FG000|Persistence Year 9|Lost to Follow-up|2
7713409|NCT00489970|12135855|FG001|Persistence Year 9|Lost to Follow-up|2
7713410|NCT00489970|12135856|FG002|Persistence Year 9|Lost to Follow-up|3
7713411|NCT00489970|12135854|FG000|Persistence Year 9|Other|1
7713412|NCT00489970|12135855|FG001|Persistence Year 9|Other|0
7713413|NCT00489970|12135856|FG002|Persistence Year 9|Other|2
7713414|NCT00490022|12135874|FG000|Overall Study|Adverse Event|0
7713415|NCT00490022|12135875|FG001|Overall Study|Adverse Event|2
7713416|NCT00490022|12135874|FG000|Overall Study|Withdrawal by Subject|1
7713417|NCT00490022|12135875|FG001|Overall Study|Withdrawal by Subject|0
7713418|NCT00490022|12135874|FG000|Overall Study|Subject failed to disclose concommitant|0
7713419|NCT00490022|12135875|FG001|Overall Study|Subject failed to disclose concommitant|1
7713420|NCT00490061|12135881|FG000|Overall Study|Physician Decision|1
7713421|NCT00490139|12135894|FG000|Overall Study|Death|106
7713422|NCT00490139|12135895|FG001|Overall Study|Death|119
7713423|NCT00490139|12135896|FG002|Overall Study|Death|168
7713424|NCT00490139|12135897|FG003|Overall Study|Death|135
7713425|NCT00490139|12135894|FG000|Overall Study|Lost to Follow-up|56
7713426|NCT00490139|12135895|FG001|Overall Study|Lost to Follow-up|46
7713427|NCT00490139|12135896|FG002|Overall Study|Lost to Follow-up|58
7713428|NCT00490139|12135897|FG003|Overall Study|Lost to Follow-up|56
7713429|NCT00490139|12135894|FG000|Overall Study|Participant Withdrew Consent|146
7713430|NCT00490139|12135895|FG001|Overall Study|Participant Withdrew Consent|110
7713431|NCT00490139|12135896|FG002|Overall Study|Participant Withdrew Consent|208
7713432|NCT00490139|12135897|FG003|Overall Study|Participant Withdrew Consent|116
7713433|NCT00490282|12135927|FG000|Overall Study|Withdrawal by Subject|3
7713434|NCT00490451|12135934|FG000|Overall Study|Adverse Event|3
7713435|NCT00490451|12135935|FG001|Overall Study|Adverse Event|3
7713436|NCT00490451|12135934|FG000|Overall Study|Death|3
7713437|NCT00490451|12135935|FG001|Overall Study|Death|1
7713438|NCT00490451|12135934|FG000|Overall Study|Withdrawal by Subject|2
7713439|NCT00490451|12135935|FG001|Overall Study|Withdrawal by Subject|0
7713440|NCT00490451|12135934|FG000|Overall Study|Investigator Decision|1
7713441|NCT00490451|12135935|FG001|Overall Study|Investigator Decision|0
7713442|NCT00490451|12135934|FG000|Overall Study|Protocol Violation|1
7713443|NCT00490451|12135935|FG001|Overall Study|Protocol Violation|0
7713444|NCT00490451|12135934|FG000|Overall Study|Progressive Disease|53
7713445|NCT00490451|12135935|FG001|Overall Study|Progressive Disease|34
7713446|NCT00490490|12135950|FG000|Completed Assessment for TTP|Withdrawal by Subject|1
7713447|NCT00490490|12135950|FG000|Completed Assessment for TTP|Lost to Follow-up|2
7713448|NCT00490529|12135954|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4
7713449|NCT00490529|12135954|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4
7713450|NCT00490529|12135954|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1
7713451|NCT00490529|12135954|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1
7713452|NCT00490529|12135954|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1
7713453|NCT00490529|12135954|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1
7713454|NCT00490542|12135960|FG000|Overall Study|Lost to Follow-up|3
7713455|NCT00490542|12135961|FG001|Overall Study|Lost to Follow-up|0
7713456|NCT00490542|12135960|FG000|Overall Study|Adverse Event|3
7713457|NCT00490542|12135961|FG001|Overall Study|Adverse Event|3
7713458|NCT00490542|12135960|FG000|Overall Study|Lack of Efficacy|1
7713459|NCT00490542|12135961|FG001|Overall Study|Lack of Efficacy|1
7713460|NCT00490555|12135971|FG000|Overall Study|noncompliant with drug administration|0
7713461|NCT00490555|12135972|FG001|Overall Study|noncompliant with drug administration|0
7713462|NCT00490555|12135973|FG002|Overall Study|noncompliant with drug administration|2
7713463|NCT00490555|12135974|FG003|Overall Study|noncompliant with drug administration|0
7713464|NCT00490568|12135984|FG000|Overall Study|Adverse Event|116
7713465|NCT00490568|12135984|FG000|Overall Study|Lost to Follow-up|13
7713466|NCT00490568|12135984|FG000|Overall Study|Protocol Violation|45
7713467|NCT00490568|12135984|FG000|Overall Study|Withdrawal by Subject|135
7713468|NCT00490568|12135984|FG000|Overall Study|Still in the study at termination|974
7713469|NCT00490568|12135984|FG000|Overall Study|Other|1
7713470|NCT00490568|12135984|FG000|Overall Study|Exclusion criteria met|1
7713471|NCT00490568|12135984|FG000|Overall Study|Caregiver related|20
7713472|NCT00490568|12135984|FG000|Overall Study|Abnormal ECG|25
7713473|NCT00490568|12135984|FG000|Overall Study|Participant refused follow-up|9
7713474|NCT00490568|12135984|FG000|Overall Study|Legal representative withdrew consent|1
7713475|NCT00490568|12135984|FG000|Overall Study|Disease progression|4
7713476|NCT00490568|12135984|FG000|Overall Study|Unmet inclusion-exclusion criteria|5
7713477|NCT00490568|12135984|FG000|Overall Study|Investigator decision|3
7713478|NCT00490568|12135984|FG000|Overall Study|Non-Compliance|7
7713479|NCT00490568|12135984|FG000|Overall Study|Efficacy related|3
7713480|NCT00490568|12135984|FG000|Overall Study|Participant died|1
7713481|NCT00490568|12135984|FG000|Overall Study|Participant withdrawal due to surgery|1
7713482|NCT00490646|12135991|FG000|Overall Study|Still on trastuzumab monotherapy|1
7713483|NCT00490646|12135992|FG001|Overall Study|Still on trastuzumab monotherapy|1
7713484|NCT00490646|12135991|FG000|Overall Study|Never Treated (had an adverse event)|1
7713485|NCT00490646|12135992|FG001|Overall Study|Never Treated (had an adverse event)|0
7713486|NCT00490646|12135991|FG000|Overall Study|Never Treated (withdrew consent)|0
7713487|NCT00490646|12135992|FG001|Overall Study|Never Treated (withdrew consent)|1
7713488|NCT00490698|12135998|FG000|Overall Study|Withdrawal by Subject|1
7713489|NCT00490698|12135998|FG000|Overall Study|Disease Progression|7
7713490|NCT00490698|12135998|FG000|Overall Study|Physician Decision|2
7713491|NCT00490724|12136005|FG000|Period I|Physician Decision|0
7713492|NCT00490724|12136006|FG001|Period I|Physician Decision|0
7713493|NCT00490724|12136007|FG002|Period I|Physician Decision|1
7713494|NCT00490724|12136005|FG000|Period II|Treatment Discontinuation|3
7713495|NCT00490724|12136006|FG001|Period II|Treatment Discontinuation|1
7713496|NCT00490724|12136007|FG002|Period II|Treatment Discontinuation|3
7713497|NCT00490815|12136027|FG000|Overall Study|Adverse Event|2
7713498|NCT00490815|12136028|FG001|Overall Study|Adverse Event|3
7713499|NCT00490815|12136027|FG000|Overall Study|Withdrawal by Subject|4
7713500|NCT00490815|12136028|FG001|Overall Study|Withdrawal by Subject|0
7713501|NCT00490815|12136027|FG000|Overall Study|Lost to Follow-up|1
7713502|NCT00490815|12136028|FG001|Overall Study|Lost to Follow-up|3
7713503|NCT00490815|12136027|FG000|Overall Study|Death|1
7713504|NCT00490815|12136028|FG001|Overall Study|Death|3
7713505|NCT00490841|12136034|FG000|Overall Study|Death|5
7713506|NCT00490841|12136034|FG000|Overall Study|Withdrawal by Subject|4
7713507|NCT00490841|12136034|FG000|Overall Study|Lost to Follow-up|1
7713508|NCT00490841|12136034|FG000|Overall Study|30 day f/u, only non-study stent used|3
7713509|NCT00490919|12136041|FG000|Open-label Run-in Period|Adverse Event|239
7713510|NCT00490919|12136042|FG001|Open-label Run-in Period|Adverse Event|0
7713511|NCT00490919|12136043|FG002|Open-label Run-in Period|Adverse Event|0
7713512|NCT00490919|12136041|FG000|Open-label Run-in Period|Withdrawal by Subject|37
7713513|NCT00490919|12136042|FG001|Open-label Run-in Period|Withdrawal by Subject|0
7713514|NCT00490919|12136043|FG002|Open-label Run-in Period|Withdrawal by Subject|0
7713515|NCT00490919|12136041|FG000|Open-label Run-in Period|Lost to Follow-up|21
7713516|NCT00490919|12136042|FG001|Open-label Run-in Period|Lost to Follow-up|0
7713517|NCT00490919|12136043|FG002|Open-label Run-in Period|Lost to Follow-up|0
7713518|NCT00490919|12136041|FG000|Open-label Run-in Period|Lack of Efficacy|143
7713519|NCT00490919|12136042|FG001|Open-label Run-in Period|Lack of Efficacy|0
7713520|NCT00490919|12136043|FG002|Open-label Run-in Period|Lack of Efficacy|0
7713521|NCT00490919|12136041|FG000|Open-label Run-in Period|Administrative|40
7713522|NCT00490919|12136042|FG001|Open-label Run-in Period|Administrative|0
7713523|NCT00490919|12136043|FG002|Open-label Run-in Period|Administrative|0
7713524|NCT00490919|12136041|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3
7713525|NCT00490919|12136042|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0
7713526|NCT00490919|12136043|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0
7713527|NCT00490919|12136041|FG000|Double-blind Phase|Adverse Event|0
7713528|NCT00490919|12136042|FG001|Double-blind Phase|Adverse Event|40
7713529|NCT00490919|12136043|FG002|Double-blind Phase|Adverse Event|20
7713530|NCT00490919|12136041|FG000|Double-blind Phase|Withdrawal by Subject|0
7713531|NCT00490919|12136042|FG001|Double-blind Phase|Withdrawal by Subject|10
7713532|NCT00490919|12136043|FG002|Double-blind Phase|Withdrawal by Subject|11
7713533|NCT00490919|12136041|FG000|Double-blind Phase|Lost to Follow-up|0
7713534|NCT00490919|12136042|FG001|Double-blind Phase|Lost to Follow-up|8
7713535|NCT00490919|12136043|FG002|Double-blind Phase|Lost to Follow-up|11
7713536|NCT00490919|12136041|FG000|Double-blind Phase|Lack of Efficacy|0
7713537|NCT00490919|12136042|FG001|Double-blind Phase|Lack of Efficacy|22
7713538|NCT00490919|12136043|FG002|Double-blind Phase|Lack of Efficacy|36
7713539|NCT00490919|12136041|FG000|Double-blind Phase|Administrative|0
7713540|NCT00490919|12136042|FG001|Double-blind Phase|Administrative|6
7713541|NCT00490919|12136043|FG002|Double-blind Phase|Administrative|6
7713542|NCT00490945|12136055|FG000|Overall Study|Adverse Event|0
7713543|NCT00490945|12136056|FG001|Overall Study|Adverse Event|1
7713544|NCT00490945|12136057|FG002|Overall Study|Adverse Event|0
7713545|NCT00490945|12136058|FG003|Overall Study|Adverse Event|0
7713546|NCT00490945|12136059|FG004|Overall Study|Adverse Event|0
7713547|NCT00490971|12136079|FG000|Acute/Continuation|Adverse Event|62
7713548|NCT00490971|12136080|FG001|Acute/Continuation|Adverse Event|13
7713549|NCT00490971|12136081|FG002|Acute/Continuation|Adverse Event|0
7713550|NCT00490971|12136082|FG003|Acute/Continuation|Adverse Event|0
7713551|NCT00490971|12136083|FG004|Acute/Continuation|Adverse Event|0
7713552|NCT00490971|12136079|FG000|Acute/Continuation|Death|2
7713553|NCT00490971|12136080|FG001|Acute/Continuation|Death|0
7713554|NCT00490971|12136081|FG002|Acute/Continuation|Death|0
7713555|NCT00490971|12136082|FG003|Acute/Continuation|Death|0
7713556|NCT00490971|12136083|FG004|Acute/Continuation|Death|0
7713557|NCT00490971|12136079|FG000|Acute/Continuation|Lack of Efficacy|106
7713558|NCT00490971|12136080|FG001|Acute/Continuation|Lack of Efficacy|12
7713559|NCT00490971|12136081|FG002|Acute/Continuation|Lack of Efficacy|0
7713560|NCT00490971|12136082|FG003|Acute/Continuation|Lack of Efficacy|0
7713561|NCT00490971|12136083|FG004|Acute/Continuation|Lack of Efficacy|0
7713562|NCT00490971|12136079|FG000|Acute/Continuation|Lost to Follow-up|23
7713563|NCT00490971|12136080|FG001|Acute/Continuation|Lost to Follow-up|7
7713564|NCT00490971|12136081|FG002|Acute/Continuation|Lost to Follow-up|0
7713565|NCT00490971|12136082|FG003|Acute/Continuation|Lost to Follow-up|0
7713566|NCT00490971|12136083|FG004|Acute/Continuation|Lost to Follow-up|0
7713567|NCT00490971|12136079|FG000|Acute/Continuation|Protocol Violation|10
7713568|NCT00490971|12136080|FG001|Acute/Continuation|Protocol Violation|2
7713569|NCT00490971|12136081|FG002|Acute/Continuation|Protocol Violation|0
7713570|NCT00490971|12136082|FG003|Acute/Continuation|Protocol Violation|0
7713571|NCT00490971|12136083|FG004|Acute/Continuation|Protocol Violation|0
7713572|NCT00490971|12136079|FG000|Acute/Continuation|Withdrawal by Subject|92
7713573|NCT00490971|12136080|FG001|Acute/Continuation|Withdrawal by Subject|24
7713574|NCT00490971|12136081|FG002|Acute/Continuation|Withdrawal by Subject|0
7713575|NCT00490971|12136082|FG003|Acute/Continuation|Withdrawal by Subject|0
7713576|NCT00490971|12136083|FG004|Acute/Continuation|Withdrawal by Subject|0
7713577|NCT00490971|12136079|FG000|Acute/Continuation|Other|11
7713578|NCT00490971|12136080|FG001|Acute/Continuation|Other|4
7713579|NCT00490971|12136081|FG002|Acute/Continuation|Other|0
7713580|NCT00490971|12136082|FG003|Acute/Continuation|Other|0
7713581|NCT00490971|12136083|FG004|Acute/Continuation|Other|0
7713582|NCT00490971|12136079|FG000|Maintenance|Adverse Event|0
7713583|NCT00490971|12136080|FG001|Maintenance|Adverse Event|0
7713584|NCT00490971|12136081|FG002|Maintenance|Adverse Event|4
7713585|NCT00490971|12136082|FG003|Maintenance|Adverse Event|5
7713586|NCT00490971|12136083|FG004|Maintenance|Adverse Event|7
7713587|NCT00490971|12136079|FG000|Maintenance|Death|0
7713588|NCT00490971|12136080|FG001|Maintenance|Death|0
7713589|NCT00490971|12136081|FG002|Maintenance|Death|0
7713590|NCT00490971|12136082|FG003|Maintenance|Death|2
7713591|NCT00490971|12136083|FG004|Maintenance|Death|0
7713592|NCT00490971|12136079|FG000|Maintenance|Lost to Follow-up|0
7713593|NCT00490971|12136080|FG001|Maintenance|Lost to Follow-up|0
7713594|NCT00490971|12136081|FG002|Maintenance|Lost to Follow-up|5
7713595|NCT00490971|12136082|FG003|Maintenance|Lost to Follow-up|8
7713596|NCT00490971|12136083|FG004|Maintenance|Lost to Follow-up|10
7713597|NCT00490971|12136079|FG000|Maintenance|Pregnancy|0
7713598|NCT00490971|12136080|FG001|Maintenance|Pregnancy|0
7713599|NCT00490971|12136081|FG002|Maintenance|Pregnancy|1
7713600|NCT00490971|12136082|FG003|Maintenance|Pregnancy|0
7713601|NCT00490971|12136083|FG004|Maintenance|Pregnancy|0
7713602|NCT00490971|12136079|FG000|Maintenance|Protocol Violation|0
7713603|NCT00490971|12136080|FG001|Maintenance|Protocol Violation|0
7713604|NCT00490971|12136081|FG002|Maintenance|Protocol Violation|4
7713605|NCT00490971|12136082|FG003|Maintenance|Protocol Violation|1
7713606|NCT00490971|12136083|FG004|Maintenance|Protocol Violation|1
7713607|NCT00490971|12136079|FG000|Maintenance|Withdrawal by Subject|0
7713608|NCT00490971|12136080|FG001|Maintenance|Withdrawal by Subject|0
7713609|NCT00490971|12136081|FG002|Maintenance|Withdrawal by Subject|26
7713610|NCT00490971|12136082|FG003|Maintenance|Withdrawal by Subject|28
7713611|NCT00490971|12136083|FG004|Maintenance|Withdrawal by Subject|18
7713612|NCT00490971|12136079|FG000|Maintenance|Other|0
7713613|NCT00490971|12136080|FG001|Maintenance|Other|0
7713614|NCT00490971|12136081|FG002|Maintenance|Other|11
7713615|NCT00490971|12136082|FG003|Maintenance|Other|9
7713616|NCT00490971|12136083|FG004|Maintenance|Other|3
7713617|NCT00491075|12136095|FG000|Overall Study|Withdrawal by Subject|1
7713618|NCT00491075|12136095|FG000|Overall Study|Physician Decision|1
7713619|NCT00491179|12136101|FG000|Overall Study|Adverse Event|5
7713620|NCT00491179|12136102|FG001|Overall Study|Adverse Event|1
7713621|NCT00491179|12136101|FG000|Overall Study|Withdrawal by Subject|2
7713622|NCT00491179|12136102|FG001|Overall Study|Withdrawal by Subject|1
7713623|NCT00491322|12136119|FG000|Overall Study|Protocol Violation|1
7713624|NCT00491322|12136120|FG001|Overall Study|Protocol Violation|0
7713625|NCT00491322|12136119|FG000|Overall Study|Pregnancy|0
7713626|NCT00491322|12136120|FG001|Overall Study|Pregnancy|1
7713627|NCT00491530|12136147|FG000|Overall Study|Adverse Event|6
7713628|NCT00491530|12136148|FG001|Overall Study|Adverse Event|1
7713629|NCT00491530|12136149|FG002|Overall Study|Adverse Event|2
7713630|NCT00491530|12136147|FG000|Overall Study|Withdrawal by Subject|3
7713631|NCT00491530|12136148|FG001|Overall Study|Withdrawal by Subject|0
7713632|NCT00491530|12136149|FG002|Overall Study|Withdrawal by Subject|0
7713633|NCT00491530|12136147|FG000|Overall Study|Lost to Follow-up|3
7713634|NCT00491530|12136148|FG001|Overall Study|Lost to Follow-up|2
7713635|NCT00491530|12136149|FG002|Overall Study|Lost to Follow-up|2
7713636|NCT00491530|12136147|FG000|Overall Study|Lack of Efficacy|0
7713637|NCT00491530|12136148|FG001|Overall Study|Lack of Efficacy|1
7713638|NCT00491530|12136149|FG002|Overall Study|Lack of Efficacy|0
7713639|NCT00491530|12136147|FG000|Overall Study|Investigator Discretion|0
7713640|NCT00491530|12136148|FG001|Overall Study|Investigator Discretion|1
7713641|NCT00491530|12136149|FG002|Overall Study|Investigator Discretion|0
7713642|NCT00491530|12136147|FG000|Overall Study|Patient Request|0
7713643|NCT00491530|12136148|FG001|Overall Study|Patient Request|1
7713644|NCT00491530|12136149|FG002|Overall Study|Patient Request|0
7713645|NCT00491530|12136147|FG000|Overall Study|Use of Prohibited Medication|0
7713646|NCT00491530|12136148|FG001|Overall Study|Use of Prohibited Medication|0
7713647|NCT00491530|12136149|FG002|Overall Study|Use of Prohibited Medication|1
7713648|NCT00491556|12136159|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
7713649|NCT00491556|12136160|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
7713650|NCT00491556|12136159|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
7713651|NCT00491556|12136160|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
7713652|NCT00491556|12136159|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
7713653|NCT00491556|12136160|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
7713654|NCT00491556|12136159|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
7713655|NCT00491556|12136160|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
7713656|NCT00491556|12136159|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
7713657|NCT00491556|12136160|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
7713658|NCT00491556|12136159|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
7713659|NCT00491556|12136160|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
7713660|NCT00491556|12136159|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
7713661|NCT00491556|12136160|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
7713662|NCT00491556|12136159|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
7713663|NCT00491556|12136160|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
7713664|NCT00491556|12136159|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3
7713665|NCT00491556|12136160|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0
7713666|NCT00491556|12136159|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
7713667|NCT00491556|12136160|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
7713668|NCT00491556|12136159|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
7713669|NCT00491556|12136160|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
7713670|NCT00491556|12136159|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
7713671|NCT00491556|12136160|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
7713672|NCT00491556|12136159|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
7713673|NCT00491556|12136160|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
7713674|NCT00491556|12136159|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
7713675|NCT00491556|12136160|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
7713676|NCT00491556|12136159|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
7713677|NCT00491556|12136160|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
7713678|NCT00491556|12136159|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
7713679|NCT00491556|12136160|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
7713680|NCT00491556|12136159|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
7713681|NCT00491556|12136160|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
7713682|NCT00491556|12136159|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2
7713683|NCT00491556|12136160|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0
7713684|NCT00491556|12136159|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
7713685|NCT00491556|12136160|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
7713686|NCT00491556|12136159|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
7713687|NCT00491556|12136160|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
7713688|NCT00491608|12136166|FG000|Overall Study|Death|2
7713689|NCT00491608|12136166|FG000|Overall Study|Withdrawal by Subject|1
7713690|NCT00491764|12136191|FG000|Overall Study|Adverse Event|1
7713691|NCT00491764|12136192|FG001|Overall Study|Adverse Event|2
7713692|NCT00491764|12136193|FG002|Overall Study|Adverse Event|4
7713693|NCT00491764|12136194|FG003|Overall Study|Adverse Event|4
7713694|NCT00491764|12136195|FG004|Overall Study|Adverse Event|0
7713695|NCT00491764|12136196|FG005|Overall Study|Adverse Event|1
7713696|NCT00491764|12136191|FG000|Overall Study|Lost to Follow-up|0
7713697|NCT00491764|12136192|FG001|Overall Study|Lost to Follow-up|1
7713698|NCT00491764|12136193|FG002|Overall Study|Lost to Follow-up|0
7713699|NCT00491764|12136194|FG003|Overall Study|Lost to Follow-up|1
7713700|NCT00491764|12136195|FG004|Overall Study|Lost to Follow-up|0
7713701|NCT00491764|12136196|FG005|Overall Study|Lost to Follow-up|3
7713702|NCT00491764|12136191|FG000|Overall Study|Withdrawal by Subject|2
7713703|NCT00491764|12136192|FG001|Overall Study|Withdrawal by Subject|3
7713704|NCT00491764|12136193|FG002|Overall Study|Withdrawal by Subject|1
7713705|NCT00491764|12136194|FG003|Overall Study|Withdrawal by Subject|2
7713706|NCT00491764|12136195|FG004|Overall Study|Withdrawal by Subject|2
7713707|NCT00491764|12136196|FG005|Overall Study|Withdrawal by Subject|4
7713708|NCT00491764|12136191|FG000|Overall Study|Non Compliance with the Protocol|1
7713709|NCT00491764|12136192|FG001|Overall Study|Non Compliance with the Protocol|0
7713710|NCT00491764|12136193|FG002|Overall Study|Non Compliance with the Protocol|0
7713711|NCT00491764|12136194|FG003|Overall Study|Non Compliance with the Protocol|0
7713712|NCT00491764|12136195|FG004|Overall Study|Non Compliance with the Protocol|0
7713713|NCT00491764|12136196|FG005|Overall Study|Non Compliance with the Protocol|0
7713714|NCT00491764|12136191|FG000|Overall Study|Did not Meet Protocol Eligibility|0
7713715|NCT00491764|12136192|FG001|Overall Study|Did not Meet Protocol Eligibility|1
7713716|NCT00491764|12136193|FG002|Overall Study|Did not Meet Protocol Eligibility|1
7713717|NCT00491764|12136194|FG003|Overall Study|Did not Meet Protocol Eligibility|0
7713718|NCT00491764|12136195|FG004|Overall Study|Did not Meet Protocol Eligibility|1
7713719|NCT00491764|12136196|FG005|Overall Study|Did not Meet Protocol Eligibility|1
7713720|NCT00491764|12136191|FG000|Overall Study|Administrative|1
7713721|NCT00491764|12136192|FG001|Overall Study|Administrative|0
7713722|NCT00491764|12136193|FG002|Overall Study|Administrative|2
7713723|NCT00491764|12136194|FG003|Overall Study|Administrative|1
7713724|NCT00491764|12136195|FG004|Overall Study|Administrative|0
7713725|NCT00491764|12136196|FG005|Overall Study|Administrative|0
7713726|NCT00491894|12136223|FG000|Overall Study|Adverse Event|14
7713727|NCT00491894|12136223|FG000|Overall Study|Withdrawal by Subject|5
7713728|NCT00491894|12136223|FG000|Overall Study|Death|3
7713729|NCT00491894|12136223|FG000|Overall Study|Lost to Follow-up|3
7713730|NCT00491894|12136223|FG000|Overall Study|Lack of Efficacy|2
7713731|NCT00491894|12136223|FG000|Overall Study|Other-Failed to meet any criteria|2
7713732|NCT00491894|12136223|FG000|Overall Study|Physician Decision|2
7713733|NCT00491894|12136223|FG000|Overall Study|Protocol Violation|2
7713734|NCT00491894|12136223|FG000|Overall Study|Other-Intake of prohibited medication|1
7713735|NCT00492024|12136229|FG000|Treatment|Adverse Event|3
7713736|NCT00492024|12136230|FG001|Treatment|Adverse Event|1
7713737|NCT00492024|12136229|FG000|Treatment|Lack of Efficacy|21
7713738|NCT00492024|12136230|FG001|Treatment|Lack of Efficacy|20
7713739|NCT00492024|12136229|FG000|Treatment|Lost to Follow-up|3
7713740|NCT00492024|12136230|FG001|Treatment|Lost to Follow-up|1
7713741|NCT00492024|12136229|FG000|Treatment|Withdrawal by Subject|2
7713742|NCT00492024|12136230|FG001|Treatment|Withdrawal by Subject|0
7713743|NCT00492024|12136229|FG000|Follow up|Lack of Efficacy|0
7713744|NCT00492024|12136230|FG001|Follow up|Lack of Efficacy|1
7713745|NCT00492024|12136229|FG000|Follow up|Lost to Follow-up|1
7713746|NCT00492024|12136230|FG001|Follow up|Lost to Follow-up|1
7713747|NCT00492063|12136240|FG000|Overall Study|Death|0
7713748|NCT00492063|12136241|FG001|Overall Study|Death|0
7713749|NCT00492063|12136242|FG002|Overall Study|Death|1
7713750|NCT00492063|12136243|FG003|Overall Study|Death|2
7713751|NCT00492063|12136240|FG000|Overall Study|Withdrawal by Subject|4
7713752|NCT00492063|12136241|FG001|Overall Study|Withdrawal by Subject|3
7713753|NCT00492063|12136242|FG002|Overall Study|Withdrawal by Subject|5
7713754|NCT00492063|12136243|FG003|Overall Study|Withdrawal by Subject|4
7713755|NCT00492063|12136240|FG000|Overall Study|Lost to Follow-up|6
7713756|NCT00492063|12136241|FG001|Overall Study|Lost to Follow-up|11
7713757|NCT00492063|12136242|FG002|Overall Study|Lost to Follow-up|5
7713758|NCT00492063|12136243|FG003|Overall Study|Lost to Follow-up|3
7713759|NCT00492063|12136240|FG000|Overall Study|Protocol Violation|0
7713760|NCT00492063|12136241|FG001|Overall Study|Protocol Violation|0
7713761|NCT00492063|12136242|FG002|Overall Study|Protocol Violation|0
7713762|NCT00492063|12136243|FG003|Overall Study|Protocol Violation|1
7713763|NCT00492115|12136264|FG000|Overall Study|Withdrawal by Subject|3
7713764|NCT00492115|12136265|FG001|Overall Study|Withdrawal by Subject|4
7713765|NCT00492232|12136279|FG000|Placebo Run-in|Adverse Event|0
7713766|NCT00492232|12136280|FG001|Placebo Run-in|Adverse Event|2
7713767|NCT00492232|12136279|FG000|Placebo Run-in|Protocol Violation|0
7713768|NCT00492232|12136280|FG001|Placebo Run-in|Protocol Violation|3
7713769|NCT00492232|12136279|FG000|Placebo Run-in|Lost to Follow-up|0
7713770|NCT00492232|12136280|FG001|Placebo Run-in|Lost to Follow-up|3
7713771|NCT00492232|12136279|FG000|Placebo Run-in|Withdrawal by Subject|0
7713772|NCT00492232|12136280|FG001|Placebo Run-in|Withdrawal by Subject|8
7713773|NCT00492232|12136279|FG000|Placebo Run-in|Pregnancy|0
7713774|NCT00492232|12136280|FG001|Placebo Run-in|Pregnancy|1
7713775|NCT00492232|12136279|FG000|Placebo Run-in|Entrance criteria not met|0
7713776|NCT00492232|12136280|FG001|Placebo Run-in|Entrance criteria not met|45
7713777|NCT00492232|12136279|FG000|Placebo Run-in|Other|0
7713778|NCT00492232|12136280|FG001|Placebo Run-in|Other|6
7713779|NCT00492232|12136279|FG000|Placebo Run-in|Missing|0
7713780|NCT00492232|12136280|FG001|Placebo Run-in|Missing|2
7713781|NCT00492232|12136279|FG000|Double-Blind Treatment|Adverse Event|1
7713782|NCT00492232|12136280|FG001|Double-Blind Treatment|Adverse Event|2
7713783|NCT00492232|12136279|FG000|Double-Blind Treatment|Protocol Violation|3
7713784|NCT00492232|12136280|FG001|Double-Blind Treatment|Protocol Violation|7
7713785|NCT00492232|12136279|FG000|Double-Blind Treatment|Lost to Follow-up|2
7713786|NCT00492232|12136280|FG001|Double-Blind Treatment|Lost to Follow-up|3
7713787|NCT00492232|12136279|FG000|Double-Blind Treatment|Withdrawal by Subject|4
7713788|NCT00492232|12136280|FG001|Double-Blind Treatment|Withdrawal by Subject|8
7713789|NCT00492232|12136279|FG000|Double-Blind Treatment|Lack of Efficacy|1
7713790|NCT00492232|12136280|FG001|Double-Blind Treatment|Lack of Efficacy|0
7713791|NCT00492232|12136279|FG000|Double-Blind Treatment|Other|6
7713792|NCT00492232|12136280|FG001|Double-Blind Treatment|Other|5
7713793|NCT00492232|12136279|FG000|Double-Blind Treatment|Randomized not treated|1
7713794|NCT00492232|12136280|FG001|Double-Blind Treatment|Randomized not treated|0
7713795|NCT00492232|12136279|FG000|Open-Label Treatment|Withdrawal by Subject|1
7713796|NCT00492232|12136280|FG001|Open-Label Treatment|Withdrawal by Subject|0
7713797|NCT00492284|12136290|FG000|Overall Study|Adverse Event|0
7713798|NCT00492284|12136291|FG001|Overall Study|Adverse Event|1
7713799|NCT00492284|12136292|FG002|Overall Study|Adverse Event|1
7713800|NCT00492284|12136293|FG003|Overall Study|Adverse Event|2
7713801|NCT00492284|12136290|FG000|Overall Study|Lost to Follow-up|0
7713802|NCT00492284|12136291|FG001|Overall Study|Lost to Follow-up|0
7713803|NCT00492284|12136292|FG002|Overall Study|Lost to Follow-up|3
7713804|NCT00492284|12136293|FG003|Overall Study|Lost to Follow-up|1
7713805|NCT00492284|12136290|FG000|Overall Study|Death|0
7713806|NCT00492284|12136291|FG001|Overall Study|Death|3
7713807|NCT00492284|12136292|FG002|Overall Study|Death|2
7713808|NCT00492284|12136293|FG003|Overall Study|Death|5
7713809|NCT00492284|12136290|FG000|Overall Study|Withdrawal by Subject|1
7713810|NCT00492284|12136291|FG001|Overall Study|Withdrawal by Subject|0
7713811|NCT00492284|12136292|FG002|Overall Study|Withdrawal by Subject|0
7713812|NCT00492284|12136293|FG003|Overall Study|Withdrawal by Subject|2
7713813|NCT00492297|12136303|FG000|Treatment|Death|2
7713814|NCT00492297|12136303|FG000|Treatment|Study terminated by sponsor|3
7713815|NCT00492297|12136303|FG000|Active Follow-up 30(+4) Days Duration|Death|17
7713816|NCT00492297|12136303|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
7713817|NCT00492297|12136303|FG000|Survival Only Follow-up|Death|46
7713818|NCT00492297|12136303|FG000|Survival Only Follow-up|Lack of Efficacy|1
7713819|NCT00492297|12136303|FG000|Survival Only Follow-up|Study terminated by sponsor|12
7713820|NCT00492531|12136324|FG000|Overall Study|Withdrawn(More than one reason selected)|22
7713821|NCT00492531|12136325|FG001|Overall Study|Withdrawn(More than one reason selected)|23
7713822|NCT00492557|12136337|FG000|Overall Study|Subject request|12
7713823|NCT00492557|12136338|FG001|Overall Study|Subject request|11
7713824|NCT00492557|12136337|FG000|Overall Study|Protocol Violation|7
7713825|NCT00492557|12136338|FG001|Overall Study|Protocol Violation|8
7713826|NCT00492557|12136337|FG000|Overall Study|Other|2
7713827|NCT00492557|12136338|FG001|Overall Study|Other|2
7713828|NCT00492557|12136337|FG000|Overall Study|Death|1
7713829|NCT00492557|12136338|FG001|Overall Study|Death|1
7713830|NCT00492557|12136337|FG000|Overall Study|Adverse Event|1
7713831|NCT00492557|12136338|FG001|Overall Study|Adverse Event|0
7713832|NCT00492557|12136337|FG000|Overall Study|Failed to return|1
7713833|NCT00492557|12136338|FG001|Overall Study|Failed to return|0
7713834|NCT00492557|12136337|FG000|Overall Study|Lost to Follow-up|0
7713835|NCT00492557|12136338|FG001|Overall Study|Lost to Follow-up|1
7713836|NCT00492648|12136366|FG000|Month 30 (109671 Study)|Protocol Violation|0
7713837|NCT00492648|12136367|FG001|Month 30 (109671 Study)|Protocol Violation|1
7713838|NCT00492726|12136375|FG000|Overall Study|Adverse Event|10
7713839|NCT00492726|12136376|FG001|Overall Study|Adverse Event|6
7713840|NCT00492726|12136375|FG000|Overall Study|Death|7
7713841|NCT00492726|12136376|FG001|Overall Study|Death|2
7713842|NCT00492726|12136375|FG000|Overall Study|Lack of Efficacy|0
7713843|NCT00492726|12136376|FG001|Overall Study|Lack of Efficacy|2
7713844|NCT00492726|12136375|FG000|Overall Study|Lost to Follow-up|27
7713845|NCT00492726|12136376|FG001|Overall Study|Lost to Follow-up|19
7713846|NCT00492726|12136375|FG000|Overall Study|Physician Decision|0
7713847|NCT00492726|12136376|FG001|Overall Study|Physician Decision|1
7713848|NCT00492726|12136375|FG000|Overall Study|Withdrawal by Subject|6
7713849|NCT00492726|12136376|FG001|Overall Study|Withdrawal by Subject|3
7713850|NCT00492726|12136375|FG000|Overall Study|Non compliant with study medication|0
7713851|NCT00492726|12136376|FG001|Overall Study|Non compliant with study medication|3
7713852|NCT00492752|12136384|FG000|Double Blind Treatment|Death|13
7713853|NCT00492752|12136385|FG001|Double Blind Treatment|Death|0
7713854|NCT00492752|12136386|FG002|Double Blind Treatment|Death|2
7713855|NCT00492752|12136387|FG003|Double Blind Treatment|Death|0
7713856|NCT00492752|12136384|FG000|Double Blind Treatment|Adverse Event|1
7713857|NCT00492752|12136385|FG001|Double Blind Treatment|Adverse Event|0
7713858|NCT00492752|12136386|FG002|Double Blind Treatment|Adverse Event|0
7713859|NCT00492752|12136387|FG003|Double Blind Treatment|Adverse Event|0
7713860|NCT00492752|12136384|FG000|Double Blind Treatment|Protocol Violation|0
7713861|NCT00492752|12136385|FG001|Double Blind Treatment|Protocol Violation|0
7713862|NCT00492752|12136386|FG002|Double Blind Treatment|Protocol Violation|1
7713863|NCT00492752|12136387|FG003|Double Blind Treatment|Protocol Violation|0
7713864|NCT00492752|12136384|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0
7713865|NCT00492752|12136385|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2
7713866|NCT00492752|12136386|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0
7713867|NCT00492752|12136387|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2
7713868|NCT00492752|12136384|FG000|Follow-up and/or Open Label Sorafenib|Death|75
7713869|NCT00492752|12136385|FG001|Follow-up and/or Open Label Sorafenib|Death|5
7713870|NCT00492752|12136386|FG002|Follow-up and/or Open Label Sorafenib|Death|45
7713871|NCT00492752|12136387|FG003|Follow-up and/or Open Label Sorafenib|Death|1
7713872|NCT00492752|12136384|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
7713873|NCT00492752|12136385|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
7713874|NCT00492752|12136386|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
7713875|NCT00492752|12136387|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
7713956|NCT00493038|12136440|FG001|Treatment|Other|1
7713876|NCT00492752|12136384|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
7713877|NCT00492752|12136385|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
7713878|NCT00492752|12136386|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
7713879|NCT00492752|12136387|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
7713880|NCT00492752|12136384|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
7713881|NCT00492752|12136385|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
7713882|NCT00492752|12136386|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
7713883|NCT00492752|12136387|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
7713884|NCT00492752|12136384|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
7713885|NCT00492752|12136385|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
7713886|NCT00492752|12136386|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
7713887|NCT00492752|12136387|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
7713888|NCT00492752|12136384|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
7713889|NCT00492752|12136385|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
7713890|NCT00492752|12136386|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
7713891|NCT00492752|12136387|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
7713892|NCT00492752|12136384|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
7713893|NCT00492752|12136385|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
7713894|NCT00492752|12136386|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
7713895|NCT00492752|12136387|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
7713896|NCT00492856|12136394|FG000|Induction|Adverse Event|2
7713897|NCT00492856|12136395|FG001|Induction|Adverse Event|0
7713898|NCT00492856|12136396|FG002|Induction|Adverse Event|0
7713899|NCT00492856|12136397|FG003|Induction|Adverse Event|0
7713900|NCT00492856|12136394|FG000|Induction|Withdrawal by Subject|1
7713901|NCT00492856|12136395|FG001|Induction|Withdrawal by Subject|0
7713902|NCT00492856|12136396|FG002|Induction|Withdrawal by Subject|0
7713903|NCT00492856|12136397|FG003|Induction|Withdrawal by Subject|0
7713904|NCT00492856|12136394|FG000|Induction|Death|3
7713905|NCT00492856|12136395|FG001|Induction|Death|0
7713906|NCT00492856|12136396|FG002|Induction|Death|0
7713907|NCT00492856|12136397|FG003|Induction|Death|0
7713908|NCT00492856|12136394|FG000|Consolidation|Adverse Event|6
7713909|NCT00492856|12136395|FG001|Consolidation|Adverse Event|0
7713910|NCT00492856|12136396|FG002|Consolidation|Adverse Event|0
7713911|NCT00492856|12136397|FG003|Consolidation|Adverse Event|0
7713912|NCT00492856|12136394|FG000|Consolidation|Not protocol specified|2
7713913|NCT00492856|12136395|FG001|Consolidation|Not protocol specified|0
7713914|NCT00492856|12136396|FG002|Consolidation|Not protocol specified|0
7713915|NCT00492856|12136397|FG003|Consolidation|Not protocol specified|0
7713916|NCT00492856|12136394|FG000|Consolidation|Lost to Follow-up|1
7713917|NCT00492856|12136395|FG001|Consolidation|Lost to Follow-up|0
7713918|NCT00492856|12136396|FG002|Consolidation|Lost to Follow-up|0
7713919|NCT00492856|12136397|FG003|Consolidation|Lost to Follow-up|0
7713920|NCT00492856|12136394|FG000|Post-consolidation|Adverse Event|0
7713921|NCT00492856|12136395|FG001|Post-consolidation|Adverse Event|4
7713922|NCT00492856|12136396|FG002|Post-consolidation|Adverse Event|0
7713923|NCT00492856|12136397|FG003|Post-consolidation|Adverse Event|1
7713924|NCT00492856|12136394|FG000|Post-consolidation|Withdrawal by Subject|0
7713925|NCT00492856|12136395|FG001|Post-consolidation|Withdrawal by Subject|4
7713926|NCT00492856|12136396|FG002|Post-consolidation|Withdrawal by Subject|0
7713927|NCT00492856|12136397|FG003|Post-consolidation|Withdrawal by Subject|0
7713928|NCT00492856|12136394|FG000|Post-consolidation|Death|0
7713929|NCT00492856|12136395|FG001|Post-consolidation|Death|1
7713930|NCT00492856|12136396|FG002|Post-consolidation|Death|0
7713931|NCT00492856|12136397|FG003|Post-consolidation|Death|0
7713932|NCT00492856|12136394|FG000|Post-consolidation|Not protocol specified|0
7713933|NCT00492856|12136395|FG001|Post-consolidation|Not protocol specified|1
7713934|NCT00492856|12136396|FG002|Post-consolidation|Not protocol specified|0
7713935|NCT00492856|12136397|FG003|Post-consolidation|Not protocol specified|0
7713936|NCT00492856|12136394|FG000|Post-consolidation|Lost to Follow-up|0
7713937|NCT00492856|12136395|FG001|Post-consolidation|Lost to Follow-up|2
7713938|NCT00492856|12136396|FG002|Post-consolidation|Lost to Follow-up|0
7713939|NCT00492856|12136397|FG003|Post-consolidation|Lost to Follow-up|0
7713940|NCT00492856|12136394|FG000|Post-consolidation|Observation Arm|0
7713941|NCT00492856|12136395|FG001|Post-consolidation|Observation Arm|0
7713942|NCT00492856|12136396|FG002|Post-consolidation|Observation Arm|27
7713943|NCT00492856|12136397|FG003|Post-consolidation|Observation Arm|0
7713944|NCT00492921|12136409|FG000|Overall Study|Death|1
7713945|NCT00492921|12136410|FG001|Overall Study|Death|0
7713946|NCT00492921|12136411|FG002|Overall Study|Death|1
7713947|NCT00493012|12136430|FG000|Overall Study|Lost to Follow-up|18
7713948|NCT00493012|12136431|FG001|Overall Study|Lost to Follow-up|17
7713949|NCT00493038|12136439|FG000|Treatment|Adverse Event|8
7713950|NCT00493038|12136440|FG001|Treatment|Adverse Event|4
7713951|NCT00493038|12136439|FG000|Treatment|Lost to Follow-up|5
7713952|NCT00493038|12136440|FG001|Treatment|Lost to Follow-up|3
7713953|NCT00493038|12136439|FG000|Treatment|Withdrawal by Subject|11
7713954|NCT00493038|12136440|FG001|Treatment|Withdrawal by Subject|12
7713955|NCT00493038|12136439|FG000|Treatment|Other|0
7713957|NCT00493038|12136439|FG000|Follow-up|Lost to Follow-up|1
7713958|NCT00493038|12136440|FG001|Follow-up|Lost to Follow-up|0
7713959|NCT00493220|12136460|FG000|Third Intervention|Withdrawal by Subject|1
7713960|NCT00493220|12136461|FG001|Third Intervention|Withdrawal by Subject|0
7713961|NCT00493220|12136462|FG002|Third Intervention|Withdrawal by Subject|0
7713962|NCT00493220|12136463|FG003|Third Intervention|Withdrawal by Subject|0
7713963|NCT00493220|12136464|FG004|Third Intervention|Withdrawal by Subject|0
7713964|NCT00493220|12136465|FG005|Third Intervention|Withdrawal by Subject|0
7713965|NCT00493246|12136483|FG000|Overall Study|Withdrawal by Subject|0
7713966|NCT00493246|12136484|FG001|Overall Study|Withdrawal by Subject|0
7713967|NCT00493246|12136485|FG002|Overall Study|Withdrawal by Subject|0
7713968|NCT00493246|12136486|FG003|Overall Study|Withdrawal by Subject|0
7713969|NCT00493246|12136487|FG004|Overall Study|Withdrawal by Subject|1
7713970|NCT00493246|12136488|FG005|Overall Study|Withdrawal by Subject|0
7713971|NCT00493246|12136489|FG006|Overall Study|Withdrawal by Subject|0
7713972|NCT00493246|12136490|FG007|Overall Study|Withdrawal by Subject|0
7713973|NCT00493246|12136483|FG000|Overall Study|No access to draw blood|0
7713974|NCT00493246|12136484|FG001|Overall Study|No access to draw blood|0
7713975|NCT00493246|12136485|FG002|Overall Study|No access to draw blood|0
7713976|NCT00493246|12136486|FG003|Overall Study|No access to draw blood|0
7713977|NCT00493246|12136487|FG004|Overall Study|No access to draw blood|0
7713978|NCT00493246|12136488|FG005|Overall Study|No access to draw blood|1
7713979|NCT00493246|12136489|FG006|Overall Study|No access to draw blood|0
7713980|NCT00493246|12136490|FG007|Overall Study|No access to draw blood|0
7713981|NCT00493246|12136483|FG000|Overall Study|Lost to Follow-up|0
7713982|NCT00493246|12136484|FG001|Overall Study|Lost to Follow-up|0
7713983|NCT00493246|12136485|FG002|Overall Study|Lost to Follow-up|0
7713984|NCT00493246|12136486|FG003|Overall Study|Lost to Follow-up|0
7713985|NCT00493246|12136487|FG004|Overall Study|Lost to Follow-up|0
7713986|NCT00493246|12136488|FG005|Overall Study|Lost to Follow-up|0
7713987|NCT00493246|12136489|FG006|Overall Study|Lost to Follow-up|1
7713988|NCT00493246|12136490|FG007|Overall Study|Lost to Follow-up|0
7713989|NCT00493285|12136514|FG000|Overall Study|Lost to Follow-up|0
7713990|NCT00493285|12136515|FG001|Overall Study|Lost to Follow-up|0
7713991|NCT00493285|12136516|FG002|Overall Study|Lost to Follow-up|0
7713992|NCT00493285|12136517|FG003|Overall Study|Lost to Follow-up|0
7713993|NCT00493285|12136518|FG004|Overall Study|Lost to Follow-up|1
7713994|NCT00493285|12136519|FG005|Overall Study|Lost to Follow-up|0
7713995|NCT00493311|12136535|FG000|Overall Study|Need for rescue medication|2
7713996|NCT00493311|12136536|FG001|Overall Study|Need for rescue medication|2
7713997|NCT00493454|12136542|FG000|Overall Study|Withdrawal by Subject|1
7713998|NCT00493636|12136548|FG000|Overall Study|Withdrawal by Subject|1
7713999|NCT00493636|12136549|FG001|Overall Study|Withdrawal by Subject|0
7714000|NCT00493636|12136548|FG000|Overall Study|Disease progression/recurrence/relapse|0
7714001|NCT00493636|12136549|FG001|Overall Study|Disease progression/recurrence/relapse|1
7714002|NCT00493636|12136548|FG000|Overall Study|Mis-randomization|1
7714003|NCT00493636|12136549|FG001|Overall Study|Mis-randomization|1
7714004|NCT00493649|12136555|FG000|Overall Study|Adverse Event|44
7714005|NCT00493649|12136555|FG000|Overall Study|Patient Request|21
7714006|NCT00493649|12136555|FG000|Overall Study|Investigator Request|2
7714007|NCT00493649|12136555|FG000|Overall Study|Disease Progression|1
7714008|NCT00493649|12136555|FG000|Overall Study|Lost to Follow-up|1
7714009|NCT00493649|12136555|FG000|Overall Study|Other|13
7714010|NCT00493779|12136562|FG000|Overall Study|Logistical issue at site|1
7714011|NCT00493974|12136576|FG000|Overall Study|Death|1
7714012|NCT00493974|12136577|FG001|Overall Study|Death|2
7714013|NCT00493974|12136576|FG000|Overall Study|Withdrawal by Subject|8
7714014|NCT00493974|12136577|FG001|Overall Study|Withdrawal by Subject|6
7714015|NCT00493974|12136576|FG000|Overall Study|Lost to Follow-up|4
7714016|NCT00493974|12136577|FG001|Overall Study|Lost to Follow-up|6
7714017|NCT00494013|12136585|FG000|Overall Study|Adverse Event|0
7714018|NCT00494013|12136586|FG001|Overall Study|Adverse Event|1
7714019|NCT00494013|12136585|FG000|Overall Study|Entry Criteria Not Met|1
7714020|NCT00494013|12136586|FG001|Overall Study|Entry Criteria Not Met|4
7714021|NCT00494013|12136585|FG000|Overall Study|Lost to Follow-up|5
7714022|NCT00494013|12136586|FG001|Overall Study|Lost to Follow-up|6
7714023|NCT00494013|12136585|FG000|Overall Study|Physician Decision|3
7714024|NCT00494013|12136586|FG001|Overall Study|Physician Decision|5
7714025|NCT00494013|12136585|FG000|Overall Study|Protocol Violation|8
7714026|NCT00494013|12136586|FG001|Overall Study|Protocol Violation|5
7714027|NCT00494013|12136585|FG000|Overall Study|Withdrawal by Subject|13
7714028|NCT00494013|12136586|FG001|Overall Study|Withdrawal by Subject|14
7714029|NCT00494013|12136585|FG000|Overall Study|Sponsor Decision|0
7714030|NCT00494013|12136586|FG001|Overall Study|Sponsor Decision|1
7714031|NCT00494026|12136592|FG000|Overall Study|Sponsor Decision|4
7714032|NCT00494091|12136598|FG000|Overall Study|Death|5
7714033|NCT00494091|12136599|FG001|Overall Study|Death|54
7714034|NCT00494091|12136598|FG000|Overall Study|Lost to Follow-up|0
7714035|NCT00494091|12136599|FG001|Overall Study|Lost to Follow-up|4
7714036|NCT00494091|12136598|FG000|Overall Study|Other|1
7714037|NCT00494091|12136599|FG001|Overall Study|Other|11
7714038|NCT00494091|12136598|FG000|Overall Study|Withdrawal by Subject|0
7714039|NCT00494091|12136599|FG001|Overall Study|Withdrawal by Subject|7
7714040|NCT00494221|12136626|FG000|Overall Study|Death|15
7714041|NCT00494221|12136627|FG001|Overall Study|Death|9
7714042|NCT00494221|12136628|FG002|Overall Study|Death|14
7714043|NCT00494221|12136626|FG000|Overall Study|Withdrawal by Subject|1
7714044|NCT00494221|12136627|FG001|Overall Study|Withdrawal by Subject|2
7714045|NCT00494221|12136628|FG002|Overall Study|Withdrawal by Subject|0
7714046|NCT00494299|12136638|FG000|Overall Study|Adverse Event|93
7714047|NCT00494299|12136639|FG001|Overall Study|Adverse Event|13
7714048|NCT00494299|12136638|FG000|Overall Study|Lost to Follow-up|1
7714049|NCT00494299|12136639|FG001|Overall Study|Lost to Follow-up|0
7714050|NCT00494299|12136638|FG000|Overall Study|Physician Decision|0
7714051|NCT00494299|12136639|FG001|Overall Study|Physician Decision|2
7714052|NCT00494299|12136638|FG000|Overall Study|Protocol Violation|1
7714053|NCT00494299|12136639|FG001|Overall Study|Protocol Violation|2
7714054|NCT00494299|12136638|FG000|Overall Study|Withdrawal by Subject|8
7714055|NCT00494299|12136639|FG001|Overall Study|Withdrawal by Subject|3
7714056|NCT00494299|12136638|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109
7714057|NCT00494299|12136639|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185
7714058|NCT00494299|12136638|FG000|Overall Study|Participant Did Not Take Study Drug|0
7714059|NCT00494299|12136639|FG001|Overall Study|Participant Did Not Take Study Drug|2
7714060|NCT00494299|12136638|FG000|Overall Study|Site Closed by Sponsor|6
7714061|NCT00494299|12136639|FG001|Overall Study|Site Closed by Sponsor|0
7714062|NCT00494299|12136638|FG000|Overall Study|Protocol Driven Decision Point|11
7714063|NCT00494299|12136639|FG001|Overall Study|Protocol Driven Decision Point|22
7714064|NCT00494442|12136647|FG000|Overall Study|Death|1
7714065|NCT00494442|12136648|FG001|Overall Study|Death|1
7714066|NCT00494442|12136647|FG000|Overall Study|Lack of Efficacy|16
7714067|NCT00494442|12136648|FG001|Overall Study|Lack of Efficacy|10
7714068|NCT00494442|12136647|FG000|Overall Study|Adverse Event|0
7714069|NCT00494442|12136648|FG001|Overall Study|Adverse Event|2
7714070|NCT00494442|12136647|FG000|Overall Study|Physician Decision|0
7714071|NCT00494442|12136648|FG001|Overall Study|Physician Decision|1
7714072|NCT00494442|12136647|FG000|Overall Study|Non-compliance|0
7714073|NCT00494442|12136648|FG001|Overall Study|Non-compliance|1
7714074|NCT00494442|12136647|FG000|Overall Study|Intercurrent illness|0
7714075|NCT00494442|12136648|FG001|Overall Study|Intercurrent illness|1
7714076|NCT00494481|12136656|FG000|Overall Study|Condition under investigation worsened|11
7714077|NCT00494481|12136657|FG001|Overall Study|Condition under investigation worsened|13
7714078|NCT00494481|12136656|FG000|Overall Study|Adverse Event|15
7714079|NCT00494481|12136657|FG001|Overall Study|Adverse Event|11
7714080|NCT00494481|12136656|FG000|Overall Study|Other|1
7714081|NCT00494481|12136657|FG001|Overall Study|Other|0
7714082|NCT00494481|12136656|FG000|Overall Study|Never received IP|2
7714083|NCT00494481|12136657|FG001|Overall Study|Never received IP|0
7714084|NCT00494507|12136676|FG000|Double-Blind Phase|Adverse Event|2
7714085|NCT00494507|12136677|FG001|Double-Blind Phase|Adverse Event|0
7714086|NCT00494507|12136678|FG002|Double-Blind Phase|Adverse Event|1
7714087|NCT00494507|12136679|FG003|Double-Blind Phase|Adverse Event|0
7714088|NCT00494507|12136676|FG000|Double-Blind Phase|Withdrawal by Subject|1
7714089|NCT00494507|12136677|FG001|Double-Blind Phase|Withdrawal by Subject|0
7714090|NCT00494507|12136678|FG002|Double-Blind Phase|Withdrawal by Subject|0
7714091|NCT00494507|12136679|FG003|Double-Blind Phase|Withdrawal by Subject|0
7714092|NCT00494507|12136676|FG000|Double-Blind Phase|Subject Non-compliance|0
7714093|NCT00494507|12136677|FG001|Double-Blind Phase|Subject Non-compliance|0
7714094|NCT00494507|12136678|FG002|Double-Blind Phase|Subject Non-compliance|1
7714095|NCT00494507|12136679|FG003|Double-Blind Phase|Subject Non-compliance|0
7714096|NCT00494507|12136676|FG000|Double-Blind Phase|Negative DNA test|0
7714097|NCT00494507|12136677|FG001|Double-Blind Phase|Negative DNA test|0
7714098|NCT00494507|12136678|FG002|Double-Blind Phase|Negative DNA test|0
7714099|NCT00494507|12136679|FG003|Double-Blind Phase|Negative DNA test|1
7714100|NCT00494507|12136676|FG000|Open-Label Phase|Adverse Event|0
7714101|NCT00494507|12136677|FG001|Open-Label Phase|Adverse Event|1
7714102|NCT00494507|12136678|FG002|Open-Label Phase|Adverse Event|5
7714103|NCT00494507|12136679|FG003|Open-Label Phase|Adverse Event|3
7714104|NCT00494507|12136676|FG000|Open-Label Phase|Worsening Disease|0
7714105|NCT00494507|12136677|FG001|Open-Label Phase|Worsening Disease|0
7714106|NCT00494507|12136678|FG002|Open-Label Phase|Worsening Disease|0
7714107|NCT00494507|12136679|FG003|Open-Label Phase|Worsening Disease|2
7714108|NCT00494676|12136703|FG000|Allocation|Withdrawal by Subject|2
7714109|NCT00494676|12136704|FG001|Allocation|Withdrawal by Subject|4
7714110|NCT00494676|12136703|FG000|First Intervention|Withdrawal by Subject|1
7714111|NCT00494676|12136704|FG001|First Intervention|Withdrawal by Subject|3
7714112|NCT00494676|12136703|FG000|Second Intervention|Withdrawal by Subject|1
7714113|NCT00494676|12136704|FG001|Second Intervention|Withdrawal by Subject|1
7714114|NCT00494780|12136712|FG000|Overall Study|Adverse Event|1
7714115|NCT00494780|12136713|FG001|Overall Study|Adverse Event|0
7714116|NCT00494780|12136712|FG000|Overall Study|Withdrew before Dosed|0
7714117|NCT00494780|12136713|FG001|Overall Study|Withdrew before Dosed|1
7714118|NCT00494780|12136712|FG000|Overall Study|Progression of Study Disease|7
7714119|NCT00494780|12136713|FG001|Overall Study|Progression of Study Disease|8
7714120|NCT00494780|12136712|FG000|Overall Study|New Treatment|2
7714121|NCT00494780|12136713|FG001|Overall Study|New Treatment|2
7714122|NCT00494780|12136712|FG000|Overall Study|Non-compliance|1
7714123|NCT00494780|12136713|FG001|Overall Study|Non-compliance|0
7714124|NCT00494780|12136712|FG000|Overall Study|Residual Tumour Mass|0
7714125|NCT00494780|12136713|FG001|Overall Study|Residual Tumour Mass|1
7714126|NCT00494780|12136712|FG000|Overall Study|Insurance Issues|0
7714127|NCT00494780|12136713|FG001|Overall Study|Insurance Issues|1
7714128|NCT00494871|12136732|FG000|Double-blind (DB) Treatment Period|Adverse Event|73
7714129|NCT00494871|12136733|FG001|Double-blind (DB) Treatment Period|Adverse Event|70
7714130|NCT00494871|12136732|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
7714131|NCT00494871|12136733|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
7714132|NCT00494871|12136732|FG000|Double-blind (DB) Treatment Period|Death|8
7714133|NCT00494871|12136733|FG001|Double-blind (DB) Treatment Period|Death|3
7714134|NCT00494871|12136732|FG000|Double-blind (DB) Treatment Period|Physician Decision|4
7714135|NCT00494871|12136733|FG001|Double-blind (DB) Treatment Period|Physician Decision|13
7714136|NCT00494871|12136732|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4
7714137|NCT00494871|12136733|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1
7714138|NCT00494871|12136732|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9
7714139|NCT00494871|12136733|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9
7714140|NCT00494871|12136732|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
7714141|NCT00494871|12136733|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
7714142|NCT00494871|12136732|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
7714143|NCT00494871|12136733|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
7714144|NCT00494871|12136732|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
7714145|NCT00494871|12136733|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
7714146|NCT00494871|12136732|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
7714147|NCT00494871|12136733|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
7714148|NCT00494871|12136732|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
7714149|NCT00494871|12136733|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
7714150|NCT00494871|12136732|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
7714151|NCT00494871|12136733|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
7714152|NCT00494871|12136732|FG000|Follow-up (FU) Period|Adverse Event|1
7714153|NCT00494871|12136733|FG001|Follow-up (FU) Period|Adverse Event|1
7714154|NCT00494871|12136732|FG000|Follow-up (FU) Period|Death|13
7714155|NCT00494871|12136733|FG001|Follow-up (FU) Period|Death|12
7714156|NCT00494871|12136732|FG000|Follow-up (FU) Period|Lost to Follow-up|6
7714157|NCT00494871|12136733|FG001|Follow-up (FU) Period|Lost to Follow-up|2
7714158|NCT00494871|12136732|FG000|Follow-up (FU) Period|Physician Decision|0
7714159|NCT00494871|12136733|FG001|Follow-up (FU) Period|Physician Decision|1
7714160|NCT00494871|12136732|FG000|Follow-up (FU) Period|Protocol Violation|1
7714161|NCT00494871|12136733|FG001|Follow-up (FU) Period|Protocol Violation|0
7714162|NCT00494871|12136732|FG000|Follow-up (FU) Period|Withdrawal by Subject|5
7714163|NCT00494871|12136733|FG001|Follow-up (FU) Period|Withdrawal by Subject|5
7714164|NCT00494871|12136732|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3
7714165|NCT00494871|12136733|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2
7714166|NCT00495040|12136750|FG000|Overall Study|Withdrawal by Subject|3
7714167|NCT00495170|12136774|FG000|Overall Study|Lost to Follow-up|9
7714168|NCT00495170|12136774|FG000|Overall Study|Withdrawal by Subject|3
7714169|NCT00495170|12136774|FG000|Overall Study|Inappropriate staging|8
7714170|NCT00495391|12136780|FG000|Overall Study|Lack of Efficacy|34
7714171|NCT00495391|12136781|FG001|Overall Study|Lack of Efficacy|18
7714172|NCT00495391|12136780|FG000|Overall Study|Withdrawal by Subject|2
7714173|NCT00495391|12136781|FG001|Overall Study|Withdrawal by Subject|3
7714174|NCT00495469|12136794|FG000|Overall Study|Adverse Event|0
7714175|NCT00495469|12136795|FG001|Overall Study|Adverse Event|1
7714176|NCT00495469|12136796|FG002|Overall Study|Adverse Event|3
7714177|NCT00495469|12136797|FG003|Overall Study|Adverse Event|0
7714178|NCT00495469|12136798|FG004|Overall Study|Adverse Event|1
7714179|NCT00495469|12136799|FG005|Overall Study|Adverse Event|1
7714180|NCT00495469|12136800|FG006|Overall Study|Adverse Event|1
7714181|NCT00495469|12136794|FG000|Overall Study|Lost to Follow-up|1
7714182|NCT00495469|12136795|FG001|Overall Study|Lost to Follow-up|1
7714183|NCT00495469|12136796|FG002|Overall Study|Lost to Follow-up|3
7714184|NCT00495469|12136797|FG003|Overall Study|Lost to Follow-up|1
7714185|NCT00495469|12136798|FG004|Overall Study|Lost to Follow-up|0
7714186|NCT00495469|12136799|FG005|Overall Study|Lost to Follow-up|0
7714187|NCT00495469|12136800|FG006|Overall Study|Lost to Follow-up|0
7714188|NCT00495469|12136794|FG000|Overall Study|Protocol Violation|0
7714189|NCT00495469|12136795|FG001|Overall Study|Protocol Violation|0
7714190|NCT00495469|12136796|FG002|Overall Study|Protocol Violation|0
7714191|NCT00495469|12136797|FG003|Overall Study|Protocol Violation|0
7714192|NCT00495469|12136798|FG004|Overall Study|Protocol Violation|1
7714193|NCT00495469|12136799|FG005|Overall Study|Protocol Violation|2
7714194|NCT00495469|12136800|FG006|Overall Study|Protocol Violation|0
7714195|NCT00495469|12136794|FG000|Overall Study|Withdrawal by Subject|5
7714196|NCT00495469|12136795|FG001|Overall Study|Withdrawal by Subject|3
7714197|NCT00495469|12136796|FG002|Overall Study|Withdrawal by Subject|1
7714198|NCT00495469|12136797|FG003|Overall Study|Withdrawal by Subject|3
7714199|NCT00495469|12136798|FG004|Overall Study|Withdrawal by Subject|3
7714200|NCT00495469|12136799|FG005|Overall Study|Withdrawal by Subject|2
7714201|NCT00495469|12136800|FG006|Overall Study|Withdrawal by Subject|3
7714202|NCT00495469|12136794|FG000|Overall Study|Lack of Efficacy|0
7714203|NCT00495469|12136795|FG001|Overall Study|Lack of Efficacy|0
7714204|NCT00495469|12136796|FG002|Overall Study|Lack of Efficacy|0
7714205|NCT00495469|12136797|FG003|Overall Study|Lack of Efficacy|0
7714206|NCT00495469|12136798|FG004|Overall Study|Lack of Efficacy|0
7714207|NCT00495469|12136799|FG005|Overall Study|Lack of Efficacy|0
7714208|NCT00495469|12136800|FG006|Overall Study|Lack of Efficacy|1
7714209|NCT00495469|12136794|FG000|Overall Study|Liver function test abnormality|0
7714210|NCT00495469|12136795|FG001|Overall Study|Liver function test abnormality|1
7714211|NCT00495469|12136796|FG002|Overall Study|Liver function test abnormality|0
7714212|NCT00495469|12136797|FG003|Overall Study|Liver function test abnormality|0
7714213|NCT00495469|12136798|FG004|Overall Study|Liver function test abnormality|0
7714214|NCT00495469|12136799|FG005|Overall Study|Liver function test abnormality|0
7714215|NCT00495469|12136800|FG006|Overall Study|Liver function test abnormality|0
7714216|NCT00495469|12136794|FG000|Overall Study|ST depression at randomisation in ECG|0
7714217|NCT00495469|12136795|FG001|Overall Study|ST depression at randomisation in ECG|1
7714218|NCT00495469|12136796|FG002|Overall Study|ST depression at randomisation in ECG|0
7714219|NCT00495469|12136797|FG003|Overall Study|ST depression at randomisation in ECG|0
7714220|NCT00495469|12136798|FG004|Overall Study|ST depression at randomisation in ECG|0
7714221|NCT00495469|12136799|FG005|Overall Study|ST depression at randomisation in ECG|0
7714222|NCT00495469|12136800|FG006|Overall Study|ST depression at randomisation in ECG|0
7714223|NCT00495495|12136823|FG000|Overall Study|Protocol Violation|99
7714224|NCT00495521|12136830|FG000|Overall Study|Physician Decision|0
7714225|NCT00495521|12136831|FG001|Overall Study|Physician Decision|1
7714226|NCT00495586|12136839|FG000|Overall Study|Withdrawal by Subject|4
7714227|NCT00495586|12136840|FG001|Overall Study|Withdrawal by Subject|4
7714228|NCT00495612|12136850|FG000|Overall Study|Lost to Follow-up|1
7714229|NCT00495612|12136851|FG001|Overall Study|Lost to Follow-up|0
7714230|NCT00495612|12136850|FG000|Overall Study|Subject's Decision to Withdraw|3
7714231|NCT00495612|12136851|FG001|Overall Study|Subject's Decision to Withdraw|0
7714232|NCT00495625|12136857|FG000|Overall Study|Did not complete at least 1 42 day cycle|10
7714233|NCT00495677|12136868|FG000|Stage 1 (25 Days)|Adverse Event|0
7714234|NCT00495677|12136869|FG001|Stage 1 (25 Days)|Adverse Event|0
7714235|NCT00495677|12136870|FG002|Stage 1 (25 Days)|Adverse Event|1
7714236|NCT00495677|12136871|FG003|Stage 1 (25 Days)|Adverse Event|0
7714237|NCT00495677|12136872|FG004|Stage 1 (25 Days)|Adverse Event|0
7714238|NCT00495677|12136873|FG005|Stage 1 (25 Days)|Adverse Event|0
7714239|NCT00495677|12136874|FG006|Stage 1 (25 Days)|Adverse Event|0
7714240|NCT00495755|12136890|FG000|Overall Study|Adverse Event|3
7714241|NCT00495794|12136897|FG000|Overall Study|Pharmacist did not activate patient|522
7714242|NCT00495794|12136898|FG001|Overall Study|Pharmacist did not activate patient|0
7714243|NCT00495820|12136906|FG000|Overall Study|Adverse Event|1
7714244|NCT00495820|12136907|FG001|Overall Study|Adverse Event|1
7714245|NCT00496015|12136918|FG000|Overall Study|Other|1
7714246|NCT00496015|12136919|FG001|Overall Study|Other|0
7714247|NCT00496015|12136920|FG002|Overall Study|Other|0
7714248|NCT00496015|12136921|FG003|Overall Study|Other|1
7714249|NCT00496015|12136922|FG004|Overall Study|Other|0
7714250|NCT00496054|12136942|FG000|Overall Study|Adverse Event|1
7714251|NCT00496054|12136942|FG000|Overall Study|Lost to Follow-up|7
7714252|NCT00496080|12136946|FG000|Overall Study|Lost to Follow-up|9
7714253|NCT00496080|12136946|FG000|Overall Study|Surgical re-intervention|7
7714254|NCT00496080|12136946|FG000|Overall Study|Withdrawal by Subject|5
7714255|NCT00496080|12136946|FG000|Overall Study|Physician Decision|6
7714256|NCT00496197|12136951|FG000|Overall Study|Discontinued study due to death|43
7714257|NCT00496197|12136951|FG000|Overall Study|Adverse Event|13
7714258|NCT00496197|12136951|FG000|Overall Study|Does not meet entrance criteria|5
7714259|NCT00496197|12136951|FG000|Overall Study|Insufficient clinical response|3
7714260|NCT00496197|12136951|FG000|Overall Study|Insufficient bacteriological response|10
7714261|NCT00496197|12136951|FG000|Overall Study|Lost to Follow-up|11
7714262|NCT00496197|12136951|FG000|Overall Study|Withdrawal by Subject|11
7714263|NCT00496197|12136951|FG000|Overall Study|Pathogen not isolated baseline specimen|4
7714264|NCT00496197|12136951|FG000|Overall Study|Other|14
7714265|NCT00496197|12136951|FG000|Overall Study|Protocol Violation|8
7714266|NCT00496366|12136965|FG000|Overall Study|Death|1
7714267|NCT00496470|12136975|FG000|Overall Study|Adverse Event|8
7714268|NCT00496470|12136976|FG001|Overall Study|Adverse Event|10
7714269|NCT00496470|12136975|FG000|Overall Study|Withdrawal by Subject|5
7714270|NCT00496470|12136976|FG001|Overall Study|Withdrawal by Subject|12
7714271|NCT00496470|12136975|FG000|Overall Study|Incorrectly enrolled|13
7714272|NCT00496470|12136976|FG001|Overall Study|Incorrectly enrolled|5
7714273|NCT00496470|12136975|FG000|Overall Study|Other reason|0
7714274|NCT00496470|12136976|FG001|Overall Study|Other reason|2
7714275|NCT00496483|12136982|FG000|Overall Study|Not dosed|9
7714276|NCT00496483|12136982|FG000|Overall Study|Adverse Event|2
7714277|NCT00496483|12136982|FG000|Overall Study|Lack of Efficacy|1
7714278|NCT00496587|12136989|FG000|Overall Study|Adverse Event|2
7714279|NCT00496587|12136989|FG000|Overall Study|Progressive Disease|24
7714280|NCT00496587|12136989|FG000|Overall Study|Withdrawal by Subject|2
7714281|NCT00496587|12136989|FG000|Overall Study|Death|1
7714282|NCT00496587|12136989|FG000|Overall Study|Complications unrelated|2
7714283|NCT00496626|12136995|FG000|Overall Study|Lost to Follow-up|0
7714284|NCT00496626|12136996|FG001|Overall Study|Lost to Follow-up|1
7714285|NCT00496626|12136995|FG000|Overall Study|Protocol Violation|1
7714286|NCT00496626|12136996|FG001|Overall Study|Protocol Violation|0
7714287|NCT00496626|12136995|FG000|Overall Study|Withdrawal by Subject|5
7714288|NCT00496626|12136996|FG001|Overall Study|Withdrawal by Subject|4
7714289|NCT00496626|12136995|FG000|Overall Study|Relocated|0
7714290|NCT00496626|12136996|FG001|Overall Study|Relocated|1
7714291|NCT00496769|12137008|FG000|Double Blind|>=1 reason assigned per patient|558
7714292|NCT00496769|12137009|FG001|Double Blind|>=1 reason assigned per patient|649
7714293|NCT00496769|12137010|FG002|Double Blind|>=1 reason assigned per patient|0
7714294|NCT00496769|12137008|FG000|Open Label|>=1 reason assigned per patient|0
7714295|NCT00496769|12137009|FG001|Open Label|>=1 reason assigned per patient|0
7714296|NCT00496769|12137010|FG002|Open Label|>=1 reason assigned per patient|1011
7714297|NCT00496873|12137036|FG000|Overall Study|Ineligible|2
7714298|NCT00496873|12137036|FG000|Overall Study|Death|2
7714299|NCT00496873|12137036|FG000|Overall Study|Withdrawal by Subject|3
7714300|NCT00496964|12137042|FG000|Overall Study|Withdrawal by Subject|0
7714301|NCT00496964|12137043|FG001|Overall Study|Withdrawal by Subject|1
7714302|NCT00497146|12137071|FG000|Treatment Period|Adverse Event|6
7714303|NCT00497146|12137072|FG001|Treatment Period|Adverse Event|2
7714304|NCT00497146|12137071|FG000|Treatment Period|Withdrawal by Subject|5
7714305|NCT00497146|12137072|FG001|Treatment Period|Withdrawal by Subject|9
7714306|NCT00497146|12137071|FG000|Treatment Period|Lost to Follow-up|1
7714307|NCT00497146|12137072|FG001|Treatment Period|Lost to Follow-up|3
7714308|NCT00497146|12137071|FG000|Treatment Period|Required dialysis|4
7714309|NCT00497146|12137072|FG001|Treatment Period|Required dialysis|1
7714310|NCT00497146|12137071|FG000|Treatment Period|Change in RAAS inhibitor therapy|5
7714311|NCT00497146|12137072|FG001|Treatment Period|Change in RAAS inhibitor therapy|2
7714312|NCT00497146|12137071|FG000|Treatment Period|Unable to dose reduce per protocol|4
7714313|NCT00497146|12137072|FG001|Treatment Period|Unable to dose reduce per protocol|1
7714314|NCT00497146|12137071|FG000|Treatment Period|Other Reason|2
7714315|NCT00497146|12137072|FG001|Treatment Period|Other Reason|3
7714316|NCT00497146|12137071|FG000|Long-term Follow-up Period|Adverse Event|2
7714317|NCT00497146|12137072|FG001|Long-term Follow-up Period|Adverse Event|2
7714318|NCT00497146|12137071|FG000|Long-term Follow-up Period|Withdrawal by Subject|8
7714319|NCT00497146|12137072|FG001|Long-term Follow-up Period|Withdrawal by Subject|2
7714320|NCT00497146|12137071|FG000|Long-term Follow-up Period|Lost to Follow-up|5
7714321|NCT00497146|12137072|FG001|Long-term Follow-up Period|Lost to Follow-up|1
7714322|NCT00497146|12137071|FG000|Long-term Follow-up Period|Other|0
7714323|NCT00497146|12137072|FG001|Long-term Follow-up Period|Other|1
7714324|NCT00497198|12137082|FG000|Overall Study|Adverse Event|4
7714325|NCT00497198|12137083|FG001|Overall Study|Adverse Event|2
7714326|NCT00497198|12137082|FG000|Overall Study|Physician Decision|1
7714327|NCT00497198|12137083|FG001|Overall Study|Physician Decision|2
7714328|NCT00497198|12137082|FG000|Overall Study|Withdrawal by Subject|0
7714329|NCT00497198|12137083|FG001|Overall Study|Withdrawal by Subject|1
7714330|NCT00497796|12137120|FG000|Overall Study|Adverse event (not related)|9
7714331|NCT00497796|12137121|FG001|Overall Study|Adverse event (not related)|9
7714332|NCT00497796|12137120|FG000|Overall Study|Adverse event (related)|5
7714333|NCT00497796|12137121|FG001|Overall Study|Adverse event (related)|4
7714334|NCT00497796|12137120|FG000|Overall Study|CMV infection or disease treatment|30
7714335|NCT00497796|12137121|FG001|Overall Study|CMV infection or disease treatment|4
7714336|NCT00497796|12137120|FG000|Overall Study|Consent withdrawn|10
7714337|NCT00497796|12137121|FG001|Overall Study|Consent withdrawn|3
7714338|NCT00497796|12137120|FG000|Overall Study|Investigator/sponsor discretion|31
7714339|NCT00497796|12137121|FG001|Overall Study|Investigator/sponsor discretion|34
7714340|NCT00497796|12137120|FG000|Overall Study|Lost to Follow-up|0
7714341|NCT00497796|12137121|FG001|Overall Study|Lost to Follow-up|1
7714342|NCT00497796|12137120|FG000|Overall Study|Not applicable (randomized not treated)|0
7714343|NCT00497796|12137121|FG001|Overall Study|Not applicable (randomized not treated)|4
7714344|NCT00497874|12137129|FG000|Overall Study|Withdrawal by Subject|48
7714345|NCT00497874|12137130|FG001|Overall Study|Withdrawal by Subject|17
7714346|NCT00497874|12137129|FG000|Overall Study|Illness|8
7714347|NCT00497874|12137130|FG001|Overall Study|Illness|4
7714348|NCT00497874|12137129|FG000|Overall Study|Death|2
7714349|NCT00497874|12137130|FG001|Overall Study|Death|4
7714350|NCT00497874|12137129|FG000|Overall Study|Unable to contact|52
7714351|NCT00497874|12137130|FG001|Overall Study|Unable to contact|67
7714352|NCT00497874|12137129|FG000|Overall Study|Unable to schedule|37
7714353|NCT00497874|12137130|FG001|Overall Study|Unable to schedule|24
7714354|NCT00498173|12137140|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
7714355|NCT00498173|12137141|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
7714356|NCT00498173|12137142|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
7714357|NCT00498186|12137150|FG000|Overall Study|Protocol Violation|10
7714358|NCT00498186|12137150|FG000|Overall Study|Lack of Efficacy|31
7714359|NCT00498186|12137150|FG000|Overall Study|Adverse Event|89
7714360|NCT00498186|12137150|FG000|Overall Study|Unsatisfactory compliance of subject|12
7714361|NCT00498186|12137150|FG000|Overall Study|Withdrawal by Subject|18
7714362|NCT00498186|12137150|FG000|Overall Study|Lost to Follow-up|3
7714363|NCT00498186|12137150|FG000|Overall Study|Other|10
7714364|NCT00498355|12137154|FG000|Overall Study|Lost to Follow-up|1
7714365|NCT00498368|12137161|FG000|Overall Study|Withdrawal by Subject|3
7714366|NCT00498368|12137162|FG001|Overall Study|Withdrawal by Subject|2
7714367|NCT00498433|12137171|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
7714368|NCT00498433|12137172|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
7714621|NCT00500331|12137577|FG003|Overall Study|Withdrawal by Subject|5
7714369|NCT00498433|12137173|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
7714370|NCT00498433|12137171|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
7714371|NCT00498433|12137172|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
7714372|NCT00498433|12137173|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
7714373|NCT00498433|12137171|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
7714374|NCT00498433|12137172|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
7714375|NCT00498433|12137173|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
7714376|NCT00498433|12137171|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
7714377|NCT00498433|12137172|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
7714378|NCT00498433|12137173|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
7714379|NCT00498485|12137192|FG000|Overall Study|Adverse Event|1
7714380|NCT00498485|12137193|FG001|Overall Study|Adverse Event|5
7714381|NCT00498602|12137217|FG000|Overall Study|Death|0
7714382|NCT00498602|12137218|FG001|Overall Study|Death|0
7714383|NCT00498602|12137219|FG002|Overall Study|Death|0
7714384|NCT00498602|12137220|FG003|Overall Study|Death|0
7714385|NCT00498602|12137221|FG004|Overall Study|Death|0
7714386|NCT00498602|12137222|FG005|Overall Study|Death|1
7714387|NCT00498602|12137223|FG006|Overall Study|Death|0
7714388|NCT00498602|12137217|FG000|Overall Study|Lack of Efficacy|1
7714389|NCT00498602|12137218|FG001|Overall Study|Lack of Efficacy|0
7714390|NCT00498602|12137219|FG002|Overall Study|Lack of Efficacy|0
7714391|NCT00498602|12137220|FG003|Overall Study|Lack of Efficacy|0
7714392|NCT00498602|12137221|FG004|Overall Study|Lack of Efficacy|0
7714393|NCT00498602|12137222|FG005|Overall Study|Lack of Efficacy|0
7714394|NCT00498602|12137223|FG006|Overall Study|Lack of Efficacy|0
7714395|NCT00498602|12137217|FG000|Overall Study|Lost to Follow-up|0
7714396|NCT00498602|12137218|FG001|Overall Study|Lost to Follow-up|2
7714397|NCT00498602|12137219|FG002|Overall Study|Lost to Follow-up|0
7714398|NCT00498602|12137220|FG003|Overall Study|Lost to Follow-up|2
7714399|NCT00498602|12137221|FG004|Overall Study|Lost to Follow-up|0
7714400|NCT00498602|12137222|FG005|Overall Study|Lost to Follow-up|0
7714401|NCT00498602|12137223|FG006|Overall Study|Lost to Follow-up|0
7714402|NCT00498602|12137217|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1
7714403|NCT00498602|12137218|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0
7714404|NCT00498602|12137219|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3
7714405|NCT00498602|12137220|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2
7714406|NCT00498602|12137221|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0
7714407|NCT00498602|12137222|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1
7714408|NCT00498602|12137223|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0
7714409|NCT00498602|12137217|FG000|Overall Study|AE not related to Study Drug|1
7714410|NCT00498602|12137218|FG001|Overall Study|AE not related to Study Drug|3
7714411|NCT00498602|12137219|FG002|Overall Study|AE not related to Study Drug|0
7714412|NCT00498602|12137220|FG003|Overall Study|AE not related to Study Drug|0
7714413|NCT00498602|12137221|FG004|Overall Study|AE not related to Study Drug|2
7714414|NCT00498602|12137222|FG005|Overall Study|AE not related to Study Drug|2
7714415|NCT00498602|12137223|FG006|Overall Study|AE not related to Study Drug|1
7714416|NCT00498602|12137217|FG000|Overall Study|Caregiver Request|2
7714417|NCT00498602|12137218|FG001|Overall Study|Caregiver Request|2
7714418|NCT00498602|12137219|FG002|Overall Study|Caregiver Request|2
7714419|NCT00498602|12137220|FG003|Overall Study|Caregiver Request|0
7714420|NCT00498602|12137221|FG004|Overall Study|Caregiver Request|1
7714421|NCT00498602|12137222|FG005|Overall Study|Caregiver Request|2
7714422|NCT00498602|12137223|FG006|Overall Study|Caregiver Request|0
7714423|NCT00498602|12137217|FG000|Overall Study|Investigator Request|0
7714424|NCT00498602|12137218|FG001|Overall Study|Investigator Request|0
7714425|NCT00498602|12137219|FG002|Overall Study|Investigator Request|1
7714426|NCT00498602|12137220|FG003|Overall Study|Investigator Request|0
7714427|NCT00498602|12137221|FG004|Overall Study|Investigator Request|0
7714428|NCT00498602|12137222|FG005|Overall Study|Investigator Request|0
7714429|NCT00498602|12137223|FG006|Overall Study|Investigator Request|0
7714430|NCT00498602|12137217|FG000|Overall Study|Subject Request|3
7714431|NCT00498602|12137218|FG001|Overall Study|Subject Request|0
7714432|NCT00498602|12137219|FG002|Overall Study|Subject Request|1
7714433|NCT00498602|12137220|FG003|Overall Study|Subject Request|1
7714434|NCT00498602|12137221|FG004|Overall Study|Subject Request|1
7714435|NCT00498602|12137222|FG005|Overall Study|Subject Request|4
7714436|NCT00498602|12137223|FG006|Overall Study|Subject Request|1
7714437|NCT00498602|12137217|FG000|Overall Study|Other|2
7714438|NCT00498602|12137218|FG001|Overall Study|Other|3
7714439|NCT00498602|12137219|FG002|Overall Study|Other|1
7714440|NCT00498602|12137220|FG003|Overall Study|Other|0
7714441|NCT00498602|12137221|FG004|Overall Study|Other|0
7714442|NCT00498602|12137222|FG005|Overall Study|Other|3
7714443|NCT00498602|12137223|FG006|Overall Study|Other|0
7714444|NCT00498797|12137282|FG000|Overall Study|Withdrawal by Subject|4
7714445|NCT00498797|12137283|FG001|Overall Study|Withdrawal by Subject|2
7714446|NCT00498797|12137282|FG000|Overall Study|Adverse Event|12
7714447|NCT00498797|12137283|FG001|Overall Study|Adverse Event|5
7714448|NCT00498797|12137282|FG000|Overall Study|Condition under investigation worsened|19
7714449|NCT00498797|12137283|FG001|Overall Study|Condition under investigation worsened|21
7714450|NCT00498797|12137282|FG000|Overall Study|Other|3
7714451|NCT00498797|12137283|FG001|Overall Study|Other|1
7714452|NCT00499031|12137302|FG000|Overall Study|Improper pre-protocol treatment|1
7714453|NCT00499031|12137302|FG000|Overall Study|Required test not done|1
7714454|NCT00499031|12137302|FG000|Overall Study|Never treated|1
7714455|NCT00499083|12137306|FG000|Overall Study|Not evaluable|3
7714456|NCT00499122|12137333|FG000|Overall Study|Withdrawal by Subject|2
7714457|NCT00499174|12137340|FG000|Overall Study|Physician Decision|78
7714458|NCT00499174|12137341|FG001|Overall Study|Physician Decision|9
7714459|NCT00499252|12137349|FG000|Overall Study|Adverse Event|3
7714460|NCT00499252|12137349|FG000|Overall Study|Refused further treatment|2
7714461|NCT00499252|12137349|FG000|Overall Study|Ineligible|4
7714462|NCT00499252|12137349|FG000|Overall Study|<no further label>|3
7714463|NCT00499369|12137371|FG000|Overall Study|Adverse Event|2
7714464|NCT00499369|12137372|FG001|Overall Study|Adverse Event|2
7714465|NCT00499369|12137373|FG002|Overall Study|Adverse Event|3
7714466|NCT00499369|12137374|FG003|Overall Study|Adverse Event|1
7714467|NCT00499369|12137375|FG004|Overall Study|Adverse Event|2
7714468|NCT00499369|12137371|FG000|Overall Study|Withdrawal by Subject|0
7714469|NCT00499369|12137372|FG001|Overall Study|Withdrawal by Subject|1
7714470|NCT00499369|12137373|FG002|Overall Study|Withdrawal by Subject|1
7714471|NCT00499369|12137374|FG003|Overall Study|Withdrawal by Subject|0
7714472|NCT00499369|12137375|FG004|Overall Study|Withdrawal by Subject|0
7714473|NCT00499369|12137371|FG000|Overall Study|Progression|10
7714474|NCT00499369|12137372|FG001|Overall Study|Progression|12
7714475|NCT00499369|12137373|FG002|Overall Study|Progression|9
7714476|NCT00499369|12137374|FG003|Overall Study|Progression|6
7714477|NCT00499369|12137375|FG004|Overall Study|Progression|10
7714478|NCT00499369|12137371|FG000|Overall Study|Death|0
7714479|NCT00499369|12137372|FG001|Overall Study|Death|1
7714480|NCT00499369|12137373|FG002|Overall Study|Death|0
7714481|NCT00499369|12137374|FG003|Overall Study|Death|0
7714482|NCT00499369|12137375|FG004|Overall Study|Death|0
7714483|NCT00499369|12137371|FG000|Overall Study|Not protocol specified|2
7714484|NCT00499369|12137372|FG001|Overall Study|Not protocol specified|0
7714485|NCT00499369|12137373|FG002|Overall Study|Not protocol specified|3
7714486|NCT00499369|12137374|FG003|Overall Study|Not protocol specified|1
7714487|NCT00499369|12137375|FG004|Overall Study|Not protocol specified|0
7714488|NCT00499369|12137371|FG000|Overall Study|Ineligible|2
7714489|NCT00499369|12137372|FG001|Overall Study|Ineligible|2
7714490|NCT00499369|12137373|FG002|Overall Study|Ineligible|1
7714491|NCT00499369|12137374|FG003|Overall Study|Ineligible|1
7714492|NCT00499369|12137375|FG004|Overall Study|Ineligible|0
7714493|NCT00499460|12137397|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1
7714494|NCT00499460|12137398|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0
7714495|NCT00499460|12137397|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
7714496|NCT00499460|12137398|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
7714497|NCT00499460|12137397|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0
7714498|NCT00499460|12137398|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1
7714499|NCT00499486|12137423|FG000|Overall Study|Withdrawal by Subject|16
7714500|NCT00499603|12137429|FG000|Overall Study|Adverse Event|0
7714501|NCT00499603|12137430|FG001|Overall Study|Adverse Event|1
7714502|NCT00499616|12137442|FG000|Overall Study|Death|1
7714503|NCT00499616|12137443|FG001|Overall Study|Death|5
7714504|NCT00499616|12137444|FG002|Overall Study|Death|3
7714505|NCT00499616|12137445|FG003|Overall Study|Death|1
7714506|NCT00499616|12137442|FG000|Overall Study|Lack of Efficacy|5
7714507|NCT00499616|12137443|FG001|Overall Study|Lack of Efficacy|0
7714508|NCT00499616|12137444|FG002|Overall Study|Lack of Efficacy|19
7714509|NCT00499616|12137445|FG003|Overall Study|Lack of Efficacy|0
7714510|NCT00499616|12137442|FG000|Overall Study|Lost to Follow-up|0
7714511|NCT00499616|12137443|FG001|Overall Study|Lost to Follow-up|0
7714512|NCT00499616|12137444|FG002|Overall Study|Lost to Follow-up|1
7714513|NCT00499616|12137445|FG003|Overall Study|Lost to Follow-up|0
7714514|NCT00499616|12137442|FG000|Overall Study|Physician Decision|6
7714515|NCT00499616|12137443|FG001|Overall Study|Physician Decision|16
7714516|NCT00499616|12137444|FG002|Overall Study|Physician Decision|9
7714517|NCT00499616|12137445|FG003|Overall Study|Physician Decision|0
7714518|NCT00499616|12137442|FG000|Overall Study|Withdrawal by Subject|1
7714519|NCT00499616|12137443|FG001|Overall Study|Withdrawal by Subject|0
7714520|NCT00499616|12137444|FG002|Overall Study|Withdrawal by Subject|1
7714521|NCT00499616|12137445|FG003|Overall Study|Withdrawal by Subject|0
7714522|NCT00499616|12137442|FG000|Overall Study|Ineligible|1
7714523|NCT00499616|12137443|FG001|Overall Study|Ineligible|2
7714524|NCT00499616|12137444|FG002|Overall Study|Ineligible|0
7714525|NCT00499616|12137445|FG003|Overall Study|Ineligible|15
7714526|NCT00499616|12137442|FG000|Overall Study|Not evaluable|0
7714527|NCT00499616|12137443|FG001|Overall Study|Not evaluable|0
7714528|NCT00499616|12137444|FG002|Overall Study|Not evaluable|0
7714529|NCT00499616|12137445|FG003|Overall Study|Not evaluable|41
7714530|NCT00499616|12137442|FG000|Overall Study|Patient/Parent Refusal|1
7714531|NCT00499616|12137443|FG001|Overall Study|Patient/Parent Refusal|5
7714532|NCT00499616|12137444|FG002|Overall Study|Patient/Parent Refusal|3
7714533|NCT00499616|12137445|FG003|Overall Study|Patient/Parent Refusal|0
7714534|NCT00499681|12137470|FG000|Overall Study|toxicity|0
7714535|NCT00499681|12137471|FG001|Overall Study|toxicity|1
7714536|NCT00499681|12137470|FG000|Overall Study|disease progression|0
7714537|NCT00499681|12137471|FG001|Overall Study|disease progression|1
7714538|NCT00499694|12137477|FG000|Overall Study|Patient never received treatment.|1
7714539|NCT00499746|12137482|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
7714540|NCT00499746|12137482|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
7714541|NCT00499746|12137482|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1
7714542|NCT00499746|12137482|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1
7714543|NCT00499863|12137498|FG000|Overall Study|Lack of Efficacy|21
7714544|NCT00499863|12137499|FG001|Overall Study|Lack of Efficacy|27
7714545|NCT00499863|12137498|FG000|Overall Study|Protocol Violation|12
7714546|NCT00499863|12137499|FG001|Overall Study|Protocol Violation|7
7714547|NCT00499863|12137498|FG000|Overall Study|Withdrawal by Subject|6
7714548|NCT00499863|12137499|FG001|Overall Study|Withdrawal by Subject|4
7714549|NCT00499863|12137498|FG000|Overall Study|Adverse Event|8
7714550|NCT00499863|12137499|FG001|Overall Study|Adverse Event|2
7714551|NCT00499863|12137498|FG000|Overall Study|Sponsor decision|2
7714552|NCT00499863|12137499|FG001|Overall Study|Sponsor decision|2
7714553|NCT00499863|12137498|FG000|Overall Study|Lost to Follow-up|1
7714554|NCT00499863|12137499|FG001|Overall Study|Lost to Follow-up|1
7714555|NCT00499889|12137505|FG000|Overall Study|Infection prior to treatment|1
7714556|NCT00500110|12137518|FG000|Overall Study|Withdrawal by Subject|3
7714557|NCT00500149|12137522|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
7714558|NCT00500149|12137523|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
7714559|NCT00500149|12137522|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8
7714560|NCT00500149|12137523|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0
7714561|NCT00500149|12137522|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1
7714562|NCT00500149|12137523|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0
7714563|NCT00500149|12137522|FG000|First Intervention (Cross-over Phase)|Adverse Event|0
7714564|NCT00500149|12137523|FG001|First Intervention (Cross-over Phase)|Adverse Event|1
7714565|NCT00500149|12137522|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
7714566|NCT00500149|12137523|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
7714567|NCT00500149|12137522|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1
7714568|NCT00500149|12137523|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0
7714569|NCT00500149|12137522|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
7714570|NCT00500149|12137523|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
7714571|NCT00500266|12137540|FG000|Overall Study|Death|3
7714572|NCT00500266|12137540|FG000|Overall Study|Lost to Follow-up|3
7714573|NCT00500266|12137540|FG000|Overall Study|Withdrawal by Subject|3
7714574|NCT00500266|12137540|FG000|Overall Study|Assigned, not treated|4
7714575|NCT00500292|12137548|FG000|Overall Study|Adverse Event|3
7714576|NCT00500292|12137549|FG001|Overall Study|Adverse Event|6
7714577|NCT00500292|12137550|FG002|Overall Study|Adverse Event|4
7714578|NCT00500292|12137548|FG000|Overall Study|Condition under investigation worsened|21
7714579|NCT00500292|12137549|FG001|Overall Study|Condition under investigation worsened|23
7714580|NCT00500292|12137550|FG002|Overall Study|Condition under investigation worsened|19
7714581|NCT00500292|12137548|FG000|Overall Study|Withdrawal by Subject|0
7714582|NCT00500292|12137549|FG001|Overall Study|Withdrawal by Subject|1
7714583|NCT00500292|12137550|FG002|Overall Study|Withdrawal by Subject|0
7714584|NCT00500292|12137548|FG000|Overall Study|Other|1
7714585|NCT00500292|12137549|FG001|Overall Study|Other|1
7714586|NCT00500292|12137550|FG002|Overall Study|Other|4
7714587|NCT00500318|12137560|FG000|Overall Study|Adverse Event|3
7714588|NCT00500318|12137561|FG001|Overall Study|Adverse Event|8
7714589|NCT00500318|12137560|FG000|Overall Study|Protocol Violation|1
7714590|NCT00500318|12137561|FG001|Overall Study|Protocol Violation|3
7714591|NCT00500318|12137560|FG000|Overall Study|Withdrawal by Subject|1
7714592|NCT00500318|12137561|FG001|Overall Study|Withdrawal by Subject|2
7714593|NCT00500318|12137560|FG000|Overall Study|Lack of Efficacy|0
7714594|NCT00500318|12137561|FG001|Overall Study|Lack of Efficacy|3
7714595|NCT00500318|12137560|FG000|Overall Study|Other Reason|0
7714596|NCT00500318|12137561|FG001|Overall Study|Other Reason|1
7714597|NCT00500331|12137574|FG000|Overall Study|Adverse Event|0
7714598|NCT00500331|12137575|FG001|Overall Study|Adverse Event|2
7714599|NCT00500331|12137576|FG002|Overall Study|Adverse Event|0
7714600|NCT00500331|12137577|FG003|Overall Study|Adverse Event|1
7714601|NCT00500331|12137578|FG004|Overall Study|Adverse Event|2
7714602|NCT00500331|12137579|FG005|Overall Study|Adverse Event|2
7714603|NCT00500331|12137580|FG006|Overall Study|Adverse Event|0
7714604|NCT00500331|12137574|FG000|Overall Study|Lost to Follow-up|1
7714605|NCT00500331|12137575|FG001|Overall Study|Lost to Follow-up|1
7714606|NCT00500331|12137576|FG002|Overall Study|Lost to Follow-up|1
7714607|NCT00500331|12137577|FG003|Overall Study|Lost to Follow-up|2
7714608|NCT00500331|12137578|FG004|Overall Study|Lost to Follow-up|1
7714609|NCT00500331|12137579|FG005|Overall Study|Lost to Follow-up|0
7714610|NCT00500331|12137580|FG006|Overall Study|Lost to Follow-up|0
7714611|NCT00500331|12137574|FG000|Overall Study|Protocol Violation|3
7714612|NCT00500331|12137575|FG001|Overall Study|Protocol Violation|1
7714613|NCT00500331|12137576|FG002|Overall Study|Protocol Violation|1
7714614|NCT00500331|12137577|FG003|Overall Study|Protocol Violation|0
7714615|NCT00500331|12137578|FG004|Overall Study|Protocol Violation|1
7714616|NCT00500331|12137579|FG005|Overall Study|Protocol Violation|1
7714617|NCT00500331|12137580|FG006|Overall Study|Protocol Violation|1
7714618|NCT00500331|12137574|FG000|Overall Study|Withdrawal by Subject|4
7714619|NCT00500331|12137575|FG001|Overall Study|Withdrawal by Subject|0
7714620|NCT00500331|12137576|FG002|Overall Study|Withdrawal by Subject|1
7714622|NCT00500331|12137578|FG004|Overall Study|Withdrawal by Subject|0
7714623|NCT00500331|12137579|FG005|Overall Study|Withdrawal by Subject|1
7714624|NCT00500331|12137580|FG006|Overall Study|Withdrawal by Subject|1
7714625|NCT00500331|12137574|FG000|Overall Study|Lack of Efficacy|3
7714626|NCT00500331|12137575|FG001|Overall Study|Lack of Efficacy|1
7714627|NCT00500331|12137576|FG002|Overall Study|Lack of Efficacy|0
7714628|NCT00500331|12137577|FG003|Overall Study|Lack of Efficacy|0
7714629|NCT00500331|12137578|FG004|Overall Study|Lack of Efficacy|0
7714630|NCT00500331|12137579|FG005|Overall Study|Lack of Efficacy|0
7714631|NCT00500331|12137580|FG006|Overall Study|Lack of Efficacy|0
7714632|NCT00500331|12137574|FG000|Overall Study|Liver function test abnormality|0
7714633|NCT00500331|12137575|FG001|Overall Study|Liver function test abnormality|0
7714634|NCT00500331|12137576|FG002|Overall Study|Liver function test abnormality|1
7714635|NCT00500331|12137577|FG003|Overall Study|Liver function test abnormality|0
7714636|NCT00500331|12137578|FG004|Overall Study|Liver function test abnormality|0
7714637|NCT00500331|12137579|FG005|Overall Study|Liver function test abnormality|0
7714638|NCT00500331|12137580|FG006|Overall Study|Liver function test abnormality|0
7714639|NCT00500331|12137574|FG000|Overall Study|Increased serum creatinine from Baseline|0
7714640|NCT00500331|12137575|FG001|Overall Study|Increased serum creatinine from Baseline|0
7714641|NCT00500331|12137576|FG002|Overall Study|Increased serum creatinine from Baseline|0
7714642|NCT00500331|12137577|FG003|Overall Study|Increased serum creatinine from Baseline|0
7714643|NCT00500331|12137578|FG004|Overall Study|Increased serum creatinine from Baseline|0
7714644|NCT00500331|12137579|FG005|Overall Study|Increased serum creatinine from Baseline|1
7714645|NCT00500331|12137580|FG006|Overall Study|Increased serum creatinine from Baseline|0
7714646|NCT00500331|12137574|FG000|Overall Study|Didn't return for continuation of study|1
7714647|NCT00500331|12137575|FG001|Overall Study|Didn't return for continuation of study|0
7714648|NCT00500331|12137576|FG002|Overall Study|Didn't return for continuation of study|0
7714649|NCT00500331|12137577|FG003|Overall Study|Didn't return for continuation of study|0
7714650|NCT00500331|12137578|FG004|Overall Study|Didn't return for continuation of study|0
7714651|NCT00500331|12137579|FG005|Overall Study|Didn't return for continuation of study|0
7714652|NCT00500331|12137580|FG006|Overall Study|Didn't return for continuation of study|0
7714653|NCT00500331|12137574|FG000|Overall Study|Exclusion citeria not met on Visit 4|1
7714654|NCT00500331|12137575|FG001|Overall Study|Exclusion citeria not met on Visit 4|0
7714655|NCT00500331|12137576|FG002|Overall Study|Exclusion citeria not met on Visit 4|0
7714656|NCT00500331|12137577|FG003|Overall Study|Exclusion citeria not met on Visit 4|0
7714657|NCT00500331|12137578|FG004|Overall Study|Exclusion citeria not met on Visit 4|0
7714658|NCT00500331|12137579|FG005|Overall Study|Exclusion citeria not met on Visit 4|0
7714659|NCT00500331|12137580|FG006|Overall Study|Exclusion citeria not met on Visit 4|0
7714660|NCT00500331|12137574|FG000|Overall Study|Sponsor decided to withdraw participant|1
7714661|NCT00500331|12137575|FG001|Overall Study|Sponsor decided to withdraw participant|0
7714662|NCT00500331|12137576|FG002|Overall Study|Sponsor decided to withdraw participant|0
7714663|NCT00500331|12137577|FG003|Overall Study|Sponsor decided to withdraw participant|0
7714664|NCT00500331|12137578|FG004|Overall Study|Sponsor decided to withdraw participant|0
7714665|NCT00500331|12137579|FG005|Overall Study|Sponsor decided to withdraw participant|0
7714666|NCT00500331|12137580|FG006|Overall Study|Sponsor decided to withdraw participant|0
7714667|NCT00500331|12137574|FG000|Overall Study|Participant was randomized by mistake|1
7714668|NCT00500331|12137575|FG001|Overall Study|Participant was randomized by mistake|0
7714669|NCT00500331|12137576|FG002|Overall Study|Participant was randomized by mistake|0
7714670|NCT00500331|12137577|FG003|Overall Study|Participant was randomized by mistake|0
7714671|NCT00500331|12137578|FG004|Overall Study|Participant was randomized by mistake|0
7714672|NCT00500331|12137579|FG005|Overall Study|Participant was randomized by mistake|0
7714673|NCT00500331|12137580|FG006|Overall Study|Participant was randomized by mistake|0
7714674|NCT00500331|12137574|FG000|Overall Study|Diabetologist nurse in the study|0
7714675|NCT00500331|12137575|FG001|Overall Study|Diabetologist nurse in the study|0
7714676|NCT00500331|12137576|FG002|Overall Study|Diabetologist nurse in the study|1
7714677|NCT00500331|12137577|FG003|Overall Study|Diabetologist nurse in the study|0
7714678|NCT00500331|12137578|FG004|Overall Study|Diabetologist nurse in the study|0
7714679|NCT00500331|12137579|FG005|Overall Study|Diabetologist nurse in the study|0
7714680|NCT00500331|12137580|FG006|Overall Study|Diabetologist nurse in the study|0
7714681|NCT00500331|12137574|FG000|Overall Study|State ban of biological samples export|0
7714682|NCT00500331|12137575|FG001|Overall Study|State ban of biological samples export|0
7714683|NCT00500331|12137576|FG002|Overall Study|State ban of biological samples export|0
7714684|NCT00500331|12137577|FG003|Overall Study|State ban of biological samples export|1
7714685|NCT00500331|12137578|FG004|Overall Study|State ban of biological samples export|0
7714686|NCT00500331|12137579|FG005|Overall Study|State ban of biological samples export|0
7714687|NCT00500331|12137580|FG006|Overall Study|State ban of biological samples export|0
7714688|NCT00500331|12137574|FG000|Overall Study|Protocol violated|0
7714689|NCT00500331|12137575|FG001|Overall Study|Protocol violated|0
7714690|NCT00500331|12137576|FG002|Overall Study|Protocol violated|0
7714691|NCT00500331|12137577|FG003|Overall Study|Protocol violated|1
7714692|NCT00500331|12137578|FG004|Overall Study|Protocol violated|0
7714693|NCT00500331|12137579|FG005|Overall Study|Protocol violated|0
7714694|NCT00500331|12137580|FG006|Overall Study|Protocol violated|0
7714695|NCT00500357|12137597|FG000|Overall Study|Death|1
7714696|NCT00500370|12137614|FG000|Overall Study|Adverse Event|9
7714697|NCT00500370|12137615|FG001|Overall Study|Adverse Event|3
7714698|NCT00500370|12137614|FG000|Overall Study|Lost to Follow-up|10
7714699|NCT00500370|12137615|FG001|Overall Study|Lost to Follow-up|10
7714700|NCT00500370|12137614|FG000|Overall Study|Protocol Violation|2
7714701|NCT00500370|12137615|FG001|Overall Study|Protocol Violation|4
7714702|NCT00500370|12137614|FG000|Overall Study|Sponsor Decision|2
7714703|NCT00500370|12137615|FG001|Overall Study|Sponsor Decision|0
7714704|NCT00500370|12137614|FG000|Overall Study|Subject Decision|10
7714705|NCT00500370|12137615|FG001|Overall Study|Subject Decision|17
7714706|NCT00500539|12137630|FG000|Treatment Period (24 Weeks)|Adverse Event|4
7714707|NCT00500539|12137630|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
7714708|NCT00500539|12137630|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1
7714709|NCT00500539|12137630|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2
7714710|NCT00500539|12137630|FG000|Treatment Period (24 Weeks)|Administrative problems|2
7714711|NCT00500539|12137630|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5
7714712|NCT00500539|12137630|FG000|Follow-up Period (16 Weeks)|Adverse Event|1
7714713|NCT00500539|12137630|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2
7714714|NCT00500539|12137630|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3
7714715|NCT00500539|12137630|FG000|Follow-up Period (16 Weeks)|Administrative problems|1
7714716|NCT00500539|12137630|FG000|Follow-up Period (16 Weeks)|Death|1
7714717|NCT00500539|12137630|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1
7714718|NCT00500539|12137630|FG000|Follow-up Period (16 Weeks)|Missing|3
7714719|NCT00500760|12137665|FG000|Overall Study|Death|32
7714720|NCT00500760|12137666|FG001|Overall Study|Death|15
7714721|NCT00500760|12137665|FG000|Overall Study|Withdrawal by Subject|5
7714722|NCT00500760|12137666|FG001|Overall Study|Withdrawal by Subject|7
7714723|NCT00500760|12137665|FG000|Overall Study|Administrative decision|2
7714724|NCT00500760|12137666|FG001|Overall Study|Administrative decision|0
7714725|NCT00500760|12137665|FG000|Overall Study|Lost to Follow-up|3
7714726|NCT00500760|12137666|FG001|Overall Study|Lost to Follow-up|0
7714727|NCT00500760|12137665|FG000|Overall Study|Other|1
7714728|NCT00500760|12137666|FG001|Overall Study|Other|2
7714729|NCT00500903|12137675|FG000|Overall Study|Occurrence of Adverse Event(s)|10
7714730|NCT00500903|12137676|FG001|Overall Study|Occurrence of Adverse Event(s)|0
7714731|NCT00500903|12137677|FG002|Overall Study|Occurrence of Adverse Event(s)|0
7714732|NCT00500903|12137675|FG000|Overall Study|Unsatisfactory Therapeutic Response|2
7714733|NCT00500903|12137676|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
7714734|NCT00500903|12137677|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
7714735|NCT00500903|12137675|FG000|Overall Study|Progressive Disease|41
7714736|NCT00500903|12137676|FG001|Overall Study|Progressive Disease|2
7714737|NCT00500903|12137677|FG002|Overall Study|Progressive Disease|15
7714738|NCT00500903|12137675|FG000|Overall Study|Patient Declined Further Treatment|0
7714739|NCT00500903|12137676|FG001|Overall Study|Patient Declined Further Treatment|0
7714740|NCT00500903|12137677|FG002|Overall Study|Patient Declined Further Treatment|3
7714741|NCT00500903|12137675|FG000|Overall Study|Symptomatic Deterioration|2
7714742|NCT00500903|12137676|FG001|Overall Study|Symptomatic Deterioration|0
7714743|NCT00500903|12137677|FG002|Overall Study|Symptomatic Deterioration|0
7714744|NCT00500903|12137675|FG000|Overall Study|Reason Not Specified|10
7714745|NCT00500903|12137676|FG001|Overall Study|Reason Not Specified|0
7714746|NCT00500903|12137677|FG002|Overall Study|Reason Not Specified|2
7714747|NCT00501007|12137715|FG000|Overall Study|Inclusion criteria not met.|29
7714748|NCT00501007|12137716|FG001|Overall Study|Inclusion criteria not met.|25
7714749|NCT00501059|12137724|FG000|Overall Study|Protocol Violation|80
7714750|NCT00501059|12137725|FG001|Overall Study|Protocol Violation|69
7714751|NCT00501059|12137724|FG000|Overall Study|Death|140
7714752|NCT00501059|12137725|FG001|Overall Study|Death|137
7714753|NCT00501059|12137724|FG000|Overall Study|Other|236
7714754|NCT00501059|12137725|FG001|Overall Study|Other|239
7714755|NCT00501059|12137724|FG000|Overall Study|Missing end-of-study page|91
7714756|NCT00501059|12137725|FG001|Overall Study|Missing end-of-study page|92
7714757|NCT00501059|12137724|FG000|Overall Study|Clinical endpoint reached|110
7714758|NCT00501059|12137725|FG001|Overall Study|Clinical endpoint reached|123
7714759|NCT00501059|12137724|FG000|Overall Study|Insufficient therapeutic effect|4
7714760|NCT00501059|12137725|FG001|Overall Study|Insufficient therapeutic effect|5
7714761|NCT00501059|12137724|FG000|Overall Study|Consent withdrawn by subject|817
7714762|NCT00501059|12137725|FG001|Overall Study|Consent withdrawn by subject|873
7714763|NCT00501059|12137724|FG000|Overall Study|Non-compliant with study treatment|23
7714764|NCT00501059|12137725|FG001|Overall Study|Non-compliant with study treatment|16
7714765|NCT00501059|12137724|FG000|Overall Study|Reason not given|3
7714766|NCT00501059|12137725|FG001|Overall Study|Reason not given|1
7714767|NCT00501059|12137724|FG000|Overall Study|Adverse Event|129
7714768|NCT00501059|12137725|FG001|Overall Study|Adverse Event|122
7714769|NCT00501059|12137724|FG000|Overall Study|Lost to Follow-up|210
7714770|NCT00501059|12137725|FG001|Overall Study|Lost to Follow-up|198
7714771|NCT00501059|12137724|FG000|Overall Study|Not treated|25
7714772|NCT00501059|12137725|FG001|Overall Study|Not treated|17
7714773|NCT00501085|12137733|FG000|Overall Study|Lost to Follow-up|195
7714774|NCT00501085|12137733|FG000|Overall Study|Withdrawal by Subject|34
7714775|NCT00501085|12137733|FG000|Overall Study|Subject Decision|1
7714776|NCT00501085|12137733|FG000|Overall Study|Revision Surgery|7
7714777|NCT00501085|12137733|FG000|Overall Study|Explantation Surgery|26
7714778|NCT00501085|12137733|FG000|Overall Study|Adverse Event|4
7714779|NCT00501085|12137733|FG000|Overall Study|Non-Compliance|24
7714780|NCT00501085|12137733|FG000|Overall Study|Study closed by sponsor|109
7714781|NCT00501085|12137733|FG000|Overall Study|Other loss to follow-up|32
7714782|NCT00501293|12137739|FG000|Optimization Period|Enrolled in error|1
7714783|NCT00501293|12137740|FG001|Optimization Period|Enrolled in error|0
7714784|NCT00501293|12137739|FG000|Maintenance Period|Withdrawal by Subject|14
7714785|NCT00501293|12137740|FG001|Maintenance Period|Withdrawal by Subject|13
7714786|NCT00501293|12137739|FG000|Maintenance Period|Lost to Follow-up|12
7714787|NCT00501293|12137740|FG001|Maintenance Period|Lost to Follow-up|7
7714788|NCT00501293|12137739|FG000|Maintenance Period|Adverse Event|6
7714789|NCT00501293|12137740|FG001|Maintenance Period|Adverse Event|6
7714790|NCT00501293|12137739|FG000|Maintenance Period|Protocol Violation|2
7714791|NCT00501293|12137740|FG001|Maintenance Period|Protocol Violation|1
7714792|NCT00501293|12137739|FG000|Maintenance Period|Lack of Efficacy|4
7714793|NCT00501293|12137740|FG001|Maintenance Period|Lack of Efficacy|1
7714794|NCT00501293|12137739|FG000|Maintenance Period|Noncompliant with study medication|5
7714795|NCT00501293|12137740|FG001|Maintenance Period|Noncompliant with study medication|0
7714796|NCT00501293|12137739|FG000|Maintenance Period|Went into rehabilitation|1
7714797|NCT00501293|12137740|FG001|Maintenance Period|Went into rehabilitation|0
7714798|NCT00501293|12137739|FG000|Maintenance Period|Would not wear patch|1
7714799|NCT00501293|12137740|FG001|Maintenance Period|Would not wear patch|0
7714800|NCT00501293|12137739|FG000|Maintenance Period|Application site reaction|1
7714801|NCT00501293|12137740|FG001|Maintenance Period|Application site reaction|0
7714802|NCT00501540|12137747|FG000|Overall Study|Death|5
7714803|NCT00501644|12137773|FG000|Overall Study|Adverse Event|4
7714804|NCT00501644|12137773|FG000|Overall Study|Withdrawal by Subject|1
7714805|NCT00501852|12137777|FG000|Overall Study|Adverse Event|3
7714806|NCT00501852|12137777|FG000|Overall Study|Withdrawal by Subject|2
7714807|NCT00501969|12137807|FG000|Overall Study|Major Protocol Violation|4
7714808|NCT00501969|12137807|FG000|Overall Study|Lack of Efficacy|29
7714809|NCT00501969|12137807|FG000|Overall Study|Adverse Event|76
7714810|NCT00501969|12137807|FG000|Overall Study|Unsatisfactory compliance of subject|7
7714811|NCT00501969|12137807|FG000|Overall Study|Subject withdrew consent|51
7714812|NCT00501969|12137807|FG000|Overall Study|Lost to Follow-up|4
7714813|NCT00501969|12137807|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1
7714814|NCT00501969|12137807|FG000|Overall Study|Other: Sponsors Request|10
7714815|NCT00501969|12137807|FG000|Overall Study|Other: Sponsor Termination at Site|1
7714816|NCT00501969|12137807|FG000|Overall Study|Other: Sponsor Stopped Study|12
7714817|NCT00501969|12137807|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1
7714818|NCT00501969|12137807|FG000|Overall Study|Other: Patients + Investigator Agreement|1
7714819|NCT00501969|12137807|FG000|Overall Study|Other: Patient is Going to Have DBS|1
7714820|NCT00501969|12137807|FG000|Overall Study|Other: Pat Pending Surgery for PD|1
7714821|NCT00501969|12137807|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
7714822|NCT00501969|12137807|FG000|Overall Study|Other: As Required by Local EC|2
7714823|NCT00501969|12137807|FG000|Overall Study|Other: Admin Request from the Sponsor|3
7714824|NCT00501969|12137807|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1
7714825|NCT00502203|12137815|FG000|Overall Study|Inevaluable|1
7714826|NCT00502242|12137830|FG000|Overall Study|Lack of Efficacy|1
7714827|NCT00502242|12137831|FG001|Overall Study|Lack of Efficacy|11
7714828|NCT00502242|12137830|FG000|Overall Study|Adverse Event|31
7714829|NCT00502242|12137831|FG001|Overall Study|Adverse Event|20
7714830|NCT00502242|12137830|FG000|Overall Study|Physician Decision|2
7714831|NCT00502242|12137831|FG001|Overall Study|Physician Decision|3
7714832|NCT00502242|12137830|FG000|Overall Study|Other - Unspecified|8
7714833|NCT00502242|12137831|FG001|Overall Study|Other - Unspecified|14
7714834|NCT00502242|12137830|FG000|Overall Study|Protocol Violation|3
7714835|NCT00502242|12137831|FG001|Overall Study|Protocol Violation|1
7714836|NCT00502242|12137830|FG000|Overall Study|Withdrawal by Subject|6
7714837|NCT00502242|12137831|FG001|Overall Study|Withdrawal by Subject|7
7714838|NCT00502307|12137837|FG000|Open Label Period (16 Weeks)|Progressive disease|50
7714839|NCT00502307|12137838|FG001|Open Label Period (16 Weeks)|Progressive disease|0
7714840|NCT00502307|12137839|FG002|Open Label Period (16 Weeks)|Progressive disease|0
7714841|NCT00502307|12137837|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26
7714842|NCT00502307|12137838|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
7714843|NCT00502307|12137839|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
7714844|NCT00502307|12137837|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0
7714845|NCT00502307|12137838|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23
7714846|NCT00502307|12137839|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2
7714847|NCT00502307|12137837|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0
7714848|NCT00502307|12137838|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3
7714849|NCT00502307|12137839|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7
7714850|NCT00502307|12137837|FG000|Maintenance Period|Progressive disease|80
7714851|NCT00502307|12137838|FG001|Maintenance Period|Progressive disease|0
7714852|NCT00502307|12137839|FG002|Maintenance Period|Progressive disease|0
7714853|NCT00502307|12137837|FG000|Maintenance Period|Discontinued due to other reasons|68
7714854|NCT00502307|12137838|FG001|Maintenance Period|Discontinued due to other reasons|0
7714855|NCT00502307|12137839|FG002|Maintenance Period|Discontinued due to other reasons|0
7714856|NCT00502320|12137858|FG000|Overall Study|Lost to Follow-up|1
7714857|NCT00502320|12137859|FG001|Overall Study|Lost to Follow-up|1
7714858|NCT00502320|12137858|FG000|Overall Study|Withdrew Consent|1
7714859|NCT00502320|12137859|FG001|Overall Study|Withdrew Consent|0
7714860|NCT00502320|12137858|FG000|Overall Study|No longer met criteria|1
7714861|NCT00502320|12137859|FG001|Overall Study|No longer met criteria|0
7714862|NCT00502320|12137858|FG000|Overall Study|Screen Failure|0
7714863|NCT00502320|12137859|FG001|Overall Study|Screen Failure|1
7714864|NCT00502320|12137858|FG000|Overall Study|Adverse Event|3
7714865|NCT00502320|12137859|FG001|Overall Study|Adverse Event|5
7714866|NCT00502593|12137877|FG000|Overall Study|Withdrawn unspecified reason|1
7714867|NCT00502593|12137878|FG001|Overall Study|Withdrawn unspecified reason|1
7714868|NCT00502593|12137879|FG002|Overall Study|Withdrawn unspecified reason|3
7714869|NCT00502593|12137880|FG003|Overall Study|Withdrawn unspecified reason|1
7714870|NCT00502593|12137881|FG004|Overall Study|Withdrawn unspecified reason|2
7714871|NCT00502593|12137882|FG005|Overall Study|Withdrawn unspecified reason|0
7714872|NCT00502593|12137883|FG006|Overall Study|Withdrawn unspecified reason|2
7714873|NCT00502593|12137884|FG007|Overall Study|Withdrawn unspecified reason|0
7714874|NCT00502593|12137885|FG008|Overall Study|Withdrawn unspecified reason|0
7714875|NCT00502593|12137886|FG009|Overall Study|Withdrawn unspecified reason|0
7714876|NCT00502593|12137887|FG010|Overall Study|Withdrawn unspecified reason|0
7714877|NCT00502593|12137888|FG011|Overall Study|Withdrawn unspecified reason|0
7714878|NCT00502593|12137877|FG000|Overall Study|Withdrawal by Subject|0
7714879|NCT00502593|12137878|FG001|Overall Study|Withdrawal by Subject|0
7714880|NCT00502593|12137879|FG002|Overall Study|Withdrawal by Subject|6
7714881|NCT00502593|12137880|FG003|Overall Study|Withdrawal by Subject|2
7714882|NCT00502593|12137881|FG004|Overall Study|Withdrawal by Subject|2
7714883|NCT00502593|12137882|FG005|Overall Study|Withdrawal by Subject|0
7714884|NCT00502593|12137883|FG006|Overall Study|Withdrawal by Subject|3
7714885|NCT00502593|12137884|FG007|Overall Study|Withdrawal by Subject|0
7714886|NCT00502593|12137885|FG008|Overall Study|Withdrawal by Subject|3
7714887|NCT00502593|12137886|FG009|Overall Study|Withdrawal by Subject|0
7714888|NCT00502593|12137887|FG010|Overall Study|Withdrawal by Subject|1
7714889|NCT00502593|12137888|FG011|Overall Study|Withdrawal by Subject|0
7714890|NCT00502593|12137877|FG000|Overall Study|Lost to Follow-up|2
7714891|NCT00502593|12137878|FG001|Overall Study|Lost to Follow-up|1
7714892|NCT00502593|12137879|FG002|Overall Study|Lost to Follow-up|1
7714893|NCT00502593|12137880|FG003|Overall Study|Lost to Follow-up|1
7714894|NCT00502593|12137881|FG004|Overall Study|Lost to Follow-up|0
7714895|NCT00502593|12137882|FG005|Overall Study|Lost to Follow-up|0
7714896|NCT00502593|12137883|FG006|Overall Study|Lost to Follow-up|0
7714897|NCT00502593|12137884|FG007|Overall Study|Lost to Follow-up|0
7714898|NCT00502593|12137885|FG008|Overall Study|Lost to Follow-up|3
7714899|NCT00502593|12137886|FG009|Overall Study|Lost to Follow-up|0
7714900|NCT00502593|12137887|FG010|Overall Study|Lost to Follow-up|1
7714901|NCT00502593|12137888|FG011|Overall Study|Lost to Follow-up|0
7714902|NCT00502671|12137937|FG000|Overall Study|Disease Progression|13
7714903|NCT00502671|12137937|FG000|Overall Study|Personal Reasons|22
7714904|NCT00502671|12137937|FG000|Overall Study|Lost to Follow-up|7
7714905|NCT00502671|12137937|FG000|Overall Study|Protocol Violation|16
7714906|NCT00502671|12137937|FG000|Overall Study|Adverse Event|19
7714907|NCT00502697|12137943|FG000|Overall Study|Withdrawal by Subject|3
7714908|NCT00502697|12137944|FG001|Overall Study|Withdrawal by Subject|1
7714909|NCT00502697|12137943|FG000|Overall Study|disenrolled due to pregnancy loss|3
7714910|NCT00502697|12137944|FG001|Overall Study|disenrolled due to pregnancy loss|5
7714911|NCT00502697|12137943|FG000|Overall Study|found not to meet eligibility criteria|3
7714912|NCT00502697|12137944|FG001|Overall Study|found not to meet eligibility criteria|4
7714913|NCT00502697|12137943|FG000|Overall Study|did not meet assignment criteria|4
7714914|NCT00502697|12137944|FG001|Overall Study|did not meet assignment criteria|2
7714915|NCT00502775|12137953|FG000|Overall Study|Adverse Event|1
7714916|NCT00502775|12137954|FG001|Overall Study|Adverse Event|2
7714917|NCT00502775|12137955|FG002|Overall Study|Adverse Event|1
7714918|NCT00502775|12137953|FG000|Overall Study|Protocol Violation|1
7714919|NCT00502775|12137954|FG001|Overall Study|Protocol Violation|5
7714920|NCT00502775|12137955|FG002|Overall Study|Protocol Violation|2
7714921|NCT00502775|12137953|FG000|Overall Study|Withdrawal by Subject|1
7714922|NCT00502775|12137954|FG001|Overall Study|Withdrawal by Subject|1
7714923|NCT00502775|12137955|FG002|Overall Study|Withdrawal by Subject|2
7714924|NCT00502775|12137953|FG000|Overall Study|Sponsor Terminated Study|1
7714925|NCT00502775|12137954|FG001|Overall Study|Sponsor Terminated Study|0
7714926|NCT00502775|12137955|FG002|Overall Study|Sponsor Terminated Study|1
7714927|NCT00502775|12137953|FG000|Overall Study|Non-compliance with eDiary|4
7714928|NCT00502775|12137954|FG001|Overall Study|Non-compliance with eDiary|1
7714929|NCT00502775|12137955|FG002|Overall Study|Non-compliance with eDiary|1
7714930|NCT00502775|12137953|FG000|Overall Study|Subject unable to swallow capsule|1
7714931|NCT00502775|12137954|FG001|Overall Study|Subject unable to swallow capsule|0
7714932|NCT00502775|12137955|FG002|Overall Study|Subject unable to swallow capsule|1
7714933|NCT00502775|12137953|FG000|Overall Study|Logpad compliance <80%|1
7714934|NCT00502775|12137954|FG001|Overall Study|Logpad compliance <80%|0
7714935|NCT00502775|12137955|FG002|Overall Study|Logpad compliance <80%|0
7714936|NCT00502775|12137953|FG000|Overall Study|Randomized in error|0
7714937|NCT00502775|12137954|FG001|Overall Study|Randomized in error|1
7714938|NCT00502775|12137955|FG002|Overall Study|Randomized in error|1
7714939|NCT00502775|12137953|FG000|Overall Study|Non-compliance|0
7714940|NCT00502775|12137954|FG001|Overall Study|Non-compliance|2
7714941|NCT00502775|12137955|FG002|Overall Study|Non-compliance|2
7714942|NCT00502775|12137953|FG000|Overall Study|Outside pollen area more than 48 hours|0
7714943|NCT00502775|12137954|FG001|Overall Study|Outside pollen area more than 48 hours|1
7714944|NCT00502775|12137955|FG002|Overall Study|Outside pollen area more than 48 hours|0
7714945|NCT00502775|12137953|FG000|Overall Study|Declining pollen counts|0
7714946|NCT00502775|12137954|FG001|Overall Study|Declining pollen counts|1
7714947|NCT00502775|12137955|FG002|Overall Study|Declining pollen counts|1
7714948|NCT00502775|12137953|FG000|Overall Study|Subject in jail|0
7714949|NCT00502775|12137954|FG001|Overall Study|Subject in jail|1
7714950|NCT00502775|12137955|FG002|Overall Study|Subject in jail|0
7714951|NCT00502775|12137953|FG000|Overall Study|Subject took disallowed drug|0
7714952|NCT00502775|12137954|FG001|Overall Study|Subject took disallowed drug|0
7714953|NCT00502775|12137955|FG002|Overall Study|Subject took disallowed drug|1
7714954|NCT00502801|12137963|FG000|Treatment Period|Withdrawal by Subject|3
7714955|NCT00502801|12137963|FG000|Treatment Period|Adverse Event|7
7714956|NCT00502801|12137963|FG000|Treatment Period|Death|14
7714957|NCT00502801|12137963|FG000|Treatment Period|OTHER|30
7714958|NCT00502801|12137963|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1
7714959|NCT00502801|12137963|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2
7714960|NCT00502801|12137963|FG000|End of Therapy to Test of Cure|Death|3
7714961|NCT00502801|12137963|FG000|End of Therapy to Test of Cure|OTHER|2
7714962|NCT00502840|12137967|FG000|Overall Study|Adverse Event|5
7714963|NCT00502840|12137967|FG000|Overall Study|Additional or changed therapy|48
7714964|NCT00502840|12137967|FG000|Overall Study|Lack of Efficacy|11
7714965|NCT00502840|12137967|FG000|Overall Study|Protocol Violation|4
7714966|NCT00502840|12137967|FG000|Overall Study|Withdrawal by Subject|5
7714967|NCT00502840|12137967|FG000|Overall Study|Lost to Follow-up|6
7714968|NCT00502840|12137967|FG000|Overall Study|Administrative problems|1
7714969|NCT00502840|12137967|FG000|Overall Study|Other|20
7714970|NCT00502996|12137990|FG000|Overall Study|Lost to Follow-up|9
7714971|NCT00502996|12137990|FG000|Overall Study|Protocol Violation|2
7714972|NCT00502996|12137990|FG000|Overall Study|Treatment failure|25
7714973|NCT00502996|12137990|FG000|Overall Study|Withdrawal Informed Consent|6
7714974|NCT00502996|12137990|FG000|Overall Study|Adverse Event|2
7714975|NCT00503139|12138007|FG000|Overall Study|Case Report Forms were not collected|4
7714976|NCT00503139|12138007|FG000|Overall Study|Protocol Violation|4
7714977|NCT00503308|12138013|FG000|Overall Study|Protocol Violation|2
7714978|NCT00503308|12138014|FG001|Overall Study|Protocol Violation|1
7714979|NCT00503399|12138022|FG000|Overall Study|Death|2
7714980|NCT00503399|12138023|FG001|Overall Study|Death|1
7714981|NCT00503399|12138022|FG000|Overall Study|Protocol Violation|1
7714982|NCT00503399|12138023|FG001|Overall Study|Protocol Violation|0
7714983|NCT00503399|12138022|FG000|Overall Study|Withdrawal by Subject|4
7714984|NCT00503399|12138023|FG001|Overall Study|Withdrawal by Subject|2
7714985|NCT00503399|12138022|FG000|Overall Study|Adverse Event|0
7714986|NCT00503399|12138023|FG001|Overall Study|Adverse Event|3
7714987|NCT00503399|12138022|FG000|Overall Study|Lost to Follow-up|0
7714988|NCT00503399|12138023|FG001|Overall Study|Lost to Follow-up|2
7714989|NCT00503425|12138029|FG000|Overall Study|Participant files lost|6
7714990|NCT00503425|12138029|FG000|Overall Study|Adverse Event|5
7714991|NCT00503425|12138029|FG000|Overall Study|Lack of Efficacy|25
7714992|NCT00503425|12138029|FG000|Overall Study|Withdrawal by Subject|8
7714993|NCT00503425|12138029|FG000|Overall Study|Lost to Follow-up|3
7714994|NCT00503425|12138029|FG000|Overall Study|Death|3
7714995|NCT00503425|12138029|FG000|Overall Study|Missing Data/Unknown|4
7714996|NCT00503685|12138037|FG000|Overall Study|Adverse Event|0
7714997|NCT00503685|12138038|FG001|Overall Study|Adverse Event|0
7714998|NCT00503685|12138039|FG002|Overall Study|Adverse Event|2
7714999|NCT00503685|12138037|FG000|Overall Study|Withdrawal by Subject|0
7715000|NCT00503685|12138038|FG001|Overall Study|Withdrawal by Subject|1
7715001|NCT00503685|12138039|FG002|Overall Study|Withdrawal by Subject|0
7715002|NCT00503685|12138037|FG000|Overall Study|Protocol Violation|0
7715003|NCT00503685|12138038|FG001|Overall Study|Protocol Violation|1
7715004|NCT00503685|12138039|FG002|Overall Study|Protocol Violation|0
7715005|NCT00503685|12138037|FG000|Overall Study|Eligibility Criteria Not Met|0
7715006|NCT00503685|12138038|FG001|Overall Study|Eligibility Criteria Not Met|1
7715007|NCT00503685|12138039|FG002|Overall Study|Eligibility Criteria Not Met|0
7715008|NCT00503698|12138050|FG000|Overall Study|Protocol Violation|5
7715009|NCT00503698|12138051|FG001|Overall Study|Protocol Violation|6
7715010|NCT00503698|12138050|FG000|Overall Study|Adverse Event|52
7715011|NCT00503698|12138051|FG001|Overall Study|Adverse Event|41
7715012|NCT00503698|12138050|FG000|Overall Study|Death|1
7715013|NCT00503698|12138051|FG001|Overall Study|Death|0
7715014|NCT00503698|12138050|FG000|Overall Study|Lack of Efficacy|3
7715015|NCT00503698|12138051|FG001|Overall Study|Lack of Efficacy|4
7715016|NCT00503698|12138050|FG000|Overall Study|Trial terminated|216
7715017|NCT00503698|12138051|FG001|Overall Study|Trial terminated|253
7715018|NCT00503698|12138050|FG000|Overall Study|End hemodialysis due to renal transplant|10
7715019|NCT00503698|12138051|FG001|Overall Study|End hemodialysis due to renal transplant|4
7715020|NCT00503698|12138050|FG000|Overall Study|Pregnancy/intention to become pregnant|1
7715021|NCT00503698|12138051|FG001|Overall Study|Pregnancy/intention to become pregnant|0
7715022|NCT00503698|12138050|FG000|Overall Study|Any condition in exclusion criteria|4
7715108|NCT00504426|12138206|FG001|Overall Study|Protocol Violation|1
7715023|NCT00503698|12138051|FG001|Overall Study|Any condition in exclusion criteria|6
7715024|NCT00503698|12138050|FG000|Overall Study|Switch to peritoneal or home dialysis|2
7715025|NCT00503698|12138051|FG001|Overall Study|Switch to peritoneal or home dialysis|2
7715026|NCT00503698|12138050|FG000|Overall Study|Move to nonparticipating dialysis center|2
7715027|NCT00503698|12138051|FG001|Overall Study|Move to nonparticipating dialysis center|1
7715028|NCT00503698|12138050|FG000|Overall Study|Critically ill|2
7715029|NCT00503698|12138051|FG001|Overall Study|Critically ill|0
7715030|NCT00503698|12138050|FG000|Overall Study|Unclassified|48
7715031|NCT00503698|12138051|FG001|Overall Study|Unclassified|32
7715032|NCT00503698|12138050|FG000|Overall Study|Not exposed to trial drug|11
7715033|NCT00503698|12138051|FG001|Overall Study|Not exposed to trial drug|6
7715034|NCT00503776|12138065|FG000|Overall Study|Withdrawal by Subject|1
7715035|NCT00503776|12138066|FG001|Overall Study|Withdrawal by Subject|0
7715036|NCT00503776|12138067|FG002|Overall Study|Withdrawal by Subject|1
7715037|NCT00503776|12138068|FG003|Overall Study|Withdrawal by Subject|1
7715038|NCT00503776|12138065|FG000|Overall Study|Physician Decision|0
7715039|NCT00503776|12138066|FG001|Overall Study|Physician Decision|0
7715040|NCT00503776|12138067|FG002|Overall Study|Physician Decision|1
7715041|NCT00503776|12138068|FG003|Overall Study|Physician Decision|1
7715042|NCT00503867|12138083|FG000|Overall Study|Lost to Follow-up|1
7715043|NCT00503867|12138083|FG000|Overall Study|Adverse Event|1
7715044|NCT00503906|12138087|FG000|Overall Study|Withdrawal by Subject|1
7715045|NCT00503984|12138094|FG000|Overall Study|Protocol Violation|0
7715046|NCT00503984|12138095|FG001|Overall Study|Protocol Violation|1
7715047|NCT00503984|12138096|FG002|Overall Study|Protocol Violation|0
7715048|NCT00503984|12138097|FG003|Overall Study|Protocol Violation|0
7715049|NCT00503984|12138098|FG004|Overall Study|Protocol Violation|0
7715050|NCT00503984|12138099|FG005|Overall Study|Protocol Violation|0
7715051|NCT00503984|12138094|FG000|Overall Study|Adverse Event|0
7715052|NCT00503984|12138095|FG001|Overall Study|Adverse Event|1
7715053|NCT00503984|12138096|FG002|Overall Study|Adverse Event|0
7715054|NCT00503984|12138097|FG003|Overall Study|Adverse Event|0
7715055|NCT00503984|12138098|FG004|Overall Study|Adverse Event|0
7715056|NCT00503984|12138099|FG005|Overall Study|Adverse Event|0
7715057|NCT00503984|12138094|FG000|Overall Study|Death|0
7715058|NCT00503984|12138095|FG001|Overall Study|Death|0
7715059|NCT00503984|12138096|FG002|Overall Study|Death|0
7715060|NCT00503984|12138097|FG003|Overall Study|Death|0
7715061|NCT00503984|12138098|FG004|Overall Study|Death|1
7715062|NCT00503984|12138099|FG005|Overall Study|Death|0
7715063|NCT00503997|12138123|FG000|Overall Study|disease progression|1
7715064|NCT00503997|12138123|FG000|Overall Study|Adverse Event|5
7715065|NCT00503997|12138123|FG000|Overall Study|Death|1
7715066|NCT00503997|12138123|FG000|Overall Study|Withdrawal by Subject|1
7715067|NCT00504075|12138131|FG000|Overall Study|Adverse Event|1
7715068|NCT00504075|12138131|FG000|Overall Study|Lost to Follow-up|5
7715069|NCT00504075|12138131|FG000|Overall Study|Withdrawal by Subject|1
7715070|NCT00504075|12138131|FG000|Overall Study|Required other therapeutic intervention|1
7715071|NCT00504153|12138136|FG000|Overall Study|Withdrawal by Subject|1
7715072|NCT00504153|12138136|FG000|Overall Study|Adverse Event|4
7715073|NCT00504153|12138136|FG000|Overall Study|Death|1
7715074|NCT00504166|12138142|FG000|Overall Study|Adverse Event|1
7715075|NCT00504166|12138143|FG001|Overall Study|Adverse Event|4
7715076|NCT00504166|12138142|FG000|Overall Study|Withdrawal by Subject|3
7715077|NCT00504166|12138143|FG001|Overall Study|Withdrawal by Subject|6
7715078|NCT00504166|12138142|FG000|Overall Study|Physician Decision|1
7715079|NCT00504166|12138143|FG001|Overall Study|Physician Decision|1
7715080|NCT00504166|12138142|FG000|Overall Study|Lost to Follow-up|1
7715081|NCT00504166|12138143|FG001|Overall Study|Lost to Follow-up|3
7715082|NCT00504231|12138153|FG000|Overall Study|Discrepant chart documentation re route|0
7715083|NCT00504231|12138154|FG001|Overall Study|Discrepant chart documentation re route|0
7715084|NCT00504231|12138155|FG002|Overall Study|Discrepant chart documentation re route|1
7715085|NCT00504231|12138156|FG003|Overall Study|Discrepant chart documentation re route|0
7715086|NCT00504257|12138170|FG000|Overall Study|Withdrawal by Subject|2
7715087|NCT00504257|12138170|FG000|Overall Study|ineligible histology|2
7715088|NCT00504309|12138180|FG000|Overall Study|Death|0
7715089|NCT00504309|12138181|FG001|Overall Study|Death|0
7715090|NCT00504309|12138182|FG002|Overall Study|Death|0
7715091|NCT00504309|12138183|FG003|Overall Study|Death|0
7715092|NCT00504309|12138184|FG004|Overall Study|Death|1
7715093|NCT00504309|12138185|FG005|Overall Study|Death|0
7715094|NCT00504309|12138180|FG000|Overall Study|Withdrawal by Subject|0
7715095|NCT00504309|12138181|FG001|Overall Study|Withdrawal by Subject|0
7715096|NCT00504309|12138182|FG002|Overall Study|Withdrawal by Subject|1
7715097|NCT00504309|12138183|FG003|Overall Study|Withdrawal by Subject|0
7715098|NCT00504309|12138184|FG004|Overall Study|Withdrawal by Subject|0
7715099|NCT00504309|12138185|FG005|Overall Study|Withdrawal by Subject|0
7715100|NCT00504348|12138197|FG000|Overall Study|Adverse Event|3
7715101|NCT00504348|12138197|FG000|Overall Study|Lack of Efficacy|4
7715102|NCT00504348|12138197|FG000|Overall Study|Physician Decision|1
7715103|NCT00504426|12138205|FG000|Overall Study|Adverse Event|0
7715104|NCT00504426|12138206|FG001|Overall Study|Adverse Event|0
7715105|NCT00504426|12138207|FG002|Overall Study|Adverse Event|2
7715106|NCT00504426|12138208|FG003|Overall Study|Adverse Event|0
7715107|NCT00504426|12138205|FG000|Overall Study|Protocol Violation|1
7715109|NCT00504426|12138207|FG002|Overall Study|Protocol Violation|2
7715110|NCT00504426|12138208|FG003|Overall Study|Protocol Violation|0
7715111|NCT00504426|12138205|FG000|Overall Study|Withdrawal by Subject|2
7715112|NCT00504426|12138206|FG001|Overall Study|Withdrawal by Subject|0
7715113|NCT00504426|12138207|FG002|Overall Study|Withdrawal by Subject|0
7715114|NCT00504426|12138208|FG003|Overall Study|Withdrawal by Subject|0
7715115|NCT00504556|12138230|FG000|Overall Study|Adverse Event|11
7715116|NCT00504556|12138231|FG001|Overall Study|Adverse Event|11
7715117|NCT00504556|12138232|FG002|Overall Study|Adverse Event|14
7715118|NCT00504556|12138233|FG003|Overall Study|Adverse Event|13
7715119|NCT00504556|12138234|FG004|Overall Study|Adverse Event|5
7715120|NCT00504556|12138230|FG000|Overall Study|Death|3
7715121|NCT00504556|12138231|FG001|Overall Study|Death|3
7715122|NCT00504556|12138232|FG002|Overall Study|Death|1
7715123|NCT00504556|12138233|FG003|Overall Study|Death|0
7715124|NCT00504556|12138234|FG004|Overall Study|Death|2
7715125|NCT00504556|12138230|FG000|Overall Study|Protocol Violation|1
7715126|NCT00504556|12138231|FG001|Overall Study|Protocol Violation|3
7715127|NCT00504556|12138232|FG002|Overall Study|Protocol Violation|2
7715128|NCT00504556|12138233|FG003|Overall Study|Protocol Violation|1
7715129|NCT00504556|12138234|FG004|Overall Study|Protocol Violation|2
7715130|NCT00504556|12138230|FG000|Overall Study|Lost to Follow-up|0
7715131|NCT00504556|12138231|FG001|Overall Study|Lost to Follow-up|0
7715132|NCT00504556|12138232|FG002|Overall Study|Lost to Follow-up|1
7715133|NCT00504556|12138233|FG003|Overall Study|Lost to Follow-up|1
7715134|NCT00504556|12138234|FG004|Overall Study|Lost to Follow-up|1
7715135|NCT00504556|12138230|FG000|Overall Study|Withdrawal by Subject|16
7715136|NCT00504556|12138231|FG001|Overall Study|Withdrawal by Subject|16
7715137|NCT00504556|12138232|FG002|Overall Study|Withdrawal by Subject|7
7715138|NCT00504556|12138233|FG003|Overall Study|Withdrawal by Subject|8
7715139|NCT00504556|12138234|FG004|Overall Study|Withdrawal by Subject|12
7715140|NCT00504556|12138230|FG000|Overall Study|administrative reasons|0
7715141|NCT00504556|12138231|FG001|Overall Study|administrative reasons|2
7715142|NCT00504556|12138232|FG002|Overall Study|administrative reasons|2
7715143|NCT00504556|12138233|FG003|Overall Study|administrative reasons|1
7715144|NCT00504556|12138234|FG004|Overall Study|administrative reasons|2
7715145|NCT00504556|12138230|FG000|Overall Study|did not meet entry criteria|2
7715146|NCT00504556|12138231|FG001|Overall Study|did not meet entry criteria|0
7715147|NCT00504556|12138232|FG002|Overall Study|did not meet entry criteria|1
7715148|NCT00504556|12138233|FG003|Overall Study|did not meet entry criteria|1
7715149|NCT00504556|12138234|FG004|Overall Study|did not meet entry criteria|0
7715150|NCT00504556|12138230|FG000|Overall Study|data monitor committee decision|0
7715151|NCT00504556|12138231|FG001|Overall Study|data monitor committee decision|0
7715152|NCT00504556|12138232|FG002|Overall Study|data monitor committee decision|0
7715153|NCT00504556|12138233|FG003|Overall Study|data monitor committee decision|100
7715154|NCT00504556|12138234|FG004|Overall Study|data monitor committee decision|0
7715155|NCT00504556|12138230|FG000|Overall Study|Other|2
7715156|NCT00504556|12138231|FG001|Overall Study|Other|2
7715157|NCT00504556|12138232|FG002|Overall Study|Other|2
7715158|NCT00504556|12138233|FG003|Overall Study|Other|3
7715159|NCT00504556|12138234|FG004|Overall Study|Other|0
7715160|NCT00504556|12138230|FG000|Overall Study|not in safety analysis set|0
7715161|NCT00504556|12138231|FG001|Overall Study|not in safety analysis set|1
7715162|NCT00504556|12138232|FG002|Overall Study|not in safety analysis set|1
7715163|NCT00504556|12138233|FG003|Overall Study|not in safety analysis set|0
7715164|NCT00504556|12138234|FG004|Overall Study|not in safety analysis set|1
7715165|NCT00504595|12138250|FG000|Overall Study|Lack of Efficacy|1
7715166|NCT00504595|12138251|FG001|Overall Study|Lack of Efficacy|0
7715167|NCT00504595|12138252|FG002|Overall Study|Lack of Efficacy|0
7715168|NCT00504595|12138253|FG003|Overall Study|Lack of Efficacy|0
7715169|NCT00504595|12138250|FG000|Overall Study|Other|0
7715170|NCT00504595|12138251|FG001|Overall Study|Other|0
7715171|NCT00504595|12138252|FG002|Overall Study|Other|2
7715172|NCT00504595|12138253|FG003|Overall Study|Other|0
7715173|NCT00504725|12138274|FG000|Overall Study|Protocol Violation|1
7715174|NCT00504725|12138275|FG001|Overall Study|Protocol Violation|0
7715175|NCT00504777|12138285|FG000|Overall Study|Adverse Event|1
7715176|NCT00504829|12138292|FG000|Overall Study|Protocol Violation|6
7715177|NCT00504829|12138293|FG001|Overall Study|Protocol Violation|4
7715178|NCT00504829|12138294|FG002|Overall Study|Protocol Violation|10
7715179|NCT00504881|12138304|FG000|Overall Study|Lack of Efficacy|1
7715180|NCT00504881|12138305|FG001|Overall Study|Lack of Efficacy|5
7715181|NCT00504881|12138304|FG000|Overall Study|Lost to Follow-up|0
7715182|NCT00504881|12138305|FG001|Overall Study|Lost to Follow-up|2
7715183|NCT00504881|12138304|FG000|Overall Study|Withdrawal by Subject|1
7715184|NCT00504881|12138305|FG001|Overall Study|Withdrawal by Subject|4
7715185|NCT00504881|12138304|FG000|Overall Study|Non-Compliance|1
7715186|NCT00504881|12138305|FG001|Overall Study|Non-Compliance|0
7715187|NCT00504881|12138304|FG000|Overall Study|No Birth Control|0
7715188|NCT00504881|12138305|FG001|Overall Study|No Birth Control|1
7715189|NCT00504881|12138304|FG000|Overall Study|Safety Visit not performed|0
7715190|NCT00504881|12138305|FG001|Overall Study|Safety Visit not performed|1
7715191|NCT00504881|12138304|FG000|Overall Study|AE, serious fatal|0
7715192|NCT00504881|12138305|FG001|Overall Study|AE, serious fatal|1
7715193|NCT00504881|12138304|FG000|Overall Study|SAE, non-fatal|2
7715194|NCT00504881|12138305|FG001|Overall Study|SAE, non-fatal|6
7715195|NCT00504881|12138304|FG000|Overall Study|AE, non-serious non-fatal|4
7715196|NCT00504881|12138305|FG001|Overall Study|AE, non-serious non-fatal|14
7715197|NCT00504881|12138304|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7715198|NCT00504881|12138305|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
7715199|NCT00504881|12138304|FG000|Overall Study|AE of unknown type|1
7715200|NCT00504881|12138305|FG001|Overall Study|AE of unknown type|0
7715201|NCT00504894|12138316|FG000|Overall Study|fMRI technical problems|1
7715202|NCT00504894|12138317|FG001|Overall Study|fMRI technical problems|1
7715203|NCT00504894|12138318|FG002|Overall Study|fMRI technical problems|0
7715204|NCT00504894|12138316|FG000|Overall Study|Withdrawal by Subject|0
7715205|NCT00504894|12138317|FG001|Overall Study|Withdrawal by Subject|1
7715206|NCT00504894|12138318|FG002|Overall Study|Withdrawal by Subject|0
7715207|NCT00504894|12138316|FG000|Overall Study|Infusion technical problems|0
7715208|NCT00504894|12138317|FG001|Overall Study|Infusion technical problems|1
7715209|NCT00504894|12138318|FG002|Overall Study|Infusion technical problems|0
7715210|NCT00504894|12138316|FG000|Overall Study|poor subject data|2
7715211|NCT00504894|12138317|FG001|Overall Study|poor subject data|0
7715212|NCT00504894|12138318|FG002|Overall Study|poor subject data|0
7715213|NCT00505076|12138329|FG000|Overall Study|Adverse Event|1
7715214|NCT00505076|12138330|FG001|Overall Study|Adverse Event|0
7715215|NCT00505076|12138331|FG002|Overall Study|Adverse Event|1
7715216|NCT00505076|12138329|FG000|Overall Study|Protocol Violation|2
7715217|NCT00505076|12138330|FG001|Overall Study|Protocol Violation|1
7715218|NCT00505076|12138331|FG002|Overall Study|Protocol Violation|2
7715219|NCT00505076|12138329|FG000|Overall Study|Withdrawal by Subject|0
7715220|NCT00505076|12138330|FG001|Overall Study|Withdrawal by Subject|1
7715221|NCT00505076|12138331|FG002|Overall Study|Withdrawal by Subject|2
7715222|NCT00505284|12138344|FG000|Overall Study|Adverse Event|3
7715223|NCT00505284|12138345|FG001|Overall Study|Adverse Event|7
7715224|NCT00505284|12138346|FG002|Overall Study|Adverse Event|9
7715225|NCT00505284|12138347|FG003|Overall Study|Adverse Event|14
7715226|NCT00505284|12138348|FG004|Overall Study|Adverse Event|22
7715227|NCT00505284|12138344|FG000|Overall Study|Protocol Violation|0
7715228|NCT00505284|12138345|FG001|Overall Study|Protocol Violation|1
7715229|NCT00505284|12138346|FG002|Overall Study|Protocol Violation|1
7715230|NCT00505284|12138347|FG003|Overall Study|Protocol Violation|0
7715231|NCT00505284|12138348|FG004|Overall Study|Protocol Violation|0
7715232|NCT00505284|12138344|FG000|Overall Study|Withdrawal by Subject|2
7715233|NCT00505284|12138345|FG001|Overall Study|Withdrawal by Subject|6
7715234|NCT00505284|12138346|FG002|Overall Study|Withdrawal by Subject|1
7715235|NCT00505284|12138347|FG003|Overall Study|Withdrawal by Subject|0
7715236|NCT00505284|12138348|FG004|Overall Study|Withdrawal by Subject|6
7715237|NCT00505284|12138344|FG000|Overall Study|Lack of Efficacy|0
7715238|NCT00505284|12138345|FG001|Overall Study|Lack of Efficacy|1
7715239|NCT00505284|12138346|FG002|Overall Study|Lack of Efficacy|1
7715240|NCT00505284|12138347|FG003|Overall Study|Lack of Efficacy|1
7715241|NCT00505284|12138348|FG004|Overall Study|Lack of Efficacy|1
7715242|NCT00505284|12138344|FG000|Overall Study|Physician Decision|0
7715243|NCT00505284|12138345|FG001|Overall Study|Physician Decision|1
7715244|NCT00505284|12138346|FG002|Overall Study|Physician Decision|0
7715245|NCT00505284|12138347|FG003|Overall Study|Physician Decision|0
7715246|NCT00505284|12138348|FG004|Overall Study|Physician Decision|0
7715247|NCT00505284|12138344|FG000|Overall Study|Other|5
7715248|NCT00505284|12138345|FG001|Overall Study|Other|0
7715249|NCT00505284|12138346|FG002|Overall Study|Other|0
7715250|NCT00505284|12138347|FG003|Overall Study|Other|4
7715251|NCT00505284|12138348|FG004|Overall Study|Other|4
7715252|NCT00505375|12138371|FG000|Overall Study|Death|1
7715253|NCT00505375|12138372|FG001|Overall Study|Death|0
7715254|NCT00505375|12138371|FG000|Overall Study|Withdrawal by Subject|2
7715255|NCT00505375|12138372|FG001|Overall Study|Withdrawal by Subject|2
7715256|NCT00505375|12138371|FG000|Overall Study|Lost to Follow-up|0
7715257|NCT00505375|12138372|FG001|Overall Study|Lost to Follow-up|2
7715258|NCT00505375|12138371|FG000|Overall Study|Pregnancy|1
7715259|NCT00505375|12138372|FG001|Overall Study|Pregnancy|0
7715260|NCT00505375|12138371|FG000|Overall Study|Travel issues|0
7715261|NCT00505375|12138372|FG001|Overall Study|Travel issues|1
7715262|NCT00505414|12138380|FG000|Titration Phase|Adverse Event|0
7715263|NCT00505414|12138381|FG001|Titration Phase|Adverse Event|0
7715264|NCT00505414|12138382|FG002|Titration Phase|Adverse Event|0
7715265|NCT00505414|12138383|FG003|Titration Phase|Adverse Event|8
7715266|NCT00505414|12138384|FG004|Titration Phase|Adverse Event|3
7715267|NCT00505414|12138380|FG000|Titration Phase|Death|0
7715268|NCT00505414|12138381|FG001|Titration Phase|Death|0
7715269|NCT00505414|12138382|FG002|Titration Phase|Death|0
7715270|NCT00505414|12138383|FG003|Titration Phase|Death|2
7715271|NCT00505414|12138384|FG004|Titration Phase|Death|0
7715272|NCT00505414|12138380|FG000|Titration Phase|Lack of Efficacy|0
7715273|NCT00505414|12138381|FG001|Titration Phase|Lack of Efficacy|0
7715274|NCT00505414|12138382|FG002|Titration Phase|Lack of Efficacy|0
7715275|NCT00505414|12138383|FG003|Titration Phase|Lack of Efficacy|10
7715276|NCT00505414|12138384|FG004|Titration Phase|Lack of Efficacy|1
7715277|NCT00505414|12138380|FG000|Titration Phase|Protocol Violation|0
7715278|NCT00505414|12138381|FG001|Titration Phase|Protocol Violation|0
7715279|NCT00505414|12138382|FG002|Titration Phase|Protocol Violation|0
7715280|NCT00505414|12138383|FG003|Titration Phase|Protocol Violation|0
7715281|NCT00505414|12138384|FG004|Titration Phase|Protocol Violation|1
7715282|NCT00505414|12138380|FG000|Titration Phase|Withdrawal by Subject|0
7715283|NCT00505414|12138381|FG001|Titration Phase|Withdrawal by Subject|0
7715284|NCT00505414|12138382|FG002|Titration Phase|Withdrawal by Subject|0
7715285|NCT00505414|12138383|FG003|Titration Phase|Withdrawal by Subject|3
7715286|NCT00505414|12138384|FG004|Titration Phase|Withdrawal by Subject|4
7715287|NCT00505414|12138380|FG000|Titration Phase|Underlying disease and therapy required|0
7715288|NCT00505414|12138381|FG001|Titration Phase|Underlying disease and therapy required|0
7715289|NCT00505414|12138382|FG002|Titration Phase|Underlying disease and therapy required|0
7715290|NCT00505414|12138383|FG003|Titration Phase|Underlying disease and therapy required|7
7715291|NCT00505414|12138384|FG004|Titration Phase|Underlying disease and therapy required|3
7715292|NCT00505414|12138380|FG000|Maintenance Phase|Adverse Event|2
7715293|NCT00505414|12138381|FG001|Maintenance Phase|Adverse Event|2
7715294|NCT00505414|12138382|FG002|Maintenance Phase|Adverse Event|3
7715295|NCT00505414|12138383|FG003|Maintenance Phase|Adverse Event|0
7715296|NCT00505414|12138384|FG004|Maintenance Phase|Adverse Event|0
7715297|NCT00505414|12138380|FG000|Maintenance Phase|Death|2
7715298|NCT00505414|12138381|FG001|Maintenance Phase|Death|0
7715299|NCT00505414|12138382|FG002|Maintenance Phase|Death|1
7715300|NCT00505414|12138383|FG003|Maintenance Phase|Death|0
7715301|NCT00505414|12138384|FG004|Maintenance Phase|Death|0
7715302|NCT00505414|12138380|FG000|Maintenance Phase|Lack of Efficacy|2
7715303|NCT00505414|12138381|FG001|Maintenance Phase|Lack of Efficacy|1
7715304|NCT00505414|12138382|FG002|Maintenance Phase|Lack of Efficacy|1
7715305|NCT00505414|12138383|FG003|Maintenance Phase|Lack of Efficacy|0
7715306|NCT00505414|12138384|FG004|Maintenance Phase|Lack of Efficacy|0
7715307|NCT00505414|12138380|FG000|Maintenance Phase|Withdrawal by Subject|0
7715308|NCT00505414|12138381|FG001|Maintenance Phase|Withdrawal by Subject|0
7715309|NCT00505414|12138382|FG002|Maintenance Phase|Withdrawal by Subject|1
7715310|NCT00505414|12138383|FG003|Maintenance Phase|Withdrawal by Subject|0
7715311|NCT00505414|12138384|FG004|Maintenance Phase|Withdrawal by Subject|0
7715312|NCT00505414|12138380|FG000|Maintenance Phase|underlying disease and therapy required|0
7715313|NCT00505414|12138381|FG001|Maintenance Phase|underlying disease and therapy required|2
7715314|NCT00505414|12138382|FG002|Maintenance Phase|underlying disease and therapy required|2
7715315|NCT00505414|12138383|FG003|Maintenance Phase|underlying disease and therapy required|0
7715316|NCT00505414|12138384|FG004|Maintenance Phase|underlying disease and therapy required|0
7715317|NCT00505622|12138403|FG000|Overall Study|Adverse Event|5
7715318|NCT00505622|12138404|FG001|Overall Study|Adverse Event|6
7715319|NCT00505622|12138405|FG002|Overall Study|Adverse Event|4
7715320|NCT00505622|12138403|FG000|Overall Study|Protocol Violation|1
7715321|NCT00505622|12138404|FG001|Overall Study|Protocol Violation|1
7715322|NCT00505622|12138405|FG002|Overall Study|Protocol Violation|0
7715323|NCT00505622|12138403|FG000|Overall Study|Withdrawal by Subject|0
7715324|NCT00505622|12138404|FG001|Overall Study|Withdrawal by Subject|3
7715325|NCT00505622|12138405|FG002|Overall Study|Withdrawal by Subject|2
7715326|NCT00505622|12138403|FG000|Overall Study|Study termination by sponsor|115
7715327|NCT00505622|12138404|FG001|Overall Study|Study termination by sponsor|98
7715328|NCT00505622|12138405|FG002|Overall Study|Study termination by sponsor|90
7715329|NCT00505661|12138417|FG000|Overall Study|Not Eligible|4
7715330|NCT00505687|12138421|FG000|Overall Study|Important protocol violation|2
7715331|NCT00505687|12138421|FG000|Overall Study|Lack of Efficacy|15
7715332|NCT00505687|12138421|FG000|Overall Study|Adverse Event|48
7715333|NCT00505687|12138421|FG000|Overall Study|Subject withdrew consent|15
7715334|NCT00505687|12138421|FG000|Overall Study|Lost to Follow-up|1
7715335|NCT00505687|12138421|FG000|Overall Study|Other: Underwent Implantation Of DBS|1
7715336|NCT00505687|12138421|FG000|Overall Study|Other: Scheduled DBS Surgery|1
7715337|NCT00505687|12138421|FG000|Overall Study|Other: Prolonged Hospitalization|1
7715338|NCT00505687|12138421|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
7715339|NCT00505687|12138421|FG000|Overall Study|Other: Neupro Given In Hospital|1
7715340|NCT00505687|12138421|FG000|Overall Study|Other: Disease Progression|1
7715341|NCT00505687|12138421|FG000|Overall Study|Other: As Per Sponsor|8
7715342|NCT00505752|12138429|FG000|Overall Study|Adverse Event|1
7715343|NCT00505752|12138430|FG001|Overall Study|Adverse Event|0
7715344|NCT00505752|12138431|FG002|Overall Study|Adverse Event|1
7715345|NCT00505752|12138432|FG003|Overall Study|Adverse Event|0
7715346|NCT00505752|12138429|FG000|Overall Study|Lost to Follow-up|1
7715347|NCT00505752|12138430|FG001|Overall Study|Lost to Follow-up|0
7715348|NCT00505752|12138431|FG002|Overall Study|Lost to Follow-up|0
7715349|NCT00505752|12138432|FG003|Overall Study|Lost to Follow-up|0
7715350|NCT00505752|12138429|FG000|Overall Study|Lack of ovarian response|1
7715351|NCT00505752|12138430|FG001|Overall Study|Lack of ovarian response|3
7715352|NCT00505752|12138431|FG002|Overall Study|Lack of ovarian response|0
7715353|NCT00505752|12138432|FG003|Overall Study|Lack of ovarian response|0
7715354|NCT00505752|12138429|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1
7715355|NCT00505752|12138430|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1
7715356|NCT00505752|12138431|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3
7715357|NCT00505752|12138432|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1
7715358|NCT00505752|12138429|FG000|Overall Study|No oocytes retrieved|0
7715359|NCT00505752|12138430|FG001|Overall Study|No oocytes retrieved|2
7715360|NCT00505752|12138431|FG002|Overall Study|No oocytes retrieved|0
7715361|NCT00505752|12138432|FG003|Overall Study|No oocytes retrieved|1
7715362|NCT00505752|12138429|FG000|Overall Study|No Fertilization|1
7715363|NCT00505752|12138430|FG001|Overall Study|No Fertilization|1
7715364|NCT00505752|12138431|FG002|Overall Study|No Fertilization|2
7715365|NCT00505752|12138432|FG003|Overall Study|No Fertilization|1
7715366|NCT00505752|12138429|FG000|Overall Study|All embryos/blastocysts discarded|0
7715367|NCT00505752|12138430|FG001|Overall Study|All embryos/blastocysts discarded|0
7715368|NCT00505752|12138431|FG002|Overall Study|All embryos/blastocysts discarded|1
7715369|NCT00505752|12138432|FG003|Overall Study|All embryos/blastocysts discarded|1
7715370|NCT00505752|12138429|FG000|Overall Study|Other|1
7715371|NCT00505752|12138430|FG001|Overall Study|Other|2
7715372|NCT00505752|12138431|FG002|Overall Study|Other|1
7715373|NCT00505752|12138432|FG003|Overall Study|Other|2
7715374|NCT00505765|12138445|FG000|Overall Study|Withdrawal by Subject|1
7715375|NCT00505765|12138446|FG001|Overall Study|Withdrawal by Subject|0
7715376|NCT00505765|12138447|FG002|Overall Study|Withdrawal by Subject|0
7715377|NCT00505765|12138445|FG000|Overall Study|Adverse Event|1
7715378|NCT00505765|12138446|FG001|Overall Study|Adverse Event|2
7715379|NCT00505765|12138447|FG002|Overall Study|Adverse Event|0
7715380|NCT00505765|12138445|FG000|Overall Study|Noncompliance|0
7715381|NCT00505765|12138446|FG001|Overall Study|Noncompliance|1
7715382|NCT00505765|12138447|FG002|Overall Study|Noncompliance|3
7715383|NCT00505778|12138457|FG000|Overall Study|Adverse Event|2
7715384|NCT00505778|12138458|FG001|Overall Study|Adverse Event|7
7715385|NCT00505778|12138457|FG000|Overall Study|Physician Decision|8
7715386|NCT00505778|12138458|FG001|Overall Study|Physician Decision|14
7715387|NCT00505778|12138457|FG000|Overall Study|Lost to Follow-up|17
7715388|NCT00505778|12138458|FG001|Overall Study|Lost to Follow-up|23
7715389|NCT00505778|12138457|FG000|Overall Study|Unable to Meet Protocol Criteria|4
7715390|NCT00505778|12138458|FG001|Overall Study|Unable to Meet Protocol Criteria|1
7715391|NCT00505778|12138457|FG000|Overall Study|Protocol Violation|7
7715392|NCT00505778|12138458|FG001|Overall Study|Protocol Violation|9
7715393|NCT00505778|12138457|FG000|Overall Study|Withdrawal by Subject|29
7715394|NCT00505778|12138458|FG001|Overall Study|Withdrawal by Subject|14
7715395|NCT00505778|12138457|FG000|Overall Study|Relapse|65
7715396|NCT00505778|12138458|FG001|Overall Study|Relapse|65
7715397|NCT00505778|12138457|FG000|Overall Study|Took No Study Drug|2
7715398|NCT00505778|12138458|FG001|Overall Study|Took No Study Drug|2
7715399|NCT00505921|12138473|FG000|Overall Study|Ineligible|1
7715400|NCT00505921|12138473|FG000|Overall Study|Failed to Mobilize|8
7715401|NCT00505934|12138477|FG000|Overall Study|Adverse Event|1
7715402|NCT00505934|12138477|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1
7715403|NCT00505934|12138477|FG000|Overall Study|Other: IV dose needed to be changed|1
7715404|NCT00506077|12138496|FG000|Treatment Period 1|Adverse Event|2
7715405|NCT00506077|12138497|FG001|Treatment Period 1|Adverse Event|1
7715406|NCT00506077|12138496|FG000|Treatment Period 1|Lost to Follow-up|0
7715407|NCT00506077|12138497|FG001|Treatment Period 1|Lost to Follow-up|2
7715408|NCT00506077|12138496|FG000|Treatment Period 1|Withdrawal by Subject|2
7715409|NCT00506077|12138497|FG001|Treatment Period 1|Withdrawal by Subject|0
7715410|NCT00506077|12138496|FG000|Treatment Period 2|Adverse Event|0
7715411|NCT00506077|12138497|FG001|Treatment Period 2|Adverse Event|1
7715412|NCT00506077|12138496|FG000|Treatment Period 2|Withdrawal by Subject|1
7715413|NCT00506077|12138497|FG001|Treatment Period 2|Withdrawal by Subject|0
7715414|NCT00506129|12138503|FG000|Overall Study|Disease Progression/Relapse|15
7715415|NCT00506129|12138503|FG000|Overall Study|Death|7
7715416|NCT00506142|12138509|FG000|Overall Study|Adverse Event|8
7715417|NCT00506142|12138510|FG001|Overall Study|Adverse Event|7
7715418|NCT00506142|12138509|FG000|Overall Study|Lack of Efficacy|21
7715419|NCT00506142|12138510|FG001|Overall Study|Lack of Efficacy|7
7715420|NCT00506142|12138509|FG000|Overall Study|Withdrawal by Subject|4
7715421|NCT00506142|12138510|FG001|Overall Study|Withdrawal by Subject|5
7715422|NCT00506142|12138509|FG000|Overall Study|Physician Decision|1
7715423|NCT00506142|12138510|FG001|Overall Study|Physician Decision|0
7715424|NCT00506142|12138509|FG000|Overall Study|New health condition|1
7715425|NCT00506142|12138510|FG001|Overall Study|New health condition|0
7715426|NCT00506285|12138522|FG000|3 Week Screening Phase|Withdrawal by Subject|17
7715427|NCT00506285|12138523|FG001|3 Week Screening Phase|Withdrawal by Subject|10
7715428|NCT00506285|12138522|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4
7715429|NCT00506285|12138523|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3
7715430|NCT00506285|12138522|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5
7715431|NCT00506285|12138523|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2
7715432|NCT00506285|12138522|FG000|6-month Open Label Phase|Lost to Follow-up|1
7715433|NCT00506285|12138523|FG001|6-month Open Label Phase|Lost to Follow-up|7
7715434|NCT00506285|12138522|FG000|6-month Open Label Phase|Withdrawal by Subject|9
7715435|NCT00506285|12138523|FG001|6-month Open Label Phase|Withdrawal by Subject|5
7715436|NCT00506350|12138540|FG000|Overall Study|Serious Adverse Event|1
7715437|NCT00506350|12138541|FG001|Overall Study|Serious Adverse Event|0
7715438|NCT00506350|12138542|FG002|Overall Study|Serious Adverse Event|0
7715439|NCT00506350|12138543|FG003|Overall Study|Serious Adverse Event|0
7715440|NCT00506350|12138544|FG004|Overall Study|Serious Adverse Event|0
7715441|NCT00506350|12138545|FG005|Overall Study|Serious Adverse Event|0
7715442|NCT00506350|12138546|FG006|Overall Study|Serious Adverse Event|0
7715443|NCT00506350|12138547|FG007|Overall Study|Serious Adverse Event|0
7715444|NCT00506350|12138548|FG008|Overall Study|Serious Adverse Event|0
7715445|NCT00506350|12138540|FG000|Overall Study|Adverse Event|0
7715446|NCT00506350|12138541|FG001|Overall Study|Adverse Event|0
7715447|NCT00506350|12138542|FG002|Overall Study|Adverse Event|0
7715448|NCT00506350|12138543|FG003|Overall Study|Adverse Event|0
7715449|NCT00506350|12138544|FG004|Overall Study|Adverse Event|0
7715450|NCT00506350|12138545|FG005|Overall Study|Adverse Event|0
7715451|NCT00506350|12138546|FG006|Overall Study|Adverse Event|0
7715452|NCT00506350|12138547|FG007|Overall Study|Adverse Event|1
7715453|NCT00506350|12138548|FG008|Overall Study|Adverse Event|1
7715454|NCT00506350|12138540|FG000|Overall Study|Protocol Violation|0
7715455|NCT00506350|12138541|FG001|Overall Study|Protocol Violation|0
7715456|NCT00506350|12138542|FG002|Overall Study|Protocol Violation|1
7715457|NCT00506350|12138543|FG003|Overall Study|Protocol Violation|0
7715458|NCT00506350|12138544|FG004|Overall Study|Protocol Violation|0
7715459|NCT00506350|12138545|FG005|Overall Study|Protocol Violation|0
7715460|NCT00506350|12138546|FG006|Overall Study|Protocol Violation|1
7715461|NCT00506350|12138547|FG007|Overall Study|Protocol Violation|0
7715462|NCT00506350|12138548|FG008|Overall Study|Protocol Violation|0
7715463|NCT00506350|12138540|FG000|Overall Study|Withdrawal by Subject|0
7715464|NCT00506350|12138541|FG001|Overall Study|Withdrawal by Subject|1
7715465|NCT00506350|12138542|FG002|Overall Study|Withdrawal by Subject|1
7715466|NCT00506350|12138543|FG003|Overall Study|Withdrawal by Subject|1
7715467|NCT00506350|12138544|FG004|Overall Study|Withdrawal by Subject|4
7715468|NCT00506350|12138545|FG005|Overall Study|Withdrawal by Subject|1
7715469|NCT00506350|12138546|FG006|Overall Study|Withdrawal by Subject|1
7715470|NCT00506350|12138547|FG007|Overall Study|Withdrawal by Subject|2
7715471|NCT00506350|12138548|FG008|Overall Study|Withdrawal by Subject|0
7715472|NCT00506350|12138540|FG000|Overall Study|Lost to Follow-up|1
7715473|NCT00506350|12138541|FG001|Overall Study|Lost to Follow-up|1
7715474|NCT00506350|12138542|FG002|Overall Study|Lost to Follow-up|1
7715475|NCT00506350|12138543|FG003|Overall Study|Lost to Follow-up|1
7715476|NCT00506350|12138544|FG004|Overall Study|Lost to Follow-up|2
7715477|NCT00506350|12138545|FG005|Overall Study|Lost to Follow-up|1
7715478|NCT00506350|12138546|FG006|Overall Study|Lost to Follow-up|0
7715479|NCT00506350|12138547|FG007|Overall Study|Lost to Follow-up|0
7715480|NCT00506350|12138548|FG008|Overall Study|Lost to Follow-up|2
7715481|NCT00506350|12138540|FG000|Overall Study|Medical Reason|0
7715482|NCT00506350|12138541|FG001|Overall Study|Medical Reason|0
7715483|NCT00506350|12138542|FG002|Overall Study|Medical Reason|0
7715484|NCT00506350|12138543|FG003|Overall Study|Medical Reason|0
7715485|NCT00506350|12138544|FG004|Overall Study|Medical Reason|1
7715486|NCT00506350|12138545|FG005|Overall Study|Medical Reason|0
7715487|NCT00506350|12138546|FG006|Overall Study|Medical Reason|0
7715488|NCT00506350|12138547|FG007|Overall Study|Medical Reason|0
7715489|NCT00506350|12138548|FG008|Overall Study|Medical Reason|0
7715490|NCT00506350|12138540|FG000|Overall Study|Other|1
7715491|NCT00506350|12138541|FG001|Overall Study|Other|1
7715492|NCT00506350|12138542|FG002|Overall Study|Other|3
7715493|NCT00506350|12138543|FG003|Overall Study|Other|0
7715494|NCT00506350|12138544|FG004|Overall Study|Other|3
7715495|NCT00506350|12138545|FG005|Overall Study|Other|0
7715496|NCT00506350|12138546|FG006|Overall Study|Other|0
7715497|NCT00506350|12138547|FG007|Overall Study|Other|2
7715498|NCT00506350|12138548|FG008|Overall Study|Other|2
7715499|NCT00506389|12138578|FG000|In-treatment Period|Other|3
7715500|NCT00506389|12138579|FG001|In-treatment Period|Other|3
7715501|NCT00506389|12138580|FG002|In-treatment Period|Other|4
7715502|NCT00506389|12138578|FG000|In-treatment Period|Lost to Follow-up|0
7715503|NCT00506389|12138579|FG001|In-treatment Period|Lost to Follow-up|0
7715504|NCT00506389|12138580|FG002|In-treatment Period|Lost to Follow-up|1
7715505|NCT00506389|12138578|FG000|In-treatment Period|Lack of compliance|1
7715506|NCT00506389|12138579|FG001|In-treatment Period|Lack of compliance|0
7715507|NCT00506389|12138580|FG002|In-treatment Period|Lack of compliance|0
7715508|NCT00506389|12138578|FG000|In-treatment Period|Reasons not related to trial|4
7715509|NCT00506389|12138579|FG001|In-treatment Period|Reasons not related to trial|1
7715510|NCT00506389|12138580|FG002|In-treatment Period|Reasons not related to trial|0
7715511|NCT00506389|12138578|FG000|In-treatment Period|Withdrawal by Subject|3
7715512|NCT00506389|12138579|FG001|In-treatment Period|Withdrawal by Subject|3
7715513|NCT00506389|12138580|FG002|In-treatment Period|Withdrawal by Subject|4
7715514|NCT00506389|12138578|FG000|In-treatment Period|Lack of Efficacy|0
7715515|NCT00506389|12138579|FG001|In-treatment Period|Lack of Efficacy|2
7715516|NCT00506389|12138580|FG002|In-treatment Period|Lack of Efficacy|0
7715517|NCT00506389|12138578|FG000|In-treatment Period|Adverse Event|11
7715518|NCT00506389|12138579|FG001|In-treatment Period|Adverse Event|5
7715519|NCT00506389|12138580|FG002|In-treatment Period|Adverse Event|2
7715520|NCT00506389|12138578|FG000|In-treatment Period|Randomized but not treated|4
7715521|NCT00506389|12138579|FG001|In-treatment Period|Randomized but not treated|1
7715522|NCT00506389|12138580|FG002|In-treatment Period|Randomized but not treated|1
7715523|NCT00506415|12138591|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
7715524|NCT00506415|12138592|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
7715525|NCT00506415|12138593|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
7715526|NCT00506415|12138594|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
7715527|NCT00506415|12138591|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
7715528|NCT00506415|12138592|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
7715529|NCT00506415|12138593|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
7715530|NCT00506415|12138594|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
7715531|NCT00506415|12138591|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
7715532|NCT00506415|12138592|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
7715533|NCT00506415|12138593|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
7715534|NCT00506415|12138594|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
7715535|NCT00506415|12138591|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
7715536|NCT00506415|12138592|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7715537|NCT00506415|12138593|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7715538|NCT00506415|12138594|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7715539|NCT00506415|12138591|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
7715540|NCT00506415|12138592|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7715541|NCT00506415|12138593|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7715542|NCT00506415|12138594|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7715543|NCT00506415|12138591|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
7715544|NCT00506415|12138592|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7715545|NCT00506415|12138593|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7715546|NCT00506415|12138594|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7715547|NCT00506415|12138591|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
7715548|NCT00506415|12138592|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
7715549|NCT00506415|12138593|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
7715550|NCT00506415|12138594|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
7715551|NCT00506415|12138591|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22
7715552|NCT00506415|12138592|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0
7715553|NCT00506415|12138593|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0
7715554|NCT00506415|12138594|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0
7715555|NCT00506415|12138591|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
7715556|NCT00506415|12138592|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
7715557|NCT00506415|12138593|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
7715558|NCT00506415|12138594|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
7715559|NCT00506415|12138591|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0
7715560|NCT00506415|12138592|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33
7715561|NCT00506415|12138593|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28
7715562|NCT00506415|12138594|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0
7715563|NCT00506415|12138591|FG000|Double Blind (Maximum 48 Weeks )|Death|0
7715564|NCT00506415|12138592|FG001|Double Blind (Maximum 48 Weeks )|Death|5
7715565|NCT00506415|12138593|FG002|Double Blind (Maximum 48 Weeks )|Death|3
7715566|NCT00506415|12138594|FG003|Double Blind (Maximum 48 Weeks )|Death|0
7715567|NCT00506415|12138591|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
7715568|NCT00506415|12138592|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
7715569|NCT00506415|12138593|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
7715570|NCT00506415|12138594|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
7715571|NCT00506415|12138591|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
7715572|NCT00506415|12138592|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
7715573|NCT00506415|12138593|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
7715574|NCT00506415|12138594|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
7715575|NCT00506415|12138591|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
7715576|NCT00506415|12138592|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
7715577|NCT00506415|12138593|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
7715578|NCT00506415|12138594|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
7715579|NCT00506415|12138591|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
7715580|NCT00506415|12138592|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
7715581|NCT00506415|12138593|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
7715582|NCT00506415|12138594|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
7715583|NCT00506415|12138591|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0
7715584|NCT00506415|12138592|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3
7715585|NCT00506415|12138593|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2
7715586|NCT00506415|12138594|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0
7715587|NCT00506415|12138591|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
7715588|NCT00506415|12138592|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
7715589|NCT00506415|12138593|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
7715590|NCT00506415|12138594|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
7715591|NCT00506415|12138591|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
7715592|NCT00506415|12138592|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
7715593|NCT00506415|12138593|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
7715594|NCT00506415|12138594|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
7715595|NCT00506415|12138591|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
7715596|NCT00506415|12138592|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
7715597|NCT00506415|12138593|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
7715598|NCT00506415|12138594|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
7715599|NCT00506415|12138591|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7715600|NCT00506415|12138592|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7715601|NCT00506415|12138593|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7715602|NCT00506415|12138594|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
7715603|NCT00506415|12138591|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7715604|NCT00506415|12138592|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7715605|NCT00506415|12138593|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7715606|NCT00506415|12138594|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
7715607|NCT00506415|12138591|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
7715608|NCT00506415|12138592|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
7715609|NCT00506415|12138593|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
7715610|NCT00506415|12138594|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
7715611|NCT00506415|12138591|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7715612|NCT00506415|12138592|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7715613|NCT00506415|12138593|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7715614|NCT00506415|12138594|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
7715615|NCT00506415|12138591|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0
7715616|NCT00506415|12138592|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0
7715617|NCT00506415|12138593|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0
7715618|NCT00506415|12138594|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7
7715619|NCT00506441|12138607|FG000|Period 1; Open-label Period|Adverse Event|21
7715620|NCT00506441|12138608|FG001|Period 1; Open-label Period|Adverse Event|0
7715621|NCT00506441|12138607|FG000|Period 1; Open-label Period|Lack of Efficacy|13
7715622|NCT00506441|12138608|FG001|Period 1; Open-label Period|Lack of Efficacy|0
7715623|NCT00506441|12138607|FG000|Period 1; Open-label Period|Lost to Follow-up|2
7715624|NCT00506441|12138608|FG001|Period 1; Open-label Period|Lost to Follow-up|0
7715625|NCT00506441|12138607|FG000|Period 1; Open-label Period|Physician Decision|5
7715626|NCT00506441|12138608|FG001|Period 1; Open-label Period|Physician Decision|0
7715627|NCT00506441|12138607|FG000|Period 1; Open-label Period|Protocol Violation|9
7715628|NCT00506441|12138608|FG001|Period 1; Open-label Period|Protocol Violation|0
7715629|NCT00506441|12138607|FG000|Period 1; Open-label Period|Withdrawal by Subject|13
7715630|NCT00506441|12138608|FG001|Period 1; Open-label Period|Withdrawal by Subject|0
7715631|NCT00506441|12138607|FG000|Period 1; Open-label Period|Other Reasons|13
7715632|NCT00506441|12138608|FG001|Period 1; Open-label Period|Other Reasons|0
7715633|NCT00506441|12138607|FG000|Period 2; Double-blind Period|Adverse Event|0
7715634|NCT00506441|12138608|FG001|Period 2; Double-blind Period|Adverse Event|1
7715635|NCT00506441|12138607|FG000|Period 2; Double-blind Period|Lack of Efficacy|0
7715636|NCT00506441|12138608|FG001|Period 2; Double-blind Period|Lack of Efficacy|2
7715637|NCT00506441|12138607|FG000|Period 2; Double-blind Period|Physician Decision|1
7715638|NCT00506441|12138608|FG001|Period 2; Double-blind Period|Physician Decision|1
7715639|NCT00506441|12138607|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1
7715640|NCT00506441|12138608|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0
7715641|NCT00506441|12138607|FG000|Period 2; Double-blind Period|Other Reason|1
7715642|NCT00506441|12138608|FG001|Period 2; Double-blind Period|Other Reason|1
7715643|NCT00506454|12138618|FG000|Overall Study|Withdrawal by Subject|1
7715644|NCT00506454|12138619|FG001|Overall Study|Withdrawal by Subject|1
7715645|NCT00506493|12138625|FG000|Overall Study|Death|6
7715646|NCT00506493|12138625|FG000|Overall Study|Withdrawal by Subject|5
7715647|NCT00506519|12138634|FG000|Overall Study|Death|4
7715648|NCT00506519|12138635|FG001|Overall Study|Death|6
7715649|NCT00506519|12138636|FG002|Overall Study|Death|0
7715650|NCT00506519|12138634|FG000|Overall Study|Adverse Event|1
7715651|NCT00506519|12138635|FG001|Overall Study|Adverse Event|0
7715652|NCT00506519|12138636|FG002|Overall Study|Adverse Event|0
7715653|NCT00506662|12138653|FG000|Overall Study|Adverse Event|0
7715654|NCT00506662|12138654|FG001|Overall Study|Adverse Event|2
7715655|NCT00506662|12138653|FG000|Overall Study|Lack of Efficacy|1
7715656|NCT00506662|12138654|FG001|Overall Study|Lack of Efficacy|0
7715657|NCT00506662|12138653|FG000|Overall Study|Protocol Violation|2
7715658|NCT00506662|12138654|FG001|Overall Study|Protocol Violation|4
7715659|NCT00506662|12138653|FG000|Overall Study|Trial terminated|10
7715660|NCT00506662|12138654|FG001|Overall Study|Trial terminated|16
7715661|NCT00506662|12138653|FG000|Overall Study|Not recorded|4
7715662|NCT00506662|12138654|FG001|Overall Study|Not recorded|6
7715663|NCT00506753|12138682|FG000|Overall Study|Lost to Follow-up|21
7715664|NCT00506753|12138683|FG001|Overall Study|Lost to Follow-up|15
7715665|NCT00506779|12138691|FG000|Overall Study|Withdrawal by Subject|1
7715666|NCT00506779|12138692|FG001|Overall Study|Withdrawal by Subject|0
7715667|NCT00506779|12138693|FG002|Overall Study|Withdrawal by Subject|1
7715668|NCT00506779|12138694|FG003|Overall Study|Withdrawal by Subject|0
7715669|NCT00506779|12138691|FG000|Overall Study|Adverse Event|0
7715670|NCT00506779|12138692|FG001|Overall Study|Adverse Event|1
7715671|NCT00506779|12138693|FG002|Overall Study|Adverse Event|1
7715672|NCT00506779|12138694|FG003|Overall Study|Adverse Event|1
7715673|NCT00506831|12138705|FG000|Overall Study|Death|1
7715674|NCT00506831|12138705|FG000|Overall Study|Withdrawal by Subject|1
7715675|NCT00506883|12138717|FG000|Overall Study|Lost to Follow-up|1
7715676|NCT00506883|12138718|FG001|Overall Study|Lost to Follow-up|1
7715677|NCT00506883|12138719|FG002|Overall Study|Lost to Follow-up|1
7715678|NCT00506883|12138717|FG000|Overall Study|Withdrawal by Subject|1
7715679|NCT00506883|12138718|FG001|Overall Study|Withdrawal by Subject|0
7715680|NCT00506883|12138719|FG002|Overall Study|Withdrawal by Subject|1
7715681|NCT00506883|12138717|FG000|Overall Study|Lack of Efficacy|0
7715682|NCT00506883|12138718|FG001|Overall Study|Lack of Efficacy|1
7715683|NCT00506883|12138719|FG002|Overall Study|Lack of Efficacy|1
7715684|NCT00506883|12138717|FG000|Overall Study|Other|5
7715685|NCT00506883|12138718|FG001|Overall Study|Other|1
7715686|NCT00506883|12138719|FG002|Overall Study|Other|1
7715687|NCT00506922|12138732|FG000|Overall Study|Physician Decision|0
7715688|NCT00506922|12138733|FG001|Overall Study|Physician Decision|0
7715689|NCT00506922|12138734|FG002|Overall Study|Physician Decision|0
7715690|NCT00506922|12138735|FG003|Overall Study|Physician Decision|2
7715691|NCT00506922|12138736|FG004|Overall Study|Physician Decision|0
7715692|NCT00506922|12138732|FG000|Overall Study|Withdrawal by Subject|0
7715693|NCT00506922|12138733|FG001|Overall Study|Withdrawal by Subject|0
7715694|NCT00506922|12138734|FG002|Overall Study|Withdrawal by Subject|0
7715695|NCT00506922|12138735|FG003|Overall Study|Withdrawal by Subject|0
7715696|NCT00506922|12138736|FG004|Overall Study|Withdrawal by Subject|1
7715697|NCT00506948|12138744|FG000|Overall Study|Death|4
7715698|NCT00506948|12138744|FG000|Overall Study|Adverse Event|5
7715699|NCT00506948|12138744|FG000|Overall Study|Physician Decision|1
7715700|NCT00507026|12138751|FG000|Overall Study|Lack of Efficacy|6
7715701|NCT00507026|12138752|FG001|Overall Study|Lack of Efficacy|4
7715702|NCT00507026|12138753|FG002|Overall Study|Lack of Efficacy|21
7715703|NCT00507026|12138751|FG000|Overall Study|Withdrawal by Subject|2
7715704|NCT00507026|12138752|FG001|Overall Study|Withdrawal by Subject|0
7715705|NCT00507026|12138753|FG002|Overall Study|Withdrawal by Subject|0
7715706|NCT00507026|12138751|FG000|Overall Study|Investigator Decision|1
7715707|NCT00507026|12138752|FG001|Overall Study|Investigator Decision|0
7715708|NCT00507026|12138753|FG002|Overall Study|Investigator Decision|0
7715709|NCT00507026|12138751|FG000|Overall Study|Adverse Event|2
7715710|NCT00507026|12138752|FG001|Overall Study|Adverse Event|0
7715711|NCT00507026|12138753|FG002|Overall Study|Adverse Event|0
7715712|NCT00507026|12138751|FG000|Overall Study|Protocol Violation|1
7715713|NCT00507026|12138752|FG001|Overall Study|Protocol Violation|0
7715714|NCT00507026|12138753|FG002|Overall Study|Protocol Violation|0
7715715|NCT00507026|12138751|FG000|Overall Study|Other|1
7715716|NCT00507026|12138752|FG001|Overall Study|Other|0
7715717|NCT00507026|12138753|FG002|Overall Study|Other|0
7715718|NCT00507130|12138765|FG000|Overall Study|Lost to Follow-up|0
7715719|NCT00507130|12138766|FG001|Overall Study|Lost to Follow-up|0
7715720|NCT00507130|12138767|FG002|Overall Study|Lost to Follow-up|1
7715721|NCT00507130|12138768|FG003|Overall Study|Lost to Follow-up|1
7715722|NCT00507130|12138765|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
7715723|NCT00507130|12138766|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
7715724|NCT00507130|12138767|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
7715725|NCT00507130|12138768|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
7715726|NCT00507416|12138790|FG000|Overall Study|Adverse Event|58
7715727|NCT00507416|12138791|FG001|Overall Study|Adverse Event|67
7715728|NCT00507416|12138792|FG002|Overall Study|Adverse Event|65
7715729|NCT00507416|12138790|FG000|Overall Study|Protocol Violation|1
7715730|NCT00507416|12138791|FG001|Overall Study|Protocol Violation|2
7715731|NCT00507416|12138792|FG002|Overall Study|Protocol Violation|0
7715732|NCT00507416|12138790|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7
7715733|NCT00507416|12138791|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7
7715734|NCT00507416|12138792|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8
7715735|NCT00507416|12138790|FG000|Overall Study|Progressive Disease|20
7715736|NCT00507416|12138791|FG001|Overall Study|Progressive Disease|10
7715737|NCT00507416|12138792|FG002|Overall Study|Progressive Disease|13
7715738|NCT00507416|12138790|FG000|Overall Study|Patient declined further treatment|18
7715739|NCT00507416|12138791|FG001|Overall Study|Patient declined further treatment|14
7715740|NCT00507416|12138792|FG002|Overall Study|Patient declined further treatment|11
7715741|NCT00507416|12138790|FG000|Overall Study|Other|11
7715742|NCT00507416|12138791|FG001|Overall Study|Other|16
7715743|NCT00507416|12138792|FG002|Overall Study|Other|13
7715744|NCT00507416|12138790|FG000|Overall Study|Did not Receive Study Treatment|3
7715745|NCT00507416|12138791|FG001|Overall Study|Did not Receive Study Treatment|9
7715746|NCT00507416|12138792|FG002|Overall Study|Did not Receive Study Treatment|4
7715747|NCT00507429|12138802|FG000|Treatment Phase|Disease Progression|12
7715748|NCT00507429|12138803|FG001|Treatment Phase|Disease Progression|5
7715749|NCT00507429|12138802|FG000|Treatment Phase|Adverse Event|12
7715750|NCT00507429|12138803|FG001|Treatment Phase|Adverse Event|5
7715751|NCT00507429|12138802|FG000|Treatment Phase|Withdrawal by Subject|3
7715752|NCT00507429|12138803|FG001|Treatment Phase|Withdrawal by Subject|3
7715753|NCT00507429|12138802|FG000|Treatment Phase|Physician Decision|4
7715754|NCT00507429|12138803|FG001|Treatment Phase|Physician Decision|2
7715755|NCT00507429|12138802|FG000|Treatment Phase|Other|6
7715756|NCT00507429|12138803|FG001|Treatment Phase|Other|3
7715757|NCT00507429|12138802|FG000|Maintenance Phase|Progressive Disease|14
7715758|NCT00507429|12138803|FG001|Maintenance Phase|Progressive Disease|0
7715759|NCT00507442|12138815|FG000|Overall Study|Adverse Event|8
7715760|NCT00507442|12138816|FG001|Overall Study|Adverse Event|11
7715761|NCT00507442|12138817|FG002|Overall Study|Adverse Event|4
7715762|NCT00507442|12138818|FG003|Overall Study|Adverse Event|1
7715763|NCT00507442|12138815|FG000|Overall Study|Protocol Violation|0
7715764|NCT00507442|12138816|FG001|Overall Study|Protocol Violation|1
7715765|NCT00507442|12138817|FG002|Overall Study|Protocol Violation|0
7715766|NCT00507442|12138818|FG003|Overall Study|Protocol Violation|0
7715767|NCT00507442|12138815|FG000|Overall Study|Lost to Follow-up|0
7715768|NCT00507442|12138816|FG001|Overall Study|Lost to Follow-up|0
7715769|NCT00507442|12138817|FG002|Overall Study|Lost to Follow-up|1
7715770|NCT00507442|12138818|FG003|Overall Study|Lost to Follow-up|0
7715771|NCT00507442|12138815|FG000|Overall Study|Physician Decision|0
7715772|NCT00507442|12138816|FG001|Overall Study|Physician Decision|2
7715773|NCT00507442|12138817|FG002|Overall Study|Physician Decision|4
7715774|NCT00507442|12138818|FG003|Overall Study|Physician Decision|1
7715775|NCT00507442|12138815|FG000|Overall Study|Progressive Disease|2
7715776|NCT00507442|12138816|FG001|Overall Study|Progressive Disease|4
7715777|NCT00507442|12138817|FG002|Overall Study|Progressive Disease|2
7715778|NCT00507442|12138818|FG003|Overall Study|Progressive Disease|0
7715779|NCT00507442|12138815|FG000|Overall Study|Withdrawal by Subject|4
7715780|NCT00507442|12138816|FG001|Overall Study|Withdrawal by Subject|4
7715781|NCT00507442|12138817|FG002|Overall Study|Withdrawal by Subject|2
7715782|NCT00507442|12138818|FG003|Overall Study|Withdrawal by Subject|1
7715783|NCT00507442|12138815|FG000|Overall Study|Other|2
7715784|NCT00507442|12138816|FG001|Overall Study|Other|5
7715785|NCT00507442|12138817|FG002|Overall Study|Other|2
7715786|NCT00507442|12138818|FG003|Overall Study|Other|2
7715787|NCT00507455|12138835|FG000|Overall Study|Adverse Event|3
7715788|NCT00507455|12138836|FG001|Overall Study|Adverse Event|3
7715789|NCT00507455|12138837|FG002|Overall Study|Adverse Event|6
7715790|NCT00507455|12138835|FG000|Overall Study|Withdrawal by Subject|2
7715791|NCT00507455|12138836|FG001|Overall Study|Withdrawal by Subject|1
7715792|NCT00507455|12138837|FG002|Overall Study|Withdrawal by Subject|2
7715793|NCT00507455|12138835|FG000|Overall Study|Protocol Violation|4
7715794|NCT00507455|12138836|FG001|Overall Study|Protocol Violation|1
7715795|NCT00507455|12138837|FG002|Overall Study|Protocol Violation|1
7715796|NCT00507455|12138835|FG000|Overall Study|Lost to Follow-up|2
7715797|NCT00507455|12138836|FG001|Overall Study|Lost to Follow-up|0
7715798|NCT00507455|12138837|FG002|Overall Study|Lost to Follow-up|2
7715799|NCT00507455|12138835|FG000|Overall Study|Lack of Efficacy|0
7715800|NCT00507455|12138836|FG001|Overall Study|Lack of Efficacy|1
7715801|NCT00507455|12138837|FG002|Overall Study|Lack of Efficacy|0
7715802|NCT00507455|12138835|FG000|Overall Study|Other - miscellaneous reason|1
7715803|NCT00507455|12138836|FG001|Overall Study|Other - miscellaneous reason|0
7715804|NCT00507455|12138837|FG002|Overall Study|Other - miscellaneous reason|1
7715805|NCT00507507|12138847|FG000|Treatment Period|Lost to Follow-up|0
7715806|NCT00507507|12138848|FG001|Treatment Period|Lost to Follow-up|2
7715807|NCT00507507|12138847|FG000|Treatment Period|Physician Decision|4
7715808|NCT00507507|12138848|FG001|Treatment Period|Physician Decision|1
7715809|NCT00507507|12138847|FG000|Treatment Period|Protocol Violation|1
7715810|NCT00507507|12138848|FG001|Treatment Period|Protocol Violation|2
7715811|NCT00507507|12138847|FG000|Treatment Period|Adverse Event|1
7715812|NCT00507507|12138848|FG001|Treatment Period|Adverse Event|1
7715813|NCT00507507|12138847|FG000|Treatment Period|Withdrawal by Subject|46
7715814|NCT00507507|12138848|FG001|Treatment Period|Withdrawal by Subject|47
7715815|NCT00507507|12138847|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1
7715816|NCT00507507|12138848|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0
7715817|NCT00507507|12138847|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0
7715818|NCT00507507|12138848|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1
7715819|NCT00507507|12138847|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
7715820|NCT00507507|12138848|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
7715821|NCT00507546|12138858|FG000|Overall Study|Withdrawal by Subject|1
7715822|NCT00507546|12138859|FG001|Overall Study|Withdrawal by Subject|0
7715823|NCT00507546|12138858|FG000|Overall Study|Protocol Violation|1
7715824|NCT00507546|12138859|FG001|Overall Study|Protocol Violation|0
7715825|NCT00507546|12138858|FG000|Overall Study|Physician Decision|0
7715826|NCT00507546|12138859|FG001|Overall Study|Physician Decision|1
7715827|NCT00507689|12138874|FG000|Pre-Randomization Period|Adverse Event|1
7715828|NCT00507689|12138875|FG001|Pre-Randomization Period|Adverse Event|0
7715829|NCT00507689|12138874|FG000|Pre-Randomization Period|Physician Decision|1
7715830|NCT00507689|12138875|FG001|Pre-Randomization Period|Physician Decision|0
7715831|NCT00507689|12138874|FG000|Pre-Randomization Period|Withdrawal by Subject|1
7715832|NCT00507689|12138875|FG001|Pre-Randomization Period|Withdrawal by Subject|0
7715833|NCT00507689|12138874|FG000|Randomized Period|Adverse Event|1
7715834|NCT00507689|12138875|FG001|Randomized Period|Adverse Event|1
7715835|NCT00507689|12138874|FG000|Randomized Period|Withdrawal by Subject|0
7715836|NCT00507689|12138875|FG001|Randomized Period|Withdrawal by Subject|1
7715837|NCT00507728|12138885|FG000|Randomization to Month 3|Lost to Follow-up|15
7715838|NCT00507728|12138886|FG001|Randomization to Month 3|Lost to Follow-up|14
7715839|NCT00507728|12138887|FG002|Randomization to Month 3|Lost to Follow-up|20
7715840|NCT00507728|12138885|FG000|From 3 Months to 6 Months|Lost to Follow-up|6
7715841|NCT00507728|12138886|FG001|From 3 Months to 6 Months|Lost to Follow-up|10
7715842|NCT00507728|12138887|FG002|From 3 Months to 6 Months|Lost to Follow-up|9
7715843|NCT00507819|12138905|FG000|Washout (6 Weeks)|Withdrawal by Subject|1
7715844|NCT00507819|12138906|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
7715845|NCT00508001|12138915|FG000|Overall Study|Adverse Event|2
7715846|NCT00508001|12138916|FG001|Overall Study|Adverse Event|0
7715847|NCT00508001|12138917|FG002|Overall Study|Adverse Event|4
7715848|NCT00508001|12138915|FG000|Overall Study|condition under investigation worsened|13
7715849|NCT00508001|12138916|FG001|Overall Study|condition under investigation worsened|7
7715850|NCT00508001|12138917|FG002|Overall Study|condition under investigation worsened|1
7715851|NCT00508001|12138915|FG000|Overall Study|Death|0
7715852|NCT00508001|12138916|FG001|Overall Study|Death|1
7715853|NCT00508001|12138917|FG002|Overall Study|Death|1
7715854|NCT00508001|12138915|FG000|Overall Study|Withdrawal by Subject|4
7715855|NCT00508001|12138916|FG001|Overall Study|Withdrawal by Subject|4
7715856|NCT00508001|12138917|FG002|Overall Study|Withdrawal by Subject|1
7715857|NCT00508027|12138925|FG000|Dose Level 1|Lost to Follow-up|4
7715858|NCT00508027|12138925|FG000|Dose Level 1|Withdrawal by Subject|2
7715859|NCT00508027|12138925|FG000|Dose Level 1|Physician Decision|2
7715860|NCT00508027|12138925|FG000|Dose Level 2|Lost to Follow-up|2
7715861|NCT00508027|12138925|FG000|Dose Level 2|Withdrawal by Subject|2
7715862|NCT00508144|12138958|FG000|Overall Study|Not eligible|6
7715863|NCT00508144|12138958|FG000|Overall Study|Death|5
7715864|NCT00508157|12138964|FG000|Overall Study|Adverse Event|0
7715865|NCT00508157|12138965|FG001|Overall Study|Adverse Event|1
7715866|NCT00508157|12138964|FG000|Overall Study|Subject Withdrew Consent|1
7715867|NCT00508157|12138965|FG001|Overall Study|Subject Withdrew Consent|0
7715868|NCT00508157|12138964|FG000|Overall Study|Lost to Follow-up|1
7715869|NCT00508157|12138965|FG001|Overall Study|Lost to Follow-up|0
7715870|NCT00508157|12138964|FG000|Overall Study|Subject no longer met study criteria|0
7715871|NCT00508157|12138965|FG001|Overall Study|Subject no longer met study criteria|1
7715872|NCT00508157|12138964|FG000|Overall Study|Other known cause|0
7715873|NCT00508157|12138965|FG001|Overall Study|Other known cause|1
7715874|NCT00508261|12138991|FG000|Overall Study|Other|0
7715875|NCT00508261|12138992|FG001|Overall Study|Other|1
7715876|NCT00508261|12138993|FG002|Overall Study|Other|1
7715877|NCT00508261|12138994|FG003|Overall Study|Other|0
7715878|NCT00508261|12138991|FG000|Overall Study|Serious Adverse Event|0
7715879|NCT00508261|12138992|FG001|Overall Study|Serious Adverse Event|1
7715880|NCT00508261|12138993|FG002|Overall Study|Serious Adverse Event|0
7715881|NCT00508261|12138994|FG003|Overall Study|Serious Adverse Event|0
7715882|NCT00508261|12138991|FG000|Overall Study|Withdrawal by Subject|3
7715883|NCT00508261|12138992|FG001|Overall Study|Withdrawal by Subject|4
7715884|NCT00508261|12138993|FG002|Overall Study|Withdrawal by Subject|4
7715885|NCT00508261|12138994|FG003|Overall Study|Withdrawal by Subject|0
7715886|NCT00508261|12138991|FG000|Overall Study|Migrated/ moved from study area|0
7715887|NCT00508261|12138992|FG001|Overall Study|Migrated/ moved from study area|1
7715888|NCT00508261|12138993|FG002|Overall Study|Migrated/ moved from study area|0
7715889|NCT00508261|12138994|FG003|Overall Study|Migrated/ moved from study area|0
7715890|NCT00508261|12138991|FG000|Overall Study|Lost to Follow-up|0
7715891|NCT00508261|12138992|FG001|Overall Study|Lost to Follow-up|1
7715892|NCT00508261|12138993|FG002|Overall Study|Lost to Follow-up|1
7715893|NCT00508261|12138994|FG003|Overall Study|Lost to Follow-up|1
7715894|NCT00508274|12139008|FG000|Overall Study|Adverse Event|5
7715895|NCT00508274|12139008|FG000|Overall Study|Death|7
7715896|NCT00508274|12139008|FG000|Overall Study|Disease progression|32
7715897|NCT00508274|12139008|FG000|Overall Study|Withdrawal by Subject|1
7715898|NCT00508274|12139008|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2
7715899|NCT00508274|12139008|FG000|Overall Study|Missing|3
7715900|NCT00508391|12139023|FG000|First Treatment|Withdrawal by Subject|6
7715901|NCT00508391|12139024|FG001|First Treatment|Withdrawal by Subject|3
7715902|NCT00508391|12139023|FG000|Second Treatment|Withdrawal by Subject|2
7715903|NCT00508391|12139024|FG001|Second Treatment|Withdrawal by Subject|0
7715904|NCT00508404|12139032|FG000|Overall Study|Ongoing at Data Cut-off|12
7715905|NCT00508404|12139032|FG000|Overall Study|Adverse Event|2
7715906|NCT00508404|12139032|FG000|Overall Study|Death|16
7715907|NCT00508404|12139032|FG000|Overall Study|Physician Decision|2
7715908|NCT00508404|12139032|FG000|Overall Study|Withdrawal by Subject|3
7715909|NCT00508404|12139032|FG000|Overall Study|Protocol-specified Criteria|2
7715910|NCT00508404|12139032|FG000|Overall Study|Lost to Follow-up|2
7715911|NCT00508404|12139032|FG000|Overall Study|Other - Not Specified|3
7715912|NCT00508482|12139049|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9
7715913|NCT00508482|12139050|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7
7715914|NCT00508482|12139051|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4
7715915|NCT00508482|12139049|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12
7715916|NCT00508482|12139050|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10
7715917|NCT00508482|12139051|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16
7715918|NCT00508482|12139049|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20
7715919|NCT00508482|12139050|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6
7715920|NCT00508482|12139051|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1
7715921|NCT00508651|12139066|FG000|Overall Study|Lost to Follow-up|3
7715922|NCT00508651|12139067|FG001|Overall Study|Lost to Follow-up|1
7715923|NCT00508651|12139066|FG000|Overall Study|Withdrawal by Subject|1
7715924|NCT00508651|12139067|FG001|Overall Study|Withdrawal by Subject|1
7715925|NCT00508742|12139084|FG000|Period 1: Infant Series|Adverse Event|5
7715926|NCT00508742|12139085|FG001|Period 1: Infant Series|Adverse Event|4
7715927|NCT00508742|12139084|FG000|Period 1: Infant Series|Protocol Violation|1
7715928|NCT00508742|12139085|FG001|Period 1: Infant Series|Protocol Violation|0
7715929|NCT00508742|12139084|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31
7715930|NCT00508742|12139085|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40
7715931|NCT00508742|12139084|FG000|Period 1: Infant Series|Physician Decision|1
7715932|NCT00508742|12139085|FG001|Period 1: Infant Series|Physician Decision|0
7715933|NCT00508742|12139084|FG000|Period 1: Infant Series|Other|4
7715934|NCT00508742|12139085|FG001|Period 1: Infant Series|Other|1
7715935|NCT00508742|12139084|FG000|Period 2: After Infant Series|Adverse Event|2
7715936|NCT00508742|12139085|FG001|Period 2: After Infant Series|Adverse Event|6
7715937|NCT00508742|12139084|FG000|Period 2: After Infant Series|Lost to Follow-up|1
7715938|NCT00508742|12139085|FG001|Period 2: After Infant Series|Lost to Follow-up|1
7715939|NCT00508742|12139084|FG000|Period 2: After Infant Series|Protocol Violation|1
7715940|NCT00508742|12139085|FG001|Period 2: After Infant Series|Protocol Violation|0
7715941|NCT00508742|12139084|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0
7715942|NCT00508742|12139085|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3
7715943|NCT00508742|12139084|FG000|Period 2: After Infant Series|Failed to Return|1
7715944|NCT00508742|12139085|FG001|Period 2: After Infant Series|Failed to Return|0
7715945|NCT00508742|12139084|FG000|Period 2: After Infant Series|Other|2
7715946|NCT00508742|12139085|FG001|Period 2: After Infant Series|Other|1
7715947|NCT00508742|12139084|FG000|Period 3: Toddler Dose|Adverse Event|1
7715948|NCT00508742|12139085|FG001|Period 3: Toddler Dose|Adverse Event|0
7715949|NCT00508742|12139084|FG000|Period 3: Toddler Dose|Lost to Follow-up|2
7715950|NCT00508742|12139085|FG001|Period 3: Toddler Dose|Lost to Follow-up|3
7715951|NCT00508742|12139084|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
7715952|NCT00508742|12139085|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
7715953|NCT00508742|12139084|FG000|Period 3: Toddler Dose|Other|5
7715954|NCT00508742|12139085|FG001|Period 3: Toddler Dose|Other|4
7715955|NCT00508755|12139097|FG000|Overall Study|Withdrawal by Subject|1
7715956|NCT00508924|12139107|FG000|Overall Study|Protocol Violation|0
7715957|NCT00508924|12139108|FG001|Overall Study|Protocol Violation|0
7715958|NCT00508924|12139109|FG002|Overall Study|Protocol Violation|1
7715959|NCT00508924|12139110|FG003|Overall Study|Protocol Violation|1
7715960|NCT00509028|12139126|FG000|Overall Study|Adverse Event|2
7715961|NCT00509028|12139127|FG001|Overall Study|Adverse Event|0
7715962|NCT00509028|12139126|FG000|Overall Study|Withdrawal by Subject|4
7715963|NCT00509028|12139127|FG001|Overall Study|Withdrawal by Subject|3
7715964|NCT00509028|12139126|FG000|Overall Study|Lost to Follow-up|0
7715965|NCT00509028|12139127|FG001|Overall Study|Lost to Follow-up|1
7715966|NCT00509028|12139126|FG000|Overall Study|Protocol Violation|4
7715967|NCT00509028|12139127|FG001|Overall Study|Protocol Violation|2
7715968|NCT00509028|12139126|FG000|Overall Study|Non-compliance|2
7715969|NCT00509028|12139127|FG001|Overall Study|Non-compliance|1
7715970|NCT00509067|12139139|FG000|Overall Study|Lost to Follow-up|1
7715971|NCT00509067|12139140|FG001|Overall Study|Lost to Follow-up|1
7715972|NCT00509067|12139139|FG000|Overall Study|Adverse Event|3
7715973|NCT00509067|12139140|FG001|Overall Study|Adverse Event|1
7715974|NCT00509067|12139139|FG000|Overall Study|Protocol Violation|0
7715975|NCT00509067|12139140|FG001|Overall Study|Protocol Violation|3
7715976|NCT00509093|12139150|FG000|Overall Study|Adverse Event|10
7715977|NCT00509093|12139150|FG000|Overall Study|Disease Progression|9
7715978|NCT00509093|12139150|FG000|Overall Study|Transformed into MDS|1
7715979|NCT00509093|12139150|FG000|Overall Study|Withdrawal by Subject|3
7715980|NCT00509093|12139150|FG000|Overall Study|Physician Decision|1
7715981|NCT00509106|12139156|FG000|Overall Study|Adverse Event|3
7715982|NCT00509106|12139157|FG001|Overall Study|Adverse Event|2
7715983|NCT00509106|12139156|FG000|Overall Study|Noncompliance|0
7715984|NCT00509106|12139157|FG001|Overall Study|Noncompliance|1
7715985|NCT00509106|12139156|FG000|Overall Study|At the request of sponsor/investigator|1
7715986|NCT00509106|12139157|FG001|Overall Study|At the request of sponsor/investigator|2
7715987|NCT00509106|12139156|FG000|Overall Study|Withdrew consent|4
7715988|NCT00509106|12139157|FG001|Overall Study|Withdrew consent|8
7715989|NCT00509106|12139156|FG000|Overall Study|Lost to Follow-up|16
7715990|NCT00509106|12139157|FG001|Overall Study|Lost to Follow-up|10
7715991|NCT00509106|12139156|FG000|Overall Study|Other|1
7715992|NCT00509106|12139157|FG001|Overall Study|Other|0
7715993|NCT00509106|12139156|FG000|Overall Study|Death|6
7715994|NCT00509106|12139157|FG001|Overall Study|Death|6
7715995|NCT00509145|12139165|FG000|Overall Study|Death|0
7715996|NCT00509145|12139166|FG001|Overall Study|Death|2
7715997|NCT00509145|12139165|FG000|Overall Study|Adverse Event|42
7715998|NCT00509145|12139166|FG001|Overall Study|Adverse Event|28
7715999|NCT00509145|12139165|FG000|Overall Study|Withdrawal by Subject|32
7716000|NCT00509145|12139166|FG001|Overall Study|Withdrawal by Subject|38
7716001|NCT00509145|12139165|FG000|Overall Study|Physician Decision|11
7716002|NCT00509145|12139166|FG001|Overall Study|Physician Decision|14
7716003|NCT00509145|12139165|FG000|Overall Study|Protocol Violation|1
7716004|NCT00509145|12139166|FG001|Overall Study|Protocol Violation|6
7716005|NCT00509145|12139165|FG000|Overall Study|Pregnancy|3
7716006|NCT00509145|12139166|FG001|Overall Study|Pregnancy|8
7716007|NCT00509145|12139165|FG000|Overall Study|Lost to Follow-up|6
7716008|NCT00509145|12139166|FG001|Overall Study|Lost to Follow-up|5
7716009|NCT00509145|12139165|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12
7716010|NCT00509145|12139166|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22
7716011|NCT00509145|12139165|FG000|Overall Study|Other|6
7716012|NCT00509145|12139166|FG001|Overall Study|Other|6
7716013|NCT00509223|12139194|FG000|Overall Study|Lost to Follow-up|1
7716014|NCT00509223|12139195|FG001|Overall Study|Lost to Follow-up|1
7716015|NCT00509223|12139194|FG000|Overall Study|Adverse Event|1
7716016|NCT00509223|12139195|FG001|Overall Study|Adverse Event|1
7716017|NCT00509223|12139194|FG000|Overall Study|Withdrawal by Subject|25
7716018|NCT00509223|12139195|FG001|Overall Study|Withdrawal by Subject|6
7716019|NCT00509223|12139194|FG000|Overall Study|Including: subject change of address|5
7716020|NCT00509223|12139195|FG001|Overall Study|Including: subject change of address|2
7716021|NCT00509223|12139194|FG000|Overall Study|Did not meet revised inclusion criteria|56
7716022|NCT00509223|12139195|FG001|Overall Study|Did not meet revised inclusion criteria|62
7716023|NCT00509236|12139203|FG000|Overall Study|Adverse Event|7
7716024|NCT00509236|12139204|FG001|Overall Study|Adverse Event|9
7716025|NCT00509236|12139203|FG000|Overall Study|Withdrawal by Subject|5
7716026|NCT00509236|12139204|FG001|Overall Study|Withdrawal by Subject|10
7716027|NCT00509236|12139203|FG000|Overall Study|Protocol Violation|3
7716028|NCT00509236|12139204|FG001|Overall Study|Protocol Violation|0
7716029|NCT00509236|12139203|FG000|Overall Study|Excluded Medication|1
7716030|NCT00509236|12139204|FG001|Overall Study|Excluded Medication|1
7716031|NCT00509236|12139203|FG000|Overall Study|Scheduled Kidney Transplant|1
7716032|NCT00509236|12139204|FG001|Overall Study|Scheduled Kidney Transplant|0
7716033|NCT00509262|12139216|FG000|Overall Study|Adverse Event|16
7716034|NCT00509262|12139217|FG001|Overall Study|Adverse Event|18
7716035|NCT00509262|12139216|FG000|Overall Study|Other|2
7716036|NCT00509262|12139217|FG001|Overall Study|Other|2
7716037|NCT00509262|12139216|FG000|Overall Study|Lack of Efficacy|1
7716038|NCT00509262|12139217|FG001|Overall Study|Lack of Efficacy|0
7716039|NCT00509262|12139216|FG000|Overall Study|Lost to Follow-up|1
7716040|NCT00509262|12139217|FG001|Overall Study|Lost to Follow-up|6
7716041|NCT00509262|12139216|FG000|Overall Study|Physician Decision|1
7716042|NCT00509262|12139217|FG001|Overall Study|Physician Decision|3
7716043|NCT00509262|12139216|FG000|Overall Study|Protocol Violation|2
7716044|NCT00509262|12139217|FG001|Overall Study|Protocol Violation|2
7716045|NCT00509262|12139216|FG000|Overall Study|Withdrawal by Subject|24
7716046|NCT00509262|12139217|FG001|Overall Study|Withdrawal by Subject|11
7716047|NCT00509366|12139237|FG000|Overall Study|Not Treated (Screen Failure)|1
7716048|NCT00509366|12139238|FG001|Overall Study|Not Treated (Screen Failure)|1
7716049|NCT00509366|12139239|FG002|Overall Study|Not Treated (Screen Failure)|1
7716050|NCT00509366|12139240|FG003|Overall Study|Not Treated (Screen Failure)|0
7716051|NCT00509366|12139241|FG004|Overall Study|Not Treated (Screen Failure)|0
7716052|NCT00509769|12139278|FG000|Overall Study|Progressive disease|77
7716053|NCT00509769|12139278|FG000|Overall Study|Adverse Event|4
7716054|NCT00509769|12139278|FG000|Overall Study|Patient's decision|1
7716055|NCT00509769|12139278|FG000|Overall Study|Physician Decision|8
7716056|NCT00509769|12139278|FG000|Overall Study|Use of prohibited therapies during study|1
7716057|NCT00509795|12139286|FG000|Overall Study|Adverse Event|4
7716058|NCT00509795|12139287|FG001|Overall Study|Adverse Event|3
7716059|NCT00509795|12139288|FG002|Overall Study|Adverse Event|5
7716060|NCT00509795|12139289|FG003|Overall Study|Adverse Event|4
7716061|NCT00509795|12139286|FG000|Overall Study|Death|3
7716062|NCT00509795|12139287|FG001|Overall Study|Death|1
7716063|NCT00509795|12139288|FG002|Overall Study|Death|2
7716064|NCT00509795|12139289|FG003|Overall Study|Death|7
7716065|NCT00509795|12139286|FG000|Overall Study|Lack of Efficacy|0
7716066|NCT00509795|12139287|FG001|Overall Study|Lack of Efficacy|0
7716067|NCT00509795|12139288|FG002|Overall Study|Lack of Efficacy|2
7716068|NCT00509795|12139289|FG003|Overall Study|Lack of Efficacy|2
7716069|NCT00509795|12139286|FG000|Overall Study|Lost to Follow-up|1
7716070|NCT00509795|12139287|FG001|Overall Study|Lost to Follow-up|2
7716071|NCT00509795|12139288|FG002|Overall Study|Lost to Follow-up|4
7716072|NCT00509795|12139289|FG003|Overall Study|Lost to Follow-up|4
7716073|NCT00509795|12139286|FG000|Overall Study|OTHER|1
7716074|NCT00509795|12139287|FG001|Overall Study|OTHER|0
7716075|NCT00509795|12139288|FG002|Overall Study|OTHER|4
7716076|NCT00509795|12139289|FG003|Overall Study|OTHER|1
7716077|NCT00509795|12139286|FG000|Overall Study|Protocol Violation|3
7716078|NCT00509795|12139287|FG001|Overall Study|Protocol Violation|0
7716079|NCT00509795|12139288|FG002|Overall Study|Protocol Violation|3
7716080|NCT00509795|12139289|FG003|Overall Study|Protocol Violation|1
7716081|NCT00509795|12139286|FG000|Overall Study|Withdrawal by Subject|10
7716082|NCT00509795|12139287|FG001|Overall Study|Withdrawal by Subject|5
7716083|NCT00509795|12139288|FG002|Overall Study|Withdrawal by Subject|7
7716084|NCT00509795|12139289|FG003|Overall Study|Withdrawal by Subject|8
7716085|NCT00509821|12139302|FG000|Study Period 1 (Induction)|Death|0
7716086|NCT00509821|12139303|FG001|Study Period 1 (Induction)|Death|1
7716087|NCT00509821|12139302|FG000|Study Period 1 (Induction)|Adverse Event|0
7716088|NCT00509821|12139303|FG001|Study Period 1 (Induction)|Adverse Event|2
7716089|NCT00509821|12139302|FG000|Study Period 1 (Induction)|Progressive Disease|0
7716090|NCT00509821|12139303|FG001|Study Period 1 (Induction)|Progressive Disease|1
7716091|NCT00509899|12139331|FG000|Overall Study|Progressive disease|1
7716092|NCT00509899|12139332|FG001|Overall Study|Progressive disease|3
7716093|NCT00509899|12139333|FG002|Overall Study|Progressive disease|5
7716094|NCT00509899|12139334|FG003|Overall Study|Progressive disease|1
7716095|NCT00509899|12139335|FG004|Overall Study|Progressive disease|0
7716096|NCT00509899|12139336|FG005|Overall Study|Progressive disease|1
7716097|NCT00509899|12139337|FG006|Overall Study|Progressive disease|0
7716098|NCT00509899|12139338|FG007|Overall Study|Progressive disease|0
7716099|NCT00509899|12139331|FG000|Overall Study|Unacceptable Toxicity|1
7716100|NCT00509899|12139332|FG001|Overall Study|Unacceptable Toxicity|0
7716101|NCT00509899|12139333|FG002|Overall Study|Unacceptable Toxicity|0
7716102|NCT00509899|12139334|FG003|Overall Study|Unacceptable Toxicity|2
7716103|NCT00509899|12139335|FG004|Overall Study|Unacceptable Toxicity|0
7716104|NCT00509899|12139336|FG005|Overall Study|Unacceptable Toxicity|0
7716105|NCT00509899|12139337|FG006|Overall Study|Unacceptable Toxicity|0
7716106|NCT00509899|12139338|FG007|Overall Study|Unacceptable Toxicity|0
7716107|NCT00509899|12139331|FG000|Overall Study|Withdrawal by Subject|6
7716108|NCT00509899|12139332|FG001|Overall Study|Withdrawal by Subject|2
7716109|NCT00509899|12139333|FG002|Overall Study|Withdrawal by Subject|3
7716110|NCT00509899|12139334|FG003|Overall Study|Withdrawal by Subject|0
7716111|NCT00509899|12139335|FG004|Overall Study|Withdrawal by Subject|3
7716112|NCT00509899|12139336|FG005|Overall Study|Withdrawal by Subject|2
7716113|NCT00509899|12139337|FG006|Overall Study|Withdrawal by Subject|0
7716114|NCT00509899|12139338|FG007|Overall Study|Withdrawal by Subject|0
7716115|NCT00509899|12139331|FG000|Overall Study|Physician Decision|4
7716116|NCT00509899|12139332|FG001|Overall Study|Physician Decision|2
7716117|NCT00509899|12139333|FG002|Overall Study|Physician Decision|7
7716118|NCT00509899|12139334|FG003|Overall Study|Physician Decision|0
7716119|NCT00509899|12139335|FG004|Overall Study|Physician Decision|1
7716120|NCT00509899|12139336|FG005|Overall Study|Physician Decision|4
7716121|NCT00509899|12139337|FG006|Overall Study|Physician Decision|0
7716122|NCT00509899|12139338|FG007|Overall Study|Physician Decision|0
7716123|NCT00509899|12139331|FG000|Overall Study|Intercurrent Illness|1
7716124|NCT00509899|12139332|FG001|Overall Study|Intercurrent Illness|0
7716125|NCT00509899|12139333|FG002|Overall Study|Intercurrent Illness|0
7716126|NCT00509899|12139334|FG003|Overall Study|Intercurrent Illness|1
7716127|NCT00509899|12139335|FG004|Overall Study|Intercurrent Illness|0
7716128|NCT00509899|12139336|FG005|Overall Study|Intercurrent Illness|1
7716129|NCT00509899|12139337|FG006|Overall Study|Intercurrent Illness|0
7716130|NCT00509899|12139338|FG007|Overall Study|Intercurrent Illness|0
7716131|NCT00509899|12139331|FG000|Overall Study|Death|2
7716132|NCT00509899|12139332|FG001|Overall Study|Death|2
7716133|NCT00509899|12139333|FG002|Overall Study|Death|3
7716134|NCT00509899|12139334|FG003|Overall Study|Death|0
7716135|NCT00509899|12139335|FG004|Overall Study|Death|1
7716136|NCT00509899|12139336|FG005|Overall Study|Death|1
7716137|NCT00509899|12139337|FG006|Overall Study|Death|1
7716138|NCT00509899|12139338|FG007|Overall Study|Death|1
7716139|NCT00509899|12139331|FG000|Overall Study|Lack of Efficacy|1
7716140|NCT00509899|12139332|FG001|Overall Study|Lack of Efficacy|0
7716141|NCT00509899|12139333|FG002|Overall Study|Lack of Efficacy|2
7716142|NCT00509899|12139334|FG003|Overall Study|Lack of Efficacy|0
7716143|NCT00509899|12139335|FG004|Overall Study|Lack of Efficacy|0
7716144|NCT00509899|12139336|FG005|Overall Study|Lack of Efficacy|1
7716145|NCT00509899|12139337|FG006|Overall Study|Lack of Efficacy|0
7716146|NCT00509899|12139338|FG007|Overall Study|Lack of Efficacy|0
7716147|NCT00509925|12139352|FG000|Overall Study|Personal reasons|0
7716148|NCT00509925|12139353|FG001|Overall Study|Personal reasons|1
7716149|NCT00510068|12139363|FG000|Double-blind Period|Disease progression|98
7716150|NCT00510068|12139364|FG001|Double-blind Period|Disease progression|169
7716151|NCT00510068|12139363|FG000|Double-blind Period|Final primary analysis|52
7716152|NCT00510068|12139364|FG001|Double-blind Period|Final primary analysis|18
7716153|NCT00510068|12139363|FG000|Double-blind Period|Adverse Event|37
7716154|NCT00510068|12139364|FG001|Double-blind Period|Adverse Event|7
7716155|NCT00510068|12139363|FG000|Double-blind Period|Withdrawal by Subject|8
7716156|NCT00510068|12139364|FG001|Double-blind Period|Withdrawal by Subject|6
7716157|NCT00510068|12139363|FG000|Double-blind Period|Death|4
7716158|NCT00510068|12139364|FG001|Double-blind Period|Death|3
7716159|NCT00510068|12139363|FG000|Double-blind Period|Abnormal test result (s)|1
7716160|NCT00510068|12139364|FG001|Double-blind Period|Abnormal test result (s)|0
7716161|NCT00510068|12139363|FG000|Double-blind Period|Lost to Follow-up|1
7716162|NCT00510068|12139364|FG001|Double-blind Period|Lost to Follow-up|0
7716163|NCT00510068|12139363|FG000|Double-blind Period|Protocol Violation|6
7716164|NCT00510068|12139364|FG001|Double-blind Period|Protocol Violation|0
7716165|NCT00510068|12139363|FG000|Open-label Period|Disease Progression|124
7716166|NCT00510068|12139364|FG001|Open-label Period|Disease Progression|0
7716167|NCT00510068|12139363|FG000|Open-label Period|Adverse Event|46
7716168|NCT00510068|12139364|FG001|Open-label Period|Adverse Event|0
7716169|NCT00510068|12139363|FG000|Open-label Period|Withdrawal by Subject|21
7716170|NCT00510068|12139364|FG001|Open-label Period|Withdrawal by Subject|0
7716171|NCT00510068|12139363|FG000|Open-label Period|Administrative problems|17
7716172|NCT00510068|12139364|FG001|Open-label Period|Administrative problems|0
7716173|NCT00510068|12139363|FG000|Open-label Period|Death|7
7716174|NCT00510068|12139364|FG001|Open-label Period|Death|0
7716175|NCT00510068|12139363|FG000|Open-label Period|New cancer therapy|7
7716176|NCT00510068|12139364|FG001|Open-label Period|New cancer therapy|0
7716177|NCT00510068|12139363|FG000|Open-label Period|Protocol Violation|2
7716178|NCT00510068|12139364|FG001|Open-label Period|Protocol Violation|0
7716179|NCT00510068|12139363|FG000|Open-label Period|Abnormal laboratory value (s)|1
7716180|NCT00510068|12139364|FG001|Open-label Period|Abnormal laboratory value (s)|0
7716181|NCT00510146|12139374|FG000|Double-Blind Treatment|Adverse Event|30
7716182|NCT00510146|12139375|FG001|Double-Blind Treatment|Adverse Event|13
7716183|NCT00510146|12139374|FG000|Double-Blind Treatment|Lack of Efficacy|6
7716184|NCT00510146|12139375|FG001|Double-Blind Treatment|Lack of Efficacy|13
7716185|NCT00510146|12139374|FG000|Double-Blind Treatment|Lost to Follow-up|3
7716186|NCT00510146|12139375|FG001|Double-Blind Treatment|Lost to Follow-up|7
7716187|NCT00510146|12139374|FG000|Double-Blind Treatment|Physician Decision|6
7716188|NCT00510146|12139375|FG001|Double-Blind Treatment|Physician Decision|0
7716189|NCT00510146|12139374|FG000|Double-Blind Treatment|Protocol Violation|1
7716190|NCT00510146|12139375|FG001|Double-Blind Treatment|Protocol Violation|2
7716191|NCT00510146|12139374|FG000|Double-Blind Treatment|Withdrawal by Subject|27
7716192|NCT00510146|12139375|FG001|Double-Blind Treatment|Withdrawal by Subject|13
7716193|NCT00510146|12139374|FG000|Double-Blind Treatment|Clinical Relapse|0
7716194|NCT00510146|12139375|FG001|Double-Blind Treatment|Clinical Relapse|1
7716195|NCT00510146|12139374|FG000|Double-Blind Treatment|Entry Criteria Not Met|3
7716196|NCT00510146|12139375|FG001|Double-Blind Treatment|Entry Criteria Not Met|0
7716197|NCT00510146|12139374|FG000|Open-Label Treatment|Adverse Event|22
7716198|NCT00510146|12139375|FG001|Open-Label Treatment|Adverse Event|8
7716199|NCT00510146|12139374|FG000|Open-Label Treatment|Death|1
7716200|NCT00510146|12139375|FG001|Open-Label Treatment|Death|1
7716201|NCT00510146|12139374|FG000|Open-Label Treatment|Lack of Efficacy|4
7716202|NCT00510146|12139375|FG001|Open-Label Treatment|Lack of Efficacy|0
7716203|NCT00510146|12139374|FG000|Open-Label Treatment|Lost to Follow-up|10
7716204|NCT00510146|12139375|FG001|Open-Label Treatment|Lost to Follow-up|1
7716205|NCT00510146|12139374|FG000|Open-Label Treatment|Physician Decision|3
7716206|NCT00510146|12139375|FG001|Open-Label Treatment|Physician Decision|1
7716207|NCT00510146|12139374|FG000|Open-Label Treatment|Protocol Violation|4
7716208|NCT00510146|12139375|FG001|Open-Label Treatment|Protocol Violation|2
7716209|NCT00510146|12139374|FG000|Open-Label Treatment|Withdrawal by Subject|24
7716210|NCT00510146|12139375|FG001|Open-Label Treatment|Withdrawal by Subject|12
7716211|NCT00510146|12139374|FG000|Open-Label Treatment|Clinical Relapse|1
7716212|NCT00510146|12139375|FG001|Open-Label Treatment|Clinical Relapse|1
7716213|NCT00510146|12139374|FG000|Open-Label Treatment|Sponsor Decision|2
7716214|NCT00510146|12139375|FG001|Open-Label Treatment|Sponsor Decision|0
7716215|NCT00510198|12139385|FG000|Overall Study|Withdrawal by Subject|5
7716216|NCT00510198|12139386|FG001|Overall Study|Withdrawal by Subject|4
7716217|NCT00510276|12139400|FG000|Acute Double-Blind Phase|Adverse Event|21
7716218|NCT00510276|12139401|FG001|Acute Double-Blind Phase|Adverse Event|6
7716219|NCT00510276|12139400|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1
7716220|NCT00510276|12139401|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1
7716221|NCT00510276|12139400|FG000|Acute Double-Blind Phase|Lack of Efficacy|3
7716222|NCT00510276|12139401|FG001|Acute Double-Blind Phase|Lack of Efficacy|4
7716223|NCT00510276|12139400|FG000|Acute Double-Blind Phase|Lost to Follow-up|48
7716224|NCT00510276|12139401|FG001|Acute Double-Blind Phase|Lost to Follow-up|49
7716225|NCT00510276|12139400|FG000|Acute Double-Blind Phase|Physician Decision|0
7716226|NCT00510276|12139401|FG001|Acute Double-Blind Phase|Physician Decision|3
7716227|NCT00510276|12139400|FG000|Acute Double-Blind Phase|Protocol Violation|4
7716228|NCT00510276|12139401|FG001|Acute Double-Blind Phase|Protocol Violation|3
7716229|NCT00510276|12139400|FG000|Acute Double-Blind Phase|Sponsor Decision|2
7716230|NCT00510276|12139401|FG001|Acute Double-Blind Phase|Sponsor Decision|1
7716231|NCT00510276|12139400|FG000|Acute Double-Blind Phase|Subject Decision|26
7716232|NCT00510276|12139401|FG001|Acute Double-Blind Phase|Subject Decision|28
7716233|NCT00510276|12139400|FG000|Extension Open-Label Phase|Adverse Event|9
7716234|NCT00510276|12139401|FG001|Extension Open-Label Phase|Adverse Event|18
7716235|NCT00510276|12139400|FG000|Extension Open-Label Phase|Lack of Efficacy|2
7716236|NCT00510276|12139401|FG001|Extension Open-Label Phase|Lack of Efficacy|7
7716237|NCT00510276|12139400|FG000|Extension Open-Label Phase|Lost to Follow-up|12
7716238|NCT00510276|12139401|FG001|Extension Open-Label Phase|Lost to Follow-up|10
7716239|NCT00510276|12139400|FG000|Extension Open-Label Phase|Physician Decision|2
7716240|NCT00510276|12139401|FG001|Extension Open-Label Phase|Physician Decision|3
7716241|NCT00510276|12139400|FG000|Extension Open-Label Phase|Protocol Violation|0
7716242|NCT00510276|12139401|FG001|Extension Open-Label Phase|Protocol Violation|1
7716243|NCT00510276|12139400|FG000|Extension Open-Label Phase|Sponsor Decision|1
7716244|NCT00510276|12139401|FG001|Extension Open-Label Phase|Sponsor Decision|0
7716245|NCT00510276|12139400|FG000|Extension Open-Label Phase|Subject Decision|7
7716246|NCT00510276|12139401|FG001|Extension Open-Label Phase|Subject Decision|9
7716247|NCT00510289|12139414|FG000|Overall Study|Withdrawal by Subject|7
7716248|NCT00510289|12139414|FG000|Overall Study|Refused bone marrow biopsy|2
7716249|NCT00510289|12139414|FG000|Overall Study|Lost to Follow-up|1
7716250|NCT00510289|12139414|FG000|Overall Study|Progressed prior to starting drug|2
7716251|NCT00510458|12139419|FG000|Overall Study|5 year not evaluable/missed|21
7716252|NCT00510458|12139419|FG000|Overall Study|Death|1
7716253|NCT00510458|12139419|FG000|Overall Study|Terminated|14
7716254|NCT00510458|12139419|FG000|Overall Study|Lost to Follow-up|6
7716255|NCT00510458|12139419|FG000|Overall Study|Withdrawal by Subject|3
7716256|NCT00510458|12139419|FG000|Overall Study|Revision|2
7716257|NCT00510484|12139426|FG000|Wash-out Period|Adverse Event|0
7716258|NCT00510484|12139427|FG001|Wash-out Period|Adverse Event|1
7716259|NCT00510510|12139440|FG000|Overall Study|Adverse Event|4
7716260|NCT00510510|12139441|FG001|Overall Study|Adverse Event|3
7716261|NCT00510510|12139442|FG002|Overall Study|Adverse Event|6
7716262|NCT00510510|12139440|FG000|Overall Study|Lack of Efficacy|0
7716263|NCT00510510|12139441|FG001|Overall Study|Lack of Efficacy|1
7716264|NCT00510510|12139442|FG002|Overall Study|Lack of Efficacy|1
7716265|NCT00510510|12139440|FG000|Overall Study|Subjects no longer requires study drug|0
7716266|NCT00510510|12139441|FG001|Overall Study|Subjects no longer requires study drug|0
7716267|NCT00510510|12139442|FG002|Overall Study|Subjects no longer requires study drug|2
7716268|NCT00510510|12139440|FG000|Overall Study|Withdrawal by Subject|1
7716269|NCT00510510|12139441|FG001|Overall Study|Withdrawal by Subject|2
7716270|NCT00510510|12139442|FG002|Overall Study|Withdrawal by Subject|3
7716271|NCT00510510|12139440|FG000|Overall Study|Lost to Follow-up|0
7716272|NCT00510510|12139441|FG001|Overall Study|Lost to Follow-up|0
7716273|NCT00510510|12139442|FG002|Overall Study|Lost to Follow-up|1
7716274|NCT00510510|12139440|FG000|Overall Study|Protocol Violation|0
7716275|NCT00510510|12139441|FG001|Overall Study|Protocol Violation|3
7716276|NCT00510510|12139442|FG002|Overall Study|Protocol Violation|4
7716277|NCT00510653|12139450|FG000|Overall Study|Withdrawal by Subject|8
7716278|NCT00510653|12139450|FG000|Overall Study|Monetary|3
7716279|NCT00510692|12139456|FG000|Overall Study|Adverse Event|1
7716280|NCT00510692|12139457|FG001|Overall Study|Adverse Event|3
7716281|NCT00510692|12139456|FG000|Overall Study|Withdrawal by Subject|1
7716282|NCT00510692|12139457|FG001|Overall Study|Withdrawal by Subject|0
7716283|NCT00510718|12139472|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1
7716284|NCT00510718|12139473|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8
7716285|NCT00510718|12139472|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3
7716286|NCT00510718|12139473|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6
7716287|NCT00510718|12139472|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8
7716288|NCT00510718|12139473|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11
7716289|NCT00510718|12139472|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1
7716290|NCT00510718|12139473|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3
7716291|NCT00510718|12139472|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1
7716292|NCT00510718|12139473|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3
7716293|NCT00510718|12139472|FG000|Multiple Dose Period: 12 Weeks|Other|1
7716294|NCT00510718|12139473|FG001|Multiple Dose Period: 12 Weeks|Other|1
7716295|NCT00510783|12139498|FG000|Overall Study|Lost to Follow-up|29
7716296|NCT00510783|12139499|FG001|Overall Study|Lost to Follow-up|25
7716297|NCT00510783|12139498|FG000|Overall Study|Withdrawal by Subject|2
7716298|NCT00510783|12139499|FG001|Overall Study|Withdrawal by Subject|3
7716299|NCT00510783|12139498|FG000|Overall Study|Protocol Violation|0
7716300|NCT00510783|12139499|FG001|Overall Study|Protocol Violation|1
7716301|NCT00510835|12139521|FG000|Overall Study|Withdrawal by Subject|6
7716302|NCT00510835|12139522|FG001|Overall Study|Withdrawal by Subject|2
7716303|NCT00510835|12139523|FG002|Overall Study|Withdrawal by Subject|2
7716304|NCT00510874|12139538|FG000|Overall Study|Withdrawal by Subject|1
7716305|NCT00510874|12139539|FG001|Overall Study|Withdrawal by Subject|1
7716306|NCT00510874|12139540|FG002|Overall Study|Withdrawal by Subject|0
7716307|NCT00510874|12139541|FG003|Overall Study|Withdrawal by Subject|0
7716308|NCT00510874|12139542|FG004|Overall Study|Withdrawal by Subject|3
7716309|NCT00510874|12139543|FG005|Overall Study|Withdrawal by Subject|0
7716310|NCT00510874|12139544|FG006|Overall Study|Withdrawal by Subject|0
7716311|NCT00510874|12139538|FG000|Overall Study|Lost to Follow-up|2
7716312|NCT00510874|12139539|FG001|Overall Study|Lost to Follow-up|3
7716313|NCT00510874|12139540|FG002|Overall Study|Lost to Follow-up|1
7716314|NCT00510874|12139541|FG003|Overall Study|Lost to Follow-up|3
7716315|NCT00510874|12139542|FG004|Overall Study|Lost to Follow-up|4
7716316|NCT00510874|12139543|FG005|Overall Study|Lost to Follow-up|0
7716317|NCT00510874|12139544|FG006|Overall Study|Lost to Follow-up|1
7716318|NCT00510887|12139561|FG000|Overall Study|Lost to Follow-up|1
7716319|NCT00510952|12139567|FG000|Overall Study|Adverse Event|1
7716320|NCT00510952|12139568|FG001|Overall Study|Adverse Event|0
7716321|NCT00510952|12139567|FG000|Overall Study|Entry Criteria Not Met|3
7716322|NCT00510952|12139568|FG001|Overall Study|Entry Criteria Not Met|1
7716323|NCT00510952|12139567|FG000|Overall Study|Lost to Follow-up|5
7716324|NCT00510952|12139568|FG001|Overall Study|Lost to Follow-up|3
7716325|NCT00510952|12139567|FG000|Overall Study|Physician Decision|1
7716326|NCT00510952|12139568|FG001|Overall Study|Physician Decision|1
7716327|NCT00510952|12139567|FG000|Overall Study|Protocol Violation|7
7716328|NCT00510952|12139568|FG001|Overall Study|Protocol Violation|4
7716329|NCT00510952|12139567|FG000|Overall Study|Sponsor Decision|1
7716330|NCT00510952|12139568|FG001|Overall Study|Sponsor Decision|0
7716331|NCT00510952|12139567|FG000|Overall Study|Withdrawal by Subject|6
7716332|NCT00510952|12139568|FG001|Overall Study|Withdrawal by Subject|7
7716333|NCT00510952|12139567|FG000|Overall Study|Did Not Receive Study Drug|2
7716334|NCT00510952|12139568|FG001|Overall Study|Did Not Receive Study Drug|0
7716335|NCT00511004|12139577|FG000|Overall Study|Lost to Follow-up|0
7716336|NCT00511004|12139578|FG001|Overall Study|Lost to Follow-up|0
7716337|NCT00511004|12139579|FG002|Overall Study|Lost to Follow-up|4
7716338|NCT00511108|12139604|FG000|Overall Study|Adverse Event|2
7716339|NCT00511108|12139605|FG001|Overall Study|Adverse Event|0
7716340|NCT00511108|12139606|FG002|Overall Study|Adverse Event|1
7716341|NCT00511108|12139607|FG003|Overall Study|Adverse Event|2
7716342|NCT00511108|12139604|FG000|Overall Study|Lost to Follow-up|0
7716343|NCT00511108|12139605|FG001|Overall Study|Lost to Follow-up|2
7716344|NCT00511108|12139606|FG002|Overall Study|Lost to Follow-up|1
7716345|NCT00511108|12139607|FG003|Overall Study|Lost to Follow-up|0
7716346|NCT00511108|12139604|FG000|Overall Study|Physician Decision|0
7716347|NCT00511108|12139605|FG001|Overall Study|Physician Decision|0
7716348|NCT00511108|12139606|FG002|Overall Study|Physician Decision|0
7716349|NCT00511108|12139607|FG003|Overall Study|Physician Decision|1
7716350|NCT00511108|12139604|FG000|Overall Study|Withdrawal by Subject|4
7716351|NCT00511108|12139605|FG001|Overall Study|Withdrawal by Subject|0
7716352|NCT00511108|12139606|FG002|Overall Study|Withdrawal by Subject|3
7716353|NCT00511108|12139607|FG003|Overall Study|Withdrawal by Subject|2
7716354|NCT00511147|12139617|FG000|Overall Study|Withdrawal by Subject|1
7716355|NCT00511147|12139617|FG000|Overall Study|Disease progression|5
7716356|NCT00511147|12139617|FG000|Overall Study|Required platelet transfusion|1
7716357|NCT00511238|12139628|FG000|Overall Study|Adverse Event|13
7716358|NCT00511238|12139629|FG001|Overall Study|Adverse Event|33
7716359|NCT00511238|12139628|FG000|Overall Study|Withdrawal by Subject|2
7716360|NCT00511238|12139629|FG001|Overall Study|Withdrawal by Subject|22
7716361|NCT00511238|12139628|FG000|Overall Study|Progressive Disease|23
7716362|NCT00511238|12139629|FG001|Overall Study|Progressive Disease|157
7716363|NCT00511238|12139628|FG000|Overall Study|various reasons|4
7716364|NCT00511238|12139629|FG001|Overall Study|various reasons|14
7716365|NCT00511472|12139647|FG000|Overall Study|Clinical Adverse Event|1
7716366|NCT00511472|12139648|FG001|Overall Study|Clinical Adverse Event|2
7716367|NCT00511472|12139647|FG000|Overall Study|Laboratory Adverse Event|0
7716368|NCT00511472|12139648|FG001|Overall Study|Laboratory Adverse Event|2
7716369|NCT00511472|12139647|FG000|Overall Study|Not reported|2
7716370|NCT00511472|12139648|FG001|Overall Study|Not reported|2
7716371|NCT00511667|12139665|FG000|Overall Study|Adverse Event|1
7716372|NCT00511667|12139666|FG001|Overall Study|Adverse Event|0
7716373|NCT00511667|12139665|FG000|Overall Study|Protocol Violation|1
7716374|NCT00511667|12139666|FG001|Overall Study|Protocol Violation|1
7716375|NCT00511667|12139665|FG000|Overall Study|Withdrawal by Subject|2
7716376|NCT00511667|12139666|FG001|Overall Study|Withdrawal by Subject|0
7716377|NCT00511667|12139665|FG000|Overall Study|Site terminated|6
7716378|NCT00511667|12139666|FG001|Overall Study|Site terminated|1
7716379|NCT00511667|12139665|FG000|Overall Study|Other|2
7716380|NCT00511667|12139666|FG001|Overall Study|Other|1
7716381|NCT00511797|12139691|FG000|Overall Study|Adverse Event|1
7716382|NCT00511797|12139692|FG001|Overall Study|Adverse Event|2
7716383|NCT00511797|12139693|FG002|Overall Study|Adverse Event|2
7716384|NCT00511797|12139694|FG003|Overall Study|Adverse Event|2
7716385|NCT00511797|12139691|FG000|Overall Study|Lost to Follow-up|1
7716386|NCT00511797|12139692|FG001|Overall Study|Lost to Follow-up|0
7716387|NCT00511797|12139693|FG002|Overall Study|Lost to Follow-up|0
7716388|NCT00511797|12139694|FG003|Overall Study|Lost to Follow-up|1
7716389|NCT00511797|12139691|FG000|Overall Study|Pregnancy|0
7716390|NCT00511797|12139692|FG001|Overall Study|Pregnancy|0
7716391|NCT00511797|12139693|FG002|Overall Study|Pregnancy|0
7716392|NCT00511797|12139694|FG003|Overall Study|Pregnancy|1
7716393|NCT00511797|12139691|FG000|Overall Study|Protocol Violation|0
7716394|NCT00511797|12139692|FG001|Overall Study|Protocol Violation|2
7716395|NCT00511797|12139693|FG002|Overall Study|Protocol Violation|2
7716396|NCT00511797|12139694|FG003|Overall Study|Protocol Violation|3
7716397|NCT00511797|12139691|FG000|Overall Study|Withdrawal by Subject|3
7716398|NCT00511797|12139692|FG001|Overall Study|Withdrawal by Subject|3
7716399|NCT00511797|12139693|FG002|Overall Study|Withdrawal by Subject|4
7716400|NCT00511797|12139694|FG003|Overall Study|Withdrawal by Subject|2
7716401|NCT00511797|12139691|FG000|Overall Study|Never dispensed|1
7716402|NCT00511797|12139692|FG001|Overall Study|Never dispensed|0
7716403|NCT00511797|12139693|FG002|Overall Study|Never dispensed|1
7716404|NCT00511797|12139694|FG003|Overall Study|Never dispensed|3
7716405|NCT00511797|12139691|FG000|Overall Study|Study drug not taken|0
7716406|NCT00511797|12139692|FG001|Overall Study|Study drug not taken|1
7716407|NCT00511797|12139693|FG002|Overall Study|Study drug not taken|0
7716408|NCT00511797|12139694|FG003|Overall Study|Study drug not taken|1
7716409|NCT00511797|12139691|FG000|Overall Study|Partially missing diary|0
7716410|NCT00511797|12139692|FG001|Overall Study|Partially missing diary|0
7716411|NCT00511797|12139693|FG002|Overall Study|Partially missing diary|1
7716412|NCT00511797|12139694|FG003|Overall Study|Partially missing diary|0
7716413|NCT00511797|12139691|FG000|Overall Study|Other (moving etc)|1
7716414|NCT00511797|12139692|FG001|Overall Study|Other (moving etc)|0
7716415|NCT00511797|12139693|FG002|Overall Study|Other (moving etc)|1
7716416|NCT00511797|12139694|FG003|Overall Study|Other (moving etc)|2
7716417|NCT00511810|12139706|FG000|Overall Study|Lost to Follow-up|1
7716418|NCT00511810|12139707|FG001|Overall Study|Lost to Follow-up|2
7716419|NCT00511810|12139706|FG000|Overall Study|Lack of Efficacy|0
7716420|NCT00511810|12139707|FG001|Overall Study|Lack of Efficacy|2
7716421|NCT00511810|12139706|FG000|Overall Study|Refused second scn|0
7716422|NCT00511810|12139707|FG001|Overall Study|Refused second scn|1
7716423|NCT00511836|12139715|FG000|Double-blind Period|Lost to Follow-up|1
7716424|NCT00511836|12139716|FG001|Double-blind Period|Lost to Follow-up|0
7716425|NCT00511875|12139740|FG000|Overall Study|Lost to Follow-up|4
7716426|NCT00511875|12139741|FG001|Overall Study|Lost to Follow-up|0
7716427|NCT00511875|12139740|FG000|Overall Study|Missing variables|1
7716428|NCT00511875|12139741|FG001|Overall Study|Missing variables|0
7716429|NCT00511901|12139749|FG000|Overall Study|Withdrawal by Subject|1
7716430|NCT00511901|12139750|FG001|Overall Study|Withdrawal by Subject|3
7716431|NCT00512096|12139769|FG000|Overall Study|Adverse Event|2
7716432|NCT00512096|12139769|FG000|Overall Study|Withdrawal by Subject|2
7716433|NCT00512096|12139769|FG000|Overall Study|Lack of Efficacy|3
7716434|NCT00512135|12139773|FG000|Overall Study|Not Treated|5
7716435|NCT00512135|12139773|FG000|Overall Study|Lack of Efficacy|2
7716436|NCT00512135|12139773|FG000|Overall Study|Adverse Event|6
7716437|NCT00512135|12139773|FG000|Overall Study|Withdrawal by Subject|22
7716438|NCT00512135|12139773|FG000|Overall Study|Lost to Follow-up|27
7716439|NCT00512135|12139773|FG000|Overall Study|Other|22
7716440|NCT00512148|12139778|FG000|Primay Study Period|Withdrawal by Subject|1
7716441|NCT00512252|12139787|FG000|Overall Study|Lost to Follow-up|0
7716442|NCT00512252|12139788|FG001|Overall Study|Lost to Follow-up|0
7716443|NCT00512252|12139789|FG002|Overall Study|Lost to Follow-up|1
7716444|NCT00512252|12139787|FG000|Overall Study|Protocol Violation|0
7716445|NCT00512252|12139788|FG001|Overall Study|Protocol Violation|0
7716446|NCT00512252|12139789|FG002|Overall Study|Protocol Violation|1
7716447|NCT00512252|12139787|FG000|Overall Study|Death|0
7716448|NCT00512252|12139788|FG001|Overall Study|Death|0
7716449|NCT00512252|12139789|FG002|Overall Study|Death|1
7716450|NCT00512707|12139817|FG000|Overall Study|Lost to Follow-up|5
7716451|NCT00512707|12139818|FG001|Overall Study|Lost to Follow-up|11
7716452|NCT00512707|12139817|FG000|Overall Study|Developed skin irritation|2
7716453|NCT00512707|12139818|FG001|Overall Study|Developed skin irritation|1
7716454|NCT00512707|12139817|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2
7716455|NCT00512707|12139818|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0
7716456|NCT00512707|12139817|FG000|Overall Study|Unable to tolerate the smell of the gel|1
7716457|NCT00512707|12139818|FG001|Overall Study|Unable to tolerate the smell of the gel|0
7716458|NCT00512798|12139826|FG000|Overall Study|Death|0
7716459|NCT00512798|12139827|FG001|Overall Study|Death|3
7716460|NCT00512798|12139826|FG000|Overall Study|Adverse Event|2
7716461|NCT00512798|12139827|FG001|Overall Study|Adverse Event|4
7716462|NCT00512798|12139826|FG000|Overall Study|Progression of disease|14
7716463|NCT00512798|12139827|FG001|Overall Study|Progression of disease|20
7716464|NCT00512798|12139826|FG000|Overall Study|Withdrawal by Subject|3
7716465|NCT00512798|12139827|FG001|Overall Study|Withdrawal by Subject|0
7716466|NCT00512902|12139838|FG000|Overall Study|Adverse Event|7
7716467|NCT00512902|12139838|FG000|Overall Study|Lost to Follow-up|1
7716468|NCT00513019|12139844|FG000|Overall Study|Adverse Event|1
7716469|NCT00513019|12139845|FG001|Overall Study|Adverse Event|0
7716470|NCT00513019|12139844|FG000|Overall Study|Withdrawal by Subject|4
7716471|NCT00513019|12139845|FG001|Overall Study|Withdrawal by Subject|5
7716472|NCT00513071|12139851|FG000|Overall Study|Adverse Event|1
7716473|NCT00513071|12139851|FG000|Overall Study|Withdrawal by Subject|1
7716474|NCT00513071|12139851|FG000|Overall Study|Physician Decision|3
7716475|NCT00513240|12139857|FG000|Overall Study|Did not have intended surgery|3
7716476|NCT00513240|12139858|FG001|Overall Study|Did not have intended surgery|0
7716477|NCT00513240|12139857|FG000|Overall Study|Death|3
7716478|NCT00513240|12139858|FG001|Overall Study|Death|3
7716479|NCT00513240|12139857|FG000|Overall Study|Withdrawal by Subject|7
7716480|NCT00513240|12139858|FG001|Overall Study|Withdrawal by Subject|4
7716481|NCT00513305|12139878|FG000|Overall Study|Adverse Event|6
7716482|NCT00513305|12139879|FG001|Overall Study|Adverse Event|2
7716483|NCT00513305|12139878|FG000|Overall Study|Death (through Consolidation Treatment)|2
7716484|NCT00513305|12139879|FG001|Overall Study|Death (through Consolidation Treatment)|2
7716485|NCT00513305|12139878|FG000|Overall Study|Lack of Efficacy|8
7716486|NCT00513305|12139879|FG001|Overall Study|Lack of Efficacy|13
7716487|NCT00513305|12139878|FG000|Overall Study|Withdrawal by Subject|1
7716488|NCT00513305|12139879|FG001|Overall Study|Withdrawal by Subject|2
7716489|NCT00513305|12139878|FG000|Overall Study|Disease progression|8
7716490|NCT00513305|12139879|FG001|Overall Study|Disease progression|5
7716491|NCT00513305|12139878|FG000|Overall Study|Eligible for stem cell transplant|1
7716492|NCT00513305|12139879|FG001|Overall Study|Eligible for stem cell transplant|0
7716493|NCT00513305|12139878|FG000|Overall Study|Hematologic counts did not recover|1
7716494|NCT00513305|12139879|FG001|Overall Study|Hematologic counts did not recover|0
7716495|NCT00513305|12139878|FG000|Overall Study|Physician Decision|1
7716496|NCT00513305|12139879|FG001|Overall Study|Physician Decision|0
7716497|NCT00513305|12139878|FG000|Overall Study|Persistent hypocellularity|0
7716498|NCT00513305|12139879|FG001|Overall Study|Persistent hypocellularity|1
7716499|NCT00513305|12139878|FG000|Overall Study|Sponsor Decision|0
7716500|NCT00513305|12139879|FG001|Overall Study|Sponsor Decision|2
7716501|NCT00513357|12139895|FG000|Overall Study|did not receive allocated placebo|2
7716502|NCT00513357|12139896|FG001|Overall Study|did not receive allocated placebo|3
7716503|NCT00513357|12139895|FG000|Overall Study|Adverse Event|4
7716504|NCT00513357|12139896|FG001|Overall Study|Adverse Event|2
7716505|NCT00513357|12139895|FG000|Overall Study|Death|2
7716506|NCT00513357|12139896|FG001|Overall Study|Death|0
7716507|NCT00513357|12139895|FG000|Overall Study|Withdrawal by Subject|5
7716508|NCT00513357|12139896|FG001|Overall Study|Withdrawal by Subject|4
7716509|NCT00513357|12139895|FG000|Overall Study|Disease Progression|2
7716510|NCT00513357|12139896|FG001|Overall Study|Disease Progression|1
7716511|NCT00513409|12139910|FG000|Overall Study|Adverse Event|0
7716512|NCT00513409|12139911|FG001|Overall Study|Adverse Event|1
7716513|NCT00513409|12139910|FG000|Overall Study|Withdrawal by Subject|0
7716514|NCT00513409|12139911|FG001|Overall Study|Withdrawal by Subject|2
7716515|NCT00513409|12139910|FG000|Overall Study|Lost to Follow-up|0
7716516|NCT00513409|12139911|FG001|Overall Study|Lost to Follow-up|1
7716517|NCT00513409|12139910|FG000|Overall Study|Physician Decision|1
7716518|NCT00513409|12139911|FG001|Overall Study|Physician Decision|0
7716519|NCT00513409|12139910|FG000|Overall Study|Visit 3 not done|1
7716520|NCT00513409|12139911|FG001|Overall Study|Visit 3 not done|2
7716521|NCT00513474|12139932|FG000|Overall Study|Death|6
7716522|NCT00513474|12139933|FG001|Overall Study|Death|9
7716523|NCT00513474|12139932|FG000|Overall Study|Participant Withdrew Consent|1
7716524|NCT00513474|12139933|FG001|Overall Study|Participant Withdrew Consent|0
7716525|NCT00513500|12139941|FG000|Overall Study|Lost to Follow-up|35
7716526|NCT00513500|12139942|FG001|Overall Study|Lost to Follow-up|39
7716527|NCT00513500|12139941|FG000|Overall Study|Death|2
7716528|NCT00513500|12139942|FG001|Overall Study|Death|1
7716529|NCT00513500|12139941|FG000|Overall Study|Hospitalized|4
7716530|NCT00513500|12139942|FG001|Overall Study|Hospitalized|14
7716531|NCT00513604|12139959|FG000|Overall Study|Not treated|2
7716532|NCT00513604|12139960|FG001|Overall Study|Not treated|0
7716533|NCT00513604|12139961|FG002|Overall Study|Not treated|1
7716534|NCT00513604|12139962|FG003|Overall Study|Not treated|0
7716535|NCT00513604|12139963|FG004|Overall Study|Not treated|0
7716536|NCT00513604|12139959|FG000|Overall Study|Death during treatment|0
7716537|NCT00513604|12139960|FG001|Overall Study|Death during treatment|3
7716538|NCT00513604|12139961|FG002|Overall Study|Death during treatment|2
7716539|NCT00513604|12139962|FG003|Overall Study|Death during treatment|0
7716540|NCT00513604|12139963|FG004|Overall Study|Death during treatment|0
7716541|NCT00513682|12139975|FG000|Washout Phase|Adverse Event|2
7716542|NCT00513695|12139982|FG000|Overall Study|Discontinued therapy|2
7716543|NCT00513695|12139982|FG000|Overall Study|Progression prior to surgery|3
7716544|NCT00513708|12139989|FG000|Overall Study|Lost to Follow-up|4
7716545|NCT00513708|12139990|FG001|Overall Study|Lost to Follow-up|4
7716546|NCT00513708|12139991|FG002|Overall Study|Lost to Follow-up|4
7716547|NCT00514020|12140035|FG000|Overall Study|Adverse Event|6
7716548|NCT00514020|12140035|FG000|Overall Study|Withdrawal by Subject|3
7716549|NCT00514020|12140035|FG000|Overall Study|Physician Decision|1
7716550|NCT00514020|12140035|FG000|Overall Study|disease progression|9
7716551|NCT00514020|12140035|FG000|Overall Study|other complicating disease|2
7716552|NCT00514020|12140035|FG000|Overall Study|patient went to radiation treatment|1
7716553|NCT00514020|12140035|FG000|Overall Study|"patients moved to the no tx group"|6
7716554|NCT00514046|12140048|FG000|Overall Study|transferred to another protocol|2
7716555|NCT00514046|12140049|FG001|Overall Study|transferred to another protocol|1
7716556|NCT00514046|12140050|FG002|Overall Study|transferred to another protocol|3
7716557|NCT00514046|12140051|FG003|Overall Study|transferred to another protocol|0
7716558|NCT00514046|12140052|FG004|Overall Study|transferred to another protocol|1
7716559|NCT00514046|12140053|FG005|Overall Study|transferred to another protocol|0
7716560|NCT00514046|12140054|FG006|Overall Study|transferred to another protocol|0
7716561|NCT00514046|12140055|FG007|Overall Study|transferred to another protocol|0
7716562|NCT00514046|12140056|FG008|Overall Study|transferred to another protocol|0
7716563|NCT00514046|12140048|FG000|Overall Study|Getting vandetanib via the REMS program|1
7716564|NCT00514046|12140049|FG001|Overall Study|Getting vandetanib via the REMS program|0
7716565|NCT00514046|12140050|FG002|Overall Study|Getting vandetanib via the REMS program|0
7716566|NCT00514046|12140051|FG003|Overall Study|Getting vandetanib via the REMS program|0
7716567|NCT00514046|12140052|FG004|Overall Study|Getting vandetanib via the REMS program|0
7716568|NCT00514046|12140053|FG005|Overall Study|Getting vandetanib via the REMS program|0
7716569|NCT00514046|12140054|FG006|Overall Study|Getting vandetanib via the REMS program|0
7716570|NCT00514046|12140055|FG007|Overall Study|Getting vandetanib via the REMS program|1
7716571|NCT00514046|12140056|FG008|Overall Study|Getting vandetanib via the REMS program|1
7716572|NCT00514046|12140048|FG000|Overall Study|Disease progression on study|0
7716573|NCT00514046|12140049|FG001|Overall Study|Disease progression on study|0
7716574|NCT00514046|12140050|FG002|Overall Study|Disease progression on study|2
7716575|NCT00514046|12140051|FG003|Overall Study|Disease progression on study|0
7716576|NCT00514046|12140052|FG004|Overall Study|Disease progression on study|0
7716577|NCT00514046|12140053|FG005|Overall Study|Disease progression on study|1
7716578|NCT00514046|12140054|FG006|Overall Study|Disease progression on study|0
7716579|NCT00514046|12140055|FG007|Overall Study|Disease progression on study|0
7716580|NCT00514046|12140056|FG008|Overall Study|Disease progression on study|0
7716581|NCT00514449|12140088|FG000|Overall Study|Withdrawal by Subject|1
7716582|NCT00514449|12140089|FG001|Overall Study|Withdrawal by Subject|2
7716583|NCT00514449|12140088|FG000|Overall Study|Protocol Violation|1
7716584|NCT00514449|12140089|FG001|Overall Study|Protocol Violation|2
7716585|NCT00514449|12140088|FG000|Overall Study|Lost to Follow-up|1
7716586|NCT00514449|12140089|FG001|Overall Study|Lost to Follow-up|0
7716587|NCT00514514|12140105|FG000|Pre-phase|Death|10
7716588|NCT00514514|12140106|FG001|Pre-phase|Death|0
7716589|NCT00514514|12140107|FG002|Pre-phase|Death|0
7716590|NCT00514514|12140105|FG000|Pre-phase|administrative problems|2
7716591|NCT00514514|12140106|FG001|Pre-phase|administrative problems|0
7716592|NCT00514514|12140107|FG002|Pre-phase|administrative problems|0
7716593|NCT00514514|12140105|FG000|Pre-phase|Protocol Violation|6
7716594|NCT00514514|12140106|FG001|Pre-phase|Protocol Violation|0
7716595|NCT00514514|12140107|FG002|Pre-phase|Protocol Violation|0
7716596|NCT00514514|12140105|FG000|Pre-phase|condition no longer requires study drug|7
7716597|NCT00514514|12140106|FG001|Pre-phase|condition no longer requires study drug|0
7716598|NCT00514514|12140107|FG002|Pre-phase|condition no longer requires study drug|0
7716599|NCT00514514|12140105|FG000|Pre-phase|abnormal test procedure results|15
7716600|NCT00514514|12140106|FG001|Pre-phase|abnormal test procedure results|0
7716601|NCT00514514|12140107|FG002|Pre-phase|abnormal test procedure results|0
7716602|NCT00514514|12140105|FG000|Pre-phase|Lost to Follow-up|2
7716603|NCT00514514|12140106|FG001|Pre-phase|Lost to Follow-up|0
7716604|NCT00514514|12140107|FG002|Pre-phase|Lost to Follow-up|0
7716605|NCT00514514|12140105|FG000|Pre-phase|abnormal lab values|23
7716606|NCT00514514|12140106|FG001|Pre-phase|abnormal lab values|0
7716607|NCT00514514|12140107|FG002|Pre-phase|abnormal lab values|0
7716608|NCT00514514|12140105|FG000|Pre-phase|Lack of Efficacy|35
7716609|NCT00514514|12140106|FG001|Pre-phase|Lack of Efficacy|0
7716610|NCT00514514|12140107|FG002|Pre-phase|Lack of Efficacy|0
7716611|NCT00514514|12140105|FG000|Pre-phase|Adverse Event|137
7716612|NCT00514514|12140106|FG001|Pre-phase|Adverse Event|0
7716613|NCT00514514|12140107|FG002|Pre-phase|Adverse Event|0
7716614|NCT00514514|12140105|FG000|Pre-phase|Withdrawal by Subject|66
7716615|NCT00514514|12140106|FG001|Pre-phase|Withdrawal by Subject|0
7716616|NCT00514514|12140107|FG002|Pre-phase|Withdrawal by Subject|0
7716617|NCT00514514|12140105|FG000|Randomized - 9 Month|Death|3
7716618|NCT00514514|12140106|FG001|Randomized - 9 Month|Death|2
7716619|NCT00514514|12140107|FG002|Randomized - 9 Month|Death|2
7716620|NCT00514514|12140105|FG000|Randomized - 9 Month|Administrative problems|1
7716621|NCT00514514|12140106|FG001|Randomized - 9 Month|Administrative problems|1
7716622|NCT00514514|12140107|FG002|Randomized - 9 Month|Administrative problems|2
7716623|NCT00514514|12140105|FG000|Randomized - 9 Month|Withdrawal by Subject|7
7716624|NCT00514514|12140106|FG001|Randomized - 9 Month|Withdrawal by Subject|7
7716625|NCT00514514|12140107|FG002|Randomized - 9 Month|Withdrawal by Subject|5
7716626|NCT00514514|12140105|FG000|Randomized - 9 Month|Protocol Violation|1
7716627|NCT00514514|12140106|FG001|Randomized - 9 Month|Protocol Violation|1
7716628|NCT00514514|12140107|FG002|Randomized - 9 Month|Protocol Violation|0
7716629|NCT00514514|12140105|FG000|Randomized - 9 Month|Lack of Efficacy|2
7716630|NCT00514514|12140106|FG001|Randomized - 9 Month|Lack of Efficacy|3
7716631|NCT00514514|12140107|FG002|Randomized - 9 Month|Lack of Efficacy|1
7716632|NCT00514514|12140105|FG000|Randomized - 9 Month|Abnormal laboratory values|0
7716633|NCT00514514|12140106|FG001|Randomized - 9 Month|Abnormal laboratory values|3
7716634|NCT00514514|12140107|FG002|Randomized - 9 Month|Abnormal laboratory values|1
7716635|NCT00514514|12140105|FG000|Randomized - 9 Month|Adverse Event|25
7716636|NCT00514514|12140106|FG001|Randomized - 9 Month|Adverse Event|44
7716637|NCT00514514|12140107|FG002|Randomized - 9 Month|Adverse Event|27
7716638|NCT00514514|12140105|FG000|Extension - 4 Years|Withdrawal by Subject|5
7716639|NCT00514514|12140106|FG001|Extension - 4 Years|Withdrawal by Subject|2
7716640|NCT00514514|12140107|FG002|Extension - 4 Years|Withdrawal by Subject|2
7716641|NCT00514514|12140105|FG000|Extension - 4 Years|Lost to Follow-up|12
7716642|NCT00514514|12140106|FG001|Extension - 4 Years|Lost to Follow-up|10
7716643|NCT00514514|12140107|FG002|Extension - 4 Years|Lost to Follow-up|9
7716644|NCT00514514|12140105|FG000|Extension - 4 Years|Administrative problems|3
7716645|NCT00514514|12140106|FG001|Extension - 4 Years|Administrative problems|1
7716646|NCT00514514|12140107|FG002|Extension - 4 Years|Administrative problems|1
7716647|NCT00514514|12140105|FG000|Extension - 4 Years|Death|8
7716648|NCT00514514|12140106|FG001|Extension - 4 Years|Death|3
7716649|NCT00514514|12140107|FG002|Extension - 4 Years|Death|6
7716650|NCT00514514|12140105|FG000|Extension - 4 Years|Adverse Event|9
7716651|NCT00514514|12140106|FG001|Extension - 4 Years|Adverse Event|6
7716652|NCT00514514|12140107|FG002|Extension - 4 Years|Adverse Event|3
7716653|NCT00514540|12140115|FG000|First-Line Chemo|Withdrawal by Subject|1
7716654|NCT00514540|12140115|FG000|First-Line Chemo|Protocol Violation|7
7716655|NCT00514540|12140115|FG000|Second-Line|Physician/Patient Decision|31
7716656|NCT00514683|12140132|FG000|Overall Study|Not treated|2
7716657|NCT00514683|12140133|FG001|Overall Study|Not treated|1
7716658|NCT00514683|12140134|FG002|Overall Study|Not treated|0
7716659|NCT00514683|12140135|FG003|Overall Study|Not treated|0
7716660|NCT00514683|12140136|FG004|Overall Study|Not treated|1
7716661|NCT00514683|12140132|FG000|Overall Study|Adverse Event|21
7716662|NCT00514683|12140133|FG001|Overall Study|Adverse Event|20
7716663|NCT00514683|12140134|FG002|Overall Study|Adverse Event|15
7716664|NCT00514683|12140135|FG003|Overall Study|Adverse Event|13
7716665|NCT00514683|12140136|FG004|Overall Study|Adverse Event|27
7716666|NCT00514683|12140132|FG000|Overall Study|Protocol Violation|1
7716667|NCT00514683|12140133|FG001|Overall Study|Protocol Violation|1
7716668|NCT00514683|12140134|FG002|Overall Study|Protocol Violation|0
7716669|NCT00514683|12140135|FG003|Overall Study|Protocol Violation|1
7716670|NCT00514683|12140136|FG004|Overall Study|Protocol Violation|0
7716671|NCT00514683|12140132|FG000|Overall Study|Withdrawal by Subject|2
7716672|NCT00514683|12140133|FG001|Overall Study|Withdrawal by Subject|2
7716673|NCT00514683|12140134|FG002|Overall Study|Withdrawal by Subject|1
7716674|NCT00514683|12140135|FG003|Overall Study|Withdrawal by Subject|0
7716675|NCT00514683|12140136|FG004|Overall Study|Withdrawal by Subject|4
7716676|NCT00514683|12140132|FG000|Overall Study|Reason other than listed above|0
7716677|NCT00514683|12140133|FG001|Overall Study|Reason other than listed above|1
7716678|NCT00514683|12140134|FG002|Overall Study|Reason other than listed above|2
7716679|NCT00514683|12140135|FG003|Overall Study|Reason other than listed above|0
7716680|NCT00514683|12140136|FG004|Overall Study|Reason other than listed above|1
7716681|NCT00514735|12140165|FG000|Overall Study|Withdrawal by Subject|13
7716682|NCT00514735|12140166|FG001|Overall Study|Withdrawal by Subject|5
7716683|NCT00514735|12140165|FG000|Overall Study|Death|1
7716684|NCT00514735|12140166|FG001|Overall Study|Death|0
7716685|NCT00514735|12140165|FG000|Overall Study|Lost to Follow-up|0
7716686|NCT00514735|12140166|FG001|Overall Study|Lost to Follow-up|1
7716687|NCT00514904|12140185|FG000|Overall Study|Withdrawal by Subject|3
7716688|NCT00514904|12140186|FG001|Overall Study|Withdrawal by Subject|2
7716689|NCT00514904|12140185|FG000|Overall Study|Lost to Follow-up|21
7716690|NCT00514904|12140186|FG001|Overall Study|Lost to Follow-up|3
7716691|NCT00514917|12140194|FG000|Overall Study|Death|4
7716692|NCT00514917|12140195|FG001|Overall Study|Death|10
7716693|NCT00514917|12140194|FG000|Overall Study|Protocol Violation|1
7716694|NCT00514917|12140195|FG001|Overall Study|Protocol Violation|0
7716695|NCT00514917|12140194|FG000|Overall Study|Lost to Follow-up|4
7716696|NCT00514917|12140195|FG001|Overall Study|Lost to Follow-up|3
7716697|NCT00514917|12140194|FG000|Overall Study|Withdrawal by Subject|18
7716698|NCT00514917|12140195|FG001|Overall Study|Withdrawal by Subject|16
7716699|NCT00514917|12140194|FG000|Overall Study|Discontinued due to study closure|88
7716700|NCT00514917|12140195|FG001|Overall Study|Discontinued due to study closure|81
7716701|NCT00514917|12140194|FG000|Overall Study|Undefined|11
7716702|NCT00514917|12140195|FG001|Overall Study|Undefined|5
7716703|NCT00514943|12140205|FG000|Stage 1|Progressive disease|4
7716704|NCT00514943|12140206|FG001|Stage 1|Progressive disease|8
7716705|NCT00514943|12140205|FG000|Stage 1|Other Adverse Event|16
7716706|NCT00514943|12140206|FG001|Stage 1|Other Adverse Event|6
7716707|NCT00514943|12140205|FG000|Stage 1|Not treated|1
7716708|NCT00514943|12140206|FG001|Stage 1|Not treated|2
7716709|NCT00514943|12140205|FG000|Stage 1|Patient refused to continue study meds|8
7716710|NCT00514943|12140206|FG001|Stage 1|Patient refused to continue study meds|3
7716711|NCT00514943|12140205|FG000|Stage 1|Other than stated above|1
7716712|NCT00514943|12140206|FG001|Stage 1|Other than stated above|7
7716713|NCT00514943|12140205|FG000|Stage 2|Progressive disease|27
7716714|NCT00514943|12140206|FG001|Stage 2|Progressive disease|24
7716715|NCT00514943|12140205|FG000|Stage 2|Other Adverse Event|3
7716716|NCT00514943|12140206|FG001|Stage 2|Other Adverse Event|10
7716717|NCT00514943|12140205|FG000|Stage 2|Patient refused to continue study meds|2
7716718|NCT00514943|12140206|FG001|Stage 2|Patient refused to continue study meds|0
7716719|NCT00514943|12140205|FG000|Stage 2|Other than stated above|0
7716720|NCT00514943|12140206|FG001|Stage 2|Other than stated above|2
7716721|NCT00515008|12140229|FG000|Overall Study|Lost to Follow-up|1
7716722|NCT00515008|12140230|FG001|Overall Study|Lost to Follow-up|0
7716723|NCT00515008|12140229|FG000|Overall Study|Declined|0
7716724|NCT00515008|12140230|FG001|Overall Study|Declined|3
7716725|NCT00515008|12140229|FG000|Overall Study|Left the Boston Area|1
7716726|NCT00515008|12140230|FG001|Overall Study|Left the Boston Area|1
7716727|NCT00515008|12140229|FG000|Overall Study|Scheduling conflict|1
7716728|NCT00515008|12140230|FG001|Overall Study|Scheduling conflict|0
7716729|NCT00515034|12140254|FG000|Overall Study|Adverse Event|2
7716730|NCT00515034|12140255|FG001|Overall Study|Adverse Event|0
7716731|NCT00515034|12140256|FG002|Overall Study|Adverse Event|1
7716732|NCT00515034|12140257|FG003|Overall Study|Adverse Event|0
7716733|NCT00515034|12140254|FG000|Overall Study|Death|4
7716734|NCT00515034|12140255|FG001|Overall Study|Death|2
7716735|NCT00515034|12140256|FG002|Overall Study|Death|1
7716736|NCT00515034|12140257|FG003|Overall Study|Death|3
7716737|NCT00515034|12140254|FG000|Overall Study|Withdrawal by Subject|1
7716738|NCT00515034|12140255|FG001|Overall Study|Withdrawal by Subject|0
7716739|NCT00515034|12140256|FG002|Overall Study|Withdrawal by Subject|3
7716740|NCT00515034|12140257|FG003|Overall Study|Withdrawal by Subject|0
7716741|NCT00515034|12140254|FG000|Overall Study|Physician Decision|0
7716742|NCT00515034|12140255|FG001|Overall Study|Physician Decision|0
7716743|NCT00515034|12140256|FG002|Overall Study|Physician Decision|1
7716744|NCT00515034|12140257|FG003|Overall Study|Physician Decision|1
7716745|NCT00515034|12140254|FG000|Overall Study|Other|1
7716746|NCT00515034|12140255|FG001|Overall Study|Other|0
7716747|NCT00515034|12140256|FG002|Overall Study|Other|2
7716748|NCT00515034|12140257|FG003|Overall Study|Other|1
7716749|NCT00515073|12140267|FG000|Overall Study|Withdrawal by Subject|1
7716750|NCT00515073|12140267|FG000|Overall Study|Physician Decision|1
7716751|NCT00515086|12140275|FG000|Overall Study|Adverse Event|1
7716752|NCT00515086|12140276|FG001|Overall Study|Adverse Event|1
7716753|NCT00515086|12140277|FG002|Overall Study|Adverse Event|2
7716754|NCT00515086|12140278|FG003|Overall Study|Adverse Event|3
7716755|NCT00515086|12140275|FG000|Overall Study|Administrative|1
7716756|NCT00515086|12140276|FG001|Overall Study|Administrative|1
7716757|NCT00515086|12140277|FG002|Overall Study|Administrative|0
7716758|NCT00515086|12140278|FG003|Overall Study|Administrative|0
7716759|NCT00515086|12140275|FG000|Overall Study|Withdrawal by Subject|1
7716760|NCT00515086|12140276|FG001|Overall Study|Withdrawal by Subject|0
7716761|NCT00515086|12140277|FG002|Overall Study|Withdrawal by Subject|0
7716762|NCT00515086|12140278|FG003|Overall Study|Withdrawal by Subject|1
7716763|NCT00515086|12140275|FG000|Overall Study|Unsatisfactory therapeutic effect|18
7716926|NCT00516386|12140557|FG000|Overall Study|Lost to Follow-up|2
7716764|NCT00515086|12140276|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7716765|NCT00515086|12140277|FG002|Overall Study|Unsatisfactory therapeutic effect|3
7716766|NCT00515086|12140278|FG003|Overall Study|Unsatisfactory therapeutic effect|2
7716767|NCT00515086|12140275|FG000|Overall Study|Lost to Follow-up|1
7716768|NCT00515086|12140276|FG001|Overall Study|Lost to Follow-up|0
7716769|NCT00515086|12140277|FG002|Overall Study|Lost to Follow-up|0
7716770|NCT00515086|12140278|FG003|Overall Study|Lost to Follow-up|0
7716771|NCT00515086|12140275|FG000|Overall Study|Study drug no longer required|0
7716772|NCT00515086|12140276|FG001|Overall Study|Study drug no longer required|1
7716773|NCT00515086|12140277|FG002|Overall Study|Study drug no longer required|0
7716774|NCT00515086|12140278|FG003|Overall Study|Study drug no longer required|0
7716775|NCT00515086|12140275|FG000|Overall Study|Death|2
7716776|NCT00515086|12140276|FG001|Overall Study|Death|0
7716777|NCT00515086|12140277|FG002|Overall Study|Death|0
7716778|NCT00515086|12140278|FG003|Overall Study|Death|0
7716779|NCT00515099|12140296|FG000|Overall Study|Lost to Follow-up|0
7716780|NCT00515099|12140297|FG001|Overall Study|Lost to Follow-up|4
7716781|NCT00515099|12140296|FG000|Overall Study|Withdrawal by Subject|2
7716782|NCT00515099|12140297|FG001|Overall Study|Withdrawal by Subject|0
7716783|NCT00515099|12140296|FG000|Overall Study|IRB Recommendation|1
7716784|NCT00515099|12140297|FG001|Overall Study|IRB Recommendation|0
7716785|NCT00515216|12140322|FG000|Overall Study|Withdrawal by Subject|1
7716786|NCT00515294|12140331|FG000|Overall Study|Lost to Follow-up|3
7716787|NCT00515294|12140332|FG001|Overall Study|Lost to Follow-up|2
7716788|NCT00515294|12140333|FG002|Overall Study|Lost to Follow-up|3
7716789|NCT00515294|12140334|FG003|Overall Study|Lost to Follow-up|1
7716790|NCT00515294|12140331|FG000|Overall Study|Driver simulator problems|1
7716791|NCT00515294|12140332|FG001|Overall Study|Driver simulator problems|1
7716792|NCT00515294|12140333|FG002|Overall Study|Driver simulator problems|1
7716793|NCT00515294|12140334|FG003|Overall Study|Driver simulator problems|3
7716794|NCT00515294|12140331|FG000|Overall Study|Caffeine amount inaccurate|5
7716795|NCT00515294|12140332|FG001|Overall Study|Caffeine amount inaccurate|0
7716796|NCT00515294|12140333|FG002|Overall Study|Caffeine amount inaccurate|7
7716797|NCT00515294|12140334|FG003|Overall Study|Caffeine amount inaccurate|0
7716798|NCT00515463|12140376|FG000|Overall Study|Physician Decision|4
7716799|NCT00515463|12140377|FG001|Overall Study|Physician Decision|2
7716800|NCT00515463|12140376|FG000|Overall Study|Adverse Event|1
7716801|NCT00515463|12140377|FG001|Overall Study|Adverse Event|2
7716802|NCT00515463|12140376|FG000|Overall Study|Withdrawal by Subject|3
7716803|NCT00515463|12140377|FG001|Overall Study|Withdrawal by Subject|4
7716804|NCT00515463|12140376|FG000|Overall Study|Lost to Follow-up|6
7716805|NCT00515463|12140377|FG001|Overall Study|Lost to Follow-up|5
7716806|NCT00515463|12140376|FG000|Overall Study|Other|0
7716807|NCT00515463|12140377|FG001|Overall Study|Other|1
7716808|NCT00515502|12140384|FG000|Treatment Period 1|Adverse Event|0
7716809|NCT00515502|12140385|FG001|Treatment Period 1|Adverse Event|0
7716810|NCT00515502|12140386|FG002|Treatment Period 1|Adverse Event|0
7716811|NCT00515502|12140387|FG003|Treatment Period 1|Adverse Event|0
7716812|NCT00515502|12140388|FG004|Treatment Period 1|Adverse Event|0
7716813|NCT00515502|12140389|FG005|Treatment Period 1|Adverse Event|0
7716814|NCT00515502|12140390|FG006|Treatment Period 1|Adverse Event|1
7716815|NCT00515502|12140391|FG007|Treatment Period 1|Adverse Event|0
7716816|NCT00515502|12140392|FG008|Treatment Period 1|Adverse Event|1
7716817|NCT00515502|12140393|FG009|Treatment Period 1|Adverse Event|0
7716818|NCT00515502|12140394|FG010|Treatment Period 1|Adverse Event|0
7716819|NCT00515502|12140395|FG011|Treatment Period 1|Adverse Event|1
7716820|NCT00515502|12140384|FG000|Treatment Period 2|Adverse Event|0
7716821|NCT00515502|12140385|FG001|Treatment Period 2|Adverse Event|1
7716822|NCT00515502|12140386|FG002|Treatment Period 2|Adverse Event|0
7716823|NCT00515502|12140387|FG003|Treatment Period 2|Adverse Event|0
7716824|NCT00515502|12140388|FG004|Treatment Period 2|Adverse Event|0
7716825|NCT00515502|12140389|FG005|Treatment Period 2|Adverse Event|0
7716826|NCT00515502|12140390|FG006|Treatment Period 2|Adverse Event|0
7716827|NCT00515502|12140391|FG007|Treatment Period 2|Adverse Event|0
7716828|NCT00515502|12140392|FG008|Treatment Period 2|Adverse Event|0
7716829|NCT00515502|12140393|FG009|Treatment Period 2|Adverse Event|0
7716830|NCT00515502|12140394|FG010|Treatment Period 2|Adverse Event|0
7716831|NCT00515502|12140395|FG011|Treatment Period 2|Adverse Event|0
7716832|NCT00515541|12140425|FG000|Overall Study|Physician Decision|0
7716833|NCT00515541|12140426|FG001|Overall Study|Physician Decision|2
7716834|NCT00515541|12140427|FG002|Overall Study|Physician Decision|0
7716835|NCT00515541|12140428|FG003|Overall Study|Physician Decision|1
7716836|NCT00515541|12140425|FG000|Overall Study|No show for appointments|0
7716837|NCT00515541|12140426|FG001|Overall Study|No show for appointments|1
7716838|NCT00515541|12140427|FG002|Overall Study|No show for appointments|0
7716839|NCT00515541|12140428|FG003|Overall Study|No show for appointments|2
7716840|NCT00515541|12140425|FG000|Overall Study|Withdrawal by Subject|0
7716841|NCT00515541|12140426|FG001|Overall Study|Withdrawal by Subject|2
7716842|NCT00515541|12140427|FG002|Overall Study|Withdrawal by Subject|0
7716843|NCT00515541|12140428|FG003|Overall Study|Withdrawal by Subject|2
7716844|NCT00515619|12140438|FG000|Overall Study|Adverse Event|34
7716845|NCT00515619|12140438|FG000|Overall Study|Lack of Efficacy|92
7716846|NCT00515619|12140438|FG000|Overall Study|Withdrawal by Subject|66
7716847|NCT00515619|12140438|FG000|Overall Study|Protocol Violation|3
7716848|NCT00515619|12140438|FG000|Overall Study|Lost to Follow-up|4
7716849|NCT00515619|12140438|FG000|Overall Study|Unsatisfactory compliance|6
7716850|NCT00515619|12140438|FG000|Overall Study|Other: Site discontinuing trials|2
7716851|NCT00515619|12140438|FG000|Overall Study|Other: Subject cannot attend visits|2
7716852|NCT00515619|12140438|FG000|Overall Study|Other: Subject required surgery|1
7716853|NCT00515619|12140438|FG000|Overall Study|Other: Subject moved to another country|1
7716854|NCT00515619|12140438|FG000|Overall Study|Other: Investigator decision|1
7716855|NCT00515619|12140438|FG000|Overall Study|Other: Subject became pregnant|1
7716856|NCT00515619|12140438|FG000|Overall Study|Other: Request from sponsor|1
7716857|NCT00515619|12140438|FG000|Overall Study|Other: Drug available on license|1
7716858|NCT00515619|12140438|FG000|Overall Study|Other: Subject interested in other AED|1
7716859|NCT00515827|12140466|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
7716860|NCT00515827|12140467|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
7716861|NCT00515827|12140466|FG000|Second Intervention (12 Weeks)|Consent withdraw|1
7716862|NCT00515827|12140467|FG001|Second Intervention (12 Weeks)|Consent withdraw|0
7716863|NCT00516048|12140488|FG000|Overall Study|Death|0
7716864|NCT00516048|12140489|FG001|Overall Study|Death|0
7716865|NCT00516048|12140490|FG002|Overall Study|Death|1
7716866|NCT00516048|12140488|FG000|Overall Study|Subject Decision|0
7716867|NCT00516048|12140489|FG001|Overall Study|Subject Decision|2
7716868|NCT00516048|12140490|FG002|Overall Study|Subject Decision|0
7716869|NCT00516074|12140500|FG000|Overall Study|Adverse Event|0
7716870|NCT00516074|12140501|FG001|Overall Study|Adverse Event|1
7716871|NCT00516074|12140500|FG000|Overall Study|Subject Decision|4
7716872|NCT00516074|12140501|FG001|Overall Study|Subject Decision|2
7716873|NCT00516074|12140500|FG000|Overall Study|Loss of Glucose Control|2
7716874|NCT00516074|12140501|FG001|Overall Study|Loss of Glucose Control|0
7716875|NCT00516139|12140507|FG000|Overall Study|Adverse Event|27
7716876|NCT00516139|12140507|FG000|Overall Study|Lost to Follow-up|1
7716877|NCT00516139|12140507|FG000|Overall Study|Protocol Violation|1
7716878|NCT00516139|12140507|FG000|Overall Study|Withdrawal by Subject|8
7716879|NCT00516139|12140507|FG000|Overall Study|Lack of Efficacy|1
7716880|NCT00516269|12140525|FG000|Overall Study|Adverse Event|2
7716881|NCT00516269|12140526|FG001|Overall Study|Adverse Event|1
7716882|NCT00516269|12140525|FG000|Overall Study|Lost to Follow-up|0
7716883|NCT00516269|12140526|FG001|Overall Study|Lost to Follow-up|1
7716884|NCT00516269|12140525|FG000|Overall Study|Protocol Violation|0
7716885|NCT00516269|12140526|FG001|Overall Study|Protocol Violation|1
7716886|NCT00516295|12140535|FG000|Overall Study|Lack of Efficacy|2
7716887|NCT00516295|12140536|FG001|Overall Study|Lack of Efficacy|0
7716888|NCT00516295|12140537|FG002|Overall Study|Lack of Efficacy|0
7716889|NCT00516295|12140535|FG000|Overall Study|Ineligible|1
7716890|NCT00516295|12140536|FG001|Overall Study|Ineligible|0
7716891|NCT00516295|12140537|FG002|Overall Study|Ineligible|0
7716892|NCT00516321|12140547|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
7716893|NCT00516321|12140548|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
7716894|NCT00516321|12140549|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
7716895|NCT00516321|12140547|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
7716896|NCT00516321|12140548|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
7716897|NCT00516321|12140549|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
7716898|NCT00516321|12140547|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
7716899|NCT00516321|12140548|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
7716900|NCT00516321|12140549|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
7716901|NCT00516321|12140547|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
7716902|NCT00516321|12140548|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
7716903|NCT00516321|12140549|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
7716904|NCT00516321|12140547|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
7716905|NCT00516321|12140548|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
7716906|NCT00516321|12140549|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
7716907|NCT00516321|12140547|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
7716908|NCT00516321|12140548|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
7716909|NCT00516321|12140549|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
7716910|NCT00516321|12140547|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
7716911|NCT00516321|12140548|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
7716912|NCT00516321|12140549|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
7716913|NCT00516321|12140547|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
7716914|NCT00516321|12140548|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
7716915|NCT00516321|12140549|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
7716916|NCT00516321|12140547|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0
7716917|NCT00516321|12140548|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8
7716918|NCT00516321|12140549|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13
7716919|NCT00516321|12140547|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
7716920|NCT00516321|12140548|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
7716921|NCT00516321|12140549|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
7716922|NCT00516321|12140547|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0
7716923|NCT00516321|12140548|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2
7716924|NCT00516321|12140549|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0
7716925|NCT00516386|12140557|FG000|Overall Study|not interested in the study|4
7716927|NCT00516893|12140570|FG000|Overall Study|Lost to Follow-up|4
7716928|NCT00516893|12140570|FG000|Overall Study|Adverse Event|3
7716929|NCT00516893|12140570|FG000|Overall Study|Withdrawal by Subject|2
7716930|NCT00516893|12140570|FG000|Overall Study|Noncompliance|2
7716931|NCT00516893|12140570|FG000|Overall Study|Death|1
7716932|NCT00516893|12140570|FG000|Overall Study|Persistent Antibodies per Protocol|6
7716933|NCT00516893|12140570|FG000|Overall Study|Relocated|1
7716934|NCT00516893|12140570|FG000|Overall Study|Pregnancy|1
7716935|NCT00516893|12140570|FG000|Overall Study|Received Medication From Another Study|1
7716936|NCT00516906|12140576|FG000|Overall Study|Final Dressing Removal Data not captured|6
7716937|NCT00516906|12140577|FG001|Overall Study|Final Dressing Removal Data not captured|2
7716938|NCT00517296|12140596|FG000|Overall Study|Withdrawal by Subject|1
7716939|NCT00517296|12140597|FG001|Overall Study|Withdrawal by Subject|0
7716940|NCT00517413|12140603|FG000|Overall Study|Adverse Event|7
7716941|NCT00517413|12140603|FG000|Overall Study|Death|13
7716942|NCT00517413|12140603|FG000|Overall Study|Protocol Violation|15
7716943|NCT00517413|12140603|FG000|Overall Study|Withdrawal by Subject|2
7716944|NCT00517413|12140603|FG000|Overall Study|Failure to return|1
7716945|NCT00517413|12140603|FG000|Overall Study|Other-Reasons|23
7716946|NCT00517634|12140664|FG000|Second Treatment Period|Withdrawal by Subject|0
7716947|NCT00517634|12140665|FG001|Second Treatment Period|Withdrawal by Subject|0
7716948|NCT00517634|12140666|FG002|Second Treatment Period|Withdrawal by Subject|0
7716949|NCT00517634|12140667|FG003|Second Treatment Period|Withdrawal by Subject|0
7716950|NCT00517634|12140668|FG004|Second Treatment Period|Withdrawal by Subject|1
7716951|NCT00517634|12140669|FG005|Second Treatment Period|Withdrawal by Subject|0
7716952|NCT00517751|12140677|FG000|Overall Study|Death|3
7716953|NCT00517751|12140677|FG000|Overall Study|Withdrawal by Subject|37
7716954|NCT00517751|12140677|FG000|Overall Study|Lost to Follow-up|4
7716955|NCT00517751|12140677|FG000|Overall Study|patient not over due|6
7716956|NCT00517751|12140677|FG000|Overall Study|Patient not due for visit|76
7716957|NCT00517751|12140677|FG000|Overall Study|Missing|3
7716958|NCT00517829|12140683|FG000|Overall Study|Adverse Event|22
7716959|NCT00517829|12140684|FG001|Overall Study|Adverse Event|34
7716960|NCT00517829|12140683|FG000|Overall Study|Disease Progression|39
7716961|NCT00517829|12140684|FG001|Overall Study|Disease Progression|32
7716962|NCT00517829|12140683|FG000|Overall Study|Patient Request|6
7716963|NCT00517829|12140684|FG001|Overall Study|Patient Request|5
7716964|NCT00517829|12140683|FG000|Overall Study|Investigator Request|5
7716965|NCT00517829|12140684|FG001|Overall Study|Investigator Request|3
7716966|NCT00517829|12140683|FG000|Overall Study|Other|3
7716967|NCT00517829|12140684|FG001|Overall Study|Other|1
7716968|NCT00517881|12140690|FG000|Overall Study|Protocol Violation|2
7716969|NCT00517881|12140690|FG000|Overall Study|Adverse Event|1
7716970|NCT00517881|12140690|FG000|Overall Study|Renal transplantation|2
7716971|NCT00517933|12140696|FG000|Period 1|Death|2
7716972|NCT00517933|12140697|FG001|Period 1|Death|1
7716973|NCT00517933|12140696|FG000|Period 1|Adverse Event|4
7716974|NCT00517933|12140697|FG001|Period 1|Adverse Event|4
7716975|NCT00517933|12140696|FG000|Period 1|Lost to Follow-up|2
7716976|NCT00517933|12140697|FG001|Period 1|Lost to Follow-up|0
7716977|NCT00517933|12140696|FG000|Period 1|Underwent lung transplant|0
7716978|NCT00517933|12140697|FG001|Period 1|Underwent lung transplant|1
7716979|NCT00517933|12140696|FG000|Period 2|Death|2
7716980|NCT00517933|12140697|FG001|Period 2|Death|4
7716981|NCT00517933|12140696|FG000|Period 2|Adverse Event|2
7716982|NCT00517933|12140697|FG001|Period 2|Adverse Event|4
7716983|NCT00517933|12140696|FG000|Period 2|Physician Decision|1
7716984|NCT00517933|12140697|FG001|Period 2|Physician Decision|0
7716985|NCT00517933|12140696|FG000|Period 2|Withdrawal by Subject|1
7716986|NCT00517933|12140697|FG001|Period 2|Withdrawal by Subject|3
7716987|NCT00517933|12140696|FG000|Period 2|Underwent lung transplant|0
7716988|NCT00517933|12140697|FG001|Period 2|Underwent lung transplant|2
7716989|NCT00518011|12140708|FG000|Overall Study|Death|1
7716990|NCT00518011|12140709|FG001|Overall Study|Death|1
7716991|NCT00518011|12140708|FG000|Overall Study|Adverse Event|2
7716992|NCT00518011|12140709|FG001|Overall Study|Adverse Event|3
7716993|NCT00518011|12140708|FG000|Overall Study|Disease Progression|2
7716994|NCT00518011|12140709|FG001|Overall Study|Disease Progression|2
7716995|NCT00518011|12140708|FG000|Overall Study|Other Reasons|3
7716996|NCT00518011|12140709|FG001|Overall Study|Other Reasons|2
7716997|NCT00518011|12140708|FG000|Overall Study|Withdrawal by Subject|1
7716998|NCT00518011|12140709|FG001|Overall Study|Withdrawal by Subject|0
7716999|NCT00518115|12140735|FG000|Overall Study|Adverse Event|6
7717000|NCT00518115|12140736|FG001|Overall Study|Adverse Event|1
7717001|NCT00518115|12140737|FG002|Overall Study|Adverse Event|5
7717002|NCT00518115|12140738|FG003|Overall Study|Adverse Event|6
7717003|NCT00518115|12140739|FG004|Overall Study|Adverse Event|5
7717004|NCT00518115|12140740|FG005|Overall Study|Adverse Event|5
7717005|NCT00518115|12140741|FG006|Overall Study|Adverse Event|5
7717006|NCT00518115|12140742|FG007|Overall Study|Adverse Event|10
7717007|NCT00518115|12140743|FG008|Overall Study|Adverse Event|2
7717008|NCT00518115|12140744|FG009|Overall Study|Adverse Event|9
7717009|NCT00518115|12140735|FG000|Overall Study|Lost to Follow-up|0
7717010|NCT00518115|12140736|FG001|Overall Study|Lost to Follow-up|0
7717011|NCT00518115|12140737|FG002|Overall Study|Lost to Follow-up|2
7717012|NCT00518115|12140738|FG003|Overall Study|Lost to Follow-up|3
7717013|NCT00518115|12140739|FG004|Overall Study|Lost to Follow-up|1
7717014|NCT00518115|12140740|FG005|Overall Study|Lost to Follow-up|3
7717015|NCT00518115|12140741|FG006|Overall Study|Lost to Follow-up|0
7717016|NCT00518115|12140742|FG007|Overall Study|Lost to Follow-up|1
7717017|NCT00518115|12140743|FG008|Overall Study|Lost to Follow-up|1
7717018|NCT00518115|12140744|FG009|Overall Study|Lost to Follow-up|1
7717019|NCT00518115|12140735|FG000|Overall Study|Protocol Violation|1
7717020|NCT00518115|12140736|FG001|Overall Study|Protocol Violation|3
7717021|NCT00518115|12140737|FG002|Overall Study|Protocol Violation|1
7717022|NCT00518115|12140738|FG003|Overall Study|Protocol Violation|0
7717023|NCT00518115|12140739|FG004|Overall Study|Protocol Violation|0
7717024|NCT00518115|12140740|FG005|Overall Study|Protocol Violation|0
7717025|NCT00518115|12140741|FG006|Overall Study|Protocol Violation|0
7717026|NCT00518115|12140742|FG007|Overall Study|Protocol Violation|0
7717027|NCT00518115|12140743|FG008|Overall Study|Protocol Violation|0
7717028|NCT00518115|12140744|FG009|Overall Study|Protocol Violation|0
7717029|NCT00518115|12140735|FG000|Overall Study|Withdrawal by Subject|1
7717030|NCT00518115|12140736|FG001|Overall Study|Withdrawal by Subject|1
7717031|NCT00518115|12140737|FG002|Overall Study|Withdrawal by Subject|5
7717032|NCT00518115|12140738|FG003|Overall Study|Withdrawal by Subject|0
7717033|NCT00518115|12140739|FG004|Overall Study|Withdrawal by Subject|2
7717034|NCT00518115|12140740|FG005|Overall Study|Withdrawal by Subject|1
7717035|NCT00518115|12140741|FG006|Overall Study|Withdrawal by Subject|0
7717036|NCT00518115|12140742|FG007|Overall Study|Withdrawal by Subject|2
7717037|NCT00518115|12140743|FG008|Overall Study|Withdrawal by Subject|1
7717038|NCT00518115|12140744|FG009|Overall Study|Withdrawal by Subject|3
7717039|NCT00518115|12140735|FG000|Overall Study|Lack of Efficacy|1
7717040|NCT00518115|12140736|FG001|Overall Study|Lack of Efficacy|0
7717041|NCT00518115|12140737|FG002|Overall Study|Lack of Efficacy|1
7717042|NCT00518115|12140738|FG003|Overall Study|Lack of Efficacy|1
7717043|NCT00518115|12140739|FG004|Overall Study|Lack of Efficacy|0
7717044|NCT00518115|12140740|FG005|Overall Study|Lack of Efficacy|0
7717045|NCT00518115|12140741|FG006|Overall Study|Lack of Efficacy|0
7717046|NCT00518115|12140742|FG007|Overall Study|Lack of Efficacy|1
7717047|NCT00518115|12140743|FG008|Overall Study|Lack of Efficacy|0
7717048|NCT00518115|12140744|FG009|Overall Study|Lack of Efficacy|0
7717049|NCT00518115|12140735|FG000|Overall Study|Non-Compliance|1
7717050|NCT00518115|12140736|FG001|Overall Study|Non-Compliance|0
7717051|NCT00518115|12140737|FG002|Overall Study|Non-Compliance|1
7717052|NCT00518115|12140738|FG003|Overall Study|Non-Compliance|0
7717053|NCT00518115|12140739|FG004|Overall Study|Non-Compliance|1
7717054|NCT00518115|12140740|FG005|Overall Study|Non-Compliance|1
7717055|NCT00518115|12140741|FG006|Overall Study|Non-Compliance|1
7717056|NCT00518115|12140742|FG007|Overall Study|Non-Compliance|1
7717057|NCT00518115|12140743|FG008|Overall Study|Non-Compliance|0
7717058|NCT00518115|12140744|FG009|Overall Study|Non-Compliance|1
7717059|NCT00518115|12140735|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1
7717060|NCT00518115|12140736|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1
7717061|NCT00518115|12140737|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0
7717062|NCT00518115|12140738|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0
7717063|NCT00518115|12140739|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0
7717064|NCT00518115|12140740|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4
7717065|NCT00518115|12140741|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0
7717066|NCT00518115|12140742|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0
7717067|NCT00518115|12140743|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0
7717068|NCT00518115|12140744|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0
7717069|NCT00518115|12140735|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1
7717070|NCT00518115|12140736|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0
7717071|NCT00518115|12140737|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0
7717072|NCT00518115|12140738|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0
7717073|NCT00518115|12140739|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0
7717074|NCT00518115|12140740|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0
7717075|NCT00518115|12140741|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0
7717076|NCT00518115|12140742|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0
7717077|NCT00518115|12140743|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0
7717078|NCT00518115|12140744|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0
7717079|NCT00518115|12140735|FG000|Overall Study|Different Monotherapy Diabetic Drug|0
7717080|NCT00518115|12140736|FG001|Overall Study|Different Monotherapy Diabetic Drug|0
7717081|NCT00518115|12140737|FG002|Overall Study|Different Monotherapy Diabetic Drug|1
7717082|NCT00518115|12140738|FG003|Overall Study|Different Monotherapy Diabetic Drug|0
7717083|NCT00518115|12140739|FG004|Overall Study|Different Monotherapy Diabetic Drug|0
7717084|NCT00518115|12140740|FG005|Overall Study|Different Monotherapy Diabetic Drug|0
7717085|NCT00518115|12140741|FG006|Overall Study|Different Monotherapy Diabetic Drug|0
7717086|NCT00518115|12140742|FG007|Overall Study|Different Monotherapy Diabetic Drug|0
7717087|NCT00518115|12140743|FG008|Overall Study|Different Monotherapy Diabetic Drug|1
7717088|NCT00518115|12140744|FG009|Overall Study|Different Monotherapy Diabetic Drug|0
7717089|NCT00518115|12140735|FG000|Overall Study|Wrong Monotherapy Administered|0
7717090|NCT00518115|12140736|FG001|Overall Study|Wrong Monotherapy Administered|0
7717091|NCT00518115|12140737|FG002|Overall Study|Wrong Monotherapy Administered|1
7717092|NCT00518115|12140738|FG003|Overall Study|Wrong Monotherapy Administered|0
7717093|NCT00518115|12140739|FG004|Overall Study|Wrong Monotherapy Administered|0
7717094|NCT00518115|12140740|FG005|Overall Study|Wrong Monotherapy Administered|0
7717095|NCT00518115|12140741|FG006|Overall Study|Wrong Monotherapy Administered|1
7717096|NCT00518115|12140742|FG007|Overall Study|Wrong Monotherapy Administered|0
7717097|NCT00518115|12140743|FG008|Overall Study|Wrong Monotherapy Administered|0
7717098|NCT00518115|12140744|FG009|Overall Study|Wrong Monotherapy Administered|0
7717099|NCT00518115|12140735|FG000|Overall Study|Violation of Exclusion Criteria|0
7717100|NCT00518115|12140736|FG001|Overall Study|Violation of Exclusion Criteria|0
7717101|NCT00518115|12140737|FG002|Overall Study|Violation of Exclusion Criteria|0
7717102|NCT00518115|12140738|FG003|Overall Study|Violation of Exclusion Criteria|1
7717103|NCT00518115|12140739|FG004|Overall Study|Violation of Exclusion Criteria|0
7717104|NCT00518115|12140740|FG005|Overall Study|Violation of Exclusion Criteria|0
7717105|NCT00518115|12140741|FG006|Overall Study|Violation of Exclusion Criteria|1
7717106|NCT00518115|12140742|FG007|Overall Study|Violation of Exclusion Criteria|0
7717107|NCT00518115|12140743|FG008|Overall Study|Violation of Exclusion Criteria|0
7717108|NCT00518115|12140744|FG009|Overall Study|Violation of Exclusion Criteria|0
7717109|NCT00518115|12140735|FG000|Overall Study|Family Emergency; Had to Go to England|0
7717110|NCT00518115|12140736|FG001|Overall Study|Family Emergency; Had to Go to England|0
7717111|NCT00518115|12140737|FG002|Overall Study|Family Emergency; Had to Go to England|0
7717112|NCT00518115|12140738|FG003|Overall Study|Family Emergency; Had to Go to England|0
7717113|NCT00518115|12140739|FG004|Overall Study|Family Emergency; Had to Go to England|1
7717114|NCT00518115|12140740|FG005|Overall Study|Family Emergency; Had to Go to England|0
7717115|NCT00518115|12140741|FG006|Overall Study|Family Emergency; Had to Go to England|0
7717116|NCT00518115|12140742|FG007|Overall Study|Family Emergency; Had to Go to England|0
7717117|NCT00518115|12140743|FG008|Overall Study|Family Emergency; Had to Go to England|0
7717118|NCT00518115|12140744|FG009|Overall Study|Family Emergency; Had to Go to England|0
7717119|NCT00518115|12140735|FG000|Overall Study|Withdrew Consent|0
7717120|NCT00518115|12140736|FG001|Overall Study|Withdrew Consent|0
7717121|NCT00518115|12140737|FG002|Overall Study|Withdrew Consent|0
7717122|NCT00518115|12140738|FG003|Overall Study|Withdrew Consent|0
7717123|NCT00518115|12140739|FG004|Overall Study|Withdrew Consent|0
7717124|NCT00518115|12140740|FG005|Overall Study|Withdrew Consent|1
7717125|NCT00518115|12140741|FG006|Overall Study|Withdrew Consent|0
7717126|NCT00518115|12140742|FG007|Overall Study|Withdrew Consent|0
7717127|NCT00518115|12140743|FG008|Overall Study|Withdrew Consent|0
7717128|NCT00518115|12140744|FG009|Overall Study|Withdrew Consent|0
7717129|NCT00518115|12140735|FG000|Overall Study|Moved Out of State|0
7717130|NCT00518115|12140736|FG001|Overall Study|Moved Out of State|0
7717131|NCT00518115|12140737|FG002|Overall Study|Moved Out of State|0
7717132|NCT00518115|12140738|FG003|Overall Study|Moved Out of State|0
7717133|NCT00518115|12140739|FG004|Overall Study|Moved Out of State|0
7717134|NCT00518115|12140740|FG005|Overall Study|Moved Out of State|0
7717135|NCT00518115|12140741|FG006|Overall Study|Moved Out of State|0
7717136|NCT00518115|12140742|FG007|Overall Study|Moved Out of State|0
7717137|NCT00518115|12140743|FG008|Overall Study|Moved Out of State|0
7717138|NCT00518115|12140744|FG009|Overall Study|Moved Out of State|1
7717139|NCT00518180|12140774|FG000|Overall Study|Withdrawal by Subject|29
7717140|NCT00518180|12140775|FG001|Overall Study|Withdrawal by Subject|30
7717141|NCT00518180|12140776|FG002|Overall Study|Withdrawal by Subject|42
7717142|NCT00518180|12140774|FG000|Overall Study|Lost to Follow-up|30
7717143|NCT00518180|12140775|FG001|Overall Study|Lost to Follow-up|28
7717144|NCT00518180|12140776|FG002|Overall Study|Lost to Follow-up|34
7717145|NCT00518180|12140774|FG000|Overall Study|Administrative reason|0
7717146|NCT00518180|12140775|FG001|Overall Study|Administrative reason|2
7717147|NCT00518180|12140776|FG002|Overall Study|Administrative reason|2
7717148|NCT00518180|12140774|FG000|Overall Study|Protocol Violation|5
7717149|NCT00518180|12140775|FG001|Overall Study|Protocol Violation|7
7717150|NCT00518180|12140776|FG002|Overall Study|Protocol Violation|4
7717151|NCT00518180|12140774|FG000|Overall Study|Unable to classify|0
7717152|NCT00518180|12140775|FG001|Overall Study|Unable to classify|2
7717153|NCT00518180|12140776|FG002|Overall Study|Unable to classify|0
7717154|NCT00518180|12140774|FG000|Overall Study|Adverse Event|1
7717155|NCT00518180|12140775|FG001|Overall Study|Adverse Event|0
7717156|NCT00518180|12140776|FG002|Overall Study|Adverse Event|0
7717157|NCT00518206|12140795|FG000|Overall Study|Disease Progression Requiring Therapy|6
7717158|NCT00518206|12140796|FG001|Overall Study|Disease Progression Requiring Therapy|6
7717159|NCT00518206|12140795|FG000|Overall Study|Withdrawal by Subject|2
7717160|NCT00518206|12140796|FG001|Overall Study|Withdrawal by Subject|0
7717161|NCT00518206|12140795|FG000|Overall Study|Drug Supply Issue|1
7717162|NCT00518206|12140796|FG001|Overall Study|Drug Supply Issue|0
7717163|NCT00518206|12140795|FG000|Overall Study|Reason Unknown|1
7717164|NCT00518206|12140796|FG001|Overall Study|Reason Unknown|0
7717165|NCT00518206|12140795|FG000|Overall Study|Completion Status Unknown|1
7717166|NCT00518206|12140796|FG001|Overall Study|Completion Status Unknown|0
7717167|NCT00518284|12140806|FG000|Overall Study|Adverse Event|0
7717168|NCT00518284|12140807|FG001|Overall Study|Adverse Event|1
7717169|NCT00518284|12140808|FG002|Overall Study|Adverse Event|0
7717170|NCT00518284|12140809|FG003|Overall Study|Adverse Event|0
7717171|NCT00518284|12140806|FG000|Overall Study|Study Termination|0
7717172|NCT00518284|12140807|FG001|Overall Study|Study Termination|2
7717173|NCT00518284|12140808|FG002|Overall Study|Study Termination|1
7717174|NCT00518284|12140809|FG003|Overall Study|Study Termination|2
7717175|NCT00518323|12140823|FG000|Overall Study|Lack of Efficacy|14
7717176|NCT00518323|12140824|FG001|Overall Study|Lack of Efficacy|2
7717177|NCT00518323|12140825|FG002|Overall Study|Lack of Efficacy|4
7717178|NCT00518323|12140826|FG003|Overall Study|Lack of Efficacy|20
7717179|NCT00518323|12140823|FG000|Overall Study|Withdrawal by Subject|1
7717180|NCT00518323|12140824|FG001|Overall Study|Withdrawal by Subject|2
7717181|NCT00518323|12140825|FG002|Overall Study|Withdrawal by Subject|4
7717182|NCT00518323|12140826|FG003|Overall Study|Withdrawal by Subject|2
7717183|NCT00518323|12140823|FG000|Overall Study|Lost to Follow-up|0
7717184|NCT00518323|12140824|FG001|Overall Study|Lost to Follow-up|2
7717185|NCT00518323|12140825|FG002|Overall Study|Lost to Follow-up|1
7717186|NCT00518323|12140826|FG003|Overall Study|Lost to Follow-up|3
7717187|NCT00518323|12140823|FG000|Overall Study|Adverse Event|1
7717188|NCT00518323|12140824|FG001|Overall Study|Adverse Event|1
7717189|NCT00518323|12140825|FG002|Overall Study|Adverse Event|1
7717190|NCT00518323|12140826|FG003|Overall Study|Adverse Event|0
7717191|NCT00518323|12140823|FG000|Overall Study|Prohibited medication and others|3
7717192|NCT00518323|12140824|FG001|Overall Study|Prohibited medication and others|1
7717193|NCT00518323|12140825|FG002|Overall Study|Prohibited medication and others|1
7717194|NCT00518323|12140826|FG003|Overall Study|Prohibited medication and others|0
7717195|NCT00518336|12140838|FG000|Year 7|Lost to Follow-up|2
7717196|NCT00518336|12140839|FG001|Year 7|Lost to Follow-up|0
7717197|NCT00518336|12140838|FG000|Year 7|Could not attend in time|0
7717198|NCT00518336|12140839|FG001|Year 7|Could not attend in time|3
7717199|NCT00518336|12140838|FG000|Year 8|Lost to Follow-up|1
7717200|NCT00518336|12140839|FG001|Year 8|Lost to Follow-up|1
7717201|NCT00518336|12140838|FG000|Year 8|Could not attend in time|0
7717202|NCT00518336|12140839|FG001|Year 8|Could not attend in time|1
7717203|NCT00518336|12140838|FG000|Year 9|Migrated/moved from study area|1
7717204|NCT00518336|12140839|FG001|Year 9|Migrated/moved from study area|1
7717205|NCT00518336|12140838|FG000|Year 9|Lost to Follow-up|3
7717206|NCT00518336|12140839|FG001|Year 9|Lost to Follow-up|0
7717207|NCT00518336|12140838|FG000|Year 9|Personal reasons|1
7717208|NCT00518336|12140839|FG001|Year 9|Personal reasons|0
7717209|NCT00518531|12140856|FG000|Treatment Period 1|Adverse Event|5
7717210|NCT00518531|12140857|FG001|Treatment Period 1|Adverse Event|0
7717211|NCT00518531|12140856|FG000|Treatment Period 1|Lost to Follow-up|5
7717212|NCT00518531|12140857|FG001|Treatment Period 1|Lost to Follow-up|3
7717213|NCT00518531|12140856|FG000|Treatment Period 1|Physician Decision|1
7717214|NCT00518531|12140857|FG001|Treatment Period 1|Physician Decision|0
7717215|NCT00518531|12140856|FG000|Treatment Period 1|Protocol Violation|2
7717216|NCT00518531|12140857|FG001|Treatment Period 1|Protocol Violation|0
7717217|NCT00518531|12140856|FG000|Treatment Period 1|Withdrawal by Subject|4
7717218|NCT00518531|12140857|FG001|Treatment Period 1|Withdrawal by Subject|6
7717219|NCT00518531|12140856|FG000|Treatment Period 1|Early crossover|1
7717220|NCT00518531|12140857|FG001|Treatment Period 1|Early crossover|3
7717221|NCT00518531|12140856|FG000|Treatment Period 2|Withdrawal by Subject|0
7717222|NCT00518531|12140857|FG001|Treatment Period 2|Withdrawal by Subject|8
7717223|NCT00518531|12140856|FG000|Treatment Period 2|Complete out of scheduled visit window|1
7717224|NCT00518531|12140857|FG001|Treatment Period 2|Complete out of scheduled visit window|2
7717225|NCT00518531|12140856|FG000|Treatment Period 2|Adverse Event|1
7717226|NCT00518531|12140857|FG001|Treatment Period 2|Adverse Event|7
7717227|NCT00518531|12140856|FG000|Treatment Period 2|Protocol-specified criteria|0
7717228|NCT00518531|12140857|FG001|Treatment Period 2|Protocol-specified criteria|1
7717229|NCT00518531|12140856|FG000|Treatment Period 2|Non-compliance|1
7717230|NCT00518531|12140857|FG001|Treatment Period 2|Non-compliance|2
7717231|NCT00518622|12140873|FG000|Overall Study|Lost to Follow-up|0
7717232|NCT00518622|12140874|FG001|Overall Study|Lost to Follow-up|0
7717233|NCT00518622|12140875|FG002|Overall Study|Lost to Follow-up|1
7717234|NCT00518622|12140876|FG003|Overall Study|Lost to Follow-up|0
7717235|NCT00518622|12140877|FG004|Overall Study|Lost to Follow-up|0
7717236|NCT00518622|12140878|FG005|Overall Study|Lost to Follow-up|0
7717237|NCT00518622|12140879|FG006|Overall Study|Lost to Follow-up|0
7717238|NCT00518622|12140880|FG007|Overall Study|Lost to Follow-up|0
7717239|NCT00518622|12140873|FG000|Overall Study|Study medication taken incorrectly|0
7717240|NCT00518622|12140874|FG001|Overall Study|Study medication taken incorrectly|1
7717241|NCT00518622|12140875|FG002|Overall Study|Study medication taken incorrectly|0
7717242|NCT00518622|12140876|FG003|Overall Study|Study medication taken incorrectly|0
7717243|NCT00518622|12140877|FG004|Overall Study|Study medication taken incorrectly|0
7717244|NCT00518622|12140878|FG005|Overall Study|Study medication taken incorrectly|0
7717245|NCT00518622|12140879|FG006|Overall Study|Study medication taken incorrectly|0
7717246|NCT00518622|12140880|FG007|Overall Study|Study medication taken incorrectly|0
7717247|NCT00518687|12140900|FG000|Overall Study|Adverse Event|201
7717248|NCT00518687|12140901|FG001|Overall Study|Adverse Event|177
7717249|NCT00518687|12140900|FG000|Overall Study|Lost to Follow-up|144
7717250|NCT00518687|12140901|FG001|Overall Study|Lost to Follow-up|155
7717251|NCT00518687|12140900|FG000|Overall Study|Physician Decision|42
7717252|NCT00518687|12140901|FG001|Overall Study|Physician Decision|48
7717253|NCT00518687|12140900|FG000|Overall Study|Progressive disease|2
7717254|NCT00518687|12140901|FG001|Overall Study|Progressive disease|2
7717255|NCT00518687|12140900|FG000|Overall Study|Protocol Violation|8
7717256|NCT00518687|12140901|FG001|Overall Study|Protocol Violation|10
7717257|NCT00518687|12140900|FG000|Overall Study|Study terminated by sponsor|930
7717258|NCT00518687|12140901|FG001|Overall Study|Study terminated by sponsor|918
7717259|NCT00518687|12140900|FG000|Overall Study|Withdrawal by Subject|110
7717260|NCT00518687|12140901|FG001|Overall Study|Withdrawal by Subject|110
7717261|NCT00518882|12140926|FG000|Double-Blind, Week 0-26|Adverse Event|23
7717262|NCT00518882|12140927|FG001|Double-Blind, Week 0-26|Adverse Event|31
7717263|NCT00518882|12140926|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1
7717264|NCT00518882|12140927|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0
7717265|NCT00518882|12140926|FG000|Double-Blind, Week 0-26|Protocol Violation|4
7717266|NCT00518882|12140927|FG001|Double-Blind, Week 0-26|Protocol Violation|3
7717267|NCT00518882|12140926|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1
7717268|NCT00518882|12140927|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1
7717269|NCT00518882|12140926|FG000|Double-Blind, Week 0-26|Lost to follow up|2
7717270|NCT00518882|12140927|FG001|Double-Blind, Week 0-26|Lost to follow up|1
7717271|NCT00518882|12140926|FG000|Double-Blind, Week 0-26|Subject decision|1
7717272|NCT00518882|12140927|FG001|Double-Blind, Week 0-26|Subject decision|1
7717273|NCT00518882|12140926|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1
7717274|NCT00518882|12140927|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3
7717275|NCT00518882|12140926|FG000|Double-Blind, Week 0-26|Loss of trust|0
7717276|NCT00518882|12140927|FG001|Double-Blind, Week 0-26|Loss of trust|1
7717277|NCT00518882|12140926|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
7717278|NCT00518882|12140927|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
7717279|NCT00518882|12140926|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0
7717280|NCT00518882|12140927|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2
7717281|NCT00518882|12140926|FG000|Double-Blind, Week 0-26|Mutual consent|0
7717282|NCT00518882|12140927|FG001|Double-Blind, Week 0-26|Mutual consent|1
7717283|NCT00518882|12140926|FG000|Open-Label Extension, Week 26-78|Adverse Event|3
7717284|NCT00518882|12140927|FG001|Open-Label Extension, Week 26-78|Adverse Event|9
7717285|NCT00518882|12140926|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6
7717286|NCT00518882|12140927|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5
7717287|NCT00518882|12140926|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3
7717288|NCT00518882|12140927|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4
7717289|NCT00518882|12140926|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1
7717290|NCT00518882|12140927|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2
7717291|NCT00518882|12140926|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0
7717292|NCT00518882|12140927|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1
7717293|NCT00518882|12140926|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1
7717294|NCT00518882|12140927|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1
7717295|NCT00518882|12140926|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2
7717296|NCT00518882|12140927|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1
7717297|NCT00518882|12140926|FG000|Open-Label Extension, Week 26-78|Change in treatment|1
7717298|NCT00518882|12140927|FG001|Open-Label Extension, Week 26-78|Change in treatment|1
7717299|NCT00518882|12140926|FG000|Open-Label Extension, Week 26-78|Creatine increased|1
7717300|NCT00518882|12140927|FG001|Open-Label Extension, Week 26-78|Creatine increased|0
7717301|NCT00518882|12140926|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1
7717302|NCT00518882|12140927|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0
7717303|NCT00518882|12140926|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2
7717304|NCT00518882|12140927|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0
7717305|NCT00518882|12140926|FG000|Open-Label Extension, Week 26-78|Subject decision|2
7717306|NCT00518882|12140927|FG001|Open-Label Extension, Week 26-78|Subject decision|0
7717307|NCT00518882|12140926|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
7717308|NCT00518882|12140927|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
7717309|NCT00518973|12140935|FG000|Overall Study|Withdrawal by Subject|3
7717310|NCT00518973|12140936|FG001|Overall Study|Withdrawal by Subject|2
7717311|NCT00518986|12140944|FG000|Overall Study|Adverse Event|12
7717312|NCT00518986|12140945|FG001|Overall Study|Adverse Event|7
7717313|NCT00518986|12140944|FG000|Overall Study|Lack of Efficacy|0
7717314|NCT00518986|12140945|FG001|Overall Study|Lack of Efficacy|2
7717315|NCT00518986|12140944|FG000|Overall Study|Lost to Follow-up|3
7717316|NCT00518986|12140945|FG001|Overall Study|Lost to Follow-up|2
7717317|NCT00518986|12140944|FG000|Overall Study|Physician Decision|0
7717318|NCT00518986|12140945|FG001|Overall Study|Physician Decision|3
7717319|NCT00518986|12140944|FG000|Overall Study|Protocol Violation|5
7717320|NCT00518986|12140945|FG001|Overall Study|Protocol Violation|7
7717321|NCT00518986|12140944|FG000|Overall Study|Withdrawal by Subject|4
7717322|NCT00518986|12140945|FG001|Overall Study|Withdrawal by Subject|4
7717323|NCT00518986|12140944|FG000|Overall Study|Non-Specific|2
7717324|NCT00518986|12140945|FG001|Overall Study|Non-Specific|1
7717325|NCT00519077|12140951|FG000|Overall Study|Death|6
7717326|NCT00519077|12140951|FG000|Overall Study|Other|2
7717327|NCT00519194|12140955|FG000|Overall Study|Withdrawal by Subject|9
7717328|NCT00519194|12140955|FG000|Overall Study|Death|9
7717329|NCT00519194|12140955|FG000|Overall Study|Lost to Follow-up|3
7717330|NCT00519285|12140961|FG000|Overall Study|Adverse Event|127
7717331|NCT00519285|12140962|FG001|Overall Study|Adverse Event|266
7717332|NCT00519285|12140961|FG000|Overall Study|Disease progression|334
7717333|NCT00519285|12140962|FG001|Overall Study|Disease progression|186
7717334|NCT00519285|12140961|FG000|Overall Study|Physician Decision|75
7717335|NCT00519285|12140962|FG001|Overall Study|Physician Decision|47
7717336|NCT00519285|12140961|FG000|Overall Study|Participant's request|53
7717337|NCT00519285|12140962|FG001|Overall Study|Participant's request|84
7717338|NCT00519285|12140961|FG000|Overall Study|Consent withdrawn|4
7717339|NCT00519285|12140962|FG001|Overall Study|Consent withdrawn|5
7717340|NCT00519285|12140961|FG000|Overall Study|Poor compliance to protocol|5
7717341|NCT00519285|12140962|FG001|Overall Study|Poor compliance to protocol|7
7717342|NCT00519285|12140961|FG000|Overall Study|Reason unspecified|5
7717343|NCT00519285|12140962|FG001|Overall Study|Reason unspecified|8
7717344|NCT00519285|12140961|FG000|Overall Study|Not treated|8
7717345|NCT00519285|12140962|FG001|Overall Study|Not treated|7
7717346|NCT00519285|12140961|FG000|Overall Study|Treatment ongoing|1
7717347|NCT00519285|12140962|FG001|Overall Study|Treatment ongoing|2
7717348|NCT00519376|12140968|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7717349|NCT00519376|12140969|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7717350|NCT00519376|12140970|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7717351|NCT00519376|12140971|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7717352|NCT00519376|12140972|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7717353|NCT00519376|12140973|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7717354|NCT00519376|12140974|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7717355|NCT00519376|12140975|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7717356|NCT00519376|12140976|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7717357|NCT00519376|12140977|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7717358|NCT00519376|12140978|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7717359|NCT00519376|12140979|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7717360|NCT00519376|12140980|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
7717361|NCT00519376|12140981|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7717362|NCT00519376|12140982|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7717363|NCT00519376|12140983|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7717364|NCT00519376|12140968|FG000|Treatment Period 4|Lost to Follow-up|0
7717365|NCT00519376|12140969|FG001|Treatment Period 4|Lost to Follow-up|0
7717366|NCT00519376|12140970|FG002|Treatment Period 4|Lost to Follow-up|1
7717367|NCT00519376|12140971|FG003|Treatment Period 4|Lost to Follow-up|0
7717368|NCT00519376|12140972|FG004|Treatment Period 4|Lost to Follow-up|0
7717369|NCT00519376|12140973|FG005|Treatment Period 4|Lost to Follow-up|0
7717370|NCT00519376|12140974|FG006|Treatment Period 4|Lost to Follow-up|0
7717371|NCT00519376|12140975|FG007|Treatment Period 4|Lost to Follow-up|0
7717372|NCT00519376|12140976|FG008|Treatment Period 4|Lost to Follow-up|0
7717373|NCT00519376|12140977|FG009|Treatment Period 4|Lost to Follow-up|0
7717374|NCT00519376|12140978|FG010|Treatment Period 4|Lost to Follow-up|0
7717375|NCT00519376|12140979|FG011|Treatment Period 4|Lost to Follow-up|0
7717376|NCT00519376|12140980|FG012|Treatment Period 4|Lost to Follow-up|0
7717377|NCT00519376|12140981|FG013|Treatment Period 4|Lost to Follow-up|0
7717378|NCT00519376|12140982|FG014|Treatment Period 4|Lost to Follow-up|0
7717379|NCT00519376|12140983|FG015|Treatment Period 4|Lost to Follow-up|0
7717380|NCT00519428|12140998|FG000|Overall Study|Adverse Event|5
7717381|NCT00519428|12140999|FG001|Overall Study|Adverse Event|2
7717382|NCT00519428|12141000|FG002|Overall Study|Adverse Event|10
7717383|NCT00519428|12140998|FG000|Overall Study|Lost to Follow-up|7
7717384|NCT00519428|12140999|FG001|Overall Study|Lost to Follow-up|7
7717385|NCT00519428|12141000|FG002|Overall Study|Lost to Follow-up|6
7717386|NCT00519428|12140998|FG000|Overall Study|Withdrawal by Subject|8
7717387|NCT00519428|12140999|FG001|Overall Study|Withdrawal by Subject|3
7717388|NCT00519428|12141000|FG002|Overall Study|Withdrawal by Subject|7
7717389|NCT00519428|12140998|FG000|Overall Study|unstated|1
7717390|NCT00519428|12140999|FG001|Overall Study|unstated|3
7717391|NCT00519428|12141000|FG002|Overall Study|unstated|2
7717392|NCT00519532|12141011|FG000|Overall Study|Adverse Event|11
7717393|NCT00519532|12141011|FG000|Overall Study|Withdrawal by Subject|5
7717394|NCT00519532|12141011|FG000|Overall Study|Lost to Follow-up|2
7717395|NCT00519623|12141032|FG000|Overall Study|Adverse Event|1
7717396|NCT00519636|12141040|FG000|Treatment Period 1|Adverse Event|1
7717397|NCT00519636|12141041|FG001|Treatment Period 1|Adverse Event|0
7717398|NCT00519636|12141042|FG002|Treatment Period 1|Adverse Event|1
7717399|NCT00519636|12141043|FG003|Treatment Period 1|Adverse Event|0
7717400|NCT00519636|12141040|FG000|Treatment Period 1|Sponsor request due to missed visit|1
7717401|NCT00519636|12141041|FG001|Treatment Period 1|Sponsor request due to missed visit|0
7717402|NCT00519636|12141042|FG002|Treatment Period 1|Sponsor request due to missed visit|0
7717403|NCT00519636|12141043|FG003|Treatment Period 1|Sponsor request due to missed visit|0
7717404|NCT00519636|12141040|FG000|Washout Period|Adverse Event|2
7717405|NCT00519636|12141041|FG001|Washout Period|Adverse Event|1
7717406|NCT00519636|12141042|FG002|Washout Period|Adverse Event|1
7717407|NCT00519636|12141043|FG003|Washout Period|Adverse Event|0
7717408|NCT00519636|12141040|FG000|Washout Period|Lost to Follow-up|1
7717409|NCT00519636|12141041|FG001|Washout Period|Lost to Follow-up|0
7717410|NCT00519636|12141042|FG002|Washout Period|Lost to Follow-up|0
7717411|NCT00519636|12141043|FG003|Washout Period|Lost to Follow-up|0
7717412|NCT00519636|12141040|FG000|Washout Period|Protocol Violation|0
7717413|NCT00519636|12141041|FG001|Washout Period|Protocol Violation|0
7717414|NCT00519636|12141042|FG002|Washout Period|Protocol Violation|1
7717415|NCT00519636|12141043|FG003|Washout Period|Protocol Violation|2
7717416|NCT00519636|12141040|FG000|Washout Period|Withdrawal by Subject|1
7717417|NCT00519636|12141041|FG001|Washout Period|Withdrawal by Subject|0
7717418|NCT00519636|12141042|FG002|Washout Period|Withdrawal by Subject|1
7883406|NCT01781572|12383069|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0
7883407|NCT01781572|12383067|FG000|MEK162 45mg BID+LEE011 300mg|Death|1
7883408|NCT01781572|12383068|FG001|MEK162 45mg BID+LEE011 300mg|Death|0
7883409|NCT01781572|12383069|FG002|MEK162 45mg BID+LEE011 300mg|Death|0
7883410|NCT01781572|12383067|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0
7883411|NCT01781572|12383068|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5
7883412|NCT01781572|12383069|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0
7883413|NCT01781572|12383067|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0
7883414|NCT01781572|12383068|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1
7883415|NCT01781572|12383069|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0
7883416|NCT01781572|12383067|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0
7883417|NCT01781572|12383068|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2
7883418|NCT01781572|12383069|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0
7883419|NCT01781572|12383067|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0
7883420|NCT01781572|12383068|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6
7883421|NCT01781572|12383069|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0
7883422|NCT01781572|12383067|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0
7883423|NCT01781572|12383068|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1
7883424|NCT01781572|12383069|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0
7883425|NCT01781572|12383067|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0
7883426|NCT01781572|12383068|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5
7883427|NCT01781572|12383069|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0
7883428|NCT01781611|12383100|FG000|Overall Study|Adverse Event|4
7883429|NCT01781611|12383101|FG001|Overall Study|Adverse Event|0
7883430|NCT01781832|12383117|FG000|Overall Study|Withdrawal by Subject|1
7883431|NCT01781962|12383121|FG000|Overall Study|Other Miscellaneous Reasons|5
7883432|NCT01781975|12383127|FG000|Overall Study|Death|1
7883433|NCT01781975|12383128|FG001|Overall Study|Death|0
7883434|NCT01781975|12383127|FG000|Overall Study|Withdrawal by Subject|1
7883435|NCT01781975|12383128|FG001|Overall Study|Withdrawal by Subject|1
7883436|NCT01782131|12383136|FG000|Overall Study|Death|93
7883437|NCT01782131|12383137|FG001|Overall Study|Death|96
7883438|NCT01782131|12383136|FG000|Overall Study|Lost to Follow-up|1
7883439|NCT01782131|12383137|FG001|Overall Study|Lost to Follow-up|3
7883440|NCT01782131|12383136|FG000|Overall Study|Withdrawal by Subject|10
7883441|NCT01782131|12383137|FG001|Overall Study|Withdrawal by Subject|10
7883442|NCT01782131|12383136|FG000|Overall Study|Randomized but not treated|5
7883443|NCT01782131|12383137|FG001|Overall Study|Randomized but not treated|5
7883444|NCT01782131|12383136|FG000|Overall Study|Reason not provided|0
7883445|NCT01782131|12383137|FG001|Overall Study|Reason not provided|1
7883446|NCT01782222|12383150|FG000|Overall Study|Adverse Event|4
7883447|NCT01782222|12383151|FG001|Overall Study|Adverse Event|5
7883448|NCT01782222|12383152|FG002|Overall Study|Adverse Event|3
7883449|NCT01782222|12383150|FG000|Overall Study|Lack of Efficacy|2
7883450|NCT01782222|12383151|FG001|Overall Study|Lack of Efficacy|1
7883451|NCT01782222|12383152|FG002|Overall Study|Lack of Efficacy|0
7883452|NCT01782222|12383150|FG000|Overall Study|Protocol Violation|1
7883453|NCT01782222|12383151|FG001|Overall Study|Protocol Violation|0
7883454|NCT01782222|12383152|FG002|Overall Study|Protocol Violation|0
7883455|NCT01782222|12383150|FG000|Overall Study|Withdrawal by Subject|1
7883456|NCT01782222|12383151|FG001|Overall Study|Withdrawal by Subject|4
7883457|NCT01782222|12383152|FG002|Overall Study|Withdrawal by Subject|1
7883458|NCT01782222|12383150|FG000|Overall Study|Moved to other state|0
7883459|NCT01782222|12383151|FG001|Overall Study|Moved to other state|1
7883460|NCT01782222|12383152|FG002|Overall Study|Moved to other state|0
7883461|NCT01782313|12383160|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3
7883462|NCT01782313|12383160|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3
7883463|NCT01782313|12383160|FG000|Treated Cycle 3|Progressive Disease|21
7883464|NCT01782313|12383160|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
7883465|NCT01782313|12383160|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
7883466|NCT01782313|12383160|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6
7883467|NCT01782313|12383160|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
7883468|NCT01782313|12383160|FG000|Survival Follow up|Lost to Follow-up|1
7883469|NCT01782326|12383166|FG000|Planned Treatment Epoch|Subject/guardian decision|149
7883470|NCT01782326|12383167|FG001|Planned Treatment Epoch|Subject/guardian decision|151
7883471|NCT01782326|12383166|FG000|Planned Treatment Epoch|Death|29
7883472|NCT01782326|12383167|FG001|Planned Treatment Epoch|Death|30
7883473|NCT01782326|12383166|FG000|Planned Treatment Epoch|Physician Decision|18
7883474|NCT01782326|12383167|FG001|Planned Treatment Epoch|Physician Decision|16
7883475|NCT01782326|12383166|FG000|Planned Treatment Epoch|Protocol deviation|2
7883476|NCT01782326|12383167|FG001|Planned Treatment Epoch|Protocol deviation|3
7883477|NCT01782326|12383166|FG000|Planned Treatment Epoch|Lost to Follow-up|4
7883478|NCT01782326|12383167|FG001|Planned Treatment Epoch|Lost to Follow-up|4
7883479|NCT01782326|12383166|FG000|Planned Treatment Epoch|Technical problems|0
7883480|NCT01782326|12383167|FG001|Planned Treatment Epoch|Technical problems|4
7883481|NCT01782326|12383166|FG000|Double-blind Treatment|Adverse Event|129
7883482|NCT01782326|12383167|FG001|Double-blind Treatment|Adverse Event|145
7883483|NCT01782326|12383166|FG000|Double-blind Treatment|Subject/guardian decision|111
7883484|NCT01782326|12383167|FG001|Double-blind Treatment|Subject/guardian decision|125
7883485|NCT01782326|12383166|FG000|Double-blind Treatment|Lack of Efficacy|17
7883495|NCT01782378|12383175|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0
7883496|NCT01782378|12383176|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25
7883497|NCT01782378|12383175|FG000|Second Series|Lost to Follow-up|8
7883498|NCT01782378|12383176|FG001|Second Series|Lost to Follow-up|7
7883499|NCT01782378|12383175|FG000|Second Series|Did not choose to complete S2 Optional|18
7883500|NCT01782378|12383176|FG001|Second Series|Did not choose to complete S2 Optional|0
7883501|NCT01782469|12383182|FG000|Overall Study|Lost to Follow-up|1
7883502|NCT01782482|12383188|FG000|Overall Study|Adverse Event|2
7883503|NCT01782482|12383189|FG001|Overall Study|Adverse Event|1
7883504|NCT01782482|12383188|FG000|Overall Study|Lost to Follow-up|2
7883505|NCT01782482|12383189|FG001|Overall Study|Lost to Follow-up|3
7883506|NCT01782482|12383188|FG000|Overall Study|Physician Decision|1
7883507|NCT01782482|12383189|FG001|Overall Study|Physician Decision|0
7883508|NCT01782482|12383188|FG000|Overall Study|Protocol Violation|1
7883509|NCT01782482|12383189|FG001|Overall Study|Protocol Violation|0
7883510|NCT01782482|12383188|FG000|Overall Study|Withdrawal by Subject|2
7883511|NCT01782482|12383189|FG001|Overall Study|Withdrawal by Subject|3
7883512|NCT01782482|12383188|FG000|Overall Study|Randomized in Error|2
7883513|NCT01782482|12383189|FG001|Overall Study|Randomized in Error|2
7883514|NCT01782482|12383188|FG000|Overall Study|Habitually wearing toric lens OS|0
7883515|NCT01782482|12383189|FG001|Overall Study|Habitually wearing toric lens OS|1
7883516|NCT01782495|12383206|FG000|Overall Study|Adverse Event|0
7883517|NCT01782495|12383207|FG001|Overall Study|Adverse Event|0
7883518|NCT01782495|12383208|FG002|Overall Study|Adverse Event|0
7883519|NCT01782495|12383209|FG003|Overall Study|Adverse Event|0
7883520|NCT01782495|12383210|FG004|Overall Study|Adverse Event|0
7883521|NCT01782495|12383211|FG005|Overall Study|Adverse Event|0
7883522|NCT01782495|12383212|FG006|Overall Study|Adverse Event|0
7883523|NCT01782495|12383213|FG007|Overall Study|Adverse Event|2
7883524|NCT01782495|12383214|FG008|Overall Study|Adverse Event|0
7883525|NCT01782495|12383215|FG009|Overall Study|Adverse Event|0
7883526|NCT01782495|12383216|FG010|Overall Study|Adverse Event|0
7883527|NCT01782495|12383206|FG000|Overall Study|Withdrew Consent|0
7883528|NCT01782495|12383207|FG001|Overall Study|Withdrew Consent|1
7883529|NCT01782495|12383208|FG002|Overall Study|Withdrew Consent|0
7883530|NCT01782495|12383209|FG003|Overall Study|Withdrew Consent|0
7883531|NCT01782495|12383210|FG004|Overall Study|Withdrew Consent|0
7883532|NCT01782495|12383211|FG005|Overall Study|Withdrew Consent|0
7883533|NCT01782495|12383212|FG006|Overall Study|Withdrew Consent|0
7883534|NCT01782495|12383213|FG007|Overall Study|Withdrew Consent|1
7883535|NCT01782495|12383214|FG008|Overall Study|Withdrew Consent|0
7883536|NCT01782495|12383215|FG009|Overall Study|Withdrew Consent|0
7883537|NCT01782495|12383216|FG010|Overall Study|Withdrew Consent|0
7883538|NCT01782664|12383246|FG000|Overall Study|Adverse Event|2
7883539|NCT01782664|12383247|FG001|Overall Study|Adverse Event|2
7883540|NCT01782664|12383248|FG002|Overall Study|Adverse Event|2
7883541|NCT01782664|12383249|FG003|Overall Study|Adverse Event|2
7883542|NCT01782664|12383250|FG004|Overall Study|Adverse Event|0
7883543|NCT01782664|12383251|FG005|Overall Study|Adverse Event|0
7883544|NCT01782664|12383246|FG000|Overall Study|Lack of Efficacy|2
7883545|NCT01782664|12383247|FG001|Overall Study|Lack of Efficacy|0
7883546|NCT01782664|12383248|FG002|Overall Study|Lack of Efficacy|2
7883547|NCT01782664|12383249|FG003|Overall Study|Lack of Efficacy|2
7883548|NCT01782664|12383250|FG004|Overall Study|Lack of Efficacy|0
7883549|NCT01782664|12383251|FG005|Overall Study|Lack of Efficacy|0
7883550|NCT01782664|12383246|FG000|Overall Study|Protocol Violation|0
7883551|NCT01782664|12383247|FG001|Overall Study|Protocol Violation|1
7883552|NCT01782664|12383248|FG002|Overall Study|Protocol Violation|0
7883553|NCT01782664|12383249|FG003|Overall Study|Protocol Violation|1
7883554|NCT01782664|12383250|FG004|Overall Study|Protocol Violation|0
7883555|NCT01782664|12383251|FG005|Overall Study|Protocol Violation|0
7883556|NCT01782664|12383246|FG000|Overall Study|Withdrawal by Subject|2
7883557|NCT01782664|12383247|FG001|Overall Study|Withdrawal by Subject|2
7883558|NCT01782664|12383248|FG002|Overall Study|Withdrawal by Subject|0
7883559|NCT01782664|12383249|FG003|Overall Study|Withdrawal by Subject|0
7883560|NCT01782664|12383250|FG004|Overall Study|Withdrawal by Subject|0
7883561|NCT01782664|12383251|FG005|Overall Study|Withdrawal by Subject|0
7883562|NCT01782690|12383265|FG000|Overall Study|Not reported|7
7883563|NCT01782690|12383265|FG000|Overall Study|Toxicity of gemcitabine|1
7883564|NCT01782690|12383265|FG000|Overall Study|Toxicity of erlotinib|1
7883565|NCT01782690|12383265|FG000|Overall Study|Lost to Follow-up|31
7883566|NCT01782690|12383265|FG000|Overall Study|Withdrawal of informed consent|2
7883567|NCT01782690|12383265|FG000|Overall Study|Absent rash|9
7883568|NCT01782690|12383265|FG000|Overall Study|Physician Decision|13
7883569|NCT01782690|12383265|FG000|Overall Study|Patient's wish|21
7883570|NCT01782690|12383265|FG000|Overall Study|Tumor progression|74
7883571|NCT01782690|12383265|FG000|Overall Study|Death|133
7883572|NCT01782690|12383265|FG000|Overall Study|Study completion unknown|7
7883573|NCT01782742|12383271|FG000|Double-blind Treatment Phase|Adverse Event|1
7883574|NCT01782742|12383272|FG001|Double-blind Treatment Phase|Adverse Event|0
7883575|NCT01782859|12383286|FG000|Overall Study|Protocol Violation|6
7883576|NCT01782859|12383287|FG001|Overall Study|Protocol Violation|6
7883577|NCT01782859|12383286|FG000|Overall Study|Withdrawal by Subject|0
7883578|NCT01782859|12383287|FG001|Overall Study|Withdrawal by Subject|1
7883579|NCT01782872|12383298|FG000|Overall Study|Protocol Violation|0
7883612|NCT01783444|12383366|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7
7883613|NCT01783444|12383367|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8
7883614|NCT01783444|12383368|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11
7883615|NCT01783444|12383366|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9
7883616|NCT01783444|12383367|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7
7883617|NCT01783444|12383368|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5
7883618|NCT01783444|12383366|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4
7883619|NCT01783444|12383367|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
7883620|NCT01783444|12383368|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
7883621|NCT01783444|12383366|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
7883622|NCT01783444|12383367|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1
7883623|NCT01783444|12383368|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
7883624|NCT01783444|12383366|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7
7883625|NCT01783444|12383367|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16
7883626|NCT01783444|12383368|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15
7883627|NCT01783444|12383366|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69
7883628|NCT01783444|12383367|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53
7883629|NCT01783444|12383368|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52
7883630|NCT01783483|12383387|FG000|Overall Study|Death|3
7883631|NCT01783483|12383388|FG001|Overall Study|Death|3
7883632|NCT01783483|12383387|FG000|Overall Study|Lost to Follow-up|14
7883633|NCT01783483|12383388|FG001|Overall Study|Lost to Follow-up|10
7883634|NCT01783483|12383387|FG000|Overall Study|Withdrawal by Subject|2
7883635|NCT01783483|12383388|FG001|Overall Study|Withdrawal by Subject|1
7883636|NCT01783483|12383387|FG000|Overall Study|Physician Decision|1
7883637|NCT01783483|12383388|FG001|Overall Study|Physician Decision|1
7883638|NCT01783496|12383400|FG000|Overall Study|Lost to Follow-up|0
7883639|NCT01783496|12383401|FG001|Overall Study|Lost to Follow-up|0
7883640|NCT01783496|12383402|FG002|Overall Study|Lost to Follow-up|0
7883641|NCT01783496|12383403|FG003|Overall Study|Lost to Follow-up|2
7883642|NCT01783496|12383404|FG004|Overall Study|Lost to Follow-up|0
7883643|NCT01783496|12383405|FG005|Overall Study|Lost to Follow-up|1
7883644|NCT01783496|12383400|FG000|Overall Study|Withdrawal by Subject|1
7883645|NCT01783496|12383401|FG001|Overall Study|Withdrawal by Subject|0
7883646|NCT01783496|12383402|FG002|Overall Study|Withdrawal by Subject|0
7883647|NCT01783496|12383403|FG003|Overall Study|Withdrawal by Subject|0
7883648|NCT01783496|12383404|FG004|Overall Study|Withdrawal by Subject|0
7883649|NCT01783496|12383405|FG005|Overall Study|Withdrawal by Subject|0
